id|nct_id|mesh_term|downcase_mesh_term|mesh_type
139086791|NCT03610438|Immunotoxins|immunotoxins|mesh-ancestor
139216835|NCT01367028|Bevacizumab|bevacizumab|mesh-list
139086996|NCT02527772|Leucovorin|leucovorin|mesh-list
139087149|NCT01148576|Vitamin E|vitamin e|mesh-list
139217296|NCT01344681|Micafungin|micafungin|mesh-list
139217369|NCT01360710|Irbesartan|irbesartan|mesh-list
139217510|NCT01369602|Vitamins|vitamins|mesh-ancestor
139217733|NCT03004131|Xhance|xhance|mesh-list
139218027|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139088186|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
139218401|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218479|NCT02453464|Antidotes|antidotes|mesh-ancestor
139218628|NCT03232450|Aspirin|aspirin|mesh-list
139218702|NCT03228238|Protective Agents|protective agents|mesh-ancestor
139218929|NCT02450968|Dexamethasone|dexamethasone|mesh-list
139219007|NCT03210766|Nabilone|nabilone|mesh-list
139219191|NCT03208894|Furosemide|furosemide|mesh-list
139089380|NCT01063127|Insulin|insulin|mesh-list
139090057|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
139176713|NCT01164709|Nelfinavir|nelfinavir|mesh-list
139220206|NCT02444260|Lidocaine|lidocaine|mesh-list
139220289|NCT03746249|Antibodies|antibodies|mesh-list
139221108|NCT03715699|Hormones|hormones|mesh-ancestor
139091248|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
139221342|NCT04620252|Antacids|antacids|mesh-ancestor
139221486|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
139221565|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
139091780|NCT04007055|Ticagrelor|ticagrelor|mesh-list
139222085|NCT00702520|Hormones|hormones|mesh-list
139179041|NCT00002651|Goserelin|goserelin|mesh-list
139092667|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139222678|NCT03439670|Hormones|hormones|mesh-ancestor
139092818|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
139222931|NCT02417506|Ibuprofen|ibuprofen|mesh-list
139093196|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
139223283|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
139223809|NCT02407834|Eusol|eusol|mesh-list
139094022|NCT03978845|Lidocaine|lidocaine|mesh-list
139224028|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224102|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224103|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
139224104|NCT03631355|Coagulants|coagulants|mesh-ancestor
139224111|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
139224112|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139224113|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224177|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139094407|NCT04472494|Abatacept|abatacept|mesh-list
139224773|NCT02393482|Antacids|antacids|mesh-ancestor
139224849|NCT02696434|Naltrexone|naltrexone|mesh-list
139094994|NCT03955458|Bupivacaine|bupivacaine|mesh-list
139095146|NCT01060787|Hormones|hormones|mesh-ancestor
139095220|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
139225527|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
139095664|NCT03175120|Hormones|hormones|mesh-ancestor
139225755|NCT03387852|Fluticasone|fluticasone|mesh-list
139225828|NCT03164512|Cannabidiol|cannabidiol|mesh-list
139096293|NCT00282347|Prednisone|prednisone|mesh-list
139226509|NCT05675644|Drospirenone|drospirenone|mesh-list
139226592|NCT03639545|Metformin|metformin|mesh-list
139096948|NCT01303094|Trabectedin|trabectedin|mesh-list
139227759|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
139228151|NCT03464292|Capsaicin|capsaicin|mesh-list
139185165|NCT03792217|Eusol|eusol|mesh-list
139228686|NCT04498286|Antibodies|antibodies|mesh-list
139228928|NCT03158090|Octreotide|octreotide|mesh-list
139228988|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
139091668|NCT04370301|Fludarabine|fludarabine|mesh-list
139230060|NCT02370550|Antacids|antacids|mesh-ancestor
139230448|NCT03085914|Antidotes|antidotes|mesh-ancestor
139230512|NCT03112564|Fentanyl|fentanyl|mesh-list
139100693|NCT04551040|Terazosin|terazosin|mesh-list
139231627|NCT02343718|Sirolimus|sirolimus|mesh-list
139231775|NCT04824274|Narcotics|narcotics|mesh-ancestor
139232371|NCT02329054|Favipiravir|favipiravir|mesh-list
139102563|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
139232695|NCT01065350|Ketamine|ketamine|mesh-list
139232742|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139232743|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
139232744|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139232745|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139232746|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
139232747|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139232748|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
139232749|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232822|NCT02327416|Entecavir|entecavir|mesh-list
139103154|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233189|NCT03427619|Picibanil|picibanil|mesh-list
139233337|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139233410|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139103681|NCT01122966|Bevacizumab|bevacizumab|mesh-list
139233880|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
139104346|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
139234560|NCT00659646|Ofloxacin|ofloxacin|mesh-list
139234709|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
139234776|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
139234930|NCT01182727|Analgesics|analgesics|mesh-ancestor
139235220|NCT03626298|Niacin|niacin|mesh-list
139235710|NCT03532555|Zinc|zinc|mesh-list
139235823|NCT05681429|Anesthetics|anesthetics|mesh-ancestor
139105983|NCT05765604|Vaccines|vaccines|mesh-list
139106803|NCT04415476|Hormones|hormones|mesh-ancestor
139106951|NCT04119037|Analgesics|analgesics|mesh-ancestor
139107044|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
139107261|NCT03510884|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139107859|NCT00861068|Lacosamide|lacosamide|mesh-list
139108159|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
139108313|NCT04349124|Nifedipine|nifedipine|mesh-list
139108457|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
139108533|NCT01257139|Docetaxel|docetaxel|mesh-list
139108607|NCT01329666|Vitamin D|vitamin d|mesh-list
139238510|NCT03023046|Dasatinib|dasatinib|mesh-list
139108831|NCT00160667|Brivaracetam|brivaracetam|mesh-list
139239264|NCT05383820|Ketorolac|ketorolac|mesh-list
139109430|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139109957|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
139240090|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
139110521|NCT04631510|Gabapentin|gabapentin|mesh-list
139091622|NCT04381936|Autonomic Agents|autonomic agents|mesh-ancestor
139110749|NCT02759185|Hormones|hormones|mesh-ancestor
139110897|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
139241213|NCT04053972|Lenvatinib|lenvatinib|mesh-list
139241289|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
139111723|NCT01266174|Eltoprazine|eltoprazine|mesh-list
139111869|NCT01162824|Adenosine|adenosine|mesh-list
139242036|NCT03579758|Gemcitabine|gemcitabine|mesh-list
139242114|NCT02849171|Choline|choline|mesh-list
139112638|NCT05625347|Aspirin|aspirin|mesh-list
139242787|NCT00092209|Losartan|losartan|mesh-list
139243007|NCT02847494|Prednisolone|prednisolone|mesh-list
139243386|NCT01337323|Fluticasone|fluticasone|mesh-list
139243531|NCT01342939|Incretins|incretins|mesh-list
139243620|NCT05708534|Abatacept|abatacept|mesh-list
139113820|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
139243754|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139113966|NCT01176318|Expectorants|expectorants|mesh-ancestor
139244354|NCT02035982|Donepezil|donepezil|mesh-list
139244513|NCT01854385|Sumatriptan|sumatriptan|mesh-list
139114871|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
139244869|NCT01336595|Cobalt|cobalt|mesh-list
139115035|NCT01294956|Laxatives|laxatives|mesh-ancestor
139244876|NCT01336595|Hormones|hormones|mesh-ancestor
139245022|NCT01341743|Entecavir|entecavir|mesh-list
139245096|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245467|NCT02062190|Resveratrol|resveratrol|mesh-list
139115852|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
139116010|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
139246074|NCT01343303|Naproxen|naproxen|mesh-list
139246966|NCT04550455|Cladribine|cladribine|mesh-list
139247046|NCT02961881|Blinatumomab|blinatumomab|mesh-list
139117277|NCT05688384|Alfentanil|alfentanil|mesh-list
139247284|NCT01358045|Calcitriol|calcitriol|mesh-list
139117741|NCT05211622|Vitamins|vitamins|mesh-ancestor
139117880|NCT03768882|Acetaminophen|acetaminophen|mesh-list
139118339|NCT04236258|Enalapril|enalapril|mesh-list
139248246|NCT02091908|Lactitol|lactitol|mesh-list
139118806|NCT04495374|Pregabalin|pregabalin|mesh-list
139119030|NCT04139018|Timolol|timolol|mesh-list
139119244|NCT04439214|Nivolumab|nivolumab|mesh-list
139091626|NCT04381936|Hormones|hormones|mesh-ancestor
139249247|NCT05656131|Fluzoparib|fluzoparib|mesh-list
139249323|NCT04988425|Prednisolone|prednisolone|mesh-list
139119999|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
139120375|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
139250290|NCT02035488|Tobramycin|tobramycin|mesh-list
139250291|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139250292|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250293|NCT03602430|Vitamin D|vitamin d|mesh-list
139250517|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
139251502|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
139252175|NCT03602898|Fludarabine|fludarabine|mesh-list
139122625|NCT03702946|Oxytocin|oxytocin|mesh-list
139252550|NCT02138552|Octenidine|octenidine|mesh-list
139252855|NCT02135354|Azithromycin|azithromycin|mesh-list
139252927|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139123296|NCT03028012|Hormones|hormones|mesh-ancestor
139253307|NCT05417893|Sirolimus|sirolimus|mesh-list
139253539|NCT05575544|Morphine|morphine|mesh-list
139254583|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
139254584|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139254585|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
139254586|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254587|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254588|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
139254660|NCT04544267|Vaccines|vaccines|mesh-list
139254737|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
139254809|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139254877|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
139125127|NCT03444584|Metformin|metformin|mesh-list
139255254|NCT05330364|Immunologic Factors|immunologic factors|mesh-ancestor
139091714|NCT04270019|Laxatives|laxatives|mesh-ancestor
139255401|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125703|NCT04562441|Avelumab|avelumab|mesh-list
139125924|NCT02748564|Aldesleukin|aldesleukin|mesh-list
139255920|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139126308|NCT01096329|Testosterone|testosterone|mesh-list
139256663|NCT00446225|Gemcitabine|gemcitabine|mesh-list
139256811|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139127285|NCT01209429|Hormones|hormones|mesh-list
139127354|NCT03941925|Levan|levan|mesh-list
139257187|NCT05757999|Magnesium Sulfate|magnesium sulfate|mesh-list
139257331|NCT04901377|Dienogest|dienogest|mesh-list
139127602|NCT01211457|Decitabine|decitabine|mesh-list
139257630|NCT03347292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257631|NCT03182426|Liraglutide|liraglutide|mesh-list
139257632|NCT03182426|Plerixafor|plerixafor|mesh-list
139257710|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139257711|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139257714|NCT02694978|Hematinics|hematinics|mesh-ancestor
139258009|NCT02151968|Anesthetics|anesthetics|mesh-list
139258083|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139258084|NCT01307423|Growth Substances|growth substances|mesh-ancestor
139258085|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
139258086|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258098|NCT02156336|Ranolazine|ranolazine|mesh-list
139258099|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139258100|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139258101|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258102|NCT03542240|Curcumin|curcumin|mesh-list
139258103|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139258104|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139258535|NCT04401709|Gemcitabine|gemcitabine|mesh-list
139091716|NCT04239703|Antibodies|antibodies|mesh-list
139258726|NCT00911547|Hormones|hormones|mesh-ancestor
139258829|NCT00898677|Rizatriptan|rizatriptan|mesh-list
139129088|NCT03643666|Hormones|hormones|mesh-ancestor
139129307|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139259123|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139259124|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139259125|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
139259126|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
139259127|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259128|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139259129|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139259130|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259169|NCT04050735|Ethanol|ethanol|mesh-list
139259200|NCT03625011|Gabapentin|gabapentin|mesh-list
139259876|NCT03502031|Diuretics|diuretics|mesh-ancestor
139130358|NCT01237275|Sertraline|sertraline|mesh-list
139260476|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139130886|NCT04125550|Propofol|propofol|mesh-list
139260783|NCT03688659|Vancomycin|vancomycin|mesh-list
139260853|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
139260999|NCT03682497|Diuretics|diuretics|mesh-ancestor
139261074|NCT02186366|Buspirone|buspirone|mesh-list
139131574|NCT02523820|Xhance|xhance|mesh-list
139261753|NCT03675555|Hormones|hormones|mesh-ancestor
139261804|NCT02060604|Ketorolac|ketorolac|mesh-list
139262030|NCT02195492|Hylan|hylan|mesh-list
139262632|NCT02207660|Fluorouracil|fluorouracil|mesh-list
139263155|NCT02205554|Analgesics|analgesics|mesh-ancestor
139263612|NCT02220218|Metformin|metformin|mesh-list
139263755|NCT02075112|Genistein|genistein|mesh-list
139263851|NCT02226926|Aspirin|aspirin|mesh-list
139264206|NCT05761327|Antioxidants|antioxidants|mesh-ancestor
139264433|NCT03881852|Reboxetine|reboxetine|mesh-list
139264578|NCT02235428|Bromides|bromides|mesh-list
139264892|NCT02264834|Dsuvia|dsuvia|mesh-list
139135155|NCT03862287|Lidocaine|lidocaine|mesh-list
139265089|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
139265835|NCT05893797|TEMPO|tempo|mesh-list
139266052|NCT05619289|Ergocalciferols|ergocalciferols|mesh-list
139266053|NCT05619289|Vitamins|vitamins|mesh-ancestor
139266054|NCT05619289|Micronutrients|micronutrients|mesh-ancestor
139266132|NCT05462730|Antiemetics|antiemetics|mesh-ancestor
139266809|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
139137180|NCT01295151|Adalimumab|adalimumab|mesh-list
139137561|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
139137710|NCT01199367|Letrozole|letrozole|mesh-list
139267633|NCT02092038|Temozolomide|temozolomide|mesh-list
139267711|NCT02783404|Amoxicillin|amoxicillin|mesh-list
139267935|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
139268015|NCT05624840|Ritonavir|ritonavir|mesh-list
139268159|NCT01468831|Minocycline|minocycline|mesh-list
139268233|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
139268466|NCT01000922|Insulin|insulin|mesh-list
139138910|NCT02049190|Onapristone|onapristone|mesh-list
139268909|NCT03664869|Mitomycins|mitomycins|mesh-list
139139221|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
139269196|NCT00835484|Cefdinir|cefdinir|mesh-list
139269350|NCT05198531|Gemcitabine|gemcitabine|mesh-list
139269430|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
139269566|NCT00830102|Xhance|xhance|mesh-list
139269944|NCT05116228|Rituximab|rituximab|mesh-list
139270100|NCT02281292|Ranibizumab|ranibizumab|mesh-list
139270694|NCT00427856|Rituximab|rituximab|mesh-list
139271146|NCT02285972|Tenoxicam|tenoxicam|mesh-list
139271369|NCT02283320|Docetaxel|docetaxel|mesh-list
139142296|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
139142372|NCT02096224|Desflurane|desflurane|mesh-list
139272321|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
139272396|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139272621|NCT05125588|Analgesics|analgesics|mesh-ancestor
139142982|NCT03258710|Tenofovir|tenofovir|mesh-list
139272918|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273672|NCT05724056|Viscosupplements|viscosupplements|mesh-ancestor
139273749|NCT05723900|Castor Oil|castor oil|mesh-list
139273967|NCT00127634|Insulin|insulin|mesh-list
139144330|NCT06065176|Vaccines|vaccines|mesh-list
139274521|NCT02129400|Xenon|xenon|mesh-list
139275011|NCT04742348|Levodopa|levodopa|mesh-list
139275062|NCT05479578|Dexamethasone|dexamethasone|mesh-list
139091719|NCT04224987|Azithromycin|azithromycin|mesh-list
139275279|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
139275408|NCT04671355|Xhance|xhance|mesh-list
139145758|NCT01844986|Olaparib|olaparib|mesh-list
139145902|NCT02131948|Insulin|insulin|mesh-list
139276167|NCT04504331|Tamoxifen|tamoxifen|mesh-list
139276240|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139276241|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139276242|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
139276243|NCT04060030|Leucovorin|leucovorin|mesh-list
139276244|NCT04060030|Calcium|calcium|mesh-list
139276245|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
139276246|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139276249|NCT04060030|Antidotes|antidotes|mesh-ancestor
139146523|NCT03549832|Ritonavir|ritonavir|mesh-list
139276833|NCT02959983|Eluxadoline|eluxadoline|mesh-list
139276984|NCT02297594|Ziresovir|ziresovir|mesh-list
139277204|NCT05887505|Vitamin D|vitamin d|mesh-list
139091722|NCT04222972|Paclitaxel|paclitaxel|mesh-list
139277592|NCT03508726|Vitamins|vitamins|mesh-ancestor
139147847|NCT00121199|Prednisone|prednisone|mesh-list
139278109|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
139148606|NCT03730857|Olanzapine|olanzapine|mesh-list
139278486|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278487|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278488|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
139278489|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
139278490|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278491|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
139278492|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139278493|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
139278513|NCT03473977|Benralizumab|benralizumab|mesh-list
139278514|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139278515|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
139278516|NCT01361464|Tipifarnib|tipifarnib|mesh-list
139278517|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278518|NCT04051255|Metronidazole|metronidazole|mesh-list
139278519|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278520|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139278521|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139278652|NCT03098368|Rotigotine|rotigotine|mesh-list
139278863|NCT05045248|Apraclonidine|apraclonidine|mesh-list
139279388|NCT03499184|Metronidazole|metronidazole|mesh-list
139150023|NCT02184910|Gastrins|gastrins|mesh-list
139150176|NCT02190994|Prednisone|prednisone|mesh-list
139150246|NCT02256748|Midazolam|midazolam|mesh-list
139150557|NCT03534388|Eusol|eusol|mesh-list
139280582|NCT00104052|Ribavirin|ribavirin|mesh-list
139150919|NCT02221102|Analgesics|analgesics|mesh-ancestor
139281251|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151743|NCT01582997|Dabrafenib|dabrafenib|mesh-list
139151973|NCT02262598|Diuretics|diuretics|mesh-ancestor
139282098|NCT06058663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139282099|NCT06058663|Immunoglobulin G|immunoglobulin g|mesh-list
139282100|NCT06058663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282101|NCT06058663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282102|NCT06058663|Immunologic Factors|immunologic factors|mesh-ancestor
139282103|NCT06058663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282104|NCT06058663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282105|NCT06058663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282106|NCT06029127|Docetaxel|docetaxel|mesh-list
139282107|NCT06029127|Tislelizumab|tislelizumab|mesh-list
139282108|NCT06029127|Ramucirumab|ramucirumab|mesh-list
139282109|NCT06029127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282110|NCT06029127|Tubulin Modulators|tubulin modulators|mesh-ancestor
139282111|NCT06029127|Antimitotic Agents|antimitotic agents|mesh-ancestor
139282112|NCT06029127|Mitosis Modulators|mitosis modulators|mesh-ancestor
139152640|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
139152717|NCT01616524|Immunologic Factors|immunologic factors|mesh-ancestor
139282615|NCT05337137|Nivolumab|nivolumab|mesh-list
139282767|NCT05092412|Carboplatin|carboplatin|mesh-list
139282768|NCT05092412|Etoposide|etoposide|mesh-list
139282769|NCT05092412|Durvalumab|durvalumab|mesh-list
139283140|NCT04215978|Tislelizumab|tislelizumab|mesh-list
139283225|NCT03958474|Remifentanil|remifentanil|mesh-list
139091725|NCT04222972|Gemcitabine|gemcitabine|mesh-list
139284498|NCT06095141|Cisplatin|cisplatin|mesh-list
139154883|NCT01103635|Ipilimumab|ipilimumab|mesh-list
139284783|NCT05567731|Hormones|hormones|mesh-list
139284858|NCT05315999|Palonosetron|palonosetron|mesh-list
139284949|NCT05028075|Cobalt|cobalt|mesh-list
139285008|NCT04904302|Nivolumab|nivolumab|mesh-list
139285083|NCT04745949|Hormones|hormones|mesh-ancestor
139091727|NCT04222972|Pemetrexed|pemetrexed|mesh-list
139285453|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
139155778|NCT02281396|Vaccines|vaccines|mesh-list
139091728|NCT04222972|Pralsetinib|pralsetinib|mesh-list
139286304|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
138869942|NCT04173858|Naloxegol|naloxegol|mesh-list
139286695|NCT03539328|Paclitaxel|paclitaxel|mesh-list
139286758|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139286981|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138870891|NCT02651610|Taxane|taxane|mesh-list
139157587|NCT06216262|Propolis|propolis|mesh-list
139287658|NCT02174250|Rifampin|rifampin|mesh-list
139288251|NCT03940690|Bevacizumab|bevacizumab|mesh-list
139288849|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
139289720|NCT03624205|Paclitaxel|paclitaxel|mesh-list
139290332|NCT02225652|Epirubicin|epirubicin|mesh-list
139160692|NCT04467957|Xenon|xenon|mesh-list
139290853|NCT05826275|Pembrolizumab|pembrolizumab|mesh-list
139290854|NCT05826275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139290855|NCT05826275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290858|NCT05774249|Bupivacaine|bupivacaine|mesh-list
139291006|NCT05413096|Propolis|propolis|mesh-list
139291467|NCT01664910|Rituximab|rituximab|mesh-list
139291991|NCT03874286|Liver Extracts|liver extracts|mesh-list
139292221|NCT03473210|Hormones|hormones|mesh-ancestor
139292454|NCT03562533|Paclitaxel|paclitaxel|mesh-list
139292595|NCT03061006|Warfarin|warfarin|mesh-list
139292743|NCT04965532|Sevoflurane|sevoflurane|mesh-list
139292967|NCT05708625|Doxycycline|doxycycline|mesh-list
139293192|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
139293299|NCT04693715|RNS60|rns60|mesh-list
139293645|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
139164137|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
139164652|NCT06128434|Fluorides|fluorides|mesh-list
139165402|NCT03220022|Prednisone|prednisone|mesh-list
139295427|NCT04869046|Ibuprofen|ibuprofen|mesh-list
139295656|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165918|NCT05267366|Carboplatin|carboplatin|mesh-list
139166074|NCT04777071|Edetic Acid|edetic acid|mesh-list
139295956|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139166217|NCT04183101|Enalaprilat|enalaprilat|mesh-list
139166448|NCT03103152|Aspirin|aspirin|mesh-list
139296326|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
139296398|NCT05331690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139296476|NCT02235324|Antidotes|antidotes|mesh-ancestor
139166745|NCT03523390|Avelumab|avelumab|mesh-list
139296547|NCT04838080|Vaccines|vaccines|mesh-list
139296617|NCT06059547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296618|NCT06059547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139296619|NCT06059547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296620|NCT06059469|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139296628|NCT06059287|Metformin|metformin|mesh-list
139296773|NCT05903092|Carboplatin|carboplatin|mesh-list
139167044|NCT03132688|Propofol|propofol|mesh-list
139296844|NCT05752903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139296845|NCT05752903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296846|NCT05752903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296847|NCT05752903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139296848|NCT05752903|Analgesics|analgesics|mesh-ancestor
139296849|NCT05752903|Sensory System Agents|sensory system agents|mesh-ancestor
139296850|NCT05752903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296851|NCT05752903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139296852|NCT05752903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139296853|NCT05752903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139296854|NCT05752903|Adrenergic Agents|adrenergic agents|mesh-ancestor
139296855|NCT05752903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296859|NCT05752903|Anesthetics|anesthetics|mesh-ancestor
139296991|NCT05383495|Anesthetics, General|anesthetics, general|mesh-ancestor
139091733|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
139424051|NCT02223364|Bupivacaine|bupivacaine|mesh-list
139424127|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
139424213|NCT03494387|Vitamins|vitamins|mesh-ancestor
139424348|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
139424798|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
139425096|NCT01653158|Docetaxel|docetaxel|mesh-list
139425253|NCT03484091|Hylan|hylan|mesh-list
139425530|NCT04339049|Lidocaine|lidocaine|mesh-list
139425602|NCT03990077|Docetaxel|docetaxel|mesh-list
139425677|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
139426435|NCT04923659|Lorazepam|lorazepam|mesh-list
139426566|NCT05174845|Vitamins|vitamins|mesh-ancestor
139426884|NCT05096715|Atezolizumab|atezolizumab|mesh-list
139426962|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
139427335|NCT03443141|Vitamin E|vitamin e|mesh-list
139427562|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139428082|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
139428304|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
139428535|NCT03440359|Letrozole|letrozole|mesh-list
139428825|NCT03422419|Heparin|heparin|mesh-list
139429111|NCT03425929|Oxytocin|oxytocin|mesh-list
139429187|NCT00950989|Vitamins|vitamins|mesh-ancestor
139429359|NCT05116371|Estradiol|estradiol|mesh-list
139429492|NCT03411109|Hydromorphone|hydromorphone|mesh-list
139429943|NCT05168137|Colchicine|colchicine|mesh-list
139430015|NCT04435743|Growth Substances|growth substances|mesh-ancestor
139430161|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
139430263|NCT03392623|Niacin|niacin|mesh-list
139430763|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139430912|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431592|NCT04446091|Irinotecan|irinotecan|mesh-list
139432042|NCT04526353|Urological Agents|urological agents|mesh-ancestor
139432193|NCT02518789|Midazolam|midazolam|mesh-list
139432267|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139432415|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432563|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432564|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139432565|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139432566|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
139432567|NCT03366025|Progesterone|progesterone|mesh-list
139432568|NCT03366025|Progestins|progestins|mesh-ancestor
139432569|NCT03366025|Hormones|hormones|mesh-ancestor
139432570|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139432571|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432572|NCT05115591|Anesthetics|anesthetics|mesh-list
139432573|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432574|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432575|NCT05403099|Hyaluronic Acid|hyaluronic acid|mesh-list
139432576|NCT05403099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139432577|NCT05403099|Immunologic Factors|immunologic factors|mesh-ancestor
139432578|NCT05403099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432658|NCT02519335|Razoxane|razoxane|mesh-list
139432779|NCT04841499|Niacin|niacin|mesh-list
139432885|NCT05364619|Bismuth|bismuth|mesh-list
139433245|NCT03122665|Nefopam|nefopam|mesh-list
139433546|NCT04501783|Favipiravir|favipiravir|mesh-list
139433616|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
139433691|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
139433996|NCT05877846|Vitamin D|vitamin d|mesh-list
139434145|NCT05626920|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139434295|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139434446|NCT04781855|Nivolumab|nivolumab|mesh-list
139434671|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
139434672|NCT04245839|Fludarabine|fludarabine|mesh-list
139434673|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139434674|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
139434675|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434676|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139434677|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139434678|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
139434679|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434680|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434681|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139434682|NCT04239716|Anesthetics|anesthetics|mesh-list
139434683|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139434684|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434685|NCT04140487|Azacitidine|azacitidine|mesh-list
139434686|NCT04140487|Venetoclax|venetoclax|mesh-list
139434687|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139434688|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
139434689|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434690|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434691|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434749|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139434750|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139434752|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139434818|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139434819|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
139434820|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
139434821|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
139434822|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139434823|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434824|NCT04009343|Lumefantrine|lumefantrine|mesh-list
139434825|NCT04009343|Artemether|artemether|mesh-list
139434826|NCT04009343|Piperaquine|piperaquine|mesh-list
139434924|NCT03853395|Antibodies|antibodies|mesh-list
139434925|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
139434926|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434927|NCT03819660|Amifampridine|amifampridine|mesh-list
139434928|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139434929|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434930|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434931|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139434932|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139434933|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434934|NCT03818672|Rifaximin|rifaximin|mesh-list
139434935|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139434936|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434937|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139434938|NCT03792490|Fasudil|fasudil|mesh-list
139434939|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139434940|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139434941|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434942|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139434943|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434944|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
139434945|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139434946|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434947|NCT03771612|Naproxen|naproxen|mesh-list
139434948|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139434949|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139434950|NCT03771612|Analgesics|analgesics|mesh-ancestor
139435283|NCT01867606|Antibodies|antibodies|mesh-list
139435425|NCT05638399|Zoledronic Acid|zoledronic acid|mesh-list
139435426|NCT05638399|Denosumab|denosumab|mesh-list
139435427|NCT05638399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139435428|NCT05638399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435429|NCT02512471|Ropivacaine|ropivacaine|mesh-list
139435430|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
139435431|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
139435432|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139435433|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435434|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
139435435|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435436|NCT02507479|Thiotepa|thiotepa|mesh-list
139435437|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139435498|NCT01376167|Chloroquine|chloroquine|mesh-list
139435659|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
139435731|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
139436106|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139436275|NCT03120715|Heparin|heparin|mesh-list
139436335|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139436411|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
139436496|NCT03332719|Analgesics|analgesics|mesh-ancestor
139436704|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
139436782|NCT02487433|Tofacitinib|tofacitinib|mesh-list
139436941|NCT02490865|RNS60|rns60|mesh-list
139437621|NCT03099759|Vitamin D|vitamin d|mesh-list
139437695|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437994|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
139438074|NCT03174847|Diuretics|diuretics|mesh-ancestor
139438296|NCT03311425|Protective Agents|protective agents|mesh-ancestor
139438448|NCT05727163|Antidotes|antidotes|mesh-ancestor
139438920|NCT03294577|Docetaxel|docetaxel|mesh-list
139439358|NCT04527055|Antacids|antacids|mesh-ancestor
139439429|NCT03361397|Lidocaine|lidocaine|mesh-list
139439502|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
139439579|NCT03920527|Itraconazole|itraconazole|mesh-list
139439816|NCT03280849|Chitosan|chitosan|mesh-list
139440174|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440325|NCT05513807|Vasodilator Agents|vasodilator agents|mesh-ancestor
139440857|NCT04500743|Leuprolide|leuprolide|mesh-list
139441076|NCT03148613|Gasotransmitters|gasotransmitters|mesh-ancestor
139442407|NCT06055712|Cephalexin|cephalexin|mesh-list
139442558|NCT05688202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442559|NCT05688202|Sensory System Agents|sensory system agents|mesh-ancestor
139442560|NCT05688202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442561|NCT05688202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139442562|NCT05688202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139442563|NCT05688202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139442564|NCT05688202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139442565|NCT05688202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442566|NCT05688202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139442567|NCT05688202|Analgesics|analgesics|mesh-ancestor
139442644|NCT05401110|Osimertinib|osimertinib|mesh-list
139442729|NCT05258279|Carboplatin|carboplatin|mesh-list
139442861|NCT04673448|Niraparib|niraparib|mesh-list
139443110|NCT03998176|Tenofovir|tenofovir|mesh-list
139443170|NCT03884556|Paclitaxel|paclitaxel|mesh-list
139443622|NCT01929915|Fentanyl|fentanyl|mesh-list
139443776|NCT03334487|Hormones|hormones|mesh-ancestor
139443927|NCT05024877|Stanozolol|stanozolol|mesh-list
139444302|NCT05006469|Dexamethasone|dexamethasone|mesh-list
139444605|NCT02487407|Simendan|simendan|mesh-list
139444745|NCT03119623|Valsartan|valsartan|mesh-list
139445198|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
139445649|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
139445874|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446327|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
139446400|NCT03108833|Saruplase|saruplase|mesh-list
139446477|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
139446612|NCT03309215|Nickel|nickel|mesh-list
139446930|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
139446984|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139447056|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139447288|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
139447510|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
139447656|NCT04083963|Paclitaxel|paclitaxel|mesh-list
139447805|NCT00379041|Bleomycin|bleomycin|mesh-list
139447882|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
139448037|NCT01670721|Vitamins|vitamins|mesh-ancestor
139448126|NCT03290417|Vitamin D|vitamin d|mesh-list
139448261|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448333|NCT04971291|Bupropion|bupropion|mesh-list
139448408|NCT00777127|Analgesics|analgesics|mesh-ancestor
139448484|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
139449466|NCT04965051|Insulin|insulin|mesh-list
139450574|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451023|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139451024|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
139451025|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451026|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451027|NCT03047109|Protective Agents|protective agents|mesh-ancestor
139451028|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139451029|NCT03047265|Paclitaxel|paclitaxel|mesh-list
139451030|NCT03047265|Cisplatin|cisplatin|mesh-list
139451031|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139451037|NCT05256147|Ibuprofen|ibuprofen|mesh-list
139451108|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
139451478|NCT06210217|Dobutamine|dobutamine|mesh-list
139452298|NCT05224102|Faricimab|faricimab|mesh-list
139452518|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
139452670|NCT04564157|Nivolumab|nivolumab|mesh-list
139452764|NCT04390399|Vitamins|vitamins|mesh-ancestor
139453195|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
139453345|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
139453424|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
139453949|NCT02452151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454347|NCT03047733|Tacrolimus|tacrolimus|mesh-list
139454408|NCT02505581|Metronidazole|metronidazole|mesh-list
139454556|NCT03209219|Interferons|interferons|mesh-list
139454638|NCT04429191|Antibodies|antibodies|mesh-list
139454779|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139454929|NCT03040401|Analgesics|analgesics|mesh-ancestor
139455821|NCT02596971|Hormones|hormones|mesh-ancestor
139455972|NCT03231683|Analgesics|analgesics|mesh-ancestor
139456045|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139456273|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
139456507|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139456663|NCT02173054|Adapalene|adapalene|mesh-list
139456872|NCT04757740|Lidocaine|lidocaine|mesh-list
139456960|NCT02142712|Famotidine|famotidine|mesh-list
139457462|NCT05695287|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139457701|NCT02441933|Taxane|taxane|mesh-list
139457770|NCT03192059|Aspirin|aspirin|mesh-list
139458002|NCT02435459|Calcium|calcium|mesh-list
139458135|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139458208|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139458355|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
139458509|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458826|NCT02422121|RNS60|rns60|mesh-list
139458880|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
139459048|NCT02100670|Diclofenac|diclofenac|mesh-list
139459178|NCT02571777|Fluticasone|fluticasone|mesh-list
139459634|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139459786|NCT03175679|Interleukin-2|interleukin-2|mesh-list
139459938|NCT02067676|Antacids|antacids|mesh-ancestor
139460231|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139460459|NCT02564211|Hormones|hormones|mesh-ancestor
139460755|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139460832|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
139460987|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
139461662|NCT02542605|Erenumab|erenumab|mesh-list
139461952|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461953|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
139461954|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139461956|NCT02536833|Lorecivivint|lorecivivint|mesh-list
139462408|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139462557|NCT02381717|Narcotics|narcotics|mesh-ancestor
139462858|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139462943|NCT03959891|Letrozole|letrozole|mesh-list
139463008|NCT02369939|Mitomycins|mitomycins|mesh-list
139463306|NCT02769689|Hormones|hormones|mesh-ancestor
139463388|NCT03112577|Xhance|xhance|mesh-list
139463457|NCT02357849|Fluoxetine|fluoxetine|mesh-list
139463535|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
139463628|NCT02356445|Infliximab|infliximab|mesh-list
139463752|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463838|NCT02354027|Metformin|metformin|mesh-list
139463907|NCT03112187|Iron|iron|mesh-list
139463978|NCT02348333|Dotinurad|dotinurad|mesh-list
139464193|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
139464413|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139464494|NCT02331251|Paclitaxel|paclitaxel|mesh-list
139464711|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
139465006|NCT02440399|Analgesics|analgesics|mesh-ancestor
139465156|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466198|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
139466273|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
139466651|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
139466731|NCT02412085|Golimumab|golimumab|mesh-list
139466800|NCT02416765|Glucagon|glucagon|mesh-list
139466872|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
139467031|NCT03197207|Camphor|camphor|mesh-list
139467396|NCT01964716|Vaccines|vaccines|mesh-list
139467470|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467774|NCT04530539|Protective Agents|protective agents|mesh-ancestor
139468149|NCT02404051|Everolimus|everolimus|mesh-list
139468297|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
139468447|NCT02009878|Tolvaptan|tolvaptan|mesh-list
139468523|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468524|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468525|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139468526|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468528|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
139468763|NCT06121011|Miglustat|miglustat|mesh-list
139469129|NCT05497726|Bevacizumab|bevacizumab|mesh-list
139469200|NCT05445921|Anesthetics, Local|anesthetics, local|mesh-ancestor
139469349|NCT04979780|Tinzaparin|tinzaparin|mesh-list
139469350|NCT04979780|Dalteparin|dalteparin|mesh-list
139469351|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
139469352|NCT04979780|Anticoagulants|anticoagulants|mesh-list
139469353|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139469354|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139469355|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469356|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139469357|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
139469358|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139469359|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
139469360|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469361|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
139469362|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139469363|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
139469364|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469365|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469502|NCT04676646|Spironolactone|spironolactone|mesh-list
139469572|NCT04226365|Nortriptyline|nortriptyline|mesh-list
139469648|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
139469733|NCT03453931|Hormones|hormones|mesh-ancestor
139470320|NCT04255277|Hormones|hormones|mesh-ancestor
139470546|NCT01958476|Morphine|morphine|mesh-list
139470695|NCT05746351|Fentanyl|fentanyl|mesh-list
139470773|NCT05701423|Natalizumab|natalizumab|mesh-list
139470920|NCT04657939|Pioglitazone|pioglitazone|mesh-list
139470993|NCT01374451|Hormones|hormones|mesh-ancestor
139471068|NCT05128175|Levodopa|levodopa|mesh-list
139471287|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471435|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471511|NCT04637555|Valsartan|valsartan|mesh-list
139471588|NCT05900674|Reteplase|reteplase|mesh-list
139472040|NCT04588688|Mifepristone|mifepristone|mesh-list
139472119|NCT04281108|Xhance|xhance|mesh-list
139472257|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139472624|NCT05103215|Lidocaine|lidocaine|mesh-list
139472850|NCT02391883|Clopidogrel|clopidogrel|mesh-list
139473072|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
139473205|NCT01957150|Xhance|xhance|mesh-list
139473221|NCT01946152|Dexamethasone|dexamethasone|mesh-list
139473320|NCT01953328|Evolocumab|evolocumab|mesh-list
139473521|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139473991|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139474073|NCT05057663|Fluorouracil|fluorouracil|mesh-list
139474828|NCT01949116|Vitamins|vitamins|mesh-ancestor
139474969|NCT02350231|Hormones|hormones|mesh-ancestor
139475346|NCT02343289|Esketamine|esketamine|mesh-list
139475490|NCT05991622|Rilpivirine|rilpivirine|mesh-list
139475862|NCT05222191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139476170|NCT04071457|Lenalidomide|lenalidomide|mesh-list
139476312|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
139476388|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139477431|NCT05207709|Paclitaxel|paclitaxel|mesh-list
139477505|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
139478041|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
139478270|NCT04047472|Aflibercept|aflibercept|mesh-list
139478342|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478490|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478491|NCT03593655|Tenofovir|tenofovir|mesh-list
139478492|NCT03593655|Emtricitabine|emtricitabine|mesh-list
139478493|NCT03593655|Dapivirine|dapivirine|mesh-list
139478494|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
139478495|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478496|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139478793|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139478794|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478795|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
139479097|NCT00675922|Mafenide|mafenide|mesh-list
139479242|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
139479402|NCT00003237|Paclitaxel|paclitaxel|mesh-list
139479702|NCT04509973|Hormones|hormones|mesh-ancestor
139479993|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
139480224|NCT05076955|Vancomycin|vancomycin|mesh-list
139480900|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
139480977|NCT04988789|Paclitaxel|paclitaxel|mesh-list
139481051|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139481273|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481496|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139481876|NCT02819479|Diuretics|diuretics|mesh-ancestor
139481958|NCT04262869|Paclitaxel|paclitaxel|mesh-list
139482100|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139482122|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
139482123|NCT03493061|Irinotecan|irinotecan|mesh-list
139482124|NCT03493061|Floxuridine|floxuridine|mesh-list
139482125|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482126|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139482127|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139482128|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482129|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482130|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139482131|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
139482132|NCT04523935|Topiramate|topiramate|mesh-list
139482133|NCT04523935|Lamotrigine|lamotrigine|mesh-list
139482134|NCT04523935|Diazepam|diazepam|mesh-list
139482135|NCT04523935|Gabapentin|gabapentin|mesh-list
139482136|NCT04523935|Amitriptyline|amitriptyline|mesh-list
139482137|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
139482138|NCT04523935|Clonazepam|clonazepam|mesh-list
139482139|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
139482140|NCT04523935|Baclofen|baclofen|mesh-list
139482141|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
139482142|NCT04523935|Analgesics|analgesics|mesh-ancestor
139482143|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
139482186|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
139482257|NCT01618708|Hylan|hylan|mesh-list
139482695|NCT02660281|Mesna|mesna|mesh-list
139482856|NCT04964219|Ketamine|ketamine|mesh-list
139483016|NCT03060785|Tenofovir|tenofovir|mesh-list
139483234|NCT04942769|Selenium|selenium|mesh-list
139483385|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139484063|NCT04911413|Coagulants|coagulants|mesh-ancestor
139484141|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
139484361|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
139485162|NCT03047837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139485311|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139485507|NCT02455141|Taxane|taxane|mesh-list
139485685|NCT04847687|Prednisolone|prednisolone|mesh-list
139485836|NCT05244811|Hormones|hormones|mesh-ancestor
139485837|NCT05244811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139485838|NCT05244811|Estrogens|estrogens|mesh-ancestor
139485848|NCT02710669|Propafenone|propafenone|mesh-list
139485849|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139485850|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139485851|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139485852|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139486149|NCT04622917|Hormones|hormones|mesh-ancestor
139486288|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486590|NCT05046457|Provitamins|provitamins|mesh-ancestor
139486972|NCT04814069|Tislelizumab|tislelizumab|mesh-list
139487090|NCT05028049|Dsuvia|dsuvia|mesh-list
139487189|NCT05021887|Xhance|xhance|mesh-list
139487629|NCT05347173|Dexmedetomidine|dexmedetomidine|mesh-list
139488002|NCT06147518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488457|NCT05223582|Fluzoparib|fluzoparib|mesh-list
139488531|NCT04976855|Naloxone|naloxone|mesh-list
139488685|NCT04705415|Niclosamide|niclosamide|mesh-list
139488988|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139489140|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139489141|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139489142|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139489143|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
139489144|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
139489145|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
139489146|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139489147|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139489148|NCT03396276|Narcotics|narcotics|mesh-ancestor
139489151|NCT03396276|Analgesics|analgesics|mesh-ancestor
139489215|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
139489307|NCT02870920|Durvalumab|durvalumab|mesh-list
139489434|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139489508|NCT02638129|Naltrexone|naltrexone|mesh-list
139489732|NCT03072121|Aspirin|aspirin|mesh-list
139490033|NCT04785911|Histamine|histamine|mesh-list
139490261|NCT05445791|Metformin|metformin|mesh-list
139490408|NCT05176821|Amoxicillin|amoxicillin|mesh-list
139490488|NCT05611463|Docetaxel|docetaxel|mesh-list
139490705|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
139490854|NCT05054361|Mannitol|mannitol|mesh-list
139491384|NCT03063073|Analgesics|analgesics|mesh-ancestor
139491541|NCT01665599|Hormones|hormones|mesh-ancestor
139491621|NCT04977427|Hormones|hormones|mesh-ancestor
139491755|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
139491912|NCT05697185|Evolocumab|evolocumab|mesh-list
139492055|NCT02500641|Febuxostat|febuxostat|mesh-list
139492227|NCT04959721|Hormones|hormones|mesh-ancestor
139492280|NCT01664039|Bimatoprost|bimatoprost|mesh-list
139492581|NCT04946383|Quercetin|quercetin|mesh-list
139492806|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139492956|NCT03056599|Aldesleukin|aldesleukin|mesh-list
139493108|NCT02495883|Ethanol|ethanol|mesh-list
139493333|NCT04901065|Lidocaine|lidocaine|mesh-list
139493408|NCT04393207|Dexamethasone|dexamethasone|mesh-list
139493789|NCT02417961|Benralizumab|benralizumab|mesh-list
139493934|NCT04884919|Chitosan|chitosan|mesh-list
139494086|NCT03946891|Furosemide|furosemide|mesh-list
139494161|NCT05216575|Almitrine|almitrine|mesh-list
139494313|NCT04622735|Analgesics|analgesics|mesh-ancestor
139494462|NCT04872985|Epirubicin|epirubicin|mesh-list
139494536|NCT05506319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495366|NCT04831255|Hormones|hormones|mesh-ancestor
139495424|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495500|NCT04831099|Hormones|hormones|mesh-ancestor
139495740|NCT02604199|Tenofovir|tenofovir|mesh-list
139495800|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
139495945|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496244|NCT05188339|Heparin|heparin|mesh-list
139496697|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139496996|NCT05866614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139497144|NCT05379972|Pembrolizumab|pembrolizumab|mesh-list
139497238|NCT04074161|Hormones|hormones|mesh-ancestor
139497296|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497489|NCT05533255|Z 350|z 350|mesh-list
139497671|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
139497817|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
139497893|NCT05520853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498039|NCT05506501|Anesthetics|anesthetics|mesh-list
139498268|NCT02563561|Apaziquone|apaziquone|mesh-list
139498834|NCT04577963|Tislelizumab|tislelizumab|mesh-list
139498972|NCT01174199|Sirolimus|sirolimus|mesh-list
139499274|NCT05485259|Vitamins|vitamins|mesh-ancestor
139499790|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
139500242|NCT01607905|Acetaminophen|acetaminophen|mesh-list
139500607|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
139500679|NCT05225155|Enoxaparin|enoxaparin|mesh-list
139500751|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139500903|NCT04983121|Antibodies|antibodies|mesh-list
139500976|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
139501053|NCT02289417|Apremilast|apremilast|mesh-list
139501124|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501352|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139501428|NCT02493517|Lanreotide|lanreotide|mesh-list
139501506|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
139502187|NCT02263365|Loperamide|loperamide|mesh-list
139502252|NCT02256969|Emollients|emollients|mesh-ancestor
139502323|NCT02254551|Bortezomib|bortezomib|mesh-list
139502846|NCT04435431|Mesdopetam|mesdopetam|mesh-list
139503379|NCT02396953|Lanreotide|lanreotide|mesh-list
139503514|NCT02391337|Bisoprolol|bisoprolol|mesh-list
139504047|NCT02337907|Donepezil|donepezil|mesh-list
139505252|NCT05178485|Hormones|hormones|mesh-ancestor
139505336|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
139505866|NCT02047227|Hormones|hormones|mesh-ancestor
139505970|NCT02101359|Tetracaine|tetracaine|mesh-list
139506296|NCT01903252|Mesalamine|mesalamine|mesh-list
139506363|NCT02499575|Bupivacaine|bupivacaine|mesh-list
139506829|NCT02473913|Silymarin|silymarin|mesh-list
139506965|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
139507489|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
139507714|NCT02349295|Ixekizumab|ixekizumab|mesh-list
139507790|NCT02280421|Cyclosporine|cyclosporine|mesh-list
139507864|NCT02358668|PAZ320|paz320|mesh-list
139507931|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
139508610|NCT02087943|Thalidomide|thalidomide|mesh-list
139508905|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509055|NCT04726618|Xenon|xenon|mesh-list
139509502|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
139510178|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
139510442|NCT02311478|Copper|copper|mesh-list
139510930|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
139511003|NCT02003391|Timolol|timolol|mesh-list
139511090|NCT01763164|Dacarbazine|dacarbazine|mesh-list
139511224|NCT01999335|Pomalidomide|pomalidomide|mesh-list
139511324|NCT01729156|Metformin|metformin|mesh-list
139511681|NCT05552196|Carbamazepine|carbamazepine|mesh-list
139511822|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
139511972|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
139512126|NCT02782949|Curcumin|curcumin|mesh-list
139512200|NCT01983462|Clonidine|clonidine|mesh-list
139512275|NCT00565851|Antibodies|antibodies|mesh-list
139512352|NCT05652517|Ethanol|ethanol|mesh-list
139512431|NCT01945593|BAX 855|bax 855|mesh-list
139512731|NCT02740699|Atorvastatin|atorvastatin|mesh-list
139513170|NCT02249767|Tretinoin|tretinoin|mesh-list
139513250|NCT04745689|Etoposide|etoposide|mesh-list
139513391|NCT01646255|Rotigotine|rotigotine|mesh-list
139513543|NCT01750840|Cimetidine|cimetidine|mesh-list
139513993|NCT02298179|Antacids|antacids|mesh-ancestor
139514141|NCT02257385|Albuterol|albuterol|mesh-list
139514220|NCT04865237|Remdesivir|remdesivir|mesh-list
139514292|NCT02289833|Trastuzumab|trastuzumab|mesh-list
139514441|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
139514593|NCT01738594|Romidepsin|romidepsin|mesh-list
139514663|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514820|NCT05345678|Durvalumab|durvalumab|mesh-list
139514969|NCT04178642|Idarubicin|idarubicin|mesh-list
139515190|NCT05651750|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139515260|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515482|NCT01975064|Sevoflurane|sevoflurane|mesh-list
139515713|NCT01691482|Albuterol|albuterol|mesh-list
139515781|NCT04619979|Anesthetics|anesthetics|mesh-list
139516003|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
139516316|NCT01568866|Bortezomib|bortezomib|mesh-list
139516385|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
139516683|NCT02231918|Pramipexole|pramipexole|mesh-list
139516760|NCT04660643|Incretins|incretins|mesh-ancestor
139516988|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
139517219|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
139517380|NCT02161718|Olanzapine|olanzapine|mesh-list
139517437|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
139517822|NCT02184572|Vaccines|vaccines|mesh-list
139517883|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
139517957|NCT02212730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139518109|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518257|NCT01516216|Antidotes|antidotes|mesh-ancestor
139518335|NCT01950741|Aflibercept|aflibercept|mesh-list
139518488|NCT01487200|FX006|fx006|mesh-list
139518557|NCT01898091|Glycerol|glycerol|mesh-list
139518782|NCT01485094|Pregabalin|pregabalin|mesh-list
139518857|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
139519008|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
139519457|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139519537|NCT01500694|Guanfacine|guanfacine|mesh-list
139519836|NCT02229227|Insulin|insulin|mesh-list
139519926|NCT01460290|Asenapine|asenapine|mesh-list
139520132|NCT01623752|Etanercept|etanercept|mesh-list
139520205|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
139520428|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
139520508|NCT02116309|Indomethacin|indomethacin|mesh-list
139520580|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139522014|NCT02107274|Azithromycin|azithromycin|mesh-list
139522221|NCT02054702|Aripiprazole|aripiprazole|mesh-list
139522450|NCT05886998|Heparin|heparin|mesh-list
139522687|NCT05535738|Xhance|xhance|mesh-list
139522824|NCT05095922|Valsartan|valsartan|mesh-list
139523183|NCT00452023|Interferons|interferons|mesh-list
139523260|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
139523333|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139523858|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523932|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524230|NCT01988402|Allopurinol|allopurinol|mesh-list
139524304|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
139524386|NCT01964755|Antidotes|antidotes|mesh-ancestor
139524537|NCT01985126|Acetaminophen|acetaminophen|mesh-list
139524617|NCT01984424|Ezetimibe|ezetimibe|mesh-list
139524824|NCT01767909|Insulin|insulin|mesh-list
139525197|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139525288|NCT01597973|Meropenem|meropenem|mesh-list
139525614|NCT02020577|Cetuximab|cetuximab|mesh-list
139525874|NCT01955707|Natalizumab|natalizumab|mesh-list
139526026|NCT01944098|Lidocaine|lidocaine|mesh-list
139526096|NCT01942148|Aripiprazole|aripiprazole|mesh-list
139526401|NCT01958918|Ranibizumab|ranibizumab|mesh-list
139526767|NCT01419184|Vancomycin|vancomycin|mesh-list
139526915|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
139527212|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139527301|NCT01987895|Vancomycin|vancomycin|mesh-list
139527369|NCT01925612|Hormones|hormones|mesh-ancestor
139527617|NCT02003573|Decitabine|decitabine|mesh-list
139527952|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139529069|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139529152|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
139529236|NCT02157883|Itraconazole|itraconazole|mesh-list
139529371|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
139529445|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529821|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
139530054|NCT00210184|Leucovorin|leucovorin|mesh-list
139530584|NCT04026022|Fentanyl|fentanyl|mesh-list
139530643|NCT04029610|Lidocaine|lidocaine|mesh-list
139531025|NCT04143880|Hormones|hormones|mesh-ancestor
139531126|NCT04414137|Daptomycin|daptomycin|mesh-list
139531406|NCT03584074|Celecoxib|celecoxib|mesh-list
139531768|NCT02081014|Incretins|incretins|mesh-ancestor
139531846|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
139531992|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
139532217|NCT01693185|Analgesics|analgesics|mesh-ancestor
139532455|NCT03684538|Zinc|zinc|mesh-list
139532818|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
139532910|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
139533206|NCT01610336|Gefitinib|gefitinib|mesh-list
139533659|NCT01908829|Mirabegron|mirabegron|mesh-list
139534077|NCT01686633|Xhance|xhance|mesh-list
139534102|NCT03141424|Hormones|hormones|mesh-ancestor
139534394|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534541|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
139535072|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
139535144|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139535220|NCT04410081|Lazertinib|lazertinib|mesh-list
139535295|NCT01924624|Thalidomide|thalidomide|mesh-list
139535371|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
139535593|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
139535670|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536936|NCT02974738|Belzutifan|belzutifan|mesh-list
139537032|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
139537187|NCT01452724|Lansoprazole|lansoprazole|mesh-list
139537785|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139537858|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
139538077|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139538153|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
139538527|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
139538604|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539131|NCT00176878|Fludarabine|fludarabine|mesh-list
139539350|NCT00006244|Interleukin-2|interleukin-2|mesh-list
139539736|NCT00112918|Leucovorin|leucovorin|mesh-list
139539802|NCT00049036|Etoposide|etoposide|mesh-list
139539877|NCT00217438|Protective Agents|protective agents|mesh-ancestor
139540173|NCT05688904|Adrenergic Agents|adrenergic agents|mesh-ancestor
139540475|NCT04735510|Cyclosporins|cyclosporins|mesh-list
139540553|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541000|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139541607|NCT06023602|Cetrorelix|cetrorelix|mesh-list
139541978|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
139542055|NCT04797767|Venetoclax|venetoclax|mesh-list
139542302|NCT04478734|Biotin|biotin|mesh-list
139542522|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
139542747|NCT02903368|Prednisone|prednisone|mesh-list
139543128|NCT05388877|Dabrafenib|dabrafenib|mesh-list
139543355|NCT04594382|Narcotics|narcotics|mesh-ancestor
139543428|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543514|NCT04050462|Nivolumab|nivolumab|mesh-list
139543654|NCT03531918|Analgesics|analgesics|mesh-ancestor
139543877|NCT01858740|Fludarabine|fludarabine|mesh-list
139543962|NCT00679042|Analgesics|analgesics|mesh-ancestor
139544102|NCT00119158|Fluticasone|fluticasone|mesh-list
139544194|NCT00121810|Sirolimus|sirolimus|mesh-list
139544264|NCT00223678|Sirolimus|sirolimus|mesh-list
139544634|NCT00234832|Sibutramine|sibutramine|mesh-list
139545760|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139545906|NCT00392392|Growth Substances|growth substances|mesh-ancestor
139546132|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
139546354|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139546504|NCT00373360|Treprostinil|treprostinil|mesh-list
139546810|NCT01796782|Capecitabine|capecitabine|mesh-list
139546885|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547929|NCT00520468|Cyclosporine|cyclosporine|mesh-list
139548080|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
139548303|NCT01390857|Valacyclovir|valacyclovir|mesh-list
139548458|NCT01400451|Ipilimumab|ipilimumab|mesh-list
139548606|NCT01879579|Insulin|insulin|mesh-list
139549056|NCT00215943|Hormones|hormones|mesh-ancestor
139549131|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
139549208|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139549733|NCT06057896|Vitamins|vitamins|mesh-ancestor
139550032|NCT05985590|Diuretics|diuretics|mesh-ancestor
139550333|NCT05553132|Hemostatics|hemostatics|mesh-ancestor
139550858|NCT04567615|Nivolumab|nivolumab|mesh-list
139550937|NCT04418167|Dabrafenib|dabrafenib|mesh-list
139551379|NCT03699475|Alkylating Agents|alkylating agents|mesh-ancestor
139551609|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
139552062|NCT02068443|Incretins|incretins|mesh-ancestor
139552214|NCT00754338|Dipivefrin|dipivefrin|mesh-list
139552367|NCT00418886|Pemetrexed|pemetrexed|mesh-list
139553060|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
139553180|NCT02134210|Etanercept|etanercept|mesh-list
139553801|NCT00683332|Tigecycline|tigecycline|mesh-list
139553882|NCT00687076|Niacin|niacin|mesh-list
139554117|NCT00706264|Silicon|silicon|mesh-list
139554168|NCT00661960|Efavirenz|efavirenz|mesh-list
139554313|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
139554382|NCT02999776|Etanercept|etanercept|mesh-list
139554601|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139554751|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
139555050|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
139555274|NCT03586869|Avelumab|avelumab|mesh-list
139555432|NCT03586947|Vitamin D|vitamin d|mesh-list
139555652|NCT01998893|Rituximab|rituximab|mesh-list
139555952|NCT01967225|Linezolid|linezolid|mesh-list
139556037|NCT00246376|Niacin|niacin|mesh-list
139556249|NCT00243022|Vitamins|vitamins|mesh-ancestor
139556324|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139556396|NCT05743504|Paclitaxel|paclitaxel|mesh-list
139556470|NCT04414267|Vaccines|vaccines|mesh-list
139556548|NCT03808168|Nivolumab|nivolumab|mesh-list
139556768|NCT01782313|Tivozanib|tivozanib|mesh-list
139556918|NCT00792142|Thalidomide|thalidomide|mesh-list
139557442|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139557606|NCT01702987|Vitamins|vitamins|mesh-ancestor
139557671|NCT01701973|Incretins|incretins|mesh-ancestor
139558263|NCT00860938|Hormones|hormones|mesh-ancestor
139558412|NCT02986321|Budesonide|budesonide|mesh-list
139558853|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558934|NCT01910519|Vaccines|vaccines|mesh-list
139559232|NCT00883168|Xhance|xhance|mesh-list
139559385|NCT01616459|Vaccines|vaccines|mesh-list
139559751|NCT00911326|Dextrans|dextrans|mesh-list
139559833|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
139559977|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
139560070|NCT01836016|Xhance|xhance|mesh-list
139560133|NCT01726816|Probucol|probucol|mesh-list
139560656|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139561130|NCT01699178|Hormones|hormones|mesh-ancestor
139562008|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562079|NCT00704769|Desloratadine|desloratadine|mesh-list
139562235|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
139562457|NCT03422523|Rituximab|rituximab|mesh-list
139562604|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562980|NCT03483363|Bacitracin|bacitracin|mesh-list
139563207|NCT01005706|Tacrolimus|tacrolimus|mesh-list
139563577|NCT00417664|Propofol|propofol|mesh-list
139563654|NCT05395702|Interferons|interferons|mesh-list
139563727|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139563877|NCT05025033|Apatinib|apatinib|mesh-list
139564251|NCT04757571|Paroxetine|paroxetine|mesh-list
139564492|NCT01893827|Naltrexone|naltrexone|mesh-list
139564624|NCT01055704|Analgesics|analgesics|mesh-ancestor
139564774|NCT01062568|Dexamethasone|dexamethasone|mesh-list
139564871|NCT01066624|Calcium|calcium|mesh-list
139564917|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
139564996|NCT01071538|Buprenorphine|buprenorphine|mesh-list
139565218|NCT03182673|Fluzoparib|fluzoparib|mesh-list
139565367|NCT01922427|Analgesics|analgesics|mesh-ancestor
139565511|NCT01044862|Letrozole|letrozole|mesh-list
139565583|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
139565736|NCT05376228|Vancomycin|vancomycin|mesh-list
139565883|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566036|NCT05309460|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139566335|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
139566564|NCT03451734|Metformin|metformin|mesh-list
139566887|NCT03707028|Paclitaxel|paclitaxel|mesh-list
139567387|NCT01218958|Naltrexone|naltrexone|mesh-list
139567768|NCT03274752|Paroxetine|paroxetine|mesh-list
139568292|NCT04395105|Hormones|hormones|mesh-ancestor
139568373|NCT03427944|Calcium|calcium|mesh-list
139568513|NCT06153433|Antimetabolites|antimetabolites|mesh-ancestor
139568665|NCT06045793|Dopamine Agents|dopamine agents|mesh-ancestor
139568816|NCT05761860|Narcotics|narcotics|mesh-ancestor
139568900|NCT05586360|Simvastatin|simvastatin|mesh-list
139569043|NCT05244226|Anesthetics, General|anesthetics, general|mesh-ancestor
139569429|NCT03850782|Bimatoprost|bimatoprost|mesh-list
139569567|NCT03347760|Octreotide|octreotide|mesh-list
139569720|NCT02626455|Prednisone|prednisone|mesh-list
139569954|NCT01253824|Norethindrone|norethindrone|mesh-list
139570019|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
139570094|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
139570466|NCT01296646|Naltrexone|naltrexone|mesh-list
139571086|NCT01410058|Efavirenz|efavirenz|mesh-list
139571368|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571575|NCT01394614|Vaccines|vaccines|mesh-list
139571614|NCT01423162|Vitamins|vitamins|mesh-ancestor
139571694|NCT01396486|Inositol|inositol|mesh-list
139571745|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
139571899|NCT03395730|Oxytocin|oxytocin|mesh-list
139571973|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572348|NCT01546402|Dexamethasone|dexamethasone|mesh-list
139573091|NCT05565274|Pentazocine|pentazocine|mesh-list
139573168|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
139573245|NCT01516684|Narcotics|narcotics|mesh-ancestor
139573468|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573834|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
139574458|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
139574530|NCT03361098|Exenatide|exenatide|mesh-list
139575137|NCT01376310|Trametinib|trametinib|mesh-list
139575289|NCT05098704|Clopidogrel|clopidogrel|mesh-list
139575362|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139575437|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
139575513|NCT01692340|Lycopene|lycopene|mesh-list
139576645|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139576812|NCT01690546|Naltrexone|naltrexone|mesh-list
139576936|NCT02245672|Xhance|xhance|mesh-list
139576946|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139577091|NCT01713400|Sirolimus|sirolimus|mesh-list
139577093|NCT01713400|Tacrolimus|tacrolimus|mesh-list
139577167|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577544|NCT05946785|Insulin Aspart|insulin aspart|mesh-list
139577617|NCT05897307|Sensory System Agents|sensory system agents|mesh-ancestor
139577914|NCT05315479|Analgesics|analgesics|mesh-ancestor
139578145|NCT04727151|Pembrolizumab|pembrolizumab|mesh-list
139578213|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578288|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
139578437|NCT04191889|Apatinib|apatinib|mesh-list
139578772|NCT03555565|Metformin|metformin|mesh-list
139578927|NCT02708836|Anesthetics|anesthetics|mesh-list
139579069|NCT01921166|Leuprolide|leuprolide|mesh-list
139579136|NCT01485861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579625|NCT03331302|Xenon|xenon|mesh-list
139579666|NCT05316376|Paclitaxel|paclitaxel|mesh-list
139580498|NCT02481180|T0001|t0001|mesh-list
139580787|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
139580937|NCT02470026|Yohimbine|yohimbine|mesh-list
139581457|NCT03832894|Estradiol|estradiol|mesh-list
139581904|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582051|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
139582277|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582657|NCT04124913|Hormones|hormones|mesh-ancestor
139582891|NCT01951066|Hormones|hormones|mesh-ancestor
139583034|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139583113|NCT01606319|Acetaminophen|acetaminophen|mesh-list
139583189|NCT01453881|Hormones|hormones|mesh-ancestor
139583412|NCT01455909|Exenatide|exenatide|mesh-list
139583636|NCT05320068|Vancomycin|vancomycin|mesh-list
139583785|NCT04650074|Lidocaine|lidocaine|mesh-list
139583853|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
139584310|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
139585442|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139586697|NCT03268902|Niacin|niacin|mesh-list
139587033|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139587136|NCT03548220|Mitapivat|mitapivat|mesh-list
139587183|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587336|NCT03474276|Azithromycin|azithromycin|mesh-list
139587645|NCT06111521|Anesthetics|anesthetics|mesh-ancestor
139588553|NCT04579848|Folic Acid|folic acid|mesh-list
139588713|NCT04207931|Clobetasol|clobetasol|mesh-list
139588844|NCT03920215|Varenicline|varenicline|mesh-list
139588991|NCT03240861|Busulfan|busulfan|mesh-list
139589300|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
139589598|NCT03243006|Acetaminophen|acetaminophen|mesh-list
139589741|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589813|NCT03248700|Vitamins|vitamins|mesh-list
139589886|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139590485|NCT00158223|Pimozide|pimozide|mesh-list
139590558|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
139590860|NCT03221166|Infliximab|infliximab|mesh-list
139591010|NCT01898169|Nicotine|nicotine|mesh-list
139591162|NCT02402062|Sunitinib|sunitinib|mesh-list
139591379|NCT00186069|Analgesics|analgesics|mesh-ancestor
139591830|NCT00099021|Pioglitazone|pioglitazone|mesh-list
139591905|NCT03202446|Chitosan|chitosan|mesh-list
139591983|NCT05372380|Atorvastatin|atorvastatin|mesh-list
139592053|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
139592353|NCT06074757|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139592591|NCT05608499|Clobetasol|clobetasol|mesh-list
139593032|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139593567|NCT01605071|Estrogens|estrogens|mesh-ancestor
139593883|NCT03193710|Remifentanil|remifentanil|mesh-list
139594200|NCT03117894|Etoricoxib|etoricoxib|mesh-list
139594404|NCT05716672|Lazertinib|lazertinib|mesh-list
139595153|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
139595531|NCT00255801|Doxorubicin|doxorubicin|mesh-list
139596065|NCT01700387|Topiramate|topiramate|mesh-list
139596129|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
139596359|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
139596801|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139597061|NCT02407626|Propofol|propofol|mesh-list
139597102|NCT01695317|Vitamins|vitamins|mesh-ancestor
139597327|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139598082|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598387|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139598466|NCT04707742|Povidone|povidone|mesh-list
139598687|NCT02691702|Protective Agents|protective agents|mesh-ancestor
139598917|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
139598993|NCT01556165|Rasagiline|rasagiline|mesh-list
139599513|NCT03161574|Irinotecan|irinotecan|mesh-list
139599745|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
139599820|NCT01524887|Antibodies|antibodies|mesh-list
139599887|NCT05240781|Sirolimus|sirolimus|mesh-list
139600259|NCT05549154|Cholecalciferol|cholecalciferol|mesh-list
139600636|NCT02381730|Aflibercept|aflibercept|mesh-list
139600870|NCT01500317|Oxycodone|oxycodone|mesh-list
139601002|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
139601603|NCT05702333|Dobutamine|dobutamine|mesh-list
139602283|NCT02374008|Analgesics|analgesics|mesh-ancestor
139602743|NCT04438980|Prednisolone|prednisolone|mesh-list
139602961|NCT04751175|Dexamethasone|dexamethasone|mesh-list
139603344|NCT02353182|Analgesics|analgesics|mesh-ancestor
139603717|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
139603790|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139603870|NCT02338674|Tenofovir|tenofovir|mesh-list
139603941|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
139604322|NCT06102707|Apatinib|apatinib|mesh-list
139604919|NCT04308330|Vorinostat|vorinostat|mesh-list
139605065|NCT03750786|Leucovorin|leucovorin|mesh-list
139605296|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605447|NCT01711554|Vitamin A|vitamin a|mesh-list
139605549|NCT01225913|Xhance|xhance|mesh-list
139605677|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139606125|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606271|NCT01545817|Everolimus|everolimus|mesh-list
139606719|NCT04618523|Amodiaquine|amodiaquine|mesh-list
139606798|NCT01506193|Vaccines|vaccines|mesh-list
139607096|NCT01466387|Vaccines|vaccines|mesh-list
139607179|NCT00461331|Insulin|insulin|mesh-list
139607631|NCT00478335|Diuretics|diuretics|mesh-ancestor
139607925|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
139608524|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
139608672|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
139609119|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139609269|NCT05362851|Narcotics|narcotics|mesh-ancestor
139609495|NCT00606489|Ibuprofen|ibuprofen|mesh-list
139609641|NCT01569464|Rotigotine|rotigotine|mesh-list
139609791|NCT01547390|Analgesics|analgesics|mesh-ancestor
139610758|NCT01418209|Progestins|progestins|mesh-ancestor
139610910|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
139611284|NCT04797312|Sufentanil|sufentanil|mesh-list
139611430|NCT01430611|Vaccines|vaccines|mesh-list
139611512|NCT01429285|Hydromorphone|hydromorphone|mesh-list
139611884|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612184|NCT00695409|Melphalan|melphalan|mesh-list
139613169|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
139613245|NCT05374356|Morphine|morphine|mesh-list
139613393|NCT06123377|Growth Substances|growth substances|mesh-ancestor
139613618|NCT06118710|Autonomic Agents|autonomic agents|mesh-ancestor
139613692|NCT06118398|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139613776|NCT06117644|Aflutinib|aflutinib|mesh-list
139613847|NCT06115473|Autonomic Agents|autonomic agents|mesh-ancestor
139614511|NCT05417971|Fludarabine|fludarabine|mesh-list
139614587|NCT05333250|Modafinil|modafinil|mesh-list
139614968|NCT04858529|Carboplatin|carboplatin|mesh-list
139615190|NCT04473820|Lidocaine|lidocaine|mesh-list
139615263|NCT04305691|Ixazomib|ixazomib|mesh-list
139615330|NCT04256421|Carboplatin|carboplatin|mesh-list
139615631|NCT03907475|Capecitabine|capecitabine|mesh-list
139616247|NCT03008278|Olaparib|olaparib|mesh-list
139616850|NCT01133990|Vitamin B Complex|vitamin b complex|mesh-ancestor
139617153|NCT03594565|Xhance|xhance|mesh-list
139617224|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
139617449|NCT04356534|Antibodies|antibodies|mesh-list
139617824|NCT05575518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617895|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618133|NCT03841526|Insulin|insulin|mesh-list
139618351|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139618729|NCT00722553|Vitamins|vitamins|mesh-list
139618877|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139619105|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
139619181|NCT04917588|Lidocaine|lidocaine|mesh-list
139619480|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
139619557|NCT03580681|Vitamin E|vitamin e|mesh-list
139619780|NCT03159559|Clopidogrel|clopidogrel|mesh-list
139619864|NCT01462578|Azacitidine|azacitidine|mesh-list
139620547|NCT01427309|Vaccines|vaccines|mesh-list
139620610|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
139620762|NCT03825757|Analgesics|analgesics|mesh-ancestor
139621137|NCT05123976|Olanzapine|olanzapine|mesh-list
139621442|NCT02536794|Ipilimumab|ipilimumab|mesh-list
139621591|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
139621984|NCT00088465|Olanzapine|olanzapine|mesh-list
139622716|NCT00089635|Panitumumab|panitumumab|mesh-list
139622945|NCT04403191|Ondansetron|ondansetron|mesh-list
139623539|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139623614|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139623911|NCT01496846|Carticaine|carticaine|mesh-list
139624210|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
139624365|NCT01673646|Hormones|hormones|mesh-ancestor
139624513|NCT00835185|Vitamins|vitamins|mesh-ancestor
139624735|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139624888|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
139625712|NCT03221400|Leucovorin|leucovorin|mesh-list
139625783|NCT01471574|Interferons|interferons|mesh-list
139626457|NCT05243706|Histamine Agents|histamine agents|mesh-ancestor
139626532|NCT05242081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626607|NCT01723059|Amoxicillin|amoxicillin|mesh-list
139626833|NCT04377867|Abatacept|abatacept|mesh-list
139627131|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
139627205|NCT01046643|Progestins|progestins|mesh-ancestor
139627799|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
139628183|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
139628484|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
139628559|NCT05013060|Butyric Acid|butyric acid|mesh-list
139628779|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139628861|NCT05006898|Miotics|miotics|mesh-ancestor
139629004|NCT02245269|Ritonavir|ritonavir|mesh-list
139629241|NCT04912596|Miotics|miotics|mesh-ancestor
139629454|NCT04406051|Norepinephrine|norepinephrine|mesh-list
139629611|NCT04145921|Tacrine|tacrine|mesh-list
139629838|NCT04358367|Analgesics|analgesics|mesh-ancestor
139629911|NCT04461288|Nicotine|nicotine|mesh-list
139630132|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
139630207|NCT00951561|Ibuprofen|ibuprofen|mesh-list
139630508|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139630588|NCT01674257|Fluorides|fluorides|mesh-list
139631062|NCT03814109|Niacin|niacin|mesh-list
139631185|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139631261|NCT05394909|Hormones|hormones|mesh-ancestor
139632089|NCT01025427|Tenofovir|tenofovir|mesh-list
139632386|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
139632534|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632993|NCT05181150|Glucagon|glucagon|mesh-list
139633365|NCT04202809|Durvalumab|durvalumab|mesh-list
139633443|NCT03875872|Propofol|propofol|mesh-list
139633514|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
139634126|NCT01034553|Bortezomib|bortezomib|mesh-list
139634199|NCT03013959|Analgesics|analgesics|mesh-ancestor
139635026|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
139635100|NCT02185131|Mirtazapine|mirtazapine|mesh-list
139635174|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635697|NCT01219881|Sevoflurane|sevoflurane|mesh-list
139636075|NCT06220643|Lidocaine|lidocaine|mesh-list
139636220|NCT06170489|Alkylating Agents|alkylating agents|mesh-ancestor
139636372|NCT06088290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139636836|NCT05617820|Estradiol|estradiol|mesh-list
139637731|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
139638019|NCT04065074|FX006|fx006|mesh-list
139638181|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
139638327|NCT03197194|Aspirin|aspirin|mesh-list
139638402|NCT03089957|Urinastatin|urinastatin|mesh-list
139638587|NCT02468583|FX006|fx006|mesh-list
139639012|NCT01158885|Cytarabine|cytarabine|mesh-list
139639305|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639754|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
139639836|NCT04278677|Melatonin|melatonin|mesh-list
139640055|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139640357|NCT01920113|Analgesics|analgesics|mesh-ancestor
139640512|NCT01922375|Naftopidil|naftopidil|mesh-list
139640813|NCT03100253|Analgesics|analgesics|mesh-ancestor
139640882|NCT01925729|Histamine|histamine|mesh-list
139641192|NCT05793359|Prednisolone|prednisolone|mesh-list
139641341|NCT05456932|Iron|iron|mesh-list
139641407|NCT05128344|Vigabatrin|vigabatrin|mesh-list
139641556|NCT03908307|Hormones|hormones|mesh-ancestor
139641637|NCT02728037|Analgesics|analgesics|mesh-ancestor
139641721|NCT02760667|Cisplatin|cisplatin|mesh-list
139210863|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210864|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139210941|NCT02203526|Cytarabine|cytarabine|mesh-list
139210942|NCT02203526|Isavuconazole|isavuconazole|mesh-list
139210943|NCT02203526|Rituximab|rituximab|mesh-list
139210944|NCT02203526|Methotrexate|methotrexate|mesh-list
139211112|NCT01842282|Amlexanox|amlexanox|mesh-list
139211249|NCT01192568|Urological Agents|urological agents|mesh-ancestor
139211496|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
139211497|NCT00186888|Carboplatin|carboplatin|mesh-list
139211498|NCT00186888|Doxorubicin|doxorubicin|mesh-list
139211499|NCT00186888|Etoposide|etoposide|mesh-list
139211500|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
139211501|NCT00186888|Vincristine|vincristine|mesh-list
139211502|NCT00186888|Topotecan|topotecan|mesh-list
139211503|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139211504|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
139211505|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211506|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211507|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139211508|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
139211509|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211510|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211511|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139211512|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139211513|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139211552|NCT05183334|Tramadol|tramadol|mesh-list
139168395|NCT03538938|Nicotine|nicotine|mesh-list
139212007|NCT05500599|Narcotics|narcotics|mesh-ancestor
139212081|NCT05267470|Carboplatin|carboplatin|mesh-list
139212082|NCT05267470|Pembrolizumab|pembrolizumab|mesh-list
139212083|NCT05267470|Bemarituzumab|bemarituzumab|mesh-list
139212084|NCT05267470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139212092|NCT05257655|Analgesics, Opioid|analgesics, opioid|mesh-list
139212618|NCT03611556|Antidotes|antidotes|mesh-ancestor
139213076|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139213077|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139213078|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213079|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
139213080|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213081|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213082|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139213083|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213161|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
139213162|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139213163|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213164|NCT03311542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139213165|NCT03311542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213166|NCT03311464|Adalimumab|adalimumab|mesh-list
139213167|NCT03311464|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139213168|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213169|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139213170|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
139213171|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
139213172|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213173|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139213373|NCT01347996|Analgesics|analgesics|mesh-ancestor
139213447|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213676|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
139170722|NCT03502642|Morphine|morphine|mesh-list
139642132|NCT01311687|Hormones|hormones|mesh-ancestor
139214494|NCT03295786|Protective Agents|protective agents|mesh-ancestor
139214569|NCT03295162|Melatonin|melatonin|mesh-list
139215092|NCT05821517|Anesthetics|anesthetics|mesh-ancestor
139215318|NCT04970108|Empagliflozin|empagliflozin|mesh-list
139215398|NCT04753294|Diazepam|diazepam|mesh-list
139215621|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
139215622|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215623|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139215624|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
139215625|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215626|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139215627|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139215700|NCT03737240|Incretins|incretins|mesh-ancestor
139215772|NCT03363659|Copper|copper|mesh-list
139216299|NCT01335321|Hylan|hylan|mesh-list
139216318|NCT03282838|Analgesics|analgesics|mesh-ancestor
139262474|NCT01377103|Hormones|hormones|mesh-ancestor
139262475|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139262476|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262477|NCT01377025|Sorafenib|sorafenib|mesh-list
139262478|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262479|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139262480|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262481|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262482|NCT02342275|Propranolol|propranolol|mesh-list
139262483|NCT02342275|Atenolol|atenolol|mesh-list
139262484|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139262485|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139262486|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
139262487|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139262488|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262489|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262490|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139262491|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139262492|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
139262493|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
139262494|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
139262495|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262496|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139262497|NCT01827553|Gemcitabine|gemcitabine|mesh-list
139262498|NCT01827553|Folfirinox|folfirinox|mesh-list
139262499|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139262500|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
139262501|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262502|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262503|NCT02207348|Liraglutide|liraglutide|mesh-list
139262504|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139262505|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262506|NCT02207348|Incretins|incretins|mesh-ancestor
139262507|NCT02207348|Hormones|hormones|mesh-ancestor
139262508|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139262509|NCT02066454|Apixaban|apixaban|mesh-list
139262510|NCT02066454|Anticoagulants|anticoagulants|mesh-list
139262511|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139262512|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
139262513|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139262514|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
139262515|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262516|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262518|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139262519|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262520|NCT00777491|Cisplatin|cisplatin|mesh-list
139262521|NCT00777491|Gemcitabine|gemcitabine|mesh-list
139262522|NCT00777491|Fluorouracil|fluorouracil|mesh-list
139262523|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262524|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139262525|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
139262526|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262527|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139262528|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
139262529|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262530|NCT02199392|Lenvatinib|lenvatinib|mesh-list
139262531|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262532|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139262533|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262534|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262535|NCT05320627|Edoxaban|edoxaban|mesh-list
139262536|NCT05320627|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139262537|NCT05320627|Antithrombins|antithrombins|mesh-ancestor
139262538|NCT05320627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139262539|NCT05320627|Protease Inhibitors|protease inhibitors|mesh-ancestor
139262540|NCT05320627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262541|NCT05320627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262542|NCT05320627|Anticoagulants|anticoagulants|mesh-ancestor
139262543|NCT03559920|Propofol|propofol|mesh-list
139262544|NCT03559920|Anesthetics|anesthetics|mesh-list
139262545|NCT03559920|Sevoflurane|sevoflurane|mesh-list
139262546|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139262547|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139262548|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262549|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139262550|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
139262551|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139262552|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139262553|NCT02203760|Gemcitabine|gemcitabine|mesh-list
139262554|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139262555|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
139262556|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262557|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262558|NCT03703271|Methotrexate|methotrexate|mesh-list
139262559|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139262560|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
139262561|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139262562|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262563|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139262564|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
139262565|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262566|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262567|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
139262568|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262569|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139262570|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139262571|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
139262572|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139262573|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139262574|NCT03532802|Metoprolol|metoprolol|mesh-list
139262575|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139262576|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139262577|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
139262578|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
139262579|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262580|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262581|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139262582|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139262583|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139262584|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
139262585|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139262586|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262587|NCT03430531|Lidocaine|lidocaine|mesh-list
139262588|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
139262589|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
138845958|NCT00871039|Midazolam|midazolam|mesh-list
139262591|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262592|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
139262593|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262594|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139262595|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139262596|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139262597|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139262598|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262599|NCT02066532|Trastuzumab|trastuzumab|mesh-list
139262600|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139262601|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262602|NCT05763329|Lemborexant|lemborexant|mesh-list
139262603|NCT05763329|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139262604|NCT05763329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139262605|NCT05763329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262606|NCT05763329|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139262607|NCT05763329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139262608|NCT05763329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139262609|NCT05763329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262610|NCT04088513|Aspirin|aspirin|mesh-list
139262611|NCT04088513|Clopidogrel|clopidogrel|mesh-list
139262612|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139262613|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139262614|NCT04088513|Analgesics|analgesics|mesh-ancestor
139262615|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
139262616|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262617|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262618|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139262619|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139262620|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139262621|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139262622|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262623|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139262624|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139262625|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262626|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
139262627|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139262628|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139262629|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139262630|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
139262631|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139262633|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262634|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
139262635|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262636|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139262637|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139262638|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
139262639|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262640|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
139262641|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139262642|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262643|NCT02069418|Alovudine|alovudine|mesh-list
139262644|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139262645|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139262646|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262647|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
139262648|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262649|NCT02208128|Bevacizumab|bevacizumab|mesh-list
139262650|NCT02208128|Sunitinib|sunitinib|mesh-list
139262651|NCT02208128|Everolimus|everolimus|mesh-list
139262652|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139262653|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262654|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139262655|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139262656|NCT02208128|Growth Substances|growth substances|mesh-ancestor
139262657|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262658|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
139262659|NCT02208128|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139262660|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139262661|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262662|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262663|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139262664|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
139262665|NCT02066610|Selenium|selenium|mesh-list
139262666|NCT02066610|Selenious Acid|selenious acid|mesh-list
139262667|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
139262668|NCT02066610|Selenic Acid|selenic acid|mesh-list
139262669|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
139262670|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262671|NCT02066610|Protective Agents|protective agents|mesh-ancestor
139262672|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262673|NCT02066610|Trace Elements|trace elements|mesh-ancestor
139262674|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
139262675|NCT03077711|Trimethoprim|trimethoprim|mesh-list
139262676|NCT03077711|Methenamine|methenamine|mesh-list
139262677|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
139262678|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
139262679|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139262680|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262681|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
139262682|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139262683|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139262684|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139262685|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262686|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262687|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139262688|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139381610|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
139262689|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139262690|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139262691|NCT04374019|Artesunate|artesunate|mesh-list
139262692|NCT04374019|Ivermectin|ivermectin|mesh-list
139262693|NCT04374019|Camostat|camostat|mesh-list
139262694|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
139262695|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139262696|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139262697|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262698|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262699|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
139262700|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
139262701|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139262702|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
139262703|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
139262704|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262705|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262706|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139262707|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139262708|NCT02069808|Leuprolide|leuprolide|mesh-list
139262709|NCT02069808|Menotropins|menotropins|mesh-list
139262710|NCT02069808|Ganirelix|ganirelix|mesh-list
139262711|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139262712|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
139262713|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139262714|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262715|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139262716|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262717|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
139262718|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139262719|NCT03673605|Warfarin|warfarin|mesh-list
139262720|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
139262721|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
139262722|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139262723|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
139262724|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139262725|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
139262726|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262727|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262728|NCT02069886|Deferasirox|deferasirox|mesh-list
139262729|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139262730|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
139262731|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
139262732|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262733|NCT04311463|Paroxetine|paroxetine|mesh-list
139262734|NCT04311463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139262735|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139262736|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139262737|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262738|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139262739|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
139262740|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262741|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139262742|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
139262743|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139262744|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139262745|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139262746|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262747|NCT02065128|Capsaicin|capsaicin|mesh-list
139262748|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
139262749|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
139262750|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
139262751|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262752|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262753|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
139262754|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139262755|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
139262756|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262757|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
139262758|NCT03677895|Protective Agents|protective agents|mesh-ancestor
139262759|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139262760|NCT04295005|Empagliflozin|empagliflozin|mesh-list
139262761|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139262762|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262763|NCT04295005|Incretins|incretins|mesh-ancestor
139262764|NCT04295005|Hormones|hormones|mesh-ancestor
139262765|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139262766|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139262767|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
139262768|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262769|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262770|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139262771|NCT03174353|Lanreotide|lanreotide|mesh-list
139262772|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262773|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139262774|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262775|NCT04080947|Montelukast|montelukast|mesh-list
139262776|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139262777|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
139262778|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139262779|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
139262780|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139133037|NCT01261689|Dsuvia|dsuvia|mesh-list
139262781|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262782|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139262783|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139262784|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262785|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
139262786|NCT02066688|Vitamin D|vitamin d|mesh-list
139262787|NCT02066688|Folic Acid|folic acid|mesh-list
139262788|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
139262789|NCT02066688|Calcium|calcium|mesh-list
139262790|NCT02066688|Vitamins|vitamins|mesh-ancestor
139262791|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
139262792|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262793|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139262794|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139262795|NCT02066688|Hematinics|hematinics|mesh-ancestor
139262796|NCT03671733|Liraglutide|liraglutide|mesh-list
139262797|NCT03671733|Exenatide|exenatide|mesh-list
139262798|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139262799|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262800|NCT03671733|Incretins|incretins|mesh-ancestor
139262801|NCT03671733|Hormones|hormones|mesh-ancestor
139262802|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139262803|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139262804|NCT03119363|Methamphetamine|methamphetamine|mesh-list
139262805|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139262806|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262807|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
139262808|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
139262809|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262810|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
139262811|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139262812|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262813|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
139262814|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139262815|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139262816|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139262817|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139262819|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139262820|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262821|NCT03671655|Paclitaxel|paclitaxel|mesh-list
139262822|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139262823|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262824|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
139262825|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
139262826|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
139262827|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262828|NCT02200094|Telmisartan|telmisartan|mesh-list
139262829|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139262830|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139262831|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139262832|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262833|NCT01370538|Esomeprazole|esomeprazole|mesh-list
139381621|NCT02428257|Ephedrine|ephedrine|mesh-list
139262834|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139262835|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139262836|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139262837|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262838|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262839|NCT03248297|Amoxicillin|amoxicillin|mesh-list
139262840|NCT03248297|Azithromycin|azithromycin|mesh-list
139262841|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139262842|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262843|NCT02208596|Pentazocine|pentazocine|mesh-list
139262844|NCT02208596|Propofol|propofol|mesh-list
139262845|NCT02208596|Etomidate|etomidate|mesh-list
139262846|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139262847|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139262848|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262849|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139262850|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
139262851|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
139262852|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139262853|NCT02208596|Narcotics|narcotics|mesh-ancestor
139262854|NCT02208596|Analgesics|analgesics|mesh-ancestor
139262855|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
139642288|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262856|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262857|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139262858|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139262859|NCT02070120|Mitomycins|mitomycins|mesh-list
139262860|NCT02070120|Mitomycin|mitomycin|mesh-list
139262861|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139262862|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262863|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
139262864|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262865|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139262866|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262867|NCT02200172|Melatonin|melatonin|mesh-list
139262868|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
139262869|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262870|NCT02200172|Protective Agents|protective agents|mesh-ancestor
139262871|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262872|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139262873|NCT03673137|Gemcitabine|gemcitabine|mesh-list
139262874|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139262875|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
139262876|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262877|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262878|NCT02066844|Betamethasone|betamethasone|mesh-list
139262879|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
139262880|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139262881|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
139262882|NCT02066844|Lidocaine|lidocaine|mesh-list
139262883|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139262884|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
139262885|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
139091687|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262886|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139262887|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262888|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
139262889|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262890|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139262891|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139262892|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139262893|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139262894|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262895|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139262896|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
139262897|NCT02066844|Hormones|hormones|mesh-ancestor
139262898|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139262899|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139262900|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
139262901|NCT03669783|Dactinomycin|dactinomycin|mesh-list
139262902|NCT03669783|Carboplatin|carboplatin|mesh-list
139262903|NCT03669783|Doxorubicin|doxorubicin|mesh-list
139262904|NCT03669783|Etoposide|etoposide|mesh-list
139262905|NCT03669783|Vincristine|vincristine|mesh-list
139262906|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262907|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139262908|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139262909|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139262910|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262911|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262912|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139262913|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139262914|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262915|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139262916|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139262917|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
139262918|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
139262919|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
139262920|NCT02067078|Dexamethasone|dexamethasone|mesh-list
139262921|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
139262922|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139262923|NCT02067078|Clonidine|clonidine|mesh-list
139262924|NCT02067078|Epinephrine|epinephrine|mesh-list
139262925|NCT02067078|Racepinephrine|racepinephrine|mesh-list
139262926|NCT02067078|Ropivacaine|ropivacaine|mesh-list
139262927|NCT02067078|Bupivacaine|bupivacaine|mesh-list
139262928|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
139262929|NCT02067078|BB 1101|bb 1101|mesh-list
139262930|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139262931|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
139262932|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
139262933|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262934|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262935|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139262936|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
139262937|NCT02067078|Hormones|hormones|mesh-ancestor
139262938|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139262939|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139262940|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262941|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
139262942|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262943|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262944|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
139262945|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
139262946|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139262947|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
139262948|NCT02067078|Analgesics|analgesics|mesh-ancestor
139262949|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139262950|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
139262951|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139262952|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139262953|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139262954|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
139262955|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139262956|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139262957|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139262958|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139262959|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
139262960|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
139262961|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
139262962|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139262963|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139262964|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139262965|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139262966|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139262967|NCT05461235|Pembrolizumab|pembrolizumab|mesh-list
139262968|NCT05461235|Nivolumab|nivolumab|mesh-list
139262969|NCT05461235|Tislelizumab|tislelizumab|mesh-list
139262970|NCT05461235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139262971|NCT05461235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262972|NCT05461235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139262973|NCT05461235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262974|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139262975|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139262976|NCT02070198|Hormones|hormones|mesh-ancestor
139262977|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139262978|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262979|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
139262980|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139262981|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
139262982|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139262983|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139262984|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139262985|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262986|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139262987|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139262988|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139262989|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139262990|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262991|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139262992|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262993|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
139262994|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139262995|NCT02204852|Iloprost|iloprost|mesh-list
139262996|NCT02204852|Eptifibatide|eptifibatide|mesh-list
139262997|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139262998|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
139262999|NCT02070510|Lisinopril|lisinopril|mesh-list
139263000|NCT02070510|Warfarin|warfarin|mesh-list
139263001|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
139263002|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139263003|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
139263004|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263005|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263006|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139263007|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139263008|NCT02070510|Protective Agents|protective agents|mesh-ancestor
139263009|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263010|NCT02200562|Ipilimumab|ipilimumab|mesh-list
139263011|NCT02200562|Dabrafenib|dabrafenib|mesh-list
139263012|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139263013|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263014|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139263015|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263016|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139263017|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263018|NCT02200640|Losartan|losartan|mesh-list
139263019|NCT02200640|Telmisartan|telmisartan|mesh-list
139263020|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139263021|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139263022|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139263023|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139263024|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263025|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
139263026|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139263027|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
139263028|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263029|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139263030|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
139263031|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139263032|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
139263033|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139263034|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263035|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138846405|NCT00868855|Bradykinin|bradykinin|mesh-list
139263036|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139263037|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263038|NCT02067780|Levofloxacin|levofloxacin|mesh-list
139263039|NCT02067780|Ofloxacin|ofloxacin|mesh-list
139263040|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139263041|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263042|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139263043|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139263044|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139263045|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263046|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263047|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263048|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139263049|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139263050|NCT02205164|Aprepitant|aprepitant|mesh-list
139263051|NCT02205164|Palonosetron|palonosetron|mesh-list
139263052|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
139263053|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
139263054|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263055|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263056|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139263057|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139263058|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263059|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263060|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139263061|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139263062|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
139263063|NCT02071212|Ticagrelor|ticagrelor|mesh-list
139263064|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139263065|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139263066|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139263067|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139263068|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
139263069|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263070|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263071|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263072|NCT02072382|Metformin|metformin|mesh-list
139263073|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139263074|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263075|NCT02205242|Azithromycin|azithromycin|mesh-list
139263076|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139263077|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263078|NCT02071368|Metformin|metformin|mesh-list
139263079|NCT02071368|Canagliflozin|canagliflozin|mesh-list
139263080|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139263081|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263082|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139263083|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263084|NCT03402841|Olaparib|olaparib|mesh-list
139263085|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139263086|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263087|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263088|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263089|NCT02205398|Cetuximab|cetuximab|mesh-list
139263090|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139263091|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263092|NCT02220608|Bortezomib|bortezomib|mesh-list
139263093|NCT02220608|Lenograstim|lenograstim|mesh-list
139263094|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139263095|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
139263096|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263097|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263098|NCT03630367|Dexamethasone|dexamethasone|mesh-list
139263099|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139263100|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
139263101|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
139263102|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263103|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263104|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139263105|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
139263106|NCT03630367|Hormones|hormones|mesh-ancestor
139263107|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139263108|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138846486|NCT00953615|Thalidomide|thalidomide|mesh-list
139263109|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263110|NCT02258282|Etanercept|etanercept|mesh-list
139263111|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139263112|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139263113|NCT02258282|Analgesics|analgesics|mesh-ancestor
139263114|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
139263115|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263116|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263117|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139263118|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139263119|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139263120|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139263121|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
139263122|NCT02076594|Docetaxel|docetaxel|mesh-list
139263123|NCT02076594|Capecitabine|capecitabine|mesh-list
139263124|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
139263125|NCT02076594|Epirubicin|epirubicin|mesh-list
139263126|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263127|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
139263128|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
139263129|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
139263130|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263131|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139263132|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
139263133|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139263134|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139263135|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139263136|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263137|NCT04175509|Acetaminophen|acetaminophen|mesh-list
139263138|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139263139|NCT04175509|Analgesics|analgesics|mesh-ancestor
139263140|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
139263141|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263142|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263143|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
139263144|NCT02220842|Atezolizumab|atezolizumab|mesh-list
139263145|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
139263146|NCT02220842|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139263147|NCT02220842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263148|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139263149|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263150|NCT02205554|Tramadol|tramadol|mesh-list
139263151|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139263152|NCT02205554|Narcotics|narcotics|mesh-ancestor
139263153|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263154|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263156|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
139263157|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263158|NCT02076750|Vitamin D|vitamin d|mesh-list
139263159|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
139263160|NCT02076750|Vitamins|vitamins|mesh-ancestor
139263161|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
139263162|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263163|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139263164|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139263165|NCT05262608|Olaparib|olaparib|mesh-list
139263166|NCT05262608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139263167|NCT05262608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263168|NCT05262608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263169|NCT05262608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263170|NCT01380457|Dronabinol|dronabinol|mesh-list
139263171|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
139263172|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263173|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139263174|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139263175|NCT01380457|Analgesics|analgesics|mesh-ancestor
139263176|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
139263177|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263178|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139263179|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139263180|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263181|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263182|NCT01380457|Hormones|hormones|mesh-ancestor
138846555|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
139263183|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139263184|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139263185|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263186|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263187|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263188|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139263189|NCT01380301|Miltefosine|miltefosine|mesh-list
139263190|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
139263191|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263192|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263193|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139263194|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139263195|NCT02076828|Zinc|zinc|mesh-list
139263196|NCT02076828|Glycine|glycine|mesh-list
139263197|NCT02076828|Trace Elements|trace elements|mesh-ancestor
139263198|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
139263199|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263200|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
139263201|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263202|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263203|NCT02221154|Folic Acid|folic acid|mesh-list
139263204|NCT02221154|Hematinics|hematinics|mesh-ancestor
139263205|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
139263206|NCT02221154|Vitamins|vitamins|mesh-ancestor
139263207|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
139263208|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263209|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
139263210|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139263211|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263212|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139263213|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139263214|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263215|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263216|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263217|NCT03787849|Anesthetics|anesthetics|mesh-list
139263218|NCT03787849|Propofol|propofol|mesh-list
139263219|NCT03787849|Sevoflurane|sevoflurane|mesh-list
139263220|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263221|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263222|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139263223|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139263224|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
139263225|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139263226|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139263227|NCT03671265|Apatinib|apatinib|mesh-list
139263228|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263229|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139263230|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263231|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263232|NCT02881957|Vitamin D|vitamin d|mesh-list
139263233|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
139263234|NCT02881957|Vitamins|vitamins|mesh-ancestor
139263235|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
139263236|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263237|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139263238|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139263239|NCT02206022|Remifentanil|remifentanil|mesh-list
139263240|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139263241|NCT02206022|Narcotics|narcotics|mesh-ancestor
139263242|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263243|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263244|NCT02206022|Analgesics|analgesics|mesh-ancestor
139263245|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
139263246|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263247|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
139263248|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139263249|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
139263250|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263251|NCT02073552|Protective Agents|protective agents|mesh-ancestor
139263252|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263253|NCT02073552|Vitamins|vitamins|mesh-ancestor
139263254|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
139263255|NCT02073552|Laxatives|laxatives|mesh-ancestor
139263256|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139263257|NCT02210156|Micronutrients|micronutrients|mesh-list
139263258|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263259|NCT02080026|Chloroquine|chloroquine|mesh-list
139263260|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139263261|NCT02080026|Atovaquone|atovaquone|mesh-list
139263262|NCT02080026|Proguanil|proguanil|mesh-list
139091688|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139263263|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
139263264|NCT02080026|Amebicides|amebicides|mesh-ancestor
139263265|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139263266|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139263267|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263268|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
139263269|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139263270|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139263271|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139263272|NCT02080026|Analgesics|analgesics|mesh-ancestor
139263273|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
139263274|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263275|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263276|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139263277|NCT02080026|Filaricides|filaricides|mesh-ancestor
139263278|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
139263279|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
139263280|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263281|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263282|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
139263283|NCT02206178|Acetaminophen|acetaminophen|mesh-list
139263284|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
139263285|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139263286|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139263287|NCT02206178|Analgesics|analgesics|mesh-ancestor
139263288|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
139263289|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263290|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263291|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
139263292|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
139263293|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263294|NCT02206178|Expectorants|expectorants|mesh-ancestor
139263295|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
139263296|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139263297|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
139263298|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263299|NCT02206178|Protective Agents|protective agents|mesh-ancestor
139263300|NCT02206178|Antidotes|antidotes|mesh-ancestor
139263301|NCT02080104|Oxytocin|oxytocin|mesh-list
139263302|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
139263303|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139263304|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263305|NCT02211326|Warfarin|warfarin|mesh-list
139263306|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
139263307|NCT02691793|Sunitinib|sunitinib|mesh-list
139263308|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263309|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139263310|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139263311|NCT02691793|Growth Substances|growth substances|mesh-ancestor
139263312|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263313|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
139263314|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139263315|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263316|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263317|NCT02221622|Pregnanolone|pregnanolone|mesh-list
139263318|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139263319|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
139263320|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263321|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263322|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
139263323|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139263324|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
139263325|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263326|NCT02080182|Expectorants|expectorants|mesh-ancestor
139263327|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
139263328|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139263329|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
139263330|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263331|NCT02080182|Protective Agents|protective agents|mesh-ancestor
139263332|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263333|NCT02080182|Antidotes|antidotes|mesh-ancestor
139263334|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
139263335|NCT02750930|Incretins|incretins|mesh-ancestor
139263336|NCT02750930|Hormones|hormones|mesh-ancestor
139263337|NCT02750930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139263338|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263339|NCT02080416|Nelfinavir|nelfinavir|mesh-list
139263340|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139263341|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139263342|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
139263343|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263344|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263345|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139263346|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139263347|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
139263348|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263349|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
139263350|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139263351|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139263352|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263353|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
139263354|NCT02080494|Coagulants|coagulants|mesh-ancestor
139263355|NCT02213744|Gemcitabine|gemcitabine|mesh-list
139263356|NCT02213744|Capecitabine|capecitabine|mesh-list
139263357|NCT02213744|Trastuzumab|trastuzumab|mesh-list
139263358|NCT02213744|Vinorelbine|vinorelbine|mesh-list
139263359|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139263360|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
139263361|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263362|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263363|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139263364|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139263365|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
139263366|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
139263367|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
139263368|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
139263370|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139263371|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263372|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263373|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139263374|NCT01378741|Analgesics|analgesics|mesh-ancestor
139263375|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
139263376|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263377|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139263378|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139263379|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139263380|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
139263381|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297251|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133590|NCT01267305|PENTA|penta|mesh-list
139263382|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263383|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139263384|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
139263385|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
139263386|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
139263387|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263388|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139263389|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263390|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263391|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
139263392|NCT02225054|Ropivacaine|ropivacaine|mesh-list
139263393|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139263394|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263395|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263396|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139263397|NCT02225054|Analgesics|analgesics|mesh-ancestor
139263398|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
139263399|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263400|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139263401|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139263402|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139263403|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
139263404|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263405|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263406|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
139263407|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
139263408|NCT02080728|Ropivacaine|ropivacaine|mesh-list
139263409|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
139263410|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
139263411|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263412|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846786|NCT02066220|Lomustine|lomustine|mesh-list
139263413|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
139263414|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263415|NCT03078907|Selexipag|selexipag|mesh-list
139263416|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139263417|NCT02225210|Midazolam|midazolam|mesh-list
139263418|NCT02225210|Fentanyl|fentanyl|mesh-list
139263419|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
139263420|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139263421|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263422|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263423|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139263424|NCT02225210|Analgesics|analgesics|mesh-ancestor
139263425|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
139263426|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263427|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139263428|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139263429|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139263430|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
139263431|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263432|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263433|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139263434|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139263435|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139263436|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139263437|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139263438|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
139263439|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
139263440|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
139263441|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
139263442|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139263443|NCT02225210|Narcotics|narcotics|mesh-ancestor
139263444|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
139263445|NCT02217020|Irinotecan|irinotecan|mesh-list
139263446|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263447|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139263448|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139263449|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263450|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263451|NCT03249714|Ofatumumab|ofatumumab|mesh-list
139263452|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139263453|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263454|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
139263455|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263456|NCT02222168|BI 409306|bi 409306|mesh-list
139263457|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139263458|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263459|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263460|NCT02925117|Upadacitinib|upadacitinib|mesh-list
139263461|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139263462|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139263463|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263464|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263465|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139263466|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
139263467|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139263468|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263469|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
139263470|NCT02225756|Cyclosporine|cyclosporine|mesh-list
139263471|NCT02225756|Cyclosporins|cyclosporins|mesh-list
139263472|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263473|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263474|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139263475|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
139263476|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263477|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
139263478|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263479|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
139263480|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139263481|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139263482|NCT02225834|Atorvastatin|atorvastatin|mesh-list
139263483|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139263484|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139263485|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
139263486|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263487|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139263488|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138846859|NCT00875173|Selenium|selenium|mesh-list
139263489|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263490|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
139263491|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263492|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
139263493|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139263494|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263495|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139263496|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139263497|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197854|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
139263498|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263499|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263500|NCT02074800|Siltuximab|siltuximab|mesh-list
139263501|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139263502|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263503|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
139263504|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263505|NCT04504045|Metformin|metformin|mesh-list
139263506|NCT04504045|Efavirenz|efavirenz|mesh-list
139263507|NCT04504045|Losartan|losartan|mesh-list
139263508|NCT04504045|Metoprolol|metoprolol|mesh-list
139263509|NCT04504045|Midazolam|midazolam|mesh-list
139263510|NCT04504045|Caffeine|caffeine|mesh-list
139263511|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139263512|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263513|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139263514|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139263515|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263516|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139263517|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139263518|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139263519|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139263520|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
139263521|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
139263522|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
139263523|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
139263524|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263525|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263526|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139263527|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139263528|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139263529|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139263530|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139263531|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139263532|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133735|NCT03882099|Vitamin D|vitamin d|mesh-list
139263533|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139263534|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139263535|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
139263536|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139263537|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139263538|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
139263539|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263540|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139263541|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139263542|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139263543|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139263544|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139263545|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139263546|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
139263547|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
139263548|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263549|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139263550|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139263551|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139263552|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
139263553|NCT03283488|Megestrol|megestrol|mesh-list
139263554|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
139263555|NCT03283488|Mirtazapine|mirtazapine|mesh-list
139263556|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
139263557|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139263558|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139263559|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
139263560|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
139263561|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263562|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263563|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263564|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139263565|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139263566|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263567|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139263568|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139263570|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
139263571|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139263572|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139263573|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
139263574|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139263575|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139263576|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139263577|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139263578|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
139263579|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139263580|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139263581|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139263582|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139263583|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263584|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
139263585|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139263586|NCT02258204|Ketamine|ketamine|mesh-list
139263587|NCT02258204|Analgesics|analgesics|mesh-ancestor
139263588|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
139263589|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263590|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263591|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139263592|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139263593|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
139263594|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
139263595|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263596|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139263597|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139263598|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263599|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263600|NCT02226068|Cyclosporine|cyclosporine|mesh-list
139263601|NCT02226068|Cyclosporins|cyclosporins|mesh-list
139263602|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263603|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642289|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139263604|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139263605|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
139263606|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263607|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
139263608|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263609|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
139263610|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139263611|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139263613|NCT02220218|Canagliflozin|canagliflozin|mesh-list
139263614|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139263615|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263616|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139263617|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263618|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139263619|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139263620|NCT02222480|Diuretics|diuretics|mesh-ancestor
139263621|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
139263622|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263623|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139263624|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139263625|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263626|NCT03670875|Curcumin|curcumin|mesh-list
139263627|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139263628|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139263629|NCT03670875|Analgesics|analgesics|mesh-ancestor
139263630|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
139263631|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263632|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263633|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139263634|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139263635|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263636|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847005|NCT06124118|Paclitaxel|paclitaxel|mesh-list
138847083|NCT06000787|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139263637|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263638|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
139263639|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139263640|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263642|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139263643|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
139263644|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139263645|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263646|NCT02074878|Sunitinib|sunitinib|mesh-list
139263647|NCT02074878|Crizotinib|crizotinib|mesh-list
139263648|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263649|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139263650|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139263651|NCT02074878|Growth Substances|growth substances|mesh-ancestor
139263652|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263653|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
139263654|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139263655|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263656|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263657|NCT03075163|Ondansetron|ondansetron|mesh-list
139263658|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
139263659|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
139263660|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263661|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263662|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139263663|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
139263664|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
139263665|NCT03075163|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139263666|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139263667|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
139263668|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263669|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263670|NCT02220530|Midazolam|midazolam|mesh-list
139263671|NCT02220530|Fentanyl|fentanyl|mesh-list
139263672|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139263673|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139263674|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263675|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263676|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139133897|NCT01268709|Doxepin|doxepin|mesh-list
139263677|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139263678|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139263679|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139263680|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
139263681|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
139263682|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
139263683|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
139263684|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263685|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263686|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139263687|NCT02220530|Narcotics|narcotics|mesh-ancestor
139263688|NCT02220530|Analgesics|analgesics|mesh-ancestor
139263689|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
139263690|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263691|NCT02078232|Pancrelipase|pancrelipase|mesh-list
139263692|NCT02078232|Pancreatin|pancreatin|mesh-list
139263693|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139263694|NCT02075034|ON 01910|on 01910|mesh-list
139263695|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263696|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139263697|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263698|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263699|NCT02567175|Domperidone|domperidone|mesh-list
139263700|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
139263701|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
139263702|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263703|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263704|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139263705|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139263706|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
139263707|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263708|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263709|NCT02078388|Doxorubicin|doxorubicin|mesh-list
139263710|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139263711|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263713|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139263714|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263715|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263716|NCT02222636|Fentanyl|fentanyl|mesh-list
139263717|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
139263718|NCT02222636|Anesthetics|anesthetics|mesh-list
139263719|NCT02222636|Sevoflurane|sevoflurane|mesh-list
139263720|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263721|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263722|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139263723|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139263724|NCT02222636|Analgesics|analgesics|mesh-ancestor
139263725|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
139263726|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263727|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139263728|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139263729|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139263730|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
139263731|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263732|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263733|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139263734|NCT02222636|Narcotics|narcotics|mesh-ancestor
139263735|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139263736|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139263737|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
139263738|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139263739|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139263740|NCT04058145|Plerixafor|plerixafor|mesh-list
139263741|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
139263742|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139263743|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263744|NCT04058145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139263745|NCT04058145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263746|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139263747|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139263748|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
139263749|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139263750|NCT02230982|Nintedanib|nintedanib|mesh-list
139263751|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263752|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139642290|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139263753|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263754|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263756|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263757|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139263758|NCT02075112|Protective Agents|protective agents|mesh-ancestor
139263759|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263760|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139263761|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263762|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263763|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
139263764|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139263765|NCT02075112|Estrogens|estrogens|mesh-ancestor
139263766|NCT02075112|Hormones|hormones|mesh-ancestor
139263767|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139263768|NCT02223026|Metformin|metformin|mesh-list
139263769|NCT02223026|Linagliptin|linagliptin|mesh-list
139263770|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139263771|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263772|NCT02223026|Incretins|incretins|mesh-ancestor
139263773|NCT02223026|Hormones|hormones|mesh-ancestor
139263774|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139263775|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139263776|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
139263777|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263778|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263779|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139263780|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139263781|NCT02477384|Propranolol|propranolol|mesh-list
139263782|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139263783|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139263784|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
139263785|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263786|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263787|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263788|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139263789|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139263790|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
139263791|NCT02231294|Pramipexole|pramipexole|mesh-list
139263792|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
138289230|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263793|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263794|NCT02231294|Protective Agents|protective agents|mesh-ancestor
139263795|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263796|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139263797|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139263798|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
139263799|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
139263800|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263801|NCT02223416|Teriparatide|teriparatide|mesh-list
139263802|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139263803|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263804|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139263805|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
139263806|NCT02082054|Atropine|atropine|mesh-list
139263807|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
139263808|NCT02082054|Ephedrine|ephedrine|mesh-list
139263809|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139263810|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139263811|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139263812|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
139263813|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263814|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263815|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139263816|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
139263817|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
139263818|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
139263819|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139263820|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139263821|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
139263822|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263823|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263824|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
139263825|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139263826|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139263827|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
139263828|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
139263829|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
139263830|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
139263831|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139263832|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
139263833|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
139263834|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139263835|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139263836|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139263837|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
139263838|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263839|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263840|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139263841|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
139263842|NCT02884544|Dextroamphetamine|dextroamphetamine|mesh-list
139263843|NCT02884544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139263844|NCT02884544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263845|NCT02884544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139263846|NCT02884544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139263847|NCT02884544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139263848|NCT02884544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263849|NCT02884544|Dopamine Agents|dopamine agents|mesh-ancestor
139263850|NCT02884544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263852|NCT02226926|Dipyridamole|dipyridamole|mesh-list
139263853|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
139263854|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139263855|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139263856|NCT02226926|Analgesics|analgesics|mesh-ancestor
139263857|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
139263858|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263859|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263860|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139263862|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139263863|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139263864|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263865|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139263866|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139198227|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
139263867|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263868|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
139263869|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139263870|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
139263871|NCT02924883|Trastuzumab|trastuzumab|mesh-list
139263872|NCT02924883|Atezolizumab|atezolizumab|mesh-list
139263873|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139263874|NCT02924883|Maytansine|maytansine|mesh-list
139263875|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139263876|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263877|NCT02924883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139263878|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263879|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139263880|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
139263881|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
139263882|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
139263883|NCT02924883|Immunotoxins|immunotoxins|mesh-ancestor
139263884|NCT02924883|Immunoconjugates|immunoconjugates|mesh-ancestor
139263885|NCT02924883|Immunologic Factors|immunologic factors|mesh-ancestor
139263886|NCT02924883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263887|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
139263888|NCT02075970|Hematinics|hematinics|mesh-ancestor
139263889|NCT02231450|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
139263890|NCT02231450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139263891|NCT02231450|Serotonin Agents|serotonin agents|mesh-ancestor
139263892|NCT02231450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263893|NCT02231450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263894|NCT02231450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263895|NCT02227082|Olaparib|olaparib|mesh-list
139263896|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139263897|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139263898|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263899|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263900|NCT01369680|Ketamine|ketamine|mesh-list
139263901|NCT01369680|Analgesics|analgesics|mesh-ancestor
139263902|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
139263903|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263904|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263905|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139263906|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139263907|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
139263908|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
139263909|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139263910|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139263911|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139263912|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263913|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263914|NCT04780321|Antibodies|antibodies|mesh-list
139263915|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139263916|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
139263917|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263918|NCT03670095|Memantine|memantine|mesh-list
139263919|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139263920|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139263921|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
139263922|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263923|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263924|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263925|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139263926|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139263927|NCT01378039|Budesonide|budesonide|mesh-list
139263928|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139263929|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139263930|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
139263931|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263932|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263933|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139263934|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
139263935|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
139263936|NCT01378039|Hormones|hormones|mesh-ancestor
139263937|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139263938|NCT01377961|Lycopene|lycopene|mesh-list
139263939|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139263940|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
139263941|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263942|NCT01377961|Protective Agents|protective agents|mesh-ancestor
139263943|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263944|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139263945|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139263946|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263947|NCT03558750|Rituximab|rituximab|mesh-list
139263948|NCT03558750|Nivolumab|nivolumab|mesh-list
139263949|NCT03558750|Lenalidomide|lenalidomide|mesh-list
139263950|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139263951|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263952|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
139263953|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263954|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139263955|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139263956|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263957|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139263958|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139263959|NCT03558750|Growth Substances|growth substances|mesh-ancestor
139263960|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
139263961|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139263962|NCT02751320|Citric Acid|citric acid|mesh-list
139263963|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
139263964|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
139263965|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139263966|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
139263967|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
139263968|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263969|NCT03559764|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
139263970|NCT03559764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139263971|NCT03559764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263972|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
139263973|NCT04931641|Trace Elements|trace elements|mesh-ancestor
139263974|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
139263975|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263976|NCT02083536|Docetaxel|docetaxel|mesh-list
139263977|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139263978|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
139263979|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
139263980|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
139263981|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263982|NCT02231606|Methamphetamine|methamphetamine|mesh-list
139263983|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139263984|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263985|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
139263986|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
139263987|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139263988|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
139263989|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139263990|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139263991|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
139263992|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139263993|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139263994|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139263995|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139263996|NCT02083692|Metformin|metformin|mesh-list
139263997|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139263998|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139263999|NCT02227550|Vitamin K|vitamin k|mesh-list
139264000|NCT02227550|Warfarin|warfarin|mesh-list
139264001|NCT02227550|Apixaban|apixaban|mesh-list
139264002|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
139264003|NCT02227550|Fluindione|fluindione|mesh-list
139264004|NCT02227550|Vitamins|vitamins|mesh-ancestor
139264005|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
139264006|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264007|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
139264008|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139264009|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
139264010|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139264011|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
139264012|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264013|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264014|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139264015|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139264016|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
139264017|NCT02227550|Coagulants|coagulants|mesh-ancestor
139264018|NCT02206035|Methotrexate|methotrexate|mesh-list
139264019|NCT02206035|Tacrolimus|tacrolimus|mesh-list
139264020|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139264021|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
139264022|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139264023|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264024|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139264025|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
139264026|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264027|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264028|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
139264029|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264030|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139264031|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139264032|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
139264033|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139264034|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139264035|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139264036|NCT02258828|Memantine|memantine|mesh-list
139264037|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139264038|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139264039|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
139264040|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264041|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264042|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264043|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139264044|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139264045|NCT02083068|Vaccines|vaccines|mesh-list
139264046|NCT02083068|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139264047|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
139264048|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264049|NCT02083068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139264050|NCT02228252|Caseins|caseins|mesh-list
139264051|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
139264052|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
139264053|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264054|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
139264055|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139264056|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139264057|NCT02591953|Prednisolone|prednisolone|mesh-list
139264058|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
139264059|NCT02591953|Lidocaine|lidocaine|mesh-list
139264060|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139264061|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
139264062|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
139264063|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
139264064|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139264065|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264066|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
139264067|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264068|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139264069|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139264070|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139264071|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139264072|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264073|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139264074|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
139264075|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
139264076|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139264077|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
139264078|NCT02591953|Hormones|hormones|mesh-ancestor
139264079|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139264080|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139264081|NCT02591953|Protective Agents|protective agents|mesh-ancestor
139264082|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139264083|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264084|NCT02223884|Carboplatin|carboplatin|mesh-list
139264085|NCT02223884|Docetaxel|docetaxel|mesh-list
139264086|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264087|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
139264088|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
139264089|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
139264090|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264091|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
139264092|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139264093|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
139264094|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264095|NCT02569489|Paclitaxel|paclitaxel|mesh-list
139264096|NCT02569489|Trastuzumab|trastuzumab|mesh-list
139264097|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139264098|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264099|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
139264100|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
139264101|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
139264102|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264103|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139264104|NCT02079558|Oxytocin|oxytocin|mesh-list
139264105|NCT02079558|Carbetocin|carbetocin|mesh-list
139264106|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
139264107|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139264108|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264109|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
139264110|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139264111|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139264112|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139264113|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139264114|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264115|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
139264116|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264117|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264118|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139264119|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264120|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139264121|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
139264122|NCT03669003|Coagulants|coagulants|mesh-ancestor
139264123|NCT04313959|Dexamethasone|dexamethasone|mesh-list
139264124|NCT04313959|Ropivacaine|ropivacaine|mesh-list
139264125|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139264126|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
139264127|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
139264128|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264129|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264130|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139264131|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
139264132|NCT04313959|Hormones|hormones|mesh-ancestor
139264133|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139264134|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139264135|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264136|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
139264137|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
139264138|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139264139|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
139264140|NCT03073213|Ixekizumab|ixekizumab|mesh-list
139264141|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
139264142|NCT03070483|Vitamin D|vitamin d|mesh-list
139264143|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
139264144|NCT03070483|Vitamins|vitamins|mesh-ancestor
139264145|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
139264146|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264147|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139264148|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139264149|NCT04107727|Cytarabine|cytarabine|mesh-list
139264150|NCT04107727|Idarubicin|idarubicin|mesh-list
139264151|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139264152|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
139264153|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264154|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264155|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
139264156|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264157|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138847532|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
139264158|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
139264159|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264160|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139264161|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139264162|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139264164|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139264165|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139264166|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139264167|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139264168|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264169|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264170|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264171|NCT01074151|Analgesics|analgesics|mesh-ancestor
139264172|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
139264173|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264174|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
139264175|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139264176|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
139264177|NCT02786329|Lidocaine|lidocaine|mesh-list
139264178|NCT02786329|Sevoflurane|sevoflurane|mesh-list
139264179|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
139264180|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
139264181|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139264182|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264183|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
139264184|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264185|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139264186|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139264187|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139264188|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139264189|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264190|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139264191|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139264192|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
139264193|NCT05761327|Curcumin|curcumin|mesh-list
139264194|NCT05761327|Resveratrol|resveratrol|mesh-list
139264195|NCT05761327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139264196|NCT05761327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139264197|NCT05761327|Analgesics|analgesics|mesh-ancestor
139264198|NCT05761327|Sensory System Agents|sensory system agents|mesh-ancestor
139264199|NCT05761327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264200|NCT05761327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264201|NCT05761327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139264202|NCT05761327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139264203|NCT05761327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264204|NCT05761327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264205|NCT05761327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264207|NCT05761327|Protective Agents|protective agents|mesh-ancestor
139264208|NCT05761327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139264209|NCT02231762|Temozolomide|temozolomide|mesh-list
139264210|NCT02231762|Lanreotide|lanreotide|mesh-list
139264211|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139264212|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
139264213|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264214|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264215|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
139264216|NCT01191957|Busulfan|busulfan|mesh-list
139264217|NCT01191957|Fludarabine|fludarabine|mesh-list
139264218|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139264219|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
139264220|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264221|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139264222|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139264223|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
139264224|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264225|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264226|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139264227|NCT01050855|Busulfan|busulfan|mesh-list
139264228|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
139264229|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
139264230|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264231|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139264232|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
139264233|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264234|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139264235|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264236|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139264237|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139264238|NCT04459286|Ritonavir|ritonavir|mesh-list
139264239|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139264240|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
139264241|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139264242|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139264243|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
139264244|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264245|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264246|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139264247|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139264248|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
139264249|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264250|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139264251|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139264252|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139264253|NCT00744081|Topotecan|topotecan|mesh-list
139264254|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
139264255|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139264256|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139264257|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264258|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264259|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264260|NCT00744081|Analgesics|analgesics|mesh-ancestor
139264261|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
139264262|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264263|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264264|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139264265|NCT02229266|Cytarabine|cytarabine|mesh-list
139264266|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139264267|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
139264268|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264269|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264270|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
139264271|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264272|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139264273|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
139264274|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264275|NCT02224040|Azithromycin|azithromycin|mesh-list
139264276|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
139264277|NCT02224040|Cefixime|cefixime|mesh-list
139264278|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139264279|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264280|NCT04448834|Vincristine|vincristine|mesh-list
139264281|NCT04448834|Blinatumomab|blinatumomab|mesh-list
139264282|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139264283|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264284|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
139264285|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
139264286|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
139264287|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264288|NCT02232308|Lisinopril|lisinopril|mesh-list
139264289|NCT02232308|Nizatidine|nizatidine|mesh-list
139264290|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139264291|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
139264292|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264293|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264294|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139264295|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139264296|NCT02232308|Protective Agents|protective agents|mesh-ancestor
139264297|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264298|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139264299|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139264300|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139264301|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
139264302|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
139264303|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264304|NCT02229734|Androgens|androgens|mesh-list
139264305|NCT02229734|Hormones|hormones|mesh-ancestor
139264306|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139264307|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264308|NCT04333160|Hylan|hylan|mesh-list
139264309|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
139264310|NCT04333160|Protective Agents|protective agents|mesh-ancestor
139381640|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
139264311|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264312|NCT02258906|Urinastatin|urinastatin|mesh-list
139264313|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139264314|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139264315|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
139264316|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264317|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264318|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139264319|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139264320|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139264321|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264322|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139264323|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139264324|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139264325|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264326|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
139264327|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264328|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139264329|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264330|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264331|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
139264332|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139264333|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264334|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139264335|NCT03068455|Nivolumab|nivolumab|mesh-list
139264336|NCT03068455|Ipilimumab|ipilimumab|mesh-list
139264337|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139264338|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264339|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139264340|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264341|NCT04207736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139264342|NCT04207736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139264343|NCT02232932|Capecitabine|capecitabine|mesh-list
139264344|NCT02232932|Liver Extracts|liver extracts|mesh-list
139264345|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139264346|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
139264347|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264348|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264349|NCT02232932|Hematinics|hematinics|mesh-ancestor
139264350|NCT02230358|Anesthetics|anesthetics|mesh-list
139264351|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139264352|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264353|NCT03494504|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139264354|NCT03494504|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139264355|NCT04049864|Lenalidomide|lenalidomide|mesh-list
139264356|NCT04049864|Vaccines|vaccines|mesh-list
139264357|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
139264358|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264359|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139264360|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139264361|NCT04049864|Growth Substances|growth substances|mesh-ancestor
139264362|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
139264363|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264364|NCT03475706|Solabegron|solabegron|mesh-list
139264365|NCT03475706|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139264366|NCT03475706|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139264367|NCT03475706|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139264368|NCT03475706|Adrenergic Agents|adrenergic agents|mesh-ancestor
139264369|NCT03475706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264370|NCT03475706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264371|NCT03475706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264372|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139264373|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139264374|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139264375|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
139264376|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264377|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139264378|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139264379|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264380|NCT03928184|Lorecivivint|lorecivivint|mesh-list
139264381|NCT03928184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139264382|NCT02259374|Ropivacaine|ropivacaine|mesh-list
139264383|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
139264384|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
139264385|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139264386|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264387|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
139264388|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264389|NCT04921982|Propranolol|propranolol|mesh-list
139264390|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139264391|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139264392|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
139264393|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264394|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264395|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264396|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139264397|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139264398|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
139264399|NCT04874324|Levonadifloxacin|levonadifloxacin|mesh-list
139264400|NCT04874324|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139264401|NCT04874324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264402|NCT04874324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264403|NCT04874324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139264404|NCT04874324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264405|NCT04866056|Azacitidine|azacitidine|mesh-list
139264406|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139264407|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
139264408|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264409|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264410|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264411|NCT03911102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139264412|NCT03911102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139264413|NCT03911102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139264414|NCT03911102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264415|NCT03911102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264416|NCT03911102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139264417|NCT03911102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139264418|NCT03911102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264419|NCT03911102|Cholinergic Agents|cholinergic agents|mesh-ancestor
139264420|NCT03911102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264421|NCT04789148|Oxytocin|oxytocin|mesh-list
139264422|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
139264423|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139264424|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264425|NCT03172910|Rivaroxaban|rivaroxaban|mesh-list
139134635|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
139264426|NCT03172910|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139264427|NCT03172910|Antithrombins|antithrombins|mesh-ancestor
139264428|NCT03172910|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139264429|NCT03172910|Protease Inhibitors|protease inhibitors|mesh-ancestor
139264430|NCT03172910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264431|NCT03172910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264432|NCT03172910|Anticoagulants|anticoagulants|mesh-ancestor
139264434|NCT03881852|Antidepressive Agents|antidepressive agents|mesh-ancestor
139264435|NCT03881852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139264436|NCT03881852|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139264437|NCT03881852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139264438|NCT03881852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139264439|NCT03881852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264440|NCT03881852|Adrenergic Agents|adrenergic agents|mesh-ancestor
139264441|NCT03881852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264442|NCT03881852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264443|NCT03818828|Iodine|iodine|mesh-list
139264444|NCT03818828|Cadexomer iodine|cadexomer iodine|mesh-list
139264445|NCT03818828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139264446|NCT03818828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264447|NCT03818828|Trace Elements|trace elements|mesh-ancestor
139264448|NCT03818828|Micronutrients|micronutrients|mesh-ancestor
139264449|NCT03818828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264450|NCT02804282|Furosemide|furosemide|mesh-list
139264451|NCT02804282|Diuretics|diuretics|mesh-ancestor
139264452|NCT02804282|Natriuretic Agents|natriuretic agents|mesh-ancestor
139264453|NCT02804282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264454|NCT02804282|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139264455|NCT02804282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138847838|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
139264456|NCT02804282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264457|NCT02233244|Midazolam|midazolam|mesh-list
139264458|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139264459|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139264460|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139264461|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264462|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139264463|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139264464|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139264465|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139264466|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
139264467|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
139264468|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
139264469|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
139264470|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264471|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264472|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
139264473|NCT02234882|Fostemsavir|fostemsavir|mesh-list
139264474|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139264475|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139264476|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139264477|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
139264478|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264479|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139264480|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139264481|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264482|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139264483|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139264484|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
139264485|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264486|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139264487|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139264488|NCT03727022|Lorecivivint|lorecivivint|mesh-list
139264489|NCT03727022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139264490|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
139264491|NCT02233322|Hematinics|hematinics|mesh-ancestor
139264492|NCT02233400|Acetaminophen|acetaminophen|mesh-list
139264493|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139264494|NCT02233400|Analgesics|analgesics|mesh-ancestor
139264495|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
139264496|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264497|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264498|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
139642291|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
139134713|NCT03435003|Fentanyl|fentanyl|mesh-list
139264499|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139264500|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139264501|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
139264502|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264503|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139264504|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264505|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139264506|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264507|NCT02235194|Chromium|chromium|mesh-list
139264508|NCT02235194|Picolinic acid|picolinic acid|mesh-list
139264509|NCT02235194|Trace Elements|trace elements|mesh-ancestor
139264510|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
139264511|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264512|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139264513|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
139264514|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
139264515|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264516|NCT03684278|Infliximab|infliximab|mesh-list
139264517|NCT03684278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139264518|NCT03684278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139264519|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
139264520|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139264521|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139264522|NCT02726659|Celecoxib|celecoxib|mesh-list
139264523|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139264524|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139264525|NCT02726659|Analgesics|analgesics|mesh-ancestor
139264526|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
139264527|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264528|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264529|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139264530|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138847916|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
139264532|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139264533|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264534|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264535|NCT03660878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139264536|NCT03660878|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139264537|NCT03951961|Midostaurin|midostaurin|mesh-list
139264538|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264539|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139264540|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264541|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264542|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139264543|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139264544|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139264545|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139264546|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264547|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264548|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264549|NCT02232542|Analgesics|analgesics|mesh-ancestor
139264550|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
139264551|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264552|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
139264553|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139264554|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
139264555|NCT02600923|Letrozole|letrozole|mesh-list
139264556|NCT02600923|Palbociclib|palbociclib|mesh-list
139264557|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264558|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139264559|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139264560|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264561|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264562|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139264563|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
139264564|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139264565|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264566|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139264567|NCT02232776|Losartan|losartan|mesh-list
139264568|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139264569|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139297252|NCT04109222|Vaccines|vaccines|mesh-list
139642292|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139264570|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139264571|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139264572|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264573|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
139264574|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139264575|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264576|NCT03847519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139264577|NCT03847519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264579|NCT02235428|Albuterol|albuterol|mesh-list
139264580|NCT02235428|Ipratropium|ipratropium|mesh-list
139264581|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
139264582|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139264583|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
139264584|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264585|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264586|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139264587|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
139264588|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
139264589|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139264590|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139264591|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139264592|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139264593|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
139264594|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264595|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198959|NCT01193387|Insulin|insulin|mesh-list
139264596|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139264597|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
139264598|NCT03070171|Dabigatran|dabigatran|mesh-list
139264599|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
139264600|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139264601|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
139264602|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264603|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264604|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
139264605|NCT02262572|Telmisartan|telmisartan|mesh-list
139264606|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139264607|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139264608|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139264609|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139264610|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264611|NCT02262572|Diuretics|diuretics|mesh-ancestor
139264612|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
139264613|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264614|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139264615|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139264616|NCT02235584|Dexamethasone|dexamethasone|mesh-list
139264617|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139264618|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
139264619|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
139264620|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264621|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264622|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139264623|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
139264624|NCT02235584|Hormones|hormones|mesh-ancestor
139264625|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139264626|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139264627|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264628|NCT02235662|Tenofovir|tenofovir|mesh-list
139264629|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
139264630|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
139264631|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264632|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139264633|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139264634|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264635|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264636|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139264637|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139264638|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139264639|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
139264640|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139264641|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264642|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139264643|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139264644|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139264645|NCT02262650|Telmisartan|telmisartan|mesh-list
139264646|NCT02262650|Clopidogrel|clopidogrel|mesh-list
139264647|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139264648|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139264649|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139264650|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139264651|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
139264652|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264653|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264654|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264655|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139264656|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139264657|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139264658|NCT02784002|Fidaxomicin|fidaxomicin|mesh-list
139264659|NCT02784002|Ridinilazole|ridinilazole|mesh-list
139264660|NCT02784002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139264661|NCT02784002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264662|NCT02233556|Memantine|memantine|mesh-list
139264663|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139264664|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139264665|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
139264666|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264667|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264668|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264669|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139264670|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139264671|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139264672|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139264673|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264674|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
139264675|NCT02236052|Vaccines|vaccines|mesh-list
139264676|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
139264677|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264679|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139264680|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
139264681|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
139264682|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264683|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264684|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139264685|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
139264686|NCT04908592|Hormones|hormones|mesh-ancestor
139264687|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139264688|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139264689|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264690|NCT04759768|Naltrexone|naltrexone|mesh-list
139264691|NCT04759768|Nalmefene|nalmefene|mesh-list
139264692|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139264693|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264694|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
139264695|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264696|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139264697|NCT02564744|Rituximab|rituximab|mesh-list
139264698|NCT02564744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139264699|NCT02564744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264700|NCT02564744|Immunologic Factors|immunologic factors|mesh-ancestor
139264701|NCT02564744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264702|NCT02564744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139264703|NCT05759767|Tamsulosin|tamsulosin|mesh-list
139264704|NCT05759767|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139264705|NCT05759767|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139264706|NCT05759767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139264707|NCT05759767|Adrenergic Agents|adrenergic agents|mesh-ancestor
139264708|NCT05759767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264709|NCT05759767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264710|NCT05759767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264711|NCT05759767|Urological Agents|urological agents|mesh-ancestor
139264712|NCT02750306|Suvorexant|suvorexant|mesh-list
139264713|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139264714|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139264715|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139264716|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264717|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139134935|NCT03756129|Ketamine|ketamine|mesh-list
139264718|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264719|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264720|NCT03845140|Praziquantel|praziquantel|mesh-list
139264721|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
139264722|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139264723|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264724|NCT01816165|Acipimox|acipimox|mesh-list
139264725|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139264726|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
139264727|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264728|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139264729|NCT04476680|Vitamin D|vitamin d|mesh-list
139264730|NCT04476680|Vitamins|vitamins|mesh-ancestor
139264731|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
139264732|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264733|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139264734|NCT04952350|Atorvastatin|atorvastatin|mesh-list
139264735|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139264736|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139264737|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
139264738|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264739|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139264740|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139264741|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264742|NCT05376202|Cetuximab|cetuximab|mesh-list
139264743|NCT05376202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139264744|NCT05376202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264745|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
139264746|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139264747|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139264748|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
139264749|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139264750|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264751|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139264752|NCT04788550|Listerine|listerine|mesh-list
139264753|NCT04788550|Fluorides|fluorides|mesh-list
139264754|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
139264755|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
139264756|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
139264757|NCT04788550|Protective Agents|protective agents|mesh-ancestor
139264758|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264759|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139264760|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264761|NCT01677988|Folfirinox|folfirinox|mesh-list
139264762|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264763|NCT02233790|Clopidogrel|clopidogrel|mesh-list
139264764|NCT02233790|Ticagrelor|ticagrelor|mesh-list
139264765|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139264766|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139264767|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139264768|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139264769|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
139264770|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264771|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264772|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264773|NCT02547818|Ibuprofen|ibuprofen|mesh-list
139264774|NCT02547818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139264775|NCT02547818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139264776|NCT02547818|Analgesics|analgesics|mesh-ancestor
139264777|NCT02547818|Sensory System Agents|sensory system agents|mesh-ancestor
139264778|NCT02547818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264779|NCT02547818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264780|NCT02547818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139264781|NCT02547818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139264782|NCT02547818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139264783|NCT02547818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264784|NCT02547818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264785|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139264786|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
139264787|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139264788|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139264789|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
139264790|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642293|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139264791|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264792|NCT03752918|Niacin|niacin|mesh-list
139264793|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
139264794|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139264795|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139264796|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
139264797|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264798|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139264799|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
139264800|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
139264801|NCT03752918|Vitamins|vitamins|mesh-ancestor
139264802|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
139264803|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264804|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
139264805|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139264806|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
139264807|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264808|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139264809|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139264810|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139264811|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
139264812|NCT04259320|Propolis|propolis|mesh-list
139264813|NCT04259320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264814|NCT04058158|Eculizumab|eculizumab|mesh-list
139264815|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139264816|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139264817|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
139264818|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264819|NCT02263196|Ethanol|ethanol|mesh-list
139264820|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
139264821|NCT02263196|Povidone|povidone|mesh-list
139264822|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139264823|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264824|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139264825|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264826|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
139264827|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
139264828|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
139264829|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139264830|NCT02926573|Gabapentin|gabapentin|mesh-list
139264831|NCT02926573|Analgesics|analgesics|mesh-ancestor
139264832|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
139264833|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264834|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264835|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
139264836|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139264837|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139264838|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139264839|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139264840|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139264841|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139264842|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264843|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264844|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
139264845|NCT04477018|Iron|iron|mesh-list
139264846|NCT04477018|Chelating Agents|chelating agents|mesh-list
139264847|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
139264848|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264849|NCT04477018|Trace Elements|trace elements|mesh-ancestor
139264850|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264851|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
139264852|NCT00158860|Valacyclovir|valacyclovir|mesh-list
139264853|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
139264854|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264855|NCT02490488|Gemcitabine|gemcitabine|mesh-list
139264856|NCT02490488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139264857|NCT02490488|Antimetabolites|antimetabolites|mesh-ancestor
139264858|NCT02490488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264859|NCT02490488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264860|NCT02471222|Amantadine|amantadine|mesh-list
139264861|NCT02471222|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139264862|NCT02471222|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139264863|NCT02471222|Antiviral Agents|antiviral agents|mesh-ancestor
139264864|NCT02471222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264865|NCT02471222|Dopamine Agents|dopamine agents|mesh-ancestor
139264866|NCT02471222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264867|NCT02471222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264868|NCT02471222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264869|NCT02471222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139264870|NCT02471222|Analgesics|analgesics|mesh-ancestor
139264871|NCT02471222|Sensory System Agents|sensory system agents|mesh-ancestor
139264872|NCT02471222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264873|NCT03136120|Bromides|bromides|mesh-list
139264874|NCT03136120|Ipratropium|ipratropium|mesh-list
139264875|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
139264876|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139264877|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
139264878|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264879|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264880|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139264881|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
139264882|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139264883|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
139264884|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264885|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264886|NCT01625234|Ensartinib|ensartinib|mesh-list
139264887|NCT01625234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264888|NCT01625234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139264889|NCT01625234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264890|NCT01625234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264891|NCT02264834|Sufentanil|sufentanil|mesh-list
139264893|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
139264894|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139264895|NCT02264834|Narcotics|narcotics|mesh-ancestor
139264896|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139264897|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264898|NCT02264834|Analgesics|analgesics|mesh-ancestor
139264899|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
139264900|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139264901|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139264902|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139264903|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
139264904|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
139264905|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
139264906|NCT05762419|Etoposide|etoposide|mesh-list
139264907|NCT05762419|Etoposide phosphate|etoposide phosphate|mesh-list
139264908|NCT05762419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139264909|NCT05762419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264910|NCT05762419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139264911|NCT05762419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139264912|NCT05762419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264913|NCT05762419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264914|NCT02264912|Clopidogrel|clopidogrel|mesh-list
139264915|NCT02264912|Ticagrelor|ticagrelor|mesh-list
139264916|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139264917|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139264918|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139264919|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139264920|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139264921|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
139264922|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264923|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264924|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264925|NCT02263352|Carotenoids|carotenoids|mesh-list
139264926|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
139264927|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264928|NCT02263352|Protective Agents|protective agents|mesh-ancestor
139264929|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264930|NCT01435226|Ribavirin|ribavirin|mesh-list
139264931|NCT01435226|Ledipasvir|ledipasvir|mesh-list
139264932|NCT01435226|Antimetabolites|antimetabolites|mesh-ancestor
139264933|NCT01435226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264934|NCT01435226|Antiviral Agents|antiviral agents|mesh-ancestor
139264935|NCT01435226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139264936|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139264937|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
139264938|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
139264939|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139264940|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139264941|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139264942|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264943|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139264944|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139264945|NCT04409509|Antibodies|antibodies|mesh-list
139264946|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139264947|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
139264948|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264949|NCT04401865|Riboflavin|riboflavin|mesh-list
139264950|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
139264951|NCT04401865|Vitamins|vitamins|mesh-ancestor
139264952|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
139264953|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264954|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139264955|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
139264956|NCT02609048|Seladelpar|seladelpar|mesh-list
139264957|NCT02609048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139264958|NCT02609048|Antimetabolites|antimetabolites|mesh-ancestor
139264959|NCT02609048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264960|NCT02609048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139264961|NCT02265068|Ticagrelor|ticagrelor|mesh-list
139264962|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139264963|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139264964|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139199333|NCT03844217|Tryptophan|tryptophan|mesh-list
139264965|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139264966|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
139264967|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139264968|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264969|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264970|NCT02262416|Leuprolide|leuprolide|mesh-list
139264971|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139264972|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
139264973|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139264974|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264975|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139264976|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848364|NCT02639273|Nalmefene|nalmefene|mesh-list
139264977|NCT01577654|Folic Acid|folic acid|mesh-list
139264978|NCT01577654|Docetaxel|docetaxel|mesh-list
139264979|NCT01577654|Vinca Alkaloids|vinca alkaloids|mesh-list
139264980|NCT01577654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139264981|NCT01577654|Tubulin Modulators|tubulin modulators|mesh-ancestor
139264982|NCT01577654|Antimitotic Agents|antimitotic agents|mesh-ancestor
139264983|NCT01577654|Mitosis Modulators|mitosis modulators|mesh-ancestor
139264984|NCT01577654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264985|NCT01577654|Hematinics|hematinics|mesh-ancestor
139264986|NCT01577654|Vitamin B Complex|vitamin b complex|mesh-ancestor
139264987|NCT01577654|Vitamins|vitamins|mesh-ancestor
139264988|NCT01577654|Micronutrients|micronutrients|mesh-ancestor
139264989|NCT01577654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139264990|NCT01423058|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
139264991|NCT01423058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139264992|NCT01423058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264993|NCT01423058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264994|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
139264995|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139264996|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
139264997|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264998|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139264999|NCT01418222|Leucovorin|leucovorin|mesh-list
139265000|NCT01418222|Bevacizumab|bevacizumab|mesh-list
139265001|NCT01418222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139265002|NCT01418222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265003|NCT01418222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139265004|NCT01418222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139265005|NCT01418222|Growth Substances|growth substances|mesh-ancestor
139265006|NCT01418222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265007|NCT01418222|Growth Inhibitors|growth inhibitors|mesh-ancestor
139265008|NCT01418222|Antidotes|antidotes|mesh-ancestor
139265009|NCT01418222|Protective Agents|protective agents|mesh-ancestor
139265010|NCT01418222|Vitamin B Complex|vitamin b complex|mesh-ancestor
139265011|NCT01418222|Vitamins|vitamins|mesh-ancestor
139265012|NCT01418222|Micronutrients|micronutrients|mesh-ancestor
139265013|NCT01256762|Paclitaxel|paclitaxel|mesh-list
139265014|NCT01256762|Bevacizumab|bevacizumab|mesh-list
139265015|NCT01256762|Imetelstat|imetelstat|mesh-list
139265016|NCT01256762|Motesanib diphosphate|motesanib diphosphate|mesh-list
139642294|NCT01457911|Metformin|metformin|mesh-list
139135252|NCT03863925|Propofol|propofol|mesh-list
139265017|NCT01256762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139265018|NCT01256762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265019|NCT01256762|Tubulin Modulators|tubulin modulators|mesh-ancestor
139265020|NCT01256762|Antimitotic Agents|antimitotic agents|mesh-ancestor
139265021|NCT01256762|Mitosis Modulators|mitosis modulators|mesh-ancestor
139265022|NCT01256762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265023|NCT01256762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139265024|NCT01256762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139265025|NCT01256762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139265026|NCT01256762|Growth Substances|growth substances|mesh-ancestor
139265027|NCT01256762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265028|NCT01256762|Growth Inhibitors|growth inhibitors|mesh-ancestor
139265029|NCT01256762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265030|NCT01256762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139265031|NCT01252628|Cetuximab|cetuximab|mesh-list
139265032|NCT01252628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139265033|NCT01252628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265034|NCT01236638|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
139265035|NCT01236638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139265036|NCT01236638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265037|NCT01236638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265038|NCT04349371|Chloroquine|chloroquine|mesh-list
139265039|NCT04349371|Amebicides|amebicides|mesh-ancestor
139265040|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139265041|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139265042|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139265043|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
139265044|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139265045|NCT01410188|Latanoprost|latanoprost|mesh-list
139265046|NCT01410188|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139265047|NCT01410188|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139265048|NCT01408082|Azithromycin|azithromycin|mesh-list
139265049|NCT01408082|Dexamethasone|dexamethasone|mesh-list
139265050|NCT01408082|Dexamethasone acetate|dexamethasone acetate|mesh-list
139265051|NCT01408082|BB 1101|bb 1101|mesh-list
139265052|NCT01408082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139265053|NCT01408082|Antiemetics|antiemetics|mesh-ancestor
139265054|NCT01408082|Autonomic Agents|autonomic agents|mesh-ancestor
139265055|NCT01408082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265056|NCT01408082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265057|NCT01408082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139265058|NCT01408082|Glucocorticoids|glucocorticoids|mesh-ancestor
139265059|NCT01408082|Hormones|hormones|mesh-ancestor
139265060|NCT01408082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265061|NCT01408082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139265062|NCT01408082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265063|NCT01408082|Protease Inhibitors|protease inhibitors|mesh-ancestor
139265064|NCT01408082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265065|NCT01408082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265066|NCT01408082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139265067|NCT01408082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139265068|NCT03071263|Spironolactone|spironolactone|mesh-list
139265069|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139265070|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
139265071|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265072|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265073|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139265074|NCT03071263|Diuretics|diuretics|mesh-ancestor
139265075|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
139265076|NCT05200663|Tamoxifen|tamoxifen|mesh-list
139265077|NCT05200663|Vitamin E|vitamin e|mesh-list
139265078|NCT05200663|Vitamins|vitamins|mesh-ancestor
139265079|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
139265080|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265081|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139265082|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
139265083|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265084|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139265085|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265086|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139265087|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139265088|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139642295|NCT01457911|Glimepiride|glimepiride|mesh-list
139265090|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265091|NCT05200663|Protective Agents|protective agents|mesh-ancestor
139265092|NCT02268422|Buprenorphine|buprenorphine|mesh-list
139265093|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139265094|NCT02268422|Narcotics|narcotics|mesh-ancestor
139265095|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265096|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265097|NCT02268422|Analgesics|analgesics|mesh-ancestor
139265098|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
139265099|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265100|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139265101|NCT01522196|Varespladib methyl|varespladib methyl|mesh-list
139265102|NCT01522196|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
139265103|NCT01522196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265104|NCT01522196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265105|NCT05049343|Ketamine|ketamine|mesh-list
139265106|NCT05049343|Analgesics|analgesics|mesh-ancestor
139265107|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
139265108|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265109|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265110|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139265111|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139265112|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
139265113|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
139265114|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265115|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139265116|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139265117|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265118|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265119|NCT01569919|Folic Acid|folic acid|mesh-list
139265120|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
139265121|NCT01569919|Dexamethasone|dexamethasone|mesh-list
139265122|NCT01569919|Pemetrexed|pemetrexed|mesh-list
139265123|NCT01569919|Vitamins|vitamins|mesh-ancestor
139265124|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
139265125|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265126|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139265127|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
138848587|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265128|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
139265129|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265130|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139265131|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
139265132|NCT01569919|Hormones|hormones|mesh-ancestor
139265133|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265134|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139265135|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265136|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265137|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265138|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139265139|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139265140|NCT01569919|Hematinics|hematinics|mesh-ancestor
139265141|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
139265142|NCT01399580|Atrasentan|atrasentan|mesh-list
139265143|NCT01399580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265144|NCT01399580|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139265145|NCT01399580|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139265146|NCT01399580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265147|NCT04069585|Lidocaine|lidocaine|mesh-list
139265148|NCT04069585|Anesthetics|anesthetics|mesh-list
139265149|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
139265150|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265151|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265152|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
139265153|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265154|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139265155|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139265156|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139265157|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139265158|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265159|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
139265160|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139265161|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
139265162|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265163|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139265164|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139265165|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
139265166|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265167|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265168|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139265169|NCT03066193|Palmidrol|palmidrol|mesh-list
139265170|NCT03066193|Dronabinol|dronabinol|mesh-list
139265171|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
139265172|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265173|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139265174|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139265175|NCT03066193|Analgesics|analgesics|mesh-ancestor
139265176|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
139265177|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265178|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139265179|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139265180|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265181|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265182|NCT03066193|Hormones|hormones|mesh-ancestor
139265183|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265184|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139265185|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139265186|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139265187|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
139265188|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139265189|NCT02263976|Bromides|bromides|mesh-list
139265190|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
139265191|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
139265192|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139265193|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
139265194|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265195|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265196|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139265197|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
139265198|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
139265199|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139265200|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
139265201|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265202|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265204|NCT02263976|Miotics|miotics|mesh-ancestor
139265205|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139265206|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139265207|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139265208|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139265209|NCT01382654|Azelastine|azelastine|mesh-list
139265210|NCT01382654|Epinastine|epinastine|mesh-list
139265211|NCT01382654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139265212|NCT01382654|Autonomic Agents|autonomic agents|mesh-ancestor
139265213|NCT01382654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265214|NCT01382654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265215|NCT01382654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139265216|NCT01382654|Respiratory System Agents|respiratory system agents|mesh-ancestor
139265217|NCT01382654|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139265218|NCT01382654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265219|NCT01382654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265220|NCT01382654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139265221|NCT01382654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139265222|NCT01382654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139265223|NCT01382654|Histamine Antagonists|histamine antagonists|mesh-ancestor
139265224|NCT01382654|Histamine Agents|histamine agents|mesh-ancestor
139265225|NCT01382654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265226|NCT01378676|Riluzole|riluzole|mesh-list
139265227|NCT01378676|Anticonvulsants|anticonvulsants|mesh-ancestor
139265228|NCT01378676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139265229|NCT01378676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139265230|NCT01378676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265231|NCT01378676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265232|NCT01378676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265233|NCT01378676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139265234|NCT01378676|Protective Agents|protective agents|mesh-ancestor
139265235|NCT01377662|Methylphenidate|methylphenidate|mesh-list
139265236|NCT01377662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139265237|NCT01377662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265238|NCT01377662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139265239|NCT01377662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139265240|NCT01377662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139265241|NCT01377662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265242|NCT01377662|Dopamine Agents|dopamine agents|mesh-ancestor
139265243|NCT01377662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265244|NCT01371578|Ribavirin|ribavirin|mesh-list
139265245|NCT01371578|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139265246|NCT01371578|Ledipasvir|ledipasvir|mesh-list
139265247|NCT01371578|Antimetabolites|antimetabolites|mesh-ancestor
139265248|NCT01371578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265249|NCT01371578|Antiviral Agents|antiviral agents|mesh-ancestor
139265250|NCT01371578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139265251|NCT01225640|Oxazolidinones|oxazolidinones|mesh-list
139265252|NCT01225640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139265253|NCT01225640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139265254|NCT01225640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265255|NCT01225640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265256|NCT01498328|Bevacizumab|bevacizumab|mesh-list
139265257|NCT01498328|Rindopepimut|rindopepimut|mesh-list
139265258|NCT01498328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139265259|NCT01498328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265260|NCT01498328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139265261|NCT01498328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139265262|NCT01498328|Growth Substances|growth substances|mesh-ancestor
139265263|NCT01498328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265264|NCT01498328|Growth Inhibitors|growth inhibitors|mesh-ancestor
139265265|NCT01497704|Apatinib|apatinib|mesh-list
139265266|NCT01497704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265267|NCT01497704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139265268|NCT01497704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265269|NCT01497704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265270|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139265271|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
139265272|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
138848672|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
139265273|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265274|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265275|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
139265276|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265277|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139265278|NCT03911713|Ivacaftor|ivacaftor|mesh-list
139265279|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139265280|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139265281|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265282|NCT02264132|Pramipexole|pramipexole|mesh-list
139265283|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
139265284|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265285|NCT02264132|Protective Agents|protective agents|mesh-ancestor
139265286|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265287|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139265288|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139265289|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
139265290|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
139265291|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265292|NCT01192880|Antipsychotic Agents|antipsychotic agents|mesh-list
139265293|NCT01192880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139265294|NCT01192880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265295|NCT01192880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265296|NCT01192880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139265297|NCT04540744|Tadalafil|tadalafil|mesh-list
139265298|NCT04540744|Macitentan|macitentan|mesh-list
139265299|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
139265300|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139265301|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139265302|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265303|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265304|NCT04540744|Urological Agents|urological agents|mesh-ancestor
139265305|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139265306|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139265307|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139265308|NCT05375734|Tislelizumab|tislelizumab|mesh-list
139265309|NCT05375734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139265310|NCT05375734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265311|NCT01489046|Tenofovir|tenofovir|mesh-list
139265312|NCT01489046|Lamivudine|lamivudine|mesh-list
139265313|NCT01489046|Efavirenz|efavirenz|mesh-list
139265314|NCT01489046|Antiviral Agents|antiviral agents|mesh-ancestor
139265315|NCT01489046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139265316|NCT01489046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139265317|NCT01489046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139265318|NCT01489046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265319|NCT01489046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265320|NCT01489046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139265321|NCT01489046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139265322|NCT01489046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139265323|NCT01489046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139265324|NCT01489046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139265325|NCT01489046|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139265326|NCT01489046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139265327|NCT01489046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139265328|NCT01180634|Levofloxacin|levofloxacin|mesh-list
139265329|NCT01180634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139265330|NCT01180634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139265331|NCT01180634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139265332|NCT01180634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139265333|NCT01180634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139265334|NCT01180634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265335|NCT01180634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265336|NCT01180634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265337|NCT01180634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139265338|NCT01180634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139265339|NCT02268890|Bortezomib|bortezomib|mesh-list
139265340|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265341|NCT02268968|Lidocaine|lidocaine|mesh-list
139265342|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
139265343|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
139265344|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265345|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265346|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
139265347|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265348|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139265349|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139265350|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139265351|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139265352|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265353|NCT01359566|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
139265354|NCT01359566|Baclofen|baclofen|mesh-list
139265355|NCT01359566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139265356|NCT01359566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265357|NCT01359566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139265358|NCT01359566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265359|NCT01359566|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139265360|NCT01359566|GABA Agonists|gaba agonists|mesh-ancestor
139265361|NCT01359566|GABA Agents|gaba agents|mesh-ancestor
139265362|NCT01359566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265363|NCT01359566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265364|NCT04885816|Sirolimus|sirolimus|mesh-list
139265365|NCT04885816|Everolimus|everolimus|mesh-list
139265366|NCT04885816|MTOR Inhibitors|mtor inhibitors|mesh-list
139265367|NCT04885816|Temsirolimus|temsirolimus|mesh-list
139265368|NCT04885816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139265369|NCT04885816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265370|NCT04885816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265371|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139265372|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
139265373|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265374|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265375|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139265376|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139265377|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139265378|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
139265379|NCT04865614|Sevoflurane|sevoflurane|mesh-list
139265380|NCT04865614|Etomidate|etomidate|mesh-list
139265381|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139265382|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139265383|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
139265384|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
139265385|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265386|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265387|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139265388|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139265389|NCT02269046|Simvastatin|simvastatin|mesh-list
139265390|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139265391|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139265392|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
139265393|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265394|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139265395|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139265396|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265397|NCT01483742|Ritonavir|ritonavir|mesh-list
139265398|NCT01483742|Ribavirin|ribavirin|mesh-list
139265399|NCT01483742|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139265400|NCT01483742|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139265401|NCT01483742|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139265402|NCT01483742|Protease Inhibitors|protease inhibitors|mesh-ancestor
139265403|NCT01483742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265404|NCT01483742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265405|NCT01483742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139265406|NCT01483742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139265407|NCT01483742|Antiviral Agents|antiviral agents|mesh-ancestor
139265408|NCT01483742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139265409|NCT01483742|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139265410|NCT01483742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139265411|NCT01483742|Antimetabolites|antimetabolites|mesh-ancestor
139265412|NCT04691128|Anesthetics|anesthetics|mesh-list
139265413|NCT04691128|Propofol|propofol|mesh-list
139265414|NCT04691128|Desflurane|desflurane|mesh-list
139265415|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265416|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265417|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139265418|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139265419|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
139265420|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139265421|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
139265422|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139265423|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265425|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139265426|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139265427|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265428|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265429|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139265430|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139265431|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139265432|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139265433|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
139265434|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
139265435|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
139265436|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
139265437|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265438|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265439|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
139265440|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139265441|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
139265442|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139265443|NCT01353248|Ribavirin|ribavirin|mesh-list
139265444|NCT01353248|Ledipasvir|ledipasvir|mesh-list
139265445|NCT01353248|Antimetabolites|antimetabolites|mesh-ancestor
139265446|NCT01353248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265447|NCT01353248|Antiviral Agents|antiviral agents|mesh-ancestor
139265448|NCT01353248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139265449|NCT05095636|Apatinib|apatinib|mesh-list
139265450|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265451|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139265452|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265453|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265454|NCT01343966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139265455|NCT01343966|Immunologic Factors|immunologic factors|mesh-ancestor
139265456|NCT01343966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265457|NCT05095480|Red yeast rice|red yeast rice|mesh-list
139265458|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139265459|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139265460|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139265461|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
139265462|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265463|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265464|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139265465|NCT06091891|Tranexamic Acid|tranexamic acid|mesh-list
139265466|NCT06091891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139265467|NCT06091891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139265468|NCT06091891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265469|NCT06091891|Hemostatics|hemostatics|mesh-ancestor
139265470|NCT06091891|Coagulants|coagulants|mesh-ancestor
139265471|NCT06091852|Caseins|caseins|mesh-list
139265472|NCT06091852|Chelating Agents|chelating agents|mesh-ancestor
139265473|NCT06091852|Sequestering Agents|sequestering agents|mesh-ancestor
139265474|NCT06091852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265475|NCT06091787|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139265476|NCT06091787|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139265477|NCT06091787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139265478|NCT06091748|Edotreotide|edotreotide|mesh-list
139265479|NCT06091748|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139265480|NCT06091748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265481|NCT06091631|Magnesium Sulfate|magnesium sulfate|mesh-list
139265482|NCT06091631|Analgesics|analgesics|mesh-ancestor
139265483|NCT06091631|Sensory System Agents|sensory system agents|mesh-ancestor
139265484|NCT06091631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265485|NCT06091631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265486|NCT06091631|Anesthetics|anesthetics|mesh-ancestor
139265487|NCT06091631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265488|NCT06091631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139265489|NCT06091631|Anticonvulsants|anticonvulsants|mesh-ancestor
139265490|NCT06091631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139265491|NCT06091631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139265492|NCT06091631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265493|NCT06091631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139265494|NCT06091631|Tocolytic Agents|tocolytic agents|mesh-ancestor
139265495|NCT06091631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139265496|NCT06091579|Treprostinil|treprostinil|mesh-list
139265497|NCT06091579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139265499|NCT06091553|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139265500|NCT06091553|Amitriptyline|amitriptyline|mesh-list
139265501|NCT06091553|Analgesics|analgesics|mesh-ancestor
139265502|NCT06091553|Sensory System Agents|sensory system agents|mesh-ancestor
139265503|NCT06091553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265504|NCT06091553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265505|NCT06091553|Anticonvulsants|anticonvulsants|mesh-ancestor
139265506|NCT06091553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139265507|NCT06091553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139265508|NCT06091553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265509|NCT06091553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139265510|NCT06091553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139265511|NCT06091553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139265512|NCT06091553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265513|NCT06091553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265514|NCT06091553|Antimanic Agents|antimanic agents|mesh-ancestor
139265515|NCT06091553|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139265516|NCT06091553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139265517|NCT06091553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139265518|NCT06091553|Antidepressive Agents|antidepressive agents|mesh-ancestor
139265519|NCT06091553|Dopamine Agents|dopamine agents|mesh-ancestor
139265520|NCT06091553|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139265521|NCT06091553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139265522|NCT06091553|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139265523|NCT06091553|Adrenergic Agents|adrenergic agents|mesh-ancestor
139265524|NCT06091475|Dapagliflozin|dapagliflozin|mesh-list
139265525|NCT06091475|Empagliflozin|empagliflozin|mesh-list
139265526|NCT06091475|Eplerenone|eplerenone|mesh-list
139265527|NCT06091475|Spironolactone|spironolactone|mesh-list
139265528|NCT06091475|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139265529|NCT06091475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265530|NCT06091475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139265531|NCT06091475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265532|NCT06091475|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139265533|NCT06091475|Hormone Antagonists|hormone antagonists|mesh-ancestor
139265534|NCT06091475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265535|NCT06091475|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139265536|NCT06091475|Diuretics|diuretics|mesh-ancestor
139265537|NCT06091475|Natriuretic Agents|natriuretic agents|mesh-ancestor
139265538|NCT06091475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139265539|NCT06091436|Progesterone|progesterone|mesh-list
139265540|NCT06091436|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139265541|NCT06091436|Ganirelix|ganirelix|mesh-list
139265542|NCT06091436|Progestins|progestins|mesh-ancestor
139265543|NCT06091436|Hormones|hormones|mesh-ancestor
139265544|NCT06091436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265545|NCT06091436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265546|NCT06091436|Hormone Antagonists|hormone antagonists|mesh-ancestor
139265547|NCT06091410|Vaccines|vaccines|mesh-list
139265548|NCT06091410|Immunologic Factors|immunologic factors|mesh-ancestor
139265549|NCT06091410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265550|NCT06091345|Midodrine|midodrine|mesh-list
139265551|NCT06091345|Sympathomimetics|sympathomimetics|mesh-ancestor
139265552|NCT06091345|Autonomic Agents|autonomic agents|mesh-ancestor
139265553|NCT06091345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265554|NCT06091345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265555|NCT06091345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139265556|NCT06091345|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139265557|NCT06091345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139265558|NCT06091345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139265559|NCT06091345|Adrenergic Agents|adrenergic agents|mesh-ancestor
139265560|NCT06091345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265561|NCT06091345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265562|NCT06091332|Sirolimus|sirolimus|mesh-list
139265563|NCT06091332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139265564|NCT06091332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139265565|NCT06091332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139265566|NCT06091332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265567|NCT06091332|Antifungal Agents|antifungal agents|mesh-ancestor
139265568|NCT06091332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139265569|NCT06091332|Immunologic Factors|immunologic factors|mesh-ancestor
138848965|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139265570|NCT06091332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265571|NCT06091241|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
139265572|NCT06091241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139265573|NCT06091241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139265574|NCT06091241|Analgesics|analgesics|mesh-ancestor
139265575|NCT06091241|Sensory System Agents|sensory system agents|mesh-ancestor
139265576|NCT06091241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265577|NCT06091241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265578|NCT06091241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139265579|NCT06091241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139265580|NCT06091085|Acetazolamide|acetazolamide|mesh-list
139265581|NCT06091085|Anticonvulsants|anticonvulsants|mesh-ancestor
139265582|NCT06091085|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139265583|NCT06091085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265584|NCT06091085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265585|NCT06091085|Diuretics|diuretics|mesh-ancestor
139265586|NCT06091085|Natriuretic Agents|natriuretic agents|mesh-ancestor
139265587|NCT06091085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265588|NCT06090981|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139265589|NCT06090981|Respiratory System Agents|respiratory system agents|mesh-ancestor
139265590|NCT06090955|Lidocaine|lidocaine|mesh-list
139265591|NCT06090955|Dexmedetomidine|dexmedetomidine|mesh-list
139265592|NCT06090955|Anesthetics, Local|anesthetics, local|mesh-ancestor
139265593|NCT06090955|Anesthetics|anesthetics|mesh-ancestor
139265594|NCT06090955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265595|NCT06090955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265596|NCT06090955|Sensory System Agents|sensory system agents|mesh-ancestor
139265597|NCT06090955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265598|NCT06090955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139265599|NCT06090955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139265600|NCT06090955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139265601|NCT06090955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139265602|NCT06090955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265603|NCT06090955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139265604|NCT06090955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139265605|NCT06090955|Analgesics|analgesics|mesh-ancestor
139265606|NCT06090955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139265607|NCT06090955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139265608|NCT06090955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139265609|NCT06090955|Adrenergic Agents|adrenergic agents|mesh-ancestor
139265610|NCT06090955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265611|NCT06090890|Aspirin|aspirin|mesh-list
139265612|NCT06090890|Prednisone|prednisone|mesh-list
139265613|NCT06090890|Colchicine|colchicine|mesh-list
139265614|NCT06090890|Hypolipidemic Agents|hypolipidemic agents|mesh-list
139265615|NCT06090890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
139265616|NCT06090890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139265617|NCT06090890|Glucocorticoids|glucocorticoids|mesh-ancestor
139265618|NCT06090890|Hormones|hormones|mesh-ancestor
139265619|NCT06090890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265620|NCT06090890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265621|NCT06090890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139265622|NCT06090890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265623|NCT06090890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139265624|NCT06090890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139265625|NCT06090890|Analgesics|analgesics|mesh-ancestor
139265626|NCT06090890|Sensory System Agents|sensory system agents|mesh-ancestor
139265627|NCT06090890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265628|NCT06090890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139265629|NCT06090890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139265630|NCT06090890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139265631|NCT06090890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265632|NCT06090890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139265633|NCT06090890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139265634|NCT06090890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265635|NCT06090890|Antipyretics|antipyretics|mesh-ancestor
139265636|NCT06090890|Gout Suppressants|gout suppressants|mesh-ancestor
139265637|NCT06090890|Tubulin Modulators|tubulin modulators|mesh-ancestor
139265638|NCT06090890|Antimitotic Agents|antimitotic agents|mesh-ancestor
139265639|NCT06090890|Mitosis Modulators|mitosis modulators|mesh-ancestor
139265640|NCT06090890|Antimetabolites|antimetabolites|mesh-ancestor
139265641|NCT06090890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139265642|NCT06090890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139265643|NCT06090890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139265644|NCT06090890|Purinergic Agents|purinergic agents|mesh-ancestor
139265645|NCT06090890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265646|NCT06090656|Bevacizumab|bevacizumab|mesh-list
139265647|NCT06090656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139265648|NCT06090656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265649|NCT06090656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139265650|NCT06090656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139265651|NCT06090656|Growth Substances|growth substances|mesh-ancestor
139265652|NCT06090656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265653|NCT06090656|Growth Inhibitors|growth inhibitors|mesh-ancestor
139265654|NCT06090500|Dexamethasone|dexamethasone|mesh-list
139265655|NCT06090500|Diclofenac|diclofenac|mesh-list
139265656|NCT06090500|Dexamethasone acetate|dexamethasone acetate|mesh-list
139265657|NCT06090500|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139265658|NCT06090500|BB 1101|bb 1101|mesh-list
139265659|NCT06090500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139265660|NCT06090500|Antiemetics|antiemetics|mesh-ancestor
139265661|NCT06090500|Autonomic Agents|autonomic agents|mesh-ancestor
139265662|NCT06090500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265663|NCT06090500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265664|NCT06090500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139265665|NCT06090500|Glucocorticoids|glucocorticoids|mesh-ancestor
139265666|NCT06090500|Hormones|hormones|mesh-ancestor
139265667|NCT06090500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265668|NCT06090500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139265669|NCT06090500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265670|NCT06090500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139265671|NCT06090500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139265672|NCT06090500|Analgesics|analgesics|mesh-ancestor
139265673|NCT06090500|Sensory System Agents|sensory system agents|mesh-ancestor
139265674|NCT06090500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139265675|NCT06090500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139265676|NCT06090500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265677|NCT06090500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265678|NCT06090500|Protease Inhibitors|protease inhibitors|mesh-ancestor
139265679|NCT06090422|Midazolam|midazolam|mesh-list
139265680|NCT06090422|Ketamine|ketamine|mesh-list
139265681|NCT06090422|Analgesics|analgesics|mesh-ancestor
139265682|NCT06090422|Sensory System Agents|sensory system agents|mesh-ancestor
139265683|NCT06090422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265684|NCT06090422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265685|NCT06090422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139265686|NCT06090422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139265687|NCT06090422|Anesthetics, General|anesthetics, general|mesh-ancestor
139265688|NCT06090422|Anesthetics|anesthetics|mesh-ancestor
139265689|NCT06090422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265690|NCT06090422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139265691|NCT06090422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139265692|NCT06090422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265693|NCT06090422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265694|NCT06090422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139265695|NCT06090422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139265696|NCT06090422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139265697|NCT06090422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139265698|NCT06090422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139265699|NCT06090422|GABA Modulators|gaba modulators|mesh-ancestor
139265700|NCT06090422|GABA Agents|gaba agents|mesh-ancestor
139265701|NCT06090318|Atezolizumab|atezolizumab|mesh-list
139265702|NCT06090318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139265703|NCT06090318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265704|NCT06090318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139265705|NCT06090318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265706|NCT06090123|Itraconazole|itraconazole|mesh-list
139265707|NCT06090123|Rifampin|rifampin|mesh-list
139265708|NCT06090123|Antifungal Agents|antifungal agents|mesh-ancestor
139265709|NCT06090123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139265710|NCT06090123|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139265711|NCT06090123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139265712|NCT06090123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265713|NCT06090123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265714|NCT06090123|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139265715|NCT06090123|Hormone Antagonists|hormone antagonists|mesh-ancestor
139265716|NCT06090123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265717|NCT06090123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849117|NCT00879385|Decitabine|decitabine|mesh-list
139265718|NCT06090123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139265719|NCT06090123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139265720|NCT06090123|Antitubercular Agents|antitubercular agents|mesh-ancestor
139265721|NCT06090123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139265722|NCT06090123|Leprostatic Agents|leprostatic agents|mesh-ancestor
139265723|NCT06090123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139265724|NCT06090123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139265725|NCT06090123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139265726|NCT06090123|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139265727|NCT06090123|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139265728|NCT06090123|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139265729|NCT06090123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139265730|NCT06088446|Anesthetics|anesthetics|mesh-list
139265731|NCT06088446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265732|NCT06088446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265734|NCT06087510|Antidepressive Agents|antidepressive agents|mesh-ancestor
139265735|NCT06087510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139265736|NCT06068153|Lenvatinib|lenvatinib|mesh-list
139265737|NCT06068153|Sotorasib|sotorasib|mesh-list
139265738|NCT06068153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265739|NCT06068153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139265740|NCT06068153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265741|NCT06068153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265742|NCT06068153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139265743|NCT06068153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139265744|NCT06012929|TIC10 compound|tic10 compound|mesh-list
139265745|NCT06012929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265746|NCT05971849|Hormones|hormones|mesh-list
139265747|NCT05971849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265748|NCT05971849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265749|NCT05970887|Vaccines|vaccines|mesh-list
139265750|NCT05970887|Immunologic Factors|immunologic factors|mesh-ancestor
139265751|NCT05970887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265752|NCT05963022|Tirzepatide|tirzepatide|mesh-list
139265753|NCT05963022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139265754|NCT05963022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265755|NCT05963022|Incretins|incretins|mesh-ancestor
139265756|NCT05963022|Hormones|hormones|mesh-ancestor
139297253|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
139135983|NCT04862260|Evolocumab|evolocumab|mesh-list
139265757|NCT05963022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265758|NCT05962970|Ropivacaine|ropivacaine|mesh-list
139265759|NCT05962970|Anesthetics, Local|anesthetics, local|mesh-ancestor
139265760|NCT05962970|Anesthetics|anesthetics|mesh-ancestor
139265761|NCT05962970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265762|NCT05962970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265763|NCT05962970|Sensory System Agents|sensory system agents|mesh-ancestor
139265764|NCT05962970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265765|NCT05955040|Labetalol|labetalol|mesh-list
139265766|NCT05955040|Nifedipine|nifedipine|mesh-list
139265767|NCT05955040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139265768|NCT05955040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139265769|NCT05955040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265770|NCT05955040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139265771|NCT05955040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265772|NCT05955040|Vasodilator Agents|vasodilator agents|mesh-ancestor
139265773|NCT05955040|Tocolytic Agents|tocolytic agents|mesh-ancestor
139265774|NCT05955040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139265775|NCT05955040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139265776|NCT05955040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139265777|NCT05955040|Adrenergic Agents|adrenergic agents|mesh-ancestor
139265778|NCT05955040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265779|NCT05955040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139265780|NCT05955040|Sympathomimetics|sympathomimetics|mesh-ancestor
139265781|NCT05955040|Autonomic Agents|autonomic agents|mesh-ancestor
139265782|NCT05955040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265783|NCT05955040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139265784|NCT05955040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139265785|NCT05954104|Calcipotriene|calcipotriene|mesh-list
139265786|NCT05954104|Dermatologic Agents|dermatologic agents|mesh-ancestor
139265787|NCT05930405|Sufentanil|sufentanil|mesh-list
139265788|NCT05930405|Ropivacaine|ropivacaine|mesh-list
139265789|NCT05930405|Anesthetics, Local|anesthetics, local|mesh-ancestor
139265790|NCT05930405|Anesthetics|anesthetics|mesh-ancestor
139265791|NCT05930405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265792|NCT05930405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265793|NCT05930405|Sensory System Agents|sensory system agents|mesh-ancestor
139265794|NCT05930405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265795|NCT05930405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139265796|NCT05930405|Narcotics|narcotics|mesh-ancestor
139265797|NCT05930405|Analgesics|analgesics|mesh-ancestor
139265798|NCT05930405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139265799|NCT05930405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139265800|NCT05930405|Anesthetics, General|anesthetics, general|mesh-ancestor
139265801|NCT05924126|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139265802|NCT05924126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139265803|NCT05919745|Acetaminophen|acetaminophen|mesh-list
139265804|NCT05919745|Ibuprofen|ibuprofen|mesh-list
139265805|NCT05919745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139265806|NCT05919745|Analgesics|analgesics|mesh-ancestor
139265807|NCT05919745|Sensory System Agents|sensory system agents|mesh-ancestor
139265808|NCT05919745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265809|NCT05919745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265810|NCT05919745|Antipyretics|antipyretics|mesh-ancestor
139265811|NCT05919745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139265812|NCT05919745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139265813|NCT05919745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139265814|NCT05919745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139265815|NCT05919745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265816|NCT05919745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265817|NCT05917223|Caseins|caseins|mesh-list
139265818|NCT05917223|Chelating Agents|chelating agents|mesh-ancestor
139265819|NCT05917223|Sequestering Agents|sequestering agents|mesh-ancestor
139265820|NCT05917223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265821|NCT05900336|Naproxen|naproxen|mesh-list
139265822|NCT05900336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139265823|NCT05900336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139265824|NCT05900336|Analgesics|analgesics|mesh-ancestor
139265825|NCT05900336|Sensory System Agents|sensory system agents|mesh-ancestor
139265826|NCT05900336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265827|NCT05900336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265828|NCT05900336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139265829|NCT05900336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139265830|NCT05900336|Gout Suppressants|gout suppressants|mesh-ancestor
139642296|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139265831|NCT05900336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139265832|NCT05900336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265833|NCT05900336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265834|NCT05893797|Insulin Lispro|insulin lispro|mesh-list
139265836|NCT05893797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139265837|NCT05893797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265838|NCT05893797|Antioxidants|antioxidants|mesh-ancestor
139265839|NCT05893797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265840|NCT05893797|Protective Agents|protective agents|mesh-ancestor
139265841|NCT05856084|Vaccines|vaccines|mesh-list
139265842|NCT05856084|Immunologic Factors|immunologic factors|mesh-ancestor
139265843|NCT05856084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265844|NCT05853601|Theophylline|theophylline|mesh-list
139265845|NCT05853601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139265846|NCT05853601|Autonomic Agents|autonomic agents|mesh-ancestor
139265847|NCT05853601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265848|NCT05853601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265849|NCT05853601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139265850|NCT05853601|Respiratory System Agents|respiratory system agents|mesh-ancestor
139265851|NCT05853601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139265852|NCT05853601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265853|NCT05853601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265854|NCT05853601|Vasodilator Agents|vasodilator agents|mesh-ancestor
139265855|NCT05853601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139265856|NCT05853601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139265857|NCT05853601|Purinergic Agents|purinergic agents|mesh-ancestor
139265858|NCT05853601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265859|NCT05853341|Rivastigmine|rivastigmine|mesh-list
139265860|NCT05853341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139265861|NCT05853341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265862|NCT05853341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265863|NCT05853341|Cholinergic Agents|cholinergic agents|mesh-ancestor
139265864|NCT05853341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265865|NCT05853341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849263|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265866|NCT05853341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139265867|NCT05853341|Protective Agents|protective agents|mesh-ancestor
139265868|NCT05803421|Insulin Glargine|insulin glargine|mesh-list
139265869|NCT05803421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139265870|NCT05803421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265871|NCT05800288|Propofol|propofol|mesh-list
139265872|NCT05800288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139265873|NCT05800288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265874|NCT05800288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265875|NCT05800288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139265876|NCT05800288|Anesthetics, General|anesthetics, general|mesh-ancestor
139265877|NCT05800288|Anesthetics|anesthetics|mesh-ancestor
139265878|NCT05799729|Ketamine|ketamine|mesh-list
139265879|NCT05799729|Analgesics|analgesics|mesh-ancestor
139265880|NCT05799729|Sensory System Agents|sensory system agents|mesh-ancestor
139265881|NCT05799729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265882|NCT05799729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265883|NCT05799729|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139265884|NCT05799729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139265885|NCT05799729|Anesthetics, General|anesthetics, general|mesh-ancestor
139265886|NCT05799729|Anesthetics|anesthetics|mesh-ancestor
139265887|NCT05799729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265888|NCT05799729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139265889|NCT05799729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139265890|NCT05799729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265891|NCT05799729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265892|NCT05794828|Bupivacaine|bupivacaine|mesh-list
139265893|NCT05794828|Anesthetics, Local|anesthetics, local|mesh-ancestor
139265894|NCT05794828|Anesthetics|anesthetics|mesh-ancestor
139265895|NCT05794828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265896|NCT05794828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265897|NCT05794828|Sensory System Agents|sensory system agents|mesh-ancestor
139265898|NCT05794828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265899|NCT05776160|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139265900|NCT05776160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139265901|NCT05776160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265902|NCT05773976|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139265903|NCT05773976|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139136136|NCT04346394|Urological Agents|urological agents|mesh-ancestor
139265904|NCT05773963|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139265905|NCT05773963|Lubricant Eye Drops|lubricant eye drops|mesh-list
139265906|NCT05773963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139265907|NCT05769010|Bevacizumab|bevacizumab|mesh-list
139265908|NCT05769010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139265909|NCT05769010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265910|NCT05769010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139265911|NCT05769010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139265912|NCT05769010|Growth Substances|growth substances|mesh-ancestor
139265913|NCT05769010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265914|NCT05769010|Growth Inhibitors|growth inhibitors|mesh-ancestor
139265915|NCT05767021|Mirikizumab|mirikizumab|mesh-list
139265916|NCT05767021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139265917|NCT05767021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139265918|NCT05767021|Analgesics|analgesics|mesh-ancestor
139265919|NCT05767021|Sensory System Agents|sensory system agents|mesh-ancestor
139265920|NCT05767021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265921|NCT05767021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265922|NCT05767021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139265923|NCT05767021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139265924|NCT05767021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139265925|NCT05767021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139265926|NCT05762146|Perphenazine|perphenazine|mesh-list
139265927|NCT05762146|Riociguat|riociguat|mesh-list
139265928|NCT05762146|Propylthiouracil|propylthiouracil|mesh-list
139265929|NCT05762146|Enzyme Activators|enzyme activators|mesh-ancestor
139265930|NCT05762146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265931|NCT05762146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139265932|NCT05762146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139265933|NCT05762146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265934|NCT05762146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265935|NCT05762146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139265936|NCT05762146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139265937|NCT05762146|Dopamine Agents|dopamine agents|mesh-ancestor
139265938|NCT05762146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139265939|NCT05762146|Antimetabolites|antimetabolites|mesh-ancestor
139265940|NCT05762146|Antithyroid Agents|antithyroid agents|mesh-ancestor
139265941|NCT05762146|Hormone Antagonists|hormone antagonists|mesh-ancestor
139265942|NCT05762146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265943|NCT05737199|Pembrolizumab|pembrolizumab|mesh-list
139265944|NCT05737199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139265945|NCT05737199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139265946|NCT05737199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139265947|NCT05737199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265949|NCT05702463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139265950|NCT05702463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139265951|NCT05702463|Analgesics|analgesics|mesh-ancestor
139265952|NCT05702463|Sensory System Agents|sensory system agents|mesh-ancestor
139265953|NCT05702463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265954|NCT05702463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265955|NCT05702463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139265956|NCT05702463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139265957|NCT05702463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139265958|NCT05702463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139265959|NCT05702463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265960|NCT05702463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139265961|NCT05702463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139265962|NCT05702463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139265963|NCT05702463|Antipyretics|antipyretics|mesh-ancestor
139265964|NCT05697783|Fentanyl|fentanyl|mesh-list
139265965|NCT05697783|Methadone|methadone|mesh-list
139265966|NCT05697783|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139265967|NCT05697783|Narcotics|narcotics|mesh-ancestor
139265968|NCT05697783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139265969|NCT05697783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265970|NCT05697783|Analgesics|analgesics|mesh-ancestor
139265971|NCT05697783|Sensory System Agents|sensory system agents|mesh-ancestor
139265972|NCT05697783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265973|NCT05697783|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139265974|NCT05697783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139642297|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265975|NCT05697783|Anesthetics, General|anesthetics, general|mesh-ancestor
139265976|NCT05697783|Anesthetics|anesthetics|mesh-ancestor
139265977|NCT05697783|Antitussive Agents|antitussive agents|mesh-ancestor
139265978|NCT05697783|Respiratory System Agents|respiratory system agents|mesh-ancestor
139265979|NCT05681611|Rocuronium|rocuronium|mesh-list
139265980|NCT05681611|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139265981|NCT05681611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139265982|NCT05681611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139265983|NCT05681611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139265984|NCT05681611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265985|NCT05676684|Dapagliflozin|dapagliflozin|mesh-list
139265986|NCT05676684|Spironolactone|spironolactone|mesh-list
139265987|NCT05676684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139265988|NCT05676684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139265989|NCT05676684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139265990|NCT05676684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139265991|NCT05676684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139265992|NCT05676684|Hormone Antagonists|hormone antagonists|mesh-ancestor
139265993|NCT05676684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139265994|NCT05676684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139265995|NCT05676684|Diuretics|diuretics|mesh-ancestor
139265996|NCT05676684|Natriuretic Agents|natriuretic agents|mesh-ancestor
139265997|NCT05672680|Bupivacaine|bupivacaine|mesh-list
139265998|NCT05672680|Anesthetics, Local|anesthetics, local|mesh-ancestor
139265999|NCT05672680|Anesthetics|anesthetics|mesh-ancestor
139266000|NCT05672680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139266001|NCT05672680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266002|NCT05672680|Sensory System Agents|sensory system agents|mesh-ancestor
139266003|NCT05672680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266004|NCT05668676|Prednisone|prednisone|mesh-list
139266005|NCT05668676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266006|NCT05668676|Glucocorticoids|glucocorticoids|mesh-ancestor
139266007|NCT05668676|Hormones|hormones|mesh-ancestor
139266008|NCT05668676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266009|NCT05668676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266010|NCT05668676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139266011|NCT05668676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266012|NCT05667376|Curcumin|curcumin|mesh-list
139266013|NCT05667376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139266014|NCT05667376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139266015|NCT05667376|Analgesics|analgesics|mesh-ancestor
139266016|NCT05667376|Sensory System Agents|sensory system agents|mesh-ancestor
139266017|NCT05667376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266018|NCT05667376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266019|NCT05667376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266020|NCT05667376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139266021|NCT05667376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266022|NCT05667376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266023|NCT05667376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266024|NCT05624957|Lidocaine|lidocaine|mesh-list
139266025|NCT05624957|Epinephrine|epinephrine|mesh-list
139266026|NCT05624957|Racepinephrine|racepinephrine|mesh-list
139266027|NCT05624957|Epinephryl borate|epinephryl borate|mesh-list
139266028|NCT05624957|Anesthetics, Local|anesthetics, local|mesh-ancestor
139266029|NCT05624957|Anesthetics|anesthetics|mesh-ancestor
139266030|NCT05624957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139266031|NCT05624957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266032|NCT05624957|Sensory System Agents|sensory system agents|mesh-ancestor
139266033|NCT05624957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266034|NCT05624957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139266035|NCT05624957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139266036|NCT05624957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139266037|NCT05624957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139266038|NCT05624957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266039|NCT05624957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139266040|NCT05624957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139266041|NCT05624957|Adrenergic Agents|adrenergic agents|mesh-ancestor
139266042|NCT05624957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139266043|NCT05624957|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139266044|NCT05624957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139266045|NCT05624957|Autonomic Agents|autonomic agents|mesh-ancestor
139266046|NCT05624957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139266047|NCT05624957|Respiratory System Agents|respiratory system agents|mesh-ancestor
139266048|NCT05624957|Mydriatics|mydriatics|mesh-ancestor
139266049|NCT05624957|Sympathomimetics|sympathomimetics|mesh-ancestor
139266050|NCT05624957|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139266051|NCT05619289|Vitamin D|vitamin d|mesh-list
139266055|NCT05619289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266056|NCT05619289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139266057|NCT05619289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139266058|NCT05600296|Levobupivacaine|levobupivacaine|mesh-list
139266059|NCT05600296|Anesthetics, Local|anesthetics, local|mesh-ancestor
139266060|NCT05600296|Anesthetics|anesthetics|mesh-ancestor
139266061|NCT05600296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139266062|NCT05600296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266063|NCT05600296|Sensory System Agents|sensory system agents|mesh-ancestor
139266064|NCT05600296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266065|NCT05585580|Paclitaxel|paclitaxel|mesh-list
139266066|NCT05585580|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139266067|NCT05585580|Lenvatinib|lenvatinib|mesh-list
139266068|NCT05585580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139266069|NCT05585580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266070|NCT05585580|Tubulin Modulators|tubulin modulators|mesh-ancestor
139266071|NCT05585580|Antimitotic Agents|antimitotic agents|mesh-ancestor
139266072|NCT05585580|Mitosis Modulators|mitosis modulators|mesh-ancestor
139266073|NCT05585580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266074|NCT05585580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139266075|NCT05585580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266076|NCT05577819|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
139266077|NCT05577819|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139266078|NCT05577819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266079|NCT05564039|Dulaglutide|dulaglutide|mesh-list
139266080|NCT05564039|Tirzepatide|tirzepatide|mesh-list
139266081|NCT05564039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139266082|NCT05564039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266083|NCT05564039|Incretins|incretins|mesh-ancestor
139266084|NCT05564039|Hormones|hormones|mesh-ancestor
139266085|NCT05564039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266086|NCT05559437|Bupivacaine|bupivacaine|mesh-list
139266087|NCT05559437|Levobupivacaine|levobupivacaine|mesh-list
139266088|NCT05559437|Anesthetics, Local|anesthetics, local|mesh-ancestor
139266089|NCT05559437|Anesthetics|anesthetics|mesh-ancestor
139266090|NCT05559437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139266091|NCT05559437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266092|NCT05559437|Sensory System Agents|sensory system agents|mesh-ancestor
139266093|NCT05559437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266095|NCT05556512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139266096|NCT05556512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266097|NCT05556512|Incretins|incretins|mesh-ancestor
139266098|NCT05556512|Hormones|hormones|mesh-ancestor
139266099|NCT05556512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266100|NCT05521048|Doxycycline|doxycycline|mesh-list
139266101|NCT05521048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139266102|NCT05521048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266103|NCT05521048|Antimalarials|antimalarials|mesh-ancestor
139266104|NCT05521048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139266105|NCT05521048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139266106|NCT05504083|Benzbromarone|benzbromarone|mesh-list
139266107|NCT05504083|Uricosuric Agents|uricosuric agents|mesh-ancestor
139266108|NCT05504083|Gout Suppressants|gout suppressants|mesh-ancestor
139266109|NCT05504083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139266110|NCT05500508|Eflornithine|eflornithine|mesh-list
139266111|NCT05500508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266112|NCT05500508|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139266113|NCT05500508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139266114|NCT05500508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139266115|NCT05500508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266116|NCT05500508|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139266117|NCT05500508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266118|NCT05500508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266122|NCT05485831|Cannabidiol|cannabidiol|mesh-list
139266123|NCT05485831|Anticonvulsants|anticonvulsants|mesh-ancestor
139266124|NCT05462730|Methylprednisolone|methylprednisolone|mesh-list
139266125|NCT05462730|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139266126|NCT05462730|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139266127|NCT05462730|Prednisolone|prednisolone|mesh-list
139266128|NCT05462730|Prednisolone acetate|prednisolone acetate|mesh-list
139266129|NCT05462730|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139266130|NCT05462730|Prednisolone phosphate|prednisolone phosphate|mesh-list
139266131|NCT05462730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266133|NCT05462730|Autonomic Agents|autonomic agents|mesh-ancestor
139266134|NCT05462730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266135|NCT05462730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266136|NCT05462730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139266137|NCT05462730|Glucocorticoids|glucocorticoids|mesh-ancestor
139266138|NCT05462730|Hormones|hormones|mesh-ancestor
139266139|NCT05462730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266140|NCT05462730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139266141|NCT05462730|Protective Agents|protective agents|mesh-ancestor
139266142|NCT05462730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139266143|NCT05462730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266144|NCT05457933|Dapagliflozin|dapagliflozin|mesh-list
139266145|NCT05457933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139266146|NCT05457933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266147|NCT05457933|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139266148|NCT05457933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266149|NCT05438953|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139266150|NCT05438953|Antiviral Agents|antiviral agents|mesh-ancestor
139266151|NCT05438953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266152|NCT05433584|Tirzepatide|tirzepatide|mesh-list
139266153|NCT05433584|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139266154|NCT05433584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266155|NCT05433584|Incretins|incretins|mesh-ancestor
139266156|NCT05433584|Hormones|hormones|mesh-ancestor
139266157|NCT05433584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266158|NCT05412758|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
139266159|NCT05412758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266160|NCT05392075|Vaccines|vaccines|mesh-list
139266161|NCT05392075|Immunologic Factors|immunologic factors|mesh-ancestor
139266162|NCT05392075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266163|NCT05362916|Letermovir|letermovir|mesh-list
139266164|NCT05362916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139266165|NCT05362916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266166|NCT05362916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266167|NCT05362916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266168|NCT05362916|Antiviral Agents|antiviral agents|mesh-ancestor
139266169|NCT05362916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266170|NCT05325632|Paclitaxel|paclitaxel|mesh-list
139266171|NCT05325632|Trastuzumab|trastuzumab|mesh-list
139266172|NCT05325632|Pertuzumab|pertuzumab|mesh-list
139266173|NCT05325632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139266174|NCT05325632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266175|NCT05325632|Tubulin Modulators|tubulin modulators|mesh-ancestor
139266176|NCT05325632|Antimitotic Agents|antimitotic agents|mesh-ancestor
139266177|NCT05325632|Mitosis Modulators|mitosis modulators|mesh-ancestor
139266178|NCT05325632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266179|NCT05325632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139266180|NCT05317000|Nivolumab|nivolumab|mesh-list
139266181|NCT05317000|Azacitidine|azacitidine|mesh-list
139266182|NCT05317000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139266183|NCT05317000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266184|NCT05317000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139266185|NCT05317000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266186|NCT05317000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139266187|NCT05317000|Antimetabolites|antimetabolites|mesh-ancestor
139266188|NCT05317000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266189|NCT05315713|Atezolizumab|atezolizumab|mesh-list
139266190|NCT05315713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139266191|NCT05315713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266192|NCT05315713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139266193|NCT05315713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266194|NCT05299086|Fluticasone|fluticasone|mesh-list
139266195|NCT05299086|Xhance|xhance|mesh-list
139266196|NCT05299086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266197|NCT05299086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139266198|NCT05299086|Autonomic Agents|autonomic agents|mesh-ancestor
139266199|NCT05299086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266200|NCT05299086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266201|NCT05299086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139266202|NCT05299086|Respiratory System Agents|respiratory system agents|mesh-ancestor
139266203|NCT05299086|Dermatologic Agents|dermatologic agents|mesh-ancestor
139266204|NCT05299086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139266205|NCT05288166|Prednisone|prednisone|mesh-list
139266206|NCT05288166|Prednisolone|prednisolone|mesh-list
139266207|NCT05288166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266208|NCT05288166|Glucocorticoids|glucocorticoids|mesh-ancestor
139266209|NCT05288166|Hormones|hormones|mesh-ancestor
139266210|NCT05288166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266211|NCT05288166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266212|NCT05288166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139266213|NCT05288166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266214|NCT05262777|Lidocaine|lidocaine|mesh-list
139266215|NCT05262777|Anesthetics, Local|anesthetics, local|mesh-ancestor
139266216|NCT05262777|Anesthetics|anesthetics|mesh-ancestor
139266217|NCT05262777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139266218|NCT05262777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266219|NCT05262777|Sensory System Agents|sensory system agents|mesh-ancestor
139266220|NCT05262777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266221|NCT05262777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139266222|NCT05262777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139266223|NCT05262777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139266224|NCT05262777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139266225|NCT05262777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266226|NCT05253846|Fluorouracil|fluorouracil|mesh-list
139266227|NCT05253846|Oxaliplatin|oxaliplatin|mesh-list
139266228|NCT05253846|Irinotecan|irinotecan|mesh-list
139266229|NCT05253846|Antimetabolites|antimetabolites|mesh-ancestor
139266230|NCT05253846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266231|NCT05253846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139266232|NCT05253846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266233|NCT05253846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139266234|NCT05253846|Immunologic Factors|immunologic factors|mesh-ancestor
139266235|NCT05253846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266236|NCT05253846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139266237|NCT05253846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139266238|NCT05253846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266239|NCT05215730|Copper|copper|mesh-list
139266240|NCT05215730|Trace Elements|trace elements|mesh-ancestor
139266241|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
139266242|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266243|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139266244|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139266245|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266246|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
139266248|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266249|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139266250|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266251|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266252|NCT05169424|Fluticasone|fluticasone|mesh-list
139266253|NCT05169424|Xhance|xhance|mesh-list
139266254|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
139266255|NCT05169424|Olodaterol|olodaterol|mesh-list
139266256|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266257|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139266258|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
139266259|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266260|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266261|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139266262|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
139266263|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
139266264|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139266265|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
139266266|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139266267|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
139266268|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139266269|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266270|NCT05150691|Ritonavir|ritonavir|mesh-list
139266271|NCT05150691|Itraconazole|itraconazole|mesh-list
139266272|NCT05150691|Pertuzumab|pertuzumab|mesh-list
139266273|NCT05150691|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139266274|NCT05150691|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139266275|NCT05150691|Protease Inhibitors|protease inhibitors|mesh-ancestor
139266276|NCT05150691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266277|NCT05150691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266278|NCT05150691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139266279|NCT05150691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139266280|NCT05150691|Antiviral Agents|antiviral agents|mesh-ancestor
139266281|NCT05150691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266282|NCT05150691|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139266283|NCT05150691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139266284|NCT05150691|Antifungal Agents|antifungal agents|mesh-ancestor
139266285|NCT05150691|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139266286|NCT05150691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139266287|NCT05150691|Hormone Antagonists|hormone antagonists|mesh-ancestor
139266288|NCT05150691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266289|NCT05150691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266290|NCT05150691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139266291|NCT05150691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266292|NCT05126784|Denosumab|denosumab|mesh-list
139381660|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139266293|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139266294|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266295|NCT05108428|Capecitabine|capecitabine|mesh-list
139266296|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139266297|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
139266298|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266299|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266300|NCT05105919|Aspirin|aspirin|mesh-list
139266301|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139266302|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139266303|NCT05105919|Analgesics|analgesics|mesh-ancestor
139266304|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
139266305|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266306|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266307|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266308|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139266309|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139266310|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139266311|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266312|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139266313|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138849722|NCT02775006|Docetaxel|docetaxel|mesh-list
139266314|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266315|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
139266316|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
139266317|NCT05092451|Fludarabine|fludarabine|mesh-list
139266318|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
139266319|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139266320|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
139266321|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266322|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139266323|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139266324|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
139266325|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266326|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266327|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139266328|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139266329|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
139266330|NCT05089630|Vaccines|vaccines|mesh-list
139266331|NCT05089630|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
139266332|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
139266333|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266334|NCT05089630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139266335|NCT05068752|Sorafenib|sorafenib|mesh-list
139266336|NCT05068752|Vemurafenib|vemurafenib|mesh-list
139266337|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266338|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139266339|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266340|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266341|NCT05051293|Testosterone|testosterone|mesh-list
139266342|NCT05051293|Estrogens|estrogens|mesh-list
139266343|NCT05051293|Androgens|androgens|mesh-ancestor
139266344|NCT05051293|Hormones|hormones|mesh-ancestor
139266345|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266346|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266347|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
139266348|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139266349|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139266350|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266351|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139266352|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266353|NCT05042505|Incretins|incretins|mesh-ancestor
139266354|NCT05042505|Hormones|hormones|mesh-ancestor
139266355|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266356|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139266357|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
139266358|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266359|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
139266360|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139266361|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266362|NCT05014282|Nicotine|nicotine|mesh-list
139266363|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139266364|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
139266365|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266366|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266367|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139266368|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139266369|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
139266370|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139266371|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266372|NCT05010200|Poly ICLC|poly iclc|mesh-list
139266373|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
139266374|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
139266375|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266376|NCT04983615|Midazolam|midazolam|mesh-list
139266377|NCT04983615|Fentanyl|fentanyl|mesh-list
139266378|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139266379|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139266380|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139266381|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266382|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139266383|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139266384|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139266385|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139266386|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
139266387|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
139266388|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
138849792|NCT02772354|Metoprolol|metoprolol|mesh-list
139266389|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
139266390|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139266391|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266392|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139266393|NCT04983615|Narcotics|narcotics|mesh-ancestor
139266394|NCT04983615|Analgesics|analgesics|mesh-ancestor
139266395|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
139266396|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266397|NCT04975308|Fulvestrant|fulvestrant|mesh-list
139266399|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139266400|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266401|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139266402|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139266403|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
139266404|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266405|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266406|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139266407|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139266408|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266409|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266410|NCT04975152|Cemiplimab|cemiplimab|mesh-list
139266411|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139266412|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266413|NCT04948333|Niacinamide|niacinamide|mesh-list
139266414|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
139266415|NCT04948333|Vitamins|vitamins|mesh-ancestor
139266416|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
139266417|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266418|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
139266419|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139266420|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139266421|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139266422|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139266423|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266424|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
139266425|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139266426|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266427|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139266428|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266429|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
139266430|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
139266431|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139266432|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
139266433|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266434|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266435|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
139266436|NCT04917679|Diacerein|diacerein|mesh-list
139266437|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266438|NCT04905316|Durvalumab|durvalumab|mesh-list
139266439|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139266440|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266441|NCT04875702|Prednisone|prednisone|mesh-list
139266442|NCT04875702|Naproxen|naproxen|mesh-list
139266443|NCT04875702|Colchicine|colchicine|mesh-list
139266444|NCT04875702|Allopurinol|allopurinol|mesh-list
139266445|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266446|NCT04875702|Glucocorticoids|glucocorticoids|mesh-ancestor
139266447|NCT04875702|Hormones|hormones|mesh-ancestor
139266448|NCT04875702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266449|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266450|NCT04875702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139266451|NCT04875702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266452|NCT04875702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139266453|NCT04875702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139266454|NCT04875702|Analgesics|analgesics|mesh-ancestor
139266455|NCT04875702|Sensory System Agents|sensory system agents|mesh-ancestor
139266456|NCT04875702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266457|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139266458|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
139266459|NCT04875702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139266460|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266461|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266462|NCT04875702|Tubulin Modulators|tubulin modulators|mesh-ancestor
139266463|NCT04875702|Antimitotic Agents|antimitotic agents|mesh-ancestor
138849859|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
139266464|NCT04875702|Mitosis Modulators|mitosis modulators|mesh-ancestor
139266465|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
139266466|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139266467|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
139266468|NCT04875702|Protective Agents|protective agents|mesh-ancestor
139266469|NCT04847921|Dalbavancin|dalbavancin|mesh-list
139266470|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139266471|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266472|NCT04801953|Nimodipine|nimodipine|mesh-list
139266473|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139266474|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139266475|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139266476|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266477|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139266478|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266479|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
139266480|NCT04771130|Posaconazole|posaconazole|mesh-list
139266481|NCT04771130|Azacitidine|azacitidine|mesh-list
139266482|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139266483|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
139266484|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266485|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266486|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266487|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
139266488|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266489|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139266490|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139266491|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139266492|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139266493|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139266494|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139266495|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
139266496|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266497|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266498|NCT04765709|Carboplatin|carboplatin|mesh-list
139266499|NCT04765709|Pemetrexed|pemetrexed|mesh-list
139266500|NCT04765709|Durvalumab|durvalumab|mesh-list
139266501|NCT04765709|Vinorelbine|vinorelbine|mesh-list
139266502|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139266503|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266504|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266505|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266506|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139266507|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139266508|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139266509|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
139266510|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266511|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139266512|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
139200902|NCT02500498|Abatacept|abatacept|mesh-list
139266513|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
139266514|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
139266515|NCT04762498|Methotrexate|methotrexate|mesh-list
139266516|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139266517|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
139266518|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139266519|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266520|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139266521|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
139266522|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266523|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266524|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
139266525|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266526|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139266527|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139266528|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
139266529|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139266530|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139266531|NCT04738097|Clopidogrel|clopidogrel|mesh-list
139266532|NCT04738097|Ticagrelor|ticagrelor|mesh-list
139266533|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139266534|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139266535|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139266536|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139266537|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
139266538|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139266539|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266540|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266542|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
139266543|NCT04666623|Esketamine|esketamine|mesh-list
139266544|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
139266545|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139266546|NCT04649398|Nimodipine|nimodipine|mesh-list
139266547|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139266548|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139266549|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139266550|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266551|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139266552|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266553|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
139266554|NCT04648189|Cetuximab|cetuximab|mesh-list
139266555|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139266556|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266557|NCT04609514|Nicotine|nicotine|mesh-list
139266558|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139266559|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
139266560|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266561|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266562|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139266563|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139266564|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
139266565|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139266566|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266567|NCT04562532|Sirolimus|sirolimus|mesh-list
139266568|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139266569|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266570|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139266571|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266572|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
139266573|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139266574|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
139266575|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266576|NCT04533646|Insulin|insulin|mesh-list
139266577|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139266578|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266579|NCT04523064|Empagliflozin|empagliflozin|mesh-list
139266580|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139266581|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266582|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139266583|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266584|NCT04511702|Methotrexate|methotrexate|mesh-list
139266585|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139266586|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
139266587|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139266588|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266589|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139266590|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
139266591|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266592|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266593|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
139266594|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266595|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139266596|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139266597|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
139266598|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139266599|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139266600|NCT04497584|Prednisone|prednisone|mesh-list
139266601|NCT04497584|Afatinib|afatinib|mesh-list
139266602|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266603|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
139266604|NCT04497584|Hormones|hormones|mesh-ancestor
139266605|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266606|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266607|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139266608|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266609|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139266610|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850016|NCT02541643|Elotuzumab|elotuzumab|mesh-list
139266611|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266612|NCT04489771|Belzutifan|belzutifan|mesh-list
139266613|NCT04489771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266614|NCT04488081|Cyproheptadine|cyproheptadine|mesh-list
139266615|NCT04488081|Cyclosporine|cyclosporine|mesh-list
139266616|NCT04488081|Remdesivir|remdesivir|mesh-list
139266617|NCT04488081|Cenicriviroc|cenicriviroc|mesh-list
139266618|NCT04488081|Dexamethasone|dexamethasone|mesh-list
139266619|NCT04488081|Celecoxib|celecoxib|mesh-list
139266620|NCT04488081|Apremilast|apremilast|mesh-list
139266621|NCT04488081|Icatibant|icatibant|mesh-list
139266622|NCT04488081|Imatinib Mesylate|imatinib mesylate|mesh-list
139266623|NCT04488081|Famotidine|famotidine|mesh-list
139266624|NCT04488081|Cyclosporins|cyclosporins|mesh-list
139266625|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266626|NCT04488081|Antiemetics|antiemetics|mesh-ancestor
139266627|NCT04488081|Autonomic Agents|autonomic agents|mesh-ancestor
139266628|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266629|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266630|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139266631|NCT04488081|Glucocorticoids|glucocorticoids|mesh-ancestor
139266632|NCT04488081|Hormones|hormones|mesh-ancestor
139266633|NCT04488081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266634|NCT04488081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139266635|NCT04488081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266636|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266637|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266638|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139266639|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
139266640|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
139266641|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266642|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
139266643|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139266644|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139266645|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139266646|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139266647|NCT04488081|Analgesics|analgesics|mesh-ancestor
139266648|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
139266649|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139266650|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139266651|NCT04488081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139266652|NCT04488081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139266653|NCT04488081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139266654|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139266655|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139266656|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
139266657|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
139266658|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139266659|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
139266660|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
139266661|NCT04488081|Antipruritics|antipruritics|mesh-ancestor
139266662|NCT04488081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139266663|NCT04488081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139266664|NCT04488081|Serotonin Agents|serotonin agents|mesh-ancestor
139266665|NCT04488081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139266666|NCT04488081|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
139266667|NCT04488081|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
139266668|NCT04488081|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139266669|NCT04488081|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139266670|NCT04488081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139266671|NCT04488081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139266672|NCT04456699|Leucovorin|leucovorin|mesh-list
139266673|NCT04456699|Bevacizumab|bevacizumab|mesh-list
139266674|NCT04456699|Capecitabine|capecitabine|mesh-list
139266675|NCT04456699|Fluorouracil|fluorouracil|mesh-list
139266676|NCT04456699|Olaparib|olaparib|mesh-list
139266677|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
139266678|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139266679|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266680|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139266681|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139266682|NCT04456699|Growth Substances|growth substances|mesh-ancestor
139266683|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266684|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
139266685|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139266686|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
139266687|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266688|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139266689|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
139266690|NCT04456699|Antidotes|antidotes|mesh-ancestor
139266691|NCT04456699|Protective Agents|protective agents|mesh-ancestor
139266692|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
139266693|NCT04456699|Vitamins|vitamins|mesh-ancestor
139266694|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
139266695|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139266696|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266697|NCT04452877|Trametinib|trametinib|mesh-list
139266698|NCT04452877|Dabrafenib|dabrafenib|mesh-list
139266699|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266700|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139266701|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266702|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266703|NCT04444869|Cisplatin|cisplatin|mesh-list
139266704|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266705|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139266706|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139266707|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139266708|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266709|NCT04388839|Dactinomycin|dactinomycin|mesh-list
139266710|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
139266711|NCT04388839|Vincristine|vincristine|mesh-list
139266712|NCT04388839|Vinorelbine|vinorelbine|mesh-list
139266713|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139266714|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
139266715|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266716|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139266717|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139266718|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
139266719|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266720|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266721|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139266722|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139266723|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
139266724|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
139266725|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
139266726|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139266727|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266728|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139266729|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139266730|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266731|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139266732|NCT04280562|Acetaminophen|acetaminophen|mesh-list
139266733|NCT04280562|Analgesics|analgesics|mesh-list
139266734|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139266735|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
139266736|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266737|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266738|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
139266739|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
139266740|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139266741|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
139266742|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139266743|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
139266744|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266745|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266746|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
139266747|NCT04267926|Ubiquinone|ubiquinone|mesh-list
139266748|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
139266749|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266750|NCT04255433|Dulaglutide|dulaglutide|mesh-list
139266751|NCT04255433|Tirzepatide|tirzepatide|mesh-list
139266752|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139266753|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266754|NCT04255433|Incretins|incretins|mesh-ancestor
139266755|NCT04255433|Hormones|hormones|mesh-ancestor
139266756|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266757|NCT04225819|Vitamin D|vitamin d|mesh-list
139266758|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
139266759|NCT04225819|Vitamins|vitamins|mesh-ancestor
139266760|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
139266761|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266762|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139266763|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139266764|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
139266765|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139266766|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139266767|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266769|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
139266770|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266771|NCT04192773|Lidocaine|lidocaine|mesh-list
139266772|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
139266773|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
139266774|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139266775|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266776|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
139266777|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266778|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139266779|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139266780|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139266781|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139266782|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266783|NCT04158635|Paclitaxel|paclitaxel|mesh-list
139266784|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139266785|NCT04158635|Gemcitabine|gemcitabine|mesh-list
139266786|NCT04158635|Bosentan|bosentan|mesh-list
139266787|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139266788|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266789|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
139266790|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
139266791|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
139266792|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266793|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139266794|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
139266795|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139266796|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139266797|NCT04113863|Anastrozole|anastrozole|mesh-list
139266798|NCT04113863|Tretinoin|tretinoin|mesh-list
139266799|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139266800|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266801|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139266802|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139266803|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266804|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266805|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139266806|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
139266807|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266808|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266810|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
139266811|NCT04086745|Adalimumab|adalimumab|mesh-list
139266812|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139266813|NCT04086745|Etanercept|etanercept|mesh-list
139266814|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266815|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139266816|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139266817|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139266818|NCT04086745|Analgesics|analgesics|mesh-ancestor
139266819|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
139266820|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266821|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266822|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139266823|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139266824|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
139266825|NCT04023110|Carvedilol|carvedilol|mesh-list
139266826|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139266827|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139266828|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
139266829|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139266830|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266831|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266832|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139266833|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
139266834|NCT04023110|Protective Agents|protective agents|mesh-ancestor
139266835|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139266836|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139266837|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139266838|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
139266839|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139266840|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139266841|NCT03924791|Dexamethasone|dexamethasone|mesh-list
139266842|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
139266843|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139266844|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139266845|NCT03924791|Prednisolone|prednisolone|mesh-list
139266846|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
139266847|NCT03924791|Lidocaine|lidocaine|mesh-list
139266848|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139266849|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
139266850|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266851|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
139266852|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
139266853|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266854|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266855|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139266856|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
139266857|NCT03924791|Hormones|hormones|mesh-ancestor
139266858|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266859|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139266860|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266861|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
139266862|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
139266863|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139266864|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
139266865|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139266866|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139266867|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139266868|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139266869|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266870|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139266871|NCT03924791|Protective Agents|protective agents|mesh-ancestor
139266872|NCT03872401|Evolocumab|evolocumab|mesh-list
139266873|NCT03872401|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139266874|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139266875|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139266876|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
139266877|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266878|NCT03872401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139266879|NCT03872401|Protease Inhibitors|protease inhibitors|mesh-ancestor
139266880|NCT03872401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266881|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139266882|NCT03854799|Capecitabine|capecitabine|mesh-list
139266883|NCT03854799|Avelumab|avelumab|mesh-list
139266884|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139266885|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
139266886|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266887|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266888|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139266889|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
139266890|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139266891|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
139266892|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266893|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266894|NCT03672643|Crizotinib|crizotinib|mesh-list
139266895|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266896|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139266897|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266898|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266899|NCT03630705|Vaccines|vaccines|mesh-list
139266900|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
139266901|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266902|NCT03628209|Nivolumab|nivolumab|mesh-list
139266903|NCT03628209|Azacitidine|azacitidine|mesh-list
139266904|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139266905|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266906|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139266907|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266908|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139266909|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
139266910|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266911|NCT03614949|Atezolizumab|atezolizumab|mesh-list
139266912|NCT03614949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139266913|NCT03614949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266914|NCT03614949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139266915|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266916|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
139266917|NCT03605654|Tacrolimus|tacrolimus|mesh-list
139266918|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139266919|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
139266920|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266921|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139266922|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266923|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266924|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139266925|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266926|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139266927|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
139266928|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139266929|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266930|NCT03591510|Cytarabine|cytarabine|mesh-list
139266931|NCT03591510|Fludarabine|fludarabine|mesh-list
139266932|NCT03591510|Etoposide|etoposide|mesh-list
139266933|NCT03591510|Daunorubicin|daunorubicin|mesh-list
139266934|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
139266935|NCT03591510|Idarubicin|idarubicin|mesh-list
139266936|NCT03591510|Midostaurin|midostaurin|mesh-list
139266937|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266938|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139266939|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
139266940|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266941|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139266942|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
139266943|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266944|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139266945|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139266946|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139266947|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266948|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
139266949|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266950|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139266951|NCT03591510|Analgesics|analgesics|mesh-ancestor
139266952|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
139266953|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266954|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139266955|NCT03543969|Nivolumab|nivolumab|mesh-list
139266956|NCT03543969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139266957|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266958|NCT03543969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139266959|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266960|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139266961|NCT03534180|Venetoclax|venetoclax|mesh-list
139266962|NCT03534180|Romidepsin|romidepsin|mesh-list
139266963|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139266964|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266965|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139266966|NCT03534180|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139266967|NCT03534180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139266968|NCT03534180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266969|NCT03519945|Mirikizumab|mirikizumab|mesh-list
139266970|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139266971|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139266972|NCT03519945|Analgesics|analgesics|mesh-ancestor
139266973|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
139266974|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139266975|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266976|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266977|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139266978|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139266979|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139266980|NCT03511196|Prednisone|prednisone|mesh-list
139266981|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
139266982|NCT03511196|Androgens|androgens|mesh-list
139266983|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139266984|NCT03511196|Hormones|hormones|mesh-ancestor
139266985|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139266986|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266987|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139266988|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266989|NCT03477539|Lenalidomide|lenalidomide|mesh-list
139266990|NCT03477539|Daratumumab|daratumumab|mesh-list
139266991|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
139266992|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139266993|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139266994|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139266995|NCT03477539|Growth Substances|growth substances|mesh-ancestor
139266996|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
139266997|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139266998|NCT03476642|Epinephrine|epinephrine|mesh-list
139266999|NCT03476642|Ropivacaine|ropivacaine|mesh-list
139267000|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
139267001|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
139267002|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139267003|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267004|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
139267005|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267006|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139267007|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139267008|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
139267009|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267010|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267011|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139267012|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139267013|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
139267014|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139267015|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
139267016|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
139267017|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
139267018|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139267019|NCT03367156|Dexamethasone|dexamethasone|mesh-list
139267020|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
139267021|NCT03367156|Ichthammol|ichthammol|mesh-list
139267022|NCT03367156|BB 1101|bb 1101|mesh-list
139267023|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139267024|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
139267025|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
139267026|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267027|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267028|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139267029|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
139267030|NCT03367156|Hormones|hormones|mesh-ancestor
139267031|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139267032|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139267033|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267034|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
139267035|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201421|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139267036|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267037|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
139267038|NCT03302299|Pyridoxine|pyridoxine|mesh-list
139267039|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
139267040|NCT03302299|Isoniazid|isoniazid|mesh-list
139267041|NCT03302299|Vitamins|vitamins|mesh-ancestor
139267042|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
139267043|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267044|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
139267045|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
139267046|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139267047|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267048|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139267049|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139267050|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
139267051|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267052|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139267053|NCT03262935|Capecitabine|capecitabine|mesh-list
139267054|NCT03262935|Trastuzumab|trastuzumab|mesh-list
139267055|NCT03262935|Vinorelbine|vinorelbine|mesh-list
139267056|NCT03262935|Lapatinib|lapatinib|mesh-list
139267057|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139267058|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
139267059|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267060|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267061|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139267062|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139267063|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
139267064|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
139267065|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
139267066|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139267067|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267068|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
139267069|NCT03200847|Tretinoin|tretinoin|mesh-list
139267070|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139267071|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267072|NCT03200847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139267073|NCT03200847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267074|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
139267075|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
139267076|NCT03019003|Durvalumab|durvalumab|mesh-list
139267077|NCT03019003|Decitabine|decitabine|mesh-list
139267078|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139267079|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267080|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139267081|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
139267082|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267083|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267084|NCT02964078|Aldesleukin|aldesleukin|mesh-list
139267085|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
139267086|NCT02964078|Interleukin-2|interleukin-2|mesh-list
139267087|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139267088|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267089|NCT02964078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139267090|NCT02964078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267091|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139267092|NCT02964078|Analgesics|analgesics|mesh-ancestor
139267093|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
139267094|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267095|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267096|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139267097|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139267098|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
139267099|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267100|NCT02956447|Hormones|hormones|mesh-list
139267101|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139267102|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267103|NCT02953457|Durvalumab|durvalumab|mesh-list
139267104|NCT02953457|Ipilimumab|ipilimumab|mesh-list
139267105|NCT02953457|Olaparib|olaparib|mesh-list
139267106|NCT02953457|Tremelimumab|tremelimumab|mesh-list
139267107|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139267108|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
139267109|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139267110|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
139267111|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139267112|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267113|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
139267114|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267115|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267116|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267117|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139267118|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
139267119|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
139267120|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267121|NCT02910700|Nivolumab|nivolumab|mesh-list
139267122|NCT02910700|Trametinib|trametinib|mesh-list
139267123|NCT02910700|Dabrafenib|dabrafenib|mesh-list
139267124|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139267125|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267126|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139267127|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267128|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139267129|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267130|NCT02586727|Aflibercept|aflibercept|mesh-list
139267131|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139267132|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139267133|NCT02586727|Growth Substances|growth substances|mesh-ancestor
139267134|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267135|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
139267136|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267137|NCT02555358|Docetaxel|docetaxel|mesh-list
139267138|NCT02555358|Capecitabine|capecitabine|mesh-list
138850546|NCT00607789|Analgesics|analgesics|mesh-ancestor
139267139|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
139267140|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267141|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
139267142|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
139267143|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
139267144|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267145|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139267146|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
139267147|NCT02532231|Nivolumab|nivolumab|mesh-list
139267148|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139267149|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267150|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139267151|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267152|NCT02497365|Cefazolin|cefazolin|mesh-list
139267153|NCT02497365|Tobramycin|tobramycin|mesh-list
139267154|NCT02497365|Besifloxacin|besifloxacin|mesh-list
139267155|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139267156|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267157|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139267158|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139267159|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267160|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267161|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267162|NCT02458690|Dopamine|dopamine|mesh-list
139267163|NCT02458690|Norepinephrine|norepinephrine|mesh-list
139267164|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
139267165|NCT02458690|Serotonin|serotonin|mesh-list
139267166|NCT02458690|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139267167|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
139267168|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139267169|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139267170|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
139267171|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267172|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267173|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267174|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
139267175|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
139267176|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267177|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139267178|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139267179|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139267180|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
139267181|NCT02458690|Protective Agents|protective agents|mesh-ancestor
139267182|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139267183|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
139267184|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139137442|NCT01199757|Xhance|xhance|mesh-list
139267185|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139267186|NCT02446457|Rituximab|rituximab|mesh-list
139267187|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139267188|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
139267189|NCT02446457|Lenalidomide|lenalidomide|mesh-list
139267190|NCT02446457|Antibodies|antibodies|mesh-list
139267191|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
139267192|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139267193|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
139267194|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267195|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267196|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139267197|NCT02446457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139267198|NCT02446457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267199|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139267200|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139267201|NCT02446457|Growth Substances|growth substances|mesh-ancestor
139267202|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
139267203|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
139267204|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267205|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139267206|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267207|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267208|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
139267209|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139267210|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267211|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139267212|NCT02308280|Bortezomib|bortezomib|mesh-list
139267213|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267214|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
139267215|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139267216|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138850616|NCT00891163|Lidocaine|lidocaine|mesh-list
139267217|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
139267218|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267219|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139267220|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139267221|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267222|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267223|NCT02124421|Paclitaxel|paclitaxel|mesh-list
139267224|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139267225|NCT02124421|Carboplatin|carboplatin|mesh-list
139267226|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139267227|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267228|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
139267229|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
139267230|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
139267231|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267232|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
139267233|NCT02081378|Dasatinib|dasatinib|mesh-list
139267234|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267235|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139267236|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267237|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267238|NCT01914900|Cisplatin|cisplatin|mesh-list
139267239|NCT01914900|Docetaxel|docetaxel|mesh-list
139267240|NCT01914900|Fluorouracil|fluorouracil|mesh-list
139267241|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267242|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
139267243|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
139267244|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
139267245|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267246|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
139267247|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139267248|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139267249|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
139267250|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267251|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
139267252|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267253|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139267254|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267255|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267256|NCT01703455|Sorafenib|sorafenib|mesh-list
139267257|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642298|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139137482|NCT01199835|Calcium|calcium|mesh-list
139267258|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139267259|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267260|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267261|NCT01701674|Aldesleukin|aldesleukin|mesh-list
139267262|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
139267263|NCT01701674|Fludarabine|fludarabine|mesh-list
139267264|NCT01701674|Ipilimumab|ipilimumab|mesh-list
139267265|NCT01701674|Interleukin-2|interleukin-2|mesh-list
139267266|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139267267|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
139267268|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267269|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139267270|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139267271|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
139267272|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267273|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267274|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139267275|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139267276|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139267277|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139267278|NCT01701674|Analgesics|analgesics|mesh-ancestor
139267279|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
139267280|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267281|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139267282|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139267283|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
139267284|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267285|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
139267286|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139267287|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139267288|NCT01496976|Prednisolone|prednisolone|mesh-list
139267289|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
139267290|NCT01496976|Lenalidomide|lenalidomide|mesh-list
139267291|NCT01496976|Ofatumumab|ofatumumab|mesh-list
139267292|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139267293|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
139267294|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
139267295|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267296|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139267297|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139267298|NCT01496976|Growth Substances|growth substances|mesh-ancestor
139267299|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
139267300|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267301|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139267303|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
139267304|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267305|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139267306|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
139267307|NCT01496976|Hormones|hormones|mesh-ancestor
139267308|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139267309|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139267310|NCT01496976|Protective Agents|protective agents|mesh-ancestor
139267311|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139267312|NCT01409161|Vitamins|vitamins|mesh-list
139267313|NCT01409161|Vitamin A|vitamin a|mesh-list
139267314|NCT01409161|Tretinoin|tretinoin|mesh-list
139267315|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
139267316|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
139267317|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
139267318|NCT01409161|Calicheamicins|calicheamicins|mesh-list
139267319|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
139267320|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267321|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267322|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
139267323|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
139267324|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
139267325|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267326|NCT01409161|Protective Agents|protective agents|mesh-ancestor
139267327|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139267328|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139267329|NCT01409161|Immunotoxins|immunotoxins|mesh-ancestor
139267330|NCT01409161|Immunoconjugates|immunoconjugates|mesh-ancestor
139267331|NCT01409161|Immunologic Factors|immunologic factors|mesh-ancestor
139642299|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139267332|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139267333|NCT01140516|Trimethoprim|trimethoprim|mesh-list
139267334|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139267335|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267336|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
139267337|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139267338|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139267339|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139267340|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267341|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267342|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139267343|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139267344|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139267345|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139267346|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139267347|NCT00984399|Estradiol|estradiol|mesh-list
139267348|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139267349|NCT00984399|Estrogens|estrogens|mesh-ancestor
139267350|NCT00984399|Hormones|hormones|mesh-ancestor
139267351|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139267352|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267353|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139267354|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
139267355|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139267356|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139267357|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
139267358|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139267359|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
139267360|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267361|NCT00775476|Expectorants|expectorants|mesh-ancestor
139267362|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
139267363|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139267364|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
139267365|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267366|NCT00775476|Protective Agents|protective agents|mesh-ancestor
139267367|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850756|NCT02768376|Narcotics|narcotics|mesh-ancestor
139267368|NCT00775476|Antidotes|antidotes|mesh-ancestor
139267369|NCT02915016|Vaccines|vaccines|mesh-list
139267370|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
139267371|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
139267372|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267373|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139267374|NCT01170650|Doxorubicin|doxorubicin|mesh-list
139267375|NCT01170650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139267376|NCT01170650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139267377|NCT01170650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267378|NCT01170650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139267379|NCT01170650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139267380|NCT01170650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267381|NCT01170650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267382|NCT01168310|Fluticasone|fluticasone|mesh-list
139267383|NCT01168310|Xhance|xhance|mesh-list
139267384|NCT01168310|Formoterol Fumarate|formoterol fumarate|mesh-list
139267385|NCT01168310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139267386|NCT01168310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139267387|NCT01168310|Autonomic Agents|autonomic agents|mesh-ancestor
139267388|NCT01168310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267389|NCT01168310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267390|NCT01168310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139267391|NCT01168310|Respiratory System Agents|respiratory system agents|mesh-ancestor
139267392|NCT01168310|Dermatologic Agents|dermatologic agents|mesh-ancestor
139267393|NCT01168310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139267394|NCT01168310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139267395|NCT01168310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139267396|NCT01168310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139267397|NCT01168310|Adrenergic Agents|adrenergic agents|mesh-ancestor
139267398|NCT01168310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267399|NCT01168310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267400|NCT01472198|Gemcitabine|gemcitabine|mesh-list
139267401|NCT01472198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139267402|NCT01472198|Antimetabolites|antimetabolites|mesh-ancestor
139267403|NCT01472198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267404|NCT01472198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267405|NCT02269358|Methotrexate|methotrexate|mesh-list
139381672|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139267406|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139267407|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
139267408|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139267409|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267410|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139267411|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
139267412|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267413|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267414|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
139267415|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267416|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139267417|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139267418|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
139267419|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139267420|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139267421|NCT04504240|Famotidine|famotidine|mesh-list
139267422|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139267423|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139267424|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139267425|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
139267426|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
139267427|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267428|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267429|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267430|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
139267431|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139267432|NCT02269514|Nicotine|nicotine|mesh-list
139267433|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139267434|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
139267435|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267436|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267437|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139267438|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139267439|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
139267440|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267441|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267442|NCT01332812|Dexamethasone|dexamethasone|mesh-list
139267443|NCT01332812|Dexamethasone acetate|dexamethasone acetate|mesh-list
139267444|NCT01332812|BB 1101|bb 1101|mesh-list
139267445|NCT01332812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139267446|NCT01332812|Antiemetics|antiemetics|mesh-ancestor
139267447|NCT01332812|Autonomic Agents|autonomic agents|mesh-ancestor
139267448|NCT01332812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267449|NCT01332812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267450|NCT01332812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139267451|NCT01332812|Glucocorticoids|glucocorticoids|mesh-ancestor
139267452|NCT01332812|Hormones|hormones|mesh-ancestor
139267453|NCT01332812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139267454|NCT01332812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139267455|NCT01332812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267456|NCT01332812|Protease Inhibitors|protease inhibitors|mesh-ancestor
139267457|NCT01332812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267458|NCT01332812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267459|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
139267460|NCT03408652|Denosumab|denosumab|mesh-list
139267461|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139267462|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267463|NCT01332656|Paclitaxel|paclitaxel|mesh-list
139267464|NCT01332656|Carboplatin|carboplatin|mesh-list
139267465|NCT01332656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139267466|NCT01332656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267467|NCT01332656|Tubulin Modulators|tubulin modulators|mesh-ancestor
139267468|NCT01332656|Antimitotic Agents|antimitotic agents|mesh-ancestor
139267469|NCT01332656|Mitosis Modulators|mitosis modulators|mesh-ancestor
139267470|NCT01332656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267471|NCT02084472|Petrolatum|petrolatum|mesh-list
139267472|NCT02084472|Glycerol|glycerol|mesh-list
139267473|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139267474|NCT02084472|Protective Agents|protective agents|mesh-ancestor
139267475|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267476|NCT02084472|Emollients|emollients|mesh-ancestor
139267477|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
139267478|NCT02266784|Nicotine|nicotine|mesh-list
139267479|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139267480|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
139267481|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267482|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267483|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139267484|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139267485|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
139267486|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267487|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267488|NCT02090790|Dexamethasone|dexamethasone|mesh-list
139267489|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
139267490|NCT02090790|BB 1101|bb 1101|mesh-list
139267491|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139267492|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
139267493|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
139267494|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267495|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267496|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139267497|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
139267498|NCT02090790|Hormones|hormones|mesh-ancestor
139267499|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139267500|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139267501|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267502|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
139267503|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267504|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267505|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
139267506|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139267507|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139267508|NCT01443728|Vitamin D|vitamin d|mesh-list
139267509|NCT01443728|Ergocalciferols|ergocalciferols|mesh-list
139267510|NCT01443728|Cholecalciferol|cholecalciferol|mesh-list
139267511|NCT01443728|Vitamins|vitamins|mesh-list
139267512|NCT01443728|Micronutrients|micronutrients|mesh-ancestor
139267513|NCT01443728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267514|NCT01443728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139267515|NCT01443728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139267516|NCT01324466|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
139267517|NCT01324466|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
139267518|NCT01324466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267519|NCT01324466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267521|NCT01312454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139267522|NCT01312454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139267523|NCT02084784|Methylene Blue|methylene blue|mesh-list
139267524|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267525|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267526|NCT02091180|Mannitol|mannitol|mesh-list
139267527|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139267528|NCT02091180|Diuretics|diuretics|mesh-ancestor
139267529|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
139267530|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267531|NCT02269748|Analgesics|analgesics|mesh-list
139267532|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
139267533|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267534|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267535|NCT02269904|Fluorouracil|fluorouracil|mesh-list
139267536|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
139267537|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267538|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139267539|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267540|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139267541|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
139267542|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267543|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
139267544|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267545|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139267546|NCT01300208|CC-11050|cc-11050|mesh-list
139267547|NCT01300208|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139267548|NCT01300208|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139267549|NCT01300208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267550|NCT01300208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267551|NCT02085018|Omeprazole|omeprazole|mesh-list
139267552|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139267553|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139267554|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139267555|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267556|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267557|NCT02091336|Metformin|metformin|mesh-list
139267558|NCT02091336|Glyburide|glyburide|mesh-list
139267559|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139267560|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267561|NCT01442090|Everolimus|everolimus|mesh-list
139267562|NCT01442090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139267563|NCT01442090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139267564|NCT01442090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267565|NCT01442090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267566|NCT01442090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139267567|NCT01442090|Immunologic Factors|immunologic factors|mesh-ancestor
139267568|NCT01442090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267569|NCT01442090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267570|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
139267571|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139267572|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267573|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139267574|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267575|NCT02088450|Nitrendipine|nitrendipine|mesh-list
139267576|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139267577|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139267578|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139267579|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267580|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139267581|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267582|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
139267583|NCT03688828|Amoxicillin|amoxicillin|mesh-list
139267584|NCT03688828|Clarithromycin|clarithromycin|mesh-list
139267585|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
139267586|NCT03688828|Esomeprazole|esomeprazole|mesh-list
139267587|NCT03688828|Bismuth|bismuth|mesh-list
139267588|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267589|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139267590|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267591|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139267592|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139210363|NCT03516981|Lenvatinib|lenvatinib|mesh-list
139267593|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139267594|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267595|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139267596|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139267597|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139267598|NCT03688828|Antacids|antacids|mesh-ancestor
139267599|NCT03688828|Diuretics|diuretics|mesh-ancestor
139267600|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
139267601|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267602|NCT03688828|Expectorants|expectorants|mesh-ancestor
139267603|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
139267604|NCT02091492|Teriparatide|teriparatide|mesh-list
139267605|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139267606|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267607|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139267608|NCT02266940|DS-1971a|ds-1971a|mesh-list
139267609|NCT02266940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139267610|NCT02266940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139267611|NCT02266940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139267612|NCT02266940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267613|NCT03981952|Vaccines|vaccines|mesh-list
139267614|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
139267615|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267616|NCT04475120|Lactoferrin|lactoferrin|mesh-list
139267617|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267618|NCT02088528|Mitomycins|mitomycins|mesh-list
139267619|NCT02088528|Mitomycin|mitomycin|mesh-list
139267620|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139267621|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267622|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
139267623|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267624|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139202031|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
139267625|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267626|NCT03634150|Doxorubicin|doxorubicin|mesh-list
139267627|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139267628|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267629|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139267630|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139267631|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267632|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267634|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139267635|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
139267636|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267637|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267638|NCT02272166|Propofol|propofol|mesh-list
139267639|NCT02272166|Sevoflurane|sevoflurane|mesh-list
139267640|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139267641|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139267642|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267643|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139267644|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
139267645|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
139267646|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139267647|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139267648|NCT02088684|Fulvestrant|fulvestrant|mesh-list
139267649|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139267650|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267651|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139267652|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139267653|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
139267654|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139267655|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267656|NCT01137968|Bevacizumab|bevacizumab|mesh-list
139267657|NCT01137968|Imetelstat|imetelstat|mesh-list
139267658|NCT01137968|Motesanib diphosphate|motesanib diphosphate|mesh-list
139267659|NCT01137968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139267660|NCT01137968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267661|NCT01137968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139267662|NCT01137968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139267663|NCT01137968|Growth Substances|growth substances|mesh-ancestor
139267664|NCT01137968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267665|NCT01137968|Growth Inhibitors|growth inhibitors|mesh-ancestor
139267666|NCT01137968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267667|NCT01137968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267668|NCT01137968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139267670|NCT02249910|Digoxin|digoxin|mesh-list
139267671|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139267672|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267673|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139267674|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139267675|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267676|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267677|NCT02249910|Protective Agents|protective agents|mesh-ancestor
139267678|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139267679|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139267680|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139267681|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139267682|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
139267683|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267684|NCT02398396|Lactitol|lactitol|mesh-list
139267685|NCT02398396|Cathartics|cathartics|mesh-ancestor
139267686|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139267687|NCT05628584|Metformin|metformin|mesh-list
139267688|NCT05628584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139267689|NCT05628584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267690|NCT02088918|Metformin|metformin|mesh-list
139267691|NCT02088918|Nateglinide|nateglinide|mesh-list
139267692|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139267693|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267694|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
139267695|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139267696|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267697|NCT02092428|Adenosine|adenosine|mesh-list
139267698|NCT02092428|Regadenoson|regadenoson|mesh-list
139267699|NCT02092428|Analgesics|analgesics|mesh-ancestor
139267700|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
139267701|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267702|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267703|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139267704|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
139267705|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139267706|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
139267707|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
139267708|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267709|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267710|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139267712|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
139267713|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
139267714|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139267715|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267716|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139267717|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267718|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267719|NCT01097018|Capecitabine|capecitabine|mesh-list
139267720|NCT01097018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139267721|NCT01097018|Antimetabolites|antimetabolites|mesh-ancestor
139267722|NCT01097018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267723|NCT01097018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267724|NCT01096862|Peficitinib|peficitinib|mesh-list
139267725|NCT01096862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267726|NCT01096862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267727|NCT01096862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139267728|NCT01096862|Immunologic Factors|immunologic factors|mesh-ancestor
139267729|NCT01096862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267730|NCT02092506|Amoxicillin|amoxicillin|mesh-list
139267731|NCT02092506|Metronidazole|metronidazole|mesh-list
139267732|NCT02092506|Clarithromycin|clarithromycin|mesh-list
139267733|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139267734|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139267735|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267736|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139267737|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139267738|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139267739|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267740|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267741|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139267742|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139267743|NCT01092104|Cenicriviroc|cenicriviroc|mesh-list
139267744|NCT01092104|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139267745|NCT01092104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267746|NCT01092104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139267747|NCT01092104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139267748|NCT01092104|Antiviral Agents|antiviral agents|mesh-ancestor
139267749|NCT01092104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267750|NCT01128530|Linezolid|linezolid|mesh-list
139267751|NCT01128530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139267752|NCT01128530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267753|NCT01128530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139267754|NCT01128530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267755|NCT01128530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267756|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139267757|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139267758|NCT02086032|Estradiol|estradiol|mesh-list
139267759|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139267760|NCT02086032|Estrogens|estrogens|mesh-list
139267761|NCT02086032|Progesterone|progesterone|mesh-list
139267762|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
139267763|NCT02086032|Hormones|hormones|mesh-ancestor
139267764|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139267765|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267766|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139267767|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
139267768|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139267769|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139267770|NCT02086032|Progestins|progestins|mesh-ancestor
139267771|NCT02092818|Riociguat|riociguat|mesh-list
139267772|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
139267773|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267774|NCT02267408|Warfarin|warfarin|mesh-list
139267775|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
139267776|NCT02092896|Liraglutide|liraglutide|mesh-list
139267777|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139267778|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267779|NCT02092896|Incretins|incretins|mesh-ancestor
139267780|NCT02092896|Hormones|hormones|mesh-ancestor
139267781|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139267782|NCT02092974|Citalopram|citalopram|mesh-list
139267783|NCT02092974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139267784|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139267785|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139267786|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267787|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267788|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
139267789|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267790|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139267791|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
139267792|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139267793|NCT05097508|Bromides|bromides|mesh-list
139267794|NCT05097508|Rocuronium|rocuronium|mesh-list
139267795|NCT05097508|Atracurium|atracurium|mesh-list
139267796|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
139267797|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139267798|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139267799|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139267800|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267801|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267802|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139267803|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139267804|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
139267805|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267806|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267807|NCT02089308|Nicotine|nicotine|mesh-list
139267808|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139267809|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
139267810|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267811|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267812|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139267813|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139267814|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
139267815|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267816|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267817|NCT00153920|Bortezomib|bortezomib|mesh-list
139267818|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267819|NCT05095714|Liver Extracts|liver extracts|mesh-list
139267820|NCT05095714|Hematinics|hematinics|mesh-ancestor
139267821|NCT02660242|Glucagon|glucagon|mesh-list
139267822|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139267823|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267824|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139267825|NCT02660242|Hormones|hormones|mesh-ancestor
139267826|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139267827|NCT02660242|Incretins|incretins|mesh-ancestor
139267828|NCT02089386|Tamoxifen|tamoxifen|mesh-list
139267829|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139267830|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
139267831|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139267832|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267833|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139267834|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267835|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139267836|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139267837|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139267838|NCT03557580|Isosorbide|isosorbide|mesh-list
139267839|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139267840|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139267841|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139267842|NCT03557580|Diuretics|diuretics|mesh-ancestor
139267843|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
139267844|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267845|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
139267846|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139267847|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267848|NCT02089542|Methylene Blue|methylene blue|mesh-list
139267849|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267850|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267851|NCT01295060|Octreotide|octreotide|mesh-list
139267852|NCT01295060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139267853|NCT01295060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139267854|NCT01295060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267855|NCT02086656|Bevacizumab|bevacizumab|mesh-list
139267856|NCT02086656|Capecitabine|capecitabine|mesh-list
139267857|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
139267858|NCT02086656|Irinotecan|irinotecan|mesh-list
139267859|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139267860|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267861|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139267862|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139267863|NCT02086656|Growth Substances|growth substances|mesh-ancestor
139267864|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267865|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
139267866|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139267867|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
139267868|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267869|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139267870|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139267871|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267872|NCT01294202|Imatinib Mesylate|imatinib mesylate|mesh-list
139267873|NCT01294202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267874|NCT01294202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139267875|NCT01294202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267876|NCT01294202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267877|NCT01071902|Moxifloxacin|moxifloxacin|mesh-list
139267878|NCT01071902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139267879|NCT01071902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139267880|NCT01071902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267881|NCT01071902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139267882|NCT01071902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139267883|NCT01071902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267884|NCT01071902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267885|NCT01071902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267886|NCT01126970|Orlistat|orlistat|mesh-list
139267887|NCT01126970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267888|NCT01126970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267889|NCT01126970|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139267890|NCT01126970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139267891|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
139267892|NCT03557424|Cathartics|cathartics|mesh-ancestor
138851287|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
139267894|NCT05057572|Carvedilol|carvedilol|mesh-list
139267895|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139267896|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139267897|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
139267898|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267899|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267900|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267901|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139267902|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
139267903|NCT05057572|Protective Agents|protective agents|mesh-ancestor
139267904|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139267905|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139267906|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139267907|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
139267908|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139267909|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139267910|NCT02093598|Sirolimus|sirolimus|mesh-list
139267911|NCT02093598|Temsirolimus|temsirolimus|mesh-list
139267912|NCT02093598|MTOR Inhibitors|mtor inhibitors|mesh-list
139267913|NCT02093598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139267914|NCT02093598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267915|NCT02093598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267916|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139267917|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
139267918|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267919|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267920|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139267921|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139267922|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139267923|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
139267924|NCT01124552|Botulinum Toxins|botulinum toxins|mesh-list
139267925|NCT01124552|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139267926|NCT01124552|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139267927|NCT01124552|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139267928|NCT01124552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139267929|NCT01124552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267930|NCT01124552|Cholinergic Agents|cholinergic agents|mesh-ancestor
139267931|NCT01124552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267932|NCT01124552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267933|NCT01124552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139267934|NCT01124552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267936|NCT02087202|Ketamine|ketamine|mesh-list
139267937|NCT02087202|Analgesics|analgesics|mesh-ancestor
139267938|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
139267939|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267940|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267941|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139267942|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139267943|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
139267944|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
139267945|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139267946|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139267947|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139267948|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267949|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267950|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139267951|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
139267952|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139267953|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139267954|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139267955|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
139267956|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139267957|NCT01283594|Levodopa|levodopa|mesh-list
139267958|NCT01283594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139267959|NCT01283594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139267960|NCT01283594|Dopamine Agents|dopamine agents|mesh-ancestor
139267961|NCT01283594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139267962|NCT01283594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267963|NCT01283594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267964|NCT01281254|Trebananib|trebananib|mesh-list
139267965|NCT01281254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139267967|NCT01281254|Growth Substances|growth substances|mesh-ancestor
139267968|NCT01281254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267969|NCT01281254|Growth Inhibitors|growth inhibitors|mesh-ancestor
139267970|NCT01281254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267971|NCT05104138|Eplerenone|eplerenone|mesh-list
139267972|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139267973|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
139267974|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139267975|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267976|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139267977|NCT05104138|Diuretics|diuretics|mesh-ancestor
139267978|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
139267979|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139267980|NCT03072043|Azacitidine|azacitidine|mesh-list
139267981|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139267982|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
139267983|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267984|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139267985|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267986|NCT05626010|Acetaminophen|acetaminophen|mesh-list
139267987|NCT05626010|Ibuprofen|ibuprofen|mesh-list
139267988|NCT05626010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139267989|NCT05626010|Analgesics|analgesics|mesh-ancestor
139267990|NCT05626010|Sensory System Agents|sensory system agents|mesh-ancestor
139267991|NCT05626010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267992|NCT05626010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139267993|NCT05626010|Antipyretics|antipyretics|mesh-ancestor
139267994|NCT05626010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139267995|NCT05626010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139267996|NCT05626010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139267997|NCT05626010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139267998|NCT05626010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139267999|NCT05626010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268000|NCT02089854|Toremifene|toremifene|mesh-list
139268001|NCT02089854|Anastrozole|anastrozole|mesh-list
139268002|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139268003|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268004|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139268005|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139268006|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268007|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268008|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139268009|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
139268010|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139268011|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268012|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139268013|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139268014|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139268016|NCT05624840|Nirmatrelvir|nirmatrelvir|mesh-list
139268017|NCT05624840|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139268018|NCT05624840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139268019|NCT05624840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139268020|NCT05624840|Protease Inhibitors|protease inhibitors|mesh-ancestor
139268021|NCT05624840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268022|NCT05624840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268023|NCT05624840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139268024|NCT05624840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139268025|NCT05624840|Antiviral Agents|antiviral agents|mesh-ancestor
139268026|NCT05624840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268027|NCT05624840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139268028|NCT05624840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139268029|NCT02093910|Dexamethasone|dexamethasone|mesh-list
139268030|NCT02093910|Bortezomib|bortezomib|mesh-list
139268031|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139268032|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
139268033|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
139268034|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268035|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268036|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139268037|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
139268038|NCT02093910|Hormones|hormones|mesh-ancestor
139268039|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139268040|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139268041|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268042|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
139268043|NCT04437160|Epirubicin|epirubicin|mesh-list
139268044|NCT04437160|Pirarubicin|pirarubicin|mesh-list
139268045|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139268046|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
139268047|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268048|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139268049|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139268050|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
139268051|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268052|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268053|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139268054|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139268055|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139268056|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139268057|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268058|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
139268059|NCT02089932|Bupivacaine|bupivacaine|mesh-list
139268060|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
139268061|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
139268062|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268063|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268064|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
139268065|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268066|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139268067|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139268068|NCT02089932|Analgesics|analgesics|mesh-ancestor
139268069|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139381684|NCT04843280|Coal Tar|coal tar|mesh-list
139268070|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139268071|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139268072|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
139268073|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139268074|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268075|NCT01037036|Latanoprost|latanoprost|mesh-list
139268076|NCT01037036|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139268077|NCT01037036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139268078|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
139268079|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
139268080|NCT03069313|Vitamins|vitamins|mesh-ancestor
139268081|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
139268082|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268083|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
139268084|NCT03069313|Hematinics|hematinics|mesh-ancestor
139268085|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
139268086|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139268087|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139268088|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268089|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
139268090|NCT02094066|Coagulants|coagulants|mesh-ancestor
139268091|NCT01033292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139268092|NCT01033292|Iniparib|iniparib|mesh-list
139268093|NCT01033292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268094|NCT01033292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268095|NCT01033292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268096|NCT03068767|Vitamin D|vitamin d|mesh-list
139268097|NCT03068767|Vitamins|vitamins|mesh-ancestor
139268098|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
139268099|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268100|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139268101|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
139268102|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268103|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
139268104|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
139268105|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
139268106|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139268107|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139268108|NCT01110902|Agomelatine|agomelatine|mesh-list
139268109|NCT01110902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139268110|NCT01110902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268111|NCT01110902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268112|NCT05204173|Paclitaxel|paclitaxel|mesh-list
139268113|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139268114|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268115|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
139268116|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
139268117|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
139268118|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268119|NCT01025648|Epinephrine|epinephrine|mesh-list
139268120|NCT01025648|Racepinephrine|racepinephrine|mesh-list
139268121|NCT01025648|Epinephryl borate|epinephryl borate|mesh-list
139268122|NCT01025648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139268123|NCT01025648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139268124|NCT01025648|Adrenergic Agents|adrenergic agents|mesh-ancestor
139268125|NCT01025648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139268126|NCT01025648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268127|NCT01025648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268128|NCT01025648|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139268129|NCT01025648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139268130|NCT01025648|Autonomic Agents|autonomic agents|mesh-ancestor
139268131|NCT01025648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268132|NCT01025648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139268133|NCT01025648|Respiratory System Agents|respiratory system agents|mesh-ancestor
139268134|NCT01025648|Mydriatics|mydriatics|mesh-ancestor
139268135|NCT01025648|Sympathomimetics|sympathomimetics|mesh-ancestor
139268136|NCT01025648|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139268137|NCT01110746|Insulin|insulin|mesh-list
139268138|NCT01110746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139268139|NCT01110746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139268140|NCT01110746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268141|NCT05622968|Dinoprostone|dinoprostone|mesh-list
139268142|NCT05622968|Oxytocics|oxytocics|mesh-ancestor
139268143|NCT05622968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139268144|NCT05622968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268145|NCT02268032|Androgens|androgens|mesh-list
139268146|NCT02268032|Hormones|hormones|mesh-ancestor
139268147|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139268148|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268149|NCT03019965|Meropenem|meropenem|mesh-list
139268150|NCT03019965|Tazobactam|tazobactam|mesh-list
139268151|NCT03019965|Piperacillin|piperacillin|mesh-list
139268152|NCT03019965|Imipenem|imipenem|mesh-list
139268153|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139268154|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139268155|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268156|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139268157|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642300|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
139268158|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268160|NCT01468831|Bevacizumab|bevacizumab|mesh-list
139268161|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139268162|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268163|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139268164|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139268165|NCT01468831|Growth Substances|growth substances|mesh-ancestor
139268166|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268167|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
139268168|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139268169|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268170|NCT05627414|Paclitaxel|paclitaxel|mesh-list
139268171|NCT05627414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139268172|NCT05627414|Tegafur|tegafur|mesh-list
139268173|NCT05627414|Disitamab vedotin|disitamab vedotin|mesh-list
139268174|NCT05627414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139268175|NCT05627414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268176|NCT05627414|Tubulin Modulators|tubulin modulators|mesh-ancestor
139268177|NCT05627414|Antimitotic Agents|antimitotic agents|mesh-ancestor
139268178|NCT05627414|Mitosis Modulators|mitosis modulators|mesh-ancestor
139268179|NCT05627414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268180|NCT05627414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139268181|NCT05627414|Antimetabolites|antimetabolites|mesh-ancestor
139268182|NCT05627414|Immunoconjugates|immunoconjugates|mesh-ancestor
139268183|NCT05627414|Immunologic Factors|immunologic factors|mesh-ancestor
139268184|NCT05627414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268185|NCT05617508|Niacinamide|niacinamide|mesh-list
139268186|NCT05617508|Niacin|niacin|mesh-list
139268187|NCT05617508|Nicotinic Acids|nicotinic acids|mesh-list
139268188|NCT05617508|Vitamin B Complex|vitamin b complex|mesh-ancestor
139268189|NCT05617508|Vitamins|vitamins|mesh-ancestor
139268190|NCT05617508|Micronutrients|micronutrients|mesh-ancestor
139268191|NCT05617508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268192|NCT05617508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139268193|NCT05617508|Antimetabolites|antimetabolites|mesh-ancestor
139268194|NCT05617508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268195|NCT05617508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139268196|NCT05617508|Vasodilator Agents|vasodilator agents|mesh-ancestor
139268197|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139268198|NCT03018249|Entinostat|entinostat|mesh-list
139268199|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
139268200|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139268201|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139268202|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139268203|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139268204|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
139268205|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139268206|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268207|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139268208|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139268209|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139268210|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139268211|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268212|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268213|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268214|NCT05380154|Botulinum Toxins|botulinum toxins|mesh-list
139268215|NCT05380154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139268216|NCT05380154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139268217|NCT05380154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139268218|NCT05380154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139268219|NCT05380154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268220|NCT05380154|Cholinergic Agents|cholinergic agents|mesh-ancestor
139268221|NCT05380154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139268222|NCT05380154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268223|NCT05380154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139268224|NCT05380154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268225|NCT05374252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139268226|NCT05374252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268227|NCT05374252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139268228|NCT05374252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268229|NCT00905606|Topiramate|topiramate|mesh-list
139268230|NCT00905606|Anticonvulsants|anticonvulsants|mesh-ancestor
139268231|NCT00905606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139268232|NCT00905606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268234|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
139268235|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
139268236|NCT03017235|Citric Acid|citric acid|mesh-list
139268237|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
139268238|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139268239|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
139268240|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
139268241|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268242|NCT03017235|Antacids|antacids|mesh-ancestor
139268243|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139268244|NCT03017235|Cathartics|cathartics|mesh-ancestor
139268245|NCT05048134|Trametinib|trametinib|mesh-list
139268246|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268247|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139268248|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268249|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268250|NCT04438928|Micronutrients|micronutrients|mesh-list
139268251|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268252|NCT03667677|Amlodipine|amlodipine|mesh-list
139268253|NCT03667677|Tandospirone|tandospirone|mesh-list
139268254|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139268255|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139268256|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139268257|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268258|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139268259|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268260|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
139268261|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139268262|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139268263|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268264|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139268265|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139268266|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
139268267|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139268268|NCT04176718|Dexamethasone|dexamethasone|mesh-list
139268269|NCT04176718|Daratumumab|daratumumab|mesh-list
139268270|NCT04176718|Pomalidomide|pomalidomide|mesh-list
139268271|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139268272|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
139268273|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
139268274|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268275|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268276|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139268277|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
139268278|NCT04176718|Hormones|hormones|mesh-ancestor
139268279|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139268280|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139268281|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268282|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
139268283|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139268284|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139268285|NCT04176718|Growth Substances|growth substances|mesh-ancestor
139268286|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
139268287|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
139268288|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139268289|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268290|NCT02880371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139268291|NCT02880371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268292|NCT00813956|Carboplatin|carboplatin|mesh-list
139268293|NCT00813956|Gemcitabine|gemcitabine|mesh-list
139268294|NCT00813956|Iniparib|iniparib|mesh-list
139268295|NCT00813956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268296|NCT00813956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139268297|NCT00813956|Antimetabolites|antimetabolites|mesh-ancestor
139268298|NCT00813956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268299|NCT00813956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139268300|NCT00813956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268301|NCT01002248|Dexamethasone|dexamethasone|mesh-list
139268302|NCT01002248|Bortezomib|bortezomib|mesh-list
139268303|NCT01002248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139268304|NCT01002248|Antiemetics|antiemetics|mesh-ancestor
139268305|NCT01002248|Autonomic Agents|autonomic agents|mesh-ancestor
139268306|NCT01002248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268307|NCT01002248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138537|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
139268308|NCT01002248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139268309|NCT01002248|Glucocorticoids|glucocorticoids|mesh-ancestor
139268310|NCT01002248|Hormones|hormones|mesh-ancestor
139268311|NCT01002248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139268312|NCT01002248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139268313|NCT01002248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268314|NCT02837029|Nivolumab|nivolumab|mesh-list
139268315|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139268316|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268317|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139268318|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268319|NCT03667131|Enalapril|enalapril|mesh-list
139268320|NCT03667131|Enalaprilat|enalaprilat|mesh-list
139268321|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139268322|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139268323|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268324|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
139268325|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139268326|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139268327|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139268328|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
139268329|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139268330|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268331|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
139268332|NCT04976374|Gabapentin|gabapentin|mesh-list
139268333|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139268334|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268335|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268336|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139268337|NCT04976374|Analgesics|analgesics|mesh-ancestor
139268338|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
139268339|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268340|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139268341|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139268342|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139268343|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
139268344|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139268345|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268346|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
139268347|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139268348|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139268349|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139268350|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139268351|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139268352|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
139268353|NCT00894530|Azithromycin|azithromycin|mesh-list
139268354|NCT00894530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139268355|NCT00894530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139268356|NCT00894530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139268357|NCT00894530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268358|NCT01376999|Hormones|hormones|mesh-list
139268359|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139268360|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268361|NCT00892970|Azithromycin|azithromycin|mesh-list
139268362|NCT00892970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139268363|NCT00892970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139268364|NCT00892970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139268365|NCT00892970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268366|NCT05340257|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139268367|NCT05340257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139268368|NCT05340257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268369|NCT05340257|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139268370|NCT05340257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268371|NCT05340257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268372|NCT02201381|Metformin|metformin|mesh-list
139268373|NCT02201381|Doxycycline|doxycycline|mesh-list
139268374|NCT02201381|Mebendazole|mebendazole|mesh-list
139268375|NCT02201381|Atorvastatin|atorvastatin|mesh-list
139268376|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139268377|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268378|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139268379|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139268380|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
139642301|NCT02893423|Ropivacaine|ropivacaine|mesh-list
139268381|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268382|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139268383|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139268384|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268385|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139268386|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268387|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
139268388|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139268389|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139268390|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
139268391|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
139268392|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
139268393|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
139268394|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
139268395|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268396|NCT00803114|Morphine|morphine|mesh-list
139268397|NCT00803114|Narcotics|narcotics|mesh-list
139268398|NCT00803114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139268399|NCT00803114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268400|NCT00803114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268401|NCT00803114|Analgesics|analgesics|mesh-ancestor
139268402|NCT00803114|Sensory System Agents|sensory system agents|mesh-ancestor
139268403|NCT00803114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268404|NCT05519384|Cyclophosphamide|cyclophosphamide|mesh-list
139268405|NCT05519384|Fludarabine|fludarabine|mesh-list
139268406|NCT05519384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139268407|NCT05519384|Immunologic Factors|immunologic factors|mesh-ancestor
139268408|NCT05519384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268409|NCT05519384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139268410|NCT05519384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139268411|NCT05519384|Alkylating Agents|alkylating agents|mesh-ancestor
139268412|NCT05519384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268413|NCT05519384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268414|NCT05519384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139268415|NCT00799292|Vasopressins|vasopressins|mesh-list
139268416|NCT00799292|Arginine Vasopressin|arginine vasopressin|mesh-list
139268417|NCT00799292|Hemostatics|hemostatics|mesh-ancestor
139268418|NCT00799292|Coagulants|coagulants|mesh-ancestor
139268419|NCT00799292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139268420|NCT00799292|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139268421|NCT00799292|Natriuretic Agents|natriuretic agents|mesh-ancestor
139268422|NCT00799292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268423|NCT02914275|Vaccines|vaccines|mesh-list
139268424|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
139268425|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268426|NCT01941875|Progesterone|progesterone|mesh-list
139268427|NCT01941875|Progestins|progestins|mesh-ancestor
139268428|NCT01941875|Hormones|hormones|mesh-ancestor
139268429|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139268430|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268431|NCT01814657|Lidocaine|lidocaine|mesh-list
139268432|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
139268433|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
139268434|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268435|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268436|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
139268437|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268438|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139268439|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139268440|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139268441|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139268442|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268443|NCT01773395|Methotrexate|methotrexate|mesh-list
139268444|NCT01773395|Fludarabine|fludarabine|mesh-list
139268445|NCT01773395|Busulfan|busulfan|mesh-list
139268446|NCT01773395|Tacrolimus|tacrolimus|mesh-list
139268447|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139268448|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
139268449|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139268450|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268451|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139268452|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
139268453|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268454|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268455|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
139268456|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268457|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139268458|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139268459|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
139268460|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139268461|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139268462|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139268463|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
139268464|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139268465|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139268467|NCT01000922|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139268468|NCT01000922|Insulin Glargine|insulin glargine|mesh-list
139268469|NCT01000922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139268470|NCT01000922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268471|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
139268472|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268473|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
139268474|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
139268475|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139268476|NCT03666195|Protective Agents|protective agents|mesh-ancestor
139268477|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268478|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
139268479|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139268480|NCT00889382|Paclitaxel|paclitaxel|mesh-list
139268481|NCT00889382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139268482|NCT00889382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268483|NCT00889382|Tubulin Modulators|tubulin modulators|mesh-ancestor
139268484|NCT00889382|Antimitotic Agents|antimitotic agents|mesh-ancestor
139268485|NCT00889382|Mitosis Modulators|mitosis modulators|mesh-ancestor
139268486|NCT00889382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268488|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268489|NCT05375188|Dexmedetomidine|dexmedetomidine|mesh-list
139268490|NCT05375188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139268491|NCT05375188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268492|NCT05375188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268493|NCT05375188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139268494|NCT05375188|Analgesics|analgesics|mesh-ancestor
139268495|NCT05375188|Sensory System Agents|sensory system agents|mesh-ancestor
139268496|NCT05375188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268497|NCT05375188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139268498|NCT05375188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139268499|NCT05375188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139268500|NCT05375188|Adrenergic Agents|adrenergic agents|mesh-ancestor
139268501|NCT05375188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139268502|NCT05375188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268503|NCT00994292|Darexaban|darexaban|mesh-list
139268504|NCT00994292|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139268505|NCT00994292|Antithrombins|antithrombins|mesh-ancestor
139268506|NCT00994292|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139268507|NCT00994292|Protease Inhibitors|protease inhibitors|mesh-ancestor
139268508|NCT00994292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268509|NCT00994292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268510|NCT00994292|Anticoagulants|anticoagulants|mesh-ancestor
139268511|NCT02604433|Luspatercept|luspatercept|mesh-list
139268512|NCT02604433|Hematinics|hematinics|mesh-ancestor
139268513|NCT04437004|Fenfluramine|fenfluramine|mesh-list
139268514|NCT04437004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139268515|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139268516|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139268517|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268518|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139268519|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
139268520|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268521|NCT00992732|Valganciclovir|valganciclovir|mesh-list
139268522|NCT00992732|Ganciclovir|ganciclovir|mesh-list
139268523|NCT00992732|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139268524|NCT00992732|Arginine butyrate|arginine butyrate|mesh-list
139268525|NCT00992732|Antiviral Agents|antiviral agents|mesh-ancestor
139268526|NCT00992732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268527|NCT00992732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139268528|NCT00992732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268529|NCT00992732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268530|NCT00992732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268531|NCT00884234|Botulinum Toxins|botulinum toxins|mesh-list
139268532|NCT00884234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139268533|NCT00884234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139268534|NCT00884234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139268535|NCT00884234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139268536|NCT00884234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268537|NCT00884234|Cholinergic Agents|cholinergic agents|mesh-ancestor
139268538|NCT00884234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139268539|NCT00884234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268540|NCT00884234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139268541|NCT00884234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268542|NCT03006393|Infliximab|infliximab|mesh-list
139268543|NCT03006393|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139268544|NCT03006393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139268545|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
139268546|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139268547|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139268548|NCT00991172|Fasinumab|fasinumab|mesh-list
139268549|NCT00991172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139268550|NCT00991172|Analgesics|analgesics|mesh-ancestor
139268551|NCT00991172|Sensory System Agents|sensory system agents|mesh-ancestor
139268552|NCT00991172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268553|NCT00991172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268554|NCT01383109|Pyronaridine|pyronaridine|mesh-list
139268555|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
139268556|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139268557|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139268558|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268559|NCT00882440|Losartan|losartan|mesh-list
139268560|NCT00882440|Enalapril|enalapril|mesh-list
139268561|NCT00882440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139268562|NCT00882440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139268563|NCT00882440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139268564|NCT00882440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139268565|NCT00882440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268566|NCT00882440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139268567|NCT00882440|Protease Inhibitors|protease inhibitors|mesh-ancestor
139268569|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
139268570|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268571|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139268572|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268573|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268574|NCT00880490|Formoterol Fumarate|formoterol fumarate|mesh-list
139268575|NCT00880490|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139268576|NCT00880490|Autonomic Agents|autonomic agents|mesh-ancestor
139268577|NCT00880490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268578|NCT00880490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268579|NCT00880490|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139268580|NCT00880490|Respiratory System Agents|respiratory system agents|mesh-ancestor
139268581|NCT00880490|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139268582|NCT00880490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139268583|NCT00880490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139268584|NCT00880490|Adrenergic Agents|adrenergic agents|mesh-ancestor
139268585|NCT00880490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139268586|NCT00880490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268587|NCT05214157|Bupivacaine|bupivacaine|mesh-list
139268588|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
139268589|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
139268590|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268591|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268592|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
139268593|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268594|NCT04549467|Tenofovir|tenofovir|mesh-list
139268595|NCT04549467|Lamivudine|lamivudine|mesh-list
139268596|NCT04549467|Emtricitabine|emtricitabine|mesh-list
139268597|NCT04549467|Dolutegravir|dolutegravir|mesh-list
139268598|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
139268599|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268600|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139268601|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139268602|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268603|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268604|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139268605|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139268606|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139268607|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139268608|NCT03630341|Clomiphene|clomiphene|mesh-list
139268609|NCT03630341|Enclomiphene|enclomiphene|mesh-list
139268610|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
139268611|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139268612|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
139268613|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139268614|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268615|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139268616|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
139268617|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139268618|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139268619|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139268620|NCT02632396|Rituximab|rituximab|mesh-list
139268621|NCT02632396|Ixazomib|ixazomib|mesh-list
139268622|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139268623|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268624|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
139268625|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268626|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139268627|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268628|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
139268629|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268630|NCT05102422|Propofol|propofol|mesh-list
139268631|NCT05102422|Sevoflurane|sevoflurane|mesh-list
139268632|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139268633|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268634|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268635|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139268636|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
139268637|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
139268638|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139268639|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139268640|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
139268641|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139268642|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
139268643|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268644|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139268645|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139268646|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
139268647|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268648|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268649|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139268650|NCT03665181|Bismuth|bismuth|mesh-list
139268651|NCT03665181|Antacids|antacids|mesh-ancestor
139268652|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268653|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139268654|NCT05326906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139268655|NCT05326906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268656|NCT05326906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139268657|NCT05326906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268658|NCT05101954|Mitogens|mitogens|mesh-list
139268659|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
139268660|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268661|NCT00875108|Insulin|insulin|mesh-list
139268662|NCT00875108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139268663|NCT00875108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139268664|NCT00875108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268665|NCT04044209|Nivolumab|nivolumab|mesh-list
139268666|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139268667|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268668|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138289231|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139268669|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268670|NCT03817463|Empagliflozin|empagliflozin|mesh-list
139268671|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139268672|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139268673|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268674|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139268675|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268676|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
139268677|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268678|NCT05207683|Antibodies|antibodies|mesh-list
139268679|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
139268680|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
139268681|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268682|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139268683|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
139268684|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268685|NCT05213065|Bupivacaine|bupivacaine|mesh-list
139268686|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
139268687|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
139268688|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268689|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268690|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
139268691|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268692|NCT00969722|Tretinoin|tretinoin|mesh-list
139268693|NCT00969722|Molgramostim|molgramostim|mesh-list
139268694|NCT00969722|Isotretinoin|isotretinoin|mesh-list
139268695|NCT00969722|Sargramostim|sargramostim|mesh-list
139268696|NCT00969722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268697|NCT00969722|Keratolytic Agents|keratolytic agents|mesh-ancestor
139268698|NCT00969722|Dermatologic Agents|dermatologic agents|mesh-ancestor
139268699|NCT00969722|Immunologic Factors|immunologic factors|mesh-ancestor
139268700|NCT00969722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268701|NCT05099614|Naloxone|naloxone|mesh-list
139268702|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139268703|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268704|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
139268705|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268706|NCT00968942|Botulinum Toxins|botulinum toxins|mesh-list
139268707|NCT00968942|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139268708|NCT00968942|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139268709|NCT00968942|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139268710|NCT00968942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139268711|NCT00968942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268712|NCT00968942|Cholinergic Agents|cholinergic agents|mesh-ancestor
139268713|NCT00968942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139268714|NCT00968942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268715|NCT00968942|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139268716|NCT00968942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268717|NCT00869336|Luliconazole|luliconazole|mesh-list
139268718|NCT00869336|Antifungal Agents|antifungal agents|mesh-ancestor
139268719|NCT00869336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268720|NCT02371889|Topiramate|topiramate|mesh-list
139268721|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
139268722|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139268723|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268724|NCT00860288|Metformin|metformin|mesh-list
139268725|NCT00860288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139268726|NCT00860288|Vildagliptin|vildagliptin|mesh-list
139268727|NCT00860288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139268728|NCT00860288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268729|NCT00860288|Incretins|incretins|mesh-ancestor
139268730|NCT00860288|Hormones|hormones|mesh-ancestor
139268731|NCT00860288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139268732|NCT00860288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139268733|NCT00860288|Protease Inhibitors|protease inhibitors|mesh-ancestor
139268734|NCT00860288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268735|NCT00860288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268736|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139268737|NCT03630029|Hematinics|hematinics|mesh-ancestor
139268738|NCT05212597|Losartan|losartan|mesh-list
139268739|NCT05212597|Amlodipine|amlodipine|mesh-list
139268740|NCT05212597|Valsartan|valsartan|mesh-list
139268741|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139268742|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139268743|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139268744|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139268745|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268746|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139268747|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268748|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
139268749|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139268750|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139268751|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139268752|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139268753|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268754|NCT03629717|Vitamin D|vitamin d|mesh-list
139268755|NCT03629717|Denosumab|denosumab|mesh-list
139268756|NCT03629717|Calcium|calcium|mesh-list
139268757|NCT03629717|Vitamins|vitamins|mesh-ancestor
139268758|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
139268759|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268760|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139268761|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139268762|NCT05108350|Metformin|metformin|mesh-list
139268763|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139268764|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268765|NCT00859430|Levetiracetam|levetiracetam|mesh-list
139268766|NCT00859430|Anticonvulsants|anticonvulsants|mesh-ancestor
139268767|NCT00859430|Nootropic Agents|nootropic agents|mesh-ancestor
139268768|NCT00855764|Paclitaxel|paclitaxel|mesh-list
139268769|NCT00855764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139268770|NCT00855764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268771|NCT00855764|Tubulin Modulators|tubulin modulators|mesh-ancestor
139268772|NCT00855764|Antimitotic Agents|antimitotic agents|mesh-ancestor
139268773|NCT00855764|Mitosis Modulators|mitosis modulators|mesh-ancestor
139268774|NCT00855764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268775|NCT00959036|Methotrexate|methotrexate|mesh-list
139268776|NCT00959036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139268777|NCT00959036|Abortifacient Agents|abortifacient agents|mesh-ancestor
139268778|NCT00959036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139268779|NCT00959036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268780|NCT00959036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139268781|NCT00959036|Antimetabolites|antimetabolites|mesh-ancestor
139268782|NCT00959036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268783|NCT00959036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268784|NCT00959036|Dermatologic Agents|dermatologic agents|mesh-ancestor
139268785|NCT00959036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268786|NCT00959036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139268787|NCT00959036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139268788|NCT00959036|Immunologic Factors|immunologic factors|mesh-ancestor
139268789|NCT00959036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139268790|NCT00959036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139268791|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
139268792|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
139268793|NCT04129723|Protective Agents|protective agents|mesh-ancestor
139268794|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268795|NCT04474262|Midodrine|midodrine|mesh-list
139268796|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
139268797|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
139268798|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268799|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268800|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139268801|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139268802|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139268803|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139268804|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
139268805|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139268806|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268807|NCT05211583|Progesterone|progesterone|mesh-list
139268808|NCT05211583|Progestins|progestins|mesh-ancestor
139268809|NCT05211583|Hormones|hormones|mesh-ancestor
139268810|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139268811|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268812|NCT04031599|Hormones|hormones|mesh-list
139268813|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268814|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139268815|NCT04724759|Lidocaine|lidocaine|mesh-list
139268816|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
139268817|NCT04724759|Ketamine|ketamine|mesh-list
139268818|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
139268819|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
139268820|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268821|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268822|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
139268823|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268824|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139268825|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139268826|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139268827|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139268828|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268829|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139268830|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139268831|NCT04724759|Analgesics|analgesics|mesh-ancestor
139268832|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139268833|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139268834|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139268835|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
139268836|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139268837|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139268838|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139268839|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
139268840|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139268841|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139268842|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
139268843|NCT05186467|Analgesics|analgesics|mesh-ancestor
139268844|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
139268845|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268846|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268847|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
139268848|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268849|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139268850|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
139268851|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139268852|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139268853|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268854|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139268855|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
139268856|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139268857|NCT00771134|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139268858|NCT00771134|Antidepressive Agents|antidepressive agents|mesh-ancestor
139268859|NCT00771134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139268860|NCT00771134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139268861|NCT00771134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139268862|NCT00771134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268863|NCT00771134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268864|NCT00768482|Buprenorphine|buprenorphine|mesh-list
139268865|NCT00768482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139268866|NCT00768482|Narcotics|narcotics|mesh-ancestor
139268867|NCT00768482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268868|NCT00768482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268869|NCT00768482|Analgesics|analgesics|mesh-ancestor
139268870|NCT00768482|Sensory System Agents|sensory system agents|mesh-ancestor
139268871|NCT00768482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268872|NCT00768482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139268874|NCT00840866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139268875|NCT00840866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268876|NCT05043116|Vitamin D|vitamin d|mesh-list
139268877|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
139268878|NCT05043116|Vitamins|vitamins|mesh-ancestor
139268879|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
139268880|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268881|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139268882|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139268883|NCT00840632|Trandolapril|trandolapril|mesh-list
139268884|NCT00840632|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139268885|NCT00840632|Protease Inhibitors|protease inhibitors|mesh-ancestor
139268886|NCT00840632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268887|NCT00840632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268888|NCT00840632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139268889|NCT00840476|Meloxicam|meloxicam|mesh-list
139268890|NCT00840476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139268891|NCT00840476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139268892|NCT00840476|Analgesics|analgesics|mesh-ancestor
139268893|NCT00840476|Sensory System Agents|sensory system agents|mesh-ancestor
139268894|NCT00840476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268895|NCT00840476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268896|NCT00840476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139268897|NCT00840476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139268898|NCT00840476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139268899|NCT00840476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139268900|NCT00840476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268901|NCT00840476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268902|NCT00765830|Vildagliptin|vildagliptin|mesh-list
139268903|NCT00765830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139268904|NCT00765830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268905|NCT00765830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139139136|NCT03809949|Narcotics|narcotics|mesh-ancestor
139268906|NCT00765830|Protease Inhibitors|protease inhibitors|mesh-ancestor
139268907|NCT00765830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268908|NCT00765830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268910|NCT03664869|Mitomycin|mitomycin|mesh-list
139268911|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139268912|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268913|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
139268914|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268915|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139268916|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268917|NCT00953420|Dexamethasone|dexamethasone|mesh-list
139268918|NCT00953420|Carboplatin|carboplatin|mesh-list
139268919|NCT00953420|Docetaxel|docetaxel|mesh-list
139268920|NCT00953420|Lenograstim|lenograstim|mesh-list
139268921|NCT00953420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139268922|NCT00953420|Antiemetics|antiemetics|mesh-ancestor
139268923|NCT00953420|Autonomic Agents|autonomic agents|mesh-ancestor
139268924|NCT00953420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268925|NCT00953420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268926|NCT00953420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139268927|NCT00953420|Glucocorticoids|glucocorticoids|mesh-ancestor
139268928|NCT00953420|Hormones|hormones|mesh-ancestor
139268929|NCT00953420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139268930|NCT00953420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139268931|NCT00953420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268932|NCT00953420|Tubulin Modulators|tubulin modulators|mesh-ancestor
139268933|NCT00953420|Antimitotic Agents|antimitotic agents|mesh-ancestor
139268934|NCT00953420|Mitosis Modulators|mitosis modulators|mesh-ancestor
139268935|NCT00953420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268936|NCT00953420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139268937|NCT00953420|Immunologic Factors|immunologic factors|mesh-ancestor
139268938|NCT01602562|Valacyclovir|valacyclovir|mesh-list
138852335|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
139268939|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
139268940|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139268941|NCT01945775|Talazoparib|talazoparib|mesh-list
139268942|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139268943|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268944|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268945|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139268946|NCT00839930|Cilostazol|cilostazol|mesh-list
139268947|NCT00839930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139268948|NCT00839930|Autonomic Agents|autonomic agents|mesh-ancestor
139268949|NCT00839930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268950|NCT00839930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268951|NCT00839930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139268952|NCT00839930|Respiratory System Agents|respiratory system agents|mesh-ancestor
139268953|NCT00839930|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139268954|NCT00839930|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139268955|NCT00839930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268956|NCT00839930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139268957|NCT00839930|Vasodilator Agents|vasodilator agents|mesh-ancestor
139268958|NCT00839930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139268959|NCT00839930|Protective Agents|protective agents|mesh-ancestor
139268960|NCT00839930|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139268961|NCT00839930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139268962|NCT00839930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139268963|NCT00838136|Lamotrigine|lamotrigine|mesh-list
139268964|NCT00838136|Anticonvulsants|anticonvulsants|mesh-ancestor
139268965|NCT00838136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139268966|NCT00838136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139268967|NCT00838136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268968|NCT00838136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139268969|NCT00838136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268970|NCT00838136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139268971|NCT00838136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139268972|NCT00838136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139268973|NCT00838136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139268974|NCT00838136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139268975|NCT00944294|Adenosine|adenosine|mesh-list
139268976|NCT00944294|Binodenoson|binodenoson|mesh-list
139268977|NCT00944294|Analgesics|analgesics|mesh-ancestor
139642302|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
139268978|NCT00944294|Sensory System Agents|sensory system agents|mesh-ancestor
139268979|NCT00944294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268980|NCT00944294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268981|NCT00944294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139268982|NCT00944294|Vasodilator Agents|vasodilator agents|mesh-ancestor
139268983|NCT00944294|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139268984|NCT00944294|Purinergic Agonists|purinergic agonists|mesh-ancestor
139268985|NCT00944294|Purinergic Agents|purinergic agents|mesh-ancestor
139268986|NCT00944294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139268987|NCT00944294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268988|NCT00758966|Naltrexone|naltrexone|mesh-list
139268989|NCT00758966|Fluoxetine|fluoxetine|mesh-list
139268990|NCT00758966|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139268991|NCT00758966|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139268992|NCT00758966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139268993|NCT00758966|Sensory System Agents|sensory system agents|mesh-ancestor
139268994|NCT00758966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139268995|NCT00758966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139268996|NCT00758966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139268997|NCT00758966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139268998|NCT00758966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139268999|NCT00758966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269000|NCT00758966|Serotonin Agents|serotonin agents|mesh-ancestor
139269001|NCT00758966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139269002|NCT00758966|Antidepressive Agents|antidepressive agents|mesh-ancestor
139269003|NCT00758966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139269004|NCT00758966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139269005|NCT00758966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139269006|NCT00758966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269007|NCT03072719|Fluorides|fluorides|mesh-list
139269008|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
139269009|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
139269010|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
139269011|NCT03072719|Protective Agents|protective agents|mesh-ancestor
139269012|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269013|NCT05106400|Lidocaine|lidocaine|mesh-list
138852410|NCT02695212|Apremilast|apremilast|mesh-list
139269014|NCT05106400|Menthol|menthol|mesh-list
139269015|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
139269016|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
139269017|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139269018|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269019|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
139269020|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269021|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139269022|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139269023|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139269024|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139269025|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269026|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
139269027|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
139269028|NCT00754988|Metformin|metformin|mesh-list
139269029|NCT00754988|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139269030|NCT00754988|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139269031|NCT00754988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139269032|NCT00754988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269033|NCT00754988|Incretins|incretins|mesh-ancestor
139269034|NCT00754988|Hormones|hormones|mesh-ancestor
139269035|NCT00754988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269036|NCT00754988|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139269037|NCT00754988|Protease Inhibitors|protease inhibitors|mesh-ancestor
139269038|NCT00754988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269039|NCT00754988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269040|NCT01416935|Amiodarone|amiodarone|mesh-list
139269041|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139269042|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
139269043|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139269044|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139269045|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269046|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139269047|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139642303|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
139269048|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139269049|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269050|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139269051|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139269052|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139269053|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
139269054|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139269055|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
139269056|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139269057|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139269058|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269059|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
139269060|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269061|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269062|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139269063|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
139269064|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
139269065|NCT05012566|Protective Agents|protective agents|mesh-ancestor
139269066|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139269067|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269068|NCT05202665|Fluorides|fluorides|mesh-list
139269069|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
139269070|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
139269071|NCT05202665|Protective Agents|protective agents|mesh-ancestor
139269072|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269073|NCT04438772|Anesthetics|anesthetics|mesh-list
139269074|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139269075|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269076|NCT04560634|Norepinephrine|norepinephrine|mesh-list
139269077|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139269078|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139269079|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
139269080|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269081|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269082|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269083|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
139269084|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
138852485|NCT00605917|Sertraline|sertraline|mesh-list
139269085|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269086|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139269087|NCT00927914|Ranirestat|ranirestat|mesh-list
139269088|NCT00927914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269089|NCT00927914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269090|NCT05261464|Metoprolol|metoprolol|mesh-list
139269091|NCT05261464|Diltiazem|diltiazem|mesh-list
139269092|NCT05261464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139269093|NCT05261464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139269094|NCT05261464|Sympatholytics|sympatholytics|mesh-ancestor
139269095|NCT05261464|Autonomic Agents|autonomic agents|mesh-ancestor
139269096|NCT05261464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269097|NCT05261464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269098|NCT05261464|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139269099|NCT05261464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139269100|NCT05261464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139269101|NCT05261464|Adrenergic Agents|adrenergic agents|mesh-ancestor
139269102|NCT05261464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269103|NCT05261464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269104|NCT05261464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139203555|NCT01306097|Zinc|zinc|mesh-list
139269105|NCT05261464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139269106|NCT05261464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139269107|NCT05261464|Vasodilator Agents|vasodilator agents|mesh-ancestor
139269108|NCT00835796|Finasteride|finasteride|mesh-list
139269109|NCT00835796|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139269110|NCT00835796|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139269111|NCT00835796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269112|NCT00835796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269113|NCT00835796|Hormone Antagonists|hormone antagonists|mesh-ancestor
139269114|NCT00835796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269115|NCT00835796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269116|NCT00835796|Urological Agents|urological agents|mesh-ancestor
139269117|NCT05106712|Vitamin D|vitamin d|mesh-list
139269118|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
139269119|NCT05106712|Letrozole|letrozole|mesh-list
139269120|NCT05106712|Clomiphene|clomiphene|mesh-list
139269121|NCT05106712|Enclomiphene|enclomiphene|mesh-list
139269122|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
139269123|NCT05106712|Vitamins|vitamins|mesh-ancestor
139269124|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
139269125|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269126|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139269127|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269128|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139269129|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269130|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139269131|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139269132|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269133|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139269134|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
139269135|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269136|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139269137|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
139269138|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139269139|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139269140|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139269141|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
139269142|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139269143|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139269144|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269145|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139269146|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269147|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
139269148|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269149|NCT00835640|Fexofenadine|fexofenadine|mesh-list
139269150|NCT00835640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139269151|NCT00835640|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139269152|NCT00835640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139269153|NCT00835640|Histamine Antagonists|histamine antagonists|mesh-ancestor
139269154|NCT00835640|Histamine Agents|histamine agents|mesh-ancestor
139269155|NCT00835640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269156|NCT00835640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269157|NCT00835640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269158|NCT00752570|Trebananib|trebananib|mesh-list
139269159|NCT00752570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139269160|NCT00752570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139269161|NCT00752570|Growth Substances|growth substances|mesh-ancestor
139269162|NCT00752570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269163|NCT00752570|Growth Inhibitors|growth inhibitors|mesh-ancestor
139269164|NCT00752570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269165|NCT05083000|Topotecan|topotecan|mesh-list
139269166|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139269167|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139269168|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269169|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269170|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269171|NCT00752258|Botulinum Toxins|botulinum toxins|mesh-list
139269172|NCT00752258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139269173|NCT00752258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139269174|NCT00752258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139269175|NCT00752258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139269176|NCT00752258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269177|NCT00752258|Cholinergic Agents|cholinergic agents|mesh-ancestor
139269178|NCT00752258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269179|NCT00752258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269180|NCT00752258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139269181|NCT00752258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269182|NCT02942017|Brexanolone|brexanolone|mesh-list
139269183|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
139269184|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269185|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269186|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269187|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
139269188|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
139269189|NCT04447781|Citric Acid|citric acid|mesh-list
139269190|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
139269191|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
139269192|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139269193|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
139269194|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
139269195|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269197|NCT00835484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139269198|NCT00835484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139269199|NCT00835406|Alendronate|alendronate|mesh-list
139269200|NCT00835406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139269201|NCT00835406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269202|NCT05202275|Olanzapine|olanzapine|mesh-list
139269203|NCT05202275|Aprepitant|aprepitant|mesh-list
139269204|NCT05202275|Palonosetron|palonosetron|mesh-list
139269205|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
139269206|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
139269207|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269208|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269209|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139269210|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139269211|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139269212|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139269213|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139269214|NCT05202275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139269215|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139269216|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139269217|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269218|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269219|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
139269220|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139269221|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139269222|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139269223|NCT00744926|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139269224|NCT00744926|Incretins|incretins|mesh-ancestor
139269225|NCT00744926|Hormones|hormones|mesh-ancestor
139269226|NCT00744926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269227|NCT00744926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269228|NCT03838744|Olaparib|olaparib|mesh-list
139269229|NCT03838744|Trabectedin|trabectedin|mesh-list
139269230|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139269231|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269232|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091689|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139269233|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269234|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139269236|NCT05327348|Ascorbic Acid|ascorbic acid|mesh-list
139269237|NCT05327348|Antioxidants|antioxidants|mesh-ancestor
139269238|NCT05327348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269239|NCT05327348|Protective Agents|protective agents|mesh-ancestor
139269240|NCT05327348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269241|NCT05327348|Vitamins|vitamins|mesh-ancestor
139269242|NCT05327348|Micronutrients|micronutrients|mesh-ancestor
139269243|NCT04695106|Aspirin|aspirin|mesh-list
139269244|NCT04695106|Dabigatran|dabigatran|mesh-list
139269245|NCT04695106|Clopidogrel|clopidogrel|mesh-list
139269246|NCT04695106|Ticagrelor|ticagrelor|mesh-list
139269247|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139269248|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139269249|NCT04695106|Analgesics|analgesics|mesh-ancestor
139269250|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
139269251|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269252|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269253|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139269254|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139269255|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139269256|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139269257|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269258|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139269259|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139269260|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269261|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
139269262|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139269263|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139269264|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139269265|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
139269266|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269267|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
139269268|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139269269|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
139269270|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
139269271|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
139269272|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139269273|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
139269274|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139269275|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
139269276|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269277|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269278|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
139269279|NCT03629639|Metformin|metformin|mesh-list
139269280|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139269281|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269282|NCT00835172|Glimepiride|glimepiride|mesh-list
139269283|NCT00835172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139269284|NCT00835172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139269285|NCT00835172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269286|NCT00835172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139269287|NCT00835172|Immunologic Factors|immunologic factors|mesh-ancestor
139269288|NCT04941755|Famotidine|famotidine|mesh-list
139269289|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139269290|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139269291|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139269292|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
139269293|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
139269294|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269295|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269296|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269297|NCT04921735|Cisatracurium|cisatracurium|mesh-list
139269298|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139269299|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139269300|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269301|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269302|NCT01676116|Liraglutide|liraglutide|mesh-list
139269303|NCT01676116|Exenatide|exenatide|mesh-list
139269304|NCT01676116|Xultophy|xultophy|mesh-list
139269305|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139269306|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269307|NCT01676116|Incretins|incretins|mesh-ancestor
139269308|NCT01676116|Hormones|hormones|mesh-ancestor
139269309|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269310|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139269311|NCT05200793|Metformin|metformin|mesh-list
139269312|NCT05200793|Empagliflozin|empagliflozin|mesh-list
139269313|NCT05200793|Linagliptin|linagliptin|mesh-list
139269314|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139269315|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269316|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139269317|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269318|NCT05200793|Incretins|incretins|mesh-ancestor
139269319|NCT05200793|Hormones|hormones|mesh-ancestor
139269320|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269321|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139269322|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
139269323|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269324|NCT03383224|Nicotine|nicotine|mesh-list
139269325|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139269326|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
139269327|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269328|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269329|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139269330|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139269331|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
139269332|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269333|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269334|NCT04699357|Atropine|atropine|mesh-list
139269335|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139269336|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139269337|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139269338|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
139269339|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269340|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269341|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139269342|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
139269343|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
139269344|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
139269345|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139269346|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139269347|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
139269348|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269349|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269351|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269352|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139269353|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
139269354|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269355|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
139269356|NCT01869829|Clotrimazole|clotrimazole|mesh-list
139269357|NCT01869829|Miconazole|miconazole|mesh-list
139269358|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139269359|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139269360|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139269361|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139269362|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269363|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269364|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139269365|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
139269366|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269367|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269368|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139269369|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139269370|NCT02683018|Dronabinol|dronabinol|mesh-list
139269371|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
139269372|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269373|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139269374|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139269375|NCT02683018|Analgesics|analgesics|mesh-ancestor
139269376|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
139269377|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269378|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139269379|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139269380|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091690|NCT04348045|Fluorouracil|fluorouracil|mesh-list
139269381|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269383|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269384|NCT03982576|Nicotine|nicotine|mesh-list
139269385|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139269386|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
139269387|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269388|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269389|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139269390|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139269391|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
139269392|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269393|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269394|NCT02675842|Dronabinol|dronabinol|mesh-list
139269395|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
139269396|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269397|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139269398|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139269399|NCT02675842|Analgesics|analgesics|mesh-ancestor
139269400|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
139269401|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269402|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139269403|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139269404|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269405|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269406|NCT02675842|Hormones|hormones|mesh-ancestor
139269407|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269408|NCT04528108|Hemostatics|hemostatics|mesh-list
139269409|NCT04528108|Coagulants|coagulants|mesh-ancestor
139269410|NCT04251689|Mannitol|mannitol|mesh-list
139269411|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139269412|NCT04251689|Diuretics|diuretics|mesh-ancestor
139269413|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
139269414|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269415|NCT04232423|Olanzapine|olanzapine|mesh-list
139269416|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
139269417|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
139269418|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269419|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269420|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139269421|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139269422|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139269423|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139269424|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139269425|NCT04232423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139269426|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139269427|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139269428|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269429|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269431|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139269432|NCT04178993|Methylphenidate|methylphenidate|mesh-list
139269433|NCT04178993|Methamphetamine|methamphetamine|mesh-list
139269434|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139269435|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269436|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139269437|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139269438|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139269439|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269440|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
139269441|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269442|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139269443|NCT04178993|Analgesics|analgesics|mesh-ancestor
139269444|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
139269445|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269446|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
139269447|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139269448|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
139269449|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
139269450|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
139269451|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139269452|NCT04436536|Methamphetamine|methamphetamine|mesh-list
138852859|NCT02823236|Triamcinolone|triamcinolone|mesh-list
139269453|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139269454|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269455|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
139269456|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
139269457|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269458|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
139269459|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269460|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269461|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
139269462|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139269463|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139269464|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139269465|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139269466|NCT05762003|Interferons|interferons|mesh-list
139269467|NCT05762003|Teriflunomide|teriflunomide|mesh-list
139269468|NCT05762003|Rituximab|rituximab|mesh-list
139269469|NCT05762003|Alemtuzumab|alemtuzumab|mesh-list
139269470|NCT05762003|Ofatumumab|ofatumumab|mesh-list
139269471|NCT05762003|Cladribine|cladribine|mesh-list
139269472|NCT05762003|Glatiramer Acetate|glatiramer acetate|mesh-list
139269473|NCT05762003|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139269474|NCT05762003|Ocrelizumab|ocrelizumab|mesh-list
139269475|NCT05762003|Natalizumab|natalizumab|mesh-list
139269476|NCT05762003|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139269477|NCT05762003|(T,G)-A-L|(t,g)-a-l|mesh-list
139269478|NCT05762003|Ponesimod|ponesimod|mesh-list
139269479|NCT05762003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139269480|NCT05762003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269481|NCT05762003|Immunologic Factors|immunologic factors|mesh-ancestor
139269482|NCT05762003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269483|NCT05762003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139269484|NCT05762003|Antiviral Agents|antiviral agents|mesh-ancestor
139269485|NCT05762003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139269486|NCT05762003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139269487|NCT05762003|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139269488|NCT05762003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269489|NCT05762003|Dermatologic Agents|dermatologic agents|mesh-ancestor
139269490|NCT05762003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139269491|NCT05762003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139269492|NCT05762003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139269493|NCT05762003|Analgesics|analgesics|mesh-ancestor
139269494|NCT05762003|Sensory System Agents|sensory system agents|mesh-ancestor
139269495|NCT05762003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269496|NCT05762003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139269497|NCT03001557|Lemborexant|lemborexant|mesh-list
139269498|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139269499|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269500|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269501|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139269502|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139269503|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139269504|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269505|NCT03134612|Lidocaine|lidocaine|mesh-list
139269506|NCT03134612|Ondansetron|ondansetron|mesh-list
139269507|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
139269508|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
139269509|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139269510|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269511|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
139269512|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269513|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139269514|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139269515|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139269516|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139269517|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269518|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
139269519|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
139269520|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139269521|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
139269522|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
139269523|NCT03134612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139269524|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139269525|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
139269526|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091691|NCT04348045|Irinotecan|irinotecan|mesh-list
139269527|NCT00831662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139269528|NCT00831662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139269529|NCT04365985|Naltrexone|naltrexone|mesh-list
139269530|NCT04365985|Ketamine|ketamine|mesh-list
139269531|NCT04365985|Analgesics|analgesics|mesh-ancestor
139269532|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
139269533|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269534|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269535|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139269536|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139269537|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
139269538|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
139269539|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139269540|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139269541|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139269542|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269543|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269544|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139269545|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139269546|NCT05111860|Bevacizumab|bevacizumab|mesh-list
139269547|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139269548|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269549|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139269550|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139269551|NCT05111860|Growth Substances|growth substances|mesh-ancestor
139269552|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269553|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
139269554|NCT00830336|Azithromycin|azithromycin|mesh-list
139269555|NCT00830336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139269556|NCT00830336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139269557|NCT00830258|Pravastatin|pravastatin|mesh-list
139269558|NCT00830258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139269559|NCT00830258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139269560|NCT00830258|Antimetabolites|antimetabolites|mesh-ancestor
139269561|NCT00830258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269562|NCT00830258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139269563|NCT00830258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139269564|NCT00830258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269565|NCT00830102|Fluticasone|fluticasone|mesh-list
139269567|NCT00830102|Formoterol Fumarate|formoterol fumarate|mesh-list
139269568|NCT00830102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139269569|NCT00830102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139269570|NCT00830102|Autonomic Agents|autonomic agents|mesh-ancestor
139269571|NCT00830102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269572|NCT00830102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269573|NCT00830102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139269574|NCT00830102|Respiratory System Agents|respiratory system agents|mesh-ancestor
139269575|NCT00830102|Dermatologic Agents|dermatologic agents|mesh-ancestor
139269576|NCT00830102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139269577|NCT00830102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139269578|NCT00830102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139269579|NCT00830102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139269580|NCT00830102|Adrenergic Agents|adrenergic agents|mesh-ancestor
139269581|NCT00830102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269582|NCT00830102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269583|NCT03349775|Metformin|metformin|mesh-list
139269584|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139269585|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269586|NCT00830024|Alprazolam|alprazolam|mesh-list
139269587|NCT00830024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139269588|NCT00830024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139269589|NCT00830024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269590|NCT00830024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139269591|NCT00830024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139269592|NCT00830024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139269593|NCT00830024|GABA Modulators|gaba modulators|mesh-ancestor
139269594|NCT00830024|GABA Agents|gaba agents|mesh-ancestor
139269595|NCT00830024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269596|NCT00830024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269597|NCT00829868|Zaleplon|zaleplon|mesh-list
139269598|NCT00829868|Anticonvulsants|anticonvulsants|mesh-ancestor
139269599|NCT00829868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139269600|NCT00829868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139269601|NCT00829868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269602|NCT00829868|GABA Modulators|gaba modulators|mesh-ancestor
139091692|NCT04348045|Durvalumab|durvalumab|mesh-list
139269603|NCT00829868|GABA Agents|gaba agents|mesh-ancestor
139269604|NCT00829868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269605|NCT00829868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269606|NCT00721760|Enoxaparin|enoxaparin|mesh-list
139269607|NCT00721760|Semuloparin|semuloparin|mesh-list
139269608|NCT00721760|Enoxaparin sodium|enoxaparin sodium|mesh-list
139269609|NCT00721760|Anticoagulants|anticoagulants|mesh-ancestor
139269610|NCT00721760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139269611|NCT00721760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139269612|NCT00721760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269613|NCT00829790|Doxycycline|doxycycline|mesh-list
139269614|NCT00829790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139269615|NCT00829790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139269616|NCT00829790|Antimalarials|antimalarials|mesh-ancestor
139269617|NCT00829790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139269618|NCT00829790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139269619|NCT03207815|Prednisone|prednisone|mesh-list
139269620|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139269621|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
139269622|NCT03207815|Hormones|hormones|mesh-ancestor
139269623|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269624|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269625|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139269626|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269627|NCT02911935|Azithromycin|azithromycin|mesh-list
139269628|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139269629|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139269630|NCT05193487|Anesthetics|anesthetics|mesh-list
139269631|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139269632|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269633|NCT03479762|Liraglutide|liraglutide|mesh-list
139269634|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139269635|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269636|NCT03479762|Incretins|incretins|mesh-ancestor
139269637|NCT03479762|Hormones|hormones|mesh-ancestor
139269638|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269639|NCT00829712|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
139269640|NCT00829712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139269641|NCT00829712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269642|NCT00829712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139269643|NCT00829712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139269644|NCT00829712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139269645|NCT00829712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269646|NCT00829712|Dopamine Agents|dopamine agents|mesh-ancestor
139269647|NCT00829712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269648|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139269649|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139269650|NCT05079802|Chitosan|chitosan|mesh-list
139269651|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139269652|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
139269653|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139269654|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139269655|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
139269656|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269657|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139269658|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
139269659|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
139269660|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
139269661|NCT05079802|Coagulants|coagulants|mesh-ancestor
139269662|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139269663|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
139269664|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
139269665|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139269666|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
139269667|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269668|NCT03899636|Folfirinox|folfirinox|mesh-list
139269669|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269670|NCT03386942|Farletuzumab|farletuzumab|mesh-list
139269671|NCT03386942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269672|NCT04910230|Niacinamide|niacinamide|mesh-list
139269673|NCT04910230|Niacin|niacin|mesh-list
139269674|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
139269675|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
139269676|NCT04910230|Vitamins|vitamins|mesh-ancestor
139269677|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
139269678|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269679|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139269680|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
139269681|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269682|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139269683|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
139269684|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
139269685|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139269686|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269687|NCT04995094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139269688|NCT04995094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269690|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
139269691|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
139269692|NCT05202821|Protective Agents|protective agents|mesh-ancestor
139269693|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269694|NCT02560805|Losartan|losartan|mesh-list
139269695|NCT02560805|Atenolol|atenolol|mesh-list
139269696|NCT02560805|Nitroprusside|nitroprusside|mesh-list
139269697|NCT02560805|Phenylephrine|phenylephrine|mesh-list
139269698|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
139269699|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139269700|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139269701|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139381694|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
139269702|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139269703|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269704|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139269705|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
139269706|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
139269707|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269708|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269709|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
139269710|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139269711|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
139269712|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
139269713|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139269714|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139269715|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139269716|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
139269717|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269718|NCT02560805|Protective Agents|protective agents|mesh-ancestor
139269719|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
139269720|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139269721|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139269722|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139269723|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
139269724|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139269725|NCT04615936|Methylene Blue|methylene blue|mesh-list
139269726|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269727|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269728|NCT03797222|Vitamin E|vitamin e|mesh-list
139269729|NCT03797222|Tocopherols|tocopherols|mesh-list
139269730|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
139269731|NCT03797222|Vitamins|vitamins|mesh-ancestor
139269732|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
139269733|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269734|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
139269735|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269736|NCT03797222|Protective Agents|protective agents|mesh-ancestor
139269737|NCT04471675|Docetaxel|docetaxel|mesh-list
139269738|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269739|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
139269740|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
139269741|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
139269742|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269743|NCT04461028|Dexamethasone|dexamethasone|mesh-list
139269744|NCT04461028|Bupivacaine|bupivacaine|mesh-list
139269745|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139269746|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
139269747|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
139269748|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269749|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269750|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139269751|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
139269752|NCT04461028|Hormones|hormones|mesh-ancestor
139269753|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269754|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139269755|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269756|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
139269758|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139269759|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
139269760|NCT00716534|Paclitaxel|paclitaxel|mesh-list
139269761|NCT00716534|Carboplatin|carboplatin|mesh-list
139269762|NCT00716534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139269763|NCT00716534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269764|NCT00716534|Tubulin Modulators|tubulin modulators|mesh-ancestor
139269765|NCT00716534|Antimitotic Agents|antimitotic agents|mesh-ancestor
139269766|NCT00716534|Mitosis Modulators|mitosis modulators|mesh-ancestor
139269767|NCT00716534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269768|NCT02283476|Gemcitabine|gemcitabine|mesh-list
139269769|NCT02283476|Endostar protein|endostar protein|mesh-list
139269770|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269771|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139269772|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
139269773|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269774|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139269775|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139269776|NCT02283476|Growth Substances|growth substances|mesh-ancestor
139269777|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269778|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
139269779|NCT05156879|Aspirin|aspirin|mesh-list
139269780|NCT05156879|Drospirenone|drospirenone|mesh-list
139269781|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139269782|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139269783|NCT05156879|Estradiol|estradiol|mesh-list
139269784|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139269785|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139269786|NCT05156879|Analgesics|analgesics|mesh-ancestor
139269787|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
139269788|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269789|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269790|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139269791|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139269792|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139269793|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139269794|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269795|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139269796|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139269797|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269798|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
139269799|NCT05156879|Estrogens|estrogens|mesh-ancestor
139269800|NCT05156879|Hormones|hormones|mesh-ancestor
139269801|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269802|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139269803|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
139269804|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139269805|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139269806|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139269807|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139269808|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139269809|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
139269810|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139269811|NCT05156879|Diuretics|diuretics|mesh-ancestor
139269812|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
139269813|NCT02283554|Metformin|metformin|mesh-list
139269814|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139269815|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269816|NCT00641732|Enoxaparin|enoxaparin|mesh-list
139269817|NCT00641732|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
139269818|NCT00641732|Anticoagulants|anticoagulants|mesh-ancestor
139269819|NCT00641732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139269820|NCT00641732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139269821|NCT00641732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269822|NCT00641732|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139269823|NCT00641732|Antithrombins|antithrombins|mesh-ancestor
139269824|NCT00641732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139269825|NCT00641732|Protease Inhibitors|protease inhibitors|mesh-ancestor
139269826|NCT00641732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269827|NCT00790829|Nicotine|nicotine|mesh-list
139269828|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139091693|NCT04348045|Olaparib|olaparib|mesh-list
139269829|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
139269831|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269832|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139269833|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139269834|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
139269835|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269836|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269837|NCT00640484|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139269838|NCT00640484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139269839|NCT00640484|Autonomic Agents|autonomic agents|mesh-ancestor
139269840|NCT00640484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269841|NCT00640484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269842|NCT00640484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139269843|NCT00640484|Respiratory System Agents|respiratory system agents|mesh-ancestor
139269844|NCT00640484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139269845|NCT00640484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139269846|NCT00640484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139269847|NCT00640484|Adrenergic Agents|adrenergic agents|mesh-ancestor
139269848|NCT00640484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269849|NCT00640484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269850|NCT03065933|Clonidine|clonidine|mesh-list
139269851|NCT03065933|Analgesics|analgesics|mesh-ancestor
139269852|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
139269853|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269854|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269855|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139269856|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
139269857|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
139269858|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139269859|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139269860|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139269861|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
139269862|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269863|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269864|NCT00630656|Talactoferrin alfa|talactoferrin alfa|mesh-list
139269865|NCT00630656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269866|NCT04256629|Allopurinol|allopurinol|mesh-list
139269867|NCT04256629|Verinurad|verinurad|mesh-list
139269868|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
139269869|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269870|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269871|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
139269872|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139269873|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139269874|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
139269875|NCT04256629|Protective Agents|protective agents|mesh-ancestor
139269876|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269877|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
139269878|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139269879|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139269880|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
139269881|NCT00696332|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid|mesh-list
139269882|NCT00696332|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
139269883|NCT00696332|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139269884|NCT00696332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139269885|NCT00696332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269886|NCT00696332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269887|NCT05125523|Sirolimus|sirolimus|mesh-list
139269888|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139269889|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139269890|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139269891|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269892|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
139269893|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139269894|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
139269895|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269896|NCT00625664|Gemcitabine|gemcitabine|mesh-list
139269897|NCT00625664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269898|NCT00625664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139269899|NCT00625664|Antimetabolites|antimetabolites|mesh-ancestor
139269900|NCT00625664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269901|NCT02947165|Spartalizumab|spartalizumab|mesh-list
139269902|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139091694|NCT04348045|Antimetabolites|antimetabolites|mesh-ancestor
139269903|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269904|NCT02947165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139269905|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269906|NCT03629093|Anesthetics|anesthetics|mesh-list
139269907|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
139269908|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139269909|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269910|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
139269911|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139269912|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269913|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269914|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139269915|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139269916|NCT02283710|Protective Agents|protective agents|mesh-ancestor
139269917|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269918|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
139269919|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139269920|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
139269921|NCT05055947|Atezolizumab|atezolizumab|mesh-list
139269922|NCT05055947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139269923|NCT05055947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269924|NCT05055947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139269925|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269926|NCT03943342|Venetoclax|venetoclax|mesh-list
139269927|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269928|NCT00694928|Clindamycin|clindamycin|mesh-list
139269929|NCT00694928|Clindamycin palmitate|clindamycin palmitate|mesh-list
139269930|NCT00694928|Clindamycin phosphate|clindamycin phosphate|mesh-list
139269931|NCT00694928|Butoconazole|butoconazole|mesh-list
139269932|NCT00694928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139269933|NCT00694928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139269934|NCT00694928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139269935|NCT00694928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269936|NCT00694928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269937|NCT00694928|Antifungal Agents|antifungal agents|mesh-ancestor
139269938|NCT00694382|Semuloparin|semuloparin|mesh-list
139269939|NCT00694382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139269940|NCT00694382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139269941|NCT00694382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139269942|NCT00694382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269943|NCT00694382|Anticoagulants|anticoagulants|mesh-ancestor
139269945|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139269946|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269947|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
139269948|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269949|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139269950|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
139269951|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139269952|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269953|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
139269954|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269955|NCT05116150|Protective Agents|protective agents|mesh-ancestor
139269956|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269957|NCT00136903|Cyclosporine|cyclosporine|mesh-list
139269958|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
139269959|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
139269960|NCT00136903|Prednisone|prednisone|mesh-list
139269961|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
139269962|NCT00136903|Tacrolimus|tacrolimus|mesh-list
139269963|NCT00136903|Cyclosporins|cyclosporins|mesh-list
139269964|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139269965|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
139269966|NCT00136903|Hormones|hormones|mesh-ancestor
139269967|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139269968|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269969|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139269970|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269971|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139269972|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
139269973|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139269974|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139269975|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269976|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
139269977|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139269978|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
139269979|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139269980|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139269981|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139269982|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
139269983|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139269984|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
139269985|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
139269986|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269987|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139269988|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139269989|NCT00136903|Protective Agents|protective agents|mesh-ancestor
139269990|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
139269991|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
139269992|NCT04917029|Bupivacaine|bupivacaine|mesh-list
139269993|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
139269994|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
139269995|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139269996|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269997|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
139269998|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139269999|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139270000|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139270001|NCT04917029|Analgesics|analgesics|mesh-ancestor
139270002|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139270003|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139270004|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139270005|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
139270006|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270007|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270008|NCT04189510|Pancrelipase|pancrelipase|mesh-list
139270009|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139270010|NCT03632759|Liraglutide|liraglutide|mesh-list
139270012|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139270013|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270014|NCT03632759|Incretins|incretins|mesh-ancestor
139270015|NCT03632759|Hormones|hormones|mesh-ancestor
139270016|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139270017|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139270018|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139270019|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139270020|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
139270021|NCT02953093|Acarbose|acarbose|mesh-list
139270022|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139270023|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270024|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270025|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139270026|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270027|NCT04518280|Capecitabine|capecitabine|mesh-list
139270028|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
139270029|NCT04518280|Antibodies|antibodies|mesh-list
139270030|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
139270031|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270032|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139270033|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
139270034|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270035|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270036|NCT00498836|Sorafenib|sorafenib|mesh-list
139270037|NCT00498836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270038|NCT00498836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139270039|NCT00498836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270040|NCT00498836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270041|NCT02283866|Desflurane|desflurane|mesh-list
139270042|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139270043|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
139270044|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
139270045|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139270046|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270047|NCT04517110|Pregabalin|pregabalin|mesh-list
139270048|NCT04517110|Analgesics|analgesics|mesh-ancestor
139270049|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
139270050|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270051|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270052|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
139270053|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139270054|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139270055|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270056|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139270057|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139270058|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139270059|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139270060|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139270061|NCT00498212|1018 oligonucleotide|1018 oligonucleotide|mesh-list
139270062|NCT00498212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139270063|NCT00498212|Immunologic Factors|immunologic factors|mesh-ancestor
139270064|NCT00498212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270066|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139270067|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270068|NCT02281058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139270069|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270070|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139270071|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
138289232|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139270072|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270073|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139270074|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
139270075|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139270076|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139270077|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139270078|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139270079|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270080|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
139270081|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270082|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270083|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139270084|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270085|NCT05205317|Metformin|metformin|mesh-list
139270086|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139270087|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270088|NCT00691964|Etanercept|etanercept|mesh-list
139270089|NCT00691964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139270090|NCT00691964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139270091|NCT00691964|Analgesics|analgesics|mesh-ancestor
139270092|NCT00691964|Sensory System Agents|sensory system agents|mesh-ancestor
139270093|NCT00691964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270094|NCT00691964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140343|NCT03763227|Growth Substances|growth substances|mesh-ancestor
139270095|NCT00691964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139270096|NCT00691964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139270097|NCT00691964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139270098|NCT00691964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139270099|NCT00691964|Immunologic Factors|immunologic factors|mesh-ancestor
139270101|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139270102|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139270103|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139270104|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139270105|NCT02281292|Growth Substances|growth substances|mesh-ancestor
139270106|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270107|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
139270108|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270109|NCT03723772|Insulin|insulin|mesh-list
139270110|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139270111|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139270112|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270113|NCT02660827|Insulin|insulin|mesh-list
139270114|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139270115|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270116|NCT00491738|Bevacizumab|bevacizumab|mesh-list
139270117|NCT00491738|Sunitinib|sunitinib|mesh-list
139270118|NCT00491738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139270119|NCT00491738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270120|NCT00491738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139270121|NCT00491738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139270122|NCT00491738|Growth Substances|growth substances|mesh-ancestor
139270123|NCT00491738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270124|NCT00491738|Growth Inhibitors|growth inhibitors|mesh-ancestor
138853535|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270125|NCT00491738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139270126|NCT00491738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270127|NCT00491738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270128|NCT02281370|Cyclosporine|cyclosporine|mesh-list
139270129|NCT02281370|Cyclosporins|cyclosporins|mesh-list
139270130|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270131|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270132|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139270133|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
139270134|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270135|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
139270136|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270137|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
139270138|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139270139|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139270140|NCT00680342|Silymarin|silymarin|mesh-list
139270141|NCT00680342|Antioxidants|antioxidants|mesh-ancestor
139270142|NCT00680342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270143|NCT00680342|Protective Agents|protective agents|mesh-ancestor
139270144|NCT00680342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270145|NCT04057365|Nivolumab|nivolumab|mesh-list
139270146|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139270147|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270148|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139270149|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270150|NCT00616148|Cenobamate|cenobamate|mesh-list
139270151|NCT00616148|Anticonvulsants|anticonvulsants|mesh-ancestor
139270152|NCT03622827|Endostar protein|endostar protein|mesh-list
139270153|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139270154|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139270155|NCT03622827|Growth Substances|growth substances|mesh-ancestor
139270156|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270157|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
139270158|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270159|NCT00486512|Aspirin|aspirin|mesh-list
139270160|NCT00486512|Calcium, Dietary|calcium, dietary|mesh-list
139270161|NCT00486512|Calcitriol|calcitriol|mesh-list
139270162|NCT00486512|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
139270163|NCT00486512|Calcium Carbonate|calcium carbonate|mesh-list
139270164|NCT00486512|Calcium|calcium|mesh-list
139642304|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139270165|NCT00486512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139270166|NCT00486512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270167|NCT00486512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139140426|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
139270168|NCT00486512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139270169|NCT00486512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139270170|NCT00486512|Analgesics|analgesics|mesh-ancestor
139270171|NCT00486512|Sensory System Agents|sensory system agents|mesh-ancestor
139270172|NCT00486512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270173|NCT00486512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139270174|NCT00486512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139270175|NCT00486512|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139270176|NCT00486512|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139270177|NCT00486512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270178|NCT00486512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139270179|NCT00486512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139270180|NCT00486512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270181|NCT00486512|Antipyretics|antipyretics|mesh-ancestor
139270182|NCT00486512|Antacids|antacids|mesh-ancestor
139270183|NCT00486512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139270184|NCT00486512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139270185|NCT00486512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139270186|NCT00486512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139270187|NCT00486512|Vitamins|vitamins|mesh-ancestor
139270188|NCT00486512|Micronutrients|micronutrients|mesh-ancestor
139270189|NCT04057989|Ketamine|ketamine|mesh-list
139270190|NCT04057989|Analgesics|analgesics|mesh-ancestor
139270191|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
139270192|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270193|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270194|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139270195|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139270196|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
139270197|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
139270198|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139270199|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138853641|NCT04627142|Irinotecan|irinotecan|mesh-list
139270200|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139270201|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270202|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270203|NCT00486200|Valacyclovir|valacyclovir|mesh-list
139270204|NCT00486200|Antiviral Agents|antiviral agents|mesh-ancestor
139270205|NCT00486200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270206|NCT00479258|Insulin|insulin|mesh-list
139270207|NCT00479258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139270208|NCT00479258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139270209|NCT00479258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270210|NCT00612170|Reboxetine|reboxetine|mesh-list
139270211|NCT00612170|Antidepressive Agents|antidepressive agents|mesh-ancestor
139270212|NCT00612170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139270213|NCT00612170|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139270214|NCT00612170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139270215|NCT00612170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139270216|NCT00612170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270217|NCT00612170|Adrenergic Agents|adrenergic agents|mesh-ancestor
139270218|NCT00612170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270219|NCT00612170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270220|NCT05068336|Anesthetics|anesthetics|mesh-list
139270221|NCT05068336|Sevoflurane|sevoflurane|mesh-list
139270222|NCT05068336|Desflurane|desflurane|mesh-list
139270223|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139270224|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270225|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139270226|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139270227|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
139270228|NCT00607256|Reboxetine|reboxetine|mesh-list
139270229|NCT00607256|Antidepressive Agents|antidepressive agents|mesh-ancestor
139270230|NCT00607256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139270231|NCT00607256|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139270232|NCT00607256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139270233|NCT00607256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139270234|NCT00607256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270235|NCT00607256|Adrenergic Agents|adrenergic agents|mesh-ancestor
139270236|NCT00607256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270237|NCT00607256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270238|NCT02774590|Timolol|timolol|mesh-list
139270239|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139642305|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270240|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139270241|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
139270242|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270243|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270244|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270245|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139270246|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139270247|NCT01069341|Ranibizumab|ranibizumab|mesh-list
139270248|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139270249|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139270250|NCT01069341|Growth Substances|growth substances|mesh-ancestor
139270251|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270252|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
139270253|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270254|NCT00676832|Prednisolone|prednisolone|mesh-list
139270255|NCT00676832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139270256|NCT00676832|Methylprednisolone|methylprednisolone|mesh-list
139270257|NCT00676832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139270258|NCT00676832|Prednisolone acetate|prednisolone acetate|mesh-list
139270259|NCT00676832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139270260|NCT00676832|Prednisolone phosphate|prednisolone phosphate|mesh-list
139270261|NCT00676832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139270262|NCT00676832|Glucocorticoids|glucocorticoids|mesh-ancestor
139270263|NCT00676832|Hormones|hormones|mesh-ancestor
139270264|NCT00676832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139270265|NCT00676832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270266|NCT00676832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139270267|NCT00676832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270268|NCT00676832|Antiemetics|antiemetics|mesh-ancestor
139270269|NCT00676832|Autonomic Agents|autonomic agents|mesh-ancestor
139270270|NCT00676832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270271|NCT00676832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139270272|NCT00676832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139270273|NCT00676832|Protective Agents|protective agents|mesh-ancestor
138853682|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139270274|NCT01909414|Vaccines|vaccines|mesh-list
139270275|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
139270276|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270277|NCT00467402|Agomelatine|agomelatine|mesh-list
139270278|NCT00467402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139270279|NCT00467402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139270280|NCT00467402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270281|NCT02996097|Triamcinolone|triamcinolone|mesh-list
139270282|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139270283|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139270284|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139270285|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139270286|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
139270287|NCT02996097|Hormones|hormones|mesh-ancestor
139270288|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139270289|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270290|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139270291|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
139270292|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270293|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270294|NCT04054713|Acetic Acid|acetic acid|mesh-list
139270295|NCT04054713|Retinol acetate|retinol acetate|mesh-list
139270296|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139270297|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270298|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139270299|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
139270300|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270301|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139270302|NCT04054713|Protective Agents|protective agents|mesh-ancestor
139270303|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270304|NCT03314181|Dexamethasone|dexamethasone|mesh-list
139270305|NCT03314181|Bortezomib|bortezomib|mesh-list
139270306|NCT03314181|Venetoclax|venetoclax|mesh-list
139270307|NCT03314181|Daratumumab|daratumumab|mesh-list
139270308|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139270309|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
139270310|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
139270311|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270312|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270313|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139270314|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
139270315|NCT03314181|Hormones|hormones|mesh-ancestor
139270316|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139270317|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139270318|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270319|NCT03133832|Praziquantel|praziquantel|mesh-list
139270320|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
139270321|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139270322|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270323|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
139270324|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139270325|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139270326|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270327|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139270328|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139270329|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139270330|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270331|NCT04161430|Incretins|incretins|mesh-ancestor
139270332|NCT04161430|Hormones|hormones|mesh-ancestor
139270333|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139270334|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139270335|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
139270336|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270337|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270338|NCT00673478|Tiotropium Bromide|tiotropium bromide|mesh-list
139270339|NCT00673478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139270340|NCT00673478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139270341|NCT00673478|Autonomic Agents|autonomic agents|mesh-ancestor
139270342|NCT00673478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270343|NCT00673478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270344|NCT00673478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139270345|NCT00673478|Respiratory System Agents|respiratory system agents|mesh-ancestor
139270346|NCT00673478|Parasympatholytics|parasympatholytics|mesh-ancestor
139270347|NCT00673478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139270348|NCT00673478|Cholinergic Agents|cholinergic agents|mesh-ancestor
138853755|NCT02817932|Ranolazine|ranolazine|mesh-list
139270349|NCT00673478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270350|NCT00673478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270351|NCT00673478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139270352|NCT00673478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139270353|NCT00673478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139270354|NCT00673478|Adrenergic Agents|adrenergic agents|mesh-ancestor
139270355|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
139270356|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139270357|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
139270358|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270359|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270360|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139270361|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
139270362|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
139270363|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139270364|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
139270365|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270366|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270367|NCT00672386|Metformin|metformin|mesh-list
139270368|NCT00672386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139270369|NCT00672386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270370|NCT04056897|Teriflunomide|teriflunomide|mesh-list
139270371|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139270372|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139270373|NCT04056897|Analgesics|analgesics|mesh-ancestor
139270374|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
139270375|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270376|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270377|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139270378|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139270379|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139270380|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
139270381|NCT02281682|Fluorouracil|fluorouracil|mesh-list
139270382|NCT02281682|Imiquimod|imiquimod|mesh-list
139270383|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139270384|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
139270385|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270386|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139270387|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270388|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139270389|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
139270390|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270391|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139270392|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
139270393|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139270394|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
139270395|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139270396|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139270397|NCT04056975|Antibodies|antibodies|mesh-list
139270398|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
139270399|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270400|NCT02281916|Immunomodulating Agents|immunomodulating agents|mesh-list
139270401|NCT02281916|Immunologic Factors|immunologic factors|mesh-ancestor
139270402|NCT02281916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270403|NCT03662763|Guanfacine|guanfacine|mesh-list
139270404|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139270405|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139270406|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139270407|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139270408|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
139270409|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270410|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270411|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270412|NCT00458978|Cediranib|cediranib|mesh-list
139270413|NCT00458978|Maleic acid|maleic acid|mesh-list
139270414|NCT00458978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270415|NCT00458978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270416|NCT00458978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270417|NCT00458978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139270418|NCT00458276|Tezosentan|tezosentan|mesh-list
139270419|NCT00458276|Vasodilator Agents|vasodilator agents|mesh-ancestor
139270420|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
139270421|NCT04520074|Carboplatin|carboplatin|mesh-list
139270422|NCT04520074|Etoposide|etoposide|mesh-list
138853831|NCT02743104|Propofol|propofol|mesh-list
139270423|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139270424|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
139270425|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270426|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139270427|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139270428|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
139270429|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270430|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270431|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139270432|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139270433|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139270434|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139270435|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270436|NCT00455156|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139270437|NCT00455156|ST 1435|st 1435|mesh-list
139270438|NCT00455156|Estradiol|estradiol|mesh-list
139270439|NCT00455156|Estrogens|estrogens|mesh-ancestor
139270440|NCT00455156|Hormones|hormones|mesh-ancestor
139270441|NCT00455156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139270442|NCT00455156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270443|NCT00455156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139270444|NCT00455156|Contraceptive Agents|contraceptive agents|mesh-ancestor
139270445|NCT00455156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139270446|NCT00455156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139270447|NCT00455156|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139270448|NCT00455156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139270449|NCT03661515|Cytarabine|cytarabine|mesh-list
139270450|NCT03661515|Fludarabine|fludarabine|mesh-list
139270451|NCT03661515|Idarubicin|idarubicin|mesh-list
139270452|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270453|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139270454|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
139270455|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270456|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139270457|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
139270458|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270459|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
139270460|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270461|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139270462|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139270463|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139140721|NCT03764163|Xenon|xenon|mesh-list
139270464|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270465|NCT01624480|Modafinil|modafinil|mesh-list
139270466|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139270467|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270468|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139270469|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139270470|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139270471|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270472|NCT00448058|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139270473|NCT00448058|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139270474|NCT00448058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139270475|NCT00448058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139270476|NCT00448058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270477|NCT00448058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270478|NCT00448058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270479|NCT00448058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139270480|NCT00448058|Antidepressive Agents|antidepressive agents|mesh-ancestor
139270481|NCT00448058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139270482|NCT02284412|Neostigmine|neostigmine|mesh-list
139381728|NCT02424435|Prednisolone|prednisolone|mesh-list
139270483|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139270484|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270485|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270486|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
139270487|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270488|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270489|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139270490|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
139270491|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270492|NCT02284490|Pemetrexed|pemetrexed|mesh-list
139270493|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270494|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270495|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270496|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139270497|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139270498|NCT02273570|Vitamin D|vitamin d|mesh-list
139270499|NCT02273570|Calcium|calcium|mesh-list
139270500|NCT02273570|Vitamins|vitamins|mesh-ancestor
139270501|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
139270502|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270503|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139270504|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139270505|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
139270506|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139270507|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139270508|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139270509|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139270510|NCT00579020|Moxifloxacin|moxifloxacin|mesh-list
139270511|NCT00579020|Dexamethasone|dexamethasone|mesh-list
139270512|NCT00579020|Dexamethasone acetate|dexamethasone acetate|mesh-list
139270513|NCT00579020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139270514|NCT00579020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139270515|NCT00579020|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139270516|NCT00579020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139270517|NCT00579020|BB 1101|bb 1101|mesh-list
139270518|NCT00579020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139270519|NCT00579020|Antiemetics|antiemetics|mesh-ancestor
139270520|NCT00579020|Autonomic Agents|autonomic agents|mesh-ancestor
139270521|NCT00579020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270522|NCT00579020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270523|NCT00579020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139270524|NCT00579020|Glucocorticoids|glucocorticoids|mesh-ancestor
139270525|NCT00579020|Hormones|hormones|mesh-ancestor
139270526|NCT00579020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139270527|NCT00579020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139270528|NCT00579020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270529|NCT00579020|Protease Inhibitors|protease inhibitors|mesh-ancestor
139270530|NCT00579020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270531|NCT00579020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270532|NCT00579020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139270533|NCT00579020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270534|NCT00579020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139642306|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
139140793|NCT05320107|Ketamine|ketamine|mesh-list
139270535|NCT00579020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139270536|NCT00579020|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139270537|NCT00579020|Contraceptive Agents|contraceptive agents|mesh-ancestor
139270538|NCT00579020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139270539|NCT00579020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139270540|NCT00579020|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139270541|NCT00579020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139270542|NCT04530604|Defibrotide|defibrotide|mesh-list
139270543|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139270544|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139270545|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270546|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139270547|NCT04169698|Denosumab|denosumab|mesh-list
139270548|NCT04169698|Alendronate|alendronate|mesh-list
139270549|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139270550|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270551|NCT04470752|Capsaicin|capsaicin|mesh-list
139270552|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139270553|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
139270554|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
139270555|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
139270556|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270557|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270558|NCT02273804|Topiramate|topiramate|mesh-list
139270559|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
139270560|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139270561|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270562|NCT00578474|Ofloxacin|ofloxacin|mesh-list
139270563|NCT00578474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139270564|NCT00578474|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139270565|NCT00578474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270566|NCT00578474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139270567|NCT00578474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139270568|NCT00578474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139270569|NCT00578474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853983|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270570|NCT00578474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270571|NCT00578474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270572|NCT00578474|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139270573|NCT00578474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139270574|NCT00577148|Rimonabant|rimonabant|mesh-list
139270575|NCT00577148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139270576|NCT00577148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
139270577|NCT00577148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139270578|NCT00577148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270579|NCT00577148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270580|NCT00577148|Hormones|hormones|mesh-ancestor
139270581|NCT00577148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139270582|NCT00577148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270583|NCT03673228|Nicotine|nicotine|mesh-list
139270584|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139270585|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
139270586|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270587|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270588|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139270589|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139270590|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
139270591|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270592|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270593|NCT05116462|Paclitaxel|paclitaxel|mesh-list
139270594|NCT05116462|Docetaxel|docetaxel|mesh-list
139270595|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139270596|NCT05116462|Carboplatin|carboplatin|mesh-list
139270597|NCT05116462|Gemcitabine|gemcitabine|mesh-list
139270598|NCT05116462|Pemetrexed|pemetrexed|mesh-list
139270599|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139270600|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270601|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
139270602|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
139270603|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
139270604|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270605|NCT05116462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139270606|NCT05116462|Antimetabolites|antimetabolites|mesh-ancestor
139642307|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140862|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139270607|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270608|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139270609|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139270610|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
139270611|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139270612|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
139270613|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270614|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
139270615|NCT05116306|Protective Agents|protective agents|mesh-ancestor
139270616|NCT00570986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139270617|NCT00570986|Immunologic Factors|immunologic factors|mesh-ancestor
139270618|NCT00570986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270619|NCT00570752|Atorvastatin|atorvastatin|mesh-list
139270620|NCT00570752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139270621|NCT00570752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139270622|NCT00570752|Antimetabolites|antimetabolites|mesh-ancestor
139270623|NCT00570752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270624|NCT00570752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139205051|NCT05432531|Cyclophosphamide|cyclophosphamide|mesh-list
139270625|NCT00570752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139270626|NCT00570752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270627|NCT02282384|Oseltamivir|oseltamivir|mesh-list
139270628|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
139270629|NCT02282384|Antacids|antacids|mesh-ancestor
139270630|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270631|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139270632|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
139270633|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270634|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270635|NCT02989389|Itraconazole|itraconazole|mesh-list
139270636|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
139270637|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270638|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139270639|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139270640|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270641|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270642|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139270643|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
139270644|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138854130|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
139270645|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270646|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139270647|NCT02653300|Insulin|insulin|mesh-list
139270648|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139270649|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270650|NCT00436670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139270651|NCT00436670|Immunologic Factors|immunologic factors|mesh-ancestor
139270652|NCT00436670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270653|NCT03187509|Torsemide|torsemide|mesh-list
139270654|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139270655|NCT03187509|Diuretics|diuretics|mesh-ancestor
139270656|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
139270657|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270658|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139270659|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139270660|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270661|NCT00430508|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139270662|NCT00430508|Olmesartan|olmesartan|mesh-list
139270663|NCT00430508|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139270664|NCT00430508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139270665|NCT00430508|Diuretics|diuretics|mesh-ancestor
139270666|NCT00430508|Natriuretic Agents|natriuretic agents|mesh-ancestor
139270667|NCT00430508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270668|NCT00430508|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139270669|NCT00430508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139270670|NCT00430508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270671|NCT00430508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139270672|NCT00430508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139270673|NCT04221880|Lidocaine|lidocaine|mesh-list
139270674|NCT04221880|Bupivacaine|bupivacaine|mesh-list
139270675|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139270676|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
139270677|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
139642308|NCT05586919|Ethanol|ethanol|mesh-list
139140942|NCT05280873|Prednisolone|prednisolone|mesh-list
139270678|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139270679|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270680|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
139270681|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270682|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139270683|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139270684|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139270685|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139270686|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270687|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
139270688|NCT04055415|Expectorants|expectorants|mesh-list
139270689|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
139270690|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270691|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270692|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139270693|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
139270695|NCT00427856|Obatoclax|obatoclax|mesh-list
139270696|NCT00427856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139270697|NCT00427856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270698|NCT00427856|Immunologic Factors|immunologic factors|mesh-ancestor
139270699|NCT00427856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270700|NCT00427856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139270701|NCT00427856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270702|NCT00427856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270703|NCT00427154|Insulin|insulin|mesh-list
139270704|NCT00427154|Metformin|metformin|mesh-list
139270705|NCT00427154|Glimepiride|glimepiride|mesh-list
139270706|NCT00427154|Rosiglitazone|rosiglitazone|mesh-list
139270707|NCT00427154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139270708|NCT00427154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139270709|NCT00427154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270710|NCT00427154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139270711|NCT00427154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139270712|NCT00427154|Immunologic Factors|immunologic factors|mesh-ancestor
139270713|NCT02988219|Epinephrine|epinephrine|mesh-list
139270714|NCT02988219|Fentanyl|fentanyl|mesh-list
139270715|NCT02988219|Bupivacaine|bupivacaine|mesh-list
139270716|NCT02988219|Anesthetics|anesthetics|mesh-list
139270717|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
139270718|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139270719|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270720|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
139270721|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270722|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139270723|NCT02988219|Narcotics|narcotics|mesh-ancestor
139270724|NCT02988219|Analgesics|analgesics|mesh-ancestor
139270725|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139270726|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139270727|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
139270728|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139270729|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139270730|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
139270731|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270732|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270733|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139270734|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139270735|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
139270736|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139270737|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
139270738|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
139270739|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
139270740|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139270741|NCT01346059|Vancomycin|vancomycin|mesh-list
139270742|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139270743|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270744|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
139270745|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
139270746|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
139270747|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270748|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270749|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
139270750|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139270751|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139270752|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
139642309|NCT05586919|Polidocanol|polidocanol|mesh-list
139270753|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270754|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270755|NCT04548973|Esketamine|esketamine|mesh-list
139270756|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
139270757|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139270758|NCT02277938|Amantadine|amantadine|mesh-list
139270759|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139270760|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139270761|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
139270762|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270763|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
139270764|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270765|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270766|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270767|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139270768|NCT02277938|Analgesics|analgesics|mesh-ancestor
139270769|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
139270770|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270771|NCT00415142|Escitalopram|escitalopram|mesh-list
139205206|NCT03764267|Lidocaine|lidocaine|mesh-list
139270772|NCT00415142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139270773|NCT00415142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139270774|NCT00415142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139270775|NCT00415142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270776|NCT00415142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270777|NCT00415142|Serotonin Agents|serotonin agents|mesh-ancestor
139270778|NCT00415142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270779|NCT03661125|Saracatinib|saracatinib|mesh-list
139270780|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270781|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270782|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270783|NCT00413114|Obatoclax|obatoclax|mesh-list
139270784|NCT00413114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270785|NCT00413114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270786|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
139270787|NCT01318915|Sirolimus|sirolimus|mesh-list
139270788|NCT01318915|Rituximab|rituximab|mesh-list
139270789|NCT01318915|Tacrolimus|tacrolimus|mesh-list
139270790|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
139270791|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139270792|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138854204|NCT04237532|Analgesics|analgesics|mesh-ancestor
139270793|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270794|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
139270795|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270796|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139270797|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139270798|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139270799|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270800|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270801|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139270802|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139270803|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
139270804|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139270805|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270806|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
139270807|NCT04688177|Nicotine|nicotine|mesh-list
139270808|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
139270809|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139270810|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
139270811|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270812|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270813|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139270814|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139270815|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
139270816|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270817|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270818|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
139270819|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
139270820|NCT00411242|Agomelatine|agomelatine|mesh-list
139270821|NCT00411242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139270822|NCT00411242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139270823|NCT00411242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270824|NCT05203913|Paclitaxel|paclitaxel|mesh-list
139270825|NCT05203913|Nivolumab|nivolumab|mesh-list
139270826|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139270827|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270828|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
139270829|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
139270830|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
139270831|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270832|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139270833|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139270834|NCT00402428|Interferons|interferons|mesh-list
139270835|NCT00402428|Ribavirin|ribavirin|mesh-list
139270836|NCT00402428|Interferon-alpha|interferon-alpha|mesh-list
139270837|NCT00402428|Interferon alpha-2|interferon alpha-2|mesh-list
139270838|NCT00402428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139270839|NCT00402428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270840|NCT00402428|Antiviral Agents|antiviral agents|mesh-ancestor
139270841|NCT00402428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270842|NCT00402428|Antimetabolites|antimetabolites|mesh-ancestor
139270843|NCT00402428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270844|NCT00402428|Immunologic Factors|immunologic factors|mesh-ancestor
139270845|NCT00402428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270846|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
139270847|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139270848|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139270849|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270850|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
139270851|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
139270852|NCT03660267|Caffeine|caffeine|mesh-list
139270853|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139270854|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270855|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139270856|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270857|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270858|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139270859|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139270860|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
139270861|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270862|NCT03950245|Glucagon|glucagon|mesh-list
139270863|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139270864|NCT03950245|Incretins|incretins|mesh-ancestor
139270865|NCT03950245|Hormones|hormones|mesh-ancestor
139270866|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139270867|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270868|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139270869|NCT00401570|Gemcitabine|gemcitabine|mesh-list
139270870|NCT00401570|Volociximab|volociximab|mesh-list
139270871|NCT00401570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139270872|NCT00401570|Antimetabolites|antimetabolites|mesh-ancestor
139270873|NCT00401570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270874|NCT00401570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270875|NCT00401570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139270876|NCT00401570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139270877|NCT00401570|Growth Substances|growth substances|mesh-ancestor
139270878|NCT00401570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270879|NCT00401570|Growth Inhibitors|growth inhibitors|mesh-ancestor
139270880|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
139270881|NCT05193565|Sirolimus|sirolimus|mesh-list
139270882|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139270883|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270884|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139270885|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
139270886|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139270887|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270888|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270889|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270890|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
139270891|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139270892|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
139270893|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270894|NCT04471922|Rabeprazole|rabeprazole|mesh-list
139270895|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139270896|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139270897|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139270898|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270899|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270900|NCT04368364|Morphine|morphine|mesh-list
139270901|NCT04368364|Bupivacaine|bupivacaine|mesh-list
139270902|NCT04368364|Ropivacaine|ropivacaine|mesh-list
139270903|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
139270904|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
139270905|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139270906|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270907|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
139270908|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270909|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139270910|NCT04368364|Narcotics|narcotics|mesh-ancestor
139270911|NCT04368364|Analgesics|analgesics|mesh-ancestor
139270912|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139270913|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
139270914|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270915|NCT00543374|Remestemcel-l|remestemcel-l|mesh-list
139270916|NCT00543374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139270917|NCT00543374|Antiviral Agents|antiviral agents|mesh-ancestor
139270918|NCT00543374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139270919|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139270920|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139270921|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270922|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139270923|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270924|NCT05229796|Empagliflozin|empagliflozin|mesh-list
139270925|NCT05229796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139270926|NCT05229796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270927|NCT05229796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139270928|NCT05229796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270929|NCT00151892|Mesalamine|mesalamine|mesh-list
139270930|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139270931|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139270932|NCT00151892|Analgesics|analgesics|mesh-ancestor
139270933|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
139270934|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270935|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270936|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139270937|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139270938|NCT02740127|Dexamethasone|dexamethasone|mesh-list
139270939|NCT02740127|Clonidine|clonidine|mesh-list
139270940|NCT02740127|Epinephrine|epinephrine|mesh-list
139270941|NCT02740127|Propofol|propofol|mesh-list
139270942|NCT02740127|Ropivacaine|ropivacaine|mesh-list
139270943|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139270944|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
139270945|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
139270946|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139270947|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270948|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139270949|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
139270950|NCT02740127|Hormones|hormones|mesh-ancestor
139270951|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139270952|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139270953|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270954|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270955|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139270956|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139270957|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139270958|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
139270959|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
139270960|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
139270961|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
139270962|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139270963|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139270964|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
139270965|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139270966|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139270967|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139270968|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139270969|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
139270970|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
139270971|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
139270972|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139270973|NCT02740127|Analgesics|analgesics|mesh-ancestor
139270974|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139270975|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
139270976|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139270977|NCT04450498|Vaccines|vaccines|mesh-list
139270978|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
139270979|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139270980|NCT00654992|Epoetin Alfa|epoetin alfa|mesh-list
139270981|NCT00654992|Hematinics|hematinics|mesh-ancestor
139270982|NCT02921919|Talazoparib|talazoparib|mesh-list
139270983|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139270984|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139270985|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270986|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270987|NCT00393068|Paclitaxel|paclitaxel|mesh-list
139270988|NCT00393068|Bevacizumab|bevacizumab|mesh-list
139270989|NCT00393068|Carboplatin|carboplatin|mesh-list
139270990|NCT00393068|Fluorouracil|fluorouracil|mesh-list
139270991|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139270992|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139270993|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139270994|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
139270995|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
139270996|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
139270997|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139270998|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139270999|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139271000|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139271001|NCT00393068|Growth Substances|growth substances|mesh-ancestor
139271002|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271003|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
139271004|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
139271005|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139271006|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139271007|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
139271008|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139271009|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271010|NCT02280278|Immunomodulating Agents|immunomodulating agents|mesh-list
139271011|NCT02280278|Immunologic Factors|immunologic factors|mesh-ancestor
139271012|NCT02280278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271013|NCT04769401|Progesterone|progesterone|mesh-list
139271014|NCT04769401|Progestins|progestins|mesh-ancestor
139271015|NCT04769401|Hormones|hormones|mesh-ancestor
139271016|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139271017|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271018|NCT02094222|Glycerol|glycerol|mesh-list
139271019|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139271020|NCT02094222|Protective Agents|protective agents|mesh-ancestor
139271021|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271022|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139271023|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139271024|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139271025|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
139271026|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271027|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139271028|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139271029|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271031|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139271032|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271033|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139271034|NCT02282774|Lidocaine|lidocaine|mesh-list
139271035|NCT02282774|Bupivacaine|bupivacaine|mesh-list
139271036|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
139271037|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
139271038|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139271039|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271040|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
139271041|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271042|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139271043|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139271044|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139271045|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139271046|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271047|NCT02090322|Bevacizumab|bevacizumab|mesh-list
139271048|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139271049|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271050|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139271051|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139271052|NCT02090322|Growth Substances|growth substances|mesh-ancestor
139271053|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271054|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
139271055|NCT03658785|Aldesleukin|aldesleukin|mesh-list
139271056|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
139271057|NCT03658785|Fludarabine|fludarabine|mesh-list
139271058|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139271059|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
139271060|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271061|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271062|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139271063|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
139271064|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271065|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271066|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139271067|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139271068|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139271069|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
139271070|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271071|NCT02095782|Paclitaxel|paclitaxel|mesh-list
139271072|NCT02095782|Carboplatin|carboplatin|mesh-list
139271073|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139271074|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139271075|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271076|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
139271077|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
139271078|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
139271079|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271080|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139271081|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271082|NCT02094378|Esketamine|esketamine|mesh-list
139271083|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
139271084|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139271085|NCT02285738|Aspirin|aspirin|mesh-list
139271086|NCT02285738|Simvastatin|simvastatin|mesh-list
139271087|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139271088|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139271089|NCT02285738|Analgesics|analgesics|mesh-ancestor
139271090|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
139271091|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271092|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271093|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271094|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271095|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139271096|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139271097|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271098|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139271099|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139271100|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271101|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
139271102|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139271103|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139271104|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
139271105|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139271106|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139271107|NCT00650702|Latanoprost|latanoprost|mesh-list
139271108|NCT00650702|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139271109|NCT00650702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139271110|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
139271111|NCT02090400|Calcium|calcium|mesh-list
139271112|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139271113|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271114|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139271115|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139271116|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
139271117|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139271118|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139271119|NCT03134846|Cetuximab|cetuximab|mesh-list
139271120|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139271121|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271122|NCT01068717|Metformin|metformin|mesh-list
139271123|NCT01068717|Saxagliptin|saxagliptin|mesh-list
139271124|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139271125|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271126|NCT01068717|Incretins|incretins|mesh-ancestor
139271127|NCT01068717|Hormones|hormones|mesh-ancestor
139297254|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271128|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139271129|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139271130|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
139271131|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271132|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271133|NCT02095938|Amisulpride|amisulpride|mesh-list
139271134|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139271135|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139271136|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139271137|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271138|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139271139|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139271140|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
139271141|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139271142|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271143|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139271144|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
139271145|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139271147|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139271148|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139271149|NCT02285972|Analgesics|analgesics|mesh-ancestor
139271150|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
139271151|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271152|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271153|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271154|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271155|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139271156|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271157|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271158|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
139271159|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139271160|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271161|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
139271162|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
139271163|NCT02921763|Progestins|progestins|mesh-ancestor
139271164|NCT02921763|Hormones|hormones|mesh-ancestor
139271165|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139271166|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271167|NCT03658473|Naproxen|naproxen|mesh-list
139271168|NCT03658473|Rabeprazole|rabeprazole|mesh-list
139271169|NCT03658473|Rebamipide|rebamipide|mesh-list
139271170|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139271171|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139271172|NCT03658473|Analgesics|analgesics|mesh-ancestor
139271173|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
139271174|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271175|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271176|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271177|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271178|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
139271179|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139271180|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271181|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271182|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139271183|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139271184|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139271185|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
139271186|NCT03658473|Protective Agents|protective agents|mesh-ancestor
139271187|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
139271188|NCT02096250|Edetic Acid|edetic acid|mesh-list
139271189|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
139271190|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
139271191|NCT02096250|Trace Elements|trace elements|mesh-ancestor
139271192|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
139271193|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271194|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139271195|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
139271196|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
139271197|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271198|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
139271199|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139271200|NCT02096250|Hematinics|hematinics|mesh-ancestor
139271201|NCT02096328|Murepavadin|murepavadin|mesh-list
139271202|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139271203|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271204|NCT01318135|Metformin|metformin|mesh-list
139271205|NCT01318135|Glimepiride|glimepiride|mesh-list
139271206|NCT01318135|Alogliptin|alogliptin|mesh-list
139271207|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139271208|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271209|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139271210|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139271211|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
139271212|NCT01318135|Incretins|incretins|mesh-ancestor
139271213|NCT01318135|Hormones|hormones|mesh-ancestor
139271214|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139271215|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139271216|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
139271217|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271218|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271219|NCT02094924|Candesartan|candesartan|mesh-list
139271220|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
139271221|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139271222|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139271223|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139271224|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271225|NCT02286206|Clozapine|clozapine|mesh-list
139271226|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139271227|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
139271228|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139271229|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271230|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271231|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139271232|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139271233|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139271234|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139271235|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
139271236|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
139271237|NCT03104283|Apatinib|apatinib|mesh-list
139271238|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271239|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139271240|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271241|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271242|NCT00529178|Pravastatin|pravastatin|mesh-list
139271243|NCT00529178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139271244|NCT00529178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139271245|NCT00529178|Antimetabolites|antimetabolites|mesh-ancestor
139271246|NCT00529178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271247|NCT00529178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139271248|NCT00529178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139271250|NCT00382460|Pravastatin|pravastatin|mesh-list
139271251|NCT00382460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139271252|NCT00382460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139271253|NCT00382460|Antimetabolites|antimetabolites|mesh-ancestor
139271254|NCT00382460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271255|NCT00382460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139271256|NCT00382460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139271257|NCT00382460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271258|NCT00523250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139271259|NCT00523250|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139271260|NCT02286596|Heparin|heparin|mesh-list
139271261|NCT02286596|Dextrans|dextrans|mesh-list
139271262|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
139271263|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139271264|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139271265|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271266|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
139271267|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
139271268|NCT02098824|Methylphenidate|methylphenidate|mesh-list
139271269|NCT02098824|Galantamine|galantamine|mesh-list
139271270|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139271271|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271272|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139271273|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139271274|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139271275|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271276|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
139271277|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139271278|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139271279|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271280|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
139271281|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139271282|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
139271283|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271284|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
139271285|NCT03658317|Uric Acid|uric acid|mesh-list
139271286|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
139271287|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271288|NCT03658317|Protective Agents|protective agents|mesh-ancestor
139271289|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271290|NCT02286752|Neostigmine|neostigmine|mesh-list
139271291|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139271292|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271293|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271294|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
139271295|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139271296|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271297|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139271298|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
139271299|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271300|NCT02095314|Vaccines|vaccines|mesh-list
139271301|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
139271302|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271303|NCT02098980|Vitamin D|vitamin d|mesh-list
139271304|NCT02098980|Vitamins|vitamins|mesh-ancestor
139271305|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
139271306|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271307|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139271308|NCT00372944|Capecitabine|capecitabine|mesh-list
139271309|NCT00372944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139271310|NCT00372944|Antimetabolites|antimetabolites|mesh-ancestor
139271311|NCT00372944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271312|NCT00372944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271313|NCT02099136|Celecoxib|celecoxib|mesh-list
139271314|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139271315|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139271316|NCT02099136|Analgesics|analgesics|mesh-ancestor
139271317|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
139271318|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854733|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139271319|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271320|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271321|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271322|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139271323|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139271324|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271325|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271327|NCT00117650|Etoposide phosphate|etoposide phosphate|mesh-list
139271328|NCT00117650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139271329|NCT00117650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271330|NCT00117650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139271331|NCT00117650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139271332|NCT00117650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271333|NCT00117650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271334|NCT02095548|Lorecivivint|lorecivivint|mesh-list
139271335|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271336|NCT00113438|Paclitaxel|paclitaxel|mesh-list
139271337|NCT00113438|Fosbretabulin|fosbretabulin|mesh-list
139271338|NCT00113438|Combretastatin|combretastatin|mesh-list
139271339|NCT00113438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139271340|NCT00113438|Carboplatin|carboplatin|mesh-list
139271341|NCT00113438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139271342|NCT00113438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271343|NCT00113438|Tubulin Modulators|tubulin modulators|mesh-ancestor
139271344|NCT00113438|Antimitotic Agents|antimitotic agents|mesh-ancestor
139271345|NCT00113438|Mitosis Modulators|mitosis modulators|mesh-ancestor
139271346|NCT00113438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271347|NCT04087408|Hormones|hormones|mesh-list
139271348|NCT04087408|Progesterone|progesterone|mesh-list
139271349|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139271350|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271351|NCT04087408|Progestins|progestins|mesh-ancestor
139271352|NCT02099292|Rituximab|rituximab|mesh-list
139297255|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
139271353|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139271354|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271355|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
139271356|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271357|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271358|NCT02283242|Galantamine|galantamine|mesh-list
139271359|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139271360|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271361|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271362|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
139271363|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139271364|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271365|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139271366|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
139271367|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271368|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
139271370|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271371|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
139271372|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
139271373|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
139271374|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271375|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
139271376|NCT03556098|Hormones|hormones|mesh-list
139271377|NCT03556098|Incretins|incretins|mesh-list
139271378|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271379|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139271380|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139271381|NCT02286986|Cannabidiol|cannabidiol|mesh-list
139271382|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
139271383|NCT04995874|Micronutrients|micronutrients|mesh-list
139271384|NCT04995874|Trace Elements|trace elements|mesh-list
139271385|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271386|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
139271387|NCT02287064|Antibodies|antibodies|mesh-list
139271388|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
139271389|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139271390|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139271391|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
139271392|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271393|NCT02095704|Acetaminophen|acetaminophen|mesh-list
139271394|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139271395|NCT02095704|Analgesics|analgesics|mesh-ancestor
139271396|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
139271397|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271398|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271399|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
139271401|NCT02099604|Interferons|interferons|mesh-list
139271402|NCT02099604|Ribavirin|ribavirin|mesh-list
139271403|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
139271404|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
139271405|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139271406|NCT02099604|Vitamins|vitamins|mesh-ancestor
139271407|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
139271408|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271409|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139271410|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271411|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
139271412|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271413|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
139271414|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271415|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
139271416|NCT02099916|Menotropins|menotropins|mesh-list
139271417|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271418|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139271419|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
139271420|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139271421|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139271422|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
139271423|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139271424|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
139271425|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139271426|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271427|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139271428|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139271429|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271430|NCT00366704|Risperidone|risperidone|mesh-list
139271431|NCT00366704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139271432|NCT00366704|Serotonin Agents|serotonin agents|mesh-ancestor
139271433|NCT00366704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139271434|NCT00366704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271435|NCT00366704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271436|NCT00366704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139271437|NCT00366704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139271438|NCT00366704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139271439|NCT00366704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139271440|NCT00366704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139271441|NCT00366704|Dopamine Agents|dopamine agents|mesh-ancestor
139271442|NCT02097264|Adalimumab|adalimumab|mesh-list
139271443|NCT02097264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139271444|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271445|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271446|NCT02097342|Linagliptin|linagliptin|mesh-list
139271447|NCT02097342|Voglibose|voglibose|mesh-list
139271448|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139271449|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271450|NCT02097342|Incretins|incretins|mesh-ancestor
139271451|NCT02097342|Hormones|hormones|mesh-ancestor
139271452|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139271453|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139271454|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
139271455|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271456|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271457|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139271458|NCT04294498|Entecavir|entecavir|mesh-list
139271459|NCT04294498|Durvalumab|durvalumab|mesh-list
139271460|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139271461|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271462|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
139271463|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271464|NCT00359450|Taxane|taxane|mesh-list
139271465|NCT00359450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271466|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
139271467|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
139271468|NCT03530462|Rituximab|rituximab|mesh-list
139271469|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
139271470|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139271471|NCT03530462|Antibodies|antibodies|mesh-list
139271472|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
139271487|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271488|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139271489|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
139271491|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139271492|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139271493|NCT03530462|Protective Agents|protective agents|mesh-ancestor
139271494|NCT02103192|Antioxidants|antioxidants|mesh-list
139271495|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271496|NCT02103192|Protective Agents|protective agents|mesh-ancestor
139271497|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271498|NCT02097810|Entrectinib|entrectinib|mesh-list
139271499|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139271500|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271501|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271502|NCT02100462|Aspirin|aspirin|mesh-list
139271503|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139271504|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
139271505|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139271506|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139271507|NCT02100462|Analgesics|analgesics|mesh-ancestor
139271508|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
139271509|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271510|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271511|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271512|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271513|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139271514|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139271515|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271516|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139271517|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139271518|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271519|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
139271520|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139271521|NCT02100462|Diuretics|diuretics|mesh-ancestor
139271522|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
139271523|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139271524|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139271525|NCT00150176|Asenapine|asenapine|mesh-list
139271526|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139271527|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139271528|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139271529|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271530|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138854957|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
139271577|NCT00057980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271578|NCT00057980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271579|NCT00057980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271581|NCT00057980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139271582|NCT00057980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139271583|NCT00057980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271584|NCT00057980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271585|NCT00057980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139271586|NCT00057980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271587|NCT00057980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139271588|NCT00057980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139271589|NCT02985879|Tilavonemab|tilavonemab|mesh-list
139271590|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
139271591|NCT02097966|Ribavirin|ribavirin|mesh-list
139271592|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
139271593|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
139271594|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271595|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
139271596|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271597|NCT00052598|Aldesleukin|aldesleukin|mesh-list
139271598|NCT00052598|Interleukin-2|interleukin-2|mesh-list
139271599|NCT00052598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271600|NCT00052598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139271601|NCT00052598|Analgesics|analgesics|mesh-ancestor
139271602|NCT00052598|Sensory System Agents|sensory system agents|mesh-ancestor
139271603|NCT00052598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271604|NCT00052598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271605|NCT00052598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139271606|NCT00052598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139271607|NCT00052598|Antiviral Agents|antiviral agents|mesh-ancestor
139271608|NCT00052598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271609|NCT05037994|Prednisolone|prednisolone|mesh-list
139271610|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139271611|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
139271612|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139271613|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
139271614|NCT05037994|Gabapentin|gabapentin|mesh-list
139271615|NCT05037994|Bupivacaine|bupivacaine|mesh-list
139271616|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139271617|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
139271618|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271619|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
139271620|NCT05037994|Hormones|hormones|mesh-ancestor
139271621|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139271622|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271623|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139271624|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271625|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
139271626|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
139271627|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271628|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139271629|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139271630|NCT05037994|Protective Agents|protective agents|mesh-ancestor
139271631|NCT05037994|Analgesics|analgesics|mesh-ancestor
139271632|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
139271633|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
139271634|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139271635|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139271636|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139271637|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139271638|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139271639|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139271640|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139271641|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271642|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
139271643|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
139271644|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
139271645|NCT00052520|Aldesleukin|aldesleukin|mesh-list
139271646|NCT00052520|Interleukin-2|interleukin-2|mesh-list
139271647|NCT00052520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271648|NCT00052520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139271649|NCT00052520|Analgesics|analgesics|mesh-ancestor
139271650|NCT00052520|Sensory System Agents|sensory system agents|mesh-ancestor
139271651|NCT00052520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271652|NCT00052520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271653|NCT00052520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139271654|NCT00052520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139271655|NCT00052520|Antiviral Agents|antiviral agents|mesh-ancestor
139271656|NCT00052520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271657|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
139271658|NCT05036434|Lenvatinib|lenvatinib|mesh-list
139271659|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139271660|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271661|NCT05036434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139271662|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271663|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139271664|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271665|NCT00051038|Entecavir|entecavir|mesh-list
139271666|NCT00051038|Antiviral Agents|antiviral agents|mesh-ancestor
139271667|NCT00051038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271668|NCT05035186|Amoxicillin|amoxicillin|mesh-list
139271669|NCT05035186|Clarithromycin|clarithromycin|mesh-list
139271670|NCT05035186|Levofloxacin|levofloxacin|mesh-list
139271671|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139271672|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271673|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139271674|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271675|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271676|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139271677|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139271678|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139271679|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139271680|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139271681|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271682|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139271683|NCT01067469|Bevacizumab|bevacizumab|mesh-list
139271684|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139271685|NCT01067469|Lomustine|lomustine|mesh-list
139271686|NCT01067469|Antibodies|antibodies|mesh-list
139271687|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
139271688|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139271689|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271690|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139271691|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139271692|NCT01067469|Growth Substances|growth substances|mesh-ancestor
139271693|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271694|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
139271695|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
139271696|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139271697|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
139271698|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271699|NCT00050102|Ipilimumab|ipilimumab|mesh-list
139271700|NCT00050102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139271701|NCT00050102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271702|NCT00050102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139271703|NCT00050102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271704|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139271705|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
139271706|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
139271707|NCT02103660|Progestins|progestins|mesh-list
139271708|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139271709|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271710|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139271711|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139271712|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139271713|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139271714|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139271715|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139271716|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139271717|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271718|NCT02103660|Hormones|hormones|mesh-ancestor
139271719|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139271720|NCT00358982|Mocetinostat|mocetinostat|mesh-list
139271721|NCT00358982|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139271722|NCT00358982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271723|NCT00358982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271724|NCT02101164|Denosumab|denosumab|mesh-list
139271725|NCT02101164|Pamidronate|pamidronate|mesh-list
139271726|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139271727|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271728|NCT00036608|Entecavir|entecavir|mesh-list
139271729|NCT00036608|Antiviral Agents|antiviral agents|mesh-ancestor
139271730|NCT00036608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271731|NCT02103738|Ranibizumab|ranibizumab|mesh-list
139271732|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139271733|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139271734|NCT02103738|Growth Substances|growth substances|mesh-ancestor
139271735|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271736|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
139271737|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271738|NCT02985021|Carboplatin|carboplatin|mesh-list
139271739|NCT02985021|Docetaxel|docetaxel|mesh-list
139271740|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271741|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
139271742|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
139271743|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
139271744|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271745|NCT05714540|Magnesium Sulfate|magnesium sulfate|mesh-list
139271746|NCT05714540|Ketamine|ketamine|mesh-list
139271747|NCT05714540|Analgesics|analgesics|mesh-ancestor
139271748|NCT05714540|Sensory System Agents|sensory system agents|mesh-ancestor
139271749|NCT05714540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271750|NCT05714540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271751|NCT05714540|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139271752|NCT05714540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139271753|NCT05714540|Anesthetics, General|anesthetics, general|mesh-ancestor
139271754|NCT05714540|Anesthetics|anesthetics|mesh-ancestor
139271755|NCT05714540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139271756|NCT05714540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139271757|NCT05714540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139271758|NCT05714540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139271759|NCT05714540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271760|NCT05714540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139271761|NCT05714540|Anticonvulsants|anticonvulsants|mesh-ancestor
139271762|NCT05714540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139271763|NCT05714540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139271764|NCT05714540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139271765|NCT05714540|Tocolytic Agents|tocolytic agents|mesh-ancestor
139271766|NCT05714540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139271767|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
139271768|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139271769|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
139271770|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138855176|NCT01126190|Doxorubicin|doxorubicin|mesh-list
139271771|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271772|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139271773|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139271774|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139271775|NCT04441424|Azithromycin|azithromycin|mesh-list
139271776|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
139271777|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139271778|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271779|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
139271780|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139271781|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139271782|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271783|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271784|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271785|NCT03530228|Esomeprazole|esomeprazole|mesh-list
139271786|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139271787|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139271788|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139271789|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271790|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271791|NCT01066923|Aspirin|aspirin|mesh-list
139271792|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139271793|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139271794|NCT01066923|Analgesics|analgesics|mesh-ancestor
139271795|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
139271796|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271797|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271798|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271799|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271800|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139271801|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139271802|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271803|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139271804|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139271805|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271806|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
139271807|NCT03530150|Pirfenidone|pirfenidone|mesh-list
139271808|NCT03530150|Analgesics|analgesics|mesh-ancestor
139271809|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
139271810|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271811|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271812|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139271813|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139271814|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271815|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271816|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271817|NCT02098590|Chloroquine|chloroquine|mesh-list
139271818|NCT02098590|Atovaquone|atovaquone|mesh-list
139271819|NCT02098590|Proguanil|proguanil|mesh-list
139271820|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
139271821|NCT02098590|Amebicides|amebicides|mesh-ancestor
139271822|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139271823|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139271824|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271825|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
139271826|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271827|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271828|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271829|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
139271830|NCT03657381|Antibodies|antibodies|mesh-list
139271831|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139271832|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
139271833|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271834|NCT00005918|Lamivudine|lamivudine|mesh-list
139271835|NCT00005918|Efavirenz|efavirenz|mesh-list
139271836|NCT00005918|Stavudine|stavudine|mesh-list
139271837|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139271838|NCT00005918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139271839|NCT00005918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271840|NCT00005918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271841|NCT00005918|Antiviral Agents|antiviral agents|mesh-ancestor
139271842|NCT00005918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271843|NCT00005918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139271844|NCT00005918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139271845|NCT00005918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139271846|NCT00005918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139271847|NCT00005918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139271848|NCT00005918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139271849|NCT00005918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139271850|NCT00005918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139271851|NCT00005918|Antimetabolites|antimetabolites|mesh-ancestor
139271852|NCT02656797|Amphotericin B|amphotericin b|mesh-list
139271853|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139271854|NCT02656797|Amebicides|amebicides|mesh-ancestor
139271855|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139271856|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139271857|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139271858|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139271859|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
139271860|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
139271861|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139271862|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139271863|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139271864|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139271865|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271866|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
139271867|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139271868|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271869|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139271870|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271871|NCT02101476|Acetaminophen|acetaminophen|mesh-list
139271872|NCT02101476|Oxycodone|oxycodone|mesh-list
139271873|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139271874|NCT02101476|Analgesics|analgesics|mesh-ancestor
139271875|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
139271876|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271877|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271878|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
139271879|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139271880|NCT02101476|Narcotics|narcotics|mesh-ancestor
139271881|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139271882|NCT02104128|Bupropion|bupropion|mesh-list
139271883|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139271884|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
139271885|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139271886|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139271887|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139271888|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139271889|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271890|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
139271891|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139271892|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271893|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139271894|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139271895|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271896|NCT00004916|Paclitaxel|paclitaxel|mesh-list
139271897|NCT00004916|Ifosfamide|ifosfamide|mesh-list
139271898|NCT00004916|Teniposide|teniposide|mesh-list
139271899|NCT00004916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139271900|NCT00004916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271901|NCT00004916|Tubulin Modulators|tubulin modulators|mesh-ancestor
139271902|NCT00004916|Antimitotic Agents|antimitotic agents|mesh-ancestor
139271903|NCT00004916|Mitosis Modulators|mitosis modulators|mesh-ancestor
139271904|NCT00004916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271905|NCT00004916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139271906|NCT00004916|Alkylating Agents|alkylating agents|mesh-ancestor
139271907|NCT00004916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139271908|NCT00004916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139271909|NCT00004916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271910|NCT02101632|Petrolatum|petrolatum|mesh-list
139271911|NCT02101632|Emollients|emollients|mesh-ancestor
139271912|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
139271913|NCT02101710|Isosorbide|isosorbide|mesh-list
139271914|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139271915|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139271916|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139271917|NCT02101710|Diuretics|diuretics|mesh-ancestor
139271918|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
139271919|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271920|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
139271921|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139271922|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271923|NCT03878368|Sulforaphane|sulforaphane|mesh-list
139271924|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139271925|NCT03878368|Protective Agents|protective agents|mesh-ancestor
139271926|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271927|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271928|NCT02910063|Blinatumomab|blinatumomab|mesh-list
139271929|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271930|NCT04441762|Ketorolac|ketorolac|mesh-list
139271931|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139271932|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139271933|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139271934|NCT04441762|Analgesics|analgesics|mesh-ancestor
139271935|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
139271936|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271937|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271938|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271939|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271940|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139271941|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139271942|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271943|NCT02104284|Mannitol|mannitol|mesh-list
139271944|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
139271945|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139271946|NCT02104284|Diuretics|diuretics|mesh-ancestor
139271947|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
139271948|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271949|NCT02104284|Miotics|miotics|mesh-ancestor
139271950|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
139271951|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271952|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139271953|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139271954|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
139271955|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139271956|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139271957|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
139271958|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139271959|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271960|NCT00337532|Paclitaxel|paclitaxel|mesh-list
139271961|NCT00337532|Cisplatin|cisplatin|mesh-list
139271962|NCT00337532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139271963|NCT00337532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271964|NCT00337532|Tubulin Modulators|tubulin modulators|mesh-ancestor
139271965|NCT00337532|Antimitotic Agents|antimitotic agents|mesh-ancestor
139271966|NCT00337532|Mitosis Modulators|mitosis modulators|mesh-ancestor
139271967|NCT00337532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271968|NCT02625441|Trastuzumab|trastuzumab|mesh-list
139271969|NCT02625441|Pertuzumab|pertuzumab|mesh-list
139271970|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139271971|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271972|NCT04209868|Bupivacaine|bupivacaine|mesh-list
139271973|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
139271974|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
139271975|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
139271976|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139271977|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271978|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
139271979|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271980|NCT02361801|Dobutamine|dobutamine|mesh-list
139271981|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139271982|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
139271983|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
139271984|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139271985|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271986|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139271987|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139271988|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139271989|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
139271990|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139271991|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271992|NCT02361801|Protective Agents|protective agents|mesh-ancestor
139271993|NCT03965728|Methotrexate|methotrexate|mesh-list
139271994|NCT03965728|Midazolam|midazolam|mesh-list
139271995|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139271996|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
139271997|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139271998|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271999|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139272001|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272002|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272003|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
139272004|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272005|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139272006|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139272007|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
139272008|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139272009|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139272010|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139272011|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139272012|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272013|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139272014|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139272015|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139272016|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139272017|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
139272018|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
139272019|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
139272020|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
139272021|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272022|NCT00337454|Dasatinib|dasatinib|mesh-list
139272023|NCT00337454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272024|NCT00337454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139272025|NCT00337454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272026|NCT00337454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272027|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
139272028|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139272029|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139272030|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272031|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
139272032|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272033|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272034|NCT00004898|Cyclophosphamide|cyclophosphamide|mesh-list
139272035|NCT00004898|Etoposide|etoposide|mesh-list
139272036|NCT00004898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139272037|NCT00004898|Immunologic Factors|immunologic factors|mesh-ancestor
139272038|NCT00004898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272039|NCT00004898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139272040|NCT00004898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139272041|NCT00004898|Alkylating Agents|alkylating agents|mesh-ancestor
139272042|NCT00004898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272043|NCT00004898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272044|NCT00004898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139272045|NCT00004898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139272046|NCT00004898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139272047|NCT00004898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139272048|NCT00004898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272049|NCT02106468|Prednisone|prednisone|mesh-list
139272050|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139272051|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
139272052|NCT02106468|Hormones|hormones|mesh-ancestor
139272053|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139272054|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272055|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139272056|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272057|NCT03956446|Doxycycline|doxycycline|mesh-list
139272058|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139272059|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272060|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
139272061|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139272062|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139272063|NCT00325364|Insulin|insulin|mesh-list
139272064|NCT00325364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139272065|NCT00325364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139272066|NCT00325364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272067|NCT02104674|Montelukast|montelukast|mesh-list
139272068|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139272069|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
139272070|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139272071|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
139272072|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139272073|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272074|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139272075|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139272076|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272078|NCT01903330|Bevacizumab|bevacizumab|mesh-list
139272079|NCT01903330|Sargramostim|sargramostim|mesh-list
139272080|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139272081|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
139272082|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272083|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139272084|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139272085|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
139272086|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272087|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272088|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139272089|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139272090|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139272091|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139272092|NCT01903330|Growth Substances|growth substances|mesh-ancestor
139272093|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
139272094|NCT02907177|Ponesimod|ponesimod|mesh-list
139272095|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139272096|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272097|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139272098|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
139272099|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272100|NCT00004172|Cyclophosphamide|cyclophosphamide|mesh-list
139272101|NCT00004172|Ifosfamide|ifosfamide|mesh-list
139272102|NCT00004172|Thiotepa|thiotepa|mesh-list
139272103|NCT00004172|Carboplatin|carboplatin|mesh-list
139272104|NCT00004172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139272105|NCT00004172|Immunologic Factors|immunologic factors|mesh-ancestor
139272106|NCT00004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272107|NCT00004172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139272108|NCT00004172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139272109|NCT00004172|Alkylating Agents|alkylating agents|mesh-ancestor
139272110|NCT00004172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272111|NCT00004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272112|NCT00004172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139272113|NCT04353310|Curcumin|curcumin|mesh-list
139272114|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139272115|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139272116|NCT04353310|Analgesics|analgesics|mesh-ancestor
139272117|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
139272118|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272119|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272120|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139272121|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139272122|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272123|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272124|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272125|NCT00004166|Amifostine|amifostine|mesh-list
139272126|NCT00004166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139272127|NCT00004166|Protective Agents|protective agents|mesh-ancestor
139272128|NCT00004166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272129|NCT00004106|Temozolomide|temozolomide|mesh-list
139272130|NCT00004106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139272131|NCT00004106|Alkylating Agents|alkylating agents|mesh-ancestor
139272132|NCT00004106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272133|NCT00004106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272134|NCT00002246|Stavudine|stavudine|mesh-list
139272135|NCT00002246|Antimetabolites|antimetabolites|mesh-ancestor
139272136|NCT00002246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272137|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139272138|NCT00002246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139272139|NCT00002246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272140|NCT00002246|Antiviral Agents|antiviral agents|mesh-ancestor
139272141|NCT00002246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272142|NCT00002246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139272143|NCT00002246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139272144|NCT00002240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139272145|NCT00002240|Nelfinavir|nelfinavir|mesh-list
139272146|NCT00002240|Didanosine|didanosine|mesh-list
139272147|NCT00002240|Stavudine|stavudine|mesh-list
139272149|NCT00002240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139272150|NCT00002240|Protease Inhibitors|protease inhibitors|mesh-ancestor
139272151|NCT00002240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272152|NCT00002240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272153|NCT00002240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139272154|NCT00002240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139272155|NCT00002240|Antiviral Agents|antiviral agents|mesh-ancestor
139272156|NCT00002240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272157|NCT00002240|Antimetabolites|antimetabolites|mesh-ancestor
139272158|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139272159|NCT00002240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139272160|NCT02250924|Caffeine|caffeine|mesh-list
139272161|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139272162|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272163|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139272164|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272165|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272166|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139272167|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139272168|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
139272169|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272170|NCT03645148|Molgramostim|molgramostim|mesh-list
139272171|NCT03645148|Sargramostim|sargramostim|mesh-list
139272172|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
139272173|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272174|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272175|NCT04082728|Dipyrone|dipyrone|mesh-list
139272176|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139272177|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139272178|NCT04082728|Analgesics|analgesics|mesh-ancestor
139272179|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
139272180|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272181|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272182|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139272183|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139272184|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
139272185|NCT02906709|Insulin|insulin|mesh-list
139272186|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139272187|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272188|NCT00321308|Pemetrexed|pemetrexed|mesh-list
139272189|NCT00321308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272190|NCT00321308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272191|NCT00321308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272192|NCT00321308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139272193|NCT00321308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139272194|NCT02110134|Hydroquinone|hydroquinone|mesh-list
139272195|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
139272196|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272197|NCT02110134|Protective Agents|protective agents|mesh-ancestor
139272198|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272199|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139272200|NCT00318656|Metformin|metformin|mesh-list
139272201|NCT00318656|Glimepiride|glimepiride|mesh-list
139272202|NCT00318656|Rosiglitazone|rosiglitazone|mesh-list
139272203|NCT00318656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139272204|NCT00318656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272205|NCT00318656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139272206|NCT00318656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139272207|NCT00318656|Immunologic Factors|immunologic factors|mesh-ancestor
139272208|NCT02110524|Paclitaxel|paclitaxel|mesh-list
139272209|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139272210|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272211|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
139272212|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
139272213|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
139272214|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272215|NCT00317486|Bosentan|bosentan|mesh-list
139272216|NCT00317486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139272217|NCT00317486|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139272218|NCT00317486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272219|NCT02107170|Remifentanil|remifentanil|mesh-list
139272220|NCT02107170|Propofol|propofol|mesh-list
139272221|NCT02107170|Sevoflurane|sevoflurane|mesh-list
139272222|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139272223|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272224|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272225|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139272226|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
139272227|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
139272228|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139272229|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139272230|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139272231|NCT02107170|Narcotics|narcotics|mesh-ancestor
139272232|NCT02107170|Analgesics|analgesics|mesh-ancestor
139272233|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
139272234|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272235|NCT00313196|Bosentan|bosentan|mesh-list
139272236|NCT00313196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139272237|NCT00313196|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139272238|NCT00313196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272240|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139272241|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272242|NCT03656679|Trace Elements|trace elements|mesh-ancestor
139272243|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
139272244|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272245|NCT03663166|Nivolumab|nivolumab|mesh-list
139272246|NCT03663166|Ipilimumab|ipilimumab|mesh-list
139272247|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139272248|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272249|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139272250|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272251|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
139272252|NCT03554304|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
139272253|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139272254|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139272255|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272256|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139272257|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139272258|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272259|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272260|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272261|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139272262|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
139272263|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139272264|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272265|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139272266|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139272267|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139272268|NCT02107716|Lidocaine|lidocaine|mesh-list
139272269|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
139272270|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
139272271|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272272|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272273|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
139272274|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272275|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139272276|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139272277|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139272278|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139272279|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272280|NCT02110992|Docetaxel|docetaxel|mesh-list
139272281|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272282|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
139272283|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
139272284|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
139272285|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272286|NCT03306394|Trifluridine|trifluridine|mesh-list
139272287|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
139272288|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272289|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
139272290|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272291|NCT00311090|Idraparinux|idraparinux|mesh-list
139272292|NCT00311090|Idrabiotaparinux|idrabiotaparinux|mesh-list
139272293|NCT00311090|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139272294|NCT00311090|Antithrombins|antithrombins|mesh-ancestor
139272295|NCT00311090|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139272296|NCT00311090|Protease Inhibitors|protease inhibitors|mesh-ancestor
139272297|NCT00311090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272298|NCT00311090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272299|NCT00311090|Anticoagulants|anticoagulants|mesh-ancestor
139272300|NCT02105610|Anesthetics|anesthetics|mesh-list
139272301|NCT02105610|Sevoflurane|sevoflurane|mesh-list
139272302|NCT02105610|Desflurane|desflurane|mesh-list
139272303|NCT02105610|Isoflurane|isoflurane|mesh-list
139272304|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
139272305|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272306|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272307|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139272308|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139272309|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
139272310|NCT00301262|Sildenafil Citrate|sildenafil citrate|mesh-list
139272311|NCT00301262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272312|NCT00301262|Vasodilator Agents|vasodilator agents|mesh-ancestor
139272313|NCT00301262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139272314|NCT00301262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139272315|NCT00301262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272316|NCT00301262|Urological Agents|urological agents|mesh-ancestor
139272317|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139272318|NCT02254941|Antibodies|antibodies|mesh-list
139272319|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
139272320|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139272322|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272323|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272324|NCT03077620|Suvorexant|suvorexant|mesh-list
139272325|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139272326|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139272327|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272328|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272329|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139272330|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272331|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272332|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
139272333|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139272334|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139272335|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272336|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
139272337|NCT03656445|Coagulants|coagulants|mesh-ancestor
139272338|NCT01903486|Prednisone|prednisone|mesh-list
139272339|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139272340|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
139272341|NCT01903486|Hormones|hormones|mesh-ancestor
139272342|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139272343|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272344|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139272345|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272346|NCT03656289|Etonogestrel|etonogestrel|mesh-list
139272347|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139272348|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
139272349|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139272350|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272351|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139272352|NCT00599170|Rituximab|rituximab|mesh-list
139272353|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139272354|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272355|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
139272356|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272357|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139272358|NCT04256434|Nalbuphine|nalbuphine|mesh-list
139272359|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139272360|NCT04256434|Narcotics|narcotics|mesh-ancestor
139272361|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272362|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272363|NCT04256434|Analgesics|analgesics|mesh-ancestor
139272364|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
139272365|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272366|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
139272367|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139272368|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
139272369|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139272370|NCT02107950|Carboplatin|carboplatin|mesh-list
139272371|NCT02107950|Gemcitabine|gemcitabine|mesh-list
139272372|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272373|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139272374|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
139272375|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272377|NCT02108106|Enzyme Activators|enzyme activators|mesh-ancestor
139272378|NCT02108106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272379|NCT02113800|Everolimus|everolimus|mesh-list
139272380|NCT02113800|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139272381|NCT02113800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139272382|NCT02113800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272383|NCT02113800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272384|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139272385|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
139272386|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272387|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272388|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139272389|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
139272390|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139272391|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139272392|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139272393|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272394|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272395|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139272397|NCT02112006|Bupivacaine|bupivacaine|mesh-list
139272398|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
139272399|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
139272400|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272401|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272402|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
139272403|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272404|NCT02251158|Ritonavir|ritonavir|mesh-list
139272405|NCT02251158|Tipranavir|tipranavir|mesh-list
139272406|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139272407|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139272408|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139272409|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
139272410|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272411|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272412|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139272413|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139272414|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
139272415|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272416|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139272417|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139272418|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
139272419|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139272420|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
139272421|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272422|NCT05404516|Cytarabine|cytarabine|mesh-list
139272423|NCT05404516|Sorafenib|sorafenib|mesh-list
139272424|NCT05404516|Idarubicin|idarubicin|mesh-list
139272425|NCT05404516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139272426|NCT05404516|Antimetabolites|antimetabolites|mesh-ancestor
139272427|NCT05404516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272428|NCT05404516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272429|NCT05404516|Antiviral Agents|antiviral agents|mesh-ancestor
139272430|NCT05404516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272431|NCT05404516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139272432|NCT05404516|Immunologic Factors|immunologic factors|mesh-ancestor
139272433|NCT05404516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272434|NCT05404516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139272435|NCT05404516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272436|NCT05404516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139272437|NCT05404516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139272438|NCT05404516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139272439|NCT02114346|Atorvastatin|atorvastatin|mesh-list
139272440|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139272441|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139272442|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
139272443|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272444|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139272445|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139272446|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272447|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
139272448|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139272449|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139272450|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272451|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
139272452|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
139272453|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272455|NCT02108808|Ticagrelor|ticagrelor|mesh-list
139272456|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139272457|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139272458|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139272459|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139272460|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139272461|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
139272462|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272463|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272464|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272465|NCT02108886|Montelukast|montelukast|mesh-list
139272466|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139272467|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
139272468|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139272469|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
139272470|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139272471|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272472|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139272473|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139272474|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272475|NCT02114502|Pyridoxine|pyridoxine|mesh-list
139272476|NCT02114502|Dexamethasone|dexamethasone|mesh-list
139272477|NCT02114502|Gemcitabine|gemcitabine|mesh-list
139272478|NCT02114502|Melphalan|melphalan|mesh-list
139272479|NCT02114502|Busulfan|busulfan|mesh-list
139272480|NCT02114502|Vorinostat|vorinostat|mesh-list
139272481|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139272482|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
139272483|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
139272484|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272485|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272486|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139272487|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
139272488|NCT02114502|Hormones|hormones|mesh-ancestor
139272489|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139272490|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139272491|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272492|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139272493|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
139272494|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272495|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139272496|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
139272497|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139272498|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139272499|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
139272500|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139272501|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272502|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
139272503|NCT02114502|Vitamins|vitamins|mesh-ancestor
139272504|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
139272505|NCT03654027|Docetaxel|docetaxel|mesh-list
139272506|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272507|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
139272508|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
139272509|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
139272510|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272511|NCT02114658|Sorafenib|sorafenib|mesh-list
139272512|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272513|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139272514|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272515|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272516|NCT05126602|Vitamin D|vitamin d|mesh-list
139272517|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
139272518|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
139272519|NCT05126602|Vitamins|vitamins|mesh-list
139272520|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
139272521|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272522|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138856015|NCT05681273|Valsartan|valsartan|mesh-list
139272523|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139272524|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
139272525|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139272526|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139272527|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139272528|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272529|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
139272530|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272531|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272532|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139272533|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272534|NCT02112552|Paclitaxel|paclitaxel|mesh-list
139272535|NCT02112552|Carboplatin|carboplatin|mesh-list
139272536|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139272537|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272538|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
139272539|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
139272540|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
139272541|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272542|NCT02109354|Vaccines|vaccines|mesh-list
139272543|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
139272544|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272545|NCT02109510|Lidocaine|lidocaine|mesh-list
139272546|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
139272547|NCT02109510|Ketamine|ketamine|mesh-list
139272548|NCT02109510|Anesthetics|anesthetics|mesh-list
139272549|NCT02109510|Propofol|propofol|mesh-list
139272550|NCT02109510|Sevoflurane|sevoflurane|mesh-list
139272551|NCT02109510|Rocuronium|rocuronium|mesh-list
139272552|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
139272553|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272554|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272555|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
139272556|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272557|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139272558|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139272559|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139272560|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139272561|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272562|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139272563|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139272564|NCT02109510|Analgesics|analgesics|mesh-ancestor
139272565|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139272566|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139272567|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139272568|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
139272569|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272570|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139272571|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
139272572|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139272573|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139272574|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139272575|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139272576|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139272577|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139272578|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139272579|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139272580|NCT02109666|Abatacept|abatacept|mesh-list
139272581|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139272582|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272583|NCT02109666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139272584|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272585|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139272586|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
139272587|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272588|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139272589|NCT02865928|Bupivacaine|bupivacaine|mesh-list
139272590|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
139272591|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
139272592|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272593|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272594|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
139272595|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272596|NCT02109900|Progesterone|progesterone|mesh-list
139272597|NCT02109900|Progestins|progestins|mesh-ancestor
139272598|NCT02109900|Hormones|hormones|mesh-ancestor
139272599|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139272600|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272601|NCT02112630|Interferons|interferons|mesh-list
139272602|NCT02112630|Ribavirin|ribavirin|mesh-list
139272603|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
139272604|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
139272605|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139272606|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139272607|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139272608|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272609|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
139272610|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272611|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
139272612|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272613|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
139272614|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272615|NCT04873375|Cemiplimab|cemiplimab|mesh-list
139272616|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139272617|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272618|NCT05125588|Meloxicam|meloxicam|mesh-list
139272619|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139272620|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139272622|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
139272623|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272624|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272625|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139272626|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139272627|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139272628|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139272629|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272630|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272631|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
139272632|NCT02115204|Docetaxel|docetaxel|mesh-list
139272633|NCT02115204|Fluorouracil|fluorouracil|mesh-list
139272634|NCT02115204|Methotrexate|methotrexate|mesh-list
139272635|NCT02115204|Epirubicin|epirubicin|mesh-list
139272636|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139272637|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
139272638|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272639|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139272640|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139272641|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
139272642|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272643|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272644|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139272645|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
139272646|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
139272647|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
139272648|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
139272649|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139272650|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139272651|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
139272652|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139272653|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
139272654|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272655|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139272656|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139272657|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139272658|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139272659|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139272660|NCT02115360|Calcitonin|calcitonin|mesh-list
139272661|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
139272662|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139272663|NCT02115360|Fentanyl|fentanyl|mesh-list
139272664|NCT02115360|Katacalcin|katacalcin|mesh-list
139272665|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139272666|NCT02115360|Narcotics|narcotics|mesh-ancestor
139272667|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272668|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272669|NCT02115360|Analgesics|analgesics|mesh-ancestor
139272670|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
139272671|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272672|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139272673|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139272674|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
139272675|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
139272676|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139272677|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139272678|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
139272679|NCT02432404|NuvaRing|nuvaring|mesh-list
139272680|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139272681|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
139272682|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139272683|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272684|NCT02113176|Minocycline|minocycline|mesh-list
139272685|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139272686|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272687|NCT02118870|Aspirin|aspirin|mesh-list
139272688|NCT02118870|Clopidogrel|clopidogrel|mesh-list
139272689|NCT02118870|Ticagrelor|ticagrelor|mesh-list
139272690|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139272691|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139272692|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139272693|NCT02118870|Analgesics|analgesics|mesh-ancestor
139272694|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
139272695|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272696|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272697|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139272698|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139272699|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139272700|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139272701|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272702|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139272703|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139272704|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272705|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
139272706|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139272707|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139272708|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139272709|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
139272710|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272711|NCT03552666|Vitamin D|vitamin d|mesh-list
139272712|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
139272713|NCT03552666|Vitamins|vitamins|mesh-ancestor
139272714|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
139272715|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272716|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139272717|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139272718|NCT02115594|Fulvestrant|fulvestrant|mesh-list
139272719|NCT02115594|Entinostat|entinostat|mesh-list
139272720|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139272721|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272722|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139272723|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139272724|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
139272725|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139272726|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272727|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139272728|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272729|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272730|NCT05125042|Amiodarone|amiodarone|mesh-list
139272731|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139272732|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
139272733|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139272734|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139272735|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272736|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139272737|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139272738|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139272739|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272740|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139272741|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139272742|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139272743|NCT02113332|Liraglutide|liraglutide|mesh-list
139272744|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139272745|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272746|NCT02113332|Incretins|incretins|mesh-ancestor
139272747|NCT02113332|Hormones|hormones|mesh-ancestor
139272748|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139272749|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139272750|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139272751|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
139272752|NCT02918877|Propofol|propofol|mesh-list
139272753|NCT02918877|Sevoflurane|sevoflurane|mesh-list
139272754|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139272755|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272756|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272757|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139272758|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
139272759|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
139272760|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139272761|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139272762|NCT03652857|Apatinib|apatinib|mesh-list
139272763|NCT03652857|Vinorelbine|vinorelbine|mesh-list
139272764|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272765|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139272766|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272767|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272768|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139272769|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
139272770|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
139272771|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
139272772|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
139272773|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139272774|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272775|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139272776|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
139272777|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139272778|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272779|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272780|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272781|NCT02113566|Acetaminophen|acetaminophen|mesh-list
139272782|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139272783|NCT02113566|Analgesics|analgesics|mesh-ancestor
139272784|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
139272785|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272786|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272787|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
139272788|NCT05124730|Metformin|metformin|mesh-list
139272789|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139272790|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272791|NCT02251626|Ubiquinone|ubiquinone|mesh-list
139272792|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
139272793|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
139272794|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272795|NCT02251626|Vitamins|vitamins|mesh-ancestor
139272796|NCT02123004|Clopidogrel|clopidogrel|mesh-list
139272797|NCT02123004|Ticagrelor|ticagrelor|mesh-list
139272798|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139272799|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139272800|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139272801|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139272802|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
139272803|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272804|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272805|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272806|NCT01674712|Simvastatin|simvastatin|mesh-list
139272807|NCT01674712|Fenofibrate|fenofibrate|mesh-list
139272808|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139272809|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139272810|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
139272811|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272812|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139272813|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139272814|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272815|NCT01368432|Escitalopram|escitalopram|mesh-list
139272816|NCT01368432|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139272817|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139272818|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139272819|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272820|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272821|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
139272822|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272823|NCT05122780|Acetylcholine|acetylcholine|mesh-list
139272824|NCT05122780|Anticoagulants|anticoagulants|mesh-list
139272825|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139272826|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139272827|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139272828|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
139272829|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272830|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272831|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272832|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
139272833|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139272834|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
139272835|NCT02119806|Midazolam|midazolam|mesh-list
139272836|NCT02119806|Fentanyl|fentanyl|mesh-list
139272837|NCT02119806|Propofol|propofol|mesh-list
139272838|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139272839|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272840|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272841|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139272842|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
139272843|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
139272844|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139272845|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139272846|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139272847|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139272848|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
139272849|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
139272850|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272851|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272852|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139272853|NCT02119806|Narcotics|narcotics|mesh-ancestor
139272854|NCT02119806|Analgesics|analgesics|mesh-ancestor
139272855|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
139272856|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272857|NCT02119884|Octreotide|octreotide|mesh-list
139272858|NCT02119884|Terlipressin|terlipressin|mesh-list
139272859|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139272860|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139272861|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272862|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139272863|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139272864|NCT05104918|Vortioxetine|vortioxetine|mesh-list
139272865|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139272866|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139272867|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139272868|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139272869|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272870|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272871|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272872|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139272873|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
139272874|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139272875|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139272876|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139272877|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272878|NCT05104918|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139272879|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
139272880|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139272881|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139272882|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139272883|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139272884|NCT05089942|Insulin|insulin|mesh-list
139272885|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139272886|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139272887|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272888|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
139272889|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139272890|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272891|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272892|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139272893|NCT04941508|Analgesics|analgesics|mesh-ancestor
139272894|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
139272895|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138856315|NCT04052880|Hormones|hormones|mesh-ancestor
139272896|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139272897|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139272898|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139272899|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
139272900|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272901|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272902|NCT01062555|Cyclosporine|cyclosporine|mesh-list
139272903|NCT01062555|Sirolimus|sirolimus|mesh-list
139272904|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
139272905|NCT01062555|Tacrolimus|tacrolimus|mesh-list
139272906|NCT01062555|Cyclosporins|cyclosporins|mesh-list
139272907|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139272908|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
139272909|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272910|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139272911|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272912|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272913|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
139272914|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272915|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
139272916|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139272917|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139272919|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139272920|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
139272921|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139272922|NCT03622047|Sufentanil|sufentanil|mesh-list
139272923|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
139272924|NCT03622047|Ropivacaine|ropivacaine|mesh-list
139272925|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139272926|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272927|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272928|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139272929|NCT03622047|Analgesics|analgesics|mesh-ancestor
139272930|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
139272931|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272932|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139272933|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139272934|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139272935|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
139272936|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272937|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272938|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
139272939|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
139272940|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139272941|NCT03622047|Narcotics|narcotics|mesh-ancestor
139272942|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139272943|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139272944|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
139272945|NCT05073562|Folic Acid|folic acid|mesh-list
139272946|NCT05073562|Mebendazole|mebendazole|mesh-list
139272947|NCT05073562|Piperazine|piperazine|mesh-list
139272948|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
139272949|NCT05073562|DMP 777|dmp 777|mesh-list
139272950|NCT05073562|Hematinics|hematinics|mesh-ancestor
139272951|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
139272952|NCT05073562|Vitamins|vitamins|mesh-ancestor
139272953|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
139272954|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272955|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
139272956|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
139272957|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139272958|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139272959|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
139272960|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
139272961|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
139381779|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
139272962|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272963|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272964|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139272965|NCT01368276|Molgramostim|molgramostim|mesh-list
139272966|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139272967|NCT01368276|Sargramostim|sargramostim|mesh-list
139272968|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
139272969|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272970|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272971|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139272972|NCT02116842|Fentanyl|fentanyl|mesh-list
139272973|NCT02116842|Bupivacaine|bupivacaine|mesh-list
139272974|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
139272975|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
139272976|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139272977|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272978|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
139272979|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272980|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139272981|NCT02116842|Narcotics|narcotics|mesh-ancestor
139272982|NCT02116842|Analgesics|analgesics|mesh-ancestor
139272983|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139272984|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139272985|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
139272987|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139272988|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
139272989|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
139272990|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
139272991|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139272992|NCT04054089|Tenofovir|tenofovir|mesh-list
139272993|NCT04054089|Lamivudine|lamivudine|mesh-list
139272994|NCT04054089|Emtricitabine|emtricitabine|mesh-list
139272995|NCT04054089|Dolutegravir|dolutegravir|mesh-list
139272996|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
139272997|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143194|NCT02112292|Hormones|hormones|mesh-ancestor
139272998|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139272999|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139273000|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273001|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273002|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139273003|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139273004|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139273005|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139273006|NCT02120196|Rifaximin|rifaximin|mesh-list
139273007|NCT02120196|Norfloxacin|norfloxacin|mesh-list
139273008|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139273009|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273010|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139273011|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139273012|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139273013|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273014|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273015|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273016|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139273017|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139273018|NCT05001802|Ropivacaine|ropivacaine|mesh-list
139273019|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
139273020|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
139273021|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139273022|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273023|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
139273024|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139273025|NCT02120274|Vitamin D|vitamin d|mesh-list
139273026|NCT02120274|Vitamins|vitamins|mesh-list
139273027|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
139273028|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
139273029|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
139273030|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273031|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139273032|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
139273033|NCT02120274|Hematinics|hematinics|mesh-ancestor
139273034|NCT02402842|Docetaxel|docetaxel|mesh-list
139273035|NCT02402842|Fluorouracil|fluorouracil|mesh-list
139273036|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273037|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
139273038|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
139273039|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
139273040|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273041|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
139273042|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139273043|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139273044|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
139273045|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273046|NCT01061775|Exenatide|exenatide|mesh-list
139273047|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138856467|NCT03317457|Durvalumab|durvalumab|mesh-list
139273048|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273049|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139273050|NCT01061775|Incretins|incretins|mesh-ancestor
139273051|NCT01061775|Hormones|hormones|mesh-ancestor
139273052|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273054|NCT02123628|Doxycycline|doxycycline|mesh-list
139273055|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
139273056|NCT02123628|Levofloxacin|levofloxacin|mesh-list
139273057|NCT02123628|Rifampin|rifampin|mesh-list
139273058|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
139273059|NCT02123628|Linezolid|linezolid|mesh-list
139273060|NCT02123628|Cefepime|cefepime|mesh-list
139273061|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139273062|NCT02123628|Cefotaxime|cefotaxime|mesh-list
139273063|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
139273064|NCT02123628|Trimethoprim|trimethoprim|mesh-list
139273065|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
139273066|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273067|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139273068|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
139273069|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
139273070|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139273071|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139273072|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139273073|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139273074|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642310|NCT05586919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139273075|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273076|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273077|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139273078|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139273079|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139273080|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
139273081|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139273082|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139273083|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139273084|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139273085|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139273086|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139273087|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139273088|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139273089|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139273090|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139273091|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139273092|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
139273093|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
139273094|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
139273095|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139273096|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139273097|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273098|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273099|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273100|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
139273101|NCT03652467|Deferoxamine|deferoxamine|mesh-list
139273102|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139273103|NCT03652467|Estrogens|estrogens|mesh-ancestor
139273104|NCT03652467|Hormones|hormones|mesh-ancestor
139207495|NCT05826015|Paclitaxel|paclitaxel|mesh-list
139273105|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273106|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273107|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139273108|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273109|NCT03652467|Siderophores|siderophores|mesh-ancestor
139273110|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139273111|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
139273112|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
139273113|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273114|NCT03528824|Diclofenac|diclofenac|mesh-list
139273115|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139273116|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139273117|NCT03528824|Analgesics|analgesics|mesh-ancestor
139273118|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
139273119|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139273120|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273121|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139273122|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139273123|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139273124|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273125|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273126|NCT00289640|Ipilimumab|ipilimumab|mesh-list
139273127|NCT00289640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139273128|NCT00289640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273129|NCT00289640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139273130|NCT00289640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273131|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
139273132|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
139273133|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139273134|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273135|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273136|NCT03552432|Alirocumab|alirocumab|mesh-list
139273137|NCT03552432|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139273138|NCT03552432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139273139|NCT03552432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139273140|NCT03552432|Antimetabolites|antimetabolites|mesh-ancestor
139273141|NCT03552432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273142|NCT03552432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139273143|NCT03552432|Protease Inhibitors|protease inhibitors|mesh-ancestor
139273144|NCT03552432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273145|NCT03552432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139273146|NCT03765632|Busulfan|busulfan|mesh-list
139273147|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
139273148|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273149|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139273150|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
139273151|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273152|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139273153|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273154|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139273155|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
139273156|NCT02973477|Glimepiride|glimepiride|mesh-list
139273157|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139273158|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273159|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139273160|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273161|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139273162|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139273163|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
139273164|NCT03552354|Argatroban|argatroban|mesh-list
139273165|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
139273166|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139273167|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
139273168|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273169|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273170|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
139273171|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139273172|NCT02288000|Memantine|memantine|mesh-list
139273173|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139273174|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139273175|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
139273176|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273177|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273178|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273179|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139273180|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139273181|NCT02788656|Valsartan|valsartan|mesh-list
139273182|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
139273183|NCT02788656|Giapreza|giapreza|mesh-list
139273184|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
139273185|NCT02788656|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139273186|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139273187|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139273188|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
139273189|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139273190|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139273191|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273192|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
139273193|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139273194|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139273195|NCT05258110|Midazolam|midazolam|mesh-list
139273196|NCT05258110|BI 425809|bi 425809|mesh-list
139273197|NCT05258110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139273198|NCT05258110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139273199|NCT05258110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139273200|NCT05258110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273201|NCT05258110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139273202|NCT05258110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139273203|NCT05258110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139273204|NCT05258110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139273205|NCT05258110|Anesthetics, General|anesthetics, general|mesh-ancestor
139273206|NCT05258110|Anesthetics|anesthetics|mesh-ancestor
139273207|NCT05258110|GABA Modulators|gaba modulators|mesh-ancestor
139273208|NCT05258110|GABA Agents|gaba agents|mesh-ancestor
139273209|NCT05258110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273210|NCT05258110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273211|NCT05258110|Nootropic Agents|nootropic agents|mesh-ancestor
139273212|NCT03652233|Nivolumab|nivolumab|mesh-list
139273213|NCT03652233|Afatinib|afatinib|mesh-list
139273214|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139273215|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273216|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139273217|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273218|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139273219|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273220|NCT02117466|Cetuximab|cetuximab|mesh-list
139273221|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139273222|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273223|NCT02117622|Insulin|insulin|mesh-list
139273224|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139273225|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273226|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139273227|NCT04529902|Abatacept|abatacept|mesh-list
139273228|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139273229|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273230|NCT04529902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139273231|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273232|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139273233|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
139273234|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273235|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139273236|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139273237|NCT02288078|Dexamethasone|dexamethasone|mesh-list
139273238|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139273239|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139273240|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
139273241|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
139273242|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139273243|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273244|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139273245|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
139273246|NCT02288078|Hormones|hormones|mesh-ancestor
139273247|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273248|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139273249|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273250|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273251|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273252|NCT02288234|Telavancin|telavancin|mesh-list
139273253|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139273254|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273255|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139273256|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139273257|NCT04654312|Diuretics|diuretics|mesh-ancestor
139273258|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
139273259|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273260|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139273261|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139273262|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273263|NCT02973087|Factor VIII|factor viii|mesh-list
139273264|NCT02973087|Coagulants|coagulants|mesh-ancestor
139273265|NCT05284656|Folic Acid|folic acid|mesh-list
139273266|NCT05284656|Vitamin B Complex|vitamin b complex|mesh-list
139273267|NCT05284656|Pentoxifylline|pentoxifylline|mesh-list
139273268|NCT05284656|Hematinics|hematinics|mesh-ancestor
139273269|NCT05284656|Vitamins|vitamins|mesh-ancestor
139273270|NCT05284656|Micronutrients|micronutrients|mesh-ancestor
139273271|NCT05284656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273272|NCT05284656|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138856693|NCT01164228|Gemcitabine|gemcitabine|mesh-list
139273273|NCT05284656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273274|NCT05284656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273275|NCT05284656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139273276|NCT05284656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139273277|NCT05284656|Protective Agents|protective agents|mesh-ancestor
139273278|NCT05284656|Vasodilator Agents|vasodilator agents|mesh-ancestor
139273279|NCT05284656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139273280|NCT05284656|Antioxidants|antioxidants|mesh-ancestor
139273281|NCT02124174|Azacitidine|azacitidine|mesh-list
139273282|NCT02124174|Valproic Acid|valproic acid|mesh-list
139273283|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139273284|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
139273285|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273286|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273287|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273288|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
139273289|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
139273290|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273291|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273292|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
139273293|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139273294|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139273295|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139273296|NCT03956368|Atorvastatin|atorvastatin|mesh-list
139273297|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139273298|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139273299|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
139273300|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273301|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139273302|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139273303|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273304|NCT02124330|Bentonite|bentonite|mesh-list
139273305|NCT02124330|Antidotes|antidotes|mesh-ancestor
139273306|NCT02124330|Protective Agents|protective agents|mesh-ancestor
139273307|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273308|NCT02118090|Chloroquine|chloroquine|mesh-list
139273309|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139273310|NCT02118090|Amebicides|amebicides|mesh-ancestor
139273311|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139273312|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139273313|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273314|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
139273315|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139273316|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139273317|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139273318|NCT02118090|Analgesics|analgesics|mesh-ancestor
139273319|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
139273320|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139273321|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273322|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139273323|NCT02118090|Filaricides|filaricides|mesh-ancestor
139273324|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
139273325|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
139273326|NCT03551808|Ketorolac|ketorolac|mesh-list
139273327|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139273328|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139273329|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139273330|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139273331|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139273332|NCT03551808|Analgesics|analgesics|mesh-ancestor
139273333|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
139273334|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139273335|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273336|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139273337|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139273338|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139273339|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273340|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273341|NCT04053543|CXA-10|cxa-10|mesh-list
139273342|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139273343|NCT04202458|Tenecteplase|tenecteplase|mesh-list
139273344|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139273345|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139273346|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273347|NCT00273650|Vitamin B 12|vitamin b 12|mesh-list
139273348|NCT00273650|Vitamins|vitamins|mesh-ancestor
139273349|NCT00273650|Micronutrients|micronutrients|mesh-ancestor
139273350|NCT00273650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273351|NCT00273650|Vitamin B Complex|vitamin b complex|mesh-ancestor
139273352|NCT02121288|Clopidogrel|clopidogrel|mesh-list
139273353|NCT02121288|Ticagrelor|ticagrelor|mesh-list
139273354|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139273355|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139273356|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139273357|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139273358|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
139273359|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273360|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273361|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273362|NCT01525329|Fluorouracil|fluorouracil|mesh-list
139273363|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
139273364|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273365|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139273366|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273367|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139273368|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
139273369|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273370|NCT02121366|Ethanol|ethanol|mesh-list
139273371|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139273372|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273373|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139273374|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273375|NCT02121444|Interferons|interferons|mesh-list
139273376|NCT02121444|Interferon-beta|interferon-beta|mesh-list
139273377|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
139273378|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273379|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
139273380|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273381|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
139273382|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273383|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139273384|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
139273385|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139273386|NCT04413526|Estrogens|estrogens|mesh-ancestor
139273387|NCT04413526|Hormones|hormones|mesh-ancestor
139273388|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273389|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273390|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139273391|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273392|NCT03665506|Trifluridine|trifluridine|mesh-list
139273393|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
139273394|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273395|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
139273396|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273397|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
139273398|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139273399|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
139273400|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273401|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
139273402|NCT03318874|Protective Agents|protective agents|mesh-ancestor
139273403|NCT03551652|Rocuronium|rocuronium|mesh-list
139273404|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139273405|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139273406|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139273407|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139273408|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273409|NCT00263042|Rimonabant|rimonabant|mesh-list
139273410|NCT00263042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139273411|NCT00263042|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
139273412|NCT00263042|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139273413|NCT00263042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273414|NCT00263042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273415|NCT00263042|Hormones|hormones|mesh-ancestor
139273416|NCT00263042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273417|NCT00263042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273418|NCT05002192|Eucalyptol|eucalyptol|mesh-list
139273419|NCT05002192|Ambroxol|ambroxol|mesh-list
139273420|NCT05002192|Expectorants|expectorants|mesh-list
139273421|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
139273422|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273423|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
139273424|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
139273425|NCT05002192|Protective Agents|protective agents|mesh-ancestor
139273426|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273428|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139273429|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139273430|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273431|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273432|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
139273433|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273434|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139273435|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139273436|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139273437|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139273438|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139273439|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139273440|NCT05724446|Prednisolone|prednisolone|mesh-list
139273441|NCT05724446|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139273442|NCT05724446|Methylprednisolone|methylprednisolone|mesh-list
139273443|NCT05724446|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139273444|NCT05724446|Prednisolone acetate|prednisolone acetate|mesh-list
139273445|NCT05724446|Clobetasol|clobetasol|mesh-list
139273446|NCT05724446|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139273447|NCT05724446|Prednisolone phosphate|prednisolone phosphate|mesh-list
139273448|NCT05724446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139273449|NCT05724446|Glucocorticoids|glucocorticoids|mesh-ancestor
139273450|NCT05724446|Hormones|hormones|mesh-ancestor
139273451|NCT05724446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273452|NCT05724446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273453|NCT05724446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139273454|NCT05724446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273455|NCT05724446|Antiemetics|antiemetics|mesh-ancestor
139273456|NCT05724446|Autonomic Agents|autonomic agents|mesh-ancestor
139273457|NCT05724446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139273458|NCT05724446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139273459|NCT05724446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139273460|NCT05724446|Protective Agents|protective agents|mesh-ancestor
139273461|NCT02124642|Folic Acid|folic acid|mesh-list
139273462|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
139273463|NCT02124642|Hematinics|hematinics|mesh-ancestor
139273464|NCT02124642|Vitamins|vitamins|mesh-ancestor
139273465|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
139273466|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273467|NCT03094234|Propranolol|propranolol|mesh-list
139273468|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139273469|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139273470|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
139273471|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273472|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273473|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273474|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139273475|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139273476|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
139273477|NCT00260156|Vildagliptin|vildagliptin|mesh-list
139273478|NCT00260156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139273479|NCT00260156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273480|NCT00260156|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139273481|NCT00260156|Protease Inhibitors|protease inhibitors|mesh-ancestor
139273482|NCT00260156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273483|NCT00260156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273484|NCT04367103|Phenylephrine|phenylephrine|mesh-list
139273485|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
139273486|NCT04367103|Norepinephrine|norepinephrine|mesh-list
139273487|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139273488|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
139273489|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
139273490|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139273491|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273492|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
139273493|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139273494|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
139273495|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
139273496|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139273497|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139273498|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138856920|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
139273499|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
139273500|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273501|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273502|NCT04367103|Protective Agents|protective agents|mesh-ancestor
139273503|NCT00260078|Ritonavir|ritonavir|mesh-list
139273504|NCT00260078|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139273505|NCT00260078|Darunavir|darunavir|mesh-list
139273506|NCT00260078|Tenofovir|tenofovir|mesh-list
139273507|NCT00260078|Nevirapine|nevirapine|mesh-list
139273508|NCT00260078|Efavirenz|efavirenz|mesh-list
139273509|NCT00260078|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139273510|NCT00260078|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139273511|NCT00260078|Protease Inhibitors|protease inhibitors|mesh-ancestor
139273512|NCT00260078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273513|NCT00260078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273514|NCT00260078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139273515|NCT00260078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139273516|NCT00260078|Antiviral Agents|antiviral agents|mesh-ancestor
139273517|NCT00260078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273518|NCT00260078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139273519|NCT00260078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139273520|NCT00260078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139273521|NCT00260078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139273522|NCT00260078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139273523|NCT00260078|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139273524|NCT00260078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139273525|NCT00260078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139273526|NCT00260078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139273527|NCT03034564|Droxidopa|droxidopa|mesh-list
139273528|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139273529|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139273530|NCT05342532|Amoxicillin|amoxicillin|mesh-list
139273531|NCT05342532|Clarithromycin|clarithromycin|mesh-list
139273532|NCT05342532|Omeprazole|omeprazole|mesh-list
139273533|NCT05342532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139273534|NCT05342532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273535|NCT05342532|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139273536|NCT05342532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139273537|NCT05342532|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139273538|NCT05342532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273539|NCT05342532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273540|NCT05342532|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139273541|NCT05342532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139273542|NCT05342532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139273543|NCT04469114|Tofacitinib|tofacitinib|mesh-list
139273544|NCT04469114|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139273545|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139273546|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273547|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273548|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
139273549|NCT02400567|Letrozole|letrozole|mesh-list
139273550|NCT02400567|Epirubicin|epirubicin|mesh-list
139273551|NCT02400567|Palbociclib|palbociclib|mesh-list
139273552|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139273553|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
139273554|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273555|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139273556|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139273557|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
139273558|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273559|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273560|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139273561|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139273562|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139273563|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273564|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139273565|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
139273566|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273567|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139273568|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139273569|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139273570|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139273571|NCT00228176|Rimonabant|rimonabant|mesh-list
139273572|NCT00228176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138857000|NCT00003283|Prednisone|prednisone|mesh-list
139273573|NCT00228176|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
139273574|NCT00228176|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139273575|NCT00228176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273576|NCT00228176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273578|NCT00228176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273579|NCT00228176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273580|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
139273581|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
139273582|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273583|NCT01308190|Capecitabine|capecitabine|mesh-list
139273584|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139273585|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
139273586|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273587|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273588|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
139273589|NCT01210768|Doxorubicin|doxorubicin|mesh-list
139273590|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139273591|NCT01210768|Epirubicin|epirubicin|mesh-list
139273592|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139273593|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
139273594|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273595|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139143794|NCT02118376|Hormones|hormones|mesh-ancestor
139273596|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139273597|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
139273598|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273599|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273600|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139273601|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139273602|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139273603|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139273604|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273605|NCT02971605|Psilocybin|psilocybin|mesh-list
139273606|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
139273607|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273608|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139273609|NCT04410874|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139273610|NCT04410874|Vaccines|vaccines|mesh-list
139273611|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
139273612|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273613|NCT04410874|Antiviral Agents|antiviral agents|mesh-ancestor
139273614|NCT04410874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273615|NCT02124954|Digoxin|digoxin|mesh-list
139273616|NCT02124954|Midazolam|midazolam|mesh-list
139273617|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139273618|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139273619|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139273620|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273621|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139273622|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139273623|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139273624|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139273625|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
139273626|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
139273627|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
139273628|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
139273629|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273630|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273631|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139273632|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139273633|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273634|NCT02124954|Protective Agents|protective agents|mesh-ancestor
139273635|NCT04441112|Triamcinolone|triamcinolone|mesh-list
139273636|NCT04441112|Ketorolac|ketorolac|mesh-list
139273637|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139273638|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
139273639|NCT04441112|Hormones|hormones|mesh-ancestor
139273640|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273641|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273642|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273643|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273644|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139273645|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139273646|NCT04441112|Analgesics|analgesics|mesh-ancestor
139273647|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
139273648|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139273649|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139273650|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139273651|NCT02121990|Paclitaxel|paclitaxel|mesh-list
139273652|NCT02121990|Bevacizumab|bevacizumab|mesh-list
139273653|NCT02121990|Olaparib|olaparib|mesh-list
139273654|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139273655|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273656|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
139273657|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
139273658|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
139273659|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273660|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139273661|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139273662|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139273663|NCT02121990|Growth Substances|growth substances|mesh-ancestor
139273664|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273665|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
139273666|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139273667|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273668|NCT05724056|Hyaluronic Acid|hyaluronic acid|mesh-list
139642311|NCT05586919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091718|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273669|NCT05724056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139273670|NCT05724056|Immunologic Factors|immunologic factors|mesh-ancestor
139273671|NCT05724056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273673|NCT05724056|Protective Agents|protective agents|mesh-ancestor
139273674|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
139273675|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
139273676|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
139273677|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273678|NCT01060059|Exenatide|exenatide|mesh-list
139273679|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139273680|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273681|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139273682|NCT01060059|Incretins|incretins|mesh-ancestor
139273683|NCT01060059|Hormones|hormones|mesh-ancestor
139273684|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273685|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
139273686|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
139273687|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139273688|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139273689|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273690|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289233|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139273691|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273692|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139273693|NCT04307797|Exenatide|exenatide|mesh-list
139273694|NCT04307797|Glucagon|glucagon|mesh-list
139273695|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139273696|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139273697|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273698|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139273699|NCT04307797|Incretins|incretins|mesh-ancestor
139273700|NCT04307797|Hormones|hormones|mesh-ancestor
139273701|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273702|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139273703|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139273704|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
139273705|NCT02125188|Coagulants|coagulants|mesh-ancestor
139273706|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139273707|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
139273708|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273709|NCT02125344|Paclitaxel|paclitaxel|mesh-list
139273710|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
139273711|NCT02125344|Carboplatin|carboplatin|mesh-list
139273712|NCT02125344|Doxorubicin|doxorubicin|mesh-list
139273713|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139273714|NCT02125344|Trastuzumab|trastuzumab|mesh-list
139273715|NCT02125344|Epirubicin|epirubicin|mesh-list
139273716|NCT02125344|Pertuzumab|pertuzumab|mesh-list
139273717|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139273718|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273719|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
139273720|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
139273721|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
139273722|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273723|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139273724|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
139273725|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273726|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139273727|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139273728|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
139273729|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139273730|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139273731|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139273732|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139273733|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273734|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139273736|NCT05468840|Analgesics|analgesics|mesh-ancestor
139273737|NCT05468840|Sensory System Agents|sensory system agents|mesh-ancestor
139273738|NCT05468840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139273739|NCT05468840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273740|NCT05468840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139273741|NCT05468840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139273742|NCT05468840|Anesthetics, General|anesthetics, general|mesh-ancestor
139273743|NCT05468840|Anesthetics|anesthetics|mesh-ancestor
139642312|NCT05586919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139273744|NCT05468840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139273745|NCT05468840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139273746|NCT05468840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139273747|NCT05468840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273748|NCT05468840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273750|NCT05723900|Cathartics|cathartics|mesh-ancestor
139273751|NCT05723900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139273752|NCT02127138|Sirolimus|sirolimus|mesh-list
139273753|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139273754|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273755|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139273756|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273757|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
139273758|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139273759|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
139273760|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273761|NCT03651531|Metformin|metformin|mesh-list
139273762|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139273763|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273764|NCT02903511|Metformin|metformin|mesh-list
139273765|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139273766|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273767|NCT05325528|Oxaliplatin|oxaliplatin|mesh-list
139273768|NCT05325528|Tislelizumab|tislelizumab|mesh-list
139273769|NCT05325528|Tegafur|tegafur|mesh-list
139273770|NCT05325528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273771|NCT05325528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139273772|NCT05325528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139273773|NCT05325528|Antimetabolites|antimetabolites|mesh-ancestor
139273774|NCT05325528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273775|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
139273776|NCT02125500|Ledipasvir|ledipasvir|mesh-list
139273777|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
139273778|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273779|NCT02125578|Interferons|interferons|mesh-list
139273780|NCT02125578|Interferon-beta|interferon-beta|mesh-list
139273781|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
139273782|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273783|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
139273784|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273785|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
139273786|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273787|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139273788|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139273789|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139273790|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139273791|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139273792|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139273793|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273794|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139273795|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139273796|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273797|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
139273798|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273799|NCT05606965|Vaccines|vaccines|mesh-list
139273800|NCT05606965|Immunologic Factors|immunologic factors|mesh-ancestor
139273801|NCT05606965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273802|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139273803|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139273804|NCT00141284|Lamivudine|lamivudine|mesh-list
139273805|NCT00141284|Zidovudine|zidovudine|mesh-list
139273806|NCT00141284|Nelfinavir|nelfinavir|mesh-list
139273807|NCT00141284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139273808|NCT00141284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139273809|NCT00141284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273810|NCT00141284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273811|NCT00141284|Antiviral Agents|antiviral agents|mesh-ancestor
139273812|NCT00141284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273813|NCT00141284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139273814|NCT00141284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139273815|NCT00141284|Antimetabolites|antimetabolites|mesh-ancestor
139273816|NCT00141284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139273817|NCT00141284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139273818|NCT00141284|Protease Inhibitors|protease inhibitors|mesh-ancestor
139273819|NCT04328506|Vorolanib|vorolanib|mesh-list
139273820|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139273821|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273822|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273823|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
139273824|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139273825|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273826|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139273827|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139273828|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273829|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273830|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273831|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
139273832|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139273833|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139273834|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273835|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
139273836|NCT02125890|Coagulants|coagulants|mesh-ancestor
139273837|NCT05287984|Cyclophosphamide|cyclophosphamide|mesh-list
139273838|NCT05287984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139273839|NCT05287984|Rituximab|rituximab|mesh-list
139273840|NCT05287984|Fludarabine|fludarabine|mesh-list
139273841|NCT05287984|Zanubrutinib|zanubrutinib|mesh-list
139273842|NCT05287984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139273843|NCT05287984|Immunologic Factors|immunologic factors|mesh-ancestor
139273844|NCT05287984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273845|NCT05287984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139273846|NCT05287984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139273847|NCT05287984|Alkylating Agents|alkylating agents|mesh-ancestor
139273848|NCT05287984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273849|NCT05287984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273850|NCT05287984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139273851|NCT05287984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139273852|NCT05287984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139273853|NCT05287984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273854|NCT00134264|Atorvastatin|atorvastatin|mesh-list
139273855|NCT00134264|Torcetrapib|torcetrapib|mesh-list
139273856|NCT00134264|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139273857|NCT00134264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139273858|NCT00134264|Antimetabolites|antimetabolites|mesh-ancestor
139273859|NCT00134264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273860|NCT00134264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139273861|NCT00134264|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139273862|NCT00134264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273863|NCT05285800|Bupivacaine|bupivacaine|mesh-list
139273864|NCT05285800|Anesthetics, Local|anesthetics, local|mesh-ancestor
139273865|NCT05285800|Anesthetics|anesthetics|mesh-ancestor
139273866|NCT05285800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139273867|NCT05285800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273868|NCT05285800|Sensory System Agents|sensory system agents|mesh-ancestor
139273869|NCT05285800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139273870|NCT02122692|Itraconazole|itraconazole|mesh-list
139273871|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139273872|NCT02122692|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
139273873|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
138857304|NCT02737254|Oxytocin|oxytocin|mesh-list
139273874|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273875|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139273876|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139273877|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273878|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273879|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139273880|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
139273881|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273882|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273883|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139273884|NCT02122692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139273885|NCT02122692|Serotonin Agents|serotonin agents|mesh-ancestor
139273886|NCT02122692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273887|NCT00131924|Estrogens|estrogens|mesh-list
139273888|NCT00131924|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
139273889|NCT00131924|Hormones|hormones|mesh-ancestor
139273890|NCT00131924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273891|NCT00131924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273892|NCT05284474|Mitogens|mitogens|mesh-list
139144114|NCT06148545|Iron|iron|mesh-list
139273893|NCT05284474|Mitosis Modulators|mitosis modulators|mesh-ancestor
139273894|NCT05284474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273895|NCT05609695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139273896|NCT05609695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273897|NCT05609695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139273898|NCT05609695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273899|NCT04246060|Cysteamine|cysteamine|mesh-list
139273900|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
139273901|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273902|NCT05129176|Metronidazole|metronidazole|mesh-list
139273903|NCT05129176|Levofloxacin|levofloxacin|mesh-list
139273904|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273905|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139273906|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139273907|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139273908|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139273909|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139273910|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139273911|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273912|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273913|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273914|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139273915|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139273916|NCT02127684|Ranibizumab|ranibizumab|mesh-list
139273917|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139273918|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139273919|NCT02127684|Growth Substances|growth substances|mesh-ancestor
139273920|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273921|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
139273922|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273923|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139273924|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139273925|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139273926|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
139273927|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273928|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139273929|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139273930|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273931|NCT02127840|Epinephrine|epinephrine|mesh-list
139273932|NCT02127840|Racepinephrine|racepinephrine|mesh-list
139273933|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
139273934|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139273935|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139273936|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
139273937|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139273938|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273939|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273940|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139273941|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139273942|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
139273943|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139273944|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138857367|NCT04259333|Analgesics|analgesics|mesh-ancestor
139273946|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
139273947|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
139273948|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139273949|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
139273950|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
139273951|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
139273952|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139273953|NCT05031442|Protective Agents|protective agents|mesh-ancestor
139273954|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273955|NCT02127918|Clobazam|clobazam|mesh-list
139273956|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
139273957|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139273958|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139273959|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139273960|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273961|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139273962|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139273963|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
139273964|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
139273965|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642313|NCT05586919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273966|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139273968|NCT00127634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139273969|NCT00127634|Insulin Glargine|insulin glargine|mesh-list
139273970|NCT00127634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139273971|NCT00127634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273972|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139273973|NCT02127996|Incretins|incretins|mesh-ancestor
139273974|NCT02127996|Hormones|hormones|mesh-ancestor
139273975|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139273976|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273977|NCT02131350|Ranibizumab|ranibizumab|mesh-list
139273978|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139273979|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139273980|NCT02131350|Growth Substances|growth substances|mesh-ancestor
139273981|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139273982|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
139273983|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273984|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
139273985|NCT02128308|Levofloxacin|levofloxacin|mesh-list
139273986|NCT02128308|Ofloxacin|ofloxacin|mesh-list
139273987|NCT02128308|Cycloserine|cycloserine|mesh-list
139273988|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
139273989|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
139273990|NCT02128308|Streptomycin|streptomycin|mesh-list
139273991|NCT02128308|Kanamycin|kanamycin|mesh-list
139273992|NCT02128308|Prothionamide|prothionamide|mesh-list
139273993|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139273994|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139273995|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139273996|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139273997|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139273998|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139273999|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274000|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274001|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139274002|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
139274003|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139274004|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274005|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139274006|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139274007|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139274008|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139274009|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139274010|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139274011|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139274012|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
139274013|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
139274014|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139274015|NCT02131506|Lapatinib|lapatinib|mesh-list
139274016|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139274017|NCT02131506|Doxorubicin|doxorubicin|mesh-list
139274018|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274019|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139274020|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274021|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274022|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139274023|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139274024|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139274025|NCT01674010|Inositol|inositol|mesh-list
139274026|NCT01674010|Lamotrigine|lamotrigine|mesh-list
139274027|NCT01674010|Valproic Acid|valproic acid|mesh-list
139274028|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
139274029|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139274030|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139274031|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274032|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139274033|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274034|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139274035|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139274036|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274037|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139274038|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139274039|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274040|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
139274041|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139274042|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
139274043|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
139274044|NCT01674010|Vitamins|vitamins|mesh-ancestor
139274045|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
139274046|NCT02252328|Simvastatin|simvastatin|mesh-list
139274047|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139274048|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139274049|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
139274050|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274051|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139274052|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139274053|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274054|NCT04656964|Midazolam|midazolam|mesh-list
139274055|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139274056|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139274057|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274058|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274059|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139274060|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139274061|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139274062|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139274063|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
139274064|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
139274065|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
139274066|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
139274067|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139274068|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274069|NCT02136030|Amphotericin B|amphotericin b|mesh-list
139274070|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139274071|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
139274072|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
139274073|NCT02136030|Amebicides|amebicides|mesh-ancestor
139274074|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139274075|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139274076|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274077|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139274078|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
139274079|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139274080|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139274081|NCT02131818|Amoxicillin|amoxicillin|mesh-list
139274082|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139274083|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274084|NCT04605796|Bevacizumab|bevacizumab|mesh-list
139274085|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139274086|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274087|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139274088|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139274089|NCT04605796|Growth Substances|growth substances|mesh-ancestor
139274090|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274091|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
139274092|NCT01345669|Afatinib|afatinib|mesh-list
139274093|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274094|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138857518|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
139274095|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274096|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274098|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
139274099|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
139274100|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139274101|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
139274102|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274103|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274104|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139274105|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
139274106|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139274107|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139274108|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139274109|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139274110|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274111|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
139274112|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139274113|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274114|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139274115|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274116|NCT03527732|Ivermectin|ivermectin|mesh-list
139274117|NCT03527732|Albendazole|albendazole|mesh-list
139274118|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139274119|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274120|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
139274121|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
139274122|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139274123|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139274124|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
139274125|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
139274126|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
139274127|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274128|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274129|NCT01673854|Ipilimumab|ipilimumab|mesh-list
139274130|NCT01673854|Vemurafenib|vemurafenib|mesh-list
139274131|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139274132|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274133|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139274134|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274135|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139274136|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274137|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
139274138|NCT03549702|Povidone|povidone|mesh-list
139274139|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
139274140|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
139274141|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139274142|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274143|NCT02529904|Vaccines|vaccines|mesh-list
139274144|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
139274145|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274146|NCT01367886|Fesoterodine|fesoterodine|mesh-list
139274147|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139274148|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139274149|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
139274150|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139274151|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274152|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274153|NCT01367886|Urological Agents|urological agents|mesh-ancestor
139274154|NCT05706337|Propofol|propofol|mesh-list
139274155|NCT05706337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139274156|NCT05706337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274157|NCT05706337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274158|NCT05706337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139274159|NCT05706337|Anesthetics, General|anesthetics, general|mesh-ancestor
139274160|NCT05706337|Anesthetics|anesthetics|mesh-ancestor
139274161|NCT05222113|Remdesivir|remdesivir|mesh-list
139274162|NCT05222113|Favipiravir|favipiravir|mesh-list
139274163|NCT05222113|Antimetabolites|antimetabolites|mesh-ancestor
139274164|NCT05222113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274165|NCT05222113|Antiviral Agents|antiviral agents|mesh-ancestor
139274166|NCT05222113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274167|NCT03854578|Citalopram|citalopram|mesh-list
139274168|NCT03854578|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139274169|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138857594|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139274170|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139274171|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274172|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139274173|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
139274174|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274175|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139274176|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
139274177|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139274178|NCT03038594|Hormones|hormones|mesh-list
139274179|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139274180|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274181|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
139274182|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139274183|NCT02136888|Ponesimod|ponesimod|mesh-list
139274184|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139274185|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274186|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139274187|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139274188|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642314|NCT05586919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139274189|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274190|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274191|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139274192|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
139274193|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139274194|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274195|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139274196|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139274197|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139274198|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139274199|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139274200|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
139274201|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139274202|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
139274203|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139274204|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139274205|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139274206|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274207|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274208|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
139274209|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
139274210|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
139274211|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139274212|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274213|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139274214|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274215|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274216|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
139274217|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139274218|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274219|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139274220|NCT02132442|Vitamin D|vitamin d|mesh-list
139274221|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
139274222|NCT02132442|Vitamins|vitamins|mesh-ancestor
139274223|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
139274224|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274225|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139274226|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139274227|NCT05010148|Lidocaine|lidocaine|mesh-list
139274228|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
139274229|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
139274230|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274231|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274232|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
139274233|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274234|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139274235|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139274236|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139274237|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139274238|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274239|NCT05138146|Doxorubicin|doxorubicin|mesh-list
139274240|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138857671|NCT02800694|Analgesics|analgesics|mesh-ancestor
139274241|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139274242|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274243|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139274244|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139274245|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274246|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274247|NCT05221879|Enoxaparin|enoxaparin|mesh-list
139274248|NCT05221879|Anticoagulants|anticoagulants|mesh-ancestor
139274249|NCT05221879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139274250|NCT05221879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139274251|NCT05221879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274252|NCT03450772|Pancrelipase|pancrelipase|mesh-list
139274253|NCT03450772|Pancreatin|pancreatin|mesh-list
139274254|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139274255|NCT02129088|Esketamine|esketamine|mesh-list
139274256|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
139274257|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139274258|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
139274259|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139274260|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139274261|NCT05137522|Prednisolone|prednisolone|mesh-list
139274262|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
139274263|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139274264|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
139274265|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139274266|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
139274267|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
139274268|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274269|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274270|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139274271|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
139274272|NCT05137522|Hormones|hormones|mesh-ancestor
139274273|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139274274|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139274275|NCT05137522|Protective Agents|protective agents|mesh-ancestor
139274276|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139274277|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274278|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
139274279|NCT02129166|Dasatinib|dasatinib|mesh-list
139274280|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274281|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139274282|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274283|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274284|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
139274285|NCT02137278|Levodopa|levodopa|mesh-list
139274286|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
139274287|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
139274288|NCT02137278|Diuretics|diuretics|mesh-list
139274289|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139274290|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
139274291|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274292|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
139274293|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139274294|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274295|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139274296|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139274297|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139274298|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274299|NCT05705635|Docetaxel|docetaxel|mesh-list
139274300|NCT05705635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274301|NCT05705635|Tubulin Modulators|tubulin modulators|mesh-ancestor
139274302|NCT05705635|Antimitotic Agents|antimitotic agents|mesh-ancestor
139274303|NCT05705635|Mitosis Modulators|mitosis modulators|mesh-ancestor
139274304|NCT05705635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274305|NCT05204550|Heparin|heparin|mesh-list
139274306|NCT05204550|Calcium heparin|calcium heparin|mesh-list
139274307|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
139274308|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139274309|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139274310|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274311|NCT00085774|Albuterol|albuterol|mesh-list
139274312|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139274313|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
139274314|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274315|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274316|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139274317|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
139274362|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139274364|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139274365|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139274366|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
139274367|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139274368|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139274369|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
139274370|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
139274371|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139274372|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139274373|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139274374|NCT02137356|Capecitabine|capecitabine|mesh-list
139274375|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139274376|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
139274377|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274378|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274379|NCT05137288|Atropine|atropine|mesh-list
139274380|NCT05137288|Ondansetron|ondansetron|mesh-list
139274381|NCT05137288|Bupivacaine|bupivacaine|mesh-list
139274382|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
139274383|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
139274384|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274385|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274386|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
139274387|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274388|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
139274389|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
139274390|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139274391|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
139274392|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
139274393|NCT05137288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139274394|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139274395|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
139274396|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139274397|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274398|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139274399|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139274400|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139274401|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139274402|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
139274403|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
139274404|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
139274405|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139274406|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139274407|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
139274408|NCT05135182|Metronidazole|metronidazole|mesh-list
139274409|NCT05135182|Furazolidone|furazolidone|mesh-list
139274410|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274411|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139274412|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139274413|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139274414|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139274415|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139274416|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139274417|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139274418|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274419|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274420|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
139274421|NCT02137434|Calcium|calcium|mesh-list
139274422|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139274423|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274424|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139274425|NCT02137668|Vancomycin|vancomycin|mesh-list
139274426|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139274427|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274428|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
139274429|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
139274430|NCT03522428|Vitamins|vitamins|mesh-ancestor
139274431|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
139274432|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274433|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
139274434|NCT03522428|Hematinics|hematinics|mesh-ancestor
139274435|NCT05575999|Ketorolac|ketorolac|mesh-list
139274436|NCT05575999|Ketamine|ketamine|mesh-list
139274437|NCT05575999|Bupivacaine|bupivacaine|mesh-list
139274438|NCT05575999|Anesthetics, Local|anesthetics, local|mesh-ancestor
139274439|NCT05575999|Anesthetics|anesthetics|mesh-ancestor
139274440|NCT05575999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274441|NCT05575999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274442|NCT05575999|Sensory System Agents|sensory system agents|mesh-ancestor
139274443|NCT05575999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274444|NCT05575999|Analgesics|analgesics|mesh-ancestor
139274445|NCT05575999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139274446|NCT05575999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139274447|NCT05575999|Anesthetics, General|anesthetics, general|mesh-ancestor
139274448|NCT05575999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139274449|NCT05575999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139274450|NCT05575999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139274451|NCT05575999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274452|NCT05575999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139274453|NCT05575999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139274454|NCT05575999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139274455|NCT05575999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139274456|NCT05575999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139274457|NCT05575999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274458|NCT01062399|Everolimus|everolimus|mesh-list
139274459|NCT01062399|Temozolomide|temozolomide|mesh-list
139274460|NCT01062399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139274461|NCT01062399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139274462|NCT01062399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381807|NCT03181815|Cytarabine|cytarabine|mesh-list
139274463|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274464|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139274465|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
139274466|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274467|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274468|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139274469|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
139274471|NCT05136508|Sevoflurane|sevoflurane|mesh-list
139274472|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139274473|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274474|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274475|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139274476|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
139274477|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
139274478|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139274479|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139274480|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
139274481|NCT02129322|Sorafenib|sorafenib|mesh-list
139274482|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274483|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139274484|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274485|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274486|NCT03767712|Antibodies|antibodies|mesh-list
139274487|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
139274488|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
139274489|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274490|NCT05221411|Mycophenolic Acid|mycophenolic acid|mesh-list
139274491|NCT05221411|Tacrolimus|tacrolimus|mesh-list
139274492|NCT05221411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139274493|NCT05221411|Immunologic Factors|immunologic factors|mesh-ancestor
139274494|NCT05221411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274495|NCT05221411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139274496|NCT05221411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274497|NCT05221411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274498|NCT05221411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139274499|NCT05221411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274500|NCT05221411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139274501|NCT05221411|Antitubercular Agents|antitubercular agents|mesh-ancestor
139274502|NCT05221411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139274503|NCT05221411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274504|NCT05306002|Antioxidants|antioxidants|mesh-list
139274505|NCT05306002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274506|NCT05306002|Protective Agents|protective agents|mesh-ancestor
139274507|NCT05306002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274508|NCT04346914|Carboplatin|carboplatin|mesh-list
139274509|NCT04346914|Etoposide|etoposide|mesh-list
139274510|NCT04346914|Antibodies|antibodies|mesh-list
139274511|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139274512|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
139274513|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274514|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274515|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139274516|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139274517|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139274518|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274519|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274520|NCT02129400|Anesthetics|anesthetics|mesh-list
139274522|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274523|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274524|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139274525|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
139274526|NCT05305768|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139274527|NCT05305768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139274528|NCT05305768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274529|NCT05305768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274530|NCT05305768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139274531|NCT05305768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139274532|NCT05305768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274533|NCT05305768|Cholinergic Agents|cholinergic agents|mesh-ancestor
139274534|NCT05305768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139274535|NCT02133378|Hemostatics|hemostatics|mesh-list
139274536|NCT02133378|Coagulants|coagulants|mesh-ancestor
139274537|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
139274538|NCT04171622|Lenvatinib|lenvatinib|mesh-list
139274539|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138857966|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139274540|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274541|NCT04171622|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139274542|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274543|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139274544|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274545|NCT05234580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139274546|NCT02138058|Topiramate|topiramate|mesh-list
139274547|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
139274548|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139274549|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274550|NCT02129634|Paclitaxel|paclitaxel|mesh-list
139274551|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139274552|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274553|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
139274554|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
139274555|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
139274556|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274557|NCT05174455|Niraparib|niraparib|mesh-list
139274558|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139274559|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274560|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274561|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274562|NCT02138292|Trametinib|trametinib|mesh-list
139274563|NCT02138292|Digoxin|digoxin|mesh-list
139274564|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274565|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139274566|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274567|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274568|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139274569|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139274570|NCT02138292|Protective Agents|protective agents|mesh-ancestor
139274571|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274572|NCT02133612|Paclitaxel|paclitaxel|mesh-list
139274573|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139274574|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139274575|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274576|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
139274577|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
139274578|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
139274579|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274580|NCT03522194|Propofol|propofol|mesh-list
139274581|NCT03522194|Sevoflurane|sevoflurane|mesh-list
139274582|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139274583|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274584|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274585|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139274586|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
139274587|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
139274588|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139274589|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139274590|NCT04820686|Tenofovir|tenofovir|mesh-list
139274591|NCT04820686|Entecavir|entecavir|mesh-list
139274592|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
139274593|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274594|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139274595|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139274596|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274597|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274598|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139274599|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139274600|NCT02260908|Enoxaparin|enoxaparin|mesh-list
139274601|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
139274602|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139274603|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139274604|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274605|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
139274606|NCT02969655|Glycine|glycine|mesh-list
139274607|NCT02969655|Hematinics|hematinics|mesh-ancestor
139274608|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
139274609|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138289234|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139274610|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274611|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274612|NCT04488874|Mannitol|mannitol|mesh-list
139274613|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139274614|NCT04488874|Diuretics|diuretics|mesh-ancestor
139274615|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
139274616|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274617|NCT03651219|Irinotecan|irinotecan|mesh-list
139274618|NCT03651219|Apatinib|apatinib|mesh-list
139274619|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139274620|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139274621|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274622|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274623|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274624|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139274625|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139274626|NCT02648698|Levofloxacin|levofloxacin|mesh-list
139274627|NCT02648698|Tinidazole|tinidazole|mesh-list
139274628|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274629|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139274630|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139274631|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139274632|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274633|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274634|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274635|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139274636|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139274637|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
139274638|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139274639|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139274640|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139274641|NCT03524846|Vitamins|vitamins|mesh-list
139274642|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
139274643|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
139274644|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274645|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
139274646|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274647|NCT03524846|Protective Agents|protective agents|mesh-ancestor
139274648|NCT05134558|Xenon|xenon|mesh-list
139274649|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139274650|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
139274651|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
139274652|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274653|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274654|NCT02970669|Valsartan|valsartan|mesh-list
139274655|NCT02970669|Enalapril|enalapril|mesh-list
139274656|NCT02970669|Enalaprilat|enalaprilat|mesh-list
139274657|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139274658|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139274659|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139274660|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139274661|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274662|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139274663|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
139274664|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274665|NCT02134002|Disulfiram|disulfiram|mesh-list
139274666|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139274667|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139274668|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274669|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274670|NCT03650361|Adapalene|adapalene|mesh-list
139274671|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139274672|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139274673|NCT03650361|Analgesics|analgesics|mesh-ancestor
139274674|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
139274675|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274676|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274677|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139274678|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139274679|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
139274680|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139274681|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
139274682|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274683|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139274684|NCT05303818|Rivaroxaban|rivaroxaban|mesh-list
139274685|NCT05303818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139274686|NCT05303818|Antithrombins|antithrombins|mesh-ancestor
139274687|NCT05303818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139274688|NCT05303818|Protease Inhibitors|protease inhibitors|mesh-ancestor
139274689|NCT05303818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274690|NCT05303818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274691|NCT05303818|Anticoagulants|anticoagulants|mesh-ancestor
139274692|NCT02902965|Dexamethasone|dexamethasone|mesh-list
139274693|NCT02902965|Bortezomib|bortezomib|mesh-list
139274694|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139274695|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
139274696|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
139274697|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274698|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274699|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139274700|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
139274701|NCT02902965|Hormones|hormones|mesh-ancestor
139274702|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139274703|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139274704|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274705|NCT02130414|Cyclosporine|cyclosporine|mesh-list
139274706|NCT02130414|Cyclosporins|cyclosporins|mesh-list
139274707|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274708|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274709|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139274710|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
139274711|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274712|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
139274713|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274714|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
139274715|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139274716|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139274717|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139274718|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
139274719|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274720|NCT02134470|Testosterone|testosterone|mesh-list
139274721|NCT02134470|Androgens|androgens|mesh-ancestor
139274722|NCT02134470|Hormones|hormones|mesh-ancestor
139274723|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139274724|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274725|NCT02134626|Simvastatin|simvastatin|mesh-list
139274726|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139274727|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139274728|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
139274729|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274730|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139274731|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139274732|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274733|NCT02969187|Bupivacaine|bupivacaine|mesh-list
139274734|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
139274735|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
139274736|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274737|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274738|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
139274739|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274740|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139274741|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139274742|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139274743|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
139274744|NCT05285085|Atorvastatin|atorvastatin|mesh-list
139274745|NCT05285085|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139274746|NCT05285085|Simvastatin|simvastatin|mesh-list
139274747|NCT05285085|Pravastatin|pravastatin|mesh-list
139274748|NCT05285085|Pitavastatin|pitavastatin|mesh-list
139274749|NCT05285085|Lovastatin|lovastatin|mesh-list
139274750|NCT05285085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139274751|NCT05285085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139274752|NCT05285085|Antimetabolites|antimetabolites|mesh-ancestor
139274753|NCT05285085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274754|NCT05285085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139274755|NCT05285085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139274756|NCT05285085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274757|NCT02139930|Nicotine|nicotine|mesh-list
139274758|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139274759|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
139274760|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274761|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144931|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
139274762|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139274763|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139274764|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
139274765|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139274766|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274767|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139274768|NCT02130804|Salicylates|salicylates|mesh-list
139274769|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139274770|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139274772|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
139274773|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274774|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274775|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139274776|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139274777|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139274778|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274779|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274780|NCT05303272|Mycophenolic Acid|mycophenolic acid|mesh-list
139274781|NCT05303272|Abatacept|abatacept|mesh-list
139274782|NCT05303272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139274783|NCT05303272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274784|NCT05303272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139274785|NCT05303272|Antitubercular Agents|antitubercular agents|mesh-ancestor
139274786|NCT05303272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139274787|NCT05303272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274788|NCT05303272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274789|NCT05303272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274790|NCT05303272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139274791|NCT05303272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139274792|NCT05303272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139274793|NCT05303272|Immunologic Factors|immunologic factors|mesh-ancestor
139274794|NCT05303272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274795|NCT05303272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139274796|NCT03549312|Tenofovir|tenofovir|mesh-list
139274797|NCT03549312|Emtricitabine|emtricitabine|mesh-list
139274798|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
139274799|NCT03549312|Cobicistat|cobicistat|mesh-list
139274800|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139274801|NCT03549312|Velpatasvir|velpatasvir|mesh-list
139274802|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139274803|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139274804|NCT03549312|Elvitegravir|elvitegravir|mesh-list
139274805|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
139274806|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274807|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139274808|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139274809|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274810|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274811|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139274812|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139274813|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139274814|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139274815|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139274816|NCT03649269|Bezafibrate|bezafibrate|mesh-list
139274817|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139274818|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
139274819|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274820|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139274821|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
139274822|NCT02134938|Cathartics|cathartics|mesh-ancestor
139274823|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139274824|NCT05373446|Ritonavir|ritonavir|mesh-list
139274825|NCT05373446|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139274826|NCT05373446|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139274827|NCT05373446|Protease Inhibitors|protease inhibitors|mesh-ancestor
139274828|NCT05373446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274829|NCT05373446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274830|NCT05373446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139274831|NCT05373446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139274832|NCT05373446|Antiviral Agents|antiviral agents|mesh-ancestor
139274833|NCT05373446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139642315|NCT05586919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139642316|NCT01890889|Ezetimibe|ezetimibe|mesh-list
139274834|NCT05373446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139274835|NCT05373446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139274836|NCT04734028|Clopidogrel|clopidogrel|mesh-list
139274837|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274838|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274839|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139274840|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139274841|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139274842|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139274843|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
139274844|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139274845|NCT05285397|Liraglutide|liraglutide|mesh-list
139274846|NCT05285397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139274847|NCT05285397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274848|NCT05285397|Incretins|incretins|mesh-ancestor
139274849|NCT05285397|Hormones|hormones|mesh-ancestor
139274850|NCT05285397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139274851|NCT03050359|Lansoprazole|lansoprazole|mesh-list
139274852|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
139274853|NCT03050359|Bismuth|bismuth|mesh-list
139274854|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139274855|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139274856|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139274857|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274858|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274859|NCT03050359|Antacids|antacids|mesh-ancestor
139274860|NCT05302726|Estrogens|estrogens|mesh-list
139274861|NCT05302726|Hormones|hormones|mesh-ancestor
139274862|NCT05302726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139274863|NCT05302726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274864|NCT02253264|Rituximab|rituximab|mesh-list
139274865|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139274866|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274867|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
139274868|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274869|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139274870|NCT03648333|Niacin|niacin|mesh-list
139274871|NCT03648333|Amlodipine|amlodipine|mesh-list
139274872|NCT03648333|Valsartan|valsartan|mesh-list
139274873|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
139274874|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139274875|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139274876|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139274877|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274878|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139274879|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274880|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
139274881|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139274882|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139274883|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139274884|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
139274885|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139274886|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
139274887|NCT03648333|Vitamins|vitamins|mesh-ancestor
139274888|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
139274889|NCT02252796|Paclitaxel|paclitaxel|mesh-list
139274890|NCT02252796|Carboplatin|carboplatin|mesh-list
139274891|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139274892|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274893|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
139274894|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
139274895|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
139274896|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274897|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
139274898|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139274899|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274900|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139274901|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139274902|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274903|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274904|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274905|NCT04660123|Bismuth|bismuth|mesh-list
139274906|NCT04660123|Antacids|antacids|mesh-ancestor
139274907|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274908|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139274909|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139274910|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139274911|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139274912|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
139274913|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274914|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139274915|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
139274916|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139274917|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139274918|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274919|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
139274921|NCT05579418|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139274922|NCT05579418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139274923|NCT05579418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139274924|NCT05579418|Antimetabolites|antimetabolites|mesh-ancestor
139274925|NCT05579418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274926|NCT05579418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139274927|NCT05579418|Protease Inhibitors|protease inhibitors|mesh-ancestor
139274928|NCT05579418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274929|NCT05579418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139274930|NCT02968173|Palivizumab|palivizumab|mesh-list
139274931|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
139274932|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274933|NCT02135640|Denosumab|denosumab|mesh-list
139274934|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139274935|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274936|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139274937|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
139274938|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139274939|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
139274940|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274941|NCT02253342|Levonadifloxacin|levonadifloxacin|mesh-list
139274942|NCT02253342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139274943|NCT02253342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139274944|NCT02253342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274945|NCT02253342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139274946|NCT02253342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274947|NCT00495508|Lumefantrine|lumefantrine|mesh-list
139274948|NCT00495508|Artemether|artemether|mesh-list
139274949|NCT00495508|Quinine|quinine|mesh-list
139274950|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139274951|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
139274952|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139274953|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139274954|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139274955|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139274956|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274957|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139274958|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274959|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139274960|NCT00495508|Analgesics|analgesics|mesh-ancestor
139274961|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
139274962|NCT05284851|Vaccines|vaccines|mesh-list
139274963|NCT05284851|Immunologic Factors|immunologic factors|mesh-ancestor
139274964|NCT05284851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274965|NCT03049735|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139274966|NCT03049735|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139274967|NCT03049735|Norethindrone|norethindrone|mesh-list
139274968|NCT03049735|Norethindrone Acetate|norethindrone acetate|mesh-list
139274969|NCT03049735|Estradiol|estradiol|mesh-list
139274970|NCT03049735|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139274971|NCT03049735|Relugolix|relugolix|mesh-list
139274972|NCT03049735|Estrogens|estrogens|mesh-ancestor
139274973|NCT03049735|Hormones|hormones|mesh-ancestor
139274974|NCT03049735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139274975|NCT03049735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274976|NCT03049735|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139274977|NCT03049735|Contraceptive Agents|contraceptive agents|mesh-ancestor
139274978|NCT03049735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139274979|NCT03049735|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139274980|NCT03049735|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139274981|NCT03049735|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139274982|NCT03049735|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139274983|NCT03049735|Androgen Antagonists|androgen antagonists|mesh-ancestor
139274984|NCT03049735|Hormone Antagonists|hormone antagonists|mesh-ancestor
139274985|NCT04785638|Bupivacaine|bupivacaine|mesh-list
139274986|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
139274987|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
139274988|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139274989|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274990|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
139274991|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274992|NCT04762472|Montelukast|montelukast|mesh-list
139274993|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139274994|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
139274995|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139274996|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
139274997|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139274998|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274999|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139275000|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139275001|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275002|NCT01295944|Bevacizumab|bevacizumab|mesh-list
139275003|NCT01295944|Carboplatin|carboplatin|mesh-list
139275004|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139275005|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275006|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139275007|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139275008|NCT01295944|Growth Substances|growth substances|mesh-ancestor
139275009|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275010|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
139275012|NCT04742348|Carbidopa|carbidopa|mesh-list
139275013|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139275014|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139275015|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139275016|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
139275017|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275018|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275019|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275020|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139275021|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275022|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139275023|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
139275024|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
139275025|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
139275026|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139275027|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139275028|NCT02140632|Prednisolone|prednisolone|mesh-list
139275029|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
139275030|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139275031|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
139275032|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139275033|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
139275034|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
139275035|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275036|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275037|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139275038|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
139275039|NCT02140632|Hormones|hormones|mesh-ancestor
139275040|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275041|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139275042|NCT02140632|Protective Agents|protective agents|mesh-ancestor
139275043|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139275044|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275045|NCT05578404|Cholecalciferol|cholecalciferol|mesh-list
139275046|NCT05578404|Vitamin D|vitamin d|mesh-list
139275047|NCT05578404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139275048|NCT05578404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275049|NCT05578404|Vitamins|vitamins|mesh-ancestor
139275050|NCT05578404|Micronutrients|micronutrients|mesh-ancestor
139275051|NCT05578404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139275052|NCT03521960|Buspirone|buspirone|mesh-list
139275053|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139275054|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139275055|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275056|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275057|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139275058|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139275059|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
139275060|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275061|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275063|NCT05479578|Dexamethasone acetate|dexamethasone acetate|mesh-list
139275064|NCT05479578|Cyclophosphamide|cyclophosphamide|mesh-list
139275065|NCT05479578|Ichthammol|ichthammol|mesh-list
139275066|NCT05479578|BB 1101|bb 1101|mesh-list
139275067|NCT05479578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139275068|NCT05479578|Immunologic Factors|immunologic factors|mesh-ancestor
139275069|NCT05479578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275070|NCT05479578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139275071|NCT05479578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139275072|NCT05479578|Alkylating Agents|alkylating agents|mesh-ancestor
139275073|NCT05479578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275074|NCT05479578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275075|NCT05479578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139275076|NCT05479578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139275077|NCT05479578|Antiemetics|antiemetics|mesh-ancestor
139275078|NCT05479578|Autonomic Agents|autonomic agents|mesh-ancestor
139275079|NCT05479578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275080|NCT05479578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139275081|NCT05479578|Glucocorticoids|glucocorticoids|mesh-ancestor
139275083|NCT05479578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275084|NCT05479578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139275085|NCT05479578|Protease Inhibitors|protease inhibitors|mesh-ancestor
139275086|NCT05479578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275087|NCT05479578|Dermatologic Agents|dermatologic agents|mesh-ancestor
139275088|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139275089|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275090|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
139275091|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
139275092|NCT04853628|Ethanol|ethanol|mesh-list
139275093|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139275094|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275095|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275096|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275097|NCT03521726|Amoxicillin|amoxicillin|mesh-list
139275098|NCT03521726|Rabeprazole|rabeprazole|mesh-list
139275099|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139275100|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275101|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139275102|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139275103|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139275104|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275105|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275106|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
139275107|NCT03546426|Interleukin-2|interleukin-2|mesh-list
139275108|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139275109|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275110|NCT03546426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139275111|NCT03546426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275112|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139275113|NCT03546426|Analgesics|analgesics|mesh-ancestor
139275114|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
139275115|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275116|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275117|NCT02897349|Linagliptin|linagliptin|mesh-list
139275118|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139275119|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275120|NCT02897349|Incretins|incretins|mesh-ancestor
139275121|NCT02897349|Hormones|hormones|mesh-ancestor
139275122|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275123|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139275124|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
139275125|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275126|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275127|NCT03134378|Amoxicillin|amoxicillin|mesh-list
139275128|NCT03134378|Clarithromycin|clarithromycin|mesh-list
139275129|NCT03134378|Rabeprazole|rabeprazole|mesh-list
139275130|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139275131|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275132|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139275133|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275134|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275135|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139275136|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139275137|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139275138|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139275139|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139275140|NCT05434104|Metronidazole|metronidazole|mesh-list
139275141|NCT05434104|Fluconazole|fluconazole|mesh-list
138858570|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
139275142|NCT05434104|Lactoferrin|lactoferrin|mesh-list
139275143|NCT05434104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275144|NCT05434104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139275145|NCT05434104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139275146|NCT05434104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139275147|NCT05434104|Antifungal Agents|antifungal agents|mesh-ancestor
139275148|NCT05434104|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139275149|NCT05434104|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139275150|NCT05434104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275151|NCT05434104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275152|NCT05434104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139275153|NCT05434104|Hormone Antagonists|hormone antagonists|mesh-ancestor
139275154|NCT05434104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275155|NCT05434104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275156|NCT05434104|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139275157|NCT05434104|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139275158|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139275159|NCT03523832|Celecoxib|celecoxib|mesh-list
139275160|NCT03523832|Pregabalin|pregabalin|mesh-list
139275161|NCT03523832|Analgesics|analgesics|mesh-ancestor
139275162|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
139275163|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275164|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275165|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
139275166|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139275167|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139275168|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275169|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139275170|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139275171|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139275172|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275173|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139275174|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139275175|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139275176|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139275177|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139275178|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139275179|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139275180|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275181|NCT05577624|Rifampin|rifampin|mesh-list
139275182|NCT05577624|Sotorasib|sotorasib|mesh-list
139275183|NCT05577624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139275184|NCT05577624|Antitubercular Agents|antitubercular agents|mesh-ancestor
139275185|NCT05577624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139275186|NCT05577624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275187|NCT05577624|Leprostatic Agents|leprostatic agents|mesh-ancestor
139275188|NCT05577624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139275189|NCT05577624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275190|NCT05577624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275191|NCT05577624|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139275192|NCT05577624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139275193|NCT05577624|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139275194|NCT05577624|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139275195|NCT05577624|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139275196|NCT05577624|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138289235|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275197|NCT05577624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139275198|NCT05577624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139275199|NCT05577624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275200|NCT03294694|Fulvestrant|fulvestrant|mesh-list
139275201|NCT03294694|Spartalizumab|spartalizumab|mesh-list
139275202|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139275203|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275204|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139091720|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139275205|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139275206|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
139275207|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275208|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275209|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139275210|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275211|NCT03294694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139275212|NCT03523754|Isosorbide|isosorbide|mesh-list
139275213|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139275214|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139275216|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139275217|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
139275218|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139275219|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275220|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139275221|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139275222|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
139275223|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139275224|NCT03523754|Diuretics|diuretics|mesh-ancestor
139275225|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
139275226|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
139275227|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139275228|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275229|NCT04727034|Propofol|propofol|mesh-list
139275230|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139275231|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275232|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275233|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139275234|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
139275235|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
139275236|NCT03644511|Sorafenib|sorafenib|mesh-list
139275237|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275238|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139275239|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275240|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275241|NCT03290560|Kallikreins|kallikreins|mesh-list
139275242|NCT03290560|Coagulants|coagulants|mesh-ancestor
139275243|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
139275244|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
139275245|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139275246|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275247|NCT01316419|Amlodipine|amlodipine|mesh-list
139275248|NCT01316419|Telmisartan|telmisartan|mesh-list
139275249|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139275250|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139275251|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139275252|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275253|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139275254|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275255|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
139275256|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139275257|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139275258|NCT03547362|Caseins|caseins|mesh-list
139275259|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
139275260|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
139275261|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275262|NCT04258150|Nivolumab|nivolumab|mesh-list
139275263|NCT04258150|Ipilimumab|ipilimumab|mesh-list
139275264|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139275265|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275266|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139275267|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275268|NCT02854696|Insulin|insulin|mesh-list
139275269|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139275270|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275271|NCT02289248|Ketamine|ketamine|mesh-list
139275272|NCT02289248|Analgesics|analgesics|mesh-ancestor
139275273|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
139275274|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275275|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275276|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139275277|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139642317|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139275278|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
139275280|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275281|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139275282|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139275283|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275284|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275285|NCT02253420|Itraconazole|itraconazole|mesh-list
139275286|NCT02253420|Rifampin|rifampin|mesh-list
138858717|NCT06005324|Cetuximab|cetuximab|mesh-list
139275288|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275289|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139275290|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139275291|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275292|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275293|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139275294|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
139275295|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275296|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275297|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139275298|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139275299|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
139275300|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139275301|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
139275302|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139275303|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139275304|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139275305|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139275306|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139275307|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139275308|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139275309|NCT02028364|Everolimus|everolimus|mesh-list
139275310|NCT02028364|Exemestane|exemestane|mesh-list
139275311|NCT02028364|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139275312|NCT02028364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139275313|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275314|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275315|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139275316|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
139275317|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275318|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275319|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139275320|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139275321|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139275322|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
139275323|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275324|NCT02897115|Adalimumab|adalimumab|mesh-list
139275325|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139275326|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139275327|NCT02897115|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139275328|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139275329|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139275330|NCT02897115|Analgesics|analgesics|mesh-ancestor
139275331|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
139275332|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275333|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275334|NCT02289482|Ritonavir|ritonavir|mesh-list
139275335|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
139275336|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139275337|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139275338|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
139275339|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275340|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275341|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139275342|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139275343|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
139275344|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275345|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139275346|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139275347|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
139275348|NCT04030195|Fludarabine|fludarabine|mesh-list
139275349|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139275350|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
139275351|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275352|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139275353|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139275354|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
139275355|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275356|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858793|NCT06004947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139275357|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139275358|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139275359|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
139275360|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139275361|NCT02253966|Prednisolone|prednisolone|mesh-list
139275362|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
139275363|NCT02253966|Lidocaine|lidocaine|mesh-list
139275364|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139275365|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
139275366|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
139275367|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
139275368|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275369|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275370|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
139275371|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275372|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139275373|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139275374|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139275375|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139275376|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275377|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139275378|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
139275379|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
139275380|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139275381|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
139275382|NCT02253966|Hormones|hormones|mesh-ancestor
139275383|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275384|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139275385|NCT02253966|Protective Agents|protective agents|mesh-ancestor
139275386|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139275387|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275388|NCT01673620|Loratadine|loratadine|mesh-list
139275389|NCT01673620|Montelukast|montelukast|mesh-list
139275390|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139275391|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
139275392|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139275393|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
139275394|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275395|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275396|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139275397|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139275398|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275399|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
139275400|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
139275401|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139275402|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139275403|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139275404|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
139275405|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
139275406|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275407|NCT04671355|Fluticasone|fluticasone|mesh-list
139275409|NCT04671355|Beclomethasone|beclomethasone|mesh-list
139275410|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
139275411|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
139275412|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139275413|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139275414|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
139209798|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
139275415|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275416|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275417|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139275418|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
139275419|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
139275420|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139275421|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139275422|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139275423|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139275424|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
139275425|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275426|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275427|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139275428|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139275429|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139275430|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
139275431|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
139275432|NCT04671355|Hormones|hormones|mesh-ancestor
139275433|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275434|NCT03521492|Vitamin D|vitamin d|mesh-list
139275435|NCT03521492|Calcium|calcium|mesh-list
139275436|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
139275437|NCT03521492|Hormones|hormones|mesh-list
139275438|NCT03521492|Vitamins|vitamins|mesh-ancestor
139275439|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
139275440|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275441|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139275442|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139275443|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275444|NCT03521414|Sevoflurane|sevoflurane|mesh-list
139275445|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139275446|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139275447|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
139275448|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
139275449|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275450|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275451|NCT00432094|Paclitaxel|paclitaxel|mesh-list
139275452|NCT00432094|Etoposide|etoposide|mesh-list
139275453|NCT00432094|Carboplatin|carboplatin|mesh-list
139275454|NCT00432094|Ifosfamide|ifosfamide|mesh-list
139275455|NCT00432094|Thiotepa|thiotepa|mesh-list
139275456|NCT00432094|Mesna|mesna|mesh-list
139275457|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139275458|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275459|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
139275460|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
139275461|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
139275462|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275463|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139275464|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139275465|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275466|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
139275467|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275468|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139275469|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
139275470|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139275471|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139275472|NCT00432094|Protective Agents|protective agents|mesh-ancestor
139275473|NCT04562779|Naltrexone|naltrexone|mesh-list
139275474|NCT04562779|Ketamine|ketamine|mesh-list
139275475|NCT04562779|Analgesics|analgesics|mesh-ancestor
139275476|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
139275477|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275478|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275479|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139275480|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139275481|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
139275482|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
139275483|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275484|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139275485|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139275486|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275487|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275488|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139275489|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139275490|NCT03751761|Paclitaxel|paclitaxel|mesh-list
139275491|NCT03751761|Durvalumab|durvalumab|mesh-list
139275492|NCT03751761|Tremelimumab|tremelimumab|mesh-list
139275493|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139275494|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275495|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
139275496|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
139275497|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
139275498|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642318|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139275499|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139275500|NCT03644823|Atezolizumab|atezolizumab|mesh-list
139275501|NCT03644823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139275502|NCT03644823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275503|NCT03644823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139275504|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275505|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
139275506|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138858943|NCT05887882|Mitogens|mitogens|mesh-list
138859019|NCT05773950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139275507|NCT00072358|Irinotecan|irinotecan|mesh-list
139275508|NCT00072358|Temozolomide|temozolomide|mesh-list
139275509|NCT00072358|Molgramostim|molgramostim|mesh-list
139275510|NCT00072358|Isotretinoin|isotretinoin|mesh-list
139275511|NCT00072358|Antibodies|antibodies|mesh-list
139275512|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
139275513|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139275514|NCT00072358|Sargramostim|sargramostim|mesh-list
139275515|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
139275516|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
139275517|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275518|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275519|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139275520|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139275521|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275522|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275523|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139275524|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
139275525|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
139275526|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139275527|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275528|NCT03104998|Ubiquinone|ubiquinone|mesh-list
139275529|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
139275530|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
139275531|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275532|NCT03104998|Vitamins|vitamins|mesh-ancestor
139275533|NCT03990766|Theophylline|theophylline|mesh-list
139275534|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139275535|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
139275536|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275537|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275538|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139275539|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
139275540|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139275541|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275542|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275543|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
139275544|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139275545|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139275546|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
139275547|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275548|NCT02294162|Ketamine|ketamine|mesh-list
139275549|NCT02294162|Analgesics|analgesics|mesh-ancestor
139275550|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
139275551|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275552|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275553|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139275554|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139275555|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
139275556|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
139275557|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275558|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139275559|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139275560|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275561|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275562|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139275563|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139275564|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139275565|NCT05176158|Analgesics|analgesics|mesh-ancestor
139275566|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
139275567|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275568|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275569|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139275570|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139275571|NCT02294240|Folic Acid|folic acid|mesh-list
139275572|NCT02294240|Hematinics|hematinics|mesh-ancestor
139275573|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
139275574|NCT02294240|Vitamins|vitamins|mesh-ancestor
139275575|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
139275576|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275577|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
139275578|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139275579|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139275580|NCT04481724|Analgesics|analgesics|mesh-ancestor
139275581|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
139275582|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275583|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275584|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139275585|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139275586|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139275587|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
139275588|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275589|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139275590|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
139275591|NCT02298218|Meloxicam|meloxicam|mesh-list
139275592|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139275593|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139275594|NCT02298218|Analgesics|analgesics|mesh-ancestor
139275595|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
139275596|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275597|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275598|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139275599|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139275600|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139275601|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139275602|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275603|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275604|NCT03547830|Plerixafor|plerixafor|mesh-list
139275605|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139275606|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139275607|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
139275608|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275609|NCT04390945|Capecitabine|capecitabine|mesh-list
139275610|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139275611|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
139275612|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275613|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275614|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
139275615|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139275616|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275617|NCT03734809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139275618|NCT03734809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275619|NCT02291666|Tolbutamide|tolbutamide|mesh-list
139275620|NCT02291666|Midazolam|midazolam|mesh-list
139275621|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
139275622|NCT02291666|Caffeine|caffeine|mesh-list
139275623|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
139275624|NCT02291666|Bupropion|bupropion|mesh-list
139275625|NCT02291666|Omeprazole|omeprazole|mesh-list
139275626|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139275627|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139275628|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275629|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275630|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139275631|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139275632|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139275633|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139275634|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
139275635|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
139275636|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
139275637|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
139275638|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275639|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275640|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139275641|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139275642|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275643|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139275644|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139275645|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
139275646|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139275647|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139145833|NCT00823563|Adenosine|adenosine|mesh-list
139275648|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139275649|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139275650|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
139275651|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139275652|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139275653|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139275654|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
139275655|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139275656|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139275657|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
139275658|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
139275659|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139275660|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139275662|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139275663|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139275664|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275665|NCT03102658|Micafungin|micafungin|mesh-list
139275666|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
139275667|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275668|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
139275669|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139275670|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275671|NCT02646748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139275672|NCT02646748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275673|NCT03624985|Lidocaine|lidocaine|mesh-list
139275674|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
139275675|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
139275676|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275677|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275678|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
139275679|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275680|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139275681|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139275682|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139275683|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139275684|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275685|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
139275686|NCT03521024|Ether|ether|mesh-list
139275687|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
139275688|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139275689|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275690|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275691|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
139275692|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139275693|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275694|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275695|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139275696|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
139275697|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
139275698|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
139275699|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
139275700|NCT02294552|Busulfan|busulfan|mesh-list
139275701|NCT02294552|Fludarabine|fludarabine|mesh-list
139275702|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
139275703|NCT02294552|Tacrolimus|tacrolimus|mesh-list
139275704|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139275705|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
139275706|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275707|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139275708|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139275709|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
139275710|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275711|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275712|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139275713|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139275714|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
139275715|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139275716|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275717|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139275718|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139275719|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
139275720|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139642319|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
139275721|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275722|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
139275723|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139275724|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275725|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139275726|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
139275727|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139275728|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275729|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275730|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275731|NCT03869944|Lamivudine|lamivudine|mesh-list
138859245|NCT05065372|Metformin|metformin|mesh-list
139275732|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139275733|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139275734|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275735|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275736|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
139275737|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275738|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139275739|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139275740|NCT04435522|Maraviroc|maraviroc|mesh-list
139275741|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139275742|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139275743|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275744|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139275745|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139275746|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
139275747|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275748|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139275749|NCT03843970|Bupivacaine|bupivacaine|mesh-list
139275750|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
139275751|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139275752|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
139275753|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
139275754|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275755|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275756|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
139275757|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275758|NCT03043651|Treprostinil|treprostinil|mesh-list
139275759|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139275760|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
139275761|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
139275762|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275763|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139275764|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139275765|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
139275766|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275767|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275768|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139275769|NCT04465292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139275770|NCT04465292|Immunologic Factors|immunologic factors|mesh-ancestor
139275771|NCT04465292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275772|NCT02298530|Caffeine|caffeine|mesh-list
139275773|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139275774|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275775|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139275776|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275777|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275778|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139275779|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139275780|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
139275781|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275782|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
139275783|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
139275784|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
139275785|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275786|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139275787|NCT03644589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139275788|NCT03644589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275789|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
139275790|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275791|NCT03514550|Propofol|propofol|mesh-list
139275792|NCT03514550|Sevoflurane|sevoflurane|mesh-list
139145976|NCT03968237|Naloxone|naloxone|mesh-list
139275793|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139275794|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275795|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275796|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139275797|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
139275798|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
139275799|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139275800|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139275801|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
139275802|NCT04173988|Fludarabine|fludarabine|mesh-list
139275803|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139275804|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
139275805|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275806|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139275807|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139275808|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
139275809|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275810|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275811|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139275812|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
139275813|NCT01344759|Propofol|propofol|mesh-list
139275814|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139275815|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275816|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275817|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139275818|NCT01344759|Analgesics|analgesics|mesh-ancestor
139275819|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
139275820|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275821|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139275822|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139275823|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139275824|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
139275825|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275826|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275827|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139275828|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
139275829|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
139275830|NCT05885386|Temozolomide|temozolomide|mesh-list
139275831|NCT05885386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139275832|NCT05885386|Alkylating Agents|alkylating agents|mesh-ancestor
139275833|NCT05885386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275834|NCT05885386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275835|NCT05885360|Istradefylline|istradefylline|mesh-list
139275836|NCT05885360|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
139275837|NCT05885360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139275838|NCT05885360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139275839|NCT05885360|Purinergic Agents|purinergic agents|mesh-ancestor
139275840|NCT05885360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275841|NCT05885360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275842|NCT05885360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275843|NCT05885269|Clobetasol|clobetasol|mesh-list
139275844|NCT05885269|Tacrolimus|tacrolimus|mesh-list
139275845|NCT05885269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139275846|NCT05885269|Immunologic Factors|immunologic factors|mesh-ancestor
139275847|NCT05885269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275848|NCT05885269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139275849|NCT05885269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275850|NCT05885269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275851|NCT05885269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139275852|NCT05885269|Glucocorticoids|glucocorticoids|mesh-ancestor
139275853|NCT05885269|Hormones|hormones|mesh-ancestor
139275854|NCT05885269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275855|NCT05885035|Calcium|calcium|mesh-list
139275856|NCT05885035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139275857|NCT05885035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275858|NCT05884983|Vaccines|vaccines|mesh-list
139275859|NCT05884983|Immunologic Factors|immunologic factors|mesh-ancestor
139275860|NCT05884983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275861|NCT05884970|Albuterol|albuterol|mesh-list
139275862|NCT05884970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139275863|NCT05884970|Autonomic Agents|autonomic agents|mesh-ancestor
139275864|NCT05884970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642464|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091721|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275865|NCT05884970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275866|NCT05884970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139275867|NCT05884970|Respiratory System Agents|respiratory system agents|mesh-ancestor
139275868|NCT05884970|Tocolytic Agents|tocolytic agents|mesh-ancestor
139275869|NCT05884970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139275870|NCT05884970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139275871|NCT05884970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139275872|NCT05884970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139275873|NCT05884970|Adrenergic Agents|adrenergic agents|mesh-ancestor
139275874|NCT05884970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275875|NCT05884970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275876|NCT05884502|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139275877|NCT05884502|Ezetimibe|ezetimibe|mesh-list
139275878|NCT05884502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139275879|NCT05884502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139275880|NCT05884502|Antimetabolites|antimetabolites|mesh-ancestor
139275881|NCT05884502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275882|NCT05884502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139275883|NCT05884502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139275884|NCT05884502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275885|NCT05884463|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139275886|NCT05884463|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139275887|NCT05884463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275888|NCT05884268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139275889|NCT05884268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139275890|NCT05884268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139275891|NCT05884268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139275892|NCT05884268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275893|NCT05884268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275894|NCT05884268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275895|NCT05884268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139275896|NCT05884268|Antidepressive Agents|antidepressive agents|mesh-ancestor
139275897|NCT05884268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139275898|NCT05884255|Octreotide|octreotide|mesh-list
139275899|NCT05884255|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139275900|NCT05884255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139275901|NCT05884255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139275902|NCT05884255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275903|NCT05884255|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139275904|NCT05884255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275905|NCT05884151|Tranexamic Acid|tranexamic acid|mesh-list
139275906|NCT05884151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139275907|NCT05884151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139275908|NCT05884151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275909|NCT05884151|Hemostatics|hemostatics|mesh-ancestor
139275910|NCT05884151|Coagulants|coagulants|mesh-ancestor
139275911|NCT05883891|Thrombin|thrombin|mesh-list
139275912|NCT05883891|Hemostatics|hemostatics|mesh-ancestor
139275913|NCT05883891|Coagulants|coagulants|mesh-ancestor
139275914|NCT05883865|Fenofibrate|fenofibrate|mesh-list
139275915|NCT05883865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139275916|NCT05883865|Antimetabolites|antimetabolites|mesh-ancestor
139275917|NCT05883865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275918|NCT05883865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139275919|NCT05883709|Lenalidomide|lenalidomide|mesh-list
139275920|NCT05883709|Immunologic Factors|immunologic factors|mesh-ancestor
139275921|NCT05883709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275922|NCT05883709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139275923|NCT05883709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139275924|NCT05883709|Growth Substances|growth substances|mesh-ancestor
139275925|NCT05883709|Growth Inhibitors|growth inhibitors|mesh-ancestor
139275926|NCT05883709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275927|NCT05881720|Valsartan|valsartan|mesh-list
139275928|NCT05881720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139275929|NCT05881720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139275930|NCT05881720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139275931|NCT05881720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139275932|NCT05881720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275933|NCT05873725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139275934|NCT05873725|Hormones|hormones|mesh-ancestor
139642465|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
139275935|NCT05873725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275936|NCT05873725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275937|NCT05860530|Olaparib|olaparib|mesh-list
139275938|NCT05860530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139275939|NCT05860530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275940|NCT05860530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275941|NCT05860530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275942|NCT05830799|Tolbutamide|tolbutamide|mesh-list
139275943|NCT05830799|Nintedanib|nintedanib|mesh-list
139275944|NCT05830799|Midazolam|midazolam|mesh-list
139275945|NCT05830799|Caffeine|caffeine|mesh-list
139275946|NCT05830799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139275947|NCT05830799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139275948|NCT05830799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275949|NCT05830799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275950|NCT05830799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139275951|NCT05830799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139275952|NCT05830799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139275953|NCT05830799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139275954|NCT05830799|Anesthetics, General|anesthetics, general|mesh-ancestor
139275956|NCT05830799|GABA Modulators|gaba modulators|mesh-ancestor
139275957|NCT05830799|GABA Agents|gaba agents|mesh-ancestor
139275958|NCT05830799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139275959|NCT05830799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139275960|NCT05830799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139275961|NCT05830799|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139275962|NCT05830799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139275963|NCT05830799|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139275964|NCT05830799|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139275965|NCT05830799|Purinergic Agents|purinergic agents|mesh-ancestor
139275966|NCT05830799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275967|NCT05830799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139275968|NCT05830799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139275969|NCT05827523|Cisplatin|cisplatin|mesh-list
139275970|NCT05827523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275971|NCT05731843|Ruzasvir|ruzasvir|mesh-list
139275972|NCT05731843|Antiviral Agents|antiviral agents|mesh-ancestor
139275973|NCT05731843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275974|NCT05720949|Dexamethasone|dexamethasone|mesh-list
139275975|NCT05720949|Bupivacaine|bupivacaine|mesh-list
139275976|NCT05720949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139275977|NCT05720949|Antiemetics|antiemetics|mesh-ancestor
139275978|NCT05720949|Autonomic Agents|autonomic agents|mesh-ancestor
139275979|NCT05720949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139275980|NCT05720949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139275981|NCT05720949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139275982|NCT05720949|Glucocorticoids|glucocorticoids|mesh-ancestor
139275983|NCT05720949|Hormones|hormones|mesh-ancestor
139275984|NCT05720949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139275985|NCT05720949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139275986|NCT05720949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275987|NCT05720949|Anesthetics, Local|anesthetics, local|mesh-ancestor
139275988|NCT05720949|Anesthetics|anesthetics|mesh-ancestor
139275989|NCT05720949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275990|NCT05720949|Sensory System Agents|sensory system agents|mesh-ancestor
139275991|NCT05676411|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139275992|NCT05676411|Dermatologic Agents|dermatologic agents|mesh-ancestor
139275993|NCT05633563|Trimetazidine|trimetazidine|mesh-list
139275994|NCT05633563|Vasodilator Agents|vasodilator agents|mesh-ancestor
139275995|NCT05627271|Ofatumumab|ofatumumab|mesh-list
139275996|NCT05627271|Ocrelizumab|ocrelizumab|mesh-list
139275997|NCT05627271|Natalizumab|natalizumab|mesh-list
139275998|NCT05627271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139275999|NCT05627271|Immunologic Factors|immunologic factors|mesh-ancestor
139276000|NCT05627271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276001|NCT05571514|Calcium Carbonate|calcium carbonate|mesh-list
139276002|NCT05571514|Calcium|calcium|mesh-list
139276003|NCT05571514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139276004|NCT05571514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276005|NCT05571514|Antacids|antacids|mesh-ancestor
139276006|NCT05571514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276007|NCT05571514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139276008|NCT05556720|Vaccines|vaccines|mesh-list
139276009|NCT05556720|Immunologic Factors|immunologic factors|mesh-ancestor
139276010|NCT05556720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276011|NCT05498389|Osimertinib|osimertinib|mesh-list
139276012|NCT05498389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276013|NCT05498389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139276014|NCT05498389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276015|NCT05498389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276016|NCT05334056|Cocaine|cocaine|mesh-list
139276017|NCT05334056|Anesthetics, Local|anesthetics, local|mesh-ancestor
139276018|NCT05334056|Anesthetics|anesthetics|mesh-ancestor
139276019|NCT05334056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139276020|NCT05334056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276021|NCT05334056|Sensory System Agents|sensory system agents|mesh-ancestor
139276022|NCT05334056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276023|NCT05334056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139276024|NCT05334056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139276025|NCT05334056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139276026|NCT05334056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139276027|NCT05334056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276028|NCT05334056|Dopamine Agents|dopamine agents|mesh-ancestor
139276029|NCT05334056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139276030|NCT05328414|Prednisolone|prednisolone|mesh-list
139276031|NCT05328414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139276032|NCT05328414|Glucocorticoids|glucocorticoids|mesh-ancestor
139276033|NCT05328414|Hormones|hormones|mesh-ancestor
139276034|NCT05328414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276035|NCT05328414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276036|NCT05328414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139276037|NCT05328414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276038|NCT05298085|Oxytocin|oxytocin|mesh-list
139276039|NCT05298085|Oxytocics|oxytocics|mesh-ancestor
139276040|NCT05298085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139276041|NCT05298085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276042|NCT05291598|Ketorolac|ketorolac|mesh-list
139276043|NCT05291598|Meloxicam|meloxicam|mesh-list
139276044|NCT05291598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139276045|NCT05291598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139276046|NCT05291598|Analgesics|analgesics|mesh-ancestor
139276047|NCT05291598|Sensory System Agents|sensory system agents|mesh-ancestor
139276048|NCT05291598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276049|NCT05291598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276050|NCT05291598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139276051|NCT05291598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139276052|NCT05291598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139276053|NCT05291598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276054|NCT05291598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276055|NCT05291598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139276056|NCT05190432|Taxifolin|taxifolin|mesh-list
139276057|NCT05190432|Ergothioneine|ergothioneine|mesh-list
139276058|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
139276059|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276060|NCT05190432|Protective Agents|protective agents|mesh-ancestor
139276061|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276062|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139276063|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139276064|NCT05190432|Analgesics|analgesics|mesh-ancestor
139276065|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
139276066|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276067|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139276068|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139276069|NCT05123131|Dexamethasone|dexamethasone|mesh-list
139276070|NCT05123131|Lenalidomide|lenalidomide|mesh-list
139276071|NCT05123131|Bortezomib|bortezomib|mesh-list
139276072|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139276073|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
139276074|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
139276075|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276076|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276077|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139276078|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
139276079|NCT05123131|Hormones|hormones|mesh-ancestor
139276080|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276081|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139276082|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276083|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
139276084|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139276085|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139276086|NCT05123131|Growth Substances|growth substances|mesh-ancestor
139276087|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
139146280|NCT02252692|Enalapril|enalapril|mesh-list
139276088|NCT05101187|Amphotericin B|amphotericin b|mesh-list
139276089|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139276090|NCT05101187|Olorofim|olorofim|mesh-list
139276091|NCT05101187|Amebicides|amebicides|mesh-ancestor
139276092|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139276093|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139276094|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139276095|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139276096|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
139276097|NCT05024045|Pirtobrutinib|pirtobrutinib|mesh-list
139276098|NCT05024045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139276099|NCT05024045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276100|NCT05024045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276101|NCT05000047|Silicon|silicon|mesh-list
139276102|NCT05000047|Trace Elements|trace elements|mesh-ancestor
139276103|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
139276104|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276105|NCT04974047|Tislelizumab|tislelizumab|mesh-list
139276106|NCT04974047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139276107|NCT04974047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276108|NCT04920942|Ivermectin|ivermectin|mesh-list
139276109|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139276110|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139276111|NCT04821687|Opicapone|opicapone|mesh-list
139276112|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
139276113|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276114|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276115|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
139276116|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139276117|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276118|NCT04821687|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139276119|NCT04821687|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139276120|NCT04821687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139276121|NCT04764344|Haloperidol|haloperidol|mesh-list
139276122|NCT04764344|Ondansetron|ondansetron|mesh-list
139276123|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
139276124|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
139276125|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
139276126|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276127|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276128|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139276129|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
139276130|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
139276131|NCT04764344|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139276132|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139276133|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
139276134|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139276135|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276136|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139276137|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139276138|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139276139|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139276140|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139276141|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
139276142|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139276143|NCT04738981|Basiliximab|basiliximab|mesh-list
139276144|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139276145|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
139276146|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276147|NCT04709185|Dexamethasone|dexamethasone|mesh-list
139276148|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139276149|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
139276150|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
139276151|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276152|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276153|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139276154|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
139276155|NCT04709185|Hormones|hormones|mesh-ancestor
139276156|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276157|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139276158|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276159|NCT04693156|Bupivacaine|bupivacaine|mesh-list
139642466|NCT01891513|Losartan|losartan|mesh-list
139276160|NCT04693156|Prilocaine|prilocaine|mesh-list
139276161|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
139276162|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
139276163|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139276164|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276165|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
139276166|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276168|NCT04504331|Infigratinib|infigratinib|mesh-list
139276169|NCT04504331|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139276170|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139276171|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
139276172|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276173|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276174|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139276175|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276176|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139276177|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139276178|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139276179|NCT04504331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139276180|NCT04504331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276181|NCT04504331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276183|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139276184|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276185|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139276186|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276187|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
139276188|NCT04313985|Immunomodulating Agents|immunomodulating agents|mesh-list
139276189|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276190|NCT04283578|Oxytocin|oxytocin|mesh-list
139276191|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
139276192|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139276193|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276194|NCT04123873|Acetaminophen|acetaminophen|mesh-list
139276195|NCT04123873|Dexamethasone|dexamethasone|mesh-list
139276196|NCT04123873|Ibuprofen|ibuprofen|mesh-list
139276197|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139276198|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
139276199|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
139276200|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276201|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276202|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139276203|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
139276204|NCT04123873|Hormones|hormones|mesh-ancestor
139276205|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276206|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139276207|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276208|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139276209|NCT04123873|Analgesics|analgesics|mesh-ancestor
139276210|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
139276211|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
139276212|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139276213|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139276214|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139276215|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276216|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276217|NCT04116203|Metformin|metformin|mesh-list
139276218|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139276219|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276220|NCT04106362|Cisplatin|cisplatin|mesh-list
139276221|NCT04106362|Cetuximab|cetuximab|mesh-list
139276222|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139276223|NCT04106362|Antibodies|antibodies|mesh-list
139276224|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
139276225|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139276226|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
139276227|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276228|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276229|NCT04079088|Interferons|interferons|mesh-list
139276230|NCT04079088|Interferon-beta|interferon-beta|mesh-list
139276231|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
139276232|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
139276233|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
139276234|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276235|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
139276236|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139276237|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
139276238|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276239|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139276247|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276248|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139276250|NCT04060030|Protective Agents|protective agents|mesh-ancestor
139276251|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
139276252|NCT04060030|Vitamins|vitamins|mesh-ancestor
139276253|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
138859712|NCT01463072|Paclitaxel|paclitaxel|mesh-list
139276261|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139276262|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
139276263|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139276264|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276265|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276266|NCT03819465|Paclitaxel|paclitaxel|mesh-list
139276267|NCT03819465|Carboplatin|carboplatin|mesh-list
139276268|NCT03819465|Gemcitabine|gemcitabine|mesh-list
139276269|NCT03819465|Pemetrexed|pemetrexed|mesh-list
139276270|NCT03819465|Durvalumab|durvalumab|mesh-list
139276271|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139276272|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276273|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
139276274|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
139276275|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
139276276|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276277|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139276278|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
139276279|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276280|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139276281|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139276282|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139276283|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
139276284|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139276285|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276286|NCT03637803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139276287|NCT03637803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276288|NCT03567720|Paclitaxel|paclitaxel|mesh-list
139276289|NCT03567720|Carboplatin|carboplatin|mesh-list
139276290|NCT03567720|Gemcitabine|gemcitabine|mesh-list
139276291|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
139276292|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139276293|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276294|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
139276295|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
139276296|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
139276297|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276298|NCT03567720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139276299|NCT03567720|Antimetabolites|antimetabolites|mesh-ancestor
139276300|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139276301|NCT03567720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139276302|NCT03519906|Metoprolol|metoprolol|mesh-list
139276303|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139276304|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139276305|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
139276306|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
139276307|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276308|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276309|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139276310|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139276311|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139276312|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
139276313|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139276314|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276315|NCT03519893|Losartan|losartan|mesh-list
139276316|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139276317|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139276318|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139276319|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139276320|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276321|NCT03519256|Nivolumab|nivolumab|mesh-list
139276322|NCT03519256|Linrodostat|linrodostat|mesh-list
139276323|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139276324|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276325|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139276326|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276327|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276328|NCT03507608|Flutamide|flutamide|mesh-list
139276329|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
138859782|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276330|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
139276331|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276332|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276333|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139276334|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276335|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139276336|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139276337|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276338|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139276339|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139276340|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276341|NCT03215927|Abatacept|abatacept|mesh-list
139276342|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139276343|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276344|NCT03215927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139276345|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276346|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139276347|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
139276348|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276349|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139276350|NCT02999230|Listerine|listerine|mesh-list
139276351|NCT02999230|Fluorides|fluorides|mesh-list
139276352|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
139276353|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
139276354|NCT02999230|Protective Agents|protective agents|mesh-ancestor
139276355|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276356|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139276357|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139276358|NCT02941315|Captopril|captopril|mesh-list
139276359|NCT02941315|Spironolactone|spironolactone|mesh-list
139276360|NCT02941315|Furosemide|furosemide|mesh-list
139276361|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139276362|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139276363|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
139276364|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276365|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276366|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139276367|NCT02941315|Diuretics|diuretics|mesh-ancestor
139276368|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
139276369|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139276370|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
139276371|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139276372|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276373|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139276374|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
139276375|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276376|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139276377|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139276378|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139276379|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139276380|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139276381|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276382|NCT02918721|Lidocaine|lidocaine|mesh-list
139276383|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
139276384|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
139276385|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
139276386|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139276387|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276388|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
139276389|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276390|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139276391|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139276392|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139276393|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139276394|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276395|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139276396|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
139276397|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
139276398|NCT02918721|Protective Agents|protective agents|mesh-ancestor
139276399|NCT02884180|Dexamethasone|dexamethasone|mesh-list
139276400|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139276401|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
138859861|NCT00101101|Analgesics|analgesics|mesh-ancestor
139276402|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
139276403|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276404|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276405|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139276406|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
139276407|NCT02884180|Hormones|hormones|mesh-ancestor
139276408|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276409|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139276410|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276411|NCT02799602|Docetaxel|docetaxel|mesh-list
139276412|NCT02799602|Androgens|androgens|mesh-list
139276413|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276414|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
139276415|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
139276416|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
139276417|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276418|NCT02799602|Hormones|hormones|mesh-ancestor
139276419|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276420|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276421|NCT02770040|Infliximab|infliximab|mesh-list
139276422|NCT02770040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139276423|NCT02770040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139276424|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
139276425|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139276426|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139276427|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139276428|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139276429|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276430|NCT02291705|Tramadol|tramadol|mesh-list
139276431|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139276432|NCT02291705|Narcotics|narcotics|mesh-ancestor
139276433|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139276434|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276435|NCT02291705|Analgesics|analgesics|mesh-ancestor
139276436|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
139276437|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276438|NCT02243709|Mifepristone|mifepristone|mesh-list
139276439|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139276440|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
139276441|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139276442|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276443|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139276444|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139276445|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139276446|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
139276447|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139276448|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139276449|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
139276450|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276451|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
139276452|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139276453|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139276454|NCT01896011|Teriparatide|teriparatide|mesh-list
139276455|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139276456|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276457|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139146658|NCT02253940|Ritonavir|ritonavir|mesh-list
139276458|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
139276459|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139276460|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
139276461|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276462|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
139276463|NCT01891396|Protective Agents|protective agents|mesh-ancestor
139276464|NCT01746225|Paclitaxel|paclitaxel|mesh-list
139276465|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139276466|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276467|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
139276468|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
139276469|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
139276470|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276471|NCT01716806|Nivolumab|nivolumab|mesh-list
139276472|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139276473|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139276474|NCT01716806|Dacarbazine|dacarbazine|mesh-list
139276475|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139276476|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276477|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139276478|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276479|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139276480|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
139276481|NCT01716806|Immunotoxins|immunotoxins|mesh-ancestor
139276482|NCT01716806|Immunoconjugates|immunoconjugates|mesh-ancestor
139276483|NCT01716806|Immunologic Factors|immunologic factors|mesh-ancestor
139276484|NCT01716806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276485|NCT01650545|Cyclosporine|cyclosporine|mesh-list
139276486|NCT01650545|Sirolimus|sirolimus|mesh-list
139276487|NCT01650545|Tacrolimus|tacrolimus|mesh-list
139276488|NCT01650545|Cyclosporins|cyclosporins|mesh-list
139276489|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139276490|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
139276491|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276492|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139276493|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276494|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276495|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
139276496|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139276497|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
139276498|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139276499|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139276500|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139276501|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276502|NCT01191008|Timolol|timolol|mesh-list
139276503|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139276504|NCT01191008|Latanoprost|latanoprost|mesh-list
139276505|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139276506|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276507|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139276508|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139276509|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
139276510|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139276511|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276512|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139276513|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139276514|NCT01155232|Teriparatide|teriparatide|mesh-list
139276515|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
139276516|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276517|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139276518|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139276519|NCT00821587|Cyclosporine|cyclosporine|mesh-list
139276520|NCT00821587|Tacrolimus|tacrolimus|mesh-list
139276521|NCT00821587|Cyclosporins|cyclosporins|mesh-list
139276522|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139276523|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
139276524|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276525|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139276526|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276527|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276528|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
139276529|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139276530|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
139276531|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139276532|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139642467|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139146733|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
139276533|NCT00751829|Olmesartan|olmesartan|mesh-list
139276534|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139276535|NCT00751829|Nitrendipine|nitrendipine|mesh-list
139276536|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139276537|NCT00751829|Diuretics|diuretics|mesh-ancestor
139276538|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
139276539|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276540|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139276541|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139276542|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276543|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139276544|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139276545|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139276546|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139276547|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
139276548|NCT00645801|Lubiprostone|lubiprostone|mesh-list
139276549|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139276550|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139276551|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276552|NCT00424099|Methylphenidate|methylphenidate|mesh-list
139276553|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139276554|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276555|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139276556|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139276557|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139276558|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276559|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
139276560|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139276561|NCT00382213|Olmesartan|olmesartan|mesh-list
139276562|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139276563|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139276564|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139276565|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139276566|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276567|NCT00176267|Paclitaxel|paclitaxel|mesh-list
139276568|NCT00176267|Carboplatin|carboplatin|mesh-list
139276569|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139276570|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276571|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
139276572|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
139276573|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
139276574|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276575|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
139276576|NCT02298920|Zoliflodacin|zoliflodacin|mesh-list
139276577|NCT02298920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139276578|NCT02298920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139276579|NCT02298920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276580|NCT02298920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276581|NCT02298920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276582|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139276583|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139276584|NCT03517670|Milrinone|milrinone|mesh-list
139276585|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139276586|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139276587|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
139276588|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139276589|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139276590|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276591|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276592|NCT03517670|Protective Agents|protective agents|mesh-ancestor
139276593|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276594|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
139276595|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139276596|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276597|NCT03316573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139276598|NCT03316573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276599|NCT00109668|Beclomethasone|beclomethasone|mesh-list
139276600|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139276601|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
139276602|NCT00109668|Hormones|hormones|mesh-ancestor
139642320|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276603|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276604|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276605|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139276606|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
139276607|NCT03104140|Ketamine|ketamine|mesh-list
139276608|NCT03104140|Thiopental|thiopental|mesh-list
139276609|NCT03104140|Analgesics|analgesics|mesh-ancestor
139276610|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
139276611|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276612|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276613|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139276614|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139276615|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
139276616|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
139276617|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139276618|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139276619|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139276620|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139276621|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276622|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
139276623|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139276624|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
139276625|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
139276626|NCT03520478|Bicalutamide|bicalutamide|mesh-list
139276627|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
139276628|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
139276629|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276630|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276631|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276632|NCT00102648|Temozolomide|temozolomide|mesh-list
139276633|NCT00102648|Lonafarnib|lonafarnib|mesh-list
139276634|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139276635|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
139276636|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276637|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276638|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276639|NCT03290287|Bromides|bromides|mesh-list
139276640|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
139276641|NCT02253888|Ritonavir|ritonavir|mesh-list
139276642|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139276643|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139276644|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
139276645|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276646|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276647|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139276648|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139276649|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
139276650|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139276651|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139276652|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139276653|NCT05430802|Pemetrexed|pemetrexed|mesh-list
139276654|NCT05430802|Aflutinib|aflutinib|mesh-list
139276655|NCT05430802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276656|NCT05430802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276657|NCT05430802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276658|NCT05430802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139276659|NCT05430802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139276660|NCT05430802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139276661|NCT05524038|Dexamethasone|dexamethasone|mesh-list
139276662|NCT05524038|Dexamethasone acetate|dexamethasone acetate|mesh-list
139276663|NCT05524038|Bupivacaine|bupivacaine|mesh-list
139276664|NCT05524038|BB 1101|bb 1101|mesh-list
139276665|NCT05524038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139276666|NCT05524038|Antiemetics|antiemetics|mesh-ancestor
139276667|NCT05524038|Autonomic Agents|autonomic agents|mesh-ancestor
139276668|NCT05524038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276669|NCT05524038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276670|NCT05524038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139276671|NCT05524038|Glucocorticoids|glucocorticoids|mesh-ancestor
139276672|NCT05524038|Hormones|hormones|mesh-ancestor
139276673|NCT05524038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276674|NCT05524038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139276675|NCT05524038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276676|NCT05524038|Protease Inhibitors|protease inhibitors|mesh-ancestor
139276677|NCT05524038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276678|NCT05524038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276679|NCT05524038|Anesthetics, Local|anesthetics, local|mesh-ancestor
139276680|NCT05524038|Anesthetics|anesthetics|mesh-ancestor
139276681|NCT05524038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139276682|NCT05524038|Sensory System Agents|sensory system agents|mesh-ancestor
139276683|NCT03240835|Docetaxel|docetaxel|mesh-list
139276684|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276685|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
139276686|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
139276687|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
139276688|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276689|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
139276690|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139276691|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276692|NCT04118868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139276693|NCT04118868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276694|NCT04900350|Azacitidine|azacitidine|mesh-list
139276695|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139276696|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
139276697|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276698|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276699|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276700|NCT02292290|Pioglitazone|pioglitazone|mesh-list
139276701|NCT02292290|Liraglutide|liraglutide|mesh-list
139276702|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139276703|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276704|NCT02292290|Incretins|incretins|mesh-ancestor
139276705|NCT02292290|Hormones|hormones|mesh-ancestor
139276706|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276707|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
139276708|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139276709|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139276710|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276711|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139276712|NCT02299232|Analgesics|analgesics|mesh-ancestor
139276713|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
139276714|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276715|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139276716|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139276717|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139276718|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
139276719|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139276720|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276721|NCT02963493|Dexamethasone|dexamethasone|mesh-list
139276722|NCT02963493|Melphalan|melphalan|mesh-list
139276723|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139276724|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
139276725|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
139276726|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276727|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276728|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139276729|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
139276730|NCT02963493|Hormones|hormones|mesh-ancestor
139276731|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276732|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139276733|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276734|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139276735|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
139276736|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276737|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139276738|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139276739|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
139276740|NCT02299310|Valsartan|valsartan|mesh-list
139276741|NCT02299310|Perindopril|perindopril|mesh-list
139276742|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139276743|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139276744|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139276745|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276746|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139276747|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
139276748|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276749|NCT03519776|Progesterone|progesterone|mesh-list
139276750|NCT03519776|Progestins|progestins|mesh-ancestor
139276751|NCT03519776|Hormones|hormones|mesh-ancestor
139276752|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276753|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276754|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
139276755|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139276756|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
139276757|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276758|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276759|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139276760|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
139276761|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139276762|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
139276763|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276764|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139276765|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139276766|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
139276767|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
139276768|NCT02295566|Protective Agents|protective agents|mesh-ancestor
139276769|NCT05283681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139276770|NCT05283681|Immunologic Factors|immunologic factors|mesh-ancestor
139276771|NCT05283681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276772|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139276773|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139276774|NCT03738397|Upadacitinib|upadacitinib|mesh-list
139276775|NCT03738397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139276776|NCT03738397|Immunologic Factors|immunologic factors|mesh-ancestor
139276777|NCT03738397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276778|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139276779|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139276780|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276781|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276782|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139276783|NCT03643497|Meropenem|meropenem|mesh-list
139276784|NCT03643497|Linezolid|linezolid|mesh-list
139276785|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
139276786|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139276787|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139276788|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276789|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276790|NCT03519542|Sunitinib|sunitinib|mesh-list
139276791|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276792|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139276793|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139276794|NCT03519542|Growth Substances|growth substances|mesh-ancestor
139276795|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276796|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
139276797|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139276798|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276799|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276800|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139276801|NCT03516500|Hematinics|hematinics|mesh-ancestor
139276802|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
139276803|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139276804|NCT02293148|Glycine|glycine|mesh-list
139276805|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139276806|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139276807|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139276808|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139276809|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276810|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276811|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276812|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139276813|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
139276814|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139276815|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276816|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139276817|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139276818|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139276819|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
139276820|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139276821|NCT03519152|Diclofenac|diclofenac|mesh-list
139276822|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139276823|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139276824|NCT03519152|Analgesics|analgesics|mesh-ancestor
139276825|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
139276826|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276827|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276828|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139276829|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139276830|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139276831|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276832|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276834|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139276835|NCT03516188|Antacids|antacids|mesh-list
139276836|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276837|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139276838|NCT03512990|Bupivacaine|bupivacaine|mesh-list
139276839|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
139276840|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
139276841|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139276842|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276843|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
139276844|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860305|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139276845|NCT03512834|Paclitaxel|paclitaxel|mesh-list
139276846|NCT03512834|Avelumab|avelumab|mesh-list
139276847|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139276848|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276849|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
139276850|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
139276851|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
139276852|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276853|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139276854|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139276855|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
139276856|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139276857|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
139276858|NCT03640221|Diuretics|diuretics|mesh-ancestor
139276859|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
139276860|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276861|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139276862|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139276863|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276864|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139276865|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139276866|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139276867|NCT03518528|Estradiol|estradiol|mesh-list
139276868|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139276869|NCT03518528|Estrogens|estrogens|mesh-ancestor
139276870|NCT03518528|Hormones|hormones|mesh-ancestor
139276871|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276872|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276873|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139276874|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
139276875|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139276876|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139276877|NCT03515798|Paclitaxel|paclitaxel|mesh-list
139276878|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139276879|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
139276880|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
139276881|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139276882|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276883|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
139276884|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
139276885|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
139276886|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276887|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139276888|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
139276889|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276890|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139276891|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139276892|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
139276893|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139276894|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139276895|NCT03515798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139276896|NCT03041701|Dasatinib|dasatinib|mesh-list
139276897|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276898|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276899|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139276900|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276901|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139276902|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
139276903|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139276904|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139276905|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139276906|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
139276907|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139276908|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276909|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139276910|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139276911|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139276912|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139276913|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276914|NCT02956629|Ribavirin|ribavirin|mesh-list
139276915|NCT02956629|Ruzasvir|ruzasvir|mesh-list
139276916|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
139276917|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
139276918|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276920|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139276921|NCT02297204|Aflibercept|aflibercept|mesh-list
139276922|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139276923|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139276924|NCT02297204|Growth Substances|growth substances|mesh-ancestor
139276925|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276926|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
139276927|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276928|NCT02294006|Metformin|metformin|mesh-list
139276929|NCT02294006|Everolimus|everolimus|mesh-list
139276930|NCT02294006|Octreotide|octreotide|mesh-list
139276931|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139276932|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276933|NCT02294006|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139276934|NCT02294006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139276935|NCT02294006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276936|NCT02294006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276937|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139276938|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
139276939|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276940|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139276941|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139276942|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139276943|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139276944|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276945|NCT02294084|Incretins|incretins|mesh-ancestor
139276946|NCT02294084|Hormones|hormones|mesh-ancestor
139276947|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139276948|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139276949|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
139276950|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276951|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276952|NCT01597258|Crizotinib|crizotinib|mesh-list
139276953|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139276954|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139276955|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139276956|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276957|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
139276958|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139276959|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
139276960|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276961|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
139276962|NCT02958267|Protective Agents|protective agents|mesh-ancestor
139276963|NCT02302430|Oxytocin|oxytocin|mesh-list
139276964|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
139276965|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139276966|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276967|NCT02300948|Folic Acid|folic acid|mesh-list
139276968|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
139276969|NCT02300948|Hematinics|hematinics|mesh-ancestor
139276970|NCT02300948|Vitamins|vitamins|mesh-ancestor
139276971|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
139276972|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276973|NCT02302508|Clopidogrel|clopidogrel|mesh-list
139276974|NCT02302508|Ticagrelor|ticagrelor|mesh-list
139276975|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139276976|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139276977|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139276978|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139276979|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139276980|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
139276981|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139276982|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276983|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276985|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
139276986|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139276987|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139276988|NCT02301026|Hematinics|hematinics|mesh-ancestor
139276989|NCT01952574|Erenumab|erenumab|mesh-list
139276990|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139276991|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139276992|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276993|NCT01952574|Analgesics|analgesics|mesh-ancestor
139276994|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
139276995|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139276996|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139276998|NCT02302586|Morphine|morphine|mesh-list
139276999|NCT02302586|Bupivacaine|bupivacaine|mesh-list
139277000|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
139277001|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
139277002|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139277003|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277004|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
139277005|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277006|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139277007|NCT02302586|Narcotics|narcotics|mesh-ancestor
139277008|NCT02302586|Analgesics|analgesics|mesh-ancestor
139277009|NCT01551472|Vitamin E|vitamin e|mesh-list
139277010|NCT01551472|Vitamins|vitamins|mesh-ancestor
139277011|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
139277012|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277013|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
139277014|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277015|NCT01551472|Protective Agents|protective agents|mesh-ancestor
139277016|NCT02254044|Maytansine|maytansine|mesh-list
139277017|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
139277018|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139277019|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277020|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
139277021|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
139277022|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
139277023|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277024|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277025|NCT02254044|Immunotoxins|immunotoxins|mesh-ancestor
139277026|NCT02254044|Immunoconjugates|immunoconjugates|mesh-ancestor
139277027|NCT02254044|Immunologic Factors|immunologic factors|mesh-ancestor
139277028|NCT02254044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277029|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
139277030|NCT02959437|Azacitidine|azacitidine|mesh-list
139277031|NCT02959437|INCB057643|incb057643|mesh-list
139277032|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277033|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277034|NCT02959437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139277035|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277036|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139277037|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
139277038|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277039|NCT02297906|Ketorolac|ketorolac|mesh-list
139277040|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139277041|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139277042|NCT02297906|Analgesics|analgesics|mesh-ancestor
139277043|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
139277044|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277045|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277046|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139277047|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139277048|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139277049|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277050|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277051|NCT03511820|Amphotericin B|amphotericin b|mesh-list
139277052|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139277053|NCT03511820|Amebicides|amebicides|mesh-ancestor
139277054|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139277055|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139277056|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277057|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139277058|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
139277059|NCT02957331|Propranolol|propranolol|mesh-list
139277060|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139277061|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139277062|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
139277063|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139277064|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277065|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277066|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139277067|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139277068|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
139277069|NCT02298062|Infliximab|infliximab|mesh-list
138860534|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139277070|NCT02298062|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139277071|NCT02298062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139277072|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
139277073|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139277074|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139277075|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
139277076|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
139277077|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277078|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139277079|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277080|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277081|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
139381850|NCT03180957|Adalimumab|adalimumab|mesh-list
139277082|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139277083|NCT03748966|Calcitriol|calcitriol|mesh-list
139277084|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
139277085|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139277086|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277087|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139277088|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139277089|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277090|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139277091|NCT03748966|Vitamins|vitamins|mesh-ancestor
139277092|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
139277093|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139277094|NCT05891145|Midazolam|midazolam|mesh-list
139277095|NCT05891145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139277096|NCT05891145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139277097|NCT05891145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139277098|NCT05891145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277099|NCT05891145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139277100|NCT05891145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139277101|NCT05891145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139277102|NCT05891145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139277103|NCT05891145|Anesthetics, General|anesthetics, general|mesh-ancestor
139277104|NCT05891145|Anesthetics|anesthetics|mesh-ancestor
139277105|NCT05891145|GABA Modulators|gaba modulators|mesh-ancestor
139277106|NCT05891145|GABA Agents|gaba agents|mesh-ancestor
139277107|NCT05891145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139277108|NCT05891145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277109|NCT05891080|Paclitaxel|paclitaxel|mesh-list
139277110|NCT05891080|Carboplatin|carboplatin|mesh-list
139277111|NCT05891080|Pemetrexed|pemetrexed|mesh-list
139277112|NCT05891080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139277113|NCT05891080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277114|NCT05891080|Tubulin Modulators|tubulin modulators|mesh-ancestor
139277115|NCT05891080|Antimitotic Agents|antimitotic agents|mesh-ancestor
139277116|NCT05891080|Mitosis Modulators|mitosis modulators|mesh-ancestor
139277117|NCT05891080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277118|NCT05891080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277119|NCT05891080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139277120|NCT05891080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139277121|NCT05890911|Dopamine|dopamine|mesh-list
139277122|NCT05890911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139277123|NCT05890911|Sympathomimetics|sympathomimetics|mesh-ancestor
139277124|NCT05890911|Autonomic Agents|autonomic agents|mesh-ancestor
139277125|NCT05890911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277126|NCT05890911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147328|NCT02145832|Fluconazole|fluconazole|mesh-list
139277127|NCT05890911|Dopamine Agents|dopamine agents|mesh-ancestor
139277128|NCT05890911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139277129|NCT05890911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277130|NCT05890911|Protective Agents|protective agents|mesh-ancestor
139277131|NCT05890768|Risperidone|risperidone|mesh-list
139277132|NCT05890768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139277133|NCT05890768|Serotonin Agents|serotonin agents|mesh-ancestor
139277134|NCT05890768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139277135|NCT05890768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277136|NCT05890768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277137|NCT05890768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139277138|NCT05890768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139277139|NCT05890768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139277140|NCT05890768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139277141|NCT05890768|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139277142|NCT05890768|Dopamine Agents|dopamine agents|mesh-ancestor
139277143|NCT05890703|Lidocaine|lidocaine|mesh-list
139277144|NCT05890703|Tetracaine|tetracaine|mesh-list
139277145|NCT05890703|Anesthetics, Local|anesthetics, local|mesh-ancestor
139277146|NCT05890703|Anesthetics|anesthetics|mesh-ancestor
139277147|NCT05890703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139277148|NCT05890703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277149|NCT05890703|Sensory System Agents|sensory system agents|mesh-ancestor
139277150|NCT05890703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277151|NCT05890703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139277152|NCT05890703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139277153|NCT05890703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138838319|NCT00815269|Desflurane|desflurane|mesh-list
139277154|NCT05890703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139277155|NCT05890703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277156|NCT05890664|Colchicine|colchicine|mesh-list
139277157|NCT05890664|Gout Suppressants|gout suppressants|mesh-ancestor
139277158|NCT05890664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139277159|NCT05890664|Tubulin Modulators|tubulin modulators|mesh-ancestor
139277160|NCT05890664|Antimitotic Agents|antimitotic agents|mesh-ancestor
139277161|NCT05890664|Mitosis Modulators|mitosis modulators|mesh-ancestor
139277162|NCT05890664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277163|NCT05890664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277164|NCT05890495|Lidocaine|lidocaine|mesh-list
139277165|NCT05890495|Anesthetics, Local|anesthetics, local|mesh-ancestor
139277166|NCT05890495|Anesthetics|anesthetics|mesh-ancestor
139277167|NCT05890495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139277168|NCT05890495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277169|NCT05890495|Sensory System Agents|sensory system agents|mesh-ancestor
139277170|NCT05890495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277171|NCT05890495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139277172|NCT05890495|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139277173|NCT05890495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139277174|NCT05890495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139277175|NCT05890495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277176|NCT05890287|Tamoxifen|tamoxifen|mesh-list
139277177|NCT05890287|Letrozole|letrozole|mesh-list
139277178|NCT05890287|Fulvestrant|fulvestrant|mesh-list
139277179|NCT05890287|Anastrozole|anastrozole|mesh-list
139277180|NCT05890287|Exemestane|exemestane|mesh-list
139277181|NCT05890287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277182|NCT05890287|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139277183|NCT05890287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139277184|NCT05890287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277185|NCT05890287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277186|NCT05890287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139277187|NCT05890287|Hormone Antagonists|hormone antagonists|mesh-ancestor
139277188|NCT05890287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139277189|NCT05890287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277190|NCT05890287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139277191|NCT05890287|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139277192|NCT05890287|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139277193|NCT05890287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139277194|NCT05890287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139277195|NCT05890235|Tamsulosin|tamsulosin|mesh-list
139277196|NCT05890235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139277197|NCT05890235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139277198|NCT05890235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139642468|NCT01891513|Perindopril|perindopril|mesh-list
139277199|NCT05890235|Adrenergic Agents|adrenergic agents|mesh-ancestor
139277200|NCT05890235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139277201|NCT05890235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277202|NCT05890235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277203|NCT05890235|Urological Agents|urological agents|mesh-ancestor
139277205|NCT05887505|Vitamins|vitamins|mesh-ancestor
139277206|NCT05887505|Micronutrients|micronutrients|mesh-ancestor
139277207|NCT05887505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277208|NCT05887505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139277209|NCT05882162|Calcium|calcium|mesh-list
139277210|NCT05882162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139277211|NCT05882162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277212|NCT05881486|Ondansetron|ondansetron|mesh-list
139277213|NCT05881486|Fosaprepitant|fosaprepitant|mesh-list
139277214|NCT05881486|Aprepitant|aprepitant|mesh-list
139277215|NCT05881486|Antiemetics|antiemetics|mesh-ancestor
139277216|NCT05881486|Autonomic Agents|autonomic agents|mesh-ancestor
139277217|NCT05881486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277218|NCT05881486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277219|NCT05881486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139277223|NCT05881486|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139277224|NCT05881486|Serotonin Agents|serotonin agents|mesh-ancestor
139277225|NCT05881486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139277226|NCT05881486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277227|NCT05881486|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139277228|NCT05770297|Propolis|propolis|mesh-list
139277229|NCT05770297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277230|NCT05760378|Carboplatin|carboplatin|mesh-list
139277231|NCT05760378|Capecitabine|capecitabine|mesh-list
139277232|NCT05760378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277233|NCT05760378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139277234|NCT05760378|Antimetabolites|antimetabolites|mesh-ancestor
139277235|NCT05760378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277236|NCT05744635|Tacrolimus|tacrolimus|mesh-list
139277237|NCT05744635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139277238|NCT05744635|Immunologic Factors|immunologic factors|mesh-ancestor
139277239|NCT05744635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277240|NCT05744635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139277241|NCT05744635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277242|NCT05744635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277243|NCT05733689|Paclitaxel|paclitaxel|mesh-list
139277244|NCT05733689|Docetaxel|docetaxel|mesh-list
139277245|NCT05733689|Carboplatin|carboplatin|mesh-list
139277246|NCT05733689|Pembrolizumab|pembrolizumab|mesh-list
139277247|NCT05733689|Nivolumab|nivolumab|mesh-list
139277248|NCT05733689|Irinotecan|irinotecan|mesh-list
139277249|NCT05733689|Folfirinox|folfirinox|mesh-list
139277250|NCT05733689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139277251|NCT05733689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277252|NCT05733689|Tubulin Modulators|tubulin modulators|mesh-ancestor
139277253|NCT05733689|Antimitotic Agents|antimitotic agents|mesh-ancestor
139277254|NCT05733689|Mitosis Modulators|mitosis modulators|mesh-ancestor
139277255|NCT05733689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277256|NCT05733689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277257|NCT05733689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139277258|NCT05733689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139277259|NCT05733689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139277260|NCT05733689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277261|NCT05723874|Bosentan|bosentan|mesh-list
139277262|NCT05723874|BI 425809|bi 425809|mesh-list
139277263|NCT05723874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139277264|NCT05723874|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139277265|NCT05723874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277266|NCT05723874|Nootropic Agents|nootropic agents|mesh-ancestor
139277267|NCT05663957|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139277268|NCT05663957|Antiviral Agents|antiviral agents|mesh-ancestor
139277269|NCT05663957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277273|NCT05608837|Dexamethasone|dexamethasone|mesh-list
139277274|NCT05608837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139277275|NCT05608837|Antiemetics|antiemetics|mesh-ancestor
139277276|NCT05608837|Autonomic Agents|autonomic agents|mesh-ancestor
139277277|NCT05608837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277278|NCT05608837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277279|NCT05608837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139277280|NCT05608837|Glucocorticoids|glucocorticoids|mesh-ancestor
139277281|NCT05608837|Hormones|hormones|mesh-ancestor
139277282|NCT05608837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139277283|NCT05608837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139277284|NCT05608837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277285|NCT05489887|Ceritinib|ceritinib|mesh-list
139277286|NCT05489887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277287|NCT05489887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139277288|NCT05489887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277289|NCT05489887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277290|NCT05446727|Ropivacaine|ropivacaine|mesh-list
139277291|NCT05446727|Anesthetics, Local|anesthetics, local|mesh-ancestor
139277292|NCT05446727|Anesthetics|anesthetics|mesh-ancestor
139277293|NCT05446727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139277294|NCT05446727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277295|NCT05446727|Sensory System Agents|sensory system agents|mesh-ancestor
138860828|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
139277296|NCT05446727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277297|NCT05354102|Nivolumab|nivolumab|mesh-list
139277298|NCT05354102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277299|NCT05354102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277300|NCT05354102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139277301|NCT05354102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277302|NCT05349890|Pembrolizumab|pembrolizumab|mesh-list
139277303|NCT05349890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277304|NCT05349890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277305|NCT05349890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139277306|NCT05349890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277307|NCT05301517|Epoetin Alfa|epoetin alfa|mesh-list
139277308|NCT05301517|Hematinics|hematinics|mesh-ancestor
139277309|NCT05296304|Bexarotene|bexarotene|mesh-list
139277310|NCT05296304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277311|NCT05271448|Losartan|losartan|mesh-list
139277312|NCT05271448|Valsartan|valsartan|mesh-list
139277313|NCT05271448|Candesartan|candesartan|mesh-list
139277314|NCT05271448|Candesartan cilexetil|candesartan cilexetil|mesh-list
139277315|NCT05271448|Ramipril|ramipril|mesh-list
139277316|NCT05271448|Enalapril|enalapril|mesh-list
139277317|NCT05271448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139277318|NCT05271448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139277319|NCT05271448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139277320|NCT05271448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139277321|NCT05271448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277322|NCT05271448|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139277323|NCT05271448|Protease Inhibitors|protease inhibitors|mesh-ancestor
139277324|NCT05271448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277325|NCT05254405|Brexanolone|brexanolone|mesh-list
139277326|NCT05254405|Neurosteroids|neurosteroids|mesh-ancestor
139277327|NCT05254405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139277328|NCT05254405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277329|NCT05254405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277330|NCT05254405|GABA Modulators|gaba modulators|mesh-ancestor
139277331|NCT05254405|GABA Agents|gaba agents|mesh-ancestor
139277332|NCT05215106|Durvalumab|durvalumab|mesh-list
139277333|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277334|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277335|NCT05177731|Cytarabine|cytarabine|mesh-list
139277336|NCT05177731|Decitabine|decitabine|mesh-list
139277337|NCT05177731|Venetoclax|venetoclax|mesh-list
139277338|NCT05177731|Idarubicin|idarubicin|mesh-list
139277339|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139277340|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
139277341|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277342|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277343|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
139277344|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277345|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139277346|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
139277347|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277348|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277349|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139277350|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139277351|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139277352|NCT05110482|Oxytocin|oxytocin|mesh-list
139277353|NCT05110482|Carbetocin|carbetocin|mesh-list
139277354|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
139277355|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139277356|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277357|NCT05029960|Brivaracetam|brivaracetam|mesh-list
139277358|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
139277359|NCT05005000|Triamcinolone|triamcinolone|mesh-list
139277360|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139277361|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139277362|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139277363|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139277364|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
139277365|NCT05005000|Hormones|hormones|mesh-ancestor
139277366|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139277367|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277368|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139277369|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
139277370|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277371|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277373|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277374|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277375|NCT04987996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139277376|NCT04987996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277377|NCT04916509|Fulvestrant|fulvestrant|mesh-list
139277378|NCT04916509|Palbociclib|palbociclib|mesh-list
139277379|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139277380|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139277381|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838542|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
139277382|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139277383|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139277384|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
139277385|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139277386|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277387|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139277388|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277389|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277390|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139277391|NCT04882774|Treprostinil|treprostinil|mesh-list
139277392|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139277393|NCT04846920|Belzutifan|belzutifan|mesh-list
139277394|NCT04846920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277395|NCT04774406|Olaparib|olaparib|mesh-list
139277396|NCT04774406|Niraparib|niraparib|mesh-list
139277397|NCT04774406|Talazoparib|talazoparib|mesh-list
139277398|NCT04774406|Veliparib|veliparib|mesh-list
139277399|NCT04774406|Fluzoparib|fluzoparib|mesh-list
139277400|NCT04774406|Rucaparib|rucaparib|mesh-list
139277401|NCT04774406|Pamiparib|pamiparib|mesh-list
139277402|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139277403|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277404|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277405|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277406|NCT04752813|Vitamin K|vitamin k|mesh-list
139277407|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
139277408|NCT04752813|Temozolomide|temozolomide|mesh-list
139277409|NCT04752813|Vitamins|vitamins|mesh-ancestor
139277410|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
139277411|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277412|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139277413|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
139277414|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277415|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277416|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139277417|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139277418|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
139277419|NCT04752813|Coagulants|coagulants|mesh-ancestor
139277420|NCT04735367|Letrozole|letrozole|mesh-list
139277421|NCT04735367|Palbociclib|palbociclib|mesh-list
139277422|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277423|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139277424|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139277425|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277426|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277427|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139277428|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
139277429|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139277430|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277431|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139277432|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
139277433|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
139277434|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139277435|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139277436|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277437|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277438|NCT04715113|Urological Agents|urological agents|mesh-ancestor
139277439|NCT04713657|Propranolol|propranolol|mesh-list
139277440|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139277441|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139277442|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
139277443|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139277444|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277445|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860901|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
139277446|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139277447|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139277448|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
139277449|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
139277450|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
139277451|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139277452|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139277453|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277454|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277455|NCT04706546|Urological Agents|urological agents|mesh-ancestor
139277456|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
139277457|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
139277458|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139277459|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139277460|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277461|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277462|NCT04704440|Urological Agents|urological agents|mesh-ancestor
139277463|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
139277464|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
139277465|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139277466|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139277467|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277468|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277469|NCT04697862|Urological Agents|urological agents|mesh-ancestor
139277470|NCT04696029|Eflornithine|eflornithine|mesh-list
139277471|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277472|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139277473|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139277474|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139277475|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277476|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139277477|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277478|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277479|NCT04652544|Vitamin D|vitamin d|mesh-list
139277480|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
139277481|NCT04652544|Vitamins|vitamins|mesh-ancestor
139277482|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
139277483|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277484|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139277485|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139277486|NCT04625699|Durvalumab|durvalumab|mesh-list
139277487|NCT04625699|Tremelimumab|tremelimumab|mesh-list
139277488|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277489|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277490|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139277491|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139277492|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139277493|NCT04510584|Bevacizumab|bevacizumab|mesh-list
139277494|NCT04510584|Atezolizumab|atezolizumab|mesh-list
139277495|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277496|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277497|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139277498|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139277499|NCT04510584|Growth Substances|growth substances|mesh-ancestor
139277500|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277501|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
139277502|NCT04510584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139277503|NCT04510584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277504|NCT04500847|Emtricitabine|emtricitabine|mesh-list
139277505|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
139277506|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277507|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139277508|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139277509|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277510|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277511|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139277512|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139277513|NCT04484532|Vaccines|vaccines|mesh-list
139277514|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
139277515|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277516|NCT04483583|Clopidogrel|clopidogrel|mesh-list
139277517|NCT04483583|Ticagrelor|ticagrelor|mesh-list
139277518|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139277519|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139277520|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139277522|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
139277523|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139277524|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277525|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277526|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
139277527|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
139277528|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139277529|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139277530|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277531|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277532|NCT04447989|Urological Agents|urological agents|mesh-ancestor
139277533|NCT04375527|Nivolumab|nivolumab|mesh-list
139277534|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277535|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277536|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139277537|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277538|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
139277539|NCT04218799|Mupirocin|mupirocin|mesh-list
139277540|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139277541|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277542|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
139277543|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139277544|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139277545|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277546|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277547|NCT04189445|Futibatinib|futibatinib|mesh-list
139277548|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277549|NCT04179032|Belimumab|belimumab|mesh-list
139277550|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139277551|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
139277552|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277553|NCT04026776|Allopurinol|allopurinol|mesh-list
139277554|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
139277555|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277556|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277557|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
139277558|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139277559|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139277560|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
139277561|NCT04026776|Protective Agents|protective agents|mesh-ancestor
139277562|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277563|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
139277564|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277565|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139277566|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277567|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277568|NCT03831113|Buprenorphine|buprenorphine|mesh-list
139277569|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139277570|NCT03831113|Narcotics|narcotics|mesh-ancestor
139277571|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139277572|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277573|NCT03831113|Analgesics|analgesics|mesh-ancestor
139277574|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
139277575|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277576|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139277577|NCT03824561|Vedolizumab|vedolizumab|mesh-list
139277578|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139277579|NCT03821857|Corticosterone|corticosterone|mesh-list
139277580|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139277581|NCT04305236|Fulvestrant|fulvestrant|mesh-list
139277582|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139277583|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277584|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139277585|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139277586|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
139277587|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139277588|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277589|NCT03657160|Vedolizumab|vedolizumab|mesh-list
139277590|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139277591|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
139277593|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
138861068|NCT02711202|Infliximab|infliximab|mesh-list
139277594|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277595|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
139277596|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277597|NCT03508726|Protective Agents|protective agents|mesh-ancestor
139277598|NCT03404661|Secretin|secretin|mesh-list
139277599|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139277600|NCT03404661|Hormones|hormones|mesh-ancestor
139277601|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139277602|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277603|NCT03370172|Factor VIII|factor viii|mesh-list
139277604|NCT03370172|Coagulants|coagulants|mesh-ancestor
139277605|NCT03319537|Pemetrexed|pemetrexed|mesh-list
139277606|NCT03319537|Pevonedistat|pevonedistat|mesh-list
139277607|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277608|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277609|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277610|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139277611|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139277612|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
139277613|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277614|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277615|NCT03279692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139277616|NCT03279692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277617|NCT03100786|Dexamethasone|dexamethasone|mesh-list
139277618|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139277619|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
139277620|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
139277621|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277622|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277623|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139277624|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
139277625|NCT03100786|Hormones|hormones|mesh-ancestor
139277626|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139277627|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139277628|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277629|NCT03043053|Oxytocin|oxytocin|mesh-list
139277630|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
139277631|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139277632|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277633|NCT03001882|Nivolumab|nivolumab|mesh-list
139277634|NCT03001882|Ipilimumab|ipilimumab|mesh-list
139277635|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277636|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277637|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139277638|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277639|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
139277640|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139277641|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277642|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139277643|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277644|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
139277645|NCT02932956|Fludarabine|fludarabine|mesh-list
139277646|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
139277647|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139277648|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
139277649|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277650|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139277651|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139277652|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
139277653|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277654|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277655|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139277656|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139277657|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
139277658|NCT02843165|Immunomodulating Agents|immunomodulating agents|mesh-list
139277659|NCT02843165|Immunologic Factors|immunologic factors|mesh-list
139277660|NCT02843165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277661|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
139277662|NCT02807467|Propofol|propofol|mesh-list
139277663|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139277664|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139277665|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277666|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139277667|NCT02807467|Analgesics|analgesics|mesh-ancestor
139277669|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277670|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139277671|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139277672|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139277673|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
139277674|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139277675|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277676|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139277677|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
139277678|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
139277679|NCT02794428|Eflornithine|eflornithine|mesh-list
139277680|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277681|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139277682|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139277683|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139277684|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277685|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139277686|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277687|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277688|NCT02740179|Eplerenone|eplerenone|mesh-list
139277689|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139277690|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
139277691|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139277692|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277693|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139277694|NCT02740179|Diuretics|diuretics|mesh-ancestor
139277695|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
139277696|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139277697|NCT02679144|Eflornithine|eflornithine|mesh-list
139277698|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277699|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139277700|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139277701|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139277702|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277703|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139277704|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277705|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277706|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
139277707|NCT02650986|Decitabine|decitabine|mesh-list
139277708|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139277709|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
139277710|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277711|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139277712|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139277713|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
139277714|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277715|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277716|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139277717|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139277718|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
139277719|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277720|NCT02619409|Bupivacaine|bupivacaine|mesh-list
139277721|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
139277722|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
139277723|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139277724|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277725|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
139277726|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277727|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
139277728|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139277729|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139277730|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277731|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
139277732|NCT02606045|Coagulants|coagulants|mesh-ancestor
139277733|NCT02603432|Avelumab|avelumab|mesh-list
139277734|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139277735|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277736|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277737|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
139277738|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277739|NCT02582866|Lacosamide|lacosamide|mesh-list
139277740|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
138861206|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
139277741|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139277742|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139277743|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139277744|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277745|NCT02559778|Eflornithine|eflornithine|mesh-list
139277746|NCT02559778|Sorafenib|sorafenib|mesh-list
139277747|NCT02559778|Dasatinib|dasatinib|mesh-list
139277748|NCT02559778|Vorinostat|vorinostat|mesh-list
139277749|NCT02559778|Ceritinib|ceritinib|mesh-list
139277750|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277751|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139277752|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277753|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277754|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139277755|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139277756|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139277757|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139277758|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277759|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139277760|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
139277761|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139277762|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
139277763|NCT02453373|Plasminogen|plasminogen|mesh-list
139277764|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139277765|NCT02453373|Propofol|propofol|mesh-list
139277766|NCT02453373|Etomidate|etomidate|mesh-list
139277767|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139277768|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139277769|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277770|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139277771|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
139277772|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
139277773|NCT02453373|Analgesics|analgesics|mesh-ancestor
139277774|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
139277775|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277776|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139277777|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
139277778|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139277779|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139277780|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277781|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139277782|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
139277783|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139277784|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139277785|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139277786|NCT01734928|Thalidomide|thalidomide|mesh-list
139277787|NCT01734928|Dexamethasone|dexamethasone|mesh-list
139277788|NCT01734928|Bortezomib|bortezomib|mesh-list
139277789|NCT01734928|Pomalidomide|pomalidomide|mesh-list
139277790|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139277791|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
139277792|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
139277793|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277794|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277795|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139277796|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
139277797|NCT01734928|Hormones|hormones|mesh-ancestor
139277798|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139277799|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139277800|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277801|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
139277802|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139277803|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139277804|NCT01734928|Growth Substances|growth substances|mesh-ancestor
139277805|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
139277806|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139277807|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
139277808|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139277809|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277810|NCT01682616|Rituximab|rituximab|mesh-list
139277811|NCT01682616|Venetoclax|venetoclax|mesh-list
139277812|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277813|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277814|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
139277815|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277816|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139277817|NCT01430572|Everolimus|everolimus|mesh-list
139277819|NCT01430572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139277820|NCT01430572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277821|NCT01430572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277822|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139277823|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
139277824|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277825|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277826|NCT00950430|Corticosterone|corticosterone|mesh-list
139277827|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139277828|NCT00909051|Acarbose|acarbose|mesh-list
139277829|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139277830|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277831|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277832|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139277833|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277834|NCT05015608|Carboplatin|carboplatin|mesh-list
139277835|NCT05015608|Pemetrexed|pemetrexed|mesh-list
139277836|NCT05015608|Osimertinib|osimertinib|mesh-list
139277837|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277838|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277839|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277840|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139277841|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139277842|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139277843|NCT03510416|Apatinib|apatinib|mesh-list
139277844|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277845|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139277846|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277847|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277848|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
139277849|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139277850|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277851|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
139277852|NCT02646124|Naproxen|naproxen|mesh-list
139277853|NCT02646124|Diazepam|diazepam|mesh-list
139277854|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139277855|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139277856|NCT02646124|Analgesics|analgesics|mesh-ancestor
139277857|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
139277858|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139277859|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277860|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139277861|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139277862|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
139277863|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139277864|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277865|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277866|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139277867|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
139277868|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
139277869|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
139277870|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139277871|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139277872|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139277873|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139277874|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139277875|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139277876|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139277877|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139277878|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139277879|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
139277880|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
139277881|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
139277882|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
139277883|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139277884|NCT02306564|Cabergoline|cabergoline|mesh-list
139277885|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139277886|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139277887|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
139277888|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
139277889|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139277890|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277891|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277892|NCT02301494|Fluocinonide|fluocinonide|mesh-list
139277893|NCT02301494|Imiquimod|imiquimod|mesh-list
139277894|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139277895|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
139277896|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277897|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277898|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
139277899|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139277900|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
139277902|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139277903|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139277904|NCT03101800|Azathioprine|azathioprine|mesh-list
139277905|NCT03101800|Allopurinol|allopurinol|mesh-list
139277906|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
139277907|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277908|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277909|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
139277910|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139277911|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139277912|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
139277913|NCT03101800|Protective Agents|protective agents|mesh-ancestor
139277914|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277915|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139277916|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277917|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139277918|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
139277919|NCT03507842|Cytarabine|cytarabine|mesh-list
139277920|NCT03507842|Daunorubicin|daunorubicin|mesh-list
139277921|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139277922|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
139277923|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277924|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277925|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
139277926|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277927|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139277928|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
139277929|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277930|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139277931|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139277932|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139277933|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277934|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
139277935|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
139277936|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139277937|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
139277938|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277939|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139277940|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139277941|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
139277942|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277943|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277944|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139277945|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277946|NCT02301650|Tenofovir|tenofovir|mesh-list
139277947|NCT02301650|Lamivudine|lamivudine|mesh-list
139277948|NCT02301650|Telbivudine|telbivudine|mesh-list
139277949|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
139277950|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277951|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139277952|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139277953|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277954|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277955|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139277956|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139277957|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
139277958|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
139277959|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139277960|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139277961|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277962|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277963|NCT03510338|Urological Agents|urological agents|mesh-ancestor
139277964|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
139277965|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277966|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277967|NCT02303366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138861429|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
139277968|NCT02303366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277969|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139277970|NCT02301806|Glimepiride|glimepiride|mesh-list
139277971|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139277972|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139277973|NCT02301806|Incretins|incretins|mesh-ancestor
139277975|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139277976|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139277977|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
139277978|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277979|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277980|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139277981|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139277982|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
139277983|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
139277984|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139277985|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139277986|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
139277987|NCT02301962|Panitumumab|panitumumab|mesh-list
139277988|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139277989|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139277990|NCT03507374|Alirocumab|alirocumab|mesh-list
139277991|NCT03507374|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139277992|NCT03507374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139277993|NCT03507374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139277994|NCT03507374|Antimetabolites|antimetabolites|mesh-ancestor
139277995|NCT03507374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277996|NCT03507374|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139277997|NCT03507374|Protease Inhibitors|protease inhibitors|mesh-ancestor
139277998|NCT03507374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139277999|NCT03507374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139278000|NCT02639650|Dactinomycin|dactinomycin|mesh-list
139278001|NCT02639650|Paclitaxel|paclitaxel|mesh-list
139278002|NCT02639650|Etoposide|etoposide|mesh-list
139278003|NCT02639650|Vincristine|vincristine|mesh-list
139278004|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
139278005|NCT02639650|Carboplatin|carboplatin|mesh-list
139278006|NCT02639650|Methotrexate|methotrexate|mesh-list
139278007|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139278008|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278009|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
139278010|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
139278011|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
139278012|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278013|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139278014|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
139278015|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278016|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139278017|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139278018|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
139278019|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139278020|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139278021|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
139278022|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139278023|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139278024|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
139278025|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
139278026|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278027|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139278028|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139278029|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139278030|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139278031|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139278032|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278033|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139278034|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139278035|NCT03581734|Vaccines|vaccines|mesh-list
139278036|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
139278037|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278038|NCT02306798|Mesalamine|mesalamine|mesh-list
139278039|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139278040|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139278041|NCT02306798|Analgesics|analgesics|mesh-ancestor
139278042|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
138861505|NCT04688814|Morphine|morphine|mesh-list
139278043|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278044|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278045|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139278046|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139278047|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
139278048|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
139278049|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278050|NCT03509714|Protective Agents|protective agents|mesh-ancestor
139278051|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278052|NCT03509714|Vitamins|vitamins|mesh-ancestor
139278053|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
139278054|NCT02302274|Flecainide|flecainide|mesh-list
139278055|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139278056|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139278057|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139278058|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139278059|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278060|NCT02303600|Montelukast|montelukast|mesh-list
139278061|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139278062|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
139278063|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139278064|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
139278065|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139278066|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278067|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139278068|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139278069|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278070|NCT04463342|Methamphetamine|methamphetamine|mesh-list
139278071|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139278072|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278073|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
139278074|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
139278075|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278076|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
139278077|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278078|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278079|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
139278080|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139278081|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139278082|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139278083|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139278084|NCT02303912|Carboplatin|carboplatin|mesh-list
139278085|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278086|NCT01597492|Belimumab|belimumab|mesh-list
139278087|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139278088|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
139278089|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278090|NCT04569994|Insulin|insulin|mesh-list
139278091|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139278092|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278093|NCT00109590|Ritonavir|ritonavir|mesh-list
139278094|NCT00109590|Lopinavir|lopinavir|mesh-list
139278095|NCT00109590|Zidovudine|zidovudine|mesh-list
139278096|NCT00109590|Nevirapine|nevirapine|mesh-list
139278097|NCT00109590|Didanosine|didanosine|mesh-list
139278098|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139278099|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139278100|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
139278101|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278102|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278103|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139278104|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139278105|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
139278106|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278107|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139278108|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139278110|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139278111|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139278112|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139278113|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139278114|NCT05243446|Losartan|losartan|mesh-list
139278115|NCT05243446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139278116|NCT05243446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139278117|NCT05243446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139278118|NCT05243446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139278119|NCT05243446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278121|NCT02143362|Anesthetics|anesthetics|mesh-list
139278122|NCT02143362|Propofol|propofol|mesh-list
139278123|NCT02143362|Cisatracurium|cisatracurium|mesh-list
139278124|NCT02143362|Atracurium|atracurium|mesh-list
139278125|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139278126|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278127|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139278128|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139278129|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
139278130|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139278131|NCT02143362|Narcotics|narcotics|mesh-ancestor
139278132|NCT02143362|Analgesics|analgesics|mesh-ancestor
139278133|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
139278134|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278135|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139278136|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139278137|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139278138|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139278139|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139278140|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
139278141|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278142|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278143|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
139278144|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139278145|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278146|NCT02143440|Insulin|insulin|mesh-list
139278147|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139278148|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278149|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139278150|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
139278151|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139278152|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
139278153|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278154|NCT02143518|Antacids|antacids|mesh-ancestor
139278155|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278156|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139278157|NCT03682770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139278158|NCT03682770|Immunologic Factors|immunologic factors|mesh-ancestor
139278159|NCT03682770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278160|NCT03506828|Phenol|phenol|mesh-list
139278161|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139278162|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278163|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
139278164|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139278165|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139278166|NCT00054964|Albuterol|albuterol|mesh-list
139278167|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139278168|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
139278169|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278170|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278171|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139278172|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
139278173|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
139278174|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139278175|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139278176|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139278177|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139278178|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
139278179|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278180|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278181|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
139278182|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139278183|NCT02781558|Velpatasvir|velpatasvir|mesh-list
139278184|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
139148375|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139278185|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278186|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
139278187|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139278188|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278189|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278190|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139278191|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139278193|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278194|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
139278195|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139278196|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
139278197|NCT05073094|Esmolol|esmolol|mesh-list
139278198|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138839353|NCT00822133|Lidocaine|lidocaine|mesh-list
139278199|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139278200|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139278201|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
139278202|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278203|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278204|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278205|NCT03509246|Doxorubicin|doxorubicin|mesh-list
139278206|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139278207|NCT03509246|Bortezomib|bortezomib|mesh-list
139278208|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139278209|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278210|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139278211|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139278212|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278213|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278214|NCT03509168|Misoprostol|misoprostol|mesh-list
139278215|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139278216|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
139278217|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139278218|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278219|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139278220|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139278221|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
139278222|NCT05072938|Nizatidine|nizatidine|mesh-list
139278223|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139278224|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139278225|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139278226|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
139278227|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
139278228|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278229|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278230|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278231|NCT03041311|Carboplatin|carboplatin|mesh-list
139278232|NCT03041311|Etoposide|etoposide|mesh-list
139278233|NCT03041311|Atezolizumab|atezolizumab|mesh-list
139278234|NCT03041311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278235|NCT03041311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139278236|NCT03041311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139278237|NCT03041311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139278238|NCT03041311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278239|NCT03041311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278240|NCT03041311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139278241|NCT03041311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139278242|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
139278243|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139278244|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139278245|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278246|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
139278247|NCT05072860|Coagulants|coagulants|mesh-ancestor
139278248|NCT02311946|Palbociclib|palbociclib|mesh-list
139278249|NCT02311946|Rabeprazole|rabeprazole|mesh-list
139278250|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139278251|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278252|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139278253|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278254|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278255|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139278256|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139642321|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139278257|NCT04302766|Remdesivir|remdesivir|mesh-list
139278258|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
139278259|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278260|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
139278261|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278262|NCT02312102|Lenalidomide|lenalidomide|mesh-list
139278263|NCT02312102|Bortezomib|bortezomib|mesh-list
139278264|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
139278265|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278266|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139278267|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139278268|NCT02312102|Growth Substances|growth substances|mesh-ancestor
139278269|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
139278270|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278271|NCT05408221|Lenvatinib|lenvatinib|mesh-list
139278272|NCT05408221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278273|NCT05408221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139278274|NCT05408221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278275|NCT05408221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278276|NCT02307968|Insulin|insulin|mesh-list
139278277|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139278278|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278279|NCT02312180|Plasminogen|plasminogen|mesh-list
139278280|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139278281|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139278282|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278283|NCT03504566|Empagliflozin|empagliflozin|mesh-list
139278284|NCT03504566|Linagliptin|linagliptin|mesh-list
139278285|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
139278286|NCT03504566|Telmisartan|telmisartan|mesh-list
139278287|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139278288|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278289|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139278290|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278291|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139278292|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139278293|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139278294|NCT03504566|Incretins|incretins|mesh-ancestor
139278295|NCT03504566|Hormones|hormones|mesh-ancestor
139278296|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139278297|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139278298|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
139278299|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278300|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
139278301|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139278302|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
139278303|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139278304|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139278305|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139278306|NCT05070520|Lumefantrine|lumefantrine|mesh-list
139278307|NCT05070520|Artemether|artemether|mesh-list
139278308|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139278309|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
139278310|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139278311|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139278312|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278313|NCT05070598|Paclitaxel|paclitaxel|mesh-list
139278314|NCT05070598|Tegafur|tegafur|mesh-list
139278315|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139278316|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278317|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
139278318|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
139278319|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
139278320|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278321|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139278322|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
139278323|NCT03884452|Atorvastatin|atorvastatin|mesh-list
139278324|NCT03884452|Simvastatin|simvastatin|mesh-list
139278325|NCT03884452|Ezetimibe|ezetimibe|mesh-list
139278326|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139278327|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139278328|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
139278329|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278330|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139278331|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139278332|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278333|NCT03882892|Ezetimibe|ezetimibe|mesh-list
139278334|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139278335|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139278336|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
139278337|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278338|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139278339|NCT02305160|Poractant alfa|poractant alfa|mesh-list
139278340|NCT02305160|Beractant|beractant|mesh-list
139278341|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139278342|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
139278343|NCT02305394|Ketamine|ketamine|mesh-list
139278344|NCT02305394|Propofol|propofol|mesh-list
139278345|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139278346|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139278347|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278348|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139278349|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
139278350|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
139278351|NCT02305394|Analgesics|analgesics|mesh-ancestor
139278352|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
139278353|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278354|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139278355|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139278356|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139278357|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278358|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278359|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
139278360|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139278361|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
139278362|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278363|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278364|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139278365|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
139278366|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139278367|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
139278368|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278369|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278370|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139278371|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
139278372|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
139278373|NCT02305550|Protective Agents|protective agents|mesh-ancestor
139278374|NCT03506516|Ethanol|ethanol|mesh-list
139278375|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139278376|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278377|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139278378|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278379|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
139278380|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278381|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278382|NCT02643394|Acetaminophen|acetaminophen|mesh-list
139278383|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139278384|NCT02643394|Analgesics|analgesics|mesh-ancestor
139278385|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
139278386|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278387|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278388|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
139278389|NCT03101644|Darunavir|darunavir|mesh-list
139278390|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139278391|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139278392|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
139278393|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278394|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278395|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139278396|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139278397|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
139278398|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278399|NCT03132272|Autoantibodies|autoantibodies|mesh-list
139278400|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
139278401|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278402|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
139278403|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139278404|NCT02308982|Antibodies|antibodies|mesh-list
139278405|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
139278406|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139278407|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
139278408|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278409|NCT05515627|Atezolizumab|atezolizumab|mesh-list
139278410|NCT05515627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139278411|NCT05515627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278412|NCT05515627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139278413|NCT05515627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278414|NCT02144064|Heparin|heparin|mesh-list
139278415|NCT02144064|Calcium heparin|calcium heparin|mesh-list
139278416|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
139278417|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139278418|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139278419|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278420|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
139278421|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138839577|NCT00568399|Antidotes|antidotes|mesh-ancestor
139278422|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139278423|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139278424|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139278425|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
139278426|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278427|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139278428|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139278429|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278430|NCT02305940|Doxycycline|doxycycline|mesh-list
139278431|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139278432|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278433|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
139278434|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139278435|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139278436|NCT02312804|Paclitaxel|paclitaxel|mesh-list
139278437|NCT02312804|Carboplatin|carboplatin|mesh-list
139278438|NCT02312804|Infigratinib|infigratinib|mesh-list
139278439|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139278440|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278441|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
139278442|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
139278443|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
139278444|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278445|NCT03099616|Propofol|propofol|mesh-list
139278446|NCT03099616|Desflurane|desflurane|mesh-list
139278447|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139278448|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139278449|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278450|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139278451|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
139278452|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
139278453|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139278454|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
139278455|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139278456|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139278457|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278458|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
139278459|NCT04463966|Coagulants|coagulants|mesh-ancestor
139278460|NCT00794248|Fexofenadine|fexofenadine|mesh-list
139278461|NCT00794248|Desloratadine|desloratadine|mesh-list
139278462|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139278463|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
139278464|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278465|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278466|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278467|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139278468|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139278469|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
139278470|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
139278471|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139278472|NCT02309450|Asunaprevir|asunaprevir|mesh-list
139278473|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
139278474|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278475|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278476|NCT04475224|Mitogens|mitogens|mesh-list
139278477|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
139278478|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278479|NCT00353496|Lanreotide|lanreotide|mesh-list
139278480|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278481|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
139278482|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139278483|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139278484|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
139278485|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278522|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139278523|NCT03505736|Adenosine|adenosine|mesh-list
139278524|NCT03505736|Regadenoson|regadenoson|mesh-list
139278525|NCT03505736|Analgesics|analgesics|mesh-ancestor
139278526|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
139278527|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278528|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278529|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139278530|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
139278531|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139278532|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
139278533|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
139278534|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278535|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278536|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139278537|NCT02316626|Progesterone|progesterone|mesh-list
139278538|NCT02316626|Progestins|progestins|mesh-ancestor
139278539|NCT02316626|Hormones|hormones|mesh-ancestor
139278540|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139278541|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278542|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
139278543|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139278544|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139278545|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278546|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
139278547|NCT03505502|Coagulants|coagulants|mesh-ancestor
139278548|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
139278549|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139278550|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278551|NCT02316704|Tacrine|tacrine|mesh-list
139278552|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139278553|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278554|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278555|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
139278556|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278557|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278558|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139278559|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
139278560|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278561|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
139278562|NCT03501680|Insulin|insulin|mesh-list
139278563|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139278564|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278565|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139278566|NCT02310074|Hormones|hormones|mesh-list
139278567|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139278568|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139278569|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278570|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139278571|NCT02313584|Dabigatran|dabigatran|mesh-list
139278572|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
139278573|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139278574|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
139278575|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278576|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278577|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
139278578|NCT05063578|Lidocaine|lidocaine|mesh-list
139278579|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
139278580|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
139278581|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139278582|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278583|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
139278584|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278585|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139278586|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139278587|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139278588|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139278589|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278590|NCT05063422|Trimethoprim|trimethoprim|mesh-list
139278591|NCT05063422|Polymyxins|polymyxins|mesh-list
139278592|NCT05063422|Polymyxin B|polymyxin b|mesh-list
139278593|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139278594|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139278595|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278596|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
139278597|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139278598|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139278599|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139278600|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278601|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278602|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139278603|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139278604|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139278605|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139278606|NCT05063422|Laxatives|laxatives|mesh-ancestor
139278607|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139278608|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
139278609|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139278610|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139278611|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278612|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
139278613|NCT03782350|Coagulants|coagulants|mesh-ancestor
139278614|NCT03098680|Verapamil|verapamil|mesh-list
139278615|NCT03098680|Nicardipine|nicardipine|mesh-list
139278616|NCT03098680|Phentolamine|phentolamine|mesh-list
139278617|NCT03098680|Phenylephrine|phenylephrine|mesh-list
139278618|NCT03098680|Dobutamine|dobutamine|mesh-list
139278619|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
139278620|NCT03098680|Albuterol|albuterol|mesh-list
139278621|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139278622|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
139278623|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278624|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278625|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139278626|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
139278627|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
139278628|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139278629|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139278630|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139278631|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139278632|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
139278633|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278634|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278635|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139278636|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
139278637|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
139278638|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139278639|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
139278640|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139278641|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139278642|NCT03098680|Protective Agents|protective agents|mesh-ancestor
139278643|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139278644|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139278645|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139278646|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139278647|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
139278648|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139278649|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139278650|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139278651|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139278653|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
139278654|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
139278655|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278656|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278657|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278658|NCT05062486|Curcumin|curcumin|mesh-list
139278659|NCT05062486|Resveratrol|resveratrol|mesh-list
139278660|NCT05062486|Quercetin|quercetin|mesh-list
139278661|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139278662|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139278663|NCT05062486|Analgesics|analgesics|mesh-ancestor
139278664|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
139278665|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278666|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278667|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139278668|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139278669|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278670|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278671|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278672|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
139278673|NCT05062486|Protective Agents|protective agents|mesh-ancestor
139278674|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139278675|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139278676|NCT02314208|Resveratrol|resveratrol|mesh-list
139278677|NCT02314208|Atorvastatin|atorvastatin|mesh-list
139278678|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139278679|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139278680|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
139278681|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278682|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139278683|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139278684|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278685|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
139278686|NCT02314208|Protective Agents|protective agents|mesh-ancestor
139278687|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278688|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139278689|NCT02314208|Cathartics|cathartics|mesh-ancestor
139278690|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139278691|NCT03100318|Dotinurad|dotinurad|mesh-list
139278692|NCT03100318|Benzbromarone|benzbromarone|mesh-list
139278693|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
139278694|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
139278695|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139278696|NCT02311010|Tacrolimus|tacrolimus|mesh-list
139278697|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139278698|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
139278699|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278700|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139278701|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278702|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278703|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139278704|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139278705|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139278706|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
139278707|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278708|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139278709|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139278710|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278711|NCT03132194|Dapsone|dapsone|mesh-list
139278712|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278713|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
139278714|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139278715|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139278716|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139278717|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278718|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278719|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
139278720|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139278721|NCT02311088|Caffeine|caffeine|mesh-list
139278722|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139278723|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278724|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139278726|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278727|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139278728|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139278729|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
139278730|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278731|NCT03501212|Anesthetics|anesthetics|mesh-list
139278732|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
139278733|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139278734|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278735|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
139278736|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278737|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139278738|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
139278739|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278740|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139278741|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278742|NCT04435210|Hydralazine|hydralazine|mesh-list
139278743|NCT04435210|Nifedipine|nifedipine|mesh-list
139278744|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139278745|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139278746|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278747|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139278748|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278749|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
139278750|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
139278751|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139278752|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139278753|NCT03501056|Antibodies|antibodies|mesh-list
139278754|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139278755|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
139278756|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278757|NCT03292146|Denosumab|denosumab|mesh-list
139278758|NCT03292146|Alendronate|alendronate|mesh-list
139278759|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139278760|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278761|NCT02144376|Psyllium|psyllium|mesh-list
139278762|NCT02144376|Cathartics|cathartics|mesh-ancestor
139278763|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139278764|NCT02314754|Misoprostol|misoprostol|mesh-list
139278765|NCT02314754|Mifepristone|mifepristone|mesh-list
139278766|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139278767|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
139278768|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139278769|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278770|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139278771|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139278772|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
139278773|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139278774|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139278775|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139278776|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139278777|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
139278778|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139278779|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139278780|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
139278781|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139278782|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
139278783|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139278784|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139278785|NCT02317640|Testosterone|testosterone|mesh-list
139278786|NCT02317640|Androgens|androgens|mesh-ancestor
139278787|NCT02317640|Hormones|hormones|mesh-ancestor
139297256|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139148976|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
139278788|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139278789|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278790|NCT02716948|Nivolumab|nivolumab|mesh-list
139278791|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139278792|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278793|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139278794|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278795|NCT03500900|Vildagliptin|vildagliptin|mesh-list
139278796|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139278797|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278798|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139278799|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
139278800|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278801|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278802|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139278803|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
139278804|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278805|NCT02141100|Thioguanine|thioguanine|mesh-list
139278806|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139278807|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
139278808|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278809|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278810|NCT02141178|Bupivacaine|bupivacaine|mesh-list
139278811|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
139278812|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
139278813|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139278814|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278815|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
139278816|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278817|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
139278818|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139278819|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139278820|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278821|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139278822|NCT02141412|Analgesics|analgesics|mesh-ancestor
139278823|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
139278824|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278825|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139278826|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139278827|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139278828|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
139278829|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278830|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278831|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
139278832|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139278833|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278834|NCT03210558|Testosterone|testosterone|mesh-list
139278835|NCT03210558|Androgens|androgens|mesh-ancestor
139278836|NCT03210558|Hormones|hormones|mesh-ancestor
139278837|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139278838|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278839|NCT05046262|Calcium|calcium|mesh-list
139278840|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139278841|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278842|NCT05036824|Tinzaparin|tinzaparin|mesh-list
139278843|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139278844|NCT05036824|Dalteparin|dalteparin|mesh-list
139278845|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
139278846|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139278847|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139278848|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278849|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
139278850|NCT04462250|Narcotics|narcotics|mesh-ancestor
139278851|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139278852|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278853|NCT04462250|Analgesics|analgesics|mesh-ancestor
139278854|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
139278855|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278856|NCT02144766|Ropivacaine|ropivacaine|mesh-list
139278857|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
139278858|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
139278859|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642322|NCT04951752|Ropivacaine|ropivacaine|mesh-list
139278860|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278861|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
139278862|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278864|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139278865|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139278866|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139278867|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
139278868|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278869|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862345|NCT00614328|Naltrexone|naltrexone|mesh-list
139278870|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278871|NCT02144922|Pitavastatin|pitavastatin|mesh-list
139278872|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139278873|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139278874|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139278875|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
139278876|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278877|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278878|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139278879|NCT02261064|Amlodipine|amlodipine|mesh-list
139278880|NCT02261064|Telmisartan|telmisartan|mesh-list
139278881|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139278882|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139278883|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139278884|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139278885|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278886|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139278887|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278888|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
139278889|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139278890|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139278891|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139278892|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139278893|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278894|NCT05035498|Phenylephrine|phenylephrine|mesh-list
139278895|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
139278896|NCT05035498|Norepinephrine|norepinephrine|mesh-list
139278897|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139278898|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139278899|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
139278900|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
139278901|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278902|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278903|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
139278904|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
139278905|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
139278906|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139278907|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139278908|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139278909|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
139278910|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278911|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278912|NCT05035498|Protective Agents|protective agents|mesh-ancestor
139278913|NCT03498326|Celecoxib|celecoxib|mesh-list
139278914|NCT03498326|Gemcitabine|gemcitabine|mesh-list
139278915|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139278916|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
139278917|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278918|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139278919|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139278920|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139278921|NCT03498326|Analgesics|analgesics|mesh-ancestor
139278922|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
139278923|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278924|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278925|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139278926|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139278927|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139278928|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139278929|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278930|NCT03498248|Lenograstim|lenograstim|mesh-list
139278931|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139278932|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
139278933|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278934|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
139278935|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
139278936|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139278937|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278938|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139278939|NCT03498170|Itraconazole|itraconazole|mesh-list
139278940|NCT03498170|Acumapimod|acumapimod|mesh-list
139278941|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
139278942|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278943|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139278944|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139278945|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139278946|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278947|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139278948|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
139278949|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139278950|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278951|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139278952|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139278954|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139278955|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278956|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
139278957|NCT03498092|Bupivacaine|bupivacaine|mesh-list
139278958|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
139278959|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
139278960|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139278961|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278962|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
139278963|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278964|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139278965|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139278966|NCT03498092|Analgesics|analgesics|mesh-ancestor
139278967|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139278968|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139278969|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139278970|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
139278971|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139278972|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278973|NCT03500432|Lidocaine|lidocaine|mesh-list
138840110|NCT00824707|Entecavir|entecavir|mesh-list
139278974|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
139278975|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
139278976|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139278977|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139278978|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
139278979|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278980|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139278981|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139278982|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139278983|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139278984|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139278985|NCT02315690|Piperaquine|piperaquine|mesh-list
139278986|NCT02315690|Artenimol|artenimol|mesh-list
139278987|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
139278988|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139278989|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139278990|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278991|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
139278992|NCT02639338|Velpatasvir|velpatasvir|mesh-list
139278993|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
139278994|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139278995|NCT01754857|Rituximab|rituximab|mesh-list
139278996|NCT01754857|Lenalidomide|lenalidomide|mesh-list
139278997|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139278998|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139278999|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279000|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
139279001|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279002|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139279003|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139279004|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139279005|NCT01754857|Growth Substances|growth substances|mesh-ancestor
139279006|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
139297257|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
139279007|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139279008|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
139279009|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279010|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
139279011|NCT03497702|Docetaxel|docetaxel|mesh-list
139279012|NCT03497702|Doxorubicin|doxorubicin|mesh-list
139279013|NCT03497702|Letrozole|letrozole|mesh-list
139279014|NCT03497702|Leuprolide|leuprolide|mesh-list
139279015|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139279016|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
139279017|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279018|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139279019|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139279020|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
139279021|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279022|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279023|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139279024|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
139279025|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
139279026|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
139279027|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139279028|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139279029|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139279030|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279031|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139279032|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139279033|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139279034|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
139279035|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139279036|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139279037|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
139279038|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139279039|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139279040|NCT02900352|Zonisamide|zonisamide|mesh-list
139279041|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
139279042|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139279043|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139279044|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279045|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138840190|NCT00929006|Progesterone|progesterone|mesh-list
139279046|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279047|NCT05034406|Lidocaine|lidocaine|mesh-list
139279048|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
139279049|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
139279050|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
139279051|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279052|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279053|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
139279054|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279055|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139279056|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139279057|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139279058|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139279059|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279060|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
139279061|NCT02254668|Everolimus|everolimus|mesh-list
139279062|NCT02254668|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139279063|NCT02254668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139279064|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279065|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279066|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139279067|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
139279068|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279069|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279070|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139279071|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139279072|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
139279073|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139279074|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279075|NCT03095404|Lidocaine|lidocaine|mesh-list
139279076|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139279077|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
139279078|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
139279079|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279080|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279081|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
139279082|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279083|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139279084|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139279085|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139279086|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139279087|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279088|NCT02145546|Amiodarone|amiodarone|mesh-list
139279089|NCT02145546|Sotalol|sotalol|mesh-list
139279090|NCT02145546|Propafenone|propafenone|mesh-list
139279091|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139279093|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139279094|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139279095|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279096|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139279097|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139279098|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139279099|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279100|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139279101|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139279102|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139279103|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139279104|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139279105|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
139279106|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279107|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279108|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
139279109|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
139279110|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279111|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139279112|NCT03039673|Interleukin-2|interleukin-2|mesh-list
139279113|NCT03039673|Riluzole|riluzole|mesh-list
139279114|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279115|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139279116|NCT03039673|Analgesics|analgesics|mesh-ancestor
139279117|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
139279118|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279119|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279120|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
139279121|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139279122|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139279123|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279124|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279125|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139279126|NCT03039673|Protective Agents|protective agents|mesh-ancestor
139279127|NCT02145624|Vaccines|vaccines|mesh-list
139279128|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
139279129|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279130|NCT02321384|Ritonavir|ritonavir|mesh-list
139279131|NCT02321384|Midazolam|midazolam|mesh-list
139279132|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139279133|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139279134|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279135|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279136|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139279137|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139279138|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139279139|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139279140|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
139279141|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
139279142|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
139279143|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
139279144|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279145|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279146|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139279147|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139279148|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
139279149|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279150|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139279151|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139279152|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
139279153|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279154|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139279155|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139279156|NCT03095326|Zinc|zinc|mesh-list
139279157|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
139279158|NCT03095326|Vaccines|vaccines|mesh-list
139279159|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
139279160|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279161|NCT03095326|Trace Elements|trace elements|mesh-ancestor
139279162|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
139279163|NCT03095326|Astringents|astringents|mesh-ancestor
139279164|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
139279165|NCT02318810|Rocuronium|rocuronium|mesh-list
139279166|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139279167|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139279168|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139279169|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279170|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279171|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
139279172|NCT03500120|Captopril|captopril|mesh-list
139279173|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139279174|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
139279175|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279176|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279177|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139279178|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139279179|NCT02141958|Fenretinide|fenretinide|mesh-list
139279180|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279181|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139279182|NCT02141958|Protective Agents|protective agents|mesh-ancestor
139279183|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279184|NCT02142036|Trastuzumab|trastuzumab|mesh-list
139279185|NCT02142036|Cetuximab|cetuximab|mesh-list
139279186|NCT02142036|Panitumumab|panitumumab|mesh-list
139279187|NCT02142036|Everolimus|everolimus|mesh-list
139279188|NCT02142036|Sunitinib|sunitinib|mesh-list
139279189|NCT02142036|Dasatinib|dasatinib|mesh-list
139279190|NCT02142036|Gefitinib|gefitinib|mesh-list
139279191|NCT02142036|Lapatinib|lapatinib|mesh-list
139279192|NCT02142036|Temsirolimus|temsirolimus|mesh-list
139279193|NCT02142036|Afatinib|afatinib|mesh-list
139279194|NCT02142036|Vemurafenib|vemurafenib|mesh-list
139279195|NCT02142036|Dabrafenib|dabrafenib|mesh-list
139279196|NCT02142036|Crizotinib|crizotinib|mesh-list
139279197|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139279198|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279199|NCT02142036|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139279200|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139279201|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279202|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279203|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139279204|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
139279205|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279206|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139279207|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139279208|NCT02142036|Growth Substances|growth substances|mesh-ancestor
139279209|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
139279210|NCT05053594|Neostigmine|neostigmine|mesh-list
139279211|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139279212|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279213|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279214|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
139279215|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279216|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279217|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139279218|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
139279219|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279220|NCT02318888|Icodextrin|icodextrin|mesh-list
139279221|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
139279222|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139279223|NCT02142192|Natalizumab|natalizumab|mesh-list
139279224|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
139279225|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279226|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
139279227|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139279228|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279229|NCT02324582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139279230|NCT02324582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279231|NCT01255891|Androgens|androgens|mesh-list
139279232|NCT01255891|Hormones|hormones|mesh-ancestor
139279233|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139279234|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279235|NCT02777190|Misoprostol|misoprostol|mesh-list
139279236|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139279237|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
139279238|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139279239|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279240|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139279241|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139279242|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
139279243|NCT03494426|Pregabalin|pregabalin|mesh-list
139279244|NCT03494426|Tramadol|tramadol|mesh-list
139279245|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
139279246|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
139279247|NCT03494426|Analgesics|analgesics|mesh-ancestor
139279248|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
139279249|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279250|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279251|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
139279252|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139279253|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139279254|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279255|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139279256|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139279257|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139279258|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279259|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139279260|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139279261|NCT03494426|Narcotics|narcotics|mesh-ancestor
139279263|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279264|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279265|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139279266|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139279267|NCT00108732|Metronidazole|metronidazole|mesh-list
139279268|NCT00108732|Goserelin|goserelin|mesh-list
139279269|NCT00108732|Bicalutamide|bicalutamide|mesh-list
139279270|NCT00108732|Vaccines|vaccines|mesh-list
139279271|NCT00108732|Sargramostim|sargramostim|mesh-list
139279272|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
139279273|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279274|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279275|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139279276|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
139279277|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
139279278|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139279279|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279280|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139279281|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139279282|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139279283|NCT02319200|Metformin|metformin|mesh-list
139279284|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139279285|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279286|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139279287|NCT02319278|Hematinics|hematinics|mesh-ancestor
139279288|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139279289|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139279290|NCT02324738|Piperaquine|piperaquine|mesh-list
139279291|NCT02324738|Artenimol|artenimol|mesh-list
139279292|NCT02324738|Mefloquine|mefloquine|mesh-list
139279293|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
139279294|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139279295|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139279296|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279297|NCT02321852|Mannitol|mannitol|mesh-list
139279298|NCT02321852|Triflusal|triflusal|mesh-list
139279299|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139279300|NCT02321852|Diuretics|diuretics|mesh-ancestor
139279301|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
139279302|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279303|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139279304|NCT03499886|Ketamine|ketamine|mesh-list
139279305|NCT03499886|Analgesics|analgesics|mesh-ancestor
139279306|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
139279307|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279308|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279309|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139279310|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139279311|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
139279312|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
139279313|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139149495|NCT02176720|Fluorides|fluorides|mesh-list
139279314|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139279315|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138862776|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139279316|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279317|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279318|NCT02325050|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139279319|NCT02325050|Antiviral Agents|antiviral agents|mesh-ancestor
139279320|NCT02325050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279321|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139279322|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279323|NCT02322008|Adalimumab|adalimumab|mesh-list
139279324|NCT02322008|Infliximab|infliximab|mesh-list
139279325|NCT02322008|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139279326|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139279327|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139279328|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
139279329|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139279330|NCT02647554|Urinastatin|urinastatin|mesh-list
139279331|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
139279332|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139279333|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
139279334|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279335|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279336|NCT03499730|Midazolam|midazolam|mesh-list
139279337|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139279338|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139279339|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279340|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279341|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139279342|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139279343|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139279344|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139279345|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
139279346|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
139279347|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
139279348|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
139279349|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279350|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279351|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
139279352|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139279353|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279354|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139279355|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279356|NCT02325362|Miglustat|miglustat|mesh-list
139279357|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
139279358|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279359|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279360|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139279361|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139279362|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
139279363|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279364|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139279365|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139279366|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279367|NCT04462094|Ketamine|ketamine|mesh-list
139279368|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
139279369|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279370|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279371|NCT04462094|Analgesics|analgesics|mesh-ancestor
139279372|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
139279373|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279374|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139279375|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139279376|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
139279377|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139279378|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139279379|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279380|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279381|NCT02325440|Natalizumab|natalizumab|mesh-list
139279382|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139279383|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
139279384|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642323|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
139279385|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139279386|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279387|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139279389|NCT03499184|Amoxicillin|amoxicillin|mesh-list
139279390|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279391|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139279392|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139279393|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139279394|NCT00107952|Vancomycin|vancomycin|mesh-list
139279395|NCT00107952|Telavancin|telavancin|mesh-list
139279396|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139279397|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279398|NCT03499106|Itraconazole|itraconazole|mesh-list
139279399|NCT03499106|Praliciguat|praliciguat|mesh-list
139279400|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
139279401|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279402|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139279403|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139279404|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279405|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279406|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139279407|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
139279408|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139279409|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279410|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139279411|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139279412|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
139279413|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139279415|NCT02146638|Morphine|morphine|mesh-list
139279416|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139279417|NCT02146638|Narcotics|narcotics|mesh-ancestor
139279418|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279419|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279420|NCT02146638|Analgesics|analgesics|mesh-ancestor
139279421|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
139279422|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279423|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139279424|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139279425|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
139279426|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
139279427|NCT02320448|Cisplatin|cisplatin|mesh-list
139279428|NCT02320448|Doxorubicin|doxorubicin|mesh-list
139279429|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
139279430|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279431|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139279432|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139279433|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139279434|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279435|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279436|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139279437|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
139279438|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279439|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139279440|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139279441|NCT03493568|Dolutegravir|dolutegravir|mesh-list
139279442|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139279443|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139279444|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139279445|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279446|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279447|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139279448|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139279449|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
139279450|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279451|NCT01366638|Ribavirin|ribavirin|mesh-list
139279452|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139279453|NCT01366638|Simeprevir|simeprevir|mesh-list
139279454|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
139279455|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279456|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
139279457|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279458|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
139279459|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279460|NCT02147808|Midazolam|midazolam|mesh-list
139279461|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139279462|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139279463|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279464|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279465|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139279466|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139279467|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139279468|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139279469|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
138862924|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139279470|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
139279471|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
139279472|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
139279473|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279474|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279475|NCT03543072|Diphosphonates|diphosphonates|mesh-list
139279476|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139279477|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279478|NCT02147964|Ketoconazole|ketoconazole|mesh-list
139279479|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
139279480|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139279481|NCT02147964|Testosterone|testosterone|mesh-list
139279482|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
139279483|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
139279484|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139279485|NCT02147964|Dutasteride|dutasteride|mesh-list
139279486|NCT02147964|Acyline|acyline|mesh-list
139279487|NCT02147964|Androgens|androgens|mesh-ancestor
139279488|NCT02147964|Hormones|hormones|mesh-ancestor
139279489|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139279490|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279491|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139279492|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279493|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
139279494|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
139279495|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279496|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139279497|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139279498|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279499|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279500|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139279501|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
139279502|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139279503|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139279504|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139279505|NCT02780700|Capecitabine|capecitabine|mesh-list
139279506|NCT02780700|Nintedanib|nintedanib|mesh-list
139279507|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139279508|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
139279509|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279510|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279511|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139279512|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279513|NCT02147262|Doxycycline|doxycycline|mesh-list
139279514|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139279515|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279516|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
139279517|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139279518|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139279519|NCT02447276|Fasinumab|fasinumab|mesh-list
139279520|NCT02447276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139279521|NCT02447276|Analgesics|analgesics|mesh-ancestor
139279522|NCT02447276|Sensory System Agents|sensory system agents|mesh-ancestor
139279523|NCT02447276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279524|NCT02447276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279525|NCT02323412|Amoxicillin|amoxicillin|mesh-list
139279526|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139279527|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279528|NCT04537910|Bamlanivimab|bamlanivimab|mesh-list
139279529|NCT04537910|Antiviral Agents|antiviral agents|mesh-ancestor
139279530|NCT04537910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279531|NCT03109730|Tenofovir|tenofovir|mesh-list
139279532|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139279533|NCT03109730|Entecavir|entecavir|mesh-list
139279534|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
139279535|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279536|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139279537|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139279538|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279539|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279540|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139279541|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139279542|NCT03495206|Edaravone|edaravone|mesh-list
138863010|NCT04500236|Anesthetics|anesthetics|mesh-list
139279543|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139279544|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
139279545|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279546|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139279547|NCT03495206|Protective Agents|protective agents|mesh-ancestor
139279548|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279549|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
139279550|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139279551|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279552|NCT03491696|Metyrapone|metyrapone|mesh-list
139279553|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
139279554|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279555|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279556|NCT03492866|Gentamicins|gentamicins|mesh-list
139279557|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139279558|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279559|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139279560|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279561|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279562|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
139279563|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139279564|NCT03492710|Antibodies|antibodies|mesh-list
139279565|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
139279566|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279567|NCT03954938|Cocaine|cocaine|mesh-list
139279568|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
139279569|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
139279570|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279571|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279572|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
139279573|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279574|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139279575|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139279576|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139279577|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139279578|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279579|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
139279580|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279581|NCT02148120|Beclomethasone|beclomethasone|mesh-list
139279582|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
139279583|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139279584|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
139279585|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279586|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279587|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139279588|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
139279589|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139279590|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139279591|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139279592|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
139279593|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279594|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279595|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139279596|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
139279597|NCT02148120|Hormones|hormones|mesh-ancestor
139279598|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139279599|NCT03492632|Hormones|hormones|mesh-list
139279600|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139279601|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279602|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
139279603|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139279604|NCT02147730|Anesthetics|anesthetics|mesh-list
139279605|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279606|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279607|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
139279608|NCT02151630|Salicylates|salicylates|mesh-list
139279609|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279610|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
139279611|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
139279612|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
139279613|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139279614|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139279615|NCT02151630|Analgesics|analgesics|mesh-ancestor
139279616|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
139279617|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279618|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863072|NCT02692248|Hormones|hormones|mesh-ancestor
139279619|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139279620|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139279621|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139279622|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279623|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279624|NCT03494972|Tetracycline|tetracycline|mesh-list
139279625|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139279626|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279627|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139279628|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279629|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279630|NCT02224573|Cannabidiol|cannabidiol|mesh-list
139279631|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
139279632|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139279633|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139279634|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139279635|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279636|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279637|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
139279638|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279639|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139279640|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139279641|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
139279642|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139279643|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279644|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279645|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139279646|NCT02148432|Analgesics|analgesics|mesh-ancestor
139279647|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
139279648|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279649|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139279650|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139279651|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139279652|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
139279653|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279654|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279655|NCT03350984|Insulin|insulin|mesh-list
139279656|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139279657|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
139279658|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
139279659|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
139279660|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
139279661|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
139279662|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139279663|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279664|NCT03504423|Leucovorin|leucovorin|mesh-list
139279665|NCT03504423|Folic Acid|folic acid|mesh-list
139279666|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
139279667|NCT03504423|Irinotecan|irinotecan|mesh-list
139279668|NCT03504423|Folfirinox|folfirinox|mesh-list
139279669|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
139279670|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279671|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139279672|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139279673|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279674|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279675|NCT03504423|Antidotes|antidotes|mesh-ancestor
139279676|NCT03504423|Protective Agents|protective agents|mesh-ancestor
139279677|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279678|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
139279679|NCT03504423|Vitamins|vitamins|mesh-ancestor
139279680|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
139279681|NCT03504423|Hematinics|hematinics|mesh-ancestor
139279682|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139279683|NCT03097198|Tropicamide|tropicamide|mesh-list
139279684|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139279685|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
139149870|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
139279686|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
139279687|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279688|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279689|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139279690|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139279691|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
139279692|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863139|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
139279693|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279694|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139279695|NCT02770248|Brinzolamide|brinzolamide|mesh-list
139279696|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139279697|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139279698|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139279699|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139279700|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
139279701|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279702|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279703|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279704|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139279705|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279706|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139279707|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139279708|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
139279709|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279710|NCT02686346|Etoposide|etoposide|mesh-list
139279711|NCT02686346|Ifosfamide|ifosfamide|mesh-list
139279712|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139279713|NCT02686346|Carboplatin|carboplatin|mesh-list
139279714|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139279715|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279716|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139279717|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139279718|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279719|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279720|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139279721|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
139279722|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139279723|NCT02686346|Immunotoxins|immunotoxins|mesh-ancestor
139279724|NCT02686346|Immunoconjugates|immunoconjugates|mesh-ancestor
139279725|NCT02686346|Immunologic Factors|immunologic factors|mesh-ancestor
139279726|NCT02686346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279727|NCT03489044|Levetiracetam|levetiracetam|mesh-list
139279728|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
139279729|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
139279730|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139279731|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139279732|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139279733|NCT01344369|Norethindrone|norethindrone|mesh-list
139279734|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
139279735|NCT01344369|Estradiol|estradiol|mesh-list
139279736|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139279737|NCT01344369|Estrogens|estrogens|mesh-ancestor
139279738|NCT01344369|Hormones|hormones|mesh-ancestor
139279739|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139279740|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279741|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139279742|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
139279743|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139279744|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139279745|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139279746|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139279747|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139279748|NCT03491072|Fentanyl|fentanyl|mesh-list
139279749|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139279750|NCT03491072|Narcotics|narcotics|mesh-ancestor
139279751|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279752|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279753|NCT03491072|Analgesics|analgesics|mesh-ancestor
139279754|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
139279755|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279756|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139279757|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139279758|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
139642324|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
139279759|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
139279760|NCT03503409|Ivosidenib|ivosidenib|mesh-list
139279761|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279762|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279763|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279764|NCT03490994|Warfarin|warfarin|mesh-list
139279765|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
139279766|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
139279767|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139279768|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
139279769|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139279770|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
139279772|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279773|NCT01360762|Pentamidine|pentamidine|mesh-list
139279774|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
139279775|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279776|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139279777|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139279778|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139279779|NCT04382924|Ifenprodil|ifenprodil|mesh-list
139279780|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139279781|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139279782|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
139279783|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279784|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279785|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279786|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
139279787|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139279788|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139279789|NCT00002601|Doxorubicin|doxorubicin|mesh-list
139279790|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139279791|NCT00002601|Melphalan|melphalan|mesh-list
139279792|NCT00002601|Ifosfamide|ifosfamide|mesh-list
139279793|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279794|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139279795|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139279796|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139279797|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279798|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279799|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
139279800|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279801|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139279802|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
139279803|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139279804|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139279805|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
139279806|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
139279807|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
139279808|NCT02031861|Nifedipine|nifedipine|mesh-list
139279809|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139279810|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139279811|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279812|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139279813|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279814|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
139279815|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
139279816|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139279817|NCT02645474|Ropivacaine|ropivacaine|mesh-list
139279818|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
139279819|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
139279820|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279821|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279822|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
139279823|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279824|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
139279825|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139279826|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
139279827|NCT05052814|Calcium|calcium|mesh-list
139279828|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139279829|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279830|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139279831|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279832|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
139279833|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
139279834|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
139279835|NCT03615417|Anesthetics|anesthetics|mesh-list
139279836|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279837|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279838|NCT02155530|Atorvastatin|atorvastatin|mesh-list
139279839|NCT02155530|Pravastatin|pravastatin|mesh-list
139279840|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139279841|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139279842|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
139279843|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279844|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138863362|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139279845|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139279846|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279847|NCT05051956|Palbociclib|palbociclib|mesh-list
139279848|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279849|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139279850|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279851|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279852|NCT02769624|Treprostinil|treprostinil|mesh-list
139279853|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139279854|NCT03543774|Simvastatin|simvastatin|mesh-list
139279855|NCT03543774|Ezetimibe|ezetimibe|mesh-list
139279856|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
139279857|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139279858|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139279859|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
139279860|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279861|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139279862|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139279863|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279864|NCT02152176|Morphine|morphine|mesh-list
139279865|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139279866|NCT02152176|Narcotics|narcotics|mesh-ancestor
139279867|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279868|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279869|NCT02152176|Analgesics|analgesics|mesh-ancestor
139279870|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
139279871|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279872|NCT03617055|Cystatins|cystatins|mesh-list
139279873|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139279874|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
139279875|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279876|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279877|NCT03488888|Bupivacaine|bupivacaine|mesh-list
139279878|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
139279879|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
139279880|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279881|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279882|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
139279883|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279884|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
139279885|NCT05031676|Anesthetics|anesthetics|mesh-list
139279886|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279887|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279888|NCT05031676|Narcotics|narcotics|mesh-ancestor
139279889|NCT05031676|Analgesics|analgesics|mesh-ancestor
139279890|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
139279891|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279892|NCT03488810|Hormones|hormones|mesh-list
139279893|NCT03488810|Androgens|androgens|mesh-list
139279894|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
139279895|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
139279896|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139279897|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279898|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
139279899|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139279900|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279901|NCT03492242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139279902|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279903|NCT03572283|Bethanechol|bethanechol|mesh-list
139279904|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139279905|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
139279906|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279907|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279908|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139279909|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139279910|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
139279911|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139279912|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279913|NCT02254824|Atorvastatin|atorvastatin|mesh-list
139279914|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139279915|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139279916|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
139279917|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279918|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139279919|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139279920|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279922|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279923|NCT01673386|Sunitinib|sunitinib|mesh-list
139279924|NCT01673386|Tivozanib|tivozanib|mesh-list
139279925|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279926|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139279927|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139279928|NCT01673386|Growth Substances|growth substances|mesh-ancestor
139279929|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279930|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
139279931|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139279932|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279933|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279934|NCT00103740|Vitamin D|vitamin d|mesh-list
139279935|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
139279936|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
139279937|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
139279938|NCT00103740|Calcium|calcium|mesh-list
139279939|NCT00103740|Vitamins|vitamins|mesh-ancestor
139279940|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
139279941|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279942|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139279943|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139279944|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139279945|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139279946|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279947|NCT03616509|Hormones|hormones|mesh-list
139279948|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139279949|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279950|NCT02869893|Secretin|secretin|mesh-list
139279951|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139279952|NCT02869893|Hormones|hormones|mesh-ancestor
139279953|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139279954|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279955|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
139279956|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139279957|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139279958|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139279959|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139279960|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139279961|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139279962|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279963|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139279964|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139279965|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
139279966|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139279967|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279968|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139279969|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139279970|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139279971|NCT05118308|Liver Extracts|liver extracts|mesh-list
139279972|NCT05118308|Hematinics|hematinics|mesh-ancestor
139279973|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
139279974|NCT03617289|Analgesics|analgesics|mesh-ancestor
139279975|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
139279976|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279977|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279978|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
139279979|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279980|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139279981|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
139279982|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139279983|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139279984|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139279985|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139279986|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
139279987|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139279988|NCT02152410|Morphine|morphine|mesh-list
139279989|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138863453|NCT02702622|Vitamins|vitamins|mesh-ancestor
139279990|NCT02152410|Narcotics|narcotics|mesh-ancestor
139279991|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139279992|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139279994|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
139279995|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139279996|NCT05043688|Paclitaxel|paclitaxel|mesh-list
139279997|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139279998|NCT05043688|Carboplatin|carboplatin|mesh-list
139279999|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139280000|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280001|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
139280002|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
139280003|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
139280004|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280005|NCT03614715|Interferons|interferons|mesh-list
139280006|NCT03614715|Interferon-beta|interferon-beta|mesh-list
139280007|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
139280008|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280009|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
139280010|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280011|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
139280012|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280013|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139280014|NCT00363038|Vitamins|vitamins|mesh-list
139280015|NCT00363038|Vitamin K|vitamin k|mesh-list
139280016|NCT00363038|Vitamin A|vitamin a|mesh-list
139280017|NCT00363038|Petrolatum|petrolatum|mesh-list
139280018|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
139280019|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280020|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139280021|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139280022|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280023|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
139280024|NCT00363038|Coagulants|coagulants|mesh-ancestor
139280025|NCT00363038|Emollients|emollients|mesh-ancestor
139280026|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
139280027|NCT03489668|Metformin|metformin|mesh-list
139280028|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139280029|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280030|NCT02872311|Vaccines|vaccines|mesh-list
139280031|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
139280032|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280033|NCT03614403|Vitamin D|vitamin d|mesh-list
139280034|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
139280035|NCT03614403|Vitamins|vitamins|mesh-ancestor
139280036|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
139280037|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280038|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139280039|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139280040|NCT03488186|Lansoprazole|lansoprazole|mesh-list
139280041|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
139280042|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139280043|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139280044|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139280045|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280046|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280047|NCT05103644|Atorvastatin|atorvastatin|mesh-list
139280048|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139280049|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139280050|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
139280051|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280052|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139280053|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139280054|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280055|NCT03887624|Ethosuximide|ethosuximide|mesh-list
139280056|NCT03887624|Escitalopram|escitalopram|mesh-list
139280057|NCT03887624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139280058|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139280059|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139280060|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280061|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280062|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
139280063|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863514|NCT02702076|Apomorphine|apomorphine|mesh-list
139280064|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
139280065|NCT02446028|Insulin Lispro|insulin lispro|mesh-list
139280066|NCT02446028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139280067|NCT02446028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280068|NCT03485846|Ritonavir|ritonavir|mesh-list
139280069|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139280070|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139280071|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
139280072|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280073|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280074|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139280075|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139280076|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
139280077|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280078|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139280079|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139280080|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
139280081|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139280082|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
139280083|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139280084|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
139280085|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280086|NCT03613857|Clopidogrel|clopidogrel|mesh-list
139280087|NCT03613857|Ticagrelor|ticagrelor|mesh-list
139280088|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139280089|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139280090|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139280091|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139280092|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
139280093|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280094|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280095|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280096|NCT03613389|Vitamin E|vitamin e|mesh-list
139280097|NCT03613389|Vitamins|vitamins|mesh-ancestor
139280098|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
139280099|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280100|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
139280101|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280102|NCT03613389|Protective Agents|protective agents|mesh-ancestor
139280103|NCT03614013|Immunomodulating Agents|immunomodulating agents|mesh-list
139280104|NCT03614013|Immunologic Factors|immunologic factors|mesh-ancestor
139280105|NCT03614013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280106|NCT02259777|Amlodipine|amlodipine|mesh-list
139280107|NCT02259777|Telmisartan|telmisartan|mesh-list
139280108|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139280109|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139280110|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139280111|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139280112|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280113|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139280114|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280115|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
139280116|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139280117|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139280118|NCT03261375|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139280119|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
139280120|NCT03261375|Nifedipine|nifedipine|mesh-list
139280121|NCT03261375|Diuretics|diuretics|mesh-ancestor
139280122|NCT03261375|Natriuretic Agents|natriuretic agents|mesh-ancestor
139280123|NCT03261375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280124|NCT03261375|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139280125|NCT03261375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139280126|NCT03261375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280127|NCT03261375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139280128|NCT03261375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139280129|NCT03261375|Vasodilator Agents|vasodilator agents|mesh-ancestor
139280130|NCT03261375|Tocolytic Agents|tocolytic agents|mesh-ancestor
139280131|NCT03261375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139280132|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139280133|NCT03613545|Rifaximin|rifaximin|mesh-list
139280134|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
139280135|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280136|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139280137|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139280138|NCT01361308|Paroxetine|paroxetine|mesh-list
139280139|NCT01361308|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139280140|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139280141|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139280142|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280143|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280144|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
139280145|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280146|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139280147|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
139280148|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139280149|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139280150|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139280151|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280152|NCT05043142|Antibodies|antibodies|mesh-list
139280153|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
139280154|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280155|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139280156|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280157|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
139280158|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139280159|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139280160|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139280161|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
139280162|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280163|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280164|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280165|NCT00103662|Plerixafor|plerixafor|mesh-list
139280166|NCT00103662|Lenograstim|lenograstim|mesh-list
139280167|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139280168|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
139280169|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280170|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139280171|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139280172|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
139280173|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280174|NCT03612219|Apatinib|apatinib|mesh-list
139280175|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280176|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139280177|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280178|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280179|NCT05030116|Domperidone|domperidone|mesh-list
139280180|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
139280181|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
139280182|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139280183|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280184|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139280185|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139280186|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
139280187|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280188|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280189|NCT03015129|Durvalumab|durvalumab|mesh-list
139280190|NCT03015129|Tremelimumab|tremelimumab|mesh-list
139280191|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139280192|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280193|NCT02148978|Saxagliptin|saxagliptin|mesh-list
139280194|NCT02148978|Incretins|incretins|mesh-ancestor
139280195|NCT02148978|Hormones|hormones|mesh-ancestor
139280196|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139280197|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280198|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139280199|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
139280200|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280201|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280202|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139280203|NCT05048914|Acetaminophen|acetaminophen|mesh-list
139280204|NCT05048914|Dipyrone|dipyrone|mesh-list
139280205|NCT05048914|Ibuprofen|ibuprofen|mesh-list
139280206|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139280207|NCT05048914|Analgesics|analgesics|mesh-ancestor
139280208|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
139280209|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139280210|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280211|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
139280212|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138863658|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280213|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139280214|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139280215|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139280216|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280217|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280218|NCT03046017|Lidocaine|lidocaine|mesh-list
139280219|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
139280220|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
139280221|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139280222|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280223|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
139280224|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139280225|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139280226|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139280227|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139280228|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139280229|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280230|NCT02149212|Aminaftone|aminaftone|mesh-list
139280231|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
139280232|NCT02149212|Coagulants|coagulants|mesh-ancestor
139280233|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
139280234|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
139280235|NCT03611985|Taxane|taxane|mesh-list
139280236|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280237|NCT03097900|Caffeine|caffeine|mesh-list
139280238|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
139280239|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280240|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139280241|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280242|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139280243|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280244|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139280245|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139280246|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
139280247|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280248|NCT00104676|Paclitaxel|paclitaxel|mesh-list
139280249|NCT00104676|Etoposide|etoposide|mesh-list
139280250|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
139280251|NCT00104676|Ifosfamide|ifosfamide|mesh-list
139280252|NCT00104676|Bleomycin|bleomycin|mesh-list
139280253|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139280254|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280255|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
139280256|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
139280257|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
139280258|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280259|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139280260|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139280261|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280262|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139280263|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
139280264|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139280265|NCT00354835|Dactinomycin|dactinomycin|mesh-list
139280266|NCT00354835|Cactinomycin|cactinomycin|mesh-list
139280267|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
139280268|NCT00354835|Irinotecan|irinotecan|mesh-list
139280269|NCT00354835|Vincristine|vincristine|mesh-list
139280270|NCT00354835|Camptothecin|camptothecin|mesh-list
139280271|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139280272|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
139280273|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280274|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139280275|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139280276|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
139280277|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280278|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280279|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139280280|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139280281|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139280282|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280283|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139280284|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
139280285|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
139280286|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
138863730|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280287|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139280288|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280289|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139280290|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139280291|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139280292|NCT02768298|Enalapril|enalapril|mesh-list
139280293|NCT02768298|Enalaprilat|enalaprilat|mesh-list
139280294|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139280295|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139280296|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
139280297|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280298|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280299|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139280300|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139280301|NCT05028322|Imiquimod|imiquimod|mesh-list
139280302|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139280303|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
139280304|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280305|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280306|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
139280307|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
139280308|NCT03096340|Irinotecan|irinotecan|mesh-list
139280309|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139280310|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280311|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139280312|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139280313|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280314|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280315|NCT02152800|Valacyclovir|valacyclovir|mesh-list
139280316|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
139280317|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280318|NCT02149758|Etoricoxib|etoricoxib|mesh-list
139280319|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139280320|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139280321|NCT02149758|Analgesics|analgesics|mesh-ancestor
139280322|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
139280323|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139280324|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280325|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139280326|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139280327|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139280328|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139280329|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280330|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280331|NCT03542214|Calcium|calcium|mesh-list
139280332|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139280333|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280334|NCT03094468|Terbinafine|terbinafine|mesh-list
139280335|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
139280336|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280337|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280338|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280339|NCT03744546|Tilavonemab|tilavonemab|mesh-list
139280340|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
139280341|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
139280342|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
139280343|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139280344|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139280345|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139280346|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280347|NCT03095872|Petrolatum|petrolatum|mesh-list
139280348|NCT03095872|Emollients|emollients|mesh-ancestor
139280349|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
139280350|NCT03096184|Apatinib|apatinib|mesh-list
139280351|NCT03096184|Tegafur|tegafur|mesh-list
139280352|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280353|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139280354|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280355|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280356|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139280357|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
139280358|NCT02157012|Tofacitinib|tofacitinib|mesh-list
139280359|NCT02157012|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139280360|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139280361|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280362|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280363|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
138863803|NCT04218890|Coagulants|coagulants|mesh-ancestor
139280365|NCT03096028|Vitamins|vitamins|mesh-ancestor
139280366|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
139280367|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280368|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
139280369|NCT03096028|Hematinics|hematinics|mesh-ancestor
139280370|NCT02149914|Rabeprazole|rabeprazole|mesh-list
139280371|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139280372|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139280373|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139280374|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280375|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280376|NCT02149992|Inositol|inositol|mesh-list
139280377|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
139280378|NCT02149992|Vitamins|vitamins|mesh-ancestor
139280379|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
139280380|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280381|NCT04833582|Gemcitabine|gemcitabine|mesh-list
139280382|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139280383|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
139280384|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280385|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280386|NCT05041582|Citalopram|citalopram|mesh-list
139280387|NCT05041582|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139280388|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139280389|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139280390|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280391|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280392|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
139280393|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280394|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139280395|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
139280396|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139280397|NCT02150070|ASP2408|asp2408|mesh-list
139280398|NCT02150070|Immunoconjugates|immunoconjugates|mesh-ancestor
139280399|NCT02150070|Immunologic Factors|immunologic factors|mesh-ancestor
139280400|NCT02150070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280401|NCT02153424|Apixaban|apixaban|mesh-list
139280402|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139280403|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
139280404|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139280405|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
139280406|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280407|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280408|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
139280409|NCT04434430|Gabapentin|gabapentin|mesh-list
139280410|NCT04434430|Analgesics|analgesics|mesh-ancestor
139280411|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
139280412|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139280413|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280414|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
139280415|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139280416|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139280417|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139280418|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139280419|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139280420|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139280421|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280422|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280423|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
139280424|NCT03094156|Resveratrol|resveratrol|mesh-list
139280425|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
139280426|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
139280427|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280428|NCT03094156|Protective Agents|protective agents|mesh-ancestor
139280429|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280430|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280431|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139280432|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
139280433|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280434|NCT02964273|Tolvaptan|tolvaptan|mesh-list
139280435|NCT02964273|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139280436|NCT02964273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280437|NCT02964273|Natriuretic Agents|natriuretic agents|mesh-ancestor
138863930|NCT04218500|Niacin|niacin|mesh-list
139280438|NCT02964273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280439|NCT05040724|Ivermectin|ivermectin|mesh-list
139280440|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139280441|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280442|NCT03542058|Carvedilol|carvedilol|mesh-list
139280443|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139280444|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139280445|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
139280446|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280447|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280448|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280449|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139280450|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
139280451|NCT03542058|Protective Agents|protective agents|mesh-ancestor
139280452|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139280453|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139280454|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139280455|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
139280456|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139280457|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139280458|NCT03321513|Bevacizumab|bevacizumab|mesh-list
139280459|NCT03321513|Aflibercept|aflibercept|mesh-list
139280460|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139280461|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280462|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139280463|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139280464|NCT03321513|Growth Substances|growth substances|mesh-ancestor
139280465|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280466|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
139280467|NCT02032797|Progesterone|progesterone|mesh-list
139280468|NCT02032797|Progestins|progestins|mesh-ancestor
139280469|NCT02032797|Hormones|hormones|mesh-ancestor
139280470|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139280471|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280472|NCT05024266|Paclitaxel|paclitaxel|mesh-list
139280473|NCT05024266|Carboplatin|carboplatin|mesh-list
139280474|NCT05024266|Tislelizumab|tislelizumab|mesh-list
139280475|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139280476|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280477|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
139280478|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
139280479|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
139280480|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280481|NCT05024266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139280482|NCT02773368|Insulin|insulin|mesh-list
139280483|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139280484|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
139280485|NCT02773368|Liraglutide|liraglutide|mesh-list
139280486|NCT02773368|Xultophy|xultophy|mesh-list
139280487|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139280488|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280489|NCT02773368|Incretins|incretins|mesh-ancestor
139280490|NCT02773368|Hormones|hormones|mesh-ancestor
139280491|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139280492|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
139280493|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139280494|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280495|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
139280496|NCT02157558|Fexofenadine|fexofenadine|mesh-list
139280497|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139280498|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139280499|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139280500|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
139280501|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
139280502|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280503|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280504|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280505|NCT05018182|Leucovorin|leucovorin|mesh-list
139280506|NCT05018182|Folic Acid|folic acid|mesh-list
139280507|NCT05018182|Capecitabine|capecitabine|mesh-list
139280508|NCT05018182|Fluorouracil|fluorouracil|mesh-list
139280509|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
139280510|NCT05018182|Irinotecan|irinotecan|mesh-list
139280511|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
139280512|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139280513|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
139280514|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280515|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280516|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139280517|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
139280518|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280519|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139280520|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139280521|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280522|NCT05018182|Antidotes|antidotes|mesh-ancestor
139280523|NCT05018182|Protective Agents|protective agents|mesh-ancestor
139280524|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
139280525|NCT05018182|Vitamins|vitamins|mesh-ancestor
139280526|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
139280527|NCT05018182|Hematinics|hematinics|mesh-ancestor
139280528|NCT01336569|Timolol|timolol|mesh-list
139280529|NCT01336569|Travoprost|travoprost|mesh-list
139280530|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280531|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139280532|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139280533|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
139280534|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280535|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280536|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139280537|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139280538|NCT03092986|Paclitaxel|paclitaxel|mesh-list
139280539|NCT03092986|Vinblastine|vinblastine|mesh-list
139280540|NCT03092986|Carboplatin|carboplatin|mesh-list
139280541|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139280542|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280543|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
139280544|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
139280545|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
139280546|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280547|NCT03092908|Acetic Acid|acetic acid|mesh-list
139280548|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139280549|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280550|NCT03543306|Trametinib|trametinib|mesh-list
139280551|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280552|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139280553|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280554|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280555|NCT02157792|Carboplatin|carboplatin|mesh-list
139280556|NCT02157792|Gemcitabine|gemcitabine|mesh-list
139280557|NCT02157792|Irinotecan|irinotecan|mesh-list
139280558|NCT02157792|Etoposide|etoposide|mesh-list
139280559|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280560|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139280561|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
139280562|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280563|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139280564|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139280565|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280566|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139280567|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139280568|NCT05023408|Bleomycin|bleomycin|mesh-list
139280569|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139280570|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280571|NCT02772978|Tolcapone|tolcapone|mesh-list
139280572|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139280573|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139280574|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139280575|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280576|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280577|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
139280578|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139280579|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139280580|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280581|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139280583|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139280584|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
139280585|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
139280586|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280587|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
139280588|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280589|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
139280590|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280591|NCT05038072|Triamcinolone|triamcinolone|mesh-list
139280592|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139280593|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139280594|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139280595|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139280596|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
139280598|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139280599|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280600|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139280601|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
139280602|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280603|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280604|NCT02777970|Acetaminophen|acetaminophen|mesh-list
139280605|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139280606|NCT02777970|Tramadol|tramadol|mesh-list
139280607|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139280608|NCT02777970|Analgesics|analgesics|mesh-ancestor
139280609|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
139280610|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139280611|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280612|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
139280613|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139280614|NCT02777970|Narcotics|narcotics|mesh-ancestor
139280615|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139280616|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139280617|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139280618|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139280619|NCT02150616|Sevoflurane|sevoflurane|mesh-list
139280620|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139280621|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139280622|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
139280623|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
139280624|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139280625|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280626|NCT01336023|Insulin|insulin|mesh-list
139280627|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139280628|NCT01336023|Liraglutide|liraglutide|mesh-list
139280629|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
139280630|NCT01336023|Xultophy|xultophy|mesh-list
139280631|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139280632|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280633|NCT01336023|Incretins|incretins|mesh-ancestor
139280634|NCT01336023|Hormones|hormones|mesh-ancestor
139280635|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139280636|NCT02255292|Cannabidiol|cannabidiol|mesh-list
139280637|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
139280638|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139280639|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139280640|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
139280641|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280642|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139280643|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139280644|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280645|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280646|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139280647|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139280648|NCT02254980|Vitamin E|vitamin e|mesh-list
139280649|NCT02254980|Vitamins|vitamins|mesh-ancestor
139280650|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
139280651|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280652|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
139280653|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280654|NCT02254980|Protective Agents|protective agents|mesh-ancestor
139280655|NCT05281003|Paclitaxel|paclitaxel|mesh-list
139280656|NCT05281003|Pembrolizumab|pembrolizumab|mesh-list
139280657|NCT05281003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139280658|NCT05281003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280659|NCT05281003|Tubulin Modulators|tubulin modulators|mesh-ancestor
139280660|NCT05281003|Antimitotic Agents|antimitotic agents|mesh-ancestor
139280661|NCT05281003|Mitosis Modulators|mitosis modulators|mesh-ancestor
139280662|NCT05281003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280663|NCT05281003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139280664|NCT05281003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139280665|NCT02158182|Rifaximin|rifaximin|mesh-list
139280666|NCT02158182|Lactulose|lactulose|mesh-list
139280668|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139280669|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280670|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139280671|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
139280672|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139280673|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280674|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280675|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280676|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
139280677|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139280678|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280679|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
139280680|NCT02154360|Aprepitant|aprepitant|mesh-list
139280681|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
139280682|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
139280683|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139280684|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280685|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139280686|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139280687|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280688|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280689|NCT02033031|Bevacizumab|bevacizumab|mesh-list
139280690|NCT02033031|Ranibizumab|ranibizumab|mesh-list
139280691|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139280692|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280693|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139280694|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139280695|NCT02033031|Growth Substances|growth substances|mesh-ancestor
139280696|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280697|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
139280698|NCT05034367|Mannitol|mannitol|mesh-list
139280699|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139280700|NCT05034367|Diuretics|diuretics|mesh-ancestor
139280701|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
139280702|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280703|NCT02150928|Asparaginase|asparaginase|mesh-list
139280704|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280705|NCT03611049|Vitamin D|vitamin d|mesh-list
139280706|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
139280707|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
139280708|NCT03611049|Vitamins|vitamins|mesh-list
139280709|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
139280710|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280711|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139280712|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139280713|NCT03610893|Dexamethasone|dexamethasone|mesh-list
139280714|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
139280715|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139280716|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
139280717|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
139280718|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139280719|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280720|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139280721|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
139280722|NCT03610893|Hormones|hormones|mesh-ancestor
139280723|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139280724|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139280725|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280726|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139280727|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139280728|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139280729|NCT03610893|Analgesics|analgesics|mesh-ancestor
139280730|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
139280731|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139280732|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139280733|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139280734|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
139280735|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280736|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280737|NCT02154438|Ketamine|ketamine|mesh-list
139280738|NCT02154438|Analgesics|analgesics|mesh-ancestor
139280739|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
138864177|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139280740|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139280741|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280742|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139280743|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139280744|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
139280746|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139280747|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139280748|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139280749|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280750|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280751|NCT02520921|Aspirin|aspirin|mesh-list
139280752|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139280753|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139280754|NCT02520921|Analgesics|analgesics|mesh-ancestor
139280755|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
139280756|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139280757|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280758|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139280759|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139280760|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139280761|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139280762|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280763|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139280764|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139280765|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280766|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
139280767|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
139280768|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139280769|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139280770|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280771|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
139280772|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
139280773|NCT03610347|Paclitaxel|paclitaxel|mesh-list
139280774|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139280775|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280776|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
139280777|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
139280778|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
139280779|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280780|NCT01518517|Asparaginase|asparaginase|mesh-list
139280781|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280782|NCT02863575|Ibuprofen|ibuprofen|mesh-list
139280783|NCT02863575|Caffeine|caffeine|mesh-list
139280784|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139280785|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139280786|NCT02863575|Analgesics|analgesics|mesh-ancestor
139280787|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
139280788|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139280789|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280790|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139280791|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139280792|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139280793|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280794|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280795|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139280796|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139280797|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139280798|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139280799|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
139280800|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280801|NCT05021770|Thiotepa|thiotepa|mesh-list
139280802|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139280803|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
139280804|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280805|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280806|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139280807|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139280808|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
139280809|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280810|NCT05230303|Caffeine|caffeine|mesh-list
139280811|NCT05230303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139280812|NCT05230303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280813|NCT05230303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139280814|NCT05230303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280815|NCT05230303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280816|NCT05230303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139280817|NCT05230303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139280818|NCT05230303|Purinergic Agents|purinergic agents|mesh-ancestor
139280819|NCT05230303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280820|NCT04287790|Naltrexone|naltrexone|mesh-list
139280821|NCT04287790|Disulfiram|disulfiram|mesh-list
139280822|NCT04287790|Acamprosate|acamprosate|mesh-list
139280823|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139280824|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139280825|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280826|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
139280827|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139280828|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139280829|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280830|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280831|NCT03723967|Paclitaxel|paclitaxel|mesh-list
139280832|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139280833|NCT03723967|Carboplatin|carboplatin|mesh-list
139280834|NCT03723967|Durvalumab|durvalumab|mesh-list
139280835|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139280836|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139280837|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280838|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
139280839|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
139280840|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
139280841|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280842|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139280843|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
139280844|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280845|NCT05008666|Azacitidine|azacitidine|mesh-list
139280846|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139280847|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
139280848|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280849|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280850|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280851|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139280852|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139280853|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280854|NCT03659461|Incretins|incretins|mesh-ancestor
139280855|NCT03659461|Hormones|hormones|mesh-ancestor
139280856|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139280857|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139280858|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
139280859|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280860|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280861|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
139280862|NCT01227187|Protein C|protein c|mesh-list
139280863|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280864|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
139280865|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139280866|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139280867|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280868|NCT03088072|Aspirin|aspirin|mesh-list
139280869|NCT03088072|Warfarin|warfarin|mesh-list
139280870|NCT03088072|Edoxaban|edoxaban|mesh-list
139280871|NCT03088072|Clopidogrel|clopidogrel|mesh-list
139280872|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139280873|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139280874|NCT03088072|Analgesics|analgesics|mesh-ancestor
139280875|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
139280876|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139280877|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280878|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139280879|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139280880|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139280881|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139151090|NCT02205892|Lupeol|lupeol|mesh-list
139280882|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280883|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139280884|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139280885|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280886|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
139280887|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138864327|NCT02745470|Lixisenatide|lixisenatide|mesh-list
139280888|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139280889|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139280890|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
139280891|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280892|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
139280893|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139280894|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
139280895|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139280896|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
139280897|NCT01077817|Alendronate|alendronate|mesh-list
139280898|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
139280899|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
139280900|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139280901|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
139280902|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139280903|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280904|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139280905|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139280906|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280907|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139280908|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139280909|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
139280910|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139280911|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139280912|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139280913|NCT02638012|Hemostatics|hemostatics|mesh-list
139280914|NCT02638012|Coagulants|coagulants|mesh-ancestor
139280915|NCT05014906|Minocycline|minocycline|mesh-list
139280916|NCT05014906|Azelaic acid|azelaic acid|mesh-list
139280917|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139280918|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280919|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280920|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
139280921|NCT00103506|Doxorubicin|doxorubicin|mesh-list
139280922|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139280923|NCT00103506|Bortezomib|bortezomib|mesh-list
139280924|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139280925|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280926|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139280927|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139280928|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280929|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280930|NCT02151240|Acyclovir|acyclovir|mesh-list
139280931|NCT02151240|Foscarnet|foscarnet|mesh-list
139280932|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
139280933|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
139280934|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280935|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139280936|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139280937|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280938|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280939|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
139280940|NCT02159196|Albuterol|albuterol|mesh-list
139280941|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139280942|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
139280943|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280944|NCT02159196|Expectorants|expectorants|mesh-ancestor
139280945|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
139280946|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139280947|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
139280948|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280949|NCT02159196|Protective Agents|protective agents|mesh-ancestor
139280950|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280951|NCT02159196|Antidotes|antidotes|mesh-ancestor
139280952|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139280953|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
139280954|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642325|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151144|NCT02222350|Firuglipel|firuglipel|mesh-list
139280955|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139280956|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
139280957|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139280958|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139280959|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139280960|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139280961|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
139280962|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139280963|NCT02765490|Simeprevir|simeprevir|mesh-list
138864403|NCT02744378|Clobetasol|clobetasol|mesh-list
139280964|NCT02765490|Odalasvir|odalasvir|mesh-list
139280965|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
139280966|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139280967|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
139280968|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280969|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280970|NCT02639182|Axitinib|axitinib|mesh-list
139280971|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280972|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139381885|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
139280973|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139280974|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280975|NCT02863419|Liraglutide|liraglutide|mesh-list
139280976|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139280977|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280978|NCT02863419|Incretins|incretins|mesh-ancestor
139280979|NCT02863419|Hormones|hormones|mesh-ancestor
139280980|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139280981|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139280982|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139280983|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139280984|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139280985|NCT04961632|Tamoxifen|tamoxifen|mesh-list
139280986|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139280987|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
139280988|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139280989|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139280990|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139280991|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139280992|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139280993|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139280994|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139280995|NCT02155374|Insulin|insulin|mesh-list
139280996|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139280997|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
139280998|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
139280999|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139281000|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281001|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
139281002|NCT02765100|Minocycline|minocycline|mesh-list
139281003|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139281004|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281005|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
139281006|NCT03091894|Propofol|propofol|mesh-list
139281007|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139281008|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139281009|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281010|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139281011|NCT03091894|Analgesics|analgesics|mesh-ancestor
139281012|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
139281013|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281014|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139281015|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139281016|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139281017|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
139281018|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281019|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281020|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139281021|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
139281022|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
139281023|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
139281024|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139281025|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281026|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139642326|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281027|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281028|NCT02761980|Acetaminophen|acetaminophen|mesh-list
139281029|NCT02761980|Ibuprofen|ibuprofen|mesh-list
139281030|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139281031|NCT02761980|Analgesics|analgesics|mesh-ancestor
139281032|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
139281033|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281034|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281035|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
139281036|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138864477|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281037|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139281038|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139281039|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139281040|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281041|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281042|NCT05007340|Dimercaprol|dimercaprol|mesh-list
139281043|NCT05007340|Chelating Agents|chelating agents|mesh-ancestor
139281044|NCT05007340|Sequestering Agents|sequestering agents|mesh-ancestor
139281045|NCT05007340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281046|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
139281047|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139281048|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281049|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281050|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139281051|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139281052|NCT02163174|Protective Agents|protective agents|mesh-ancestor
139281053|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281054|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
139281055|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139281056|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
139281057|NCT01744912|Lenalidomide|lenalidomide|mesh-list
139281058|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
139281059|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281060|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139281061|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139281062|NCT01744912|Growth Substances|growth substances|mesh-ancestor
139281063|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
139281064|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281065|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
139281066|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
139281067|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139281068|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139281069|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281070|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281071|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281072|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139281073|NCT02159820|Paclitaxel|paclitaxel|mesh-list
139281074|NCT02159820|Carboplatin|carboplatin|mesh-list
139281075|NCT02159820|Decitabine|decitabine|mesh-list
139281076|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139281077|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281078|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
139281079|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
139281080|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
139281081|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281082|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139281083|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
139281084|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281085|NCT02862171|Dapivirine|dapivirine|mesh-list
139281086|NCT02862171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139281087|NCT02862171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139281088|NCT02862171|Antiviral Agents|antiviral agents|mesh-ancestor
139281089|NCT02862171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281090|NCT05013112|Metformin|metformin|mesh-list
139281091|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139281092|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139281093|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281094|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281095|NCT05013034|Basiliximab|basiliximab|mesh-list
139281096|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139281097|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
139281098|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281099|NCT02638948|Methotrexate|methotrexate|mesh-list
139281100|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139281101|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
139281102|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139281103|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281104|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139281105|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
139281106|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281107|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281108|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
139281109|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281110|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139281111|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139281112|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
139281113|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139281114|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139281115|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
139281116|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281117|NCT04465864|Dexamethasone|dexamethasone|mesh-list
139281118|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139281119|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
139281120|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
139281121|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281122|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281123|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139281124|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
139281125|NCT04465864|Hormones|hormones|mesh-ancestor
139281126|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139281127|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139281128|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281129|NCT03091504|Albuterol|albuterol|mesh-list
139281130|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139281131|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
139281132|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281133|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281134|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139281135|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
139281136|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
139281137|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139281138|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139281139|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139281140|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139281141|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
139281142|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281143|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281144|NCT05019586|Amoxicillin|amoxicillin|mesh-list
139281145|NCT05019586|Clarithromycin|clarithromycin|mesh-list
139281146|NCT05019586|Levofloxacin|levofloxacin|mesh-list
139281147|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139281148|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281149|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139281150|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281151|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281152|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139281153|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139281154|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139281155|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139281156|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139281157|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281158|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139281159|NCT03081676|Glimepiride|glimepiride|mesh-list
139281160|NCT03081676|Glucagon|glucagon|mesh-list
139281161|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
139281162|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139281163|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139281164|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139281165|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281166|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139281167|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
139281168|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139281169|NCT03081676|Hormones|hormones|mesh-ancestor
139281170|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139281171|NCT03081676|Incretins|incretins|mesh-ancestor
139281172|NCT05013268|Paclitaxel|paclitaxel|mesh-list
139281173|NCT05013268|Docetaxel|docetaxel|mesh-list
139281174|NCT05013268|Carboplatin|carboplatin|mesh-list
139281175|NCT05013268|Tislelizumab|tislelizumab|mesh-list
139281176|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139151368|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
139281177|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281178|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
139281179|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
139281180|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
139281181|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281182|NCT05013268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139281183|NCT00102960|Ritonavir|ritonavir|mesh-list
139281184|NCT00102960|Lopinavir|lopinavir|mesh-list
139281185|NCT00102960|Lamivudine|lamivudine|mesh-list
139281186|NCT00102960|Zidovudine|zidovudine|mesh-list
139281187|NCT00102960|Nevirapine|nevirapine|mesh-list
139281189|NCT00102960|Didanosine|didanosine|mesh-list
139281190|NCT00102960|Efavirenz|efavirenz|mesh-list
139281191|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139281192|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139281193|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
139281194|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281195|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281196|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139281197|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139281198|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
139281199|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281200|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139281201|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139281202|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139281203|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139281204|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
139281205|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139281206|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139281207|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139281208|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139281209|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139281210|NCT02858895|Interleukin-4|interleukin-4|mesh-list
139281211|NCT02858895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139281212|NCT02858895|Immunologic Factors|immunologic factors|mesh-ancestor
139281213|NCT02858895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281214|NCT02858895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281215|NCT02858895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139281216|NCT05018962|Paclitaxel|paclitaxel|mesh-list
139281217|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139281218|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281219|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
139281220|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
139281221|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
139281222|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281223|NCT02160054|Tacrolimus|tacrolimus|mesh-list
139281224|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139281225|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
139281226|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281227|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139281228|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281229|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281230|NCT03609489|Capecitabine|capecitabine|mesh-list
139281231|NCT03609489|Apatinib|apatinib|mesh-list
139281232|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139281233|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
139281234|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281235|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281236|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139281237|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281238|NCT02033967|Milrinone|milrinone|mesh-list
139281239|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
139281240|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139281241|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139281242|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139281243|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139281244|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281245|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281246|NCT02033967|Protective Agents|protective agents|mesh-ancestor
139281247|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281248|NCT02163330|Acetazolamide|acetazolamide|mesh-list
139281249|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
139281250|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139642327|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
139281252|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281253|NCT02163330|Diuretics|diuretics|mesh-ancestor
139281254|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
139281255|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281256|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
139281257|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
139281258|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
139281259|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281260|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
139281261|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139281262|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139281263|NCT02160132|Prednisolone|prednisolone|mesh-list
139281264|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
139281265|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139281266|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
139281267|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139281268|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
139281269|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
139281270|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281271|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281272|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139281273|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
139281274|NCT02160132|Hormones|hormones|mesh-ancestor
139281275|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139281276|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139281277|NCT02160132|Protective Agents|protective agents|mesh-ancestor
139281278|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139281279|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281280|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139281281|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139281282|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281283|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139281284|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139281285|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139281286|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281287|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
139281288|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281289|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
139281290|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
139281291|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281292|NCT02858037|Dapivirine|dapivirine|mesh-list
139281293|NCT02858037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139281294|NCT02858037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139281295|NCT02858037|Antiviral Agents|antiviral agents|mesh-ancestor
139281296|NCT02858037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281297|NCT04266340|Midazolam|midazolam|mesh-list
139281298|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
139281299|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139281300|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139281301|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281302|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139281303|NCT04266340|Analgesics|analgesics|mesh-ancestor
139281304|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
139281305|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281306|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139281307|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139281308|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139281309|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
139281310|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281311|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281312|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139281313|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139281314|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139281315|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139281316|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139281317|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
139281318|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
139281319|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
139281320|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
139281321|NCT02856555|Firsocostat|firsocostat|mesh-list
139281322|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281323|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281324|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
139281325|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139281326|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281327|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139281328|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139281329|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281330|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281331|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281332|NCT05000086|Diphosphonates|diphosphonates|mesh-list
139281333|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
139281334|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138864779|NCT02733458|Hormones|hormones|mesh-ancestor
139281335|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281336|NCT01242267|Thalidomide|thalidomide|mesh-list
139281337|NCT01242267|Bortezomib|bortezomib|mesh-list
139281338|NCT01242267|Melphalan|melphalan|mesh-list
139281339|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281340|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139281341|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
139281342|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281343|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139281344|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139281345|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
139281346|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281347|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
139281348|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139281349|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281350|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139281351|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139281352|NCT01242267|Growth Substances|growth substances|mesh-ancestor
139281353|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
139281354|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139281355|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139281356|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139281357|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139281358|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139281359|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
139281360|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281361|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281362|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281363|NCT02635984|Olanzapine|olanzapine|mesh-list
139281364|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
139281365|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
139281366|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281367|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281368|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139281369|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139281370|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139281371|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139281372|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139281373|NCT02635984|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139281374|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139281375|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139281376|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281377|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281378|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
139281379|NCT03073408|Propofol|propofol|mesh-list
139281380|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139281381|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139281382|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281383|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139281384|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
139281385|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
139281386|NCT04993222|Amphotericin B|amphotericin b|mesh-list
139281387|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139281388|NCT04993222|Amebicides|amebicides|mesh-ancestor
139281389|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139281390|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139281391|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281392|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139281393|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
139281394|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139281395|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139281396|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139281397|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281398|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281399|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139151593|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
139281400|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139281401|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281402|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
139281403|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281404|NCT02747043|Rituximab|rituximab|mesh-list
139281405|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139281406|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281407|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
139281408|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281409|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138864864|NCT02733380|Hormones|hormones|mesh-ancestor
139281411|NCT05004142|Fulvestrant|fulvestrant|mesh-list
139281412|NCT05004142|Goserelin|goserelin|mesh-list
139281413|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281414|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139281415|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139281416|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281417|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281418|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139281419|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
139281420|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139281421|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281422|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139281423|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139281424|NCT03076684|Allopurinol|allopurinol|mesh-list
139281425|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
139281426|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281427|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281428|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
139281429|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139281430|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139281431|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
139281432|NCT03076684|Protective Agents|protective agents|mesh-ancestor
139281433|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281434|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
139281435|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139281436|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
139281437|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281438|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281439|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139281440|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
139281441|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
139281442|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139281443|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
139281444|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281445|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281446|NCT03607851|Lacosamide|lacosamide|mesh-list
139281447|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
139281448|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139281449|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139281450|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139281451|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281452|NCT04999540|Fulvestrant|fulvestrant|mesh-list
139281453|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139281454|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281455|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139281456|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139281457|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
139281458|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139281459|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281460|NCT03608007|Ensartinib|ensartinib|mesh-list
139281461|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281462|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139281463|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281464|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281465|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
139281466|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139281467|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139281468|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
139281469|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
139281470|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642328|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281471|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281472|NCT03075358|Lidocaine|lidocaine|mesh-list
139281473|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
139281474|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
139281475|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139281476|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281477|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
139281478|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281479|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139281480|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139281481|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138864930|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
138842622|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
139281482|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139281483|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281484|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
139281485|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139281486|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139281487|NCT05003596|Prednisolone|prednisolone|mesh-list
139281488|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
139281489|NCT05003596|Narcotics|narcotics|mesh-list
139281490|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139281491|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
139281492|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139281493|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
139281494|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
139281495|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281496|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281497|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139281498|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
139281499|NCT05003596|Hormones|hormones|mesh-ancestor
139281500|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139281501|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139281502|NCT05003596|Protective Agents|protective agents|mesh-ancestor
139281503|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139281504|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281505|NCT05003596|Analgesics|analgesics|mesh-ancestor
139281506|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
139281507|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139281508|NCT04433572|Sirolimus|sirolimus|mesh-list
139281509|NCT04433572|Temsirolimus|temsirolimus|mesh-list
139281510|NCT04433572|MTOR Inhibitors|mtor inhibitors|mesh-list
139281511|NCT04433572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139281512|NCT04433572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281513|NCT04433572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281514|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139281515|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
139281516|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281517|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281518|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139281519|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281520|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139281521|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
139281522|NCT03073018|Fosinopril|fosinopril|mesh-list
139281523|NCT03073018|Pravastatin|pravastatin|mesh-list
139281524|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139281525|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139281526|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
139281527|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281528|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139281529|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139281530|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281531|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139281532|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
139281533|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139281534|NCT06205134|Epinephrine|epinephrine|mesh-list
139281535|NCT06205134|Racepinephrine|racepinephrine|mesh-list
139281536|NCT06205134|Epinephryl borate|epinephryl borate|mesh-list
139281537|NCT06205134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139281538|NCT06205134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139281539|NCT06205134|Adrenergic Agents|adrenergic agents|mesh-ancestor
139281540|NCT06205134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281541|NCT06205134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281542|NCT06205134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281543|NCT06205134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139281544|NCT06205134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139281545|NCT06205134|Autonomic Agents|autonomic agents|mesh-ancestor
139281546|NCT06205134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281547|NCT06205134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139281548|NCT06205134|Respiratory System Agents|respiratory system agents|mesh-ancestor
139281549|NCT06205134|Mydriatics|mydriatics|mesh-ancestor
139281550|NCT06205134|Sympathomimetics|sympathomimetics|mesh-ancestor
139281551|NCT06205134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139281552|NCT06205095|Factor VIII|factor viii|mesh-list
139281553|NCT06205095|Coagulants|coagulants|mesh-ancestor
139281554|NCT06205056|Complement Factor H|complement factor h|mesh-list
139281555|NCT06205056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139281556|NCT06205056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139281557|NCT06205056|Immunologic Factors|immunologic factors|mesh-ancestor
139281558|NCT06205056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281559|NCT06204991|Aldesleukin|aldesleukin|mesh-list
139281560|NCT06204991|Cyclophosphamide|cyclophosphamide|mesh-list
139281561|NCT06204991|Fludarabine|fludarabine|mesh-list
139281562|NCT06204991|Fludarabine phosphate|fludarabine phosphate|mesh-list
139281563|NCT06204991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139281564|NCT06204991|Immunologic Factors|immunologic factors|mesh-ancestor
139281565|NCT06204991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281566|NCT06204991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139281567|NCT06204991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139281568|NCT06204991|Alkylating Agents|alkylating agents|mesh-ancestor
139281569|NCT06204991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281570|NCT06204991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281571|NCT06204991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139281572|NCT06204991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139281573|NCT06204991|Antimetabolites|antimetabolites|mesh-ancestor
139281574|NCT06204991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139281575|NCT06204991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139281576|NCT06204991|Antiviral Agents|antiviral agents|mesh-ancestor
139281577|NCT06204991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281578|NCT06204796|Vitamin D|vitamin d|mesh-list
139281579|NCT06204796|Prednisone|prednisone|mesh-list
139281580|NCT06204796|Vitamins|vitamins|mesh-ancestor
139281581|NCT06204796|Micronutrients|micronutrients|mesh-ancestor
139281582|NCT06204796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281583|NCT06204796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139281584|NCT06204796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139281585|NCT06204796|Glucocorticoids|glucocorticoids|mesh-ancestor
139281586|NCT06204796|Hormones|hormones|mesh-ancestor
139281587|NCT06204796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139281588|NCT06204796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139281589|NCT06204796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281590|NCT06204679|Ruzasvir|ruzasvir|mesh-list
139281591|NCT06204679|Antiviral Agents|antiviral agents|mesh-ancestor
139281592|NCT06204679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281593|NCT06204640|Spironolactone|spironolactone|mesh-list
139281594|NCT06204640|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139281595|NCT06204640|Hormone Antagonists|hormone antagonists|mesh-ancestor
139281596|NCT06204640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139281597|NCT06204640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281598|NCT06204640|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139281599|NCT06204640|Diuretics|diuretics|mesh-ancestor
139281600|NCT06204640|Natriuretic Agents|natriuretic agents|mesh-ancestor
139281601|NCT06204614|Paclitaxel|paclitaxel|mesh-list
139281602|NCT06204614|Vinblastine|vinblastine|mesh-list
139281603|NCT06204614|Docetaxel|docetaxel|mesh-list
139281604|NCT06204614|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139281605|NCT06204614|Cisplatin|cisplatin|mesh-list
139281606|NCT06204614|Carboplatin|carboplatin|mesh-list
139281607|NCT06204614|Gemcitabine|gemcitabine|mesh-list
139281608|NCT06204614|Doxorubicin|doxorubicin|mesh-list
139281609|NCT06204614|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139281610|NCT06204614|Pembrolizumab|pembrolizumab|mesh-list
139281611|NCT06204614|Nivolumab|nivolumab|mesh-list
139281612|NCT06204614|Methotrexate|methotrexate|mesh-list
139281613|NCT06204614|Ifosfamide|ifosfamide|mesh-list
139281614|NCT06204614|Avelumab|avelumab|mesh-list
139281615|NCT06204614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139281616|NCT06204614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139281617|NCT06204614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281618|NCT06204614|Tubulin Modulators|tubulin modulators|mesh-ancestor
139281619|NCT06204614|Antimitotic Agents|antimitotic agents|mesh-ancestor
139281620|NCT06204614|Mitosis Modulators|mitosis modulators|mesh-ancestor
139281621|NCT06204614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281622|NCT06204614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139281623|NCT06204614|Antimetabolites|antimetabolites|mesh-ancestor
139281624|NCT06204614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139281625|NCT06204614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139281626|NCT06204614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139281627|NCT06204614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281628|NCT06204614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139281629|NCT06204614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139281630|NCT06204614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139281631|NCT06204614|Abortifacient Agents|abortifacient agents|mesh-ancestor
139281632|NCT06204614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139281633|NCT06204614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281634|NCT06204614|Dermatologic Agents|dermatologic agents|mesh-ancestor
139281635|NCT06204614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139281636|NCT06204614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139281637|NCT06204614|Immunologic Factors|immunologic factors|mesh-ancestor
139281638|NCT06204614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139281639|NCT06204614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139281640|NCT06204614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139281641|NCT06204614|Alkylating Agents|alkylating agents|mesh-ancestor
139281642|NCT06204432|Citric Acid|citric acid|mesh-list
139281643|NCT06204432|Sodium Citrate|sodium citrate|mesh-list
139281644|NCT06204432|Anticoagulants|anticoagulants|mesh-ancestor
139281645|NCT06204432|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139281646|NCT06204432|Chelating Agents|chelating agents|mesh-ancestor
139281647|NCT06204432|Sequestering Agents|sequestering agents|mesh-ancestor
139281648|NCT06204432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281649|NCT06204185|Metformin|metformin|mesh-list
139281650|NCT06204185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139281651|NCT06204185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281652|NCT06204120|Morphine|morphine|mesh-list
139281653|NCT06204120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139281654|NCT06204120|Narcotics|narcotics|mesh-ancestor
139281655|NCT06204120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139281656|NCT06204120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281657|NCT06204120|Analgesics|analgesics|mesh-ancestor
139281658|NCT06204120|Sensory System Agents|sensory system agents|mesh-ancestor
139281659|NCT06204120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281660|NCT06204107|Metformin|metformin|mesh-list
139281661|NCT06204107|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139281662|NCT06204107|Empagliflozin|empagliflozin|mesh-list
139281663|NCT06204107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139281664|NCT06204107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281665|NCT06204107|Incretins|incretins|mesh-ancestor
139281666|NCT06204107|Hormones|hormones|mesh-ancestor
139281667|NCT06204107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139281668|NCT06204107|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139281669|NCT06204107|Protease Inhibitors|protease inhibitors|mesh-ancestor
139281670|NCT06204107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281671|NCT06204107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281672|NCT06204107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139281673|NCT06204094|Capecitabine|capecitabine|mesh-list
139281674|NCT06204094|Oxaliplatin|oxaliplatin|mesh-list
139281675|NCT06204094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139281676|NCT06204094|Antimetabolites|antimetabolites|mesh-ancestor
139281677|NCT06204094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281678|NCT06204094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281679|NCT06204016|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139281680|NCT06204016|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139281681|NCT06204016|Estradiol|estradiol|mesh-list
139281682|NCT06204016|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139281683|NCT06204016|Estrogens|estrogens|mesh-ancestor
139281684|NCT06204016|Hormones|hormones|mesh-ancestor
139281685|NCT06204016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139281686|NCT06204016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281687|NCT06204016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139281688|NCT06204016|Contraceptive Agents|contraceptive agents|mesh-ancestor
139281689|NCT06204016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139281690|NCT06204016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139281691|NCT06203977|Colchicine|colchicine|mesh-list
139281692|NCT06203977|Gout Suppressants|gout suppressants|mesh-ancestor
139281693|NCT06203977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139281694|NCT06203977|Tubulin Modulators|tubulin modulators|mesh-ancestor
139281695|NCT06203977|Antimitotic Agents|antimitotic agents|mesh-ancestor
139281696|NCT06203977|Mitosis Modulators|mitosis modulators|mesh-ancestor
139281697|NCT06203977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151899|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
139281698|NCT06203977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281699|NCT06203769|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139281700|NCT06203769|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139281701|NCT06203769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281702|NCT06203769|Antitubercular Agents|antitubercular agents|mesh-ancestor
139281703|NCT06203600|Paclitaxel|paclitaxel|mesh-list
139281704|NCT06203600|Nivolumab|nivolumab|mesh-list
139281705|NCT06203600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139281706|NCT06203600|Ramucirumab|ramucirumab|mesh-list
139381891|NCT03037892|Fentanyl|fentanyl|mesh-list
139281707|NCT06203600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139281708|NCT06203600|Antibodies|antibodies|mesh-list
139281709|NCT06203600|Immunoglobulins|immunoglobulins|mesh-list
139281710|NCT06203600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139281711|NCT06203600|Lexatumumab|lexatumumab|mesh-list
139281712|NCT06203600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139281713|NCT06203600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281714|NCT06203600|Tubulin Modulators|tubulin modulators|mesh-ancestor
139281715|NCT06203600|Antimitotic Agents|antimitotic agents|mesh-ancestor
139281716|NCT06203600|Mitosis Modulators|mitosis modulators|mesh-ancestor
139281717|NCT06203600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281718|NCT06203600|Immunologic Factors|immunologic factors|mesh-ancestor
139281719|NCT06203600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281720|NCT06203600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139281721|NCT06203470|Calcipotriene|calcipotriene|mesh-list
139281722|NCT06203470|Botulinum Toxins|botulinum toxins|mesh-list
139281723|NCT06203470|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139281724|NCT06203470|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139281725|NCT06203470|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139281726|NCT06203470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139281727|NCT06203470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281728|NCT06203470|Cholinergic Agents|cholinergic agents|mesh-ancestor
139281729|NCT06203470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281730|NCT06203470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281731|NCT06203470|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139281732|NCT06203470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281733|NCT06203470|Dermatologic Agents|dermatologic agents|mesh-ancestor
139281734|NCT06203431|Etomidate|etomidate|mesh-list
139281735|NCT06203431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139281736|NCT06203431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139281737|NCT06203431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281738|NCT06203431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139281739|NCT06203431|Anesthetics, General|anesthetics, general|mesh-ancestor
139281740|NCT06203431|Anesthetics|anesthetics|mesh-ancestor
139281741|NCT06203405|Midazolam|midazolam|mesh-list
139281742|NCT06203405|Fentanyl|fentanyl|mesh-list
139281743|NCT06203405|Dexmedetomidine|dexmedetomidine|mesh-list
139281744|NCT06203405|Propofol|propofol|mesh-list
139281745|NCT06203405|Cisatracurium|cisatracurium|mesh-list
139281746|NCT06203405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139281747|NCT06203405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139281748|NCT06203405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281749|NCT06203405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139281750|NCT06203405|Analgesics|analgesics|mesh-ancestor
139281751|NCT06203405|Sensory System Agents|sensory system agents|mesh-ancestor
139281752|NCT06203405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281753|NCT06203405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139281754|NCT06203405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139281755|NCT06203405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139281756|NCT06203405|Adrenergic Agents|adrenergic agents|mesh-ancestor
139281757|NCT06203405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281758|NCT06203405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281759|NCT06203405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139281760|NCT06203405|Anesthetics, General|anesthetics, general|mesh-ancestor
139281761|NCT06203405|Anesthetics|anesthetics|mesh-ancestor
139281762|NCT06203405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139281763|NCT06203405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139281764|NCT06203405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139281765|NCT06203405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139281766|NCT06203405|GABA Modulators|gaba modulators|mesh-ancestor
139281767|NCT06203405|GABA Agents|gaba agents|mesh-ancestor
139281768|NCT06203405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139281769|NCT06203405|Narcotics|narcotics|mesh-ancestor
139281770|NCT06203405|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139281771|NCT06203405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139281772|NCT06203314|Antibodies|antibodies|mesh-list
139281773|NCT06203314|Immunologic Factors|immunologic factors|mesh-ancestor
139642329|NCT01315665|Sulforaphane|sulforaphane|mesh-list
139281774|NCT06203314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281775|NCT06203275|Paroxetine|paroxetine|mesh-list
139281776|NCT06203275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139281777|NCT06203275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139281778|NCT06203275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139281779|NCT06203275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281780|NCT06203275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281781|NCT06203275|Serotonin Agents|serotonin agents|mesh-ancestor
139281782|NCT06203275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281783|NCT06203275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139281784|NCT06203275|Antidepressive Agents|antidepressive agents|mesh-ancestor
139281785|NCT06203275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139281786|NCT06203275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139281787|NCT06203275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139281789|NCT06203236|Furosemide|furosemide|mesh-list
139281790|NCT06203236|Diuretics|diuretics|mesh-list
139281791|NCT06203236|Natriuretic Agents|natriuretic agents|mesh-ancestor
139281792|NCT06203236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281793|NCT06203236|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139281794|NCT06203236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139281795|NCT06203236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281796|NCT06203210|Topotecan|topotecan|mesh-list
139281797|NCT06203210|Amrubicin|amrubicin|mesh-list
139281798|NCT06203210|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139281799|NCT06203210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139281800|NCT06203210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281801|NCT06203210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281802|NCT06203210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281803|NCT06203145|Bortezomib|bortezomib|mesh-list
139281804|NCT06203145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281805|NCT06203132|Tenofovir|tenofovir|mesh-list
139281806|NCT06203132|Lamivudine|lamivudine|mesh-list
139281807|NCT06203132|Emtricitabine|emtricitabine|mesh-list
139281808|NCT06203132|Dolutegravir|dolutegravir|mesh-list
139281809|NCT06203132|Antiviral Agents|antiviral agents|mesh-ancestor
139281810|NCT06203132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281811|NCT06203132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139281812|NCT06203132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139281813|NCT06203132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281814|NCT06203132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281815|NCT06203132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139281816|NCT06203132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139281817|NCT06203132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139281818|NCT06203132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139281819|NCT06203080|Nonoxynol|nonoxynol|mesh-list
139281820|NCT06203080|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
139281821|NCT06203080|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
139281822|NCT06203080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281823|NCT06203080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139281824|NCT06203080|Contraceptive Agents|contraceptive agents|mesh-ancestor
139281825|NCT06203080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139281826|NCT06203080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139281827|NCT06203041|Vitamin D|vitamin d|mesh-list
139281828|NCT06203041|Cholecalciferol|cholecalciferol|mesh-list
139281829|NCT06203041|Vitamins|vitamins|mesh-ancestor
139281830|NCT06203041|Micronutrients|micronutrients|mesh-ancestor
139281831|NCT06203041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281832|NCT06203041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139281833|NCT06203041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139281834|NCT06202963|Triamcinolone|triamcinolone|mesh-list
139281835|NCT06202963|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139281836|NCT06202963|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139281837|NCT06202963|Lidocaine|lidocaine|mesh-list
139281838|NCT06202963|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139281839|NCT06202963|Anesthetics, Local|anesthetics, local|mesh-ancestor
139281840|NCT06202963|Anesthetics|anesthetics|mesh-ancestor
139281841|NCT06202963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139281842|NCT06202963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281843|NCT06202963|Sensory System Agents|sensory system agents|mesh-ancestor
139281844|NCT06202963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281845|NCT06202963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139281846|NCT06202963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139281847|NCT06202963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139281848|NCT06202963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139281849|NCT06202963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281850|NCT06202963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139281851|NCT06202963|Glucocorticoids|glucocorticoids|mesh-ancestor
139281852|NCT06202963|Hormones|hormones|mesh-ancestor
139281853|NCT06202963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139281854|NCT06202963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139281855|NCT06202963|Immunologic Factors|immunologic factors|mesh-ancestor
139281856|NCT06202963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281857|NCT06202911|Acetylcysteine|acetylcysteine|mesh-list
139281858|NCT06202911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139281859|NCT06202911|Antiviral Agents|antiviral agents|mesh-ancestor
139281860|NCT06202911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281861|NCT06202911|Expectorants|expectorants|mesh-ancestor
139281862|NCT06202911|Respiratory System Agents|respiratory system agents|mesh-ancestor
138865310|NCT00782288|Digitoxin|digitoxin|mesh-list
139281872|NCT06202781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139281873|NCT06202781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281874|NCT06202781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139281875|NCT06202781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281876|NCT06201871|Lidocaine|lidocaine|mesh-list
139281877|NCT06201871|Anesthetics, Local|anesthetics, local|mesh-ancestor
139281878|NCT06201871|Anesthetics|anesthetics|mesh-ancestor
139281879|NCT06201871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139281880|NCT06201871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281881|NCT06201871|Sensory System Agents|sensory system agents|mesh-ancestor
139281882|NCT06201871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281883|NCT06201871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139281884|NCT06201871|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139281885|NCT06201871|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139281886|NCT06201871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139281887|NCT06201871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281888|NCT06201507|Rituximab|rituximab|mesh-list
139281889|NCT06201507|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139281890|NCT06201507|Doxorubicin|doxorubicin|mesh-list
139281891|NCT06201507|Vincristine|vincristine|mesh-list
139281892|NCT06201507|Dacarbazine|dacarbazine|mesh-list
139281893|NCT06201507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139281894|NCT06201507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281895|NCT06201507|Immunologic Factors|immunologic factors|mesh-ancestor
139281896|NCT06201507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281897|NCT06201507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139281898|NCT06201507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139281899|NCT06201507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139281900|NCT06201507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139281901|NCT06201507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281902|NCT06201507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281903|NCT06201507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139281904|NCT06201507|Tubulin Modulators|tubulin modulators|mesh-ancestor
139281905|NCT06201507|Antimitotic Agents|antimitotic agents|mesh-ancestor
139281906|NCT06201507|Mitosis Modulators|mitosis modulators|mesh-ancestor
139281907|NCT06201507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139281908|NCT06201507|Alkylating Agents|alkylating agents|mesh-ancestor
139281909|NCT06201507|Immunotoxins|immunotoxins|mesh-ancestor
139281910|NCT06201507|Immunoconjugates|immunoconjugates|mesh-ancestor
139281911|NCT06201377|Chlorhexidine|chlorhexidine|mesh-list
139281912|NCT06201377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139281913|NCT06201377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139281914|NCT06201377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281915|NCT06201377|Disinfectants|disinfectants|mesh-ancestor
139281916|NCT06201377|Dermatologic Agents|dermatologic agents|mesh-ancestor
139281917|NCT06200233|Apatinib|apatinib|mesh-list
139281918|NCT06200233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281919|NCT06200233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139281920|NCT06200233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139281921|NCT06200233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281927|NCT06194981|Capecitabine|capecitabine|mesh-list
139281928|NCT06194981|Oxaliplatin|oxaliplatin|mesh-list
139281929|NCT06194981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139281930|NCT06194981|Antimetabolites|antimetabolites|mesh-ancestor
139281931|NCT06194981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281932|NCT06194981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281941|NCT06190665|Chlorotrianisene|chlorotrianisene|mesh-list
139281942|NCT06190665|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139281944|NCT06190665|Hormones|hormones|mesh-ancestor
139281945|NCT06190665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139281946|NCT06190665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281947|NCT06190665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139281948|NCT06190665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281949|NCT06190275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139281950|NCT06190275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281951|NCT06190275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139281952|NCT06190275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281953|NCT06182124|Vaccines|vaccines|mesh-list
139281954|NCT06182124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139281955|NCT06182124|Immunologic Factors|immunologic factors|mesh-ancestor
139281956|NCT06182124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281957|NCT06162377|Methylnaltrexone|methylnaltrexone|mesh-list
139281958|NCT06162377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139281959|NCT06162377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281960|NCT06162377|Sensory System Agents|sensory system agents|mesh-ancestor
139281961|NCT06162377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139281962|NCT06154707|Denosumab|denosumab|mesh-list
139281963|NCT06154707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139281964|NCT06154707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281965|NCT06154252|Cyclophosphamide|cyclophosphamide|mesh-list
139281966|NCT06154252|Fludarabine|fludarabine|mesh-list
139281967|NCT06154252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139281968|NCT06154252|Immunologic Factors|immunologic factors|mesh-ancestor
139281969|NCT06154252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281970|NCT06154252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139281971|NCT06154252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139281972|NCT06154252|Alkylating Agents|alkylating agents|mesh-ancestor
139281973|NCT06154252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281974|NCT06154252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281975|NCT06154252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139281976|NCT06117891|Bevacizumab|bevacizumab|mesh-list
139281977|NCT06117891|Atezolizumab|atezolizumab|mesh-list
139281978|NCT06117891|Durvalumab|durvalumab|mesh-list
139281979|NCT06117891|Tremelimumab|tremelimumab|mesh-list
139281980|NCT06117891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139281981|NCT06117891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281982|NCT06117891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139281983|NCT06117891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139281984|NCT06117891|Growth Substances|growth substances|mesh-ancestor
139281985|NCT06117891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281986|NCT06117891|Growth Inhibitors|growth inhibitors|mesh-ancestor
139281987|NCT06117891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139281988|NCT06117891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281989|NCT06114628|Moxifloxacin|moxifloxacin|mesh-list
139281990|NCT06114628|Rifampin|rifampin|mesh-list
139281991|NCT06114628|Isoniazid|isoniazid|mesh-list
139281992|NCT06114628|Linezolid|linezolid|mesh-list
139281993|NCT06114628|Pyrazinamide|pyrazinamide|mesh-list
139281994|NCT06114628|Ethambutol|ethambutol|mesh-list
139281995|NCT06114628|Bedaquiline|bedaquiline|mesh-list
139281996|NCT06114628|GSK656|gsk656|mesh-list
139281997|NCT06114628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139281998|NCT06114628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139281999|NCT06114628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139282000|NCT06114628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139282001|NCT06114628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282002|NCT06114628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282003|NCT06114628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282004|NCT06114628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139282005|NCT06114628|Antitubercular Agents|antitubercular agents|mesh-ancestor
139282006|NCT06114628|Leprostatic Agents|leprostatic agents|mesh-ancestor
139282007|NCT06114628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139282008|NCT06114628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139282009|NCT06114628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139282010|NCT06114628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139282011|NCT06114628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139282012|NCT06114628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139282013|NCT06114628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139282014|NCT06114628|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139282016|NCT06114628|Antimetabolites|antimetabolites|mesh-ancestor
139282017|NCT06114628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139282018|NCT06114628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139282019|NCT06108050|Pembrolizumab|pembrolizumab|mesh-list
139282020|NCT06108050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282021|NCT06108050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282022|NCT06108050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282023|NCT06108050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282024|NCT06102824|Carboplatin|carboplatin|mesh-list
139282025|NCT06102824|Gemcitabine|gemcitabine|mesh-list
139282026|NCT06102824|Capecitabine|capecitabine|mesh-list
139282027|NCT06102824|Trastuzumab|trastuzumab|mesh-list
139282028|NCT06102824|Vinorelbine|vinorelbine|mesh-list
139282029|NCT06102824|Taxane|taxane|mesh-list
139282030|NCT06102824|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139282031|NCT06102824|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139282032|NCT06102824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282033|NCT06102824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139282034|NCT06102824|Antimetabolites|antimetabolites|mesh-ancestor
139282035|NCT06102824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282036|NCT06102824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282037|NCT06102824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139282038|NCT06102824|Tubulin Modulators|tubulin modulators|mesh-ancestor
139282039|NCT06102824|Antimitotic Agents|antimitotic agents|mesh-ancestor
139282040|NCT06102824|Mitosis Modulators|mitosis modulators|mesh-ancestor
139282041|NCT06102824|Immunoconjugates|immunoconjugates|mesh-ancestor
139282042|NCT06102824|Immunologic Factors|immunologic factors|mesh-ancestor
139282043|NCT06102824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282044|NCT06091943|Tislelizumab|tislelizumab|mesh-list
139282045|NCT06091943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282046|NCT06091943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282047|NCT06083454|Durvalumab|durvalumab|mesh-list
139282048|NCT06083454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282049|NCT06083454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282050|NCT06082102|Rituximab|rituximab|mesh-list
139282051|NCT06082102|Lenalidomide|lenalidomide|mesh-list
139282052|NCT06082102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282053|NCT06082102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282054|NCT06082102|Immunologic Factors|immunologic factors|mesh-ancestor
139282055|NCT06082102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282056|NCT06082102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139282057|NCT06082102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139282058|NCT06082102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139282059|NCT06082102|Growth Substances|growth substances|mesh-ancestor
139282060|NCT06082102|Growth Inhibitors|growth inhibitors|mesh-ancestor
139282061|NCT06082037|Azithromycin|azithromycin|mesh-list
139282062|NCT06082037|Belumosudil|belumosudil|mesh-list
139282063|NCT06082037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139282064|NCT06082037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139282065|NCT06082037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282066|NCT06082037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282067|NCT06082037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282068|NCT06081049|Colchicine|colchicine|mesh-list
139282069|NCT06081049|Gout Suppressants|gout suppressants|mesh-ancestor
139282070|NCT06081049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139282071|NCT06081049|Tubulin Modulators|tubulin modulators|mesh-ancestor
139282072|NCT06081049|Antimitotic Agents|antimitotic agents|mesh-ancestor
139282073|NCT06081049|Mitosis Modulators|mitosis modulators|mesh-ancestor
139282074|NCT06081049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282075|NCT06081049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282076|NCT06080698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139282077|NCT06080698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139282078|NCT06080698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139282079|NCT06080698|Antitubercular Agents|antitubercular agents|mesh-ancestor
139282080|NCT06067737|Buprenorphine|buprenorphine|mesh-list
139282081|NCT06067737|Psilocybin|psilocybin|mesh-list
139282082|NCT06067737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139282083|NCT06067737|Narcotics|narcotics|mesh-ancestor
139282084|NCT06067737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139282085|NCT06067737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282086|NCT06067737|Analgesics|analgesics|mesh-ancestor
139282087|NCT06067737|Sensory System Agents|sensory system agents|mesh-ancestor
139282088|NCT06067737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139282089|NCT06067737|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139282090|NCT06067737|Hallucinogens|hallucinogens|mesh-ancestor
139282091|NCT06067737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139282092|NCT06063317|Blinatumomab|blinatumomab|mesh-list
139282093|NCT06063317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282094|NCT06058663|Durvalumab|durvalumab|mesh-list
139282095|NCT06058663|Ipilimumab|ipilimumab|mesh-list
139282096|NCT06058663|Tremelimumab|tremelimumab|mesh-list
139282097|NCT06058663|Immunoglobulins|immunoglobulins|mesh-list
139282113|NCT06029127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282114|NCT06029127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282130|NCT06010758|Listerine|listerine|mesh-list
139282131|NCT06010758|Sodium Fluoride|sodium fluoride|mesh-list
139282132|NCT06010758|Cariostatic Agents|cariostatic agents|mesh-ancestor
139282133|NCT06010758|Protective Agents|protective agents|mesh-ancestor
139282134|NCT06010758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282135|NCT06010758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139282136|NCT06010758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139282137|NCT06010303|Tislelizumab|tislelizumab|mesh-list
139282138|NCT06010303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282139|NCT06010303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282140|NCT06006546|MEDI9197|medi9197|mesh-list
139282141|NCT06006546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139282142|NCT06006546|Immunologic Factors|immunologic factors|mesh-ancestor
139282143|NCT06006546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282144|NCT05989074|Fexofenadine|fexofenadine|mesh-list
139282145|NCT05989074|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139282146|NCT05989074|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139282147|NCT05989074|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139282148|NCT05989074|Histamine Antagonists|histamine antagonists|mesh-ancestor
139282149|NCT05989074|Histamine Agents|histamine agents|mesh-ancestor
139282150|NCT05989074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139282151|NCT05989074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282152|NCT05989074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282153|NCT05962151|Nalbuphine|nalbuphine|mesh-list
139282154|NCT05962151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139282155|NCT05962151|Narcotics|narcotics|mesh-ancestor
139282156|NCT05962151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139282157|NCT05962151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282158|NCT05962151|Analgesics|analgesics|mesh-ancestor
139282159|NCT05962151|Sensory System Agents|sensory system agents|mesh-ancestor
139282160|NCT05962151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139282161|NCT05956041|Pembrolizumab|pembrolizumab|mesh-list
138865603|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
139282162|NCT05956041|Mogamulizumab|mogamulizumab|mesh-list
139282163|NCT05956041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282164|NCT05956041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282165|NCT05956041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282166|NCT05956041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282168|NCT05955365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139282169|NCT05955365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139282170|NCT05955365|Analgesics|analgesics|mesh-ancestor
139282171|NCT05955365|Sensory System Agents|sensory system agents|mesh-ancestor
139282172|NCT05955365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152350|NCT00066365|Molgramostim|molgramostim|mesh-list
139282173|NCT05955365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282174|NCT05955365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139282175|NCT05955365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139282176|NCT05955365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139282177|NCT05955365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139282178|NCT05955365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282179|NCT05955365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139282180|NCT05955365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139282181|NCT05955365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282182|NCT05955365|Antipyretics|antipyretics|mesh-ancestor
139282183|NCT05928390|Pasireotide|pasireotide|mesh-list
139282184|NCT05928390|Hormones|hormones|mesh-ancestor
139282185|NCT05928390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139282186|NCT05928390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282187|NCT05909683|Anti-Infective Agents|anti-infective agents|mesh-list
139282188|NCT05909683|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139282189|NCT05900895|Olaparib|olaparib|mesh-list
139282190|NCT05900895|Estradiol|estradiol|mesh-list
139282191|NCT05900895|Estrogens|estrogens|mesh-ancestor
139282192|NCT05900895|Hormones|hormones|mesh-ancestor
139282193|NCT05900895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139282194|NCT05900895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282195|NCT05900895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139282196|NCT05900895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282197|NCT05900895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282198|NCT05900895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282199|NCT05888870|Daratumumab|daratumumab|mesh-list
139282200|NCT05888870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282201|NCT05876351|Eculizumab|eculizumab|mesh-list
139282202|NCT05876351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139282203|NCT05876351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139282204|NCT05876351|Immunologic Factors|immunologic factors|mesh-ancestor
139282205|NCT05876351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282206|NCT05853289|Analgesics, Opioid|analgesics, opioid|mesh-list
139282207|NCT05853289|Narcotics|narcotics|mesh-ancestor
139282208|NCT05853289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139282209|NCT05853289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282210|NCT05853289|Analgesics|analgesics|mesh-ancestor
139282211|NCT05853289|Sensory System Agents|sensory system agents|mesh-ancestor
139282212|NCT05853289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139282213|NCT05840159|Doxycycline|doxycycline|mesh-list
139282214|NCT05840159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139282215|NCT05840159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139282216|NCT05840159|Antimalarials|antimalarials|mesh-ancestor
139282217|NCT05840159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139282218|NCT05840159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139282219|NCT05838768|Irinotecan|irinotecan|mesh-list
139282220|NCT05838768|Tislelizumab|tislelizumab|mesh-list
139282221|NCT05838768|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139282222|NCT05838768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139282223|NCT05838768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282224|NCT05838768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282225|NCT05838768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282226|NCT05838768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282227|NCT05827016|Lenalidomide|lenalidomide|mesh-list
139282228|NCT05827016|Immunologic Factors|immunologic factors|mesh-ancestor
139282229|NCT05827016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282230|NCT05827016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139282231|NCT05827016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139282232|NCT05827016|Growth Substances|growth substances|mesh-ancestor
139282233|NCT05827016|Growth Inhibitors|growth inhibitors|mesh-ancestor
139282234|NCT05827016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282235|NCT05826990|Cefepime|cefepime|mesh-list
139282236|NCT05826990|Enmetazobactam|enmetazobactam|mesh-list
139282237|NCT05826990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138865678|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139282239|NCT05826990|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139282240|NCT05826990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282241|NCT05826990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282242|NCT05822583|Abatacept|abatacept|mesh-list
139282243|NCT05822583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282244|NCT05822583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282245|NCT05822583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139642330|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139282246|NCT05822583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282247|NCT05822583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139282248|NCT05822583|Immunologic Factors|immunologic factors|mesh-ancestor
139282249|NCT05822583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282250|NCT05822583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139282251|NCT05821478|Metronidazole|metronidazole|mesh-list
139282252|NCT05821478|Rifampin|rifampin|mesh-list
139282253|NCT05821478|Ceftriaxone|ceftriaxone|mesh-list
139282254|NCT05821478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139282255|NCT05821478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139282256|NCT05821478|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139282257|NCT05821478|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139282258|NCT05821478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139282259|NCT05821478|Antitubercular Agents|antitubercular agents|mesh-ancestor
139282260|NCT05821478|Leprostatic Agents|leprostatic agents|mesh-ancestor
139282261|NCT05821478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139282262|NCT05821478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282263|NCT05821478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282264|NCT05821478|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139282265|NCT05821478|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139282266|NCT05821478|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139282267|NCT05821478|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139282268|NCT05821478|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139282269|NCT05821478|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139282270|NCT05775380|Pioglitazone|pioglitazone|mesh-list
139282271|NCT05775380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139282272|NCT05775380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282273|NCT05768854|Diphosphonates|diphosphonates|mesh-list
139282274|NCT05768854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139282275|NCT05768854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282276|NCT05760313|Linaclotide|linaclotide|mesh-list
139282277|NCT05760313|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139282278|NCT05760313|Enzyme Activators|enzyme activators|mesh-ancestor
139282279|NCT05760313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282280|NCT05760313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139282281|NCT05717140|Nivolumab|nivolumab|mesh-list
139282282|NCT05717140|Sargramostim|sargramostim|mesh-list
139282283|NCT05717140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282284|NCT05717140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282285|NCT05717140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282286|NCT05717140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282287|NCT05717140|Immunologic Factors|immunologic factors|mesh-ancestor
139282288|NCT05717140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282289|NCT05714059|Insulin|insulin|mesh-list
139282290|NCT05714059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139282291|NCT05714059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282292|NCT05707377|Zanubrutinib|zanubrutinib|mesh-list
139282293|NCT05707377|Tacrolimus|tacrolimus|mesh-list
139282294|NCT05707377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139282295|NCT05707377|Immunologic Factors|immunologic factors|mesh-ancestor
139282296|NCT05707377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282297|NCT05707377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139282298|NCT05707377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282299|NCT05707377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282300|NCT05707377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282301|NCT05707377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282302|NCT05685004|Temozolomide|temozolomide|mesh-list
139282303|NCT05685004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139282304|NCT05685004|Alkylating Agents|alkylating agents|mesh-ancestor
139282305|NCT05685004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282306|NCT05685004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282307|NCT05681481|Prednisone|prednisone|mesh-list
139282308|NCT05681481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139282309|NCT05681481|Glucocorticoids|glucocorticoids|mesh-ancestor
139282310|NCT05681481|Hormones|hormones|mesh-ancestor
139282311|NCT05681481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139282312|NCT05681481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282313|NCT05681481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139282314|NCT05681481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282315|NCT05678673|Nivolumab|nivolumab|mesh-list
139282316|NCT05678673|Sunitinib|sunitinib|mesh-list
139282317|NCT05678673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282318|NCT05678673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282319|NCT05678673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282320|NCT05678673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282321|NCT05678673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139282322|NCT05678673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139282323|NCT05678673|Growth Substances|growth substances|mesh-ancestor
139282324|NCT05678673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282325|NCT05678673|Growth Inhibitors|growth inhibitors|mesh-ancestor
139282326|NCT05678673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282327|NCT05678673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282328|NCT05673187|Adagrasib|adagrasib|mesh-list
139282329|NCT05673187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282330|NCT05663710|Nivolumab|nivolumab|mesh-list
139282331|NCT05663710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282332|NCT05663710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282333|NCT05663710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282334|NCT05663710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282335|NCT05650554|Vaccines|vaccines|mesh-list
139282336|NCT05650554|Immunologic Factors|immunologic factors|mesh-ancestor
139282337|NCT05650554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282338|NCT05650437|Vitamin D|vitamin d|mesh-list
139282339|NCT05650437|Vitamins|vitamins|mesh-ancestor
139282340|NCT05650437|Micronutrients|micronutrients|mesh-ancestor
139282341|NCT05650437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282342|NCT05650437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139282343|NCT05643560|Factor VIII|factor viii|mesh-list
139282344|NCT05643560|Coagulants|coagulants|mesh-ancestor
139282345|NCT05635708|Paclitaxel|paclitaxel|mesh-list
139282346|NCT05635708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139282347|NCT05635708|Carboplatin|carboplatin|mesh-list
139282348|NCT05635708|Pemetrexed|pemetrexed|mesh-list
139282349|NCT05635708|Tislelizumab|tislelizumab|mesh-list
139282350|NCT05635708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139282351|NCT05635708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282352|NCT05635708|Tubulin Modulators|tubulin modulators|mesh-ancestor
139282353|NCT05635708|Antimitotic Agents|antimitotic agents|mesh-ancestor
139282354|NCT05635708|Mitosis Modulators|mitosis modulators|mesh-ancestor
139282355|NCT05635708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282356|NCT05635708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282357|NCT05635708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139282358|NCT05635708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139282359|NCT05635708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282360|NCT05635227|Dexamethasone|dexamethasone|mesh-list
139282361|NCT05635227|Olanzapine|olanzapine|mesh-list
139282362|NCT05635227|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139282363|NCT05635227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139282364|NCT05635227|Antiemetics|antiemetics|mesh-ancestor
139282365|NCT05635227|Autonomic Agents|autonomic agents|mesh-ancestor
139282366|NCT05635227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139282367|NCT05635227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282368|NCT05635227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139282369|NCT05635227|Glucocorticoids|glucocorticoids|mesh-ancestor
139282370|NCT05635227|Hormones|hormones|mesh-ancestor
139282371|NCT05635227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139282372|NCT05635227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139282373|NCT05635227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282374|NCT05635227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139282375|NCT05635227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139282376|NCT05635227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139282377|NCT05635227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139282378|NCT05635227|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139282379|NCT05635227|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139282380|NCT05635227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139282381|NCT05635227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282382|NCT05635227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139282383|NCT05635227|Serotonin Agents|serotonin agents|mesh-ancestor
139282384|NCT05624281|Nintedanib|nintedanib|mesh-list
139282385|NCT05624281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282386|NCT05624281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282387|NCT05624281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282388|NCT05624281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282389|NCT05620407|Deucravacitinib|deucravacitinib|mesh-list
139282390|NCT05620407|Dermatologic Agents|dermatologic agents|mesh-ancestor
139282391|NCT05620407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282392|NCT05620407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282393|NCT05620407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282394|NCT05617677|Deucravacitinib|deucravacitinib|mesh-list
139152571|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
139282395|NCT05617677|Dermatologic Agents|dermatologic agents|mesh-ancestor
139282396|NCT05617677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282397|NCT05617677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282398|NCT05617677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282399|NCT05609370|Bevacizumab|bevacizumab|mesh-list
139282400|NCT05609370|Tislelizumab|tislelizumab|mesh-list
139282401|NCT05609370|Capecitabine|capecitabine|mesh-list
139282402|NCT05609370|Fluorouracil|fluorouracil|mesh-list
139282403|NCT05609370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282404|NCT05609370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282405|NCT05609370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139282406|NCT05609370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139282407|NCT05609370|Growth Substances|growth substances|mesh-ancestor
139282408|NCT05609370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282409|NCT05609370|Growth Inhibitors|growth inhibitors|mesh-ancestor
139282410|NCT05609370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139282411|NCT05609370|Antimetabolites|antimetabolites|mesh-ancestor
139282412|NCT05609370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282413|NCT05609370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139282414|NCT05609370|Immunologic Factors|immunologic factors|mesh-ancestor
139282415|NCT05607017|Losartan|losartan|mesh-list
139282416|NCT05607017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139282417|NCT05607017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139282418|NCT05607017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139282419|NCT05607017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139282420|NCT05607017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282421|NCT05595369|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139282422|NCT05595369|Antiviral Agents|antiviral agents|mesh-ancestor
139282423|NCT05595369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139282424|NCT05560009|Levodopa|levodopa|mesh-list
139282425|NCT05560009|Fluorides|fluorides|mesh-list
139282426|NCT05560009|Cariostatic Agents|cariostatic agents|mesh-ancestor
139282427|NCT05560009|Protective Agents|protective agents|mesh-ancestor
139282428|NCT05560009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282429|NCT05560009|Dopamine Agents|dopamine agents|mesh-ancestor
139282430|NCT05560009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139282431|NCT05560009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282432|NCT05560009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139282433|NCT05560009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139282434|NCT05556265|Deucravacitinib|deucravacitinib|mesh-list
139282435|NCT05556265|Dermatologic Agents|dermatologic agents|mesh-ancestor
139282436|NCT05556265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282437|NCT05556265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282438|NCT05556265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282439|NCT05526755|Osimertinib|osimertinib|mesh-list
139282440|NCT05526755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282441|NCT05526755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282442|NCT05526755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282443|NCT05526755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282444|NCT05506943|Paclitaxel|paclitaxel|mesh-list
139282445|NCT05506943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139282446|NCT05506943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282447|NCT05506943|Tubulin Modulators|tubulin modulators|mesh-ancestor
139282448|NCT05506943|Antimitotic Agents|antimitotic agents|mesh-ancestor
139282449|NCT05506943|Mitosis Modulators|mitosis modulators|mesh-ancestor
139282450|NCT05506943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282451|NCT05503875|Adalimumab|adalimumab|mesh-list
139282452|NCT05503875|Methotrexate|methotrexate|mesh-list
139282453|NCT05503875|Ixekizumab|ixekizumab|mesh-list
139282454|NCT05503875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139282455|NCT05503875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139282456|NCT05503875|Abortifacient Agents|abortifacient agents|mesh-ancestor
139282457|NCT05503875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139282458|NCT05503875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865902|NCT02637375|Paclitaxel|paclitaxel|mesh-list
139282459|NCT05503875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139282460|NCT05503875|Antimetabolites|antimetabolites|mesh-ancestor
139282461|NCT05503875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282462|NCT05503875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282463|NCT05503875|Dermatologic Agents|dermatologic agents|mesh-ancestor
139282464|NCT05503875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282465|NCT05503875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139282466|NCT05503875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139642331|NCT01315665|Protective Agents|protective agents|mesh-ancestor
139282467|NCT05503875|Immunologic Factors|immunologic factors|mesh-ancestor
139282468|NCT05503875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139282469|NCT05503875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139282470|NCT05503875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139282471|NCT05503875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139282472|NCT05503875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282473|NCT05493215|Imatinib Mesylate|imatinib mesylate|mesh-list
139282474|NCT05493215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282475|NCT05493215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282476|NCT05493215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282477|NCT05493215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282478|NCT05492682|Cyclophosphamide|cyclophosphamide|mesh-list
139282479|NCT05492682|Pembrolizumab|pembrolizumab|mesh-list
139282480|NCT05492682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139282481|NCT05492682|Immunologic Factors|immunologic factors|mesh-ancestor
139282482|NCT05492682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282483|NCT05492682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139282484|NCT05492682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139282485|NCT05492682|Alkylating Agents|alkylating agents|mesh-ancestor
139282486|NCT05492682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282487|NCT05492682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282488|NCT05492682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139282489|NCT05492682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282490|NCT05492682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282491|NCT05488847|Acetaminophen|acetaminophen|mesh-list
139282492|NCT05488847|Dexamethasone|dexamethasone|mesh-list
139282493|NCT05488847|Ibuprofen|ibuprofen|mesh-list
139282494|NCT05488847|Celecoxib|celecoxib|mesh-list
139282495|NCT05488847|Ketorolac|ketorolac|mesh-list
139282496|NCT05488847|Pregabalin|pregabalin|mesh-list
139282497|NCT05488847|Epinephrine|epinephrine|mesh-list
139282498|NCT05488847|Oxycodone|oxycodone|mesh-list
139282499|NCT05488847|Tramadol|tramadol|mesh-list
139282500|NCT05488847|Tizanidine|tizanidine|mesh-list
139282501|NCT05488847|Magnesium Oxide|magnesium oxide|mesh-list
139282502|NCT05488847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139282503|NCT05488847|Antiemetics|antiemetics|mesh-ancestor
139282504|NCT05488847|Autonomic Agents|autonomic agents|mesh-ancestor
139282505|NCT05488847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139282506|NCT05488847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282507|NCT05488847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139282508|NCT05488847|Glucocorticoids|glucocorticoids|mesh-ancestor
139282509|NCT05488847|Hormones|hormones|mesh-ancestor
139282510|NCT05488847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139282511|NCT05488847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139282512|NCT05488847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282513|NCT05488847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139282514|NCT05488847|Analgesics|analgesics|mesh-ancestor
139282515|NCT05488847|Sensory System Agents|sensory system agents|mesh-ancestor
139282516|NCT05488847|Antipyretics|antipyretics|mesh-ancestor
139282517|NCT05488847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139282518|NCT05488847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139282519|NCT05488847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139282520|NCT05488847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282521|NCT05488847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282522|NCT05488847|Anticonvulsants|anticonvulsants|mesh-ancestor
139282523|NCT05488847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139282524|NCT05488847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139282525|NCT05488847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139282526|NCT05488847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139282527|NCT05488847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139282528|NCT05488847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139282529|NCT05488847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139282530|NCT05488847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138865977|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139282531|NCT05488847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139282532|NCT05488847|Adrenergic Agents|adrenergic agents|mesh-ancestor
139282533|NCT05488847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139282534|NCT05488847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139282535|NCT05488847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139282536|NCT05488847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139282537|NCT05488847|Respiratory System Agents|respiratory system agents|mesh-ancestor
139282538|NCT05488847|Mydriatics|mydriatics|mesh-ancestor
139282539|NCT05488847|Sympathomimetics|sympathomimetics|mesh-ancestor
139282540|NCT05488847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139282541|NCT05488847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139282542|NCT05488847|Narcotics|narcotics|mesh-ancestor
139282543|NCT05488847|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139282544|NCT05488847|Antacids|antacids|mesh-ancestor
139282545|NCT05488847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139282546|NCT05488847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139282547|NCT05488847|Parasympatholytics|parasympatholytics|mesh-ancestor
139282548|NCT05488847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139282549|NCT05485662|Listerine|listerine|mesh-list
139282550|NCT05485662|Fluorides|fluorides|mesh-list
139282551|NCT05485662|Sodium Fluoride|sodium fluoride|mesh-list
139282552|NCT05485662|Cariostatic Agents|cariostatic agents|mesh-ancestor
139282553|NCT05485662|Protective Agents|protective agents|mesh-ancestor
139282554|NCT05485662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282555|NCT05485662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139282556|NCT05485662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139282557|NCT05483400|Atezolizumab|atezolizumab|mesh-list
139282558|NCT05483400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282559|NCT05483400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282560|NCT05483400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282561|NCT05483400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282562|NCT05430035|Mitomycins|mitomycins|mesh-list
139282563|NCT05430035|Mitomycin|mitomycin|mesh-list
139282564|NCT05430035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139282565|NCT05430035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282566|NCT05430035|Alkylating Agents|alkylating agents|mesh-ancestor
139282567|NCT05430035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282568|NCT05430035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139282569|NCT05430035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282570|NCT05406713|Pembrolizumab|pembrolizumab|mesh-list
139282571|NCT05406713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282572|NCT05406713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282573|NCT05406713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282574|NCT05406713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282575|NCT05395299|Ethylene|ethylene|mesh-list
139282576|NCT05395299|Plant Growth Regulators|plant growth regulators|mesh-ancestor
139282577|NCT05395299|Growth Substances|growth substances|mesh-ancestor
139282578|NCT05395299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282579|NCT05383170|Pembrolizumab|pembrolizumab|mesh-list
139282580|NCT05383170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282581|NCT05383170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282582|NCT05383170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282583|NCT05383170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282584|NCT05378100|Midazolam|midazolam|mesh-list
139282585|NCT05378100|Ketamine|ketamine|mesh-list
139282586|NCT05378100|Analgesics|analgesics|mesh-ancestor
139282587|NCT05378100|Sensory System Agents|sensory system agents|mesh-ancestor
139282588|NCT05378100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139282589|NCT05378100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282590|NCT05378100|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139282591|NCT05378100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139282592|NCT05378100|Anesthetics, General|anesthetics, general|mesh-ancestor
139282593|NCT05378100|Anesthetics|anesthetics|mesh-ancestor
139282594|NCT05378100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139282595|NCT05378100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139282596|NCT05378100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139282597|NCT05378100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139282598|NCT05378100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282599|NCT05378100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139282600|NCT05378100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139282601|NCT05378100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139282602|NCT05378100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139282603|NCT05378100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139282604|NCT05378100|GABA Modulators|gaba modulators|mesh-ancestor
139282605|NCT05378100|GABA Agents|gaba agents|mesh-ancestor
138866048|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139282606|NCT05351593|Lenalidomide|lenalidomide|mesh-list
139282607|NCT05351593|Immunologic Factors|immunologic factors|mesh-ancestor
139282608|NCT05351593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282610|NCT05351593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139282611|NCT05351593|Growth Substances|growth substances|mesh-ancestor
139282612|NCT05351593|Growth Inhibitors|growth inhibitors|mesh-ancestor
139282613|NCT05351593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282614|NCT05337137|Bevacizumab|bevacizumab|mesh-list
139282616|NCT05337137|Relatlimab|relatlimab|mesh-list
139282617|NCT05337137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282618|NCT05337137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282619|NCT05337137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139282620|NCT05337137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139282621|NCT05337137|Growth Substances|growth substances|mesh-ancestor
139282622|NCT05337137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282623|NCT05337137|Growth Inhibitors|growth inhibitors|mesh-ancestor
139282624|NCT05337137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282625|NCT05337137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282626|NCT05334004|Ritonavir|ritonavir|mesh-list
139282627|NCT05334004|Lopinavir|lopinavir|mesh-list
139282628|NCT05334004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139282629|NCT05334004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139282630|NCT05334004|Protease Inhibitors|protease inhibitors|mesh-ancestor
139282631|NCT05334004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282632|NCT05334004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282633|NCT05334004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139282634|NCT05334004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139282635|NCT05334004|Antiviral Agents|antiviral agents|mesh-ancestor
139282636|NCT05334004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139282637|NCT05334004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139282638|NCT05334004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139282639|NCT05288062|Dexamethasone|dexamethasone|mesh-list
139282640|NCT05288062|Dexamethasone acetate|dexamethasone acetate|mesh-list
139282641|NCT05288062|Lenalidomide|lenalidomide|mesh-list
139282642|NCT05288062|Pomalidomide|pomalidomide|mesh-list
139282643|NCT05288062|Ichthammol|ichthammol|mesh-list
139282644|NCT05288062|BB 1101|bb 1101|mesh-list
139282645|NCT05288062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139282646|NCT05288062|Antiemetics|antiemetics|mesh-ancestor
139282647|NCT05288062|Autonomic Agents|autonomic agents|mesh-ancestor
139282648|NCT05288062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139282649|NCT05288062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282650|NCT05288062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139282651|NCT05288062|Glucocorticoids|glucocorticoids|mesh-ancestor
139282652|NCT05288062|Hormones|hormones|mesh-ancestor
139282653|NCT05288062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139282654|NCT05288062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139282655|NCT05288062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282656|NCT05288062|Protease Inhibitors|protease inhibitors|mesh-ancestor
139282657|NCT05288062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282658|NCT05288062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282659|NCT05288062|Immunologic Factors|immunologic factors|mesh-ancestor
139282660|NCT05288062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139282661|NCT05288062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139282662|NCT05288062|Growth Substances|growth substances|mesh-ancestor
139282663|NCT05288062|Growth Inhibitors|growth inhibitors|mesh-ancestor
139282664|NCT05288062|Dermatologic Agents|dermatologic agents|mesh-ancestor
139282665|NCT05284747|Evolocumab|evolocumab|mesh-list
139282666|NCT05284747|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139282667|NCT05284747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139282668|NCT05284747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139282669|NCT05284747|Antimetabolites|antimetabolites|mesh-ancestor
139282670|NCT05284747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282671|NCT05284747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139282672|NCT05284747|Protease Inhibitors|protease inhibitors|mesh-ancestor
139282673|NCT05284747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282674|NCT05284747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139282675|NCT05282550|Trazodone|trazodone|mesh-list
139282676|NCT05282550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139282677|NCT05282550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139282678|NCT05282550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139282679|NCT05282550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282680|NCT05282550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139282681|NCT05282550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139282682|NCT05282550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139282683|NCT05282550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139282684|NCT05282550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282685|NCT05282550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139282687|NCT05282550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139282688|NCT05282550|Antidepressive Agents|antidepressive agents|mesh-ancestor
139282689|NCT05272878|Irbesartan|irbesartan|mesh-list
139282690|NCT05272878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139282691|NCT05272878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139282692|NCT05272878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139282693|NCT05272878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282694|NCT05268562|Ketamine|ketamine|mesh-list
139282695|NCT05268562|Propofol|propofol|mesh-list
139282696|NCT05268562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139282697|NCT05268562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139282698|NCT05268562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282699|NCT05268562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139282700|NCT05268562|Anesthetics, General|anesthetics, general|mesh-ancestor
139282701|NCT05268562|Anesthetics|anesthetics|mesh-ancestor
139282702|NCT05268562|Analgesics|analgesics|mesh-ancestor
139282703|NCT05268562|Sensory System Agents|sensory system agents|mesh-ancestor
139282704|NCT05268562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139282705|NCT05268562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139282706|NCT05268562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139282707|NCT05268562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139282708|NCT05268562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139282709|NCT05268562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282710|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
139282711|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139282712|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139282713|NCT05197621|Vaccines|vaccines|mesh-list
139282714|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
139282715|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282716|NCT05191446|Ethanol|ethanol|mesh-list
139282717|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139282718|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139282719|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139282720|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282721|NCT05176483|Nivolumab|nivolumab|mesh-list
139282722|NCT05176483|Ipilimumab|ipilimumab|mesh-list
139282723|NCT05176483|Relatlimab|relatlimab|mesh-list
139282724|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282725|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282726|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282727|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282728|NCT05145413|Xanomeline|xanomeline|mesh-list
139282729|NCT05145413|Trospium chloride|trospium chloride|mesh-list
139282730|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
139282731|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
139282732|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139282733|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282734|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139282735|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139282736|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
139282737|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139282738|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282739|NCT05145413|Urological Agents|urological agents|mesh-ancestor
139282740|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139282741|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139282742|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139282743|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139282744|NCT05107674|Paclitaxel|paclitaxel|mesh-list
139282745|NCT05107674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139282746|NCT05107674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282747|NCT05107674|Tubulin Modulators|tubulin modulators|mesh-ancestor
139282748|NCT05107674|Antimitotic Agents|antimitotic agents|mesh-ancestor
139282749|NCT05107674|Mitosis Modulators|mitosis modulators|mesh-ancestor
139282750|NCT05107674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282751|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
139282752|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282753|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282754|NCT05098132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282755|NCT05098132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282756|NCT05095116|Fluticasone|fluticasone|mesh-list
139282757|NCT05095116|Xhance|xhance|mesh-list
139282759|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139282760|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
139282761|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139282762|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282763|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139282764|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
139282765|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
139282766|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139282770|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282771|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139282772|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139282773|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139282774|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282775|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282776|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282777|NCT05091567|Carboplatin|carboplatin|mesh-list
139282778|NCT05091567|Etoposide|etoposide|mesh-list
139282779|NCT05091567|Atezolizumab|atezolizumab|mesh-list
139282780|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282781|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139282782|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139282783|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139282784|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282785|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282786|NCT05091567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282787|NCT05091567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282788|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
139282789|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
139282790|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139282791|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139282792|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
139282793|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282796|NCT05036278|Factor VIII|factor viii|mesh-list
139282797|NCT05036278|Coagulants|coagulants|mesh-ancestor
139282798|NCT05032157|Remibrutinib|remibrutinib|mesh-list
139282799|NCT05032157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282800|NCT05032157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282801|NCT05032157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282802|NCT05016310|Vitamin D|vitamin d|mesh-list
139282803|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
139282804|NCT05016310|Cholecalciferol|cholecalciferol|mesh-list
139282805|NCT05016310|Vitamins|vitamins|mesh-list
139282806|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
139282807|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282808|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139282809|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139282810|NCT05014828|Lenvatinib|lenvatinib|mesh-list
139282811|NCT05014828|Tislelizumab|tislelizumab|mesh-list
139282812|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282813|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282814|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282815|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282816|NCT05014828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282817|NCT05011123|Vaccines|vaccines|mesh-list
139282818|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
139282819|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282820|NCT04956640|Carboplatin|carboplatin|mesh-list
139282821|NCT04956640|Pembrolizumab|pembrolizumab|mesh-list
139282822|NCT04956640|Pemetrexed|pemetrexed|mesh-list
139282823|NCT04956640|Cetuximab|cetuximab|mesh-list
139282824|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282825|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282826|NCT04956640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282827|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282828|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282829|NCT04956640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139282830|NCT04956640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139282831|NCT04943536|Bicalutamide|bicalutamide|mesh-list
139282832|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
139282833|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
139282834|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139282835|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282836|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282837|NCT04941898|Factor VIII|factor viii|mesh-list
139282838|NCT04941898|BAX 855|bax 855|mesh-list
139282839|NCT04941898|Coagulants|coagulants|mesh-ancestor
139282840|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
139282841|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
139282842|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139282843|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139153020|NCT02264626|Remifentanil|remifentanil|mesh-list
139282844|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139282845|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282846|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282847|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139282848|NCT04908189|Apremilast|apremilast|mesh-list
139282849|NCT04908189|Deucravacitinib|deucravacitinib|mesh-list
139282850|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139282851|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139282852|NCT04908189|Analgesics|analgesics|mesh-ancestor
139282853|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
139282854|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139282855|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282856|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139282857|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139282858|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139282859|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139282860|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282861|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282862|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
139282863|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282864|NCT04864782|Paclitaxel|paclitaxel|mesh-list
139282865|NCT04864782|Carboplatin|carboplatin|mesh-list
139282866|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139282867|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282868|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
139282869|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
139282870|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
139282871|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282872|NCT04862780|Osimertinib|osimertinib|mesh-list
139282873|NCT04862780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282874|NCT04862780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139282875|NCT04862780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381902|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
139282876|NCT04862780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282877|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
139282878|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139282879|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
139282880|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139282881|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282882|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139282883|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
139282884|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139282885|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
139282886|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282887|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139282888|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139282889|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
139282890|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
139282891|NCT04842331|Protective Agents|protective agents|mesh-ancestor
139282892|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
139282893|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139282894|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282895|NCT04827862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139282896|NCT04827862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282897|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139282898|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
139282899|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282900|NCT04804735|Anesthetics|anesthetics|mesh-list
139282901|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139282902|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282903|NCT04782687|Dexamethasone|dexamethasone|mesh-list
139282904|NCT04782687|Lenalidomide|lenalidomide|mesh-list
138866348|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139282905|NCT04782687|Daratumumab|daratumumab|mesh-list
139282906|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139282907|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
139282909|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139282910|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282911|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139282912|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
139282913|NCT04782687|Hormones|hormones|mesh-ancestor
139282914|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139282915|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139642332|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282916|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282917|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
139282918|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139282919|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139282920|NCT04782687|Growth Substances|growth substances|mesh-ancestor
139282921|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
139282922|NCT04765137|Atorvastatin|atorvastatin|mesh-list
139282923|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139282924|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139282925|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
139282926|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282927|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139282928|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139282929|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282930|NCT04760691|Tenofovir|tenofovir|mesh-list
139282931|NCT04760691|Emtricitabine|emtricitabine|mesh-list
139282932|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139282933|NCT04760691|Leuprolide|leuprolide|mesh-list
139282934|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139282935|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139282936|NCT04760691|Estradiol|estradiol|mesh-list
139282937|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139282938|NCT04760691|Estrogens|estrogens|mesh-list
139282939|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
139282940|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139282941|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139282942|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139282943|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282944|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282945|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139282946|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139282947|NCT04760691|Hormones|hormones|mesh-ancestor
139282948|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139282949|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282950|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139282951|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
139282952|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139282953|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139282954|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139282955|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
139282956|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139282957|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282958|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
139282959|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
139282960|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282961|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139282962|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139282963|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
139282964|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139282965|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282966|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139282967|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139282968|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139282969|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139282970|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282971|NCT04663308|Volixibat|volixibat|mesh-list
139282972|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139282973|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
139282974|NCT04637763|Fludarabine|fludarabine|mesh-list
139282975|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139282976|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
139282977|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282978|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139282979|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139282980|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
139282981|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282982|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282983|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139282984|NCT04617457|Leucovorin|leucovorin|mesh-list
139282985|NCT04617457|Folic Acid|folic acid|mesh-list
139282986|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
139282987|NCT04617457|Irinotecan|irinotecan|mesh-list
139282988|NCT04617457|Fluorouracil|fluorouracil|mesh-list
139282989|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
139282990|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282991|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139282992|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139282993|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139282994|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139282995|NCT04617457|Antidotes|antidotes|mesh-ancestor
139282996|NCT04617457|Protective Agents|protective agents|mesh-ancestor
139282997|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139282998|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
139282999|NCT04617457|Vitamins|vitamins|mesh-ancestor
139283000|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
139283001|NCT04617457|Hematinics|hematinics|mesh-ancestor
139283002|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
139283003|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139283004|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283005|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
139283006|NCT04599140|Nivolumab|nivolumab|mesh-list
139283007|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139283008|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283009|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139283010|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283011|NCT04597411|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139283012|NCT04597411|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139283013|NCT04597411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283014|NCT04574778|Acetaminophen|acetaminophen|mesh-list
139283015|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139283016|NCT04574778|Analgesics|analgesics|mesh-ancestor
139283017|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
139283018|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283019|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283020|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
139283021|NCT04554485|Blinatumomab|blinatumomab|mesh-list
139283022|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283023|NCT04529772|Prednisone|prednisone|mesh-list
139283024|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
139283025|NCT04529772|Rituximab|rituximab|mesh-list
139283026|NCT04529772|Doxorubicin|doxorubicin|mesh-list
139283027|NCT04529772|Vincristine|vincristine|mesh-list
139283028|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
139283029|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283030|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
139283031|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283032|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139283033|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139283034|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
139283035|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283036|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283037|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139283038|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139283039|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139283040|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139283041|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139283042|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283043|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139283044|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
139283045|NCT04529772|Hormones|hormones|mesh-ancestor
139283046|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139283047|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139283048|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139283049|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
139283050|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
139283051|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
139283052|NCT04446962|Lenalidomide|lenalidomide|mesh-list
138866492|NCT00880191|Analgesics|analgesics|mesh-ancestor
139283053|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
139283054|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283055|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139283056|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139283057|NCT04446962|Growth Substances|growth substances|mesh-ancestor
139283058|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
139283059|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283060|NCT04438824|Palbociclib|palbociclib|mesh-list
139283061|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283062|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139283063|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283064|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283065|NCT04413123|Nivolumab|nivolumab|mesh-list
139283066|NCT04413123|Ipilimumab|ipilimumab|mesh-list
139153244|NCT01189396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139283067|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139283068|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283069|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139283070|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283071|NCT04341350|Analgesics|analgesics|mesh-list
139283072|NCT04341350|Propofol|propofol|mesh-list
139283073|NCT04341350|Isoflurane|isoflurane|mesh-list
139283074|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139283075|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139283076|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283077|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139283078|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
139283079|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
139283080|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
139283081|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283082|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139283083|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
139283084|NCT04305795|Cemiplimab|cemiplimab|mesh-list
139283085|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139283086|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283087|NCT04305795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139283088|NCT04305795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283089|NCT04296006|Amphetamine|amphetamine|mesh-list
139283090|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
139283091|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139283092|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283093|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
139283094|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
139283095|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283096|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
139283097|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139283098|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283099|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
139283100|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139283101|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139283102|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139283103|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139283104|NCT04292054|Cefazolin|cefazolin|mesh-list
139283105|NCT04292054|Tazobactam|tazobactam|mesh-list
139283106|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139283107|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139283108|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139283109|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283110|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283111|NCT04279847|INCB057643|incb057643|mesh-list
139283112|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283113|NCT04276493|Docetaxel|docetaxel|mesh-list
139283114|NCT04276493|Capecitabine|capecitabine|mesh-list
139283115|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
139283116|NCT04276493|Tislelizumab|tislelizumab|mesh-list
139283117|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283118|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
139283119|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
139283120|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
139283121|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283122|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139283123|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
139283124|NCT04276493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139283125|NCT04253262|Rucaparib|rucaparib|mesh-list
139283126|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139283127|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283128|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283129|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283130|NCT04243837|Pirfenidone|pirfenidone|mesh-list
138866579|NCT00660153|Tivozanib|tivozanib|mesh-list
139283131|NCT04243837|Analgesics|analgesics|mesh-ancestor
139283132|NCT04243837|Sensory System Agents|sensory system agents|mesh-ancestor
139283133|NCT04243837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283134|NCT04243837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283135|NCT04243837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139283136|NCT04243837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139283137|NCT04243837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139283138|NCT04243837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139642333|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283139|NCT04243837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283141|NCT04215978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139283142|NCT04215978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283143|NCT04178005|Cladribine|cladribine|mesh-list
139283144|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283145|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283146|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
139283147|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283148|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
139283149|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139283150|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
139283151|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283152|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283153|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139283154|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139283155|NCT04164199|Capecitabine|capecitabine|mesh-list
139283156|NCT04164199|Pemetrexed|pemetrexed|mesh-list
139283157|NCT04164199|Temozolomide|temozolomide|mesh-list
139283158|NCT04164199|Tislelizumab|tislelizumab|mesh-list
139283159|NCT04164199|Pamiparib|pamiparib|mesh-list
139283160|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139283161|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
139283162|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283163|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283164|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283165|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139283166|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139283167|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139283168|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
139283169|NCT04164199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139283170|NCT04164199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139283171|NCT04130542|Pembrolizumab|pembrolizumab|mesh-list
139283172|NCT04130542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139283173|NCT04130542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283174|NCT04130542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139283175|NCT04130542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283176|NCT04064060|Luspatercept|luspatercept|mesh-list
139283177|NCT04064060|Hematinics|hematinics|mesh-ancestor
139283178|NCT04051619|Oxytocin|oxytocin|mesh-list
139283179|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
139283180|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139283181|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283182|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
139283183|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139283184|NCT04044690|Antibodies|antibodies|mesh-list
139283185|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
139283186|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
139283187|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283188|NCT04028765|Misoprostol|misoprostol|mesh-list
139283189|NCT04028765|Oxytocin|oxytocin|mesh-list
139283190|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
139283191|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139283192|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283193|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139283194|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
139283195|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139283196|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139283197|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
139283198|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
139283199|NCT03959241|Methotrexate|methotrexate|mesh-list
139283200|NCT03959241|Tacrolimus|tacrolimus|mesh-list
139283201|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283202|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
139283203|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283204|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139283205|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139283206|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
139283207|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283208|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283209|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139283210|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139283211|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
139283212|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139283213|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139283214|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
139283215|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
139283216|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283217|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139283218|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139283219|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139283220|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139283221|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139283222|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
139283223|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139283224|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139283226|NCT03958474|Oxycodone|oxycodone|mesh-list
139283227|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139283228|NCT03958474|Narcotics|narcotics|mesh-ancestor
139283229|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139283230|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283231|NCT03958474|Analgesics|analgesics|mesh-ancestor
139283232|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
139283233|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283234|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139283235|NCT03907488|Nivolumab|nivolumab|mesh-list
139283236|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139283237|NCT03907488|Doxorubicin|doxorubicin|mesh-list
139283238|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139283239|NCT03907488|Dacarbazine|dacarbazine|mesh-list
139283240|NCT03907488|Vinblastine|vinblastine|mesh-list
139283241|NCT03907488|Antibodies|antibodies|mesh-list
139283242|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
139283243|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139283244|NCT03907488|Lenograstim|lenograstim|mesh-list
139283245|NCT03907488|Imidazole|imidazole|mesh-list
139283246|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
139283247|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
139283248|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283249|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283250|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139283251|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139283252|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139283253|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283254|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283255|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139283256|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139283257|NCT03907488|Immunotoxins|immunotoxins|mesh-ancestor
139283258|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139283259|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
139283260|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139283261|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
139283262|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
139283263|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
139283264|NCT03856515|Nicotine|nicotine|mesh-list
139283265|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139283266|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
139283267|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283268|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283269|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139283270|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139283271|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
139283272|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139283273|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283274|NCT03847272|Prednisone|prednisone|mesh-list
139283275|NCT03847272|Ustekinumab|ustekinumab|mesh-list
139283276|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139283277|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
139283278|NCT03847272|Hormones|hormones|mesh-ancestor
139283279|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139283280|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283281|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138866716|NCT00666627|Alendronate|alendronate|mesh-list
139283282|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283283|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
139283285|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139283286|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
139283287|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283288|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283289|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139283290|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139283291|NCT03775096|Carvedilol|carvedilol|mesh-list
139091723|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139283292|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139283293|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139283294|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
139283295|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139283296|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283297|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283298|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139283299|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
139283300|NCT03775096|Protective Agents|protective agents|mesh-ancestor
139283301|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139283302|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139283303|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139283304|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
139283305|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139283306|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139283307|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
139283308|NCT03734731|Narcotics|narcotics|mesh-ancestor
139283309|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139283310|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283311|NCT03734731|Analgesics|analgesics|mesh-ancestor
139283312|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
139283313|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283314|NCT03720990|Cholic Acids|cholic acids|mesh-list
139283315|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139283316|NCT03687957|Temozolomide|temozolomide|mesh-list
139283317|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139283318|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
139283319|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283320|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283321|NCT03672487|Benzonidazole|benzonidazole|mesh-list
139283322|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283323|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
139283324|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283325|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139283326|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139283327|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139283328|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139283329|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
139283330|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283331|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
139283332|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283333|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139283334|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139283335|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
139283336|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283337|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283338|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139283339|NCT03519971|Paclitaxel|paclitaxel|mesh-list
139283340|NCT03519971|Etoposide|etoposide|mesh-list
139283341|NCT03519971|Cisplatin|cisplatin|mesh-list
139283342|NCT03519971|Carboplatin|carboplatin|mesh-list
139283343|NCT03519971|Pemetrexed|pemetrexed|mesh-list
139283344|NCT03519971|Durvalumab|durvalumab|mesh-list
139283345|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139283346|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283347|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
139283348|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
139283349|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
139283350|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283351|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139283352|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139283353|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283354|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139283355|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139283356|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138866797|NCT00667797|Albuterol|albuterol|mesh-list
139283357|NCT03493945|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139283358|NCT03493945|Antiviral Agents|antiviral agents|mesh-ancestor
139283359|NCT03493945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139283360|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
139283361|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139283362|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642334|NCT01454089|Carboplatin|carboplatin|mesh-list
139642335|NCT01454089|Gemcitabine|gemcitabine|mesh-list
139153548|NCT01001338|Allopurinol|allopurinol|mesh-list
139283363|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283364|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139283365|NCT03480061|Analgesics|analgesics|mesh-ancestor
139283366|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
139283367|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283368|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139283369|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139283370|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139283371|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
139283372|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139283373|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283374|NCT03467958|Ozanimod|ozanimod|mesh-list
139283375|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139283376|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283377|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283378|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
139283379|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283380|NCT03464097|Ozanimod|ozanimod|mesh-list
139283381|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139283382|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283383|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283384|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
139283385|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283386|NCT03440450|Gemcitabine|gemcitabine|mesh-list
139283387|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139283388|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
139283389|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283390|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283391|NCT03440372|Ozanimod|ozanimod|mesh-list
139283392|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139283393|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283394|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283395|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
139283396|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283397|NCT03414684|Carboplatin|carboplatin|mesh-list
139283398|NCT03414684|Nivolumab|nivolumab|mesh-list
139283399|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283400|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139283401|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139283402|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283403|NCT03346083|Betrixaban|betrixaban|mesh-list
139283404|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139283405|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
139283406|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139283407|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
139283408|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283409|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283410|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
139283411|NCT03298451|Sorafenib|sorafenib|mesh-list
139283412|NCT03298451|Durvalumab|durvalumab|mesh-list
139283413|NCT03298451|Tremelimumab|tremelimumab|mesh-list
139283414|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139283415|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283416|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139283417|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283418|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283419|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139283420|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
139283421|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283422|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
139283423|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139283424|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283425|NCT03073967|Cidofovir|cidofovir|mesh-list
139283426|NCT03073967|Foscarnet|foscarnet|mesh-list
139283427|NCT03073967|Pritelivir|pritelivir|mesh-list
139283428|NCT03073967|Imiquimod|imiquimod|mesh-list
139283429|NCT03073967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139283430|NCT03073967|Immunologic Factors|immunologic factors|mesh-ancestor
139283431|NCT03073967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283432|NCT03073967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283433|NCT03073967|Interferon Inducers|interferon inducers|mesh-ancestor
139283434|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
139642336|NCT01454089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283435|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139283436|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283437|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283438|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139283439|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139283440|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
139283441|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283442|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
139283443|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283444|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139283445|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139283446|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
139283447|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283448|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283449|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139283450|NCT02843035|Venglustat|venglustat|mesh-list
139283451|NCT02843035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283452|NCT02843035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283453|NCT02723994|Leucovorin|leucovorin|mesh-list
139283454|NCT02723994|Cytarabine|cytarabine|mesh-list
139283455|NCT02723994|Dexamethasone|dexamethasone|mesh-list
139283456|NCT02723994|Prednisone|prednisone|mesh-list
139283457|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
139283458|NCT02723994|Doxorubicin|doxorubicin|mesh-list
139283459|NCT02723994|Methotrexate|methotrexate|mesh-list
139283460|NCT02723994|Vincristine|vincristine|mesh-list
139283461|NCT02723994|Asparaginase|asparaginase|mesh-list
139283462|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
139283463|NCT02723994|Pegaspargase|pegaspargase|mesh-list
139283464|NCT02723994|Thioguanine|thioguanine|mesh-list
139283465|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
139283466|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283467|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
139283468|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283469|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139283470|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139283471|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
139283472|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283473|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283474|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139283475|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139283476|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
139283477|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
139283478|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283479|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139283480|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
139283481|NCT02723994|Hormones|hormones|mesh-ancestor
139283482|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139283483|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139283484|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139283485|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139283486|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139283487|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283488|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139283489|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
139283490|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139283491|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139283492|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
139283493|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
139283494|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139283495|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139283496|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
139283497|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139283498|NCT02723994|Antidotes|antidotes|mesh-ancestor
139283499|NCT02723994|Protective Agents|protective agents|mesh-ancestor
139283500|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
139283501|NCT02723994|Vitamins|vitamins|mesh-ancestor
139283502|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
139283503|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139283504|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
139283505|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
139283506|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
139283507|NCT02685969|Flutemetamol|flutemetamol|mesh-list
139283508|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139283509|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283510|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
139283511|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153698|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
139283512|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
139283513|NCT02512926|Etoposide|etoposide|mesh-list
139283514|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283515|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
139283516|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283517|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139283518|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139283519|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
139283520|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283521|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283522|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139283523|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139283524|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139283525|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139283526|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283527|NCT02427451|Venetoclax|venetoclax|mesh-list
139283528|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
139283529|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283530|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139283531|NCT02397083|Everolimus|everolimus|mesh-list
139283532|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
139283533|NCT02397083|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139283534|NCT02397083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139283535|NCT02397083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283536|NCT02397083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283537|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283538|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
139283539|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283540|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283541|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139283542|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
139283543|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139283544|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139283545|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139283546|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139283547|NCT02386800|Panobinostat|panobinostat|mesh-list
139283548|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283549|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139283550|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283551|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283552|NCT02310321|Cytarabine|cytarabine|mesh-list
139283553|NCT02310321|Idarubicin|idarubicin|mesh-list
139283554|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139283555|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
139283556|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283557|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283558|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
139283559|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139283560|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283561|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
139283562|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283563|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139283564|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139283565|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139283566|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283567|NCT02293980|Nivolumab|nivolumab|mesh-list
139283568|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139283569|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283570|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139283571|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283572|NCT02288247|Prednisolone|prednisolone|mesh-list
139283573|NCT02288247|Docetaxel|docetaxel|mesh-list
139283574|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283575|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
139283576|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
139283577|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
139283578|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283579|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139283580|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
138867017|NCT04150575|Paclitaxel|paclitaxel|mesh-list
139283581|NCT02288247|Hormones|hormones|mesh-ancestor
139283582|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139283583|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642337|NCT01454089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139283584|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139283585|NCT02255799|Donepezil|donepezil|mesh-list
139283586|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139283587|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283588|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283589|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
139283590|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139283591|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283592|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
139283593|NCT02139397|Eflornithine|eflornithine|mesh-list
139283594|NCT02139397|Bortezomib|bortezomib|mesh-list
139283595|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283596|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139283597|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139283598|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139283599|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139283600|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139283601|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283602|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283603|NCT02079740|Trametinib|trametinib|mesh-list
139283604|NCT02079740|Navitoclax|navitoclax|mesh-list
139283605|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283606|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139283607|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283608|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283609|NCT02038777|Cytarabine|cytarabine|mesh-list
139283610|NCT02038777|Azacitidine|azacitidine|mesh-list
139283611|NCT02038777|Daunorubicin|daunorubicin|mesh-list
139283612|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139283613|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
139283614|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283615|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283616|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
139283617|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139283618|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283619|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
139283620|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283621|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283622|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139283623|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139283624|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139283625|NCT01991457|Fludarabine|fludarabine|mesh-list
139283626|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283627|NCT01943994|Psilocybin|psilocybin|mesh-list
139283628|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
139283629|NCT01943994|Nicotine|nicotine|mesh-list
139283630|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139283631|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
139283632|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283633|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283634|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139283635|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139283636|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
139283637|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139283638|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283639|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
139283640|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139283641|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139283642|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
139283643|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139283644|NCT01899989|Carboplatin|carboplatin|mesh-list
139283645|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283646|NCT01817166|Vitamin D|vitamin d|mesh-list
139283647|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
139283648|NCT01817166|Vitamins|vitamins|mesh-ancestor
139283649|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
139283650|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283651|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139283652|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139283653|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
139283654|NCT00902044|Fludarabine|fludarabine|mesh-list
139283655|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139283656|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
139283657|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283658|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139283659|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139283660|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
139283661|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283662|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283663|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139283664|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139283665|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
139283666|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
139283668|NCT03608241|Estrogens|estrogens|mesh-ancestor
139283669|NCT03608241|Hormones|hormones|mesh-ancestor
139283670|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139283671|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283672|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139283673|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139283674|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139283675|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139283676|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
139283677|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139283678|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139283679|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139283680|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139283681|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139283682|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283683|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283684|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283685|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139283686|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
139283687|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139283688|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283689|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139283690|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139283691|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139283692|NCT03607383|Red yeast rice|red yeast rice|mesh-list
139283693|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139283694|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139283695|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139283696|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
139283697|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283698|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283699|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139283700|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
139283701|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
139283702|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
139283703|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139283704|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283705|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
139283706|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283707|NCT03607149|Pemetrexed|pemetrexed|mesh-list
139283708|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283709|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283710|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283711|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139283712|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139283713|NCT04998838|Tenofovir|tenofovir|mesh-list
139283714|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
139283715|NCT04998838|Antibodies|antibodies|mesh-list
139283716|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
139283717|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139283718|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139283719|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
139283720|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139283721|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139283722|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139283723|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283724|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283725|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139283726|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139283727|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
139283728|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283729|NCT03607071|Prednisolone|prednisolone|mesh-list
139283730|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139283731|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
139283733|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139283734|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642338|NCT01454089|Antimetabolites|antimetabolites|mesh-ancestor
139283735|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139283736|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283737|NCT02035215|Atorvastatin|atorvastatin|mesh-list
139283738|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139283739|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139283740|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
139283741|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283742|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139283743|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139283744|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283745|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
139283746|NCT03605589|Blinatumomab|blinatumomab|mesh-list
139283747|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139283748|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283749|NCT03605589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139283750|NCT03605589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283751|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139283752|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139283753|NCT03074968|Benzydamine|benzydamine|mesh-list
139283754|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139283755|NCT04991584|Amoxicillin|amoxicillin|mesh-list
139283756|NCT04991584|Levofloxacin|levofloxacin|mesh-list
139283757|NCT04991584|Tetracycline|tetracycline|mesh-list
139283758|NCT04991584|Furazolidone|furazolidone|mesh-list
139283759|NCT04991584|Esomeprazole|esomeprazole|mesh-list
139283760|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139283761|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139283762|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139283763|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139283764|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139283765|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283766|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283767|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139283768|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139283769|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139283770|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283771|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139283772|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139283773|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139283774|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139283775|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139283776|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139283777|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139283778|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139283779|NCT05001412|Carboplatin|carboplatin|mesh-list
139283780|NCT05001412|Etoposide|etoposide|mesh-list
139283781|NCT05001412|Apatinib|apatinib|mesh-list
139283782|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283783|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139283784|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139283785|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139283786|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283787|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283788|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139283789|NCT04991896|Metoprolol|metoprolol|mesh-list
139283790|NCT04991896|Sotalol|sotalol|mesh-list
139283791|NCT04991896|Flecainide|flecainide|mesh-list
139283792|NCT04991896|Bisoprolol|bisoprolol|mesh-list
139283793|NCT04991896|Betaxolol|betaxolol|mesh-list
139283794|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139283795|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139283796|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
139283797|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
139283798|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283799|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283800|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139283801|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139283802|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139283803|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
139283804|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139283805|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283806|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139283807|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139283808|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139283809|NCT03072394|Lidocaine|lidocaine|mesh-list
139283810|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
139283811|NCT03072394|Anesthetics|anesthetics|mesh-list
139283812|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381928|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139283813|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283814|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
139283815|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283816|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139283817|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139283818|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139283819|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139283820|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283821|NCT03072082|Aspirin|aspirin|mesh-list
139283822|NCT03072082|Metoprolol|metoprolol|mesh-list
139283823|NCT03072082|Isosorbide|isosorbide|mesh-list
139283824|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139283825|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139283826|NCT03072082|Trimetazidine|trimetazidine|mesh-list
139283827|NCT03072082|Clopidogrel|clopidogrel|mesh-list
139283828|NCT03072082|Atorvastatin|atorvastatin|mesh-list
139283829|NCT03072082|Calcium|calcium|mesh-list
139283830|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139283831|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283832|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139283833|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139283834|NCT03072082|Analgesics|analgesics|mesh-ancestor
139283835|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
139283836|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283837|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139283838|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139283839|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139283840|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139283841|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283842|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139283843|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139283844|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283845|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
139283846|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139283847|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139283848|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
139283849|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139283850|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139283851|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139283852|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139283853|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139283854|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
139283855|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139283856|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139283857|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139283858|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
139283859|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
139283860|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139283861|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139283862|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139283863|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
139283864|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139283865|NCT03072082|Diuretics|diuretics|mesh-ancestor
139283866|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
139283867|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
139283868|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139283869|NCT04934020|Metronidazole|metronidazole|mesh-list
139283870|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139283871|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139283872|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139283873|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139283874|NCT04987450|Prednisone|prednisone|mesh-list
139283875|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
139283876|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139283877|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138867326|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
139283878|NCT04987450|Prednisolone|prednisolone|mesh-list
139283879|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
139283880|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139283881|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
139283882|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139283883|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
139283884|NCT04987450|Hormones|hormones|mesh-ancestor
139283885|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139091724|NCT04222972|Carboplatin|carboplatin|mesh-list
139283886|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283887|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139283888|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283889|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
139283890|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
139283891|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283892|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139283893|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139283894|NCT04987450|Protective Agents|protective agents|mesh-ancestor
139283895|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139283896|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139283897|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
139283898|NCT03074578|Hormones|hormones|mesh-ancestor
139283899|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139283900|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283901|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139283902|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283903|NCT04991194|Zamicastat|zamicastat|mesh-list
139283904|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283905|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283906|NCT02853435|Gepotidacin|gepotidacin|mesh-list
139283907|NCT02853435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139283908|NCT02853435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283909|NCT02853435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283910|NCT02853435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283911|NCT03071770|Ivosidenib|ivosidenib|mesh-list
139283912|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283913|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283914|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283915|NCT04986982|Opicapone|opicapone|mesh-list
139283916|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139283917|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283918|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283919|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139283920|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139283921|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
139283922|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139283923|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
139283924|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283925|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
139283926|NCT03074344|Protective Agents|protective agents|mesh-ancestor
139283927|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
139283928|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
139283929|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283930|NCT02035371|Insulin|insulin|mesh-list
139283931|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139283932|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
139283933|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
139283934|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139283935|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139283936|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283937|NCT03069820|Docetaxel|docetaxel|mesh-list
139283938|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283939|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
139283940|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
139283941|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
139283942|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283943|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
139283944|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139283945|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
139283946|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139283947|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
139283948|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283949|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283950|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
139283951|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
139283952|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
139283953|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
138867387|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139283954|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283955|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283956|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
139381930|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642469|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139283957|NCT03606681|Calcium|calcium|mesh-list
139283958|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139283959|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283960|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139283961|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
139283962|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139283963|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
139283964|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139283965|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
139283966|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283967|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283968|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
139283969|NCT03605199|Denosumab|denosumab|mesh-list
139283970|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139283971|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283972|NCT03606369|Ondansetron|ondansetron|mesh-list
139283973|NCT03606369|Palonosetron|palonosetron|mesh-list
139283974|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
139283975|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
139283976|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139283977|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283978|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139283979|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
139283980|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
139283981|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139283982|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139283983|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
139283984|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139283985|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283986|NCT02635204|Clobetasol|clobetasol|mesh-list
139283987|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139283988|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
139283989|NCT02635204|Hormones|hormones|mesh-ancestor
139283990|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139283991|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139283992|NCT00102804|Pemetrexed|pemetrexed|mesh-list
139283993|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139283994|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139283995|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139283996|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139283997|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139283998|NCT03038113|Immunomodulating Agents|immunomodulating agents|mesh-list
139283999|NCT03038113|Immunologic Factors|immunologic factors|mesh-ancestor
139284000|NCT03038113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284001|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139284002|NCT02163720|Doxorubicin|doxorubicin|mesh-list
139284003|NCT02163720|Trabectedin|trabectedin|mesh-list
139284004|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139284005|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284006|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139284007|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139284008|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284009|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284010|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139284011|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
139284012|NCT03487874|Ropivacaine|ropivacaine|mesh-list
139284013|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
139284014|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
139284015|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139284016|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284017|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
139284018|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284019|NCT04989400|Misoprostol|misoprostol|mesh-list
139284020|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
139284021|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139284022|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
139284023|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139284024|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284025|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139284026|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139284027|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
138867472|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
139284028|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138845161|NCT02610153|Vitamin K|vitamin k|mesh-list
139284029|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
139284030|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139284032|NCT02163954|Ticagrelor|ticagrelor|mesh-list
139284033|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139284034|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139284035|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139284036|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139284037|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
139284038|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139284039|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284040|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284041|NCT04985656|Decitabine|decitabine|mesh-list
139284042|NCT04985656|Pevonedistat|pevonedistat|mesh-list
139284043|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139284044|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
139284045|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284046|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284047|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284048|NCT02164032|Insulin|insulin|mesh-list
139284049|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139284050|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139284051|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284052|NCT04682288|Levofloxacin|levofloxacin|mesh-list
139284053|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139284054|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284055|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139284056|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139284057|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139284058|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284059|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284060|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284061|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139284062|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139284063|NCT00968149|Montelukast|montelukast|mesh-list
139284064|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139284065|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
139284066|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139284067|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
139284068|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284069|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284070|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139284071|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139284072|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284073|NCT02164110|Vaccines|vaccines|mesh-list
139284074|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
139284075|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284076|NCT02167464|Coal Tar|coal tar|mesh-list
139284077|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139284078|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
139284079|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
139284080|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
139284081|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284082|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284083|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139284084|NCT02167464|Diuretics|diuretics|mesh-ancestor
139284085|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
139284086|NCT03485456|Tobramycin|tobramycin|mesh-list
139284087|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139284088|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284089|NCT03487562|Amoxicillin|amoxicillin|mesh-list
139284090|NCT03487562|Clarithromycin|clarithromycin|mesh-list
139284091|NCT03487562|Lansoprazole|lansoprazole|mesh-list
139284092|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
139284093|NCT03487562|Fexuprazan|fexuprazan|mesh-list
139284094|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139284095|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284096|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139284097|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284098|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284099|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139284100|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139284101|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138845235|NCT00812955|Simvastatin|simvastatin|mesh-list
139284102|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139284103|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139284105|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139284106|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284107|NCT03485300|Warfarin|warfarin|mesh-list
139284108|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
139284109|NCT00963469|Loratadine|loratadine|mesh-list
139284110|NCT00963469|Montelukast|montelukast|mesh-list
139284111|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139284112|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
139284113|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139284114|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
139284115|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284116|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284117|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139284118|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139284119|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284120|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
139284121|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
139284122|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139284123|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139284124|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139284125|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
139284126|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
139284127|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139284128|NCT00897949|Rizatriptan|rizatriptan|mesh-list
139284129|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139284130|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
139284131|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139284132|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284133|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284134|NCT03487406|Aspirin|aspirin|mesh-list
139284135|NCT03487406|Ticagrelor|ticagrelor|mesh-list
139284136|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139284137|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139284138|NCT03487406|Analgesics|analgesics|mesh-ancestor
139284139|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
139284140|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284141|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284142|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139284143|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139284144|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139284145|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139284146|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284147|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139284148|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139284149|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284150|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
139284151|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139284152|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139284153|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139284154|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
139284155|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139284156|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139284157|NCT00725491|Ganirelix|ganirelix|mesh-list
139284158|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
139284159|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139284160|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
139284161|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139284162|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284163|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139284164|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139284165|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284166|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
139284167|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284168|NCT00724789|Ganirelix|ganirelix|mesh-list
139284169|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
139284170|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284171|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284172|NCT00711607|Estradiol|estradiol|mesh-list
139284173|NCT00711607|Estrogens|estrogens|mesh-ancestor
139284174|NCT00711607|Hormones|hormones|mesh-ancestor
138845312|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
139284175|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284176|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284177|NCT03893318|Lidocaine|lidocaine|mesh-list
139284178|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
139284179|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
139284180|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139284181|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284182|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
139284183|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284184|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139284185|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139284186|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139284187|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139284188|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284189|NCT03625531|Letrozole|letrozole|mesh-list
139284190|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284191|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139284192|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139284193|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284194|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284195|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139284196|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
139284197|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284198|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284199|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
139284200|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139284201|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139284202|NCT02167698|Prednisolone|prednisolone|mesh-list
139284203|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
139284204|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139284205|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
139284206|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139284207|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
139284208|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
139284209|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284210|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284211|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139284212|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
139284213|NCT02167698|Hormones|hormones|mesh-ancestor
139284214|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284215|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139284216|NCT02167698|Protective Agents|protective agents|mesh-ancestor
139284217|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139284218|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284219|NCT02634580|Ezetimibe|ezetimibe|mesh-list
139284220|NCT02634580|Evolocumab|evolocumab|mesh-list
139284221|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139284222|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139284223|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139284224|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
139284225|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284226|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139284227|NCT02634580|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139284228|NCT02634580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139284229|NCT02634580|Protease Inhibitors|protease inhibitors|mesh-ancestor
139284230|NCT02634580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284231|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
139284232|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284233|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139284234|NCT00697255|Hormones|hormones|mesh-list
139284235|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139284236|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284237|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284238|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139284239|NCT00548912|Spironolactone|spironolactone|mesh-list
139284240|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139284241|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
139284242|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284243|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284244|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139284245|NCT00548912|Diuretics|diuretics|mesh-ancestor
139284246|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
138867690|NCT03170882|Hormones|hormones|mesh-ancestor
139284248|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139284249|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284250|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139284251|NCT03071068|Antibodies|antibodies|mesh-list
139284252|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
139284253|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139284254|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
139284255|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284256|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284257|NCT06161441|Paclitaxel|paclitaxel|mesh-list
139284258|NCT06161441|Carboplatin|carboplatin|mesh-list
139284259|NCT06161441|Pemetrexed|pemetrexed|mesh-list
139284260|NCT06161441|Cemiplimab|cemiplimab|mesh-list
139284261|NCT06161441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139284262|NCT06161441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284263|NCT06161441|Tubulin Modulators|tubulin modulators|mesh-ancestor
139284264|NCT06161441|Antimitotic Agents|antimitotic agents|mesh-ancestor
139284265|NCT06161441|Mitosis Modulators|mitosis modulators|mesh-ancestor
139284266|NCT06161441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284267|NCT06161441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284268|NCT06161441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139284269|NCT06161441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139284270|NCT06161441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139284271|NCT06161415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139284272|NCT06161415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139284273|NCT06161272|Apatinib|apatinib|mesh-list
139284274|NCT06161272|Fluzoparib|fluzoparib|mesh-list
139284275|NCT06161272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284276|NCT06161272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139284277|NCT06161272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284278|NCT06161272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284279|NCT06161272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139284280|NCT06161220|Moxifloxacin|moxifloxacin|mesh-list
139284281|NCT06161220|Carbidopa|carbidopa|mesh-list
139284282|NCT06161220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139284283|NCT06161220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284284|NCT06161220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139284285|NCT06161220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139284286|NCT06161220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284287|NCT06161220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284288|NCT06161220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284289|NCT06161220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284290|NCT06161220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139284291|NCT06161220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139284292|NCT06161220|Dopamine Agents|dopamine agents|mesh-ancestor
139284293|NCT06161220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139284294|NCT06161220|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139284295|NCT06161064|Hyaluronic Acid|hyaluronic acid|mesh-list
139284296|NCT06161064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139284297|NCT06161064|Immunologic Factors|immunologic factors|mesh-ancestor
139284298|NCT06161064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284299|NCT06161064|Viscosupplements|viscosupplements|mesh-ancestor
139284300|NCT06161064|Protective Agents|protective agents|mesh-ancestor
139284301|NCT06160843|Pembrolizumab|pembrolizumab|mesh-list
139284302|NCT06160843|Olaparib|olaparib|mesh-list
139284303|NCT06160843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139284304|NCT06160843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284305|NCT06160843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139284306|NCT06160843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284307|NCT06160843|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139284308|NCT06160843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284309|NCT06160791|Dexamethasone|dexamethasone|mesh-list
139284310|NCT06160791|Etoposide|etoposide|mesh-list
139284311|NCT06160791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139284312|NCT06160791|Antiemetics|antiemetics|mesh-ancestor
139284313|NCT06160791|Autonomic Agents|autonomic agents|mesh-ancestor
139284314|NCT06160791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284315|NCT06160791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284316|NCT06160791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139284317|NCT06160791|Glucocorticoids|glucocorticoids|mesh-ancestor
139284318|NCT06160791|Hormones|hormones|mesh-ancestor
139284319|NCT06160791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284320|NCT06160791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139284321|NCT06160791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284322|NCT06160791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139284323|NCT06160791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139284324|NCT06160791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139284325|NCT06160791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284326|NCT06160791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284327|NCT06160778|Ketorolac|ketorolac|mesh-list
139284328|NCT06160778|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139284329|NCT06160778|Morphine|morphine|mesh-list
139284330|NCT06160778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139284331|NCT06160778|Narcotics|narcotics|mesh-ancestor
139284332|NCT06160778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139284333|NCT06160778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284334|NCT06160778|Analgesics|analgesics|mesh-ancestor
139284335|NCT06160778|Sensory System Agents|sensory system agents|mesh-ancestor
139284336|NCT06160778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284337|NCT06160778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139284338|NCT06160778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139284339|NCT06160778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139284340|NCT06160778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139284341|NCT06160778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139284342|NCT06160778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284343|NCT06160778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284344|NCT06160739|Sirolimus|sirolimus|mesh-list
139284345|NCT06160739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139284346|NCT06160739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284347|NCT06160739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139284348|NCT06160739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284349|NCT06160739|Antifungal Agents|antifungal agents|mesh-ancestor
139284350|NCT06160739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139284351|NCT06160739|Immunologic Factors|immunologic factors|mesh-ancestor
139284352|NCT06160739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284353|NCT06160479|Calcium|calcium|mesh-list
139284354|NCT06160479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139284355|NCT06160479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284356|NCT06160362|Cyclophosphamide|cyclophosphamide|mesh-list
139284357|NCT06160362|Fludarabine|fludarabine|mesh-list
139284358|NCT06160362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139284359|NCT06160362|Immunologic Factors|immunologic factors|mesh-ancestor
139284360|NCT06160362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284361|NCT06160362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139284362|NCT06160362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139284363|NCT06160362|Alkylating Agents|alkylating agents|mesh-ancestor
139284364|NCT06160362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284365|NCT06160362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284366|NCT06160362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139284367|NCT06160284|Psilocybin|psilocybin|mesh-list
139284368|NCT06160284|Hallucinogens|hallucinogens|mesh-ancestor
139284369|NCT06160284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284370|NCT06160284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139284371|NCT06160232|Psilocybin|psilocybin|mesh-list
139284372|NCT06160232|Hallucinogens|hallucinogens|mesh-ancestor
139284373|NCT06160232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284374|NCT06160232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139284375|NCT06160219|Hydroxocobalamin|hydroxocobalamin|mesh-list
139284376|NCT06160219|Vitamin B 12|vitamin b 12|mesh-list
139284377|NCT06160219|Hematinics|hematinics|mesh-ancestor
139284378|NCT06160219|Vitamin B Complex|vitamin b complex|mesh-ancestor
139284379|NCT06160219|Vitamins|vitamins|mesh-ancestor
139284380|NCT06160219|Micronutrients|micronutrients|mesh-ancestor
139284381|NCT06160219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284382|NCT06160206|Bevacizumab|bevacizumab|mesh-list
139284383|NCT06160206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139284384|NCT06160206|Endothelial Growth Factors|endothelial growth factors|mesh-list
139284385|NCT06160206|Antibodies|antibodies|mesh-list
139284386|NCT06160206|Immunoglobulins|immunoglobulins|mesh-list
139284387|NCT06160206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139284388|NCT06160206|Immunoglobulin G|immunoglobulin g|mesh-list
139284389|NCT06160206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284390|NCT06160206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139284391|NCT06160206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139284392|NCT06160206|Growth Substances|growth substances|mesh-ancestor
139284393|NCT06160206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284394|NCT06160206|Growth Inhibitors|growth inhibitors|mesh-ancestor
139284395|NCT06160206|Immunologic Factors|immunologic factors|mesh-ancestor
139284396|NCT06160180|Dexamethasone|dexamethasone|mesh-list
139284397|NCT06160180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139284398|NCT06160180|Antiemetics|antiemetics|mesh-ancestor
139284399|NCT06160180|Autonomic Agents|autonomic agents|mesh-ancestor
139284400|NCT06160180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284401|NCT06160180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284402|NCT06160180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139284403|NCT06160180|Glucocorticoids|glucocorticoids|mesh-ancestor
139284405|NCT06160180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154584|NCT00770848|Prednisone|prednisone|mesh-list
139284406|NCT06160180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139284407|NCT06160180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284408|NCT06159959|Oxytocin|oxytocin|mesh-list
139284409|NCT06159959|Carbetocin|carbetocin|mesh-list
139284410|NCT06159959|Oxytocics|oxytocics|mesh-ancestor
139284411|NCT06159959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139284412|NCT06159959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284413|NCT06159907|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139284414|NCT06159907|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139284415|NCT06159907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284416|NCT06159842|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139284417|NCT06159842|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139284418|NCT06159842|Dermatologic Agents|dermatologic agents|mesh-ancestor
139284419|NCT06159790|Pembrolizumab|pembrolizumab|mesh-list
139284420|NCT06159790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139284421|NCT06159790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284422|NCT06159790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139284423|NCT06159790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284424|NCT06159621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139284425|NCT06159621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284426|NCT06159621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139284427|NCT06159621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284428|NCT06159608|Nitric Oxide|nitric oxide|mesh-list
139284429|NCT06159608|Estrogens|estrogens|mesh-list
139284430|NCT06159608|Nitroarginine|nitroarginine|mesh-list
139284431|NCT06159608|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
139284432|NCT06159608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139284433|NCT06159608|Autonomic Agents|autonomic agents|mesh-ancestor
139284434|NCT06159608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284435|NCT06159608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284436|NCT06159608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139284437|NCT06159608|Respiratory System Agents|respiratory system agents|mesh-ancestor
139284438|NCT06159608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139284439|NCT06159608|Antioxidants|antioxidants|mesh-ancestor
139284440|NCT06159608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284441|NCT06159608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139284442|NCT06159608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139284443|NCT06159608|Vasodilator Agents|vasodilator agents|mesh-ancestor
139284444|NCT06159608|Gasotransmitters|gasotransmitters|mesh-ancestor
139284445|NCT06159608|Protective Agents|protective agents|mesh-ancestor
139284446|NCT06159608|Hormones|hormones|mesh-ancestor
139284447|NCT06159608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284448|NCT06159608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284449|NCT06153368|Leucovorin|leucovorin|mesh-list
139284450|NCT06153368|Fluorouracil|fluorouracil|mesh-list
139284451|NCT06153368|Oxaliplatin|oxaliplatin|mesh-list
139284452|NCT06153368|Irinotecan|irinotecan|mesh-list
139284453|NCT06153368|Antimetabolites|antimetabolites|mesh-ancestor
139284454|NCT06153368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284455|NCT06153368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139284456|NCT06153368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284457|NCT06153368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139284458|NCT06153368|Immunologic Factors|immunologic factors|mesh-ancestor
139284459|NCT06153368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284460|NCT06153368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139284461|NCT06153368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139284462|NCT06153368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284463|NCT06153368|Antidotes|antidotes|mesh-ancestor
139284464|NCT06153368|Protective Agents|protective agents|mesh-ancestor
139284465|NCT06153368|Vitamin B Complex|vitamin b complex|mesh-ancestor
139284466|NCT06153368|Vitamins|vitamins|mesh-ancestor
139284467|NCT06153368|Micronutrients|micronutrients|mesh-ancestor
139284468|NCT06152874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139284469|NCT06150768|Cobalt|cobalt|mesh-list
139284470|NCT06150768|Chromium|chromium|mesh-list
139284471|NCT06150768|Trace Elements|trace elements|mesh-ancestor
139284472|NCT06150768|Micronutrients|micronutrients|mesh-ancestor
139284473|NCT06150768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284474|NCT06149247|Hypericin|hypericin|mesh-list
139284475|NCT06149247|Mechlorethamine|mechlorethamine|mesh-list
139284476|NCT06149247|Alkylating Agents|alkylating agents|mesh-ancestor
139284477|NCT06149247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284478|NCT06149247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139284479|NCT06149247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284480|NCT06149247|Antidepressive Agents|antidepressive agents|mesh-ancestor
139642470|NCT01891513|Diuretics|diuretics|mesh-list
139284481|NCT06149247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139284482|NCT06149247|Antiviral Agents|antiviral agents|mesh-ancestor
139284483|NCT06149247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284484|NCT06149247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284485|NCT06149247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139284486|NCT06149247|Immunologic Factors|immunologic factors|mesh-ancestor
139284487|NCT06149247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284488|NCT06121271|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139284489|NCT06121271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139284490|NCT06121271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284491|NCT06096090|Interleukin-2|interleukin-2|mesh-list
139284492|NCT06096090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284493|NCT06096090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139284494|NCT06096090|Analgesics|analgesics|mesh-ancestor
139284495|NCT06096090|Sensory System Agents|sensory system agents|mesh-ancestor
139284496|NCT06096090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284497|NCT06096090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284499|NCT06095141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284500|NCT06084845|Cisplatin|cisplatin|mesh-list
139284501|NCT06084845|Carboplatin|carboplatin|mesh-list
139284502|NCT06084845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284503|NCT06081829|Ivosidenib|ivosidenib|mesh-list
139284504|NCT06081829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284505|NCT06081829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284506|NCT06081829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284507|NCT06081179|Methylphenidate|methylphenidate|mesh-list
139284508|NCT06081179|Psilocybin|psilocybin|mesh-list
139284509|NCT06081179|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139284510|NCT06081179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139284511|NCT06081179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284512|NCT06081179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139284513|NCT06081179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139284514|NCT06081179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139284515|NCT06081179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284516|NCT06081179|Dopamine Agents|dopamine agents|mesh-ancestor
139284517|NCT06081179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139284518|NCT06081179|Hallucinogens|hallucinogens|mesh-ancestor
139284519|NCT06081179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139284520|NCT06081179|Serotonin Agents|serotonin agents|mesh-ancestor
139284521|NCT06081179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139284522|NCT06081179|Adrenergic Agents|adrenergic agents|mesh-ancestor
139284523|NCT06075264|Artesunate|artesunate|mesh-list
139284524|NCT06075264|Artenimol|artenimol|mesh-list
139284525|NCT06075264|Artemisinins|artemisinins|mesh-list
139284526|NCT06075264|Artemisinin|artemisinin|mesh-list
139284527|NCT06075264|Antimalarials|antimalarials|mesh-ancestor
139284528|NCT06075264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139284529|NCT06075264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139284530|NCT06075264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284531|NCT06075264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284532|NCT06075264|Antiviral Agents|antiviral agents|mesh-ancestor
139284533|NCT06075264|Schistosomicides|schistosomicides|mesh-ancestor
139284534|NCT06075264|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139284535|NCT06075264|Anthelmintics|anthelmintics|mesh-ancestor
139284536|NCT06053411|Diclofenac|diclofenac|mesh-list
139284537|NCT06053411|Curcumin|curcumin|mesh-list
139284538|NCT06053411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139284539|NCT06053411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139284540|NCT06053411|Analgesics|analgesics|mesh-ancestor
139284541|NCT06053411|Sensory System Agents|sensory system agents|mesh-ancestor
139284542|NCT06053411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284543|NCT06053411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284544|NCT06053411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139284545|NCT06053411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139284546|NCT06053411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139284547|NCT06053411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284548|NCT06053411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284549|NCT06053411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867984|NCT04209426|Tacrine|tacrine|mesh-list
139284550|NCT06044740|Sevoflurane|sevoflurane|mesh-list
139284551|NCT06044740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139284552|NCT06044740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139284553|NCT06044740|Anesthetics, General|anesthetics, general|mesh-ancestor
139284554|NCT06044740|Anesthetics|anesthetics|mesh-ancestor
139284555|NCT06044740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139284556|NCT06044740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091726|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
139284557|NCT06022003|Azacitidine|azacitidine|mesh-list
139284558|NCT06022003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139284559|NCT06022003|Antimetabolites|antimetabolites|mesh-ancestor
139284560|NCT06022003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284561|NCT06022003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284562|NCT06022003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284563|NCT06021808|Anticoagulants|anticoagulants|mesh-list
139284564|NCT05989932|Upadacitinib|upadacitinib|mesh-list
139284565|NCT05989932|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139284566|NCT05989932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139284567|NCT05989932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284568|NCT05989932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284569|NCT05989932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139284570|NCT05980091|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139284571|NCT05980091|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139284572|NCT05980091|Estradiol|estradiol|mesh-list
139284573|NCT05980091|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139284574|NCT05980091|Progesterone|progesterone|mesh-list
139284575|NCT05980091|Estrogens|estrogens|mesh-ancestor
139284576|NCT05980091|Hormones|hormones|mesh-ancestor
139284577|NCT05980091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284578|NCT05980091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284579|NCT05980091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139284580|NCT05980091|Contraceptive Agents|contraceptive agents|mesh-ancestor
139284581|NCT05980091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139284582|NCT05980091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139284583|NCT05980091|Progestins|progestins|mesh-ancestor
139284584|NCT05965726|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139284585|NCT05965726|Antiviral Agents|antiviral agents|mesh-ancestor
139284586|NCT05965726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284587|NCT05963074|Venetoclax|venetoclax|mesh-list
139284588|NCT05963074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284589|NCT05925309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139284590|NCT05925309|Meropenem|meropenem|mesh-list
139284591|NCT05925309|Imipenem|imipenem|mesh-list
139284592|NCT05925309|Cefaclor|cefaclor|mesh-list
139284593|NCT05925309|Sulfamethoxazole|sulfamethoxazole|mesh-list
139284594|NCT05925309|Sulperazone|sulperazone|mesh-list
139284595|NCT05925309|Methylprednisolone|methylprednisolone|mesh-list
139284596|NCT05925309|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
139284597|NCT05925309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139284598|NCT05925309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284599|NCT05925309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284600|NCT05925309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139284601|NCT05925309|Antiemetics|antiemetics|mesh-ancestor
139284602|NCT05925309|Autonomic Agents|autonomic agents|mesh-ancestor
139284603|NCT05925309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284604|NCT05925309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139284605|NCT05925309|Glucocorticoids|glucocorticoids|mesh-ancestor
139284606|NCT05925309|Hormones|hormones|mesh-ancestor
139284607|NCT05925309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284608|NCT05925309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139284609|NCT05925309|Protective Agents|protective agents|mesh-ancestor
139284610|NCT05925309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139284611|NCT05925309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139284612|NCT05897385|Lidocaine|lidocaine|mesh-list
139284613|NCT05897385|Anesthetics, Local|anesthetics, local|mesh-ancestor
139284614|NCT05897385|Anesthetics|anesthetics|mesh-ancestor
139284615|NCT05897385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139284616|NCT05897385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284617|NCT05897385|Sensory System Agents|sensory system agents|mesh-ancestor
139284618|NCT05897385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284619|NCT05897385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139284620|NCT05897385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139284621|NCT05897385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139284622|NCT05897385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139284623|NCT05897385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284624|NCT05881811|Probenecid|probenecid|mesh-list
138868059|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139284625|NCT05881811|Cimetidine|cimetidine|mesh-list
139284626|NCT05881811|Uricosuric Agents|uricosuric agents|mesh-ancestor
139284627|NCT05881811|Gout Suppressants|gout suppressants|mesh-ancestor
139284628|NCT05881811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139284629|NCT05881811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139284630|NCT05881811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139642339|NCT01454089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284631|NCT05881811|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139284632|NCT05881811|Histamine Antagonists|histamine antagonists|mesh-ancestor
139284633|NCT05881811|Histamine Agents|histamine agents|mesh-ancestor
139284634|NCT05881811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139284635|NCT05881811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284636|NCT05881811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284637|NCT05881811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139284638|NCT05881811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139284639|NCT05881811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284640|NCT05876754|Ivosidenib|ivosidenib|mesh-list
139284641|NCT05876754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284642|NCT05876754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284643|NCT05876754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284644|NCT05871177|Hyaluronic Acid|hyaluronic acid|mesh-list
139284645|NCT05871177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139284646|NCT05871177|Immunologic Factors|immunologic factors|mesh-ancestor
139284647|NCT05871177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284648|NCT05871177|Viscosupplements|viscosupplements|mesh-ancestor
139284649|NCT05871177|Protective Agents|protective agents|mesh-ancestor
139284650|NCT05849090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139284651|NCT05849090|Vancomycin|vancomycin|mesh-list
139284652|NCT05849090|Clindamycin|clindamycin|mesh-list
139284653|NCT05849090|Clindamycin palmitate|clindamycin palmitate|mesh-list
139284654|NCT05849090|Clindamycin phosphate|clindamycin phosphate|mesh-list
139284655|NCT05849090|Cefazolin|cefazolin|mesh-list
139284656|NCT05849090|Ceftriaxone|ceftriaxone|mesh-list
139284657|NCT05849090|Tobramycin|tobramycin|mesh-list
139284658|NCT05849090|Cephalosporins|cephalosporins|mesh-list
139284659|NCT05849090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139284660|NCT05849090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284661|NCT05849090|Antitubercular Agents|antitubercular agents|mesh-ancestor
139284662|NCT05849090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139284663|NCT05849090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284664|NCT05849090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284665|NCT05846646|Pembrolizumab|pembrolizumab|mesh-list
139284666|NCT05846646|Nivolumab|nivolumab|mesh-list
139284667|NCT05846646|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139284668|NCT05846646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139284669|NCT05846646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284670|NCT05846646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284671|NCT05846451|Oxycodone|oxycodone|mesh-list
139284672|NCT05846451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139284673|NCT05846451|Narcotics|narcotics|mesh-ancestor
139284674|NCT05846451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139284675|NCT05846451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284676|NCT05846451|Analgesics|analgesics|mesh-ancestor
139284677|NCT05846451|Sensory System Agents|sensory system agents|mesh-ancestor
139284678|NCT05846451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284679|NCT05766124|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139284680|NCT05766124|Plasminogen|plasminogen|mesh-list
139284681|NCT05766124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139284682|NCT05766124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139284683|NCT05766124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284684|NCT05685719|Itraconazole|itraconazole|mesh-list
139284685|NCT05685719|Rifampin|rifampin|mesh-list
139284686|NCT05685719|Antifungal Agents|antifungal agents|mesh-ancestor
139284687|NCT05685719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284688|NCT05685719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139284689|NCT05685719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139284690|NCT05685719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381936|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284691|NCT05685719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284692|NCT05685719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139284693|NCT05685719|Hormone Antagonists|hormone antagonists|mesh-ancestor
139284694|NCT05685719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284695|NCT05685719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284696|NCT05685719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139284697|NCT05685719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139284698|NCT05685719|Antitubercular Agents|antitubercular agents|mesh-ancestor
139284699|NCT05685719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139284700|NCT05685719|Leprostatic Agents|leprostatic agents|mesh-ancestor
139284701|NCT05685719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139284702|NCT05685719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139284703|NCT05685719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139284704|NCT05685719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139284705|NCT05685719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139284706|NCT05685719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139284707|NCT05685719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139284708|NCT05653427|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
139284709|NCT05653427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139284710|NCT05653427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284711|NCT05645380|Cyclophosphamide|cyclophosphamide|mesh-list
139284712|NCT05645380|Carboplatin|carboplatin|mesh-list
139284714|NCT05645380|Doxorubicin|doxorubicin|mesh-list
139284715|NCT05645380|Pembrolizumab|pembrolizumab|mesh-list
139284716|NCT05645380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139284717|NCT05645380|Immunologic Factors|immunologic factors|mesh-ancestor
139284718|NCT05645380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284719|NCT05645380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139284720|NCT05645380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139284721|NCT05645380|Alkylating Agents|alkylating agents|mesh-ancestor
139284722|NCT05645380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284723|NCT05645380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284724|NCT05645380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139284725|NCT05645380|Tubulin Modulators|tubulin modulators|mesh-ancestor
139284726|NCT05645380|Antimitotic Agents|antimitotic agents|mesh-ancestor
139284727|NCT05645380|Mitosis Modulators|mitosis modulators|mesh-ancestor
139284728|NCT05645380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139284729|NCT05645380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139284730|NCT05645380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139284731|NCT05645380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284732|NCT05645380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139284733|NCT05645380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139284734|NCT05641142|Anticoagulants|anticoagulants|mesh-list
139284735|NCT05627739|Mycophenolic Acid|mycophenolic acid|mesh-list
139284736|NCT05627739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139284737|NCT05627739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284738|NCT05627739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139284739|NCT05627739|Antitubercular Agents|antitubercular agents|mesh-ancestor
139284740|NCT05627739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139284741|NCT05627739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284742|NCT05627739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284743|NCT05627739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284744|NCT05621668|Cyclophosphamide|cyclophosphamide|mesh-list
139284745|NCT05621668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139284746|NCT05621668|Immunologic Factors|immunologic factors|mesh-ancestor
139284747|NCT05621668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284748|NCT05621668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139284749|NCT05621668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139284750|NCT05621668|Alkylating Agents|alkylating agents|mesh-ancestor
139284751|NCT05621668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284752|NCT05621668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284753|NCT05621668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139284754|NCT05601882|Upadacitinib|upadacitinib|mesh-list
139284755|NCT05601882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139284756|NCT05601882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139284757|NCT05601882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284758|NCT05601882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284759|NCT05601882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139284760|NCT05590416|Adalimumab|adalimumab|mesh-list
139284761|NCT05590416|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139284762|NCT05590416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139284763|NCT05590416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139284764|NCT05578287|Celecoxib|celecoxib|mesh-list
139284765|NCT05578287|Tislelizumab|tislelizumab|mesh-list
139284766|NCT05578287|Disitamab vedotin|disitamab vedotin|mesh-list
139284767|NCT05578287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139284768|NCT05578287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139284769|NCT05578287|Analgesics|analgesics|mesh-ancestor
139284770|NCT05578287|Sensory System Agents|sensory system agents|mesh-ancestor
139284771|NCT05578287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284772|NCT05578287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284773|NCT05578287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139284774|NCT05578287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139284775|NCT05578287|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139284776|NCT05578287|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139284777|NCT05578287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284778|NCT05578287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284779|NCT05578287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139284780|NCT05578287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284781|NCT05578287|Immunoconjugates|immunoconjugates|mesh-ancestor
139284782|NCT05578287|Immunologic Factors|immunologic factors|mesh-ancestor
139284784|NCT05567731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284785|NCT05567731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284786|NCT05560230|Clonidine|clonidine|mesh-list
139284787|NCT05560230|Analgesics|analgesics|mesh-ancestor
139284788|NCT05560230|Sensory System Agents|sensory system agents|mesh-ancestor
139284789|NCT05560230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284790|NCT05560230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284791|NCT05560230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139284792|NCT05560230|Sympatholytics|sympatholytics|mesh-ancestor
139284793|NCT05560230|Autonomic Agents|autonomic agents|mesh-ancestor
139284794|NCT05560230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139284795|NCT05560230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139284796|NCT05560230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139284797|NCT05560230|Adrenergic Agents|adrenergic agents|mesh-ancestor
139284798|NCT05560230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139284799|NCT05560230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284800|NCT05487040|Ritonavir|ritonavir|mesh-list
139284801|NCT05487040|Nirmatrelvir|nirmatrelvir|mesh-list
139284802|NCT05487040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139284803|NCT05487040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139284804|NCT05487040|Protease Inhibitors|protease inhibitors|mesh-ancestor
139284805|NCT05487040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284806|NCT05487040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284807|NCT05487040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139284808|NCT05487040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139284809|NCT05487040|Antiviral Agents|antiviral agents|mesh-ancestor
139284810|NCT05487040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284811|NCT05487040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139284812|NCT05487040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139284813|NCT05473910|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
139284814|NCT05473910|Antioxidants|antioxidants|mesh-ancestor
139284815|NCT05473910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284816|NCT05473910|Protective Agents|protective agents|mesh-ancestor
139284817|NCT05473910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284818|NCT05473910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139284819|NCT05473910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284820|NCT05461508|Amoxicillin|amoxicillin|mesh-list
139284821|NCT05461508|Fucoidan|fucoidan|mesh-list
139284822|NCT05461508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139284823|NCT05461508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284824|NCT05461508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139284825|NCT05461508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139284826|NCT05461508|Anticoagulants|anticoagulants|mesh-ancestor
139284827|NCT05461508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284828|NCT05432934|Dexamethasone|dexamethasone|mesh-list
139284829|NCT05432934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139284830|NCT05432934|Antiemetics|antiemetics|mesh-ancestor
139284831|NCT05432934|Autonomic Agents|autonomic agents|mesh-ancestor
139284832|NCT05432934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284833|NCT05432934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284834|NCT05432934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139284835|NCT05432934|Glucocorticoids|glucocorticoids|mesh-ancestor
139284836|NCT05432934|Hormones|hormones|mesh-ancestor
139284837|NCT05432934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284838|NCT05432934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139284839|NCT05432934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284840|NCT05367440|Abiraterone Acetate|abiraterone acetate|mesh-list
139284841|NCT05367440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284842|NCT05367440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139284843|NCT05367440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284844|NCT05367440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284845|NCT05367440|Hormone Antagonists|hormone antagonists|mesh-ancestor
139284846|NCT05367440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284847|NCT05367440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284848|NCT05367440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139284849|NCT05334485|Bromides|bromides|mesh-list
139284851|NCT05334485|Anticonvulsants|anticonvulsants|mesh-ancestor
139284852|NCT05334485|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139284853|NCT05334485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284854|NCT05334485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284855|NCT05334485|Cholinergic Agents|cholinergic agents|mesh-ancestor
139284856|NCT05334485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139284857|NCT05334485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284859|NCT05315999|Antiemetics|antiemetics|mesh-ancestor
139284860|NCT05315999|Autonomic Agents|autonomic agents|mesh-ancestor
139284861|NCT05315999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284862|NCT05315999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284863|NCT05315999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139284864|NCT05315999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139284865|NCT05315999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139284866|NCT05315999|Serotonin Agents|serotonin agents|mesh-ancestor
139284867|NCT05315999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139284868|NCT05315999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284869|NCT05301842|Durvalumab|durvalumab|mesh-list
139284870|NCT05301842|Lenvatinib|lenvatinib|mesh-list
139284871|NCT05301842|Tremelimumab|tremelimumab|mesh-list
139284872|NCT05301842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139284873|NCT05301842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284874|NCT05301842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139284875|NCT05301842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284876|NCT05301842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284877|NCT05252988|Loperamide|loperamide|mesh-list
139284878|NCT05252988|Antidiarrheals|antidiarrheals|mesh-list
139284879|NCT05252988|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139284880|NCT05252988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139284881|NCT05252988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139284882|NCT05252988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139284883|NCT05252988|Antimetabolites|antimetabolites|mesh-ancestor
139284884|NCT05252988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284885|NCT05252988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139284886|NCT05243563|Clobetasol|clobetasol|mesh-list
139284887|NCT05243563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139284888|NCT05243563|Glucocorticoids|glucocorticoids|mesh-ancestor
139284889|NCT05243563|Hormones|hormones|mesh-ancestor
139284890|NCT05243563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284891|NCT05243563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284892|NCT05176951|Treprostinil|treprostinil|mesh-list
139284893|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139284894|NCT05157672|Letrozole|letrozole|mesh-list
139284895|NCT05157672|Nicotine|nicotine|mesh-list
139284896|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139284897|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
139284898|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284899|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284900|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139284901|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139284902|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
139284903|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139284904|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284905|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284906|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139284907|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139284908|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284909|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139284910|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
139284911|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139284912|NCT05147090|Empagliflozin|empagliflozin|mesh-list
139284913|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139284914|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284915|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139284916|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284917|NCT05104229|Aspirin|aspirin|mesh-list
139284918|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139284919|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139284920|NCT05104229|Analgesics|analgesics|mesh-ancestor
139284921|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
139284922|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284923|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284924|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139284925|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139284926|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139284927|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139155103|NCT01327729|Interferons|interferons|mesh-list
139284928|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284929|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139284930|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139284931|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284932|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
139284933|NCT05089734|Docetaxel|docetaxel|mesh-list
139284934|NCT05089734|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139284935|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284936|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
139284937|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
139284938|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
139284939|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284940|NCT05089734|Immunoconjugates|immunoconjugates|mesh-ancestor
139284941|NCT05089734|Immunologic Factors|immunologic factors|mesh-ancestor
139284942|NCT05089734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284943|NCT05057247|Docetaxel|docetaxel|mesh-list
139284944|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284945|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
139284946|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
139284947|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
139284948|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284950|NCT05028075|Trace Elements|trace elements|mesh-ancestor
139284951|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
139284952|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284953|NCT05018273|Atezolizumab|atezolizumab|mesh-list
139284954|NCT05018273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139284955|NCT05018273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284956|NCT05018273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139284957|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284958|NCT05010629|Carboplatin|carboplatin|mesh-list
139284959|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139284960|NCT05010304|Amoxicillin|amoxicillin|mesh-list
139284961|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139284962|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284963|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
139284964|NCT05008523|Narcotics|narcotics|mesh-ancestor
139284965|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139284966|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284967|NCT05008523|Analgesics|analgesics|mesh-ancestor
139284968|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
139284969|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284970|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
139284971|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139284972|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
139284973|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284974|NCT04987775|Expectorants|expectorants|mesh-ancestor
139284975|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
139284976|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139284977|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
139284978|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284979|NCT04987775|Protective Agents|protective agents|mesh-ancestor
139284980|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284981|NCT04987775|Antidotes|antidotes|mesh-ancestor
139284982|NCT04967664|Capsaicin|capsaicin|mesh-list
139284983|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
139284984|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
139284985|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
139284986|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139284987|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284988|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
139284989|NCT04937907|Benazepril|benazepril|mesh-list
139284990|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
139284991|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139284992|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139284993|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139284994|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139284995|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284996|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139284997|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139284998|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
139284999|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139285000|NCT04934475|Lenalidomide|lenalidomide|mesh-list
139285001|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
139285002|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642340|NCT01457989|Ezogabine|ezogabine|mesh-list
139285003|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139285004|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139285005|NCT04934475|Growth Substances|growth substances|mesh-ancestor
139285006|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
139285007|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285009|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285010|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285011|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139285012|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285013|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139285014|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139285015|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285016|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
139285017|NCT04895735|Pemetrexed|pemetrexed|mesh-list
139285018|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285019|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285020|NCT04895735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139285021|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285022|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285023|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139285024|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139285025|NCT04879225|Menthol|menthol|mesh-list
139285026|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
139285027|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
139285028|NCT04865939|Gemcitabine|gemcitabine|mesh-list
139285029|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139285030|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
139285031|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285032|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285033|NCT04817969|Cimetidine|cimetidine|mesh-list
139285034|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139285035|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139285036|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139285037|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
139285038|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
139285039|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139285040|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285041|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285042|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139285043|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139285044|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285045|NCT04777994|Mitogens|mitogens|mesh-list
139285046|NCT04777994|Endothelial Growth Factors|endothelial growth factors|mesh-list
139285047|NCT04777994|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139285048|NCT04777994|Mitosis Modulators|mitosis modulators|mesh-ancestor
139285049|NCT04777994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285050|NCT04777994|Growth Substances|growth substances|mesh-ancestor
139285051|NCT04777994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285052|NCT04777994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139285053|NCT04777994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285054|NCT04745949|Prednisone|prednisone|mesh-list
139285055|NCT04745949|Cortisone|cortisone|mesh-list
139285056|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
139285057|NCT04745949|Rituximab|rituximab|mesh-list
139285058|NCT04745949|Doxorubicin|doxorubicin|mesh-list
139285059|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139285060|NCT04745949|Nivolumab|nivolumab|mesh-list
139285061|NCT04745949|Daunorubicin|daunorubicin|mesh-list
139285062|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139285063|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139285064|NCT04745949|Antibodies|antibodies|mesh-list
139285065|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
139285066|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139285067|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
139285068|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139285069|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
139285070|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285071|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139285072|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139285073|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
139285074|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285075|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285076|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139285077|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139285078|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139285079|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139285080|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285081|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139285084|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139285085|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139285086|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139285087|NCT04745949|Immunotoxins|immunotoxins|mesh-ancestor
139285088|NCT04721613|Melatonin|melatonin|mesh-list
139285089|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
139285090|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285091|NCT04721613|Protective Agents|protective agents|mesh-ancestor
139285092|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285093|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139285094|NCT04717375|Carboplatin|carboplatin|mesh-list
139285095|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
139285096|NCT04717375|Pemetrexed|pemetrexed|mesh-list
139285097|NCT04717375|Cetuximab|cetuximab|mesh-list
139285098|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285099|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285100|NCT04717375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139285101|NCT04717375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285102|NCT04717375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285103|NCT04717375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139285104|NCT04717375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139285105|NCT04643002|Dexamethasone|dexamethasone|mesh-list
139285106|NCT04643002|Pomalidomide|pomalidomide|mesh-list
139285107|NCT04643002|Belumosudil|belumosudil|mesh-list
139285108|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139285109|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
139285110|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
139285111|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285112|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285113|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139285114|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
139285115|NCT04643002|Hormones|hormones|mesh-ancestor
139285116|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139285117|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139285118|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285119|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
139285120|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139285121|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139285122|NCT04643002|Growth Substances|growth substances|mesh-ancestor
139285123|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
139285124|NCT04643002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139285125|NCT04643002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285126|NCT04643002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285127|NCT04642261|Empagliflozin|empagliflozin|mesh-list
139285128|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139285129|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285130|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139285131|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285132|NCT04551482|Oxytocin|oxytocin|mesh-list
139285133|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
139285134|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139285135|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285136|NCT04517851|Elotuzumab|elotuzumab|mesh-list
139285137|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285138|NCT04493164|Cytarabine|cytarabine|mesh-list
139285139|NCT04493164|Daunorubicin|daunorubicin|mesh-list
139285140|NCT04493164|Ivosidenib|ivosidenib|mesh-list
139285141|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139285142|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
139285143|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285144|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285145|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
139285146|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139285147|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139285148|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
139285149|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868654|NCT00110435|Atorvastatin|atorvastatin|mesh-list
139285150|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139285151|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139285152|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139155329|NCT01337570|Dapivirine|dapivirine|mesh-list
139285153|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285154|NCT04417465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139285155|NCT04417465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285156|NCT04417465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285157|NCT04417465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285159|NCT04359823|L 647318|l 647318|mesh-list
139285160|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
139285161|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139285162|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139285163|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
139285164|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285165|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139285166|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139285167|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285168|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
139285169|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139285170|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139285171|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
139285172|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139285173|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139285174|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285175|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
139285176|NCT04304625|Coagulants|coagulants|mesh-ancestor
139285177|NCT04274023|Dostarlimab|dostarlimab|mesh-list
139285178|NCT04274023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285179|NCT04255602|Ticagrelor|ticagrelor|mesh-list
139285180|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139285181|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139285182|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139285183|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139285184|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
139285185|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139285186|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285187|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285188|NCT04240756|Amphetamine|amphetamine|mesh-list
139285189|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139285190|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285191|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
139285192|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
139285193|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285194|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
139285195|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139285196|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285197|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
139285198|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139285199|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139285200|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139285201|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139285202|NCT04228263|Aspirin|aspirin|mesh-list
139285203|NCT04228263|Folic Acid|folic acid|mesh-list
139285204|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
139285205|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139285206|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139285207|NCT04228263|Analgesics|analgesics|mesh-ancestor
139285208|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
139285209|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285210|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285211|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139285212|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139285213|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139285214|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139285215|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285216|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139285217|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139285218|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285219|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
139285220|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
139285221|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139285222|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139285224|NCT04228263|Hematinics|hematinics|mesh-ancestor
139285225|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
139285226|NCT04228263|Vitamins|vitamins|mesh-ancestor
139285227|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
139642341|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
139285228|NCT04205812|Paclitaxel|paclitaxel|mesh-list
139285229|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139285230|NCT04205812|Carboplatin|carboplatin|mesh-list
139285231|NCT04205812|Pemetrexed|pemetrexed|mesh-list
139285232|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139285233|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285234|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
139285235|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
139285236|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
139285237|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285238|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285239|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139285240|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139285241|NCT04175886|Tofacitinib|tofacitinib|mesh-list
139285242|NCT04175886|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139285243|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139285244|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285245|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285246|NCT04151082|Prednisone|prednisone|mesh-list
139285247|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
139285248|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139285249|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139285250|NCT04151082|Prednisolone|prednisolone|mesh-list
139285251|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
139285252|NCT04151082|Cortisone|cortisone|mesh-list
139285253|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139285254|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
139285255|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139285256|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
139285257|NCT04151082|Hormones|hormones|mesh-ancestor
139285258|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139285259|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285260|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139285261|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285262|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
139285263|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
139285264|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285265|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139285266|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139285267|NCT04151082|Protective Agents|protective agents|mesh-ancestor
139285268|NCT04134884|Talazoparib|talazoparib|mesh-list
139285269|NCT04134884|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139285270|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139285271|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285272|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285273|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285274|NCT04134884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139285275|NCT04134884|Antimetabolites|antimetabolites|mesh-ancestor
139285276|NCT04132960|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139285277|NCT04132960|Immunoconjugates|immunoconjugates|mesh-ancestor
139285278|NCT04132960|Immunologic Factors|immunologic factors|mesh-ancestor
139285279|NCT04132960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285280|NCT04101357|Carboplatin|carboplatin|mesh-list
139285281|NCT04101357|Etoposide|etoposide|mesh-list
139285282|NCT04101357|Atezolizumab|atezolizumab|mesh-list
139285283|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285284|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139285285|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139285286|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139285287|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285288|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285289|NCT04101357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139285290|NCT04101357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285291|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
139285292|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
139285293|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
139285294|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285295|NCT03970304|Vaccines|vaccines|mesh-list
139285296|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
138868725|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
139285297|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285298|NCT03921008|Paclitaxel|paclitaxel|mesh-list
139285299|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139285300|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285301|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
139285302|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
139285303|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
139285304|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285305|NCT03914742|Temozolomide|temozolomide|mesh-list
139285306|NCT03914742|Pamiparib|pamiparib|mesh-list
139285307|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139285308|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139285309|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
139285310|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285311|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285312|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285313|NCT03870919|Palbociclib|palbociclib|mesh-list
139285314|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285315|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139285316|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285317|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285318|NCT03867357|Goserelin|goserelin|mesh-list
139285319|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139285320|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285321|NCT03850574|Venetoclax|venetoclax|mesh-list
139285322|NCT03850574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285323|NCT03800381|Rifampin|rifampin|mesh-list
139285324|NCT03800381|Isoniazid|isoniazid|mesh-list
139285325|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
139285326|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139285327|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
139285328|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139285329|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139285330|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
139285331|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139285332|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285333|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285334|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139285335|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139285336|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139285337|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139285338|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139285339|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139285340|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139285341|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139285342|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
139285343|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139285344|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
139285345|NCT03785249|Cetuximab|cetuximab|mesh-list
139285346|NCT03785249|Afatinib|afatinib|mesh-list
139285347|NCT03785249|Adagrasib|adagrasib|mesh-list
139285348|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285349|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285350|NCT03785249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139285351|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285352|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139285353|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285354|NCT03715946|Nivolumab|nivolumab|mesh-list
139285355|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285356|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285357|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139285358|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285359|NCT03701763|Apremilast|apremilast|mesh-list
139285360|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139285361|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139285362|NCT03701763|Analgesics|analgesics|mesh-ancestor
139285363|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
139285364|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285365|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285366|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139285367|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139285368|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139285369|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139285370|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285371|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285372|NCT03700541|Morphine|morphine|mesh-list
139285373|NCT03700541|Pirinitramide|pirinitramide|mesh-list
139285374|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139285375|NCT03700541|Narcotics|narcotics|mesh-ancestor
139285376|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139285377|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285378|NCT03700541|Analgesics|analgesics|mesh-ancestor
139285379|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
139285380|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285381|NCT03700411|Morphine|morphine|mesh-list
139285382|NCT03700411|Pirinitramide|pirinitramide|mesh-list
139285383|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139285384|NCT03700411|Narcotics|narcotics|mesh-ancestor
139285385|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139285386|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285387|NCT03700411|Analgesics|analgesics|mesh-ancestor
139285388|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
139285389|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285390|NCT03624101|Ivacaftor|ivacaftor|mesh-list
139285391|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139285392|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139285393|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285394|NCT03586661|Niraparib|niraparib|mesh-list
139285395|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139285396|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285397|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285398|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285399|NCT03502733|Nivolumab|nivolumab|mesh-list
139285400|NCT03502733|Ipilimumab|ipilimumab|mesh-list
139285401|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285402|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285403|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139285404|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285405|NCT03493048|Leucovorin|leucovorin|mesh-list
139285406|NCT03493048|Fluorouracil|fluorouracil|mesh-list
139285407|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
139285408|NCT03493048|Irinotecan|irinotecan|mesh-list
139285409|NCT03493048|Cetuximab|cetuximab|mesh-list
139285410|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
139285411|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285412|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139285413|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285414|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139285415|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
139285416|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285417|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139285418|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139285419|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285420|NCT03493048|Antidotes|antidotes|mesh-ancestor
139285421|NCT03493048|Protective Agents|protective agents|mesh-ancestor
139285422|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
139285423|NCT03493048|Vitamins|vitamins|mesh-ancestor
139285424|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
139285425|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285426|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139285427|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
139285428|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139285429|NCT03434730|Cyclosporine|cyclosporine|mesh-list
139285430|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
139285431|NCT03434730|Lenograstim|lenograstim|mesh-list
139285432|NCT03434730|Cyclosporins|cyclosporins|mesh-list
139285433|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139285434|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
139285435|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285436|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285437|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285438|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139285439|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
139285440|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139285441|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
139285442|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139285443|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139285444|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139285445|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868876|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
139285446|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139285447|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
139285448|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139285449|NCT03433001|Dexamethasone|dexamethasone|mesh-list
139285450|NCT03433001|Lenalidomide|lenalidomide|mesh-list
139285451|NCT03433001|Ixazomib|ixazomib|mesh-list
139285452|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139285454|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
139285455|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285456|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285457|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139285458|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
139285459|NCT03433001|Hormones|hormones|mesh-ancestor
139285460|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139285461|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139285462|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285463|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
139285464|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139285465|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139285466|NCT03433001|Growth Substances|growth substances|mesh-ancestor
139285467|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
139285468|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
139285469|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285470|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285471|NCT03422822|Abrocitinib|abrocitinib|mesh-list
139285472|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139285473|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285474|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285475|NCT03422328|Macitentan|macitentan|mesh-list
139285476|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139285477|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139285478|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285479|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139285480|NCT03412565|Dexamethasone|dexamethasone|mesh-list
139285481|NCT03412565|Prednisone|prednisone|mesh-list
139285482|NCT03412565|Lenalidomide|lenalidomide|mesh-list
139285483|NCT03412565|Bortezomib|bortezomib|mesh-list
139285484|NCT03412565|Melphalan|melphalan|mesh-list
139285485|NCT03412565|Daratumumab|daratumumab|mesh-list
139285486|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139285487|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
139285488|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
139285489|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285490|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285491|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139285492|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
139285493|NCT03412565|Hormones|hormones|mesh-ancestor
139285494|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139285495|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139285496|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285497|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
139285498|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139285499|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139285500|NCT03412565|Growth Substances|growth substances|mesh-ancestor
139285501|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
139285502|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139285503|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
139285504|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285505|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139285506|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139285507|NCT03383575|Azacitidine|azacitidine|mesh-list
139285508|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139285509|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
139285510|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285511|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285512|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285513|NCT03330847|Olaparib|olaparib|mesh-list
139285514|NCT03330847|Adavosertib|adavosertib|mesh-list
139285515|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139285516|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285517|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285518|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285519|NCT03314935|Leucovorin|leucovorin|mesh-list
139285520|NCT03314935|Paclitaxel|paclitaxel|mesh-list
139285521|NCT03314935|Gemcitabine|gemcitabine|mesh-list
138868951|NCT05663892|Estrogens|estrogens|mesh-ancestor
139285552|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139285553|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
139285554|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139285555|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285556|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
139285557|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
139285558|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
139285559|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285560|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139285561|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139285562|NCT03181100|Growth Substances|growth substances|mesh-ancestor
139285563|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285564|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
139285565|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
139285566|NCT03181100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139285567|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139285568|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285569|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
139285570|NCT03171818|Hematinics|hematinics|mesh-ancestor
138869028|NCT00619268|Interferons|interferons|mesh-list
139285571|NCT03169361|Ixazomib|ixazomib|mesh-list
139285572|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285573|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
139285574|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285575|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285576|NCT03101748|Paclitaxel|paclitaxel|mesh-list
139285577|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
139285578|NCT03101748|Doxorubicin|doxorubicin|mesh-list
139285579|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139285580|NCT03101748|Trastuzumab|trastuzumab|mesh-list
139285581|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139285582|NCT03101748|Daunorubicin|daunorubicin|mesh-list
139285583|NCT03101748|Pertuzumab|pertuzumab|mesh-list
139285584|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139285585|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139285586|NCT03101748|Antibodies|antibodies|mesh-list
139285587|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
139285588|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139285589|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139285590|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285591|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
139285592|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
139285593|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
139285594|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285595|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139285596|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
139285597|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285598|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139285599|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139285600|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
139285601|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139285602|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139285603|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139285604|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139285605|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285606|NCT02831764|Tenofovir|tenofovir|mesh-list
139285607|NCT02831764|Lamivudine|lamivudine|mesh-list
139285608|NCT02831764|Emtricitabine|emtricitabine|mesh-list
139285609|NCT02831764|Dolutegravir|dolutegravir|mesh-list
139285610|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
139285611|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139285612|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139285613|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139285614|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285615|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285616|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139285617|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139285618|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139285619|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139285620|NCT02754011|Capecitabine|capecitabine|mesh-list
139285621|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139285622|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
139285623|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285624|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285625|NCT02567422|Cisplatin|cisplatin|mesh-list
139285626|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285627|NCT02530034|Antibodies|antibodies|mesh-list
139285628|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139285629|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
139285630|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285631|NCT02528175|Capecitabine|capecitabine|mesh-list
139285632|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139285633|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
139285634|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285635|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285636|NCT02339532|Carboplatin|carboplatin|mesh-list
139285637|NCT02339532|Docetaxel|docetaxel|mesh-list
139285638|NCT02339532|Trastuzumab|trastuzumab|mesh-list
139285639|NCT02339532|Pertuzumab|pertuzumab|mesh-list
139285640|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285641|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
139285642|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
139285643|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
139285644|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869101|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139285645|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285646|NCT02101944|Dexamethasone|dexamethasone|mesh-list
139285647|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
139285648|NCT02101944|Ichthammol|ichthammol|mesh-list
139285649|NCT02101944|BB 1101|bb 1101|mesh-list
139285650|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139285651|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
139285652|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
139285653|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285654|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285655|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139285656|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
139285657|NCT02101944|Hormones|hormones|mesh-ancestor
139285658|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139285659|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139285660|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285661|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
139285662|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285663|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285664|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
139285665|NCT02034981|Crizotinib|crizotinib|mesh-list
139285666|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285667|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139285668|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285669|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285670|NCT02003222|Cytarabine|cytarabine|mesh-list
139285671|NCT02003222|Dexamethasone|dexamethasone|mesh-list
139285672|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
139285673|NCT02003222|Prednisone|prednisone|mesh-list
139285674|NCT02003222|Cortisone|cortisone|mesh-list
139285675|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
139285676|NCT02003222|Rituximab|rituximab|mesh-list
139285677|NCT02003222|Methotrexate|methotrexate|mesh-list
139285678|NCT02003222|Etoposide|etoposide|mesh-list
139285679|NCT02003222|Vincristine|vincristine|mesh-list
139285680|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
139285681|NCT02003222|Daunorubicin|daunorubicin|mesh-list
139285682|NCT02003222|Asparaginase|asparaginase|mesh-list
139285683|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
139285684|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
139285685|NCT02003222|Pegaspargase|pegaspargase|mesh-list
139285686|NCT02003222|Blinatumomab|blinatumomab|mesh-list
139285687|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139285688|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
139285689|NCT02003222|Antibodies|antibodies|mesh-list
139285690|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
139285691|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139285692|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139285693|NCT02003222|BB 1101|bb 1101|mesh-list
139285694|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139285695|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
139285696|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285697|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139285698|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139285699|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
139285700|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285701|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285702|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139285703|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139285704|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
139285705|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
139285706|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285707|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139285708|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
139285709|NCT02003222|Hormones|hormones|mesh-ancestor
139285710|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139285711|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139285712|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
139285713|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285714|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139285715|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
139285716|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139285717|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139285718|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
139285719|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
139285720|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139285721|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139285722|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139285723|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139285724|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139285725|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
139285726|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139285727|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
139285728|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
139285729|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
139285730|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139285731|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
139285732|NCT01897480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139285733|NCT01897480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285734|NCT01897480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139285735|NCT01897480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285736|NCT01897480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285737|NCT01665144|Siponimod|siponimod|mesh-list
139285738|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139285739|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285740|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139285741|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
139285742|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285743|NCT01661881|Cytarabine|cytarabine|mesh-list
139285744|NCT01661881|Rituximab|rituximab|mesh-list
139285745|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139285746|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285747|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285748|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
139285749|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285750|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139285751|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139285752|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
139285753|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285754|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
139285755|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139285756|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139285757|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139285758|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
139285759|NCT01582269|Lomustine|lomustine|mesh-list
139285760|NCT01582269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139285761|NCT01582269|Alkylating Agents|alkylating agents|mesh-ancestor
139285762|NCT01582269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285763|NCT01582269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285764|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
139285765|NCT01550003|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139285766|NCT01550003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139285767|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139285768|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
139285769|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285770|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139285771|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
139285772|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139285773|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
139285774|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139285775|NCT01209871|Antibodies|antibodies|mesh-list
139285776|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
139285777|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285778|NCT03487172|Mannitol|mannitol|mesh-list
139285779|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139285780|NCT03487172|Diuretics|diuretics|mesh-ancestor
139285781|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
139285782|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285783|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
139285784|NCT04995016|Axitinib|axitinib|mesh-list
139285785|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285786|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285787|NCT04995016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139285788|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285789|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139285790|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285791|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
139285792|NCT04994860|Zamicastat|zamicastat|mesh-list
139285793|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
139285794|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139285795|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139285796|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285797|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285798|NCT04994860|Urological Agents|urological agents|mesh-ancestor
138869250|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139285799|NCT03481400|Calcitonin|calcitonin|mesh-list
139285800|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
139285801|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139285802|NCT03481400|Katacalcin|katacalcin|mesh-list
139285803|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139285804|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285805|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139285806|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
139285807|NCT02851407|Defibrotide|defibrotide|mesh-list
139285808|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139285809|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139285810|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285811|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139285812|NCT02167854|Trastuzumab|trastuzumab|mesh-list
139285813|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285814|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285815|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139285816|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139285817|NCT02161614|Estradiol|estradiol|mesh-list
139285818|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139285819|NCT02161614|Estrogens|estrogens|mesh-ancestor
139285820|NCT02161614|Hormones|hormones|mesh-ancestor
139285821|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139285822|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285823|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139285824|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
139285825|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139285826|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139285827|NCT04994626|Rituximab|rituximab|mesh-list
139285828|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139285829|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285830|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
139285831|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285832|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139285833|NCT02168010|Neurotropin|neurotropin|mesh-list
139285834|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139285835|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
139285836|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285837|NCT02168010|Analgesics|analgesics|mesh-ancestor
139285838|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
139285839|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285840|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
139285841|NCT04994314|Fluorides|fluorides|mesh-list
139285842|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285843|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
139285844|NCT04994314|Protective Agents|protective agents|mesh-ancestor
139285845|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
139285846|NCT02161692|Carboplatin|carboplatin|mesh-list
139285847|NCT02161692|Etoposide|etoposide|mesh-list
139285848|NCT02161692|Bleomycin|bleomycin|mesh-list
139285849|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139285850|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
139285851|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285852|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139285853|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139285854|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
139285855|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285856|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285857|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139285858|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139285859|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139285860|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139285861|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285862|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139285863|NCT02746575|Metoprolol|metoprolol|mesh-list
139285864|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139285865|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139285866|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
139285867|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
139285868|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285869|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285870|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139285871|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139285872|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139285873|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
139285874|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139285875|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285877|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285878|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139285879|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285880|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285881|NCT03604575|Insulin|insulin|mesh-list
139285882|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139285883|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
139285884|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139285885|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285886|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
139285887|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139285888|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
139285889|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381955|NCT02426697|Analgesics|analgesics|mesh-ancestor
139285890|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285891|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139285892|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
139285893|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139285894|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
139285895|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285896|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139285897|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139285898|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
139285899|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
139285900|NCT04988932|Protective Agents|protective agents|mesh-ancestor
139285901|NCT03625466|Ivacaftor|ivacaftor|mesh-list
139285902|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139285903|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139285904|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285905|NCT03604419|Metformin|metformin|mesh-list
139285906|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139285907|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285908|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139285909|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
139285910|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
139285911|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
139285912|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139285913|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285914|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
139285915|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285916|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139285917|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139285918|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139285919|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139285920|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139285921|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
139285922|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139285923|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139285924|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
139285925|NCT02164812|Efavirenz|efavirenz|mesh-list
139285926|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139285927|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139285928|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139285929|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139285930|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285931|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285932|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285933|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139285934|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139285935|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
139285936|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139285937|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139285938|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139285939|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139285940|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139285941|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139285942|NCT04988776|Bupivacaine|bupivacaine|mesh-list
139285943|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
139285944|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
139285945|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381973|NCT02423811|Vitamins|vitamins|mesh-ancestor
139285946|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285947|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
139285948|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285950|NCT02853123|Olodaterol|olodaterol|mesh-list
139285951|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139285952|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
139285953|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285954|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285955|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139285956|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
139285957|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
139285958|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139285959|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
139285960|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139285961|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285962|NCT02255370|Curcumin|curcumin|mesh-list
139285963|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139285964|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139285965|NCT02255370|Analgesics|analgesics|mesh-ancestor
139285966|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
139285967|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285968|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285969|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139285970|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139285971|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285972|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139285973|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285974|NCT04984408|Vaccines|vaccines|mesh-list
139285975|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
139285976|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285977|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
139285978|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139285979|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139285980|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285981|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
139285982|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139285983|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285984|NCT04459676|Mitogens|mitogens|mesh-list
139285985|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
139285986|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285987|NCT02164890|Micafungin|micafungin|mesh-list
139285988|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
139285989|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139285990|NCT02634346|Olanzapine|olanzapine|mesh-list
139285991|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
139285992|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
139285993|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139285994|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285995|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139285996|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139285997|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139285998|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139285999|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139286000|NCT02634346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139286001|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139286002|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139286003|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286004|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286005|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
139286006|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
139286007|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139286008|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139286009|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286010|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
139286011|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286012|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286013|NCT00812240|Imatinib Mesylate|imatinib mesylate|mesh-list
139286014|NCT00812240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286015|NCT00812240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139286016|NCT00812240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381987|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286017|NCT00812240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286018|NCT02165046|Budesonide|budesonide|mesh-list
139286019|NCT02165046|Procaterol|procaterol|mesh-list
139286020|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138869477|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286021|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139286022|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
139286023|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286024|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286025|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139286026|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
139286027|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
139286028|NCT02165046|Hormones|hormones|mesh-ancestor
139286029|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286030|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
139286031|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139286032|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139286033|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139286034|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
139286035|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286036|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286037|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139286038|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
139286039|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139286040|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286041|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139286042|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286043|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139286044|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139286045|NCT03070678|Analgesics|analgesics|mesh-ancestor
139286046|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
139286047|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286048|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139286049|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139286050|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139286051|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286052|NCT00101166|Vaccines|vaccines|mesh-list
139286053|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
139286054|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286055|NCT04994236|Leucovorin|leucovorin|mesh-list
139286056|NCT04994236|Fluorouracil|fluorouracil|mesh-list
139286057|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
139286058|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
139286059|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286060|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139286061|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286062|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139286063|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
139286064|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286065|NCT04994236|Antidotes|antidotes|mesh-ancestor
139286066|NCT04994236|Protective Agents|protective agents|mesh-ancestor
139286067|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
139286068|NCT04994236|Vitamins|vitamins|mesh-ancestor
139286069|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
139286070|NCT03601611|Prednisolone|prednisolone|mesh-list
139286071|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139286072|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
139286073|NCT03601611|Hormones|hormones|mesh-ancestor
139286074|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286075|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286076|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139286077|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286078|NCT03597945|Lidocaine|lidocaine|mesh-list
139286079|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
139286080|NCT03597945|Epinephrine|epinephrine|mesh-list
139286081|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
139286082|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
139286083|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139286084|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286085|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
139286086|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286087|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138847234|NCT05630768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139286088|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139286089|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139286090|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139286091|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286092|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138869551|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139286093|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139286094|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
139286095|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286096|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139286097|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139286098|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
139286099|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139286100|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
139286101|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
139286102|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
139286103|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139286104|NCT03597945|Analgesics|analgesics|mesh-ancestor
139286105|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
139286106|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139286107|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139286108|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
139286109|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139286110|NCT03601533|Phenol|phenol|mesh-list
139286111|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139286112|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139286113|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
139286114|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139286115|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139286116|NCT03486626|Metformin|metformin|mesh-list
139286117|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139286118|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286119|NCT04983550|Doxorubicin|doxorubicin|mesh-list
139286120|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139286121|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139286122|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286123|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139286124|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139286125|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286126|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286127|NCT02255682|Simvastatin|simvastatin|mesh-list
139286128|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139286129|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139286130|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
139286131|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286132|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139286133|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139286134|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286135|NCT05153486|Ethanol|ethanol|mesh-list
139286136|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139286137|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139286138|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139286139|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286140|NCT03136263|Oxytocin|oxytocin|mesh-list
139286141|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
139286142|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139286143|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286144|NCT03486548|Dexamethasone|dexamethasone|mesh-list
139286145|NCT03486548|Lidocaine|lidocaine|mesh-list
139286146|NCT03486548|Bupivacaine|bupivacaine|mesh-list
139286147|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139286148|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
139286149|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
139286150|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286151|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286152|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139286153|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
139286154|NCT03486548|Hormones|hormones|mesh-ancestor
139642342|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139286155|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286156|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139286157|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286158|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
139286159|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
139286160|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139286161|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
139286162|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139286163|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139286164|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139286165|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138869627|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139286166|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286167|NCT04983160|Allopurinol|allopurinol|mesh-list
139286169|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286170|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286171|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
139286172|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139286173|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139286174|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
139286175|NCT04983160|Protective Agents|protective agents|mesh-ancestor
139286176|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286177|NCT02759016|BI 836826|bi 836826|mesh-list
139286178|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139286179|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286180|NCT02852967|Belumosudil|belumosudil|mesh-list
139286181|NCT02852967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139286182|NCT02852967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286183|NCT02852967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286184|NCT03593044|Atropine|atropine|mesh-list
139286185|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139286186|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139286187|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139286188|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
139286189|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286190|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286191|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139286192|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
139286193|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
139286194|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
139286195|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139286196|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139286197|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
139286198|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286199|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286200|NCT03597087|Anesthetics|anesthetics|mesh-list
139286201|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139286202|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286203|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
139286204|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139286205|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
139286206|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139286207|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139286208|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286209|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139286210|NCT03596775|Analgesics|analgesics|mesh-ancestor
139286211|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
139286212|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286213|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139286214|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139286215|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139286216|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
139286217|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286218|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286219|NCT03066466|Methotrexate|methotrexate|mesh-list
139286220|NCT03066466|Atorvastatin|atorvastatin|mesh-list
139286221|NCT03066466|Tacrolimus|tacrolimus|mesh-list
139286222|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139286223|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
139286224|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139286225|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286226|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139286227|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
139286228|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286229|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286230|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
139286231|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286232|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139286233|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139286234|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
139286235|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139286236|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139286237|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139286238|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138869701|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139286239|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139286240|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139286241|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139286242|NCT03603249|Trimetazidine|trimetazidine|mesh-list
139286243|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
139286244|NCT03068260|Acetaminophen|acetaminophen|mesh-list
139286246|NCT03068260|Morphine|morphine|mesh-list
139286247|NCT03068260|Ropivacaine|ropivacaine|mesh-list
139286248|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139286249|NCT03068260|Narcotics|narcotics|mesh-ancestor
139286250|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139286251|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286252|NCT03068260|Analgesics|analgesics|mesh-ancestor
139286253|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
139286254|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286255|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
139286256|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
139286257|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139286258|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
139286259|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139286260|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139286261|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139286262|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139286263|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286264|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286265|NCT02237859|Vancomycin|vancomycin|mesh-list
139286266|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139286267|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139286268|NCT03594825|Valsartan|valsartan|mesh-list
139286269|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139286270|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139286271|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139286272|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286273|NCT02162550|Exenatide|exenatide|mesh-list
139286274|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139286275|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286276|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139286277|NCT02162550|Incretins|incretins|mesh-ancestor
139286278|NCT02162550|Hormones|hormones|mesh-ancestor
139286279|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286280|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
139286281|NCT02852265|Etonogestrel|etonogestrel|mesh-list
139286282|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139286283|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286284|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139286285|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139286286|NCT02162784|Budesonide|budesonide|mesh-list
139286287|NCT02162784|Albuterol|albuterol|mesh-list
139286288|NCT02162784|Procaterol|procaterol|mesh-list
139286289|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139286290|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139286291|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
139286292|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286293|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286294|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139286295|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
139286296|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
139286297|NCT02162784|Hormones|hormones|mesh-ancestor
139286298|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286299|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
139286300|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139286301|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139286302|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139286303|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139286305|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286306|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286307|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
139286308|NCT03539718|Taurolidine|taurolidine|mesh-list
139286309|NCT03539718|Heparin|heparin|mesh-list
139286310|NCT03539718|Calcium heparin|calcium heparin|mesh-list
139286311|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
139286312|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139286313|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139286314|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286315|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139286316|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139286317|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286319|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139286320|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139286321|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
139286322|NCT02166450|Ionophores|ionophores|mesh-ancestor
139286323|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139286324|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286325|NCT03600363|Metformin|metformin|mesh-list
139286326|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139286327|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286328|NCT03600129|Ropivacaine|ropivacaine|mesh-list
139286329|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
139286330|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
139286331|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139286332|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286333|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
139286334|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286335|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
139286336|NCT02169570|Vitamin D|vitamin d|mesh-list
139286337|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
139286338|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
139286339|NCT02169570|Vitamins|vitamins|mesh-list
139286340|NCT02169570|Calcium|calcium|mesh-list
139286341|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
139286342|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286343|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139286344|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139286345|NCT02169648|Ranibizumab|ranibizumab|mesh-list
139286346|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139286347|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139286348|NCT02169648|Growth Substances|growth substances|mesh-ancestor
139286349|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286350|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
139286351|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286352|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139286353|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286354|NCT02170896|Pantoprazole|pantoprazole|mesh-list
139286355|NCT02170896|Dabigatran|dabigatran|mesh-list
139286356|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139286357|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139286358|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139286359|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286360|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286361|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
139286362|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139286363|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
139286364|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
139286365|NCT03594513|Dipyrone|dipyrone|mesh-list
139286366|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
139286367|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139286368|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139286369|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
139286370|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139286371|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139286372|NCT03594513|Analgesics|analgesics|mesh-ancestor
139286373|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
139286374|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286375|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286376|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139286377|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139286378|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
139286379|NCT02633800|Carboplatin|carboplatin|mesh-list
139286380|NCT02633800|Cetuximab|cetuximab|mesh-list
139286381|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156527|NCT00445198|Navitoclax|navitoclax|mesh-list
139286382|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139286383|NCT02169804|Enclomiphene|enclomiphene|mesh-list
139286384|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139286385|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
139286386|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286387|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286388|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139286389|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
139286390|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139286391|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139286392|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139286393|NCT02170974|Dabigatran|dabigatran|mesh-list
139286394|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
139286395|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139286396|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
139286397|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286398|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286399|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
139286401|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
139286402|NCT02174718|Vitamins|vitamins|mesh-ancestor
139286403|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
139286404|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286405|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139286406|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139286407|NCT02238171|Ipratropium|ipratropium|mesh-list
139286408|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139286409|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
139286410|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286411|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286412|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139286413|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
139286414|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139286415|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
139286416|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286417|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286418|NCT02169882|Rifampin|rifampin|mesh-list
139286419|NCT02169882|Dexamethasone|dexamethasone|mesh-list
139286420|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139286421|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
139286422|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
139286423|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286424|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286425|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139286426|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
139286427|NCT02169882|Hormones|hormones|mesh-ancestor
139286428|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286429|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139286430|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286431|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139286432|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
139286433|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139286434|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139286435|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
139286436|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139286437|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286438|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286439|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139286440|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139286441|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139286442|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139286443|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139286444|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139286445|NCT03602547|Vorolanib|vorolanib|mesh-list
139286446|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139286447|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286448|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286449|NCT03602469|Bupivacaine|bupivacaine|mesh-list
139286450|NCT03602469|Propofol|propofol|mesh-list
139286451|NCT03602469|Sevoflurane|sevoflurane|mesh-list
139286452|NCT03602469|Rocuronium|rocuronium|mesh-list
139286453|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
139286454|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
139642343|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286455|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139286456|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286457|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
139286458|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286459|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139286460|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139286461|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
139286462|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139286463|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139286464|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139286465|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139286466|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139286467|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139286468|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
139286469|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139286470|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
139286471|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139286472|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286473|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139286474|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139286475|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139286476|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139286477|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139286478|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
139286479|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139286480|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139286481|NCT05001373|Vaccines|vaccines|mesh-list
139286482|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
139286483|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286484|NCT02171052|Digoxin|digoxin|mesh-list
139286485|NCT02171052|Dabigatran|dabigatran|mesh-list
139286486|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
139286487|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139286488|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
139286489|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286490|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286491|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
139286492|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139286493|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139286494|NCT02171052|Protective Agents|protective agents|mesh-ancestor
139286495|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286496|NCT03591549|Fulvestrant|fulvestrant|mesh-list
139286497|NCT03591549|Goserelin|goserelin|mesh-list
139286498|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139286499|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286500|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139286501|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139286502|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
139286503|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286504|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286505|NCT02261220|Durvalumab|durvalumab|mesh-list
139286506|NCT02261220|Tremelimumab|tremelimumab|mesh-list
139286507|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139286508|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286509|NCT02237937|Amitriptyline|amitriptyline|mesh-list
139286510|NCT02237937|Citalopram|citalopram|mesh-list
139286511|NCT02237937|Paroxetine|paroxetine|mesh-list
139286512|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139286513|NCT02237937|Sertraline|sertraline|mesh-list
139286514|NCT02237937|Nortriptyline|nortriptyline|mesh-list
139286515|NCT02237937|Trimipramine|trimipramine|mesh-list
139286516|NCT02237937|Escitalopram|escitalopram|mesh-list
139286517|NCT02237937|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139286518|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139286519|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139286520|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286521|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286522|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
139286523|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286524|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286525|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139286526|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
139286527|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139286528|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139286529|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139286530|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286531|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139286532|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139286533|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139286534|NCT02237937|Analgesics|analgesics|mesh-ancestor
139286535|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
139286536|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139286537|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
139286538|NCT02170116|Dabigatran|dabigatran|mesh-list
139286539|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
138870011|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
139286543|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286545|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139286546|NCT03539562|Promethazine|promethazine|mesh-list
139286547|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
139286548|NCT03539562|Morphine|morphine|mesh-list
139286549|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139286550|NCT03539562|Narcotics|narcotics|mesh-ancestor
139286551|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139286552|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286553|NCT03539562|Analgesics|analgesics|mesh-ancestor
139286554|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
139286555|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286556|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
139286557|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
139286558|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139286559|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
139286560|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
139286561|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286562|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286563|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139286564|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139286565|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139286566|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
139286567|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
139286568|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
139286569|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
139286570|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139286571|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139286572|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139286573|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286574|NCT00394069|Montelukast|montelukast|mesh-list
139286575|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139286576|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
139286577|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139286578|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
139286579|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286580|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286581|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139286582|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139286583|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286584|NCT03598959|Tofacitinib|tofacitinib|mesh-list
139286585|NCT03598959|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139286586|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139286587|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286588|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286589|NCT02238717|Pregabalin|pregabalin|mesh-list
139286590|NCT02238717|PF-06372865|pf-06372865|mesh-list
139286591|NCT02238717|Analgesics|analgesics|mesh-ancestor
139286592|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
139286593|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286594|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286595|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
139286596|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139286597|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139286598|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286599|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139286600|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139286601|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139286602|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139286603|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139286604|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
139286605|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
139286606|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286611|NCT03470311|Benralizumab|benralizumab|mesh-list
139286612|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139286613|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
139286614|NCT03580005|Methylphenidate|methylphenidate|mesh-list
139286615|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139286617|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139286618|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139286619|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139286620|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286621|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
139286622|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286623|NCT03579927|Cytarabine|cytarabine|mesh-list
139286624|NCT03579927|Rituximab|rituximab|mesh-list
139286625|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139286626|NCT03579927|Etoposide|etoposide|mesh-list
139286627|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
139286628|NCT03579927|Melphalan|melphalan|mesh-list
139286629|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
139286630|NCT03579927|Carmustine|carmustine|mesh-list
139286631|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
139286632|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139286633|NCT03579927|Antibodies|antibodies|mesh-list
139286634|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
139286635|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139286636|NCT03579927|Lenograstim|lenograstim|mesh-list
139286637|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
139286638|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286639|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286640|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139286641|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139286642|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139286643|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139286644|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286645|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286646|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139286647|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
139286648|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
139286649|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139286650|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139286651|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139286652|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139286653|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
139286654|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139286655|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
139286656|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
139286657|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
139286658|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
139286659|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
139286660|NCT03587025|Amitriptyline|amitriptyline|mesh-list
139286661|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139286662|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
139286663|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139286664|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139286665|NCT03587025|Analgesics|analgesics|mesh-ancestor
139286666|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
139286667|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286668|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286669|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139286670|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139286671|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139286672|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286673|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
139286674|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286675|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139286676|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
139286677|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139286678|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
139286679|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286680|NCT00140881|Montelukast|montelukast|mesh-list
139286681|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139286682|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
139286683|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139286684|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
139642344|NCT01458067|GSK2636771|gsk2636771|mesh-list
139286685|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286686|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286687|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139286688|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139286689|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286690|NCT02848833|Empagliflozin|empagliflozin|mesh-list
139286691|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139286692|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286693|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139286694|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286696|NCT03539328|Gemcitabine|gemcitabine|mesh-list
139286697|NCT03539328|Doxorubicin|doxorubicin|mesh-list
139286698|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139286699|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
139286700|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139286701|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286702|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
139286703|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
139286704|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
139286705|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286706|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139286707|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
139286708|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139286709|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139286710|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139286711|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286712|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139286713|NCT03539328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139286714|NCT00111709|Rizatriptan|rizatriptan|mesh-list
139286715|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286716|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286717|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286718|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139286719|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
139286720|NCT02171442|Dabigatran|dabigatran|mesh-list
139286721|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
139286722|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139286723|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
139286724|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286725|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286726|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
139286727|NCT02035527|Docetaxel|docetaxel|mesh-list
139286728|NCT02035527|Sorafenib|sorafenib|mesh-list
139286729|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286730|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
139286731|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
139286732|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
139286733|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286734|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139286735|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286736|NCT00092131|Montelukast|montelukast|mesh-list
139286737|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139286738|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
139286739|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139286740|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
139286741|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286742|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286743|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139286744|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139286745|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286746|NCT02170584|Dabigatran|dabigatran|mesh-list
139286747|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
139286748|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139286749|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
139286750|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286751|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286752|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
139286753|NCT03577977|Interferons|interferons|mesh-list
139286754|NCT03577977|Interferon-beta|interferon-beta|mesh-list
139286755|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
139286756|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286757|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
139286759|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
139286760|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286761|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139286762|NCT02668783|Ibuprofen|ibuprofen|mesh-list
138870231|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
139286763|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139286764|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139286765|NCT02668783|Etonogestrel|etonogestrel|mesh-list
139286766|NCT02668783|Estradiol|estradiol|mesh-list
139286767|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139286768|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139286769|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139286770|NCT02668783|Analgesics|analgesics|mesh-ancestor
139286771|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
139286772|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286773|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286774|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139286775|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139286776|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139286777|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286778|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286779|NCT02668783|Estrogens|estrogens|mesh-ancestor
139286780|NCT02668783|Hormones|hormones|mesh-ancestor
139286781|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286782|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139286783|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
139286784|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139286785|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139286786|NCT03577899|Aflibercept|aflibercept|mesh-list
139286787|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139286788|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139286789|NCT03577899|Growth Substances|growth substances|mesh-ancestor
139286790|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286791|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
139286792|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286793|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
139286794|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139286795|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
139286796|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286797|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286798|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139286799|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
139286800|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
139286801|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139286802|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
139286803|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286804|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286805|NCT02171520|Dabigatran|dabigatran|mesh-list
139286806|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
139286807|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139286808|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
139286809|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286810|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286811|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
139286812|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
139286813|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139286814|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286815|NCT00101010|Prednisone|prednisone|mesh-list
139286816|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
139286817|NCT00101010|Rituximab|rituximab|mesh-list
139286818|NCT00101010|Doxorubicin|doxorubicin|mesh-list
139286819|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139286820|NCT00101010|Vincristine|vincristine|mesh-list
139286821|NCT00101010|Lenograstim|lenograstim|mesh-list
139286822|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139286823|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
139286824|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286825|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139286826|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139286827|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
139286828|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286829|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286830|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139286831|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139286832|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139286833|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139286834|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139286835|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286836|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139286837|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
139286838|NCT00101010|Hormones|hormones|mesh-ancestor
139286839|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286840|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139286841|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139286842|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139286843|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
139286844|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
139286845|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
139286846|NCT03539172|Apatinib|apatinib|mesh-list
139286847|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286848|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139286849|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286850|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286851|NCT03209401|Carboplatin|carboplatin|mesh-list
139286852|NCT03209401|Niraparib|niraparib|mesh-list
139286853|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286854|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139286855|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286856|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286857|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
139286858|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
139286859|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286860|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139286861|NCT02170740|Pantoprazole|pantoprazole|mesh-list
139286862|NCT02170740|Dabigatran|dabigatran|mesh-list
139286863|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139286864|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139286865|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139286866|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286867|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286868|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
139286869|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139286870|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
139286871|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
139286872|NCT02848599|Morphine|morphine|mesh-list
139286873|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
139286874|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139286875|NCT02848599|Narcotics|narcotics|mesh-ancestor
139286876|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139286877|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286878|NCT02848599|Analgesics|analgesics|mesh-ancestor
139286879|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
139286880|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286881|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
139286882|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
139286883|NCT02171598|Dabigatran|dabigatran|mesh-list
139286884|NCT02171598|Clopidogrel|clopidogrel|mesh-list
139286885|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139286886|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139286887|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139286888|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139286889|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
139286890|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139382012|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286891|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286892|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286893|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
139286894|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139286895|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
139286896|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286897|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
139286898|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139286899|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139286900|NCT02171676|Docetaxel|docetaxel|mesh-list
139286901|NCT02171676|Afatinib|afatinib|mesh-list
139286902|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286903|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
139286904|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
139286905|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
139286906|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286907|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139157048|NCT06097026|Antioxidants|antioxidants|mesh-ancestor
139286908|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286909|NCT03577743|Bevacizumab|bevacizumab|mesh-list
139286910|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139286911|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286912|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139286913|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139286914|NCT03577743|Growth Substances|growth substances|mesh-ancestor
139286915|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286916|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
139286917|NCT04794790|Buprenorphine|buprenorphine|mesh-list
139286918|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139286919|NCT04794790|Naloxone|naloxone|mesh-list
139286920|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139286921|NCT04794790|Narcotics|narcotics|mesh-ancestor
139286922|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139286923|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286924|NCT04794790|Analgesics|analgesics|mesh-ancestor
139286925|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
139286926|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286927|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139286928|NCT02171754|Ritonavir|ritonavir|mesh-list
139286929|NCT02171754|Afatinib|afatinib|mesh-list
139286930|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139286931|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139286932|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
139286933|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286934|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286935|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139286936|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139286937|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
139286938|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139286939|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139286940|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139286941|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286942|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139286943|NCT02171832|Olodaterol|olodaterol|mesh-list
139286944|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139286945|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
139286946|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286947|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286948|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139286949|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
139286950|NCT02171910|Doxapram|doxapram|mesh-list
139286951|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139286952|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286953|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
139286954|NCT02178306|Telmisartan|telmisartan|mesh-list
139286955|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139286956|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139286957|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139286958|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286959|NCT05729386|Metformin|metformin|mesh-list
139286960|NCT05729386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139286961|NCT05729386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286962|NCT05729308|Anesthetics|anesthetics|mesh-list
139286963|NCT05729308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139286964|NCT05729308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286965|NCT00778999|Desogestrel|desogestrel|mesh-list
139286966|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139286967|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139286968|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139286969|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
139286970|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139286971|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286972|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139286973|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139286974|NCT00778999|Progestins|progestins|mesh-ancestor
139286975|NCT00778999|Hormones|hormones|mesh-ancestor
139286976|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139286977|NCT02171988|Propranolol|propranolol|mesh-list
139286978|NCT02171988|Bisoprolol|bisoprolol|mesh-list
139286979|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139286980|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139642345|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139286982|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
139286983|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139286984|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139286985|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139286986|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139286987|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138870460|NCT00633425|Glimepiride|glimepiride|mesh-list
139286988|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
139286989|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
139286990|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
139286991|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139286992|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139286993|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139286994|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286995|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
139286996|NCT00725413|Etonogestrel|etonogestrel|mesh-list
139286997|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139286998|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
139286999|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139287000|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287001|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139287002|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139287003|NCT00103038|Hematinics|hematinics|mesh-ancestor
139287004|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139287005|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139287006|NCT00620035|Etonogestrel|etonogestrel|mesh-list
139287007|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139287008|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
139287009|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139287010|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287011|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139287012|NCT02175888|Iron|iron|mesh-list
139287013|NCT02175888|Trace Elements|trace elements|mesh-ancestor
139287014|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
139287015|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287016|NCT05577637|Tacrolimus|tacrolimus|mesh-list
139287017|NCT05577637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139287018|NCT05577637|Immunologic Factors|immunologic factors|mesh-ancestor
139287019|NCT05577637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287020|NCT05577637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139287021|NCT05577637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287022|NCT05577637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287023|NCT02176044|Nitroprusside|nitroprusside|mesh-list
139287024|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139287025|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
139287026|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139287027|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287028|NCT02176122|Meropenem|meropenem|mesh-list
139287029|NCT02176122|Tazobactam|tazobactam|mesh-list
139287030|NCT02176122|Piperacillin|piperacillin|mesh-list
139287031|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139287032|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139287033|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287034|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139287035|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287036|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287037|NCT04887064|Sotorasib|sotorasib|mesh-list
139287038|NCT04887064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139287039|NCT04887064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287040|NCT04887064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139287041|NCT04887064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287042|NCT02967757|Liraglutide|liraglutide|mesh-list
139287043|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139287044|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287045|NCT02967757|Incretins|incretins|mesh-ancestor
139287046|NCT02967757|Hormones|hormones|mesh-ancestor
139287047|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139287048|NCT02261298|Nivolumab|nivolumab|mesh-list
139287049|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139287050|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287051|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139287052|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287053|NCT02176200|Fenoterol|fenoterol|mesh-list
139157199|NCT06092437|Diuretics|diuretics|mesh-list
139287054|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139287055|NCT02176200|Ipratropium|ipratropium|mesh-list
139287056|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139287057|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
139287058|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287059|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287060|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139287061|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
139287062|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
139287064|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139287065|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139287066|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139287067|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139287068|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
139287069|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287070|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287071|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139287072|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
139287073|NCT03537612|Clonidine|clonidine|mesh-list
139287074|NCT03537612|Morphine|morphine|mesh-list
139287075|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139287076|NCT03537612|Narcotics|narcotics|mesh-ancestor
139287077|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139287078|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287079|NCT03537612|Analgesics|analgesics|mesh-ancestor
139287080|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
139287081|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287082|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139287083|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
139287084|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
139287085|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139287086|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139287087|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139287088|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
139287089|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287090|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287091|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
139287092|NCT02172144|Olodaterol|olodaterol|mesh-list
139287093|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139287094|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287095|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139287096|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139287097|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287098|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287099|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287100|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287101|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139287102|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
139287103|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287104|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139287105|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
139287106|NCT05729074|Pimecrolimus|pimecrolimus|mesh-list
139287107|NCT05729074|Varespladib methyl|varespladib methyl|mesh-list
139287108|NCT05729074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138848279|NCT03117049|Paclitaxel|paclitaxel|mesh-list
139287109|NCT05729074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139287110|NCT05729074|Analgesics|analgesics|mesh-ancestor
139287111|NCT05729074|Sensory System Agents|sensory system agents|mesh-ancestor
139287112|NCT05729074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287113|NCT05729074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287114|NCT05729074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139287115|NCT05729074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139287116|NCT05729074|Dermatologic Agents|dermatologic agents|mesh-ancestor
139287117|NCT05729074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139287118|NCT05729074|Immunologic Factors|immunologic factors|mesh-ancestor
139287119|NCT05729074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139287120|NCT05729074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287121|NCT05729074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287122|NCT05729074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
139287123|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139287124|NCT02176512|Telmisartan|telmisartan|mesh-list
139287125|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139287126|NCT02176512|Diuretics|diuretics|mesh-ancestor
139287127|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
139642346|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139287128|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287129|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139287130|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139287131|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287132|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139287133|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139287134|NCT03537534|Lidocaine|lidocaine|mesh-list
139287135|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
139287136|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
139287137|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139287138|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287139|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
139287140|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287141|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139287142|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139287143|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139287144|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139287145|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287146|NCT03068650|Rindopepimut|rindopepimut|mesh-list
139287147|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139287148|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287149|NCT02757768|Tamsulosin|tamsulosin|mesh-list
139287150|NCT02757768|Mirabegron|mirabegron|mesh-list
139287151|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139287152|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139287153|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139287154|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
139287155|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287156|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287157|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287158|NCT02757768|Urological Agents|urological agents|mesh-ancestor
139287159|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139287160|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139287161|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139287162|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
139287163|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
139287164|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
139287165|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287166|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
139287167|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139287168|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287169|NCT05225077|Dapagliflozin|dapagliflozin|mesh-list
139287170|NCT05225077|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139287171|NCT05225077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287172|NCT05225077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139287173|NCT05225077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287174|NCT03067792|Leucovorin|leucovorin|mesh-list
139287175|NCT03067792|Docetaxel|docetaxel|mesh-list
139287176|NCT03067792|Fluorouracil|fluorouracil|mesh-list
139287177|NCT03067792|Irinotecan|irinotecan|mesh-list
139287178|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287179|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
139287180|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
139287181|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
139287182|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287183|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
139287184|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139287185|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139287186|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
139287187|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287188|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139287189|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139287190|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287191|NCT03067792|Antidotes|antidotes|mesh-ancestor
139287192|NCT03067792|Protective Agents|protective agents|mesh-ancestor
139287193|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
139287194|NCT03067792|Vitamins|vitamins|mesh-ancestor
139287195|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
139287196|NCT05224999|Nivolumab|nivolumab|mesh-list
139287197|NCT05224999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139287198|NCT05224999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287199|NCT05224999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139297258|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287200|NCT05224999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287201|NCT03066154|Ritonavir|ritonavir|mesh-list
139287202|NCT03066154|Docetaxel|docetaxel|mesh-list
139287203|NCT03066154|Androgens|androgens|mesh-list
139287204|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287205|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
139287206|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
139287207|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
139287208|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287209|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139287210|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139287211|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
139287212|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287213|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139287214|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139287215|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
139287216|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287217|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139287218|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139287219|NCT03066154|Hormones|hormones|mesh-ancestor
139287220|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139287221|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287222|NCT05224687|Daptomycin|daptomycin|mesh-list
139287223|NCT05224687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139287224|NCT05224687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287225|NCT02753946|Tazobactam|tazobactam|mesh-list
139287226|NCT02753946|Piperacillin|piperacillin|mesh-list
139287227|NCT02753946|Fosfomycin|fosfomycin|mesh-list
139287228|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139287229|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139287230|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287231|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139287232|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287233|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287234|NCT00431431|Tibolone|tibolone|mesh-list
139287235|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
139287236|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
139287237|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139287238|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287239|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139287240|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139287241|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287242|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139287243|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
139287244|NCT00431431|Hormones|hormones|mesh-ancestor
139287245|NCT02172222|Linagliptin|linagliptin|mesh-list
139287246|NCT02172222|Empagliflozin|empagliflozin|mesh-list
139287247|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139287248|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287249|NCT02172222|Incretins|incretins|mesh-ancestor
139287250|NCT02172222|Hormones|hormones|mesh-ancestor
139287251|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139287252|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139287253|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
139287254|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287255|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287256|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139287257|NCT03625219|Prednisone|prednisone|mesh-list
139287258|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139287259|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
139287260|NCT03625219|Hormones|hormones|mesh-ancestor
139287261|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139287262|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287263|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139287264|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287265|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
139287266|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139287267|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287268|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139287269|NCT02179008|Latanoprost|latanoprost|mesh-list
139287270|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139287271|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
139287272|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139287273|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
139287274|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287275|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287276|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139287277|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
139287278|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
139287279|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139287280|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
139287281|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287282|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287283|NCT05223907|Propofol|propofol|mesh-list
139287284|NCT05223907|Etomidate|etomidate|mesh-list
139287285|NCT05223907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139287286|NCT05223907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139287287|NCT05223907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287288|NCT05223907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139287289|NCT05223907|Anesthetics, General|anesthetics, general|mesh-ancestor
139287290|NCT05223907|Anesthetics|anesthetics|mesh-ancestor
139287291|NCT03065998|Baclofen|baclofen|mesh-list
139287292|NCT03065998|Opipramol|opipramol|mesh-list
139287293|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139287294|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287295|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139287296|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287297|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139287298|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
139287299|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
139287300|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287301|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287302|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139287303|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
139287304|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139287305|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139287306|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139287307|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139287308|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
139287309|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
139287310|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139287311|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
139287312|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287313|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287314|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139287315|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
139287316|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
139287317|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139287318|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
139287319|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287320|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287321|NCT05728528|Factor VIII|factor viii|mesh-list
139287322|NCT05728528|Coagulants|coagulants|mesh-ancestor
139287323|NCT02256228|Ropivacaine|ropivacaine|mesh-list
139287324|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
139287325|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
139287326|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139287327|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287328|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
139287329|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287330|NCT03067168|Bupivacaine|bupivacaine|mesh-list
139287331|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
139287332|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
139287333|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139287334|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287335|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
139287336|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287337|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139287338|NCT04774237|Carbachol|carbachol|mesh-list
139287339|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139287340|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139287341|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139287342|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139287343|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
139287344|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287345|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287346|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287347|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139287348|NCT04774237|Miotics|miotics|mesh-ancestor
139287349|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
139287350|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287351|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139287352|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
139287353|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139287354|NCT04774237|Analgesics|analgesics|mesh-ancestor
139287355|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
139287356|NCT04774237|Protective Agents|protective agents|mesh-ancestor
139287357|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
139287358|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139287359|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
139287360|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287361|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287362|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139287363|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
139287364|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
139287365|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139287366|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
139287367|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287368|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287370|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
139287371|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139287372|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
139287373|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287374|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287375|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139287376|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
139287377|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
139287378|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139287379|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
139287380|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287381|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287382|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
139287383|NCT04713631|Artesunate|artesunate|mesh-list
139287384|NCT04713631|Curcumin|curcumin|mesh-list
139287385|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139287386|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139287387|NCT04713631|Analgesics|analgesics|mesh-ancestor
139287388|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
139287389|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287390|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287391|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139287392|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139287393|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287394|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287395|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287396|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
139287397|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139287398|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139287399|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287400|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
139287401|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
139382018|NCT03183297|Naproxen|naproxen|mesh-list
139287402|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139287403|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
139287404|NCT04459078|Apatinib|apatinib|mesh-list
139287405|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139287406|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287407|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139287408|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287409|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287410|NCT04459078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139287411|NCT02756832|Alogliptin|alogliptin|mesh-list
139287412|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139287413|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287414|NCT02756832|Incretins|incretins|mesh-ancestor
139287415|NCT02756832|Hormones|hormones|mesh-ancestor
139287416|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139287417|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139287418|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
139287419|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287420|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287421|NCT00108810|Ketoprofen|ketoprofen|mesh-list
139287422|NCT00108810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139287423|NCT00108810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139287424|NCT00108810|Analgesics|analgesics|mesh-ancestor
139287425|NCT00108810|Sensory System Agents|sensory system agents|mesh-ancestor
139287426|NCT00108810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287427|NCT00108810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287428|NCT00108810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139287429|NCT00108810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139287430|NCT00108810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139287431|NCT00108810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287432|NCT00108810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287433|NCT05588284|Rivaroxaban|rivaroxaban|mesh-list
139287434|NCT05588284|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139287436|NCT05588284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139287437|NCT05588284|Protease Inhibitors|protease inhibitors|mesh-ancestor
139287438|NCT05588284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287439|NCT05588284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287440|NCT05588284|Anticoagulants|anticoagulants|mesh-ancestor
139287441|NCT02256150|Mizoribine|mizoribine|mesh-list
139287442|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
139287443|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139287444|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
139287445|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287446|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139287447|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139287448|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
139287449|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287450|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287451|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139287452|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139287453|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139287454|NCT02256150|Analgesics|analgesics|mesh-ancestor
139287455|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
139287456|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287457|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139287458|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139287459|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287460|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139287461|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
139287462|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139287463|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139287464|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287465|NCT02177370|Fenoterol|fenoterol|mesh-list
139287466|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139287467|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
139287468|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287469|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287470|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139287471|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
139287472|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
139287473|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
139287474|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139287475|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139287476|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139287477|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139287478|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
139287479|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287480|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287481|NCT03538704|Metformin|metformin|mesh-list
139287482|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139287483|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287484|NCT02172768|Micafungin|micafungin|mesh-list
139287485|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
139287486|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287487|NCT02172846|Paclitaxel|paclitaxel|mesh-list
139287488|NCT02172846|Carboplatin|carboplatin|mesh-list
139287489|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139287490|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287491|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
139287492|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
139287493|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
139287494|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287495|NCT00106626|Pemetrexed|pemetrexed|mesh-list
139287496|NCT00106626|Vorinostat|vorinostat|mesh-list
139287497|NCT00106626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287498|NCT00106626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287499|NCT00106626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287500|NCT00106626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139287501|NCT00106626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139287502|NCT00106626|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139287503|NCT02177448|Enalapril|enalapril|mesh-list
139287504|NCT02177448|Enalaprilat|enalaprilat|mesh-list
139287505|NCT02177448|Telmisartan|telmisartan|mesh-list
139287506|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139287507|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
139287508|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287509|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287510|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139287511|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139287512|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139287513|NCT03537144|Acetaminophen|acetaminophen|mesh-list
139287514|NCT03537144|Indomethacin|indomethacin|mesh-list
139287515|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139287516|NCT03537144|Analgesics|analgesics|mesh-ancestor
139287517|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
139287518|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287519|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287520|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
139287521|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139287522|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139287523|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139287524|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
139287525|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
139287526|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139287527|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139287528|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287529|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287530|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
139287531|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139287532|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287533|NCT03065764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139287534|NCT03065764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287535|NCT02755818|Heparin|heparin|mesh-list
139287536|NCT02755818|Calcium heparin|calcium heparin|mesh-list
139287537|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
139287538|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139287539|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139287540|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287541|NCT02177760|Sirolimus|sirolimus|mesh-list
139287542|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139287543|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287544|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139287545|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287546|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
139287547|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139287548|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
139287549|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287550|NCT02173782|Fenoterol|fenoterol|mesh-list
139287551|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139287552|NCT02173782|Ipratropium|ipratropium|mesh-list
139287553|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139287554|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
139287555|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287556|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287557|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139287558|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
139287559|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
139287560|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
139287561|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139287562|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139287563|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139287564|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139287565|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
139287566|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287567|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287568|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139287569|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
139287570|NCT05717374|Dexamethasone|dexamethasone|mesh-list
139287571|NCT05717374|Dexamethasone acetate|dexamethasone acetate|mesh-list
139287572|NCT05717374|Methylprednisolone|methylprednisolone|mesh-list
139287573|NCT05717374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139287574|NCT05717374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139287575|NCT05717374|Prednisolone|prednisolone|mesh-list
139287576|NCT05717374|Prednisolone acetate|prednisolone acetate|mesh-list
139287577|NCT05717374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139287578|NCT05717374|Prednisolone phosphate|prednisolone phosphate|mesh-list
139287579|NCT05717374|BB 1101|bb 1101|mesh-list
139287580|NCT05717374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139287581|NCT05717374|Antiemetics|antiemetics|mesh-ancestor
139287582|NCT05717374|Autonomic Agents|autonomic agents|mesh-ancestor
139287583|NCT05717374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287584|NCT05717374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287585|NCT05717374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139287586|NCT05717374|Glucocorticoids|glucocorticoids|mesh-ancestor
139287587|NCT05717374|Hormones|hormones|mesh-ancestor
139287588|NCT05717374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139287589|NCT05717374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139287590|NCT05717374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287591|NCT05717374|Protease Inhibitors|protease inhibitors|mesh-ancestor
139287592|NCT05717374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287593|NCT05717374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287594|NCT05717374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139287595|NCT05717374|Protective Agents|protective agents|mesh-ancestor
139287596|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
139287597|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
139287598|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139287599|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
139287600|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139287601|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287602|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139287603|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139287604|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139287605|NCT02174094|Clobazam|clobazam|mesh-list
139287606|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
139287607|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139287608|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139287609|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139287610|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287611|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139287612|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139287613|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
139287614|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
139287615|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287616|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287617|NCT02174172|Interferons|interferons|mesh-list
139287618|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
139287619|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
139287620|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139287621|NCT02174172|Bevacizumab|bevacizumab|mesh-list
139287622|NCT02174172|Ipilimumab|ipilimumab|mesh-list
139287623|NCT02174172|Atezolizumab|atezolizumab|mesh-list
139287624|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
139287625|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139287626|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287627|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139287628|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139287629|NCT02174172|Growth Substances|growth substances|mesh-ancestor
139287630|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287631|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
139287632|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
139287633|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287634|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139287635|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287636|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
139287637|NCT02180334|Acetaminophen|acetaminophen|mesh-list
139287638|NCT02180334|Linagliptin|linagliptin|mesh-list
139287639|NCT02180334|Mosapride|mosapride|mesh-list
139287640|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139287641|NCT02180334|Analgesics|analgesics|mesh-ancestor
139287642|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
139287643|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287644|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287645|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
139287646|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287647|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139287648|NCT02180334|Incretins|incretins|mesh-ancestor
139287649|NCT02180334|Hormones|hormones|mesh-ancestor
139287650|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139287651|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139287652|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
139287653|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287654|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139287655|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139287656|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
139287657|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287659|NCT02174250|Istradefylline|istradefylline|mesh-list
139287660|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139287661|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
139287662|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139287663|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287664|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
139287665|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139287666|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287667|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287668|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139287669|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139287670|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139287671|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139287672|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139287673|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139287674|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
139287675|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139287676|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139287677|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
139287678|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287679|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287680|NCT02174328|Aspirin|aspirin|mesh-list
139287681|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139287682|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139287683|NCT02174328|Analgesics|analgesics|mesh-ancestor
139287684|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
139287685|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287686|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287687|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139287688|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139287689|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139287690|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139287691|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287692|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139287693|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139287694|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287695|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
139287696|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
139287697|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139287698|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287699|NCT02755116|Olanzapine|olanzapine|mesh-list
139287700|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
139287701|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
139287702|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287703|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287704|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139287705|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139287706|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139287707|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139287708|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139287709|NCT02755116|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139287710|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139287711|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139287712|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287713|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287714|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
139287715|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
139287716|NCT02178150|Antacids|antacids|mesh-ancestor
139287717|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287718|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139287719|NCT04411030|Itraconazole|itraconazole|mesh-list
139287720|NCT04411030|Midazolam|midazolam|mesh-list
139287721|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139287722|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139287723|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139287724|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287725|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139287726|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139287727|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139287728|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139287729|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
139287730|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
139287731|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
139287732|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
139287733|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287734|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871200|NCT06096181|Analgesics|analgesics|mesh-ancestor
139287735|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
139287736|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287737|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139287738|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139287739|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287740|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139287741|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
139287742|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139287743|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139287745|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139287746|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
139287747|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139287748|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
139287749|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287750|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287751|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
139287752|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
139287753|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139287754|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
139287755|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
139287756|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
139287757|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139287758|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287759|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
139287760|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287761|NCT02182050|Nintedanib|nintedanib|mesh-list
139287762|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287763|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139287764|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287765|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287766|NCT02182128|Nintedanib|nintedanib|mesh-list
139287767|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287768|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139287769|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287770|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287771|NCT02182206|Nintedanib|nintedanib|mesh-list
139287772|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287773|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139287774|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287775|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287776|NCT03963544|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139287777|NCT03963544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139287778|NCT03963544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287779|NCT03963544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287780|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
139287781|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287782|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
139287783|NCT02657889|Niraparib|niraparib|mesh-list
139287784|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139287785|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287786|NCT02657889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139287787|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287788|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139287789|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287790|NCT03536208|Warfarin|warfarin|mesh-list
139287791|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
139287792|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139287793|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139287794|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
139287795|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287796|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287797|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139287798|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
139287799|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139287800|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139287801|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139287802|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
139287803|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287804|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287805|NCT02631538|Rituximab|rituximab|mesh-list
139287806|NCT02631538|Belimumab|belimumab|mesh-list
139287807|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139287808|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287809|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
139287810|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287811|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139287812|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139287813|NCT03578679|Ivermectin|ivermectin|mesh-list
139287814|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139287815|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287816|NCT04930783|Nivolumab|nivolumab|mesh-list
139287817|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139287818|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287819|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139287820|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287821|NCT05666206|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139287822|NCT05666206|Hemostatics|hemostatics|mesh-ancestor
139287823|NCT05666206|Coagulants|coagulants|mesh-ancestor
139287824|NCT02256462|Adalimumab|adalimumab|mesh-list
139287825|NCT02256462|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139287826|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139287827|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139287828|NCT02631148|Melatonin|melatonin|mesh-list
139287829|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
139287830|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287831|NCT02631148|Protective Agents|protective agents|mesh-ancestor
139287832|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287833|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139287834|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
139287835|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139287836|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
139287837|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287838|NCT02239107|Expectorants|expectorants|mesh-ancestor
139287839|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
139287840|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139287841|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
139287842|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287843|NCT02239107|Protective Agents|protective agents|mesh-ancestor
139287844|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287845|NCT02239107|Antidotes|antidotes|mesh-ancestor
139287846|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
139287847|NCT02182518|Ephedrine|ephedrine|mesh-list
139287848|NCT02182518|Epinastine|epinastine|mesh-list
139287849|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139287850|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
139287851|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287852|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287853|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139287854|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
139287855|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
139287856|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139287857|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139287858|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
139287859|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
139287860|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287861|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287862|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139287863|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
139287864|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
139287865|NCT05486182|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
139287866|NCT05486182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287867|NCT03574857|Metolazone|metolazone|mesh-list
139287868|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
139287869|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139287870|NCT03574857|Diuretics|diuretics|mesh-ancestor
139287871|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
139287872|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287873|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139287874|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139287875|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287876|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
139287877|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139287878|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139287879|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287880|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
139287881|NCT02238639|Coagulants|coagulants|mesh-ancestor
139287882|NCT02186028|Vitamin D|vitamin d|mesh-list
139287883|NCT02186028|Vitamins|vitamins|mesh-ancestor
139287884|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
139287885|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287886|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139287887|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
139287888|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139287889|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287890|NCT02182596|Immunotoxins|immunotoxins|mesh-ancestor
139287891|NCT02182596|Immunoconjugates|immunoconjugates|mesh-ancestor
139287892|NCT02182596|Immunologic Factors|immunologic factors|mesh-ancestor
139287893|NCT02182596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287894|NCT03574701|Vitamin A|vitamin a|mesh-list
139287895|NCT03574701|Vitamins|vitamins|mesh-ancestor
139287896|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
139287897|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287898|NCT02180880|Pregabalin|pregabalin|mesh-list
139287899|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
139287900|NCT02180880|Analgesics|analgesics|mesh-ancestor
139287901|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
139287902|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287903|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287904|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
139287905|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139287906|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139287907|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287908|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139287909|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139287910|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139382034|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
139287911|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139287912|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139287913|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139287914|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139287915|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139287916|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139287917|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
139287918|NCT02186106|Vitamin D|vitamin d|mesh-list
139287919|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139287920|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287921|NCT02186106|Vitamins|vitamins|mesh-ancestor
139287922|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
139287923|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139287924|NCT03943147|Mycophenolic Acid|mycophenolic acid|mesh-list
139287925|NCT03943147|Deucravacitinib|deucravacitinib|mesh-list
139287926|NCT03943147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139287927|NCT03943147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287928|NCT03943147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139287929|NCT03943147|Antitubercular Agents|antitubercular agents|mesh-ancestor
139287930|NCT03943147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139287931|NCT03943147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139287932|NCT03943147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287933|NCT03943147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287934|NCT03943147|Dermatologic Agents|dermatologic agents|mesh-ancestor
139287935|NCT03943147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139287936|NCT02182752|Tramadol|tramadol|mesh-list
139287937|NCT02182752|Ropivacaine|ropivacaine|mesh-list
139287938|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
139287939|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
139287940|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139287941|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287942|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
139287943|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287944|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139287945|NCT02182752|Narcotics|narcotics|mesh-ancestor
139287946|NCT02182752|Analgesics|analgesics|mesh-ancestor
139287947|NCT03536598|Amlodipine|amlodipine|mesh-list
139287948|NCT03536598|Valsartan|valsartan|mesh-list
139287949|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139287950|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139287951|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139287952|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139287953|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287954|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139287955|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287956|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
139287957|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139287958|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138871427|NCT06081257|Antioxidants|antioxidants|mesh-ancestor
139287959|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
139287960|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139287961|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139287962|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287963|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139287964|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139287965|NCT03576963|Nivolumab|nivolumab|mesh-list
139287966|NCT03576963|Guadecitabine|guadecitabine|mesh-list
139287967|NCT03576963|Azacitidine|azacitidine|mesh-list
139287968|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139287969|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139287970|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139287971|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287972|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139287973|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
139287974|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139287975|NCT02186496|Amlodipine|amlodipine|mesh-list
139287976|NCT02186496|Candesartan|candesartan|mesh-list
139287977|NCT02186496|Candesartan cilexetil|candesartan cilexetil|mesh-list
139287978|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139287979|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139287980|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139287981|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139287982|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139382035|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
139287983|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287984|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
139287985|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139287986|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139287987|NCT05615194|Dexmedetomidine|dexmedetomidine|mesh-list
139287988|NCT05615194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139287989|NCT05615194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139287990|NCT05615194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139287991|NCT05615194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139287992|NCT05615194|Analgesics|analgesics|mesh-ancestor
139287993|NCT05615194|Sensory System Agents|sensory system agents|mesh-ancestor
139287994|NCT05615194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139287995|NCT05615194|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139287996|NCT05615194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139287997|NCT05615194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139287998|NCT05615194|Adrenergic Agents|adrenergic agents|mesh-ancestor
139287999|NCT05615194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139288000|NCT05615194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288001|NCT02186574|Tenofovir|tenofovir|mesh-list
139288002|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
139288003|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288004|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139288005|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139288006|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288007|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288008|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139288009|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139288010|NCT03066700|Hemostatics|hemostatics|mesh-list
139288011|NCT03066700|Coagulants|coagulants|mesh-ancestor
139288012|NCT03066544|Dexamethasone|dexamethasone|mesh-list
139288013|NCT03066544|Ketorolac|ketorolac|mesh-list
139288014|NCT03066544|Naratriptan|naratriptan|mesh-list
139288015|NCT03066544|Bupivacaine|bupivacaine|mesh-list
139288016|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288017|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
139288018|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
139288019|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288020|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288021|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139288022|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
139288023|NCT03066544|Hormones|hormones|mesh-ancestor
139288024|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288025|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139288026|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288027|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
139288028|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
139288029|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288030|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
139288031|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139288032|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138871501|NCT05952882|Incretins|incretins|mesh-ancestor
139288033|NCT03066544|Analgesics|analgesics|mesh-ancestor
139288034|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139288035|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139288036|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288037|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288038|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139288039|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139288040|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139288041|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
139288042|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139288043|NCT03182179|Ondansetron|ondansetron|mesh-list
139288044|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
139288045|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
139288046|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288047|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288048|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139288049|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
139288050|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
139288051|NCT03182179|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139288052|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139288053|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
139288054|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139288055|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288056|NCT03576651|Bevacizumab|bevacizumab|mesh-list
139288057|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139288058|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288059|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139288060|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139288061|NCT03576651|Growth Substances|growth substances|mesh-ancestor
139288062|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288063|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
139288064|NCT03064906|Pancrelipase|pancrelipase|mesh-list
139288065|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139288066|NCT03034135|Copper|copper|mesh-list
139288067|NCT03034135|Temozolomide|temozolomide|mesh-list
139288068|NCT03034135|Disulfiram|disulfiram|mesh-list
139288069|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139288070|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
139288071|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288072|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288073|NCT03034135|Trace Elements|trace elements|mesh-ancestor
139288074|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
139288075|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288076|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139288077|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139288078|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288079|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139288080|NCT02239731|Doxycycline|doxycycline|mesh-list
139288081|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288082|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
139288083|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139288084|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139288085|NCT03571815|Listerine|listerine|mesh-list
139288086|NCT03571815|Fluorides|fluorides|mesh-list
139288087|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
139288088|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
139288089|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
139288090|NCT03571815|Protective Agents|protective agents|mesh-ancestor
139288091|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288092|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139288093|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288094|NCT03571737|Ibuprofen|ibuprofen|mesh-list
139288095|NCT03571737|Lidocaine|lidocaine|mesh-list
139288096|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
139288097|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
139288098|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288099|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288100|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
139288101|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288102|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139288103|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139288104|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139288105|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139288106|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288107|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139288108|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138871649|NCT05509777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139288109|NCT03571737|Analgesics|analgesics|mesh-ancestor
139288110|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288111|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139288112|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139288113|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288114|NCT03573999|Mannitol|mannitol|mesh-list
139288115|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139288116|NCT03573999|Diuretics|diuretics|mesh-ancestor
139288117|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
139288118|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288119|NCT03063190|Vitamin D|vitamin d|mesh-list
139288120|NCT03063190|Vitamins|vitamins|mesh-ancestor
139288121|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
139288122|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288123|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139288124|NCT03573687|Caseins|caseins|mesh-list
139288125|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
139288126|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
139288127|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288128|NCT01671280|Azithromycin|azithromycin|mesh-list
139288129|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139288130|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288131|NCT03575637|Olanzapine|olanzapine|mesh-list
139288132|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
139288133|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
139288134|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288135|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288136|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139288137|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139288138|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139288139|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288140|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139288141|NCT03575637|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139288142|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139288143|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139288144|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288145|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139288146|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
139288147|NCT03062800|Thalidomide|thalidomide|mesh-list
139288148|NCT03062800|Carboplatin|carboplatin|mesh-list
139288149|NCT03062800|Pemetrexed|pemetrexed|mesh-list
139288150|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288151|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288152|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288153|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139288154|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139288155|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139288156|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
139288157|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288158|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
139288159|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139288160|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288161|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139288162|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139288163|NCT03062800|Growth Substances|growth substances|mesh-ancestor
139288164|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
139288165|NCT05709015|Chlorhexidine|chlorhexidine|mesh-list
139288166|NCT05709015|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139288167|NCT05709015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139288168|NCT05709015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288169|NCT05709015|Disinfectants|disinfectants|mesh-ancestor
139288170|NCT05709015|Dermatologic Agents|dermatologic agents|mesh-ancestor
139288171|NCT03573063|Androgens|androgens|mesh-list
139288172|NCT03573063|Hormones|hormones|mesh-ancestor
139288173|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288174|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288175|NCT03572829|Dexamethasone|dexamethasone|mesh-list
139288176|NCT03572829|Ondansetron|ondansetron|mesh-list
139288177|NCT03572829|Aprepitant|aprepitant|mesh-list
139288178|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288179|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
139288180|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
139288181|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288182|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288183|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139288184|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
139288185|NCT03572829|Hormones|hormones|mesh-ancestor
139288186|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288187|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139288188|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288189|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288190|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
139288191|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
139288192|NCT03572829|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139288193|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139288194|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
139288195|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139288196|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139288197|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
139288198|NCT03575247|Hormones|hormones|mesh-ancestor
139288199|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288200|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288201|NCT03704623|Acetaminophen|acetaminophen|mesh-list
139288202|NCT03704623|Parecoxib|parecoxib|mesh-list
139288203|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139288204|NCT03704623|Analgesics|analgesics|mesh-ancestor
139288205|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
139288206|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288207|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288208|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
139288209|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139288210|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139288211|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288212|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288213|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139288214|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288215|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139288216|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139288217|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139288218|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288219|NCT03572517|Morphine|morphine|mesh-list
139288220|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139288221|NCT03572517|Narcotics|narcotics|mesh-ancestor
139288222|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288223|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288224|NCT03572517|Analgesics|analgesics|mesh-ancestor
139288225|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
139288226|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288227|NCT03570645|Dexamethasone|dexamethasone|mesh-list
139288228|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
139288229|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288230|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
139288231|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
139288232|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288233|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288234|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139288235|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
139288236|NCT03570645|Hormones|hormones|mesh-ancestor
139288237|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288238|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139288239|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288240|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139288241|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288242|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139288243|NCT03570645|Analgesics|analgesics|mesh-ancestor
139288244|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
139288245|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139288246|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139288247|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139288248|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
139288249|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139288250|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288252|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139288253|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288254|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139288255|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139288256|NCT03940690|Growth Substances|growth substances|mesh-ancestor
139288257|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288258|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
139288259|NCT03567135|Temozolomide|temozolomide|mesh-list
139288260|NCT03567135|Apatinib|apatinib|mesh-list
139288261|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139288262|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
139288263|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288264|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288265|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139288266|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288267|NCT03698383|Trastuzumab|trastuzumab|mesh-list
139288268|NCT03698383|Gedatolisib|gedatolisib|mesh-list
139288269|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139288270|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288271|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139288272|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288273|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288274|NCT04760782|Abaloparatide|abaloparatide|mesh-list
139288275|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139288276|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288277|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
139288278|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139288279|NCT04740580|Glycine|glycine|mesh-list
139288280|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
139288281|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288282|NCT04740580|Expectorants|expectorants|mesh-ancestor
139288283|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
139288284|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139288285|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
139288286|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288287|NCT04740580|Protective Agents|protective agents|mesh-ancestor
139288288|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288289|NCT04740580|Antidotes|antidotes|mesh-ancestor
139288290|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
139288291|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139288292|NCT03064282|Papaverine|papaverine|mesh-list
139288293|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139288294|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288295|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288296|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
139288297|NCT03064282|Urological Agents|urological agents|mesh-ancestor
139288298|NCT04679818|Fentanyl|fentanyl|mesh-list
139288299|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
139288300|NCT04679818|Narcotics|narcotics|mesh-ancestor
139288301|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288302|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288303|NCT04679818|Analgesics|analgesics|mesh-ancestor
139288304|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
139288305|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288306|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139288307|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139288308|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
139288309|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
139288310|NCT03027609|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139288311|NCT03027609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288312|NCT03063112|Ethanol|ethanol|mesh-list
139288313|NCT03063112|Lidocaine|lidocaine|mesh-list
139288314|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
139288315|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
139288316|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288317|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288318|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
139288319|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288320|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139288321|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139288322|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139288323|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139288324|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288325|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139288326|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288327|NCT04767217|Lumefantrine|lumefantrine|mesh-list
139288328|NCT04767217|Artemether|artemether|mesh-list
139288329|NCT04767217|Piperaquine|piperaquine|mesh-list
139288330|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139288331|NCT04767217|Artenimol|artenimol|mesh-list
139288332|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
139288333|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139288334|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138871802|NCT04993352|Antibodies|antibodies|mesh-list
139288335|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288337|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288338|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288339|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
139288340|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139288341|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139288342|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139288343|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139288344|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288345|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
139288346|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139288347|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288348|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139288349|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288350|NCT03698227|Doxorubicin|doxorubicin|mesh-list
139288351|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
139288352|NCT03698227|Razoxane|razoxane|mesh-list
139288353|NCT03698227|Olaratumab|olaratumab|mesh-list
139288354|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139288355|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288356|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139288357|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139288358|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288359|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288360|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139288361|NCT03698227|Protective Agents|protective agents|mesh-ancestor
139288362|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288363|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
139288364|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
139288365|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139288366|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288367|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139288368|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288369|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288370|NCT02181348|Vitamin E|vitamin e|mesh-list
139288371|NCT02181348|Vitamins|vitamins|mesh-ancestor
139288372|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
139288373|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288374|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
139288375|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288376|NCT02181348|Protective Agents|protective agents|mesh-ancestor
139288377|NCT02186886|Golimumab|golimumab|mesh-list
139288378|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139288379|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288380|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139288381|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
139288382|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288383|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139288384|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
139288385|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288386|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
139288387|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
139288388|NCT03536910|Coagulants|coagulants|mesh-ancestor
139288389|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139288390|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139288391|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
139288392|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288393|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
139288394|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139288395|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139288396|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288397|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
139288398|NCT03697681|Coagulants|coagulants|mesh-ancestor
139288399|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
139288400|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297259|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
139288401|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288402|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
139288403|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139288404|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288405|NCT02183064|Meloxicam|meloxicam|mesh-list
139288406|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139288407|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139288408|NCT02183064|Analgesics|analgesics|mesh-ancestor
139288409|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
139288410|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288411|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288412|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288414|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139288415|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139288416|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288417|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288418|NCT03704077|Paclitaxel|paclitaxel|mesh-list
139288419|NCT03704077|Nivolumab|nivolumab|mesh-list
139288420|NCT03704077|Ramucirumab|ramucirumab|mesh-list
139288421|NCT03704077|Relatlimab|relatlimab|mesh-list
139288422|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139288423|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288424|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
139288425|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
139288426|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
139288427|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288428|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139288429|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139288430|NCT02183142|Meloxicam|meloxicam|mesh-list
139288431|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139288432|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139288433|NCT02183142|Analgesics|analgesics|mesh-ancestor
139288434|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
139288435|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288436|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288437|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288438|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139288439|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139288440|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139288441|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288442|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288443|NCT02183220|Aspirin|aspirin|mesh-list
139288444|NCT02183220|Dipyrone|dipyrone|mesh-list
139288445|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139288446|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139288447|NCT02183220|Analgesics|analgesics|mesh-ancestor
139288448|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
139288449|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288450|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288451|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288452|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139288453|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139288454|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139288455|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288456|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139288457|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139288458|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288459|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
139288460|NCT02187588|Ibuprofen|ibuprofen|mesh-list
139288461|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139288462|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139288463|NCT02187588|Analgesics|analgesics|mesh-ancestor
139288464|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
139288465|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288466|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288467|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288468|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139288469|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139288470|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288471|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288472|NCT05364489|Bevacizumab|bevacizumab|mesh-list
139288473|NCT05364489|Oxaliplatin|oxaliplatin|mesh-list
139288474|NCT05364489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139288475|NCT05364489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288476|NCT05364489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139288477|NCT05364489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139288478|NCT05364489|Growth Substances|growth substances|mesh-ancestor
139288479|NCT05364489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288480|NCT05364489|Growth Inhibitors|growth inhibitors|mesh-ancestor
139288481|NCT02183298|Linagliptin|linagliptin|mesh-list
139288482|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138871958|NCT04277858|Cisplatin|cisplatin|mesh-list
139288483|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288484|NCT02183298|Incretins|incretins|mesh-ancestor
139288485|NCT02183298|Hormones|hormones|mesh-ancestor
139288486|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288487|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139288488|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
139288489|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288490|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288491|NCT03697057|Anesthetics|anesthetics|mesh-list
139288492|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288493|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288494|NCT02183376|Linagliptin|linagliptin|mesh-list
139288495|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139288496|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288497|NCT02183376|Incretins|incretins|mesh-ancestor
139288498|NCT02183376|Hormones|hormones|mesh-ancestor
139288499|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288500|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139288501|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
139288502|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288503|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288505|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288506|NCT03696901|Dalbavancin|dalbavancin|mesh-list
139288507|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139288508|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288509|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
139288510|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
139288511|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139288512|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288513|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139288514|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
139288515|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139288516|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288517|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288518|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288519|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139288520|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139288521|NCT02187900|Protective Agents|protective agents|mesh-ancestor
139288522|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288523|NCT03062644|Celecoxib|celecoxib|mesh-list
139288524|NCT03062644|Tramadol|tramadol|mesh-list
139288525|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139288526|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139288527|NCT03062644|Analgesics|analgesics|mesh-ancestor
139288528|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
139288529|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288530|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288531|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288532|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139288533|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139288534|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139288535|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288536|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288537|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139288538|NCT03062644|Narcotics|narcotics|mesh-ancestor
139288539|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288540|NCT02190318|Losartan|losartan|mesh-list
139288541|NCT02190318|Spironolactone|spironolactone|mesh-list
139288542|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139288543|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139288544|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139288545|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139288546|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288547|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139288548|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
139297260|NCT04105920|Protective Agents|protective agents|mesh-ancestor
139158709|NCT04835805|Nivolumab|nivolumab|mesh-list
139288549|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288550|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288551|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139288552|NCT02190318|Diuretics|diuretics|mesh-ancestor
139288553|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
139288554|NCT02183532|Linagliptin|linagliptin|mesh-list
138872021|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
139288555|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139288556|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288557|NCT02183532|Incretins|incretins|mesh-ancestor
139288558|NCT02183532|Hormones|hormones|mesh-ancestor
139288559|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288560|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139288561|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
139288562|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288563|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288564|NCT03569631|BPN14770|bpn14770|mesh-list
139288565|NCT03569631|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139288566|NCT03569631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139288567|NCT03569631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288568|NCT03569631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288569|NCT02629822|Tenofovir|tenofovir|mesh-list
139288570|NCT02629822|Lamivudine|lamivudine|mesh-list
139288571|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
139288572|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849754|NCT00635076|Alprazolam|alprazolam|mesh-list
139288573|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139288574|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139288575|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288576|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288577|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139288578|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139288579|NCT03700801|Insulin|insulin|mesh-list
139288580|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139288581|NCT03700801|Metformin|metformin|mesh-list
139288582|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
139288583|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
139288584|NCT03700801|Saxagliptin|saxagliptin|mesh-list
139288585|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139288586|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288587|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139288588|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288589|NCT03700801|Incretins|incretins|mesh-ancestor
139288590|NCT03700801|Hormones|hormones|mesh-ancestor
139288591|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288592|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139288593|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
139288594|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288595|NCT03700645|Allopurinol|allopurinol|mesh-list
139288596|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
139288597|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288598|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288599|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
139288600|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139288601|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139288602|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
139288603|NCT03700645|Protective Agents|protective agents|mesh-ancestor
139288604|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288605|NCT04499053|Durvalumab|durvalumab|mesh-list
139288606|NCT04499053|Tremelimumab|tremelimumab|mesh-list
139288607|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139288608|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288609|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
139288610|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
139288611|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139288612|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139288613|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139288614|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288615|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139288616|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139288617|NCT03567447|Droxidopa|droxidopa|mesh-list
139288618|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139288619|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139288620|NCT03567369|Dexamethasone|dexamethasone|mesh-list
139642347|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158785|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139288621|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
139288622|NCT03567369|BB 1101|bb 1101|mesh-list
139288623|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288624|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
139288625|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
139288626|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288627|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288628|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139288629|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
139288630|NCT03567369|Hormones|hormones|mesh-ancestor
139288631|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288632|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139288633|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288635|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288636|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288637|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
139288638|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139288639|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288640|NCT03397654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139288641|NCT03397654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288642|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
139288643|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139288644|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139288645|NCT03266146|Prednisolone|prednisolone|mesh-list
139288646|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
139288647|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139288648|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
139288649|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288650|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
139288651|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
139288652|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288653|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288654|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139288655|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
139288656|NCT03266146|Hormones|hormones|mesh-ancestor
139288657|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288658|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139288659|NCT03266146|Protective Agents|protective agents|mesh-ancestor
139288660|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139288661|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288662|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
139288663|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
139288664|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139288665|NCT03700489|Protective Agents|protective agents|mesh-ancestor
139288666|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288667|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
139288668|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139288669|NCT02800941|Warfarin|warfarin|mesh-list
139288670|NCT02800941|Anticoagulants|anticoagulants|mesh-list
139288671|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
139288672|NCT02800941|Fluindione|fluindione|mesh-list
139288673|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
139288674|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139288675|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
139288676|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
139288677|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288678|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288679|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139288680|NCT03695887|Analgesics|analgesics|mesh-ancestor
139288681|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
139288682|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288683|NCT04432714|Prednisone|prednisone|mesh-list
139288684|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
139288685|NCT04432714|Rituximab|rituximab|mesh-list
139288686|NCT04432714|Doxorubicin|doxorubicin|mesh-list
139288687|NCT04432714|Etoposide|etoposide|mesh-list
139288688|NCT04432714|Vincristine|vincristine|mesh-list
139288689|NCT04432714|Lenalidomide|lenalidomide|mesh-list
139288690|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139288691|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
139288692|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288693|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139642348|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288694|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139288695|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
139288696|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158860|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288697|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288698|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139288699|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139288700|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139288701|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139288702|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139288703|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288704|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288705|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
139288706|NCT04432714|Hormones|hormones|mesh-ancestor
139288707|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288708|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139288709|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139288710|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
139288711|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
139288712|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
139288713|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139288714|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139288715|NCT04432714|Growth Substances|growth substances|mesh-ancestor
139288716|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
139288718|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139288719|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288720|NCT02752074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139288721|NCT02752074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288722|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
139288723|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
139288724|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139288725|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288726|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139288727|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139288728|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
139288729|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139288730|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
139288731|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139288732|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288733|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288734|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139288735|NCT03624595|Analgesics|analgesics|mesh-ancestor
139288736|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
139288737|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288738|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139288739|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139288740|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139288741|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
139288742|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139288743|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288744|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
139288745|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139288746|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139288747|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288748|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
139288749|NCT03063892|Coagulants|coagulants|mesh-ancestor
139288750|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139288751|NCT03063580|Rifampin|rifampin|mesh-list
139288752|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139288753|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
139288754|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139288755|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288756|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
139288757|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139288758|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288759|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288760|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139288761|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139288762|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139288763|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139288764|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139288765|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139288766|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139642349|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139288767|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139288768|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288769|NCT05353101|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139288770|NCT05353101|Cyclosporine|cyclosporine|mesh-list
139288771|NCT05353101|Tobramycin|tobramycin|mesh-list
139288772|NCT05353101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139288773|NCT05353101|Cyclosporins|cyclosporins|mesh-list
139288774|NCT05353101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288775|NCT05353101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288776|NCT05353101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138872247|NCT02937272|Paclitaxel|paclitaxel|mesh-list
139288777|NCT05353101|Immunologic Factors|immunologic factors|mesh-ancestor
139288778|NCT05353101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288779|NCT05353101|Antifungal Agents|antifungal agents|mesh-ancestor
139288780|NCT05353101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288781|NCT05353101|Dermatologic Agents|dermatologic agents|mesh-ancestor
139288782|NCT05353101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139288783|NCT05353101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139288784|NCT05353101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139288785|NCT05353101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139288786|NCT05353101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139288787|NCT03700333|Pemetrexed|pemetrexed|mesh-list
139288788|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382044|NCT02108483|Dapsone|dapsone|mesh-list
139288789|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288790|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288791|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139288792|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139288793|NCT03700177|Dexamethasone|dexamethasone|mesh-list
139288794|NCT03700177|Ropivacaine|ropivacaine|mesh-list
139288795|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288796|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
139288797|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
139288798|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288799|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288800|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139288801|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
139288802|NCT03700177|Hormones|hormones|mesh-ancestor
139288803|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288804|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139288805|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288806|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
139288807|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
139288808|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288809|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
139288810|NCT02183610|Linagliptin|linagliptin|mesh-list
139288811|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139288812|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139288813|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288814|NCT02183610|Incretins|incretins|mesh-ancestor
139288815|NCT02183610|Hormones|hormones|mesh-ancestor
139288816|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139288817|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139288818|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
139288819|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288820|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288821|NCT02183688|Acetaminophen|acetaminophen|mesh-list
139288822|NCT02183688|Caffeine|caffeine|mesh-list
139288823|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139288824|NCT02183688|Analgesics|analgesics|mesh-ancestor
139288825|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
139288826|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288827|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288828|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
139288829|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139288830|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139288831|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288832|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288833|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139288834|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139288835|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
139288836|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139288837|NCT02190708|Midazolam|midazolam|mesh-list
139288838|NCT02190708|Omeprazole|omeprazole|mesh-list
139288839|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139288840|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139288841|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139288842|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288843|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288844|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139288845|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139288846|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139288847|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139288848|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
139288850|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
139288851|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
139288852|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139288853|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288854|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139288855|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139288856|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288857|NCT05338983|Anesthetics|anesthetics|mesh-list
139288858|NCT05338983|Mepivacaine|mepivacaine|mesh-list
139288859|NCT05338983|Anesthetics, Local|anesthetics, local|mesh-list
139288860|NCT05338983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288861|NCT05338983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288862|NCT05338983|Sensory System Agents|sensory system agents|mesh-ancestor
139382046|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
139288863|NCT05338983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288864|NCT03063658|Acetaminophen|acetaminophen|mesh-list
139288865|NCT03063658|Ibuprofen|ibuprofen|mesh-list
139288866|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139288867|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139288868|NCT03063658|Analgesics|analgesics|mesh-ancestor
139288869|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
139288870|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288871|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288872|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288873|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139288874|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139288875|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288876|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288877|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
139288878|NCT03695107|Nifedipine|nifedipine|mesh-list
139288879|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139288880|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139288881|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288882|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139288883|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288884|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
139288885|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
139288886|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139288887|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
139288888|NCT02835339|Analgesics|analgesics|mesh-ancestor
139288889|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
139288890|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288891|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288892|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
139288893|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288894|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139288895|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
139288896|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139288897|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139288898|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288899|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139288900|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
139288901|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139288902|NCT03695029|Tenofovir|tenofovir|mesh-list
139288903|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
139288904|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288905|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139288906|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139288907|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288908|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288909|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139288910|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139288911|NCT02259855|Interferons|interferons|mesh-list
139288912|NCT02259855|Ritonavir|ritonavir|mesh-list
139288913|NCT02259855|Ribavirin|ribavirin|mesh-list
139288914|NCT02259855|Tipranavir|tipranavir|mesh-list
139288915|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288916|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
139091729|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139288917|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288918|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139288919|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139288920|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
139288921|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288922|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288923|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139288924|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139288925|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139288926|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139288927|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
139288928|NCT03703063|Leucovorin|leucovorin|mesh-list
139288929|NCT03703063|Paclitaxel|paclitaxel|mesh-list
139288930|NCT03703063|Gemcitabine|gemcitabine|mesh-list
139288931|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139288932|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288933|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
139288934|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
139288935|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
139288936|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288937|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139288938|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
139288939|NCT03703063|Antidotes|antidotes|mesh-ancestor
139288940|NCT03703063|Protective Agents|protective agents|mesh-ancestor
139288941|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288942|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
139288943|NCT03703063|Vitamins|vitamins|mesh-ancestor
139288944|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
139288945|NCT03702985|Capecitabine|capecitabine|mesh-list
139288946|NCT03702985|Irinotecan|irinotecan|mesh-list
139288947|NCT03702985|Amifostine|amifostine|mesh-list
139288948|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139288949|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
139288950|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288951|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288952|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139288953|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139288954|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288955|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139288956|NCT03702985|Protective Agents|protective agents|mesh-ancestor
139288957|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288958|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139288959|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139288960|NCT02184078|Nevirapine|nevirapine|mesh-list
139288961|NCT02184078|Rifabutin|rifabutin|mesh-list
139288962|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139288963|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139288964|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288965|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288966|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
139288967|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288968|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139288969|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139288970|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139288971|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139288972|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139288973|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139288974|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
139288975|NCT04323436|Spartalizumab|spartalizumab|mesh-list
139288976|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139288977|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288978|NCT04323436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139288979|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288980|NCT03694873|Celecoxib|celecoxib|mesh-list
139288981|NCT03694873|Tramadol|tramadol|mesh-list
139288982|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139288983|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139288984|NCT03694873|Analgesics|analgesics|mesh-ancestor
139288985|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
139288986|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139288987|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139288988|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139288989|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139642350|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139159167|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288990|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139288991|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139288992|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139288993|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139288994|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139288995|NCT03694873|Narcotics|narcotics|mesh-ancestor
139288996|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139288997|NCT02191020|Acitretin|acitretin|mesh-list
139288998|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
139288999|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
139289000|NCT04476199|Decitabine|decitabine|mesh-list
139289001|NCT04476199|Venetoclax|venetoclax|mesh-list
139289002|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138872474|NCT00889421|Apremilast|apremilast|mesh-list
139289003|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
139289004|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289005|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289006|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289007|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
139289008|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
139289009|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
139289010|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139289011|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139289012|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289013|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289014|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289015|NCT02184312|Nevirapine|nevirapine|mesh-list
139289016|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139289017|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139289018|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289019|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289020|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
139289021|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289022|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139289023|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139289024|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139289025|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139289026|NCT02191332|Nevirapine|nevirapine|mesh-list
139289027|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139289028|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139289029|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289030|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289031|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
139289032|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289033|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139289034|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139289035|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139289036|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139289037|NCT02256774|Ritonavir|ritonavir|mesh-list
139289038|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139289039|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139289040|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139289041|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
139289042|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289043|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289044|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139289045|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139289046|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
139289047|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289048|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139289049|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139289050|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139289051|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139289052|NCT02189304|Budesonide|budesonide|mesh-list
139289053|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
139289054|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
139289055|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139289056|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289057|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139289058|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
139289059|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642351|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289060|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289061|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139289062|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
139289063|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
139289064|NCT02189304|Hormones|hormones|mesh-ancestor
139289065|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289066|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139289067|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139289068|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139289069|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
139289070|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289071|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289072|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139289073|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138872551|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
139289074|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139289075|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
139289076|NCT02184858|Lisinopril|lisinopril|mesh-list
139289077|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139289078|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
139289079|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289080|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289081|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139289082|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139289083|NCT02184858|Protective Agents|protective agents|mesh-ancestor
139289084|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289085|NCT03535662|Itraconazole|itraconazole|mesh-list
139289086|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
139289087|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289088|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139289089|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139289090|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289091|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289092|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139289093|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
139289094|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289095|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289096|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139289097|NCT03702205|Betaine|betaine|mesh-list
139289098|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139289099|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
139289100|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139289101|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
139289102|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289103|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139289104|NCT02189694|Hormones|hormones|mesh-list
139289105|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289106|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289107|NCT02189772|Metadoxine|metadoxine|mesh-list
139289108|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139289109|NCT02192424|Insulin|insulin|mesh-list
139289110|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139289111|NCT02192424|Metformin|metformin|mesh-list
139289112|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
139289113|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
139289114|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139289115|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289116|NCT04276597|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
139289117|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139289118|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289119|NCT02257008|Ritonavir|ritonavir|mesh-list
139289120|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139289121|NCT02257008|Nelfinavir|nelfinavir|mesh-list
139289122|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139289123|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139289124|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
139289125|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289126|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289127|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139289128|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139289129|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
139289130|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289131|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139289132|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139289133|NCT03693391|Fluorides|fluorides|mesh-list
139289134|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
139289135|NCT03693391|Protective Agents|protective agents|mesh-ancestor
139289136|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289137|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
139289138|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289139|NCT02185326|Hormones|hormones|mesh-list
139289140|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289141|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289142|NCT04412707|Dexamethasone|dexamethasone|mesh-list
139289143|NCT04412707|Melphalan|melphalan|mesh-list
139289144|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289145|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
139289146|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
138872618|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289147|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289148|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289149|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139289150|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
139289151|NCT04412707|Hormones|hormones|mesh-ancestor
139289152|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289153|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139289154|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289155|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139289156|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
139289157|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289158|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139289159|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139289160|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
139289161|NCT03698695|Mefloquine|mefloquine|mesh-list
139289162|NCT03698695|Donepezil|donepezil|mesh-list
139289163|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139289164|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289165|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289166|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
139289167|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289168|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289169|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
139289170|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
139289171|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139289172|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139289173|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289174|NCT04729296|Golimumab|golimumab|mesh-list
139289175|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139289176|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289177|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139289178|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
139289179|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289180|NCT03698617|Propofol|propofol|mesh-list
139289181|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139289182|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139289183|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289184|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139289185|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
139289186|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
139289187|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
139289188|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139289189|NCT02194374|Rituximab|rituximab|mesh-list
139289190|NCT02194374|Fludarabine|fludarabine|mesh-list
139289191|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
139289192|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139289193|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
139289194|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289195|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139289196|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139289197|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
139289198|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289199|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289200|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139289201|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139289202|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139289203|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
139289204|NCT02194452|Octreotide|octreotide|mesh-list
139289205|NCT02194452|Edotreotide|edotreotide|mesh-list
139289206|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139289207|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139289208|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289209|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139289210|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289211|NCT01358721|Nivolumab|nivolumab|mesh-list
139289212|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139289213|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289214|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139289215|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289216|NCT02194686|Cilostazol|cilostazol|mesh-list
139289217|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139289218|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
139289219|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289220|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289221|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139289222|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
139289223|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139289224|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139289225|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289226|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139289227|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
139289228|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139289229|NCT02194686|Protective Agents|protective agents|mesh-ancestor
139289230|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139289231|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139289232|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289234|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139289235|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
139289236|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
139289237|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
139289238|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289239|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289240|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139289241|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139289242|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139289243|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139289244|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139289245|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139289246|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139289247|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139289248|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139289249|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
139289250|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
139289251|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
139289252|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
139289253|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289254|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289255|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139289256|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
139289257|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289258|NCT02194764|Naltrexone|naltrexone|mesh-list
139289259|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139289260|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139289261|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289262|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
139289263|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289264|NCT02967640|Ketamine|ketamine|mesh-list
139289265|NCT02967640|Analgesics|analgesics|mesh-ancestor
139289266|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
139289267|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289268|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289269|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139289270|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139289271|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
139289272|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
139289273|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139289274|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139289275|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139289276|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289277|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289278|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
139289279|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139289280|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289281|NCT00005584|Prednisone|prednisone|mesh-list
139289282|NCT00005584|Epirubicin|epirubicin|mesh-list
139289283|NCT00005584|Bleomycin|bleomycin|mesh-list
139289284|NCT00005584|Vinblastine|vinblastine|mesh-list
139289285|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289286|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
139289287|NCT00005584|Hormones|hormones|mesh-ancestor
139289288|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289289|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289290|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139289291|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289292|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139289293|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139289294|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139289295|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850502|NCT00887263|Budesonide|budesonide|mesh-list
139289296|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289298|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
139289299|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
139289300|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
139289301|NCT02194218|Nevirapine|nevirapine|mesh-list
139289302|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139289303|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139289304|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289305|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289306|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
139289307|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289308|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139289309|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139289310|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139289311|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139289312|NCT02194296|Ambroxol|ambroxol|mesh-list
139289313|NCT02194296|Expectorants|expectorants|mesh-ancestor
139289314|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
139289315|NCT02197026|Hylan|hylan|mesh-list
139289316|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
139289317|NCT02197026|Protective Agents|protective agents|mesh-ancestor
139289318|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289319|NCT02197104|Choline|choline|mesh-list
139289320|NCT02197104|Lipotropic Agents|lipotropic agents|mesh-ancestor
139289321|NCT02197104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139289322|NCT02197104|Antimetabolites|antimetabolites|mesh-ancestor
139289323|NCT02197104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289324|NCT02197104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139289325|NCT02197104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139289326|NCT02197104|Nootropic Agents|nootropic agents|mesh-ancestor
139289327|NCT02197182|Copper|copper|mesh-list
139289328|NCT02197182|Metronidazole|metronidazole|mesh-list
139289329|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289330|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139289331|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139289332|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139289333|NCT02197182|Trace Elements|trace elements|mesh-ancestor
139289334|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
139289335|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289336|NCT02197260|Amoxicillin|amoxicillin|mesh-list
139289337|NCT02197260|Metronidazole|metronidazole|mesh-list
139289338|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139289339|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289340|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139289341|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139289342|NCT03687931|Dexamethasone|dexamethasone|mesh-list
139289343|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289344|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
139289345|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
139289346|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289347|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289348|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139289349|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
139289350|NCT03687931|Hormones|hormones|mesh-ancestor
139289351|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289352|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139289353|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289354|NCT03534024|Curcumin|curcumin|mesh-list
139289355|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139289356|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139289357|NCT03534024|Analgesics|analgesics|mesh-ancestor
139289358|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
139289359|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289360|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159554|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
139289361|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289362|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139289363|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289364|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289365|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289366|NCT02753686|Tamoxifen|tamoxifen|mesh-list
139289367|NCT02753686|Everolimus|everolimus|mesh-list
139289368|NCT02753686|Letrozole|letrozole|mesh-list
139289369|NCT02753686|Fulvestrant|fulvestrant|mesh-list
139289370|NCT02753686|Anastrozole|anastrozole|mesh-list
139289371|NCT02753686|Exemestane|exemestane|mesh-list
139289372|NCT02753686|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139289373|NCT02753686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139289374|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289375|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289376|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139289377|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
139289378|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289379|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289380|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139289381|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139289382|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139289383|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
139289384|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289385|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139289386|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139289387|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139289388|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139289389|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139289391|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139289392|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
139289393|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289394|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289395|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139289396|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
139289397|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139289398|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
139289399|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289400|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289401|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139289402|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
139289403|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
139289404|NCT04216927|Protective Agents|protective agents|mesh-ancestor
139289405|NCT02329834|Furosemide|furosemide|mesh-list
139289406|NCT02329834|Diuretics|diuretics|mesh-ancestor
139289407|NCT02329834|Natriuretic Agents|natriuretic agents|mesh-ancestor
139289408|NCT02329834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289409|NCT02329834|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139289410|NCT02329834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139289411|NCT02329834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289412|NCT02195466|Ritonavir|ritonavir|mesh-list
139289413|NCT02195466|Tipranavir|tipranavir|mesh-list
139289414|NCT02195466|Fluconazole|fluconazole|mesh-list
139289415|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139289416|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139289417|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
139289418|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289419|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289420|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139289421|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139289422|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
139289423|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289424|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139289425|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139289426|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
139289427|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139289428|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139289429|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
139289430|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289431|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289432|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139642352|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
139159634|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
139289433|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139289434|NCT02195544|Hylan|hylan|mesh-list
139289435|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
139289436|NCT02195544|Protective Agents|protective agents|mesh-ancestor
139289437|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289438|NCT02197494|Valsartan|valsartan|mesh-list
139289439|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139289440|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139289441|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139289442|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289443|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139289444|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
138872915|NCT02645370|Topiramate|topiramate|mesh-list
139289445|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289446|NCT03692299|Metronidazole|metronidazole|mesh-list
139289447|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289448|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139289449|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139289450|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139289451|NCT02197650|Asparaginase|asparaginase|mesh-list
139289452|NCT02197650|Eryaspase|eryaspase|mesh-list
139289453|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289454|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
139289455|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139289456|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
139289457|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289458|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139289459|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139289460|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
139289461|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289462|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289463|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139289464|NCT03682939|Vaccines|vaccines|mesh-list
139289465|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
139289466|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289467|NCT02201992|Crizotinib|crizotinib|mesh-list
139289468|NCT02201992|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139289469|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289470|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139289471|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289472|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289473|NCT03534492|Durvalumab|durvalumab|mesh-list
139289474|NCT03534492|Olaparib|olaparib|mesh-list
139289475|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139289476|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289477|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139289478|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289479|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289480|NCT03624283|Betahistine|betahistine|mesh-list
139289481|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
139289482|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
139289483|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
139289484|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289485|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289486|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289487|NCT03687463|Decitabine|decitabine|mesh-list
139289488|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139289489|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
139289490|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289491|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289492|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289493|NCT03692143|Alendronate|alendronate|mesh-list
139289494|NCT03692143|Teriparatide|teriparatide|mesh-list
139289495|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139289496|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289497|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139289498|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
139289499|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139289500|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289501|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139642353|NCT04959786|Ribavirin|ribavirin|mesh-list
139642354|NCT04959786|Ivermectin|ivermectin|mesh-list
139289502|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289503|NCT02197884|Clarithromycin|clarithromycin|mesh-list
139289504|NCT02197884|Itraconazole|itraconazole|mesh-list
139289505|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139289506|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289507|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139289508|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289509|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289510|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139289511|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139289512|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
139289513|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139289514|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139289515|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
138872991|NCT00887159|Cisplatin|cisplatin|mesh-list
139289516|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289517|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289518|NCT02201082|Amikacin|amikacin|mesh-list
139289519|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139289520|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289521|NCT03687229|Insulin|insulin|mesh-list
139289522|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139289523|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289524|NCT05085054|Osimertinib|osimertinib|mesh-list
139289525|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289526|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139289527|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289528|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289529|NCT03969121|Palbociclib|palbociclib|mesh-list
139289530|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289531|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139289532|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289533|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289534|NCT02201238|Diclofenac|diclofenac|mesh-list
139289535|NCT02201238|Menthol|menthol|mesh-list
139289536|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139289537|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139289538|NCT02201238|Analgesics|analgesics|mesh-ancestor
139289539|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
139289540|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289541|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289542|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289543|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139289544|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139289545|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289546|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289547|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
139289548|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
139289549|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
139289550|NCT02257398|Gepotidacin|gepotidacin|mesh-list
139289551|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139289552|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139289553|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289554|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139289555|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139289556|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289557|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289558|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289559|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139289560|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
139289561|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139289562|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289563|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139289564|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139289565|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139289566|NCT02201316|Mosapride|mosapride|mesh-list
139289567|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289568|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139289569|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139289570|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
139289571|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289572|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289573|NCT02198820|Anesthetics|anesthetics|mesh-list
139289574|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139289575|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289576|NCT02257476|Dexamethasone|dexamethasone|mesh-list
139289577|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289578|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
139289579|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
139289580|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289581|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289582|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139289583|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
139289584|NCT02257476|Hormones|hormones|mesh-ancestor
139289585|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289586|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139289587|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289588|NCT03946111|Naltrexone|naltrexone|mesh-list
138873063|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289589|NCT03946111|Bupropion|bupropion|mesh-list
139289590|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139289591|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139289592|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289593|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
139289594|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289595|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139289596|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
139289597|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139289598|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139289599|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139289600|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139289601|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289602|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
139289603|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289604|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139289605|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139289606|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289607|NCT03943927|Metoprolol|metoprolol|mesh-list
139289608|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139289609|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139289610|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
139289611|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
139289612|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289613|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289614|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139289615|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139289616|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139289617|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
139289618|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289619|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289620|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
139289621|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139289622|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289623|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
139289624|NCT03687073|Silybin|silybin|mesh-list
139289625|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
139289626|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139289627|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289628|NCT03687073|Protective Agents|protective agents|mesh-ancestor
139289629|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289630|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139289631|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
139289632|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139289633|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139289634|NCT02198352|Olcegepant|olcegepant|mesh-list
139289635|NCT02198352|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139289636|NCT02198352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289637|NCT02198352|Analgesics|analgesics|mesh-ancestor
139289638|NCT02198352|Sensory System Agents|sensory system agents|mesh-ancestor
139289639|NCT02198352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289640|NCT02198352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289641|NCT02202564|Ganciclovir|ganciclovir|mesh-list
139289642|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139289643|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
139289644|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289645|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139289646|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159869|NCT05877807|GABA Agents|gaba agents|mesh-ancestor
139289647|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289648|NCT02198508|Deferasirox|deferasirox|mesh-list
139289649|NCT02198508|Deferiprone|deferiprone|mesh-list
139289650|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139289651|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
139289652|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
139289653|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289654|NCT02202720|Sevoflurane|sevoflurane|mesh-list
139289655|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139289656|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139289657|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
139289658|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
138873137|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139289659|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139289660|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289661|NCT02206308|Antibodies|antibodies|mesh-list
139289662|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139289663|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
139289664|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289665|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139289666|NCT03028129|Isoniazid|isoniazid|mesh-list
139289667|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289668|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
139289669|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139289670|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139289671|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
139289672|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289673|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139289674|NCT04059679|Aspirin|aspirin|mesh-list
139289675|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
139289676|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139289677|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139289678|NCT04059679|Analgesics|analgesics|mesh-ancestor
139289679|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
139289680|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289681|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289682|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289683|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139289684|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139289685|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139289686|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289687|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139289688|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139289689|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289690|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
139289691|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139289692|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
139289693|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139289694|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
139289695|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
139289696|NCT03533556|Caffeine|caffeine|mesh-list
139289697|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139289698|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289699|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139289700|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289701|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289702|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139289703|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139289704|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
139289705|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289706|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
139289707|NCT02206854|Tarenflurbil|tarenflurbil|mesh-list
139289708|NCT02206854|Analgesics|analgesics|mesh-ancestor
139289709|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
139289710|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289711|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289712|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139289713|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139289714|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289715|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139289716|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139289717|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289718|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642355|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
139289719|NCT02206854|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139289721|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139289722|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289723|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
139289724|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
139289725|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
139289726|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289727|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
139289728|NCT02206932|Simeprevir|simeprevir|mesh-list
139289729|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
139289730|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289731|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
139289732|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289733|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289734|NCT02207010|Adavosertib|adavosertib|mesh-list
139289735|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289736|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289737|NCT02203422|Cyclosporine|cyclosporine|mesh-list
139289738|NCT02203422|Cyclosporins|cyclosporins|mesh-list
139289739|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289740|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289741|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139289742|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
139289743|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289744|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
139289745|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289746|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
139289747|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139289748|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139289749|NCT03532854|Valsartan|valsartan|mesh-list
139289750|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139289751|NCT03532854|Ezetimibe|ezetimibe|mesh-list
139289752|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139289753|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139289754|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
139289755|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289756|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139289757|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139289758|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289759|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139289760|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139289761|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139289762|NCT02203500|Telmisartan|telmisartan|mesh-list
139289763|NCT02203500|Lacidipine|lacidipine|mesh-list
139289764|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139289765|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139289766|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139289767|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289768|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139289769|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139289770|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139289771|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289772|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
139289773|NCT02203656|Testosterone|testosterone|mesh-list
139289774|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
139289775|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
139289776|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139289777|NCT02203656|Androgens|androgens|mesh-ancestor
139289778|NCT02203656|Hormones|hormones|mesh-ancestor
139289779|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289780|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289781|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139289782|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289783|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
139289784|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
139289785|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
139289786|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
139289787|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139289788|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289789|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
139289790|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289791|NCT02199444|Sevelamer|sevelamer|mesh-list
139289792|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
139289793|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
139289794|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289795|NCT02199522|Propofol|propofol|mesh-list
139289796|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139382054|NCT01648348|Bevacizumab|bevacizumab|mesh-list
139289797|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139289798|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289799|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139289800|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
139289801|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
139289802|NCT03532698|Aspirin|aspirin|mesh-list
139289803|NCT03532698|Osimertinib|osimertinib|mesh-list
139289804|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139289805|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139289806|NCT03532698|Analgesics|analgesics|mesh-ancestor
139289807|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
139289808|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289809|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289810|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289811|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139289812|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139289813|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139289814|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289815|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139289816|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139289817|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289819|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289820|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139289821|NCT03690739|Paclitaxel|paclitaxel|mesh-list
139289822|NCT03690739|Bevacizumab|bevacizumab|mesh-list
139289823|NCT03690739|Carboplatin|carboplatin|mesh-list
139289824|NCT03690739|Gemcitabine|gemcitabine|mesh-list
139289825|NCT03690739|Trabectedin|trabectedin|mesh-list
139289826|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139289827|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289828|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
139289829|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
139289830|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
139289831|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289832|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139289833|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139289834|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139289835|NCT03690739|Growth Substances|growth substances|mesh-ancestor
139289836|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289837|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
139289838|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139289839|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
139289840|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139289841|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
139289842|NCT02199678|Ketamine|ketamine|mesh-list
139289843|NCT02199678|Analgesics|analgesics|mesh-ancestor
139289844|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
139289845|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289846|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289847|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139289848|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139289849|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
139289850|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
139289851|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139289852|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139289853|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139289854|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289855|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289856|NCT03681613|Pyrantel|pyrantel|mesh-list
139289857|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
139289858|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
139289859|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
139289860|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139289861|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289862|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139289863|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139289864|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139289865|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289866|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289867|NCT03690583|Zinc|zinc|mesh-list
139289868|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
139289869|NCT03690583|Trace Elements|trace elements|mesh-ancestor
139289870|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
138851095|NCT00895609|Neostigmine|neostigmine|mesh-list
139289871|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289872|NCT03690583|Astringents|astringents|mesh-ancestor
139289873|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
139289874|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139289875|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
139289876|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139289877|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139289878|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289879|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
139289880|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
139289881|NCT02200146|Prednisone|prednisone|mesh-list
139289882|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289883|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
139289884|NCT02200146|Hormones|hormones|mesh-ancestor
139289885|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289886|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289887|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139289888|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289890|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139289891|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139289892|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289893|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289894|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289895|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139289896|NCT02208492|Levetiracetam|levetiracetam|mesh-list
139289897|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
139289898|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
139289899|NCT01933048|Vaccines|vaccines|mesh-list
139289900|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
139289901|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289902|NCT02208882|Midazolam|midazolam|mesh-list
139289903|NCT02208882|BMS-986120|bms-986120|mesh-list
139289904|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139289905|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139289906|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139289907|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289908|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139289909|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139289910|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139289911|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139289912|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
139289913|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
139289914|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
139289915|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
139289916|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289917|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289918|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139289919|NCT03690115|Ponatinib|ponatinib|mesh-list
139289920|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289921|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139289922|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289923|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289924|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139289925|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139289926|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289927|NCT01886794|Estrogens|estrogens|mesh-list
139289928|NCT01886794|Hormones|hormones|mesh-ancestor
139289929|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139289930|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289931|NCT02209350|Aspirin|aspirin|mesh-list
139289932|NCT02209350|Clopidogrel|clopidogrel|mesh-list
139289933|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139289934|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139289935|NCT02209350|Analgesics|analgesics|mesh-ancestor
139289936|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
139289937|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139289938|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289939|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289940|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139289941|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139289942|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139289943|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289944|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139289945|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139289946|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289947|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
139289948|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139289949|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139289950|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139289951|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
139289952|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139289953|NCT02209428|Temozolomide|temozolomide|mesh-list
139289954|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139289955|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
139289956|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289957|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289958|NCT02200848|Rituximab|rituximab|mesh-list
139289959|NCT02200848|Lenalidomide|lenalidomide|mesh-list
139289960|NCT02200848|Glutarimide|glutarimide|mesh-list
139289961|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139289962|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289963|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
139289964|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289965|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139289966|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139289967|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139289968|NCT02200848|Growth Substances|growth substances|mesh-ancestor
139289969|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
139289970|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139289971|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289972|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289973|NCT02751450|Fluorides|fluorides|mesh-list
139289974|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
139289975|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
139289976|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
139289977|NCT02751450|Protective Agents|protective agents|mesh-ancestor
139289978|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139289979|NCT02209740|Tenofovir|tenofovir|mesh-list
139289980|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
139289981|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289982|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139289983|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139289984|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289985|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289986|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139289987|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139289988|NCT02257788|Leronlimab|leronlimab|mesh-list
139289989|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139289990|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139289991|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139289992|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139289993|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139289994|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
139289995|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139289996|NCT02220660|Olodaterol|olodaterol|mesh-list
139289997|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139289998|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
139289999|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290000|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290001|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139290002|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
139290003|NCT04973722|Denosumab|denosumab|mesh-list
139290004|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139382058|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
139290005|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290006|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
139290007|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139290008|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139290009|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139290010|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
139290011|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290012|NCT02209974|Fluticasone|fluticasone|mesh-list
139290013|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139290014|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139290015|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
139290016|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290017|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290018|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139290019|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
139290020|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
139290021|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139290022|NCT02212392|Meropenem|meropenem|mesh-list
139290023|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139290024|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139290025|NCT03679897|Ropivacaine|ropivacaine|mesh-list
139290026|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
139290027|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139290028|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
139290029|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
139290030|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290031|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290032|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
139290033|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290034|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
139290035|NCT03060070|Ketamine|ketamine|mesh-list
139290036|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139290037|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290038|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290039|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139290040|NCT03060070|Analgesics|analgesics|mesh-ancestor
139290041|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
139290042|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290043|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139290044|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139290045|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139290046|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
139290047|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290048|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290049|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139290050|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139290051|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
139290052|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
139290053|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139290054|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139290055|NCT03683563|Citric Acid|citric acid|mesh-list
139290056|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
139290057|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
139290058|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139290059|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
139290060|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
139290061|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290062|NCT03563625|Bupivacaine|bupivacaine|mesh-list
139290063|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
139290064|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
139290065|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290066|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290067|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
139290068|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290069|NCT02832375|Fluorides|fluorides|mesh-list
139290070|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
139290071|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
139290072|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
139290073|NCT02832375|Protective Agents|protective agents|mesh-ancestor
139290074|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290075|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139290076|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139290077|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
139290078|NCT02218476|Vitamins|vitamins|mesh-ancestor
139290079|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
139290080|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290081|NCT02205996|Insulin|insulin|mesh-list
139290082|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139290083|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139290084|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290085|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
139290086|NCT02220036|Antacids|antacids|mesh-ancestor
139290087|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290088|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139290089|NCT02220114|Vigabatrin|vigabatrin|mesh-list
139290090|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
139290091|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290092|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290093|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
139290094|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290095|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290096|NCT02221596|Vitamin D|vitamin d|mesh-list
139290097|NCT02221596|Vitamins|vitamins|mesh-ancestor
139290098|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
139290099|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290100|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139290101|NCT02221752|Folic Acid|folic acid|mesh-list
139290102|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
139290103|NCT02221752|Hematinics|hematinics|mesh-ancestor
139290104|NCT02221752|Vitamins|vitamins|mesh-ancestor
139290105|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
139290106|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290107|NCT04971382|Curcumin|curcumin|mesh-list
139290108|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138873586|NCT04185194|Lidocaine|lidocaine|mesh-list
139290109|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139290110|NCT04971382|Analgesics|analgesics|mesh-ancestor
139290111|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
139290112|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290113|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290114|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139290115|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139290116|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290117|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290118|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290120|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139290121|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
139290122|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290123|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139290124|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
139290125|NCT04151680|Apixaban|apixaban|mesh-list
139290126|NCT04151680|Edoxaban|edoxaban|mesh-list
139290127|NCT04151680|Dabigatran|dabigatran|mesh-list
139290128|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139290129|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
139290130|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139290131|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
139290132|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290133|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290134|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
139290135|NCT02221830|Oxytocin|oxytocin|mesh-list
139290136|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
139290137|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139290138|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290139|NCT02224950|Emollients|emollients|mesh-list
139290140|NCT02224950|Chitosan|chitosan|mesh-list
139290141|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139290142|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139290143|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
139290144|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290145|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139290146|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
139290147|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
139290148|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
139290149|NCT02224950|Coagulants|coagulants|mesh-ancestor
139290150|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
139290151|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139290152|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
139290153|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139290154|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
139290155|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290156|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290157|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139290158|NCT04970602|Methylene Blue|methylene blue|mesh-list
139290159|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290160|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290161|NCT02831673|Tenofovir|tenofovir|mesh-list
139290162|NCT02831673|Lamivudine|lamivudine|mesh-list
139290163|NCT02831673|Emtricitabine|emtricitabine|mesh-list
139290164|NCT02831673|Dolutegravir|dolutegravir|mesh-list
139290165|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
139290166|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139290167|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139290168|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139290169|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290170|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290171|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139290172|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139290173|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139290174|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139290175|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
139290176|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139290177|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290178|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290179|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139290180|NCT04962958|Leucovorin|leucovorin|mesh-list
139290181|NCT04962958|Fluorouracil|fluorouracil|mesh-list
139290182|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
139290183|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
139290184|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290185|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139290186|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290187|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139290188|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
139290189|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290190|NCT04962958|Antidotes|antidotes|mesh-ancestor
139290191|NCT04962958|Protective Agents|protective agents|mesh-ancestor
139290192|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
139290193|NCT04962958|Vitamins|vitamins|mesh-ancestor
139290194|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
139290195|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
139290196|NCT02031510|Bupivacaine|bupivacaine|mesh-list
139290197|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
139290198|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
139290199|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290200|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290201|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
139290202|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290203|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139290204|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139290205|NCT02031510|Analgesics|analgesics|mesh-ancestor
139290206|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139290207|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139290208|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139290209|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
139290210|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290211|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290212|NCT04961788|Antibodies|antibodies|mesh-list
139290213|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
139290214|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290215|NCT02222142|Anesthetics|anesthetics|mesh-list
139290216|NCT02222142|Isoflurane|isoflurane|mesh-list
139290217|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290218|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290219|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139290220|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
139290221|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
139290222|NCT04425382|Ritonavir|ritonavir|mesh-list
139290223|NCT04425382|Lopinavir|lopinavir|mesh-list
139290224|NCT04425382|Darunavir|darunavir|mesh-list
139290225|NCT04425382|Cobicistat|cobicistat|mesh-list
139290226|NCT04425382|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139290227|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139290228|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139290229|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
139290230|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290231|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290232|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139290233|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139290234|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
139290235|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139290236|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139290237|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139290238|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
139290239|NCT03563937|Apixaban|apixaban|mesh-list
139290240|NCT03563937|Edoxaban|edoxaban|mesh-list
139290241|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
139290242|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139290243|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
139290244|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139290245|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
139290246|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290247|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290248|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
139290249|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139290250|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139290251|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
139290252|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290253|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290254|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139297261|NCT04066348|Etanercept|etanercept|mesh-list
139290255|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
139290256|NCT02225418|Ropivacaine|ropivacaine|mesh-list
139290257|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
139290258|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
139290259|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290260|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290261|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
139290262|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290263|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139290264|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139290265|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
139290266|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873732|NCT02821559|Bevacizumab|bevacizumab|mesh-list
139290268|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139290269|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
139290270|NCT05057130|Cisplatin|cisplatin|mesh-list
139290271|NCT05057130|Doxorubicin|doxorubicin|mesh-list
139290272|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139290273|NCT05057130|Methotrexate|methotrexate|mesh-list
139290274|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290275|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139290276|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139290277|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139290278|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290279|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290280|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139290281|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
139290282|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139290283|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290284|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139290285|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
139290286|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
139290287|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139290288|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139290289|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
139290290|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139290291|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139290292|NCT02222220|Metoclopramide|metoclopramide|mesh-list
139290293|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
139290294|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
139290295|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290296|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290297|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139290298|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139290299|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139290300|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
139290301|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290302|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290303|NCT03677323|Sufentanil|sufentanil|mesh-list
139290304|NCT03677323|Droperidol|droperidol|mesh-list
139290305|NCT03677323|Propofol|propofol|mesh-list
139290306|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139290307|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290308|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290309|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139290310|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
139290311|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
139290312|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139290313|NCT03677323|Narcotics|narcotics|mesh-ancestor
139290314|NCT03677323|Analgesics|analgesics|mesh-ancestor
139290315|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
139290316|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290317|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139290318|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
139290319|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
139290320|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139290321|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139290322|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139290323|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139290324|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139290325|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139290326|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
139290327|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290328|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290329|NCT02225652|Paclitaxel|paclitaxel|mesh-list
139290330|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
139290331|NCT02225652|Fluorouracil|fluorouracil|mesh-list
139290333|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139290334|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290335|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
139290336|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
139290337|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
139290338|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290339|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139290340|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
139290341|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290342|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139290343|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139290344|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
139290345|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139290346|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
139290347|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139290348|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139290349|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139290350|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139290351|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290352|NCT02222376|Pirfenidone|pirfenidone|mesh-list
139290353|NCT02222376|Analgesics|analgesics|mesh-ancestor
139290354|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
139290355|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290356|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290357|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139290358|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139290359|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139290360|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139290361|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290362|NCT02231658|Liraglutide|liraglutide|mesh-list
139290363|NCT02231658|Lixisenatide|lixisenatide|mesh-list
139290364|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139290365|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290366|NCT02231658|Incretins|incretins|mesh-ancestor
139290367|NCT02231658|Hormones|hormones|mesh-ancestor
139290368|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139290369|NCT04542408|Heparin|heparin|mesh-list
139290370|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139290371|NCT04542408|Tinzaparin|tinzaparin|mesh-list
139290372|NCT04542408|Dalteparin|dalteparin|mesh-list
139290373|NCT04542408|Edoxaban|edoxaban|mesh-list
139290374|NCT04542408|Anticoagulants|anticoagulants|mesh-list
139290375|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139290376|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139290377|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290378|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139290379|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
139290380|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139290381|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
139290382|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290383|NCT03059134|Mirabegron|mirabegron|mesh-list
139290384|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139290385|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139290386|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139290387|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
139290388|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290389|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290390|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290391|NCT03059134|Urological Agents|urological agents|mesh-ancestor
139290392|NCT02928991|Vidarabine|vidarabine|mesh-list
139290393|NCT02928991|Fludarabine|fludarabine|mesh-list
139290394|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
139290395|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290396|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139290397|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
139290398|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290399|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139290400|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
139290401|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290402|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
139290403|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139290404|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139290405|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139290406|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290407|NCT04957420|Rotigotine|rotigotine|mesh-list
139160619|NCT04699461|Idelalisib|idelalisib|mesh-list
139290408|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
139290409|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
139290410|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290411|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290412|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290413|NCT03350035|Ganaxolone|ganaxolone|mesh-list
139290414|NCT03350035|Neurosteroids|neurosteroids|mesh-ancestor
139290415|NCT03350035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290416|NCT03350035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290417|NCT03350035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290418|NCT03350035|GABA Modulators|gaba modulators|mesh-ancestor
139290419|NCT03350035|GABA Agents|gaba agents|mesh-ancestor
139290420|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
139290421|NCT02905188|Fludarabine|fludarabine|mesh-list
138851638|NCT02758782|Celecoxib|celecoxib|mesh-list
139290422|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139290423|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
139290424|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290425|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139290426|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139290427|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
139290428|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290429|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290430|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139290431|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
139290432|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
139290433|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139290434|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
139290435|NCT03671941|Ticagrelor|ticagrelor|mesh-list
139290436|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139290437|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139290438|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139290439|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139290440|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
139290441|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290442|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290443|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290444|NCT03058900|Methotrexate|methotrexate|mesh-list
139290445|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139290446|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
139290447|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139290448|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290449|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139290450|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
139290451|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290452|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290453|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
139290454|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290455|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139290456|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139290457|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
139290458|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139290459|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139290460|NCT02226510|Metformin|metformin|mesh-list
139290461|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139290462|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290463|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
139290464|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
139290465|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290466|NCT02225886|Protective Agents|protective agents|mesh-ancestor
139290467|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290468|NCT02225886|Vitamins|vitamins|mesh-ancestor
139290469|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
139290470|NCT03671707|Nicotine|nicotine|mesh-list
139290471|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139290472|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
139290473|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290474|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290475|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139290476|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139290477|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
139290478|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290479|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290480|NCT02226588|Misoprostol|misoprostol|mesh-list
139423885|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
139290481|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139290482|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
139290483|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139290484|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290485|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139290486|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139290487|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
139290488|NCT03676621|Misoprostol|misoprostol|mesh-list
139290489|NCT03676621|Oxytocin|oxytocin|mesh-list
139290490|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
139290491|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139290492|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290493|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139290494|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
139290495|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139290496|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139290497|NCT03678649|Capecitabine|capecitabine|mesh-list
139290498|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139290499|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
139290500|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290501|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290502|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
139290503|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139290504|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290505|NCT02845297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139290506|NCT02845297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290507|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139290508|NCT02232360|Fenofibrate|fenofibrate|mesh-list
139290509|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139290510|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139290511|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
139290512|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290513|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139290514|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139290515|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290517|NCT02226978|Tipranavir|tipranavir|mesh-list
139290518|NCT02226978|Valacyclovir|valacyclovir|mesh-list
139290519|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139290520|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139290521|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
139290522|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290523|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290524|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139290525|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139290526|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
139290527|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139290528|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139290529|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139290530|NCT02227056|Methylphenidate|methylphenidate|mesh-list
139290531|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139290532|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290533|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139290534|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139290535|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139290536|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290537|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
139290538|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290539|NCT05708157|Histamine Antagonists|histamine antagonists|mesh-list
139290540|NCT05708157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139290541|NCT05708157|Histamine Agents|histamine agents|mesh-ancestor
139290542|NCT05708157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290543|NCT05708157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290544|NCT05708157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290545|NCT03058744|Clobetasol|clobetasol|mesh-list
139290546|NCT03058744|Halobetasol|halobetasol|mesh-list
139290547|NCT03058744|Tazarotene|tazarotene|mesh-list
139290548|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
139290549|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
139290550|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139290551|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139290552|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
139290553|NCT03058744|Hormones|hormones|mesh-ancestor
139290554|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139290555|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290556|NCT02734537|Cisplatin|cisplatin|mesh-list
139290557|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290558|NCT03059056|Empagliflozin|empagliflozin|mesh-list
139290559|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139290560|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290561|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139290562|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290563|NCT03058666|Calfactant|calfactant|mesh-list
139290564|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139290565|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
139290566|NCT02227212|Insulin|insulin|mesh-list
139290567|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
139290568|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139290569|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290570|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
139290571|NCT00303849|Carboplatin|carboplatin|mesh-list
139290572|NCT00303849|Etoposide|etoposide|mesh-list
139290573|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
139290574|NCT00303849|Melphalan|melphalan|mesh-list
139290575|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
139290576|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
139290577|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139290578|NCT00303849|Mannitol|mannitol|mesh-list
139290579|NCT00303849|Antidotes|antidotes|mesh-list
139290580|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290581|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139290582|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139290583|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139290584|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290585|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290586|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139290587|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
139290588|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139290589|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139290590|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
139290591|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290592|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139290593|NCT00303849|Diuretics|diuretics|mesh-ancestor
139290594|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
139290595|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
139290596|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
139290597|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
139290598|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
139290599|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
139290600|NCT00303849|Protective Agents|protective agents|mesh-ancestor
139290601|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
139290602|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
139290603|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139290604|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139290605|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
139290606|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
139290607|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
139290608|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139290609|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
139290610|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290611|NCT01355523|Melatonin|melatonin|mesh-list
139290612|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
139290613|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290614|NCT01355523|Protective Agents|protective agents|mesh-ancestor
139290615|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290616|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290617|NCT02227914|Sorafenib|sorafenib|mesh-list
139290618|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290619|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139290620|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290621|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290622|NCT04161456|Apremilast|apremilast|mesh-list
139290623|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139290624|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139290625|NCT04161456|Analgesics|analgesics|mesh-ancestor
139290626|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
139290627|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290628|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290629|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139290630|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139290631|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139290632|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139290633|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290634|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290635|NCT02224014|Brotizolam|brotizolam|mesh-list
139290636|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139290637|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290638|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290639|NCT03671161|Insulin|insulin|mesh-list
139290640|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139290641|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874106|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
139290642|NCT04950400|Apatinib|apatinib|mesh-list
139290643|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290644|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139290645|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290646|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290647|NCT04949932|Turmeric extract|turmeric extract|mesh-list
139290648|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
139290649|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290650|NCT04949932|Protective Agents|protective agents|mesh-ancestor
139290651|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290652|NCT02826603|Ustekinumab|ustekinumab|mesh-list
139290653|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
139290654|NCT02224170|Dexamethasone|dexamethasone|mesh-list
139290655|NCT02224170|Lidocaine|lidocaine|mesh-list
139290656|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139290657|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
139290658|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
139290659|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290660|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290661|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139290662|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
139290663|NCT02224170|Hormones|hormones|mesh-ancestor
139290664|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139290665|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139290666|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290667|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
139290668|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
139290669|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290670|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
139290671|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139290672|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139290673|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139290674|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139290675|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290676|NCT05956639|Androgen Antagonists|androgen antagonists|mesh-list
139290677|NCT05956639|Hormone Antagonists|hormone antagonists|mesh-ancestor
139290678|NCT05956639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139290679|NCT05956639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290680|NCT05956600|Amisulpride|amisulpride|mesh-list
139290681|NCT05956600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139290682|NCT05956600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139290683|NCT05956600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290684|NCT05956600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290685|NCT05956600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139290686|NCT05956600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139290687|NCT05956600|Dopamine Agents|dopamine agents|mesh-ancestor
139290688|NCT05956600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290689|NCT05956600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290690|NCT05956600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139290691|NCT05956600|Antidepressive Agents|antidepressive agents|mesh-ancestor
139290692|NCT05956561|Vitamin D|vitamin d|mesh-list
139290693|NCT05956561|Vitamins|vitamins|mesh-ancestor
139290694|NCT05956561|Micronutrients|micronutrients|mesh-ancestor
139290695|NCT05956561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290696|NCT05956561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139290697|NCT05956522|Empagliflozin|empagliflozin|mesh-list
139290698|NCT05956522|Linagliptin|linagliptin|mesh-list
139290699|NCT05956522|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139290700|NCT05956522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290701|NCT05956522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139290702|NCT05956522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290703|NCT05956522|Incretins|incretins|mesh-ancestor
139290704|NCT05956522|Hormones|hormones|mesh-ancestor
139290705|NCT05956522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139290706|NCT05956522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139290707|NCT05956522|Protease Inhibitors|protease inhibitors|mesh-ancestor
139290708|NCT05956522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290709|NCT05956431|Simendan|simendan|mesh-list
139290710|NCT05956431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139290711|NCT05956431|Vasodilator Agents|vasodilator agents|mesh-ancestor
139290712|NCT05956431|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139290713|NCT05956431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139290714|NCT05956431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290715|NCT05956431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290716|NCT05956431|Protective Agents|protective agents|mesh-ancestor
138874255|NCT02684708|Hormones|hormones|mesh-ancestor
139290717|NCT05956431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290718|NCT05956418|Citric Acid|citric acid|mesh-list
139290719|NCT05956418|Sodium Citrate|sodium citrate|mesh-list
139290720|NCT05956418|Anticoagulants|anticoagulants|mesh-ancestor
139290721|NCT05956418|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139290722|NCT05956418|Chelating Agents|chelating agents|mesh-ancestor
139290723|NCT05956418|Sequestering Agents|sequestering agents|mesh-ancestor
139290724|NCT05956418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290725|NCT05956275|Tramadol|tramadol|mesh-list
139290726|NCT05956275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139290727|NCT05956275|Narcotics|narcotics|mesh-ancestor
139290728|NCT05956275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290729|NCT05956275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290730|NCT05956275|Analgesics|analgesics|mesh-ancestor
139290731|NCT05956275|Sensory System Agents|sensory system agents|mesh-ancestor
139290732|NCT05956275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290733|NCT05956145|Colchicine|colchicine|mesh-list
139290734|NCT05956145|Gout Suppressants|gout suppressants|mesh-ancestor
139290735|NCT05956145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139290736|NCT05956145|Tubulin Modulators|tubulin modulators|mesh-ancestor
139290737|NCT05956145|Antimitotic Agents|antimitotic agents|mesh-ancestor
139290738|NCT05956145|Mitosis Modulators|mitosis modulators|mesh-ancestor
139290739|NCT05956145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290740|NCT05956145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290741|NCT05955833|Trastuzumab|trastuzumab|mesh-list
139290742|NCT05955833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139290743|NCT05955833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290744|NCT05955677|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139290745|NCT05955677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139290746|NCT05955677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290747|NCT05955313|Naltrexone|naltrexone|mesh-list
139290748|NCT05955313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139290749|NCT05955313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139290750|NCT05955313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290751|NCT05955313|Sensory System Agents|sensory system agents|mesh-ancestor
139290752|NCT05955313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290753|NCT05955209|Disitamab vedotin|disitamab vedotin|mesh-list
139290754|NCT05955209|Immunoconjugates|immunoconjugates|mesh-ancestor
139290755|NCT05955209|Immunologic Factors|immunologic factors|mesh-ancestor
139290756|NCT05955209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290757|NCT05952349|Metformin|metformin|mesh-list
139290758|NCT05952349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139290759|NCT05952349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290760|NCT05952310|Immunomodulating Agents|immunomodulating agents|mesh-list
139290761|NCT05952310|Immunologic Factors|immunologic factors|mesh-ancestor
139290762|NCT05952310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290763|NCT05951504|Methylprednisolone|methylprednisolone|mesh-list
139290764|NCT05951504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139290765|NCT05951504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139290766|NCT05951504|Prednisolone|prednisolone|mesh-list
139290767|NCT05951504|Prednisolone acetate|prednisolone acetate|mesh-list
139290768|NCT05951504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139290769|NCT05951504|Prednisolone phosphate|prednisolone phosphate|mesh-list
139290770|NCT05951504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139290771|NCT05951504|Antiemetics|antiemetics|mesh-ancestor
139290772|NCT05951504|Autonomic Agents|autonomic agents|mesh-ancestor
139290773|NCT05951504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290774|NCT05951504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290775|NCT05951504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139290776|NCT05951504|Glucocorticoids|glucocorticoids|mesh-ancestor
139290777|NCT05951504|Hormones|hormones|mesh-ancestor
139290778|NCT05951504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139290779|NCT05951504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139160989|NCT03748134|Paclitaxel|paclitaxel|mesh-list
139290780|NCT05951504|Protective Agents|protective agents|mesh-ancestor
139290781|NCT05951504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139290782|NCT05951504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290783|NCT05946200|Anesthetics|anesthetics|mesh-list
139290784|NCT05946200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290785|NCT05946200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290786|NCT05925166|Triamcinolone|triamcinolone|mesh-list
139290787|NCT05925166|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139290788|NCT05925166|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139290789|NCT05925166|Etanercept|etanercept|mesh-list
139290790|NCT05925166|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139382118|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139290791|NCT05925166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139290792|NCT05925166|Glucocorticoids|glucocorticoids|mesh-ancestor
139290793|NCT05925166|Hormones|hormones|mesh-ancestor
139290794|NCT05925166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139290795|NCT05925166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290796|NCT05925166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139290797|NCT05925166|Immunologic Factors|immunologic factors|mesh-ancestor
139290798|NCT05925166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290799|NCT05925166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290800|NCT05925166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139290801|NCT05925166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139290802|NCT05925166|Analgesics|analgesics|mesh-ancestor
139290803|NCT05925166|Sensory System Agents|sensory system agents|mesh-ancestor
139290804|NCT05925166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290805|NCT05925166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139290806|NCT05925166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139290807|NCT05914155|Rituximab|rituximab|mesh-list
139290808|NCT05914155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139290809|NCT05914155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290810|NCT05914155|Immunologic Factors|immunologic factors|mesh-ancestor
139290811|NCT05914155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290812|NCT05914155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139290813|NCT05896293|Hormones|hormones|mesh-list
139290814|NCT05896293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139290815|NCT05896293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290816|NCT05881928|Lamotrigine|lamotrigine|mesh-list
139290817|NCT05881928|Valproic Acid|valproic acid|mesh-list
139290818|NCT05881928|Anticonvulsants|anticonvulsants|mesh-ancestor
139290819|NCT05881928|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139290820|NCT05881928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139290821|NCT05881928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290822|NCT05881928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139290823|NCT05881928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290824|NCT05881928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139290825|NCT05881928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139290826|NCT05881928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290827|NCT05881928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139290828|NCT05881928|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139290829|NCT05881928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290830|NCT05881928|GABA Agents|gaba agents|mesh-ancestor
139290831|NCT05881928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290832|NCT05881928|Antimanic Agents|antimanic agents|mesh-ancestor
139290833|NCT05872893|Dexamethasone|dexamethasone|mesh-list
139290834|NCT05872893|Ondansetron|ondansetron|mesh-list
139290835|NCT05872893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139290836|NCT05872893|Antiemetics|antiemetics|mesh-ancestor
139290837|NCT05872893|Autonomic Agents|autonomic agents|mesh-ancestor
139290838|NCT05872893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290839|NCT05872893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290840|NCT05872893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139290841|NCT05872893|Glucocorticoids|glucocorticoids|mesh-ancestor
139290842|NCT05872893|Hormones|hormones|mesh-ancestor
139290843|NCT05872893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139290844|NCT05872893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139290845|NCT05872893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290846|NCT05872893|Antipruritics|antipruritics|mesh-ancestor
139290847|NCT05872893|Dermatologic Agents|dermatologic agents|mesh-ancestor
139290848|NCT05872893|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139290849|NCT05872893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139290850|NCT05872893|Serotonin Agents|serotonin agents|mesh-ancestor
139290851|NCT05872893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290852|NCT05872893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423886|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
139290856|NCT05826275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139290857|NCT05826275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290859|NCT05774249|Anesthetics, Local|anesthetics, local|mesh-ancestor
139290860|NCT05774249|Anesthetics|anesthetics|mesh-ancestor
139290861|NCT05774249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290862|NCT05774249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290863|NCT05774249|Sensory System Agents|sensory system agents|mesh-ancestor
139290864|NCT05774249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290865|NCT05767398|Zanubrutinib|zanubrutinib|mesh-list
139290866|NCT05767398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290867|NCT05767398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139290868|NCT05767398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290869|NCT05767398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290870|NCT05742438|Lidocaine|lidocaine|mesh-list
139290871|NCT05742438|Dexmedetomidine|dexmedetomidine|mesh-list
139290872|NCT05742438|Morphine|morphine|mesh-list
139290873|NCT05742438|Anesthetics, Local|anesthetics, local|mesh-ancestor
139290874|NCT05742438|Anesthetics|anesthetics|mesh-ancestor
139290875|NCT05742438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290876|NCT05742438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290877|NCT05742438|Sensory System Agents|sensory system agents|mesh-ancestor
139290878|NCT05742438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290879|NCT05742438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139290880|NCT05742438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139290881|NCT05742438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139290882|NCT05742438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139290883|NCT05742438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290884|NCT05742438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139290885|NCT05742438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139290886|NCT05742438|Analgesics|analgesics|mesh-ancestor
139290887|NCT05742438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139290888|NCT05742438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139290889|NCT05742438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139290890|NCT05742438|Adrenergic Agents|adrenergic agents|mesh-ancestor
139290891|NCT05742438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290892|NCT05742438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139290893|NCT05742438|Narcotics|narcotics|mesh-ancestor
139290894|NCT05730751|Anesthetics|anesthetics|mesh-list
139290895|NCT05730751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290896|NCT05730751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290901|NCT05634174|Mirabegron|mirabegron|mesh-list
139290902|NCT05634174|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139290903|NCT05634174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139290904|NCT05634174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139290905|NCT05634174|Adrenergic Agents|adrenergic agents|mesh-ancestor
139290906|NCT05634174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290907|NCT05634174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290908|NCT05634174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290909|NCT05634174|Urological Agents|urological agents|mesh-ancestor
139290910|NCT05619705|Benzocaine|benzocaine|mesh-list
139290911|NCT05619705|Anesthetics, Local|anesthetics, local|mesh-ancestor
139290912|NCT05619705|Anesthetics|anesthetics|mesh-ancestor
139290913|NCT05619705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290914|NCT05619705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290915|NCT05619705|Sensory System Agents|sensory system agents|mesh-ancestor
139290916|NCT05619705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290917|NCT05604859|Methylprednisolone|methylprednisolone|mesh-list
139290918|NCT05604859|Heparin|heparin|mesh-list
139290919|NCT05604859|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139290920|NCT05604859|Tinzaparin|tinzaparin|mesh-list
139290921|NCT05604859|Dalteparin|dalteparin|mesh-list
139290922|NCT05604859|Immunoglobulins|immunoglobulins|mesh-list
139290923|NCT05604859|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139290924|NCT05604859|gamma-Globulins|gamma-globulins|mesh-list
139290925|NCT05604859|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139290926|NCT05604859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139290927|NCT05604859|Antiemetics|antiemetics|mesh-ancestor
139290928|NCT05604859|Autonomic Agents|autonomic agents|mesh-ancestor
139290929|NCT05604859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290930|NCT05604859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290931|NCT05604859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139290932|NCT05604859|Glucocorticoids|glucocorticoids|mesh-ancestor
139290933|NCT05604859|Hormones|hormones|mesh-ancestor
139290934|NCT05604859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139290935|NCT05604859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139290936|NCT05604859|Protective Agents|protective agents|mesh-ancestor
139290937|NCT05604859|Anticoagulants|anticoagulants|mesh-ancestor
139290938|NCT05604859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139290939|NCT05604859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139290940|NCT05604859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290941|NCT05604859|Immunologic Factors|immunologic factors|mesh-ancestor
139290942|NCT05590234|Dexmedetomidine|dexmedetomidine|mesh-list
139290944|NCT05590234|Anesthetics, Local|anesthetics, local|mesh-ancestor
139290945|NCT05590234|Anesthetics|anesthetics|mesh-ancestor
139290946|NCT05590234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139290947|NCT05590234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290948|NCT05590234|Sensory System Agents|sensory system agents|mesh-ancestor
139290949|NCT05590234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139290950|NCT05590234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139290951|NCT05590234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139290952|NCT05590234|Analgesics|analgesics|mesh-ancestor
139290953|NCT05590234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139290954|NCT05590234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139290955|NCT05590234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139290956|NCT05590234|Adrenergic Agents|adrenergic agents|mesh-ancestor
139290957|NCT05590234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139290958|NCT05590234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290959|NCT05572749|Metformin|metformin|mesh-list
139290960|NCT05572749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139290961|NCT05572749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290962|NCT05540223|Sirolimus|sirolimus|mesh-list
139290963|NCT05540223|Everolimus|everolimus|mesh-list
139290964|NCT05540223|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139290965|NCT05540223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139290966|NCT05540223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139290967|NCT05540223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290968|NCT05540223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139290969|NCT05540223|Immunologic Factors|immunologic factors|mesh-ancestor
139290970|NCT05540223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290971|NCT05540223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290972|NCT05540223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139290973|NCT05540223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139290974|NCT05540223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139290975|NCT05540223|Antifungal Agents|antifungal agents|mesh-ancestor
139290976|NCT05476172|Dienogest|dienogest|mesh-list
139290977|NCT05476172|Norethindrone|norethindrone|mesh-list
139290978|NCT05476172|Norethindrone Acetate|norethindrone acetate|mesh-list
139290979|NCT05476172|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139290980|NCT05476172|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139290981|NCT05476172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139290982|NCT05476172|Contraceptive Agents|contraceptive agents|mesh-ancestor
139290983|NCT05476172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139290984|NCT05476172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139290985|NCT05476172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139290986|NCT05476172|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139290987|NCT05476172|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139290988|NCT05476172|Hormone Antagonists|hormone antagonists|mesh-ancestor
139290989|NCT05476172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139290990|NCT05476172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139290991|NCT05476172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139290992|NCT05432518|Everolimus|everolimus|mesh-list
139290993|NCT05432518|Dasatinib|dasatinib|mesh-list
139290994|NCT05432518|Olaparib|olaparib|mesh-list
139290995|NCT05432518|Palbociclib|palbociclib|mesh-list
139290996|NCT05432518|Afatinib|afatinib|mesh-list
139290997|NCT05432518|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139290998|NCT05432518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139290999|NCT05432518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291000|NCT05432518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291001|NCT05432518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139291002|NCT05432518|Immunologic Factors|immunologic factors|mesh-ancestor
139291003|NCT05432518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291004|NCT05432518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291005|NCT05432518|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139291007|NCT05413096|Diclofenac|diclofenac|mesh-list
139291008|NCT05413096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139291009|NCT05413096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139291010|NCT05413096|Analgesics|analgesics|mesh-ancestor
139291011|NCT05413096|Sensory System Agents|sensory system agents|mesh-ancestor
139291012|NCT05413096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291013|NCT05413096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291014|NCT05413096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139291015|NCT05413096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291016|NCT05413096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139291017|NCT05413096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291018|NCT05413096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291019|NCT05413096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139291020|NCT05391061|Abrocitinib|abrocitinib|mesh-list
139291021|NCT05391061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139291022|NCT05391061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291023|NCT05391061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291024|NCT05375994|Adagrasib|adagrasib|mesh-list
139291025|NCT05375994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291026|NCT05338320|Fentanyl|fentanyl|mesh-list
139291027|NCT05338320|Morphine|morphine|mesh-list
139291028|NCT05338320|Anesthetics|anesthetics|mesh-ancestor
139291029|NCT05338320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139291030|NCT05338320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291031|NCT05338320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139291032|NCT05338320|Narcotics|narcotics|mesh-ancestor
139291033|NCT05338320|Analgesics|analgesics|mesh-ancestor
139291034|NCT05338320|Sensory System Agents|sensory system agents|mesh-ancestor
139291035|NCT05338320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291036|NCT05338320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139291037|NCT05338320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139291038|NCT05338320|Anesthetics, General|anesthetics, general|mesh-ancestor
139291039|NCT05260073|Tirbanibulin|tirbanibulin|mesh-list
139291040|NCT05260073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291041|NCT05260073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291042|NCT05214287|Nitrox|nitrox|mesh-list
139291043|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139291044|NCT05214287|Protective Agents|protective agents|mesh-ancestor
139291045|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291046|NCT05182931|Trametinib|trametinib|mesh-list
139291047|NCT05182931|Dabrafenib|dabrafenib|mesh-list
139291048|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291049|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139291050|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291051|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291052|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
139291053|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
139291054|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291055|NCT05128734|Temozolomide|temozolomide|mesh-list
139291056|NCT05128734|Olaparib|olaparib|mesh-list
139291057|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139291058|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
139291059|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291060|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291061|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139291062|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291063|NCT05126836|Cilostazol|cilostazol|mesh-list
139291064|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139291065|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
139291066|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291067|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291068|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139291069|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
139291070|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139291071|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139291072|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291073|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139291074|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
139291075|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139291076|NCT05126836|Protective Agents|protective agents|mesh-ancestor
139291077|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139291078|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139291079|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291080|NCT05050357|Norethindrone|norethindrone|mesh-list
139291081|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
139291082|NCT05050357|Progestins|progestins|mesh-list
139291083|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139291084|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139291085|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139291086|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
139291087|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139291088|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291089|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139291090|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139291091|NCT05050357|Hormones|hormones|mesh-ancestor
139291092|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139291093|NCT05008809|Leucovorin|leucovorin|mesh-list
139291094|NCT05008809|Fluorouracil|fluorouracil|mesh-list
139291095|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
139291096|NCT05008809|Irinotecan|irinotecan|mesh-list
139291097|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
139291098|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
139291099|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291100|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139291101|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291102|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139291103|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
139291104|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291105|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139291106|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139291107|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291108|NCT05008809|Antidotes|antidotes|mesh-ancestor
139291109|NCT05008809|Protective Agents|protective agents|mesh-ancestor
139291110|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
139291111|NCT05008809|Vitamins|vitamins|mesh-ancestor
139291112|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
139291113|NCT04975334|Naloxone|naloxone|mesh-list
139291114|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139291115|NCT04975334|Hormones|hormones|mesh-ancestor
139291116|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139291117|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291118|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139291119|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
139291120|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291121|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
139291122|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139291123|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
139291124|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139291125|NCT04964843|Expectorants|expectorants|mesh-ancestor
139291126|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
139291127|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139291128|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
139291129|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291130|NCT04964843|Protective Agents|protective agents|mesh-ancestor
139291131|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291132|NCT04964843|Antidotes|antidotes|mesh-ancestor
139291133|NCT04946825|Nicotine|nicotine|mesh-list
139291134|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139291135|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
139291136|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291137|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291138|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139291139|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139291140|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
139291141|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139291142|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291143|NCT04908579|Ketamine|ketamine|mesh-list
139291144|NCT04908579|Bupivacaine|bupivacaine|mesh-list
139291145|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
139291146|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
139291147|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139291148|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291149|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
139291150|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291151|NCT04908579|Analgesics|analgesics|mesh-ancestor
139291152|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139291153|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139291154|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
139291155|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139291156|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139291157|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139291158|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291159|NCT04898387|Timolol|timolol|mesh-list
139291160|NCT04898387|Bimatoprost|bimatoprost|mesh-list
139291161|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139291162|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139291163|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
139291164|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139291165|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291166|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291167|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138874637|NCT00602030|Entinostat|entinostat|mesh-list
139291168|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139291169|NCT04848753|Paclitaxel|paclitaxel|mesh-list
139291170|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139291171|NCT04848753|Cisplatin|cisplatin|mesh-list
139291172|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139291173|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291174|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
139291175|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
139291176|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
139291177|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291178|NCT04823247|Interleukin-23|interleukin-23|mesh-list
139291179|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139291180|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139291181|NCT04823247|Growth Substances|growth substances|mesh-ancestor
139291182|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291183|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
139291184|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291185|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
139291186|NCT04772222|Morphine|morphine|mesh-list
139291187|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139291188|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139291189|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291190|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139291191|NCT04772222|Analgesics|analgesics|mesh-ancestor
139291192|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
139291193|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291194|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139291195|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139291196|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139291197|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
139291198|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139291199|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291200|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139291201|NCT04772222|Narcotics|narcotics|mesh-ancestor
139291202|NCT04766021|Mirabegron|mirabegron|mesh-list
139291203|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139291204|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139291205|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139291206|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
139291207|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139291208|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291209|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291210|NCT04766021|Urological Agents|urological agents|mesh-ancestor
139291211|NCT04728360|Ustekinumab|ustekinumab|mesh-list
139291212|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
139291213|NCT04648969|Hormones|hormones|mesh-list
139291214|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139291215|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291216|NCT04545866|Budesonide|budesonide|mesh-list
139291217|NCT04545866|Poractant alfa|poractant alfa|mesh-list
139291218|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139291219|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139291220|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139291221|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
139291222|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291223|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291224|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139291225|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
139291226|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
139291227|NCT04545866|Hormones|hormones|mesh-ancestor
139291228|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139291229|NCT04407442|Dexamethasone|dexamethasone|mesh-list
139291230|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
139291231|NCT04407442|Azacitidine|azacitidine|mesh-list
139291232|NCT04407442|Daratumumab|daratumumab|mesh-list
139291233|NCT04407442|Ichthammol|ichthammol|mesh-list
139291234|NCT04407442|BB 1101|bb 1101|mesh-list
139291235|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139291236|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
139291237|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
139291238|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291239|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291240|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139291241|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
139291242|NCT04407442|Hormones|hormones|mesh-ancestor
139291243|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139291244|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139291245|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291246|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
139291247|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291248|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291249|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139291250|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
139291251|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
139291252|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139291253|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
139291254|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291255|NCT04345796|Empagliflozin|empagliflozin|mesh-list
139291256|NCT04345796|Carvedilol|carvedilol|mesh-list
139291257|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139291258|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291259|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139291260|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291261|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139291262|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139291263|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
139291264|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139291265|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139291266|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
139291267|NCT04345796|Protective Agents|protective agents|mesh-ancestor
139291268|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139291269|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139291270|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139291271|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
139291272|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139291273|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139291274|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139291275|NCT04265612|Laxatives|laxatives|mesh-ancestor
139291276|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139291277|NCT04222088|Chloroquine|chloroquine|mesh-list
139291278|NCT04222088|Lumefantrine|lumefantrine|mesh-list
139291279|NCT04222088|Primaquine|primaquine|mesh-list
139291280|NCT04222088|Amebicides|amebicides|mesh-ancestor
139291281|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139291282|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139291283|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139291284|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
139291285|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291286|NCT03978520|Upadacitinib|upadacitinib|mesh-list
139291287|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139291288|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139291289|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291290|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291291|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291292|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139291293|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139291294|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291295|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139291296|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
139291297|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291298|NCT03896685|Linezolid|linezolid|mesh-list
139291299|NCT03896685|Bedaquiline|bedaquiline|mesh-list
139291300|NCT03896685|Clofazimine|clofazimine|mesh-list
139291301|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139291302|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139291303|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139291304|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291305|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291306|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
139291307|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139291308|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
139291309|NCT03874715|Insulin|insulin|mesh-list
139291310|NCT03874715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139291311|NCT03874715|Insulin Glargine|insulin glargine|mesh-list
139291312|NCT03874715|Insulin Aspart|insulin aspart|mesh-list
139291313|NCT03874715|Insulin, Long-Acting|insulin, long-acting|mesh-list
139291314|NCT03874715|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139291315|NCT03874715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139291316|NCT03874715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291317|NCT03801863|Ropivacaine|ropivacaine|mesh-list
139291318|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
139291319|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
139291320|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139291321|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291322|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
139291323|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291324|NCT03664037|Dexamethasone|dexamethasone|mesh-list
139291325|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139291326|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139291327|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
139291328|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
139291329|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291330|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291331|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139291332|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
139291333|NCT03664037|Hormones|hormones|mesh-ancestor
139291334|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139291335|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139291336|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291337|NCT03538457|Acetaminophen|acetaminophen|mesh-list
139291338|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139291339|NCT03538457|Analgesics|analgesics|mesh-ancestor
139291340|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
139291341|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291342|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291343|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
139291344|NCT03535376|Valsartan|valsartan|mesh-list
139291345|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139291346|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139291347|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139291348|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291349|NCT03336242|Cannabidiol|cannabidiol|mesh-list
139291350|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
139291351|NCT03333395|Heparin|heparin|mesh-list
139291352|NCT03333395|Albuterol|albuterol|mesh-list
139291353|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
139291354|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139291355|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139291356|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291357|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139291358|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
139291359|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291360|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291361|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139291362|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
139291363|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
139291364|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139291365|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139291366|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139291367|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139291368|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
139291369|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139291370|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
139291371|NCT03328104|Etoposide|etoposide|mesh-list
139291372|NCT03328104|Everolimus|everolimus|mesh-list
139291373|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139291374|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
139291375|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291376|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291377|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139291378|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
139291379|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291380|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291381|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139291382|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139291383|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139291384|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139291385|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291386|NCT03328104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139291387|NCT03328104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139291388|NCT02919449|Atezolizumab|atezolizumab|mesh-list
139291389|NCT02919449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139291390|NCT02919449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291391|NCT02919449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139291392|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291393|NCT02904291|Amlodipine|amlodipine|mesh-list
138874847|NCT02682134|Dexamethasone|dexamethasone|mesh-list
139291394|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139291395|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139291396|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139291397|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291398|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139291399|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291400|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
139291401|NCT02796859|Siltuximab|siltuximab|mesh-list
139291402|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291403|NCT02769832|Paclitaxel|paclitaxel|mesh-list
139291404|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139291405|NCT02769832|Gemcitabine|gemcitabine|mesh-list
139291406|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139291407|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291408|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
139291409|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
139291410|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
139291411|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291412|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139291413|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
139291414|NCT02706704|Adalimumab|adalimumab|mesh-list
139291415|NCT02706704|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139291416|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139291417|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291418|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
139291419|NCT02326311|Dasatinib|dasatinib|mesh-list
139291420|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291421|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139291422|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291423|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291424|NCT02324543|Gemcitabine|gemcitabine|mesh-list
139291425|NCT02324543|Docetaxel|docetaxel|mesh-list
139291426|NCT02324543|Capecitabine|capecitabine|mesh-list
139291427|NCT02324543|Irinotecan|irinotecan|mesh-list
139291428|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291429|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139291430|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
139291431|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291432|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
139291433|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
139291434|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
139291435|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139291436|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139291437|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291438|NCT02215265|Cisplatin|cisplatin|mesh-list
139291439|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291440|NCT02055638|SRX246|srx246|mesh-list
139291441|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139291442|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291443|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
139291444|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291445|NCT01850524|Dexamethasone|dexamethasone|mesh-list
139291446|NCT01850524|Lenalidomide|lenalidomide|mesh-list
139291447|NCT01850524|Ixazomib|ixazomib|mesh-list
139291448|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139291449|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
139291450|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
139291451|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291452|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291453|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139291454|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
139291455|NCT01850524|Hormones|hormones|mesh-ancestor
139291456|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139291457|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139291458|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291459|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
139291460|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139291461|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139291462|NCT01850524|Growth Substances|growth substances|mesh-ancestor
139291463|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
139291464|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
139291465|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291466|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291468|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139291469|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139291470|NCT01664910|Methotrexate|methotrexate|mesh-list
139291471|NCT01664910|Fludarabine|fludarabine|mesh-list
139291472|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
139291473|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139291474|NCT01664910|Antibodies|antibodies|mesh-list
139291475|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
139291476|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139291477|NCT01664910|Tacrolimus|tacrolimus|mesh-list
139291478|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
139291479|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139291480|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
139291481|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291482|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291483|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291484|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139291485|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
139291486|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139291487|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139291488|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
139291489|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291490|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
139291491|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291492|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139291493|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139291494|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139291495|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139291496|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139291497|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
139291498|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139291499|NCT01664910|Immunotoxins|immunotoxins|mesh-ancestor
139291500|NCT01664910|Immunoconjugates|immunoconjugates|mesh-ancestor
139291501|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
139291502|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139291503|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
139291504|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291505|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139291506|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291507|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291508|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
139291509|NCT00576979|Etoposide|etoposide|mesh-list
139291510|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
139291511|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139291512|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
139291513|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291514|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291515|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139291516|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
139291517|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291518|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291519|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139291520|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139291521|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139291522|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139291523|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291524|NCT03563235|Calcitriol|calcitriol|mesh-list
139291525|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139291526|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291527|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139291528|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139291529|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291530|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139291531|NCT03563235|Vitamins|vitamins|mesh-ancestor
139291532|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
139291533|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139291534|NCT01329900|Etoposide|etoposide|mesh-list
139291535|NCT01329900|Ifosfamide|ifosfamide|mesh-list
139291536|NCT01329900|Ofatumumab|ofatumumab|mesh-list
139291537|NCT01329900|Lenograstim|lenograstim|mesh-list
139291538|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139291539|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291540|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139291541|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139291542|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291543|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291544|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139291545|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
138874998|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
139291546|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139291547|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
139291548|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291549|NCT04948372|Terlipressin|terlipressin|mesh-list
139291550|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139291551|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139291552|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139291553|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139291554|NCT04947826|Antibodies|antibodies|mesh-list
139291555|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
139291556|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
139291557|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291558|NCT02228616|Lactulose|lactulose|mesh-list
139291559|NCT02228616|Prucalopride|prucalopride|mesh-list
139291560|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139291561|NCT02228616|Laxatives|laxatives|mesh-ancestor
139291562|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139291563|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139291564|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
139291565|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139291566|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291567|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291568|NCT02228772|Cytarabine|cytarabine|mesh-list
139291569|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
139291570|NCT02228772|Doxorubicin|doxorubicin|mesh-list
139291571|NCT02228772|Methotrexate|methotrexate|mesh-list
139291572|NCT02228772|Vincristine|vincristine|mesh-list
139291573|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
139291574|NCT02228772|Ixazomib|ixazomib|mesh-list
139291575|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139291576|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
139291577|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291578|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291579|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139291580|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
139291581|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291582|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291583|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139291584|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139291585|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139291586|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139291587|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291588|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139291589|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
139291590|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139291591|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139291592|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
139291593|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
139291594|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139291595|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139291596|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
139291597|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139291598|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139291599|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
139291600|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
139291601|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
139291602|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
139291603|NCT02228850|Alprostadil|alprostadil|mesh-list
139291604|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139291605|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
139291606|NCT02228850|Urological Agents|urological agents|mesh-ancestor
139291607|NCT03563001|Budesonide|budesonide|mesh-list
139291608|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
139291609|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139291610|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139291611|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
139291612|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291613|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291614|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139291615|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
139291616|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
139291617|NCT03563001|Hormones|hormones|mesh-ancestor
139291618|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139291619|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139291620|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139291621|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139291622|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
139291623|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139291624|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291625|NCT02228928|Capsaicin|capsaicin|mesh-list
139291626|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
139291627|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
139291628|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
139291629|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291630|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291631|NCT03888378|Minocycline|minocycline|mesh-list
139291632|NCT03888378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139291633|NCT03888378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139291634|NCT03603288|Idebenone|idebenone|mesh-list
139291635|NCT03603288|Antioxidants|antioxidants|mesh-ancestor
139291636|NCT03603288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291637|NCT03603288|Protective Agents|protective agents|mesh-ancestor
139291638|NCT03603288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291639|NCT03857646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139291640|NCT03857646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139291641|NCT03857646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139291642|NCT03857646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139291643|NCT03844074|Bevacizumab|bevacizumab|mesh-list
139291644|NCT03844074|Ranibizumab|ranibizumab|mesh-list
139291645|NCT03844074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139291646|NCT03844074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291647|NCT03844074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139291648|NCT03844074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139291649|NCT03844074|Growth Substances|growth substances|mesh-ancestor
139291650|NCT03844074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291651|NCT03844074|Growth Inhibitors|growth inhibitors|mesh-ancestor
139291652|NCT02624986|Rituximab|rituximab|mesh-list
139291653|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
139291654|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139291655|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291656|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
139291657|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291658|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291659|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
139291660|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139291661|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
139291662|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291663|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291664|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139291665|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
139291666|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291667|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291668|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139291669|NCT04945096|Cytarabine|cytarabine|mesh-list
139291670|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
139291671|NCT04945096|Cyclosporine|cyclosporine|mesh-list
139291672|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
139291673|NCT04945096|Busulfan|busulfan|mesh-list
139291674|NCT04945096|Semustine|semustine|mesh-list
139291675|NCT04945096|Decitabine|decitabine|mesh-list
139291676|NCT04945096|Cyclosporins|cyclosporins|mesh-list
139291677|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
139291678|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139291679|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139291680|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
139291681|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291682|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291683|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139291684|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
139291685|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291686|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291687|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139291688|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139291689|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
139291690|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
139291691|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139291692|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852958|NCT04239560|Boron|boron|mesh-list
139291693|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
139291694|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
139291695|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139291696|NCT04945096|Expectorants|expectorants|mesh-ancestor
139291697|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
139291698|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139291699|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
139291700|NCT04945096|Protective Agents|protective agents|mesh-ancestor
139291701|NCT04944082|Ivermectin|ivermectin|mesh-list
139291702|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139291703|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139291704|NCT04943692|Metformin|metformin|mesh-list
139291705|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139291706|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291707|NCT02587598|Cytarabine|cytarabine|mesh-list
139291708|NCT02587598|Azacitidine|azacitidine|mesh-list
139291709|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139291710|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
139291711|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291712|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291713|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
139291714|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139291715|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139291716|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
139291717|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291718|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291719|NCT04943146|Aspirin|aspirin|mesh-list
139291720|NCT04943146|Prednisone|prednisone|mesh-list
139291721|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139291722|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
139291723|NCT04943146|Hormones|hormones|mesh-ancestor
139291724|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139291725|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291726|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139291727|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291728|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139291729|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139291730|NCT04943146|Analgesics|analgesics|mesh-ancestor
139291731|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
139291732|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291733|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291734|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139291735|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139291736|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291737|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139291738|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139291739|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291740|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
139291741|NCT02485574|Calcium|calcium|mesh-list
139291742|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139291743|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291744|NCT04942834|Amiodarone|amiodarone|mesh-list
139291745|NCT04942834|Sotalol|sotalol|mesh-list
139291746|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139291747|NCT04942834|Dronedarone|dronedarone|mesh-list
139291748|NCT04942834|Propafenone|propafenone|mesh-list
139291749|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
139291750|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139291751|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139291752|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291753|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139291754|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139291755|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139291756|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291757|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139291758|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139291759|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139291760|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139291761|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139291762|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
139291763|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139291764|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291765|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
139291766|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
139291767|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291768|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139291769|NCT04941976|Benzydamine|benzydamine|mesh-list
139291770|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139291771|NCT01291004|Drospirenone|drospirenone|mesh-list
139291772|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139291773|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139291774|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
138875233|NCT02802215|Folic Acid|folic acid|mesh-list
139291775|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139291776|NCT01291004|Desogestrel|desogestrel|mesh-list
139291777|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
139291778|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
139291779|NCT01291004|Estradiol|estradiol|mesh-list
139291780|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139291781|NCT01291004|Estrogens|estrogens|mesh-ancestor
139291782|NCT01291004|Hormones|hormones|mesh-ancestor
139291783|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139291784|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291785|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139291786|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139291787|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139291788|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139291789|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139291790|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139291791|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
139291792|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139291793|NCT01291004|Diuretics|diuretics|mesh-ancestor
139291794|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
139291795|NCT01291004|Progestins|progestins|mesh-ancestor
139291796|NCT04941118|Anesthetics|anesthetics|mesh-list
139291797|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
139291798|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139291799|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291800|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
139291801|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291802|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
139291803|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139291804|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
139291805|NCT00374660|Irofulven|irofulven|mesh-list
139291806|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291807|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139291808|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
139291809|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291810|NCT02624050|Propofol|propofol|mesh-list
139291811|NCT02624050|Methohexital|methohexital|mesh-list
139291812|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139291813|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139291814|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291815|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139291816|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
139291817|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
139291818|NCT03131882|Triamcinolone|triamcinolone|mesh-list
139291819|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139291820|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139291821|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
139291822|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139291823|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139291824|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
139291825|NCT03131882|Hormones|hormones|mesh-ancestor
139291826|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139291827|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291828|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139291829|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
139291830|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291831|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291832|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139291833|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
139291834|NCT03131882|Protective Agents|protective agents|mesh-ancestor
139291835|NCT03483350|Midazolam|midazolam|mesh-list
139291836|NCT03483350|Granisetron|granisetron|mesh-list
139291837|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139291838|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139291839|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139291840|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291841|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139291842|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139291843|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139291844|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139291845|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
139291846|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
139291847|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
139291848|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
139291849|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139291850|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291851|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
139291853|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291854|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139291855|NCT03483350|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139291856|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139291857|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
139291858|NCT03480308|Dexamethasone|dexamethasone|mesh-list
139291859|NCT03480308|Fentanyl|fentanyl|mesh-list
139291860|NCT03480308|Bupivacaine|bupivacaine|mesh-list
139291861|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139291862|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
139291863|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
139291864|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291865|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291866|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139291867|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
139291868|NCT03480308|Hormones|hormones|mesh-ancestor
139291869|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139291870|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139291871|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291872|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
139291873|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
139291874|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139291875|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
139291876|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139291877|NCT03480308|Narcotics|narcotics|mesh-ancestor
139291878|NCT03480308|Analgesics|analgesics|mesh-ancestor
139291879|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139291880|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139291881|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
139291882|NCT05151614|Colchicine|colchicine|mesh-list
139291883|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
139291884|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291885|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
139291886|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
139291887|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
139291888|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291889|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291890|NCT04937140|Antibodies|antibodies|mesh-list
139291891|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
139291892|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291893|NCT03482960|Xenon|xenon|mesh-list
139291894|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139291895|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
139291896|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
139291897|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139291898|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291899|NCT03479996|Bupivacaine|bupivacaine|mesh-list
139291900|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
139291901|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
139291902|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139291903|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291904|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
139291905|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291906|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
139291907|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
139291908|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139291909|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139291910|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291911|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291912|NCT02524184|Urological Agents|urological agents|mesh-ancestor
139291913|NCT03486236|Ivacaftor|ivacaftor|mesh-list
139291914|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139291915|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139291916|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291917|NCT03479918|Prednisone|prednisone|mesh-list
139291918|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
139291919|NCT03479918|Doxorubicin|doxorubicin|mesh-list
139291920|NCT03479918|Etoposide|etoposide|mesh-list
139291921|NCT03479918|Vincristine|vincristine|mesh-list
139291922|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139291923|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
139291924|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291925|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139291926|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138875382|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
139291927|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
139291928|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291929|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139291930|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139291931|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139291932|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139291933|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139291934|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291935|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139291936|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139291937|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
139291938|NCT03479918|Hormones|hormones|mesh-ancestor
139291939|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139291940|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139291941|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
139291942|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
139291943|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
139291944|NCT03486080|Lenograstim|lenograstim|mesh-list
139291945|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139291946|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
139291947|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291948|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139291949|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
139291950|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
139291951|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139291952|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139291953|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291954|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139291955|NCT03477344|Analgesics|analgesics|mesh-ancestor
139291956|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
139291957|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291958|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139291959|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139291960|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139291961|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
139291962|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139291963|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291964|NCT04933864|Methylene Blue|methylene blue|mesh-list
139291965|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139291966|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291967|NCT03477266|Mosapride|mosapride|mesh-list
139291968|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139291969|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139291970|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
139291971|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139291972|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139291973|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291974|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139291975|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139291976|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139291977|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
139291978|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
139291979|NCT03131336|Coagulants|coagulants|mesh-ancestor
139291980|NCT03482492|Acetaminophen|acetaminophen|mesh-list
139291981|NCT03482492|Tramadol|tramadol|mesh-list
139291982|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139291983|NCT03482492|Analgesics|analgesics|mesh-ancestor
139291984|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
139291985|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139291986|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291987|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
139291988|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139291989|NCT03482492|Narcotics|narcotics|mesh-ancestor
139291990|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139291992|NCT03874286|Hematinics|hematinics|mesh-ancestor
139291993|NCT05259098|Sufentanil|sufentanil|mesh-list
139291994|NCT05259098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139291995|NCT05259098|Narcotics|narcotics|mesh-ancestor
139291996|NCT05259098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139291997|NCT05259098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139291998|NCT05259098|Analgesics|analgesics|mesh-ancestor
139291999|NCT05259098|Sensory System Agents|sensory system agents|mesh-ancestor
139292000|NCT05259098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875453|NCT02681198|Lofexidine|lofexidine|mesh-list
139292001|NCT05259098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139292002|NCT05259098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139292003|NCT05259098|Anesthetics, General|anesthetics, general|mesh-ancestor
139292004|NCT05259098|Anesthetics|anesthetics|mesh-ancestor
139292005|NCT03482180|Atorvastatin|atorvastatin|mesh-list
139292006|NCT03482180|Calcium|calcium|mesh-list
139292007|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139292008|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292009|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139292010|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139292011|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
139292012|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292013|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139292014|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139292015|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292016|NCT04294550|Naloxegol|naloxegol|mesh-list
139292017|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139292018|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292019|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
139292020|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292021|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
139292022|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139292023|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292024|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292025|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139292026|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139292027|NCT03476564|Protective Agents|protective agents|mesh-ancestor
139292028|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292029|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
139292030|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139292031|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
139292032|NCT05258474|Niacinamide|niacinamide|mesh-list
139292033|NCT05258474|Niacin|niacin|mesh-list
139292034|NCT05258474|Nicotinic Acids|nicotinic acids|mesh-list
139292035|NCT05258474|Vitamin B Complex|vitamin b complex|mesh-ancestor
139292036|NCT05258474|Vitamins|vitamins|mesh-ancestor
139292037|NCT05258474|Micronutrients|micronutrients|mesh-ancestor
139292038|NCT05258474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292039|NCT05258474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139292040|NCT05258474|Antimetabolites|antimetabolites|mesh-ancestor
139292041|NCT05258474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292042|NCT05258474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139292043|NCT05258474|Vasodilator Agents|vasodilator agents|mesh-ancestor
139292044|NCT03478436|Doxycycline|doxycycline|mesh-list
139292045|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139292046|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292047|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
139292048|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139292049|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139292050|NCT01338987|Alovudine|alovudine|mesh-list
139292051|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
139292052|NCT01338987|Busulfan|busulfan|mesh-list
139292053|NCT01338987|Methotrexate|methotrexate|mesh-list
139292054|NCT01338987|Fludarabine|fludarabine|mesh-list
139292055|NCT01338987|Leuprolide|leuprolide|mesh-list
139292056|NCT01338987|Tacrolimus|tacrolimus|mesh-list
139292057|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139292058|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
139292059|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292060|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139292061|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139292062|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
139292063|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292064|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292065|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139292066|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139292067|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
139162274|NCT03083704|Enoxaparin|enoxaparin|mesh-list
139292068|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139292069|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139292070|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
139292071|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
139292072|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292073|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139292074|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139292075|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139292076|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139292077|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
139292078|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138875527|NCT00963313|Adalimumab|adalimumab|mesh-list
139292079|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
139292080|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292081|NCT03478280|Brodalumab|brodalumab|mesh-list
139292082|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
139292083|NCT04856007|Metformin|metformin|mesh-list
139292084|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
139292085|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139292086|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292087|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139292088|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292089|NCT04736979|Amoxicillin|amoxicillin|mesh-list
139292090|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
139292091|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
139292092|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139292093|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139292094|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292095|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139292096|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292097|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292098|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139292099|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139292100|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
139292101|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292102|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292103|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139292104|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
139292105|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
139292106|NCT03562923|Hormones|hormones|mesh-ancestor
139292107|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139292108|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
139292109|NCT03593252|Metronidazole|metronidazole|mesh-list
139292110|NCT03593252|Cefazolin|cefazolin|mesh-list
139292111|NCT03593252|Neomycin|neomycin|mesh-list
139292112|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
139292113|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
139292114|NCT03593252|Citric Acid|citric acid|mesh-list
139292115|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
139292116|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292117|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139292118|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139292119|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139292120|NCT03593252|Cathartics|cathartics|mesh-ancestor
139292121|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139292122|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
139292123|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139292124|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
139292125|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
139292126|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292127|NCT03593252|Antacids|antacids|mesh-ancestor
139292128|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139292129|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292130|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
139292131|NCT03476174|Interleukin-2|interleukin-2|mesh-list
139292132|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139292133|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292134|NCT03476174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139292135|NCT03476174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292136|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139292137|NCT03476174|Analgesics|analgesics|mesh-ancestor
139292138|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
139292139|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292140|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292141|NCT02523638|Interferons|interferons|mesh-list
139423887|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139292142|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
139292143|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
139292144|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292145|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
139292146|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292147|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
139292148|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292149|NCT05257148|Nebivolol|nebivolol|mesh-list
139292150|NCT05257148|Zofenopril|zofenopril|mesh-list
139292151|NCT05257148|Captopril|captopril|mesh-list
139292152|NCT05257148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139292153|NCT05257148|Vasodilator Agents|vasodilator agents|mesh-ancestor
139292154|NCT05257148|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139292155|NCT05257148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139292156|NCT05257148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139292157|NCT05257148|Adrenergic Agents|adrenergic agents|mesh-ancestor
139292158|NCT05257148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292159|NCT05257148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292160|NCT05257148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292161|NCT05257148|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139292162|NCT05257148|Protease Inhibitors|protease inhibitors|mesh-ancestor
139292163|NCT05257148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292164|NCT03481790|Folic Acid|folic acid|mesh-list
139292165|NCT03481790|Lactoferrin|lactoferrin|mesh-list
139292166|NCT03481790|Vitamins|vitamins|mesh-ancestor
139292167|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
139292168|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292169|NCT03481790|Hematinics|hematinics|mesh-ancestor
139292170|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
139292171|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292172|NCT03475862|Oxycodone|oxycodone|mesh-list
139292173|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139292174|NCT03475862|Narcotics|narcotics|mesh-ancestor
139292175|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139292176|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292177|NCT03475862|Analgesics|analgesics|mesh-ancestor
139292178|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
139292179|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292180|NCT03368066|Cosyntropin|cosyntropin|mesh-list
139292181|NCT03368066|Hormones|hormones|mesh-ancestor
139292182|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139292183|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292184|NCT03475628|Daratumumab|daratumumab|mesh-list
139292185|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292186|NCT05195450|Tenofovir|tenofovir|mesh-list
139292187|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
139292188|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292189|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139292190|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139292191|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292192|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292193|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139292194|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139292195|NCT03477422|Meropenem|meropenem|mesh-list
139292196|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
139292197|NCT03477422|Sulbactam|sulbactam|mesh-list
139292198|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139292199|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292200|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139292201|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292202|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292203|NCT01355289|Interferons|interferons|mesh-list
139292204|NCT01355289|Ribavirin|ribavirin|mesh-list
139292205|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292206|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
139292207|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292208|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
139292209|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292210|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139292211|NCT03473210|Erythromycin|erythromycin|mesh-list
139292212|NCT03473210|Ampicillin|ampicillin|mesh-list
139292213|NCT03473210|Dexamethasone|dexamethasone|mesh-list
139292214|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139292215|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
139292216|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
139292217|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292218|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292219|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139292220|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
139091730|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292222|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139292223|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139292224|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292225|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292226|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292227|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292228|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139292229|NCT03473132|Thrombin|thrombin|mesh-list
139292230|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
139292231|NCT03473132|Coagulants|coagulants|mesh-ancestor
139292232|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
139292233|NCT03475160|Citric Acid|citric acid|mesh-list
139292234|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
139292235|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
139292236|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139292237|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
139292238|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
139292239|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292240|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
139292241|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139292242|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139292243|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292244|NCT03475160|Urological Agents|urological agents|mesh-ancestor
139292245|NCT00308516|Leucovorin|leucovorin|mesh-list
139292246|NCT00308516|Bevacizumab|bevacizumab|mesh-list
139292247|NCT00308516|Fluorouracil|fluorouracil|mesh-list
139292248|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
139292249|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139292250|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292251|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139292252|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139292253|NCT00308516|Growth Substances|growth substances|mesh-ancestor
139292254|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292255|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
139292256|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
139292257|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292258|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139292259|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139292260|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
139292261|NCT00308516|Antidotes|antidotes|mesh-ancestor
139292262|NCT00308516|Protective Agents|protective agents|mesh-ancestor
139292263|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
139292264|NCT00308516|Vitamins|vitamins|mesh-ancestor
139292265|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
139292266|NCT05155592|Adalimumab|adalimumab|mesh-list
139292267|NCT05155592|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139292268|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139292269|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139292270|NCT03474614|Propranolol|propranolol|mesh-list
139292271|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139292272|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139292273|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
139292274|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292275|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292276|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292277|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139292278|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139292279|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
139292280|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
139292281|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
139292282|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139292283|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
139292284|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292285|NCT02737358|Expectorants|expectorants|mesh-ancestor
139292286|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
139292287|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139292288|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
139292289|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292290|NCT02737358|Protective Agents|protective agents|mesh-ancestor
139292291|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292292|NCT02737358|Antidotes|antidotes|mesh-ancestor
139292293|NCT05052710|Midazolam|midazolam|mesh-list
139292294|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139292295|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139423888|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139292296|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139292297|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292298|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139292299|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139292300|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139292301|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139292302|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
139292303|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
139292304|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
139292305|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
139292306|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292307|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292308|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
139292309|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139292310|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139292311|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292312|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
139292313|NCT02866838|Coagulants|coagulants|mesh-ancestor
139292314|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
139292315|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139292316|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139292317|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292318|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
139292319|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
139292320|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
139292321|NCT01090154|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139292322|NCT01090154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139292323|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139292324|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
139292325|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292326|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139292327|NCT01354431|Nivolumab|nivolumab|mesh-list
139292328|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139292329|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292330|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139292331|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292332|NCT02736578|Cetuximab|cetuximab|mesh-list
139292333|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139292334|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292335|NCT05157542|Paclitaxel|paclitaxel|mesh-list
139292336|NCT05157542|Durvalumab|durvalumab|mesh-list
139292337|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139292338|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139292339|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292340|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
139292341|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
139292342|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
139292343|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292344|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139292345|NCT03472976|Imiquimod|imiquimod|mesh-list
139292346|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139292347|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
139292348|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292349|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292350|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
139292351|NCT03473600|Triamcinolone|triamcinolone|mesh-list
139292352|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139292353|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139292354|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139292355|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139292356|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
139292357|NCT03473600|Hormones|hormones|mesh-ancestor
139292358|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139292359|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292360|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139292361|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
139292362|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292363|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292364|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139292365|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139292366|NCT02622724|Interferons|interferons|mesh-list
139292367|NCT02622724|Interferon-beta|interferon-beta|mesh-list
139292368|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
139292369|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292370|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
139292371|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292372|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
139292373|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292374|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139292375|NCT01354353|Aripiprazole|aripiprazole|mesh-list
139292376|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
139292377|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139292378|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139292379|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139292380|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139292381|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292382|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
139292383|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
139292384|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292385|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292386|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139292387|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138875829|NCT00657774|Prednisone|prednisone|mesh-list
139292388|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
139292389|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139292390|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139292391|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139292392|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139292393|NCT04931524|Mitogens|mitogens|mesh-list
139292394|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
139292395|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292396|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
139292397|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
139292398|NCT03562611|Nalbuphine|nalbuphine|mesh-list
139292399|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139292400|NCT03562611|Narcotics|narcotics|mesh-ancestor
139292401|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139292402|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292403|NCT03562611|Analgesics|analgesics|mesh-ancestor
139292404|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
139292405|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292406|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139292407|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139292408|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139292409|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139292410|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139292411|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292412|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292413|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139292414|NCT03057574|Hormones|hormones|mesh-ancestor
139292415|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139292416|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292417|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139292418|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139292419|NCT04929652|Irinotecan|irinotecan|mesh-list
139292420|NCT04929652|Molgramostim|molgramostim|mesh-list
139292421|NCT04929652|Sargramostim|sargramostim|mesh-list
139292422|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139292423|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139292424|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292425|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292426|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292427|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
139292428|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292429|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139292430|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139292431|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139292432|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139292433|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292434|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292435|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292436|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
139292437|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139292438|NCT04927936|Vaccines|vaccines|mesh-list
139292439|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
139292440|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292441|NCT04167813|Ondansetron|ondansetron|mesh-list
139292442|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
139292443|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
139642356|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
139292444|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292445|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292446|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139292447|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
139292448|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
139292449|NCT04167813|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139292450|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139292451|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
139292452|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292453|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292455|NCT03562533|Carboplatin|carboplatin|mesh-list
139292456|NCT03562533|Doxorubicin|doxorubicin|mesh-list
139292457|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139292458|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139292459|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292460|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
138875914|NCT02634528|Insulin|insulin|mesh-list
139292461|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
139292462|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
139292463|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292464|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139292465|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139292466|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139292467|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292468|NCT04927858|Empagliflozin|empagliflozin|mesh-list
139292469|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139292470|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292471|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139292472|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292473|NCT04927000|Tofacitinib|tofacitinib|mesh-list
139292474|NCT04927000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139292475|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139292476|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292477|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292478|NCT04926532|Sorafenib|sorafenib|mesh-list
139292479|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292480|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139292481|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292482|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292483|NCT03842709|Pramipexole|pramipexole|mesh-list
139292484|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
139292485|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292486|NCT03842709|Protective Agents|protective agents|mesh-ancestor
139292487|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292488|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139292489|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139292490|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
139292491|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
139292492|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292493|NCT05707533|Cefoxitin|cefoxitin|mesh-list
139292494|NCT05707533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139292495|NCT05707533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292496|NCT03056482|Haloperidol|haloperidol|mesh-list
139292497|NCT03056482|Ondansetron|ondansetron|mesh-list
139292498|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
139292499|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
139292500|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
139292501|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292502|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292503|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139292504|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
139292505|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
139292506|NCT03056482|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139292507|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139292508|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
139292509|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292510|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292511|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139292512|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139292513|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139292514|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139292515|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139292516|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
139292517|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139292518|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
139292519|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
139292520|NCT02817555|Hematinics|hematinics|mesh-ancestor
139292521|NCT04924192|Irinotecan|irinotecan|mesh-list
139292522|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139292523|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139292524|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292525|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292526|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292527|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
139292528|NCT02036073|Hematinics|hematinics|mesh-ancestor
139292529|NCT02036229|Ivermectin|ivermectin|mesh-list
139292530|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139292531|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292532|NCT04922008|Capecitabine|capecitabine|mesh-list
139292533|NCT04922008|Trastuzumab|trastuzumab|mesh-list
139292534|NCT04922008|Vinorelbine|vinorelbine|mesh-list
139292535|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138875974|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139292536|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
139292537|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292538|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292539|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139292540|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139292541|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
139292542|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
139292543|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
139292544|NCT03056092|Ranibizumab|ranibizumab|mesh-list
139292545|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139292546|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139292547|NCT03056092|Growth Substances|growth substances|mesh-ancestor
139292548|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292549|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
139292550|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292551|NCT04921306|Clenbuterol|clenbuterol|mesh-list
139292552|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139292553|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139292554|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
139292555|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292556|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292557|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292558|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139292559|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
139292560|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292561|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139292562|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
139292563|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
139292564|NCT04920760|Vitamin A|vitamin a|mesh-list
139292565|NCT04920760|Vitamins|vitamins|mesh-ancestor
139292566|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
139292567|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292568|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
139292569|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
139292570|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139292571|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292572|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292573|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
139292574|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139292575|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139292576|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292577|NCT04920604|Anesthetics|anesthetics|mesh-list
139292578|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139292579|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292580|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
139292581|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139292582|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
139292583|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292584|NCT04920448|Expectorants|expectorants|mesh-ancestor
139292585|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
139292586|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139292587|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
139292588|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292589|NCT04920448|Protective Agents|protective agents|mesh-ancestor
139292590|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292591|NCT04920448|Antidotes|antidotes|mesh-ancestor
139292592|NCT04969354|Immunomodulating Agents|immunomodulating agents|mesh-list
139292593|NCT04969354|Immunologic Factors|immunologic factors|mesh-ancestor
139292594|NCT04969354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292596|NCT03061006|Dabigatran|dabigatran|mesh-list
139292597|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
139292598|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
139292599|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139292600|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
139292601|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292602|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292603|NCT03060850|Abivertinib|abivertinib|mesh-list
139292604|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139292605|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292606|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292607|NCT04432558|Acetaminophen|acetaminophen|mesh-list
139292608|NCT04432558|Diclofenac|diclofenac|mesh-list
138876088|NCT00880620|Carbidopa|carbidopa|mesh-list
139292609|NCT04432558|Tramadol|tramadol|mesh-list
139292610|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139292611|NCT04432558|Analgesics|analgesics|mesh-ancestor
139292612|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
139292613|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292614|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292615|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
139292616|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139292617|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139292618|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139292619|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139292620|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292621|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292622|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139292623|NCT04432558|Narcotics|narcotics|mesh-ancestor
139292624|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139292625|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
139292626|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139292627|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139292628|NCT04979650|Prednisolone|prednisolone|mesh-list
139292629|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
139292630|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139292631|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
139292632|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139292633|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
139292634|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
139292635|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292636|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292637|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139292638|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
139292639|NCT04979650|Hormones|hormones|mesh-ancestor
139292640|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139292641|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139292642|NCT04979650|Protective Agents|protective agents|mesh-ancestor
139292643|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139292644|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292645|NCT04650152|Fenofibrate|fenofibrate|mesh-list
139292646|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139292647|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
139292648|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292649|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139292650|NCT04967950|Methotrexate|methotrexate|mesh-list
139292651|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139292652|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139292653|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
139292654|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139292655|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382138|NCT02426463|Oxycodone|oxycodone|mesh-list
139292656|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139292657|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
139292658|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292659|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292660|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
139292661|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292662|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139292663|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139292664|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
139292665|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139292666|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139292667|NCT04967326|Carbamazepine|carbamazepine|mesh-list
139292668|NCT04967326|Phenytoin|phenytoin|mesh-list
139292669|NCT04967326|Valproic Acid|valproic acid|mesh-list
139292670|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
139292671|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292672|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292673|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
139292674|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292675|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292676|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
139292677|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139292678|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139292679|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139292680|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139292681|NCT04967326|Analgesics|analgesics|mesh-ancestor
139292682|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
139292683|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292684|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139292685|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139292686|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138876124|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
139292687|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139292688|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139292689|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139292690|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139292691|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139292692|NCT02620384|Metolazone|metolazone|mesh-list
139292693|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139292694|NCT02620384|Diuretics|diuretics|mesh-ancestor
139292695|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
139292696|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292697|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139292698|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139292699|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292700|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
139292701|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139292702|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139292703|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292704|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
139292705|NCT04918576|Coagulants|coagulants|mesh-ancestor
139292706|NCT03472508|Folic Acid|folic acid|mesh-list
139292707|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
139292708|NCT03472508|Enalapril|enalapril|mesh-list
139292709|NCT03472508|Enalaprilat|enalaprilat|mesh-list
139292710|NCT03472508|Hematinics|hematinics|mesh-ancestor
139292711|NCT03472508|Vitamins|vitamins|mesh-ancestor
139292712|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
139292713|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292714|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292715|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292716|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139292717|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
139292718|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139292719|NCT04966234|Posaconazole|posaconazole|mesh-list
139292720|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
139292721|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292722|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139292723|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139292724|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139292725|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139292726|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139292727|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292728|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382145|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
139292729|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139292730|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
139292731|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139292732|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292733|NCT03915860|Trifarotene|trifarotene|mesh-list
139292734|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
139292735|NCT04170998|Metformin|metformin|mesh-list
139292736|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
139292737|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139292738|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292739|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139292740|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292741|NCT04965532|Anesthetics|anesthetics|mesh-list
139292742|NCT04965532|Propofol|propofol|mesh-list
139162951|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
139292744|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139292745|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292746|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139292747|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139292748|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
139292749|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139292750|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139292751|NCT03055546|Oxytocin|oxytocin|mesh-list
139292752|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
139292753|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139292754|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292755|NCT04918264|Capecitabine|capecitabine|mesh-list
139292756|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139292757|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
139292758|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292759|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292760|NCT04917718|Tacrolimus|tacrolimus|mesh-list
139292761|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139292762|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
139292763|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292764|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139292765|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292766|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292767|NCT06016530|Dexamethasone|dexamethasone|mesh-list
139292768|NCT06016530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139292769|NCT06016530|Antiemetics|antiemetics|mesh-ancestor
139292770|NCT06016530|Autonomic Agents|autonomic agents|mesh-ancestor
139292771|NCT06016530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292772|NCT06016530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292773|NCT06016530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139292774|NCT06016530|Glucocorticoids|glucocorticoids|mesh-ancestor
139292775|NCT06016530|Hormones|hormones|mesh-ancestor
139292776|NCT06016530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139292777|NCT06016530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139292778|NCT06016530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292779|NCT06016517|Adalimumab|adalimumab|mesh-list
139292780|NCT06016517|Upadacitinib|upadacitinib|mesh-list
139292781|NCT06016517|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139292782|NCT06016517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139292783|NCT06016517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139292784|NCT06016517|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139292785|NCT06016517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139292786|NCT06016517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292787|NCT06016517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292788|NCT06016413|Paclitaxel|paclitaxel|mesh-list
139292789|NCT06016413|Carboplatin|carboplatin|mesh-list
139292790|NCT06016413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139292791|NCT06016413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292792|NCT06016413|Tubulin Modulators|tubulin modulators|mesh-ancestor
139292793|NCT06016413|Antimitotic Agents|antimitotic agents|mesh-ancestor
139292794|NCT06016413|Mitosis Modulators|mitosis modulators|mesh-ancestor
139292795|NCT06016413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292796|NCT06016400|Alfacalcidol|alfacalcidol|mesh-list
139292797|NCT06016400|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139292798|NCT06016400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139292799|NCT06016400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292800|NCT06016400|Vitamins|vitamins|mesh-ancestor
139292801|NCT06016400|Micronutrients|micronutrients|mesh-ancestor
139292802|NCT06015828|Lactoferrin|lactoferrin|mesh-list
139292803|NCT06015828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292804|NCT06015594|Metformin|metformin|mesh-list
139292805|NCT06015594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139292806|NCT06015594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292807|NCT06015477|Ticagrelor|ticagrelor|mesh-list
139292808|NCT06015477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139292809|NCT06015477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139292810|NCT06015477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139292811|NCT06015477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139292812|NCT06015477|Purinergic Agents|purinergic agents|mesh-ancestor
139292813|NCT06015477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292814|NCT06015477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292815|NCT06015477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292816|NCT06015373|Carvedilol|carvedilol|mesh-list
139292817|NCT06015373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139292818|NCT06015373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139292819|NCT06015373|Adrenergic Agents|adrenergic agents|mesh-ancestor
139292820|NCT06015373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292821|NCT06015373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292822|NCT06015373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292823|NCT06015373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139292824|NCT06015373|Antioxidants|antioxidants|mesh-ancestor
139292825|NCT06015373|Protective Agents|protective agents|mesh-ancestor
139292826|NCT06015373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139292827|NCT06015373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139292828|NCT06015373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139292829|NCT06015373|Vasodilator Agents|vasodilator agents|mesh-ancestor
139292830|NCT06015373|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139292831|NCT06015373|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139292832|NCT06015269|Vaccines|vaccines|mesh-list
139292833|NCT06015269|Immunologic Factors|immunologic factors|mesh-ancestor
139292834|NCT06015269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292835|NCT06015152|Tazarotene|tazarotene|mesh-list
138876285|NCT05277038|Clonidine|clonidine|mesh-list
139292836|NCT06015152|Dermatologic Agents|dermatologic agents|mesh-ancestor
139292837|NCT06015152|Keratolytic Agents|keratolytic agents|mesh-ancestor
139292839|NCT06015126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139292840|NCT06015126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292841|NCT06015126|Tubulin Modulators|tubulin modulators|mesh-ancestor
139292842|NCT06015126|Antimitotic Agents|antimitotic agents|mesh-ancestor
139292843|NCT06015126|Mitosis Modulators|mitosis modulators|mesh-ancestor
139292844|NCT06015126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292845|NCT06015113|Disitamab vedotin|disitamab vedotin|mesh-list
139292846|NCT06015113|Immunoconjugates|immunoconjugates|mesh-ancestor
139292847|NCT06015113|Immunologic Factors|immunologic factors|mesh-ancestor
139292848|NCT06015113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292849|NCT06015100|Capecitabine|capecitabine|mesh-list
139292850|NCT06015100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139292851|NCT06015100|Antimetabolites|antimetabolites|mesh-ancestor
139292852|NCT06015100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292853|NCT06015100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139292854|NCT06015074|Propofol|propofol|mesh-list
139292855|NCT06015074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139292856|NCT06015074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139292857|NCT06015074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292858|NCT06015074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139292859|NCT06015074|Anesthetics, General|anesthetics, general|mesh-ancestor
139292860|NCT06015074|Anesthetics|anesthetics|mesh-ancestor
139292861|NCT05999773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139292862|NCT05999773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292863|NCT05999773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139292864|NCT05999773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292865|NCT05903820|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139292866|NCT05903820|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139292867|NCT05903820|Estradiol|estradiol|mesh-list
139292868|NCT05903820|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139292869|NCT05903820|Progesterone|progesterone|mesh-list
139292870|NCT05903820|Estrogens|estrogens|mesh-ancestor
139292871|NCT05903820|Hormones|hormones|mesh-ancestor
139292872|NCT05903820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139292873|NCT05903820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292874|NCT05903820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139292875|NCT05903820|Contraceptive Agents|contraceptive agents|mesh-ancestor
139292876|NCT05903820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139292877|NCT05903820|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139292878|NCT05903820|Progestins|progestins|mesh-ancestor
139292879|NCT05888402|Immunomodulating Agents|immunomodulating agents|mesh-list
139292880|NCT05888402|Immunologic Factors|immunologic factors|mesh-ancestor
139292881|NCT05888402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292882|NCT05888207|Fluvoxamine|fluvoxamine|mesh-list
139292883|NCT05888207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139292884|NCT05888207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139292885|NCT05888207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139292886|NCT05888207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292887|NCT05888207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139292888|NCT05888207|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139292889|NCT05888207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139292890|NCT05888207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139292891|NCT05888207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292892|NCT05888207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292893|NCT05888207|Serotonin Agents|serotonin agents|mesh-ancestor
139292894|NCT05888207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139292895|NCT05888207|Antidepressive Agents|antidepressive agents|mesh-ancestor
139292896|NCT05888207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139292897|NCT05888207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139292898|NCT05888207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292899|NCT05888207|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139292900|NCT05887843|Mometasone Furoate|mometasone furoate|mesh-list
139292901|NCT05887843|Azelastine|azelastine|mesh-list
139292902|NCT05887843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139292903|NCT05887843|Dermatologic Agents|dermatologic agents|mesh-ancestor
139292904|NCT05887843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139292905|NCT05887843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139292906|NCT05887843|Autonomic Agents|autonomic agents|mesh-ancestor
139292907|NCT05887843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292908|NCT05887843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292910|NCT05887843|Respiratory System Agents|respiratory system agents|mesh-ancestor
139292911|NCT05887843|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139292912|NCT05887843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292913|NCT05887843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292914|NCT05887843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139292915|NCT05887843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139292916|NCT05887843|Histamine Antagonists|histamine antagonists|mesh-ancestor
139292917|NCT05887843|Histamine Agents|histamine agents|mesh-ancestor
139292918|NCT05887843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292919|NCT05878405|Anti-Infective Agents|anti-infective agents|mesh-list
139292920|NCT05878405|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139292921|NCT05878405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139292922|NCT05878405|Analgesics|analgesics|mesh-list
139292923|NCT05878405|Methylene Blue|methylene blue|mesh-list
139292924|NCT05878405|Sensory System Agents|sensory system agents|mesh-ancestor
139292925|NCT05878405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292926|NCT05878405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292927|NCT05878405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292928|NCT05878405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292929|NCT05866367|Insulin|insulin|mesh-list
139292930|NCT05866367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139292931|NCT05866367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139292932|NCT05866367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292933|NCT05836272|Norepinephrine|norepinephrine|mesh-list
139292934|NCT05836272|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139292935|NCT05836272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139292936|NCT05836272|Adrenergic Agents|adrenergic agents|mesh-ancestor
139292937|NCT05836272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292938|NCT05836272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292939|NCT05836272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292940|NCT05836272|Sympathomimetics|sympathomimetics|mesh-ancestor
139292941|NCT05836272|Autonomic Agents|autonomic agents|mesh-ancestor
139292942|NCT05836272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292943|NCT05836272|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139292944|NCT05795504|Vitamin D|vitamin d|mesh-list
139292945|NCT05795504|Calcium|calcium|mesh-list
139292946|NCT05795504|Vitamins|vitamins|mesh-ancestor
139292947|NCT05795504|Micronutrients|micronutrients|mesh-ancestor
139292948|NCT05795504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382147|NCT02426463|Narcotics|narcotics|mesh-ancestor
139292949|NCT05795504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139292950|NCT05795504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139292951|NCT05738135|Aminophylline|aminophylline|mesh-list
139292952|NCT05738135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139292953|NCT05738135|Autonomic Agents|autonomic agents|mesh-ancestor
139292954|NCT05738135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292955|NCT05738135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292956|NCT05738135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139292957|NCT05738135|Respiratory System Agents|respiratory system agents|mesh-ancestor
139292958|NCT05738135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139292959|NCT05738135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139292960|NCT05738135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292961|NCT05738135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292962|NCT05738135|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139292963|NCT05738135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139292964|NCT05738135|Purinergic Agents|purinergic agents|mesh-ancestor
139292965|NCT05738135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139292966|NCT05738135|Protective Agents|protective agents|mesh-ancestor
139292968|NCT05708625|Voriconazole|voriconazole|mesh-list
139292969|NCT05708625|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
139292970|NCT05708625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139292971|NCT05708625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139292972|NCT05708625|Antimalarials|antimalarials|mesh-ancestor
139292973|NCT05708625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139292974|NCT05708625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139292975|NCT05708625|Antifungal Agents|antifungal agents|mesh-ancestor
139292976|NCT05708625|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139292977|NCT05708625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139292978|NCT05708625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139292979|NCT05708625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292980|NCT05708625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139292981|NCT05708625|Hormone Antagonists|hormone antagonists|mesh-ancestor
138876423|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
139292982|NCT05708625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139292983|NCT05708625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292984|NCT05708625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139292985|NCT05708625|Schistosomicides|schistosomicides|mesh-ancestor
139292986|NCT05708625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139292987|NCT05708625|Anthelmintics|anthelmintics|mesh-ancestor
139292988|NCT05697276|Lidocaine|lidocaine|mesh-list
139292989|NCT05697276|Bupivacaine|bupivacaine|mesh-list
139292990|NCT05697276|Anesthetics, Local|anesthetics, local|mesh-ancestor
139292991|NCT05697276|Anesthetics|anesthetics|mesh-ancestor
139292992|NCT05697276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139292993|NCT05697276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139292994|NCT05697276|Sensory System Agents|sensory system agents|mesh-ancestor
139292995|NCT05697276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139292996|NCT05697276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139292997|NCT05697276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139292998|NCT05697276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139292999|NCT05697276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139293000|NCT05697276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293001|NCT05690204|Colchicine|colchicine|mesh-list
139293002|NCT05690204|Gout Suppressants|gout suppressants|mesh-ancestor
139293003|NCT05690204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139293004|NCT05690204|Tubulin Modulators|tubulin modulators|mesh-ancestor
139293005|NCT05690204|Antimitotic Agents|antimitotic agents|mesh-ancestor
139293006|NCT05690204|Mitosis Modulators|mitosis modulators|mesh-ancestor
139293007|NCT05690204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293008|NCT05690204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293009|NCT05672784|Acetaminophen|acetaminophen|mesh-list
139293010|NCT05672784|Meloxicam|meloxicam|mesh-list
139293011|NCT05672784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139293012|NCT05672784|Analgesics|analgesics|mesh-ancestor
139293013|NCT05672784|Sensory System Agents|sensory system agents|mesh-ancestor
139293014|NCT05672784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293015|NCT05672784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293016|NCT05672784|Antipyretics|antipyretics|mesh-ancestor
139293017|NCT05672784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139293018|NCT05672784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139293019|NCT05672784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139293020|NCT05672784|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139293021|NCT05672784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139293022|NCT05672784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293023|NCT05672784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293024|NCT05661253|Bupivacaine|bupivacaine|mesh-list
139293025|NCT05661253|Anesthetics, Local|anesthetics, local|mesh-ancestor
139293026|NCT05661253|Anesthetics|anesthetics|mesh-ancestor
139293027|NCT05661253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293028|NCT05661253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293029|NCT05661253|Sensory System Agents|sensory system agents|mesh-ancestor
139293030|NCT05661253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293031|NCT05617885|Leuprolide|leuprolide|mesh-list
139293032|NCT05617885|Goserelin|goserelin|mesh-list
139293033|NCT05617885|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139293034|NCT05617885|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139293035|NCT05617885|Fertility Agents|fertility agents|mesh-ancestor
139293036|NCT05617885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139293037|NCT05617885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293038|NCT05617885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139293039|NCT05617885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293040|NCT05617885|Hormones|hormones|mesh-ancestor
139293041|NCT05617885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139293042|NCT05603832|Acetaminophen|acetaminophen|mesh-list
139293043|NCT05603832|Bupivacaine|bupivacaine|mesh-list
139293044|NCT05603832|Methocarbamol|methocarbamol|mesh-list
139293045|NCT05603832|Anesthetics, Local|anesthetics, local|mesh-ancestor
139293046|NCT05603832|Anesthetics|anesthetics|mesh-ancestor
139293047|NCT05603832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293048|NCT05603832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293049|NCT05603832|Sensory System Agents|sensory system agents|mesh-ancestor
139293050|NCT05603832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293051|NCT05603832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139293052|NCT05603832|Analgesics|analgesics|mesh-ancestor
139293053|NCT05603832|Antipyretics|antipyretics|mesh-ancestor
139293054|NCT05603832|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139293055|NCT05603832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138876500|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
139293056|NCT05601271|Allopurinol|allopurinol|mesh-list
139293057|NCT05601271|Antimetabolites|antimetabolites|mesh-ancestor
139293058|NCT05601271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293059|NCT05601271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293060|NCT05601271|Gout Suppressants|gout suppressants|mesh-ancestor
139293061|NCT05601271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139293062|NCT05601271|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139293063|NCT05601271|Antioxidants|antioxidants|mesh-ancestor
139293064|NCT05601271|Protective Agents|protective agents|mesh-ancestor
139293065|NCT05601271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293066|NCT05565495|Hydromorphone|hydromorphone|mesh-list
139293067|NCT05565495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139293068|NCT05565495|Narcotics|narcotics|mesh-ancestor
139293069|NCT05565495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293070|NCT05565495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293071|NCT05565495|Analgesics|analgesics|mesh-ancestor
139293072|NCT05565495|Sensory System Agents|sensory system agents|mesh-ancestor
139293073|NCT05565495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293074|NCT05542394|Curcumin|curcumin|mesh-list
139293075|NCT05542394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139293076|NCT05542394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139293077|NCT05542394|Analgesics|analgesics|mesh-ancestor
139293078|NCT05542394|Sensory System Agents|sensory system agents|mesh-ancestor
139293079|NCT05542394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293080|NCT05542394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293081|NCT05542394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139293082|NCT05542394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139293083|NCT05542394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293084|NCT05542394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293085|NCT05542394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293086|NCT05519579|Methotrexate|methotrexate|mesh-list
139293087|NCT05519579|Blinatumomab|blinatumomab|mesh-list
139293088|NCT05519579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139293089|NCT05519579|Abortifacient Agents|abortifacient agents|mesh-ancestor
139293090|NCT05519579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139293091|NCT05519579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293092|NCT05519579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139293093|NCT05519579|Antimetabolites|antimetabolites|mesh-ancestor
139293094|NCT05519579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293095|NCT05519579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293096|NCT05519579|Dermatologic Agents|dermatologic agents|mesh-ancestor
139293097|NCT05519579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293098|NCT05519579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139293099|NCT05519579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139293100|NCT05519579|Immunologic Factors|immunologic factors|mesh-ancestor
139293101|NCT05519579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139293102|NCT05519579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139293103|NCT05470517|Ceftriaxone|ceftriaxone|mesh-list
139293104|NCT05470517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139293105|NCT05470517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293106|NCT05390515|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139293107|NCT05390515|Immunologic Factors|immunologic factors|mesh-ancestor
139293108|NCT05390515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293109|NCT05372588|Vaccines|vaccines|mesh-list
139293110|NCT05372588|Immunologic Factors|immunologic factors|mesh-ancestor
139293111|NCT05372588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293112|NCT05363267|Curcumin|curcumin|mesh-list
139293113|NCT05363267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139293114|NCT05363267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139293115|NCT05363267|Analgesics|analgesics|mesh-ancestor
139293116|NCT05363267|Sensory System Agents|sensory system agents|mesh-ancestor
139293117|NCT05363267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293118|NCT05363267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293119|NCT05363267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139293120|NCT05363267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139293121|NCT05363267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293122|NCT05363267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293123|NCT05363267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293124|NCT05276492|Prednisone|prednisone|mesh-list
139293125|NCT05276492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139293126|NCT05276492|Glucocorticoids|glucocorticoids|mesh-ancestor
139293127|NCT05276492|Hormones|hormones|mesh-ancestor
139293128|NCT05276492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139293129|NCT05276492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293130|NCT05276492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139293131|NCT05276492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293132|NCT05190315|Temozolomide|temozolomide|mesh-list
139293133|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
139293134|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139293135|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
139293136|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293137|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293138|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
139293139|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
139293140|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293141|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293142|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139293143|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139293144|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139293145|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293146|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139293147|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139293148|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
139293149|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139293150|NCT05143840|Niacinamide|niacinamide|mesh-list
139293151|NCT05143840|Imatinib Mesylate|imatinib mesylate|mesh-list
139293152|NCT05143840|Dasatinib|dasatinib|mesh-list
139293153|NCT05143840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293154|NCT05143840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139293155|NCT05143840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293156|NCT05143840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293157|NCT05143840|Vitamin B Complex|vitamin b complex|mesh-ancestor
139293158|NCT05143840|Vitamins|vitamins|mesh-ancestor
139293159|NCT05143840|Micronutrients|micronutrients|mesh-ancestor
139293160|NCT05143840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293161|NCT05134974|Phentolamine|phentolamine|mesh-list
139293162|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139293163|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139293164|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139293165|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139293166|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
139293167|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139293168|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293169|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293170|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139293171|NCT05134922|Gedatolisib|gedatolisib|mesh-list
139293172|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139293173|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293174|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293175|NCT05109442|Atezolizumab|atezolizumab|mesh-list
139293176|NCT05109442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139293177|NCT05109442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293178|NCT05109442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139293179|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293180|NCT05108870|Paclitaxel|paclitaxel|mesh-list
139293181|NCT05108870|Carboplatin|carboplatin|mesh-list
139293182|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139293183|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293184|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
139293185|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
139293186|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
139293187|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293188|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
139293189|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139293190|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139293191|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293193|NCT05099276|Coagulants|coagulants|mesh-ancestor
139293194|NCT05096481|Temozolomide|temozolomide|mesh-list
139293195|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139293196|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
139293197|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293198|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293199|NCT05070650|Acetaminophen|acetaminophen|mesh-list
139293200|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
139293201|NCT05070650|Phenylephrine|phenylephrine|mesh-list
139293202|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
139293203|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139293204|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139293205|NCT05070650|Analgesics|analgesics|mesh-ancestor
139293206|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
139293207|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293208|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293210|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
139293211|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293212|NCT05070650|Expectorants|expectorants|mesh-ancestor
139293213|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
139293214|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139293215|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
139293216|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293217|NCT05070650|Protective Agents|protective agents|mesh-ancestor
139293218|NCT05070650|Antidotes|antidotes|mesh-ancestor
139293219|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139293220|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
139293221|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
139293222|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
139293223|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139293224|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
139293225|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139293226|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139293227|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139293228|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
139293229|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139293230|NCT05047211|Dextrans|dextrans|mesh-list
139293231|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
139293232|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
139293233|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
139293234|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
139293235|NCT05047211|Hematinics|hematinics|mesh-ancestor
139293236|NCT04956432|Allopurinol|allopurinol|mesh-list
139293237|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
139293238|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293239|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293240|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
139293241|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139293242|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139293243|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
139293244|NCT04956432|Protective Agents|protective agents|mesh-ancestor
139293245|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293246|NCT04912492|Ethanol|ethanol|mesh-list
139293247|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139293248|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293249|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293250|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293251|NCT04906278|Oxytocin|oxytocin|mesh-list
139293252|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
139293253|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139293254|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293255|NCT04895202|Siponimod|siponimod|mesh-list
139293256|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139293257|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293258|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139293259|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
139293260|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293261|NCT04845399|Factor VIII|factor viii|mesh-list
139293262|NCT04845399|Coagulants|coagulants|mesh-ancestor
139293263|NCT04766853|Dexamethasone|dexamethasone|mesh-list
139293264|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
139293265|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139293266|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
139293267|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
139293268|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293269|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293270|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139293271|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
139293272|NCT04766853|Hormones|hormones|mesh-ancestor
139293273|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139293274|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139293275|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293276|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139293277|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
139293278|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
139293279|NCT04766853|Protective Agents|protective agents|mesh-ancestor
139293280|NCT04755218|Misoprostol|misoprostol|mesh-list
139293281|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139293282|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
139293283|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139293284|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293285|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139293286|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139293287|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
139293288|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
139293289|NCT04732845|Fludarabine|fludarabine|mesh-list
139293290|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139293291|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
139293292|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293293|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139293294|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139293295|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
139293296|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293297|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293298|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139293300|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139293301|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139293302|NCT04693715|Analgesics|analgesics|mesh-ancestor
139293303|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
139293304|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293305|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293306|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139293307|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139293308|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139293309|NCT04614610|Lidocaine|lidocaine|mesh-list
139293310|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
139293311|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
139293312|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293313|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293314|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
139293315|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293316|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139293317|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139293318|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139293319|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139293320|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293321|NCT04613453|Midazolam|midazolam|mesh-list
139293322|NCT04613453|Ketamine|ketamine|mesh-list
139293323|NCT04613453|Analgesics|analgesics|mesh-ancestor
139293324|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
139293325|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293326|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293327|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139293328|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139293329|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
139293330|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
139293331|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293332|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139293333|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139293334|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139293335|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293336|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139293337|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139293338|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139293339|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139293340|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139293341|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
139293342|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
139293343|NCT04511234|Sirolimus|sirolimus|mesh-list
139293344|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139293345|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293346|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139293347|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293348|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
139293349|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139293350|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
139293351|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293352|NCT04499924|Paclitaxel|paclitaxel|mesh-list
139293353|NCT04499924|Trastuzumab|trastuzumab|mesh-list
139293354|NCT04499924|Ramucirumab|ramucirumab|mesh-list
139293355|NCT04499924|Tucatinib|tucatinib|mesh-list
139293356|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139293357|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293358|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
139293359|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
139293360|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
139293361|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293362|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139293363|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139293364|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293365|NCT04481555|Azithromycin|azithromycin|mesh-list
139293366|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139293367|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293368|NCT04439357|Trametinib|trametinib|mesh-list
139293369|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139293370|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293371|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139293372|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293373|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293374|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139293375|NCT04439357|Protective Agents|protective agents|mesh-ancestor
139293376|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293377|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139293378|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
139293379|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
139293380|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139293381|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293382|NCT04370587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139293383|NCT04370587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293384|NCT04318938|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139293385|NCT04318938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139293386|NCT04318938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293387|NCT04318938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293388|NCT04311723|Anesthetics|anesthetics|mesh-list
139293389|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293390|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293391|NCT04238754|Cannabidiol|cannabidiol|mesh-list
139293392|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
139293393|NCT04232358|Anesthetics|anesthetics|mesh-list
139293394|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293395|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293396|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
139293397|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139293398|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
139293399|NCT04208958|Vancomycin|vancomycin|mesh-list
139293400|NCT04208958|Nivolumab|nivolumab|mesh-list
139293401|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139293402|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293403|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139293404|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293405|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139293406|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293407|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
139293408|NCT04144153|Anesthetics|anesthetics|mesh-list
139293409|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293410|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293411|NCT04144153|Narcotics|narcotics|mesh-ancestor
139293412|NCT04144153|Analgesics|analgesics|mesh-ancestor
139293413|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
139293414|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293415|NCT03920293|Ravulizumab|ravulizumab|mesh-list
139293416|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139293417|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139293418|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
139293419|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293420|NCT03910387|Paclitaxel|paclitaxel|mesh-list
139293421|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139293422|NCT03910387|Gemcitabine|gemcitabine|mesh-list
139293423|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139293424|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293425|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
139293426|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
139293427|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
139293428|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293429|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139293430|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
139293431|NCT03844815|Decitabine|decitabine|mesh-list
139293432|NCT03844815|Venetoclax|venetoclax|mesh-list
139293433|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139293434|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
139293435|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293436|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293437|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293439|NCT03837899|Tremelimumab|tremelimumab|mesh-list
139293440|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139293441|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139293442|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293443|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
139293444|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293445|NCT03820830|Palbociclib|palbociclib|mesh-list
139293446|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293447|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139293448|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293449|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293450|NCT03530189|Insulin|insulin|mesh-list
139293451|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139293452|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293453|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
139293454|NCT03434769|Fludarabine|fludarabine|mesh-list
139293455|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139293456|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
139293457|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293458|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139293459|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139293460|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
139293461|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293462|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293463|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139293464|NCT03331198|Venetoclax|venetoclax|mesh-list
139293465|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293466|NCT03326310|Azacitidine|azacitidine|mesh-list
139293467|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139293468|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
139293469|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293470|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293471|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293472|NCT03317496|Cisplatin|cisplatin|mesh-list
139293473|NCT03317496|Carboplatin|carboplatin|mesh-list
139293474|NCT03317496|Gemcitabine|gemcitabine|mesh-list
139293475|NCT03317496|Pemetrexed|pemetrexed|mesh-list
139293476|NCT03317496|Avelumab|avelumab|mesh-list
139293477|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139293478|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293479|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139293480|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
139293481|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293482|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293483|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139293484|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139293485|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139293486|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
139293487|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293488|NCT03301506|Seladelpar|seladelpar|mesh-list
139293489|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139293490|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
139293491|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293492|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139293493|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
139293494|NCT03228667|Nivolumab|nivolumab|mesh-list
139293495|NCT03228667|Atezolizumab|atezolizumab|mesh-list
139163687|NCT03528070|Tranilast|tranilast|mesh-list
139293496|NCT03228667|Durvalumab|durvalumab|mesh-list
139293497|NCT03228667|Avelumab|avelumab|mesh-list
139293498|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139293499|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139293500|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293501|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139293502|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293503|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
139293504|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293505|NCT03127215|Olaparib|olaparib|mesh-list
139293506|NCT03127215|Trabectedin|trabectedin|mesh-list
139293507|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139293508|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293509|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876953|NCT02668094|Analgesics|analgesics|mesh-ancestor
139293510|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293511|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139293512|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
139293513|NCT03125811|Ethanol|ethanol|mesh-list
139293514|NCT03125811|Ondansetron|ondansetron|mesh-list
139293515|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139293516|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293517|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293518|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293519|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
139293520|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
139293521|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293522|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139293523|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
139293524|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
139293525|NCT03125811|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139293526|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139293527|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
139293528|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139293529|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293530|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
139293531|NCT02962401|Idelalisib|idelalisib|mesh-list
139293532|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139293533|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293534|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293535|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293536|NCT02700841|Melphalan|melphalan|mesh-list
139293537|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
139293538|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139293539|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
139293540|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293541|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293542|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139293543|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139293544|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
139293545|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293546|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
139293547|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
139293548|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139293549|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
139293550|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293551|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
139293552|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139293553|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293554|NCT02669186|Fentanyl|fentanyl|mesh-list
139293555|NCT02669186|Bupivacaine|bupivacaine|mesh-list
139293556|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
139293557|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
139293558|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293559|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293560|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
139293561|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293562|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139293563|NCT02669186|Narcotics|narcotics|mesh-ancestor
139293564|NCT02669186|Analgesics|analgesics|mesh-ancestor
139293565|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139293566|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139293567|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
139293568|NCT02568566|Vaccines|vaccines|mesh-list
139423889|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293569|NCT02568566|Immunologic Factors|immunologic factors|mesh-ancestor
139293570|NCT02568566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293571|NCT02536183|Doxorubicin|doxorubicin|mesh-list
139293572|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139293573|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139293574|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293575|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139293576|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139293577|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293578|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293579|NCT02365766|Gemcitabine|gemcitabine|mesh-list
139293580|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
139293581|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293582|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139293583|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
139293584|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877023|NCT00884832|Clonidine|clonidine|mesh-list
139293585|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139293586|NCT02365766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139293587|NCT02317874|Paclitaxel|paclitaxel|mesh-list
139293588|NCT02317874|Carboplatin|carboplatin|mesh-list
139293589|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139293590|NCT02317874|Talazoparib|talazoparib|mesh-list
139293591|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139293592|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293593|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
139293594|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
139293595|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
139293596|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293597|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139293598|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293599|NCT02221999|Paclitaxel|paclitaxel|mesh-list
139293600|NCT02221999|Letrozole|letrozole|mesh-list
139293601|NCT02221999|Hormones|hormones|mesh-list
139293602|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139293603|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293604|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
139293605|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
139293606|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
139293607|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293608|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139293609|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293610|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139293611|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139293612|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293613|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139293614|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
139293615|NCT01849562|Ribavirin|ribavirin|mesh-list
139293616|NCT01849562|Odalasvir|odalasvir|mesh-list
139293617|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
139293618|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293619|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
139293620|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293621|NCT01700179|Ribavirin|ribavirin|mesh-list
139293622|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
139293623|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293624|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
139293625|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293626|NCT01659606|Cyclosporine|cyclosporine|mesh-list
139293627|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
139293628|NCT01659606|Fludarabine|fludarabine|mesh-list
139293629|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
139293630|NCT01659606|Tacrolimus|tacrolimus|mesh-list
139293631|NCT01659606|Cyclosporins|cyclosporins|mesh-list
139293632|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293633|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293634|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139293635|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
139293636|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293637|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139293638|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293639|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
139293640|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293641|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
139293642|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139293643|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139423890|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293644|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139293646|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139293647|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139293648|NCT01474200|Furosemide|furosemide|mesh-list
139293649|NCT01474200|Diuretics|diuretics|mesh-list
139293650|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
139293651|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
139293652|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293653|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139293654|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293655|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139293656|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
139293657|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139293658|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139293659|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
139293660|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293661|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293662|NCT03055234|Treprostinil|treprostinil|mesh-list
139293663|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139293664|NCT03055312|Bicalutamide|bicalutamide|mesh-list
139293665|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
139293666|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
139293667|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139293668|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293669|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293670|NCT04977544|Sertraline|sertraline|mesh-list
139293671|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
139293672|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139293673|NCT04977544|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139293674|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139293675|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139293676|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293677|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139293678|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
139293679|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293680|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
139293681|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139293682|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139293683|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293684|NCT02626000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139293685|NCT02626000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293686|NCT03769376|Salvin|salvin|mesh-list
139293687|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139293688|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293689|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
139293690|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293691|NCT03769376|Protective Agents|protective agents|mesh-ancestor
139293692|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293693|NCT05156450|Prednisone|prednisone|mesh-list
139293694|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
139293695|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139293696|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
139293697|NCT05156450|Hormones|hormones|mesh-ancestor
139293698|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139293699|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293700|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139293701|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293702|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139293703|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293704|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293705|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
139293706|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139293707|NCT03060304|Tamoxifen|tamoxifen|mesh-list
139293708|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139293709|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139293710|NCT03060304|Estradiol|estradiol|mesh-list
139293711|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139293712|NCT03060304|Estrogens|estrogens|mesh-ancestor
139293713|NCT03060304|Hormones|hormones|mesh-ancestor
139293714|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139293715|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091731|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
139293716|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139293717|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
139293718|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139293719|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139293720|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139293721|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
139293722|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139293723|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293724|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139293725|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139293726|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139293727|NCT04432402|Gemcitabine|gemcitabine|mesh-list
139293728|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
139293729|NCT04432402|Lenalidomide|lenalidomide|mesh-list
139293730|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293731|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
139293732|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293733|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139293734|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
139293735|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293736|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139293737|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139293738|NCT04432402|Growth Substances|growth substances|mesh-ancestor
139293739|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
139293740|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
139293741|NCT04432324|Antibodies|antibodies|mesh-list
139293742|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
139293743|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139293744|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139293745|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
139293746|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293747|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
139293748|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139293749|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139293750|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139293751|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139293752|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293753|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
139293754|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139293755|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293756|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139293757|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293758|NCT04977388|Droxidopa|droxidopa|mesh-list
139293759|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139293760|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139293761|NCT03470480|Methamphetamine|methamphetamine|mesh-list
139293762|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139293763|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293764|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
139293765|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
139293766|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293767|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
139293768|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139293769|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293770|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
139293771|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139293772|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139293773|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139293774|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139293775|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139293776|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139293777|NCT04917250|Dexamethasone|dexamethasone|mesh-list
139293778|NCT04917250|Gemcitabine|gemcitabine|mesh-list
139293779|NCT04917250|Etoposide|etoposide|mesh-list
139293780|NCT04917250|Pegaspargase|pegaspargase|mesh-list
139293781|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139293782|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
139293783|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
139293784|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293785|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293786|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139293787|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
139293788|NCT04917250|Hormones|hormones|mesh-ancestor
139423891|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293789|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139293790|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139293791|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293792|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139293793|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
139293794|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293795|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139293796|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139293797|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139293798|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293799|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
139293800|NCT04859582|Capecitabine|capecitabine|mesh-list
139293801|NCT04859582|Fluorouracil|fluorouracil|mesh-list
139293802|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
139293803|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293804|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139293805|NCT04859582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139293806|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877243|NCT00660894|Leucovorin|leucovorin|mesh-list
139293807|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139293808|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
139293809|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139293810|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
139293811|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293812|NCT03469700|Anesthetics|anesthetics|mesh-list
139293813|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293814|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293815|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
139293816|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
139293817|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139293818|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139293819|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293820|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293821|NCT04912726|Urological Agents|urological agents|mesh-ancestor
139293822|NCT02603900|Bupivacaine|bupivacaine|mesh-list
139293823|NCT02603900|Ropivacaine|ropivacaine|mesh-list
139293824|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
139293825|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
139293826|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293827|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293828|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
139293829|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293830|NCT01669798|Nintedanib|nintedanib|mesh-list
139293831|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293832|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139293833|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293834|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293835|NCT02334722|Levetiracetam|levetiracetam|mesh-list
139293836|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
139293837|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
139293838|NCT04458116|Curcumin|curcumin|mesh-list
139293839|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139293840|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139293841|NCT04458116|Analgesics|analgesics|mesh-ancestor
139293842|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
139293843|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293844|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293845|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139293846|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139293847|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293848|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293849|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293850|NCT03469544|Hormones|hormones|mesh-list
139293851|NCT03469544|Antibodies|antibodies|mesh-list
139293852|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139293853|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293854|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
139293855|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139293856|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293857|NCT04912258|Irinotecan|irinotecan|mesh-list
139293858|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139293859|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139293860|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293861|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164067|NCT04001894|Clopidogrel|clopidogrel|mesh-list
139293862|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293863|NCT01952288|Simvastatin|simvastatin|mesh-list
139293864|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139293865|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139293866|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
139293867|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293868|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139293869|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139293870|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293871|NCT03054532|Durvalumab|durvalumab|mesh-list
139293872|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139293873|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293874|NCT04975360|Caffeine|caffeine|mesh-list
139293875|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139293876|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293877|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139293878|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293879|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293880|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139293881|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139293882|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
139293883|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139293884|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139293885|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
139293886|NCT00563576|Estradiol|estradiol|mesh-list
139293887|NCT00563576|Estrogens|estrogens|mesh-ancestor
139293888|NCT00563576|Hormones|hormones|mesh-ancestor
139293889|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139293890|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293891|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139293892|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
139293893|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139293894|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139293895|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139293896|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139293897|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139293898|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139293899|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139293900|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293901|NCT03782636|Aldesleukin|aldesleukin|mesh-list
139293902|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293903|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139293904|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139293905|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
139293906|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293907|NCT04911244|Dimercaprol|dimercaprol|mesh-list
139293908|NCT04911244|Chelating Agents|chelating agents|mesh-ancestor
139293909|NCT04911244|Sequestering Agents|sequestering agents|mesh-ancestor
138855120|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139293910|NCT04911244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293911|NCT03761810|Tretinoin|tretinoin|mesh-list
139293912|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139293913|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
139293914|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293915|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
139293916|NCT04915456|Prednisolone|prednisolone|mesh-list
139293917|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139293918|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
139293919|NCT04915456|Hormones|hormones|mesh-ancestor
139293920|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139293921|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293922|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139293923|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293924|NCT04841668|Metformin|metformin|mesh-list
139293925|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139293926|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293927|NCT03469310|Acetaminophen|acetaminophen|mesh-list
139293928|NCT03469310|Tramadol|tramadol|mesh-list
139293929|NCT03469310|Codeine|codeine|mesh-list
139293930|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139293931|NCT03469310|Analgesics|analgesics|mesh-ancestor
139293932|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
139293933|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293934|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293935|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
139423892|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139293936|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139293937|NCT03469310|Narcotics|narcotics|mesh-ancestor
139293938|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293939|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
139293940|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
139293941|NCT03527186|Risperidone|risperidone|mesh-list
139293942|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139293943|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
139293944|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139293945|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293946|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293947|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139293948|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139293949|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293950|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139293951|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139293952|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
139293953|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
139293954|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139293955|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293956|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139293957|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293958|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139293959|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139293961|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
139293962|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
139293963|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293964|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293965|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139293966|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139293967|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139293968|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139293969|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
139293970|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139293971|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293972|NCT04914598|Cisplatin|cisplatin|mesh-list
139293973|NCT04914598|Endostar protein|endostar protein|mesh-list
139293974|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139293975|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139293976|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139293977|NCT04914598|Growth Substances|growth substances|mesh-ancestor
139293978|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293979|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
139293980|NCT03054220|Tramadol|tramadol|mesh-list
139293981|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139293982|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
139293983|NCT03054220|Paroxetine|paroxetine|mesh-list
139293984|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139293985|NCT03054220|Narcotics|narcotics|mesh-ancestor
139293986|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139293987|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139293988|NCT03054220|Analgesics|analgesics|mesh-ancestor
139293989|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
139293990|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139293991|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139293992|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139293993|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139293994|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139293995|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139293996|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
139293997|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139293998|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
139293999|NCT03054220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139294000|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
139294001|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139294002|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139294003|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139294004|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294005|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
139294006|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
139294007|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139423893|NCT02317679|Bosentan|bosentan|mesh-list
139294008|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139294009|NCT05388188|Sufentanil|sufentanil|mesh-list
139294010|NCT05388188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139294011|NCT05388188|Narcotics|narcotics|mesh-ancestor
139294012|NCT05388188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294013|NCT05388188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294014|NCT05388188|Analgesics|analgesics|mesh-ancestor
139294015|NCT05388188|Sensory System Agents|sensory system agents|mesh-ancestor
139294016|NCT05388188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294017|NCT05388188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139294018|NCT05388188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139294019|NCT05388188|Anesthetics, General|anesthetics, general|mesh-ancestor
139294020|NCT05388188|Anesthetics|anesthetics|mesh-ancestor
139294021|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
139294022|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139294023|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294024|NCT04118036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139294025|NCT04118036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294026|NCT04909918|Dexamethasone|dexamethasone|mesh-list
139294027|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
139294028|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139294029|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139294030|NCT04909918|Prednisolone|prednisolone|mesh-list
139294031|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
139294032|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139294033|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
139294034|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294035|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
139294036|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
139294037|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294038|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294039|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139294040|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
139294041|NCT04909918|Hormones|hormones|mesh-ancestor
139294042|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139294043|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139294044|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294045|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139294046|NCT04909918|Protective Agents|protective agents|mesh-ancestor
139294047|NCT04903678|Melphalan|melphalan|mesh-list
139294048|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139294049|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
139294050|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294051|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294052|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139294053|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139294054|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
139294055|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294056|NCT04903366|Timolol|timolol|mesh-list
139294057|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294058|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139294059|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139294060|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
139294061|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294062|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294063|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139294064|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139294065|NCT03054610|Betamethasone|betamethasone|mesh-list
139294066|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
139294067|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139294068|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
139294069|NCT03054610|Ropivacaine|ropivacaine|mesh-list
139294070|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
139294071|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139294072|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
139294073|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139294074|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139294075|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
139294076|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
139294077|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294078|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294079|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
139294080|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294081|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139294082|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139294083|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294084|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
139294085|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294086|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294087|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
139294088|NCT03054610|Hormones|hormones|mesh-ancestor
139294089|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139294090|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139294091|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
139294092|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139294093|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139294094|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
139294095|NCT03053830|Ketamine|ketamine|mesh-list
139294096|NCT03053830|Analgesics|analgesics|mesh-ancestor
139294097|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
139294098|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294099|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294100|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139294101|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139294102|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
139294103|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
139294104|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294105|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139294106|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139294107|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294108|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294109|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
139294110|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139294111|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294112|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294113|NCT04913896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139294114|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139294115|NCT03053284|Pasireotide|pasireotide|mesh-list
139294116|NCT03053284|Hormones|hormones|mesh-ancestor
139294117|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139294118|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294119|NCT04908982|Aspirin|aspirin|mesh-list
139294120|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139294121|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139294122|NCT04908982|Analgesics|analgesics|mesh-ancestor
139294123|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
139294124|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294125|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294126|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294127|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139382158|NCT01648270|Buprenorphine|buprenorphine|mesh-list
139294128|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139294129|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139294130|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294131|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139294132|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139294133|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294134|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
139294135|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
139294136|NCT04430998|Polaprezinc|polaprezinc|mesh-list
139294137|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139294138|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294139|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
139294140|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139294141|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139294142|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
139294143|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139294144|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139294145|NCT04900948|Prednisolone|prednisolone|mesh-list
139294146|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
139294147|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
139294148|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
139294149|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139294150|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
139294151|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294152|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
139294153|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
139294154|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294155|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294156|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139294157|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
139294158|NCT04900948|Hormones|hormones|mesh-ancestor
139294159|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139294160|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139294161|NCT04900948|Protective Agents|protective agents|mesh-ancestor
139294162|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139294163|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294164|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139294165|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139294166|NCT04900948|Analgesics|analgesics|mesh-ancestor
139294167|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
139294168|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139294169|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
139294170|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139294171|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
139294172|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139294173|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294174|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294175|NCT04901104|Thymalfasin|thymalfasin|mesh-list
139294176|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138877620|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
139294177|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
139294178|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294179|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
139294180|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139294181|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139294182|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294184|NCT04907812|Coagulants|coagulants|mesh-ancestor
139294185|NCT01889186|Venetoclax|venetoclax|mesh-list
139294186|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294187|NCT04892212|Sirolimus|sirolimus|mesh-list
139294188|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139294189|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294190|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139294191|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294192|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
139294193|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139294194|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
139294195|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294196|NCT01510184|Rituximab|rituximab|mesh-list
139294197|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139294198|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139294199|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294200|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
139294201|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294202|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139294203|NCT04907344|Paclitaxel|paclitaxel|mesh-list
139294204|NCT04907344|Carboplatin|carboplatin|mesh-list
139294205|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139294206|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294207|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
139294208|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
139294209|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
139294210|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294211|NCT04906876|Gemcitabine|gemcitabine|mesh-list
139294212|NCT04906876|Docetaxel|docetaxel|mesh-list
139294213|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139294214|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
139294215|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294216|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294217|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
139294218|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
139294219|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
139294220|NCT04891744|Thalidomide|thalidomide|mesh-list
139294221|NCT04891744|Dexamethasone|dexamethasone|mesh-list
139294222|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294223|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
139294224|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
139294225|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294226|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294227|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139294228|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
139294229|NCT04891744|Hormones|hormones|mesh-ancestor
139294230|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139294231|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139294232|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294233|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139294234|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
139294235|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
139294236|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139294237|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294238|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139294239|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139294240|NCT04891744|Growth Substances|growth substances|mesh-ancestor
139294241|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
139294242|NCT04891900|Capecitabine|capecitabine|mesh-list
139294243|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
139294244|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139294245|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139294246|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
139294247|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294248|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294249|NCT04891900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139294250|NCT04891588|Timolol|timolol|mesh-list
139294251|NCT04891588|Latanoprost|latanoprost|mesh-list
139294252|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139294253|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139294254|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294255|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139294256|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139294257|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
139294258|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294259|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294260|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139294261|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139294262|NCT03050866|Antiemetics|antiemetics|mesh-list
139294264|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
139294265|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139294266|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
139294267|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
139294268|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294269|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294270|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294271|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
139294272|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294273|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139294274|NCT03052660|Midazolam|midazolam|mesh-list
139294275|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139294276|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139294277|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294278|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294279|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139294280|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139294281|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139294282|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139294283|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
139294284|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
139294285|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
139294286|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
139294287|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294288|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294289|NCT05162456|Antibodies|antibodies|mesh-list
139294290|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
139294291|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
139294292|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
139294293|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294294|NCT05137886|Decitabine|decitabine|mesh-list
139294295|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139294296|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139294297|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
139294298|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294299|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294300|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294301|NCT05137886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139294302|NCT04890418|Ketamine|ketamine|mesh-list
139294303|NCT04890418|Analgesics|analgesics|mesh-ancestor
139294304|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
139294305|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294306|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294307|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139294308|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139294309|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
139294310|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
139164506|NCT01125553|Insulin|insulin|mesh-list
139294311|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294312|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139294313|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139294314|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294315|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294316|NCT04455932|Liver Extracts|liver extracts|mesh-list
139294317|NCT04455932|Hematinics|hematinics|mesh-ancestor
139294318|NCT03051022|Dexamethasone|dexamethasone|mesh-list
139294319|NCT03051022|Morphine|morphine|mesh-list
139294320|NCT03051022|Bupivacaine|bupivacaine|mesh-list
139294321|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294322|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
139294323|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
139294324|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294325|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294326|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139294327|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
139294328|NCT03051022|Hormones|hormones|mesh-ancestor
139294329|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139294330|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139294331|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294332|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
139294333|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
139294334|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294335|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
139294336|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139294337|NCT03051022|Narcotics|narcotics|mesh-ancestor
139294338|NCT03051022|Analgesics|analgesics|mesh-ancestor
139294339|NCT04648826|Azacitidine|azacitidine|mesh-list
139294340|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139294341|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
139294342|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294343|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294344|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294345|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
139294346|NCT03052348|Betamethasone|betamethasone|mesh-list
139294347|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
139294348|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139294349|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
139294350|NCT03052348|Ether|ether|mesh-list
139294351|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139294352|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294353|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
139294354|NCT03052348|Hormones|hormones|mesh-ancestor
139294355|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139294356|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294357|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139294358|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
139294359|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139294360|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
139294361|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
139294362|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294363|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139294364|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294365|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139294366|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294367|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294368|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139294369|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294370|NCT03963518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139294371|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294372|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
139294373|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
139294374|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
139294375|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139294376|NCT04101890|Protective Agents|protective agents|mesh-ancestor
139294377|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294378|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
139294379|NCT04456712|Levofloxacin|levofloxacin|mesh-list
139294380|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139294381|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294382|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139294383|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139294384|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423894|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139294385|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294386|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294387|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139294388|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139294389|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139294390|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139294391|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139294392|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294393|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139294394|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
139294395|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139294396|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139294397|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
139294398|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139294399|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
139294400|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139294401|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
139294402|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294403|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294404|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139294405|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
139294406|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139294407|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
139294408|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294409|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294410|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139294411|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
139294412|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
139294413|NCT04456088|Protective Agents|protective agents|mesh-ancestor
139294414|NCT04454840|Riluzole|riluzole|mesh-list
139294415|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
139294416|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139294417|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139294418|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139382169|NCT02108795|Narcotics|narcotics|mesh-ancestor
139294419|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294420|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294421|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139294422|NCT04454840|Protective Agents|protective agents|mesh-ancestor
139294423|NCT03050710|Lidocaine|lidocaine|mesh-list
139294424|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
139294425|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
139294426|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294427|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294428|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
139294429|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294430|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139294431|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139294432|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139294433|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139294434|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294435|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139294436|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139294437|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294438|NCT03993314|Bupivacaine|bupivacaine|mesh-list
139294439|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
139294440|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
139294441|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
139294442|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294443|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294444|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
139294445|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294446|NCT04883164|Antibodies|antibodies|mesh-list
139294447|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
139294448|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294449|NCT03161054|Prednisone|prednisone|mesh-list
139294450|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
139294451|NCT03161054|Rituximab|rituximab|mesh-list
139294452|NCT03161054|Etoposide|etoposide|mesh-list
139294453|NCT03161054|Vinorelbine|vinorelbine|mesh-list
139294454|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139294455|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
139294456|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294457|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139294458|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139294459|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
139294460|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294461|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294462|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139294463|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139294464|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294465|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
139294466|NCT03161054|Hormones|hormones|mesh-ancestor
139294467|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139294468|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139294469|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139294470|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139294471|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139294472|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294473|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
139294474|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
139294475|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
139294476|NCT03050554|Avelumab|avelumab|mesh-list
139294477|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138877918|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
139294478|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294479|NCT03050164|Gefitinib|gefitinib|mesh-list
139294480|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294481|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139294482|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294483|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294484|NCT03049930|Ketamine|ketamine|mesh-list
139294485|NCT03049930|Analgesics|analgesics|mesh-ancestor
139294486|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
139294487|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294488|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294489|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139294490|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139294491|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
139294492|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
139294493|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294494|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139294495|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139294496|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294497|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294498|NCT02036463|Prednisone|prednisone|mesh-list
139294499|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294500|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
139294501|NCT02036463|Hormones|hormones|mesh-ancestor
139294502|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139294503|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294504|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139294505|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294506|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
139294507|NCT04887844|Lidocaine|lidocaine|mesh-list
139294508|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
139294509|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
139294510|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294511|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294512|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
139294513|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294514|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139294515|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139294516|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139294517|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139294518|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294519|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294520|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
139294521|NCT04887844|Hormones|hormones|mesh-ancestor
139294522|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139294523|NCT02595320|Capecitabine|capecitabine|mesh-list
139294524|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139294525|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
139294526|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294527|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294528|NCT02809053|Rituximab|rituximab|mesh-list
139294529|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139294530|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294531|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
139294532|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294533|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139294534|NCT04666688|Paclitaxel|paclitaxel|mesh-list
139294535|NCT04666688|Gemcitabine|gemcitabine|mesh-list
139294536|NCT04666688|Tislelizumab|tislelizumab|mesh-list
139294537|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139294538|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294539|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
139294540|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
139294541|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
139294542|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294543|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139294544|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
139294545|NCT04666688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139294546|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
139294547|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139294548|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139294549|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139294550|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139294551|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294552|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
139294553|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294554|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294555|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139294556|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294557|NCT02047539|Aspirin|aspirin|mesh-list
139294558|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139294559|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139294560|NCT02047539|Analgesics|analgesics|mesh-ancestor
139294561|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
139294562|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294563|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294564|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294565|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139294566|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139294567|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139294568|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294569|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139294570|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139294571|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294572|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
139294573|NCT02522858|Atropine|atropine|mesh-list
139294574|NCT02522858|Ephedrine|ephedrine|mesh-list
139294575|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
139294576|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139294577|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294578|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294579|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139294580|NCT02522858|Analgesics|analgesics|mesh-ancestor
139294581|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
139294582|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294583|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139294584|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139294585|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139294586|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
139294587|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294588|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294589|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139294590|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139294591|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139294592|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
139294593|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139294594|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
139294595|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
139294596|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
139294597|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139294598|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139294599|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
139294600|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139294601|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
139294602|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139164802|NCT06086171|Methadone|methadone|mesh-list
139294603|NCT02036697|Fentanyl|fentanyl|mesh-list
139294604|NCT02036697|Morphine|morphine|mesh-list
139294605|NCT02036697|Bupivacaine|bupivacaine|mesh-list
139294606|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
139294607|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
139294608|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294609|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294610|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
139294611|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294612|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139294613|NCT02036697|Narcotics|narcotics|mesh-ancestor
139294614|NCT02036697|Analgesics|analgesics|mesh-ancestor
139294615|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139294616|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139294617|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
139294618|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
139294619|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139294620|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294621|NCT03106688|Carfentanil|carfentanil|mesh-list
139294622|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139294623|NCT03106688|Narcotics|narcotics|mesh-ancestor
139294624|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294625|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294626|NCT03106688|Analgesics|analgesics|mesh-ancestor
139294627|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
139294628|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294629|NCT02037009|Anesthetics|anesthetics|mesh-list
139294630|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294631|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294632|NCT02260011|Bromides|bromides|mesh-list
139294633|NCT02260011|Norflurane|norflurane|mesh-list
139294634|NCT02260011|Ipratropium|ipratropium|mesh-list
139294635|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
139294636|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139294637|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
139294638|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294639|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294640|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139294641|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
139294642|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139294643|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
139294644|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294645|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294646|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
139294647|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294648|NCT02047773|Meropenem|meropenem|mesh-list
139294649|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139294650|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294651|NCT04886752|Vitamins|vitamins|mesh-list
139294652|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
139294653|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
139294654|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
139294655|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294656|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
139294657|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294658|NCT04886752|Protective Agents|protective agents|mesh-ancestor
139294659|NCT04895800|Caffeine|caffeine|mesh-list
139294660|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139294661|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294662|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139294663|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294664|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294665|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139294666|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139294667|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
139294668|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294669|NCT04886362|Ivermectin|ivermectin|mesh-list
139294670|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139294671|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294672|NCT02048007|Azithromycin|azithromycin|mesh-list
139294673|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139294674|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294675|NCT02048085|Clopidogrel|clopidogrel|mesh-list
139294676|NCT02048085|Ticagrelor|ticagrelor|mesh-list
139294677|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139294678|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139423895|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139164871|NCT05867329|Cyclosporine|cyclosporine|mesh-list
139294679|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139294680|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139294681|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
139294682|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294683|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294684|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294685|NCT02808975|Adalimumab|adalimumab|mesh-list
139294686|NCT02808975|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139294687|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294688|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139294689|NCT04885894|Ozanimod|ozanimod|mesh-list
139294690|NCT04885894|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139294691|NCT04885894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294692|NCT04885894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139294693|NCT04885894|Immunologic Factors|immunologic factors|mesh-ancestor
139294694|NCT04885894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294695|NCT04885660|Lisinopril|lisinopril|mesh-list
139294696|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139294697|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
139294698|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294699|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294700|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139294701|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139294702|NCT04885660|Protective Agents|protective agents|mesh-ancestor
139294703|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294704|NCT02037633|Fentanyl|fentanyl|mesh-list
139294705|NCT02037633|Ropivacaine|ropivacaine|mesh-list
139294706|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
139294707|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
139294708|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294709|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294710|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
139294711|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294712|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139294713|NCT02037633|Narcotics|narcotics|mesh-ancestor
139294714|NCT02037633|Analgesics|analgesics|mesh-ancestor
139294715|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139294716|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139294717|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
139294718|NCT05684211|Cetuximab|cetuximab|mesh-list
139294719|NCT05684211|Antibodies|antibodies|mesh-list
139294720|NCT05684211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139294721|NCT05684211|Immunologic Factors|immunologic factors|mesh-ancestor
139294722|NCT05684211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294723|NCT05684211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139294724|NCT05684211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294725|NCT03130634|Silymarin|silymarin|mesh-list
139294726|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
139294727|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294728|NCT03130634|Protective Agents|protective agents|mesh-ancestor
139294729|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294730|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
139294731|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139294732|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139294733|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294734|NCT04880746|Cladribine|cladribine|mesh-list
139294735|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294736|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139294737|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
139294738|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294739|NCT03050086|Minocycline|minocycline|mesh-list
139294740|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139294741|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294742|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
139294743|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139294744|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139294745|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139294746|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
139294747|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294748|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294749|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294750|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
139294751|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139642471|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
139294752|NCT04885270|Cisplatin|cisplatin|mesh-list
139294753|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294754|NCT04885426|Metformin|metformin|mesh-list
139294755|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139294756|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294757|NCT02808819|Benralizumab|benralizumab|mesh-list
139294758|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139294759|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
139294760|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
139294761|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139294762|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
139294763|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139294764|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294765|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139294766|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139294767|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139294768|NCT04872322|Ropivacaine|ropivacaine|mesh-list
139294769|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139294770|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
139294771|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
138878212|NCT05263583|Bromides|bromides|mesh-list
139294772|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294773|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294774|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
139294775|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294777|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
139294778|NCT04879030|Levofloxacin|levofloxacin|mesh-list
139294779|NCT04879030|Meropenem|meropenem|mesh-list
139294780|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
139294781|NCT04879030|Tazobactam|tazobactam|mesh-list
139294782|NCT04879030|Piperacillin|piperacillin|mesh-list
139294783|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
139294784|NCT04879030|Imipenem|imipenem|mesh-list
138856030|NCT05656742|Vitamin D|vitamin d|mesh-list
139294785|NCT04879030|Ceftazidime|ceftazidime|mesh-list
139294786|NCT04879030|Ertapenem|ertapenem|mesh-list
139294787|NCT04879030|Lactams|lactams|mesh-list
139294788|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139294789|NCT04879030|Cefotaxime|cefotaxime|mesh-list
139294790|NCT04879030|Cefixime|cefixime|mesh-list
139294791|NCT04879030|beta-Lactams|beta-lactams|mesh-list
139294792|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
139294793|NCT04879030|Ticarcillin|ticarcillin|mesh-list
139294794|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139294795|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294796|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139294797|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139294798|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294799|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294800|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294801|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139294802|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139294803|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139294804|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139294805|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139294806|NCT04878718|Vancomycin|vancomycin|mesh-list
139294807|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139294808|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294809|NCT04878016|Carboplatin|carboplatin|mesh-list
139294810|NCT04878016|Etoposide|etoposide|mesh-list
139294811|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294812|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139294813|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139294814|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139294815|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294816|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294817|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139294818|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139294819|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139294820|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294821|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294822|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139294823|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139294824|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294825|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
139294826|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294827|NCT04870372|Selegiline|selegiline|mesh-list
139294828|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
139294829|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139091732|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
139294830|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139294831|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139294832|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139294833|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294834|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294835|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139294836|NCT04870372|Protective Agents|protective agents|mesh-ancestor
139294837|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294838|NCT02048319|Ethanol|ethanol|mesh-list
139294839|NCT02048319|Pasireotide|pasireotide|mesh-list
139294840|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139294841|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294842|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294843|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294844|NCT02048319|Hormones|hormones|mesh-ancestor
139294845|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139294846|NCT01594762|Pexiganan|pexiganan|mesh-list
139294847|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139294848|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294849|NCT02048475|Desflurane|desflurane|mesh-list
139294850|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139294851|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
139294852|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
139294853|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294854|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294856|NCT03562143|Trace Elements|trace elements|mesh-ancestor
139294857|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
139294858|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294859|NCT02048865|Apixaban|apixaban|mesh-list
139294860|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139294861|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
139294862|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139294863|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
139294864|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294865|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294866|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
139294867|NCT02048943|Paclitaxel|paclitaxel|mesh-list
139294868|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139294869|NCT02048943|Gemcitabine|gemcitabine|mesh-list
139294870|NCT02048943|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139294871|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139294872|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294873|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
139294874|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
139294875|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
139294876|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294877|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139294878|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
139294879|NCT02048943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139294880|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294881|NCT02050893|Midazolam|midazolam|mesh-list
139294882|NCT02050893|Propofol|propofol|mesh-list
139294883|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139294884|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294885|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294886|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139294887|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
139294888|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
139294889|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139294890|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139294891|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139294892|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139294893|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
139294894|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
139294895|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294896|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294897|NCT02806947|Sirolimus|sirolimus|mesh-list
139294898|NCT02806947|Prednisone|prednisone|mesh-list
139294899|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294900|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
139294901|NCT02806947|Hormones|hormones|mesh-ancestor
139294902|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139294903|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294904|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139423896|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294905|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294906|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139294907|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294908|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139294909|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
139294910|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139294911|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
139294912|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
139294913|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294914|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
139294915|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294916|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294917|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139294918|NCT02037399|Dexamethasone|dexamethasone|mesh-list
139294919|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139294920|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
139294921|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
139294922|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294923|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294924|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139294925|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
139294926|NCT02037399|Hormones|hormones|mesh-ancestor
138878362|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139294927|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139294928|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139294929|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294930|NCT02260089|Telmisartan|telmisartan|mesh-list
139294931|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139294932|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139294933|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139294934|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294935|NCT02049255|Bupivacaine|bupivacaine|mesh-list
139294936|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
139294937|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
139294938|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
139294939|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294940|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294941|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
139294942|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294943|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
139294944|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
139294945|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
139294946|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294947|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294948|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
139294949|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294950|NCT03561675|Acetazolamide|acetazolamide|mesh-list
139294951|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
139294952|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139294953|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294954|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294955|NCT03561675|Diuretics|diuretics|mesh-ancestor
139294956|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
139294957|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294958|NCT02049411|Ketamine|ketamine|mesh-list
139294959|NCT02049411|Analgesics|analgesics|mesh-ancestor
139294960|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
139294961|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139294962|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294963|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139294964|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139294965|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
139294966|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
139294967|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139294968|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139294969|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139294970|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294971|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294972|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
139294973|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294974|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
139294975|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
139294976|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
139294977|NCT02051751|Paclitaxel|paclitaxel|mesh-list
139423897|NCT03475381|Ivacaftor|ivacaftor|mesh-list
139294978|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139294979|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294980|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
139294981|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
139294982|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
139294983|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294984|NCT02049801|Cytarabine|cytarabine|mesh-list
139294985|NCT02049801|Idarubicin|idarubicin|mesh-list
139294986|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139294987|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
139294988|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139294989|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139294990|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
139294991|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139294992|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139294993|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
139294994|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294995|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139294996|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139294997|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139294998|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294999|NCT02802345|Nintedanib|nintedanib|mesh-list
139295000|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
139295001|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
139295002|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139295003|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139295004|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295005|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295006|NCT02802345|Urological Agents|urological agents|mesh-ancestor
139295007|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295008|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139295009|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139295010|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
139295011|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139295012|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
139295013|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139295014|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295015|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139295016|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139295017|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295018|NCT02056041|Liver Extracts|liver extracts|mesh-list
139295019|NCT02056041|Hematinics|hematinics|mesh-ancestor
139295020|NCT02053857|Amoxicillin|amoxicillin|mesh-list
139295021|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139295022|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139295023|NCT02053935|Dopamine|dopamine|mesh-list
139295024|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139295025|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
139295026|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
139295027|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295028|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295029|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
139295030|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295031|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295032|NCT02053935|Protective Agents|protective agents|mesh-ancestor
139295033|NCT02056353|Insulin|insulin|mesh-list
139295034|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139295035|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295036|NCT02056587|Everolimus|everolimus|mesh-list
139295037|NCT02056587|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139295038|NCT02056587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139295039|NCT02056587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295040|NCT02056587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295041|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139295042|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
139295043|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295044|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295045|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139295046|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139295047|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
139295048|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
139295049|NCT02038335|Etonogestrel|etonogestrel|mesh-list
139295050|NCT02038335|Norethindrone|norethindrone|mesh-list
139295051|NCT02038335|Estradiol|estradiol|mesh-list
139295052|NCT02038335|Estrogens|estrogens|mesh-ancestor
139295053|NCT02038335|Hormones|hormones|mesh-ancestor
139423898|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139295054|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139295055|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295056|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139295057|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
139295058|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139295059|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139295060|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139295061|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139295062|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139295063|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139295064|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139295065|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295066|NCT02056665|Minocycline|minocycline|mesh-list
139295067|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139295068|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139295069|NCT02056743|Fexofenadine|fexofenadine|mesh-list
139295070|NCT02056743|Losartan|losartan|mesh-list
139295071|NCT02056743|Midazolam|midazolam|mesh-list
139295072|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
139295073|NCT02056743|Caffeine|caffeine|mesh-list
139295074|NCT02056743|Omeprazole|omeprazole|mesh-list
139295075|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139295076|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139295077|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295078|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295079|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139295080|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139295081|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139295082|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139295083|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
139295084|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
139295085|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
139295086|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
139295087|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295088|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295089|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139295090|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139295091|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139295092|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139295093|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139295094|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139295095|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295096|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139295097|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139295098|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
139295099|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139295100|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139295101|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139295102|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
139295103|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
139295104|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139295105|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139295106|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139295107|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139295108|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139295109|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
139295110|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
139295111|NCT02052375|ASP2408|asp2408|mesh-list
139295112|NCT02052375|Immunoconjugates|immunoconjugates|mesh-ancestor
139295113|NCT02052375|Immunologic Factors|immunologic factors|mesh-ancestor
139295114|NCT02052375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295115|NCT02054637|Lanreotide|lanreotide|mesh-list
139295116|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295117|NCT02054793|Itraconazole|itraconazole|mesh-list
139295118|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
139295119|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139295120|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139295121|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139295122|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295123|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295124|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139295125|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
139295126|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139295127|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165329|NCT03845894|Bupivacaine|bupivacaine|mesh-list
139295128|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139295129|NCT02052687|Imiquimod|imiquimod|mesh-list
139295130|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139295131|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
139295132|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295133|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295134|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
139295135|NCT02057289|Micafungin|micafungin|mesh-list
139295136|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
139295137|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139295138|NCT02057367|Bupivacaine|bupivacaine|mesh-list
139295139|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
139295140|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
139295141|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295142|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295143|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
139295144|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295145|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
139295146|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139295147|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
139295148|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139295149|NCT02054949|Expectorants|expectorants|mesh-ancestor
139295150|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
139295151|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139295152|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
139295153|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878590|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139295154|NCT02054949|Protective Agents|protective agents|mesh-ancestor
139295155|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295156|NCT02054949|Antidotes|antidotes|mesh-ancestor
139295157|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139295159|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139295160|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139295161|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
139295162|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295163|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139295164|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139295165|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295166|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
139295167|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
139295168|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
139295169|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295170|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295171|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
139295172|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295173|NCT02057679|Amoxicillin|amoxicillin|mesh-list
139295174|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139295175|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139295176|NCT02038491|Anesthetics|anesthetics|mesh-list
139295177|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295178|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295179|NCT02055183|Antitoxins|antitoxins|mesh-list
139295180|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
139295181|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
139295182|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295183|NCT02748213|Docetaxel|docetaxel|mesh-list
139295184|NCT02748213|Capecitabine|capecitabine|mesh-list
139295185|NCT02748213|Trastuzumab|trastuzumab|mesh-list
139295186|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295187|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
139295188|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
139295189|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
139295190|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295191|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139295192|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
139295193|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139295194|NCT03804099|Aflibercept|aflibercept|mesh-list
139295195|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139295196|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139295197|NCT03804099|Growth Substances|growth substances|mesh-ancestor
139295198|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295199|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
139295200|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295201|NCT02058303|Bupivacaine|bupivacaine|mesh-list
139295202|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
139423899|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139295203|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
139295204|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295205|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295206|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
139295207|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295208|NCT04870060|Curcumin|curcumin|mesh-list
139295209|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139295210|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139295211|NCT04870060|Analgesics|analgesics|mesh-ancestor
139295212|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
139295213|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295214|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295215|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139295216|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139295217|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295218|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295219|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295220|NCT02613910|Acetaminophen|acetaminophen|mesh-list
139295221|NCT02613910|Cetirizine|cetirizine|mesh-list
139295222|NCT02613910|Prednisone|prednisone|mesh-list
139295223|NCT02613910|Prednisolone|prednisolone|mesh-list
139295224|NCT02613910|Ofatumumab|ofatumumab|mesh-list
139295225|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
138878668|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139295226|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139295227|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139295228|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
139295229|NCT02613910|Hormones|hormones|mesh-ancestor
139295230|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139295231|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295232|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139295233|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295234|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139295235|NCT02613910|Analgesics|analgesics|mesh-ancestor
139295236|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
139295237|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295238|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
139295239|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139295240|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139295241|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
139295242|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295243|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295244|NCT02802735|Apremilast|apremilast|mesh-list
139295245|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139295246|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139295247|NCT02802735|Analgesics|analgesics|mesh-ancestor
139295248|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
139295249|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295250|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295251|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139295252|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139295253|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139295254|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139295255|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295256|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295257|NCT03048214|Anesthetics|anesthetics|mesh-list
139295258|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295259|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295260|NCT02060955|Bevacizumab|bevacizumab|mesh-list
139295261|NCT02060955|Irinotecan|irinotecan|mesh-list
139295262|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139295263|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295264|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139295265|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139295266|NCT02060955|Growth Substances|growth substances|mesh-ancestor
139295267|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295268|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
139295269|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139295270|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139295271|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295272|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295273|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139295274|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165473|NCT03043313|Trastuzumab|trastuzumab|mesh-list
139295275|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139295276|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295277|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295278|NCT04877626|Artesunate|artesunate|mesh-list
139295279|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
139295280|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139295281|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139295282|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139295283|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295284|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
139295285|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
139295286|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139295287|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
139295288|NCT05255848|Heparin|heparin|mesh-list
139295289|NCT05255848|Calcium heparin|calcium heparin|mesh-list
139295290|NCT05255848|Anticoagulants|anticoagulants|mesh-ancestor
139295291|NCT05255848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139295292|NCT05255848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139295293|NCT05255848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295294|NCT04430062|Anesthetics|anesthetics|mesh-list
139295295|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295296|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295297|NCT02799381|Levodopa|levodopa|mesh-list
139295298|NCT02799381|Carbidopa|carbidopa|mesh-list
139295299|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139295300|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
139295301|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139295302|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
139295303|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295304|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295305|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295306|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139295307|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295308|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139295309|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
139295310|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
139295312|NCT04387942|Interleukin-2|interleukin-2|mesh-list
139295313|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295314|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139295315|NCT04387942|Analgesics|analgesics|mesh-ancestor
139295316|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
139295317|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295318|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295319|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139295320|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139295321|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
139295322|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139295323|NCT01333059|Midazolam|midazolam|mesh-list
139295324|NCT01333059|Fentanyl|fentanyl|mesh-list
139295325|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139295326|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139295327|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295328|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295329|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139295330|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139295331|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139295332|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139295333|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
139295334|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
139295335|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
139295336|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
139295337|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295338|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295339|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139295340|NCT01333059|Narcotics|narcotics|mesh-ancestor
139295341|NCT01333059|Analgesics|analgesics|mesh-ancestor
139295342|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
139295343|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295344|NCT02060253|Paclitaxel|paclitaxel|mesh-list
139295345|NCT02060253|Trastuzumab|trastuzumab|mesh-list
139295346|NCT02060253|Pertuzumab|pertuzumab|mesh-list
139295347|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139295348|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295349|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
139295350|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
139295351|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
139423900|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295352|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295353|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139295354|NCT03560973|Gemcitabine|gemcitabine|mesh-list
139295355|NCT03560973|Ramucirumab|ramucirumab|mesh-list
139295356|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139295357|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
139295358|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295359|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295360|NCT04383574|Vaccines|vaccines|mesh-list
139295361|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
139295362|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295363|NCT03046108|Triamcinolone|triamcinolone|mesh-list
139295364|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139295365|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139295366|NCT03046108|Mepivacaine|mepivacaine|mesh-list
139295367|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139295368|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139295369|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
139295370|NCT03046108|Hormones|hormones|mesh-ancestor
139295371|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139295372|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295373|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139295374|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
139295375|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295376|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295377|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
139295378|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
139295379|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295380|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
139295381|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295383|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
139295384|NCT02061267|Vitamins|vitamins|mesh-ancestor
139295385|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
139295386|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295387|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
139295388|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139295389|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
139295390|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295391|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139295392|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
139295393|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139295394|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139295395|NCT01370655|Diuretics|diuretics|mesh-ancestor
139295396|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
139295397|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295398|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139295399|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139295400|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295401|NCT02612194|Crizotinib|crizotinib|mesh-list
139295402|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295403|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139295404|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295405|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295406|NCT03044626|Nivolumab|nivolumab|mesh-list
139295407|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139295408|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295409|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139295410|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295411|NCT04865224|Chrysarobin|chrysarobin|mesh-list
139295412|NCT04865224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139295413|NCT04865224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139295414|NCT04865224|Analgesics|analgesics|mesh-ancestor
139295415|NCT04865224|Sensory System Agents|sensory system agents|mesh-ancestor
139295416|NCT04865224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295417|NCT04865224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295418|NCT04865224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139295419|NCT04865224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139295420|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
139295421|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139295422|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139295423|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295424|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
139295425|NCT04865380|Coagulants|coagulants|mesh-ancestor
139295426|NCT04869046|Acetaminophen|acetaminophen|mesh-list
139295428|NCT04869046|Analgesics|analgesics|mesh-list
139295429|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
139295430|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139295431|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
139295432|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295433|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295434|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
139295435|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139295436|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139295437|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139295438|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139295439|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295440|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295441|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
139295442|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
139295443|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295444|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
139295445|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139295446|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139295447|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139295448|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
139295449|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
139295450|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139295451|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
139295452|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295453|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
139295454|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139295455|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139295457|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
139295458|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295459|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139295460|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139295461|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295462|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139295463|NCT05654415|Melatonin|melatonin|mesh-list
139295464|NCT05654415|Antioxidants|antioxidants|mesh-ancestor
139295465|NCT05654415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295466|NCT05654415|Protective Agents|protective agents|mesh-ancestor
139295467|NCT05654415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295468|NCT05654415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295469|NCT03044938|Albuterol|albuterol|mesh-list
139295470|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139295471|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
139295472|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295473|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295474|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139295475|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
139295476|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
139295477|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139295478|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139295479|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139295480|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139295481|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
139295482|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295483|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295484|NCT03045484|Oxycodone|oxycodone|mesh-list
139295485|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139295486|NCT03045484|Narcotics|narcotics|mesh-ancestor
139295487|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295488|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295489|NCT03045484|Analgesics|analgesics|mesh-ancestor
139295490|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
139295491|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295492|NCT04874506|TEMPO|tempo|mesh-list
139295493|NCT04874506|TEMPOL-H|tempol-h|mesh-list
139295494|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
139295495|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295496|NCT04874506|Protective Agents|protective agents|mesh-ancestor
139295497|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295498|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139295499|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
139295500|NCT04874428|Apixaban|apixaban|mesh-list
139295501|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139295502|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
139295503|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139295504|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
139295505|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295506|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295507|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
139295508|NCT04867720|Everolimus|everolimus|mesh-list
139295509|NCT04867720|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139295510|NCT04867720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139295511|NCT04867720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295512|NCT04867720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295513|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139295514|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
139295515|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295516|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295517|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139295518|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139295519|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
139295520|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
139295521|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139295522|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139295523|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
139295524|NCT03045406|Dalteparin|dalteparin|mesh-list
139295525|NCT03045406|Tinzaparin|tinzaparin|mesh-list
139295526|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139295527|NCT03045406|Apixaban|apixaban|mesh-list
139295528|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139295529|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
138878964|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
139295530|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139295532|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295533|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295534|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
139295535|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139295536|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139295537|NCT02798835|Dexamethasone|dexamethasone|mesh-list
139295538|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
139295539|NCT02798835|Fentanyl|fentanyl|mesh-list
139295540|NCT02798835|Bupivacaine|bupivacaine|mesh-list
139295541|NCT02798835|Ropivacaine|ropivacaine|mesh-list
139295542|NCT02798835|BB 1101|bb 1101|mesh-list
139295543|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139295544|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
139295545|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
139295546|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295547|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295548|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139295549|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
139295550|NCT02798835|Hormones|hormones|mesh-ancestor
139295551|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139295552|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139295553|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295554|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
139295555|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295556|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295557|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
139295558|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
139295559|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295560|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
139295561|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139295562|NCT02798835|Narcotics|narcotics|mesh-ancestor
139295563|NCT02798835|Analgesics|analgesics|mesh-ancestor
139295564|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139295565|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139295566|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
139295567|NCT02061657|Misoprostol|misoprostol|mesh-list
139295568|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139295569|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
139295570|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139295571|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295572|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139295573|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139295574|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
139295575|NCT03048136|Nivolumab|nivolumab|mesh-list
139295576|NCT03048136|Ipilimumab|ipilimumab|mesh-list
139295577|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139295578|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295579|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139295580|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295581|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
139295582|NCT02062203|Glycine|glycine|mesh-list
139295583|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139295584|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139295585|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139295586|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139295587|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295588|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295589|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295590|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295591|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
139295592|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295593|NCT04863742|Prednisolone|prednisolone|mesh-list
139295594|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139295595|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
139295596|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139295597|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
139295598|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139295599|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
139295600|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139295601|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
139295602|NCT04863742|Hormones|hormones|mesh-ancestor
139295603|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139295604|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295605|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139295606|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295608|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
139295609|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295610|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139295611|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139295612|NCT04863742|Protective Agents|protective agents|mesh-ancestor
139295613|NCT02611882|Edetic Acid|edetic acid|mesh-list
139295614|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
139295615|NCT02611882|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139295616|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
139295617|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
139295618|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295619|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
139295620|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139295621|NCT02611882|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139295622|NCT02062281|Vaccines|vaccines|mesh-list
139295623|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139295624|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
139295625|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295626|NCT03560583|Metoclopramide|metoclopramide|mesh-list
139295627|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
139295628|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
139295629|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295630|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295631|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139295632|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139295633|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139295634|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
139295635|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295636|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295637|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139295638|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139295639|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139295640|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139295641|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295642|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295643|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295644|NCT03560427|Analgesics|analgesics|mesh-ancestor
139295645|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
139295646|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295647|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
139295648|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139295649|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
139295650|NCT03797547|Aflibercept|aflibercept|mesh-list
139295651|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139295652|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139295653|NCT03797547|Growth Substances|growth substances|mesh-ancestor
139295654|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295655|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
139295657|NCT04867252|Inositol|inositol|mesh-list
139295658|NCT04867252|Metformin|metformin|mesh-list
139295659|NCT04867252|Pioglitazone|pioglitazone|mesh-list
139295660|NCT04867252|Resveratrol|resveratrol|mesh-list
139295661|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139295662|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295663|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
139295664|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295665|NCT04867252|Protective Agents|protective agents|mesh-ancestor
139295666|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295667|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139295668|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
139295669|NCT04867252|Vitamins|vitamins|mesh-ancestor
139295670|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
139295671|NCT04863274|Atorvastatin|atorvastatin|mesh-list
139295672|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139295673|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139295674|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
139295675|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295676|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139295677|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139295678|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879117|NCT00978913|Vaccines|vaccines|mesh-list
139295679|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
139295680|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139295681|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
139295682|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295683|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
139295684|NCT02063373|Protective Agents|protective agents|mesh-ancestor
139295685|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
139295686|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295687|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139295688|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
139295689|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139295690|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
139295691|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295692|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295693|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139295694|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
139295695|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139295696|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139295697|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139295698|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
139295699|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295700|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295701|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139295702|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139295703|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139295704|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139295705|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295706|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295707|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139295708|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139295709|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295710|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
139295711|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295712|NCT04429282|Ibuprofen|ibuprofen|mesh-list
139295713|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139295714|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139295715|NCT04429282|Analgesics|analgesics|mesh-ancestor
139295716|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
139295717|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295718|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295719|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139295720|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139295721|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139295722|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295723|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295724|NCT02063529|Leucovorin|leucovorin|mesh-list
139295725|NCT02063529|Fluorouracil|fluorouracil|mesh-list
139295726|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
139295727|NCT02063529|Irinotecan|irinotecan|mesh-list
139295728|NCT02063529|Cetuximab|cetuximab|mesh-list
139295729|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
139295730|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
139295731|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295732|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139295733|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295734|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139295735|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
139295736|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295737|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139295738|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139295739|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295740|NCT02063529|Antidotes|antidotes|mesh-ancestor
139295741|NCT02063529|Protective Agents|protective agents|mesh-ancestor
139295742|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
139295743|NCT02063529|Vitamins|vitamins|mesh-ancestor
139295744|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
139295745|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139295746|NCT02062983|Trastuzumab|trastuzumab|mesh-list
139295747|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139295748|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295749|NCT02613208|Paclitaxel|paclitaxel|mesh-list
139295750|NCT02613208|Bevacizumab|bevacizumab|mesh-list
139295751|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139295752|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295753|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
138879186|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295754|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
139295755|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
139295756|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295757|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139295758|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139295759|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139295760|NCT02613208|Growth Substances|growth substances|mesh-ancestor
139295761|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295762|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
139295763|NCT02063841|Bismuth|bismuth|mesh-list
139295764|NCT02063841|Antacids|antacids|mesh-ancestor
139295765|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295766|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139295767|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
139295768|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139295769|NCT04872634|Cetuximab|cetuximab|mesh-list
139295770|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139295771|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295772|NCT01668784|Nivolumab|nivolumab|mesh-list
139295773|NCT01668784|Everolimus|everolimus|mesh-list
139295774|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139295775|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295776|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139295777|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295778|NCT01668784|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139295779|NCT01668784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139295780|NCT01668784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295781|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139295782|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
139295783|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295784|NCT02750514|Nivolumab|nivolumab|mesh-list
139295785|NCT02750514|Ipilimumab|ipilimumab|mesh-list
139295786|NCT02750514|Relatlimab|relatlimab|mesh-list
139295787|NCT02750514|Dasatinib|dasatinib|mesh-list
139295788|NCT02750514|Linrodostat|linrodostat|mesh-list
139295789|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139295790|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295791|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139295792|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295793|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139295794|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295795|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
139295796|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139295797|NCT02229240|Incretins|incretins|mesh-ancestor
139295798|NCT02229240|Hormones|hormones|mesh-ancestor
139295799|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139295800|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295801|NCT02820714|Laxatives|laxatives|mesh-list
139295802|NCT02820714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139295803|NCT02259426|Piperaquine|piperaquine|mesh-list
139295804|NCT02259426|Primaquine|primaquine|mesh-list
139295805|NCT02259426|Artenimol|artenimol|mesh-list
139295806|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
139295807|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139295808|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139295809|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139295810|NCT03742518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139295811|NCT03412890|Norethindrone|norethindrone|mesh-list
139295812|NCT03412890|Norethindrone Acetate|norethindrone acetate|mesh-list
139295813|NCT03412890|Estradiol|estradiol|mesh-list
139295814|NCT03412890|Relugolix|relugolix|mesh-list
139295815|NCT03412890|Estrogens|estrogens|mesh-ancestor
139295816|NCT03412890|Hormones|hormones|mesh-ancestor
139295817|NCT03412890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139295818|NCT03412890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295819|NCT03412890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139295820|NCT03412890|Contraceptive Agents|contraceptive agents|mesh-ancestor
139295821|NCT03412890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139295822|NCT03412890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139295823|NCT03412890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139295824|NCT03412890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139295825|NCT03412890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139295826|NCT03412890|Androgen Antagonists|androgen antagonists|mesh-ancestor
139295827|NCT03412890|Hormone Antagonists|hormone antagonists|mesh-ancestor
139295828|NCT03371082|Insulin Glargine|insulin glargine|mesh-list
139295829|NCT03371082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139295830|NCT03371082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295831|NCT03340974|Manganese|manganese|mesh-list
139295832|NCT03340974|Avasopasem manganese|avasopasem manganese|mesh-list
139295833|NCT03340974|Trace Elements|trace elements|mesh-ancestor
139295834|NCT03340974|Micronutrients|micronutrients|mesh-ancestor
139295835|NCT03340974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295836|NCT03340974|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139295837|NCT03340974|Antioxidants|antioxidants|mesh-ancestor
139295838|NCT03340974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295839|NCT03340974|Protective Agents|protective agents|mesh-ancestor
139295840|NCT02229786|Acetaminophen|acetaminophen|mesh-list
139295841|NCT02229786|Scopolamine|scopolamine|mesh-list
139295842|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139295843|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139295844|NCT02229786|Analgesics|analgesics|mesh-ancestor
139295845|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
139295846|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295847|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295848|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
139295849|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
139295850|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
139295851|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139295852|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139295853|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
139295854|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295855|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295856|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139295857|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
139295858|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139295859|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
139295860|NCT03287232|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139295861|NCT03287232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139295862|NCT03287232|Immunologic Factors|immunologic factors|mesh-ancestor
139295863|NCT03287232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295864|NCT02229942|Rituximab|rituximab|mesh-list
139295865|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139295866|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295867|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
139295868|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295869|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139295870|NCT03047278|Cetirizine|cetirizine|mesh-list
139295871|NCT03047278|Gabapentin|gabapentin|mesh-list
139295872|NCT03047278|Analgesics|analgesics|mesh-ancestor
139295873|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
139295874|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295875|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295876|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
139295877|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139295878|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139295879|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295880|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139295881|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139295882|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139295883|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295884|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295885|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
139295886|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139295887|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139295888|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139295889|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
139295890|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
139295891|NCT03045016|Prazosin|prazosin|mesh-list
139295892|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139295893|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139295894|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139295895|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139295896|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
139295897|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295898|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295899|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295900|NCT04849858|Bupivacaine|bupivacaine|mesh-list
139295901|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
139295902|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
139295903|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295904|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295905|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
139295906|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295907|NCT03043612|Doxazosin|doxazosin|mesh-list
139295908|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139295909|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139295910|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139295911|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139295912|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
139295913|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295914|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295915|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295916|NCT02230176|Sunitinib|sunitinib|mesh-list
139295917|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139295918|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295919|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139295920|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139295921|NCT02230176|Growth Substances|growth substances|mesh-ancestor
139295922|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295923|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
139295924|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139295925|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295926|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295927|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139295928|NCT02232516|Lenalidomide|lenalidomide|mesh-list
139295929|NCT02232516|Romidepsin|romidepsin|mesh-list
139295930|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
139295931|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295932|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139295933|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139295934|NCT02232516|Growth Substances|growth substances|mesh-ancestor
139295935|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
139295936|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295937|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139295938|NCT02232516|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139295939|NCT02232516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295940|NCT02232516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295941|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139295942|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139295943|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
139295944|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295945|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295946|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139295947|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
139295948|NCT04858516|Trastuzumab|trastuzumab|mesh-list
139295949|NCT04858516|Palbociclib|palbociclib|mesh-list
139295950|NCT04858516|Exemestane|exemestane|mesh-list
139295951|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139295952|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295953|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139295954|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295955|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295957|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139295958|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139295959|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
139295960|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139295961|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295962|NCT03148860|Methotrexate|methotrexate|mesh-list
139295963|NCT03148860|Ustekinumab|ustekinumab|mesh-list
138857205|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295964|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139295965|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
139295966|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139295967|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295968|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139295969|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
139295970|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295971|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139295972|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
139295973|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139295974|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139295975|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139295976|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
139295977|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139295978|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139295979|NCT03131154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139295980|NCT03131154|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138879421|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
139295982|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
139295983|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139295984|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
139295985|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139295986|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139295987|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139295988|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
139295989|NCT05072262|Dexamethasone|dexamethasone|mesh-list
139295990|NCT05072262|Nepafenac|nepafenac|mesh-list
139295991|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139295992|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
139295993|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
139295994|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139295995|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139295996|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139295997|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
139295998|NCT05072262|Hormones|hormones|mesh-ancestor
139295999|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139296000|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139296001|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296002|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139296003|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139296004|NCT05072262|Analgesics|analgesics|mesh-ancestor
139296005|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
139296006|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139296007|NCT04858048|Anesthetics|anesthetics|mesh-list
139296008|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296009|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296010|NCT02234466|Dexamethasone|dexamethasone|mesh-list
139296011|NCT02234466|Ondansetron|ondansetron|mesh-list
139296012|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139296013|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
139296014|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
139296015|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296016|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296017|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139296018|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
139296019|NCT02234466|Hormones|hormones|mesh-ancestor
139296020|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139296021|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139296022|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296023|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
139296024|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
139296025|NCT02234466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139296026|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139296027|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
139296028|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296029|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296030|NCT02230800|Tocovid|tocovid|mesh-list
139296031|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
139296032|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139296033|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296034|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296035|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139296036|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139296037|NCT02230800|Protective Agents|protective agents|mesh-ancestor
139296038|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296039|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
139296040|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139296041|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
139296042|NCT02230800|Vitamins|vitamins|mesh-ancestor
139296043|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
139296044|NCT02234544|Vitamin D|vitamin d|mesh-list
139296045|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
139296046|NCT02234544|Ezetimibe|ezetimibe|mesh-list
139296047|NCT02234544|Vitamins|vitamins|mesh-ancestor
139296048|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
139296049|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296050|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139296051|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139296052|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139296053|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139296054|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
139296055|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296056|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138879566|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296057|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139296058|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139296059|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296060|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
139296061|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
139296062|NCT04860076|Nivolumab|nivolumab|mesh-list
139296063|NCT04860076|Ipilimumab|ipilimumab|mesh-list
139296064|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139296065|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296066|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139296067|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296068|NCT04856878|Vancomycin|vancomycin|mesh-list
139296069|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139296070|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296071|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
139296072|NCT04856644|Rifapentine|rifapentine|mesh-list
139296073|NCT04856644|Rifampin|rifampin|mesh-list
139296074|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139296075|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296076|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139296077|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139296078|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296079|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296080|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296081|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139296082|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
139296083|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
139296084|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139296085|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139296086|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139296087|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139296088|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139296089|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139296090|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139296091|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
139296092|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
139296093|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296094|NCT04984278|Nabiximols|nabiximols|mesh-list
139296095|NCT04984278|Analgesics|analgesics|mesh-ancestor
139296096|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
139296097|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296098|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296099|NCT02233218|Amlodipine|amlodipine|mesh-list
139296100|NCT02233218|Telmisartan|telmisartan|mesh-list
139296101|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139296102|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139296103|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139296104|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139296105|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296106|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139296107|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296108|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
139296109|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139296110|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139296111|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
138857358|NCT00938353|Hormones|hormones|mesh-ancestor
139296112|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139296113|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139296114|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296115|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139296116|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139296117|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
139296118|NCT02262546|Pramipexole|pramipexole|mesh-list
139296119|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139296120|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139296121|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296122|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139296123|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139296124|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296125|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296126|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296127|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139296128|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
139296129|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139296130|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296131|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139296133|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139296134|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
139296135|NCT02262546|Protective Agents|protective agents|mesh-ancestor
139296136|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139296137|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139296138|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
139296139|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
139296140|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296141|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
139296142|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139296143|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139296144|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296145|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
139296146|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296147|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296148|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
139296149|NCT04856098|Bromides|bromides|mesh-list
139296150|NCT04856098|Maleic acid|maleic acid|mesh-list
139296151|NCT04856098|Charcoal|charcoal|mesh-list
139296152|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
139296153|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296154|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296155|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139296156|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139296157|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139296158|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
139296159|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296160|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296161|NCT04856098|Antidotes|antidotes|mesh-ancestor
139296162|NCT04856098|Protective Agents|protective agents|mesh-ancestor
139296163|NCT04859452|Metformin|metformin|mesh-list
139296164|NCT04859452|Glyburide|glyburide|mesh-list
139296165|NCT04859452|Valsartan|valsartan|mesh-list
139296166|NCT04859452|Simvastatin|simvastatin|mesh-list
139296167|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139296168|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296169|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139296170|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139296171|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
139296172|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296173|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139296174|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139296175|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296176|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139296177|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139296178|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139296179|NCT02262624|Telmisartan|telmisartan|mesh-list
139296180|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139296181|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139296182|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139296183|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139296184|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296185|NCT02262624|Diuretics|diuretics|mesh-ancestor
139296186|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
139296187|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296188|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139296189|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139296190|NCT02233452|Ketamine|ketamine|mesh-list
139296191|NCT02233452|Methadone|methadone|mesh-list
139296192|NCT02233452|Analgesics|analgesics|mesh-ancestor
139296193|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
139296194|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296195|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296196|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139296197|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139296198|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
139296199|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
139296200|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296201|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139296202|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139296203|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879641|NCT04073758|Analgesics|analgesics|mesh-ancestor
139296204|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296205|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139296206|NCT02233452|Narcotics|narcotics|mesh-ancestor
139296207|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
139296208|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
139296209|NCT02262702|Acetaminophen|acetaminophen|mesh-list
139296210|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139296211|NCT02262702|Analgesics|analgesics|mesh-ancestor
139296212|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
139296213|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296214|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296215|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
139296216|NCT04846894|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139296217|NCT04846894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139296218|NCT04846894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296219|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
139296220|NCT04845880|Paraproteins|paraproteins|mesh-list
139296221|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
139296222|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296223|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139296224|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139296225|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296226|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139296227|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296228|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296229|NCT03041506|Lidocaine|lidocaine|mesh-list
139296230|NCT03041506|Midazolam|midazolam|mesh-list
139296231|NCT03041506|Ketamine|ketamine|mesh-list
139296232|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
139296233|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
139296234|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296235|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296236|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
139296237|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296238|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139296239|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139296240|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139296241|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139296242|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296243|NCT03041506|Analgesics|analgesics|mesh-ancestor
139296244|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139296245|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139296246|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
139296247|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139296248|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139296249|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296250|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139296251|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139296252|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139296253|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139296254|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139296255|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
139296256|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
139296257|NCT02580708|Trametinib|trametinib|mesh-list
139296258|NCT02580708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296259|NCT02580708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139296260|NCT02580708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296261|NCT02580708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296262|NCT04845646|Itraconazole|itraconazole|mesh-list
139296263|NCT04845646|Phenytoin|phenytoin|mesh-list
139296264|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
139296265|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296266|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139296267|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139296268|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296269|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296270|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139296271|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
139296272|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139296273|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296274|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139296275|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
139296276|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139296277|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139296278|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139296279|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139296280|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139296281|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
139296282|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
139296283|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
139296284|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296285|NCT03038776|Coagulants|coagulants|mesh-ancestor
139296286|NCT02570490|Linezolid|linezolid|mesh-list
139296287|NCT02570490|Fusidic Acid|fusidic acid|mesh-list
139296288|NCT02570490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139296289|NCT02570490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296290|NCT02570490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139296291|NCT02570490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296292|NCT02570490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296293|NCT02565732|Botulinum Toxins|botulinum toxins|mesh-list
139296294|NCT02565732|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139296295|NCT02565732|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139296296|NCT02565732|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139296297|NCT02565732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139296298|NCT02565732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296299|NCT02565732|Cholinergic Agents|cholinergic agents|mesh-ancestor
139296300|NCT02565732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296301|NCT02565732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296302|NCT02565732|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139296303|NCT02565732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296304|NCT02561442|Ceftriaxone|ceftriaxone|mesh-list
139296305|NCT02561442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139296306|NCT02561442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296307|NCT02262858|Telmisartan|telmisartan|mesh-list
139296308|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139296309|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139296310|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139296311|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139296312|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296313|NCT02262858|Diuretics|diuretics|mesh-ancestor
139296314|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
139296315|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296316|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139296317|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139296318|NCT02235012|Ketamine|ketamine|mesh-list
139296319|NCT02235012|Analgesics|analgesics|mesh-ancestor
139296320|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
139296321|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296322|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296323|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139296324|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139296325|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
139296327|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296328|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139296329|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139296330|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296331|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296332|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139296333|NCT02262936|Fesoterodine|fesoterodine|mesh-list
139296334|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139296335|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139296336|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
139296337|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296338|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296339|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296340|NCT02262936|Urological Agents|urological agents|mesh-ancestor
139296341|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
139296342|NCT02262936|Coagulants|coagulants|mesh-ancestor
139296343|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139296344|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
139296345|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
139296346|NCT04838704|Methotrexate|methotrexate|mesh-list
139296347|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139296348|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
139296349|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139296350|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296351|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139296352|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
139296353|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296354|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296355|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
139296356|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296357|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139296358|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139296359|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
139296360|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139296361|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139296362|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139296363|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139296364|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
139296365|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139296366|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296367|NCT02259738|Kallikreins|kallikreins|mesh-list
139296368|NCT02259738|Coagulants|coagulants|mesh-ancestor
139296369|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
139296370|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
139296371|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139296372|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296373|NCT04854460|Ivermectin|ivermectin|mesh-list
139296374|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139296375|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296376|NCT04854538|Budesonide|budesonide|mesh-list
139296377|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139296378|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139296379|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
139296380|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296381|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296382|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139296383|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
139296384|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
139296385|NCT04854538|Hormones|hormones|mesh-ancestor
139296386|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139296387|NCT05331690|Dexamethasone|dexamethasone|mesh-list
139296388|NCT05331690|Nepafenac|nepafenac|mesh-list
139296389|NCT05331690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139296390|NCT05331690|Antiemetics|antiemetics|mesh-ancestor
139296391|NCT05331690|Autonomic Agents|autonomic agents|mesh-ancestor
139296392|NCT05331690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296393|NCT05331690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296394|NCT05331690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139296395|NCT05331690|Glucocorticoids|glucocorticoids|mesh-ancestor
139296396|NCT05331690|Hormones|hormones|mesh-ancestor
139296397|NCT05331690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139296399|NCT05331690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296400|NCT05331690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139296401|NCT05331690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139296402|NCT05331690|Analgesics|analgesics|mesh-ancestor
139296403|NCT05331690|Sensory System Agents|sensory system agents|mesh-ancestor
139296404|NCT05331690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139296405|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139296406|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296407|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296408|NCT02263170|Phenobarbital|phenobarbital|mesh-list
139296409|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
139296410|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139296411|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296412|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296413|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139296414|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139296415|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296416|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296417|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
139296418|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
139296419|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139296420|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139296421|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139296422|NCT03038230|Antibodies|antibodies|mesh-list
139296423|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139296424|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
139296425|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296426|NCT04853758|Valsartan|valsartan|mesh-list
139296427|NCT04853758|Enalapril|enalapril|mesh-list
139296428|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139296429|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139296430|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139296431|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139296432|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139296433|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139296434|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296435|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
139296436|NCT02784288|Paclitaxel|paclitaxel|mesh-list
139296437|NCT02784288|Carboplatin|carboplatin|mesh-list
139296438|NCT02784288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139296439|NCT02784288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296440|NCT02784288|Tubulin Modulators|tubulin modulators|mesh-ancestor
139296441|NCT02784288|Antimitotic Agents|antimitotic agents|mesh-ancestor
139296442|NCT02784288|Mitosis Modulators|mitosis modulators|mesh-ancestor
139296443|NCT02784288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296444|NCT03040180|Bleomycin|bleomycin|mesh-list
139296445|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139296446|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296447|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
139296448|NCT02235246|Analgesics|analgesics|mesh-ancestor
139296449|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
139296450|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296451|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296452|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
139296453|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296454|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139296455|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
139296456|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139296457|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139296458|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296459|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139296460|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
139296461|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139296462|NCT02235324|Leucovorin|leucovorin|mesh-list
139296463|NCT02235324|Fluorouracil|fluorouracil|mesh-list
139296464|NCT02235324|Aflibercept|aflibercept|mesh-list
139296465|NCT02235324|Calcium|calcium|mesh-list
139296466|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
139296467|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
139296468|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139296469|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296470|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
139296471|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296472|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139296473|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296474|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139296475|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
139296477|NCT02235324|Protective Agents|protective agents|mesh-ancestor
139296478|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
139296479|NCT02235324|Vitamins|vitamins|mesh-ancestor
139296480|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
139296481|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139296482|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139296483|NCT02235324|Growth Substances|growth substances|mesh-ancestor
139296484|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
139296485|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
139296486|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139296487|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
139296488|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139296489|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296490|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139296491|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139296492|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139296493|NCT02263248|Buprenorphine|buprenorphine|mesh-list
139296494|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139296495|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139296496|NCT02263248|Narcotics|narcotics|mesh-ancestor
139296497|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296498|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296499|NCT02263248|Analgesics|analgesics|mesh-ancestor
139296500|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
139296501|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296502|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139296503|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139296504|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139296505|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139296506|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296507|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296508|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139296509|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
139296510|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139296511|NCT04838860|Siltuximab|siltuximab|mesh-list
139296512|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296513|NCT04853524|Tenofovir|tenofovir|mesh-list
139296514|NCT04853524|Emtricitabine|emtricitabine|mesh-list
139296515|NCT04853524|JNJ-56136379|jnj-56136379|mesh-list
139296516|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
139296517|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296518|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139296519|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139296520|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296521|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296522|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139296523|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139296524|NCT04852510|Metformin|metformin|mesh-list
139296525|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139296526|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296527|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
139296528|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139296529|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296530|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296531|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139296532|NCT05163704|Analgesics|analgesics|mesh-ancestor
139296533|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
139296534|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296535|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139296536|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139296537|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139296538|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
139296539|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296540|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296541|NCT03130556|Rabeprazole|rabeprazole|mesh-list
139296542|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139296543|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139296544|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139296545|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296546|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296548|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
139296549|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296550|NCT04842838|Paclitaxel|paclitaxel|mesh-list
139296551|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139296552|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296553|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
139296554|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
139296555|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
139296556|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296557|NCT03037606|Rabeprazole|rabeprazole|mesh-list
139296558|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139296559|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139296560|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139296561|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296562|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296563|NCT04842370|PHI-101|phi-101|mesh-list
139296564|NCT04842370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139296565|NCT04842370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296566|NCT04842370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139296567|NCT04842370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296568|NCT03037372|Atorvastatin|atorvastatin|mesh-list
139296569|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139296570|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139296571|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139296572|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139296573|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
139296574|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296575|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139296576|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296577|NCT04842526|Irinotecan|irinotecan|mesh-list
139296578|NCT04842526|Temozolomide|temozolomide|mesh-list
139296579|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139296580|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139296581|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296582|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296583|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296584|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139296585|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
139296586|NCT04850950|Tenofovir|tenofovir|mesh-list
139296587|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
139296588|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296589|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139296590|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139296591|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296592|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296593|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139296594|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139296595|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
139296596|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139296597|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296598|NCT04850560|Decitabine|decitabine|mesh-list
139296599|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139296600|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
139296601|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296602|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296603|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296604|NCT04850404|Ropivacaine|ropivacaine|mesh-list
139296605|NCT04850404|Rocuronium|rocuronium|mesh-list
139296606|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
139296607|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
139296608|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296609|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296610|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
139296611|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296612|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139296613|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139296614|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139296615|NCT06059547|Nivolumab|nivolumab|mesh-list
139296616|NCT06059547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139296621|NCT06059469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139296622|NCT06059469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296629|NCT06059287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139296630|NCT06059287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296631|NCT06059261|Endostatins|endostatins|mesh-list
139296632|NCT06059261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382203|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139296633|NCT06059261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139296634|NCT06059261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139296635|NCT06059261|Growth Substances|growth substances|mesh-ancestor
139296636|NCT06059261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296637|NCT06059261|Growth Inhibitors|growth inhibitors|mesh-ancestor
139296638|NCT06059144|Norepinephrine|norepinephrine|mesh-list
139296639|NCT06059144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139296640|NCT06059144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139296641|NCT06059144|Adrenergic Agents|adrenergic agents|mesh-ancestor
139296642|NCT06059144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296643|NCT06059144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296644|NCT06059144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296645|NCT06059144|Sympathomimetics|sympathomimetics|mesh-ancestor
139296646|NCT06059144|Autonomic Agents|autonomic agents|mesh-ancestor
139296647|NCT06059144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296648|NCT06059144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138880102|NCT04686929|Abatacept|abatacept|mesh-list
139296649|NCT06059001|Paclitaxel|paclitaxel|mesh-list
139296650|NCT06059001|Gemcitabine|gemcitabine|mesh-list
139296651|NCT06059001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139296652|NCT06059001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296653|NCT06059001|Tubulin Modulators|tubulin modulators|mesh-ancestor
139296654|NCT06059001|Antimitotic Agents|antimitotic agents|mesh-ancestor
139296655|NCT06059001|Mitosis Modulators|mitosis modulators|mesh-ancestor
139296656|NCT06059001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296657|NCT06059001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139296658|NCT06059001|Antimetabolites|antimetabolites|mesh-ancestor
139296659|NCT06058988|Trastuzumab|trastuzumab|mesh-list
139296660|NCT06058988|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139296661|NCT06058988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139296662|NCT06058988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296663|NCT06058988|Immunoconjugates|immunoconjugates|mesh-ancestor
139296664|NCT06058988|Immunologic Factors|immunologic factors|mesh-ancestor
139296665|NCT06058988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296666|NCT06058702|Dronabinol|dronabinol|mesh-list
139296667|NCT06058702|Hallucinogens|hallucinogens|mesh-ancestor
139296668|NCT06058702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296669|NCT06058702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139296670|NCT06058702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139296671|NCT06058702|Analgesics|analgesics|mesh-ancestor
139296672|NCT06058702|Sensory System Agents|sensory system agents|mesh-ancestor
139296673|NCT06058702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296674|NCT06058702|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139296675|NCT06058702|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139296676|NCT06058702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296677|NCT06058702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296678|NCT06058702|Hormones|hormones|mesh-ancestor
139296679|NCT06058702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139296680|NCT06058689|Thalidomide|thalidomide|mesh-list
139296681|NCT06058689|Pomalidomide|pomalidomide|mesh-list
139296682|NCT06058689|Immunologic Factors|immunologic factors|mesh-ancestor
139296683|NCT06058689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296684|NCT06058689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139296685|NCT06058689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139296686|NCT06058689|Growth Substances|growth substances|mesh-ancestor
139296687|NCT06058689|Growth Inhibitors|growth inhibitors|mesh-ancestor
139296688|NCT06058689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296689|NCT06058689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139296690|NCT06058689|Leprostatic Agents|leprostatic agents|mesh-ancestor
139296691|NCT06058689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139296692|NCT06058689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296693|NCT06058585|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139296694|NCT06058585|Mineralocorticoids|mineralocorticoids|mesh-list
139296695|NCT06058585|Hormone Antagonists|hormone antagonists|mesh-ancestor
139296696|NCT06058585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139296697|NCT06058585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296698|NCT06058585|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139296699|NCT06058585|Diuretics|diuretics|mesh-ancestor
139296700|NCT06058585|Natriuretic Agents|natriuretic agents|mesh-ancestor
139296701|NCT06058585|Hormones|hormones|mesh-ancestor
139296702|NCT06058299|Linezolid|linezolid|mesh-list
139296703|NCT06058299|Bedaquiline|bedaquiline|mesh-list
139296704|NCT06058299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139296705|NCT06058299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296706|NCT06058299|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139296707|NCT06058299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296708|NCT06058299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296709|NCT06058299|Antitubercular Agents|antitubercular agents|mesh-ancestor
139296710|NCT06058234|Antibodies|antibodies|mesh-list
139296711|NCT06058234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139296712|NCT06058234|Immunologic Factors|immunologic factors|mesh-ancestor
139296713|NCT06058234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296714|NCT06057935|Carboplatin|carboplatin|mesh-list
139296715|NCT06057935|Pemetrexed|pemetrexed|mesh-list
139296716|NCT06057935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296717|NCT06057935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296718|NCT06057935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296719|NCT06057935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139296720|NCT06057935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139296721|NCT06057831|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139296722|NCT06057831|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139296723|NCT06057831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296724|NCT06056687|Thioctic Acid|thioctic acid|mesh-list
139296725|NCT06056687|Antioxidants|antioxidants|mesh-ancestor
139296726|NCT06056687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296727|NCT06056687|Protective Agents|protective agents|mesh-ancestor
139296728|NCT06056687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296729|NCT06056687|Vitamin B Complex|vitamin b complex|mesh-ancestor
139296730|NCT06056687|Vitamins|vitamins|mesh-ancestor
139296731|NCT06056687|Micronutrients|micronutrients|mesh-ancestor
139296732|NCT06056349|Midazolam|midazolam|mesh-list
139296733|NCT06056349|Clonazepam|clonazepam|mesh-list
139296734|NCT06056349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139296735|NCT06056349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139296736|NCT06056349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296737|NCT06056349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296738|NCT06056349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139296739|NCT06056349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139296740|NCT06056349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139296741|NCT06056349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139296742|NCT06056349|Anesthetics, General|anesthetics, general|mesh-ancestor
139296743|NCT06056349|Anesthetics|anesthetics|mesh-ancestor
139296744|NCT06056349|GABA Modulators|gaba modulators|mesh-ancestor
139296745|NCT06056349|GABA Agents|gaba agents|mesh-ancestor
139296746|NCT06056349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296747|NCT06056349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296748|NCT06056349|Anticonvulsants|anticonvulsants|mesh-ancestor
139296749|NCT06047262|Dapansutrile|dapansutrile|mesh-list
139296750|NCT06047262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139296751|NCT06021860|Spironolactone|spironolactone|mesh-list
139296752|NCT06021860|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139296753|NCT06021860|Hormone Antagonists|hormone antagonists|mesh-ancestor
139296754|NCT06021860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139296755|NCT06021860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296756|NCT06021860|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139296757|NCT06021860|Diuretics|diuretics|mesh-ancestor
139296758|NCT06021860|Natriuretic Agents|natriuretic agents|mesh-ancestor
139296759|NCT05994820|Vaccines|vaccines|mesh-list
139296760|NCT05994820|Immunologic Factors|immunologic factors|mesh-ancestor
139296761|NCT05994820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296762|NCT05989165|Minoxidil|minoxidil|mesh-list
139296763|NCT05989165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139296764|NCT05989165|Vasodilator Agents|vasodilator agents|mesh-ancestor
139296765|NCT05913921|Amphotericin B|amphotericin b|mesh-list
139296766|NCT05913921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139296767|NCT05913921|Amebicides|amebicides|mesh-ancestor
139296768|NCT05913921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139296769|NCT05913921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139296770|NCT05913921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139296771|NCT05913921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139296772|NCT05913921|Antifungal Agents|antifungal agents|mesh-ancestor
139296774|NCT05903092|Etoposide|etoposide|mesh-list
139296775|NCT05903092|Durvalumab|durvalumab|mesh-list
139296776|NCT05903092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296777|NCT05903092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139296778|NCT05903092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139296779|NCT05903092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139296780|NCT05903092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296781|NCT05903092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296782|NCT05903092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139296783|NCT05864742|Rituximab|rituximab|mesh-list
139296784|NCT05864742|Venetoclax|venetoclax|mesh-list
139296785|NCT05864742|Navitoclax|navitoclax|mesh-list
139296786|NCT05864742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139296787|NCT05864742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296788|NCT05864742|Immunologic Factors|immunologic factors|mesh-ancestor
139296789|NCT05864742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296790|NCT05864742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139296791|NCT05845996|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
139296792|NCT05845996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139296793|NCT05845996|Immunologic Factors|immunologic factors|mesh-ancestor
139296794|NCT05845996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296795|NCT05843253|Everolimus|everolimus|mesh-list
139296796|NCT05843253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139296797|NCT05843253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139296798|NCT05843253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296799|NCT05843253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296800|NCT05843253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139296801|NCT05843253|Immunologic Factors|immunologic factors|mesh-ancestor
139296802|NCT05843253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296803|NCT05843253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296804|NCT05825235|Pramipexole|pramipexole|mesh-list
139296805|NCT05825235|Antioxidants|antioxidants|mesh-ancestor
139296806|NCT05825235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296807|NCT05825235|Protective Agents|protective agents|mesh-ancestor
139296808|NCT05825235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296809|NCT05825235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139296810|NCT05825235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139296811|NCT05825235|Dopamine Agonists|dopamine agonists|mesh-ancestor
139296812|NCT05825235|Dopamine Agents|dopamine agents|mesh-ancestor
139296813|NCT05825235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296814|NCT05785442|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139296815|NCT05785442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139296816|NCT05769309|Fentanyl|fentanyl|mesh-list
139296817|NCT05769309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139296818|NCT05769309|Narcotics|narcotics|mesh-ancestor
139296819|NCT05769309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296820|NCT05769309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296821|NCT05769309|Analgesics|analgesics|mesh-ancestor
139296822|NCT05769309|Sensory System Agents|sensory system agents|mesh-ancestor
139296823|NCT05769309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296824|NCT05769309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139296825|NCT05769309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139296826|NCT05769309|Anesthetics, General|anesthetics, general|mesh-ancestor
139296827|NCT05769309|Anesthetics|anesthetics|mesh-ancestor
139296828|NCT05753059|Bendroflumethiazide|bendroflumethiazide|mesh-list
139296829|NCT05753059|Amiloride|amiloride|mesh-list
139296830|NCT05753059|Diuretics|diuretics|mesh-ancestor
139296831|NCT05753059|Natriuretic Agents|natriuretic agents|mesh-ancestor
139296832|NCT05753059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296833|NCT05753059|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139296834|NCT05753059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139296835|NCT05753059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139296836|NCT05753059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296837|NCT05753059|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139296838|NCT05753059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139296839|NCT05753059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139296840|NCT05753059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139296841|NCT05752903|Dexmedetomidine|dexmedetomidine|mesh-list
139296842|NCT05752903|Ketamine|ketamine|mesh-list
139296843|NCT05752903|Propofol|propofol|mesh-list
139296856|NCT05752903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296857|NCT05752903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139296858|NCT05752903|Anesthetics, General|anesthetics, general|mesh-ancestor
139296860|NCT05752903|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139296861|NCT05752903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139296862|NCT05752903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139296863|NCT05735353|Methamphetamine|methamphetamine|mesh-list
139296864|NCT05735353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139296865|NCT05735353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296866|NCT05735353|Sympathomimetics|sympathomimetics|mesh-ancestor
139296867|NCT05735353|Autonomic Agents|autonomic agents|mesh-ancestor
139296868|NCT05735353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296869|NCT05735353|Dopamine Agents|dopamine agents|mesh-ancestor
139296870|NCT05735353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296871|NCT05735353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296872|NCT05735353|Adrenergic Agents|adrenergic agents|mesh-ancestor
139296873|NCT05735353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139296874|NCT05735353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139296875|NCT05735353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139296876|NCT05735353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139296877|NCT05728619|Temozolomide|temozolomide|mesh-list
139296878|NCT05728619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139296879|NCT05728619|Alkylating Agents|alkylating agents|mesh-ancestor
139296880|NCT05728619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296881|NCT05728619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296882|NCT05726032|Empagliflozin|empagliflozin|mesh-list
139296883|NCT05726032|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139296884|NCT05726032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296885|NCT05726032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139296886|NCT05726032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296887|NCT05694286|Hyaluronic Acid|hyaluronic acid|mesh-list
139296888|NCT05694286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139296889|NCT05694286|Immunologic Factors|immunologic factors|mesh-ancestor
139296890|NCT05694286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296891|NCT05694286|Viscosupplements|viscosupplements|mesh-ancestor
139296892|NCT05694286|Protective Agents|protective agents|mesh-ancestor
139296906|NCT05593341|Analgesics, Opioid|analgesics, opioid|mesh-list
139296907|NCT05593341|Narcotics|narcotics|mesh-ancestor
139296908|NCT05593341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296909|NCT05593341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296910|NCT05593341|Analgesics|analgesics|mesh-ancestor
139296911|NCT05593341|Sensory System Agents|sensory system agents|mesh-ancestor
139296912|NCT05593341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296913|NCT05590312|Anesthetics|anesthetics|mesh-list
139296914|NCT05590312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296915|NCT05590312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296916|NCT05569512|Fludarabine|fludarabine|mesh-list
139296917|NCT05569512|Busulfan|busulfan|mesh-list
139296918|NCT05569512|Clofarabine|clofarabine|mesh-list
139296919|NCT05569512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296920|NCT05569512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139296921|NCT05569512|Antimetabolites|antimetabolites|mesh-ancestor
139296922|NCT05569512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296923|NCT05569512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139296924|NCT05569512|Immunologic Factors|immunologic factors|mesh-ancestor
139296925|NCT05569512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296926|NCT05569512|Alkylating Agents|alkylating agents|mesh-ancestor
139296927|NCT05569512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139296928|NCT05569512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139296929|NCT05561959|Nitroglycerin|nitroglycerin|mesh-list
139296930|NCT05561959|Vasodilator Agents|vasodilator agents|mesh-ancestor
139296931|NCT05487755|Tadalafil|tadalafil|mesh-list
139296932|NCT05487755|Pentoxifylline|pentoxifylline|mesh-list
139296933|NCT05487755|Vasodilator Agents|vasodilator agents|mesh-ancestor
139296934|NCT05487755|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139296935|NCT05487755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139296936|NCT05487755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296937|NCT05487755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296938|NCT05487755|Urological Agents|urological agents|mesh-ancestor
139296939|NCT05487755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139296940|NCT05487755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139296941|NCT05487755|Protective Agents|protective agents|mesh-ancestor
139296942|NCT05487755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296943|NCT05487755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139296944|NCT05487755|Antioxidants|antioxidants|mesh-ancestor
139296945|NCT05476952|Rocuronium|rocuronium|mesh-list
139296946|NCT05476952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139296947|NCT05476952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139296948|NCT05476952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139296949|NCT05476952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296950|NCT05476952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296951|NCT05426174|Vaccines|vaccines|mesh-list
139296952|NCT05426174|Immunologic Factors|immunologic factors|mesh-ancestor
139296953|NCT05426174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296954|NCT05414838|Vitamin D|vitamin d|mesh-list
139296955|NCT05414838|Curcumin|curcumin|mesh-list
139296956|NCT05414838|Vitamins|vitamins|mesh-ancestor
139296957|NCT05414838|Micronutrients|micronutrients|mesh-ancestor
139296958|NCT05414838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296959|NCT05414838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139296960|NCT05414838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139296961|NCT05414838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139296962|NCT05414838|Analgesics|analgesics|mesh-ancestor
139296963|NCT05414838|Sensory System Agents|sensory system agents|mesh-ancestor
139296964|NCT05414838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296965|NCT05414838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139296966|NCT05414838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139296967|NCT05414838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139296968|NCT05414838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139296969|NCT05414838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296970|NCT05383495|Midazolam|midazolam|mesh-list
139296971|NCT05383495|Dexmedetomidine|dexmedetomidine|mesh-list
139296972|NCT05383495|Nitrous Oxide|nitrous oxide|mesh-list
139296973|NCT05383495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139296974|NCT05383495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139296975|NCT05383495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139296976|NCT05383495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139296977|NCT05383495|Analgesics|analgesics|mesh-ancestor
139296978|NCT05383495|Sensory System Agents|sensory system agents|mesh-ancestor
139296979|NCT05383495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139296980|NCT05383495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139296981|NCT05383495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139296982|NCT05383495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139296983|NCT05383495|Adrenergic Agents|adrenergic agents|mesh-ancestor
139296984|NCT05383495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139296985|NCT05383495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139296986|NCT05383495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139296987|NCT05383495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139296988|NCT05383495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139296989|NCT05383495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139296990|NCT05383495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139296992|NCT05383495|Anesthetics|anesthetics|mesh-ancestor
139296993|NCT05383495|GABA Modulators|gaba modulators|mesh-ancestor
139296994|NCT05383495|GABA Agents|gaba agents|mesh-ancestor
139296995|NCT05383495|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139296996|NCT05368012|Dexamethasone|dexamethasone|mesh-list
139296997|NCT05368012|Bupivacaine|bupivacaine|mesh-list
139296998|NCT05368012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139296999|NCT05368012|Antiemetics|antiemetics|mesh-ancestor
139297000|NCT05368012|Autonomic Agents|autonomic agents|mesh-ancestor
139297001|NCT05368012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297002|NCT05368012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297003|NCT05368012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139297004|NCT05368012|Glucocorticoids|glucocorticoids|mesh-ancestor
139297005|NCT05368012|Hormones|hormones|mesh-ancestor
139297006|NCT05368012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139297007|NCT05368012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139297008|NCT05368012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297009|NCT05368012|Anesthetics, Local|anesthetics, local|mesh-ancestor
139297010|NCT05368012|Anesthetics|anesthetics|mesh-ancestor
139297011|NCT05368012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139297012|NCT05368012|Sensory System Agents|sensory system agents|mesh-ancestor
139297013|NCT05343702|Rocuronium|rocuronium|mesh-list
139297014|NCT05343702|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139297015|NCT05343702|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139297016|NCT05343702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139297017|NCT05343702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297018|NCT05343702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297019|NCT05238025|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139297020|NCT05238025|Antiviral Agents|antiviral agents|mesh-ancestor
139297021|NCT05238025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297022|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
138880460|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
139297023|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297024|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297025|NCT05182164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139297026|NCT05182164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297027|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139297029|NCT05169658|Antibodies|antibodies|mesh-list
139297030|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
139297031|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138858236|NCT02798510|Gemcitabine|gemcitabine|mesh-list
139297032|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139297033|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
139297034|NCT05169658|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139297035|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
139297036|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297037|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297038|NCT05093621|Torsemide|torsemide|mesh-list
139297039|NCT05093621|Furosemide|furosemide|mesh-list
139297040|NCT05093621|Diuretics|diuretics|mesh-ancestor
139297041|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
139297042|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297043|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139297044|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139297045|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297046|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139297047|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
139297048|NCT04977453|Lenvatinib|lenvatinib|mesh-list
139297049|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297050|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297051|NCT04977453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139297052|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297053|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139297054|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297055|NCT04960930|Minocycline|minocycline|mesh-list
139297056|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139297057|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297058|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
139297059|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139297060|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
139297061|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297062|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
139297063|NCT04883892|Protective Agents|protective agents|mesh-ancestor
139297064|NCT04874311|Doxorubicin|doxorubicin|mesh-list
139297065|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139297066|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297067|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139297068|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139297069|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297070|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297071|NCT04807816|Gemcitabine|gemcitabine|mesh-list
139297072|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139297073|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
139297074|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297075|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297076|NCT04771962|Sevoflurane|sevoflurane|mesh-list
139297077|NCT04771962|Desflurane|desflurane|mesh-list
139297078|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139297079|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139297080|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
139297081|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
139297082|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139297083|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297084|NCT04771026|Dexamethasone|dexamethasone|mesh-list
139297085|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139297086|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
139297087|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
139297088|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297089|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297090|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139297091|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
139297092|NCT04771026|Hormones|hormones|mesh-ancestor
139297093|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139297094|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139297095|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297096|NCT04768010|Misoprostol|misoprostol|mesh-list
139297097|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138880537|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
139297098|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
139297099|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139297100|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297101|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139297102|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139297104|NCT04749108|Folfirinox|folfirinox|mesh-list
139297105|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297106|NCT04730544|Nivolumab|nivolumab|mesh-list
139297107|NCT04730544|Ipilimumab|ipilimumab|mesh-list
139297108|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297109|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297110|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139297111|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297112|NCT04667234|Sotorasib|sotorasib|mesh-list
139297113|NCT04667234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139297114|NCT04667234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297115|NCT04667234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297116|NCT04667234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297117|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139297118|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139297119|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297120|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
139297121|NCT04604353|Calcium|calcium|mesh-list
139297122|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139297123|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297124|NCT04540861|Siponimod|siponimod|mesh-list
139297125|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139297126|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297127|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139297128|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
139297129|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297130|NCT04508244|Propranolol|propranolol|mesh-list
139297131|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139297132|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139297133|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
139297134|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297135|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297136|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297137|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139423901|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139423902|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139423903|NCT04535505|Erythromycin|erythromycin|mesh-list
139423904|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
139423905|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139423906|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
139423907|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139423908|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139423909|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139423910|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139423911|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423912|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423913|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
139423914|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139423915|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
139423916|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139423917|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423918|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139423919|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
139423920|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139423921|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
139423922|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423923|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139423924|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139423925|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
139423926|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
139423927|NCT03500783|Protective Agents|protective agents|mesh-ancestor
139423928|NCT03353233|Ropivacaine|ropivacaine|mesh-list
139423929|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
139423930|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
139423931|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139423932|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423933|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
139423934|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139423935|NCT02320877|Methaqualone|methaqualone|mesh-list
139423936|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139423937|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139423938|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423939|NCT01322971|Metronidazole|metronidazole|mesh-list
139423940|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139423941|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139423942|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139423943|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139423944|NCT04454281|Naloxone|naloxone|mesh-list
139423945|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139423946|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423947|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
139423948|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139423949|NCT02318225|Misoprostol|misoprostol|mesh-list
139423950|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139423951|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
139423952|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139423953|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423954|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139423955|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139423956|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
139423957|NCT01378429|Ciclesonide|ciclesonide|mesh-list
139423958|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
139423959|NCT01378429|Hormones|hormones|mesh-ancestor
139423960|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139423961|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423962|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139423963|NCT01599754|Axitinib|axitinib|mesh-list
139423964|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423965|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139423966|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423967|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423968|NCT02321267|Ranibizumab|ranibizumab|mesh-list
139423969|NCT02321267|Aflibercept|aflibercept|mesh-list
139423970|NCT02321267|Verteporfin|verteporfin|mesh-list
139423971|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139423972|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139210641|NCT03044613|Paclitaxel|paclitaxel|mesh-list
139423973|NCT02321267|Growth Substances|growth substances|mesh-ancestor
139423974|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423975|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
139423976|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423977|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139423978|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
139423979|NCT02318537|Cannabidiol|cannabidiol|mesh-list
139423980|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139423981|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
139423982|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
139423983|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423984|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423985|NCT02318771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423986|NCT02318771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423987|NCT04936399|Nivolumab|nivolumab|mesh-list
139423988|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423989|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423990|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423991|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423992|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
139423993|NCT02319161|Calcium|calcium|mesh-list
139423994|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139423995|NCT02319161|Esmolol|esmolol|mesh-list
139423996|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139423997|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423998|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139423999|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
139424000|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139424001|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424002|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139424003|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139424004|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
139424005|NCT02321579|Pyridoxal|pyridoxal|mesh-list
139424006|NCT02321579|Pyridoxine|pyridoxine|mesh-list
139424007|NCT02321579|Vitamins|vitamins|mesh-ancestor
139424008|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
139424009|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424010|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
139424011|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
139424012|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139424013|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139424014|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
139424015|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
139424016|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424017|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424018|NCT03109691|Dexamethasone|dexamethasone|mesh-list
139424019|NCT03109691|Bupivacaine|bupivacaine|mesh-list
139424020|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139424021|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
139424022|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
139424023|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424024|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424025|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139424026|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
139424027|NCT03109691|Hormones|hormones|mesh-ancestor
139424028|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139424029|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139424030|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424031|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
139424032|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
139424033|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424034|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
139424035|NCT03497351|Nicardipine|nicardipine|mesh-list
139424036|NCT03497351|Urapidil|urapidil|mesh-list
139424037|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139424038|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139424039|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139424040|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424041|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139424042|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424043|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
139424044|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139424045|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
139424046|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139424047|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139424048|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139424049|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139210718|NCT02792465|Fulvestrant|fulvestrant|mesh-list
139424050|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
139424052|NCT02223364|Ropivacaine|ropivacaine|mesh-list
139424053|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
139424054|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
139424055|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424056|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424057|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
139424058|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424059|NCT01378975|Vemurafenib|vemurafenib|mesh-list
139424060|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424061|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139424062|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424063|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424064|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
139424065|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139424066|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139424067|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424068|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
139424069|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
139424070|NCT03499457|Amoxicillin|amoxicillin|mesh-list
139424071|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139424072|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424073|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
139424074|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139424075|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
139424076|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139424077|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424078|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139424079|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139424080|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139424081|NCT02322203|Niacin|niacin|mesh-list
139424082|NCT02322203|Niacinamide|niacinamide|mesh-list
139424083|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
139424084|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139424085|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
139424086|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424087|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139424088|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
139424089|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
139424090|NCT02322203|Vitamins|vitamins|mesh-ancestor
139424091|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
139424092|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424093|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139424094|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139424095|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139424096|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
139424097|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139424098|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139424099|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424100|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
139424101|NCT04691362|Coagulants|coagulants|mesh-ancestor
139424102|NCT03499223|Ranibizumab|ranibizumab|mesh-list
139424103|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139424104|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139424105|NCT03499223|Growth Substances|growth substances|mesh-ancestor
139424106|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424107|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
139424108|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424109|NCT02319707|Oxytocin|oxytocin|mesh-list
139424110|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
139424111|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139424112|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424113|NCT05398861|Bevacizumab|bevacizumab|mesh-list
139424114|NCT05398861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139424115|NCT05398861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424116|NCT05398861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139424117|NCT05398861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139424118|NCT05398861|Growth Substances|growth substances|mesh-ancestor
139424119|NCT05398861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424120|NCT05398861|Growth Inhibitors|growth inhibitors|mesh-ancestor
139424121|NCT02448329|Paclitaxel|paclitaxel|mesh-list
139424122|NCT02448329|Adavosertib|adavosertib|mesh-list
139424123|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139424124|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424125|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
139424126|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
139424128|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424129|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424130|NCT05398393|Tenofovir|tenofovir|mesh-list
139424131|NCT05398393|Amlodipine|amlodipine|mesh-list
139424132|NCT05398393|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
139424133|NCT05398393|Atorvastatin|atorvastatin|mesh-list
139424134|NCT05398393|Hypolipidemic Agents|hypolipidemic agents|mesh-list
139424135|NCT05398393|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139424136|NCT05398393|Antimetabolites|antimetabolites|mesh-ancestor
139424137|NCT05398393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424138|NCT05398393|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139424139|NCT05398393|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139424140|NCT05398393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424141|NCT05398393|Antiviral Agents|antiviral agents|mesh-ancestor
139424142|NCT05398393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424143|NCT05398393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139424144|NCT05398393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139424145|NCT05398393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139424146|NCT05398393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139424147|NCT05398393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139424148|NCT05398393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139424149|NCT05398393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139424150|NCT05398393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139424151|NCT05398393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424152|NCT05398393|Vasodilator Agents|vasodilator agents|mesh-ancestor
139424153|NCT02319941|Clopidogrel|clopidogrel|mesh-list
139424154|NCT02319941|Ticagrelor|ticagrelor|mesh-list
139424155|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139424156|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139424157|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139424158|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139424159|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
139424160|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139424161|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424162|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424163|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
139424164|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
139424165|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139424166|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424167|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424168|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139424169|NCT05164627|Analgesics|analgesics|mesh-ancestor
139424170|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
139424171|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424172|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139424173|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139424174|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139424175|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
139424176|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139424177|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424178|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
139424179|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139424180|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
139424181|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139424182|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139424183|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139424184|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
139424185|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139424186|NCT02322671|Montelukast|montelukast|mesh-list
139424187|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139424188|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
139424189|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139424190|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
139424191|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139424192|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424193|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139424194|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139424195|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424196|NCT05096143|Valsartan|valsartan|mesh-list
139424197|NCT05096143|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139424198|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139424199|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139424200|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139424201|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424202|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
139424203|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
139424204|NCT03494387|Antioxidants|antioxidants|mesh-list
139424205|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
139424206|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424207|NCT03494387|Expectorants|expectorants|mesh-ancestor
139424208|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
139424209|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139424210|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424211|NCT03494387|Protective Agents|protective agents|mesh-ancestor
139424212|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424214|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
139424215|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139424216|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139424217|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139424218|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424219|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
139424220|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139424221|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424222|NCT02324621|TIC10 compound|tic10 compound|mesh-list
139424223|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424224|NCT03821545|Lidocaine|lidocaine|mesh-list
139424225|NCT03821545|Ketamine|ketamine|mesh-list
139424226|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
139424227|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
139424228|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424229|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424230|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
139424231|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424232|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139424233|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139424234|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139424235|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139382213|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
139424236|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424237|NCT03821545|Analgesics|analgesics|mesh-ancestor
139424238|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139424239|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139424240|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
139424241|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139424242|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139424243|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139424244|NCT02324933|Fentanyl|fentanyl|mesh-list
139424245|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139424246|NCT02324933|Narcotics|narcotics|mesh-ancestor
139424247|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424248|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424249|NCT02324933|Analgesics|analgesics|mesh-ancestor
139424250|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
139424251|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424252|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139424253|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139424254|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
139424255|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
139424256|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
139424257|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139424258|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
139424259|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139424260|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424261|NCT01378117|Incretins|incretins|mesh-ancestor
139424262|NCT01378117|Hormones|hormones|mesh-ancestor
139424263|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139424264|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139424265|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
139424266|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424267|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424268|NCT02323139|Azacitidine|azacitidine|mesh-list
139424269|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139424270|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
139424271|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424272|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424273|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424274|NCT02325245|Metformin|metformin|mesh-list
139424275|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139424276|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424277|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
139424278|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139424279|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139424280|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424281|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
139424282|NCT02323373|Coagulants|coagulants|mesh-ancestor
139424283|NCT02325479|Enoxaparin|enoxaparin|mesh-list
139424284|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
139424285|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139424286|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139424287|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424288|NCT05236231|Tadalafil|tadalafil|mesh-list
139424289|NCT05236231|Macitentan|macitentan|mesh-list
139424290|NCT05236231|Vasodilator Agents|vasodilator agents|mesh-ancestor
139424291|NCT05236231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139424292|NCT05236231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139424293|NCT05236231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424294|NCT05236231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424295|NCT05236231|Urological Agents|urological agents|mesh-ancestor
139424296|NCT05236231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139424297|NCT05236231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139424298|NCT05236231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139424299|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
139424300|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139424301|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424302|NCT02325557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139424303|NCT02325557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424304|NCT03495323|Prexasertib|prexasertib|mesh-list
139424305|NCT03495323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139424306|NCT03495323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424307|NCT03495323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424308|NCT02323451|Chitosan|chitosan|mesh-list
139424309|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
139424310|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139424311|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
139424312|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424313|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
139424314|NCT02323451|Protective Agents|protective agents|mesh-ancestor
139424315|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139424316|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139424317|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
139424318|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424319|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139424320|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
139424321|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
139424322|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
139424323|NCT02323451|Coagulants|coagulants|mesh-ancestor
139424324|NCT02323529|Nitisinone|nitisinone|mesh-list
139424325|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424326|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424327|NCT02323607|Cytarabine|cytarabine|mesh-list
139424328|NCT02323607|Decitabine|decitabine|mesh-list
139424329|NCT02323607|Daunorubicin|daunorubicin|mesh-list
139424330|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139424331|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
139424332|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424333|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424334|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
139424335|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424336|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139424337|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
139424338|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424339|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139424340|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139424341|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139424342|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424343|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
139424344|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
139424345|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424346|NCT03493841|Protective Agents|protective agents|mesh-ancestor
139211017|NCT01949129|Etoposide|etoposide|mesh-list
139424347|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424349|NCT03493841|Vitamins|vitamins|mesh-ancestor
139424350|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
139424351|NCT05118737|Colchicine|colchicine|mesh-list
139424352|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
139424353|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139424354|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
139424355|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
139424356|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
139424357|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424358|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424359|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
139424360|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139424361|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139424362|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424363|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
139424364|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
139424365|NCT03491579|Cytarabine|cytarabine|mesh-list
139424366|NCT03491579|Cladribine|cladribine|mesh-list
139424367|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139424368|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
139424369|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424370|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424371|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
139424372|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424373|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139424374|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
139424375|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424376|NCT04600895|Favipiravir|favipiravir|mesh-list
139424377|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
139424378|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424379|NCT03492593|Beta Carotene|beta carotene|mesh-list
139424380|NCT03492593|Lycopene|lycopene|mesh-list
139424381|NCT03492593|Carotenoids|carotenoids|mesh-list
139424382|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
139424383|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424384|NCT03492593|Protective Agents|protective agents|mesh-ancestor
139424385|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424386|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139424387|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139424388|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139424389|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424390|NCT03492593|Provitamins|provitamins|mesh-ancestor
139424391|NCT03492593|Vitamins|vitamins|mesh-ancestor
139424392|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
139424393|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
139424394|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
139424395|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139424396|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139424397|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424398|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424399|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424400|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139424401|NCT03914885|Fludarabine|fludarabine|mesh-list
139424402|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139424403|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424404|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424405|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139424406|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
139424407|NCT03779243|Melatonin|melatonin|mesh-list
139424408|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
139424409|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424410|NCT03779243|Protective Agents|protective agents|mesh-ancestor
139424411|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424412|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424413|NCT03757013|Apremilast|apremilast|mesh-list
139424414|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139424415|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139424416|NCT03757013|Analgesics|analgesics|mesh-ancestor
139424417|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
139424418|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424419|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424420|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139424421|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139424422|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139211106|NCT01842386|Rituximab|rituximab|mesh-list
139424423|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139424424|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424425|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424426|NCT02736409|Budesonide|budesonide|mesh-list
139424427|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139424428|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139424429|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
139424430|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424431|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424432|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139424433|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
139424434|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
139424435|NCT02736409|Hormones|hormones|mesh-ancestor
139424436|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139424437|NCT05396677|Acetaminophen|acetaminophen|mesh-list
139424438|NCT05396677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139424439|NCT05396677|Analgesics|analgesics|mesh-ancestor
139424440|NCT05396677|Sensory System Agents|sensory system agents|mesh-ancestor
139424441|NCT05396677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424442|NCT05396677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424443|NCT05396677|Antipyretics|antipyretics|mesh-ancestor
139424444|NCT05131867|Nimodipine|nimodipine|mesh-list
139424445|NCT05131867|Milrinone|milrinone|mesh-list
139424446|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139424447|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139424448|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
139424449|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139424450|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139424451|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424452|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424453|NCT05131867|Protective Agents|protective agents|mesh-ancestor
139424454|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424455|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139424456|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139424457|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139424458|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139424459|NCT02837783|Linaclotide|linaclotide|mesh-list
139424460|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139424461|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
139424462|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424463|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139424464|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139424465|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139424466|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139424467|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139424468|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424469|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
139424470|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139424471|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424472|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139424473|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424474|NCT05007145|Paclitaxel|paclitaxel|mesh-list
139424475|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139424476|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139424477|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139424478|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424479|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
139424480|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
139424481|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
139424482|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424483|NCT05007145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139424484|NCT04952857|Vitamin D|vitamin d|mesh-list
139424485|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
139424486|NCT04952857|Vitamins|vitamins|mesh-ancestor
139424487|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
139424488|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424489|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139424490|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139424491|NCT02220712|Aripiprazole|aripiprazole|mesh-list
139424492|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
139424493|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139424494|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139424495|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139211191|NCT01280994|Xenon|xenon|mesh-list
139424496|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424497|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424498|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
139424499|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
139424500|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139424501|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424502|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139424503|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139424504|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
139424505|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139424506|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139424507|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139424508|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139424509|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
139424510|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139424511|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424512|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139424513|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424514|NCT05396209|Dimenhydrinate|dimenhydrinate|mesh-list
139424515|NCT05396209|Antiemetics|antiemetics|mesh-ancestor
139424516|NCT05396209|Autonomic Agents|autonomic agents|mesh-ancestor
139424517|NCT05396209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424518|NCT05396209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424519|NCT05396209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139424520|NCT05396209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139424521|NCT05396209|Histamine Antagonists|histamine antagonists|mesh-ancestor
139424522|NCT05396209|Histamine Agents|histamine agents|mesh-ancestor
139424523|NCT05396209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139424524|NCT05396209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424525|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
139424526|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139424527|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139424528|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424529|NCT00846430|Interferons|interferons|mesh-list
139424530|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
139424531|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
139424532|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139424533|NCT00846430|Celecoxib|celecoxib|mesh-list
139424534|NCT00846430|Vincristine|vincristine|mesh-list
139424535|NCT00846430|Temozolomide|temozolomide|mesh-list
139424536|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424537|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
139424538|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424539|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139424540|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
139424541|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
139424542|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
139424543|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424544|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139424545|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
139424546|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
139424547|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424548|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139424549|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139424550|NCT00846430|Analgesics|analgesics|mesh-ancestor
139424551|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
139424552|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424553|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139424554|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139424555|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139424556|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139424557|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424558|NCT05439577|Heparinoids|heparinoids|mesh-list
139424559|NCT05439577|Glucocorticoids|glucocorticoids|mesh-list
139424560|NCT05439577|Hormones|hormones|mesh-ancestor
139424561|NCT05439577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139424562|NCT05439577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424563|NCT05439577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139424564|NCT05439577|Anticoagulants|anticoagulants|mesh-ancestor
139424565|NCT05385523|Dexamethasone|dexamethasone|mesh-list
139424566|NCT05385523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139424567|NCT05385523|Antiemetics|antiemetics|mesh-ancestor
139424568|NCT05385523|Autonomic Agents|autonomic agents|mesh-ancestor
139424569|NCT05385523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424570|NCT05385523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424571|NCT05385523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139424572|NCT05385523|Glucocorticoids|glucocorticoids|mesh-ancestor
139424573|NCT05385523|Hormones|hormones|mesh-ancestor
139424574|NCT05385523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139424575|NCT05385523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139424576|NCT05385523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424577|NCT03910621|Miglustat|miglustat|mesh-list
139424578|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424579|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424580|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139424581|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139424582|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
139424583|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424584|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139424585|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139424586|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424587|NCT02218372|Vancomycin|vancomycin|mesh-list
139424588|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
139424589|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139424590|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424591|NCT02217982|Simethicone|simethicone|mesh-list
139424592|NCT02217982|Loperamide|loperamide|mesh-list
139424593|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
139424594|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139424595|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
139424596|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424597|NCT02217982|Emollients|emollients|mesh-ancestor
139424598|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
139424599|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
139424600|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139424601|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
139424602|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424603|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
139424604|NCT02207608|Protective Agents|protective agents|mesh-ancestor
139424605|NCT03530995|Itraconazole|itraconazole|mesh-list
139424606|NCT03530995|Rifampin|rifampin|mesh-list
139424607|NCT03530995|Omeprazole|omeprazole|mesh-list
139424608|NCT03530995|Rabeprazole|rabeprazole|mesh-list
139424609|NCT03530995|Belumosudil|belumosudil|mesh-list
139424610|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139424611|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139424612|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139424613|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424614|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424615|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
139424616|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424617|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139424618|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139424619|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139424620|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
139424621|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139424622|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424623|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139424624|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139424625|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
139424626|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139424627|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
139424628|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139424629|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139424630|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139424631|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139424632|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139424633|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139424634|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139424635|NCT03530995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139424636|NCT02207530|Durvalumab|durvalumab|mesh-list
139424637|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139424638|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424639|NCT05359315|Interferons|interferons|mesh-list
139424640|NCT05359315|Interferon-gamma|interferon-gamma|mesh-list
139424641|NCT05359315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424642|NCT05359315|Antiviral Agents|antiviral agents|mesh-ancestor
139424643|NCT05359315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424644|NCT02616055|XL647|xl647|mesh-list
139424645|NCT02616055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424646|NCT02616055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139424647|NCT02616055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424648|NCT02616055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424649|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139424650|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
139424651|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424652|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424653|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139424654|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424655|NCT02786537|Ritonavir|ritonavir|mesh-list
139424656|NCT02786537|Ribavirin|ribavirin|mesh-list
139424657|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
139424658|NCT02786537|Grazoprevir|grazoprevir|mesh-list
139424659|NCT02786537|Ledipasvir|ledipasvir|mesh-list
139424660|NCT02786537|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139424661|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139424662|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139424663|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
139424664|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424665|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424666|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139424667|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139424668|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
139424669|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424670|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139424671|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139424672|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
139424673|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
139424674|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139424675|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424676|NCT03307759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139424677|NCT03307759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424678|NCT03466645|Vancomycin|vancomycin|mesh-list
139424679|NCT03466645|Cefazolin|cefazolin|mesh-list
139424680|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139424681|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424682|NCT04461665|Vitamin D|vitamin d|mesh-list
139424683|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
139424684|NCT04461665|Cholecalciferol|cholecalciferol|mesh-list
139424685|NCT04461665|Vitamins|vitamins|mesh-list
139424686|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
139424687|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424688|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139424689|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139424690|NCT02252536|Gabapentin|gabapentin|mesh-list
139424691|NCT02252536|Analgesics|analgesics|mesh-ancestor
139424692|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
139424693|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424694|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424695|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
139424696|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139424697|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139424698|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424699|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139424700|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139424701|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139424702|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139424703|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424704|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
139424705|NCT03490487|Prednisolone|prednisolone|mesh-list
139424706|NCT03490487|Carbamazepine|carbamazepine|mesh-list
139424707|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
139424708|NCT03490487|Levetiracetam|levetiracetam|mesh-list
139424709|NCT03490487|Valproic Acid|valproic acid|mesh-list
139424710|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
139424711|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139424712|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
139424713|NCT03490487|Hormones|hormones|mesh-ancestor
139424714|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139424715|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424716|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139424717|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424718|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424719|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
139424720|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424721|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424722|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
139424723|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139424724|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
139424725|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139424726|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424727|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139424728|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139424729|NCT03490487|Analgesics|analgesics|mesh-ancestor
139424730|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
139424731|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139424732|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139424733|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139424734|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139424735|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139424736|NCT05271331|Anesthetics|anesthetics|mesh-list
139424737|NCT05271331|Anesthetics, Local|anesthetics, local|mesh-list
139424738|NCT05271331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424739|NCT05271331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424740|NCT05271331|Sensory System Agents|sensory system agents|mesh-ancestor
139424741|NCT05271331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424742|NCT03466567|Cyclosporine|cyclosporine|mesh-list
139424743|NCT03466567|Probenecid|probenecid|mesh-list
139424744|NCT03466567|Cyclosporins|cyclosporins|mesh-list
139424745|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424746|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424747|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139424748|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
139424749|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424750|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
139424751|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424752|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
139424753|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139424754|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139424755|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
139424756|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
139424757|NCT03130153|Aspirin|aspirin|mesh-list
139424758|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
139424759|NCT03130153|Salicylates|salicylates|mesh-list
139424760|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139424761|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139424762|NCT03130153|Analgesics|analgesics|mesh-ancestor
139424763|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
139424764|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424765|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424766|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139424767|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139424768|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139424769|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139424770|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424771|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139424772|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139424773|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424774|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
139424775|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424776|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
139424777|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
139424778|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
139424779|NCT03466333|Enalapril|enalapril|mesh-list
139424780|NCT03466333|Enalaprilat|enalaprilat|mesh-list
139424781|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424782|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424783|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139424784|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
139424785|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139424786|NCT05382715|Ozanimod|ozanimod|mesh-list
139424787|NCT05382715|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139424788|NCT05382715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424789|NCT05382715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139424790|NCT05382715|Immunologic Factors|immunologic factors|mesh-ancestor
139424791|NCT05382715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424792|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
139424793|NCT03492047|Paclitaxel|paclitaxel|mesh-list
139424794|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139424795|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139424796|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424797|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
139424799|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
139424800|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424801|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
139424802|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424803|NCT03492047|Expectorants|expectorants|mesh-ancestor
139424804|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
139424805|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139424806|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
139424807|NCT03492047|Protective Agents|protective agents|mesh-ancestor
139424808|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424809|NCT03492047|Antidotes|antidotes|mesh-ancestor
139424810|NCT02251990|Grazoprevir|grazoprevir|mesh-list
139424811|NCT02251990|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139424812|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
139424813|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424814|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
139424815|NCT03490097|Simvastatin|simvastatin|mesh-list
139424816|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139424817|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139424818|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
139424819|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424820|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139424821|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139424822|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424823|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
139424824|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424825|NCT04453735|Atorvastatin|atorvastatin|mesh-list
139424826|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139424827|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139424828|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
139424829|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424830|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139424831|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139424832|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424833|NCT03490019|Metformin|metformin|mesh-list
139424834|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139424835|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424836|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
139424837|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
139424838|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424839|NCT03491969|Protective Agents|protective agents|mesh-ancestor
139424840|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424841|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
139424842|NCT03491969|Vitamins|vitamins|mesh-ancestor
139424843|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
139424844|NCT05349409|Fluzoparib|fluzoparib|mesh-list
139424845|NCT05349409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139424846|NCT05349409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424847|NCT05349409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424848|NCT05349409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424849|NCT02251912|Oxytocin|oxytocin|mesh-list
139424850|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
139424851|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139424852|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424853|NCT01976273|Glycolic acid|glycolic acid|mesh-list
139424854|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
139424855|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
139424856|NCT02206048|Proflavine|proflavine|mesh-list
139424857|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139424858|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424859|NCT03466021|Liraglutide|liraglutide|mesh-list
139424860|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139424861|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424862|NCT03466021|Incretins|incretins|mesh-ancestor
139424863|NCT03466021|Hormones|hormones|mesh-ancestor
139424864|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139424865|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139424866|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
139424867|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
139424868|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
139424869|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
139211560|NCT05183334|Narcotics|narcotics|mesh-ancestor
139424870|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424871|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139424872|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139424873|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
139424874|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424875|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139424876|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
139424877|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424878|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139424879|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139424880|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424881|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
139424882|NCT03489005|Zamicastat|zamicastat|mesh-list
139424883|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139424884|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424885|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139424886|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139424887|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424888|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424889|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424890|NCT02215252|Pregabalin|pregabalin|mesh-list
139424891|NCT02215252|Analgesics|analgesics|mesh-ancestor
139424892|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
139424893|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424894|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424895|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
139424896|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139424897|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139424898|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424899|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139424900|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139424901|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139424902|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424903|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139424904|NCT04894721|Ivermectin|ivermectin|mesh-list
139424905|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139424906|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424907|NCT02204410|Methylphenidate|methylphenidate|mesh-list
139424908|NCT02204410|Amphetamine|amphetamine|mesh-list
139424909|NCT02204410|Adderall|adderall|mesh-list
139424910|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
139424911|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139424912|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424913|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139424914|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139424915|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139424916|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424917|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
139424918|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139424919|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
139424920|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
139424921|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424922|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
139424923|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139424924|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139424925|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
139424926|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424927|NCT03461575|Cyclosporine|cyclosporine|mesh-list
139424928|NCT03461575|Cyclosporins|cyclosporins|mesh-list
139424929|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424930|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424931|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139424932|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
139424933|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424934|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
139424935|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424936|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
139424937|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139424938|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139424939|NCT03131843|Ethanol|ethanol|mesh-list
139424940|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139424941|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424942|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424943|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424944|NCT02213380|Anesthetics|anesthetics|mesh-list
139424945|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139424946|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424947|NCT03488147|Esomeprazole|esomeprazole|mesh-list
139424948|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139424949|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139424950|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139424951|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424952|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424953|NCT03797261|Venetoclax|venetoclax|mesh-list
139424954|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139424955|NCT02202850|Etanercept|etanercept|mesh-list
139424956|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139424957|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139424958|NCT02202850|Analgesics|analgesics|mesh-ancestor
139424959|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
139424960|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139424961|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424962|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139424963|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139424964|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139424965|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139424966|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
139424967|NCT03489395|Edoxaban|edoxaban|mesh-list
139424968|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139424969|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
139424970|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139424971|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
139424972|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424973|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424974|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
139424975|NCT03489317|Metformin|metformin|mesh-list
139424976|NCT03489317|Amlodipine|amlodipine|mesh-list
139424977|NCT03489317|Simvastatin|simvastatin|mesh-list
139424978|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139424979|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139424980|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139424981|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139424982|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139424983|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139424984|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139424985|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
139424986|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139424987|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139424988|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
139424989|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139424990|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139424991|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139424992|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
139424993|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139424994|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
139424995|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139424996|NCT02212678|Expectorants|expectorants|mesh-ancestor
139424997|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
139424998|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139424999|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
139425000|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425001|NCT02212678|Protective Agents|protective agents|mesh-ancestor
139425002|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425003|NCT02212678|Antidotes|antidotes|mesh-ancestor
139425004|NCT03489239|Tenofovir|tenofovir|mesh-list
139425005|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
139425006|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425007|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139425008|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139425009|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425010|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425011|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139425012|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139425013|NCT03489161|Buprenorphine|buprenorphine|mesh-list
139425014|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139425015|NCT03489161|Narcotics|narcotics|mesh-ancestor
139425016|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139425017|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425018|NCT03489161|Analgesics|analgesics|mesh-ancestor
139425019|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
139425020|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425021|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139425022|NCT04804709|Panobinostat|panobinostat|mesh-list
139425023|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425024|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139425025|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425026|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425027|NCT04690673|Acetaminophen|acetaminophen|mesh-list
139425028|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139425029|NCT04690673|Analgesics|analgesics|mesh-ancestor
139425030|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
139425031|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425032|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425033|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
139425034|NCT03104075|Vaccines|vaccines|mesh-list
139425035|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139425036|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
139425037|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425038|NCT04388501|Atorvastatin|atorvastatin|mesh-list
139425039|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139425040|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139425041|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
139425042|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425043|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139425044|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139425045|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425046|NCT02249182|Ribavirin|ribavirin|mesh-list
139425047|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
139382222|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139425048|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139425049|NCT02249182|Ledipasvir|ledipasvir|mesh-list
139425050|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
139425051|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425052|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
139425053|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425054|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139425055|NCT03487211|Escitalopram|escitalopram|mesh-list
139425056|NCT03487211|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139425057|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139425058|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139425059|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425060|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425061|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
139425062|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425063|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425064|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
139425065|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139425066|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139425067|NCT03487211|Analgesics|analgesics|mesh-ancestor
139425068|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
139425069|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
139425070|NCT03487133|Dexamethasone|dexamethasone|mesh-list
139425071|NCT03487133|Bortezomib|bortezomib|mesh-list
139425072|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139425073|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
139425074|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
139425075|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425076|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425077|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139425078|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
139425079|NCT03487133|Hormones|hormones|mesh-ancestor
139425080|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425081|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139425082|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425083|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139425084|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139425085|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139425086|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139425087|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425088|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425089|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425090|NCT02248480|Analgesics|analgesics|mesh-ancestor
139425091|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
139425092|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425093|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
139425094|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139425095|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
139425097|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425098|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
139425099|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
139425100|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
139425101|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425102|NCT00701207|Nicotine|nicotine|mesh-list
139425103|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139425104|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
139425105|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425106|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425107|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139425108|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139425109|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
139425110|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425111|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425112|NCT02247466|Rocuronium|rocuronium|mesh-list
139425113|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139425114|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139425115|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139425116|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425117|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425118|NCT03417479|Gabapentin|gabapentin|mesh-list
139425119|NCT03417479|Analgesics|analgesics|mesh-ancestor
139425120|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
138859596|NCT02827877|Copper|copper|mesh-list
139425121|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425122|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425123|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
139425124|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139425125|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139425126|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139425127|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139425128|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139425129|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139425130|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425131|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425132|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
139425133|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
139425134|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
139425135|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139425136|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139425137|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425138|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
139425139|NCT03317795|Coagulants|coagulants|mesh-ancestor
139425140|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139425141|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
139425142|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139425143|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425144|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139425145|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139425146|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139425147|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
139425148|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425149|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139425150|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139425151|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139425152|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
139425153|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425154|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425155|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139425156|NCT03876119|Plasminogen|plasminogen|mesh-list
139425157|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139425158|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139425159|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425160|NCT02455076|Exenatide|exenatide|mesh-list
139425161|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
139425162|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139425163|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425164|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139425165|NCT02455076|Incretins|incretins|mesh-ancestor
139425166|NCT02455076|Hormones|hormones|mesh-ancestor
139211848|NCT05907993|Analgesics|analgesics|mesh-ancestor
139425167|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425168|NCT02432846|Sunitinib|sunitinib|mesh-list
139425169|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425170|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139425171|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139425172|NCT02432846|Growth Substances|growth substances|mesh-ancestor
139425173|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425174|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
139425175|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139425176|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425177|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425178|NCT03486509|Afatinib|afatinib|mesh-list
139425179|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425180|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139425181|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425182|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425183|NCT04460807|Exemestane|exemestane|mesh-list
139425184|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425185|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139425186|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139425187|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425188|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425189|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139425190|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
139425191|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138859664|NCT02598557|Exemestane|exemestane|mesh-list
139425192|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425193|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139425194|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
139425195|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425196|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139425197|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139425198|NCT04928222|Doxorubicin|doxorubicin|mesh-list
139425199|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139425200|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425201|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139425202|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139425203|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425204|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425205|NCT00805961|Bevacizumab|bevacizumab|mesh-list
139425206|NCT00805961|Everolimus|everolimus|mesh-list
139425207|NCT00805961|Temozolomide|temozolomide|mesh-list
139425208|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139425209|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425210|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139425211|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139425212|NCT00805961|Growth Substances|growth substances|mesh-ancestor
139425213|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425214|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
139425215|NCT00805961|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139425216|NCT00805961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139425217|NCT00805961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425218|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425219|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139425220|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
139425221|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139425222|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
139425223|NCT02454608|Verapamil|verapamil|mesh-list
139425224|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139425225|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139425226|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139425227|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425228|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139425229|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425230|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
139425231|NCT05152355|Budesonide|budesonide|mesh-list
139425232|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139425233|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139425234|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
139425235|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425236|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425237|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139425238|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
139425239|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
139425240|NCT05152355|Hormones|hormones|mesh-ancestor
139425241|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425242|NCT02246764|Timolol|timolol|mesh-list
139425243|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139425244|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139425245|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425246|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139425247|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139425248|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
139425249|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425250|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425251|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139425252|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139425254|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
139425255|NCT03484091|Protective Agents|protective agents|mesh-ancestor
139425256|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425257|NCT03486353|Azacitidine|azacitidine|mesh-list
139425258|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139425259|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
139425260|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425261|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425262|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425263|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139425264|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139425265|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139425266|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139425267|NCT02431676|Metformin|metformin|mesh-list
139425268|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139425269|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425270|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139425271|NCT03483545|Hormones|hormones|mesh-ancestor
139425272|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425273|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425274|NCT03483389|Ethanol|ethanol|mesh-list
139425275|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139425276|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425277|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139425278|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425279|NCT03486119|Nivolumab|nivolumab|mesh-list
139425280|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139425281|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425282|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139425283|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425284|NCT02523833|Albuterol|albuterol|mesh-list
139425285|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139425286|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
139425287|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425288|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425289|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139425290|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
139425291|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
139425292|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139425293|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139425294|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139425295|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139425296|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
139425297|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425298|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425299|NCT04234529|Caffeine|caffeine|mesh-list
139425300|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139425301|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425302|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139425303|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425304|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425305|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139211998|NCT05500599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139211999|NCT05500599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139212000|NCT05500599|Anesthetics, General|anesthetics, general|mesh-ancestor
139212001|NCT05500599|Anesthetics|anesthetics|mesh-ancestor
139212002|NCT05500599|GABA Modulators|gaba modulators|mesh-ancestor
139212003|NCT05500599|GABA Agents|gaba agents|mesh-ancestor
139425306|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139425307|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
139425308|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425309|NCT01652690|Denosumab|denosumab|mesh-list
139425310|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139425311|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425312|NCT03481517|Bupivacaine|bupivacaine|mesh-list
139425313|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
139425314|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
139425315|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139425316|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425317|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
139425318|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425319|NCT02429258|Metformin|metformin|mesh-list
139425320|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
139425321|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139425322|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425323|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139425324|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425325|NCT02201524|Abrocitinib|abrocitinib|mesh-list
139425326|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139425327|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425328|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425329|NCT05153603|Olaparib|olaparib|mesh-list
139425330|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139425331|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425332|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425333|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425334|NCT02137252|Naltrexone|naltrexone|mesh-list
139425335|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139425336|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139425337|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425338|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
139425339|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425340|NCT05152667|Dienogest|dienogest|mesh-list
139425341|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
139425342|NCT05152667|Progestins|progestins|mesh-list
139425343|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139425344|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
139425345|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139425346|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425347|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139425348|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139425349|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139425350|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139425351|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139425352|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
139425353|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425354|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139425355|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425356|NCT05152667|Hormones|hormones|mesh-ancestor
139425357|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
139425358|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139425359|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425360|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425361|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139425362|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139425363|NCT05152511|Protective Agents|protective agents|mesh-ancestor
139425364|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425365|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
139425366|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139425367|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
139425368|NCT02568449|Nintedanib|nintedanib|mesh-list
139425369|NCT02568449|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139425370|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425371|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139425372|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425373|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425374|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
139425375|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
139425376|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425377|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
139425378|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139425379|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
139425380|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
139425381|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139425382|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425383|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139425384|NCT04884893|Analgesics|analgesics|mesh-ancestor
139425385|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
139425386|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425387|NCT03479879|Misoprostol|misoprostol|mesh-list
139425388|NCT03479879|Estradiol|estradiol|mesh-list
139425389|NCT03479879|Estrogens|estrogens|mesh-ancestor
139425390|NCT03479879|Hormones|hormones|mesh-ancestor
139425391|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425392|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425393|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139425394|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139425395|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
139425396|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139425397|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139425398|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
139425399|NCT03479411|Itraconazole|itraconazole|mesh-list
139425400|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139425401|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
139425402|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425403|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139425404|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139425405|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425406|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425407|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139425408|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
139425409|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425410|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425411|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139425412|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
139425413|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139425414|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139425415|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425416|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139425417|NCT03131375|Analgesics|analgesics|mesh-ancestor
139425418|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
139425419|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425420|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139425421|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139425422|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139425423|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
139425424|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425425|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425426|NCT03475589|Apatinib|apatinib|mesh-list
139425427|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425428|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139425429|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425430|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425431|NCT03478709|Norepinephrine|norepinephrine|mesh-list
139425432|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139425433|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139425434|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
139425435|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425436|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425437|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425438|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
139425439|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
139425440|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425441|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139425442|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
139425443|NCT03478475|Vitamin D|vitamin d|mesh-list
139425444|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139425445|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425446|NCT03478475|Vitamins|vitamins|mesh-ancestor
139425447|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
139425448|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139425449|NCT03475121|Topotecan|topotecan|mesh-list
139425450|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139425451|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139425452|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425453|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425454|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425455|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139425456|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425457|NCT02523755|Ropivacaine|ropivacaine|mesh-list
139425458|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
139425459|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
139425460|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139425461|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425462|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
139425463|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425464|NCT02168842|Isradipine|isradipine|mesh-list
139425465|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139425466|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139425467|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139425468|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425469|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139425470|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425471|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
139425472|NCT03347123|Nivolumab|nivolumab|mesh-list
139425473|NCT03347123|Ipilimumab|ipilimumab|mesh-list
139425474|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139425475|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425476|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138859969|NCT03633110|Nivolumab|nivolumab|mesh-list
139425477|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425478|NCT03131141|Lefamulin|lefamulin|mesh-list
139425479|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139425480|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425481|NCT05258045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139425482|NCT05258045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139425483|NCT05258045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425484|NCT03477929|Cetrorelix|cetrorelix|mesh-list
139425485|NCT03477929|Ganirelix|ganirelix|mesh-list
139425486|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
139425487|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425488|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425489|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139425490|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
139425491|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139425492|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139425493|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139425494|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425495|NCT03474263|Antibodies|antibodies|mesh-list
139425496|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139425497|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
139425498|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425499|NCT03477461|Terlipressin|terlipressin|mesh-list
139425500|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139425501|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139425502|NCT02553161|Escitalopram|escitalopram|mesh-list
139425503|NCT02553161|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139425504|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139425505|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139425506|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425507|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425508|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
139425509|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425510|NCT03473093|Pregabalin|pregabalin|mesh-list
139425511|NCT03473093|Morphine|morphine|mesh-list
139425512|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139425513|NCT03473093|Narcotics|narcotics|mesh-ancestor
139425514|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139425515|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425516|NCT03473093|Analgesics|analgesics|mesh-ancestor
139425517|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
139425518|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425519|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
139425520|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139425521|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139425522|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425523|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139425524|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139425525|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139425526|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139425527|NCT02523131|Insulin|insulin|mesh-list
139425528|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139425529|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425531|NCT04339049|Misoprostol|misoprostol|mesh-list
139425532|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
139425533|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
139425534|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139425535|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425536|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
139425537|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425538|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139425539|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139425540|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139425541|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139425542|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425543|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139425544|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
139425545|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139425546|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139425547|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139425548|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
139425549|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
139425550|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
139425551|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425552|NCT02133664|Protective Agents|protective agents|mesh-ancestor
139425553|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425554|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
139425555|NCT02133664|Vitamins|vitamins|mesh-ancestor
139425556|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
139425557|NCT02133352|Ranolazine|ranolazine|mesh-list
139425558|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139425559|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139425560|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425561|NCT04418128|Nafamostat|nafamostat|mesh-list
139425562|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139425563|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139425564|NCT04418128|Analgesics|analgesics|mesh-ancestor
139425565|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
139425566|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425567|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425568|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139425569|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139425570|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
139425571|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
139425572|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425573|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425574|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139425575|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139425576|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139425577|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139425578|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
139425579|NCT02555657|Gemcitabine|gemcitabine|mesh-list
139425580|NCT02555657|Capecitabine|capecitabine|mesh-list
139425581|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
139425582|NCT02555657|Vinorelbine|vinorelbine|mesh-list
139425583|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139425584|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
139425585|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425586|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425587|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139425588|NCT02555657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139425589|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139425590|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
139425591|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
139425592|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
139425593|NCT02195518|Tenofovir|tenofovir|mesh-list
139425594|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
139425595|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425596|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139425597|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139425598|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425599|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425600|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139212302|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139425601|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139425603|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425604|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
139425605|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
139425606|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
139425607|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425608|NCT05134415|Menthol|menthol|mesh-list
139425609|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
139425610|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
139425611|NCT03380507|Thiamine|thiamine|mesh-list
139425612|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
139425613|NCT03380507|Vitamins|vitamins|mesh-ancestor
139425614|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
139425615|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425616|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139425617|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
139425618|NCT03471455|Itraconazole|itraconazole|mesh-list
139425619|NCT03471455|Terbinafine|terbinafine|mesh-list
139425620|NCT03471455|Isotretinoin|isotretinoin|mesh-list
139425621|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
139425622|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425623|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139425624|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139425625|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425626|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425627|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139425628|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
139425629|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425630|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425631|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139425632|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
139425633|NCT02824679|Scopolamine|scopolamine|mesh-list
139425634|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139425635|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139425636|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
139425637|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
139425638|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425639|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425640|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139425641|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
139425642|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139425643|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
139425644|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425645|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425646|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139425647|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
139425648|NCT03202667|Empagliflozin|empagliflozin|mesh-list
139425649|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139425650|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425651|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139425652|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425653|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
139425654|NCT02133742|Axitinib|axitinib|mesh-list
139425655|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139425656|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425657|NCT02133742|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139425658|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425659|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139425660|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425661|NCT05157893|Analgesics|analgesics|mesh-list
139425662|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
139425663|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425664|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425665|NCT02523053|Fluorouracil|fluorouracil|mesh-list
139425666|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
139425667|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425668|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139425669|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425670|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139425671|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
139425672|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425673|NCT04457609|Azithromycin|azithromycin|mesh-list
139425674|NCT04457609|Oseltamivir|oseltamivir|mesh-list
139212388|NCT04515238|Venetoclax|venetoclax|mesh-list
139425675|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139425676|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425678|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425679|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425680|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
139425681|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139425682|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425683|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
139425684|NCT04457765|Povidone|povidone|mesh-list
139425685|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
139425686|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
139425687|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139425688|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425689|NCT03795233|Vancomycin|vancomycin|mesh-list
139425690|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139425691|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425692|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139425693|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
139425694|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139425695|NCT04503707|Hormones|hormones|mesh-ancestor
139425696|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425697|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425698|NCT03470597|Iodine|iodine|mesh-list
139425699|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139425700|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425701|NCT03470597|Trace Elements|trace elements|mesh-ancestor
139425702|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
139425703|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425704|NCT02522897|Ranibizumab|ranibizumab|mesh-list
139425705|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139425706|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139425707|NCT02522897|Growth Substances|growth substances|mesh-ancestor
139425708|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425709|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
139425710|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425711|NCT04351061|Acetazolamide|acetazolamide|mesh-list
139425712|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
139425713|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139425714|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425715|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425716|NCT04351061|Diuretics|diuretics|mesh-ancestor
139425717|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
139425718|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425719|NCT03130829|Fucoidan|fucoidan|mesh-list
139425720|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139425721|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139425722|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
139425723|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425724|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139425725|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
139425726|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
139425727|NCT04206761|Bromides|bromides|mesh-list
139425728|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
139425729|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139425730|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
139425731|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139425732|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139425733|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139425734|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139425735|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
139425736|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425737|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425738|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425739|NCT03181529|Psilocybin|psilocybin|mesh-list
139425740|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
139425741|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425742|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139425743|NCT03668639|Dexamethasone|dexamethasone|mesh-list
139425744|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139425745|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
139425746|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
139425747|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425748|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425749|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139425750|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
139425751|NCT03668639|Hormones|hormones|mesh-ancestor
139212455|NCT04311099|Ropivacaine|ropivacaine|mesh-list
139425752|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425753|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139425754|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425755|NCT03470363|Sufentanil|sufentanil|mesh-list
139425756|NCT03470363|Bupivacaine|bupivacaine|mesh-list
139425757|NCT03470363|Sevoflurane|sevoflurane|mesh-list
139425758|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
139425759|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
139425760|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139425761|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425762|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
139425763|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425764|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139425765|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139425766|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
139425767|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139425768|NCT03470363|Narcotics|narcotics|mesh-ancestor
139425769|NCT03470363|Analgesics|analgesics|mesh-ancestor
139425770|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139425771|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139425772|NCT03469895|Idelalisib|idelalisib|mesh-list
139425773|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425774|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425775|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425776|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
139425777|NCT05160623|Povidone|povidone|mesh-list
139425778|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
139425779|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
139425780|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139425781|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425782|NCT04713137|Erythritol|erythritol|mesh-list
139425783|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
139425784|NCT04456985|Folic Acid|folic acid|mesh-list
139425785|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
139425786|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
139425787|NCT04456985|Vitamins|vitamins|mesh-ancestor
139425788|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
139425789|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425790|NCT04456985|Hematinics|hematinics|mesh-ancestor
139425791|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
139425792|NCT03469583|Entecavir|entecavir|mesh-list
139425793|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
139425794|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425795|NCT05096039|Valsartan|valsartan|mesh-list
139425796|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139425797|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139425798|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139425799|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139425800|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425801|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
139425802|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139425803|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425804|NCT03361865|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139425805|NCT03361865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425806|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139425807|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139425808|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
139425809|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425810|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425811|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139425812|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139425813|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139425814|NCT02421341|Fentanyl|fentanyl|mesh-list
139425815|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
139425816|NCT02421341|Analgesics|analgesics|mesh-list
139425817|NCT02421341|Narcotics|narcotics|mesh-ancestor
139425818|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139425819|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425820|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
139425821|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425822|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139425823|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139425824|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
139425825|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
139425826|NCT02149121|Rituximab|rituximab|mesh-list
139425827|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139425828|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425829|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
139425830|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425831|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139425832|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
139425833|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139425834|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
139425835|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425836|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
139425837|NCT05161403|Protective Agents|protective agents|mesh-ancestor
139425838|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
139425839|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139425840|NCT03166085|Paclitaxel|paclitaxel|mesh-list
139425841|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
139425842|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139425843|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425844|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
139425845|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
138860331|NCT05341076|Oxytocin|oxytocin|mesh-list
139425846|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
139425847|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425848|NCT05390255|Mometasone Furoate|mometasone furoate|mesh-list
139425849|NCT05390255|Omalizumab|omalizumab|mesh-list
139425850|NCT05390255|Hormones|hormones|mesh-list
139425851|NCT05390255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425852|NCT05390255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425853|NCT05390255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139425854|NCT05390255|Dermatologic Agents|dermatologic agents|mesh-ancestor
139425855|NCT05390255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139425856|NCT05390255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139425857|NCT05390255|Respiratory System Agents|respiratory system agents|mesh-ancestor
139425858|NCT04456829|Resveratrol|resveratrol|mesh-list
139425859|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
139425860|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425861|NCT04456829|Protective Agents|protective agents|mesh-ancestor
139425862|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425863|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425864|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139425865|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
139425866|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139425867|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139425868|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
139425869|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425870|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425871|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425872|NCT02522221|Warfarin|warfarin|mesh-list
139425873|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
139425874|NCT05389943|Vitamin D|vitamin d|mesh-list
139425875|NCT05389943|Ergocalciferols|ergocalciferols|mesh-list
139425876|NCT05389943|Cholecalciferol|cholecalciferol|mesh-list
139425877|NCT05389943|Vitamins|vitamins|mesh-list
139425878|NCT05389943|Micronutrients|micronutrients|mesh-ancestor
139425879|NCT05389943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425880|NCT05389943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139425881|NCT05389943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139425882|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
139425883|NCT02522975|Hematinics|hematinics|mesh-ancestor
139425884|NCT04508803|Trastuzumab|trastuzumab|mesh-list
139425885|NCT04508803|Niraparib|niraparib|mesh-list
139425886|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139425887|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425888|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139425889|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425890|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425891|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
139425892|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139425893|NCT03461185|Growth Substances|growth substances|mesh-ancestor
139425894|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425895|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
139425896|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425897|NCT04453423|Carboplatin|carboplatin|mesh-list
139425898|NCT04453423|Pemetrexed|pemetrexed|mesh-list
139425899|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425900|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425901|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425902|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139425903|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139425904|NCT04453189|Lansoprazole|lansoprazole|mesh-list
139425905|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
139425906|NCT04453189|Famotidine|famotidine|mesh-list
139425907|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139425908|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139425909|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139425910|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425911|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425912|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139425913|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
139425914|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
139425915|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139425916|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425917|NCT03465085|Heparin|heparin|mesh-list
139425918|NCT03465085|Calcium heparin|calcium heparin|mesh-list
139425919|NCT03465085|Streptokinase|streptokinase|mesh-list
139425920|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
139425921|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139425922|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139425923|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425924|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
139425925|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139425926|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
139425927|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139425928|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
139425929|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425930|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
139425931|NCT04453111|Protective Agents|protective agents|mesh-ancestor
139425932|NCT03468595|Listerine|listerine|mesh-list
139425933|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139425934|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425935|NCT04453345|Thalidomide|thalidomide|mesh-list
139425936|NCT04453345|Prednisone|prednisone|mesh-list
139425937|NCT04453345|Methotrexate|methotrexate|mesh-list
139425938|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139425939|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
139425940|NCT04453345|Hormones|hormones|mesh-ancestor
139425941|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139425942|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425943|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139425944|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425945|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139425946|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
139425947|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139425948|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139425949|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
139425950|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425951|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
139425952|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139425953|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139425954|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139425955|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
139425956|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139425957|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139425958|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
139425959|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139425960|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139425961|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139425962|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139425963|NCT04453345|Growth Substances|growth substances|mesh-ancestor
139425964|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
139425965|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
139425966|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139425967|NCT03464539|Chitosan|chitosan|mesh-list
139425968|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139425969|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139425970|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
139425971|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425972|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139425973|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
139425974|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
139425975|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
139425976|NCT03464539|Coagulants|coagulants|mesh-ancestor
139425977|NCT03460405|Vaccines|vaccines|mesh-list
139425978|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
139425979|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425980|NCT05166005|Vitamin D|vitamin d|mesh-list
139425981|NCT05166005|Vitamins|vitamins|mesh-ancestor
139425982|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
139425983|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425984|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139425985|NCT03464305|Aspirin|aspirin|mesh-list
139425986|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139425987|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139425988|NCT03464305|Analgesics|analgesics|mesh-ancestor
139425989|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
139425990|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139425991|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139425992|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139425993|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139425994|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139425995|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139425996|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139425997|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139425998|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139425999|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426000|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
139426001|NCT05165615|Insulin|insulin|mesh-list
139426002|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139426003|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426004|NCT03468439|Phenol|phenol|mesh-list
139426005|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139426006|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426007|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
139426008|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139426009|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139426010|NCT05165303|Lidocaine|lidocaine|mesh-list
139426011|NCT05165303|Propofol|propofol|mesh-list
139426012|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
139426013|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
139426014|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139426015|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426016|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
139426017|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426018|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139426019|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139426020|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139426021|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139426022|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426023|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139426024|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139426025|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
139426026|NCT03376763|Aripiprazole|aripiprazole|mesh-list
139426027|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
139426028|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139426029|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139426030|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139426031|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139426032|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426033|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
139426034|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
139426035|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426036|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426037|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139426038|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139426039|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
139426040|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139426041|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139426042|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139426043|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139426044|NCT05153135|Palbociclib|palbociclib|mesh-list
139426045|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426046|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139426047|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426048|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426049|NCT04857307|Alprazolam|alprazolam|mesh-list
139426050|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139426051|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139426052|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426053|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139426054|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139426055|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139426056|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
139426057|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
139426058|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426059|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426060|NCT03467893|Antacids|antacids|mesh-list
139426061|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426062|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139426063|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
139426064|NCT05170711|Anesthetics|anesthetics|mesh-list
139426065|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139426066|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426067|NCT03454945|Doxycycline|doxycycline|mesh-list
139426068|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139426069|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426070|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
139426071|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139426072|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139426073|NCT01857115|Dexamethasone|dexamethasone|mesh-list
139426074|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
139426075|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139426076|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
139426077|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426078|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139426079|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139426080|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
139426081|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426082|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426083|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139426084|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139426085|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
139426086|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
139426087|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426088|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139426089|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
139426090|NCT01857115|Hormones|hormones|mesh-ancestor
139426091|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139426092|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139426093|NCT03453541|Ketorolac|ketorolac|mesh-list
139426094|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139426095|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139426096|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139426097|NCT03453541|Analgesics|analgesics|mesh-ancestor
139426098|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
139426099|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426100|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426101|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139426102|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139426103|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139426104|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426105|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426106|NCT00893789|Modafinil|modafinil|mesh-list
139426107|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139426108|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426109|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139426110|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139426111|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139426112|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426113|NCT03449251|Verapamil|verapamil|mesh-list
139426114|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
139426115|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139426116|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139426117|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139426118|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426119|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139426120|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426121|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
139426122|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426123|NCT05322499|Paclitaxel|paclitaxel|mesh-list
139426124|NCT05322499|Docetaxel|docetaxel|mesh-list
139426125|NCT05322499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139426126|NCT05322499|Irinotecan|irinotecan|mesh-list
139426127|NCT05322499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139426128|NCT05322499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426129|NCT05322499|Tubulin Modulators|tubulin modulators|mesh-ancestor
139426130|NCT05322499|Antimitotic Agents|antimitotic agents|mesh-ancestor
139426131|NCT05322499|Mitosis Modulators|mitosis modulators|mesh-ancestor
139426132|NCT05322499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426133|NCT05322499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139426134|NCT05322499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139426135|NCT05322499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426136|NCT03449173|Sunitinib|sunitinib|mesh-list
139426137|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426138|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139426139|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139426140|NCT03449173|Growth Substances|growth substances|mesh-ancestor
139426141|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426142|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
139426143|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139426144|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426145|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426146|NCT04760041|Midazolam|midazolam|mesh-list
139426147|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139426148|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139426149|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139426150|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426151|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139426152|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139426153|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139426154|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139426155|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
139426156|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
139426157|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
139426158|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
139426159|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426160|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426161|NCT05322265|Epinephrine|epinephrine|mesh-list
139426162|NCT05322265|Racepinephrine|racepinephrine|mesh-list
139426163|NCT05322265|Epinephryl borate|epinephryl borate|mesh-list
139426164|NCT05322265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139426165|NCT05322265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139426166|NCT05322265|Adrenergic Agents|adrenergic agents|mesh-ancestor
139426167|NCT05322265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426168|NCT05322265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426169|NCT05322265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426170|NCT05322265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139426171|NCT05322265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139426172|NCT05322265|Autonomic Agents|autonomic agents|mesh-ancestor
139426173|NCT05322265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426174|NCT05322265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139426175|NCT05322265|Respiratory System Agents|respiratory system agents|mesh-ancestor
139426176|NCT05322265|Mydriatics|mydriatics|mesh-ancestor
139426177|NCT05322265|Sympathomimetics|sympathomimetics|mesh-ancestor
139426178|NCT05322265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139426179|NCT02164864|Aspirin|aspirin|mesh-list
139426180|NCT02164864|Warfarin|warfarin|mesh-list
139426181|NCT02164864|Dabigatran|dabigatran|mesh-list
139426182|NCT02164864|Clopidogrel|clopidogrel|mesh-list
139426183|NCT02164864|Ticagrelor|ticagrelor|mesh-list
139426184|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139426185|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139426186|NCT02164864|Analgesics|analgesics|mesh-ancestor
139426187|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
139426188|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426189|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426190|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139426191|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139426192|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139426193|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139426194|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426195|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139426196|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139426197|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426198|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
139426199|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139426200|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139426201|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139426202|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
139426203|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426204|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
139426205|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
139426206|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139426207|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
139426208|NCT05579249|Liraglutide|liraglutide|mesh-list
139426209|NCT05579249|Topiramate|topiramate|mesh-list
139426210|NCT05579249|Orlistat|orlistat|mesh-list
139426211|NCT05579249|Phentermine|phentermine|mesh-list
139426212|NCT05579249|Naltrexone|naltrexone|mesh-list
139426213|NCT05579249|Bupropion|bupropion|mesh-list
139426214|NCT05579249|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139426215|NCT05579249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139426216|NCT05579249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426217|NCT05579249|Sensory System Agents|sensory system agents|mesh-ancestor
139426218|NCT05579249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426219|NCT05579249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139426220|NCT05579249|Incretins|incretins|mesh-ancestor
139426221|NCT05579249|Hormones|hormones|mesh-ancestor
139426222|NCT05579249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139426223|NCT05579249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139426224|NCT05579249|Antidepressive Agents|antidepressive agents|mesh-ancestor
139426225|NCT05579249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139426226|NCT05579249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139426227|NCT05579249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139426228|NCT05579249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139426229|NCT05579249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426230|NCT05579249|Dopamine Agents|dopamine agents|mesh-ancestor
139426231|NCT05579249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426232|NCT05579249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139426233|NCT05579249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139426234|NCT05579249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426235|NCT05579249|Anticonvulsants|anticonvulsants|mesh-ancestor
139426236|NCT05579249|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139426237|NCT05579249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139426238|NCT05579249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139426239|NCT05579249|Appetite Depressants|appetite depressants|mesh-ancestor
139426240|NCT05579249|Sympathomimetics|sympathomimetics|mesh-ancestor
139426241|NCT05579249|Autonomic Agents|autonomic agents|mesh-ancestor
139426242|NCT05579249|Adrenergic Agents|adrenergic agents|mesh-ancestor
139426243|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139426244|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
139426245|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139426246|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426247|NCT05386589|Molnupiravir|molnupiravir|mesh-list
139426248|NCT05386589|Antiviral Agents|antiviral agents|mesh-ancestor
139426249|NCT05386589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426250|NCT01998529|Cisplatin|cisplatin|mesh-list
139426251|NCT01998529|Amifostine|amifostine|mesh-list
139426252|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426253|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139426254|NCT01998529|Protective Agents|protective agents|mesh-ancestor
139426255|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426256|NCT03448705|Vaccines|vaccines|mesh-list
139426257|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
139426258|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426259|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
139426260|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139426261|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
139426262|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426263|NCT03448549|Capecitabine|capecitabine|mesh-list
139426264|NCT03448549|Tegafur|tegafur|mesh-list
139426265|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
139426266|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139426267|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
139426268|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426269|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426270|NCT03679091|Clopidogrel|clopidogrel|mesh-list
139426271|NCT03679091|Ticagrelor|ticagrelor|mesh-list
139426272|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139426273|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139426274|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139426275|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139426276|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
139426277|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426278|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212998|NCT04490980|Butorphanol|butorphanol|mesh-list
139426279|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426280|NCT01628926|Ropinirole|ropinirole|mesh-list
139426281|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139426282|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139426283|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
139426284|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
139426285|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426286|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426287|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426288|NCT05313659|Ketamine|ketamine|mesh-list
139426289|NCT05313659|Analgesics|analgesics|mesh-ancestor
139426290|NCT05313659|Sensory System Agents|sensory system agents|mesh-ancestor
139426291|NCT05313659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426292|NCT05313659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426293|NCT05313659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139426294|NCT05313659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139426295|NCT05313659|Anesthetics, General|anesthetics, general|mesh-ancestor
139426296|NCT05313659|Anesthetics|anesthetics|mesh-ancestor
139426297|NCT05313659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139426298|NCT05313659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139426299|NCT05313659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139426300|NCT05313659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426301|NCT05313659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426302|NCT05322187|Pembrolizumab|pembrolizumab|mesh-list
139426303|NCT05322187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139426304|NCT05322187|Lenvatinib|lenvatinib|mesh-list
139426305|NCT05322187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139426306|NCT05322187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426307|NCT05322187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426308|NCT05322187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139426309|NCT05322187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426310|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
139426311|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
139426312|NCT03436199|Amantadine|amantadine|mesh-list
139426313|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139426314|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139426315|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
139426316|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426317|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
139426318|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426319|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426320|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426321|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139426322|NCT03436199|Analgesics|analgesics|mesh-ancestor
139426323|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
139426324|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426325|NCT02131324|Clobetasol|clobetasol|mesh-list
139426326|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139426327|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
139426328|NCT02131324|Hormones|hormones|mesh-ancestor
139426329|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139382261|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
139426330|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426331|NCT04749394|Apatinib|apatinib|mesh-list
139426332|NCT04749394|Antibodies|antibodies|mesh-list
139426333|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
139426334|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139426335|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
139426336|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426337|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426338|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139426339|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426340|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426341|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
139426342|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139426343|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
139426344|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426345|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139426346|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139426347|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
139426348|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426349|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426350|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139426351|NCT05159219|Colchicine|colchicine|mesh-list
139426352|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
139426353|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139426354|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
139426355|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
139426356|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
139426357|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426358|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426359|NCT05321329|Capecitabine|capecitabine|mesh-list
139426360|NCT05321329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139426361|NCT05321329|Antimetabolites|antimetabolites|mesh-ancestor
139426362|NCT05321329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426363|NCT05321329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426364|NCT02521831|Bupivacaine|bupivacaine|mesh-list
139426365|NCT02521831|Anesthetics|anesthetics|mesh-list
139426366|NCT02521831|Isoflurane|isoflurane|mesh-list
139426367|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
139426368|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139426369|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426370|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
139426371|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426372|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139426373|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
139426374|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
139426375|NCT03447925|Salicylates|salicylates|mesh-list
139426376|NCT03447925|Petrolatum|petrolatum|mesh-list
139426377|NCT03447925|Emollients|emollients|mesh-ancestor
139426378|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
139426379|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139426380|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139426381|NCT03447925|Analgesics|analgesics|mesh-ancestor
139426382|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
139426383|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426384|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426385|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139426386|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139426387|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139426388|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426389|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426390|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426391|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
139426392|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
139426393|NCT04928183|Nitroprusside|nitroprusside|mesh-list
139426394|NCT04928183|Phenylephrine|phenylephrine|mesh-list
139426395|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
139426396|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
139426397|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139426398|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
139426399|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
139426400|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426401|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426402|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
139426403|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139426404|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
139426405|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
139426406|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139426407|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139426408|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139426409|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
139426410|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426411|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426412|NCT04928183|Protective Agents|protective agents|mesh-ancestor
139426413|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
139426414|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
139426415|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139426416|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
139426417|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139426418|NCT03447691|Remifentanil|remifentanil|mesh-list
139426419|NCT03447691|Anesthetics|anesthetics|mesh-list
139426420|NCT03447691|Propofol|propofol|mesh-list
139426421|NCT03447691|Desflurane|desflurane|mesh-list
139426422|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139426423|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426424|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139426425|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139426426|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
139426427|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139426428|NCT03447691|Narcotics|narcotics|mesh-ancestor
139426429|NCT03447691|Analgesics|analgesics|mesh-ancestor
139426430|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
139426431|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426432|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139426433|NCT04923659|Nimodipine|nimodipine|mesh-list
139426434|NCT04923659|Carbamazepine|carbamazepine|mesh-list
139426436|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
139426437|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
139426438|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
139426439|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139426440|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139426441|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426442|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426443|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426444|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
139426445|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
139426446|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
139426447|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426448|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139426449|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139426450|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139426451|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139426452|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139426453|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139426454|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
139426455|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
139426456|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
139426457|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139426458|NCT04923659|Analgesics|analgesics|mesh-ancestor
139426459|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
139426460|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139426461|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139426462|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139426463|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139426464|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139426465|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139426466|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139426467|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
139426468|NCT05398679|Amoxicillin|amoxicillin|mesh-list
139426469|NCT05398679|Moxifloxacin|moxifloxacin|mesh-list
139426470|NCT05398679|Ciprofloxacin|ciprofloxacin|mesh-list
139426471|NCT05398679|Levofloxacin|levofloxacin|mesh-list
139426472|NCT05398679|Ofloxacin|ofloxacin|mesh-list
139426473|NCT05398679|Rifampin|rifampin|mesh-list
139426474|NCT05398679|Clindamycin|clindamycin|mesh-list
139426475|NCT05398679|Clindamycin palmitate|clindamycin palmitate|mesh-list
139426476|NCT05398679|Clindamycin phosphate|clindamycin phosphate|mesh-list
139426477|NCT05398679|Linezolid|linezolid|mesh-list
139426478|NCT05398679|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139426479|NCT05398679|Tedizolid|tedizolid|mesh-list
139426480|NCT05398679|Fusidic Acid|fusidic acid|mesh-list
139426481|NCT05398679|Dicloxacillin|dicloxacillin|mesh-list
139426482|NCT05398679|Cefaclor|cefaclor|mesh-list
139426483|NCT05398679|Trimethoprim|trimethoprim|mesh-list
139426484|NCT05398679|Sulfamethoxazole|sulfamethoxazole|mesh-list
139426485|NCT05398679|Oxazolidinones|oxazolidinones|mesh-list
139426486|NCT05398679|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139426487|NCT05398679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139426488|NCT05398679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426489|NCT05398679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139426490|NCT05398679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139426491|NCT05398679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426492|NCT05398679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426493|NCT05398679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426494|NCT05398679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139426495|NCT05398679|Contraceptive Agents|contraceptive agents|mesh-ancestor
139426496|NCT05398679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139426497|NCT05398679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426498|NCT05398679|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139426499|NCT05398679|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139426500|NCT05398679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139426501|NCT05398679|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139426502|NCT05398679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139426503|NCT05398679|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139426504|NCT05398679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139426505|NCT05398679|Antitubercular Agents|antitubercular agents|mesh-ancestor
139426506|NCT05398679|Leprostatic Agents|leprostatic agents|mesh-ancestor
139426507|NCT05398679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139426508|NCT05398679|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139426509|NCT05398679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139213223|NCT03305536|Vitamin D|vitamin d|mesh-list
139426510|NCT05398679|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139426511|NCT05398679|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139426512|NCT05398679|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139426513|NCT05398679|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139426514|NCT05398679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139426515|NCT05398679|Antimalarials|antimalarials|mesh-ancestor
139426516|NCT05398679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139426517|NCT05398679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139426518|NCT05398679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139426519|NCT05398679|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139426520|NCT05398679|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139426521|NCT04817501|Edetic Acid|edetic acid|mesh-list
139426522|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
139426523|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139426524|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
139426525|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
139426526|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426527|NCT05398055|Azithromycin|azithromycin|mesh-list
139426528|NCT05398055|Doxycycline|doxycycline|mesh-list
139426529|NCT05398055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139426530|NCT05398055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426531|NCT05398055|Antimalarials|antimalarials|mesh-ancestor
139426532|NCT05398055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139426533|NCT05398055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139426534|NCT01378325|Phenylephrine|phenylephrine|mesh-list
139426535|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
139426536|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139426537|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
139426538|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
139426539|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426540|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426541|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
139426542|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139426543|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
139426544|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
139426545|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139426546|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139426547|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139426548|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
139426549|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426550|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426551|NCT01378325|Protective Agents|protective agents|mesh-ancestor
139426552|NCT01093573|Azacitidine|azacitidine|mesh-list
139426553|NCT01093573|Midostaurin|midostaurin|mesh-list
139426554|NCT01093573|Staurosporine|staurosporine|mesh-list
139426555|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139426556|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
139426557|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426558|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426559|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426560|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139426561|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
139426562|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
139426563|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426564|NCT05174845|Protective Agents|protective agents|mesh-ancestor
139426565|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426567|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
139426568|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
139426569|NCT04155203|Mupirocin|mupirocin|mesh-list
139426570|NCT04155203|Calcium|calcium|mesh-list
139426571|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139426572|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426573|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139426574|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139426575|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426576|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139426577|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426578|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426579|NCT04238143|Complement Factor H|complement factor h|mesh-list
139426580|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139426581|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139426582|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
139426583|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426584|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
139213294|NCT03305068|Celecoxib|celecoxib|mesh-list
139426585|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139426586|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426587|NCT03057613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139426588|NCT03057613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426589|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
139426590|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139426591|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426592|NCT03446911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139426593|NCT03446911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426594|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
139426595|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
139426596|NCT03446599|Methylene Blue|methylene blue|mesh-list
139426597|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426598|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426599|NCT03446599|Hematinics|hematinics|mesh-ancestor
139426600|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
139426601|NCT03446599|Vitamins|vitamins|mesh-ancestor
139426602|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
139426603|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426604|NCT02856451|Nivolumab|nivolumab|mesh-list
139426605|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139426606|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426607|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139426608|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426609|NCT03446443|Metronidazole|metronidazole|mesh-list
139426610|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426611|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139426612|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139426613|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139426614|NCT05102071|Metformin|metformin|mesh-list
139426615|NCT05102071|Empagliflozin|empagliflozin|mesh-list
139426616|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139426617|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426618|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139426619|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382282|NCT02114021|Betamethasone|betamethasone|mesh-list
139426620|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
139426621|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139426622|NCT03130517|Antibodies|antibodies|mesh-list
139426623|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
139426624|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139426625|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
139426626|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426627|NCT03445897|Miltefosine|miltefosine|mesh-list
139426628|NCT03445897|Pentamidine|pentamidine|mesh-list
139426629|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
139426630|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426631|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426632|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139426633|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139426634|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139426635|NCT03234491|Insulin|insulin|mesh-list
139426636|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139426637|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139426638|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426639|NCT01961063|Busulfan|busulfan|mesh-list
139426640|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
139426641|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426642|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139426643|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
139426644|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426645|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139426646|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426647|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139426648|NCT02951377|Dexamethasone|dexamethasone|mesh-list
139426649|NCT02951377|Lidocaine|lidocaine|mesh-list
139426650|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139426651|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
139426652|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
139426653|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426654|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426655|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139426656|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
139426657|NCT02951377|Hormones|hormones|mesh-ancestor
139426658|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139426659|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139213368|NCT01347996|Interleukin-2|interleukin-2|mesh-list
139426660|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426661|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
139426662|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
139426663|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139426664|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
139426665|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139426666|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139426667|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139426668|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139426669|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426670|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
139426671|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426672|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426673|NCT03442621|Cortisone|cortisone|mesh-list
139426674|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139426675|NCT03444649|Cytarabine|cytarabine|mesh-list
139426676|NCT03444649|Daunorubicin|daunorubicin|mesh-list
139426677|NCT03444649|Idarubicin|idarubicin|mesh-list
139426678|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139426679|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
139426680|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426681|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426682|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
139426683|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426684|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139426685|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
139426686|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426687|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139426688|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139426689|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139426690|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426691|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139426692|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426693|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139426694|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426695|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426696|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
139426697|NCT03466775|Giapreza|giapreza|mesh-list
139426698|NCT03466775|Antibodies|antibodies|mesh-list
139426699|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
139426700|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
139426701|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426702|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139426703|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139426704|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
139426705|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426706|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426707|NCT02611817|Vedolizumab|vedolizumab|mesh-list
139426708|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139426709|NCT05430893|Botulinum Toxins|botulinum toxins|mesh-list
139426710|NCT05430893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139426711|NCT05430893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139426712|NCT05430893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139426713|NCT05430893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139426714|NCT05430893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426715|NCT05430893|Cholinergic Agents|cholinergic agents|mesh-ancestor
139426716|NCT05430893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426717|NCT05430893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426718|NCT05430893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139426719|NCT05430893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426720|NCT02557139|Belumosudil|belumosudil|mesh-list
139426721|NCT02557139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139426722|NCT02557139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426723|NCT02557139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426724|NCT01677741|Dabrafenib|dabrafenib|mesh-list
139426725|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426726|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139426727|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426728|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426729|NCT02457221|Prednisone|prednisone|mesh-list
139426730|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
139426731|NCT02457221|Tacrolimus|tacrolimus|mesh-list
139426732|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139426733|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
139426734|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426735|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139426736|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139426737|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
139426738|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426739|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426740|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139426741|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139426742|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
139426743|NCT02457221|Hormones|hormones|mesh-ancestor
139426744|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139426745|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139426746|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139426747|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426748|NCT05263895|Ritonavir|ritonavir|mesh-list
139426749|NCT05263895|Nirmatrelvir|nirmatrelvir|mesh-list
139426750|NCT05263895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139426751|NCT05263895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139426752|NCT05263895|Protease Inhibitors|protease inhibitors|mesh-ancestor
139426753|NCT05263895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426754|NCT05263895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426755|NCT05263895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139426756|NCT05263895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139426757|NCT05263895|Antiviral Agents|antiviral agents|mesh-ancestor
139426758|NCT05263895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426759|NCT05263895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139426760|NCT05263895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139426761|NCT01709981|Colchicine|colchicine|mesh-list
139426762|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
139426763|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139426764|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
139426765|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
139426766|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
139426767|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426768|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426769|NCT03268083|Vaccines|vaccines|mesh-list
139426770|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
139426771|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426772|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
139426773|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426774|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139426775|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426776|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426777|NCT03170817|Regadenoson|regadenoson|mesh-list
139426778|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139426779|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139426780|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
139426781|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
139426782|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426783|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426784|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426785|NCT05101005|Sirolimus|sirolimus|mesh-list
139426786|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139426787|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426788|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139426789|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426790|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
139426791|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139426792|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
139426793|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426794|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139426795|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139426796|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426797|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
139426798|NCT05015387|Procyanidin|procyanidin|mesh-list
139426799|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
139426800|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426801|NCT05015387|Protective Agents|protective agents|mesh-ancestor
139426802|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426803|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139426804|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139426805|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426806|NCT00003857|Tamoxifen|tamoxifen|mesh-list
139426807|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139426808|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
139213519|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139426809|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139426810|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426811|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139426812|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426813|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139426814|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139426815|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139426816|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139426817|NCT03464435|Tobramycin|tobramycin|mesh-list
139426818|NCT03464435|Tacrolimus|tacrolimus|mesh-list
139426819|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139426820|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
139426821|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426822|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139426823|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426824|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426825|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139426826|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426827|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139426828|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139426829|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426830|NCT03463967|Lycopene|lycopene|mesh-list
139382296|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
139426831|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139426832|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
139426833|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426834|NCT03463967|Protective Agents|protective agents|mesh-ancestor
139426835|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426836|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139426837|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139426838|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426839|NCT03463733|Temozolomide|temozolomide|mesh-list
139426840|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
139426841|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139426842|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
139426843|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426844|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426845|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
139426846|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426847|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139426848|NCT04222595|Vaccines|vaccines|mesh-list
139426849|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
139426850|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426851|NCT03468023|Calpastatin|calpastatin|mesh-list
139426852|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139426853|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
139426854|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426855|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426856|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
139426857|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
139426858|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426859|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426860|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426861|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
139426862|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
139426863|NCT05100303|Cytarabine|cytarabine|mesh-list
139426864|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
139426865|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139426866|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
139426867|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426868|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426869|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
139426870|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426871|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139426872|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
139426873|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426874|NCT05100303|Analgesics|analgesics|mesh-ancestor
139426875|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
139426876|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426877|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139426878|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139426879|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426880|NCT03462173|Yimitasvir|yimitasvir|mesh-list
139426881|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
139426882|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139426883|NCT05096715|Bevacizumab|bevacizumab|mesh-list
139426885|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139426886|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426887|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139426888|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139426889|NCT05096715|Growth Substances|growth substances|mesh-ancestor
139426890|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426891|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
139426892|NCT05096715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139426893|NCT05096715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426894|NCT05099601|Silymarin|silymarin|mesh-list
139426895|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
139426896|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426897|NCT05099601|Protective Agents|protective agents|mesh-ancestor
139426898|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426899|NCT03461783|Charcoal|charcoal|mesh-list
139426900|NCT03461783|Antidotes|antidotes|mesh-ancestor
139426901|NCT03461783|Protective Agents|protective agents|mesh-ancestor
139426902|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426903|NCT01677507|Timolol|timolol|mesh-list
139426904|NCT01677507|Latanoprost|latanoprost|mesh-list
139426905|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139426906|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139426907|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
139426908|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426909|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426910|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426911|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139426912|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139426913|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139426914|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139426915|NCT04796363|Anesthetics|anesthetics|mesh-list
139426916|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139426917|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426918|NCT03593109|Immunomodulating Agents|immunomodulating agents|mesh-list
139426919|NCT03593109|Immunologic Factors|immunologic factors|mesh-ancestor
139426920|NCT03593109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426921|NCT05103813|Beraprost|beraprost|mesh-list
139426922|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139426923|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
139426924|NCT03461627|Fluticasone|fluticasone|mesh-list
139426925|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139426926|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139426927|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139426928|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139426929|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
139426930|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426931|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426932|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139426933|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
139426934|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
139426935|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139426936|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139426937|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139426938|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139426939|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
139426940|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139426941|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426942|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
139426943|NCT03461627|Hormones|hormones|mesh-ancestor
139426944|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139426945|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
139426946|NCT04452929|Calcitonin|calcitonin|mesh-list
139426947|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
139426948|NCT04452929|Cilostazol|cilostazol|mesh-list
139426949|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139426950|NCT04452929|Erenumab|erenumab|mesh-list
139426951|NCT04452929|Katacalcin|katacalcin|mesh-list
139426952|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139426953|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
139426954|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139426955|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426956|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139426957|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
139426958|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139426959|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139426960|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426961|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139426963|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139426964|NCT04452929|Protective Agents|protective agents|mesh-ancestor
139426965|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139426966|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139426967|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426968|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139426969|NCT04452929|Analgesics|analgesics|mesh-ancestor
139426970|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
139426971|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139426972|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139426973|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
139426974|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139426975|NCT05103501|Fluorouracil|fluorouracil|mesh-list
139426976|NCT05103501|Cisplatin|cisplatin|mesh-list
139426977|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139426978|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139426979|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426980|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
139426981|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139426982|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139426983|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
139426984|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139426985|NCT02522117|Atorvastatin|atorvastatin|mesh-list
139426986|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139426987|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139426988|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
139426989|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426990|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139426991|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139426992|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139426993|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
139426994|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139426995|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139426996|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139426997|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
139426998|NCT05087199|Coagulants|coagulants|mesh-ancestor
139426999|NCT03461081|Amlodipine|amlodipine|mesh-list
139427000|NCT03461081|Telmisartan|telmisartan|mesh-list
139427001|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139427002|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
139427003|NCT03461081|Atorvastatin|atorvastatin|mesh-list
139427004|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139427005|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139427006|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
139427007|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427008|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139427009|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139427010|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427011|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139427012|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139427013|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139427014|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139427015|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427016|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
139427017|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139427018|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139427019|NCT02522039|Timolol|timolol|mesh-list
139427020|NCT02522039|Dorzolamide|dorzolamide|mesh-list
139427021|NCT02522039|Latanoprost|latanoprost|mesh-list
139427022|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139427023|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139427024|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
139427025|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427026|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427027|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427028|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139427029|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139427030|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139427031|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139427032|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139427033|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427034|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139427035|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139427036|NCT04430699|Cisplatin|cisplatin|mesh-list
139427037|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
139427038|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427039|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139427040|NCT04430699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139427041|NCT04430699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427042|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139427043|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
139427044|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427045|NCT04358003|Coal Tar|coal tar|mesh-list
139427046|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
139427047|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
139427048|NCT04519905|Paclitaxel|paclitaxel|mesh-list
139427049|NCT04519905|Carboplatin|carboplatin|mesh-list
139427050|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139427051|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427052|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
139427053|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
139427054|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
139427055|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427056|NCT04423341|Cannabidiol|cannabidiol|mesh-list
139427057|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
139427058|NCT03378479|Posaconazole|posaconazole|mesh-list
139427059|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
139427060|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139427061|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139427062|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139427063|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139427064|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139427065|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139427066|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427067|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427068|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139427069|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
139427070|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139427071|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427072|NCT03460145|Propofol|propofol|mesh-list
139427073|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139427074|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427075|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427076|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139427077|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
139427078|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
139427079|NCT04125771|Diclofenac|diclofenac|mesh-list
139427080|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139427081|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139427082|NCT04125771|Analgesics|analgesics|mesh-ancestor
139427083|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
139427084|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427085|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427086|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139427087|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139427088|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139427089|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427090|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427091|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139427092|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139427093|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139427094|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139427095|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427096|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427097|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427098|NCT05115123|Analgesics|analgesics|mesh-ancestor
139427099|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
139427100|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427101|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
139427102|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139427103|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
139427104|NCT04636671|Dexamethasone|dexamethasone|mesh-list
139427105|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
139427106|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139427107|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139427108|NCT04636671|Prednisolone|prednisolone|mesh-list
139427109|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
139427110|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139427111|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
139427112|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139427113|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
139427114|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
139427115|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427116|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427117|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139427118|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
139427119|NCT04636671|Hormones|hormones|mesh-ancestor
139427120|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139427121|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139427122|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427123|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139427124|NCT04636671|Protective Agents|protective agents|mesh-ancestor
139427125|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139427126|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139427127|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139427128|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139427129|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427130|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427131|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
139427132|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139427133|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427134|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427135|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139427136|NCT03645603|Analgesics|analgesics|mesh-ancestor
139427137|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
139427138|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427139|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139427140|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139427141|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139427142|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
139427143|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427144|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427145|NCT04771689|Buprenorphine|buprenorphine|mesh-list
139427146|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139427147|NCT04771689|Naloxone|naloxone|mesh-list
139427148|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139427149|NCT04771689|Narcotics|narcotics|mesh-ancestor
139427150|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427151|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427152|NCT04771689|Analgesics|analgesics|mesh-ancestor
139427153|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
139427154|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427155|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139427156|NCT04674345|Sorafenib|sorafenib|mesh-list
139427157|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427158|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139427159|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427160|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427161|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
139427162|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
139427163|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427164|NCT04165239|Protective Agents|protective agents|mesh-ancestor
139427165|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427166|NCT04576767|Anesthetics|anesthetics|mesh-list
139427167|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427168|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427169|NCT03248531|Adalimumab|adalimumab|mesh-list
139427170|NCT03248531|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139427171|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139427172|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139427173|NCT03129347|Nalmefene|nalmefene|mesh-list
139427174|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139427175|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427176|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
139427177|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427178|NCT02262923|Metoclopramide|metoclopramide|mesh-list
139427179|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
139427180|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
139427181|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427182|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427183|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139427184|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139427185|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139427186|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
139427187|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427188|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427189|NCT02194595|Insulin|insulin|mesh-list
139427190|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139427191|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
139427192|NCT02194595|Exenatide|exenatide|mesh-list
139427193|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
139427194|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139427195|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427196|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139427197|NCT02194595|Incretins|incretins|mesh-ancestor
139427198|NCT02194595|Hormones|hormones|mesh-ancestor
138861691|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427199|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139427200|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139427201|NCT02656329|Lugol's solution|lugol's solution|mesh-list
139427202|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427203|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427204|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427205|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139427206|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
139427207|NCT02656329|Coagulants|coagulants|mesh-ancestor
139427208|NCT02712905|Nivolumab|nivolumab|mesh-list
139427209|NCT02712905|Azacitidine|azacitidine|mesh-list
139427210|NCT02712905|Tretinoin|tretinoin|mesh-list
139427211|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139427212|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427213|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139427214|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427215|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139427216|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
139427217|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427218|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
139427219|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
139427220|NCT01166633|Atorvastatin|atorvastatin|mesh-list
139427221|NCT01166633|Pitavastatin|pitavastatin|mesh-list
139427222|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139427223|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139427224|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
139427225|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427226|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139427227|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139427228|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427229|NCT04315311|Pancrelipase|pancrelipase|mesh-list
139427230|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139427231|NCT03596073|Calcipotriene|calcipotriene|mesh-list
139427232|NCT03596073|Petrolatum|petrolatum|mesh-list
139427233|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
139427234|NCT03596073|Emollients|emollients|mesh-ancestor
139427235|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
139427236|NCT03449693|Antacids|antacids|mesh-ancestor
139427237|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427238|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139427239|NCT03449537|Caseins|caseins|mesh-list
139427240|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
139427241|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
139427242|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427243|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
139427244|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139427245|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427246|NCT03371979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139427247|NCT03371979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427248|NCT05104437|Vaccines|vaccines|mesh-list
139427249|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
139427250|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427251|NCT03179943|Atezolizumab|atezolizumab|mesh-list
139427252|NCT03179943|Guadecitabine|guadecitabine|mesh-list
139427253|NCT03179943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139427254|NCT03179943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427255|NCT03179943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139427256|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427257|NCT05114499|Donepezil|donepezil|mesh-list
139427258|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139427259|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427260|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427261|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
139427262|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427263|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427264|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
139427265|NCT04520997|Hyaluronic Acid|hyaluronic acid|mesh-list
139427266|NCT04520997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139427267|NCT04520997|Immunologic Factors|immunologic factors|mesh-ancestor
139427268|NCT04520997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427269|NCT04520997|Viscosupplements|viscosupplements|mesh-ancestor
139427270|NCT04520997|Protective Agents|protective agents|mesh-ancestor
139427271|NCT05109585|Antibodies|antibodies|mesh-list
139427272|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
139427273|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
139427274|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
139427275|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427276|NCT05283161|Dronabinol|dronabinol|mesh-list
139427277|NCT05283161|Cannabidiol|cannabidiol|mesh-list
139427278|NCT05283161|Anticonvulsants|anticonvulsants|mesh-ancestor
139427279|NCT05283161|Hallucinogens|hallucinogens|mesh-ancestor
139427280|NCT05283161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427281|NCT05283161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139427282|NCT05283161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139427283|NCT05283161|Analgesics|analgesics|mesh-ancestor
139427284|NCT05283161|Sensory System Agents|sensory system agents|mesh-ancestor
139427285|NCT05283161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427286|NCT05283161|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139427287|NCT05283161|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139427288|NCT05283161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427289|NCT05283161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427290|NCT05283161|Hormones|hormones|mesh-ancestor
139427291|NCT05283161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139427292|NCT03691311|Denosumab|denosumab|mesh-list
139427293|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139427294|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427295|NCT03448835|Docetaxel|docetaxel|mesh-list
139427296|NCT03448835|Capecitabine|capecitabine|mesh-list
139427297|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
139427298|NCT03448835|Atezolizumab|atezolizumab|mesh-list
139427299|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427300|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
139427301|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
139427302|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
139427303|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427304|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139427305|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
139427306|NCT03448835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139427307|NCT03448835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139427308|NCT03690453|Ivermectin|ivermectin|mesh-list
139427309|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139427310|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139427311|NCT05184335|RP5063|rp5063|mesh-list
139427312|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139427313|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139427314|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427315|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427316|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139427317|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
139427318|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427319|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427320|NCT03443609|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139427321|NCT03443609|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139427322|NCT03443609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427323|NCT01709123|Chromium|chromium|mesh-list
139427324|NCT01709123|Trace Elements|trace elements|mesh-ancestor
139427325|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
139427326|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427327|NCT01301807|Panobinostat|panobinostat|mesh-list
139427328|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427329|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139427330|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427331|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427332|NCT04962893|Vaccines|vaccines|mesh-list
139427333|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
139427334|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427336|NCT03443141|Vitamins|vitamins|mesh-ancestor
139427337|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
139427338|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427339|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
139427340|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427341|NCT03443141|Protective Agents|protective agents|mesh-ancestor
139427342|NCT04937543|Beclomethasone|beclomethasone|mesh-list
139427343|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
139427344|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
139427345|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139427346|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
139427347|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427348|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427349|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138861836|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139427350|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
139427351|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139427352|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139427353|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139427354|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
139427355|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427356|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427357|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139427358|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
139427359|NCT04937543|Hormones|hormones|mesh-ancestor
139427360|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139427361|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139427362|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139427363|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139427364|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
139427365|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139427366|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
139427367|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139427368|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427369|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427370|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139427371|NCT04923737|Analgesics|analgesics|mesh-ancestor
139427372|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
139427373|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427374|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139427375|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139427376|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139427377|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
139427378|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427379|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427380|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
139427381|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139427382|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427383|NCT02452424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139427384|NCT02452424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427385|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139427386|NCT02419508|Bimatoprost|bimatoprost|mesh-list
139427387|NCT02419508|Travoprost|travoprost|mesh-list
139427388|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139427389|NCT02419508|Latanoprost|latanoprost|mesh-list
139427390|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139427391|NCT02419508|Brinzolamide|brinzolamide|mesh-list
139427392|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139427393|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139427394|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139427395|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139427396|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
139427397|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427398|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427399|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427400|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139427401|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427402|NCT03442283|Vitamins|vitamins|mesh-list
139427403|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
139427404|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427405|NCT03441815|Histamine|histamine|mesh-list
139427406|NCT03441815|Glutarimide|glutarimide|mesh-list
139427407|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
139427408|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
139427409|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427410|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427411|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427412|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139427413|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427414|NCT02426918|Vancomycin|vancomycin|mesh-list
139427415|NCT02426918|Linezolid|linezolid|mesh-list
139427416|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139427417|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139427418|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139427419|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427420|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427421|NCT02387762|Methotrexate|methotrexate|mesh-list
139427422|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
139427423|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139427424|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
139427425|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139427426|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427427|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139427428|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
139427429|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427430|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427431|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
139427432|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427433|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139427434|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139427435|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
139427436|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139427437|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139427438|NCT02418182|Acetaminophen|acetaminophen|mesh-list
139427439|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139427440|NCT02418182|Analgesics|analgesics|mesh-ancestor
139427441|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
139427442|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427443|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427444|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
139427445|NCT02387372|Tazobactam|tazobactam|mesh-list
139427446|NCT02387372|Ceftolozane|ceftolozane|mesh-list
139427447|NCT02387372|Cephalosporins|cephalosporins|mesh-list
139427448|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
139427449|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
139427450|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139427451|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139427452|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139427453|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427454|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427455|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139427456|NCT03446495|Trabectedin|trabectedin|mesh-list
139427457|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139427458|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
139427459|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427460|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427461|NCT03441035|Anesthetics|anesthetics|mesh-list
139427462|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427463|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427464|NCT04807673|Paclitaxel|paclitaxel|mesh-list
139427465|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
139427466|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139427467|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427468|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
139427469|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
139427470|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
139427471|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427472|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139427473|NCT04807673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139427474|NCT02656173|Tamsulosin|tamsulosin|mesh-list
139427475|NCT02656173|Mirabegron|mirabegron|mesh-list
139427476|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139427477|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139427478|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139427479|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
139427480|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427481|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427482|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427483|NCT02656173|Urological Agents|urological agents|mesh-ancestor
139427484|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139427485|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139427486|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139427487|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139427488|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
139427489|NCT04418895|Leucovorin|leucovorin|mesh-list
139427490|NCT04418895|Capecitabine|capecitabine|mesh-list
139427491|NCT04418895|Fluorouracil|fluorouracil|mesh-list
139427492|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
139427493|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
139427494|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427495|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139427496|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
139427497|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427498|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427499|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139427500|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
139427501|NCT04418895|Antidotes|antidotes|mesh-ancestor
139427502|NCT04418895|Protective Agents|protective agents|mesh-ancestor
139427503|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
139427504|NCT04418895|Vitamins|vitamins|mesh-ancestor
139427505|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
139427506|NCT04715633|Apatinib|apatinib|mesh-list
139427507|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139427508|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427509|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139427510|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427511|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427512|NCT04715633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139427513|NCT03439943|Lixisenatide|lixisenatide|mesh-list
139427514|NCT03439943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139427515|NCT03439943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427516|NCT03439787|Epinephrine|epinephrine|mesh-list
139427517|NCT03439787|Bupivacaine|bupivacaine|mesh-list
139427518|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
139427519|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
139427520|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427521|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427522|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
139427523|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427524|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139427525|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139427526|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
139427527|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427528|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427529|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139427530|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139427531|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
139427532|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139427533|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
139427534|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
139427535|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
139427536|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139427537|NCT05082155|Bupivacaine|bupivacaine|mesh-list
139427538|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
139427539|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
139427540|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427541|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427542|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
139427543|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427544|NCT02656017|Metformin|metformin|mesh-list
139427545|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139427546|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427547|NCT03439709|Lanreotide|lanreotide|mesh-list
139427548|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427549|NCT04451447|SMOFlipid|smoflipid|mesh-list
139427550|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139427551|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139427552|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139427553|NCT04516941|Colchicine|colchicine|mesh-list
139427554|NCT04516941|Edoxaban|edoxaban|mesh-list
139427555|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
139427556|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139427557|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
139427558|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
139427559|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
139427560|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427561|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427563|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
139427564|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139427565|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
139427566|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427567|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
139427568|NCT03444467|Glucagon|glucagon|mesh-list
139427569|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139427570|NCT03444467|Hormones|hormones|mesh-ancestor
139427571|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139427572|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427573|NCT02657343|Trastuzumab|trastuzumab|mesh-list
139427574|NCT02657343|Fulvestrant|fulvestrant|mesh-list
139427575|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139427576|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427577|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139427578|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139427579|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139427580|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
139427581|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139427582|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427583|NCT03445169|Belzutifan|belzutifan|mesh-list
139427584|NCT03445169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427585|NCT04542837|Lenvatinib|lenvatinib|mesh-list
139427586|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427587|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139427588|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427589|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427590|NCT02655237|Leuprolide|leuprolide|mesh-list
139427591|NCT02655237|Relugolix|relugolix|mesh-list
139427592|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139427593|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
139427594|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139427595|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427596|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139427597|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427598|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
139427599|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
139427600|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139427601|NCT03890133|Pregabalin|pregabalin|mesh-list
139427602|NCT03890133|Analgesics|analgesics|mesh-ancestor
139427603|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
139427604|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427605|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427606|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
139427607|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139427608|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139427609|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427610|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139427611|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139427612|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139427613|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427614|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139427615|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139427616|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139427617|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
139427618|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427619|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427620|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427621|NCT03443921|Paclitaxel|paclitaxel|mesh-list
139427622|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139427623|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427624|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
139427625|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
139427626|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
139427627|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427628|NCT03443843|Fluticasone|fluticasone|mesh-list
139427629|NCT03443843|Xhance|xhance|mesh-list
139427630|NCT03443843|Loratadine|loratadine|mesh-list
139427631|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
139427632|NCT03443843|Ephedrine|ephedrine|mesh-list
139427633|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139427634|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139427635|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
139427636|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427637|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427638|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139427639|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
139427640|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
139427641|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139427642|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
139427643|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139427644|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139427645|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
139427646|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
139427647|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427648|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427649|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
139427650|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139427651|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139427652|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
139427653|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
139427654|NCT03438227|Dextrans|dextrans|mesh-list
139427655|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
139427656|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
139427657|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
139427658|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
139427659|NCT03438227|Hematinics|hematinics|mesh-ancestor
139427660|NCT03433235|Edoxaban|edoxaban|mesh-list
139427661|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139427662|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
139427663|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139427664|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
139427665|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427666|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427667|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
139427668|NCT03342417|Nivolumab|nivolumab|mesh-list
139427669|NCT03342417|Ipilimumab|ipilimumab|mesh-list
139427670|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139427671|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427672|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139427673|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427674|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139427675|NCT03234309|Hematinics|hematinics|mesh-ancestor
139427676|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139427677|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139427678|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
139427679|NCT02657031|Promethazine|promethazine|mesh-list
139427680|NCT02657031|Ketamine|ketamine|mesh-list
139427681|NCT02657031|Ondansetron|ondansetron|mesh-list
139427682|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
139427683|NCT02657031|Analgesics|analgesics|mesh-ancestor
139427684|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
139427685|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427686|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427687|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139427688|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139427689|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
139427690|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
139427691|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427692|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139427693|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139427694|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427695|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427696|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
139427697|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
139427698|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139427699|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
139427700|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
139427701|NCT02657031|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139427702|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139427703|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
139427704|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139427705|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139427706|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
139427707|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139427708|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
139427709|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
139214426|NCT01822275|Temozolomide|temozolomide|mesh-list
139427710|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139427711|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139427712|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139427713|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139427714|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139427715|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
139427716|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
139427717|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139427718|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139427719|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139427720|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139427721|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427722|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
139427723|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427724|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427725|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139427726|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427727|NCT03797469|Niacinamide|niacinamide|mesh-list
139427728|NCT03797469|Niacin|niacin|mesh-list
139427729|NCT03797469|Nicotinic Acids|nicotinic acids|mesh-list
139427730|NCT03797469|Vitamins|vitamins|mesh-ancestor
139427731|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
139427732|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427733|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
139427734|NCT03797469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139427735|NCT03797469|Antimetabolites|antimetabolites|mesh-ancestor
139427736|NCT03797469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427737|NCT03797469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139427738|NCT03797469|Vasodilator Agents|vasodilator agents|mesh-ancestor
139427739|NCT03432923|Benzocaine|benzocaine|mesh-list
139427740|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
139427741|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
139427742|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427743|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427744|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
139427745|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427746|NCT02384577|Budesonide|budesonide|mesh-list
139427747|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
139427748|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139427749|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139427750|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
139427751|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427752|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427753|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139427754|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
139427755|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
139427756|NCT02384577|Hormones|hormones|mesh-ancestor
139427757|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139427758|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139427759|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139427760|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139427761|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
139427762|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427763|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427764|NCT03437213|Anesthetics|anesthetics|mesh-list
139427765|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427766|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427767|NCT02030457|Beclomethasone|beclomethasone|mesh-list
139427768|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139427769|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
139427770|NCT02030457|Hormones|hormones|mesh-ancestor
139427771|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139427772|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427773|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139427774|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
139427775|NCT03432767|Chrysarobin|chrysarobin|mesh-list
139427776|NCT03432767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139427777|NCT03432767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139427778|NCT03432767|Analgesics|analgesics|mesh-ancestor
139427779|NCT03432767|Sensory System Agents|sensory system agents|mesh-ancestor
139427780|NCT03432767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427781|NCT03432767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427782|NCT03432767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139427783|NCT03432767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139427784|NCT03437057|Aspirin|aspirin|mesh-list
139214502|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
139427785|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139427786|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139427787|NCT03437057|Analgesics|analgesics|mesh-ancestor
139427788|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
139427789|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427790|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427791|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139427792|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139427793|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139427794|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139427795|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427796|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139427797|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139427798|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427799|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
139427800|NCT03579693|Niacinamide|niacinamide|mesh-list
139427801|NCT03579693|Niacin|niacin|mesh-list
139427802|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
139427803|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
139427804|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
139427805|NCT03579693|Vitamins|vitamins|mesh-ancestor
139427806|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
139427807|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427808|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139427809|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
139427810|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427811|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139427812|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
139427813|NCT03432689|Cycloserine|cycloserine|mesh-list
139427814|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139427815|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139427816|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139427817|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
139427818|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139427819|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
139427820|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427821|NCT02991807|Everolimus|everolimus|mesh-list
139427822|NCT02991807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139427823|NCT02991807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139427824|NCT02991807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427825|NCT02991807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427826|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139427827|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
139427828|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427829|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427830|NCT04380311|Tacrolimus|tacrolimus|mesh-list
139427831|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139427832|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
139427833|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427834|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139427835|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427836|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427837|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139427838|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139427839|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139427840|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139427841|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427842|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427843|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427844|NCT05018013|Analgesics|analgesics|mesh-ancestor
139427845|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
139427846|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427847|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
139427848|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139427849|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
139427850|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139427851|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139427852|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139427853|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139427854|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427855|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427856|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427857|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
139427858|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139427859|NCT05112471|Erythritol|erythritol|mesh-list
139427860|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
139427861|NCT02387216|Docetaxel|docetaxel|mesh-list
139427862|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427863|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
139427864|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
139427865|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
139427866|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427867|NCT03431909|Aspirin|aspirin|mesh-list
139427868|NCT03431909|Kallikreins|kallikreins|mesh-list
139427869|NCT03431909|Clopidogrel|clopidogrel|mesh-list
139427870|NCT03431909|Atorvastatin|atorvastatin|mesh-list
139427871|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139427872|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139427873|NCT03431909|Analgesics|analgesics|mesh-ancestor
139427874|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
139427875|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427876|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427877|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139427878|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139427879|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139427880|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139427881|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427882|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139427883|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139427884|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427885|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
139427886|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139427887|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139427888|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
139427889|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139427890|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139427891|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139427892|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139427893|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139427894|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
139427895|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427896|NCT03431909|Coagulants|coagulants|mesh-ancestor
139427897|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
139427898|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
139427899|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139427900|NCT03436121|Midazolam|midazolam|mesh-list
139427901|NCT03436121|Ketamine|ketamine|mesh-list
139427902|NCT03436121|Analgesics|analgesics|mesh-ancestor
139427903|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
139427904|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427905|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427906|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139427907|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139427908|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
139427909|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
139427910|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427911|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139427912|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139427913|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427914|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427915|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139427916|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139427917|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139427918|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139427919|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139427920|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
139427921|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
139427922|NCT02417246|Metoprolol|metoprolol|mesh-list
139427923|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139427924|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139427925|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
139427926|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
139427927|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427928|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427929|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139427930|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139427931|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139427932|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
139427933|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427934|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427935|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
139427936|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139427937|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139427938|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139427939|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139427940|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427941|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427942|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427943|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139427944|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139427945|NCT02424734|Ampicillin|ampicillin|mesh-list
139427946|NCT02424734|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139427947|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139427948|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139427949|NCT03431597|Micronutrients|micronutrients|mesh-list
139427950|NCT03431597|Trace Elements|trace elements|mesh-list
139427951|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427952|NCT02424578|Diclofenac|diclofenac|mesh-list
139427953|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139427954|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139427955|NCT02424578|Analgesics|analgesics|mesh-ancestor
139427956|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
139427957|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427958|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427959|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139427960|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139427961|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139427962|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427963|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427964|NCT03431285|Ketamine|ketamine|mesh-list
139427965|NCT03431285|Morphine|morphine|mesh-list
139427966|NCT03431285|Analgesics|analgesics|mesh-ancestor
139427967|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
139427968|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427969|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427970|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139427971|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139427972|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
139427973|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
139427974|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139427975|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139427976|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139427977|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139427978|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427979|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139427980|NCT03431285|Narcotics|narcotics|mesh-ancestor
139427981|NCT02416934|Dexamethasone|dexamethasone|mesh-list
139427982|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139427983|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
139427984|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
139427985|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139427986|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139427987|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139427988|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
139427989|NCT02416934|Hormones|hormones|mesh-ancestor
139427990|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139427991|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139427992|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139427993|NCT02819635|Upadacitinib|upadacitinib|mesh-list
139427994|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139427995|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139427996|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139427997|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139427998|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139427999|NCT03874325|Durvalumab|durvalumab|mesh-list
139428000|NCT03874325|Letrozole|letrozole|mesh-list
139428001|NCT03874325|Anastrozole|anastrozole|mesh-list
139428002|NCT03874325|Exemestane|exemestane|mesh-list
139428003|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139428004|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428005|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139428006|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139428007|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428008|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428009|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139428010|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
139428011|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138862500|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139428012|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428013|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139428014|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
139428015|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139428016|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
139428017|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428018|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428019|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139428020|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
139428021|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139428022|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139428023|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139428024|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
139428025|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428026|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428027|NCT03861611|Ibuprofen|ibuprofen|mesh-list
139428028|NCT03861611|Diclofenac|diclofenac|mesh-list
139428029|NCT03861611|Ketorolac|ketorolac|mesh-list
139428030|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139428031|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139428032|NCT03861611|Analgesics|analgesics|mesh-ancestor
139428033|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
139428034|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428035|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428036|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428037|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139428038|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139428039|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428040|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428041|NCT03430817|Amantadine|amantadine|mesh-list
139428042|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139428043|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139428044|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139428045|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
139428046|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428047|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
139428048|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428049|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428050|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428051|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139428052|NCT03430817|Analgesics|analgesics|mesh-ancestor
139428053|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
139428054|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428055|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
139428056|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139428057|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139428058|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428059|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139428060|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428061|NCT03430505|Albuterol|albuterol|mesh-list
139428062|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139428063|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
139428064|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428065|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428066|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139428067|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
139428068|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
139428069|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139428070|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139428071|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139428072|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139428073|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
139428074|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428075|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428076|NCT03434951|Morphine|morphine|mesh-list
139428077|NCT03434951|Bupivacaine|bupivacaine|mesh-list
139428078|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
139428079|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
139428080|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428081|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428083|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428084|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139428085|NCT03434951|Narcotics|narcotics|mesh-ancestor
139428086|NCT03434951|Analgesics|analgesics|mesh-ancestor
139428087|NCT02234323|Factor VIII|factor viii|mesh-list
139428088|NCT02234323|Coagulants|coagulants|mesh-ancestor
139428089|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
139428090|NCT02413346|Sarecycline|sarecycline|mesh-list
139428091|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139428092|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428093|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
139428094|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139428095|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139428096|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139428097|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428098|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428099|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139428100|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139428101|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428102|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
139428103|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428104|NCT03429179|Butorphanol|butorphanol|mesh-list
139428105|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139428106|NCT03429179|Narcotics|narcotics|mesh-ancestor
139428107|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428108|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428109|NCT03429179|Analgesics|analgesics|mesh-ancestor
139428110|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
139428111|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428112|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
139428113|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
139428114|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139428115|NCT03429101|Trastuzumab|trastuzumab|mesh-list
139428116|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139428117|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139428118|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428119|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
139428120|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
139428121|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
139428122|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428123|NCT03429101|Immunotoxins|immunotoxins|mesh-ancestor
139428124|NCT03429101|Immunoconjugates|immunoconjugates|mesh-ancestor
139428125|NCT03429101|Immunologic Factors|immunologic factors|mesh-ancestor
139428126|NCT03429101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428127|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139428128|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
139428129|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428130|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
139428131|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139428132|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139428133|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139428134|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
139428135|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139428136|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428137|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139428138|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139428139|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
139428140|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139428141|NCT02732639|Interferons|interferons|mesh-list
139428142|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428143|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
139428144|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428145|NCT02412878|Dexamethasone|dexamethasone|mesh-list
139428146|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428147|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
139428148|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
139428149|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428150|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428151|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139428152|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
139428153|NCT02412878|Hormones|hormones|mesh-ancestor
139428154|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139428155|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139428156|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428157|NCT03423329|Ibuprofen|ibuprofen|mesh-list
139428158|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139428159|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139428160|NCT03423329|Analgesics|analgesics|mesh-ancestor
139428161|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
139428162|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428163|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428164|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428165|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139428166|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139428167|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428168|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428169|NCT02380742|Lidocaine|lidocaine|mesh-list
139428170|NCT02380742|Prilocaine|prilocaine|mesh-list
139428171|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139428172|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
139428173|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
139428174|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428175|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428176|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
139428177|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428178|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139428179|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139428180|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139428181|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139428182|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428183|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139428184|NCT02944019|Edoxaban|edoxaban|mesh-list
139428185|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139428186|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
139428187|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139428188|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
139428189|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428190|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428191|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
139428192|NCT02022059|Lidocaine|lidocaine|mesh-list
139428193|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
139428194|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
139428195|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428196|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428197|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
139428198|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428199|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139428200|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139428201|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139428202|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139428203|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428204|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
139428205|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139428206|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
139428207|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139428208|NCT03422315|Propofol|propofol|mesh-list
139428209|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139428210|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428211|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428212|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139428213|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
139428214|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
139428215|NCT03427385|Ropivacaine|ropivacaine|mesh-list
139428216|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
139428217|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
139428218|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428219|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428220|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
139428221|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428222|NCT03427229|Vancomycin|vancomycin|mesh-list
139428223|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139428224|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428225|NCT04449185|Amoxicillin|amoxicillin|mesh-list
139428226|NCT04449185|Clarithromycin|clarithromycin|mesh-list
139428227|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139214950|NCT06028737|Antidotes|antidotes|mesh-ancestor
139428228|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428229|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138862729|NCT02763722|Emollients|emollients|mesh-list
139428230|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428231|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428232|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139428233|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139428234|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
139428235|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
139428236|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
139428237|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428238|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428239|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139428240|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139428241|NCT03426527|Analgesics|analgesics|mesh-ancestor
139428242|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
139428243|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428244|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139428245|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139428246|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139428247|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
139428248|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428249|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428250|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
139428251|NCT02805257|Mitomycins|mitomycins|mesh-list
139428252|NCT02805257|Mitomycin|mitomycin|mesh-list
139428253|NCT02805257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139428254|NCT02805257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428255|NCT02805257|Alkylating Agents|alkylating agents|mesh-ancestor
139428256|NCT02805257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428257|NCT02805257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139428258|NCT02805257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428259|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139428260|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
139428261|NCT02636387|Coagulants|coagulants|mesh-ancestor
139428262|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139428263|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
139428264|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428265|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
139428266|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
139428267|NCT03425747|Calcium|calcium|mesh-list
139428268|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139428269|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428270|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139428271|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428272|NCT03425747|Antacids|antacids|mesh-ancestor
139428273|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139428274|NCT03424889|Xylometazoline|xylometazoline|mesh-list
139428275|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
139428276|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139428277|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
139428278|NCT03424733|Acetaminophen|acetaminophen|mesh-list
139428279|NCT03424733|Interferons|interferons|mesh-list
139428280|NCT03424733|Interferon-beta|interferon-beta|mesh-list
139428281|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
139428282|NCT03424733|Prednisone|prednisone|mesh-list
139428283|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428284|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
139428285|NCT03424733|Hormones|hormones|mesh-ancestor
139428286|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139428287|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428288|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139428289|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428290|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
139428291|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428292|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139428293|NCT03424733|Analgesics|analgesics|mesh-ancestor
139428294|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
139428295|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428296|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
139428297|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
139428298|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139428299|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139428300|NCT03441841|Lidocaine|lidocaine|mesh-list
139428301|NCT03441841|Prilocaine|prilocaine|mesh-list
139428302|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139215025|NCT05959720|Hormones|hormones|mesh-ancestor
139428303|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
139428305|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428306|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428307|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
139428308|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428309|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139428310|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139428311|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139428312|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139428313|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428314|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139428315|NCT02692339|Dexamethasone|dexamethasone|mesh-list
139428316|NCT02692339|Lenalidomide|lenalidomide|mesh-list
139428317|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428318|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
139428319|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
139428320|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428321|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428322|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139428323|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
139428324|NCT02692339|Hormones|hormones|mesh-ancestor
139428325|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139428326|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139428327|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428328|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
139428329|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139428330|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139428331|NCT02692339|Growth Substances|growth substances|mesh-ancestor
139428332|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
139428333|NCT03444025|Goserelin|goserelin|mesh-list
139428334|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139428335|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428336|NCT03438253|Anesthetics|anesthetics|mesh-list
139428337|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428338|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428339|NCT02535325|Cisplatin|cisplatin|mesh-list
139428340|NCT02535325|Pemetrexed|pemetrexed|mesh-list
139428341|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428342|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428343|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428344|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139428345|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139428346|NCT03441529|Tazobactam|tazobactam|mesh-list
139428347|NCT03441529|Piperacillin|piperacillin|mesh-list
139428348|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139428349|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139428350|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428351|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139428352|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428353|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428354|NCT03441373|Histamine|histamine|mesh-list
139428355|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
139428356|NCT03441373|Glutarimide|glutarimide|mesh-list
139428357|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
139428358|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
139428359|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428360|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428361|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428362|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139428363|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428364|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
139428365|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139428366|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139428367|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139428368|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428369|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
139428370|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428371|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139428372|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428373|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428374|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
139428375|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139428376|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428377|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139428378|NCT03437785|Ethanol|ethanol|mesh-list
139428379|NCT03437785|Rebamipide|rebamipide|mesh-list
139428380|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139428381|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428382|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428383|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428384|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139428385|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139428386|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
139428387|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428388|NCT03437785|Protective Agents|protective agents|mesh-ancestor
139428389|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428390|NCT03437707|Acetaminophen|acetaminophen|mesh-list
139428391|NCT03437707|Ibuprofen|ibuprofen|mesh-list
139428392|NCT03437707|Morphine|morphine|mesh-list
139428393|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139428394|NCT03437707|Narcotics|narcotics|mesh-ancestor
139428395|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428396|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428397|NCT03437707|Analgesics|analgesics|mesh-ancestor
139428398|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
139428399|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428400|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139428401|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139428402|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428403|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139428404|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139428405|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428406|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428407|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
139428408|NCT03437629|Calcium|calcium|mesh-list
139428409|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139428410|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428411|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139428412|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
139428413|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428414|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428415|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428416|NCT03441217|Scopolamine|scopolamine|mesh-list
139428417|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139428418|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139428419|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
139428420|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
139428421|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428422|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428423|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139428424|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
139428425|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139428426|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
139428427|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428428|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428429|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139428430|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
139428431|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
139428432|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428433|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
139428434|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428435|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428436|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139428437|NCT02521441|Lenograstim|lenograstim|mesh-list
139428438|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139428439|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
139428440|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428441|NCT04451239|Cyclosporine|cyclosporine|mesh-list
139428442|NCT04451239|Cyclosporins|cyclosporins|mesh-list
139428443|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428444|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428445|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139428446|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
139428447|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428448|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
139428449|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215184|NCT05552287|Infliximab|infliximab|mesh-list
139428450|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
139428451|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139428452|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139428453|NCT03440515|Prednisone|prednisone|mesh-list
139428454|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428455|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
139428456|NCT03440515|Hormones|hormones|mesh-ancestor
139428457|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139428458|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428459|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139428460|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428461|NCT03432793|Itraconazole|itraconazole|mesh-list
139428462|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
139428463|NCT03432793|Caffeine|caffeine|mesh-list
139428464|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139428465|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428466|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139428467|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428468|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428469|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139428470|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139428471|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
139428472|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428473|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
139428474|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428475|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139428476|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139428477|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139428478|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
139428479|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139428480|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139428481|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139428482|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139428483|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428484|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139428485|NCT03432793|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139428486|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139428487|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139428488|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
139428489|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139428490|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
139428491|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139428492|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139428493|NCT03436693|Canagliflozin|canagliflozin|mesh-list
139428494|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139428495|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428496|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139428497|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428498|NCT03432637|Anesthetics|anesthetics|mesh-list
139428499|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428500|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428501|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
139428502|NCT03436303|Progestins|progestins|mesh-ancestor
139428503|NCT03436303|Hormones|hormones|mesh-ancestor
139428504|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139428505|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428506|NCT03436225|Dexamethasone|dexamethasone|mesh-list
139428507|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
139428508|NCT03436225|Budesonide|budesonide|mesh-list
139428509|NCT03436225|Albuterol|albuterol|mesh-list
139428510|NCT03436225|BB 1101|bb 1101|mesh-list
139428511|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428512|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
139428513|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
139428514|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428515|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428516|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139428517|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
139428518|NCT03436225|Hormones|hormones|mesh-ancestor
139428519|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139428520|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139428521|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428522|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
139428523|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428524|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428525|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139428526|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139428527|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
139428528|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
139428529|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139428530|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139428531|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139428532|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139428533|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
139428534|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428536|NCT03440359|Progesterone|progesterone|mesh-list
139428537|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428538|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139428539|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139428540|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428541|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428542|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139428543|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
139428544|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139428545|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428546|NCT03440359|Progestins|progestins|mesh-ancestor
139428547|NCT03440359|Hormones|hormones|mesh-ancestor
139428548|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139428549|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
139428550|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428551|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139428552|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
139428553|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
139428554|NCT03431623|Hematinics|hematinics|mesh-ancestor
139428555|NCT04451395|Micronutrients|micronutrients|mesh-list
139428556|NCT04451395|Trace Elements|trace elements|mesh-list
139428557|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428558|NCT04451083|Camostat|camostat|mesh-list
139428559|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
139428560|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428561|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428562|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139428563|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139428564|NCT03435289|Paclitaxel|paclitaxel|mesh-list
139428565|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139428566|NCT03435289|Gemcitabine|gemcitabine|mesh-list
139428567|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139428568|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428569|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
139428570|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
139428571|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
139428572|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428573|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139428574|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
139428575|NCT03435133|Ticagrelor|ticagrelor|mesh-list
139428576|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139428577|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139428578|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139428579|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139428580|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139428581|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
139428582|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428583|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428584|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428585|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
139428586|NCT03431077|Giapreza|giapreza|mesh-list
139428587|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
139428588|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139428589|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139428590|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
139428591|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428592|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428593|NCT03439501|Avelumab|avelumab|mesh-list
139428594|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139382317|NCT04826822|Diuretics|diuretics|mesh-ancestor
139428595|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428596|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139428597|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139428598|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428599|NCT04255381|Pancrelipase|pancrelipase|mesh-list
139428600|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139428601|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
139428602|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139428603|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428604|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428605|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139428606|NCT03757897|Analgesics|analgesics|mesh-ancestor
139428607|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
139428608|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428609|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139428610|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139428611|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139428612|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
139428613|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428614|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428615|NCT03434197|Diclofenac|diclofenac|mesh-list
139428616|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139428617|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139428618|NCT03434197|Analgesics|analgesics|mesh-ancestor
139428619|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
139428620|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428621|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428622|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428623|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139428624|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139428625|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428626|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428627|NCT03430609|Hormones|hormones|mesh-list
139428628|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139428629|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428630|NCT03438955|Telmisartan|telmisartan|mesh-list
139428631|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139428632|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139428633|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139428634|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428635|NCT04219735|Minocycline|minocycline|mesh-list
139428636|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139428637|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428638|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139428639|NCT03621553|Vitamin D|vitamin d|mesh-list
139428640|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
139428641|NCT03621553|Cholecalciferol|cholecalciferol|mesh-list
139428642|NCT03621553|Vitamins|vitamins|mesh-list
139428643|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
139428644|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428645|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139428646|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139428647|NCT01559363|XL647|xl647|mesh-list
139428648|NCT01559363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428649|NCT01559363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139428650|NCT01559363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428651|NCT01559363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428652|NCT01504919|Nicotine|nicotine|mesh-list
139428653|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139428654|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
139428655|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428656|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428657|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139428658|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139428659|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
139428660|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428661|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428662|NCT02732327|Vancomycin|vancomycin|mesh-list
139428663|NCT02732327|Meropenem|meropenem|mesh-list
139428664|NCT02732327|Tazobactam|tazobactam|mesh-list
139428665|NCT02732327|Linezolid|linezolid|mesh-list
139428666|NCT02732327|Piperacillin|piperacillin|mesh-list
139428667|NCT02732327|Cefepime|cefepime|mesh-list
139382318|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
139428668|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139428669|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139428670|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428671|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139428672|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428673|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428674|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139428675|NCT03428503|Acetaminophen|acetaminophen|mesh-list
139428676|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139428677|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139428678|NCT03428503|Analgesics|analgesics|mesh-ancestor
139428679|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
139428680|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428681|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428682|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
139428683|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139428684|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428685|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139428686|NCT03428425|Paclitaxel|paclitaxel|mesh-list
139428687|NCT03428425|Apatinib|apatinib|mesh-list
139428688|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139428689|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428690|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
139428691|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
139428692|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
139428693|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428694|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139428695|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428696|NCT03416777|Tocopherols|tocopherols|mesh-list
139428697|NCT03416777|Vitamin E|vitamin e|mesh-list
139428698|NCT03416777|Tocotrienols|tocotrienols|mesh-list
139428699|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
139428700|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
139428701|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428702|NCT03416777|Protective Agents|protective agents|mesh-ancestor
139428703|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428704|NCT03416777|Vitamins|vitamins|mesh-ancestor
139428705|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
139428706|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
139428707|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428708|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
139428709|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
139428710|NCT03422887|Nalbuphine|nalbuphine|mesh-list
139428711|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139428712|NCT03422887|Narcotics|narcotics|mesh-ancestor
139428713|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428714|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428715|NCT03422887|Analgesics|analgesics|mesh-ancestor
139428716|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
139428717|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428718|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139428719|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139428720|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428721|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139428722|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139428723|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428724|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428725|NCT02521207|Ibuprofen|ibuprofen|mesh-list
139428726|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139428727|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139428728|NCT02521207|Analgesics|analgesics|mesh-ancestor
139428729|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
139428730|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428731|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428732|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428733|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139428734|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139428735|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428736|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428737|NCT03179605|Clobetasol|clobetasol|mesh-list
139428738|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428739|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
139428740|NCT03179605|Hormones|hormones|mesh-ancestor
139382320|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139428741|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139428742|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428743|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
139428744|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
139428745|NCT03173053|Clarithromycin|clarithromycin|mesh-list
139428746|NCT03173053|Doxycycline|doxycycline|mesh-list
139428747|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
139428748|NCT03173053|Rifampin|rifampin|mesh-list
139428749|NCT03173053|Clindamycin|clindamycin|mesh-list
139428750|NCT03173053|Trimethoprim|trimethoprim|mesh-list
139428751|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
139428752|NCT03173053|Mupirocin|mupirocin|mesh-list
139428753|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
139428754|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139428755|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139428756|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428757|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
139428758|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139428759|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139428760|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428761|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428762|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139428763|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139428764|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
139428765|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139428766|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139428767|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139428768|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139428769|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428770|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139428771|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139428772|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
139428773|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
139428774|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139428775|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139428776|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139428777|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139428778|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139428779|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139428780|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139428781|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139428782|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139428783|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139428784|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139428785|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
139428786|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139428787|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139428788|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
139428789|NCT03428191|Remifentanil|remifentanil|mesh-list
139428790|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139428791|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428792|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428793|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139428794|NCT03428191|Analgesics|analgesics|mesh-ancestor
139428795|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
139428796|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428797|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139428798|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139428799|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139428800|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
139428801|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428802|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428803|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139428804|NCT03428191|Narcotics|narcotics|mesh-ancestor
139428805|NCT03422575|Etoricoxib|etoricoxib|mesh-list
139428806|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139428807|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139428808|NCT03422575|Analgesics|analgesics|mesh-ancestor
139428809|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
139428810|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428811|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428812|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139428813|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139428814|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139428815|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139428816|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428817|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428818|NCT02412722|Paclitaxel|paclitaxel|mesh-list
139428819|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139428820|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428821|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
139428822|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
139428823|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
139428824|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428826|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
139428827|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139428828|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139428829|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428830|NCT04449289|Lidocaine|lidocaine|mesh-list
139428831|NCT04449289|Ropivacaine|ropivacaine|mesh-list
139428832|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
139428833|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
139428834|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428835|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428836|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
139428837|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428838|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139428839|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139428840|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139428841|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139428842|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428843|NCT03128203|Oxytocin|oxytocin|mesh-list
139428844|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
139428845|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139428846|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428847|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
139428848|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139428849|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139428850|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139428851|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139428852|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428853|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
139428854|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428855|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428856|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139428857|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428858|NCT02935309|Capecitabine|capecitabine|mesh-list
139428859|NCT02935309|Lenvatinib|lenvatinib|mesh-list
139428860|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139428861|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
139428862|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428863|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428864|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139428865|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428866|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
139428867|NCT03463993|Oxytocin|oxytocin|mesh-list
139428868|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
139428869|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139428870|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428871|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139428872|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139428873|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428874|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
139428875|NCT03463993|Coagulants|coagulants|mesh-ancestor
139428876|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139428877|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138863368|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
139428878|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428879|NCT03417037|Nivolumab|nivolumab|mesh-list
139428880|NCT03417037|Linrodostat|linrodostat|mesh-list
139428881|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139428882|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428883|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139428884|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428885|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428886|NCT02378480|Linezolid|linezolid|mesh-list
139428887|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139428888|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428889|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139428890|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428891|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428892|NCT03421717|Chitosan|chitosan|mesh-list
139428893|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139428894|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139428895|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
139215629|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428896|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428897|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139428898|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
139428899|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
139428900|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
139428901|NCT03421717|Coagulants|coagulants|mesh-ancestor
139428902|NCT03427801|Hematinics|hematinics|mesh-list
139428903|NCT03416569|Prazosin|prazosin|mesh-list
139428904|NCT03416569|Nicotine|nicotine|mesh-list
139428905|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139428906|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
139428907|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428908|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428909|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139428910|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139428911|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
139428912|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428913|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428914|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139428915|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139428916|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139428917|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139428918|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
139428919|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
139428920|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
139428921|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139428922|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
139428923|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139428924|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428925|NCT01004029|Progestins|progestins|mesh-ancestor
139428926|NCT01004029|Hormones|hormones|mesh-ancestor
139428927|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
139428928|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
139428929|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428930|NCT03420937|Atropine|atropine|mesh-list
139428931|NCT03420937|Neostigmine|neostigmine|mesh-list
139428932|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139428933|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139428934|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139428935|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
139428936|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428937|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428938|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139428939|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
139428940|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
139428941|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
139428942|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139428943|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139428944|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
139428945|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428946|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428947|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139428948|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428949|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139428950|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
138863467|NCT02702778|Hormones|hormones|mesh-ancestor
139428951|NCT02900443|Azathioprine|azathioprine|mesh-list
139428952|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139428953|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139428954|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139428955|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
139428956|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139428957|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139428958|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139428959|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428960|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
139428961|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139428962|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139428963|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
139428964|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428965|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139428966|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
139428967|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139428968|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139428969|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139428970|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139428971|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139428972|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428973|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
139428974|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428975|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428976|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139428977|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428978|NCT03420703|Morphine|morphine|mesh-list
139428979|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139428980|NCT03420703|Narcotics|narcotics|mesh-ancestor
139428981|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139428982|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428983|NCT03420703|Analgesics|analgesics|mesh-ancestor
139428984|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
139428985|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139428986|NCT03420469|Bupropion|bupropion|mesh-list
139428987|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139428988|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
139428989|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139428990|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139428991|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139428992|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139428993|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139428994|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
139428995|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139428996|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139428997|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139428998|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139428999|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429000|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
139429001|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429002|NCT03415711|Mesalamine|mesalamine|mesh-list
139429003|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139429004|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139429005|NCT03415711|Analgesics|analgesics|mesh-ancestor
139429006|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
139429007|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429008|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429009|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139429010|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139429011|NCT03420313|Buprenorphine|buprenorphine|mesh-list
139429012|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139429013|NCT03420313|Naloxone|naloxone|mesh-list
139429014|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139429015|NCT03420313|Narcotics|narcotics|mesh-ancestor
139429016|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429017|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429018|NCT03420313|Analgesics|analgesics|mesh-ancestor
139429019|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
139429020|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429021|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139429022|NCT03415477|Denosumab|denosumab|mesh-list
139429023|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139429024|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429025|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
139429026|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
139429027|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429028|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139429029|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139429030|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429031|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429032|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139429033|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139429034|NCT03419923|Citric Acid|citric acid|mesh-list
139215780|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
139215781|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215782|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139215783|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139215784|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215785|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
139215786|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215787|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215788|NCT03295227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215790|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
139429035|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
139429036|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
139429037|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139429038|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
139429039|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
139429040|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429041|NCT03426553|Riboflavin|riboflavin|mesh-list
139429042|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
139429043|NCT03426553|Vitamins|vitamins|mesh-ancestor
139429044|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
139429045|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429046|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139429047|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
139429048|NCT03415087|Fentanyl|fentanyl|mesh-list
139429049|NCT03415087|Bupivacaine|bupivacaine|mesh-list
139429050|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
139429051|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
139429052|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429053|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429054|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
139429055|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429056|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139429057|NCT03415087|Narcotics|narcotics|mesh-ancestor
139429058|NCT03415087|Analgesics|analgesics|mesh-ancestor
139429059|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139429060|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139429061|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
139429062|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
139429063|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429064|NCT03419767|Melatonin|melatonin|mesh-list
139429065|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
139429066|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429067|NCT03419767|Protective Agents|protective agents|mesh-ancestor
139429068|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429069|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429070|NCT03414931|Sertraline|sertraline|mesh-list
139429071|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
139429072|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139429073|NCT03414931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139429074|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139429075|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139429076|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429077|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429078|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
139429079|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429080|NCT04448821|Metformin|metformin|mesh-list
139429081|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139429082|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429083|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139429084|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139429085|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139429086|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
139429087|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139429088|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429089|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139429090|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139429091|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139429092|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139429093|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139429094|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429095|NCT04448587|Incretins|incretins|mesh-ancestor
139429096|NCT04448587|Hormones|hormones|mesh-ancestor
139429097|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139429098|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139429099|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
139429100|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429101|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429102|NCT03426085|Liraglutide|liraglutide|mesh-list
139429103|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139429104|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429105|NCT03426085|Incretins|incretins|mesh-ancestor
139429106|NCT03426085|Hormones|hormones|mesh-ancestor
139429107|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139429108|NCT03418597|Anesthetics|anesthetics|mesh-list
139429109|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429110|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429112|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
139429113|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139429114|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429115|NCT03127189|Rilpivirine|rilpivirine|mesh-list
139429116|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139429117|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139429118|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429119|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429120|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
139429121|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429122|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139429123|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139429124|NCT02521051|Bevacizumab|bevacizumab|mesh-list
139429125|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139429126|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429127|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139429128|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139429129|NCT02521051|Growth Substances|growth substances|mesh-ancestor
139429130|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429131|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
139429132|NCT01239797|Dexamethasone|dexamethasone|mesh-list
139429133|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
139429134|NCT01239797|Lenalidomide|lenalidomide|mesh-list
139429135|NCT01239797|Elotuzumab|elotuzumab|mesh-list
139429136|NCT01239797|BB 1101|bb 1101|mesh-list
139429137|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139429138|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
139429139|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
139429140|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429141|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429142|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139429143|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
139429144|NCT01239797|Hormones|hormones|mesh-ancestor
139429145|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139429146|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139429147|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429148|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
139429149|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429150|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429151|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
139429152|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139429153|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139429154|NCT01239797|Growth Substances|growth substances|mesh-ancestor
139429155|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
139429156|NCT01092143|Fluticasone|fluticasone|mesh-list
139429157|NCT01092143|Xhance|xhance|mesh-list
139429158|NCT01092143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382338|NCT02114099|Atorvastatin|atorvastatin|mesh-list
139429159|NCT01092143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139429160|NCT01092143|Autonomic Agents|autonomic agents|mesh-ancestor
139429161|NCT01092143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429162|NCT01092143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429163|NCT01092143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139429164|NCT01092143|Respiratory System Agents|respiratory system agents|mesh-ancestor
139429165|NCT01092143|Dermatologic Agents|dermatologic agents|mesh-ancestor
139429166|NCT01092143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139429167|NCT00950989|Folic Acid|folic acid|mesh-list
139429168|NCT00950989|Methotrexate|methotrexate|mesh-list
139429169|NCT00950989|Brodalumab|brodalumab|mesh-list
139429170|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139429171|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
139429172|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139429173|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429174|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139429175|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
139429176|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429177|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429178|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
139429179|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429180|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139429181|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139429182|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
139429183|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139429184|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139429185|NCT00950989|Hematinics|hematinics|mesh-ancestor
139429186|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
139429188|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
139429189|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139429190|NCT03420911|Midazolam|midazolam|mesh-list
139429191|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139429192|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139429193|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429194|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429195|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139429196|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139429197|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139429198|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139429199|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
139429200|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
139429201|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
139429202|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
139429203|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429204|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429205|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139429206|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139429207|NCT03420911|Analgesics|analgesics|mesh-ancestor
139429208|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
139429209|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429210|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139429211|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139429212|NCT03416231|Docetaxel|docetaxel|mesh-list
139429213|NCT03416231|Apatinib|apatinib|mesh-list
139429214|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429215|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
139429216|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
139429217|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
139429218|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429219|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139429220|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429221|NCT03415763|Leucovorin|leucovorin|mesh-list
139429222|NCT03415763|Capecitabine|capecitabine|mesh-list
139429223|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
139429224|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139429225|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
139429226|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429227|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429228|NCT03415763|Antidotes|antidotes|mesh-ancestor
139429229|NCT03415763|Protective Agents|protective agents|mesh-ancestor
139429230|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429231|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
139429232|NCT03415763|Vitamins|vitamins|mesh-ancestor
139429233|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
139429234|NCT00593567|Levofloxacin|levofloxacin|mesh-list
139429235|NCT00593567|Gentamicins|gentamicins|mesh-list
139382339|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139429236|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139429237|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429238|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139429239|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139429240|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139429241|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429242|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429243|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429244|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139429245|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139429246|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139429247|NCT03419975|Latanoprost|latanoprost|mesh-list
139429248|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139429249|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139429250|NCT00006455|Leucovorin|leucovorin|mesh-list
139429251|NCT00006455|Cytarabine|cytarabine|mesh-list
139429252|NCT00006455|Dexamethasone|dexamethasone|mesh-list
139429253|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
139429254|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139429255|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139429256|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139429257|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
139429258|NCT00006455|Ifosfamide|ifosfamide|mesh-list
139429259|NCT00006455|Doxorubicin|doxorubicin|mesh-list
139429260|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139429261|NCT00006455|Methotrexate|methotrexate|mesh-list
139429262|NCT00006455|Etoposide|etoposide|mesh-list
139429263|NCT00006455|Vinblastine|vinblastine|mesh-list
139429264|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
139429265|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139429266|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
139429267|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429268|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139429269|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139429270|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
139429271|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429272|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429273|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139429274|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139429275|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
139429276|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
139429277|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429278|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139429279|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
139429280|NCT00006455|Hormones|hormones|mesh-ancestor
139429281|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139429282|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139429283|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139429284|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139429285|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139429286|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429287|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139429288|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
139429289|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139429290|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139429291|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
139429292|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
139429293|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139429294|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139429295|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139429296|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
139429297|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429298|NCT00006455|Antidotes|antidotes|mesh-ancestor
139429299|NCT00006455|Protective Agents|protective agents|mesh-ancestor
139429300|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
139429301|NCT00006455|Vitamins|vitamins|mesh-ancestor
139429302|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
139429303|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
139429304|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
139429305|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
139429306|NCT01602315|Cetuximab|cetuximab|mesh-list
139429307|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139429308|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429309|NCT02537197|Naltrexone|naltrexone|mesh-list
139429310|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139429311|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138863802|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
139429312|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429313|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
139429314|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429315|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139429316|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139429317|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139429318|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139429319|NCT03413371|Acetaminophen|acetaminophen|mesh-list
139429320|NCT03413371|Lidocaine|lidocaine|mesh-list
139429321|NCT03413371|Bupivacaine|bupivacaine|mesh-list
139429322|NCT03413371|Ropivacaine|ropivacaine|mesh-list
139429323|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
139429324|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
139429325|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429326|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429327|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
139429328|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429329|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139429330|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139429331|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139429332|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139429333|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429334|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139429335|NCT03413371|Analgesics|analgesics|mesh-ancestor
139429336|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
139429337|NCT02344004|Amikacin|amikacin|mesh-list
139429338|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139429339|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429340|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
139429341|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139429342|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429343|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429344|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139429345|NCT03677115|Analgesics|analgesics|mesh-ancestor
139429346|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
139429347|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429348|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139429349|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139429350|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139429351|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
139429352|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429353|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429354|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
139429355|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139429356|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
139429357|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
139429358|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139429360|NCT05116371|Estrogens|estrogens|mesh-ancestor
139429361|NCT05116371|Hormones|hormones|mesh-ancestor
139429362|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139429363|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429364|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139429365|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139429366|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139429367|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139429368|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139429369|NCT01328093|Aripiprazole|aripiprazole|mesh-list
139429370|NCT01328093|Antidepressive Agents|antidepressive agents|mesh-ancestor
139429371|NCT01328093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139429372|NCT01328093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139429373|NCT01328093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139429374|NCT01328093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429375|NCT01328093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429376|NCT01328093|Dopamine Agonists|dopamine agonists|mesh-ancestor
139429377|NCT01328093|Dopamine Agents|dopamine agents|mesh-ancestor
139429378|NCT01328093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429379|NCT01328093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429380|NCT01328093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139429381|NCT01328093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139429382|NCT01328093|Serotonin Agents|serotonin agents|mesh-ancestor
139429383|NCT01328093|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139429384|NCT01328093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139429385|NCT01328093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139429386|NCT01328093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139429387|NCT03417427|Cytarabine|cytarabine|mesh-list
139429388|NCT03417427|Decitabine|decitabine|mesh-list
139429389|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139429390|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
139429391|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429392|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429393|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
139429394|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429395|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139429396|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
139429397|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429398|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429399|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
139429400|NCT03425617|Olodaterol|olodaterol|mesh-list
139429401|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139429402|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
139429403|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429404|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429405|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139429406|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
139429407|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
139429408|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139429409|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
139429410|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429411|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429412|NCT03419429|Simvastatin|simvastatin|mesh-list
139429413|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139216159|NCT03292822|Paclitaxel|paclitaxel|mesh-list
139429414|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139429415|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
139429416|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429417|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139429418|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139429419|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429420|NCT02654145|Omalizumab|omalizumab|mesh-list
139429421|NCT02654145|Albuterol|albuterol|mesh-list
139429422|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139429423|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
139429424|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429425|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429426|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139429427|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
139429428|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
139429429|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139429430|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139429431|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139429432|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139429433|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
139429434|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429435|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429436|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139429437|NCT05122455|Edoxaban|edoxaban|mesh-list
139429438|NCT05122455|Clopidogrel|clopidogrel|mesh-list
139429439|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139429440|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139429441|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139429442|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139429443|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
139429444|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429445|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429446|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429447|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139429448|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
139429449|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139429450|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
139429451|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429452|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
139429453|NCT03413059|Triamcinolone|triamcinolone|mesh-list
139429454|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139429455|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139429456|NCT03413059|Morphine|morphine|mesh-list
139429457|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139429458|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139429459|NCT03413059|Narcotics|narcotics|mesh-ancestor
139429460|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429461|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429462|NCT03413059|Analgesics|analgesics|mesh-ancestor
139429463|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
139429464|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429465|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139429466|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
139429467|NCT03413059|Hormones|hormones|mesh-ancestor
139429468|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139429469|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139429470|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
139429471|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429472|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429473|NCT05122377|Goserelin|goserelin|mesh-list
139429474|NCT05122377|Leuprolide|leuprolide|mesh-list
139429475|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139429476|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429477|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139429478|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
139429479|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139429480|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429481|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139429482|NCT03425461|Nivolumab|nivolumab|mesh-list
139429483|NCT03425461|Ipilimumab|ipilimumab|mesh-list
139429484|NCT03425461|Antibodies|antibodies|mesh-list
139429485|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
139429486|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139429487|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
139429488|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429489|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429490|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139429491|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429493|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139429494|NCT03411109|Narcotics|narcotics|mesh-ancestor
139429495|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429496|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429497|NCT03411109|Analgesics|analgesics|mesh-ancestor
139429498|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
139429499|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429500|NCT01111565|Aripiprazole|aripiprazole|mesh-list
139429501|NCT01111565|Escitalopram|escitalopram|mesh-list
139429502|NCT01111565|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139429503|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139429504|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139429505|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429506|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429507|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
139429508|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429509|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
139429510|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139429511|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139429512|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139429513|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429514|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
139429515|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
139429516|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139429517|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139429518|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139429519|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139429520|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139429521|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139429522|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139429523|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139429524|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
139429525|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429526|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429527|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429528|NCT03412513|Mirabegron|mirabegron|mesh-list
139429529|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139429530|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139429531|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139429532|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
139429533|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429534|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429535|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429536|NCT03412513|Urological Agents|urological agents|mesh-ancestor
139429537|NCT04370379|Aflibercept|aflibercept|mesh-list
139429538|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139429539|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139429540|NCT04370379|Growth Substances|growth substances|mesh-ancestor
139429541|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429542|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
139429543|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429544|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
139429545|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139429546|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139429547|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429548|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
139429549|NCT03413891|Coagulants|coagulants|mesh-ancestor
139429550|NCT03317613|Capsaicin|capsaicin|mesh-list
139429551|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
139429552|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
139429553|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
139429554|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429555|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429556|NCT03126877|Mitomycins|mitomycins|mesh-list
139429557|NCT03126877|Mitomycin|mitomycin|mesh-list
139429558|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139429559|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429560|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
139429561|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429562|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139429563|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429564|NCT04260477|Rifampin|rifampin|mesh-list
139429565|NCT04260477|Isoniazid|isoniazid|mesh-list
139429566|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
139429567|NCT04260477|Ethambutol|ethambutol|mesh-list
139429568|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139429569|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
139429570|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139429571|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429572|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
139429573|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139429574|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429575|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429576|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139429577|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139429578|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139429579|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139429580|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139429581|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139429582|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139429583|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139429584|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
139429585|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139429586|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
139429587|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
139429588|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139429589|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
139429590|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429591|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429592|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139429593|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
139429594|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139429595|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139429596|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139429597|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
139429598|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429599|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429600|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139429601|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139429602|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139429603|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
139429604|NCT03424759|Osimertinib|osimertinib|mesh-list
139429605|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429606|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139429607|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429608|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429609|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
139429610|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139429611|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429612|NCT04814745|Morphine|morphine|mesh-list
139429613|NCT04814745|Tramadol|tramadol|mesh-list
139429614|NCT04814745|Ropivacaine|ropivacaine|mesh-list
139429615|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139429616|NCT04814745|Narcotics|narcotics|mesh-ancestor
139429617|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429618|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429619|NCT04814745|Analgesics|analgesics|mesh-ancestor
139429620|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
139429621|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429622|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
139429623|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
139429624|NCT04640571|Metformin|metformin|mesh-list
139429625|NCT04640571|Valacyclovir|valacyclovir|mesh-list
139429626|NCT04640571|Enalaprilat|enalaprilat|mesh-list
139429627|NCT04640571|Enalapril|enalapril|mesh-list
139429628|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139429629|NCT04640571|Pravastatin|pravastatin|mesh-list
139429630|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139429631|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429632|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139429633|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139429634|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
139429635|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429636|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139429637|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139429638|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429639|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
139429640|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429641|NCT04640571|Cathartics|cathartics|mesh-ancestor
139429642|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139429643|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139429644|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
139429645|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139429646|NCT04431141|Empagliflozin|empagliflozin|mesh-list
139429647|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139429648|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429649|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139429650|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429651|NCT05229627|Methylphenidate|methylphenidate|mesh-list
139429652|NCT05229627|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139429653|NCT05229627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139429654|NCT05229627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429655|NCT05229627|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139429656|NCT05229627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139429657|NCT05229627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139429658|NCT05229627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429659|NCT05229627|Dopamine Agents|dopamine agents|mesh-ancestor
139429660|NCT05229627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429661|NCT05229627|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139429662|NCT05229627|Adrenergic Agents|adrenergic agents|mesh-ancestor
139429663|NCT01976169|Palbociclib|palbociclib|mesh-list
139429664|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139429665|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429666|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139429667|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429668|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429669|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139429670|NCT01976169|Immunotoxins|immunotoxins|mesh-ancestor
139429671|NCT01976169|Immunoconjugates|immunoconjugates|mesh-ancestor
139429672|NCT01976169|Immunologic Factors|immunologic factors|mesh-ancestor
139429673|NCT01976169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429674|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
139429675|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
139429676|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
139429677|NCT00148629|Mebendazole|mebendazole|mesh-list
139429678|NCT00148629|Piperazine|piperazine|mesh-list
139429679|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
139429680|NCT00148629|DMP 777|dmp 777|mesh-list
139429681|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
139429682|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
139429683|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139429684|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429685|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
139429686|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
139429687|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
139429688|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429689|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429690|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429691|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
139429692|NCT04448015|Narcotics|narcotics|mesh-ancestor
139429693|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429694|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429695|NCT04448015|Analgesics|analgesics|mesh-ancestor
139429696|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
139429697|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429698|NCT01328041|Dolutegravir|dolutegravir|mesh-list
139429699|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139429700|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139429701|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429702|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429703|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139429704|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139429705|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
139429706|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429707|NCT03412721|Analgesics|analgesics|mesh-list
139429708|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
139429709|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429710|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216458|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
139429711|NCT03418337|Lansoprazole|lansoprazole|mesh-list
139429712|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
139429713|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139429714|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139429715|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139429716|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429717|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429718|NCT03411967|Docetaxel|docetaxel|mesh-list
139429719|NCT03411967|Apatinib|apatinib|mesh-list
139429720|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429721|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
139429722|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
139429723|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
139429724|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429725|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139429726|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429727|NCT03412409|Cytarabine|cytarabine|mesh-list
139429728|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
139429729|NCT03412409|Busulfan|busulfan|mesh-list
139429730|NCT03412409|Semustine|semustine|mesh-list
139429731|NCT03412409|Fludarabine|fludarabine|mesh-list
139429732|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139429733|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139429734|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
139429735|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429736|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139429737|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139429738|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
139429739|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429740|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429741|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139429742|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139429743|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
139429744|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
139429745|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429746|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
139429747|NCT02410772|Rifapentine|rifapentine|mesh-list
139429748|NCT02410772|Rifampin|rifampin|mesh-list
139429749|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139429750|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429751|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139429752|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139429753|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429754|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429755|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429756|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139429757|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
139429758|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
139429759|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139429760|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139429761|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139429762|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139429763|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139429764|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139429765|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139429766|NCT03814317|Treprostinil|treprostinil|mesh-list
139429767|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139429768|NCT03127319|Docetaxel|docetaxel|mesh-list
139429769|NCT03127319|Apatinib|apatinib|mesh-list
139429770|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429771|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
139429772|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
139429773|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
139429774|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429775|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139429776|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429777|NCT03417947|Vitamin D|vitamin d|mesh-list
139429778|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
139429779|NCT03417947|Vitamins|vitamins|mesh-ancestor
139429780|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
139429781|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429782|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139429783|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139429784|NCT03905811|Terazosin|terazosin|mesh-list
139429785|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139429786|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139429787|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139429788|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
139216531|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139429789|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429790|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429791|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429792|NCT03905811|Urological Agents|urological agents|mesh-ancestor
139429793|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139429794|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139429795|NCT05171309|Apatinib|apatinib|mesh-list
139429796|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429797|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139429798|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429799|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429800|NCT03409237|Mannitol|mannitol|mesh-list
139429801|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139429802|NCT03409237|Diuretics|diuretics|mesh-ancestor
139429803|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
139429804|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429805|NCT03408847|Beclomethasone|beclomethasone|mesh-list
139429806|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139429807|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
139429808|NCT03408847|Hormones|hormones|mesh-ancestor
139429809|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139429810|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429811|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139429812|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
139429813|NCT03424291|Apatinib|apatinib|mesh-list
139429814|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429815|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139429816|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429817|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429818|NCT04412889|Immunomodulating Agents|immunomodulating agents|mesh-list
139429819|NCT04412889|Immunologic Factors|immunologic factors|mesh-ancestor
139429820|NCT04412889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429821|NCT03407521|Isosorbide|isosorbide|mesh-list
139429822|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139429823|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139429824|NCT03407521|Misoprostol|misoprostol|mesh-list
139429825|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139429826|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
139429827|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139429828|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429829|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139429830|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139429831|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
139429832|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139429833|NCT03407521|Diuretics|diuretics|mesh-ancestor
139429834|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
139429835|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
139429836|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139429837|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429838|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
139429839|NCT03424135|Promethazine|promethazine|mesh-list
139429840|NCT03424135|Naproxen|naproxen|mesh-list
139429841|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139429842|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139429843|NCT03424135|Analgesics|analgesics|mesh-ancestor
139429844|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
139429845|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429846|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429847|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139429848|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139429849|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
139429850|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139429851|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429852|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429853|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139429854|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139429855|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429856|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
139429857|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
139429858|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
139429859|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
139429860|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139429861|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139429862|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
139429863|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
139429864|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429865|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139429866|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
139429867|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
139429868|NCT03411941|Aflibercept|aflibercept|mesh-list
139429869|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139429870|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139429871|NCT03411941|Growth Substances|growth substances|mesh-ancestor
139429872|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429873|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
139429874|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429875|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139429876|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
139429877|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139429878|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429879|NCT03406819|Nitroprusside|nitroprusside|mesh-list
139429880|NCT03406819|Tirofiban|tirofiban|mesh-list
139429881|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139429882|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
139429883|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139429884|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429885|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139429886|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139429887|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139429888|NCT05170217|Cannabidiol|cannabidiol|mesh-list
139429889|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
139429890|NCT03411551|Anesthetics|anesthetics|mesh-list
139429891|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429892|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429893|NCT05170061|Valsartan|valsartan|mesh-list
139429894|NCT05170061|Nebivolol|nebivolol|mesh-list
139429895|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139429896|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139429897|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139429898|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429899|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
139429900|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139429901|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139429902|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139429903|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
139429904|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139429905|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429906|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
139429907|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139429908|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139429909|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
139429910|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429911|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139429912|NCT02520635|Temozolomide|temozolomide|mesh-list
139429913|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139429914|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
139429915|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429916|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429917|NCT03404947|Ethanol|ethanol|mesh-list
139429918|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139429919|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429920|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139429921|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429922|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
139429923|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139429924|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429925|NCT03411473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139429926|NCT03411473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429927|NCT03423823|Ranibizumab|ranibizumab|mesh-list
139429928|NCT03423823|Aflibercept|aflibercept|mesh-list
139429929|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429930|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139429931|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139429932|NCT03423823|Growth Substances|growth substances|mesh-ancestor
139429933|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429934|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
139429935|NCT03411161|Paclitaxel|paclitaxel|mesh-list
139429936|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139429937|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139429938|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216680|NCT03279796|Hormones|hormones|mesh-ancestor
139429939|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
139429940|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
139429941|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
139429942|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429944|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
139429945|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139429946|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
139429947|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
139429948|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
139429949|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429950|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429951|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139429952|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429953|NCT05168059|Clevidipine|clevidipine|mesh-list
139429954|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139429955|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139429956|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429957|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139429958|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429959|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
139429960|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139429961|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
139429962|NCT02375295|Trimethoprim|trimethoprim|mesh-list
139429963|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139429964|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139429965|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139429966|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139429967|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139429968|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429969|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429970|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139429971|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139429972|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139429973|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
139429974|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139429975|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139429976|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139429977|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139429978|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139429979|NCT03394105|Docetaxel|docetaxel|mesh-list
139429980|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139429981|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
139429982|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
139429983|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
139429984|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139429985|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
139429986|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139429987|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139429988|NCT03393949|Prednisolone|prednisolone|mesh-list
139429989|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
139429990|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139429991|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
139429992|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139429993|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
139429994|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
139429995|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139429996|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139429997|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139429998|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
139429999|NCT03393949|Hormones|hormones|mesh-ancestor
139430000|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430001|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139430002|NCT03393949|Protective Agents|protective agents|mesh-ancestor
139430003|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139430004|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430005|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
139430006|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139430007|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
139430008|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139430009|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139430010|NCT04435743|Lenalidomide|lenalidomide|mesh-list
139430011|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
139430012|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430013|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139430014|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139430016|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
139430017|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430018|NCT03393715|Perindopril|perindopril|mesh-list
139430019|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139430020|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
139430021|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430022|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430023|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139430024|NCT03397537|Letrozole|letrozole|mesh-list
139430025|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430026|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139430027|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139430028|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430029|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430030|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139430031|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
139430032|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430033|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430034|NCT03612921|Amantadine|amantadine|mesh-list
139430035|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139430036|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139430037|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
139430038|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139430039|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
139430040|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430041|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430042|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430043|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139430044|NCT03612921|Analgesics|analgesics|mesh-ancestor
139430045|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
139430046|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430047|NCT03393481|Enoxaparin|enoxaparin|mesh-list
139430048|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
139430049|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139430050|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139430051|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430052|NCT01936857|Buprenorphine|buprenorphine|mesh-list
139430053|NCT01936857|Methadone|methadone|mesh-list
139430054|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139430055|NCT01936857|Naloxone|naloxone|mesh-list
139430056|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139430057|NCT01936857|Narcotics|narcotics|mesh-ancestor
139430058|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430059|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430060|NCT01936857|Analgesics|analgesics|mesh-ancestor
139430061|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
139430062|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430063|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139430064|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
139430065|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
139430066|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
139430067|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139430068|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430069|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430070|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139430071|NCT03393403|Analgesics|analgesics|mesh-ancestor
139430072|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
139430073|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430074|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139430075|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139430076|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139430077|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
139430078|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430079|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430080|NCT03399955|Amphotericin B|amphotericin b|mesh-list
139430081|NCT03399955|Paromomycin|paromomycin|mesh-list
139430082|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139430083|NCT03399955|Miltefosine|miltefosine|mesh-list
139430084|NCT03399955|Amebicides|amebicides|mesh-ancestor
139430085|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139430086|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139216837|NCT01367028|Docetaxel|docetaxel|mesh-list
139430087|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139430088|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139430089|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
139430090|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430091|NCT03397199|Apatinib|apatinib|mesh-list
139430092|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430093|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139430094|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430095|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430096|NCT03393325|Tadalafil|tadalafil|mesh-list
139430097|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
139430098|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139430099|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139430100|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430101|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430102|NCT03393325|Urological Agents|urological agents|mesh-ancestor
139430103|NCT03399643|Atezolizumab|atezolizumab|mesh-list
139430104|NCT03399643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139430105|NCT03399643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430106|NCT03399643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139430107|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430108|NCT03393247|Infliximab|infliximab|mesh-list
139430109|NCT03393247|Azathioprine|azathioprine|mesh-list
139430110|NCT03393247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139430111|NCT03393247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139430112|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
139430113|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139430114|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139430115|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
139430116|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430117|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139430118|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430119|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139430120|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
139430121|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430122|NCT03407027|Triamcinolone|triamcinolone|mesh-list
139430123|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139430124|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139430125|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139430126|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139430127|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
139430128|NCT03407027|Hormones|hormones|mesh-ancestor
139430129|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430130|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430131|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139430132|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
139430133|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430134|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430135|NCT03343197|Ivosidenib|ivosidenib|mesh-list
139430136|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430137|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430138|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430139|NCT01602224|Dexamethasone|dexamethasone|mesh-list
139430140|NCT01602224|Bortezomib|bortezomib|mesh-list
139430141|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139430142|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
139430143|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
139430144|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430145|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430146|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139430147|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
139430148|NCT01602224|Hormones|hormones|mesh-ancestor
139430149|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430150|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139430151|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430152|NCT03399487|Ceritinib|ceritinib|mesh-list
139430153|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430154|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139430155|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430156|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430157|NCT05161429|Insulin|insulin|mesh-list
139430158|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139430159|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430160|NCT03984045|Lidocaine|lidocaine|mesh-list
139216920|NCT01316757|Paclitaxel|paclitaxel|mesh-list
139430162|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
139430163|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
139430164|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430165|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430166|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
139430167|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430168|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139430169|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139430170|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139430171|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139430172|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430173|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
139430174|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
139430175|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139430176|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139430177|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139430178|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139430179|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139430180|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
139430181|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430182|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139430183|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139430184|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139430185|NCT05060991|Antimetabolites|antimetabolites|mesh-list
139430186|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430187|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139430188|NCT03397069|Midazolam|midazolam|mesh-list
139430189|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139430190|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139430191|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430192|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430193|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139430194|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139430195|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139430196|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139430197|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
139430198|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
139430199|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
139430200|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
139430201|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430202|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430203|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
139430204|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139430205|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430206|NCT03396497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139430207|NCT03396497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430208|NCT03399019|Midazolam|midazolam|mesh-list
139430209|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
139430210|NCT03399019|Propofol|propofol|mesh-list
139430211|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139430212|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430213|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430214|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139430215|NCT03399019|Analgesics|analgesics|mesh-ancestor
139430216|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
139430217|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430218|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139430219|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139430220|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139430221|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
139430222|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430223|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430224|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139430225|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
139430226|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
139430227|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139430228|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139430229|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139430230|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139430231|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
139430232|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
139430233|NCT04452383|Ketamine|ketamine|mesh-list
139430234|NCT04452383|Propofol|propofol|mesh-list
139430235|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139430236|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430237|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430238|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139430239|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
139430240|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
139430241|NCT04452383|Analgesics|analgesics|mesh-ancestor
139430242|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
139430243|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430244|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139430245|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139430246|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139430247|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430248|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430249|NCT02520479|Pegaspargase|pegaspargase|mesh-list
139430250|NCT02520479|Asparaginase|asparaginase|mesh-list
139430251|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430252|NCT02520947|Desflurane|desflurane|mesh-list
139430253|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139430254|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
139430255|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
139430256|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430257|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430258|NCT03398941|Octreotide|octreotide|mesh-list
139430259|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139430260|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139430261|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430262|NCT03392623|Niacinamide|niacinamide|mesh-list
139430264|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
139430265|NCT03392623|Tretinoin|tretinoin|mesh-list
139430266|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
139430267|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430268|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
139430269|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
139430270|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139430271|NCT03392623|Protective Agents|protective agents|mesh-ancestor
139430272|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430273|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
139430274|NCT03392623|Vitamins|vitamins|mesh-ancestor
139430275|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
139430276|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139430277|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
139430278|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430279|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139430280|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
139430281|NCT03396107|Dexamethasone|dexamethasone|mesh-list
139430282|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139430283|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
139430284|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
139430285|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430286|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430287|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139430288|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
139430289|NCT03396107|Hormones|hormones|mesh-ancestor
139430290|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430291|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139430292|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430293|NCT03398785|Epinephrine|epinephrine|mesh-list
139430294|NCT03398785|Racepinephrine|racepinephrine|mesh-list
139430295|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
139430296|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139430297|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139430298|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
139430299|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430300|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430301|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430302|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139430303|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139430304|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
139430305|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430306|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139430307|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
139430308|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
139430309|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
139430310|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139430311|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
139430312|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
139430313|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430314|NCT03126695|Ticagrelor|ticagrelor|mesh-list
139430315|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139430316|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139430317|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139430318|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139430319|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
139430320|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430321|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430322|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430323|NCT04647643|Paclitaxel|paclitaxel|mesh-list
139430324|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139430325|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430326|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
139430327|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
139430328|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
139430329|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430330|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139430331|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
139430332|NCT04167761|Glipizide|glipizide|mesh-list
139430333|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430334|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139430335|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430336|NCT03401177|Naproxen|naproxen|mesh-list
139430337|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139430338|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139430339|NCT03401177|Analgesics|analgesics|mesh-ancestor
139430340|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
139430341|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430342|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430343|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139430344|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139430345|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
139430346|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139430347|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430348|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430349|NCT04446715|Sufentanil|sufentanil|mesh-list
139430350|NCT04446715|Meperidine|meperidine|mesh-list
139430351|NCT04446715|Bupivacaine|bupivacaine|mesh-list
139430352|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
139430353|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
139430354|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430355|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430356|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
139430357|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430358|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139430359|NCT04446715|Narcotics|narcotics|mesh-ancestor
139430360|NCT04446715|Analgesics|analgesics|mesh-ancestor
139430361|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139430362|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139430363|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
139430364|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
139430365|NCT03398473|Hematinics|hematinics|mesh-ancestor
139430366|NCT03395951|Diuretics|diuretics|mesh-list
139430367|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
139430368|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430369|NCT04535791|Vitamin D|vitamin d|mesh-list
139430370|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
139430371|NCT04535791|Vitamins|vitamins|mesh-ancestor
139430372|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
139430373|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430374|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139430375|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139430376|NCT03395873|Decitabine|decitabine|mesh-list
139430377|NCT03395873|Avelumab|avelumab|mesh-list
139430378|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139430379|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
139430380|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430381|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430382|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430383|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139217154|NCT01344291|Curcumin|curcumin|mesh-list
139430384|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139430385|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139430386|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139430387|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
139430388|NCT03396523|Losartan|losartan|mesh-list
139430389|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139430390|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139430391|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139430392|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139430393|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430394|NCT03126097|Drospirenone|drospirenone|mesh-list
139430395|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139430396|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139430397|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139430398|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139430399|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139430400|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
139430401|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139430402|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430403|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139430404|NCT03126097|Estrogens|estrogens|mesh-ancestor
139430405|NCT03126097|Hormones|hormones|mesh-ancestor
139430406|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430407|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139430408|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
139430409|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139430410|NCT03126097|Diuretics|diuretics|mesh-ancestor
139430411|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
139430412|NCT03398083|Alprazolam|alprazolam|mesh-list
139430413|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139430414|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430415|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430416|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139430417|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139430418|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139430419|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
139430420|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
139430421|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430422|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430423|NCT03126721|Midazolam|midazolam|mesh-list
139430424|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138864923|NCT02732522|Misoprostol|misoprostol|mesh-list
139430425|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139430426|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430427|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430428|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139430429|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139430430|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139430431|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139430432|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
139430433|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
139430434|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
139430435|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
139430436|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430437|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430438|NCT04928521|Bupivacaine|bupivacaine|mesh-list
139430439|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
139430440|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
139430441|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430442|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430443|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
139430444|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430445|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
139430446|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
139430447|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430448|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
139430449|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430450|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430451|NCT03391843|Cetuximab|cetuximab|mesh-list
139430452|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
139430453|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139430454|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430455|NCT03389659|Vitamin D|vitamin d|mesh-list
139430456|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
139430457|NCT03389659|Vitamins|vitamins|mesh-ancestor
139430458|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
139430459|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430460|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139430461|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139217202|NCT04735965|Meperidine|meperidine|mesh-list
139430462|NCT04446637|Albuterol|albuterol|mesh-list
139430463|NCT04446637|Ipratropium|ipratropium|mesh-list
139430464|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139430465|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
139430466|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430467|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430468|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139430469|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
139430470|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
139430471|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139430472|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139430473|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139430474|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139430475|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
139430476|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430477|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430478|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139430479|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
139430480|NCT03395171|Vitamin D|vitamin d|mesh-list
139430481|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
139430482|NCT03395171|Vitamins|vitamins|mesh-ancestor
139430483|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
139430484|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430485|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139430486|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139430487|NCT03395977|Febuxostat|febuxostat|mesh-list
139430488|NCT03395977|Rasburicase|rasburicase|mesh-list
139430489|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
139430490|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139430491|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
139430492|NCT02678143|Sirolimus|sirolimus|mesh-list
139430493|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
139430494|NCT02678143|Fludarabine|fludarabine|mesh-list
139430495|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
139430496|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139430497|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
139430498|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430499|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139430500|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139430501|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
139430502|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430503|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430504|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139430505|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139430506|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139430507|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
139430508|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139430509|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139430510|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430511|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
139430512|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139430513|NCT03395093|Midazolam|midazolam|mesh-list
139430514|NCT03395093|Fentanyl|fentanyl|mesh-list
139430515|NCT03395093|Propofol|propofol|mesh-list
139430516|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139430517|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430518|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430519|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139430520|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
139430521|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
139430522|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139430523|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139430524|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139430525|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139430526|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
139430527|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
139430528|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430529|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430530|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139430531|NCT03395093|Narcotics|narcotics|mesh-ancestor
139430532|NCT03395093|Analgesics|analgesics|mesh-ancestor
139430533|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
139430534|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430535|NCT03389191|Acyclovir|acyclovir|mesh-list
139430536|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
139430537|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139430538|NCT04330183|Ketamine|ketamine|mesh-list
139430539|NCT04330183|Analgesics|analgesics|mesh-ancestor
139430540|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
139430541|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430542|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430543|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139430544|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139430545|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
139430546|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
139430547|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430548|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139430549|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139430550|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430551|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430552|NCT03398993|Clomiphene|clomiphene|mesh-list
139430553|NCT03398993|Enclomiphene|enclomiphene|mesh-list
139430554|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
139430555|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139430556|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139430557|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
139430558|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430559|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430560|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139430561|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
139430562|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139430563|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139430564|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139430565|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
139430566|NCT04249297|Progestins|progestins|mesh-ancestor
139430567|NCT04249297|Hormones|hormones|mesh-ancestor
139430568|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430569|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430570|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
139430571|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139430572|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430573|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430574|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139430575|NCT03391609|Analgesics|analgesics|mesh-ancestor
139430576|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
139430577|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430578|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139430579|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139430580|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139430581|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
139430582|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430583|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430584|NCT03398837|Dronabinol|dronabinol|mesh-list
139430585|NCT03398837|Lenabasum|lenabasum|mesh-list
139430586|NCT03398837|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139430587|NCT03398837|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139430588|NCT03398837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430589|NCT03398837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430590|NCT03398837|Hormones|hormones|mesh-ancestor
139430591|NCT03398837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430592|NCT03398837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430593|NCT03398837|Hallucinogens|hallucinogens|mesh-ancestor
139430594|NCT03398837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139430595|NCT03398837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139430596|NCT03398837|Analgesics|analgesics|mesh-ancestor
139430597|NCT03398837|Sensory System Agents|sensory system agents|mesh-ancestor
139430598|NCT03398837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430599|NCT03398759|Butorphanol|butorphanol|mesh-list
139430600|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139430601|NCT03398759|Narcotics|narcotics|mesh-ancestor
139430602|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430603|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430604|NCT03398759|Analgesics|analgesics|mesh-ancestor
139430605|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
139430606|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430607|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
139430608|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
139430609|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139430610|NCT03391219|Bevacizumab|bevacizumab|mesh-list
139430611|NCT03391219|Fasudil|fasudil|mesh-list
139430612|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139430613|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430614|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139430615|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139430616|NCT03391219|Growth Substances|growth substances|mesh-ancestor
139430617|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430618|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
139430619|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139430620|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139430621|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430622|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139430623|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
139430624|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139430625|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430626|NCT04446923|Propranolol|propranolol|mesh-list
139430627|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139430628|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139430629|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
139430630|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430631|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430632|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430633|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139430634|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139430635|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
139430636|NCT05237843|Hydroxychloroquine|hydroxychloroquine|mesh-list
139430637|NCT05237843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139430638|NCT05237843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430639|NCT05237843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430640|NCT05237843|Antimalarials|antimalarials|mesh-ancestor
139430641|NCT05237843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139430642|NCT05237843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139430643|NCT05237843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139430644|NCT04447105|Anesthetics|anesthetics|mesh-list
139430645|NCT04447105|Propofol|propofol|mesh-list
139430646|NCT04447105|Desflurane|desflurane|mesh-list
139430647|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430648|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430649|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139430650|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139430651|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
139430652|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139430653|NCT03126461|Nivolumab|nivolumab|mesh-list
139430654|NCT03126461|Ipilimumab|ipilimumab|mesh-list
139430655|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139430656|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430657|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139430658|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430659|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139430660|NCT03394001|Ketorolac|ketorolac|mesh-list
139430661|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139430662|NCT03394001|Lidocaine|lidocaine|mesh-list
139430663|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
139430664|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
139430665|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430666|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430667|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
139430668|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430669|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139430670|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139430671|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139430672|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139430673|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430674|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139430675|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139430676|NCT03394001|Analgesics|analgesics|mesh-ancestor
139430677|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139430678|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139430679|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139430680|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430681|NCT03393767|Ranibizumab|ranibizumab|mesh-list
139430682|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139430683|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139430684|NCT03393767|Growth Substances|growth substances|mesh-ancestor
139430685|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430686|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
139430687|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430688|NCT03389321|Macitentan|macitentan|mesh-list
139430689|NCT03389321|Riociguat|riociguat|mesh-list
139430690|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139430691|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139430692|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430693|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139430694|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
139430695|NCT03393377|Valsartan|valsartan|mesh-list
139430696|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139430697|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139430698|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139430699|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430700|NCT02421263|Psilocybin|psilocybin|mesh-list
139430701|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
139430702|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430703|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139430704|NCT01889303|Docetaxel|docetaxel|mesh-list
139430705|NCT01889303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430706|NCT01889303|Tubulin Modulators|tubulin modulators|mesh-ancestor
139430707|NCT01889303|Antimitotic Agents|antimitotic agents|mesh-ancestor
139430708|NCT01889303|Mitosis Modulators|mitosis modulators|mesh-ancestor
139430709|NCT01889303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430710|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139430711|NCT00783263|Ezetimibe|ezetimibe|mesh-list
139430712|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139430713|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139430714|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
139430715|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430716|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139430717|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138865230|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
139430718|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430719|NCT00664937|Montelukast|montelukast|mesh-list
139430720|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139430721|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
139430722|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139430723|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
139430724|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430725|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430726|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139430727|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139430728|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430729|NCT00540839|Fluticasone|fluticasone|mesh-list
139430730|NCT00540839|Xhance|xhance|mesh-list
139430731|NCT00540839|Montelukast|montelukast|mesh-list
139430732|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139430733|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139430734|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
139430735|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430736|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430737|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139430738|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
139430739|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
139430740|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139430741|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139430742|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
139430743|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430744|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139430745|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139430746|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430747|NCT03389087|Etoposide|etoposide|mesh-list
139430748|NCT03389087|Apatinib|apatinib|mesh-list
139430749|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139430750|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430751|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139430752|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139430753|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430754|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430755|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139430756|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
139430757|NCT03388853|Doxofylline|doxofylline|mesh-list
139430758|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139430759|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
139430760|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139430761|NCT03388853|Expectorants|expectorants|mesh-ancestor
139430762|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
139430764|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
139430765|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430766|NCT03388853|Protective Agents|protective agents|mesh-ancestor
139430767|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430768|NCT03388853|Antidotes|antidotes|mesh-ancestor
139430769|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
139430770|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139430771|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
139430772|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430773|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139430774|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139430775|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430776|NCT00380705|Montelukast|montelukast|mesh-list
139430777|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139430778|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
139430779|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139430780|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
139430781|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430782|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430783|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139430784|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139430785|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430786|NCT03388697|Insulin|insulin|mesh-list
139430787|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139430788|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430789|NCT03987919|Tirzepatide|tirzepatide|mesh-list
139430790|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139430791|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430792|NCT03987919|Incretins|incretins|mesh-ancestor
139430793|NCT03987919|Hormones|hormones|mesh-ancestor
139430794|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430795|NCT03388957|Propranolol|propranolol|mesh-list
139430796|NCT03388957|Midazolam|midazolam|mesh-list
139430797|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139430798|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139430799|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430800|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430801|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139430802|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139430803|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139430804|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139430805|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
139430806|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
139430807|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
139430808|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
139430809|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430810|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430811|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139430812|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139430813|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
139430814|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139430815|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139430816|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
139430817|NCT03395665|Estradiol|estradiol|mesh-list
139430818|NCT03395665|Progesterone|progesterone|mesh-list
139430819|NCT03395665|Estrogens|estrogens|mesh-ancestor
139430820|NCT03395665|Hormones|hormones|mesh-ancestor
139430821|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430822|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430823|NCT03395665|Progestins|progestins|mesh-ancestor
139430824|NCT00535405|Atorvastatin|atorvastatin|mesh-list
139430825|NCT00535405|Simvastatin|simvastatin|mesh-list
139430826|NCT00535405|Ezetimibe|ezetimibe|mesh-list
139430827|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139430828|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139430829|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
139430830|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430831|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139430832|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139430833|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430834|NCT00271817|Niacin|niacin|mesh-list
139430835|NCT00271817|Niacinamide|niacinamide|mesh-list
139430836|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
139430837|NCT00271817|Simvastatin|simvastatin|mesh-list
139430838|NCT00271817|Ezetimibe|ezetimibe|mesh-list
139430839|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
139430840|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139430841|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139430842|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
139430843|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430844|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139430845|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139430846|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430847|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
139430848|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
139430849|NCT00271817|Vitamins|vitamins|mesh-ancestor
139430850|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
139430851|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430852|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
139430853|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139430854|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430855|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430856|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139430857|NCT03388541|Analgesics|analgesics|mesh-ancestor
139430858|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
139430859|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430860|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139430861|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139430862|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139430863|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
139430864|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430865|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430866|NCT00092989|Montelukast|montelukast|mesh-list
139430867|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139430868|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
139430869|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139430870|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
139430871|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430872|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430873|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139430874|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139430875|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430876|NCT03388463|Omeprazole|omeprazole|mesh-list
139430877|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139430878|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139430879|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139430880|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430881|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430882|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
139430883|NCT03858049|Progestins|progestins|mesh-ancestor
139430884|NCT03858049|Hormones|hormones|mesh-ancestor
139430885|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139430886|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430887|NCT03388151|Midazolam|midazolam|mesh-list
139430888|NCT03388151|Propofol|propofol|mesh-list
139430889|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139430890|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430891|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430892|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139430893|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
139430894|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
139430895|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139430896|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139430897|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139430898|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139430899|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
139430900|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
139430901|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430902|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430903|NCT03392909|Gentamicins|gentamicins|mesh-list
139430904|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139430905|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139430906|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139430907|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430908|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430909|NCT04501211|Granisetron|granisetron|mesh-list
139430910|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
139430911|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
139217656|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
139430913|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430914|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139430915|NCT04501211|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139430916|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139430917|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
139430918|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430919|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430920|NCT03126071|Bevacizumab|bevacizumab|mesh-list
139430921|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
139430922|NCT03126071|Irinotecan|irinotecan|mesh-list
139430923|NCT03126071|Raltitrexed|raltitrexed|mesh-list
139430924|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139430925|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430926|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139430927|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139430928|NCT03126071|Growth Substances|growth substances|mesh-ancestor
139430929|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430930|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
139430931|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139430932|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139430933|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430934|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430935|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139430936|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
139430937|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139430938|NCT03392051|Clopidogrel|clopidogrel|mesh-list
139430939|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138865458|NCT02650479|Hormones|hormones|mesh-ancestor
139430940|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139430941|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139430942|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139430943|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
139430944|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430945|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430946|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430947|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
139430948|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139430949|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139430950|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
139430951|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139430952|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139430953|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
139430954|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
139430955|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139430956|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
139430957|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430958|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
139430959|NCT04446533|Protective Agents|protective agents|mesh-ancestor
139430960|NCT03386591|Naloxone|naloxone|mesh-list
139430961|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139430962|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430963|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
139430964|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430965|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
139430966|NCT03386279|Abrocitinib|abrocitinib|mesh-list
139430967|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139430968|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139430969|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139430970|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139430971|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430972|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430973|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139430974|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139430975|NCT03386201|Methylene Blue|methylene blue|mesh-list
139430976|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139430977|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430978|NCT03268811|Teduglutide|teduglutide|mesh-list
139430979|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139430980|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139430981|NCT03268811|Protective Agents|protective agents|mesh-ancestor
139430982|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430983|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
139430984|NCT03385967|Ropivacaine|ropivacaine|mesh-list
139430985|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139430986|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139430987|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139430988|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139430989|NCT03385967|Analgesics|analgesics|mesh-ancestor
139430990|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
139430991|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139430992|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139430993|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139430994|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139430995|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
139430996|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139430997|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139430998|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
139430999|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
139431000|NCT02732015|Dexamethasone|dexamethasone|mesh-list
139431001|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
139431002|NCT02732015|Doxorubicin|doxorubicin|mesh-list
139431003|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139431004|NCT02732015|Vincristine|vincristine|mesh-list
139431005|NCT02732015|Daunorubicin|daunorubicin|mesh-list
139431006|NCT02732015|Ifosfamide|ifosfamide|mesh-list
139431007|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
139431008|NCT02732015|Ondansetron|ondansetron|mesh-list
139431009|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
139431010|NCT02732015|Aprepitant|aprepitant|mesh-list
139431011|NCT02732015|BB 1101|bb 1101|mesh-list
139431012|NCT02732015|Rolapitant|rolapitant|mesh-list
139431013|NCT02732015|Mesna|mesna|mesh-list
139431014|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139431015|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
139431016|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
139431017|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431018|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431019|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139431020|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
139431021|NCT02732015|Hormones|hormones|mesh-ancestor
139431022|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139431023|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139431024|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431025|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
139431026|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431027|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431028|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139431029|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139431030|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139431031|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139431032|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
139431033|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
139431034|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
139431035|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
139431036|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
139431037|NCT02732015|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139431038|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139431039|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
139431040|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431041|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139431042|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
139431043|NCT02732015|Protective Agents|protective agents|mesh-ancestor
139431044|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139431045|NCT02520245|Cemiplimab|cemiplimab|mesh-list
139431046|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139431047|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431048|NCT03537833|Pemetrexed|pemetrexed|mesh-list
139431049|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431050|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431051|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431052|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139431053|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139431054|NCT03439085|Durvalumab|durvalumab|mesh-list
139431055|NCT03439085|Interleukin-12|interleukin-12|mesh-list
139431056|NCT03439085|Vaccines|vaccines|mesh-list
139431057|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
139431058|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139431059|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
139431060|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
139431061|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431062|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139431063|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431064|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139431065|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139431066|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139431067|NCT03439085|Growth Substances|growth substances|mesh-ancestor
139431068|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
139431069|NCT01964807|Nicotine|nicotine|mesh-list
139431070|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139431071|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
139431072|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431073|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431074|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139431075|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139431076|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
139431077|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431078|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431079|NCT00999401|Roscovitine|roscovitine|mesh-list
139431080|NCT00999401|Sapacitabine|sapacitabine|mesh-list
139431081|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431082|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
139431083|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431084|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139431085|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431086|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431087|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139431088|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
139431089|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431090|NCT04446065|Protective Agents|protective agents|mesh-ancestor
139431091|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431092|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139431093|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139431094|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431095|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139431096|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
139431097|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139431098|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
139431099|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431100|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
139431101|NCT00225095|Protective Agents|protective agents|mesh-ancestor
139431102|NCT02732119|Everolimus|everolimus|mesh-list
139431103|NCT02732119|Exemestane|exemestane|mesh-list
139431104|NCT02732119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139431105|NCT02732119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139431106|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431107|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431108|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139431109|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
139431110|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431111|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431112|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139431113|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139431114|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139431115|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
139431116|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139431117|NCT04448717|Antibodies|antibodies|mesh-list
139431118|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
139431119|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431120|NCT05174195|Desogestrel|desogestrel|mesh-list
139431121|NCT05174195|Etonogestrel|etonogestrel|mesh-list
139431122|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139431123|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139431124|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139431125|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
139431126|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139431127|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431128|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139431129|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139431130|NCT05174195|Progestins|progestins|mesh-ancestor
139431131|NCT05174195|Hormones|hormones|mesh-ancestor
139431132|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139431133|NCT05238727|Carticaine|carticaine|mesh-list
139431134|NCT05238727|Mepivacaine|mepivacaine|mesh-list
139431135|NCT05238727|Anesthetics, Local|anesthetics, local|mesh-ancestor
139431136|NCT05238727|Anesthetics|anesthetics|mesh-ancestor
139431137|NCT05238727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431138|NCT05238727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431139|NCT05238727|Sensory System Agents|sensory system agents|mesh-ancestor
139431140|NCT05238727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431141|NCT03754153|Atropine|atropine|mesh-list
139431142|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139431143|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139431144|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139431145|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
139431146|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431147|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431148|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139431149|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
139431150|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
139431151|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
139431152|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139431153|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139431154|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
139431155|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431156|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431157|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
139431158|NCT03380039|Fludarabine|fludarabine|mesh-list
139431159|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139431160|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
139431161|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431162|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139431163|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139431164|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
138865671|NCT00652821|Narcotics|narcotics|mesh-ancestor
139431165|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431166|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431167|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139431168|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139431169|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
139431170|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431171|NCT02520817|Vitamins|vitamins|mesh-list
139431172|NCT02520817|Vitamin E|vitamin e|mesh-list
139431173|NCT02520817|Vitamin A|vitamin a|mesh-list
139431174|NCT02520817|Lactulose|lactulose|mesh-list
139431175|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
139431176|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431177|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
139431178|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431179|NCT02520817|Protective Agents|protective agents|mesh-ancestor
139431180|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139431181|NCT03387943|Cisplatin|cisplatin|mesh-list
139431182|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431183|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
139431184|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139431185|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
139431186|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431187|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
139431188|NCT03384095|Protective Agents|protective agents|mesh-ancestor
139431189|NCT03379181|Propranolol|propranolol|mesh-list
139431190|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139431191|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139431192|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
139431193|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431194|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431195|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431196|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139431197|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139431198|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
139431199|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139431200|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139431201|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139431202|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
139431203|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431204|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431205|NCT03379103|Propofol|propofol|mesh-list
139431206|NCT03379103|Sevoflurane|sevoflurane|mesh-list
139431207|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139431208|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431209|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431210|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139431211|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
139431212|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
139217954|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
139431213|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139431214|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139431215|NCT03387631|Lumefantrine|lumefantrine|mesh-list
139431216|NCT03387631|Artemether|artemether|mesh-list
139431217|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139431218|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
139431219|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139431220|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139431221|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431222|NCT03383393|Adenosine|adenosine|mesh-list
139431223|NCT03383393|Eptifibatide|eptifibatide|mesh-list
139431224|NCT03383393|Analgesics|analgesics|mesh-ancestor
139431225|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
139431226|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431227|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431228|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139431229|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
139431230|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139431231|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
139431232|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
139431233|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431234|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431235|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139431236|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
139431237|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
139431238|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
139431239|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431240|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431241|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
139431242|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431243|NCT03383315|Tramadol|tramadol|mesh-list
139431244|NCT03383315|Metoclopramide|metoclopramide|mesh-list
139431245|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139431246|NCT03383315|Narcotics|narcotics|mesh-ancestor
139431247|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431248|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431249|NCT03383315|Analgesics|analgesics|mesh-ancestor
139431250|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
139431251|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431252|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
139431253|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
139431254|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139431255|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139431256|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139431257|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
139431258|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431259|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431260|NCT03394729|Propolis|propolis|mesh-list
139431261|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431262|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
139431263|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139431264|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
139431265|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431266|NCT03252925|Expectorants|expectorants|mesh-ancestor
139431267|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
139431268|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139431269|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
139431270|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431271|NCT03252925|Protective Agents|protective agents|mesh-ancestor
139431272|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431273|NCT03252925|Antidotes|antidotes|mesh-ancestor
139431274|NCT03383237|Apatinib|apatinib|mesh-list
139431275|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431276|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139431277|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431278|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431279|NCT03387241|Fluticasone|fluticasone|mesh-list
139431280|NCT03387241|Xhance|xhance|mesh-list
139431281|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
139431282|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139431283|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139431284|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139431285|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139431286|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
139431287|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431288|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431289|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139431290|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
139431291|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
139431292|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139431293|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139431294|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139431295|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139431296|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
139431297|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431298|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431299|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
139431300|NCT03387241|Hormones|hormones|mesh-ancestor
139431301|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139431302|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
139431303|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
139431304|NCT03378791|Trace Elements|trace elements|mesh-ancestor
139431305|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
139431306|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431307|NCT03383003|Amoxicillin|amoxicillin|mesh-list
139431308|NCT03383003|Metronidazole|metronidazole|mesh-list
139431309|NCT03383003|Clarithromycin|clarithromycin|mesh-list
139431310|NCT03383003|Esomeprazole|esomeprazole|mesh-list
139431311|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139431312|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431313|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139431314|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139431315|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139431316|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139431317|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139431318|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431319|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431320|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139431321|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139431322|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139431323|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
139431324|NCT03378713|Testosterone|testosterone|mesh-list
139431325|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
139431326|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
139431327|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139431328|NCT03378713|Androgens|androgens|mesh-ancestor
139431329|NCT03378713|Hormones|hormones|mesh-ancestor
139431330|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139431331|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431332|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139431333|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431334|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
139431335|NCT03378323|Anesthetics|anesthetics|mesh-list
139431336|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
139431337|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431338|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431339|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
139431340|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431341|NCT03378401|Octenidine|octenidine|mesh-list
139431342|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431343|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139431344|NCT01327885|Dacarbazine|dacarbazine|mesh-list
139431345|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139431346|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
139431347|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431348|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431349|NCT03381833|Hepcidins|hepcidins|mesh-list
139431350|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431351|NCT02976337|Naloxone|naloxone|mesh-list
139431352|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139431353|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431354|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
139431355|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431356|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139431357|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
139431358|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
139431359|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431360|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431361|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431362|NCT03381755|Ticagrelor|ticagrelor|mesh-list
139431363|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139431364|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139431365|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139431366|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139431367|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
139431368|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431369|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431370|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431371|NCT03387163|Valsartan|valsartan|mesh-list
139431372|NCT03387163|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139431373|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139431374|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139431375|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139431376|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431377|NCT04446403|Anesthetics|anesthetics|mesh-list
139431378|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431379|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431380|NCT05237791|Magnesium Sulfate|magnesium sulfate|mesh-list
139431381|NCT05237791|Analgesics|analgesics|mesh-ancestor
139431382|NCT05237791|Sensory System Agents|sensory system agents|mesh-ancestor
139431383|NCT05237791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431384|NCT05237791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431385|NCT05237791|Anesthetics|anesthetics|mesh-ancestor
139431386|NCT05237791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431387|NCT05237791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139431388|NCT05237791|Anticonvulsants|anticonvulsants|mesh-ancestor
139431389|NCT05237791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139431390|NCT05237791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139431391|NCT05237791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431392|NCT05237791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139431393|NCT05237791|Tocolytic Agents|tocolytic agents|mesh-ancestor
139431394|NCT05237791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139431395|NCT03381599|Lenograstim|lenograstim|mesh-list
139431396|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139431397|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
139431398|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431399|NCT03394573|Aflibercept|aflibercept|mesh-list
139431400|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139431401|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139431402|NCT03394573|Growth Substances|growth substances|mesh-ancestor
139431403|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431404|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
139431405|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431406|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
139431407|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431408|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139431409|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431410|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431411|NCT03380975|Montelukast|montelukast|mesh-list
139431412|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139431413|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
139431414|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139431415|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
139431416|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139431417|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431418|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139431419|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139431420|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431421|NCT03460015|Propofol|propofol|mesh-list
139431422|NCT03460015|Sevoflurane|sevoflurane|mesh-list
139431423|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139431424|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431425|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431426|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139431427|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
139431428|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
139431429|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139431430|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139431431|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
139431432|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139431433|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431434|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139431435|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139431436|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
139431437|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431438|NCT03375515|Hydromorphone|hydromorphone|mesh-list
139431439|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139431440|NCT03375515|Narcotics|narcotics|mesh-ancestor
139431441|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431442|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431443|NCT03375515|Analgesics|analgesics|mesh-ancestor
139431444|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
139431445|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431446|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
139431447|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139431448|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431449|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139431450|NCT03374501|PAZ320|paz320|mesh-list
139431451|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139431452|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431453|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
139431454|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431455|NCT03374345|Mitogens|mitogens|mesh-ancestor
139431456|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
139431457|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431458|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
139431459|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139431460|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431461|NCT03373955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139431462|NCT03373955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431463|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
139431464|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
139431465|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431466|NCT02814695|Protective Agents|protective agents|mesh-ancestor
139431467|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431468|NCT02814695|Vitamins|vitamins|mesh-ancestor
139431469|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
139431470|NCT03386305|Tacrolimus|tacrolimus|mesh-list
139431471|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139431472|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
139431473|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431474|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139431475|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431476|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431477|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139431478|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431479|NCT05237323|Mycophenolic Acid|mycophenolic acid|mesh-list
139431480|NCT05237323|Azathioprine|azathioprine|mesh-list
139431481|NCT05237323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139431482|NCT05237323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431483|NCT05237323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139431484|NCT05237323|Antitubercular Agents|antitubercular agents|mesh-ancestor
139431485|NCT05237323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139431486|NCT05237323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431487|NCT05237323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431488|NCT05237323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431489|NCT05237323|Antimetabolites|antimetabolites|mesh-ancestor
139431490|NCT05237323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139431491|NCT05237323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139431492|NCT05237323|Immunologic Factors|immunologic factors|mesh-ancestor
139431493|NCT05237323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431494|NCT05237323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139431495|NCT02520505|Citric Acid|citric acid|mesh-list
139431496|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
139431497|NCT02520505|Clomiphene|clomiphene|mesh-list
139431498|NCT02520505|Enclomiphene|enclomiphene|mesh-list
139431499|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
139431500|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
139431501|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139431502|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
139431503|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
139431504|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431505|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139431506|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
139431507|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139431508|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431509|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139431510|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
139431511|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139431512|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139431513|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139431514|NCT03380689|Bevacizumab|bevacizumab|mesh-list
139431515|NCT03380689|Irinotecan|irinotecan|mesh-list
139431516|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139431517|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431518|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139431519|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139431520|NCT03380689|Growth Substances|growth substances|mesh-ancestor
139431521|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431522|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
139431523|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139431524|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139431525|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431526|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431527|NCT03380533|Buprenorphine|buprenorphine|mesh-list
139431528|NCT03380533|Tramadol|tramadol|mesh-list
139431529|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139431530|NCT03380533|Narcotics|narcotics|mesh-ancestor
139431531|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866038|NCT02693210|Rituximab|rituximab|mesh-list
139431532|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431533|NCT03380533|Analgesics|analgesics|mesh-ancestor
139431534|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
139431535|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431536|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139431537|NCT03386149|Loxoprofen|loxoprofen|mesh-list
139431538|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139431539|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139431540|NCT03386149|Analgesics|analgesics|mesh-ancestor
139431541|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
139431542|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431543|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431544|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139431545|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139431546|NCT03386071|Trametinib|trametinib|mesh-list
139431547|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431548|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139431549|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431550|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431551|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
139431552|NCT03231085|Trace Elements|trace elements|mesh-ancestor
139431553|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
139431554|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431555|NCT03385135|Allopurinol|allopurinol|mesh-list
139431556|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
139431557|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431558|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431559|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
139431560|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139431561|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139431562|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
139431563|NCT03385135|Protective Agents|protective agents|mesh-ancestor
139431564|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431565|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
139431566|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139431567|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431568|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139431569|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431570|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431571|NCT04436965|Cisplatin|cisplatin|mesh-list
139431572|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431573|NCT04420741|Iloprost|iloprost|mesh-list
139431574|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139431575|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
139431576|NCT04409041|Naltrexone|naltrexone|mesh-list
139431577|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139431578|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139431579|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431580|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
139431581|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431582|NCT03090997|Vitamins|vitamins|mesh-list
139431583|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
139431584|NCT03090997|Resveratrol|resveratrol|mesh-list
139431585|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
139431586|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431587|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
139431588|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431589|NCT03090997|Protective Agents|protective agents|mesh-ancestor
139431590|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218331|NCT03255148|Oxytocin|oxytocin|mesh-list
139431591|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139431593|NCT04446091|Apatinib|apatinib|mesh-list
139431594|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
139431595|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139431596|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139431597|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431598|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431599|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431600|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139431601|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139431602|NCT04446091|Growth Substances|growth substances|mesh-ancestor
139431603|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431604|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
139431605|NCT04445935|Bivalirudin|bivalirudin|mesh-list
139431606|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
139382348|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139431607|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139431608|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
139431609|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431610|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431611|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
139431612|NCT03385057|Acetaminophen|acetaminophen|mesh-list
139431613|NCT03385057|Ibuprofen|ibuprofen|mesh-list
139431614|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139431615|NCT03385057|Analgesics|analgesics|mesh-ancestor
139431616|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
139431617|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431618|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431619|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
139431620|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139431621|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139431622|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139431623|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139431624|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431625|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431626|NCT02051309|Guanfacine|guanfacine|mesh-list
139431627|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139431628|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139431629|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139431630|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139431631|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
139431632|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431633|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431634|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431635|NCT00372073|Roscovitine|roscovitine|mesh-list
139431636|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431637|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
139431638|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431639|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139431640|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431641|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431642|NCT03373409|Albuterol|albuterol|mesh-list
139431643|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139431644|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
139431645|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431646|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431647|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139431648|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
139431649|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
139431650|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139431651|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139431652|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139431653|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139431654|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
139431655|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431656|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431657|NCT03379987|Morphine|morphine|mesh-list
139431658|NCT03379987|Bupivacaine|bupivacaine|mesh-list
139431659|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
139431660|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
139431661|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431662|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431663|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
139218402|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139431664|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431665|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139431666|NCT03379987|Narcotics|narcotics|mesh-ancestor
139431667|NCT03379987|Analgesics|analgesics|mesh-ancestor
139431668|NCT02730793|Aztreonam|aztreonam|mesh-list
139431669|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139431670|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431671|NCT02678533|Plerixafor|plerixafor|mesh-list
139431672|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139431673|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139431674|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
139431675|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431676|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
139431677|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139431678|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431679|NCT03379441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139431680|NCT03379441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431681|NCT03384511|Apatinib|apatinib|mesh-list
139431682|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431683|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139431684|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431685|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431686|NCT03385525|Valproic Acid|valproic acid|mesh-list
139431687|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
139431688|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431689|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431690|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
139431691|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431692|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431693|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
139431694|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139431695|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431696|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139431697|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
139431698|NCT05172739|Anesthetics|anesthetics|mesh-list
139431699|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431700|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431701|NCT05172739|Narcotics|narcotics|mesh-ancestor
139431702|NCT05172739|Analgesics|analgesics|mesh-ancestor
139431703|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
139431704|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431705|NCT03375463|Tirzepatide|tirzepatide|mesh-list
139431706|NCT03375463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139431707|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431708|NCT03375463|Incretins|incretins|mesh-ancestor
139431709|NCT03375463|Hormones|hormones|mesh-ancestor
139431710|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139431711|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139431712|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139431713|NCT04445311|Ivermectin|ivermectin|mesh-list
139431714|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139431715|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431716|NCT03384121|Rifampin|rifampin|mesh-list
139431717|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139431718|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
139431719|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139431720|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431721|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
139431722|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139431723|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431724|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431725|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139431726|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139431727|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139431728|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139431729|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139431730|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139431731|NCT03378661|Benzonidazole|benzonidazole|mesh-list
139431732|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139431733|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
139431734|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431735|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139431736|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139431737|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139431738|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218478|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431739|NCT03378427|Doxycycline|doxycycline|mesh-list
139431740|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
139431741|NCT03378427|Levofloxacin|levofloxacin|mesh-list
139431742|NCT03378427|Ofloxacin|ofloxacin|mesh-list
139431743|NCT03378427|Minocycline|minocycline|mesh-list
139431744|NCT03378427|Rifampin|rifampin|mesh-list
139431745|NCT03378427|Clindamycin|clindamycin|mesh-list
139431746|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139431747|NCT03378427|Tedizolid|tedizolid|mesh-list
139431748|NCT03378427|Teicoplanin|teicoplanin|mesh-list
139431749|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
139431750|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
139431751|NCT03378427|Trimethoprim|trimethoprim|mesh-list
139431752|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
139431753|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139431754|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431755|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
139431756|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139431757|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139431758|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139431759|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139431760|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431761|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431762|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431763|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139431764|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139431765|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139431766|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139431767|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
139431768|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
139431769|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139431770|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139431771|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139431772|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139431773|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139431774|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139431775|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139431776|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139431777|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139431778|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139431779|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139431780|NCT05172115|Heparin|heparin|mesh-list
139431781|NCT05172115|Enoxaparin|enoxaparin|mesh-list
139431782|NCT05172115|Plasminogen|plasminogen|mesh-list
139431783|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139431784|NCT05172115|Tinzaparin|tinzaparin|mesh-list
139431785|NCT05172115|Dalteparin|dalteparin|mesh-list
139431786|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139431787|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
139431788|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139431789|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139431790|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431791|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139431792|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
139431793|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
139431794|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
139431795|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139431796|NCT03383185|Progestins|progestins|mesh-list
139431797|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139431798|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431799|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139431800|NCT03383185|Hormones|hormones|mesh-ancestor
139431801|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139431802|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139431803|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139431804|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139431805|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139431806|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139431807|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431808|NCT03374293|Antibodies|antibodies|mesh-list
139431809|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
139431810|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431811|NCT02730871|Timolol|timolol|mesh-list
139431812|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139431813|NCT02730871|Travoprost|travoprost|mesh-list
139431814|NCT02730871|Brinzolamide|brinzolamide|mesh-list
139431815|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139431816|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139431817|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
139431818|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431819|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431820|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431821|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139431822|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139431823|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139431824|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139431825|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139431826|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139431827|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431828|NCT03377335|Metformin|metformin|mesh-list
139431829|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
139431830|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139431831|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431832|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139431833|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431834|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
139431835|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
139431836|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139431837|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139431838|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
139431839|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431840|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431841|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431842|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431843|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139431844|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431845|NCT03373903|Everolimus|everolimus|mesh-list
139431846|NCT03373903|Dactolisib|dactolisib|mesh-list
139431847|NCT03373903|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139431848|NCT03373903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139431849|NCT03373903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431850|NCT03373903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431851|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139431852|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
139431853|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431854|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431855|NCT04445857|Calcitonin|calcitonin|mesh-list
139431856|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
139431857|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139431858|NCT04445857|Katacalcin|katacalcin|mesh-list
139431859|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139431860|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431861|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139431862|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
139431863|NCT03373825|Fentanyl|fentanyl|mesh-list
139431864|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139431865|NCT03373825|Narcotics|narcotics|mesh-ancestor
139431866|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431867|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431868|NCT03373825|Analgesics|analgesics|mesh-ancestor
139431869|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
139431870|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431871|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139431872|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139431873|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
139431874|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
139431875|NCT04445779|Ubiquinone|ubiquinone|mesh-list
139431876|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
139431877|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
139431878|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431879|NCT04445779|Vitamins|vitamins|mesh-ancestor
139431880|NCT03377101|Fulvestrant|fulvestrant|mesh-list
139431881|NCT03377101|Palbociclib|palbociclib|mesh-list
139431882|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139431883|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431884|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139431885|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139431886|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
139431887|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139431888|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431889|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139431890|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431891|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431892|NCT04445467|Favipiravir|favipiravir|mesh-list
139431893|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
139431894|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431895|NCT03373669|Vaccines|vaccines|mesh-list
139431896|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
139431897|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431898|NCT03382717|Amorolfine|amorolfine|mesh-list
139431899|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
139431900|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431901|NCT03125473|Vaccines|vaccines|mesh-list
139431902|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
139431903|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431904|NCT03376789|MYL-1501D|myl-1501d|mesh-list
139431905|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139431906|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431907|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
139431908|NCT03376555|Acetylcholine|acetylcholine|mesh-list
139431909|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
139431910|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139431911|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
139431912|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431913|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431914|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431915|NCT03376243|Emollients|emollients|mesh-list
139431916|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
139431917|NCT03381859|Grazoprevir|grazoprevir|mesh-list
139431918|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139431919|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
139431920|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431921|NCT03381781|Cytarabine|cytarabine|mesh-list
139431922|NCT03381781|Decitabine|decitabine|mesh-list
139431923|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
139431924|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139431925|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
139431926|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431927|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431928|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
139431929|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139431930|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139431931|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
139431932|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431933|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431934|NCT03381703|YH12852|yh12852|mesh-list
139431935|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139431936|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139431937|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
139431938|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431939|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431940|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431941|NCT03372265|Ropivacaine|ropivacaine|mesh-list
139431942|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
139431943|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
139431944|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139431945|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431946|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
139431947|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431948|NCT03372109|Calcium|calcium|mesh-list
139431949|NCT03372109|Turmeric extract|turmeric extract|mesh-list
139431950|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139431951|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431952|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
139431953|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431954|NCT03372109|Protective Agents|protective agents|mesh-ancestor
139431955|NCT03371953|Atracurium|atracurium|mesh-list
139431956|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
139431957|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139431958|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139431959|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139431960|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431961|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431962|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139431963|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139431964|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
139431965|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139431966|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431967|NCT03371797|Amlodipine|amlodipine|mesh-list
139431968|NCT03371797|Valsartan|valsartan|mesh-list
139431969|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139431970|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139431971|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139431972|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431973|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139431974|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431975|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
139431976|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139431977|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139431978|NCT02520115|Dexamethasone|dexamethasone|mesh-list
139431979|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
139431980|NCT02520115|Valproic Acid|valproic acid|mesh-list
139431981|NCT02520115|Ichthammol|ichthammol|mesh-list
139431982|NCT02520115|BB 1101|bb 1101|mesh-list
139431983|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139431984|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
139431985|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
139431986|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139431987|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139431988|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139431989|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
139431990|NCT02520115|Hormones|hormones|mesh-ancestor
139431991|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139431992|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139431993|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139431994|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
139431995|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139431996|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139431997|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
139431998|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
139431999|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432000|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
139432001|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139432002|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432003|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139432004|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
139432005|NCT03375775|Immunomodulating Agents|immunomodulating agents|mesh-list
139432006|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
139432007|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432008|NCT04527133|Aprotinin|aprotinin|mesh-list
139432009|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
139432010|NCT04527133|Coagulants|coagulants|mesh-ancestor
139432011|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139432012|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139432013|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
139432014|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432015|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432016|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139432017|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139432018|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139432019|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
139432020|NCT03369847|Budesonide|budesonide|mesh-list
139432021|NCT03369847|Beclomethasone|beclomethasone|mesh-list
139432022|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139432023|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139432024|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
139432025|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432026|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432027|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139432028|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
139432029|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
139432030|NCT03369847|Hormones|hormones|mesh-ancestor
139432031|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139432032|NCT04526353|Oxybutynin|oxybutynin|mesh-list
139432033|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
139432034|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
139432035|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432036|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432037|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139432038|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139432039|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
139432040|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432041|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218775|NCT00238420|Antibodies|antibodies|mesh-list
139432043|NCT03371173|Ferric maltol|ferric maltol|mesh-list
139432044|NCT03371173|Hematinics|hematinics|mesh-ancestor
139432045|NCT03371095|Infliximab|infliximab|mesh-list
139432046|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
139432047|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139432048|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
139432049|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432050|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139432051|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139432052|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
139432053|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432054|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432055|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139432056|NCT03371095|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139432057|NCT03371095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139432058|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
139432059|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139432060|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139432061|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139432062|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
139432063|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139432064|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139432065|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139432066|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139432067|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432068|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432069|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432070|NCT03370861|Immunomodulating Agents|immunomodulating agents|mesh-list
139432071|NCT03370861|Immunologic Factors|immunologic factors|mesh-ancestor
139432072|NCT03370861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432073|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
139432074|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
139432075|NCT03370705|Captopril|captopril|mesh-list
139432076|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139432077|NCT03370705|Atorvastatin|atorvastatin|mesh-list
139432078|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139432079|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139432080|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139432081|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
139432082|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432083|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139432084|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139432085|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432086|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
139432087|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139432088|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
139432089|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139432090|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139432091|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139432092|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432093|NCT03370705|Analgesics|analgesics|mesh-ancestor
139432094|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
139432095|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432096|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139432097|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139432098|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139432099|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139432100|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139432101|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
139432102|NCT03369379|Vitamins|vitamins|mesh-ancestor
139432103|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
139432104|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432105|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139432106|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139432107|NCT03362905|Lidocaine|lidocaine|mesh-list
139432108|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
139432109|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
139432110|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432111|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432112|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
139432113|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432114|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139218851|NCT03119428|Nivolumab|nivolumab|mesh-list
139432115|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139432116|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139432117|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139432118|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432119|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
139432120|NCT03370159|Docetaxel|docetaxel|mesh-list
139432121|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432122|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
139432123|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
139432124|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
139432125|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432126|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
139432127|NCT03370159|Protective Agents|protective agents|mesh-ancestor
139432128|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432129|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
139432130|NCT03370159|Vitamins|vitamins|mesh-ancestor
139432131|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
139432132|NCT04522297|Octreotide|octreotide|mesh-list
139432133|NCT04522297|Epinephrine|epinephrine|mesh-list
139432134|NCT04522297|Midodrine|midodrine|mesh-list
139432135|NCT04522297|Norepinephrine|norepinephrine|mesh-list
139432136|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139432137|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139432138|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
139432139|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432140|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432141|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432142|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139432143|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139432144|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
139432145|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432146|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139432147|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
139432148|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
139432149|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
139432150|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139432151|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139432152|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139432153|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432154|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139432155|NCT03369067|Insulin|insulin|mesh-list
139432156|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139432157|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139432158|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432159|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139432160|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432161|NCT04525729|Rituximab|rituximab|mesh-list
139432162|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139432163|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432164|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
139432165|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432166|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139432167|NCT04525495|Dopamine|dopamine|mesh-list
139432168|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139432169|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
139432170|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
139432171|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432172|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432173|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
139432174|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432175|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432176|NCT04525495|Protective Agents|protective agents|mesh-ancestor
139432177|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139432178|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432179|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139432180|NCT03362281|Amoxicillin|amoxicillin|mesh-list
139432181|NCT03362281|Clarithromycin|clarithromycin|mesh-list
139432182|NCT03362281|Omeprazole|omeprazole|mesh-list
139432183|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139432184|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139432185|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139432186|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139432187|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139432188|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432189|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432190|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139218937|NCT02450968|Hormones|hormones|mesh-ancestor
139432191|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139432192|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139432194|NCT02518789|Fentanyl|fentanyl|mesh-list
139432195|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
139432196|NCT02518789|Remifentanil|remifentanil|mesh-list
139432197|NCT02518789|Propofol|propofol|mesh-list
139432198|NCT02518789|Etomidate|etomidate|mesh-list
139432199|NCT02518789|Atracurium|atracurium|mesh-list
139432200|NCT02518789|Rocuronium|rocuronium|mesh-list
139432201|NCT02518789|Cisatracurium|cisatracurium|mesh-list
139432202|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139432203|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432204|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432205|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139432206|NCT02518789|Analgesics|analgesics|mesh-ancestor
139432207|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
139432208|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432209|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139432210|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139432211|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139432212|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
139432213|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432214|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432215|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139432216|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
139432217|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
139432218|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139432219|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139432220|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139432221|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139432222|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
139432223|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
139432224|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139432225|NCT02518789|Narcotics|narcotics|mesh-ancestor
139432226|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139432227|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139432228|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139432229|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139432230|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139432231|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
139432232|NCT02929485|Bromocriptine|bromocriptine|mesh-list
139432233|NCT02929485|Tolcapone|tolcapone|mesh-list
139432234|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139432235|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139432236|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
139432237|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139432238|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432239|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
139432240|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
139432241|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432242|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432243|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139432244|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432245|NCT04523623|Ibuprofen|ibuprofen|mesh-list
139432246|NCT04523623|Oxycodone|oxycodone|mesh-list
139432247|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139432248|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139432249|NCT04523623|Analgesics|analgesics|mesh-ancestor
139432250|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
139432251|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432252|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432253|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139432254|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139432255|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139432256|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432257|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432258|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139432259|NCT04523623|Narcotics|narcotics|mesh-ancestor
139432260|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432261|NCT03357289|Immunomodulating Agents|immunomodulating agents|mesh-list
139432262|NCT03357289|Immunologic Factors|immunologic factors|mesh-ancestor
139432263|NCT03357289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432264|NCT03368131|Capecitabine|capecitabine|mesh-list
139432265|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
139432266|NCT03368131|Trastuzumab|trastuzumab|mesh-list
139219005|NCT01561937|Warfarin|warfarin|mesh-list
139432268|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
139432269|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432270|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432271|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139432272|NCT04521751|Acarbose|acarbose|mesh-list
139432273|NCT04521751|Orlistat|orlistat|mesh-list
139432274|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139432275|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432276|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432277|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138866788|NCT00667641|Paclitaxel|paclitaxel|mesh-list
139432278|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432279|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139432280|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139432281|NCT04521517|Imidacloprid|imidacloprid|mesh-list
139432282|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
139432283|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432284|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432285|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432286|NCT01675167|Buprenorphine|buprenorphine|mesh-list
139432287|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139432288|NCT01675167|Narcotics|narcotics|mesh-ancestor
139432289|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432290|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432291|NCT01675167|Analgesics|analgesics|mesh-ancestor
139432292|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
139432293|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432294|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139432295|NCT03370627|Antibodies|antibodies|mesh-list
139432296|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
139432297|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432298|NCT03367663|Prednisone|prednisone|mesh-list
139432299|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139432300|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
139432301|NCT03367663|Hormones|hormones|mesh-ancestor
139432302|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139432303|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432304|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139432305|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432306|NCT03123289|Gallium citrate|gallium citrate|mesh-list
139432307|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432308|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139432309|NCT04521049|Saxagliptin|saxagliptin|mesh-list
139432310|NCT04521049|Incretins|incretins|mesh-ancestor
139432311|NCT04521049|Hormones|hormones|mesh-ancestor
139432312|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139432313|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432314|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139432315|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
139432316|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432317|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432318|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139432319|NCT02267343|Nivolumab|nivolumab|mesh-list
139432320|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139432321|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432322|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139432323|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432324|NCT03123445|Gemcitabine|gemcitabine|mesh-list
139432325|NCT03123445|Endostar protein|endostar protein|mesh-list
139432326|NCT03123445|Endostatins|endostatins|mesh-list
139432327|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432328|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139432329|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
139432330|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432331|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139432332|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139432333|NCT03123445|Growth Substances|growth substances|mesh-ancestor
139432334|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432335|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
139432336|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139432337|NCT03357133|Tirofiban|tirofiban|mesh-list
139432338|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139432339|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139432340|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432341|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139432342|NCT03357055|Ketamine|ketamine|mesh-list
139432343|NCT03357055|Analgesics|analgesics|mesh-ancestor
139432344|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
139432345|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432346|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432347|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139432348|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139432349|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
139432350|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
139432351|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432352|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139432353|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139432354|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432355|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432356|NCT03367585|Vitamin D|vitamin d|mesh-list
139432357|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
139432358|NCT03367585|Vitamins|vitamins|mesh-ancestor
139432359|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
139432360|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432361|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139432362|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139432363|NCT03360955|Anesthetics|anesthetics|mesh-list
139432364|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432365|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432366|NCT00584025|Levetiracetam|levetiracetam|mesh-list
139432367|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
139432368|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
139432369|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
139432370|NCT01735461|Calcium|calcium|mesh-list
139432371|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139432372|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432373|NCT01735461|Antacids|antacids|mesh-ancestor
139432374|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432375|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139432376|NCT01595841|Sirolimus|sirolimus|mesh-list
139432377|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139432378|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139432379|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139432380|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432381|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
139432382|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139432383|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
139432384|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432385|NCT05405049|Lidocaine|lidocaine|mesh-list
139432386|NCT05405049|Fentanyl|fentanyl|mesh-list
139432387|NCT05405049|Morphine|morphine|mesh-list
139432388|NCT05405049|Bupivacaine|bupivacaine|mesh-list
139432389|NCT05405049|Anesthetics, Local|anesthetics, local|mesh-ancestor
139432390|NCT05405049|Anesthetics|anesthetics|mesh-ancestor
139432391|NCT05405049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432392|NCT05405049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432393|NCT05405049|Sensory System Agents|sensory system agents|mesh-ancestor
139432394|NCT05405049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432395|NCT05405049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139432396|NCT05405049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139432397|NCT05405049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139432398|NCT05405049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139432399|NCT05405049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432400|NCT05405049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139432401|NCT05405049|Narcotics|narcotics|mesh-ancestor
139432402|NCT05405049|Analgesics|analgesics|mesh-ancestor
139432403|NCT05405049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139432404|NCT05405049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139432405|NCT05405049|Anesthetics, General|anesthetics, general|mesh-ancestor
139432406|NCT02871843|Temozolomide|temozolomide|mesh-list
139432407|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139432408|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
139432409|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432410|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432411|NCT03356899|Bupivacaine|bupivacaine|mesh-list
139432412|NCT03356899|Anesthetics|anesthetics|mesh-list
139432413|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
139219160|NCT02451748|Hormones|hormones|mesh-ancestor
139432414|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432416|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
139432417|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432418|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
139432419|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
139432420|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139432421|NCT04523467|Growth Substances|growth substances|mesh-ancestor
139432422|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432423|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
139432424|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432425|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139432426|NCT02801097|Irinotecan|irinotecan|mesh-list
139432427|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139432428|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139432429|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432430|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432431|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432432|NCT03367195|Omeprazole|omeprazole|mesh-list
139432433|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139432434|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139432435|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139432436|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432437|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432438|NCT05123781|Metformin|metformin|mesh-list
139432439|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139432440|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432441|NCT04523233|Vitamins|vitamins|mesh-list
139432442|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
139432443|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432444|NCT05127369|Fluoxetine|fluoxetine|mesh-list
139432445|NCT05127369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139432446|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139432447|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139432448|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432449|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432450|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
139432451|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432452|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139432453|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
139432454|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139432455|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139432456|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139432457|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432458|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
139432459|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432460|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
139432461|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139432462|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139432463|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432464|NCT03356353|Urological Agents|urological agents|mesh-ancestor
139432465|NCT04520035|Paclitaxel|paclitaxel|mesh-list
139432466|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139432467|NCT04520035|Cisplatin|cisplatin|mesh-list
139432468|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139432469|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432470|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
139432471|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
139432472|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
139432473|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432474|NCT04208997|Amiodarone|amiodarone|mesh-list
139432475|NCT04208997|Sotalol|sotalol|mesh-list
139432476|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139432477|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
139432478|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139432479|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139432480|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432481|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139432482|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139432483|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139432484|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432485|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139432486|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139432487|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139432488|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139432489|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139432490|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
139432491|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432492|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432493|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
139432494|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
139432495|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432496|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
139432497|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139432498|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139432499|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139432500|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139432501|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432502|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
139432503|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432504|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432505|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139432506|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432507|NCT04518475|Rituximab|rituximab|mesh-list
139432508|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139432509|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432510|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
139432511|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432512|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139432513|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139432514|NCT04278651|Hematinics|hematinics|mesh-ancestor
139432515|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139432516|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139432517|NCT05125575|Metformin|metformin|mesh-list
139432518|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139432519|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432520|NCT03366883|Paclitaxel|paclitaxel|mesh-list
139432521|NCT03366883|Cisplatin|cisplatin|mesh-list
139432522|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139432523|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432524|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
139432525|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
139432526|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
139432527|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432528|NCT03366571|Entecavir|entecavir|mesh-list
139432529|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
139432530|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139432531|NCT05124951|Carboplatin|carboplatin|mesh-list
139432532|NCT05124951|Etoposide|etoposide|mesh-list
139432533|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
139432534|NCT05124951|Ifosfamide|ifosfamide|mesh-list
139432535|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432536|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139432537|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139432538|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139432539|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432540|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432541|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139432542|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
139432543|NCT04523077|Antibodies|antibodies|mesh-list
139432544|NCT04523077|Hormones|hormones|mesh-list
139432545|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
139432546|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432547|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139432548|NCT05124717|Metformin|metformin|mesh-list
139432549|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139432550|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432551|NCT04139655|Colchicine|colchicine|mesh-list
139432552|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
139432553|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139432554|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
139432555|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
139432556|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
139432557|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432558|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432559|NCT03366259|Misoprostol|misoprostol|mesh-list
139432560|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139432561|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
139432562|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139432579|NCT05403099|Viscosupplements|viscosupplements|mesh-ancestor
139432580|NCT05403099|Protective Agents|protective agents|mesh-ancestor
139432581|NCT03365869|Sirolimus|sirolimus|mesh-list
139432582|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139432583|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139432584|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139432585|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432586|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
139432587|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139432588|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
139432589|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432590|NCT04932213|Tropicamide|tropicamide|mesh-list
139432591|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
139432592|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
139432593|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432594|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432595|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139432596|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139432597|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
139432598|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432599|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432618|NCT03365479|Iloprost|iloprost|mesh-list
139432619|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139432620|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
139432621|NCT03355027|Atorvastatin|atorvastatin|mesh-list
139432622|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139432623|NCT03355027|Simvastatin|simvastatin|mesh-list
139432624|NCT03355027|Ezetimibe|ezetimibe|mesh-list
139432625|NCT03355027|Alirocumab|alirocumab|mesh-list
139432626|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139432627|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139432628|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
139432629|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432630|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139432631|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139432632|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432633|NCT03355027|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139432634|NCT03355027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139432635|NCT03355027|Protease Inhibitors|protease inhibitors|mesh-ancestor
139432636|NCT03828045|Apremilast|apremilast|mesh-list
139432637|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139432638|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139432639|NCT03828045|Analgesics|analgesics|mesh-ancestor
139432640|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
139432641|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432642|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432643|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139432644|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139432645|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139432646|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139432647|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432648|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432649|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
139432650|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139432651|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432652|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139432653|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
139432654|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139432655|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
139432656|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432657|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
139432659|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432660|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139432661|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139432662|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139432663|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432664|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432665|NCT02519335|Protective Agents|protective agents|mesh-ancestor
139432666|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432667|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
139432668|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
139432669|NCT04509583|Vitamin E|vitamin e|mesh-list
139432670|NCT04509583|Vitamins|vitamins|mesh-ancestor
139432671|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
139432672|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432673|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
139432674|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432675|NCT04509583|Protective Agents|protective agents|mesh-ancestor
139432676|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
139432677|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
139432678|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432679|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432680|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139432681|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
139432682|NCT03350737|Heparin|heparin|mesh-list
139432683|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
139432684|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139432685|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139432686|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432687|NCT03350659|Midodrine|midodrine|mesh-list
139432688|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139432689|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139432690|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139432691|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139432692|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432693|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
139432694|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432695|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432696|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
139432697|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
139432698|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432699|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139432700|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139432701|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139432702|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139432703|NCT04443517|Propofol|propofol|mesh-list
139432704|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
139432705|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432706|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432707|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139432708|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139432709|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
139432710|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
139432711|NCT03350347|Hematinics|hematinics|mesh-ancestor
139432712|NCT03350191|Exenatide|exenatide|mesh-list
139432713|NCT03350191|Glucagon|glucagon|mesh-list
139432714|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139432715|NCT03350191|Hormones|hormones|mesh-ancestor
139432716|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139432717|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432718|NCT03350191|Incretins|incretins|mesh-ancestor
139432719|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139432720|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139432721|NCT02649231|Ketamine|ketamine|mesh-list
139432722|NCT02649231|Analgesics|analgesics|mesh-ancestor
139432723|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
139432724|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432725|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432726|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139432727|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139432728|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
139432729|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
139432730|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432731|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139432732|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139432733|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432734|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432735|NCT03364075|Propranolol|propranolol|mesh-list
139432736|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139432737|NCT03364075|Serotonin|serotonin|mesh-list
139432738|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139432739|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139432740|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139432741|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432742|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432743|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432744|NCT03364075|Analgesics|analgesics|mesh-ancestor
139432745|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
139432746|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432747|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
139432748|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139432749|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
139432750|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139432751|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139432752|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
139432753|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139432754|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139432755|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
139432756|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139432757|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
139432758|NCT03349957|Idarubicin|idarubicin|mesh-list
139432759|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139432760|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432761|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139432762|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139432763|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432764|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432765|NCT04524169|Thymalfasin|thymalfasin|mesh-list
139432766|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139432767|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
139432768|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432769|NCT03568929|Idelalisib|idelalisib|mesh-list
139432770|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432771|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432772|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432773|NCT04503967|Nivolumab|nivolumab|mesh-list
139432774|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139432775|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432776|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139432777|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432778|NCT04841499|Niacinamide|niacinamide|mesh-list
139432780|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
139432781|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
139432782|NCT04841499|Vitamins|vitamins|mesh-ancestor
139432783|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
139432784|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432785|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139432786|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
139432787|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432788|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139432789|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
139432790|NCT04773405|Lidocaine|lidocaine|mesh-list
139432791|NCT04773405|Epinephrine|epinephrine|mesh-list
139432792|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
139432793|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
139432794|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
139432795|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432796|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432797|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
139432798|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432799|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139432800|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139432801|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139432802|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139432803|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432804|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139432805|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139432806|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
139432807|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432808|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139432809|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139432810|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
139432811|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139432812|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
139432813|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
139432814|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
139432815|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139432816|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
139432817|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139432818|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432819|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139432820|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432821|NCT01376245|Fluticasone|fluticasone|mesh-list
139432822|NCT01376245|Xhance|xhance|mesh-list
139432823|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139432824|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139432825|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
139432826|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432827|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432828|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139432829|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
139432830|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
139432831|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139432832|NCT03349489|Insulin|insulin|mesh-list
139432833|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139432834|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139432835|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432836|NCT04584567|Doxycycline|doxycycline|mesh-list
139432837|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139432838|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139432839|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
139432840|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139432841|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139432842|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
139432843|NCT03349177|Docetaxel|docetaxel|mesh-list
139432844|NCT03349177|Fluorouracil|fluorouracil|mesh-list
139432845|NCT03349177|Epirubicin|epirubicin|mesh-list
139432846|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139432847|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
139432848|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432849|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139432850|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139432851|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
139432852|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432853|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432854|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139432855|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
139432856|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
139432857|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
139432858|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
139432859|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139432860|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139432861|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139432862|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139432863|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432864|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
139432865|NCT04691505|Methotrexate|methotrexate|mesh-list
139432866|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139432867|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
139432868|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139432869|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432870|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139432871|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
139432872|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432873|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432874|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
139432875|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432876|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139432877|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139432878|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
139432879|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139432880|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139432881|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
139432882|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139432883|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139432884|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139432886|NCT05364619|Antacids|antacids|mesh-ancestor
139432887|NCT05364619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432888|NCT05364619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139432889|NCT03353857|Rifampin|rifampin|mesh-list
139432890|NCT03353857|Dienogest|dienogest|mesh-list
139432891|NCT03353857|Drospirenone|drospirenone|mesh-list
139432892|NCT03353857|Midazolam|midazolam|mesh-list
139432893|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
139432894|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139432895|NCT03353857|Norethindrone|norethindrone|mesh-list
139432896|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
139432897|NCT03353857|Desogestrel|desogestrel|mesh-list
139432898|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139432899|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139432900|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432901|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432902|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139432903|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139432904|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139432905|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139432906|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
139432907|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
139432908|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
139432909|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
139432910|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432911|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432912|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139432913|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
139432914|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139432915|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139432916|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139432917|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139432918|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139432919|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
139432920|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139432921|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139432922|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
139432923|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139432924|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432925|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139432926|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139432927|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139432928|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139432929|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139432930|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139432931|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139432932|NCT03353857|Estrogens|estrogens|mesh-ancestor
139432933|NCT03353857|Hormones|hormones|mesh-ancestor
139432934|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139432935|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139432936|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
139432937|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139432938|NCT03353857|Diuretics|diuretics|mesh-ancestor
139432939|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
139432940|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139432941|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139432942|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432943|NCT03353857|Progestins|progestins|mesh-ancestor
139432944|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139432945|NCT04499859|Ezetimibe|ezetimibe|mesh-list
139432946|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139432947|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139432948|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
139432949|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432950|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139432951|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139432952|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139432953|NCT05306899|Ketamine|ketamine|mesh-list
139432954|NCT05306899|Analgesics|analgesics|mesh-ancestor
139432955|NCT05306899|Sensory System Agents|sensory system agents|mesh-ancestor
139432956|NCT05306899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139432957|NCT05306899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432958|NCT05306899|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139432959|NCT05306899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139432960|NCT05306899|Anesthetics, General|anesthetics, general|mesh-ancestor
139432961|NCT05306899|Anesthetics|anesthetics|mesh-ancestor
139432962|NCT05306899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432963|NCT05306899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139432964|NCT05306899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139432965|NCT05306899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139432966|NCT05306899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432967|NCT00807651|Insulin|insulin|mesh-list
139432968|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139432969|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139432970|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432971|NCT00700791|Vitamins|vitamins|mesh-list
139432972|NCT00700791|Vitamin E|vitamin e|mesh-list
139432973|NCT00700791|Tocopherols|tocopherols|mesh-list
139432974|NCT00700791|Tocotrienols|tocotrienols|mesh-list
139432975|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
139432976|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
139432977|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432978|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
139432979|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432980|NCT00700791|Protective Agents|protective agents|mesh-ancestor
139432981|NCT05344365|Iloperidone|iloperidone|mesh-list
139432982|NCT05344365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139432983|NCT05344365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139432984|NCT05344365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139432985|NCT05344365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139432986|NCT05344365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139432987|NCT04373733|Favipiravir|favipiravir|mesh-list
139432988|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
139432989|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139432990|NCT05403489|Dimercaprol|dimercaprol|mesh-list
139432991|NCT05403489|Chelating Agents|chelating agents|mesh-ancestor
139432992|NCT05403489|Sequestering Agents|sequestering agents|mesh-ancestor
139432993|NCT05403489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432994|NCT04969731|Gemcitabine|gemcitabine|mesh-list
139432995|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139432996|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
139432997|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139432998|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139432999|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
139433000|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
139433001|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
139433002|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433003|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433004|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139433005|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139433006|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
139433007|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
139433008|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433009|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433010|NCT01674621|Abaloparatide|abaloparatide|mesh-list
139433011|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
139433012|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139433013|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433014|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139433015|NCT04644705|Niclosamide|niclosamide|mesh-list
139433016|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
139433017|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139433018|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
139433019|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139433020|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433021|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
139433022|NCT04038489|Aspirin|aspirin|mesh-list
139433023|NCT04038489|Tamoxifen|tamoxifen|mesh-list
139433024|NCT04038489|Paclitaxel|paclitaxel|mesh-list
139433025|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
139433026|NCT04038489|Doxorubicin|doxorubicin|mesh-list
139433027|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139433028|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433029|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
139433030|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
139433031|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
139433032|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433033|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139433034|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
139433035|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433036|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139433037|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139433038|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
139433039|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139433040|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139433041|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139433042|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139433043|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433044|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139433045|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139433046|NCT04038489|Analgesics|analgesics|mesh-ancestor
139433047|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
139433048|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433049|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139433050|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139433051|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139433052|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139433053|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139433054|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
139433055|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139433056|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
139382359|NCT02114333|Vaccines|vaccines|mesh-list
139433057|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433058|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139433059|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139433060|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139433061|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139433062|NCT04468425|Tofacitinib|tofacitinib|mesh-list
139433063|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433064|NCT04468425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139433065|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139433066|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433067|NCT04287855|Dexamethasone|dexamethasone|mesh-list
139433068|NCT04287855|Pomalidomide|pomalidomide|mesh-list
139433069|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139433070|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
139433071|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
139433072|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433073|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433074|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139433075|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
139433076|NCT04287855|Hormones|hormones|mesh-ancestor
139433077|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433078|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139433079|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433080|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
139433081|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139433082|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139433083|NCT04287855|Growth Substances|growth substances|mesh-ancestor
139433084|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
139433085|NCT04435587|Ritonavir|ritonavir|mesh-list
139433086|NCT04435587|Darunavir|darunavir|mesh-list
139433087|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
139433088|NCT04435587|Ivermectin|ivermectin|mesh-list
139433089|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139219829|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
139433090|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139433091|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
139433092|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433093|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433094|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139433095|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139433096|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
139433097|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433098|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139433099|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139433100|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
139433101|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139433102|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139433103|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139433104|NCT05131893|Tamoxifen|tamoxifen|mesh-list
139433105|NCT05131893|Docetaxel|docetaxel|mesh-list
139433106|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
139433107|NCT05131893|Capecitabine|capecitabine|mesh-list
139433108|NCT05131893|Trastuzumab|trastuzumab|mesh-list
139433109|NCT05131893|Letrozole|letrozole|mesh-list
139433110|NCT05131893|Epirubicin|epirubicin|mesh-list
139433111|NCT05131893|Pertuzumab|pertuzumab|mesh-list
139433112|NCT05131893|Goserelin|goserelin|mesh-list
139433113|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433114|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
139433115|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
139433116|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
139433117|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433118|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139433119|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
139433120|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433121|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139433122|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139433123|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
139433124|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139433125|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139433126|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
139433127|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139433128|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139433129|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139433130|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433131|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139433132|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
139433133|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433134|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139433135|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139433136|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139433137|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139433138|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139433139|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139433140|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139433141|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
139433142|NCT02889237|Vitamin D|vitamin d|mesh-list
139433143|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
139433144|NCT02889237|Cholecalciferol|cholecalciferol|mesh-list
139433145|NCT02889237|Vitamins|vitamins|mesh-list
139433146|NCT02889237|Calcium|calcium|mesh-list
139433147|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
139433148|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433149|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139433150|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139433151|NCT02689167|Sunitinib|sunitinib|mesh-list
139433152|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433153|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139433154|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139433155|NCT02689167|Growth Substances|growth substances|mesh-ancestor
139433156|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433157|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
139433158|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139433159|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433160|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433161|NCT02582697|Cisplatin|cisplatin|mesh-list
139433162|NCT02582697|Etoposide|etoposide|mesh-list
139433163|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
139433164|NCT02582697|Bleomycin|bleomycin|mesh-list
139433165|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433166|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139433167|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139433168|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139433169|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433170|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433171|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139433172|NCT01503489|Norepinephrine|norepinephrine|mesh-list
139433173|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
139433174|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
139433175|NCT01503489|Serotonin|serotonin|mesh-list
139433176|NCT01503489|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139433177|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139433178|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139433179|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
139433180|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433181|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433182|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433183|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
139433184|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
139433185|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433186|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139433187|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139433188|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139433189|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
139433190|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139433191|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139433192|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139433193|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139433194|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433195|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433196|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139433197|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139433198|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433199|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
139433200|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433201|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
139433202|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139433203|NCT05185167|Propofol|propofol|mesh-list
139433204|NCT05185167|Anesthetics|anesthetics|mesh-list
139433205|NCT05185167|Desflurane|desflurane|mesh-list
139433206|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
139433207|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139433208|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139433209|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433210|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139433211|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139433212|NCT05133453|Pirfenidone|pirfenidone|mesh-list
139433213|NCT05133453|Analgesics|analgesics|mesh-ancestor
139433214|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
139433215|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433216|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433217|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139433218|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139433219|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139433220|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139433221|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433222|NCT04244877|Rifaximin|rifaximin|mesh-list
139433223|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139433224|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433225|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139433226|NCT05118945|Insulin|insulin|mesh-list
139433227|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139433228|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139433229|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433230|NCT05305131|Bevacizumab|bevacizumab|mesh-list
139433231|NCT05305131|Pembrolizumab|pembrolizumab|mesh-list
139433232|NCT05305131|Cisplatin|cisplatin|mesh-list
139433233|NCT05305131|Gemcitabine|gemcitabine|mesh-list
139433234|NCT05305131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139433235|NCT05305131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433236|NCT05305131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139433237|NCT05305131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139433238|NCT05305131|Growth Substances|growth substances|mesh-ancestor
139433239|NCT05305131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433240|NCT05305131|Growth Inhibitors|growth inhibitors|mesh-ancestor
139433241|NCT05305131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139433242|NCT05305131|Antimetabolites|antimetabolites|mesh-ancestor
139433243|NCT05305131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433244|NCT05305131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139433246|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139433247|NCT03122665|Analgesics|analgesics|mesh-ancestor
139433248|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
139433249|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433250|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433251|NCT05099913|Flupenthixol|flupenthixol|mesh-list
139433252|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139433253|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139433254|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139433255|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433256|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139433257|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139433258|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
139433259|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433260|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433261|NCT03346993|Bupivacaine|bupivacaine|mesh-list
139433262|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
139433263|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
139433264|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139433265|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433266|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
139433267|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433268|NCT03346837|Itraconazole|itraconazole|mesh-list
139433269|NCT03346837|Rifampin|rifampin|mesh-list
139433270|NCT03346837|Linrodostat|linrodostat|mesh-list
139433271|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
139433272|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433273|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139433274|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139433275|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433276|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433277|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139433278|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
139433279|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433280|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433281|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139433282|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139433283|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
139433284|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139433285|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
139433286|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139433287|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139433288|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139433289|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139433290|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139433291|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139433292|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139433293|NCT05303961|Rebamipide|rebamipide|mesh-list
139433294|NCT05303961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139433295|NCT05303961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139433296|NCT05303961|Antioxidants|antioxidants|mesh-ancestor
139433297|NCT05303961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433298|NCT05303961|Protective Agents|protective agents|mesh-ancestor
139433299|NCT05303961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433300|NCT05303961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433301|NCT03122353|Calcitriol|calcitriol|mesh-list
139433302|NCT03122353|Betamethasone|betamethasone|mesh-list
139433303|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
139433304|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139433305|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
139433306|NCT03122353|Calcipotriene|calcipotriene|mesh-list
139433307|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139433308|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139433309|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
139433310|NCT03122353|Hormones|hormones|mesh-ancestor
139433311|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433312|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433313|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139433314|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
139433315|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
139433316|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139433317|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139433318|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139433319|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433320|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139433321|NCT03122353|Vitamins|vitamins|mesh-ancestor
139433322|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
139433323|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139433324|NCT05303259|Bevacizumab|bevacizumab|mesh-list
139433325|NCT05303259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139433326|NCT05303259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433327|NCT05303259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139433328|NCT05303259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139433329|NCT05303259|Growth Substances|growth substances|mesh-ancestor
139433330|NCT05303259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433331|NCT05303259|Growth Inhibitors|growth inhibitors|mesh-ancestor
139433332|NCT03121963|Acetaminophen|acetaminophen|mesh-list
139433333|NCT03121963|Celecoxib|celecoxib|mesh-list
139433334|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139433335|NCT03121963|Oxycodone|oxycodone|mesh-list
139433336|NCT03121963|Gabapentin|gabapentin|mesh-list
139433337|NCT03121963|Hydrocodone|hydrocodone|mesh-list
139433338|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139433339|NCT03121963|Analgesics|analgesics|mesh-ancestor
139433340|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
139433341|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433342|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433343|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
139433344|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139433345|NCT03121963|Narcotics|narcotics|mesh-ancestor
139433346|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139433347|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139433348|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139433349|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139433350|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139433351|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139433352|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433353|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433354|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
139433355|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139433356|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139433357|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139433358|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139433359|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139433360|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433361|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
139433362|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
139433363|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
139433364|NCT04502251|Naltrexone|naltrexone|mesh-list
139433365|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139433366|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139433367|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433368|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
139433369|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433370|NCT02648217|Insulin|insulin|mesh-list
139433371|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139433372|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
139433373|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
139433374|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139433375|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
139433376|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139433377|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433378|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139433379|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139433380|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433381|NCT03122041|Incretins|incretins|mesh-ancestor
139433382|NCT03122041|Hormones|hormones|mesh-ancestor
139433383|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433384|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139433385|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
139433386|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433387|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433388|NCT04943679|Interferons|interferons|mesh-list
139433389|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
139433390|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433391|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
139433392|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433393|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
139433394|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433395|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
139433396|NCT04507165|Anesthetics|anesthetics|mesh-list
139433397|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139433398|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433399|NCT04507165|Narcotics|narcotics|mesh-ancestor
139433400|NCT04507165|Analgesics|analgesics|mesh-ancestor
139433401|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
139433402|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433403|NCT04475991|Maraviroc|maraviroc|mesh-list
139433404|NCT04475991|Favipiravir|favipiravir|mesh-list
139433405|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139433406|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139433407|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433408|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139433409|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139433410|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
139433411|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433412|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139433413|NCT03387475|Deferasirox|deferasirox|mesh-list
139433414|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139433415|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
139433416|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
139433417|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433418|NCT04502017|Clopidogrel|clopidogrel|mesh-list
139433419|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139382365|NCT02114645|Leuprolide|leuprolide|mesh-list
139433420|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139433421|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139433422|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139433423|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
139433424|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433425|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433426|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433427|NCT05302713|Calcium, Dietary|calcium, dietary|mesh-list
139433428|NCT05302713|Calcium Carbonate|calcium carbonate|mesh-list
139433429|NCT05302713|Calcium|calcium|mesh-list
139433430|NCT05302713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139433431|NCT05302713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433432|NCT05302713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139433433|NCT05302713|Antacids|antacids|mesh-ancestor
139433434|NCT05302713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433435|NCT05302713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139433436|NCT04921033|Prednisolone|prednisolone|mesh-list
139433437|NCT04921033|Budesonide|budesonide|mesh-list
139433438|NCT04921033|Azathioprine|azathioprine|mesh-list
139433439|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139433440|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
139433441|NCT04921033|Hormones|hormones|mesh-ancestor
139433442|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433443|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433444|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139433445|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433446|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
139433447|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433448|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139433449|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139433450|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
139433451|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
139433452|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433453|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139433454|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139433455|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
139433456|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139433457|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
139433458|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139433459|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
139433460|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433461|NCT03346681|Expectorants|expectorants|mesh-ancestor
139433462|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
139433463|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139433464|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
139433465|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433466|NCT03346681|Protective Agents|protective agents|mesh-ancestor
139220209|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139433467|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433468|NCT03346681|Antidotes|antidotes|mesh-ancestor
139433469|NCT00709735|Propranolol|propranolol|mesh-list
139433470|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139433471|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139433472|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
139433473|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433474|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433475|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433476|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139433477|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139433478|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
139433479|NCT04505995|Azacitidine|azacitidine|mesh-list
139433480|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
139433481|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139433482|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
139433483|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433484|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433485|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433486|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139433487|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139433488|NCT04486911|Letrozole|letrozole|mesh-list
139433489|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433490|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139433491|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139433492|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433493|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433494|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139433495|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
139433496|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433497|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433498|NCT05135013|Drospirenone|drospirenone|mesh-list
139433499|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139433500|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139433501|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139433502|NCT05135013|Norethindrone|norethindrone|mesh-list
139433503|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
139433504|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139433505|NCT05135013|Estradiol|estradiol|mesh-list
139433506|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139433507|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
139433508|NCT05135013|Estrogens|estrogens|mesh-ancestor
139433509|NCT05135013|Hormones|hormones|mesh-ancestor
139433510|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433511|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433512|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139433513|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
139433514|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139433515|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139433516|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139433517|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139433518|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139433519|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
139433520|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139433521|NCT05135013|Diuretics|diuretics|mesh-ancestor
139433522|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
139433523|NCT05135013|Progestins|progestins|mesh-ancestor
139433524|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139433525|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139433526|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433527|NCT04505917|Misoprostol|misoprostol|mesh-list
139433528|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139433529|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
139433530|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139433531|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433532|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139433533|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139433534|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
139433535|NCT04505683|Ertapenem|ertapenem|mesh-list
139433536|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139433537|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433538|NCT05576155|Compound 21|compound 21|mesh-list
139433539|NCT05576155|Losartan|losartan|mesh-list
139433540|NCT05576155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139433541|NCT05576155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139220288|NCT03746249|Lenvatinib|lenvatinib|mesh-list
139433542|NCT05576155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139433543|NCT05576155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139433544|NCT05576155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433545|NCT05576155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139433547|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
139433548|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433549|NCT03351751|PF-06372865|pf-06372865|mesh-list
139433550|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
139433551|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
139433552|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433553|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433554|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433555|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
139433556|NCT03347461|Dexamethasone|dexamethasone|mesh-list
139433557|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139433558|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
139433559|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
139433560|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433561|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433562|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139433563|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
139433564|NCT03347461|Hormones|hormones|mesh-ancestor
139433565|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433566|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139433567|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433568|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433569|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433570|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139433571|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433572|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139433573|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139433574|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139433575|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139433576|NCT03351517|Tapentadol|tapentadol|mesh-list
139433577|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139433578|NCT03351517|Narcotics|narcotics|mesh-ancestor
139433579|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139433580|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433581|NCT03351517|Analgesics|analgesics|mesh-ancestor
139433582|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
139433583|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433584|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139433585|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139433586|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139433587|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433588|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
139433589|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433590|NCT03346525|Penicillins|penicillins|mesh-list
139433591|NCT03346525|Penicillin G|penicillin g|mesh-list
139433592|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139433593|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
139433594|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139433595|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433596|NCT05060523|Tolvaptan|tolvaptan|mesh-list
139433597|NCT05060523|Midodrine|midodrine|mesh-list
139433598|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139433599|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433600|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
139433601|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433602|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
139433603|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
139433604|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433605|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139433606|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139433607|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139433608|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139433609|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
139433610|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433611|NCT04502641|Docetaxel|docetaxel|mesh-list
139433612|NCT04502641|Fluorouracil|fluorouracil|mesh-list
139433613|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433614|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
139433615|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
139433617|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433618|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
139433619|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139433620|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139433621|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
139433622|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433623|NCT05555797|Betamethasone|betamethasone|mesh-list
139433624|NCT05555797|Betamethasone Valerate|betamethasone valerate|mesh-list
139433625|NCT05555797|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139433626|NCT05555797|Betamethasone benzoate|betamethasone benzoate|mesh-list
139433627|NCT05555797|Tazarotene|tazarotene|mesh-list
139433628|NCT05555797|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139433629|NCT05555797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139433630|NCT05555797|Glucocorticoids|glucocorticoids|mesh-ancestor
139433631|NCT05555797|Hormones|hormones|mesh-ancestor
139433632|NCT05555797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433633|NCT05555797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433634|NCT05555797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139433635|NCT05555797|Respiratory System Agents|respiratory system agents|mesh-ancestor
139433636|NCT05555797|Dermatologic Agents|dermatologic agents|mesh-ancestor
139433637|NCT05555797|Keratolytic Agents|keratolytic agents|mesh-ancestor
139433638|NCT03955575|Liraglutide|liraglutide|mesh-list
139433639|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139433640|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139433641|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433642|NCT03955575|Incretins|incretins|mesh-ancestor
139433643|NCT03955575|Hormones|hormones|mesh-ancestor
139433644|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433645|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139433646|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139433647|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
139433648|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433649|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139433650|NCT04163419|Tanezumab|tanezumab|mesh-list
139433651|NCT04163419|Analgesics|analgesics|mesh-ancestor
139433652|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
139433653|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433654|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433655|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139433656|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139433657|NCT03351205|Estradiol|estradiol|mesh-list
139433658|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139433659|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
139433660|NCT03351205|Estrogens|estrogens|mesh-ancestor
139433661|NCT03351205|Hormones|hormones|mesh-ancestor
139433662|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433663|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433664|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139433665|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
139433666|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139433667|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139433668|NCT03351205|Progestins|progestins|mesh-ancestor
139433669|NCT04698057|Amoxicillin|amoxicillin|mesh-list
139433670|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
139433671|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
139433672|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
139433673|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139433674|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139433675|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433676|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139433677|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139433678|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433679|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433680|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433681|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139433682|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139433683|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139433684|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139433685|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
139433686|NCT02449005|Coagulants|coagulants|mesh-ancestor
139433687|NCT04132791|Aspirin|aspirin|mesh-list
139433688|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139433689|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139433690|NCT04132791|Analgesics|analgesics|mesh-ancestor
139433692|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433693|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433694|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139433695|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139433696|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139433697|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139433698|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433699|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139433700|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139433701|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433702|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
139433703|NCT04250493|Insulin|insulin|mesh-list
139433704|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139433705|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433706|NCT04147221|Imipenem|imipenem|mesh-list
139433707|NCT04147221|Relebactam|relebactam|mesh-list
138848376|NCT02436707|Dexamethasone|dexamethasone|mesh-list
139433708|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139433709|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433710|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139433711|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433712|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433713|NCT02517619|Dexamethasone|dexamethasone|mesh-list
139433714|NCT02517619|Prednisolone|prednisolone|mesh-list
139433715|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139433716|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
139433717|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139433718|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
139433719|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139433720|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139433721|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
139433722|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139433723|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139433724|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
139433725|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
139433726|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433727|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433728|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139433729|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
139433730|NCT02517619|Hormones|hormones|mesh-ancestor
139433731|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139433732|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139433733|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433734|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139433735|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139433736|NCT02517619|Protective Agents|protective agents|mesh-ancestor
139433737|NCT03892395|Vitamin D|vitamin d|mesh-list
139433738|NCT03892395|Vitamins|vitamins|mesh-list
139433739|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
139433740|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
139433741|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433742|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139433743|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
139433744|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139433745|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139433746|NCT04086147|Tenecteplase|tenecteplase|mesh-list
139433747|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139433748|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139433749|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433750|NCT03161223|Azacitidine|azacitidine|mesh-list
139433751|NCT03161223|Durvalumab|durvalumab|mesh-list
139433752|NCT03161223|Romidepsin|romidepsin|mesh-list
139433753|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139433754|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
139433755|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433756|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433757|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433758|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139433759|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139433760|NCT03161223|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139433761|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139433762|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
139433763|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139433764|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
139220515|NCT02442466|BQ 788|bq 788|mesh-list
139433765|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139433766|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433767|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139433768|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139433769|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433770|NCT06152458|Thiamine|thiamine|mesh-list
139433771|NCT06152458|Vitamins|vitamins|mesh-ancestor
139433772|NCT06152458|Micronutrients|micronutrients|mesh-ancestor
139433773|NCT06152458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433774|NCT06152458|Vitamin B Complex|vitamin b complex|mesh-ancestor
139433775|NCT06152393|Antibodies|antibodies|mesh-list
139433776|NCT06152393|Immunologic Factors|immunologic factors|mesh-ancestor
139433777|NCT06152393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433778|NCT06152367|Aldesleukin|aldesleukin|mesh-list
139433779|NCT06152367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433780|NCT06152367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139433781|NCT06152367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139433782|NCT06152367|Antiviral Agents|antiviral agents|mesh-ancestor
139433783|NCT06152367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433784|NCT06151743|Cetuximab|cetuximab|mesh-list
139433785|NCT06151743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139433786|NCT06151743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433787|NCT06151652|Thioctic Acid|thioctic acid|mesh-list
139433788|NCT06151652|Antioxidants|antioxidants|mesh-ancestor
139433789|NCT06151652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433790|NCT06151652|Protective Agents|protective agents|mesh-ancestor
139433791|NCT06151652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433792|NCT06151652|Vitamin B Complex|vitamin b complex|mesh-ancestor
139433793|NCT06151652|Vitamins|vitamins|mesh-ancestor
139433794|NCT06151652|Micronutrients|micronutrients|mesh-ancestor
139433795|NCT06151639|Anesthetics|anesthetics|mesh-list
139433796|NCT06151639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139433797|NCT06151639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433798|NCT06151522|Norepinephrine|norepinephrine|mesh-list
139433799|NCT06151522|Adrenergic Agents|adrenergic agents|mesh-list
139433800|NCT06151522|Adrenergic Agonists|adrenergic agonists|mesh-list
139433801|NCT06151522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139433802|NCT06151522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433803|NCT06151522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433804|NCT06151522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433805|NCT06151522|Sympathomimetics|sympathomimetics|mesh-ancestor
139433806|NCT06151522|Autonomic Agents|autonomic agents|mesh-ancestor
139433807|NCT06151522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433808|NCT06151522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139433809|NCT06151509|Norepinephrine|norepinephrine|mesh-list
139433810|NCT06151509|Adrenergic Agents|adrenergic agents|mesh-list
139433811|NCT06151509|Adrenergic Agonists|adrenergic agonists|mesh-list
139433812|NCT06151509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139433813|NCT06151509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433814|NCT06151509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433815|NCT06151509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433816|NCT06151509|Sympathomimetics|sympathomimetics|mesh-ancestor
139433817|NCT06151509|Autonomic Agents|autonomic agents|mesh-ancestor
139433818|NCT06151509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433819|NCT06151509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139433820|NCT06151496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139433821|NCT06151496|Adrenergic Agents|adrenergic agents|mesh-list
139433822|NCT06151496|Adrenergic Agonists|adrenergic agonists|mesh-list
139433823|NCT06151496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433824|NCT06151496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433825|NCT06151496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433826|NCT06151470|Phenylephrine|phenylephrine|mesh-list
139433827|NCT06151470|Oxymetazoline|oxymetazoline|mesh-list
139433828|NCT06151470|Adrenergic Agents|adrenergic agents|mesh-list
139433829|NCT06151470|Adrenergic Agonists|adrenergic agonists|mesh-list
139433830|NCT06151470|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139433831|NCT06151470|Mydriatics|mydriatics|mesh-ancestor
139433832|NCT06151470|Autonomic Agents|autonomic agents|mesh-ancestor
139433833|NCT06151470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433834|NCT06151470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433835|NCT06151470|Sympathomimetics|sympathomimetics|mesh-ancestor
139433836|NCT06151470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139433837|NCT06151470|Nasal Decongestants|nasal decongestants|mesh-ancestor
139433838|NCT06151470|Respiratory System Agents|respiratory system agents|mesh-ancestor
139433839|NCT06151470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139433840|NCT06151470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139220588|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
139433841|NCT06151470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433842|NCT06151470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433843|NCT06151470|Protective Agents|protective agents|mesh-ancestor
139433844|NCT06151457|Norepinephrine|norepinephrine|mesh-list
139433845|NCT06151457|Adrenergic Agents|adrenergic agents|mesh-list
139433846|NCT06151457|Adrenergic Agonists|adrenergic agonists|mesh-list
139433847|NCT06151457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139433848|NCT06151457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433849|NCT06151457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433850|NCT06151457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433851|NCT06151457|Sympathomimetics|sympathomimetics|mesh-ancestor
139433852|NCT06151457|Autonomic Agents|autonomic agents|mesh-ancestor
139433853|NCT06151457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433854|NCT06151457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139433855|NCT06151444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139433856|NCT06151444|Adrenergic Agents|adrenergic agents|mesh-list
139433857|NCT06151444|Adrenergic Agonists|adrenergic agonists|mesh-list
139433858|NCT06151444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433859|NCT06151444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433860|NCT06151444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433861|NCT06151392|Zinc|zinc|mesh-list
139433862|NCT06151392|Zinc Sulfate|zinc sulfate|mesh-list
139433863|NCT06151392|Trace Elements|trace elements|mesh-ancestor
139433864|NCT06151392|Micronutrients|micronutrients|mesh-ancestor
139433865|NCT06151392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433866|NCT06151392|Astringents|astringents|mesh-ancestor
139433867|NCT06151392|Dermatologic Agents|dermatologic agents|mesh-ancestor
139433868|NCT06147622|Cyproheptadine|cyproheptadine|mesh-list
139433869|NCT06147622|Prazosin|prazosin|mesh-list
139433870|NCT06147622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139433871|NCT06147622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139433872|NCT06147622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139433873|NCT06147622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139433874|NCT06147622|Adrenergic Agents|adrenergic agents|mesh-ancestor
139433875|NCT06147622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139433876|NCT06147622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433877|NCT06147622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433878|NCT06147622|Antipruritics|antipruritics|mesh-ancestor
139433879|NCT06147622|Dermatologic Agents|dermatologic agents|mesh-ancestor
139433880|NCT06147622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139433881|NCT06147622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139433882|NCT06147622|Histamine Antagonists|histamine antagonists|mesh-ancestor
139433883|NCT06147622|Histamine Agents|histamine agents|mesh-ancestor
139433884|NCT06147622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139433885|NCT06147622|Serotonin Agents|serotonin agents|mesh-ancestor
139433886|NCT06147622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139433887|NCT06138600|Tenofovir|tenofovir|mesh-list
139433888|NCT06138600|Lamivudine|lamivudine|mesh-list
139433889|NCT06138600|Emtricitabine|emtricitabine|mesh-list
139433890|NCT06138600|Cabotegravir|cabotegravir|mesh-list
139433891|NCT06138600|Antiviral Agents|antiviral agents|mesh-ancestor
139433892|NCT06138600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433893|NCT06138600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139433894|NCT06138600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139433895|NCT06138600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433896|NCT06138600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433897|NCT06138600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139433898|NCT06138600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139433899|NCT06138600|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139433900|NCT06138600|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139433901|NCT06108596|Interleukin-2|interleukin-2|mesh-list
139433902|NCT06108596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433903|NCT06108596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139433904|NCT06108596|Analgesics|analgesics|mesh-ancestor
139433905|NCT06108596|Sensory System Agents|sensory system agents|mesh-ancestor
139433906|NCT06108596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433907|NCT06108596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433908|NCT06085144|Erenumab|erenumab|mesh-list
139433909|NCT06085144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139433910|NCT06085144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433911|NCT06085144|Analgesics|analgesics|mesh-ancestor
139433912|NCT06085144|Sensory System Agents|sensory system agents|mesh-ancestor
139433913|NCT06085144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139433914|NCT06085144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433915|NCT06061354|Teriparatide|teriparatide|mesh-list
139433916|NCT06061354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139433917|NCT06061354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433918|NCT06061354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139433919|NCT06046482|Docetaxel|docetaxel|mesh-list
139433920|NCT06046482|Pembrolizumab|pembrolizumab|mesh-list
139433921|NCT06046482|Cetuximab|cetuximab|mesh-list
139433922|NCT06046482|Magrolimab|magrolimab|mesh-list
139433923|NCT06046482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433924|NCT06046482|Tubulin Modulators|tubulin modulators|mesh-ancestor
139433925|NCT06046482|Antimitotic Agents|antimitotic agents|mesh-ancestor
139433926|NCT06046482|Mitosis Modulators|mitosis modulators|mesh-ancestor
139433927|NCT06046482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433928|NCT06046482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139433929|NCT06046482|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139433930|NCT06037564|Lamivudine|lamivudine|mesh-list
139433931|NCT06037564|Dolutegravir|dolutegravir|mesh-list
139433932|NCT06037564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139433933|NCT06037564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139433934|NCT06037564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433935|NCT06037564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433936|NCT06037564|Antiviral Agents|antiviral agents|mesh-ancestor
139433937|NCT06037564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433938|NCT06037564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139433939|NCT06037564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139433940|NCT06037564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139433941|NCT06037564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139433942|NCT06033352|Ivermectin|ivermectin|mesh-list
139433943|NCT06033352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139433944|NCT06033352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139433945|NCT06000423|Tranexamic Acid|tranexamic acid|mesh-list
139433946|NCT06000423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139433947|NCT06000423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139433948|NCT06000423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433949|NCT06000423|Hemostatics|hemostatics|mesh-ancestor
139433950|NCT06000423|Coagulants|coagulants|mesh-ancestor
139433951|NCT05994768|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139433952|NCT05994768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139433953|NCT05994768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433954|NCT05990465|Pirtobrutinib|pirtobrutinib|mesh-list
139433955|NCT05990465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139433956|NCT05990465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433957|NCT05990465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433958|NCT05986240|Venetoclax|venetoclax|mesh-list
139433959|NCT05986240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433960|NCT05978648|Paclitaxel|paclitaxel|mesh-list
139433961|NCT05978648|Docetaxel|docetaxel|mesh-list
139433962|NCT05978648|Cyclophosphamide|cyclophosphamide|mesh-list
139433963|NCT05978648|Carboplatin|carboplatin|mesh-list
139433964|NCT05978648|Trastuzumab|trastuzumab|mesh-list
139433965|NCT05978648|Epirubicin|epirubicin|mesh-list
139433966|NCT05978648|Pertuzumab|pertuzumab|mesh-list
139433967|NCT05978648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139433968|NCT05978648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139433969|NCT05978648|Tubulin Modulators|tubulin modulators|mesh-ancestor
139433970|NCT05978648|Antimitotic Agents|antimitotic agents|mesh-ancestor
139433971|NCT05978648|Mitosis Modulators|mitosis modulators|mesh-ancestor
139433972|NCT05978648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139433973|NCT05978648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139433974|NCT05978648|Immunologic Factors|immunologic factors|mesh-ancestor
139433975|NCT05978648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433976|NCT05978648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139433977|NCT05978648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139433978|NCT05978648|Alkylating Agents|alkylating agents|mesh-ancestor
139433979|NCT05978648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139433980|NCT05978648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139433981|NCT05978648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139433982|NCT05978648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139433983|NCT05978648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139433984|NCT05978648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139433985|NCT05964361|Vaccines|vaccines|mesh-list
139433986|NCT05964361|Immunologic Factors|immunologic factors|mesh-ancestor
139433987|NCT05964361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139433988|NCT05904743|Insulin|insulin|mesh-list
139433989|NCT05904743|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139433990|NCT05904743|Insulin, Short-Acting|insulin, short-acting|mesh-list
139433991|NCT05904743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139433992|NCT05904743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220735|NCT03186040|Lacosamide|lacosamide|mesh-list
139433993|NCT05898633|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139433994|NCT05898633|Pulmonary Surfactant-Associated Protein D|pulmonary surfactant-associated protein d|mesh-list
139433995|NCT05898633|Respiratory System Agents|respiratory system agents|mesh-ancestor
139433997|NCT05877846|Ergocalciferols|ergocalciferols|mesh-list
139433998|NCT05877846|Cholecalciferol|cholecalciferol|mesh-list
139433999|NCT05877846|Vitamins|vitamins|mesh-list
139434000|NCT05877846|Micronutrients|micronutrients|mesh-ancestor
139434001|NCT05877846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434002|NCT05877846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139434003|NCT05877846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139434004|NCT05876806|Trametinib|trametinib|mesh-list
139434005|NCT05876806|Dabrafenib|dabrafenib|mesh-list
139434006|NCT05876806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434007|NCT05876806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139434008|NCT05876806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092475|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
139434009|NCT05876806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434010|NCT05868577|Anesthetics|anesthetics|mesh-list
139434011|NCT05868577|Anesthetics, Local|anesthetics, local|mesh-list
139434012|NCT05868577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139434013|NCT05868577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434014|NCT05868577|Sensory System Agents|sensory system agents|mesh-ancestor
139434015|NCT05868577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434016|NCT05868109|Nitric Oxide|nitric oxide|mesh-list
139434017|NCT05868109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139434018|NCT05868109|Autonomic Agents|autonomic agents|mesh-ancestor
139434019|NCT05868109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434020|NCT05868109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434021|NCT05868109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139434022|NCT05868109|Respiratory System Agents|respiratory system agents|mesh-ancestor
139434023|NCT05868109|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139434024|NCT05868109|Antioxidants|antioxidants|mesh-ancestor
139434025|NCT05868109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434026|NCT05868109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139434027|NCT05868109|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139434028|NCT05868109|Vasodilator Agents|vasodilator agents|mesh-ancestor
139434029|NCT05868109|Gasotransmitters|gasotransmitters|mesh-ancestor
139434030|NCT05868109|Protective Agents|protective agents|mesh-ancestor
139434031|NCT05859464|Pembrolizumab|pembrolizumab|mesh-list
139434032|NCT05859464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139434033|NCT05859464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434034|NCT05859464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139434035|NCT05859464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434036|NCT05821686|Aldesleukin|aldesleukin|mesh-list
139434037|NCT05821686|Interleukin-2|interleukin-2|mesh-list
139434038|NCT05821686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434039|NCT05821686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139434040|NCT05821686|Analgesics|analgesics|mesh-ancestor
139434041|NCT05821686|Sensory System Agents|sensory system agents|mesh-ancestor
139434042|NCT05821686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434043|NCT05821686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434044|NCT05821686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139434045|NCT05821686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139434046|NCT05821686|Antiviral Agents|antiviral agents|mesh-ancestor
139434047|NCT05821686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434048|NCT05807620|Sunscreening Agents|sunscreening agents|mesh-list
139434049|NCT05807620|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139434050|NCT05807620|Protective Agents|protective agents|mesh-ancestor
139434051|NCT05807620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434052|NCT05807620|Dermatologic Agents|dermatologic agents|mesh-ancestor
139434053|NCT05763823|Letermovir|letermovir|mesh-list
139434054|NCT05763823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139434055|NCT05763823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434056|NCT05763823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434057|NCT05763823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434058|NCT05763823|Antiviral Agents|antiviral agents|mesh-ancestor
139434059|NCT05763823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434060|NCT05741658|Dapagliflozin|dapagliflozin|mesh-list
139434061|NCT05741658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139434062|NCT05741658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434063|NCT05741658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139434064|NCT05741658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434065|NCT05738148|Vasopressins|vasopressins|mesh-list
139434066|NCT05738148|Arginine Vasopressin|arginine vasopressin|mesh-list
139220812|NCT03789318|Narcotics|narcotics|mesh-ancestor
139434067|NCT05738148|Epinephrine|epinephrine|mesh-list
139434068|NCT05738148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139434069|NCT05738148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139434070|NCT05738148|Adrenergic Agents|adrenergic agents|mesh-ancestor
139434071|NCT05738148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139434072|NCT05738148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434073|NCT05738148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434074|NCT05738148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139434075|NCT05738148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139434076|NCT05738148|Autonomic Agents|autonomic agents|mesh-ancestor
139434077|NCT05738148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434078|NCT05738148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139434079|NCT05738148|Respiratory System Agents|respiratory system agents|mesh-ancestor
139434080|NCT05738148|Mydriatics|mydriatics|mesh-ancestor
139434081|NCT05738148|Sympathomimetics|sympathomimetics|mesh-ancestor
139434082|NCT05738148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139434083|NCT05738148|Hemostatics|hemostatics|mesh-ancestor
139434084|NCT05738148|Coagulants|coagulants|mesh-ancestor
139434085|NCT05738148|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139434086|NCT05738148|Natriuretic Agents|natriuretic agents|mesh-ancestor
139434087|NCT05715216|Nivolumab|nivolumab|mesh-list
139434088|NCT05715216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139434089|NCT05715216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434090|NCT05715216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139434091|NCT05715216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434092|NCT05698095|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
139434093|NCT05698095|Hallucinogens|hallucinogens|mesh-ancestor
139434094|NCT05698095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434095|NCT05698095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139434096|NCT05698095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139434097|NCT05698095|Serotonin Agents|serotonin agents|mesh-ancestor
139434098|NCT05698095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139434099|NCT05698095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434100|NCT05698095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139434101|NCT05686356|Acetylcysteine|acetylcysteine|mesh-list
139434102|NCT05686356|Bedaquiline|bedaquiline|mesh-list
139434103|NCT05686356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139434104|NCT05686356|Antiviral Agents|antiviral agents|mesh-ancestor
139434105|NCT05686356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434106|NCT05686356|Expectorants|expectorants|mesh-ancestor
139434107|NCT05686356|Respiratory System Agents|respiratory system agents|mesh-ancestor
139434108|NCT05686356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139434109|NCT05686356|Antioxidants|antioxidants|mesh-ancestor
139434110|NCT05686356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434111|NCT05686356|Protective Agents|protective agents|mesh-ancestor
139434112|NCT05686356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434113|NCT05686356|Antidotes|antidotes|mesh-ancestor
139434114|NCT05686356|Antitubercular Agents|antitubercular agents|mesh-ancestor
139434115|NCT05686356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139434116|NCT05670379|Exenatide|exenatide|mesh-list
139434117|NCT05670379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139434118|NCT05670379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434119|NCT05670379|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139434120|NCT05670379|Incretins|incretins|mesh-ancestor
139434121|NCT05670379|Hormones|hormones|mesh-ancestor
139434122|NCT05670379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139434123|NCT05658510|Dexmedetomidine|dexmedetomidine|mesh-list
139434124|NCT05658510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139434125|NCT05658510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139434126|NCT05658510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434127|NCT05658510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139434128|NCT05658510|Analgesics|analgesics|mesh-ancestor
139434129|NCT05658510|Sensory System Agents|sensory system agents|mesh-ancestor
139434130|NCT05658510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434131|NCT05658510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139434132|NCT05658510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139434133|NCT05658510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139434134|NCT05658510|Adrenergic Agents|adrenergic agents|mesh-ancestor
139434135|NCT05658510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139434136|NCT05658510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434137|NCT05633979|Trastuzumab|trastuzumab|mesh-list
139434138|NCT05633979|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139434139|NCT05633979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139434140|NCT05633979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434141|NCT05633979|Immunoconjugates|immunoconjugates|mesh-ancestor
139434142|NCT05633979|Immunologic Factors|immunologic factors|mesh-ancestor
139434143|NCT05633979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434144|NCT05626920|Disulfiram|disulfiram|mesh-list
139434146|NCT05626920|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139434147|NCT05626920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434148|NCT05626920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434149|NCT05622812|Lidocaine|lidocaine|mesh-list
139434150|NCT05622812|Anesthetics, Local|anesthetics, local|mesh-ancestor
139434151|NCT05622812|Anesthetics|anesthetics|mesh-ancestor
139434152|NCT05622812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139434153|NCT05622812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434154|NCT05622812|Sensory System Agents|sensory system agents|mesh-ancestor
139434155|NCT05622812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434156|NCT05622812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139434157|NCT05622812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139434158|NCT05622812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139434159|NCT05622812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139434160|NCT05622812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434161|NCT05620108|Rocuronium|rocuronium|mesh-list
139434162|NCT05620108|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139434163|NCT05620108|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139434164|NCT05620108|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139434165|NCT05620108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434166|NCT05620108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434167|NCT05615779|Levan|levan|mesh-list
139434168|NCT05615779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434169|NCT05603741|Lidocaine|lidocaine|mesh-list
139434170|NCT05603741|Anesthetics, Local|anesthetics, local|mesh-ancestor
139434171|NCT05603741|Anesthetics|anesthetics|mesh-ancestor
139434172|NCT05603741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139434173|NCT05603741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434174|NCT05603741|Sensory System Agents|sensory system agents|mesh-ancestor
139434175|NCT05603741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434176|NCT05603741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139434177|NCT05603741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139434178|NCT05603741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139434179|NCT05603741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139434180|NCT05603741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434181|NCT05537883|Bupivacaine|bupivacaine|mesh-list
139434182|NCT05537883|Anesthetics, Local|anesthetics, local|mesh-ancestor
139434183|NCT05537883|Anesthetics|anesthetics|mesh-ancestor
139434184|NCT05537883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139434185|NCT05537883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434186|NCT05537883|Sensory System Agents|sensory system agents|mesh-ancestor
139434187|NCT05537883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434188|NCT05505552|Vitamin K|vitamin k|mesh-list
139434189|NCT05505552|Vitamin K 1|vitamin k 1|mesh-list
139434190|NCT05505552|Vitamins|vitamins|mesh-ancestor
139434191|NCT05505552|Micronutrients|micronutrients|mesh-ancestor
139434192|NCT05505552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434193|NCT05505552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139434194|NCT05505552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139434195|NCT05505552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434196|NCT05505552|Hemostatics|hemostatics|mesh-ancestor
139434197|NCT05505552|Coagulants|coagulants|mesh-ancestor
139434198|NCT05471076|Complement C4b|complement c4b|mesh-list
139434199|NCT05471076|Immunologic Factors|immunologic factors|mesh-ancestor
139434200|NCT05471076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434201|NCT05441215|Ritonavir|ritonavir|mesh-list
139434202|NCT05441215|Nirmatrelvir|nirmatrelvir|mesh-list
139434203|NCT05441215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139434204|NCT05441215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139434205|NCT05441215|Protease Inhibitors|protease inhibitors|mesh-ancestor
139434206|NCT05441215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434207|NCT05441215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434208|NCT05441215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139434209|NCT05441215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139434210|NCT05441215|Antiviral Agents|antiviral agents|mesh-ancestor
139434211|NCT05441215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434212|NCT05441215|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139434213|NCT05441215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139434214|NCT05413122|Nicotine|nicotine|mesh-list
139434215|NCT05413122|Varenicline|varenicline|mesh-list
139434216|NCT05413122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139434217|NCT05413122|Autonomic Agents|autonomic agents|mesh-ancestor
139434218|NCT05413122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434219|NCT05413122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434220|NCT05413122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139434221|NCT05413122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139434222|NCT05413122|Cholinergic Agents|cholinergic agents|mesh-ancestor
139434223|NCT05413122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139434224|NCT05413122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434225|NCT05369533|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139434226|NCT05369533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139434227|NCT05369533|Immunologic Factors|immunologic factors|mesh-ancestor
139434228|NCT05369533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434229|NCT05369533|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139434230|NCT05369533|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139434231|NCT05369533|Dopamine Agonists|dopamine agonists|mesh-ancestor
139434232|NCT05369533|Dopamine Agents|dopamine agents|mesh-ancestor
139434233|NCT05369533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139434234|NCT05369533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434235|NCT05357794|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139434236|NCT05357794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139434237|NCT05357794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434238|NCT05357794|Immunotoxins|immunotoxins|mesh-ancestor
139434239|NCT05357794|Immunoconjugates|immunoconjugates|mesh-ancestor
139434240|NCT05357794|Immunologic Factors|immunologic factors|mesh-ancestor
139434241|NCT05357794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434242|NCT05345002|Tretinoin|tretinoin|mesh-list
139434243|NCT05345002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434244|NCT05345002|Keratolytic Agents|keratolytic agents|mesh-ancestor
139434245|NCT05345002|Dermatologic Agents|dermatologic agents|mesh-ancestor
139434246|NCT05326347|Brexpiprazole|brexpiprazole|mesh-list
139434247|NCT05326347|Serotonin Agents|serotonin agents|mesh-ancestor
139434248|NCT05326347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139434249|NCT05326347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434250|NCT05326347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434251|NCT05326347|Dopamine Agonists|dopamine agonists|mesh-ancestor
139434252|NCT05326347|Dopamine Agents|dopamine agents|mesh-ancestor
139434253|NCT05325645|Brexpiprazole|brexpiprazole|mesh-list
139434254|NCT05325645|Serotonin Agents|serotonin agents|mesh-ancestor
139434255|NCT05325645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139434256|NCT05325645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434257|NCT05325645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434258|NCT05325645|Dopamine Agonists|dopamine agonists|mesh-ancestor
139434259|NCT05325645|Dopamine Agents|dopamine agents|mesh-ancestor
139434260|NCT05294679|Propofol|propofol|mesh-list
139434261|NCT05294679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139434262|NCT05294679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139434263|NCT05294679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434264|NCT05294679|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139434265|NCT05294679|Anesthetics, General|anesthetics, general|mesh-ancestor
139434266|NCT05294679|Anesthetics|anesthetics|mesh-ancestor
139434267|NCT05269615|Valsartan|valsartan|mesh-list
139434268|NCT05269615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139434269|NCT05269615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139434270|NCT05269615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139434271|NCT05269615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434272|NCT05231122|Bevacizumab|bevacizumab|mesh-list
139434273|NCT05231122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139434274|NCT05231122|Pembrolizumab|pembrolizumab|mesh-list
139434275|NCT05231122|Endothelial Growth Factors|endothelial growth factors|mesh-list
139434276|NCT05231122|Antibodies|antibodies|mesh-list
139434277|NCT05231122|Immunoglobulins|immunoglobulins|mesh-list
139434278|NCT05231122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139434279|NCT05231122|Immunoglobulin G|immunoglobulin g|mesh-list
139434280|NCT05231122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434281|NCT05231122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139434282|NCT05231122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139434283|NCT05231122|Growth Substances|growth substances|mesh-ancestor
139434284|NCT05231122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434285|NCT05231122|Growth Inhibitors|growth inhibitors|mesh-ancestor
139434286|NCT05231122|Immunologic Factors|immunologic factors|mesh-ancestor
139434287|NCT05231122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139434288|NCT05231122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434289|NCT05180968|Dronabinol|dronabinol|mesh-list
139434290|NCT05180968|Nabilone|nabilone|mesh-list
139434291|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
139434292|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
139434293|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434294|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434296|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139434297|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139434298|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139434299|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139434300|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
139434301|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139434302|NCT05180968|Analgesics|analgesics|mesh-ancestor
139434303|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
139434304|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139434305|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139434306|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139434307|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434308|NCT05180968|Hormones|hormones|mesh-ancestor
139434309|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139434310|NCT05176379|Fluconazole|fluconazole|mesh-list
139434311|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
139434312|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434313|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139434314|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139434315|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434316|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434317|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139434318|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
139434319|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139434320|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434321|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139434322|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139434323|NCT05130619|Ethanol|ethanol|mesh-list
139434324|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139434325|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434326|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139434327|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434328|NCT05130268|Dronedarone|dronedarone|mesh-list
139434329|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139434330|NCT05082285|Vaccines|vaccines|mesh-list
139434331|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
139434332|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434333|NCT05055323|Pyrvinium|pyrvinium|mesh-list
139434334|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
139434335|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139434336|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434337|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
139434338|NCT05036681|Futibatinib|futibatinib|mesh-list
139434339|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139434340|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434341|NCT05036681|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139434342|NCT05036681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434343|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
139434344|NCT05004519|Remifentanil|remifentanil|mesh-list
139434345|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139434346|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139434347|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434348|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139434349|NCT05004519|Analgesics|analgesics|mesh-ancestor
139434350|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
139434351|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434352|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139434353|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139434354|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139434355|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
139434356|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139434357|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434358|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139434359|NCT05004519|Narcotics|narcotics|mesh-ancestor
139434360|NCT04991103|Dexamethasone|dexamethasone|mesh-list
139434361|NCT04991103|Lenalidomide|lenalidomide|mesh-list
139434362|NCT04991103|Bortezomib|bortezomib|mesh-list
139434363|NCT04991103|Daratumumab|daratumumab|mesh-list
139434364|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139434365|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
139434366|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
139221105|NCT03715699|Leflunomide|leflunomide|mesh-list
139434367|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434368|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434369|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139434370|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
139434371|NCT04991103|Hormones|hormones|mesh-ancestor
139434372|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139434373|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139434374|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434375|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
139434376|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139434377|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139434378|NCT04991103|Growth Substances|growth substances|mesh-ancestor
139434379|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
139434380|NCT04988256|Cyclosporine|cyclosporine|mesh-list
139434381|NCT04988256|Prednisone|prednisone|mesh-list
139434382|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
139434383|NCT04988256|Cyclosporins|cyclosporins|mesh-list
139434384|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139434385|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
139434386|NCT04988256|Hormones|hormones|mesh-ancestor
139434387|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139434388|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434389|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139434390|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434391|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434392|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434393|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139434394|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
139434395|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
139434396|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434397|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
139434398|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139434399|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139434400|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
139434401|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
139434402|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434403|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139434404|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139434405|NCT04988256|Protective Agents|protective agents|mesh-ancestor
139434406|NCT04948203|Sirolimus|sirolimus|mesh-list
139434407|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139434408|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434409|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139434410|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434411|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
139434412|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139434413|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
139434414|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434415|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
139434416|NCT04939623|Probenecid|probenecid|mesh-list
139434417|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
139434418|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
139434419|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139434420|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
139434421|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434422|NCT04897516|Benzonidazole|benzonidazole|mesh-list
139434423|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139434424|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
139434425|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434426|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139434427|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139434428|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139434429|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434430|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139434431|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139434432|NCT04828226|Clonidine|clonidine|mesh-list
139434433|NCT04828226|Analgesics|analgesics|mesh-ancestor
139434434|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
139434435|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434436|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434437|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139434438|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
139434439|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
139434440|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139434441|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139434442|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139434443|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
139434444|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139434445|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434447|NCT04781855|Ipilimumab|ipilimumab|mesh-list
139434448|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139434449|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434450|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139434451|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434452|NCT04757610|Ranibizumab|ranibizumab|mesh-list
139434453|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139434454|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139434455|NCT04757610|Growth Substances|growth substances|mesh-ancestor
139434456|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434457|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
139434458|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434459|NCT04754399|Cannabidiol|cannabidiol|mesh-list
139434460|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
139434461|NCT04734990|Azacitidine|azacitidine|mesh-list
139434462|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139434463|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
139434464|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434465|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434466|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434467|NCT04661280|Donepezil|donepezil|mesh-list
139434468|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139434469|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434470|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434471|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
139434472|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139434473|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434474|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
139434475|NCT04646187|Adalimumab|adalimumab|mesh-list
139434476|NCT04646187|Infliximab|infliximab|mesh-list
139434477|NCT04646187|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139434478|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139434479|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139434480|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
139434481|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139434482|NCT04617522|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139434483|NCT04617522|Immunoconjugates|immunoconjugates|mesh-ancestor
139434484|NCT04617522|Immunologic Factors|immunologic factors|mesh-ancestor
139434485|NCT04617522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434486|NCT04606914|Maytansine|maytansine|mesh-list
139434487|NCT04606914|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139434488|NCT04606914|Immunoconjugates|immunoconjugates|mesh-ancestor
139434489|NCT04606914|Immunologic Factors|immunologic factors|mesh-ancestor
139434490|NCT04606914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434491|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139434492|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434493|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
139434494|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
139434495|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
139434496|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434497|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
139434498|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139434499|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
139434500|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434501|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139434502|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139434503|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
139434504|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434505|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434506|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139434507|NCT04552223|Nivolumab|nivolumab|mesh-list
139434508|NCT04552223|Relatlimab|relatlimab|mesh-list
139434509|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139434510|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434511|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139434512|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434513|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
139434514|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139434515|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139434516|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
139434517|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434518|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139221257|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
139434519|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139434520|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434521|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434522|NCT04511039|Trifluridine|trifluridine|mesh-list
139434523|NCT04511039|Talazoparib|talazoparib|mesh-list
139434524|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139434525|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434526|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434527|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434528|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
139434529|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
139434530|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434531|NCT04504825|Dexamethasone|dexamethasone|mesh-list
139434532|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
139434533|NCT04504825|Bortezomib|bortezomib|mesh-list
139434534|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139434535|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
139434536|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434537|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139434538|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139434539|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
139434540|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434541|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434542|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139434543|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139434544|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
139434545|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
139434546|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434547|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139434548|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
139434549|NCT04504825|Hormones|hormones|mesh-ancestor
139434550|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139434551|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139434552|NCT04427072|Docetaxel|docetaxel|mesh-list
139434553|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434554|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
139434555|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
139434556|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
139434557|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434558|NCT04401774|Nivolumab|nivolumab|mesh-list
139434559|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139434560|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434561|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139434562|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434563|NCT04374773|Dronabinol|dronabinol|mesh-list
139434564|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
139434565|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434566|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139434567|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139434568|NCT04374773|Analgesics|analgesics|mesh-ancestor
139434569|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
139434570|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434571|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139434572|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139434573|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139434574|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434575|NCT04374773|Hormones|hormones|mesh-ancestor
139434576|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139434577|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
139434578|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139434579|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
139434580|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434581|NCT04353492|Ofatumumab|ofatumumab|mesh-list
139434582|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434583|NCT04331704|Tenofovir|tenofovir|mesh-list
139434584|NCT04331704|Emtricitabine|emtricitabine|mesh-list
139434585|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
139434586|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434587|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139434588|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139434589|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434590|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434591|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139434592|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139434593|NCT04304144|Dexamethasone|dexamethasone|mesh-list
139434594|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
139434595|NCT04304144|Bortezomib|bortezomib|mesh-list
139434596|NCT04304144|Daratumumab|daratumumab|mesh-list
139434597|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139434598|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
139382380|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139434599|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434600|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139434601|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139434602|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
139434603|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434604|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434605|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139434606|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139434607|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
139434608|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
139434609|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434610|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139434611|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
139434612|NCT04304144|Hormones|hormones|mesh-ancestor
139434613|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139434614|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139434615|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
139434616|NCT04300751|Narcotics|narcotics|mesh-ancestor
139434617|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139434618|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434619|NCT04300751|Analgesics|analgesics|mesh-ancestor
139434620|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
139434621|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434622|NCT04285086|Anagrelide|anagrelide|mesh-list
139434623|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139434624|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139434625|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434626|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139434627|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
139434628|NCT04265872|Bortezomib|bortezomib|mesh-list
139434629|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434630|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139434631|NCT04265872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139434632|NCT04265872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434633|NCT04249037|Tenofovir|tenofovir|mesh-list
139434634|NCT04249037|Emtricitabine|emtricitabine|mesh-list
139434635|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139434636|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139434637|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
139434638|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434639|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139434640|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139434641|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434642|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434643|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139434644|NCT04245865|Leucovorin|leucovorin|mesh-list
139434645|NCT04245865|Tocotrienols|tocotrienols|mesh-list
139434646|NCT04245865|Vitamin E|vitamin e|mesh-list
139434647|NCT04245865|Tocopherols|tocopherols|mesh-list
139434648|NCT04245865|Bevacizumab|bevacizumab|mesh-list
139434649|NCT04245865|Capecitabine|capecitabine|mesh-list
139434650|NCT04245865|Fluorouracil|fluorouracil|mesh-list
139434651|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
139434652|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
139434653|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139434654|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434655|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139434656|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139434657|NCT04245865|Growth Substances|growth substances|mesh-ancestor
139434658|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434659|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
139434660|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139434661|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
139434662|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434663|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139434664|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
139434665|NCT04245865|Antidotes|antidotes|mesh-ancestor
139434666|NCT04245865|Protective Agents|protective agents|mesh-ancestor
139434667|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
139434668|NCT04245865|Vitamins|vitamins|mesh-ancestor
139434669|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
139434670|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
139434692|NCT04140396|Lidocaine|lidocaine|mesh-list
139434693|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
139434694|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
139434695|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139434696|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434697|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
139434698|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434699|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139434700|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139434701|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139434702|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139434703|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434704|NCT04135456|Mannitol|mannitol|mesh-list
139434705|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139434706|NCT04135456|Diuretics|diuretics|mesh-ancestor
139434707|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
139434708|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434709|NCT04128748|Cytarabine|cytarabine|mesh-list
139434710|NCT04128748|Daunorubicin|daunorubicin|mesh-list
139434711|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139434712|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
139434713|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434714|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434715|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
139434716|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434717|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139434718|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
139434719|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434720|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139434721|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139434722|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139434723|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434751|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434753|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
139434754|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434755|NCT04068519|Tislelizumab|tislelizumab|mesh-list
139434756|NCT04068519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139434757|NCT04068519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434758|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
139434759|NCT04059458|Calcium|calcium|mesh-list
139434760|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139434761|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434762|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139434763|NCT04059172|Ibuprofen|ibuprofen|mesh-list
139434764|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139434765|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139434766|NCT04059172|Analgesics|analgesics|mesh-ancestor
139434767|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
139434768|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434769|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434770|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139434771|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139434772|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139434773|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434774|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434775|NCT04057898|Ibudilast|ibudilast|mesh-list
139434776|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139434777|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
139434778|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434779|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434780|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139434781|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
139434782|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139434783|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434784|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434785|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139434786|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
139434787|NCT04047641|Cytarabine|cytarabine|mesh-list
139434788|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
139434789|NCT04047641|Idarubicin|idarubicin|mesh-list
139434790|NCT04047641|Cladribine|cladribine|mesh-list
139434791|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139434792|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
139434793|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434794|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434795|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
139434796|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434797|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139434798|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
139434799|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434800|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139434801|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139434802|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139434803|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434804|NCT04038008|Fluconazole|fluconazole|mesh-list
139434805|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
139434806|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434807|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139434808|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139434809|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434810|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434811|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139434812|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
139434813|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139434814|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434815|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139434816|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139434817|NCT04019821|Insulin|insulin|mesh-list
139434827|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139434828|NCT04009343|Artenimol|artenimol|mesh-list
139434829|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
139434830|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139434831|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139434832|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434833|NCT03940703|Osimertinib|osimertinib|mesh-list
139434834|NCT03940703|Tepotinib|tepotinib|mesh-list
139434835|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434836|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139434837|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434838|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434839|NCT03939897|Fulvestrant|fulvestrant|mesh-list
139434840|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139434841|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434842|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139434843|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139434844|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
139434845|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139434846|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434847|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
139434848|NCT03918798|Procaine|procaine|mesh-list
139434849|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139434850|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
139434851|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
139434852|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139434853|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434854|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
139434855|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434856|NCT03909737|Azithromycin|azithromycin|mesh-list
139434857|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139434858|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434859|NCT03900793|Sunitinib|sunitinib|mesh-list
139434860|NCT03900793|Losartan|losartan|mesh-list
139434861|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434862|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139434863|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139434864|NCT03900793|Growth Substances|growth substances|mesh-ancestor
139434865|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434866|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
139434867|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139434868|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434869|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434870|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139434871|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139434872|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139434873|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139434874|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
139434875|NCT03861403|Avelumab|avelumab|mesh-list
139382384|NCT02112695|Diprenorphine|diprenorphine|mesh-list
139434876|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139434877|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
139434878|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434879|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139434880|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139434881|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
139434882|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434883|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434884|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139434885|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139434951|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
139434952|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139434953|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434954|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139434955|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139434956|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
139434957|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139434958|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434959|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434960|NCT03752216|Niraparib|niraparib|mesh-list
139434961|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139434962|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434963|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434964|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434965|NCT03729687|Capecitabine|capecitabine|mesh-list
139434966|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
139434967|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139434968|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
139221724|NCT03693248|Paclitaxel|paclitaxel|mesh-list
139434969|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434970|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434971|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
139434972|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
139434973|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139434974|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139434975|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434976|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434977|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139434978|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
139434979|NCT03710421|Fludarabine|fludarabine|mesh-list
139434980|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139434981|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
139434982|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139434983|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139434984|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139434985|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
139434986|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434987|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434988|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139434989|NCT03661307|Decitabine|decitabine|mesh-list
139434990|NCT03661307|Venetoclax|venetoclax|mesh-list
139434991|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139434992|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
139434993|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139434994|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139434995|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139434996|NCT03618537|Dexamethasone|dexamethasone|mesh-list
139434997|NCT03618537|Ixazomib|ixazomib|mesh-list
139434998|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139434999|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
139435000|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
139435001|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435002|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435003|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139435004|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
139435005|NCT03618537|Hormones|hormones|mesh-ancestor
139435006|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139435007|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139435008|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435009|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
139435010|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435011|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435012|NCT03612960|Nicotine|nicotine|mesh-list
139435013|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139435014|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
139435015|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435016|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435017|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139435018|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139435019|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
139435020|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435021|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435022|NCT03605758|Ivermectin|ivermectin|mesh-list
139435023|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139435024|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435025|NCT03595124|Nivolumab|nivolumab|mesh-list
139435026|NCT03595124|Axitinib|axitinib|mesh-list
139435027|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139435028|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435029|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139435030|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435031|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139435032|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435033|NCT03586414|Ubiquinone|ubiquinone|mesh-list
139435034|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
139435035|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435036|NCT03546894|Ceritinib|ceritinib|mesh-list
139435037|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435038|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139435039|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435040|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435041|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
139435042|NCT03531736|Fludarabine|fludarabine|mesh-list
139435043|NCT03531736|Rituximab|rituximab|mesh-list
139435044|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139435045|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
139435046|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139435047|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
139435048|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435049|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139435050|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139435051|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
139435052|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435053|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435054|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139435055|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139435056|NCT03504501|Lamotrigine|lamotrigine|mesh-list
139435057|NCT03504501|Lovastatin|lovastatin|mesh-list
139435058|NCT03504501|L 647318|l 647318|mesh-list
139435059|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
139435060|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
139435061|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139435062|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139435063|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435064|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139435065|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435066|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139435067|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139435068|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139435069|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139435070|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139435071|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139435072|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139435073|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
139435074|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139435075|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139435076|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435077|NCT03371017|Carboplatin|carboplatin|mesh-list
139435078|NCT03371017|Gemcitabine|gemcitabine|mesh-list
139435079|NCT03371017|Capecitabine|capecitabine|mesh-list
139435080|NCT03371017|Atezolizumab|atezolizumab|mesh-list
139435081|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435082|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139435083|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
139435084|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435085|NCT03371017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139435086|NCT03371017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139435087|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
139435088|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139435089|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435090|NCT03341143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139435091|NCT03341143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435092|NCT03283917|Dexamethasone|dexamethasone|mesh-list
139435093|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
139435094|NCT03283917|Daratumumab|daratumumab|mesh-list
139435095|NCT03283917|Ixazomib|ixazomib|mesh-list
139435096|NCT03283917|Ichthammol|ichthammol|mesh-list
139435097|NCT03283917|BB 1101|bb 1101|mesh-list
139435098|NCT03283917|Glycine|glycine|mesh-list
139435099|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139435100|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
139435101|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
139435102|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435103|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435104|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139435105|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
139435106|NCT03283917|Hormones|hormones|mesh-ancestor
139435107|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139435108|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139435109|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435110|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
139435111|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435112|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435113|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
139435114|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
139435115|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435116|NCT03214562|Cytarabine|cytarabine|mesh-list
139435117|NCT03214562|Fludarabine|fludarabine|mesh-list
139435118|NCT03214562|Venetoclax|venetoclax|mesh-list
139435119|NCT03214562|Idarubicin|idarubicin|mesh-list
139435120|NCT03214562|Lenograstim|lenograstim|mesh-list
139435121|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435122|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139435123|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
139435124|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435125|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139435126|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
139435127|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435128|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
139435129|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435130|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139435131|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139435132|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139435133|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139435134|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435135|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
139435136|NCT03076021|Isotretinoin|isotretinoin|mesh-list
139435137|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
139435138|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
139435139|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139435140|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139435141|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435142|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435143|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435144|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
139435145|NCT03049189|Everolimus|everolimus|mesh-list
139435146|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139435147|NCT03049189|Edotreotide|edotreotide|mesh-list
139435148|NCT03049189|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
139435149|NCT03049189|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139435150|NCT03049189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139435151|NCT03049189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435152|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435153|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139435154|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
139435155|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435156|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435157|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139435158|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
139435159|NCT03016377|Fludarabine|fludarabine|mesh-list
139435160|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139435161|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
139435162|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435163|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139435164|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139435165|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
139435166|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435167|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435168|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139435169|NCT03005782|Cemiplimab|cemiplimab|mesh-list
139435170|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139435171|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435172|NCT02911792|Metformin|metformin|mesh-list
139435173|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
139435174|NCT02911792|Glipizide|glipizide|mesh-list
139435175|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139435176|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435177|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139435178|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435179|NCT02804815|Aspirin|aspirin|mesh-list
139435180|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139435181|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139435182|NCT02804815|Analgesics|analgesics|mesh-ancestor
139435183|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
139435184|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435185|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435186|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139435187|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139435188|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139435189|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139435190|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435191|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139435192|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139435193|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435194|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
139221942|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
139435195|NCT02622854|Insulin|insulin|mesh-list
139435196|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139435197|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435198|NCT02460887|Cisplatin|cisplatin|mesh-list
139435199|NCT02460887|Gemcitabine|gemcitabine|mesh-list
139435200|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435201|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139435202|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
139435203|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435204|NCT02390427|Paclitaxel|paclitaxel|mesh-list
139435205|NCT02390427|Maytansine|maytansine|mesh-list
139435206|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139435207|NCT02390427|Trastuzumab|trastuzumab|mesh-list
139435208|NCT02390427|Pertuzumab|pertuzumab|mesh-list
139435209|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139435210|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435211|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
139435212|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
139435213|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
139435214|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435215|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139435216|NCT02390427|Immunotoxins|immunotoxins|mesh-ancestor
139435217|NCT02390427|Immunoconjugates|immunoconjugates|mesh-ancestor
139435218|NCT02390427|Immunologic Factors|immunologic factors|mesh-ancestor
139435219|NCT02390427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435220|NCT02203643|Dexamethasone|dexamethasone|mesh-list
139435221|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
139435222|NCT02203643|Lenalidomide|lenalidomide|mesh-list
139435223|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139435224|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
139435225|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435226|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139435227|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139435228|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
139435229|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435230|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435231|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139435232|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139435233|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
139435234|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
139435235|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435236|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139435237|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
139435238|NCT02203643|Hormones|hormones|mesh-ancestor
139435239|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139435240|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139435241|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139435242|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139435243|NCT02203643|Growth Substances|growth substances|mesh-ancestor
139435244|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
139435245|NCT02152995|Iodine|iodine|mesh-list
139435246|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
139435247|NCT02152995|Trametinib|trametinib|mesh-list
139435248|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139435249|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435250|NCT02152995|Trace Elements|trace elements|mesh-ancestor
139435251|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
139435252|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435253|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435254|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139435255|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435256|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435257|NCT02035787|Metformin|metformin|mesh-list
139435258|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139435259|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435260|NCT02029001|Everolimus|everolimus|mesh-list
139435261|NCT02029001|Sorafenib|sorafenib|mesh-list
139435262|NCT02029001|Durvalumab|durvalumab|mesh-list
139435263|NCT02029001|Olaparib|olaparib|mesh-list
139435264|NCT02029001|Lapatinib|lapatinib|mesh-list
139435265|NCT02029001|Tremelimumab|tremelimumab|mesh-list
139435266|NCT02029001|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139435267|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139435268|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435269|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435270|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139435271|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
139435272|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435273|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435274|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139435275|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139435276|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
139435277|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139435278|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
139435279|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435280|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139435281|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
139435282|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139435284|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
139435285|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435286|NCT01828112|Docetaxel|docetaxel|mesh-list
139435287|NCT01828112|Pemetrexed|pemetrexed|mesh-list
139435288|NCT01828112|Ceritinib|ceritinib|mesh-list
139435289|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435290|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
139435291|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
139435292|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
139435293|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435294|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435295|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139435296|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139435297|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139435298|NCT01740427|Letrozole|letrozole|mesh-list
139435299|NCT01740427|Palbociclib|palbociclib|mesh-list
139435300|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435301|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139435302|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139435303|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435304|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435305|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139435306|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
139435307|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139435308|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435309|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139435310|NCT01684397|Bevacizumab|bevacizumab|mesh-list
139435311|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139435312|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
139435313|NCT01684397|Antibodies|antibodies|mesh-list
139435314|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
139435315|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139435316|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
139435317|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435318|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139435319|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139435320|NCT01684397|Growth Substances|growth substances|mesh-ancestor
139435321|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435322|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
139435323|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
139435324|NCT01657682|Crenolanib|crenolanib|mesh-list
139435325|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435326|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
139435327|NCT01135199|Pomalidomide|pomalidomide|mesh-list
139435328|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
139435329|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435330|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139435331|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139435332|NCT01135199|Growth Substances|growth substances|mesh-ancestor
139435333|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
139435334|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435335|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139435336|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139435337|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
139435338|NCT00882193|Ribavirin|ribavirin|mesh-list
139435339|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139435340|NCT00882193|Betaine|betaine|mesh-list
139435341|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
139435342|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435343|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
139435344|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435345|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139435346|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
139435347|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139435348|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139435349|NCT00755898|Amantadine|amantadine|mesh-list
139435350|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139435351|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139435352|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
139435353|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435354|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
139435355|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435356|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435357|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435358|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139435359|NCT00755898|Analgesics|analgesics|mesh-ancestor
139435360|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
139435361|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435362|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
139435363|NCT00567606|Etidronic Acid|etidronic acid|mesh-list
139435364|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139435365|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139435366|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435367|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139435368|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435369|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139435370|NCT00540995|Etoposide|etoposide|mesh-list
139435371|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
139435372|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
139435373|NCT00540995|Busulfan|busulfan|mesh-list
139435374|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139435375|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435376|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139435377|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139435378|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435379|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435380|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
139435381|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139435382|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
139435383|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435384|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139435385|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139435386|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
139435387|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
139435388|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
139435389|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
139435390|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
139435391|NCT01285557|Cisplatin|cisplatin|mesh-list
139435392|NCT01285557|Fluorouracil|fluorouracil|mesh-list
139435393|NCT01285557|Tegafur|tegafur|mesh-list
139435394|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435395|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
139435396|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435397|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139435398|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139435399|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
139435400|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435401|NCT03083067|Budesonide|budesonide|mesh-list
139435402|NCT03083067|Bromides|bromides|mesh-list
139435403|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
139435404|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
139435405|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139435406|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139435407|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
139435408|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435409|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435410|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139435411|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
139435412|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
139435413|NCT03083067|Hormones|hormones|mesh-ancestor
139435414|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139435415|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139435416|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139435417|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139435418|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
139435419|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435420|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435421|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
139435422|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139435423|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
139435424|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
139435438|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
139435439|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435440|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435441|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139435442|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139435443|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
139435444|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435445|NCT02512315|Cisplatin|cisplatin|mesh-list
139435446|NCT02512315|Docetaxel|docetaxel|mesh-list
139435447|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435448|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
139435449|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
139435450|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
139435451|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435452|NCT02507323|Ticagrelor|ticagrelor|mesh-list
139435453|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139435454|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139435455|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139435456|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139435457|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139435458|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
139435459|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435460|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435461|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435462|NCT02507245|Hormones|hormones|mesh-list
139435463|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
139435464|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139435465|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435479|NCT05431257|Venetoclax|venetoclax|mesh-list
139435480|NCT05431257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435481|NCT05431023|Lactoferrin|lactoferrin|mesh-list
139435482|NCT05431023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435483|NCT02507167|Rifampin|rifampin|mesh-list
139435484|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139435485|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
139435486|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139435487|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435488|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
139435489|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139435490|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435491|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435492|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139435493|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139435494|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139435495|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139435496|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139435497|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139435499|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139435500|NCT01376167|Primaquine|primaquine|mesh-list
139435501|NCT01376167|Tafenoquine|tafenoquine|mesh-list
139435502|NCT01376167|Amebicides|amebicides|mesh-ancestor
139435503|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139435504|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139435505|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435506|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
139435507|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139435508|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139435509|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139435510|NCT01376167|Analgesics|analgesics|mesh-ancestor
139435511|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
139435512|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435513|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435514|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139435515|NCT01376167|Filaricides|filaricides|mesh-ancestor
139435516|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
139435517|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
139435518|NCT02511613|Squalamine|squalamine|mesh-list
139435519|NCT02511613|Ranibizumab|ranibizumab|mesh-list
139435520|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139435521|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139435522|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139435523|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139435524|NCT02511613|Growth Substances|growth substances|mesh-ancestor
139435525|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435526|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
139435527|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435528|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139435529|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435530|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139435531|NCT02511613|Protective Agents|protective agents|mesh-ancestor
139435532|NCT02506699|Analgesics|analgesics|mesh-list
139435533|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
139435534|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435535|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435536|NCT02506777|Metformin|metformin|mesh-list
139435537|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
139435538|NCT02506777|Doxorubicin|doxorubicin|mesh-list
139435539|NCT02506777|Fluorouracil|fluorouracil|mesh-list
139435540|NCT02506777|Melatonin|melatonin|mesh-list
139435541|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139435542|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
139435543|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435544|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139435545|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139435546|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
139435547|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435548|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435549|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139435550|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139435551|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139435552|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139435553|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139435554|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435555|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
139435556|NCT02506777|Protective Agents|protective agents|mesh-ancestor
139435557|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139435558|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
139435559|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139435560|NCT02516527|Ipilimumab|ipilimumab|mesh-list
139435561|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139435562|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435563|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139435564|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435565|NCT02511847|Afatinib|afatinib|mesh-list
139382389|NCT04361162|Nivolumab|nivolumab|mesh-list
139435566|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435567|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139435568|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435569|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435570|NCT02506855|Ropivacaine|ropivacaine|mesh-list
139435571|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
139435572|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
139435573|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139435574|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435575|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
139435576|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435577|NCT02511223|Olaparib|olaparib|mesh-list
139435578|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139435579|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435580|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435581|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435582|NCT02516059|Oxycodone|oxycodone|mesh-list
139435583|NCT02516059|Naloxone|naloxone|mesh-list
139435584|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139435585|NCT02516059|Narcotics|narcotics|mesh-ancestor
139435586|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139435587|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435588|NCT02516059|Analgesics|analgesics|mesh-ancestor
139435589|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
139435590|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435591|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139435592|NCT02506231|Leucovorin|leucovorin|mesh-list
139435593|NCT02506231|Folic Acid|folic acid|mesh-list
139435594|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
139435595|NCT02506231|Antidotes|antidotes|mesh-ancestor
139435596|NCT02506231|Protective Agents|protective agents|mesh-ancestor
139435597|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435598|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
139435599|NCT02506231|Vitamins|vitamins|mesh-ancestor
139435600|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
139435601|NCT02506231|Hematinics|hematinics|mesh-ancestor
139435602|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139435603|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139435604|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
139435605|NCT02505997|Delafloxacin|delafloxacin|mesh-list
139435606|NCT02505997|Midazolam|midazolam|mesh-list
139435607|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139435608|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139435609|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139435610|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435611|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139435612|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139435613|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139435614|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139435615|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
139435616|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
139435617|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
139435618|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
139435619|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435620|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435621|NCT02505997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435622|NCT02505841|Ropivacaine|ropivacaine|mesh-list
139435623|NCT02505841|Succinylcholine|succinylcholine|mesh-list
139435624|NCT02505841|Curare|curare|mesh-list
139435625|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
139435626|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
139435627|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139435628|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435629|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
139435630|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435631|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139435632|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139435633|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139435634|NCT02505841|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139435635|NCT02505841|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139435636|NCT02505841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139435637|NCT02505841|Cholinergic Agents|cholinergic agents|mesh-ancestor
139435638|NCT02505841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435639|NCT02505841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435640|NCT03345667|Ranibizumab|ranibizumab|mesh-list
139435641|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139094014|NCT01200212|Taxane|taxane|mesh-list
139435642|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139435643|NCT03345667|Growth Substances|growth substances|mesh-ancestor
139435644|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435645|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
139435646|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435647|NCT04499989|Isoniazid|isoniazid|mesh-list
139222394|NCT03184324|Esomeprazole|esomeprazole|mesh-list
139435648|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
139435649|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139435650|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435651|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139435652|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139435653|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
139435654|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435655|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139435656|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
139435657|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
139435658|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435660|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
139435661|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435662|NCT02505451|Dobutamine|dobutamine|mesh-list
139435663|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139435664|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
139435665|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
139435666|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435667|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435668|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139435669|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139435670|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139435671|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
139435672|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435673|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435674|NCT02505451|Protective Agents|protective agents|mesh-ancestor
139435675|NCT02505295|Selenium|selenium|mesh-list
139435676|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
139435677|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435678|NCT02505295|Protective Agents|protective agents|mesh-ancestor
139435679|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435680|NCT02505295|Trace Elements|trace elements|mesh-ancestor
139435681|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
139435682|NCT02510911|Caffeine|caffeine|mesh-list
139435683|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139435684|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435685|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139435686|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435687|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435688|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139435689|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139435690|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
139435691|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435692|NCT03121807|Leucovorin|leucovorin|mesh-list
139435693|NCT03121807|Fluorouracil|fluorouracil|mesh-list
139435694|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
139435695|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
139435696|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435697|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139435698|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435699|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139435700|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
139435701|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435702|NCT03121807|Antidotes|antidotes|mesh-ancestor
139435703|NCT03121807|Protective Agents|protective agents|mesh-ancestor
139435704|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
139435705|NCT03121807|Vitamins|vitamins|mesh-ancestor
139435706|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
139435707|NCT03343873|Midazolam|midazolam|mesh-list
139435708|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
139435709|NCT03343873|Propofol|propofol|mesh-list
139435710|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139435711|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139435712|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435713|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139435714|NCT03343873|Analgesics|analgesics|mesh-ancestor
139435715|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
139435716|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094050|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
139435717|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139435718|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139435719|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139435720|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
139435721|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435722|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435723|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139435724|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
139435725|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
139222466|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
139435726|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139435727|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139435728|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139435729|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139435730|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
139435732|NCT03343795|Progesterone|progesterone|mesh-list
139435733|NCT03343795|Progestins|progestins|mesh-ancestor
139435734|NCT03343795|Hormones|hormones|mesh-ancestor
139435735|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139435736|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435737|NCT02510287|Lidocaine|lidocaine|mesh-list
139435738|NCT02510287|Fentanyl|fentanyl|mesh-list
139435739|NCT02510287|Bupivacaine|bupivacaine|mesh-list
139435740|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
139435741|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
139435742|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139435743|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435744|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
139435745|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435746|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139435747|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139435748|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139435749|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139435750|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435751|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139435752|NCT02510287|Narcotics|narcotics|mesh-ancestor
139435753|NCT02510287|Analgesics|analgesics|mesh-ancestor
139435754|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139435755|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139435756|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
139435757|NCT02515435|Apatinib|apatinib|mesh-list
139435758|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435759|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139435760|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435761|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435762|NCT02515201|Taurolidine|taurolidine|mesh-list
139435763|NCT02515201|Heparin|heparin|mesh-list
139435764|NCT02515201|Calcium heparin|calcium heparin|mesh-list
139435765|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
139435766|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139435767|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139435768|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435769|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435770|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139435771|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435772|NCT02504983|Sorafenib|sorafenib|mesh-list
139435773|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435774|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139435775|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435776|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435777|NCT02510053|Caspofungin|caspofungin|mesh-list
139435778|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
139435779|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435780|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435781|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435782|NCT02504359|Cytarabine|cytarabine|mesh-list
139435783|NCT02504359|Methotrexate|methotrexate|mesh-list
139435784|NCT02504359|Etoposide|etoposide|mesh-list
139435785|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
139435786|NCT02504359|Melphalan|melphalan|mesh-list
139435787|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
139435788|NCT02504359|Carmustine|carmustine|mesh-list
139435789|NCT02504359|Ixazomib|ixazomib|mesh-list
139435790|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
139435791|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139435792|NCT02504359|Tacrolimus|tacrolimus|mesh-list
139435793|NCT02504359|Glycine|glycine|mesh-list
139435794|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139435795|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
139435796|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139435797|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435798|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139222555|NCT01358409|Nebivolol|nebivolol|mesh-list
139435799|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
139435800|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435801|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435802|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
139435803|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435804|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139435805|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139435806|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
139435807|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139435808|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139435809|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139435810|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139435811|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139435812|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
139435813|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435814|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139435815|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139435816|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
139435817|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139435818|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
139435819|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
139435820|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
139435821|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
139435822|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
139435823|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
139435824|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435825|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
139435826|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139435827|NCT02729545|Cyproterone|cyproterone|mesh-list
139435828|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139435829|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139435830|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139435831|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
139435832|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139435833|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435834|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139435835|NCT02729545|Estrogens|estrogens|mesh-ancestor
139435836|NCT02729545|Hormones|hormones|mesh-ancestor
139435837|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139435838|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
139435839|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
139435840|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435841|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139435842|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
139435843|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139435844|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139435845|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435846|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
139435847|NCT02504125|Coagulants|coagulants|mesh-ancestor
139435848|NCT02509429|Insulin|insulin|mesh-list
139435849|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139435850|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
139435851|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
139435852|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139435853|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
139435854|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139435855|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435856|NCT02509273|Clonidine|clonidine|mesh-list
139435857|NCT02509273|Midazolam|midazolam|mesh-list
139435858|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139435859|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139435860|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139435861|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435862|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139435863|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139435864|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139435865|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139435866|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
139435867|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
139435868|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
139435869|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
139435870|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435871|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435872|NCT02509273|Analgesics|analgesics|mesh-ancestor
139435873|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
139435874|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435875|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139435876|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
139435877|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
139435878|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139435879|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139222612|NCT03117166|Lidocaine|lidocaine|mesh-list
139435880|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139435881|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
139435882|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
139435883|NCT02514343|Bupivacaine|bupivacaine|mesh-list
139435884|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
139435885|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
139435886|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139435887|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435888|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
139435889|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435890|NCT02514343|Analgesics|analgesics|mesh-ancestor
139435891|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139435892|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
139435893|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139435894|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139435895|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435896|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139435897|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
139435898|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139435899|NCT02514421|Paclitaxel|paclitaxel|mesh-list
139435900|NCT02514421|Gemcitabine|gemcitabine|mesh-list
139435901|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139435902|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435903|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
139435904|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
139435905|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
139435906|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435907|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139435908|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
139435909|NCT04499209|Naproxen|naproxen|mesh-list
139435910|NCT04499209|Pregabalin|pregabalin|mesh-list
139435911|NCT04499209|Analgesics|analgesics|mesh-ancestor
139435912|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
139435913|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435914|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435915|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
139435916|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139435917|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139435918|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435919|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139435920|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139435921|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139435922|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139435923|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139435924|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139435925|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139435926|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139435927|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139435928|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
139435929|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139435930|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435931|NCT02509351|Misoprostol|misoprostol|mesh-list
139435932|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139435933|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
139435934|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139435935|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435936|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139435937|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139435938|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
139435939|NCT02509195|Lamivudine|lamivudine|mesh-list
139435940|NCT02509195|Abacavir|abacavir|mesh-list
139435941|NCT02509195|Dolutegravir|dolutegravir|mesh-list
139435942|NCT02509195|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
139435943|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139435944|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139435945|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435946|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435947|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
139435948|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139435949|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139435950|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139435951|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139435952|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139435953|NCT02508805|Diclofenac|diclofenac|mesh-list
139222706|NCT02930343|Hormones|hormones|mesh-ancestor
139435954|NCT02508805|Tizanidine|tizanidine|mesh-list
139435955|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139435956|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139435957|NCT02508805|Analgesics|analgesics|mesh-ancestor
139435958|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
139435959|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435960|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435961|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139435962|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139435963|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139435964|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139435965|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435966|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
139435967|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139435968|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139435969|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
139435970|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
139435971|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139435972|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139435973|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139435974|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
139435975|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435976|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139435977|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139435978|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139435979|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139435980|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435981|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139435982|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139435983|NCT03121573|Analgesics|analgesics|mesh-ancestor
139435984|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
139435985|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139435986|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
139435987|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139435988|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
139435989|NCT03121417|Nivolumab|nivolumab|mesh-list
139435990|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139435991|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435992|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139435993|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139435994|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139435995|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139435996|NCT02502643|Picibanil|picibanil|mesh-list
139435997|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139435998|NCT02502565|Uric Acid|uric acid|mesh-list
139435999|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
139436000|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436001|NCT02502565|Protective Agents|protective agents|mesh-ancestor
139436002|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436003|NCT04498897|Acamprosate|acamprosate|mesh-list
139436004|NCT04498897|Vortioxetine|vortioxetine|mesh-list
139436005|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
139436006|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139436007|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139436008|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139436009|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436010|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436011|NCT04498897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139436012|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139436013|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139436014|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436015|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436016|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
139436017|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139436018|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139436019|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139436020|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139436021|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139436022|NCT02502877|Midazolam|midazolam|mesh-list
139436023|NCT02502877|Propofol|propofol|mesh-list
139436024|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139436025|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436026|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436027|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139436028|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
139436029|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
139436030|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139436031|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139436032|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139436033|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139436034|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
139436035|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
139436036|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436037|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436038|NCT03121339|Vaccines|vaccines|mesh-list
139436039|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
139436040|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436041|NCT03343327|Hydrocortisone|hydrocortisone|mesh-list
139436042|NCT03343327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139436043|NCT02502175|Methadone|methadone|mesh-list
139436044|NCT02502175|Opium|opium|mesh-list
139436045|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139436046|NCT02502175|Narcotics|narcotics|mesh-ancestor
139436047|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436048|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436049|NCT02502175|Analgesics|analgesics|mesh-ancestor
139436050|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
139436051|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436052|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
139436053|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
139436054|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
139436055|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139436056|NCT02500927|Naquotinib|naquotinib|mesh-list
139436057|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436058|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139436059|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436060|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436061|NCT02501863|Fentanyl|fentanyl|mesh-list
139436062|NCT02501863|Ropivacaine|ropivacaine|mesh-list
139436063|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
139436064|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
139436065|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436066|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436067|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
139436068|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436069|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139436070|NCT02501863|Narcotics|narcotics|mesh-ancestor
139436071|NCT02501863|Analgesics|analgesics|mesh-ancestor
139436072|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139436073|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139436074|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
139436075|NCT02500459|Topotecan|topotecan|mesh-list
139436076|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139436077|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139436078|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436079|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436080|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436081|NCT02500225|Sevoflurane|sevoflurane|mesh-list
139436082|NCT02500225|Etomidate|etomidate|mesh-list
139436083|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139436084|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139436085|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
139436086|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
139436087|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436088|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436089|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139436090|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139436091|NCT02507635|Levocetirizine|levocetirizine|mesh-list
139436092|NCT02507635|Desloratadine|desloratadine|mesh-list
139436093|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139436094|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139436095|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
139436096|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
139436097|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436098|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436099|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436100|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139436101|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
139436102|NCT04495933|Vaccines|vaccines|mesh-list
139436103|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
139436104|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
139436105|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436107|NCT02500069|Caseins|caseins|mesh-list
139436108|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
139436109|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
139436110|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436111|NCT03344029|Vaccines|vaccines|mesh-list
139436112|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
139436113|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436114|NCT03120637|Methylene Blue|methylene blue|mesh-list
139436115|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436116|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436117|NCT02499757|Nicotine|nicotine|mesh-list
139436118|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139436119|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
139436120|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436121|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436122|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139436123|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139436124|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
139436125|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436126|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436127|NCT00706849|Mipomersen|mipomersen|mesh-list
139436128|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139436129|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139436130|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
139436131|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436132|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139436133|NCT02499445|Sufentanil|sufentanil|mesh-list
139436134|NCT02499445|Remifentanil|remifentanil|mesh-list
139436135|NCT02499445|Propofol|propofol|mesh-list
139436136|NCT02499445|Sevoflurane|sevoflurane|mesh-list
139436137|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139436138|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436139|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436140|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139436141|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
139436142|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
139436143|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139436144|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139436145|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139436146|NCT02499445|Narcotics|narcotics|mesh-ancestor
139436147|NCT02499445|Analgesics|analgesics|mesh-ancestor
139436148|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
139436149|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436150|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139436151|NCT04443049|Mebendazole|mebendazole|mesh-list
139436152|NCT04443049|Piperazine|piperazine|mesh-list
139436153|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
139436154|NCT04443049|Lenvatinib|lenvatinib|mesh-list
139436155|NCT04443049|DMP 777|dmp 777|mesh-list
139436156|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436157|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139436158|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436159|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436160|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
139436161|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
139436162|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139436163|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139436164|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
139436165|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
139436166|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
139436167|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139436168|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
139436169|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436170|NCT03341845|Avelumab|avelumab|mesh-list
139436171|NCT03341845|Axitinib|axitinib|mesh-list
139436172|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139436173|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436174|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139436175|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436176|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436177|NCT02498977|Cyclosporine|cyclosporine|mesh-list
139436178|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
139436179|NCT02498977|Azathioprine|azathioprine|mesh-list
139436180|NCT02498977|Tacrolimus|tacrolimus|mesh-list
139436181|NCT02498977|Cyclosporins|cyclosporins|mesh-list
139436182|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139436183|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
139436184|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436185|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139436186|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436187|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436188|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
139436189|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139436190|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
139436191|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139436192|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139436193|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436194|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139436195|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
139436196|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139436197|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
139436198|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139436199|NCT02494687|Domperidone|domperidone|mesh-list
139436200|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
139436201|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
139436202|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436203|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436204|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139436205|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139436206|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
139436207|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436208|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436209|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139436210|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
139436211|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
139436212|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139436213|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436214|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139436215|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139436216|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436217|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139436218|NCT03341767|Clofazimine|clofazimine|mesh-list
139436219|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139436220|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
139436221|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139436222|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139436223|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
139436224|NCT02498509|Levocabastine|levocabastine|mesh-list
139436225|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139436226|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
139436227|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139436228|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139436229|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139436230|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
139436231|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
139436232|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436233|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436234|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436235|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
139436236|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139436237|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
139382395|NCT04823390|Midazolam|midazolam|mesh-list
139436238|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139436239|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436240|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139436241|NCT02493283|Dapsone|dapsone|mesh-list
139436242|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139436243|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
139436244|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139436245|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139436246|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139436247|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436248|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436249|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
139436250|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139436251|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
139436252|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139436253|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436254|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436255|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139436256|NCT03335527|Analgesics|analgesics|mesh-ancestor
139436257|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
139436258|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436259|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139436260|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139436261|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139436262|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
139436263|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436264|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436265|NCT02493049|Domperidone|domperidone|mesh-list
139436266|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436267|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
139436268|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
139436269|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436270|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436271|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139436272|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139436273|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
139436274|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436276|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139436277|NCT03120715|Tinzaparin|tinzaparin|mesh-list
139436278|NCT03120715|Dalteparin|dalteparin|mesh-list
139436279|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139436280|NCT03120715|Progesterone|progesterone|mesh-list
139436281|NCT03120715|Estrogens|estrogens|mesh-list
139436282|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
139436283|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139436284|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139436285|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436286|NCT03120715|Progestins|progestins|mesh-ancestor
139436287|NCT03120715|Hormones|hormones|mesh-ancestor
139436288|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139436289|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436290|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139436291|NCT03120403|Morphine|morphine|mesh-list
139436292|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139436293|NCT03120403|Narcotics|narcotics|mesh-ancestor
139436294|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436295|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436296|NCT03120403|Analgesics|analgesics|mesh-ancestor
139436297|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
139436298|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436299|NCT03335293|Epinephrine|epinephrine|mesh-list
139436300|NCT03335293|Racepinephrine|racepinephrine|mesh-list
139436301|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
139436302|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139436303|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139436304|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
139436305|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436306|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436307|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436308|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139436309|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139436310|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
139436311|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436312|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139436313|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
139436314|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
139436315|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
139436316|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139436317|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139436318|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139436319|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436320|NCT03340597|Olorofim|olorofim|mesh-list
139436321|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
139436322|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139436323|NCT00707161|Cisplatin|cisplatin|mesh-list
139436324|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436325|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
139436326|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139436327|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436328|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436329|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139436330|NCT03120247|Analgesics|analgesics|mesh-ancestor
139436331|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
139436332|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436333|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139436334|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139436336|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
139436337|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436338|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436339|NCT03335059|Mitomycins|mitomycins|mesh-list
139436340|NCT03335059|Mitomycin|mitomycin|mesh-list
139436341|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139436342|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436343|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
139436344|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436345|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139436346|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436347|NCT03334981|Buprenorphine|buprenorphine|mesh-list
139436348|NCT03334981|Methadone|methadone|mesh-list
139436349|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139436350|NCT03334981|Narcotics|narcotics|mesh-ancestor
139436351|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436352|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436353|NCT03334981|Analgesics|analgesics|mesh-ancestor
139436354|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
139436355|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436356|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139436357|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
139436358|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
139436359|NCT02492503|Paclitaxel|paclitaxel|mesh-list
139436360|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139436361|NCT02492503|Carboplatin|carboplatin|mesh-list
139436362|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139436363|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436364|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
139436365|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
139436366|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
139436367|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436368|NCT03334591|Apatinib|apatinib|mesh-list
139436369|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436370|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139436371|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436372|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436373|NCT03334513|Bevacizumab|bevacizumab|mesh-list
139436374|NCT03334513|Ranibizumab|ranibizumab|mesh-list
139436375|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139436376|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436377|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139436378|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139436379|NCT03334513|Growth Substances|growth substances|mesh-ancestor
139436380|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436381|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
139436382|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
139436383|NCT02130466|Trametinib|trametinib|mesh-list
139436384|NCT02130466|Dabrafenib|dabrafenib|mesh-list
139436385|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139436386|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436387|NCT02130466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139436388|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436389|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139436390|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436391|NCT03339427|Vitamin D|vitamin d|mesh-list
139436392|NCT03339427|Vitamins|vitamins|mesh-ancestor
139436393|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
139436394|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436395|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139436396|NCT03339349|Enoxaparin|enoxaparin|mesh-list
139436397|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
139436398|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139436399|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139436400|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436401|NCT02496715|Fluticasone|fluticasone|mesh-list
139436402|NCT02496715|Xhance|xhance|mesh-list
139436403|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139436404|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139436405|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139436406|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
139223139|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
139436407|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436408|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436409|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139436410|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
139436412|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139436413|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139436414|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139436415|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139436416|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
139436417|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436418|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436419|NCT02492581|Nalmefene|nalmefene|mesh-list
139436420|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139436421|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436422|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
139436423|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436424|NCT04494763|Propranolol|propranolol|mesh-list
139436425|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139436426|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139436427|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
139436428|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436429|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436430|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436431|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139436432|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139436433|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
139436434|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
139436435|NCT02162758|Lansoprazole|lansoprazole|mesh-list
139436436|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139436437|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139436438|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139436439|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436440|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436441|NCT03333499|Trimetazidine|trimetazidine|mesh-list
139436442|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
139436443|NCT03340753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139436444|NCT03340753|Mineralocorticoids|mineralocorticoids|mesh-list
139436445|NCT03340753|Hormone Antagonists|hormone antagonists|mesh-ancestor
139436446|NCT03340753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139436447|NCT03340753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436448|NCT03340753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139436449|NCT03340753|Diuretics|diuretics|mesh-ancestor
139436450|NCT03340753|Natriuretic Agents|natriuretic agents|mesh-ancestor
139436451|NCT03340753|Hormones|hormones|mesh-ancestor
139436452|NCT02491879|Ketoprofen|ketoprofen|mesh-list
139436453|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139436454|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139436455|NCT02491879|Analgesics|analgesics|mesh-ancestor
139436456|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
139436457|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436458|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436459|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139436460|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139436461|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139436462|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436463|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436464|NCT03332953|Nicotine|nicotine|mesh-list
139436465|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139436466|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
139436467|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436468|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436469|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139436470|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139436471|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
139436472|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436473|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436474|NCT02491723|Azithromycin|azithromycin|mesh-list
139436475|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139436476|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139436477|NCT03332719|Etanercept|etanercept|mesh-list
139436478|NCT03332719|Methotrexate|methotrexate|mesh-list
139436479|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139436480|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
139436481|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139436482|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436483|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139436484|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
139436485|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436486|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436487|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
139436488|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436489|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139436490|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139436491|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
139436492|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139436493|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139436494|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139436495|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139436497|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
139436498|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436499|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139436500|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139436501|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
139436502|NCT03330613|Anesthetics|anesthetics|mesh-list
139436503|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436504|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436505|NCT03332329|Entecavir|entecavir|mesh-list
139436506|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139436507|NCT03332329|Molgramostim|molgramostim|mesh-list
139436508|NCT03332329|Vaccines|vaccines|mesh-list
139436509|NCT03332329|Sargramostim|sargramostim|mesh-list
139436510|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
139436511|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436512|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
139436513|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139436514|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436515|NCT03330223|Clopidogrel|clopidogrel|mesh-list
139436516|NCT03330223|Ticagrelor|ticagrelor|mesh-list
139436517|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139436518|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139436519|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139436520|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139436521|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
139436522|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436523|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436524|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436525|NCT03331861|Metformin|metformin|mesh-list
139436526|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139436527|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436528|NCT03329443|Spironolactone|spironolactone|mesh-list
139436529|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139436530|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
139436531|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139436532|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436533|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139436534|NCT03329443|Diuretics|diuretics|mesh-ancestor
139436535|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
139436536|NCT03328975|Dexamethasone|dexamethasone|mesh-list
139436537|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139436538|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
139436539|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
139436540|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436541|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436542|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139436543|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
139436544|NCT03328975|Hormones|hormones|mesh-ancestor
139436545|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139436546|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139436547|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436548|NCT05430711|Dinoprostone|dinoprostone|mesh-list
139436549|NCT05430711|Oxytocics|oxytocics|mesh-ancestor
139436550|NCT05430711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139436551|NCT05430711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436552|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
139436553|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139436554|NCT03324685|Estradiol|estradiol|mesh-list
139436555|NCT03324685|Estrogens|estrogens|mesh-ancestor
139436556|NCT03324685|Hormones|hormones|mesh-ancestor
139223290|NCT05200260|Niraparib|niraparib|mesh-list
139436557|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139436558|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436559|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139436560|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
139436561|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139436562|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139436563|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139436564|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139436565|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139436566|NCT03324139|Heparin|heparin|mesh-list
139436567|NCT03324139|Calcium heparin|calcium heparin|mesh-list
139436568|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139436569|NCT03324139|Tinzaparin|tinzaparin|mesh-list
139436570|NCT03324139|Dalteparin|dalteparin|mesh-list
139436571|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
139436572|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139436573|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139436574|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436575|NCT03324061|Fulvestrant|fulvestrant|mesh-list
139436576|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139436577|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436578|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139436579|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139436580|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
139436581|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139436582|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436583|NCT02488603|Tamoxifen|tamoxifen|mesh-list
139436584|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139436585|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
139436586|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139436587|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436588|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139436589|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436590|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139436591|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139436592|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139436593|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
139436594|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436595|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139436596|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436597|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436598|NCT05430087|Vitamin D|vitamin d|mesh-list
139436599|NCT05430087|Cholecalciferol|cholecalciferol|mesh-list
139436600|NCT05430087|Curcumin|curcumin|mesh-list
139436601|NCT05430087|Piperine|piperine|mesh-list
139436602|NCT05430087|Vitamins|vitamins|mesh-ancestor
139436603|NCT05430087|Micronutrients|micronutrients|mesh-ancestor
139436604|NCT05430087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436605|NCT05430087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139436606|NCT05430087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139436607|NCT05430087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139436608|NCT05430087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139436609|NCT05430087|Analgesics|analgesics|mesh-ancestor
139436610|NCT05430087|Sensory System Agents|sensory system agents|mesh-ancestor
139436611|NCT05430087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436612|NCT05430087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139436613|NCT05430087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139436614|NCT05430087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436615|NCT05430087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436616|NCT05430087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436617|NCT05430087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139436618|NCT03327727|Voriconazole|voriconazole|mesh-list
139436619|NCT03327727|Amphotericin B|amphotericin b|mesh-list
139436620|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139436621|NCT03327727|Isavuconazole|isavuconazole|mesh-list
139436622|NCT03327727|VL-2397|vl-2397|mesh-list
139436623|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
139436624|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139436625|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139436626|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139436627|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436628|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436629|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139436630|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
139436631|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139436632|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436633|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139436634|NCT03327727|Amebicides|amebicides|mesh-ancestor
139436635|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139436636|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139436637|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139436638|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
139436639|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139436640|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139436641|NCT03323671|Analgesics|analgesics|mesh-ancestor
139436642|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
139436643|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436644|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436645|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139436646|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139436647|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139436648|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436649|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436650|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
139436651|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139436652|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436653|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436654|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139436655|NCT03323593|Analgesics|analgesics|mesh-ancestor
139436656|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
139436657|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436658|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139436659|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139436660|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139436661|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
139436662|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436663|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436664|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
139436665|NCT02499003|Pixantrone|pixantrone|mesh-list
139436666|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139436667|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436668|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139436669|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139436670|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436671|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436672|NCT04492813|Remifentanil|remifentanil|mesh-list
139436673|NCT04492813|Propofol|propofol|mesh-list
139436674|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139436675|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436676|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436677|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139436678|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
139436679|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
139436680|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139436681|NCT04492813|Narcotics|narcotics|mesh-ancestor
139436682|NCT04492813|Analgesics|analgesics|mesh-ancestor
139436683|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
139436684|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436685|NCT03102801|Insulin|insulin|mesh-list
139436686|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139436687|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139436688|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436689|NCT02488057|Liraglutide|liraglutide|mesh-list
139436690|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139436691|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436692|NCT02488057|Incretins|incretins|mesh-ancestor
139436693|NCT02488057|Hormones|hormones|mesh-ancestor
139436694|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139436695|NCT04039347|Cyclosporine|cyclosporine|mesh-list
139436696|NCT04039347|Cyclosporins|cyclosporins|mesh-list
139436697|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436698|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436699|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139436700|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
139436701|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436702|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
139436703|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223436|NCT03672812|Liraglutide|liraglutide|mesh-list
139436705|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139436706|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139436707|NCT02488291|Sufentanil|sufentanil|mesh-list
139436708|NCT02488291|Dsuvia|dsuvia|mesh-list
139436709|NCT02488291|Ropivacaine|ropivacaine|mesh-list
139436710|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
139436711|NCT02488291|Anesthetics|anesthetics|mesh-list
139436712|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436713|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436714|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
139436715|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436716|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139436717|NCT02488291|Narcotics|narcotics|mesh-ancestor
139436718|NCT02488291|Analgesics|analgesics|mesh-ancestor
139436719|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139436720|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139436721|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
139436722|NCT03323047|Acetaminophen|acetaminophen|mesh-list
139436723|NCT03323047|Dexamethasone|dexamethasone|mesh-list
139436724|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
139436725|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139436726|NCT03323047|BB 1101|bb 1101|mesh-list
139436727|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139436728|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
139436729|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
139436730|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436731|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436732|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139436733|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
139436734|NCT03323047|Hormones|hormones|mesh-ancestor
139436735|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139436736|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139436737|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436738|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
139436739|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436740|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436741|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139436742|NCT03323047|Analgesics|analgesics|mesh-ancestor
139436743|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
139436744|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
139436745|NCT03322969|Paclitaxel|paclitaxel|mesh-list
139436746|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139436747|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436748|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
139436749|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
139436750|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
139436751|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436752|NCT05464303|Antibodies|antibodies|mesh-list
139436753|NCT05464303|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139436754|NCT05464303|gamma-Globulins|gamma-globulins|mesh-list
139436755|NCT05464303|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139436756|NCT05464303|Immunologic Factors|immunologic factors|mesh-ancestor
139436757|NCT05464303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436758|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
139436759|NCT03322735|Fludarabine|fludarabine|mesh-list
139436760|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139436761|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
139436762|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436763|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139436764|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139436765|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
139436766|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436767|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436768|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139436769|NCT02487823|Bicalutamide|bicalutamide|mesh-list
139436770|NCT02487823|Buserelin|buserelin|mesh-list
139436771|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
139436772|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
139436773|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139436774|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436775|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436776|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139436777|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
139436778|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139436779|NCT05463913|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139436780|NCT05463913|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139436781|NCT05463913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436783|NCT02487433|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139436784|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139436785|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436786|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436787|NCT04493125|Mosapride|mosapride|mesh-list
139436788|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436789|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139436790|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139436791|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
139436792|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436793|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436794|NCT03318835|Thalidomide|thalidomide|mesh-list
139436795|NCT03318835|Prednisone|prednisone|mesh-list
139436796|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
139436797|NCT03318835|Vincristine|vincristine|mesh-list
139436798|NCT03318835|Rituximab|rituximab|mesh-list
139436799|NCT03318835|Doxorubicin|doxorubicin|mesh-list
139436800|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139436801|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
139436802|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436803|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
139436804|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139436805|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139436806|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139436807|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139436808|NCT03318835|Growth Substances|growth substances|mesh-ancestor
139436809|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
139436810|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436811|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139436812|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139436813|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
139436814|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436815|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139436816|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139436817|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
139436818|NCT03318835|Hormones|hormones|mesh-ancestor
139436819|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139436820|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139436821|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139436822|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
139436823|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
139436824|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
139436825|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139436826|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139436827|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139436828|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139436829|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436830|NCT03318757|Bupivacaine|bupivacaine|mesh-list
139436831|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
139436832|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
139436833|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436834|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436835|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
139436836|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436837|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
139436838|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
139436839|NCT02487355|Bupivacaine|bupivacaine|mesh-list
139436840|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
139436841|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
139436842|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436843|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436844|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
139436845|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436846|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139436847|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139436848|NCT02487355|Analgesics|analgesics|mesh-ancestor
139436849|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139436850|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139436851|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139436852|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
139436853|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436854|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436855|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139436856|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
139436857|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139436858|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139436859|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139436860|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
139436861|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139436862|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
139436863|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139436864|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436865|NCT03325465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139436866|NCT03325465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436867|NCT01876953|Cytarabine|cytarabine|mesh-list
139436868|NCT01876953|Dasatinib|dasatinib|mesh-list
139436869|NCT01876953|Idarubicin|idarubicin|mesh-list
139436870|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139436871|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
139436872|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436873|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436874|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
139436875|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139436876|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139436877|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
139436878|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436879|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139436880|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436881|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139436882|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139436883|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139436884|NCT03321955|Ziconotide|ziconotide|mesh-list
139436885|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139436886|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139436887|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436888|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139436889|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436890|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139436891|NCT03321955|Protective Agents|protective agents|mesh-ancestor
139436892|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139436893|NCT03321955|Analgesics|analgesics|mesh-ancestor
139436894|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
139436895|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436896|NCT04493281|Edaravone|edaravone|mesh-list
139436897|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139436898|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
139436899|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436900|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139436901|NCT04493281|Protective Agents|protective agents|mesh-ancestor
139436902|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436903|NCT01764711|Cosyntropin|cosyntropin|mesh-list
139436904|NCT01764711|Hormones|hormones|mesh-ancestor
139436905|NCT01764711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139436906|NCT01764711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436907|NCT04493515|Oxytocin|oxytocin|mesh-list
139436908|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
139436909|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139436910|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436911|NCT03318445|Irinotecan|irinotecan|mesh-list
139436912|NCT03318445|Rucaparib|rucaparib|mesh-list
139436913|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139436914|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139436915|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436916|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436917|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436918|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139436919|NCT02485015|Apatinib|apatinib|mesh-list
139436920|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436921|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139436922|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139436923|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436924|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
139436925|NCT03316339|Remifentanil|remifentanil|mesh-list
139436926|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139436927|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223658|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139436928|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436929|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139436930|NCT03316339|Analgesics|analgesics|mesh-ancestor
139436931|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
139436932|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436933|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139436934|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139436935|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139436936|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
139436937|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139436938|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436939|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139436940|NCT03316339|Narcotics|narcotics|mesh-ancestor
139436942|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139436943|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139436944|NCT02490865|Analgesics|analgesics|mesh-ancestor
139436945|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
139436946|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436947|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436948|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139436949|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139436950|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139436951|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
139436952|NCT03318211|Analgesics|analgesics|mesh-ancestor
139436953|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
139436954|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436955|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436956|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
139436957|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436958|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139436959|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
139436960|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139436961|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139436962|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436963|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139436964|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
139436965|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139436966|NCT02483767|Goserelin|goserelin|mesh-list
139436967|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139436968|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139436969|NCT02483845|Natalizumab|natalizumab|mesh-list
139436970|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
139436971|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436972|NCT02486341|Insulin|insulin|mesh-list
139436973|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139436974|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436975|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139436976|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
139436977|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139436978|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139436979|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139436980|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139436981|NCT02483923|Ropivacaine|ropivacaine|mesh-list
139436982|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
139436983|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
139436984|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436985|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436986|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
139436987|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436988|NCT02483689|Bupivacaine|bupivacaine|mesh-list
139436989|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
139436990|NCT02483689|Anesthetics|anesthetics|mesh-list
139436991|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139436992|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436993|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
139436994|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139436995|NCT02490085|Insulin|insulin|mesh-list
139436996|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139436997|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139436998|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139436999|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
139437000|NCT03102021|Hematinics|hematinics|mesh-ancestor
139437001|NCT04916691|Ropivacaine|ropivacaine|mesh-list
139437002|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
139437003|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
139437004|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437005|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437006|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
139437007|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437008|NCT05105139|Triclosan|triclosan|mesh-list
139437009|NCT05105139|Coal Tar|coal tar|mesh-list
139437010|NCT05105139|Allantoin|allantoin|mesh-list
139437011|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139437012|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437013|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139437014|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139437015|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
139437016|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437017|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139437018|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
139437019|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
139437020|NCT03317275|Fluorides|fluorides|mesh-list
139437021|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
139437022|NCT03317275|Protective Agents|protective agents|mesh-ancestor
139437023|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437024|NCT03317197|Vasopressins|vasopressins|mesh-list
139437025|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
139437026|NCT03317197|Epinephrine|epinephrine|mesh-list
139437027|NCT03317197|Racepinephrine|racepinephrine|mesh-list
139437028|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
139437029|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139437030|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139437031|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
139437032|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437033|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437034|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437035|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139437036|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139437037|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
139437038|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437039|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139437040|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
139437041|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
139437042|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
139437043|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139437044|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
139437045|NCT03317197|Coagulants|coagulants|mesh-ancestor
139437046|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139437047|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
139437048|NCT02483299|Metformin|metformin|mesh-list
139437049|NCT02483299|Liraglutide|liraglutide|mesh-list
139437050|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139437051|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437052|NCT02483299|Incretins|incretins|mesh-ancestor
139437053|NCT02483299|Hormones|hormones|mesh-ancestor
139437054|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139437055|NCT01597479|Anesthetics|anesthetics|mesh-list
139437056|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
139437057|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
139437058|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437059|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437060|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
139437061|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437062|NCT03316963|Neostigmine|neostigmine|mesh-list
139437063|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139437064|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437065|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437066|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
139437067|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437068|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437069|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139437070|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
139437071|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437072|NCT02489929|Azacitidine|azacitidine|mesh-list
139437073|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139437074|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
139437075|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437076|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437077|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437078|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139437079|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
139437080|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
139437081|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
139437082|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437083|NCT02483143|Expectorants|expectorants|mesh-ancestor
139437084|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
139437085|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139437086|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
139437087|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437088|NCT02483143|Protective Agents|protective agents|mesh-ancestor
139437089|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437090|NCT02483221|Morphine|morphine|mesh-list
139437091|NCT02483221|Hydromorphone|hydromorphone|mesh-list
139437092|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139437093|NCT02483221|Narcotics|narcotics|mesh-ancestor
139437094|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437095|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437096|NCT02483221|Analgesics|analgesics|mesh-ancestor
139437097|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
139437098|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437099|NCT02489461|Efavirenz|efavirenz|mesh-list
139437100|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
139437101|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139437102|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139437103|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139437104|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437105|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437106|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
139437107|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437108|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139437109|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139437110|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139437111|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139437112|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139437113|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139437114|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139437115|NCT02485873|Vitamin K|vitamin k|mesh-list
139437116|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
139437117|NCT02485873|Vitamins|vitamins|mesh-ancestor
139437118|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
139437119|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437120|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139437121|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
139437122|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139437123|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
139437124|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437125|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437126|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
139437127|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139437128|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139437129|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
139437130|NCT02485873|Coagulants|coagulants|mesh-ancestor
139437131|NCT04412421|Vitamins|vitamins|mesh-list
139437132|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
139437133|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437134|NCT03315091|Adavosertib|adavosertib|mesh-list
139437135|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437136|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437137|NCT02488993|Rifaximin|rifaximin|mesh-list
139437138|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139437139|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437140|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139437141|NCT02485327|Insulin|insulin|mesh-list
139437142|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139437143|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139437144|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437145|NCT02485249|Dexamethasone|dexamethasone|mesh-list
139437146|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
139437147|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139437148|NCT02485249|BB 1101|bb 1101|mesh-list
139437149|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139437150|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
139437151|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
139437152|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437153|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437154|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139437155|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
139437156|NCT02485249|Hormones|hormones|mesh-ancestor
139642357|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437157|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139437158|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139437159|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437160|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
139437161|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437162|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437163|NCT03320707|Daratumumab|daratumumab|mesh-list
139437164|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437165|NCT03320629|Apatinib|apatinib|mesh-list
139437166|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437167|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139437168|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437169|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437170|NCT03316417|Immunomodulating Agents|immunomodulating agents|mesh-list
139437171|NCT03316417|Immunologic Factors|immunologic factors|mesh-ancestor
139437172|NCT03316417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437173|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139437174|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139437175|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139437176|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
139437177|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437178|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139437179|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139437180|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437181|NCT02476981|Ephedrine|ephedrine|mesh-list
139437182|NCT02476981|Midazolam|midazolam|mesh-list
139437183|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
139437184|NCT02476981|Remifentanil|remifentanil|mesh-list
139437185|NCT02476981|Propofol|propofol|mesh-list
139437186|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139437187|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437188|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437189|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139437190|NCT02476981|Analgesics|analgesics|mesh-ancestor
139437191|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
139437192|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437193|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139437194|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139437195|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139437196|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
139437197|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437198|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437199|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139437200|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
139437201|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
139437202|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139437203|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139437204|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139437205|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139437206|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
139437207|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
139437208|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139437209|NCT02476981|Narcotics|narcotics|mesh-ancestor
139437210|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139437211|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
139437212|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
139437213|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139437214|NCT04248465|Ravulizumab|ravulizumab|mesh-list
139437215|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139437216|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139437217|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
139437218|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437219|NCT02480335|Bosentan|bosentan|mesh-list
139437220|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139437221|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139437222|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437223|NCT05245227|Misoprostol|misoprostol|mesh-list
139437224|NCT05245227|Oxytocin|oxytocin|mesh-list
139437225|NCT05245227|Oxytocics|oxytocics|mesh-ancestor
139437226|NCT05245227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139437227|NCT05245227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437228|NCT05245227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139437229|NCT05245227|Abortifacient Agents|abortifacient agents|mesh-ancestor
139437230|NCT05245227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139437231|NCT05245227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139437232|NCT02479867|Cefadroxil|cefadroxil|mesh-list
139437233|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139437234|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437235|NCT05244837|Paclitaxel|paclitaxel|mesh-list
139437236|NCT05244837|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139437237|NCT05244837|Carboplatin|carboplatin|mesh-list
139437238|NCT05244837|Pemetrexed|pemetrexed|mesh-list
139437239|NCT05244837|Tislelizumab|tislelizumab|mesh-list
139437240|NCT05244837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139437241|NCT05244837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437242|NCT05244837|Tubulin Modulators|tubulin modulators|mesh-ancestor
139437243|NCT05244837|Antimitotic Agents|antimitotic agents|mesh-ancestor
139437244|NCT05244837|Mitosis Modulators|mitosis modulators|mesh-ancestor
139437245|NCT05244837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437246|NCT05244837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437247|NCT05244837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139437248|NCT05244837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139437249|NCT05244837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139437250|NCT03103893|Sirolimus|sirolimus|mesh-list
139437251|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139437252|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437253|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139437254|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437255|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
139437256|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139437257|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
139437258|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437259|NCT02479789|Lidocaine|lidocaine|mesh-list
139437260|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
139437261|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
139437262|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437263|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437264|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
139437265|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437266|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139437267|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139437268|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139437269|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139437270|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437271|NCT02726113|Vitamin D|vitamin d|mesh-list
139437272|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
139437273|NCT02726113|Vitamins|vitamins|mesh-ancestor
139437274|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
139437275|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437276|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139437277|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139437278|NCT05243355|Endostatins|endostatins|mesh-list
139437279|NCT05243355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437280|NCT05243355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139437281|NCT05243355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139437282|NCT05243355|Growth Substances|growth substances|mesh-ancestor
139437283|NCT05243355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437284|NCT05243355|Growth Inhibitors|growth inhibitors|mesh-ancestor
139437285|NCT02479711|Methamphetamine|methamphetamine|mesh-list
139437286|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139437287|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437288|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
139437289|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
139437290|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437291|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
139437292|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437293|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437294|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
139437295|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139437296|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139437297|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139437298|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139437299|NCT05196945|Amoxicillin|amoxicillin|mesh-list
139437300|NCT05196945|Clarithromycin|clarithromycin|mesh-list
139437301|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
139437302|NCT05196945|Esomeprazole|esomeprazole|mesh-list
139437303|NCT05196945|Bismuth|bismuth|mesh-list
139437304|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437305|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139437306|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437307|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139437308|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139437309|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139437310|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437311|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139437312|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139437313|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139437314|NCT05196945|Antacids|antacids|mesh-ancestor
139437315|NCT05196945|Diuretics|diuretics|mesh-ancestor
139437316|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
139437317|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437318|NCT05196945|Expectorants|expectorants|mesh-ancestor
139437319|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
139437320|NCT03800979|Tofacitinib|tofacitinib|mesh-list
139437321|NCT03800979|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139437322|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139437323|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437324|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437325|NCT02476123|Nivolumab|nivolumab|mesh-list
139437326|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
139437327|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139437328|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437329|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139437330|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437331|NCT02481193|Cisatracurium|cisatracurium|mesh-list
139437332|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139437333|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139437334|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437335|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437336|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
139437337|NCT03101709|Fludarabine|fludarabine|mesh-list
139437338|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139437339|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
139437340|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437341|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139437342|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139437343|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
139437344|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437345|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437346|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139437347|NCT03101319|Vitamin D|vitamin d|mesh-list
139437348|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
139437349|NCT03101319|Vitamins|vitamins|mesh-ancestor
139437350|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
139437351|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437352|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139095673|NCT03054766|Ranibizumab|ranibizumab|mesh-list
139437353|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139437354|NCT02479555|Dexamethasone|dexamethasone|mesh-list
139437355|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
139437356|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139437357|NCT02479555|BB 1101|bb 1101|mesh-list
139437358|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139437359|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
139437360|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
139437361|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437362|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437363|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139437364|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
139437365|NCT02479555|Hormones|hormones|mesh-ancestor
139437366|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139437367|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139437368|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437369|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
139437370|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437371|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437372|NCT02476045|Leucovorin|leucovorin|mesh-list
139437373|NCT02476045|Fluorouracil|fluorouracil|mesh-list
139437374|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
139437375|NCT02476045|Panitumumab|panitumumab|mesh-list
139437376|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
139437377|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
139437378|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437379|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139437380|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437381|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139437382|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
139437383|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437384|NCT02476045|Antidotes|antidotes|mesh-ancestor
139437385|NCT02476045|Protective Agents|protective agents|mesh-ancestor
139437386|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
139437387|NCT02476045|Vitamins|vitamins|mesh-ancestor
139437388|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
139437389|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139437390|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
139437391|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139437392|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437393|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139437394|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437395|NCT03885921|Atorvastatin|atorvastatin|mesh-list
139437396|NCT03885921|Simvastatin|simvastatin|mesh-list
139437397|NCT03885921|Ezetimibe|ezetimibe|mesh-list
139437398|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139437399|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139437400|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
139437401|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437402|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139437403|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139437404|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437405|NCT02480881|Fostemsavir|fostemsavir|mesh-list
139437406|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
139437407|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
139437408|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
139437409|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139437410|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437411|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139437412|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139437413|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139437414|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139437415|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
139437416|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139437417|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139437418|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139437419|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
139437420|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437421|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139437422|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139437423|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437424|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
139437425|NCT02480647|Etonogestrel|etonogestrel|mesh-list
139437426|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139437427|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
139437428|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139437429|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437430|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139437431|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139437432|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139437433|NCT03100071|Apixaban|apixaban|mesh-list
139437434|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139437435|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
139437436|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139437437|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
139437438|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437439|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437440|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
139437441|NCT02479165|Oxycodone|oxycodone|mesh-list
139437442|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139437443|NCT02479165|Narcotics|narcotics|mesh-ancestor
139437444|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437445|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437446|NCT02479165|Analgesics|analgesics|mesh-ancestor
139437447|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
139437448|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437449|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
139437450|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139437451|NCT05072691|Antibodies|antibodies|mesh-list
139437452|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
139437453|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437454|NCT05377255|Naloxone|naloxone|mesh-list
139437455|NCT05377255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139437456|NCT05377255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437457|NCT05377255|Sensory System Agents|sensory system agents|mesh-ancestor
139642358|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
139437458|NCT05377255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437459|NCT02475499|Metformin|metformin|mesh-list
139437460|NCT02475499|Pioglitazone|pioglitazone|mesh-list
139437461|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139437462|NCT02475499|Liraglutide|liraglutide|mesh-list
139437463|NCT02475499|Exenatide|exenatide|mesh-list
139437464|NCT02475499|Glimepiride|glimepiride|mesh-list
139437465|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
139437466|NCT02475499|Vildagliptin|vildagliptin|mesh-list
139437467|NCT02475499|Saxagliptin|saxagliptin|mesh-list
139437468|NCT02475499|Acarbose|acarbose|mesh-list
139437469|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139437470|NCT02475499|Repaglinide|repaglinide|mesh-list
139437471|NCT02475499|Gliclazide|gliclazide|mesh-list
139437472|NCT02475499|Glipizide|glipizide|mesh-list
139437473|NCT02475499|Biguanides|biguanides|mesh-list
139437474|NCT02475499|Tolbutamide|tolbutamide|mesh-list
139437475|NCT02475499|Voglibose|voglibose|mesh-list
139437476|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
139437477|NCT02475499|Nateglinide|nateglinide|mesh-list
139437478|NCT02475499|Miglitol|miglitol|mesh-list
139437479|NCT02475499|Troglitazone|troglitazone|mesh-list
139437480|NCT02475499|Meglitinide|meglitinide|mesh-list
139437481|NCT02475499|Acetohexamide|acetohexamide|mesh-list
139437482|NCT02475499|Buformin|buformin|mesh-list
139437483|NCT02475499|Phenformin|phenformin|mesh-list
139437484|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
139437485|NCT02475499|Glibornuride|glibornuride|mesh-list
139437486|NCT02475499|Tolazamide|tolazamide|mesh-list
139437487|NCT02475499|Carbutamide|carbutamide|mesh-list
139437488|NCT02475499|Gliquidone|gliquidone|mesh-list
139437489|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139437490|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
139437491|NCT02475499|Incretins|incretins|mesh-list
139437492|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437493|NCT02475499|Hormones|hormones|mesh-ancestor
139437494|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139437495|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
139437496|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437497|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437498|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139437499|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139437500|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139437501|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
139437502|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
139437503|NCT03375645|Narcotics|narcotics|mesh-ancestor
139437504|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437505|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437506|NCT03375645|Analgesics|analgesics|mesh-ancestor
139437507|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
139437508|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437509|NCT03136809|Copper|copper|mesh-list
139437510|NCT03136809|Trace Elements|trace elements|mesh-ancestor
139437511|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
139437512|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437513|NCT02475421|Glucagon|glucagon|mesh-list
139437514|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139437515|NCT02475421|Hormones|hormones|mesh-ancestor
139437516|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139437517|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437518|NCT02475343|Riboflavin|riboflavin|mesh-list
139437519|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
139437520|NCT02475343|Vitamins|vitamins|mesh-ancestor
139437521|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
139437522|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437523|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139437524|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
139437525|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139437526|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139437527|NCT04492501|Remdesivir|remdesivir|mesh-list
139437528|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
139437529|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437530|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
139437531|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437532|NCT03101085|Equol|equol|mesh-list
139224269|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139437533|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
139437534|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139437535|NCT03101085|Estrogens|estrogens|mesh-ancestor
139437536|NCT03101085|Hormones|hormones|mesh-ancestor
139437537|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139437538|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437539|NCT05070195|Midazolam|midazolam|mesh-list
139437540|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139437541|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139437542|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437543|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437544|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139437545|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139437546|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139437547|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139437548|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
139437549|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
139437550|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
139437551|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
139437552|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437553|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437554|NCT02474953|Curcumin|curcumin|mesh-list
139437555|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139437556|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139437557|NCT02474953|Analgesics|analgesics|mesh-ancestor
139437558|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
139437559|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437560|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437561|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139437562|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139437563|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437564|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437565|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437566|NCT05714371|Pembrolizumab|pembrolizumab|mesh-list
139437567|NCT05714371|Nivolumab|nivolumab|mesh-list
139437568|NCT05714371|Ipilimumab|ipilimumab|mesh-list
139437569|NCT05714371|Trametinib|trametinib|mesh-list
139437570|NCT05714371|Dabrafenib|dabrafenib|mesh-list
139437571|NCT05714371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139437572|NCT05714371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437573|NCT05714371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139437574|NCT05714371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437575|NCT05714371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139437576|NCT05714371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437577|NCT02472613|Fluoxetine|fluoxetine|mesh-list
139437578|NCT02472613|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139437579|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139437580|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139437581|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437582|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437583|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
139437584|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437585|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139437586|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
139437587|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139437588|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139437589|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139437590|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437591|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
139437592|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139437593|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
139437594|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139437595|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
139437596|NCT02478229|Ledipasvir|ledipasvir|mesh-list
139437597|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
139437598|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437599|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139437600|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139437601|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139437602|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437603|NCT05713045|Vitamin K 1|vitamin k 1|mesh-list
139437604|NCT05713045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139437605|NCT05713045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139437606|NCT05713045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437607|NCT05713045|Hemostatics|hemostatics|mesh-ancestor
139437608|NCT05713045|Coagulants|coagulants|mesh-ancestor
139437609|NCT05713045|Vitamins|vitamins|mesh-ancestor
139437610|NCT05713045|Micronutrients|micronutrients|mesh-ancestor
139437611|NCT05713045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437612|NCT00653835|Simvastatin|simvastatin|mesh-list
139437613|NCT00653835|Ezetimibe|ezetimibe|mesh-list
139437614|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139437615|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139437616|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
139437617|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437618|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139437619|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139437620|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437622|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
139437623|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
139437624|NCT03099759|Vitamins|vitamins|mesh-ancestor
139437625|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
139437626|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437627|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139437628|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139437629|NCT05244577|Olanzapine|olanzapine|mesh-list
139437630|NCT05244577|Antiemetics|antiemetics|mesh-ancestor
139437631|NCT05244577|Autonomic Agents|autonomic agents|mesh-ancestor
139437632|NCT05244577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437633|NCT05244577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437634|NCT05244577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139437635|NCT05244577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139437636|NCT05244577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139437637|NCT05244577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437638|NCT05244577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139437639|NCT05244577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139437640|NCT05244577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139437641|NCT05244577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139437642|NCT05244577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437643|NCT05244577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437644|NCT05244577|Serotonin Agents|serotonin agents|mesh-ancestor
139437645|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139437646|NCT05067699|Calcifediol|calcifediol|mesh-list
139437647|NCT05067699|Vitamins|vitamins|mesh-ancestor
139437648|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
139437649|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437650|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139437651|NCT05067153|Heparin|heparin|mesh-list
139437652|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139437653|NCT05067153|Tinzaparin|tinzaparin|mesh-list
139437654|NCT05067153|Dalteparin|dalteparin|mesh-list
139437655|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
139437656|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139437657|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139437658|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437659|NCT05067309|Letrozole|letrozole|mesh-list
139437660|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437661|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139437662|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139437663|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437664|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437665|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139437666|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
139437667|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139437668|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437669|NCT02474563|Prednisone|prednisone|mesh-list
139437670|NCT02474563|Bortezomib|bortezomib|mesh-list
139437671|NCT02474563|Melphalan|melphalan|mesh-list
139437672|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139437673|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
139437674|NCT02474563|Hormones|hormones|mesh-ancestor
139437675|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139437676|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437677|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139437678|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437679|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139437680|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
139437681|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437682|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139437683|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139437684|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
139437685|NCT02477995|Vaccines|vaccines|mesh-list
139437686|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
139437687|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437688|NCT03098823|Prednisone|prednisone|mesh-list
139437689|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139437690|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
139437691|NCT03098823|Hormones|hormones|mesh-ancestor
139437692|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139437693|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437694|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139437696|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
139437697|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139437698|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437699|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437700|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139437701|NCT03108937|Analgesics|analgesics|mesh-ancestor
139437702|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
139437703|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437704|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139437705|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139437706|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139437707|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
139437708|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437709|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437710|NCT03913845|Lidocaine|lidocaine|mesh-list
139437711|NCT03913845|Epinephrine|epinephrine|mesh-list
139437712|NCT03913845|Racepinephrine|racepinephrine|mesh-list
139437713|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
139437714|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
139437715|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
139437716|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437717|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437718|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
139437719|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437720|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139437721|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139437722|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139437723|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139437724|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437725|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139437726|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139437727|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
139437728|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437729|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139437730|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139437731|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
139437732|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139437733|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
139437734|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
139437735|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
139437736|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139437737|NCT00705523|Varenicline|varenicline|mesh-list
139437738|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139437739|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139437740|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
139437741|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437742|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437743|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437744|NCT03903939|Iloprost|iloprost|mesh-list
139437745|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139437746|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
139437747|NCT02725411|Celecoxib|celecoxib|mesh-list
139437748|NCT02725411|Tanezumab|tanezumab|mesh-list
139437749|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139437750|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139437751|NCT02725411|Analgesics|analgesics|mesh-ancestor
139437752|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
139437753|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437754|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437755|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139437756|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139437757|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139437758|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139437759|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437760|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437761|NCT05058105|Meropenem|meropenem|mesh-list
139437762|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139437763|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437764|NCT05649943|Androgens|androgens|mesh-list
139437765|NCT05649943|Hormones|hormones|mesh-ancestor
139437766|NCT05649943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139437767|NCT05649943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437768|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
139437769|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139437770|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437771|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
139437772|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139437773|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139437774|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437775|NCT03099213|Ramipril|ramipril|mesh-list
139437776|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139437777|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
139437778|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437779|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437780|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139437781|NCT05061147|Azacitidine|azacitidine|mesh-list
139437782|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139437783|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
139437784|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437785|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437786|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437787|NCT02127970|Dalbavancin|dalbavancin|mesh-list
139437788|NCT02127970|Teicoplanin|teicoplanin|mesh-list
139437789|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139437790|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437791|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
139437792|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437793|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139437794|NCT02471677|Hormones|hormones|mesh-ancestor
139437795|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139437796|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437797|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
139437798|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139437799|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
139437800|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437801|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
139437802|NCT04755634|Protective Agents|protective agents|mesh-ancestor
139437803|NCT04470843|Acetazolamide|acetazolamide|mesh-list
139437804|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
139437805|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139437806|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437807|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437808|NCT04470843|Diuretics|diuretics|mesh-ancestor
139437809|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
139437810|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437811|NCT05161741|Insulin|insulin|mesh-list
139437812|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139437813|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437814|NCT02473627|Pioglitazone|pioglitazone|mesh-list
139437815|NCT02473627|Tolbutamide|tolbutamide|mesh-list
139437816|NCT02473627|DS-1971a|ds-1971a|mesh-list
139437817|NCT02473627|Midazolam|midazolam|mesh-list
139437818|NCT02473627|Omeprazole|omeprazole|mesh-list
139437819|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139437820|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139437821|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437822|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437823|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139437824|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139437825|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139437826|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139437827|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
139437828|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
139437829|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
139437830|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
139437831|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437832|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437833|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139437834|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139437835|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139437836|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139437837|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139437838|NCT02473627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139437839|NCT02473627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139437840|NCT02473627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139437841|NCT03095703|Sirolimus|sirolimus|mesh-list
139437842|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139437843|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437844|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139437845|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437846|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
139437847|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139437848|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
139437849|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437850|NCT05035953|Edaravone|edaravone|mesh-list
139437851|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139437852|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
139437853|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437854|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139437855|NCT05035953|Protective Agents|protective agents|mesh-ancestor
139437856|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437857|NCT02471209|Sevoflurane|sevoflurane|mesh-list
139437858|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139437859|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139437860|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
139437861|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
139437862|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437863|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437864|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
139437865|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139437866|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
139437867|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437868|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
139437869|NCT02476903|Protective Agents|protective agents|mesh-ancestor
139437870|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
139437871|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139437872|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
139437873|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437874|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437875|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139437876|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
139437877|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
139437878|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139437879|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
139437880|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437881|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437882|NCT04220125|Midazolam|midazolam|mesh-list
139437883|NCT04220125|Ketamine|ketamine|mesh-list
139437884|NCT04220125|Analgesics|analgesics|mesh-ancestor
139437885|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
139437886|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139437887|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437888|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139437889|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139437890|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
139437891|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
139437892|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437893|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139437894|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139437895|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437896|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437897|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139437898|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139437899|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139437900|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139437901|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139437902|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
139437903|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
139437904|NCT02472691|Lenalidomide|lenalidomide|mesh-list
139437905|NCT02472691|Azacitidine|azacitidine|mesh-list
139437906|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
139437907|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437908|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139437909|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139437910|NCT02472691|Growth Substances|growth substances|mesh-ancestor
139437911|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
139437912|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437913|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139437914|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
139437915|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437916|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224656|NCT03167164|Vitamins|vitamins|mesh-ancestor
139437917|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
139437918|NCT02470663|Calcium|calcium|mesh-list
139437919|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139437920|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437921|NCT02470663|Antacids|antacids|mesh-ancestor
139437922|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437923|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139437924|NCT00705367|Abatacept|abatacept|mesh-list
139437925|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139437926|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437927|NCT00705367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139437928|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437929|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139437930|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
139437931|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437932|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139437933|NCT03043729|Leucovorin|leucovorin|mesh-list
139437934|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
139437935|NCT03043729|Aflibercept|aflibercept|mesh-list
139437936|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437937|NCT03043729|Antidotes|antidotes|mesh-ancestor
139437938|NCT03043729|Protective Agents|protective agents|mesh-ancestor
139437939|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437940|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
139437941|NCT03043729|Vitamins|vitamins|mesh-ancestor
139437942|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
139437943|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139437944|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139437945|NCT03043729|Growth Substances|growth substances|mesh-ancestor
139437946|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
139437947|NCT05306431|Biguanides|biguanides|mesh-list
139437948|NCT05306431|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139437949|NCT05306431|Polihexanide|polihexanide|mesh-list
139437950|NCT05306431|Eusol|eusol|mesh-list
139437951|NCT05306431|Disinfectants|disinfectants|mesh-ancestor
139437952|NCT05306431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437953|NCT05306431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139437954|NCT05306431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437955|NCT03108313|Fluorides|fluorides|mesh-list
139437956|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
139437957|NCT03108313|Protective Agents|protective agents|mesh-ancestor
139437958|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437959|NCT03108625|Vortioxetine|vortioxetine|mesh-list
139437960|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
139437961|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139437962|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139437963|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139437964|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139437965|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437966|NCT03108625|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139437967|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139437968|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139437969|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437970|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139437971|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
139437972|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139437973|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139437974|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139437975|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139437976|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
139437977|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139437978|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437979|NCT03310567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139437980|NCT03310567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437981|NCT03900949|Cytarabine|cytarabine|mesh-list
139437982|NCT03900949|Daunorubicin|daunorubicin|mesh-list
139437983|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
139437984|NCT03900949|Midostaurin|midostaurin|mesh-list
139437985|NCT03900949|Calicheamicins|calicheamicins|mesh-list
139437986|NCT03900949|Staurosporine|staurosporine|mesh-list
139437987|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139437988|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
139437989|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139437990|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139437991|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
139437992|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139437993|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139437995|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139437996|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139437997|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139437998|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139437999|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438000|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139438001|NCT03900949|Immunotoxins|immunotoxins|mesh-ancestor
139438002|NCT03900949|Immunoconjugates|immunoconjugates|mesh-ancestor
139438003|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139438004|NCT02468791|Rituximab|rituximab|mesh-list
139438005|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139438006|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438007|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
139438008|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438009|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139438010|NCT02693821|Gabapentin|gabapentin|mesh-list
139438011|NCT02693821|Analgesics|analgesics|mesh-ancestor
139438012|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
139438013|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438014|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438015|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
139438016|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139438017|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139438018|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438019|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139438020|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139438021|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139438022|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438023|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438024|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
139438025|NCT02470117|Antacids|antacids|mesh-list
139438026|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438027|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139438028|NCT03310333|Dinoprostone|dinoprostone|mesh-list
139438029|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
139438030|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139438031|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438032|NCT00705289|Infliximab|infliximab|mesh-list
139438033|NCT00705289|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139438034|NCT00705289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139438035|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
139438036|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139438037|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139438038|NCT03309865|Vedolizumab|vedolizumab|mesh-list
139438039|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139438040|NCT03309709|Progesterone|progesterone|mesh-list
139438041|NCT03309709|Progestins|progestins|mesh-ancestor
139438042|NCT03309709|Hormones|hormones|mesh-ancestor
139438043|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139438044|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438045|NCT01720147|Quercetin|quercetin|mesh-list
139438046|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
139438047|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438048|NCT01720147|Protective Agents|protective agents|mesh-ancestor
139438049|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438050|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
139438051|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139438052|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438053|NCT03309163|Tramadol|tramadol|mesh-list
139438054|NCT03309163|Hydromorphone|hydromorphone|mesh-list
139438055|NCT03309163|Ropivacaine|ropivacaine|mesh-list
139438056|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
139438057|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
139438058|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438059|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438060|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
139438061|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438062|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139438063|NCT03309163|Narcotics|narcotics|mesh-ancestor
139438064|NCT03309163|Analgesics|analgesics|mesh-ancestor
139438065|NCT03174847|Eplerenone|eplerenone|mesh-list
139438066|NCT03174847|Amiloride|amiloride|mesh-list
139438067|NCT03174847|Spironolactone|spironolactone|mesh-list
139438068|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139438069|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
139438070|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
139438071|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139438072|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438073|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139438075|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
139438076|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139438077|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139438078|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139438079|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139438080|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438081|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139438082|NCT03174847|Hormones|hormones|mesh-ancestor
139438083|NCT03313531|Thrombin|thrombin|mesh-list
139438084|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
139438085|NCT03313531|Coagulants|coagulants|mesh-ancestor
139438086|NCT02468167|Polidocanol|polidocanol|mesh-list
139438087|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139438088|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139438089|NCT03308149|Triamcinolone|triamcinolone|mesh-list
139438090|NCT03308149|Bupivacaine|bupivacaine|mesh-list
139438091|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
139438092|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
139438093|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438094|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438095|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
139438096|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438097|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139438098|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
139438099|NCT03308149|Hormones|hormones|mesh-ancestor
139438100|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139438101|NCT03303235|Methylergonovine|methylergonovine|mesh-list
139438102|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
139438103|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139438104|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438105|NCT03307993|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
139438106|NCT03307993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139438107|NCT03307993|Serotonin Agents|serotonin agents|mesh-ancestor
139438108|NCT03307993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438109|NCT03307993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438110|NCT03307993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438111|NCT03302845|Omeprazole|omeprazole|mesh-list
139438112|NCT03302845|Famotidine|famotidine|mesh-list
139438113|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139438114|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139438115|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139438116|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438117|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438118|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139438119|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
139438120|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
139438121|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438122|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438123|NCT03302689|Ropivacaine|ropivacaine|mesh-list
139438124|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
139438125|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139438126|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
139438127|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
139438128|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438129|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438130|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
139438131|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438132|NCT03307603|Nivolumab|nivolumab|mesh-list
139438133|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139438134|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438135|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139438136|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438137|NCT02468323|Ondansetron|ondansetron|mesh-list
139438138|NCT02468323|Palonosetron|palonosetron|mesh-list
139438139|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
139438140|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
139438141|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438142|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438143|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139438144|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
139438145|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
139438146|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139438147|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139438148|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
139438149|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438150|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438151|NCT02469259|Oxytocin|oxytocin|mesh-list
139438152|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
139438153|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139438154|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438155|NCT03307213|Sirolimus|sirolimus|mesh-list
139438156|NCT03307213|Umirolimus|umirolimus|mesh-list
139438157|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139438158|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139438159|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
139438160|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438161|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139438162|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139438163|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139438164|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438165|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
139438166|NCT03302221|Ropivacaine|ropivacaine|mesh-list
139438167|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
139438168|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438169|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438170|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
139438171|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
139438172|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438173|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
139438174|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139438175|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
139438176|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438177|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438178|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139438179|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
139438180|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
139438181|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139438182|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
139438183|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438184|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438185|NCT03306745|Folic Acid|folic acid|mesh-list
139438186|NCT03306745|Hematinics|hematinics|mesh-ancestor
139438187|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
139438188|NCT03306745|Vitamins|vitamins|mesh-ancestor
139438189|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
139438190|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438191|NCT03306667|Dotinurad|dotinurad|mesh-list
139438192|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
139438193|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
139438194|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139438195|NCT03312283|Ranibizumab|ranibizumab|mesh-list
139438196|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139438197|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139438198|NCT03312283|Growth Substances|growth substances|mesh-ancestor
139438199|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438200|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
139438201|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438202|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
139438203|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139438204|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438205|NCT03301207|Midazolam|midazolam|mesh-list
139438206|NCT03301207|Bupropion|bupropion|mesh-list
139438207|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
139438208|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139438209|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139438210|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139438211|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139438212|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438213|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438214|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139438215|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139438216|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139438217|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139438218|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
139438219|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
139438220|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
139438221|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
139438222|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438223|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438224|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139438225|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
139438226|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139438227|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139438228|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139438229|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
139438230|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139438231|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139438232|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438233|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139438234|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
139438235|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139438236|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139438237|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139438238|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139438239|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139438240|NCT03301207|Estrogens|estrogens|mesh-ancestor
139438241|NCT03301207|Hormones|hormones|mesh-ancestor
139438242|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139438243|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139438244|NCT03311971|Methamphetamine|methamphetamine|mesh-list
139438245|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139438246|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438247|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
139438248|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
139438249|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438250|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
139438251|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438252|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438253|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
139438254|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139438255|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139438256|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139438257|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139438258|NCT03311737|Anesthetics|anesthetics|mesh-list
139438259|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438260|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438261|NCT02467543|Ethanol|ethanol|mesh-list
139438262|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139438263|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139438264|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438265|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438266|NCT03311581|Propofol|propofol|mesh-list
139438267|NCT03311581|Sevoflurane|sevoflurane|mesh-list
139438268|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139438269|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438270|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438271|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139438272|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
139438273|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
139438274|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139438275|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139438276|NCT03311425|Dexamethasone|dexamethasone|mesh-list
139438277|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
139438278|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139438279|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139438280|NCT03311425|Prednisolone|prednisolone|mesh-list
139438281|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
139438282|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139438283|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
139438284|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139438285|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
139438286|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
139438287|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438288|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438289|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139438290|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
139438291|NCT03311425|Hormones|hormones|mesh-ancestor
139438292|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139438293|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139438294|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438295|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139438297|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
139438298|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
139438299|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139438300|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139438301|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139438302|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438303|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438304|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139438305|NCT03300115|Abivertinib|abivertinib|mesh-list
139438306|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139438307|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438308|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438309|NCT00702949|Pregabalin|pregabalin|mesh-list
139438310|NCT00702949|Analgesics|analgesics|mesh-ancestor
139438311|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
139438312|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438313|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438314|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
139438315|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139438316|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139438317|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438318|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139438319|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139438320|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139438321|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438322|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139438323|NCT04791475|Dexamethasone|dexamethasone|mesh-list
139438324|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
139438325|NCT04791475|Bupivacaine|bupivacaine|mesh-list
139438326|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139438327|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
139438328|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
139438329|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438330|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438331|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139438332|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
139438333|NCT04791475|Hormones|hormones|mesh-ancestor
139438334|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139438335|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139438336|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438337|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
139438338|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
139438339|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438340|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
139438341|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139438342|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139438343|NCT04791475|Analgesics|analgesics|mesh-ancestor
139438344|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139438345|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139438346|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139438347|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
139438348|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438349|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438350|NCT03299725|Bismuth|bismuth|mesh-list
139438351|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438352|NCT03299725|Antacids|antacids|mesh-ancestor
139438353|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139438354|NCT02466997|Tacrolimus|tacrolimus|mesh-list
139438355|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139438356|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
139438357|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438358|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139438359|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438360|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438361|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
139438362|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139438363|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139438364|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139438365|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139438366|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438367|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
139438368|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225101|NCT03359395|Alfentanil|alfentanil|mesh-list
139438369|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438370|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139438371|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438372|NCT03299257|Donepezil|donepezil|mesh-list
139438373|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139438374|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438375|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438376|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
139438377|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438378|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438379|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
139438380|NCT02466373|Clonidine|clonidine|mesh-list
139438381|NCT02466373|Analgesics|analgesics|mesh-ancestor
139438382|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
139438383|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438384|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438385|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139438386|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
139438387|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
139438388|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139438389|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139438390|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139438391|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
139438392|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438393|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438394|NCT02466919|Amoxicillin|amoxicillin|mesh-list
139438395|NCT02466919|Metronidazole|metronidazole|mesh-list
139438396|NCT02466919|Clarithromycin|clarithromycin|mesh-list
139438397|NCT02466919|Levofloxacin|levofloxacin|mesh-list
139438398|NCT02466919|Pantoprazole|pantoprazole|mesh-list
139438399|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139438400|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139438401|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139438402|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139438403|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139438404|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438405|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438406|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139438407|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139438408|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139438409|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139438410|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139438411|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438412|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139438413|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139438414|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139438415|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139438416|NCT05727163|Leucovorin|leucovorin|mesh-list
139438417|NCT05727163|Dexamethasone|dexamethasone|mesh-list
139438418|NCT05727163|Anisodamine|anisodamine|mesh-list
139438419|NCT05727163|Bevacizumab|bevacizumab|mesh-list
139438420|NCT05727163|Fluorouracil|fluorouracil|mesh-list
139438421|NCT05727163|Oxaliplatin|oxaliplatin|mesh-list
139438422|NCT05727163|Irinotecan|irinotecan|mesh-list
139438423|NCT05727163|Levoleucovorin|levoleucovorin|mesh-list
139438424|NCT05727163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139438425|NCT05727163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438426|NCT05727163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139438427|NCT05727163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139438428|NCT05727163|Growth Substances|growth substances|mesh-ancestor
139438429|NCT05727163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438430|NCT05727163|Growth Inhibitors|growth inhibitors|mesh-ancestor
139438431|NCT05727163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139438432|NCT05727163|Antiemetics|antiemetics|mesh-ancestor
139438433|NCT05727163|Autonomic Agents|autonomic agents|mesh-ancestor
139438434|NCT05727163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438435|NCT05727163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139438436|NCT05727163|Glucocorticoids|glucocorticoids|mesh-ancestor
139438437|NCT05727163|Hormones|hormones|mesh-ancestor
139438438|NCT05727163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139438439|NCT05727163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139438440|NCT05727163|Antimetabolites|antimetabolites|mesh-ancestor
139438441|NCT05727163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438442|NCT05727163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139225174|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
139438443|NCT05727163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139438444|NCT05727163|Immunologic Factors|immunologic factors|mesh-ancestor
139438445|NCT05727163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139438446|NCT05727163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139438447|NCT05727163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438449|NCT05727163|Protective Agents|protective agents|mesh-ancestor
139438450|NCT05727163|Vitamin B Complex|vitamin b complex|mesh-ancestor
139438451|NCT05727163|Vitamins|vitamins|mesh-ancestor
139438452|NCT05727163|Micronutrients|micronutrients|mesh-ancestor
139438453|NCT05727163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139438454|NCT05727163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139438455|NCT05727163|Adrenergic Agents|adrenergic agents|mesh-ancestor
139438456|NCT05727163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438457|NCT05727163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139438458|NCT05727163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139438459|NCT05727163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139438460|NCT05727163|Analgesics|analgesics|mesh-ancestor
139438461|NCT05727163|Sensory System Agents|sensory system agents|mesh-ancestor
139438462|NCT05727163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139438463|NCT05727163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139438464|NCT05727163|Parasympatholytics|parasympatholytics|mesh-ancestor
139438465|NCT05727163|Vasodilator Agents|vasodilator agents|mesh-ancestor
139438466|NCT05727163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139438467|NCT05727163|Antioxidants|antioxidants|mesh-ancestor
139438468|NCT05259709|Cemiplimab|cemiplimab|mesh-list
139438469|NCT05259709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139438470|NCT05259709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438471|NCT05302531|Amoxicillin|amoxicillin|mesh-list
139438472|NCT05302531|Levofloxacin|levofloxacin|mesh-list
139438473|NCT05302531|Ofloxacin|ofloxacin|mesh-list
139438474|NCT05302531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139438475|NCT05302531|Trimethoprim|trimethoprim|mesh-list
139438476|NCT05302531|Sulfamethoxazole|sulfamethoxazole|mesh-list
139438477|NCT05302531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139438478|NCT05302531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139438479|NCT05302531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139438480|NCT05302531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139438481|NCT05302531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139438482|NCT05302531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438483|NCT05302531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438484|NCT05302531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438485|NCT05302531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139438486|NCT05302531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139438487|NCT05302531|Antimalarials|antimalarials|mesh-ancestor
139438488|NCT05302531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139438489|NCT05302531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139438490|NCT05302531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139438491|NCT05302531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139438492|NCT05302531|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139438493|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
139438494|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438495|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139438496|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438497|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438498|NCT00702325|Budesonide|budesonide|mesh-list
139438499|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
139438500|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139438501|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139438502|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139438503|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
139438504|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438505|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438506|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139438507|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
139438508|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
139438509|NCT00702325|Hormones|hormones|mesh-ancestor
139438510|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139438511|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139438512|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139438513|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139438514|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
139438515|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438516|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438517|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139225254|NCT04792801|Choline|choline|mesh-list
139438518|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
139438519|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438520|NCT02464813|Pregabalin|pregabalin|mesh-list
139438521|NCT02464813|Oxycodone|oxycodone|mesh-list
139438522|NCT02464813|Analgesics|analgesics|mesh-ancestor
139438523|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
139438524|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438525|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438526|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
139438527|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139438528|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139438529|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438530|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139438531|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139438532|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139438533|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438534|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139438535|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139438536|NCT02464813|Narcotics|narcotics|mesh-ancestor
139438537|NCT05726929|Capsaicin|capsaicin|mesh-list
139438538|NCT05726929|Antipruritics|antipruritics|mesh-ancestor
139438539|NCT05726929|Dermatologic Agents|dermatologic agents|mesh-ancestor
139438540|NCT05726929|Sensory System Agents|sensory system agents|mesh-ancestor
139438541|NCT05726929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438542|NCT05726929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438543|NCT05122351|Acetaminophen|acetaminophen|mesh-list
139438544|NCT05122351|Bupivacaine|bupivacaine|mesh-list
139438545|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
139438546|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
139438547|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438548|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438549|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
139438550|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438551|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139438552|NCT05122351|Analgesics|analgesics|mesh-ancestor
139438553|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
139438554|NCT02464501|Paclitaxel|paclitaxel|mesh-list
139438555|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139438556|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438557|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
139438558|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
139438559|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
139438560|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438561|NCT02465827|Ropivacaine|ropivacaine|mesh-list
139438562|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
139438563|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
139438564|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438565|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438566|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
139438567|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438568|NCT04368403|Brodalumab|brodalumab|mesh-list
139438569|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
139438570|NCT05679661|Chlorhexidine|chlorhexidine|mesh-list
139438571|NCT05679661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139438572|NCT05679661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139438573|NCT05679661|Disinfectants|disinfectants|mesh-ancestor
139438574|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
139438575|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139438576|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
139438577|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438578|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139438579|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139438580|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
139438581|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438582|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438583|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139438584|NCT02465749|Vitamins|vitamins|mesh-list
139438585|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
139438586|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438587|NCT00701779|Tamsulosin|tamsulosin|mesh-list
139438588|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139438589|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139438590|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139438591|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
139438592|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438593|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438594|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438595|NCT00701779|Urological Agents|urological agents|mesh-ancestor
139438596|NCT02463643|Rabeprazole|rabeprazole|mesh-list
139438597|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139438598|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139438599|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139438600|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438601|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438602|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139438603|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139438604|NCT04150861|Hormones|hormones|mesh-ancestor
139438605|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139438606|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438607|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
139438608|NCT02465359|Antibodies|antibodies|mesh-list
139438609|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
139438610|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139438611|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139438612|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
139438613|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438614|NCT02463019|Tenofovir|tenofovir|mesh-list
139438615|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
139438616|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139438617|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139438618|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139438619|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438620|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438621|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139438622|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139438623|NCT02462941|Adenosine|adenosine|mesh-list
139438624|NCT02462941|Analgesics|analgesics|mesh-ancestor
139438625|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
139438626|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438627|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438628|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139438629|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
139438630|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139438631|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
139438632|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
139438633|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438634|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438635|NCT02462707|Nirogacestat|nirogacestat|mesh-list
139438636|NCT02462707|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139438637|NCT02462707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438638|NCT02462707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438639|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
139438640|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139438641|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139438642|NCT03297073|Acetaminophen|acetaminophen|mesh-list
139438643|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139438644|NCT03297073|Analgesics|analgesics|mesh-ancestor
139438645|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
139438646|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438647|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438648|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
139438649|NCT02462317|Baclofen|baclofen|mesh-list
139438650|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139438651|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139438652|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139438653|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438654|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139438655|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438656|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139438657|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
139438658|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
139438659|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438660|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438661|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139438662|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139438663|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
139438664|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139438665|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
139438666|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139438667|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
139438668|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438669|NCT03332095|Tenofovir|tenofovir|mesh-list
139438670|NCT03332095|Lamivudine|lamivudine|mesh-list
139438671|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139438672|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
139438673|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139438674|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139438675|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139438676|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438677|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438678|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139438679|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
139438680|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139438681|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139438682|NCT04489849|Apixaban|apixaban|mesh-list
139438683|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139438684|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
139438685|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139438686|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
139438687|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438688|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438689|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
139438690|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
139438691|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139438692|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139438693|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438694|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
139438695|NCT04488367|Coagulants|coagulants|mesh-ancestor
139438696|NCT04489459|Meropenem|meropenem|mesh-list
139438697|NCT04489459|Colistin|colistin|mesh-list
139438698|NCT04489459|Tigecycline|tigecycline|mesh-list
139438699|NCT04489459|Polymyxins|polymyxins|mesh-list
139438700|NCT04489459|Polymyxin B|polymyxin b|mesh-list
139438701|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139438702|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139438703|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139438704|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438705|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438706|NCT03296137|Aldesleukin|aldesleukin|mesh-list
139438707|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
139438708|NCT03296137|Nivolumab|nivolumab|mesh-list
139438709|NCT03296137|Ipilimumab|ipilimumab|mesh-list
139438710|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
139438711|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139438712|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
139438713|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438714|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139438715|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139438716|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
139438717|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438718|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438719|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139438720|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139438721|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139438722|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139438723|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
139438724|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139438725|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139438726|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
139438727|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139438728|NCT03295903|Cannabidiol|cannabidiol|mesh-list
139438729|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
139438730|NCT02460913|Morphine|morphine|mesh-list
139438731|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139438732|NCT02460913|Narcotics|narcotics|mesh-ancestor
139438733|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438734|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438735|NCT02460913|Analgesics|analgesics|mesh-ancestor
139438736|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
139438737|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438738|NCT03295825|Heparin|heparin|mesh-list
139438739|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
139438740|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139438741|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139438742|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438743|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
139225471|NCT03638869|Methadone|methadone|mesh-list
139438744|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139438745|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
139438746|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438747|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
139438748|NCT03290365|Protective Agents|protective agents|mesh-ancestor
139438749|NCT02764489|Thrombin|thrombin|mesh-list
139438750|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
139438751|NCT02764489|Coagulants|coagulants|mesh-list
139438752|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
139438753|NCT02462161|Insulin|insulin|mesh-list
139438754|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139438755|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
139438756|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
139438757|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139438758|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139438759|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438760|NCT03289819|Paclitaxel|paclitaxel|mesh-list
139438761|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139438762|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
139438763|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
139438764|NCT03289819|Epirubicin|epirubicin|mesh-list
139438765|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139438766|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438767|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
139438768|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
139438769|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
139438770|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438771|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139438772|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
139438773|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438774|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139438775|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139438776|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
139438777|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139438778|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139438779|NCT03289819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139438780|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139438781|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139438782|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139438783|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438784|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
139438785|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139438786|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438787|NCT02713867|Nivolumab|nivolumab|mesh-list
139438788|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139438789|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438790|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139438791|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438792|NCT03372785|Aspirin|aspirin|mesh-list
139438793|NCT03372785|Metoprolol|metoprolol|mesh-list
139438794|NCT03372785|Clopidogrel|clopidogrel|mesh-list
139438795|NCT03372785|Ticagrelor|ticagrelor|mesh-list
139438796|NCT03372785|Atorvastatin|atorvastatin|mesh-list
139438797|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139438798|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139438799|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139438800|NCT03372785|Analgesics|analgesics|mesh-ancestor
139438801|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
139438802|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438803|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438804|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139438805|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139438806|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139438807|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139438808|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438809|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139438810|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139438811|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438812|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
139438813|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139438814|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139438815|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
139438816|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139438817|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139438818|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139438819|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139438820|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139438821|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
139438822|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438823|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139438824|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139438825|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
139438826|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
139438827|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139438828|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139438829|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139438830|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
139438831|NCT03372473|Loratadine|loratadine|mesh-list
139438832|NCT03372473|Montelukast|montelukast|mesh-list
139438833|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139438834|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
139438835|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139438836|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
139438837|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139438838|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438839|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139438840|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139438841|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438842|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
139438843|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
139438844|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139438845|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139438846|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139438847|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
139438848|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
139438849|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438850|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
139438851|NCT03289429|Atorvastatin|atorvastatin|mesh-list
139438852|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139438853|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139438854|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
139438855|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438856|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139438857|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139438858|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438859|NCT03289429|Analgesics|analgesics|mesh-ancestor
139438860|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
139438861|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438862|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438863|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
139438864|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139438865|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139438866|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
139438867|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139438868|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139438869|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139438870|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
139438871|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139438872|NCT03372239|Tryptophan|tryptophan|mesh-list
139438873|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139438874|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
139438875|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139438876|NCT03294967|Vitamin E|vitamin e|mesh-list
139438877|NCT03294967|Caffeine|caffeine|mesh-list
139438878|NCT03294967|Vitamins|vitamins|mesh-ancestor
139438879|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
139438880|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438881|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139438882|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139438883|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438884|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438885|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139438886|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139438887|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
139438888|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438889|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
139438890|NCT03294967|Protective Agents|protective agents|mesh-ancestor
139438891|NCT03371849|Montelukast|montelukast|mesh-list
139438892|NCT03371849|Levocetirizine|levocetirizine|mesh-list
139438893|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139438894|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
139438895|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139438896|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
139225633|NCT03635957|Vitamins|vitamins|mesh-ancestor
139438897|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139438898|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438899|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139438900|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139438901|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438902|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139438903|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139438904|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
139438905|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
139438906|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438907|NCT04307329|Trastuzumab|trastuzumab|mesh-list
139438908|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139438909|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438910|NCT03371069|Methylphenidate|methylphenidate|mesh-list
139438911|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139438912|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438913|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139438914|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139438915|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139438916|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438917|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
139438918|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438919|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
139438921|NCT03294577|Doxorubicin|doxorubicin|mesh-list
139438922|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139438923|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
139438924|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438925|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139438926|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139438927|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
139438928|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438929|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438930|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139438931|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
139438932|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
139438933|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
139438934|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139438935|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139438936|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139438937|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438938|NCT03370835|Metoprolol|metoprolol|mesh-list
139438939|NCT03370835|Carvedilol|carvedilol|mesh-list
139438940|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139438941|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139438942|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
139438943|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
139438944|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139438945|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438946|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139438947|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139438948|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139438949|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
139382470|NCT02113397|Tobramycin|tobramycin|mesh-list
139438950|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139438951|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438952|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
139438953|NCT03370835|Protective Agents|protective agents|mesh-ancestor
139438954|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139438955|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139438956|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139438957|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
139438958|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139438959|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139438960|NCT02460367|Docetaxel|docetaxel|mesh-list
139438961|NCT02460367|Tryptophan|tryptophan|mesh-list
139438962|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438963|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
139438964|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
139438965|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
139438966|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438967|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139438968|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
139438969|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139438970|NCT03370601|Infliximab|infliximab|mesh-list
139438971|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
139438972|NCT03370601|Azathioprine|azathioprine|mesh-list
139438973|NCT03370601|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139438974|NCT03370601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139438975|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
139438976|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139438977|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139438978|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
139438979|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438980|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139438981|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139438982|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139438983|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
139438984|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139438985|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139438986|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438987|NCT03376529|Tazobactam|tazobactam|mesh-list
139438988|NCT03376529|Piperacillin|piperacillin|mesh-list
139438989|NCT03376529|Ceftazidime|ceftazidime|mesh-list
139438990|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139438991|NCT03376529|Aztreonam|aztreonam|mesh-list
139438992|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139438993|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139438994|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139438995|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139438996|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139438997|NCT04132661|Bisacodyl|bisacodyl|mesh-list
139438998|NCT04132661|Cathartics|cathartics|mesh-ancestor
139438999|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139439000|NCT04132661|Laxatives|laxatives|mesh-ancestor
139439001|NCT02460211|Vitamin D|vitamin d|mesh-list
139439002|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
139439003|NCT02460211|Vitamins|vitamins|mesh-ancestor
139439004|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
139439005|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439006|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139439007|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139439008|NCT03288259|Anesthetics|anesthetics|mesh-list
139439009|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
139439010|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439011|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439012|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
139439013|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439014|NCT01653925|Dutasteride|dutasteride|mesh-list
139439015|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139439016|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139439017|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439018|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439019|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
139439020|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139439021|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439022|NCT02730455|Natalizumab|natalizumab|mesh-list
139439023|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
139439024|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439025|NCT03376139|Zonisamide|zonisamide|mesh-list
139439026|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
139439027|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139439028|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139439029|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439030|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139439031|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439032|NCT03369119|Montelukast|montelukast|mesh-list
139439033|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139439034|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
139439035|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139439036|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
139439037|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139439038|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439039|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139439040|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139439041|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439042|NCT03287011|Listerine|listerine|mesh-list
139439043|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
139439044|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
139439045|NCT03287011|Protective Agents|protective agents|mesh-ancestor
139439046|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439047|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139439048|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139439049|NCT03293641|Folic Acid|folic acid|mesh-list
139439050|NCT03293641|Penicillins|penicillins|mesh-list
139439051|NCT03293641|Penicillin V|penicillin v|mesh-list
139439052|NCT03293641|Proguanil|proguanil|mesh-list
139439053|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
139439054|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
139439055|NCT03293641|Hematinics|hematinics|mesh-ancestor
139439056|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
139439057|NCT03293641|Vitamins|vitamins|mesh-ancestor
139439058|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
139439059|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439060|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439061|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
139439062|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439063|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439064|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139439065|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139439066|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139439067|NCT03293641|Astringents|astringents|mesh-ancestor
139439068|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
139439069|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
139439070|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139439071|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139439072|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
139439073|NCT02519543|Metformin|metformin|mesh-list
139439074|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139439075|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439076|NCT03293407|Iloprost|iloprost|mesh-list
139439077|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139439078|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
139439079|NCT02519699|Norepinephrine|norepinephrine|mesh-list
139439080|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139439081|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139439082|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
139439083|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439084|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439085|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439086|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
139439087|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
139439088|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439089|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139439090|NCT00701311|Apremilast|apremilast|mesh-list
139439091|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139439092|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139439093|NCT00701311|Analgesics|analgesics|mesh-ancestor
139439094|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
139439095|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439096|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439097|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139439098|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139439099|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139439100|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139439101|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439102|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439103|NCT03375671|Midazolam|midazolam|mesh-list
139439104|NCT03375671|Ketamine|ketamine|mesh-list
139439105|NCT03375671|Haloperidol|haloperidol|mesh-list
139439106|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
139439107|NCT03375671|Analgesics|analgesics|mesh-ancestor
139439108|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
139439109|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439110|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439111|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139439112|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139439113|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
139439114|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
139225858|NCT03670706|Analgesics|analgesics|mesh-list
139439115|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439116|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139439117|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139439118|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439119|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439120|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139439121|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139439122|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139439123|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139439124|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139439125|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
139439126|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
139439127|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
139439128|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
139439129|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139439130|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139439131|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139439132|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
139439133|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139439134|NCT03375593|Acetaminophen|acetaminophen|mesh-list
139439135|NCT03375593|Ibuprofen|ibuprofen|mesh-list
139439136|NCT03375593|Oxycodone|oxycodone|mesh-list
139439137|NCT03375593|Hydrocodone|hydrocodone|mesh-list
139439138|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139439139|NCT03375593|Analgesics|analgesics|mesh-ancestor
139439140|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
139439141|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439142|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439143|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
139439144|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139439145|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139439146|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139439147|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139439148|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439149|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439150|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139439151|NCT03375593|Narcotics|narcotics|mesh-ancestor
139439152|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439153|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
139439154|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
139439155|NCT04525235|Tolbutamide|tolbutamide|mesh-list
139439156|NCT04525235|Rifampin|rifampin|mesh-list
139439157|NCT04525235|Digoxin|digoxin|mesh-list
139439158|NCT04525235|Midazolam|midazolam|mesh-list
139439159|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
139439160|NCT04525235|Caffeine|caffeine|mesh-list
139439161|NCT04525235|Omeprazole|omeprazole|mesh-list
139439162|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139439163|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139439164|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439165|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439166|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139439167|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139439168|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139439169|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139439170|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
139439171|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
139439172|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
139439173|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
139439174|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439175|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439176|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139439177|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139439178|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439179|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139439180|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139439181|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
139439182|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139439183|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139439184|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139439185|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139439186|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
139439187|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139439188|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139439189|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
139439190|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139439191|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139439192|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139225933|NCT03678038|Hormones|hormones|mesh-ancestor
139439193|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139439194|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139439195|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139439196|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139439197|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139439198|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139439199|NCT04525235|Protective Agents|protective agents|mesh-ancestor
139439200|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
139439201|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
139439202|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139439203|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139439204|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139439205|NCT03363815|Vitamin K|vitamin k|mesh-list
139439206|NCT03363815|Metformin|metformin|mesh-list
139439207|NCT03363815|Nintedanib|nintedanib|mesh-list
139439208|NCT03363815|Digoxin|digoxin|mesh-list
139439209|NCT03363815|Midazolam|midazolam|mesh-list
139439210|NCT03363815|Omeprazole|omeprazole|mesh-list
139439211|NCT03363815|Warfarin|warfarin|mesh-list
139439212|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139439213|NCT03363815|Vitamins|vitamins|mesh-ancestor
139439214|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
139439215|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439216|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139439217|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139439218|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139439219|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439220|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139439221|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139439222|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139439223|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139439224|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
139439225|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
139439226|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
139439227|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
139439228|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439229|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439230|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139439231|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139439232|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
139439233|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139439234|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139439235|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439236|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
139439237|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139439238|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139439239|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139439240|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139439241|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139439242|NCT03363815|Protective Agents|protective agents|mesh-ancestor
139439243|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139439244|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139439245|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
139439246|NCT03363815|Coagulants|coagulants|mesh-ancestor
139439247|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439248|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139439249|NCT03363425|Lidocaine|lidocaine|mesh-list
139439250|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
139439251|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
139439252|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
139439253|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439254|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439255|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
139439256|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439257|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139439258|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139439259|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139439260|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139439261|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439262|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139439263|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139439264|NCT03363425|Analgesics|analgesics|mesh-ancestor
139439265|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139439266|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139439267|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139439268|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
139439269|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439270|NCT02459977|Basiliximab|basiliximab|mesh-list
139439271|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139439272|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
139439273|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439274|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
139439275|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
139439276|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139439277|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139439278|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439279|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439280|NCT02519153|Urological Agents|urological agents|mesh-ancestor
139439281|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
139439282|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139439283|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139439284|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139439285|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139439286|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439287|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439288|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439289|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139439290|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139439291|NCT03363191|Fluticasone|fluticasone|mesh-list
139439292|NCT03363191|Xhance|xhance|mesh-list
139439293|NCT03363191|Albuterol|albuterol|mesh-list
139439294|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139439295|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139439296|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
139439297|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439298|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439299|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139439300|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
139439301|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
139439302|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139439303|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
139439304|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139439305|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139439306|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139439307|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139439308|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
139439309|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439310|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439311|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
139439312|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139439313|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139439314|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439315|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
139439316|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439317|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439318|NCT03285607|Paclitaxel|paclitaxel|mesh-list
139439319|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
139439320|NCT03285607|Doxorubicin|doxorubicin|mesh-list
139439321|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139439322|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439323|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
139439324|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
139439325|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
139439326|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439327|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139439328|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
139439329|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439330|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139439331|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139439332|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
139439333|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139439334|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139439335|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139439336|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139439337|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439338|NCT03298321|Azacitidine|azacitidine|mesh-list
139439339|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139439340|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
139439341|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439342|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439343|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439344|NCT04527055|Metronidazole|metronidazole|mesh-list
139439345|NCT04527055|Tetracycline|tetracycline|mesh-list
139439346|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
139439347|NCT04527055|Esomeprazole|esomeprazole|mesh-list
139439348|NCT04527055|Bismuth|bismuth|mesh-list
139226072|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
139439349|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139439350|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139439351|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139439352|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139439353|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139439354|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139439355|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139439356|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439357|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439359|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139439360|NCT02518763|Vitamin D|vitamin d|mesh-list
139439361|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
139439362|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
139439363|NCT02518763|Vitamins|vitamins|mesh-list
139439364|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
139439365|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439366|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139439367|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139439368|NCT03362411|Linrodostat|linrodostat|mesh-list
139439369|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439370|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439371|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
139439372|NCT03291457|Hormones|hormones|mesh-ancestor
139439373|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139439374|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439375|NCT03361709|Dexamethasone|dexamethasone|mesh-list
139439376|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139439377|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
139439378|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
139439379|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439380|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439381|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139439382|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
139439383|NCT03361709|Hormones|hormones|mesh-ancestor
139439384|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139439385|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139439386|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439387|NCT03284749|Copper|copper|mesh-list
139439388|NCT03284749|Trace Elements|trace elements|mesh-ancestor
139439389|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
139439390|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439391|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
139439392|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139439393|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
139439394|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139439395|NCT04523675|Expectorants|expectorants|mesh-ancestor
139439396|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
139439397|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139439398|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
139439399|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439400|NCT04523675|Protective Agents|protective agents|mesh-ancestor
139439401|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439402|NCT04523675|Antidotes|antidotes|mesh-ancestor
139439403|NCT03298009|Canagliflozin|canagliflozin|mesh-list
139439404|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139439405|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439406|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139439407|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439408|NCT03291145|Spironolactone|spironolactone|mesh-list
139439409|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139439410|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139439411|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
139439412|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139439413|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439414|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139439415|NCT03291145|Diuretics|diuretics|mesh-ancestor
139439416|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
139439417|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139439418|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
139439419|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439420|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439421|NCT03297931|Iproplatin|iproplatin|mesh-list
139439422|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439423|NCT03284593|Azacitidine|azacitidine|mesh-list
139439424|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139439425|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
139439426|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439427|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439428|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439430|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
139439431|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
139439432|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439433|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439434|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
139439435|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439436|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139439437|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139439438|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139439439|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139439440|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439441|NCT03109379|Trospium chloride|trospium chloride|mesh-list
139439442|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
139439443|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
139439444|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439445|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439446|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139439447|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139439448|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
139439449|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439450|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439451|NCT03109379|Urological Agents|urological agents|mesh-ancestor
139439452|NCT03361319|Paclitaxel|paclitaxel|mesh-list
139439453|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139439454|NCT03361319|Nintedanib|nintedanib|mesh-list
139439455|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139439456|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439457|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
139439458|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
139439459|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
139439460|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439461|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139439462|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439463|NCT04489147|Metformin|metformin|mesh-list
139439464|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139439465|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439466|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
139439467|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
139439468|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139439469|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139439470|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439471|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
139439472|NCT03365999|Coagulants|coagulants|mesh-ancestor
139439473|NCT02460055|Dexamethasone|dexamethasone|mesh-list
139439474|NCT02460055|Fentanyl|fentanyl|mesh-list
139439475|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
139439476|NCT02460055|Ondansetron|ondansetron|mesh-list
139439477|NCT02460055|Propofol|propofol|mesh-list
139439478|NCT02460055|Sevoflurane|sevoflurane|mesh-list
139439479|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139439480|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
139439481|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
139439482|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439483|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439484|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139439485|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
139439486|NCT02460055|Hormones|hormones|mesh-ancestor
139439487|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139439488|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139439489|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439490|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139439491|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439492|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139439493|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
139439494|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
139439495|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139439496|NCT02460055|Narcotics|narcotics|mesh-ancestor
139439497|NCT02460055|Analgesics|analgesics|mesh-ancestor
139439498|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
139439499|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139439500|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139439501|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139439503|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
139439504|NCT02460055|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139439505|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139439506|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
139439507|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439508|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439509|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139439510|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
139439511|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139439512|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139439513|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
139439514|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439515|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439516|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439517|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139439518|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139439519|NCT03365765|Fluorouracil|fluorouracil|mesh-list
139439520|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
139439521|NCT03365765|Apatinib|apatinib|mesh-list
139439522|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
139439523|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439524|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139439525|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439526|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139439527|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
139439528|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439529|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139439530|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439531|NCT03297463|Ipilimumab|ipilimumab|mesh-list
139439532|NCT03297463|Interleukin-2|interleukin-2|mesh-list
139439533|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139439534|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439535|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139439536|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439537|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139439538|NCT03297463|Analgesics|analgesics|mesh-ancestor
139439539|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
139439540|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439541|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439542|NCT03282643|Heparin|heparin|mesh-list
139439543|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139439544|NCT03282643|Tinzaparin|tinzaparin|mesh-list
139439545|NCT03282643|Dalteparin|dalteparin|mesh-list
139439546|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
139439547|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
139439548|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139439549|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139439550|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439551|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139439552|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
139439553|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139439554|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
139439555|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439556|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
139439557|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139439558|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
139439559|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
139439560|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
139439561|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139439562|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139439563|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439564|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
139439565|NCT02458729|Coagulants|coagulants|mesh-ancestor
139439566|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139439567|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
139439568|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139439569|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
139439570|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439571|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
139439572|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
139439573|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139439574|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139439575|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139439576|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139439577|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439578|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439580|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
139439581|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139439582|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139439583|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139439584|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439585|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439586|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139439587|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
139439588|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139439589|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439590|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139439591|NCT03536455|Acetazolamide|acetazolamide|mesh-list
139439592|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
139439593|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139439594|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439595|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439596|NCT03536455|Diuretics|diuretics|mesh-ancestor
139439597|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
139439598|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439599|NCT03529825|Rifaximin|rifaximin|mesh-list
139439600|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139439601|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139439602|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139439603|NCT03281941|Capsaicin|capsaicin|mesh-list
139439604|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
139439605|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
139439606|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
139439607|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439608|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439609|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
139439610|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139439611|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439612|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439613|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139439614|NCT02459509|Analgesics|analgesics|mesh-ancestor
139439615|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
139439616|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439617|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139439618|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139439619|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139439620|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
139439621|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439622|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439623|NCT03264781|CycloProvera|cycloprovera|mesh-list
139439624|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139439625|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139439626|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139439627|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
139439628|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139439629|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439630|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139439631|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139439632|NCT03281863|Antibodies|antibodies|mesh-list
139439633|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
139439634|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
139439635|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439636|NCT03264625|Vitamin D|vitamin d|mesh-list
139439637|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
139439638|NCT03264625|Vitamins|vitamins|mesh-ancestor
139439639|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
139439640|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439641|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139439642|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139439643|NCT03269929|Midazolam|midazolam|mesh-list
139439644|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139439645|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139439646|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439647|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226376|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139439648|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139439649|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139439650|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139439651|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139439652|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
139439653|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
139439654|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
139439655|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
139439656|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439657|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439658|NCT02730377|Liraglutide|liraglutide|mesh-list
139439659|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
139439660|NCT02730377|Meglitinide|meglitinide|mesh-list
139439661|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139439662|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139439663|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
139439664|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139439665|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439666|NCT02730377|Incretins|incretins|mesh-ancestor
139439667|NCT02730377|Hormones|hormones|mesh-ancestor
139439668|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139439669|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439670|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
139439671|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439672|NCT03264547|Paclitaxel|paclitaxel|mesh-list
139439673|NCT03264547|Docetaxel|docetaxel|mesh-list
139439674|NCT03264547|Trastuzumab|trastuzumab|mesh-list
139439675|NCT03264547|Pertuzumab|pertuzumab|mesh-list
139439676|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139439677|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439678|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
139439679|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
139439680|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
139439681|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439682|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139439683|NCT03365141|Triamcinolone|triamcinolone|mesh-list
139439684|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139439685|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139439686|NCT03365141|Tacrolimus|tacrolimus|mesh-list
139439687|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139439688|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139439689|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
139439690|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439691|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139439692|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439693|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439694|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139439695|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
139439696|NCT03365141|Hormones|hormones|mesh-ancestor
139439697|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139439698|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
139439699|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139439700|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439701|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139439702|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439703|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
139439704|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139439705|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139439706|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139439707|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
139439708|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439709|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439710|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439711|NCT03359837|Insulin|insulin|mesh-list
139439712|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139439713|NCT03359837|Metformin|metformin|mesh-list
139439714|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
139439715|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
139439716|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
139439717|NCT03359837|Acarbose|acarbose|mesh-list
139439718|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139439719|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
139439720|NCT03359837|Repaglinide|repaglinide|mesh-list
139439721|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139439722|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226458|NCT02676466|Losartan|losartan|mesh-list
139439723|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139439724|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439725|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439726|NCT03359681|Metformin|metformin|mesh-list
139439727|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139439728|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439729|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
139439730|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139439731|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139439732|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439733|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
139439734|NCT03359525|Coagulants|coagulants|mesh-ancestor
139439735|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
139439736|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139439737|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139439738|NCT03359291|Macitentan|macitentan|mesh-list
139439739|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139439740|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139439741|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
139439742|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439743|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139439744|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139439745|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439746|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139439747|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139439748|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139439749|NCT03358277|Methylphenidate|methylphenidate|mesh-list
139439750|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439751|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
139439752|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439753|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439754|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139439755|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139439756|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139439757|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139439758|NCT03359057|Folic Acid|folic acid|mesh-list
139439759|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
139439760|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
139439761|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139439762|NCT03359057|Estradiol|estradiol|mesh-list
139439763|NCT03359057|Estrogens|estrogens|mesh-ancestor
139439764|NCT03359057|Hormones|hormones|mesh-ancestor
139439765|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139439766|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439767|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139439768|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
139439769|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139439770|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139439771|NCT03359057|Hematinics|hematinics|mesh-ancestor
139439772|NCT03359057|Vitamins|vitamins|mesh-ancestor
139439773|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
139439774|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139439775|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139439776|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139439777|NCT02714569|Atorvastatin|atorvastatin|mesh-list
139439778|NCT02714569|Simvastatin|simvastatin|mesh-list
139439779|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139439780|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139439781|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
139439782|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439783|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139439784|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139439785|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439786|NCT04522037|Morphine|morphine|mesh-list
139439787|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139439788|NCT04522037|Narcotics|narcotics|mesh-ancestor
139439789|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439790|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439791|NCT04522037|Analgesics|analgesics|mesh-ancestor
139439792|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
139439793|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439794|NCT03357653|Losartan|losartan|mesh-list
139226523|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139439795|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139439796|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139439797|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139439798|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139439799|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439800|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
139439801|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139439802|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
139439803|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439804|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
139439805|NCT03357575|Protective Agents|protective agents|mesh-ancestor
139439806|NCT03280927|Efinaconazole|efinaconazole|mesh-list
139439807|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
139439808|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139439809|NCT03269383|Bupivacaine|bupivacaine|mesh-list
139439810|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
139439811|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
139439812|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439813|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439814|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
139439815|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439817|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139439818|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139439819|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
139439820|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439821|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139439822|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
139439823|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
139439824|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
139439825|NCT03280849|Coagulants|coagulants|mesh-ancestor
139439826|NCT04521491|Leucovorin|leucovorin|mesh-list
139439827|NCT04521491|Fluorouracil|fluorouracil|mesh-list
139439828|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
139439829|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
139439830|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439831|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139439832|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439833|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139439834|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
139439835|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439836|NCT04521491|Antidotes|antidotes|mesh-ancestor
139439837|NCT04521491|Protective Agents|protective agents|mesh-ancestor
139439838|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
139439839|NCT04521491|Vitamins|vitamins|mesh-ancestor
139439840|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
139439841|NCT04509635|Cetuximab|cetuximab|mesh-list
139439842|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139439843|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439844|NCT04444817|Tacrolimus|tacrolimus|mesh-list
139439845|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139439846|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
139439847|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439848|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139439849|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439850|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439851|NCT04509323|Huperzine A|huperzine a|mesh-list
139439852|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139439853|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439854|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439855|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
139439856|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439857|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439858|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139439859|NCT04509323|Protective Agents|protective agents|mesh-ancestor
139439860|NCT04443647|Oxytocin|oxytocin|mesh-list
139439861|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
139439862|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139439863|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439864|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139439865|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139439866|NCT02458339|Methotrexate|methotrexate|mesh-list
139439867|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139439868|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
139439869|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139439870|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439871|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139439872|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
139439873|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439874|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439875|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
139439876|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439877|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139439878|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139439879|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
139439880|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139439881|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139439882|NCT03268525|Bupivacaine|bupivacaine|mesh-list
139439883|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
139439884|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
139439885|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439886|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439887|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
139439888|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439889|NCT02456935|Esomeprazole|esomeprazole|mesh-list
139439890|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139439891|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139439892|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139439893|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439894|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439895|NCT03263689|Morphine|morphine|mesh-list
139439896|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139439897|NCT03263689|Narcotics|narcotics|mesh-ancestor
139439898|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439899|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439900|NCT03263689|Analgesics|analgesics|mesh-ancestor
139439901|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
139439902|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439903|NCT03279679|Ropivacaine|ropivacaine|mesh-list
139439904|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
139439905|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
139439906|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139439907|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439908|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
139439909|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439910|NCT02518451|Valsartan|valsartan|mesh-list
139439911|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139439912|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139439913|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139439914|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439915|NCT03263299|Aspirin|aspirin|mesh-list
139439916|NCT03263299|Cabergoline|cabergoline|mesh-list
139439917|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139439918|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139439919|NCT03263299|Analgesics|analgesics|mesh-ancestor
139439920|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
139439921|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139439922|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439923|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139439924|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139439925|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139439926|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139439927|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439928|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139439929|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139439930|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439931|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
139439932|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139439933|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139439934|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
139439935|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
139439936|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139439937|NCT04444349|Ubiquinone|ubiquinone|mesh-list
139439938|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
139439939|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
139439940|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439941|NCT04444349|Vitamins|vitamins|mesh-ancestor
139439942|NCT03263533|Vorinostat|vorinostat|mesh-list
139439943|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439944|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139439945|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226674|NCT03555305|Insulin|insulin|mesh-list
139439946|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439947|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
139439948|NCT03123107|Vitamins|vitamins|mesh-ancestor
139439949|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
139439950|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439951|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
139439952|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439953|NCT03123107|Protective Agents|protective agents|mesh-ancestor
139439954|NCT04516655|Rituximab|rituximab|mesh-list
139439955|NCT04516655|Methotrexate|methotrexate|mesh-list
139439956|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139439957|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439958|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
139439959|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439960|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139439961|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139439962|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
139439963|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139439964|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139439965|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
139439966|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439967|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
139439968|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439969|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139439970|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139439971|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139439972|NCT02458183|Vaccines|vaccines|mesh-list
139439973|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
139439974|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439975|NCT04444193|Durvalumab|durvalumab|mesh-list
139439976|NCT04444193|Lenvatinib|lenvatinib|mesh-list
139439977|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139439978|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139439979|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439980|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
139439981|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439982|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139439983|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139439984|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139439985|NCT03984955|Mannitol|mannitol|mesh-list
139439986|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
139439987|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139439988|NCT03984955|Diuretics|diuretics|mesh-ancestor
139439989|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
139439990|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139439991|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139439992|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
139439993|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
139439994|NCT03984955|Protective Agents|protective agents|mesh-ancestor
139439995|NCT03946969|Paclitaxel|paclitaxel|mesh-list
139439996|NCT03946969|Cisplatin|cisplatin|mesh-list
139439997|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139439998|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139439999|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
139440000|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
139440001|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
139440002|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440003|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139440004|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139440005|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139440006|NCT03277573|Analgesics|analgesics|mesh-ancestor
139440007|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
139440008|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440009|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440010|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139440011|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139440012|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
139440013|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139440014|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
139440015|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440016|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
139440017|NCT03353909|Protective Agents|protective agents|mesh-ancestor
139440018|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
139440019|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139440020|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440021|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139440022|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440023|NCT04508231|Hormones|hormones|mesh-list
139440024|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139440025|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440026|NCT03263065|Psyllium|psyllium|mesh-list
139440027|NCT03263065|Cathartics|cathartics|mesh-ancestor
139440028|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139440029|NCT02518373|Omeprazole|omeprazole|mesh-list
139440030|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139440031|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139440032|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139440033|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440034|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440035|NCT03266965|Carbidopa|carbidopa|mesh-list
139440036|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139440037|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139440038|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
139440039|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440040|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440041|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440042|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139440043|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440044|NCT03266731|Aspirin|aspirin|mesh-list
139440045|NCT03266731|Clopidogrel|clopidogrel|mesh-list
139440046|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139440047|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139440048|NCT03266731|Analgesics|analgesics|mesh-ancestor
139440049|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
139440050|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440051|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440052|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139440053|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139440054|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139440055|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139440056|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440057|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139440058|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139440059|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440060|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
139440061|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139440062|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139440063|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139440064|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
139440065|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440066|NCT02458963|Menotropins|menotropins|mesh-list
139440067|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139440068|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
139440069|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139440070|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440071|NCT04507607|Tenofovir|tenofovir|mesh-list
139440072|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
139440073|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440074|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139440075|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139440076|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440077|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440078|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139440079|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139440080|NCT03353441|Glycine|glycine|mesh-list
139440081|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
139440082|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440083|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440084|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440085|NCT03353363|Bupivacaine|bupivacaine|mesh-list
139440086|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
139440087|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
139440088|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440089|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440090|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
139440091|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440092|NCT04511195|Diclofenac|diclofenac|mesh-list
139440093|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139440094|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139440095|NCT04511195|Analgesics|analgesics|mesh-ancestor
139440096|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
139440097|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440098|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440099|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139440100|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139440101|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139440102|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440103|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440104|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
139440105|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
139440106|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
139440107|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139440108|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139440109|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440110|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440111|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440112|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139440113|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
139440114|NCT03262363|Curcumin|curcumin|mesh-list
139440115|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139440116|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139440117|NCT03262363|Analgesics|analgesics|mesh-ancestor
139440118|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
139440119|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440120|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440121|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139440122|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139440123|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440124|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440125|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440126|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
139440127|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139440128|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
139440129|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440130|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
139440131|NCT04506827|Protective Agents|protective agents|mesh-ancestor
139440132|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
139440133|NCT03352895|Resveratrol|resveratrol|mesh-list
139440134|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
139440135|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440136|NCT03352895|Protective Agents|protective agents|mesh-ancestor
139440137|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440138|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440139|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139440140|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139440141|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440142|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139440143|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440144|NCT03350633|Azathioprine|azathioprine|mesh-list
139440145|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
139440146|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440147|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139440148|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440149|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139440150|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
139440151|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440152|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139440153|NCT03265795|Ether|ether|mesh-list
139440154|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139440155|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
139440156|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
139440157|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440158|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440159|NCT03350399|Mitogens|mitogens|mesh-list
139440160|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
139440161|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440162|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
139440163|NCT03350321|Hematinics|hematinics|mesh-ancestor
139440164|NCT03352349|Terlipressin|terlipressin|mesh-list
139440165|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139440166|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139440167|NCT03265171|Plasminogen|plasminogen|mesh-list
139440168|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139440169|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139440170|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440171|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
139440172|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440173|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139440175|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440176|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139440177|NCT04669561|Lifitegrast|lifitegrast|mesh-list
139440178|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139440179|NCT02729909|Lubiprostone|lubiprostone|mesh-list
139440180|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139440181|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139440182|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440183|NCT03352115|Prednisolone|prednisolone|mesh-list
139440184|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139440185|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
139440186|NCT03352115|Hormones|hormones|mesh-ancestor
139440187|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139440188|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440189|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139440190|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440191|NCT03252457|Dexamethasone|dexamethasone|mesh-list
139440192|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
139440193|NCT03252457|Decitabine|decitabine|mesh-list
139440194|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139440195|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
139440196|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
139440197|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440198|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440199|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139440200|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
139440201|NCT03252457|Hormones|hormones|mesh-ancestor
139440202|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139440203|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139440204|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440205|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139440206|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
139440207|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440208|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440209|NCT03258931|Cytarabine|cytarabine|mesh-list
139440210|NCT03258931|Midostaurin|midostaurin|mesh-list
139440211|NCT03258931|Crenolanib|crenolanib|mesh-list
139440212|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139440213|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
139440214|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440215|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440216|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
139440217|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440218|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139440219|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
139440220|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440221|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139440222|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440223|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
139440224|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139440225|NCT03261349|Ledipasvir|ledipasvir|mesh-list
139440226|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
139440227|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440228|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
139440229|NCT02455609|Ketamine|ketamine|mesh-list
139440230|NCT02455609|Bupivacaine|bupivacaine|mesh-list
139440231|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
139440232|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
139440233|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440234|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440235|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
139440236|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440237|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139440238|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139440239|NCT02455609|Analgesics|analgesics|mesh-ancestor
139440240|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139440241|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139440242|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139440243|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
139440244|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440245|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440246|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139440247|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139440248|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
139440249|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139440250|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139440251|NCT05723627|Propofol|propofol|mesh-list
139440252|NCT05723627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139440253|NCT05723627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440254|NCT05723627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440255|NCT05723627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139440256|NCT05723627|Anesthetics, General|anesthetics, general|mesh-ancestor
139440257|NCT05723627|Anesthetics|anesthetics|mesh-ancestor
139440258|NCT03349619|Resveratrol|resveratrol|mesh-list
139440259|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
139440260|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440261|NCT03349619|Protective Agents|protective agents|mesh-ancestor
139440262|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440263|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440264|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139440265|NCT04505657|Celecoxib|celecoxib|mesh-list
139440266|NCT04505657|Lidocaine|lidocaine|mesh-list
139440267|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
139440268|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
139440269|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440270|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440271|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
139440272|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440273|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139440274|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139440275|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139440276|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139440277|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440278|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139440279|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139440280|NCT04505657|Analgesics|analgesics|mesh-ancestor
139440281|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139440282|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139440283|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139440284|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139440285|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440286|NCT03259243|Bupivacaine|bupivacaine|mesh-list
139440287|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
139440288|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
139440289|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440290|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440291|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
139440292|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440293|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
139440294|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
139440295|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
139440296|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440297|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440298|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
139440299|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440300|NCT02456701|Vemurafenib|vemurafenib|mesh-list
139440301|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440302|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139440303|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440304|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440305|NCT03252067|Azithromycin|azithromycin|mesh-list
139440306|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139440307|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139440308|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440309|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139440310|NCT03252223|Hormones|hormones|mesh-list
139440311|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139440312|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139440313|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440314|NCT05513807|Niacinamide|niacinamide|mesh-list
139440315|NCT05513807|Niacin|niacin|mesh-list
139440316|NCT05513807|Nicotinic Acids|nicotinic acids|mesh-list
139440317|NCT05513807|Vitamin B Complex|vitamin b complex|mesh-ancestor
139440318|NCT05513807|Vitamins|vitamins|mesh-ancestor
139440319|NCT05513807|Micronutrients|micronutrients|mesh-ancestor
139440320|NCT05513807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440321|NCT05513807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139440322|NCT05513807|Antimetabolites|antimetabolites|mesh-ancestor
139440323|NCT05513807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440324|NCT05513807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139440326|NCT04504877|Cannabidiol|cannabidiol|mesh-list
139440327|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
139440328|NCT02518295|Sulfalene|sulfalene|mesh-list
139440329|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440330|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139440331|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
139440332|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139440333|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139440334|NCT03257683|Ranolazine|ranolazine|mesh-list
139440335|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139440336|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139440337|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440338|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
139440339|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139440340|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139440341|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440342|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
139440343|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440344|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440345|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
139440346|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139440347|NCT03351569|Antibodies|antibodies|mesh-list
139440348|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
139440349|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139440350|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
139440351|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440352|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
139440353|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
139440354|NCT03348917|Povidone|povidone|mesh-list
139440355|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139440356|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440357|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
139440358|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
139440359|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
139440360|NCT03251365|Gemcitabine|gemcitabine|mesh-list
139440361|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139440362|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
139440363|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440364|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440365|NCT03251443|Apatinib|apatinib|mesh-list
139440366|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440367|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139440368|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440369|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440370|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139440371|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139440372|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440373|NCT05350943|Gemcitabine|gemcitabine|mesh-list
139440374|NCT05350943|Oxaliplatin|oxaliplatin|mesh-list
139440375|NCT05350943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139440376|NCT05350943|Antimetabolites|antimetabolites|mesh-ancestor
139440377|NCT05350943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440378|NCT05350943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440379|NCT03261427|Pregabalin|pregabalin|mesh-list
139440380|NCT03261427|Analgesics|analgesics|mesh-ancestor
139440381|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
139440382|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440383|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440384|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
139440385|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139440386|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139440387|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440388|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139440389|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139440390|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139440391|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440392|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139440393|NCT03261115|Anesthetics|anesthetics|mesh-list
139440394|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440395|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440396|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
139440397|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
139440398|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
139440399|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139440400|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440401|NCT05320133|Bismuth|bismuth|mesh-list
139440402|NCT05320133|Antacids|antacids|mesh-ancestor
139440403|NCT05320133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440404|NCT05320133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139440405|NCT03122561|Acetaminophen|acetaminophen|mesh-list
139440406|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139440407|NCT03122561|Analgesics|analgesics|mesh-ancestor
139440408|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
139440409|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440410|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440411|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
139440412|NCT04503629|Rabeprazole|rabeprazole|mesh-list
139440413|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139440414|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139440415|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139440416|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440417|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440418|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
139440419|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139440420|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
139440421|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
139440422|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440423|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440424|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
139440425|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139440426|NCT03348371|Ethanol|ethanol|mesh-list
139440427|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139440428|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440429|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440430|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440431|NCT05231603|Ivermectin|ivermectin|mesh-list
139440432|NCT05231603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139440433|NCT05231603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440434|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139440435|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139440436|NCT03434041|Sertraline|sertraline|mesh-list
139440437|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
139440438|NCT03434041|Esketamine|esketamine|mesh-list
139440439|NCT03434041|Escitalopram|escitalopram|mesh-list
139440440|NCT03434041|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139440441|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139440442|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139440443|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440444|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440445|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
139440446|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440447|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440448|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139440449|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139440450|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139440451|NCT03434041|Analgesics|analgesics|mesh-ancestor
139440452|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
139440453|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
139440454|NCT03250741|Rotigotine|rotigotine|mesh-list
139440455|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
139440456|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
139440457|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440458|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440459|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440460|NCT03255811|Apatinib|apatinib|mesh-list
139440461|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440462|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139440463|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440464|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440465|NCT01842035|Regadenoson|regadenoson|mesh-list
139440466|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139440467|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139440468|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
139440469|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
139440470|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440471|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440472|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440473|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
139440474|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440475|NCT05585177|Hormones|hormones|mesh-list
139440476|NCT05585177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139440477|NCT05585177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440478|NCT03250039|Abrocitinib|abrocitinib|mesh-list
139440479|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139440480|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440481|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440482|NCT02517827|Paclitaxel|paclitaxel|mesh-list
139440483|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139440484|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440485|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
139440486|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
139440487|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
139440488|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440489|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139440490|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139440491|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440492|NCT03246451|Metformin|metformin|mesh-list
139440493|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139440494|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440495|NCT05013437|Acetaminophen|acetaminophen|mesh-list
139440496|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
139440497|NCT05013437|Promethazine|promethazine|mesh-list
139440498|NCT05013437|Melphalan|melphalan|mesh-list
139440499|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
139440500|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139440501|NCT05013437|Analgesics|analgesics|mesh-ancestor
139440502|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
139440503|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440504|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440505|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
139440506|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139440507|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
139440508|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440509|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440510|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139440511|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139440512|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
139440513|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139440514|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139440515|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440516|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
139440517|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
139440518|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
139440519|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
139440520|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139440521|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139440522|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
139440523|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
139440524|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440525|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139440526|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
139440527|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
139440528|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139440529|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139440530|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139440531|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139440532|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
139440533|NCT03246295|Insulin|insulin|mesh-list
139440534|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139440535|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440536|NCT03346733|Psyllium|psyllium|mesh-list
139440537|NCT03346733|Cathartics|cathartics|mesh-ancestor
139440538|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139440539|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139440540|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139440541|NCT03346187|Atorvastatin|atorvastatin|mesh-list
139440542|NCT03346187|Fenofibrate|fenofibrate|mesh-list
139440543|NCT03346187|Calcium|calcium|mesh-list
139440544|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139440545|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440546|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139227270|NCT05443178|Amebicides|amebicides|mesh-ancestor
139440547|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139440548|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
139440549|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440550|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139440551|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139440552|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440553|NCT04487743|Liraglutide|liraglutide|mesh-list
139440554|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139440555|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440556|NCT04487743|Incretins|incretins|mesh-ancestor
139440557|NCT04487743|Hormones|hormones|mesh-ancestor
139440558|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139440559|NCT05584631|Immunoglobulins|immunoglobulins|mesh-list
139440560|NCT05584631|Antibodies|antibodies|mesh-list
139440561|NCT05584631|gamma-Globulins|gamma-globulins|mesh-list
139440562|NCT05584631|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139440563|NCT05584631|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139440564|NCT05584631|Immunoglobulin G|immunoglobulin g|mesh-list
139440565|NCT05584631|Immunologic Factors|immunologic factors|mesh-ancestor
139440566|NCT05584631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440567|NCT03249259|Choline|choline|mesh-list
139440568|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
139440569|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139440570|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
139440571|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440572|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139440573|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139440574|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
139440575|NCT04487587|Olaparib|olaparib|mesh-list
139440576|NCT04487587|Cediranib|cediranib|mesh-list
139440577|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139440578|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440579|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440580|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440581|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139440582|NCT04833413|Insulin|insulin|mesh-list
139440583|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139440584|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139440585|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440586|NCT02454751|Fentanyl|fentanyl|mesh-list
139440587|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139440588|NCT02454751|Narcotics|narcotics|mesh-ancestor
139440589|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440590|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440591|NCT02454751|Analgesics|analgesics|mesh-ancestor
139440592|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
139440593|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440594|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139440595|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139440596|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
139440597|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
139440598|NCT02455921|Atropine|atropine|mesh-list
139440599|NCT02455921|Neostigmine|neostigmine|mesh-list
139440600|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139440601|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139440602|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139440603|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
139440604|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440605|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440606|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139440607|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
139440608|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
139440609|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
139440610|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139440611|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139440612|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
139440613|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440614|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440615|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139440616|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440617|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139440618|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
139440619|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139440620|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
139440621|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440622|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
139440623|NCT04786613|Protective Agents|protective agents|mesh-ancestor
139227339|NCT05400122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440624|NCT00700999|Paroxetine|paroxetine|mesh-list
139440625|NCT00700999|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139440626|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139440627|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139440628|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440629|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440630|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
139440631|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440632|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139440633|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
139440634|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139440635|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139440636|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139440637|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440638|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
139440639|NCT04502771|Clotrimazole|clotrimazole|mesh-list
139440640|NCT04502771|Miconazole|miconazole|mesh-list
139440641|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440642|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139440643|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139440644|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139440645|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440646|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440647|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139440648|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
139440649|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139440650|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440651|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139440652|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139440653|NCT04761887|Ropivacaine|ropivacaine|mesh-list
139440654|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
139440655|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
139440656|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440657|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440658|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
139440659|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440660|NCT03249025|Lidocaine|lidocaine|mesh-list
139440661|NCT03249025|Ketamine|ketamine|mesh-list
139440662|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
139440663|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
139440664|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440665|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440666|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
139440667|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440668|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139440669|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139440670|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139440671|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139440672|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440673|NCT03249025|Analgesics|analgesics|mesh-ancestor
139440674|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139440675|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139440676|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
139440677|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139440678|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139440679|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440680|NCT03248713|Mifepristone|mifepristone|mesh-list
139440681|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139440682|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
139440683|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139440684|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440685|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139440686|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139440687|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139440688|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
139440689|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139440690|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139440691|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
139440692|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139440693|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
139440694|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139440695|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139440696|NCT03245671|Dexamethasone|dexamethasone|mesh-list
139440697|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
139440698|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139440699|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139440700|NCT03245671|BB 1101|bb 1101|mesh-list
139440701|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139440702|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
139440703|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
139440704|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440705|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440706|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139440707|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
139440708|NCT03245671|Hormones|hormones|mesh-ancestor
139440709|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139440710|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139440711|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440712|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
139440713|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440714|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440715|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139440716|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
139440717|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139440718|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139440719|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440720|NCT03245515|Branebrutinib|branebrutinib|mesh-list
139440721|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139440722|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440723|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440724|NCT03363503|Fluticasone|fluticasone|mesh-list
139440725|NCT03363503|Xhance|xhance|mesh-list
139440726|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139440727|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139440728|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139440729|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
139440730|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440731|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440732|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139440733|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
139440734|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
139440735|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139440736|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139440737|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139440738|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139440739|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
139440740|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440741|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440742|NCT03248791|Phenylephrine|phenylephrine|mesh-list
139440743|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
139440744|NCT03248791|Norepinephrine|norepinephrine|mesh-list
139440745|NCT03248791|Bupivacaine|bupivacaine|mesh-list
139440746|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
139440747|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
139440748|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440749|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440750|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
139440751|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440752|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139440753|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
139440754|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
139440755|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
139440756|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139440757|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
139440758|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
139440759|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139440760|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139440761|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139440762|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
139440763|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440764|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440765|NCT03248791|Protective Agents|protective agents|mesh-ancestor
139440766|NCT03254173|Mirtazapine|mirtazapine|mesh-list
139440767|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
139440768|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139440769|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139440770|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
139440771|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
139440772|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440773|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440774|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440775|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139440776|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139440777|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440778|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139440779|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139440780|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139440781|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
139440782|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139440783|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139440784|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
139440785|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139440786|NCT03248401|Aspirin|aspirin|mesh-list
139440787|NCT03248401|Cilostazol|cilostazol|mesh-list
139440788|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139440789|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139440790|NCT03248401|Analgesics|analgesics|mesh-ancestor
139440791|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
139440792|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440793|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440794|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139440795|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139440796|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139440797|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139440798|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440799|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139440800|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139440801|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440802|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
139440803|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139440804|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
139440805|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139440806|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
139440807|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
139440808|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139440809|NCT03248401|Protective Agents|protective agents|mesh-ancestor
139440810|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139440811|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139440812|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
139440813|NCT02516423|Dexamethasone|dexamethasone|mesh-list
139440814|NCT02516423|Lenalidomide|lenalidomide|mesh-list
139440815|NCT02516423|Ixazomib|ixazomib|mesh-list
139440816|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139440817|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
139440818|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
139440819|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440820|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440821|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139440822|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
139440823|NCT02516423|Hormones|hormones|mesh-ancestor
139440824|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139440825|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139440826|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440827|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
139440828|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139440829|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139440830|NCT02516423|Growth Substances|growth substances|mesh-ancestor
139440831|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
139440832|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139440833|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
139440834|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440835|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440836|NCT03245281|Diuretics|diuretics|mesh-list
139440837|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
139440838|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440839|NCT02515955|Minocycline|minocycline|mesh-list
139440840|NCT02515955|Amphetamine|amphetamine|mesh-list
139440841|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
139440842|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139440843|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440844|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139440845|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440846|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
139440847|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
139440848|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440849|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
139440850|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440851|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440852|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
139440853|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139440854|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139440855|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139440856|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139440858|NCT04500743|Dienogest|dienogest|mesh-list
139440859|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139440860|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
139440861|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139440862|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440863|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139440864|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440865|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139440866|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
139440867|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139440868|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139440869|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139440870|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139440871|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
139440872|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139440873|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139440874|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440875|NCT03239353|Entecavir|entecavir|mesh-list
139440876|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
139440877|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440878|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
139440879|NCT03347591|Hemostatics|hemostatics|mesh-list
139440880|NCT03347591|Coagulants|coagulants|mesh-ancestor
139440881|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139440882|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
139440883|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099196|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
139440884|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139440885|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440886|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
139440887|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440888|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
139440889|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139440890|NCT03347591|Protective Agents|protective agents|mesh-ancestor
139440891|NCT04486651|Irinotecan|irinotecan|mesh-list
139440892|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139440893|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139440894|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440895|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440896|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440897|NCT03347513|Glycine|glycine|mesh-list
139440898|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
139440899|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440900|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440901|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440902|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
139440903|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
139440904|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440905|NCT04088591|Protective Agents|protective agents|mesh-ancestor
139440906|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440907|NCT04088591|Vitamins|vitamins|mesh-ancestor
139440908|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
139440909|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
139440910|NCT04501289|Analgesics|analgesics|mesh-ancestor
139440911|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
139440912|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440913|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440914|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
139440915|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139440916|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139440917|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
139440918|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139440919|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139440920|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440921|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139440922|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
139440923|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139440924|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
139440925|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139440926|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139440927|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440928|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
139440929|NCT03244423|Coagulants|coagulants|mesh-ancestor
139440930|NCT03347357|Tacrolimus|tacrolimus|mesh-list
139440931|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139440932|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
139440933|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440934|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139440935|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440936|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440937|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
139440938|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440939|NCT02515877|Carboplatin|carboplatin|mesh-list
139440940|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440941|NCT03952091|Dexamethasone|dexamethasone|mesh-list
139440942|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
139440943|NCT03952091|Lenalidomide|lenalidomide|mesh-list
139440944|NCT03952091|BB 1101|bb 1101|mesh-list
139440945|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139440946|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
139440947|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
139440948|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440949|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440950|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139440951|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
139440952|NCT03952091|Hormones|hormones|mesh-ancestor
139440953|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139440954|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139440955|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139440956|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
139440957|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099270|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
139440958|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440959|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
139440960|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139440961|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139440962|NCT03952091|Growth Substances|growth substances|mesh-ancestor
139440963|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
139440964|NCT03246919|Oxytocin|oxytocin|mesh-list
139440965|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
139440966|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139440967|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440968|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
139440969|NCT04502537|Hematinics|hematinics|mesh-ancestor
139440970|NCT02453659|Nicotine|nicotine|mesh-list
139440971|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139440972|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
139440973|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139440974|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139440975|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139440976|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139440977|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
139440978|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139440979|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440980|NCT02513147|Lopinavir|lopinavir|mesh-list
139440981|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139440982|NCT02513147|Darunavir|darunavir|mesh-list
139440983|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
139440984|NCT02513147|Dolutegravir|dolutegravir|mesh-list
139440985|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139440986|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139440987|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
139440988|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139440989|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139440990|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139440991|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139440992|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
139440993|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139440994|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139440995|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139440996|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139440997|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139440998|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
139440999|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139441000|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441001|NCT03246685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139441002|NCT03246685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441003|NCT02453893|Risperidone|risperidone|mesh-list
139441004|NCT02453893|Iloperidone|iloperidone|mesh-list
139441005|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139441006|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
139441007|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441008|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441009|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441010|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139441011|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139441012|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441013|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139441014|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139441015|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
139441016|NCT02513069|Nicotine|nicotine|mesh-list
139441017|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
139441018|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139441019|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
139441020|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441021|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441022|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139441023|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139441024|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
139441025|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441026|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441027|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
139441028|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
139441029|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
139441030|NCT02454205|Levofloxacin|levofloxacin|mesh-list
139441031|NCT02454205|Isoniazid|isoniazid|mesh-list
139441032|NCT02454205|Linezolid|linezolid|mesh-list
139441033|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
139441034|NCT02454205|Bedaquiline|bedaquiline|mesh-list
139441035|NCT02454205|Kanamycin|kanamycin|mesh-list
139441036|NCT02454205|Ethionamide|ethionamide|mesh-list
139441037|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139441038|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441039|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139441040|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139441041|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441042|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441043|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441044|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139441045|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139441046|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139441047|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
139441048|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139441049|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139441050|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
139441051|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139441052|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139441053|NCT03235141|Azithromycin|azithromycin|mesh-list
139441054|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139441055|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139441056|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441057|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139441058|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139441059|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
139441060|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441061|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
139441062|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139441063|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139441064|NCT03234673|Calcipotriene|calcipotriene|mesh-list
139441065|NCT03234673|Tacrolimus|tacrolimus|mesh-list
139441066|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139441067|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
139441068|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441069|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139441070|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441071|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441072|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
139441073|NCT03148613|Carbon Monoxide|carbon monoxide|mesh-list
139441074|NCT03148613|Antimetabolites|antimetabolites|mesh-ancestor
139227794|NCT04578535|Antibodies|antibodies|mesh-list
139441075|NCT03148613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441077|NCT03148613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441078|NCT03148613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441079|NCT03243643|Apatinib|apatinib|mesh-list
139441080|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441081|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139441082|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441083|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441084|NCT03234517|Clindamycin|clindamycin|mesh-list
139441085|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
139441086|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
139441087|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139441088|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441089|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139441090|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441091|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441092|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
139441093|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139441094|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
139441095|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441096|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
139441097|NCT03238183|Protective Agents|protective agents|mesh-ancestor
139441098|NCT02729051|Albuterol|albuterol|mesh-list
139441099|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139441100|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
139441101|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441102|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441103|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139441104|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
139441105|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
139441106|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139441107|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139441108|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139441109|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139441110|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
139441111|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441112|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441113|NCT03237637|Propranolol|propranolol|mesh-list
139441114|NCT03237637|Atenolol|atenolol|mesh-list
139441115|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139441116|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139441117|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
139441118|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441119|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441120|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441121|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139441122|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139441123|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
139441124|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
139441125|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
139441126|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441127|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139441128|NCT03243331|Gedatolisib|gedatolisib|mesh-list
139441129|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139441130|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441131|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441132|NCT03237715|Bilirubin|bilirubin|mesh-list
139441133|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
139441134|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441135|NCT03237715|Protective Agents|protective agents|mesh-ancestor
139441136|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441137|NCT02515565|Erythromycin|erythromycin|mesh-list
139441138|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
139441139|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139441140|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
139441141|NCT02515565|Cephalosporins|cephalosporins|mesh-list
139441142|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139441143|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441144|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139441145|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139441146|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441147|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441148|NCT05600075|Insulin|insulin|mesh-list
139441149|NCT05600075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139441150|NCT05600075|Glycolic acid|glycolic acid|mesh-list
139441151|NCT05600075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139441152|NCT05600075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441153|NCT05600075|Keratolytic Agents|keratolytic agents|mesh-ancestor
139441154|NCT05600075|Dermatologic Agents|dermatologic agents|mesh-ancestor
139441155|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
139441156|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
139441157|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139441158|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
139441159|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441160|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139441161|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139441162|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139441163|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139441164|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441165|NCT03233815|Propofol|propofol|mesh-list
139441166|NCT03233815|Sevoflurane|sevoflurane|mesh-list
139441167|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139441168|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441169|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441170|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139441171|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
139441172|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
139441173|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139441174|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139441175|NCT02507609|Rocuronium|rocuronium|mesh-list
139441176|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441177|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139441178|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139441179|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139441180|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441181|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139441182|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139441183|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441184|NCT02512523|Incretins|incretins|mesh-ancestor
139441185|NCT02512523|Hormones|hormones|mesh-ancestor
139441186|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139441187|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139441188|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
139441189|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441190|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441191|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
139441192|NCT03233893|Calcium|calcium|mesh-list
139441193|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139441194|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441195|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139441196|NCT05597813|Timolol|timolol|mesh-list
139441197|NCT05597813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139441198|NCT05597813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139441199|NCT05597813|Adrenergic Agents|adrenergic agents|mesh-ancestor
139441200|NCT05597813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441201|NCT05597813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441202|NCT05597813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441203|NCT05597813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139441204|NCT05597813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139441205|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
139441206|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139441207|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
139441208|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441209|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
139441210|NCT03242707|Protective Agents|protective agents|mesh-ancestor
139441211|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
139441212|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139441213|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441214|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441215|NCT02512055|Atropine|atropine|mesh-list
139441216|NCT02512055|Ketamine|ketamine|mesh-list
139441217|NCT02512055|Analgesics|analgesics|mesh-ancestor
139441218|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
139441219|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441220|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441221|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139441222|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139441223|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
139441224|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
139441225|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441226|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139441227|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139441228|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441229|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441230|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139441231|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139441232|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139441233|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
139441234|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139441235|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
139441236|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
139441237|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
139441238|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139441239|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139441240|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
139441241|NCT02514941|Acetaminophen|acetaminophen|mesh-list
139441242|NCT02514941|Amoxicillin|amoxicillin|mesh-list
139441243|NCT02514941|Talinolol|talinolol|mesh-list
139441244|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139441245|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441246|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139441247|NCT02514941|Analgesics|analgesics|mesh-ancestor
139441248|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
139441249|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441250|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441251|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
139441252|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139441253|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139441254|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
139441255|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441256|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441257|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139441258|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139441259|NCT02511665|Metformin|metformin|mesh-list
139441260|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139441261|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441262|NCT02514629|Metformin|metformin|mesh-list
139441263|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
139441264|NCT02514629|Testosterone|testosterone|mesh-list
139441265|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
139441266|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
139441267|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139441268|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139441269|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441270|NCT02514629|Androgens|androgens|mesh-ancestor
139441271|NCT02514629|Hormones|hormones|mesh-ancestor
139441272|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139441273|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139441274|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441275|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
139441276|NCT02511353|Ivermectin|ivermectin|mesh-list
139441277|NCT02511353|Piperaquine|piperaquine|mesh-list
139441278|NCT02511353|Artenimol|artenimol|mesh-list
139441279|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139441280|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441281|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
139441282|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139441283|NCT03242317|Mitomycins|mitomycins|mesh-list
139441284|NCT03242317|Mitomycin|mitomycin|mesh-list
139441285|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139441286|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441287|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
139441288|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441289|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139441290|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441291|NCT02453503|Triamcinolone|triamcinolone|mesh-list
139441292|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139441293|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139441294|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139441295|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139441296|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
139441297|NCT02453503|Hormones|hormones|mesh-ancestor
139441298|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139441299|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441300|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139441301|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
139441302|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441303|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441304|NCT04499885|Mineral Oil|mineral oil|mesh-list
139441305|NCT04499885|Emollients|emollients|mesh-ancestor
139441306|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
139441307|NCT02453425|Norepinephrine|norepinephrine|mesh-list
139441308|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139441309|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139441310|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
139441311|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441312|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441313|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441314|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
139441315|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
139441316|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441317|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139441318|NCT03233035|Ketamine|ketamine|mesh-list
139441319|NCT03233035|Analgesics|analgesics|mesh-ancestor
139441320|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
139441321|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441322|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441323|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139441324|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139441325|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
139441326|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
139441327|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441328|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139441329|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139441330|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441331|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441332|NCT03242239|Trastuzumab|trastuzumab|mesh-list
139441333|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139441334|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441335|NCT03232957|Morphine|morphine|mesh-list
139441336|NCT03232957|Bupivacaine|bupivacaine|mesh-list
139441337|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
139441338|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
139441339|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441340|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441341|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
139441342|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441343|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139441344|NCT03232957|Narcotics|narcotics|mesh-ancestor
139441345|NCT03232957|Analgesics|analgesics|mesh-ancestor
139441346|NCT02513849|Tamoxifen|tamoxifen|mesh-list
139441347|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139441348|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
139441349|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139441350|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441351|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139441352|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441353|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139441354|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139441355|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139441356|NCT02513927|Metoprolol|metoprolol|mesh-list
139441357|NCT02513927|Nifedipine|nifedipine|mesh-list
139441358|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139441359|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139441360|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
139441361|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
139441362|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441363|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441364|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139441365|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139441366|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139441367|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
139441368|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441369|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441370|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139228093|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228094|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441371|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139228095|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139441372|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139441373|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
139441374|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
139441375|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139441376|NCT03236623|Menthol|menthol|mesh-list
139441377|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
139441378|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
139441379|NCT03121313|Tegafur|tegafur|mesh-list
139441380|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139441381|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
139441382|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441383|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441384|NCT03236233|PC-786|pc-786|mesh-list
139441385|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
139441386|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441387|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441388|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441389|NCT02513693|Rocuronium|rocuronium|mesh-list
139441390|NCT02513693|Neostigmine|neostigmine|mesh-list
139441391|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139441392|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139441393|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139441394|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441395|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441396|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139441397|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441398|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441399|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
139441400|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441401|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139441402|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
139441403|NCT03121547|Tramadol|tramadol|mesh-list
139441404|NCT03121547|Tapentadol|tapentadol|mesh-list
139441405|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441406|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139441407|NCT03121547|Narcotics|narcotics|mesh-ancestor
139441408|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441409|NCT03121547|Analgesics|analgesics|mesh-ancestor
139441410|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
139441411|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441412|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139441413|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139441414|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139441415|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441416|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
139441417|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441418|NCT03241381|Vitamin D|vitamin d|mesh-list
139441419|NCT03241381|Vitamins|vitamins|mesh-ancestor
139441420|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
139441421|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441422|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139441423|NCT03241303|Acarbose|acarbose|mesh-list
139441424|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139441425|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441426|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441427|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139441428|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441429|NCT02510963|Tenofovir|tenofovir|mesh-list
139441430|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
139441431|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441432|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139441433|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139441434|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441435|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228177|NCT03421353|Paclitaxel|paclitaxel|mesh-list
139228178|NCT03421353|Carboplatin|carboplatin|mesh-list
139228179|NCT03421353|Gemcitabine|gemcitabine|mesh-list
139228180|NCT03421353|Durvalumab|durvalumab|mesh-list
139228181|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139228182|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228183|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
139228184|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
139228185|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
139228186|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228187|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139441436|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139441437|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139441438|NCT02513381|Vitamin D|vitamin d|mesh-list
139441439|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
139441440|NCT02513381|Vitamins|vitamins|mesh-ancestor
139441441|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
139441442|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441443|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139441444|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139441445|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
139441446|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
139441447|NCT03232021|Pregabalin|pregabalin|mesh-list
139441448|NCT03232021|Analgesics|analgesics|mesh-ancestor
139441449|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
139441450|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441451|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441452|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
139441453|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139441454|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139441455|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441456|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139441457|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139441458|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139441459|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441460|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139441461|NCT03235609|Fentanyl|fentanyl|mesh-list
139441462|NCT03235609|Ketamine|ketamine|mesh-list
139441463|NCT03235609|Analgesics|analgesics|mesh-ancestor
139441464|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
139441465|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441466|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441467|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139441468|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139441469|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
139441470|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
139441471|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441472|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139441473|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139441474|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441475|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441476|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139441477|NCT03235609|Narcotics|narcotics|mesh-ancestor
139441478|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139441479|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
139441480|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139441481|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441482|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441483|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139441484|NCT02509949|Analgesics|analgesics|mesh-ancestor
139441485|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
139441486|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441487|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139441488|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139441489|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139441490|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
139441491|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441492|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441493|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
139441494|NCT03344705|Fludarabine|fludarabine|mesh-list
139441495|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139441496|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
139441497|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441498|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139441499|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139441500|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
139441501|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441502|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441503|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139441504|NCT02501603|Paclitaxel|paclitaxel|mesh-list
139441505|NCT02501603|Afatinib|afatinib|mesh-list
139441506|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139441507|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441508|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
139441509|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
139441510|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
139441511|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441512|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139441513|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441514|NCT03344627|Meropenem|meropenem|mesh-list
139441515|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139441516|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441517|NCT02501213|Furosemide|furosemide|mesh-list
139441518|NCT02501213|Spironolactone|spironolactone|mesh-list
139441519|NCT02501213|Diuretics|diuretics|mesh-ancestor
139441520|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
139441521|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441522|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139441523|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139441524|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441525|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139441526|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
139441527|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139441528|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139441529|NCT02501291|Thalidomide|thalidomide|mesh-list
139441530|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139441531|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
139441532|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441533|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
139441534|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139441535|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441536|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139441537|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139441538|NCT02501291|Growth Substances|growth substances|mesh-ancestor
139441539|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
139441540|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441541|NCT02509559|Propranolol|propranolol|mesh-list
139099873|NCT06096844|Pemetrexed|pemetrexed|mesh-list
139441542|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139441543|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139441544|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
139441545|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441546|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441547|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441548|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139441549|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139441550|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
139441551|NCT00707993|Alogliptin|alogliptin|mesh-list
139441552|NCT00707993|Glipizide|glipizide|mesh-list
139441553|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139441554|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441555|NCT00707993|Incretins|incretins|mesh-ancestor
139441556|NCT00707993|Hormones|hormones|mesh-ancestor
139441557|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139441558|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139441559|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
139441560|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441561|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441562|NCT02509091|Amikacin|amikacin|mesh-list
139441563|NCT02509091|Dimercaprol|dimercaprol|mesh-list
139441564|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139441565|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441566|NCT02509091|Chelating Agents|chelating agents|mesh-ancestor
139441567|NCT02509091|Sequestering Agents|sequestering agents|mesh-ancestor
139441568|NCT02509091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441569|NCT02508857|Ketorolac|ketorolac|mesh-list
139441570|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
139441571|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139441572|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139441573|NCT02508857|Analgesics|analgesics|mesh-ancestor
139441574|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
139441575|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441576|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441577|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139441578|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139441579|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139441580|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441581|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441582|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
139441583|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441584|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139441585|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
139441586|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139441587|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139441588|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139441589|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
139441590|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139441591|NCT02508623|Rifaximin|rifaximin|mesh-list
139441592|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139441593|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441594|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139441595|NCT02500667|Rifampin|rifampin|mesh-list
139441596|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139441597|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
139441598|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139441599|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441600|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
139441601|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139441602|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441603|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441604|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139441605|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139441606|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139441607|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139441608|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139441609|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139441610|NCT02500511|Vaccines|vaccines|mesh-list
139441611|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
139441612|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441613|NCT03344393|Ketamine|ketamine|mesh-list
139441614|NCT03344393|Analgesics|analgesics|mesh-ancestor
139441615|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
139441616|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441617|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441618|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139441619|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139441620|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
139441621|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
139441622|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441623|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139441624|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139441625|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441626|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441627|NCT04498793|Paclitaxel|paclitaxel|mesh-list
139441628|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
139441629|NCT04498793|Doxorubicin|doxorubicin|mesh-list
139441630|NCT04498793|Epirubicin|epirubicin|mesh-list
139441631|NCT04498793|Tislelizumab|tislelizumab|mesh-list
139441632|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139441633|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441634|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
139441635|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
139441636|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
139441637|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441638|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139441639|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
139441640|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441641|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139441642|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139441643|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
139441644|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139441645|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139441646|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139441647|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139441648|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441649|NCT04498793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139441650|NCT04498325|Antibodies|antibodies|mesh-list
139441651|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
139441652|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441653|NCT02507843|Vitamin D|vitamin d|mesh-list
139441654|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
139441655|NCT02507843|Vitamins|vitamins|mesh-ancestor
139441656|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
139441657|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382494|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441658|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139642359|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441659|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139441660|NCT02425891|Paclitaxel|paclitaxel|mesh-list
139441661|NCT02425891|Atezolizumab|atezolizumab|mesh-list
139441662|NCT02425891|Antibodies|antibodies|mesh-list
139441663|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139441664|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139441665|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441666|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
139441667|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
139441668|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
139441669|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441670|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
139441671|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441672|NCT02425891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139441673|NCT02425891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139441674|NCT02499965|Anesthetics|anesthetics|mesh-list
139441675|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
139441676|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441677|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441678|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
139441679|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
139441680|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441681|NCT05504057|Amantadine|amantadine|mesh-list
139441682|NCT05504057|Histamine Antagonists|histamine antagonists|mesh-list
139441683|NCT05504057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139441684|NCT05504057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139441685|NCT05504057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139441686|NCT05504057|Antiviral Agents|antiviral agents|mesh-ancestor
139441687|NCT05504057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441688|NCT05504057|Dopamine Agents|dopamine agents|mesh-ancestor
139441689|NCT05504057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441690|NCT05504057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441691|NCT05504057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441692|NCT05504057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139441693|NCT05504057|Analgesics|analgesics|mesh-ancestor
139441694|NCT05504057|Sensory System Agents|sensory system agents|mesh-ancestor
139441695|NCT05504057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441696|NCT05504057|Histamine Agents|histamine agents|mesh-ancestor
139441697|NCT03344003|Factor VIII|factor viii|mesh-list
139441698|NCT03344003|Coagulants|coagulants|mesh-ancestor
139441699|NCT03235531|Valproic Acid|valproic acid|mesh-list
139441700|NCT03235531|Lorazepam|lorazepam|mesh-list
139441701|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
139441702|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441703|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441704|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
139441705|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441706|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441707|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
139441708|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139441709|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441710|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139441711|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
139441712|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
139441713|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441714|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139441715|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139441716|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139441717|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
139441718|NCT02506829|Nicotine|nicotine|mesh-list
139441719|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139441720|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
139441721|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441722|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441723|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139441724|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139441725|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
139441726|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441727|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441728|NCT02506439|Vitamin D|vitamin d|mesh-list
139441729|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
139441730|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
139441731|NCT02506439|Vitamins|vitamins|mesh-list
139441732|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
139441733|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441734|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139441735|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139441736|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
139441737|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441738|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139441739|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441740|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441741|NCT02499341|Ketamine|ketamine|mesh-list
139441742|NCT02499341|Tramadol|tramadol|mesh-list
139441743|NCT02499341|Analgesics|analgesics|mesh-ancestor
139441744|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
139441745|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441746|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441747|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139441748|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139441749|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
139441750|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
139441751|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441752|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139441753|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139441754|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441755|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441756|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139441757|NCT02499341|Narcotics|narcotics|mesh-ancestor
139441758|NCT02495285|Polygeline|polygeline|mesh-list
139441759|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
139441760|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
139441761|NCT02495363|Bupivacaine|bupivacaine|mesh-list
139441762|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
139441763|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
139441764|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441765|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441766|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
139441767|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441768|NCT03121079|Interferons|interferons|mesh-list
139441769|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
139441770|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441771|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
139441772|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441773|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
139441774|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441775|NCT02494895|Aspirin|aspirin|mesh-list
139441776|NCT02494895|Ticagrelor|ticagrelor|mesh-list
139441777|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139441778|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139441779|NCT02494895|Analgesics|analgesics|mesh-ancestor
139441780|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
139441781|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441782|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441783|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139441784|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139441785|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139441786|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139441787|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441788|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139441789|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139441790|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441791|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
139441792|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139441793|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139441794|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139441795|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
139441796|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441797|NCT03341741|Tobramycin|tobramycin|mesh-list
139441798|NCT03341741|Colistin|colistin|mesh-list
139441799|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139441800|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441801|NCT01597245|Etanercept|etanercept|mesh-list
139441802|NCT01597245|Ixekizumab|ixekizumab|mesh-list
139441803|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139441804|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139441805|NCT01597245|Analgesics|analgesics|mesh-ancestor
139441806|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
139441807|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228555|NCT00171002|Amlodipine|amlodipine|mesh-list
139441808|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441809|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139441810|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139441811|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139441812|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139441813|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
139441814|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
139441815|NCT03341429|Liraglutide|liraglutide|mesh-list
139441816|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139441817|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441818|NCT03341429|Incretins|incretins|mesh-ancestor
139441819|NCT03341429|Hormones|hormones|mesh-ancestor
139441820|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139441821|NCT04494659|Rifampin|rifampin|mesh-list
139441822|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139441823|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
139441824|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139441825|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441826|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
139441827|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139441828|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441829|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441830|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139441831|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139441832|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139441833|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139441834|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139441835|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139441836|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
139441837|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
139441838|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441839|NCT03342599|Protective Agents|protective agents|mesh-ancestor
139441840|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441841|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
139441842|NCT03342599|Vitamins|vitamins|mesh-ancestor
139441843|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
139441844|NCT03341117|Aspirin|aspirin|mesh-list
139441845|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
139441846|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139441847|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139441848|NCT03341117|Analgesics|analgesics|mesh-ancestor
139441849|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
139441850|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441851|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441852|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139441853|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139441854|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139441855|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139441856|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441857|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139441858|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139441859|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441860|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
139441861|NCT03341117|Antacids|antacids|mesh-ancestor
139441862|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139441863|NCT02498171|Fentanyl|fentanyl|mesh-list
139441864|NCT02498171|Morphine|morphine|mesh-list
139441865|NCT02498171|Bupivacaine|bupivacaine|mesh-list
139441866|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
139441867|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
139441868|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441869|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441870|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
139441871|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441872|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139441873|NCT02498171|Narcotics|narcotics|mesh-ancestor
139441874|NCT02498171|Analgesics|analgesics|mesh-ancestor
139441875|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139441876|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139441877|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
139441878|NCT03120533|Treprostinil|treprostinil|mesh-list
139441879|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139441880|NCT03342443|Memantine|memantine|mesh-list
139441881|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139441882|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139441883|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
139441884|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441885|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441886|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441887|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139441888|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139441889|NCT05035485|Phenylephrine|phenylephrine|mesh-list
139441890|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
139441891|NCT05035485|Norepinephrine|norepinephrine|mesh-list
139441892|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139441893|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139441894|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
139441895|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
139441896|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441897|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441898|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
139441899|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
139441900|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
139441901|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139441902|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139441903|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139441904|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
139441905|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441906|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441907|NCT05035485|Protective Agents|protective agents|mesh-ancestor
139441908|NCT02498015|Ribavirin|ribavirin|mesh-list
139441909|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
139441910|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441911|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
139441912|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441913|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
139441914|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139441915|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441916|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139441917|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
139441918|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139441919|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139441920|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441921|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441922|NCT03340493|Tenecteplase|tenecteplase|mesh-list
139441923|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139441924|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139441925|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441926|NCT03098199|Menotropins|menotropins|mesh-list
139441927|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441928|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139441929|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
139441930|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139441931|NCT00707057|Ibuprofen|ibuprofen|mesh-list
139441932|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139441933|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139441934|NCT00707057|Analgesics|analgesics|mesh-ancestor
139441935|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
139441936|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441937|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441938|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139441939|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139441940|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139441941|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139441942|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441943|NCT02494349|Tamsulosin|tamsulosin|mesh-list
139441944|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
139441945|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139441946|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139441947|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139441948|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
139441949|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441950|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441951|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441952|NCT02494349|Urological Agents|urological agents|mesh-ancestor
139441953|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139441954|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139441955|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
139441956|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
139441957|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139441958|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139441959|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441960|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139441961|NCT03095469|Analgesics|analgesics|mesh-ancestor
139441962|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
139441963|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139441964|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139441965|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139441966|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139441967|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
139441968|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139441969|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139441970|NCT02497547|Oxytocin|oxytocin|mesh-list
139441971|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
139441972|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139441973|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441974|NCT05043129|Vaccines|vaccines|mesh-list
139441975|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
139441976|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441977|NCT02497313|Metformin|metformin|mesh-list
139441978|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
139441979|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139441980|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441981|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139441982|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139441983|NCT02497157|Leucovorin|leucovorin|mesh-list
139441984|NCT02497157|Bevacizumab|bevacizumab|mesh-list
139441985|NCT02497157|Fluorouracil|fluorouracil|mesh-list
139441986|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
139441987|NCT02497157|Irinotecan|irinotecan|mesh-list
139441988|NCT02497157|Calcium|calcium|mesh-list
139441989|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
139441990|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139441991|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139441992|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139441993|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139441994|NCT02497157|Growth Substances|growth substances|mesh-ancestor
139441995|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139441996|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
139441997|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139441998|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
139441999|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442000|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139442001|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139442002|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
139442003|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139442004|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139442005|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442006|NCT02497157|Antidotes|antidotes|mesh-ancestor
139442007|NCT02497157|Protective Agents|protective agents|mesh-ancestor
139442008|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
139442009|NCT02497157|Vitamins|vitamins|mesh-ancestor
139442010|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
139442011|NCT03095079|Endostatins|endostatins|mesh-list
139442012|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139442013|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139442014|NCT03095079|Growth Substances|growth substances|mesh-ancestor
139442015|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442016|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
139442017|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442018|NCT03120923|Triamcinolone|triamcinolone|mesh-list
139442019|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139442020|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139442021|NCT03120923|Lidocaine|lidocaine|mesh-list
139442022|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139442023|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
139442024|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
139442025|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442026|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442027|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
139442028|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442029|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138850977|NCT00798603|Pemetrexed|pemetrexed|mesh-list
139442030|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139442031|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139442032|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139442033|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442034|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139442035|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
139442036|NCT03120923|Hormones|hormones|mesh-ancestor
139442037|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139442038|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139442039|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
139442040|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442041|NCT02497079|Formaldehyde|formaldehyde|mesh-list
139442042|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
139442043|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442044|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
139442045|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139442046|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
139442047|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139442048|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
139442049|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442050|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442051|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
139442052|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
139442053|NCT02639247|Velpatasvir|velpatasvir|mesh-list
139442054|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
139442055|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442056|NCT05033535|Olmesartan|olmesartan|mesh-list
139442057|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139442058|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139442059|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139442060|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139442061|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442062|NCT05053893|Valsartan|valsartan|mesh-list
139442063|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139442064|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139442065|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139442066|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139442067|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442068|NCT03096327|Montelukast|montelukast|mesh-list
139442069|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139442070|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
139442071|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139442072|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
139442073|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139442074|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442075|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139442076|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139442077|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442078|NCT03098121|Grazoprevir|grazoprevir|mesh-list
139442079|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
139442080|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442081|NCT03095001|Paclitaxel|paclitaxel|mesh-list
139442082|NCT03095001|Bevacizumab|bevacizumab|mesh-list
139442083|NCT03095001|Carboplatin|carboplatin|mesh-list
139442084|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139442085|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442086|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
139442087|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
139442088|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
139442089|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442090|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139442091|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139442092|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139442093|NCT03095001|Growth Substances|growth substances|mesh-ancestor
139442094|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442095|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
139442096|NCT05042271|Meropenem|meropenem|mesh-list
139442097|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139442098|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442099|NCT02138955|Curcumin|curcumin|mesh-list
139442100|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139442101|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139442102|NCT02138955|Analgesics|analgesics|mesh-ancestor
139442103|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
139442104|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442105|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442106|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139442107|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139442108|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442109|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442110|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442111|NCT03096405|Methicillin|methicillin|mesh-list
139228840|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
139442112|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139442113|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442114|NCT05032287|Tamsulosin|tamsulosin|mesh-list
139442115|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139442116|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139442117|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139442118|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
139442119|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139442120|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442121|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442122|NCT05032287|Urological Agents|urological agents|mesh-ancestor
139442123|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139442124|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139442125|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442126|NCT02493959|Incretins|incretins|mesh-ancestor
139442127|NCT02493959|Hormones|hormones|mesh-ancestor
139442128|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139442129|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139442130|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
139442131|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442132|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442133|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
139442134|NCT02496377|Glycine|glycine|mesh-list
139442135|NCT02496377|Hematinics|hematinics|mesh-ancestor
139442136|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
139442137|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139442138|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442139|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442140|NCT02496455|Tramadol|tramadol|mesh-list
139442141|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139442142|NCT02496455|Narcotics|narcotics|mesh-ancestor
139442143|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442144|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442145|NCT02496455|Analgesics|analgesics|mesh-ancestor
139442146|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
139442147|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442148|NCT02496299|Dexamethasone|dexamethasone|mesh-list
139442149|NCT02496299|Bupivacaine|bupivacaine|mesh-list
139442150|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139442151|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
139442152|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
139442153|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442154|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442155|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139442156|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
139442157|NCT02496299|Hormones|hormones|mesh-ancestor
139442158|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139442159|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139442160|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442161|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
139442162|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
139442163|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442164|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
139442165|NCT02493725|Eculizumab|eculizumab|mesh-list
139442166|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139442167|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139442168|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
139442169|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442170|NCT02121405|Capecitabine|capecitabine|mesh-list
139442171|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
139442172|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139442173|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
139442174|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442175|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442176|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
139442177|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139442178|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442179|NCT03337841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139442180|NCT03337841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442181|NCT02493335|Budesonide|budesonide|mesh-list
139442182|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139442183|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139442184|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
139442185|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228922|NCT04055480|Insulin|insulin|mesh-list
139442186|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442187|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139442188|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
139442189|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
139442190|NCT02493335|Hormones|hormones|mesh-ancestor
139442191|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139442192|NCT03336593|Vaccines|vaccines|mesh-list
139442193|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
139442194|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442195|NCT03337607|Celecoxib|celecoxib|mesh-list
139442196|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139442197|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139442198|NCT03337607|Eperisone|eperisone|mesh-list
139442199|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
139442200|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139442201|NCT03337607|Analgesics|analgesics|mesh-ancestor
139442202|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
139442203|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442204|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442205|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139442206|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139442207|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139442208|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442209|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442210|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
139442211|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139442212|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139442213|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139442214|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139442215|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139442216|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
139228993|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139442217|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
139442218|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
139442219|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139442220|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139442221|NCT02493179|Analgesics|analgesics|mesh-ancestor
139442222|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
139442223|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442224|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442225|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139442226|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139442227|NCT03336437|Estradiol|estradiol|mesh-list
139442228|NCT03336437|Estrogens|estrogens|mesh-ancestor
139442229|NCT03336437|Hormones|hormones|mesh-ancestor
139442230|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139442231|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442232|NCT03337373|Cisatracurium|cisatracurium|mesh-list
139442233|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139442234|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139442235|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442236|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442237|NCT03336281|Ustekinumab|ustekinumab|mesh-list
139442238|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
139442239|NCT03336125|Vitamin D|vitamin d|mesh-list
139442240|NCT03336125|Vitamins|vitamins|mesh-ancestor
139442241|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
139442242|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442243|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139442244|NCT05051163|Gentamicins|gentamicins|mesh-list
139442245|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
139442246|NCT05051163|Ampicillin|ampicillin|mesh-list
139442247|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139442248|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442249|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139442250|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442251|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442252|NCT06067412|Phenytoin|phenytoin|mesh-list
139442253|NCT06067412|Levetiracetam|levetiracetam|mesh-list
139442254|NCT06067412|Anticonvulsants|anticonvulsants|mesh-ancestor
139442255|NCT06067412|Nootropic Agents|nootropic agents|mesh-ancestor
139442256|NCT06067412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139442257|NCT06067412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139442258|NCT06067412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139442259|NCT06067412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442260|NCT06067412|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139442261|NCT06067412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139442262|NCT06067386|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139442263|NCT06067386|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139442264|NCT06067386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442265|NCT06067386|Antitubercular Agents|antitubercular agents|mesh-ancestor
139442266|NCT06067256|Contraceptive Agents|contraceptive agents|mesh-list
139442267|NCT06067256|Contraceptive Agents, Female|contraceptive agents, female|mesh-list
139442268|NCT06067256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139442269|NCT06067256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442270|NCT06067061|Atezolizumab|atezolizumab|mesh-list
139442271|NCT06067061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139442272|NCT06067061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442273|NCT06067061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139442274|NCT06067061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442275|NCT06067048|Zanubrutinib|zanubrutinib|mesh-list
139442276|NCT06067048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442277|NCT06067048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139442278|NCT06067048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442279|NCT06067048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442280|NCT06066879|Ketamine|ketamine|mesh-list
139442281|NCT06066879|Analgesics|analgesics|mesh-ancestor
139442282|NCT06066879|Sensory System Agents|sensory system agents|mesh-ancestor
139442283|NCT06066879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442284|NCT06066879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442285|NCT06066879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139442286|NCT06066879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139442287|NCT06066879|Anesthetics, General|anesthetics, general|mesh-ancestor
139442288|NCT06066879|Anesthetics|anesthetics|mesh-ancestor
139442289|NCT06066879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442290|NCT06066879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139442291|NCT06066879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139442292|NCT06066879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139442293|NCT06066879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442294|NCT06066840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139442295|NCT06066840|Vedolizumab|vedolizumab|mesh-list
139442296|NCT06066840|Antibodies|antibodies|mesh-list
139442297|NCT06066840|Immunoglobulins|immunoglobulins|mesh-list
139442298|NCT06066840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139442299|NCT06066840|Basiliximab|basiliximab|mesh-list
139442300|NCT06066840|Immunologic Factors|immunologic factors|mesh-ancestor
139442301|NCT06066840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442302|NCT06066840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442303|NCT06066840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139442304|NCT06066840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139442305|NCT06066645|Travoprost|travoprost|mesh-list
139442306|NCT06066645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139442307|NCT06066606|Fluticasone|fluticasone|mesh-list
139442308|NCT06066606|Xhance|xhance|mesh-list
139442309|NCT06066606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139442310|NCT06066606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139442311|NCT06066606|Autonomic Agents|autonomic agents|mesh-ancestor
139442312|NCT06066606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442313|NCT06066606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442314|NCT06066606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139442315|NCT06066606|Respiratory System Agents|respiratory system agents|mesh-ancestor
139442316|NCT06066606|Dermatologic Agents|dermatologic agents|mesh-ancestor
139442317|NCT06066606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139442318|NCT06066554|Methotrexate|methotrexate|mesh-list
139442319|NCT06066554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139442320|NCT06066554|Abortifacient Agents|abortifacient agents|mesh-ancestor
139442321|NCT06066554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139100684|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
139442322|NCT06066554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442323|NCT06066554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139442324|NCT06066554|Antimetabolites|antimetabolites|mesh-ancestor
139442325|NCT06066554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442326|NCT06066554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442327|NCT06066554|Dermatologic Agents|dermatologic agents|mesh-ancestor
139442328|NCT06066554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442329|NCT06066554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139442330|NCT06066554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139442331|NCT06066554|Immunologic Factors|immunologic factors|mesh-ancestor
139442332|NCT06066554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139442333|NCT06066554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139442334|NCT06066333|Pembrolizumab|pembrolizumab|mesh-list
139642360|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139442335|NCT06066333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139442336|NCT06066333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442337|NCT06066333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139442338|NCT06066333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442339|NCT06066255|Thymoglobulin|thymoglobulin|mesh-list
139442340|NCT06066255|Immunologic Factors|immunologic factors|mesh-ancestor
139442341|NCT06066255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442342|NCT06066255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139442343|NCT06066112|Amisulpride|amisulpride|mesh-list
139442344|NCT06066112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139442345|NCT06066112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139442346|NCT06066112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442347|NCT06066112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442348|NCT06066112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139442349|NCT06066112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139442350|NCT06066112|Dopamine Agents|dopamine agents|mesh-ancestor
139442351|NCT06066112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139442352|NCT06066112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442353|NCT06066112|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139442354|NCT06066112|Antidepressive Agents|antidepressive agents|mesh-ancestor
139442355|NCT06066060|Metformin|metformin|mesh-list
139442356|NCT06066060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139442357|NCT06066060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442358|NCT06065956|Morphine|morphine|mesh-list
139442359|NCT06065956|Esmolol|esmolol|mesh-list
139442360|NCT06065956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139442361|NCT06065956|Narcotics|narcotics|mesh-ancestor
139442362|NCT06065956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442363|NCT06065956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442364|NCT06065956|Analgesics|analgesics|mesh-ancestor
139442365|NCT06065956|Sensory System Agents|sensory system agents|mesh-ancestor
139442366|NCT06065956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442367|NCT06065956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139442368|NCT06065956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139442369|NCT06065956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139442370|NCT06065956|Adrenergic Agents|adrenergic agents|mesh-ancestor
139442371|NCT06065956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139442372|NCT06065956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442373|NCT06065735|Paroxetine|paroxetine|mesh-list
139442374|NCT06065735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139442375|NCT06065735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139442376|NCT06065735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139442377|NCT06065735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442378|NCT06065735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139442379|NCT06065735|Serotonin Agents|serotonin agents|mesh-ancestor
139442380|NCT06065735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442381|NCT06065735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139442382|NCT06065735|Antidepressive Agents|antidepressive agents|mesh-ancestor
139442383|NCT06065735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139442384|NCT06065735|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139442385|NCT06065735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139442386|NCT06065735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442387|NCT06065722|Olanzapine|olanzapine|mesh-list
139442388|NCT06065722|Antiemetics|antiemetics|mesh-ancestor
139442389|NCT06065722|Autonomic Agents|autonomic agents|mesh-ancestor
139442390|NCT06065722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442391|NCT06065722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442392|NCT06065722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139442393|NCT06065722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139442394|NCT06065722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139442395|NCT06065722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442396|NCT06065722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139442397|NCT06065722|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139442398|NCT06065722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139442399|NCT06065722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139442400|NCT06065722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442401|NCT06065722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139442402|NCT06065722|Serotonin Agents|serotonin agents|mesh-ancestor
139442403|NCT06062550|Esketamine|esketamine|mesh-list
139442404|NCT06062550|Antidepressive Agents|antidepressive agents|mesh-ancestor
139442405|NCT06062550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139442406|NCT06055712|Cefazolin|cefazolin|mesh-list
139229102|NCT01068158|Ivermectin|ivermectin|mesh-list
139442408|NCT06055712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139442409|NCT06055712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442410|NCT06038929|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
139442411|NCT06038929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442412|NCT06014957|Anesthetics|anesthetics|mesh-list
139442413|NCT06014957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442414|NCT06014957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442415|NCT06013163|Orlistat|orlistat|mesh-list
139442416|NCT06013163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442417|NCT06013163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442418|NCT06013163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139442419|NCT06013163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139442420|NCT05999084|Antibodies|antibodies|mesh-list
139442421|NCT05999084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139442422|NCT05999084|Immunologic Factors|immunologic factors|mesh-ancestor
139442423|NCT05999084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442424|NCT05916963|Furosemide|furosemide|mesh-list
139442425|NCT05916963|Diuretics|diuretics|mesh-ancestor
139442426|NCT05916963|Natriuretic Agents|natriuretic agents|mesh-ancestor
139442427|NCT05916963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442428|NCT05916963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139442429|NCT05916963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139442430|NCT05916963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442431|NCT05879250|Tyrphostins|tyrphostins|mesh-list
139442432|NCT05879250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442433|NCT05879250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442434|NCT05879250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442435|NCT05850611|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139442436|NCT05850611|Methylene Blue|methylene blue|mesh-list
139442437|NCT05850611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442438|NCT05850611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442439|NCT05850611|Hemostatics|hemostatics|mesh-ancestor
139442440|NCT05850611|Coagulants|coagulants|mesh-ancestor
139442441|NCT05831098|Antibodies|antibodies|mesh-list
139442442|NCT05831098|Immunologic Factors|immunologic factors|mesh-ancestor
139442443|NCT05831098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442444|NCT05824832|Dexamethasone|dexamethasone|mesh-list
139442445|NCT05824832|Dexamethasone acetate|dexamethasone acetate|mesh-list
139442446|NCT05824832|Clonidine|clonidine|mesh-list
139442447|NCT05824832|Buprenorphine|buprenorphine|mesh-list
139442448|NCT05824832|BB 1101|bb 1101|mesh-list
139442449|NCT05824832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139442450|NCT05824832|Antiemetics|antiemetics|mesh-ancestor
139442451|NCT05824832|Autonomic Agents|autonomic agents|mesh-ancestor
139442452|NCT05824832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442453|NCT05824832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442454|NCT05824832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139442455|NCT05824832|Glucocorticoids|glucocorticoids|mesh-ancestor
139442456|NCT05824832|Hormones|hormones|mesh-ancestor
139442457|NCT05824832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139442458|NCT05824832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139442459|NCT05824832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442460|NCT05824832|Protease Inhibitors|protease inhibitors|mesh-ancestor
139442461|NCT05824832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442462|NCT05824832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442463|NCT05824832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139442464|NCT05824832|Narcotics|narcotics|mesh-ancestor
139442465|NCT05824832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442466|NCT05824832|Analgesics|analgesics|mesh-ancestor
139442467|NCT05824832|Sensory System Agents|sensory system agents|mesh-ancestor
139442468|NCT05824832|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139442469|NCT05824832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139442470|NCT05824832|Sympatholytics|sympatholytics|mesh-ancestor
139442471|NCT05824832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139442472|NCT05824832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139442473|NCT05824832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139442474|NCT05824832|Adrenergic Agents|adrenergic agents|mesh-ancestor
139442475|NCT05824832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139442476|NCT05809609|Ketamine|ketamine|mesh-list
139442477|NCT05809609|Analgesics|analgesics|mesh-ancestor
139442478|NCT05809609|Sensory System Agents|sensory system agents|mesh-ancestor
139442479|NCT05809609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442480|NCT05809609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442481|NCT05809609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139442482|NCT05809609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139442483|NCT05809609|Anesthetics, General|anesthetics, general|mesh-ancestor
139442484|NCT05809609|Anesthetics|anesthetics|mesh-ancestor
139442485|NCT05809609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442486|NCT05809609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139442487|NCT05809609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139442488|NCT05809609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139442489|NCT05809609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442490|NCT05807412|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139442491|NCT05807412|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139442492|NCT05807412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139442493|NCT05807412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442494|NCT05807412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442495|NCT05807412|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139442496|NCT05807412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139442497|NCT05807412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442498|NCT05807412|Cholinergic Agents|cholinergic agents|mesh-ancestor
139442499|NCT05807412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139442500|NCT05787600|Chlorhexidine|chlorhexidine|mesh-list
139442501|NCT05787600|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139442502|NCT05787600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139442503|NCT05787600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442504|NCT05787600|Disinfectants|disinfectants|mesh-ancestor
139442505|NCT05787600|Dermatologic Agents|dermatologic agents|mesh-ancestor
139442506|NCT05756764|Liraglutide|liraglutide|mesh-list
139442507|NCT05756764|Topiramate|topiramate|mesh-list
139442508|NCT05756764|Phentermine|phentermine|mesh-list
139442509|NCT05756764|Glucagon|glucagon|mesh-list
139442510|NCT05756764|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139442511|NCT05756764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139442512|NCT05756764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442513|NCT05756764|Incretins|incretins|mesh-ancestor
139442514|NCT05756764|Hormones|hormones|mesh-ancestor
139442515|NCT05756764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139442516|NCT05756764|Anticonvulsants|anticonvulsants|mesh-ancestor
139442517|NCT05756764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139442518|NCT05756764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139442519|NCT05756764|Appetite Depressants|appetite depressants|mesh-ancestor
139442520|NCT05756764|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139442521|NCT05756764|Sympathomimetics|sympathomimetics|mesh-ancestor
139442522|NCT05756764|Autonomic Agents|autonomic agents|mesh-ancestor
139442523|NCT05756764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442524|NCT05756764|Adrenergic Agents|adrenergic agents|mesh-ancestor
139442525|NCT05756764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139442526|NCT05756764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442527|NCT05742269|Atezolizumab|atezolizumab|mesh-list
139442528|NCT05742269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139442529|NCT05742269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442530|NCT05742269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139442531|NCT05742269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442532|NCT05708742|Bupivacaine|bupivacaine|mesh-list
139442533|NCT05708742|Anesthetics, Local|anesthetics, local|mesh-list
139442534|NCT05708742|Anesthetics|anesthetics|mesh-list
139442535|NCT05708742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442536|NCT05708742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442537|NCT05708742|Sensory System Agents|sensory system agents|mesh-ancestor
139442538|NCT05708742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442539|NCT05705427|Tenofovir|tenofovir|mesh-list
139442540|NCT05705427|Vaccines|vaccines|mesh-list
139442541|NCT05705427|Immunologic Factors|immunologic factors|mesh-ancestor
139442542|NCT05705427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442543|NCT05705427|Antiviral Agents|antiviral agents|mesh-ancestor
139442544|NCT05705427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442545|NCT05705427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139442546|NCT05705427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139442547|NCT05705427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442548|NCT05705427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442549|NCT05705427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139442550|NCT05705427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139442551|NCT05688202|Acetaminophen|acetaminophen|mesh-list
139442552|NCT05688202|Lidocaine|lidocaine|mesh-list
139442553|NCT05688202|Prilocaine|prilocaine|mesh-list
139442554|NCT05688202|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139442555|NCT05688202|Anesthetics, Local|anesthetics, local|mesh-ancestor
139442556|NCT05688202|Anesthetics|anesthetics|mesh-ancestor
139442557|NCT05688202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442568|NCT05688202|Antipyretics|antipyretics|mesh-ancestor
139442569|NCT05688202|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139442570|NCT05621759|Cyclophosphamide|cyclophosphamide|mesh-list
139442571|NCT05621759|Abatacept|abatacept|mesh-list
139442572|NCT05621759|Tacrolimus|tacrolimus|mesh-list
139442573|NCT05621759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139442574|NCT05621759|Immunologic Factors|immunologic factors|mesh-ancestor
139442575|NCT05621759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442576|NCT05621759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139442577|NCT05621759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139442578|NCT05621759|Alkylating Agents|alkylating agents|mesh-ancestor
139442579|NCT05621759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442580|NCT05621759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442581|NCT05621759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139442582|NCT05621759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139442583|NCT05621759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442584|NCT05621759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139442585|NCT05621759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139442586|NCT05586516|Paclitaxel|paclitaxel|mesh-list
139442587|NCT05586516|Gemcitabine|gemcitabine|mesh-list
139442588|NCT05586516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139442589|NCT05586516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442590|NCT05586516|Tubulin Modulators|tubulin modulators|mesh-ancestor
139442591|NCT05586516|Antimitotic Agents|antimitotic agents|mesh-ancestor
139442592|NCT05586516|Mitosis Modulators|mitosis modulators|mesh-ancestor
139442593|NCT05586516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442594|NCT05586516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139442595|NCT05586516|Antimetabolites|antimetabolites|mesh-ancestor
139442607|NCT05519241|Paclitaxel|paclitaxel|mesh-list
139442608|NCT05519241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139442609|NCT05519241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442610|NCT05519241|Tubulin Modulators|tubulin modulators|mesh-ancestor
139442611|NCT05519241|Antimitotic Agents|antimitotic agents|mesh-ancestor
139442612|NCT05519241|Mitosis Modulators|mitosis modulators|mesh-ancestor
139442613|NCT05519241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442614|NCT05512962|Triamcinolone|triamcinolone|mesh-list
139442615|NCT05512962|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139442616|NCT05512962|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139442617|NCT05512962|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139442618|NCT05512962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139442619|NCT05512962|Glucocorticoids|glucocorticoids|mesh-ancestor
139442620|NCT05512962|Hormones|hormones|mesh-ancestor
139442621|NCT05512962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139442622|NCT05512962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442623|NCT05512962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139442624|NCT05512962|Immunologic Factors|immunologic factors|mesh-ancestor
139442625|NCT05512962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442626|NCT05512962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442627|NCT05404919|Tenofovir|tenofovir|mesh-list
139442628|NCT05404919|Entecavir|entecavir|mesh-list
139442629|NCT05404919|Immunoglobulins|immunoglobulins|mesh-list
139442630|NCT05404919|Antibodies|antibodies|mesh-list
139442631|NCT05404919|gamma-Globulins|gamma-globulins|mesh-list
139442632|NCT05404919|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139442633|NCT05404919|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139442634|NCT05404919|Antiviral Agents|antiviral agents|mesh-ancestor
139442635|NCT05404919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442636|NCT05404919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139442637|NCT05404919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139442638|NCT05404919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442639|NCT05404919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442640|NCT05404919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139442641|NCT05404919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139442642|NCT05404919|Immunologic Factors|immunologic factors|mesh-ancestor
139442643|NCT05404919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442645|NCT05401110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442646|NCT05401110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139442647|NCT05401110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442648|NCT05401110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442649|NCT05388656|Estradiol|estradiol|mesh-list
139442650|NCT05388656|Progesterone|progesterone|mesh-list
139442651|NCT05388656|Estrogens|estrogens|mesh-ancestor
139442652|NCT05388656|Hormones|hormones|mesh-ancestor
139442653|NCT05388656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139442654|NCT05388656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442655|NCT05388656|Progestins|progestins|mesh-ancestor
139442656|NCT05381623|Hemostatics|hemostatics|mesh-list
139442657|NCT05381623|Coagulants|coagulants|mesh-ancestor
139442658|NCT05378971|Pomalidomide|pomalidomide|mesh-list
139442659|NCT05378971|Immunologic Factors|immunologic factors|mesh-ancestor
139442660|NCT05378971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442661|NCT05378971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139442662|NCT05378971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139442663|NCT05378971|Growth Substances|growth substances|mesh-ancestor
139442664|NCT05378971|Growth Inhibitors|growth inhibitors|mesh-ancestor
139442665|NCT05378971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442666|NCT05378880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139442667|NCT05378880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442668|NCT05347069|Aspirin|aspirin|mesh-list
139442669|NCT05347069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139442670|NCT05347069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139442671|NCT05347069|Analgesics|analgesics|mesh-ancestor
139442672|NCT05347069|Sensory System Agents|sensory system agents|mesh-ancestor
139442673|NCT05347069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442674|NCT05347069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442675|NCT05347069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139442676|NCT05347069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139442677|NCT05347069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139442678|NCT05347069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139442679|NCT05347069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442680|NCT05347069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139442681|NCT05347069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139442682|NCT05347069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442683|NCT05347069|Antipyretics|antipyretics|mesh-ancestor
139442684|NCT05338086|Vitamin D|vitamin d|mesh-list
139442685|NCT05338086|Denosumab|denosumab|mesh-list
139442686|NCT05338086|Calcium|calcium|mesh-list
139442687|NCT05338086|Vitamins|vitamins|mesh-ancestor
139442688|NCT05338086|Micronutrients|micronutrients|mesh-ancestor
139442689|NCT05338086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442690|NCT05338086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139442691|NCT05338086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139442692|NCT05312398|Irinotecan|irinotecan|mesh-list
139442693|NCT05312398|Cetuximab|cetuximab|mesh-list
139442694|NCT05312398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139442695|NCT05312398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139442696|NCT05312398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442697|NCT05312398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442698|NCT05312398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442699|NCT05312398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139442700|NCT05291156|Cetuximab|cetuximab|mesh-list
139442701|NCT05291156|Avelumab|avelumab|mesh-list
139442702|NCT05291156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139442703|NCT05291156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442704|NCT05268120|Doxycycline|doxycycline|mesh-list
139442705|NCT05268120|Rifampin|rifampin|mesh-list
139442706|NCT05268120|Trimethoprim|trimethoprim|mesh-list
139442707|NCT05268120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139442708|NCT05268120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442709|NCT05268120|Antimalarials|antimalarials|mesh-ancestor
139442710|NCT05268120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139442711|NCT05268120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139442712|NCT05268120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139442713|NCT05268120|Antitubercular Agents|antitubercular agents|mesh-ancestor
139442714|NCT05268120|Leprostatic Agents|leprostatic agents|mesh-ancestor
139442715|NCT05268120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139442716|NCT05268120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442717|NCT05268120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442718|NCT05268120|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139442719|NCT05268120|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139442720|NCT05268120|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139442721|NCT05268120|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139442722|NCT05268120|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139442723|NCT05268120|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139442724|NCT05268120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139442725|NCT05268120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139442726|NCT05268120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139442727|NCT05268120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139442728|NCT05268120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139442730|NCT05258279|Pembrolizumab|pembrolizumab|mesh-list
139442731|NCT05258279|Pemetrexed|pemetrexed|mesh-list
139442732|NCT05258279|Lenvatinib|lenvatinib|mesh-list
139442733|NCT05258279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442734|NCT05258279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139442735|NCT05258279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139442736|NCT05258279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442737|NCT05258279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442738|NCT05258279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139442739|NCT05258279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139442740|NCT05258279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139442741|NCT05142267|Oxycodone|oxycodone|mesh-list
139442742|NCT05142267|Naloxone|naloxone|mesh-list
139442743|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139442744|NCT05142267|Narcotics|narcotics|mesh-ancestor
139442745|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442746|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442747|NCT05142267|Analgesics|analgesics|mesh-ancestor
139442748|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
139442749|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442750|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139442751|NCT05121246|Palivizumab|palivizumab|mesh-list
139442752|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
139442753|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442754|NCT05113368|Fulvestrant|fulvestrant|mesh-list
139442755|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139442756|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442757|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139442758|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139442759|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
139442760|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139442761|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442762|NCT05083026|Antibodies|antibodies|mesh-list
139442763|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
139442764|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
139442765|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442766|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
139442767|NCT05077254|Vaccines|vaccines|mesh-list
139442768|NCT05077254|Tacrolimus|tacrolimus|mesh-list
139442769|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
139442770|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442771|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139442772|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139442773|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442774|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442775|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139442776|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442777|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139442778|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
139442779|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139442780|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442781|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139442782|NCT05038839|Pamiparib|pamiparib|mesh-list
139229484|NCT02381158|Beclomethasone|beclomethasone|mesh-list
139442783|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442784|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442785|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442786|NCT05032950|Ritonavir|ritonavir|mesh-list
139442787|NCT05032950|Nirmatrelvir|nirmatrelvir|mesh-list
139442788|NCT05032950|Midazolam|midazolam|mesh-list
139442789|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139442790|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139442791|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442792|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442793|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139442794|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139442795|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139442796|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139442797|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
139442798|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
139442799|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
139442800|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
139442801|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139442802|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442803|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139442804|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139442805|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
139442806|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442807|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139442808|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139442809|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
139442810|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442811|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139442812|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139442813|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
139442814|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139442815|NCT04877990|Deucravacitinib|deucravacitinib|mesh-list
139442816|NCT04877990|Dermatologic Agents|dermatologic agents|mesh-ancestor
139442817|NCT04877990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139442818|NCT04877990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442819|NCT04877990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442820|NCT04856488|Lugol's solution|lugol's solution|mesh-list
139442821|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139442822|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
139442823|NCT04856488|Coagulants|coagulants|mesh-ancestor
139442824|NCT04840264|Docetaxel|docetaxel|mesh-list
139442825|NCT04840264|Fluorouracil|fluorouracil|mesh-list
139442826|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
139442827|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442828|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
139442829|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
139442830|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
139442831|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442832|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
139442833|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139442834|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139442835|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
139442836|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442837|NCT04808973|Lamivudine|lamivudine|mesh-list
139442838|NCT04808973|Dolutegravir|dolutegravir|mesh-list
139442839|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139442840|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139442841|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442842|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442843|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
139442844|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442845|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139442846|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139442847|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139442848|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139442849|NCT04758975|Rituximab|rituximab|mesh-list
139442850|NCT04758975|Venetoclax|venetoclax|mesh-list
139442851|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139442852|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442853|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
139442854|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442855|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139442856|NCT04708067|Atezolizumab|atezolizumab|mesh-list
139442857|NCT04708067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139442858|NCT04708067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442859|NCT04708067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139442860|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442862|NCT04673448|Dostarlimab|dostarlimab|mesh-list
139442863|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
139442864|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
139442865|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
139442866|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442867|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139442868|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442869|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442870|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442871|NCT04631029|Carboplatin|carboplatin|mesh-list
139442872|NCT04631029|Etoposide|etoposide|mesh-list
139442873|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
139442874|NCT04631029|Atezolizumab|atezolizumab|mesh-list
139442875|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
139442876|NCT04631029|Entinostat|entinostat|mesh-list
139442877|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139442878|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139442879|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442880|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139442881|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139442882|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139442883|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442884|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442885|NCT04631029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139442886|NCT04631029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139442887|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
139442888|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442889|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
139442890|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
139442891|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
139442892|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
139442893|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
139442894|NCT04542148|Insulin|insulin|mesh-list
139442895|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139442896|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
139442897|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
139442898|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139442899|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442900|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
139442901|NCT04521946|Fludarabine|fludarabine|mesh-list
139442902|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
139442903|NCT04521946|Etoposide|etoposide|mesh-list
139442904|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
139442905|NCT04521946|Melphalan|melphalan|mesh-list
139442906|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
139442907|NCT04521946|Thiotepa|thiotepa|mesh-list
139442908|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
139442909|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139442910|NCT04521946|Tacrolimus|tacrolimus|mesh-list
139442911|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
139442912|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139442913|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
139442914|NCT04521946|Antibodies|antibodies|mesh-list
139442915|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
139442916|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139442917|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139442918|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442919|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139442920|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
139442921|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442922|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139442923|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
139442924|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442925|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139442926|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139442927|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139442928|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442929|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139442930|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139442931|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139442932|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
139442933|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139442934|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139442935|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139442936|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
139442937|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139442938|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
139442939|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
139442940|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
139442941|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
139442942|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
139442943|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
139442944|NCT04505774|Empagliflozin|empagliflozin|mesh-list
139442945|NCT04505774|Canagliflozin|canagliflozin|mesh-list
139442946|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139442947|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
139442948|NCT04505774|Heparin|heparin|mesh-list
139442949|NCT04505774|Calcium heparin|calcium heparin|mesh-list
139442950|NCT04505774|Enoxaparin|enoxaparin|mesh-list
139442951|NCT04505774|Dalteparin|dalteparin|mesh-list
139442952|NCT04505774|Tinzaparin|tinzaparin|mesh-list
139442953|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139442954|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
139442955|NCT04505774|Clopidogrel|clopidogrel|mesh-list
139442956|NCT04505774|Ticagrelor|ticagrelor|mesh-list
139442957|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139442958|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139442959|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139442960|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139442961|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
139442962|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139442963|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442964|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442965|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
139442966|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139442967|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139442968|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139442969|NCT04472299|Ropivacaine|ropivacaine|mesh-list
139442970|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
139442971|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
139442972|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139442973|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442974|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
139442975|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139442976|NCT04464798|Rituximab|rituximab|mesh-list
139442977|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
139442978|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139442979|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442980|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
139442981|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442982|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139442983|NCT04360785|Methotrexate|methotrexate|mesh-list
139442984|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139442985|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
139442986|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139442987|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139442988|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139442989|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
139442990|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139442991|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139442992|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
139442993|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139442994|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139442995|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139442996|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
139442997|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139442998|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139442999|NCT04338022|Teriflunomide|teriflunomide|mesh-list
139443000|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139443001|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139443002|NCT04338022|Analgesics|analgesics|mesh-ancestor
139443003|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
139443004|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443005|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443006|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139443007|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139443008|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139443009|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
139443010|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139443011|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139443012|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139443013|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139443014|NCT04226495|Sufentanil|sufentanil|mesh-list
139443015|NCT04226495|Dsuvia|dsuvia|mesh-list
139443016|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139443017|NCT04226495|Narcotics|narcotics|mesh-ancestor
139443018|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443019|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443020|NCT04226495|Analgesics|analgesics|mesh-ancestor
139443021|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
139443022|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443023|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139443024|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139443025|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
139443026|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
139443027|NCT04203641|Doxorubicin|doxorubicin|mesh-list
139443028|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139443029|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443030|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139443031|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139443032|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443033|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443034|NCT04186247|Azithromycin|azithromycin|mesh-list
139443035|NCT04186247|Metronidazole|metronidazole|mesh-list
139443036|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139443037|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443038|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139443039|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139443040|NCT04175613|Apremilast|apremilast|mesh-list
139443041|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139443042|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139443043|NCT04175613|Analgesics|analgesics|mesh-ancestor
139443044|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
139443045|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443046|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443047|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139443048|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139443049|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139443050|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139443051|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443052|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443053|NCT04098393|Fludarabine|fludarabine|mesh-list
139443054|NCT04098393|Melphalan|melphalan|mesh-list
139443055|NCT04098393|Busulfan|busulfan|mesh-list
139443056|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139443057|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443058|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443059|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139443060|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
139443061|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443062|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139443063|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
139443064|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139443065|NCT04095221|Irinotecan|irinotecan|mesh-list
139443066|NCT04095221|Prexasertib|prexasertib|mesh-list
139443067|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139443068|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139443069|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443070|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443071|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443072|NCT04095221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139443073|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
139443074|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139443075|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443076|NCT04074759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139443077|NCT04074759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443078|NCT04011163|Morphine|morphine|mesh-list
139443079|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139443080|NCT04011163|Narcotics|narcotics|mesh-ancestor
139443081|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443082|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443083|NCT04011163|Analgesics|analgesics|mesh-ancestor
139443084|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
139443085|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443086|NCT04007991|Ecopipam|ecopipam|mesh-list
139443087|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139443088|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139443089|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443090|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443091|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139443092|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139443093|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
139443094|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443095|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443096|NCT03998670|Methamphetamine|methamphetamine|mesh-list
139443097|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139443098|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443099|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
139443100|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
139443101|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443102|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
139443103|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443104|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443105|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
139443106|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139443107|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139443108|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139443109|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139443111|NCT03998176|Emtricitabine|emtricitabine|mesh-list
139443112|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139443113|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
139443114|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443115|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139443116|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139443117|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443118|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443119|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139443120|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139443121|NCT03950830|Disulfiram|disulfiram|mesh-list
139443122|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139443123|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139443124|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443125|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443126|NCT03935217|Secnidazole|secnidazole|mesh-list
139443127|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139443128|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139443129|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443130|NCT03916341|Nicotine|nicotine|mesh-list
139443131|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139443132|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
139443133|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443134|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443135|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139443136|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139443137|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
139443138|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443139|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443140|NCT03916068|Vitamin E|vitamin e|mesh-list
139443141|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
139443142|NCT03916068|Vitamins|vitamins|mesh-ancestor
139443143|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
139443144|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443145|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
139443146|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443147|NCT03916068|Protective Agents|protective agents|mesh-ancestor
139443148|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139443149|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443150|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139443151|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139443152|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
139443153|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139443154|NCT03899428|Sorafenib|sorafenib|mesh-list
139443155|NCT03899428|Durvalumab|durvalumab|mesh-list
139443156|NCT03899428|Lenvatinib|lenvatinib|mesh-list
139443157|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443158|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139443159|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443160|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443161|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139443162|NCT03895502|Edoxaban|edoxaban|mesh-list
139443163|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139443164|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
139443165|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139443166|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
139443167|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443168|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443169|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
139443171|NCT03884556|Gemcitabine|gemcitabine|mesh-list
139443172|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
139443173|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139443174|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443175|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
139443176|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
139443177|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
139443178|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443179|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139443180|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
139443181|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139443182|NCT03884556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139443183|NCT03861871|Fenfluramine|fenfluramine|mesh-list
139443184|NCT03861871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139443185|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139443186|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139443187|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443188|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443189|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
139443190|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443191|NCT03851835|Ondansetron|ondansetron|mesh-list
139443192|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
139443193|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
139443194|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443195|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443196|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139443197|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
139443198|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
139443199|NCT03851835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139443200|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139443201|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
139443202|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443203|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443204|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
139443205|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443206|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
139443207|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
139443208|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
139443209|NCT03806933|Botulinum Toxins|botulinum toxins|mesh-list
139443210|NCT03806933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139443211|NCT03806933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139443212|NCT03806933|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139443213|NCT03806933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139443214|NCT03806933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139443215|NCT03806933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443216|NCT03806933|Cholinergic Agents|cholinergic agents|mesh-ancestor
139443217|NCT03806933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443218|NCT03806933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443219|NCT03806933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139443220|NCT03806933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443221|NCT03758989|Prednisone|prednisone|mesh-list
139443222|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
139443223|NCT03758989|Rituximab|rituximab|mesh-list
139443224|NCT03758989|Doxorubicin|doxorubicin|mesh-list
139443225|NCT03758989|Vincristine|vincristine|mesh-list
139443226|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139443227|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
139443228|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443229|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139443230|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139443231|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
139443232|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443233|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443234|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139443235|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139443236|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139443237|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139443238|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139443239|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443240|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139443241|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
139443242|NCT03758989|Hormones|hormones|mesh-ancestor
139443243|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139443244|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139443245|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139443246|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
139443247|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
139443248|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
139443249|NCT03730337|Nivolumab|nivolumab|mesh-list
139443250|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139443251|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443252|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139443253|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443254|NCT03693807|Gemcitabine|gemcitabine|mesh-list
139443255|NCT03693807|Fluorouracil|fluorouracil|mesh-list
139443256|NCT03693807|Floxuridine|floxuridine|mesh-list
139443257|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
139443258|NCT03693807|Irinotecan|irinotecan|mesh-list
139443259|NCT03693807|Cetuximab|cetuximab|mesh-list
139443260|NCT03693807|Panitumumab|panitumumab|mesh-list
139443261|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139443262|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
139443263|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443264|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443265|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139443266|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
139443267|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443268|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139443269|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139443270|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443271|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139443272|NCT03680521|Nivolumab|nivolumab|mesh-list
139443273|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139443274|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443275|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139443276|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443277|NCT03568968|Niacinamide|niacinamide|mesh-list
139443278|NCT03568968|Niacin|niacin|mesh-list
139443279|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
139443280|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
139443281|NCT03568968|Vitamins|vitamins|mesh-ancestor
139443282|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
139443283|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443284|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139443285|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
139443286|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443287|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139443288|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
139443289|NCT03374085|Dexamethasone|dexamethasone|mesh-list
139443290|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139443291|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
139443292|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
139443293|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443294|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443295|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139443296|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
139443297|NCT03374085|Hormones|hormones|mesh-ancestor
139443298|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139443299|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139443300|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443301|NCT03369223|Nivolumab|nivolumab|mesh-list
139443302|NCT03369223|Ipilimumab|ipilimumab|mesh-list
139443303|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139443304|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443305|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139443306|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443307|NCT03246906|Cyclosporine|cyclosporine|mesh-list
139443308|NCT03246906|Sirolimus|sirolimus|mesh-list
139443309|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
139443310|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
139443311|NCT03246906|Cyclosporins|cyclosporins|mesh-list
139443312|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139443313|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
139443314|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443315|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139443316|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139443317|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
139443318|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443319|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443320|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139443321|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443322|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
139443323|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443324|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
139443325|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139443326|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139443327|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139443328|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
139443329|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139443330|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
139443331|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139443332|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443333|NCT03162627|Olaparib|olaparib|mesh-list
139443334|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139443335|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443336|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443337|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443338|NCT03072628|Nicotine|nicotine|mesh-list
139443339|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139443340|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
139443341|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443342|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443343|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139443344|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139443345|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
139443346|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443347|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443348|NCT03017833|Metformin|metformin|mesh-list
139443349|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139443350|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443351|NCT02979977|Cetuximab|cetuximab|mesh-list
139443352|NCT02979977|Afatinib|afatinib|mesh-list
139443353|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139443354|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443355|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139443356|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443357|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443358|NCT02754856|Durvalumab|durvalumab|mesh-list
139443359|NCT02754856|Ipilimumab|ipilimumab|mesh-list
139443360|NCT02754856|Tremelimumab|tremelimumab|mesh-list
139443361|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
139443362|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139443363|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
139443364|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139443365|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443366|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
139443367|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443368|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139443369|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443370|NCT02710097|Ethanol|ethanol|mesh-list
139443371|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139443372|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443373|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443374|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443375|NCT02709954|Ethanol|ethanol|mesh-list
139443376|NCT02709954|Dronabinol|dronabinol|mesh-list
139443377|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139443378|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443379|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443380|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443381|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
139443382|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139443383|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139443384|NCT02709954|Analgesics|analgesics|mesh-ancestor
139443385|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
139443386|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443387|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139443388|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139443389|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443390|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443391|NCT02709954|Hormones|hormones|mesh-ancestor
139443392|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139443393|NCT02689258|Bupivacaine|bupivacaine|mesh-list
139443394|NCT02689258|Anesthetics, Local|anesthetics, local|mesh-ancestor
139443395|NCT02689258|Anesthetics|anesthetics|mesh-ancestor
139443396|NCT02689258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443397|NCT02689258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443398|NCT02689258|Sensory System Agents|sensory system agents|mesh-ancestor
139443399|NCT02689258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443400|NCT02685735|Gabapentin|gabapentin|mesh-list
139443401|NCT02685735|Analgesics|analgesics|mesh-ancestor
139443402|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
139443403|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443404|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443405|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
139443406|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139443407|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139443408|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443409|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139443410|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139443411|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139443412|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443413|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443414|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
139443415|NCT02649764|Cytarabine|cytarabine|mesh-list
139443416|NCT02649764|Fludarabine|fludarabine|mesh-list
139443417|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
139443418|NCT02649764|Prexasertib|prexasertib|mesh-list
139443419|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443420|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139443421|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
139443422|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443423|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139443424|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
139443425|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443426|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
139443427|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443428|NCT02649764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139443429|NCT02649764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443430|NCT02606136|Mitogens|mitogens|mesh-list
139443431|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
139443432|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443433|NCT02546232|Paclitaxel|paclitaxel|mesh-list
139443434|NCT02546232|Carboplatin|carboplatin|mesh-list
139443435|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139443436|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443437|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
139443438|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
139443439|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
139443440|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443441|NCT02520154|Paclitaxel|paclitaxel|mesh-list
139443442|NCT02520154|Carboplatin|carboplatin|mesh-list
139443443|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
139443444|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139443445|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139443446|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443447|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
139443448|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
139443449|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
139443450|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443451|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139443452|NCT02520154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139443453|NCT02404688|Ethanol|ethanol|mesh-list
139443454|NCT02404688|Dronabinol|dronabinol|mesh-list
139443455|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139443456|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443457|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443458|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443459|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
139443460|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139443461|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139443462|NCT02404688|Analgesics|analgesics|mesh-ancestor
139443463|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
139230142|NCT01509339|Vancomycin|vancomycin|mesh-list
139443464|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443465|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139443466|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139443467|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443468|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443469|NCT02404688|Hormones|hormones|mesh-ancestor
139443470|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139443471|NCT02392572|TIC10 compound|tic10 compound|mesh-list
139443472|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443473|NCT02292706|Ribavirin|ribavirin|mesh-list
139443474|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
139443475|NCT02292706|Antimetabolites|antimetabolites|mesh-ancestor
139443476|NCT02292706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443477|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
139443478|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443479|NCT02278601|Fentanyl|fentanyl|mesh-list
139443480|NCT02278601|Ropivacaine|ropivacaine|mesh-list
139443481|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
139443482|NCT02278601|Anesthetics|anesthetics|mesh-list
139443483|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443484|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443485|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
139443486|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443487|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139443488|NCT02278601|Narcotics|narcotics|mesh-ancestor
139443489|NCT02278601|Analgesics|analgesics|mesh-ancestor
139443490|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139443491|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139443492|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
139443493|NCT01931033|Oxytocin|oxytocin|mesh-list
139443494|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
139443495|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139443496|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443497|NCT01459484|Cisplatin|cisplatin|mesh-list
139443498|NCT01459484|Doxorubicin|doxorubicin|mesh-list
139443499|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139443500|NCT01459484|Methotrexate|methotrexate|mesh-list
139443501|NCT01459484|Ifosfamide|ifosfamide|mesh-list
139443502|NCT01459484|Mifamurtide|mifamurtide|mesh-list
139443503|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
139443504|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443505|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139443506|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139443507|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139443508|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443509|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443510|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139443511|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
139443512|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139443513|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443514|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139443515|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
139443516|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
139443517|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139443518|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139443519|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
139443520|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139443521|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139443522|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139443523|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
139443524|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139443525|NCT01060384|Lenalidomide|lenalidomide|mesh-list
139443526|NCT01060384|Ofatumumab|ofatumumab|mesh-list
139443527|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
139443528|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443529|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139443530|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139443531|NCT01060384|Growth Substances|growth substances|mesh-ancestor
139443532|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
139443533|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443534|NCT00980954|Paclitaxel|paclitaxel|mesh-list
139443535|NCT00980954|Carboplatin|carboplatin|mesh-list
139443536|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139443537|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443538|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
139443539|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
139443540|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
139443541|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443542|NCT00618657|Paclitaxel|paclitaxel|mesh-list
139443543|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139443544|NCT00618657|Bevacizumab|bevacizumab|mesh-list
139443545|NCT00618657|Carboplatin|carboplatin|mesh-list
139443546|NCT00618657|Trastuzumab|trastuzumab|mesh-list
139443547|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139443548|NCT00618657|Antibodies|antibodies|mesh-list
139443549|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
139443550|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139443551|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139443552|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443553|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
139443554|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
139443555|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
139443556|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443557|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139443558|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139443559|NCT00618657|Growth Substances|growth substances|mesh-ancestor
139443560|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443561|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
139443562|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
139443563|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
139443564|NCT00580047|Vitamin D|vitamin d|mesh-list
139443565|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
139443566|NCT00580047|Alendronate|alendronate|mesh-list
139443567|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
139443568|NCT00580047|Calcium|calcium|mesh-list
139443569|NCT00580047|Vitamins|vitamins|mesh-ancestor
139443570|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
139443571|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443572|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139443573|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139443574|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443575|NCT00580047|Antacids|antacids|mesh-ancestor
139443576|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139443577|NCT00242944|Atorvastatin|atorvastatin|mesh-list
139443578|NCT00242944|Pitavastatin|pitavastatin|mesh-list
139443579|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139443580|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139443581|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
139443582|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443583|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139443584|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139443585|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443586|NCT00204919|Vitamin D|vitamin d|mesh-list
139443587|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
139443588|NCT00204919|Vitamins|vitamins|mesh-ancestor
139443589|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
139443590|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443591|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139443592|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139443593|NCT00084799|Antibodies|antibodies|mesh-list
139443594|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139443595|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
139443596|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443597|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139443598|NCT00072410|Antibodies|antibodies|mesh-list
139443599|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
139443600|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139443601|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
139443602|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443603|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443604|NCT00006099|Antibodies|antibodies|mesh-list
139443605|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139443606|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
139443607|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443608|NCT00006046|Antibodies|antibodies|mesh-list
139443609|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139443610|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
139443611|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443612|NCT00003102|Antibodies|antibodies|mesh-list
139443613|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139443614|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
139443615|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443616|NCT03331211|Dasatinib|dasatinib|mesh-list
139443617|NCT03331211|Ponatinib|ponatinib|mesh-list
139443618|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230297|NCT02359162|Hormones|hormones|mesh-ancestor
139443619|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139443620|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443621|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443623|NCT01929915|Morphine|morphine|mesh-list
139443624|NCT01929915|Bupivacaine|bupivacaine|mesh-list
139443625|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
139443626|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
139443627|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443628|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443629|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
139443630|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443631|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139443632|NCT01929915|Narcotics|narcotics|mesh-ancestor
139443633|NCT01929915|Analgesics|analgesics|mesh-ancestor
139443634|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139443635|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139443636|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
139443637|NCT05464745|Perindopril|perindopril|mesh-list
139443638|NCT05464745|Indapamide|indapamide|mesh-list
139443639|NCT05464745|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139443640|NCT05464745|Protease Inhibitors|protease inhibitors|mesh-ancestor
139443641|NCT05464745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443642|NCT05464745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443643|NCT05464745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139443644|NCT05464745|Diuretics|diuretics|mesh-ancestor
139443645|NCT05464745|Natriuretic Agents|natriuretic agents|mesh-ancestor
139443646|NCT05464745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443647|NCT05464745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139443648|NCT05464745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139443649|NCT03094533|Propofol|propofol|mesh-list
139443650|NCT03094533|Sevoflurane|sevoflurane|mesh-list
139443651|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139443652|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443653|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443654|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139443655|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
139443656|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
139443657|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139443658|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139443659|NCT05028231|Immunomodulating Agents|immunomodulating agents|mesh-list
139443660|NCT05028231|Immunologic Factors|immunologic factors|mesh-ancestor
139443661|NCT05028231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443662|NCT03335579|Sufentanil|sufentanil|mesh-list
139443663|NCT03335579|Remifentanil|remifentanil|mesh-list
139443664|NCT03335579|Propofol|propofol|mesh-list
139443665|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
139443666|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443667|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443668|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139443669|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139443670|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
139443671|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139443672|NCT03335579|Narcotics|narcotics|mesh-ancestor
139443673|NCT03335579|Analgesics|analgesics|mesh-ancestor
139443674|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
139443675|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443676|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139443677|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
139443678|NCT05050071|Calcium|calcium|mesh-list
139443679|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139443680|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443681|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139443682|NCT03335501|Pancrelipase|pancrelipase|mesh-list
139443683|NCT03335501|Hormones|hormones|mesh-list
139443684|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443685|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139443686|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139443687|NCT02492945|Lidocaine|lidocaine|mesh-list
139443688|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139443689|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
139443690|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
139443691|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102025|NCT00070018|Hormones|hormones|mesh-ancestor
139443692|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443693|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
139443694|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443695|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139443696|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139443697|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139443698|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139443699|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443700|NCT03335423|Metformin|metformin|mesh-list
139443701|NCT03335423|Codeine|codeine|mesh-list
139443702|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139443703|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443704|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139443705|NCT03335423|Narcotics|narcotics|mesh-ancestor
139443706|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443707|NCT03335423|Analgesics|analgesics|mesh-ancestor
139443708|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
139443709|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443710|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
139443711|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
139443712|NCT05038605|Metronidazole|metronidazole|mesh-list
139443713|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443714|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139443715|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139443716|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139443717|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139443718|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139443719|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139443720|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
139443721|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443722|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139443723|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139443724|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443725|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139443726|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139443727|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139443728|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443729|NCT03095547|Cyclosporine|cyclosporine|mesh-list
139443730|NCT03095547|Posaconazole|posaconazole|mesh-list
139443731|NCT03095547|Olorofim|olorofim|mesh-list
139443732|NCT03095547|Pantoprazole|pantoprazole|mesh-list
139443733|NCT03095547|Tacrolimus|tacrolimus|mesh-list
139443734|NCT03095547|Cyclosporins|cyclosporins|mesh-list
139443735|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139443736|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
139443737|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443738|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139443739|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443740|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443741|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
139443742|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443743|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
139443744|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139443745|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139443746|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139443747|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139443748|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139443749|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139443750|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139443751|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139443752|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139443753|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139443754|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
139443755|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139443756|NCT03329651|Metformin|metformin|mesh-list
139443757|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139443758|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443759|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139443760|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139443761|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443762|NCT05049681|Apatinib|apatinib|mesh-list
139443763|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443764|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139443765|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443766|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443767|NCT03334487|Dexamethasone|dexamethasone|mesh-list
139443768|NCT03334487|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
139443769|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139443770|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
139443771|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
139443772|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443773|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443774|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139443775|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
139443777|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139443778|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139443779|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443780|NCT03334487|Immunoconjugates|immunoconjugates|mesh-ancestor
139443781|NCT03334487|Immunologic Factors|immunologic factors|mesh-ancestor
139443782|NCT05038449|Colchicine|colchicine|mesh-list
139443783|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
139443784|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139443785|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
139443786|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
139443787|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
139443788|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443789|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443790|NCT05038059|Acetic Acid|acetic acid|mesh-list
139443791|NCT05038059|Retinol acetate|retinol acetate|mesh-list
139443792|NCT05038059|Ethylene|ethylene|mesh-list
139443793|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139443794|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443795|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139443796|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
139443797|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443798|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139443799|NCT05038059|Protective Agents|protective agents|mesh-ancestor
139443800|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443801|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
139443802|NCT05038059|Growth Substances|growth substances|mesh-ancestor
139443803|NCT01236547|Paclitaxel|paclitaxel|mesh-list
139443804|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139443805|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139443806|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443807|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
139443808|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
139443809|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
139443810|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443811|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
139443812|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
139443813|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443814|NCT03329339|Protective Agents|protective agents|mesh-ancestor
139443815|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443816|NCT03329339|Vitamins|vitamins|mesh-ancestor
139443817|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
139443818|NCT03329261|Clopidogrel|clopidogrel|mesh-list
139443819|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139443820|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139443821|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139443822|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139443823|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
139443824|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443825|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443826|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443827|NCT03329183|Irinotecan|irinotecan|mesh-list
139443828|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139443829|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139443830|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443831|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443832|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443833|NCT05048511|Vitamin D|vitamin d|mesh-list
139443834|NCT05048511|Vitamins|vitamins|mesh-ancestor
139443835|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
139443836|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443837|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139443838|NCT02167945|Ritonavir|ritonavir|mesh-list
139443839|NCT02167945|Ribavirin|ribavirin|mesh-list
139443840|NCT02167945|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139443841|NCT02167945|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139443842|NCT02167945|Protease Inhibitors|protease inhibitors|mesh-ancestor
139443843|NCT02167945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443844|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443845|NCT02167945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139443846|NCT02167945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139443847|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
139230520|NCT03112564|Analgesics|analgesics|mesh-ancestor
139443848|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443849|NCT02167945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139443850|NCT02167945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139443851|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
139443852|NCT03328481|Anesthetics|anesthetics|mesh-list
139443853|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443854|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443855|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
139443856|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139443857|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139443858|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
139443859|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443860|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443861|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443862|NCT02452879|Urological Agents|urological agents|mesh-ancestor
139443863|NCT05024799|Fentanyl|fentanyl|mesh-list
139443864|NCT05024799|Butorphanol|butorphanol|mesh-list
139443865|NCT05024799|Propofol|propofol|mesh-list
139443866|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139443867|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443868|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443869|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139443870|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
139443871|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
139443872|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139443873|NCT05024799|Narcotics|narcotics|mesh-ancestor
139443874|NCT05024799|Analgesics|analgesics|mesh-ancestor
139443875|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
139443876|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443877|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139443878|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
139443879|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
139443880|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139443881|NCT05018637|Teriparatide|teriparatide|mesh-list
139443882|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139443883|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443884|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139443885|NCT03327701|Benralizumab|benralizumab|mesh-list
139443886|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139443887|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
139443888|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
139443889|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139443890|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139443891|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443892|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139443893|NCT03327389|Analgesics|analgesics|mesh-ancestor
139443894|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
139443895|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443896|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139443897|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139443898|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139443899|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
139443900|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443901|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443902|NCT03333083|Lamivudine|lamivudine|mesh-list
139443903|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
139443904|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139443905|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139443906|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443907|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443908|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
139443909|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443910|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139443911|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139443912|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139443913|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139443914|NCT03093597|Petrolatum|petrolatum|mesh-list
139443915|NCT03093597|Emollients|emollients|mesh-ancestor
139443916|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
139443917|NCT03327155|Tenofovir|tenofovir|mesh-list
139443918|NCT03327155|Emtricitabine|emtricitabine|mesh-list
139443919|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
139443920|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443921|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139443922|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139443923|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443924|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443925|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139443926|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139443928|NCT05024877|Androgens|androgens|mesh-ancestor
139443929|NCT05024877|Hormones|hormones|mesh-ancestor
139443930|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139443931|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443932|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
139443933|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
139443934|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139443935|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139443936|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139443937|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139443938|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443939|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
139443940|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139443941|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443942|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139443943|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443944|NCT03230851|Aspirin|aspirin|mesh-list
139443945|NCT03230851|Indobufen|indobufen|mesh-list
139443946|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139443947|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139443948|NCT03230851|Analgesics|analgesics|mesh-ancestor
139443949|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
139443950|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443951|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443952|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139443953|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139443954|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139443955|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139443956|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443957|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139443958|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139443959|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443960|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
139443961|NCT05464433|Tislelizumab|tislelizumab|mesh-list
139443962|NCT05464433|Mitoxantrone|mitoxantrone|mesh-list
139443963|NCT05464433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139443964|NCT05464433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139443965|NCT05464433|Analgesics|analgesics|mesh-ancestor
139443966|NCT05464433|Sensory System Agents|sensory system agents|mesh-ancestor
139443967|NCT05464433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139443968|NCT05464433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443969|NCT05464433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139443970|NCT05464433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139443971|NCT05464433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443972|NCT05464433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443973|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139443974|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443975|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139443976|NCT05024565|Lactams|lactams|mesh-list
139443977|NCT05024565|beta-Lactams|beta-lactams|mesh-list
139443978|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139443979|NCT03228901|Oxytocin|oxytocin|mesh-list
139443980|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
139443981|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139443982|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139443983|NCT03228823|Amiodarone|amiodarone|mesh-list
139443984|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139443985|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
139443986|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139443987|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139443988|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139443989|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139443990|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139443991|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139443992|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139443993|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139443994|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139443995|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139443996|NCT03332225|Interferons|interferons|mesh-list
139443997|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
139443998|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139443999|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444000|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
139444001|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444002|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139444003|NCT05023941|Acetazolamide|acetazolamide|mesh-list
139444004|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
139444005|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139444006|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444007|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444008|NCT05023941|Diuretics|diuretics|mesh-ancestor
139444009|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
139444010|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444011|NCT03332069|Cisplatin|cisplatin|mesh-list
139444012|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444013|NCT03090087|Regadenoson|regadenoson|mesh-list
139444014|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139444015|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139444016|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
139444017|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
139444018|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444019|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444020|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444021|NCT03326609|Ropivacaine|ropivacaine|mesh-list
139444022|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
139444023|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
139444024|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444025|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444026|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
139444027|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444028|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
139444029|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139444030|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139444031|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139444032|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139444033|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444034|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
139444035|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444036|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444037|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139444038|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444039|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
139444040|NCT03090009|Analgesics|analgesics|mesh-ancestor
139444041|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
139444042|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444043|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444044|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139444045|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139444046|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444047|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139444048|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139444049|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444050|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444051|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
139444052|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139444053|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139444054|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444055|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
139444056|NCT02492087|Coagulants|coagulants|mesh-ancestor
139444057|NCT03093129|Artesunate|artesunate|mesh-list
139444058|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
139444059|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139444060|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139444061|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444062|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444063|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
139444064|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
139444065|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139444066|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
139444067|NCT02491697|Capecitabine|capecitabine|mesh-list
139444068|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139444069|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
139444070|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444071|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230745|NCT02354872|Nicotine|nicotine|mesh-list
139444072|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
139444073|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139444074|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444075|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
139444076|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139444077|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139444078|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444079|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
139444080|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444081|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444082|NCT03331523|Betamethasone|betamethasone|mesh-list
139444083|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
139444084|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139444085|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
139444086|NCT03331523|Calcipotriene|calcipotriene|mesh-list
139444087|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139444088|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444089|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
139444090|NCT03331523|Hormones|hormones|mesh-ancestor
139444091|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139444092|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444093|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139444094|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
139444095|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
139444096|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
139444097|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
139444098|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444099|NCT05023863|Protective Agents|protective agents|mesh-ancestor
139444100|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444101|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
139444102|NCT05023863|Vitamins|vitamins|mesh-ancestor
139444103|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
139444104|NCT05463809|Oxycodone|oxycodone|mesh-list
139444105|NCT05463809|Analgesics|analgesics|mesh-list
139444106|NCT05463809|Ropivacaine|ropivacaine|mesh-list
139444107|NCT05463809|Anesthetics, Local|anesthetics, local|mesh-ancestor
139444108|NCT05463809|Anesthetics|anesthetics|mesh-ancestor
139444109|NCT05463809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444110|NCT05463809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444111|NCT05463809|Sensory System Agents|sensory system agents|mesh-ancestor
139444112|NCT05463809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444113|NCT05463809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139444114|NCT05463809|Narcotics|narcotics|mesh-ancestor
139444115|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
139444116|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139444117|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
139444118|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444119|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444120|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139444121|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
139444122|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139444123|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
139444124|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444125|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444126|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139444127|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
139444128|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
139444129|NCT03331445|Protective Agents|protective agents|mesh-ancestor
139444130|NCT05008029|Anesthetics|anesthetics|mesh-list
139444131|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444132|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444133|NCT05008263|Liver Extracts|liver extracts|mesh-list
139444134|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
139444135|NCT05008263|Hematinics|hematinics|mesh-ancestor
139444136|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139444137|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444138|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139444139|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444140|NCT05016063|Fludarabine|fludarabine|mesh-list
139444141|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
139444142|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444143|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230826|NCT02354170|Mifepristone|mifepristone|mesh-list
139444144|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139444145|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
139444146|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444147|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139444148|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139444149|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
139444150|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139444151|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
139444152|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139444153|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
139444154|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444155|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444156|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139444157|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
139444158|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139444159|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
139444160|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444161|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444162|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139444163|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
139444164|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
139444165|NCT03078933|Protective Agents|protective agents|mesh-ancestor
139444166|NCT03092193|Naproxen|naproxen|mesh-list
139444167|NCT03092193|Esomeprazole|esomeprazole|mesh-list
139444168|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139444169|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139444170|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139444171|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444172|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444173|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139444174|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139444175|NCT03092193|Analgesics|analgesics|mesh-ancestor
139444176|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
139444177|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444178|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444179|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444180|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139444181|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
139444182|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139444183|NCT05015907|Ropivacaine|ropivacaine|mesh-list
139444184|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
139444185|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
139444186|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444187|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444188|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
139444189|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444190|NCT05015595|Memantine|memantine|mesh-list
139444191|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139444192|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139444193|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
139444194|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444195|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444196|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444197|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139444198|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139444199|NCT05015829|Dobutamine|dobutamine|mesh-list
139444200|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139444201|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
139444202|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
139444203|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444204|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444205|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139444206|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139444207|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139444208|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
139444209|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444210|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444211|NCT05015829|Protective Agents|protective agents|mesh-ancestor
139444212|NCT05015361|Propofol|propofol|mesh-list
139444213|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139444214|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444215|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444216|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139444217|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
139444218|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
139444219|NCT01375075|Atorvastatin|atorvastatin|mesh-list
139444220|NCT01375075|Evacetrapib|evacetrapib|mesh-list
139444221|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139444222|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139444223|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
139444224|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444225|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139444226|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139444227|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444228|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139444229|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139444230|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
139444231|NCT03240055|Etomidate|etomidate|mesh-list
139444232|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
139444233|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444234|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444235|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139444236|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139444237|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
139444238|NCT03087201|Nabiximols|nabiximols|mesh-list
139444239|NCT03087201|Analgesics|analgesics|mesh-ancestor
139444240|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
139444241|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444242|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444243|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
139444244|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139444245|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
139444246|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139444247|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444248|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139444249|NCT03239743|Midazolam|midazolam|mesh-list
139444250|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139444251|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139444252|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444253|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444254|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139444255|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139444256|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139444257|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139444258|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
139444259|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
139444260|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
139444261|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
139444262|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444263|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444264|NCT03239821|Codeine|codeine|mesh-list
139444265|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139444266|NCT03239821|Narcotics|narcotics|mesh-ancestor
139444267|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444268|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444269|NCT03239821|Analgesics|analgesics|mesh-ancestor
139444270|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
139444271|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444272|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
139444273|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
139444274|NCT03230227|Bupivacaine|bupivacaine|mesh-list
139444275|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
139444276|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
139444277|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444278|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444279|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
139382546|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139444280|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444281|NCT03078465|Clopidogrel|clopidogrel|mesh-list
139444282|NCT03078465|Ticagrelor|ticagrelor|mesh-list
139444283|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139444284|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139444285|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139444286|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139444287|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
139444288|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444289|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444290|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444291|NCT03324815|Morphine|morphine|mesh-list
139444292|NCT03324815|Methadone|methadone|mesh-list
139444293|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139444294|NCT03324815|Narcotics|narcotics|mesh-ancestor
139444295|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444296|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444297|NCT03324815|Analgesics|analgesics|mesh-ancestor
139444298|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
139444299|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444300|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
139444301|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
139444303|NCT05006469|Doxorubicin|doxorubicin|mesh-list
139444304|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139444305|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139444306|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444307|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
139444308|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
139444309|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444310|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444311|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139444312|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
139444313|NCT05006469|Hormones|hormones|mesh-ancestor
139444314|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139444315|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139444316|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444317|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444318|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444319|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139444320|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139444321|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139444322|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139444323|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
139444324|NCT03084783|Dexamethasone|dexamethasone|mesh-list
139444325|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444326|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
139444327|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
139444328|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444329|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444330|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139444331|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
139444332|NCT03084783|Hormones|hormones|mesh-ancestor
139444333|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139444334|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139444335|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444336|NCT03228355|Cromakalim|cromakalim|mesh-list
139444337|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139444338|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139444339|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
139444340|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444341|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444342|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139444343|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
139444344|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
139444345|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
139444346|NCT03324503|Prednisone|prednisone|mesh-list
139444347|NCT03324503|Prednisolone|prednisolone|mesh-list
139444348|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139444349|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
139444350|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139444351|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
139444352|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139444353|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
139444354|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
139444355|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444356|NCT03324503|Hormones|hormones|mesh-ancestor
139444357|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139444358|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444359|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139444360|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444361|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
139444362|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
139444363|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444364|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139444365|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139444366|NCT03324503|Protective Agents|protective agents|mesh-ancestor
139444367|NCT05006001|Colchicine|colchicine|mesh-list
139444368|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
139444369|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139444370|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
139231055|NCT04796922|Rituximab|rituximab|mesh-list
139444371|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
139444372|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
139444373|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444374|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444375|NCT04493489|Propranolol|propranolol|mesh-list
139444376|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139444377|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139444378|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
139444379|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444380|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444381|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444382|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139444383|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139444384|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
139444385|NCT03228043|Apatinib|apatinib|mesh-list
139444386|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444387|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139444388|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444389|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444390|NCT03119857|Docetaxel|docetaxel|mesh-list
139444391|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
139444392|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444393|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
139444394|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
139444395|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
139444396|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444397|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
139444398|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139444399|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444400|NCT03320603|Thrombin|thrombin|mesh-list
139444401|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
139444402|NCT03320603|Coagulants|coagulants|mesh-ancestor
139444403|NCT03227653|Ritonavir|ritonavir|mesh-list
139444404|NCT03227653|Lopinavir|lopinavir|mesh-list
139444405|NCT03227653|Nevirapine|nevirapine|mesh-list
139444406|NCT03227653|Efavirenz|efavirenz|mesh-list
139444407|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139444408|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139444409|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
139444410|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444411|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444412|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139444413|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139444414|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
139444415|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444416|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139444417|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139444418|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139444419|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139444420|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139444421|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139444422|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139444423|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139444424|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139444425|NCT03320447|Lidocaine|lidocaine|mesh-list
139444426|NCT03320447|Prilocaine|prilocaine|mesh-list
139444427|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139444428|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139444429|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139444430|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
139444431|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
139444432|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444433|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444434|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
139444435|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444436|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139444437|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139444438|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139444439|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139444440|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444441|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139444442|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
139444443|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139444444|NCT04434105|Triamcinolone|triamcinolone|mesh-list
139444445|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139231113|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
139444446|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139444447|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139444448|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444449|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
139444450|NCT04434105|Hormones|hormones|mesh-ancestor
139444451|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139444452|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444453|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139444454|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
139444455|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444456|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444457|NCT03078777|Fexofenadine|fexofenadine|mesh-list
139444458|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139444459|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139444460|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139444461|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
139444462|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
139444463|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444464|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444465|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444466|NCT03078309|Cannabidiol|cannabidiol|mesh-list
139444467|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
139444468|NCT03208309|Diacerein|diacerein|mesh-list
139444469|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444470|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139444471|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
139444472|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
139444473|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444474|NCT03323567|Lidocaine|lidocaine|mesh-list
139444475|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139444476|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
139444477|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
139444478|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444479|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444480|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
139444481|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444482|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139444483|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139444484|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139444485|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139444486|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444487|NCT04492709|Midazolam|midazolam|mesh-list
139444488|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139444489|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139444490|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444491|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444492|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139444493|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139444494|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139444495|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139444496|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
139444497|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
139444498|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
139444499|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
139444500|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444501|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444502|NCT05006235|Epinephrine|epinephrine|mesh-list
139444503|NCT05006235|Albuterol|albuterol|mesh-list
139444504|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139444505|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139444506|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
139444507|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444508|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444509|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444510|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139444511|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139444512|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
139444513|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444514|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139444515|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
139444516|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
139444517|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
139444518|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139444519|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
139444520|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139444521|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139444522|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
139444523|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139444524|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444525|NCT03319823|Diuretics|diuretics|mesh-ancestor
139444526|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
139444527|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444528|NCT02487953|Nicotine|nicotine|mesh-list
139444529|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139444530|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
139444531|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444532|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444533|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139444534|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139444535|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
139444536|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444537|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444538|NCT03091569|Vitamin K|vitamin k|mesh-list
139444539|NCT03091569|Vitamins|vitamins|mesh-ancestor
139444540|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
139444541|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444542|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139444543|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139444544|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444545|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
139444546|NCT03091569|Coagulants|coagulants|mesh-ancestor
139444547|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
139444548|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444549|NCT02487719|Teferrol|teferrol|mesh-list
139444550|NCT02487719|Hematinics|hematinics|mesh-ancestor
139444551|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139444552|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
139444553|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444554|NCT04940871|Favipiravir|favipiravir|mesh-list
139444555|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
139444556|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444557|NCT03207139|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139444558|NCT03207139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139444559|NCT03207139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444560|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
139444561|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
139444562|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444563|NCT03221881|Docetaxel|docetaxel|mesh-list
139444564|NCT03221881|Doxorubicin|doxorubicin|mesh-list
139444565|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139444566|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444567|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
139444568|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
139444569|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
139444570|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444571|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139444572|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139444573|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139444574|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444575|NCT03091257|Trametinib|trametinib|mesh-list
139444576|NCT03091257|Dabrafenib|dabrafenib|mesh-list
139444577|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444578|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139444579|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444580|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444581|NCT03078231|Mydriatics|mydriatics|mesh-list
139444582|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
139444583|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444584|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444585|NCT03319121|Theophylline|theophylline|mesh-list
139444586|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
139444587|NCT03319121|Lansoprazole|lansoprazole|mesh-list
139444588|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139444589|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
139444590|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444591|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444592|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139444593|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
139444594|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139444595|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642361|NCT01452451|Exenatide|exenatide|mesh-list
139444596|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444597|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
139444598|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139444599|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139444600|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
139444601|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444602|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139444603|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139444604|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139444606|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139444607|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
139444608|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139444609|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139444610|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444611|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444612|NCT02487407|Protective Agents|protective agents|mesh-ancestor
139444613|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444614|NCT03221569|Ketorolac|ketorolac|mesh-list
139444615|NCT03221569|Ketamine|ketamine|mesh-list
139444616|NCT03221569|Analgesics|analgesics|mesh-ancestor
139444617|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
139444618|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444619|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444620|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139444621|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139444622|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
139444623|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
139444624|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444625|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139444626|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139444627|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444628|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444629|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139444630|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139444631|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444632|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139444633|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139444634|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444635|NCT03319043|Budesonide|budesonide|mesh-list
139444636|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
139444637|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444638|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139444639|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
139444640|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444641|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444642|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139444643|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
139444644|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
139444645|NCT03319043|Hormones|hormones|mesh-ancestor
139444646|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139444647|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139444648|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139444649|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139444650|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
139444651|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444652|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444653|NCT02451475|Amitriptyline|amitriptyline|mesh-list
139444654|NCT02451475|Paroxetine|paroxetine|mesh-list
139444655|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139444656|NCT02451475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139444657|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139444658|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139444659|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444660|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444661|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
139444662|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444663|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139444664|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
139444665|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139444666|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139444667|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139444668|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444669|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139444670|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139444671|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139444672|NCT02451475|Analgesics|analgesics|mesh-ancestor
139444673|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
139444674|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444675|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139444676|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
139444677|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139444678|NCT05019417|Glycerol|glycerol|mesh-list
139444679|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139444680|NCT05019417|Protective Agents|protective agents|mesh-ancestor
139444681|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444682|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444683|NCT03225937|Trastuzumab|trastuzumab|mesh-list
139444684|NCT03225937|Pertuzumab|pertuzumab|mesh-list
139444685|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139444686|NCT03225937|Lapatinib|lapatinib|mesh-list
139444687|NCT03225937|Maytansine|maytansine|mesh-list
139444688|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139444689|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444690|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139444691|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444692|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444693|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139444694|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
139444695|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
139444696|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
139444697|NCT03225937|Immunotoxins|immunotoxins|mesh-ancestor
139444698|NCT03225937|Immunoconjugates|immunoconjugates|mesh-ancestor
139444699|NCT03225937|Immunologic Factors|immunologic factors|mesh-ancestor
139444700|NCT03225937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444701|NCT03318887|Ribavirin|ribavirin|mesh-list
139444702|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
139444703|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
139444704|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444705|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
139444706|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444707|NCT03119077|Itraconazole|itraconazole|mesh-list
139444708|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
139444709|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444710|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139444711|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139444712|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444713|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444714|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139444715|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
139444716|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139444717|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444718|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139444719|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
139444720|NCT02487329|Calcium|calcium|mesh-list
139444721|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139444722|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444723|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139444724|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
139444725|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139444726|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444727|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139444728|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444729|NCT04493099|Decitabine|decitabine|mesh-list
139444730|NCT04493099|Venetoclax|venetoclax|mesh-list
139444731|NCT04493099|Alvocidib|alvocidib|mesh-list
139444732|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139444733|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
139444734|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444735|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444736|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444737|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
139444738|NCT04493099|Growth Substances|growth substances|mesh-ancestor
139444739|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444740|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139444741|NCT05004909|Tretinoin|tretinoin|mesh-list
139444742|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444743|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
139444744|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
139444746|NCT03119623|Enalapril|enalapril|mesh-list
139444747|NCT03119623|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139444748|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139444749|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139444750|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139444751|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444752|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139444753|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
139444754|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444755|NCT03318419|Cytarabine|cytarabine|mesh-list
139444756|NCT03318419|Pegaspargase|pegaspargase|mesh-list
139444757|NCT03318419|Asparaginase|asparaginase|mesh-list
139444758|NCT03318419|Cladribine|cladribine|mesh-list
139444759|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139444760|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
139444761|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444762|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444763|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
139444764|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444765|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139444766|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
139444767|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444768|NCT03321773|Amoxicillin|amoxicillin|mesh-list
139444769|NCT03321773|Metronidazole|metronidazole|mesh-list
139444770|NCT03321773|Clarithromycin|clarithromycin|mesh-list
139444771|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
139444772|NCT03321773|Pantoprazole|pantoprazole|mesh-list
139444773|NCT03321773|Bismuth|bismuth|mesh-list
139444774|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139444775|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444776|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139444777|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139444778|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139444779|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444780|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444781|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139444782|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139444783|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139444784|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139444785|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139444786|NCT03321773|Antacids|antacids|mesh-ancestor
139444787|NCT03077217|Rifaximin|rifaximin|mesh-list
139444788|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139444789|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444790|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139444791|NCT05001243|Bromfenac|bromfenac|mesh-list
139444792|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139444793|NCT05001243|Phenylephrine|phenylephrine|mesh-list
139444794|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
139444795|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
139444796|NCT05001243|Pilocarpine|pilocarpine|mesh-list
139444797|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139444798|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
139444799|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444800|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
139444801|NCT05001243|Protective Agents|protective agents|mesh-ancestor
139444802|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139444803|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139444804|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139444805|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139444806|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
139444807|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444808|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444809|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
139444810|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
139444811|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444812|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
139444813|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139444814|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
139444815|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139444816|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
139444817|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139444818|NCT05001243|Miotics|miotics|mesh-ancestor
139444819|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139444820|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139444821|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
139444822|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139444823|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139444824|NCT05001243|Analgesics|analgesics|mesh-ancestor
139444825|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
139444826|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444827|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139444828|NCT03225781|Bleomycin|bleomycin|mesh-list
139444829|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139444830|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444831|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139444832|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139444833|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444834|NCT03205891|Immunotoxins|immunotoxins|mesh-ancestor
139444835|NCT03205891|Immunoconjugates|immunoconjugates|mesh-ancestor
139444836|NCT03205891|Immunologic Factors|immunologic factors|mesh-ancestor
139444837|NCT03205891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444838|NCT03221023|Vancomycin|vancomycin|mesh-list
139444839|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139444840|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444841|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139444842|NCT02490839|Amoxicillin|amoxicillin|mesh-list
139444843|NCT02490839|Metronidazole|metronidazole|mesh-list
139444844|NCT02490839|Tetracycline|tetracycline|mesh-list
139444845|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139444846|NCT02490839|Rabeprazole|rabeprazole|mesh-list
139444847|NCT02490839|Bismuth|bismuth|mesh-list
139444848|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139444849|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444850|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
139444851|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139444852|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139444853|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139444854|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139444855|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444856|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444857|NCT02490839|Antacids|antacids|mesh-ancestor
139444858|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139444859|NCT02490527|Simvastatin|simvastatin|mesh-list
139444860|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139444861|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139444862|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
139444863|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444864|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139444865|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139444866|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444867|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
139444868|NCT02490449|Lansoprazole|lansoprazole|mesh-list
139444869|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139444870|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139444871|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139444872|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444873|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444874|NCT02452177|Vitamin D|vitamin d|mesh-list
139444875|NCT02452177|Vitamins|vitamins|mesh-ancestor
139444876|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
139444877|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444878|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139444879|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
139444880|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444881|NCT03224923|Aspirin|aspirin|mesh-list
139444882|NCT03224923|Clopidogrel|clopidogrel|mesh-list
139444883|NCT03224923|Ticagrelor|ticagrelor|mesh-list
139444884|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139444885|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139444886|NCT03224923|Analgesics|analgesics|mesh-ancestor
139444887|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
139444888|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444889|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444890|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444891|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139444892|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139444893|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139231568|NCT02344732|Hormones|hormones|mesh-ancestor
139444894|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444895|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139444896|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139444897|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444898|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
139444899|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139444900|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139444901|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139444902|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
139444903|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444904|NCT05004753|Artemisinins|artemisinins|mesh-list
139444905|NCT05004753|Artemisinin|artemisinin|mesh-list
139444906|NCT05004753|Dexamethasone|dexamethasone|mesh-list
139444907|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444908|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
139444909|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
139444910|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444911|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444912|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139444913|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
139444914|NCT05004753|Hormones|hormones|mesh-ancestor
139444915|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139444916|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139444917|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139444918|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
139444919|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139444920|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139444921|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444922|NCT02486549|Bupivacaine|bupivacaine|mesh-list
139444923|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
139444924|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
139444925|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444926|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444927|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
139444928|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444929|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
139444930|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444931|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
139444932|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
139444933|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
139444934|NCT04485403|Ibuprofen|ibuprofen|mesh-list
139444935|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139444936|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139444937|NCT04485403|Analgesics|analgesics|mesh-ancestor
139444938|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
139444939|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444940|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444941|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139444942|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139444943|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139444944|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139444945|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444946|NCT03220867|Risperidone|risperidone|mesh-list
139444947|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139444948|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
139444949|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444950|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444951|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444952|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139444953|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139444954|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444955|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139444956|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139444957|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
139444958|NCT03318029|Vitamin D|vitamin d|mesh-list
139444959|NCT03318029|Vitamins|vitamins|mesh-ancestor
139444960|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
139444961|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444962|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139444963|NCT03076281|Metformin|metformin|mesh-list
139444964|NCT03076281|Doxycycline|doxycycline|mesh-list
139444965|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139444966|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444967|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139444968|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139444969|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
139444970|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139444971|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139444972|NCT02452255|Propranolol|propranolol|mesh-list
139444973|NCT02452255|Metoprolol|metoprolol|mesh-list
139444974|NCT02452255|Fenofibrate|fenofibrate|mesh-list
139444975|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139444976|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139444977|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
139444978|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139444979|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444980|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444981|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139444982|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139444983|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
139444984|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
139444985|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
139444986|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139444987|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139444988|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139444989|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
139444990|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139444991|NCT03205033|Melatonin|melatonin|mesh-list
139444992|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
139444993|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139444994|NCT03205033|Protective Agents|protective agents|mesh-ancestor
139444995|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139444996|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139444997|NCT03076905|Olorofim|olorofim|mesh-list
139444998|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
139444999|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139445000|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139445001|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139445002|NCT02452099|Protective Agents|protective agents|mesh-ancestor
139445003|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445004|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139445005|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
139445006|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445007|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139445008|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139445009|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445010|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445011|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139445012|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139445013|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445014|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
139445015|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445016|NCT03220789|Methamphetamine|methamphetamine|mesh-list
139445017|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139445018|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445019|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
139445020|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
139445021|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445022|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
139445023|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445024|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445025|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
139445026|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139445027|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139445028|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139445029|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139445030|NCT03220555|Lidocaine|lidocaine|mesh-list
139445031|NCT03220555|Prilocaine|prilocaine|mesh-list
139445032|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
139445033|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
139445034|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445035|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445036|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
139445037|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445038|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139445039|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139445040|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139445041|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139445042|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445043|NCT03204877|Melatonin|melatonin|mesh-list
139445044|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
139445045|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445046|NCT03204877|Protective Agents|protective agents|mesh-ancestor
139445047|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642362|NCT01452451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139445048|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445049|NCT03204799|Metformin|metformin|mesh-list
139445050|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139445051|NCT03204799|Ezetimibe|ezetimibe|mesh-list
139445052|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139445053|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445054|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139445055|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139445056|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
139445057|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445058|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139445059|NCT03317327|Nivolumab|nivolumab|mesh-list
139445060|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139445061|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445062|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139445063|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445064|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139445065|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139445066|NCT03204331|Norethindrone|norethindrone|mesh-list
139445067|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
139445068|NCT03204331|Estradiol|estradiol|mesh-list
139445069|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139445070|NCT03204331|Relugolix|relugolix|mesh-list
139445071|NCT03204331|Estrogens|estrogens|mesh-ancestor
139445072|NCT03204331|Hormones|hormones|mesh-ancestor
139445073|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139445074|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445075|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139445076|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
139445077|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139445078|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139445079|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139445080|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139445081|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139445082|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
139445083|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
139445084|NCT03072849|Fluticasone|fluticasone|mesh-list
139445085|NCT03072849|Azithromycin|azithromycin|mesh-list
139445086|NCT03072849|Montelukast|montelukast|mesh-list
139445087|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139445088|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139445089|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
139445090|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445091|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445092|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139445093|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
139445094|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
139445095|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139445096|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139445097|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139445098|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139445099|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
139445100|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139445101|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139445102|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139445103|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445104|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
139445105|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
139445106|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139445107|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445108|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445109|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
139445110|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139445111|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445112|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445113|NCT03075657|Haloperidol|haloperidol|mesh-list
139445114|NCT03075657|Risperidone|risperidone|mesh-list
139445115|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
139445116|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139445117|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
139445118|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445119|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445120|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231787|NCT02509494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139445121|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139445122|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139445123|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445124|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139445125|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139445126|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
139445127|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
139445128|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
139445129|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445130|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139445131|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139445132|NCT02451865|Docetaxel|docetaxel|mesh-list
139445133|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445134|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
139445135|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
139445136|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
139445137|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445138|NCT05004207|Lactulose|lactulose|mesh-list
139445139|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139445140|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
139445141|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
139445142|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139445143|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139445144|NCT02489513|Ivosidenib|ivosidenib|mesh-list
139445145|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445146|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445147|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445148|NCT03317015|Fluticasone|fluticasone|mesh-list
139445149|NCT03317015|Triamcinolone|triamcinolone|mesh-list
139445150|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139445151|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139445152|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
139445153|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445154|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445155|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139445156|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
139445157|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
139445158|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139445159|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
139445160|NCT03317015|Hormones|hormones|mesh-ancestor
139445161|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139445162|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
139445163|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139445164|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
139445165|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445166|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
139445167|NCT03204565|Protective Agents|protective agents|mesh-ancestor
139445168|NCT03224377|Antibodies|antibodies|mesh-list
139445169|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
139445170|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
139445171|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445172|NCT02451787|Vitamin D|vitamin d|mesh-list
139445173|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
139445174|NCT02451787|Vitamins|vitamins|mesh-ancestor
139445175|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
139445176|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445177|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139445178|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139445179|NCT03224221|Fluorouracil|fluorouracil|mesh-list
139445180|NCT03224221|Apatinib|apatinib|mesh-list
139445181|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
139445182|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445183|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139445184|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445185|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139445186|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
139445187|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445188|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139445189|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445190|NCT03204097|Alendronate|alendronate|mesh-list
139445191|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139445192|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231865|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
139445193|NCT03223519|Ibuprofen|ibuprofen|mesh-list
139445194|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445195|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139445196|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139445197|NCT03223519|Analgesics|analgesics|mesh-ancestor
139445199|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445200|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139445201|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139445202|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139445203|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445204|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445205|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
139445206|NCT03320915|Vitamin D|vitamin d|mesh-list
139445207|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139445208|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445209|NCT03320915|Vitamins|vitamins|mesh-ancestor
139445210|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
139445211|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139445212|NCT02488889|Ethanol|ethanol|mesh-list
139445213|NCT02488889|Varenicline|varenicline|mesh-list
139445214|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139445215|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139445216|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445217|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445218|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139445219|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139445220|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
139445221|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445222|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445223|NCT03220009|Nivolumab|nivolumab|mesh-list
139445224|NCT03220009|Ipilimumab|ipilimumab|mesh-list
139445225|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139445226|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445227|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139445228|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445229|NCT02485613|Dexamethasone|dexamethasone|mesh-list
139445230|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139445231|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
139445232|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
139445233|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445234|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445235|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139445236|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
139445237|NCT02485613|Hormones|hormones|mesh-ancestor
139445238|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139445239|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139445240|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445241|NCT02484833|Cetuximab|cetuximab|mesh-list
139445242|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139445243|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445244|NCT03204019|Thalidomide|thalidomide|mesh-list
139445245|NCT03204019|Temozolomide|temozolomide|mesh-list
139445246|NCT03204019|Tegafur|tegafur|mesh-list
139382553|NCT04428632|Protease Inhibitors|protease inhibitors|mesh-ancestor
139445247|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139445248|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
139445249|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445250|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445251|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139445252|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
139445253|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445254|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
139445255|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139445256|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139445257|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139445258|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139445259|NCT03204019|Growth Substances|growth substances|mesh-ancestor
139445260|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
139445261|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139445262|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
139445263|NCT02485145|Diclofenac|diclofenac|mesh-list
139445264|NCT02485145|Orphenadrine|orphenadrine|mesh-list
139445265|NCT02485145|Bupivacaine|bupivacaine|mesh-list
139445266|NCT02485145|Baclofen|baclofen|mesh-list
139445267|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
139445268|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
139445269|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445270|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445271|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
139445272|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445273|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139445274|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139445275|NCT02485145|Analgesics|analgesics|mesh-ancestor
139445276|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139445277|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139445278|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139445279|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445280|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445281|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139445282|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139445283|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139445284|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
139445285|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
139445286|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445287|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139445288|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139445289|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
139445290|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
139445291|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139445292|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139445293|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
139445294|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
139445295|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139445296|NCT02484755|Gefitinib|gefitinib|mesh-list
139445297|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445298|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139445299|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445300|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445301|NCT03316469|Clomiphene|clomiphene|mesh-list
139445302|NCT03316469|Enclomiphene|enclomiphene|mesh-list
139445303|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
139445304|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139445305|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
139445306|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139445307|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445308|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139445309|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
139445310|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139445311|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139445312|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139445313|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139445314|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139445315|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139445316|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
139445317|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445318|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445319|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445320|NCT02485067|Urological Agents|urological agents|mesh-ancestor
139445321|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139445322|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139445323|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139445324|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139445325|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445326|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
139445327|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445328|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445329|NCT03203317|Insulin|insulin|mesh-list
139445330|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139445331|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445332|NCT03316313|Antibodies|antibodies|mesh-list
139445333|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
139445334|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
139445335|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445336|NCT03201601|Inositol|inositol|mesh-list
139445337|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
139445338|NCT03201601|Vitamins|vitamins|mesh-ancestor
139445339|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
139445340|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445341|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
139445342|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139445343|NCT02480387|Ledipasvir|ledipasvir|mesh-list
139445344|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
139445345|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139445346|NCT04999293|Clopidogrel|clopidogrel|mesh-list
139232012|NCT05198388|Endorphins|endorphins|mesh-list
139445347|NCT04999293|Ticagrelor|ticagrelor|mesh-list
139445348|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139445349|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139445350|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139445351|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139445352|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
139445353|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445354|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445355|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445356|NCT03315923|Rituximab|rituximab|mesh-list
139445357|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
139445358|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
139445359|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139445360|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445361|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
139445362|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445363|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139445364|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139445365|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139445366|NCT03315845|Anesthetics|anesthetics|mesh-list
139445367|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445368|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445369|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
139445370|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139445371|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
139445372|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139445373|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
139445374|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445375|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445376|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
139445377|NCT04998903|Dimercaprol|dimercaprol|mesh-list
139445378|NCT04998903|Chelating Agents|chelating agents|mesh-ancestor
139445379|NCT04998903|Sequestering Agents|sequestering agents|mesh-ancestor
139445380|NCT04998903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445381|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
139445382|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
139445383|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139445384|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
139445385|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445386|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139445387|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139445388|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
139445389|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445390|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445391|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139445392|NCT02484209|Metformin|metformin|mesh-list
139445393|NCT02484209|Glimepiride|glimepiride|mesh-list
139445394|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139445395|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445396|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139445397|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139445398|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
139445399|NCT04999137|Vitamins|vitamins|mesh-list
139445400|NCT04999137|Thiamine|thiamine|mesh-list
139445401|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
139445402|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445403|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
139445404|NCT02484053|Rituximab|rituximab|mesh-list
139445405|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139445406|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445407|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
139445408|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445409|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139445410|NCT03200821|Gemcitabine|gemcitabine|mesh-list
139445411|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139445412|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
139445413|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445414|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445415|NCT02483897|Tetracaine|tetracaine|mesh-list
139445416|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139445417|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
139445418|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
139445419|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445420|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445421|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
139232085|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
139445422|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445423|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139445424|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139445425|NCT01374919|Hematinics|hematinics|mesh-ancestor
139445426|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139445427|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139445428|NCT03202615|Lactoferrin|lactoferrin|mesh-list
139445429|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139445430|NCT03202459|Pregabalin|pregabalin|mesh-list
139445431|NCT03202459|Gabapentin|gabapentin|mesh-list
139445432|NCT03202459|Analgesics|analgesics|mesh-ancestor
139445433|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
139445434|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445435|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445436|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
139445437|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139445438|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139445439|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445440|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139445441|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139445442|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139445443|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445444|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139445445|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139445446|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139445447|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445448|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
139445449|NCT04991181|Zamicastat|zamicastat|mesh-list
139445450|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445451|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445452|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139445453|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139445454|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445455|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139445456|NCT04456959|Immunotoxins|immunotoxins|mesh-ancestor
139445457|NCT04456959|Immunoconjugates|immunoconjugates|mesh-ancestor
139445458|NCT04456959|Immunologic Factors|immunologic factors|mesh-ancestor
139445459|NCT04456959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445460|NCT05713721|Dopamine|dopamine|mesh-list
139445461|NCT05713721|Dopamine Agonists|dopamine agonists|mesh-list
139445462|NCT05713721|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139445463|NCT05713721|Sympathomimetics|sympathomimetics|mesh-ancestor
139445464|NCT05713721|Autonomic Agents|autonomic agents|mesh-ancestor
139445465|NCT05713721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445466|NCT05713721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445467|NCT05713721|Dopamine Agents|dopamine agents|mesh-ancestor
139445468|NCT05713721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103802|NCT01220076|Tamoxifen|tamoxifen|mesh-list
139445469|NCT05713721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445470|NCT05713721|Protective Agents|protective agents|mesh-ancestor
139445471|NCT05002725|Lidocaine|lidocaine|mesh-list
139445472|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
139445473|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
139445474|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445475|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445476|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
139445477|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445478|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139445479|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139445480|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139445481|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139445482|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445483|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139445484|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139445485|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139445486|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139445487|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445488|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445489|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445490|NCT03315533|Analgesics|analgesics|mesh-ancestor
139445491|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
139445492|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445493|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
139445494|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139445495|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
139445496|NCT05437835|Ropivacaine|ropivacaine|mesh-list
139445497|NCT05437835|Anesthetics, Local|anesthetics, local|mesh-ancestor
139445498|NCT05437835|Anesthetics|anesthetics|mesh-ancestor
139445499|NCT05437835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445500|NCT05437835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445501|NCT05437835|Sensory System Agents|sensory system agents|mesh-ancestor
139445502|NCT05437835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445503|NCT03200197|Menthol|menthol|mesh-list
139445504|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
139445505|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
139445506|NCT04997967|Ketamine|ketamine|mesh-list
139445507|NCT04997967|Propofol|propofol|mesh-list
139445508|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139445509|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445510|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445511|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139445512|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
139445513|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
139445514|NCT04997967|Analgesics|analgesics|mesh-ancestor
139445515|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
139445516|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445517|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139445518|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139445519|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139445520|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445521|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445522|NCT02483195|Minoxidil|minoxidil|mesh-list
139445523|NCT02483195|Spironolactone|spironolactone|mesh-list
139445524|NCT02483195|Finasteride|finasteride|mesh-list
139445525|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139445526|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
139445527|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139445528|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445529|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139445530|NCT02483195|Diuretics|diuretics|mesh-ancestor
139445531|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
139445532|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139445533|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
139445534|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139445535|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139445536|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445537|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445538|NCT02483195|Urological Agents|urological agents|mesh-ancestor
139445539|NCT02450149|Sorafenib|sorafenib|mesh-list
139445540|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445541|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139445542|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445543|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445544|NCT02479217|Docetaxel|docetaxel|mesh-list
139445545|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445546|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
139445547|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
139445548|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
139445549|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445550|NCT02479529|Norepinephrine|norepinephrine|mesh-list
139445551|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139445552|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139445553|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
139445554|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445555|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445556|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445557|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
139445558|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
139445559|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445560|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139445561|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
139445562|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
139445563|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
139445564|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445565|NCT03202147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139445566|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139445567|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139445568|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
139445569|NCT03213769|Ubiquinone|ubiquinone|mesh-list
139232237|NCT03697408|Everolimus|everolimus|mesh-list
139445570|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
139445571|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
139445572|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445573|NCT03213769|Vitamins|vitamins|mesh-ancestor
139445574|NCT05002101|Zinc|zinc|mesh-list
139445575|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
139445576|NCT05002101|Trace Elements|trace elements|mesh-ancestor
139445577|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
139445578|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445579|NCT05002101|Astringents|astringents|mesh-ancestor
139445580|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
139445581|NCT03201913|Estrogens|estrogens|mesh-list
139445582|NCT03201913|Hormones|hormones|mesh-ancestor
139445583|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139445584|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445585|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139445586|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
139445587|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139445588|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
139445589|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139445590|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445591|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139445592|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139445593|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445594|NCT03212677|Iron|iron|mesh-list
139445595|NCT03212677|Trace Elements|trace elements|mesh-ancestor
139445596|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
139445597|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445598|NCT03199339|Midazolam|midazolam|mesh-list
139445599|NCT03199339|Bupropion|bupropion|mesh-list
139445600|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139445601|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139445602|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445603|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445604|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139445605|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139445606|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139445607|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139445608|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
139445609|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
139445610|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
139445611|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
139445612|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445613|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445614|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139445615|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
139445616|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139445617|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139445618|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139445619|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
139445620|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139445621|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139445622|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445623|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
139445624|NCT03071679|Imiquimod|imiquimod|mesh-list
139445625|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139445626|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
139445627|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445628|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445629|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
139445630|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139445631|NCT03199261|Exenatide|exenatide|mesh-list
139445632|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139445633|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445634|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139445635|NCT03199261|Incretins|incretins|mesh-ancestor
139445636|NCT03199261|Hormones|hormones|mesh-ancestor
139445637|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139445638|NCT02482961|Colistin|colistin|mesh-list
139445639|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139445640|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139445641|NCT04990713|Ropivacaine|ropivacaine|mesh-list
139445642|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
139445643|NCT04990713|Anesthetics|anesthetics|mesh-list
139445644|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445645|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445646|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
139445647|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445648|NCT04990791|Aspirin|aspirin|mesh-list
139445650|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139445651|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139445652|NCT04990791|Analgesics|analgesics|mesh-ancestor
139445653|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
139445654|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445655|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445656|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139445657|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139445658|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139445659|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139445660|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445661|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139445662|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139445663|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445664|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
139445665|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139445666|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
139445667|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139445668|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
139445669|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
139445670|NCT03201835|Nabiximols|nabiximols|mesh-list
139445671|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445672|NCT03201835|Analgesics|analgesics|mesh-ancestor
139445673|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
139445674|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445675|NCT02478515|Ranibizumab|ranibizumab|mesh-list
139445676|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139445677|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139445678|NCT02478515|Growth Substances|growth substances|mesh-ancestor
139445679|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445680|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
139445681|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445682|NCT02448199|Meloxicam|meloxicam|mesh-list
139445683|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
139445684|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139445685|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139445686|NCT02448199|Analgesics|analgesics|mesh-ancestor
139445687|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
139445688|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382559|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139445689|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445690|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139445691|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139445692|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139445693|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445694|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445695|NCT03071289|Cisplatin|cisplatin|mesh-list
139445696|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445697|NCT03199105|Tetracaine|tetracaine|mesh-list
139445698|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
139445699|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
139445700|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445701|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445702|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
139445703|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445704|NCT02482649|Methylphenidate|methylphenidate|mesh-list
139445705|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139445706|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139445707|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445708|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139445709|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139445710|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139445711|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445712|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
139445713|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445714|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139445715|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
139445716|NCT03198637|Cisatracurium|cisatracurium|mesh-list
139445717|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139445718|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139445719|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445720|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445721|NCT02478281|Methylene Blue|methylene blue|mesh-list
139445722|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445723|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445724|NCT02478125|Docetaxel|docetaxel|mesh-list
139445725|NCT02478125|Lenograstim|lenograstim|mesh-list
139445726|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445727|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
139445728|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
139445729|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
139445730|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445731|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139445732|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
139445733|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445734|NCT02478047|Dexamethasone|dexamethasone|mesh-list
139445735|NCT02478047|Ramosetron|ramosetron|mesh-list
139445736|NCT02478047|Antiemetics|antiemetics|mesh-list
139445737|NCT02478047|Tropisetron|tropisetron|mesh-list
139445738|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139445739|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
139445740|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445741|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445742|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139445743|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
139445744|NCT02478047|Hormones|hormones|mesh-ancestor
139445745|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139445746|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139445747|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445748|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139445749|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
139445750|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445751|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445752|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139445753|NCT04996485|Ustekinumab|ustekinumab|mesh-list
139445754|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
139445755|NCT02447965|Bupivacaine|bupivacaine|mesh-list
139445756|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
139445757|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
139445758|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445759|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445760|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
139445761|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445762|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139445763|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
139445764|NCT03070275|Coagulants|coagulants|mesh-ancestor
139445765|NCT05713019|Adenosine|adenosine|mesh-list
139445766|NCT05713019|Capsaicin|capsaicin|mesh-list
139445767|NCT05713019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139445768|NCT05713019|Antipruritics|antipruritics|mesh-ancestor
139445769|NCT05713019|Dermatologic Agents|dermatologic agents|mesh-ancestor
139445770|NCT05713019|Sensory System Agents|sensory system agents|mesh-ancestor
139445771|NCT05713019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445772|NCT05713019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445773|NCT05713019|Analgesics|analgesics|mesh-ancestor
139445774|NCT05713019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139445775|NCT05713019|Vasodilator Agents|vasodilator agents|mesh-ancestor
139445776|NCT05713019|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139445777|NCT05713019|Purinergic Agonists|purinergic agonists|mesh-ancestor
139445778|NCT05713019|Purinergic Agents|purinergic agents|mesh-ancestor
139445779|NCT05713019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445780|NCT05713019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445781|NCT03198403|Epinephrine|epinephrine|mesh-list
139445782|NCT03198403|Bupivacaine|bupivacaine|mesh-list
139445783|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
139445784|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
139445785|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445786|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445787|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
139445788|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445789|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139445790|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139445791|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
139445792|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445793|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445794|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139445795|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139445796|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
139445797|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139445798|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
139445799|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
139445800|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
139445801|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139445802|NCT03198949|Everolimus|everolimus|mesh-list
139445803|NCT03198949|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139445804|NCT03198949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139445805|NCT03198949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445806|NCT03198949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445807|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139445808|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
139445809|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445810|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445811|NCT02447809|Aspirin|aspirin|mesh-list
139445812|NCT02447809|Clopidogrel|clopidogrel|mesh-list
139445813|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139445814|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139445815|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139445816|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139445817|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
139445818|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445819|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445820|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445821|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139445822|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139445823|NCT02447809|Analgesics|analgesics|mesh-ancestor
139445824|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
139445825|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445826|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139445827|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139445828|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139445829|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139445830|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139445831|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445832|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
139445833|NCT04989855|Tislelizumab|tislelizumab|mesh-list
139445834|NCT04989855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139445835|NCT04989855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445836|NCT04915287|Maleic acid|maleic acid|mesh-list
139445837|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382560|NCT02789111|Alvimopan|alvimopan|mesh-list
139445838|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445839|NCT05709353|Niacin|niacin|mesh-list
139445840|NCT05709353|Methamphetamine|methamphetamine|mesh-list
139445841|NCT05709353|Vitamins|vitamins|mesh-ancestor
139445842|NCT05709353|Micronutrients|micronutrients|mesh-ancestor
139445843|NCT05709353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445844|NCT05709353|Vitamin B Complex|vitamin b complex|mesh-ancestor
139445845|NCT05709353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139445846|NCT05709353|Antimetabolites|antimetabolites|mesh-ancestor
139445847|NCT05709353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445848|NCT05709353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139445849|NCT05709353|Vasodilator Agents|vasodilator agents|mesh-ancestor
139445850|NCT05709353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139445851|NCT05709353|Sympathomimetics|sympathomimetics|mesh-ancestor
139445852|NCT05709353|Autonomic Agents|autonomic agents|mesh-ancestor
139445853|NCT05709353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445854|NCT05709353|Dopamine Agents|dopamine agents|mesh-ancestor
139445855|NCT05709353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445856|NCT05709353|Adrenergic Agents|adrenergic agents|mesh-ancestor
139445857|NCT05709353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139445858|NCT05709353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139445859|NCT05709353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139445860|NCT05709353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139445861|NCT03195673|Terazosin|terazosin|mesh-list
139445862|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139445863|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139445864|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139445865|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
139445866|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139445867|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445868|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445869|NCT03195673|Urological Agents|urological agents|mesh-ancestor
139445870|NCT02481791|Remifentanil|remifentanil|mesh-list
139445871|NCT02481791|Propofol|propofol|mesh-list
139445872|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139445873|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445875|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139445876|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
139445877|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
139445878|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139445879|NCT02481791|Narcotics|narcotics|mesh-ancestor
139445880|NCT02481791|Analgesics|analgesics|mesh-ancestor
139445881|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
139445882|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445883|NCT04484467|Menthol|menthol|mesh-list
139445884|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
139445885|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
139445886|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
139445887|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139445888|NCT02726399|Capecitabine|capecitabine|mesh-list
139445889|NCT02726399|Trastuzumab|trastuzumab|mesh-list
139445890|NCT02726399|Ramucirumab|ramucirumab|mesh-list
139445891|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445892|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139445893|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
139445894|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445895|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139445896|NCT02477969|Metformin|metformin|mesh-list
139445897|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139445898|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445899|NCT03195205|Antibodies|antibodies|mesh-list
139445900|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
139445901|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445902|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139445903|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
139445904|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139445905|NCT02481323|Cilostazol|cilostazol|mesh-list
139445906|NCT02481323|Isosorbide|isosorbide|mesh-list
139445907|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139445908|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139445909|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139445910|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
139445911|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445912|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445913|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139445914|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
139445915|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139445916|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139445917|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445918|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139445919|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
139445920|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139445921|NCT02481323|Protective Agents|protective agents|mesh-ancestor
139445922|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139445923|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139445924|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445925|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139445926|NCT02481323|Diuretics|diuretics|mesh-ancestor
139445927|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
139445928|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139445929|NCT03197779|Aspirin|aspirin|mesh-list
139445930|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139445931|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139445932|NCT03197779|Analgesics|analgesics|mesh-ancestor
139445933|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
139445934|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139445935|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445936|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139445937|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139445938|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139445939|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139445940|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445941|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139445942|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139445943|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445944|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
139445945|NCT03197623|Alendronate|alendronate|mesh-list
139445946|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139445947|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445948|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
139445949|NCT02449603|Exenatide|exenatide|mesh-list
139445950|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
139445951|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139445952|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139445953|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445954|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139445955|NCT02449603|Incretins|incretins|mesh-ancestor
139445956|NCT02449603|Hormones|hormones|mesh-ancestor
139445957|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139445958|NCT02481479|Saxagliptin|saxagliptin|mesh-list
139445959|NCT02481479|Incretins|incretins|mesh-ancestor
139445960|NCT02481479|Hormones|hormones|mesh-ancestor
139445961|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139445962|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445963|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139445964|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
139445965|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139445966|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445967|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139445968|NCT03195049|Bilirubin|bilirubin|mesh-list
139445969|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
139445970|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445971|NCT03195049|Protective Agents|protective agents|mesh-ancestor
139445972|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445973|NCT03198013|Prednisolone|prednisolone|mesh-list
139445974|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139445975|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
139445976|NCT03198013|Hormones|hormones|mesh-ancestor
139445977|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139445978|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445979|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139445980|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445981|NCT05651399|Propofol|propofol|mesh-list
139445982|NCT05651399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139445983|NCT05651399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139445984|NCT05651399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139445985|NCT05651399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139445986|NCT05651399|Anesthetics, General|anesthetics, general|mesh-ancestor
139445987|NCT05651399|Anesthetics|anesthetics|mesh-ancestor
139445988|NCT02477891|Daratumumab|daratumumab|mesh-list
139445989|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445990|NCT02477813|Temozolomide|temozolomide|mesh-list
139445991|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139445992|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
139445993|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139445994|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139445995|NCT02480543|Misoprostol|misoprostol|mesh-list
139445996|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139445997|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
139445998|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139445999|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446000|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139446001|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139446002|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
139446003|NCT03197233|Vitamin D|vitamin d|mesh-list
139446004|NCT03197233|Vitamins|vitamins|mesh-list
139446005|NCT03197233|Vitamin A|vitamin a|mesh-list
139446006|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
139446007|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
139446008|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446009|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
139446010|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446011|NCT03197233|Protective Agents|protective agents|mesh-ancestor
139446012|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139446013|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446014|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139446015|NCT02447185|Triamcinolone|triamcinolone|mesh-list
139446016|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139446017|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139446018|NCT02447185|Ranibizumab|ranibizumab|mesh-list
139446019|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139446020|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139446021|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139446022|NCT02447185|Growth Substances|growth substances|mesh-ancestor
139232683|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
139446023|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446024|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
139446025|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446026|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139446027|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
139446028|NCT02447185|Hormones|hormones|mesh-ancestor
139446029|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139446030|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139446031|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
139446032|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446033|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446034|NCT03196921|Amphotericin B|amphotericin b|mesh-list
139446035|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139446036|NCT03196921|Amebicides|amebicides|mesh-ancestor
139446037|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139446038|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139446039|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446040|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139446041|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
139446042|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139446043|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139446044|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446045|NCT02480465|Incretins|incretins|mesh-ancestor
139446046|NCT02480465|Hormones|hormones|mesh-ancestor
139446047|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139446048|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139446049|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
139446050|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446051|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446052|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139446053|NCT03208465|Empagliflozin|empagliflozin|mesh-list
139446054|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139446055|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446056|NCT03208465|Incretins|incretins|mesh-ancestor
139446057|NCT03208465|Hormones|hormones|mesh-ancestor
139446058|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139446059|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139446060|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
139446061|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446062|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446063|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139446064|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
139446065|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446066|NCT04484779|Insulin|insulin|mesh-list
139446067|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
139446068|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
139446069|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139446070|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446071|NCT02477501|Norepinephrine|norepinephrine|mesh-list
139446072|NCT02477501|Ephedrine|ephedrine|mesh-list
139446073|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139446074|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139446075|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
139446076|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446077|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446078|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446079|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
139446080|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
139446081|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446082|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139446083|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139446084|NCT02446795|Sunitinib|sunitinib|mesh-list
139446085|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446086|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139446087|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139446088|NCT02446795|Growth Substances|growth substances|mesh-ancestor
139446089|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446090|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
139446091|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139446092|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446093|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446094|NCT02477267|Buprenorphine|buprenorphine|mesh-list
139446095|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139446096|NCT02477267|Naloxone|naloxone|mesh-list
139446097|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139446098|NCT02477267|Narcotics|narcotics|mesh-ancestor
139446099|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139446100|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446101|NCT02477267|Analgesics|analgesics|mesh-ancestor
139446102|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
139446103|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446104|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139446105|NCT03196843|Raltitrexed|raltitrexed|mesh-list
139446106|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139446107|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
139446108|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446109|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446110|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139446111|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446112|NCT02476955|Paclitaxel|paclitaxel|mesh-list
139446113|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139446114|NCT02476955|Carboplatin|carboplatin|mesh-list
139446115|NCT02476955|Anastrozole|anastrozole|mesh-list
139446116|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139446117|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446118|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
139446119|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
139446120|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
139446121|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446122|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139446123|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139446124|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139446125|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446126|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139446127|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
139446128|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139446129|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446130|NCT02634801|Methotrexate|methotrexate|mesh-list
139446131|NCT02634801|Ixekizumab|ixekizumab|mesh-list
139446132|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139446133|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
139446134|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139446135|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446136|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139446137|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
139446138|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446139|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446140|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
139446141|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446142|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139446143|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139446144|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
139446145|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139446146|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139446147|NCT03196531|Loratadine|loratadine|mesh-list
139446148|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
139446149|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
139446150|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139446151|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139446152|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139446153|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
139446154|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
139446155|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446156|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446157|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446158|NCT02476799|Ketorolac|ketorolac|mesh-list
139446159|NCT02476799|Fentanyl|fentanyl|mesh-list
139446160|NCT02476799|Ropivacaine|ropivacaine|mesh-list
139446161|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
139446162|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
139446163|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139446164|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446165|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
139446166|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446167|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139446168|NCT02476799|Narcotics|narcotics|mesh-ancestor
139446169|NCT02476799|Analgesics|analgesics|mesh-ancestor
139446170|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139446171|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139446172|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
139446173|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139446174|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139446175|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139446176|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139446177|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139446178|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446179|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446180|NCT02449369|Acetaminophen|acetaminophen|mesh-list
139446181|NCT02449369|Oxycodone|oxycodone|mesh-list
139446182|NCT02449369|Hydromorphone|hydromorphone|mesh-list
139446183|NCT02449369|Orphenadrine|orphenadrine|mesh-list
139446184|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139446185|NCT02449369|Analgesics|analgesics|mesh-ancestor
139446186|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
139446187|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446188|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446189|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
139446190|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139446191|NCT02449369|Narcotics|narcotics|mesh-ancestor
139446192|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139446193|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139446194|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139446195|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139446196|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139446197|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
139446198|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
139446199|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139446200|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139446201|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
139446202|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446203|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446204|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
139446205|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139446206|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446207|NCT03192943|Nivolumab|nivolumab|mesh-list
139446208|NCT03192943|Linrodostat|linrodostat|mesh-list
139446209|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139446210|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446211|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139446212|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446213|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446214|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
139446215|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139446216|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139446217|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446218|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
139446219|NCT04986813|Coagulants|coagulants|mesh-ancestor
139446220|NCT04986735|Empagliflozin|empagliflozin|mesh-list
139446221|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139446222|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446223|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139446224|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446225|NCT02475863|Warfarin|warfarin|mesh-list
139446226|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
139446227|NCT03071055|Ranibizumab|ranibizumab|mesh-list
139446228|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139446229|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139446230|NCT03071055|Growth Substances|growth substances|mesh-ancestor
139446231|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446232|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
139446233|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446234|NCT04433559|Tadalafil|tadalafil|mesh-list
139446235|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
139446236|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139446237|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139446238|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446239|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446240|NCT04433559|Urological Agents|urological agents|mesh-ancestor
139446241|NCT04911959|Lenvatinib|lenvatinib|mesh-list
139446242|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446243|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139446244|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446245|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446246|NCT03070665|Norepinephrine|norepinephrine|mesh-list
139446247|NCT03070665|Ephedrine|ephedrine|mesh-list
139446248|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139446249|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139232908|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
139446250|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
139446251|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446252|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446253|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446254|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
139446255|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
139446256|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446257|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139446258|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139446259|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139446260|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139446261|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139446262|NCT02475161|Rabeprazole|rabeprazole|mesh-list
139446263|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139446264|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139446265|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139446266|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446267|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446268|NCT03074097|Bupivacaine|bupivacaine|mesh-list
139446269|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
139446270|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
139446271|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139446272|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446273|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
139446274|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446275|NCT04433481|Dabigatran|dabigatran|mesh-list
139446276|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
139446277|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139446278|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
139446279|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446280|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446281|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
139446282|NCT04860635|Celecoxib|celecoxib|mesh-list
139446283|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139446284|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139446285|NCT04860635|Analgesics|analgesics|mesh-ancestor
139446286|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
139446287|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446288|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446289|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139446290|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139446291|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139446292|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139446293|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446294|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446295|NCT04988607|Bevacizumab|bevacizumab|mesh-list
139446296|NCT04988607|Osimertinib|osimertinib|mesh-list
139446297|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139446298|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446299|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139446300|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139446301|NCT04988607|Growth Substances|growth substances|mesh-ancestor
139446302|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446303|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
139446304|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139446305|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446306|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446307|NCT02475317|Volixibat|volixibat|mesh-list
139446308|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139446309|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139446310|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139446311|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446312|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139446313|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139446314|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139446315|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446316|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
139446317|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446318|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
139446319|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
139446320|NCT02472275|Hormones|hormones|mesh-list
139446321|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139232979|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446322|NCT02472275|Androgens|androgens|mesh-list
139446323|NCT02472275|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139446324|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
139446325|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139446326|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446328|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446329|NCT02472275|Protective Agents|protective agents|mesh-ancestor
139446330|NCT02472275|Vitamins|vitamins|mesh-ancestor
139446331|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
139446332|NCT02472275|Estrogens|estrogens|mesh-ancestor
139446333|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139446334|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446335|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
139446336|NCT02472275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139446337|NCT02472275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446338|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
139446339|NCT04491773|Tadalafil|tadalafil|mesh-list
139446340|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
139446341|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139446342|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139446343|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446344|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446345|NCT04491773|Urological Agents|urological agents|mesh-ancestor
139446346|NCT03070353|Dextrans|dextrans|mesh-list
139446347|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
139446348|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
139446349|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
139446350|NCT03073863|Atorvastatin|atorvastatin|mesh-list
139446351|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139446352|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139446353|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
139446354|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104676|NCT01130688|Analgesics|analgesics|mesh-ancestor
139446355|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139446356|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139446357|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446358|NCT02471963|Empagliflozin|empagliflozin|mesh-list
139446359|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139446360|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446361|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139446362|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446363|NCT01375751|Evolocumab|evolocumab|mesh-list
139446364|NCT01375751|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139446365|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139446366|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139446367|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
139446368|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446369|NCT01375751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139446370|NCT01375751|Protease Inhibitors|protease inhibitors|mesh-ancestor
139446371|NCT01375751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446372|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139446373|NCT05249621|Mannitol|mannitol|mesh-list
139446374|NCT05249621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139446375|NCT05249621|Diuretics|diuretics|mesh-ancestor
139446376|NCT05249621|Natriuretic Agents|natriuretic agents|mesh-ancestor
139446377|NCT05249621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446378|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139446379|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139446380|NCT00705575|Diuretics|diuretics|mesh-ancestor
139446381|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
139446382|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446383|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139446384|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139446385|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446386|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139446387|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139446388|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139446389|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139446390|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446391|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446392|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446393|NCT03068247|Analgesics|analgesics|mesh-ancestor
139446394|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
139446395|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446396|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
139446397|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139446398|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
139446399|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139446401|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139446402|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139446403|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446404|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
139446405|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139446406|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446407|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139446408|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139446409|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446410|NCT04450953|Eplerenone|eplerenone|mesh-list
139446411|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139446412|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
139446413|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139446414|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446415|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139446416|NCT04450953|Diuretics|diuretics|mesh-ancestor
139446417|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
139446418|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139446419|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139446420|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139446421|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139446422|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446423|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446424|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
139446425|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446426|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139446427|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139446428|NCT02474225|Bevacizumab|bevacizumab|mesh-list
139446429|NCT02474225|Ranibizumab|ranibizumab|mesh-list
139446430|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
139446431|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139446432|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446433|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139446434|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139446435|NCT02474225|Growth Substances|growth substances|mesh-ancestor
139446436|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446437|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
139446438|NCT04430855|Upadacitinib|upadacitinib|mesh-list
139446439|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139446440|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139446441|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446442|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446443|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139446444|NCT02471105|Bimatoprost|bimatoprost|mesh-list
139446445|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139446446|NCT03108989|Neostigmine|neostigmine|mesh-list
139446447|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139446448|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446449|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446450|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
139446451|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446452|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446453|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139446454|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
139446455|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446456|NCT02473601|Mivacurium|mivacurium|mesh-list
139446457|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139446458|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139446459|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139446460|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446461|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446462|NCT02470559|Aldesleukin|aldesleukin|mesh-list
139446463|NCT02470559|Interleukin-2|interleukin-2|mesh-list
139446464|NCT02470559|Sargramostim|sargramostim|mesh-list
139446465|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139446466|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446467|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139446468|NCT02470559|Analgesics|analgesics|mesh-ancestor
139446469|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
139446470|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446471|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446472|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
139446473|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139446474|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139446475|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
139446476|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446478|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
139446479|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446480|NCT02470637|Insulin|insulin|mesh-list
139446481|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139446482|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
139446483|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139446484|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446485|NCT03948347|Liraglutide|liraglutide|mesh-list
139446486|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139446487|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446488|NCT03948347|Incretins|incretins|mesh-ancestor
139446489|NCT03948347|Hormones|hormones|mesh-ancestor
139446490|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139446491|NCT02723591|Tacrolimus|tacrolimus|mesh-list
139446492|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139446493|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
139446494|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446495|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139446496|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446497|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446498|NCT00705341|Fluticasone|fluticasone|mesh-list
139446499|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139446500|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139446501|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
139446502|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446503|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446504|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139446505|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
139446506|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
139446507|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139446508|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
139446509|NCT03193931|Methotrexate|methotrexate|mesh-list
139446510|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139446511|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446512|NCT03193931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139446513|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446514|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139446515|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
139446516|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139446517|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446518|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139446519|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
139446520|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
139446521|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446522|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139446523|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139446524|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
139446525|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139446526|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139446527|NCT00705263|Ribavirin|ribavirin|mesh-list
139446528|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139446529|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
139446530|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446531|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
139446532|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446533|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
139446534|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139446535|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139446536|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446537|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
139446538|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
139446539|NCT03310463|Durlobactam|durlobactam|mesh-list
139446540|NCT03310463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139446541|NCT03310463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233205|NCT02435433|Ramucirumab|ramucirumab|mesh-list
139446542|NCT03310463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446543|NCT03310463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139446544|NCT03310463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446545|NCT00704405|Interferons|interferons|mesh-list
139446546|NCT00704405|Ribavirin|ribavirin|mesh-list
139446547|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446548|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
139446549|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446550|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
139446551|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446552|NCT01470755|Albuterol|albuterol|mesh-list
139446553|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139446554|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
139446555|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446556|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446557|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139446558|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
139446559|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
139446560|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139446561|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139446562|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139446563|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139446564|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
139446565|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446566|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446567|NCT03310073|Vaccines|vaccines|mesh-list
139446568|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
139446569|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446570|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
139446571|NCT03309527|Promethazine|promethazine|mesh-list
139446572|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139446573|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139446574|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139446575|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446576|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
139446577|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
139446578|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
139446579|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446580|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
139446581|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
139446582|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139446583|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139446584|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
139446585|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
139446586|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446587|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446588|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139446589|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
139446590|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
139446591|NCT03313661|Gliclazide|gliclazide|mesh-list
139446592|NCT03313661|Cabergoline|cabergoline|mesh-list
139446593|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139446594|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139446595|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
139446596|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
139446597|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446598|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446599|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446600|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139446601|NCT00703781|Bromfenac|bromfenac|mesh-list
139446602|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139446603|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139446604|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139446605|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139446606|NCT00703781|Analgesics|analgesics|mesh-ancestor
139446607|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
139446608|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446609|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446610|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139446611|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139446613|NCT03309215|Trace Elements|trace elements|mesh-ancestor
139446614|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
139446615|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233277|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446616|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
139446617|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
139446618|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
139446619|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139446620|NCT03309059|Protective Agents|protective agents|mesh-ancestor
139446621|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446622|NCT02469545|Sertraline|sertraline|mesh-list
139446623|NCT02469545|Escitalopram|escitalopram|mesh-list
139446624|NCT02469545|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139446625|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139446626|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139446627|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446628|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446629|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
139446630|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446631|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
139446632|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139446633|NCT03308357|Infliximab|infliximab|mesh-list
139446634|NCT03308357|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139446635|NCT03308357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139446636|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
139446637|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139446638|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139446639|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
139446640|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139446641|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139446642|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446643|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
139446644|NCT03308201|Letrozole|letrozole|mesh-list
139446645|NCT03308201|Fulvestrant|fulvestrant|mesh-list
139446646|NCT03308201|Exemestane|exemestane|mesh-list
139446647|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446648|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139446649|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139446650|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104969|NCT01132794|Analgesics|analgesics|mesh-ancestor
139446651|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446652|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139446653|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
139446654|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139446655|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446656|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139446657|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139446658|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
139446659|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139446660|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139446661|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446662|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139446663|NCT03312413|Analgesics|analgesics|mesh-ancestor
139446664|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
139446665|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446666|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139446667|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139446668|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139446669|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
139446670|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446671|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446672|NCT02722967|Aripiprazole|aripiprazole|mesh-list
139446673|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
139446674|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139446675|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139446676|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139446677|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139446678|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446679|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
139446680|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
139446681|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446682|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446683|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139446684|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139446685|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
139446686|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139446687|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139446688|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139446689|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139446690|NCT04442633|Miconazole|miconazole|mesh-list
139446691|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
139446692|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233351|NCT01375335|Dobutamine|dobutamine|mesh-list
139446693|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139446694|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139446695|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446696|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446697|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139446698|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
139446699|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139446700|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446701|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139446702|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139446703|NCT03312335|Aldesleukin|aldesleukin|mesh-list
139446704|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446705|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139446706|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139446707|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
139446708|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446709|NCT03312179|Incretins|incretins|mesh-list
139446710|NCT03312179|Hormones|hormones|mesh-ancestor
139446711|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139446712|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446713|NCT02468531|Xenon|xenon|mesh-list
139382572|NCT02251925|Estradiol|estradiol|mesh-list
139446714|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139446715|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
139446716|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
139446717|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139446718|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446719|NCT03311945|Lamivudine|lamivudine|mesh-list
139446720|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
139446721|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139446722|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139446723|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446724|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446725|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
139446726|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446727|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139446728|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139446729|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139446730|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139446731|NCT03311789|Gemcitabine|gemcitabine|mesh-list
139446732|NCT03311789|Nivolumab|nivolumab|mesh-list
139446733|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139446734|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446735|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139446736|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
139446737|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446738|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139446739|NCT02468999|Insulin|insulin|mesh-list
139446740|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139446741|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139446742|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446743|NCT03311321|Vitamin K|vitamin k|mesh-list
139446744|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
139446745|NCT03311321|Menaquinone 7|menaquinone 7|mesh-list
139446746|NCT03311321|Vitamins|vitamins|mesh-ancestor
139446747|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
139446748|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446749|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139446750|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139446751|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446752|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
139446753|NCT03311321|Coagulants|coagulants|mesh-ancestor
139446754|NCT02468297|Ibuprofen|ibuprofen|mesh-list
139446755|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139446756|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139446757|NCT02468297|Analgesics|analgesics|mesh-ancestor
139446758|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
139446759|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446760|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446761|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139446762|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139446763|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139446764|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446765|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446766|NCT02468375|Mirabegron|mirabegron|mesh-list
139446767|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139446768|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139446769|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139446770|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
139446771|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446772|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446773|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446774|NCT02468375|Urological Agents|urological agents|mesh-ancestor
139446775|NCT03304457|Olanzapine|olanzapine|mesh-list
139446776|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139446777|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
139446778|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
139446779|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446780|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446781|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139446782|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139446783|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139446784|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139446785|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139446786|NCT03304457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139446787|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139105107|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
139446788|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139446789|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446790|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446791|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
139446792|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139446793|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139446794|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139446795|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
139446796|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139446797|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139446798|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139446799|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139446800|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
139446801|NCT04490837|Antibodies|antibodies|mesh-list
139446802|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
139446803|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446804|NCT03305471|Sevelamer|sevelamer|mesh-list
139446805|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
139446806|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
139446807|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446808|NCT03303677|Vancomycin|vancomycin|mesh-list
139446809|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
139446810|NCT03303677|Gentamicins|gentamicins|mesh-list
139446811|NCT03303677|Mupirocin|mupirocin|mesh-list
139446812|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139446813|NCT03303677|Trimethoprim|trimethoprim|mesh-list
139446814|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
139446815|NCT03303677|Budesonide|budesonide|mesh-list
139446816|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139446817|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139446818|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
139446819|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446820|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446821|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139446822|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
139446823|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
139446824|NCT03303677|Hormones|hormones|mesh-ancestor
139446825|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139446826|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446827|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139446828|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139446829|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446830|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446831|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446832|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139446833|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139446834|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139446835|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139446836|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
139446837|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139446838|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139446839|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139446840|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139446841|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139446842|NCT02468063|Terlipressin|terlipressin|mesh-list
139446843|NCT02468063|Norepinephrine|norepinephrine|mesh-list
139446844|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139446845|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139446846|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139446847|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139446848|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
139446849|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446850|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446851|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446852|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
139446853|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
139446854|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446855|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
139446856|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139446857|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446858|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139446859|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446860|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
139446861|NCT03303209|Narcotics|narcotics|mesh-ancestor
139446862|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139446863|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446864|NCT03303209|Analgesics|analgesics|mesh-ancestor
139446865|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
139446866|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446867|NCT03303053|Prednisolone|prednisolone|mesh-list
139446868|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
139446869|NCT03303053|Carbimazole|carbimazole|mesh-list
139446870|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139446871|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
139446872|NCT03303053|Hormones|hormones|mesh-ancestor
139446873|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139446874|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446875|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139446876|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446877|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139446878|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139446879|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
139446880|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446881|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139446882|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
139446883|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
139446884|NCT02467907|Paclitaxel|paclitaxel|mesh-list
139446885|NCT02467907|Bevacizumab|bevacizumab|mesh-list
139446886|NCT02467907|Carboplatin|carboplatin|mesh-list
139446887|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139446888|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446889|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
139446890|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
139446891|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
139446892|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446893|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139446894|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139446895|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139446896|NCT02467907|Growth Substances|growth substances|mesh-ancestor
139446897|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446898|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
139446899|NCT02467127|Vitamin D|vitamin d|mesh-list
139446900|NCT02467127|Vitamins|vitamins|mesh-ancestor
139446901|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
139446902|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446903|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139446904|NCT03302585|Vitamin D|vitamin d|mesh-list
139446905|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
139446906|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
139446907|NCT03302585|Vitamins|vitamins|mesh-list
139446908|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
139446909|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446910|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139446911|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139446912|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
139446913|NCT03302351|Ketamine|ketamine|mesh-list
139446914|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139446915|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139446916|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446917|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139446918|NCT03302351|Analgesics|analgesics|mesh-ancestor
139446919|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
139446920|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446921|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139446922|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139446923|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139446924|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
139446925|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446926|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446927|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139446928|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139446929|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
139446931|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139446932|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139446933|NCT05727683|Cyclophosphamide|cyclophosphamide|mesh-list
139446934|NCT05727683|Fludarabine|fludarabine|mesh-list
139446935|NCT05727683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139446936|NCT05727683|Immunologic Factors|immunologic factors|mesh-ancestor
139446937|NCT05727683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446938|NCT05727683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139446939|NCT05727683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139446940|NCT05727683|Alkylating Agents|alkylating agents|mesh-ancestor
139446941|NCT05727683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446942|NCT05727683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446943|NCT05727683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139446944|NCT03302039|Phenylephrine|phenylephrine|mesh-list
139446945|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
139446946|NCT03302039|Bupivacaine|bupivacaine|mesh-list
139446947|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
139446948|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
139446949|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139446950|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446951|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
139446952|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446953|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139446954|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
139446955|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
139446956|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
139446957|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139446958|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
139446959|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
139446960|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139446961|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139446962|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139446963|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
139446964|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446965|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446966|NCT03302039|Protective Agents|protective agents|mesh-ancestor
139446967|NCT02721875|Azacitidine|azacitidine|mesh-list
139446968|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139446969|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
139446970|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446971|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139446972|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446973|NCT02466503|Fluticasone|fluticasone|mesh-list
139446974|NCT02466503|Xhance|xhance|mesh-list
139446975|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139446976|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139446977|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139446978|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
139446979|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139446980|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139446981|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139446982|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
139446983|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
139233650|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233660|NCT03106077|Maytansine|maytansine|mesh-list
139233661|NCT03106077|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139233662|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139233663|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233664|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
139233665|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
139233666|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
139233667|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446985|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139446986|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139446987|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139446988|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
139446989|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139446990|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139446991|NCT03301181|Itraconazole|itraconazole|mesh-list
139446992|NCT03301181|Rifampin|rifampin|mesh-list
139446993|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
139446994|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
139446995|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139446996|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139446997|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139446998|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139446999|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447000|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139447001|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
139447002|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139447003|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447004|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139447005|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139447006|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
139447007|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139447008|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
139447009|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139447010|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139447011|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139447012|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139447013|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139447014|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139447015|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139447016|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447017|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139447018|NCT00702221|Vaccines|vaccines|mesh-list
139447019|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
139447020|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447021|NCT03301025|Pregabalin|pregabalin|mesh-list
139447022|NCT03301025|Analgesics|analgesics|mesh-ancestor
139447023|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
139447024|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447025|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447026|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
139447027|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139447028|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447029|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447030|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139447031|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139447032|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139447033|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447034|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139447035|NCT05726903|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139447036|NCT05726903|Medroxyprogesterone|medroxyprogesterone|mesh-list
139447037|NCT05726903|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139447038|NCT05726903|Contraceptive Agents|contraceptive agents|mesh-ancestor
139447039|NCT05726903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139447040|NCT05726903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447041|NCT05726903|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139447042|NCT05726903|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139447043|NCT05726903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139447044|NCT05726903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447045|NCT05726903|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139447046|NCT05726903|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139447047|NCT05726903|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139447048|NCT02467595|Fentanyl|fentanyl|mesh-list
139447049|NCT02467595|Bromides|bromides|mesh-list
139447050|NCT02467595|Propofol|propofol|mesh-list
139447051|NCT02467595|Sevoflurane|sevoflurane|mesh-list
139447052|NCT02467595|Rocuronium|rocuronium|mesh-list
139447053|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139447054|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233726|NCT03822975|Calcium heparin|calcium heparin|mesh-list
139447055|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447057|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
139447058|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
139447059|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139447060|NCT02467595|Narcotics|narcotics|mesh-ancestor
139447061|NCT02467595|Analgesics|analgesics|mesh-ancestor
139447062|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
139447063|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447064|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139447065|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139447066|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139447067|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
139447068|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139447069|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139447070|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139447071|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
139447072|NCT02467517|Ketamine|ketamine|mesh-list
139447073|NCT02467517|Analgesics|analgesics|mesh-ancestor
139447074|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
139382579|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
139447075|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447076|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447077|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139447078|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139447079|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
139447080|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
139447081|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447082|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139447083|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139447084|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447085|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447086|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139447087|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
139447088|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139447089|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447090|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139447091|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
139447092|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139447093|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139447094|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139447095|NCT02467673|Estradiol|estradiol|mesh-list
139447096|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139447097|NCT02467673|Progesterone|progesterone|mesh-list
139447098|NCT02467673|Estrogens|estrogens|mesh-ancestor
139447099|NCT02467673|Hormones|hormones|mesh-ancestor
139447100|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139447101|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447102|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139447103|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
139447104|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139447105|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139447106|NCT02467673|Progestins|progestins|mesh-ancestor
139447107|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139447108|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
139447109|NCT02953145|Coagulants|coagulants|mesh-ancestor
139447110|NCT03300089|Anesthetics|anesthetics|mesh-list
139447111|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447112|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447113|NCT00702923|Tremelimumab|tremelimumab|mesh-list
139447114|NCT00702923|Bicalutamide|bicalutamide|mesh-list
139447115|NCT00702923|Ipilimumab|ipilimumab|mesh-list
139447116|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139447117|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447118|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
139447119|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447120|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
139447121|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
139447122|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139447123|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139447124|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139447125|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447126|NCT05294055|Cyclophosphamide|cyclophosphamide|mesh-list
139447127|NCT05294055|Etoposide|etoposide|mesh-list
139447128|NCT05294055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139447129|NCT05294055|Immunologic Factors|immunologic factors|mesh-ancestor
139447130|NCT05294055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382582|NCT03552653|Vitamin D|vitamin d|mesh-list
139447131|NCT05294055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139447132|NCT05294055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139447133|NCT05294055|Alkylating Agents|alkylating agents|mesh-ancestor
139447134|NCT05294055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447135|NCT05294055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447136|NCT05294055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139447137|NCT05294055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139447138|NCT05294055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139447139|NCT05294055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139447140|NCT05294055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447141|NCT03299621|Rocuronium|rocuronium|mesh-list
139447142|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139447143|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139447144|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139447145|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447146|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447147|NCT05718167|Tislelizumab|tislelizumab|mesh-list
139447148|NCT05718167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139447149|NCT05718167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447150|NCT03299387|Gentamicins|gentamicins|mesh-list
139447151|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
139447152|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139447153|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139447154|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139447155|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447156|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447157|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139447158|NCT04794699|Paclitaxel|paclitaxel|mesh-list
139447159|NCT04794699|Docetaxel|docetaxel|mesh-list
139447160|NCT04794699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139447161|NCT04794699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447162|NCT04794699|Tubulin Modulators|tubulin modulators|mesh-ancestor
139447163|NCT04794699|Antimitotic Agents|antimitotic agents|mesh-ancestor
139447164|NCT04794699|Mitosis Modulators|mitosis modulators|mesh-ancestor
139447165|NCT04794699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447166|NCT02466347|Fluticasone|fluticasone|mesh-list
139447167|NCT02466347|Xhance|xhance|mesh-list
139447168|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139447169|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139447170|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139447171|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
139447172|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447173|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447174|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139447175|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
139447176|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
139447177|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139447178|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139447179|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139447180|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139447181|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
139447182|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447183|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447184|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
139447185|NCT03067935|Immunoconjugates|immunoconjugates|mesh-ancestor
139447186|NCT03067935|Immunologic Factors|immunologic factors|mesh-ancestor
139447187|NCT03067935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447188|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139447189|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447190|NCT02466191|Gabapentin|gabapentin|mesh-list
139447191|NCT02466191|Memantine|memantine|mesh-list
139447192|NCT02466191|Analgesics|analgesics|mesh-ancestor
139447193|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
139447194|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447195|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447196|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
139447197|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139447198|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139447199|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447200|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139447201|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139447202|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139447203|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233876|NCT05186454|Hormones|hormones|mesh-ancestor
139447204|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447205|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
139447206|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139447207|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139447208|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
139447209|NCT05555069|Menthol|menthol|mesh-list
139447210|NCT05555069|Antipruritics|antipruritics|mesh-ancestor
139447211|NCT05555069|Dermatologic Agents|dermatologic agents|mesh-ancestor
139447212|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
139447213|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
139447214|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447215|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
139447216|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447217|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447218|NCT03069339|Carvedilol|carvedilol|mesh-list
139447219|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139447220|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139447221|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
139447222|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447223|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447224|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447225|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139447226|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
139447227|NCT03069339|Protective Agents|protective agents|mesh-ancestor
139447228|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139447229|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447230|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139447231|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
139447232|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139447233|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139447234|NCT05542589|Phenytoin|phenytoin|mesh-list
139447235|NCT05542589|Anticonvulsants|anticonvulsants|mesh-ancestor
139447236|NCT05542589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139447237|NCT05542589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139447238|NCT05542589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447239|NCT05542589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447240|NCT05542589|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139447241|NCT05542589|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139447242|NCT03069027|Lidocaine|lidocaine|mesh-list
139447243|NCT03069027|Epinephrine|epinephrine|mesh-list
139447244|NCT03069027|Racepinephrine|racepinephrine|mesh-list
139447245|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
139447246|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
139447247|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
139447248|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447249|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447250|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
139447251|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447252|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139447253|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139447254|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139447255|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447256|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447257|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139447258|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139447259|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
139447260|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447261|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139447262|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139447263|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
139447264|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139447265|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
139447266|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
139447267|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
139447268|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139447269|NCT05635071|Nintedanib|nintedanib|mesh-list
139447270|NCT05635071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447271|NCT05635071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139447272|NCT05635071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447273|NCT05635071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233952|NCT03447353|Narcotics|narcotics|mesh-ancestor
139447274|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139447275|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139447276|NCT02720081|Albuterol|albuterol|mesh-list
139447277|NCT02720081|Montelukast|montelukast|mesh-list
139447278|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139447279|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
139447280|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139447281|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
139447282|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139447283|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447284|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139447285|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139447286|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447287|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139447289|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447290|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
139447291|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139447292|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139447293|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139447294|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139447295|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
139447296|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447297|NCT04552197|Tofacitinib|tofacitinib|mesh-list
139447298|NCT04552197|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139447299|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139447300|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447301|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447302|NCT05244473|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139447303|NCT05244473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139447304|NCT05244473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447305|NCT05244473|Immunotoxins|immunotoxins|mesh-ancestor
139447306|NCT05244473|Immunoconjugates|immunoconjugates|mesh-ancestor
139447307|NCT05244473|Immunologic Factors|immunologic factors|mesh-ancestor
139447308|NCT05244473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447309|NCT04809233|Tipifarnib|tipifarnib|mesh-list
139447310|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447311|NCT02310269|Pasireotide|pasireotide|mesh-list
139447312|NCT02310269|Hormones|hormones|mesh-ancestor
139447313|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139447314|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447315|NCT04489745|Androgens|androgens|mesh-list
139447316|NCT04489745|Hormones|hormones|mesh-ancestor
139447317|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139447318|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447319|NCT02464865|Thiamine|thiamine|mesh-list
139447320|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
139447321|NCT02464865|Vitamins|vitamins|mesh-ancestor
139447322|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
139447323|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447324|NCT02466035|Caseins|caseins|mesh-list
139447325|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
139447326|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
139447327|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447328|NCT05173337|Nefopam|nefopam|mesh-list
139447329|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139447330|NCT05173337|Analgesics|analgesics|mesh-ancestor
139447331|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
139447332|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447333|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447334|NCT02464631|Ribavirin|ribavirin|mesh-list
139447335|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
139447336|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
139447337|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447338|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
139447339|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139447340|NCT04880577|Tenofovir|tenofovir|mesh-list
139447341|NCT04880577|Rituximab|rituximab|mesh-list
139447342|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
139447343|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139447344|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447345|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
139447346|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447347|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139447348|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
139447349|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139447350|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139447351|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139447352|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447353|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447354|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139447355|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139447356|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139447357|NCT04490213|Laxatives|laxatives|mesh-ancestor
139447358|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139447359|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
139447360|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139447361|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447362|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
139447363|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139447364|NCT04562597|Expectorants|expectorants|mesh-ancestor
139447365|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
139447366|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139447367|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
139447368|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447369|NCT04562597|Protective Agents|protective agents|mesh-ancestor
139447370|NCT04562597|Antidotes|antidotes|mesh-ancestor
139447371|NCT04504175|Ketamine|ketamine|mesh-list
139447372|NCT04504175|Analgesics|analgesics|mesh-ancestor
139447373|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
139447374|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447375|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447376|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139447377|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139447378|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
139447379|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
139447380|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447381|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139447382|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139447383|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447384|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447385|NCT05723367|Anesthetics|anesthetics|mesh-list
139447386|NCT05723367|Anesthetics, Local|anesthetics, local|mesh-list
139447387|NCT05723367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447388|NCT05723367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447389|NCT05723367|Sensory System Agents|sensory system agents|mesh-ancestor
139447390|NCT05723367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447391|NCT04433169|Tretinoin|tretinoin|mesh-list
139447392|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447393|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
139447394|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
139447395|NCT02717195|Olanzapine|olanzapine|mesh-list
139447396|NCT02717195|Risperidone|risperidone|mesh-list
139447397|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139447398|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
139447399|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447400|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447401|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447402|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139447403|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139447404|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447405|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139447406|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139447407|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
139447408|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
139447409|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
139447410|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447411|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139447412|NCT02717195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139447413|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139447414|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447415|NCT05582031|Tislelizumab|tislelizumab|mesh-list
139447416|NCT05582031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139447417|NCT05582031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447418|NCT04424225|Niacin|niacin|mesh-list
139447419|NCT04424225|Psilocybin|psilocybin|mesh-list
139447420|NCT04424225|Vitamins|vitamins|mesh-ancestor
139447421|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
139447422|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447423|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
139447424|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139447425|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
139447426|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447427|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139447428|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
139447429|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
139447430|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139447431|NCT05581719|Nivolumab|nivolumab|mesh-list
139447432|NCT05581719|Tislelizumab|tislelizumab|mesh-list
139447433|NCT05581719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139447434|NCT05581719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447435|NCT05581719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139447436|NCT05581719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447437|NCT05626101|Gemcitabine|gemcitabine|mesh-list
139447438|NCT05626101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139447439|NCT05626101|Antimetabolites|antimetabolites|mesh-ancestor
139447440|NCT05626101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447441|NCT05626101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447442|NCT02465801|Lenograstim|lenograstim|mesh-list
139447443|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139447444|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
139447445|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447446|NCT02465645|Carvedilol|carvedilol|mesh-list
139447447|NCT02465645|Simvastatin|simvastatin|mesh-list
139447448|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139447449|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139447450|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
139447451|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447452|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139447453|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139447454|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447455|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139447456|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139447457|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
139447458|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447459|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447460|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139447461|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
139447462|NCT02465645|Protective Agents|protective agents|mesh-ancestor
139447463|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139447464|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447465|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139447466|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
139447467|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139447468|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139447469|NCT04872257|Vitamin D|vitamin d|mesh-list
139447470|NCT04872257|Vitamins|vitamins|mesh-ancestor
139447471|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
139447472|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447473|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139447474|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139447475|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139447476|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139447477|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447478|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447479|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447480|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447481|NCT04970121|Analgesics|analgesics|mesh-ancestor
139447482|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
139447483|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447484|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
139447485|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139447486|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
139447487|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
139447488|NCT02463929|Promethazine|promethazine|mesh-list
139447489|NCT02463929|Ketamine|ketamine|mesh-list
139447490|NCT02463929|Bupivacaine|bupivacaine|mesh-list
139447491|NCT02463929|Sevoflurane|sevoflurane|mesh-list
139447492|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
139447493|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
139447494|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447495|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447496|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
139447497|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447498|NCT02463929|Analgesics|analgesics|mesh-ancestor
139447499|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139447500|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139447501|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
139447502|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139447503|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139447504|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447505|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447506|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139447507|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139447508|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139447509|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139447511|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
139447512|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139447513|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139447514|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
139447515|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
139447516|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139447517|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
139447518|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
139447519|NCT02465255|Acetaminophen|acetaminophen|mesh-list
139447520|NCT02465255|Ketorolac|ketorolac|mesh-list
139447521|NCT02465255|Tramadol|tramadol|mesh-list
139447522|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139447523|NCT02465255|Analgesics|analgesics|mesh-ancestor
139447524|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
139447525|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447526|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447527|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
139447528|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139447529|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139447530|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139447531|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139447532|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447533|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447534|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139447535|NCT02465255|Narcotics|narcotics|mesh-ancestor
139447536|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447537|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139447538|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139447539|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139447540|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
139447541|NCT02462915|Lidocaine|lidocaine|mesh-list
139447542|NCT02462915|Fentanyl|fentanyl|mesh-list
139447543|NCT02462915|Propofol|propofol|mesh-list
139447544|NCT02462915|Cisatracurium|cisatracurium|mesh-list
139447545|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
139447546|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
139447547|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447548|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447549|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
139447550|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447551|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139447552|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139447553|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139447554|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447555|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447556|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139447557|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139447558|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
139447559|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139447560|NCT02462915|Narcotics|narcotics|mesh-ancestor
139447561|NCT02462915|Analgesics|analgesics|mesh-ancestor
139447562|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139447563|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139447564|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139447565|NCT05505123|Propofol|propofol|mesh-list
139447566|NCT05505123|Sevoflurane|sevoflurane|mesh-list
139447567|NCT05505123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139447568|NCT05505123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447569|NCT05505123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447570|NCT05505123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139447571|NCT05505123|Anesthetics, General|anesthetics, general|mesh-ancestor
139447572|NCT05505123|Anesthetics|anesthetics|mesh-ancestor
139447573|NCT05505123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139447574|NCT05505123|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139447575|NCT02462525|Dexamethasone|dexamethasone|mesh-list
139447576|NCT02462525|Pomalidomide|pomalidomide|mesh-list
139447577|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139447578|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
139447579|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
139447580|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447581|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447582|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139447583|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
139447584|NCT02462525|Hormones|hormones|mesh-ancestor
139447585|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139447586|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139447587|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447588|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
139447589|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139447590|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139447591|NCT02462525|Growth Substances|growth substances|mesh-ancestor
139447592|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
139447593|NCT04111419|Amlodipine|amlodipine|mesh-list
139447594|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
139447595|NCT04111419|Atorvastatin|atorvastatin|mesh-list
139447596|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139447597|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139447598|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
139447599|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447600|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139447601|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139447602|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447603|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139447604|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139447605|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447606|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139447607|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447608|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
139447609|NCT02462447|Choline|choline|mesh-list
139447610|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
139447611|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139447612|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
139447613|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447614|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139447615|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139447616|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
139447617|NCT02462681|Ketamine|ketamine|mesh-list
139447618|NCT02462681|Analgesics|analgesics|mesh-ancestor
139447619|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
139447620|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447621|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447622|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139447623|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139447624|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
139447625|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
139447626|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447627|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139447628|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139447629|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447630|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447631|NCT04129151|Palbociclib|palbociclib|mesh-list
139447632|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447633|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139447634|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447635|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447636|NCT02462369|Glimepiride|glimepiride|mesh-list
139447637|NCT02462369|Saxagliptin|saxagliptin|mesh-list
139447638|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139447639|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139447640|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447641|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139447642|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
139447643|NCT02462369|Incretins|incretins|mesh-ancestor
139447644|NCT02462369|Hormones|hormones|mesh-ancestor
139447645|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139447646|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139447647|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
139447648|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447649|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447650|NCT04072835|Etripamil|etripamil|mesh-list
139447651|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139447652|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447653|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447654|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139447655|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447657|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
139447658|NCT04083963|Carboplatin|carboplatin|mesh-list
139447659|NCT04083963|Doxorubicin|doxorubicin|mesh-list
139447660|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139447661|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447662|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
139447663|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
139447664|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
139447665|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447666|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139447667|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
139447668|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447669|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139447670|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139447671|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
139447672|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139447673|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139447674|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139447675|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139447676|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447677|NCT02463383|Ibuprofen|ibuprofen|mesh-list
139447678|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139447679|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139447680|NCT02463383|Analgesics|analgesics|mesh-ancestor
139447681|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
139447682|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447683|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447684|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139447685|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139447686|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139447687|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447688|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447689|NCT03108365|Hemostatics|hemostatics|mesh-list
139447690|NCT03108365|Chitosan|chitosan|mesh-list
139447691|NCT03108365|Coagulants|coagulants|mesh-ancestor
139447692|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139447693|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139447694|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
139447695|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447696|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139447697|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
139447698|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
139447699|NCT05345457|Amoxicillin|amoxicillin|mesh-list
139447700|NCT05345457|Azithromycin|azithromycin|mesh-list
139447701|NCT05345457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139447702|NCT05345457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139447703|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139447704|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139447705|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139447706|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447707|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447708|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139447709|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447710|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447711|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
139447712|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447713|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
139447714|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
139447715|NCT03064191|Calcium|calcium|mesh-list
139447716|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139447717|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447718|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139447719|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139447720|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139447721|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
139447722|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
139447723|NCT02629965|Olodaterol|olodaterol|mesh-list
139447724|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139447725|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
139447726|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447727|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447728|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139447729|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
139447730|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
139447731|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139447732|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
139447733|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447734|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447735|NCT03062787|Triamcinolone|triamcinolone|mesh-list
139447736|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139447737|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139447738|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
139447739|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139447740|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139447741|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
139447742|NCT03062787|Hormones|hormones|mesh-ancestor
139447743|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139447744|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447745|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139447746|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
139447747|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447748|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447749|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139447750|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
139447751|NCT03062787|Protective Agents|protective agents|mesh-ancestor
139447752|NCT04601883|Colchicine|colchicine|mesh-list
139447753|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
139447754|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139447755|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
139447756|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
139447757|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
139447758|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447759|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447760|NCT05223075|Lidocaine|lidocaine|mesh-list
139447761|NCT05223075|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139447762|NCT05223075|Carticaine|carticaine|mesh-list
139447763|NCT05223075|Anesthetics, Local|anesthetics, local|mesh-ancestor
139447764|NCT05223075|Anesthetics|anesthetics|mesh-ancestor
139447765|NCT05223075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447766|NCT05223075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447767|NCT05223075|Sensory System Agents|sensory system agents|mesh-ancestor
139447768|NCT05223075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447769|NCT05223075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139447770|NCT05223075|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139447771|NCT05223075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139447772|NCT05223075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447773|NCT05223075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447774|NCT03719313|Interferons|interferons|mesh-list
139447775|NCT03719313|Ritonavir|ritonavir|mesh-list
139447776|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
139447777|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139447778|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
139447779|NCT03719313|Lonafarnib|lonafarnib|mesh-list
139447780|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447781|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
139447782|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139447783|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139447784|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139447785|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
139447786|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447787|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447788|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139447789|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139447790|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139447791|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139447792|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
139447793|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447794|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
139447795|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
139447796|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139447797|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
139447798|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139447799|NCT03063723|Ledipasvir|ledipasvir|mesh-list
139447800|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
139234477|NCT03274687|Androgens|androgens|mesh-list
139447801|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139447802|NCT00379041|Prednisone|prednisone|mesh-list
139447803|NCT00379041|Doxorubicin|doxorubicin|mesh-list
139447804|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139447806|NCT00379041|Vincristine|vincristine|mesh-list
139447807|NCT00379041|Vinblastine|vinblastine|mesh-list
139447808|NCT00379041|Procarbazine|procarbazine|mesh-list
139447809|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
139447810|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139447811|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447812|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139447813|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139447814|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447815|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447816|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139447817|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
139447818|NCT00379041|Hormones|hormones|mesh-ancestor
139447819|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139447820|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447821|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139447822|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139447823|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
139447824|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
139447825|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
139447826|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
139447827|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139447828|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139447829|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139447830|NCT03305445|Nivolumab|nivolumab|mesh-list
139447831|NCT03305445|Ipilimumab|ipilimumab|mesh-list
139447832|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139447833|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447834|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139447835|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447836|NCT04436913|Fluorides|fluorides|mesh-list
139447837|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
139447838|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
139447839|NCT04436913|Protective Agents|protective agents|mesh-ancestor
139447840|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447841|NCT02487095|Topotecan|topotecan|mesh-list
139447842|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139447843|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139447844|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447845|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447846|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447847|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139447848|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139447849|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447850|NCT03742193|Apatinib|apatinib|mesh-list
139447851|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447852|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139447853|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447854|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447855|NCT03108287|Amoxicillin|amoxicillin|mesh-list
139447856|NCT03108287|Clarithromycin|clarithromycin|mesh-list
139447857|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
139447858|NCT03108287|Rabeprazole|rabeprazole|mesh-list
139447859|NCT03108287|Bismuth|bismuth|mesh-list
139447860|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139447861|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139447862|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139447863|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447864|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447865|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139447866|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139447867|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139447868|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139447869|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139447870|NCT03108287|Antacids|antacids|mesh-ancestor
139447871|NCT02461121|Cyclosporine|cyclosporine|mesh-list
139447872|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
139447873|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
139447874|NCT02461121|Fludarabine|fludarabine|mesh-list
139447875|NCT02461121|Cyclosporins|cyclosporins|mesh-list
139447876|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139447877|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139447878|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
139447879|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447880|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139447881|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139447883|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447884|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447885|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139447886|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447887|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
139447888|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139447889|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
139447890|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139447891|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139447892|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139447893|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
139447894|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139447895|NCT00701363|Lanreotide|lanreotide|mesh-list
139447896|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447897|NCT02461043|Paclitaxel|paclitaxel|mesh-list
139447898|NCT02461043|Cisplatin|cisplatin|mesh-list
139447899|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139447900|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447901|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
139447902|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
139447903|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
139447904|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447905|NCT03296657|Fluorides|fluorides|mesh-list
139447906|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
139447907|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
139447908|NCT03296657|Protective Agents|protective agents|mesh-ancestor
139447909|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447910|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
139447911|NCT03296579|Aminophylline|aminophylline|mesh-list
139447912|NCT03296579|Albuterol|albuterol|mesh-list
139447913|NCT03296579|Ipratropium|ipratropium|mesh-list
139447914|NCT03296579|Analgesics|analgesics|mesh-ancestor
139447915|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
139447916|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447917|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447918|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
139447919|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447920|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139447921|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
139447922|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139447923|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139447924|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447925|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139447926|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
139447927|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139447928|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139447929|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
139447930|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139447931|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
139447932|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139447933|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139447934|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139447935|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
139447936|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139447937|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139447938|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
139447939|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139447940|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139447941|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447942|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139447943|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139447944|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
139447945|NCT03296579|Protective Agents|protective agents|mesh-ancestor
139447946|NCT02461667|Alendronate|alendronate|mesh-list
139447947|NCT02461667|Metformin|metformin|mesh-list
139447948|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139447949|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447950|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139447951|NCT01670877|Trastuzumab|trastuzumab|mesh-list
139447952|NCT01670877|Fulvestrant|fulvestrant|mesh-list
139447953|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139447954|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447955|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139234626|NCT04434300|Daptomycin|daptomycin|mesh-list
139447956|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139447957|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139447958|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
139447959|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139447960|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447961|NCT00701129|Rituximab|rituximab|mesh-list
139447962|NCT00701129|Methotrexate|methotrexate|mesh-list
139447963|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139447964|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447965|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
139447966|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447967|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139447968|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139447969|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
139447970|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139447971|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139447972|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
139447973|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139447974|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
139447975|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139447976|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139447977|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139447978|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139447979|NCT03296189|Dexamethasone|dexamethasone|mesh-list
139447980|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
139447981|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
139447982|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139447983|NCT03296189|BB 1101|bb 1101|mesh-list
139447984|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139447985|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
139447986|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
139447987|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139447988|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139447989|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139447990|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
139447991|NCT03296189|Hormones|hormones|mesh-ancestor
139447992|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139447993|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139447994|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139447995|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
139447996|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
139447997|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139447998|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
139447999|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
139448000|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448001|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448002|NCT03295955|Amoxicillin|amoxicillin|mesh-list
139448003|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
139448004|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
139448005|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139448006|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139448007|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448008|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139448009|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448010|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448011|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
139448012|NCT03298373|Nandrolone|nandrolone|mesh-list
139448013|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
139448014|NCT03298373|Androgens|androgens|mesh-ancestor
139448015|NCT03298373|Hormones|hormones|mesh-ancestor
139448016|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139448017|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448018|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
139448019|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139448020|NCT01670721|Leucovorin|leucovorin|mesh-list
139448021|NCT01670721|Fluorouracil|fluorouracil|mesh-list
139448022|NCT01670721|Irinotecan|irinotecan|mesh-list
139448023|NCT01670721|Aflibercept|aflibercept|mesh-list
139448024|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
139448025|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448026|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139448027|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448028|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139448029|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
139448030|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448031|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139448032|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139448033|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448034|NCT01670721|Antidotes|antidotes|mesh-ancestor
139448035|NCT01670721|Protective Agents|protective agents|mesh-ancestor
139448036|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
139448038|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
139448039|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139448040|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139448041|NCT01670721|Growth Substances|growth substances|mesh-ancestor
139448042|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
139448043|NCT03287427|Tislelizumab|tislelizumab|mesh-list
139448044|NCT03287427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139448045|NCT03287427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448046|NCT04491695|Tirofiban|tirofiban|mesh-list
139448047|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139448048|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139448049|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448050|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139448051|NCT04982055|Nadroparin|nadroparin|mesh-list
139448052|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
139448053|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139448054|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139448055|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448056|NCT04981743|Vitamin D|vitamin d|mesh-list
139448057|NCT04981743|Vitamins|vitamins|mesh-ancestor
139448058|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
139448059|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448060|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139448061|NCT04489121|Omalizumab|omalizumab|mesh-list
139448062|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139448063|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139448064|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
139448065|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
139448066|NCT04982211|Propranolol|propranolol|mesh-list
139448067|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139448068|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139448069|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
139448070|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448071|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448072|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448073|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139448074|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139448075|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
139448076|NCT03290963|Ketamine|ketamine|mesh-list
139448077|NCT03290963|Analgesics|analgesics|mesh-ancestor
139448078|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
139448079|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448080|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448081|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139448082|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139448083|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
139448084|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
139448085|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448086|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139448087|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139448088|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448089|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448090|NCT03294707|Coal Tar|coal tar|mesh-list
139448091|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
139448092|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
139448093|NCT03062319|Anticoagulants|anticoagulants|mesh-list
139448094|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139448095|NCT03290495|Ketamine|ketamine|mesh-list
139448096|NCT03290495|Analgesics|analgesics|mesh-ancestor
139448097|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
139448098|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448099|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448100|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139448101|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139448102|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
139448103|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
139448104|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448105|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139448106|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139448107|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448108|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448109|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
139448110|NCT04429893|Bupivacaine|bupivacaine|mesh-list
139448111|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
139448112|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
139448113|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448114|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448115|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
139448116|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448117|NCT04429893|Analgesics|analgesics|mesh-ancestor
139448118|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139448119|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
139448120|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139448121|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139448122|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448123|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139448124|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
139448125|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139448127|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
139448128|NCT03290417|Cholecalciferol|cholecalciferol|mesh-list
139448129|NCT03290417|Vitamins|vitamins|mesh-list
139448130|NCT03290417|Curcumin|curcumin|mesh-list
139448131|NCT03290417|Turmeric extract|turmeric extract|mesh-list
139448132|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
139448133|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448134|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139448135|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139448136|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139448137|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139448138|NCT03290417|Analgesics|analgesics|mesh-ancestor
139448139|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
139448140|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448141|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139448142|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139448143|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448144|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448145|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448146|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
139448147|NCT03290417|Protective Agents|protective agents|mesh-ancestor
139448148|NCT04429347|Gabapentin|gabapentin|mesh-list
139448149|NCT04429347|Tizanidine|tizanidine|mesh-list
139448150|NCT04429347|Analgesics|analgesics|mesh-ancestor
139448151|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
139448152|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448153|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448154|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
139448155|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139448156|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139448157|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448158|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139448159|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139448160|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139448161|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448162|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448163|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
139448164|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139448165|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139448166|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
139448167|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
139448168|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139448169|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139448170|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139448171|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
139448172|NCT03294551|Vaccines|vaccines|mesh-list
139448173|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
139448174|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448175|NCT04156581|Dexamethasone|dexamethasone|mesh-list
139448176|NCT04156581|Bupivacaine|bupivacaine|mesh-list
139448177|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139448178|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
139448179|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
139448180|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448181|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234854|NCT05071794|Propofol|propofol|mesh-list
139448182|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139448183|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
139448184|NCT04156581|Hormones|hormones|mesh-ancestor
139448185|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139448186|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139448187|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448188|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
139448189|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
139448190|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448191|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
139448192|NCT02983071|Fulvestrant|fulvestrant|mesh-list
139448193|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139448194|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448195|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139448196|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139448197|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
139106548|NCT04771728|Metronidazole|metronidazole|mesh-list
139448198|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139448199|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448200|NCT03294395|Gentamicins|gentamicins|mesh-list
139448201|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
139448202|NCT03294395|Ertapenem|ertapenem|mesh-list
139448203|NCT03294395|Fosfomycin|fosfomycin|mesh-list
139448204|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139448205|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448206|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139448207|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448208|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448209|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
139448210|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139448211|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139448212|NCT04980105|Prednisolone|prednisolone|mesh-list
139448213|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
139448214|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139448215|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
139448216|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
139448217|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139448218|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
139448219|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
139448220|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448221|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448222|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139448223|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
139448224|NCT04980105|Hormones|hormones|mesh-ancestor
139448225|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139448226|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139448227|NCT04980105|Protective Agents|protective agents|mesh-ancestor
139448228|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139448229|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448230|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139448231|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
139448232|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
139448233|NCT04973319|Trastuzumab|trastuzumab|mesh-list
139448234|NCT04973319|Pertuzumab|pertuzumab|mesh-list
139448235|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139448236|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448237|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
139448238|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139448239|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139448240|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448241|NCT03289871|Amorolfine|amorolfine|mesh-list
139448242|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
139448243|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448244|NCT03289637|Vitamin D|vitamin d|mesh-list
139448245|NCT03289637|Vitamins|vitamins|mesh-ancestor
139448246|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
139448247|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448248|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139448249|NCT04854837|Remdesivir|remdesivir|mesh-list
139448250|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
139448251|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448252|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
139448253|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448254|NCT03289559|Testosterone|testosterone|mesh-list
139448255|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139448256|NCT03289559|Androgens|androgens|mesh-ancestor
139448257|NCT03289559|Hormones|hormones|mesh-ancestor
139448258|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139448259|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448260|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139448262|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448263|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139448264|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
139448265|NCT03293927|Fentanyl|fentanyl|mesh-list
139448266|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
139448267|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139448268|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448269|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448270|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139448271|NCT03293927|Analgesics|analgesics|mesh-ancestor
139448272|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
139448273|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448274|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139448275|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139448276|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139448277|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
139448278|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448279|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448280|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139448281|NCT03293927|Narcotics|narcotics|mesh-ancestor
139448282|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139448283|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139448284|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
139448285|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
139448286|NCT02730429|Letrozole|letrozole|mesh-list
139448287|NCT02730429|Palbociclib|palbociclib|mesh-list
139448288|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448289|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139448290|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139448291|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448292|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448293|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139448294|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
139448295|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139448296|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448297|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139448298|NCT04971759|Fentanyl|fentanyl|mesh-list
139448299|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
139448300|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
139448301|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139448302|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448303|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448304|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139448305|NCT04971759|Analgesics|analgesics|mesh-ancestor
139448306|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
139448307|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448308|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139448309|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139448310|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139448311|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
139448312|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448313|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448314|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139448315|NCT04971759|Narcotics|narcotics|mesh-ancestor
139448316|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139448317|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139448318|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
139448319|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
139448320|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
139448321|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139448322|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139448323|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448324|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448325|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139448326|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139448327|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448328|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
139448329|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448330|NCT04979091|Hormones|hormones|mesh-list
139448331|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139448332|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448334|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139448335|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
139448336|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139448337|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139448338|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139448339|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139448340|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448341|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
139448342|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448343|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448344|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139448345|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139448346|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448347|NCT03107507|Levetiracetam|levetiracetam|mesh-list
139448348|NCT03107507|Phenobarbital|phenobarbital|mesh-list
139448349|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
139448350|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
139448351|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139448352|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448353|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448354|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139448355|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139448356|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448357|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448358|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
139448359|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
139448360|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139448361|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139448362|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139448363|NCT02711137|Paclitaxel|paclitaxel|mesh-list
139448364|NCT02711137|Gemcitabine|gemcitabine|mesh-list
139448365|NCT02711137|Azacitidine|azacitidine|mesh-list
139448366|NCT02711137|Rucaparib|rucaparib|mesh-list
139448367|NCT02711137|INCB057643|incb057643|mesh-list
139448368|NCT02711137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139448369|NCT02711137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448370|NCT02711137|Tubulin Modulators|tubulin modulators|mesh-ancestor
139448371|NCT02711137|Antimitotic Agents|antimitotic agents|mesh-ancestor
139448372|NCT02711137|Mitosis Modulators|mitosis modulators|mesh-ancestor
139448373|NCT02711137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448374|NCT02711137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139448375|NCT02711137|Antimetabolites|antimetabolites|mesh-ancestor
139448376|NCT02711137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448377|NCT02711137|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139448378|NCT04155411|Dasatinib|dasatinib|mesh-list
139448379|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448380|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139448381|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448382|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448383|NCT04970667|Flupenthixol|flupenthixol|mesh-list
139448384|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
139448385|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139448386|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139448387|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448388|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448389|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139448390|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139448391|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
139448392|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448393|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448394|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
139448395|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
139448396|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448397|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
139448398|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448399|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448400|NCT03288077|Tryptophan|tryptophan|mesh-list
139448401|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139448402|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
139448403|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139448404|NCT00777127|Diclofenac|diclofenac|mesh-list
139448405|NCT00777127|Imiquimod|imiquimod|mesh-list
139448406|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139448407|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139448409|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
139448410|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448411|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448412|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139448413|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139448414|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139448415|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448416|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448417|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139448418|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
139448419|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448420|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
139448421|NCT00761371|Imiquimod|imiquimod|mesh-list
139448422|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139448423|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
139448424|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448425|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448426|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
139448427|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
139448428|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
139448429|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448430|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448431|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139448432|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
139448433|NCT03287609|Evolocumab|evolocumab|mesh-list
139448434|NCT03287609|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139448435|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139448436|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139448437|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
139448438|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448439|NCT03287609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139448440|NCT03287609|Protease Inhibitors|protease inhibitors|mesh-ancestor
139448441|NCT03287609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448442|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139448443|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139448444|NCT03291821|Cetrorelix|cetrorelix|mesh-list
139448445|NCT03291821|Menotropins|menotropins|mesh-list
139448446|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139448447|NCT03291821|Ganirelix|ganirelix|mesh-list
139448448|NCT03291821|Hormones|hormones|mesh-ancestor
139448449|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139448450|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448451|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
139448452|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139448453|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
139448454|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139448455|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139448456|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139448457|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448458|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139448459|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
139448460|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
139448461|NCT02448901|Edoxaban|edoxaban|mesh-list
139448462|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139448463|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
139448464|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139448465|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
139448466|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448467|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448468|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
139448469|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
139448470|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139448471|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448472|NCT03291353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139448473|NCT03291353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448474|NCT02460341|Ondansetron|ondansetron|mesh-list
139448475|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
139448476|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
139448477|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448478|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448479|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139448480|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
139448481|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
139448482|NCT02460341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139448483|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139448485|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448486|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448487|NCT00189319|Flecainide|flecainide|mesh-list
139448488|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139448489|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139448490|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139448491|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139448492|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448493|NCT00189241|Imiquimod|imiquimod|mesh-list
139448494|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139448495|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
139448496|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448497|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448498|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
139448499|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
139448500|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139448501|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139448502|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139448503|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139448504|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448505|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
139448506|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448507|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448508|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139448509|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448510|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
139448511|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
139448512|NCT03286673|Calcium|calcium|mesh-list
139448513|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139448514|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448515|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139448516|NCT03286673|Antacids|antacids|mesh-ancestor
139448517|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448518|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139448519|NCT02448589|TAS-119|tas-119|mesh-list
139448520|NCT02448589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448521|NCT02448589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139448522|NCT02448589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448523|NCT02448589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448524|NCT02445703|Vaccines|vaccines|mesh-list
139448525|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
139448526|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448527|NCT03194659|Choline|choline|mesh-list
139448528|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
139448529|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139448530|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
139448531|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448532|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139448533|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139448534|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
139448535|NCT02445547|Hormones|hormones|mesh-list
139448536|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139448537|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448538|NCT03190603|Celecoxib|celecoxib|mesh-list
139448539|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139448540|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139448541|NCT03190603|Analgesics|analgesics|mesh-ancestor
139448542|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
139448543|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448544|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448545|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139448546|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139448547|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139448548|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139448549|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448550|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448551|NCT03285503|Aripiprazole|aripiprazole|mesh-list
139448552|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
139448553|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139448554|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139448555|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139448556|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448557|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448558|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
139448559|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
139448560|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448561|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448562|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139448563|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139448564|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
139448565|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139448566|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139448567|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139448568|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139448569|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
139448570|NCT02439697|Hematinics|hematinics|mesh-ancestor
139448571|NCT03284645|Tenofovir|tenofovir|mesh-list
139448572|NCT03284645|Lamivudine|lamivudine|mesh-list
139448573|NCT03284645|Zidovudine|zidovudine|mesh-list
139448574|NCT03284645|Efavirenz|efavirenz|mesh-list
139448575|NCT03284645|Abacavir|abacavir|mesh-list
139448576|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
139448577|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448578|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139448579|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139448580|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448581|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448582|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139448583|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139448584|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
139448585|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139448586|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139448587|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139448588|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139448589|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139448590|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139448591|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139448592|NCT03190447|Laxatives|laxatives|mesh-ancestor
139448593|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139448594|NCT03284177|Calcium|calcium|mesh-list
139448595|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139448596|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448597|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
139448598|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
139448599|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139448600|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139448601|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448602|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448603|NCT03192709|Urological Agents|urological agents|mesh-ancestor
139448604|NCT03283943|Durvalumab|durvalumab|mesh-list
139448605|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139448606|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448607|NCT02710045|Vaccines|vaccines|mesh-list
139448608|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
139448609|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448610|NCT02444767|Bimatoprost|bimatoprost|mesh-list
139448611|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139448612|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
139448613|NCT02443285|Cefotaxime|cefotaxime|mesh-list
139448614|NCT02443285|Cefoxitin|cefoxitin|mesh-list
139448615|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139448616|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448617|NCT03193957|Etanercept|etanercept|mesh-list
139448618|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139448619|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139448620|NCT03193957|Analgesics|analgesics|mesh-ancestor
139448621|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
139448622|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448623|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448624|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139448625|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139448626|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139448627|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139448628|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
139235314|NCT03044886|Vitamin D|vitamin d|mesh-list
139448629|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
139448630|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139448631|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
139448632|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448633|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448634|NCT02444611|Vaccines|vaccines|mesh-list
139448635|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
139448636|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
139448637|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448638|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139448639|NCT02438761|Gedatolisib|gedatolisib|mesh-list
139448640|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139448641|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448642|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448643|NCT03536429|Acetazolamide|acetazolamide|mesh-list
139448644|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
139448645|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139448646|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448647|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448648|NCT03536429|Diuretics|diuretics|mesh-ancestor
139448649|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
139448650|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448651|NCT02438683|BI 409306|bi 409306|mesh-list
139448652|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139448653|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448654|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448655|NCT03270839|Meclizine|meclizine|mesh-list
139448656|NCT03270839|Scopolamine|scopolamine|mesh-list
139448657|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139448658|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
139448659|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
139448660|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448661|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448662|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139448663|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
139448664|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139448665|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
139448666|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448667|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448668|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139448669|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139448670|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
139448671|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
139448672|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139448673|NCT02458547|Bupivacaine|bupivacaine|mesh-list
139448674|NCT02458547|Propofol|propofol|mesh-list
139448675|NCT02458547|Desflurane|desflurane|mesh-list
139448676|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
139448677|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
139448678|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448679|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448680|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
139448681|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448682|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139448683|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139448684|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
139448685|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139448686|NCT02458625|Iron|iron|mesh-list
139448687|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139448688|NCT02458625|Trace Elements|trace elements|mesh-ancestor
139448689|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
139448690|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448691|NCT02458625|Hematinics|hematinics|mesh-ancestor
139448692|NCT04978155|Anesthetics|anesthetics|mesh-list
139448693|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448694|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448695|NCT04970043|Pemetrexed|pemetrexed|mesh-list
139448696|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448697|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448698|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448699|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139448700|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139448701|NCT04977843|Dimercaprol|dimercaprol|mesh-list
139448702|NCT04977843|Chelating Agents|chelating agents|mesh-ancestor
139448703|NCT04977843|Sequestering Agents|sequestering agents|mesh-ancestor
139448704|NCT04977843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448705|NCT04432233|Metronidazole|metronidazole|mesh-list
139448706|NCT04432233|Levofloxacin|levofloxacin|mesh-list
139448707|NCT04432233|Esomeprazole|esomeprazole|mesh-list
139448708|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448709|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139448710|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139448711|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139448712|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139448713|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139448714|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139448715|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448716|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448717|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139448718|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139448719|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139448720|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448721|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139448722|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139448723|NCT03269747|Prednisone|prednisone|mesh-list
139448724|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139448725|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
139448726|NCT03269747|Hormones|hormones|mesh-ancestor
139448727|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139448728|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448729|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139448730|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448731|NCT04369469|Ravulizumab|ravulizumab|mesh-list
139448732|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139448733|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139448734|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
139448735|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448736|NCT03269591|Diclofenac|diclofenac|mesh-list
139448737|NCT03269591|Progesterone|progesterone|mesh-list
139448738|NCT03269591|Progestins|progestins|mesh-ancestor
139448739|NCT03269591|Hormones|hormones|mesh-ancestor
139448740|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139448741|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448742|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139448743|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139448744|NCT03269591|Analgesics|analgesics|mesh-ancestor
139448745|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
139448746|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448747|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139448748|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139448749|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139448750|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448751|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448752|NCT03989609|Midazolam|midazolam|mesh-list
139448753|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
139448754|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139448755|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448756|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448757|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139448758|NCT03989609|Analgesics|analgesics|mesh-ancestor
139448759|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
139448760|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448761|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139448762|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139448763|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139448764|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
139448765|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448766|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448767|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139448768|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139448769|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139448770|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139448771|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139448772|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
139448773|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
139448774|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
139448775|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
139448776|NCT03988205|Cytarabine|cytarabine|mesh-list
139448777|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139448778|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
139642363|NCT01452451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235445|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448779|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448780|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448781|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
139448782|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448783|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139448784|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
139448785|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448786|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139448787|NCT03280277|Hematinics|hematinics|mesh-ancestor
139448788|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139448789|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139448790|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
139448791|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139448792|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448793|NCT03269279|Misoprostol|misoprostol|mesh-list
139448794|NCT03269279|Mifepristone|mifepristone|mesh-list
139448795|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139448796|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
139448797|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139448798|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448799|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139448800|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139448801|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
139448802|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139448803|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139448804|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139448805|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139448806|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
139448807|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139448808|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139448809|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
139448810|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139448811|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
139448812|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139448813|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139448814|NCT03278483|Rifampin|rifampin|mesh-list
139448815|NCT03278483|Isoniazid|isoniazid|mesh-list
139448816|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139448817|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
139448818|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139448819|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448820|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
139448821|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139448822|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448823|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448824|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139448825|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139448826|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139448827|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139448828|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139448829|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139448830|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139448831|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139448832|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
139448833|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139448834|NCT03268733|Folic Acid|folic acid|mesh-list
139448835|NCT03268733|Hematinics|hematinics|mesh-ancestor
139448836|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
139448837|NCT03268733|Vitamins|vitamins|mesh-ancestor
139448838|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
139448839|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448840|NCT03277391|Droperidol|droperidol|mesh-list
139448841|NCT03277391|Morphine|morphine|mesh-list
139448842|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139448843|NCT03277391|Narcotics|narcotics|mesh-ancestor
139448844|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448845|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448846|NCT03277391|Analgesics|analgesics|mesh-ancestor
139448847|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
139448848|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448849|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139448850|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
139448851|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
139448852|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139448853|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139448854|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139448855|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139448856|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139448857|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139448858|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
139448859|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448860|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448861|NCT03277001|Enoxaparin|enoxaparin|mesh-list
139448862|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
139448863|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139448864|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
139448865|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139448866|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
139448867|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448868|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448869|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
139448870|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139448871|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139448872|NCT03272711|Vortioxetine|vortioxetine|mesh-list
139448873|NCT03272711|Antidepressive Agents|antidepressive agents|mesh-ancestor
139448874|NCT03272711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139448875|NCT03272711|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139448876|NCT03272711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139448877|NCT03272711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448878|NCT03272711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448879|NCT03272711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139448880|NCT03272711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139448881|NCT03272711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139448882|NCT03272711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448883|NCT03272711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448884|NCT03272711|Serotonin Agents|serotonin agents|mesh-ancestor
139448885|NCT03272711|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139448886|NCT03272711|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139448887|NCT03272711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139448888|NCT03272711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139448889|NCT03267407|Fluconazole|fluconazole|mesh-list
139448890|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
139448891|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448892|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139448893|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139448894|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448895|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448896|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139448897|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
139448898|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139448899|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448900|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139448901|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139448902|NCT03267329|Telmisartan|telmisartan|mesh-list
139448903|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139448904|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139448905|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139448906|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448907|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
139448908|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448909|NCT05073965|Vitamin D|vitamin d|mesh-list
139448910|NCT05073965|Vitamins|vitamins|mesh-ancestor
139448911|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
139448912|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448913|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139448914|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
139448915|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139448916|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139448917|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448918|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
139448919|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448920|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448921|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
139448922|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139448923|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448924|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448925|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139448926|NCT05065775|Analgesics|analgesics|mesh-ancestor
139448927|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
139448928|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448929|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139448930|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139448931|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139448932|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
139448933|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448934|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448935|NCT03266159|Trametinib|trametinib|mesh-list
139448936|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448937|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139448938|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448939|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448940|NCT02458781|Metronidazole|metronidazole|mesh-list
139448941|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
139448942|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
139448943|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448944|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139448945|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139448946|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139448947|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139448948|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139448949|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448950|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448951|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139448952|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139448953|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139448954|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139448955|NCT04647383|Lemborexant|lemborexant|mesh-list
139448956|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139448957|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139448958|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448959|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139448960|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139448961|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448962|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448963|NCT02458157|Furosemide|furosemide|mesh-list
139448964|NCT02458157|Diuretics|diuretics|mesh-ancestor
139448965|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
139448966|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448967|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139448968|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139448969|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448970|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
139448971|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139448972|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139448973|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139448974|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139448975|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139448976|NCT02458079|Protective Agents|protective agents|mesh-ancestor
139448977|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448978|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
139448979|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139448980|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
139448981|NCT03264911|Amoxicillin|amoxicillin|mesh-list
139448982|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139448983|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139448984|NCT03265223|Ropivacaine|ropivacaine|mesh-list
139448985|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
139448986|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
139448987|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139448988|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139448989|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
139448990|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139448991|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
139448992|NCT02456363|Adalimumab|adalimumab|mesh-list
139448993|NCT02456363|Golimumab|golimumab|mesh-list
139448994|NCT02456363|Etanercept|etanercept|mesh-list
139448995|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139448996|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139448997|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139448998|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139448999|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139449000|NCT02456363|Analgesics|analgesics|mesh-ancestor
139449001|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
139449002|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449003|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449004|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139449005|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139449006|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
139449007|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449008|NCT03259607|Nicotine|nicotine|mesh-list
139449009|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139449010|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
139449011|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449012|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449013|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139449014|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139449015|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
139449016|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449017|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449018|NCT02456129|Itraconazole|itraconazole|mesh-list
139449019|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
139449020|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449021|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139449022|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139449023|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449024|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449025|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139449026|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
139449027|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139449028|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449029|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139449030|NCT03263741|Paclitaxel|paclitaxel|mesh-list
139449031|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139449032|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
139449033|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139449034|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449035|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
139449036|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
139449037|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
139449038|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449039|NCT02456207|Rituximab|rituximab|mesh-list
139449040|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139449041|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449042|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
139449043|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449044|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139449045|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
139449046|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
139449047|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139449048|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
139449049|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449050|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449051|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139449052|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
139449053|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139449054|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139449055|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139449056|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
139449057|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449058|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449059|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
139449060|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139449061|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
139449062|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
139449063|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139449064|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449065|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139449066|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139449067|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449068|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449069|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449070|NCT04976673|Triamcinolone|triamcinolone|mesh-list
139449071|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139449072|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139235783|NCT03707795|Hormones|hormones|mesh-ancestor
139449073|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139449074|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139449075|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
139449076|NCT04976673|Hormones|hormones|mesh-ancestor
139449077|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139449078|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449079|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139449080|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
139449081|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449082|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449083|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
139449084|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139449085|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139449086|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
139449087|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449088|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449089|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449090|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139449091|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449092|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
139449093|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139449094|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449095|NCT03263039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139449096|NCT03263039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449097|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
139449098|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449099|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
139449100|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139449101|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139449102|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449103|NCT03262961|Urological Agents|urological agents|mesh-ancestor
139449104|NCT01670097|Dexamethasone|dexamethasone|mesh-list
139449105|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139449106|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
139449107|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
139449108|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449109|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449110|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139449111|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
139449112|NCT01670097|Hormones|hormones|mesh-ancestor
139449113|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139449114|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139449115|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449116|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
139449117|NCT03257423|Metronidazole|metronidazole|mesh-list
139449118|NCT03257423|Levofloxacin|levofloxacin|mesh-list
139449119|NCT03257423|Ertapenem|ertapenem|mesh-list
139449120|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139449121|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449122|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139449123|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139449124|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449125|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449126|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449127|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139449128|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139449129|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139449130|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139449131|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139449132|NCT01670019|Asenapine|asenapine|mesh-list
139449133|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139449134|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139449135|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449136|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449137|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139449138|NCT03262727|Deucravacitinib|deucravacitinib|mesh-list
139449139|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139449140|NCT03262727|Norethindrone|norethindrone|mesh-list
139449141|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
139449142|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
139235818|NCT05681429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235819|NCT05681429|Antipyretics|antipyretics|mesh-ancestor
139235820|NCT05681429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139449143|NCT03262727|Estradiol|estradiol|mesh-list
139449144|NCT03262727|Estrogens|estrogens|mesh-ancestor
139449145|NCT03262727|Hormones|hormones|mesh-ancestor
139449146|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139449147|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449148|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139449149|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
139449150|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139449151|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139449152|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139449153|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139449154|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139449155|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
139449156|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139449157|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449158|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449159|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139449160|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
139449161|NCT04975971|Dexamethasone|dexamethasone|mesh-list
139449162|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139449163|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
139449164|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
139449165|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449166|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449167|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139449168|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
139449169|NCT04975971|Hormones|hormones|mesh-ancestor
139449170|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139449171|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139449172|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449173|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
139449174|NCT03062163|Resveratrol|resveratrol|mesh-list
139449175|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
139449176|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449177|NCT03062163|Protective Agents|protective agents|mesh-ancestor
139449178|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449179|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449180|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139449181|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
139449182|NCT03062163|Vitamins|vitamins|mesh-ancestor
139449183|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
139449184|NCT02456597|Lidocaine|lidocaine|mesh-list
139449185|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
139449186|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
139449187|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449188|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449189|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
139449190|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449191|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139449192|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139449193|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139449194|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139449195|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449196|NCT03261635|Indomethacin|indomethacin|mesh-list
139449197|NCT03261635|Ranibizumab|ranibizumab|mesh-list
139449198|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139449199|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139449200|NCT03261635|Growth Substances|growth substances|mesh-ancestor
139449201|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449202|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
139449203|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449204|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139449205|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139449206|NCT03261635|Analgesics|analgesics|mesh-ancestor
139449207|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
139449208|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449209|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139449210|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139449211|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
139449212|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
139449213|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139449214|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139449215|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449216|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449217|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
139449218|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139449219|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139449220|NCT03059979|Prednisolone|prednisolone|mesh-list
139449221|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
139449222|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139449223|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
139449224|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139449225|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
139449226|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
139449227|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449228|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449229|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139449230|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
139449231|NCT03059979|Hormones|hormones|mesh-ancestor
139449232|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139449233|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139449234|NCT03059979|Protective Agents|protective agents|mesh-ancestor
139449235|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139449236|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449237|NCT03256721|Docetaxel|docetaxel|mesh-list
139449238|NCT03256721|Pemetrexed|pemetrexed|mesh-list
139449239|NCT03256721|Apatinib|apatinib|mesh-list
139449240|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449241|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
139449242|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
139449243|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
139449244|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449245|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449246|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139449247|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139449248|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139449249|NCT04967859|Gentamicins|gentamicins|mesh-list
139449250|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139449251|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449252|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139449253|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449254|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449255|NCT03256487|Morphine|morphine|mesh-list
139449256|NCT03256487|Buprenorphine|buprenorphine|mesh-list
139449257|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139449258|NCT03256487|Narcotics|narcotics|mesh-ancestor
139449259|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449260|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449261|NCT03256487|Analgesics|analgesics|mesh-ancestor
139449262|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
139449263|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449264|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139449265|NCT03061227|Glucagon|glucagon|mesh-list
139449266|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139449267|NCT03061227|Hormones|hormones|mesh-ancestor
139449268|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139449269|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449270|NCT03261791|Apatinib|apatinib|mesh-list
139449271|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449272|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139449273|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449274|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449275|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
139449276|NCT03060603|Hematinics|hematinics|mesh-ancestor
139449277|NCT04488107|Letrozole|letrozole|mesh-list
139449278|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449279|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139449280|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139449281|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449282|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449283|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139449284|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
139449285|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139449286|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449287|NCT04974723|Teriparatide|teriparatide|mesh-list
139449288|NCT04974723|Abaloparatide|abaloparatide|mesh-list
139449289|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139449290|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449291|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139449292|NCT03060681|Bupivacaine|bupivacaine|mesh-list
139449293|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
139449294|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
139449295|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449296|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449297|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
139449298|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449299|NCT03254849|Empagliflozin|empagliflozin|mesh-list
139449300|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139449301|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139449302|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449303|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139449304|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449305|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139449306|NCT03254849|Diuretics|diuretics|mesh-ancestor
139449307|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
139449308|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139449309|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139449310|NCT04963881|Antibodies|antibodies|mesh-list
139449311|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
139449312|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449313|NCT04432155|Xenon|xenon|mesh-list
139449314|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139449315|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
139449316|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
139449317|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449318|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449319|NCT04487951|Vitamin D|vitamin d|mesh-list
139449320|NCT04487951|Vitamins|vitamins|mesh-ancestor
139449321|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
139449322|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449323|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139449324|NCT04963257|Aripiprazole|aripiprazole|mesh-list
139449325|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
139449326|NCT04963257|Sertraline|sertraline|mesh-list
139449327|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
139449328|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139449329|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139449330|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139449331|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449332|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449333|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
139449334|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
139449335|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449336|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449337|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139449338|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139449339|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
139449340|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139449341|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139449342|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139449343|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139449344|NCT04963257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139449345|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139449346|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139449347|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139449348|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139449349|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139449350|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139449351|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449352|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139449353|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
139449354|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
139449355|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449356|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
139449357|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449358|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449359|NCT04953741|Fluticasone|fluticasone|mesh-list
139449360|NCT04953741|Xhance|xhance|mesh-list
139449361|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139449362|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139449363|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
139449364|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449365|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449366|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139449367|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
139449368|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
139449369|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139449370|NCT03259919|Metformin|metformin|mesh-list
139449371|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139449372|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449373|NCT04965831|Aflutinib|aflutinib|mesh-list
139449374|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139449375|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449376|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449377|NCT04953117|Paclitaxel|paclitaxel|mesh-list
139449378|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139449379|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449380|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
139449381|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
139449382|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
139449383|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449384|NCT03259529|Rituximab|rituximab|mesh-list
139449385|NCT03259529|Nivolumab|nivolumab|mesh-list
139449386|NCT03259529|Gemcitabine|gemcitabine|mesh-list
139449387|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139449388|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139449389|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449390|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
139449391|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449392|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139449393|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139449394|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
139449395|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449396|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139449397|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139449398|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
139449399|NCT03252665|Nicorandil|nicorandil|mesh-list
139449400|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
139449401|NCT03252665|Alprostadil|alprostadil|mesh-list
139449402|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
139449403|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139449404|NCT03252665|Urological Agents|urological agents|mesh-ancestor
139449405|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139449406|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139449407|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
139449408|NCT03252665|Vitamins|vitamins|mesh-ancestor
139449409|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
139449410|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449411|NCT03059667|Carboplatin|carboplatin|mesh-list
139449412|NCT03059667|Etoposide|etoposide|mesh-list
139449413|NCT03059667|Atezolizumab|atezolizumab|mesh-list
139449414|NCT03059667|Topotecan|topotecan|mesh-list
139449415|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449416|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139449417|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139449418|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139449419|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449420|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449421|NCT03059667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139449422|NCT03059667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139449423|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139449424|NCT03058419|Midazolam|midazolam|mesh-list
139449425|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
139449426|NCT03058419|Caffeine|caffeine|mesh-list
139449427|NCT03058419|Bupropion|bupropion|mesh-list
139449428|NCT03058419|Omeprazole|omeprazole|mesh-list
139449429|NCT03058419|Warfarin|warfarin|mesh-list
139449430|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139449431|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139449432|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449433|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449434|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139449435|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139449436|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139449437|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139449438|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
139449439|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
139449440|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
139449441|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
139449442|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449443|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449444|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
139449445|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139449446|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139449447|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449448|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139449449|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139449450|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
139449451|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139449452|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139449453|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139449454|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139449455|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
139449456|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139449457|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139449458|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139449459|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
139449460|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139449461|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139449462|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
139449463|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
139449464|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139449465|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139449467|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139449468|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
139449469|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139449470|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449471|NCT02455271|Eszopiclone|eszopiclone|mesh-list
139449472|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139449473|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449474|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449475|NCT04964583|Azithromycin|azithromycin|mesh-list
139449476|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
139449477|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139449478|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449479|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
139449480|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139449481|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139449482|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449483|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449484|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139449485|NCT03251417|Irinotecan|irinotecan|mesh-list
139449486|NCT03251417|Apatinib|apatinib|mesh-list
139449487|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139449488|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139449489|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449490|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449491|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449492|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139449493|NCT04961931|Empagliflozin|empagliflozin|mesh-list
139449494|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139449495|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449496|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139449497|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449498|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
139449499|NCT02454881|Oxycodone|oxycodone|mesh-list
139449500|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139449501|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449502|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449503|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139449504|NCT02454881|Analgesics|analgesics|mesh-ancestor
139449505|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
139449506|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449507|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139449508|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139449509|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139449510|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
139449511|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139382647|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139449512|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449513|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139449514|NCT02454881|Narcotics|narcotics|mesh-ancestor
139449515|NCT03058341|Propofol|propofol|mesh-list
139449516|NCT03058341|Sevoflurane|sevoflurane|mesh-list
139449517|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139236191|NCT04869371|Prednisone|prednisone|mesh-list
139449518|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449519|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449520|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139449521|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
139449522|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
139449523|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139449524|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139449525|NCT04951791|SMOFlipid|smoflipid|mesh-list
139449526|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139449527|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139449528|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139449529|NCT04951713|Clarithromycin|clarithromycin|mesh-list
139449530|NCT04951713|Rifampin|rifampin|mesh-list
139449531|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139449532|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449533|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139449534|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449535|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449536|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139449537|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139449538|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139449539|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
139449540|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
139449541|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139449542|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139449543|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139449544|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139449545|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139449546|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139449547|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139449548|NCT04944069|Bevacizumab|bevacizumab|mesh-list
139449549|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139449550|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449551|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139449552|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139449553|NCT04944069|Growth Substances|growth substances|mesh-ancestor
139449554|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449555|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
139449556|NCT04951167|Norepinephrine|norepinephrine|mesh-list
139449557|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139449558|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139449559|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
139449560|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449561|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449562|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449563|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
139449564|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
139449565|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449566|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139449567|NCT04950933|Riluzole|riluzole|mesh-list
139449568|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
139449569|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139449570|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139449571|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449572|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449573|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449574|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139449575|NCT04950933|Protective Agents|protective agents|mesh-ancestor
139449576|NCT04961307|Trastuzumab|trastuzumab|mesh-list
139449577|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139449578|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449579|NCT03058263|Neostigmine|neostigmine|mesh-list
139449580|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139449581|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449582|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449583|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
139449584|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449585|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449586|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139449587|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
139449588|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449589|NCT04415853|Irinotecan|irinotecan|mesh-list
139449590|NCT04415853|Tegafur|tegafur|mesh-list
139449591|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139449592|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139449593|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449594|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449595|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449596|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139449597|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
139449598|NCT04415151|Tofacitinib|tofacitinib|mesh-list
139449599|NCT04415151|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139449600|NCT04415151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139449601|NCT04415151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449602|NCT04415151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449603|NCT03059277|Aflibercept|aflibercept|mesh-list
139449604|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139449605|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139449606|NCT03059277|Growth Substances|growth substances|mesh-ancestor
139449607|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449608|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
139449609|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449610|NCT00700817|Metformin|metformin|mesh-list
139449611|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139449612|NCT00700817|Liraglutide|liraglutide|mesh-list
139449613|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139449614|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449615|NCT00700817|Incretins|incretins|mesh-ancestor
139449616|NCT00700817|Hormones|hormones|mesh-ancestor
139449617|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139449618|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139449619|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
139449620|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449621|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449622|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139449623|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
139449624|NCT04960293|Coagulants|coagulants|mesh-ancestor
139449625|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139449626|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449627|NCT04941417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139449628|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449629|NCT04948125|Apatinib|apatinib|mesh-list
139449630|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449631|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139449632|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449633|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449634|NCT02455115|Chromium|chromium|mesh-list
139449635|NCT02455115|Norepinephrine|norepinephrine|mesh-list
139449636|NCT02455115|Edetic Acid|edetic acid|mesh-list
139449637|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
139449638|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139449639|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139449640|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
139449641|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449642|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449643|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449644|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
139449645|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
139449646|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449647|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139449648|NCT02455115|Trace Elements|trace elements|mesh-ancestor
139449649|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
139449650|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
139449651|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139449652|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
139449653|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
139449654|NCT02455115|Antidotes|antidotes|mesh-ancestor
139449655|NCT02455115|Protective Agents|protective agents|mesh-ancestor
139449656|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139449657|NCT03094247|Amoxicillin|amoxicillin|mesh-list
139449658|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139449659|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449660|NCT04947423|Scopolamine|scopolamine|mesh-list
139449661|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139449662|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
139449663|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
139449664|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449665|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236340|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
139449666|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139449667|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
139449668|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139449669|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
139449670|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449671|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449672|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139449673|NCT03250481|Oxycodone|oxycodone|mesh-list
139449674|NCT03250481|Propofol|propofol|mesh-list
139449675|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139449676|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449677|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449678|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139449679|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
139449680|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
139449681|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139449682|NCT03250481|Narcotics|narcotics|mesh-ancestor
139449683|NCT03250481|Analgesics|analgesics|mesh-ancestor
139449684|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
139449685|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449686|NCT04947267|Epinephrine|epinephrine|mesh-list
139449687|NCT04947267|Mepivacaine|mepivacaine|mesh-list
139449688|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139449689|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139449690|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
139449691|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449692|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449693|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449694|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139449695|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139449696|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
139449697|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449698|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139449699|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
139449700|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
139449701|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
139449702|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139449703|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
139449704|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
139449705|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449706|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
139449707|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
139449708|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139449709|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
139449710|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449711|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139449712|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139449713|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
139449714|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449715|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449716|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139449717|NCT04423731|Leucovorin|leucovorin|mesh-list
139449718|NCT04423731|Paclitaxel|paclitaxel|mesh-list
139449719|NCT04423731|Gemcitabine|gemcitabine|mesh-list
139449720|NCT04423731|Fluorouracil|fluorouracil|mesh-list
139449721|NCT04423731|Folfirinox|folfirinox|mesh-list
139449722|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139449723|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449724|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
139449725|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
139449726|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
139449727|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449728|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139449729|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
139449730|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139449731|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
139449732|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449733|NCT04423731|Antidotes|antidotes|mesh-ancestor
139449734|NCT04423731|Protective Agents|protective agents|mesh-ancestor
139449735|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
139449736|NCT04423731|Vitamins|vitamins|mesh-ancestor
139449737|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
139449738|NCT04947111|Antibodies|antibodies|mesh-list
139449739|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
139449740|NCT04947111|Antibodies, Blocking|antibodies, blocking|mesh-list
139449741|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
139449742|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449743|NCT04947345|Propofol|propofol|mesh-list
139449744|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139449745|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449746|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449747|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139449748|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
139449749|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
139449750|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139449751|NCT03249311|Milnacipran|milnacipran|mesh-list
139449752|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
139449753|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139449754|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139449755|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139449756|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449757|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449758|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449759|NCT03249311|Analgesics|analgesics|mesh-ancestor
139449760|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
139449761|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449762|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
139449763|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139449764|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
139449765|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139449766|NCT02454491|Verapamil|verapamil|mesh-list
139449767|NCT02454491|Heparin|heparin|mesh-list
139449768|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
139449769|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139449770|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139449771|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449772|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139449773|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139449774|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139449775|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139449776|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449777|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
139449778|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
139449779|NCT03248765|Narcotics|narcotics|mesh-ancestor
139449780|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449781|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449782|NCT03248765|Analgesics|analgesics|mesh-ancestor
139449783|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
139449784|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449785|NCT04939857|Trimetazidine|trimetazidine|mesh-list
139449786|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
139449787|NCT04939779|Delpazolid|delpazolid|mesh-list
139449788|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
139449789|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139449790|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449791|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139449792|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449793|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449794|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
139449795|NCT03247595|Bisacodyl|bisacodyl|mesh-list
139449796|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139449797|NCT03247595|Cathartics|cathartics|mesh-ancestor
139449798|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139449799|NCT03247595|Laxatives|laxatives|mesh-ancestor
139449800|NCT03247283|Linrodostat|linrodostat|mesh-list
139449801|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449802|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449803|NCT04938297|Rituximab|rituximab|mesh-list
139449804|NCT04938297|Lenalidomide|lenalidomide|mesh-list
139449805|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
139449806|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139449807|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449808|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
139449809|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449810|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139449811|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139449812|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139449813|NCT04938297|Growth Substances|growth substances|mesh-ancestor
139449814|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
139449815|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139449816|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449817|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449818|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
139449819|NCT02625909|Velpatasvir|velpatasvir|mesh-list
139449820|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
139449821|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449822|NCT03246659|Polygeline|polygeline|mesh-list
139449823|NCT03246659|Gastrins|gastrins|mesh-list
139449824|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
139449825|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
139449826|NCT03246659|Hormones|hormones|mesh-ancestor
139449827|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139449828|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449829|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
139449830|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139449831|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
139449832|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449833|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449834|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139449835|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
139449836|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
139449837|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139449838|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
139449839|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449840|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449841|NCT03246113|Temozolomide|temozolomide|mesh-list
139449842|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139449843|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
139449844|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449845|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449846|NCT04937673|Paclitaxel|paclitaxel|mesh-list
139449847|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139449848|NCT04937673|Cisplatin|cisplatin|mesh-list
139449849|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139449850|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449851|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
139449852|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
139449853|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
139449854|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449855|NCT04944381|Vaccines|vaccines|mesh-list
139449856|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
139449857|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449858|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
139449859|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139449860|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449861|NCT03245177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139449862|NCT03245177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449863|NCT03245333|Hormones|hormones|mesh-list
139449864|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139449865|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449866|NCT04958187|Mitogens|mitogens|mesh-list
139449867|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
139449868|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449869|NCT03244319|Warfarin|warfarin|mesh-list
139449870|NCT03244319|Edoxaban|edoxaban|mesh-list
139449871|NCT03244319|Anticoagulants|anticoagulants|mesh-list
139449872|NCT03244319|Coagulants|coagulants|mesh-list
139449873|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139449874|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
139449875|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139449876|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
139449877|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449878|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449879|NCT03244553|Prucalopride|prucalopride|mesh-list
139449880|NCT03244553|Laxatives|laxatives|mesh-ancestor
139449881|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139449882|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139449883|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139449884|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
139449885|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139449886|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449887|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449888|NCT03244241|Insulin|insulin|mesh-list
139449889|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139449890|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449891|NCT03243851|Metformin|metformin|mesh-list
139449892|NCT03243851|Temozolomide|temozolomide|mesh-list
139449893|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139449894|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642364|NCT01452451|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139449895|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139449896|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
139449897|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449898|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449899|NCT02623959|Doxycycline|doxycycline|mesh-list
139449900|NCT02623959|Fentanyl|fentanyl|mesh-list
139449901|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139449902|NCT02623959|Narcotics|narcotics|mesh-ancestor
139449903|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449904|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449905|NCT02623959|Analgesics|analgesics|mesh-ancestor
139449906|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
139449907|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449908|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139449909|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139449910|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
139449911|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
139449912|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139449913|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449914|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
139449915|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139449916|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139449917|NCT03242993|Folic Acid|folic acid|mesh-list
139449918|NCT03242993|Hematinics|hematinics|mesh-ancestor
139449919|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
139449920|NCT03242993|Vitamins|vitamins|mesh-ancestor
139449921|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
139449922|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449923|NCT04487093|Vaccines|vaccines|mesh-list
139449924|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
139449925|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449926|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
139449927|NCT04936971|Everolimus|everolimus|mesh-list
139449928|NCT04936971|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139449929|NCT04936971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139449930|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449931|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449932|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139449933|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
139449934|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449935|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449936|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139449937|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139449938|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
139449939|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139449940|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449941|NCT04931433|Lidocaine|lidocaine|mesh-list
139449942|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
139449943|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
139449944|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139449945|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449946|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
139449947|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139449948|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139449949|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139449950|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139449951|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139449952|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449953|NCT04931121|Viscosupplements|viscosupplements|mesh-list
139449954|NCT04931121|Protective Agents|protective agents|mesh-ancestor
139449955|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449956|NCT03241901|Lumefantrine|lumefantrine|mesh-list
139449957|NCT03241901|Artemether|artemether|mesh-list
139449958|NCT03241901|Primaquine|primaquine|mesh-list
139449959|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139449960|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
139449961|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139449962|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139449963|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139449964|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
139449965|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139449966|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139449967|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449968|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449969|NCT03241043|Tacrolimus|tacrolimus|mesh-list
139449970|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139449971|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
139449972|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449973|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139449974|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449975|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449976|NCT02453867|Tacrolimus|tacrolimus|mesh-list
139449977|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139449978|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
139449979|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449980|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139449981|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139449982|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449983|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139449984|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
139449985|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
139449986|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139449987|NCT03239327|Alprostadil|alprostadil|mesh-list
139449988|NCT03239327|Misoprostol|misoprostol|mesh-list
139449989|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139449990|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
139449991|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139449992|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139449993|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139449994|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139449995|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
139449996|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139449997|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
139449998|NCT03239327|Urological Agents|urological agents|mesh-ancestor
139449999|NCT04930185|Vaccines|vaccines|mesh-list
139450000|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
139450001|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450002|NCT02314559|Propofol|propofol|mesh-list
139450003|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139450004|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139450005|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450006|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139450007|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
139450008|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
139450009|NCT03238703|Tamoxifen|tamoxifen|mesh-list
139450010|NCT03238703|Toremifene|toremifene|mesh-list
139450011|NCT03238703|Letrozole|letrozole|mesh-list
139450012|NCT03238703|Anastrozole|anastrozole|mesh-list
139450013|NCT03238703|Exemestane|exemestane|mesh-list
139450014|NCT03238703|Citric Acid|citric acid|mesh-list
139450015|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
139450016|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
139450017|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139450018|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
139450019|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
139450020|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450021|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450022|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139450023|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139450024|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450025|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139450026|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
139450027|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450028|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450029|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139450030|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139450031|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139450032|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139450033|NCT03238625|Lidocaine|lidocaine|mesh-list
139450034|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
139450035|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
139450036|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139450037|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450038|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
139450039|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450040|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139450041|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139450042|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139450043|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139450044|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450045|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
139450046|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139450047|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
139450048|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450049|NCT05387681|Endostatins|endostatins|mesh-list
139450050|NCT05387681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450051|NCT05387681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139450052|NCT05387681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139450053|NCT05387681|Growth Substances|growth substances|mesh-ancestor
139450054|NCT05387681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450055|NCT05387681|Growth Inhibitors|growth inhibitors|mesh-ancestor
139450056|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139450057|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139450058|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
139450059|NCT03238157|Hormones|hormones|mesh-ancestor
139450060|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450061|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450062|NCT04485845|Metformin|metformin|mesh-list
139450063|NCT04485845|Vildagliptin|vildagliptin|mesh-list
139450064|NCT04485845|Captopril|captopril|mesh-list
139450065|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139450066|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450067|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139450068|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
139450069|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450070|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450071|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139450072|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139450073|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139450074|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139450075|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139450076|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139450077|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450078|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
139450079|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450080|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450081|NCT03237533|Promethazine|promethazine|mesh-list
139450082|NCT03237533|Doxycycline|doxycycline|mesh-list
139450083|NCT03237533|Nystatin|nystatin|mesh-list
139450084|NCT03237533|Dexamethasone|dexamethasone|mesh-list
139450085|NCT03237533|Triamcinolone|triamcinolone|mesh-list
139450086|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139450087|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
139450088|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
139450089|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450090|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450091|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139450092|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
139450093|NCT03237533|Hormones|hormones|mesh-ancestor
139450094|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450095|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139450096|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450097|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450098|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139450099|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139450100|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
139450101|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139450102|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139450103|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
139450104|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
139450105|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139450106|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
139450107|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
139450108|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450109|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139450110|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
139450111|NCT03237533|Ionophores|ionophores|mesh-ancestor
139450112|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139450113|NCT03235973|Fludarabine|fludarabine|mesh-list
139450114|NCT03235973|Busulfan|busulfan|mesh-list
139450115|NCT03235973|Cladribine|cladribine|mesh-list
139450116|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450117|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450118|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139236787|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
139450119|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
139450120|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450121|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
139450122|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139450123|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139450124|NCT02453087|Rituximab|rituximab|mesh-list
139450125|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
139450126|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139450127|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450128|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
139450129|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450130|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139450131|NCT02124772|Trametinib|trametinib|mesh-list
139450132|NCT02124772|Dabrafenib|dabrafenib|mesh-list
139450133|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450134|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139450135|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450136|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450137|NCT02159482|Interferons|interferons|mesh-list
139450138|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
139450139|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
139450140|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450141|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
139450142|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139450143|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
139450144|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450145|NCT05269030|Ivermectin|ivermectin|mesh-list
139450146|NCT05269030|Budesonide|budesonide|mesh-list
139450147|NCT05269030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139450148|NCT05269030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139450149|NCT05269030|Autonomic Agents|autonomic agents|mesh-ancestor
139450150|NCT05269030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450151|NCT05269030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450152|NCT05269030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139450153|NCT05269030|Respiratory System Agents|respiratory system agents|mesh-ancestor
139450154|NCT05269030|Glucocorticoids|glucocorticoids|mesh-ancestor
139450155|NCT05269030|Hormones|hormones|mesh-ancestor
139450156|NCT05269030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450157|NCT05269030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139450158|NCT05269030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139450159|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
139450160|NCT02622321|Coagulants|coagulants|mesh-ancestor
139450161|NCT02187172|Ustekinumab|ustekinumab|mesh-list
139450162|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
139450163|NCT03057015|Dexamethasone|dexamethasone|mesh-list
139450164|NCT03057015|Clonidine|clonidine|mesh-list
139450165|NCT03057015|Epinephrine|epinephrine|mesh-list
139450166|NCT03057015|Ropivacaine|ropivacaine|mesh-list
139450167|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139450168|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
139450169|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
139450170|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450171|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450172|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139450173|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
139450174|NCT03057015|Hormones|hormones|mesh-ancestor
139450175|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450176|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139450177|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450178|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
139450179|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
139450180|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139450181|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
139450182|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139450183|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139108560|NCT01141452|Fluticasone|fluticasone|mesh-list
139450184|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
139450185|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450186|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450187|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139450188|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139450189|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139450190|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
139450191|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
139450192|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
139450193|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139450194|NCT03057015|Analgesics|analgesics|mesh-ancestor
139450195|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139450196|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
139450197|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139450198|NCT03057483|Vaccines|vaccines|mesh-list
139450199|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
139450200|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450201|NCT04922151|Ranibizumab|ranibizumab|mesh-list
139450202|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139450203|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139450204|NCT04922151|Growth Substances|growth substances|mesh-ancestor
139450205|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450206|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
139450207|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450208|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
139450209|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
139450210|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139450211|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
139450212|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450213|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139450214|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139450215|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
139450216|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139450217|NCT04920747|Taxane|taxane|mesh-list
139450218|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450219|NCT04927299|Losartan|losartan|mesh-list
139450220|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139450221|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
139450222|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139450223|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139450224|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139450225|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139450226|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450227|NCT04927299|Diuretics|diuretics|mesh-ancestor
139450228|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
139450229|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450230|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139450231|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139450232|NCT03056625|Vitamin A|vitamin a|mesh-list
139450233|NCT03056625|Vitamins|vitamins|mesh-ancestor
139450234|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
139450235|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450236|NCT04913103|Rituximab|rituximab|mesh-list
139450237|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139450238|NCT04913103|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139450239|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139450240|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450241|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
139450242|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450243|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139450244|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139450245|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
139450246|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450247|NCT04913103|Immunoconjugates|immunoconjugates|mesh-ancestor
139450248|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
139450249|NCT04920669|Bupivacaine|bupivacaine|mesh-list
139450250|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
139450251|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
139450252|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139450253|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450254|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
139450255|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450256|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139450257|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139450258|NCT04920669|Analgesics|analgesics|mesh-ancestor
139450259|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139450260|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139450261|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139450262|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
139450263|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450264|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450265|NCT04926753|Fluorouracil|fluorouracil|mesh-list
139450266|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450267|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
139450268|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450269|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139450270|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139450271|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
139450272|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450273|NCT02621931|Calcitonin|calcitonin|mesh-list
139642365|NCT01452451|Incretins|incretins|mesh-ancestor
139450274|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139450275|NCT02621931|Katacalcin|katacalcin|mesh-list
139450276|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139450277|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450278|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139450279|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
139450280|NCT04912167|Valsartan|valsartan|mesh-list
139450281|NCT04912167|Enalapril|enalapril|mesh-list
139450282|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139450283|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139450284|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139450285|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139450286|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450287|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139450288|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
139450289|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450290|NCT03056703|Aspirin|aspirin|mesh-list
139450291|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139450292|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139450293|NCT03056703|Analgesics|analgesics|mesh-ancestor
139450294|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
139450295|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450296|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450297|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139450298|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139450299|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139450300|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139450301|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450302|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139450303|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139450304|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450305|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
139450306|NCT02158936|Azacitidine|azacitidine|mesh-list
139450307|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139450308|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
139450309|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450310|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450311|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450312|NCT04924647|Dexamethasone|dexamethasone|mesh-list
139450313|NCT04924647|Lenalidomide|lenalidomide|mesh-list
139450314|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139450315|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
139450316|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
139450317|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450318|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450319|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139450320|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
139450321|NCT04924647|Hormones|hormones|mesh-ancestor
139450322|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450323|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139450324|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450325|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
139450326|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139450327|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139450328|NCT04924647|Growth Substances|growth substances|mesh-ancestor
139450329|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
139450330|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
139450331|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139450332|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
139450333|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450334|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450335|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139450336|NCT04912011|Diuretics|diuretics|mesh-ancestor
139450337|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
139450338|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
139450339|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139450340|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
139450341|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139450342|NCT04918719|Expectorants|expectorants|mesh-ancestor
139450343|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
139450344|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139450345|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
139450346|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450347|NCT04918719|Protective Agents|protective agents|mesh-ancestor
139450348|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450349|NCT04918719|Antidotes|antidotes|mesh-ancestor
139450350|NCT03056391|Acetaminophen|acetaminophen|mesh-list
139450351|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139450352|NCT03056391|Analgesics|analgesics|mesh-ancestor
139450353|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
139450354|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450355|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450356|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
139450357|NCT04924413|Tislelizumab|tislelizumab|mesh-list
139450358|NCT04924413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139450359|NCT04924413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450360|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
139450361|NCT04918563|Acetylcholine|acetylcholine|mesh-list
139450362|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
139450363|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139450364|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
139450365|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450366|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450367|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450368|NCT02123446|Cephalexin|cephalexin|mesh-list
139450369|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139450370|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139450371|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
139450372|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139450373|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139450374|NCT04918953|Prednisolone|prednisolone|mesh-list
139450375|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
139450376|NCT04918953|Budesonide|budesonide|mesh-list
139450377|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139450378|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
139450379|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139450380|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
139450381|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
139450382|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450383|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450384|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139450385|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
139450386|NCT04918953|Hormones|hormones|mesh-ancestor
139450387|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450388|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139450389|NCT04918953|Protective Agents|protective agents|mesh-ancestor
139450390|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139450391|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450392|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139450393|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139450394|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
139450395|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
139450396|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139450397|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139450398|NCT03054207|Clopidogrel|clopidogrel|mesh-list
139450399|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139450400|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139450401|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139450402|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139450403|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139450404|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
139450405|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450406|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450407|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450408|NCT02185534|Clopidogrel|clopidogrel|mesh-list
139450409|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139450410|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139450411|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139450412|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139450413|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
139450414|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450415|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450416|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450417|NCT03056079|Aflibercept|aflibercept|mesh-list
139450418|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139450419|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139450420|NCT03056079|Growth Substances|growth substances|mesh-ancestor
139450421|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450422|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
139450423|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450424|NCT02157376|Esomeprazole|esomeprazole|mesh-list
139450425|NCT02157376|Cimetidine|cimetidine|mesh-list
139450426|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139450427|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139450428|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139450429|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450430|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450431|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139450432|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
139450433|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
139450434|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450435|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450436|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139450437|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139450438|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139450439|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450440|NCT04922541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139450441|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450442|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
139450443|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139450444|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450445|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139450446|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450447|NCT03054285|Levetiracetam|levetiracetam|mesh-list
139450448|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
139450449|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
139450450|NCT04917627|Vancomycin|vancomycin|mesh-list
139450451|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139450452|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139450453|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
139450454|NCT04903743|Bupivacaine|bupivacaine|mesh-list
139450455|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
139450456|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
139450457|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139450458|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450459|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
139450460|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450461|NCT04903743|Analgesics|analgesics|mesh-ancestor
139450462|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139450463|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
139450464|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139450465|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139450466|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450467|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139450468|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
139450469|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139450470|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
139450471|NCT04903275|Fluorides|fluorides|mesh-list
139450472|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
139450473|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
139450474|NCT04903275|Protective Agents|protective agents|mesh-ancestor
139450475|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450476|NCT02121262|Dexamethasone|dexamethasone|mesh-list
139450477|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139450478|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
139450479|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
139450480|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450481|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450482|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139450483|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
139450484|NCT02121262|Hormones|hormones|mesh-ancestor
139450485|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450486|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139450487|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450488|NCT03053739|Bosentan|bosentan|mesh-list
139450489|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
139450490|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
139450491|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139450492|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139450493|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450494|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450495|NCT03053739|Urological Agents|urological agents|mesh-ancestor
139450496|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139642366|NCT01452451|Hormones|hormones|mesh-ancestor
139450497|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139450498|NCT04916925|Vitamin D|vitamin d|mesh-list
139450499|NCT04916925|Vitamins|vitamins|mesh-ancestor
139450500|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
139450501|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450502|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139450503|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
139450504|NCT04902027|Analgesics|analgesics|mesh-ancestor
139450505|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
139450506|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450507|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450508|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450509|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139450510|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139450511|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450512|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450513|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
139450514|NCT04902105|Valproic Acid|valproic acid|mesh-list
139450515|NCT04902105|Ecopipam|ecopipam|mesh-list
139450516|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
139450517|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450518|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450519|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
139450520|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450521|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450522|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
139450523|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139450524|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139450525|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139450526|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139450527|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139450528|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
139450529|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139450530|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139450531|NCT04902105|Analgesics|analgesics|mesh-ancestor
139450532|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
139450533|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450534|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139450535|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139450536|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139450537|NCT02120950|Aflibercept|aflibercept|mesh-list
139450538|NCT02120950|Verteporfin|verteporfin|mesh-list
139450539|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139450540|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139450541|NCT02120950|Growth Substances|growth substances|mesh-ancestor
139450542|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450543|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
139450544|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450545|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139450546|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
139450547|NCT02120794|Insulin|insulin|mesh-list
139450548|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139450549|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450550|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
139450551|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
139450552|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
139450553|NCT04900311|Paclitaxel|paclitaxel|mesh-list
139450554|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139450555|NCT04900311|Trastuzumab|trastuzumab|mesh-list
139450556|NCT04900311|Pertuzumab|pertuzumab|mesh-list
139450557|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139450558|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450559|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
139450560|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
139450561|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
139450562|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450563|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139450564|NCT02155738|Acetaminophen|acetaminophen|mesh-list
139450565|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139450566|NCT02155738|Analgesics|analgesics|mesh-ancestor
139450567|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
139450568|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450569|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450570|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
139450571|NCT03053505|Vancomycin|vancomycin|mesh-list
139237233|NCT04780581|Dexamethasone|dexamethasone|mesh-list
139450572|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
139450573|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139450575|NCT02181790|Acitretin|acitretin|mesh-list
139450576|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
139450577|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
139450578|NCT03051945|Ketamine|ketamine|mesh-list
139450579|NCT03051945|Analgesics|analgesics|mesh-ancestor
139450580|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
139450581|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450582|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450583|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139450584|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139450585|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
139450586|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
139450587|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139450588|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139450589|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139450590|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450591|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450592|NCT04899453|Rituximab|rituximab|mesh-list
139450593|NCT04899453|Methotrexate|methotrexate|mesh-list
139450594|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
139450595|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139450596|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450597|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
139450598|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450599|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139450600|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139450601|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
139450602|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139450603|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139450604|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
139450605|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450606|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
139450607|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450608|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139450609|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139450610|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139450611|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139450612|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139450613|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139450614|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450615|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
139450616|NCT04898751|Nivolumab|nivolumab|mesh-list
139450617|NCT04898751|Ipilimumab|ipilimumab|mesh-list
139450618|NCT04898751|Atezolizumab|atezolizumab|mesh-list
139450619|NCT04898751|Durvalumab|durvalumab|mesh-list
139450620|NCT04898751|Avelumab|avelumab|mesh-list
139450621|NCT04898751|Cemiplimab|cemiplimab|mesh-list
139450622|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139450623|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139450624|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450625|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450626|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
139450627|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139450628|NCT04898907|Mitogens|mitogens|mesh-list
139450629|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139450630|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139450631|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139450632|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139450633|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450634|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450635|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450636|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139450637|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
139450638|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139450639|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450640|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139450641|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139450642|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139450643|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
139450644|NCT04908813|Capecitabine|capecitabine|mesh-list
139450645|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
139450646|NCT04908813|Trastuzumab|trastuzumab|mesh-list
139450647|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139450648|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
139450649|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450650|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450651|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139450652|NCT04913571|Tislelizumab|tislelizumab|mesh-list
139450653|NCT04913571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139450654|NCT04913571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450655|NCT03051711|Pyrazole|pyrazole|mesh-list
139450656|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450657|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450658|NCT04908345|Fentanyl|fentanyl|mesh-list
139450659|NCT04908345|Methadone|methadone|mesh-list
139450660|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139450661|NCT04908345|Narcotics|narcotics|mesh-ancestor
139450662|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139450663|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450664|NCT04908345|Analgesics|analgesics|mesh-ancestor
139450665|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
139450666|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450667|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139450668|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139450669|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
139450670|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
139450671|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
139450672|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
139450673|NCT04893993|Thiamine|thiamine|mesh-list
139450674|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
139450675|NCT04893993|Vitamins|vitamins|mesh-ancestor
139450676|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
139450677|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450678|NCT03051243|Insulin|insulin|mesh-list
139450679|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139450680|NCT03051243|Linagliptin|linagliptin|mesh-list
139450681|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139450682|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450683|NCT03051243|Incretins|incretins|mesh-ancestor
139450684|NCT03051243|Hormones|hormones|mesh-ancestor
139450685|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450686|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139450687|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
139450688|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450689|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450690|NCT04897737|Tenofovir|tenofovir|mesh-list
139450691|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
139450692|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139450693|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139450694|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139450695|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450696|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450697|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139450698|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139450699|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
139450700|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139450701|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139450702|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450703|NCT04896177|Sirolimus|sirolimus|mesh-list
139450704|NCT04896177|Paclitaxel|paclitaxel|mesh-list
139450705|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139450706|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450707|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
139450708|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
139450709|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
139450710|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450711|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139450712|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139450713|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139450714|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
139450715|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139450716|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
139450717|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450718|NCT03052569|Agerafenib|agerafenib|mesh-list
139450719|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139450720|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450721|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450722|NCT04906317|Midazolam|midazolam|mesh-list
139450723|NCT04906317|Dezocine|dezocine|mesh-list
139237383|NCT03697746|Ibuprofen|ibuprofen|mesh-list
139450724|NCT04906317|Propofol|propofol|mesh-list
139450725|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139450726|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139450727|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450728|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139450729|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
139450730|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
139450731|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139450732|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139450733|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139450734|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139450735|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
139450736|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
139450737|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450738|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450739|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139450740|NCT04906317|Narcotics|narcotics|mesh-ancestor
139450741|NCT04906317|Analgesics|analgesics|mesh-ancestor
139450742|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
139450743|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450744|NCT03051087|Ganirelix|ganirelix|mesh-list
139450745|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
139450746|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450747|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450748|NCT04430361|Dexamethasone|dexamethasone|mesh-list
139450749|NCT04430361|Megestrol|megestrol|mesh-list
139450750|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
139450751|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139450752|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
139450753|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
139450754|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450755|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450756|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139450757|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
139450758|NCT04430361|Hormones|hormones|mesh-ancestor
139450759|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450760|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139450761|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450762|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139450763|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139450764|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139450765|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
139450766|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139450767|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139450768|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139450769|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
139450770|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139450771|NCT04906083|Mitogens|mitogens|mesh-list
139450772|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
139450773|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450774|NCT02616783|Lamivudine|lamivudine|mesh-list
139450775|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139450776|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139109183|NCT01244880|Ketamine|ketamine|mesh-list
139450777|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450778|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450779|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
139450780|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139450781|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139450782|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139450783|NCT04895007|Vaccines|vaccines|mesh-list
139450784|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
139450785|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450786|NCT04890561|Lemborexant|lemborexant|mesh-list
139450787|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139450788|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450789|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450790|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139450791|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139450792|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139450793|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450794|NCT04894617|Amantadine|amantadine|mesh-list
139450795|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139237455|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450796|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139450797|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
139450798|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139450799|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
139450800|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450801|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450802|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450803|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139450804|NCT04894617|Analgesics|analgesics|mesh-ancestor
139450805|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
139450806|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450807|NCT04397991|Furosemide|furosemide|mesh-list
139450808|NCT04397991|Diuretics|diuretics|mesh-ancestor
139450809|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
139450810|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450811|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139450812|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139450813|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450814|NCT04906161|Vitamin D|vitamin d|mesh-list
139450815|NCT04906161|Calcium|calcium|mesh-list
139450816|NCT04906161|Vitamins|vitamins|mesh-ancestor
139450817|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
139450818|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450819|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139450820|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139450821|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139450822|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
139450823|NCT03051009|Coagulants|coagulants|mesh-ancestor
139450824|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139450825|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
139450826|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450827|NCT04889781|Dexamethasone|dexamethasone|mesh-list
139450828|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
139450829|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139450830|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
139450831|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
139450832|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450833|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450834|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139450835|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
139450836|NCT04889781|Hormones|hormones|mesh-ancestor
139450837|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450838|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139450839|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450840|NCT02616393|XL647|xl647|mesh-list
139450841|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450842|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139450843|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450844|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450845|NCT04905147|Mosapride|mosapride|mesh-list
139450846|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139450847|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139450848|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
139450849|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450850|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450851|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450852|NCT03050229|Empagliflozin|empagliflozin|mesh-list
139450853|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139450854|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450855|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139450856|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450857|NCT04882683|Prednisone|prednisone|mesh-list
139450858|NCT04882683|Adalimumab|adalimumab|mesh-list
139450859|NCT04882683|Azathioprine|azathioprine|mesh-list
139450860|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139450861|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
139450862|NCT04882683|Hormones|hormones|mesh-ancestor
139450863|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139450864|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450865|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139450866|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450867|NCT04882683|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139450868|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139450869|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
139450870|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450871|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139450872|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139450873|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
139450874|NCT02155660|Benralizumab|benralizumab|mesh-list
139450875|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139450876|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
139450877|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139450878|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139450879|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139450880|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
139450881|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450882|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139450883|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139450884|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450885|NCT04880811|Afatinib|afatinib|mesh-list
139450886|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450887|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139450888|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450889|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450890|NCT02181634|Paclitaxel|paclitaxel|mesh-list
139450891|NCT02181634|Gemcitabine|gemcitabine|mesh-list
139450892|NCT02181634|Antimetabolites|antimetabolites|mesh-list
139450893|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139450894|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450895|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
139450896|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
139450897|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
139450898|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450899|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139450900|NCT04569045|Lidocaine|lidocaine|mesh-list
139450901|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
139450902|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
139450903|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139450904|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450905|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
139450906|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139450907|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139450908|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139450909|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139450910|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139450911|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450912|NCT04425291|Vaccines|vaccines|mesh-list
139450913|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
139450914|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450915|NCT04886193|Leucovorin|leucovorin|mesh-list
139450916|NCT04886193|Docetaxel|docetaxel|mesh-list
139450917|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
139450918|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450919|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
139450920|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
139450921|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
139450922|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450923|NCT04886193|Antidotes|antidotes|mesh-ancestor
139450924|NCT04886193|Protective Agents|protective agents|mesh-ancestor
139450925|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450926|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
139450927|NCT04886193|Vitamins|vitamins|mesh-ancestor
139450928|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
139450929|NCT04337073|Propofol|propofol|mesh-list
139450930|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139450931|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139450932|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450933|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139450934|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
139450935|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
139450936|NCT04885803|Vitamin D|vitamin d|mesh-list
139450937|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
139450938|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
139450939|NCT04885803|Vitamins|vitamins|mesh-list
139450940|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
139450941|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450942|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139450943|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139450944|NCT03049059|Hydroquinone|hydroquinone|mesh-list
139450945|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
139450946|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450947|NCT03049059|Protective Agents|protective agents|mesh-ancestor
139450948|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450949|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139450950|NCT04885413|Niraparib|niraparib|mesh-list
139450951|NCT04885413|Antibodies|antibodies|mesh-list
139450952|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
139450953|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450954|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139450955|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450956|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450957|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450958|NCT03049293|Midazolam|midazolam|mesh-list
139450959|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139450960|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139450961|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139450962|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139450963|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139450964|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139450965|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139450966|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139450967|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
139450968|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
139450969|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
139450970|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
139450971|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139450972|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450973|NCT01595529|Trimethoprim|trimethoprim|mesh-list
139450974|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
139450975|NCT01595529|Cephalexin|cephalexin|mesh-list
139450976|NCT01595529|Cefixime|cefixime|mesh-list
139450977|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139450978|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139450979|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
139450980|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139450981|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139450982|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139450983|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450984|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450985|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139450986|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139450987|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139450988|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139450989|NCT04368507|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
139450990|NCT04368507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450991|NCT05257395|Letrozole|letrozole|mesh-list
139450992|NCT05257395|Anastrozole|anastrozole|mesh-list
139450993|NCT05257395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139450994|NCT05257395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139450995|NCT05257395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139450996|NCT05257395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139450997|NCT05257395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139450998|NCT05257395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139450999|NCT05257395|Hormone Antagonists|hormone antagonists|mesh-ancestor
139451000|NCT05257395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139451001|NCT05257395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451002|NCT05257395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139451003|NCT05256693|Vancomycin|vancomycin|mesh-list
139451004|NCT05256693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139451005|NCT05256693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451006|NCT03046953|Avelumab|avelumab|mesh-list
139451007|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451008|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451009|NCT03047109|Phenylephrine|phenylephrine|mesh-list
139451010|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
139451011|NCT03047109|Ephedrine|ephedrine|mesh-list
139451012|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139451013|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
139451014|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
139451015|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451016|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451017|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
139451018|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139451019|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
139451020|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
139451021|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139237680|NCT03691818|Ibuprofen|ibuprofen|mesh-list
139451022|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139451032|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451033|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
139451034|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
139451035|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
139451036|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451038|NCT05256147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139451039|NCT05256147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139451040|NCT05256147|Analgesics|analgesics|mesh-ancestor
139451041|NCT05256147|Sensory System Agents|sensory system agents|mesh-ancestor
139451042|NCT05256147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451043|NCT05256147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451044|NCT05256147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139451045|NCT05256147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139451046|NCT05256147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139451047|NCT05256147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451048|NCT05256147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451049|NCT05214417|Ketamine|ketamine|mesh-list
139451050|NCT05214417|Analgesics|analgesics|mesh-ancestor
139451051|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
139451052|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451053|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451054|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139451055|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139451056|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
139451057|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
139451058|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139451059|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139451060|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139451061|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451062|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451072|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
139451073|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451074|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451075|NCT04387461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139451076|NCT04387461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451077|NCT03046719|Bupivacaine|bupivacaine|mesh-list
139451078|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
139451079|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
139451080|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139451081|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451082|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
139451083|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451084|NCT04876755|TEMPO|tempo|mesh-list
139451085|NCT04876755|TEMPOL-H|tempol-h|mesh-list
139451086|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
139451087|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451088|NCT04876755|Protective Agents|protective agents|mesh-ancestor
139451089|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451090|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139451091|NCT04876521|Olanzapine|olanzapine|mesh-list
139451092|NCT04876521|Amisulpride|amisulpride|mesh-list
139451093|NCT04876521|Fluoxetine|fluoxetine|mesh-list
139451094|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
139451095|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
139451096|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451097|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451098|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139451099|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139451100|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139451101|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139451102|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139451103|NCT04876521|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139451104|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139451105|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139451106|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451107|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451109|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139451110|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
139451111|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139451112|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139451113|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451114|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139451115|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
139451116|NCT02119156|Belimumab|belimumab|mesh-list
139451117|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139451118|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
139451119|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451120|NCT02181556|Aflibercept|aflibercept|mesh-list
139451121|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139451122|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139451123|NCT02181556|Growth Substances|growth substances|mesh-ancestor
139451124|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451125|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
139451126|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451127|NCT04865991|Propofol|propofol|mesh-list
139451128|NCT04865991|Sevoflurane|sevoflurane|mesh-list
139451129|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139451130|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139451131|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382684|NCT02120339|Carvedilol|carvedilol|mesh-list
139451132|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139451133|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
139451134|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
139451135|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139451136|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139451137|NCT04865211|Bupivacaine|bupivacaine|mesh-list
139451138|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
139451139|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
139451140|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139451141|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451142|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
139451143|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451144|NCT04865445|Midazolam|midazolam|mesh-list
139451145|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139451146|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139451147|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139451148|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451149|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139451150|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139451151|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139451152|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139451153|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
139451154|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
139451155|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
139451156|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
139451157|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451158|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451159|NCT04875819|Vaccines|vaccines|mesh-list
139451160|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139451161|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
139451162|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451163|NCT04864977|Insulin|insulin|mesh-list
139451164|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139451165|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451166|NCT03046173|Mitogens|mitogens|mesh-list
139451167|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
139451168|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451169|NCT04869579|Selenium|selenium|mesh-list
139451170|NCT04869579|Selenious Acid|selenious acid|mesh-list
139451171|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
139451172|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451173|NCT04869579|Protective Agents|protective agents|mesh-ancestor
139451174|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451175|NCT04869579|Trace Elements|trace elements|mesh-ancestor
139451176|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
139451177|NCT06212401|Dexmedetomidine|dexmedetomidine|mesh-list
139451178|NCT06212401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139451179|NCT06212401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139451180|NCT06212401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451181|NCT06212401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139451182|NCT06212401|Analgesics|analgesics|mesh-ancestor
139451183|NCT06212401|Sensory System Agents|sensory system agents|mesh-ancestor
139451184|NCT06212401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451185|NCT06212401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139451186|NCT06212401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139451187|NCT06212401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139451188|NCT06212401|Adrenergic Agents|adrenergic agents|mesh-ancestor
139451189|NCT06212401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451190|NCT06212401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451191|NCT06212336|Ribavirin|ribavirin|mesh-list
139451192|NCT06212336|Favipiravir|favipiravir|mesh-list
139451193|NCT06212336|Dexamethasone|dexamethasone|mesh-list
139451194|NCT06212336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139451195|NCT06212336|Antiemetics|antiemetics|mesh-ancestor
139451196|NCT06212336|Autonomic Agents|autonomic agents|mesh-ancestor
139451197|NCT06212336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451198|NCT06212336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451199|NCT06212336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139451200|NCT06212336|Glucocorticoids|glucocorticoids|mesh-ancestor
139451201|NCT06212336|Hormones|hormones|mesh-ancestor
139451202|NCT06212336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139451203|NCT06212336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139451204|NCT06212336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451205|NCT06212336|Antimetabolites|antimetabolites|mesh-ancestor
139451206|NCT06212336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451207|NCT06212336|Antiviral Agents|antiviral agents|mesh-ancestor
139451208|NCT06212336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451209|NCT06212271|Colchicine|colchicine|mesh-list
139451210|NCT06212271|Gout Suppressants|gout suppressants|mesh-ancestor
139451211|NCT06212271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139451212|NCT06212271|Tubulin Modulators|tubulin modulators|mesh-ancestor
139451213|NCT06212271|Antimitotic Agents|antimitotic agents|mesh-ancestor
139451214|NCT06212271|Mitosis Modulators|mitosis modulators|mesh-ancestor
139451215|NCT06212271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451216|NCT06212271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451217|NCT06211985|Arginine Vasopressin|arginine vasopressin|mesh-list
139451218|NCT06211985|Hemostatics|hemostatics|mesh-ancestor
139451219|NCT06211985|Coagulants|coagulants|mesh-ancestor
139451220|NCT06211985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139451221|NCT06211985|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139451222|NCT06211985|Natriuretic Agents|natriuretic agents|mesh-ancestor
139451223|NCT06211985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451224|NCT06211881|Gemcitabine|gemcitabine|mesh-list
139451225|NCT06211881|Vinorelbine|vinorelbine|mesh-list
139451226|NCT06211881|Mitoxantrone|mitoxantrone|mesh-list
139451227|NCT06211881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139451228|NCT06211881|Antimetabolites|antimetabolites|mesh-ancestor
139451229|NCT06211881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451230|NCT06211881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451231|NCT06211881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139451232|NCT06211881|Tubulin Modulators|tubulin modulators|mesh-ancestor
139451233|NCT06211881|Antimitotic Agents|antimitotic agents|mesh-ancestor
139451234|NCT06211881|Mitosis Modulators|mitosis modulators|mesh-ancestor
139451235|NCT06211881|Analgesics|analgesics|mesh-ancestor
139451236|NCT06211881|Sensory System Agents|sensory system agents|mesh-ancestor
139451237|NCT06211881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451238|NCT06211881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451239|NCT06211881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139451240|NCT06211881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139451241|NCT06211881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451242|NCT06211790|Everolimus|everolimus|mesh-list
139451243|NCT06211790|Tislelizumab|tislelizumab|mesh-list
139451244|NCT06211790|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139451245|NCT06211790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139451246|NCT06211790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451247|NCT06211790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451248|NCT06211790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139451249|NCT06211790|Immunologic Factors|immunologic factors|mesh-ancestor
139451250|NCT06211790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451251|NCT06211790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451252|NCT06211790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451253|NCT06211764|Gemcitabine|gemcitabine|mesh-list
139451254|NCT06211764|Mitomycins|mitomycins|mesh-list
139451255|NCT06211764|Mitomycin|mitomycin|mesh-list
139451256|NCT06211764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139451257|NCT06211764|Antimetabolites|antimetabolites|mesh-ancestor
139451258|NCT06211764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451259|NCT06211764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451260|NCT06211764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139451261|NCT06211764|Alkylating Agents|alkylating agents|mesh-ancestor
139451262|NCT06211764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139451263|NCT06211764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451264|NCT06211712|Kallikreins|kallikreins|mesh-list
139451265|NCT06211712|Coagulants|coagulants|mesh-ancestor
139451266|NCT06211712|Fertility Agents, Male|fertility agents, male|mesh-ancestor
139451267|NCT06211712|Fertility Agents|fertility agents|mesh-ancestor
139451268|NCT06211712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139451269|NCT06211712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451270|NCT06211478|Vitamin E|vitamin e|mesh-list
139451271|NCT06211478|Vitamins|vitamins|mesh-ancestor
139451272|NCT06211478|Micronutrients|micronutrients|mesh-ancestor
139451273|NCT06211478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451274|NCT06211478|Antioxidants|antioxidants|mesh-ancestor
139451275|NCT06211478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451276|NCT06211478|Protective Agents|protective agents|mesh-ancestor
139451277|NCT06211335|Pembrolizumab|pembrolizumab|mesh-list
139451278|NCT06211335|Losartan|losartan|mesh-list
139451279|NCT06211335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451280|NCT06211335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451281|NCT06211335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139451282|NCT06211335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451283|NCT06211335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139451284|NCT06211335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139451285|NCT06211335|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139451286|NCT06211335|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139451287|NCT06211114|Axitinib|axitinib|mesh-list
139451288|NCT06211114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451289|NCT06211114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139451290|NCT06211114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451291|NCT06211114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451292|NCT06211088|Famotidine|famotidine|mesh-list
139451293|NCT06211088|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139451294|NCT06211088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139451295|NCT06211088|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139451296|NCT06211088|Histamine Antagonists|histamine antagonists|mesh-ancestor
139451297|NCT06211088|Histamine Agents|histamine agents|mesh-ancestor
139451298|NCT06211088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451299|NCT06211088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451300|NCT06211088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451301|NCT06211036|Durvalumab|durvalumab|mesh-list
139451302|NCT06211036|AMG 757|amg 757|mesh-list
139451303|NCT06211036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451304|NCT06211036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451305|NCT06211023|Carboplatin|carboplatin|mesh-list
139451306|NCT06211023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451307|NCT06210984|Caffeine|caffeine|mesh-list
139451308|NCT06210984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139451309|NCT06210984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451310|NCT06210984|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139451311|NCT06210984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451312|NCT06210984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451313|NCT06210984|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139451314|NCT06210984|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139451315|NCT06210984|Purinergic Agents|purinergic agents|mesh-ancestor
139451316|NCT06210984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451317|NCT06210971|Capecitabine|capecitabine|mesh-list
139451318|NCT06210971|Irinotecan|irinotecan|mesh-list
139451319|NCT06210971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139451320|NCT06210971|Antimetabolites|antimetabolites|mesh-ancestor
139451321|NCT06210971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451322|NCT06210971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451323|NCT06210971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139451324|NCT06210971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139451325|NCT06210971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451326|NCT06210945|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
139451327|NCT06210945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451328|NCT06210750|Cytarabine|cytarabine|mesh-list
139451329|NCT06210750|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
139451330|NCT06210750|Dexamethasone|dexamethasone|mesh-list
139451331|NCT06210750|Dexamethasone acetate|dexamethasone acetate|mesh-list
139451332|NCT06210750|Cyclophosphamide|cyclophosphamide|mesh-list
139451333|NCT06210750|Doxorubicin|doxorubicin|mesh-list
139451334|NCT06210750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139451335|NCT06210750|Methotrexate|methotrexate|mesh-list
139451336|NCT06210750|Vincristine|vincristine|mesh-list
139451337|NCT06210750|Daunorubicin|daunorubicin|mesh-list
139451338|NCT06210750|Venetoclax|venetoclax|mesh-list
139451339|NCT06210750|Asparaginase|asparaginase|mesh-list
139451340|NCT06210750|Mercaptopurine|mercaptopurine|mesh-list
139451341|NCT06210750|Pegaspargase|pegaspargase|mesh-list
139451342|NCT06210750|Thioguanine|thioguanine|mesh-list
139451343|NCT06210750|Navitoclax|navitoclax|mesh-list
139451344|NCT06210750|BB 1101|bb 1101|mesh-list
139451345|NCT06210750|2-Aminopurine|2-aminopurine|mesh-list
139451346|NCT06210750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139451347|NCT06210750|Immunologic Factors|immunologic factors|mesh-ancestor
139451348|NCT06210750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451349|NCT06210750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139451350|NCT06210750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139451351|NCT06210750|Alkylating Agents|alkylating agents|mesh-ancestor
139451352|NCT06210750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451353|NCT06210750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451354|NCT06210750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139451355|NCT06210750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139451356|NCT06210750|Antiemetics|antiemetics|mesh-ancestor
139451357|NCT06210750|Autonomic Agents|autonomic agents|mesh-ancestor
139451358|NCT06210750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451359|NCT06210750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139451360|NCT06210750|Glucocorticoids|glucocorticoids|mesh-ancestor
139451361|NCT06210750|Hormones|hormones|mesh-ancestor
139451362|NCT06210750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139451363|NCT06210750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139451364|NCT06210750|Protease Inhibitors|protease inhibitors|mesh-ancestor
139451365|NCT06210750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451366|NCT06210750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139451367|NCT06210750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139451368|NCT06210750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139451369|NCT06210750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139451370|NCT06210750|Abortifacient Agents|abortifacient agents|mesh-ancestor
139451371|NCT06210750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139451372|NCT06210750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139451373|NCT06210750|Antimetabolites|antimetabolites|mesh-ancestor
139451374|NCT06210750|Dermatologic Agents|dermatologic agents|mesh-ancestor
139451375|NCT06210750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139451376|NCT06210750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139451377|NCT06210750|Antiviral Agents|antiviral agents|mesh-ancestor
139451378|NCT06210750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451379|NCT06210750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139451380|NCT06210750|Tubulin Modulators|tubulin modulators|mesh-ancestor
139451381|NCT06210750|Antimitotic Agents|antimitotic agents|mesh-ancestor
139451382|NCT06210750|Mitosis Modulators|mitosis modulators|mesh-ancestor
139451383|NCT06210724|Chrysarobin|chrysarobin|mesh-list
139451384|NCT06210724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139451385|NCT06210724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139451386|NCT06210724|Analgesics|analgesics|mesh-ancestor
139451387|NCT06210724|Sensory System Agents|sensory system agents|mesh-ancestor
139451388|NCT06210724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451389|NCT06210724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451390|NCT06210724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139451391|NCT06210724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139451392|NCT06210646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139451393|NCT06210646|Nootropic Agents|nootropic agents|mesh-ancestor
139451394|NCT06210594|Chlorhexidine|chlorhexidine|mesh-list
139451395|NCT06210594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139451396|NCT06210594|Mupirocin|mupirocin|mesh-list
139451397|NCT06210594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139238065|NCT03680976|CXA-10|cxa-10|mesh-list
139451398|NCT06210594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451399|NCT06210594|Disinfectants|disinfectants|mesh-ancestor
139451400|NCT06210594|Dermatologic Agents|dermatologic agents|mesh-ancestor
139451401|NCT06210594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139451402|NCT06210594|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139451403|NCT06210594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451404|NCT06210594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451405|NCT06210542|Ceftazidime|ceftazidime|mesh-list
139451406|NCT06210542|Avibactam|avibactam|mesh-list
139451407|NCT06210542|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
139451408|NCT06210542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139451409|NCT06210542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451410|NCT06210542|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139451411|NCT06210542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451412|NCT06210542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451413|NCT06210490|Disitamab vedotin|disitamab vedotin|mesh-list
139451414|NCT06210490|Immunoconjugates|immunoconjugates|mesh-ancestor
139451415|NCT06210490|Immunologic Factors|immunologic factors|mesh-ancestor
139451416|NCT06210490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451417|NCT06210477|Muscarinic Antagonists|muscarinic antagonists|mesh-list
139451418|NCT06210477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139451419|NCT06210477|Cholinergic Agents|cholinergic agents|mesh-ancestor
139451420|NCT06210477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451421|NCT06210477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451422|NCT06210477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451423|NCT06210438|Bevacizumab|bevacizumab|mesh-list
139451424|NCT06210438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451425|NCT06210438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451426|NCT06210438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139451427|NCT06210438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139451428|NCT06210438|Growth Substances|growth substances|mesh-ancestor
139451429|NCT06210438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451430|NCT06210438|Growth Inhibitors|growth inhibitors|mesh-ancestor
139451431|NCT06210373|Pantothenic Acid|pantothenic acid|mesh-list
139451432|NCT06210373|Vitamin B Complex|vitamin b complex|mesh-ancestor
139451433|NCT06210373|Vitamins|vitamins|mesh-ancestor
139451434|NCT06210373|Micronutrients|micronutrients|mesh-ancestor
139451435|NCT06210373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451436|NCT06210360|Leucovorin|leucovorin|mesh-list
139451437|NCT06210360|Fluorouracil|fluorouracil|mesh-list
139451438|NCT06210360|Oxaliplatin|oxaliplatin|mesh-list
139451439|NCT06210360|Irinotecan|irinotecan|mesh-list
139451440|NCT06210360|Antimetabolites|antimetabolites|mesh-ancestor
139451441|NCT06210360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451442|NCT06210360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139451443|NCT06210360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451444|NCT06210360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139451445|NCT06210360|Immunologic Factors|immunologic factors|mesh-ancestor
139451446|NCT06210360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451447|NCT06210360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139451448|NCT06210360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139451449|NCT06210360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451450|NCT06210360|Antidotes|antidotes|mesh-ancestor
139451451|NCT06210360|Protective Agents|protective agents|mesh-ancestor
139451452|NCT06210360|Vitamin B Complex|vitamin b complex|mesh-ancestor
139451453|NCT06210360|Vitamins|vitamins|mesh-ancestor
139451454|NCT06210360|Micronutrients|micronutrients|mesh-ancestor
139451455|NCT06210334|Lenvatinib|lenvatinib|mesh-list
139451456|NCT06210334|Tislelizumab|tislelizumab|mesh-list
139451457|NCT06210334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451458|NCT06210334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139451459|NCT06210334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451460|NCT06210334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451461|NCT06210334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451462|NCT06210321|Escitalopram|escitalopram|mesh-list
139451463|NCT06210321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139451464|NCT06210321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139451465|NCT06210321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139451466|NCT06210321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451467|NCT06210321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451468|NCT06210321|Serotonin Agents|serotonin agents|mesh-ancestor
139451469|NCT06210321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451470|NCT06210269|Moxifloxacin|moxifloxacin|mesh-list
139451471|NCT06210269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139451472|NCT06210269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451473|NCT06210269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139451474|NCT06210269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139238133|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139451475|NCT06210269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451476|NCT06210269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451477|NCT06210269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451479|NCT06210217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139451480|NCT06210217|Sympathomimetics|sympathomimetics|mesh-ancestor
139451481|NCT06210217|Autonomic Agents|autonomic agents|mesh-ancestor
139451482|NCT06210217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451483|NCT06210217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451484|NCT06210217|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139451485|NCT06210217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139451486|NCT06210217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139451487|NCT06210217|Adrenergic Agents|adrenergic agents|mesh-ancestor
139451488|NCT06210217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451489|NCT06210217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451490|NCT06210217|Protective Agents|protective agents|mesh-ancestor
139451491|NCT06210165|Atropine|atropine|mesh-list
139451492|NCT06210165|Neostigmine|neostigmine|mesh-list
139451493|NCT06210165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139451494|NCT06210165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139451495|NCT06210165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139451496|NCT06210165|Autonomic Agents|autonomic agents|mesh-ancestor
139451497|NCT06210165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451498|NCT06210165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451499|NCT06210165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139451500|NCT06210165|Respiratory System Agents|respiratory system agents|mesh-ancestor
139451501|NCT06210165|Mydriatics|mydriatics|mesh-ancestor
139451502|NCT06210165|Parasympatholytics|parasympatholytics|mesh-ancestor
139451503|NCT06210165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139451504|NCT06210165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139451505|NCT06210165|Cholinergic Agents|cholinergic agents|mesh-ancestor
139451506|NCT06210165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451507|NCT06210165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451508|NCT06210165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139451509|NCT06210165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451510|NCT06210165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139451511|NCT06210061|Fentanyl|fentanyl|mesh-list
139451512|NCT06210061|Dexmedetomidine|dexmedetomidine|mesh-list
139451513|NCT06210061|Propofol|propofol|mesh-list
139451514|NCT06210061|Sevoflurane|sevoflurane|mesh-list
139451515|NCT06210061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139451516|NCT06210061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139451517|NCT06210061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451518|NCT06210061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139451519|NCT06210061|Analgesics|analgesics|mesh-ancestor
139451520|NCT06210061|Sensory System Agents|sensory system agents|mesh-ancestor
139451521|NCT06210061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451522|NCT06210061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139451523|NCT06210061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139451524|NCT06210061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139451525|NCT06210061|Adrenergic Agents|adrenergic agents|mesh-ancestor
139451526|NCT06210061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451527|NCT06210061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451528|NCT06210061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139451529|NCT06210061|Anesthetics, General|anesthetics, general|mesh-ancestor
139451530|NCT06210061|Anesthetics|anesthetics|mesh-ancestor
139451531|NCT06210061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139451532|NCT06210061|Narcotics|narcotics|mesh-ancestor
139451533|NCT06210061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139451534|NCT06210061|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139451535|NCT06210061|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139451536|NCT06207058|Baloxavir|baloxavir|mesh-list
139451537|NCT06207058|Antiviral Agents|antiviral agents|mesh-ancestor
139451538|NCT06207058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451539|NCT06207058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451540|NCT06207058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451541|NCT06206044|Fentanyl|fentanyl|mesh-list
139451542|NCT06206044|Morphine|morphine|mesh-list
139451543|NCT06206044|Bupivacaine|bupivacaine|mesh-list
139451544|NCT06206044|Anesthetics, Local|anesthetics, local|mesh-ancestor
139451545|NCT06206044|Anesthetics|anesthetics|mesh-ancestor
139451546|NCT06206044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139451547|NCT06206044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451548|NCT06206044|Sensory System Agents|sensory system agents|mesh-ancestor
139451549|NCT06206044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238212|NCT03181789|Vaccines|vaccines|mesh-list
139451550|NCT06206044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139451551|NCT06206044|Narcotics|narcotics|mesh-ancestor
139451552|NCT06206044|Analgesics|analgesics|mesh-ancestor
139451553|NCT06206044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139451554|NCT06206044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139451555|NCT06206044|Anesthetics, General|anesthetics, general|mesh-ancestor
139451556|NCT06205290|Cyclophosphamide|cyclophosphamide|mesh-list
139451557|NCT06205290|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139451558|NCT06205290|Rituximab|rituximab|mesh-list
139451559|NCT06205290|Fludarabine|fludarabine|mesh-list
139451560|NCT06205290|Idelalisib|idelalisib|mesh-list
139451561|NCT06205290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139451562|NCT06205290|Immunologic Factors|immunologic factors|mesh-ancestor
139451563|NCT06205290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451564|NCT06205290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139451565|NCT06205290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139451566|NCT06205290|Alkylating Agents|alkylating agents|mesh-ancestor
139451567|NCT06205290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451568|NCT06205290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451569|NCT06205290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139451570|NCT06205290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451571|NCT06205290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451572|NCT06201819|Liraglutide|liraglutide|mesh-list
139451573|NCT06201819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139451574|NCT06201819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451575|NCT06201819|Incretins|incretins|mesh-ancestor
139451576|NCT06201819|Hormones|hormones|mesh-ancestor
139451577|NCT06201819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139451578|NCT06198894|Glucocorticoids|glucocorticoids|mesh-list
139451579|NCT06198894|Hormones|hormones|mesh-ancestor
139451580|NCT06198894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139451581|NCT06198894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451582|NCT06197282|Anesthetics|anesthetics|mesh-list
139451583|NCT06197282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139451584|NCT06197282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451585|NCT06192680|Bevacizumab|bevacizumab|mesh-list
139451586|NCT06192680|Capecitabine|capecitabine|mesh-list
139451587|NCT06192680|Irinotecan|irinotecan|mesh-list
139451588|NCT06192680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451589|NCT06192680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451590|NCT06192680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139451591|NCT06192680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139451592|NCT06192680|Growth Substances|growth substances|mesh-ancestor
139451593|NCT06192680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451594|NCT06192680|Growth Inhibitors|growth inhibitors|mesh-ancestor
139451595|NCT06192680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139451596|NCT06192680|Antimetabolites|antimetabolites|mesh-ancestor
139451597|NCT06192680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451598|NCT06192680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139451599|NCT06192680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139451600|NCT06192680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451601|NCT06192589|Morphine|morphine|mesh-list
139451602|NCT06192589|Cannabidiol|cannabidiol|mesh-list
139451603|NCT06192589|Citalopram|citalopram|mesh-list
139451604|NCT06192589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139451605|NCT06192589|Narcotics|narcotics|mesh-ancestor
139451606|NCT06192589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139451607|NCT06192589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451608|NCT06192589|Analgesics|analgesics|mesh-ancestor
139451609|NCT06192589|Sensory System Agents|sensory system agents|mesh-ancestor
139451610|NCT06192589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451611|NCT06192589|Anticonvulsants|anticonvulsants|mesh-ancestor
139451612|NCT06192589|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139451613|NCT06192589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139451614|NCT06192589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139451615|NCT06192589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451616|NCT06192589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451617|NCT06192589|Serotonin Agents|serotonin agents|mesh-ancestor
139451618|NCT06192589|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139451619|NCT06192589|Antidepressive Agents|antidepressive agents|mesh-ancestor
139451620|NCT06192589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139451621|NCT06188520|Palbociclib|palbociclib|mesh-list
139451622|NCT06188520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451623|NCT06188520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139238282|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139451624|NCT06188520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451625|NCT06188520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451626|NCT06155396|Disitamab vedotin|disitamab vedotin|mesh-list
139451627|NCT06155396|Immunoconjugates|immunoconjugates|mesh-ancestor
139451628|NCT06155396|Immunologic Factors|immunologic factors|mesh-ancestor
139451629|NCT06155396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451630|NCT06139536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139451631|NCT06139536|Antibodies|antibodies|mesh-list
139451632|NCT06139536|Immunoglobulins|immunoglobulins|mesh-list
139451633|NCT06139536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139451634|NCT06139536|Immunologic Factors|immunologic factors|mesh-ancestor
139451635|NCT06139536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451636|NCT06139536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451637|NCT06122649|Apremilast|apremilast|mesh-list
139451638|NCT06122649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139451639|NCT06122649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139451640|NCT06122649|Analgesics|analgesics|mesh-ancestor
139451641|NCT06122649|Sensory System Agents|sensory system agents|mesh-ancestor
139451642|NCT06122649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451643|NCT06122649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451644|NCT06122649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139451645|NCT06122649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139451646|NCT06122649|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139451647|NCT06122649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139451648|NCT06122649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451649|NCT06122649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451650|NCT06116526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139451651|NCT06116526|Immunologic Factors|immunologic factors|mesh-ancestor
139451652|NCT06116526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451653|NCT06116136|Pembrolizumab|pembrolizumab|mesh-list
139451654|NCT06116136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451655|NCT06116136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451656|NCT06116136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139451657|NCT06116136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451658|NCT06112847|Lenalidomide|lenalidomide|mesh-list
139451659|NCT06112847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139451660|NCT06112847|Immunologic Factors|immunologic factors|mesh-ancestor
139451661|NCT06112847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451662|NCT06112847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139451663|NCT06112847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139451664|NCT06112847|Growth Substances|growth substances|mesh-ancestor
139451665|NCT06112847|Growth Inhibitors|growth inhibitors|mesh-ancestor
139451666|NCT06112847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451667|NCT06111196|Pembrolizumab|pembrolizumab|mesh-list
139451668|NCT06111196|Antibodies|antibodies|mesh-list
139451669|NCT06111196|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139451670|NCT06111196|Immunologic Factors|immunologic factors|mesh-ancestor
139451671|NCT06111196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451672|NCT06111196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451673|NCT06111196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451674|NCT06111196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139451675|NCT06111196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451676|NCT06094179|Antibodies|antibodies|mesh-list
139451677|NCT06094179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139451678|NCT06094179|Immunologic Factors|immunologic factors|mesh-ancestor
139451679|NCT06094179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451680|NCT06090539|Rituximab|rituximab|mesh-list
139451681|NCT06090539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451682|NCT06090539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451683|NCT06090539|Immunologic Factors|immunologic factors|mesh-ancestor
139451684|NCT06090539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451685|NCT06090539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139451686|NCT06087835|Dapagliflozin|dapagliflozin|mesh-list
139451687|NCT06087835|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139451688|NCT06087835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451689|NCT06087835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139451690|NCT06087835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451691|NCT06083766|Hormones|hormones|mesh-list
139451692|NCT06083766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139451693|NCT06083766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451694|NCT06073821|Venetoclax|venetoclax|mesh-list
139451695|NCT06073821|Obinutuzumab|obinutuzumab|mesh-list
139451696|NCT06073821|Zanubrutinib|zanubrutinib|mesh-list
139451697|NCT06073821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451698|NCT06073821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451699|NCT06073821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139451700|NCT06073821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451701|NCT06073821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451702|NCT06058078|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139451703|NCT06058078|Immunologic Factors|immunologic factors|mesh-ancestor
139451704|NCT06058078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451705|NCT06055452|Empagliflozin|empagliflozin|mesh-list
139451706|NCT06055452|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139451707|NCT06055452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451708|NCT06055452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139451709|NCT06055452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451710|NCT06053749|Interferon-beta|interferon-beta|mesh-list
139451711|NCT06053749|Interferon beta-1b|interferon beta-1b|mesh-list
139451712|NCT06053749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139451713|NCT06053749|Immunologic Factors|immunologic factors|mesh-ancestor
139451714|NCT06053749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451715|NCT06053749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451716|NCT06053749|Antiviral Agents|antiviral agents|mesh-ancestor
139451717|NCT06053749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451718|NCT06031441|Atezolizumab|atezolizumab|mesh-list
139451719|NCT06031441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139451720|NCT06031441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451721|NCT06031441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451722|NCT06031441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451723|NCT06030037|Pembrolizumab|pembrolizumab|mesh-list
139451724|NCT06030037|Lenvatinib|lenvatinib|mesh-list
139451725|NCT06030037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451726|NCT06030037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451727|NCT06030037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139451728|NCT06030037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451729|NCT06030037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139451730|NCT06030037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451731|NCT06014489|Cobicistat|cobicistat|mesh-list
139451732|NCT06014489|Azacitidine|azacitidine|mesh-list
139451733|NCT06014489|Venetoclax|venetoclax|mesh-list
139451734|NCT06014489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139451735|NCT06014489|Antimetabolites|antimetabolites|mesh-ancestor
139451736|NCT06014489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451737|NCT06014489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451738|NCT06014489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451739|NCT06014489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139451740|NCT06014489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139451741|NCT06014489|Antiviral Agents|antiviral agents|mesh-ancestor
139451742|NCT06014489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451743|NCT06014489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139451744|NCT06014489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139451745|NCT05984277|Paclitaxel|paclitaxel|mesh-list
139451746|NCT05984277|Carboplatin|carboplatin|mesh-list
139451747|NCT05984277|Pembrolizumab|pembrolizumab|mesh-list
139451748|NCT05984277|Pemetrexed|pemetrexed|mesh-list
139451749|NCT05984277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139451750|NCT05984277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451751|NCT05984277|Tubulin Modulators|tubulin modulators|mesh-ancestor
139451752|NCT05984277|Antimitotic Agents|antimitotic agents|mesh-ancestor
139451753|NCT05984277|Mitosis Modulators|mitosis modulators|mesh-ancestor
139451754|NCT05984277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451755|NCT05984277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451756|NCT05984277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139451757|NCT05984277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451758|NCT05984277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139451759|NCT05984277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139451760|NCT05983367|Bevacizumab|bevacizumab|mesh-list
139451761|NCT05983367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451762|NCT05983367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451763|NCT05983367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139451764|NCT05983367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139451765|NCT05983367|Growth Substances|growth substances|mesh-ancestor
139451766|NCT05983367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451767|NCT05983367|Growth Inhibitors|growth inhibitors|mesh-ancestor
139451768|NCT05982340|Lithium Carbonate|lithium carbonate|mesh-list
139451769|NCT05982340|Antidepressive Agents|antidepressive agents|mesh-ancestor
139451770|NCT05982340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139238433|NCT02224872|Fludarabine|fludarabine|mesh-list
139451771|NCT05982340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451772|NCT05982340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451773|NCT05982340|Antimanic Agents|antimanic agents|mesh-ancestor
139451774|NCT05982340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139451775|NCT05982340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139451776|NCT05982340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451777|NCT05967182|Gemcitabine|gemcitabine|mesh-list
139451778|NCT05967182|Pembrolizumab|pembrolizumab|mesh-list
139451779|NCT05967182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451780|NCT05967182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139451781|NCT05967182|Antimetabolites|antimetabolites|mesh-ancestor
139451782|NCT05967182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451783|NCT05967182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451784|NCT05967182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139451785|NCT05964413|Vilobelimab|vilobelimab|mesh-list
139451786|NCT05964413|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139451787|NCT05964413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139451788|NCT05964413|Immunologic Factors|immunologic factors|mesh-ancestor
139451789|NCT05964413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451790|NCT05959629|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139451791|NCT05959629|Eusol|eusol|mesh-list
139451792|NCT05959629|Disinfectants|disinfectants|mesh-ancestor
139451793|NCT05959629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451794|NCT05958342|Vasopressins|vasopressins|mesh-list
139451795|NCT05958342|Arginine Vasopressin|arginine vasopressin|mesh-list
139451796|NCT05958342|Calcium|calcium|mesh-list
139451797|NCT05958342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139451798|NCT05958342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451799|NCT05958342|Hemostatics|hemostatics|mesh-ancestor
139451800|NCT05958342|Coagulants|coagulants|mesh-ancestor
139451801|NCT05958342|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139451802|NCT05958342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139451803|NCT05958342|Natriuretic Agents|natriuretic agents|mesh-ancestor
139451804|NCT05946941|Deucravacitinib|deucravacitinib|mesh-list
139451805|NCT05946941|Dermatologic Agents|dermatologic agents|mesh-ancestor
139451806|NCT05946941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139451807|NCT05946941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451808|NCT05946941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451809|NCT05941715|Aflibercept|aflibercept|mesh-list
139451810|NCT05941715|Faricimab|faricimab|mesh-list
139451811|NCT05941715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139451812|NCT05941715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139451813|NCT05941715|Growth Substances|growth substances|mesh-ancestor
139451814|NCT05941715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451815|NCT05941715|Growth Inhibitors|growth inhibitors|mesh-ancestor
139451816|NCT05941715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451817|NCT05922761|Fluticasone|fluticasone|mesh-list
139451818|NCT05922761|Xhance|xhance|mesh-list
139451819|NCT05922761|Azithromycin|azithromycin|mesh-list
139451820|NCT05922761|Prednisone|prednisone|mesh-list
139451821|NCT05922761|Montelukast|montelukast|mesh-list
139451822|NCT05922761|Belumosudil|belumosudil|mesh-list
139451823|NCT05922761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139451824|NCT05922761|Glucocorticoids|glucocorticoids|mesh-ancestor
139451825|NCT05922761|Hormones|hormones|mesh-ancestor
139451826|NCT05922761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139451827|NCT05922761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451828|NCT05922761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139451829|NCT05922761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451830|NCT05922761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139451831|NCT05922761|Autonomic Agents|autonomic agents|mesh-ancestor
139451832|NCT05922761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451833|NCT05922761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139451834|NCT05922761|Respiratory System Agents|respiratory system agents|mesh-ancestor
139451835|NCT05922761|Dermatologic Agents|dermatologic agents|mesh-ancestor
139451836|NCT05922761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139451837|NCT05922761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139451838|NCT05922761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451839|NCT05922761|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139451840|NCT05922761|Hormone Antagonists|hormone antagonists|mesh-ancestor
139451841|NCT05922761|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139451842|NCT05922761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139451843|NCT05922761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451844|NCT05922761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139451845|NCT05922761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451846|NCT05910801|Lenalidomide|lenalidomide|mesh-list
139451847|NCT05910801|Venetoclax|venetoclax|mesh-list
139451848|NCT05910801|Immunoglobulins|immunoglobulins|mesh-list
139451849|NCT05910801|Immunologic Factors|immunologic factors|mesh-ancestor
139451850|NCT05910801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451851|NCT05910801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139451852|NCT05910801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139451853|NCT05910801|Growth Substances|growth substances|mesh-ancestor
139451854|NCT05910801|Growth Inhibitors|growth inhibitors|mesh-ancestor
139451855|NCT05910801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451856|NCT05898022|Furosemide|furosemide|mesh-list
139451857|NCT05898022|Diuretics|diuretics|mesh-ancestor
139451858|NCT05898022|Natriuretic Agents|natriuretic agents|mesh-ancestor
139451859|NCT05898022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451860|NCT05898022|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139451861|NCT05898022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139451862|NCT05898022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451863|NCT05893888|Cisplatin|cisplatin|mesh-list
139451864|NCT05893888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451865|NCT05888831|Nivolumab|nivolumab|mesh-list
139451866|NCT05888831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451867|NCT05888831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451868|NCT05888831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139451869|NCT05888831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451870|NCT05884957|Nitric Oxide|nitric oxide|mesh-list
139110242|NCT05860270|Vitamin D|vitamin d|mesh-list
139451871|NCT05884957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139451872|NCT05884957|Autonomic Agents|autonomic agents|mesh-ancestor
139451873|NCT05884957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451874|NCT05884957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451875|NCT05884957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139451876|NCT05884957|Respiratory System Agents|respiratory system agents|mesh-ancestor
139451877|NCT05884957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139451878|NCT05884957|Antioxidants|antioxidants|mesh-ancestor
139451879|NCT05884957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451880|NCT05884957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451881|NCT05884957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139451882|NCT05884957|Vasodilator Agents|vasodilator agents|mesh-ancestor
139451883|NCT05884957|Gasotransmitters|gasotransmitters|mesh-ancestor
139451884|NCT05884957|Protective Agents|protective agents|mesh-ancestor
139451885|NCT05882877|KHK4083|khk4083|mesh-list
139451886|NCT05882877|Dermatologic Agents|dermatologic agents|mesh-ancestor
139451887|NCT05864846|Cannabidiol|cannabidiol|mesh-list
139451888|NCT05864846|Anticonvulsants|anticonvulsants|mesh-ancestor
139451889|NCT05851768|Dexmedetomidine|dexmedetomidine|mesh-list
139451890|NCT05851768|Bupivacaine|bupivacaine|mesh-list
139451891|NCT05851768|Anesthetics, Local|anesthetics, local|mesh-ancestor
139451892|NCT05851768|Anesthetics|anesthetics|mesh-ancestor
139451893|NCT05851768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139451894|NCT05851768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451895|NCT05851768|Sensory System Agents|sensory system agents|mesh-ancestor
139451896|NCT05851768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451897|NCT05851768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139451898|NCT05851768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139451899|NCT05851768|Analgesics|analgesics|mesh-ancestor
139451900|NCT05851768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139451901|NCT05851768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139451902|NCT05851768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139451903|NCT05851768|Adrenergic Agents|adrenergic agents|mesh-ancestor
139451904|NCT05851768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451905|NCT05851768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451906|NCT05844735|Ciprofloxacin|ciprofloxacin|mesh-list
139451907|NCT05844735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139451908|NCT05844735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451909|NCT05844735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139451910|NCT05844735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139451911|NCT05844735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451912|NCT05844735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451913|NCT05844735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451914|NCT05844735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139451915|NCT05844735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139451916|NCT05844150|Etoposide|etoposide|mesh-list
139451917|NCT05844150|Atezolizumab|atezolizumab|mesh-list
139451918|NCT05844150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139451919|NCT05844150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451920|NCT05844150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139451921|NCT05844150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139238584|NCT03021018|Lorazepam|lorazepam|mesh-list
139451922|NCT05844150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451923|NCT05844150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451924|NCT05844150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139451925|NCT05844150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451926|NCT05838573|Metformin|metformin|mesh-list
139451927|NCT05838573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139451928|NCT05838573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451929|NCT05799079|Decitabine|decitabine|mesh-list
139451930|NCT05799079|Venetoclax|venetoclax|mesh-list
139451931|NCT05799079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139451932|NCT05799079|Antimetabolites|antimetabolites|mesh-ancestor
139451933|NCT05799079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451934|NCT05799079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451935|NCT05799079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451936|NCT05797805|Pembrolizumab|pembrolizumab|mesh-list
139451937|NCT05797805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451938|NCT05797805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451939|NCT05797805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139451940|NCT05797805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451941|NCT05789589|Dexamethasone|dexamethasone|mesh-list
139451942|NCT05789589|Methylprednisolone|methylprednisolone|mesh-list
139451943|NCT05789589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139451944|NCT05789589|Antiemetics|antiemetics|mesh-ancestor
139451945|NCT05789589|Autonomic Agents|autonomic agents|mesh-ancestor
139451946|NCT05789589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139451947|NCT05789589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451948|NCT05789589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139451949|NCT05789589|Glucocorticoids|glucocorticoids|mesh-ancestor
139451950|NCT05789589|Hormones|hormones|mesh-ancestor
139451951|NCT05789589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139451952|NCT05789589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139451953|NCT05789589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451954|NCT05789589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139451955|NCT05789589|Protective Agents|protective agents|mesh-ancestor
139451956|NCT05777993|Mitapivat|mitapivat|mesh-list
139451957|NCT05777993|Enzyme Activators|enzyme activators|mesh-ancestor
139451958|NCT05777993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451959|NCT05756660|Sodium thiosulfate|sodium thiosulfate|mesh-list
139451960|NCT05756660|Cisplatin|cisplatin|mesh-list
139451961|NCT05756660|Vorinostat|vorinostat|mesh-list
139451962|NCT05756660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451963|NCT05756660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139451964|NCT05756660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451965|NCT05756660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451966|NCT05756660|Antidotes|antidotes|mesh-ancestor
139451967|NCT05756660|Protective Agents|protective agents|mesh-ancestor
139451968|NCT05756660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451969|NCT05756660|Antioxidants|antioxidants|mesh-ancestor
139451970|NCT05756660|Antitubercular Agents|antitubercular agents|mesh-ancestor
139451971|NCT05756660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139451972|NCT05756660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139451973|NCT05756660|Chelating Agents|chelating agents|mesh-ancestor
139451974|NCT05756660|Sequestering Agents|sequestering agents|mesh-ancestor
139451975|NCT05752279|Plasma-lyte 148|plasma-lyte 148|mesh-list
139451976|NCT05752279|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139451977|NCT05752279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139451978|NCT05724849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139451979|NCT05724849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139451980|NCT05724849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139451981|NCT05724849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139451982|NCT05724849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451983|NCT05724849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139451984|NCT05724849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139451985|NCT05724849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139451986|NCT05724849|Antidepressive Agents|antidepressive agents|mesh-ancestor
139451987|NCT05724849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139451988|NCT05718323|Niraparib|niraparib|mesh-list
139451989|NCT05718323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139451990|NCT05718323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139451991|NCT05718323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451992|NCT05718323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451993|NCT05718297|Durvalumab|durvalumab|mesh-list
139451994|NCT05718297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139451995|NCT05718297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139451996|NCT05661578|Atezolizumab|atezolizumab|mesh-list
139451997|NCT05661578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139451998|NCT05661578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139451999|NCT05661578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452000|NCT05661578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452001|NCT05660395|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139452002|NCT05660395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452003|NCT05660395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452004|NCT05653661|Paclitaxel|paclitaxel|mesh-list
139452005|NCT05653661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139452006|NCT05653661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139452007|NCT05653661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452008|NCT05653661|Tubulin Modulators|tubulin modulators|mesh-ancestor
139452009|NCT05653661|Antimitotic Agents|antimitotic agents|mesh-ancestor
139452010|NCT05653661|Mitosis Modulators|mitosis modulators|mesh-ancestor
139452011|NCT05653661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452012|NCT05643573|Apixaban|apixaban|mesh-list
139452013|NCT05643573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139452014|NCT05643573|Antithrombins|antithrombins|mesh-ancestor
139452015|NCT05643573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139110399|NCT05303311|Anesthetics|anesthetics|mesh-ancestor
139452016|NCT05643573|Protease Inhibitors|protease inhibitors|mesh-ancestor
139452017|NCT05643573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452018|NCT05643573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452019|NCT05643573|Anticoagulants|anticoagulants|mesh-ancestor
139452020|NCT05629702|Temozolomide|temozolomide|mesh-list
139452021|NCT05629702|Nabiximols|nabiximols|mesh-list
139452022|NCT05629702|Dronabinol|dronabinol|mesh-list
139452023|NCT05629702|Cannabidiol|cannabidiol|mesh-list
139452024|NCT05629702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139452025|NCT05629702|Alkylating Agents|alkylating agents|mesh-ancestor
139452026|NCT05629702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452027|NCT05629702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452028|NCT05629702|Analgesics|analgesics|mesh-ancestor
139452029|NCT05629702|Sensory System Agents|sensory system agents|mesh-ancestor
139452030|NCT05629702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452031|NCT05629702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452032|NCT05629702|Anticonvulsants|anticonvulsants|mesh-ancestor
139452033|NCT05629702|Hallucinogens|hallucinogens|mesh-ancestor
139452034|NCT05629702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139452035|NCT05629702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139452036|NCT05629702|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139452037|NCT05629702|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139452038|NCT05629702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139452039|NCT05629702|Hormones|hormones|mesh-ancestor
139452040|NCT05629702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139452041|NCT05626803|Vaccines|vaccines|mesh-list
139452042|NCT05626803|Immunologic Factors|immunologic factors|mesh-ancestor
139452043|NCT05626803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452044|NCT05625399|Nivolumab|nivolumab|mesh-list
139452045|NCT05625399|Relatlimab|relatlimab|mesh-list
139452046|NCT05625399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452047|NCT05625399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452048|NCT05625399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452049|NCT05625399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452050|NCT05613088|Paclitaxel|paclitaxel|mesh-list
139452051|NCT05613088|Doxorubicin|doxorubicin|mesh-list
139452052|NCT05613088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139452053|NCT05613088|Topotecan|topotecan|mesh-list
139452054|NCT05613088|Farletuzumab|farletuzumab|mesh-list
139452055|NCT05613088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139452056|NCT05613088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452057|NCT05613088|Tubulin Modulators|tubulin modulators|mesh-ancestor
139452058|NCT05613088|Antimitotic Agents|antimitotic agents|mesh-ancestor
139452059|NCT05613088|Mitosis Modulators|mitosis modulators|mesh-ancestor
139452060|NCT05613088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452061|NCT05613088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139452062|NCT05613088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139452063|NCT05613088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139452064|NCT05613088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452065|NCT05613088|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139452066|NCT05591417|Dexamethasone|dexamethasone|mesh-list
139452067|NCT05591417|Dexamethasone acetate|dexamethasone acetate|mesh-list
139452068|NCT05591417|Dexmedetomidine|dexmedetomidine|mesh-list
139452069|NCT05591417|Morphine|morphine|mesh-list
139452070|NCT05591417|BB 1101|bb 1101|mesh-list
139452071|NCT05591417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139452072|NCT05591417|Antiemetics|antiemetics|mesh-ancestor
139452073|NCT05591417|Autonomic Agents|autonomic agents|mesh-ancestor
139452074|NCT05591417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452075|NCT05591417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452076|NCT05591417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139452077|NCT05591417|Glucocorticoids|glucocorticoids|mesh-ancestor
139452078|NCT05591417|Hormones|hormones|mesh-ancestor
139452079|NCT05591417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139452080|NCT05591417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139452081|NCT05591417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452082|NCT05591417|Protease Inhibitors|protease inhibitors|mesh-ancestor
139452083|NCT05591417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452084|NCT05591417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452085|NCT05591417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139452086|NCT05591417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139452087|NCT05591417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139452088|NCT05591417|Analgesics|analgesics|mesh-ancestor
139452089|NCT05591417|Sensory System Agents|sensory system agents|mesh-ancestor
139452090|NCT05591417|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139452091|NCT05591417|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139452092|NCT05591417|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139452093|NCT05591417|Adrenergic Agents|adrenergic agents|mesh-ancestor
139452094|NCT05591417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139452095|NCT05591417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139452096|NCT05591417|Narcotics|narcotics|mesh-ancestor
139452097|NCT05589402|Lidocaine|lidocaine|mesh-list
139452098|NCT05589402|Anesthetics, Local|anesthetics, local|mesh-ancestor
139452099|NCT05589402|Anesthetics|anesthetics|mesh-ancestor
139452100|NCT05589402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139452101|NCT05589402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452102|NCT05589402|Sensory System Agents|sensory system agents|mesh-ancestor
139452103|NCT05589402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452104|NCT05589402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139452105|NCT05589402|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139452106|NCT05589402|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139452107|NCT05589402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139452108|NCT05589402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452109|NCT05581004|Atezolizumab|atezolizumab|mesh-list
139452110|NCT05581004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452111|NCT05581004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452112|NCT05581004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452113|NCT05581004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452114|NCT05557695|Acalabrutinib|acalabrutinib|mesh-list
139452115|NCT05557695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452116|NCT05550207|Meloxicam|meloxicam|mesh-list
139452117|NCT05550207|Rizatriptan|rizatriptan|mesh-list
139452118|NCT05550207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139452119|NCT05550207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139452120|NCT05550207|Analgesics|analgesics|mesh-ancestor
139452121|NCT05550207|Sensory System Agents|sensory system agents|mesh-ancestor
139452122|NCT05550207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452123|NCT05550207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452124|NCT05550207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139452125|NCT05550207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139452126|NCT05550207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139452127|NCT05550207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139452128|NCT05550207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452129|NCT05550207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452130|NCT05550207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139452131|NCT05550207|Serotonin Agents|serotonin agents|mesh-ancestor
139452132|NCT05550207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139452133|NCT05543642|Vaccines|vaccines|mesh-list
139452134|NCT05543642|Immunologic Factors|immunologic factors|mesh-ancestor
139452135|NCT05543642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452136|NCT05526989|Niraparib|niraparib|mesh-list
139452137|NCT05526989|Dostarlimab|dostarlimab|mesh-list
139452138|NCT05526989|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139452139|NCT05526989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452140|NCT05526989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452141|NCT05526989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452142|NCT05506982|Psilocybin|psilocybin|mesh-list
139452143|NCT05506982|Hallucinogens|hallucinogens|mesh-ancestor
139452144|NCT05506982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452145|NCT05506982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139452146|NCT05479045|Nivolumab|nivolumab|mesh-list
139452147|NCT05479045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452148|NCT05479045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452149|NCT05479045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452150|NCT05479045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452151|NCT05470985|Ozanimod|ozanimod|mesh-list
139452152|NCT05470985|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139452153|NCT05470985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452154|NCT05470985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139452155|NCT05470985|Immunologic Factors|immunologic factors|mesh-ancestor
139452156|NCT05470985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452157|NCT05469737|Azacitidine|azacitidine|mesh-list
139452158|NCT05469737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139452159|NCT05469737|Antimetabolites|antimetabolites|mesh-ancestor
139452160|NCT05469737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452161|NCT05469737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452162|NCT05469737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452163|NCT05463393|Xanthohumol|xanthohumol|mesh-list
139452164|NCT05463393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452165|NCT05463393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139452166|NCT05463393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139452167|NCT05463393|Growth Substances|growth substances|mesh-ancestor
139452168|NCT05463393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452169|NCT05463393|Growth Inhibitors|growth inhibitors|mesh-ancestor
139452170|NCT05399641|Ibrexafungerp|ibrexafungerp|mesh-list
139452171|NCT05399641|Antifungal Agents|antifungal agents|mesh-ancestor
139452172|NCT05399641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139452173|NCT05388929|Analgesics, Opioid|analgesics, opioid|mesh-list
139452174|NCT05388929|Methocarbamol|methocarbamol|mesh-list
139452175|NCT05388929|Narcotics|narcotics|mesh-ancestor
139452176|NCT05388929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139452177|NCT05388929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452178|NCT05388929|Analgesics|analgesics|mesh-ancestor
139452179|NCT05388929|Sensory System Agents|sensory system agents|mesh-ancestor
139452180|NCT05388929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452181|NCT05388929|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139452182|NCT05388929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139452183|NCT05381909|Paclitaxel|paclitaxel|mesh-list
139452184|NCT05381909|Carboplatin|carboplatin|mesh-list
139452185|NCT05381909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139452186|NCT05381909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452187|NCT05381909|Tubulin Modulators|tubulin modulators|mesh-ancestor
139452188|NCT05381909|Antimitotic Agents|antimitotic agents|mesh-ancestor
139452189|NCT05381909|Mitosis Modulators|mitosis modulators|mesh-ancestor
139452190|NCT05381909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452191|NCT05364073|Aflutinib|aflutinib|mesh-list
139452192|NCT05364073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139452193|NCT05364073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452194|NCT05364073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452195|NCT05363670|Albuterol|albuterol|mesh-list
139452196|NCT05363670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139452197|NCT05363670|Autonomic Agents|autonomic agents|mesh-ancestor
139452198|NCT05363670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452199|NCT05363670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452200|NCT05363670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139452201|NCT05363670|Respiratory System Agents|respiratory system agents|mesh-ancestor
139452202|NCT05363670|Tocolytic Agents|tocolytic agents|mesh-ancestor
139452203|NCT05363670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139452204|NCT05363670|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139452205|NCT05363670|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139452206|NCT05363670|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139452207|NCT05363670|Adrenergic Agents|adrenergic agents|mesh-ancestor
139452208|NCT05363670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139452209|NCT05363670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452210|NCT05361837|Dexmedetomidine|dexmedetomidine|mesh-list
139452211|NCT05361837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139452212|NCT05361837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139452213|NCT05361837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452214|NCT05361837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139452215|NCT05361837|Analgesics|analgesics|mesh-ancestor
139452216|NCT05361837|Sensory System Agents|sensory system agents|mesh-ancestor
139452217|NCT05361837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452218|NCT05361837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139452219|NCT05361837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139452220|NCT05361837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139452221|NCT05361837|Adrenergic Agents|adrenergic agents|mesh-ancestor
139452222|NCT05361837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139452223|NCT05361837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452224|NCT05319353|Maribavir|maribavir|mesh-list
139452225|NCT05319353|Antiviral Agents|antiviral agents|mesh-ancestor
139452226|NCT05319353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139452227|NCT05313009|Sotorasib|sotorasib|mesh-list
139452228|NCT05313009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452229|NCT05313009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452230|NCT05313009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452231|NCT05313009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452232|NCT05300048|Paclitaxel|paclitaxel|mesh-list
139452233|NCT05300048|Serabelisib|serabelisib|mesh-list
139452234|NCT05300048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139452235|NCT05300048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452236|NCT05300048|Tubulin Modulators|tubulin modulators|mesh-ancestor
139452237|NCT05300048|Antimitotic Agents|antimitotic agents|mesh-ancestor
139452238|NCT05300048|Mitosis Modulators|mitosis modulators|mesh-ancestor
139110623|NCT03755791|Sorafenib|sorafenib|mesh-list
139452239|NCT05300048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452240|NCT05300048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452241|NCT05286814|Leucovorin|leucovorin|mesh-list
139452242|NCT05286814|Dexamethasone|dexamethasone|mesh-list
139452243|NCT05286814|Gemcitabine|gemcitabine|mesh-list
139452244|NCT05286814|Fluorouracil|fluorouracil|mesh-list
139452245|NCT05286814|Oxaliplatin|oxaliplatin|mesh-list
139452246|NCT05286814|Irinotecan|irinotecan|mesh-list
139452247|NCT05286814|Floxuridine|floxuridine|mesh-list
139452248|NCT05286814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139452249|NCT05286814|Antiemetics|antiemetics|mesh-ancestor
139452250|NCT05286814|Autonomic Agents|autonomic agents|mesh-ancestor
139452251|NCT05286814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452252|NCT05286814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452253|NCT05286814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139452254|NCT05286814|Glucocorticoids|glucocorticoids|mesh-ancestor
139452255|NCT05286814|Hormones|hormones|mesh-ancestor
139452256|NCT05286814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139452257|NCT05286814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139452258|NCT05286814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452259|NCT05286814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139452260|NCT05286814|Antimetabolites|antimetabolites|mesh-ancestor
139452261|NCT05286814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452262|NCT05286814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139452263|NCT05286814|Immunologic Factors|immunologic factors|mesh-ancestor
139452264|NCT05286814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139452265|NCT05286814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139452266|NCT05286814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452267|NCT05286814|Antidotes|antidotes|mesh-ancestor
139452268|NCT05286814|Protective Agents|protective agents|mesh-ancestor
139452269|NCT05286814|Vitamin B Complex|vitamin b complex|mesh-ancestor
139452270|NCT05286814|Vitamins|vitamins|mesh-ancestor
139452271|NCT05286814|Micronutrients|micronutrients|mesh-ancestor
139452272|NCT05268003|Venetoclax|venetoclax|mesh-list
139452273|NCT05268003|Ponatinib|ponatinib|mesh-list
139452274|NCT05268003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452275|NCT05268003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139452276|NCT05268003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452277|NCT05268003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452278|NCT05266469|Ofatumumab|ofatumumab|mesh-list
139452279|NCT05266469|Ocrelizumab|ocrelizumab|mesh-list
139452280|NCT05266469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452281|NCT05266469|Immunologic Factors|immunologic factors|mesh-ancestor
139452282|NCT05266469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452283|NCT05260957|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139452284|NCT05260957|Immunoconjugates|immunoconjugates|mesh-ancestor
139452285|NCT05260957|Immunologic Factors|immunologic factors|mesh-ancestor
139452286|NCT05260957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452287|NCT05243654|Metformin|metformin|mesh-list
139452288|NCT05243654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139452289|NCT05243654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452290|NCT05237492|Tramadol|tramadol|mesh-list
139452291|NCT05237492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139452292|NCT05237492|Narcotics|narcotics|mesh-ancestor
139452293|NCT05237492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139452294|NCT05237492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452295|NCT05237492|Analgesics|analgesics|mesh-ancestor
139452296|NCT05237492|Sensory System Agents|sensory system agents|mesh-ancestor
139238961|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
139452297|NCT05237492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452299|NCT05224102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139452300|NCT05224102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139452301|NCT05224102|Growth Substances|growth substances|mesh-ancestor
139452302|NCT05224102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452303|NCT05224102|Growth Inhibitors|growth inhibitors|mesh-ancestor
139452304|NCT05224102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452305|NCT05222906|Venglustat|venglustat|mesh-list
139452306|NCT05222906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452307|NCT05222906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452308|NCT05221840|Durvalumab|durvalumab|mesh-list
139452309|NCT05221840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452310|NCT05221840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452311|NCT05219513|Obinutuzumab|obinutuzumab|mesh-list
139452312|NCT05219513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452313|NCT05219513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452314|NCT05206773|Venglustat|venglustat|mesh-list
139452315|NCT05206773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452316|NCT05206773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452317|NCT05175105|Mitapivat|mitapivat|mesh-list
139452318|NCT05175105|Enzyme Activators|enzyme activators|mesh-ancestor
139452319|NCT05175105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452320|NCT05155033|Aldesleukin|aldesleukin|mesh-list
139452321|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
139452322|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452323|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452324|NCT05155033|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452325|NCT05155033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452326|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139452327|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139452328|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
139452329|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139452330|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139452331|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139452332|NCT05144256|Mitapivat|mitapivat|mesh-list
139452333|NCT05144256|Enzyme Activators|enzyme activators|mesh-ancestor
139452334|NCT05144256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452335|NCT05136677|Carboplatin|carboplatin|mesh-list
139452336|NCT05136677|Nivolumab|nivolumab|mesh-list
139452337|NCT05136677|Pemetrexed|pemetrexed|mesh-list
139452338|NCT05136677|Ipilimumab|ipilimumab|mesh-list
139452339|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452340|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452341|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452342|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452343|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452344|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139452345|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139452346|NCT05126966|Ranibizumab|ranibizumab|mesh-list
139452347|NCT05126966|Aflibercept|aflibercept|mesh-list
139452348|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139452349|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139452350|NCT05126966|Growth Substances|growth substances|mesh-ancestor
139452351|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452352|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
139452353|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452354|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
139452355|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139452356|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
139452357|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452358|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139452359|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452360|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139452361|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
139452362|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139452363|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
139452364|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139452365|NCT05123365|Expectorants|expectorants|mesh-ancestor
139452366|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
139452367|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139452368|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
139452369|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239036|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139452370|NCT05123365|Protective Agents|protective agents|mesh-ancestor
139452371|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452372|NCT05123365|Antidotes|antidotes|mesh-ancestor
139452373|NCT05116085|Tislelizumab|tislelizumab|mesh-list
139452374|NCT05116085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452375|NCT05116085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452376|NCT05113745|Reboxetine|reboxetine|mesh-list
139452377|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
139452378|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139452379|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139452380|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139452381|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139452382|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452383|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
139452384|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139452385|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452386|NCT05087992|Bevacizumab|bevacizumab|mesh-list
139452387|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452388|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452389|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139452390|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139452391|NCT05087992|Growth Substances|growth substances|mesh-ancestor
139452392|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452393|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
139452394|NCT05082025|Fulvestrant|fulvestrant|mesh-list
139452395|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139452396|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452397|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139452398|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139452399|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
139452400|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139452401|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452402|NCT05073003|Vaccines|vaccines|mesh-list
139452403|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
139452404|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452405|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
139452406|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139452407|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139452408|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139452409|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139452410|NCT05058612|Midodrine|midodrine|mesh-list
139452411|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
139452412|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
139452413|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452414|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452415|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139452416|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139452417|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139452418|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139452419|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
139452420|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139452421|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452422|NCT05048342|Remibrutinib|remibrutinib|mesh-list
139452423|NCT05048342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139452424|NCT05048342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452425|NCT05048342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452426|NCT05037617|Oxytocin|oxytocin|mesh-list
139452427|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
139452428|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139452429|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452430|NCT05022004|Brinzolamide|brinzolamide|mesh-list
139452431|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139452432|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452433|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452434|NCT05004259|Daratumumab|daratumumab|mesh-list
139452435|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452436|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139452437|NCT04985760|Vaccines|vaccines|mesh-list
139452438|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
139452439|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
139452440|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452441|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139452442|NCT04985760|Antacids|antacids|mesh-ancestor
139452443|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452444|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239109|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452445|NCT04973605|Dexamethasone|dexamethasone|mesh-list
139452446|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139452447|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
139452448|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
139452449|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452450|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452451|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139452452|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
139452453|NCT04973605|Hormones|hormones|mesh-ancestor
139452454|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139452455|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139452456|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452457|NCT04952610|Etripamil|etripamil|mesh-list
139452458|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139452459|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139452460|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110841|NCT01591577|Temozolomide|temozolomide|mesh-list
139452461|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139452462|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452463|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
139452464|NCT04947553|Bupropion|bupropion|mesh-list
139452465|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139452466|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
139452467|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139452468|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139452469|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139452470|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139452471|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452472|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
139452473|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139452474|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452475|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139452476|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139452477|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452478|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
139452479|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
139452480|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139452481|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139452482|NCT04939597|Memantine|memantine|mesh-list
139452483|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139452484|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139452485|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
139452486|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139452487|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452488|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452489|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139452490|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139452491|NCT04938830|Palivizumab|palivizumab|mesh-list
139452492|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
139452493|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139452494|NCT04898894|Cytarabine|cytarabine|mesh-list
139452495|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
139452496|NCT04898894|Methotrexate|methotrexate|mesh-list
139452497|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
139452498|NCT04898894|Fludarabine|fludarabine|mesh-list
139452499|NCT04898894|Venetoclax|venetoclax|mesh-list
139452500|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139452501|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
139452502|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139452503|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452504|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139452505|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
139452506|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452507|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452508|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
139452509|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452510|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139452511|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139452512|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
139452513|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139452514|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139452515|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
139452516|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139452517|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139239197|NCT02032394|Povidone|povidone|mesh-list
139452519|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452520|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452521|NCT04895722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452522|NCT04895722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452523|NCT04893109|Paclitaxel|paclitaxel|mesh-list
139452524|NCT04893109|Maytansine|maytansine|mesh-list
139452525|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139452526|NCT04893109|Trastuzumab|trastuzumab|mesh-list
139452527|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139452528|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452529|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
139452530|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
139452531|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
139452532|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452533|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452534|NCT04893109|Immunotoxins|immunotoxins|mesh-ancestor
139452535|NCT04893109|Immunoconjugates|immunoconjugates|mesh-ancestor
139452536|NCT04893109|Immunologic Factors|immunologic factors|mesh-ancestor
139452537|NCT04893109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452538|NCT04892446|Dexamethasone|dexamethasone|mesh-list
139452539|NCT04892446|Bortezomib|bortezomib|mesh-list
139452540|NCT04892446|Daratumumab|daratumumab|mesh-list
139452541|NCT04892446|Pomalidomide|pomalidomide|mesh-list
139452542|NCT04892446|Magrolimab|magrolimab|mesh-list
139452543|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139452544|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
139452545|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
139452546|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452547|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452548|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139452549|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
139452550|NCT04892446|Hormones|hormones|mesh-ancestor
139452551|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139452552|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139452553|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452554|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
139452555|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139452556|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139452557|NCT04892446|Growth Substances|growth substances|mesh-ancestor
139452558|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
139452559|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452560|NCT04866017|Durvalumab|durvalumab|mesh-list
139452561|NCT04866017|Tislelizumab|tislelizumab|mesh-list
139452562|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452563|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452564|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
139452565|NCT04828486|Futibatinib|futibatinib|mesh-list
139452566|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452567|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452568|NCT04828486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452569|NCT04828486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452570|NCT04810078|Nivolumab|nivolumab|mesh-list
139452571|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452572|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452573|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452574|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452575|NCT04790370|Heparin|heparin|mesh-list
139452576|NCT04790370|Calcium heparin|calcium heparin|mesh-list
139452577|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
139452578|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139452579|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139452580|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452581|NCT04785326|Ustekinumab|ustekinumab|mesh-list
139452582|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
139452583|NCT04770753|Mitapivat|mitapivat|mesh-list
139452584|NCT04770753|Enzyme Activators|enzyme activators|mesh-ancestor
139452585|NCT04770753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452586|NCT04759833|Prucalopride|prucalopride|mesh-list
139452587|NCT04759833|Laxatives|laxatives|mesh-ancestor
139452588|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139452589|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139452590|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139452591|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
139452592|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239261|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
139452593|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452594|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452595|NCT04749628|Cannabidiol|cannabidiol|mesh-list
139452596|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
139452597|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139452598|NCT04747847|Atorvastatin|atorvastatin|mesh-list
139452599|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139452600|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139452601|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
139452602|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452603|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139452604|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139452605|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452606|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139452607|NCT04740931|Aflibercept|aflibercept|mesh-list
139452608|NCT04740931|Faricimab|faricimab|mesh-list
139452609|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139452610|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139452611|NCT04740931|Growth Substances|growth substances|mesh-ancestor
139452612|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452613|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
139452614|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452615|NCT04727242|Gemcitabine|gemcitabine|mesh-list
139452616|NCT04727242|Dacarbazine|dacarbazine|mesh-list
139452617|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139452618|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
139452619|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452620|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452621|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139452622|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
139452623|NCT04711889|Urinastatin|urinastatin|mesh-list
139452624|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139452625|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139452626|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
139452627|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452628|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452629|NCT04708470|Entinostat|entinostat|mesh-list
139452630|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452631|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139452632|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452633|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452634|NCT04703101|Leucovorin|leucovorin|mesh-list
139452635|NCT04703101|Capecitabine|capecitabine|mesh-list
139452636|NCT04703101|Fluorouracil|fluorouracil|mesh-list
139452637|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
139452638|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139452639|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
139452640|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452641|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452642|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139452643|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
139452644|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452645|NCT04703101|Antidotes|antidotes|mesh-ancestor
139452646|NCT04703101|Protective Agents|protective agents|mesh-ancestor
139452647|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
139452648|NCT04703101|Vitamins|vitamins|mesh-ancestor
139452649|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
139452650|NCT04645160|Tivozanib|tivozanib|mesh-list
139452651|NCT04645160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139452652|NCT04645160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452653|NCT04645160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452654|NCT04603807|Crizotinib|crizotinib|mesh-list
139452655|NCT04603807|Entrectinib|entrectinib|mesh-list
139452656|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452657|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139452658|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452659|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452660|NCT04598477|Prednisone|prednisone|mesh-list
139452661|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139452662|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
139452663|NCT04598477|Hormones|hormones|mesh-ancestor
139452664|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139452665|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452666|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139452667|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452668|NCT04564157|Paclitaxel|paclitaxel|mesh-list
139452669|NCT04564157|Carboplatin|carboplatin|mesh-list
139452671|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139452672|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452673|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
139452674|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
139452675|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
139452676|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452677|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452678|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452679|NCT04542135|Sulindac|sulindac|mesh-list
139452680|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139452681|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139452682|NCT04542135|Analgesics|analgesics|mesh-ancestor
139452683|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
139452684|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452685|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452686|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139452687|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139452688|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452689|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139452690|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452691|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452692|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
139452693|NCT04539366|Fludarabine|fludarabine|mesh-list
139452694|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
139452695|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
139452696|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452697|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139452698|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139452699|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139452700|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
139452701|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452702|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452703|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139452704|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139452705|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
139452706|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
139452707|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139452708|NCT04471428|Docetaxel|docetaxel|mesh-list
139452709|NCT04471428|Atezolizumab|atezolizumab|mesh-list
139452710|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452711|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
139452712|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
139452713|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
139452714|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452715|NCT04471428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452716|NCT04471428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452717|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
139452718|NCT04448886|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139452719|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452720|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452721|NCT04448886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452722|NCT04448886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452723|NCT04448886|Immunoconjugates|immunoconjugates|mesh-ancestor
139452724|NCT04448886|Immunologic Factors|immunologic factors|mesh-ancestor
139452725|NCT04448886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452726|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
139452727|NCT04418661|Adagrasib|adagrasib|mesh-list
139452728|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452729|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452730|NCT04418661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452731|NCT04418661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452732|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
139452733|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139452734|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139452735|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
139452736|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452737|NCT04390399|Leucovorin|leucovorin|mesh-list
139452738|NCT04390399|Paclitaxel|paclitaxel|mesh-list
139452739|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
139452740|NCT04390399|Gemcitabine|gemcitabine|mesh-list
139452741|NCT04390399|Fluorouracil|fluorouracil|mesh-list
139452742|NCT04390399|Irinotecan|irinotecan|mesh-list
139452743|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139452744|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452745|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
139452746|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
139452747|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
139452748|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452749|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139452750|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
139452751|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452752|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139452753|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139452754|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
139452755|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139452756|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139452757|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
139452758|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139452759|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139452760|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452761|NCT04390399|Antidotes|antidotes|mesh-ancestor
139452762|NCT04390399|Protective Agents|protective agents|mesh-ancestor
139452763|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
139452765|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
139452766|NCT04368559|Fluconazole|fluconazole|mesh-list
139452767|NCT04368559|Posaconazole|posaconazole|mesh-list
139452768|NCT04368559|Rezafungin|rezafungin|mesh-list
139452769|NCT04368559|Trimethoprim|trimethoprim|mesh-list
139452770|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
139452771|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139452772|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
139452773|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139452774|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139452775|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139452776|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452777|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452778|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139452779|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
139452780|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139452781|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452782|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139452783|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139452784|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139452785|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
139452786|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139452787|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139452788|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139452789|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139452790|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139452791|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139452792|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139452793|NCT04364620|Docetaxel|docetaxel|mesh-list
139452794|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452795|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
139452796|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
139452797|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
139452798|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452799|NCT04333706|Capecitabine|capecitabine|mesh-list
139452800|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139452801|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
139452802|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452803|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452804|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
139452805|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139452806|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139452807|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
139452808|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452809|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452810|NCT04323202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452811|NCT04323202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452812|NCT04302025|Atezolizumab|atezolizumab|mesh-list
139452813|NCT04302025|Vemurafenib|vemurafenib|mesh-list
139452814|NCT04302025|Pralsetinib|pralsetinib|mesh-list
139452815|NCT04302025|Entrectinib|entrectinib|mesh-list
139452816|NCT04302025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452817|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452818|NCT04302025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452819|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452820|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139452821|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452822|NCT04266301|Azacitidine|azacitidine|mesh-list
139452823|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139452824|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
139452825|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452826|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452827|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452828|NCT04262206|Atorvastatin|atorvastatin|mesh-list
139452829|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139452830|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139452831|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
139452832|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452833|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139452834|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139452835|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452836|NCT04214249|Cytarabine|cytarabine|mesh-list
139452837|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
139452838|NCT04214249|Daunorubicin|daunorubicin|mesh-list
139452839|NCT04214249|Idarubicin|idarubicin|mesh-list
139452840|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452841|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452842|NCT04214249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452843|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452844|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139452845|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
139452846|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
139452847|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139452848|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139452849|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
139452850|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452851|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139452852|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139452853|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139452854|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452855|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
139452856|NCT04213794|Cisplatin|cisplatin|mesh-list
139452857|NCT04213794|Doxorubicin|doxorubicin|mesh-list
139452858|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139452859|NCT04213794|Daunorubicin|daunorubicin|mesh-list
139452860|NCT04213794|Antidotes|antidotes|mesh-list
139452861|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452862|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139452863|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139452864|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139452865|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452866|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452867|NCT04213794|Protective Agents|protective agents|mesh-ancestor
139452868|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452869|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
139452870|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
139452871|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139452872|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139452873|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
139452874|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
139452875|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139452876|NCT04163952|Panitumumab|panitumumab|mesh-list
139452877|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139452878|NCT04163952|Antibodies|antibodies|mesh-list
139452879|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
139452880|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139452881|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
139452882|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452883|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452884|NCT04150029|Azacitidine|azacitidine|mesh-list
139452885|NCT04150029|Venetoclax|venetoclax|mesh-list
139452886|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139452887|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
139452888|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239562|NCT03205163|Coagulants|coagulants|mesh-ancestor
139452889|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452890|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452891|NCT04143061|Vaccines|vaccines|mesh-list
139452892|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
139452893|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452894|NCT04141644|Ipilimumab|ipilimumab|mesh-list
139452895|NCT04141644|Osimertinib|osimertinib|mesh-list
139452896|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452897|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452898|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452899|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452900|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139452901|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452902|NCT04106856|Losartan|losartan|mesh-list
139452903|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139452904|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139452905|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139452906|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139452907|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452908|NCT04098250|Erenumab|erenumab|mesh-list
139452909|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139452910|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452911|NCT04098250|Analgesics|analgesics|mesh-ancestor
139452912|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
139452913|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452914|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452915|NCT04097028|Trifluridine|trifluridine|mesh-list
139452916|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
139452917|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452918|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
139452919|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452920|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
139452921|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139452922|NCT04039607|Nivolumab|nivolumab|mesh-list
139452923|NCT04039607|Ipilimumab|ipilimumab|mesh-list
139452924|NCT04039607|Sorafenib|sorafenib|mesh-list
139452925|NCT04039607|Lenvatinib|lenvatinib|mesh-list
139452926|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452927|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452928|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452929|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452930|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139452931|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139452932|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
139452933|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
139452934|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452935|NCT04026412|Nivolumab|nivolumab|mesh-list
139452936|NCT04026412|Ipilimumab|ipilimumab|mesh-list
139452937|NCT04026412|Durvalumab|durvalumab|mesh-list
139452938|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452939|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452940|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452941|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452942|NCT03980561|Varenicline|varenicline|mesh-list
139452943|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139452944|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139452945|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
139452946|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139452947|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452948|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452949|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
139452950|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
139452951|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452952|NCT03966807|Nicotine|nicotine|mesh-list
139452953|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139452954|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
139452955|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452956|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452957|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139452958|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139452959|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
139452960|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139452961|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452962|NCT03936309|Lidocaine|lidocaine|mesh-list
139452963|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
139452964|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
139452965|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139452966|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452967|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
139452968|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452969|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139452970|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139452971|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139452972|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139452973|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452974|NCT03929029|Nivolumab|nivolumab|mesh-list
139452975|NCT03929029|Ipilimumab|ipilimumab|mesh-list
139452976|NCT03929029|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139452977|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139452978|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139452979|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139452980|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139452981|NCT03929029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139452982|NCT03929029|Immunologic Factors|immunologic factors|mesh-ancestor
139452983|NCT03929029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452984|NCT03926299|Clobetasol|clobetasol|mesh-list
139452985|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139452986|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
139452987|NCT03926299|Hormones|hormones|mesh-ancestor
139452988|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139452989|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452990|NCT03917914|Bisoprolol|bisoprolol|mesh-list
139452991|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139452992|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
139452993|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
139452994|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139452995|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139452996|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139452997|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139452998|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139452999|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
139453000|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139453001|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453002|NCT03912363|Insulin|insulin|mesh-list
139453003|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139453004|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453005|NCT03899155|Nivolumab|nivolumab|mesh-list
139453006|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453007|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453008|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453009|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453010|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
139453011|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139453012|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
139453013|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139453014|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
139453015|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453016|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453017|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
139453018|NCT03873402|Nivolumab|nivolumab|mesh-list
139453019|NCT03873402|Ipilimumab|ipilimumab|mesh-list
139453020|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453021|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453022|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453023|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453024|NCT03863613|Progesterone|progesterone|mesh-list
139453025|NCT03863613|Progestins|progestins|mesh-ancestor
139453026|NCT03863613|Hormones|hormones|mesh-ancestor
139453027|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453028|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453029|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
139453030|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453031|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453032|NCT03861793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453033|NCT03861793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453034|NCT03853798|Mitapivat|mitapivat|mesh-list
139453035|NCT03853798|Enzyme Activators|enzyme activators|mesh-ancestor
139453036|NCT03853798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453037|NCT03844620|Trifluridine|trifluridine|mesh-list
139453038|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
139453039|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453040|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
139453041|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139453042|NCT03841357|Abatacept|abatacept|mesh-list
139453043|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453044|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453045|NCT03841357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453046|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453047|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139453048|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
139453049|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453050|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139453051|NCT03838159|Paclitaxel|paclitaxel|mesh-list
139453052|NCT03838159|Carboplatin|carboplatin|mesh-list
139453053|NCT03838159|Nivolumab|nivolumab|mesh-list
139453054|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139453055|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453056|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
139453057|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
139453058|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
139453059|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453060|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453061|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453062|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
139453063|NCT03835286|Vitamins|vitamins|mesh-ancestor
139453064|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
139453065|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453066|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
139453067|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453068|NCT03835286|Protective Agents|protective agents|mesh-ancestor
139453069|NCT03834363|Fentanyl|fentanyl|mesh-list
139453070|NCT03834363|Morphine|morphine|mesh-list
139453071|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139453072|NCT03834363|Narcotics|narcotics|mesh-ancestor
139453073|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139453074|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453075|NCT03834363|Analgesics|analgesics|mesh-ancestor
139453076|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
139453077|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139453078|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139453079|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139453080|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
139453081|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
139453082|NCT03802799|Cannabidiol|cannabidiol|mesh-list
139453083|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
139453084|NCT03778229|Osimertinib|osimertinib|mesh-list
139453085|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453086|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453087|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453088|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453089|NCT03740737|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139453090|NCT03740737|Hormones|hormones|mesh-ancestor
139453091|NCT03740737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453092|NCT03740737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453093|NCT03740334|Dexamethasone|dexamethasone|mesh-list
139453094|NCT03740334|Everolimus|everolimus|mesh-list
139453095|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139453096|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
139453097|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
139453098|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139453099|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453100|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139453101|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
139453102|NCT03740334|Hormones|hormones|mesh-ancestor
139453103|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453104|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139453105|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453106|NCT03740334|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139453107|NCT03740334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453108|NCT03740334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453109|NCT03740334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453110|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139453111|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
139453112|NCT03738618|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139453113|NCT03738618|Hormones|hormones|mesh-ancestor
139453114|NCT03738618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453115|NCT03738618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453116|NCT03737643|Paclitaxel|paclitaxel|mesh-list
139453117|NCT03737643|Bevacizumab|bevacizumab|mesh-list
139453118|NCT03737643|Carboplatin|carboplatin|mesh-list
139453119|NCT03737643|Durvalumab|durvalumab|mesh-list
139453120|NCT03737643|Olaparib|olaparib|mesh-list
139453121|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139453122|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139453123|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453124|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
139453125|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
139453126|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
139453127|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453128|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453129|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139453130|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139453131|NCT03737643|Growth Substances|growth substances|mesh-ancestor
139453132|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453133|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
139453134|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
139453135|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139453136|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453137|NCT03717415|Carboplatin|carboplatin|mesh-list
139453138|NCT03717415|Rebastinib|rebastinib|mesh-list
139453139|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453140|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453141|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453142|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453143|NCT03708822|Docetaxel|docetaxel|mesh-list
139453144|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
139453145|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453146|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
139453147|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
139453148|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
139453149|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453150|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453151|NCT03694249|Ifetroban|ifetroban|mesh-list
139453152|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139453153|NCT03677154|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139453154|NCT03677154|Immunoconjugates|immunoconjugates|mesh-ancestor
139453155|NCT03677154|Immunologic Factors|immunologic factors|mesh-ancestor
139453156|NCT03677154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453157|NCT03604406|Vaccines|vaccines|mesh-list
139453158|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
139453159|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453160|NCT03581292|Temozolomide|temozolomide|mesh-list
139453161|NCT03581292|Veliparib|veliparib|mesh-list
139453162|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139453163|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
139453164|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453165|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453166|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139453167|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453168|NCT03535506|Palbociclib|palbociclib|mesh-list
139453169|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453170|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453171|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453172|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453173|NCT03533283|Atezolizumab|atezolizumab|mesh-list
139453174|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
139453175|NCT03533283|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139453176|NCT03533283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453177|NCT03533283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453178|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453179|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453180|NCT03533283|Immunoconjugates|immunoconjugates|mesh-ancestor
139453181|NCT03533283|Immunologic Factors|immunologic factors|mesh-ancestor
139453182|NCT03533283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453183|NCT03505762|Prednisone|prednisone|mesh-list
139453184|NCT03505762|Cortisone|cortisone|mesh-list
139453185|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
139453186|NCT03505762|Rituximab|rituximab|mesh-list
139453187|NCT03505762|Doxorubicin|doxorubicin|mesh-list
139453188|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139453189|NCT03505762|Vincristine|vincristine|mesh-list
139453190|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139453191|NCT03505762|Antibodies|antibodies|mesh-list
139453192|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
139453193|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139453194|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139453196|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453197|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139453198|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139453199|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
139453200|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111585|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
139453201|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453202|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139453203|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139453204|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139453205|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139453206|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453207|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139453208|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
139453209|NCT03505762|Hormones|hormones|mesh-ancestor
139453210|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453211|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139453212|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139453213|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
139453214|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
139453215|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
139453216|NCT03491059|Nicotine|nicotine|mesh-list
139453217|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139453218|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
139453219|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139453220|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453221|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139453222|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139453223|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
139453224|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139453225|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453226|NCT03484923|Spartalizumab|spartalizumab|mesh-list
139453227|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453228|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453229|NCT03484923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453230|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453231|NCT03479502|Doxycycline|doxycycline|mesh-list
139453232|NCT03479502|Prednisone|prednisone|mesh-list
139453233|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
139453234|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139453235|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139453236|NCT03479502|Prednisolone|prednisolone|mesh-list
139453237|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
139453238|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139453239|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
139453240|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139453241|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
139453242|NCT03479502|Hormones|hormones|mesh-ancestor
139453243|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453244|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453245|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139453246|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453247|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
139453248|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
139453249|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139453250|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139453251|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139453252|NCT03479502|Protective Agents|protective agents|mesh-ancestor
139453253|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139453254|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139453255|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
139453256|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139453257|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139453258|NCT03471364|Ketoconazole|ketoconazole|mesh-list
139453259|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
139453260|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139453261|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139453262|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139453263|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453264|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453265|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139453266|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
139453267|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453268|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453269|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139453270|NCT03448042|Trastuzumab|trastuzumab|mesh-list
139453271|NCT03448042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453272|NCT03448042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453273|NCT03433469|Osimertinib|osimertinib|mesh-list
139453274|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453275|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453276|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453277|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453278|NCT03427736|Ketorolac|ketorolac|mesh-list
139453279|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139453280|NCT03427736|Ketamine|ketamine|mesh-list
139453281|NCT03427736|Morphine|morphine|mesh-list
139453282|NCT03427736|Oxycodone|oxycodone|mesh-list
139453283|NCT03427736|Hydromorphone|hydromorphone|mesh-list
139453284|NCT03427736|Analgesics|analgesics|mesh-ancestor
139453285|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
139453286|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139453287|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453288|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139453289|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139453290|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
139453291|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
139453292|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139453293|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139453294|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139453295|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139453296|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453297|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139453298|NCT03427736|Narcotics|narcotics|mesh-ancestor
139453299|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139453300|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139453301|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139453302|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139453303|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139453304|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453305|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139453306|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139453307|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139453308|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
139453309|NCT03377361|Nivolumab|nivolumab|mesh-list
139453310|NCT03377361|Ipilimumab|ipilimumab|mesh-list
139453311|NCT03377361|Trametinib|trametinib|mesh-list
139453312|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453313|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453314|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453315|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453316|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453317|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453318|NCT03367572|Dexamethasone|dexamethasone|mesh-list
139453319|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
139453320|NCT03367572|Olanzapine|olanzapine|mesh-list
139453321|NCT03367572|Palonosetron|palonosetron|mesh-list
139453322|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
139453323|NCT03367572|Ichthammol|ichthammol|mesh-list
139453324|NCT03367572|BB 1101|bb 1101|mesh-list
139453325|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139453326|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
139453327|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
139453328|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139453329|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453330|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139453331|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
139453332|NCT03367572|Hormones|hormones|mesh-ancestor
139453333|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453334|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139453335|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453336|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139453337|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139453338|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139453339|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139453340|NCT03367572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139453341|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139453342|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139453343|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453344|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139453346|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
139453347|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453348|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139453349|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139453350|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
139453351|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139453352|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
139453353|NCT03323151|Ixazomib|ixazomib|mesh-list
139453354|NCT03323151|Glycine|glycine|mesh-list
139453355|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453356|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
139453357|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453358|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453359|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
139453360|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139453361|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453362|NCT03308578|Atorvastatin|atorvastatin|mesh-list
139453363|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139453364|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139453365|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
139453366|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453367|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139453368|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139453369|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453370|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
139453371|NCT03276832|Imiquimod|imiquimod|mesh-list
139453372|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453373|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453374|NCT03276832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453375|NCT03276832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453376|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139453377|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
139453378|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453379|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
139453380|NCT03274258|Nivolumab|nivolumab|mesh-list
139453381|NCT03274258|Ipilimumab|ipilimumab|mesh-list
139453382|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453383|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453384|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453385|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453386|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
139453387|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453388|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453389|NCT03179917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453390|NCT03179917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453391|NCT03146650|Nivolumab|nivolumab|mesh-list
139453392|NCT03146650|Ipilimumab|ipilimumab|mesh-list
139453393|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453394|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453395|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453396|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453397|NCT03138512|Nivolumab|nivolumab|mesh-list
139453398|NCT03138512|Ipilimumab|ipilimumab|mesh-list
139453399|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453400|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453401|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453402|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453403|NCT03132532|Paclitaxel|paclitaxel|mesh-list
139453404|NCT03132532|Etoposide|etoposide|mesh-list
139453405|NCT03132532|Podophyllotoxin|podophyllotoxin|mesh-list
139453406|NCT03132532|Cisplatin|cisplatin|mesh-list
139453407|NCT03132532|Carboplatin|carboplatin|mesh-list
139453408|NCT03132532|Pemetrexed|pemetrexed|mesh-list
139453409|NCT03132532|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139453410|NCT03132532|Etoposide phosphate|etoposide phosphate|mesh-list
139453411|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139453412|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453413|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
139453414|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
139453415|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
139453416|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453417|NCT03132532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139453418|NCT03132532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139453419|NCT03132532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453420|NCT03132532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139453421|NCT03132532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139453422|NCT03132532|Keratolytic Agents|keratolytic agents|mesh-ancestor
139453423|NCT03132532|Dermatologic Agents|dermatologic agents|mesh-ancestor
139453425|NCT03131908|GSK2636771|gsk2636771|mesh-list
139453426|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453427|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453428|NCT03131908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453429|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453430|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453431|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453432|NCT03128034|Cyclosporine|cyclosporine|mesh-list
139453433|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
139453434|NCT03128034|Fludarabine|fludarabine|mesh-list
139453435|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
139453436|NCT03128034|Cyclosporins|cyclosporins|mesh-list
139453437|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453438|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139453439|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
139453440|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453441|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139453442|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
139453443|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453444|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453445|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
139453446|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139453447|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
139453448|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139453449|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139453450|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139453451|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139453452|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
139453453|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139453454|NCT03091192|Sunitinib|sunitinib|mesh-list
139453455|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453456|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139453457|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139453458|NCT03091192|Growth Substances|growth substances|mesh-ancestor
139453459|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453460|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
139453461|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453462|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453463|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453464|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
139453465|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453466|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453467|NCT03087760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453468|NCT03087760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453469|NCT03081689|Paclitaxel|paclitaxel|mesh-list
139453470|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139453471|NCT03081689|Carboplatin|carboplatin|mesh-list
139453472|NCT03081689|Nivolumab|nivolumab|mesh-list
139453473|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139453474|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453475|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
139453476|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
139453477|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
139453478|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453479|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453480|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453481|NCT02968212|Clofazimine|clofazimine|mesh-list
139453482|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139453483|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
139453484|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139453485|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139453486|NCT02871219|Lenalidomide|lenalidomide|mesh-list
139453487|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
139453488|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
139453489|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453490|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139453491|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139453492|NCT02871219|Growth Substances|growth substances|mesh-ancestor
139453493|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
139453494|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453495|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453496|NCT02860000|Fulvestrant|fulvestrant|mesh-list
139453497|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139453498|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453499|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139453500|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139453501|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
139453502|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453503|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453504|NCT02829723|Spartalizumab|spartalizumab|mesh-list
139453505|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453506|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453507|NCT02829723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453508|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453509|NCT02735057|Paclitaxel|paclitaxel|mesh-list
139453510|NCT02735057|Carboplatin|carboplatin|mesh-list
139453511|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139453512|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453513|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
139453514|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
139453515|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
139453516|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453517|NCT02722616|Pancrelipase|pancrelipase|mesh-list
139453518|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139453519|NCT02720068|Leucovorin|leucovorin|mesh-list
139453520|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
139453521|NCT02720068|Fluorouracil|fluorouracil|mesh-list
139453522|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
139453523|NCT02720068|Irinotecan|irinotecan|mesh-list
139453524|NCT02720068|Lenvatinib|lenvatinib|mesh-list
139453525|NCT02720068|Calcium|calcium|mesh-list
139453526|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
139453527|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453528|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453529|NCT02720068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453530|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453531|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139453532|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453533|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
139453534|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139453535|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139453536|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
139453537|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139453538|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139453539|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453540|NCT02720068|Antidotes|antidotes|mesh-ancestor
139453541|NCT02720068|Protective Agents|protective agents|mesh-ancestor
139453542|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
139453543|NCT02720068|Vitamins|vitamins|mesh-ancestor
139453544|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
139453545|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453546|NCT02658487|Cytarabine|cytarabine|mesh-list
139453547|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139453548|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
139453549|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453550|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453551|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
139453552|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139453553|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139453554|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
139453555|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453556|NCT02604914|Levodopa|levodopa|mesh-list
139453557|NCT02604914|Carbidopa|carbidopa|mesh-list
139453558|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139453559|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139453560|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139453561|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
139453562|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139453563|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453564|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382720|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453565|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139453566|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453567|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139453568|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
139453569|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
139453570|NCT02593175|Paclitaxel|paclitaxel|mesh-list
139453571|NCT02593175|Carboplatin|carboplatin|mesh-list
139453572|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139453573|NCT02593175|Panitumumab|panitumumab|mesh-list
139453574|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139453575|NCT02593175|Antibodies|antibodies|mesh-list
139453576|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
139453577|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139453578|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139453579|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453580|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
139453581|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
139453582|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
139453583|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453584|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
139453585|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453586|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
139453587|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453588|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
139453589|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453590|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453591|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139453592|NCT02553460|Leucovorin|leucovorin|mesh-list
139453593|NCT02553460|Cytarabine|cytarabine|mesh-list
139453594|NCT02553460|Dexamethasone|dexamethasone|mesh-list
139453595|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
139453596|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
139453597|NCT02553460|Methotrexate|methotrexate|mesh-list
139453598|NCT02553460|Etoposide|etoposide|mesh-list
139453599|NCT02553460|Vincristine|vincristine|mesh-list
139453600|NCT02553460|Bortezomib|bortezomib|mesh-list
139453601|NCT02553460|Asparaginase|asparaginase|mesh-list
139453602|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
139453603|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
139453604|NCT02553460|Vorinostat|vorinostat|mesh-list
139453605|NCT02553460|Pegaspargase|pegaspargase|mesh-list
139453606|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
139453607|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139453608|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
139453609|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453610|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139453611|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139453612|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
139453613|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453614|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453615|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139453616|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139453617|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
139453618|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
139453619|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139453620|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139453621|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
139453622|NCT02553460|Hormones|hormones|mesh-ancestor
139453623|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453624|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139453625|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139453626|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
139453627|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139453628|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139453629|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
139453630|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
139453631|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453632|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139453633|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139453634|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139453635|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139453636|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139453637|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
139453638|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139453639|NCT02553460|Antidotes|antidotes|mesh-ancestor
139453640|NCT02553460|Protective Agents|protective agents|mesh-ancestor
139453641|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
139453642|NCT02553460|Vitamins|vitamins|mesh-ancestor
139453643|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
139453644|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
139453645|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
139453646|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
139453647|NCT02553460|Analgesics|analgesics|mesh-ancestor
139453648|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
139453649|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139453650|NCT02525757|Paclitaxel|paclitaxel|mesh-list
139453651|NCT02525757|Carboplatin|carboplatin|mesh-list
139453652|NCT02525757|Atezolizumab|atezolizumab|mesh-list
139453653|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139453654|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453655|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
139453656|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
139453657|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
139453658|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453659|NCT02525757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453660|NCT02525757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453661|NCT02502266|Paclitaxel|paclitaxel|mesh-list
139453662|NCT02502266|Doxorubicin|doxorubicin|mesh-list
139453663|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139453664|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139453665|NCT02502266|Topotecan|topotecan|mesh-list
139453666|NCT02502266|Olaparib|olaparib|mesh-list
139453667|NCT02502266|Cediranib|cediranib|mesh-list
139453668|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139453669|NCT02502266|Maleic acid|maleic acid|mesh-list
139453670|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139453671|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453672|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
139453673|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
139453674|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
139453675|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453676|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139453677|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139453678|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139453679|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453680|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139453681|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453682|NCT02453282|Paclitaxel|paclitaxel|mesh-list
139453683|NCT02453282|Cisplatin|cisplatin|mesh-list
139453684|NCT02453282|Carboplatin|carboplatin|mesh-list
139453685|NCT02453282|Gemcitabine|gemcitabine|mesh-list
139453686|NCT02453282|Pemetrexed|pemetrexed|mesh-list
139453687|NCT02453282|Durvalumab|durvalumab|mesh-list
139453688|NCT02453282|Tremelimumab|tremelimumab|mesh-list
139453689|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139453690|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139453691|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453692|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
139453693|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
139453694|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
139453695|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453696|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139453697|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
139453698|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453699|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139453700|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139453701|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453702|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
139453703|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453704|NCT02435212|Deferasirox|deferasirox|mesh-list
139453705|NCT02435212|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139453706|NCT02435212|Chelating Agents|chelating agents|mesh-ancestor
139453707|NCT02435212|Sequestering Agents|sequestering agents|mesh-ancestor
139453708|NCT02435212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453709|NCT02344290|Pitavastatin|pitavastatin|mesh-list
139453710|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139453711|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139453712|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139453713|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
139453714|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453715|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453716|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139453717|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139453718|NCT02296125|Gefitinib|gefitinib|mesh-list
139453719|NCT02296125|Osimertinib|osimertinib|mesh-list
139453720|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453721|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453722|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453723|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453724|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
139453725|NCT02287311|Fludarabine|fludarabine|mesh-list
139453726|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139453727|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
139453728|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453729|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139453730|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139453731|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
139453732|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453733|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453734|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139453735|NCT02276443|Immunomodulating Agents|immunomodulating agents|mesh-list
139453736|NCT02276443|Immunologic Factors|immunologic factors|mesh-ancestor
139453737|NCT02276443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453738|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139453739|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453740|NCT02096601|Levodopa|levodopa|mesh-list
139453741|NCT02096601|Carbidopa|carbidopa|mesh-list
139453742|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139453743|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139453744|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
139453745|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139453746|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453747|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453748|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139453749|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453750|NCT02087423|Durvalumab|durvalumab|mesh-list
139453751|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453752|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453753|NCT02031419|Rituximab|rituximab|mesh-list
139453754|NCT02031419|Spebrutinib|spebrutinib|mesh-list
139453755|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453756|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453757|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
139453758|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453759|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139453760|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453761|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453762|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453763|NCT01954979|Abatacept|abatacept|mesh-list
139453764|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139453765|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453766|NCT01954979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139453767|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453768|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139453769|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
139453770|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453771|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139453772|NCT01883505|Levodopa|levodopa|mesh-list
139453773|NCT01883505|Carbidopa|carbidopa|mesh-list
139453774|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139453775|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139453776|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
139453777|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139453778|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453779|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453780|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139453781|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453782|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
139453783|NCT01878617|Gemcitabine|gemcitabine|mesh-list
139453784|NCT01878617|Vincristine|vincristine|mesh-list
139453785|NCT01878617|Pemetrexed|pemetrexed|mesh-list
139453786|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139453787|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
139453788|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453789|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139453790|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139453791|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
139453792|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453793|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453794|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139453795|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139453796|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
139453797|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139453798|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
139240488|NCT03426657|Durvalumab|durvalumab|mesh-list
139453799|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
139453800|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
139453801|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453802|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139453803|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139453804|NCT01874353|Olaparib|olaparib|mesh-list
139453805|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139453806|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453807|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453808|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453809|NCT01802632|Osimertinib|osimertinib|mesh-list
139453810|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453811|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453812|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453813|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453814|NCT01782131|Voriconazole|voriconazole|mesh-list
139453815|NCT01782131|Posaconazole|posaconazole|mesh-list
139453816|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
139453817|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139453818|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139453819|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139453820|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453821|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453822|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139453823|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
139453824|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453825|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453826|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139453827|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139453828|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139453829|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139453830|NCT01725802|Levodopa|levodopa|mesh-list
139453831|NCT01725802|Carbidopa|carbidopa|mesh-list
139453832|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139453833|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139453834|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
139453835|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139453836|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453837|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453838|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139453839|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453840|NCT01582191|Everolimus|everolimus|mesh-list
139453841|NCT01582191|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139453842|NCT01582191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453843|NCT01582191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453844|NCT01582191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453845|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139453846|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
139453847|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453848|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453849|NCT03235037|Levodopa|levodopa|mesh-list
139453850|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139453851|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139453852|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
139453853|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139453854|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453855|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453856|NCT00700271|Amlodipine|amlodipine|mesh-list
139453857|NCT00700271|Valsartan|valsartan|mesh-list
139453858|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139453859|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139453860|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139453861|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453862|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139453863|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453864|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
139453865|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139453866|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139453867|NCT03228797|Ropivacaine|ropivacaine|mesh-list
139453868|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
139453869|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
139453870|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139453871|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453872|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
139453873|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139453874|NCT03044379|Dapivirine|dapivirine|mesh-list
139453875|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139453876|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139453877|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
139453878|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139453879|NCT04864509|Melatonin|melatonin|mesh-list
139453880|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
139453881|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453882|NCT04864509|Protective Agents|protective agents|mesh-ancestor
139453883|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453884|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139453885|NCT04875039|Dexamethasone|dexamethasone|mesh-list
139453886|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
139453887|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
139453888|NCT04875039|BB 1101|bb 1101|mesh-list
139453889|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139453890|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
139453891|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
139453892|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139453893|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453894|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139453895|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
139453896|NCT04875039|Hormones|hormones|mesh-ancestor
139453897|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453898|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139453899|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453900|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
139453901|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453902|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453903|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139453904|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139453905|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139453906|NCT04875039|Analgesics|analgesics|mesh-ancestor
139453907|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
139453908|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139453909|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139453910|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139453911|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
139453912|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139453913|NCT02452385|Vorolanib|vorolanib|mesh-list
139453914|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139453915|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453916|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453917|NCT03045783|Cefotiam|cefotiam|mesh-list
139453918|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139453919|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139453920|NCT01375049|Aztreonam|aztreonam|mesh-list
139453921|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139453922|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139453923|NCT04146207|Prednisone|prednisone|mesh-list
139453924|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139453925|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
139453926|NCT04146207|Hormones|hormones|mesh-ancestor
139453927|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453928|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453929|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139453930|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453931|NCT04863807|Anesthetics|anesthetics|mesh-list
139112324|NCT03874260|Fenofibrate|fenofibrate|mesh-list
139453932|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139453933|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453934|NCT02452307|Imiquimod|imiquimod|mesh-list
139453935|NCT02452307|Molgramostim|molgramostim|mesh-list
139453936|NCT02452307|Protamines|protamines|mesh-list
139453937|NCT02452307|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139453938|NCT02452307|Sargramostim|sargramostim|mesh-list
139453939|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139453940|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
139453941|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453942|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453943|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
139453944|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
139453945|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453946|NCT02452307|Coagulants|coagulants|mesh-ancestor
139453947|NCT02452151|Infliximab|infliximab|mesh-list
139453948|NCT02452151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139453950|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
139453951|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139453952|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139453953|NCT04485299|Listerine|listerine|mesh-list
139453954|NCT04485299|Fluorides|fluorides|mesh-list
139453955|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
139453956|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
139453957|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
139453958|NCT04485299|Protective Agents|protective agents|mesh-ancestor
139453959|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453960|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139453961|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139453962|NCT01594749|Dexamethasone|dexamethasone|mesh-list
139453963|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
139453964|NCT01594749|Ondansetron|ondansetron|mesh-list
139453965|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
139453966|NCT01594749|Aprepitant|aprepitant|mesh-list
139453967|NCT01594749|BB 1101|bb 1101|mesh-list
139453968|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139453969|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
139453970|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
139453971|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139453972|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139453973|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139453974|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
139453975|NCT01594749|Hormones|hormones|mesh-ancestor
139453976|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139453977|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139453978|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139453979|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
139453980|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139453981|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139453982|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
139453983|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
139453984|NCT01594749|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139453985|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139453986|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
139453987|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139453988|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139453989|NCT03226145|Scopolamine|scopolamine|mesh-list
139453990|NCT03226145|Bisacodyl|bisacodyl|mesh-list
139453991|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139453992|NCT03226145|Cathartics|cathartics|mesh-ancestor
139453993|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139453994|NCT03226145|Laxatives|laxatives|mesh-ancestor
139453995|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139453996|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
139453997|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
139453998|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139453999|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454000|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
139454001|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139454002|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
139454003|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454004|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454005|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139454006|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
139454007|NCT04863183|Triamcinolone|triamcinolone|mesh-list
139454008|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139454009|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139454010|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139454011|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454012|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
139454013|NCT04863183|Hormones|hormones|mesh-ancestor
139454014|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454015|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454016|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139454017|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
139454018|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454019|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454020|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
139454021|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139454022|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139240701|NCT01335529|Interferons|interferons|mesh-list
139454023|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139454024|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139454025|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454026|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
139454027|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454028|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454029|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139454030|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454031|NCT04380753|Sotorasib|sotorasib|mesh-list
139454032|NCT04380753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139454033|NCT04380753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454034|NCT04380753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139454035|NCT04380753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454036|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
139454037|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454038|NCT02453009|Prednisone|prednisone|mesh-list
139454039|NCT02453009|Docetaxel|docetaxel|mesh-list
139454040|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454041|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
139454042|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
139454043|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
139454044|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454045|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454046|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
139454047|NCT02453009|Hormones|hormones|mesh-ancestor
139454048|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454049|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454050|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139454051|NCT04868175|Timolol|timolol|mesh-list
139454052|NCT04868175|Travoprost|travoprost|mesh-list
139454053|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139454054|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139454055|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
139454056|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454057|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454058|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454059|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139454060|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139454061|NCT02452775|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139454062|NCT02452775|Poly ICLC|poly iclc|mesh-list
139454063|NCT02452775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139454064|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
139454065|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454066|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
139454067|NCT03045627|Cytarabine|cytarabine|mesh-list
139454068|NCT03045627|Aclarubicin|aclarubicin|mesh-list
139454069|NCT03045627|Lenograstim|lenograstim|mesh-list
139454070|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139454071|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
139454072|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454073|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454074|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
139454075|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454076|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139454077|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
139454078|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454079|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139454080|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139454081|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139454082|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139454083|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454084|NCT04868019|Fenofibrate|fenofibrate|mesh-list
139454085|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139454086|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
139454087|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454088|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139454089|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
139454090|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454091|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139454092|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454093|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454094|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
139454095|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454096|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454097|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139454098|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
139454099|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139454100|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454101|NCT02179918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139454102|NCT02179918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454103|NCT03233321|Heparin|heparin|mesh-list
139454104|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139454105|NCT03233321|Tinzaparin|tinzaparin|mesh-list
139454106|NCT03233321|Dalteparin|dalteparin|mesh-list
139454107|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
139454108|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139454109|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139454110|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454111|NCT04868253|Oxazepam|oxazepam|mesh-list
139454112|NCT04868253|Metyrapone|metyrapone|mesh-list
139454113|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
139454114|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454115|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454116|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139454117|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139454118|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454119|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139454120|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139454121|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139454122|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
139454123|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
139454124|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454125|NCT02153788|Temazepam|temazepam|mesh-list
139454126|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139454127|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139454128|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454129|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139454130|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139454131|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139454132|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
139454133|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
139454134|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454135|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454136|NCT03224039|Sufentanil|sufentanil|mesh-list
139454137|NCT03224039|Morphine|morphine|mesh-list
139454138|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139454139|NCT03224039|Narcotics|narcotics|mesh-ancestor
139454140|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139454141|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454142|NCT03224039|Analgesics|analgesics|mesh-ancestor
139454143|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
139454144|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454145|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139454146|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139454147|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
139454148|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
139454149|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
139454150|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454151|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139454152|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454153|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454154|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
139454155|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454156|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454157|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139454158|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
139454159|NCT03223961|Hematinics|hematinics|mesh-ancestor
139454160|NCT03045471|Prednisolone|prednisolone|mesh-list
139454161|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139454162|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
139454163|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139454164|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
139454165|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
139454166|NCT03045471|Rituximab|rituximab|mesh-list
139454167|NCT03045471|Etoposide|etoposide|mesh-list
139454168|NCT03045471|Vincristine|vincristine|mesh-list
139454169|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139454170|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
139454171|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139454172|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
139454173|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454174|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139454175|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139454176|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
139454177|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454178|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454179|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139454180|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139454181|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139454182|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139454183|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139454184|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454185|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454186|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
139454187|NCT03045471|Hormones|hormones|mesh-ancestor
139454188|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454189|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139454190|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
139454191|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
139454192|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454193|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139454194|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139454195|NCT03045471|Protective Agents|protective agents|mesh-ancestor
139454196|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
139454197|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
139454198|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
139454199|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
139454200|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139454201|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139454202|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139454203|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139454204|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454205|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
139454206|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454207|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454208|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139454209|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454210|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
139454211|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454212|NCT04873479|Ketamine|ketamine|mesh-list
139454213|NCT04873479|Esketamine|esketamine|mesh-list
139454214|NCT04873479|Analgesics|analgesics|mesh-ancestor
139454215|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
139454216|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454217|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454218|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139454219|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139454220|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
139454221|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
139454222|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139454223|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139454224|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139454225|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454226|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454227|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
139454228|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139454229|NCT02451527|Digoxin|digoxin|mesh-list
139454230|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139454231|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139454232|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454233|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454234|NCT02451527|Protective Agents|protective agents|mesh-ancestor
139454235|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454236|NCT04873011|Quinine|quinine|mesh-list
139454237|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
139454238|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139454239|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139454240|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454241|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139454242|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454243|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139454244|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454245|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139454246|NCT04873011|Analgesics|analgesics|mesh-ancestor
139454247|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
139454248|NCT02451605|Analgesics|analgesics|mesh-list
139454249|NCT02451605|Ropivacaine|ropivacaine|mesh-list
139454250|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
139454251|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
139454252|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139454253|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454254|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
139454255|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454256|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
139454257|NCT03222323|Ropivacaine|ropivacaine|mesh-list
139454258|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139454259|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139454260|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454261|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139454262|NCT03222323|Analgesics|analgesics|mesh-ancestor
139454263|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
139454264|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454265|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139454266|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139454267|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139454268|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
139454269|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454270|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454271|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
139454272|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
139454273|NCT03043677|Adalimumab|adalimumab|mesh-list
139454274|NCT03043677|Infliximab|infliximab|mesh-list
139454275|NCT03043677|Golimumab|golimumab|mesh-list
139454276|NCT03043677|Ustekinumab|ustekinumab|mesh-list
139454277|NCT03043677|Vedolizumab|vedolizumab|mesh-list
139454278|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139454279|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454280|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139454281|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
139454282|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139454283|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139454284|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
139454285|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454286|NCT03222089|Leucovorin|leucovorin|mesh-list
139454287|NCT03222089|Fluorouracil|fluorouracil|mesh-list
139454288|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
139454289|NCT03222089|Irinotecan|irinotecan|mesh-list
139454290|NCT03222089|Interleukin-2|interleukin-2|mesh-list
139454291|NCT03222089|Molgramostim|molgramostim|mesh-list
139454292|NCT03222089|Sargramostim|sargramostim|mesh-list
139454293|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
139454294|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
139454295|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454296|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139454297|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454298|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139454299|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
139454300|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454301|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139454302|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139454303|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454304|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139454305|NCT03222089|Analgesics|analgesics|mesh-ancestor
139454306|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
139454307|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454308|NCT03222089|Antidotes|antidotes|mesh-ancestor
139454309|NCT03222089|Protective Agents|protective agents|mesh-ancestor
139454310|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
139454311|NCT03222089|Vitamins|vitamins|mesh-ancestor
139454312|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
139454313|NCT03043989|Clarithromycin|clarithromycin|mesh-list
139454314|NCT03043989|Docetaxel|docetaxel|mesh-list
139454315|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454316|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
139454317|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
139454318|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
139454319|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454320|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139454321|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454322|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139454323|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454324|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139454325|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139454326|NCT03222167|Grazoprevir|grazoprevir|mesh-list
139454327|NCT03222167|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139454328|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
139454329|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454330|NCT03221855|Domperidone|domperidone|mesh-list
139454331|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
139454332|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
139454333|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454334|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454335|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139454336|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139454337|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
139454338|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454339|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454340|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
139454341|NCT03043521|Lansoprazole|lansoprazole|mesh-list
139454342|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139454343|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139454344|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139454345|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454346|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454348|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139454349|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
139454350|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454351|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139454352|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454353|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454354|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
139454355|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139454356|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
139454357|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454358|NCT03221231|Expectorants|expectorants|mesh-ancestor
139454359|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
139454360|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139454361|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
139454362|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454363|NCT03221231|Protective Agents|protective agents|mesh-ancestor
139454364|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454365|NCT03221231|Antidotes|antidotes|mesh-ancestor
139454366|NCT03221621|Adalimumab|adalimumab|mesh-list
139454367|NCT03221621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139454368|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454369|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139454370|NCT03220841|Adalimumab|adalimumab|mesh-list
139454371|NCT03220841|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139454372|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454373|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139454374|NCT03045393|Maytansine|maytansine|mesh-list
139454375|NCT03045393|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139454376|NCT03045393|Immunoconjugates|immunoconjugates|mesh-ancestor
139454377|NCT03045393|Immunologic Factors|immunologic factors|mesh-ancestor
139454378|NCT03045393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454379|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139454380|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454381|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
139454382|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
139454383|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
139454384|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454385|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
139454386|NCT01374971|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139454387|NCT01374971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454388|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139454389|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
139454390|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454391|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139454392|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
139454393|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454394|NCT02505971|Propranolol|propranolol|mesh-list
139454395|NCT02505971|Nadolol|nadolol|mesh-list
139454396|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139454397|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139454398|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
139454399|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454400|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454401|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454402|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139454403|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139454404|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
139454405|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
139454406|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
139454407|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454409|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
139454410|NCT02505581|Cefuroxime|cefuroxime|mesh-list
139454411|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
139454412|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454413|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139454414|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139454415|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139454416|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139454417|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139454418|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454419|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454420|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454421|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139454422|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139454423|NCT02451293|Melatonin|melatonin|mesh-list
139454424|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
139454425|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454426|NCT02451293|Protective Agents|protective agents|mesh-ancestor
139454427|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454428|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139454429|NCT02505113|Montelukast|montelukast|mesh-list
139454430|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139454431|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
139454432|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139454433|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
139454434|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454435|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454436|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139454437|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139454438|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454439|NCT02504801|Budesonide|budesonide|mesh-list
139454440|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454441|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139454442|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
139454443|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454444|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454445|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139454446|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
139454447|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
139454448|NCT02504801|Hormones|hormones|mesh-ancestor
139454449|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454450|NCT02504177|Anticoagulants|anticoagulants|mesh-list
139454451|NCT02450981|Bevacizumab|bevacizumab|mesh-list
139454452|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139454453|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454454|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139454455|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139454456|NCT02450981|Growth Substances|growth substances|mesh-ancestor
139454457|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454458|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
139454459|NCT02503943|Metformin|metformin|mesh-list
139454460|NCT02503943|Liraglutide|liraglutide|mesh-list
139454461|NCT02503943|Mitiglinide|mitiglinide|mesh-list
139454462|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139454463|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454464|NCT02503943|Incretins|incretins|mesh-ancestor
139454465|NCT02503943|Hormones|hormones|mesh-ancestor
139454466|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454467|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
139454468|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139454469|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139454470|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454471|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139454472|NCT03213743|Analgesics|analgesics|mesh-ancestor
139454473|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
139454474|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454475|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139454476|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139454477|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139241164|NCT02237534|Calcium|calcium|mesh-list
139454478|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
139454479|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454480|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454481|NCT03212495|Neostigmine|neostigmine|mesh-list
139454482|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454483|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454484|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454485|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454486|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139454487|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454488|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
139454489|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139454490|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
139454491|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
139454492|NCT02503319|Oxytocin|oxytocin|mesh-list
139454493|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
139454494|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139454495|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454496|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139454497|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139454498|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454499|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
139454500|NCT02503319|Coagulants|coagulants|mesh-ancestor
139454501|NCT02610777|Azacitidine|azacitidine|mesh-list
139454502|NCT02610777|Pevonedistat|pevonedistat|mesh-list
139454503|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139454504|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
139454505|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454506|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454507|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454508|NCT01628692|Ribavirin|ribavirin|mesh-list
139454509|NCT01628692|Simeprevir|simeprevir|mesh-list
139454510|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
139454511|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454512|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
139454513|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454514|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
139454515|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454516|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139454517|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139454518|NCT04496921|Vitamins|vitamins|mesh-list
139454519|NCT04496921|Vitamin K|vitamin k|mesh-list
139454520|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
139454521|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454522|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139454523|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139454524|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454525|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
139454526|NCT04496921|Coagulants|coagulants|mesh-ancestor
139454527|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
139454528|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139454529|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139454530|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139454531|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139454532|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454533|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
139454534|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454535|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454536|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139454537|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454538|NCT03043443|Melatonin|melatonin|mesh-list
139454539|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
139454540|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454541|NCT03043443|Protective Agents|protective agents|mesh-ancestor
139454542|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454543|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139454544|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
139454545|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
139454546|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454547|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454548|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
139454549|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139454550|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139454551|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
139454552|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139241241|NCT03075891|Ivermectin|ivermectin|mesh-list
139454553|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
139454554|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
139454555|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
139454557|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
139454558|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
139454559|NCT03209219|Cyclosporine|cyclosporine|mesh-list
139454560|NCT03209219|Cyclosporins|cyclosporins|mesh-list
139454561|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454562|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
139454563|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454564|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454565|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454566|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139454567|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
139454568|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454569|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
139454570|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
139454571|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139454572|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139454573|NCT04872231|Voriconazole|voriconazole|mesh-list
139454574|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
139454575|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454576|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139454577|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139454578|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454579|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454580|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139454581|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
139454582|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454583|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454584|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139454585|NCT04860531|Betamethasone|betamethasone|mesh-list
139454586|NCT04860531|Lidocaine|lidocaine|mesh-list
139454587|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
139454588|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
139454589|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139454590|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454591|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
139454592|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454593|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139454594|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139454595|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139454596|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139454597|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454598|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454599|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
139454600|NCT04860531|Hormones|hormones|mesh-ancestor
139454601|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454602|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139454603|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
139454604|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
139454605|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139454606|NCT01594827|Vancomycin|vancomycin|mesh-list
139454607|NCT01594827|Doxycycline|doxycycline|mesh-list
139454608|NCT01594827|Rifampin|rifampin|mesh-list
139454609|NCT01594827|Trimethoprim|trimethoprim|mesh-list
139454610|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
139454611|NCT01594827|Mupirocin|mupirocin|mesh-list
139454612|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139454613|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454614|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
139454615|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
139454616|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139454617|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
139454618|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139454619|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139454620|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139454621|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
139454622|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
139454623|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139454624|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454625|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454626|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139454627|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139454628|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139454629|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139454630|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139454631|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139454632|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139454633|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139454634|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139454635|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139454636|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139454637|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139454639|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139454640|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
139454641|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454642|NCT02610231|Istradefylline|istradefylline|mesh-list
139454643|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
139454644|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139454645|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139454646|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
139454647|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454648|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454649|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454650|NCT04850157|Tislelizumab|tislelizumab|mesh-list
139454651|NCT04850157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139454652|NCT04850157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454653|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
139454654|NCT04849533|Prednisone|prednisone|mesh-list
139454655|NCT04849533|Everolimus|everolimus|mesh-list
139454656|NCT04849533|Abatacept|abatacept|mesh-list
139454657|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
139454658|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139454659|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454660|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
139454661|NCT04849533|Hormones|hormones|mesh-ancestor
139454662|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454663|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454664|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139454665|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454666|NCT04849533|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139454667|NCT04849533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139454668|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454669|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454670|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139454671|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
139454672|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139454673|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139454674|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
139454675|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139454676|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454677|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139454678|NCT04849533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139454679|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139454680|NCT03040635|Risdiplam|risdiplam|mesh-list
139454681|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139454682|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454683|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454684|NCT02178358|Sorafenib|sorafenib|mesh-list
139454685|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454686|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139454687|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454688|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454689|NCT01598896|Clonidine|clonidine|mesh-list
139454690|NCT01598896|Dronabinol|dronabinol|mesh-list
139454691|NCT01598896|Analgesics|analgesics|mesh-ancestor
139454692|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
139454693|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454694|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454695|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139454696|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
139454697|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
139454698|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139454699|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139454700|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139454701|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
139454702|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454703|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454704|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
139454705|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139454706|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139454707|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139454708|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139454709|NCT01598896|Hormones|hormones|mesh-ancestor
139454710|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454711|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
139454712|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139454713|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
139454714|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139454715|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454716|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139454717|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139454718|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139454719|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
139454720|NCT03042429|Ifosfamide|ifosfamide|mesh-list
139454721|NCT03042429|Cisplatin|cisplatin|mesh-list
139454722|NCT03042429|Doxorubicin|doxorubicin|mesh-list
139454723|NCT03042429|Etoposide|etoposide|mesh-list
139454724|NCT03042429|Topotecan|topotecan|mesh-list
139454725|NCT03042429|Vindesine|vindesine|mesh-list
139454726|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139454727|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
139454728|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454729|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139454730|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139454731|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
139454732|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454733|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454734|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139454735|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139454736|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139454737|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139454738|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454739|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139454740|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139454741|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
139454742|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
139454743|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
139454744|NCT04849299|Cyclosporine|cyclosporine|mesh-list
139454745|NCT04849299|Cyclosporins|cyclosporins|mesh-list
139454746|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454747|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454748|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139454749|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
139454750|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454751|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
139454752|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454753|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
139454754|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139454755|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139454756|NCT02117050|Interferons|interferons|mesh-list
139454757|NCT02117050|Interferon-beta|interferon-beta|mesh-list
139454758|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
139454759|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454760|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
139454761|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454762|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
139454763|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454764|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139454765|NCT04860219|Lactoferrin|lactoferrin|mesh-list
139454766|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454767|NCT02728895|Vedolizumab|vedolizumab|mesh-list
139454768|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139454769|NCT04847895|Ranibizumab|ranibizumab|mesh-list
139454770|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139454771|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139454772|NCT04847895|Growth Substances|growth substances|mesh-ancestor
139454773|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454774|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
139454775|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454776|NCT02450513|Adalimumab|adalimumab|mesh-list
139454777|NCT02450513|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139241460|NCT03606590|Sorafenib|sorafenib|mesh-list
139454778|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454780|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
139454781|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139454782|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139454783|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454784|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139454785|NCT04859283|Analgesics|analgesics|mesh-ancestor
139454786|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
139454787|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454788|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139454789|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139454790|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139454791|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
139454792|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454793|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454794|NCT04857801|Teduglutide|teduglutide|mesh-list
139454795|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139454796|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139454797|NCT04857801|Protective Agents|protective agents|mesh-ancestor
139454798|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454799|NCT03208361|Amoxicillin|amoxicillin|mesh-list
139454800|NCT03208361|Penicillins|penicillins|mesh-list
139454801|NCT03208361|Penicillin V|penicillin v|mesh-list
139454802|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139454803|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454804|NCT02501837|Oxytocin|oxytocin|mesh-list
139454805|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
139454806|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139454807|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454808|NCT04859361|Imiquimod|imiquimod|mesh-list
139454809|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139454810|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
139454811|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454812|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454813|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
139454814|NCT04496141|Antibodies|antibodies|mesh-list
139454815|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
139454816|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454817|NCT03039075|Metformin|metformin|mesh-list
139454818|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139454819|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454820|NCT04857177|Ranibizumab|ranibizumab|mesh-list
139454821|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139454822|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139454823|NCT04857177|Growth Substances|growth substances|mesh-ancestor
139454824|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454825|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
139454826|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454827|NCT02606877|Pirfenidone|pirfenidone|mesh-list
139454828|NCT02606877|Nintedanib|nintedanib|mesh-list
139454829|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454830|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139454831|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454832|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454833|NCT02606877|Analgesics|analgesics|mesh-ancestor
139454834|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
139382757|NCT02121197|Dexamethasone|dexamethasone|mesh-list
139454835|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454836|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454837|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139454838|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139454839|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454840|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139454841|NCT03206957|Endostatins|endostatins|mesh-list
139454842|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
139454843|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454844|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139454845|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139454846|NCT03206957|Growth Substances|growth substances|mesh-ancestor
139454847|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454848|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
139454849|NCT03206723|Hydrocodone|hydrocodone|mesh-list
139454850|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139454851|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139454852|NCT03206723|Narcotics|narcotics|mesh-ancestor
139454853|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139454854|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454855|NCT03206723|Analgesics|analgesics|mesh-ancestor
139454856|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
139454857|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454858|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
139454859|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
139454860|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139454861|NCT03201185|Ramipril|ramipril|mesh-list
139454862|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139454863|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
139454864|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454865|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454866|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139454867|NCT04856787|Fluorouracil|fluorouracil|mesh-list
139454868|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
139454869|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454870|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139454871|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454872|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139454873|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
139454874|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454875|NCT03206177|Paclitaxel|paclitaxel|mesh-list
139454876|NCT03206177|Carboplatin|carboplatin|mesh-list
139454877|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139454878|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454879|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
139454880|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
139454881|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
139454882|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454883|NCT04839471|Afatinib|afatinib|mesh-list
139454884|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454885|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139454886|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454887|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454888|NCT04839237|Metformin|metformin|mesh-list
139454889|NCT04839237|Liraglutide|liraglutide|mesh-list
139454890|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139454891|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454892|NCT04839237|Incretins|incretins|mesh-ancestor
139454893|NCT04839237|Hormones|hormones|mesh-ancestor
139454894|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139454895|NCT03038607|Aspirin|aspirin|mesh-list
139454896|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139454897|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139454898|NCT03038607|Analgesics|analgesics|mesh-ancestor
139454899|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
139454900|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454901|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454902|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454903|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139454904|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139454905|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139454906|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454907|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139454908|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139454909|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139454910|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
139454911|NCT03038451|Amlodipine|amlodipine|mesh-list
139454912|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139454913|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139454914|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139454915|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454916|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139454917|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454918|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
139454919|NCT03040401|Aldesleukin|aldesleukin|mesh-list
139454920|NCT03040401|Interleukin-2|interleukin-2|mesh-list
139454921|NCT03040401|Histamine|histamine|mesh-list
139454922|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
139454923|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454924|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139454925|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139454926|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
139454927|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454928|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139454930|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
139454931|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454932|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454933|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
139454934|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
139454935|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454936|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454937|NCT03038295|Propranolol|propranolol|mesh-list
139454938|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139454939|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139454940|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
139454941|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454942|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454943|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454944|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139454945|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139454946|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
139454947|NCT03038217|Capecitabine|capecitabine|mesh-list
139454948|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
139454949|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139454950|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
139454951|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454952|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139454953|NCT02609607|Bisacodyl|bisacodyl|mesh-list
139454954|NCT02609607|Cathartics|cathartics|mesh-ancestor
139454955|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139454956|NCT02609607|Laxatives|laxatives|mesh-ancestor
139454957|NCT03040167|Epinephrine|epinephrine|mesh-list
139454958|NCT03040167|Bupivacaine|bupivacaine|mesh-list
139454959|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
139454960|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
139454961|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139454962|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454963|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
139454964|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454965|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139454966|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139454967|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
139454968|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139454969|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454970|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139454971|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139454972|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
139454973|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139454974|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
139454975|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
139454976|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
139454977|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139454978|NCT04843839|Nepafenac|nepafenac|mesh-list
139454979|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139454980|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139454981|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
139454982|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139454983|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139454984|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139454985|NCT04843839|Analgesics|analgesics|mesh-ancestor
139454986|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
139454987|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139454988|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139454989|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139454990|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139454991|NCT04843839|Laxatives|laxatives|mesh-ancestor
139454992|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139454993|NCT04838145|Ribavirin|ribavirin|mesh-list
139454994|NCT04838145|Pleconaril|pleconaril|mesh-list
139454995|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
139454996|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139454997|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
139454998|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139454999|NCT03041259|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
139455000|NCT03041259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139455001|NCT03041259|Antioxidants|antioxidants|mesh-ancestor
139455002|NCT03041259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455003|NCT03041259|Protective Agents|protective agents|mesh-ancestor
139455004|NCT03041259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455005|NCT04429035|Vitamin K|vitamin k|mesh-list
139455006|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
139455007|NCT04429035|Vitamins|vitamins|mesh-ancestor
139455008|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
139455009|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455010|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139455011|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139455012|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455013|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
139455014|NCT04429035|Coagulants|coagulants|mesh-ancestor
139455015|NCT04843449|Itraconazole|itraconazole|mesh-list
139455016|NCT04843449|Rifampin|rifampin|mesh-list
139455017|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
139455018|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455019|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139455020|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139455021|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455022|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455023|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139455024|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
139455025|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139455026|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455027|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139455028|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139455029|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
139455030|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139455031|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
139455032|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139455033|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139455034|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139455035|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139455036|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139455037|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139455038|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139455039|NCT03037593|Vitamin D|vitamin d|mesh-list
139455040|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
139455041|NCT03037593|Vitamins|vitamins|mesh-ancestor
139455042|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
139455043|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455044|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139455045|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139455046|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
139455047|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139455048|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139455049|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455050|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
139455051|NCT03037515|Coagulants|coagulants|mesh-ancestor
139455052|NCT04842825|Cetrorelix|cetrorelix|mesh-list
139455053|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139455054|NCT04842825|Hormones|hormones|mesh-ancestor
139455055|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139455056|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455057|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139455058|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
139455059|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139455060|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
139455061|NCT02606253|Metolazone|metolazone|mesh-list
139455062|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
139455063|NCT02606253|Tolvaptan|tolvaptan|mesh-list
139455064|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139455065|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455066|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
139455067|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455068|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139455069|NCT02606253|Diuretics|diuretics|mesh-ancestor
139455070|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139455071|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139455072|NCT04854759|Amantadine|amantadine|mesh-list
139455073|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139455074|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139455075|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
139455076|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455077|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
139455078|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455079|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455080|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455081|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139455082|NCT04854759|Analgesics|analgesics|mesh-ancestor
139455083|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
139455084|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455085|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
139455086|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139455087|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
139455088|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455089|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
139455090|NCT02607735|Velpatasvir|velpatasvir|mesh-list
139455091|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
139455092|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455093|NCT04772313|Methotrexate|methotrexate|mesh-list
139455094|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139455095|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
139455096|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139455097|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455098|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139455099|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
139455100|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455101|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455102|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
139455103|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455104|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139455105|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139455106|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
139455107|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139455108|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139455109|NCT03040791|Nivolumab|nivolumab|mesh-list
139455110|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139455111|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455112|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139455113|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455114|NCT04428879|Topotecan|topotecan|mesh-list
139455115|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139455116|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139455117|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455118|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455119|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455120|NCT04836819|Lidocaine|lidocaine|mesh-list
139455121|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
139455122|NCT04836819|Ketamine|ketamine|mesh-list
139455123|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
139455124|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
139455125|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139455126|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455127|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
139455128|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455129|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139455130|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139455131|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139455132|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139455133|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455134|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139455135|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139455136|NCT04836819|Analgesics|analgesics|mesh-ancestor
139455137|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139455138|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139455139|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139455140|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
139455141|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455142|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139455143|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139455144|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
139455145|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139455146|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139455147|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
139455148|NCT04836507|Fludarabine|fludarabine|mesh-list
139455149|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139455150|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
139455151|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455152|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139455153|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139455154|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
139455155|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455156|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455157|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139455158|NCT04835259|Selenium|selenium|mesh-list
139455159|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
139455160|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455161|NCT04835259|Protective Agents|protective agents|mesh-ancestor
139455162|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455163|NCT04835259|Trace Elements|trace elements|mesh-ancestor
139455164|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
139455165|NCT04853901|Remdesivir|remdesivir|mesh-list
139455166|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455167|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455168|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
139455169|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
139455170|NCT01668537|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139455171|NCT01668537|Antiviral Agents|antiviral agents|mesh-ancestor
139455172|NCT01668537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455173|NCT04834791|Letrozole|letrozole|mesh-list
139455174|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455175|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139455176|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139455177|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455178|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455179|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139455180|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
139455181|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139455182|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455183|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139455184|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455185|NCT04835025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139455186|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455187|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
139455188|NCT03038919|Testosterone|testosterone|mesh-list
139455189|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
139455190|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
139455191|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139455192|NCT03038919|Androgens|androgens|mesh-ancestor
139455193|NCT03038919|Hormones|hormones|mesh-ancestor
139455194|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139455195|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455196|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139455197|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455198|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
139455199|NCT03036891|Naloxegol|naloxegol|mesh-list
139455200|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139455201|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455202|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
139455203|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455204|NCT01668147|Ritonavir|ritonavir|mesh-list
139455205|NCT01668147|Efavirenz|efavirenz|mesh-list
139455206|NCT01668147|Loperamide|loperamide|mesh-list
139455207|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
139455208|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139455209|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139455210|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
139455211|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455212|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455213|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139455214|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139455215|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
139455216|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455217|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139455218|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139455219|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139455220|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139455221|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139455222|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139455223|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139455224|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139455225|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139455226|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139455227|NCT04833777|Lidocaine|lidocaine|mesh-list
139455228|NCT04833777|Bupivacaine|bupivacaine|mesh-list
139455229|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
139455230|NCT04833777|Anesthetics|anesthetics|mesh-list
139455231|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139455232|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455233|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
139455234|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455235|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139455236|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139455237|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139455238|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139455239|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455240|NCT03036501|Risdiplam|risdiplam|mesh-list
139455241|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139455242|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455243|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455244|NCT04851015|Trimethoprim|trimethoprim|mesh-list
139455245|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139455246|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
139455247|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139455248|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455249|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
139455250|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139455251|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139455252|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139455253|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455254|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455255|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139455256|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139455257|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139455258|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139455259|NCT04365933|Interferons|interferons|mesh-list
139455260|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
139455261|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
139455262|NCT04365933|Entecavir|entecavir|mesh-list
139455263|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139455264|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455265|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
139455266|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455267|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
139455268|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455269|NCT04824261|Clotrimazole|clotrimazole|mesh-list
139455270|NCT04824261|Miconazole|miconazole|mesh-list
139455271|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139455272|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455273|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
139455274|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139455275|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139455276|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455277|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455278|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139455279|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
139455280|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139455281|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455282|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139455283|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139455284|NCT04850235|Paclitaxel|paclitaxel|mesh-list
139455285|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139455286|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455287|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
139455288|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
139455289|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
139455290|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455291|NCT04850001|Aspirin|aspirin|mesh-list
139455292|NCT04850001|Clopidogrel|clopidogrel|mesh-list
139455293|NCT04850001|Atorvastatin|atorvastatin|mesh-list
139455294|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139455295|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139241979|NCT03620513|Ephedrine|ephedrine|mesh-list
139455296|NCT04850001|Analgesics|analgesics|mesh-ancestor
139455297|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
139455298|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455299|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455300|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139455301|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139455302|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139455303|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139455304|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455305|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139455306|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139455307|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455308|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
139455309|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139455310|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139455311|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
139455312|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139455313|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139455314|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139455315|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139455316|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139455317|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
139455318|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455319|NCT03036111|Trimebutine|trimebutine|mesh-list
139455320|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139455321|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
139455322|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
139455323|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455324|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455325|NCT04830579|Etoricoxib|etoricoxib|mesh-list
139455326|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139455327|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139455328|NCT04830579|Analgesics|analgesics|mesh-ancestor
139455329|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
139455330|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455331|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455332|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139455333|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139455334|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139455335|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139455336|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455337|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455338|NCT04816461|Piperaquine|piperaquine|mesh-list
139455339|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
139455340|NCT04816461|Amodiaquine|amodiaquine|mesh-list
139455341|NCT04816461|Artenimol|artenimol|mesh-list
139455342|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
139455343|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139455344|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139455345|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455346|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139455347|NCT04427865|Lactoferrin|lactoferrin|mesh-list
139455348|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455349|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
139455350|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139455351|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455352|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139455353|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139455354|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455355|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455356|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455357|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139455358|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139455359|NCT04427787|Lanreotide|lanreotide|mesh-list
139455360|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455361|NCT04829487|Vitamin D|vitamin d|mesh-list
139455362|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
139455363|NCT04829487|Vitamins|vitamins|mesh-ancestor
139455364|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
139455365|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455366|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139455367|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139455368|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
139455369|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139455370|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139455371|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455372|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
139455373|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455374|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455375|NCT04821765|Paclitaxel|paclitaxel|mesh-list
139455376|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139455377|NCT04821765|Antibodies|antibodies|mesh-list
139455378|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139455379|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455380|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
139455381|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
139455382|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
139455383|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455384|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
139455385|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455386|NCT04829097|Temozolomide|temozolomide|mesh-list
139455387|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139455388|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
139455389|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455390|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455391|NCT04829019|Osimertinib|osimertinib|mesh-list
139455392|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455393|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139455394|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455395|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455396|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
139455397|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
139455398|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
139455399|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139455400|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139455401|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
139455402|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
139455403|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455404|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455405|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455406|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139455407|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
139455408|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139455409|NCT04828395|Paclitaxel|paclitaxel|mesh-list
139455410|NCT04828395|Etoposide|etoposide|mesh-list
139455411|NCT04828395|Cisplatin|cisplatin|mesh-list
139455412|NCT04828395|Carboplatin|carboplatin|mesh-list
139455413|NCT04828395|Pemetrexed|pemetrexed|mesh-list
139455414|NCT04828395|Fluzoparib|fluzoparib|mesh-list
139455415|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139455416|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455417|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
139455418|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
139455419|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
139455420|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455421|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139455422|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139455423|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455424|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139455425|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139455426|NCT04828395|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139455427|NCT04820439|Pertuzumab|pertuzumab|mesh-list
139455428|NCT04820439|Antibodies|antibodies|mesh-list
139455429|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139455430|NCT04820439|Mitogens|mitogens|mesh-list
139455431|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
139455432|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455433|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
139455434|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455435|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139455436|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455437|NCT05619315|Calcium Carbonate|calcium carbonate|mesh-list
139455438|NCT05619315|Calcium|calcium|mesh-list
139455439|NCT05619315|Charcoal|charcoal|mesh-list
139455440|NCT05619315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139455441|NCT05619315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455442|NCT05619315|Antacids|antacids|mesh-ancestor
139455443|NCT05619315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455444|NCT05619315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139455445|NCT05619315|Antidotes|antidotes|mesh-ancestor
139455446|NCT05619315|Protective Agents|protective agents|mesh-ancestor
139455447|NCT04814511|Permethrin|permethrin|mesh-list
139455448|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455449|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455450|NCT04814043|Lenvatinib|lenvatinib|mesh-list
139455451|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139455452|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455453|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139455454|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455455|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455456|NCT04814043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139455457|NCT04814589|Ezetimibe|ezetimibe|mesh-list
139455458|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139455459|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139455460|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
139455461|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455462|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139455463|NCT04826679|Paclitaxel|paclitaxel|mesh-list
139455464|NCT04826679|Cisplatin|cisplatin|mesh-list
139455465|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139455466|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455467|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
139455468|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
139455469|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
139455470|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455471|NCT02601573|Ribavirin|ribavirin|mesh-list
139455472|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
139455473|NCT02601573|Grazoprevir|grazoprevir|mesh-list
139455474|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
139455475|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455476|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
139455477|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455478|NCT04818723|Montelukast|montelukast|mesh-list
139455479|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139455480|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
139455481|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139455482|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
139455483|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139455484|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455485|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139455486|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139455487|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455488|NCT02601027|Acetaminophen|acetaminophen|mesh-list
139455489|NCT02601027|Oxycodone|oxycodone|mesh-list
139455490|NCT02601027|Hydromorphone|hydromorphone|mesh-list
139455491|NCT02601027|Ondansetron|ondansetron|mesh-list
139455492|NCT02601027|Bupivacaine|bupivacaine|mesh-list
139455493|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
139455494|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
139455495|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139455496|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455497|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
139455498|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455499|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139455500|NCT02601027|Narcotics|narcotics|mesh-ancestor
139455501|NCT02601027|Analgesics|analgesics|mesh-ancestor
139455502|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
139455503|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
139455504|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139455505|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
139455506|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
139455507|NCT02601027|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139455508|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139455509|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
139455510|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455511|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455512|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139455513|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
139455514|NCT04411875|Amlodipine|amlodipine|mesh-list
139455515|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139455516|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139455517|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139455518|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455519|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139455520|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455521|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
139455522|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
139455523|NCT02600871|Povidone|povidone|mesh-list
139455524|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
139455525|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
139455526|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139455527|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455528|NCT04818099|Vortioxetine|vortioxetine|mesh-list
139455529|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
139455530|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139455531|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139455532|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139455533|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139455534|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455535|NCT04818099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139455536|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139455537|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139455538|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382786|NCT05617430|Leucovorin|leucovorin|mesh-list
139455539|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455540|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
139455541|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139455542|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139455543|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139455544|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139455545|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
139455546|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455547|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
139455548|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139455549|NCT04807569|Tamsulosin|tamsulosin|mesh-list
139455550|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139455551|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139455552|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139455553|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
139455554|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455555|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455556|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455557|NCT04807569|Urological Agents|urological agents|mesh-ancestor
139455558|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
139455559|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139455560|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
139455561|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455562|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455563|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139455564|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
139455565|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139455566|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
139455567|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455568|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455569|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139455570|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
139455571|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
139455572|NCT04807413|Protective Agents|protective agents|mesh-ancestor
139455573|NCT04807335|Sufentanil|sufentanil|mesh-list
139455574|NCT04807335|Ketamine|ketamine|mesh-list
139455575|NCT04807335|Analgesics|analgesics|mesh-ancestor
139455576|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
139455577|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455578|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455579|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139455580|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139455581|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
139455582|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
139455583|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139455584|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139455585|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139455586|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455587|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455588|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139455589|NCT04807335|Narcotics|narcotics|mesh-ancestor
139455590|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139455591|NCT05616507|Fucoidan|fucoidan|mesh-list
139455592|NCT05616507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139455593|NCT05616507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139455594|NCT05616507|Anticoagulants|anticoagulants|mesh-ancestor
139455595|NCT05616507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455596|NCT04806945|Paclitaxel|paclitaxel|mesh-list
139455597|NCT04806945|Carboplatin|carboplatin|mesh-list
139455598|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139455599|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455600|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
139455601|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
139455602|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
139455603|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455604|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
139455605|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139455606|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455607|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139455608|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455609|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
139455610|NCT04805229|Narcotics|narcotics|mesh-ancestor
139455611|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139455612|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455613|NCT04805229|Analgesics|analgesics|mesh-ancestor
139455614|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
139455615|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455616|NCT04811313|Bupivacaine|bupivacaine|mesh-list
139455617|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
139455618|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
139455619|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
139455620|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139455621|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455622|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
139455623|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455624|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139455625|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139455626|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455627|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
139455628|NCT04811313|Coagulants|coagulants|mesh-ancestor
139455629|NCT04352439|Aspirin|aspirin|mesh-list
139455630|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139455631|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139455632|NCT04352439|Analgesics|analgesics|mesh-ancestor
139455633|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
139455634|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455635|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455636|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139455637|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139455638|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139455639|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139455640|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455641|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139455642|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139455643|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455644|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
139455645|NCT04796025|Bevacizumab|bevacizumab|mesh-list
139455646|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139455647|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455648|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139455649|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139455650|NCT04796025|Growth Substances|growth substances|mesh-ancestor
139455651|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455652|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
139455653|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
139455654|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139455655|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455656|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139455657|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139455658|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455659|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455660|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455661|NCT02595723|Megestrol|megestrol|mesh-list
139455662|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
139455663|NCT02595723|Phenytoin|phenytoin|mesh-list
139455664|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139455665|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139455666|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139455667|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
139455668|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139455669|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455670|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139455671|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139455672|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139455673|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455674|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
139455675|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139455676|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
139455677|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139455678|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139455679|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139455680|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455681|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139455682|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139455683|NCT01667679|Sumatriptan|sumatriptan|mesh-list
139455684|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139455685|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139455686|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139455687|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
139455688|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455689|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455690|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455691|NCT02597049|Metformin|metformin|mesh-list
139455692|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
139455693|NCT02597049|Empagliflozin|empagliflozin|mesh-list
139455694|NCT02597049|Canagliflozin|canagliflozin|mesh-list
139455695|NCT02597049|Dulaglutide|dulaglutide|mesh-list
139455696|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139455697|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139455698|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455699|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455700|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
139455701|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455702|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
139455703|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
139455704|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
139455705|NCT04802967|Ketoprofen|ketoprofen|mesh-list
139455706|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
139455707|NCT04802967|Gabapentin|gabapentin|mesh-list
139455708|NCT04802967|Analgesics|analgesics|mesh-ancestor
139455709|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
139455710|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455711|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455712|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
139455713|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139455714|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139455715|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139455716|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139455717|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139455718|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139455719|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455720|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455721|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
139455722|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139455723|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139455724|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139455725|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139455726|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139455727|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455728|NCT05616117|Vitamin D|vitamin d|mesh-list
139455729|NCT05616117|Vitamins|vitamins|mesh-list
139455730|NCT05616117|Micronutrients|micronutrients|mesh-ancestor
139455731|NCT05616117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455732|NCT05616117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139455733|NCT02594163|Rituximab|rituximab|mesh-list
139455734|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139455735|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139455736|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139455737|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455738|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
139455739|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455740|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139455741|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139455742|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
139455743|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455744|NCT02594163|Immunotoxins|immunotoxins|mesh-ancestor
139455745|NCT02594163|Immunoconjugates|immunoconjugates|mesh-ancestor
139455746|NCT03206255|Vaccines|vaccines|mesh-list
139455747|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
139455748|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455749|NCT03206411|Hormones|hormones|mesh-list
139455750|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139455751|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455752|NCT03206021|Carboplatin|carboplatin|mesh-list
139455753|NCT03206021|Azacitidine|azacitidine|mesh-list
139455754|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455755|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139455756|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
139455757|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455758|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455759|NCT03200561|Prednisolone|prednisolone|mesh-list
139455760|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
139455761|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139455762|NCT03200561|Antibodies|antibodies|mesh-list
139455763|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139455764|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
139455765|NCT03200561|Hormones|hormones|mesh-ancestor
139455766|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139455767|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455768|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139455769|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455770|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
139455771|NCT02449811|Amlodipine|amlodipine|mesh-list
139455772|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139455773|NCT02449811|Olmesartan|olmesartan|mesh-list
139455774|NCT02449811|Perindopril|perindopril|mesh-list
139455775|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139455776|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139455777|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139455778|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455779|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139455780|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455781|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
139455782|NCT02449811|Diuretics|diuretics|mesh-ancestor
139455783|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
139455784|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139455785|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139455786|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139455787|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139455788|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
139455789|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455790|NCT03200093|Vancomycin|vancomycin|mesh-list
139455791|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139455792|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455793|NCT03204929|Copper|copper|mesh-list
139455794|NCT03204929|Trace Elements|trace elements|mesh-ancestor
139455795|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
139455796|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455797|NCT02596971|Prednisone|prednisone|mesh-list
139455798|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
139455799|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139455800|NCT02596971|Rituximab|rituximab|mesh-list
139455801|NCT02596971|Doxorubicin|doxorubicin|mesh-list
139455802|NCT02596971|Vincristine|vincristine|mesh-list
139455803|NCT02596971|Atezolizumab|atezolizumab|mesh-list
139455804|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
139455805|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139455806|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
139455807|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455808|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139455809|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139455810|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
139455811|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455812|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455813|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139455814|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139455815|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139455816|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139455817|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139242496|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139455818|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455819|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139455820|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
139455822|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139455823|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139455824|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139455825|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
139455826|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
139455827|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
139455828|NCT02596971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139455829|NCT04808739|Adalimumab|adalimumab|mesh-list
139455830|NCT04808739|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139455831|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139455832|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139455833|NCT04808895|Aspirin|aspirin|mesh-list
139455834|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139455835|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139455836|NCT04808895|Analgesics|analgesics|mesh-ancestor
139455837|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
139455838|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455839|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455840|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139455841|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139455842|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139455843|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139455844|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455845|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139455846|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139455847|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455848|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
139455849|NCT04485689|Capsaicin|capsaicin|mesh-list
139455850|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
139455851|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
139455852|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
139455853|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455854|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455855|NCT03204071|Metformin|metformin|mesh-list
139455856|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139455857|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455858|NCT04801017|Artemisinins|artemisinins|mesh-list
139455859|NCT04801017|Artemisinin|artemisinin|mesh-list
139455860|NCT04801017|Trabedersen|trabedersen|mesh-list
139455861|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
139455862|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139455863|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139455864|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455865|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455866|NCT03107429|Acetazolamide|acetazolamide|mesh-list
139455867|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
139455868|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139455869|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455870|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455871|NCT03107429|Diuretics|diuretics|mesh-ancestor
139455872|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
139455873|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455874|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
139455875|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139455876|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139455877|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455878|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
139455879|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
139455880|NCT04800081|Valsartan|valsartan|mesh-list
139455881|NCT04800081|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139455882|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139455883|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139455884|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139455885|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455886|NCT03202979|Trazodone|trazodone|mesh-list
139455887|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139455888|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139455889|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139455890|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455891|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139455892|NCT03202979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139455893|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139455894|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139455895|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455896|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455897|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
139455898|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139455899|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
139455900|NCT04799925|Febuxostat|febuxostat|mesh-list
139455901|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
139455902|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139455903|NCT03232307|Dexamethasone|dexamethasone|mesh-list
139455904|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
139455905|NCT03232307|Rituximab|rituximab|mesh-list
139455906|NCT03232307|Lenalidomide|lenalidomide|mesh-list
139455907|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139455908|NCT03232307|Antibodies|antibodies|mesh-list
139455909|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
139455910|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139455911|NCT03232307|BB 1101|bb 1101|mesh-list
139455912|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
139455913|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455914|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139455915|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
139455916|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
139455917|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455918|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139455919|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
139455920|NCT03232307|Hormones|hormones|mesh-ancestor
139455921|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139455922|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139455923|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455924|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139455925|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139455926|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139455927|NCT03232307|Growth Substances|growth substances|mesh-ancestor
139455928|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
139455929|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
139455930|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139455931|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455932|NCT05615727|Dexmedetomidine|dexmedetomidine|mesh-list
139455933|NCT05615727|Zolpidem|zolpidem|mesh-list
139455934|NCT05615727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139455935|NCT05615727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139455936|NCT05615727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455937|NCT05615727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139455938|NCT05615727|Analgesics|analgesics|mesh-ancestor
139455939|NCT05615727|Sensory System Agents|sensory system agents|mesh-ancestor
139455940|NCT05615727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455941|NCT05615727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139455942|NCT05615727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139455943|NCT05615727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139455944|NCT05615727|Adrenergic Agents|adrenergic agents|mesh-ancestor
139455945|NCT05615727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455946|NCT05615727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455947|NCT05615727|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139455948|NCT05615727|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139455949|NCT05615727|GABA Agonists|gaba agonists|mesh-ancestor
139455950|NCT05615727|GABA Agents|gaba agents|mesh-ancestor
139455951|NCT02450279|Edetic Acid|edetic acid|mesh-list
139455952|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
139455953|NCT02450279|Antidotes|antidotes|mesh-ancestor
139455954|NCT02450279|Protective Agents|protective agents|mesh-ancestor
139455955|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455956|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
139455957|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
139455958|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455959|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139455960|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
139455961|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139455962|NCT03231683|Ketamine|ketamine|mesh-list
139455963|NCT03231683|Remifentanil|remifentanil|mesh-list
139455964|NCT03231683|Propofol|propofol|mesh-list
139455965|NCT03231683|Esketamine|esketamine|mesh-list
139455966|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139455967|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139455968|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455969|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139242647|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
139455970|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
139455971|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
139455973|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
139455974|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139455975|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139455976|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139455977|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139455978|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139455979|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139455980|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139455981|NCT03231683|Narcotics|narcotics|mesh-ancestor
139455982|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
139455983|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139455984|NCT02593773|Interferons|interferons|mesh-list
139455985|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
139455986|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139455987|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
139455988|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139455989|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
139455990|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139455991|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
139382872|NCT04427540|Oxytocin|oxytocin|mesh-list
139455992|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139455993|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
139455994|NCT04798443|Protective Agents|protective agents|mesh-ancestor
139455995|NCT02450045|Bupivacaine|bupivacaine|mesh-list
139455996|NCT02450045|Ropivacaine|ropivacaine|mesh-list
139455997|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
139455998|NCT02450045|Anesthetics|anesthetics|mesh-list
139455999|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139456000|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456001|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
139456002|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456003|NCT02593539|Nemiralisib|nemiralisib|mesh-list
139456004|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139456005|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456006|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456007|NCT02593305|Methamphetamine|methamphetamine|mesh-list
139456008|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139456009|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456010|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
139456011|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
139456012|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456013|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
139456014|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456015|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456016|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
139456017|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139456018|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139456019|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456020|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139456021|NCT04389411|Montelukast|montelukast|mesh-list
139456022|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139456023|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
139456024|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139456025|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
139456026|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139456027|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456028|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139456029|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139456030|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456031|NCT02448251|Abivertinib|abivertinib|mesh-list
139456032|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139456033|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456034|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456035|NCT03195569|Paclitaxel|paclitaxel|mesh-list
139456036|NCT03195569|Bevacizumab|bevacizumab|mesh-list
139456037|NCT03195569|Carboplatin|carboplatin|mesh-list
139456038|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139456039|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456040|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
139456041|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
139456042|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
139456043|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242729|NCT04462965|Temozolomide|temozolomide|mesh-list
139456044|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139456046|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139456047|NCT03195569|Growth Substances|growth substances|mesh-ancestor
139456048|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456049|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
139456050|NCT02447939|Trametinib|trametinib|mesh-list
139456051|NCT02447939|Dabrafenib|dabrafenib|mesh-list
139456052|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456053|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139456054|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456055|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456056|NCT04785183|Melatonin|melatonin|mesh-list
139456057|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
139456058|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456059|NCT04785183|Protective Agents|protective agents|mesh-ancestor
139456060|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456061|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139456062|NCT03195491|Nivolumab|nivolumab|mesh-list
139456063|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139456064|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456065|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139456066|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456067|NCT03195413|Lidocaine|lidocaine|mesh-list
139456068|NCT03195413|Epinephrine|epinephrine|mesh-list
139456069|NCT03195413|Racepinephrine|racepinephrine|mesh-list
139456070|NCT03195413|Bupivacaine|bupivacaine|mesh-list
139456071|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
139456072|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
139456073|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
139456074|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139456075|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456076|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
139456077|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456078|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139456079|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139456080|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139456081|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456082|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456083|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139456084|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139456085|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
139456086|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456087|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139456088|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139456089|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
139456090|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139456091|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
139456092|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
139456093|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
139456094|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139456095|NCT02447705|Telbivudine|telbivudine|mesh-list
139456096|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
139456097|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139456098|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139456099|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456100|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456101|NCT03195257|Glucagon|glucagon|mesh-list
139456102|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
139456103|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139456104|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139456105|NCT03195257|Hormones|hormones|mesh-ancestor
139456106|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139456107|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456108|NCT03195257|Incretins|incretins|mesh-ancestor
139456109|NCT02447393|Cetirizine|cetirizine|mesh-list
139456110|NCT02447393|Levocetirizine|levocetirizine|mesh-list
139456111|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139456112|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139456113|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139456114|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
139456115|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
139456116|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456117|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456118|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456119|NCT02447315|Pilocarpine|pilocarpine|mesh-list
139456120|NCT02447315|Miotics|miotics|mesh-ancestor
139456121|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
139456122|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456123|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456124|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139456125|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139456126|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
139456127|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456128|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456129|NCT04792515|Apatinib|apatinib|mesh-list
139456130|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456131|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139456132|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456133|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456134|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139456135|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139456136|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456137|NCT03195023|Amlodipine|amlodipine|mesh-list
139456138|NCT03195023|Lisinopril|lisinopril|mesh-list
139456139|NCT03195023|Lercanidipine|lercanidipine|mesh-list
139456140|NCT03195023|Furosemide|furosemide|mesh-list
139456141|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139456142|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139456143|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139456144|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139456145|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456146|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456147|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139456148|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456149|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
139456150|NCT03195023|Diuretics|diuretics|mesh-ancestor
139456151|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
139456152|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139456153|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
139456154|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139456155|NCT03195023|Protective Agents|protective agents|mesh-ancestor
139456156|NCT02446301|Nalbuphine|nalbuphine|mesh-list
139456157|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139456158|NCT02446301|Narcotics|narcotics|mesh-ancestor
139456159|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139456160|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456161|NCT02446301|Analgesics|analgesics|mesh-ancestor
139456162|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
139456163|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456164|NCT04791345|Dexamethasone|dexamethasone|mesh-list
139456165|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
139456166|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
139456167|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139456168|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139456169|NCT04791345|Prednisolone|prednisolone|mesh-list
139456170|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
139456171|NCT04791345|Deflazacort|deflazacort|mesh-list
139456172|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139456173|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
139456174|NCT04791345|BB 1101|bb 1101|mesh-list
139456175|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456176|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
139456177|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
139456178|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456179|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456180|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139456181|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
139456182|NCT04791345|Hormones|hormones|mesh-ancestor
139456183|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139456184|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139456185|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456186|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
139456187|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456188|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456189|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139456190|NCT04791345|Protective Agents|protective agents|mesh-ancestor
139456191|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139456192|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
139456193|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
139456194|NCT02445989|NuvaRing|nuvaring|mesh-list
139456195|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139456196|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456197|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139456198|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
139456199|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139456200|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139456201|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139456202|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
139456203|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456204|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139456205|NCT03231215|Dexamethasone|dexamethasone|mesh-list
139456206|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456207|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
139456208|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
139456209|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456210|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456211|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139456212|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
139456213|NCT03231215|Hormones|hormones|mesh-ancestor
139456214|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139456215|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139456216|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456217|NCT04784481|Ivermectin|ivermectin|mesh-list
139456218|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139456219|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139456220|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
139456221|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
139456222|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139456223|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456224|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139456225|NCT03526185|Nivolumab|nivolumab|mesh-list
139456226|NCT03526185|Ipilimumab|ipilimumab|mesh-list
139456227|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139456228|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456229|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139456230|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456231|NCT02445599|Dipyrone|dipyrone|mesh-list
139456232|NCT02445599|Diclofenac|diclofenac|mesh-list
139456233|NCT02445599|Atropine|atropine|mesh-list
139456234|NCT02445599|Midazolam|midazolam|mesh-list
139456235|NCT02445599|Fentanyl|fentanyl|mesh-list
139456236|NCT02445599|Tramadol|tramadol|mesh-list
139456237|NCT02445599|Nalbuphine|nalbuphine|mesh-list
139456238|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139456239|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139456240|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139456241|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456242|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139456243|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139456244|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139456245|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139456246|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
139456247|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
139456248|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
139456249|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
139456250|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456251|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456252|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139456253|NCT02445599|Narcotics|narcotics|mesh-ancestor
139456254|NCT02445599|Analgesics|analgesics|mesh-ancestor
139456255|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
139456256|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456257|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139456258|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139456259|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456260|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139456261|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139456262|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456263|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139456264|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139456265|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
139456266|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139456267|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
139456268|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
139456269|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
139456270|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139456271|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139456272|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
139456274|NCT03194633|Nifedipine|nifedipine|mesh-list
139114728|NCT01183494|Irinotecan|irinotecan|mesh-list
139456275|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139456276|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456277|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456278|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139456279|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456280|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
139456281|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
139456282|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139456283|NCT03194555|Acetaminophen|acetaminophen|mesh-list
139456284|NCT03194555|Naltrexone|naltrexone|mesh-list
139456285|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139456286|NCT03194555|Analgesics|analgesics|mesh-ancestor
139456287|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
139456288|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456289|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456290|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
139456291|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139456292|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139456293|NCT04790331|Verapamil|verapamil|mesh-list
139456294|NCT04790331|Diltiazem|diltiazem|mesh-list
139456295|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139456296|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139456297|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456298|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456299|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139456300|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456301|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
139456302|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139456303|NCT04789941|Irinotecan|irinotecan|mesh-list
139456304|NCT04789941|Cisplatin|cisplatin|mesh-list
139456305|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139456306|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139456307|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456308|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456309|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456310|NCT02445053|Ivacaftor|ivacaftor|mesh-list
139456311|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139456312|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456313|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456314|NCT02444897|Fentanyl|fentanyl|mesh-list
139456315|NCT02444897|Nefopam|nefopam|mesh-list
139456316|NCT02444897|Ramosetron|ramosetron|mesh-list
139456317|NCT02444897|Ropivacaine|ropivacaine|mesh-list
139456318|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
139456319|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
139456320|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139456321|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456322|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
139456323|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456324|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139456325|NCT02444897|Narcotics|narcotics|mesh-ancestor
139456326|NCT02444897|Analgesics|analgesics|mesh-ancestor
139456327|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139456328|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139456329|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
139456330|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
139456331|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
139456332|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139456333|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139456334|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
139456335|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456336|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456337|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139456338|NCT03229889|Tadalafil|tadalafil|mesh-list
139456339|NCT03229889|Tamsulosin|tamsulosin|mesh-list
139456340|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
139456341|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139456342|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139456343|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456344|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456345|NCT03229889|Urological Agents|urological agents|mesh-ancestor
139456346|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139456347|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139456348|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139456349|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
139456350|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456351|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456352|NCT02444585|Denosumab|denosumab|mesh-list
139456353|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139456354|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456355|NCT03120221|Iodine|iodine|mesh-list
139456356|NCT03120221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139456357|NCT03120221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139456358|NCT03120221|Trace Elements|trace elements|mesh-ancestor
139456359|NCT03120221|Micronutrients|micronutrients|mesh-ancestor
139456360|NCT03120221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456361|NCT03193073|Mitogens|mitogens|mesh-list
139456362|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
139456363|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456364|NCT02444507|Esomeprazole|esomeprazole|mesh-list
139456365|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139456366|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139456367|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139456368|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456369|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456370|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139456371|NCT01626352|Ofatumumab|ofatumumab|mesh-list
139456372|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139456373|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
139456374|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456375|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456376|NCT02080767|Tecovirimat|tecovirimat|mesh-list
139456377|NCT02080767|Antiviral Agents|antiviral agents|mesh-ancestor
139456378|NCT02080767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139456379|NCT01626118|Indomethacin|indomethacin|mesh-list
139456380|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139456381|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139456382|NCT01626118|Analgesics|analgesics|mesh-ancestor
139456383|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
139456384|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456385|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456386|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456387|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139456388|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
139456389|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
139456390|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139456391|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139456392|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456393|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456394|NCT04789005|Phenylephrine|phenylephrine|mesh-list
139456395|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
139456396|NCT04789005|Norepinephrine|norepinephrine|mesh-list
139456397|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139456398|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
139456399|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
139456400|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456401|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456402|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
139456403|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139456404|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
139456405|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
139456406|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139456407|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139456408|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139456409|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
139456410|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456411|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456412|NCT04789005|Protective Agents|protective agents|mesh-ancestor
139456413|NCT02152384|Insulin|insulin|mesh-list
139456414|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139456415|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
139456416|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
139456417|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139456418|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456419|NCT05469243|Hallucinogens|hallucinogens|mesh-list
139456420|NCT05469243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456421|NCT05469243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139456422|NCT02177266|Colchicine|colchicine|mesh-list
139456423|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
139456424|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139456425|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
139456426|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
139456427|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
139456428|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456429|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456430|NCT04788381|Bevacizumab|bevacizumab|mesh-list
139456431|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139456432|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456433|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139456434|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139456435|NCT04788381|Growth Substances|growth substances|mesh-ancestor
139456436|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456437|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
139456438|NCT05474937|Midazolam|midazolam|mesh-list
139456439|NCT05474937|Ketamine|ketamine|mesh-list
139456440|NCT05474937|Propofol|propofol|mesh-list
139456441|NCT05474937|Sevoflurane|sevoflurane|mesh-list
139456442|NCT05474937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139456443|NCT05474937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139456444|NCT05474937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456445|NCT05474937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139456446|NCT05474937|Anesthetics, General|anesthetics, general|mesh-ancestor
139456447|NCT05474937|Anesthetics|anesthetics|mesh-ancestor
139456448|NCT05474937|Analgesics|analgesics|mesh-ancestor
139456449|NCT05474937|Sensory System Agents|sensory system agents|mesh-ancestor
139456450|NCT05474937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456451|NCT05474937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139456452|NCT05474937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139456453|NCT05474937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139456454|NCT05474937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456455|NCT05474937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456456|NCT05474937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139456457|NCT05474937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139456458|NCT05474937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139456459|NCT05474937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139456460|NCT05474937|GABA Modulators|gaba modulators|mesh-ancestor
139456461|NCT05474937|GABA Agents|gaba agents|mesh-ancestor
139456462|NCT05474937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139456463|NCT05474937|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139456464|NCT05474781|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139456465|NCT05474781|Antiviral Agents|antiviral agents|mesh-ancestor
139456466|NCT05474781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139456467|NCT02177032|Vaccines|vaccines|mesh-list
139456468|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
139456469|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139456470|NCT02177032|Antibodies|antibodies|mesh-list
139456471|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
139456472|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456473|NCT02176642|Oxybutynin|oxybutynin|mesh-list
139456474|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
139456475|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
139456476|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456477|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456478|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139456479|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139456480|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
139456481|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456482|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456483|NCT02176642|Urological Agents|urological agents|mesh-ancestor
139456484|NCT02116660|Ritonavir|ritonavir|mesh-list
139456485|NCT02116660|Lopinavir|lopinavir|mesh-list
139456486|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139456487|NCT02116660|Darunavir|darunavir|mesh-list
139456488|NCT02116660|Tenofovir|tenofovir|mesh-list
139456489|NCT02116660|Lamivudine|lamivudine|mesh-list
139456490|NCT02116660|Emtricitabine|emtricitabine|mesh-list
139456491|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
139456492|NCT02116660|Nevirapine|nevirapine|mesh-list
139456493|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139456494|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139456495|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
139456496|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456497|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456498|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139456499|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139456500|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
139114962|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
139456501|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139456502|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139456503|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139456504|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139456505|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139456506|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139456508|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139456509|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139456510|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139456511|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
139456512|NCT02176018|Quinidine|quinidine|mesh-list
139456513|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
139456514|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
139456515|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
139456516|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139456517|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139456518|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456519|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456520|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456521|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139456522|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139456523|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
139456524|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139456525|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
139456526|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139456527|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139456528|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139456529|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456530|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139456531|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139456532|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
139456533|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139456534|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139456535|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456536|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139456537|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139456538|NCT05611827|Quercetin|quercetin|mesh-list
139456539|NCT05611827|Antioxidants|antioxidants|mesh-ancestor
139456540|NCT05611827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456541|NCT05611827|Protective Agents|protective agents|mesh-ancestor
139456542|NCT05611827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456543|NCT05612607|Immunoglobulins|immunoglobulins|mesh-list
139456544|NCT05612607|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139456545|NCT05612607|Antibodies|antibodies|mesh-list
139456546|NCT05612607|Immunologic Factors|immunologic factors|mesh-ancestor
139456547|NCT05612607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456548|NCT02589639|Empagliflozin|empagliflozin|mesh-list
139456549|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139456550|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456551|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139456552|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456553|NCT05611749|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139456554|NCT05611749|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139456555|NCT05611749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139456556|NCT05611749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456557|NCT05611749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456558|NCT05611749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456559|NCT05611749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456560|NCT05611749|Analgesics|analgesics|mesh-ancestor
139456561|NCT05611749|Sensory System Agents|sensory system agents|mesh-ancestor
139456562|NCT05611749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456563|NCT05611749|Antidepressive Agents|antidepressive agents|mesh-ancestor
139456564|NCT05611749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139456565|NCT05611749|Dopamine Agents|dopamine agents|mesh-ancestor
139456566|NCT05611593|Finasteride|finasteride|mesh-list
139456567|NCT05611593|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139456568|NCT05611593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139456569|NCT05611593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456570|NCT05611593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456571|NCT05611593|Hormone Antagonists|hormone antagonists|mesh-ancestor
139456572|NCT05611593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139243253|NCT01334879|Ranibizumab|ranibizumab|mesh-list
139456573|NCT05611593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456574|NCT05611593|Urological Agents|urological agents|mesh-ancestor
139456575|NCT05612451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139456576|NCT05612451|Calcium|calcium|mesh-list
139456577|NCT05612451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139456578|NCT05612451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456579|NCT05612451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139456580|NCT02151682|Morphine|morphine|mesh-list
139456581|NCT02151682|Tapentadol|tapentadol|mesh-list
139456582|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139456583|NCT02151682|Narcotics|narcotics|mesh-ancestor
139456584|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139456585|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456586|NCT02151682|Analgesics|analgesics|mesh-ancestor
139456587|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
139456588|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456589|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139456590|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139456591|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456592|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456593|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
139456594|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456595|NCT04331691|Amiloride|amiloride|mesh-list
139456596|NCT04331691|Spironolactone|spironolactone|mesh-list
139456597|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139456598|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
139456599|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139456600|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456601|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139456602|NCT04331691|Diuretics|diuretics|mesh-ancestor
139456603|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
139456604|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139456605|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139456606|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456607|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456608|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139456609|NCT02174848|Deferiprone|deferiprone|mesh-list
139456610|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139456611|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
139456612|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
139456613|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456614|NCT02151058|Listerine|listerine|mesh-list
139456615|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
139456616|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
139456617|NCT02151058|Protective Agents|protective agents|mesh-ancestor
139456618|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456619|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139456620|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139456621|NCT05205759|Sotrovimab|sotrovimab|mesh-list
139456622|NCT05205759|Bamlanivimab|bamlanivimab|mesh-list
139456623|NCT05205759|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
139456624|NCT05205759|Antiviral Agents|antiviral agents|mesh-ancestor
139456625|NCT05205759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139456626|NCT02149264|Testosterone|testosterone|mesh-list
139456627|NCT02149264|Androgens|androgens|mesh-ancestor
139456628|NCT02149264|Hormones|hormones|mesh-ancestor
139456629|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139456630|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456631|NCT05557149|Cocaine|cocaine|mesh-list
139456632|NCT05557149|Anesthetics, Local|anesthetics, local|mesh-ancestor
139456633|NCT05557149|Anesthetics|anesthetics|mesh-ancestor
139456634|NCT05557149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139456635|NCT05557149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456636|NCT05557149|Sensory System Agents|sensory system agents|mesh-ancestor
139456637|NCT05557149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456638|NCT05557149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139456639|NCT05557149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139456640|NCT05557149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139456641|NCT05557149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456642|NCT05557149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456643|NCT05557149|Dopamine Agents|dopamine agents|mesh-ancestor
139456644|NCT05557149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456645|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
139456646|NCT02115256|Terbutaline|terbutaline|mesh-list
139456647|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
139456648|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139456649|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
139456650|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456651|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456652|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139456653|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
139456654|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
139456655|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
139456656|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139456657|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139456658|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139456659|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139456660|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
139456661|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456662|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456664|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139456665|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139456666|NCT02173054|Analgesics|analgesics|mesh-ancestor
139456667|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
139456668|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456669|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456670|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456671|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139456672|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
139456673|NCT04225221|Leuprolide|leuprolide|mesh-list
139456674|NCT04225221|Estradiol|estradiol|mesh-list
139456675|NCT04225221|Progesterone|progesterone|mesh-list
139456676|NCT04225221|Estrogens|estrogens|mesh-ancestor
139456677|NCT04225221|Hormones|hormones|mesh-ancestor
139456678|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139456679|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456680|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139456681|NCT04225221|Progestins|progestins|mesh-ancestor
139456682|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139456683|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
139456684|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139456685|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456686|NCT04425993|Indomethacin|indomethacin|mesh-list
139456687|NCT04425993|Isosorbide|isosorbide|mesh-list
139456688|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139456689|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139456690|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139456691|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139456692|NCT04425993|Analgesics|analgesics|mesh-ancestor
139456693|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
139456694|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456695|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456696|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456697|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139456698|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
139456699|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
139456700|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139456701|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139456702|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456703|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456704|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139456705|NCT04425993|Diuretics|diuretics|mesh-ancestor
139456706|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
139456707|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
139456708|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139456709|NCT03971643|Vilobelimab|vilobelimab|mesh-list
139456710|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139456711|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139456712|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
139456713|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456714|NCT02149108|Nintedanib|nintedanib|mesh-list
139456715|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456716|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139456717|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456718|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456719|NCT02148718|Adalimumab|adalimumab|mesh-list
139456720|NCT02148718|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139456721|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139243406|NCT03067610|Paclitaxel|paclitaxel|mesh-list
139456722|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139456723|NCT03397953|Vinorelbine|vinorelbine|mesh-list
139456724|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139456725|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456726|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
139456727|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
139456728|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
139456729|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456730|NCT05549973|Dexamethasone|dexamethasone|mesh-list
139456731|NCT05549973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456732|NCT05549973|Antiemetics|antiemetics|mesh-ancestor
139456733|NCT05549973|Autonomic Agents|autonomic agents|mesh-ancestor
139456734|NCT05549973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456735|NCT05549973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456736|NCT05549973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139456737|NCT05549973|Glucocorticoids|glucocorticoids|mesh-ancestor
139456738|NCT05549973|Hormones|hormones|mesh-ancestor
139456739|NCT05549973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139456740|NCT05549973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139456741|NCT05549973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456742|NCT02148250|Insulin|insulin|mesh-list
139456743|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139456744|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139456745|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456746|NCT04870359|Prednisolone|prednisolone|mesh-list
139456747|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139456748|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456749|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
139456750|NCT04870359|Hormones|hormones|mesh-ancestor
139456751|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139456752|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456753|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139456754|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456755|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
139456756|NCT05549583|Metformin|metformin|mesh-list
139456757|NCT05549583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139456758|NCT05549583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139456759|NCT05549583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456760|NCT05549583|Incretins|incretins|mesh-ancestor
139456761|NCT05549583|Hormones|hormones|mesh-ancestor
139456762|NCT05549583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139456763|NCT05549583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139456764|NCT05549583|Protease Inhibitors|protease inhibitors|mesh-ancestor
139456765|NCT05549583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456766|NCT05549583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456767|NCT05554731|Hemostatics|hemostatics|mesh-list
139456768|NCT05554731|Coagulants|coagulants|mesh-ancestor
139456769|NCT02172040|Celecoxib|celecoxib|mesh-list
139456770|NCT02172040|Amlodipine|amlodipine|mesh-list
139456771|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139456772|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139456773|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456774|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456775|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139456776|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456777|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
139456778|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139456779|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139456780|NCT02172040|Analgesics|analgesics|mesh-ancestor
139456781|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
139456782|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456783|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456784|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139456785|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139456786|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139456787|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456788|NCT02367105|Testosterone|testosterone|mesh-list
139456789|NCT02367105|Androgens|androgens|mesh-ancestor
139456790|NCT02367105|Hormones|hormones|mesh-ancestor
139456791|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139456792|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456793|NCT05554185|Aspirin|aspirin|mesh-list
139456794|NCT05554185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139243477|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
139456795|NCT05554185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139456796|NCT05554185|Analgesics|analgesics|mesh-ancestor
139456797|NCT05554185|Sensory System Agents|sensory system agents|mesh-ancestor
139456798|NCT05554185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456799|NCT05554185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456800|NCT05554185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456801|NCT05554185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139456802|NCT05554185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139456803|NCT05554185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139456804|NCT05554185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456805|NCT05554185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139456806|NCT05554185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139456807|NCT05554185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456808|NCT05554185|Antipyretics|antipyretics|mesh-ancestor
139456809|NCT05558397|Morphine|morphine|mesh-list
139456810|NCT05558397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139456811|NCT05558397|Narcotics|narcotics|mesh-ancestor
139456812|NCT05558397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139456813|NCT05558397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456814|NCT05558397|Analgesics|analgesics|mesh-ancestor
139456815|NCT05558397|Sensory System Agents|sensory system agents|mesh-ancestor
139456816|NCT05558397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456817|NCT05558319|Dexamethasone|dexamethasone|mesh-list
139456818|NCT05558319|Lenalidomide|lenalidomide|mesh-list
139456819|NCT05558319|Bortezomib|bortezomib|mesh-list
139456820|NCT05558319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456821|NCT05558319|Antiemetics|antiemetics|mesh-ancestor
139456822|NCT05558319|Autonomic Agents|autonomic agents|mesh-ancestor
139456823|NCT05558319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456824|NCT05558319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456825|NCT05558319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139456826|NCT05558319|Glucocorticoids|glucocorticoids|mesh-ancestor
139456827|NCT05558319|Hormones|hormones|mesh-ancestor
139456828|NCT05558319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139456829|NCT05558319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139456830|NCT05558319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456831|NCT05558319|Immunologic Factors|immunologic factors|mesh-ancestor
139456832|NCT05558319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139456833|NCT05558319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139456834|NCT05558319|Growth Substances|growth substances|mesh-ancestor
139456835|NCT05558319|Growth Inhibitors|growth inhibitors|mesh-ancestor
139456836|NCT05553717|Carvedilol|carvedilol|mesh-list
139456837|NCT05553717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139456838|NCT05553717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139456839|NCT05553717|Adrenergic Agents|adrenergic agents|mesh-ancestor
139456840|NCT05553717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456841|NCT05553717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456842|NCT05553717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456843|NCT05553717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139456844|NCT05553717|Antioxidants|antioxidants|mesh-ancestor
139456845|NCT05553717|Protective Agents|protective agents|mesh-ancestor
139456846|NCT05553717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139456847|NCT05553717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456848|NCT05553717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139456849|NCT05553717|Vasodilator Agents|vasodilator agents|mesh-ancestor
139456850|NCT05553717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139456851|NCT05553717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139456852|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
139456853|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139456854|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
139456855|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139456856|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456857|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139456858|NCT05553093|Insulin|insulin|mesh-list
139456859|NCT05553093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139456860|NCT05553093|Insulin Glargine|insulin glargine|mesh-list
139456861|NCT05553093|Tirzepatide|tirzepatide|mesh-list
139456862|NCT05553093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139456863|NCT05553093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456864|NCT05553093|Incretins|incretins|mesh-ancestor
139456865|NCT05553093|Hormones|hormones|mesh-ancestor
139456866|NCT05553093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139243552|NCT04851821|Protective Agents|protective agents|mesh-ancestor
139456867|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
139456868|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139456869|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139456870|NCT04757740|Prednisolone|prednisolone|mesh-list
139456871|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
139456873|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139456874|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
139456875|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
139456876|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
139456877|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139456878|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456879|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
139456880|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456881|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139456882|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139456883|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139456884|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139456885|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456886|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456887|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
139456888|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
139456889|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139456890|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
139456891|NCT04757740|Hormones|hormones|mesh-ancestor
139456892|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139456893|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139456894|NCT04757740|Protective Agents|protective agents|mesh-ancestor
139456895|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139456896|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456897|NCT05552937|Lenalidomide|lenalidomide|mesh-list
139456898|NCT05552937|Immunologic Factors|immunologic factors|mesh-ancestor
139456899|NCT05552937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456900|NCT05552937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139456901|NCT05552937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139456902|NCT05552937|Growth Substances|growth substances|mesh-ancestor
139456903|NCT05552937|Growth Inhibitors|growth inhibitors|mesh-ancestor
139456904|NCT05552937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139456905|NCT02112448|Acetaminophen|acetaminophen|mesh-list
139456906|NCT02112448|Ketorolac|ketorolac|mesh-list
139456907|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139456908|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139456909|NCT02112448|Analgesics|analgesics|mesh-ancestor
139456910|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
139456911|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456912|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456913|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
139456914|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139456915|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456916|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139456917|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139456918|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456919|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456920|NCT02109562|Risperidone|risperidone|mesh-list
139456921|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139456922|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
139456923|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456924|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456925|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456926|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139456927|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139456928|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139456929|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139456930|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139456931|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
139456932|NCT02109484|Vaccines|vaccines|mesh-list
139456933|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
139456934|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456935|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
139456936|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139456937|NCT05134792|Antibodies|antibodies|mesh-list
139456938|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
139456939|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139456940|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
139456941|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456942|NCT02105974|Fluticasone|fluticasone|mesh-list
139456943|NCT02105974|Xhance|xhance|mesh-list
139456944|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139456945|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139456946|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
139456947|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456948|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456949|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139456950|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
139456951|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
139456952|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139456953|NCT02105662|Grazoprevir|grazoprevir|mesh-list
139456954|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
139456955|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139456956|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
139456957|NCT02142712|Promethazine|promethazine|mesh-list
139456958|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
139456959|NCT02142712|Pantoprazole|pantoprazole|mesh-list
139456961|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139456962|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139456963|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139456964|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139456965|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456966|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139456967|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139456968|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139456969|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456970|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
139456971|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
139456972|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
139456973|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139456974|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
139456975|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
139456976|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139456977|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
139456978|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
139456979|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456980|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139456981|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
139456982|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
139456983|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
139456984|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
139456985|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139456986|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139456987|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139456988|NCT02105272|Carteolol|carteolol|mesh-list
139456989|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139456990|NCT02105272|Latanoprost|latanoprost|mesh-list
139456991|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139456992|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139456993|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139456994|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
139456995|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139456996|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139456997|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139456998|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139456999|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139457000|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
139457001|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
139457002|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457003|NCT02141854|Fluticasone|fluticasone|mesh-list
139457004|NCT02141854|Xhance|xhance|mesh-list
139457005|NCT02141854|Albuterol|albuterol|mesh-list
139457006|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139457007|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
139457008|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139457009|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139457010|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
139457011|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457012|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457013|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139457014|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
139457015|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
139457016|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139457017|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139457018|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139457019|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
139457020|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139243711|NCT03565406|Nivolumab|nivolumab|mesh-list
139457021|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457022|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
139457023|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139457024|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
139457025|NCT02141620|Cocaine|cocaine|mesh-list
139457026|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139457027|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
139457028|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457029|NCT02141620|Expectorants|expectorants|mesh-ancestor
139457030|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
139457031|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139457032|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
139457033|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457034|NCT02141620|Protective Agents|protective agents|mesh-ancestor
139457035|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457036|NCT02141620|Antidotes|antidotes|mesh-ancestor
139457037|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
139457038|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
139457039|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457040|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
139457041|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457042|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139457043|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139457044|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139457045|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139457046|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
139457047|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139457048|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139457049|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139457050|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
139457051|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139457052|NCT01664949|Laxatives|laxatives|mesh-ancestor
139457053|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139457054|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
139457055|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
139457056|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
139457057|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457058|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457059|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
139457060|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457061|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
139457062|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139457063|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457064|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139457065|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139457066|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457067|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457068|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457069|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139457070|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139457071|NCT05552391|Dexmedetomidine|dexmedetomidine|mesh-list
139457072|NCT05552391|Ketamine|ketamine|mesh-list
139457073|NCT05552391|Bupivacaine|bupivacaine|mesh-list
139457074|NCT05552391|Anesthetics, Local|anesthetics, local|mesh-ancestor
139457075|NCT05552391|Anesthetics|anesthetics|mesh-ancestor
139457076|NCT05552391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457077|NCT05552391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457078|NCT05552391|Sensory System Agents|sensory system agents|mesh-ancestor
139457079|NCT05552391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457080|NCT05552391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139457081|NCT05552391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139457082|NCT05552391|Analgesics|analgesics|mesh-ancestor
139457083|NCT05552391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139457084|NCT05552391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139457085|NCT05552391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139457086|NCT05552391|Adrenergic Agents|adrenergic agents|mesh-ancestor
139457087|NCT05552391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139457088|NCT05552391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457089|NCT05552391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139457090|NCT05552391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139457091|NCT05552391|Anesthetics, General|anesthetics, general|mesh-ancestor
139457092|NCT05552391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139457093|NCT05552391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139457094|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
139457095|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139457096|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139243774|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139457097|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457098|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139457099|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457100|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139457101|NCT02105116|Cytarabine|cytarabine|mesh-list
139457102|NCT02105116|Fludarabine|fludarabine|mesh-list
139457103|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
139457104|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457105|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139457106|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
139457107|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457108|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139457109|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
139457110|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457111|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
139457112|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457113|NCT05551767|Cisplatin|cisplatin|mesh-list
139457114|NCT05551767|Pembrolizumab|pembrolizumab|mesh-list
139457115|NCT05551767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457116|NCT05551767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139457117|NCT05551767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139457118|NCT05551767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457119|NCT05551689|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139457120|NCT05551689|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139457121|NCT05551689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457122|NCT05551689|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139457123|NCT05551689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139457124|NCT05551689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139457125|NCT05551689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457126|NCT05551689|Dopamine Agents|dopamine agents|mesh-ancestor
139457127|NCT05551689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139457128|NCT05547789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139457129|NCT05547789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139457130|NCT05547789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139457131|NCT05547789|Analgesics|analgesics|mesh-ancestor
139457132|NCT05547789|Sensory System Agents|sensory system agents|mesh-ancestor
139457133|NCT05547789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457134|NCT05547789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457135|NCT05547789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139457136|NCT05542095|Simvastatin|simvastatin|mesh-list
139457137|NCT05542095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139457138|NCT05542095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139457139|NCT05542095|Antimetabolites|antimetabolites|mesh-ancestor
139457140|NCT05542095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457141|NCT05542095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139457142|NCT05542095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139457143|NCT05542095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457144|NCT05551221|Tamsulosin|tamsulosin|mesh-list
139457145|NCT05551221|Silodosin|silodosin|mesh-list
139457146|NCT05551221|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139457147|NCT05551221|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139457148|NCT05551221|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139457149|NCT05551221|Adrenergic Agents|adrenergic agents|mesh-ancestor
139457150|NCT05551221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139457151|NCT05551221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457152|NCT05551221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457153|NCT05551221|Urological Agents|urological agents|mesh-ancestor
139457154|NCT02104804|Insulin|insulin|mesh-list
139457155|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139457156|NCT02104804|Metformin|metformin|mesh-list
139457157|NCT02104804|Saxagliptin|saxagliptin|mesh-list
139457158|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
139457159|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139457160|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457161|NCT02104804|Incretins|incretins|mesh-ancestor
139457162|NCT02104804|Hormones|hormones|mesh-ancestor
139457163|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457164|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139457165|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
139457166|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457167|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457168|NCT05550441|Dapagliflozin|dapagliflozin|mesh-list
139243857|NCT02836652|Aspirin|aspirin|mesh-list
139457169|NCT05550441|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139457170|NCT05550441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457171|NCT05550441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139457172|NCT05550441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457173|NCT05546619|Tislelizumab|tislelizumab|mesh-list
139457174|NCT05546619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139457175|NCT05546619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457176|NCT05540145|Paclitaxel|paclitaxel|mesh-list
139457177|NCT05540145|Antibodies|antibodies|mesh-list
139457178|NCT05540145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139457179|NCT05540145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457180|NCT05540145|Tubulin Modulators|tubulin modulators|mesh-ancestor
139457181|NCT05540145|Antimitotic Agents|antimitotic agents|mesh-ancestor
139457182|NCT05540145|Mitosis Modulators|mitosis modulators|mesh-ancestor
139457183|NCT05540145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457184|NCT05540145|Immunologic Factors|immunologic factors|mesh-ancestor
139457185|NCT05540145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457186|NCT05592327|Citric Acid|citric acid|mesh-list
139457187|NCT05592327|Sodium Citrate|sodium citrate|mesh-list
139457188|NCT05592327|Anticoagulants|anticoagulants|mesh-ancestor
139457189|NCT05592327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139457190|NCT05592327|Chelating Agents|chelating agents|mesh-ancestor
139457191|NCT05592327|Sequestering Agents|sequestering agents|mesh-ancestor
139457192|NCT05592327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457193|NCT05592171|Chlorotrianisene|chlorotrianisene|mesh-list
139457194|NCT05592171|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139457195|NCT05592171|Estrogens|estrogens|mesh-ancestor
139457196|NCT05592171|Hormones|hormones|mesh-ancestor
139457197|NCT05592171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457198|NCT05592171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457199|NCT05592171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139457200|NCT05592171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457201|NCT05539521|Propofol|propofol|mesh-list
139457202|NCT05539521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139457203|NCT05539521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457204|NCT05539521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457205|NCT05539521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139457206|NCT05539521|Anesthetics, General|anesthetics, general|mesh-ancestor
139457207|NCT05539521|Anesthetics|anesthetics|mesh-ancestor
139457208|NCT05592015|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139457209|NCT05592015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139457210|NCT05592015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457211|NCT05592015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457212|NCT05538507|Memantine|memantine|mesh-list
139457213|NCT05538507|Donepezil|donepezil|mesh-list
139457214|NCT05538507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139457215|NCT05538507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457216|NCT05538507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457217|NCT05538507|Cholinergic Agents|cholinergic agents|mesh-ancestor
139457218|NCT05538507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139457219|NCT05538507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457220|NCT05538507|Nootropic Agents|nootropic agents|mesh-ancestor
139457221|NCT05538507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139457222|NCT05538507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139457223|NCT05538507|Dopamine Agents|dopamine agents|mesh-ancestor
139457224|NCT05538507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139457225|NCT05538507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139457226|NCT05591235|Metformin|metformin|mesh-list
139457227|NCT05591235|Pioglitazone|pioglitazone|mesh-list
139457228|NCT05591235|Dapagliflozin|dapagliflozin|mesh-list
139457229|NCT05591235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139457230|NCT05591235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457231|NCT05591235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139457232|NCT05591235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457233|NCT01666119|Buprenorphine|buprenorphine|mesh-list
139457234|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139457235|NCT01666119|Narcotics|narcotics|mesh-ancestor
139457236|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457237|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457238|NCT01666119|Analgesics|analgesics|mesh-ancestor
139457239|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
139457240|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457241|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139243922|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457242|NCT05361993|Aripiprazole|aripiprazole|mesh-list
139457243|NCT05361993|Antidepressive Agents|antidepressive agents|mesh-ancestor
139457244|NCT05361993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139457245|NCT05361993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139457246|NCT05361993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139457247|NCT05361993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457248|NCT05361993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457249|NCT05361993|Dopamine Agonists|dopamine agonists|mesh-ancestor
139457250|NCT05361993|Dopamine Agents|dopamine agents|mesh-ancestor
139457251|NCT05361993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139457252|NCT05361993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457253|NCT05361993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139457254|NCT05361993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139457255|NCT05361993|Serotonin Agents|serotonin agents|mesh-ancestor
139457256|NCT05361993|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139457257|NCT05361993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139457258|NCT05361993|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139457259|NCT05361993|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139457260|NCT04425681|Bevacizumab|bevacizumab|mesh-list
139457261|NCT04425681|Osimertinib|osimertinib|mesh-list
139457262|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139457263|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457264|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139457265|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139457266|NCT04425681|Growth Substances|growth substances|mesh-ancestor
139457267|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457268|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
139457269|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139457270|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457271|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457272|NCT05545059|Amlodipine|amlodipine|mesh-list
139457273|NCT05545059|Valsartan|valsartan|mesh-list
139457274|NCT05545059|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139457275|NCT05545059|Spironolactone|spironolactone|mesh-list
139457276|NCT05545059|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139457277|NCT05545059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139457278|NCT05545059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139457279|NCT05545059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139457280|NCT05545059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457281|NCT05545059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139457282|NCT05545059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457283|NCT05545059|Vasodilator Agents|vasodilator agents|mesh-ancestor
139457284|NCT05545059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139457285|NCT05545059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139457286|NCT05545059|Diuretics|diuretics|mesh-ancestor
139457287|NCT05545059|Natriuretic Agents|natriuretic agents|mesh-ancestor
139457288|NCT05545059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139457289|NCT05545059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139457290|NCT05545059|Hormone Antagonists|hormone antagonists|mesh-ancestor
139457291|NCT05545059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457292|NCT05545059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139457293|NCT05128773|Tamoxifen|tamoxifen|mesh-list
139457294|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139457295|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
139457296|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457297|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457298|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139457299|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457300|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139457301|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139457302|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139457303|NCT04809051|Metronidazole|metronidazole|mesh-list
139457304|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457305|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139457306|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139457307|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139457308|NCT04677855|Prednisone|prednisone|mesh-list
139457309|NCT04677855|Dutasteride|dutasteride|mesh-list
139457310|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139457311|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
139457312|NCT04677855|Hormones|hormones|mesh-ancestor
139457313|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139244006|NCT00871351|Ezetimibe|ezetimibe|mesh-list
139457314|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457315|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139457316|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457317|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139457318|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139457319|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457320|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457321|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
139457322|NCT02584959|Complement C1s|complement c1s|mesh-list
139457323|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139457324|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
139457325|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
139457326|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457327|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139457328|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139457329|NCT02584257|Albuterol|albuterol|mesh-list
139457330|NCT02584257|Procaterol|procaterol|mesh-list
139457331|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
139457332|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139457333|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
139457334|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457335|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457336|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139457337|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
139457338|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
139457339|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139457340|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139457341|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139457342|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139457343|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
139457344|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139457345|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457346|NCT02584257|Miotics|miotics|mesh-ancestor
139457347|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139457348|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139457349|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139457350|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139457351|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
139457352|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
139457353|NCT04090203|Immunomodulating Agents|immunomodulating agents|mesh-list
139457354|NCT04090203|Immunologic Factors|immunologic factors|mesh-ancestor
139457355|NCT04090203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457356|NCT04062201|Levofloxacin|levofloxacin|mesh-list
139457357|NCT04062201|Ofloxacin|ofloxacin|mesh-list
139457358|NCT04062201|Isoniazid|isoniazid|mesh-list
139457359|NCT04062201|Linezolid|linezolid|mesh-list
139457360|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
139457361|NCT04062201|Ethambutol|ethambutol|mesh-list
139457362|NCT04062201|Bedaquiline|bedaquiline|mesh-list
139457363|NCT04062201|Clofazimine|clofazimine|mesh-list
139457364|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139457365|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457366|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139457367|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139457368|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139457369|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457370|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457371|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457372|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139457373|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139457374|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
139457375|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139457376|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139457377|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
139457378|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139457379|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139457380|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139457381|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
139457382|NCT02583477|Paclitaxel|paclitaxel|mesh-list
139457383|NCT02583477|Gemcitabine|gemcitabine|mesh-list
139457384|NCT02583477|Durvalumab|durvalumab|mesh-list
139457385|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139457386|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139457387|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244074|NCT01317433|Doxycycline|doxycycline|mesh-list
139457388|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
139457389|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
139457390|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
139457391|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457392|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139457393|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
139457394|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139457395|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
139457396|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457397|NCT02583399|Ibuprofen|ibuprofen|mesh-list
139457398|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139457399|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139457400|NCT02583399|Analgesics|analgesics|mesh-ancestor
139457401|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
139457402|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457403|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457404|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139457405|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139457406|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139457407|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457408|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457409|NCT02580591|Empagliflozin|empagliflozin|mesh-list
139457410|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139457411|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457412|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139457413|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457414|NCT05319249|Talazoparib|talazoparib|mesh-list
139457415|NCT05319249|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139457416|NCT05319249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457417|NCT05319249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457418|NCT05319249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457419|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139457420|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
139457421|NCT02577315|Metformin|metformin|mesh-list
139457422|NCT02577315|Empagliflozin|empagliflozin|mesh-list
139457423|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139457424|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457425|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139457426|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457427|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
139457428|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139457429|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457430|NCT03526887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139457431|NCT03526887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457432|NCT03496779|Gemcitabine|gemcitabine|mesh-list
139457433|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139457434|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139457435|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139457436|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
139457437|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457438|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457439|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139457440|NCT03496779|Immunotoxins|immunotoxins|mesh-ancestor
139457441|NCT03496779|Immunoconjugates|immunoconjugates|mesh-ancestor
139457442|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
139457443|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457444|NCT03398655|Paclitaxel|paclitaxel|mesh-list
139457445|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139457446|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139457447|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457448|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
139457449|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
139457450|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
139457451|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457452|NCT05695287|Propofol|propofol|mesh-list
139457453|NCT05695287|Sevoflurane|sevoflurane|mesh-list
139457454|NCT05695287|Isoflurane|isoflurane|mesh-list
139457455|NCT05695287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139457456|NCT05695287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457457|NCT05695287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457458|NCT05695287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139457459|NCT05695287|Anesthetics, General|anesthetics, general|mesh-ancestor
139457460|NCT05695287|Anesthetics|anesthetics|mesh-ancestor
139457461|NCT05695287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139244151|NCT01348321|Levamisole|levamisole|mesh-list
139457463|NCT00591227|Insulin|insulin|mesh-list
139457464|NCT00591227|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139457465|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
139457466|NCT00591227|Insulin Detemir|insulin detemir|mesh-list
139457467|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139457468|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457469|NCT00408473|Flecainide|flecainide|mesh-list
139457470|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139457471|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139457472|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139457473|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139457474|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457475|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
139457476|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
139457477|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457478|NCT00328601|Protective Agents|protective agents|mesh-ancestor
139457479|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457480|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
139457481|NCT00328601|Vitamins|vitamins|mesh-ancestor
139457482|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
139457483|NCT00189293|Imiquimod|imiquimod|mesh-list
139457484|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139457485|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
139457486|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457487|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457488|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
139457489|NCT03194009|Metformin|metformin|mesh-list
139457490|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139457491|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457492|NCT02581995|Aflibercept|aflibercept|mesh-list
139457493|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139457494|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139457495|NCT02581995|Growth Substances|growth substances|mesh-ancestor
139457496|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457497|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
139457498|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457499|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139457500|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
139457501|NCT03193307|BI 409306|bi 409306|mesh-list
139457502|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139457503|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457504|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457505|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139457506|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
139457507|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139457508|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457509|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139457510|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139457511|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139457512|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139457513|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139457514|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
139457515|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139457516|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139457517|NCT02910843|Capecitabine|capecitabine|mesh-list
139457518|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139457519|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
139457520|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457521|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457522|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139457523|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
139457524|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139457525|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
139457526|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139457527|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457528|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139457529|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139457530|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457531|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
139457532|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139457533|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139457534|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139457535|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139457536|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457537|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
139457538|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139457539|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457540|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139457541|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457542|NCT03193463|Topotecan|topotecan|mesh-list
139457543|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139457544|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139457545|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457546|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457547|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457548|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139457549|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
139457550|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139457551|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457552|NCT02577003|Incretins|incretins|mesh-ancestor
139457553|NCT02577003|Hormones|hormones|mesh-ancestor
139457554|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457555|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139457556|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
139457557|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457558|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457559|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139457560|NCT05487417|Minocycline|minocycline|mesh-list
139457561|NCT05487417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139457562|NCT05487417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457563|NCT03471611|Lenograstim|lenograstim|mesh-list
139457564|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139457565|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
139457566|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457567|NCT05674305|Cisplatin|cisplatin|mesh-list
139457568|NCT05674305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457569|NCT03192449|Albendazole|albendazole|mesh-list
139457570|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
139457571|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139457572|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457573|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
139457574|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139457575|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139457576|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
139457577|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
139457578|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
139457579|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457580|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457581|NCT05691933|Morphine|morphine|mesh-list
139457582|NCT05691933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139457583|NCT05691933|Narcotics|narcotics|mesh-ancestor
139457584|NCT05691933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457585|NCT05691933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457586|NCT05691933|Analgesics|analgesics|mesh-ancestor
139457587|NCT05691933|Sensory System Agents|sensory system agents|mesh-ancestor
139457588|NCT05691933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457589|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
139457590|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
139457591|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457592|NCT00977483|Protective Agents|protective agents|mesh-ancestor
139457593|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457594|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
139457595|NCT00977483|Vitamins|vitamins|mesh-ancestor
139457596|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
139457597|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
139457598|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139457599|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457600|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457601|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139457602|NCT02439905|Analgesics|analgesics|mesh-ancestor
139457603|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
139457604|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457605|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139457606|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139457607|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139457608|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
139457609|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139457610|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457611|NCT03192371|Vaccines|vaccines|mesh-list
139457612|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
139457613|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457614|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
139457615|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139457616|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457617|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
139457618|NCT02442791|Exenatide|exenatide|mesh-list
139457619|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139457620|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457621|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139457622|NCT02442791|Incretins|incretins|mesh-ancestor
139457623|NCT02442791|Hormones|hormones|mesh-ancestor
139457624|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457625|NCT04756557|Fluorides|fluorides|mesh-list
139457626|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
139457627|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
139457628|NCT04756557|Protective Agents|protective agents|mesh-ancestor
139457629|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457630|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
139457631|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139457632|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139457633|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457634|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457635|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139457636|NCT02442713|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139457637|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139457638|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139457639|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457640|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139457641|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
139457642|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139457643|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
139457644|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139457645|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139457646|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457647|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139457648|NCT03189953|Exenatide|exenatide|mesh-list
139457649|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139457650|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457651|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139457652|NCT03189953|Incretins|incretins|mesh-ancestor
139457653|NCT03189953|Hormones|hormones|mesh-ancestor
139457654|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457655|NCT02204085|Decitabine|decitabine|mesh-list
139457656|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139457657|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
139457658|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457659|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457660|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457661|NCT04314843|Lenzilumab|lenzilumab|mesh-list
139457662|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
139457663|NCT04314843|Fludarabine|fludarabine|mesh-list
139457664|NCT04314843|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139457665|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139457666|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
139457667|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457668|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139457669|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139457670|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
139457671|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457672|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457673|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139457674|NCT04314843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139457675|NCT04314843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139457676|NCT03192293|Metformin|metformin|mesh-list
139457677|NCT03192293|Fulvestrant|fulvestrant|mesh-list
139457678|NCT03192293|Simvastatin|simvastatin|mesh-list
139457679|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139457680|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457681|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139457682|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139457683|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
139457684|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457685|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139457686|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139457687|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457688|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139457689|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457690|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139457691|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139457692|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
139457693|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457694|NCT02439125|Eltoprazine|eltoprazine|mesh-list
139457695|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139457696|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
139457697|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139457698|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457699|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457700|NCT02441933|Carboplatin|carboplatin|mesh-list
139457702|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457703|NCT01604265|Nabiximols|nabiximols|mesh-list
139457704|NCT01604265|Analgesics|analgesics|mesh-ancestor
139457705|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
139457706|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457707|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457708|NCT04483427|Ketorolac|ketorolac|mesh-list
139457709|NCT04483427|Nalbuphine|nalbuphine|mesh-list
139457710|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139457711|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139457712|NCT04483427|Analgesics|analgesics|mesh-ancestor
139457713|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
139457714|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457715|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457716|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139457717|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139457718|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139457719|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457720|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457721|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139457722|NCT04483427|Narcotics|narcotics|mesh-ancestor
139457723|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457724|NCT01664247|Liraglutide|liraglutide|mesh-list
139457725|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139457726|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457727|NCT01664247|Incretins|incretins|mesh-ancestor
139457728|NCT01664247|Hormones|hormones|mesh-ancestor
139457729|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457730|NCT02441465|Vemurafenib|vemurafenib|mesh-list
139457731|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457732|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139457733|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457734|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457735|NCT02438657|Lidocaine|lidocaine|mesh-list
139457736|NCT02438657|Epinephrine|epinephrine|mesh-list
139457737|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
139457738|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
139457739|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457740|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457741|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
139457742|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457743|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139457744|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139457745|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139116231|NCT03816072|Phenylephrine|phenylephrine|mesh-list
139457746|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139457747|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457748|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139457749|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139457750|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
139457751|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139457752|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139457753|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139457754|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
139457755|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139457756|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
139457757|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
139457758|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
139457759|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139457760|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
139457761|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139457762|NCT01441947|Fulvestrant|fulvestrant|mesh-list
139457763|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139457764|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457765|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139457766|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139457767|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
139457768|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457769|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457771|NCT03192059|Vitamin D|vitamin d|mesh-list
139457772|NCT03192059|Curcumin|curcumin|mesh-list
139457773|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
139457774|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
139457775|NCT03192059|Lansoprazole|lansoprazole|mesh-list
139457776|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
139457777|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139457778|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
139457779|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457780|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139457781|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139457782|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
139457783|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457784|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457785|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139457786|NCT03192059|Vitamins|vitamins|mesh-ancestor
139457787|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
139457788|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139457789|NCT03192059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139457790|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139457791|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139457792|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139457793|NCT03192059|Analgesics|analgesics|mesh-ancestor
139457794|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
139457795|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457796|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139457797|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139457798|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139457799|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139457800|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139457801|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457802|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
139457803|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139457804|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139457805|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139457806|NCT02441075|Ethanol|ethanol|mesh-list
139457807|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139457808|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457809|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457810|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457811|NCT02438345|Leronlimab|leronlimab|mesh-list
139457812|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139457813|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139457814|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457815|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139457816|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139457817|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
139457818|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457819|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
139457820|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
139457821|NCT03191981|Lenalidomide|lenalidomide|mesh-list
139457822|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139457823|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
139457824|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457825|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139457826|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139457827|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
139457828|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457829|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457830|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139457831|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139457832|NCT03191981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139457833|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139457834|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139457835|NCT03191981|Growth Substances|growth substances|mesh-ancestor
139457836|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
139457837|NCT05530785|Bevacizumab|bevacizumab|mesh-list
139457838|NCT05530785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139457839|NCT05530785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457840|NCT05530785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139457841|NCT05530785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139457842|NCT05530785|Growth Substances|growth substances|mesh-ancestor
139457843|NCT05530785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457844|NCT05530785|Growth Inhibitors|growth inhibitors|mesh-ancestor
139457845|NCT05530395|Testosterone|testosterone|mesh-list
139457846|NCT05530395|Androgens|androgens|mesh-ancestor
139457847|NCT05530395|Hormones|hormones|mesh-ancestor
139457848|NCT05530395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457849|NCT05530395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457850|NCT04529265|Methylene Blue|methylene blue|mesh-list
139457851|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457852|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457853|NCT03191903|Triamcinolone|triamcinolone|mesh-list
139457854|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139457855|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139457856|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139457857|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139457858|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
139457859|NCT03191903|Hormones|hormones|mesh-ancestor
139457860|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457861|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457862|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139457863|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
139457864|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457865|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457866|NCT05534685|Budesonide|budesonide|mesh-list
139457867|NCT05534685|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139457868|NCT05534685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139457869|NCT05534685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139457870|NCT05534685|Autonomic Agents|autonomic agents|mesh-ancestor
139457871|NCT05534685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457872|NCT05534685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457873|NCT05534685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139457874|NCT05534685|Respiratory System Agents|respiratory system agents|mesh-ancestor
139457875|NCT05534685|Glucocorticoids|glucocorticoids|mesh-ancestor
139457876|NCT05534685|Hormones|hormones|mesh-ancestor
139457877|NCT05534685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457878|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
139457879|NCT02437955|Trace Elements|trace elements|mesh-ancestor
139457880|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
139457881|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457882|NCT02437721|Folic Acid|folic acid|mesh-list
139457883|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
139457884|NCT02437721|Hematinics|hematinics|mesh-ancestor
139457885|NCT02437721|Vitamins|vitamins|mesh-ancestor
139457886|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
139457887|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457888|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
139457889|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457890|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
139457891|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
139457892|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
139457893|NCT05533983|Nivolumab|nivolumab|mesh-list
139457894|NCT05533983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139457895|NCT05533983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457896|NCT05533983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139457897|NCT05533983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457898|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
139457899|NCT02436395|Povidone|povidone|mesh-list
139457900|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
139457901|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
139457902|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139457903|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457904|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139457905|NCT02436083|Cefuroxime|cefuroxime|mesh-list
139457906|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
139457907|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457908|NCT03117335|Endostatins|endostatins|mesh-list
139457909|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457910|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139457911|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139457912|NCT03117335|Growth Substances|growth substances|mesh-ancestor
139457913|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457914|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
139457915|NCT02435927|Leucovorin|leucovorin|mesh-list
139457916|NCT02435927|Capecitabine|capecitabine|mesh-list
139457917|NCT02435927|Fluorouracil|fluorouracil|mesh-list
139457918|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
139457919|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139457920|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
139457921|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457922|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457923|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139457924|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
139457925|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457926|NCT02435927|Antidotes|antidotes|mesh-ancestor
139457927|NCT02435927|Protective Agents|protective agents|mesh-ancestor
139457928|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
139457929|NCT02435927|Vitamins|vitamins|mesh-ancestor
139457930|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
139457931|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
139457932|NCT02435771|Vitamin D|vitamin d|mesh-list
139457933|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139457934|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457935|NCT02435771|Vitamins|vitamins|mesh-ancestor
139457936|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
139457937|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139457938|NCT02440841|Itraconazole|itraconazole|mesh-list
139457939|NCT02440841|Rifampin|rifampin|mesh-list
139457940|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
139457941|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139457942|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139457943|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139457944|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457945|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457946|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139457947|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
139457948|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139457949|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457950|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139457951|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139457952|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
139457953|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139457954|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
139457955|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139457956|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139457957|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139457958|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139457959|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139457960|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139457961|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139457962|NCT02576145|Daclizumab|daclizumab|mesh-list
139457963|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139457964|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
139457965|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457966|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
139457967|NCT02435537|Morphine|morphine|mesh-list
139457968|NCT02435537|Bupivacaine|bupivacaine|mesh-list
139457969|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
139457970|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
139457971|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139457972|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457973|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
139457974|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139457975|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139457976|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139457977|NCT02435537|Analgesics|analgesics|mesh-ancestor
139457978|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139457979|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139457980|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139457981|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
139457982|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139457983|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457984|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139457985|NCT02435537|Narcotics|narcotics|mesh-ancestor
139457986|NCT02576067|Methotrexate|methotrexate|mesh-list
139457987|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139457988|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
139457989|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139457990|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139457991|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139457992|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
139457993|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139457994|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139457995|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
139457996|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139457997|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139457998|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139457999|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
139458000|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458001|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139458003|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139458004|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458005|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
139458006|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458007|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139458008|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458009|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458010|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
139458011|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
139458012|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139458013|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139458014|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458015|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458016|NCT02435303|Urological Agents|urological agents|mesh-ancestor
139458017|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139458018|NCT02434757|Hormones|hormones|mesh-ancestor
139458019|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139458020|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458021|NCT03189329|Lidocaine|lidocaine|mesh-list
139458022|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
139458023|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
139458024|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
139458025|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458026|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458027|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
139458028|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458029|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139458030|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139458031|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139458032|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139458033|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458034|NCT02575833|Erenumab|erenumab|mesh-list
139458035|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139458036|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458037|NCT02575833|Analgesics|analgesics|mesh-ancestor
139458038|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
139458039|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458040|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458041|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
139458042|NCT02709083|Dasatinib|dasatinib|mesh-list
139458043|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458044|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139458045|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458046|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458047|NCT02709005|Monolaurin|monolaurin|mesh-list
139458048|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
139458049|NCT02709005|Protective Agents|protective agents|mesh-ancestor
139458050|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458051|NCT03188471|Aspirin|aspirin|mesh-list
139458052|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458053|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139458054|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139458055|NCT03188471|Analgesics|analgesics|mesh-ancestor
139458056|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
139458057|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458058|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458059|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458060|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139458061|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139458062|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458063|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139458064|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139458065|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458066|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
139458067|NCT04650087|Apixaban|apixaban|mesh-list
139458068|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139458069|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
139458070|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139458071|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
139458072|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458073|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458074|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
139458075|NCT03188159|Vinorelbine|vinorelbine|mesh-list
139458076|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139458077|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458078|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
139458079|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
139458080|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
139458081|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458082|NCT05532501|Oxytocin|oxytocin|mesh-list
139458083|NCT05532501|Oxytocics|oxytocics|mesh-ancestor
139458084|NCT05532501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139458085|NCT05532501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458086|NCT05524857|Decitabine|decitabine|mesh-list
139458087|NCT05524857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139458088|NCT05524857|Antimetabolites|antimetabolites|mesh-ancestor
139458089|NCT05524857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458090|NCT05524857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458091|NCT05524857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458092|NCT05327439|Nicotine|nicotine|mesh-list
139458093|NCT05327439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139458094|NCT05327439|Autonomic Agents|autonomic agents|mesh-ancestor
139458095|NCT05327439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458096|NCT05327439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458097|NCT05327439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139458098|NCT05327439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139458099|NCT05327439|Cholinergic Agents|cholinergic agents|mesh-ancestor
139458100|NCT05327439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139458101|NCT05327439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458102|NCT03187691|Amphotericin B|amphotericin b|mesh-list
139458103|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139458104|NCT03187691|Amebicides|amebicides|mesh-ancestor
139458105|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139458106|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139458107|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458108|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139458109|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
139458110|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
139458111|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139458112|NCT02433899|Dexamethasone|dexamethasone|mesh-list
139458113|NCT02433899|Epinephrine|epinephrine|mesh-list
139458114|NCT02433899|Mepivacaine|mepivacaine|mesh-list
139458115|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458116|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
139458117|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
139458118|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458119|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458120|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139458121|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
139458122|NCT02433899|Hormones|hormones|mesh-ancestor
139458123|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139458124|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139458125|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458126|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139458127|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458128|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
139458129|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
139458130|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139458131|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139458132|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
139244821|NCT02053766|Analgesics|analgesics|mesh-ancestor
139458133|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139458134|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458136|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139458137|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139458138|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
139458139|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
139458140|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
139458141|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139458142|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
139458143|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
139458144|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458145|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
139458146|NCT05532267|Ciprofloxacin|ciprofloxacin|mesh-list
139458147|NCT05532267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139458148|NCT05532267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458149|NCT05532267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139458150|NCT05532267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139458151|NCT05532267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458152|NCT05532267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458153|NCT05532267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458154|NCT05532267|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139458155|NCT05532267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139458156|NCT03187457|Metronidazole|metronidazole|mesh-list
139458157|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458158|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139458159|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139458160|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139458161|NCT03187223|Melphalan|melphalan|mesh-list
139458162|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139458163|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139458164|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
139458165|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458166|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458167|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139458168|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139458169|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
139458170|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458171|NCT05532111|Cyclophosphamide|cyclophosphamide|mesh-list
139458172|NCT05532111|Rituximab|rituximab|mesh-list
139458173|NCT05532111|Tacrolimus|tacrolimus|mesh-list
139458174|NCT05532111|Glucocorticoids|glucocorticoids|mesh-list
139458175|NCT05532111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139458176|NCT05532111|Immunologic Factors|immunologic factors|mesh-ancestor
139458177|NCT05532111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458178|NCT05532111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458179|NCT05532111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139458180|NCT05532111|Alkylating Agents|alkylating agents|mesh-ancestor
139458181|NCT05532111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458182|NCT05532111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458183|NCT05532111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139458184|NCT05532111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139458185|NCT05532111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139458186|NCT05532111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458187|NCT05532111|Hormones|hormones|mesh-ancestor
139458188|NCT05532111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139458189|NCT05524077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139458190|NCT04299867|Metronidazole|metronidazole|mesh-list
139458191|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458192|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139458193|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139458194|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139458195|NCT02433587|Aspirin|aspirin|mesh-list
139458196|NCT02433587|Clopidogrel|clopidogrel|mesh-list
139458197|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139458198|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139458199|NCT02433587|Analgesics|analgesics|mesh-ancestor
139458200|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
139458201|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458202|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458203|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458204|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458205|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139458206|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139458207|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458209|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139458210|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458211|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
139458212|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139458213|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139458214|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139458215|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
139458216|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139458217|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139458218|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139458219|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139458220|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139458221|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458222|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139458223|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458224|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139458225|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
139458226|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139458227|NCT03190733|Fludarabine|fludarabine|mesh-list
139458228|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458229|NCT04425135|Carboplatin|carboplatin|mesh-list
139458230|NCT04425135|Apatinib|apatinib|mesh-list
139458231|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458232|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139458233|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458234|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458235|NCT02573883|Clobetasol|clobetasol|mesh-list
139458236|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458237|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
139458238|NCT02573883|Hormones|hormones|mesh-ancestor
139458239|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139458240|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458241|NCT02432885|Enalapril|enalapril|mesh-list
139458242|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139458243|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
139458244|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458245|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458246|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139458247|NCT02433041|Ketamine|ketamine|mesh-list
139458248|NCT02433041|Haloperidol|haloperidol|mesh-list
139458249|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
139458250|NCT02433041|Analgesics|analgesics|mesh-ancestor
139458251|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
139458252|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458253|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458254|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139458255|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139458256|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
139458257|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
139458258|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458259|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139458260|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139458261|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139458262|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458263|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
139458264|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
139458265|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139458266|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139458267|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139458268|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139458269|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139458270|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
139458271|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139458272|NCT02429921|Selenium|selenium|mesh-list
139458273|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
139458274|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458275|NCT02429921|Protective Agents|protective agents|mesh-ancestor
139458276|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458277|NCT02429921|Trace Elements|trace elements|mesh-ancestor
139458278|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
139458279|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139458280|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139458281|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458282|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139458283|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
139458284|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458285|NCT02432807|Vancomycin|vancomycin|mesh-list
139458286|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139458287|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458288|NCT05527275|Mitoxantrone|mitoxantrone|mesh-list
139458289|NCT05527275|Analgesics|analgesics|mesh-ancestor
139458290|NCT05527275|Sensory System Agents|sensory system agents|mesh-ancestor
139458291|NCT05527275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458292|NCT05527275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458293|NCT05527275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458294|NCT05527275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139458295|NCT05527275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139458296|NCT05527275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458297|NCT05527275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458298|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
139458299|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139458300|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
139458301|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458302|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458303|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139458304|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
139458305|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139458306|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139458307|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139458308|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
139458309|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139458310|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458311|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
139458312|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139458313|NCT03186053|Protective Agents|protective agents|mesh-ancestor
139458314|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458315|NCT02429219|Ethanol|ethanol|mesh-list
139458316|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139458317|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458318|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458319|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458320|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139458321|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
139458322|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458323|NCT02429453|Thrombin|thrombin|mesh-list
139458324|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
139458325|NCT02429453|Coagulants|coagulants|mesh-ancestor
139458326|NCT02428751|Prednisone|prednisone|mesh-list
139458327|NCT02428751|Rituximab|rituximab|mesh-list
139458328|NCT02428751|Doxorubicin|doxorubicin|mesh-list
139458329|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139458330|NCT02428751|Vincristine|vincristine|mesh-list
139458331|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139458332|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458333|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
139458334|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458335|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458336|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139458337|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139458338|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139458339|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458340|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458341|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458342|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
139458343|NCT02428751|Hormones|hormones|mesh-ancestor
139458344|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139458345|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139458346|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139458347|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
139458348|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
139458349|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
139458350|NCT05526807|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139458351|NCT05526807|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139458352|NCT05526807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139458353|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139458354|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139458356|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458357|NCT02432651|Xanthohumol|xanthohumol|mesh-list
139458358|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458359|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139458360|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139458361|NCT02432651|Growth Substances|growth substances|mesh-ancestor
139458362|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458363|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
139458364|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139458365|NCT02707757|Hematinics|hematinics|mesh-ancestor
139458366|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
139458367|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139458368|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458369|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139458370|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
139458371|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139458372|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458373|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458374|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458375|NCT03184805|Aspirin|aspirin|mesh-list
139458376|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139458377|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139458378|NCT03184805|Analgesics|analgesics|mesh-ancestor
139458379|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
139458380|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458381|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458382|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458383|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458384|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139458385|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139458386|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458387|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139458388|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139458389|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458390|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
139458391|NCT05518383|Cytarabine|cytarabine|mesh-list
139458392|NCT05518383|Dexamethasone|dexamethasone|mesh-list
139458393|NCT05518383|Dexamethasone acetate|dexamethasone acetate|mesh-list
139458394|NCT05518383|Cyclophosphamide|cyclophosphamide|mesh-list
139458395|NCT05518383|Melphalan|melphalan|mesh-list
139458396|NCT05518383|Ifosfamide|ifosfamide|mesh-list
139458397|NCT05518383|Isophosphamide mustard|isophosphamide mustard|mesh-list
139458398|NCT05518383|Doxorubicin|doxorubicin|mesh-list
139458399|NCT05518383|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139458400|NCT05518383|Methotrexate|methotrexate|mesh-list
139458401|NCT05518383|Etoposide|etoposide|mesh-list
139458402|NCT05518383|Etoposide phosphate|etoposide phosphate|mesh-list
139458403|NCT05518383|Vincristine|vincristine|mesh-list
139458404|NCT05518383|Idarubicin|idarubicin|mesh-list
139458405|NCT05518383|Carboplatin|carboplatin|mesh-list
139458406|NCT05518383|BB 1101|bb 1101|mesh-list
139458407|NCT05518383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139458408|NCT05518383|Immunologic Factors|immunologic factors|mesh-ancestor
139458409|NCT05518383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458410|NCT05518383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458411|NCT05518383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139458412|NCT05518383|Alkylating Agents|alkylating agents|mesh-ancestor
139458413|NCT05518383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458414|NCT05518383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458415|NCT05518383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139458416|NCT05518383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458417|NCT05518383|Antiemetics|antiemetics|mesh-ancestor
139458418|NCT05518383|Autonomic Agents|autonomic agents|mesh-ancestor
139458419|NCT05518383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458420|NCT05518383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139458421|NCT05518383|Glucocorticoids|glucocorticoids|mesh-ancestor
139458422|NCT05518383|Hormones|hormones|mesh-ancestor
139458423|NCT05518383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139458424|NCT05518383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139458425|NCT05518383|Protease Inhibitors|protease inhibitors|mesh-ancestor
139458426|NCT05518383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458427|NCT05518383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139458428|NCT05518383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139458429|NCT05518383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139458430|NCT05518383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139458431|NCT05518383|Abortifacient Agents|abortifacient agents|mesh-ancestor
139458432|NCT05518383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139458433|NCT05518383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139458434|NCT05518383|Antimetabolites|antimetabolites|mesh-ancestor
139458435|NCT05518383|Dermatologic Agents|dermatologic agents|mesh-ancestor
139458436|NCT05518383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139458437|NCT05518383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139458438|NCT05518383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139458439|NCT05518383|Antiviral Agents|antiviral agents|mesh-ancestor
139458440|NCT05518383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458441|NCT05518383|Tubulin Modulators|tubulin modulators|mesh-ancestor
139458442|NCT05518383|Antimitotic Agents|antimitotic agents|mesh-ancestor
139458443|NCT05518383|Mitosis Modulators|mitosis modulators|mesh-ancestor
139458444|NCT02432027|Betamethasone|betamethasone|mesh-list
139458445|NCT02432027|Calcipotriene|calcipotriene|mesh-list
139458446|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458447|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
139458448|NCT02432027|Hormones|hormones|mesh-ancestor
139458449|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139458450|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458451|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139458452|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
139458453|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
139458454|NCT02428439|Lamotrigine|lamotrigine|mesh-list
139458455|NCT02428439|Bupropion|bupropion|mesh-list
139458456|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139458457|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
139458458|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139458459|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139458460|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139458461|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139458462|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458463|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
139458464|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139458465|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458466|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139458467|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139458468|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458469|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
139458470|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139458471|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139458472|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139458473|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139458474|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458475|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139458476|NCT03186443|Pregabalin|pregabalin|mesh-list
139458477|NCT03186443|Gabapentin|gabapentin|mesh-list
139458478|NCT03186443|Analgesics|analgesics|mesh-ancestor
139458479|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
139458480|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458481|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458482|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
139458483|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139458484|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139458485|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458486|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139458487|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139458488|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139382922|NCT06173596|Sensory System Agents|sensory system agents|mesh-ancestor
139458489|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458490|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139458491|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139458492|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139458493|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139458494|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
139458495|NCT03186131|Vitamin D|vitamin d|mesh-list
139458496|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
139458497|NCT03186131|Vitamins|vitamins|mesh-ancestor
139458498|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
139458499|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458500|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139458501|NCT03184649|Acetaminophen|acetaminophen|mesh-list
139458502|NCT03184649|Ibuprofen|ibuprofen|mesh-list
139458503|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139458504|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139458505|NCT03184649|Analgesics|analgesics|mesh-ancestor
139458506|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
139458507|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458508|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458510|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458511|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139458512|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458513|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458514|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
139458515|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
139458516|NCT02432261|ST 1435|st 1435|mesh-list
139458517|NCT02432261|Testosterone|testosterone|mesh-list
139458518|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
139458519|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
139458520|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139458521|NCT02432261|Androgens|androgens|mesh-ancestor
139458522|NCT02432261|Hormones|hormones|mesh-ancestor
139458523|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139458524|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458525|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139458526|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458527|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
139458528|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139458529|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
139458530|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139458531|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139458532|NCT02428283|Remifentanil|remifentanil|mesh-list
139458533|NCT02428283|Ropivacaine|ropivacaine|mesh-list
139458534|NCT02428283|Sevoflurane|sevoflurane|mesh-list
139458535|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
139458536|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
139458537|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458538|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458539|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
139458540|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458541|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139458542|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139458543|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
139458544|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139458545|NCT02428283|Narcotics|narcotics|mesh-ancestor
139458546|NCT02428283|Analgesics|analgesics|mesh-ancestor
139458547|NCT02427893|Vemurafenib|vemurafenib|mesh-list
139458548|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458549|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139458550|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458551|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458552|NCT03184493|Metformin|metformin|mesh-list
139458553|NCT03184493|Celecoxib|celecoxib|mesh-list
139458554|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139458555|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458556|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139458557|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139458558|NCT03184493|Analgesics|analgesics|mesh-ancestor
139458559|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
139458560|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458561|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458562|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458563|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139458564|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139458565|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458566|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458567|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
139458568|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458569|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139458570|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458571|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458572|NCT02431325|Teduglutide|teduglutide|mesh-list
139458573|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139458574|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139458575|NCT02431325|Protective Agents|protective agents|mesh-ancestor
139458576|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458577|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
139458578|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
139458579|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
139458580|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458581|NCT02103478|Decitabine|decitabine|mesh-list
139458582|NCT02103478|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139458583|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139458584|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
139458585|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458586|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458587|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458588|NCT02431013|Cilostazol|cilostazol|mesh-list
139458589|NCT02431013|Simvastatin|simvastatin|mesh-list
139458590|NCT02431013|Pravastatin|pravastatin|mesh-list
139458591|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139458592|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139458593|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
139458594|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458595|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139458596|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139458597|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458598|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139458599|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
139458600|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458601|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458602|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139458603|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
139458604|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139458605|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139458606|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139458607|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
139458608|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139458609|NCT02431013|Protective Agents|protective agents|mesh-ancestor
139458610|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139458611|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139458612|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
139458613|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
139458614|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458615|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139458616|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458617|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139458618|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
139458619|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458620|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458621|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139458622|NCT02430545|Rifampin|rifampin|mesh-list
139458623|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139458624|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
139458625|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139458626|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458627|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
139458628|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139458629|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458630|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458631|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139458632|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139458633|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139458634|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139458635|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139458636|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139458637|NCT03117725|Melatonin|melatonin|mesh-list
139458638|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
139458639|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458640|NCT03117725|Protective Agents|protective agents|mesh-ancestor
139458641|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458642|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458643|NCT03185351|Midazolam|midazolam|mesh-list
139458644|NCT03185351|Bupivacaine|bupivacaine|mesh-list
139458645|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
139458646|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
139458647|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458648|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458649|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
139458650|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458651|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139458652|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139458653|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139458654|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139458655|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139458656|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139458657|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
139458658|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
139458659|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
139458660|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139458661|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458662|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
139458663|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139458664|NCT02707601|Ledipasvir|ledipasvir|mesh-list
139458665|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139458666|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
139458667|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458668|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139458669|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139458670|NCT03183557|Vitamin D|vitamin d|mesh-list
139458671|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
139458672|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
139458673|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139458674|NCT03183557|Vitamins|vitamins|mesh-ancestor
139458675|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
139458676|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458677|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139458678|NCT02426723|Dexamethasone|dexamethasone|mesh-list
139458679|NCT02426723|Lenalidomide|lenalidomide|mesh-list
139458680|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458681|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
139458682|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
139458683|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458684|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458685|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139458686|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
139458687|NCT02426723|Hormones|hormones|mesh-ancestor
139458688|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139458689|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139458690|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458691|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
139458692|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139458693|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139458694|NCT02426723|Growth Substances|growth substances|mesh-ancestor
139458695|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
139458696|NCT02425241|Vaccines|vaccines|mesh-list
139458697|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
139458698|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458699|NCT03182855|Ticagrelor|ticagrelor|mesh-list
139458700|NCT03182855|Cangrelor|cangrelor|mesh-list
139458701|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139458702|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139458703|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139458704|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139458705|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
139458706|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139458707|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458708|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458709|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
139458710|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458711|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139458712|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458713|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458714|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
139458715|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139458716|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458717|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139458718|NCT02426177|Labetalol|labetalol|mesh-list
139458719|NCT02426177|Nifedipine|nifedipine|mesh-list
139458720|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139458721|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139458722|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458723|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139458724|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458725|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
139458726|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
139458727|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139458728|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139458729|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139458730|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
139458731|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139458732|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139458733|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
139458734|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
139458735|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458736|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139458737|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139458738|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
139458739|NCT02426099|Spironolactone|spironolactone|mesh-list
139458740|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139458741|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
139458742|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139458743|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458744|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139458745|NCT02426099|Diuretics|diuretics|mesh-ancestor
139458746|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
139458747|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139458748|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
139458749|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458750|NCT02425709|Diclofenac|diclofenac|mesh-list
139458751|NCT02425709|Tramadol|tramadol|mesh-list
139458752|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139458753|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139458754|NCT02425709|Analgesics|analgesics|mesh-ancestor
139458755|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
139458756|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458757|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458758|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458759|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458760|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139458761|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458762|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458763|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139458764|NCT02425709|Narcotics|narcotics|mesh-ancestor
139458765|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458766|NCT02073682|Heparin|heparin|mesh-list
139458767|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139458768|NCT02073682|Tinzaparin|tinzaparin|mesh-list
139458769|NCT02073682|Dalteparin|dalteparin|mesh-list
139458770|NCT02073682|Edoxaban|edoxaban|mesh-list
139458771|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
139458772|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139458773|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139458774|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458775|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139458776|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
139458777|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139458778|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
139458779|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458780|NCT03181919|Letrozole|letrozole|mesh-list
139458781|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458782|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139117267|NCT03784794|Thrombin|thrombin|mesh-list
139458783|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139458784|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458785|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458786|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139458787|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
139458788|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139458789|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458790|NCT02706899|Azacitidine|azacitidine|mesh-list
139458791|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139458792|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
139458793|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458794|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458795|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458796|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
139458797|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
139458798|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139458799|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139458800|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458801|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458802|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458803|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458804|NCT02424695|Gabapentin|gabapentin|mesh-list
139458805|NCT02424695|Analgesics|analgesics|mesh-ancestor
139458806|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
139458807|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458808|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458809|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
139458810|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139458811|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139458812|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458813|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139458814|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139458815|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139458816|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139458817|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458818|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
139458819|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
139458820|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
139458821|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
139458822|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139458823|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458824|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458825|NCT02422277|Urological Agents|urological agents|mesh-ancestor
139458827|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139458828|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139458829|NCT02422121|Analgesics|analgesics|mesh-ancestor
139458830|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
139458831|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458832|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458833|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458834|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458835|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139458836|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
139458837|NCT02424461|Ofloxacin|ofloxacin|mesh-list
139458838|NCT02424461|Levofloxacin|levofloxacin|mesh-list
139458839|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139458840|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458841|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139458842|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139458843|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139458844|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458845|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458846|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458847|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139458848|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139458849|NCT02072824|Pregabalin|pregabalin|mesh-list
139458850|NCT02072824|Analgesics|analgesics|mesh-ancestor
139458851|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
139458852|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458853|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458854|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
139458855|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139458856|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139458857|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458858|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139458859|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139458860|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139458861|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458862|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139458863|NCT03117257|Cisplatin|cisplatin|mesh-list
139458864|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458865|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
139458866|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139458867|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
139458868|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139458869|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
139458870|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458871|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458872|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
139458873|NCT03181685|Cetrorelix|cetrorelix|mesh-list
139458874|NCT03181685|Progesterone|progesterone|mesh-list
139458875|NCT03181685|Progestins|progestins|mesh-ancestor
139458876|NCT03181685|Hormones|hormones|mesh-ancestor
139458877|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139245574|NCT01342679|Dasatinib|dasatinib|mesh-list
139458878|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458879|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139458881|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139458882|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
139458883|NCT02424071|Melatonin|melatonin|mesh-list
139458884|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
139458885|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458886|NCT02424071|Protective Agents|protective agents|mesh-ancestor
139458887|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458888|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458889|NCT03178955|Etanercept|etanercept|mesh-list
139458890|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139458891|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139458892|NCT03178955|Analgesics|analgesics|mesh-ancestor
139458893|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
139458894|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458895|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458896|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139458897|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458898|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139458899|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139458900|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
139458901|NCT01598506|Hydromorphone|hydromorphone|mesh-list
139458902|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139458903|NCT01598506|Narcotics|narcotics|mesh-ancestor
139458904|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458905|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458906|NCT01598506|Analgesics|analgesics|mesh-ancestor
139458907|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
139458908|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458909|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
139458910|NCT02423915|Sirolimus|sirolimus|mesh-list
139458911|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
139458912|NCT02423915|Rituximab|rituximab|mesh-list
139458913|NCT02423915|Fludarabine|fludarabine|mesh-list
139458914|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
139458915|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139458916|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
139458917|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458918|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458919|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139458920|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
139458921|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458922|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458923|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139458924|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139458925|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139458926|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
139458927|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458928|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139458929|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139458930|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
139458931|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139458932|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458933|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
139458934|NCT02423837|Rituximab|rituximab|mesh-list
139458935|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139458936|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139458937|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458938|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
139458939|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458940|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139458941|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139458942|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
139458943|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458944|NCT02140060|Travoprost|travoprost|mesh-list
139458945|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139458946|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139458947|NCT02140060|Brinzolamide|brinzolamide|mesh-list
139458948|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139458949|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139458950|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139458951|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458952|NCT03178721|Calcium|calcium|mesh-list
139458953|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139458954|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458955|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
139458956|NCT02421029|Edetic Acid|edetic acid|mesh-list
139458957|NCT02421029|Calcium|calcium|mesh-list
139458958|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
139458959|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139458960|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458961|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139458962|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
139458963|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139458964|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
139458965|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
139458966|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458967|NCT02421029|Antidotes|antidotes|mesh-ancestor
139458968|NCT02421029|Protective Agents|protective agents|mesh-ancestor
139458969|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139458970|NCT02139982|Ropivacaine|ropivacaine|mesh-list
139458971|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
139458972|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
139458973|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139458974|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458975|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
139458976|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139458977|NCT03178643|Piperaquine|piperaquine|mesh-list
139458978|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
139458979|NCT03178643|Amodiaquine|amodiaquine|mesh-list
139458980|NCT03178643|Artenimol|artenimol|mesh-list
139458981|NCT03178643|Proguanil|proguanil|mesh-list
139458982|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
139458983|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139458984|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139458985|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139458986|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139458987|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
139458988|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139458989|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139458990|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139458991|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139458992|NCT02139592|Immunotoxins|immunotoxins|mesh-ancestor
139458993|NCT02139592|Immunoconjugates|immunoconjugates|mesh-ancestor
139458994|NCT02139592|Immunologic Factors|immunologic factors|mesh-ancestor
139458995|NCT02139592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139458996|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
139458997|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139458998|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
139458999|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459000|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139459001|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139459002|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
139459003|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459004|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459005|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139459006|NCT02072434|Enoxaparin|enoxaparin|mesh-list
139459007|NCT02072434|Warfarin|warfarin|mesh-list
139459008|NCT02072434|Edoxaban|edoxaban|mesh-list
139459009|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
139459010|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139459011|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139459012|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459013|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139459014|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
139459015|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139459016|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
139459017|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459018|NCT04725994|Irinotecan|irinotecan|mesh-list
139459019|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139459020|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139459021|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459022|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459023|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459024|NCT02139046|Naproxen|naproxen|mesh-list
139459025|NCT02139046|Colchicine|colchicine|mesh-list
139459026|NCT02139046|Febuxostat|febuxostat|mesh-list
139459027|NCT02139046|Lansoprazole|lansoprazole|mesh-list
139459028|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
139459029|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139459030|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139459031|NCT02139046|Analgesics|analgesics|mesh-ancestor
139459032|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
139459033|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459034|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459035|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459036|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139459037|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
139459038|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139459039|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459040|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459041|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
139459042|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
139459043|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
139459044|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459045|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139459046|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139459047|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139459049|NCT02100670|Menthol|menthol|mesh-list
139459050|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139459051|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139459052|NCT02100670|Analgesics|analgesics|mesh-ancestor
139459053|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
139459054|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459055|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459056|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459057|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139459058|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139459059|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459060|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459061|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
139459062|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
139459063|NCT02100514|Bococizumab|bococizumab|mesh-list
139459064|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139459065|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139459066|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
139459067|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459068|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139459069|NCT02069392|Nicotine|nicotine|mesh-list
139459070|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139459071|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
139459072|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459073|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459074|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139459075|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139459076|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
139459077|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459078|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459079|NCT05522361|Risdiplam|risdiplam|mesh-list
139459080|NCT05522361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139459081|NCT05522361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459082|NCT05522361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459083|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
139459084|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139459085|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459086|NCT02046616|Methotrexate|methotrexate|mesh-list
139459087|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139459088|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
139459089|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139459090|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459091|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139459092|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
139459093|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459094|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459095|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
139459096|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459097|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139459098|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139459099|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
139459100|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139459101|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139459102|NCT05525481|Tamoxifen|tamoxifen|mesh-list
139459103|NCT05525481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139459104|NCT05525481|Hormone Antagonists|hormone antagonists|mesh-ancestor
139245858|NCT00394355|Xhance|xhance|mesh-list
139459105|NCT05525481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139459106|NCT05525481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459107|NCT05525481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139459108|NCT05525481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459109|NCT05525481|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139459110|NCT05525481|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139459111|NCT05525481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139459112|NCT02068222|Ritonavir|ritonavir|mesh-list
139459113|NCT02068222|Ribavirin|ribavirin|mesh-list
139459114|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139459115|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139459116|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
139459117|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459118|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459119|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139459120|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139459121|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
139459122|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139459123|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139459124|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139459125|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
139459126|NCT05517213|Cyclophosphamide|cyclophosphamide|mesh-list
139459127|NCT05517213|Etoposide|etoposide|mesh-list
139459128|NCT05517213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139459129|NCT05517213|Immunologic Factors|immunologic factors|mesh-ancestor
139459130|NCT05517213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459131|NCT05517213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139459132|NCT05517213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139459133|NCT05517213|Alkylating Agents|alkylating agents|mesh-ancestor
139459134|NCT05517213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459135|NCT05517213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459136|NCT05517213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139459137|NCT05517213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139459138|NCT05517213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139459139|NCT05517213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139459140|NCT05517213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459141|NCT05516745|Respiratory System Agents|respiratory system agents|mesh-list
139459142|NCT02099110|Metformin|metformin|mesh-list
139459143|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
139459144|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139459145|NCT02099110|Glimepiride|glimepiride|mesh-list
139459146|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
139459147|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139459148|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459149|NCT02099110|Incretins|incretins|mesh-ancestor
139459150|NCT02099110|Hormones|hormones|mesh-ancestor
139459151|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139459152|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139459153|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
139459154|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459155|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382929|NCT06173362|Cortisone|cortisone|mesh-list
139459156|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139459157|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139459158|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
139459159|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139459160|NCT02098876|Everolimus|everolimus|mesh-list
139459161|NCT02098876|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139459162|NCT02098876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139459163|NCT02098876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459164|NCT02098876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459165|NCT02098876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139459166|NCT02098876|Immunologic Factors|immunologic factors|mesh-ancestor
139459167|NCT02098876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459168|NCT02098876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459169|NCT01624090|Plicamycin|plicamycin|mesh-list
139459170|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139459171|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459172|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139459173|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459174|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139459175|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459176|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459177|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139459179|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139459180|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459181|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139459182|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
139459183|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459184|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459185|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139459186|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
139459187|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
139459188|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139459189|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139459190|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139459191|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139459192|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
139459193|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459194|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459195|NCT05511831|Ketotifen|ketotifen|mesh-list
139459196|NCT05511831|Antipruritics|antipruritics|mesh-ancestor
139459197|NCT05511831|Dermatologic Agents|dermatologic agents|mesh-ancestor
139459198|NCT05511831|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139459199|NCT05511831|Histamine Antagonists|histamine antagonists|mesh-ancestor
139459200|NCT05511831|Histamine Agents|histamine agents|mesh-ancestor
139459201|NCT05511831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459202|NCT05511831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459203|NCT05511831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459204|NCT05511831|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139459205|NCT02705105|Nivolumab|nivolumab|mesh-list
139459206|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
139459207|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139459208|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459209|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139459210|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459211|NCT05521347|Caffeine|caffeine|mesh-list
139459212|NCT05521347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139459213|NCT05521347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459214|NCT05521347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139459215|NCT05521347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459216|NCT05521347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459217|NCT05521347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139459218|NCT05521347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139459219|NCT05521347|Purinergic Agents|purinergic agents|mesh-ancestor
139459220|NCT05521347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459221|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139459222|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
139459223|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459224|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
139459225|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139459226|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
139459227|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
139459228|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
139459229|NCT05093517|Volagidemab|volagidemab|mesh-list
139459230|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139459231|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459232|NCT02420171|Insulin|insulin|mesh-list
139459233|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139459234|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459235|NCT03180593|Valsartan|valsartan|mesh-list
139459236|NCT03180593|Nebivolol|nebivolol|mesh-list
139459237|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139459238|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139459239|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139459240|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459241|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
139459242|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139459243|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139459244|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139459245|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
139459246|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459247|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459248|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
139459249|NCT02423759|Gentamicins|gentamicins|mesh-list
139459250|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139459251|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139459252|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139459253|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139459254|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459255|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459256|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459257|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139459258|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139459259|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139459260|NCT01623310|Fluticasone|fluticasone|mesh-list
139459261|NCT01623310|Xhance|xhance|mesh-list
139459262|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459263|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139459264|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
139459265|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459266|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459267|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139459268|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
139459269|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
139459270|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139459271|NCT03180125|Lidocaine|lidocaine|mesh-list
139459272|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
139459273|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
139459274|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
139459275|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139459276|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459277|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
139459278|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459279|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139459280|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139459281|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139459282|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139459283|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459284|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139459285|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
139459286|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
139459287|NCT03180125|Protective Agents|protective agents|mesh-ancestor
139459288|NCT02423603|Paclitaxel|paclitaxel|mesh-list
139459289|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139459290|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459291|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
139459292|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
139459293|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
139459294|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459295|NCT03178409|Liver Extracts|liver extracts|mesh-list
139459296|NCT03178409|Hematinics|hematinics|mesh-ancestor
139459297|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139459298|NCT03180281|Glimepiride|glimepiride|mesh-list
139459299|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139459300|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459301|NCT03180281|Incretins|incretins|mesh-ancestor
139459302|NCT03180281|Hormones|hormones|mesh-ancestor
139459303|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139459304|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139459305|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
139459306|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459307|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459308|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139459309|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139459310|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
139459311|NCT03116945|Gallium citrate|gallium citrate|mesh-list
139459312|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459313|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139459314|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
139459315|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139459316|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139459317|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459318|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139459319|NCT03117023|Analgesics|analgesics|mesh-ancestor
139459320|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
139459321|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459322|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139459323|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139459324|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139459325|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
139459326|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459327|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459328|NCT02097238|Halichondrin B|halichondrin b|mesh-list
139459329|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
139459330|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
139459331|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
139459332|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459333|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459334|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
139459335|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459336|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
139459337|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139459338|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139459339|NCT02419859|Insulin|insulin|mesh-list
139459340|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139459341|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139459342|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459343|NCT02419391|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139459344|NCT02419391|Antiviral Agents|antiviral agents|mesh-ancestor
139459345|NCT02419391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139459346|NCT02419235|Ethanol|ethanol|mesh-list
139459347|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139459348|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139459349|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139459350|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459351|NCT02422823|Epinephrine|epinephrine|mesh-list
139459352|NCT02422823|Carticaine|carticaine|mesh-list
139459353|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139459354|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139459355|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
139459356|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459357|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459358|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459359|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139459360|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139459361|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
139459362|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459363|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139459364|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
139459365|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
139459366|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
139459367|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139459368|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
139459369|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
139459370|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139459371|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
139459372|NCT02422589|Ceritinib|ceritinib|mesh-list
139459373|NCT02422589|Midazolam|midazolam|mesh-list
139459374|NCT02422589|Warfarin|warfarin|mesh-list
139459375|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139459376|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139459377|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139459378|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459379|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139459380|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139459381|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139459382|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139459383|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
139459384|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
139459385|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
139459386|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
139459387|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459388|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459389|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
139459390|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459391|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139459392|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459393|NCT02422199|Capecitabine|capecitabine|mesh-list
139459394|NCT02422199|Lapatinib|lapatinib|mesh-list
139459395|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139459396|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
139459397|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459398|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459399|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139459400|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459401|NCT02416739|Niacinamide|niacinamide|mesh-list
139459402|NCT02416739|Niacin|niacin|mesh-list
139459403|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
139459404|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
139459405|NCT02416739|Vitamins|vitamins|mesh-ancestor
139459406|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
139459407|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459408|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139459409|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
139459410|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459411|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139459412|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
139459413|NCT02416583|Oxytocin|oxytocin|mesh-list
139459414|NCT02416583|Dinoprostone|dinoprostone|mesh-list
139459415|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
139459416|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139459417|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459418|NCT02416427|Atorvastatin|atorvastatin|mesh-list
139459419|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139459420|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139459421|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
139459422|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459423|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139459424|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139459425|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459426|NCT02416271|Vitamin D|vitamin d|mesh-list
139459427|NCT02416271|Alendronate|alendronate|mesh-list
139459428|NCT02416271|Teriparatide|teriparatide|mesh-list
139459429|NCT02416271|Calcium|calcium|mesh-list
139459430|NCT02416271|Vitamins|vitamins|mesh-ancestor
139459431|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
139459432|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459433|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139459434|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139459435|NCT02416115|Morphine|morphine|mesh-list
139459436|NCT02416115|Ramosetron|ramosetron|mesh-list
139459437|NCT02416115|Naloxone|naloxone|mesh-list
139459438|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139459439|NCT02416115|Narcotics|narcotics|mesh-ancestor
139459440|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139459441|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459442|NCT02416115|Analgesics|analgesics|mesh-ancestor
139459443|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
139459444|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459445|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139459446|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
139459447|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
139459448|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139459449|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139459450|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
139459451|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459452|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459453|NCT02415881|Panitumumab|panitumumab|mesh-list
139459454|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139459455|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459456|NCT02415803|Clopidogrel|clopidogrel|mesh-list
139459457|NCT02415803|Ticagrelor|ticagrelor|mesh-list
139459458|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139459459|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139459460|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139459461|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139459462|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
139459463|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459464|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459465|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459466|NCT04482881|Isosorbide|isosorbide|mesh-list
139459467|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139459468|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139459469|NCT04482881|Misoprostol|misoprostol|mesh-list
139459470|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139459471|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
139459472|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139459473|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459474|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139459475|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139459476|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
139459477|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139459478|NCT04482881|Diuretics|diuretics|mesh-ancestor
139459479|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
139459480|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
139459481|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139459482|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459483|NCT02415569|Bisacodyl|bisacodyl|mesh-list
139459484|NCT02415569|Cathartics|cathartics|mesh-ancestor
139459485|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139459486|NCT02415569|Laxatives|laxatives|mesh-ancestor
139459487|NCT02415335|Dexamethasone|dexamethasone|mesh-list
139459488|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
139459489|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139459490|NCT02415335|BB 1101|bb 1101|mesh-list
139459491|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459492|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
139459493|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
139459494|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459495|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459496|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139459497|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
139459498|NCT02415335|Hormones|hormones|mesh-ancestor
139459499|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139459500|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139459501|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459502|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
139459503|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459504|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459505|NCT02415257|Gentamicins|gentamicins|mesh-list
139459506|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139459507|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139459508|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139459509|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459510|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459511|NCT02415179|Fluticasone|fluticasone|mesh-list
139459512|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
139459513|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
139459514|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139459515|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139459516|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459517|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139459518|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
139459519|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459520|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459521|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139459522|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
139459523|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
139459524|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139459525|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139459526|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139459527|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139459528|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
139459529|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459530|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459531|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
139459532|NCT02415179|Hormones|hormones|mesh-ancestor
139459533|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139459534|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
139459535|NCT02415023|Paclitaxel|paclitaxel|mesh-list
139459536|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139459537|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139459538|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459539|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
139459540|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
139459541|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
139459542|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459543|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
139459544|NCT02414945|Fludarabine|fludarabine|mesh-list
139459545|NCT02414945|Interleukin-2|interleukin-2|mesh-list
139459546|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139459547|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
139459548|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459549|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139459550|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139459551|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
139459552|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459553|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459554|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139459555|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139459556|NCT02414945|Analgesics|analgesics|mesh-ancestor
139459557|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
139459558|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459559|NCT02414555|Phenylephrine|phenylephrine|mesh-list
139459560|NCT02414555|Norepinephrine|norepinephrine|mesh-list
139459561|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139459562|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139459563|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
139459564|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
139459565|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459566|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459567|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
139459568|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
139459569|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
139459570|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139459571|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139459572|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139459573|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
139459574|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459575|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459576|NCT02414555|Protective Agents|protective agents|mesh-ancestor
139459577|NCT02046070|Dexamethasone|dexamethasone|mesh-list
139459578|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
139459579|NCT02046070|Ixazomib|ixazomib|mesh-list
139459580|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139459581|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
139459582|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459583|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139459584|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139459585|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
139459586|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459587|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459588|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139459589|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459590|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
139459591|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
139459592|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459593|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139459594|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
139459595|NCT02046070|Hormones|hormones|mesh-ancestor
139459596|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139459597|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139459598|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
139459599|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459600|NCT01663857|Carboplatin|carboplatin|mesh-list
139459601|NCT01663857|Gemcitabine|gemcitabine|mesh-list
139459602|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459603|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139459604|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
139459605|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459606|NCT02414165|Flucytosine|flucytosine|mesh-list
139459607|NCT02414165|Bevacizumab|bevacizumab|mesh-list
139459608|NCT02414165|Temozolomide|temozolomide|mesh-list
139459609|NCT02414165|Lomustine|lomustine|mesh-list
139459610|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139459611|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459612|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139459613|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139459614|NCT02414165|Growth Substances|growth substances|mesh-ancestor
139459615|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459616|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
139459617|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139459618|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
139459619|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459620|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
139459621|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139459622|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
139459623|NCT02094898|Ketamine|ketamine|mesh-list
139459624|NCT02094898|Analgesics|analgesics|mesh-ancestor
139459625|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
139459626|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459627|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459628|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139459629|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139246318|NCT04192266|Estradiol|estradiol|mesh-list
139459630|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
139459631|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
139459632|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139459633|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139459635|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459636|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459637|NCT02414009|Leucovorin|leucovorin|mesh-list
139459638|NCT02414009|Capecitabine|capecitabine|mesh-list
139459639|NCT02414009|Fluorouracil|fluorouracil|mesh-list
139459640|NCT02414009|Irinotecan|irinotecan|mesh-list
139459641|NCT02414009|Temozolomide|temozolomide|mesh-list
139459642|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139459643|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
139459644|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459645|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459646|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139459647|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
139459648|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459649|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139459650|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139459651|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459652|NCT02414009|Antidotes|antidotes|mesh-ancestor
139459653|NCT02414009|Protective Agents|protective agents|mesh-ancestor
139459654|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
139459655|NCT02414009|Vitamins|vitamins|mesh-ancestor
139459656|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
139459657|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139459658|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
139459659|NCT02413853|Leucovorin|leucovorin|mesh-list
139459660|NCT02413853|Bevacizumab|bevacizumab|mesh-list
139459661|NCT02413853|Fluorouracil|fluorouracil|mesh-list
139459662|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
139459663|NCT02413853|Calcium|calcium|mesh-list
139459664|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
139459665|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139459666|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459667|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139459668|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139459669|NCT02413853|Growth Substances|growth substances|mesh-ancestor
139459670|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459671|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
139459672|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139459673|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
139459674|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459675|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139459676|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139459677|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
139459678|NCT02413853|Antidotes|antidotes|mesh-ancestor
139459679|NCT02413853|Protective Agents|protective agents|mesh-ancestor
139459680|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
139459681|NCT02413853|Vitamins|vitamins|mesh-ancestor
139459682|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
139459683|NCT00704483|Ferric Compounds|ferric compounds|mesh-list
139459684|NCT00704483|Sevelamer|sevelamer|mesh-list
139459685|NCT00704483|Chelating Agents|chelating agents|mesh-ancestor
139459686|NCT00704483|Sequestering Agents|sequestering agents|mesh-ancestor
139459687|NCT00704483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459688|NCT00704483|Hematinics|hematinics|mesh-ancestor
139459689|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
139459690|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459691|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
139459692|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139459693|NCT03176537|Testosterone|testosterone|mesh-list
139459694|NCT03176537|Androgens|androgens|mesh-ancestor
139459695|NCT03176537|Hormones|hormones|mesh-ancestor
139459696|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139459697|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459698|NCT05511441|Aspirin|aspirin|mesh-list
139459699|NCT05511441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139459700|NCT05511441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139459701|NCT05511441|Analgesics|analgesics|mesh-ancestor
139459702|NCT05511441|Sensory System Agents|sensory system agents|mesh-ancestor
139459703|NCT05511441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459704|NCT05511441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459705|NCT05511441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459706|NCT05511441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139459707|NCT05511441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139459708|NCT05511441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139459709|NCT05511441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459710|NCT05511441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139459711|NCT05511441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139459712|NCT05511441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459713|NCT05511441|Antipyretics|antipyretics|mesh-ancestor
139459714|NCT05515731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139459715|NCT05515731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139459716|NCT02413541|Polymyxins|polymyxins|mesh-list
139459717|NCT02413541|Polymyxin B|polymyxin b|mesh-list
139459718|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139459719|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139459720|NCT02045836|Vaccines|vaccines|mesh-list
139459721|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139459722|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
139459723|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459724|NCT02412917|Valacyclovir|valacyclovir|mesh-list
139459725|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
139459726|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139459727|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
139459728|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459729|NCT02569437|Fluticasone|fluticasone|mesh-list
139459730|NCT02569437|Doxycycline|doxycycline|mesh-list
139459731|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
139459732|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139459733|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139459734|NCT02569437|Prednisolone|prednisolone|mesh-list
139459735|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
139459736|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139459737|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
139459738|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459739|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
139459740|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
139459741|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459742|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459743|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139459744|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
139459745|NCT02569437|Hormones|hormones|mesh-ancestor
139459746|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139459747|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139459748|NCT02569437|Protective Agents|protective agents|mesh-ancestor
139459749|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139459750|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459751|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139459752|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139459753|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
139459754|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139459755|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139459756|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139459757|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139459758|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
139459759|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
139459760|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139459761|NCT02412449|Glycine|glycine|mesh-list
139459762|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
139459763|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459764|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459765|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459766|NCT02412059|Prednisolone|prednisolone|mesh-list
139459767|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139459768|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
139459769|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139459770|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
139459771|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139459772|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
139459773|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459774|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
139459775|NCT02412059|Hormones|hormones|mesh-ancestor
139459776|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139459777|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459778|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139459779|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459780|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
139459781|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
139459782|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459783|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139459784|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139459785|NCT02412059|Protective Agents|protective agents|mesh-ancestor
139459787|NCT03175679|Tegafur|tegafur|mesh-list
139459788|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459789|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139459790|NCT03175679|Analgesics|analgesics|mesh-ancestor
139459791|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
139459792|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459793|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459794|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139459795|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
139459796|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459797|NCT05520645|Propofol|propofol|mesh-list
139459798|NCT05520645|Etomidate|etomidate|mesh-list
139459799|NCT05520645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139459800|NCT05520645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139459801|NCT05520645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459802|NCT05520645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139459803|NCT05520645|Anesthetics, General|anesthetics, general|mesh-ancestor
139459804|NCT05520645|Anesthetics|anesthetics|mesh-ancestor
139459805|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139459806|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139459807|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139459808|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
139459809|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459810|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139459811|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139459812|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459813|NCT05515185|Cyclophosphamide|cyclophosphamide|mesh-list
139459814|NCT05515185|Fludarabine|fludarabine|mesh-list
139459815|NCT05515185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139459816|NCT05515185|Immunologic Factors|immunologic factors|mesh-ancestor
139459817|NCT05515185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459818|NCT05515185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139459819|NCT05515185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139459820|NCT05515185|Alkylating Agents|alkylating agents|mesh-ancestor
139459821|NCT05515185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459822|NCT05515185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459823|NCT05515185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139459824|NCT02044822|Rituximab|rituximab|mesh-list
139459825|NCT02044822|Idelalisib|idelalisib|mesh-list
139459826|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139459827|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459828|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
139459829|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459830|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139459831|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459832|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459833|NCT03116555|Irinotecan|irinotecan|mesh-list
139459834|NCT03116555|Apatinib|apatinib|mesh-list
139459835|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139459836|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139459837|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459838|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459839|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459840|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139459841|NCT02044510|Mirabegron|mirabegron|mesh-list
139459842|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139459843|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139459844|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139459845|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
139459846|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459847|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459848|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459849|NCT02044510|Urological Agents|urological agents|mesh-ancestor
139459850|NCT02411903|Clopidogrel|clopidogrel|mesh-list
139459851|NCT02411903|Atorvastatin|atorvastatin|mesh-list
139459852|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139459853|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139459854|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139459855|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
139459856|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459857|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139459858|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139459859|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459860|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139459861|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139459862|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139459863|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139459864|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
139459865|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139459866|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459867|NCT02411825|Metformin|metformin|mesh-list
139459868|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139459869|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459870|NCT02410655|Oxytocin|oxytocin|mesh-list
139459871|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
139459872|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139459873|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459874|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139459875|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
139459876|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459877|NCT05510505|Antibodies|antibodies|mesh-list
139459878|NCT05510505|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139459879|NCT05510505|Immunologic Factors|immunologic factors|mesh-ancestor
139459880|NCT05510505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459881|NCT05514015|Cyclophosphamide|cyclophosphamide|mesh-list
139459882|NCT05514015|Rituximab|rituximab|mesh-list
139459883|NCT05514015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139459884|NCT05514015|Immunologic Factors|immunologic factors|mesh-ancestor
139459885|NCT05514015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459886|NCT05514015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139459887|NCT05514015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139459888|NCT05514015|Alkylating Agents|alkylating agents|mesh-ancestor
139459889|NCT05514015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459890|NCT05514015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459891|NCT05514015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139459892|NCT05514015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139459893|NCT03174821|Insulin|insulin|mesh-list
139459894|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139459895|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139459896|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459897|NCT05520021|Magnesium Sulfate|magnesium sulfate|mesh-list
139459898|NCT05520021|Nifedipine|nifedipine|mesh-list
139459899|NCT05520021|Analgesics|analgesics|mesh-ancestor
139459900|NCT05520021|Sensory System Agents|sensory system agents|mesh-ancestor
139459901|NCT05520021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459902|NCT05520021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459903|NCT05520021|Anesthetics|anesthetics|mesh-ancestor
139118387|NCT05692804|Protein S|protein s|mesh-list
139459904|NCT05520021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139459905|NCT05520021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139459906|NCT05520021|Anticonvulsants|anticonvulsants|mesh-ancestor
139459907|NCT05520021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139459908|NCT05520021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139459909|NCT05520021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459910|NCT05520021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139459911|NCT05520021|Tocolytic Agents|tocolytic agents|mesh-ancestor
139459912|NCT05520021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139459913|NCT05520021|Vasodilator Agents|vasodilator agents|mesh-ancestor
139459914|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
139459915|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139459916|NCT02410031|Cyproterone|cyproterone|mesh-list
139459917|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
139459918|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139459919|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139459920|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139459921|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
139459922|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139459923|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459924|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139459925|NCT02410031|Estrogens|estrogens|mesh-ancestor
139459926|NCT02410031|Hormones|hormones|mesh-ancestor
139459927|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139459928|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
139459929|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
139459930|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459931|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139459932|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139459933|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139459934|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139459935|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139459936|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
139459937|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459939|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459940|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139459941|NCT02409407|Alprostadil|alprostadil|mesh-list
139459942|NCT02409407|Misoprostol|misoprostol|mesh-list
139459943|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139459944|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
139459945|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139459946|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459947|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139459948|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139459949|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
139459950|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139459951|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
139459952|NCT02409407|Urological Agents|urological agents|mesh-ancestor
139459953|NCT02409563|Budesonide|budesonide|mesh-list
139459954|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459955|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139459956|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
139459957|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459958|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459959|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139459960|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
139459961|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
139459962|NCT02409563|Hormones|hormones|mesh-ancestor
139459963|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139459964|NCT02409017|Insulin|insulin|mesh-list
139459965|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139459966|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459967|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
139459968|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139459969|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139459970|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139459971|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459972|NCT02065570|Adalimumab|adalimumab|mesh-list
139459973|NCT02065570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139459974|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139459975|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139459976|NCT02408705|Acetaminophen|acetaminophen|mesh-list
139459977|NCT02408705|Liraglutide|liraglutide|mesh-list
139459978|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139459979|NCT02408705|Analgesics|analgesics|mesh-ancestor
139459980|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
139459981|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139459982|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459983|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
139459984|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139459985|NCT02408705|Incretins|incretins|mesh-ancestor
139459986|NCT02408705|Hormones|hormones|mesh-ancestor
139459987|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139459988|NCT05507697|Thioctic Acid|thioctic acid|mesh-list
139459989|NCT05507697|Antioxidants|antioxidants|mesh-ancestor
139459990|NCT05507697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139459991|NCT05507697|Protective Agents|protective agents|mesh-ancestor
139459992|NCT05507697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139459993|NCT05507697|Vitamin B Complex|vitamin b complex|mesh-ancestor
139459994|NCT05507697|Vitamins|vitamins|mesh-ancestor
139459995|NCT05507697|Micronutrients|micronutrients|mesh-ancestor
139459996|NCT04292223|Pimavanserin|pimavanserin|mesh-list
139459997|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139459998|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139459999|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139460000|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139460001|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460002|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460003|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139460004|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139460005|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139460006|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
139460007|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460008|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460009|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139246699|NCT03131479|Licogliflozin|licogliflozin|mesh-list
139460010|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
139460011|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139460012|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139460013|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139460014|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460015|NCT03174041|Itraconazole|itraconazole|mesh-list
139460016|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139460017|NCT03174041|Midazolam|midazolam|mesh-list
139460018|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139460019|NCT03174041|Simvastatin|simvastatin|mesh-list
139460020|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139460021|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139460022|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460023|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460024|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139460025|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139460026|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139460027|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139460028|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
139460029|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
139460030|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
139460031|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
139460032|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460033|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460034|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139460035|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139460036|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
139460037|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139460038|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139460039|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460040|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
139460041|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139460042|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139460043|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139460044|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139460045|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
139460046|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460047|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139460048|NCT02566005|Misoprostol|misoprostol|mesh-list
139460049|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139460050|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
139460051|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139460052|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460053|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139460054|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139460055|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
139460056|NCT02408393|Ropivacaine|ropivacaine|mesh-list
139460057|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
139460058|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
139460059|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460060|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460061|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
139460062|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460063|NCT03173963|Empagliflozin|empagliflozin|mesh-list
139460064|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139460065|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460066|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139460067|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460068|NCT05507229|Vaccines|vaccines|mesh-list
139460069|NCT05507229|Immunologic Factors|immunologic factors|mesh-ancestor
139460070|NCT05507229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460071|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
139460072|NCT03173417|Fludarabine|fludarabine|mesh-list
139460073|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139460074|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
139460075|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460076|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139460077|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139460078|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
139460079|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460080|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460081|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139460082|NCT03173339|Remifentanil|remifentanil|mesh-list
139246775|NCT02077556|Prednisolone|prednisolone|mesh-list
139460083|NCT03173339|Sevoflurane|sevoflurane|mesh-list
139460084|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139460085|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139460086|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
139460087|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
139460088|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460089|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460090|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139460091|NCT03173339|Narcotics|narcotics|mesh-ancestor
139460092|NCT03173339|Analgesics|analgesics|mesh-ancestor
139460093|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
139460094|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460095|NCT03172871|Aripiprazole|aripiprazole|mesh-list
139460096|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
139460097|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139460098|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139460099|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139460100|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460101|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460102|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
139460103|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
139460104|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460105|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460106|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139460107|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139460108|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
139460109|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139460110|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139460111|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139460112|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139460113|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
139460114|NCT02065336|Entecavir|entecavir|mesh-list
139460115|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
139460116|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139460117|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
139460118|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
139460119|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139460120|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
139460121|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
139460122|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460123|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460124|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460125|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139460126|NCT02408003|Simendan|simendan|mesh-list
139460127|NCT02408003|Milrinone|milrinone|mesh-list
139460128|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139460129|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
139460130|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139460131|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139460132|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460133|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460134|NCT02408003|Protective Agents|protective agents|mesh-ancestor
139460135|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460136|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139460137|NCT02406911|Ticagrelor|ticagrelor|mesh-list
139460138|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139460139|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139460140|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139460141|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139460142|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
139460143|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460144|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460145|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460146|NCT03172793|Telavancin|telavancin|mesh-list
139460147|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139460148|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139460149|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
139460150|NCT03116087|Testosterone|testosterone|mesh-list
139460151|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
139460152|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
139460153|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139460154|NCT03116087|Androgens|androgens|mesh-ancestor
139460155|NCT03116087|Hormones|hormones|mesh-ancestor
139460156|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460157|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460158|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139460159|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460160|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
139460161|NCT02701985|Petesicatib|petesicatib|mesh-list
139460162|NCT02701985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460163|NCT02701985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460164|NCT02406521|Sorafenib|sorafenib|mesh-list
139460165|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139460166|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460167|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139460168|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460169|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460170|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139460171|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139460172|NCT02406053|Antioxidants|antioxidants|mesh-list
139460173|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460174|NCT02406053|Protective Agents|protective agents|mesh-ancestor
139460175|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460176|NCT02064166|Insulin|insulin|mesh-list
139460177|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139460178|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460179|NCT03171623|Globalagliatin|globalagliatin|mesh-list
139460180|NCT03171623|Enzyme Activators|enzyme activators|mesh-ancestor
139460181|NCT03171623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460182|NCT03171389|Ponatinib|ponatinib|mesh-list
139460183|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460184|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139460185|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460186|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460187|NCT05508633|Mebeverine|mebeverine|mesh-list
139460188|NCT05508633|Alverine|alverine|mesh-list
139460189|NCT05508633|Parasympatholytics|parasympatholytics|mesh-ancestor
139460190|NCT05508633|Autonomic Agents|autonomic agents|mesh-ancestor
139460191|NCT05508633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460192|NCT05508633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460193|NCT05508633|Anticonvulsants|anticonvulsants|mesh-ancestor
139460194|NCT04482257|Irinotecan|irinotecan|mesh-list
139460195|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139460196|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139460197|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460198|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460199|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460200|NCT05502705|Lidocaine|lidocaine|mesh-list
139460201|NCT05502705|Anesthetics, Local|anesthetics, local|mesh-ancestor
139383162|NCT06171932|Prednisolone|prednisolone|mesh-list
139460202|NCT05502705|Anesthetics|anesthetics|mesh-ancestor
139460203|NCT05502705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460204|NCT05502705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383463|NCT05796661|Citric Acid|citric acid|mesh-list
139383536|NCT05611268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460205|NCT05502705|Sensory System Agents|sensory system agents|mesh-ancestor
139460206|NCT05502705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383755|NCT05017103|Antibodies|antibodies|mesh-list
139383832|NCT04788667|Cholinergic Agents|cholinergic agents|mesh-ancestor
139460207|NCT05502705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139383982|NCT04404283|Growth Substances|growth substances|mesh-ancestor
139384056|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
139384135|NCT04059484|Tamoxifen|tamoxifen|mesh-list
139460208|NCT05502705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139460209|NCT05502705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139460210|NCT05502705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139460211|NCT05502705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460212|NCT05506137|Pilocarpine|pilocarpine|mesh-list
139460213|NCT05506137|Miotics|miotics|mesh-ancestor
139460214|NCT05506137|Autonomic Agents|autonomic agents|mesh-ancestor
139460215|NCT05506137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460216|NCT05506137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384365|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
139460217|NCT05506137|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139460218|NCT05506137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139460219|NCT05506137|Cholinergic Agents|cholinergic agents|mesh-ancestor
139384876|NCT02129231|Simvastatin|simvastatin|mesh-list
139384990|NCT02133053|Hormones|hormones|mesh-ancestor
139460220|NCT05506137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385097|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385174|NCT02138045|Liraglutide|liraglutide|mesh-list
139385248|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460221|NCT05506137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460222|NCT04742283|Timolol|timolol|mesh-list
139460223|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139460224|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139460225|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460226|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139460227|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139460228|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
139460229|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246919|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139385320|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139460230|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460232|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139460233|NCT04289805|Letrozole|letrozole|mesh-list
139460234|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460235|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139460236|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139460237|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460238|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460239|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139460240|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
139460241|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460242|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460243|NCT05505591|Cangrelor|cangrelor|mesh-list
139460244|NCT05505591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139460245|NCT05505591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139460246|NCT05505591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139460247|NCT05505591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139460248|NCT05505591|Purinergic Agents|purinergic agents|mesh-ancestor
139460249|NCT05505591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460250|NCT05505591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460251|NCT05505591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460252|NCT05448807|Phentolamine|phentolamine|mesh-list
139460253|NCT05448807|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139460254|NCT05448807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139460255|NCT05448807|Adrenergic Agents|adrenergic agents|mesh-ancestor
139460256|NCT05448807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460257|NCT05448807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460258|NCT05448807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460259|NCT05448807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139460260|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
139460261|NCT01662999|Saxagliptin|saxagliptin|mesh-list
139460262|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139460263|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460264|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139460265|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460266|NCT01662999|Incretins|incretins|mesh-ancestor
139460267|NCT01662999|Hormones|hormones|mesh-ancestor
139460268|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460269|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139460270|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
139460271|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460272|NCT05366283|Sargramostim|sargramostim|mesh-list
139460273|NCT05366283|Immunologic Factors|immunologic factors|mesh-ancestor
139460274|NCT05366283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460275|NCT02565381|Nicotine|nicotine|mesh-list
139460276|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139460277|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
139460278|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460279|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460280|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139460281|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139460282|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
139460283|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460284|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460285|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
139460286|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
139460287|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139460288|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139460289|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460290|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139460291|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460292|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139460293|NCT02063698|Auranofin|auranofin|mesh-list
139460294|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139460295|NCT04701333|Cabergoline|cabergoline|mesh-list
139460296|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139460297|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139460298|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
139460299|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
139460300|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460301|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246999|NCT03446157|Cetuximab|cetuximab|mesh-list
139460302|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460303|NCT04701034|Prednisolone|prednisolone|mesh-list
139460304|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
139460305|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139460306|NCT04701034|Antibodies|antibodies|mesh-list
139460307|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
139460308|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139460309|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460310|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
139460311|NCT04701034|Hormones|hormones|mesh-ancestor
139460312|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460313|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460314|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139460315|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460316|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
139460317|NCT01663623|Azathioprine|azathioprine|mesh-list
139460318|NCT01663623|Belimumab|belimumab|mesh-list
139460319|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
139460320|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460321|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139460322|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460323|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139460324|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
139460325|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460326|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139460327|NCT04582305|Bleomycin|bleomycin|mesh-list
139460328|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139460329|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460330|NCT05504967|Dexamethasone|dexamethasone|mesh-list
139460331|NCT05504967|Ropivacaine|ropivacaine|mesh-list
139460332|NCT05504967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460333|NCT05504967|Antiemetics|antiemetics|mesh-ancestor
139460334|NCT05504967|Autonomic Agents|autonomic agents|mesh-ancestor
139460335|NCT05504967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460336|NCT05504967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460337|NCT05504967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139460338|NCT05504967|Glucocorticoids|glucocorticoids|mesh-ancestor
139460339|NCT05504967|Hormones|hormones|mesh-ancestor
139460340|NCT05504967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460341|NCT05504967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139460342|NCT05504967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460343|NCT05504967|Anesthetics, Local|anesthetics, local|mesh-ancestor
139460344|NCT05504967|Anesthetics|anesthetics|mesh-ancestor
139460345|NCT05504967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460346|NCT05504967|Sensory System Agents|sensory system agents|mesh-ancestor
139460347|NCT02565147|Heparin|heparin|mesh-list
139460348|NCT02565147|Bivalirudin|bivalirudin|mesh-list
139460349|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
139460350|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139460351|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139460352|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460353|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
139460354|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139460355|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
139460356|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460357|NCT02061280|Fluticasone|fluticasone|mesh-list
139460358|NCT02061280|Xhance|xhance|mesh-list
139460359|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139460360|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139460361|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460362|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139460363|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
139460364|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460365|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460366|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139460367|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
139460368|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
139460369|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139460370|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139460371|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139460372|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139460373|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
139460374|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460375|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460376|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
139460377|NCT02061280|Hormones|hormones|mesh-ancestor
139247071|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
139460378|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460379|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
139460380|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
139460381|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460382|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
139460383|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139460384|NCT04698850|Ranibizumab|ranibizumab|mesh-list
139460385|NCT04698850|Aflibercept|aflibercept|mesh-list
139460386|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139460387|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139460388|NCT04698850|Growth Substances|growth substances|mesh-ancestor
139460389|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460390|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
139460391|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460392|NCT04698226|Temazepam|temazepam|mesh-list
139460393|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139460394|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460395|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460396|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139460397|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139460398|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139460399|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
139460400|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
139460401|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460402|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460403|NCT05504577|Tranylcypromine|tranylcypromine|mesh-list
139460404|NCT05504577|Tranexamic Acid|tranexamic acid|mesh-list
139460405|NCT05504577|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139460406|NCT05504577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139460407|NCT05504577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460408|NCT05504577|Hemostatics|hemostatics|mesh-ancestor
139460409|NCT05504577|Coagulants|coagulants|mesh-ancestor
139460410|NCT05504577|Antidepressive Agents|antidepressive agents|mesh-ancestor
139460411|NCT05504577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139460412|NCT05504577|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139460413|NCT05504577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460414|NCT05504577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139460415|NCT05504577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139460416|NCT05504577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460417|NCT05504577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460418|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
139460419|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
139460420|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139460421|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139460422|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139460423|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460424|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460425|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139460426|NCT05504265|Flurbiprofen|flurbiprofen|mesh-list
139460427|NCT05504265|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
139460428|NCT05504265|Analgesics|analgesics|mesh-ancestor
139460429|NCT05504265|Sensory System Agents|sensory system agents|mesh-ancestor
139460430|NCT05504265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460431|NCT05504265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460432|NCT05504265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139460433|NCT05504265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139460434|NCT05504265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460435|NCT05504265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139460436|NCT05504265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139460437|NCT05504265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460438|NCT05504265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460439|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
139460440|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
139460441|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139460442|NCT04740099|Naloxone|naloxone|mesh-list
139460443|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139460444|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460445|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
139460446|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460447|NCT02560389|Levodopa|levodopa|mesh-list
139460448|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139460449|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139460450|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
139460451|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460452|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460453|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460454|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139460455|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
139460456|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139460457|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460458|NCT02564211|Incretins|incretins|mesh-ancestor
139460460|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460461|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139460462|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
139460463|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460464|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460465|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139460466|NCT04596579|Antibodies|antibodies|mesh-list
139460467|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
139460468|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460469|NCT04465383|Propofol|propofol|mesh-list
139460470|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139460471|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460472|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460473|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139460474|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
139460475|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
139460476|NCT05500677|Lidocaine|lidocaine|mesh-list
139460477|NCT05500677|Fentanyl|fentanyl|mesh-list
139460478|NCT05500677|Tramadol|tramadol|mesh-list
139460479|NCT05500677|Anesthetics, Local|anesthetics, local|mesh-ancestor
139460480|NCT05500677|Anesthetics|anesthetics|mesh-ancestor
139460481|NCT05500677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460482|NCT05500677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460483|NCT05500677|Sensory System Agents|sensory system agents|mesh-ancestor
139460484|NCT05500677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460485|NCT05500677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139460486|NCT05500677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139460487|NCT05500677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139460488|NCT05500677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139460489|NCT05500677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460490|NCT05500677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139460491|NCT05500677|Narcotics|narcotics|mesh-ancestor
139460492|NCT05500677|Analgesics|analgesics|mesh-ancestor
139460493|NCT05500677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139460494|NCT05500677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139460495|NCT05500677|Anesthetics, General|anesthetics, general|mesh-ancestor
139460496|NCT02093026|Folic Acid|folic acid|mesh-list
139460497|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
139460498|NCT02093026|Rituximab|rituximab|mesh-list
139460499|NCT02093026|Methotrexate|methotrexate|mesh-list
139460500|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139460501|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460502|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
139460503|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460504|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139460505|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139460506|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
139460507|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139460508|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139460509|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
139460510|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460511|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
139460512|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460513|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139460514|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139460515|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139460516|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460517|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
139460518|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
139460519|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460520|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139460521|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
139460522|NCT02093026|Hormones|hormones|mesh-ancestor
139460523|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460524|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139460525|NCT02093026|Protective Agents|protective agents|mesh-ancestor
139460526|NCT02093026|Hematinics|hematinics|mesh-ancestor
139460527|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
139460528|NCT02093026|Vitamins|vitamins|mesh-ancestor
139247223|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
139460529|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
139460530|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
139460531|NCT02059174|MK-1293|mk-1293|mesh-list
139460532|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139460533|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460534|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139460535|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
139460536|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460537|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139460538|NCT04417582|Liraglutide|liraglutide|mesh-list
139460539|NCT04417582|Orlistat|orlistat|mesh-list
139460540|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139460541|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460542|NCT04417582|Incretins|incretins|mesh-ancestor
139460543|NCT04417582|Hormones|hormones|mesh-ancestor
139460544|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460545|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460546|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460547|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139460548|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139460549|NCT02040766|Beclomethasone|beclomethasone|mesh-list
139460550|NCT02040766|Albuterol|albuterol|mesh-list
139460551|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
139460552|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
139460553|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460554|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460555|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139460556|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
139460557|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
139460558|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139460559|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139460560|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139460561|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139460562|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
139460563|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460564|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460565|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460566|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
139460567|NCT02040766|Hormones|hormones|mesh-ancestor
139460568|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460569|NCT02040532|Gabapentin|gabapentin|mesh-list
139460570|NCT02040532|Analgesics|analgesics|mesh-ancestor
139460571|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
139460572|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460573|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460574|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
139460575|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139460576|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139460577|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460578|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139460579|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139460580|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139460581|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460582|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460583|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
139460584|NCT02039908|Methylphenidate|methylphenidate|mesh-list
139460585|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139460586|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460587|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139460588|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139460589|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139460590|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460591|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
139460592|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460593|NCT04417348|Tretinoin|tretinoin|mesh-list
139460594|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460595|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
139460596|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
139460597|NCT02058940|Exenatide|exenatide|mesh-list
139460598|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139460599|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460600|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139460601|NCT02058940|Incretins|incretins|mesh-ancestor
139460602|NCT02058940|Hormones|hormones|mesh-ancestor
139460603|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460604|NCT02058628|Clindamycin|clindamycin|mesh-list
139460605|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
139460606|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
139460607|NCT02058628|Azelaic acid|azelaic acid|mesh-list
139460608|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139460609|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139460610|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139460611|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460612|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460613|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460614|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
139460615|NCT02058160|Insulin|insulin|mesh-list
139460616|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139460617|NCT02058160|Metformin|metformin|mesh-list
139460618|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
139460619|NCT02058160|Lixisenatide|lixisenatide|mesh-list
139460620|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139460621|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460622|NCT02090764|Ozenoxacin|ozenoxacin|mesh-list
139460623|NCT02090764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139460624|NCT02090764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139460625|NCT02090764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139460626|NCT02090764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460627|NCT02090764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460628|NCT02090764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460629|NCT02088034|Metformin|metformin|mesh-list
139460630|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139460631|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460632|NCT02037256|Bortezomib|bortezomib|mesh-list
139460633|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460634|NCT02035696|Vaccines|vaccines|mesh-list
139460635|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
139460636|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460637|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
139460638|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
139460639|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139460640|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139460641|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460642|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460643|NCT02057458|Urological Agents|urological agents|mesh-ancestor
139460644|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
139460645|NCT02087176|Adavosertib|adavosertib|mesh-list
139460646|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460647|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460648|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
139460649|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460650|NCT02056288|Fentanyl|fentanyl|mesh-list
139460651|NCT02056288|Ropivacaine|ropivacaine|mesh-list
139460652|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
139460653|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
139460654|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460655|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460656|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
139460657|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460658|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139460659|NCT02056288|Narcotics|narcotics|mesh-ancestor
139460660|NCT02056288|Analgesics|analgesics|mesh-ancestor
139460661|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139460662|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139460663|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
139460664|NCT03115697|Rifaximin|rifaximin|mesh-list
139460665|NCT03115697|Lactulose|lactulose|mesh-list
139460666|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139460667|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139460668|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139460669|NCT03115775|Vitamin D|vitamin d|mesh-list
139460670|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
139460671|NCT03115775|Cholecalciferol|cholecalciferol|mesh-list
139460672|NCT03115775|Vitamins|vitamins|mesh-list
139460673|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
139460674|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460675|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139460676|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139460677|NCT02404259|Ritonavir|ritonavir|mesh-list
139247369|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
139460678|NCT02404259|Lopinavir|lopinavir|mesh-list
139460679|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139460680|NCT02404259|Tenofovir|tenofovir|mesh-list
139460681|NCT02404259|Efavirenz|efavirenz|mesh-list
139460682|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139460683|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139460684|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
139460685|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460686|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460687|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139460688|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139460689|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
139460690|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139460691|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139460692|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139460693|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139460694|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139460695|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139460696|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139460697|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139460698|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139460699|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139460700|NCT03170687|Calpastatin|calpastatin|mesh-list
139460701|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139460702|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
139460703|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460704|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460705|NCT03169751|Caffeine|caffeine|mesh-list
139460706|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139460707|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460708|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139460709|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460710|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460711|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139460712|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139460713|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
139460714|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460715|NCT02403713|Fluticasone|fluticasone|mesh-list
139460716|NCT02403713|Xhance|xhance|mesh-list
139460717|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
139460718|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460719|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139460720|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
139460721|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460722|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460723|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139460724|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
139460725|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
139460726|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139460727|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139460728|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139460729|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139460730|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
139460731|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460732|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460733|NCT02700815|Diclofenac|diclofenac|mesh-list
139460734|NCT02700815|Capsaicin|capsaicin|mesh-list
139460735|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139460736|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139460737|NCT02700815|Analgesics|analgesics|mesh-ancestor
139460738|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
139460739|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460740|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460741|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460742|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139460743|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139460744|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460745|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460746|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
139460747|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
139460748|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
139460749|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139460750|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
139460751|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139460752|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460753|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139460754|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139247448|NCT02083328|Mannitol|mannitol|mesh-list
139460756|NCT02402621|Fentanyl|fentanyl|mesh-list
139460757|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139460758|NCT02402621|Narcotics|narcotics|mesh-ancestor
139460759|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460760|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460761|NCT02402621|Analgesics|analgesics|mesh-ancestor
139460762|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
139460763|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460764|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139460765|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139460766|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
139460767|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
139460768|NCT04481789|Furosemide|furosemide|mesh-list
139460769|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
139460770|NCT04481789|Edaravone|edaravone|mesh-list
139460771|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139460772|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139460773|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139460774|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
139460775|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460776|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139460777|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139460778|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460779|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
139460780|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139460781|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139460782|NCT04481789|Urological Agents|urological agents|mesh-ancestor
139460783|NCT04481789|Diuretics|diuretics|mesh-ancestor
139460784|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
139460785|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460786|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139460787|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139460788|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139460789|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
139460790|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139460791|NCT04481789|Protective Agents|protective agents|mesh-ancestor
139460792|NCT02402465|Fluticasone|fluticasone|mesh-list
139460793|NCT02402465|Xhance|xhance|mesh-list
139460794|NCT02402465|Azelastine|azelastine|mesh-list
139460795|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460796|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139460797|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
139460798|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460799|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460800|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139460801|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
139460802|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
139460803|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139460804|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139460805|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460806|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460807|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139460808|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139460809|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
139460810|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
139460811|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460812|NCT02402231|Omalizumab|omalizumab|mesh-list
139460813|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139460814|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139460815|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
139460816|NCT02402543|Acetaminophen|acetaminophen|mesh-list
139460817|NCT02402543|Dexamethasone|dexamethasone|mesh-list
139460818|NCT02402543|Ketamine|ketamine|mesh-list
139460819|NCT02402543|Gabapentin|gabapentin|mesh-list
139460820|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460821|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
139460822|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
139460823|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385393|NCT05578001|Cholinergic Agents|cholinergic agents|mesh-ancestor
139460824|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460825|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139460826|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
139460827|NCT02402543|Hormones|hormones|mesh-ancestor
139460828|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460829|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139460830|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460831|NCT02402543|Analgesics|analgesics|mesh-ancestor
139460833|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139460834|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139460835|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
139460836|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
139460837|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460838|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139460839|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139460840|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139460841|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460842|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139460843|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
139460844|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
139460845|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139460846|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139460847|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139460848|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
139460849|NCT02401295|Itraconazole|itraconazole|mesh-list
139460850|NCT02401295|Celecoxib|celecoxib|mesh-list
139460851|NCT02401295|Tretinoin|tretinoin|mesh-list
139460852|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139460853|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139460854|NCT02401295|Analgesics|analgesics|mesh-ancestor
139460855|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
139460856|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460857|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460858|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460859|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139460860|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139460861|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139460862|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460863|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460864|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
139460865|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139460866|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139460867|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139460868|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139460869|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
139460870|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460871|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139460872|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460873|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
139460874|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
139460875|NCT00708305|Listerine|listerine|mesh-list
139460876|NCT00708305|Fluorides|fluorides|mesh-list
139460877|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
139460878|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
139460879|NCT00708305|Protective Agents|protective agents|mesh-ancestor
139460880|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460881|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139460882|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139460883|NCT03169127|Ibuprofen|ibuprofen|mesh-list
139460884|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139460885|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139460886|NCT03169127|Analgesics|analgesics|mesh-ancestor
139460887|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
139460888|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460889|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460890|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460891|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139460892|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139460893|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460894|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460895|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139460896|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
139460897|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139460898|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
139460899|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139460900|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460901|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139460902|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139460903|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460904|NCT02418533|Menotropins|menotropins|mesh-list
139460905|NCT02418533|Hormones|hormones|mesh-list
139460906|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139460907|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460908|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460909|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139460910|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
139460911|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139460912|NCT02418065|Testosterone|testosterone|mesh-list
139460913|NCT02418065|Androgens|androgens|mesh-ancestor
139460914|NCT02418065|Hormones|hormones|mesh-ancestor
139460915|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460916|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460917|NCT05058443|Denosumab|denosumab|mesh-list
139460918|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139460919|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460920|NCT02400281|Cytarabine|cytarabine|mesh-list
139460921|NCT02400281|Fludarabine|fludarabine|mesh-list
139460922|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
139460923|NCT02400281|Etoposide|etoposide|mesh-list
139460924|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
139460925|NCT02400281|Azacitidine|azacitidine|mesh-list
139460926|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
139460927|NCT02400281|Idarubicin|idarubicin|mesh-list
139460928|NCT02400281|Crenolanib|crenolanib|mesh-list
139460929|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460930|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139460931|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
139460932|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460933|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139460934|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
139460935|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460936|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
139460937|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139460938|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139460939|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139460940|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139460941|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460942|NCT02400281|Analgesics|analgesics|mesh-ancestor
139460943|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
139460944|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460945|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139460946|NCT02055976|Ezetimibe|ezetimibe|mesh-list
139460947|NCT02055976|Bococizumab|bococizumab|mesh-list
139460948|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139460949|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139460950|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
139460951|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460952|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139460953|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
139460954|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139460955|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139460956|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
139460957|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
139460958|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139460959|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460960|NCT04406259|Verapamil|verapamil|mesh-list
139460961|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139460962|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139460963|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139460964|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460965|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139460966|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460967|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
139460968|NCT03972111|Tecovirimat|tecovirimat|mesh-list
139460969|NCT03972111|Antiviral Agents|antiviral agents|mesh-ancestor
139460970|NCT03972111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139460971|NCT02699099|Vitamin A|vitamin a|mesh-list
139460972|NCT02699099|Vaccines|vaccines|mesh-list
139460973|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
139460974|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460975|NCT02699099|Vitamins|vitamins|mesh-ancestor
139460976|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
139460977|NCT02400047|Dexamethasone|dexamethasone|mesh-list
139460978|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
139460979|NCT02400047|Ketoprofen|ketoprofen|mesh-list
139460980|NCT02400047|BB 1101|bb 1101|mesh-list
139460981|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139460982|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
139460983|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
139460984|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139460985|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139460986|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139460988|NCT02400047|Hormones|hormones|mesh-ancestor
139460989|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139460990|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139460991|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139460992|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
139460993|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139460994|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139460995|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139460996|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139460997|NCT02400047|Analgesics|analgesics|mesh-ancestor
139460998|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
139460999|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461000|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139461001|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
139461002|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139461003|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
139461004|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461005|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
139461006|NCT02698865|Protective Agents|protective agents|mesh-ancestor
139461007|NCT05499897|Anesthetics|anesthetics|mesh-list
139461008|NCT05499897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461009|NCT05499897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461010|NCT02417207|Entecavir|entecavir|mesh-list
139461011|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
139461012|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461013|NCT02698475|Ustekinumab|ustekinumab|mesh-list
139461014|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
139461015|NCT02399657|Dexamethasone|dexamethasone|mesh-list
139461016|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139461017|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
139461018|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
139461019|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461020|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461021|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139461022|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
139461023|NCT02399657|Hormones|hormones|mesh-ancestor
139461024|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139461025|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139461026|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461027|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
139461028|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461029|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461030|NCT02559687|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139461031|NCT02559687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461032|NCT03177317|Dexamethasone|dexamethasone|mesh-list
139461033|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139461034|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
139461035|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
139461036|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461037|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461038|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139461039|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
139461040|NCT03177317|Hormones|hormones|mesh-ancestor
139461041|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139461042|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139461043|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461044|NCT03177239|Nivolumab|nivolumab|mesh-list
139461045|NCT03177239|Ipilimumab|ipilimumab|mesh-list
139461046|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461047|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461048|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139461049|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461050|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
139461051|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139461052|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139461053|NCT04480775|Prednisolone|prednisolone|mesh-list
139461054|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
139461055|NCT04480775|Triamcinolone|triamcinolone|mesh-list
139461056|NCT04480775|Bupivacaine|bupivacaine|mesh-list
139461057|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139247739|NCT01364701|Tadalafil|tadalafil|mesh-list
139461058|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
139461059|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
139461060|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
139461061|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461062|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461063|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
139461064|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461065|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139461066|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
139461067|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
139461068|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139461069|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
139461070|NCT04480775|Hormones|hormones|mesh-ancestor
139461071|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139461072|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139461073|NCT04480775|Protective Agents|protective agents|mesh-ancestor
139461074|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139461075|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461076|NCT02416817|Thrombin|thrombin|mesh-list
139461077|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
139461078|NCT02416817|Coagulants|coagulants|mesh-ancestor
139461079|NCT02399189|Methotrexate|methotrexate|mesh-list
139461080|NCT02399189|Temozolomide|temozolomide|mesh-list
139461081|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461082|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
139461083|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461084|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461085|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139461086|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
139461087|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139461088|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139461089|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
139461090|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461091|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
139461092|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461093|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139461094|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139461095|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139461096|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139461097|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
139461098|NCT03176849|Vitamin D|vitamin d|mesh-list
139461099|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
139461100|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
139461101|NCT03176849|Vitamins|vitamins|mesh-list
139461102|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
139461103|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461104|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139461105|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139461106|NCT03106571|Methamphetamine|methamphetamine|mesh-list
139461107|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139461108|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461109|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
139461110|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
139461111|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461112|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
139461113|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461114|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461115|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
139461116|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139461117|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139461118|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139461119|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139461120|NCT03177083|Interferons|interferons|mesh-list
139461121|NCT03177083|Interferon-beta|interferon-beta|mesh-list
139461122|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
139461123|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
139461124|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461125|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
139461126|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461127|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
139461128|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461129|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139461130|NCT03629925|Carboplatin|carboplatin|mesh-list
139461131|NCT03629925|Gemcitabine|gemcitabine|mesh-list
139461132|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461133|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139461134|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
139461135|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461136|NCT02398487|Nicotine|nicotine|mesh-list
139461137|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139461138|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
139461139|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461140|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461141|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139461142|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139461143|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
139461144|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461145|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461146|NCT03250299|Lisavanbulin|lisavanbulin|mesh-list
139461147|NCT03250299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139461148|NCT03250299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461149|NCT03250299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461150|NCT03250299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461151|NCT02697617|Pioglitazone|pioglitazone|mesh-list
139461152|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139461153|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461154|NCT02396225|Voriconazole|voriconazole|mesh-list
139461155|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
139461156|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461157|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139461158|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139461159|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461160|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461161|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139461162|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
139461163|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139461164|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461165|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139461166|NCT02396303|Carbetocin|carbetocin|mesh-list
139461167|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
139461168|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139461169|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461170|NCT02397863|Cannabidiol|cannabidiol|mesh-list
139461171|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
139461172|NCT03168035|NC-4016|nc-4016|mesh-list
139461173|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461174|NCT02397395|Simeprevir|simeprevir|mesh-list
139461175|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
139461176|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461177|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
139461178|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461179|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461180|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139461181|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139461182|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461183|NCT03168191|Menthol|menthol|mesh-list
139461184|NCT03168191|Nicotine|nicotine|mesh-list
139461185|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139461186|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
139461187|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461188|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461189|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139461190|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139461191|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
139461192|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461193|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461194|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
139461195|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
139461196|NCT04280055|Psilocybin|psilocybin|mesh-list
139461197|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
139461198|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461199|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139461200|NCT05499117|Fluoxetine|fluoxetine|mesh-list
139461201|NCT05499117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139461202|NCT05499117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139461203|NCT05499117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139461204|NCT05499117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461205|NCT05499117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461206|NCT05499117|Serotonin Agents|serotonin agents|mesh-ancestor
139461207|NCT05499117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461208|NCT05499117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139461209|NCT05499117|Antidepressive Agents|antidepressive agents|mesh-ancestor
139461210|NCT05499117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139461211|NCT05499117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139461212|NCT05499117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139461213|NCT05499117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461214|NCT05498337|Calcium|calcium|mesh-list
139461215|NCT05498337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139461216|NCT05498337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461217|NCT01663233|Amlodipine|amlodipine|mesh-list
139461218|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139461219|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139461220|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139461221|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139461222|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461223|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139461224|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461225|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
139461226|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139461227|NCT05494281|Anesthetics|anesthetics|mesh-list
139461228|NCT05494281|Anesthetics, Local|anesthetics, local|mesh-list
139461229|NCT05494281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461230|NCT05494281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461231|NCT05494281|Sensory System Agents|sensory system agents|mesh-ancestor
139461232|NCT05494281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461233|NCT05494047|Vaccines|vaccines|mesh-list
139461234|NCT05494047|Immunologic Factors|immunologic factors|mesh-ancestor
139461235|NCT05494047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461236|NCT05493969|Lamivudine|lamivudine|mesh-list
139461237|NCT05493969|Dolutegravir|dolutegravir|mesh-list
139461238|NCT05493969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139461239|NCT05493969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139461240|NCT05493969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461241|NCT05493969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461242|NCT05493969|Antiviral Agents|antiviral agents|mesh-ancestor
139461243|NCT05493969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461244|NCT05493969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139461245|NCT05493969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139461246|NCT05493969|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139461247|NCT05493969|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139461248|NCT05493267|Zoledronic Acid|zoledronic acid|mesh-list
139461249|NCT05493267|Interleukin-2|interleukin-2|mesh-list
139461250|NCT05493267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461251|NCT05493267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461252|NCT05493267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139461253|NCT05493267|Analgesics|analgesics|mesh-ancestor
139461254|NCT05493267|Sensory System Agents|sensory system agents|mesh-ancestor
139461255|NCT05493267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461256|NCT05493267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139461257|NCT05492487|Megestrol Acetate|megestrol acetate|mesh-list
139461258|NCT05492487|Levonorgestrel|levonorgestrel|mesh-list
139461259|NCT05492487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139461260|NCT05492487|Contraceptive Agents|contraceptive agents|mesh-ancestor
139461261|NCT05492487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139461262|NCT05492487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461263|NCT05492487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139461264|NCT05492487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139461265|NCT05492487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139461266|NCT05492487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139461267|NCT05492487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461268|NCT05492487|Appetite Stimulants|appetite stimulants|mesh-ancestor
139461269|NCT05492487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139461270|NCT05492019|Doxycycline|doxycycline|mesh-list
139461271|NCT05492019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139461272|NCT05492019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461273|NCT05492019|Antimalarials|antimalarials|mesh-ancestor
139461274|NCT05492019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139461275|NCT05492019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139461276|NCT05491785|Oxycodone|oxycodone|mesh-list
139461277|NCT05491785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139461278|NCT05491785|Narcotics|narcotics|mesh-ancestor
139461279|NCT05491785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461280|NCT05491785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461281|NCT05491785|Analgesics|analgesics|mesh-ancestor
139461282|NCT05491785|Sensory System Agents|sensory system agents|mesh-ancestor
139461283|NCT05491785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461284|NCT05484375|Capecitabine|capecitabine|mesh-list
139461285|NCT05484375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139461286|NCT05484375|Antimetabolites|antimetabolites|mesh-ancestor
139461287|NCT05484375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461288|NCT05484375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461289|NCT05480007|Metformin|metformin|mesh-list
139461290|NCT05480007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139461291|NCT05480007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139461292|NCT05480007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461293|NCT05480007|Incretins|incretins|mesh-ancestor
139461294|NCT05480007|Hormones|hormones|mesh-ancestor
139461295|NCT05480007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139461296|NCT05480007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139461297|NCT05480007|Protease Inhibitors|protease inhibitors|mesh-ancestor
139461298|NCT05480007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461299|NCT05480007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461300|NCT05489601|Oxycodone|oxycodone|mesh-list
139461301|NCT05489601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139461302|NCT05489601|Narcotics|narcotics|mesh-ancestor
139461303|NCT05489601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461304|NCT05489601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461305|NCT05489601|Analgesics|analgesics|mesh-ancestor
139461306|NCT05489601|Sensory System Agents|sensory system agents|mesh-ancestor
139461307|NCT05489601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461308|NCT04276155|Anticoagulants|anticoagulants|mesh-list
139461309|NCT05488899|Iodine|iodine|mesh-list
139461310|NCT05488899|Cadexomer iodine|cadexomer iodine|mesh-list
139461311|NCT05488899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139461312|NCT05488899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461313|NCT05488899|Trace Elements|trace elements|mesh-ancestor
139461314|NCT05488899|Micronutrients|micronutrients|mesh-ancestor
139461315|NCT05488899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461316|NCT05483439|Cyclophosphamide|cyclophosphamide|mesh-list
139461317|NCT05483439|Carboplatin|carboplatin|mesh-list
139461318|NCT05483439|Docetaxel|docetaxel|mesh-list
139461319|NCT05483439|Trastuzumab|trastuzumab|mesh-list
139461320|NCT05483439|Epirubicin|epirubicin|mesh-list
139461321|NCT05483439|Pertuzumab|pertuzumab|mesh-list
139461322|NCT05483439|Antibodies|antibodies|mesh-list
139461323|NCT05483439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139461324|NCT05483439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139461325|NCT05483439|Immunologic Factors|immunologic factors|mesh-ancestor
139461326|NCT05483439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461327|NCT05483439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461328|NCT05483439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139461329|NCT05483439|Alkylating Agents|alkylating agents|mesh-ancestor
139461330|NCT05483439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461331|NCT05483439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461332|NCT05483439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139461333|NCT05483439|Tubulin Modulators|tubulin modulators|mesh-ancestor
139461334|NCT05483439|Antimitotic Agents|antimitotic agents|mesh-ancestor
139461335|NCT05483439|Mitosis Modulators|mitosis modulators|mesh-ancestor
139461336|NCT05483439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461337|NCT05483439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139461338|NCT05483439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139461339|NCT05483439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139461340|NCT05483439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461341|NCT03748095|Tazobactam|tazobactam|mesh-list
139461342|NCT03748095|Piperacillin|piperacillin|mesh-list
139461343|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139461344|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461345|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139461346|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461347|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461348|NCT04275375|Anesthetics|anesthetics|mesh-list
139461349|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461350|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461351|NCT05488353|Disitamab vedotin|disitamab vedotin|mesh-list
139461352|NCT05488353|Immunoconjugates|immunoconjugates|mesh-ancestor
139461353|NCT05488353|Immunologic Factors|immunologic factors|mesh-ancestor
139461354|NCT05488353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461355|NCT04543071|Paclitaxel|paclitaxel|mesh-list
139461356|NCT04543071|Gemcitabine|gemcitabine|mesh-list
139461357|NCT04543071|Cemiplimab|cemiplimab|mesh-list
139461358|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139461359|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461360|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
139461361|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
139461362|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
139461363|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461364|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139461365|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
139461366|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461367|NCT05487963|Tofacitinib|tofacitinib|mesh-list
139461368|NCT05487963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461369|NCT05487963|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139461370|NCT05487963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139461371|NCT05487963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461372|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139461373|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
139461374|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461375|NCT05476731|Antifungal Agents|antifungal agents|mesh-list
139461376|NCT05476731|Clotrimazole|clotrimazole|mesh-list
139461377|NCT05476731|Miconazole|miconazole|mesh-list
139461378|NCT05476731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461379|NCT05476731|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139461380|NCT05476731|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139461381|NCT05476731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139461382|NCT05476731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461383|NCT05476731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461384|NCT05476731|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139461385|NCT05476731|Hormone Antagonists|hormone antagonists|mesh-ancestor
139461386|NCT05476731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139461387|NCT05476731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461388|NCT05476731|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139461389|NCT05476731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139461390|NCT05482113|Bupivacaine|bupivacaine|mesh-list
139461391|NCT05482113|Anesthetics, Local|anesthetics, local|mesh-ancestor
139461392|NCT05482113|Anesthetics|anesthetics|mesh-ancestor
139461393|NCT05482113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461394|NCT05482113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461395|NCT05482113|Sensory System Agents|sensory system agents|mesh-ancestor
139461396|NCT05482113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461397|NCT05481957|Vortioxetine|vortioxetine|mesh-list
139461398|NCT05481957|Antidepressive Agents|antidepressive agents|mesh-ancestor
139461399|NCT05481957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139461400|NCT05481957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139461401|NCT05481957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139461402|NCT05481957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461403|NCT05481957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461404|NCT05481957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139461405|NCT05481957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139461406|NCT05481957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139461407|NCT05481957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461408|NCT05481957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461409|NCT05481957|Serotonin Agents|serotonin agents|mesh-ancestor
139461410|NCT05481957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139461411|NCT05481957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139461412|NCT05481957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139461413|NCT05481957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139461414|NCT05475561|Bupivacaine|bupivacaine|mesh-list
139461415|NCT05475561|Anesthetics, Local|anesthetics, local|mesh-ancestor
139461416|NCT05475561|Anesthetics|anesthetics|mesh-ancestor
139461417|NCT05475561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461418|NCT05475561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461419|NCT05475561|Sensory System Agents|sensory system agents|mesh-ancestor
139461420|NCT05475561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461421|NCT05476341|Bevacizumab|bevacizumab|mesh-list
139461422|NCT05476341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461423|NCT05476341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461424|NCT05476341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139461425|NCT05476341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139461426|NCT05476341|Growth Substances|growth substances|mesh-ancestor
139461427|NCT05476341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461428|NCT05476341|Growth Inhibitors|growth inhibitors|mesh-ancestor
139461429|NCT05481723|Norepinephrine|norepinephrine|mesh-list
139461430|NCT05481723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139248122|NCT03284853|Latanoprost|latanoprost|mesh-list
139461431|NCT05481723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139461432|NCT05481723|Adrenergic Agents|adrenergic agents|mesh-ancestor
139461433|NCT05481723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461434|NCT05481723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461435|NCT05481723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461436|NCT05481723|Sympathomimetics|sympathomimetics|mesh-ancestor
139461437|NCT05481723|Autonomic Agents|autonomic agents|mesh-ancestor
139461438|NCT05481723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461439|NCT05481723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139461440|NCT04272021|Methylphenidate|methylphenidate|mesh-list
139461441|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139461442|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461443|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139461444|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139461445|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139461446|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461447|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
139461448|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461449|NCT02697773|Tanezumab|tanezumab|mesh-list
139461450|NCT02697773|Analgesics|analgesics|mesh-ancestor
139461451|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
139461452|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461453|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461454|NCT02394821|Metronidazole|metronidazole|mesh-list
139461455|NCT02394821|Polihexanide|polihexanide|mesh-list
139461456|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461457|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139461458|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139461459|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139461460|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
139461461|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139461462|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139461463|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461464|NCT05745857|Bevacizumab|bevacizumab|mesh-list
139461465|NCT05745857|Cetuximab|cetuximab|mesh-list
139461466|NCT05745857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461467|NCT05745857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461468|NCT05745857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139461469|NCT05745857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139461470|NCT05745857|Growth Substances|growth substances|mesh-ancestor
139461471|NCT05745857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461472|NCT05745857|Growth Inhibitors|growth inhibitors|mesh-ancestor
139461473|NCT05745779|Vitamin D|vitamin d|mesh-list
139461474|NCT05745779|Vitamins|vitamins|mesh-list
139461475|NCT05745779|Vitamin B 12|vitamin b 12|mesh-list
139461476|NCT05745779|Hydroxocobalamin|hydroxocobalamin|mesh-list
139461477|NCT05745779|Micronutrients|micronutrients|mesh-ancestor
139461478|NCT05745779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461479|NCT05745779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139461480|NCT05745779|Vitamin B Complex|vitamin b complex|mesh-ancestor
139461481|NCT05745779|Hematinics|hematinics|mesh-ancestor
139461482|NCT02394197|Chloroquine|chloroquine|mesh-list
139461483|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139461484|NCT02394197|Primaquine|primaquine|mesh-list
139461485|NCT02394197|Amebicides|amebicides|mesh-ancestor
139461486|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139461487|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139461488|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461489|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
139461490|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461491|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139461492|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139461493|NCT02394197|Analgesics|analgesics|mesh-ancestor
139461494|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
139461495|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461496|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461497|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139461498|NCT02394197|Filaricides|filaricides|mesh-ancestor
139461499|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
139461500|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
139461501|NCT02394119|Rituximab|rituximab|mesh-list
139461502|NCT02394119|Ofatumumab|ofatumumab|mesh-list
139461503|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461504|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461505|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
139461506|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461507|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461508|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
139461509|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139461510|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
139461511|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461512|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
139461513|NCT03167333|Protective Agents|protective agents|mesh-ancestor
139461514|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
139461515|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139461516|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139461517|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461518|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
139461519|NCT02393963|Coagulants|coagulants|mesh-ancestor
139461520|NCT03115619|Pirfenidone|pirfenidone|mesh-list
139461521|NCT03115619|Analgesics|analgesics|mesh-ancestor
139461522|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
139461523|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461524|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461525|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139461526|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139461527|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139461528|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461529|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461530|NCT02393573|Metformin|metformin|mesh-list
139461531|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139461532|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461533|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
139461534|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139461535|NCT02693171|Dinutuximab|dinutuximab|mesh-list
139461536|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461537|NCT02392793|Irinotecan|irinotecan|mesh-list
139461538|NCT02392793|Temozolomide|temozolomide|mesh-list
139461539|NCT02392793|Talazoparib|talazoparib|mesh-list
139461540|NCT02392793|Lenograstim|lenograstim|mesh-list
139461541|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139461542|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139461543|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461544|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461545|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461546|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139461547|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
139461548|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461549|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139461550|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
139461551|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139461552|NCT03167177|Leucovorin|leucovorin|mesh-list
139461553|NCT03167177|Paclitaxel|paclitaxel|mesh-list
139461554|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
139461555|NCT03167177|Bevacizumab|bevacizumab|mesh-list
139461556|NCT03167177|Capecitabine|capecitabine|mesh-list
139461557|NCT03167177|Fluorouracil|fluorouracil|mesh-list
139461558|NCT03167177|Nivolumab|nivolumab|mesh-list
139461559|NCT03167177|Avelumab|avelumab|mesh-list
139461560|NCT03167177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139461561|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461562|NCT03167177|Tubulin Modulators|tubulin modulators|mesh-ancestor
139461563|NCT03167177|Antimitotic Agents|antimitotic agents|mesh-ancestor
139461564|NCT03167177|Mitosis Modulators|mitosis modulators|mesh-ancestor
139461565|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461566|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139461567|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
139461568|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461569|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461570|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139461571|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
139461572|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139461573|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461574|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139461575|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139461576|NCT03167177|Growth Substances|growth substances|mesh-ancestor
139461577|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
139461578|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139461579|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
139461580|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139461581|NCT03167177|Antidotes|antidotes|mesh-ancestor
139461582|NCT03167177|Protective Agents|protective agents|mesh-ancestor
139461583|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
139461584|NCT03167177|Vitamins|vitamins|mesh-ancestor
139461585|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
139248269|NCT03125941|Hormones|hormones|mesh-ancestor
139461586|NCT02392169|Methylphenidate|methylphenidate|mesh-list
139461587|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139461588|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461589|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139461590|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139461591|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139461592|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461593|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
139461594|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461595|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
139461596|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139461597|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
139461598|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461599|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
139461600|NCT03166865|Protective Agents|protective agents|mesh-ancestor
139461601|NCT03166787|Tadalafil|tadalafil|mesh-list
139461602|NCT03166787|Charcoal|charcoal|mesh-list
139461603|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
139461604|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461605|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461606|NCT03166787|Protective Agents|protective agents|mesh-ancestor
139461607|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
139461608|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139461609|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139461610|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461611|NCT03166787|Urological Agents|urological agents|mesh-ancestor
139461612|NCT03166787|Antidotes|antidotes|mesh-ancestor
139461613|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
139461614|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
139461615|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461616|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
139461617|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461618|NCT03167957|Amphotericin B|amphotericin b|mesh-list
139461619|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139461620|NCT03167957|Amebicides|amebicides|mesh-ancestor
139461621|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139461622|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139461623|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461624|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139461625|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
139461626|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
139461627|NCT03166397|Nivolumab|nivolumab|mesh-list
139461628|NCT03166397|Fludarabine|fludarabine|mesh-list
139461629|NCT03166397|Ipilimumab|ipilimumab|mesh-list
139461630|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139461631|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
139461632|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461633|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461634|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139461635|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
139461636|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461637|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461638|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139461639|NCT03166397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461640|NCT03166397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139461641|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
139461642|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461643|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461644|NCT02552355|Metformin|metformin|mesh-list
139461645|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139461646|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461647|NCT02551731|Cannabidiol|cannabidiol|mesh-list
139461648|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
139461649|NCT04479657|Cefuroxime|cefuroxime|mesh-list
139461650|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
139461651|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139461652|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461653|NCT05471661|PENTA|penta|mesh-list
139461654|NCT05471661|Anticoagulants|anticoagulants|mesh-ancestor
139461655|NCT05471661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139461656|NCT05471661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139461657|NCT05471661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461658|NCT05480631|Mitogens|mitogens|mesh-list
139461659|NCT05480631|Mitosis Modulators|mitosis modulators|mesh-ancestor
139461660|NCT05480631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461661|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
139248348|NCT02721069|Diazepam|diazepam|mesh-list
139461663|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139461664|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461665|NCT02542605|Analgesics|analgesics|mesh-ancestor
139461666|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
139461667|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461668|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461669|NCT02542605|Growth Substances|growth substances|mesh-ancestor
139461670|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
139461671|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461672|NCT02550795|Dexamethasone|dexamethasone|mesh-list
139461673|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
139461674|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139461675|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
139461676|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
139461677|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461678|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461679|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139461680|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
139461681|NCT02550795|Hormones|hormones|mesh-ancestor
139461682|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139461683|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139461684|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461685|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139461686|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461687|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139461688|NCT02550795|Analgesics|analgesics|mesh-ancestor
139461689|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
139461690|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139461691|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139461692|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139461693|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
139461694|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461695|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461696|NCT02541903|Afatinib|afatinib|mesh-list
139461697|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461698|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139461699|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461700|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461701|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139461702|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139461703|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139461704|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461705|NCT05455047|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139461706|NCT05455047|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139461707|NCT05455047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461708|NCT02688647|Belumosudil|belumosudil|mesh-list
139461709|NCT02688647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139461710|NCT02688647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120201|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
139461711|NCT02688647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461712|NCT05453799|Antibodies|antibodies|mesh-list
139461713|NCT05453799|Immunoglobulins|immunoglobulins|mesh-list
139461714|NCT05453799|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139461715|NCT05453799|Immunologic Factors|immunologic factors|mesh-ancestor
139461716|NCT05453799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461717|NCT05453487|Vaccines|vaccines|mesh-list
139461718|NCT05453487|Immunologic Factors|immunologic factors|mesh-ancestor
139461719|NCT05453487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461720|NCT05431725|Vaccines|vaccines|mesh-list
139461721|NCT05431725|Immunologic Factors|immunologic factors|mesh-ancestor
139461722|NCT05431725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461723|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139461724|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139461725|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
139461726|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139461727|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461728|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139461729|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139461730|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139461731|NCT05451615|Abatacept|abatacept|mesh-list
139461732|NCT05451615|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139461733|NCT05451615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139461734|NCT05451615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461735|NCT05451615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461736|NCT05451615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461737|NCT05451615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139461738|NCT05451615|Immunologic Factors|immunologic factors|mesh-ancestor
139461739|NCT05451615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461740|NCT05451615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461741|NCT05451615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139461742|NCT05451615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461743|NCT02534883|Misoprostol|misoprostol|mesh-list
139461744|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139461745|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
139461746|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139461747|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461748|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139461749|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139461750|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
139461751|NCT05626439|Alprazolam|alprazolam|mesh-list
139461752|NCT05626439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139461753|NCT05626439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461754|NCT05626439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461755|NCT05626439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139461756|NCT05626439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139461757|NCT05626439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139461758|NCT05626439|GABA Modulators|gaba modulators|mesh-ancestor
139461759|NCT05626439|GABA Agents|gaba agents|mesh-ancestor
139461760|NCT05626439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461761|NCT05626439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461762|NCT05430009|Pembrolizumab|pembrolizumab|mesh-list
139461763|NCT05430009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461764|NCT05430009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461765|NCT05430009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139461766|NCT05430009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461767|NCT05429697|Pembrolizumab|pembrolizumab|mesh-list
139461768|NCT05429697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461769|NCT05429697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461770|NCT05429697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139461771|NCT05429697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461772|NCT02540265|Meloxicam|meloxicam|mesh-list
139461773|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139461774|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139461775|NCT02540265|Analgesics|analgesics|mesh-ancestor
139461776|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
139461777|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461778|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461779|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139461780|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461781|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139461782|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139461783|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461784|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461785|NCT02684357|Ustekinumab|ustekinumab|mesh-list
139461786|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139461787|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
139461788|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
139461789|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461790|NCT03115073|Clotrimazole|clotrimazole|mesh-list
139461791|NCT03115073|Miconazole|miconazole|mesh-list
139461792|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139461793|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461794|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
139461795|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139461796|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139461797|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461798|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461799|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139461800|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
139461801|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139461802|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461803|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139461804|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139248506|NCT02099240|Colistin|colistin|mesh-list
139461805|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
139461806|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139461807|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461808|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
139461809|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
139461810|NCT03165929|Analgesics|analgesics|mesh-ancestor
139461811|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
139461812|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461813|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461814|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139461815|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139461816|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139461817|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461818|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139461819|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461820|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461821|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139461822|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139461823|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139461824|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
139461825|NCT02546193|Misoprostol|misoprostol|mesh-list
139461826|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139461827|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
139461828|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139461829|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461830|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139461831|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139461832|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
139461833|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
139461834|NCT01661595|Tadalafil|tadalafil|mesh-list
139461835|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
139461836|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139461837|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139461838|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461839|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461840|NCT01661595|Urological Agents|urological agents|mesh-ancestor
139461841|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
139461842|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139461843|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461844|NCT02957097|Gabapentin|gabapentin|mesh-list
139461845|NCT02957097|Analgesics|analgesics|mesh-ancestor
139461846|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
139461847|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461848|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461849|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
139461850|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139461851|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139461852|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461853|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139461854|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139461855|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139461856|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461857|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461858|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
139461859|NCT03165383|Morphine|morphine|mesh-list
139461860|NCT03165383|Bupivacaine|bupivacaine|mesh-list
139461861|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
139461862|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
139461863|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461864|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461865|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
139461866|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461867|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139461868|NCT03165383|Narcotics|narcotics|mesh-ancestor
139461869|NCT03165383|Analgesics|analgesics|mesh-ancestor
139461870|NCT03162185|Escitalopram|escitalopram|mesh-list
139461871|NCT03162185|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139461872|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139461873|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139461874|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461875|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461876|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
139461877|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461878|NCT02678351|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139461879|NCT02678351|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139461880|NCT02678351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461881|NCT05286437|Pembrolizumab|pembrolizumab|mesh-list
139461882|NCT05286437|Letrozole|letrozole|mesh-list
139461883|NCT05286437|Lenvatinib|lenvatinib|mesh-list
139461884|NCT05286437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461885|NCT05286437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461886|NCT05286437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139461887|NCT05286437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461888|NCT05286437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139461889|NCT05286437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139461890|NCT05286437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461891|NCT05286437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139461892|NCT05286437|Hormone Antagonists|hormone antagonists|mesh-ancestor
139461893|NCT05286437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139461894|NCT05286437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461895|NCT05286437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139461896|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139461897|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139461898|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461899|NCT02683187|Incretins|incretins|mesh-ancestor
139461900|NCT02683187|Hormones|hormones|mesh-ancestor
139461901|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139461902|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139461903|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
139461904|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461905|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461906|NCT05515601|Mirikizumab|mirikizumab|mesh-list
139461907|NCT05515601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139461908|NCT05515601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139461909|NCT05515601|Analgesics|analgesics|mesh-ancestor
139461910|NCT05515601|Sensory System Agents|sensory system agents|mesh-ancestor
139461911|NCT05515601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461912|NCT05515601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461913|NCT05515601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139461914|NCT05515601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461915|NCT05515601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139461916|NCT05515601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139461917|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
139461918|NCT02683109|Olodaterol|olodaterol|mesh-list
139461919|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139461920|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
139461921|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461922|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461923|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139461924|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
139461925|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
139461926|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139461927|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
139461928|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461929|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461930|NCT02544321|Bromocriptine|bromocriptine|mesh-list
139461931|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139461932|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139461933|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
139461934|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139461935|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461936|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
139461937|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
139461938|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139461939|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461940|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
139461941|NCT02533401|Rituximab|rituximab|mesh-list
139461942|NCT02533401|Fludarabine|fludarabine|mesh-list
139461943|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139461944|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
139461945|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461946|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461947|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139461948|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
139461949|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461950|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461951|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139248673|NCT05215743|Expectorants|expectorants|mesh-ancestor
139461955|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461957|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139461958|NCT02680847|Naltrexone|naltrexone|mesh-list
139461959|NCT02680847|Oxycodone|oxycodone|mesh-list
139461960|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139461961|NCT02680847|Narcotics|narcotics|mesh-ancestor
139461962|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139461963|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461964|NCT02680847|Analgesics|analgesics|mesh-ancestor
139461965|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
139461966|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139461967|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139461968|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139461969|NCT02532855|Metformin|metformin|mesh-list
139461970|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
139461971|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139461972|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139461973|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461974|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139461975|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461976|NCT02532855|Incretins|incretins|mesh-ancestor
139461977|NCT02532855|Hormones|hormones|mesh-ancestor
139461978|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139461979|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139461980|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
139461981|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139461982|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
139461983|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
139461984|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139461985|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
139461986|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139461987|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139461988|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139461989|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
139461990|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139461991|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139461992|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139461993|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461994|NCT04262427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139461995|NCT02530125|Pidilizumab|pidilizumab|mesh-list
139461996|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139461997|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462001|NCT05421819|Calcium, Dietary|calcium, dietary|mesh-list
139462002|NCT05421819|Vitamin D|vitamin d|mesh-list
139462003|NCT05421819|Ergocalciferols|ergocalciferols|mesh-list
139462004|NCT05421819|Cholecalciferol|cholecalciferol|mesh-list
139462005|NCT05421819|Vitamins|vitamins|mesh-list
139462006|NCT05421819|Calcium|calcium|mesh-list
139462007|NCT05421819|Micronutrients|micronutrients|mesh-ancestor
139462008|NCT05421819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462009|NCT05421819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139462010|NCT05421819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139462011|NCT02055820|Prednisone|prednisone|mesh-list
139462012|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
139462013|NCT02055820|Rituximab|rituximab|mesh-list
139462014|NCT02055820|Doxorubicin|doxorubicin|mesh-list
139462015|NCT02055820|Vincristine|vincristine|mesh-list
139462016|NCT02055820|Venetoclax|venetoclax|mesh-list
139462017|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
139462018|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139462019|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
139462020|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462021|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139462022|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139462023|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
139462024|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462025|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462026|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139462027|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139462028|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139462029|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139462030|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139462031|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462032|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139462033|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
139462034|NCT02055820|Hormones|hormones|mesh-ancestor
139462035|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462036|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139462037|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139462038|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
139462039|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
139462040|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
139462041|NCT02055352|Fluticasone|fluticasone|mesh-list
139462042|NCT02055352|Budesonide|budesonide|mesh-list
139462043|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139462044|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139462045|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139462046|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
139462047|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462048|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462049|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139462050|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
139462051|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
139462052|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139462053|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
139462054|NCT02055352|Hormones|hormones|mesh-ancestor
139462055|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462056|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139462057|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139462058|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139462059|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
139462060|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462061|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462062|NCT02034916|Talazoparib|talazoparib|mesh-list
139462063|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139462064|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462065|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462066|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462067|NCT01374425|Leucovorin|leucovorin|mesh-list
139462068|NCT01374425|Bevacizumab|bevacizumab|mesh-list
139462069|NCT01374425|Capecitabine|capecitabine|mesh-list
139462070|NCT01374425|Fluorouracil|fluorouracil|mesh-list
139462071|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
139462072|NCT01374425|Irinotecan|irinotecan|mesh-list
139462073|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139462074|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462075|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139462076|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139462077|NCT01374425|Growth Substances|growth substances|mesh-ancestor
139462078|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462079|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
139462080|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139462081|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
139462082|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462083|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139462084|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
139462085|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139462086|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139462087|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462088|NCT01374425|Antidotes|antidotes|mesh-ancestor
139462089|NCT01374425|Protective Agents|protective agents|mesh-ancestor
139462090|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
139462091|NCT01374425|Vitamins|vitamins|mesh-ancestor
139462092|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
139462093|NCT02085460|Rebamipide|rebamipide|mesh-list
139462094|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139462095|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139462096|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
139462097|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462098|NCT02085460|Protective Agents|protective agents|mesh-ancestor
139462099|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462100|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462101|NCT03164291|Rifabutin|rifabutin|mesh-list
139462102|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139462103|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462104|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139462105|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
139462106|NCT02084134|Dexamethasone|dexamethasone|mesh-list
139462107|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
139462108|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
139462109|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139462110|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139462111|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139462112|NCT02084134|BB 1101|bb 1101|mesh-list
139462113|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139462114|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
139462115|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
139462116|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462117|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462118|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139462119|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
139462120|NCT02084134|Hormones|hormones|mesh-ancestor
139462121|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462122|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139462123|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462124|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
139462125|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462126|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462127|NCT01374269|Acetaminophen|acetaminophen|mesh-list
139462128|NCT01374269|Celecoxib|celecoxib|mesh-list
139462129|NCT01374269|Naproxen|naproxen|mesh-list
139462130|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139462131|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139462132|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139462133|NCT01374269|Analgesics|analgesics|mesh-ancestor
139462134|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
139462135|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462136|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462137|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
139462138|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139462139|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139462140|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139462141|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462142|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462143|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
139462144|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139462145|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139462146|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462147|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
139462148|NCT03163589|Hematinics|hematinics|mesh-ancestor
139462149|NCT03163277|Emtricitabine|emtricitabine|mesh-list
139462150|NCT03163277|Maraviroc|maraviroc|mesh-list
139462151|NCT03163277|Darunavir|darunavir|mesh-list
139462152|NCT03163277|Cobicistat|cobicistat|mesh-list
139462153|NCT03163277|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139462154|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
139462155|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462156|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139462157|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139462158|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462159|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462160|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139462161|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139462162|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139462163|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139462164|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139462165|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139462166|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139462167|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
139462168|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139462169|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139462170|NCT05419817|Pembrolizumab|pembrolizumab|mesh-list
139462171|NCT05419817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139462172|NCT05419817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462173|NCT05419817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139462174|NCT05419817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462175|NCT05392205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139462176|NCT05392205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139462177|NCT05392205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462178|NCT02679755|Letrozole|letrozole|mesh-list
139462179|NCT02679755|Palbociclib|palbociclib|mesh-list
139462180|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462181|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139462182|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139462183|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462184|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462185|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139462186|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
139462187|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462188|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462189|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139462190|NCT03163121|Vaccines|vaccines|mesh-list
139462191|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
139462192|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462193|NCT03114371|Oxytocin|oxytocin|mesh-list
139462194|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
139462195|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139462196|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462197|NCT03114215|Biotin|biotin|mesh-list
139462198|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
139462199|NCT03114215|Vitamins|vitamins|mesh-ancestor
139462200|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
139462201|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462202|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139462203|NCT04205903|Paclitaxel|paclitaxel|mesh-list
139462204|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139462205|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139462206|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462207|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
139462208|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
139462209|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
139462210|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462211|NCT02670551|Cariprazine|cariprazine|mesh-list
139462212|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139462213|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139462214|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139462215|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462216|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139462217|NCT01430351|Metformin|metformin|mesh-list
139462218|NCT01430351|Mefloquine|mefloquine|mesh-list
139462219|NCT01430351|Temozolomide|temozolomide|mesh-list
139462220|NCT01430351|Memantine|memantine|mesh-list
139462221|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139462222|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462223|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139462224|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
139462225|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462226|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462227|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139462228|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139462229|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
139462230|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462231|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139462232|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139462233|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
139462234|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139462235|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139462236|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462237|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
139462238|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139462239|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462240|NCT00893399|Immunotoxins|immunotoxins|mesh-ancestor
139462241|NCT00893399|Immunoconjugates|immunoconjugates|mesh-ancestor
139462242|NCT00893399|Immunologic Factors|immunologic factors|mesh-ancestor
139462243|NCT00893399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462244|NCT05675033|Bevacizumab|bevacizumab|mesh-list
139462245|NCT05675033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139462246|NCT05675033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462247|NCT05675033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139462248|NCT05675033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139462249|NCT05675033|Growth Substances|growth substances|mesh-ancestor
139462250|NCT05675033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462251|NCT05675033|Growth Inhibitors|growth inhibitors|mesh-ancestor
139462252|NCT04479527|Apatinib|apatinib|mesh-list
139462253|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462254|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139462255|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462256|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462257|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139462258|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
139462259|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
139462260|NCT02391077|Povidone|povidone|mesh-list
139462261|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462262|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139462263|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
139462264|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
139462265|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
139462266|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139462267|NCT02390921|Hematinics|hematinics|mesh-ancestor
139462268|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
139462269|NCT02390843|Topotecan|topotecan|mesh-list
139462270|NCT02390843|Simvastatin|simvastatin|mesh-list
139462271|NCT02390843|Lenograstim|lenograstim|mesh-list
139462272|NCT02390843|Mitogens|mitogens|mesh-list
139462273|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139462274|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
139462275|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462276|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139462277|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139462278|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
139462279|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462280|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462281|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139462282|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139462283|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139462284|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
139462285|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139462286|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139462287|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462288|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139462289|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139462290|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
139462291|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139462292|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139462293|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139462294|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139462295|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
139462296|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462297|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139462298|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139462299|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462300|NCT03806309|Leucovorin|leucovorin|mesh-list
139462301|NCT03806309|Fluorouracil|fluorouracil|mesh-list
139462302|NCT03806309|Irinotecan|irinotecan|mesh-list
139462303|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
139385418|NCT05614934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462304|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462305|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139462306|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462307|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139462308|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
139462309|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462310|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139462311|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139462312|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462313|NCT03806309|Antidotes|antidotes|mesh-ancestor
139462314|NCT03806309|Protective Agents|protective agents|mesh-ancestor
139462315|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
139462316|NCT03806309|Vitamins|vitamins|mesh-ancestor
139462317|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
139462318|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
139462319|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139462320|NCT03489629|Minocycline|minocycline|mesh-list
139462321|NCT03489629|Trimethoprim|trimethoprim|mesh-list
139462322|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
139462323|NCT03489629|Mupirocin|mupirocin|mesh-list
139462324|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139462325|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139462326|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462327|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
139462328|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
139462329|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139462330|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139462331|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
139462332|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139462333|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139462334|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139462335|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462336|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462337|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139462338|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139462339|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139462340|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139462341|NCT02389751|Paclitaxel|paclitaxel|mesh-list
139462342|NCT02389751|Carboplatin|carboplatin|mesh-list
139462343|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139462344|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139462345|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462346|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
139462347|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
139462348|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
139462349|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462350|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
139462351|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139462352|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
139462353|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462354|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139462355|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139462356|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
139462357|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462358|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462359|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139462360|NCT02388035|Cefotaxime|cefotaxime|mesh-list
139462361|NCT02388035|Cefoxitin|cefoxitin|mesh-list
139462362|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139462363|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462364|NCT02389439|Artesunate|artesunate|mesh-list
139462365|NCT02389439|Pyronaridine|pyronaridine|mesh-list
139462366|NCT02389439|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139462367|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
139462368|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139462369|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139462370|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462371|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462372|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
139462373|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
139462374|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139462375|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
139462376|NCT02663687|Complement C1s|complement c1s|mesh-list
139462377|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139462378|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
139042257|NCT03872843|Ibuprofen|ibuprofen|mesh-list
139462379|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
139462380|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462381|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139462382|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139462383|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139462384|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139462385|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139462386|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139462387|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
139462388|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139462389|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139462390|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462391|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
139462392|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462393|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462394|NCT02388581|Amoxicillin|amoxicillin|mesh-list
139462395|NCT02388581|Metronidazole|metronidazole|mesh-list
139462396|NCT02388581|Clarithromycin|clarithromycin|mesh-list
139462397|NCT02388581|Lansoprazole|lansoprazole|mesh-list
139462398|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
139462399|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139462400|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462401|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139462402|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139462403|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139462404|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462405|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462406|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139462407|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139462409|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139462410|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139462411|NCT02387567|Lidocaine|lidocaine|mesh-list
139462412|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
139462413|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
139462414|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139462415|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462416|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
139462417|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462418|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139462419|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139462420|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139462421|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139462422|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462423|NCT02383121|Midodrine|midodrine|mesh-list
139462424|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
139462425|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
139462426|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462427|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462428|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139462429|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139462430|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139462431|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139462432|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
139462433|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462434|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462435|NCT02387021|Ropivacaine|ropivacaine|mesh-list
139462436|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
139462437|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
139462438|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139462439|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462440|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
139462441|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462442|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139462443|NCT02386943|Saxagliptin|saxagliptin|mesh-list
139462444|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139462445|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462446|NCT02386943|Incretins|incretins|mesh-ancestor
139462447|NCT02386943|Hormones|hormones|mesh-ancestor
139462448|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462449|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139462450|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
139462451|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462452|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462453|NCT02084056|Metformin|metformin|mesh-list
139462454|NCT02084056|Linagliptin|linagliptin|mesh-list
139462455|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139462456|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462457|NCT02084056|Incretins|incretins|mesh-ancestor
139462458|NCT02084056|Hormones|hormones|mesh-ancestor
139462459|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462460|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139462461|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
139462462|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462463|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462464|NCT04787471|Riboflavin|riboflavin|mesh-list
139462465|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
139462466|NCT04787471|Vitamins|vitamins|mesh-ancestor
139462467|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
139462468|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462469|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139462470|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
139462471|NCT02386397|Gemcitabine|gemcitabine|mesh-list
139462472|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
139462473|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139462474|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
139462475|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462476|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462477|NCT02386475|Dexetimide|dexetimide|mesh-list
139462478|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139462479|NCT02386475|Citalopram|citalopram|mesh-list
139462480|NCT02386475|Escitalopram|escitalopram|mesh-list
139462481|NCT02386475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139462482|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139462483|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139462484|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462485|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462486|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
139462487|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462488|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139462489|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
139462490|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139462491|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139462492|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139462493|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
139462494|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
139462495|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462496|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139462497|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139462498|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
139462499|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139462500|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
139462501|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
139462502|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
139462503|NCT02382653|Piroxicam|piroxicam|mesh-list
139462504|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139462505|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139462506|NCT02382653|Analgesics|analgesics|mesh-ancestor
139462507|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
139462508|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462509|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462510|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139462511|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139462512|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139462513|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462514|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462515|NCT02382263|Paclitaxel|paclitaxel|mesh-list
139462516|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139462517|NCT02382263|Gemcitabine|gemcitabine|mesh-list
139462518|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139462519|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462520|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
139462521|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
139462522|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
139462523|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462524|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139462525|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
139462526|NCT02382029|Clonazepam|clonazepam|mesh-list
139462527|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
139462528|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
139462529|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
139462530|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462531|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462532|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462533|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
139462534|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
139462535|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
139462536|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139462537|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462538|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
139462539|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462540|NCT02385461|Heparin|heparin|mesh-list
139462541|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139462542|NCT02385461|Tinzaparin|tinzaparin|mesh-list
139462543|NCT02385461|Dalteparin|dalteparin|mesh-list
139462544|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
139462545|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139462546|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139462547|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462548|NCT02381717|Morphine|morphine|mesh-list
139462549|NCT02381717|Bupivacaine|bupivacaine|mesh-list
139462550|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
139462551|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
139462552|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139462553|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462554|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
139462555|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462556|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139249284|NCT01845649|Estradiol|estradiol|mesh-list
139462558|NCT02381717|Analgesics|analgesics|mesh-ancestor
139462559|NCT02385305|Anesthetics|anesthetics|mesh-list
139462560|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139462561|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462562|NCT02385227|Nicotine|nicotine|mesh-list
139462563|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139462564|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
139462565|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462566|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462567|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139462568|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139462569|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
139462570|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462571|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462572|NCT02385071|Simeprevir|simeprevir|mesh-list
139462573|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
139462574|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462575|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
139462576|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462577|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462578|NCT02384915|Prilocaine|prilocaine|mesh-list
139462579|NCT02384915|Mepivacaine|mepivacaine|mesh-list
139462580|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
139462581|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139462582|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462583|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
139462584|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
139462585|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462586|NCT02384837|Sirolimus|sirolimus|mesh-list
139462587|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139462588|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462589|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139462590|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462591|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
139462592|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139462593|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
139462594|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462595|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
139462596|NCT03105791|Narcotics|narcotics|mesh-ancestor
139462597|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139462598|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462599|NCT03105791|Analgesics|analgesics|mesh-ancestor
139462600|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
139462601|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462602|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
139462603|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139462604|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139462605|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462606|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
139462607|NCT02384135|Coagulants|coagulants|mesh-ancestor
139462608|NCT02380625|Azithromycin|azithromycin|mesh-list
139462609|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139462610|NCT02380625|Sunitinib|sunitinib|mesh-list
139462611|NCT02380625|Irbesartan|irbesartan|mesh-list
139462612|NCT02380625|Atorvastatin|atorvastatin|mesh-list
139462613|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139462614|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139462615|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
139462616|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462617|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139462618|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139462619|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462620|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462621|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139462622|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139462623|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462624|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139462625|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139462626|NCT02380625|Growth Substances|growth substances|mesh-ancestor
139462627|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462628|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
139462629|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139462630|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139462631|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139462632|NCT02380313|Prednisone|prednisone|mesh-list
139462633|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139462634|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
139462635|NCT02380313|Hormones|hormones|mesh-ancestor
139462636|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462637|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462638|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139462639|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462640|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139462641|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139462642|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462643|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139462644|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
139462645|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462646|NCT02383901|Methotrexate|methotrexate|mesh-list
139462647|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139462648|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
139462649|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139462650|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462651|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139462652|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
139462653|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462654|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462655|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
139462656|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462657|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139462658|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139462659|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
139462660|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139462661|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139462662|NCT02383823|Estradiol|estradiol|mesh-list
139462663|NCT02383823|Estrogens|estrogens|mesh-list
139462664|NCT02383823|Hormones|hormones|mesh-ancestor
139462665|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462666|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462667|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139462668|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139462669|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139462670|NCT02380001|Analgesics|analgesics|mesh-ancestor
139462671|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
139462672|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462673|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462674|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139462675|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139462676|NCT02379767|Harmine|harmine|mesh-list
139462677|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
139462678|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462679|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139462680|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139462681|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462682|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462683|NCT02661815|Paclitaxel|paclitaxel|mesh-list
139462684|NCT02661815|Bevacizumab|bevacizumab|mesh-list
139462685|NCT02661815|Ricolinostat|ricolinostat|mesh-list
139462686|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139462687|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462688|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
139462689|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
139462690|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
139462691|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462692|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139462693|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139462694|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139462695|NCT02661815|Growth Substances|growth substances|mesh-ancestor
139462696|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462697|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
139462698|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139462699|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462700|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
139462701|NCT02377193|Tacrolimus|tacrolimus|mesh-list
139462702|NCT02377193|Basiliximab|basiliximab|mesh-list
139462703|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139462704|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
139462705|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249430|NCT03553628|Propolis|propolis|mesh-list
139462706|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139462707|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462708|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462709|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139462710|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462711|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139462712|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
139462713|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139462714|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462715|NCT04688021|Cytarabine|cytarabine|mesh-list
139462716|NCT04688021|Cyclosporine|cyclosporine|mesh-list
139462717|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
139462718|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
139462719|NCT04688021|Busulfan|busulfan|mesh-list
139462720|NCT04688021|Cyclosporins|cyclosporins|mesh-list
139462721|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139462722|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
139462723|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139462724|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
139462725|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462726|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139462727|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139462728|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
139462729|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462730|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462731|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139462732|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139462733|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
139462734|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
139462735|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462736|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462737|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
139462738|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
139462739|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139462740|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139462741|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139462742|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
139462743|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139462744|NCT02053246|Nebivolol|nebivolol|mesh-list
139462745|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139462746|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
139462747|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139462748|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139462749|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139462750|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
139462751|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462752|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462753|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462754|NCT04678661|Insulin|insulin|mesh-list
139462755|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139462756|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462757|NCT02379299|Hormones|hormones|mesh-list
139462758|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462759|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462760|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
139462761|NCT02376881|Hematinics|hematinics|mesh-ancestor
139462762|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
139462763|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
139462764|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462765|NCT02376803|Warfarin|warfarin|mesh-list
139462766|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
139462767|NCT04132427|Vancomycin|vancomycin|mesh-list
139462768|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
139462769|NCT04132427|Citric Acid|citric acid|mesh-list
139462770|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
139462771|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
139462772|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139462773|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
139462774|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
139462775|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462776|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139462777|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462778|NCT04132427|Cathartics|cathartics|mesh-ancestor
139462779|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139249508|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139462780|NCT02031640|Beclomethasone|beclomethasone|mesh-list
139462781|NCT02031640|Albuterol|albuterol|mesh-list
139462782|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
139462783|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
139462784|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462785|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462786|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139462787|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
139462788|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
139462789|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139462790|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139462791|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139462792|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139462793|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
139462794|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462795|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462796|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139462797|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
139462798|NCT02031640|Hormones|hormones|mesh-ancestor
139462799|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462800|NCT02376413|Trastuzumab|trastuzumab|mesh-list
139462801|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139462802|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462803|NCT02378441|Metformin|metformin|mesh-list
139462804|NCT02378441|Atorvastatin|atorvastatin|mesh-list
139462805|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139462806|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462807|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139462808|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139462809|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
139462810|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462811|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139462812|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139462813|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462814|NCT04600427|Anesthetics|anesthetics|mesh-list
139462815|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139462816|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462817|NCT02378129|Methamphetamine|methamphetamine|mesh-list
139462818|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139462819|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385425|NCT02135393|Vitamins|vitamins|mesh-ancestor
139462820|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
139462821|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
139462822|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462823|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
139462824|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462825|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462826|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
139462827|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139462828|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139462829|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139462830|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139462831|NCT02376335|Rituximab|rituximab|mesh-list
139462832|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139462833|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462834|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
139462835|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462836|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139462837|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
139462838|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139462839|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139462840|NCT02375867|Prednisolone|prednisolone|mesh-list
139462841|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
139462842|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139462843|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
139462844|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139462845|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
139462846|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
139462847|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462848|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462849|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139462850|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
139462851|NCT02375867|Hormones|hormones|mesh-ancestor
139462852|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462853|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139462854|NCT02375867|Protective Agents|protective agents|mesh-ancestor
139462855|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139462856|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462857|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
139462859|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139462860|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462861|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139462862|NCT02375243|Analgesics|analgesics|mesh-ancestor
139462863|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
139462864|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462865|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139462866|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139462867|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139462868|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
139462869|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462870|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462871|NCT02374931|Estradiol|estradiol|mesh-list
139462872|NCT02374931|Estrogens|estrogens|mesh-ancestor
139462873|NCT02374931|Hormones|hormones|mesh-ancestor
139462874|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462875|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462876|NCT02377661|Amlodipine|amlodipine|mesh-list
139462877|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139462878|NCT02377661|Olmesartan|olmesartan|mesh-list
139462879|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139462880|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139462881|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139462882|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139462883|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462884|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139462885|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462886|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
139462887|NCT02377661|Diuretics|diuretics|mesh-ancestor
139462888|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
139462889|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139462890|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139462891|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139462892|NCT02372357|Posaconazole|posaconazole|mesh-list
139462893|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
139462894|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462895|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139462896|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139462897|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139462898|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139462899|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139462900|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462901|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462902|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139462903|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
139462904|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462905|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462906|NCT02371577|Lenalidomide|lenalidomide|mesh-list
139462907|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
139462908|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462909|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139462910|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139462911|NCT02371577|Growth Substances|growth substances|mesh-ancestor
139462912|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
139462913|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462914|NCT02373449|Ketamine|ketamine|mesh-list
139462915|NCT02373449|Analgesics|analgesics|mesh-ancestor
139462916|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
139462917|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462918|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462919|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139462920|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139462921|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
139462922|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
139462923|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139462924|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139462925|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139462926|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462927|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462928|NCT02371421|Allopurinol|allopurinol|mesh-list
139462929|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
139462930|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462931|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462932|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
139462933|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139462934|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139462935|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
139462936|NCT02371421|Protective Agents|protective agents|mesh-ancestor
139462937|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462938|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
139462939|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
139462940|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462941|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462942|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462944|NCT03959891|Fulvestrant|fulvestrant|mesh-list
139462945|NCT03959891|Palbociclib|palbociclib|mesh-list
139462946|NCT03959891|Ipatasertib|ipatasertib|mesh-list
139462947|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139462948|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139462949|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139462950|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139462951|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462952|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139462953|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
139462954|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462955|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462956|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139462957|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139462958|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139462959|NCT02373215|Nalbuphine|nalbuphine|mesh-list
139462960|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139462961|NCT02373215|Narcotics|narcotics|mesh-ancestor
139462962|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139462963|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462964|NCT02373215|Analgesics|analgesics|mesh-ancestor
139462965|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
139462966|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462967|NCT02372903|Palmidrol|palmidrol|mesh-list
139462968|NCT02372903|Analgesics|analgesics|mesh-ancestor
139462969|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
139462970|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462971|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462972|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139462973|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139462974|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139462975|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139462976|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
139462977|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139462978|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139462979|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139462980|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139462981|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462982|NCT02372903|Hormones|hormones|mesh-ancestor
139462983|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139462984|NCT02372591|Buprenorphine|buprenorphine|mesh-list
139462985|NCT02372591|Hydromorphone|hydromorphone|mesh-list
139462986|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139462987|NCT02372591|Narcotics|narcotics|mesh-ancestor
139462988|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139462989|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139462990|NCT02372591|Analgesics|analgesics|mesh-ancestor
139462991|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
139462992|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139462993|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139462994|NCT02372669|Chitosan|chitosan|mesh-list
139462995|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139462996|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139462997|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
139462998|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139462999|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139463000|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
139463001|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
139463002|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
139463003|NCT02372669|Coagulants|coagulants|mesh-ancestor
139249727|NCT01319929|Hormones|hormones|mesh-ancestor
139463004|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139463005|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
139463006|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139463007|NCT02369939|Fluorouracil|fluorouracil|mesh-list
139463009|NCT02369939|Mitomycin|mitomycin|mesh-list
139463010|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
139463011|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463012|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139463013|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463014|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139463015|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
139463016|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463017|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139463018|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
139463019|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139463020|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463021|NCT02369549|Curcumin|curcumin|mesh-list
139463022|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139463023|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139463024|NCT02369549|Analgesics|analgesics|mesh-ancestor
139463025|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
139463026|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463027|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463028|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139463029|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463030|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463031|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463032|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463033|NCT02365415|Sirolimus|sirolimus|mesh-list
139463034|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139463035|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463036|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139463037|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463038|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
139463039|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139463040|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
139463041|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463042|NCT02369081|Bisoprolol|bisoprolol|mesh-list
139463043|NCT02369081|Doxazosin|doxazosin|mesh-list
139463044|NCT02369081|Spironolactone|spironolactone|mesh-list
139463045|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139463046|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
139463047|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139463048|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463049|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139463050|NCT02369081|Diuretics|diuretics|mesh-ancestor
139463051|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
139463052|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139463053|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
139463054|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
139463055|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463056|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139463057|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139463058|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139463059|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
139463060|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463061|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463062|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139463063|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139463064|NCT02365493|Cefazolin|cefazolin|mesh-list
139463065|NCT02365493|Lactams|lactams|mesh-list
139463066|NCT02365493|beta-Lactams|beta-lactams|mesh-list
139463067|NCT02365493|Floxacillin|floxacillin|mesh-list
139463068|NCT02365493|Cloxacillin|cloxacillin|mesh-list
139463069|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139463070|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463071|NCT02365181|Ropivacaine|ropivacaine|mesh-list
139463072|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
139463073|NCT02365181|Anesthetics|anesthetics|mesh-list
139463074|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139463075|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463076|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
139463077|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463078|NCT05653895|Metformin|metformin|mesh-list
139463079|NCT05653895|Resveratrol|resveratrol|mesh-list
139463080|NCT05653895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139463081|NCT05653895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463082|NCT05653895|Antioxidants|antioxidants|mesh-ancestor
139463083|NCT05653895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463084|NCT05653895|Protective Agents|protective agents|mesh-ancestor
139463085|NCT05653895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463086|NCT05653895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139463087|NCT02364479|Etanercept|etanercept|mesh-list
139463088|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139463089|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139463090|NCT02364479|Analgesics|analgesics|mesh-ancestor
139463091|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
139463092|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463093|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463094|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139463095|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463096|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139463097|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139463098|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
139463099|NCT05653817|Paclitaxel|paclitaxel|mesh-list
139463100|NCT05653817|Apatinib|apatinib|mesh-list
139463101|NCT05653817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139463102|NCT05653817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139463103|NCT05653817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463104|NCT05653817|Tubulin Modulators|tubulin modulators|mesh-ancestor
139463105|NCT05653817|Antimitotic Agents|antimitotic agents|mesh-ancestor
139463106|NCT05653817|Mitosis Modulators|mitosis modulators|mesh-ancestor
139463107|NCT05653817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463108|NCT05653817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139463109|NCT05653817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463110|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
139463111|NCT02052310|Hematinics|hematinics|mesh-ancestor
139463112|NCT02368379|Metyrapone|metyrapone|mesh-list
139463113|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
139463114|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463115|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463116|NCT02051296|Minocycline|minocycline|mesh-list
139463117|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139463118|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463119|NCT02367755|Lorazepam|lorazepam|mesh-list
139463120|NCT02367755|Propofol|propofol|mesh-list
139463121|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139463122|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139463123|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463124|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139463125|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
139463126|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
139463127|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
139463128|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
139463129|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
139463130|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463131|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139463132|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139463133|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139463134|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139463135|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
139463136|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
139463137|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463138|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463139|NCT02363699|Lidocaine|lidocaine|mesh-list
139463140|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
139463141|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
139463142|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139463143|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463144|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
139463145|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463146|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139463147|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139463148|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139463149|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139463150|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463151|NCT02049814|Metformin|metformin|mesh-list
139463152|NCT02049814|Acarbose|acarbose|mesh-list
139463153|NCT02049814|Voglibose|voglibose|mesh-list
139463154|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139463155|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463156|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139463157|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463158|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463159|NCT03344159|Spironolactone|spironolactone|mesh-list
139463160|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139463161|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
139463162|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139463163|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463164|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139463165|NCT03344159|Diuretics|diuretics|mesh-ancestor
139463166|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
139463167|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
139463168|NCT03324113|Promethazine|promethazine|mesh-list
139463169|NCT03324113|Dexamethasone|dexamethasone|mesh-list
139463170|NCT03324113|Naphazoline|naphazoline|mesh-list
139463171|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139463172|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139463173|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
139463174|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
139463175|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463176|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463177|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139463178|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
139463179|NCT03324113|Hormones|hormones|mesh-ancestor
139463180|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139463181|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139463182|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463183|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139463184|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139463185|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139463186|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139463187|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
139463188|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
139463189|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
139463190|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139463191|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
139463192|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
139463193|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121675|NCT03643952|Daptomycin|daptomycin|mesh-list
139463194|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463195|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139463196|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
139463197|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
139463198|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139463199|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139463200|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
139463201|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
139463202|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139463203|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
139463204|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
139463205|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139463206|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139463207|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463208|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139463209|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
139463210|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139463211|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463212|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139463213|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139463214|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139463215|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463216|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
139463217|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463218|NCT02367053|Glucagon|glucagon|mesh-list
139463219|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139463220|NCT02367053|Hormones|hormones|mesh-ancestor
139463221|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139463222|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463223|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139463224|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139463225|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139463226|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
139463227|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463228|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139463229|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139463230|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463231|NCT02366975|Testosterone|testosterone|mesh-list
139463232|NCT02366975|Androgens|androgens|mesh-ancestor
139463233|NCT02366975|Hormones|hormones|mesh-ancestor
139463234|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139463235|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463236|NCT04479371|Bupivacaine|bupivacaine|mesh-list
139463237|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
139463238|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
139463239|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139463240|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463241|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
139463242|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463243|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
139463244|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139463245|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
139463246|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139463247|NCT02366585|Cyclosporine|cyclosporine|mesh-list
139463248|NCT02366585|Cyclosporins|cyclosporins|mesh-list
139463249|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463250|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463251|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139463252|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
139463253|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463254|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
139463255|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463256|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
139463257|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463258|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139463259|NCT02079532|Rituximab|rituximab|mesh-list
139463260|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139463261|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463262|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
139463263|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463264|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463265|NCT02958917|Pirfenidone|pirfenidone|mesh-list
139463266|NCT02958917|Analgesics|analgesics|mesh-ancestor
139463267|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
139463268|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463269|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463270|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139463271|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139463272|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139463273|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463274|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463275|NCT02362529|Minocycline|minocycline|mesh-list
139463276|NCT02362529|Celecoxib|celecoxib|mesh-list
139463277|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139463278|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139463279|NCT02362529|Analgesics|analgesics|mesh-ancestor
139463280|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
139463281|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463282|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463283|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139463284|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463285|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139463286|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139463287|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463288|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463289|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139463290|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463291|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
139463292|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139463293|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139463294|NCT02769689|Prednisolone|prednisolone|mesh-list
139463295|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
139463296|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139463297|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
139463298|NCT02769689|Natalizumab|natalizumab|mesh-list
139463299|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139463300|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
139463301|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
139463302|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463303|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463304|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139463305|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
139463307|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139463308|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139463309|NCT02769689|Protective Agents|protective agents|mesh-ancestor
139463310|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139463311|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463312|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
139463313|NCT02365571|Itraconazole|itraconazole|mesh-list
139463314|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
139463315|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463316|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139463317|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139463318|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463319|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463320|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139463321|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
139463322|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139463323|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463324|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139463325|NCT02365727|Clonidine|clonidine|mesh-list
139463326|NCT02365727|Epinephrine|epinephrine|mesh-list
139463327|NCT02365727|Bupivacaine|bupivacaine|mesh-list
139463328|NCT02365727|Ropivacaine|ropivacaine|mesh-list
139463329|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
139463330|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
139463331|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139463332|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463333|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
139463334|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463335|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139463336|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139463337|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
139463338|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463339|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463340|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139463341|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139463342|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
139463343|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139463344|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
139463345|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
139463346|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
139463347|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139463348|NCT02365727|Analgesics|analgesics|mesh-ancestor
139463349|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139463350|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
139463351|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139463352|NCT02365805|Paclitaxel|paclitaxel|mesh-list
139463353|NCT02365805|Docetaxel|docetaxel|mesh-list
139463354|NCT02365805|Fluorouracil|fluorouracil|mesh-list
139463355|NCT02365805|Epirubicin|epirubicin|mesh-list
139463356|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
139463357|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139463358|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463359|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
139463360|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
139463361|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
139463362|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463363|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
139463364|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139463365|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139463366|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
139463367|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463368|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139463369|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139463370|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139463371|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463372|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463373|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139463374|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
139463375|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139463376|NCT03112889|Valproic Acid|valproic acid|mesh-list
139463377|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
139463378|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463379|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463380|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
139463381|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463382|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463383|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
139463384|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139463385|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139463386|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139463387|NCT03112577|Fluticasone|fluticasone|mesh-list
139463389|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139463390|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139463391|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
139463392|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463393|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463394|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139463395|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
139463396|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
139463397|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139463398|NCT02361905|Leuprolide|leuprolide|mesh-list
139463399|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
139463400|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139463401|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
139463402|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139463403|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463404|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139463405|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463406|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139463407|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
139463408|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139463409|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
139463410|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139463411|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139463412|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463413|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
139463414|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463415|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463416|NCT02358707|Ibuprofen|ibuprofen|mesh-list
139463417|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139463418|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139463419|NCT02358707|Analgesics|analgesics|mesh-ancestor
139463420|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
139463421|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463422|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463423|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139463424|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463425|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139463426|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463427|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463428|NCT02360501|Docetaxel|docetaxel|mesh-list
139463429|NCT02360501|Capecitabine|capecitabine|mesh-list
139463430|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463431|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
139463432|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
139463433|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
139463434|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463435|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139463436|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
139463437|NCT02360423|Sirolimus|sirolimus|mesh-list
139463438|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139463439|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463440|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139463441|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463442|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
139463443|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139463444|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
139463445|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463446|NCT02358161|Paclitaxel|paclitaxel|mesh-list
139463447|NCT02358161|Gemcitabine|gemcitabine|mesh-list
139463448|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139463449|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463450|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
139463451|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
139463452|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
139463453|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463454|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139463455|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
139463456|NCT02357849|Aripiprazole|aripiprazole|mesh-list
139463458|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
139463459|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139463460|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139463461|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139463462|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139463463|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463464|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
139463465|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
139463466|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463467|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463468|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139463469|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139463470|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
139463471|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139463472|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139463473|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139463474|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139463475|NCT02357849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139463476|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139463477|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139463478|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139463479|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139463480|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139463481|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463482|NCT02357693|Aprepitant|aprepitant|mesh-list
139463483|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
139463484|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
139463485|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463486|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463487|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138848390|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139463488|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139463489|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463490|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463491|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139463492|NCT02357615|Nifedipine|nifedipine|mesh-list
139463493|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139463494|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139463495|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463496|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139463497|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463498|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
139463499|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
139463500|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139463501|NCT03160001|Niclosamide|niclosamide|mesh-list
139463502|NCT03160001|Etanercept|etanercept|mesh-list
139463503|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139463504|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139463505|NCT03160001|Analgesics|analgesics|mesh-ancestor
139463506|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
139463507|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463508|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463509|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139463510|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463511|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139463512|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139463513|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
139463514|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
139463515|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139463516|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
139463517|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139463518|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463519|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
139463520|NCT02359643|Aspirin|aspirin|mesh-list
139463521|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139463522|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139463523|NCT02359643|Analgesics|analgesics|mesh-ancestor
139463524|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
139463525|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463526|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463527|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139463528|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463529|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139463530|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139463531|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463532|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139463533|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139463534|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463536|NCT02359721|Clarithromycin|clarithromycin|mesh-list
139463537|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139463538|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463539|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139463540|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463541|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463542|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139463543|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139463544|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
139463545|NCT02357303|Simethicone|simethicone|mesh-list
139463546|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139463547|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
139463548|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463549|NCT02357303|Expectorants|expectorants|mesh-ancestor
139463550|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
139463551|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139463552|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
139463553|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463554|NCT02357303|Protective Agents|protective agents|mesh-ancestor
139463555|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463556|NCT02357303|Antidotes|antidotes|mesh-ancestor
139463557|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
139463558|NCT02357303|Emollients|emollients|mesh-ancestor
139463559|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
139463560|NCT02357225|Bromides|bromides|mesh-list
139463561|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138848391|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
139463562|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
139463563|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139463564|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463565|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463566|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
139463567|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463568|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463569|NCT02357069|Etanercept|etanercept|mesh-list
139463570|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139463571|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139463572|NCT02357069|Analgesics|analgesics|mesh-ancestor
139463573|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
139463574|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463575|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463576|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139463577|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463578|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139463579|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139463580|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
139463581|NCT02356913|Nicotine|nicotine|mesh-list
139463582|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139463583|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
139463584|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463585|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463586|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139463587|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139463588|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
139463589|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463590|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463591|NCT02352545|Montelukast|montelukast|mesh-list
139463592|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139463593|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
139463594|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139463595|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
139463596|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139463597|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463598|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139463599|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139463600|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463601|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
139250335|NCT03552770|Bevacizumab|bevacizumab|mesh-list
139463602|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139463603|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
139463604|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463605|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463606|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139463607|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
139463608|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139463609|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
139463610|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463611|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463612|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139463613|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
139463614|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
139463615|NCT02356835|Protective Agents|protective agents|mesh-ancestor
139463616|NCT02352701|Amoxicillin|amoxicillin|mesh-list
139463617|NCT02352701|Levofloxacin|levofloxacin|mesh-list
139463618|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139463619|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463620|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139463621|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139463622|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139463623|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463624|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463625|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463626|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139463627|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139463629|NCT02356445|Methotrexate|methotrexate|mesh-list
139463630|NCT02356445|Azathioprine|azathioprine|mesh-list
139463631|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139463632|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
139463633|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139463634|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463635|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139463636|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
139463637|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463638|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463639|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
139463640|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463641|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139463642|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139463643|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
139463644|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463645|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139463646|NCT02356445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139463647|NCT02356445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139463648|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139463649|NCT02356679|Ethanol|ethanol|mesh-list
139463650|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139463651|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463652|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139463653|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463654|NCT02352155|Epinephrine|epinephrine|mesh-list
139463655|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139463656|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139463657|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
139463658|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463659|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463660|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463661|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139463662|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139463663|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
139463664|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463665|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139463666|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
139463667|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
139463668|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
139463669|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139463670|NCT02352311|Tadalafil|tadalafil|mesh-list
139463671|NCT02352311|Dutasteride|dutasteride|mesh-list
139463672|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
139463673|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139463674|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139463675|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463676|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463677|NCT02352311|Urological Agents|urological agents|mesh-ancestor
139463678|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139463679|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139463680|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
139463681|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139463682|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463683|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139463684|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463685|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139463686|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463687|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463688|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
139463689|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
139463690|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139463691|NCT02351687|Albendazole|albendazole|mesh-list
139463692|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
139463693|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139463694|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139463695|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463696|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139463697|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463698|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463699|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139463700|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
139463701|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
139463702|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139463703|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
139463704|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
139463705|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
139463706|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463707|NCT02355509|Acarbose|acarbose|mesh-list
139463708|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139463709|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463710|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463711|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139463712|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463713|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
139463714|NCT02355197|Vitamins|vitamins|mesh-ancestor
139463715|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
139463716|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463717|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
139463718|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463719|NCT02355197|Protective Agents|protective agents|mesh-ancestor
139463720|NCT02351297|Caseins|caseins|mesh-list
139463721|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
139463722|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
139463723|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463724|NCT02355119|Gemcitabine|gemcitabine|mesh-list
139463725|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139463726|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
139463727|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463728|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463729|NCT03149939|Febuxostat|febuxostat|mesh-list
139463730|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
139463731|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463732|NCT03149783|Ropivacaine|ropivacaine|mesh-list
139463733|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
139463734|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
139463735|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139463736|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463737|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
139463738|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463739|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
139463740|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139463741|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139463742|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463743|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
139463744|NCT02354885|Coagulants|coagulants|mesh-ancestor
139463745|NCT02354807|Mirabegron|mirabegron|mesh-list
139463746|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139463747|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139463748|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139463749|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
139463750|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463751|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463753|NCT02354807|Urological Agents|urological agents|mesh-ancestor
139463754|NCT03159845|Levofloxacin|levofloxacin|mesh-list
139463755|NCT03159845|Fluconazole|fluconazole|mesh-list
139463756|NCT03159845|Acyclovir|acyclovir|mesh-list
139463757|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
139463758|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139463759|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463760|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139463761|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139463762|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139463763|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463764|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463765|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463766|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139463767|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139463768|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
139463769|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139463770|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139463771|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
139463772|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139463773|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463774|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139463775|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139463776|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
139463777|NCT03159845|Astringents|astringents|mesh-ancestor
139463778|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
139463779|NCT02350751|MEDI8852|medi8852|mesh-list
139463780|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
139463781|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463782|NCT02350985|Propranolol|propranolol|mesh-list
139463783|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139463784|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139463785|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139463786|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
139463787|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463788|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463789|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463790|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139463791|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139463792|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
139463793|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139463794|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139463795|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139463796|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139463797|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
139463798|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139463799|NCT02354261|Itraconazole|itraconazole|mesh-list
139463800|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
139463801|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463802|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139463803|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139463804|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463805|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463806|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139463807|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
139463808|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139463809|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463810|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139463811|NCT02350439|Adenosine|adenosine|mesh-list
139463812|NCT02350439|Analgesics|analgesics|mesh-ancestor
139463813|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
139463814|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463815|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463816|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139463817|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
139463818|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139463819|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
139463820|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
139463821|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463822|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463823|NCT02350673|Atezolizumab|atezolizumab|mesh-list
139463824|NCT02350673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139463825|NCT02350673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463826|NCT02350673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139463827|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463828|NCT02350361|Endostatins|endostatins|mesh-list
139463829|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139463830|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139463831|NCT02350361|Growth Substances|growth substances|mesh-ancestor
139463832|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463833|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
139463834|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463835|NCT02353949|Flutemetamol|flutemetamol|mesh-list
139463836|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139463837|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463839|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139463840|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463841|NCT03149393|Mosapride|mosapride|mesh-list
139463842|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463843|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139463844|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139463845|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
139463846|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463847|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463848|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
139463849|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463850|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139463851|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463852|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463853|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
139463854|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139463855|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463856|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139463857|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
139463858|NCT02353325|Fesoterodine|fesoterodine|mesh-list
139463859|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
139463860|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463861|NCT02353325|Protective Agents|protective agents|mesh-ancestor
139463862|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463863|NCT02353325|Vitamins|vitamins|mesh-ancestor
139463864|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
139463865|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139463866|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139463867|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
139463868|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463869|NCT02353325|Urological Agents|urological agents|mesh-ancestor
139463870|NCT03157505|Immunomodulating Agents|immunomodulating agents|mesh-list
139463871|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
139463872|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463873|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
139463874|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139463875|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
139463876|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463877|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
139463878|NCT03157193|Protective Agents|protective agents|mesh-ancestor
139463879|NCT03149159|Nivolumab|nivolumab|mesh-list
139463880|NCT03149159|Ipilimumab|ipilimumab|mesh-list
139463881|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139463882|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463883|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139463884|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463885|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
139463886|NCT03155477|Vitamin D|vitamin d|mesh-list
139463887|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139463888|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463889|NCT03155477|Vitamins|vitamins|mesh-ancestor
139463890|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
139463891|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139463892|NCT02349581|Bupivacaine|bupivacaine|mesh-list
139463893|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
139463894|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
139463895|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139463896|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463897|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
139463898|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463899|NCT03154385|Rituximab|rituximab|mesh-list
139463900|NCT03154385|Belimumab|belimumab|mesh-list
139463901|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139463902|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463903|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
139463904|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463905|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463906|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139463908|NCT03112187|Trace Elements|trace elements|mesh-ancestor
139463909|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
139463910|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463911|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
139463912|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139463913|NCT03147677|Irbesartan|irbesartan|mesh-list
139463914|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139463915|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139463916|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139463917|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463918|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139463919|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463920|NCT03147677|Vitamins|vitamins|mesh-ancestor
139463921|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
139463922|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
139463923|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
139463924|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139463925|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463926|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463927|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
139463928|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139463929|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139463930|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463931|NCT03147599|Mebeverine|mebeverine|mesh-list
139463932|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
139463933|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
139463934|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
139463935|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463936|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463937|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139463938|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139463939|NCT02349113|Estrogens|estrogens|mesh-list
139463940|NCT02349113|Estradiol|estradiol|mesh-list
139463941|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139463942|NCT02349113|Hormones|hormones|mesh-ancestor
139463943|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139463944|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463945|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139463946|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
139463947|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139463948|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139463949|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139463950|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463951|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139463952|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463953|NCT02348177|Ritonavir|ritonavir|mesh-list
139463954|NCT02348177|Lopinavir|lopinavir|mesh-list
139463955|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139463956|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139463957|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
139463958|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139463959|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463960|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139463961|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139463962|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
139463963|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463964|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139463965|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139463966|NCT02348255|Bevacizumab|bevacizumab|mesh-list
139463967|NCT02348255|Carmustine|carmustine|mesh-list
139463968|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139463969|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139463970|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139463971|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139463972|NCT02348255|Growth Substances|growth substances|mesh-ancestor
139463973|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463974|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
139463975|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139463976|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
139463977|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463979|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
139463980|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
139463981|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139463982|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
139463983|NCT02343419|Miotics|miotics|mesh-ancestor
139463984|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
139463985|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139463986|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139463987|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139463988|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139463989|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
139463990|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139463991|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139463992|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
139463993|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139463994|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139463995|NCT02342717|Itraconazole|itraconazole|mesh-list
139463996|NCT02342717|BI 425809|bi 425809|mesh-list
139463997|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
139463998|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139463999|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139464000|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139464001|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464002|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464003|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139464004|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
139464005|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464006|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464007|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139464008|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
139464009|NCT04478357|Fesoterodine|fesoterodine|mesh-list
139464010|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139464011|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139464012|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
139464013|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464014|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464015|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464016|NCT04478357|Urological Agents|urological agents|mesh-ancestor
139464017|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
139464018|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139464019|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139464020|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464021|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464022|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139464023|NCT04478513|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139464024|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139464025|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139464026|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464027|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464028|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
139464029|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139464030|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
139464031|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139464032|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139464033|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464034|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139464035|NCT02342093|Drospirenone|drospirenone|mesh-list
139464036|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139464037|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
139464038|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464039|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464040|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139464041|NCT02342093|Diuretics|diuretics|mesh-ancestor
139464042|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
139464043|NCT02347319|Silymarin|silymarin|mesh-list
139464044|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
139464045|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464046|NCT02347319|Protective Agents|protective agents|mesh-ancestor
139464047|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464048|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
139464049|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139464050|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464051|NCT02341703|Metformin|metformin|mesh-list
139464052|NCT02341703|Pioglitazone|pioglitazone|mesh-list
139464053|NCT02341703|Letrozole|letrozole|mesh-list
139464054|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139464055|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464056|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464057|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139464058|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139464059|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464060|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464061|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139464062|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
139464063|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464064|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
139464065|NCT02341547|Hematinics|hematinics|mesh-ancestor
139464066|NCT02341079|Bupivacaine|bupivacaine|mesh-list
139464067|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
139464068|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
139464069|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464070|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464071|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
139464072|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464073|NCT02346539|Nicotine|nicotine|mesh-list
139122562|NCT03605862|Nitazoxanide|nitazoxanide|mesh-list
139464074|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139464075|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
139464076|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464077|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464078|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139464079|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139464080|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
139464081|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464082|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464083|NCT05254223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139464084|NCT02340455|Pregabalin|pregabalin|mesh-list
139464085|NCT02340455|Analgesics|analgesics|mesh-ancestor
139464086|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
139464087|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464088|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464089|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
139464090|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139464091|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139464092|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464093|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139464094|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139464095|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139464096|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464097|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139464098|NCT02345837|Clomiphene|clomiphene|mesh-list
139464099|NCT02345837|Enclomiphene|enclomiphene|mesh-list
139464100|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
139464101|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139464102|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
139464103|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464104|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464105|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139464106|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
139464107|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139464108|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139464109|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139464110|NCT02345993|Beclomethasone|beclomethasone|mesh-list
139464111|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
139464112|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139464113|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
139464114|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464115|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464116|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139464117|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
139464118|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139464119|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139464120|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139464121|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
139464122|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464123|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464124|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139464125|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
139464126|NCT02345993|Hormones|hormones|mesh-ancestor
139464127|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464128|NCT02345681|Furosemide|furosemide|mesh-list
139464129|NCT02345681|Diuretics|diuretics|mesh-ancestor
139464130|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
139464131|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464132|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139464133|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139464134|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464135|NCT02340611|Olaparib|olaparib|mesh-list
139464136|NCT02340611|Cediranib|cediranib|mesh-list
139464137|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139464138|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464139|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464140|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464141|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139464142|NCT03145649|Insulin|insulin|mesh-list
139464143|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139464144|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464145|NCT02345213|Donepezil|donepezil|mesh-list
139464146|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139464147|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464148|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464149|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
139464150|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464151|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464152|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
139464153|NCT02339753|Carboplatin|carboplatin|mesh-list
139464154|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464155|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
139464156|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
139464157|NCT02339441|Methotrexate|methotrexate|mesh-list
139464158|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139464159|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
139464160|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464161|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139464162|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139464163|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
139464164|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464165|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464166|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139464167|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139464168|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
139464169|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139464170|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139464171|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
139464172|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
139464173|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464174|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139464175|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139464176|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139464177|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139464178|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
139464179|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139464180|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464181|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139464182|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
139464183|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139464184|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139464185|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464186|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464187|NCT02344823|Urological Agents|urological agents|mesh-ancestor
139464188|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
139464189|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139464190|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464191|NCT03145961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139464192|NCT03145961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464194|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
139464195|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464196|NCT02344511|Vancomycin|vancomycin|mesh-list
139464197|NCT02344511|Cefazolin|cefazolin|mesh-list
139464198|NCT02344511|Dalbavancin|dalbavancin|mesh-list
139464199|NCT02344511|Oxacillin|oxacillin|mesh-list
139464200|NCT02344511|Nafcillin|nafcillin|mesh-list
139464201|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139464202|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464203|NCT02344589|Lidocaine|lidocaine|mesh-list
139464204|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
139464205|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
139464206|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464207|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464208|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
139464209|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464210|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139464211|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139464212|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139464213|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139464214|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464215|NCT02338115|Paclitaxel|paclitaxel|mesh-list
139464216|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139464217|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464218|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
139464219|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
139464220|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
139464221|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464222|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
139464223|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
139464224|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139464225|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139464226|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464227|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464228|NCT02337881|Urological Agents|urological agents|mesh-ancestor
139464229|NCT02337257|Vitamin D|vitamin d|mesh-list
139464230|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
139464231|NCT02337257|Vitamins|vitamins|mesh-ancestor
139464232|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
139464233|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464234|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139464235|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139464236|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139464237|NCT02337413|Laxatives|laxatives|mesh-ancestor
139464238|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139464239|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
139464240|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139464241|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464242|NCT04477811|Vitamins|vitamins|mesh-list
139464243|NCT04477811|Vitamin K|vitamin k|mesh-list
139464244|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
139464245|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
139464246|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
139464247|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464248|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139464249|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139464250|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464251|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
139464252|NCT04477811|Coagulants|coagulants|mesh-ancestor
139464253|NCT02332031|Sorafenib|sorafenib|mesh-list
139464254|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464255|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139464256|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464257|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464258|NCT03112031|Tamoxifen|tamoxifen|mesh-list
139464259|NCT03112031|Fluconazole|fluconazole|mesh-list
139464260|NCT03112031|Amphotericin B|amphotericin b|mesh-list
139464261|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139464262|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139464263|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
139464264|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464265|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464266|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139464267|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464268|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139464269|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139464270|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139464271|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
139464272|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464273|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139464274|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139464275|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464276|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464277|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139464278|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139464279|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139464280|NCT03112031|Amebicides|amebicides|mesh-ancestor
139464281|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139464282|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139464283|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139464284|NCT03111797|Morphine|morphine|mesh-list
139464285|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139464286|NCT03111797|Narcotics|narcotics|mesh-ancestor
139464287|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464288|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464289|NCT03111797|Analgesics|analgesics|mesh-ancestor
139464290|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
139464291|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464292|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
139464293|NCT02938013|Velpatasvir|velpatasvir|mesh-list
139464294|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139464295|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
139464296|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464297|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
139464298|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139464299|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464300|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139464301|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139464302|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464303|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464304|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464305|NCT02336633|Resveratrol|resveratrol|mesh-list
139464306|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
139464307|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464308|NCT02336633|Protective Agents|protective agents|mesh-ancestor
139464309|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464310|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464311|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139464312|NCT02336477|Mexiletine|mexiletine|mesh-list
139464313|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139464314|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139464315|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139464316|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139464317|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464318|NCT04624451|Dalbavancin|dalbavancin|mesh-list
139464319|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139464320|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464321|NCT02642315|Gabapentin|gabapentin|mesh-list
139464322|NCT02642315|Analgesics|analgesics|mesh-ancestor
139464323|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
139464324|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464325|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464326|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
139464327|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139464328|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139464329|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464330|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139464331|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139464332|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139464333|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464334|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464335|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
139464336|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
139464337|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139464338|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
139464339|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464340|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464341|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139464342|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
139464343|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
139464344|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139464345|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
139464346|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464347|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464348|NCT02709889|Dexamethasone|dexamethasone|mesh-list
139464349|NCT02709889|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
139464350|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139464351|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
139464352|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
139464353|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464354|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464355|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139464356|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
139464357|NCT02709889|Hormones|hormones|mesh-ancestor
139464358|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464359|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139464360|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464361|NCT02709889|Immunoconjugates|immunoconjugates|mesh-ancestor
139464362|NCT02709889|Immunologic Factors|immunologic factors|mesh-ancestor
139464363|NCT03189901|Simendan|simendan|mesh-list
139464364|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139464365|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
139464366|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139464367|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139464368|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464369|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464370|NCT03189901|Protective Agents|protective agents|mesh-ancestor
139464371|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464372|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139464373|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
139464374|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139464375|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139464376|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464377|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
139464378|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464379|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464380|NCT02711995|Laxatives|laxatives|mesh-ancestor
139464381|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139464382|NCT03193723|Anesthetics|anesthetics|mesh-list
139464383|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464384|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464385|NCT02437825|Octreotide|octreotide|mesh-list
139464386|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139464387|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139464388|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464389|NCT02442817|Linagliptin|linagliptin|mesh-list
139464390|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139464391|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464392|NCT02442817|Incretins|incretins|mesh-ancestor
139464393|NCT02442817|Hormones|hormones|mesh-ancestor
139464394|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464395|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139464396|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
139464397|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464398|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464399|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
139464400|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139464401|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464402|NCT02442739|Ketamine|ketamine|mesh-list
139464403|NCT02442739|Analgesics|analgesics|mesh-ancestor
139464404|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
139464405|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464406|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464407|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139464408|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139464409|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
139464410|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
139464411|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464412|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139251167|NCT05208931|Mitogens|mitogens|mesh-list
139464414|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464415|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464416|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139464417|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139464418|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
139464419|NCT02442427|Palivizumab|palivizumab|mesh-list
139464420|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
139464421|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464422|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
139464423|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139464424|NCT05233735|Betamethasone|betamethasone|mesh-list
139464425|NCT05233735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139464426|NCT05233735|Glucocorticoids|glucocorticoids|mesh-ancestor
139464427|NCT05233735|Hormones|hormones|mesh-ancestor
139464428|NCT05233735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464429|NCT05233735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464430|NCT05233735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139464431|NCT05233735|Respiratory System Agents|respiratory system agents|mesh-ancestor
139464432|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
139464433|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139464434|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139464435|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139464436|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139464437|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464438|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
139464439|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464440|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464441|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139464442|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464443|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
139464444|NCT02331563|Bupivacaine|bupivacaine|mesh-list
139464445|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
139464446|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
139464447|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464448|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464449|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
139464450|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464451|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139464452|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139464453|NCT02331563|Analgesics|analgesics|mesh-ancestor
139464454|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139464455|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139464456|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139464457|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
139464458|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464459|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464460|NCT02331173|Dorzolamide|dorzolamide|mesh-list
139464461|NCT02331173|Brinzolamide|brinzolamide|mesh-list
139464462|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139464463|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139464464|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464465|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464466|NCT02709109|Ivacaftor|ivacaftor|mesh-list
139464467|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139464468|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139464469|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464470|NCT03117595|Fentanyl|fentanyl|mesh-list
139464471|NCT03117595|Morphine|morphine|mesh-list
139464472|NCT03117595|Bupivacaine|bupivacaine|mesh-list
139464473|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
139464474|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
139464475|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464476|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464477|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
139464478|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464479|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139464480|NCT03117595|Narcotics|narcotics|mesh-ancestor
139464481|NCT03117595|Analgesics|analgesics|mesh-ancestor
139464482|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139464483|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139464484|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
139464485|NCT02039531|Mitogens|mitogens|mesh-list
139464486|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
139464487|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
139464488|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464489|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139464490|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
139464491|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464492|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
139464493|NCT02039531|Protective Agents|protective agents|mesh-ancestor
139464495|NCT02331251|Vinorelbine|vinorelbine|mesh-list
139464496|NCT02331251|Docetaxel|docetaxel|mesh-list
139464497|NCT02331251|Gemcitabine|gemcitabine|mesh-list
139464498|NCT02331251|Doxorubicin|doxorubicin|mesh-list
139464499|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139464500|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
139464501|NCT02331251|Irinotecan|irinotecan|mesh-list
139464502|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139464503|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464504|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
139464505|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
139464506|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
139464507|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464508|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139464509|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
139464510|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139464511|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139464512|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139464513|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464514|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139464515|NCT02331251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139464516|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139464517|NCT02435797|Nicorandil|nicorandil|mesh-list
139464518|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139464519|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139464520|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
139464521|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
139464522|NCT02435797|Vitamins|vitamins|mesh-ancestor
139464523|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
139464524|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464525|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139464526|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139464527|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464528|NCT02330783|Bevacizumab|bevacizumab|mesh-list
139464529|NCT02330783|Sorafenib|sorafenib|mesh-list
139464530|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139464531|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464532|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139464533|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139464534|NCT02330783|Growth Substances|growth substances|mesh-ancestor
139464535|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464536|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
139464537|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139464538|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464539|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464540|NCT02335151|Desflurane|desflurane|mesh-list
139464541|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139464542|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
139464543|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
139464544|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464545|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464546|NCT02709655|Vortioxetine|vortioxetine|mesh-list
139464547|NCT02709655|Fluoxetine|fluoxetine|mesh-list
139464548|NCT02709655|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139464549|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139464550|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139464551|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464552|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464553|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
139464554|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464555|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139464556|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
139464557|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139464558|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139464559|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139464560|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464561|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139464562|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139464563|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464564|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139464565|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139464566|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139464567|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139464568|NCT02334605|Capsaicin|capsaicin|mesh-list
139464569|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
139464570|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
139464571|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
139464572|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464573|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464574|NCT02329535|Progesterone|progesterone|mesh-list
139464575|NCT02329535|Progestins|progestins|mesh-ancestor
139464576|NCT02329535|Hormones|hormones|mesh-ancestor
139464577|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464578|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464579|NCT03187795|Mirabegron|mirabegron|mesh-list
139464580|NCT03187795|Oxybutynin|oxybutynin|mesh-list
139464581|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139464582|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139464583|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139464584|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
139464585|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464586|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464587|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464588|NCT03187795|Urological Agents|urological agents|mesh-ancestor
139464589|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
139464590|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
139464591|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464592|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139464593|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139464594|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
139464595|NCT02435563|Ritonavir|ritonavir|mesh-list
139464596|NCT02435563|Ticagrelor|ticagrelor|mesh-list
139464597|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139464598|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139464599|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
139464600|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464601|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464602|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139464603|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139464604|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
139464605|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464606|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139464607|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139464608|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139464609|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139464610|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139464611|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139464612|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
139464613|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464614|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464615|NCT02433847|Mosapride|mosapride|mesh-list
139464616|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139464617|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139464618|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
139464619|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464620|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464621|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464622|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
139464623|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139464624|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464625|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464626|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139464627|NCT02328521|Nicorandil|nicorandil|mesh-list
139464628|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139464629|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139464630|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
139464631|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
139464632|NCT02328521|Vitamins|vitamins|mesh-ancestor
139464633|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
139464634|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464635|NCT03187093|Vortioxetine|vortioxetine|mesh-list
139464636|NCT03187093|Escitalopram|escitalopram|mesh-list
139251374|NCT04823845|Analgesics|analgesics|mesh-ancestor
139464637|NCT03187093|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139464638|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139464639|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139464640|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464641|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464642|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
139464643|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464644|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
139464645|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139464646|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139464647|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139464648|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464649|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139464650|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139464651|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139464652|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139464653|NCT02039999|Citric Acid|citric acid|mesh-list
139464654|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
139464655|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139464656|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
139464657|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139464658|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
139464659|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
139464660|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464661|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
139464662|NCT02434861|Digoxin|digoxin|mesh-list
139464663|NCT02434861|Rolapitant|rolapitant|mesh-list
139464664|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139123155|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
139464665|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139464666|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464667|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464668|NCT02434861|Protective Agents|protective agents|mesh-ancestor
139464669|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464670|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464671|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139464672|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139464673|NCT02434861|Analgesics|analgesics|mesh-ancestor
139464674|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
139464675|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464676|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139464677|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139464678|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139464679|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139464680|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464681|NCT03187015|Entinostat|entinostat|mesh-list
139464682|NCT03187015|Midazolam|midazolam|mesh-list
139464683|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139464684|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139464685|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464686|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464687|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139464688|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139464689|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139464690|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139464691|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
139464692|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
139464693|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
139464694|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
139464695|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464696|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464697|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464698|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139464699|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464700|NCT02328053|Voriconazole|voriconazole|mesh-list
139464701|NCT02328053|Natamycin|natamycin|mesh-list
139464702|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
139464703|NCT02328053|Clotrimazole|clotrimazole|mesh-list
139464704|NCT02328053|Miconazole|miconazole|mesh-list
139464705|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464706|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139464707|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139464708|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464709|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464710|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139251453|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
139464712|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464713|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464714|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139464715|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139464716|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139464717|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139464718|NCT02022748|Ticagrelor|ticagrelor|mesh-list
139464719|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139464720|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139464721|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139464722|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139464723|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
139464724|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464725|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464726|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464727|NCT02333513|Vincristine|vincristine|mesh-list
139464728|NCT02333513|Lomustine|lomustine|mesh-list
139464729|NCT02333513|Procarbazine|procarbazine|mesh-list
139464730|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139464731|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464732|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
139464733|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
139464734|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
139464735|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464736|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139464737|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
139464738|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139464739|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139464740|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139464741|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464742|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
139464743|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464744|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464745|NCT02328209|Ranibizumab|ranibizumab|mesh-list
139464746|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139464747|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139464748|NCT02328209|Growth Substances|growth substances|mesh-ancestor
139464749|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464750|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
139464751|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464752|NCT02328443|Itraconazole|itraconazole|mesh-list
139464753|NCT02328443|Rifampin|rifampin|mesh-list
139464754|NCT02328443|Midazolam|midazolam|mesh-list
139464755|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139464756|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139464757|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464758|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464759|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139464760|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139464761|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139464762|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139464763|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
139464764|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
139464765|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
139464766|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
139464767|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464768|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464769|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
139464770|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464771|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139464772|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139464773|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464774|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139464775|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
139464776|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464777|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139464778|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139464779|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
139464780|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139464781|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
139251545|NCT04426825|Bevacizumab|bevacizumab|mesh-list
139464782|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139464783|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139464784|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139464785|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139464786|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139464787|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139464788|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139464789|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139464790|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139464791|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139464792|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139464793|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139464794|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
139464795|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464796|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464797|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464798|NCT03191539|Apremilast|apremilast|mesh-list
139464799|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139464800|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139464801|NCT03191539|Analgesics|analgesics|mesh-ancestor
139464802|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
139464803|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464804|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464805|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139464806|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139464807|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139464808|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139464809|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464810|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464811|NCT02433925|Resveratrol|resveratrol|mesh-list
139464812|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
139464813|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464814|NCT02433925|Protective Agents|protective agents|mesh-ancestor
139464815|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464816|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464817|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139464818|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
139464819|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464820|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464821|NCT02327663|Emtricitabine|emtricitabine|mesh-list
139464822|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
139464823|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464824|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139464825|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139464826|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464827|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464828|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139464829|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139464830|NCT02333123|Aspirin|aspirin|mesh-list
139464831|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139464832|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139464833|NCT02333123|Analgesics|analgesics|mesh-ancestor
139464834|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
139464835|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464836|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464837|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139464838|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139464839|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139464840|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139464841|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464842|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139464843|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139464844|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464845|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
139464846|NCT02332811|Sevelamer|sevelamer|mesh-list
139464847|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
139464848|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
139464849|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464850|NCT02433457|Omeprazole|omeprazole|mesh-list
139464851|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139464852|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139464853|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139251636|NCT04017598|Iron|iron|mesh-list
139464854|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464855|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464856|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
139464857|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139464858|NCT02021656|Ledipasvir|ledipasvir|mesh-list
139464859|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
139464860|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464861|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139464862|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139464863|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
139464864|NCT03145025|Hormones|hormones|mesh-ancestor
139464865|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464866|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464867|NCT03144947|Docetaxel|docetaxel|mesh-list
139464868|NCT03144947|Trastuzumab|trastuzumab|mesh-list
139464869|NCT03144947|Pertuzumab|pertuzumab|mesh-list
139464870|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464871|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
139464872|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
139464873|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
139464874|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464875|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139464876|NCT02433535|Simvastatin|simvastatin|mesh-list
139464877|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139464878|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139464879|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
139464880|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464881|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139464882|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139464883|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139464884|NCT03144713|Terlipressin|terlipressin|mesh-list
139464885|NCT03144713|Midodrine|midodrine|mesh-list
139464886|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
139464887|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
139464888|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464889|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464890|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139464891|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139464892|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139464893|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139464894|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
139464895|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464896|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464897|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139464898|NCT03191383|Vaccines|vaccines|mesh-list
139464899|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
139464900|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464901|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
139464902|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139464903|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
139464904|NCT02075632|Hormones|hormones|mesh-ancestor
139464905|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464906|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464907|NCT02430259|Isoniazid|isoniazid|mesh-list
139464908|NCT02430259|Rifapentine|rifapentine|mesh-list
139464909|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
139464910|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139464911|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464912|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139464913|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139464914|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
139464915|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464916|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139464917|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139464918|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
139464919|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
139464920|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139464921|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464922|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139464923|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464924|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
139464925|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139464926|NCT03142607|Metronidazole|metronidazole|mesh-list
139464927|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139251679|NCT03869268|Aspirin|aspirin|mesh-list
139464928|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464929|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
139464930|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
139464931|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139464932|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139464933|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139464934|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
139464935|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139464936|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139464937|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139464938|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139464939|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464940|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
139464941|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139464942|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464943|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139464944|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464945|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
139464946|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
139464947|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
139464948|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464949|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464950|NCT02326727|Fentanyl|fentanyl|mesh-list
139464951|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
139464952|NCT02326727|Propofol|propofol|mesh-list
139464953|NCT02326727|Ropivacaine|ropivacaine|mesh-list
139464954|NCT02326727|Isoflurane|isoflurane|mesh-list
139464955|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139464956|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139464957|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464958|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139464959|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
139464960|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
139464961|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
139464962|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
139464963|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139464964|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139464965|NCT02326727|Narcotics|narcotics|mesh-ancestor
139464966|NCT02326727|Analgesics|analgesics|mesh-ancestor
139464967|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139464968|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139464969|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139464970|NCT02432911|Cytarabine|cytarabine|mesh-list
139464971|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
139464972|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139464973|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
139464974|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139464975|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139464976|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
139464977|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139464978|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139464979|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
139464980|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464981|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139464982|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139464983|NCT03588767|Vitamin D|vitamin d|mesh-list
139464984|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
139464985|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
139464986|NCT03588767|Vitamins|vitamins|mesh-list
139464987|NCT03588767|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
139464988|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
139464989|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
139464990|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139464991|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139464992|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139464993|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
139464994|NCT03588767|Hormones|hormones|mesh-ancestor
139464995|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139464996|NCT03588767|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
139464997|NCT02440399|Acetaminophen|acetaminophen|mesh-list
139464998|NCT02440399|Diclofenac|diclofenac|mesh-list
139464999|NCT02440399|Morphine|morphine|mesh-list
139465000|NCT02440399|Oxycodone|oxycodone|mesh-list
139465001|NCT02440399|Tramadol|tramadol|mesh-list
139465002|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139465003|NCT02440399|Narcotics|narcotics|mesh-ancestor
139465004|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465005|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465007|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
139465008|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465009|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139465010|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
139465011|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139465012|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139465013|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139465014|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139465015|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465016|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465017|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
139465018|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139465019|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139465020|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
139465021|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465022|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465023|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465024|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
139465025|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
139465026|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465027|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
139465028|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139465029|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
139465030|NCT03191305|Warfarin|warfarin|mesh-list
139465031|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
139465032|NCT03144401|Misoprostol|misoprostol|mesh-list
139465033|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139465034|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
139465035|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139465036|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465037|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139465038|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139465039|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
139465040|NCT04483765|Anesthetics|anesthetics|mesh-list
139465041|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465042|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465043|NCT03186313|Ribavirin|ribavirin|mesh-list
139465044|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
139465045|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
139465046|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465047|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
139465048|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465049|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
139465050|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139465051|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465052|NCT03144245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139465053|NCT03144245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465054|NCT04996199|Zileuton|zileuton|mesh-list
139465055|NCT04996199|Carbamazepine|carbamazepine|mesh-list
139465056|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
139465057|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
139465058|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
139465059|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139465060|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465061|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465062|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139465063|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139465064|NCT04996199|Analgesics|analgesics|mesh-ancestor
139465065|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
139465066|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465067|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139465068|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139465069|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465070|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139465071|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139465072|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139465073|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139465074|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139465075|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139465076|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139465077|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465078|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139465079|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
139465080|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139465081|NCT02432833|Tacrolimus|tacrolimus|mesh-list
139465082|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139465083|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
139465084|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465085|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139465086|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465087|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465088|NCT02429323|Sevoflurane|sevoflurane|mesh-list
139465089|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139465090|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139465091|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
139465092|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
139465093|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465094|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465095|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
139465096|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139465097|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465098|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139465099|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139465100|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465101|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465102|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465103|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139465104|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139465105|NCT02707861|Ibalizumab|ibalizumab|mesh-list
139465106|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139465107|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
139465108|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465109|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139465110|NCT02432599|Choline|choline|mesh-list
139465111|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
139465112|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139465113|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
139465114|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465115|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139465116|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139465117|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
139465118|NCT03185143|Acetaminophen|acetaminophen|mesh-list
139465119|NCT03185143|Sumatriptan|sumatriptan|mesh-list
139465120|NCT03185143|Naltrexone|naltrexone|mesh-list
139465121|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139465122|NCT03185143|Analgesics|analgesics|mesh-ancestor
139465123|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
139465124|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465125|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465126|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
139465127|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139465128|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139465129|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139465130|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139465131|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139465132|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
139465133|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465134|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465135|NCT05076773|Morphine|morphine|mesh-list
139465136|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139465137|NCT05076773|Narcotics|narcotics|mesh-ancestor
139465138|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465139|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465140|NCT05076773|Analgesics|analgesics|mesh-ancestor
139465141|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
139465142|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465143|NCT02432677|Remifentanil|remifentanil|mesh-list
139465144|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139465145|NCT02432677|Narcotics|narcotics|mesh-ancestor
139465146|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465147|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465148|NCT02432677|Analgesics|analgesics|mesh-ancestor
139465149|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
139465150|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465151|NCT03442673|Gemcitabine|gemcitabine|mesh-list
139465152|NCT03442673|Vinorelbine|vinorelbine|mesh-list
139465153|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139465154|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
139465155|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465157|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139465158|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
139465159|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
139465160|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
139465161|NCT02432365|Paclitaxel|paclitaxel|mesh-list
139465162|NCT02432365|Cisplatin|cisplatin|mesh-list
139465163|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139465164|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465165|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
139465166|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
139465167|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
139465168|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465169|NCT05076695|Trastuzumab|trastuzumab|mesh-list
139465170|NCT05076695|Fulvestrant|fulvestrant|mesh-list
139465171|NCT05076695|Palbociclib|palbociclib|mesh-list
139465172|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139465173|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465174|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139465175|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139465176|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139465177|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
139465178|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139465179|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465180|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139465181|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465182|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465183|NCT03143933|Fentanyl|fentanyl|mesh-list
139465184|NCT03143933|Propofol|propofol|mesh-list
139465185|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139465186|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465187|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465188|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139465189|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
139465190|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
139465191|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139465192|NCT03143933|Narcotics|narcotics|mesh-ancestor
139465193|NCT03143933|Analgesics|analgesics|mesh-ancestor
139465194|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
139465195|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465196|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139465197|NCT02440243|Vaccines|vaccines|mesh-list
139465198|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
139465199|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465200|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
139465201|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139465202|NCT05076461|Ondansetron|ondansetron|mesh-list
139465203|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
139465204|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
139465205|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465206|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465207|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139465208|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
139465209|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
139465210|NCT05076461|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139465211|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139465212|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
139465213|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465214|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465215|NCT02428933|Bromocriptine|bromocriptine|mesh-list
139465216|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139465217|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139465218|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
139465219|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139465220|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465221|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
139465222|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
139465223|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465224|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465225|NCT02428777|Diclofenac|diclofenac|mesh-list
139465226|NCT02428777|Tramadol|tramadol|mesh-list
139465227|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139465228|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139465229|NCT02428777|Analgesics|analgesics|mesh-ancestor
139465230|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
139465231|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465232|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465233|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139465234|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139465235|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139465236|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465237|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465238|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139465239|NCT02428777|Narcotics|narcotics|mesh-ancestor
139465240|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465241|NCT02432053|Tacrolimus|tacrolimus|mesh-list
139465242|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139465243|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
139465244|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465245|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139465246|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465247|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465248|NCT03141827|Insulin|insulin|mesh-list
139465249|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139465250|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465251|NCT03190681|Methylphenidate|methylphenidate|mesh-list
139465252|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139465253|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465254|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139465255|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139465256|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139465257|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465258|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
139465259|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465260|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139465261|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139465262|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139465263|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139465264|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465265|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
139465266|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465267|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465268|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139465269|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465270|NCT04593563|Psilocybin|psilocybin|mesh-list
139465271|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
139465272|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465273|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139465274|NCT04551911|Calcifediol|calcifediol|mesh-list
139465275|NCT04551911|Vitamins|vitamins|mesh-ancestor
139465276|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
139465277|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465278|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139465279|NCT02431975|Ritonavir|ritonavir|mesh-list
139465280|NCT02431975|Lopinavir|lopinavir|mesh-list
139465281|NCT02431975|Lamivudine|lamivudine|mesh-list
139465282|NCT02431975|Zidovudine|zidovudine|mesh-list
139465283|NCT02431975|Nevirapine|nevirapine|mesh-list
139465284|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139465285|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139465286|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
139465287|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465288|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465289|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139465290|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139465291|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
139465292|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465293|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139465294|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139465295|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139465296|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139465297|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
139465298|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139465299|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139465300|NCT03143465|Calcitonin|calcitonin|mesh-list
139465301|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
139465302|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
139465303|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139465304|NCT03143465|Katacalcin|katacalcin|mesh-list
139465305|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
139465306|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139465307|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139465308|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465309|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465310|NCT03143465|Urological Agents|urological agents|mesh-ancestor
139465311|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139465312|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465313|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139465314|NCT05034809|Melatonin|melatonin|mesh-list
139465315|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
139465316|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465317|NCT05034809|Protective Agents|protective agents|mesh-ancestor
139465318|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465319|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465320|NCT02428543|Cytarabine|cytarabine|mesh-list
139465321|NCT02428543|Ponatinib|ponatinib|mesh-list
139465322|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139465323|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
139465324|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465325|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465326|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
139465327|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465328|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139465329|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
139465330|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465331|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139465332|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465333|NCT04428203|Cannabidiol|cannabidiol|mesh-list
139465334|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
139465335|NCT02431663|Ketamine|ketamine|mesh-list
139465336|NCT02431663|Analgesics|analgesics|mesh-ancestor
139465337|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
139465338|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465339|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465340|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139465341|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139465342|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
139465343|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
139465344|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465345|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139465346|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139465347|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465348|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465349|NCT03185845|Warfarin|warfarin|mesh-list
139465350|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
139465351|NCT03182803|Antibodies|antibodies|mesh-list
139465352|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
139465353|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465354|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139465355|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465356|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465357|NCT03185611|Rifaximin|rifaximin|mesh-list
139465358|NCT03185611|Azathioprine|azathioprine|mesh-list
139465359|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139465360|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465361|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139465362|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
139465363|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465364|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139465365|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465366|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139465367|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
139465368|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465369|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139465370|NCT02431429|Miltefosine|miltefosine|mesh-list
139465371|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
139465372|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465373|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465374|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139465375|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139465376|NCT02027428|Paclitaxel|paclitaxel|mesh-list
139465377|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139465378|NCT02027428|Carboplatin|carboplatin|mesh-list
139465379|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139252133|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
139465380|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465381|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
139465382|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
139465383|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
139465384|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465385|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139465386|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139465387|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139465388|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465389|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465390|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139465391|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139465392|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465393|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
139465394|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465395|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139465396|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465397|NCT01995136|Travoprost|travoprost|mesh-list
139465398|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139465399|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139465400|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139465401|NCT03141593|Vitamin D|vitamin d|mesh-list
139465402|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
139465403|NCT03141593|Cholecalciferol|cholecalciferol|mesh-list
139465404|NCT03141593|Vitamins|vitamins|mesh-list
139465405|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
139465406|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465407|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139465408|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139465409|NCT04102241|Hemay005|hemay005|mesh-list
139465410|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
139465411|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139465412|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139465413|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465414|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465415|NCT03576443|Idelalisib|idelalisib|mesh-list
139465416|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465417|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465418|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465419|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139465420|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139465421|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465422|NCT04438733|Anastrozole|anastrozole|mesh-list
139465423|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139465424|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465425|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139465426|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139465427|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465428|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465429|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139465430|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
139465431|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139465432|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465433|NCT04438811|Anesthetics|anesthetics|mesh-list
139465434|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465435|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465436|NCT02427295|Octreotide|octreotide|mesh-list
139465437|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139465438|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139465439|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465440|NCT01994590|Prednisone|prednisone|mesh-list
139465441|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
139465442|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139465443|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
139465444|NCT01994590|Hormones|hormones|mesh-ancestor
139465445|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139465446|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465447|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139465448|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465449|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139465450|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465451|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252208|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139465452|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
139465453|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139465454|NCT05387603|Capecitabine|capecitabine|mesh-list
139465455|NCT05387603|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
139465456|NCT05387603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139465457|NCT05387603|Antimetabolites|antimetabolites|mesh-ancestor
139465458|NCT05387603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465459|NCT05387603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465460|NCT05387603|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139465461|NCT03182413|Modafinil|modafinil|mesh-list
139465462|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139465463|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465464|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139465465|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139465466|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139465467|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465468|NCT03182257|ONO-7579|ono-7579|mesh-list
139465469|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139465470|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465471|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465472|NCT03183739|ASP8062|asp8062|mesh-list
139465473|NCT03183739|Analgesics|analgesics|mesh-ancestor
139465474|NCT03183739|Sensory System Agents|sensory system agents|mesh-ancestor
139465475|NCT03183739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465476|NCT03183739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465477|NCT03183739|GABA Modulators|gaba modulators|mesh-ancestor
139465478|NCT03183739|GABA Agents|gaba agents|mesh-ancestor
139465479|NCT03183739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465480|NCT03183739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465481|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
139465482|NCT03117439|Clotrimazole|clotrimazole|mesh-list
139465483|NCT03117439|Miconazole|miconazole|mesh-list
139465484|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465485|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139465486|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139465487|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139465488|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465489|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465490|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139465491|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
139465492|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139465493|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465494|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139465495|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139465496|NCT02426905|Trientine|trientine|mesh-list
139465497|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
139465498|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
139465499|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465500|NCT02421289|Efavirenz|efavirenz|mesh-list
139465501|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139465502|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139465503|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465504|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465505|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
139465506|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465507|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139465508|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139465509|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139465510|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139465511|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139465512|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139465513|NCT03141125|Ethanol|ethanol|mesh-list
139465514|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139465515|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465516|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465517|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465518|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
139465519|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
139465520|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
139465521|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139252285|NCT02128646|Analgesics|analgesics|mesh-ancestor
139465522|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139465523|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465524|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465525|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465526|NCT03142763|Choline|choline|mesh-list
139465527|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
139465528|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139465529|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
139465530|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465531|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139465532|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139465533|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
139465534|NCT05081765|Olaparib|olaparib|mesh-list
139465535|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139465536|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465537|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465538|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465539|NCT05078177|Rituximab|rituximab|mesh-list
139465540|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139465541|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465542|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
139465543|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465544|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139465545|NCT05387369|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139465546|NCT05387369|Antiviral Agents|antiviral agents|mesh-ancestor
139465547|NCT05387369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465548|NCT05080985|Bupivacaine|bupivacaine|mesh-list
139465549|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
139465550|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
139465551|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465552|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465553|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
139465554|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465555|NCT03139487|Dalteparin|dalteparin|mesh-list
139465556|NCT03139487|Tinzaparin|tinzaparin|mesh-list
139465557|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139465558|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
139465559|NCT03139487|Apixaban|apixaban|mesh-list
139465560|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139465561|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
139465562|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139465563|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
139465564|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465565|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465566|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
139465567|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139465568|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139465569|NCT03139253|Amoxicillin|amoxicillin|mesh-list
139465570|NCT03139253|Clarithromycin|clarithromycin|mesh-list
139465571|NCT03139253|Levofloxacin|levofloxacin|mesh-list
139465572|NCT03139253|Tetracycline|tetracycline|mesh-list
139465573|NCT03139253|Tinidazole|tinidazole|mesh-list
139465574|NCT03139253|Furazolidone|furazolidone|mesh-list
139465575|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139465576|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465577|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139465578|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465579|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465580|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139465581|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139465582|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139465583|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139465584|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139465585|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465586|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139465587|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139465588|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139465589|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139465590|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139465591|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139465592|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
139465593|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
139465594|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139465595|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465596|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
139465597|NCT02019472|Adalimumab|adalimumab|mesh-list
139465598|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139465599|NCT02019472|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139465600|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139465601|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139465602|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
139465603|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465604|NCT00157937|Theophylline|theophylline|mesh-list
139465605|NCT00157937|Montelukast|montelukast|mesh-list
139465606|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465607|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465608|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465609|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
139465610|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465611|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
139465612|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139465613|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139465614|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
139465615|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139465616|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139465617|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139465618|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139465619|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139465620|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465621|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
139465622|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139465623|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139465624|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
139465625|NCT03139565|Vaccines|vaccines|mesh-list
139465626|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
139465627|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465628|NCT03139331|Irinotecan|irinotecan|mesh-list
139465629|NCT03139331|Temozolomide|temozolomide|mesh-list
139465630|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139465631|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139465632|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465633|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465634|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465635|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139465636|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
139465637|NCT04423601|Itraconazole|itraconazole|mesh-list
139465638|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
139465639|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465640|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139465641|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139465642|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465643|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465644|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139465645|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
139465646|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139465647|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465648|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139465649|NCT02936687|Ambrisentan|ambrisentan|mesh-list
139465650|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139465651|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
139465652|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139465653|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139465654|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465655|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
139465656|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465657|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465658|NCT05083793|Pregabalin|pregabalin|mesh-list
139465659|NCT05083793|Analgesics|analgesics|mesh-ancestor
139465660|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
139465661|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465662|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465663|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
139465664|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139465665|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139465666|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465667|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139465668|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139465669|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139465670|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465671|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139465672|NCT05083013|Chrysarobin|chrysarobin|mesh-list
139465673|NCT05083013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139465674|NCT05083013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139465675|NCT05083013|Analgesics|analgesics|mesh-ancestor
139465676|NCT05083013|Sensory System Agents|sensory system agents|mesh-ancestor
139465677|NCT05083013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465678|NCT05083013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465679|NCT05083013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139465680|NCT05083013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139465681|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139465682|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139465683|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465684|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139465685|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139465686|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139465687|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
139465688|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465689|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139465690|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139465691|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465692|NCT03194165|Ritonavir|ritonavir|mesh-list
139465693|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139465694|NCT03194165|Darunavir|darunavir|mesh-list
139465695|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
139465696|NCT03194165|Nevirapine|nevirapine|mesh-list
139465697|NCT03194165|Dolutegravir|dolutegravir|mesh-list
139465698|NCT03194165|Rilpivirine|rilpivirine|mesh-list
139465699|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139465700|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139465701|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
139465702|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465703|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465704|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139465705|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139465706|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
139465707|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465708|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139465709|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139465710|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139465711|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139465712|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139465713|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139465714|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139465715|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139465716|NCT04065113|Ethanol|ethanol|mesh-list
139465717|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139465718|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465719|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465720|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465721|NCT03116737|Benzocaine|benzocaine|mesh-list
139465722|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139465723|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
139465724|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
139465725|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465726|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465727|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
139465728|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465729|NCT03116659|Doxycycline|doxycycline|mesh-list
139465730|NCT03116659|Imiquimod|imiquimod|mesh-list
139465731|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139465732|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465733|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
139465734|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139465735|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139465736|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139465737|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
139465738|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465739|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465740|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
139465741|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139465742|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
139465743|NCT01993888|Coagulants|coagulants|mesh-ancestor
139465744|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
139465745|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139465746|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139465747|NCT02425813|Prednisolone|prednisolone|mesh-list
139465748|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
139465749|NCT02425813|Budesonide|budesonide|mesh-list
139465750|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139465751|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
139465752|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139465753|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
139465754|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
139465755|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465756|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465757|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139465758|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
139465759|NCT02425813|Hormones|hormones|mesh-ancestor
139465760|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139465761|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139465762|NCT02425813|Protective Agents|protective agents|mesh-ancestor
139385452|NCT05474924|Budesonide|budesonide|mesh-list
139465763|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139465764|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465765|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139465766|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139465767|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
139465768|NCT03106831|Norepinephrine|norepinephrine|mesh-list
139465769|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139465770|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139465771|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
139465772|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465773|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465774|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465775|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
139465776|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
139465777|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465778|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139465779|NCT03138785|Itraconazole|itraconazole|mesh-list
139465780|NCT03138785|Voriconazole|voriconazole|mesh-list
139465781|NCT03138785|Levofloxacin|levofloxacin|mesh-list
139465782|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
139465783|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465784|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139465785|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139465786|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465787|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465788|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139465789|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
139465790|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139465791|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465792|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139465793|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139465794|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139465795|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139465796|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139465797|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465798|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139465799|NCT03106597|Amlodipine|amlodipine|mesh-list
139465800|NCT03106597|Manidipine|manidipine|mesh-list
139465801|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139465802|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139465803|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139465804|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465805|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139465806|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465807|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
139465808|NCT02018458|Paclitaxel|paclitaxel|mesh-list
139465809|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139465810|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
139465811|NCT02018458|Carboplatin|carboplatin|mesh-list
139465812|NCT02018458|Doxorubicin|doxorubicin|mesh-list
139465813|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139465814|NCT02018458|Vaccines|vaccines|mesh-list
139465815|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
139465816|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465817|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139465818|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465819|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
139465820|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
139465821|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
139465822|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465823|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139465824|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139465825|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139465826|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
139465827|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139465828|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139465829|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139465830|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139465831|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465832|NCT02423083|Guanabenz|guanabenz|mesh-list
139465833|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139465834|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139465835|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139465836|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139465837|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
139465838|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465839|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465840|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465841|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
139465842|NCT02423863|Nivolumab|nivolumab|mesh-list
139465843|NCT02423863|Atezolizumab|atezolizumab|mesh-list
139465844|NCT02423863|Durvalumab|durvalumab|mesh-list
139465845|NCT02423863|Cemiplimab|cemiplimab|mesh-list
139465846|NCT02423863|Poly ICLC|poly iclc|mesh-list
139465847|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139465848|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465849|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139465850|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465851|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
139465852|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
139465853|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465854|NCT03178747|Methylene Blue|methylene blue|mesh-list
139465855|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465856|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465857|NCT05392673|Bilirubin|bilirubin|mesh-list
139465858|NCT05392673|Antioxidants|antioxidants|mesh-ancestor
139465859|NCT05392673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465860|NCT05392673|Protective Agents|protective agents|mesh-ancestor
139465861|NCT05392673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465862|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
139465863|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
139465864|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465865|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
139465866|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465867|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465868|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
139465869|NCT03178591|Vildagliptin|vildagliptin|mesh-list
139465870|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139465871|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465872|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139465873|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465874|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139465875|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
139465876|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465877|NCT01993186|Glycerol|glycerol|mesh-list
139465878|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139465879|NCT01993186|Protective Agents|protective agents|mesh-ancestor
139465880|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465881|NCT03181243|Anesthetics|anesthetics|mesh-list
139465882|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465883|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465884|NCT02420665|Acetic Acid|acetic acid|mesh-list
139465885|NCT02420665|Proflavine|proflavine|mesh-list
139465886|NCT02420665|Retinol acetate|retinol acetate|mesh-list
139465887|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139465888|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465889|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139465890|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
139465891|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465892|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139465893|NCT02420665|Protective Agents|protective agents|mesh-ancestor
139465894|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465895|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139465896|NCT02016898|Mitomycins|mitomycins|mesh-list
139465897|NCT02016898|Mitomycin|mitomycin|mesh-list
139465898|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139465899|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465900|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
139465901|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465902|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139465903|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139465904|NCT04482907|Hormones|hormones|mesh-list
139465905|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139465906|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465907|NCT02420509|Leucovorin|leucovorin|mesh-list
139465908|NCT02420509|Capecitabine|capecitabine|mesh-list
139465909|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465910|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465911|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139465912|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
139465913|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465914|NCT02420509|Antidotes|antidotes|mesh-ancestor
139465915|NCT02420509|Protective Agents|protective agents|mesh-ancestor
139465916|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
139465917|NCT02420509|Vitamins|vitamins|mesh-ancestor
139465918|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
139465919|NCT02416531|Clobetasol|clobetasol|mesh-list
139465920|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139465921|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
139465922|NCT02416531|Hormones|hormones|mesh-ancestor
139465923|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139465924|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465925|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
139465926|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139465927|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139465928|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465929|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
139465930|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
139465931|NCT02416141|Tramadol|tramadol|mesh-list
139465932|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139465933|NCT02416141|Narcotics|narcotics|mesh-ancestor
139465934|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465935|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465936|NCT02416141|Analgesics|analgesics|mesh-ancestor
139465937|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
139465938|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465939|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139465940|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139465941|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465942|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
139465943|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139465944|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465945|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465946|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139465947|NCT02416063|Analgesics|analgesics|mesh-ancestor
139465948|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
139465949|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139465950|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139465951|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139465952|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139465953|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
139465954|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465955|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465956|NCT01828697|Enoxaparin|enoxaparin|mesh-list
139465957|NCT01828697|Dalteparin|dalteparin|mesh-list
139465958|NCT01828697|Tinzaparin|tinzaparin|mesh-list
139465959|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139465960|NCT01828697|Nadroparin|nadroparin|mesh-list
139465961|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
139465962|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
139465963|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139465964|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139465965|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465966|NCT02415985|Lopinavir|lopinavir|mesh-list
139465967|NCT02415985|Rifabutin|rifabutin|mesh-list
139465968|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139465969|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139465970|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
139465971|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252735|NCT01363115|Vitamin D|vitamin d|mesh-list
139465972|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465973|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139465974|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139465975|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
139465976|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139465977|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139465978|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139465979|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139465980|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139465981|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
139465982|NCT02415907|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
139465983|NCT02415907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139465984|NCT02415907|Serotonin Agents|serotonin agents|mesh-ancestor
139465985|NCT02415907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139465986|NCT02415907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465987|NCT02415907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465988|NCT02415829|Capecitabine|capecitabine|mesh-list
139465989|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
139465990|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139465991|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
139465992|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139465993|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139465994|NCT04631393|Alfentanil|alfentanil|mesh-list
139465995|NCT04631393|Propofol|propofol|mesh-list
139465996|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139465997|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139465998|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139465999|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139466000|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
139466001|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
139466002|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139466003|NCT04631393|Narcotics|narcotics|mesh-ancestor
139466004|NCT04631393|Analgesics|analgesics|mesh-ancestor
139466005|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
139466006|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466007|NCT03180775|Glycine|glycine|mesh-list
139466008|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
139466009|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466010|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466011|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466012|NCT03137927|Vaccines|vaccines|mesh-list
139466013|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
139466014|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466015|NCT04482985|Meclizine|meclizine|mesh-list
139466016|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
139466017|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
139466018|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466019|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466020|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139466021|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139466022|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
139466023|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
139466024|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466025|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466026|NCT04482985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139466027|NCT04482985|Cholinergic Agents|cholinergic agents|mesh-ancestor
139466028|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139466029|NCT05385263|Nivolumab|nivolumab|mesh-list
139466030|NCT05385263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139466031|NCT05385263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466032|NCT05385263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139466033|NCT05385263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466034|NCT03180229|Granisetron|granisetron|mesh-list
139466035|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
139466036|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
139466037|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466038|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466039|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139466040|NCT03180229|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139466041|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139466042|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
139466043|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466044|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466045|NCT03178123|Interferons|interferons|mesh-list
139466046|NCT03178123|Antibodies|antibodies|mesh-list
139466047|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139466048|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
139466049|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466050|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466051|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
139466052|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466053|NCT03820817|Rifaximin|rifaximin|mesh-list
139466054|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139466055|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466056|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139466057|NCT05111197|Immunomodulating Agents|immunomodulating agents|mesh-list
139466058|NCT05111197|Immunologic Factors|immunologic factors|mesh-ancestor
139466059|NCT05111197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466060|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
139466061|NCT05106517|Denosumab|denosumab|mesh-list
139466062|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139466063|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466064|NCT03140033|Misoprostol|misoprostol|mesh-list
139466065|NCT03140033|Ranitidine|ranitidine|mesh-list
139466066|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139466067|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139466068|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
139466069|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139466070|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466071|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139466072|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139466073|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
139466074|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139466075|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
139466076|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
139466077|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466078|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466079|NCT05338931|Gossypol acetic acid|gossypol acetic acid|mesh-list
139466080|NCT05338931|Gossypol|gossypol|mesh-list
139466081|NCT05338931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139466082|NCT05338931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466083|NCT05338931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139466084|NCT05338931|Contraceptive Agents|contraceptive agents|mesh-ancestor
139466085|NCT05338931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139466086|NCT05338931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466087|NCT05338931|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
139466088|NCT05338931|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
139466089|NCT05338931|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139466090|NCT02706691|Infigratinib|infigratinib|mesh-list
139466091|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466092|NCT02419729|Estrogens|estrogens|mesh-list
139466093|NCT02419729|Hormones|hormones|mesh-ancestor
139466094|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139466095|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466096|NCT02419651|Diclofenac|diclofenac|mesh-list
139466097|NCT02419651|Tramadol|tramadol|mesh-list
139466098|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139466099|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139466100|NCT02419651|Analgesics|analgesics|mesh-ancestor
139466101|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
139466102|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466103|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466104|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139466105|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139466106|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139466107|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466108|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466109|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139466110|NCT02419651|Narcotics|narcotics|mesh-ancestor
139466111|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466112|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139466113|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466114|NCT02419261|Analgesics|analgesics|mesh-list
139466115|NCT02419261|Ropivacaine|ropivacaine|mesh-list
139466116|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
139466117|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
139466118|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466119|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466120|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
139466121|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252885|NCT02135588|Plasminogen|plasminogen|mesh-list
139466122|NCT02414503|Oxytocin|oxytocin|mesh-list
139466123|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
139466124|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139466125|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466126|NCT03137615|Anesthetics|anesthetics|mesh-list
139466127|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
139466128|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466129|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466130|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
139466131|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466132|NCT03415061|Insulin|insulin|mesh-list
139466133|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139466134|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139466135|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466136|NCT05088083|Paclitaxel|paclitaxel|mesh-list
139466137|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139466138|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466139|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
139466140|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
139466141|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
139466142|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466143|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139466144|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139466145|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
139466146|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
139466147|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139466148|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139466149|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466150|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
139466151|NCT01990768|Coagulants|coagulants|mesh-ancestor
139466152|NCT05228327|Salicylic Acid|salicylic acid|mesh-list
139466153|NCT05228327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466154|NCT05228327|Antifungal Agents|antifungal agents|mesh-ancestor
139466155|NCT05228327|Keratolytic Agents|keratolytic agents|mesh-ancestor
139466156|NCT05228327|Dermatologic Agents|dermatologic agents|mesh-ancestor
139466157|NCT02624765|Digoxin|digoxin|mesh-list
139466158|NCT02624765|Flecainide|flecainide|mesh-list
139466159|NCT02624765|Sotalol|sotalol|mesh-list
139466160|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139466161|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139466162|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466163|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466164|NCT02624765|Protective Agents|protective agents|mesh-ancestor
139466165|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466166|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139466167|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139466168|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139466169|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139466170|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139466171|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
139466172|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466173|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
139466174|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
139466175|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466176|NCT05085587|Fluticasone|fluticasone|mesh-list
139466177|NCT05085587|Xhance|xhance|mesh-list
139466178|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139466179|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139466180|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139466181|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139466182|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
139466183|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466184|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466185|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139466186|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
139466187|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
139466188|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139466189|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139466190|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139466191|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139466192|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
139466193|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466194|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466195|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
139466196|NCT05085587|Hormones|hormones|mesh-ancestor
139466197|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139466199|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139466200|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139466201|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466202|NCT01990534|Immunotoxins|immunotoxins|mesh-ancestor
139466203|NCT01990534|Immunoconjugates|immunoconjugates|mesh-ancestor
139466204|NCT01990534|Immunologic Factors|immunologic factors|mesh-ancestor
139466205|NCT01990534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466206|NCT05084573|Bupivacaine|bupivacaine|mesh-list
139466207|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
139466208|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
139466209|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466210|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466211|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
139466212|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466213|NCT05088707|Misoprostol|misoprostol|mesh-list
139466214|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139466215|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
139466216|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139466217|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466218|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139466219|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139466220|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
139466221|NCT05028257|Vaccines|vaccines|mesh-list
139466222|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
139466223|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466224|NCT03135977|Etoposide|etoposide|mesh-list
139466225|NCT03135977|Apatinib|apatinib|mesh-list
139466226|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139466227|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466228|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139466229|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139466230|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466231|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466232|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139466233|NCT04850651|Fluconazole|fluconazole|mesh-list
139466234|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
139466235|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466236|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139466237|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139466238|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466239|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466240|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139466241|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
139466242|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139466243|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466244|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139466245|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139466246|NCT04837235|Hemay005|hemay005|mesh-list
139466247|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
139466248|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139466249|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139466250|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466251|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466252|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
139466253|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139466254|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466255|NCT02702401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139466256|NCT02702401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466257|NCT03116971|Etoposide|etoposide|mesh-list
139466258|NCT03116971|Peposertib|peposertib|mesh-list
139466259|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466260|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139466261|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139466262|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139466263|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466264|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466265|NCT03116971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139466266|NCT02414581|Ethanol|ethanol|mesh-list
139466267|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
139466268|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139466269|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139466270|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466271|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466272|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466274|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
139466275|NCT02419105|Vitamin D|vitamin d|mesh-list
139466276|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
139466277|NCT02419105|Testosterone|testosterone|mesh-list
139466278|NCT02419105|Vitamins|vitamins|mesh-ancestor
139466279|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
139466280|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466281|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139466282|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139466283|NCT02419105|Androgens|androgens|mesh-ancestor
139466284|NCT02419105|Hormones|hormones|mesh-ancestor
139466285|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139466286|NCT04643249|Repaglinide|repaglinide|mesh-list
139466287|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
139466288|NCT04643249|Midazolam|midazolam|mesh-list
139466289|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
139466290|NCT04643249|Caffeine|caffeine|mesh-list
139466291|NCT04643249|Bupropion|bupropion|mesh-list
139466292|NCT04643249|Omeprazole|omeprazole|mesh-list
139466293|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139466294|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139466295|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466296|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466297|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139466298|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139466299|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139466300|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139466301|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
139466302|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
139466303|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
139466304|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
139466305|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466306|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466307|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139466308|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139466309|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466310|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139466311|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139466312|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
139466313|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139466314|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139466315|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139466316|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139466317|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
139466318|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139466319|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139466320|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139466321|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
139466322|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139466323|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139466324|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
139466325|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
139466326|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139466327|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139466328|NCT04643249|Analgesics|analgesics|mesh-ancestor
139466329|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
139466330|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466331|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139466332|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139466333|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139466334|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139466335|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139466336|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139466337|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
139466338|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139466339|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139466340|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139466341|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139466342|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466343|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
139466344|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253112|NCT02238444|Tinzaparin|tinzaparin|mesh-list
139466345|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466346|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139466347|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466348|NCT03116893|Itraconazole|itraconazole|mesh-list
139466349|NCT03116893|Rifampin|rifampin|mesh-list
139466350|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
139466351|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466352|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139466353|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139466354|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466355|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466356|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139466357|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
139466358|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139466359|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466360|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139466361|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139466362|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
139466363|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139466364|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
139466365|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139466366|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139466367|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139466368|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139466369|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139466370|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139466371|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139466372|NCT05737511|Diazepam|diazepam|mesh-list
139466373|NCT05737511|Gabapentin|gabapentin|mesh-list
139466374|NCT05737511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139466375|NCT05737511|Milnacipran|milnacipran|mesh-list
139466376|NCT05737511|Levetiracetam|levetiracetam|mesh-list
139466377|NCT05737511|Lorazepam|lorazepam|mesh-list
139466378|NCT05737511|Clonazepam|clonazepam|mesh-list
139466379|NCT05737511|Dexetimide|dexetimide|mesh-list
139466380|NCT05737511|Olanzapine|olanzapine|mesh-list
139466381|NCT05737511|Alprazolam|alprazolam|mesh-list
139466382|NCT05737511|Mirtazapine|mirtazapine|mesh-list
139466383|NCT05737511|Fluvoxamine|fluvoxamine|mesh-list
139466384|NCT05737511|Tranylcypromine|tranylcypromine|mesh-list
139466385|NCT05737511|Risperidone|risperidone|mesh-list
139466386|NCT05737511|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139466387|NCT05737511|Citalopram|citalopram|mesh-list
139466388|NCT05737511|Bupropion|bupropion|mesh-list
139466389|NCT05737511|Sertraline|sertraline|mesh-list
139466390|NCT05737511|Fluoxetine|fluoxetine|mesh-list
139466391|NCT05737511|Paroxetine|paroxetine|mesh-list
139466392|NCT05737511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139466393|NCT05737511|Reboxetine|reboxetine|mesh-list
139466394|NCT05737511|Imipramine|imipramine|mesh-list
139466395|NCT05737511|Clomipramine|clomipramine|mesh-list
139466396|NCT05737511|Phenelzine|phenelzine|mesh-list
139466397|NCT05737511|Moclobemide|moclobemide|mesh-list
139466398|NCT05737511|Hydroxyzine|hydroxyzine|mesh-list
139466399|NCT05737511|Escitalopram|escitalopram|mesh-list
139466400|NCT05737511|Analgesics|analgesics|mesh-ancestor
139466401|NCT05737511|Sensory System Agents|sensory system agents|mesh-ancestor
139466402|NCT05737511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466403|NCT05737511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466404|NCT05737511|Anticonvulsants|anticonvulsants|mesh-ancestor
139466405|NCT05737511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139466406|NCT05737511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139466407|NCT05737511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466408|NCT05737511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139466409|NCT05737511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139466410|NCT05737511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139466411|NCT05737511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466412|NCT05737511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466413|NCT05737511|Antimanic Agents|antimanic agents|mesh-ancestor
139466414|NCT05737511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139466415|NCT05737511|Serotonin Agents|serotonin agents|mesh-ancestor
139466416|NCT05737511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139466417|NCT05737511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139466418|NCT05737511|Dopamine Agents|dopamine agents|mesh-ancestor
139466419|NCT05737511|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139466420|NCT05737511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139466421|NCT05737511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139466422|NCT05737511|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139466423|NCT05737511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139466424|NCT05737511|Parasympatholytics|parasympatholytics|mesh-ancestor
139466425|NCT05737511|Autonomic Agents|autonomic agents|mesh-ancestor
139466426|NCT05737511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139466427|NCT05737511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139466428|NCT05737511|Cholinergic Agents|cholinergic agents|mesh-ancestor
139466429|NCT05737511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139466430|NCT05737511|Antidepressive Agents|antidepressive agents|mesh-ancestor
139466431|NCT05737511|Antiemetics|antiemetics|mesh-ancestor
139466432|NCT05737511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139466433|NCT05737511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139466434|NCT05737511|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139466435|NCT05737511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139466436|NCT05737511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466437|NCT05737511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139466438|NCT05737511|Nootropic Agents|nootropic agents|mesh-ancestor
139466439|NCT05737511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139466440|NCT05737511|GABA Modulators|gaba modulators|mesh-ancestor
139466441|NCT05737511|GABA Agents|gaba agents|mesh-ancestor
139466442|NCT05737511|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139466443|NCT05737511|Histamine Antagonists|histamine antagonists|mesh-ancestor
139466444|NCT05737511|Histamine Agents|histamine agents|mesh-ancestor
139466445|NCT05737511|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139466446|NCT05737511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139466447|NCT05737511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139466448|NCT05737511|Adrenergic Agents|adrenergic agents|mesh-ancestor
139466449|NCT05737511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139466450|NCT05737511|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139466451|NCT05737511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139466452|NCT05737511|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139466453|NCT05737511|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139466454|NCT05737511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139466455|NCT05737511|Anesthetics, General|anesthetics, general|mesh-ancestor
139466456|NCT05737511|Anesthetics|anesthetics|mesh-ancestor
139466457|NCT05737511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139466458|NCT05737511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139466459|NCT05737511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139466460|NCT05737511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139466461|NCT05737511|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139466462|NCT05737511|Antipruritics|antipruritics|mesh-ancestor
139466463|NCT05737511|Dermatologic Agents|dermatologic agents|mesh-ancestor
139466464|NCT05737511|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139466465|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
139466466|NCT03179839|Sertraline|sertraline|mesh-list
139466467|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
139466468|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139466469|NCT03179839|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139466470|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139466471|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139466472|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466473|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466474|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
139466475|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466476|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139466477|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139466478|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466479|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139466480|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139466481|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139466482|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466483|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139466484|NCT05736887|Acetylcysteine|acetylcysteine|mesh-list
139466485|NCT05736887|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139466486|NCT05736887|Antiviral Agents|antiviral agents|mesh-ancestor
139466487|NCT05736887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466488|NCT05736887|Expectorants|expectorants|mesh-ancestor
139466489|NCT05736887|Respiratory System Agents|respiratory system agents|mesh-ancestor
139466490|NCT05736887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139466491|NCT05736887|Antioxidants|antioxidants|mesh-ancestor
139466492|NCT05736887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466493|NCT05736887|Protective Agents|protective agents|mesh-ancestor
139466494|NCT05736887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466495|NCT05736887|Antidotes|antidotes|mesh-ancestor
139466496|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
139466497|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139466498|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466499|NCT04483219|Antibodies|antibodies|mesh-list
139466500|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
139466501|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466502|NCT03176563|Fosfomycin|fosfomycin|mesh-list
139466503|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139466504|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466505|NCT03827447|Vancomycin|vancomycin|mesh-list
139466506|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139466507|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466508|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
139466509|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139466510|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
139466511|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466512|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
139466513|NCT01680497|Protective Agents|protective agents|mesh-ancestor
139466514|NCT02423395|Orphenadrine|orphenadrine|mesh-list
139466515|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466516|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139466517|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139466518|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139466519|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139466520|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466521|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
139466522|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
139466523|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139466524|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139466525|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
139466526|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466527|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466528|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
139466529|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139466530|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466531|NCT05694689|Vitamin D|vitamin d|mesh-list
139466532|NCT05694689|Cholecalciferol|cholecalciferol|mesh-list
139466533|NCT05694689|Vitamins|vitamins|mesh-ancestor
139466534|NCT05694689|Micronutrients|micronutrients|mesh-ancestor
139466535|NCT05694689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466536|NCT05694689|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139466537|NCT05694689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139466538|NCT02423239|Paclitaxel|paclitaxel|mesh-list
139466539|NCT02423239|Gemcitabine|gemcitabine|mesh-list
139466540|NCT02423239|Sorafenib|sorafenib|mesh-list
139466541|NCT02423239|HU 211|hu 211|mesh-list
139466542|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139466543|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466544|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
139466545|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
139466546|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
139466547|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466548|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139466549|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
139466550|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139466551|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466552|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139466553|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
139466554|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
139466555|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466556|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466557|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139466558|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139466559|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139466560|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466561|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139466562|NCT02423239|Protective Agents|protective agents|mesh-ancestor
139466563|NCT02449733|Tenofovir|tenofovir|mesh-list
139466564|NCT02449733|Emtricitabine|emtricitabine|mesh-list
139466565|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139466566|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
139466567|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466568|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139466569|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139466570|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466571|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466572|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139466573|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139466574|NCT02417467|Nicotine|nicotine|mesh-list
139466575|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139466576|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
139466577|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466578|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466579|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139466580|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139466581|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
139466582|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466583|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466584|NCT02417389|Alendronate|alendronate|mesh-list
139466585|NCT02417389|Cinacalcet|cinacalcet|mesh-list
139466586|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139466587|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466588|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139466589|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139466590|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
139466591|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139466592|NCT02413021|Cytarabine|cytarabine|mesh-list
139466593|NCT02413021|Deferasirox|deferasirox|mesh-list
139466594|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139466595|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
139466596|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466597|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466598|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
139466599|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466600|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139466601|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
139466602|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466603|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139466604|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
139466605|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
139466606|NCT01680341|Insulin|insulin|mesh-list
139466607|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139466608|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
139466609|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
139466610|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139466611|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139466612|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466613|NCT03177811|Acetazolamide|acetazolamide|mesh-list
139466614|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
139466615|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139466616|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466617|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466618|NCT03177811|Diuretics|diuretics|mesh-ancestor
139466619|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
139466620|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466621|NCT03175939|Fluorouracil|fluorouracil|mesh-list
139466622|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466623|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
139466624|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466625|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139466626|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139466627|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
139466628|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466629|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
139466630|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139466631|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139466632|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139466633|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139466634|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466635|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466636|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139466637|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139466638|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466639|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
139466640|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466641|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
139466642|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139466643|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
139466644|NCT02412475|Cytarabine|cytarabine|mesh-list
139466645|NCT02412475|Fludarabine|fludarabine|mesh-list
139466646|NCT02412475|Sorafenib|sorafenib|mesh-list
139466647|NCT02412475|Decitabine|decitabine|mesh-list
139466648|NCT02412475|Vorinostat|vorinostat|mesh-list
139466649|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466650|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139466652|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466653|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139466654|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
139466655|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466656|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
139466657|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466658|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139466659|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466660|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139466661|NCT04543643|Carvedilol|carvedilol|mesh-list
139466662|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139466663|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139466664|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
139466665|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466666|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466667|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466668|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139466669|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
139466670|NCT04543643|Protective Agents|protective agents|mesh-ancestor
139466671|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139466672|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139466673|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139466674|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
139466675|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139466676|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139466677|NCT05377619|Buspirone|buspirone|mesh-list
139466678|NCT05377619|Prucalopride|prucalopride|mesh-list
139466679|NCT05377619|Laxatives|laxatives|mesh-ancestor
139466680|NCT05377619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139466681|NCT05377619|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139466682|NCT05377619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139466683|NCT05377619|Serotonin Agents|serotonin agents|mesh-ancestor
139466684|NCT05377619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466685|NCT05377619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466686|NCT05377619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466687|NCT05377619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139466688|NCT05377619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139466689|NCT05377619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466690|NCT05377619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139466691|NCT03199157|Fentanyl|fentanyl|mesh-list
139466692|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139466693|NCT03199157|Narcotics|narcotics|mesh-ancestor
139466694|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466695|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466696|NCT03199157|Analgesics|analgesics|mesh-ancestor
139466697|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
139466698|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466699|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139466700|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139466701|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
139466702|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
139466703|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
139466704|NCT00641381|Carmustine|carmustine|mesh-list
139466705|NCT00641381|Etoposide|etoposide|mesh-list
139466706|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139466707|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
139466708|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466709|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139466710|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139466711|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
139466712|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466713|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466714|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139466715|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139466716|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139466717|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139466718|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466719|NCT02416999|Bevacizumab|bevacizumab|mesh-list
139466720|NCT02416999|Temozolomide|temozolomide|mesh-list
139466721|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139466722|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466723|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139466724|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139466725|NCT02416999|Growth Substances|growth substances|mesh-ancestor
139466726|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466727|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
139466728|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139466729|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
139466730|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466732|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139466733|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139466734|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139466735|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
139466736|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466737|NCT01679405|Cisplatin|cisplatin|mesh-list
139466738|NCT01679405|Gemcitabine|gemcitabine|mesh-list
139466739|NCT01679405|Afatinib|afatinib|mesh-list
139466740|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466741|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139466742|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
139466743|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466744|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139466745|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466746|NCT03175705|Interleukin-2|interleukin-2|mesh-list
139466747|NCT03175705|Tegafur|tegafur|mesh-list
139466748|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466749|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139466750|NCT03175705|Analgesics|analgesics|mesh-ancestor
139466751|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
139466752|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466753|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466754|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139466755|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
139466756|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466757|NCT00301457|Anastrozole|anastrozole|mesh-list
139466758|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139466759|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466760|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139466761|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139466762|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466763|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466764|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139466765|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
139466766|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139466767|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466768|NCT03177109|Fluorides|fluorides|mesh-list
139466769|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
139466770|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
139466771|NCT03177109|Protective Agents|protective agents|mesh-ancestor
139466772|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466773|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
139466774|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139466775|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
139466776|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466777|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466778|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466779|NCT02421913|Ketamine|ketamine|mesh-list
139466780|NCT02421913|Analgesics|analgesics|mesh-ancestor
139466781|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
139466782|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466783|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466784|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139466785|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139466786|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
139466787|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
139466788|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466789|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139466790|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139466791|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466792|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466793|NCT03179293|Propofol|propofol|mesh-list
139466794|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139466795|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466796|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466797|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139466798|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
139466799|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
139466801|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466802|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139466803|NCT02416765|Hormones|hormones|mesh-ancestor
139466804|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139466805|NCT02703259|Acetaminophen|acetaminophen|mesh-list
139466806|NCT02703259|Celecoxib|celecoxib|mesh-list
139466807|NCT02703259|Gabapentin|gabapentin|mesh-list
139466808|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139466809|NCT02703259|Analgesics|analgesics|mesh-ancestor
139466810|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
139466811|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466812|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466813|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
139466814|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139466815|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139466816|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139466817|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139466818|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139466819|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466820|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466821|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
139466822|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139466823|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139466824|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466825|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139466826|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139466827|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139466828|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466829|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
139466830|NCT02416687|Etonogestrel|etonogestrel|mesh-list
139466831|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139466832|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
139466833|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139466834|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466835|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139466836|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
139466837|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
139466838|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466839|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466840|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466841|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
139466842|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
139466843|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
139466844|NCT05093231|Olaparib|olaparib|mesh-list
139466845|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139466846|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466847|NCT05093231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139466848|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466849|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139466850|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466851|NCT02411149|Epinephrine|epinephrine|mesh-list
139466852|NCT02411149|Racepinephrine|racepinephrine|mesh-list
139466853|NCT02411149|Morphine|morphine|mesh-list
139466854|NCT02411149|Ropivacaine|ropivacaine|mesh-list
139466855|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
139466856|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139466857|NCT02411149|Narcotics|narcotics|mesh-ancestor
139466858|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466859|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466860|NCT02411149|Analgesics|analgesics|mesh-ancestor
139466861|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
139466862|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466863|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
139466864|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
139466865|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139466866|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139466867|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
139466868|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466869|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466870|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139466871|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139253647|NCT02239458|Hormones|hormones|mesh-ancestor
139466873|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139466874|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
139466875|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
139466876|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
139466877|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139466878|NCT04413227|Docetaxel|docetaxel|mesh-list
139466879|NCT04413227|Endostatins|endostatins|mesh-list
139466880|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466881|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
139466882|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
139466883|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
139466884|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466885|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139466886|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139466887|NCT04413227|Growth Substances|growth substances|mesh-ancestor
139466888|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466889|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
139466890|NCT02410135|Mirabegron|mirabegron|mesh-list
139466891|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139466892|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139466893|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139466894|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
139466895|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139466896|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466897|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466898|NCT02410135|Urological Agents|urological agents|mesh-ancestor
139466899|NCT02410759|Carbetocin|carbetocin|mesh-list
139466900|NCT02410759|Ergonovine|ergonovine|mesh-list
139466901|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
139466902|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139466903|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466904|NCT03175081|Ropivacaine|ropivacaine|mesh-list
139466905|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
139466906|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
139466907|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466908|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466909|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
139466910|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466911|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
139466912|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139466913|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466914|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466915|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139466916|NCT02401477|Amoxicillin|amoxicillin|mesh-list
139466917|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139466918|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466919|NCT03174457|Micafungin|micafungin|mesh-list
139466920|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
139466921|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466922|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
139466923|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139466924|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466925|NCT02409433|Lacosamide|lacosamide|mesh-list
139466926|NCT02409433|Phenytoin|phenytoin|mesh-list
139466927|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
139466928|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139466929|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139466930|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139466931|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466932|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139466933|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139466934|NCT01989754|Canagliflozin|canagliflozin|mesh-list
139466935|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139466936|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466937|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139466938|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466939|NCT01619878|Lumefantrine|lumefantrine|mesh-list
139466940|NCT01619878|Artemether|artemether|mesh-list
139466941|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139466942|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
139466943|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139466944|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139466945|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466946|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
139253733|NCT03124199|Rifaximin|rifaximin|mesh-list
139466947|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139466948|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
139466949|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466950|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
139466951|NCT01989208|Cathartics|cathartics|mesh-ancestor
139466952|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139466953|NCT01619410|Clindamycin|clindamycin|mesh-list
139466954|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
139466955|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
139466956|NCT01619410|Linezolid|linezolid|mesh-list
139466957|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139466958|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139466959|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139466960|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466961|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466962|NCT04666714|Pregabalin|pregabalin|mesh-list
139466963|NCT04666714|Analgesics|analgesics|mesh-ancestor
139466964|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
139466965|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139466966|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139466967|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
139466968|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139466969|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139466970|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466971|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139466972|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139466973|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139466974|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139466975|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139466976|NCT01261247|Panobinostat|panobinostat|mesh-list
139466977|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139466978|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466979|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466980|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466981|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139466982|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139466983|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139466984|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
139466985|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466986|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139466987|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139466988|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139466989|NCT02449655|Paclitaxel|paclitaxel|mesh-list
139466990|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139466991|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139466992|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139466993|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
139466994|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
139466995|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
139466996|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139466997|NCT04254731|Methadone|methadone|mesh-list
139466998|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139466999|NCT04254731|Narcotics|narcotics|mesh-ancestor
139467000|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467001|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467002|NCT04254731|Analgesics|analgesics|mesh-ancestor
139467003|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
139467004|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467005|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
139467006|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
139467007|NCT01603277|Antibodies|antibodies|mesh-list
139467008|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139467009|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
139467010|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467011|NCT01678313|Celecoxib|celecoxib|mesh-list
139467012|NCT01678313|Doxazosin|doxazosin|mesh-list
139467013|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139467014|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139467015|NCT01678313|Analgesics|analgesics|mesh-ancestor
139467016|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
139467017|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467018|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467019|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139467020|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139467021|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139467022|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139467023|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467024|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467025|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139467026|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139467027|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139467028|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139467029|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
139467030|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467032|NCT03197207|Salicylates|salicylates|mesh-list
139467033|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
139467034|NCT03197207|Menthol|menthol|mesh-list
139467035|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139467036|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139467037|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
139467038|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
139467039|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139467040|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139467041|NCT03197207|Analgesics|analgesics|mesh-ancestor
139467042|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
139467043|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467044|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467045|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139467046|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139467047|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139467048|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467049|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467050|NCT01603121|Lisofylline|lisofylline|mesh-list
139467051|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139467052|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
139467053|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467054|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139467055|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139467056|NCT01603121|Analgesics|analgesics|mesh-ancestor
139467057|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
139467058|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467059|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139467060|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139467061|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139467062|NCT02449265|Prednisone|prednisone|mesh-list
139467063|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
139467064|NCT02449265|Doxorubicin|doxorubicin|mesh-list
139467065|NCT02449265|Vincristine|vincristine|mesh-list
139467066|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139467067|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
139467068|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467069|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139467070|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139467071|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
139467072|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467073|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467074|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139467075|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139467076|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139467077|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139467078|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467079|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139467080|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
139467081|NCT02449265|Hormones|hormones|mesh-ancestor
139467082|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139467083|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139467084|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139467085|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
139467086|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
139467087|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
139467088|NCT03196817|Betamethasone|betamethasone|mesh-list
139467089|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
139467090|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139467091|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
139467092|NCT03196817|Lidocaine|lidocaine|mesh-list
139253866|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139467093|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139467094|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
139467095|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
139467096|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467097|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467098|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
139467099|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467100|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139467101|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139467102|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139467103|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139467104|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467105|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139467106|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
139467107|NCT03196817|Hormones|hormones|mesh-ancestor
139467108|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139467109|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139467110|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
139467111|NCT05091359|Calcium|calcium|mesh-list
139467112|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139467113|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467114|NCT02014402|Thrombin|thrombin|mesh-list
139467115|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
139467116|NCT02014402|Coagulants|coagulants|mesh-ancestor
139467117|NCT01988662|Ranibizumab|ranibizumab|mesh-list
139467118|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139467119|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139467120|NCT01988662|Growth Substances|growth substances|mesh-ancestor
139467121|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467122|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
139467123|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467124|NCT00127673|Sertraline|sertraline|mesh-list
139467125|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
139467126|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139467127|NCT00127673|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139467128|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139467129|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139467130|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467131|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467132|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
139467133|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467134|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
139467135|NCT02449187|Metformin|metformin|mesh-list
139467136|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139467137|NCT02449187|Calcium|calcium|mesh-list
139467138|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139467139|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467140|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139467141|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139467142|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139467143|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139467144|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
139467145|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467146|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139467147|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139467148|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467149|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
139467150|NCT02677181|Methotrexate|methotrexate|mesh-list
139467151|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
139467152|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139467153|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
139467154|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139467155|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467156|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139467157|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
139467158|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467159|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467160|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
139467161|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467162|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139467163|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139467164|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
139467165|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139467166|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139467167|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139253939|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467168|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139467169|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
139467170|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139467171|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139467172|NCT05095025|Bupivacaine|bupivacaine|mesh-list
139467173|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
139467174|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
139467175|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467176|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467177|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
139467178|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467179|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139467180|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139467181|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467182|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
139467183|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
139467184|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467185|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467186|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467187|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
139467188|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
139467189|NCT05084027|Fludarabine|fludarabine|mesh-list
139467190|NCT05084027|Melphalan|melphalan|mesh-list
139467191|NCT05084027|Venetoclax|venetoclax|mesh-list
139467192|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467193|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467194|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139467195|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
139467196|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467197|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139467198|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
139467199|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139467200|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
139467201|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
139467202|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467203|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467204|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467205|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
139467206|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
139467207|NCT02448797|Vinorelbine|vinorelbine|mesh-list
139467208|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139467209|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467210|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
139467211|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
139467212|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
139467213|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467214|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
139467215|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139467216|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139467217|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
139467218|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139467219|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139467220|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
139467221|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
139467222|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139467223|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
139467224|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467225|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
139467226|NCT04438421|Protective Agents|protective agents|mesh-ancestor
139467227|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
139467228|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139467229|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139467230|NCT04438577|Lidocaine|lidocaine|mesh-list
139467231|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
139467232|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
139467233|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467234|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467235|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
139467236|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467237|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139467238|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139467239|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139467240|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139467241|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254016|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
139467242|NCT05087615|Ondansetron|ondansetron|mesh-list
139467243|NCT05087615|Metoclopramide|metoclopramide|mesh-list
139467244|NCT05087615|Granisetron|granisetron|mesh-list
139467245|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
139467246|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
139467247|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467248|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467249|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139467250|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
139467251|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
139467252|NCT05087615|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139467253|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139467254|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
139467255|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467256|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467257|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139467258|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139467259|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
139467260|NCT01987102|Leucovorin|leucovorin|mesh-list
139467261|NCT01987102|Calcium|calcium|mesh-list
139467262|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
139467263|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139467264|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467265|NCT01987102|Antidotes|antidotes|mesh-ancestor
139467266|NCT01987102|Protective Agents|protective agents|mesh-ancestor
139467267|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
139467268|NCT01987102|Vitamins|vitamins|mesh-ancestor
139467269|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
139467270|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139467271|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139467272|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
139467273|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467274|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
139467275|NCT03968939|Promethazine|promethazine|mesh-list
139467276|NCT03968939|Melatonin|melatonin|mesh-list
139467277|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
139467278|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467279|NCT03968939|Protective Agents|protective agents|mesh-ancestor
139467280|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467281|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467282|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139467283|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139467284|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
139467285|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
139467286|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
139467287|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467288|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
139467289|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
139467290|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139467291|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139467292|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
139467293|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
139467294|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467295|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139467296|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
139467297|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
139467298|NCT03856619|Teriflunomide|teriflunomide|mesh-list
139467299|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139467300|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139467301|NCT03856619|Analgesics|analgesics|mesh-ancestor
139467302|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
139467303|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467304|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467305|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139467306|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139467307|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139467308|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
139467309|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
139467310|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139467311|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
139467312|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467313|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
139467314|NCT02448407|Protective Agents|protective agents|mesh-ancestor
139467315|NCT05098847|Lenvatinib|lenvatinib|mesh-list
139467316|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467317|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139467318|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467319|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467320|NCT04517357|Apatinib|apatinib|mesh-list
139467321|NCT04517357|Fluzoparib|fluzoparib|mesh-list
139467322|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467323|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139467324|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467325|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467326|NCT04517357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139467327|NCT02012296|Mifepristone|mifepristone|mesh-list
139467328|NCT02012296|Androgens|androgens|mesh-list
139467329|NCT02012296|Hormones|hormones|mesh-ancestor
139467330|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139467331|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467332|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139467333|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
139467334|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139467335|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139467336|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139467337|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139467338|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
139467339|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139467340|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139467341|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
139467342|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
139467343|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139467344|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139467345|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
139467346|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
139467347|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467348|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467349|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467350|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
139467351|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
139467352|NCT04658836|Triamcinolone|triamcinolone|mesh-list
139467353|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139467354|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139467355|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139467356|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139467357|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
139467358|NCT04658836|Hormones|hormones|mesh-ancestor
139467359|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139467360|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467361|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139467362|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
139467363|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467364|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467365|NCT01677377|Risperidone|risperidone|mesh-list
139467366|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139467367|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
139467368|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467369|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467370|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467371|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139467372|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139467373|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467374|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139467375|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139467376|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
139467377|NCT05097911|Bevacizumab|bevacizumab|mesh-list
139467378|NCT05097911|Atezolizumab|atezolizumab|mesh-list
139467379|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139467380|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467381|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139467382|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139467383|NCT05097911|Growth Substances|growth substances|mesh-ancestor
139467384|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467385|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
139467386|NCT05097911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139467387|NCT05097911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467388|NCT05097365|Folic Acid|folic acid|mesh-list
139467389|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
139467390|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
139467391|NCT05097365|Vitamins|vitamins|mesh-ancestor
139467392|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
139467393|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467394|NCT05097365|Hematinics|hematinics|mesh-ancestor
139467395|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
139467397|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139467398|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
139467399|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467400|NCT01964560|Lacosamide|lacosamide|mesh-list
139467401|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
139467402|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139467403|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139467404|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139467405|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467406|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
139467407|NCT02659943|Fludarabine|fludarabine|mesh-list
139467408|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139467409|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
139467410|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467411|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139467412|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139467413|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
139467414|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467415|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467416|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139467417|NCT05083325|Oseltamivir|oseltamivir|mesh-list
139467418|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
139467419|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139467420|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467421|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467422|NCT01677299|Metformin|metformin|mesh-list
139467423|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139467424|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467425|NCT04999631|Ethanol|ethanol|mesh-list
139467426|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
139467427|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139467428|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139467429|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467430|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467431|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139467432|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
139467433|NCT02718833|Dexamethasone|dexamethasone|mesh-list
139467434|NCT02718833|Bortezomib|bortezomib|mesh-list
139467435|NCT02718833|Pomalidomide|pomalidomide|mesh-list
139467436|NCT02718833|Elotuzumab|elotuzumab|mesh-list
139467437|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139467438|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
139467439|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
139467440|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467441|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467442|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139467443|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
139467444|NCT02718833|Hormones|hormones|mesh-ancestor
139467445|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139467446|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139467447|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467448|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
139467449|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139467450|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139467451|NCT02718833|Growth Substances|growth substances|mesh-ancestor
139467452|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
139467453|NCT04908293|Listerine|listerine|mesh-list
139467454|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
139467455|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
139467456|NCT04908293|Protective Agents|protective agents|mesh-ancestor
139467457|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467458|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139467459|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139467460|NCT01964326|Atorvastatin|atorvastatin|mesh-list
139467461|NCT01964326|Calcium|calcium|mesh-list
139467462|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139467463|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467464|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139467465|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139467466|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
139467467|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467468|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139467469|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139467471|NCT05102045|Memantine|memantine|mesh-list
139467472|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
139467473|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139467474|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139467475|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
139467476|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467477|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467478|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876534|NCT05003245|Mitogens|mitogens|mesh-list
139467479|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139467480|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139467481|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467482|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
139467483|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
139467484|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
139467485|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139467486|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139467487|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139467488|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467489|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467490|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139467491|NCT04531553|Levobupivacaine|levobupivacaine|mesh-list
139467492|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
139467493|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
139467494|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467495|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467496|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
139467497|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467498|NCT05101811|Vitamin D|vitamin d|mesh-list
139467499|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
139467500|NCT05101811|Cholecalciferol|cholecalciferol|mesh-list
139467501|NCT05101811|Vitamins|vitamins|mesh-list
139467502|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
139467503|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467504|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139467505|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139467506|NCT04088123|Ticagrelor|ticagrelor|mesh-list
139467507|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139467508|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139467509|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139467510|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139467511|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
139467512|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467513|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467514|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467515|NCT03847181|Vitamin K|vitamin k|mesh-list
139467516|NCT03847181|Warfarin|warfarin|mesh-list
139467517|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
139467518|NCT03847181|Apixaban|apixaban|mesh-list
139467519|NCT03847181|Anticoagulants|anticoagulants|mesh-list
139467520|NCT03847181|Vitamins|vitamins|mesh-ancestor
139467521|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
139467522|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467523|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139467524|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
139467525|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139467526|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
139467527|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467528|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467529|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139467530|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139467531|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
139467532|NCT03847181|Coagulants|coagulants|mesh-ancestor
139467533|NCT03477851|Tramadol|tramadol|mesh-list
139467534|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139467535|NCT03477851|Narcotics|narcotics|mesh-ancestor
139467536|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467537|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467538|NCT03477851|Analgesics|analgesics|mesh-ancestor
139467539|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
139467540|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467541|NCT02409199|Docetaxel|docetaxel|mesh-list
139467542|NCT02409199|Apatinib|apatinib|mesh-list
139467543|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467544|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
139467545|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
139467546|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
139467547|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467548|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139467549|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467550|NCT03115489|Ketamine|ketamine|mesh-list
139467551|NCT03115489|Propofol|propofol|mesh-list
139467552|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139467553|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467554|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467555|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139467556|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
139467557|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
139467558|NCT03115489|Analgesics|analgesics|mesh-ancestor
139467559|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
139467560|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467561|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139467562|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139467563|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139467564|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467565|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467566|NCT03168997|Memantine|memantine|mesh-list
139467567|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139467568|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139467569|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
139467570|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467571|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467572|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467573|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139467574|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139467575|NCT03171727|Heparin|heparin|mesh-list
139467576|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139467577|NCT03171727|Tinzaparin|tinzaparin|mesh-list
139467578|NCT03171727|Dalteparin|dalteparin|mesh-list
139467579|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
139467580|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139467581|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139467582|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467583|NCT02400931|Rocuronium|rocuronium|mesh-list
139467584|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139467585|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139467586|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139467587|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467588|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467589|NCT03116269|Aspirin|aspirin|mesh-list
139467590|NCT03116269|Cilostazol|cilostazol|mesh-list
139467591|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139467592|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139467593|NCT03116269|Analgesics|analgesics|mesh-ancestor
139467594|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
139467595|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467596|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467597|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139467598|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139467599|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139467600|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139467601|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467602|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139467603|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139467604|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467605|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
139467606|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139467607|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
139467608|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139467609|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
139467610|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
139467611|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139467612|NCT03116269|Protective Agents|protective agents|mesh-ancestor
139467613|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139467614|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139467615|NCT03174067|Clonidine|clonidine|mesh-list
139467616|NCT03174067|Buprenorphine|buprenorphine|mesh-list
139467617|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139467618|NCT03174067|Narcotics|narcotics|mesh-ancestor
139467619|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467620|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254421|NCT02140814|Niacin|niacin|mesh-list
139467621|NCT03174067|Analgesics|analgesics|mesh-ancestor
139467622|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
139467623|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467624|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139467625|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139467626|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
139467627|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
139467628|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139467629|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139467630|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139467631|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
139467632|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467633|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467634|NCT02408185|Colistin|colistin|mesh-list
139467635|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139467636|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139467637|NCT02408419|Bupivacaine|bupivacaine|mesh-list
139467638|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
139467639|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
139467640|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467641|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467642|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
139467643|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467644|NCT00708097|Fluorides|fluorides|mesh-list
139467645|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
139467646|NCT00708097|Protective Agents|protective agents|mesh-ancestor
139467647|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467648|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139467649|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139467650|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139467651|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467652|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
139467653|NCT02405689|Remifentanil|remifentanil|mesh-list
139467654|NCT02405689|Sevoflurane|sevoflurane|mesh-list
139467655|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139467656|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467657|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467658|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139467659|NCT02405689|Analgesics|analgesics|mesh-ancestor
139467660|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
139467661|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467662|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139467663|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139467664|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139467665|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
139467666|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467667|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467668|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139467669|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139467670|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
139467671|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
139467672|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139467673|NCT02405689|Narcotics|narcotics|mesh-ancestor
139467674|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
139467675|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139467676|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139467677|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139467678|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139467679|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467680|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
139467681|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467682|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467683|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139467684|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467685|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139467686|NCT02699125|Guanfacine|guanfacine|mesh-list
139467687|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139467688|NCT02699125|Diuretics|diuretics|mesh-ancestor
139467689|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
139467690|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467691|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139467692|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139467693|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467694|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139467695|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139467696|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139467697|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
139467698|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467699|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
139467700|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
139467701|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467702|NCT04279535|Protective Agents|protective agents|mesh-ancestor
139467703|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467704|NCT04279535|Vitamins|vitamins|mesh-ancestor
139467705|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
139467706|NCT02400151|Vitamin D|vitamin d|mesh-list
139467707|NCT02400151|Vitamins|vitamins|mesh-ancestor
139467708|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
139467709|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467710|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139467711|NCT02400385|Nivolumab|nivolumab|mesh-list
139467712|NCT02400385|Sunitinib|sunitinib|mesh-list
139467713|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139467714|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467715|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139467716|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467717|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139467718|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139467719|NCT02400385|Growth Substances|growth substances|mesh-ancestor
139467720|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467721|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
139467722|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139467723|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467724|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139467725|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139467726|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139467727|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139467728|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139467729|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
139467730|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467731|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467732|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467733|NCT05100719|Mebeverine|mebeverine|mesh-list
139467734|NCT05100719|Simethicone|simethicone|mesh-list
139467735|NCT05100719|Citric Acid|citric acid|mesh-list
139467736|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
139467737|NCT05100719|Alverine|alverine|mesh-list
139467738|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
139467739|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139467740|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
139467741|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
139467742|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467743|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
139467744|NCT05100719|Emollients|emollients|mesh-ancestor
139467745|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
139467746|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
139467747|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
139467748|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467749|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467750|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
139467751|NCT05100563|Naltrexone|naltrexone|mesh-list
139467752|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139467753|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139467754|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467755|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
139467756|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467757|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
139467758|NCT05100329|Analgesics|analgesics|mesh-ancestor
139467759|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
139467760|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467761|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467762|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467763|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139467764|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139467765|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467766|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467767|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
139467768|NCT04530539|Melatonin|melatonin|mesh-list
139467769|NCT04530539|Vitamins|vitamins|mesh-ancestor
139467770|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
139467771|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467772|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
139467773|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467775|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467776|NCT02698891|Paclitaxel|paclitaxel|mesh-list
139467777|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139467778|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467779|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
139467780|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
139467781|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
139467782|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467783|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
139467784|NCT04719065|Analgesics|analgesics|mesh-ancestor
139467785|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
139467786|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467787|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467788|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467789|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139467790|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139467791|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467792|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467793|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139467794|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139467795|NCT05108051|Oseltamivir|oseltamivir|mesh-list
139467796|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
139467797|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139467798|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467799|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467800|NCT03765359|Metformin|metformin|mesh-list
139467801|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139467802|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467803|NCT04351295|Chloroquine|chloroquine|mesh-list
139467804|NCT04351295|Favipiravir|favipiravir|mesh-list
139467805|NCT04351295|Amebicides|amebicides|mesh-ancestor
139467806|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139467807|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139467808|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139467809|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
139467810|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139467811|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
139467812|NCT02399137|Paclitaxel|paclitaxel|mesh-list
139467813|NCT02399137|Gemcitabine|gemcitabine|mesh-list
139467814|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139467815|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467816|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
139467817|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
139467818|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
139467819|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467820|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139467821|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
139467822|NCT05093387|Carboplatin|carboplatin|mesh-list
139467823|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
139467824|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467825|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139467826|NCT05093387|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139467827|NCT05093387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467828|NCT02850263|Aflibercept|aflibercept|mesh-list
139467829|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139467830|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139467831|NCT02850263|Growth Substances|growth substances|mesh-ancestor
139467832|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467833|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
139467834|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467835|NCT04481815|Rituximab|rituximab|mesh-list
139467836|NCT04481815|Methotrexate|methotrexate|mesh-list
139467837|NCT04481815|Lenalidomide|lenalidomide|mesh-list
139467838|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139467839|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467840|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
139467841|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467842|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139467843|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139467844|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
139467845|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139467846|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139467847|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
139467848|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467849|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
139467850|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467851|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139467852|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139467853|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139467854|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139467855|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139467856|NCT04481815|Growth Substances|growth substances|mesh-ancestor
139467857|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
139467858|NCT05106803|Amoxicillin|amoxicillin|mesh-list
139467859|NCT05106803|Vancomycin|vancomycin|mesh-list
139467860|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
139467861|NCT05106803|Clindamycin|clindamycin|mesh-list
139467862|NCT05106803|Gentamicins|gentamicins|mesh-list
139467863|NCT05106803|Tetracycline|tetracycline|mesh-list
139467864|NCT05106803|Penicillins|penicillins|mesh-list
139467865|NCT05106803|Erythromycin|erythromycin|mesh-list
139467866|NCT05106803|Ampicillin|ampicillin|mesh-list
139467867|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
139467868|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
139467869|NCT05106803|Cefepime|cefepime|mesh-list
139467870|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139467871|NCT05106803|Norfloxacin|norfloxacin|mesh-list
139467872|NCT05106803|Oxacillin|oxacillin|mesh-list
139467873|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
139467874|NCT05106803|Trimethoprim|trimethoprim|mesh-list
139467875|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
139467876|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139467877|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139467878|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139467879|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139467880|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139467881|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467882|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467883|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139467884|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139467885|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139467886|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139467887|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
139467888|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139467889|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139467890|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139467891|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139467892|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139467893|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139467894|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139467895|NCT02398357|Nadroparin|nadroparin|mesh-list
139467896|NCT02398357|Warfarin|warfarin|mesh-list
139467897|NCT02398357|Calcium|calcium|mesh-list
139467898|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139467899|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467900|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
139467901|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139467902|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139467903|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467904|NCT02398201|Bezafibrate|bezafibrate|mesh-list
139467905|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139467906|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
139467907|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467908|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139467909|NCT05106179|Propranolol|propranolol|mesh-list
139467910|NCT05106179|Atenolol|atenolol|mesh-list
139467911|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139467912|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139467913|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
139467914|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467915|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467916|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467917|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139467918|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139467919|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
139467920|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
139467921|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
139467922|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467923|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139467924|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
139467925|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
139467926|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139467927|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467928|NCT02406781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139467929|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126468|NCT02980042|Rituximab|rituximab|mesh-list
139467930|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139467931|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
139467932|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467933|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139467934|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139467935|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
139467936|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139467937|NCT05106023|Temozolomide|temozolomide|mesh-list
139467938|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139467939|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
139467940|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467941|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139467942|NCT02398123|Bupivacaine|bupivacaine|mesh-list
139467943|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
139467944|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
139467945|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467946|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467947|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
139467948|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467949|NCT02404363|Clopidogrel|clopidogrel|mesh-list
139467950|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139467951|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139467952|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139467953|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139467954|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
139467955|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467956|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467957|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467958|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
139467959|NCT02404519|Vitamin K|vitamin k|mesh-list
139467960|NCT02404519|Menaquinone 7|menaquinone 7|mesh-list
139467961|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139467962|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139467963|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467964|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
139467965|NCT02404519|Coagulants|coagulants|mesh-ancestor
139467966|NCT02404519|Vitamins|vitamins|mesh-ancestor
139467967|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
139467968|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467969|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
139467970|NCT03173131|Narcotics|narcotics|mesh-ancestor
139467971|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467972|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467973|NCT03173131|Analgesics|analgesics|mesh-ancestor
139467974|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
139467975|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467976|NCT02658149|Ketorolac|ketorolac|mesh-list
139467977|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139467978|NCT02658149|Epinephrine|epinephrine|mesh-list
139467979|NCT02658149|Morphine|morphine|mesh-list
139467980|NCT02658149|Ropivacaine|ropivacaine|mesh-list
139467981|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139467982|NCT02658149|Narcotics|narcotics|mesh-ancestor
139467983|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139467984|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139467985|NCT02658149|Analgesics|analgesics|mesh-ancestor
139467986|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
139467987|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139467988|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
139467989|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
139467990|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139467991|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139467992|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
139467993|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139467994|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139467995|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139467996|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139467997|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
139467998|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139254770|NCT01368887|Niacin|niacin|mesh-list
139467999|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
139468000|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
139468001|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
139468002|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139468003|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139385467|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139468004|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139468005|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468006|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139468007|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139468008|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468009|NCT04481971|Prednisolone|prednisolone|mesh-list
139468010|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468011|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
139468012|NCT04481971|Hormones|hormones|mesh-ancestor
139468013|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139468014|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468015|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139468016|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468017|NCT03172741|Dronabinol|dronabinol|mesh-list
139468018|NCT03172741|Cannabidiol|cannabidiol|mesh-list
139468019|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
139468020|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
139468021|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468022|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139468023|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139468024|NCT03172741|Analgesics|analgesics|mesh-ancestor
139468025|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
139468026|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468027|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139468028|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139468029|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139468030|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468031|NCT03172741|Hormones|hormones|mesh-ancestor
139468032|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139468033|NCT02702011|Empagliflozin|empagliflozin|mesh-list
139468034|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139468035|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468036|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139468037|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468038|NCT03170713|Ibuprofen|ibuprofen|mesh-list
139468039|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139468040|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139468041|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139468042|NCT03170713|Analgesics|analgesics|mesh-ancestor
139468043|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
139468044|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468045|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468046|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468047|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139468048|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139468049|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468050|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468051|NCT02657369|Lenvatinib|lenvatinib|mesh-list
139468052|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468053|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139468054|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468055|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468056|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
139468057|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139468058|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468059|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139468060|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468061|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
139468062|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139468063|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
139468064|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468065|NCT04832009|Protective Agents|protective agents|mesh-ancestor
139468066|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468067|NCT04832009|Vitamins|vitamins|mesh-ancestor
139468068|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
139468069|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139468070|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139468071|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139468072|NCT03129113|Metformin|metformin|mesh-list
139468073|NCT03129113|Maraviroc|maraviroc|mesh-list
139468074|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139468075|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468076|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139468077|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139468078|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468079|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139468080|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139468081|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
139468082|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468083|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139468084|NCT05105009|Furosemide|furosemide|mesh-list
139468085|NCT05105009|Diuretics|diuretics|mesh-ancestor
139468086|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
139468087|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468088|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139468089|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139468090|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468091|NCT05104931|Piroxicam|piroxicam|mesh-list
139468092|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139468093|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139468094|NCT05104931|Analgesics|analgesics|mesh-ancestor
139468095|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
139468096|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468097|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468098|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468099|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139468100|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139468101|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468102|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468103|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139468104|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139468105|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
139468106|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468107|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468108|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139468109|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
139468110|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139468111|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139468112|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139468113|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
139468114|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139468115|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468116|NCT02406703|Mepivacaine|mepivacaine|mesh-list
139468117|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
139468118|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
139468119|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
139468120|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468121|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468122|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
139468123|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468124|NCT02682641|Rituximab|rituximab|mesh-list
139468125|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139468126|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468127|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
139468128|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468129|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139468130|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
139468131|NCT05110469|Meperidine|meperidine|mesh-list
139468132|NCT05110469|Analgesics|analgesics|mesh-ancestor
139468133|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
139468134|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468135|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468136|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
139468137|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468138|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139468139|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
139468140|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139468141|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139468142|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468143|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139468144|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
139468145|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139468146|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139468147|NCT05110469|Narcotics|narcotics|mesh-ancestor
139468148|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139468150|NCT02404051|Fulvestrant|fulvestrant|mesh-list
139468151|NCT02404051|Exemestane|exemestane|mesh-list
139468152|NCT02404051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139468153|NCT02404051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139468154|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468155|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468156|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139468157|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
139468158|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468159|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468160|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139468161|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139468162|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139468163|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
139468164|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139468165|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139468166|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139468167|NCT05094323|Bupivacaine|bupivacaine|mesh-list
139468168|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
139468169|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
139468170|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468171|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468172|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
139468173|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468174|NCT03170323|Cyclosporine|cyclosporine|mesh-list
139468175|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
139468176|NCT03170323|Cyclosporins|cyclosporins|mesh-list
139468177|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468178|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468179|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139468180|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
139468181|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468182|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
139468183|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468184|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
139468185|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139468186|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139468187|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139468188|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468189|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139468190|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
139468191|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139468192|NCT02396563|Ropivacaine|ropivacaine|mesh-list
139468193|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
139468194|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
139468195|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468196|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468197|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
139468198|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468199|NCT05109377|Tadalafil|tadalafil|mesh-list
139468200|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
139468201|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139468202|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139468203|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468204|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468205|NCT05109377|Urological Agents|urological agents|mesh-ancestor
139468206|NCT05109299|Fluorides|fluorides|mesh-list
139468207|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
139468208|NCT05109299|Protective Agents|protective agents|mesh-ancestor
139468209|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468210|NCT05108597|Misoprostol|misoprostol|mesh-list
139468211|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139468212|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
139468213|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139468214|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468215|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139468216|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139468217|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
139468218|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
139468219|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
139254990|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
139468220|NCT02396329|Povidone|povidone|mesh-list
139468221|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139468222|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468223|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
139468224|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
139468225|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
139468226|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
139468227|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139468228|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468229|NCT03168139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139468230|NCT03168139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468231|NCT02395783|Melatonin|melatonin|mesh-list
139468232|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
139468233|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468234|NCT02395783|Protective Agents|protective agents|mesh-ancestor
139468235|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468236|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468237|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
139468238|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139468239|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139468240|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468241|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
139468242|NCT04555343|Coagulants|coagulants|mesh-ancestor
139468243|NCT04528667|Abivertinib|abivertinib|mesh-list
139468244|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468245|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468246|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139468247|NCT04309877|Theophylline|theophylline|mesh-list
139468248|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139468249|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
139468250|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468251|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468252|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139468253|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
139468254|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139468255|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468256|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468257|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
139468258|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139468259|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139468260|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
139468261|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139468262|NCT04367909|Carboplatin|carboplatin|mesh-list
139468263|NCT04367909|Docetaxel|docetaxel|mesh-list
139468264|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
139468265|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468266|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
139468267|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
139468268|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
139468269|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468270|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139468271|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
139468272|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139468273|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
139468274|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139468275|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468276|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139468277|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139468278|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139468279|NCT04196075|Andrographolide|andrographolide|mesh-list
139468280|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468281|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139468282|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139468283|NCT04196075|Analgesics|analgesics|mesh-ancestor
139468284|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
139468285|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468286|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468287|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139468288|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139468289|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139468290|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468291|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
139468292|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139468293|NCT03863483|Docetaxel|docetaxel|mesh-list
139468294|NCT03863483|Pemetrexed|pemetrexed|mesh-list
139468295|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468296|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
139468298|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
139468299|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468300|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468301|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139468302|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139468303|NCT03830411|Docetaxel|docetaxel|mesh-list
139468304|NCT03830411|Pemetrexed|pemetrexed|mesh-list
139468305|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468306|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
139468307|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
139468308|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
139468309|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468310|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468311|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139468312|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139468313|NCT03300479|Urapidil|urapidil|mesh-list
139468314|NCT03300479|Clevidipine|clevidipine|mesh-list
139468315|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139468316|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139468317|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468318|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139468319|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468320|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139468321|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
139468322|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139468323|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
139468324|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139468325|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139468326|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139468327|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139468328|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
139468329|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
139468330|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468331|NCT03540875|Remifentanil|remifentanil|mesh-list
139468332|NCT03540875|Propofol|propofol|mesh-list
139468333|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
139468334|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468335|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468336|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139468337|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139468338|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
139468339|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139468340|NCT03540875|Narcotics|narcotics|mesh-ancestor
139468341|NCT03540875|Analgesics|analgesics|mesh-ancestor
139468342|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
139468343|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468344|NCT03536507|Acetazolamide|acetazolamide|mesh-list
139468345|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
139468346|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139468347|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468348|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468349|NCT03536507|Diuretics|diuretics|mesh-ancestor
139468350|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
139468351|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468352|NCT04765787|Acetaminophen|acetaminophen|mesh-list
139468353|NCT04765787|Orphenadrine|orphenadrine|mesh-list
139468354|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139468355|NCT04765787|Analgesics|analgesics|mesh-ancestor
139468356|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
139468357|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468358|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468359|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
139468360|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139468361|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139468362|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139468363|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139468364|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
139468365|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
139468366|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139468367|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139468368|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
139468369|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139468370|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468371|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
139468372|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139468373|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468374|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
139468375|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
139468376|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468377|NCT05115149|Protective Agents|protective agents|mesh-ancestor
139468378|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468379|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139468380|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468381|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
139468382|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468383|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
139468384|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
139468385|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139468386|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139468387|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468388|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
139468389|NCT04521881|Coagulants|coagulants|mesh-ancestor
139468390|NCT04305899|Deucravacitinib|deucravacitinib|mesh-list
139468391|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
139468392|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139468393|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468394|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468395|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
139468396|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139468397|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
139468398|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468399|NCT01675661|Expectorants|expectorants|mesh-ancestor
139468400|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
139468401|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139468402|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
139468403|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468404|NCT01675661|Protective Agents|protective agents|mesh-ancestor
139468405|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468406|NCT01675661|Antidotes|antidotes|mesh-ancestor
139468407|NCT05113511|Bevacizumab|bevacizumab|mesh-list
139468408|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139468409|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468410|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139468411|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139468412|NCT05113511|Growth Substances|growth substances|mesh-ancestor
139468413|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468414|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
139468415|NCT04161989|Progesterone|progesterone|mesh-list
139468416|NCT04161989|Progestins|progestins|mesh-ancestor
139468417|NCT04161989|Hormones|hormones|mesh-ancestor
139468418|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139468419|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468420|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
139468421|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139468422|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
139468423|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468424|NCT01986010|Antacids|antacids|mesh-ancestor
139468425|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468426|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139468427|NCT04160117|Colchicine|colchicine|mesh-list
139468428|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
139468429|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139468430|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
139468431|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
139468432|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
139468433|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468434|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468435|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139468436|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139468437|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139468438|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
139468439|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468440|NCT03115255|Ranibizumab|ranibizumab|mesh-list
139468441|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139468442|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139468443|NCT03115255|Growth Substances|growth substances|mesh-ancestor
139468444|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468445|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
139255212|NCT01343043|Fludarabine|fludarabine|mesh-list
139468446|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468448|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139468449|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468450|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
139468451|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468452|NCT02009722|Morphine|morphine|mesh-list
139468453|NCT02009722|Hydromorphone|hydromorphone|mesh-list
139468454|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139468455|NCT02009722|Narcotics|narcotics|mesh-ancestor
139468456|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468457|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468458|NCT02009722|Analgesics|analgesics|mesh-ancestor
139468459|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
139468460|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468461|NCT02655419|Metronidazole|metronidazole|mesh-list
139468462|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468463|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139468464|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139468465|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139468466|NCT01962922|Tacrolimus|tacrolimus|mesh-list
139468467|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139468468|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
139468469|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468470|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139468471|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468472|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468473|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
139468474|NCT04198961|Narcotics|narcotics|mesh-ancestor
139468475|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468476|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468477|NCT04198961|Analgesics|analgesics|mesh-ancestor
139468478|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
139468479|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468480|NCT01984684|Vancomycin|vancomycin|mesh-list
139468481|NCT01984684|Aztreonam|aztreonam|mesh-list
139468482|NCT01984684|Delafloxacin|delafloxacin|mesh-list
139468483|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139468484|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468485|NCT02694523|Adalimumab|adalimumab|mesh-list
139468486|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139468487|NCT02694523|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139468488|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468489|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139468490|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
139468491|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468492|NCT05038475|Antibodies|antibodies|mesh-list
139468493|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
139468494|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468495|NCT02009332|Sirolimus|sirolimus|mesh-list
139468496|NCT02009332|Gemcitabine|gemcitabine|mesh-list
139468497|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139468498|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
139468499|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468500|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468501|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139468502|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468503|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139468504|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
139468505|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139468506|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
139468507|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468508|NCT01984294|Ribavirin|ribavirin|mesh-list
139468509|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
139468510|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468511|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
139468512|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468513|NCT03170479|Vitamin D|vitamin d|mesh-list
139468514|NCT03170479|Vitamins|vitamins|mesh-ancestor
139468515|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
139468516|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468517|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139468518|NCT01962298|Rocuronium|rocuronium|mesh-list
139468519|NCT01962298|Neostigmine|neostigmine|mesh-list
139468520|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139468521|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139468522|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139468527|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468529|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139468530|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139468531|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
139468532|NCT03169933|Androgens|androgens|mesh-list
139468533|NCT03169933|Hormones|hormones|mesh-ancestor
139468534|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139468535|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468536|NCT02403349|Atenolol|atenolol|mesh-list
139468537|NCT02403349|Valsartan|valsartan|mesh-list
139468538|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139468539|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139468540|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139468541|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468542|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139468543|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
139468544|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
139468545|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468546|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468547|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139468548|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139468549|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139468550|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
139468551|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139468552|NCT04735822|Belumosudil|belumosudil|mesh-list
139468553|NCT04735822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139468554|NCT04735822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468555|NCT04735822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468561|NCT01982812|Levetiracetam|levetiracetam|mesh-list
139468562|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
139468563|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
139468564|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
139468565|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139468566|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468567|NCT02007070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139468568|NCT02007070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468569|NCT03906617|Dexamethasone|dexamethasone|mesh-list
139468570|NCT03906617|Epinephrine|epinephrine|mesh-list
139468571|NCT03906617|Bupivacaine|bupivacaine|mesh-list
139468572|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468573|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
139468574|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
139468575|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468576|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468577|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139468578|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
139468579|NCT03906617|Hormones|hormones|mesh-ancestor
139468580|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139468581|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139468582|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468583|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
139468584|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
139468585|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468586|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
139468587|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139468588|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139468589|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
139468590|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139468591|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468592|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139468593|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139468594|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139468595|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
139468596|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
139468597|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
139468598|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139468599|NCT04655482|Aflibercept|aflibercept|mesh-list
139468600|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139468601|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139468602|NCT04655482|Growth Substances|growth substances|mesh-ancestor
139468603|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468604|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
139468605|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468606|NCT02184767|Loxapine|loxapine|mesh-list
139468607|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139468608|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139468609|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468610|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468611|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139468612|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139468613|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
139468614|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139468615|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468616|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
139468617|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139468618|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139468619|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
139468620|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139468621|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468622|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468623|NCT01981954|Urological Agents|urological agents|mesh-ancestor
139468624|NCT03727139|Rasagiline|rasagiline|mesh-list
139468625|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139468626|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468627|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468628|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139468629|NCT03727139|Protective Agents|protective agents|mesh-ancestor
139468630|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468631|NCT05120687|Cyclosporine|cyclosporine|mesh-list
139468632|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
139468633|NCT05120687|Adalimumab|adalimumab|mesh-list
139468634|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
139468635|NCT05120687|Methotrexate|methotrexate|mesh-list
139468636|NCT05120687|Cyclosporins|cyclosporins|mesh-list
139468637|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139468638|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
139468639|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468640|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139468641|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139468642|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
139468643|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468644|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468645|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139468646|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139468647|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
139468648|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139468649|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139468650|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
139468651|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
139468652|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468653|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139468654|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139468655|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
139468656|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468657|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139468658|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139468659|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139468660|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
139468661|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139468662|NCT05120687|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139468663|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468664|NCT03416855|Insulin|insulin|mesh-list
139468665|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
139468666|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139468667|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468668|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139468669|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139468670|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255433|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
139468671|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139468672|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139468673|NCT04224545|Colchicine|colchicine|mesh-list
139468674|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
139468675|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139468676|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
139468677|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
139468678|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
139468679|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468680|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468681|NCT05121233|Diclofenac|diclofenac|mesh-list
139468682|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139468683|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139468684|NCT05121233|Analgesics|analgesics|mesh-ancestor
139468685|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
139468686|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468687|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468688|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468689|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139468690|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139468691|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468692|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468693|NCT06121401|Bevacizumab|bevacizumab|mesh-list
139468694|NCT06121401|Olaparib|olaparib|mesh-list
139468695|NCT06121401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139468696|NCT06121401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468697|NCT06121401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139468698|NCT06121401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139468699|NCT06121401|Growth Substances|growth substances|mesh-ancestor
139468700|NCT06121401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468701|NCT06121401|Growth Inhibitors|growth inhibitors|mesh-ancestor
139468702|NCT06121401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139468703|NCT06121401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468704|NCT06121401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468705|NCT06121284|Cycloserine|cycloserine|mesh-list
139468706|NCT06121284|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139468707|NCT06121284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468708|NCT06121284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139468709|NCT06121284|Antitubercular Agents|antitubercular agents|mesh-ancestor
139468710|NCT06121284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139468711|NCT06121284|Antimetabolites|antimetabolites|mesh-ancestor
139468712|NCT06121284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468713|NCT06121245|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139468714|NCT06121245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468715|NCT06121245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468716|NCT06121180|Aflibercept|aflibercept|mesh-list
139468717|NCT06121180|Cemiplimab|cemiplimab|mesh-list
139468718|NCT06121180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139468719|NCT06121180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139468720|NCT06121180|Growth Substances|growth substances|mesh-ancestor
139468721|NCT06121180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468722|NCT06121180|Growth Inhibitors|growth inhibitors|mesh-ancestor
139468723|NCT06121180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468724|NCT06121180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139468725|NCT06121141|Lidocaine|lidocaine|mesh-list
139468726|NCT06121141|Epinephrine|epinephrine|mesh-list
139468727|NCT06121141|Racepinephrine|racepinephrine|mesh-list
139468728|NCT06121141|Epinephryl borate|epinephryl borate|mesh-list
139468729|NCT06121141|Anesthetics, Local|anesthetics, local|mesh-ancestor
139468730|NCT06121141|Anesthetics|anesthetics|mesh-ancestor
139468731|NCT06121141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468732|NCT06121141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468733|NCT06121141|Sensory System Agents|sensory system agents|mesh-ancestor
139468734|NCT06121141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468735|NCT06121141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139468736|NCT06121141|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139468737|NCT06121141|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139468738|NCT06121141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139468739|NCT06121141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468740|NCT06121141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139468741|NCT06121141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139468742|NCT06121141|Adrenergic Agents|adrenergic agents|mesh-ancestor
139468743|NCT06121141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139468744|NCT06121141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139468745|NCT06121141|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139468746|NCT06121141|Autonomic Agents|autonomic agents|mesh-ancestor
139468747|NCT06121141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139468748|NCT06121141|Respiratory System Agents|respiratory system agents|mesh-ancestor
139468749|NCT06121141|Mydriatics|mydriatics|mesh-ancestor
139468750|NCT06121141|Sympathomimetics|sympathomimetics|mesh-ancestor
139468751|NCT06121141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139468752|NCT06121115|Norepinephrine|norepinephrine|mesh-list
139468753|NCT06121115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139468754|NCT06121115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139468755|NCT06121115|Adrenergic Agents|adrenergic agents|mesh-ancestor
139468756|NCT06121115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139468757|NCT06121115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468758|NCT06121115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468759|NCT06121115|Sympathomimetics|sympathomimetics|mesh-ancestor
139468760|NCT06121115|Autonomic Agents|autonomic agents|mesh-ancestor
139468761|NCT06121115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468762|NCT06121115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139468764|NCT06121011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468765|NCT06121011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468766|NCT06121011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139468767|NCT06121011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139468768|NCT06121011|Antiviral Agents|antiviral agents|mesh-ancestor
139468769|NCT06121011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468770|NCT06121011|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139468771|NCT06121011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139468772|NCT06121011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468773|NCT06120673|Prednisolone|prednisolone|mesh-list
139468774|NCT06120673|Cyclophosphamide|cyclophosphamide|mesh-list
139468775|NCT06120673|Obinutuzumab|obinutuzumab|mesh-list
139468776|NCT06120673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139468777|NCT06120673|Immunologic Factors|immunologic factors|mesh-ancestor
139468778|NCT06120673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468779|NCT06120673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139468780|NCT06120673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139468781|NCT06120673|Alkylating Agents|alkylating agents|mesh-ancestor
139468782|NCT06120673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468783|NCT06120673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468784|NCT06120673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139468785|NCT06120673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468786|NCT06120673|Glucocorticoids|glucocorticoids|mesh-ancestor
139468787|NCT06120673|Hormones|hormones|mesh-ancestor
139468788|NCT06120673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139468789|NCT06120673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139468790|NCT06120673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139468791|NCT06120530|Bupivacaine|bupivacaine|mesh-list
139468792|NCT06120530|Anesthetics, Local|anesthetics, local|mesh-ancestor
139468793|NCT06120530|Anesthetics|anesthetics|mesh-ancestor
139468794|NCT06120530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468795|NCT06120530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468796|NCT06120530|Sensory System Agents|sensory system agents|mesh-ancestor
139468797|NCT06120530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468798|NCT06120439|Anesthetics|anesthetics|mesh-list
139468799|NCT06120439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468800|NCT06120439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468801|NCT06120374|Immunomodulating Agents|immunomodulating agents|mesh-list
139468802|NCT06120374|Immunologic Factors|immunologic factors|mesh-ancestor
139468803|NCT06120374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468804|NCT06120127|Antibodies|antibodies|mesh-list
139468805|NCT06120127|Immunologic Factors|immunologic factors|mesh-ancestor
139468806|NCT06120127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468807|NCT06120088|Dexamethasone|dexamethasone|mesh-list
139468808|NCT06120088|Fentanyl|fentanyl|mesh-list
139468809|NCT06120088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468810|NCT06120088|Antiemetics|antiemetics|mesh-ancestor
139468811|NCT06120088|Autonomic Agents|autonomic agents|mesh-ancestor
139468812|NCT06120088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468813|NCT06120088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468814|NCT06120088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139468815|NCT06120088|Glucocorticoids|glucocorticoids|mesh-ancestor
139468816|NCT06120088|Hormones|hormones|mesh-ancestor
139468817|NCT06120088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139468818|NCT06120088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139468819|NCT06120088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468820|NCT06120088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139468821|NCT06120088|Narcotics|narcotics|mesh-ancestor
139468822|NCT06120088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468823|NCT06120088|Analgesics|analgesics|mesh-ancestor
139468824|NCT06120088|Sensory System Agents|sensory system agents|mesh-ancestor
139468825|NCT06120088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139468826|NCT06120088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139468827|NCT06120088|Anesthetics, General|anesthetics, general|mesh-ancestor
139468828|NCT06120088|Anesthetics|anesthetics|mesh-ancestor
139468829|NCT06120036|Deoxycholic Acid|deoxycholic acid|mesh-list
139468830|NCT06120036|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139468831|NCT06120036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139468832|NCT06119880|Pancreatin|pancreatin|mesh-list
139468833|NCT06119880|Pancrelipase|pancrelipase|mesh-list
139468834|NCT06119880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139468835|NCT06119789|Imatinib Mesylate|imatinib mesylate|mesh-list
139468836|NCT06119789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468837|NCT06119789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139468838|NCT06119789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468839|NCT06119789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468840|NCT06119763|Antibodies|antibodies|mesh-list
139468841|NCT06119763|Immunologic Factors|immunologic factors|mesh-ancestor
139468842|NCT06119763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468843|NCT06119750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139468844|NCT06119672|Clobetasol|clobetasol|mesh-list
139468845|NCT06119672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468846|NCT06119672|Glucocorticoids|glucocorticoids|mesh-ancestor
139468847|NCT06119672|Hormones|hormones|mesh-ancestor
139468848|NCT06119672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139468849|NCT06119672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468850|NCT06119581|Carboplatin|carboplatin|mesh-list
139468851|NCT06119581|Pembrolizumab|pembrolizumab|mesh-list
139468852|NCT06119581|Pemetrexed|pemetrexed|mesh-list
139468853|NCT06119581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468854|NCT06119581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139468855|NCT06119581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139468856|NCT06119581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468857|NCT06119581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468858|NCT06119581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139468859|NCT06119581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139468860|NCT06119126|Fluorides|fluorides|mesh-list
139468861|NCT06119126|Cariostatic Agents|cariostatic agents|mesh-ancestor
139468862|NCT06119126|Protective Agents|protective agents|mesh-ancestor
139468863|NCT06119126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468864|NCT06115356|Vitamin D|vitamin d|mesh-list
139468865|NCT06115356|Vitamins|vitamins|mesh-ancestor
139468866|NCT06115356|Micronutrients|micronutrients|mesh-ancestor
139468867|NCT06115356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468868|NCT06115356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139468869|NCT06114719|Silymarin|silymarin|mesh-list
139468870|NCT06114719|Antioxidants|antioxidants|mesh-ancestor
139468871|NCT06114719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468872|NCT06114719|Protective Agents|protective agents|mesh-ancestor
139468873|NCT06114719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468874|NCT06108063|Losartan|losartan|mesh-list
139468875|NCT06108063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139468876|NCT06108063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139468877|NCT06108063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139468878|NCT06108063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139468879|NCT06108063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468880|NCT06103656|Omalizumab|omalizumab|mesh-list
139468881|NCT06103656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139468882|NCT06103656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139468883|NCT06103656|Respiratory System Agents|respiratory system agents|mesh-ancestor
139468884|NCT06081361|Moxifloxacin|moxifloxacin|mesh-list
139468885|NCT06081361|Levofloxacin|levofloxacin|mesh-list
139468886|NCT06081361|Linezolid|linezolid|mesh-list
139468887|NCT06081361|Cycloserine|cycloserine|mesh-list
139468888|NCT06081361|Pyrazinamide|pyrazinamide|mesh-list
139468889|NCT06081361|Ethambutol|ethambutol|mesh-list
139468890|NCT06081361|Bedaquiline|bedaquiline|mesh-list
139468891|NCT06081361|Clofazimine|clofazimine|mesh-list
139468892|NCT06081361|Aminosalicylic Acid|aminosalicylic acid|mesh-list
139468893|NCT06081361|Prothionamide|prothionamide|mesh-list
139468894|NCT06081361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139468895|NCT06081361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468896|NCT06081361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139468897|NCT06081361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139468898|NCT06081361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468899|NCT06081361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468900|NCT06081361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468901|NCT06081361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139468902|NCT06081361|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139468903|NCT06081361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139468904|NCT06081361|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139468905|NCT06081361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139468906|NCT06081361|Antitubercular Agents|antitubercular agents|mesh-ancestor
139468907|NCT06081361|Antimetabolites|antimetabolites|mesh-ancestor
139468908|NCT06081361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468909|NCT06081361|Leprostatic Agents|leprostatic agents|mesh-ancestor
139468910|NCT06077916|Azithromycin|azithromycin|mesh-list
139468911|NCT06077916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139468912|NCT06077916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139468913|NCT06076707|Tramadol|tramadol|mesh-list
139468914|NCT06076707|Bupivacaine|bupivacaine|mesh-list
139468915|NCT06076707|Anesthetics, Local|anesthetics, local|mesh-ancestor
139468916|NCT06076707|Anesthetics|anesthetics|mesh-ancestor
139468917|NCT06076707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468918|NCT06076707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468919|NCT06076707|Sensory System Agents|sensory system agents|mesh-ancestor
139468920|NCT06076707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468921|NCT06076707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139468922|NCT06076707|Narcotics|narcotics|mesh-ancestor
139468923|NCT06076707|Analgesics|analgesics|mesh-ancestor
139468924|NCT06072131|Prednisone|prednisone|mesh-list
139468925|NCT06072131|Cyclophosphamide|cyclophosphamide|mesh-list
139468926|NCT06072131|Doxorubicin|doxorubicin|mesh-list
139468927|NCT06072131|Vincristine|vincristine|mesh-list
139468928|NCT06072131|Belinostat|belinostat|mesh-list
139468929|NCT06072131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139468930|NCT06072131|Immunologic Factors|immunologic factors|mesh-ancestor
139468931|NCT06072131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468932|NCT06072131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139468933|NCT06072131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139468934|NCT06072131|Alkylating Agents|alkylating agents|mesh-ancestor
139468935|NCT06072131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468936|NCT06072131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468937|NCT06072131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139468938|NCT06072131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139468939|NCT06072131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139468940|NCT06072131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139468941|NCT06072131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468942|NCT06072131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468943|NCT06072131|Glucocorticoids|glucocorticoids|mesh-ancestor
139468944|NCT06072131|Hormones|hormones|mesh-ancestor
139468945|NCT06072131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139468946|NCT06072131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139468947|NCT06072131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139468948|NCT06072131|Tubulin Modulators|tubulin modulators|mesh-ancestor
139468949|NCT06072131|Antimitotic Agents|antimitotic agents|mesh-ancestor
139468950|NCT06072131|Mitosis Modulators|mitosis modulators|mesh-ancestor
139468951|NCT06072131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139468952|NCT06054529|Niacinamide|niacinamide|mesh-list
139468953|NCT06054529|Vitamin B Complex|vitamin b complex|mesh-ancestor
139468954|NCT06054529|Vitamins|vitamins|mesh-ancestor
139468955|NCT06054529|Micronutrients|micronutrients|mesh-ancestor
139468956|NCT06054529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468957|NCT06050512|Dexamethasone|dexamethasone|mesh-list
139468958|NCT06050512|Ixazomib|ixazomib|mesh-list
139468959|NCT06050512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139468960|NCT06050512|Antiemetics|antiemetics|mesh-ancestor
139468961|NCT06050512|Autonomic Agents|autonomic agents|mesh-ancestor
139468962|NCT06050512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468963|NCT06050512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468964|NCT06050512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139468965|NCT06050512|Glucocorticoids|glucocorticoids|mesh-ancestor
139468966|NCT06050512|Hormones|hormones|mesh-ancestor
139468967|NCT06050512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139468968|NCT06050512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139468969|NCT06050512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468970|NCT06050512|Protease Inhibitors|protease inhibitors|mesh-ancestor
139468971|NCT06050512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139468972|NCT06050512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139468973|NCT05989126|Aflibercept|aflibercept|mesh-list
139468974|NCT05989126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139468975|NCT05989126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139468976|NCT05989126|Growth Substances|growth substances|mesh-ancestor
139468977|NCT05989126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468978|NCT05989126|Growth Inhibitors|growth inhibitors|mesh-ancestor
139468979|NCT05989126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468980|NCT05965544|Fentanyl|fentanyl|mesh-list
139468981|NCT05965544|Bupivacaine|bupivacaine|mesh-list
139468982|NCT05965544|Anesthetics, Local|anesthetics, local|mesh-ancestor
139468983|NCT05965544|Anesthetics|anesthetics|mesh-ancestor
139468984|NCT05965544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139468985|NCT05965544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139468986|NCT05965544|Sensory System Agents|sensory system agents|mesh-ancestor
139468987|NCT05965544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139468988|NCT05965544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139468989|NCT05965544|Narcotics|narcotics|mesh-ancestor
139468990|NCT05965544|Analgesics|analgesics|mesh-ancestor
139468991|NCT05965544|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139468992|NCT05965544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139468993|NCT05965544|Anesthetics, General|anesthetics, general|mesh-ancestor
139468994|NCT05925530|Durvalumab|durvalumab|mesh-list
139468995|NCT05925530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139468996|NCT05925530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139468997|NCT05904470|Ruzasvir|ruzasvir|mesh-list
139468998|NCT05904470|Antiviral Agents|antiviral agents|mesh-ancestor
139468999|NCT05904470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139469000|NCT05894577|Montelukast|montelukast|mesh-list
139469001|NCT05894577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139469002|NCT05894577|Respiratory System Agents|respiratory system agents|mesh-ancestor
139469003|NCT05894577|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139469004|NCT05894577|Hormone Antagonists|hormone antagonists|mesh-ancestor
139469005|NCT05894577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139469006|NCT05894577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469007|NCT05894577|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139469008|NCT05894577|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139469009|NCT05894577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469010|NCT05842044|Acetaminophen|acetaminophen|mesh-list
139469011|NCT05842044|Ibuprofen|ibuprofen|mesh-list
139469012|NCT05842044|Ketorolac|ketorolac|mesh-list
139469013|NCT05842044|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139469014|NCT05842044|Oxycodone|oxycodone|mesh-list
139469015|NCT05842044|Hydromorphone|hydromorphone|mesh-list
139469016|NCT05842044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139469017|NCT05842044|Analgesics|analgesics|mesh-ancestor
139469018|NCT05842044|Sensory System Agents|sensory system agents|mesh-ancestor
139469019|NCT05842044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469020|NCT05842044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469021|NCT05842044|Antipyretics|antipyretics|mesh-ancestor
139469022|NCT05842044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139469023|NCT05842044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139469024|NCT05842044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139469025|NCT05842044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139469026|NCT05842044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469027|NCT05842044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469028|NCT05842044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139469029|NCT05842044|Narcotics|narcotics|mesh-ancestor
139469030|NCT05842044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139469031|NCT05839951|Trifluridine|trifluridine|mesh-list
139469032|NCT05839951|Bevacizumab|bevacizumab|mesh-list
139469033|NCT05839951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469034|NCT05839951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469035|NCT05839951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139469036|NCT05839951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139469037|NCT05839951|Growth Substances|growth substances|mesh-ancestor
139469038|NCT05839951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469039|NCT05839951|Growth Inhibitors|growth inhibitors|mesh-ancestor
139469040|NCT05839951|Antimetabolites|antimetabolites|mesh-ancestor
139469041|NCT05839951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469042|NCT05839951|Antiviral Agents|antiviral agents|mesh-ancestor
139469043|NCT05839951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139469044|NCT05785585|Vitamin B 12|vitamin b 12|mesh-list
139469045|NCT05785585|Hydroxocobalamin|hydroxocobalamin|mesh-list
139469046|NCT05785585|Vitamin B Complex|vitamin b complex|mesh-ancestor
139469047|NCT05785585|Vitamins|vitamins|mesh-ancestor
139469048|NCT05785585|Micronutrients|micronutrients|mesh-ancestor
139469049|NCT05785585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255813|NCT03631615|Antibodies|antibodies|mesh-list
139469050|NCT05785585|Hematinics|hematinics|mesh-ancestor
139469051|NCT05778760|Vitamin A|vitamin a|mesh-list
139469052|NCT05778760|Vitamins|vitamins|mesh-ancestor
139469053|NCT05778760|Micronutrients|micronutrients|mesh-ancestor
139469054|NCT05778760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469055|NCT05667116|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139469056|NCT05667116|Antiviral Agents|antiviral agents|mesh-ancestor
139469057|NCT05667116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139469058|NCT05634525|Adagrasib|adagrasib|mesh-list
139469059|NCT05634525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469060|NCT05594147|Sorafenib|sorafenib|mesh-list
139469061|NCT05594147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469062|NCT05594147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139469063|NCT05594147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469064|NCT05594147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469065|NCT05592613|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139469066|NCT05592613|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139469067|NCT05592613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139469068|NCT05592613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139469069|NCT05592613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469070|NCT05592613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469071|NCT05592613|Antiviral Agents|antiviral agents|mesh-ancestor
139469072|NCT05592613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139469073|NCT05592613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139469074|NCT05591105|Acetaminophen|acetaminophen|mesh-list
139469075|NCT05591105|Dipyrone|dipyrone|mesh-list
139469076|NCT05591105|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139469077|NCT05591105|Morphine|morphine|mesh-list
139469078|NCT05591105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139469079|NCT05591105|Narcotics|narcotics|mesh-ancestor
139469080|NCT05591105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139469081|NCT05591105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469082|NCT05591105|Analgesics|analgesics|mesh-ancestor
139469083|NCT05591105|Sensory System Agents|sensory system agents|mesh-ancestor
139469084|NCT05591105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469085|NCT05591105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139469086|NCT05591105|Antipyretics|antipyretics|mesh-ancestor
139469087|NCT05591105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139469088|NCT05591105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139469089|NCT05591105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139469090|NCT05583006|Tenofovir|tenofovir|mesh-list
139469091|NCT05583006|Antiviral Agents|antiviral agents|mesh-ancestor
139469092|NCT05583006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139469093|NCT05583006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139469094|NCT05583006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139469095|NCT05583006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469096|NCT05583006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469097|NCT05583006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139469098|NCT05583006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139469099|NCT05567601|Doxorubicin|doxorubicin|mesh-list
139469100|NCT05567601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139469101|NCT05567601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139469102|NCT05567601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469103|NCT05567601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139469104|NCT05567601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139469105|NCT05567601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469106|NCT05567601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469107|NCT05558007|Tadalafil|tadalafil|mesh-list
139469108|NCT05558007|Vasodilator Agents|vasodilator agents|mesh-ancestor
139469109|NCT05558007|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139469110|NCT05558007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139469111|NCT05558007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469112|NCT05558007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469113|NCT05558007|Urological Agents|urological agents|mesh-ancestor
139469114|NCT05501704|Tamoxifen|tamoxifen|mesh-list
139469115|NCT05501704|Anastrozole|anastrozole|mesh-list
139469116|NCT05501704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139469117|NCT05501704|Hormone Antagonists|hormone antagonists|mesh-ancestor
139469118|NCT05501704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139469119|NCT05501704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469120|NCT05501704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139469121|NCT05501704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469122|NCT05501704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139469123|NCT05501704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139469124|NCT05501704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139469125|NCT05501704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139469126|NCT05501704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139469127|NCT05501704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469128|NCT05501704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469130|NCT05497726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469131|NCT05497726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469132|NCT05497726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139469133|NCT05497726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139469134|NCT05497726|Growth Substances|growth substances|mesh-ancestor
139469135|NCT05497726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469136|NCT05497726|Growth Inhibitors|growth inhibitors|mesh-ancestor
139469137|NCT05494060|Capecitabine|capecitabine|mesh-list
139469138|NCT05494060|Oxaliplatin|oxaliplatin|mesh-list
139469139|NCT05494060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139469140|NCT05494060|Antimetabolites|antimetabolites|mesh-ancestor
139469141|NCT05494060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469142|NCT05494060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469143|NCT05478707|Dulaglutide|dulaglutide|mesh-list
139469144|NCT05478707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139469145|NCT05478707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469146|NCT05469347|Alirocumab|alirocumab|mesh-list
139469147|NCT05469347|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139469148|NCT05469347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139469149|NCT05469347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139469150|NCT05469347|Antimetabolites|antimetabolites|mesh-ancestor
139469151|NCT05469347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469152|NCT05469347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139469153|NCT05469347|Protease Inhibitors|protease inhibitors|mesh-ancestor
139469154|NCT05469347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469155|NCT05469347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139469156|NCT05462938|Dexmedetomidine|dexmedetomidine|mesh-list
139469157|NCT05462938|Propofol|propofol|mesh-list
139469158|NCT05462938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139469159|NCT05462938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139469160|NCT05462938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469161|NCT05462938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139469162|NCT05462938|Analgesics|analgesics|mesh-ancestor
139469163|NCT05462938|Sensory System Agents|sensory system agents|mesh-ancestor
139469164|NCT05462938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469165|NCT05462938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139469166|NCT05462938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139469167|NCT05462938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139469168|NCT05462938|Adrenergic Agents|adrenergic agents|mesh-ancestor
139469169|NCT05462938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139469170|NCT05462938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469171|NCT05462938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139469172|NCT05462938|Anesthetics, General|anesthetics, general|mesh-ancestor
139469173|NCT05462938|Anesthetics|anesthetics|mesh-ancestor
139469174|NCT05456542|Dexamethasone|dexamethasone|mesh-list
139469175|NCT05456542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139469176|NCT05456542|Antiemetics|antiemetics|mesh-ancestor
139469177|NCT05456542|Autonomic Agents|autonomic agents|mesh-ancestor
139469178|NCT05456542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469179|NCT05456542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469180|NCT05456542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139469181|NCT05456542|Glucocorticoids|glucocorticoids|mesh-ancestor
139469182|NCT05456542|Hormones|hormones|mesh-ancestor
139469183|NCT05456542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139469184|NCT05456542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139469185|NCT05456542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469186|NCT05453968|Berotralstat|berotralstat|mesh-list
139469187|NCT05453968|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139469188|NCT05453968|Protease Inhibitors|protease inhibitors|mesh-ancestor
139469189|NCT05453968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469190|NCT05453968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469191|NCT05450692|Docetaxel|docetaxel|mesh-list
139469192|NCT05450692|Durvalumab|durvalumab|mesh-list
139469193|NCT05450692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469194|NCT05450692|Tubulin Modulators|tubulin modulators|mesh-ancestor
139469195|NCT05450692|Antimitotic Agents|antimitotic agents|mesh-ancestor
139469196|NCT05450692|Mitosis Modulators|mitosis modulators|mesh-ancestor
139469197|NCT05450692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469198|NCT05450692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469199|NCT05445921|Mepivacaine|mepivacaine|mesh-list
139255967|NCT04726475|Cannabidiol|cannabidiol|mesh-list
139469201|NCT05445921|Anesthetics|anesthetics|mesh-ancestor
139469202|NCT05445921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139469203|NCT05445921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469204|NCT05445921|Sensory System Agents|sensory system agents|mesh-ancestor
139469205|NCT05445921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469206|NCT05444478|Lenvatinib|lenvatinib|mesh-list
139469207|NCT05444478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469208|NCT05444478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139469209|NCT05444478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469210|NCT05444478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469211|NCT05384665|Sufentanil|sufentanil|mesh-list
139469212|NCT05384665|Remifentanil|remifentanil|mesh-list
139469213|NCT05384665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139469214|NCT05384665|Narcotics|narcotics|mesh-ancestor
139469215|NCT05384665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139469216|NCT05384665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469217|NCT05384665|Analgesics|analgesics|mesh-ancestor
139469218|NCT05384665|Sensory System Agents|sensory system agents|mesh-ancestor
139469219|NCT05384665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469220|NCT05384665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139469221|NCT05384665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139469222|NCT05384665|Anesthetics, General|anesthetics, general|mesh-ancestor
139469223|NCT05384665|Anesthetics|anesthetics|mesh-ancestor
139469224|NCT05371886|Midazolam|midazolam|mesh-list
139469225|NCT05371886|Morphine|morphine|mesh-list
139469226|NCT05371886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139469227|NCT05371886|Narcotics|narcotics|mesh-ancestor
139469228|NCT05371886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139469229|NCT05371886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469230|NCT05371886|Analgesics|analgesics|mesh-ancestor
139469231|NCT05371886|Sensory System Agents|sensory system agents|mesh-ancestor
139469232|NCT05371886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469233|NCT05371886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139469234|NCT05371886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139469235|NCT05371886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139469236|NCT05371886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139469237|NCT05371886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139469238|NCT05371886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139469239|NCT05371886|Anesthetics, General|anesthetics, general|mesh-ancestor
139469240|NCT05371886|Anesthetics|anesthetics|mesh-ancestor
139469241|NCT05371886|GABA Modulators|gaba modulators|mesh-ancestor
139469242|NCT05371886|GABA Agents|gaba agents|mesh-ancestor
139469243|NCT05371886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139469244|NCT05371886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469245|NCT05361382|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
139469246|NCT05361382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469247|NCT05350696|Morphine|morphine|mesh-list
139469248|NCT05350696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139469249|NCT05350696|Narcotics|narcotics|mesh-ancestor
139469250|NCT05350696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139469251|NCT05350696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469252|NCT05350696|Analgesics|analgesics|mesh-ancestor
139469253|NCT05350696|Sensory System Agents|sensory system agents|mesh-ancestor
139469254|NCT05350696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469255|NCT05336266|Ketorolac|ketorolac|mesh-list
139469256|NCT05336266|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139469257|NCT05336266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139469258|NCT05336266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139469259|NCT05336266|Analgesics|analgesics|mesh-ancestor
139469260|NCT05336266|Sensory System Agents|sensory system agents|mesh-ancestor
139469261|NCT05336266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469262|NCT05336266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469263|NCT05336266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139469264|NCT05336266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139469265|NCT05336266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139469266|NCT05336266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469267|NCT05336266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469268|NCT05321394|Ritonavir|ritonavir|mesh-list
139469269|NCT05321394|Nirmatrelvir|nirmatrelvir|mesh-list
139469270|NCT05321394|Sotrovimab|sotrovimab|mesh-list
139469271|NCT05321394|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139469272|NCT05321394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139469273|NCT05321394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139469274|NCT05321394|Protease Inhibitors|protease inhibitors|mesh-ancestor
139469275|NCT05321394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469276|NCT05321394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469277|NCT05321394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139469278|NCT05321394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139469279|NCT05321394|Antiviral Agents|antiviral agents|mesh-ancestor
139469280|NCT05321394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139469281|NCT05321394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139469282|NCT05321394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139469283|NCT05295173|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139469284|NCT05295173|Plasminogen|plasminogen|mesh-list
139469285|NCT05295173|Reteplase|reteplase|mesh-list
139469286|NCT05295173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139469287|NCT05295173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139469288|NCT05295173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469289|NCT05157698|Naltrexone|naltrexone|mesh-list
139469290|NCT05157698|Bupropion|bupropion|mesh-list
139469291|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139469292|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139469293|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469294|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
139469295|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469296|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139469297|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
139469298|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139469299|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139469300|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139469301|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139469302|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469303|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
139469304|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139469305|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139469306|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139469307|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469308|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139469309|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
139469310|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469311|NCT05111314|Edetic Acid|edetic acid|mesh-list
139469312|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139469313|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
139469314|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
139469315|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469316|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
139469317|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139469318|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139469319|NCT05067933|Vaccines|vaccines|mesh-list
139469320|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
139469321|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469322|NCT05058677|Lidocaine|lidocaine|mesh-list
139469323|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
139469324|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
139469325|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139469326|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469327|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
139469328|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469329|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139469330|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139469331|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139469332|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139469333|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469334|NCT05052307|Vaccines|vaccines|mesh-list
139469335|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
139469336|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469337|NCT05004662|Nicotine|nicotine|mesh-list
139469338|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139469339|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
139469340|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469341|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469342|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139469343|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139469344|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
139469345|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139469346|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469347|NCT04979780|Heparin|heparin|mesh-list
139469348|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139256104|NCT05597527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469366|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139469367|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
139469368|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139469369|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
139469370|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469371|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139469372|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139469373|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
139469374|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
139469375|NCT04972513|Protective Agents|protective agents|mesh-ancestor
139469376|NCT04972110|Olaparib|olaparib|mesh-list
139469377|NCT04972110|Niraparib|niraparib|mesh-list
139469378|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139469379|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469380|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469381|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469382|NCT04953104|Nivolumab|nivolumab|mesh-list
139469383|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469384|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469385|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139469386|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469387|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
139469388|NCT04934722|Androgens|androgens|mesh-list
139469389|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469390|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469391|NCT04934722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139469392|NCT04934722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469393|NCT04934722|Hormones|hormones|mesh-ancestor
139469394|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139469395|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469396|NCT04925375|Abatacept|abatacept|mesh-list
139469397|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139469398|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469399|NCT04925375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469400|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469401|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139469402|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
139469403|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469404|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139469422|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
139256187|NCT03103763|Warfarin|warfarin|mesh-list
139469423|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139469424|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139469425|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469426|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139469427|NCT04824144|Analgesics|analgesics|mesh-ancestor
139469428|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
139469429|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469430|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139469431|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139469432|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139469433|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
139469434|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139469435|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469436|NCT04817410|Naltrexone|naltrexone|mesh-list
139469437|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139469438|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139469439|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469440|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
139469441|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469442|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
139469443|NCT04816877|Narcotics|narcotics|mesh-ancestor
139469444|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139469445|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469446|NCT04816877|Analgesics|analgesics|mesh-ancestor
139469447|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
139469448|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469449|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
139469450|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469451|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469452|NCT04798781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139469453|NCT04798781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469454|NCT04795531|Insulin|insulin|mesh-list
139469455|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139469456|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
139469457|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139469458|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469459|NCT04765267|Vitamin D|vitamin d|mesh-list
139469460|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
139469461|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
139469462|NCT04765267|Vitamins|vitamins|mesh-ancestor
139469463|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
139469464|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469465|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139469466|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139469467|NCT04765267|Astringents|astringents|mesh-ancestor
139469468|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
139469469|NCT04750902|Listerine|listerine|mesh-list
139469470|NCT04750902|Fluorides|fluorides|mesh-list
139469471|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
139469472|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
139469473|NCT04750902|Protective Agents|protective agents|mesh-ancestor
139469474|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469475|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139469476|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139469477|NCT04725383|Amitriptyline|amitriptyline|mesh-list
139469478|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139469479|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
139469480|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139469481|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139469482|NCT04725383|Analgesics|analgesics|mesh-ancestor
139469483|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
139469484|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469485|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469486|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139469487|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139469488|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139469489|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469490|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
139469491|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139469492|NCT04718389|Benralizumab|benralizumab|mesh-list
139469493|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139469494|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
139469495|NCT04677816|Vitamin D|vitamin d|mesh-list
139469496|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
139469497|NCT04677816|Vitamins|vitamins|mesh-ancestor
139469498|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
139469499|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469500|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139469501|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139469503|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139469504|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
139469505|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139469506|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469507|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139469508|NCT04676646|Diuretics|diuretics|mesh-ancestor
139469509|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
139469510|NCT04597697|Insulin|insulin|mesh-list
139469511|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139469512|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469513|NCT04566653|Calcium|calcium|mesh-list
139469514|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
139469515|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139469516|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469517|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
139469518|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
139469519|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469520|NCT04484350|Enalapril|enalapril|mesh-list
139469521|NCT04484350|Labetalol|labetalol|mesh-list
139469522|NCT04484350|Hydralazine|hydralazine|mesh-list
139469523|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139469524|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
139469525|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469526|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469527|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139469528|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139469529|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139469530|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
139469531|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139469532|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469533|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
139469534|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
139469535|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469536|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139469537|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139469538|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
139469539|NCT04481113|Niraparib|niraparib|mesh-list
139469540|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139469541|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469542|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469543|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469544|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
139469545|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469546|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469547|NCT04454489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139469548|NCT04454489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469549|NCT04271202|Erenumab|erenumab|mesh-list
139469550|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139469551|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469552|NCT04271202|Analgesics|analgesics|mesh-ancestor
139469553|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
139469554|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469555|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469556|NCT04253964|Paclitaxel|paclitaxel|mesh-list
139469557|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139469558|NCT04253964|Carboplatin|carboplatin|mesh-list
139469559|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
139469560|NCT04253964|Pemetrexed|pemetrexed|mesh-list
139469561|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139469562|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469563|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
139469564|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
139469565|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
139469566|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469567|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469568|NCT04253964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139469569|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469570|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139469571|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139469573|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139469574|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
139469575|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139469576|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139469577|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139469578|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139469579|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469580|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
139469581|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139469582|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469583|NCT04221451|Venglustat|venglustat|mesh-list
139469584|NCT04221451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469585|NCT04221451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469586|NCT04200313|Pancrelipase|pancrelipase|mesh-list
139469587|NCT04200313|Pancreatin|pancreatin|mesh-list
139469588|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139469589|NCT04184609|Albuterol|albuterol|mesh-list
139469590|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139469591|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
139469592|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469593|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469594|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139469595|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
139469596|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
139469597|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139469598|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139469599|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139469600|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139469601|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
139469602|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139469603|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469604|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
139469605|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139469606|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
139469607|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139469608|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
139469609|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469610|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469611|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
139469612|NCT04055844|Decitabine|decitabine|mesh-list
139469613|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139469614|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
139469615|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469616|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469617|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469618|NCT04053322|Durvalumab|durvalumab|mesh-list
139469619|NCT04053322|Fulvestrant|fulvestrant|mesh-list
139469620|NCT04053322|Olaparib|olaparib|mesh-list
139469621|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469622|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469623|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139469624|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139469625|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139469626|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
139469627|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139469628|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469629|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139469630|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469631|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469632|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139469633|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139469634|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469635|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
139469636|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139469637|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139469638|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139469639|NCT03751800|Dienogest|dienogest|mesh-list
139469640|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
139469641|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
139469642|NCT03751800|Estradiol|estradiol|mesh-list
139469643|NCT03751800|Estrogens|estrogens|mesh-ancestor
139469644|NCT03751800|Hormones|hormones|mesh-ancestor
139469645|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139469646|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469647|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139469649|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139469650|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139469651|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139469652|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139469653|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139469654|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139469655|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139469656|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469657|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
139469658|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
139469659|NCT03613727|Vitamins|vitamins|mesh-ancestor
139469660|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
139469661|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469662|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
139469663|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469664|NCT03613727|Protective Agents|protective agents|mesh-ancestor
139469665|NCT03582930|Calfactant|calfactant|mesh-list
139469666|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139469667|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
139469668|NCT03555149|Bevacizumab|bevacizumab|mesh-list
139469669|NCT03555149|Atezolizumab|atezolizumab|mesh-list
139469670|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469671|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469672|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139469673|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139469674|NCT03555149|Growth Substances|growth substances|mesh-ancestor
139469675|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469676|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
139469677|NCT03555149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139469678|NCT03555149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469679|NCT03530267|Aflibercept|aflibercept|mesh-list
139469680|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139469681|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139469682|NCT03530267|Growth Substances|growth substances|mesh-ancestor
139469683|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469684|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
139469685|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469686|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139469687|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139469688|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139469689|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469690|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469691|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
139469692|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139469693|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139469694|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139469695|NCT03463265|Sirolimus|sirolimus|mesh-list
139469696|NCT03463265|Bevacizumab|bevacizumab|mesh-list
139469697|NCT03463265|Temozolomide|temozolomide|mesh-list
139469698|NCT03463265|Temsirolimus|temsirolimus|mesh-list
139469699|NCT03463265|Lomustine|lomustine|mesh-list
139469700|NCT03463265|MTOR Inhibitors|mtor inhibitors|mesh-list
139469701|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469702|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469703|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139469704|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139469705|NCT03463265|Growth Substances|growth substances|mesh-ancestor
139469706|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469707|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
139469708|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139469709|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
139469710|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469711|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139469712|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139469713|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139469714|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
139469715|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139256479|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
139469716|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
139469717|NCT03463265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139469718|NCT03463265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469719|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
139469720|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139469721|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139469722|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139469723|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139469724|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469725|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
139469726|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139469727|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469728|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139469729|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469730|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139469731|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139469732|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
139469734|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139469735|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469736|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139469737|NCT03453931|Protective Agents|protective agents|mesh-ancestor
139469738|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139469739|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469740|NCT03374800|Pantoprazole|pantoprazole|mesh-list
139469741|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139469742|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139469743|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139469744|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469745|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469746|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139469747|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469748|NCT03289741|Octreotide|octreotide|mesh-list
139469749|NCT03289741|Lanreotide|lanreotide|mesh-list
139469750|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139469751|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139469752|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469753|NCT03246529|Lenograstim|lenograstim|mesh-list
139469754|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139469755|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
139469756|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469757|NCT02975934|Docetaxel|docetaxel|mesh-list
139469758|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
139469759|NCT02975934|Rucaparib|rucaparib|mesh-list
139469760|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469761|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
139469762|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
139469763|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
139469764|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469765|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139469766|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469767|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
139469768|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139469769|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469770|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139469771|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139469772|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
139469773|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139469774|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
139469775|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139469776|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
139469777|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469778|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469779|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
139469780|NCT02911142|Prednisone|prednisone|mesh-list
139469781|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
139469782|NCT02911142|Rituximab|rituximab|mesh-list
139469783|NCT02911142|Doxorubicin|doxorubicin|mesh-list
139469784|NCT02911142|Vincristine|vincristine|mesh-list
139469785|NCT02911142|Lenalidomide|lenalidomide|mesh-list
139469786|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139469787|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
139469788|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469789|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139469790|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139469791|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
139469792|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469793|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469794|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139469795|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469796|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139469797|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139469798|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139469799|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469800|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139469801|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
139469802|NCT02911142|Hormones|hormones|mesh-ancestor
139469803|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139469804|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139469805|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139469806|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
139469807|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
139469808|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
139469809|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139469810|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139469811|NCT02911142|Growth Substances|growth substances|mesh-ancestor
139469812|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
139469813|NCT02864758|Vitamin K|vitamin k|mesh-list
139469814|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
139469815|NCT02864758|Dabigatran|dabigatran|mesh-list
139469816|NCT02864758|Vitamins|vitamins|mesh-ancestor
139469817|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
139469818|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469819|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139469820|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
139469821|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139469822|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
139469823|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469824|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469825|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
139469826|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139469827|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139469828|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
139469829|NCT02864758|Coagulants|coagulants|mesh-ancestor
139469830|NCT02834975|Paclitaxel|paclitaxel|mesh-list
139469831|NCT02834975|Carboplatin|carboplatin|mesh-list
139469832|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
139469833|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139469834|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469835|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
139469836|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
139469837|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
139469838|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469839|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469840|NCT02834975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139469841|NCT02822508|Laxatives|laxatives|mesh-list
139469842|NCT02822508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139469843|NCT02755272|Carboplatin|carboplatin|mesh-list
139469844|NCT02755272|Gemcitabine|gemcitabine|mesh-list
139469845|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
139469846|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469847|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139469848|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
139469849|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469850|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469851|NCT02755272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139469852|NCT02684123|Apremilast|apremilast|mesh-list
139469853|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139469854|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139469855|NCT02684123|Analgesics|analgesics|mesh-ancestor
139469856|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
139469857|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469858|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469859|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139469860|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139469861|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139469862|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139469863|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469864|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469865|NCT02621021|Aldesleukin|aldesleukin|mesh-list
139469866|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
139256627|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139469867|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
139469868|NCT02621021|Fludarabine|fludarabine|mesh-list
139469869|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139469870|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
139469871|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469872|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139469873|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139469874|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
139469875|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469876|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469877|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139469878|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469879|NCT02621021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139469880|NCT02621021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139469881|NCT02621021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139469882|NCT02621021|Antiviral Agents|antiviral agents|mesh-ancestor
139469883|NCT02621021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139469884|NCT02606448|Bupivacaine|bupivacaine|mesh-list
139469885|NCT02606448|Ropivacaine|ropivacaine|mesh-list
139469886|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
139469887|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
139469888|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139469889|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469890|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
139469891|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469892|NCT02584309|Doxorubicin|doxorubicin|mesh-list
139469893|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139469894|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
139469895|NCT02584309|Razoxane|razoxane|mesh-list
139469896|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139469897|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469898|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139469899|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139469900|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469901|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469902|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139469903|NCT02584309|Protective Agents|protective agents|mesh-ancestor
139469904|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469905|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
139469906|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
139469907|NCT02576574|Paclitaxel|paclitaxel|mesh-list
139469908|NCT02576574|Carboplatin|carboplatin|mesh-list
139469909|NCT02576574|Gemcitabine|gemcitabine|mesh-list
139469910|NCT02576574|Pemetrexed|pemetrexed|mesh-list
139469911|NCT02576574|Avelumab|avelumab|mesh-list
139469912|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139469913|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139469914|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469915|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
139469916|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
139469917|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
139469918|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469919|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139469920|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
139469921|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469922|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139469923|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139469924|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139469925|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
139469926|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469927|NCT02229656|Olaparib|olaparib|mesh-list
139469928|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139469929|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469930|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469931|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469932|NCT02207465|Paclitaxel|paclitaxel|mesh-list
139469933|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139469934|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139469935|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469936|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
139469937|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
139469938|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
139469939|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256710|NCT01568281|Anastrozole|anastrozole|mesh-list
139469940|NCT02203331|Anastrozole|anastrozole|mesh-list
139469941|NCT02203331|Leuprolide|leuprolide|mesh-list
139469942|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
139469943|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139469944|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469945|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139469946|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139469947|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469948|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469949|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139469950|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
139469951|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139469952|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469953|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139469954|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
139469955|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139469956|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139469957|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
139469958|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139469959|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139469960|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139469961|NCT02178436|Paclitaxel|paclitaxel|mesh-list
139469962|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139469963|NCT02178436|Gemcitabine|gemcitabine|mesh-list
139469964|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139469965|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139469966|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
139469967|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
139469968|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
139469969|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469970|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139469971|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
139469972|NCT02170025|Riociguat|riociguat|mesh-list
139469973|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
139469974|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469975|NCT02164578|Aspirin|aspirin|mesh-list
139469976|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
139385485|NCT05614622|Autonomic Agents|autonomic agents|mesh-ancestor
139469977|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139469978|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139469979|NCT02164578|Analgesics|analgesics|mesh-ancestor
139469980|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
139469981|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139469982|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139469983|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139469984|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139469985|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139469986|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139469987|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139469988|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139469989|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139469990|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139469991|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
139469992|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139469993|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
139469994|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139469995|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
139469996|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
139469997|NCT02107703|Fulvestrant|fulvestrant|mesh-list
139469998|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139469999|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470000|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139470001|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139470002|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
139470003|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470004|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470005|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
139470006|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470007|NCT01932125|Bevacizumab|bevacizumab|mesh-list
139470008|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139470009|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470010|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139470011|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139470012|NCT01932125|Growth Substances|growth substances|mesh-ancestor
139470013|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470014|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
139470015|NCT01823198|Aldesleukin|aldesleukin|mesh-list
139256774|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
139470016|NCT01823198|Fludarabine|fludarabine|mesh-list
139470017|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
139470018|NCT01823198|Busulfan|busulfan|mesh-list
139470019|NCT01823198|Interleukin-2|interleukin-2|mesh-list
139470020|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470021|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139470022|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
139470023|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470024|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139470025|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
139470026|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470027|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
139470028|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139470029|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139470030|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139470031|NCT01823198|Analgesics|analgesics|mesh-ancestor
139470032|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
139470033|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470034|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139470035|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139470036|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
139470037|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139470038|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
139470039|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139470040|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470041|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470042|NCT01725113|Calcitriol|calcitriol|mesh-list
139470043|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139470044|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470045|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139470046|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139470047|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470048|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139470049|NCT01725113|Vitamins|vitamins|mesh-ancestor
139470050|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
139470051|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139470052|NCT01580293|Factor VIII|factor viii|mesh-list
139470053|NCT01580293|Coagulants|coagulants|mesh-ancestor
139470054|NCT01089933|Anesthetics|anesthetics|mesh-list
139470055|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
139470056|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470057|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470058|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
139470059|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470060|NCT00668772|Tiotropium Bromide|tiotropium bromide|mesh-list
139470061|NCT00668772|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139470062|NCT00668772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139470063|NCT00668772|Autonomic Agents|autonomic agents|mesh-ancestor
139470064|NCT00668772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470065|NCT00668772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470066|NCT00668772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139470067|NCT00668772|Respiratory System Agents|respiratory system agents|mesh-ancestor
139470068|NCT00668772|Parasympatholytics|parasympatholytics|mesh-ancestor
139470069|NCT00668772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139470070|NCT00668772|Cholinergic Agents|cholinergic agents|mesh-ancestor
139470071|NCT00668772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470072|NCT00668772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470073|NCT00668772|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139470074|NCT00668772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139470075|NCT00668772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139470076|NCT00668772|Adrenergic Agents|adrenergic agents|mesh-ancestor
139470077|NCT05745259|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139470078|NCT05745259|Tenecteplase|tenecteplase|mesh-list
139470079|NCT05745259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139470080|NCT05745259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139470081|NCT05745259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470082|NCT02893241|Cafedrine|cafedrine|mesh-list
139470083|NCT02893241|Theodrenaline|theodrenaline|mesh-list
139470084|NCT02893241|Ephedrine|ephedrine|mesh-list
139470085|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139470086|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470087|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
139470088|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
139470089|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470090|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139470091|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
139470092|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470093|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470094|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139470095|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
139470096|NCT02395237|Glimepiride|glimepiride|mesh-list
139470097|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139470098|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139470099|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470100|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139470101|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
139470102|NCT02394847|Propofol|propofol|mesh-list
139470103|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139470104|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470105|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470106|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139470107|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
139470108|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
139470109|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
139470110|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139470111|NCT05021861|Estradiol|estradiol|mesh-list
139470112|NCT05021861|Cyproterone|cyproterone|mesh-list
139470113|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
139470114|NCT05021861|Estrogens|estrogens|mesh-ancestor
139470115|NCT05021861|Hormones|hormones|mesh-ancestor
139470116|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470117|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470118|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139470119|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
139470120|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139470121|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139470122|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139470123|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139470124|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
139470125|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
139470126|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470127|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139470128|NCT02403037|Dexamethasone|dexamethasone|mesh-list
139470129|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
139470130|NCT02403037|Antiemetics|antiemetics|mesh-list
139470131|NCT02403037|Emetics|emetics|mesh-list
139470132|NCT02403037|BB 1101|bb 1101|mesh-list
139470133|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139470134|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
139470135|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470136|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470137|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139470138|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
139470139|NCT02403037|Hormones|hormones|mesh-ancestor
139470140|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470141|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139470142|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470143|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
139470144|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470145|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470146|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
139470147|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139470148|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470149|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139470150|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139470151|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
139470152|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139470153|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
139470154|NCT04480333|Remdesivir|remdesivir|mesh-list
139470155|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
139470156|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139470157|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
139470158|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470159|NCT04480333|Protective Agents|protective agents|mesh-ancestor
139470160|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470161|NCT03166891|Chiauranib|chiauranib|mesh-list
139470162|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470163|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139470164|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470165|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470166|NCT01980940|Etoricoxib|etoricoxib|mesh-list
139470167|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139470168|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139470169|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139470170|NCT01980940|Analgesics|analgesics|mesh-ancestor
139470171|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
139470172|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470173|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470174|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139470175|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139470176|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139470177|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139470178|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470179|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470180|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139470181|NCT01980940|Protective Agents|protective agents|mesh-ancestor
139470182|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139470183|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
139470184|NCT01960114|Acetaminophen|acetaminophen|mesh-list
139470185|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139470186|NCT01960114|Analgesics|analgesics|mesh-ancestor
139470187|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
139470188|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470189|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470190|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
139470191|NCT04752527|Sorafenib|sorafenib|mesh-list
139470192|NCT04752527|Decitabine|decitabine|mesh-list
139470193|NCT04752527|Venetoclax|venetoclax|mesh-list
139470194|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470195|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139470196|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470197|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470198|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139470199|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
139470200|NCT05229497|Carboplatin|carboplatin|mesh-list
139470201|NCT05229497|Fluorouracil|fluorouracil|mesh-list
139470202|NCT05229497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470203|NCT05229497|Antimetabolites|antimetabolites|mesh-ancestor
139470204|NCT05229497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470205|NCT05229497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139470206|NCT05229497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139470207|NCT05229497|Immunologic Factors|immunologic factors|mesh-ancestor
139470208|NCT05229497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470209|NCT03169777|Leucovorin|leucovorin|mesh-list
139470210|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
139470211|NCT03169777|Bevacizumab|bevacizumab|mesh-list
139470212|NCT03169777|Capecitabine|capecitabine|mesh-list
139470213|NCT03169777|Fluorouracil|fluorouracil|mesh-list
139470214|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
139470215|NCT03169777|Nivolumab|nivolumab|mesh-list
139470216|NCT03169777|Cetuximab|cetuximab|mesh-list
139470217|NCT03169777|Fulvestrant|fulvestrant|mesh-list
139470218|NCT03169777|Avelumab|avelumab|mesh-list
139470219|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470220|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470221|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139470222|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
139470223|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470224|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139470225|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139470226|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
139470227|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139470228|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139470229|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139470230|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139470231|NCT03169777|Growth Substances|growth substances|mesh-ancestor
139470232|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
139470233|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139470234|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
139470235|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139470236|NCT03169777|Antidotes|antidotes|mesh-ancestor
139470237|NCT03169777|Protective Agents|protective agents|mesh-ancestor
139470238|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
139470239|NCT03169777|Vitamins|vitamins|mesh-ancestor
139470240|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
139470241|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139470242|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139470243|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139470244|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
139470245|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470246|NCT01980706|Baclofen|baclofen|mesh-list
139470247|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139470248|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470249|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139470250|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470251|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139470252|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
139470253|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
139470254|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470255|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470256|NCT02092571|Progesterone|progesterone|mesh-list
139470257|NCT02092571|Progestins|progestins|mesh-ancestor
139470258|NCT02092571|Hormones|hormones|mesh-ancestor
139470259|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470260|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470261|NCT02402725|Dexamethasone|dexamethasone|mesh-list
139470262|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
139470263|NCT02402725|BB 1101|bb 1101|mesh-list
139470264|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139470265|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
139470266|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
139470267|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470268|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470269|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139470270|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
139470271|NCT02402725|Hormones|hormones|mesh-ancestor
139470272|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470273|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139470274|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470275|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
139470276|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470277|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470278|NCT02394145|Clopidogrel|clopidogrel|mesh-list
139470279|NCT02394145|Ticagrelor|ticagrelor|mesh-list
139470280|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139470281|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139470282|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139470283|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139470284|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
139470285|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470286|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470287|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470288|NCT02004886|Metformin|metformin|mesh-list
139470289|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139470290|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470291|NCT05228483|Mometasone Furoate|mometasone furoate|mesh-list
139470292|NCT05228483|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139470293|NCT05228483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139470294|NCT05228483|Dermatologic Agents|dermatologic agents|mesh-ancestor
139470295|NCT05228483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139470296|NCT05228483|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139470297|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
139470298|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
139470299|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139470300|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139470301|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
139470302|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
139470303|NCT04255277|Charcoal|charcoal|mesh-list
139470304|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139470305|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139470306|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139470307|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139470308|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470309|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470310|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470311|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139470312|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139470313|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470314|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139470315|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139470316|NCT04255277|Antidotes|antidotes|mesh-ancestor
139470317|NCT04255277|Protective Agents|protective agents|mesh-ancestor
139257086|NCT05952752|Dexamethasone|dexamethasone|mesh-list
139470318|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139470319|NCT04255277|Estrogens|estrogens|mesh-ancestor
139470321|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470322|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139470323|NCT04435925|Fentanyl|fentanyl|mesh-list
139470324|NCT04435925|Remifentanil|remifentanil|mesh-list
139470325|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139470326|NCT04435925|Narcotics|narcotics|mesh-ancestor
139470327|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470328|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470329|NCT04435925|Analgesics|analgesics|mesh-ancestor
139470330|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
139470331|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470332|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139470333|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139470334|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
139470335|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
139470336|NCT04649476|Cisplatin|cisplatin|mesh-list
139470337|NCT04649476|Docetaxel|docetaxel|mesh-list
139470338|NCT04649476|Fluorouracil|fluorouracil|mesh-list
139470339|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470340|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
139470341|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
139470342|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
139470343|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470344|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
139470345|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139470346|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139470347|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
139470348|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470349|NCT05117957|Sorafenib|sorafenib|mesh-list
139470350|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470351|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139470352|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470353|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470354|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
139470355|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139470356|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470357|NCT03251729|Progesterone|progesterone|mesh-list
139470358|NCT03251729|Progestins|progestins|mesh-ancestor
139470359|NCT03251729|Hormones|hormones|mesh-ancestor
139470360|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470361|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470362|NCT02696785|Adalimumab|adalimumab|mesh-list
139470363|NCT02696785|Ixekizumab|ixekizumab|mesh-list
139470364|NCT02696785|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139470365|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139470366|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139470367|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
139470368|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
139470369|NCT02004262|Pancrelipase|pancrelipase|mesh-list
139470370|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139470371|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
139470372|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470373|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139470374|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139470375|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
139470376|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470377|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470378|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139470379|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139470380|NCT02393599|Cocaine|cocaine|mesh-list
139470381|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
139470382|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
139470383|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470384|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470385|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
139470386|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470387|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139470388|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139470389|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139470390|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139470391|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470392|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
139470393|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470394|NCT02402491|Aspirin|aspirin|mesh-list
139470395|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
139470396|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139470397|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139470398|NCT02402491|Analgesics|analgesics|mesh-ancestor
139470399|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
139470400|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470401|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470402|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139470403|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139470404|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139470405|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139470406|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470407|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139470408|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139470409|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470410|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
139470411|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139470412|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139470413|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
139470414|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470415|NCT02402413|Androgens|androgens|mesh-list
139470416|NCT02402413|Hormones|hormones|mesh-ancestor
139470417|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470418|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470419|NCT02393443|Oxytocin|oxytocin|mesh-list
139470420|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
139470421|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139470422|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470423|NCT01977898|Morphine|morphine|mesh-list
139470424|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139470425|NCT01977898|Narcotics|narcotics|mesh-ancestor
139470426|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470427|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470428|NCT01977898|Analgesics|analgesics|mesh-ancestor
139470429|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
139470430|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470431|NCT02003638|Niacin|niacin|mesh-list
139470432|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139470433|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
139470434|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470435|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139470436|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
139470437|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
139470438|NCT02003638|Vitamins|vitamins|mesh-ancestor
139470439|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
139470440|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470441|NCT02402179|Tryptophan|tryptophan|mesh-list
139470442|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139470443|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
139470444|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139470445|NCT02401945|Aflibercept|aflibercept|mesh-list
139470446|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139470447|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139470448|NCT02401945|Growth Substances|growth substances|mesh-ancestor
139470449|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470450|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
139470451|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470452|NCT02003014|Pioglitazone|pioglitazone|mesh-list
139470453|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139470454|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470455|NCT01977352|Bupivacaine|bupivacaine|mesh-list
139470456|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
139470457|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
139470458|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470459|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470460|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
139470461|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470462|NCT03166111|Lidocaine|lidocaine|mesh-list
139470463|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
139470464|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
139470465|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470466|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470467|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
139257223|NCT05494385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139470468|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470469|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139470470|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139470471|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139470472|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139470473|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470474|NCT05117021|Bupivacaine|bupivacaine|mesh-list
139470475|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
139470476|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
139470477|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470478|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470479|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
139470480|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470481|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139470482|NCT02392117|Insulin|insulin|mesh-list
139470483|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139470484|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470485|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
139470486|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
139470487|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139470488|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139470489|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470490|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470491|NCT02812433|Urological Agents|urological agents|mesh-ancestor
139470492|NCT02392039|Loratadine|loratadine|mesh-list
139470493|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
139470494|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
139470495|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139470496|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139470497|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139470498|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
139470499|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
139470500|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470501|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470502|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470503|NCT03106363|Ethanol|ethanol|mesh-list
139470504|NCT03106363|Dronabinol|dronabinol|mesh-list
139470505|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139470506|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139470507|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470508|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470509|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
139470510|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139470511|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139470512|NCT03106363|Analgesics|analgesics|mesh-ancestor
139470513|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
139470514|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470515|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139470516|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139470517|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470518|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470519|NCT03106363|Hormones|hormones|mesh-ancestor
139470520|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470521|NCT03106519|Bupivacaine|bupivacaine|mesh-list
139470522|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
139470523|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
139470524|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470525|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470526|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
139470527|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470528|NCT02687815|Vitamin D|vitamin d|mesh-list
139470529|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
139470530|NCT02687815|Vitamins|vitamins|mesh-ancestor
139470531|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
139470532|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470533|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139470534|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139470535|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
139470536|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139470537|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139470538|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
139470539|NCT01959334|Glucagon|glucagon|mesh-list
139470540|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139470541|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139470542|NCT01959334|Hormones|hormones|mesh-ancestor
139470543|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470544|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470545|NCT01959334|Incretins|incretins|mesh-ancestor
139470547|NCT01958476|Methadone|methadone|mesh-list
139470548|NCT01958476|Phenobarbital|phenobarbital|mesh-list
139470549|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139470550|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139470551|NCT01958476|Narcotics|narcotics|mesh-ancestor
139470552|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470553|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470554|NCT01958476|Analgesics|analgesics|mesh-ancestor
139470555|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
139470556|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470557|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
139470558|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
139470559|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
139470560|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139470561|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139470562|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139470563|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470564|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470565|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
139470566|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
139470567|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139470568|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139470569|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139470570|NCT04809181|Azacitidine|azacitidine|mesh-list
139470571|NCT04809181|Venetoclax|venetoclax|mesh-list
139470572|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139470573|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
139470574|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470575|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470576|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470577|NCT01057121|Lenalidomide|lenalidomide|mesh-list
139470578|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
139470579|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470580|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139470581|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139470582|NCT01057121|Growth Substances|growth substances|mesh-ancestor
139470583|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
139470584|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470585|NCT02695537|Cannabidiol|cannabidiol|mesh-list
139470586|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
139470587|NCT04620941|Chrysarobin|chrysarobin|mesh-list
139470588|NCT04620941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139470589|NCT04620941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139470590|NCT04620941|Analgesics|analgesics|mesh-ancestor
139470591|NCT04620941|Sensory System Agents|sensory system agents|mesh-ancestor
139470592|NCT04620941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470593|NCT04620941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470594|NCT04620941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139470595|NCT04620941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139470596|NCT04746989|Allopurinol|allopurinol|mesh-list
139470597|NCT04746989|Probenecid|probenecid|mesh-list
139470598|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
139470599|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470600|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470601|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
139470602|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139470603|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139470604|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
139470605|NCT04746989|Protective Agents|protective agents|mesh-ancestor
139470606|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470607|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
139470608|NCT04671953|Metformin|metformin|mesh-list
139470609|NCT04671953|Deucravacitinib|deucravacitinib|mesh-list
139470610|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139470611|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470612|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
139470613|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139470614|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470615|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470616|NCT04585061|Lidocaine|lidocaine|mesh-list
139470617|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
139470618|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
139470619|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257372|NCT04654507|Dexamethasone|dexamethasone|mesh-list
139470620|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470621|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
139470622|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470623|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139470624|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139470625|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139470626|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139470627|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470628|NCT03874091|Epinephrine|epinephrine|mesh-list
139470629|NCT03874091|Racepinephrine|racepinephrine|mesh-list
139470630|NCT03874091|Morphine|morphine|mesh-list
139470631|NCT03874091|Bupivacaine|bupivacaine|mesh-list
139470632|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
139470633|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
139470634|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
139470635|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470636|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470637|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
139470638|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470639|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139470640|NCT03874091|Narcotics|narcotics|mesh-ancestor
139470641|NCT03874091|Analgesics|analgesics|mesh-ancestor
139470642|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139470643|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139470644|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
139470645|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470646|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470647|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139470648|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139470649|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
139470650|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139470651|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
139470652|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
139470653|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
139470654|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139470655|NCT01362491|Ibuprofen|ibuprofen|mesh-list
139470656|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139470657|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139470658|NCT01362491|Analgesics|analgesics|mesh-ancestor
139470659|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
139470660|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470661|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470662|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139470663|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139470664|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139470665|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470666|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470667|NCT03560297|Nitrazepam|nitrazepam|mesh-list
139470668|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
139470669|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139470670|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470671|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470672|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139470673|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139470674|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139470675|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
139470676|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
139470677|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470678|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470679|NCT04122287|Levofloxacin|levofloxacin|mesh-list
139470680|NCT04122287|Tinidazole|tinidazole|mesh-list
139470681|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139470682|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139470683|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139470684|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139470685|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139470686|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470687|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470688|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470689|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139470690|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139470691|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
139470692|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139470693|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139470694|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139470696|NCT05746351|Dexmedetomidine|dexmedetomidine|mesh-list
139470697|NCT05746351|Nalbuphine|nalbuphine|mesh-list
139470698|NCT05746351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139470699|NCT05746351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470700|NCT05746351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470701|NCT05746351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139470702|NCT05746351|Analgesics|analgesics|mesh-ancestor
139470703|NCT05746351|Sensory System Agents|sensory system agents|mesh-ancestor
139470704|NCT05746351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470705|NCT05746351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139470706|NCT05746351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139470707|NCT05746351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139470708|NCT05746351|Adrenergic Agents|adrenergic agents|mesh-ancestor
139470709|NCT05746351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470710|NCT05746351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470711|NCT05746351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139470712|NCT05746351|Narcotics|narcotics|mesh-ancestor
139470713|NCT05746351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139470714|NCT05746351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139470715|NCT05746351|Anesthetics, General|anesthetics, general|mesh-ancestor
139470716|NCT05746351|Anesthetics|anesthetics|mesh-ancestor
139470717|NCT05403281|Dapagliflozin|dapagliflozin|mesh-list
139470718|NCT05403281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139470719|NCT05403281|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139470720|NCT05403281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470721|NCT05403281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139470722|NCT05403281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470723|NCT05403281|Incretins|incretins|mesh-ancestor
139470724|NCT05403281|Hormones|hormones|mesh-ancestor
139470725|NCT05403281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470726|NCT05403281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139470727|NCT05403281|Protease Inhibitors|protease inhibitors|mesh-ancestor
139470728|NCT05403281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470729|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139470730|NCT03115099|Liraglutide|liraglutide|mesh-list
139470731|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139470732|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470733|NCT03115099|Incretins|incretins|mesh-ancestor
139470734|NCT03115099|Hormones|hormones|mesh-ancestor
139470735|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470736|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139470737|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
139470738|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470739|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470740|NCT03165097|ACT-709478|act-709478|mesh-list
139470741|NCT03165097|Midazolam|midazolam|mesh-list
139470742|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139470743|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139470744|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470745|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470746|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139470747|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139470748|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139470749|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139470750|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
139470751|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
139470752|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
139470753|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
139470754|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470755|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470756|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139470757|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139470758|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139470759|NCT03165409|Nivolumab|nivolumab|mesh-list
139470760|NCT03165409|Ipilimumab|ipilimumab|mesh-list
139470761|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139470762|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470763|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139470764|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470765|NCT05403125|Listerine|listerine|mesh-list
139470766|NCT05403125|Fluorides|fluorides|mesh-list
139470767|NCT05403125|Sodium Fluoride|sodium fluoride|mesh-list
139470768|NCT05403125|Cariostatic Agents|cariostatic agents|mesh-ancestor
139470769|NCT05403125|Protective Agents|protective agents|mesh-ancestor
139470770|NCT05403125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470771|NCT05403125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139470772|NCT05403125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139470774|NCT05701423|Immunologic Factors|immunologic factors|mesh-ancestor
139470775|NCT05701423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470776|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
139470777|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
139470778|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139470779|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139470780|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470781|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470782|NCT02795351|Urological Agents|urological agents|mesh-ancestor
139470783|NCT05403047|Tenofovir|tenofovir|mesh-list
139470784|NCT05403047|Antiviral Agents|antiviral agents|mesh-ancestor
139470785|NCT05403047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139470786|NCT05403047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139470787|NCT05403047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139470788|NCT05403047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470789|NCT05403047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470790|NCT05403047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139470791|NCT05403047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139470792|NCT03927443|Bimatoprost|bimatoprost|mesh-list
139470793|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139470794|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
139470795|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139470796|NCT05124353|Protective Agents|protective agents|mesh-ancestor
139470797|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470798|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
139470799|NCT03805841|Bromides|bromides|mesh-list
139470800|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
139470801|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
139470802|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139470803|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470804|NCT02684617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139470805|NCT02684617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470806|NCT01999972|Axitinib|axitinib|mesh-list
139470807|NCT01999972|Crizotinib|crizotinib|mesh-list
139470808|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470809|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139470810|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470811|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470812|NCT04055389|Antithrombins|antithrombins|mesh-list
139470813|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
139470814|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139470815|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
139470816|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470817|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470818|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
139470819|NCT05697055|Ritonavir|ritonavir|mesh-list
139470820|NCT05697055|Nirmatrelvir|nirmatrelvir|mesh-list
139470821|NCT05697055|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139470822|NCT05697055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139470823|NCT05697055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139470824|NCT05697055|Protease Inhibitors|protease inhibitors|mesh-ancestor
139470825|NCT05697055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470826|NCT05697055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470827|NCT05697055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139470828|NCT05697055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139470829|NCT05697055|Antiviral Agents|antiviral agents|mesh-ancestor
139470830|NCT05697055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139470831|NCT05697055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139470832|NCT05697055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139470833|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
139470834|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
139470835|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139470836|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139470837|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139470838|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139470839|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
139470840|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139470841|NCT01999894|Memantine|memantine|mesh-list
139470842|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139470843|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139257593|NCT03593759|Prednisone|prednisone|mesh-list
139470844|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
139470845|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139470846|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470847|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470848|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139470849|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139470850|NCT01976806|Aspirin|aspirin|mesh-list
139470851|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139470852|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139470853|NCT01976806|Analgesics|analgesics|mesh-ancestor
139470854|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
139470855|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470856|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470857|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139470858|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139470859|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139470860|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139470861|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470862|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139470863|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139470864|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470865|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
139470866|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139470867|NCT01976728|Hormones|hormones|mesh-ancestor
139470868|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470869|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470870|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139470871|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139470872|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470873|NCT02689219|Immunotoxins|immunotoxins|mesh-ancestor
139470874|NCT02689219|Immunoconjugates|immunoconjugates|mesh-ancestor
139470875|NCT02689219|Immunologic Factors|immunologic factors|mesh-ancestor
139470876|NCT02689219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470877|NCT03165253|Amoxicillin|amoxicillin|mesh-list
139470878|NCT03165253|Clarithromycin|clarithromycin|mesh-list
139470879|NCT03165253|Omeprazole|omeprazole|mesh-list
139470880|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139470881|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139470882|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139470883|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139470884|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139470885|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470886|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470887|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139470888|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139470889|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139470890|NCT05543317|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139470891|NCT05543317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139470892|NCT05543317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470893|NCT03161977|Mannitol|mannitol|mesh-list
139470894|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139470895|NCT03161977|Diuretics|diuretics|mesh-ancestor
139470896|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
139470897|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470898|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139470899|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139470900|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470901|NCT02683525|Incretins|incretins|mesh-ancestor
139470902|NCT02683525|Hormones|hormones|mesh-ancestor
139470903|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470904|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139470905|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
139470906|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470907|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470908|NCT01976338|Ranibizumab|ranibizumab|mesh-list
139470909|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139470910|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139470911|NCT01976338|Growth Substances|growth substances|mesh-ancestor
139470912|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470913|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
139470914|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470915|NCT02651987|Lanreotide|lanreotide|mesh-list
139470916|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470917|NCT05115773|Anesthetics|anesthetics|mesh-list
139257686|NCT02974621|Olaparib|olaparib|mesh-list
139470918|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470919|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470921|NCT04657939|Liraglutide|liraglutide|mesh-list
139470922|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139470923|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470924|NCT04657939|Incretins|incretins|mesh-ancestor
139470925|NCT04657939|Hormones|hormones|mesh-ancestor
139470926|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470927|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
139470928|NCT01999114|Naltrexone|naltrexone|mesh-list
139470929|NCT01999114|Buprenorphine|buprenorphine|mesh-list
139470930|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139470931|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139470932|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139470933|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139470934|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139470935|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470936|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470937|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470938|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139470939|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
139470940|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139470941|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470942|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139470943|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139470944|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139470945|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139470946|NCT01999114|Narcotics|narcotics|mesh-ancestor
139470947|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139470948|NCT01999114|Analgesics|analgesics|mesh-ancestor
139470949|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
139470950|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139470951|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139470952|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139470953|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139470954|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139470955|NCT04503161|Estradiol|estradiol|mesh-list
139470956|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139470957|NCT04503161|Estrogens|estrogens|mesh-ancestor
139470958|NCT04503161|Hormones|hormones|mesh-ancestor
139470959|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470960|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470961|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139470962|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
139470963|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139470964|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139470965|NCT02214407|Decitabine|decitabine|mesh-list
139470966|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
139470967|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139470968|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
139470969|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470970|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470971|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470972|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
139470973|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139470974|NCT02261285|Nivolumab|nivolumab|mesh-list
139470975|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139470976|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470977|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139470978|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470979|NCT01288625|Amifostine|amifostine|mesh-list
139470980|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139470981|NCT01288625|Protective Agents|protective agents|mesh-ancestor
139470982|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470983|NCT01374451|Everolimus|everolimus|mesh-list
139470984|NCT01374451|Pasireotide|pasireotide|mesh-list
139470985|NCT01374451|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139470986|NCT01374451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139470987|NCT01374451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139470988|NCT01374451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139470989|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139470990|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
139470991|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470992|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139470994|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139470995|NCT02674399|Hylan|hylan|mesh-list
139470996|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
139470997|NCT02674399|Protective Agents|protective agents|mesh-ancestor
139470998|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139470999|NCT03161509|Acetaminophen|acetaminophen|mesh-list
139471000|NCT03161509|Lamotrigine|lamotrigine|mesh-list
139471001|NCT03161509|Carbamazepine|carbamazepine|mesh-list
139471002|NCT03161509|Phenytoin|phenytoin|mesh-list
139471003|NCT03161509|Valproic Acid|valproic acid|mesh-list
139471004|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
139471005|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139471006|NCT03161509|Analgesics|analgesics|mesh-ancestor
139471007|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
139471008|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471009|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471010|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
139471011|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139471012|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139471013|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848394|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139471014|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139471015|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139471016|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139471017|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139471018|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139471019|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139471020|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471021|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
139471022|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139471023|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
139471024|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139471025|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139471026|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139471027|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139471028|NCT02676895|Vaccines|vaccines|mesh-list
139471029|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
139471030|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471031|NCT04440085|Midodrine|midodrine|mesh-list
139471032|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
139471033|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
139471034|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471035|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471036|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139471037|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139471038|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139471039|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139471040|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
139471041|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139471042|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471043|NCT05129033|Omalizumab|omalizumab|mesh-list
139471044|NCT05129033|Itraconazole|itraconazole|mesh-list
139471045|NCT05129033|Prednisone|prednisone|mesh-list
139471046|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471047|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
139471048|NCT05129033|Hormones|hormones|mesh-ancestor
139471049|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471050|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471051|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139471052|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471053|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
139471054|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471055|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139471056|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139471057|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471058|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471059|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139471060|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
139471061|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139471062|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139471063|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139471064|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
139471065|NCT05128721|Vaccines|vaccines|mesh-list
139257816|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
139471066|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
139471067|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471069|NCT05128175|Carbidopa|carbidopa|mesh-list
139471070|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139471071|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139471072|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139471073|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
139471074|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139471075|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471076|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471077|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139471078|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471079|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139471080|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
139471081|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
139471082|NCT04184453|Deferiprone|deferiprone|mesh-list
139471083|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139471084|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
139471085|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
139471086|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471087|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
139471088|NCT05127707|Narcotics|narcotics|mesh-ancestor
139471089|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139471090|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471091|NCT05127707|Analgesics|analgesics|mesh-ancestor
139471092|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
139471093|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471094|NCT00719225|Abatacept|abatacept|mesh-list
139471095|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139471096|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471097|NCT00719225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139471098|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471099|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139471100|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
139471101|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471102|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139471103|NCT05134337|Itraconazole|itraconazole|mesh-list
139471104|NCT05134337|Rifampin|rifampin|mesh-list
139471105|NCT05134337|Pirtobrutinib|pirtobrutinib|mesh-list
139471106|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
139471107|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471108|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139471109|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139471110|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471111|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471112|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139471113|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
139471114|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471115|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471116|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139471117|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139471118|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
139471119|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139471120|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
139471121|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139471122|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139471123|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139471124|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139471125|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139471126|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139471127|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139471128|NCT05134337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139471129|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
139471130|NCT04499495|Mesalamine|mesalamine|mesh-list
139471131|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139471132|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139471133|NCT04499495|Analgesics|analgesics|mesh-ancestor
139471134|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
139471135|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471136|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471137|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471138|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139471139|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
139471140|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139471141|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471142|NCT05323175|Ropivacaine|ropivacaine|mesh-list
139471143|NCT05323175|Anesthetics, Local|anesthetics, local|mesh-ancestor
139471144|NCT05323175|Anesthetics|anesthetics|mesh-ancestor
139471145|NCT05323175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139471146|NCT05323175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471147|NCT05323175|Sensory System Agents|sensory system agents|mesh-ancestor
139471148|NCT05323175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471149|NCT05279963|Amitriptyline|amitriptyline|mesh-list
139471150|NCT05279963|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139471151|NCT05279963|Antidepressive Agents|antidepressive agents|mesh-ancestor
139471152|NCT05279963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139471153|NCT05279963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139471154|NCT05279963|Analgesics|analgesics|mesh-ancestor
139471155|NCT05279963|Sensory System Agents|sensory system agents|mesh-ancestor
139471156|NCT05279963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471157|NCT05279963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471158|NCT05279963|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139471159|NCT05279963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139471160|NCT05279963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139471161|NCT05279963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471162|NCT05279963|Adrenergic Agents|adrenergic agents|mesh-ancestor
139471163|NCT05279963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139471164|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
139471165|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139471166|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139471167|NCT05133635|Prednisolone|prednisolone|mesh-list
139471168|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
139471169|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139471170|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
139471171|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471172|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
139471173|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
139471174|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471175|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471176|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139471177|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
139471178|NCT05133635|Hormones|hormones|mesh-ancestor
139471179|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471180|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139471181|NCT05133635|Protective Agents|protective agents|mesh-ancestor
139471182|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139471183|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471184|NCT05132777|Osimertinib|osimertinib|mesh-list
139471185|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471186|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139471187|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471188|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471189|NCT05422027|Dexamethasone|dexamethasone|mesh-list
139471190|NCT05422027|Dexamethasone acetate|dexamethasone acetate|mesh-list
139471191|NCT05422027|Lenalidomide|lenalidomide|mesh-list
139471192|NCT05422027|Bortezomib|bortezomib|mesh-list
139471193|NCT05422027|BB 1101|bb 1101|mesh-list
139471194|NCT05422027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471195|NCT05422027|Antiemetics|antiemetics|mesh-ancestor
139471196|NCT05422027|Autonomic Agents|autonomic agents|mesh-ancestor
139471197|NCT05422027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471198|NCT05422027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471199|NCT05422027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139471200|NCT05422027|Glucocorticoids|glucocorticoids|mesh-ancestor
139471201|NCT05422027|Hormones|hormones|mesh-ancestor
139471202|NCT05422027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471203|NCT05422027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139471204|NCT05422027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471205|NCT05422027|Protease Inhibitors|protease inhibitors|mesh-ancestor
139471206|NCT05422027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471207|NCT05422027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471208|NCT05422027|Immunologic Factors|immunologic factors|mesh-ancestor
139471209|NCT05422027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139471210|NCT05422027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139471211|NCT05422027|Growth Substances|growth substances|mesh-ancestor
139471212|NCT05422027|Growth Inhibitors|growth inhibitors|mesh-ancestor
139471213|NCT01674725|Ribavirin|ribavirin|mesh-list
139471214|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
139471215|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471216|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
139471217|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471218|NCT05404061|Hormones|hormones|mesh-list
139471219|NCT05404061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471220|NCT05404061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471221|NCT03161041|Bevacizumab|bevacizumab|mesh-list
139471222|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
139471223|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139471224|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471225|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139471226|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139471227|NCT03161041|Growth Substances|growth substances|mesh-ancestor
139471228|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471229|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
139471230|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
139471231|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139471232|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471233|NCT04139317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139471234|NCT04139317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471235|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
139471236|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139471237|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139471238|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471239|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139471240|NCT03163693|Analgesics|analgesics|mesh-ancestor
139471241|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
139471242|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471243|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139471244|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139471245|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139471246|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
139471247|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139471248|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471249|NCT05030545|Eplerenone|eplerenone|mesh-list
139471250|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139471251|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
139471252|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
139471253|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471254|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471255|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139471256|NCT05030545|Diuretics|diuretics|mesh-ancestor
139471257|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
139471258|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139471259|NCT05030545|Hormones|hormones|mesh-ancestor
139471260|NCT03164161|Endorphins|endorphins|mesh-list
139471261|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139471262|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471263|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471264|NCT00754949|Azithromycin|azithromycin|mesh-list
139471265|NCT00754949|Dexamethasone|dexamethasone|mesh-list
139471266|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
139471267|NCT00754949|BB 1101|bb 1101|mesh-list
139471268|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471269|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
139471270|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
139471271|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471272|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471273|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139471274|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
139471275|NCT00754949|Hormones|hormones|mesh-ancestor
139471276|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471277|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139471278|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471279|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
139471280|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471281|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471282|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139471283|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471284|NCT03160807|Levofloxacin|levofloxacin|mesh-list
139471285|NCT03160807|Ofloxacin|ofloxacin|mesh-list
139471286|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139471288|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139471289|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139471290|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139471291|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471292|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471293|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471294|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139471295|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139471296|NCT01674569|Ranibizumab|ranibizumab|mesh-list
139471297|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139471298|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139471299|NCT01674569|Growth Substances|growth substances|mesh-ancestor
139471300|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471301|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
139471302|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471303|NCT03160729|Dexamethasone|dexamethasone|mesh-list
139471304|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471305|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
139471306|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
139471307|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471308|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471309|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139471310|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
139471311|NCT03160729|Hormones|hormones|mesh-ancestor
139471312|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471313|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139471314|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471315|NCT04439929|Adalimumab|adalimumab|mesh-list
139471316|NCT04439929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139471317|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471318|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139471319|NCT05131841|Vinorelbine|vinorelbine|mesh-list
139471320|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139471321|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471322|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
139471323|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
139471324|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
139471325|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471326|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
139471327|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
139471328|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471329|NCT03163381|Apatinib|apatinib|mesh-list
139471330|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471331|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139471332|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471333|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471334|NCT05131295|Dapsone|dapsone|mesh-list
139471335|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139471336|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471337|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
139471338|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139471339|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139471340|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139471341|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471342|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471343|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
139471344|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139471345|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139471346|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
139471347|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471348|NCT05131295|Antacids|antacids|mesh-ancestor
139471349|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139471350|NCT01374217|Clarithromycin|clarithromycin|mesh-list
139471351|NCT01374217|Dexamethasone|dexamethasone|mesh-list
139471352|NCT01374217|Lenalidomide|lenalidomide|mesh-list
139471353|NCT01374217|Tadalafil|tadalafil|mesh-list
139471354|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471355|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
139471356|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
139471357|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471358|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471359|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139471360|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
139471361|NCT01374217|Hormones|hormones|mesh-ancestor
139258118|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139471362|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471363|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139471364|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471365|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
139471366|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139471367|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139471368|NCT01374217|Growth Substances|growth substances|mesh-ancestor
139471369|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
139471370|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139471371|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471372|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139471373|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471374|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471375|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139471376|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139471377|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
139471378|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139471379|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139471380|NCT01374217|Urological Agents|urological agents|mesh-ancestor
139471381|NCT04941937|Thalidomide|thalidomide|mesh-list
139471382|NCT04941937|Dexamethasone|dexamethasone|mesh-list
139471383|NCT04941937|Lenalidomide|lenalidomide|mesh-list
139471384|NCT04941937|Pomalidomide|pomalidomide|mesh-list
139471385|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471386|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
139471387|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
139471388|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471389|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471390|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139471391|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
139471392|NCT04941937|Hormones|hormones|mesh-ancestor
139471393|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471394|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139471395|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471396|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
139471397|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139471398|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139471399|NCT04941937|Growth Substances|growth substances|mesh-ancestor
139471400|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
139471401|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139471402|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
139471403|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139471404|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471405|NCT05124431|Everolimus|everolimus|mesh-list
139471406|NCT05124431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139471407|NCT05124431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139471408|NCT05124431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471409|NCT05124431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471410|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139471411|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
139471412|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471413|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471414|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
139471415|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139471416|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139471417|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471418|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139471419|NCT04955249|Analgesics|analgesics|mesh-ancestor
139471420|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
139471421|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471422|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139471423|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139471424|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139471425|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
139471426|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139471427|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471428|NCT03114085|Capecitabine|capecitabine|mesh-list
139471429|NCT03114085|Apatinib|apatinib|mesh-list
139471430|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139471431|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
139471432|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471433|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471434|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139258197|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
139471436|NCT04886453|Morphine|morphine|mesh-list
139471437|NCT04886453|Anesthetics|anesthetics|mesh-list
139471438|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139471439|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471440|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139471441|NCT04886453|Narcotics|narcotics|mesh-ancestor
139471442|NCT04886453|Analgesics|analgesics|mesh-ancestor
139471443|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
139471444|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471445|NCT05136521|Trazodone|trazodone|mesh-list
139471446|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139471447|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139471448|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139471449|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471450|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139471451|NCT05136521|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139471452|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139471453|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139471454|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471455|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139471456|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
139471457|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139471458|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
139471459|NCT05343013|Trifluridine|trifluridine|mesh-list
139471460|NCT05343013|Antimetabolites|antimetabolites|mesh-ancestor
139471461|NCT05343013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471462|NCT05343013|Antiviral Agents|antiviral agents|mesh-ancestor
139471463|NCT05343013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471464|NCT02388373|Fluticasone|fluticasone|mesh-list
139471465|NCT02388373|Xhance|xhance|mesh-list
139471466|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
139471467|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139471468|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471469|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139471470|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
139471471|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471472|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471473|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139471474|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
139471475|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
139471476|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139471477|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139471478|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139471479|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139471480|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
139471481|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139471482|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471483|NCT01674647|Vitamin K|vitamin k|mesh-list
139471484|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
139471485|NCT01674647|Vitamins|vitamins|mesh-ancestor
139471486|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
139471487|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471488|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139471489|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
139471490|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139471491|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
139471492|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471493|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471494|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
139471495|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139471496|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139471497|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
139471498|NCT01674647|Coagulants|coagulants|mesh-ancestor
139471499|NCT02669407|Lidocaine|lidocaine|mesh-list
139471500|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
139471501|NCT02669407|Anesthetics|anesthetics|mesh-list
139471502|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139471503|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471504|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
139471505|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471506|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139471507|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139471508|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139471509|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139471510|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471512|NCT04637555|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139471513|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139471514|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139471515|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139471516|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471517|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139471518|NCT02388061|Plasminogen|plasminogen|mesh-list
139471519|NCT02388061|Tenecteplase|tenecteplase|mesh-list
139471520|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139471521|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139471522|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471523|NCT04556357|Phenylephrine|phenylephrine|mesh-list
139471524|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
139471525|NCT04556357|Norepinephrine|norepinephrine|mesh-list
139471526|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139471527|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139471528|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
139471529|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
139471530|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471531|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471532|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
139471533|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
139471534|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
139471535|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139471536|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139471537|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139471538|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
139471539|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139471540|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471541|NCT04556357|Protective Agents|protective agents|mesh-ancestor
139471542|NCT04553939|Gemcitabine|gemcitabine|mesh-list
139471543|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139471544|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
139471545|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471546|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471547|NCT03113773|Aldesleukin|aldesleukin|mesh-list
139471548|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471549|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139471550|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139471551|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
139471552|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471553|NCT05306041|Inavolisib|inavolisib|mesh-list
139471554|NCT05306041|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139471555|NCT05306041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471556|NCT05306041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471557|NCT04874831|Avelumab|avelumab|mesh-list
139471558|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139471559|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471560|NCT05122169|Iodine|iodine|mesh-list
139471561|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
139471562|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139471563|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
139471564|NCT05122169|Povidone|povidone|mesh-list
139471565|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139471566|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471567|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
139471568|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
139471569|NCT05122169|Trace Elements|trace elements|mesh-ancestor
139471570|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
139471571|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471572|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
139471573|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
139471574|NCT04359329|Estradiol|estradiol|mesh-list
139471575|NCT04359329|Estrogens|estrogens|mesh-ancestor
139471576|NCT04359329|Hormones|hormones|mesh-ancestor
139471577|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471578|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471579|NCT04203875|Abatacept|abatacept|mesh-list
139471580|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139471581|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471582|NCT04203875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139471583|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258343|NCT05460455|Antibodies|antibodies|mesh-list
139471584|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139471585|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
139471586|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471587|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139471589|NCT05900674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139471590|NCT05900674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139471591|NCT05900674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471592|NCT05900661|Inositol|inositol|mesh-list
139471593|NCT05900661|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139471594|NCT05900661|Vitamin B Complex|vitamin b complex|mesh-ancestor
139471595|NCT05900661|Vitamins|vitamins|mesh-ancestor
139471596|NCT05900661|Micronutrients|micronutrients|mesh-ancestor
139471597|NCT05900661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471598|NCT05900661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139471599|NCT05900661|Immunologic Factors|immunologic factors|mesh-ancestor
139471600|NCT05900635|Lactoferrin|lactoferrin|mesh-list
139471601|NCT05900635|Glycine|glycine|mesh-list
139471602|NCT05900635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471603|NCT05900635|Glycine Agents|glycine agents|mesh-ancestor
139471604|NCT05900635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139471605|NCT05900635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471606|NCT05900635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471607|NCT05900531|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139471608|NCT05900531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139471609|NCT05900531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471610|NCT05900531|Incretins|incretins|mesh-ancestor
139471611|NCT05900531|Hormones|hormones|mesh-ancestor
139471612|NCT05900531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471613|NCT05900531|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139471614|NCT05900531|Protease Inhibitors|protease inhibitors|mesh-ancestor
139471615|NCT05900531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471616|NCT05900531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471617|NCT05900349|Caffeine|caffeine|mesh-list
139471618|NCT05900349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139471619|NCT05900349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471620|NCT05900349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139471621|NCT05900349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471622|NCT05900349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471623|NCT05900349|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139471624|NCT05900349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139471625|NCT05900349|Purinergic Agents|purinergic agents|mesh-ancestor
139471626|NCT05900349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139471627|NCT05900232|Antibodies|antibodies|mesh-list
139471628|NCT05900232|Immunologic Factors|immunologic factors|mesh-ancestor
139471629|NCT05900232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471630|NCT05900219|Vemurafenib|vemurafenib|mesh-list
139471631|NCT05900219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471632|NCT05900219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139471633|NCT05900219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471634|NCT05900219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471635|NCT05900206|Paclitaxel|paclitaxel|mesh-list
139471636|NCT05900206|Docetaxel|docetaxel|mesh-list
139471637|NCT05900206|Cyclophosphamide|cyclophosphamide|mesh-list
139471638|NCT05900206|Carboplatin|carboplatin|mesh-list
139471639|NCT05900206|Trastuzumab|trastuzumab|mesh-list
139471640|NCT05900206|Letrozole|letrozole|mesh-list
139471641|NCT05900206|Epirubicin|epirubicin|mesh-list
139471642|NCT05900206|Pertuzumab|pertuzumab|mesh-list
139471643|NCT05900206|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139471644|NCT05900206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139471645|NCT05900206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471646|NCT05900206|Tubulin Modulators|tubulin modulators|mesh-ancestor
139471647|NCT05900206|Antimitotic Agents|antimitotic agents|mesh-ancestor
139471648|NCT05900206|Mitosis Modulators|mitosis modulators|mesh-ancestor
139471649|NCT05900206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471650|NCT05900206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139471651|NCT05900206|Immunologic Factors|immunologic factors|mesh-ancestor
139471652|NCT05900206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471653|NCT05900206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139471654|NCT05900206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139258418|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
139471655|NCT05900206|Alkylating Agents|alkylating agents|mesh-ancestor
139471656|NCT05900206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139471657|NCT05900206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139471658|NCT05900206|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139471659|NCT05900206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139471660|NCT05900206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471661|NCT05900206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139471662|NCT05900206|Hormone Antagonists|hormone antagonists|mesh-ancestor
139471663|NCT05900206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471664|NCT05900206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139471665|NCT05900206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139471666|NCT05900206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139471667|NCT05900206|Immunoconjugates|immunoconjugates|mesh-ancestor
139471668|NCT05899829|Rifampin|rifampin|mesh-list
139471669|NCT05899829|Rabeprazole|rabeprazole|mesh-list
139471670|NCT05899829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139471671|NCT05899829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139471672|NCT05899829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139471673|NCT05899829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471674|NCT05899829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471675|NCT05899829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139471676|NCT05899829|Antitubercular Agents|antitubercular agents|mesh-ancestor
139471677|NCT05899829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139471678|NCT05899829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471679|NCT05899829|Leprostatic Agents|leprostatic agents|mesh-ancestor
139471680|NCT05899829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139471681|NCT05899829|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139471682|NCT05899829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139471683|NCT05899829|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139471684|NCT05899829|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139471685|NCT05899829|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139471686|NCT05899829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139471687|NCT05899764|Brivaracetam|brivaracetam|mesh-list
139471688|NCT05899764|Anticonvulsants|anticonvulsants|mesh-ancestor
139471689|NCT05899751|Methotrexate|methotrexate|mesh-list
139471690|NCT05899751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139471691|NCT05899751|Abortifacient Agents|abortifacient agents|mesh-ancestor
139471692|NCT05899751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139471693|NCT05899751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471694|NCT05899751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139471695|NCT05899751|Antimetabolites|antimetabolites|mesh-ancestor
139471696|NCT05899751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471697|NCT05899751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471698|NCT05899751|Dermatologic Agents|dermatologic agents|mesh-ancestor
139471699|NCT05899751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471700|NCT05899751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139471701|NCT05899751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139471702|NCT05899751|Immunologic Factors|immunologic factors|mesh-ancestor
139471703|NCT05899751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139471704|NCT05899751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139471705|NCT05899621|Prednisone|prednisone|mesh-list
139471706|NCT05899621|Cyclophosphamide|cyclophosphamide|mesh-list
139471707|NCT05899621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139471708|NCT05899621|Doxorubicin|doxorubicin|mesh-list
139471709|NCT05899621|Vincristine|vincristine|mesh-list
139471710|NCT05899621|Lenalidomide|lenalidomide|mesh-list
139471711|NCT05899621|Obinutuzumab|obinutuzumab|mesh-list
139471712|NCT05899621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139471713|NCT05899621|Immunologic Factors|immunologic factors|mesh-ancestor
139471714|NCT05899621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471715|NCT05899621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139471716|NCT05899621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139471717|NCT05899621|Alkylating Agents|alkylating agents|mesh-ancestor
139471718|NCT05899621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471719|NCT05899621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471720|NCT05899621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139471721|NCT05899621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139471722|NCT05899621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139471723|NCT05899621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139471724|NCT05899621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471725|NCT05899621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471726|NCT05899621|Glucocorticoids|glucocorticoids|mesh-ancestor
139471727|NCT05899621|Hormones|hormones|mesh-ancestor
139471728|NCT05899621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471729|NCT05899621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139471730|NCT05899621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139471731|NCT05899621|Tubulin Modulators|tubulin modulators|mesh-ancestor
139471732|NCT05899621|Antimitotic Agents|antimitotic agents|mesh-ancestor
139471733|NCT05899621|Mitosis Modulators|mitosis modulators|mesh-ancestor
139471734|NCT05899621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139471735|NCT05899621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139471736|NCT05899621|Growth Substances|growth substances|mesh-ancestor
139471737|NCT05899621|Growth Inhibitors|growth inhibitors|mesh-ancestor
139471738|NCT05899621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139471739|NCT05899517|Oxytocin|oxytocin|mesh-list
139471740|NCT05899517|Oxytocics|oxytocics|mesh-ancestor
139471741|NCT05899517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139471742|NCT05899517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471743|NCT05899049|Pembrolizumab|pembrolizumab|mesh-list
139471744|NCT05899049|Lenvatinib|lenvatinib|mesh-list
139471745|NCT05899049|Belzutifan|belzutifan|mesh-list
139471746|NCT05899049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139471747|NCT05899049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471748|NCT05899049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139471749|NCT05899049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471750|NCT05899049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139471751|NCT05899049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471752|NCT05898984|Beclomethasone|beclomethasone|mesh-list
139471753|NCT05898984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471754|NCT05898984|Glucocorticoids|glucocorticoids|mesh-ancestor
139471755|NCT05898984|Hormones|hormones|mesh-ancestor
139471756|NCT05898984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471757|NCT05898984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471758|NCT05898984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139471759|NCT05898984|Respiratory System Agents|respiratory system agents|mesh-ancestor
139471760|NCT05898451|Cisplatin|cisplatin|mesh-list
139471761|NCT05898451|Dacarbazine|dacarbazine|mesh-list
139471762|NCT05898451|Lomustine|lomustine|mesh-list
139471763|NCT05898451|Thymalfasin|thymalfasin|mesh-list
139471764|NCT05898451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471765|NCT05898451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139471766|NCT05898451|Alkylating Agents|alkylating agents|mesh-ancestor
139471767|NCT05898451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471768|NCT05898451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139471769|NCT05898451|Immunologic Factors|immunologic factors|mesh-ancestor
139471770|NCT05898451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471771|NCT05898373|Antineoplastic Agents|antineoplastic agents|mesh-list
139471772|NCT05898321|Goserelin|goserelin|mesh-list
139471773|NCT05898321|Mifepristone|mifepristone|mesh-list
139471774|NCT05898321|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139471775|NCT05898321|Abortifacient Agents|abortifacient agents|mesh-ancestor
139471776|NCT05898321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139471777|NCT05898321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471778|NCT05898321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139471779|NCT05898321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139471780|NCT05898321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139471781|NCT05898321|Contraceptive Agents|contraceptive agents|mesh-ancestor
139471782|NCT05898321|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139471783|NCT05898321|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139471784|NCT05898321|Hormone Antagonists|hormone antagonists|mesh-ancestor
139471785|NCT05898321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471786|NCT05898321|Luteolytic Agents|luteolytic agents|mesh-ancestor
139471787|NCT05898321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139471788|NCT05898321|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139471789|NCT05898321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139471790|NCT05898321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471791|NCT05898308|Rituximab|rituximab|mesh-list
139471792|NCT05898308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139471793|NCT05898308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471794|NCT05898308|Immunologic Factors|immunologic factors|mesh-ancestor
139471795|NCT05898308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471796|NCT05898308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139471797|NCT05898256|Gemcitabine|gemcitabine|mesh-list
139471798|NCT05898256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471799|NCT05898256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139471800|NCT05898256|Antimetabolites|antimetabolites|mesh-ancestor
139471801|NCT05898256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471802|NCT05898087|Bupivacaine|bupivacaine|mesh-list
139471803|NCT05898087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139471804|NCT05898087|Anesthetics, Local|anesthetics, local|mesh-ancestor
139471805|NCT05898087|Anesthetics|anesthetics|mesh-ancestor
139471806|NCT05898087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139471807|NCT05898087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471808|NCT05898087|Sensory System Agents|sensory system agents|mesh-ancestor
139471809|NCT05898087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471810|NCT05897918|Tranexamic Acid|tranexamic acid|mesh-list
139471811|NCT05897918|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139471812|NCT05897918|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139471813|NCT05897918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471814|NCT05897918|Hemostatics|hemostatics|mesh-ancestor
139471815|NCT05897918|Coagulants|coagulants|mesh-ancestor
139471816|NCT05897034|Doxycycline|doxycycline|mesh-list
139471817|NCT05897034|Nitazoxanide|nitazoxanide|mesh-list
139471818|NCT05897034|Pentoxifylline|pentoxifylline|mesh-list
139471819|NCT05897034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139471820|NCT05897034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471821|NCT05897034|Antimalarials|antimalarials|mesh-ancestor
139471822|NCT05897034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139471823|NCT05897034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139471824|NCT05897034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139471825|NCT05897034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471826|NCT05897034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471827|NCT05897034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139471828|NCT05897034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139471829|NCT05897034|Protective Agents|protective agents|mesh-ancestor
139471830|NCT05897034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471831|NCT05897034|Vasodilator Agents|vasodilator agents|mesh-ancestor
139471832|NCT05897034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139471833|NCT05897034|Antioxidants|antioxidants|mesh-ancestor
139471834|NCT05897008|Omalizumab|omalizumab|mesh-list
139471835|NCT05897008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139471836|NCT05897008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139471837|NCT05897008|Respiratory System Agents|respiratory system agents|mesh-ancestor
139471838|NCT05892939|Oxytocin|oxytocin|mesh-list
139471839|NCT05892939|Oxytocics|oxytocics|mesh-ancestor
139471840|NCT05892939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139471841|NCT05892939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471842|NCT05890534|Pycnogenols|pycnogenols|mesh-list
139471843|NCT05890534|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139471844|NCT05890534|Immunologic Factors|immunologic factors|mesh-ancestor
139471845|NCT05890534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471846|NCT05890534|Antioxidants|antioxidants|mesh-ancestor
139471847|NCT05890534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471848|NCT05890534|Protective Agents|protective agents|mesh-ancestor
139471849|NCT05890534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139471850|NCT05861765|Papaverine|papaverine|mesh-list
139471851|NCT05861765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139471852|NCT05861765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471853|NCT05861765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471854|NCT05861765|Vasodilator Agents|vasodilator agents|mesh-ancestor
139471855|NCT05861765|Urological Agents|urological agents|mesh-ancestor
139471856|NCT05818618|Clobetasol|clobetasol|mesh-list
139471857|NCT05818618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471858|NCT05818618|Glucocorticoids|glucocorticoids|mesh-ancestor
139471859|NCT05818618|Hormones|hormones|mesh-ancestor
139471860|NCT05818618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471861|NCT05818618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471862|NCT05804513|Lixisenatide|lixisenatide|mesh-list
139471863|NCT05804513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139471864|NCT05804513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471865|NCT05783219|Lidocaine|lidocaine|mesh-list
139471866|NCT05783219|Anesthetics, Local|anesthetics, local|mesh-ancestor
139471867|NCT05783219|Anesthetics|anesthetics|mesh-ancestor
139471868|NCT05783219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139471869|NCT05783219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471870|NCT05783219|Sensory System Agents|sensory system agents|mesh-ancestor
139471871|NCT05783219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471872|NCT05783219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139471873|NCT05783219|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139471874|NCT05783219|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139471875|NCT05783219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139471876|NCT05783219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471877|NCT05709444|Angiotensin II|angiotensin ii|mesh-list
139471878|NCT05709444|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139471879|NCT05709444|alpha-MSH|alpha-msh|mesh-list
139471880|NCT05709444|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139471881|NCT05709444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139471882|NCT05709444|Protease Inhibitors|protease inhibitors|mesh-ancestor
139471883|NCT05709444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471884|NCT05709444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471885|NCT05709444|Hormones|hormones|mesh-ancestor
139471886|NCT05709444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471887|NCT05709444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471888|NCT05583110|Trastuzumab|trastuzumab|mesh-list
139471889|NCT05583110|Vinorelbine|vinorelbine|mesh-list
139471890|NCT05583110|Tucatinib|tucatinib|mesh-list
139471891|NCT05583110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139471892|NCT05583110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471893|NCT05583110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139471894|NCT05583110|Tubulin Modulators|tubulin modulators|mesh-ancestor
139471895|NCT05583110|Antimitotic Agents|antimitotic agents|mesh-ancestor
139471896|NCT05583110|Mitosis Modulators|mitosis modulators|mesh-ancestor
139471897|NCT05583110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471898|NCT05583110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139471899|NCT05583110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471900|NCT05565937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139471901|NCT05537935|Naltrexone|naltrexone|mesh-list
139471902|NCT05537935|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139471903|NCT05537935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139471904|NCT05537935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471905|NCT05537935|Sensory System Agents|sensory system agents|mesh-ancestor
139471906|NCT05537935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471907|NCT05411679|Olaparib|olaparib|mesh-list
139471908|NCT05411679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139471909|NCT05411679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471910|NCT05411679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471911|NCT05411679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471912|NCT05406479|Bedaquiline|bedaquiline|mesh-list
139471913|NCT05406479|Antitubercular Agents|antitubercular agents|mesh-ancestor
139471914|NCT05406479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139471915|NCT05406479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471916|NCT05325281|Thioctic Acid|thioctic acid|mesh-list
139471917|NCT05325281|Gemcitabine|gemcitabine|mesh-list
139471918|NCT05325281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139471919|NCT05325281|Antimetabolites|antimetabolites|mesh-ancestor
139471920|NCT05325281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471921|NCT05325281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471922|NCT05325281|Antioxidants|antioxidants|mesh-ancestor
139471923|NCT05325281|Protective Agents|protective agents|mesh-ancestor
139471924|NCT05325281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471925|NCT05325281|Vitamin B Complex|vitamin b complex|mesh-ancestor
139471926|NCT05325281|Vitamins|vitamins|mesh-ancestor
139471927|NCT05325281|Micronutrients|micronutrients|mesh-ancestor
139471928|NCT05254275|Chlorhexidine|chlorhexidine|mesh-list
139471929|NCT05254275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139471930|NCT05254275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471931|NCT05254275|Disinfectants|disinfectants|mesh-ancestor
139471932|NCT05193994|Lamivudine|lamivudine|mesh-list
139471933|NCT05193994|Abacavir|abacavir|mesh-list
139471934|NCT05193994|Dolutegravir|dolutegravir|mesh-list
139471935|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139471936|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139471937|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471938|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471939|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
139471940|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471941|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139471942|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139471943|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139471944|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139471945|NCT05191784|Bevacizumab|bevacizumab|mesh-list
139471946|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139471947|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471948|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139471949|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139471950|NCT05191784|Growth Substances|growth substances|mesh-ancestor
139471951|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471952|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
139471953|NCT05137717|Maribavir|maribavir|mesh-list
139471954|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
139471955|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139471956|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
139471957|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139471958|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139471959|NCT05077709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139471960|NCT05077709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471961|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
139471962|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
139471963|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139471964|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471965|NCT04911062|Epinephrine|epinephrine|mesh-list
139471966|NCT04911062|Bupivacaine|bupivacaine|mesh-list
139471967|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
139471968|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
139471969|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139471970|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471971|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
139471972|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471973|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139471974|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139471975|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
139471976|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139471977|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139471978|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139471979|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139471980|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
139471981|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139471982|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
139471983|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
139471984|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
139471985|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139471986|NCT04818749|Dexamethasone|dexamethasone|mesh-list
139471987|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
139471988|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
139471989|NCT04818749|BB 1101|bb 1101|mesh-list
139471990|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139471991|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
139471992|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
139471993|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139471994|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139471995|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139471996|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
139471997|NCT04818749|Hormones|hormones|mesh-ancestor
139471998|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139471999|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139472000|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472001|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
139472002|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472003|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472004|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139472005|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139472006|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139472007|NCT04818749|Analgesics|analgesics|mesh-ancestor
139472008|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
139472009|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139472010|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139472011|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139472012|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
139472013|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472014|NCT04776395|Dexamethasone|dexamethasone|mesh-list
139472015|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
139472016|NCT04776395|Ichthammol|ichthammol|mesh-list
139472017|NCT04776395|BB 1101|bb 1101|mesh-list
139472018|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139472019|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
139472020|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
139472021|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472022|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472023|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139472024|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
139472025|NCT04776395|Hormones|hormones|mesh-ancestor
139472026|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472027|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139472028|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472029|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
139472030|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472031|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472032|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
139472033|NCT04738643|Varenicline|varenicline|mesh-list
139472034|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139258787|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
139472035|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139472036|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
139472037|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472038|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472039|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472041|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139472042|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
139472043|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139472044|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472045|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139472046|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139472047|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139472048|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
139472049|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139472050|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139472051|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
139472052|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472053|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
139472054|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139472055|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139472056|NCT04587830|Temozolomide|temozolomide|mesh-list
139472057|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139472058|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
139472059|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472060|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472061|NCT04558281|Ropivacaine|ropivacaine|mesh-list
139472062|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
139472063|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
139472064|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139472065|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472066|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
139472067|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472068|NCT04498468|Dexamethasone|dexamethasone|mesh-list
139472069|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139472070|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
139472071|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
139472072|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472073|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472074|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139472075|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
139472076|NCT04498468|Hormones|hormones|mesh-ancestor
139472077|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472078|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139472079|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472080|NCT04343222|Bromfenac|bromfenac|mesh-list
139472081|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
139472082|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139472083|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139472084|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139472085|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139472086|NCT04343222|Analgesics|analgesics|mesh-ancestor
139472087|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
139472088|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472089|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472090|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139472091|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139472092|NCT04342039|Budesonide|budesonide|mesh-list
139472093|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139472094|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139472095|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
139472096|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472097|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472098|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139472099|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
139130578|NCT03387020|Everolimus|everolimus|mesh-list
139472100|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
139472101|NCT04342039|Hormones|hormones|mesh-ancestor
139472102|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472103|NCT04311671|Ivermectin|ivermectin|mesh-list
139472104|NCT04311671|Albendazole|albendazole|mesh-list
139472105|NCT04311671|Moxidectin|moxidectin|mesh-list
139472106|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139472107|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258867|NCT02154854|Tacrolimus|tacrolimus|mesh-list
139472108|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
139472109|NCT04311671|Anticestodal Agents|anticestodal agents|mesh-ancestor
139472110|NCT04311671|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139472111|NCT04311671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139472112|NCT04311671|Tubulin Modulators|tubulin modulators|mesh-ancestor
139472113|NCT04311671|Antimitotic Agents|antimitotic agents|mesh-ancestor
139472114|NCT04311671|Mitosis Modulators|mitosis modulators|mesh-ancestor
139472115|NCT04311671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472116|NCT04311671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472117|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
139472118|NCT04281108|Fluticasone|fluticasone|mesh-list
139472120|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139472121|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139472122|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
139472123|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472124|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472125|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139472126|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
139472127|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
139472128|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139472129|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139472130|NCT04268849|Hematinics|hematinics|mesh-ancestor
139472131|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139472132|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139472133|NCT04258046|Trametinib|trametinib|mesh-list
139472134|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472135|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139472136|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472137|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472138|NCT04189055|Irinotecan|irinotecan|mesh-list
139472139|NCT04189055|Cetuximab|cetuximab|mesh-list
139472140|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139472141|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139472142|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472143|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472144|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472145|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139472146|NCT04147806|Dexamethasone|dexamethasone|mesh-list
139472147|NCT04147806|Tamsulosin|tamsulosin|mesh-list
139472148|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139472149|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
139472150|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
139472151|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472152|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472153|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139472154|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
139472155|NCT04147806|Hormones|hormones|mesh-ancestor
139472156|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472157|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139472158|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472159|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139472160|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139472161|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139472162|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
139472163|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472164|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472165|NCT04147806|Urological Agents|urological agents|mesh-ancestor
139472166|NCT04122625|Nivolumab|nivolumab|mesh-list
139472167|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139472168|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472169|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139472170|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472171|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
139472172|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139472173|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
139472174|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472175|NCT04076462|Octreotide|octreotide|mesh-list
139472176|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139472177|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139472178|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472179|NCT04044313|Lenvatinib|lenvatinib|mesh-list
139472180|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472181|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139258943|NCT02160548|Atropine|atropine|mesh-list
139472182|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472183|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472184|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
139472185|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139472186|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
139472187|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472188|NCT03828201|Levofloxacin|levofloxacin|mesh-list
139472189|NCT03828201|Linezolid|linezolid|mesh-list
139472190|NCT03828201|Bedaquiline|bedaquiline|mesh-list
139472191|NCT03828201|Clofazimine|clofazimine|mesh-list
139472192|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139472193|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139472194|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139472195|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139472196|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139472197|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472198|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472199|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472200|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139472201|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139472202|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139472203|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
139472204|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139472205|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
139472206|NCT03824704|Nivolumab|nivolumab|mesh-list
139472207|NCT03824704|Rucaparib|rucaparib|mesh-list
139472208|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139472209|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472210|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139472211|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472212|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139472213|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472214|NCT03798106|Durvalumab|durvalumab|mesh-list
139472215|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139472216|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472217|NCT03767075|Atezolizumab|atezolizumab|mesh-list
139472218|NCT03767075|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
139472219|NCT03767075|Futibatinib|futibatinib|mesh-list
139472220|NCT03767075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139472221|NCT03767075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472222|NCT03767075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139472223|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472224|NCT03766581|Aspirin|aspirin|mesh-list
139472225|NCT03766581|Clopidogrel|clopidogrel|mesh-list
139472226|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139472227|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139472228|NCT03766581|Analgesics|analgesics|mesh-ancestor
139472229|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
139472230|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472231|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472232|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139472233|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139472234|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139472235|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139472236|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472237|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139472238|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139472239|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472240|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
139472241|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139472242|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139472243|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139472244|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
139472245|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472246|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
139472247|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
139472248|NCT03670966|Fludarabine|fludarabine|mesh-list
139642628|NCT01892995|Ketamine|ketamine|mesh-list
139643076|NCT05021809|Calcium|calcium|mesh-list
139643305|NCT04926480|Anesthetics|anesthetics|mesh-list
139472249|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
139643597|NCT05872386|Buprenorphine|buprenorphine|mesh-list
139643673|NCT05711082|Dopamine|dopamine|mesh-list
139643950|NCT04190433|Carvedilol|carvedilol|mesh-list
139385583|NCT01359254|Melphalan|melphalan|mesh-list
139472250|NCT03670966|Tacrolimus|tacrolimus|mesh-list
139645153|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
139472251|NCT03670966|Antibodies|antibodies|mesh-list
139472252|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139134398|NCT01166451|Iron|iron|mesh-list
139472253|NCT03670966|Lenograstim|lenograstim|mesh-list
139135171|NCT01287351|Xhance|xhance|mesh-list
139646907|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139386011|NCT03541759|Hydromorphone|hydromorphone|mesh-list
139386125|NCT03545711|Irinotecan|irinotecan|mesh-list
139043224|NCT00135694|Hormones|hormones|mesh-ancestor
139386612|NCT02415777|Riboflavin|riboflavin|mesh-list
139386814|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386885|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139386952|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
139387225|NCT06110494|Eusol|eusol|mesh-list
139387312|NCT06109389|Lidocaine|lidocaine|mesh-list
139647269|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647270|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647271|NCT02115373|Tepotinib|tepotinib|mesh-list
139387576|NCT05993975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139387577|NCT05993975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139387578|NCT05993975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139647274|NCT03824171|Vitamin D|vitamin d|mesh-list
139387715|NCT05821075|Hormones|hormones|mesh-ancestor
139387787|NCT05624866|Triamcinolone|triamcinolone|mesh-list
139647320|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
139388618|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
139388968|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139389520|NCT05142319|Vaccines|vaccines|mesh-list
139389653|NCT04154150|Ketamine|ketamine|mesh-list
139389925|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
139389995|NCT00108953|Doxorubicin|doxorubicin|mesh-list
139390286|NCT06009497|Cyclosporine|cyclosporine|mesh-list
139390785|NCT03896009|Meloxicam|meloxicam|mesh-list
139472254|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139390898|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647544|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139390899|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
139390900|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047716|NCT01054508|Niacin|niacin|mesh-list
139472255|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
139647579|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647580|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139647581|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139647582|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647583|NCT03047538|Amlodipine|amlodipine|mesh-list
139391439|NCT06219590|Acetylcholine|acetylcholine|mesh-list
139391440|NCT06219590|Vasodilator Agents|vasodilator agents|mesh-ancestor
139391441|NCT06219590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139391442|NCT06219590|Cholinergic Agents|cholinergic agents|mesh-ancestor
139391443|NCT06219590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391444|NCT06219590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391445|NCT06219590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391446|NCT06219525|Zinc|zinc|mesh-list
139391447|NCT06219525|Trace Elements|trace elements|mesh-ancestor
139391448|NCT06219525|Micronutrients|micronutrients|mesh-ancestor
139391449|NCT06219525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391450|NCT06219486|Fibrin fragment D|fibrin fragment d|mesh-list
139647610|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139647611|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391841|NCT06136585|Autonomic Agents|autonomic agents|mesh-ancestor
139392253|NCT05840211|Capecitabine|capecitabine|mesh-list
139392373|NCT05711823|Dexamethasone|dexamethasone|mesh-list
139647717|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
139392501|NCT05562466|Budesonide|budesonide|mesh-list
139392555|NCT05516862|Analgesics|analgesics|mesh-ancestor
139392912|NCT05132582|Trastuzumab|trastuzumab|mesh-list
139392965|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647867|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139392966|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392967|NCT04950660|Caffeine|caffeine|mesh-list
139392968|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139392969|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392970|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139392971|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392972|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392973|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139392974|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139392975|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
139392976|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139392977|NCT04936230|Atezolizumab|atezolizumab|mesh-list
139392978|NCT04936230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139392979|NCT04936230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139392981|NCT04936230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139647876|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139647877|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647878|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139393038|NCT04835506|Infliximab|infliximab|mesh-list
139393039|NCT04835506|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139393040|NCT04835506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139393206|NCT04379635|Paclitaxel|paclitaxel|mesh-list
139647973|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
139647990|NCT04872270|Caffeine|caffeine|mesh-list
139647991|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139393518|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393520|NCT03600441|Abexinostat|abexinostat|mesh-list
139648002|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393789|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
139393837|NCT02979522|Immunotoxins|immunotoxins|mesh-ancestor
139393966|NCT02169310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139393967|NCT02169310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393968|NCT02085148|Irinotecan|irinotecan|mesh-list
139393969|NCT02085148|Vincristine|vincristine|mesh-list
139393970|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139393971|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139393972|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393973|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393974|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393975|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139393976|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
139393977|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
139393978|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
139393984|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139393985|NCT01896999|Nivolumab|nivolumab|mesh-list
139393986|NCT01896999|Ipilimumab|ipilimumab|mesh-list
139393987|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139393988|NCT01896999|Antibodies|antibodies|mesh-list
139393989|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
139393990|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139648078|NCT01456715|Vaccines|vaccines|mesh-list
139394039|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139394040|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394041|NCT01722240|Incretins|incretins|mesh-ancestor
139394042|NCT01722240|Hormones|hormones|mesh-ancestor
139394043|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139648079|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
139648080|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648081|NCT01895569|Metformin|metformin|mesh-list
139394101|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394352|NCT02183467|Linagliptin|linagliptin|mesh-list
139648150|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
139394485|NCT04292756|Triamcinolone|triamcinolone|mesh-list
139648241|NCT00198991|Cladribine|cladribine|mesh-list
139394860|NCT02187445|Budesonide|budesonide|mesh-list
139648332|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139648359|NCT04776655|Cetuximab|cetuximab|mesh-list
139648383|NCT04776655|Vitamins|vitamins|mesh-ancestor
139648390|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139648391|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395532|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
139395533|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
139395534|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395535|NCT02202967|Misoprostol|misoprostol|mesh-list
139395536|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139395537|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
139395538|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139395539|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395540|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139395942|NCT04907227|Hormones|hormones|mesh-ancestor
139396016|NCT04627870|Paclitaxel|paclitaxel|mesh-list
139396346|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139396347|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139396348|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139396349|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396350|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396351|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
139396352|NCT02734771|Hormones|hormones|mesh-ancestor
139396353|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396354|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139396355|NCT02734771|Immunotoxins|immunotoxins|mesh-ancestor
139396356|NCT02734771|Immunoconjugates|immunoconjugates|mesh-ancestor
139396357|NCT02689024|Acetaminophen|acetaminophen|mesh-list
139396358|NCT02689024|Dipyrone|dipyrone|mesh-list
139396359|NCT02689024|Ibuprofen|ibuprofen|mesh-list
139396360|NCT02689024|Diclofenac|diclofenac|mesh-list
139396361|NCT02689024|Naproxen|naproxen|mesh-list
139396362|NCT02689024|Fentanyl|fentanyl|mesh-list
139396363|NCT02689024|Morphine|morphine|mesh-list
139396364|NCT02689024|Bupivacaine|bupivacaine|mesh-list
139396365|NCT02689024|Ropivacaine|ropivacaine|mesh-list
139396366|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
139396367|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
139396368|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
139396369|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139396370|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648482|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
139648483|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396454|NCT02144584|Memantine|memantine|mesh-list
139396455|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139396456|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139396457|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
139396458|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139396459|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396460|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053266|NCT06048263|Anesthetics|anesthetics|mesh-ancestor
139396461|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139396462|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139396464|NCT01897571|Prednisolone acetate|prednisolone acetate|mesh-list
139396465|NCT01897571|Prednisolone phosphate|prednisolone phosphate|mesh-list
139396466|NCT01897571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396467|NCT01897571|Glucocorticoids|glucocorticoids|mesh-ancestor
139396468|NCT01897571|Hormones|hormones|mesh-ancestor
139396469|NCT01897571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396470|NCT01897571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396471|NCT01897571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139396472|NCT01897571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396473|NCT01846390|Dexamethasone|dexamethasone|mesh-list
139396474|NCT01846390|Gemcitabine|gemcitabine|mesh-list
139396475|NCT01846390|Romidepsin|romidepsin|mesh-list
139396476|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396477|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
139396478|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
139396479|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396480|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396481|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139396482|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
139396483|NCT01846390|Hormones|hormones|mesh-ancestor
139396485|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139648492|NCT01419795|Lenalidomide|lenalidomide|mesh-list
139396700|NCT00428142|Hormones|hormones|mesh-ancestor
139396827|NCT00245154|Paclitaxel|paclitaxel|mesh-list
139396828|NCT00245154|Carboplatin|carboplatin|mesh-list
139396829|NCT00245154|Cediranib|cediranib|mesh-list
139396830|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139396831|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396832|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396833|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396834|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
139053673|NCT05468489|Etoposide|etoposide|mesh-list
139396835|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396836|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396837|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396838|NCT00093457|Sorafenib|sorafenib|mesh-list
139396839|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396840|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396841|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396842|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396894|NCT00054106|Flutamide|flutamide|mesh-list
139396961|NCT02208505|Narcotics|narcotics|mesh-ancestor
139397095|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
139648785|NCT04859556|Dipivefrin|dipivefrin|mesh-list
139649004|NCT02983097|Cytarabine|cytarabine|mesh-list
139472256|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472258|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139472259|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
139472260|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472261|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472262|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139472263|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139472264|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
139472265|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139472266|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139472267|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472268|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139472269|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139472270|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
139472271|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139472272|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139472273|NCT03527745|Albendazole|albendazole|mesh-list
139472274|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
139472275|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139472276|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139472277|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
139472278|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139472279|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139472280|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
139472281|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
139472282|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
139472283|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472284|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472285|NCT03522584|Durvalumab|durvalumab|mesh-list
139472286|NCT03522584|Ipilimumab|ipilimumab|mesh-list
139472287|NCT03522584|Tremelimumab|tremelimumab|mesh-list
139472288|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
139472289|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139472290|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
139472291|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139472292|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472293|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
139472294|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472295|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139472296|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472297|NCT03284463|Glyburide|glyburide|mesh-list
139472298|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139649540|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139649977|NCT01517711|Narcotics|narcotics|mesh-ancestor
139650058|NCT04835922|Anesthetics|anesthetics|mesh-list
139650197|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
139397153|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650416|NCT00068341|Docetaxel|docetaxel|mesh-list
139650709|NCT04826016|Paclitaxel|paclitaxel|mesh-list
139472299|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472300|NCT03223103|Poly ICLC|poly iclc|mesh-list
139651010|NCT04779047|Ritonavir|ritonavir|mesh-list
139651371|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
139472301|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
139472302|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
139397413|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139397711|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
139398293|NCT02392845|Docetaxel|docetaxel|mesh-list
139398440|NCT05740371|Argatroban|argatroban|mesh-list
139398516|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
139398592|NCT03167853|Antibodies|antibodies|mesh-list
139398816|NCT05491460|Apixaban|apixaban|mesh-list
139398887|NCT05497232|Pancrelipase|pancrelipase|mesh-list
139398962|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
139399117|NCT02235337|Riboflavin|riboflavin|mesh-list
139472303|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399337|NCT05493332|Antidotes|antidotes|mesh-ancestor
139472304|NCT03174782|Bupivacaine|bupivacaine|mesh-list
139472305|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
139472306|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
139399708|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399849|NCT01379209|Sirolimus|sirolimus|mesh-list
139400072|NCT01344187|Vitamins|vitamins|mesh-ancestor
139400366|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
139400593|NCT01303783|Tocolytic Agents|tocolytic agents|mesh-ancestor
139472307|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139472308|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401187|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
139401410|NCT00845299|Lubricant Eye Drops|lubricant eye drops|mesh-list
139402230|NCT00501709|Abatacept|abatacept|mesh-list
139402304|NCT02404623|Vitamin D|vitamin d|mesh-list
139402382|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
139402690|NCT00459277|Fentanyl|fentanyl|mesh-list
139402836|NCT00583609|Laxatives|laxatives|mesh-ancestor
139403297|NCT05149365|Hormones|hormones|mesh-ancestor
139403343|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139403933|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139404089|NCT02191319|Nevirapine|nevirapine|mesh-list
139404229|NCT00317395|Antithrombins|antithrombins|mesh-ancestor
139404370|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
139404521|NCT00004231|Vitamins|vitamins|mesh-ancestor
139404676|NCT02197403|Propofol|propofol|mesh-list
139404754|NCT02195375|Hormones|hormones|mesh-ancestor
139404820|NCT00135421|Serotonin Agents|serotonin agents|mesh-ancestor
139404989|NCT02368197|Paclitaxel|paclitaxel|mesh-list
139405117|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651765|NCT03006627|Morphine|morphine|mesh-list
139405346|NCT05790330|Methotrexate|methotrexate|mesh-list
139405638|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139405932|NCT00572156|Mecasermin|mecasermin|mesh-list
139406392|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
139406466|NCT03705559|Analgesics|analgesics|mesh-ancestor
139406545|NCT02363127|Progesterone|progesterone|mesh-list
139472309|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
139406694|NCT02361645|Analgesics|analgesics|mesh-ancestor
139406844|NCT02225093|Caffeine|caffeine|mesh-list
139407104|NCT02226341|Hormones|hormones|mesh-ancestor
139407128|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
139651791|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
139407871|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139407949|NCT03146325|Omeprazole|omeprazole|mesh-list
139408096|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
139408385|NCT05230797|Zinc|zinc|mesh-list
139408551|NCT03507127|Varenicline|varenicline|mesh-list
139408918|NCT02322190|Methoxsalen|methoxsalen|mesh-list
139409215|NCT02326779|Aspirin|aspirin|mesh-list
139472310|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409443|NCT02313805|Insulin|insulin|mesh-list
139472311|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
139472312|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139409667|NCT03499171|Citalopram|citalopram|mesh-list
139409737|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139409893|NCT04881955|Ecopipam|ecopipam|mesh-list
139410130|NCT02620553|Insulin|insulin|mesh-list
139410257|NCT01536041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139410262|NCT01534403|Epratuzumab|epratuzumab|mesh-list
139410412|NCT02264873|Decitabine|decitabine|mesh-list
139410479|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
139410869|NCT02526212|Buprenorphine|buprenorphine|mesh-list
139411006|NCT01659554|Cisplatin|cisplatin|mesh-list
139411226|NCT02328963|Everolimus|everolimus|mesh-list
139411526|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
139411597|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
139411672|NCT00911963|Ribavirin|ribavirin|mesh-list
139412262|NCT05082441|Bupivacaine|bupivacaine|mesh-list
139412341|NCT00836069|Serotonin Agents|serotonin agents|mesh-ancestor
139412408|NCT00925535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139412495|NCT05227664|Paclitaxel|paclitaxel|mesh-list
139412707|NCT04875767|Coal Tar|coal tar|mesh-list
139412848|NCT04959266|Rifampin|rifampin|mesh-list
139412924|NCT00730639|Nivolumab|nivolumab|mesh-list
139412997|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
139413222|NCT03487783|Aripiprazole|aripiprazole|mesh-list
139413440|NCT00772343|Immunologic Factors|immunologic factors|mesh-ancestor
139413587|NCT00752297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413662|NCT00739349|Cyclosporine|cyclosporine|mesh-list
139413734|NCT02265796|Ranolazine|ranolazine|mesh-list
139413962|NCT05982834|Tislelizumab|tislelizumab|mesh-list
139414336|NCT04385290|Immunotoxins|immunotoxins|mesh-ancestor
139414867|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139414941|NCT05150899|Urological Agents|urological agents|mesh-ancestor
139415012|NCT00609323|Sensory System Agents|sensory system agents|mesh-ancestor
139651873|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415309|NCT05943223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139415310|NCT05943223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139415311|NCT05943223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139415312|NCT05943223|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139415313|NCT05943223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415314|NCT05943223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415828|NCT02611960|Gemcitabine|gemcitabine|mesh-list
139416124|NCT00465959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139416345|NCT04470479|Pilocarpine|pilocarpine|mesh-list
139416419|NCT02287259|Olanzapine|olanzapine|mesh-list
139416564|NCT00343109|Vaccines|vaccines|mesh-list
139472313|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416863|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
139417096|NCT03477955|Silicon|silicon|mesh-list
139417312|NCT03471559|Cannabidiol|cannabidiol|mesh-list
139472314|NCT02919969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139417835|NCT04589819|Teriparatide|teriparatide|mesh-list
139651995|NCT05365425|Choline|choline|mesh-list
139652078|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
139418362|NCT05235256|Anesthetics, Local|anesthetics, local|mesh-ancestor
139653102|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
139653699|NCT00046475|Midodrine|midodrine|mesh-list
139653998|NCT00208975|Rituximab|rituximab|mesh-list
139654290|NCT00061373|Dalteparin|dalteparin|mesh-list
139654514|NCT01678443|Antibodies|antibodies|mesh-list
139418381|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
139654734|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139143099|NCT03745599|Diclofenac|diclofenac|mesh-list
139655024|NCT00134017|Busulfan|busulfan|mesh-list
139655153|NCT00156923|Naltrexone|naltrexone|mesh-list
139655380|NCT02240589|Memantine|memantine|mesh-list
139655518|NCT04639843|Doxorubicin|doxorubicin|mesh-list
139418432|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
139656401|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
139656558|NCT00041119|Paclitaxel|paclitaxel|mesh-list
139656624|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139656699|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139656772|NCT02579616|Lenvatinib|lenvatinib|mesh-list
139656924|NCT01465802|Doxycycline|doxycycline|mesh-list
139656997|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
139657140|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658696|NCT05949554|Ketamine|ketamine|mesh-list
139658767|NCT05662228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658989|NCT06232564|Etoposide|etoposide|mesh-list
139659182|NCT06231563|Ketamine|ketamine|mesh-list
139659503|NCT06199778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139659939|NCT05872867|Pembrolizumab|pembrolizumab|mesh-list
139660169|NCT05600894|Decitabine|decitabine|mesh-list
139660241|NCT05554380|Paclitaxel|paclitaxel|mesh-list
139660686|NCT05136196|Nivolumab|nivolumab|mesh-list
139660760|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139660907|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
139418496|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
139661793|NCT03288675|Serotonin|serotonin|mesh-list
139661860|NCT03064126|Paclitaxel|paclitaxel|mesh-list
139150333|NCT02188186|Metformin|metformin|mesh-list
139662081|NCT02499354|Iron|iron|mesh-list
139662230|NCT02081755|Tacrolimus|tacrolimus|mesh-list
139662380|NCT01356290|Etoposide|etoposide|mesh-list
139662449|NCT01260870|Antimitotic Agents|antimitotic agents|mesh-ancestor
139216391|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139216392|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
139216393|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216394|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216395|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139216396|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139216397|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
139216398|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
139216399|NCT03157089|Afatinib|afatinib|mesh-list
139216400|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139216401|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216402|NCT03157089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139216403|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216404|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139216405|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216406|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
139216407|NCT01338129|Vitamins|vitamins|mesh-ancestor
139216408|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
139216409|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216410|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
139216411|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216412|NCT01338129|Protective Agents|protective agents|mesh-ancestor
139216413|NCT05181969|Dextrans|dextrans|mesh-list
139216414|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
139216415|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
139216416|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
139216417|NCT00092157|Simvastatin|simvastatin|mesh-list
139216418|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139216419|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139216420|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
139216421|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216422|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139216423|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139216424|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216425|NCT00089895|Eptifibatide|eptifibatide|mesh-list
139216426|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139216427|NCT05166291|Anesthetics|anesthetics|mesh-list
139216428|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216429|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216430|NCT01338441|Erythromycin|erythromycin|mesh-list
139216431|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
139216432|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139216433|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
139216434|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139216435|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216436|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139216437|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139216438|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216439|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216440|NCT01341951|Lenograstim|lenograstim|mesh-list
139216441|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139216442|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
139216443|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216444|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
139216445|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216446|NCT02714218|Nivolumab|nivolumab|mesh-list
139216447|NCT02714218|Ipilimumab|ipilimumab|mesh-list
139216448|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139216449|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216450|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139216451|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216452|NCT05185869|Paclitaxel|paclitaxel|mesh-list
139216453|NCT05185869|Gemcitabine|gemcitabine|mesh-list
139216454|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139216455|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216456|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
139216457|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
139173054|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
139216459|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216460|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139216461|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
139216462|NCT01338675|Busulfan|busulfan|mesh-list
139216463|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
139418511|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139216464|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216465|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139216466|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
139216467|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216468|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139216469|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216470|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139216471|NCT01338753|Bevacizumab|bevacizumab|mesh-list
139216472|NCT01338753|Docetaxel|docetaxel|mesh-list
139216473|NCT01338753|Doxorubicin|doxorubicin|mesh-list
139216474|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139216475|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216476|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139216477|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139216478|NCT01338753|Growth Substances|growth substances|mesh-ancestor
139216479|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216480|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
139216481|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
139216482|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
139216483|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
139216484|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216485|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139216486|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139216487|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139216488|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216489|NCT02457286|Metformin|metformin|mesh-list
139216490|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139216491|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216492|NCT01338909|Clopidogrel|clopidogrel|mesh-list
139216493|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139216494|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139216495|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139216496|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139216497|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139216498|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
139216499|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216500|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216501|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216502|NCT03282136|Incretins|incretins|mesh-list
139216503|NCT03282136|Hormones|hormones|mesh-ancestor
139216504|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139216505|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216506|NCT03156621|Alirocumab|alirocumab|mesh-list
139216507|NCT03156621|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139216508|NCT03156621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139216509|NCT03156621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139216510|NCT03156621|Antimetabolites|antimetabolites|mesh-ancestor
139216511|NCT03156621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216512|NCT03156621|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139216513|NCT03156621|Protease Inhibitors|protease inhibitors|mesh-ancestor
139216514|NCT03156621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216515|NCT03156621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139216516|NCT03264586|Lidocaine|lidocaine|mesh-list
139216517|NCT03264586|Prilocaine|prilocaine|mesh-list
139216518|NCT03264586|Mepivacaine|mepivacaine|mesh-list
139216519|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139216520|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
139216521|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
139216522|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216523|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216524|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
139216525|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216526|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139216527|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139216528|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139216529|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139216530|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216532|NCT01342731|Tigecycline|tigecycline|mesh-list
139216533|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139216534|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216535|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139216536|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216537|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216538|NCT01339065|Ketamine|ketamine|mesh-list
139216539|NCT01339065|Analgesics|analgesics|mesh-ancestor
139216540|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
139216541|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216542|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216543|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139216544|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139216545|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
139216546|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
139216547|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216548|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139216549|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139216550|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216551|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216552|NCT02460016|Ziresovir|ziresovir|mesh-list
139216553|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
139216554|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216555|NCT05187507|Theobromine|theobromine|mesh-list
139216556|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139216557|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
139216558|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216559|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216560|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139216561|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
139216562|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
139216563|NCT01339143|Pioglitazone|pioglitazone|mesh-list
139216564|NCT01339143|Vildagliptin|vildagliptin|mesh-list
139216565|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139216566|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216567|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139216568|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
139216569|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216570|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216571|NCT03264430|Ketamine|ketamine|mesh-list
139216572|NCT03264430|Bupivacaine|bupivacaine|mesh-list
139216573|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
139216574|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
139216575|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216576|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216577|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
139216578|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216579|NCT03264430|Analgesics|analgesics|mesh-ancestor
139216580|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139216581|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139216582|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
139216583|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139216584|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139216585|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216586|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216587|NCT03264274|Aflibercept|aflibercept|mesh-list
139216588|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139216589|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139216590|NCT03264274|Growth Substances|growth substances|mesh-ancestor
139216591|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216592|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
139216593|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216594|NCT02457208|Rifampin|rifampin|mesh-list
139216595|NCT02457208|Isoniazid|isoniazid|mesh-list
139216596|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
139216597|NCT02457208|Ethambutol|ethambutol|mesh-list
139216598|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139216599|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
139216600|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139216601|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216602|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
139216603|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139173195|NCT05194904|Analgesics|analgesics|mesh-ancestor
139216604|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216605|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216606|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139216607|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139216608|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139216609|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139216610|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139216611|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139216612|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139216613|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139216614|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
139216615|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139216616|NCT02457130|Clopidogrel|clopidogrel|mesh-list
139216617|NCT02457130|Ticagrelor|ticagrelor|mesh-list
139216618|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139216619|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139216620|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139216621|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139216622|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
139216623|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216624|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216625|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216626|NCT01340235|Erythromycin|erythromycin|mesh-list
139216627|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
139216628|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139216629|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
139216630|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139216631|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216632|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139216633|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139216634|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216635|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216636|NCT03263962|Canrenone|canrenone|mesh-list
139216637|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139216638|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
139216639|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139216640|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216641|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139216642|NCT03263962|Diuretics|diuretics|mesh-ancestor
139216643|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
139216644|NCT05186649|Warfarin|warfarin|mesh-list
139216645|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
139216646|NCT05184465|Anesthetics|anesthetics|mesh-list
139216647|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216648|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216649|NCT03152019|Tacrolimus|tacrolimus|mesh-list
139216650|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139216651|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
139216652|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216653|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139216654|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216655|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216656|NCT04813107|Tislelizumab|tislelizumab|mesh-list
139216657|NCT04813107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139216658|NCT04813107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216659|NCT02714062|Topiramate|topiramate|mesh-list
139216660|NCT02714062|Phentermine|phentermine|mesh-list
139216661|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
139216662|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139216663|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216664|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139216665|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
139216666|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139216667|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
139216668|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
139216669|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216670|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
139216671|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216672|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216673|NCT03280342|Topiramate|topiramate|mesh-list
139216674|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
139216675|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139216676|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216677|NCT03279796|Betamethasone|betamethasone|mesh-list
139216678|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216679|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
139216681|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139216682|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216683|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139216684|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
139216685|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
139216686|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139216687|NCT02713828|Immunoconjugates|immunoconjugates|mesh-ancestor
139216688|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
139216689|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216690|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139216691|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216692|NCT05183997|Verapamil|verapamil|mesh-list
139216693|NCT05183997|Thrombin|thrombin|mesh-list
139216694|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139216695|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139216696|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139216697|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216698|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139216699|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216700|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
139216701|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
139216702|NCT05183997|Coagulants|coagulants|mesh-ancestor
139216703|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
139216704|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216705|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216706|NCT05119101|Analgesics|analgesics|mesh-ancestor
139216707|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
139216708|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216709|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216710|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
139216711|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139216712|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
139216713|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139216714|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139216715|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139216716|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
139216717|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139216718|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
139216719|NCT01340547|Ifosfamide|ifosfamide|mesh-list
139216720|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139216721|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
139216722|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216723|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216724|NCT03277222|Insulin|insulin|mesh-list
139216725|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139216726|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216727|NCT04931667|Lorecivivint|lorecivivint|mesh-list
139216728|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216729|NCT03262948|Paclitaxel|paclitaxel|mesh-list
139216730|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139216731|NCT03262948|Carboplatin|carboplatin|mesh-list
139216732|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139216733|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216734|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
139216735|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
139216736|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
139216737|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216738|NCT03276598|Losartan|losartan|mesh-list
139216739|NCT03276598|Amlodipine|amlodipine|mesh-list
139216740|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139216741|NCT03276598|Bisoprolol|bisoprolol|mesh-list
139216742|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139216743|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139216744|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139216745|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216746|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139216747|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216748|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
139216749|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139216750|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139216751|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139216752|NCT03276598|Diuretics|diuretics|mesh-ancestor
139216753|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
139216754|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139216755|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
139216756|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
139216757|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216758|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139216759|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139216760|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139216761|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
139216762|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086846|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
139216763|NCT03262792|Andrographolide|andrographolide|mesh-list
139216764|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216765|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139216766|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139216767|NCT03262792|Analgesics|analgesics|mesh-ancestor
139216768|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
139216769|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216770|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216771|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139216772|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139216773|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139216774|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216775|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
139216776|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139216777|NCT01359462|Tolvaptan|tolvaptan|mesh-list
139216778|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139216779|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216780|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
139216781|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216782|NCT02875392|Fucoidan|fucoidan|mesh-list
139216783|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139216784|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139216785|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
139216786|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216787|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
139216788|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139216789|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139216790|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216791|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139216792|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139216793|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216794|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216795|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216796|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139216797|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
139216798|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139216799|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216800|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139216801|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139216802|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139216803|NCT03267628|Morphine|morphine|mesh-list
139216804|NCT03267628|Anesthetics|anesthetics|mesh-list
139216805|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
139216806|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139216807|NCT03267628|Narcotics|narcotics|mesh-ancestor
139216808|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216809|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216810|NCT03267628|Analgesics|analgesics|mesh-ancestor
139216811|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
139216812|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216813|NCT01359696|Gemcitabine|gemcitabine|mesh-list
139216814|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139216815|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
139216816|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216817|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216818|NCT03268018|Calcium|calcium|mesh-list
139216819|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139216820|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216821|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139216822|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139216823|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139216824|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216825|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216826|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139216827|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139216828|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139216829|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
139216830|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216831|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216832|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139216833|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139216834|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
139642136|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
139216836|NCT01367028|Trastuzumab|trastuzumab|mesh-list
139216838|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139216839|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216840|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139216841|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139216842|NCT01367028|Growth Substances|growth substances|mesh-ancestor
139216843|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216844|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
139216845|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
139216846|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
139216847|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
139216848|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216849|NCT03965962|Vaccines|vaccines|mesh-list
139216850|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
139216851|NCT03965962|Antibodies|antibodies|mesh-list
139216852|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
139216853|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139216854|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139216855|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
139216856|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216857|NCT03273088|Etanercept|etanercept|mesh-list
139216858|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139216859|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139216860|NCT03273088|Analgesics|analgesics|mesh-ancestor
139216861|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
139216862|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216863|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216864|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216865|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139216866|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139216867|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139216868|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
139216869|NCT04235634|Alprostadil|alprostadil|mesh-list
139216870|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139216871|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
139216872|NCT04235634|Urological Agents|urological agents|mesh-ancestor
139216873|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
139216874|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139216875|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216876|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216877|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139216878|NCT03262090|Analgesics|analgesics|mesh-ancestor
139216879|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
139216880|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216881|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139216882|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139216883|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139216884|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
139216885|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216886|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216887|NCT03151551|Adalimumab|adalimumab|mesh-list
139216888|NCT03151551|Ixekizumab|ixekizumab|mesh-list
139216889|NCT03151551|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139216890|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216891|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139216892|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
139216893|NCT01359930|Naltrexone|naltrexone|mesh-list
139216894|NCT01359930|Bupropion|bupropion|mesh-list
139216895|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139216896|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139216897|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216898|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
139216899|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216900|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139216901|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
139173505|NCT04459312|Antibodies|antibodies|mesh-list
139216902|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139216903|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139216904|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139216905|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139216906|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216907|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
139216908|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216909|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139216910|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139216911|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216912|NCT05075512|Fulvestrant|fulvestrant|mesh-list
139216913|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139216914|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216915|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139216916|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139216917|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
139216918|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139216919|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216921|NCT01316757|Carboplatin|carboplatin|mesh-list
139216922|NCT01316757|Cetuximab|cetuximab|mesh-list
139216923|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139216924|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139216925|NCT01316757|Antibodies|antibodies|mesh-list
139216926|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
139216927|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139216928|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139216929|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216930|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
139216931|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
139216932|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
139216933|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216934|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
139216935|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216936|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139216937|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216938|NCT05074966|Cetuximab|cetuximab|mesh-list
139216939|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139216940|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216941|NCT03266926|Bupivacaine|bupivacaine|mesh-list
139216942|NCT03266926|Estrogens|estrogens|mesh-list
139216943|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139216944|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
139216945|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
139216946|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216947|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216948|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
139216949|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216950|NCT03266926|Hormones|hormones|mesh-ancestor
139216951|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139216952|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
139216953|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139216954|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
139216955|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216956|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216957|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139216958|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
139216959|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139216960|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139216961|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139216962|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
139216963|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216964|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216965|NCT01367418|Sufentanil|sufentanil|mesh-list
139216966|NCT01367418|Morphine|morphine|mesh-list
139216967|NCT01367418|Bupivacaine|bupivacaine|mesh-list
139216968|NCT01367418|Ropivacaine|ropivacaine|mesh-list
139216969|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
139216970|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
139216971|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216972|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216973|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
139216974|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173568|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139216975|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139216976|NCT01367418|Narcotics|narcotics|mesh-ancestor
139216977|NCT01367418|Analgesics|analgesics|mesh-ancestor
139216978|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139216979|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139216980|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
139216981|NCT01360086|Leucovorin|leucovorin|mesh-list
139216982|NCT01360086|Fluorouracil|fluorouracil|mesh-list
139216983|NCT01360086|Cetuximab|cetuximab|mesh-list
139216984|NCT01360086|Calcium|calcium|mesh-list
139216985|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
139216986|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216987|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139216988|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216989|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
139216990|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216991|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139216992|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139216993|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
139216994|NCT01360086|Antidotes|antidotes|mesh-ancestor
139216995|NCT01360086|Protective Agents|protective agents|mesh-ancestor
139216996|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
139216997|NCT01360086|Vitamins|vitamins|mesh-ancestor
139216998|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
139216999|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139217000|NCT02458924|Niacin|niacin|mesh-list
139217001|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139217002|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
139217003|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217004|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139217005|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
139217006|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
139217007|NCT02458924|Vitamins|vitamins|mesh-ancestor
139217008|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
139217009|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217010|NCT01367496|Naltrexone|naltrexone|mesh-list
139217011|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
139217012|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139217013|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217014|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
139217015|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217016|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139217017|NCT02459158|Arbekacin|arbekacin|mesh-list
139217018|NCT02459158|Dibekacin|dibekacin|mesh-list
139217019|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139217020|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139217021|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139217022|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
139217023|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139217024|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217025|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
139217026|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217027|NCT04693689|Vaccines|vaccines|mesh-list
139217028|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
139217029|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217030|NCT03126786|Triamcinolone|triamcinolone|mesh-list
139217031|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139217032|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139217033|NCT03126786|Aflibercept|aflibercept|mesh-list
139217034|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139217035|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139217036|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
139217037|NCT03126786|Hormones|hormones|mesh-ancestor
139217038|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139217039|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217040|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139217041|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
139217042|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217043|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217044|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139217045|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139217046|NCT03126786|Growth Substances|growth substances|mesh-ancestor
139217047|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
139217048|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217049|NCT01367652|Letrozole|letrozole|mesh-list
139217050|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217051|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139217052|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139217053|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217054|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217055|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139217056|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
139217057|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139217058|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217059|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139217060|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
139217061|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139217062|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
139217063|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139217064|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217065|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139217066|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139217067|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139217068|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217069|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139217070|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139217071|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139217072|NCT03146403|Vaccines|vaccines|mesh-list
139217073|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
139217074|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217075|NCT01360476|Vitamin D|vitamin d|mesh-list
139217076|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
139217077|NCT01360476|Vitamins|vitamins|mesh-ancestor
139217078|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
139217079|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217080|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139217081|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139217082|NCT01317069|Fluorouracil|fluorouracil|mesh-list
139217083|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
139217084|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217085|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139217086|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217087|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139217088|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
139217089|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217090|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
139217091|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
139217092|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139217093|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
139217094|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139217095|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217096|NCT01317225|Progestins|progestins|mesh-ancestor
139217097|NCT01317225|Hormones|hormones|mesh-ancestor
139217098|NCT01363206|Ipilimumab|ipilimumab|mesh-list
139217099|NCT01363206|Molgramostim|molgramostim|mesh-list
139217100|NCT01363206|Sargramostim|sargramostim|mesh-list
139217101|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139217102|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217103|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139217104|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217105|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
139217106|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217107|NCT01344213|Celecoxib|celecoxib|mesh-list
139217108|NCT01344213|Pregabalin|pregabalin|mesh-list
139217109|NCT01344213|Analgesics|analgesics|mesh-ancestor
139217110|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
139217111|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217112|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217113|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
139217114|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139217115|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139217116|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217117|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139217118|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139217119|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139217120|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217121|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139217122|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139217123|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139217124|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139217125|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173721|NCT02815280|Minocycline|minocycline|mesh-list
139217126|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139217127|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139217128|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217129|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
139217130|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139217131|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
139217132|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139087224|NCT05570786|Hormones|hormones|mesh-ancestor
139217133|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
139217134|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217135|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217136|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
139217137|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139217138|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139217139|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139217140|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139217141|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217142|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217143|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217144|NCT01363284|Analgesics|analgesics|mesh-ancestor
139217145|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
139217146|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217147|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
139217148|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139217149|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
139217150|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139217151|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139217152|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139217153|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
139217155|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139217156|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139217157|NCT01344291|Analgesics|analgesics|mesh-ancestor
139217158|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
139217159|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217160|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217161|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139217162|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139217163|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217164|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217165|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217166|NCT01367964|Hormones|hormones|mesh-list
139217167|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139217168|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139217169|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
139217170|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139217171|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217172|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217173|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217174|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
139217175|NCT04326933|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139217176|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217177|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139217178|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217179|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217180|NCT04733560|Bupivacaine|bupivacaine|mesh-list
139217181|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
139217182|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
139217183|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217184|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217185|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
139217186|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217187|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
139217188|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139217189|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
139217190|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217191|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217192|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139217193|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
139217194|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139217195|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
139217196|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173794|NCT05626387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217197|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217198|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139217199|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
139217200|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
139217201|NCT01347957|Protective Agents|protective agents|mesh-ancestor
139217203|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
139642137|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139217204|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139217205|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217206|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217207|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139217208|NCT04735965|Analgesics|analgesics|mesh-ancestor
139217209|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
139217210|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217211|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139217212|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139217213|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139217214|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
139217215|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217216|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217217|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139217218|NCT04735965|Narcotics|narcotics|mesh-ancestor
139217219|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139217220|NCT02456428|Insulin|insulin|mesh-list
139217221|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139217222|NCT02456428|Metformin|metformin|mesh-list
139217223|NCT02456428|Pioglitazone|pioglitazone|mesh-list
139217224|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139217225|NCT02456428|Liraglutide|liraglutide|mesh-list
139217226|NCT02456428|Exenatide|exenatide|mesh-list
139217227|NCT02456428|Glimepiride|glimepiride|mesh-list
139217228|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
139217229|NCT02456428|Vildagliptin|vildagliptin|mesh-list
139217230|NCT02456428|Saxagliptin|saxagliptin|mesh-list
139217231|NCT02456428|Acarbose|acarbose|mesh-list
139217232|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139217233|NCT02456428|Repaglinide|repaglinide|mesh-list
139217234|NCT02456428|Gliclazide|gliclazide|mesh-list
139217235|NCT02456428|Glipizide|glipizide|mesh-list
139217236|NCT02456428|Biguanides|biguanides|mesh-list
139217237|NCT02456428|Tolbutamide|tolbutamide|mesh-list
139217238|NCT02456428|Voglibose|voglibose|mesh-list
139217239|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
139217240|NCT02456428|Nateglinide|nateglinide|mesh-list
139217241|NCT02456428|Miglitol|miglitol|mesh-list
139217242|NCT02456428|Meglitinide|meglitinide|mesh-list
139217243|NCT02456428|Troglitazone|troglitazone|mesh-list
139217244|NCT02456428|Acetohexamide|acetohexamide|mesh-list
139217245|NCT02456428|Buformin|buformin|mesh-list
139217246|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
139217247|NCT02456428|Phenformin|phenformin|mesh-list
139217248|NCT02456428|Gliquidone|gliquidone|mesh-list
139217249|NCT02456428|Carbutamide|carbutamide|mesh-list
139217250|NCT02456428|Tolazamide|tolazamide|mesh-list
139217251|NCT02456428|Glibornuride|glibornuride|mesh-list
139217252|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139217253|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
139217254|NCT02456428|Incretins|incretins|mesh-list
139217255|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217256|NCT02456428|Hormones|hormones|mesh-ancestor
139217257|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139217258|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
139217259|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217260|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217261|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139217262|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139217263|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139217264|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
139217265|NCT03259516|Cytarabine|cytarabine|mesh-list
139217266|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
139217267|NCT03259516|Melphalan|melphalan|mesh-list
139217268|NCT03259516|Nivolumab|nivolumab|mesh-list
139217269|NCT03259516|Fludarabine|fludarabine|mesh-list
139217270|NCT03259516|Azacitidine|azacitidine|mesh-list
139217271|NCT03259516|Tretinoin|tretinoin|mesh-list
139217272|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
139217273|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139217274|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
139217275|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217276|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139217277|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139217278|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
139217279|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217280|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217281|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139217282|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139217283|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139217284|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139217285|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
139217286|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
139217287|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139217288|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217289|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
139217290|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139217291|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139217292|NCT03259516|Urological Agents|urological agents|mesh-ancestor
139217293|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
139217294|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
139217295|NCT01344681|Itraconazole|itraconazole|mesh-list
139217297|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
139217298|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139217299|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139217300|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139217301|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217302|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217303|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139217304|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
139217305|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139217306|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217307|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139217308|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
139217309|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139217310|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217311|NCT03259672|Sevoflurane|sevoflurane|mesh-list
139217312|NCT03259672|Desflurane|desflurane|mesh-list
139217313|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139217314|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139217315|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
139217316|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
139217317|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217318|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217319|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
139217320|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139217321|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139217322|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
139217323|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217324|NCT03265288|Fenretinide|fenretinide|mesh-list
139217325|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217326|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139217327|NCT03265288|Protective Agents|protective agents|mesh-ancestor
139217328|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217329|NCT03261310|Acetaminophen|acetaminophen|mesh-list
139217330|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139217331|NCT03261310|Analgesics|analgesics|mesh-ancestor
139217332|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
139217333|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217334|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217335|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
139217336|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
139217337|NCT02456350|Fludarabine|fludarabine|mesh-list
139217338|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139217339|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
139217340|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217341|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139217342|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139217343|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
139217344|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217345|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217346|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139217347|NCT01319370|Minoxidil|minoxidil|mesh-list
139217348|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139217349|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
139217350|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
139217351|NCT01363752|Sirolimus|sirolimus|mesh-list
139217352|NCT01363752|Tacrolimus|tacrolimus|mesh-list
139217353|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139217354|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
139217355|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217356|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139217357|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217358|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217359|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139217360|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217361|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139217362|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
139217363|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139217364|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139217365|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
139217366|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139217367|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
139217368|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139217370|NCT01360710|Moxonidine|moxonidine|mesh-list
139217371|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139217372|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139217373|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139217374|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217375|NCT01360788|Albuterol|albuterol|mesh-list
139217376|NCT01360788|Ipratropium|ipratropium|mesh-list
139217377|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139217378|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
139217379|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217380|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217381|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139217382|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
139217383|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
139217384|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139217385|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139217386|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139217387|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139217388|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
139217389|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217390|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217391|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139217392|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
139217393|NCT01361022|Brotizolam|brotizolam|mesh-list
139217394|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139217395|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217396|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217397|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139217398|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139217399|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139217400|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
139217401|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217402|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139217403|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139217404|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217405|NCT02713204|Aflibercept|aflibercept|mesh-list
139217406|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139217407|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139217408|NCT02713204|Growth Substances|growth substances|mesh-ancestor
139217409|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217410|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
139217411|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217412|NCT03695172|Ropivacaine|ropivacaine|mesh-list
139217413|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
139217414|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
139217415|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217416|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217417|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
139217418|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217419|NCT01364376|Leucovorin|leucovorin|mesh-list
139217420|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
139217421|NCT01364376|Calcium|calcium|mesh-list
139217422|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
139217423|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139217424|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217425|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217426|NCT01364376|Antidotes|antidotes|mesh-ancestor
139217427|NCT01364376|Protective Agents|protective agents|mesh-ancestor
139217428|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
139217429|NCT01364376|Vitamins|vitamins|mesh-ancestor
139217430|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
139217431|NCT01348503|Lenalidomide|lenalidomide|mesh-list
139217432|NCT01348503|Sorafenib|sorafenib|mesh-list
139217433|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
139217434|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217435|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139217436|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139217437|NCT01348503|Growth Substances|growth substances|mesh-ancestor
139087519|NCT03892148|Diuretics|diuretics|mesh-ancestor
139217438|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
139217439|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217440|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139217441|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217442|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217443|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139217444|NCT01369290|Bupropion|bupropion|mesh-list
139217445|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139217446|NCT01369290|Escitalopram|escitalopram|mesh-list
139217447|NCT01369290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139217448|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139217449|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139217450|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217451|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217452|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
139217453|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217454|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217455|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139217456|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
139217457|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139217458|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139217459|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
139217460|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139217461|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139217462|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217463|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139217464|NCT01369290|Analgesics|analgesics|mesh-ancestor
139217465|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
139217466|NCT03533452|Ropivacaine|ropivacaine|mesh-list
139217467|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
139217468|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
139217469|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217470|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217471|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
139217472|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217473|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
139217474|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139217475|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139217476|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139217477|NCT04359147|Yohimbine|yohimbine|mesh-list
139217478|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139217479|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
139217480|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
139217481|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217482|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217483|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139217484|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139217485|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139217486|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
139217487|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217488|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217489|NCT04359147|Urological Agents|urological agents|mesh-ancestor
139217490|NCT01369368|Azacitidine|azacitidine|mesh-list
139217491|NCT01369368|Valproic Acid|valproic acid|mesh-list
139217492|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139217493|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
139217494|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217495|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217496|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217497|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
139217498|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
139217499|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217500|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217501|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
139217502|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139217503|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217504|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139217505|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
139217506|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
139642138|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139217507|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642139|NCT01311687|Growth Substances|growth substances|mesh-ancestor
139087590|NCT04462276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139217508|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217509|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
139217511|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
139217512|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217513|NCT03252496|Ephedrine|ephedrine|mesh-list
139217514|NCT03252496|Fentanyl|fentanyl|mesh-list
139217515|NCT03252496|Bupivacaine|bupivacaine|mesh-list
139217516|NCT03252496|Oxytocin|oxytocin|mesh-list
139217517|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
139217518|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
139217519|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217520|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217521|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
139217522|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217523|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139217524|NCT03252496|Narcotics|narcotics|mesh-ancestor
139217525|NCT03252496|Analgesics|analgesics|mesh-ancestor
139217526|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139217527|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139217528|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
139217529|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
139217530|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139217531|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139217532|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
139217533|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
139217534|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139217535|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
139217536|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217537|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217538|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
139217539|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
139217540|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217541|NCT03252418|Protective Agents|protective agents|mesh-ancestor
139217542|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217543|NCT03252418|Vitamins|vitamins|mesh-ancestor
139217544|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
139217545|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
139217546|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139217547|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139217548|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217549|NCT01364688|Vitamins|vitamins|mesh-ancestor
139217550|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
139217551|NCT01370148|Conivaptan|conivaptan|mesh-list
139217552|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139217553|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217554|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
139217555|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217556|NCT04684953|Hormones|hormones|mesh-list
139217557|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139217558|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217559|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
139217560|NCT01349127|Vitamin D|vitamin d|mesh-list
139217561|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
139217562|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
139217563|NCT01349127|Vitamins|vitamins|mesh-list
139217564|NCT01349127|Calcium|calcium|mesh-list
139217565|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
139217566|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217567|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139217568|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139217569|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139217570|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
139217571|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217572|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217573|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139217574|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217575|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
139217576|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
139217577|NCT01349205|Caffeine|caffeine|mesh-list
139217578|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139217579|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217580|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139642140|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
139217581|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217582|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217583|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139217584|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139217585|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
139217586|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217587|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
139217588|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139217589|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139217590|NCT01349205|Protective Agents|protective agents|mesh-ancestor
139217591|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139217592|NCT01349205|Analgesics|analgesics|mesh-ancestor
139217593|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
139217594|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217595|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139217596|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139217597|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139217598|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139217599|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217600|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217601|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217602|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139217603|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
139217604|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139217605|NCT03982485|Paclitaxel|paclitaxel|mesh-list
139217606|NCT03982485|Apatinib|apatinib|mesh-list
139217607|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139217608|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217609|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
139217610|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
139217611|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
139217612|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217613|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139217614|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217615|NCT03966339|Hormones|hormones|mesh-list
139217616|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139217617|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217618|NCT03251872|Olaparib|olaparib|mesh-list
139217619|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139217620|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217621|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217622|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217623|NCT03160521|Risperidone|risperidone|mesh-list
139217624|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139217625|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
139217626|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217627|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217628|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217629|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139217630|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139217631|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217632|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139217633|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139217634|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
139217635|NCT01365000|Naloxegol|naloxegol|mesh-list
139217636|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139217637|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217638|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
139418529|NCT03386721|Gemcitabine|gemcitabine|mesh-list
139217639|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217640|NCT03147040|Carboplatin|carboplatin|mesh-list
139217641|NCT03147040|Atezolizumab|atezolizumab|mesh-list
139217642|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217643|NCT03147040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139217644|NCT03147040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217645|NCT03147040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139217646|NCT03251170|Midazolam|midazolam|mesh-list
139217647|NCT03251170|Fentanyl|fentanyl|mesh-list
139217648|NCT03251170|Ketamine|ketamine|mesh-list
139217649|NCT03251170|Analgesics|analgesics|mesh-ancestor
139217650|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
139217651|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217652|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217653|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139217654|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139217655|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
139217657|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217658|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139217659|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139217660|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217661|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217662|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139217663|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139217664|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139217665|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139217666|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139217667|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
139217668|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
139217669|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139217670|NCT03251170|Narcotics|narcotics|mesh-ancestor
139217671|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
139217672|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
139217673|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
139217674|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139217675|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139217676|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139217677|NCT03539601|Analgesics|analgesics|mesh-ancestor
139217678|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
139217679|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217680|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217681|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139217682|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
139217683|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139217684|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
139217685|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139217686|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217687|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217688|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
139217689|NCT02455180|Vitamins|vitamins|mesh-ancestor
139217690|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
139217691|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217692|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
139217693|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217694|NCT02455180|Protective Agents|protective agents|mesh-ancestor
139217695|NCT03514719|Avelumab|avelumab|mesh-list
139217696|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139217697|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139217698|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217699|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
139217700|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217701|NCT01349439|Propranolol|propranolol|mesh-list
139217702|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139217703|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139217704|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
139217705|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217706|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217707|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217708|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139217709|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139217710|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
139217711|NCT03245554|Propranolol|propranolol|mesh-list
139217712|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139217713|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139217714|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
139217715|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217716|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217717|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217718|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139217719|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139217720|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
139217721|NCT01346007|Vaccines|vaccines|mesh-list
139217722|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139217723|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
139217724|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217725|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
139217726|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
139217727|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
139217728|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217729|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217730|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
139087818|NCT03880448|Metronidazole|metronidazole|mesh-list
139217731|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217732|NCT03004131|Fluticasone|fluticasone|mesh-list
139217734|NCT03004131|Loratadine|loratadine|mesh-list
139217735|NCT03004131|Azelastine|azelastine|mesh-list
139217736|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139217737|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139217738|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
139217739|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217740|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217741|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139217742|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
139217743|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
139217744|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139217745|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
139217746|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139217747|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139217748|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
139217749|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
139217750|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217751|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217752|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139217753|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217754|NCT01350063|Troclosene|troclosene|mesh-list
139217755|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
139217756|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139217757|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
139217758|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
139217759|NCT03421041|Dexamethasone|dexamethasone|mesh-list
139217760|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139217761|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
139217762|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
139217763|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217764|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217765|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139217766|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
139217767|NCT03421041|Hormones|hormones|mesh-ancestor
139217768|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139217769|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139217770|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217771|NCT03244774|Paclitaxel|paclitaxel|mesh-list
139217772|NCT03244774|Fluorouracil|fluorouracil|mesh-list
139217773|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
139217774|NCT03244774|Apatinib|apatinib|mesh-list
139217775|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139217776|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217777|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
139217778|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
139217779|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
139217780|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217781|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
139217782|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139217783|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139217784|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
139217785|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217786|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139217787|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217788|NCT02903823|Baclofen|baclofen|mesh-list
139217789|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139217790|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217791|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139217792|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217793|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139217794|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
139217795|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
139217796|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217797|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217798|NCT03244930|Plerixafor|plerixafor|mesh-list
139217799|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139217800|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139217801|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
139217802|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139217803|NCT02855697|Olaparib|olaparib|mesh-list
139217804|NCT02855697|Cediranib|cediranib|mesh-list
139217805|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139217806|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642141|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
139217807|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217808|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217809|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139217810|NCT03894501|Methadone|methadone|mesh-list
139217811|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139217812|NCT03894501|Narcotics|narcotics|mesh-ancestor
139217813|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217814|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217815|NCT03894501|Analgesics|analgesics|mesh-ancestor
139217816|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
139217817|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217818|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
139217819|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
139217820|NCT01346865|Cilostazol|cilostazol|mesh-list
139217821|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139217822|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
139217823|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217824|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217825|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139217826|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
139217827|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139217828|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139217829|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217830|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139217831|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
139217832|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139217833|NCT01346865|Protective Agents|protective agents|mesh-ancestor
139217834|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139217835|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139217836|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217837|NCT03244462|Methotrexate|methotrexate|mesh-list
139217838|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139217839|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
139217840|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139217841|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217842|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139217843|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
139217844|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217845|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139217846|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
139217847|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217848|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139217849|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139217850|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
139217851|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139217852|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139217853|NCT03244540|Acetaminophen|acetaminophen|mesh-list
139217854|NCT03244540|Dipyrone|dipyrone|mesh-list
139217855|NCT03244540|Ketoprofen|ketoprofen|mesh-list
139217856|NCT03244540|Bupivacaine|bupivacaine|mesh-list
139217857|NCT03244540|Ropivacaine|ropivacaine|mesh-list
139217858|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
139217859|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
139217860|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217861|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217862|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
139217863|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217864|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139217865|NCT03244540|Analgesics|analgesics|mesh-ancestor
139217866|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
139217867|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139217868|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139217869|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139217870|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139217871|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217872|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217873|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
139217874|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
139217875|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
139217876|NCT02454868|Remifentanil|remifentanil|mesh-list
139217877|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139217878|NCT02454868|Narcotics|narcotics|mesh-ancestor
139217879|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217880|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174459|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
139217881|NCT02454868|Analgesics|analgesics|mesh-ancestor
139217882|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
139217883|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217884|NCT03753087|Empagliflozin|empagliflozin|mesh-list
139217885|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139217886|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217887|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139217888|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217889|NCT02454712|Naltrexone|naltrexone|mesh-list
139217890|NCT02454712|Oxycodone|oxycodone|mesh-list
139217891|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139217892|NCT02454712|Narcotics|narcotics|mesh-ancestor
139217893|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217894|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217895|NCT02454712|Analgesics|analgesics|mesh-ancestor
139217896|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
139217897|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217898|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139217899|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139217900|NCT00832455|Montelukast|montelukast|mesh-list
139217901|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139217902|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
139217903|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139217904|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
139217905|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139217906|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217907|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139217908|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139217909|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217910|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
139217911|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139217912|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
139217913|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139217914|NCT01350921|Ticagrelor|ticagrelor|mesh-list
139217915|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139217916|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139217917|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139217918|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139217919|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
139217920|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217921|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217922|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217923|NCT00423579|Simvastatin|simvastatin|mesh-list
139217924|NCT00423579|Ezetimibe|ezetimibe|mesh-list
139217925|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
139217926|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139217927|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139217928|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
139217929|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217930|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139217931|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139217932|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217933|NCT03243604|Hormones|hormones|mesh-list
139152474|NCT00064337|Thalidomide|thalidomide|mesh-list
139217934|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139217935|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217936|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139217937|NCT02454556|Hormones|hormones|mesh-ancestor
139217938|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139217939|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217940|NCT01352559|Milnacipran|milnacipran|mesh-list
139217941|NCT01352559|Mirtazapine|mirtazapine|mesh-list
139217942|NCT01352559|Sertraline|sertraline|mesh-list
139217943|NCT01352559|Fluoxetine|fluoxetine|mesh-list
139217944|NCT01352559|Paroxetine|paroxetine|mesh-list
139217945|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139217946|NCT01352559|Nortriptyline|nortriptyline|mesh-list
139217947|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
139217948|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139217949|NCT01352559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139217950|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139217951|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139217952|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174534|NCT03904225|Tegafur|tegafur|mesh-list
139217953|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139217955|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139217956|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139217957|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139217958|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139217959|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217960|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139217961|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139217962|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
139217963|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
139217964|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139217965|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139217966|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139217967|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139217968|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139217969|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139217970|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
139217971|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139217972|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139217973|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139217974|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139217975|NCT01352559|Analgesics|analgesics|mesh-ancestor
139217976|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
139217977|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139217978|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139217979|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139217980|NCT03247972|Evolocumab|evolocumab|mesh-list
139217981|NCT03247972|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139217982|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139217983|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139217984|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
139217985|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217986|NCT03247972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139217987|NCT03247972|Protease Inhibitors|protease inhibitors|mesh-ancestor
139217988|NCT03247972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139217989|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139217990|NCT01350609|Candesartan|candesartan|mesh-list
139217991|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
139217992|NCT01350609|Nifedipine|nifedipine|mesh-list
139217993|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139217994|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139217995|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139217996|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139217997|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139217998|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139217999|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139218000|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218001|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
139218002|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
139218003|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139218004|NCT03269409|Coal Tar|coal tar|mesh-list
139218005|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
139218006|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
139218007|NCT03778372|Methadone|methadone|mesh-list
139218008|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139218009|NCT03778372|Narcotics|narcotics|mesh-ancestor
139218010|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218011|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218012|NCT03778372|Analgesics|analgesics|mesh-ancestor
139218013|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
139218014|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218015|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
139218016|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
139218017|NCT03246880|Tadalafil|tadalafil|mesh-list
139218018|NCT03246880|Tamsulosin|tamsulosin|mesh-list
139218019|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
139218020|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139218021|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139218022|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218023|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218024|NCT03246880|Urological Agents|urological agents|mesh-ancestor
139218025|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139218026|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139218028|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
139218029|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139218030|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218031|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
139218032|NCT03257722|Idelalisib|idelalisib|mesh-list
139218033|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139218034|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218035|NCT03257722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139218036|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218037|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218038|NCT03268005|Insulin|insulin|mesh-list
139218039|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139218040|NCT03268005|Metformin|metformin|mesh-list
139218041|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
139218042|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
139218043|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139218044|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139218045|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218046|NCT03239314|Dexamethasone|dexamethasone|mesh-list
139218047|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139218048|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139218049|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
139218050|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
139218051|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218052|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218053|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139218054|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
139218055|NCT03239314|Hormones|hormones|mesh-ancestor
139218056|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139218057|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139218058|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218059|NCT03241888|Megestrol|megestrol|mesh-list
139218060|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
139218061|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
139218062|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139218063|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
139218064|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139218065|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218066|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139218067|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139218068|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139218069|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139218070|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139218071|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218072|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
139218073|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139218074|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
139218075|NCT02454088|Triamcinolone|triamcinolone|mesh-list
139218076|NCT02454088|Calcium|calcium|mesh-list
139218077|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139218078|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218079|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139218080|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139218081|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
139218082|NCT02454088|Hormones|hormones|mesh-ancestor
139218083|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139218084|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139218085|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139218086|NCT02456116|Analgesics|analgesics|mesh-ancestor
139218087|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
139218088|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218089|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218090|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139218091|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139218092|NCT03239236|Anesthetics|anesthetics|mesh-list
139218093|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218094|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218095|NCT03257800|Ketamine|ketamine|mesh-list
139218096|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
139218097|NCT03257800|Sevoflurane|sevoflurane|mesh-list
139218098|NCT03257800|Analgesics|analgesics|mesh-ancestor
139174684|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
139218099|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
139218100|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218101|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218102|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139218103|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139218104|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
139218105|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
139218106|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218107|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139218108|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139218109|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139218110|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218111|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139218112|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139218113|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139218114|NCT01353339|Levofloxacin|levofloxacin|mesh-list
139218115|NCT01353339|Ofloxacin|ofloxacin|mesh-list
139218116|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139218117|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218118|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139218119|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139218120|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139218121|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218122|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218123|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218124|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139218125|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139218126|NCT03239080|Denosumab|denosumab|mesh-list
139218127|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139218128|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218129|NCT03149055|Isavuconazole|isavuconazole|mesh-list
139218130|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
139218131|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218132|NCT01352091|Goserelin|goserelin|mesh-list
139218133|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139218134|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218135|NCT02954523|Dasatinib|dasatinib|mesh-list
139218136|NCT02954523|Osimertinib|osimertinib|mesh-list
139218137|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218138|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139218139|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218140|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218141|NCT04486612|Anesthetics|anesthetics|mesh-list
139218142|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218143|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218144|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
139218145|NCT01353729|Zanamivir|zanamivir|mesh-list
139218146|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139218147|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139218148|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218149|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139218150|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139218151|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418536|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
139218152|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218153|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218154|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139218155|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
139218156|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139218157|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218158|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139218159|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139218160|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139218161|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
139218162|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
139218163|NCT01357317|Calcium|calcium|mesh-list
139218164|NCT01357317|Calcium acetate|calcium acetate|mesh-list
139218165|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139218166|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218167|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139218168|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
139218169|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
139218170|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218171|NCT03238612|Clarithromycin|clarithromycin|mesh-list
139218172|NCT03238612|Oseltamivir|oseltamivir|mesh-list
139218173|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
139218174|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139218175|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218176|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139218177|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218178|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218179|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139218180|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139218181|NCT03137121|Olanzapine|olanzapine|mesh-list
139218182|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
139218183|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
139218184|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218185|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218186|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139218187|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139218188|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139218189|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218190|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139218191|NCT03137121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139218192|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139218193|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139218194|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218195|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139218196|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
139218197|NCT02453776|Infliximab|infliximab|mesh-list
139218198|NCT02453776|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139218199|NCT02453776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139218200|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
139218201|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139218202|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139218203|NCT03256864|Everolimus|everolimus|mesh-list
139218204|NCT03256864|Tacrolimus|tacrolimus|mesh-list
139218205|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139218206|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
139218207|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218208|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139218209|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218210|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218211|NCT03256864|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139218212|NCT03256864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139218213|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218214|NCT01317849|Vitamins|vitamins|mesh-list
139218215|NCT01317849|Folic Acid|folic acid|mesh-list
139218216|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
139218217|NCT01317849|Pyridoxine|pyridoxine|mesh-list
139218218|NCT01317849|Pyridoxal|pyridoxal|mesh-list
139218219|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
139218220|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
139218221|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
139218222|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218223|NCT01317849|Hematinics|hematinics|mesh-ancestor
139218224|NCT01317927|Belinostat|belinostat|mesh-list
139218225|NCT01317927|Warfarin|warfarin|mesh-list
139218226|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
139218227|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218228|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139218229|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218230|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218231|NCT02901483|Cisplatin|cisplatin|mesh-list
139218232|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218233|NCT02874651|Apatinib|apatinib|mesh-list
139218234|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218235|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139218236|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218237|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218238|NCT02453932|Donepezil|donepezil|mesh-list
139218239|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139218240|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218241|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218242|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
139218243|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139218244|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218245|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
139218246|NCT00700570|Bevacizumab|bevacizumab|mesh-list
139218247|NCT00700570|Capecitabine|capecitabine|mesh-list
139218248|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
139218249|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139218250|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218251|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139218252|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139218253|NCT00700570|Growth Substances|growth substances|mesh-ancestor
139218254|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218255|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
139218256|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139218257|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
139218258|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218259|NCT02453698|Methylphenidate|methylphenidate|mesh-list
139218260|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139218261|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218262|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139218263|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139218264|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139218265|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218266|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
139218267|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139218268|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139218269|NCT01354275|Hormones|hormones|mesh-ancestor
139218270|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139218271|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218272|NCT01318161|Morphine|morphine|mesh-list
139218273|NCT01318161|Ropivacaine|ropivacaine|mesh-list
139218274|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139218275|NCT01318161|Narcotics|narcotics|mesh-ancestor
139218276|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218277|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218278|NCT01318161|Analgesics|analgesics|mesh-ancestor
139218279|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
139218280|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218281|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
139218282|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
139218283|NCT03255226|Tolvaptan|tolvaptan|mesh-list
139218284|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139218285|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218286|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
139218287|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218288|NCT02455726|Pregabalin|pregabalin|mesh-list
139218289|NCT02455726|Oxycodone|oxycodone|mesh-list
139218290|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
139218291|NCT02455726|Analgesics|analgesics|mesh-ancestor
139218292|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
139218293|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218294|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218295|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
139218296|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139218297|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139218298|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218299|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139218300|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139218301|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139218302|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218303|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139218304|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139218305|NCT02455726|Narcotics|narcotics|mesh-ancestor
139218306|NCT02455726|Antacids|antacids|mesh-ancestor
139218307|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139218308|NCT04488172|Vitamins|vitamins|mesh-list
139218309|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
139218310|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218311|NCT03239860|Antibodies|antibodies|mesh-list
139218312|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139218313|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
139218314|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218315|NCT04486690|Ketamine|ketamine|mesh-list
139218316|NCT04486690|Propofol|propofol|mesh-list
139218317|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139218318|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218319|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218320|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139218321|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
139218322|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
139218323|NCT04486690|Analgesics|analgesics|mesh-ancestor
139218324|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
139218325|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218326|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139218327|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139218328|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139218329|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139218330|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218332|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
139218333|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139218334|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218335|NCT03236818|Bosentan|bosentan|mesh-list
139218336|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
139218337|NCT03236818|Tadalafil|tadalafil|mesh-list
139218338|NCT03236818|Macitentan|macitentan|mesh-list
139218339|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
139218340|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139218341|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139218342|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218343|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218344|NCT03236818|Urological Agents|urological agents|mesh-ancestor
139218345|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139218346|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139218347|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139218348|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139218349|NCT03236974|Fulvestrant|fulvestrant|mesh-list
139218350|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139218351|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218352|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139218353|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139218354|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
139218355|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139218356|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218357|NCT03748043|Lactoferrin|lactoferrin|mesh-list
139218358|NCT03748043|Teferrol|teferrol|mesh-list
139218359|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218360|NCT03748043|Hematinics|hematinics|mesh-ancestor
139218361|NCT03750773|Gabapentin|gabapentin|mesh-list
139218362|NCT03750773|Analgesics|analgesics|mesh-ancestor
139218363|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
139218364|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218365|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218366|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
139218367|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139218368|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139218369|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218370|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139218371|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139218372|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139218373|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139218374|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218375|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
139218376|NCT02874924|Sirolimus|sirolimus|mesh-list
139218377|NCT02874924|Temsirolimus|temsirolimus|mesh-list
139218378|NCT02874924|MTOR Inhibitors|mtor inhibitors|mesh-list
139218379|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139218380|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218381|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139218382|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218383|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
139218384|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139218385|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
139218386|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218387|NCT02874924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139218388|NCT02874924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218389|NCT02874924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218390|NCT04425863|Aspirin|aspirin|mesh-list
139218391|NCT04425863|Ivermectin|ivermectin|mesh-list
139218392|NCT04425863|Dexamethasone|dexamethasone|mesh-list
139218393|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
139218394|NCT04425863|Enoxaparin|enoxaparin|mesh-list
139218395|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139218396|NCT04425863|BB 1101|bb 1101|mesh-list
139218397|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139218398|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
139218399|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
139218400|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174981|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
139218403|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
139218404|NCT04425863|Hormones|hormones|mesh-ancestor
139218405|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139218406|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139218407|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218408|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
139218409|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218410|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218411|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139218412|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139218413|NCT04425863|Analgesics|analgesics|mesh-ancestor
139218414|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
139218415|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139218416|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139218417|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139218418|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139218419|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139218420|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
139218421|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
139218422|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139218423|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218424|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
139218425|NCT01370772|Rituximab|rituximab|mesh-list
139218426|NCT01370772|Fludarabine|fludarabine|mesh-list
139218427|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139218428|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
139218429|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218430|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139218431|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139218432|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
139218433|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218434|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218435|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139218436|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139218437|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
139218438|NCT03234244|Vitamin D|vitamin d|mesh-list
139218439|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
139218440|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139218441|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218442|NCT03234244|Vitamins|vitamins|mesh-ancestor
139218443|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
139218444|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139218445|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139218446|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139218447|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
139218448|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139218449|NCT03234400|Dapivirine|dapivirine|mesh-list
139218450|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139218451|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139218452|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
139218453|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218454|NCT03254368|ZGN-1061|zgn-1061|mesh-list
139218455|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218456|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218457|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139218458|NCT03236740|Metformin|metformin|mesh-list
139218459|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139218460|NCT03236740|Estradiol|estradiol|mesh-list
139218461|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139218462|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218463|NCT03236740|Estrogens|estrogens|mesh-ancestor
139218464|NCT03236740|Hormones|hormones|mesh-ancestor
139218465|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139218466|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139218467|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
139218468|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139218469|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139218470|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139218471|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139218472|NCT02453464|Leucovorin|leucovorin|mesh-list
139218473|NCT02453464|Irinotecan|irinotecan|mesh-list
139218474|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139218475|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139218476|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218477|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218480|NCT02453464|Protective Agents|protective agents|mesh-ancestor
139218481|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218482|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
139218483|NCT02453464|Vitamins|vitamins|mesh-ancestor
139218484|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
139218485|NCT03233932|Leuprolide|leuprolide|mesh-list
139218486|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139218487|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
139218488|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139218489|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218490|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139218491|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218492|NCT03236584|Tenofovir|tenofovir|mesh-list
139218493|NCT03236584|Lamivudine|lamivudine|mesh-list
139218494|NCT03236584|Adefovir|adefovir|mesh-list
139218495|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
139218496|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218497|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139218498|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139218499|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218500|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218501|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139218502|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139218503|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139218504|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139218505|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139218506|NCT04614168|Glycerol|glycerol|mesh-list
139218507|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218508|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139218509|NCT04614168|Protective Agents|protective agents|mesh-ancestor
139218510|NCT01365312|Ethanol|ethanol|mesh-list
139218511|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139218512|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218513|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218514|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218515|NCT04495283|Acetaminophen|acetaminophen|mesh-list
139218516|NCT04495283|Pregabalin|pregabalin|mesh-list
139218517|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139218518|NCT04495283|Analgesics|analgesics|mesh-ancestor
139218519|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
139218520|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218521|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218522|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
139218523|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
139218524|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139218525|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139218526|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218527|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139218528|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139218529|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139218530|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218531|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139218532|NCT03634020|Sirolimus|sirolimus|mesh-list
139218533|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139218534|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218535|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139218536|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218537|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
139218538|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139218539|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
139218540|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218541|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139218542|NCT03253276|Cathartics|cathartics|mesh-ancestor
139218543|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139218544|NCT01372644|Pasireotide|pasireotide|mesh-list
139218545|NCT01372644|Hormones|hormones|mesh-ancestor
139218546|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139218547|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218548|NCT03253198|Bupivacaine|bupivacaine|mesh-list
139218549|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
139218550|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
139218551|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139175134|NCT02527603|Analgesics|analgesics|mesh-ancestor
139218552|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218553|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
139218554|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218555|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139218556|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139218557|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
139218558|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139218559|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218560|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218561|NCT04234464|Budesonide|budesonide|mesh-list
139218562|NCT04234464|Albuterol|albuterol|mesh-list
139218563|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139218564|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139218565|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
139218566|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218567|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218568|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139218569|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
139218570|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
139218571|NCT04234464|Hormones|hormones|mesh-ancestor
139218572|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139218573|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
139218574|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139218575|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139218576|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139218577|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139218578|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
139218579|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139218580|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218581|NCT03229096|Apatinib|apatinib|mesh-list
139218582|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218583|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139218584|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218585|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218586|NCT03123588|Anagrelide|anagrelide|mesh-list
139218587|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139218588|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139218589|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218590|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139218591|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
139218592|NCT02821026|Sirolimus|sirolimus|mesh-list
139218593|NCT02821026|Etanercept|etanercept|mesh-list
139218594|NCT02821026|Tacrolimus|tacrolimus|mesh-list
139218595|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
139218596|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139218597|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139218598|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
139218599|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218600|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139218601|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218602|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153152|NCT00154102|Antidotes|antidotes|mesh-ancestor
139218603|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139218604|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218605|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139218606|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
139218607|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139218608|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218609|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
139218610|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139218611|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139218612|NCT02821026|Analgesics|analgesics|mesh-ancestor
139218613|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
139218614|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218615|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139218616|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139218617|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139218618|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
139218619|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139218620|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
139218621|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
139218622|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218623|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218624|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139218625|NCT03228628|Analgesics|analgesics|mesh-ancestor
139175207|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139218626|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
139218627|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218629|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139218630|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139218631|NCT03232450|Analgesics|analgesics|mesh-ancestor
139218632|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
139218633|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218634|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218635|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139218636|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139218637|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139218638|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139218639|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218640|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139218641|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139218642|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218643|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
139218644|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
139218645|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139218646|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139218647|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
139218648|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218649|NCT04358549|Favipiravir|favipiravir|mesh-list
139218650|NCT04358549|Antiviral Agents|antiviral agents|mesh-ancestor
139218651|NCT04358549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218652|NCT01562483|Dronabinol|dronabinol|mesh-list
139218653|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
139218654|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218655|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139218656|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139218657|NCT01562483|Analgesics|analgesics|mesh-ancestor
139218658|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
139218659|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218660|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139218661|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139218662|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139218663|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218664|NCT01562483|Hormones|hormones|mesh-ancestor
139218665|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139218666|NCT00700180|Bevacizumab|bevacizumab|mesh-list
139218667|NCT00700180|Carboplatin|carboplatin|mesh-list
139218668|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139218669|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218670|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139218671|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139218672|NCT00700180|Growth Substances|growth substances|mesh-ancestor
139218673|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218674|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
139218675|NCT03222544|Methylene Blue|methylene blue|mesh-list
139218676|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218677|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218678|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
139218679|NCT03228862|Vitamin D|vitamin d|mesh-list
139218680|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139218681|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218682|NCT03228862|Vitamins|vitamins|mesh-ancestor
139218683|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
139218684|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139218685|NCT03228238|Vitamins|vitamins|mesh-list
139218686|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
139218687|NCT03228238|Vitamin E|vitamin e|mesh-list
139218688|NCT03228238|Tocopherols|tocopherols|mesh-list
139218689|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
139218690|NCT03228238|Atorvastatin|atorvastatin|mesh-list
139218691|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
139218692|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218693|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139218694|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139218695|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139218696|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
139218697|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218698|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139218699|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139218700|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218701|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
139218703|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139218704|NCT03232216|Vitamin D|vitamin d|mesh-list
139218705|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
139218706|NCT03232216|Vitamins|vitamins|mesh-ancestor
139218707|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
139218708|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218709|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139218710|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139218711|NCT03231982|Amlodipine|amlodipine|mesh-list
139218712|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139218713|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139218714|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139218715|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218716|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139218717|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218718|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
139218719|NCT03222310|Itraconazole|itraconazole|mesh-list
139218720|NCT03222310|Ipatasertib|ipatasertib|mesh-list
139218721|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
139218722|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218723|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139218724|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139218725|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218726|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218727|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139218728|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
139218729|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139218730|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218731|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139218732|NCT03222310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218733|NCT03222310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139218734|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
139218735|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139218736|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218737|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
139218738|NCT03231436|Bupivacaine|bupivacaine|mesh-list
139218739|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
139218740|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
139218741|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218742|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218743|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
139218744|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218745|NCT02452450|Acetaminophen|acetaminophen|mesh-list
139218746|NCT02452450|Ibuprofen|ibuprofen|mesh-list
139218747|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139218748|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139218749|NCT02452450|Analgesics|analgesics|mesh-ancestor
139218750|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
139218751|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218752|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218753|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139218754|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139218755|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139218756|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218757|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218758|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
139218759|NCT01204684|Poly ICLC|poly iclc|mesh-list
139218760|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
139218761|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
139218762|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218763|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
139218764|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139218765|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139218766|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218767|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139218768|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218769|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139218770|NCT00238420|Paclitaxel|paclitaxel|mesh-list
139218771|NCT00238420|Trastuzumab|trastuzumab|mesh-list
139218772|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139218773|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139175359|NCT03716388|Analgesics|analgesics|mesh-ancestor
139218774|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139218776|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
139218777|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139218778|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139218779|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218780|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
139218781|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
139218782|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
139218783|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218784|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
139218785|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218786|NCT03221998|Acetaminophen|acetaminophen|mesh-list
139218787|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139218788|NCT03221998|Analgesics|analgesics|mesh-ancestor
139218789|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
139218790|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218791|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218792|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
139218793|NCT04492475|Interferons|interferons|mesh-list
139218794|NCT04492475|Interferon-beta|interferon-beta|mesh-list
139218795|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
139218796|NCT04492475|Remdesivir|remdesivir|mesh-list
139218797|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218798|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
139218799|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218800|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
139218801|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218802|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139218803|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
139218804|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218805|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
139218806|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139218807|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
139218808|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218809|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
139218810|NCT04936763|Protective Agents|protective agents|mesh-ancestor
139218811|NCT03750383|Cyclosporine|cyclosporine|mesh-list
139218812|NCT03750383|Prednisone|prednisone|mesh-list
139218813|NCT03750383|Cyclosporins|cyclosporins|mesh-list
139218814|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139218815|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
139218816|NCT03750383|Hormones|hormones|mesh-ancestor
139218817|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139218818|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218819|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139218820|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218821|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218822|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218823|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139218824|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
139218825|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
139218826|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218827|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
139218828|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139218829|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139218830|NCT03226210|Insulin|insulin|mesh-list
139218831|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
139218832|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139218833|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218834|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139218835|NCT03229954|Hematinics|hematinics|mesh-ancestor
139218836|NCT03220126|Mirikizumab|mirikizumab|mesh-list
139218837|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139218838|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139218839|NCT03220126|Analgesics|analgesics|mesh-ancestor
139218840|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
139218841|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218842|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218843|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139218844|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139218845|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139218846|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139218847|NCT02452684|Eszopiclone|eszopiclone|mesh-list
139175432|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218848|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139218849|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218850|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218852|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139218853|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218854|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139218855|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218856|NCT04345367|Abrocitinib|abrocitinib|mesh-list
139218857|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139218858|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218859|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218860|NCT02452606|Levodopa|levodopa|mesh-list
139218861|NCT02452606|Carbidopa|carbidopa|mesh-list
139218862|NCT02452606|Entacapone|entacapone|mesh-list
139218863|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139218864|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139218865|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
139218866|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139218867|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218868|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218869|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139218870|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218871|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139218872|NCT03225352|Aspirin|aspirin|mesh-list
139218873|NCT03225352|Ibuprofen|ibuprofen|mesh-list
139218874|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139218875|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139218876|NCT03225352|Analgesics|analgesics|mesh-ancestor
139218877|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
139218878|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218879|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218880|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139218881|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139218882|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139218883|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139218884|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218885|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139218886|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139218887|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218888|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
139218889|NCT03208270|Antithrombins|antithrombins|mesh-list
139218890|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
139218891|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139218892|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
139218893|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218894|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218895|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
139218896|NCT03208426|Amoxicillin|amoxicillin|mesh-list
139218897|NCT03208426|Metronidazole|metronidazole|mesh-list
139218898|NCT03208426|Clarithromycin|clarithromycin|mesh-list
139218899|NCT03208426|Tetracycline|tetracycline|mesh-list
139218900|NCT03208426|Esomeprazole|esomeprazole|mesh-list
139153461|NCT01093157|Hormones|hormones|mesh-list
139218901|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139218902|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218903|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139218904|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139218905|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139218906|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139218907|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139218908|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218909|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218910|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139218911|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139218912|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139218913|NCT03216070|Dasatinib|dasatinib|mesh-list
139218914|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218915|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139218916|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218917|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218918|NCT03215602|Pyrantel|pyrantel|mesh-list
139218919|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
139218920|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
139218921|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
139218922|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139218923|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218924|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139218925|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139218926|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139218927|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218928|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218930|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139218931|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
139218932|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
139218933|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218934|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218935|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139218936|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
139218938|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139218939|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139218940|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218941|NCT03749915|Tetracaine|tetracaine|mesh-list
139218942|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
139218943|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
139218944|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139218945|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218946|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
139218947|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139218948|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
139218949|NCT03119116|Apixaban|apixaban|mesh-list
139218950|NCT03119116|Dabigatran|dabigatran|mesh-list
139218951|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139218952|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
139218953|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139218954|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
139218955|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218956|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218957|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
139218958|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
139218959|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
139218960|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139218961|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139218962|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218963|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218964|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218965|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139218966|NCT04403399|Varenicline|varenicline|mesh-list
139218967|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139218968|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139218969|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
139218970|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139218971|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218972|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218973|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
139218974|NCT03224572|Vitamins|vitamins|mesh-ancestor
139218975|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
139218976|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218977|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
139218978|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218979|NCT03224572|Protective Agents|protective agents|mesh-ancestor
139218980|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139218981|NCT02452216|Hematinics|hematinics|mesh-ancestor
139218982|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139218983|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139218984|NCT03207334|Cytarabine|cytarabine|mesh-list
139218985|NCT03207334|Midostaurin|midostaurin|mesh-list
139218986|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139218987|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
139218988|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139218989|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139218990|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
139218991|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139218992|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139218993|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
139218994|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139218995|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139218996|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139218997|NCT03212950|Insulin|insulin|mesh-list
139218998|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139218999|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
139175578|NCT03880981|Acetaminophen|acetaminophen|mesh-list
139219000|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
139219001|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139219002|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139219003|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219004|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
139219006|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
139219008|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
139219009|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
139219010|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219011|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219012|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139219013|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139219014|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139219015|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219016|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139219017|NCT03747341|Fentanyl|fentanyl|mesh-list
139219018|NCT03747341|Oxycodone|oxycodone|mesh-list
139219019|NCT03747341|Buprenorphine|buprenorphine|mesh-list
139219020|NCT03747341|Ondansetron|ondansetron|mesh-list
139219021|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139219022|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139219023|NCT03747341|Narcotics|narcotics|mesh-ancestor
139219024|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219025|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219026|NCT03747341|Analgesics|analgesics|mesh-ancestor
139219027|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
139219028|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219029|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139219030|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139219031|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
139219032|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
139219033|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139219034|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
139219035|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
139219036|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139219037|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
139219038|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
139219039|NCT03747341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139219040|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139219041|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
139219042|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139219043|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219044|NCT04401293|Heparin|heparin|mesh-list
139219045|NCT04401293|Enoxaparin|enoxaparin|mesh-list
139219046|NCT04401293|Calcium heparin|calcium heparin|mesh-list
139219047|NCT04401293|Dalteparin|dalteparin|mesh-list
139219048|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
139219049|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
139219050|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139219051|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139219052|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219053|NCT03209908|Tenofovir|tenofovir|mesh-list
139219054|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
139219055|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219056|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139219057|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139219058|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219059|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219060|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139219061|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139219062|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139219063|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139219064|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
139219065|NCT03224338|Dolutegravir|dolutegravir|mesh-list
139219066|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139219067|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139219068|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219069|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219070|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139219071|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139219072|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
139219073|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219074|NCT04318535|Griseofulvin|griseofulvin|mesh-list
139219075|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
139219076|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219077|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
139219078|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139219079|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
139219080|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139219081|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219082|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139219083|NCT03224416|Ethanol|ethanol|mesh-list
139219084|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139219085|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219086|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219087|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219088|NCT01562561|Repaglinide|repaglinide|mesh-list
139219089|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
139219090|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
139219091|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
139219092|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139219093|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219094|NCT03206944|Aspirin|aspirin|mesh-list
139219095|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139219096|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139219097|NCT03206944|Analgesics|analgesics|mesh-ancestor
139219098|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
139219099|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219100|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219101|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219102|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139219103|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139219104|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139219105|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219106|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139219107|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139219108|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219109|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
139219110|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139219111|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139219112|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219113|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219114|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
139219115|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219116|NCT03206554|Ropivacaine|ropivacaine|mesh-list
139219117|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
139219118|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
139219119|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219120|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219121|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
139219122|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219123|NCT03209206|Docetaxel|docetaxel|mesh-list
139219124|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219125|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
139219126|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
139219127|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
139219128|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219129|NCT03223402|Lamivudine|lamivudine|mesh-list
139219130|NCT03223402|Nevirapine|nevirapine|mesh-list
139219131|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139219132|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139219133|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219134|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219135|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
139219136|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219137|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139219138|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139219139|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139219140|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139219141|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139219142|NCT03208972|Menotropins|menotropins|mesh-list
139219143|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139219144|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219145|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139219146|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
139219147|NCT03206866|Antibodies|antibodies|mesh-list
139219148|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
139219149|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219150|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
139219151|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
139219152|NCT02451748|Prednisone|prednisone|mesh-list
139219153|NCT02451748|Triamcinolone|triamcinolone|mesh-list
139219154|NCT02451748|Naproxen|naproxen|mesh-list
139219155|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
139219156|NCT02451748|Methotrexate|methotrexate|mesh-list
139219157|NCT02451748|Leflunomide|leflunomide|mesh-list
139219158|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139089233|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
139219159|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
139219161|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219162|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219163|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139219164|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219165|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139219166|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
139219167|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139219168|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139219169|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
139219170|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219171|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
139219172|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219173|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139219174|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139219175|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
139219176|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139219177|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139219178|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
139219179|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139219180|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139219181|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219182|NCT02451748|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139219183|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139219184|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139219185|NCT02451748|Analgesics|analgesics|mesh-ancestor
139219186|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
139219187|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219188|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
139219189|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139219190|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139219192|NCT03208894|Diuretics|diuretics|mesh-ancestor
139219193|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
139219194|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219195|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139219196|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139219197|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219198|NCT02450656|Docetaxel|docetaxel|mesh-list
139219199|NCT02450656|Afatinib|afatinib|mesh-list
139219200|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219201|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
139219202|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
139219203|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
139219204|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219205|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139219206|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219207|NCT03206320|Lidocaine|lidocaine|mesh-list
139219208|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
139219209|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
139219210|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219211|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219212|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
139219213|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219214|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139219215|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139219216|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139219217|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139219218|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219219|NCT04448561|Morphine|morphine|mesh-list
139219220|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139219221|NCT04448561|Narcotics|narcotics|mesh-ancestor
139219222|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219223|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219224|NCT04448561|Analgesics|analgesics|mesh-ancestor
139219225|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
139219226|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219227|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
139219228|NCT03206008|Analgesics|analgesics|mesh-ancestor
139219229|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
139219230|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642142|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139219231|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219232|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
139219233|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219234|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139219235|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
139219236|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139219237|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139219238|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219239|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139219240|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
139219241|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139219242|NCT04978259|Remdesivir|remdesivir|mesh-list
139219243|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
139219244|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219245|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
139219246|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219247|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
139219248|NCT03208582|Diphosphonates|diphosphonates|mesh-list
139219249|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139219250|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139219251|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219252|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139219253|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219254|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139219255|NCT03200938|Zinc|zinc|mesh-list
139219256|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
139219257|NCT03200938|Trace Elements|trace elements|mesh-ancestor
139219258|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
139219259|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219260|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
139219261|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
139219262|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139219263|NCT03200938|Protective Agents|protective agents|mesh-ancestor
139219264|NCT04297241|Isosorbide|isosorbide|mesh-list
139219265|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139219266|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139219267|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139219268|NCT04297241|Diuretics|diuretics|mesh-ancestor
139219269|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
139219270|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219271|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
139219272|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139418540|NCT03386721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139219273|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219274|NCT04292171|Gabapentin|gabapentin|mesh-list
139219275|NCT04292171|Analgesics|analgesics|mesh-ancestor
139219276|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
139219277|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219278|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219279|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
139219280|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139219281|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139219282|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219283|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139219284|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139219285|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139219286|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139219287|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219288|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
139219289|NCT03200782|Empagliflozin|empagliflozin|mesh-list
139219290|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139219291|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139219292|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219293|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139219294|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219295|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139219296|NCT02449954|Ketorolac|ketorolac|mesh-list
139219297|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139219298|NCT02449954|Morphine|morphine|mesh-list
139219299|NCT02449954|Tramadol|tramadol|mesh-list
139219300|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139219301|NCT02449954|Narcotics|narcotics|mesh-ancestor
139219302|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219303|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219304|NCT02449954|Analgesics|analgesics|mesh-ancestor
139219305|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
139219306|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219307|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139219308|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139219309|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219310|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139219311|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139219312|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219313|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219314|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
139219315|NCT04393493|Furosemide|furosemide|mesh-list
139219316|NCT04393493|Spironolactone|spironolactone|mesh-list
139219317|NCT04393493|Diuretics|diuretics|mesh-ancestor
139219318|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
139219319|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219320|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139219321|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139219322|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219323|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139219324|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
139219325|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219326|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139219327|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139219328|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139219329|NCT02448082|Ichthammol|ichthammol|mesh-list
139219330|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
139219331|NCT03205228|Flupenthixol|flupenthixol|mesh-list
139219332|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
139219333|NCT03205228|Omeprazole|omeprazole|mesh-list
139219334|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139219335|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139219336|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139219337|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219338|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219339|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139219340|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139219341|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219342|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219343|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139219344|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139219345|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
139219346|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139219347|NCT03195946|Midazolam|midazolam|mesh-list
139219348|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139219349|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139219350|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219351|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219352|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139219353|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139219354|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139219355|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139219356|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
139219357|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
139219358|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
139219359|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
139219360|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139219361|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219362|NCT03204760|Dexamethasone|dexamethasone|mesh-list
139219363|NCT03204760|Prednisolone|prednisolone|mesh-list
139219364|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219365|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
139219366|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
139219367|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219368|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219369|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139219370|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
139219371|NCT03204760|Hormones|hormones|mesh-ancestor
139219372|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219373|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139219374|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219375|NCT03200392|Chromium|chromium|mesh-list
139219376|NCT03200392|Trace Elements|trace elements|mesh-ancestor
139219377|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
139219378|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219379|NCT03200080|Amphetamine|amphetamine|mesh-list
139219380|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
139219381|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139219382|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219383|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
139219384|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
139219385|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219386|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
139219387|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139219388|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219389|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
139219390|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139219391|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139219392|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139219393|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139219394|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
139219395|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
139219396|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139219397|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
139219398|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219399|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139219400|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139219401|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
139219402|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219403|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219404|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139219405|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139219406|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139219407|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
139219408|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139219409|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219410|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219411|NCT02447380|Docetaxel|docetaxel|mesh-list
139219412|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219413|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
139219414|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
139219415|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
139219416|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219417|NCT02447224|Metronidazole|metronidazole|mesh-list
139219418|NCT02447224|Ertapenem|ertapenem|mesh-list
139219419|NCT02447224|Cefdinir|cefdinir|mesh-list
139219420|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219421|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139219422|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139219423|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139219424|NCT03199690|Rifampin|rifampin|mesh-list
139219425|NCT03199690|Dolutegravir|dolutegravir|mesh-list
139219426|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139219427|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
139219428|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139219429|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219430|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
139219431|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139219432|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219433|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219434|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139219435|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139219436|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139219437|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139219438|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139219439|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139219440|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139219441|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139219442|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139219443|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139219444|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
139219445|NCT03204058|Metformin|metformin|mesh-list
139219446|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139219447|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139219448|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219449|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139219450|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139219451|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
139219452|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176034|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
139642143|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
139219453|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139219454|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139219455|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219456|NCT03203746|Lycopene|lycopene|mesh-list
139219457|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219458|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
139219459|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219460|NCT03203746|Protective Agents|protective agents|mesh-ancestor
139219461|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219462|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139219463|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139219464|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219465|NCT03203668|Choline|choline|mesh-list
139219466|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
139219467|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139219468|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
139219469|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219470|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139219471|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139219472|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
139219473|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
139219474|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139219475|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139219476|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139219477|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139219478|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219479|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
139219480|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139219481|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219482|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139418784|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219483|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219484|NCT03203356|Hormones|hormones|mesh-list
139418930|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
139219485|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219486|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219487|NCT04280705|Remdesivir|remdesivir|mesh-list
139219488|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
139419229|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
139419308|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419456|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
139219489|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419679|NCT05158699|Hormones|hormones|mesh-ancestor
139219490|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
139219491|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419910|NCT02234362|Vortioxetine|vortioxetine|mesh-list
139419977|NCT02232802|Enoxaparin|enoxaparin|mesh-list
139219492|NCT03203590|Carboplatin|carboplatin|mesh-list
139420133|NCT02307695|Saxagliptin|saxagliptin|mesh-list
139420204|NCT03506789|Dexamethasone|dexamethasone|mesh-list
139219493|NCT03203590|Vinorelbine|vinorelbine|mesh-list
139420351|NCT02449031|Tobramycin|tobramycin|mesh-list
139219494|NCT03203590|Gefitinib|gefitinib|mesh-list
139219495|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219496|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139420517|NCT02226562|Listerine|listerine|mesh-list
139219497|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
139219498|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
139420649|NCT04658173|Alfentanil|alfentanil|mesh-list
139219499|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
139420792|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420793|NCT04657809|Insulin|insulin|mesh-list
139420794|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139420795|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420796|NCT05350917|Tislelizumab|tislelizumab|mesh-list
139420797|NCT05350917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139420868|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139420944|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
139421018|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139219500|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421169|NCT06229145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421170|NCT06229145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421171|NCT06229145|Dermatologic Agents|dermatologic agents|mesh-ancestor
139421172|NCT06229145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421173|NCT06229145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139421174|NCT06229145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139421256|NCT06228586|Vaccines|vaccines|mesh-list
139421318|NCT06228092|Neostigmine|neostigmine|mesh-list
139421319|NCT06228092|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139421320|NCT06228092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421395|NCT06225947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421396|NCT06225947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421397|NCT06225947|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139421398|NCT06225947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139421399|NCT06225947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139421411|NCT06224140|Heparin|heparin|mesh-list
139219501|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139219502|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219503|NCT02077166|Rituximab|rituximab|mesh-list
139219504|NCT02077166|Lenalidomide|lenalidomide|mesh-list
139219505|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139219506|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219507|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
139219508|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421466|NCT06192186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421467|NCT06187298|Curcumin|curcumin|mesh-list
139421468|NCT06187298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139421469|NCT06187298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139421470|NCT06187298|Analgesics|analgesics|mesh-ancestor
139421471|NCT06187298|Sensory System Agents|sensory system agents|mesh-ancestor
139421472|NCT06187298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421473|NCT06187298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421474|NCT06187298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139421475|NCT06187298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139421476|NCT06187298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421477|NCT06187298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421478|NCT06187298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421500|NCT06142383|Valsartan|valsartan|mesh-list
139421501|NCT06142383|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139421502|NCT06142383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139421503|NCT06142383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139421504|NCT06142383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139421505|NCT06142383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421506|NCT06132113|Carboplatin|carboplatin|mesh-list
139421507|NCT06132113|Etoposide|etoposide|mesh-list
139421508|NCT06132113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421509|NCT06132113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139421510|NCT06132113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139219509|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139219510|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139219511|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139219512|NCT02077166|Growth Substances|growth substances|mesh-ancestor
139219513|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
139219514|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139219515|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
139421545|NCT06115031|Propofol|propofol|mesh-list
139421546|NCT06115031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139421547|NCT06115031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139421548|NCT06115031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421549|NCT06115031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139421550|NCT06115031|Anesthetics, General|anesthetics, general|mesh-ancestor
139421551|NCT06115031|Anesthetics|anesthetics|mesh-ancestor
139421555|NCT06100744|Adalimumab|adalimumab|mesh-list
139421556|NCT06100744|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139421557|NCT06100744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139421558|NCT06100744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139421562|NCT06088199|Apremilast|apremilast|mesh-list
139421565|NCT06088199|Analgesics|analgesics|mesh-ancestor
139219516|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139219517|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139219518|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219519|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219520|NCT02450188|Urological Agents|urological agents|mesh-ancestor
139219521|NCT03198676|Poly I-C|poly i-c|mesh-list
139219522|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
139219523|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219524|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
139219525|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
139219526|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219527|NCT04484506|Prednisone|prednisone|mesh-list
139089603|NCT00074490|Doxorubicin|doxorubicin|mesh-list
139219528|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
139219529|NCT04484506|Etoposide|etoposide|mesh-list
139219530|NCT04484506|Vincristine|vincristine|mesh-list
139219531|NCT04484506|Pegaspargase|pegaspargase|mesh-list
139219532|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139421611|NCT06065748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139421612|NCT06065748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421613|NCT06065748|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139421614|NCT06065748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139421615|NCT06065748|Hormone Antagonists|hormone antagonists|mesh-ancestor
139421616|NCT06065748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139421617|NCT06065748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421618|NCT06065748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139421619|NCT06065748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421620|NCT06065748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421683|NCT05987241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421684|NCT05976243|Remibrutinib|remibrutinib|mesh-list
139421685|NCT05976243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139421686|NCT05976243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421687|NCT05976243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421694|NCT05957367|Cetuximab|cetuximab|mesh-list
139219533|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
139219534|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219535|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139219536|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139219537|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
139219538|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219539|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219540|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139219541|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219542|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
139219543|NCT04484506|Hormones|hormones|mesh-ancestor
139219544|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219545|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139421758|NCT05920356|Pembrolizumab|pembrolizumab|mesh-list
139421829|NCT05891119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139421830|NCT05891119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139421831|NCT05891119|Sympatholytics|sympatholytics|mesh-ancestor
139421832|NCT05891119|Autonomic Agents|autonomic agents|mesh-ancestor
139421833|NCT05891119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421834|NCT05891119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139421835|NCT05891119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139421836|NCT05891119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139421837|NCT05891119|Adrenergic Agents|adrenergic agents|mesh-ancestor
139421838|NCT05891119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139421839|NCT05891119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139421840|NCT05891119|Hemostatics|hemostatics|mesh-ancestor
139421841|NCT05891119|Coagulants|coagulants|mesh-ancestor
139421842|NCT05886036|Deoxyglucose|deoxyglucose|mesh-list
139421843|NCT05886036|Rituximab|rituximab|mesh-list
139219546|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139219547|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139219548|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139219549|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219550|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
139219551|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
139219552|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
139219553|NCT02449564|Sirolimus|sirolimus|mesh-list
139219554|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139421904|NCT05818150|Triamcinolone|triamcinolone|mesh-list
139421905|NCT05818150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139421906|NCT05818150|Antiemetics|antiemetics|mesh-ancestor
139421907|NCT05818150|Autonomic Agents|autonomic agents|mesh-ancestor
139421908|NCT05818150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421909|NCT05818150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421910|NCT05818150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139421911|NCT05818150|Glucocorticoids|glucocorticoids|mesh-ancestor
139421912|NCT05818150|Hormones|hormones|mesh-ancestor
139421913|NCT05818150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139421914|NCT05818150|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139421915|NCT05818150|Protective Agents|protective agents|mesh-ancestor
139421924|NCT05795153|Remibrutinib|remibrutinib|mesh-list
139421925|NCT05795153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139421926|NCT05795153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421927|NCT05795153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421937|NCT05773274|Everolimus|everolimus|mesh-list
139421938|NCT05773274|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139421939|NCT05773274|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139421940|NCT05773274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139421941|NCT05773274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421942|NCT05773274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421943|NCT05773274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139421985|NCT05685225|Naltrexone|naltrexone|mesh-list
139422057|NCT05675410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422058|NCT05675410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139422059|NCT05675410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139422060|NCT05675410|Alkylating Agents|alkylating agents|mesh-ancestor
139422061|NCT05675410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422062|NCT05675410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422063|NCT05675410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139422064|NCT05675410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139422065|NCT05675410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139422066|NCT05675410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139422070|NCT05675410|Hormones|hormones|mesh-ancestor
139219555|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219556|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139219557|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219558|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
139219559|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139219560|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
139219561|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219562|NCT02449720|Ropivacaine|ropivacaine|mesh-list
139219563|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
139219564|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
139219565|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219566|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219567|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
139219568|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219569|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
139219570|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
139219571|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139219572|NCT03194620|Procyanidin|procyanidin|mesh-list
139219573|NCT03194620|Theaflavin|theaflavin|mesh-list
139219574|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
139219575|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219576|NCT03194620|Protective Agents|protective agents|mesh-ancestor
139219577|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219578|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139219579|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139219580|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219581|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139219582|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219583|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
139219584|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422138|NCT05605964|Leuprolide|leuprolide|mesh-list
139219585|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139219586|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139219587|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139219588|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
139219589|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
139219590|NCT02445976|Seviteronel|seviteronel|mesh-list
139219591|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219592|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139219593|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219594|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219595|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139219596|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139422357|NCT05422612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139422358|NCT05411081|Atezolizumab|atezolizumab|mesh-list
139422359|NCT05411081|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139422360|NCT05411081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422433|NCT05281471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139422507|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422513|NCT05120895|Pravastatin|pravastatin|mesh-list
139422514|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139422515|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139422516|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
139422517|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422518|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139422519|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139422520|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422582|NCT04930094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139422583|NCT04930094|Immunologic Factors|immunologic factors|mesh-ancestor
139422584|NCT04930094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422591|NCT04925284|Bevacizumab|bevacizumab|mesh-list
139422592|NCT04925284|Nivolumab|nivolumab|mesh-list
139422593|NCT04925284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422594|NCT04925284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422595|NCT04925284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139422596|NCT04925284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139422597|NCT04925284|Growth Substances|growth substances|mesh-ancestor
139422598|NCT04925284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422599|NCT04925284|Growth Inhibitors|growth inhibitors|mesh-ancestor
139422600|NCT04925284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422601|NCT04925284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422602|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139422655|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139422732|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139422733|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
139422734|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422735|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422736|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139422737|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139422738|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139422739|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139422740|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422741|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139422742|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
139422743|NCT04759586|Hormones|hormones|mesh-ancestor
139422745|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139219597|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422879|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139422880|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139422881|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
139422882|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139422883|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422884|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139422885|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139422886|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139422973|NCT04267848|Paclitaxel|paclitaxel|mesh-list
139423028|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139423029|NCT04181060|Bevacizumab|bevacizumab|mesh-list
139423031|NCT04181060|Osimertinib|osimertinib|mesh-list
139219598|NCT03198208|Fentanyl|fentanyl|mesh-list
139219599|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139642144|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219600|NCT03198208|Narcotics|narcotics|mesh-ancestor
139219601|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219602|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176190|NCT01160731|Etoposide|etoposide|mesh-list
139219603|NCT03198208|Analgesics|analgesics|mesh-ancestor
139219604|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
139219605|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219606|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139219607|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139219608|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
139219609|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
139423116|NCT04050410|Moxonidine|moxonidine|mesh-list
139423117|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139423118|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
139423119|NCT04047628|Ofatumumab|ofatumumab|mesh-list
139423120|NCT04047628|Cladribine|cladribine|mesh-list
139423121|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
139423122|NCT04047628|Natalizumab|natalizumab|mesh-list
139423123|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423124|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423125|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
139423126|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423127|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423128|NCT03995147|Prednisone|prednisone|mesh-list
139423129|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
139423130|NCT03995147|Doxorubicin|doxorubicin|mesh-list
139423131|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
139423132|NCT03995147|Vincristine|vincristine|mesh-list
139423133|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423134|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
139423135|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423136|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139423137|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139423180|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139423258|NCT03914625|Protective Agents|protective agents|mesh-ancestor
139423259|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
139423260|NCT03914625|Vitamins|vitamins|mesh-ancestor
139423261|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
139423262|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139423263|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
139423264|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
139423265|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
139423266|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139423267|NCT03914625|Hematinics|hematinics|mesh-ancestor
139423281|NCT03879629|Carvedilol|carvedilol|mesh-list
139423282|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139423283|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139423284|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
139423289|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
139219610|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
139219611|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
139219612|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139219613|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139219614|NCT01044056|NuvaRing|nuvaring|mesh-list
139219615|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
139219616|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139219617|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219618|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139219619|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139219620|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139219621|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139219622|NCT01044056|Estrogens|estrogens|mesh-ancestor
139219623|NCT01044056|Hormones|hormones|mesh-ancestor
139219624|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219625|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139219626|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139219627|NCT01005056|Desogestrel|desogestrel|mesh-list
139219628|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139219629|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139219630|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139219631|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
139219632|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139219633|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219634|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139423335|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423336|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423337|NCT03805594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423338|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423339|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139219635|NCT01005056|Estrogens|estrogens|mesh-ancestor
139219636|NCT01005056|Hormones|hormones|mesh-ancestor
139219637|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219638|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139219639|NCT01005056|Progestins|progestins|mesh-ancestor
139219640|NCT04796714|Aspirin|aspirin|mesh-list
139219641|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139219642|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139219643|NCT04796714|Analgesics|analgesics|mesh-ancestor
139219644|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
139219645|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219646|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219647|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219648|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139423724|NCT01553214|Hormones|hormones|mesh-ancestor
139219649|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139219650|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139219651|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219652|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139219653|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139219654|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219655|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
139219656|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
139219657|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139219658|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139219659|NCT02445898|Prednisolone|prednisolone|mesh-list
139219660|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
139219661|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139219662|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
139219663|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219664|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
139219665|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
139219666|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219667|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219668|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139219669|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
139219670|NCT02445898|Hormones|hormones|mesh-ancestor
139423778|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081476|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081627|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
139081773|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
139082003|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
139082159|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
139082384|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
139082452|NCT01311700|Metoprolol|metoprolol|mesh-list
139082529|NCT02950480|Zafirlukast|zafirlukast|mesh-list
139082795|NCT01209806|TEMPO|tempo|mesh-list
139082828|NCT01057355|Ethanol|ethanol|mesh-list
139082978|NCT01054547|Anesthetics|anesthetics|mesh-list
139083294|NCT01055483|Panobinostat|panobinostat|mesh-list
139083642|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
139083863|NCT01217294|Analgesics|analgesics|mesh-ancestor
139084085|NCT03706300|Ephedrine|ephedrine|mesh-list
139084305|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139084380|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139084598|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139085278|NCT01134848|Analgesics|analgesics|mesh-ancestor
139085429|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
139085804|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139085882|NCT04828538|Vitamin D|vitamin d|mesh-list
139085952|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139086185|NCT01058759|Enoxaparin|enoxaparin|mesh-list
139086398|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139196896|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196897|NCT03358888|Analgesics|analgesics|mesh-ancestor
139196898|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
139196920|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219671|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219672|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139219673|NCT02445898|Protective Agents|protective agents|mesh-ancestor
139197069|NCT03847896|Budesonide|budesonide|mesh-list
139219674|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139197219|NCT04443634|Bupivacaine|bupivacaine|mesh-list
139197289|NCT01182077|Midazolam|midazolam|mesh-list
139197368|NCT02518516|Atorvastatin|atorvastatin|mesh-list
139219675|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219676|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
139219677|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139197535|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
139197593|NCT05666089|Acetylcysteine|acetylcysteine|mesh-list
139197673|NCT03355612|Apatinib|apatinib|mesh-list
139219678|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139197895|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
139219679|NCT03198130|Cemiplimab|cemiplimab|mesh-list
139198046|NCT01581203|Interferons|interferons|mesh-list
139219680|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139198196|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
139219681|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219682|NCT04238780|Fentanyl|fentanyl|mesh-list
139219683|NCT04238780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139219684|NCT04238780|Narcotics|narcotics|mesh-ancestor
139219685|NCT04238780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219686|NCT04238780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219687|NCT04238780|Analgesics|analgesics|mesh-ancestor
139219688|NCT04238780|Sensory System Agents|sensory system agents|mesh-ancestor
139219689|NCT04238780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198711|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
139198792|NCT03628040|Ropivacaine|ropivacaine|mesh-list
139198861|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139199005|NCT01193621|Haloperidol|haloperidol|mesh-list
139199082|NCT05282771|Glucocorticoids|glucocorticoids|mesh-ancestor
139219690|NCT04238780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139199230|NCT02507440|Lidocaine|lidocaine|mesh-list
139219691|NCT04238780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139219692|NCT04238780|Anesthetics, General|anesthetics, general|mesh-ancestor
139219693|NCT04238780|Anesthetics|anesthetics|mesh-ancestor
139219694|NCT00944216|Emollients|emollients|mesh-list
139219695|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
139219696|NCT00878462|Asenapine|asenapine|mesh-list
139219697|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139219698|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139219699|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219700|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199750|NCT03843281|Acetaminophen|acetaminophen|mesh-list
139219701|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139219702|NCT03197818|Budesonide|budesonide|mesh-list
139219703|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
139219704|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219705|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139219706|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
139200041|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
139219707|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219708|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219709|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139219710|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
139219711|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
139219712|NCT03197818|Hormones|hormones|mesh-ancestor
139219713|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219714|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139219715|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139219716|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139219717|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
139219718|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139219719|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219720|NCT03442088|Apremilast|apremilast|mesh-list
139219721|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139219722|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139219723|NCT03442088|Analgesics|analgesics|mesh-ancestor
139219724|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
139219725|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219726|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219727|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219728|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139219729|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139219730|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139219731|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219732|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219733|NCT01562405|Dexamethasone|dexamethasone|mesh-list
139219734|NCT01562405|Lenalidomide|lenalidomide|mesh-list
139219735|NCT01562405|Pomalidomide|pomalidomide|mesh-list
139219736|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219737|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
139219738|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
139200237|NCT03344302|Oxytocin|oxytocin|mesh-list
139219739|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200386|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200463|NCT02495662|Prednisolone|prednisolone|mesh-list
139219740|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200620|NCT02494804|Temozolomide|temozolomide|mesh-list
139200685|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
139219741|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139219742|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
139219743|NCT01562405|Hormones|hormones|mesh-ancestor
139201140|NCT05863416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139472315|NCT02919969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472316|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
139219744|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219745|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139201586|NCT03345823|Upadacitinib|upadacitinib|mesh-list
139201656|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139201811|NCT00706966|Dutasteride|dutasteride|mesh-list
139201886|NCT02498860|Pemetrexed|pemetrexed|mesh-list
139219746|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219747|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
139219748|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139202260|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219749|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139219750|NCT01562405|Growth Substances|growth substances|mesh-ancestor
139202415|NCT03329248|Leucovorin|leucovorin|mesh-list
139219751|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
139219752|NCT03119194|Opicapone|opicapone|mesh-list
139202721|NCT04781192|Durvalumab|durvalumab|mesh-list
139472317|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139202863|NCT03050060|Nelfinavir|nelfinavir|mesh-list
139472318|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219753|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139219754|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203323|NCT01334424|Propofol|propofol|mesh-list
139472319|NCT02837263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139203614|NCT02694588|Vedolizumab|vedolizumab|mesh-list
139203689|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203766|NCT01335048|Clopidogrel|clopidogrel|mesh-list
139203839|NCT02489266|Aldesleukin|aldesleukin|mesh-list
139203913|NCT05694923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139203989|NCT03317548|Progesterone|progesterone|mesh-list
139204060|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139204144|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139204214|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
139204284|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139219755|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219756|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139204507|NCT05714176|Plasma Substitutes|plasma substitutes|mesh-ancestor
139204581|NCT01308983|Diuretics|diuretics|mesh-ancestor
139204656|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204733|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
139204876|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139219757|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139219758|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139205105|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
139205180|NCT03770039|PF-06700841|pf-06700841|mesh-list
139219759|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139205631|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139205714|NCT04409964|Analgesics|analgesics|mesh-ancestor
139205854|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
139206009|NCT06208917|Glucocorticoids|glucocorticoids|mesh-ancestor
139206088|NCT06208410|Antimetabolites|antimetabolites|mesh-ancestor
139206157|NCT06208033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219760|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139219761|NCT03107338|Analgesics|analgesics|mesh-ancestor
139206386|NCT06206733|Capecitabine|capecitabine|mesh-list
139206459|NCT06205823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206533|NCT06205381|Itraconazole|itraconazole|mesh-list
139206607|NCT06196320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139206683|NCT06173505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219762|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
139219763|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207218|NCT05972681|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139219764|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207388|NCT05864144|Cemiplimab|cemiplimab|mesh-list
139219765|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219766|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139219767|NCT05581940|Bupivacaine|bupivacaine|mesh-list
139219768|NCT05581940|Anesthetics|anesthetics|mesh-list
139207684|NCT05669989|Dexamethasone|dexamethasone|mesh-list
139207762|NCT05660382|Miconazole|miconazole|mesh-list
139219769|NCT05581940|Anesthetics, Local|anesthetics, local|mesh-ancestor
139219770|NCT05581940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139207983|NCT05583617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139208057|NCT05555121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139208058|NCT05555121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208059|NCT05553366|Acetaminophen|acetaminophen|mesh-list
139208060|NCT05553366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139208061|NCT05553366|Analgesics|analgesics|mesh-ancestor
139208062|NCT05553366|Sensory System Agents|sensory system agents|mesh-ancestor
139208063|NCT05553366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208064|NCT05553366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208065|NCT05553366|Antipyretics|antipyretics|mesh-ancestor
139208066|NCT05552976|Dexamethasone|dexamethasone|mesh-list
139208067|NCT05552976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139208068|NCT05552976|Antiemetics|antiemetics|mesh-ancestor
139208069|NCT05552976|Autonomic Agents|autonomic agents|mesh-ancestor
139208070|NCT05552976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208071|NCT05552976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208072|NCT05552976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139208073|NCT05552976|Glucocorticoids|glucocorticoids|mesh-ancestor
139208074|NCT05552976|Hormones|hormones|mesh-ancestor
139208134|NCT05487859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139208209|NCT05428969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219771|NCT05581940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208357|NCT05319834|Aspirin|aspirin|mesh-list
139219772|NCT05581940|Sensory System Agents|sensory system agents|mesh-ancestor
139208503|NCT05222971|Durvalumab|durvalumab|mesh-list
139219773|NCT05581940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219774|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
139219775|NCT02445508|Sevelamer|sevelamer|mesh-list
139219776|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
139208818|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
139208897|NCT04910568|Dexamethasone|dexamethasone|mesh-list
139219777|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
139219778|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219779|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139219780|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139219781|NCT03197584|Leucovorin|leucovorin|mesh-list
139209337|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209338|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139209344|NCT04603183|Paclitaxel|paclitaxel|mesh-list
139209345|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139209346|NCT04603183|Letrozole|letrozole|mesh-list
139209347|NCT04603183|Fulvestrant|fulvestrant|mesh-list
139219782|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
139219783|NCT03197584|Bevacizumab|bevacizumab|mesh-list
139219784|NCT03197584|Capecitabine|capecitabine|mesh-list
139219785|NCT03197584|Fluorouracil|fluorouracil|mesh-list
139219786|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
139219787|NCT03197584|Fulvestrant|fulvestrant|mesh-list
139219788|NCT03197584|Avelumab|avelumab|mesh-list
139209862|NCT04100018|Hormones|hormones|mesh-ancestor
139219789|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210052|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210128|NCT03775486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139210203|NCT03721497|Hormones|hormones|mesh-ancestor
139210204|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139210205|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210206|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139210207|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210208|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
139210209|NCT03717896|Thiamine|thiamine|mesh-list
139210210|NCT03717896|Vitamins|vitamins|mesh-ancestor
139210211|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
139210212|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210213|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
139210214|NCT03691610|Vaccines|vaccines|mesh-list
139210215|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
139210216|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960639|NCT00776438|Vaccines|vaccines|mesh-list
138960642|NCT00943449|Sorafenib|sorafenib|mesh-list
139210239|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
139210240|NCT03675737|Capecitabine|capecitabine|mesh-list
139210241|NCT03675737|Fluorouracil|fluorouracil|mesh-list
139210242|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
139210243|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210244|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139219790|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210291|NCT03620669|Durvalumab|durvalumab|mesh-list
138887271|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219791|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139219792|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
138837540|NCT00806767|Busulfan|busulfan|mesh-list
138837620|NCT00698763|Simendan|simendan|mesh-list
139219793|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219794|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139219795|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139219796|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
138837846|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
138837922|NCT04253678|Vortioxetine|vortioxetine|mesh-list
138837993|NCT00807625|Copper|copper|mesh-list
138838072|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
139219797|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138838145|NCT00845871|Deferasirox|deferasirox|mesh-list
139219798|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139219799|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139219800|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139219801|NCT03197584|Growth Substances|growth substances|mesh-ancestor
139219802|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
139219803|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139219804|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
139219805|NCT03197584|Antidotes|antidotes|mesh-ancestor
139219806|NCT03197584|Protective Agents|protective agents|mesh-ancestor
139219807|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
139219808|NCT03197584|Vitamins|vitamins|mesh-ancestor
139219809|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
138839035|NCT05332028|Narcotics|narcotics|mesh-ancestor
138839126|NCT00975221|Cinacalcet|cinacalcet|mesh-list
138839189|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139219810|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138839260|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139219811|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139219812|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139219813|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
139219814|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219815|NCT03722576|Calcium|calcium|mesh-list
139219816|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139219817|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219818|NCT03416348|Ethanol|ethanol|mesh-list
139219819|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139219820|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219821|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219822|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219823|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
139219824|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139219825|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139219826|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139219827|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139219828|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219830|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139219831|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219832|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139219833|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219834|NCT02449486|Ropivacaine|ropivacaine|mesh-list
139219835|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
139219836|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
139219837|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219838|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219839|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
139219840|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219841|NCT03202186|Progesterone|progesterone|mesh-list
139219842|NCT03202186|Progestins|progestins|mesh-ancestor
139219843|NCT03202186|Hormones|hormones|mesh-ancestor
139219844|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219845|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219846|NCT03625076|Lidocaine|lidocaine|mesh-list
139219847|NCT03625076|Propofol|propofol|mesh-list
139219848|NCT03625076|Etomidate|etomidate|mesh-list
139219849|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
139219850|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
139219851|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219852|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219853|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
139219854|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219855|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139219856|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139219857|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139219858|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139219859|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839600|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139219860|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139219861|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139219862|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
139219863|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139219864|NCT02445352|Ezetimibe|ezetimibe|mesh-list
139219865|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139219866|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139219867|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
139219868|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219869|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139219870|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139219871|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219872|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
139219873|NCT03693989|Difluprednate|difluprednate|mesh-list
139219874|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
139219875|NCT03693989|Hormones|hormones|mesh-ancestor
139219876|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219877|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219878|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219879|NCT04944212|Vitamin D|vitamin d|mesh-list
139219880|NCT04944212|Vitamins|vitamins|mesh-ancestor
139219881|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
139219882|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219883|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139219884|NCT03197740|Donepezil|donepezil|mesh-list
139219885|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139219886|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219887|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219888|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
139219889|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139219890|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219891|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
139219892|NCT03201796|Levofloxacin|levofloxacin|mesh-list
139219893|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
139219894|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139219895|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219896|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139219897|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139219898|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139219899|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139219900|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219901|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139219902|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139219903|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139219904|NCT02727998|Midazolam|midazolam|mesh-list
139219905|NCT02727998|Ketamine|ketamine|mesh-list
139219906|NCT02727998|Analgesics|analgesics|mesh-ancestor
139219907|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
139219908|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219909|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219910|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139219911|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139219912|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
139219913|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
139219914|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219915|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139219916|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139219917|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139219918|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219919|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139219920|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139219921|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139219922|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139219923|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139219924|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
139219925|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
139219926|NCT02636270|Mecasermin|mecasermin|mesh-list
139219927|NCT02636270|Growth Substances|growth substances|mesh-ancestor
139219928|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219929|NCT02108990|Acetaminophen|acetaminophen|mesh-list
139219930|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139219931|NCT02108990|Analgesics|analgesics|mesh-ancestor
139219932|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
139219933|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219934|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219935|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
139219936|NCT03194074|Propofol|propofol|mesh-list
139219937|NCT03194074|Desflurane|desflurane|mesh-list
139219938|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139219939|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219940|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219941|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139219942|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
139219943|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
139219944|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139219945|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139219946|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139219947|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139219948|NCT04179461|Vitamin D|vitamin d|mesh-list
139219949|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
139219950|NCT04179461|Fluticasone|fluticasone|mesh-list
139219951|NCT04179461|Xhance|xhance|mesh-list
139219952|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
139219953|NCT04179461|Cetirizine|cetirizine|mesh-list
139219954|NCT04179461|Loratadine|loratadine|mesh-list
139219955|NCT04179461|Azithromycin|azithromycin|mesh-list
139219956|NCT04179461|Budesonide|budesonide|mesh-list
139219957|NCT04179461|Beclomethasone|beclomethasone|mesh-list
139219958|NCT04179461|Emollients|emollients|mesh-list
139219959|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
139219960|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
139219961|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139219962|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138840115|NCT00824785|Epirubicin|epirubicin|mesh-list
139219963|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
139219964|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139219965|NCT04179461|Vitamins|vitamins|mesh-ancestor
139219966|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
139219967|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139219968|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139219969|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139219970|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139219971|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
139219972|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139219973|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139219974|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
139219975|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
139219976|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138840312|NCT04201808|Tenofovir|tenofovir|mesh-list
138840313|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
138840314|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840315|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138840316|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138840317|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840318|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840319|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138840320|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138840335|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
138840336|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138840337|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138840338|NCT02845388|Estradiol|estradiol|mesh-list
138840339|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138840375|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138840450|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138840524|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138840525|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138840526|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840527|NCT02840526|Acetaminophen|acetaminophen|mesh-list
138840528|NCT02840526|Fentanyl|fentanyl|mesh-list
138840529|NCT02840526|Bupivacaine|bupivacaine|mesh-list
138840530|NCT02840526|Propofol|propofol|mesh-list
138840531|NCT02840526|Sevoflurane|sevoflurane|mesh-list
138840532|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
138840533|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
138840534|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139219977|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139219978|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
139219979|NCT04179461|Hormones|hormones|mesh-ancestor
139219980|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139219981|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139219982|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139219983|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139219984|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138840675|NCT00830323|Analgesics|analgesics|mesh-ancestor
139219985|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138840972|NCT05597722|Amphetamine|amphetamine|mesh-list
138840973|NCT05597722|Adderall|adderall|mesh-list
138840974|NCT05597722|Dextroamphetamine|dextroamphetamine|mesh-list
138840975|NCT05597722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138840988|NCT05555667|Propofol|propofol|mesh-list
138841131|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
138841202|NCT04025359|Hormones|hormones|mesh-ancestor
138841279|NCT02740985|Docetaxel|docetaxel|mesh-list
138841492|NCT00633438|Celecoxib|celecoxib|mesh-list
139219986|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
139219987|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841867|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
138841949|NCT00621751|Carbamazepine|carbamazepine|mesh-list
139219988|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139219989|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
139219990|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139219991|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
139219992|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139219993|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
138842470|NCT00832039|Selenious Acid|selenious acid|mesh-list
139219994|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
139219995|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
138842656|NCT00839761|Iron|iron|mesh-list
138842699|NCT02824614|Erythritol|erythritol|mesh-list
139219996|NCT04844528|Niacinamide|niacinamide|mesh-list
139219997|NCT04844528|Niacin|niacin|mesh-list
139219998|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
138842993|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
139219999|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
138843151|NCT00961571|Sunitinib|sunitinib|mesh-list
138843219|NCT00964223|Analgesics|analgesics|mesh-ancestor
139220000|NCT04844528|Vitamins|vitamins|mesh-ancestor
139220001|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
139220002|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220003|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139220004|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
138843509|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139220005|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843658|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138843731|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220006|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138843880|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
139220007|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
139220008|NCT03196882|Iron|iron|mesh-list
139220009|NCT03196882|Trace Elements|trace elements|mesh-ancestor
139220010|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
139220011|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220012|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
138844183|NCT02806752|Hormones|hormones|mesh-ancestor
139220013|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138844340|NCT05979961|Cisplatin|cisplatin|mesh-list
139220014|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
138844483|NCT05977868|Ampicillin|ampicillin|mesh-list
139220015|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138844735|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
139220016|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139220017|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220018|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138845035|NCT02232152|Vitamins|vitamins|mesh-ancestor
138845105|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845182|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138845259|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
139220019|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845512|NCT00863239|Ribavirin|ribavirin|mesh-list
139220020|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138845556|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220021|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845719|NCT03853044|Hormones|hormones|mesh-ancestor
139220022|NCT01562717|Ibuprofen|ibuprofen|mesh-list
138846078|NCT04234932|Latanoprost|latanoprost|mesh-list
139220023|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138846152|NCT03847506|Candesartan|candesartan|mesh-list
139220024|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139220025|NCT01562717|Analgesics|analgesics|mesh-ancestor
138846300|NCT00913887|Diclofenac|diclofenac|mesh-list
138846374|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
138846451|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
138846609|NCT04200222|Vanadium|vanadium|mesh-list
139220026|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
138846679|NCT05753865|Mitosis Modulators|mitosis modulators|mesh-ancestor
138846755|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
139220027|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220028|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220029|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139220030|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139220031|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139220032|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220033|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220034|NCT03196648|Fluorides|fluorides|mesh-list
139220035|NCT03196648|Antioxidants|antioxidants|mesh-list
139220036|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
139220037|NCT03196648|Protective Agents|protective agents|mesh-ancestor
138847046|NCT06076694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139220038|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847302|NCT05470868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847397|NCT05169567|Fulvestrant|fulvestrant|mesh-list
138847472|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138847544|NCT04859764|Hormones|hormones|mesh-ancestor
138847617|NCT04743804|Ravulizumab|ravulizumab|mesh-list
138847692|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139220039|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220040|NCT03625310|Listerine|listerine|mesh-list
139220041|NCT03625310|Fluorides|fluorides|mesh-list
139220042|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
139220043|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
139220044|NCT03625310|Protective Agents|protective agents|mesh-ancestor
138848147|NCT03638375|Interferons|interferons|mesh-list
138848297|NCT03113617|Bombesin|bombesin|mesh-list
139297281|NCT03913442|Colchicine|colchicine|mesh-list
139220045|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220046|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139297711|NCT01001637|Curcumin|curcumin|mesh-list
139297783|NCT00479128|Bortezomib|bortezomib|mesh-list
139220047|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139220048|NCT03118336|Empagliflozin|empagliflozin|mesh-list
139220049|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139298158|NCT06150547|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
139220050|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220051|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139220052|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220053|NCT02444572|Enoxaparin|enoxaparin|mesh-list
139220054|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
139220055|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139220056|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139220057|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220058|NCT04165031|Docetaxel|docetaxel|mesh-list
139220059|NCT04165031|Cetuximab|cetuximab|mesh-list
139220060|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139220061|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220062|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
139220063|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
139220064|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
139220065|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220066|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139220067|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139220068|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220069|NCT05480150|Dexetimide|dexetimide|mesh-list
139220070|NCT05480150|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139220071|NCT05480150|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139220072|NCT05480150|Citalopram|citalopram|mesh-list
139220073|NCT05480150|Escitalopram|escitalopram|mesh-list
139220074|NCT05480150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139220075|NCT05480150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139220076|NCT05480150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139220077|NCT05480150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220078|NCT05480150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220079|NCT05480150|Serotonin Agents|serotonin agents|mesh-ancestor
139220080|NCT05480150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220081|NCT05480150|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139220082|NCT05480150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139220083|NCT05480150|Parasympatholytics|parasympatholytics|mesh-ancestor
139220084|NCT05480150|Autonomic Agents|autonomic agents|mesh-ancestor
139220085|NCT05480150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220086|NCT05480150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139220087|NCT05480150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139220088|NCT05480150|Cholinergic Agents|cholinergic agents|mesh-ancestor
139220089|NCT05480150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139220090|NCT05480150|Antidepressive Agents|antidepressive agents|mesh-ancestor
139220091|NCT05480150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139220092|NCT05480150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139220093|NCT05480150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139220094|NCT05480150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220095|NCT05480150|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139220096|NCT05480150|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139220097|NCT05480150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139220098|NCT05480150|Adrenergic Agents|adrenergic agents|mesh-ancestor
139220099|NCT05480150|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139220100|NCT05480150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139220101|NCT05480150|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139220102|NCT05480150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139220103|NCT05480150|Dopamine Agents|dopamine agents|mesh-ancestor
139220104|NCT05464628|Atorvastatin|atorvastatin|mesh-list
139220105|NCT05464628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139220106|NCT05464628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139220107|NCT05464628|Antimetabolites|antimetabolites|mesh-ancestor
139220108|NCT05464628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220109|NCT05464628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139220110|NCT05464628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139220111|NCT05464628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220112|NCT03193918|Paclitaxel|paclitaxel|mesh-list
139220113|NCT03193918|Ramucirumab|ramucirumab|mesh-list
139220114|NCT03193918|Crenolanib|crenolanib|mesh-list
139220115|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139220116|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220117|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
139220118|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
139220119|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
139220120|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220121|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
139220122|NCT03117790|Morphine|morphine|mesh-list
139220123|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139220124|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220125|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220126|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139220127|NCT03117790|Analgesics|analgesics|mesh-ancestor
139220128|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
139220129|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220130|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139090202|NCT00056160|Dexamethasone|dexamethasone|mesh-list
139220131|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139220132|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139220133|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
139220134|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220135|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220136|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139220137|NCT03117790|Narcotics|narcotics|mesh-ancestor
139220138|NCT03193372|Azelaic acid|azelaic acid|mesh-list
139220139|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220140|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
139220141|NCT03034772|Timolol|timolol|mesh-list
139220142|NCT03034772|Dorzolamide|dorzolamide|mesh-list
139220143|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
139220144|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139220145|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139220146|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
139220147|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220148|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220149|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220150|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139220151|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139220152|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139220153|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139220154|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139220155|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220156|NCT03193606|Fluorides|fluorides|mesh-list
139220157|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
139220158|NCT03193606|Protective Agents|protective agents|mesh-ancestor
139220159|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220160|NCT02448784|Donepezil|donepezil|mesh-list
139220161|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139220162|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220163|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220164|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
139220165|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220166|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220167|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
139220168|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
139220169|NCT04050488|Astringents|astringents|mesh-ancestor
139220170|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220171|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
139220172|NCT02449252|Prednisone|prednisone|mesh-list
139220173|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
139220174|NCT02449252|Doxorubicin|doxorubicin|mesh-list
139220175|NCT02449252|Vincristine|vincristine|mesh-list
139220176|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139220177|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
139220178|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220179|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139220180|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139220181|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
139220182|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220183|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220184|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139220185|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139220186|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139220187|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139220188|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220189|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139220190|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
139220191|NCT02449252|Hormones|hormones|mesh-ancestor
139220192|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139220193|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139220194|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139220195|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
139220196|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
139220197|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
139220198|NCT04779554|Mitomycins|mitomycins|mesh-list
139220199|NCT04779554|Mitomycin|mitomycin|mesh-list
139220200|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139220201|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220202|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
139220203|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220204|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139220205|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220207|NCT02444260|Midazolam|midazolam|mesh-list
139220208|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139220210|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220211|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220212|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139220213|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139220214|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139220215|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139220216|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
139220217|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
139220218|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
139220219|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
139220220|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220221|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220222|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
139220223|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
139220224|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220225|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139220226|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139220227|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139220228|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139220229|NCT03195634|Carvedilol|carvedilol|mesh-list
139220230|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139220231|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139220232|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
139220233|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220234|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220235|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220236|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139220237|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
139220238|NCT03195634|Protective Agents|protective agents|mesh-ancestor
139220239|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139220240|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139220241|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139220242|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
139220243|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139220244|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139220245|NCT02448550|Heparin|heparin|mesh-list
139220246|NCT02448550|Calcium heparin|calcium heparin|mesh-list
139220247|NCT02448550|Bivalirudin|bivalirudin|mesh-list
139220248|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
139220249|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139220250|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139220251|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220252|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
139220253|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139220254|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
139220255|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220256|NCT03701750|Heparin|heparin|mesh-list
139220257|NCT03701750|Enoxaparin|enoxaparin|mesh-list
139220258|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139220259|NCT03701750|Tinzaparin|tinzaparin|mesh-list
139220260|NCT03701750|Dalteparin|dalteparin|mesh-list
139220261|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
139220262|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
139220263|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139220264|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139220265|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220266|NCT03704246|Antibodies|antibodies|mesh-list
139220267|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139220268|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
139220269|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220270|NCT05239910|Tenalisib|tenalisib|mesh-list
139220271|NCT05239910|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139220272|NCT05239910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220273|NCT05239910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220274|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
139220275|NCT03701672|Analgesics|analgesics|mesh-list
139220276|NCT03701672|Narcotics|narcotics|mesh-ancestor
139220277|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220278|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220279|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
139220280|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220281|NCT03624530|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139220282|NCT03624530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139220283|NCT03624530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220284|NCT03624530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220285|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
139220286|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139220287|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139220290|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
139220291|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
139220292|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220293|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220294|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139220295|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220296|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220297|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
139220298|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
139220299|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
139220300|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
139220301|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220302|NCT03698474|Analgesics|analgesics|mesh-ancestor
139220303|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
139220304|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220305|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220306|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
139220307|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220308|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139220309|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
139220310|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139220311|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139220312|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139220313|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
139220314|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139220315|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
139220316|NCT03698474|Protective Agents|protective agents|mesh-ancestor
139220317|NCT03698474|Vitamins|vitamins|mesh-ancestor
139220318|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
139220319|NCT03698474|Cathartics|cathartics|mesh-ancestor
139220320|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139220321|NCT01194622|Fluticasone|fluticasone|mesh-list
139220322|NCT01194622|Xhance|xhance|mesh-list
139220323|NCT01194622|Azelastine|azelastine|mesh-list
139220324|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139220325|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139220326|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
139220327|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220328|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220329|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139220330|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
139220331|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
139220332|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139220333|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139220334|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220335|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220336|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139220337|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139220338|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
139220339|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
139220340|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220341|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139220342|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
139220343|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139220344|NCT02448316|Prednisolone|prednisolone|mesh-list
139220345|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
139220346|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139220347|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
139220348|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139220349|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
139220350|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
139220351|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220352|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220353|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139220354|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
139220355|NCT02448316|Hormones|hormones|mesh-ancestor
139220356|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139220357|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139220358|NCT02448316|Protective Agents|protective agents|mesh-ancestor
139220359|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139220360|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220361|NCT02443714|Insulin|insulin|mesh-list
139220362|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139220363|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
139220364|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139220365|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220366|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
139220367|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139220368|NCT03703154|Tacrolimus|tacrolimus|mesh-list
139220369|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139220370|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
139220371|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220372|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139220373|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220374|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220375|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
139220376|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
139220377|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220378|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
139220379|NCT02434276|Coagulants|coagulants|mesh-ancestor
139220380|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
139220381|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139220382|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139220383|NCT03190642|Prednisolone|prednisolone|mesh-list
139220384|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
139220385|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139220386|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
139220387|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139220388|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
139220389|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
139220390|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220391|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220392|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139220393|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
139220394|NCT03190642|Hormones|hormones|mesh-ancestor
139220395|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139220396|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139220397|NCT03190642|Protective Agents|protective agents|mesh-ancestor
139220398|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139220399|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220400|NCT03702530|Albendazole|albendazole|mesh-list
139220401|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
139220402|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139220403|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139220404|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
139220405|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139220406|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139220407|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
139220408|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
139220409|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
139220410|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220411|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220412|NCT02443246|Vitamin D|vitamin d|mesh-list
139220413|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
139220414|NCT02443246|Vitamins|vitamins|mesh-ancestor
139220415|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
139220416|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220417|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139220418|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139220419|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139220420|NCT03031496|Amiloride|amiloride|mesh-list
139220421|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
139220422|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139154759|NCT00039871|Ribavirin|ribavirin|mesh-list
139220423|NCT03031496|Diuretics|diuretics|mesh-ancestor
139220424|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
139220425|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220426|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139220427|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139220428|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220429|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139220430|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139220431|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139220432|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139220433|NCT03187912|Riboflavin|riboflavin|mesh-list
139220434|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
139220435|NCT03187912|Vitamins|vitamins|mesh-ancestor
139220436|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
139220437|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220438|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139220439|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
139220440|NCT02443012|Nepafenac|nepafenac|mesh-list
139220441|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139220442|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139220443|NCT02443012|Analgesics|analgesics|mesh-ancestor
139220444|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
139220445|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220446|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220447|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139220448|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139220449|NCT03701126|Bupivacaine|bupivacaine|mesh-list
139220450|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
139220451|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
139220452|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220453|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220454|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
139220455|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220456|NCT03702140|Teriparatide|teriparatide|mesh-list
139220457|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139220458|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220459|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139220460|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139220461|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139220462|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139220463|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139220464|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220465|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220466|NCT02433808|Neostigmine|neostigmine|mesh-list
139220467|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139220468|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220469|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220470|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
139220471|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220472|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220473|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139220474|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
139220475|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220476|NCT03701984|Lidocaine|lidocaine|mesh-list
139220477|NCT03701984|Tramadol|tramadol|mesh-list
139220478|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
139220479|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
139220480|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220481|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220482|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
139220483|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220484|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139220485|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139220486|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139220487|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139220488|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220489|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139220490|NCT03701984|Narcotics|narcotics|mesh-ancestor
139220491|NCT03701984|Analgesics|analgesics|mesh-ancestor
139220492|NCT02439190|Aspirin|aspirin|mesh-list
139220493|NCT02439190|Clopidogrel|clopidogrel|mesh-list
139220494|NCT02439190|BMS-986120|bms-986120|mesh-list
139220495|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139220496|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139220497|NCT02439190|Analgesics|analgesics|mesh-ancestor
139220498|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
139220499|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220500|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220501|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139220502|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139220503|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139220504|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139220505|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220506|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139220507|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139220508|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090576|NCT06120283|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139220509|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
139220510|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139220511|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139220512|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139220513|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
139220514|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220516|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139220517|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139220518|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139220519|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220520|NCT02439034|Acetaminophen|acetaminophen|mesh-list
139220521|NCT02439034|Ketoprofen|ketoprofen|mesh-list
139220522|NCT02439034|Codeine|codeine|mesh-list
139220523|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139220524|NCT02439034|Analgesics|analgesics|mesh-ancestor
139220525|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
139220526|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220527|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220528|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
139220529|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139220530|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139220531|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139220532|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139220533|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220534|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220535|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139220536|NCT02439034|Narcotics|narcotics|mesh-ancestor
139220537|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220538|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
139220539|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
139220540|NCT04483492|Caffeine|caffeine|mesh-list
139220541|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
139220542|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220543|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139220544|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220545|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139220546|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220547|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139220548|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139220549|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
139220550|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220551|NCT03186742|Eplerenone|eplerenone|mesh-list
139220552|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139220553|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
139220554|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139220555|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220556|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139220557|NCT03186742|Diuretics|diuretics|mesh-ancestor
139220558|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
139220559|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139220560|NCT03186664|Nabiximols|nabiximols|mesh-list
139220561|NCT03186664|Analgesics|analgesics|mesh-ancestor
139220562|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
139220563|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220564|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220565|NCT02441842|Atenolol|atenolol|mesh-list
139220566|NCT02441842|Lisinopril|lisinopril|mesh-list
139220567|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139220568|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
139220569|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220570|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220571|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139220572|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139220573|NCT02441842|Protective Agents|protective agents|mesh-ancestor
139220574|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220575|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139220576|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
139220577|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
139220578|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220579|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139220580|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139642145|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
139220581|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139220582|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
139220583|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220584|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
139220585|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139220586|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139220587|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220589|NCT02438566|Coagulants|coagulants|mesh-ancestor
139220590|NCT02433652|Vaccines|vaccines|mesh-list
139220591|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
139220592|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220593|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
139220594|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139220595|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
139220596|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139220597|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220598|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139220599|NCT02433418|Diclofenac|diclofenac|mesh-list
139220600|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139220601|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139220602|NCT02433418|Analgesics|analgesics|mesh-ancestor
139220603|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
139220604|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220605|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220606|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139220607|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139220608|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139220609|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220610|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220611|NCT02433730|Testosterone|testosterone|mesh-list
139220612|NCT02433730|Androgens|androgens|mesh-ancestor
139220613|NCT02433730|Hormones|hormones|mesh-ancestor
139220614|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139220615|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220616|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
139220617|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139220618|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
139220619|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139220620|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
139220621|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220622|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220623|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
139220624|NCT02441530|Vitamin D|vitamin d|mesh-list
139220625|NCT02441530|Vitamins|vitamins|mesh-list
139220626|NCT02441530|Vitamin E|vitamin e|mesh-list
139220627|NCT02441530|Ibuprofen|ibuprofen|mesh-list
139220628|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
139220629|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220630|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139220631|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139220632|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139220633|NCT02441530|Analgesics|analgesics|mesh-ancestor
139220634|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
139220635|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220636|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139298396|NCT06034366|Atropine|atropine|mesh-list
139220637|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139220638|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139220639|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220640|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220641|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
139220642|NCT02441530|Protective Agents|protective agents|mesh-ancestor
139220643|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
139220644|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
139220645|NCT02433184|Etanercept|etanercept|mesh-list
139220646|NCT02433184|Methotrexate|methotrexate|mesh-list
139220647|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139220648|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
139220649|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139220650|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220651|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139220652|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
139220653|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220654|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220655|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
139220656|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220657|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139220658|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139220659|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
139177244|NCT01175161|Copper|copper|mesh-list
139220660|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139220661|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139220662|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
139220663|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139220664|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139220665|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139220666|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139220667|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139220668|NCT02433184|Analgesics|analgesics|mesh-ancestor
139220669|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
139220670|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220671|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139220672|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139220673|NCT02438020|Metformin|metformin|mesh-list
139220674|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139220675|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220676|NCT02440750|Dienogest|dienogest|mesh-list
139220677|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
139220678|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139220679|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
139220680|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139220681|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220682|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139220683|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139220684|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139220685|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139220686|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
139220687|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139220688|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139220689|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220690|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
139220691|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139220692|NCT02432872|Cytarabine|cytarabine|mesh-list
139220693|NCT02432872|Daunorubicin|daunorubicin|mesh-list
139220694|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139220695|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
139220696|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220697|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220698|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
139220699|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139220700|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139220701|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
139220702|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220703|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139220704|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139220705|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139220706|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220707|NCT02436928|Vaccines|vaccines|mesh-list
139220708|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
139220709|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220710|NCT02436538|Hormones|hormones|mesh-list
139220711|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139220712|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220713|NCT02436694|Dexamethasone|dexamethasone|mesh-list
139220714|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
139220715|NCT02436694|Ropivacaine|ropivacaine|mesh-list
139220716|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
139220717|NCT02436694|Anesthetics|anesthetics|mesh-list
139220718|NCT02436694|BB 1101|bb 1101|mesh-list
139220719|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139220720|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
139220721|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
139220722|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220723|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220724|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139220725|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
139220726|NCT02436694|Hormones|hormones|mesh-ancestor
139220727|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139220728|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139220729|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220730|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
139220731|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220732|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642146|NCT00988091|Protective Agents|protective agents|mesh-ancestor
139220733|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220734|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
139220736|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
139220737|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139220738|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139220739|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139220740|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220741|NCT02659020|Gemcitabine|gemcitabine|mesh-list
139220742|NCT02659020|Docetaxel|docetaxel|mesh-list
139220743|NCT02659020|Olaratumab|olaratumab|mesh-list
139220744|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139220745|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
139220746|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220747|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220748|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
139220749|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
139220750|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
139220751|NCT03482011|Mirikizumab|mirikizumab|mesh-list
139220752|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139220753|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139220754|NCT03482011|Analgesics|analgesics|mesh-ancestor
139220755|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
139220756|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220757|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220758|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139220759|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139220760|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139220761|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139220762|NCT01374126|Azithromycin|azithromycin|mesh-list
139220763|NCT01374126|Artesunate|artesunate|mesh-list
139220764|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139220765|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139220766|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
139220767|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139220768|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139220769|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220770|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
139220771|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
139220772|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139220773|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
139220774|NCT02584920|Rituximab|rituximab|mesh-list
139220775|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139220776|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220777|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
139220778|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220779|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139220780|NCT02431936|Prazosin|prazosin|mesh-list
139220781|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139220782|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139220783|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139220784|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139220785|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
139220786|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220787|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220788|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220789|NCT02440828|Tobramycin|tobramycin|mesh-list
139220790|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139220791|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139220792|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139220793|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139220794|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220795|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220796|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139220797|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
139220798|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139220799|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220800|NCT03789318|Acetaminophen|acetaminophen|mesh-list
139220801|NCT03789318|Fentanyl|fentanyl|mesh-list
139220802|NCT03789318|Oxycodone|oxycodone|mesh-list
139220803|NCT03789318|Hydromorphone|hydromorphone|mesh-list
139220804|NCT03789318|Bupivacaine|bupivacaine|mesh-list
139220805|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
139220806|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
139220807|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220808|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220809|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
139220810|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220811|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139220813|NCT03789318|Analgesics|analgesics|mesh-ancestor
139220814|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139220815|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139220816|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
139220817|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139220818|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
139220819|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
139220820|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139220821|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220822|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139220823|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
139220824|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139220825|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139220826|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220827|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220828|NCT05160090|Bupropion|bupropion|mesh-list
139220829|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139220830|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
139220831|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139220832|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139220833|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139220834|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139220835|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220836|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
139220837|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220838|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220839|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139220840|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139220841|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220842|NCT04516616|Paclitaxel|paclitaxel|mesh-list
139220843|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139220844|NCT04516616|Cisplatin|cisplatin|mesh-list
139220845|NCT04516616|Antibodies|antibodies|mesh-list
139220846|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139220847|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139220848|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220849|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
139220850|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
139220851|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
139220852|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298405|NCT06034366|Mydriatics|mydriatics|mesh-ancestor
139220853|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
139220854|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220855|NCT00511134|Eszopiclone|eszopiclone|mesh-list
139220856|NCT00511134|Bupropion|bupropion|mesh-list
139220857|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139220858|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
139220859|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139220860|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139220861|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139220862|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139220863|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220864|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
139220865|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220866|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220867|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139220868|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139220869|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220870|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139220871|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220872|NCT05103228|Menotropins|menotropins|mesh-list
139220873|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139220874|NCT05103228|Hormones|hormones|mesh-ancestor
139220875|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139220876|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220877|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139220878|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
139220879|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139220880|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139220881|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220882|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139177469|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139220883|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220884|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220885|NCT03190798|Canagliflozin|canagliflozin|mesh-list
139220886|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139220887|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220888|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139220889|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220890|NCT03696290|Aztreonam|aztreonam|mesh-list
139220891|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139220892|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139220893|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
139220894|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139220895|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139220896|NCT03696212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139220897|NCT03696212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220898|NCT03692546|Bupivacaine|bupivacaine|mesh-list
139220899|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
139220900|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
139220901|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220902|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220903|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
139220904|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220905|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139220906|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
139220907|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220908|NCT02434822|Vaccines|vaccines|mesh-list
139220909|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
139220910|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220911|NCT01371474|Paroxetine|paroxetine|mesh-list
139220912|NCT01371474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139220913|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139220914|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139220915|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220916|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220917|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
139220918|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220919|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139220920|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
139220921|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139220922|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139220923|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139220924|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139220925|NCT03185104|Fluorides|fluorides|mesh-list
139220926|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
139220927|NCT03185104|Protective Agents|protective agents|mesh-ancestor
139220928|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220929|NCT01319994|Metformin|metformin|mesh-list
139220930|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139220931|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220932|NCT02430298|Melatonin|melatonin|mesh-list
139220933|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
139220934|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220935|NCT02430298|Protective Agents|protective agents|mesh-ancestor
139220936|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220937|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220938|NCT03626376|Valacyclovir|valacyclovir|mesh-list
139220939|NCT03626376|Acyclovir|acyclovir|mesh-list
139220940|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139220941|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139220942|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
139220943|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139220944|NCT03695822|Mirabegron|mirabegron|mesh-list
139220945|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139220946|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139220947|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139220948|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
139220949|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220950|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220951|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220952|NCT03695822|Urological Agents|urological agents|mesh-ancestor
139220953|NCT03718507|Atropine|atropine|mesh-list
139220954|NCT03718507|Fentanyl|fentanyl|mesh-list
139220955|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139220956|NCT03718507|Narcotics|narcotics|mesh-ancestor
139220957|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220958|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220959|NCT03718507|Analgesics|analgesics|mesh-ancestor
139220960|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
139220961|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220962|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139220963|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139220964|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
139220965|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
139220966|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139220967|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139220968|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
139220969|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139220970|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
139220971|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
139220972|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
139220973|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139220974|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139220975|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
139220976|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139220977|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220978|NCT01374282|Penicillamine|penicillamine|mesh-list
139220979|NCT01374282|Antidotes|antidotes|mesh-ancestor
139220980|NCT01374282|Protective Agents|protective agents|mesh-ancestor
139220981|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220982|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
139220983|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
139220984|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139220985|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139220986|NCT03691922|Epinephrine|epinephrine|mesh-list
139220987|NCT03691922|Racepinephrine|racepinephrine|mesh-list
139220988|NCT03691922|Bupivacaine|bupivacaine|mesh-list
139220989|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
139220990|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
139220991|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
139220992|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139220993|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139220994|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
139220995|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139220996|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139220997|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139220998|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
139220999|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221000|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221001|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139221002|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139221003|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
139221004|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139221005|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
139221006|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
139221007|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
139221008|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139221009|NCT03453151|Anesthetics|anesthetics|mesh-list
139221010|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
139221011|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221012|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221013|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
139221014|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221015|NCT03433248|Empagliflozin|empagliflozin|mesh-list
139221016|NCT03433248|Gliclazide|gliclazide|mesh-list
139221017|NCT03433248|Linagliptin|linagliptin|mesh-list
139221018|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139221019|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221020|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139221021|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221022|NCT03433248|Incretins|incretins|mesh-ancestor
139221023|NCT03433248|Hormones|hormones|mesh-ancestor
139221024|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139221025|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139221026|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
139221027|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221028|NCT03691688|Aspirin|aspirin|mesh-list
139221029|NCT03691688|Clopidogrel|clopidogrel|mesh-list
139221030|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139221031|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139221032|NCT03691688|Analgesics|analgesics|mesh-ancestor
139221033|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
139221034|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221035|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221036|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139221037|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139221038|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139221039|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139221040|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221041|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139221042|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139221043|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221044|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
139221045|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139221046|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139221047|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139221048|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
139221049|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221050|NCT02425462|Dienogest|dienogest|mesh-list
139221051|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139221052|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
139221053|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139221054|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221055|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139221056|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139221057|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139221058|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139221059|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
139221060|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139221061|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139221062|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221063|NCT03452527|Aflibercept|aflibercept|mesh-list
139221064|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
139221065|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139221066|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139221067|NCT03452527|Growth Substances|growth substances|mesh-ancestor
139221068|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221069|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
139221070|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221071|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
139221072|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
139221073|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139221074|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
139221075|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221076|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221077|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139221078|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
139221079|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
139221080|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139221081|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
139221082|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221083|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221084|NCT02800824|Budesonide|budesonide|mesh-list
139221085|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139221086|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139221087|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
139221088|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221089|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221090|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139221091|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
139221092|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
139221093|NCT02800824|Hormones|hormones|mesh-ancestor
139221094|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139221095|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139221096|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139221097|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221098|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221099|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139221100|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139221101|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221102|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
139221103|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221104|NCT03715699|Prednisone|prednisone|mesh-list
139177705|NCT01176175|Progesterone|progesterone|mesh-list
139221106|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139221107|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
139221109|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139221110|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221111|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139221112|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221113|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221114|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221115|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139221116|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
139221117|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
139221118|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139221119|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
139221120|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221121|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221122|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139221123|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
139221124|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139221125|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
139221126|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221127|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221128|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139221129|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
139221130|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
139221131|NCT04776408|Protective Agents|protective agents|mesh-ancestor
139221132|NCT02429596|Lamotrigine|lamotrigine|mesh-list
139221133|NCT02429596|Carbamazepine|carbamazepine|mesh-list
139221134|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
139221135|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139221136|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139298415|NCT06021977|Zanubrutinib|zanubrutinib|mesh-list
139221137|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221138|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139221139|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221140|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139221141|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139221142|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221143|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139221144|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139221145|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
139221146|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139221147|NCT02429596|Analgesics|analgesics|mesh-ancestor
139221148|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
139221149|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221150|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139221151|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139221152|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
139221153|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
139221154|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221155|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221156|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221157|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
139221158|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
139221159|NCT02653092|Heparin|heparin|mesh-list
139221160|NCT02653092|Anticoagulants|anticoagulants|mesh-list
139221161|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139221162|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139221163|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139221164|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221165|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139221166|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139221167|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139221168|NCT03691454|Docetaxel|docetaxel|mesh-list
139221169|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
139221170|NCT03691454|Trastuzumab|trastuzumab|mesh-list
139221171|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221172|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
139221173|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
139221174|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
139221175|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221176|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139221177|NCT03718273|Digoxin|digoxin|mesh-list
139177774|NCT01327859|Donepezil|donepezil|mesh-list
139221178|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139221179|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139221180|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221181|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221182|NCT03718273|Protective Agents|protective agents|mesh-ancestor
139221183|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221184|NCT02421640|Cisplatin|cisplatin|mesh-list
139221185|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221186|NCT03715387|Bacitracin|bacitracin|mesh-list
139221187|NCT03715387|Polymyxin B|polymyxin b|mesh-list
139221188|NCT03715387|Tacrolimus|tacrolimus|mesh-list
139221189|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139221190|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
139221191|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221192|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139221193|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221194|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221195|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139221196|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221197|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139221198|NCT03715309|Lenalidomide|lenalidomide|mesh-list
139221199|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
139221200|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221201|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139221202|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139221203|NCT03715309|Growth Substances|growth substances|mesh-ancestor
139221204|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
139221205|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221206|NCT03179254|Metformin|metformin|mesh-list
139221207|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139221208|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221209|NCT04147715|Dolutegravir|dolutegravir|mesh-list
139221210|NCT04147715|Midazolam|midazolam|mesh-list
139221211|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139221212|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139221213|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221214|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221215|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139221216|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139221217|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139221218|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139221219|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
139221220|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
139221221|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
139221222|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
139221223|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221224|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221225|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139221226|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139221227|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221228|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139221229|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139221230|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
139221231|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221232|NCT02420938|Rituximab|rituximab|mesh-list
139221233|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139221234|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221235|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
139221236|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221237|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139221238|NCT02429440|Molgramostim|molgramostim|mesh-list
139221239|NCT02429440|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139221240|NCT02429440|Sargramostim|sargramostim|mesh-list
139221241|NCT02429440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139221242|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
139221243|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221244|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221245|NCT02429518|Miltefosine|miltefosine|mesh-list
139221246|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
139221247|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221248|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221249|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139221250|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139221251|NCT00708526|Anesthetics|anesthetics|mesh-list
139221252|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221253|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221254|NCT03712735|Fentanyl|fentanyl|mesh-list
139221255|NCT03712735|Bupivacaine|bupivacaine|mesh-list
139221256|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
139221258|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221259|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221260|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
139221261|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221262|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139221263|NCT03712735|Narcotics|narcotics|mesh-ancestor
139221264|NCT03712735|Analgesics|analgesics|mesh-ancestor
139221265|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139221266|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139221267|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
139221268|NCT03182218|Heparin|heparin|mesh-list
139221269|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139221270|NCT03182218|Tinzaparin|tinzaparin|mesh-list
139221271|NCT03182218|Dalteparin|dalteparin|mesh-list
139221272|NCT03182218|Anticoagulants|anticoagulants|mesh-list
139221273|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139221274|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139221275|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221276|NCT02452554|Maytansine|maytansine|mesh-list
139221277|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
139221278|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139221279|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139221280|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221281|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
139221282|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
139221283|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
139298420|NCT06005532|Adalimumab|adalimumab|mesh-list
139221284|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221285|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139221286|NCT02452554|Immunotoxins|immunotoxins|mesh-ancestor
139221287|NCT02452554|Immunoconjugates|immunoconjugates|mesh-ancestor
139221288|NCT02452554|Immunologic Factors|immunologic factors|mesh-ancestor
139221289|NCT02452554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221290|NCT03182374|Hylan|hylan|mesh-list
139221291|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
139221292|NCT03182374|Protective Agents|protective agents|mesh-ancestor
139221293|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221294|NCT01319682|Lidocaine|lidocaine|mesh-list
139221295|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
139221296|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
139221297|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221298|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221299|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
139221300|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221301|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139221302|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139221303|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139221304|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139221305|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221306|NCT04009577|Lemborexant|lemborexant|mesh-list
139221307|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139221308|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221309|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221310|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139221311|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139221312|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221313|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221314|NCT02176668|Esomeprazole|esomeprazole|mesh-list
139221315|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139221316|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139221317|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139221318|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221319|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221320|NCT03712423|Docetaxel|docetaxel|mesh-list
139221321|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221322|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
139221323|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
139221324|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
139221325|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221326|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
139221327|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
139221328|NCT04620252|Citric Acid|citric acid|mesh-list
139221329|NCT04620252|Sodium Citrate|sodium citrate|mesh-list
139221330|NCT04620252|Calcium|calcium|mesh-list
139221331|NCT04620252|Fluorides|fluorides|mesh-list
139221332|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139221333|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221334|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139221335|NCT04620252|Anticoagulants|anticoagulants|mesh-ancestor
139221336|NCT04620252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139221337|NCT04620252|Chelating Agents|chelating agents|mesh-ancestor
139221338|NCT04620252|Sequestering Agents|sequestering agents|mesh-ancestor
139221339|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221340|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
139221341|NCT04620252|Protective Agents|protective agents|mesh-ancestor
139221343|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139221344|NCT03694886|Caffeine|caffeine|mesh-list
139221345|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139221346|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221347|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139221348|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221349|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221350|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139221351|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139221352|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
139221353|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221354|NCT05602675|Repaglinide|repaglinide|mesh-list
139221355|NCT05602675|Methotrexate|methotrexate|mesh-list
139221356|NCT05602675|Midazolam|midazolam|mesh-list
139221357|NCT05602675|Dextromethorphan|dextromethorphan|mesh-list
139221358|NCT05602675|Warfarin|warfarin|mesh-list
139221359|NCT05602675|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139221360|NCT05602675|Abortifacient Agents|abortifacient agents|mesh-ancestor
139221361|NCT05602675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139221362|NCT05602675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221363|NCT05602675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139221364|NCT05602675|Antimetabolites|antimetabolites|mesh-ancestor
139221365|NCT05602675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221366|NCT05602675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221367|NCT05602675|Dermatologic Agents|dermatologic agents|mesh-ancestor
139221368|NCT05602675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221369|NCT05602675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139221370|NCT05602675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139221371|NCT05602675|Immunologic Factors|immunologic factors|mesh-ancestor
139221372|NCT05602675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139221373|NCT05602675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139221374|NCT05602675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139221375|NCT05602675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139221376|NCT05602675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221377|NCT05602675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139221378|NCT05602675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139221379|NCT05602675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139221380|NCT05602675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139221381|NCT05602675|Anesthetics, General|anesthetics, general|mesh-ancestor
139221382|NCT05602675|Anesthetics|anesthetics|mesh-ancestor
139221383|NCT05602675|GABA Modulators|gaba modulators|mesh-ancestor
139221384|NCT05602675|GABA Agents|gaba agents|mesh-ancestor
139221385|NCT05602675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221386|NCT05602675|Anticoagulants|anticoagulants|mesh-ancestor
139221387|NCT05602675|Antitussive Agents|antitussive agents|mesh-ancestor
139221388|NCT05602675|Respiratory System Agents|respiratory system agents|mesh-ancestor
139221389|NCT05602675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139221390|NCT05602675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139221391|NCT05602675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139221392|NCT03714685|Firibastat|firibastat|mesh-list
139221393|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139221394|NCT02705716|Fluorides|fluorides|mesh-list
139221395|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
139221396|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
139221397|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
139221398|NCT02705716|Protective Agents|protective agents|mesh-ancestor
139221399|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221400|NCT02429050|Morphine|morphine|mesh-list
139221401|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139221402|NCT02429050|Narcotics|narcotics|mesh-ancestor
139221403|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221404|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221405|NCT02429050|Analgesics|analgesics|mesh-ancestor
139221406|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
139221407|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221408|NCT02417142|Exenatide|exenatide|mesh-list
139221409|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139221410|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221411|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139221412|NCT02417142|Incretins|incretins|mesh-ancestor
139221413|NCT02417142|Hormones|hormones|mesh-ancestor
139221414|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139221415|NCT01374750|Cyclosporine|cyclosporine|mesh-list
139221416|NCT01374750|Sirolimus|sirolimus|mesh-list
139221417|NCT01374750|Tacrolimus|tacrolimus|mesh-list
139221418|NCT01374750|Cyclosporins|cyclosporins|mesh-list
139221419|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139221420|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
139221421|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221422|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139221423|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221424|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221425|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
139221426|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221427|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
139221428|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139221429|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139221430|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139221431|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298427|NCT05995249|Efavirenz|efavirenz|mesh-list
139221432|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
139221433|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139221434|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
139221435|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139221436|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221437|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139221438|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139221439|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139221440|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139221441|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139221442|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139221443|NCT01374828|Analgesics|analgesics|mesh-ancestor
139221444|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
139221445|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221446|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221447|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139221448|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139221449|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139221450|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221451|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221452|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
139221453|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139221454|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221455|NCT03634332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139221456|NCT03634332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221457|NCT03744767|Spironolactone|spironolactone|mesh-list
139221458|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139221459|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
139221460|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139221461|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221462|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139221463|NCT03744767|Diuretics|diuretics|mesh-ancestor
139221464|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
139221465|NCT02428972|Propofol|propofol|mesh-list
139221466|NCT02428972|Sevoflurane|sevoflurane|mesh-list
139221467|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139221468|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221469|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221470|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139221471|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
139221472|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
139221473|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139221474|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139221475|NCT03699332|Labetuzumab|labetuzumab|mesh-list
139221476|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139221477|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221478|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139221479|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
139221480|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221481|NCT03178708|Amantadine|amantadine|mesh-list
139221482|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139221483|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139221484|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
139221485|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221487|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221488|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221489|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221490|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139221491|NCT03178708|Analgesics|analgesics|mesh-ancestor
139221492|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
139221493|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221494|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139221495|NCT00787176|Oxytocin|oxytocin|mesh-list
139221496|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
139221497|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139221498|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221499|NCT03744689|Bupivacaine|bupivacaine|mesh-list
139221500|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
139221501|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
139221502|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221503|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221504|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
139221505|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221506|NCT02424214|Ionophores|ionophores|mesh-list
139221507|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139221508|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221509|NCT03712111|Norepinephrine|norepinephrine|mesh-list
139221510|NCT03712111|Bupivacaine|bupivacaine|mesh-list
139221511|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
139221512|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
139221513|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221514|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221515|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
139221516|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221517|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139221518|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139221519|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
139221520|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221521|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221522|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
139221523|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
139221524|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139221525|NCT02925494|Norethindrone|norethindrone|mesh-list
139221526|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
139221527|NCT02925494|Estradiol|estradiol|mesh-list
139221528|NCT02925494|Estrogens|estrogens|mesh-ancestor
139221529|NCT02925494|Hormones|hormones|mesh-ancestor
139221530|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139221531|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221532|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139221533|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
139221534|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139221535|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139221536|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139221537|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139221538|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139221539|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
139221540|NCT04126343|Padsevonil|padsevonil|mesh-list
139221541|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139221542|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221543|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139221544|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139221545|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221546|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221547|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221548|NCT04126343|Anticonvulsants|anticonvulsants|mesh-ancestor
139221549|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
139221550|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
139221551|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
139221552|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221553|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221554|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
139221555|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221556|NCT03119610|Oxytocin|oxytocin|mesh-list
139221557|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
139221558|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139221559|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091619|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221560|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139221561|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221562|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221563|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221564|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139221566|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139221567|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139221568|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221569|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
139221570|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
139221571|NCT03689114|Topiramate|topiramate|mesh-list
139221572|NCT03689114|Lamotrigine|lamotrigine|mesh-list
139221573|NCT03689114|Zonisamide|zonisamide|mesh-list
139221574|NCT03689114|Carbamazepine|carbamazepine|mesh-list
139221575|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
139221576|NCT03689114|Gabapentin|gabapentin|mesh-list
139221577|NCT03689114|Levetiracetam|levetiracetam|mesh-list
139221578|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
139221579|NCT03689114|Valproic Acid|valproic acid|mesh-list
139221580|NCT03689114|Analgesics|analgesics|mesh-ancestor
139221581|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
139221582|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221583|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221584|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139221585|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139221586|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221587|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139221588|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139221589|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139221590|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221591|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221592|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
139221593|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139221594|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
139221595|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139221596|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139221597|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139221598|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139221599|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139221600|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221601|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
139221602|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139221603|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139221604|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139221605|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139221606|NCT02952001|Triamcinolone|triamcinolone|mesh-list
139221607|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139221608|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139221609|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139221610|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139221611|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
139221612|NCT02952001|Hormones|hormones|mesh-ancestor
139221613|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139221614|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221615|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139221616|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
139221617|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221618|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221619|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
139221620|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
139221621|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
139221622|NCT01311739|Vitamins|vitamins|mesh-ancestor
139221623|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
139221624|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221625|NCT01311739|Hematinics|hematinics|mesh-ancestor
139221626|NCT05507359|Benzocaine|benzocaine|mesh-list
139221627|NCT05507359|Anesthetics, Local|anesthetics, local|mesh-ancestor
139221628|NCT05507359|Anesthetics|anesthetics|mesh-ancestor
139221629|NCT05507359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221630|NCT05507359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221631|NCT05507359|Sensory System Agents|sensory system agents|mesh-ancestor
139221632|NCT05507359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221633|NCT04123067|Pioglitazone|pioglitazone|mesh-list
139642147|NCT04965324|Anesthetics|anesthetics|mesh-list
139221634|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139091696|NCT04348045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139221635|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221636|NCT03688958|Iodine|iodine|mesh-list
139221637|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
139221638|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139221639|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221640|NCT03688958|Trace Elements|trace elements|mesh-ancestor
139221641|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
139221642|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221643|NCT04117607|Rezafungin|rezafungin|mesh-list
139221644|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
139221645|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221646|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
139221647|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221648|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139221649|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221650|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221651|NCT05192304|Maleic acid|maleic acid|mesh-list
139221652|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221653|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221654|NCT03693638|Fentanyl|fentanyl|mesh-list
139221655|NCT03693638|Bupivacaine|bupivacaine|mesh-list
139221656|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
139221657|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
139221658|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221659|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221660|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
139221661|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221662|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139221663|NCT03693638|Narcotics|narcotics|mesh-ancestor
139221664|NCT03693638|Analgesics|analgesics|mesh-ancestor
139221665|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139221666|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139221667|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
139221668|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
139221669|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139221670|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
139221671|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221672|NCT01319838|Isotretinoin|isotretinoin|mesh-list
139221673|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
139221674|NCT05191914|Fulvestrant|fulvestrant|mesh-list
139221675|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139221676|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221677|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139221678|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139221679|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
139221680|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139221681|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221682|NCT04060394|Prednisone|prednisone|mesh-list
139221683|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139221684|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
139221685|NCT04060394|Hormones|hormones|mesh-ancestor
139221686|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139221687|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221688|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139221689|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221690|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
139221691|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139221692|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221693|NCT04099277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139221694|NCT04099277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221695|NCT03743987|Pemetrexed|pemetrexed|mesh-list
139221696|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221697|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221698|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221699|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139221700|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139221701|NCT03693326|Spartalizumab|spartalizumab|mesh-list
139221702|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139221703|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221704|NCT03693326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139221705|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221706|NCT03988907|Midazolam|midazolam|mesh-list
139221707|NCT03988907|Risdiplam|risdiplam|mesh-list
139642148|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221708|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139221709|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139221710|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221711|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221712|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139221713|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139221714|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139221715|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139221716|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
139221717|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
139221718|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
139221719|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
139221720|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221721|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221722|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139221723|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221725|NCT03693248|Carboplatin|carboplatin|mesh-list
139221726|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139221727|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221728|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
139221729|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
139221730|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
139221731|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221732|NCT03987191|Insulin|insulin|mesh-list
139221733|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
139221734|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139221735|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139221736|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221737|NCT01373970|Pantoprazole|pantoprazole|mesh-list
139221738|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139221739|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139221740|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139221741|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221742|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221743|NCT04050098|Metformin|metformin|mesh-list
139221744|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139221745|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221746|NCT03745625|Propofol|propofol|mesh-list
139221747|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139221748|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221749|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221750|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139221751|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
139221752|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
139221753|NCT03698630|Dexamethasone|dexamethasone|mesh-list
139221754|NCT03698630|Prednisolone|prednisolone|mesh-list
139221755|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139221756|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
139221757|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139221758|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
139221759|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139221760|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
139221761|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139221762|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
139221763|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
139221764|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221765|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221766|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139221767|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
139221768|NCT03698630|Hormones|hormones|mesh-ancestor
139221769|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139221770|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139221771|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221772|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139221773|NCT03698630|Protective Agents|protective agents|mesh-ancestor
139221774|NCT01375452|Letrozole|letrozole|mesh-list
139221775|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221776|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139221777|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139221778|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221779|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221780|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139221781|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
139221782|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139091843|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221783|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221784|NCT03046836|Oxytocin|oxytocin|mesh-list
139221785|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
139221786|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139178368|NCT03720873|Gefitinib|gefitinib|mesh-list
139221787|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221788|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
139221789|NCT03400033|Hematinics|hematinics|mesh-ancestor
139221790|NCT05123820|Midazolam|midazolam|mesh-list
139221791|NCT05123820|Omeprazole|omeprazole|mesh-list
139221792|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139221793|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139221794|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221795|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221796|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139221797|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139221798|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139221799|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139221800|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
139221801|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
139221802|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
139221803|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
139221804|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221805|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221806|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139221807|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139221808|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139221809|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221810|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139221811|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
139221812|NCT02876835|Hematinics|hematinics|mesh-ancestor
139221813|NCT03503318|Risperidone|risperidone|mesh-list
139221814|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139221815|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
139221816|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221817|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221818|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221819|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139221820|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139221821|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221822|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139221823|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139221824|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
139221825|NCT01375920|Metyrapone|metyrapone|mesh-list
139221826|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
139221827|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221828|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221829|NCT03683108|Resveratrol|resveratrol|mesh-list
139221830|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
139221831|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221832|NCT03683108|Protective Agents|protective agents|mesh-ancestor
139221833|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221834|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221835|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139221836|NCT05137860|Bortezomib|bortezomib|mesh-list
139221837|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221838|NCT03682952|Alprostadil|alprostadil|mesh-list
139221839|NCT03682952|Beraprost|beraprost|mesh-list
139221840|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139221841|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
139221842|NCT03682952|Urological Agents|urological agents|mesh-ancestor
139221843|NCT03682718|Misoprostol|misoprostol|mesh-list
139221844|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139221845|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
139221846|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139221847|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221848|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139221849|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139221850|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
139221851|NCT03682640|Insulin|insulin|mesh-list
139221852|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139221853|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
139642149|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221854|NCT03682640|Azithromycin|azithromycin|mesh-list
139221855|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139221856|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221857|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139221858|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221859|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
139221860|NCT01376076|Risperidone|risperidone|mesh-list
139221861|NCT01376076|Cariprazine|cariprazine|mesh-list
139221862|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139221863|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139221864|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221865|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139221866|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139221867|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221868|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221869|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221870|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139221871|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
139221872|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139221873|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221874|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139221875|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139221876|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139221877|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139221878|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
139221879|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221880|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139221881|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139221882|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221883|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139221884|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139221885|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
139221886|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139221887|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139221888|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139221889|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139221890|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221891|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221892|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221893|NCT03395353|Analgesics|analgesics|mesh-ancestor
139221894|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
139221895|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221896|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
139221897|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139221898|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
139221899|NCT01376154|Lamivudine|lamivudine|mesh-list
139221900|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139221901|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139221902|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221903|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221904|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
139221905|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221906|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139221907|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139221908|NCT01562951|Adalimumab|adalimumab|mesh-list
139221909|NCT01562951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139221910|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139221911|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139221912|NCT01375842|Atezolizumab|atezolizumab|mesh-list
139221913|NCT01375842|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139221914|NCT01375842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221915|NCT01375842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139221916|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221917|NCT03682367|Gabapentin|gabapentin|mesh-list
139221918|NCT03682367|Analgesics|analgesics|mesh-ancestor
139221919|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
139221920|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139221921|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221922|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
139221923|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139221924|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139221925|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139221926|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139221927|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139221928|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139221929|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221930|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221931|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
139221932|NCT05170464|Caffeine|caffeine|mesh-list
139221933|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139221934|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221935|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139221936|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221937|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221938|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139221939|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139221940|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
139221941|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221943|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139221944|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221945|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221946|NCT03394885|Paclitaxel|paclitaxel|mesh-list
139221947|NCT03394885|Bevacizumab|bevacizumab|mesh-list
139221948|NCT03394885|Carboplatin|carboplatin|mesh-list
139221949|NCT03394885|Atezolizumab|atezolizumab|mesh-list
139221950|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139221951|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221952|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
139221953|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
139221954|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
139221955|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221956|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139221957|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139221958|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139221959|NCT03394885|Growth Substances|growth substances|mesh-ancestor
139221960|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221961|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
139221962|NCT03394885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139221963|NCT01361373|Levodopa|levodopa|mesh-list
139221964|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139221965|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139221966|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
139221967|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139221968|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221969|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221970|NCT03677336|Progesterone|progesterone|mesh-list
139221971|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
139221972|NCT03677336|Progestins|progestins|mesh-ancestor
139221973|NCT03677336|Hormones|hormones|mesh-ancestor
139221974|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139221975|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139221976|NCT02877927|Linezolid|linezolid|mesh-list
139221977|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139221978|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221979|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139221980|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221981|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221982|NCT02706886|Lumasiran|lumasiran|mesh-list
139221983|NCT02706886|Renal Agents|renal agents|mesh-ancestor
139221984|NCT02809131|Levofloxacin|levofloxacin|mesh-list
139221985|NCT02809131|Clindamycin|clindamycin|mesh-list
139221986|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
139221987|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
139221988|NCT02809131|Cephalexin|cephalexin|mesh-list
139221989|NCT02809131|Polymyxins|polymyxins|mesh-list
139221990|NCT02809131|Bacitracin|bacitracin|mesh-list
139221991|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139221992|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139221993|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139221994|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139221995|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139221996|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139221997|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139221998|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139221999|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139222000|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139222001|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139222002|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139222003|NCT01442649|Leucovorin|leucovorin|mesh-list
139222004|NCT01442649|Folic Acid|folic acid|mesh-list
139222005|NCT01442649|Bevacizumab|bevacizumab|mesh-list
139222006|NCT01442649|Cetuximab|cetuximab|mesh-list
139222007|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
139222008|NCT01442649|Irinotecan|irinotecan|mesh-list
139222009|NCT01442649|Fluorouracil|fluorouracil|mesh-list
139222010|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
139222011|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139222012|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222013|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139222014|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139178593|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139222015|NCT01442649|Growth Substances|growth substances|mesh-ancestor
139222016|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222017|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
139222018|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139222019|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139222020|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222021|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222022|NCT01442649|Antidotes|antidotes|mesh-ancestor
139222023|NCT01442649|Protective Agents|protective agents|mesh-ancestor
139222024|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
139222025|NCT01442649|Vitamins|vitamins|mesh-ancestor
139222026|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
139222027|NCT01442649|Hematinics|hematinics|mesh-ancestor
139222028|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
139222029|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139222030|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139222031|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
139222032|NCT04995120|Paclitaxel|paclitaxel|mesh-list
139222033|NCT04995120|Cisplatin|cisplatin|mesh-list
139222034|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139222035|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222036|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
139222037|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
139222038|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
139222039|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222040|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
139222041|NCT01376232|Glycine|glycine|mesh-list
139222042|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139222043|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
139222044|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222045|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139222046|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139222047|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139222048|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222049|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
139222050|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222051|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222052|NCT01354665|Interferons|interferons|mesh-list
139222053|NCT01354665|Interferon-beta|interferon-beta|mesh-list
139222054|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
139222055|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222056|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
139222057|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139222058|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
139222059|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222060|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139222061|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139222062|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139222063|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139222064|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222065|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
139222066|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222067|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222068|NCT05008575|Fludarabine|fludarabine|mesh-list
139222069|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
139222070|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222071|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222072|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139222073|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
139222074|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222075|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139222076|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139222077|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
139222078|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139222079|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139222080|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139222081|NCT03111108|Grazoprevir|grazoprevir|mesh-list
139222082|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
139222083|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139222084|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139222086|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139222087|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139178679|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
139222088|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222089|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
139222090|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139222091|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
139222092|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139156404|NCT00361582|Narcotics|narcotics|mesh-ancestor
139222093|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139222094|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139222095|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222096|NCT05198856|Thalidomide|thalidomide|mesh-list
139222097|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139222098|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
139222099|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222100|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
139222101|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139222102|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139222103|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139222104|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139222105|NCT05198856|Growth Substances|growth substances|mesh-ancestor
139222106|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
139222107|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222108|NCT02876601|Defibrotide|defibrotide|mesh-list
139222109|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139222110|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139222111|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222112|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139222113|NCT04059536|Aspirin|aspirin|mesh-list
139222114|NCT04059536|Heparin|heparin|mesh-list
139222115|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139222116|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139222117|NCT04059536|Analgesics|analgesics|mesh-ancestor
139222118|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
139222119|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222120|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222121|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139222122|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139222123|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139222124|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139222125|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222126|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139222127|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139222128|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222129|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
139222130|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
139222131|NCT03178396|Melatonin|melatonin|mesh-list
139222132|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
139222133|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222134|NCT03178396|Protective Agents|protective agents|mesh-ancestor
139222135|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222136|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139222137|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
139222138|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139222139|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
139222140|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222141|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
139222142|NCT03677258|Protective Agents|protective agents|mesh-ancestor
139222143|NCT01361763|Dabigatran|dabigatran|mesh-list
139222144|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
139222145|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139222146|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
139222147|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222148|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222149|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
139222150|NCT02420782|Itraconazole|itraconazole|mesh-list
139222151|NCT02420782|Midazolam|midazolam|mesh-list
139222152|NCT02420782|Pilocarpine|pilocarpine|mesh-list
139222153|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139222154|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139222155|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139222156|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222157|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139222158|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139222159|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139222160|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139222161|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
139222162|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
139178754|NCT03948191|Hormones|hormones|mesh-ancestor
139222163|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
139222164|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
139222165|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156476|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139222166|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222167|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
139222168|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139222169|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139222170|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139222171|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222172|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139222173|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
139222174|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139222175|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139222176|NCT02420782|Miotics|miotics|mesh-ancestor
139222177|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
139222178|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222179|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139222180|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139222181|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
139222182|NCT04054193|Dexamethasone|dexamethasone|mesh-list
139222183|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
139222184|NCT04054193|Aprepitant|aprepitant|mesh-list
139222185|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
139222186|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139222187|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
139222188|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
139222189|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222190|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222191|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139222192|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
139222193|NCT04054193|Hormones|hormones|mesh-ancestor
139222194|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139222195|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139222196|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222197|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139222198|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222199|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222200|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139222201|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
139222202|NCT03394027|TIC10 compound|tic10 compound|mesh-list
139222203|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222204|NCT03682172|Glucagon|glucagon|mesh-list
139222205|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139222206|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139222207|NCT03682172|Hormones|hormones|mesh-ancestor
139222208|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139222209|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222210|NCT03682172|Incretins|incretins|mesh-ancestor
139222211|NCT03184480|Fluticasone|fluticasone|mesh-list
139222212|NCT03184480|Xhance|xhance|mesh-list
139222213|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139222214|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139222215|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
139222216|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222217|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222218|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139222219|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
139222220|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
139222221|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139222222|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
139222223|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139222224|NCT03136107|Protective Agents|protective agents|mesh-ancestor
139222225|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222226|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
139222227|NCT03686774|Memantine|memantine|mesh-list
139222228|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139222229|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139222230|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
139222231|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222232|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222233|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092297|NCT00026312|Vitamin A|vitamin a|mesh-list
139222234|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139222235|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139222236|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
139222237|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139222238|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222239|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139222240|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222241|NCT01562795|Fluorometholone|fluorometholone|mesh-list
139222242|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139222243|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
139222244|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139222245|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139222246|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
139222247|NCT01562795|Hormones|hormones|mesh-ancestor
139222248|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139222249|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222250|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139222251|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
139222252|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
139222253|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139222254|NCT02424136|Antibodies|antibodies|mesh-list
139222255|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
139222256|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222257|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139222258|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
139222259|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222260|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139222261|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
139222262|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139222263|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
139222264|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222265|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222266|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139222267|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
139222268|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
139222269|NCT02424136|Protective Agents|protective agents|mesh-ancestor
139222270|NCT03770676|Selenium|selenium|mesh-list
139222271|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
139222272|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222273|NCT03770676|Protective Agents|protective agents|mesh-ancestor
139222274|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222275|NCT03770676|Trace Elements|trace elements|mesh-ancestor
139222276|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
139222277|NCT01361841|Bimatoprost|bimatoprost|mesh-list
139222278|NCT01361841|Travoprost|travoprost|mesh-list
139222279|NCT01361841|Latanoprost|latanoprost|mesh-list
139222280|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139222281|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139222282|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139222283|NCT02583789|Treprostinil|treprostinil|mesh-list
139222284|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139222285|NCT01355367|Nifedipine|nifedipine|mesh-list
139222286|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139222287|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139222288|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222289|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139222290|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222291|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
139222292|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
139222293|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139222294|NCT05759520|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139222295|NCT05759520|Immunologic Factors|immunologic factors|mesh-ancestor
139222296|NCT05759520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222297|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139222298|NCT02427880|Furosemide|furosemide|mesh-list
139222299|NCT02427880|Acetazolamide|acetazolamide|mesh-list
139222300|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139222301|NCT02427880|Diuretics|diuretics|mesh-ancestor
139222302|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
139222303|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222304|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139222305|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139222306|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642150|NCT04961268|Acetaminophen|acetaminophen|mesh-list
139092367|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139222307|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139222308|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
139222309|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139222310|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222311|NCT01355445|Irinotecan|irinotecan|mesh-list
139222312|NCT01355445|Vincristine|vincristine|mesh-list
139222313|NCT01355445|Temozolomide|temozolomide|mesh-list
139222314|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139178892|NCT01588093|Mecasermin|mecasermin|mesh-list
139222315|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139222316|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222317|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222318|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222319|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139222320|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
139222321|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
139222322|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
139222323|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139222324|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
139222325|NCT02420080|Brincidofovir|brincidofovir|mesh-list
139222326|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
139222327|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139222328|NCT04483258|Sevoflurane|sevoflurane|mesh-list
139222329|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139222330|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139222331|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
139222332|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
139222333|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139222334|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222335|NCT01355757|Anesthetics|anesthetics|mesh-list
139222336|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
139222337|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139222338|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222339|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
139222340|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222341|NCT02507505|Anesthetics|anesthetics|mesh-list
139222342|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139222343|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222344|NCT03181360|Tenecteplase|tenecteplase|mesh-list
139222345|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139222346|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139222347|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222348|NCT04275531|Anesthetics|anesthetics|mesh-list
139222349|NCT04275531|Propofol|propofol|mesh-list
139222350|NCT04275531|Sevoflurane|sevoflurane|mesh-list
139222351|NCT04275531|Isoflurane|isoflurane|mesh-list
139222352|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139222353|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222354|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139222355|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139222356|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
139222357|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139222358|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139222359|NCT01361997|Ethanol|ethanol|mesh-list
139222360|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
139222361|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139222362|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139222363|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139222364|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222365|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
139222366|NCT04750824|Afatinib|afatinib|mesh-list
139222367|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222368|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139222369|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222370|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222371|NCT03180970|Lugol's solution|lugol's solution|mesh-list
139222372|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139222373|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
139222374|NCT03180970|Coagulants|coagulants|mesh-ancestor
139222375|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
139222376|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
139222377|NCT03631446|Citric Acid|citric acid|mesh-list
139222378|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
139222379|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
139222380|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139222381|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
139642151|NCT04961268|Ibuprofen|ibuprofen|mesh-list
139222382|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
139222383|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222384|NCT03631446|Antacids|antacids|mesh-ancestor
139222385|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139222386|NCT03631446|Cathartics|cathartics|mesh-ancestor
139222387|NCT01362153|Golimumab|golimumab|mesh-list
139222388|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139178975|NCT01292785|Hormones|hormones|mesh-list
139222389|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139222390|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139222391|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139222392|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
139222393|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222395|NCT03184324|Fexuprazan|fexuprazan|mesh-list
139222396|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139222397|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139222398|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139222399|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222400|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222401|NCT02427334|Dienogest|dienogest|mesh-list
139222402|NCT02427334|Fluoxetine|fluoxetine|mesh-list
139222403|NCT02427334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139222404|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139222405|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139222406|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222407|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222408|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
139222409|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222410|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139222411|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
139222412|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139222413|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139222414|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139222415|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222416|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139222417|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
139222418|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139222419|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139222420|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139222421|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139222422|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139222423|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
139222424|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139222425|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139222426|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222427|NCT03620253|Modafinil|modafinil|mesh-list
139222428|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139222429|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222430|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139222431|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139222432|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139222433|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222434|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
139222435|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139222436|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139222437|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
139222438|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222439|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222440|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139222441|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
139222442|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
139222443|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139222444|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
139222445|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222446|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222447|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139222448|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139222449|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139222450|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
139222451|NCT01358253|Cytarabine|cytarabine|mesh-list
139222452|NCT01358253|Dexamethasone|dexamethasone|mesh-list
139222453|NCT01358253|Prednisone|prednisone|mesh-list
139222454|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
139222455|NCT01358253|Rituximab|rituximab|mesh-list
139222456|NCT01358253|Doxorubicin|doxorubicin|mesh-list
139222457|NCT01358253|Methotrexate|methotrexate|mesh-list
139222458|NCT01358253|Vincristine|vincristine|mesh-list
139222459|NCT01358253|Asparaginase|asparaginase|mesh-list
139222460|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
139222461|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139222462|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
139222463|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222464|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139222465|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139222467|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222468|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222469|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139222470|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139222471|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
139222472|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
139222473|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222474|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139222475|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
139222476|NCT01358253|Hormones|hormones|mesh-ancestor
139222477|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139222478|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139222479|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139222480|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139222481|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139222482|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139222483|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222484|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139222485|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
139222486|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139222487|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139222488|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
139222489|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
139222490|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139222491|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139222492|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
139222493|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139222494|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139222495|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
139222496|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
139222497|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
139222498|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139222499|NCT03180346|Laxatives|laxatives|mesh-ancestor
139222500|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139222501|NCT01356225|Ketorolac|ketorolac|mesh-list
139222502|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139222503|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139222504|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139222505|NCT01356225|Analgesics|analgesics|mesh-ancestor
139222506|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
139222507|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222508|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222509|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139222510|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139222511|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139222512|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222513|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222514|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
139222515|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139222516|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139222517|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222518|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
139222519|NCT02427412|Coagulants|coagulants|mesh-ancestor
139222520|NCT01356303|Docetaxel|docetaxel|mesh-list
139222521|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222522|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
139222523|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
139222524|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
139222525|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222526|NCT02220309|Pramipexole|pramipexole|mesh-list
139222527|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
139298447|NCT05995249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139222528|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222529|NCT02220309|Protective Agents|protective agents|mesh-ancestor
139222530|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092590|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139222531|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139222532|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139222533|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
139222534|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
139222535|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222536|NCT02419534|Diltiazem|diltiazem|mesh-list
139222537|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139222538|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139222539|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139222540|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222541|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139222542|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222543|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
139222544|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139222545|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
139222546|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222547|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139222548|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
139222549|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222550|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222551|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139222552|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139222553|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139222554|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
139222556|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139222557|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
139222558|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139222559|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139222560|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139222561|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
139222562|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222563|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222564|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222565|NCT02423590|Carboplatin|carboplatin|mesh-list
139222566|NCT02423590|Gemcitabine|gemcitabine|mesh-list
139222567|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222568|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139222569|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
139222570|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222571|NCT01362309|Cycloserine|cycloserine|mesh-list
139222572|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139222573|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139222574|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139222575|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
139222576|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139222577|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
139222578|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222579|NCT03710863|Vorolanib|vorolanib|mesh-list
139222580|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139222581|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222582|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222583|NCT03178084|Lamivudine|lamivudine|mesh-list
139222584|NCT03178084|Zidovudine|zidovudine|mesh-list
139222585|NCT03178084|Efavirenz|efavirenz|mesh-list
139222586|NCT03178084|Maraviroc|maraviroc|mesh-list
139222587|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139222588|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139222589|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222590|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222591|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
139222592|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139222593|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139222594|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139222595|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
139222596|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139222597|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139298450|NCT05995249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139222598|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139222599|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139222600|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139222601|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139222602|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139642152|NCT04961268|Tramadol|tramadol|mesh-list
139222603|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139222604|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139222605|NCT01356381|Vildagliptin|vildagliptin|mesh-list
139222606|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139222607|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222608|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139222609|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
139222610|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222611|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222613|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
139222614|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
139222615|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139222616|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222617|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
139222618|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222619|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139222620|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139222621|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139222622|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139222623|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222624|NCT03302286|Mannitol|mannitol|mesh-list
139222625|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139222626|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139222627|NCT03302286|Diuretics|diuretics|mesh-ancestor
139222628|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
139222629|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222630|NCT01356615|Heparin|heparin|mesh-list
139222631|NCT01356615|Calcium heparin|calcium heparin|mesh-list
139222632|NCT01356615|Enoxaparin|enoxaparin|mesh-list
139222633|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139222634|NCT01356615|Tinzaparin|tinzaparin|mesh-list
139222635|NCT01356615|Dalteparin|dalteparin|mesh-list
139222636|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
139222637|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
139222638|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139222639|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139222640|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222641|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
139222642|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
139222643|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139222644|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139222645|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139222646|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222647|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222648|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139222649|NCT04583592|Gabexate|gabexate|mesh-list
139222650|NCT04583592|Camostat|camostat|mesh-list
139222651|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
139222652|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222653|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222654|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139222655|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139222656|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
139222657|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
139222658|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139222659|NCT02418988|Estrogens|estrogens|mesh-ancestor
139222660|NCT02418988|Hormones|hormones|mesh-ancestor
139222661|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139222662|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222663|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139222664|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222665|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139222666|NCT01356927|Etonogestrel|etonogestrel|mesh-list
139222667|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139222668|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
139222669|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139222670|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222671|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139222672|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139222673|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139222674|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222675|NCT03439670|Prednisone|prednisone|mesh-list
139222676|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139222677|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
139222679|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139222680|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222681|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139222682|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222683|NCT02930343|Folic Acid|folic acid|mesh-list
139222684|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
139222685|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
139222686|NCT02930343|Prednisolone|prednisolone|mesh-list
139222687|NCT02930343|Methotrexate|methotrexate|mesh-list
139222688|NCT02930343|Leflunomide|leflunomide|mesh-list
139222689|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
139222690|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139222691|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
139222692|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139222693|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222694|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139222695|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
139222696|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222697|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222698|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
139222699|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222700|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139222701|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139222702|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
139222703|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139222704|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139222705|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139222707|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139222708|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139222709|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222710|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139222711|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
139222712|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139222713|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139222714|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139222715|NCT02930343|Hematinics|hematinics|mesh-ancestor
139222716|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
139222717|NCT02930343|Vitamins|vitamins|mesh-ancestor
139222718|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
139222719|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139222720|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139222721|NCT02930343|Analgesics|analgesics|mesh-ancestor
139222722|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
139222723|NCT03686618|Secretin|secretin|mesh-list
139222724|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139222725|NCT03686618|Hormones|hormones|mesh-ancestor
139222726|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139222727|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222728|NCT02426866|Efavirenz|efavirenz|mesh-list
139222729|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139222730|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139222731|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222732|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222733|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
139222734|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139222735|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139222736|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139222737|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139222738|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139222739|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139222740|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139222741|NCT02423824|Liraglutide|liraglutide|mesh-list
139222742|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139222743|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222744|NCT02423824|Incretins|incretins|mesh-ancestor
139222745|NCT02423824|Hormones|hormones|mesh-ancestor
139222746|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139222747|NCT01012167|Galantamine|galantamine|mesh-list
139222748|NCT01012167|Oxytocin|oxytocin|mesh-list
139222749|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
139222750|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139222751|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222752|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139222753|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222754|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222755|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
139222756|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222757|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139222758|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
139222759|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222760|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
139222761|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
139222762|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222763|NCT05189067|Paclitaxel|paclitaxel|mesh-list
139222764|NCT05189067|Docetaxel|docetaxel|mesh-list
139222765|NCT05189067|Trastuzumab|trastuzumab|mesh-list
139222766|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139222767|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222768|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
139222769|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
139222770|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
139222771|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222772|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139222773|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139222774|NCT02422966|Acetaminophen|acetaminophen|mesh-list
139222775|NCT02422966|Ibuprofen|ibuprofen|mesh-list
139222776|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139222777|NCT02422966|Analgesics|analgesics|mesh-ancestor
139222778|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
139222779|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222780|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222781|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
139222782|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139222783|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139222784|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139222785|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139222786|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222787|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222788|NCT02422888|Ticagrelor|ticagrelor|mesh-list
139222789|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139222790|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139222791|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139222792|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139222793|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139222794|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
139222795|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222796|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222797|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222798|NCT03633552|Temozolomide|temozolomide|mesh-list
139222799|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139222800|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
139222801|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222802|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222803|NCT05760456|Metformin|metformin|mesh-list
139222804|NCT05760456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139222805|NCT05760456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222806|NCT02418130|Inositol|inositol|mesh-list
139222807|NCT02418130|Thiamine|thiamine|mesh-list
139222808|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139222809|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
139222810|NCT02418130|Vitamins|vitamins|mesh-ancestor
139222811|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
139222812|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222813|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139222814|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139222815|NCT03391765|Tilavonemab|tilavonemab|mesh-list
139222816|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
139222817|NCT02802228|Ifetroban|ifetroban|mesh-list
139222818|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139222819|NCT02801448|Sulforaphane|sulforaphane|mesh-list
139222820|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139222821|NCT02801448|Protective Agents|protective agents|mesh-ancestor
139222822|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222823|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222824|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
139222825|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
139222826|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139222827|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222828|NCT03674177|Vaccines|vaccines|mesh-list
139222829|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
139222830|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222831|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
139222832|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222833|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
139222834|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222835|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222836|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139222837|NCT02417896|Spironolactone|spironolactone|mesh-list
139222838|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139222839|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
139222840|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139222841|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222842|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139222843|NCT02417896|Diuretics|diuretics|mesh-ancestor
139222844|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
139222845|NCT03183544|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139222846|NCT03183544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139222847|NCT03183544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222848|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
139222849|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139222850|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
139222851|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139222852|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
139222853|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139222854|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139222855|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
139222856|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222857|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
139222858|NCT03116776|Protective Agents|protective agents|mesh-ancestor
139222859|NCT02505204|Clonidine|clonidine|mesh-list
139222860|NCT02505204|Analgesics|analgesics|mesh-ancestor
139222861|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
139222862|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222863|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222864|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139222865|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
139222866|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
139222867|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139222868|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139222869|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139222870|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
139222871|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222872|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222873|NCT01359423|Cilostazol|cilostazol|mesh-list
139222874|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139222875|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
139222876|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222877|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222878|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139222879|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
139222880|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139222881|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139222882|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222883|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139222884|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
139222885|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139222886|NCT01359423|Protective Agents|protective agents|mesh-ancestor
139222887|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139222888|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139222889|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222890|NCT01363089|Ketorolac|ketorolac|mesh-list
139222891|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139222892|NCT01363089|Phenylephrine|phenylephrine|mesh-list
139222893|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
139222894|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139222895|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139222896|NCT01363089|Analgesics|analgesics|mesh-ancestor
139222897|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
139222898|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222899|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222900|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139222901|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139222902|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139222903|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222904|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222905|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139222906|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139222907|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
139222908|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222909|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
139222910|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
139222911|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
139222912|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139222913|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
139222914|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139222915|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
139222916|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139222917|NCT01363089|Protective Agents|protective agents|mesh-ancestor
139222918|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139222919|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139222920|NCT03361748|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
139222921|NCT03361748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139222922|NCT03361748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222923|NCT03681548|Doxorubicin|doxorubicin|mesh-list
139222924|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139222925|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139222926|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222927|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139222928|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139222929|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222930|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222932|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139222933|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139222934|NCT02417506|Analgesics|analgesics|mesh-ancestor
139222935|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
139222936|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222937|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222938|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139222939|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139222940|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139222941|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222942|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222943|NCT05188911|Prednisone|prednisone|mesh-list
139222944|NCT05188911|Androgens|androgens|mesh-list
139222945|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139222946|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
139222947|NCT05188911|Hormones|hormones|mesh-ancestor
139222948|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139222949|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222950|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139222951|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222952|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139222953|NCT03676946|Antibodies|antibodies|mesh-list
139222954|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
139222955|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139222956|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
139222957|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222958|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139222959|NCT01363167|Vitamin D|vitamin d|mesh-list
139222960|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
139222961|NCT01363167|Vitamins|vitamins|mesh-ancestor
139222962|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
139222963|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222964|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139222965|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139222966|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
139222967|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
139222968|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222969|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222970|NCT02422654|Eliglustat|eliglustat|mesh-list
139222971|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222972|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222973|NCT05188833|Paroxetine|paroxetine|mesh-list
139222974|NCT05188833|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139222975|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139222976|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139093044|NCT01090206|Calcium|calcium|mesh-list
139222977|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139222978|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139222979|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
139222980|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222981|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139222982|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
139222983|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139222984|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139222985|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139222986|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139222987|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
139222988|NCT02426164|Epinephrine|epinephrine|mesh-list
139222989|NCT02426164|Morphine|morphine|mesh-list
139222990|NCT02426164|Bupivacaine|bupivacaine|mesh-list
139222991|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
139222992|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
139222993|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139222994|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139222995|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
139222996|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139222997|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139222998|NCT02426164|Narcotics|narcotics|mesh-ancestor
139222999|NCT02426164|Analgesics|analgesics|mesh-ancestor
139223000|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139223001|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
139223002|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
139223003|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139223004|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
139223005|NCT02426164|Hormones|hormones|mesh-ancestor
139223006|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139223007|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139223008|NCT02426164|Protective Agents|protective agents|mesh-ancestor
139223009|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139223010|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139223011|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
139223012|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223013|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223014|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139223015|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139223016|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139223017|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
139223018|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
139223019|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
139223020|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139223021|NCT03745157|Insulin|insulin|mesh-list
139223022|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
139223023|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139223024|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223025|NCT02426008|Mitogens|mitogens|mesh-list
139223026|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
139223027|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223028|NCT04050371|Tenofovir|tenofovir|mesh-list
139223029|NCT04050371|Emtricitabine|emtricitabine|mesh-list
139223030|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
139223031|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223032|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139223033|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139223034|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223035|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223036|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139223037|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139223038|NCT04447287|Buprenorphine|buprenorphine|mesh-list
139223039|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139223040|NCT04447287|ASP8062|asp8062|mesh-list
139223041|NCT04447287|Naloxone|naloxone|mesh-list
139223042|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139223043|NCT04447287|Narcotics|narcotics|mesh-ancestor
139223044|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223045|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223046|NCT04447287|Analgesics|analgesics|mesh-ancestor
139223047|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
139223048|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223049|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139642153|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139223050|NCT04447287|GABA Modulators|gaba modulators|mesh-ancestor
139223051|NCT04447287|GABA Agents|gaba agents|mesh-ancestor
139093126|NCT01295294|Analgesics|analgesics|mesh-ancestor
139223052|NCT04447287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223053|NCT04447287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223054|NCT01879319|Evolocumab|evolocumab|mesh-list
139223055|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139223056|NCT01879319|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139223057|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139223058|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139179638|NCT03472456|Eugenol|eugenol|mesh-list
139223059|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
139223060|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223061|NCT01879319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139223062|NCT01879319|Protease Inhibitors|protease inhibitors|mesh-ancestor
139223063|NCT01879319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223064|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139223065|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
139223066|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223067|NCT04165122|Valacyclovir|valacyclovir|mesh-list
139223068|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
139223069|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223070|NCT02422030|Atorvastatin|atorvastatin|mesh-list
139223071|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
139223072|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139223073|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139223074|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
139223075|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223076|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139223077|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139223078|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223079|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
139223080|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223081|NCT01365897|Modafinil|modafinil|mesh-list
139223082|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139223083|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223084|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139223085|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139223086|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139223087|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223088|NCT02422108|Denosumab|denosumab|mesh-list
139223089|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139223090|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223091|NCT01359657|Dexamethasone|dexamethasone|mesh-list
139223092|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
139223093|NCT01359657|Lenalidomide|lenalidomide|mesh-list
139223094|NCT01359657|Bortezomib|bortezomib|mesh-list
139223095|NCT01359657|BB 1101|bb 1101|mesh-list
139223096|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139223097|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139223098|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
139223099|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
139223100|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223101|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223102|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139223103|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
139223104|NCT01359657|Hormones|hormones|mesh-ancestor
139223105|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139223106|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139223107|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223108|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
139223109|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223110|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223111|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
139223112|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139223113|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139223114|NCT01359657|Growth Substances|growth substances|mesh-ancestor
139223115|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
139223116|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139223117|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
139223118|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139223119|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139223120|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
139223121|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223122|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
139223123|NCT02417116|Protective Agents|protective agents|mesh-ancestor
139223124|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
139223125|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
139642154|NCT04961268|Analgesics|analgesics|mesh-ancestor
139223126|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
139223127|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223128|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223129|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139223130|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139223131|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139223132|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223133|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139223134|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139223135|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
139223136|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223137|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223138|NCT03177850|Acetazolamide|acetazolamide|mesh-list
139223140|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139223141|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223142|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223143|NCT03177850|Diuretics|diuretics|mesh-ancestor
139223144|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
139223145|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223146|NCT03102918|Cannabidiol|cannabidiol|mesh-list
139223147|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
139223148|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
139223149|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139223150|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139223151|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139223152|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139223153|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223154|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
139223155|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223156|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223157|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139223158|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223159|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139223160|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
139223161|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139223162|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
139223163|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139223164|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223165|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139223166|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139223167|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223168|NCT03177538|Menotropins|menotropins|mesh-list
139223169|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139223170|NCT03177538|Hormones|hormones|mesh-ancestor
139223171|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139223172|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223173|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139223174|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
139223175|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139223176|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
139223177|NCT01363323|Naltrexone|naltrexone|mesh-list
139223178|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
139223179|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139223180|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223181|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139223182|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139223183|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223184|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223185|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223186|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223187|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139223188|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
139223189|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223190|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139223191|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
139223192|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
139223193|NCT03106948|Penicillamine|penicillamine|mesh-list
139223194|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
139223195|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223196|NCT03106948|Protective Agents|protective agents|mesh-ancestor
139223197|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223198|NCT03106948|Vitamins|vitamins|mesh-ancestor
139223199|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
139223200|NCT03106948|Antidotes|antidotes|mesh-ancestor
139223201|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
139223202|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
139223203|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139223204|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
139223205|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139223206|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223207|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
139223208|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223209|NCT01881048|Celecoxib|celecoxib|mesh-list
139223210|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139223211|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139223212|NCT01881048|Analgesics|analgesics|mesh-ancestor
139223213|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
139223214|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223215|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223216|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139223217|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139223218|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139223219|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139223220|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223221|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223222|NCT01363557|Gefitinib|gefitinib|mesh-list
139223223|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223224|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139223225|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223226|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223227|NCT01346475|Valacyclovir|valacyclovir|mesh-list
139223228|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
139223229|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223230|NCT01338636|Ambrisentan|ambrisentan|mesh-list
139223231|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139223232|NCT02416258|Betamethasone|betamethasone|mesh-list
139223233|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
139223234|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139223235|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
139223236|NCT02416258|Calcipotriene|calcipotriene|mesh-list
139223237|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139223238|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139223239|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
139223240|NCT02416258|Hormones|hormones|mesh-ancestor
139223241|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139223242|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223243|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139223244|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
139223245|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
139223246|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
139223247|NCT02410720|Cathartics|cathartics|mesh-ancestor
139223248|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139223249|NCT02416570|Clarithromycin|clarithromycin|mesh-list
139223250|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139223251|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223252|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139223253|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223254|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223255|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139223256|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139223257|NCT05328336|Paclitaxel|paclitaxel|mesh-list
139223258|NCT05328336|Tislelizumab|tislelizumab|mesh-list
139223259|NCT05328336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139223260|NCT05328336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223261|NCT05328336|Tubulin Modulators|tubulin modulators|mesh-ancestor
139223262|NCT05328336|Antimitotic Agents|antimitotic agents|mesh-ancestor
139223263|NCT05328336|Mitosis Modulators|mitosis modulators|mesh-ancestor
139223264|NCT05328336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223265|NCT05328336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139223266|NCT02873754|Bupropion|bupropion|mesh-list
139223267|NCT02873754|Nicotine|nicotine|mesh-list
139223268|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139223269|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
139223270|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223271|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223272|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139223273|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139223274|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
139223275|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223276|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223277|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139223278|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
139223279|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139223280|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139223281|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139223282|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139223284|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139223285|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139223286|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179861|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
139223287|NCT03669614|Gallium citrate|gallium citrate|mesh-list
139223288|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223289|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139223291|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139223292|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223293|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223294|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223295|NCT02416804|Buprenorphine|buprenorphine|mesh-list
139223296|NCT02416804|Tramadol|tramadol|mesh-list
139223297|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139223298|NCT02416804|Narcotics|narcotics|mesh-ancestor
139223299|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223300|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223301|NCT02416804|Analgesics|analgesics|mesh-ancestor
139223302|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
139223303|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223304|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139223305|NCT04792320|Charcoal|charcoal|mesh-list
139223306|NCT04792320|Antidotes|antidotes|mesh-ancestor
139223307|NCT04792320|Protective Agents|protective agents|mesh-ancestor
139223308|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223309|NCT03176758|Anesthetics|anesthetics|mesh-list
139223310|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
139223311|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223312|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223313|NCT03177070|Methylene Blue|methylene blue|mesh-list
139223314|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223315|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223316|NCT03680612|Cefepime|cefepime|mesh-list
139223317|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
139223318|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139223319|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223320|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139223321|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223322|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223323|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
139223324|NCT02410096|Miotics|miotics|mesh-ancestor
139223325|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
139223326|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223327|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223328|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139223329|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139223330|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
139223331|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139223332|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139223333|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
139223334|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223335|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223336|NCT04046939|Pramipexole|pramipexole|mesh-list
139223337|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
139223338|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223339|NCT04046939|Protective Agents|protective agents|mesh-ancestor
139223340|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223341|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139223342|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139223343|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
139223344|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
139223345|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223346|NCT05188131|Diclofenac|diclofenac|mesh-list
139223347|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139223348|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139223349|NCT05188131|Analgesics|analgesics|mesh-ancestor
139223350|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
139223351|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223352|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223353|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139223354|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139223355|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139223356|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223357|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223358|NCT01360437|Ticagrelor|ticagrelor|mesh-list
139223359|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139179936|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139223360|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139223361|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139223362|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139223363|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139223364|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
139223365|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223366|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223367|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223368|NCT02409862|Oxytocin|oxytocin|mesh-list
139223369|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
139223370|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139223371|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223372|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
139223373|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
139223374|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139223375|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139223376|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223377|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223378|NCT01360671|Urological Agents|urological agents|mesh-ancestor
139223379|NCT02955797|Vaccines|vaccines|mesh-list
139223380|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
139223381|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223382|NCT03680378|Cefepime|cefepime|mesh-list
139223383|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139223384|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223385|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139223386|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
139223387|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139223388|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139223389|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
139223390|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223391|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223392|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
139223393|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139223394|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223395|NCT03010176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139223396|NCT03010176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223397|NCT03176524|Glucagon|glucagon|mesh-list
139223398|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139223399|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139223400|NCT03176524|Hormones|hormones|mesh-ancestor
139223401|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139223402|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223403|NCT03176524|Incretins|incretins|mesh-ancestor
139223404|NCT03676088|Mitogens|mitogens|mesh-list
139223405|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
139223406|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223407|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
139223408|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139223409|NCT02414464|Calcium|calcium|mesh-list
139223410|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139223411|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223412|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139223413|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139223414|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223415|NCT04039503|Tirzepatide|tirzepatide|mesh-list
139223416|NCT04039503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139223417|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223418|NCT04039503|Incretins|incretins|mesh-ancestor
139223419|NCT04039503|Hormones|hormones|mesh-ancestor
139223420|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139223421|NCT05418114|Magnesium Sulfate|magnesium sulfate|mesh-list
139223422|NCT05418114|Analgesics|analgesics|mesh-ancestor
139093501|NCT03238924|Oxytocin|oxytocin|mesh-list
139223423|NCT05418114|Sensory System Agents|sensory system agents|mesh-ancestor
139223424|NCT05418114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223425|NCT05418114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223426|NCT05418114|Anesthetics|anesthetics|mesh-ancestor
139223427|NCT05418114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298518|NCT05964686|Edetic Acid|edetic acid|mesh-list
139223428|NCT05418114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139223429|NCT05418114|Anticonvulsants|anticonvulsants|mesh-ancestor
139223430|NCT05418114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139223431|NCT05418114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139223432|NCT05418114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223433|NCT05418114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139223434|NCT05418114|Tocolytic Agents|tocolytic agents|mesh-ancestor
139223435|NCT05418114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139223437|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139223438|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223439|NCT03672812|Incretins|incretins|mesh-ancestor
139223440|NCT03672812|Hormones|hormones|mesh-ancestor
139223441|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139223442|NCT05417880|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139223443|NCT05417880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223444|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
139223445|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139223446|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223447|NCT05007652|Plerixafor|plerixafor|mesh-list
139223448|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139223449|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139223450|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
139223451|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223452|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
139223453|NCT03632772|Mirabegron|mirabegron|mesh-list
139223454|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139223455|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139223456|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
139223457|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223458|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223459|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223460|NCT03632772|Urological Agents|urological agents|mesh-ancestor
139223461|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139223462|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139223463|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139223464|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
139223465|NCT01360749|Lidocaine|lidocaine|mesh-list
139223466|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
139223467|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
139223468|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223469|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223470|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
139223471|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223472|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139223473|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139223474|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139223475|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139223476|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223477|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
139223478|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139223479|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139223480|NCT03675854|Cefazolin|cefazolin|mesh-list
139223481|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139223482|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223483|NCT01360827|Cisplatin|cisplatin|mesh-list
139223484|NCT01360827|Fluorouracil|fluorouracil|mesh-list
139223485|NCT01360827|Cetuximab|cetuximab|mesh-list
139223486|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223487|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
139223488|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223489|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139223490|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139223491|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
139223492|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223493|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139223494|NCT03171610|Fentanyl|fentanyl|mesh-list
139223495|NCT03171610|Sufentanil|sufentanil|mesh-list
139642155|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
139223496|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139223497|NCT03171610|Narcotics|narcotics|mesh-ancestor
139223498|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223499|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223500|NCT03171610|Analgesics|analgesics|mesh-ancestor
139223501|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
139223502|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223503|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139223504|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139223505|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
139180087|NCT01113671|Protective Agents|protective agents|mesh-ancestor
139223506|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
139223507|NCT01364181|Udenafil|udenafil|mesh-list
139223508|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139223509|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139223510|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223511|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223512|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
139223513|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139223514|NCT03679442|Antidotes|antidotes|mesh-list
139223515|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223516|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
139223517|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223518|NCT03679442|Expectorants|expectorants|mesh-ancestor
139223519|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
139223520|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139223521|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
139223522|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223523|NCT03679442|Protective Agents|protective agents|mesh-ancestor
139223524|NCT01367535|Naltrexone|naltrexone|mesh-list
139223525|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
139223526|NCT01367535|Paroxetine|paroxetine|mesh-list
139223527|NCT01367535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139223528|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139223529|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139223530|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223531|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223532|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
139223533|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223534|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139223535|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
139223536|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139223537|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139223538|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139223539|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223540|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139223541|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
139223542|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223543|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139223544|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
139223545|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
139223546|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139223547|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139223548|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223549|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223550|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223551|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139223552|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
139223553|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139223554|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223555|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
139223556|NCT04482712|Sirolimus|sirolimus|mesh-list
139223557|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139223558|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223559|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139223560|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223561|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
139223562|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139223563|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
139223564|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223565|NCT02409004|Rifampin|rifampin|mesh-list
139223566|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139223567|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
139223568|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139223569|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223570|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
139223571|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139223572|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223573|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223574|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139223575|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139223576|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139223577|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139223578|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139223579|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139223580|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
139223581|NCT03131895|Lansoprazole|lansoprazole|mesh-list
139223582|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139223583|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139223584|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139223585|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223586|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223587|NCT04039919|Padsevonil|padsevonil|mesh-list
139223588|NCT04039919|Anticonvulsants|anticonvulsants|mesh-ancestor
139223589|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
139223590|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139223591|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223592|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
139223593|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223594|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
139223595|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139223596|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223597|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139223598|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223599|NCT01364415|Pasireotide|pasireotide|mesh-list
139223600|NCT01364415|Hormones|hormones|mesh-ancestor
139223601|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139223602|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223603|NCT03176446|Anesthetics|anesthetics|mesh-list
139223604|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
139223605|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223606|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223607|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
139223608|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223609|NCT03176212|Milk fat globule|milk fat globule|mesh-list
139223610|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223611|NCT04035473|Paclitaxel|paclitaxel|mesh-list
139223612|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139223613|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223614|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
139223615|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
139223616|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
139223617|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223618|NCT02408926|Vaccines|vaccines|mesh-list
139223619|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
139223620|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223621|NCT00704158|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
139223622|NCT00704158|Immunoconjugates|immunoconjugates|mesh-ancestor
139223623|NCT00704158|Immunologic Factors|immunologic factors|mesh-ancestor
139223624|NCT00704158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223625|NCT00704158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139223626|NCT00704158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223627|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
139223628|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139223629|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139223630|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223631|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
139223632|NCT03738527|Coagulants|coagulants|mesh-ancestor
139223633|NCT02915978|Fentanyl|fentanyl|mesh-list
139223634|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139223635|NCT02915978|Narcotics|narcotics|mesh-ancestor
139223636|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223637|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223638|NCT02915978|Analgesics|analgesics|mesh-ancestor
139223639|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
139223640|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223641|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139223642|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139223643|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
139223644|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
139223645|NCT02412904|Menotropins|menotropins|mesh-list
139093735|NCT05064020|Tenofovir|tenofovir|mesh-list
139223646|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139180232|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
139223647|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
139223648|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139223649|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223650|NCT02408302|Midazolam|midazolam|mesh-list
139223651|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139223652|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139223653|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223654|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223655|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139223656|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139223657|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139223659|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
139223660|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
139223661|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
139223662|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
139223663|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223664|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223665|NCT02408146|Celecoxib|celecoxib|mesh-list
139223666|NCT02408146|Parecoxib|parecoxib|mesh-list
139223667|NCT02408146|Fentanyl|fentanyl|mesh-list
139223668|NCT02408146|Ondansetron|ondansetron|mesh-list
139223669|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139223670|NCT02408146|Narcotics|narcotics|mesh-ancestor
139223671|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223672|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223673|NCT02408146|Analgesics|analgesics|mesh-ancestor
139223674|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
139223675|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223676|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139223677|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139223678|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
139223679|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
139223680|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298563|NCT05926258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223681|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139223682|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139223683|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139223684|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139223685|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139223686|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139223687|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223688|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
139223689|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
139223690|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139223691|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
139223692|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
139223693|NCT02408146|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139223694|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139223695|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
139223696|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223697|NCT03175666|Leucovorin|leucovorin|mesh-list
139223698|NCT03175666|Paclitaxel|paclitaxel|mesh-list
139223699|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
139223700|NCT03175666|Bevacizumab|bevacizumab|mesh-list
139223701|NCT03175666|Capecitabine|capecitabine|mesh-list
139223702|NCT03175666|Fluorouracil|fluorouracil|mesh-list
139223703|NCT03175666|Avelumab|avelumab|mesh-list
139223704|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139223705|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223706|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
139223707|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
139223708|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
139223709|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223710|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139223711|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
139223712|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223713|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139223714|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139223715|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
139223716|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139223717|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139223718|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139223719|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139223720|NCT03175666|Growth Substances|growth substances|mesh-ancestor
139223721|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
139642156|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223722|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139223723|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
139223724|NCT03175666|Antidotes|antidotes|mesh-ancestor
139223725|NCT03175666|Protective Agents|protective agents|mesh-ancestor
139223726|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
139223727|NCT03175666|Vitamins|vitamins|mesh-ancestor
139223728|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
139223729|NCT03101358|Paclitaxel|paclitaxel|mesh-list
139223730|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139223731|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139223732|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223733|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
139223734|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
139223735|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
139223736|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223737|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
139223738|NCT03171220|Fludarabine|fludarabine|mesh-list
139223739|NCT03171220|Interleukin-2|interleukin-2|mesh-list
139223740|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139223741|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
139223742|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223743|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139223744|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139223745|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
139223746|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223747|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223748|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139223749|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139223750|NCT03171220|Analgesics|analgesics|mesh-ancestor
139223751|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
139223752|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223753|NCT03116542|Alovudine|alovudine|mesh-list
139223754|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
139223755|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223756|NCT03170596|Tazarotene|tazarotene|mesh-list
139223757|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
139223758|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
139223759|NCT03173326|Anesthetics|anesthetics|mesh-list
139223760|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223761|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223762|NCT03172858|Oxytocin|oxytocin|mesh-list
139223763|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
139223764|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139223765|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223766|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
139223767|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139223768|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139223769|NCT02403856|Prednisolone|prednisolone|mesh-list
139223770|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
139223771|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139223772|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
139223773|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139223774|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
139223775|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
139223776|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223777|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223778|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139223779|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
139223780|NCT02403856|Hormones|hormones|mesh-ancestor
139223781|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139223782|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139223783|NCT02403856|Protective Agents|protective agents|mesh-ancestor
139223784|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139223785|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223786|NCT03170284|Bevacizumab|bevacizumab|mesh-list
139223787|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139223788|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223789|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139223790|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139223791|NCT03170284|Growth Substances|growth substances|mesh-ancestor
139223792|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223793|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
139223794|NCT02407912|Cisplatin|cisplatin|mesh-list
139223795|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223796|NCT03170050|Lidocaine|lidocaine|mesh-list
139223797|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
139223798|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
139223799|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223800|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223801|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
139223802|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223803|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139223804|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139223805|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139223806|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139223807|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223808|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139223810|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
139223811|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223812|NCT03169738|Leucovorin|leucovorin|mesh-list
139223813|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
139223814|NCT03169738|Bevacizumab|bevacizumab|mesh-list
139223815|NCT03169738|Capecitabine|capecitabine|mesh-list
139223816|NCT03169738|Fluorouracil|fluorouracil|mesh-list
139223817|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
139223818|NCT03169738|Nivolumab|nivolumab|mesh-list
139223819|NCT03169738|Fulvestrant|fulvestrant|mesh-list
139223820|NCT03169738|Avelumab|avelumab|mesh-list
139223821|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223822|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223823|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139223824|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
139223825|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223826|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139223827|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139223828|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
139223829|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139223830|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139223831|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139223832|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139223833|NCT03169738|Growth Substances|growth substances|mesh-ancestor
139223834|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
139223835|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139223836|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
139223837|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139223838|NCT03169738|Antidotes|antidotes|mesh-ancestor
139223839|NCT03169738|Protective Agents|protective agents|mesh-ancestor
139223840|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
139223841|NCT03169738|Vitamins|vitamins|mesh-ancestor
139223842|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
139223843|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139223844|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139223845|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139223846|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
139223847|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139223848|NCT02407600|Aprepitant|aprepitant|mesh-list
139223849|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
139223850|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
139223851|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
139223852|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223853|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223854|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139223855|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139223856|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223857|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223858|NCT02403544|Capecitabine|capecitabine|mesh-list
139223859|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
139223860|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139223861|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
139223862|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223863|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223864|NCT02411344|Pertuzumab|pertuzumab|mesh-list
139223865|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139223866|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223867|NCT03657095|Beraprost|beraprost|mesh-list
139223868|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139223869|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
139223870|NCT02407366|Carboplatin|carboplatin|mesh-list
139223871|NCT02407366|Pemetrexed|pemetrexed|mesh-list
139223872|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223873|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223874|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223875|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139223876|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139223877|NCT03738137|Lidocaine|lidocaine|mesh-list
139223878|NCT03738137|Midazolam|midazolam|mesh-list
139223879|NCT03738137|Sufentanil|sufentanil|mesh-list
139223880|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
139223881|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
139223882|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223883|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223884|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
139223885|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223886|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139223887|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139223888|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139223889|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139223890|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223891|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139223892|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139223893|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139223894|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139223895|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139223896|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139223897|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
139223898|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
139223899|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
139223900|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223901|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139223902|NCT03738137|Narcotics|narcotics|mesh-ancestor
139223903|NCT03738137|Analgesics|analgesics|mesh-ancestor
139223904|NCT02407210|Olmesartan|olmesartan|mesh-list
139223905|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139223906|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139223907|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139223908|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139223909|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139223910|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223911|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
139223912|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139223913|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139223914|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223915|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
139223916|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
139223917|NCT03175042|Chrysarobin|chrysarobin|mesh-list
139223918|NCT03175042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139223919|NCT03175042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139223920|NCT03175042|Analgesics|analgesics|mesh-ancestor
139223921|NCT03175042|Sensory System Agents|sensory system agents|mesh-ancestor
139223922|NCT03175042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223923|NCT03175042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223924|NCT03175042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139223925|NCT03175042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139223926|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
139223927|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139223928|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223929|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223930|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139223931|NCT03738059|Analgesics|analgesics|mesh-ancestor
139223932|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
139223933|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223934|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139223935|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139223936|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139223937|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
139223938|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223939|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223940|NCT05233462|Bupivacaine|bupivacaine|mesh-list
139223941|NCT05233462|Anesthetics, Local|anesthetics, local|mesh-ancestor
139223942|NCT05233462|Anesthetics|anesthetics|mesh-ancestor
139223943|NCT05233462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139223944|NCT05233462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223945|NCT05233462|Sensory System Agents|sensory system agents|mesh-ancestor
139223946|NCT05233462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223947|NCT02700412|Cannabidiol|cannabidiol|mesh-list
139223948|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
139223949|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
139223950|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139223951|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139223952|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139223953|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139223954|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223955|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
139223956|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139223957|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223958|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139223959|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139223960|NCT02288832|Azithromycin|azithromycin|mesh-list
139223961|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139223962|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139223963|NCT03116308|Opicapone|opicapone|mesh-list
139223964|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139223965|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223966|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223967|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139223968|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139223969|NCT03665441|Leucovorin|leucovorin|mesh-list
139223970|NCT03665441|Paclitaxel|paclitaxel|mesh-list
139223971|NCT03665441|Gemcitabine|gemcitabine|mesh-list
139223972|NCT03665441|Irinotecan|irinotecan|mesh-list
139223973|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139223974|NCT03665441|Asparaginase|asparaginase|mesh-list
139223975|NCT03665441|Eryaspase|eryaspase|mesh-list
139223976|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139223977|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139223978|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
139223979|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
139223980|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
139223981|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223982|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139223983|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
139223984|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139223985|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139223986|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139223987|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139223988|NCT03665441|Antidotes|antidotes|mesh-ancestor
139223989|NCT03665441|Protective Agents|protective agents|mesh-ancestor
139223990|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
139223991|NCT03665441|Vitamins|vitamins|mesh-ancestor
139223992|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
139223993|NCT03169660|Aflibercept|aflibercept|mesh-list
139223994|NCT03169660|Mitogens|mitogens|mesh-list
139223995|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
139223996|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
139223997|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139223998|NCT03169660|Growth Substances|growth substances|mesh-ancestor
139223999|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224000|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139224001|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139224002|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
139224003|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224004|NCT02401828|Dolutegravir|dolutegravir|mesh-list
139224005|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139224006|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139224007|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224008|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224009|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139224010|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139224011|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
139224012|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224013|NCT02401594|Enoxaparin|enoxaparin|mesh-list
139224014|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
139224015|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139224016|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
139224017|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139224018|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
139224019|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224020|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224021|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
139224022|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139224023|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139224024|NCT02406508|Sorafenib|sorafenib|mesh-list
139224025|NCT02406508|Melphalan|melphalan|mesh-list
139224026|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224027|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139224029|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224030|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139224031|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
139224032|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139224033|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139224034|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
139224035|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224036|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139224037|NCT03662789|Hematinics|hematinics|mesh-ancestor
139224038|NCT04481932|Trastuzumab|trastuzumab|mesh-list
139224039|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139224040|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224041|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
139224042|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
139224043|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139224044|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139224045|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224046|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224047|NCT03169582|Urological Agents|urological agents|mesh-ancestor
139224048|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
139224049|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139224050|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139224051|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139224052|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139224053|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224054|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
139224055|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224056|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224057|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139224058|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224059|NCT03169504|Fluticasone|fluticasone|mesh-list
139224060|NCT03169504|Xhance|xhance|mesh-list
139224061|NCT03169504|Bromides|bromides|mesh-list
139224062|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
139224063|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139224064|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139224065|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
139298629|NCT05859269|Glucocorticoids|glucocorticoids|mesh-ancestor
139224066|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224067|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224068|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139224069|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
139224070|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
139224071|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139224072|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
139224073|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139224074|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
139224075|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224076|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224077|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
139224078|NCT03169426|Carvedilol|carvedilol|mesh-list
139224079|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139224080|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139224081|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
139224082|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224083|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224084|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224085|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139224086|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
139224087|NCT03169426|Protective Agents|protective agents|mesh-ancestor
139224088|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139224089|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139224090|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139224091|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
139224092|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139224093|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139224094|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
139224095|NCT03169348|Ledipasvir|ledipasvir|mesh-list
139224096|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139224097|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
139224098|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224099|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
139224100|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139224101|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139224114|NCT03679052|Clonidine|clonidine|mesh-list
139180676|NCT05932303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224115|NCT03679052|Mirtazapine|mirtazapine|mesh-list
139224116|NCT03679052|Analgesics|analgesics|mesh-ancestor
139224117|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
139224118|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224119|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224120|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139224121|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
139224122|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
139224123|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139224124|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139224125|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139224126|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
139224127|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224128|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224129|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
139224130|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139224131|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139224132|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
139224133|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
139298652|NCT05849610|Bortezomib|bortezomib|mesh-list
139224134|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139224135|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139224136|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224137|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139224138|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139224139|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139224140|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139224141|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139224142|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
139224143|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139224144|NCT03540914|Acetazolamide|acetazolamide|mesh-list
139224145|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
139224146|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139224147|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224148|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224149|NCT03540914|Diuretics|diuretics|mesh-ancestor
139224150|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
139224151|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224152|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
139224153|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
139224154|NCT03629249|Growth Substances|growth substances|mesh-ancestor
139224155|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224156|NCT03671174|Aspirin|aspirin|mesh-list
139224157|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
139224158|NCT03671174|Prednisone|prednisone|mesh-list
139224159|NCT03671174|Heparin|heparin|mesh-list
139224160|NCT03671174|Enoxaparin|enoxaparin|mesh-list
139224161|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139224162|NCT03671174|Tinzaparin|tinzaparin|mesh-list
139224163|NCT03671174|Dalteparin|dalteparin|mesh-list
139224164|NCT03671174|Nadroparin|nadroparin|mesh-list
139224165|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139224166|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
139224167|NCT03671174|Hormones|hormones|mesh-ancestor
139224168|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139224169|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224170|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139224171|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224172|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139224173|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139224174|NCT03671174|Analgesics|analgesics|mesh-ancestor
139224175|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
139224176|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224178|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139224179|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139224180|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224181|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139224182|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139224183|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224184|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
139224185|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
139224186|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
139224187|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139224188|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139224189|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180748|NCT05696782|Durvalumab|durvalumab|mesh-list
139224190|NCT03172234|Amantadine|amantadine|mesh-list
139224191|NCT03172234|Gabapentin|gabapentin|mesh-list
139224192|NCT03172234|Analgesics|analgesics|mesh-ancestor
139224193|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
139224194|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224195|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224196|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
139224197|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139224198|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139224199|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224200|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139224201|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139224202|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139224203|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224204|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224205|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
139224206|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139224207|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139224208|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
139224209|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224210|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
139224211|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139224212|NCT03709849|Citric Acid|citric acid|mesh-list
139224213|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
139224214|NCT03709849|Clomiphene|clomiphene|mesh-list
139224215|NCT03709849|Enclomiphene|enclomiphene|mesh-list
139224216|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
139224217|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
139224218|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139224219|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
139224220|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
139224221|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224222|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139224223|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
139224224|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139224225|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224226|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139224227|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
139224228|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139224229|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139224230|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139224231|NCT05343325|Paclitaxel|paclitaxel|mesh-list
139224232|NCT05343325|Cisplatin|cisplatin|mesh-list
139224233|NCT05343325|Tislelizumab|tislelizumab|mesh-list
139224234|NCT05343325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139224235|NCT05343325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139224236|NCT05343325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224237|NCT05343325|Tubulin Modulators|tubulin modulators|mesh-ancestor
139224238|NCT05343325|Antimitotic Agents|antimitotic agents|mesh-ancestor
139224239|NCT05343325|Mitosis Modulators|mitosis modulators|mesh-ancestor
139224240|NCT05343325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224241|NCT05343325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139224242|NCT03349333|Folic Acid|folic acid|mesh-list
139224243|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
139224244|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
139224245|NCT03349333|Vitamins|vitamins|mesh-ancestor
139224246|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
139224247|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224248|NCT03349333|Hematinics|hematinics|mesh-ancestor
139224249|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
139224250|NCT03365791|Spartalizumab|spartalizumab|mesh-list
139224251|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139224252|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094322|NCT01201070|Antithrombins|antithrombins|mesh-list
139224253|NCT03365791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139224254|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224255|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
139224256|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139224257|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
139224258|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
139224259|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224260|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224261|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139224262|NCT03365011|Analgesics|analgesics|mesh-ancestor
139224263|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
139298661|NCT05848765|Prednisone|prednisone|mesh-list
139224264|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224265|NCT03627767|Abrocitinib|abrocitinib|mesh-list
139224266|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139224267|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224268|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224270|NCT03732365|Cefazolin|cefazolin|mesh-list
139224271|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224272|NCT03732287|Anesthetics|anesthetics|mesh-list
139224273|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224274|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224275|NCT02142738|Paclitaxel|paclitaxel|mesh-list
139224276|NCT02142738|Carboplatin|carboplatin|mesh-list
139224277|NCT02142738|Gemcitabine|gemcitabine|mesh-list
139224278|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
139224279|NCT02142738|Pemetrexed|pemetrexed|mesh-list
139224280|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139224281|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224282|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
139224283|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
139224284|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
139224285|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224286|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139224287|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
139224288|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139224289|NCT02142738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139224290|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224291|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139224292|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139224293|NCT03617861|Secretin|secretin|mesh-list
139224294|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139224295|NCT03617861|Hormones|hormones|mesh-ancestor
139224296|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139224297|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224298|NCT03614975|Vaccines|vaccines|mesh-list
139224299|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
139224300|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224301|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
139224302|NCT03613649|Zoliflodacin|zoliflodacin|mesh-list
139224303|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139224304|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224305|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139224306|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139224307|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224308|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224309|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224310|NCT03096288|Evolocumab|evolocumab|mesh-list
139224311|NCT03096288|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139224312|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139224313|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139224314|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
139224315|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224316|NCT03096288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139224317|NCT03096288|Protease Inhibitors|protease inhibitors|mesh-ancestor
139224318|NCT03096288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224319|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139224320|NCT03731897|Lidocaine|lidocaine|mesh-list
139224321|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
139224322|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
139224323|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224324|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224325|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
139224326|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224327|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139642157|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224328|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139224329|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139224330|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139224331|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224332|NCT02072148|Cisplatin|cisplatin|mesh-list
139224333|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224334|NCT05074290|Taxane|taxane|mesh-list
139158687|NCT04847453|Venetoclax|venetoclax|mesh-list
139224335|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224336|NCT03095508|Menthol|menthol|mesh-list
139224337|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
139224338|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
139224339|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139224340|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
139224341|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139224342|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139224343|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
139224344|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224345|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224346|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
139224347|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139224348|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224349|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224350|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139224351|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139224352|NCT03731741|Protective Agents|protective agents|mesh-ancestor
139224353|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224354|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
139224355|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139224356|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
139224357|NCT03736187|Metronidazole|metronidazole|mesh-list
139224358|NCT03736187|Cephalexin|cephalexin|mesh-list
139224359|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224360|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139224361|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139224362|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139224363|NCT03731429|Lidocaine|lidocaine|mesh-list
139224364|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
139224365|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
139224366|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224367|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224368|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
139224369|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224370|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139224371|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139224372|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139224373|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139224374|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224375|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139224376|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
139224377|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
139224378|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224379|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
139224380|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139224381|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139224382|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224383|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
139224384|NCT03653429|Coagulants|coagulants|mesh-ancestor
139224385|NCT03731117|Furosemide|furosemide|mesh-list
139224386|NCT03731117|Diuretics|diuretics|mesh-ancestor
139224387|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
139224388|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224389|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139224390|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139224391|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224392|NCT03735251|Metoprolol|metoprolol|mesh-list
139224393|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139224394|NCT03735251|Diuretics|diuretics|mesh-list
139224395|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
139224396|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224397|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139224398|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139224399|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
139224400|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
139224401|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224402|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139224403|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139224404|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139224405|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
139224406|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224407|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224408|NCT03098550|Nivolumab|nivolumab|mesh-list
139224409|NCT03098550|Daratumumab|daratumumab|mesh-list
139224410|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139224411|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224412|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139224413|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224414|NCT03095118|Daratumumab|daratumumab|mesh-list
139224415|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224416|NCT05386758|Molnupiravir|molnupiravir|mesh-list
139180976|NCT05030155|Azathioprine|azathioprine|mesh-list
139224417|NCT05386758|Antiviral Agents|antiviral agents|mesh-ancestor
139224418|NCT05386758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224419|NCT03169114|Amikacin|amikacin|mesh-list
139224420|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139224421|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224422|NCT03115762|Bevacizumab|bevacizumab|mesh-list
139224423|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139224424|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224425|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139224426|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139224427|NCT03115762|Growth Substances|growth substances|mesh-ancestor
139224428|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224429|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
139224430|NCT03168958|Methadone|methadone|mesh-list
139224431|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139224432|NCT03168958|Narcotics|narcotics|mesh-ancestor
139224433|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224434|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224435|NCT03168958|Analgesics|analgesics|mesh-ancestor
139224436|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
139224437|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224438|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
139224439|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
139224440|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
139224441|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139224442|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224443|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224444|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139224445|NCT03632460|Analgesics|analgesics|mesh-ancestor
139224446|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
139224447|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224448|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139224449|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139224450|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139224451|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
139224452|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224453|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224454|NCT05418660|Pembrolizumab|pembrolizumab|mesh-list
139224455|NCT05418660|Nivolumab|nivolumab|mesh-list
139224456|NCT05418660|Atezolizumab|atezolizumab|mesh-list
139224457|NCT05418660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139224458|NCT05418660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224459|NCT05418660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139224460|NCT05418660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224461|NCT03364309|Ixekizumab|ixekizumab|mesh-list
139224462|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
139224463|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139224464|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139224465|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224466|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
139224467|NCT05166096|Aspirin|aspirin|mesh-list
139224468|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139224469|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139224470|NCT05166096|Analgesics|analgesics|mesh-ancestor
139224471|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
139224472|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224473|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224474|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139094550|NCT03826940|Lovastatin|lovastatin|mesh-list
139224475|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139224476|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139224477|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139224478|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224479|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139224480|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139224481|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224482|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
139224483|NCT03168412|Vaccines|vaccines|mesh-list
139224484|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
139224485|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224486|NCT05110638|Luliconazole|luliconazole|mesh-list
139224487|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
139224488|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224489|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
139224490|NCT03700788|Calcium|calcium|mesh-list
139224491|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139224492|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224493|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139224494|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224495|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
139224496|NCT03334903|Gabapentin|gabapentin|mesh-list
139224497|NCT03334903|Analgesics|analgesics|mesh-ancestor
139224498|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
139224499|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224500|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224501|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
139224502|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139224503|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139224504|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224505|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139224506|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139224507|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139224508|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224509|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224510|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
139224511|NCT03168100|Dexamethasone|dexamethasone|mesh-list
139224512|NCT03168100|Lenalidomide|lenalidomide|mesh-list
139224513|NCT03168100|Bortezomib|bortezomib|mesh-list
139224514|NCT03168100|Elotuzumab|elotuzumab|mesh-list
139224515|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139224516|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
139224517|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
139224518|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224519|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224520|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139224521|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
139224522|NCT03168100|Hormones|hormones|mesh-ancestor
139224523|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139224524|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139224525|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224526|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
139224527|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139224528|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139224529|NCT03168100|Growth Substances|growth substances|mesh-ancestor
139224530|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
139224531|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139224532|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139224533|NCT03709381|Cosyntropin|cosyntropin|mesh-list
139224534|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
139224535|NCT03709381|Hormones|hormones|mesh-ancestor
139224536|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139224537|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224538|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224539|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224540|NCT01353664|Romidepsin|romidepsin|mesh-list
139224541|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139224542|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224543|NCT01353664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139224544|NCT01353664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224545|NCT01353664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224546|NCT02395744|Paclitaxel|paclitaxel|mesh-list
139224547|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139224548|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642158|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
139094622|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
139224549|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
139224550|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
139224551|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
139224552|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224553|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139224554|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139224555|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224556|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
139224557|NCT03168568|Valsartan|valsartan|mesh-list
139224558|NCT03168568|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139224559|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139224560|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139224561|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139224562|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224563|NCT02400112|Vancomycin|vancomycin|mesh-list
139224564|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139224565|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224566|NCT02694328|Olanzapine|olanzapine|mesh-list
139224567|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
139224568|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
139224569|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224570|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224571|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139224572|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139224573|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139224574|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224575|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139224576|NCT02694328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139224577|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139224578|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139224579|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224580|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224581|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
139224582|NCT02395510|Vortioxetine|vortioxetine|mesh-list
139224583|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
139224584|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139224585|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139224586|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139224587|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224588|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224589|NCT02395510|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139224590|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139224591|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139224592|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224593|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224594|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
139224595|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139224596|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139224597|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139224598|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139224599|NCT02399800|Triamcinolone|triamcinolone|mesh-list
139224600|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139224601|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139224602|NCT02399800|Bupivacaine|bupivacaine|mesh-list
139224603|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139224604|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
139224605|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
139224606|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224607|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224608|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
139224609|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224610|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139224611|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
139224612|NCT02399800|Hormones|hormones|mesh-ancestor
139224613|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139224614|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139224615|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
139224616|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224617|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224618|NCT02399566|Pemetrexed|pemetrexed|mesh-list
139642159|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139224619|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139224620|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224621|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224622|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224623|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139224624|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139224625|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139224626|NCT03167164|Leucovorin|leucovorin|mesh-list
139224627|NCT03167164|Paclitaxel|paclitaxel|mesh-list
139224628|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
139224629|NCT03167164|Bevacizumab|bevacizumab|mesh-list
139224630|NCT03167164|Capecitabine|capecitabine|mesh-list
139224631|NCT03167164|Fluorouracil|fluorouracil|mesh-list
139224632|NCT03167164|Avelumab|avelumab|mesh-list
139224633|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139224634|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224635|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
139224636|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
139224637|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
139224638|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224639|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139224640|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
139224641|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224642|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139224643|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139224644|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
139224645|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139224646|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139224647|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139224648|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139224649|NCT03167164|Growth Substances|growth substances|mesh-ancestor
139224650|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
139224651|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139224652|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
139224653|NCT03167164|Antidotes|antidotes|mesh-ancestor
139224654|NCT03167164|Protective Agents|protective agents|mesh-ancestor
139224655|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
139224657|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
139224658|NCT03334747|Lumefantrine|lumefantrine|mesh-list
139224659|NCT03334747|Artemether|artemether|mesh-list
139224660|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139224661|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
139224662|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139224663|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139224664|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224665|NCT02394652|Metformin|metformin|mesh-list
139224666|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
139224667|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139224668|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224669|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139224670|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224671|NCT02394496|Fulvestrant|fulvestrant|mesh-list
139224672|NCT02394496|Lapatinib|lapatinib|mesh-list
139224673|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139224674|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139224675|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224676|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139224677|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139224678|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
139224679|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139224680|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224681|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139224682|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224683|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224684|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139224685|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
139224686|NCT02394418|Propofol|propofol|mesh-list
139224687|NCT02394418|Sevoflurane|sevoflurane|mesh-list
139224688|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139224689|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224690|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224691|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139224692|NCT02394418|Analgesics|analgesics|mesh-ancestor
139224693|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
139224694|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224695|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139224696|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139224697|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139224698|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
139224699|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224700|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224701|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139224702|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
139224703|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
139224704|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139224705|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139224706|NCT02693002|Norethindrone|norethindrone|mesh-list
139224707|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
139224708|NCT02693002|Estradiol|estradiol|mesh-list
139224709|NCT02693002|Estrogens|estrogens|mesh-ancestor
139224710|NCT02693002|Hormones|hormones|mesh-ancestor
139224711|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139224712|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224713|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139224714|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
139224715|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139224716|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139224717|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139224718|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139224719|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139224720|NCT05408923|Chlorhexidine|chlorhexidine|mesh-list
139224721|NCT05408923|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139224722|NCT05408923|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139224723|NCT05408923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224724|NCT05408923|Disinfectants|disinfectants|mesh-ancestor
139224725|NCT05408923|Dermatologic Agents|dermatologic agents|mesh-ancestor
139224726|NCT03707509|Gemcitabine|gemcitabine|mesh-list
139224727|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224728|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139224729|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
139224730|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224731|NCT03710395|Nifedipine|nifedipine|mesh-list
139224732|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139224733|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139224734|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224735|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139224736|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224737|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
139224738|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
139224739|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139224740|NCT03093870|Capecitabine|capecitabine|mesh-list
139224741|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139224742|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
139224743|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224744|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224745|NCT05744908|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
139224746|NCT05744908|Anticoagulants|anticoagulants|mesh-ancestor
139224747|NCT02394106|Ofatumumab|ofatumumab|mesh-list
139224748|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224749|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
139224750|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139224751|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
139224752|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224753|NCT04793646|Expectorants|expectorants|mesh-ancestor
139224754|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
139224755|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139224756|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
139224757|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224758|NCT04793646|Protective Agents|protective agents|mesh-ancestor
139224759|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224760|NCT04793646|Antidotes|antidotes|mesh-ancestor
139224761|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
139224762|NCT02393482|Vitamin D|vitamin d|mesh-list
139224763|NCT02393482|Leuprolide|leuprolide|mesh-list
139224764|NCT02393482|Tibolone|tibolone|mesh-list
139224765|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
139224766|NCT02393482|Hormones|hormones|mesh-list
139224767|NCT02393482|Estradiol|estradiol|mesh-list
139224768|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139224769|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224770|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139224771|NCT02393482|Estrogens|estrogens|mesh-ancestor
139224772|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139224774|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224775|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139224776|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139224777|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
139224778|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139224779|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224780|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
139224781|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
139224782|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139224783|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139224784|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
139224785|NCT02393482|Vitamins|vitamins|mesh-ancestor
139224786|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
139224787|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139224788|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
139224789|NCT03346057|Rocuronium|rocuronium|mesh-list
139224790|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
139224791|NCT03346057|Neostigmine|neostigmine|mesh-list
139224792|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139224793|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139224794|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139224795|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224796|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224797|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139224798|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224799|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224800|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
139224801|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224802|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139224803|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
139224804|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139224805|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139224806|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139224807|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139224808|NCT03166306|Bevacizumab|bevacizumab|mesh-list
139224809|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139224810|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224811|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139224812|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139224813|NCT03166306|Growth Substances|growth substances|mesh-ancestor
139224814|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224815|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
139224816|NCT02398630|Hormones|hormones|mesh-list
139224817|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139224818|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224819|NCT02398552|Sunitinib|sunitinib|mesh-list
139224820|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224821|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139224822|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139224823|NCT02398552|Growth Substances|growth substances|mesh-ancestor
139224824|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224825|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
139224826|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139224827|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224828|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224829|NCT03345979|Aripiprazole|aripiprazole|mesh-list
139224830|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139224831|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
139224832|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
139224833|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139224834|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139224835|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139224836|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224837|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224838|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
139224839|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
139224840|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224841|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224842|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139224843|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139224844|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
139224845|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139224846|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139224847|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139224848|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139224850|NCT02696434|Buprenorphine|buprenorphine|mesh-list
139224851|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139224852|NCT02696434|Narcotics|narcotics|mesh-ancestor
139224853|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224854|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224855|NCT02696434|Analgesics|analgesics|mesh-ancestor
139224856|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
139224857|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224858|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139224859|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139224860|NCT03709147|Metformin|metformin|mesh-list
139224861|NCT03709147|Carboplatin|carboplatin|mesh-list
139224862|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
139224863|NCT03709147|Pemetrexed|pemetrexed|mesh-list
139224864|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224865|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139224866|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224867|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139224868|NCT03709147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139224869|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224870|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224871|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139224872|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139224873|NCT02398474|Ropivacaine|ropivacaine|mesh-list
139224874|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
139224875|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
139224876|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139224877|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224878|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
139224879|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224880|NCT03710317|Misoprostol|misoprostol|mesh-list
139224881|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
139224882|NCT03710317|Carbetocin|carbetocin|mesh-list
139224883|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139224884|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139224885|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224886|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
139224887|NCT03710317|Coagulants|coagulants|mesh-ancestor
139224888|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139224889|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
139224890|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139224891|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224892|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139224893|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139224894|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
139224895|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
139224896|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139224897|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139224898|NCT02392780|Prednisolone|prednisolone|mesh-list
139224899|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
139224900|NCT02392780|Cannabidiol|cannabidiol|mesh-list
139224901|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139224902|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
139224903|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139224904|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139224905|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
139224906|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
139224907|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224908|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224909|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139224910|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
139224911|NCT02392780|Hormones|hormones|mesh-ancestor
139224912|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139224913|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139224914|NCT02392780|Protective Agents|protective agents|mesh-ancestor
139224915|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139224916|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224917|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
139224918|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224919|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224920|NCT04053478|Phenylephrine|phenylephrine|mesh-list
139224921|NCT04053478|Vasopressins|vasopressins|mesh-list
139224922|NCT04053478|Arginine Vasopressin|arginine vasopressin|mesh-list
139224923|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
139224924|NCT04053478|Norepinephrine|norepinephrine|mesh-list
139224925|NCT04053478|Ephedrine|ephedrine|mesh-list
139224926|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139224927|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
139224928|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
139224929|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224930|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224931|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
139224932|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139224933|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
139224934|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
139224935|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139224936|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139224937|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139224938|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
139224939|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139224940|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224941|NCT04053478|Protective Agents|protective agents|mesh-ancestor
139224942|NCT04053478|Hemostatics|hemostatics|mesh-ancestor
139224943|NCT04053478|Coagulants|coagulants|mesh-ancestor
139224944|NCT04053478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139224945|NCT04053478|Natriuretic Agents|natriuretic agents|mesh-ancestor
139224946|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139224947|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139224948|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139224949|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
139224950|NCT02392702|Ivacaftor|ivacaftor|mesh-list
139224951|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139224952|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139224953|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224954|NCT02392468|BI 409306|bi 409306|mesh-list
139224955|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139224956|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224957|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224958|NCT02397928|Carboplatin|carboplatin|mesh-list
139224959|NCT02397928|Pemetrexed|pemetrexed|mesh-list
139224960|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224961|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139224962|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224963|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139224964|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139224965|NCT03734627|Acetaminophen|acetaminophen|mesh-list
139224966|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
139224967|NCT03734627|Octreotide|octreotide|mesh-list
139224968|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139224969|NCT03734627|Analgesics|analgesics|mesh-ancestor
139224970|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
139224971|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139224972|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224973|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
139224974|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139224975|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139224976|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224977|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224978|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139224979|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139224980|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139224981|NCT02397772|Albendazole|albendazole|mesh-list
139224982|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
139224983|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139224984|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139224985|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
139224986|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139224987|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139224988|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
139224989|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
139224990|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
139224991|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139224992|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139224993|NCT03592277|Vitamins|vitamins|mesh-list
139224994|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
139224995|NCT03592277|Thiamine|thiamine|mesh-list
139224996|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
139224997|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139224998|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
139224999|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225000|NCT03592277|Protective Agents|protective agents|mesh-ancestor
139225001|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
139225002|NCT03106402|Bromfenac|bromfenac|mesh-list
139225003|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139225004|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139225005|NCT03106402|Analgesics|analgesics|mesh-ancestor
139225006|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
139225007|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225008|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225009|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139225010|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139225011|NCT03734159|Ropivacaine|ropivacaine|mesh-list
139225012|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
139225013|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
139225014|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225015|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225016|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
139225017|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225018|NCT02397382|Midazolam|midazolam|mesh-list
139225019|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
139225020|NCT02397382|Caffeine|caffeine|mesh-list
139225021|NCT02397382|Omeprazole|omeprazole|mesh-list
139225022|NCT02397382|Warfarin|warfarin|mesh-list
139225023|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139225024|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139225025|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225026|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225027|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139225028|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139225029|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139225030|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139225031|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
139225032|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
139225033|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
139225034|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
139225035|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225036|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225037|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
139225038|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139225039|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139225040|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225041|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139225042|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139225043|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
139225044|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139225045|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139225046|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139225047|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
139225048|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
139225049|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139225050|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139225051|NCT02697916|Aspirin|aspirin|mesh-list
139225052|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139225053|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139225054|NCT02697916|Analgesics|analgesics|mesh-ancestor
139225055|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
139225056|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225057|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225058|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139225059|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139225060|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139225061|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139225062|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225063|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139225064|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139225065|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225066|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
139225067|NCT04762680|Vaccines|vaccines|mesh-list
139225068|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
139225069|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225070|NCT02392156|Factor VIII|factor viii|mesh-list
139225071|NCT02392156|Coagulants|coagulants|mesh-ancestor
139225072|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
139225073|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139225074|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139225075|NCT03359473|GSK2881078|gsk2881078|mesh-list
139225076|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
139225077|NCT03359473|Hormones|hormones|mesh-ancestor
139225078|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139225079|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225080|NCT03632304|Anesthetics|anesthetics|mesh-list
139225081|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225082|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225083|NCT02397538|Amlodipine|amlodipine|mesh-list
139225084|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139225085|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139225086|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139225087|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139225088|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225089|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139225090|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225091|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
139225092|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139225093|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139225094|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
139225095|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139225096|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139225097|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225098|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139225099|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139225100|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225102|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139225103|NCT03359395|Narcotics|narcotics|mesh-ancestor
139225104|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225105|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225106|NCT03359395|Analgesics|analgesics|mesh-ancestor
139225107|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
139225108|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225109|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139225110|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
139225111|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
139225112|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
139225113|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139225114|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
139225115|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225116|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225117|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139225118|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
139225119|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
139225120|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139225121|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
139225122|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225123|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225124|NCT03093402|Dronabinol|dronabinol|mesh-list
139225125|NCT03093402|Lenabasum|lenabasum|mesh-list
139225126|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139225127|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139225128|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225129|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225130|NCT03093402|Hormones|hormones|mesh-ancestor
139225131|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139225132|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225133|NCT03093402|Hallucinogens|hallucinogens|mesh-ancestor
139225134|NCT03093402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139225135|NCT03093402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139225136|NCT03093402|Analgesics|analgesics|mesh-ancestor
139225137|NCT03093402|Sensory System Agents|sensory system agents|mesh-ancestor
139159563|NCT03007147|Dexamethasone|dexamethasone|mesh-list
139225138|NCT03093402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225139|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
139225140|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225141|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
139225142|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
139225143|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
139225144|NCT03733379|Amoxicillin|amoxicillin|mesh-list
139225145|NCT03733379|Metronidazole|metronidazole|mesh-list
139225146|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139225147|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225148|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139225149|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139225150|NCT05733676|Calcium|calcium|mesh-list
139225151|NCT05733676|Fluorides|fluorides|mesh-list
139225152|NCT05733676|Caseins|caseins|mesh-list
139225153|NCT05733676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139225154|NCT05733676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225155|NCT05733676|Cariostatic Agents|cariostatic agents|mesh-ancestor
139225156|NCT05733676|Protective Agents|protective agents|mesh-ancestor
139225157|NCT05733676|Chelating Agents|chelating agents|mesh-ancestor
139225158|NCT05733676|Sequestering Agents|sequestering agents|mesh-ancestor
139225159|NCT05733676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225160|NCT03343639|Serlopitant|serlopitant|mesh-list
139225161|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139225162|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225163|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225164|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225165|NCT04479748|Dexamethasone|dexamethasone|mesh-list
139225166|NCT04479748|Prednisolone|prednisolone|mesh-list
139225167|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139225168|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
139225169|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139225170|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
139225171|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139225172|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
139225173|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139225175|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
139225176|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225177|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225178|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139225179|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
139225180|NCT04479748|Hormones|hormones|mesh-ancestor
139225181|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139225182|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139225183|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225184|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139225185|NCT04479748|Protective Agents|protective agents|mesh-ancestor
139225186|NCT02690974|Valsartan|valsartan|mesh-list
139225187|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139225188|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139225189|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139225190|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139225191|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225192|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139225193|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
139225194|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139225195|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
139225196|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225197|NCT03584009|Venetoclax|venetoclax|mesh-list
139225198|NCT03584009|Fulvestrant|fulvestrant|mesh-list
139225199|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225200|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139225201|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139225202|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139225203|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
139225204|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139225205|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225206|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
139225207|NCT03709927|Fosfomycin|fosfomycin|mesh-list
139225208|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139225209|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225210|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139225211|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139225212|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225213|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225214|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225215|NCT04167462|Deucravacitinib|deucravacitinib|mesh-list
139225216|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
139225217|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139225218|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225219|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225220|NCT04160520|Morphine|morphine|mesh-list
139225221|NCT04160520|Pramipexole|pramipexole|mesh-list
139225222|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139225223|NCT04160520|Narcotics|narcotics|mesh-ancestor
139225224|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225225|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225226|NCT04160520|Analgesics|analgesics|mesh-ancestor
139225227|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
139225228|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225229|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
139225230|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225231|NCT04160520|Protective Agents|protective agents|mesh-ancestor
139225232|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139225233|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139225234|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
139225235|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
139225236|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225237|NCT03583385|Metformin|metformin|mesh-list
139225238|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139225239|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225240|NCT05288335|Methamphetamine|methamphetamine|mesh-list
139225241|NCT05288335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139225242|NCT05288335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225243|NCT05288335|Sympathomimetics|sympathomimetics|mesh-ancestor
139225244|NCT05288335|Autonomic Agents|autonomic agents|mesh-ancestor
139225245|NCT05288335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225246|NCT05288335|Dopamine Agents|dopamine agents|mesh-ancestor
139225247|NCT05288335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225248|NCT05288335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225249|NCT05288335|Adrenergic Agents|adrenergic agents|mesh-ancestor
139225250|NCT05288335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139225251|NCT05288335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139225252|NCT05288335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139225253|NCT05288335|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139225255|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
139225256|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139225257|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
139225258|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225259|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139225260|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139225261|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
139225262|NCT05420922|Lenvatinib|lenvatinib|mesh-list
139225263|NCT05420922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139225264|NCT05420922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225265|NCT05420922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139225266|NCT05420922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225267|NCT05420922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225268|NCT05420922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139225269|NCT03582215|Salicylates|salicylates|mesh-list
139225270|NCT03582215|Avobenzone|avobenzone|mesh-list
139225271|NCT03582215|Homosalate|homosalate|mesh-list
139225272|NCT03582215|Oxybenzone|oxybenzone|mesh-list
139225273|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
139225274|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
139225275|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
139225276|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139225277|NCT03582215|Protective Agents|protective agents|mesh-ancestor
139225278|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225279|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
139225280|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139225281|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139225282|NCT03582215|Analgesics|analgesics|mesh-ancestor
139225283|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
139225284|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225285|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139225286|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139225287|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139225288|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225289|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225290|NCT05175703|Paclitaxel|paclitaxel|mesh-list
139225291|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139225292|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225293|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
139225294|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
139225295|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
139225296|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225297|NCT04102800|Benralizumab|benralizumab|mesh-list
139225298|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139225299|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
139225300|NCT03323346|Disulfiram|disulfiram|mesh-list
139225301|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139225302|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139225303|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225304|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225305|NCT05628571|Fluorides|fluorides|mesh-list
139225306|NCT05628571|Cariostatic Agents|cariostatic agents|mesh-ancestor
139225307|NCT05628571|Protective Agents|protective agents|mesh-ancestor
139225308|NCT05628571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225309|NCT05255016|Riboflavin|riboflavin|mesh-list
139225310|NCT05255016|Lubricant Eye Drops|lubricant eye drops|mesh-list
139225311|NCT05255016|Vitamin B Complex|vitamin b complex|mesh-ancestor
139225312|NCT05255016|Vitamins|vitamins|mesh-ancestor
139225313|NCT05255016|Micronutrients|micronutrients|mesh-ancestor
139225314|NCT05255016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225315|NCT05255016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139225316|NCT05255016|Dermatologic Agents|dermatologic agents|mesh-ancestor
139225317|NCT05255016|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139225318|NCT05255016|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139225319|NCT05178888|Palbociclib|palbociclib|mesh-list
139225320|NCT05178888|Adagrasib|adagrasib|mesh-list
139181878|NCT01212653|Golimumab|golimumab|mesh-list
139225321|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225322|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139225323|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225324|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225325|NCT03342001|Calcitonin|calcitonin|mesh-list
139225326|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
139225327|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139225328|NCT03342001|Katacalcin|katacalcin|mesh-list
139225329|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139225330|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225331|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139225332|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
139225333|NCT03579719|Itraconazole|itraconazole|mesh-list
139225334|NCT03579719|Balovaptan|balovaptan|mesh-list
139225335|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
139225336|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225337|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139225338|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139225339|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225340|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225341|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139225342|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
139225343|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139225344|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225345|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139225346|NCT03579719|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139225347|NCT03579719|Natriuretic Agents|natriuretic agents|mesh-ancestor
139225348|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
139225349|NCT03631602|Clotrimazole|clotrimazole|mesh-list
139225350|NCT03631602|Miconazole|miconazole|mesh-list
139225351|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225352|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139225353|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139225354|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139225355|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225356|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225357|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139225358|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
139225359|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139225360|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225361|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139225362|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139225363|NCT02688088|Midazolam|midazolam|mesh-list
139225364|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
139225365|NCT02688088|Caffeine|caffeine|mesh-list
139225366|NCT02688088|Warfarin|warfarin|mesh-list
139225367|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139225368|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139225369|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225370|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225371|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139225372|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139225373|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139225374|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139225375|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
139225376|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
139225377|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
139225378|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
139225379|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225380|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225381|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
139225382|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139225383|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139225384|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225385|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139225386|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139225387|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
139225388|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
139225389|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
139225390|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139225391|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139225392|NCT03641651|Frovatriptan|frovatriptan|mesh-list
139225393|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139225394|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
139225395|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225396|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225397|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225398|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
139225399|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139225400|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225401|NCT05666219|Aminophylline|aminophylline|mesh-list
139225402|NCT05666219|Theophylline|theophylline|mesh-list
139225403|NCT05666219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139225404|NCT05666219|Autonomic Agents|autonomic agents|mesh-ancestor
139225405|NCT05666219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225406|NCT05666219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225407|NCT05666219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139225408|NCT05666219|Respiratory System Agents|respiratory system agents|mesh-ancestor
139225409|NCT05666219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139225410|NCT05666219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225411|NCT05666219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225412|NCT05666219|Vasodilator Agents|vasodilator agents|mesh-ancestor
139225413|NCT05666219|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139225414|NCT05666219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139225415|NCT05666219|Purinergic Agents|purinergic agents|mesh-ancestor
139225416|NCT05666219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225417|NCT05666219|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139225418|NCT05666219|Protective Agents|protective agents|mesh-ancestor
139225419|NCT02949271|Fentanyl|fentanyl|mesh-list
139225420|NCT02949271|Ropivacaine|ropivacaine|mesh-list
139225421|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
139225422|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
139225423|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225424|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225425|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
139225426|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225427|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139225428|NCT02949271|Narcotics|narcotics|mesh-ancestor
139225429|NCT02949271|Analgesics|analgesics|mesh-ancestor
139225430|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139225431|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139225432|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
139225433|NCT03339583|Zopiclone|zopiclone|mesh-list
139225434|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139225435|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225436|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225437|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
139225438|NCT03639779|Antidotes|antidotes|mesh-ancestor
139225439|NCT03639779|Protective Agents|protective agents|mesh-ancestor
139225440|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225441|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
139225442|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225443|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
139225444|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139225445|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225446|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
139225447|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
139225448|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
139225449|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139225450|NCT05173441|Antibodies|antibodies|mesh-list
139225451|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
139225452|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225453|NCT03708133|Nifurtimox|nifurtimox|mesh-list
139225454|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139225455|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139225456|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139225457|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225458|NCT05075161|Pirfenidone|pirfenidone|mesh-list
139225459|NCT05075161|Analgesics|analgesics|mesh-ancestor
139225460|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
139225461|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225462|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225463|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139225464|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139225465|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139225466|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139225467|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225468|NCT05095831|Pancrelipase|pancrelipase|mesh-list
139182024|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225469|NCT05095831|Pancreatin|pancreatin|mesh-list
139225470|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139225472|NCT03638869|D-methadone|d-methadone|mesh-list
139225473|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139225474|NCT03638869|Narcotics|narcotics|mesh-ancestor
139225475|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225476|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225477|NCT03638869|Analgesics|analgesics|mesh-ancestor
139225478|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
139225479|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225480|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
139225481|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
139225482|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139225483|NCT03091920|Praliciguat|praliciguat|mesh-list
139225484|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139225485|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
139225486|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225487|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139225488|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
139225489|NCT03338569|Vitamins|vitamins|mesh-ancestor
139225490|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
139225491|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225492|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
139225493|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225494|NCT03338569|Protective Agents|protective agents|mesh-ancestor
139225495|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
139225496|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139225497|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225498|NCT03337477|Insulin|insulin|mesh-list
139225499|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139225500|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139225501|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225502|NCT03707899|Amlodipine|amlodipine|mesh-list
139225503|NCT03707899|Telmisartan|telmisartan|mesh-list
139225504|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139225505|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139225506|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139225507|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139225508|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139225509|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225510|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139225511|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225512|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
139225513|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139225514|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139225515|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
139225516|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139225517|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139225518|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225519|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139225520|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139225521|NCT03336619|Nitazoxanide|nitazoxanide|mesh-list
139225522|NCT03336619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139225523|NCT03336619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225524|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139225525|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225526|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225528|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139225529|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139225530|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225531|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
139225532|NCT03706339|Coagulants|coagulants|mesh-ancestor
139225533|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139225534|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
139225535|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139225536|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139225537|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139225538|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225539|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225540|NCT03639558|Promethazine|promethazine|mesh-list
139225541|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
139225542|NCT03639558|Haloperidol|haloperidol|mesh-list
139225543|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
139225544|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
139225545|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
139225546|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
139225547|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225548|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225549|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139225550|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139225551|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139225552|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225553|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139225554|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139225555|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
139225556|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225557|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225558|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139225559|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
139225560|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
139225561|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139225562|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
139225563|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
139225564|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139225565|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139225566|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139225567|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
139225568|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
139225569|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
139225570|NCT01353508|Valsartan|valsartan|mesh-list
139225571|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139225572|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139225573|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139225574|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139225575|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225576|NCT01568268|Palonosetron|palonosetron|mesh-list
139225577|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
139225578|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
139225579|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225580|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225581|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139225582|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139225583|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139225584|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
139225585|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225586|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225587|NCT04911361|Dexamethasone|dexamethasone|mesh-list
139225588|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139225589|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
139225590|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
139225591|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225592|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225593|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139225594|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
139225595|NCT04911361|Hormones|hormones|mesh-ancestor
139225596|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139225597|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139225598|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225599|NCT04475731|Ponatinib|ponatinib|mesh-list
139225600|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225601|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139225602|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225603|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225604|NCT03087786|Nicotine|nicotine|mesh-list
139225605|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139225606|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
139225607|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225608|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225609|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139225610|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139225611|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
139225612|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225613|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225614|NCT03635957|Folic Acid|folic acid|mesh-list
139225615|NCT03635957|Methotrexate|methotrexate|mesh-list
139225616|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139225617|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
139225618|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139225619|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225620|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139225621|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
139225622|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225623|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225624|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
139225625|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225626|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139225627|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139225628|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
139225629|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139225630|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139225631|NCT03635957|Hematinics|hematinics|mesh-ancestor
139225632|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
139225634|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
139225635|NCT05005507|Tenofovir|tenofovir|mesh-list
139225636|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139225637|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
139225638|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225639|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139225640|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139225641|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225642|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225643|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139225644|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139225645|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139225646|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139225647|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225648|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
139225649|NCT05593666|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139225650|NCT05593666|Antifungal Agents|antifungal agents|mesh-ancestor
139225651|NCT05593666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225652|NCT05593666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139225653|NCT05593666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139225654|NCT02684344|Tamsulosin|tamsulosin|mesh-list
139225655|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139225656|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139225657|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139225658|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
139225659|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225660|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225661|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225662|NCT02684344|Urological Agents|urological agents|mesh-ancestor
139225663|NCT03974100|Denosumab|denosumab|mesh-list
139225664|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139225665|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225666|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
139225667|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
139225668|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
139225669|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
139225670|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139225671|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225672|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139225673|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139225674|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139225675|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139225676|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
139225677|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
139225678|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139225679|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139225680|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225681|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225682|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225683|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139225684|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139225685|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139225686|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225687|NCT01374568|Incretins|incretins|mesh-ancestor
139225688|NCT01374568|Hormones|hormones|mesh-ancestor
139225689|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139225690|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139225691|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
139225692|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225693|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225694|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
139225695|NCT01312441|Vitamin D|vitamin d|mesh-list
139225696|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139225697|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225698|NCT01312441|Vitamins|vitamins|mesh-ancestor
139225699|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
139225700|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139225701|NCT02682784|Oxytocin|oxytocin|mesh-list
139225702|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
139225703|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139225704|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225705|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
139225706|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
139225707|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139225708|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
139225709|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225710|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
139225711|NCT03705949|Protective Agents|protective agents|mesh-ancestor
139225712|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139225713|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139225714|NCT03162562|Oregovomab|oregovomab|mesh-list
139225715|NCT03162562|Poly ICLC|poly iclc|mesh-list
139225716|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
139225717|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
139225718|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225719|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139225720|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225721|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
139225722|NCT03164590|Ketamine|ketamine|mesh-list
139225723|NCT03164590|Bupivacaine|bupivacaine|mesh-list
139225724|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
139225725|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
139225726|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225727|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225728|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
139225729|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225730|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139225731|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139225732|NCT03164590|Analgesics|analgesics|mesh-ancestor
139225733|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139225734|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139225735|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139225736|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
139225737|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225738|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225739|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139225740|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139225741|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
139225742|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139225743|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139225744|NCT05119075|Dopamine|dopamine|mesh-list
139225745|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
139225746|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139225747|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
139225748|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
139225749|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225750|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225751|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
139225752|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225753|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225754|NCT05119075|Protective Agents|protective agents|mesh-ancestor
139225756|NCT03387852|Xhance|xhance|mesh-list
139225757|NCT03387852|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139225758|NCT03387852|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139225759|NCT03387852|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139225760|NCT03387852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139225761|NCT03387852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139225762|NCT03387852|Autonomic Agents|autonomic agents|mesh-ancestor
139225763|NCT03387852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225764|NCT03387852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225765|NCT03387852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139225766|NCT03387852|Respiratory System Agents|respiratory system agents|mesh-ancestor
139225767|NCT03387852|Dermatologic Agents|dermatologic agents|mesh-ancestor
139225768|NCT03387852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139225769|NCT03387852|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139225770|NCT03387852|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139182323|NCT03408639|Vitamins|vitamins|mesh-ancestor
139225771|NCT03387852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139225772|NCT03387852|Adrenergic Agents|adrenergic agents|mesh-ancestor
139225773|NCT03387852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225774|NCT03387852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225775|NCT03387852|Immunologic Factors|immunologic factors|mesh-ancestor
139225776|NCT03387852|Glucocorticoids|glucocorticoids|mesh-ancestor
139225777|NCT03387852|Hormones|hormones|mesh-ancestor
139225778|NCT03387852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139225779|NCT03387852|Sympathomimetics|sympathomimetics|mesh-ancestor
139225780|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
139225781|NCT02679274|Testosterone|testosterone|mesh-list
139225782|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
139225783|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
139225784|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139225785|NCT02679274|Androgens|androgens|mesh-ancestor
139225786|NCT02679274|Hormones|hormones|mesh-ancestor
139225787|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139225788|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225789|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139225790|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225791|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
139225792|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139225793|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139225794|NCT03620929|Estradiol|estradiol|mesh-list
139225795|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139225796|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
139225797|NCT03620929|Estrogens|estrogens|mesh-ancestor
139225798|NCT03620929|Hormones|hormones|mesh-ancestor
139225799|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139225800|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225801|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139225802|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
139225803|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139225804|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139225805|NCT03620929|Progestins|progestins|mesh-ancestor
139225806|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
139225807|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139225808|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225809|NCT04969861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139225810|NCT04969861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225811|NCT05308849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139225812|NCT05308849|beta-Lactams|beta-lactams|mesh-list
139225813|NCT05308849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225814|NCT02678416|Acetaminophen|acetaminophen|mesh-list
139225815|NCT02678416|Morphine|morphine|mesh-list
139225816|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139225817|NCT02678416|Narcotics|narcotics|mesh-ancestor
139225818|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139225819|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225820|NCT02678416|Analgesics|analgesics|mesh-ancestor
139225821|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
139225822|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225823|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139225824|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
139225825|NCT03164668|Menthol|menthol|mesh-list
139225826|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
139225827|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
139225829|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
139225830|NCT02680756|Ferric maltol|ferric maltol|mesh-list
139225831|NCT02680756|Hematinics|hematinics|mesh-ancestor
139225832|NCT03631836|Bevacizumab|bevacizumab|mesh-list
139225833|NCT03631836|Antibodies|antibodies|mesh-list
139225834|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139225835|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139225836|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225837|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139225838|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139225839|NCT03631836|Growth Substances|growth substances|mesh-ancestor
139225840|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225841|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
139225842|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
139225843|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139225844|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139225845|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
139182396|NCT01217099|Azithromycin|azithromycin|mesh-list
139225846|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139225847|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
139225848|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225849|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225850|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139225851|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
139225852|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139225853|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139225854|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139225855|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
139225856|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225857|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225859|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
139225860|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225861|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225862|NCT03114280|Carboplatin|carboplatin|mesh-list
139225863|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225864|NCT01312363|Rivastigmine|rivastigmine|mesh-list
139225865|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139225866|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225867|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225868|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
139225869|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225870|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225871|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139225872|NCT01312363|Protective Agents|protective agents|mesh-ancestor
139225873|NCT03161678|Clopidogrel|clopidogrel|mesh-list
139225874|NCT03161678|Ticagrelor|ticagrelor|mesh-list
139225875|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139225876|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139225877|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139225878|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139225879|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
139225880|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225881|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225882|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225883|NCT03674606|Aspirin|aspirin|mesh-list
139225884|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139225885|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139225886|NCT03674606|Analgesics|analgesics|mesh-ancestor
139225887|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
139225888|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225889|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225890|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139225891|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139225892|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139225893|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139225894|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225895|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139225896|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139225897|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225898|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
139225899|NCT02677324|Venetoclax|venetoclax|mesh-list
139225900|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225901|NCT03163966|Methotrexate|methotrexate|mesh-list
139095965|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
139225902|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139225903|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
139225904|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139225905|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225906|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139225907|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
139225908|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225909|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225910|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
139225911|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225912|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139225913|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139225914|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
139225915|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139225916|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139225917|NCT03678116|Caffeine|caffeine|mesh-list
139225918|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139225919|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225920|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139182472|NCT03933761|Pamiparib|pamiparib|mesh-list
139225921|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225922|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225923|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139225924|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139225925|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
139225926|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139225927|NCT03678038|Triamcinolone|triamcinolone|mesh-list
139225928|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139225929|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139225930|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139225931|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139225932|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
139225934|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139225935|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225936|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139225937|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
139225938|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225939|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225940|NCT03163420|Diclofenac|diclofenac|mesh-list
139225941|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139225942|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139225943|NCT03163420|Analgesics|analgesics|mesh-ancestor
139225944|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
139225945|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139225946|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225947|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139225948|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139225949|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139225950|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225951|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225952|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
139225953|NCT04440436|Fludarabine|fludarabine|mesh-list
139225954|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139225955|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
139225956|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225957|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139225958|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139225959|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
139225960|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225961|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225962|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139225963|NCT05405686|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139225964|NCT05405686|Hormones|hormones|mesh-ancestor
139225965|NCT05405686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139225966|NCT05405686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225967|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139225968|NCT04711122|Cephalosporins|cephalosporins|mesh-list
139225969|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139225970|NCT05272696|Paclitaxel|paclitaxel|mesh-list
139225971|NCT05272696|Pembrolizumab|pembrolizumab|mesh-list
139225972|NCT05272696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139642160|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096037|NCT01341262|Growth Substances|growth substances|mesh-ancestor
139225973|NCT05272696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225974|NCT05272696|Tubulin Modulators|tubulin modulators|mesh-ancestor
139225975|NCT05272696|Antimitotic Agents|antimitotic agents|mesh-ancestor
139225976|NCT05272696|Mitosis Modulators|mitosis modulators|mesh-ancestor
139225977|NCT05272696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225978|NCT05272696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139225979|NCT05272696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139225980|NCT05563116|Calcium|calcium|mesh-list
139225981|NCT05563116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139225982|NCT05563116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139225983|NCT03520946|Ramucirumab|ramucirumab|mesh-list
139225984|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225985|NCT03674060|Sorafenib|sorafenib|mesh-list
139225986|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139225987|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139225988|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139225989|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225990|NCT03163576|Niacin|niacin|mesh-list
139225991|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139225992|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
139225993|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139225994|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139225995|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
139225996|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
139225997|NCT03163576|Vitamins|vitamins|mesh-ancestor
139225998|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
139225999|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226000|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
139226001|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139226002|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226003|NCT03673280|Morphine|morphine|mesh-list
139226004|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139226005|NCT03673280|Narcotics|narcotics|mesh-ancestor
139226006|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139226007|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226008|NCT03673280|Analgesics|analgesics|mesh-ancestor
139226009|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
139226010|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226011|NCT05420220|Axitinib|axitinib|mesh-list
139226012|NCT05420220|Antibodies|antibodies|mesh-list
139226013|NCT05420220|Immunologic Factors|immunologic factors|mesh-ancestor
139226014|NCT05420220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226015|NCT05420220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226016|NCT05420220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139226017|NCT05420220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226018|NCT05420220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226019|NCT01382004|Azithromycin|azithromycin|mesh-list
139226020|NCT01382004|Penicillins|penicillins|mesh-list
139226021|NCT01382004|Penicillin G|penicillin g|mesh-list
139226022|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139226023|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
139226024|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139226025|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226026|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
139226027|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139226028|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139226029|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226030|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
139226031|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
139226032|NCT01381848|Doripenem|doripenem|mesh-list
139226033|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139226034|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226035|NCT04546620|Prednisolone|prednisolone|mesh-list
139226036|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139226037|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
139226038|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139226039|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
139226040|NCT04546620|Prednisone|prednisone|mesh-list
139226041|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
139226042|NCT04546620|Rituximab|rituximab|mesh-list
139226043|NCT04546620|Doxorubicin|doxorubicin|mesh-list
139226044|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139226045|NCT04546620|Vincristine|vincristine|mesh-list
139226046|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
139226047|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139226048|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
139226049|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139642161|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139226050|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
139226051|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226052|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139226053|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139226054|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
139226055|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226056|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226057|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139226058|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139226059|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139226060|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139226061|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139226062|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226063|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139226064|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
139226065|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
139226066|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
139226067|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139226068|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
139226069|NCT04546620|Hormones|hormones|mesh-ancestor
139226070|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226071|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139226073|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
139226074|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226075|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139226076|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139226077|NCT04546620|Protective Agents|protective agents|mesh-ancestor
139226078|NCT04058210|Ivacaftor|ivacaftor|mesh-list
139226079|NCT04058210|Elexacaftor|elexacaftor|mesh-list
139226080|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139226081|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139226082|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226083|NCT02250300|Ixazomib|ixazomib|mesh-list
139226084|NCT02250300|Glycine|glycine|mesh-list
139226085|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226086|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
139226087|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226088|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226089|NCT02250300|Glycine Agents|glycine agents|mesh-ancestor
139226090|NCT02250300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226091|NCT02250300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226092|NCT03020966|Acetaminophen|acetaminophen|mesh-list
139226093|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139226094|NCT03020966|Analgesics|analgesics|mesh-ancestor
139226095|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
139226096|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226097|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226098|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
139226099|NCT04051268|Vaccines|vaccines|mesh-list
139226100|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
139226101|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226102|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
139226103|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139226104|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139226105|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226106|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
139226107|NCT04595786|Coagulants|coagulants|mesh-ancestor
139226108|NCT02108652|Atezolizumab|atezolizumab|mesh-list
139226109|NCT02108652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139226110|NCT02108652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226111|NCT02108652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139226112|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226113|NCT01381614|Bevacizumab|bevacizumab|mesh-list
139226114|NCT01381614|Sunitinib|sunitinib|mesh-list
139226115|NCT01381614|Sorafenib|sorafenib|mesh-list
139226116|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139226117|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226118|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139226119|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139226120|NCT01381614|Growth Substances|growth substances|mesh-ancestor
139226121|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226122|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
139226123|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139226124|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642162|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139226125|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226126|NCT01381536|Belimumab|belimumab|mesh-list
139226127|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139226128|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
139226129|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226130|NCT03162406|Vitamin D|vitamin d|mesh-list
139226131|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
139226132|NCT03162406|Vitamins|vitamins|mesh-ancestor
139226133|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
139226134|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226135|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139226136|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139226137|NCT02946385|Vaccines|vaccines|mesh-list
139226138|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
139226139|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226140|NCT05676190|Immunomodulating Agents|immunomodulating agents|mesh-list
139226141|NCT05676190|Immunologic Factors|immunologic factors|mesh-ancestor
139226142|NCT05676190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226143|NCT02694718|Capecitabine|capecitabine|mesh-list
139226144|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
139226145|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139226146|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
139226147|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226148|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226149|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139226150|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139226151|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
139226152|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139226153|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
139226154|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139226155|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
139226156|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226157|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226158|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
139226159|NCT05681221|Calcium|calcium|mesh-list
139226160|NCT05681221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139226161|NCT05681221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226162|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
139226163|NCT04303507|Chloroquine|chloroquine|mesh-list
139226164|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
139226165|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139226166|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139226167|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226168|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226169|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226170|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139226171|NCT04303507|Amebicides|amebicides|mesh-ancestor
139226172|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
139226173|NCT03202537|Lansoprazole|lansoprazole|mesh-list
139226174|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139226175|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139226176|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139226177|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226178|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226179|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139226180|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226181|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139226182|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226183|NCT04138615|Morphine|morphine|mesh-list
139226184|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139226185|NCT04138615|Narcotics|narcotics|mesh-ancestor
139226186|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139226187|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226188|NCT04138615|Analgesics|analgesics|mesh-ancestor
139226189|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
139226190|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226191|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
139226192|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139226193|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226194|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
139226195|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139226196|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226197|NCT03018938|Insulin|insulin|mesh-list
139226198|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139226199|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139226200|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226201|NCT04776499|Perphenazine|perphenazine|mesh-list
139226202|NCT04776499|Riociguat|riociguat|mesh-list
139226203|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
139226204|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
139226205|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226206|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139226207|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139226208|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139226209|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226210|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139226211|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139226212|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
139226213|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226214|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
139226215|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
139226216|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
139226217|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226218|NCT03668054|Bevacizumab|bevacizumab|mesh-list
139226219|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139226220|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226221|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139182784|NCT01122953|Phenytoin|phenytoin|mesh-list
139226222|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139226223|NCT03668054|Growth Substances|growth substances|mesh-ancestor
139226224|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226225|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
139226226|NCT04698187|Nivolumab|nivolumab|mesh-list
139226227|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139226228|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226229|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139226230|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226231|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
139226232|NCT03623048|Propolis|propolis|mesh-list
139226233|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139226234|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226235|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
139226236|NCT03016598|Oxytocin|oxytocin|mesh-list
139226237|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
139226238|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139226239|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226240|NCT03017846|Cantharidin|cantharidin|mesh-list
139226241|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226242|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226243|NCT03638401|Morphine|morphine|mesh-list
139226244|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139226245|NCT03638401|Narcotics|narcotics|mesh-ancestor
139226246|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139226247|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226248|NCT03638401|Analgesics|analgesics|mesh-ancestor
139226249|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
139226250|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226251|NCT03666650|Edoxaban|edoxaban|mesh-list
139226252|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139226253|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
139226254|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139226255|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
139226256|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226257|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226258|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
139226259|NCT02942485|Metronidazole|metronidazole|mesh-list
139226260|NCT02942485|Tinidazole|tinidazole|mesh-list
139226261|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226262|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139226263|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139226264|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139226265|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
139226266|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226267|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139226268|NCT03666494|Fentanyl|fentanyl|mesh-list
139226269|NCT03666494|Ketamine|ketamine|mesh-list
139226270|NCT03666494|Propofol|propofol|mesh-list
139226271|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139226272|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139226273|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226274|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139226275|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
139226276|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
139226277|NCT03666494|Analgesics|analgesics|mesh-ancestor
139226278|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
139226279|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226280|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139226281|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139226282|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139226283|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226284|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226285|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139226286|NCT03666494|Narcotics|narcotics|mesh-ancestor
139226287|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139226288|NCT03666884|Cyclosporine|cyclosporine|mesh-list
139226289|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139226290|NCT03666884|Cyclosporins|cyclosporins|mesh-list
139226291|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139226292|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226293|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226294|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139226295|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
139226296|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182848|NCT01220063|Irinotecan|irinotecan|mesh-list
139226297|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
139226298|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226299|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
139226300|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139226301|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139226302|NCT02942407|Warfarin|warfarin|mesh-list
139226303|NCT02942407|Apixaban|apixaban|mesh-list
139226304|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
139226305|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139226306|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
139226307|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139226308|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
139226309|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226310|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226311|NCT02921035|Interferons|interferons|mesh-list
139226312|NCT02921035|Interferon-beta|interferon-beta|mesh-list
139226313|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
139226314|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226315|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
139226316|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226317|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
139226318|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226319|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139226320|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139226321|NCT03667352|Fentanyl|fentanyl|mesh-list
139226322|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139226323|NCT03667352|Narcotics|narcotics|mesh-ancestor
139226324|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139226325|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226326|NCT03667352|Analgesics|analgesics|mesh-ancestor
139226327|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
139226328|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226329|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139226330|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139226331|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
139226332|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
139226333|NCT03320941|Licogliflozin|licogliflozin|mesh-list
139226334|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139226335|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226336|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139226337|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226338|NCT03559699|Mitapivat|mitapivat|mesh-list
139226339|NCT03559699|Enzyme Activators|enzyme activators|mesh-ancestor
139226340|NCT03559699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226341|NCT02573233|Fluticasone|fluticasone|mesh-list
139226342|NCT02573233|Xhance|xhance|mesh-list
139226343|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
139226344|NCT02573233|Budesonide|budesonide|mesh-list
139226345|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
139226346|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139226347|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139226348|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139226349|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
139226350|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226351|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226352|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139226353|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
139226354|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
139226355|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139226356|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
139226357|NCT02573233|Hormones|hormones|mesh-ancestor
139226358|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226359|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139226360|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139226361|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139226362|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
139226363|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226364|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226365|NCT03867487|Empagliflozin|empagliflozin|mesh-list
139226366|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139226367|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226368|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139226369|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226370|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
139226371|NCT01569048|Remifentanil|remifentanil|mesh-list
139226372|NCT01569048|Propofol|propofol|mesh-list
139226373|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139226374|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139226375|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226377|NCT01569048|Analgesics|analgesics|mesh-ancestor
139226378|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
139226379|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226380|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139226381|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139226382|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139226383|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
139226384|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226385|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226386|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139226387|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
139226388|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
139226389|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139226390|NCT01569048|Narcotics|narcotics|mesh-ancestor
139226391|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139226392|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
139226393|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139226394|NCT01380912|Prednisolone|prednisolone|mesh-list
139226395|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
139226396|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139226397|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
139226398|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139226399|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
139226400|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
139226401|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226402|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226403|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139226404|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
139226405|NCT01380912|Hormones|hormones|mesh-ancestor
139226406|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226407|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139226408|NCT01380912|Protective Agents|protective agents|mesh-ancestor
139226409|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139298857|NCT05680545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226410|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226411|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139226412|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139226413|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139226414|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139226415|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226416|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226417|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226418|NCT03315793|Analgesics|analgesics|mesh-ancestor
139226419|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
139226420|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226421|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
139226422|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139226423|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
139226424|NCT01569204|Dexamethasone|dexamethasone|mesh-list
139226425|NCT01569204|Prednisone|prednisone|mesh-list
139226426|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
139226427|NCT01569204|Dacarbazine|dacarbazine|mesh-list
139226428|NCT01569204|Doxorubicin|doxorubicin|mesh-list
139226429|NCT01569204|Etoposide|etoposide|mesh-list
139226430|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139226431|NCT01569204|Procarbazine|procarbazine|mesh-list
139226432|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139226433|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
139226434|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226435|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139226436|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139226437|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
139226438|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226439|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226440|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139226441|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139226442|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
139226443|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
139226444|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226445|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139226446|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
139226447|NCT01569204|Hormones|hormones|mesh-ancestor
139226448|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226449|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139182992|NCT01204801|Doxorubicin|doxorubicin|mesh-list
139226450|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139226451|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139226452|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139226453|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226454|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139226455|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139226456|NCT01569204|Immunotoxins|immunotoxins|mesh-ancestor
139226457|NCT01569204|Immunoconjugates|immunoconjugates|mesh-ancestor
139226459|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139226460|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139226461|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139226462|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139226463|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226464|NCT04439890|Carboplatin|carboplatin|mesh-list
139226465|NCT04439890|Pemetrexed|pemetrexed|mesh-list
139226466|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226467|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226468|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226469|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139226470|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139226471|NCT02324725|Naltrexone|naltrexone|mesh-list
139226472|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139226473|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139226474|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226475|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
139226476|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226477|NCT01380678|Bevacizumab|bevacizumab|mesh-list
139226478|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139226479|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
139226480|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139226481|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139226482|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160925|NCT03875690|Prednisolone|prednisolone|mesh-list
139226483|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139226484|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139226485|NCT01380678|Growth Substances|growth substances|mesh-ancestor
139226486|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226487|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
139226488|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
139226489|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226490|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226491|NCT01380600|Molgramostim|molgramostim|mesh-list
139226492|NCT01380600|Sargramostim|sargramostim|mesh-list
139226493|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
139226494|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226495|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226496|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
139226497|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
139226498|NCT03264118|Coagulants|coagulants|mesh-ancestor
139226499|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
139226500|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226501|NCT02674204|Atorvastatin|atorvastatin|mesh-list
139226502|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139226503|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139096564|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
139226504|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
139226505|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226506|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139226507|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139226508|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226510|NCT05675644|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139226511|NCT05675644|Hormone Antagonists|hormone antagonists|mesh-ancestor
139226512|NCT05675644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226513|NCT05675644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226514|NCT05675644|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139226515|NCT05675644|Diuretics|diuretics|mesh-ancestor
139226516|NCT05675644|Natriuretic Agents|natriuretic agents|mesh-ancestor
139226517|NCT02579044|Everolimus|everolimus|mesh-list
139226518|NCT02579044|Lonafarnib|lonafarnib|mesh-list
139226519|NCT02579044|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139226520|NCT02579044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139226521|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183066|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
139226522|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226524|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
139226525|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226526|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226527|NCT03525379|Resveratrol|resveratrol|mesh-list
139226528|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
139226529|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226530|NCT03525379|Protective Agents|protective agents|mesh-ancestor
139226531|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226532|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226533|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139226534|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139226535|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139226536|NCT03476551|Diuretics|diuretics|mesh-ancestor
139226537|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
139226538|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226539|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139226540|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139226541|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226542|NCT03521934|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139226543|NCT03521934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139226544|NCT03521934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226545|NCT03521934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139226546|NCT03521934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226547|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
139226548|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139226549|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226550|NCT01380522|Metronidazole|metronidazole|mesh-list
139226551|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226552|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139226553|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139226554|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139226555|NCT02913326|Warfarin|warfarin|mesh-list
139226556|NCT02913326|Dabigatran|dabigatran|mesh-list
139226557|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
139226558|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
139226559|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139226560|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
139226561|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226562|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226563|NCT03725891|Aspirin|aspirin|mesh-list
139226564|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139226565|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139226566|NCT03725891|Analgesics|analgesics|mesh-ancestor
139226567|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
139226568|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226569|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226570|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139226571|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139226572|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139226573|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139642163|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226574|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226575|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139226576|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139226577|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226578|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
139226579|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
139226580|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
139226581|NCT03751163|Hydroquinone|hydroquinone|mesh-list
139226582|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139226583|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139226584|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226585|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
139226586|NCT03751163|Coagulants|coagulants|mesh-ancestor
139226587|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139226588|NCT03751163|Protective Agents|protective agents|mesh-ancestor
139226589|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226590|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
139226591|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
139226593|NCT03639545|Empagliflozin|empagliflozin|mesh-list
139226594|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139226595|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226596|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139226597|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226598|NCT03181386|Warfarin|warfarin|mesh-list
139226599|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
139226600|NCT03181386|Dabigatran|dabigatran|mesh-list
139226601|NCT03181386|Apixaban|apixaban|mesh-list
139226602|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
139226603|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139226604|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
139226605|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139226606|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
139226607|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226608|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226609|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
139226610|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139226611|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
139226612|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139226613|NCT03639467|Gemcitabine|gemcitabine|mesh-list
139226614|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226615|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139226616|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
139226617|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226618|NCT01382706|Docetaxel|docetaxel|mesh-list
139226619|NCT01382706|Lapatinib|lapatinib|mesh-list
139226620|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226621|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
139226622|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
139226623|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
139226624|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226625|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139226626|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226627|NCT03665402|Isoniazid|isoniazid|mesh-list
139226628|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
139226629|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139226630|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226631|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139226632|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139226633|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
139226634|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226635|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139226636|NCT01380288|Rivastigmine|rivastigmine|mesh-list
139226637|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139226638|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226639|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226640|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
139226641|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226642|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226643|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139226644|NCT01380288|Protective Agents|protective agents|mesh-ancestor
139226645|NCT03110484|Pemetrexed|pemetrexed|mesh-list
139226646|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139226647|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226648|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226649|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096715|NCT01302236|Diuretics|diuretics|mesh-ancestor
139226650|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139226651|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139226652|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139226653|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
139226654|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139226655|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226656|NCT03110328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139226657|NCT03110328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226658|NCT00002874|Bicalutamide|bicalutamide|mesh-list
139226659|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
139226660|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
139226661|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226662|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226663|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226664|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139226665|NCT03001076|Ezetimibe|ezetimibe|mesh-list
139226666|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139226667|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139226668|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
139226669|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226670|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139226671|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226672|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139226673|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226675|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139226676|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
139226677|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139226678|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226679|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139226680|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139226681|NCT05422716|Baclofen|baclofen|mesh-list
139226682|NCT05422716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139226683|NCT05422716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226684|NCT05422716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139226685|NCT05422716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226686|NCT05422716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139226687|NCT05422716|GABA Agonists|gaba agonists|mesh-ancestor
139226688|NCT05422716|GABA Agents|gaba agents|mesh-ancestor
139226689|NCT05422716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226690|NCT05422716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226691|NCT03728777|Resveratrol|resveratrol|mesh-list
139226692|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
139226693|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226694|NCT03728777|Protective Agents|protective agents|mesh-ancestor
139226695|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226696|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226697|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139226698|NCT05421936|Osimertinib|osimertinib|mesh-list
139226699|NCT05421936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226700|NCT05421936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139226701|NCT05421936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226702|NCT05421936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226703|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139226704|NCT01382472|Simvastatin|simvastatin|mesh-list
139226705|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139226706|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139226707|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
139226708|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226709|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139226710|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139226711|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226712|NCT03725423|Apatinib|apatinib|mesh-list
139226713|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226714|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139226715|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226716|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226717|NCT06171594|Chlorhexidine|chlorhexidine|mesh-list
139226718|NCT06171594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139226719|NCT06171594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226720|NCT06171594|Disinfectants|disinfectants|mesh-ancestor
139226721|NCT06171555|Betamethasone|betamethasone|mesh-list
139642164|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096789|NCT05027594|Dexamethasone|dexamethasone|mesh-list
139226722|NCT06171555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139226723|NCT06171555|Glucocorticoids|glucocorticoids|mesh-ancestor
139226724|NCT06171555|Hormones|hormones|mesh-ancestor
139226725|NCT06171555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226726|NCT06171555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226727|NCT06171555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139226728|NCT06171555|Respiratory System Agents|respiratory system agents|mesh-ancestor
139226729|NCT06171243|Lidocaine|lidocaine|mesh-list
139226730|NCT06171243|Tetracaine|tetracaine|mesh-list
139226731|NCT06171243|Anesthetics, Local|anesthetics, local|mesh-ancestor
139226732|NCT06171243|Anesthetics|anesthetics|mesh-ancestor
139226733|NCT06171243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139226734|NCT06171243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226735|NCT06171243|Sensory System Agents|sensory system agents|mesh-ancestor
139226736|NCT06171243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226737|NCT06171243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139226738|NCT06171243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139226739|NCT06171243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139226740|NCT06171243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139226741|NCT06171243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226742|NCT06171217|Hydroxyurea|hydroxyurea|mesh-list
139183291|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
139226743|NCT06171217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226744|NCT06171217|Antisickling Agents|antisickling agents|mesh-ancestor
139226745|NCT06171217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226746|NCT06171217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226747|NCT06171217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139226748|NCT06171100|Tolvaptan|tolvaptan|mesh-list
139226749|NCT06171100|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139226750|NCT06171100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226751|NCT06171100|Natriuretic Agents|natriuretic agents|mesh-ancestor
139226752|NCT06171100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226753|NCT06171087|Domperidone|domperidone|mesh-list
139226754|NCT06171087|Antiemetics|antiemetics|mesh-ancestor
139226755|NCT06171087|Autonomic Agents|autonomic agents|mesh-ancestor
139226756|NCT06171087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226757|NCT06171087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226758|NCT06171087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139226759|NCT06171087|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139226760|NCT06171087|Dopamine Agents|dopamine agents|mesh-ancestor
139226761|NCT06171087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226762|NCT06171087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226763|NCT06170983|Azithromycin|azithromycin|mesh-list
139226764|NCT06170983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139226765|NCT06170983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226766|NCT06170723|Itraconazole|itraconazole|mesh-list
139226767|NCT06170723|Famotidine|famotidine|mesh-list
139226768|NCT06170723|Antifungal Agents|antifungal agents|mesh-ancestor
139226769|NCT06170723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226770|NCT06170723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139226771|NCT06170723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139226772|NCT06170723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226773|NCT06170723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226774|NCT06170723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139226775|NCT06170723|Hormone Antagonists|hormone antagonists|mesh-ancestor
139226776|NCT06170723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226777|NCT06170723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226778|NCT06170723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139226779|NCT06170723|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139226780|NCT06170723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139226781|NCT06170723|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139226782|NCT06170723|Histamine Antagonists|histamine antagonists|mesh-ancestor
139226783|NCT06170723|Histamine Agents|histamine agents|mesh-ancestor
139226784|NCT06170723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226785|NCT06170710|Antibodies|antibodies|mesh-list
139226786|NCT06170710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139226787|NCT06170710|Immunologic Factors|immunologic factors|mesh-ancestor
139226788|NCT06170710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226789|NCT06170593|Triamcinolone|triamcinolone|mesh-list
139226790|NCT06170593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139226791|NCT06170593|Glucocorticoids|glucocorticoids|mesh-ancestor
139226792|NCT06170593|Hormones|hormones|mesh-ancestor
139642165|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139226793|NCT06170593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226794|NCT06170593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226795|NCT06170359|Anesthetics|anesthetics|mesh-list
139226796|NCT06170359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139226797|NCT06170359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226798|NCT06170125|Tiotropium Bromide|tiotropium bromide|mesh-list
139226799|NCT06170125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139226800|NCT06170125|Autonomic Agents|autonomic agents|mesh-ancestor
139226801|NCT06170125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226802|NCT06170125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226803|NCT06170125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139226804|NCT06170125|Respiratory System Agents|respiratory system agents|mesh-ancestor
139226805|NCT06170125|Parasympatholytics|parasympatholytics|mesh-ancestor
139226806|NCT06170125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139226807|NCT06170125|Cholinergic Agents|cholinergic agents|mesh-ancestor
139226808|NCT06170125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226809|NCT06170125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226810|NCT06170008|Petrolatum|petrolatum|mesh-list
139226811|NCT06170008|Emollients|emollients|mesh-ancestor
139226812|NCT06170008|Dermatologic Agents|dermatologic agents|mesh-ancestor
139226813|NCT06169956|Nivolumab|nivolumab|mesh-list
139226814|NCT06169956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139226815|NCT06169956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226816|NCT06169956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139226817|NCT06169956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226818|NCT06169904|Atezolizumab|atezolizumab|mesh-list
139226819|NCT06169904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226820|NCT06169904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139226821|NCT06169904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226822|NCT06169904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139226823|NCT06169891|Betamethasone|betamethasone|mesh-list
139226824|NCT06169891|Antibodies|antibodies|mesh-list
139226825|NCT06169891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139226826|NCT06169891|Immunologic Factors|immunologic factors|mesh-ancestor
139226827|NCT06169891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226828|NCT06169891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139226829|NCT06169891|Glucocorticoids|glucocorticoids|mesh-ancestor
139226830|NCT06169891|Hormones|hormones|mesh-ancestor
139226831|NCT06169891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226832|NCT06169891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139226833|NCT06169891|Respiratory System Agents|respiratory system agents|mesh-ancestor
139226834|NCT06169813|Nicotine|nicotine|mesh-list
139226835|NCT06169813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139226836|NCT06169813|Autonomic Agents|autonomic agents|mesh-ancestor
139226837|NCT06169813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226838|NCT06169813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226839|NCT06169813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139226840|NCT06169813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139226841|NCT06169813|Cholinergic Agents|cholinergic agents|mesh-ancestor
139226842|NCT06169813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226843|NCT06169813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226844|NCT06168812|Glipizide|glipizide|mesh-list
139226845|NCT06168812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139226846|NCT06168812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226847|NCT06161025|Paclitaxel|paclitaxel|mesh-list
139226848|NCT06161025|Gemcitabine|gemcitabine|mesh-list
139226849|NCT06161025|Doxorubicin|doxorubicin|mesh-list
139226850|NCT06161025|Topotecan|topotecan|mesh-list
139226851|NCT06161025|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139226852|NCT06161025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139226853|NCT06161025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226854|NCT06161025|Tubulin Modulators|tubulin modulators|mesh-ancestor
139226855|NCT06161025|Antimitotic Agents|antimitotic agents|mesh-ancestor
139226856|NCT06161025|Mitosis Modulators|mitosis modulators|mesh-ancestor
139226857|NCT06161025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226858|NCT06161025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139226859|NCT06161025|Antimetabolites|antimetabolites|mesh-ancestor
139226860|NCT06161025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139226861|NCT06161025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139226862|NCT06161025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139226863|NCT06161025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226864|NCT06161025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139226865|NCT06160414|Metformin|metformin|mesh-list
139226866|NCT06160414|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139226867|NCT06160414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139226868|NCT06160414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226869|NCT06160414|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139226870|NCT06160414|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139226871|NCT06160414|Antimetabolites|antimetabolites|mesh-ancestor
139226872|NCT06160414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226873|NCT06160414|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139226874|NCT06160414|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139226875|NCT06160414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226876|NCT06155383|Capecitabine|capecitabine|mesh-list
139226877|NCT06155383|Oxaliplatin|oxaliplatin|mesh-list
139226878|NCT06155383|Disitamab vedotin|disitamab vedotin|mesh-list
139226879|NCT06155383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139226880|NCT06155383|Antimetabolites|antimetabolites|mesh-ancestor
139226881|NCT06155383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226882|NCT06155383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226883|NCT06155383|Immunoconjugates|immunoconjugates|mesh-ancestor
139226884|NCT06155383|Immunologic Factors|immunologic factors|mesh-ancestor
139226885|NCT06155383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226886|NCT06147583|Insulin|insulin|mesh-list
139226887|NCT06147583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139226888|NCT06147583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226889|NCT06123351|Salicylic Acid|salicylic acid|mesh-list
139226890|NCT06123351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226891|NCT06123351|Antifungal Agents|antifungal agents|mesh-ancestor
139226892|NCT06123351|Keratolytic Agents|keratolytic agents|mesh-ancestor
139226893|NCT06123351|Dermatologic Agents|dermatologic agents|mesh-ancestor
139226894|NCT06118333|Gemcitabine|gemcitabine|mesh-list
139226895|NCT06118333|Capecitabine|capecitabine|mesh-list
139226896|NCT06118333|Docetaxel|docetaxel|mesh-list
139226897|NCT06118333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139226898|NCT06118333|Antimetabolites|antimetabolites|mesh-ancestor
139226899|NCT06118333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226900|NCT06118333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226901|NCT06118333|Tubulin Modulators|tubulin modulators|mesh-ancestor
139226902|NCT06118333|Antimitotic Agents|antimitotic agents|mesh-ancestor
139226903|NCT06118333|Mitosis Modulators|mitosis modulators|mesh-ancestor
139226904|NCT06105918|Fluorides|fluorides|mesh-list
139226905|NCT06105918|Cariostatic Agents|cariostatic agents|mesh-ancestor
139226906|NCT06105918|Protective Agents|protective agents|mesh-ancestor
139226907|NCT06105918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226908|NCT06100237|Daratumumab|daratumumab|mesh-list
139226909|NCT06100237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226910|NCT06099769|Mifepristone|mifepristone|mesh-list
139226911|NCT06099769|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139226912|NCT06099769|Abortifacient Agents|abortifacient agents|mesh-ancestor
139226913|NCT06099769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139226914|NCT06099769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226915|NCT06099769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139226916|NCT06099769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139226917|NCT06099769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139226918|NCT06099769|Contraceptive Agents|contraceptive agents|mesh-ancestor
139226919|NCT06099769|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139226920|NCT06099769|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139226921|NCT06099769|Hormone Antagonists|hormone antagonists|mesh-ancestor
139226922|NCT06099769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226923|NCT06099769|Luteolytic Agents|luteolytic agents|mesh-ancestor
139226924|NCT06099769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139226925|NCT06099769|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139226926|NCT06040268|Fluticasone|fluticasone|mesh-list
139226927|NCT06040268|Norflurane|norflurane|mesh-list
139226928|NCT06040268|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139226929|NCT06040268|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139226930|NCT06040268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139226931|NCT06040268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139226932|NCT06040268|Autonomic Agents|autonomic agents|mesh-ancestor
139226933|NCT06040268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139226934|NCT06040268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226935|NCT06040268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139226936|NCT06040268|Respiratory System Agents|respiratory system agents|mesh-ancestor
139226937|NCT06040268|Dermatologic Agents|dermatologic agents|mesh-ancestor
139226938|NCT06040268|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139226939|NCT06040268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139226940|NCT06040268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139226941|NCT06040268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139226942|NCT06040268|Adrenergic Agents|adrenergic agents|mesh-ancestor
139226943|NCT06040268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139226944|NCT06040268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226945|NCT06040268|Glucocorticoids|glucocorticoids|mesh-ancestor
139226946|NCT06040268|Hormones|hormones|mesh-ancestor
139226947|NCT06040268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226948|NCT06040268|Sympathomimetics|sympathomimetics|mesh-ancestor
139226949|NCT06040268|Anesthetics|anesthetics|mesh-ancestor
139226950|NCT06040268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139226951|NCT06018337|Paclitaxel|paclitaxel|mesh-list
139226952|NCT06018337|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139226953|NCT06018337|Capecitabine|capecitabine|mesh-list
139226954|NCT06018337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139226955|NCT06018337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226956|NCT06018337|Tubulin Modulators|tubulin modulators|mesh-ancestor
139226957|NCT06018337|Antimitotic Agents|antimitotic agents|mesh-ancestor
139226958|NCT06018337|Mitosis Modulators|mitosis modulators|mesh-ancestor
139226959|NCT06018337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226960|NCT06018337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139226961|NCT06018337|Antimetabolites|antimetabolites|mesh-ancestor
139226962|NCT05993611|Immunoglobulins|immunoglobulins|mesh-list
139226963|NCT05993611|Immunologic Factors|immunologic factors|mesh-ancestor
139226964|NCT05993611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226965|NCT05968599|Abiraterone Acetate|abiraterone acetate|mesh-list
139226966|NCT05968599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226967|NCT05968599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139226968|NCT05968599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139226969|NCT05968599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226970|NCT05968599|Hormone Antagonists|hormone antagonists|mesh-ancestor
139226971|NCT05968599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139226972|NCT05968599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226973|NCT05968599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139226974|NCT05950113|Deoxyglucose|deoxyglucose|mesh-list
139226975|NCT05950113|Cyclophosphamide|cyclophosphamide|mesh-list
139226976|NCT05950113|Fludarabine|fludarabine|mesh-list
139226977|NCT05950113|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139226978|NCT05950113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139226979|NCT05950113|Immunologic Factors|immunologic factors|mesh-ancestor
139226980|NCT05950113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139226981|NCT05950113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139226982|NCT05950113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139226983|NCT05950113|Alkylating Agents|alkylating agents|mesh-ancestor
139226984|NCT05950113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226985|NCT05950113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226986|NCT05950113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139226987|NCT05950113|Antimetabolites|antimetabolites|mesh-ancestor
139226988|NCT05950113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139226989|NCT05950113|Antiviral Agents|antiviral agents|mesh-ancestor
139226990|NCT05950113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139226991|NCT05860296|Pembrolizumab|pembrolizumab|mesh-list
139226992|NCT05860296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139226993|NCT05860296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139226994|NCT05860296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139226995|NCT05860296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139226996|NCT05859009|Propranolol|propranolol|mesh-list
139226997|NCT05859009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139226998|NCT05859009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139226999|NCT05859009|Adrenergic Agents|adrenergic agents|mesh-ancestor
139227000|NCT05859009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139227001|NCT05859009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227002|NCT05859009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227003|NCT05859009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139227004|NCT05859009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139227005|NCT05859009|Vasodilator Agents|vasodilator agents|mesh-ancestor
139227006|NCT05849129|Ascorbic Acid|ascorbic acid|mesh-list
139227007|NCT05849129|Vitamins|vitamins|mesh-ancestor
139227008|NCT05849129|Micronutrients|micronutrients|mesh-ancestor
139227009|NCT05849129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227010|NCT05849129|Antioxidants|antioxidants|mesh-ancestor
139227011|NCT05849129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227012|NCT05849129|Protective Agents|protective agents|mesh-ancestor
139227013|NCT05846659|Pembrolizumab|pembrolizumab|mesh-list
139227014|NCT05846659|Nivolumab|nivolumab|mesh-list
139227015|NCT05846659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139227016|NCT05846659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227017|NCT05846659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227018|NCT05846659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227019|NCT05807204|Acetylcysteine|acetylcysteine|mesh-list
139227020|NCT05807204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139227021|NCT05807204|Antiviral Agents|antiviral agents|mesh-ancestor
139227022|NCT05807204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227023|NCT05807204|Expectorants|expectorants|mesh-ancestor
139227024|NCT05807204|Respiratory System Agents|respiratory system agents|mesh-ancestor
139227025|NCT05807204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139227026|NCT05807204|Antioxidants|antioxidants|mesh-ancestor
139227027|NCT05807204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227028|NCT05807204|Protective Agents|protective agents|mesh-ancestor
139227029|NCT05807204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227030|NCT05807204|Antidotes|antidotes|mesh-ancestor
139227031|NCT05776927|Fluticasone|fluticasone|mesh-list
139227032|NCT05776927|Xhance|xhance|mesh-list
139227033|NCT05776927|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139227034|NCT05776927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139227035|NCT05776927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139227036|NCT05776927|Autonomic Agents|autonomic agents|mesh-ancestor
139227037|NCT05776927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227038|NCT05776927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227039|NCT05776927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139227040|NCT05776927|Respiratory System Agents|respiratory system agents|mesh-ancestor
139227041|NCT05776927|Dermatologic Agents|dermatologic agents|mesh-ancestor
139227042|NCT05776927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139227043|NCT05776927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139227044|NCT05776927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139227045|NCT05776927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139227046|NCT05776927|Adrenergic Agents|adrenergic agents|mesh-ancestor
139227047|NCT05776927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139227048|NCT05776927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227049|NCT05725512|Prednisolone|prednisolone|mesh-list
139227050|NCT05725512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139227051|NCT05725512|Glucocorticoids|glucocorticoids|mesh-ancestor
139227052|NCT05725512|Hormones|hormones|mesh-ancestor
139227053|NCT05725512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139227054|NCT05725512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227055|NCT05725512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139227056|NCT05725512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227057|NCT05722561|Nicotine|nicotine|mesh-list
139227058|NCT05722561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139227059|NCT05722561|Autonomic Agents|autonomic agents|mesh-ancestor
139227060|NCT05722561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227061|NCT05722561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227062|NCT05722561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139227063|NCT05722561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139227064|NCT05722561|Cholinergic Agents|cholinergic agents|mesh-ancestor
139227065|NCT05722561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139227066|NCT05722561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227067|NCT05714345|Cyclophosphamide|cyclophosphamide|mesh-list
139227068|NCT05714345|Fludarabine|fludarabine|mesh-list
139227069|NCT05714345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139227070|NCT05714345|Immunologic Factors|immunologic factors|mesh-ancestor
139227071|NCT05714345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227072|NCT05714345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139227073|NCT05714345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139227074|NCT05714345|Alkylating Agents|alkylating agents|mesh-ancestor
139227075|NCT05714345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227076|NCT05714345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227077|NCT05714345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139227078|NCT05687071|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139227079|NCT05687071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139227080|NCT05687071|Antimetabolites|antimetabolites|mesh-ancestor
139227081|NCT05687071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227082|NCT05687071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139227083|NCT05687071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227084|NCT05687071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139227085|NCT05687071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227086|NCT05683340|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139227087|NCT05683340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139227088|NCT05683340|Antimetabolites|antimetabolites|mesh-ancestor
139642166|NCT04961268|Narcotics|narcotics|mesh-ancestor
139227089|NCT05683340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227090|NCT05683340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139227091|NCT05683340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227092|NCT05683340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139227093|NCT05683340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227094|NCT05676931|Docetaxel|docetaxel|mesh-list
139227095|NCT05676931|Quemliclustat|quemliclustat|mesh-list
139227096|NCT05676931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227097|NCT05676931|Tubulin Modulators|tubulin modulators|mesh-ancestor
139227098|NCT05676931|Antimitotic Agents|antimitotic agents|mesh-ancestor
139227099|NCT05676931|Mitosis Modulators|mitosis modulators|mesh-ancestor
139227100|NCT05676931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227101|NCT05676931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139227102|NCT05676931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227103|NCT05662943|Aflibercept|aflibercept|mesh-list
139227104|NCT05662943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139227105|NCT05662943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139227106|NCT05662943|Growth Substances|growth substances|mesh-ancestor
139227107|NCT05662943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227108|NCT05662943|Growth Inhibitors|growth inhibitors|mesh-ancestor
139227109|NCT05662943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227110|NCT05659381|Cisplatin|cisplatin|mesh-list
139227111|NCT05659381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227112|NCT05614648|Clonidine|clonidine|mesh-list
139227113|NCT05614648|Analgesics|analgesics|mesh-ancestor
139227114|NCT05614648|Sensory System Agents|sensory system agents|mesh-ancestor
139227115|NCT05614648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183667|NCT04565392|Famotidine|famotidine|mesh-list
139227116|NCT05614648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227117|NCT05614648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139227118|NCT05614648|Sympatholytics|sympatholytics|mesh-ancestor
139227119|NCT05614648|Autonomic Agents|autonomic agents|mesh-ancestor
139227120|NCT05614648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139227121|NCT05614648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139227122|NCT05614648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139227123|NCT05614648|Adrenergic Agents|adrenergic agents|mesh-ancestor
139227124|NCT05614648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139227125|NCT05614648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227126|NCT05613413|Pembrolizumab|pembrolizumab|mesh-list
139227127|NCT05613413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227128|NCT05613413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227129|NCT05613413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139227130|NCT05613413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227131|NCT05598905|Pregabalin|pregabalin|mesh-list
139227132|NCT05598905|Lacosamide|lacosamide|mesh-list
139227133|NCT05598905|Oxycodone|oxycodone|mesh-list
139227134|NCT05598905|Analgesics|analgesics|mesh-ancestor
139227135|NCT05598905|Sensory System Agents|sensory system agents|mesh-ancestor
139227136|NCT05598905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227137|NCT05598905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227138|NCT05598905|Anticonvulsants|anticonvulsants|mesh-ancestor
139227139|NCT05598905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139227140|NCT05598905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139227141|NCT05598905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227142|NCT05598905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139227143|NCT05598905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139227144|NCT05598905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139227145|NCT05598905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139227146|NCT05598905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139227147|NCT05598905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139227148|NCT05598905|Narcotics|narcotics|mesh-ancestor
139227149|NCT05598905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139227150|NCT05598905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139227151|NCT05577364|Prednisone|prednisone|mesh-list
139227152|NCT05577364|Cyclophosphamide|cyclophosphamide|mesh-list
139227153|NCT05577364|Doxorubicin|doxorubicin|mesh-list
139227154|NCT05577364|Vincristine|vincristine|mesh-list
139227155|NCT05577364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139227156|NCT05577364|Immunologic Factors|immunologic factors|mesh-ancestor
139227157|NCT05577364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227158|NCT05577364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139227159|NCT05577364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139227160|NCT05577364|Alkylating Agents|alkylating agents|mesh-ancestor
139227161|NCT05577364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227162|NCT05577364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097242|NCT01312298|Propofol|propofol|mesh-list
139227163|NCT05577364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139227164|NCT05577364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139227165|NCT05577364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139227166|NCT05577364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139227167|NCT05577364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227168|NCT05577364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139227169|NCT05577364|Glucocorticoids|glucocorticoids|mesh-ancestor
139227170|NCT05577364|Hormones|hormones|mesh-ancestor
139227171|NCT05577364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139227172|NCT05577364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139227173|NCT05577364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139227174|NCT05577364|Tubulin Modulators|tubulin modulators|mesh-ancestor
139227175|NCT05577364|Antimitotic Agents|antimitotic agents|mesh-ancestor
139227176|NCT05577364|Mitosis Modulators|mitosis modulators|mesh-ancestor
139227177|NCT05568095|Leucovorin|leucovorin|mesh-list
139227178|NCT05568095|Capecitabine|capecitabine|mesh-list
139227179|NCT05568095|Fluorouracil|fluorouracil|mesh-list
139227180|NCT05568095|Oxaliplatin|oxaliplatin|mesh-list
139227181|NCT05568095|Nivolumab|nivolumab|mesh-list
139227182|NCT05568095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139227183|NCT05568095|Antimetabolites|antimetabolites|mesh-ancestor
139227184|NCT05568095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227185|NCT05568095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227186|NCT05568095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139227187|NCT05568095|Immunologic Factors|immunologic factors|mesh-ancestor
139227188|NCT05568095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227189|NCT05568095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139183748|NCT05160220|Psilocybin|psilocybin|mesh-list
139227190|NCT05568095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139227191|NCT05568095|Antidotes|antidotes|mesh-ancestor
139227192|NCT05568095|Protective Agents|protective agents|mesh-ancestor
139227193|NCT05568095|Vitamin B Complex|vitamin b complex|mesh-ancestor
139227194|NCT05568095|Vitamins|vitamins|mesh-ancestor
139227195|NCT05568095|Micronutrients|micronutrients|mesh-ancestor
139227196|NCT05548426|Linezolid|linezolid|mesh-list
139227197|NCT05548426|Penicillins|penicillins|mesh-list
139227198|NCT05548426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139227199|NCT05548426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227200|NCT05548426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139227201|NCT05548426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227202|NCT05548426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227203|NCT05534529|Rezafungin|rezafungin|mesh-list
139227204|NCT05534529|Antifungal Agents|antifungal agents|mesh-ancestor
139227205|NCT05534529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227206|NCT05514197|Ascorbic Acid|ascorbic acid|mesh-list
139227207|NCT05514197|Antioxidants|antioxidants|mesh-ancestor
139227208|NCT05514197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227209|NCT05514197|Protective Agents|protective agents|mesh-ancestor
139227210|NCT05514197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227211|NCT05514197|Vitamins|vitamins|mesh-ancestor
139227212|NCT05514197|Micronutrients|micronutrients|mesh-ancestor
139227213|NCT05513313|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139227214|NCT05513313|Antiviral Agents|antiviral agents|mesh-ancestor
139227215|NCT05513313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227216|NCT05511909|Lofexidine|lofexidine|mesh-list
139227217|NCT05511909|Buspirone|buspirone|mesh-list
139227218|NCT05511909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139227219|NCT05511909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139227220|NCT05511909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139227221|NCT05511909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227222|NCT05511909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139227223|NCT05511909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139227224|NCT05511909|Serotonin Agents|serotonin agents|mesh-ancestor
139227225|NCT05511909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139227226|NCT05511909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227227|NCT05511909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139227228|NCT05511909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139227229|NCT05511909|Sensory System Agents|sensory system agents|mesh-ancestor
139227230|NCT05511909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227231|NCT05511909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139227232|NCT05511909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139227233|NCT05511909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139227234|NCT05511909|Adrenergic Agents|adrenergic agents|mesh-ancestor
139227235|NCT05496075|Orlistat|orlistat|mesh-list
139227236|NCT05496075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642167|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139227237|NCT05496075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227238|NCT05496075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139227239|NCT05496075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139227240|NCT05493735|Lidocaine|lidocaine|mesh-list
139227241|NCT05493735|Anesthetics, Local|anesthetics, local|mesh-ancestor
139227242|NCT05493735|Anesthetics|anesthetics|mesh-ancestor
139227243|NCT05493735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139227244|NCT05493735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227245|NCT05493735|Sensory System Agents|sensory system agents|mesh-ancestor
139227246|NCT05493735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227247|NCT05493735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139227248|NCT05493735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139227249|NCT05493735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139227250|NCT05493735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139227251|NCT05493735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227252|NCT05474027|Antihypertensive Agents|antihypertensive agents|mesh-list
139227253|NCT05474027|Tranexamic Acid|tranexamic acid|mesh-list
139227254|NCT05474027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139227255|NCT05474027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139227256|NCT05474027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227257|NCT05474027|Hemostatics|hemostatics|mesh-ancestor
139227258|NCT05474027|Coagulants|coagulants|mesh-ancestor
139227259|NCT05443178|Isoniazid|isoniazid|mesh-list
139227260|NCT05443178|Ethambutol|ethambutol|mesh-list
139227261|NCT05443178|Chloroquine|chloroquine|mesh-list
139227262|NCT05443178|Antitubercular Agents|antitubercular agents|mesh-ancestor
139183820|NCT05159674|Analgesics|analgesics|mesh-ancestor
139227263|NCT05443178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139227264|NCT05443178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139298884|NCT05654454|Growth Substances|growth substances|mesh-ancestor
139227265|NCT05443178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227266|NCT05443178|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139227267|NCT05443178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139227268|NCT05443178|Antimetabolites|antimetabolites|mesh-ancestor
139227269|NCT05443178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139227271|NCT05443178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139227272|NCT05443178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139227273|NCT05443178|Antimalarials|antimalarials|mesh-ancestor
139227274|NCT05443178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139227275|NCT05432466|Celiprolol|celiprolol|mesh-list
139227276|NCT05432466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139227277|NCT05432466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139227278|NCT05432466|Sympathomimetics|sympathomimetics|mesh-ancestor
139227279|NCT05432466|Autonomic Agents|autonomic agents|mesh-ancestor
139227280|NCT05432466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227281|NCT05432466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227282|NCT05432466|Vasodilator Agents|vasodilator agents|mesh-ancestor
139227283|NCT05432466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139227284|NCT05432466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139227285|NCT05432466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139227286|NCT05432466|Adrenergic Agents|adrenergic agents|mesh-ancestor
139227287|NCT05432466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139227288|NCT05432466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227289|NCT05405751|Tenofovir|tenofovir|mesh-list
139227290|NCT05405751|Emtricitabine|emtricitabine|mesh-list
139227291|NCT05405751|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139227292|NCT05405751|Antiviral Agents|antiviral agents|mesh-ancestor
139227293|NCT05405751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227294|NCT05405751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139227295|NCT05405751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139227296|NCT05405751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227297|NCT05405751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227298|NCT05405751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139227299|NCT05405751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139227300|NCT05403749|Aflibercept|aflibercept|mesh-list
139227301|NCT05403749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139227302|NCT05403749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139227303|NCT05403749|Growth Substances|growth substances|mesh-ancestor
139227304|NCT05403749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227305|NCT05403749|Growth Inhibitors|growth inhibitors|mesh-ancestor
139227306|NCT05403749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227307|NCT05403580|Olanzapine|olanzapine|mesh-list
139227308|NCT05403580|Antiemetics|antiemetics|mesh-ancestor
139227309|NCT05403580|Autonomic Agents|autonomic agents|mesh-ancestor
139227310|NCT05403580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227311|NCT05403580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227312|NCT05403580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139227313|NCT05403580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139227314|NCT05403580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139227315|NCT05403580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139227316|NCT05403580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139227317|NCT05403580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139227318|NCT05403580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139227319|NCT05403580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139227320|NCT05403580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227321|NCT05403580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139227322|NCT05403580|Serotonin Agents|serotonin agents|mesh-ancestor
139227323|NCT05400122|Cyclophosphamide|cyclophosphamide|mesh-list
139227324|NCT05400122|Fludarabine|fludarabine|mesh-list
139227325|NCT05400122|Fludarabine phosphate|fludarabine phosphate|mesh-list
139227326|NCT05400122|Vactosertib|vactosertib|mesh-list
139227327|NCT05400122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139227328|NCT05400122|Immunologic Factors|immunologic factors|mesh-ancestor
139227329|NCT05400122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227330|NCT05400122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139227331|NCT05400122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139227332|NCT05400122|Alkylating Agents|alkylating agents|mesh-ancestor
139227333|NCT05400122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227334|NCT05400122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227335|NCT05400122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138882333|NCT02643602|Theophylline|theophylline|mesh-list
139227336|NCT05400122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139227337|NCT05400122|Antimetabolites|antimetabolites|mesh-ancestor
139227338|NCT05400122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139227340|NCT05395104|Midazolam|midazolam|mesh-list
139227341|NCT05395104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139227342|NCT05395104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139227343|NCT05395104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139227344|NCT05395104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227345|NCT05395104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139227346|NCT05395104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139227347|NCT05395104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139227348|NCT05395104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139227349|NCT05395104|Anesthetics, General|anesthetics, general|mesh-ancestor
139227350|NCT05395104|Anesthetics|anesthetics|mesh-ancestor
139227351|NCT05395104|GABA Modulators|gaba modulators|mesh-ancestor
139227352|NCT05395104|GABA Agents|gaba agents|mesh-ancestor
139227353|NCT05395104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139227354|NCT05395104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227355|NCT05389462|Gemcitabine|gemcitabine|mesh-list
139227356|NCT05389462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139227357|NCT05389462|Antimetabolites|antimetabolites|mesh-ancestor
139227358|NCT05389462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227359|NCT05389462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227360|NCT05380713|Cyclophosphamide|cyclophosphamide|mesh-list
139227361|NCT05380713|Durvalumab|durvalumab|mesh-list
139227362|NCT05380713|Tremelimumab|tremelimumab|mesh-list
139227363|NCT05380713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139227364|NCT05380713|Immunologic Factors|immunologic factors|mesh-ancestor
139227365|NCT05380713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227366|NCT05380713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139227367|NCT05380713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139227368|NCT05380713|Alkylating Agents|alkylating agents|mesh-ancestor
139227369|NCT05380713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227370|NCT05380713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227371|NCT05380713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139227372|NCT05380713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227373|NCT05380453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139227374|NCT05380453|Immunologic Factors|immunologic factors|mesh-ancestor
139227375|NCT05380453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227376|NCT05351788|Carboplatin|carboplatin|mesh-list
139227377|NCT05351788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227378|NCT05350774|Immunoglobulins|immunoglobulins|mesh-list
139227379|NCT05350774|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139227380|NCT05350774|Antibodies|antibodies|mesh-list
139227381|NCT05350774|gamma-Globulins|gamma-globulins|mesh-list
139227382|NCT05350774|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139227383|NCT05350774|Immunologic Factors|immunologic factors|mesh-ancestor
139227384|NCT05350774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227385|NCT05327491|Sotorasib|sotorasib|mesh-list
139227386|NCT05327491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139227387|NCT05327491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097470|NCT00307060|Diuretics|diuretics|mesh-ancestor
139227388|NCT05327491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227389|NCT05327491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227390|NCT05321199|Tranexamic Acid|tranexamic acid|mesh-list
139227391|NCT05321199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139227392|NCT05321199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139227393|NCT05321199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227394|NCT05321199|Hemostatics|hemostatics|mesh-ancestor
139227395|NCT05321199|Coagulants|coagulants|mesh-ancestor
139227396|NCT05300282|Gemcitabine|gemcitabine|mesh-list
139227397|NCT05300282|Atezolizumab|atezolizumab|mesh-list
139227398|NCT05300282|Vinorelbine|vinorelbine|mesh-list
139227399|NCT05300282|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139227400|NCT05300282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139227401|NCT05300282|Antimetabolites|antimetabolites|mesh-ancestor
139227402|NCT05300282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227403|NCT05300282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227404|NCT05300282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139227405|NCT05300282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227406|NCT05300282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139227407|NCT05300282|Tubulin Modulators|tubulin modulators|mesh-ancestor
139227408|NCT05300282|Antimitotic Agents|antimitotic agents|mesh-ancestor
139227409|NCT05300282|Mitosis Modulators|mitosis modulators|mesh-ancestor
139227410|NCT05300282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139227411|NCT05300282|Alkylating Agents|alkylating agents|mesh-ancestor
139227412|NCT05281276|Celecoxib|celecoxib|mesh-list
139227413|NCT05281276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139227414|NCT05281276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139227415|NCT05281276|Analgesics|analgesics|mesh-ancestor
139227416|NCT05281276|Sensory System Agents|sensory system agents|mesh-ancestor
139227417|NCT05281276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227418|NCT05281276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227419|NCT05281276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139227420|NCT05281276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139227421|NCT05281276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139227422|NCT05281276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139227423|NCT05281276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227424|NCT05281276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227425|NCT05280769|Lobeline|lobeline|mesh-list
139227426|NCT05280769|Nicotine|nicotine|mesh-list
139227427|NCT05280769|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139227428|NCT05280769|Autonomic Agents|autonomic agents|mesh-ancestor
139227429|NCT05280769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227430|NCT05280769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227431|NCT05280769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139227432|NCT05280769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139227433|NCT05280769|Cholinergic Agents|cholinergic agents|mesh-ancestor
139227434|NCT05280769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139227435|NCT05280769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227436|NCT05280769|Respiratory System Agents|respiratory system agents|mesh-ancestor
139227437|NCT05279040|Ivacaftor|ivacaftor|mesh-list
139227438|NCT05279040|Elexacaftor|elexacaftor|mesh-list
139227439|NCT05279040|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139227440|NCT05279040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139227441|NCT05279040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227442|NCT05269628|Dronabinol|dronabinol|mesh-list
139227443|NCT05269628|Cannabidiol|cannabidiol|mesh-list
139227444|NCT05269628|Anticonvulsants|anticonvulsants|mesh-ancestor
139227445|NCT05269628|Hallucinogens|hallucinogens|mesh-ancestor
139227446|NCT05269628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227447|NCT05269628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139227448|NCT05269628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139227449|NCT05269628|Analgesics|analgesics|mesh-ancestor
139227450|NCT05269628|Sensory System Agents|sensory system agents|mesh-ancestor
139227451|NCT05269628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227452|NCT05269628|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139227453|NCT05269628|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139227454|NCT05269628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139227455|NCT05269628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227456|NCT05269628|Hormones|hormones|mesh-ancestor
139227457|NCT05269628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139227458|NCT05261490|Doxorubicin|doxorubicin|mesh-list
139227459|NCT05261490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139227460|NCT05261490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139642168|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139227461|NCT05261490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227462|NCT05261490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139227463|NCT05261490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139227464|NCT05261490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227465|NCT05261490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227466|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
139227467|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139227468|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227469|NCT05183737|Propolis|propolis|mesh-list
139227470|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227471|NCT05183035|Cytarabine|cytarabine|mesh-list
139227472|NCT05183035|Fludarabine|fludarabine|mesh-list
139227473|NCT05183035|Azacitidine|azacitidine|mesh-list
139227474|NCT05183035|Venetoclax|venetoclax|mesh-list
139227475|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
139298898|NCT05653024|Tocolytic Agents|tocolytic agents|mesh-ancestor
139227476|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227477|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139227478|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
139227479|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227480|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139227481|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
139227482|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227483|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
139227484|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227485|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227486|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227487|NCT05183035|Immunotoxins|immunotoxins|mesh-ancestor
139184035|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
139227488|NCT05183035|Immunoconjugates|immunoconjugates|mesh-ancestor
139227489|NCT05180799|Pembrolizumab|pembrolizumab|mesh-list
139227490|NCT05180799|Nivolumab|nivolumab|mesh-list
139227491|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227492|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227493|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139227494|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227495|NCT05176626|Phentermine|phentermine|mesh-list
139227496|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139227497|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227498|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
139227499|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139227500|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
139227501|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
139227502|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227503|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
139227504|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139227505|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227506|NCT05172245|Cisplatin|cisplatin|mesh-list
139227507|NCT05172245|Ipatasertib|ipatasertib|mesh-list
139227508|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227509|NCT05172245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139227510|NCT05172245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227511|NCT05172245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227512|NCT05154487|Fulvestrant|fulvestrant|mesh-list
139227513|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139227514|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227515|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139227516|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139227517|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
139227518|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139227519|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227520|NCT05103332|Amlodipine|amlodipine|mesh-list
139227521|NCT05103332|Olmesartan|olmesartan|mesh-list
139227522|NCT05103332|Indapamide|indapamide|mesh-list
139227523|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139227524|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139227525|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139227526|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227527|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139227528|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227529|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
139227530|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139227531|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139227532|NCT05103332|Diuretics|diuretics|mesh-ancestor
139227533|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
139227534|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139227535|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139227536|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139227537|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139227538|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139227539|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227540|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139227541|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227542|NCT05086393|Analgesics|analgesics|mesh-ancestor
139227543|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
139227544|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227545|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
139227546|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139227547|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
139227548|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
139227549|NCT05068791|Psilocybin|psilocybin|mesh-list
139227550|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
139227551|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227552|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139227553|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
139227554|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
139227555|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139227556|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139227557|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139227558|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227559|NCT04983940|Methyltestosterone|methyltestosterone|mesh-list
139227560|NCT04983940|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139227561|NCT04983940|Testosterone|testosterone|mesh-list
139227562|NCT04983940|Testosterone undecanoate|testosterone undecanoate|mesh-list
139227563|NCT04983940|Testosterone enanthate|testosterone enanthate|mesh-list
139227564|NCT04983940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139227565|NCT04983940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227566|NCT04983940|Anabolic Agents|anabolic agents|mesh-ancestor
139227567|NCT04983940|Hormones|hormones|mesh-ancestor
139227568|NCT04983940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139227569|NCT04983940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227570|NCT04983940|Androgens|androgens|mesh-ancestor
139227571|NCT04979806|Meropenem|meropenem|mesh-list
139227572|NCT04979806|Cefepime|cefepime|mesh-list
139227573|NCT04979806|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
139227574|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139227575|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227576|NCT04958122|Penicillins|penicillins|mesh-list
139227577|NCT04958122|Cefixime|cefixime|mesh-list
139227578|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139227579|NCT04958122|Penicillin G|penicillin g|mesh-list
139227580|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
139227581|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139227582|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227583|NCT04951492|Olaparib|olaparib|mesh-list
139227584|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139227585|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227586|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227587|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227588|NCT04927975|Upadacitinib|upadacitinib|mesh-list
139227589|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139227590|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139227591|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227592|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227593|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139227594|NCT04915846|Tamoxifen|tamoxifen|mesh-list
139227595|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139227596|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
139227597|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139227598|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227599|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139227600|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227601|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139227602|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139227603|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139227604|NCT04900532|Tocotrienols|tocotrienols|mesh-list
139227605|NCT04900532|Vitamin E|vitamin e|mesh-list
139227606|NCT04900532|Tocopherols|tocopherols|mesh-list
139227607|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
139227608|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227609|NCT04900532|Protective Agents|protective agents|mesh-ancestor
139227610|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227611|NCT04900532|Vitamins|vitamins|mesh-ancestor
139227612|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
139227613|NCT04900038|Lamivudine|lamivudine|mesh-list
139227614|NCT04900038|Dolutegravir|dolutegravir|mesh-list
139227615|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139227616|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139227617|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227618|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227619|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
139227620|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227621|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139227622|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139227623|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139227624|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139227625|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
139227626|NCT04880434|Fludarabine|fludarabine|mesh-list
139227627|NCT04880434|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
139227628|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139227629|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
139227630|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227631|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139227632|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139227633|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
139227634|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227635|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227636|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139227637|NCT04880434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227638|NCT04850599|Pomalidomide|pomalidomide|mesh-list
139227639|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139227640|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
139227641|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227642|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139227643|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139227644|NCT04850599|Growth Substances|growth substances|mesh-ancestor
139227645|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
139227646|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227647|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
139227648|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227649|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227650|NCT04824638|Vaccines|vaccines|mesh-list
139227651|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
139227652|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227653|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
139227654|NCT04784052|Rituximab|rituximab|mesh-list
139227655|NCT04784052|Fludarabine|fludarabine|mesh-list
139227656|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
139227657|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139227658|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139227659|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
139227660|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227661|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139227662|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139227663|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
139227664|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227665|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227666|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139227667|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227668|NCT04777201|Faricimab|faricimab|mesh-list
139227669|NCT04777201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139227670|NCT04777201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139227671|NCT04777201|Growth Substances|growth substances|mesh-ancestor
139227672|NCT04777201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227673|NCT04777201|Growth Inhibitors|growth inhibitors|mesh-ancestor
139227674|NCT04777201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227675|NCT04770779|Mitapivat|mitapivat|mesh-list
139227676|NCT04770779|Enzyme Activators|enzyme activators|mesh-ancestor
139227677|NCT04770779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227678|NCT04765202|Carisoprodol|carisoprodol|mesh-list
139227679|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139227680|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227681|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139227682|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227683|NCT04753749|Aspirin|aspirin|mesh-list
139227684|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139227685|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139097773|NCT00090298|Simvastatin|simvastatin|mesh-list
139227686|NCT04753749|Analgesics|analgesics|mesh-ancestor
139227687|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
139227688|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227689|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227690|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139227691|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139227692|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139227693|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139227694|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227695|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139227696|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139227697|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227698|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
139227699|NCT04740918|Trastuzumab|trastuzumab|mesh-list
139227700|NCT04740918|Atezolizumab|atezolizumab|mesh-list
139227701|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139227702|NCT04740918|Maytansine|maytansine|mesh-list
139227703|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227704|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227705|NCT04740918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139227706|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227707|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139227708|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
139227709|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
139227710|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
139227711|NCT04740918|Immunotoxins|immunotoxins|mesh-ancestor
139227712|NCT04740918|Immunoconjugates|immunoconjugates|mesh-ancestor
139227713|NCT04740918|Immunologic Factors|immunologic factors|mesh-ancestor
139227714|NCT04740918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227715|NCT04736173|Paclitaxel|paclitaxel|mesh-list
139227716|NCT04736173|Carboplatin|carboplatin|mesh-list
139227717|NCT04736173|Pembrolizumab|pembrolizumab|mesh-list
139227718|NCT04736173|Pemetrexed|pemetrexed|mesh-list
139227719|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139227720|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227721|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
139227722|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
139227723|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
139227724|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227725|NCT04736173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227726|NCT04736173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139227727|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227728|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139227729|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139227730|NCT04703075|Rifapentine|rifapentine|mesh-list
139227731|NCT04703075|Rifampin|rifampin|mesh-list
139227732|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139227733|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
139227734|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139227735|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227736|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
139227737|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139227738|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227739|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227740|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139227741|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139227742|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139227743|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139227744|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139227745|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139227746|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
139227747|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139227748|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
139227749|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227750|NCT04685590|Dasatinib|dasatinib|mesh-list
139227751|NCT04685590|Quercetin|quercetin|mesh-list
139227752|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227753|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139227754|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227755|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227756|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
139227757|NCT04685590|Protective Agents|protective agents|mesh-ancestor
139227758|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642169|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
139227760|NCT04675710|Trametinib|trametinib|mesh-list
139227761|NCT04675710|Dabrafenib|dabrafenib|mesh-list
139227762|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227763|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227764|NCT04675710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139227765|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227766|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139227767|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227768|NCT04648202|Pembrolizumab|pembrolizumab|mesh-list
139227769|NCT04648202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227770|NCT04648202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227771|NCT04648202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139227772|NCT04648202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227773|NCT04631484|Niacinamide|niacinamide|mesh-list
139227774|NCT04631484|Niacin|niacin|mesh-list
139227775|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
139227776|NCT04631484|Riboflavin|riboflavin|mesh-list
139227777|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
139227778|NCT04631484|Vitamins|vitamins|mesh-ancestor
139227779|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
139227780|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227781|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139227782|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
139227783|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227784|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139227785|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
139227786|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139227787|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
139227788|NCT04608903|Sulforaphane|sulforaphane|mesh-list
139184349|NCT03918551|Febuxostat|febuxostat|mesh-list
139227789|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139227790|NCT04608903|Protective Agents|protective agents|mesh-ancestor
139227791|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227792|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227793|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
139227795|NCT04578535|gamma-Globulins|gamma-globulins|mesh-list
139227796|NCT04578535|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139227797|NCT04578535|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139227798|NCT04578535|Immunoglobulin G|immunoglobulin g|mesh-list
139227799|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
139227800|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227801|NCT04570956|Tamoxifen|tamoxifen|mesh-list
139227802|NCT04570956|Afimoxifene|afimoxifene|mesh-list
139227803|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139227804|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
139227805|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139227806|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227807|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139227808|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227809|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139227810|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139227811|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139227812|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
139227813|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227814|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
139227815|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139227816|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227817|NCT04551521|Trastuzumab|trastuzumab|mesh-list
139227818|NCT04551521|Atezolizumab|atezolizumab|mesh-list
139227819|NCT04551521|Pertuzumab|pertuzumab|mesh-list
139227820|NCT04551521|Vemurafenib|vemurafenib|mesh-list
139227821|NCT04551521|Ipatasertib|ipatasertib|mesh-list
139227822|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139227823|NCT04551521|Inavolisib|inavolisib|mesh-list
139227824|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227825|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227826|NCT04551521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139227827|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227828|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
139227829|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227830|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139227831|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227832|NCT04551521|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139227833|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
139227834|NCT04545762|Fludarabine|fludarabine|mesh-list
139227835|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
139227836|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139227837|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
139227838|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227839|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139227840|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139227841|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
139227842|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227843|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227844|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139227845|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139227846|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
139227847|NCT04522973|Ethanol|ethanol|mesh-list
139227848|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139227849|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227850|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139227851|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227852|NCT04470908|Rifabutin|rifabutin|mesh-list
139227853|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
139227854|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227855|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139227856|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227857|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227858|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139227859|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227860|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139227861|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
139227862|NCT04439292|Trametinib|trametinib|mesh-list
139227863|NCT04439292|Dabrafenib|dabrafenib|mesh-list
139227864|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139227865|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227866|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139227867|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227868|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227869|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139227870|NCT04439292|Protective Agents|protective agents|mesh-ancestor
139227871|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227872|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139227873|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
139227874|NCT04439188|GSK2636771|gsk2636771|mesh-list
139227875|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227876|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139227877|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227878|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227879|NCT04439149|GSK2636771|gsk2636771|mesh-list
139227880|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227881|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139227882|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227883|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227884|NCT04416633|Durvalumab|durvalumab|mesh-list
139227885|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227886|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227887|NCT04413266|Curcumin|curcumin|mesh-list
139227888|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139227889|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139227890|NCT04413266|Analgesics|analgesics|mesh-ancestor
139227891|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
139227892|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227893|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227894|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139227895|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139227896|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227897|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227898|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227899|NCT04374630|Paclitaxel|paclitaxel|mesh-list
139227900|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139227901|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227902|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
139227903|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
139227904|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
139227905|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227906|NCT04337970|Axitinib|axitinib|mesh-list
139227907|NCT04337970|Talazoparib|talazoparib|mesh-list
139227908|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227909|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139227910|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097996|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
139227911|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227912|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139227913|NCT04318080|Tislelizumab|tislelizumab|mesh-list
139227914|NCT04318080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227915|NCT04318080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227916|NCT04254549|Rifaximin|rifaximin|mesh-list
139227917|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139227918|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139227919|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139227920|NCT04227288|Betamethasone|betamethasone|mesh-list
139227921|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
139227922|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139227923|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
139227924|NCT04227288|Calcipotriene|calcipotriene|mesh-list
139227925|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139227926|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139227927|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
139227928|NCT04227288|Hormones|hormones|mesh-ancestor
139227929|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139227930|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227931|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139227932|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
139227933|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
139227934|NCT04182204|Rituximab|rituximab|mesh-list
139227935|NCT04182204|Gemcitabine|gemcitabine|mesh-list
139227936|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
139227937|NCT04182204|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139227938|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139227939|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227940|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
139227941|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227942|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139227943|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139227944|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
139227945|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227946|NCT04182204|Immunoconjugates|immunoconjugates|mesh-ancestor
139227947|NCT04172532|Peposertib|peposertib|mesh-list
139227948|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139227949|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227950|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227951|NCT04152200|Lumasiran|lumasiran|mesh-list
139227952|NCT04152200|Renal Agents|renal agents|mesh-ancestor
139227953|NCT04144023|Molgramostim|molgramostim|mesh-list
139227954|NCT04144023|Vaccines|vaccines|mesh-list
139227955|NCT04144023|Sargramostim|sargramostim|mesh-list
139227956|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
139227957|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227958|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227959|NCT04134091|Tocopherols|tocopherols|mesh-list
139227960|NCT04134091|alpha-Tocopherol|alpha-tocopherol|mesh-list
139227961|NCT04134091|Methyltestosterone|methyltestosterone|mesh-list
139227962|NCT04134091|Testosterone|testosterone|mesh-list
139227963|NCT04134091|Testosterone undecanoate|testosterone undecanoate|mesh-list
139227964|NCT04134091|Testosterone enanthate|testosterone enanthate|mesh-list
139227965|NCT04134091|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139227966|NCT04134091|Androgens|androgens|mesh-ancestor
139227967|NCT04134091|Hormones|hormones|mesh-ancestor
139227968|NCT04134091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139227969|NCT04134091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227970|NCT04134091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139227971|NCT04134091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139227972|NCT04134091|Anabolic Agents|anabolic agents|mesh-ancestor
139227973|NCT04134091|Antioxidants|antioxidants|mesh-ancestor
139227974|NCT04134091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227975|NCT04134091|Protective Agents|protective agents|mesh-ancestor
139227976|NCT04134091|Vitamins|vitamins|mesh-ancestor
139227977|NCT04134091|Micronutrients|micronutrients|mesh-ancestor
139227978|NCT04115644|Triamcinolone|triamcinolone|mesh-list
139227979|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139227980|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139227981|NCT04115644|Ketorolac|ketorolac|mesh-list
139227982|NCT04115644|Bupivacaine|bupivacaine|mesh-list
139227983|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139227984|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
139227985|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
139227986|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642170|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227987|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139227988|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
139227989|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139227990|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139227991|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
139227992|NCT04115644|Hormones|hormones|mesh-ancestor
139227993|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139227994|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139227995|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
139227996|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139227997|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139227998|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139227999|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139228000|NCT04115644|Analgesics|analgesics|mesh-ancestor
139228001|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139228002|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139228003|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139228004|NCT04113382|Laxatives|laxatives|mesh-ancestor
139228005|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139228006|NCT04108026|Durvalumab|durvalumab|mesh-list
139228007|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228008|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228009|NCT04098666|Metformin|metformin|mesh-list
139228010|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139228011|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228012|NCT04078568|Aspirin|aspirin|mesh-list
139228013|NCT04078568|Prednisolone|prednisolone|mesh-list
139228014|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
139228015|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139228016|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
139228017|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139228018|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139228019|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139228020|NCT04078568|Analgesics|analgesics|mesh-ancestor
139228021|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
139228022|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228023|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228024|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139228025|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139228026|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139228027|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139228028|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228029|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139228030|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139228031|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228032|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
139228033|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
139228034|NCT04078568|Hormones|hormones|mesh-ancestor
139228035|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139228036|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139228037|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228038|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
139228039|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139228040|NCT04057456|Nabilone|nabilone|mesh-list
139228041|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
139228042|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
139228043|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228044|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228045|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139228046|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139228047|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139228048|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139228049|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139228050|NCT04030442|Morphine|morphine|mesh-list
139228051|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139228052|NCT04030442|Narcotics|narcotics|mesh-ancestor
139228053|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139228054|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228055|NCT04030442|Analgesics|analgesics|mesh-ancestor
139228056|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
139228057|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228058|NCT04010539|Azithromycin|azithromycin|mesh-list
139228059|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
139228060|NCT04010539|Gepotidacin|gepotidacin|mesh-list
139228061|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139228062|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139228063|NCT04010539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139228064|NCT04010539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228065|NCT04010539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228066|NCT04010539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228067|NCT03977194|Paclitaxel|paclitaxel|mesh-list
139228068|NCT03977194|Carboplatin|carboplatin|mesh-list
139228069|NCT03977194|Atezolizumab|atezolizumab|mesh-list
139228070|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139228071|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228072|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
139228073|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
139228074|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
139228075|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228076|NCT03977194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139228077|NCT03977194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228078|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
139228079|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139228080|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139228081|NCT03942887|Prednisolone|prednisolone|mesh-list
139228082|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
139228083|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
139228084|NCT03942887|Rituximab|rituximab|mesh-list
139228085|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139228086|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
139228087|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139228088|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
139228089|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228090|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139228091|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139228092|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
139184642|NCT03368859|Leucovorin|leucovorin|mesh-list
139228096|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228097|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139228098|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
139228099|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
139228100|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228101|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139228102|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
139228103|NCT03942887|Hormones|hormones|mesh-ancestor
139228104|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139228105|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139228106|NCT03942887|Protective Agents|protective agents|mesh-ancestor
139228107|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139228108|NCT03905694|Lumasiran|lumasiran|mesh-list
139228109|NCT03905694|Renal Agents|renal agents|mesh-ancestor
139228110|NCT03831503|Antibodies|antibodies|mesh-list
139228111|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
139228112|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228113|NCT03785405|Valsartan|valsartan|mesh-list
139228114|NCT03785405|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139228115|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139228116|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139228117|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139228118|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228119|NCT03774641|Lamotrigine|lamotrigine|mesh-list
139228120|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
139228121|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139228122|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139228123|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228124|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139228125|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228126|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139228127|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139228128|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139228129|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139228130|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139228131|NCT03681184|Lumasiran|lumasiran|mesh-list
139228132|NCT03681184|Renal Agents|renal agents|mesh-ancestor
139228133|NCT03673462|Vaccines|vaccines|mesh-list
139228134|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
139228135|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228136|NCT03522831|Albuterol|albuterol|mesh-list
139228137|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139228138|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
139228139|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642171|NCT01346397|Cyclosporine|cyclosporine|mesh-list
139228140|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228141|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139228142|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
139228143|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
139228144|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139228145|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139228146|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139228147|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139228148|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
139228149|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228150|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228152|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
139228153|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
139228154|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
139228155|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228156|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228157|NCT03452137|Atezolizumab|atezolizumab|mesh-list
139228158|NCT03452137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139228159|NCT03452137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228160|NCT03452137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228161|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184719|NCT03335163|Topiramate|topiramate|mesh-list
139228188|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
139228189|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228190|NCT03348969|Mitomycins|mitomycins|mesh-list
139228191|NCT03348969|Mitomycin|mitomycin|mesh-list
139228192|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139228193|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228194|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
139228195|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228196|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139228197|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228198|NCT03307785|Paclitaxel|paclitaxel|mesh-list
139228199|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139228200|NCT03307785|Bevacizumab|bevacizumab|mesh-list
139228201|NCT03307785|Carboplatin|carboplatin|mesh-list
139228202|NCT03307785|Pemetrexed|pemetrexed|mesh-list
139228203|NCT03307785|Niraparib|niraparib|mesh-list
139228204|NCT03307785|Dostarlimab|dostarlimab|mesh-list
139228205|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139228206|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228207|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
139228208|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
139228209|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
139228210|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228211|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228212|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139228213|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139228214|NCT03307785|Growth Substances|growth substances|mesh-ancestor
139228215|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228216|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
139228217|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228218|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139228219|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139228220|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139228221|NCT03260881|Liraglutide|liraglutide|mesh-list
139228222|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139228223|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228224|NCT03260881|Incretins|incretins|mesh-ancestor
139228225|NCT03260881|Hormones|hormones|mesh-ancestor
139228226|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139228227|NCT03199040|Durvalumab|durvalumab|mesh-list
139228228|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228229|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228230|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
139228231|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139228232|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139228233|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139228234|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139228235|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228236|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
139228237|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228238|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228239|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139228240|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228241|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
139228242|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
139228243|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228244|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228245|NCT03161353|Tamoxifen|tamoxifen|mesh-list
139228246|NCT03161353|Carboplatin|carboplatin|mesh-list
139228247|NCT03161353|Docetaxel|docetaxel|mesh-list
139228248|NCT03161353|Trastuzumab|trastuzumab|mesh-list
139228249|NCT03161353|Letrozole|letrozole|mesh-list
139228250|NCT03161353|Pertuzumab|pertuzumab|mesh-list
139228251|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228252|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
139228253|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
139228254|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
139228255|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228256|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228257|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139228258|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139228259|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228260|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139228261|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
139228262|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139228263|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228264|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139228265|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139228266|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139228267|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139228268|NCT03159897|Doxorubicin|doxorubicin|mesh-list
139228269|NCT03159897|Bleomycin|bleomycin|mesh-list
139228270|NCT03159897|Dacarbazine|dacarbazine|mesh-list
139228271|NCT03159897|Vinblastine|vinblastine|mesh-list
139228272|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139228273|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228274|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139228275|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139228276|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228277|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228278|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139228279|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
139228280|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139228281|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
139228282|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
139228283|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
139228284|NCT03079999|Aspirin|aspirin|mesh-list
139228285|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139228286|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139228287|NCT03079999|Analgesics|analgesics|mesh-ancestor
139228288|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
139228289|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228290|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228291|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139228292|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139228293|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139228294|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139228295|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228296|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139228297|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139228298|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228299|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
139228300|NCT03078010|Tazobactam|tazobactam|mesh-list
139228301|NCT03078010|Piperacillin|piperacillin|mesh-list
139228302|NCT03078010|Cefepime|cefepime|mesh-list
139228303|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139228304|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139228305|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139228306|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139228307|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228308|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228309|NCT03072238|Prednisone|prednisone|mesh-list
139228310|NCT03072238|Prednisolone|prednisolone|mesh-list
139228311|NCT03072238|Ipatasertib|ipatasertib|mesh-list
139228312|NCT03072238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139228313|NCT03072238|Glucocorticoids|glucocorticoids|mesh-ancestor
139228314|NCT03072238|Hormones|hormones|mesh-ancestor
139642172|NCT01346397|Tacrolimus|tacrolimus|mesh-list
139228315|NCT03072238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139184869|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139228316|NCT03072238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228317|NCT03072238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139228318|NCT03072238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228319|NCT03072238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139228320|NCT03072238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228321|NCT03072238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228322|NCT02970318|Rituximab|rituximab|mesh-list
139228323|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139228324|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
139228325|NCT02970318|Idelalisib|idelalisib|mesh-list
139228326|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228327|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228328|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
139228329|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228330|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139228331|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139228332|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
139228333|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228334|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228335|NCT02879409|Insulin|insulin|mesh-list
139228336|NCT02879409|Metformin|metformin|mesh-list
139228337|NCT02879409|Pioglitazone|pioglitazone|mesh-list
139228338|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
139228339|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139228340|NCT02879409|Liraglutide|liraglutide|mesh-list
139228341|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139228342|NCT02879409|Gliclazide|gliclazide|mesh-list
139228343|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139228344|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228345|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139228346|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228347|NCT02879409|Incretins|incretins|mesh-ancestor
139228348|NCT02879409|Hormones|hormones|mesh-ancestor
139228349|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139228350|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139228351|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
139228352|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228353|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139228354|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139228355|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228356|NCT02621398|Paclitaxel|paclitaxel|mesh-list
139228357|NCT02621398|Carboplatin|carboplatin|mesh-list
139228358|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
139228359|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139228360|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139228361|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228362|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
139228363|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
139228364|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
139228365|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228366|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228367|NCT02621398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139228368|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139228369|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139228370|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228371|NCT02427620|Cytarabine|cytarabine|mesh-list
139228372|NCT02427620|Dexamethasone|dexamethasone|mesh-list
139228373|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
139228374|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
139228375|NCT02427620|Rituximab|rituximab|mesh-list
139228376|NCT02427620|Doxorubicin|doxorubicin|mesh-list
139228377|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139228378|NCT02427620|Methotrexate|methotrexate|mesh-list
139228379|NCT02427620|Vincristine|vincristine|mesh-list
139228380|NCT02427620|Daunorubicin|daunorubicin|mesh-list
139228381|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139228382|NCT02427620|Antibodies|antibodies|mesh-list
139228383|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
139228384|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139228385|NCT02427620|BB 1101|bb 1101|mesh-list
139228386|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139228387|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
139228388|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228389|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139228390|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139228391|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
139228392|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228393|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228394|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139228395|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139228396|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
139228397|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
139228398|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228399|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139228400|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
139228401|NCT02427620|Hormones|hormones|mesh-ancestor
139228402|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139228403|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139228404|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
139228405|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228406|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139228407|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139228408|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139228409|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139228410|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
139228411|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139228412|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139228413|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
139228414|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
139228415|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139228416|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139228417|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
139228418|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139228419|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139228420|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
139228421|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
139228422|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
139228423|NCT02408549|Lacosamide|lacosamide|mesh-list
139228424|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
139228425|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139228426|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139228427|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139228428|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228429|NCT02242942|Venetoclax|venetoclax|mesh-list
139228430|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
139228431|NCT02242942|Chlorambucil|chlorambucil|mesh-list
139228432|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228433|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228434|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139228435|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
139228436|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228437|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
139228438|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139228439|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139228440|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
139228441|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228442|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228443|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
139228444|NCT02168140|Protective Agents|protective agents|mesh-ancestor
139228445|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228446|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
139228447|NCT02168140|Vitamins|vitamins|mesh-ancestor
139228448|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
139228449|NCT01837277|Efavirenz|efavirenz|mesh-list
139228450|NCT01837277|Dolutegravir|dolutegravir|mesh-list
139228451|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139228452|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139228453|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228454|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228455|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
139228456|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139228457|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139228458|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139228459|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139228460|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139228461|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139228462|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139228463|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139228464|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139228465|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139228466|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139228467|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
139228468|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228469|NCT01658878|Nivolumab|nivolumab|mesh-list
139228470|NCT01658878|Ipilimumab|ipilimumab|mesh-list
139228471|NCT01658878|Sorafenib|sorafenib|mesh-list
139228472|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228473|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228474|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139228475|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228476|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139228477|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228478|NCT01624285|Sorafenib|sorafenib|mesh-list
139228479|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228480|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139228481|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228482|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228483|NCT01523002|Artesunate|artesunate|mesh-list
139228484|NCT01523002|Pyronaridine|pyronaridine|mesh-list
139228485|NCT01523002|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139228486|NCT01523002|Metoprolol|metoprolol|mesh-list
139228487|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139228488|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139228489|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
139228490|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
139228491|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228492|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228493|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139228494|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139228495|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139228496|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
139228497|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228498|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228499|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
139228500|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139228501|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139228502|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139228503|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228504|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
139228505|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
139228506|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139228507|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
139228508|NCT01471106|Dasatinib|dasatinib|mesh-list
139228509|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228510|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139228511|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228512|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228513|NCT00489307|Dexamethasone|dexamethasone|mesh-list
139228514|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139228515|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
139228516|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
139228517|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228518|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228519|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139228520|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
139228521|NCT00489307|Hormones|hormones|mesh-ancestor
139228522|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139228523|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139228524|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228525|NCT00349310|Pramipexole|pramipexole|mesh-list
139228526|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
139228527|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228528|NCT00349310|Protective Agents|protective agents|mesh-ancestor
139228529|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228530|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139228531|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139228532|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
139228533|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
139228534|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228535|NCT00267917|Fenoterol|fenoterol|mesh-list
139228536|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139228537|NCT00267917|Ipratropium|ipratropium|mesh-list
139228538|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139228539|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
139228540|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228541|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228542|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139228543|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
139228544|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
139228545|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
139228546|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139228547|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139228548|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139228549|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139228550|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
139228551|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228552|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228553|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139228554|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
139228556|NCT00171002|Valsartan|valsartan|mesh-list
139228557|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139228558|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139228559|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139228560|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228561|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139228562|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228563|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
139228564|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139228565|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139228566|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
139228567|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
139228568|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139228569|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139228570|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139228571|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228572|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139228573|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139228574|NCT03521141|Nicotine|nicotine|mesh-list
139228575|NCT03521141|Varenicline|varenicline|mesh-list
139228576|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139228577|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
139228578|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228579|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228580|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139228581|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139228582|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
139228583|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228584|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228585|NCT03725267|Melatonin|melatonin|mesh-list
139228586|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
139228587|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228588|NCT03725267|Protective Agents|protective agents|mesh-ancestor
139228589|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228590|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139228591|NCT02997176|Talazoparib|talazoparib|mesh-list
139228592|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139228593|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228594|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228595|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228596|NCT03000452|Durvalumab|durvalumab|mesh-list
139228597|NCT03000452|Daratumumab|daratumumab|mesh-list
139228598|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228599|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228600|NCT03664388|Clopidogrel|clopidogrel|mesh-list
139228601|NCT03664388|Ticagrelor|ticagrelor|mesh-list
139228602|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139228603|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139228604|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139228605|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139228606|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
139228607|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228608|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228609|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228610|NCT01373164|Gemcitabine|gemcitabine|mesh-list
139228611|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139098666|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
139228612|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
139228613|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185170|NCT03359811|Anesthetics|anesthetics|mesh-list
139228614|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228615|NCT02999984|Busulfan|busulfan|mesh-list
139228616|NCT02999984|Alkylating Agents|alkylating agents|mesh-ancestor
139228617|NCT02999984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228618|NCT02999984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139228619|NCT02999984|Immunologic Factors|immunologic factors|mesh-ancestor
139228620|NCT02999984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228621|NCT02999984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139228622|NCT02999984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228623|NCT02999984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139228624|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139228625|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
139228626|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228627|NCT03312907|Rituximab|rituximab|mesh-list
139228628|NCT03312907|Belimumab|belimumab|mesh-list
139228629|NCT03312907|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139228630|NCT03312907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228631|NCT03312907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228632|NCT03312907|Immunologic Factors|immunologic factors|mesh-ancestor
139228633|NCT03312907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228634|NCT03312907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139228635|NCT02999672|Trastuzumab|trastuzumab|mesh-list
139228636|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139228637|NCT02999672|Maytansine|maytansine|mesh-list
139228638|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228639|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228640|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139228641|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
139228642|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
139228643|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
139228644|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228645|NCT02999672|Immunotoxins|immunotoxins|mesh-ancestor
139228646|NCT02999672|Immunoconjugates|immunoconjugates|mesh-ancestor
139228647|NCT02999672|Immunologic Factors|immunologic factors|mesh-ancestor
139228648|NCT02999672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228649|NCT03664622|Ketamine|ketamine|mesh-list
139228650|NCT03664622|Morphine|morphine|mesh-list
139228651|NCT03664622|Analgesics|analgesics|mesh-ancestor
139228652|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
139228653|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228654|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228655|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139298938|NCT05597306|Venetoclax|venetoclax|mesh-list
139298939|NCT05597306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228656|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139228657|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
139228658|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
139228659|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139228660|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139228661|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139228662|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228663|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228664|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139228665|NCT03664622|Narcotics|narcotics|mesh-ancestor
139228666|NCT04056182|Lofexidine|lofexidine|mesh-list
139228667|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139228668|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139228669|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228670|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
139228671|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228672|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139228673|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139228674|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139228675|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
139228676|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228677|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228678|NCT03573323|Ixekizumab|ixekizumab|mesh-list
139228679|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
139228680|NCT04058054|Histamine|histamine|mesh-list
139228681|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
139228682|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
139228683|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642173|NCT01346397|Cyclosporins|cyclosporins|mesh-list
139642174|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139228684|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228685|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228687|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
139185245|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
139228688|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228689|NCT01069172|Dipivefrin|dipivefrin|mesh-list
139228690|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139228691|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
139228692|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228693|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228694|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228695|NCT03724955|Estradiol|estradiol|mesh-list
139228696|NCT03724955|Estrogens|estrogens|mesh-ancestor
139228697|NCT03724955|Hormones|hormones|mesh-ancestor
139228698|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139228699|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228700|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
139228701|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
139228702|NCT04220008|Busulfan|busulfan|mesh-list
139228703|NCT04220008|Rituximab|rituximab|mesh-list
139228704|NCT04220008|Gemcitabine|gemcitabine|mesh-list
139228705|NCT04220008|Vorinostat|vorinostat|mesh-list
139228706|NCT04220008|Clofarabine|clofarabine|mesh-list
139228707|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139228708|NCT04220008|Tacrolimus|tacrolimus|mesh-list
139228709|NCT04220008|Antibodies|antibodies|mesh-list
139228710|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
139228711|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139228712|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139228713|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
139228714|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228715|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139228716|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139228717|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
139228718|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228719|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228720|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139228721|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139228722|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
139228723|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139228724|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228725|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139228726|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139228727|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
139228728|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139228729|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139228730|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139228731|NCT03721991|Butyric Acid|butyric acid|mesh-list
139228732|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228733|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228734|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228735|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
139228736|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
139228737|NCT02911688|Vitamin E|vitamin e|mesh-list
139228738|NCT02911688|Tocopherols|tocopherols|mesh-list
139228739|NCT02911688|Tocotrienols|tocotrienols|mesh-list
139228740|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
139228741|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
139228742|NCT02911688|Vitamins|vitamins|mesh-ancestor
139228743|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
139228744|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228745|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
139228746|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228747|NCT02911688|Protective Agents|protective agents|mesh-ancestor
139228748|NCT05580250|Metformin|metformin|mesh-list
139228749|NCT05580250|Simvastatin|simvastatin|mesh-list
139228750|NCT05580250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139228751|NCT05580250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228752|NCT05580250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139228753|NCT05580250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139228754|NCT05580250|Antimetabolites|antimetabolites|mesh-ancestor
139228755|NCT05580250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228756|NCT05580250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139228757|NCT05580250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139228758|NCT05580250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228759|NCT03431948|Nivolumab|nivolumab|mesh-list
139228760|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228761|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228762|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139228763|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228764|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
139228765|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139228766|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
139228767|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
139228768|NCT03662516|Estradiol|estradiol|mesh-list
139228769|NCT03662516|Abrocitinib|abrocitinib|mesh-list
139228770|NCT03662516|Estrogens|estrogens|mesh-ancestor
139228771|NCT03662516|Hormones|hormones|mesh-ancestor
139228772|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139228773|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228774|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139228775|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139228776|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139228777|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139228778|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139228779|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139228780|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228781|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228782|NCT03728465|Nivolumab|nivolumab|mesh-list
139228783|NCT03728465|Ipilimumab|ipilimumab|mesh-list
139228784|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228785|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228786|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139228787|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228788|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
139228789|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139228790|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
139228791|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228792|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139228793|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
139228794|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139228795|NCT02994056|Velpatasvir|velpatasvir|mesh-list
139228796|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
139228797|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139228798|NCT03728153|Fluoxetine|fluoxetine|mesh-list
139228799|NCT03728153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139228800|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139228801|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139228802|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228803|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228804|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
139228805|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228806|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139228807|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
139228808|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139228809|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139228810|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139228811|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228812|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
139228813|NCT04056806|Terlipressin|terlipressin|mesh-list
139228814|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139228815|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139228816|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139228817|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139228818|NCT03305575|Bupivacaine|bupivacaine|mesh-list
139228819|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
139228820|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
139228821|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
139228822|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139228823|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228824|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
139228825|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228826|NCT02993822|Maleic acid|maleic acid|mesh-list
139228827|NCT02993822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228828|NCT02993822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228829|NCT02391844|Oxycodone|oxycodone|mesh-list
139228830|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139228831|NCT02391844|Narcotics|narcotics|mesh-ancestor
139228832|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139228833|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228834|NCT02391844|Analgesics|analgesics|mesh-ancestor
139228835|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
139228836|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228837|NCT02391688|Fexofenadine|fexofenadine|mesh-list
139228838|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
139228839|NCT02391688|Midazolam|midazolam|mesh-list
139228841|NCT02391688|Caffeine|caffeine|mesh-list
139228842|NCT02391688|Bupropion|bupropion|mesh-list
139228843|NCT02391688|Omeprazole|omeprazole|mesh-list
139228844|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139228845|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139228846|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139228847|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228848|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139228849|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139228850|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139228851|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139228852|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
139228853|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
139228854|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
139228855|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
139228856|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228857|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228858|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139228859|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139228860|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228861|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139228862|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139228863|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
139228864|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139228865|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139228866|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139228867|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139228868|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
139228869|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139228870|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139228871|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139228872|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
139228873|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139228874|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139228875|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
139228876|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
139228877|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139228878|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139228879|NCT02391688|Analgesics|analgesics|mesh-ancestor
139228880|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
139228881|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228882|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139228883|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139228884|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139228885|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139228886|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139228887|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139228888|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139228889|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139228890|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
139228891|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
139228892|NCT01068860|Insulin|insulin|mesh-list
139228893|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139228894|NCT01068860|Metformin|metformin|mesh-list
139228895|NCT01068860|Glimepiride|glimepiride|mesh-list
139228896|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
139228897|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
139228898|NCT01068860|Glyburide|glyburide|mesh-list
139228899|NCT01068860|Glipizide|glipizide|mesh-list
139228900|NCT01068860|Troglitazone|troglitazone|mesh-list
139228901|NCT01068860|Tolbutamide|tolbutamide|mesh-list
139228902|NCT01068860|Acetohexamide|acetohexamide|mesh-list
139228903|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
139228904|NCT01068860|Tolazamide|tolazamide|mesh-list
139228905|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
139228906|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139228907|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139228908|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228909|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139228910|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139228911|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
139228912|NCT04056650|Caffeine|caffeine|mesh-list
139642175|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
139228913|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139228914|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228915|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139228916|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228917|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228918|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139228919|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139228920|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
139228921|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139228923|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139228924|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
139228925|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
139228926|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139228927|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228929|NCT03158090|Lanreotide|lanreotide|mesh-list
139228930|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139228931|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139228932|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228933|NCT02670538|Cariprazine|cariprazine|mesh-list
139228934|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139228935|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139228936|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139228937|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228938|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139228939|NCT03727763|Cetuximab|cetuximab|mesh-list
139228940|NCT03727763|Vemurafenib|vemurafenib|mesh-list
139228941|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228942|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228943|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139228944|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139228945|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228946|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139228947|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
139228948|NCT02991482|Gemcitabine|gemcitabine|mesh-list
139228949|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
139228950|NCT02991482|Vinorelbine|vinorelbine|mesh-list
139228951|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139228952|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
139228953|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228954|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228955|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139228956|NCT02991482|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139228957|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139228958|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
139228959|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
139228960|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
139228961|NCT02391142|Lidocaine|lidocaine|mesh-list
139228962|NCT02391142|Ropivacaine|ropivacaine|mesh-list
139228963|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
139228964|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
139228965|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139228966|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228967|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
139228968|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139228969|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139228970|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139228971|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139228972|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139228973|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228974|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139228975|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
139228976|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228977|NCT04479202|Bentonite|bentonite|mesh-list
139228978|NCT04479202|Antidotes|antidotes|mesh-ancestor
139228979|NCT04479202|Protective Agents|protective agents|mesh-ancestor
139228980|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228981|NCT01372618|Pasireotide|pasireotide|mesh-list
139228982|NCT01372618|Hormones|hormones|mesh-ancestor
139228983|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139228984|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228985|NCT03304873|Retapamulin|retapamulin|mesh-list
139228986|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139228987|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139228989|NCT04526509|Fludarabine|fludarabine|mesh-list
139228990|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139228991|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
139228992|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139228994|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139228995|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
139228996|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139228997|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139228998|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139228999|NCT03660020|Anesthetics|anesthetics|mesh-list
139229000|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
139229001|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139229002|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229003|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
139229004|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229005|NCT03661892|Dronabinol|dronabinol|mesh-list
139229006|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
139229007|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229008|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139229009|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139229010|NCT03661892|Analgesics|analgesics|mesh-ancestor
139229011|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
139229012|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229013|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139229014|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139229015|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139229016|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229017|NCT03661892|Hormones|hormones|mesh-ancestor
139229018|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229019|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139229020|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139229021|NCT03658850|Diuretics|diuretics|mesh-ancestor
139229022|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
139091627|NCT04381936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139091628|NCT04381936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139091629|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091630|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
139091631|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091632|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091633|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139091634|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139091635|NCT04381936|Analgesics|analgesics|mesh-ancestor
139091636|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
139091637|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139091638|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139091639|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139091640|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139091641|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139091642|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
139091643|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139091644|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139091645|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139091646|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139091647|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
139091648|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091649|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139091650|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139091651|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139091652|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
139091653|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139091654|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139091655|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139091656|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139091657|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
139091658|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
139091659|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
139091660|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
139091661|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
139091662|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139091663|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
139091664|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
139091665|NCT04370301|Melphalan|melphalan|mesh-list
139091666|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
139091667|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139091669|NCT04370301|Tacrolimus|tacrolimus|mesh-list
139229023|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229024|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139229025|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139229026|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229027|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
139229028|NCT03659162|Clotrimazole|clotrimazole|mesh-list
139229029|NCT03659162|Miconazole|miconazole|mesh-list
139229030|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229031|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139229032|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139229033|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139229034|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229035|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229036|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139229037|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
139229038|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229039|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229040|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139229041|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139229042|NCT03659084|Deferasirox|deferasirox|mesh-list
139229043|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139229044|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
139229045|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
139229046|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229047|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139229048|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139229049|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139229050|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
139229051|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229052|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139229053|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139229054|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229055|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139229056|NCT02921750|Laxatives|laxatives|mesh-ancestor
139229057|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139229058|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139229059|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229060|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
139229061|NCT03622502|Remifentanil|remifentanil|mesh-list
139229062|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139229063|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139229064|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229065|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139229066|NCT03622502|Analgesics|analgesics|mesh-ancestor
139229067|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
139229068|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229069|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139229070|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139229071|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139229072|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
139229073|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139229074|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229075|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139229076|NCT03622502|Narcotics|narcotics|mesh-ancestor
139229077|NCT04397354|Dexamethasone|dexamethasone|mesh-list
139229078|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
139229079|NCT04397354|BB 1101|bb 1101|mesh-list
139229080|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139229081|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
139229082|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
139229083|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229084|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229085|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139229086|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
139229087|NCT04397354|Hormones|hormones|mesh-ancestor
139229088|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229089|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139229090|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229091|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
139229092|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229093|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229094|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139185659|NCT04595591|Rocuronium|rocuronium|mesh-list
139229095|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139229096|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139229097|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
139229098|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229099|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139229100|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139229101|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229103|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139229104|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229105|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139229106|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
139229107|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229108|NCT01067846|Cycloserine|cycloserine|mesh-list
139229109|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139229110|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229111|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139229112|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
139229113|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139229114|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
139229115|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229116|NCT03874234|GSK3186899|gsk3186899|mesh-list
139229117|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139229118|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229119|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229120|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
139229121|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139229122|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229123|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139229124|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139229125|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229126|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229127|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229128|NCT05276323|Hydrocortisone|hydrocortisone|mesh-list
139229129|NCT05276323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139229130|NCT05275777|Paclitaxel|paclitaxel|mesh-list
139229131|NCT05275777|Cyclophosphamide|cyclophosphamide|mesh-list
139229132|NCT05275777|Doxorubicin|doxorubicin|mesh-list
139229133|NCT05275777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139229134|NCT05275777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229135|NCT05275777|Tubulin Modulators|tubulin modulators|mesh-ancestor
139229136|NCT05275777|Antimitotic Agents|antimitotic agents|mesh-ancestor
139229137|NCT05275777|Mitosis Modulators|mitosis modulators|mesh-ancestor
139229138|NCT05275777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229139|NCT05275777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139229140|NCT05275777|Immunologic Factors|immunologic factors|mesh-ancestor
139229141|NCT05275777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229142|NCT05275777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139229143|NCT05275777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139229144|NCT05275777|Alkylating Agents|alkylating agents|mesh-ancestor
139229145|NCT05275777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139229146|NCT05275777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139229147|NCT05275777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139229148|NCT05275777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139229149|NCT05275777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229150|NCT05672212|Sufentanil|sufentanil|mesh-list
139229151|NCT05672212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139229152|NCT05672212|Narcotics|narcotics|mesh-ancestor
139229153|NCT05672212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139229154|NCT05672212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229155|NCT05672212|Analgesics|analgesics|mesh-ancestor
139229156|NCT05672212|Sensory System Agents|sensory system agents|mesh-ancestor
139229157|NCT05672212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229158|NCT05672212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139229159|NCT05672212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139229160|NCT05672212|Anesthetics, General|anesthetics, general|mesh-ancestor
139229161|NCT05672212|Anesthetics|anesthetics|mesh-ancestor
139229162|NCT02390674|Cyclosporine|cyclosporine|mesh-list
139229163|NCT02390674|Cyclosporins|cyclosporins|mesh-list
139229164|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229165|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229166|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139229167|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
139229168|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091670|NCT04370301|Lenograstim|lenograstim|mesh-list
139229169|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
139229170|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229171|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
139229172|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139229173|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139229174|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139229175|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139229176|NCT02663674|Fluconazole|fluconazole|mesh-list
139229177|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
139229178|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229179|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139229180|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139229181|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229182|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229183|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139229184|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
139229185|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229186|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229187|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139229188|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139229189|NCT03657212|Zolpidem|zolpidem|mesh-list
139229190|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139229191|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139229192|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139229193|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229194|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139229195|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
139229196|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
139229197|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139229198|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229199|NCT03310411|Sumatriptan|sumatriptan|mesh-list
139229200|NCT03310411|Lasmiditan|lasmiditan|mesh-list
139229201|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139229202|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139229203|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139229204|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
139229205|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139229206|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229207|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229208|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
139229209|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
139229210|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139229211|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229212|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229213|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
139229214|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139229215|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139229216|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229217|NCT02390440|Bupivacaine|bupivacaine|mesh-list
139229218|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
139229219|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
139229220|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139229221|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229222|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
139229223|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229224|NCT03677830|Acetaminophen|acetaminophen|mesh-list
139229225|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139229226|NCT03677830|Analgesics|analgesics|mesh-ancestor
139229227|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
139229228|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229229|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229230|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
139229231|NCT02199691|Vaccines|vaccines|mesh-list
139229232|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
139229233|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229234|NCT05667454|Atropine|atropine|mesh-list
139229235|NCT05667454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139229236|NCT05667454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139229237|NCT05667454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139229238|NCT05667454|Autonomic Agents|autonomic agents|mesh-ancestor
139229239|NCT05667454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229240|NCT05667454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229241|NCT05667454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139185809|NCT03437980|Propofol|propofol|mesh-list
139229242|NCT05667454|Respiratory System Agents|respiratory system agents|mesh-ancestor
139229243|NCT05667454|Mydriatics|mydriatics|mesh-ancestor
139229244|NCT05667454|Parasympatholytics|parasympatholytics|mesh-ancestor
139229245|NCT05667454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139229246|NCT05667454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139229247|NCT05667454|Cholinergic Agents|cholinergic agents|mesh-ancestor
139229248|NCT05667454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139229249|NCT05667454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229250|NCT02389972|Dasatinib|dasatinib|mesh-list
139229251|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229252|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139229253|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229254|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229255|NCT02389582|Enoxaparin|enoxaparin|mesh-list
139229256|NCT02389582|Dabigatran|dabigatran|mesh-list
139229257|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
139229258|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139229259|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139229260|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229261|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
139229262|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139229263|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
139229264|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229265|NCT02389426|Bosentan|bosentan|mesh-list
139229266|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139229267|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139229268|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229269|NCT02389348|Artefenomel|artefenomel|mesh-list
139229270|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
139229271|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139229272|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139229273|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229274|NCT02387242|Rifampin|rifampin|mesh-list
139229275|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139229276|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
139229277|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139229278|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229279|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
139229280|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139229281|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229282|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229283|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139229284|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139229285|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139229286|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139229287|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139229288|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139229289|NCT03656588|Iodine|iodine|mesh-list
139229290|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
139229291|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139229292|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
139229293|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139229294|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139229295|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229296|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
139229297|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
139229298|NCT03656588|Trace Elements|trace elements|mesh-ancestor
139229299|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
139229300|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229301|NCT02387086|Aspirin|aspirin|mesh-list
139229302|NCT02387086|Thalidomide|thalidomide|mesh-list
139229303|NCT02387086|Gefitinib|gefitinib|mesh-list
139229304|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139229305|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139229306|NCT02387086|Analgesics|analgesics|mesh-ancestor
139229307|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
139229308|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229309|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229310|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139229311|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139229312|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139229313|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139229314|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229315|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139229316|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139229317|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229318|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
139229319|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139229320|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
139229321|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
139229322|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139229323|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229324|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139229325|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139229326|NCT02387086|Growth Substances|growth substances|mesh-ancestor
139229327|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
139229328|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229329|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139229330|NCT02383030|Fulvestrant|fulvestrant|mesh-list
139229331|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139229332|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229333|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139229334|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139229335|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
139229336|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229337|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229338|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139229339|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
139229340|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229341|NCT02983604|Fulvestrant|fulvestrant|mesh-list
139229342|NCT02983604|Exemestane|exemestane|mesh-list
139229343|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139229344|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229345|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139229346|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139229347|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
139229348|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229349|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229350|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139229351|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139229352|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229353|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229354|NCT03656432|Fluorides|fluorides|mesh-list
139229355|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
139229356|NCT03656432|Protective Agents|protective agents|mesh-ancestor
139229357|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229358|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
139229359|NCT02386462|Propofol|propofol|mesh-list
139229360|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139229361|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139229362|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229363|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139229364|NCT02386462|Analgesics|analgesics|mesh-ancestor
139229365|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
139229366|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229367|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139229368|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139229369|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139229370|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
139229371|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139229372|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229373|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139229374|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
139229375|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
139229376|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
139229377|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
139229378|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229379|NCT02382328|Protective Agents|protective agents|mesh-ancestor
139229380|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229381|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
139229382|NCT02382328|Vitamins|vitamins|mesh-ancestor
139229383|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
139229384|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139229385|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139229386|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229387|NCT02388490|Immunotoxins|immunotoxins|mesh-ancestor
139229388|NCT02388490|Immunoconjugates|immunoconjugates|mesh-ancestor
139229389|NCT02388490|Immunologic Factors|immunologic factors|mesh-ancestor
139229390|NCT02388490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229391|NCT02382094|Bicalutamide|bicalutamide|mesh-list
139229392|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
139229393|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
139229394|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229395|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229396|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229397|NCT02386150|Vaccines|vaccines|mesh-list
139229398|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
139229399|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229400|NCT02377180|Anesthetics|anesthetics|mesh-list
139229401|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
139229402|NCT02377180|Capsaicin|capsaicin|mesh-list
139229403|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139229404|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229405|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
139229406|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229407|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
139229408|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
139229409|NCT03656042|Lenograstim|lenograstim|mesh-list
139229410|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139229411|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
139229412|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229413|NCT03655964|Olmesartan|olmesartan|mesh-list
139229414|NCT03655964|Nebivolol|nebivolol|mesh-list
139229415|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
139229416|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139229417|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139229418|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229419|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
139229420|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139229421|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139229422|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139229423|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
139229424|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139229425|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229426|NCT02982590|Warfarin|warfarin|mesh-list
139229427|NCT02982590|Apixaban|apixaban|mesh-list
139229428|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
139229429|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139229430|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
139229431|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139229432|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
139229433|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229434|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229435|NCT02381548|Belinostat|belinostat|mesh-list
139229436|NCT02381548|Adavosertib|adavosertib|mesh-list
139229437|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229438|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229439|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229440|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139229441|NCT02381314|Ipilimumab|ipilimumab|mesh-list
139229442|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139229443|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229444|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139229445|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229446|NCT02386072|Mirabegron|mirabegron|mesh-list
139229447|NCT02386072|Oxybutynin|oxybutynin|mesh-list
139229448|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
139229449|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139229450|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139229451|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139229452|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
139229453|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139229454|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229455|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229456|NCT02386072|Urological Agents|urological agents|mesh-ancestor
139229457|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
139229458|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
139229459|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229460|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139229461|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
139229462|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
139229463|NCT02381470|Amoxicillin|amoxicillin|mesh-list
139229464|NCT02381470|Rifampin|rifampin|mesh-list
139229465|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139229466|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
139099566|NCT01105494|Hematinics|hematinics|mesh-ancestor
139229467|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
139229468|NCT02381470|Cefadroxil|cefadroxil|mesh-list
139229469|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139229470|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229471|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139229472|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
139229473|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
139229474|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139229475|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229476|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229477|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139229478|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139229479|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139229480|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139229481|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139229482|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139229483|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139229485|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139229486|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
139229487|NCT02381158|Hormones|hormones|mesh-ancestor
139229488|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229489|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229490|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139229491|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
139229492|NCT02381080|Voriconazole|voriconazole|mesh-list
139229493|NCT02381080|Erythromycin|erythromycin|mesh-list
139229494|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
139229495|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139229496|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
139229497|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
139229498|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229499|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139229500|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139229501|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229502|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229503|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139229504|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
139229505|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229506|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229507|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139229508|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139229509|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139229510|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139229511|NCT04694248|Aspirin|aspirin|mesh-list
139229512|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
139229513|NCT04694248|Anticoagulants|anticoagulants|mesh-list
139229514|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139229515|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139229516|NCT04694248|Analgesics|analgesics|mesh-ancestor
139229517|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
139229518|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229519|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229520|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139229521|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139229522|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139229523|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139229524|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229525|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139229526|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139229527|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229528|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
139229529|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139229530|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
139229531|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139229532|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
139229533|NCT02376478|Folic Acid|folic acid|mesh-list
139229534|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
139229535|NCT02376478|Adalimumab|adalimumab|mesh-list
139229536|NCT02376478|Infliximab|infliximab|mesh-list
139229537|NCT02376478|Etanercept|etanercept|mesh-list
139229538|NCT02376478|Methotrexate|methotrexate|mesh-list
139229539|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
139229540|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
139642176|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229541|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139229542|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
139229543|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139229544|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229545|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139229546|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
139229547|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229548|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229549|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
139229550|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229551|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139229552|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
139229553|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139229554|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139229555|NCT02376478|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139229556|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139229557|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139229558|NCT02376478|Hematinics|hematinics|mesh-ancestor
139229559|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
139229560|NCT02376478|Vitamins|vitamins|mesh-ancestor
139229561|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
139229562|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139229563|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139229564|NCT02376478|Analgesics|analgesics|mesh-ancestor
139229565|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
139229566|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229567|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229568|NCT02385448|Dienogest|dienogest|mesh-list
139229569|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
139229570|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139229571|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139229572|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
139229573|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139229574|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229575|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139229576|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139229577|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139229578|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139229579|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
139229580|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229581|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139229582|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229583|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139229584|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139229585|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
139229586|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139229587|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139229588|NCT02376400|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139229589|NCT02376400|Antiviral Agents|antiviral agents|mesh-ancestor
139229590|NCT02376400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229591|NCT02385058|Mebendazole|mebendazole|mesh-list
139229592|NCT02385058|Piperazine|piperazine|mesh-list
139229593|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
139229594|NCT02385058|DMP 777|dmp 777|mesh-list
139229595|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
139229596|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
139229597|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139229598|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229599|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
139229600|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
139229601|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
139229602|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229603|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229604|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229605|NCT02376088|Methimazole|methimazole|mesh-list
139229606|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
139229607|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
139229608|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229609|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229610|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
139229611|NCT03310021|Apixaban|apixaban|mesh-list
139229612|NCT03310021|Edoxaban|edoxaban|mesh-list
139229613|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139229614|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
139229615|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139186191|NCT05681247|Ezetimibe|ezetimibe|mesh-list
139229616|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
139229617|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229618|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229619|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
139229620|NCT03333109|Erenumab|erenumab|mesh-list
139229621|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139229622|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229623|NCT03333109|Analgesics|analgesics|mesh-ancestor
139229624|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
139229625|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229626|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229627|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139229628|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139229629|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139229630|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
139229631|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
139229632|NCT01312831|Vitamins|vitamins|mesh-ancestor
139229633|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
139229634|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229635|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
139229636|NCT01312831|Hematinics|hematinics|mesh-ancestor
139229637|NCT04431193|Oxytocin|oxytocin|mesh-list
139229638|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
139229639|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139229640|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229641|NCT03293485|Imipenem|imipenem|mesh-list
139229642|NCT03293485|Relebactam|relebactam|mesh-list
139229643|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
139229644|NCT03293485|Cilastatin|cilastatin|mesh-list
139229645|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139229646|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229647|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
139229648|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229649|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229650|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139229651|NCT03309943|Propranolol|propranolol|mesh-list
139229652|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139229653|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139229654|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
139229655|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139229656|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229657|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229658|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139229659|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139229660|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
139229661|NCT01732627|Vaccines|vaccines|mesh-list
139229662|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
139229663|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229664|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139229665|NCT03331315|Celecoxib|celecoxib|mesh-list
139229666|NCT03331315|Ketorolac|ketorolac|mesh-list
139229667|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139229668|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139229669|NCT03331315|Analgesics|analgesics|mesh-ancestor
139229670|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
139229671|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229672|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229673|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139229674|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139229675|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139229676|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139229677|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229678|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229679|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
139229680|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
139229681|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139229682|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229683|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229684|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
139229685|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
139229686|NCT02661490|Vaccines|vaccines|mesh-list
139229687|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
139229688|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229689|NCT03287791|Azelaic acid|azelaic acid|mesh-list
139229690|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
139229691|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139229692|NCT03287791|Protective Agents|protective agents|mesh-ancestor
139229693|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229694|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
139229695|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229696|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139229697|NCT03287635|Hormones|hormones|mesh-ancestor
139229698|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229699|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229700|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
139229701|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139229702|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229703|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139229704|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
139229705|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139229706|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229707|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
139229708|NCT02385136|Temozolomide|temozolomide|mesh-list
139229709|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139229710|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
139229711|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229712|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229713|NCT02940691|Grazoprevir|grazoprevir|mesh-list
139229714|NCT02940691|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139229715|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
139229716|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229717|NCT04949269|Deucravacitinib|deucravacitinib|mesh-list
139229718|NCT04949269|Famotidine|famotidine|mesh-list
139229719|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139229720|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139229721|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139229722|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
139229723|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
139229724|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139229725|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229726|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229727|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
139229728|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139229729|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229730|NCT02379754|Gentamicins|gentamicins|mesh-list
139229731|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139229732|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229733|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139229734|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229735|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229736|NCT01313377|Gemcitabine|gemcitabine|mesh-list
139229737|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
139229738|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139229739|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
139229740|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229741|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229742|NCT02384746|Fulvestrant|fulvestrant|mesh-list
139229743|NCT02384746|Ixazomib|ixazomib|mesh-list
139229744|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139229745|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229746|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139229747|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139229748|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
139229749|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229750|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229751|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
139229752|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229753|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229754|NCT02375464|Octreotide|octreotide|mesh-list
139229755|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139229756|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139229757|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229758|NCT03113344|Amoxicillin|amoxicillin|mesh-list
139229759|NCT03113344|Azithromycin|azithromycin|mesh-list
139229760|NCT03113344|Meropenem|meropenem|mesh-list
139229761|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
139229762|NCT03113344|Penicillins|penicillins|mesh-list
139229763|NCT03113344|Imipenem|imipenem|mesh-list
139229764|NCT03113344|Erythromycin|erythromycin|mesh-list
139229765|NCT03113344|Ceftazidime|ceftazidime|mesh-list
139229766|NCT03113344|Ampicillin|ampicillin|mesh-list
139229767|NCT03113344|Cephalosporins|cephalosporins|mesh-list
139229768|NCT03113344|Acyclovir|acyclovir|mesh-list
139229769|NCT03113344|Ganciclovir|ganciclovir|mesh-list
139229770|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
139229771|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139229772|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229773|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229774|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229775|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139229776|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139229777|NCT03113266|Antibodies|antibodies|mesh-list
139229778|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139229779|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
139229780|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229781|NCT02379676|Clopidogrel|clopidogrel|mesh-list
139229782|NCT02379676|Ticagrelor|ticagrelor|mesh-list
139229783|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139229784|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139229785|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139229786|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139229787|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
139229788|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139229789|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229790|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229791|NCT02378740|Ketamine|ketamine|mesh-list
139229792|NCT02378740|Analgesics|analgesics|mesh-ancestor
139229793|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
139229794|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229795|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229796|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139229797|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139229798|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
139229799|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
139229800|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139229801|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139229802|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139229803|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139229804|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229805|NCT01411267|Cytarabine|cytarabine|mesh-list
139229806|NCT01411267|Methotrexate|methotrexate|mesh-list
139229807|NCT01411267|Etoposide|etoposide|mesh-list
139229808|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
139229809|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139229810|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
139229811|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139229812|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229813|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139229814|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
139229815|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229816|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229817|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
139229818|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229819|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139229820|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139229821|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
139229822|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139229823|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139229824|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139229825|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139229826|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139229827|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
139229828|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229829|NCT03113110|Empagliflozin|empagliflozin|mesh-list
139229830|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139229831|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229832|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139229833|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229834|NCT02383888|BI 425809|bi 425809|mesh-list
139229835|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
139229836|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
139229837|NCT03130959|Nivolumab|nivolumab|mesh-list
139229838|NCT03130959|Ipilimumab|ipilimumab|mesh-list
139229839|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139229840|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099948|NCT06031454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229841|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139229842|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229843|NCT01370031|Charcoal|charcoal|mesh-list
139229844|NCT01370031|Antidotes|antidotes|mesh-ancestor
139229845|NCT01370031|Protective Agents|protective agents|mesh-ancestor
139229846|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229847|NCT02373514|Acetaminophen|acetaminophen|mesh-list
139229848|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139229849|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139229850|NCT02373514|Analgesics|analgesics|mesh-ancestor
139229851|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
139229852|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229853|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229854|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
139229855|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139229856|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139229857|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139229858|NCT01364493|Capecitabine|capecitabine|mesh-list
139229859|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
139229860|NCT01364493|Trastuzumab|trastuzumab|mesh-list
139229861|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139229862|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
139229863|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229864|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229865|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139229866|NCT01370187|Montelukast|montelukast|mesh-list
139229867|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139229868|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
139229869|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139229870|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
139229871|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229872|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229873|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139229874|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139229875|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229876|NCT04483960|Nafamostat|nafamostat|mesh-list
139229877|NCT04483960|Enoxaparin|enoxaparin|mesh-list
139229878|NCT04483960|Dalteparin|dalteparin|mesh-list
139229879|NCT04483960|Tinzaparin|tinzaparin|mesh-list
139229880|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139229881|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
139229882|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139229883|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139229884|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229885|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139229886|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139229887|NCT04483960|Analgesics|analgesics|mesh-ancestor
139229888|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
139229889|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229890|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229891|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139229892|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139229893|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
139229894|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229895|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139229896|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139229897|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139229898|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139229899|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
139229900|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
139229901|NCT01370343|Cyclosporine|cyclosporine|mesh-list
139229902|NCT01370343|Cyclosporins|cyclosporins|mesh-list
139229903|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
139229904|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229905|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229906|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139229907|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
139229908|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229909|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
139229910|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229911|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
139642177|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139229912|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139100028|NCT05980117|Anesthetics|anesthetics|mesh-ancestor
139229913|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139229914|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
139229915|NCT01370343|Vitamins|vitamins|mesh-ancestor
139229916|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
139229917|NCT01368003|Dutasteride|dutasteride|mesh-list
139229918|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139229919|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139229920|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229921|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229922|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
139229923|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139229924|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229925|NCT01364571|Vaccines|vaccines|mesh-list
139229926|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
139229927|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229928|NCT02377648|Everolimus|everolimus|mesh-list
139229929|NCT02377648|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139229930|NCT02377648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139229931|NCT02377648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229932|NCT02377648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229933|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139229934|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
139229935|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229936|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229937|NCT02371408|Ribavirin|ribavirin|mesh-list
139229938|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
139229939|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
139229940|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229941|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
139229942|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139229943|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
139229944|NCT01364805|Gemcitabine|gemcitabine|mesh-list
139229945|NCT01364805|Vitamins|vitamins|mesh-ancestor
139229946|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
139229947|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229948|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139229949|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
139229950|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229951|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229952|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
139229953|NCT01364805|Protective Agents|protective agents|mesh-ancestor
139229954|NCT01370889|Resveratrol|resveratrol|mesh-list
139229955|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
139229956|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229957|NCT01370889|Protective Agents|protective agents|mesh-ancestor
139229958|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229959|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229960|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139229961|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139229962|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139229963|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229964|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139229965|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229966|NCT02371096|Rituximab|rituximab|mesh-list
139229967|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139229968|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139229969|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
139229970|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229971|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139229972|NCT04420455|Enoximone|enoximone|mesh-list
139229973|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139229974|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
139229975|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139229976|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139229977|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229978|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229979|NCT04420455|Protective Agents|protective agents|mesh-ancestor
139229980|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229981|NCT03124407|Capsaicin|capsaicin|mesh-list
139229982|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
139229983|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
139229984|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
139642178|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229985|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139229986|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229987|NCT01364961|Resveratrol|resveratrol|mesh-list
139229988|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
139229989|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229990|NCT01364961|Protective Agents|protective agents|mesh-ancestor
139229991|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139229992|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229993|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139229994|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
139229995|NCT02370862|Neostigmine|neostigmine|mesh-list
139229996|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139229997|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139229998|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139229999|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
139230000|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230001|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230002|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139230003|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
139230004|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230005|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139230006|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139230007|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139230008|NCT02373280|Amoxicillin|amoxicillin|mesh-list
139230009|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
139230010|NCT02373280|Metronidazole|metronidazole|mesh-list
139230011|NCT02373280|Clarithromycin|clarithromycin|mesh-list
139230012|NCT02373280|Esomeprazole|esomeprazole|mesh-list
139230013|NCT02373280|Bismuth|bismuth|mesh-list
139230014|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139230015|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139230016|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230017|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139230018|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139230019|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230020|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230021|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230022|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139230023|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
139230024|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139230025|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230026|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139230027|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139230028|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139230029|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139230030|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139230031|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139230032|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139230033|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139230034|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139230035|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139230036|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139230037|NCT02373280|Antacids|antacids|mesh-ancestor
139230038|NCT02370550|Cyclosporine|cyclosporine|mesh-list
139230039|NCT02370550|Prednisone|prednisone|mesh-list
139230040|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
139230041|NCT02370550|Calcium|calcium|mesh-list
139230042|NCT02370550|Cyclosporins|cyclosporins|mesh-list
139230043|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139230044|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230045|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139230046|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
139230047|NCT02370550|Hormones|hormones|mesh-ancestor
139230048|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139230049|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139230050|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230051|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230052|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230053|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139230054|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
139230055|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
139230056|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230057|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
139230058|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139230059|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139100170|NCT05752305|Prednisolone phosphate|prednisolone phosphate|mesh-list
139230061|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139230062|NCT02365402|Entecavir|entecavir|mesh-list
139230063|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
139186639|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
139230064|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230065|NCT02364934|Propofol|propofol|mesh-list
139230066|NCT02364934|Sevoflurane|sevoflurane|mesh-list
139230067|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139230068|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139230069|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230070|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139230071|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
139230072|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
139230073|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139230074|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139230075|NCT02372656|Metformin|metformin|mesh-list
139230076|NCT02372656|Simvastatin|simvastatin|mesh-list
139230077|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139230078|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230079|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139230080|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139230081|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
139230082|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230083|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139230084|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139230085|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230086|NCT03123939|Tisagenlecleucel|tisagenlecleucel|mesh-list
139230087|NCT03123939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139230088|NCT03123939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230089|NCT01368627|Sirolimus|sirolimus|mesh-list
139230090|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139230091|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230092|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139230093|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230094|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
139230095|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139230096|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
139230097|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230098|NCT02358681|Ketorolac|ketorolac|mesh-list
139230099|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139230100|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139230101|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139230102|NCT02358681|Analgesics|analgesics|mesh-ancestor
139230103|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
139230104|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230105|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230106|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139230107|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139230108|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139230109|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230110|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230111|NCT03123861|Gabapentin|gabapentin|mesh-list
139230112|NCT03123861|Analgesics|analgesics|mesh-ancestor
139230113|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
139230114|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230115|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230116|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
139230117|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139230118|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139230119|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139230120|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139230121|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139230122|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139230123|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230124|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230125|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
139230126|NCT01368783|Ritonavir|ritonavir|mesh-list
139230127|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139230128|NCT01368783|Tenofovir|tenofovir|mesh-list
139230129|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139230130|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139642179|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230131|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
139230132|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230133|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230134|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139230135|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139230136|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
139230137|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230138|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139230139|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139230140|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139186715|NCT00753532|Vitamin E|vitamin e|mesh-list
139230141|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139230143|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139230144|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230145|NCT03123471|Apremilast|apremilast|mesh-list
139230146|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139230147|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139230148|NCT03123471|Analgesics|analgesics|mesh-ancestor
139230149|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
139230150|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230151|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230152|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139230153|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139230154|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139230155|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139230156|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230157|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230158|NCT02661178|Emodepside|emodepside|mesh-list
139230159|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139230160|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230161|NCT01365117|Insulin|insulin|mesh-list
139230162|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139230163|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139230164|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230165|NCT02372812|Dexamethasone|dexamethasone|mesh-list
139230166|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139230167|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
139230168|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
139230169|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230170|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230171|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139230172|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
139230173|NCT02372812|Hormones|hormones|mesh-ancestor
139230174|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139230175|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139230176|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230177|NCT02365012|Midodrine|midodrine|mesh-list
139230178|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
139230179|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
139230180|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230181|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230182|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139230183|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139230184|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139230185|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139230186|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
139230187|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230188|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230189|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139230190|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139230191|NCT01365351|Hormones|hormones|mesh-list
139230192|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139230193|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230194|NCT01372449|Memantine|memantine|mesh-list
139230195|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139230196|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139230197|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
139230198|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230199|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230200|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230201|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139230202|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139230203|NCT04666389|Atorvastatin|atorvastatin|mesh-list
139230204|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139230205|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139230206|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
139230207|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230208|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139230209|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139230210|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230211|NCT02372110|Caffeine|caffeine|mesh-list
139230212|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139230213|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230214|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139230215|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230216|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230217|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139230218|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139230219|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
139230220|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230221|NCT02372188|Caffeine|caffeine|mesh-list
139230222|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139230223|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230224|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139230225|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230226|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230227|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139230228|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139230229|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
139230230|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230231|NCT01371435|Paroxetine|paroxetine|mesh-list
139230232|NCT01371435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139230233|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139230234|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139230235|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230236|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230237|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
139230238|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230239|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139230240|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
139230241|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139230242|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139230243|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139230244|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230245|NCT01369719|Deferasirox|deferasirox|mesh-list
139230246|NCT01369719|Deferoxamine|deferoxamine|mesh-list
139230247|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139230248|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
139230249|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
139230250|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230251|NCT01369719|Siderophores|siderophores|mesh-ancestor
139230252|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
139230253|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139230254|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
139230255|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230256|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
139230257|NCT02369380|Protective Agents|protective agents|mesh-ancestor
139230258|NCT02038816|Azacitidine|azacitidine|mesh-list
139230259|NCT02038816|Deferasirox|deferasirox|mesh-list
139230260|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139230261|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
139230262|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230263|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230264|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230265|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139230266|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
139230267|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
139230268|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
139230269|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139230270|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230271|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
139230272|NCT02359162|Prednisone|prednisone|mesh-list
139230273|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
139230274|NCT02359162|Gemcitabine|gemcitabine|mesh-list
139230275|NCT02359162|Doxorubicin|doxorubicin|mesh-list
139230276|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
139230277|NCT02359162|Etoposide|etoposide|mesh-list
139230278|NCT02359162|Vincristine|vincristine|mesh-list
139230279|NCT02359162|Pegaspargase|pegaspargase|mesh-list
139230280|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139230281|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
139230282|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230283|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139230284|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139230285|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
139230286|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230287|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186862|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139230288|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139230289|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139230290|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
139230291|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139230292|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139230293|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139230294|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230295|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139230296|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
139230298|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139230299|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139230300|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139230301|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
139230302|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
139230303|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
139230304|NCT03634605|Tetracycline|tetracycline|mesh-list
139230305|NCT03634605|Lidocaine|lidocaine|mesh-list
139230306|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
139230307|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
139230308|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139230309|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230310|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
139230311|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230312|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139230313|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139230314|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139230315|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139230316|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230317|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139230318|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230319|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139230320|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230321|NCT02363764|Dimercaprol|dimercaprol|mesh-list
139230322|NCT02363764|Chelating Agents|chelating agents|mesh-ancestor
139230323|NCT02363764|Sequestering Agents|sequestering agents|mesh-ancestor
139230324|NCT02363764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230325|NCT03654794|Tacrolimus|tacrolimus|mesh-list
139230326|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139230327|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
139230328|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230329|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139230330|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230331|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230332|NCT03654170|BI 425809|bi 425809|mesh-list
139230333|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
139230334|NCT02369146|UB-421|ub-421|mesh-list
139230335|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139230336|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
139230337|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230338|NCT02363452|Lamivudine|lamivudine|mesh-list
139230339|NCT02363452|Zidovudine|zidovudine|mesh-list
139230340|NCT02363452|Abacavir|abacavir|mesh-list
139230341|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139230342|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139230343|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230344|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230345|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
139230346|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230347|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139230348|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139230349|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
139230350|NCT03634137|Afamelanotide|afamelanotide|mesh-list
139230351|NCT03634137|alpha-MSH|alpha-msh|mesh-list
139230352|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
139230353|NCT03634137|Hormones|hormones|mesh-ancestor
139230354|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139230355|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230356|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
139100480|NCT05075993|Paclitaxel|paclitaxel|mesh-list
139230357|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139230358|NCT02358694|Antibodies|antibodies|mesh-list
139230359|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
139230360|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230361|NCT04473807|Sotalol|sotalol|mesh-list
139230362|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139230363|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139230364|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
139230365|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230366|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230367|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230368|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139230369|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
139230370|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
139230371|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230372|NCT02323659|Interferons|interferons|mesh-list
139230373|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
139230374|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
139230375|NCT02323659|Methotrexate|methotrexate|mesh-list
139230376|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139230377|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
139230378|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139230379|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230380|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139230381|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
139230382|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230383|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230384|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
139230385|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230386|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139230387|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139230388|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
139230389|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139230390|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139230391|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
139230392|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230393|NCT03634059|Apatinib|apatinib|mesh-list
139230394|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230395|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139230396|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230397|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230398|NCT02358304|Calcitonin|calcitonin|mesh-list
139230399|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
139230400|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139230401|NCT02358304|Katacalcin|katacalcin|mesh-list
139230402|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139230403|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230404|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139230405|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
139230406|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
139230407|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139230408|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139230409|NCT02362906|Azithromycin|azithromycin|mesh-list
139230410|NCT02362906|Erythromycin|erythromycin|mesh-list
139230411|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
139230412|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139230413|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
139230414|NCT02362906|Cephalosporins|cephalosporins|mesh-list
139230415|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139230416|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230417|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139230418|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139230419|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230420|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230421|NCT03085914|Leucovorin|leucovorin|mesh-list
139230422|NCT03085914|Paclitaxel|paclitaxel|mesh-list
139230423|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139230424|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
139230425|NCT03085914|Carboplatin|carboplatin|mesh-list
139230426|NCT03085914|Gemcitabine|gemcitabine|mesh-list
139230427|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
139230428|NCT03085914|Fluorouracil|fluorouracil|mesh-list
139230429|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
139230430|NCT03085914|Pemetrexed|pemetrexed|mesh-list
139230431|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139230432|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642180|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
139230433|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
139230434|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
139230435|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
139230436|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230437|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139230438|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
139230439|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230440|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139230441|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139230442|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
139230443|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139230444|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139230445|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
139230446|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139230447|NCT03085914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139230449|NCT03085914|Protective Agents|protective agents|mesh-ancestor
139230450|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
139230451|NCT03085914|Vitamins|vitamins|mesh-ancestor
139230452|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
139230453|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230454|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139230455|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139230456|NCT02467608|Isoniazid|isoniazid|mesh-list
139230457|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
139230458|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139230459|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230460|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139230461|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139230462|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
139230463|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230464|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139230465|NCT02368288|Entecavir|entecavir|mesh-list
139230466|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
139230467|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230468|NCT02368054|Epinephrine|epinephrine|mesh-list
139230469|NCT02368054|Racepinephrine|racepinephrine|mesh-list
139230470|NCT02368054|Bupivacaine|bupivacaine|mesh-list
139230471|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
139230472|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
139230473|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
139230474|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139230475|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230476|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
139230477|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230478|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139230479|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139230480|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
139230481|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230482|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230483|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139230484|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139230485|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
139230486|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139230487|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
139230488|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
139230489|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
139230490|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139230491|NCT02357602|Tenofovir|tenofovir|mesh-list
139230492|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
139230493|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230494|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139230495|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139230496|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230497|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230498|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139230499|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139230500|NCT01379196|Azithromycin|azithromycin|mesh-list
139230501|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139230502|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230503|NCT01382238|Dolutegravir|dolutegravir|mesh-list
139230504|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139230505|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139230506|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230507|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230508|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139230509|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139230510|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
139230511|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230513|NCT03112564|Sevoflurane|sevoflurane|mesh-list
139230514|NCT03112564|Rocuronium|rocuronium|mesh-list
139230515|NCT03112564|Cisatracurium|cisatracurium|mesh-list
139230516|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139230517|NCT03112564|Narcotics|narcotics|mesh-ancestor
139230518|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139230519|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230521|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
139230522|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230523|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139230524|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139230525|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
139230526|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
139230527|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139230528|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139230529|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139230530|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139230531|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139230532|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
139230533|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
139230534|NCT01379976|Vitamins|vitamins|mesh-ancestor
139230535|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
139230536|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230537|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
139230538|NCT01379898|Doxazosin|doxazosin|mesh-list
139230539|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
139230540|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139230541|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139230542|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139230543|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139230544|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
139230545|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230546|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230547|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230548|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
139230549|NCT02362516|BI 425809|bi 425809|mesh-list
139230550|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
139230551|NCT02367664|Vaccines|vaccines|mesh-list
139230552|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
139230553|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230554|NCT05421000|Anesthetics|anesthetics|mesh-list
139230555|NCT05421000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139230556|NCT05421000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230557|NCT02357212|Adenosine|adenosine|mesh-list
139230558|NCT02357212|Analgesics|analgesics|mesh-ancestor
139230559|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
139230560|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230561|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230562|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139230563|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
139230564|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139230565|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
139230566|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
139230567|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230568|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230569|NCT01382160|Adalimumab|adalimumab|mesh-list
139230570|NCT01382160|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139230571|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139230572|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139230573|NCT00735748|Tramadol|tramadol|mesh-list
139230574|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139230575|NCT00735748|Narcotics|narcotics|mesh-ancestor
139230576|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139230577|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230578|NCT00735748|Analgesics|analgesics|mesh-ancestor
139230579|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
139230580|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230581|NCT02367196|Rituximab|rituximab|mesh-list
139230582|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139230583|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230584|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
139230585|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230586|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139230587|NCT05418504|Anesthetics|anesthetics|mesh-list
139230588|NCT05418504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139230589|NCT05418504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230590|NCT03408886|Vancomycin|vancomycin|mesh-list
139230591|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139230592|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230593|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
139230594|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139230595|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
139230596|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139230597|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230598|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139230599|NCT04013334|Nivolumab|nivolumab|mesh-list
139230600|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139230601|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230602|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139230603|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230604|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139230605|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
139230606|NCT02366884|Clotrimazole|clotrimazole|mesh-list
139230607|NCT02366884|Miconazole|miconazole|mesh-list
139230608|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
139230609|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230610|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139230611|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139230612|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139230613|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230614|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230615|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139230616|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
139230617|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139230618|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230619|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139230620|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139230621|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139230622|NCT02361502|Mirabegron|mirabegron|mesh-list
139230623|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139230624|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139230625|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139230626|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
139230627|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230628|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230629|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230630|NCT02361502|Urological Agents|urological agents|mesh-ancestor
139230631|NCT02367118|Prednisone|prednisone|mesh-list
139230632|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139230633|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
139230634|NCT02367118|Hormones|hormones|mesh-ancestor
139230635|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139230636|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230637|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139230638|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230639|NCT00979212|Paclitaxel|paclitaxel|mesh-list
139230640|NCT00979212|Carboplatin|carboplatin|mesh-list
139230641|NCT00979212|Panitumumab|panitumumab|mesh-list
139230642|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139230643|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230644|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
139230645|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
139230646|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
139230647|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230648|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139230649|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
139230650|NCT02361190|Testosterone|testosterone|mesh-list
139230651|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
139230652|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
139230653|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139230654|NCT02361190|Androgens|androgens|mesh-ancestor
139230655|NCT02361190|Hormones|hormones|mesh-ancestor
139230656|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139230657|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230658|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139230659|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230660|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
139230661|NCT02361112|Capecitabine|capecitabine|mesh-list
139230662|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139230663|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
139230664|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230665|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230666|NCT02360956|Olmesartan|olmesartan|mesh-list
139230667|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139187255|NCT01136759|Tenofovir|tenofovir|mesh-list
139230668|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
139230669|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139230670|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139230671|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230672|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139230673|NCT02360800|Hemostatics|hemostatics|mesh-list
139230674|NCT02360800|Coagulants|coagulants|mesh-ancestor
139230675|NCT03501966|Acetazolamide|acetazolamide|mesh-list
139230676|NCT03501966|Diuretics|diuretics|mesh-list
139230677|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
139230678|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230679|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
139230680|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139230681|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230682|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230683|NCT02355184|Leronlimab|leronlimab|mesh-list
139230684|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139230685|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139230686|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230687|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139230688|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139230689|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
139230690|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230691|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
139230692|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139230693|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
139230694|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230695|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
139230696|NCT03477630|Protective Agents|protective agents|mesh-ancestor
139230697|NCT02981342|Gemcitabine|gemcitabine|mesh-list
139230698|NCT02981342|Capecitabine|capecitabine|mesh-list
139230699|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139230700|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
139230701|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230702|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230703|NCT02360644|Vitamin D|vitamin d|mesh-list
139230704|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
139230705|NCT02360644|Vitamins|vitamins|mesh-ancestor
139230706|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
139230707|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230708|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139230709|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139230710|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
139230711|NCT02365948|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139230712|NCT02365948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139230713|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139230714|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
139230715|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230716|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139230717|NCT02354950|Cabotegravir|cabotegravir|mesh-list
139230718|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139230719|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139230720|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230721|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230722|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139230723|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139230724|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
139230725|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230726|NCT02980874|Triamcinolone|triamcinolone|mesh-list
139230727|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139230728|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139230729|NCT02980874|Aflibercept|aflibercept|mesh-list
139230730|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139230731|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139230732|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
139230733|NCT02980874|Hormones|hormones|mesh-ancestor
139230734|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139230735|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230736|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139230737|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
139230738|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230739|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230740|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139230741|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139230742|NCT02980874|Growth Substances|growth substances|mesh-ancestor
139230743|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
139230744|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230746|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139230747|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
139230748|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230749|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230750|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139230751|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139230752|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
139230753|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230754|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230755|NCT02354638|Nicotine|nicotine|mesh-list
139230756|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139230757|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
139230758|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230759|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230760|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139230761|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139230762|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
139230763|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230764|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230765|NCT02360254|Insulin|insulin|mesh-list
139230766|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139230767|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230768|NCT03112642|Anesthetics|anesthetics|mesh-list
139230769|NCT03112642|Bupivacaine|bupivacaine|mesh-list
139230770|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
139230771|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139230772|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230773|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
139230774|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230775|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139230776|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139230777|NCT01377324|Estradiol|estradiol|mesh-list
139230778|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139230779|NCT01377324|Estrogens|estrogens|mesh-ancestor
139230780|NCT01377324|Hormones|hormones|mesh-ancestor
139230781|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139230782|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230783|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139230784|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
139230785|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139230786|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139230787|NCT02359942|Citric Acid|citric acid|mesh-list
139230788|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
139230789|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
139230790|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139230791|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
139230792|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
139230793|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230794|NCT02354560|Erythromycin|erythromycin|mesh-list
139230795|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
139230796|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139230797|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
139230798|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139230799|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230800|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139230801|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139230802|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230803|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230804|NCT01378884|Domperidone|domperidone|mesh-list
139230805|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
139230806|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
139230807|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230808|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230809|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139230810|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139100925|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
139230811|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
139230812|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230813|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230814|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
139230815|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139230816|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
139230817|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230818|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230819|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139230820|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
139230821|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
139230822|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139230823|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
139230824|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139299045|NCT05414292|MTOR Inhibitors|mtor inhibitors|mesh-list
139230825|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230827|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139230828|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
139230829|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139230830|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230831|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139230832|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139230833|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139230834|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
139230835|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139230836|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139230837|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
139230838|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139230839|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
139230840|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139230841|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139230842|NCT01377246|Octreotide|octreotide|mesh-list
139230843|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139230844|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139230845|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230846|NCT02353936|Afatinib|afatinib|mesh-list
139230847|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230848|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139230849|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230850|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230851|NCT02353858|Fluorouracil|fluorouracil|mesh-list
139230852|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
139230853|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230854|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139230855|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230856|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139230857|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
139230858|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230859|NCT02353702|Ropivacaine|ropivacaine|mesh-list
139230860|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
139230861|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
139230862|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139230863|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230864|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
139230865|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230866|NCT02532660|Dexetimide|dexetimide|mesh-list
139230867|NCT02532660|Citalopram|citalopram|mesh-list
139230868|NCT02532660|Escitalopram|escitalopram|mesh-list
139230869|NCT02532660|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139230870|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139230871|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139230872|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230873|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139230874|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
139230875|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230876|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139230877|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139230878|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
139230879|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
139230880|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230881|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139230882|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139642181|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230883|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
139230884|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139230885|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
139230886|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139230887|NCT01377168|Naltrexone|naltrexone|mesh-list
139230888|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139230889|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139230890|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187465|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139230891|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
139230892|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139230893|NCT02892149|Darbepoetin alfa|darbepoetin alfa|mesh-list
139230894|NCT02892149|Hematinics|hematinics|mesh-ancestor
139230895|NCT02348398|Topotecan|topotecan|mesh-list
139230896|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139230897|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139230898|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230899|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230900|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230901|NCT05278338|Denosumab|denosumab|mesh-list
139230902|NCT05278338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139230903|NCT05278338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230904|NCT03721757|Nivolumab|nivolumab|mesh-list
139230905|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139230906|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230907|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139230908|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230909|NCT03727607|Propofol|propofol|mesh-list
139230910|NCT03727607|Desflurane|desflurane|mesh-list
139230911|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139230912|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139230913|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230914|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139230915|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
139230916|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
139230917|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139230918|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
139230919|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139230920|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139230921|NCT03157414|Empagliflozin|empagliflozin|mesh-list
139230922|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139230923|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230924|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139230925|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230926|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139230927|NCT03147196|Bicalutamide|bicalutamide|mesh-list
139230928|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
139230929|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
139230930|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139230931|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230932|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230933|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139230934|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139230935|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139230936|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139230937|NCT03153436|Inositol|inositol|mesh-list
139230938|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
139230939|NCT03153436|Vitamins|vitamins|mesh-ancestor
139230940|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
139230941|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230942|NCT03544229|Maleic acid|maleic acid|mesh-list
139230943|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230944|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230945|NCT02351908|Tenofovir|tenofovir|mesh-list
139230946|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
139230947|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139230948|NCT02351908|Dolutegravir|dolutegravir|mesh-list
139230949|NCT02351908|Cobicistat|cobicistat|mesh-list
139230950|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139230951|NCT02351908|Elvitegravir|elvitegravir|mesh-list
139230952|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
139230953|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139230954|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139230955|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139230956|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230957|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230958|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139230959|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139230960|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139230961|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139230962|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139230963|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139230964|NCT01371240|Secretin|secretin|mesh-list
139230965|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139230966|NCT01371240|Hormones|hormones|mesh-ancestor
139230967|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139230968|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230969|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139230970|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139230971|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230972|NCT03723941|Etoposide|etoposide|mesh-list
139230973|NCT03723941|Mitotane|mitotane|mesh-list
139230974|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230975|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139230976|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139230977|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139230978|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139230979|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230980|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139230981|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
139230982|NCT03721679|Nivolumab|nivolumab|mesh-list
139230983|NCT03721679|Atezolizumab|atezolizumab|mesh-list
139230984|NCT03721679|Durvalumab|durvalumab|mesh-list
139230985|NCT03721679|Poly ICLC|poly iclc|mesh-list
139230986|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139230987|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230988|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139230989|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139230990|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
139230991|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
139230992|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139230993|NCT03639948|Carboplatin|carboplatin|mesh-list
139230994|NCT03639948|Docetaxel|docetaxel|mesh-list
139230995|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
139230996|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139230997|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
139230998|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
139230999|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
139231000|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231001|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139231002|NCT03639948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139231003|NCT03510455|Infigratinib|infigratinib|mesh-list
139231004|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231005|NCT03509675|Ibuprofen|ibuprofen|mesh-list
139231006|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139231007|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139231008|NCT03509675|Analgesics|analgesics|mesh-ancestor
139231009|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
139231010|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231011|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231012|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139231013|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139231014|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139231015|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231016|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231017|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
139231018|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
139231019|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139231020|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139231021|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231022|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231023|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231024|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139231025|NCT02353078|Sucralfate|sucralfate|mesh-list
139231026|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139231027|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139231028|NCT03509207|Vorinostat|vorinostat|mesh-list
139231029|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231030|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139101138|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
139231031|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231032|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231033|NCT03727295|Idebenone|idebenone|mesh-list
139231034|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
139231035|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231036|NCT03727295|Protective Agents|protective agents|mesh-ancestor
139231037|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231038|NCT01378650|Cilostazol|cilostazol|mesh-list
139187627|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
139231039|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139231040|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
139231041|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231042|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231043|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139231044|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
139231045|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139231046|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139231047|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231048|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139231049|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
139231050|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139231051|NCT01378650|Protective Agents|protective agents|mesh-ancestor
139231052|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139231053|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139231054|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231056|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
139231057|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139231058|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231059|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
139231060|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231061|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139231062|NCT03723785|Insulin|insulin|mesh-list
139231063|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139231064|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139231065|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231066|NCT03543137|Nicotine|nicotine|mesh-list
139231067|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139231068|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
139231069|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231070|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231071|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139231072|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139231073|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
139231074|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231075|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231076|NCT02343484|Ethanol|ethanol|mesh-list
139231077|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139231078|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231079|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139231080|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231081|NCT03073980|Acetaminophen|acetaminophen|mesh-list
139231082|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139231083|NCT03073980|Analgesics|analgesics|mesh-ancestor
139231084|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
139231085|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231086|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231087|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
139231088|NCT03930186|Apremilast|apremilast|mesh-list
139231089|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139231090|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139231091|NCT03930186|Analgesics|analgesics|mesh-ancestor
139231092|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
139231093|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231094|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231095|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139231096|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139231097|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139231098|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139231099|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231100|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231101|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139231102|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139642182|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
139231103|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139231104|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139231105|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231106|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231107|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231108|NCT02351440|Analgesics|analgesics|mesh-ancestor
139231109|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
139231110|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231111|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
139231112|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139231114|NCT03504917|Balovaptan|balovaptan|mesh-list
139231115|NCT03504917|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139231116|NCT03504917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231117|NCT03504917|Natriuretic Agents|natriuretic agents|mesh-ancestor
139231118|NCT03504917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231119|NCT02351128|Lanreotide|lanreotide|mesh-list
139231120|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231121|NCT02343250|Valsartan|valsartan|mesh-list
139231122|NCT02343250|Cilnidipine|cilnidipine|mesh-list
139231123|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139231124|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139231125|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139231126|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231127|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139231128|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139231129|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139231130|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231131|NCT03565211|Progesterone|progesterone|mesh-list
139231132|NCT03565211|Progestins|progestins|mesh-ancestor
139231133|NCT03565211|Hormones|hormones|mesh-ancestor
139231134|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139231135|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231136|NCT03723395|Repaglinide|repaglinide|mesh-list
139231137|NCT03723395|Tolbutamide|tolbutamide|mesh-list
139231138|NCT03723395|Itraconazole|itraconazole|mesh-list
139231139|NCT03723395|Rifampin|rifampin|mesh-list
139231140|NCT03723395|Tucatinib|tucatinib|mesh-list
139231141|NCT03723395|Digoxin|digoxin|mesh-list
139231142|NCT03723395|Midazolam|midazolam|mesh-list
139231143|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
139231144|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139231145|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139231146|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139231147|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231148|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139231149|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139231150|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139231151|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139231152|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
139231153|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
139231154|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
139231155|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
139231156|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231157|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231158|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
139231159|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231160|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139231161|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139231162|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231163|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139231164|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
139231165|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139231166|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139231167|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139231168|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
139231169|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139231170|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
139231171|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139231172|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139231173|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139231174|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139231175|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139231176|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139231177|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139231178|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139231179|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139231180|NCT03723395|Protective Agents|protective agents|mesh-ancestor
139231181|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139231182|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231183|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139231184|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139231185|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
139231186|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139231187|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139231188|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139231189|NCT03531905|Ezetimibe|ezetimibe|mesh-list
139231190|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139231191|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139231192|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
139231193|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231194|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139231195|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231196|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139231197|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231198|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139231199|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139231200|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231201|NCT02346682|Clonazepam|clonazepam|mesh-list
139231202|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139231203|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139231204|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139231205|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139231206|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231207|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231208|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231209|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139231210|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
139231211|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139231212|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
139231213|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
139231214|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
139231215|NCT05764512|Endorphins|endorphins|mesh-list
139231216|NCT05764512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231217|NCT05764512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231218|NCT05764512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231219|NCT02342392|Ranibizumab|ranibizumab|mesh-list
139231220|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139231221|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139231222|NCT02342392|Growth Substances|growth substances|mesh-ancestor
139231223|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231224|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
139231225|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231226|NCT02342002|Misoprostol|misoprostol|mesh-list
139231227|NCT02342002|Mifepristone|mifepristone|mesh-list
139231228|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139231229|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
139231230|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139231231|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231232|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139231233|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139231234|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
139231235|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139231236|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139231237|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139231238|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139231239|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
139231240|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139231241|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139231242|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
139231243|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139231244|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
139231245|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139231246|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139231247|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
139231248|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139231249|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231250|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139231251|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139231252|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231253|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231254|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231255|NCT02345902|Haloperidol|haloperidol|mesh-list
139231256|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
139231257|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
139231258|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
139231259|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231260|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231261|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139231262|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139231263|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139231264|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139231265|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139231266|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139231267|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
139231268|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231269|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231270|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139231271|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
139231272|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
139231273|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139231274|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139231275|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231276|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231277|NCT02345980|Urological Agents|urological agents|mesh-ancestor
139231278|NCT02345746|Leucovorin|leucovorin|mesh-list
139231279|NCT02345746|Folic Acid|folic acid|mesh-list
139231280|NCT02345746|Fluorouracil|fluorouracil|mesh-list
139231281|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
139231282|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
139231283|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
139231284|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231285|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139231286|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231287|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139231288|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
139231289|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231290|NCT02345746|Antidotes|antidotes|mesh-ancestor
139231291|NCT02345746|Protective Agents|protective agents|mesh-ancestor
139231292|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
139231293|NCT02345746|Vitamins|vitamins|mesh-ancestor
139231294|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
139231295|NCT02345746|Hematinics|hematinics|mesh-ancestor
139231296|NCT03794778|Paclitaxel|paclitaxel|mesh-list
139231297|NCT03794778|Carboplatin|carboplatin|mesh-list
139231298|NCT03794778|Doxorubicin|doxorubicin|mesh-list
139231299|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139231300|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139231301|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231302|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
139231303|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
139231304|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
139231305|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231306|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139231307|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139231308|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139231309|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231310|NCT02341300|Iron|iron|mesh-list
139231311|NCT02341300|Trace Elements|trace elements|mesh-ancestor
139231312|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
139231313|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231314|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139231315|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139231316|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139231317|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139231318|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139231319|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
139231320|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231321|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231322|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231323|NCT02345590|Eplerenone|eplerenone|mesh-list
139231324|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139231325|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
139642183|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139101440|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139231326|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139231327|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231328|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139231329|NCT02345590|Diuretics|diuretics|mesh-ancestor
139231330|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
139231331|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139231332|NCT03723083|Thalidomide|thalidomide|mesh-list
139231333|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139231334|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
139231335|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231336|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
139231337|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139231338|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231339|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139231340|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139231341|NCT03723083|Growth Substances|growth substances|mesh-ancestor
139231342|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
139231343|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231344|NCT03562481|Lidocaine|lidocaine|mesh-list
139231345|NCT03562481|Epinephrine|epinephrine|mesh-list
139231346|NCT03562481|Racepinephrine|racepinephrine|mesh-list
139231347|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
139231348|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
139231349|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
139231350|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139231351|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231352|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
139231353|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231354|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139231355|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139231356|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139231357|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139231358|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231359|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139231360|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139231361|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
139231362|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231363|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139231364|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139231365|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
139231366|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139231367|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
139231368|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
139231369|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
139231370|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139231371|NCT03726593|Artesunate|artesunate|mesh-list
139231372|NCT03726593|Mefloquine|mefloquine|mesh-list
139231373|NCT03726593|Atovaquone|atovaquone|mesh-list
139231374|NCT03726593|Pyronaridine|pyronaridine|mesh-list
139231375|NCT03726593|Proguanil|proguanil|mesh-list
139231376|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
139231377|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
139231378|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139231379|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139231380|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231381|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231382|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
139231383|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
139231384|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139231385|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
139231386|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231387|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231388|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
139231389|NCT03197064|Fosaprepitant|fosaprepitant|mesh-list
139231390|NCT03197064|Aprepitant|aprepitant|mesh-list
139231391|NCT03197064|Antiemetics|antiemetics|mesh-ancestor
139231392|NCT03197064|Autonomic Agents|autonomic agents|mesh-ancestor
139231393|NCT03197064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231394|NCT03197064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231395|NCT03197064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139231396|NCT03197064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139231397|NCT03197064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231398|NCT03197064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231399|NCT02345044|Eplerenone|eplerenone|mesh-list
139231400|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139642184|NCT01347255|Betamethasone|betamethasone|mesh-list
139231401|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
139231402|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139231403|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231404|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139231405|NCT02345044|Diuretics|diuretics|mesh-ancestor
139231406|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
139231407|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139231408|NCT02349802|Exenatide|exenatide|mesh-list
139187997|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
139231409|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139231410|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231411|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139231412|NCT02349802|Incretins|incretins|mesh-ancestor
139231413|NCT02349802|Hormones|hormones|mesh-ancestor
139231414|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139231415|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
139231416|NCT03145714|Anesthetics|anesthetics|mesh-list
139231417|NCT03145714|Propofol|propofol|mesh-list
139231418|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139231419|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231420|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139231421|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139231422|NCT03145714|Analgesics|analgesics|mesh-ancestor
139231423|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
139231424|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231425|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139231426|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139231427|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139231428|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
139231429|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231430|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231431|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139231432|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
139231433|NCT02349958|Doxorubicin|doxorubicin|mesh-list
139231434|NCT02349958|Cisplatin|cisplatin|mesh-list
139231435|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139231436|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231437|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139231438|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139231439|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231440|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231441|NCT04872426|Insulin|insulin|mesh-list
139231442|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139231443|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231444|NCT02344888|Folic Acid|folic acid|mesh-list
139231445|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
139231446|NCT02344888|Prednisolone|prednisolone|mesh-list
139231447|NCT02344888|Citric Acid|citric acid|mesh-list
139231448|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
139231449|NCT02344888|Clomiphene|clomiphene|mesh-list
139231450|NCT02344888|Enclomiphene|enclomiphene|mesh-list
139231451|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
139231452|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
139231453|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139231454|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
139231455|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
139231456|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231457|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139231458|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
139231459|NCT02344888|Hormones|hormones|mesh-ancestor
139231460|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139231461|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231462|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139231463|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231464|NCT02344888|Hematinics|hematinics|mesh-ancestor
139231465|NCT02344888|Vitamins|vitamins|mesh-ancestor
139231466|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
139231467|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139231468|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
139231469|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139231470|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
139231471|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139231472|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139231473|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139231474|NCT03497429|Niraparib|niraparib|mesh-list
139231475|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139231476|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231477|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231478|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231479|NCT03146104|Propofol|propofol|mesh-list
139231480|NCT03146104|Isoflurane|isoflurane|mesh-list
139231481|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139231482|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139231483|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231484|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139231485|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
139231486|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
139231487|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139231488|NCT03497039|Diclofenac|diclofenac|mesh-list
139231489|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139231490|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139231491|NCT03497039|Analgesics|analgesics|mesh-ancestor
139231492|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
139231493|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231494|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231495|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139231496|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139231497|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139231498|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231499|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231500|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
139231501|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139231502|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139231503|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
139231504|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231505|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231506|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231507|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
139231508|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
139231509|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231510|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
139231511|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139231512|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
139231513|NCT02349490|Hemostatics|hemostatics|mesh-list
139231514|NCT02349490|Coagulants|coagulants|mesh-ancestor
139231515|NCT03720899|Nicotine|nicotine|mesh-list
139231516|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139231517|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
139231518|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231519|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231520|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139231521|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139231522|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
139231523|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231524|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231525|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
139231526|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139231527|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231528|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
139231529|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139231530|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231531|NCT03726515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139231532|NCT03726515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231533|NCT05665283|Ensartinib|ensartinib|mesh-list
139231534|NCT05665283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231535|NCT05665283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139231536|NCT05665283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231537|NCT05665283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231538|NCT03071094|Nivolumab|nivolumab|mesh-list
139231539|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139231540|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231541|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139231542|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231543|NCT03148990|Vaccines|vaccines|mesh-list
139231544|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
139231545|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231546|NCT04477642|Abatacept|abatacept|mesh-list
139231547|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139231548|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231549|NCT04477642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139231550|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231551|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139231552|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
139231553|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231554|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139231555|NCT02344732|Polymyxins|polymyxins|mesh-list
139231556|NCT02344732|Neomycin|neomycin|mesh-list
139231557|NCT02344732|Polymyxin B|polymyxin b|mesh-list
139231558|NCT02344732|Dexamethasone|dexamethasone|mesh-list
139231559|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139231560|NCT02344732|Homatropine|homatropine|mesh-list
139231561|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139231562|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
139231563|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
139231564|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231565|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231566|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139231567|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
139231569|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139231570|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139231571|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231572|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139231573|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139231574|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231575|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139231576|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231577|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231578|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
139231579|NCT03720665|Caffeine|caffeine|mesh-list
139231580|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139231581|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231582|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139231583|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231584|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231585|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139231586|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139231587|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
139231588|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231589|NCT03726281|Nivolumab|nivolumab|mesh-list
139231590|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139231591|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231592|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139231593|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231594|NCT02344264|Ropivacaine|ropivacaine|mesh-list
139231595|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
139231596|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
139231597|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139231598|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231599|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
139231600|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231601|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
139231602|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
139231603|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
139231604|NCT02339662|Gabapentin|gabapentin|mesh-list
139231605|NCT02339662|Amitriptyline|amitriptyline|mesh-list
139231606|NCT02339662|Analgesics|analgesics|mesh-ancestor
139231607|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
139231608|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231609|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231610|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
139231611|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139231612|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139231613|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139231614|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139231615|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139231616|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139231617|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231618|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231619|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
139231620|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139231621|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
139231622|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139231623|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139231624|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139231625|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139101740|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
139231626|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
139231628|NCT02343718|Temsirolimus|temsirolimus|mesh-list
139231629|NCT02343718|MTOR Inhibitors|mtor inhibitors|mesh-list
139231630|NCT02343718|Vinblastine|vinblastine|mesh-list
139231631|NCT02343718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139231632|NCT02343718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231633|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231634|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139231635|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
139231636|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231637|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231638|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139231639|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231640|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139231641|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
139231642|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139231643|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
139231644|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
139231645|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
139231646|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139231647|NCT03148522|Mirtazapine|mirtazapine|mesh-list
139231648|NCT03148522|Escitalopram|escitalopram|mesh-list
139231649|NCT03148522|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139231650|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139231651|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139231652|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231653|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231654|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
139231655|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231656|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231657|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
139231658|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139231659|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139231660|NCT03148522|Analgesics|analgesics|mesh-ancestor
139231661|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
139231662|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
139231663|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139231664|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
139231665|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
139231666|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139231667|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139231668|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139231669|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139166156|NCT04247815|Methotrexate|methotrexate|mesh-list
139231670|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139231671|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139231672|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
139231673|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139231674|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139231675|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139231676|NCT03148444|Cephalexin|cephalexin|mesh-list
139231677|NCT03148444|Roxithromycin|roxithromycin|mesh-list
139231678|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139231679|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231680|NCT03148132|Bevacizumab|bevacizumab|mesh-list
139231681|NCT03148132|Ranibizumab|ranibizumab|mesh-list
139231682|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139231683|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231684|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139231685|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139231686|NCT03148132|Growth Substances|growth substances|mesh-ancestor
139231687|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231688|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
139231689|NCT02339350|Methotrexate|methotrexate|mesh-list
139231690|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139231691|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
139231692|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139231693|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231694|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139231695|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
139231696|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231697|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642185|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
139231698|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
139231699|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231700|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139231701|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139231702|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
139231703|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139231704|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139231705|NCT02339428|Diclofenac|diclofenac|mesh-list
139231706|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139231707|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139231708|NCT02339428|Analgesics|analgesics|mesh-ancestor
139231709|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
139231710|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231711|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231712|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139231713|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139231714|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139231715|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231716|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231717|NCT02337322|Ritonavir|ritonavir|mesh-list
139231718|NCT02337322|Darunavir|darunavir|mesh-list
139231719|NCT02337322|Dolutegravir|dolutegravir|mesh-list
139231720|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139231721|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139231722|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
139231723|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231724|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231725|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139231726|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139231727|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
139231728|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231729|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139231730|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139231731|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139231732|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139231733|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
139231734|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139231735|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
139231736|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231737|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
139231738|NCT02337166|Protective Agents|protective agents|mesh-ancestor
139231739|NCT03148288|Vitamin D|vitamin d|mesh-list
139231740|NCT03148288|Vitamins|vitamins|mesh-ancestor
139231741|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
139231742|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231743|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139231744|NCT02039362|Tenofovir|tenofovir|mesh-list
139231745|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
139231746|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231747|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139231748|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139231749|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231750|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231751|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139231752|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139231753|NCT02339116|Bevacizumab|bevacizumab|mesh-list
139231754|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
139231755|NCT02339116|Irinotecan|irinotecan|mesh-list
139231756|NCT02339116|Fluorouracil|fluorouracil|mesh-list
139231757|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139231758|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231759|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139231760|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139231761|NCT02339116|Growth Substances|growth substances|mesh-ancestor
139231762|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231763|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
139231764|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139231765|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139231766|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231767|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231768|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
139231769|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139231770|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139231771|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
139231772|NCT04824274|Fentanyl|fentanyl|mesh-list
139231773|NCT04824274|Morphine|morphine|mesh-list
139231774|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139231776|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139231777|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231778|NCT04824274|Analgesics|analgesics|mesh-ancestor
139231779|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
139231780|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231781|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139231782|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139231783|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
139231784|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
139231785|NCT02509494|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139231786|NCT02509494|Antiviral Agents|antiviral agents|mesh-ancestor
139231788|NCT02348788|Chloroquine|chloroquine|mesh-list
139231789|NCT02348788|Lumefantrine|lumefantrine|mesh-list
139231790|NCT02348788|Artemether|artemether|mesh-list
139231791|NCT02348788|Primaquine|primaquine|mesh-list
139231792|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139231793|NCT02348788|Amebicides|amebicides|mesh-ancestor
139231794|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139231795|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139231796|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231797|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
139231798|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139231799|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139231800|NCT02338570|Everolimus|everolimus|mesh-list
139231801|NCT02338570|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139231802|NCT02338570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139231803|NCT02338570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231804|NCT02338570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231805|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139231806|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
139231807|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231808|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231809|NCT02336854|Tacrolimus|tacrolimus|mesh-list
139231810|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139231811|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
139231812|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231813|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139231814|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231815|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231816|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139231817|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
139231818|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231819|NCT02332174|Rufinamide|rufinamide|mesh-list
139231820|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
139231821|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139231822|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139231823|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139231824|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231825|NCT03493451|Tislelizumab|tislelizumab|mesh-list
139231826|NCT03493451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139231827|NCT03493451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231828|NCT03726125|Insulin|insulin|mesh-list
139231829|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139231830|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
139231831|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139231832|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231833|NCT02336308|Ketamine|ketamine|mesh-list
139231834|NCT02336308|Analgesics|analgesics|mesh-ancestor
139231835|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
139231836|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231837|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231838|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139231839|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139231840|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
139231841|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
139231842|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139231843|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139231844|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139231845|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231846|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231847|NCT02336386|Dexamethasone|dexamethasone|mesh-list
139231848|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
139231849|NCT02336386|Doxorubicin|doxorubicin|mesh-list
139231850|NCT02336386|Bortezomib|bortezomib|mesh-list
139231851|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139231852|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
139231853|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231854|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139231855|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139231856|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
139231857|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231858|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231859|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139231860|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139231861|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
139231862|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
139231863|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231864|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139231866|NCT02336386|Hormones|hormones|mesh-ancestor
139231867|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139299108|NCT05321043|Vitamins|vitamins|mesh-ancestor
139231868|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139231869|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231870|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139231871|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139231872|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139231873|NCT02337712|Etoposide|etoposide|mesh-list
139231874|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231875|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139231876|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139231877|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139231878|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231879|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231880|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139231881|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139231882|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139231883|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
139231884|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231885|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231886|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231887|NCT03492281|Urological Agents|urological agents|mesh-ancestor
139231888|NCT02336152|Anesthetics|anesthetics|mesh-list
139231889|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139231890|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231891|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
139231892|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139231893|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139231894|NCT02331862|Prednisolone|prednisolone|mesh-list
139231895|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
139231896|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139231897|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
139231898|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139231899|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
139231900|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
139231901|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231902|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231903|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139231904|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
139231905|NCT02331862|Hormones|hormones|mesh-ancestor
139231906|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139231907|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139231908|NCT02331862|Protective Agents|protective agents|mesh-ancestor
139231909|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139231910|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231911|NCT03525119|Vaccines|vaccines|mesh-list
139231912|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
139231913|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231914|NCT05230654|Fosaprepitant|fosaprepitant|mesh-list
139231915|NCT05230654|Aprepitant|aprepitant|mesh-list
139231916|NCT05230654|Antiemetics|antiemetics|mesh-ancestor
139231917|NCT05230654|Autonomic Agents|autonomic agents|mesh-ancestor
139231918|NCT05230654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139231919|NCT05230654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231920|NCT05230654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139231921|NCT05230654|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139231922|NCT05230654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231923|NCT05230654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231924|NCT02039518|Gemcitabine|gemcitabine|mesh-list
139231925|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139231926|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
139102042|NCT01073189|Fenoldopam|fenoldopam|mesh-list
139231927|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231928|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231929|NCT03722381|Amlodipine|amlodipine|mesh-list
139231930|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139231931|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139231932|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139231933|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231934|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139188525|NCT03367299|Blinatumomab|blinatumomab|mesh-list
139231935|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231936|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
139231937|NCT04352608|Vaccines|vaccines|mesh-list
139231938|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
139231939|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231940|NCT03722303|Cortisone|cortisone|mesh-list
139231941|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139231942|NCT03558503|Mitomycins|mitomycins|mesh-list
139231943|NCT03558503|Mitomycin|mitomycin|mesh-list
139231944|NCT03558503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139231945|NCT03558503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231946|NCT03558503|Alkylating Agents|alkylating agents|mesh-ancestor
139231947|NCT03558503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231948|NCT03558503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139231949|NCT03558503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231950|NCT02331706|Interferons|interferons|mesh-list
139231951|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
139231952|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
139231953|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139231954|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
139231955|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231956|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
139231957|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231958|NCT03489863|Ticagrelor|ticagrelor|mesh-list
139231959|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139231960|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139231961|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139231962|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139231963|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139231964|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
139231965|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231966|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231967|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231968|NCT04344444|Azithromycin|azithromycin|mesh-list
139231969|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
139231970|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139231971|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139231972|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
139231973|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139231974|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139231975|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139231976|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231977|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139231978|NCT03489551|Haloperidol|haloperidol|mesh-list
139231979|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
139231980|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
139231981|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299133|NCT05271162|Empagliflozin|empagliflozin|mesh-list
139231982|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231983|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139231984|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139231985|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139231986|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139231987|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139231988|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139231989|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
139231990|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139231991|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231992|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139231993|NCT05762952|Dapagliflozin|dapagliflozin|mesh-list
139231994|NCT05762952|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139231995|NCT05762952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139231996|NCT05762952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139231997|NCT05762952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139231998|NCT02335684|Methamphetamine|methamphetamine|mesh-list
139642186|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139231999|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139232000|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232001|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
139232002|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
139232003|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232004|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
139232005|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232006|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232007|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
139232008|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139232009|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139232010|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139232011|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139232013|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232014|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232015|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232016|NCT04210180|Varenicline|varenicline|mesh-list
139232017|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139232018|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139232019|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
139232020|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232021|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232022|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232023|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
139232024|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
139232025|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139299152|NCT05215327|Vaccines|vaccines|mesh-list
139232026|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139232027|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139232028|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139232029|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232030|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232031|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139232032|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139232033|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232034|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
139232035|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232036|NCT03105310|Interferons|interferons|mesh-list
139232037|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
139232038|NCT03105310|Ezetimibe|ezetimibe|mesh-list
139232039|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232040|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
139232041|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232042|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
139232043|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232044|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139232045|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139232046|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
139232047|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232048|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139232049|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
139232050|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139232051|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232052|NCT03144466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139232053|NCT03144466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232054|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
139232055|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139232056|NCT03105466|Tacrolimus|tacrolimus|mesh-list
139232057|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139232058|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
139232059|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232060|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139232061|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232062|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232063|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139232064|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139232065|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139232066|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232067|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
139232068|NCT03105466|Hormones|hormones|mesh-ancestor
139232069|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139232070|NCT02335372|Acetic Acid|acetic acid|mesh-list
139232071|NCT02335372|Proflavine|proflavine|mesh-list
139232072|NCT02335372|Retinol acetate|retinol acetate|mesh-list
139232073|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139232074|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232075|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139232076|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
139232077|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232078|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139232079|NCT02335372|Protective Agents|protective agents|mesh-ancestor
139232080|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232081|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139232082|NCT02334904|Risperidone|risperidone|mesh-list
139232083|NCT02334904|Aripiprazole|aripiprazole|mesh-list
139232084|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139232086|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232087|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232088|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232089|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139232090|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139232091|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232092|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139232093|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139232094|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
139232095|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
139232096|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
139232097|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139232098|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139232099|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139232100|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139232101|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139232102|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139232103|NCT03437447|Praziquantel|praziquantel|mesh-list
139232104|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
139232105|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139232106|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232107|NCT03720041|Dexamethasone|dexamethasone|mesh-list
139232108|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
139232109|NCT03720041|Lenalidomide|lenalidomide|mesh-list
139232110|NCT03720041|Ixazomib|ixazomib|mesh-list
139232111|NCT03720041|BB 1101|bb 1101|mesh-list
139232112|NCT03720041|Glycine|glycine|mesh-list
139232113|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139232114|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
139232115|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
139232116|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232117|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232118|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139232119|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
139232120|NCT03720041|Hormones|hormones|mesh-ancestor
139232121|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139232122|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139232123|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232124|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
139232125|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232126|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232127|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
139232128|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139232129|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139232130|NCT03720041|Growth Substances|growth substances|mesh-ancestor
139232131|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
139232132|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
139232133|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232134|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
139232135|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139232136|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
139232137|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232138|NCT02334670|Fluconazole|fluconazole|mesh-list
139232139|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
139232140|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232141|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139232142|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139232143|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232144|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232145|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139232146|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
139232147|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139232148|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102266|NCT05261516|Tocolytic Agents|tocolytic agents|mesh-ancestor
139232149|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139232150|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139232151|NCT02974868|PF-06700841|pf-06700841|mesh-list
139232152|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139232153|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232154|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232155|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
139232156|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139232157|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
139232158|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232159|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
139232160|NCT05076526|Protective Agents|protective agents|mesh-ancestor
139232161|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
139232162|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139232163|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232164|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139232165|NCT03143998|Grazoprevir|grazoprevir|mesh-list
139232166|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
139232167|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232168|NCT02334046|Remifentanil|remifentanil|mesh-list
139232169|NCT02334046|Sevoflurane|sevoflurane|mesh-list
139232170|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139232171|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139232172|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
139232173|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
139232174|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232175|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232176|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139232177|NCT02334046|Narcotics|narcotics|mesh-ancestor
139232178|NCT02334046|Analgesics|analgesics|mesh-ancestor
139232179|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
139232180|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232181|NCT02330380|Adalimumab|adalimumab|mesh-list
139232182|NCT02330380|Etanercept|etanercept|mesh-list
139232183|NCT02330380|Methotrexate|methotrexate|mesh-list
139232184|NCT02330380|Ustekinumab|ustekinumab|mesh-list
139232185|NCT02330380|Acitretin|acitretin|mesh-list
139232186|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139232187|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
139232188|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139232189|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232190|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139232191|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
139232192|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232193|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232194|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
139232195|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232196|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139232197|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139232198|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
139232199|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139232200|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139232201|NCT02330380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139232202|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139232203|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139232204|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139232205|NCT02330380|Analgesics|analgesics|mesh-ancestor
139232206|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
139232207|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232208|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139232209|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
139232210|NCT02333890|Chloroquine|chloroquine|mesh-list
139232211|NCT02333890|Amebicides|amebicides|mesh-ancestor
139299209|NCT05067387|Hormones|hormones|mesh-ancestor
139232212|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139232213|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139232214|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232215|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
139232216|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139232217|NCT02330302|Ropivacaine|ropivacaine|mesh-list
139232218|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
139232219|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
139232220|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232221|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232222|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
139232223|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642187|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
139232224|NCT03143530|Ropivacaine|ropivacaine|mesh-list
139232225|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
139232226|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
139232227|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232228|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232229|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
139232230|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232231|NCT01065818|Telbivudine|telbivudine|mesh-list
139232232|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
139232233|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232234|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139188825|NCT03767569|Inositol|inositol|mesh-list
139232235|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232236|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232238|NCT03697408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139232239|NCT03697408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139232240|NCT03697408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232241|NCT03697408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232242|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139232243|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
139232244|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232245|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232246|NCT02318277|Durvalumab|durvalumab|mesh-list
139232247|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139232248|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232249|NCT03143452|Lidocaine|lidocaine|mesh-list
139232250|NCT03143452|Tetracaine|tetracaine|mesh-list
139232251|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139232252|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
139232253|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
139232254|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232255|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232256|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
139232257|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232258|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139232259|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139232260|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139232261|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139232262|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232263|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139232264|NCT01063868|Oxycodone|oxycodone|mesh-list
139232265|NCT01063868|Tapentadol|tapentadol|mesh-list
139232266|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139232267|NCT01063868|Narcotics|narcotics|mesh-ancestor
139232268|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139299219|NCT05051449|Ketamine|ketamine|mesh-list
139232269|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232270|NCT01063868|Analgesics|analgesics|mesh-ancestor
139232271|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
139232272|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232273|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139232274|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139232275|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139232276|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232277|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
139232278|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232279|NCT04993924|Cetrorelix|cetrorelix|mesh-list
139232280|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139232281|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
139232282|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139232283|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232284|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
139232285|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139232286|NCT02330068|Citalopram|citalopram|mesh-list
139232287|NCT02330068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139232288|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139232289|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139232290|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232291|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232292|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
139232293|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232294|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139232295|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
139232296|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139102410|NCT03943992|Esomeprazole|esomeprazole|mesh-list
139232297|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
139232298|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139232299|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232300|NCT01312857|Panitumumab|panitumumab|mesh-list
139232301|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139232302|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232303|NCT02974010|Cycloserine|cycloserine|mesh-list
139232304|NCT02974010|Ketamine|ketamine|mesh-list
139232305|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139232306|NCT02974010|Analgesics|analgesics|mesh-ancestor
139232307|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
139232308|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232309|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232310|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139232311|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139232312|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
139232313|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
139232314|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232315|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139232316|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139232317|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232318|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232319|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139232320|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232321|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139232322|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
139232323|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139232324|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
139232325|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139232326|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139232327|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139232328|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139232329|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139232330|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139232331|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
139232332|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139232333|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139232334|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
139232335|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139232336|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139232337|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
139232338|NCT01061606|Sirolimus|sirolimus|mesh-list
139232339|NCT01061606|Temsirolimus|temsirolimus|mesh-list
139232340|NCT01061606|MTOR Inhibitors|mtor inhibitors|mesh-list
139232341|NCT01061606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139232342|NCT01061606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232343|NCT01061606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232344|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139232345|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
139232346|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232347|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232348|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139232349|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232350|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139232351|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
139232352|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
139232353|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139232354|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139232355|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232356|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
139232357|NCT02329756|Coagulants|coagulants|mesh-ancestor
139232358|NCT02329288|Triamcinolone|triamcinolone|mesh-list
139232359|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139232360|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139232361|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139232362|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139232363|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
139232364|NCT02329288|Hormones|hormones|mesh-ancestor
139232365|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139232366|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232367|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139232368|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
139642188|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139232369|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232370|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232372|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
139232373|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232374|NCT03122457|C 1027|c 1027|mesh-list
139232375|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139232376|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
139232377|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139232378|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232379|NCT04407988|Letrozole|letrozole|mesh-list
139232380|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232381|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139232382|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139232383|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232384|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232385|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139232386|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
139232387|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139232388|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232389|NCT02329132|Ranibizumab|ranibizumab|mesh-list
139232390|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139232391|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139232392|NCT02329132|Growth Substances|growth substances|mesh-ancestor
139232393|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232394|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
139232395|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232396|NCT04342078|Vitamin D|vitamin d|mesh-list
139232397|NCT04342078|Vitamins|vitamins|mesh-ancestor
139232398|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
139232399|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232400|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139232401|NCT02332954|Vortioxetine|vortioxetine|mesh-list
139232402|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
139232403|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139232404|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139232405|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139232406|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232407|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232408|NCT02332954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139232409|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139232410|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139232411|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232412|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232413|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
139232414|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139232415|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139232416|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139232417|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139232418|NCT01372761|CKD732|ckd732|mesh-list
139232419|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139232420|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139232421|NCT01372761|Growth Substances|growth substances|mesh-ancestor
139232422|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232423|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
139232424|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232425|NCT03873675|Hormones|hormones|mesh-list
139232426|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
139232427|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139232428|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232429|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139232430|NCT05173857|Paclitaxel|paclitaxel|mesh-list
139232431|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139232432|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232433|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
139232434|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
139232435|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
139232436|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232437|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
139232438|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139232439|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232440|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232441|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139232442|NCT03417999|Analgesics|analgesics|mesh-ancestor
139232443|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
139232444|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232445|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139232446|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139232447|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139232448|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
139232449|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232450|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232451|NCT03142516|Leucovorin|leucovorin|mesh-list
139232452|NCT03142516|Folic Acid|folic acid|mesh-list
139232453|NCT03142516|Fluorouracil|fluorouracil|mesh-list
139232454|NCT03142516|Irinotecan|irinotecan|mesh-list
139232455|NCT03142516|Panitumumab|panitumumab|mesh-list
139232456|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
139232457|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
139232458|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232459|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139232460|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232461|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139232462|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
139232463|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232464|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139232465|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139232466|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232467|NCT03142516|Antidotes|antidotes|mesh-ancestor
139232468|NCT03142516|Protective Agents|protective agents|mesh-ancestor
139232469|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
139232470|NCT03142516|Vitamins|vitamins|mesh-ancestor
139232471|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
139232472|NCT03142516|Hematinics|hematinics|mesh-ancestor
139232473|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139232474|NCT03719729|Rifaximin|rifaximin|mesh-list
139232475|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139232476|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232477|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139232478|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
139232479|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
139232480|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
139232481|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232482|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232483|NCT03714113|Antibodies|antibodies|mesh-list
139232484|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
139232485|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232486|NCT03472547|Diacerein|diacerein|mesh-list
139232487|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139232488|NCT00799396|Aspirin|aspirin|mesh-list
139232489|NCT00799396|Clopidogrel|clopidogrel|mesh-list
139232490|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139232491|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139232492|NCT00799396|Analgesics|analgesics|mesh-ancestor
139232493|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
139232494|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232495|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232496|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139232497|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139232498|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139232499|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139232500|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232501|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139232502|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139232503|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232504|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
139232505|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139299276|NCT04911127|Cannabidiol|cannabidiol|mesh-list
139232506|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139232507|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139232508|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
139232509|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232510|NCT03469349|Actovegin|actovegin|mesh-list
139232511|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139232512|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232513|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139232514|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139232515|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
139232516|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232517|NCT03469349|Protective Agents|protective agents|mesh-ancestor
139102634|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
139232518|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139232519|NCT03467945|Metformin|metformin|mesh-list
139232520|NCT03467945|Gliclazide|gliclazide|mesh-list
139232521|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139232522|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232523|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139232524|NCT03719261|Eusol|eusol|mesh-list
139232525|NCT03719261|Chitosan|chitosan|mesh-list
139232526|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139232527|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139232528|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
139232529|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232530|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139232531|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
139232532|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
139189129|NCT03620760|Aspirin|aspirin|mesh-list
139232533|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
139232534|NCT03719261|Coagulants|coagulants|mesh-ancestor
139232535|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
139232536|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232537|NCT00069238|Prednisone|prednisone|mesh-list
139232538|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
139232539|NCT00069238|Doxorubicin|doxorubicin|mesh-list
139232540|NCT00069238|Etoposide|etoposide|mesh-list
139232541|NCT00069238|Vincristine|vincristine|mesh-list
139232542|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
139232543|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139232544|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
139232545|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232546|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139232547|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139232548|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
139232549|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232550|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232551|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139232552|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139232553|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139232554|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139232555|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232556|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139232557|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
139232558|NCT00069238|Hormones|hormones|mesh-ancestor
139232559|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139232560|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139232561|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139232562|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
139232563|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
139232564|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
139232565|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139232566|NCT03639155|Glycine|glycine|mesh-list
139232567|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
139232568|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232569|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232570|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232571|NCT05080348|Ropivacaine|ropivacaine|mesh-list
139232572|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
139232573|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
139232574|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232575|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232576|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
139232577|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232578|NCT03073200|Etanercept|etanercept|mesh-list
139232579|NCT03073200|Ixekizumab|ixekizumab|mesh-list
139232580|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139232581|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139232582|NCT03073200|Analgesics|analgesics|mesh-ancestor
139232583|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
139232584|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232585|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232586|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139232587|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139642189|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139232588|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139232589|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139232590|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
139232591|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
139232592|NCT02030860|Gemcitabine|gemcitabine|mesh-list
139232593|NCT02030860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139232594|NCT02030860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139232595|NCT02030860|Antimetabolites|antimetabolites|mesh-ancestor
139232596|NCT02030860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232597|NCT02030860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232598|NCT01569984|Bevacizumab|bevacizumab|mesh-list
139232599|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139232600|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232601|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139232602|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139232603|NCT01569984|Growth Substances|growth substances|mesh-ancestor
139232604|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232605|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
139232606|NCT02328118|Triamcinolone|triamcinolone|mesh-list
139232607|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139232608|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139232609|NCT02328118|Ranibizumab|ranibizumab|mesh-list
139232610|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139232611|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139232612|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139232613|NCT02328118|Growth Substances|growth substances|mesh-ancestor
139232614|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232615|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
139232616|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232617|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139232618|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
139232619|NCT02328118|Hormones|hormones|mesh-ancestor
139232620|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139232621|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139232622|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
139232623|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232624|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232625|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
139232626|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232627|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139232628|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232629|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232630|NCT05079880|Caffeine|caffeine|mesh-list
139232631|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
139232632|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232633|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139232634|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232635|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139232636|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232637|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139232638|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139232639|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
139232640|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232641|NCT03716765|Vitamin D|vitamin d|mesh-list
139232642|NCT03716765|Vitamins|vitamins|mesh-ancestor
139232643|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
139232644|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232645|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139232646|NCT03070002|Denosumab|denosumab|mesh-list
139232647|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139232648|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232649|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
139232650|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139232651|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139232652|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139232653|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139232654|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232655|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
139232656|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232657|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232658|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139232659|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232660|NCT02918318|Esketamine|esketamine|mesh-list
139232661|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
139232662|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139232663|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
139232664|NCT04926454|Bupivacaine|bupivacaine|mesh-list
139232665|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
139232666|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
139642190|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
139232667|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232668|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232669|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
139232670|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232671|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139232672|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139232673|NCT04926454|Analgesics|analgesics|mesh-ancestor
139232674|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139232675|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139232676|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139232677|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
139232678|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232679|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232680|NCT03652376|Benralizumab|benralizumab|mesh-list
139232681|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139232682|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
139232684|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139232685|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232686|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
139232687|NCT01372839|Atorvastatin|atorvastatin|mesh-list
139232688|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139232689|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139232690|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
139299295|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139232691|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232692|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139232693|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139232694|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232696|NCT01065350|Propofol|propofol|mesh-list
139232697|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139232698|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232699|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232700|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139232701|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
139232702|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
139232703|NCT01065350|Analgesics|analgesics|mesh-ancestor
139232704|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
139232705|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232706|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139232707|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139232708|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139232709|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232710|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232711|NCT02914977|Daunorubicin|daunorubicin|mesh-list
139232712|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139232713|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232714|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139232715|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139232716|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232717|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232718|NCT03718715|Metformin|metformin|mesh-list
139232719|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139232720|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232721|NCT05079022|Aflutinib|aflutinib|mesh-list
139232722|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139232723|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232724|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232725|NCT05078788|Triamcinolone|triamcinolone|mesh-list
139232726|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139232727|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
139232728|NCT05078788|Hormones|hormones|mesh-ancestor
139232729|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139232730|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232731|NCT02032654|Floxacillin|floxacillin|mesh-list
139232732|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139232733|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232734|NCT04734886|Vitamin D|vitamin d|mesh-list
139232735|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
139232736|NCT04734886|Cholecalciferol|cholecalciferol|mesh-list
139232737|NCT04734886|Vitamins|vitamins|mesh-list
139232738|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
139232739|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232740|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139232741|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139232750|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232751|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
139232752|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139232753|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
139232754|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232755|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189363|NCT03759301|Cetrorelix|cetrorelix|mesh-list
139232756|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
139232757|NCT03114969|Hormones|hormones|mesh-ancestor
139232758|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139232759|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
139232760|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139232761|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
139232762|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232763|NCT03144778|Durvalumab|durvalumab|mesh-list
139232764|NCT03144778|Ipilimumab|ipilimumab|mesh-list
139232765|NCT03144778|Tremelimumab|tremelimumab|mesh-list
139232766|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
139232767|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139232768|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
139232769|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139232770|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232771|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
139232772|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232773|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139232774|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232775|NCT03142360|Beraprost|beraprost|mesh-list
139232776|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139232777|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
139232778|NCT05124678|Isoniazid|isoniazid|mesh-list
139232779|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
139232780|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139232781|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232782|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139232783|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139232784|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
139232785|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232786|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139232787|NCT03122145|Capsaicin|capsaicin|mesh-list
139232788|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
139232789|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
139232790|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
139232791|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232792|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232793|NCT03144856|Apatinib|apatinib|mesh-list
139232794|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232795|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139232796|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232797|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232807|NCT04949022|Insulin|insulin|mesh-list
139232808|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139232809|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232810|NCT02327338|Ibuprofen|ibuprofen|mesh-list
139232811|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139232812|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139232813|NCT02327338|Analgesics|analgesics|mesh-ancestor
139232814|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
139232815|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102928|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139232816|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232817|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139232818|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139232819|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139232820|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232821|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232823|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139232824|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
139232825|NCT02327416|Adefovir|adefovir|mesh-list
139232826|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139232827|NCT02327416|Molgramostim|molgramostim|mesh-list
139232828|NCT02327416|Sargramostim|sargramostim|mesh-list
139232829|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
139232830|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232831|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
139232832|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232833|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139232834|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139232835|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232836|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232837|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232838|NCT02926950|Metformin|metformin|mesh-list
139232839|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139232840|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139232841|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232842|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139232843|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232844|NCT01064414|Canagliflozin|canagliflozin|mesh-list
139232845|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139232846|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232847|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139232848|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232849|NCT03433703|Lenvatinib|lenvatinib|mesh-list
139232850|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232851|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139232852|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232853|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232854|NCT01374633|Sevoflurane|sevoflurane|mesh-list
139232855|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139232856|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139232857|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
139232858|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
139232859|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232860|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232861|NCT01178814|Lenalidomide|lenalidomide|mesh-list
139232862|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
139232863|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232864|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139232865|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139232866|NCT01178814|Growth Substances|growth substances|mesh-ancestor
139232867|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
139232868|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232869|NCT05202288|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
139232870|NCT05202288|Antiviral Agents|antiviral agents|mesh-ancestor
139232871|NCT05202288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232872|NCT05762484|Clindamycin|clindamycin|mesh-list
139232873|NCT05762484|Clindamycin palmitate|clindamycin palmitate|mesh-list
139232874|NCT05762484|Clindamycin phosphate|clindamycin phosphate|mesh-list
139232875|NCT05762484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139232876|NCT05762484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232877|NCT05762484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139232878|NCT05762484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232879|NCT05762484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232880|NCT03462641|Flumazenil|flumazenil|mesh-list
139232881|NCT03462641|Antidotes|antidotes|mesh-ancestor
139232882|NCT03462641|Protective Agents|protective agents|mesh-ancestor
139232883|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232884|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
139232885|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
139232886|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642191|NCT01347255|Hormones|hormones|mesh-ancestor
139232887|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232888|NCT05201352|Trifluridine|trifluridine|mesh-list
139232889|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
139232890|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232891|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
139232892|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232893|NCT04128956|Aspirin|aspirin|mesh-list
139232894|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139232895|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139232896|NCT04128956|Analgesics|analgesics|mesh-ancestor
139232897|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
139232898|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232899|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232900|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139232901|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139232902|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139232903|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139189500|NCT04893915|Fludarabine|fludarabine|mesh-list
139232904|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232905|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139232906|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139232907|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232909|NCT05761704|Anticoagulants|anticoagulants|mesh-list
139232910|NCT03652142|Nivolumab|nivolumab|mesh-list
139232911|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139232912|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232913|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139232914|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232915|NCT04629378|Amoxicillin|amoxicillin|mesh-list
139232916|NCT04629378|Meropenem|meropenem|mesh-list
139232917|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
139232918|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
139232919|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
139232920|NCT04629378|Bedaquiline|bedaquiline|mesh-list
139232921|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139232922|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139232923|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139232924|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139232925|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232926|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232927|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
139232928|NCT03651674|Olanzapine|olanzapine|mesh-list
139232929|NCT03651674|Clozapine|clozapine|mesh-list
139232930|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
139232931|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
139232932|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232933|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232934|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139232935|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139232936|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139232937|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232938|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139232939|NCT03651674|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139232940|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139232941|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139232942|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232943|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232944|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
139232945|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139232946|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
139232947|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
139232948|NCT01061840|Molgramostim|molgramostim|mesh-list
139232949|NCT01061840|Vaccines|vaccines|mesh-list
139232950|NCT01061840|Sargramostim|sargramostim|mesh-list
139232951|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
139232952|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232953|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232954|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139232955|NCT02926638|Rilotumumab|rilotumumab|mesh-list
139232956|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139232957|NCT02926638|Antibodies|antibodies|mesh-list
139232958|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
139232959|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139232960|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
139232961|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232962|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139232963|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139232964|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139232965|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232966|NCT03650582|Glucagon|glucagon|mesh-list
139232967|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139232968|NCT03650582|Hormones|hormones|mesh-ancestor
139232969|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139232970|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232971|NCT02903030|Silicon|silicon|mesh-list
139232972|NCT02903030|Trace Elements|trace elements|mesh-ancestor
139232973|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
139232974|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232975|NCT02969408|Albuterol|albuterol|mesh-list
139232976|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139232977|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
139189578|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
139232978|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232980|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139232981|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
139232982|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
139232983|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139232984|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139232985|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139232986|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139232987|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
139232988|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139232989|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139232990|NCT05180214|Ketorolac|ketorolac|mesh-list
139232991|NCT05180214|Bupivacaine|bupivacaine|mesh-list
139232992|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
139232993|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
139232994|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139232995|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139232996|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
139232997|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139232998|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139232999|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139233000|NCT05180214|Analgesics|analgesics|mesh-ancestor
139233001|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139233002|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139233003|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139233004|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233005|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233006|NCT01060124|Fentanyl|fentanyl|mesh-list
139233007|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139233008|NCT01060124|Narcotics|narcotics|mesh-ancestor
139233009|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233010|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233011|NCT01060124|Analgesics|analgesics|mesh-ancestor
139233012|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
139233013|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233014|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139233015|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139233016|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
139233017|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
139233018|NCT03461003|Losartan|losartan|mesh-list
139233019|NCT03461003|Amlodipine|amlodipine|mesh-list
139233020|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139233021|NCT03461003|Lisinopril|lisinopril|mesh-list
139233022|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139233023|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139233024|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139233025|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233026|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139233027|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233028|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
139233029|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139233030|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139233031|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139233032|NCT03461003|Diuretics|diuretics|mesh-ancestor
139233033|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
139233034|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139233035|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139233036|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
139233037|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233038|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139233039|NCT03461003|Protective Agents|protective agents|mesh-ancestor
139233040|NCT03650348|Atezolizumab|atezolizumab|mesh-list
139233041|NCT03650348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139233042|NCT03650348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233043|NCT03650348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139233044|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233045|NCT05761470|Paclitaxel|paclitaxel|mesh-list
139233046|NCT05761470|Fluzoparib|fluzoparib|mesh-list
139233047|NCT05761470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139233048|NCT05761470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233049|NCT05761470|Tubulin Modulators|tubulin modulators|mesh-ancestor
139233050|NCT05761470|Antimitotic Agents|antimitotic agents|mesh-ancestor
139233051|NCT05761470|Mitosis Modulators|mitosis modulators|mesh-ancestor
139189651|NCT03411850|Abatacept|abatacept|mesh-list
139233052|NCT05761470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233053|NCT05761470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139233054|NCT05761470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233055|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
139233056|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
139233057|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139233058|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139233059|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233060|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139233061|NCT02904902|Adalimumab|adalimumab|mesh-list
139233062|NCT02904902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139233063|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139233064|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139233065|NCT03650270|Phenytoin|phenytoin|mesh-list
139233066|NCT03650270|Midazolam|midazolam|mesh-list
139233067|NCT03650270|Phenobarbital|phenobarbital|mesh-list
139233068|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139233069|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139233070|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233071|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233072|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139233073|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139233074|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139233075|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139233076|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
139233077|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
139233078|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
139233079|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
139233080|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233081|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233082|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
139233083|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139233084|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139233085|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139233086|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139233087|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139233088|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139233089|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139233090|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139233091|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139233092|NCT05204628|Crizotinib|crizotinib|mesh-list
139233093|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233094|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139233095|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233096|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233097|NCT03650738|Paclitaxel|paclitaxel|mesh-list
139233098|NCT03650738|Carboplatin|carboplatin|mesh-list
139233099|NCT03650738|Apatinib|apatinib|mesh-list
139233100|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139233101|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233102|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
139233103|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
139233104|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
139233105|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233106|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139233107|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233108|NCT02904200|Silicon|silicon|mesh-list
139233109|NCT02904200|Trace Elements|trace elements|mesh-ancestor
139233110|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
139233111|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233112|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139233113|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
139233114|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233115|NCT03621800|Menthol|menthol|mesh-list
139233116|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
139233117|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
139233118|NCT03649334|Ketorolac|ketorolac|mesh-list
139233119|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139233120|NCT03649334|Fentanyl|fentanyl|mesh-list
139233121|NCT03649334|Ketamine|ketamine|mesh-list
139233122|NCT03649334|Analgesics|analgesics|mesh-ancestor
139233123|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
139233124|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233125|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233126|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139233127|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139233128|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
139233129|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
139233130|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233131|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139233132|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139233133|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233134|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233135|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139233136|NCT03649334|Narcotics|narcotics|mesh-ancestor
139233137|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139233138|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139233139|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139233140|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139233141|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139233142|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139233143|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233144|NCT02901548|Durvalumab|durvalumab|mesh-list
139233145|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139233146|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233147|NCT03457727|Omeprazole|omeprazole|mesh-list
139233148|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139233149|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139233150|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139233151|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233152|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233153|NCT03648554|Dulaglutide|dulaglutide|mesh-list
139233154|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139233155|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233156|NCT03648320|Immunomodulating Agents|immunomodulating agents|mesh-list
139233157|NCT03648320|Immunologic Factors|immunologic factors|mesh-ancestor
139233158|NCT03648320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233159|NCT05284994|Osimertinib|osimertinib|mesh-list
139233160|NCT05284994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233161|NCT05284994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139233162|NCT05284994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233163|NCT05284994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233164|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139233165|NCT03068754|Hormones|hormones|mesh-ancestor
139233166|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139233167|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233168|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
139233169|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139233170|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
139233171|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233172|NCT03430895|Durvalumab|durvalumab|mesh-list
139233173|NCT03430895|Tremelimumab|tremelimumab|mesh-list
139233174|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139233175|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233176|NCT03452189|Vancomycin|vancomycin|mesh-list
139233177|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139233178|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233179|NCT00603954|Fludarabine|fludarabine|mesh-list
139233180|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
139233181|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139233182|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233183|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139233184|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
139233185|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233186|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139233187|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
139233188|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233190|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233191|NCT03712475|Pregabalin|pregabalin|mesh-list
139233192|NCT03712475|Analgesics|analgesics|mesh-ancestor
139233193|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
139233194|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233195|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233196|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
139233197|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139233198|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139233199|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233200|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139233201|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139233202|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139233203|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233204|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139233206|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233207|NCT01372371|Vancomycin|vancomycin|mesh-list
139233208|NCT01372371|Gentamicins|gentamicins|mesh-list
139233209|NCT01372371|Cefuroxime|cefuroxime|mesh-list
139233210|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
139233211|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139233212|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233213|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139233214|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233215|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233216|NCT03120351|Lidocaine|lidocaine|mesh-list
139233217|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
139233218|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
139233219|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233220|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233221|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
139233222|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233223|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139233224|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139233225|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139233226|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139233227|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233228|NCT05165355|Aflutinib|aflutinib|mesh-list
139233229|NCT05165355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139233230|NCT05165355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233231|NCT05165355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233232|NCT01374789|Panitumumab|panitumumab|mesh-list
139233233|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139233234|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233235|NCT02354703|Ondansetron|ondansetron|mesh-list
139233236|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
139233237|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
139299375|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139233238|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233239|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233240|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139233241|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
139233242|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
139233243|NCT02354703|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139233244|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139233245|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
139233246|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233247|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233248|NCT05008887|Fluorouracil|fluorouracil|mesh-list
139233249|NCT05008887|Methotrexate|methotrexate|mesh-list
139233250|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
139233251|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233252|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139233253|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233254|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139233255|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
139233256|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233257|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139233258|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
139233259|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139233260|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
139233261|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233262|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139233263|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139233264|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139233265|NCT01376193|Naratriptan|naratriptan|mesh-list
139233266|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139233267|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139233268|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139233269|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
139233270|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233271|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233272|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233273|NCT04944771|Rabeprazole|rabeprazole|mesh-list
139233274|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139233275|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139189881|NCT03321006|Analgesics|analgesics|mesh-ancestor
139233276|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139233278|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233279|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
139233280|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139233281|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
139233282|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233283|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139233284|NCT05197101|Oxytocin|oxytocin|mesh-list
139233285|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
139233286|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139233287|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233288|NCT01375101|Quercetin|quercetin|mesh-list
139233289|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
139233290|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233291|NCT01375101|Protective Agents|protective agents|mesh-ancestor
139233292|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233293|NCT03633591|Tolcapone|tolcapone|mesh-list
139299391|NCT04752696|Antidotes|antidotes|mesh-ancestor
139233294|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139233295|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139233296|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139233297|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233298|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233299|NCT01376271|Paroxetine|paroxetine|mesh-list
139233300|NCT01376271|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139233301|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139233302|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139233303|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233304|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233305|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
139233306|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233307|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139233308|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
139233309|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139233310|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139233311|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139233312|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233313|NCT04885881|Lidocaine|lidocaine|mesh-list
139233314|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
139233315|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
139233316|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233317|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233318|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
139233319|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233320|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139233321|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139233322|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139233323|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139233324|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233325|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
139233326|NCT04820205|Ketamine|ketamine|mesh-list
139233327|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
139233328|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139233329|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233330|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233331|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139233332|NCT04820205|Analgesics|analgesics|mesh-ancestor
139233333|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
139233334|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233335|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139233336|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139233338|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
139233339|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233340|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233341|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139233342|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139233343|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
139233344|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
139233345|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139233346|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139233347|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139233348|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139233349|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233350|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
139233352|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139233353|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
139233354|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
139233355|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233356|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233357|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139233358|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139233359|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139233360|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
139233361|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233362|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233363|NCT01375335|Protective Agents|protective agents|mesh-ancestor
139233364|NCT01373463|Carboplatin|carboplatin|mesh-list
139233365|NCT01373463|Pemetrexed|pemetrexed|mesh-list
139233366|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233367|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233368|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233369|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139233370|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139233371|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139233372|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139233373|NCT03113409|Naltrexone|naltrexone|mesh-list
139233374|NCT03113409|Buprenorphine|buprenorphine|mesh-list
139233375|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139233376|NCT03113409|Narcotics|narcotics|mesh-ancestor
139233377|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233378|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233379|NCT03113409|Analgesics|analgesics|mesh-ancestor
139233380|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
139233381|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233382|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139233383|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139233384|NCT05193747|Anesthetics|anesthetics|mesh-list
139233385|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233386|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233387|NCT03634293|Alirocumab|alirocumab|mesh-list
139233388|NCT03634293|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139233389|NCT03634293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139233390|NCT03634293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139233391|NCT03634293|Antimetabolites|antimetabolites|mesh-ancestor
139233392|NCT03634293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233393|NCT03634293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139233394|NCT03634293|Protease Inhibitors|protease inhibitors|mesh-ancestor
139233395|NCT03634293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233396|NCT03634293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139233397|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
139233398|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233399|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233400|NCT03633747|Propranolol|propranolol|mesh-list
139233401|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139233402|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139233403|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
139233404|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233405|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233406|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233407|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139233408|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139233409|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
139233411|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139233412|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139233413|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139233414|NCT01373697|Ibuprofen|ibuprofen|mesh-list
139233415|NCT01373697|Ketoprofen|ketoprofen|mesh-list
139233416|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139233417|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139233418|NCT01373697|Analgesics|analgesics|mesh-ancestor
139233419|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
139233420|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233421|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233422|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139233423|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139233424|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139233425|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233426|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233427|NCT01375881|Ritonavir|ritonavir|mesh-list
139233428|NCT01375881|Darunavir|darunavir|mesh-list
139233429|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139233430|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139233431|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
139233432|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233433|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233434|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139233435|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139233436|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
139233437|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233438|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139233439|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139233440|NCT04690023|Ropivacaine|ropivacaine|mesh-list
139233441|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
139233442|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
139233443|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233444|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233445|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
139233446|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233447|NCT03066804|Valsartan|valsartan|mesh-list
139233448|NCT03066804|Enalapril|enalapril|mesh-list
139233449|NCT03066804|Enalaprilat|enalaprilat|mesh-list
139233450|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139233451|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139233452|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139233453|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139233454|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233455|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139233456|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
139233457|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233458|NCT03629262|Sufentanil|sufentanil|mesh-list
139233459|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
139233460|NCT03629262|Dsuvia|dsuvia|mesh-list
139233461|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139233462|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233463|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233464|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139233465|NCT03629262|Analgesics|analgesics|mesh-ancestor
139233466|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
139233467|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233468|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139233469|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139233470|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139233471|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
139233472|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233473|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233474|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139233475|NCT03629262|Narcotics|narcotics|mesh-ancestor
139233476|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139233477|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139233478|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
139233479|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
139233480|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
139233481|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139233482|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139233483|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
139103607|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139233484|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233485|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139233486|NCT05207904|Paclitaxel|paclitaxel|mesh-list
139233487|NCT05207904|Carboplatin|carboplatin|mesh-list
139233488|NCT05207904|Tislelizumab|tislelizumab|mesh-list
139233489|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139233490|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233491|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
139233492|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
139233493|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
139233494|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233495|NCT05207904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139233496|NCT05207514|Ethanol|ethanol|mesh-list
139233497|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
139233498|NCT05207514|Docetaxel|docetaxel|mesh-list
139233499|NCT05207514|Doxorubicin|doxorubicin|mesh-list
139233500|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139233501|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
139233502|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233503|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139233504|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139233505|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
139233506|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233507|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233508|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139233509|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
139233510|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
139233511|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
139233512|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139233513|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139233514|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139233515|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233516|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139233517|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233518|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233519|NCT03118947|Pimavanserin|pimavanserin|mesh-list
139233520|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139233521|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139233522|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139233523|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139233524|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233525|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233526|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139233527|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139233528|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139233529|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
139233530|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233531|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233532|NCT03953079|Sunitinib|sunitinib|mesh-list
139233533|NCT03953079|Aflibercept|aflibercept|mesh-list
139233534|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233535|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139233536|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139233537|NCT03953079|Growth Substances|growth substances|mesh-ancestor
139233538|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233539|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
139233540|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139233541|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233542|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233543|NCT03794427|Anesthetics|anesthetics|mesh-list
139233544|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233545|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233546|NCT03410901|Antibodies|antibodies|mesh-list
139233547|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
139233548|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233549|NCT03357939|Adalimumab|adalimumab|mesh-list
139233550|NCT03357939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139233551|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139233552|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139233553|NCT03567057|Amantadine|amantadine|mesh-list
139233554|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139642452|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233555|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139233556|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
139233557|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233558|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
139233559|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233560|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233561|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233562|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139233563|NCT03567057|Analgesics|analgesics|mesh-ancestor
139233564|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
139233565|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233566|NCT03057600|Paclitaxel|paclitaxel|mesh-list
139233567|NCT03057600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139233568|NCT03057600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233569|NCT03057600|Tubulin Modulators|tubulin modulators|mesh-ancestor
139233570|NCT03057600|Antimitotic Agents|antimitotic agents|mesh-ancestor
139233571|NCT03057600|Mitosis Modulators|mitosis modulators|mesh-ancestor
139233572|NCT03057600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233573|NCT04382937|Ribavirin|ribavirin|mesh-list
139233574|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139233575|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
139233576|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233577|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
139233578|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233579|NCT05206890|Fluzoparib|fluzoparib|mesh-list
139233580|NCT05206890|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139233581|NCT05206890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233582|NCT05206890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233583|NCT05206890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233584|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
139233585|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233586|NCT03107091|Terlipressin|terlipressin|mesh-list
139233587|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139233588|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139233589|NCT03849768|Gefitinib|gefitinib|mesh-list
139233590|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233591|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139233592|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233593|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233594|NCT03189693|Anesthetics|anesthetics|mesh-list
139233595|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233596|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233597|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
139233598|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139233599|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233600|NCT03065400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139233601|NCT03065400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233602|NCT05734716|Epoetin Alfa|epoetin alfa|mesh-list
139233603|NCT05734716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139233604|NCT05734716|Hematinics|hematinics|mesh-ancestor
139233605|NCT05733000|Thioctic Acid|thioctic acid|mesh-list
139233606|NCT05733000|Hydroxychloroquine|hydroxychloroquine|mesh-list
139233607|NCT05733000|Gemcitabine|gemcitabine|mesh-list
139233608|NCT05733000|Fluorouracil|fluorouracil|mesh-list
139233609|NCT05733000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139233610|NCT05733000|Antimetabolites|antimetabolites|mesh-ancestor
139233611|NCT05733000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233612|NCT05733000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233613|NCT05733000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139233614|NCT05733000|Immunologic Factors|immunologic factors|mesh-ancestor
139233615|NCT05733000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233616|NCT05733000|Antimalarials|antimalarials|mesh-ancestor
139233617|NCT05733000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139233618|NCT05733000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139233619|NCT05733000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233620|NCT05733000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233621|NCT05733000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139233622|NCT05733000|Antioxidants|antioxidants|mesh-ancestor
139233623|NCT05733000|Protective Agents|protective agents|mesh-ancestor
139233624|NCT05733000|Vitamin B Complex|vitamin b complex|mesh-ancestor
139233625|NCT05733000|Vitamins|vitamins|mesh-ancestor
139233626|NCT05733000|Micronutrients|micronutrients|mesh-ancestor
139233627|NCT03417180|Remifentanil|remifentanil|mesh-list
139233628|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139233629|NCT03417180|Narcotics|narcotics|mesh-ancestor
139233630|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233631|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233632|NCT03417180|Analgesics|analgesics|mesh-ancestor
139233633|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
139299434|NCT04706429|Trientine|trientine|mesh-list
139233634|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233635|NCT03085095|Leuprolide|leuprolide|mesh-list
139233636|NCT03085095|Relugolix|relugolix|mesh-list
139233637|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139233638|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
139233639|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139233640|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233641|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139233642|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233643|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
139233644|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
139233645|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139233646|NCT02811783|Naloxone|naloxone|mesh-list
139233647|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139233648|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233649|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
139233668|NCT03106077|Immunoconjugates|immunoconjugates|mesh-ancestor
139233669|NCT03106077|Immunologic Factors|immunologic factors|mesh-ancestor
139233670|NCT03106077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233671|NCT03648008|Morphine|morphine|mesh-list
139233672|NCT03648008|Hydromorphone|hydromorphone|mesh-list
139233673|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139233674|NCT03648008|Narcotics|narcotics|mesh-ancestor
139233675|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233676|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233677|NCT03648008|Analgesics|analgesics|mesh-ancestor
139233678|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
139233679|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233680|NCT05702541|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139233681|NCT05702541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139233682|NCT05702541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233683|NCT05054751|Fulvestrant|fulvestrant|mesh-list
139233684|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139233685|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233686|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139233687|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139233688|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
139233689|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139233690|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233691|NCT00604617|Interferons|interferons|mesh-list
139233692|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
139233693|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233694|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
139233695|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233696|NCT03426995|Cantharidin|cantharidin|mesh-list
139233697|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233698|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233699|NCT05200299|Leucovorin|leucovorin|mesh-list
139233700|NCT05200299|Capecitabine|capecitabine|mesh-list
139233701|NCT05200299|Fluorouracil|fluorouracil|mesh-list
139233702|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
139233703|NCT05200299|Irinotecan|irinotecan|mesh-list
139233704|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
139233705|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139233706|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
139233707|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233708|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233709|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139233710|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
139233711|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233712|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139233713|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139233714|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233715|NCT05200299|Antidotes|antidotes|mesh-ancestor
139233716|NCT05200299|Protective Agents|protective agents|mesh-ancestor
139233717|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
139233718|NCT05200299|Vitamins|vitamins|mesh-ancestor
139233719|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
139233720|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
139233721|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139299438|NCT04697719|Aspirin|aspirin|mesh-list
139233722|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233723|NCT03322566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139233724|NCT03322566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233725|NCT03822975|Heparin|heparin|mesh-list
139233727|NCT03822975|Bivalirudin|bivalirudin|mesh-list
139233728|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
139233729|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139233730|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139233731|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233732|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
139233733|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139233734|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
139233735|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233736|NCT05732532|Dexamethasone|dexamethasone|mesh-list
139233737|NCT05732532|Lidocaine|lidocaine|mesh-list
139233738|NCT05732532|Bupivacaine|bupivacaine|mesh-list
139233739|NCT05732532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139233740|NCT05732532|Antiemetics|antiemetics|mesh-ancestor
139233741|NCT05732532|Autonomic Agents|autonomic agents|mesh-ancestor
139233742|NCT05732532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233743|NCT05732532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233744|NCT05732532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139233745|NCT05732532|Glucocorticoids|glucocorticoids|mesh-ancestor
139233746|NCT05732532|Hormones|hormones|mesh-ancestor
139233747|NCT05732532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139233748|NCT05732532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139233749|NCT05732532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233750|NCT05732532|Anesthetics, Local|anesthetics, local|mesh-ancestor
139233751|NCT05732532|Anesthetics|anesthetics|mesh-ancestor
139233752|NCT05732532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233753|NCT05732532|Sensory System Agents|sensory system agents|mesh-ancestor
139233754|NCT05732532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139233755|NCT05732532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139233756|NCT05732532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139233757|NCT05732532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139233758|NCT05732532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233759|NCT05178225|Ubiquinone|ubiquinone|mesh-list
139233760|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
139233761|NCT05178225|Anticoagulants|anticoagulants|mesh-list
139233762|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
139233763|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233764|NCT05178225|Vitamins|vitamins|mesh-ancestor
139233765|NCT02969018|PF-06700841|pf-06700841|mesh-list
139233766|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139233767|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233768|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233769|NCT03255096|Rituximab|rituximab|mesh-list
139233770|NCT03255096|Venetoclax|venetoclax|mesh-list
139233771|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139233772|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233773|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
139233774|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233775|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139233776|NCT01319721|Mitomycins|mitomycins|mesh-list
139233777|NCT01319721|Mitomycin|mitomycin|mesh-list
139233778|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139233779|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233780|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
139233781|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233782|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139233783|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233784|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
139233785|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
139233786|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139233787|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139233788|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233789|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233790|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233791|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139233792|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
139233793|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
139233794|NCT05139849|Vasopressins|vasopressins|mesh-list
139233795|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139233796|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
139233797|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
139233798|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233799|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233800|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139233801|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
139233802|NCT05139849|Hormones|hormones|mesh-ancestor
139233803|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139233804|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139233805|NCT05139849|Protective Agents|protective agents|mesh-ancestor
139233806|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
139233807|NCT05139849|Coagulants|coagulants|mesh-ancestor
139233808|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139233809|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139233810|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
139233811|NCT03315741|Pirfenidone|pirfenidone|mesh-list
139233812|NCT03315741|Analgesics|analgesics|mesh-ancestor
139233813|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
139233814|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233815|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233816|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139233817|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139233818|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139233819|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139233820|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233821|NCT05077449|Fulvestrant|fulvestrant|mesh-list
139233822|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139233823|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233824|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139233825|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139233826|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
139233827|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139233828|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233829|NCT03632733|Tetracycline|tetracycline|mesh-list
139233830|NCT03632733|Clotrimazole|clotrimazole|mesh-list
139233831|NCT03632733|Miconazole|miconazole|mesh-list
139233832|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139233833|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233834|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139233835|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233836|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233837|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139233838|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
139233839|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139233840|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139233841|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139233842|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
139233843|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139233844|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233845|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139233846|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139233847|NCT03259425|Nivolumab|nivolumab|mesh-list
139299467|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139233848|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139233849|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233850|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139233851|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233852|NCT03061188|Nivolumab|nivolumab|mesh-list
139233853|NCT03061188|Veliparib|veliparib|mesh-list
139233854|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139233855|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233856|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139233857|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233858|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139233859|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233860|NCT05588453|Temozolomide|temozolomide|mesh-list
139233861|NCT05588453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139233862|NCT05588453|Alkylating Agents|alkylating agents|mesh-ancestor
139233863|NCT05588453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233864|NCT05588453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233865|NCT05186454|Dexamethasone|dexamethasone|mesh-list
139233866|NCT05186454|Midazolam|midazolam|mesh-list
139233867|NCT05186454|Morphine|morphine|mesh-list
139233868|NCT05186454|Bupivacaine|bupivacaine|mesh-list
139233869|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139233870|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
139233871|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
139233872|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233873|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233874|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139233875|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
139190475|NCT03395002|Xhance|xhance|mesh-list
139233877|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139233878|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139642453|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139233879|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233881|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
139233882|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233883|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
139233884|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139233885|NCT05186454|Narcotics|narcotics|mesh-ancestor
139233886|NCT05186454|Analgesics|analgesics|mesh-ancestor
139233887|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139233888|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139233889|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139233890|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139233891|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139233892|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139233893|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
139233894|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
139233895|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
139233896|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233897|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233898|NCT02113878|Cisplatin|cisplatin|mesh-list
139233899|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233900|NCT05162898|Lenvatinib|lenvatinib|mesh-list
139233901|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233902|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139233903|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233904|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233905|NCT05113290|Sorafenib|sorafenib|mesh-list
139233906|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233907|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139233908|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233909|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233910|NCT03461952|Nivolumab|nivolumab|mesh-list
139233911|NCT03461952|Ipilimumab|ipilimumab|mesh-list
139233912|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139233913|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233914|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139233915|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233916|NCT03619824|Gemcitabine|gemcitabine|mesh-list
139233917|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233918|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139233919|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
139233920|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233921|NCT01759836|Atorvastatin|atorvastatin|mesh-list
139233922|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139233923|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139233924|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
139233925|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233926|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139233927|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139233928|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139233929|NCT03447821|Rifamycins|rifamycins|mesh-list
139233930|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
139233931|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139233932|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139233933|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139233934|NCT05630339|Vitamin D|vitamin d|mesh-list
139233935|NCT05630339|Cholecalciferol|cholecalciferol|mesh-list
139233936|NCT05630339|Vitamins|vitamins|mesh-ancestor
139233937|NCT05630339|Micronutrients|micronutrients|mesh-ancestor
139233938|NCT05630339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233939|NCT05630339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139233940|NCT05630339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139233941|NCT03447353|Acetaminophen|acetaminophen|mesh-list
139233942|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139233943|NCT03447353|Hydrocodone|hydrocodone|mesh-list
139233944|NCT03447353|Alprazolam|alprazolam|mesh-list
139233945|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139233946|NCT03447353|Analgesics|analgesics|mesh-ancestor
139233947|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
139233948|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139233949|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233950|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
139233951|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139233953|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139233954|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
139233955|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
139233956|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139233957|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139233958|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139233959|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139233960|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
139233961|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
139233962|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233963|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233964|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139233965|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139233966|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139233967|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139233968|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139233969|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233970|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139233971|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139233972|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139233973|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139233974|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
139233975|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139233976|NCT00710970|Tamoxifen|tamoxifen|mesh-list
139233977|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139233978|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139233979|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
139233980|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139233981|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233982|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139233983|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139233984|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139233985|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139233986|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139233987|NCT03421379|Glucagon|glucagon|mesh-list
139233988|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139233989|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139233990|NCT03421379|Hormones|hormones|mesh-ancestor
139233991|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139233992|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139233993|NCT03421379|Incretins|incretins|mesh-ancestor
139233994|NCT03712241|Indomethacin|indomethacin|mesh-list
139233995|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139233996|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139233997|NCT03712241|Analgesics|analgesics|mesh-ancestor
139233998|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
139233999|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234000|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234001|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234002|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139234003|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
139234004|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
139234005|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139234006|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139234007|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234008|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234009|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
139234010|NCT02675946|Cetuximab|cetuximab|mesh-list
139234011|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139234012|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234013|NCT02675946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139234014|NCT02675946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234015|NCT02900378|Valsartan|valsartan|mesh-list
139234016|NCT02900378|Enalapril|enalapril|mesh-list
139234017|NCT02900378|Enalaprilat|enalaprilat|mesh-list
139234018|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139234019|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139234020|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139234021|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139234022|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234023|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139234024|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
139234025|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234026|NCT03058692|Vaccines|vaccines|mesh-list
139234027|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
139234028|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234029|NCT03647150|Amoxicillin|amoxicillin|mesh-list
139234030|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139234031|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234032|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
139234033|NCT03056352|Promethazine|promethazine|mesh-list
139234034|NCT03056352|Metoclopramide|metoclopramide|mesh-list
139234035|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139234036|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139299497|NCT04516993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234037|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234038|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234039|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
139234040|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
139234041|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
139234042|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234043|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
139234044|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
139234045|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234046|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139234047|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
139234048|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
139234049|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234050|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234051|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139234052|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
139234053|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
139234054|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139234055|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139234056|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
139234057|NCT04360980|Colchicine|colchicine|mesh-list
139234058|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
139234059|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139234060|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
139234061|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
139234062|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
139234063|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234064|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234065|NCT03647072|Famotidine|famotidine|mesh-list
139234066|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139234067|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234068|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139234069|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
139234070|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
139234071|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234072|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234073|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234074|NCT05284136|Prednisolone|prednisolone|mesh-list
139234075|NCT05284136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234076|NCT05284136|Glucocorticoids|glucocorticoids|mesh-ancestor
139234077|NCT05284136|Hormones|hormones|mesh-ancestor
139234078|NCT05284136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139234079|NCT05284136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234080|NCT05284136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139234081|NCT05284136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234082|NCT03646916|Dexamethasone|dexamethasone|mesh-list
139234083|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
139234084|NCT03646916|BB 1101|bb 1101|mesh-list
139234085|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234086|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
139234087|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
139234088|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234089|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234090|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234091|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
139234092|NCT03646916|Hormones|hormones|mesh-ancestor
139234093|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139234094|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139234095|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234096|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
139234097|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234098|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234099|NCT04305756|Enoxaparin|enoxaparin|mesh-list
139234100|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
139234101|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139234102|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139234103|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234104|NCT03645980|Sorafenib|sorafenib|mesh-list
139234105|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234106|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139234107|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234108|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234109|NCT04315038|Anesthetics|anesthetics|mesh-list
139234110|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234111|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234112|NCT03645200|Apatinib|apatinib|mesh-list
139234113|NCT03645200|Fluzoparib|fluzoparib|mesh-list
139234114|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234115|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139234116|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234117|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234118|NCT03645200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139234119|NCT03055338|Risperidone|risperidone|mesh-list
139234120|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139234121|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
139234122|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234123|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234124|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234125|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139234126|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139234127|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234128|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139234129|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139234130|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
139234131|NCT03645668|Meropenem|meropenem|mesh-list
139234132|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139234133|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234134|NCT03712163|Ketotifen|ketotifen|mesh-list
139234135|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
139234136|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
139234137|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139234138|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
139234139|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
139234140|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234141|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234142|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234143|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139234144|NCT01311167|Dexamethasone|dexamethasone|mesh-list
139234145|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234146|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
139234147|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
139234148|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234149|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234150|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234151|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
139234152|NCT01311167|Hormones|hormones|mesh-ancestor
139234153|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139234154|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139234155|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234156|NCT04233840|Nivolumab|nivolumab|mesh-list
139234157|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139234158|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234159|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139234160|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234161|NCT02896400|Nicotine|nicotine|mesh-list
139234162|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139234163|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
139234164|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234165|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234166|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139234167|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139234168|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
139234169|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234170|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234171|NCT03404843|Fasudil|fasudil|mesh-list
139234172|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139190778|NCT04401384|Vitamins|vitamins|mesh-ancestor
139234173|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139234174|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234175|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139234176|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234177|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
139234178|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139234179|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234180|NCT05284448|Pentoxifylline|pentoxifylline|mesh-list
139234181|NCT05284448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139234182|NCT05284448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234183|NCT05284448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234184|NCT05284448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139234185|NCT05284448|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139234186|NCT05284448|Protective Agents|protective agents|mesh-ancestor
139234187|NCT05284448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234188|NCT05284448|Vasodilator Agents|vasodilator agents|mesh-ancestor
139234189|NCT05284448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139234190|NCT05284448|Antioxidants|antioxidants|mesh-ancestor
139234191|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
139234192|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234193|NCT03444155|Folic Acid|folic acid|mesh-list
139234194|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
139234195|NCT03444155|Vitamins|vitamins|mesh-ancestor
139234196|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
139234197|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234198|NCT03444155|Hematinics|hematinics|mesh-ancestor
139234199|NCT02898116|Durvalumab|durvalumab|mesh-list
139234200|NCT02898116|Ensartinib|ensartinib|mesh-list
139234201|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139234202|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234203|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139234204|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234205|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234206|NCT03717701|Metformin|metformin|mesh-list
139234207|NCT03717701|Esomeprazole|esomeprazole|mesh-list
139234208|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139234209|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234210|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139234211|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234212|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139234213|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234214|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234215|NCT03658304|Mitomycins|mitomycins|mesh-list
139234216|NCT03658304|Mitomycin|mitomycin|mesh-list
139234217|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139234218|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234219|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
139234220|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234221|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139234222|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234223|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
139234224|NCT03422159|Thiamine|thiamine|mesh-list
139234225|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
139234226|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139234227|NCT03422159|Vitamins|vitamins|mesh-ancestor
139234228|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
139234229|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234230|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234231|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
139234232|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234233|NCT03422159|Protective Agents|protective agents|mesh-ancestor
139234234|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
139234235|NCT04538040|Tenofovir|tenofovir|mesh-list
139234236|NCT04538040|Emtricitabine|emtricitabine|mesh-list
139234237|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139234238|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
139234239|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234240|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139234241|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139234242|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234243|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234244|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139234245|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139234246|NCT02297412|Minocycline|minocycline|mesh-list
139234247|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139234248|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234249|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
139234250|NCT03644576|Ephedrine|ephedrine|mesh-list
139234251|NCT03644576|Ozanimod|ozanimod|mesh-list
139234252|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139234253|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
139234254|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234255|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234256|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139234257|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
139234258|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
139234259|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139234260|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139234261|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
139234262|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
139234263|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234264|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234265|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139234266|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139234267|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
139234268|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139234269|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139234270|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139234271|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139234272|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139234273|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139234274|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139234275|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139234276|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
139234277|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234278|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234279|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234280|NCT03418727|Laxatives|laxatives|mesh-ancestor
139234281|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234282|NCT01180374|Dronabinol|dronabinol|mesh-list
139234283|NCT01180374|Cannabidiol|cannabidiol|mesh-list
139234284|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
139234285|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
139234286|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234287|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139234288|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139234289|NCT01180374|Analgesics|analgesics|mesh-ancestor
139234290|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
139234291|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234292|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139234293|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139234294|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234295|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234296|NCT01180374|Hormones|hormones|mesh-ancestor
139234297|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139234298|NCT03418571|Gontivimab|gontivimab|mesh-list
139234299|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
139234300|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234301|NCT03715517|Morphine|morphine|mesh-list
139234302|NCT03715517|Hydromorphone|hydromorphone|mesh-list
139234303|NCT03715517|Bupivacaine|bupivacaine|mesh-list
139234304|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139234305|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
139234306|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
139234307|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234308|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234309|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
139234310|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234311|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139234312|NCT03715517|Narcotics|narcotics|mesh-ancestor
139234313|NCT03715517|Analgesics|analgesics|mesh-ancestor
139234314|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
139234315|NCT03717467|Analgesics|analgesics|mesh-ancestor
139234316|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
139234317|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234318|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234319|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
139234320|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234321|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139234322|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
139234323|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139234324|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139234325|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234326|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139234327|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
139234328|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139234329|NCT01318122|Pioglitazone|pioglitazone|mesh-list
139234330|NCT01318122|Alogliptin|alogliptin|mesh-list
139234331|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139234332|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234333|NCT01318122|Incretins|incretins|mesh-ancestor
139234334|NCT01318122|Hormones|hormones|mesh-ancestor
139234335|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139234336|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139234337|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
139234338|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234339|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234340|NCT02954159|Vedolizumab|vedolizumab|mesh-list
139234341|NCT02954159|Tacrolimus|tacrolimus|mesh-list
139234342|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139234343|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
139234344|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234345|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139234346|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234347|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234348|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234349|NCT03763422|Temozolomide|temozolomide|mesh-list
139234350|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139234351|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
139234352|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234353|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234354|NCT03667716|Nivolumab|nivolumab|mesh-list
139234355|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139234356|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234357|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139234358|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234359|NCT03440411|Dexamethasone|dexamethasone|mesh-list
139234360|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
139234361|NCT03440411|Pomalidomide|pomalidomide|mesh-list
139234362|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139234363|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
139234364|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234365|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139234366|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139234367|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
139234368|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234369|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234370|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139234371|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234372|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
139234373|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
139234374|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234375|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234376|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
139234377|NCT03440411|Hormones|hormones|mesh-ancestor
139234378|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139234379|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139234380|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139234381|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139234382|NCT03440411|Growth Substances|growth substances|mesh-ancestor
139234383|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
139234384|NCT03714737|Vaccines|vaccines|mesh-list
139234385|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
139234386|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234387|NCT03389555|Vitamins|vitamins|mesh-list
139234388|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
139234389|NCT03389555|Thiamine|thiamine|mesh-list
139234390|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
139234391|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
139234392|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234393|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234394|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
139234395|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234396|NCT03389555|Protective Agents|protective agents|mesh-ancestor
139234397|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
139234398|NCT03395639|Heparin|heparin|mesh-list
139234399|NCT03395639|Enoxaparin|enoxaparin|mesh-list
139234400|NCT03395639|Warfarin|warfarin|mesh-list
139234401|NCT03395639|Edoxaban|edoxaban|mesh-list
139234402|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
139234403|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139234404|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139234405|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234406|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139234407|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
139234408|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139234409|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
139234410|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234411|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
139234412|NCT03353922|Tolperisone|tolperisone|mesh-list
139234413|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139234414|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
139234415|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139234416|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139234417|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234418|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139234419|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234420|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139234421|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234422|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
139234423|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139234424|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234425|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139234426|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234427|NCT05467553|Tenofovir|tenofovir|mesh-list
139234428|NCT05467553|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139234429|NCT05467553|Antiviral Agents|antiviral agents|mesh-ancestor
139234430|NCT05467553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234431|NCT05467553|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139234432|NCT05467553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139234433|NCT05467553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234434|NCT05467553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234435|NCT05467553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139234436|NCT05467553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139234437|NCT05467553|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139234438|NCT05467553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234439|NCT02942004|Pregnanolone|pregnanolone|mesh-list
139234440|NCT02942004|Brexanolone|brexanolone|mesh-list
139234441|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
139234442|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234443|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234444|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234445|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
139234446|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
139234447|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
139234448|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234449|NCT03414359|Lidocaine|lidocaine|mesh-list
139234450|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
139234451|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
139234452|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
139234453|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234454|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234455|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
139299534|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
139234456|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234457|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139234458|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139234459|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139234460|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139234461|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234462|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
139234463|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
139234464|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234465|NCT02583048|Dolutegravir|dolutegravir|mesh-list
139234466|NCT02583048|Bedaquiline|bedaquiline|mesh-list
139234467|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139234468|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139234469|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234470|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234471|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139234472|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139234473|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
139234474|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234475|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
139234476|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139234478|NCT03274687|Hormones|hormones|mesh-ancestor
139234479|NCT03274687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139234480|NCT03274687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234481|NCT02542956|Bupivacaine|bupivacaine|mesh-list
139234482|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
139234483|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
139234484|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234485|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234486|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
139234487|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234488|NCT03274453|Ketamine|ketamine|mesh-list
139234489|NCT03274453|Analgesics|analgesics|mesh-ancestor
139234490|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
139234491|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234492|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234493|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139234494|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139234495|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
139234496|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
139234497|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234498|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139234499|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139234500|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234501|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234502|NCT02313870|Clobetasol|clobetasol|mesh-list
139234503|NCT02313870|Methotrexate|methotrexate|mesh-list
139234504|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139234505|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
139234506|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139234507|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234508|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139234509|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
139234510|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234511|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234512|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
139234513|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234514|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139234515|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139234516|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
139234517|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139234518|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139234519|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234520|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
139234521|NCT02313870|Hormones|hormones|mesh-ancestor
139234522|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139234523|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
139234524|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139234525|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139234526|NCT01942122|Analgesics|analgesics|mesh-ancestor
139234527|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
139234528|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234529|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234530|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234531|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139234532|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139234533|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234534|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234535|NCT02236806|Ramipril|ramipril|mesh-list
139234536|NCT02236806|Bisoprolol|bisoprolol|mesh-list
139234537|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139234538|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
139234539|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234540|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234541|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139234542|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
139234543|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
139234544|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234545|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234546|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139234547|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139191143|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
139234548|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139234549|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
139234550|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234551|NCT01578954|Lenalidomide|lenalidomide|mesh-list
139234552|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
139234553|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234554|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139234555|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139234556|NCT01578954|Growth Substances|growth substances|mesh-ancestor
139234557|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
139234558|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234559|NCT00659646|Levofloxacin|levofloxacin|mesh-list
139234561|NCT00659646|Gentamicins|gentamicins|mesh-list
139234562|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139234563|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234564|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139234565|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139234566|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139234567|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234568|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234569|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234570|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139234571|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139234572|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139234573|NCT02236572|Everolimus|everolimus|mesh-list
139234574|NCT02236572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139234575|NCT02236572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139234576|NCT02236572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234577|NCT02236572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234578|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139234579|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
139234580|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234581|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234582|NCT03054870|Xenon|xenon|mesh-list
139234583|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139234584|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
139234585|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
139234586|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234587|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234588|NCT03414047|Prexasertib|prexasertib|mesh-list
139234589|NCT03414047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139234590|NCT03414047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234591|NCT03414047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234592|NCT05448677|Bevacizumab|bevacizumab|mesh-list
139234593|NCT05448677|Atezolizumab|atezolizumab|mesh-list
139234594|NCT05448677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139234595|NCT05448677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234596|NCT05448677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139234597|NCT05448677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139234598|NCT05448677|Growth Substances|growth substances|mesh-ancestor
139234599|NCT05448677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234600|NCT05448677|Growth Inhibitors|growth inhibitors|mesh-ancestor
139234601|NCT05448677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139234602|NCT05448677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234603|NCT05222646|Metoclopramide|metoclopramide|mesh-list
139234604|NCT05222646|Antiemetics|antiemetics|mesh-ancestor
139234605|NCT05222646|Autonomic Agents|autonomic agents|mesh-ancestor
139234606|NCT05222646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234607|NCT05222646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234608|NCT05222646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234609|NCT05222646|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139234610|NCT05222646|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139234611|NCT05222646|Dopamine Agents|dopamine agents|mesh-ancestor
139234612|NCT05222646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234613|NCT05222646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234614|NCT05222334|Bupivacaine|bupivacaine|mesh-list
139234615|NCT05222334|Anesthetics, Local|anesthetics, local|mesh-ancestor
139234616|NCT05222334|Anesthetics|anesthetics|mesh-ancestor
139234617|NCT05222334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234618|NCT05222334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234619|NCT05222334|Sensory System Agents|sensory system agents|mesh-ancestor
139234620|NCT05222334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234621|NCT04465266|Tolperisone|tolperisone|mesh-list
139191219|NCT01378754|Fospropofol|fospropofol|mesh-list
139234622|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139234623|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234624|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139234625|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234627|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139234628|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234629|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
139234630|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
139234631|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139234632|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139234633|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234634|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234635|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234636|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139234637|NCT05178654|Nirmatrelvir|nirmatrelvir|mesh-list
139234638|NCT05178654|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139234639|NCT05178654|Protease Inhibitors|protease inhibitors|mesh-ancestor
139234640|NCT05178654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234641|NCT05178654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234642|NCT05178654|Antiviral Agents|antiviral agents|mesh-ancestor
139234643|NCT05178654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234644|NCT04108962|Benralizumab|benralizumab|mesh-list
139234645|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139234646|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
139234647|NCT04865796|Lactoferrin|lactoferrin|mesh-list
139234648|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234649|NCT04811118|Docetaxel|docetaxel|mesh-list
139234650|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234651|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
139234652|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
139234653|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
139234654|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234655|NCT05221164|Aspirin|aspirin|mesh-list
139234656|NCT05221164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139234657|NCT05221164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139234658|NCT05221164|Analgesics|analgesics|mesh-ancestor
139234659|NCT05221164|Sensory System Agents|sensory system agents|mesh-ancestor
139234660|NCT05221164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234661|NCT05221164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234662|NCT05221164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234663|NCT05221164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139234664|NCT05221164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139234665|NCT05221164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139234666|NCT05221164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234667|NCT05221164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139234668|NCT05221164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139234669|NCT05221164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234670|NCT05221164|Antipyretics|antipyretics|mesh-ancestor
139234671|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
139234672|NCT03627546|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139234673|NCT03627546|Velpatasvir|velpatasvir|mesh-list
139234674|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
139234675|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234676|NCT04620798|Antibodies|antibodies|mesh-list
139234677|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
139234678|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234679|NCT05220228|Prucalopride|prucalopride|mesh-list
139234680|NCT05220228|Laxatives|laxatives|mesh-ancestor
139234681|NCT05220228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234682|NCT05220228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139234683|NCT05220228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139234684|NCT05220228|Serotonin Agents|serotonin agents|mesh-ancestor
139234685|NCT05220228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234686|NCT05220228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234687|NCT05220228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234688|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
139234689|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
139234690|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139234691|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139234692|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234693|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234694|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234695|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139234696|NCT04765644|Celecoxib|celecoxib|mesh-list
139191297|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
139234697|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139234698|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139234699|NCT04765644|Analgesics|analgesics|mesh-ancestor
139234700|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
139234701|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234702|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234703|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234704|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139234705|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139234706|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139234707|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234708|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234710|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139234711|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139234712|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139234713|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139234714|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234715|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
139234716|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234717|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234718|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139234719|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234720|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139234721|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139234722|NCT05197374|Estradiol|estradiol|mesh-list
139234723|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139234724|NCT05197374|Estrogens|estrogens|mesh-ancestor
139234725|NCT05197374|Hormones|hormones|mesh-ancestor
139234726|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139234727|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234728|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139234729|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
139234730|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139234731|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139234732|NCT02951819|Dexamethasone|dexamethasone|mesh-list
139234733|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
139234734|NCT02951819|Bortezomib|bortezomib|mesh-list
139234735|NCT02951819|Daratumumab|daratumumab|mesh-list
139234736|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139234737|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
139234738|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234739|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139234740|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139234741|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
139234742|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234743|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234744|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139234745|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234746|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
139234747|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
139234748|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234749|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234750|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
139234751|NCT02951819|Hormones|hormones|mesh-ancestor
139234752|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139234753|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139234754|NCT05191290|Heparin|heparin|mesh-list
139234755|NCT05191290|Calcium heparin|calcium heparin|mesh-list
139234756|NCT05191290|Citric Acid|citric acid|mesh-list
139234757|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
139234758|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
139234759|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139234760|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
139234761|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
139234762|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234763|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139234764|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139234765|NCT05627544|Anesthetics|anesthetics|mesh-list
139234766|NCT05627544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234767|NCT05627544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234768|NCT05189028|Gemcitabine|gemcitabine|mesh-list
139234769|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234770|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139191370|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
139234771|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
139234772|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234773|NCT03383783|Listerine|listerine|mesh-list
139234774|NCT03383783|Fluorides|fluorides|mesh-list
139234775|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
139234777|NCT03383783|Protective Agents|protective agents|mesh-ancestor
139234778|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234779|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139234780|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234781|NCT03627390|Molybdenum|molybdenum|mesh-list
139234782|NCT03627390|Trace Elements|trace elements|mesh-ancestor
139234783|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
139234784|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234785|NCT03709745|Ranibizumab|ranibizumab|mesh-list
139234786|NCT03709745|Aflibercept|aflibercept|mesh-list
139234787|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139234788|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139234789|NCT03709745|Growth Substances|growth substances|mesh-ancestor
139234790|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234791|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
139234792|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234793|NCT05570526|Melatonin|melatonin|mesh-list
139234794|NCT05570526|Antioxidants|antioxidants|mesh-ancestor
139234795|NCT05570526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234796|NCT05570526|Protective Agents|protective agents|mesh-ancestor
139234797|NCT05570526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234798|NCT05570526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234799|NCT03707639|Apatinib|apatinib|mesh-list
139234800|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234801|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139234802|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234803|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234804|NCT03334721|Gabapentin|gabapentin|mesh-list
139234805|NCT03334721|Analgesics|analgesics|mesh-ancestor
139234806|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
139234807|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234808|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234809|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
139234810|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139234811|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139234812|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234813|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139234814|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139234815|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139234816|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234817|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234818|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
139234819|NCT05706090|Fentanyl|fentanyl|mesh-list
139234820|NCT05706090|Anesthetics|anesthetics|mesh-ancestor
139234821|NCT05706090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234822|NCT05706090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234823|NCT05706090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139234824|NCT05706090|Narcotics|narcotics|mesh-ancestor
139234825|NCT05706090|Analgesics|analgesics|mesh-ancestor
139234826|NCT05706090|Sensory System Agents|sensory system agents|mesh-ancestor
139234827|NCT05706090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234828|NCT05706090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139234829|NCT05706090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139234830|NCT05706090|Anesthetics, General|anesthetics, general|mesh-ancestor
139234831|NCT03380429|Albuterol|albuterol|mesh-list
139234832|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139234833|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
139234834|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234835|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234836|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139234837|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
139234838|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
139234839|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139234840|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139234841|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139234842|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139234843|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
139234844|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234845|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234846|NCT01313143|Esmolol|esmolol|mesh-list
139234847|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139234848|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139234849|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139234850|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
139234851|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234852|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234853|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234855|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139234856|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234857|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234858|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139234859|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
139234860|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
139234861|NCT03280537|Omalizumab|omalizumab|mesh-list
139234862|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139234863|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139234864|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
139234865|NCT05029050|Clonidine|clonidine|mesh-list
139234866|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
139234867|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139234868|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139234869|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234870|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139234871|NCT05029050|Analgesics|analgesics|mesh-ancestor
139234872|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
139234873|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234874|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139234875|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139234876|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139234877|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
139234878|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234879|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234880|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139234881|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
139234882|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
139234883|NCT04690231|Etoposide|etoposide|mesh-list
139234884|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
139234885|NCT04690231|Apatinib|apatinib|mesh-list
139234886|NCT04690231|Ifosfamide|ifosfamide|mesh-list
139234887|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
139234888|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139234889|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234890|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139234891|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139234892|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234893|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234894|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139234895|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139234896|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
139234897|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139234898|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139234899|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139234900|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
139234901|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234902|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139234903|NCT04234945|Doxycycline|doxycycline|mesh-list
139234904|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139234905|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234906|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
139234907|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139234908|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139234909|NCT03316807|Vaccines|vaccines|mesh-list
139234910|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
139234911|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234912|NCT03379259|Tislelizumab|tislelizumab|mesh-list
139234913|NCT03379259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139234914|NCT03379259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234915|NCT03328897|Omalizumab|omalizumab|mesh-list
139234916|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139234917|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139234918|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
139234919|NCT04918758|Sucralfate|sucralfate|mesh-list
139234920|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139234921|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234922|NCT03378635|Glucagon|glucagon|mesh-list
139234923|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139234924|NCT03378635|Hormones|hormones|mesh-ancestor
139234925|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139234926|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234927|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139234928|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139234929|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139234931|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
139234932|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234933|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234934|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234935|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139234936|NCT03334409|Vitamins|vitamins|mesh-list
139234937|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
139234938|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
139234939|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234940|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
139234941|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234942|NCT03334409|Protective Agents|protective agents|mesh-ancestor
139234943|NCT02891915|Amoxicillin|amoxicillin|mesh-list
139234944|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
139234945|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
139234946|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139234947|NCT02891915|Cefdinir|cefdinir|mesh-list
139234948|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139234949|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234950|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139234951|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234952|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234953|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
139234954|NCT03051217|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139234955|NCT03051217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139234956|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139234957|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
139234958|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234959|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139234960|NCT05035303|Epinephrine|epinephrine|mesh-list
139234961|NCT05035303|Norepinephrine|norepinephrine|mesh-list
139234962|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139234963|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139234964|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
139234965|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234966|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234967|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234968|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139234969|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139234970|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
139234971|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139234972|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139234973|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
139234974|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
139234975|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
139234976|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139234977|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139234978|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
139234979|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234980|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
139234981|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139234982|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139234983|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139234984|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
139234985|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139234986|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139234987|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139234988|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234989|NCT04580394|Oxybutynin|oxybutynin|mesh-list
139234990|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139234991|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139234992|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139234993|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139234994|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139234995|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
139234996|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139234997|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139234998|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
139234999|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
139235000|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235001|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139235002|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139235003|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
139235004|NCT04580394|Urological Agents|urological agents|mesh-ancestor
139235005|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139235006|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139235007|NCT04385173|Temozolomide|temozolomide|mesh-list
139235008|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139235009|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
139235010|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235011|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235012|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
139235013|NCT03707249|Hematinics|hematinics|mesh-ancestor
139235014|NCT05682911|Simvastatin|simvastatin|mesh-list
139235015|NCT05682911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139235016|NCT05682911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139235017|NCT05682911|Antimetabolites|antimetabolites|mesh-ancestor
139235018|NCT05682911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235019|NCT05682911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139235020|NCT05682911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139235021|NCT05682911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235022|NCT04625088|Atropine|atropine|mesh-list
139235023|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139235024|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139235025|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139235026|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
139235027|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235028|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235029|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139235030|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
139235031|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
139235032|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
139235033|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139235034|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139235035|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
139235036|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235037|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235038|NCT03568422|Paclitaxel|paclitaxel|mesh-list
139299553|NCT04447716|Growth Substances|growth substances|mesh-ancestor
139235039|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139235040|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235041|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
139235042|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
139235043|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
139235044|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235045|NCT02547493|Abatacept|abatacept|mesh-list
139235046|NCT02547493|Vaccines|vaccines|mesh-list
139235047|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139235048|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
139235049|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235050|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139235051|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235052|NCT02547493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139235053|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235054|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139235055|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139235056|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
139235057|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139235058|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235059|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
139235060|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
139235061|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235062|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235063|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235064|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
139235065|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
139235066|NCT03257995|Maleic acid|maleic acid|mesh-list
139235067|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235068|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235069|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139235070|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139191669|NCT01250405|Cinacalcet|cinacalcet|mesh-list
139235071|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
139235072|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235073|NCT03049488|Antacids|antacids|mesh-ancestor
139235074|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235075|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139235076|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
139235077|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139235078|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139235079|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235080|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139235081|NCT04484922|Analgesics|analgesics|mesh-ancestor
139235082|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
139235083|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235084|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139235085|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139235086|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139235087|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
139235088|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235089|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235090|NCT04446390|Listerine|listerine|mesh-list
139235091|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
139235092|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
139235093|NCT04446390|Protective Agents|protective agents|mesh-ancestor
139235094|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235095|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139235096|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235097|NCT02338921|Metformin|metformin|mesh-list
139235098|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
139235099|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139235100|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139235101|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235102|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139235103|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235104|NCT02338921|Incretins|incretins|mesh-ancestor
139235105|NCT02338921|Hormones|hormones|mesh-ancestor
139235106|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139235107|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139235108|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
139235109|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235110|NCT01313845|Amantadine|amantadine|mesh-list
139235111|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139235112|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139235113|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
139235114|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235115|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
139235116|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235117|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235118|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235119|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139235120|NCT01313845|Analgesics|analgesics|mesh-ancestor
139235121|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
139235122|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235123|NCT04745845|Norepinephrine|norepinephrine|mesh-list
139235124|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139235125|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139235126|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
139235127|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235128|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235129|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235130|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
139235131|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
139235132|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235133|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139235134|NCT03196986|Bevacizumab|bevacizumab|mesh-list
139235135|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139235136|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235137|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139235138|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139235139|NCT03196986|Growth Substances|growth substances|mesh-ancestor
139235140|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235141|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
139235142|NCT04051632|Insulin|insulin|mesh-list
139235143|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139235144|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235145|NCT03043560|Ezogabine|ezogabine|mesh-list
139235146|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
139235147|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139235148|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235149|NCT02145403|Tacrolimus|tacrolimus|mesh-list
139235150|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139235151|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
139235152|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235153|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139235154|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235155|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235156|NCT02899988|Mirikizumab|mirikizumab|mesh-list
139235157|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139235158|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139235159|NCT02899988|Analgesics|analgesics|mesh-ancestor
139235160|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
139235161|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235162|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235163|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139235164|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139235165|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139235166|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139235167|NCT03646526|Amitriptyline|amitriptyline|mesh-list
139235168|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139235169|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
139235170|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139235171|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139235172|NCT03646526|Analgesics|analgesics|mesh-ancestor
139235173|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
139235174|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235175|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235176|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139235177|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139235178|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139299559|NCT04447027|Dexamethasone|dexamethasone|mesh-list
139235179|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235180|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
139235181|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235182|NCT03646370|Tenofovir|tenofovir|mesh-list
139235183|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
139235184|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235185|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139235186|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139235187|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235188|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235189|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139235190|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139235191|NCT03646292|Pioglitazone|pioglitazone|mesh-list
139235192|NCT03646292|Empagliflozin|empagliflozin|mesh-list
139235193|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139235194|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235195|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139235196|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235197|NCT03345407|Albuterol|albuterol|mesh-list
139235198|NCT03345407|Nemiralisib|nemiralisib|mesh-list
139235199|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139235200|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
139235201|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235202|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235203|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139235204|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
139235205|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
139235206|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139235207|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139235208|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139235209|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139235210|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
139235211|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235212|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235213|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139235214|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235215|NCT02537418|Durvalumab|durvalumab|mesh-list
139235216|NCT02537418|Tremelimumab|tremelimumab|mesh-list
139235217|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139235218|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235219|NCT03626298|Niacinamide|niacinamide|mesh-list
139235221|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
139235222|NCT03626298|Adapalene|adapalene|mesh-list
139235223|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
139235224|NCT03626298|Vitamins|vitamins|mesh-ancestor
139235225|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
139235226|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235227|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139235228|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
139235229|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235230|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139235231|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
139235232|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139235233|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139235234|NCT03626298|Analgesics|analgesics|mesh-ancestor
139235235|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
139235236|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235237|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139235238|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139235239|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
139235240|NCT03644264|Sevelamer|sevelamer|mesh-list
139235241|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
139235242|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
139235243|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235244|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
139235245|NCT02298348|Sorafenib|sorafenib|mesh-list
139235246|NCT02298348|Topotecan|topotecan|mesh-list
139235247|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139235248|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
139235249|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235250|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139235251|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139235252|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
139235253|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235254|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235255|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139235256|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139235257|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235258|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139235259|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139235260|NCT03240133|Berotralstat|berotralstat|mesh-list
139235261|NCT03240133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139235262|NCT03240133|Protease Inhibitors|protease inhibitors|mesh-ancestor
139235263|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235264|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235265|NCT03814356|Methylphenidate|methylphenidate|mesh-list
139235266|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139235267|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235268|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139235269|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139235270|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139235271|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235272|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
139235273|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235274|NCT03707171|Liraglutide|liraglutide|mesh-list
139235275|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139235276|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235277|NCT03707171|Incretins|incretins|mesh-ancestor
139235278|NCT03707171|Hormones|hormones|mesh-ancestor
139235279|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139235280|NCT02030964|Eflornithine|eflornithine|mesh-list
139235281|NCT02030964|Celecoxib|celecoxib|mesh-list
139235282|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
139235283|NCT02030964|Topotecan|topotecan|mesh-list
139235284|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139235285|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
139235286|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235287|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139235288|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139235289|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
139235290|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235291|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235292|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139235293|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139235294|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139235295|NCT02030964|Analgesics|analgesics|mesh-ancestor
139235296|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
139235297|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235298|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139235299|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139105374|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139235300|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139235301|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235302|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139235303|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139235304|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139235305|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139235306|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139235307|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235308|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139235309|NCT03372083|Deferasirox|deferasirox|mesh-list
139235310|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139235311|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
139235312|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
139235313|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235315|NCT03044886|Vitamins|vitamins|mesh-ancestor
139235316|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
139235317|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235318|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139235319|NCT02961764|Dalbavancin|dalbavancin|mesh-list
139235320|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139235321|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235322|NCT03371459|Albuterol|albuterol|mesh-list
139235323|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139235324|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
139235325|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299562|NCT04447027|Romidepsin|romidepsin|mesh-list
139235326|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235327|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139235328|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
139235329|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
139235330|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139235331|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139235332|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139235333|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139235334|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
139235335|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235336|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235337|NCT03371381|Nivolumab|nivolumab|mesh-list
139235338|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139235339|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235340|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139235341|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235342|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
139235343|NCT03044730|Capecitabine|capecitabine|mesh-list
139235344|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139235345|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235346|NCT03044730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139235347|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235348|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139235349|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
139235350|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139235351|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235352|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139235353|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235354|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235355|NCT04783233|Chitosan|chitosan|mesh-list
139235356|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139235357|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139235358|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139235359|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
139235360|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235361|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139235362|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
139235363|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
139235364|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
139235365|NCT04783233|Coagulants|coagulants|mesh-ancestor
139235366|NCT04777539|Natalizumab|natalizumab|mesh-list
139235367|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
139235368|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235369|NCT02951429|Pirfenidone|pirfenidone|mesh-list
139235370|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
139235371|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
139235372|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139235373|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139642454|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139235374|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235375|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235376|NCT02951429|Urological Agents|urological agents|mesh-ancestor
139235377|NCT02951429|Analgesics|analgesics|mesh-ancestor
139235378|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
139235379|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235380|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235381|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139235382|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139235383|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139235384|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139235385|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235386|NCT04622709|Furosemide|furosemide|mesh-list
139235387|NCT04622709|Diuretics|diuretics|mesh-list
139235388|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
139235389|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
139235390|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235391|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139235392|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235393|NCT05214807|Chitosan|chitosan|mesh-list
139235394|NCT05214807|Hylan|hylan|mesh-list
139235395|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139235396|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139235397|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
139235398|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235399|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139235400|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
139235401|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
139235402|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
139235403|NCT05214807|Coagulants|coagulants|mesh-ancestor
139235404|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
139235405|NCT05214807|Protective Agents|protective agents|mesh-ancestor
139235406|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235407|NCT02454855|Melatonin|melatonin|mesh-list
139235408|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
139235409|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235410|NCT02454855|Protective Agents|protective agents|mesh-ancestor
139235411|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235412|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139235413|NCT03343067|Norethindrone|norethindrone|mesh-list
139235414|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
139235415|NCT03343067|Estradiol|estradiol|mesh-list
139235416|NCT03343067|Estrogens|estrogens|mesh-ancestor
139235417|NCT03343067|Hormones|hormones|mesh-ancestor
139235418|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139235419|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235420|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139235421|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
139235422|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139235423|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139235424|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139235425|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139235426|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139235427|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139235428|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139235429|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235430|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
139235431|NCT04707183|Lidocaine|lidocaine|mesh-list
139235432|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
139235433|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
139235434|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139235435|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235436|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
139235437|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235438|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139235439|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139235440|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139235441|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139235442|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192050|NCT02527733|Ranibizumab|ranibizumab|mesh-list
139235443|NCT04703205|Ivermectin|ivermectin|mesh-list
139235444|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139235446|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
139235447|NCT03706781|Benzydamine|benzydamine|mesh-list
139235448|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139235449|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235450|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139235451|NCT03706703|Carboplatin|carboplatin|mesh-list
139235452|NCT03706703|Docetaxel|docetaxel|mesh-list
139235453|NCT03706703|Pemetrexed|pemetrexed|mesh-list
139235454|NCT03706703|Endostar protein|endostar protein|mesh-list
139235455|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235456|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
139235457|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
139235458|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
139235459|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235460|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235461|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139235462|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139235463|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139235464|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139235465|NCT03706703|Growth Substances|growth substances|mesh-ancestor
139235466|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235467|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
139235468|NCT05642403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139235469|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
139235470|NCT03706547|Fludarabine|fludarabine|mesh-list
139235471|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139235472|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
139235473|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235474|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139235475|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139235476|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
139235477|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235478|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235479|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139235480|NCT05682209|Octreotide|octreotide|mesh-list
139235481|NCT05682209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139235482|NCT05682209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139235483|NCT05682209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235484|NCT03708497|Misoprostol|misoprostol|mesh-list
139235485|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
139235486|NCT03708497|Carbetocin|carbetocin|mesh-list
139235487|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139235488|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139235489|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235490|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
139235491|NCT03708497|Coagulants|coagulants|mesh-ancestor
139235492|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139235493|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
139235494|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139235495|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235496|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139235497|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139235498|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
139235499|NCT05681975|Antibodies|antibodies|mesh-list
139235500|NCT05681975|Immunoglobulins|immunoglobulins|mesh-list
139235501|NCT05681975|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139235502|NCT05681975|Immunoglobulin G|immunoglobulin g|mesh-list
139235503|NCT05681975|Immunologic Factors|immunologic factors|mesh-ancestor
139235504|NCT05681975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235505|NCT05216744|Doxycycline|doxycycline|mesh-list
139235506|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
139235507|NCT05216744|Cefixime|cefixime|mesh-list
139235508|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139235509|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235510|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
139235511|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139235512|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139235513|NCT05681897|Minoxidil|minoxidil|mesh-list
139235514|NCT05681897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139235515|NCT05681897|Vasodilator Agents|vasodilator agents|mesh-ancestor
139235516|NCT01345058|Lacosamide|lacosamide|mesh-list
139235517|NCT01345058|Levetiracetam|levetiracetam|mesh-list
139235518|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
139235519|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
139235520|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139235521|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139235522|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139235523|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235524|NCT01345292|Listerine|listerine|mesh-list
139235525|NCT01345292|Fluorides|fluorides|mesh-list
139235526|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
139235527|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
139235528|NCT01345292|Protective Agents|protective agents|mesh-ancestor
139235529|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235530|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139235531|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235532|NCT03340961|Doxycycline|doxycycline|mesh-list
139235533|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139235534|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235535|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
139235536|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139235537|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139235538|NCT03643874|Albuterol|albuterol|mesh-list
139235539|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139235540|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
139235541|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235542|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235543|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139235544|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
139235545|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
139235546|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139235547|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139235548|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139235549|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139235550|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
139235551|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235552|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235553|NCT03254485|Praliciguat|praliciguat|mesh-list
139235554|NCT03254485|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139235555|NCT03254485|Enzyme Activators|enzyme activators|mesh-ancestor
139235556|NCT03254485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235557|NCT03254485|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139235558|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
139235559|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235560|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139235561|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235562|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235563|NCT01068704|Letrozole|letrozole|mesh-list
139235564|NCT01068704|Lapatinib|lapatinib|mesh-list
139235565|NCT01068704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235566|NCT01068704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139235567|NCT01068704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139235568|NCT01068704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235569|NCT01068704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235570|NCT01068704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139235571|NCT01068704|Hormone Antagonists|hormone antagonists|mesh-ancestor
139235572|NCT01068704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139235573|NCT01068704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235574|NCT01068704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139235575|NCT03339401|Brincidofovir|brincidofovir|mesh-list
139235576|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
139235577|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235578|NCT05179525|Risperidone|risperidone|mesh-list
139235579|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139235580|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
139235581|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235582|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235583|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235584|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139235585|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139235586|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139235587|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139235588|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139235589|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
139235590|NCT03370289|Vaccines|vaccines|mesh-list
139235591|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
139235592|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235593|NCT01344824|Bevacizumab|bevacizumab|mesh-list
139235594|NCT01344824|Carboplatin|carboplatin|mesh-list
139235595|NCT01344824|Pemetrexed|pemetrexed|mesh-list
139235596|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139192195|NCT01148615|Docetaxel|docetaxel|mesh-list
139235597|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139235598|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235599|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139235600|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139235601|NCT01344824|Growth Substances|growth substances|mesh-ancestor
139642455|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
139235602|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235603|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
139235604|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235605|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235606|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139235607|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139235608|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139235609|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139235610|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
139235611|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235612|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
139235613|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139299574|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235614|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139235615|NCT05137496|Prednisolone|prednisolone|mesh-list
139235616|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
139235617|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139235618|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
139235619|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139235620|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
139235621|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
139235622|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235623|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235624|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139235625|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
139235626|NCT05137496|Hormones|hormones|mesh-ancestor
139235627|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139235628|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139235629|NCT05137496|Protective Agents|protective agents|mesh-ancestor
139235630|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139235631|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235632|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139235633|NCT02959892|Amphetamine|amphetamine|mesh-list
139235634|NCT02959892|Naxagolide|naxagolide|mesh-list
139235635|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139235636|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235637|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
139235638|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
139235639|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235640|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
139235641|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235642|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235643|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
139235644|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139235645|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139235646|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139235647|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139235648|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
139235649|NCT01661400|Thalidomide|thalidomide|mesh-list
139235650|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
139235651|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139235652|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
139235653|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235654|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139235655|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139235656|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
139235657|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235658|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235659|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139235660|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
139235661|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139235662|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235663|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139235664|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139235665|NCT01661400|Growth Substances|growth substances|mesh-ancestor
139235666|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
139235667|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
139235668|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139235669|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235670|NCT05179213|Azacitidine|azacitidine|mesh-list
139235671|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139192275|NCT01254071|Tamsulosin|tamsulosin|mesh-list
139235672|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
139235673|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235674|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235675|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105746|NCT05843344|Dexmedetomidine|dexmedetomidine|mesh-list
139235676|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
139235677|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139235678|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235679|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139235680|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235681|NCT03367793|Metronidazole|metronidazole|mesh-list
139235682|NCT03367793|Methamphetamine|methamphetamine|mesh-list
139235683|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139235684|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235685|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
139235686|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
139235687|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235688|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
139235689|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235690|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235691|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
139235692|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139235693|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139235694|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139235695|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139235696|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235697|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139235698|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139235699|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139235700|NCT05178511|Ensartinib|ensartinib|mesh-list
139235701|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235702|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139235703|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235704|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235705|NCT05571163|Sotorasib|sotorasib|mesh-list
139235706|NCT05571163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139235707|NCT05571163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235708|NCT05571163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139235709|NCT05571163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235711|NCT03532555|Trace Elements|trace elements|mesh-ancestor
139235712|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
139235713|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235714|NCT03993457|Bupropion|bupropion|mesh-list
139235715|NCT03993457|Escitalopram|escitalopram|mesh-list
139235716|NCT03993457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139235717|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139235718|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139235719|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235720|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235721|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
139235722|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235723|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139235724|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
139235725|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139235726|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139235727|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
139235728|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139235729|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139235730|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235731|NCT04677439|Flumatinib|flumatinib|mesh-list
139235732|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139235733|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235734|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235735|NCT02777424|Thrombin|thrombin|mesh-list
139235736|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
139235737|NCT02777424|Coagulants|coagulants|mesh-ancestor
139235738|NCT01347073|Glycerol|glycerol|mesh-list
139235739|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139235740|NCT01347073|Protective Agents|protective agents|mesh-ancestor
139235741|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235742|NCT01315236|Amikacin|amikacin|mesh-list
139235743|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139235744|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091671|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139235745|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139642456|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105829|NCT05840562|Analgesics|analgesics|mesh-ancestor
139235746|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
139235747|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
139235748|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235749|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
139235750|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139235751|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235752|NCT03364049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139235753|NCT03364049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235754|NCT05343078|Dapagliflozin|dapagliflozin|mesh-list
139235755|NCT05343078|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139235756|NCT05343078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235757|NCT05343078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139235758|NCT05343078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235759|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
139235760|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
139235761|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139235762|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139235763|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235764|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235765|NCT03710369|Urological Agents|urological agents|mesh-ancestor
139235766|NCT03706157|Doxorubicin|doxorubicin|mesh-list
139235767|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139235768|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139235769|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235770|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139235771|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139235772|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235773|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235774|NCT03707795|Betamethasone|betamethasone|mesh-list
139235775|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
139235776|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139235777|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
139235778|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
139235779|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
139235780|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139235781|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139235782|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
139235784|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139235785|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235786|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139235787|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
139235788|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139235789|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
139235790|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235791|NCT03042312|177Lu-PSMA-617|177lu-psma-617|mesh-list
139235792|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139235793|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235794|NCT05171231|Hemostatics|hemostatics|mesh-list
139235795|NCT05171231|Coagulants|coagulants|mesh-ancestor
139235796|NCT05692986|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139235797|NCT05692986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235798|NCT03360071|Immunomodulating Agents|immunomodulating agents|mesh-list
139235799|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
139235800|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235801|NCT05681429|Acetaminophen|acetaminophen|mesh-list
139235802|NCT05681429|Parecoxib|parecoxib|mesh-list
139235803|NCT05681429|Lidocaine|lidocaine|mesh-list
139235804|NCT05681429|Dexmedetomidine|dexmedetomidine|mesh-list
139235805|NCT05681429|Sevoflurane|sevoflurane|mesh-list
139235806|NCT05681429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139235807|NCT05681429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139235808|NCT05681429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235809|NCT05681429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139235810|NCT05681429|Analgesics|analgesics|mesh-ancestor
139235811|NCT05681429|Sensory System Agents|sensory system agents|mesh-ancestor
139235812|NCT05681429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235813|NCT05681429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139235814|NCT05681429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139235815|NCT05681429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139235816|NCT05681429|Adrenergic Agents|adrenergic agents|mesh-ancestor
139235817|NCT05681429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235821|NCT05681429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139642457|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139235822|NCT05681429|Anesthetics, General|anesthetics, general|mesh-ancestor
139235824|NCT05681429|Anesthetics, Local|anesthetics, local|mesh-ancestor
139235825|NCT05681429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139235826|NCT05681429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139235827|NCT05681429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139235828|NCT05681429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139235829|NCT05681429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139235830|NCT05681429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139235831|NCT05681429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235832|NCT05681429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139235833|NCT05681429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139235834|NCT05681429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139235835|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
139235836|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139235837|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139235838|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235839|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
139235840|NCT02949011|Oseltamivir|oseltamivir|mesh-list
139235841|NCT02949011|Baloxavir|baloxavir|mesh-list
139235842|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
139235843|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235844|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235845|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235846|NCT03705533|Telmisartan|telmisartan|mesh-list
139235847|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139235848|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139235849|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139235850|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235851|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
139235852|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
139235853|NCT03357341|Albuterol|albuterol|mesh-list
139235854|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139235855|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
139235856|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235857|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235858|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139235859|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
139235860|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
139235861|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139235862|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139235863|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139235864|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139235865|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
139235866|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235867|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235868|NCT05177237|Endostar protein|endostar protein|mesh-list
139235869|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139235870|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139235871|NCT05177237|Growth Substances|growth substances|mesh-ancestor
139235872|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235873|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
139235874|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235878|NCT04507373|Simvastatin|simvastatin|mesh-list
139235879|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139235880|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139235881|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
139235882|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235883|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139235884|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139235885|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235886|NCT01312337|Gefitinib|gefitinib|mesh-list
139235887|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235888|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139235889|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235890|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235891|NCT05551949|Estradiol|estradiol|mesh-list
139235892|NCT05551949|Estrogens|estrogens|mesh-ancestor
139235893|NCT05551949|Hormones|hormones|mesh-ancestor
139235894|NCT05551949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139235895|NCT05551949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235896|NCT05283954|Ivermectin|ivermectin|mesh-list
139235897|NCT05283954|Albendazole|albendazole|mesh-list
139235898|NCT05283954|Prednisolone|prednisolone|mesh-list
139235899|NCT05283954|Fluoxetine|fluoxetine|mesh-list
139235900|NCT05283954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235901|NCT05283954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139235902|NCT05283954|Glucocorticoids|glucocorticoids|mesh-ancestor
139235903|NCT05283954|Hormones|hormones|mesh-ancestor
139235904|NCT05283954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139235905|NCT05283954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139235906|NCT05283954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235907|NCT05283954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235908|NCT05283954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139235909|NCT05283954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139235910|NCT05283954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139235911|NCT05283954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235912|NCT05283954|Serotonin Agents|serotonin agents|mesh-ancestor
139235913|NCT05283954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139235914|NCT05283954|Antidepressive Agents|antidepressive agents|mesh-ancestor
139235915|NCT05283954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139235916|NCT05283954|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139235917|NCT05283954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139235918|NCT05283954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235919|NCT05283954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139235920|NCT05283954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235921|NCT05283954|Anthelmintics|anthelmintics|mesh-ancestor
139235922|NCT05283954|Anticestodal Agents|anticestodal agents|mesh-ancestor
139235923|NCT05283954|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139235924|NCT05283954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139235925|NCT05283954|Tubulin Modulators|tubulin modulators|mesh-ancestor
139235926|NCT05283954|Antimitotic Agents|antimitotic agents|mesh-ancestor
139235927|NCT05283954|Mitosis Modulators|mitosis modulators|mesh-ancestor
139235928|NCT01312415|Morphine|morphine|mesh-list
139235929|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
139235930|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139235931|NCT01312415|Narcotics|narcotics|mesh-ancestor
139235932|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139235933|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235934|NCT01312415|Analgesics|analgesics|mesh-ancestor
139235935|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
139235936|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235937|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
139235938|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
139235939|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
139235940|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139235941|NCT03036852|Velpatasvir|velpatasvir|mesh-list
139235942|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
139235943|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139235944|NCT01312493|Panitumumab|panitumumab|mesh-list
139235945|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139235946|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235947|NCT04313244|Vaccines|vaccines|mesh-list
139235948|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
139235949|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235950|NCT05309694|Copper|copper|mesh-list
139235951|NCT05309694|Contraceptive Agents|contraceptive agents|mesh-list
139235952|NCT05309694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139235953|NCT05309694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235954|NCT05309694|Trace Elements|trace elements|mesh-ancestor
139235955|NCT05309694|Micronutrients|micronutrients|mesh-ancestor
139235956|NCT05268510|Pembrolizumab|pembrolizumab|mesh-list
139235957|NCT05268510|Olaparib|olaparib|mesh-list
139235958|NCT05268510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139235959|NCT05268510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235960|NCT05268510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139235961|NCT05268510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235962|NCT05268510|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139235963|NCT05268510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235964|NCT05438303|Celecoxib|celecoxib|mesh-list
139235965|NCT05438303|Midazolam|midazolam|mesh-list
139235966|NCT05438303|Omeprazole|omeprazole|mesh-list
139235967|NCT05438303|Dabigatran|dabigatran|mesh-list
139235968|NCT05438303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139235969|NCT05438303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139235970|NCT05438303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139235971|NCT05438303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139235972|NCT05438303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139235973|NCT05438303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139235974|NCT05438303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139106050|NCT05671562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139235975|NCT05438303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139235976|NCT05438303|Anesthetics, General|anesthetics, general|mesh-ancestor
139235977|NCT05438303|Anesthetics|anesthetics|mesh-ancestor
139235978|NCT05438303|GABA Modulators|gaba modulators|mesh-ancestor
139235979|NCT05438303|GABA Agents|gaba agents|mesh-ancestor
139235980|NCT05438303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139235981|NCT05438303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139235982|NCT05438303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139235983|NCT05438303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139235984|NCT05438303|Analgesics|analgesics|mesh-ancestor
139235985|NCT05438303|Sensory System Agents|sensory system agents|mesh-ancestor
139235986|NCT05438303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139235987|NCT05438303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139235988|NCT05438303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139235989|NCT05438303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139235990|NCT05438303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139235991|NCT05438303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139235992|NCT05438303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139235993|NCT05438303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139235994|NCT05438303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139235995|NCT05438303|Antithrombins|antithrombins|mesh-ancestor
139235996|NCT05438303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139235997|NCT05438303|Protease Inhibitors|protease inhibitors|mesh-ancestor
139235998|NCT05438303|Anticoagulants|anticoagulants|mesh-ancestor
139235999|NCT05432141|Vaccines|vaccines|mesh-list
139236000|NCT05432141|Immunologic Factors|immunologic factors|mesh-ancestor
139236001|NCT05432141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236002|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
139236003|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236004|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139236005|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236006|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236007|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
139236008|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236009|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236010|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139236011|NCT04906889|Lidocaine|lidocaine|mesh-list
139236012|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
139236013|NCT04906889|Remifentanil|remifentanil|mesh-list
139236014|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
139236015|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
139236016|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139236017|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236018|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
139236019|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236020|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139236021|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139236022|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139236023|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139236024|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236025|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139236026|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139236027|NCT04906889|Analgesics|analgesics|mesh-ancestor
139236028|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139236029|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139236030|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139236031|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
139236032|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236033|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139236034|NCT04906889|Narcotics|narcotics|mesh-ancestor
139236035|NCT02948777|Evolocumab|evolocumab|mesh-list
139236036|NCT02948777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139236037|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139236038|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139236039|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
139299588|NCT04427826|Narcotics|narcotics|mesh-ancestor
139236040|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236041|NCT02948777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139236042|NCT02948777|Protease Inhibitors|protease inhibitors|mesh-ancestor
139236043|NCT02948777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236044|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139236045|NCT04868747|Lidocaine|lidocaine|mesh-list
139236046|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
139236047|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
139642458|NCT04941846|Nimodipine|nimodipine|mesh-list
139642459|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139236048|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139236049|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236050|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
139236051|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236052|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139236053|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139236054|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139236055|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139236056|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236057|NCT05330273|Efavirenz|efavirenz|mesh-list
139236058|NCT05330273|Lumefantrine|lumefantrine|mesh-list
139236059|NCT05330273|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139236060|NCT05330273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139236061|NCT05330273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236062|NCT05330273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236063|NCT05330273|Antiviral Agents|antiviral agents|mesh-ancestor
139236064|NCT05330273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139236065|NCT05330273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139236066|NCT05330273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139236067|NCT05330273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139236068|NCT05330273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139236069|NCT05330273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139236070|NCT05330273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139236071|NCT05330273|Antimalarials|antimalarials|mesh-ancestor
139236072|NCT05330273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139236073|NCT05330273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139236074|NCT05329259|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139236075|NCT05329259|Immunologic Factors|immunologic factors|mesh-ancestor
139236076|NCT05329259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236077|NCT05254847|Capecitabine|capecitabine|mesh-list
139236078|NCT05254847|Lenvatinib|lenvatinib|mesh-list
139236079|NCT05254847|Tislelizumab|tislelizumab|mesh-list
139236080|NCT05254847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139236081|NCT05254847|Antimetabolites|antimetabolites|mesh-ancestor
139236082|NCT05254847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236083|NCT05254847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236084|NCT05254847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139236085|NCT05254847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236086|NCT05254847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139236087|NCT05249699|Isoniazid|isoniazid|mesh-list
139236088|NCT05249699|Antitubercular Agents|antitubercular agents|mesh-list
139236089|NCT05249699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139236090|NCT05249699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139236091|NCT05249699|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139236092|NCT05249699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139236093|NCT05249699|Antimetabolites|antimetabolites|mesh-ancestor
139236094|NCT05249699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236095|NCT05249699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139236096|NCT04751669|Trace Elements|trace elements|mesh-list
139236097|NCT04751669|Micronutrients|micronutrients|mesh-list
139236098|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236099|NCT04731233|Triamcinolone|triamcinolone|mesh-list
139236100|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139236101|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139236102|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139236103|NCT04731233|Mitogens|mitogens|mesh-list
139236104|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139236105|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
139236106|NCT04731233|Hormones|hormones|mesh-ancestor
139299597|NCT04315948|Interferons|interferons|mesh-list
139236107|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236108|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236109|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139236110|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
139236111|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236112|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236113|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
139236114|NCT04695977|Nivolumab|nivolumab|mesh-list
139236115|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139236116|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192723|NCT05210192|Lidocaine|lidocaine|mesh-list
139236117|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139236118|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236119|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139106206|NCT05229991|Ritonavir|ritonavir|mesh-list
139236120|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139236121|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139236122|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139236123|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236124|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
139236125|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236126|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236127|NCT03629873|Cytarabine|cytarabine|mesh-list
139236128|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
139236129|NCT03629873|Carmustine|carmustine|mesh-list
139236130|NCT03629873|Etoposide|etoposide|mesh-list
139236131|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139236132|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
139236133|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236134|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139236135|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139236136|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
139236137|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236138|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236139|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139236140|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139236141|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139236142|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139236143|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236144|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139236145|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
139236146|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
139236147|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139236148|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
139236149|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139236150|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236151|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236152|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
139236153|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139236154|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236155|NCT02899793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139236156|NCT02899793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236157|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
139236158|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
139236159|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139236160|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139236161|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139236162|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236163|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236164|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139236165|NCT04258631|Hydromorphone|hydromorphone|mesh-list
139236166|NCT04258631|Bupivacaine|bupivacaine|mesh-list
139236167|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
139236168|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
139236169|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139236170|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236171|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
139236172|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236173|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139236174|NCT04258631|Narcotics|narcotics|mesh-ancestor
139236175|NCT04258631|Analgesics|analgesics|mesh-ancestor
139236176|NCT03638063|Adenosine|adenosine|mesh-list
139236177|NCT03638063|Capsaicin|capsaicin|mesh-list
139236178|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
139236179|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
139236180|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
139236181|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236182|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236183|NCT03638063|Analgesics|analgesics|mesh-ancestor
139236184|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139236185|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
139236186|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139236187|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
139236188|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
139236189|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236190|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192843|NCT03894839|Eusol|eusol|mesh-list
139236192|NCT04869371|Docetaxel|docetaxel|mesh-list
139236193|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139642460|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139106275|NCT05128071|Progestins|progestins|mesh-ancestor
139236194|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236195|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
139236196|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
139236197|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
139236198|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236199|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139236200|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
139236201|NCT04869371|Hormones|hormones|mesh-ancestor
139236202|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236203|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236204|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139236205|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
139236206|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139236207|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
139236208|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139236209|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139236210|NCT03320057|Mifepristone|mifepristone|mesh-list
139236211|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139236212|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
139236213|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139236214|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236215|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139236216|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139236217|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139236218|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
139236219|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139236220|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139236221|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
139236222|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236223|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
139236224|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139236225|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139236226|NCT04741139|Acetaminophen|acetaminophen|mesh-list
139236227|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
139236228|NCT04741139|Promethazine|promethazine|mesh-list
139236229|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139236230|NCT04741139|Analgesics|analgesics|mesh-ancestor
139236231|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
139236232|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236233|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236234|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
139236235|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139236236|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139236237|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139236238|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
139236239|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
139236240|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
139236241|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
139236242|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139236243|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139236244|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
139236245|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
139236246|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236247|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236248|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139236249|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
139236250|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
139236251|NCT04853147|Dexamethasone|dexamethasone|mesh-list
139236252|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
139236253|NCT04853147|Palonosetron|palonosetron|mesh-list
139236254|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
139236255|NCT04853147|Aprepitant|aprepitant|mesh-list
139236256|NCT04853147|BB 1101|bb 1101|mesh-list
139236257|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139236258|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
139236259|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
139236260|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236261|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236262|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139236263|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
139192864|NCT01259531|Silodosin|silodosin|mesh-list
139236264|NCT04853147|Hormones|hormones|mesh-ancestor
139236265|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236266|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139642461|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139236267|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236268|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
139236269|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236270|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236271|NCT04853147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139236272|NCT04853147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139236273|NCT04853147|Serotonin Agents|serotonin agents|mesh-ancestor
139236274|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236275|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139236276|NCT04689347|Leucovorin|leucovorin|mesh-list
139236277|NCT04689347|Bevacizumab|bevacizumab|mesh-list
139236278|NCT04689347|Fluorouracil|fluorouracil|mesh-list
139236279|NCT04689347|Irinotecan|irinotecan|mesh-list
139236280|NCT04689347|Temozolomide|temozolomide|mesh-list
139236281|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139236282|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236283|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139236284|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139236285|NCT04689347|Growth Substances|growth substances|mesh-ancestor
139236286|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236287|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
139236288|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
139236289|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236290|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139236291|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139236292|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
139236293|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139236294|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139236295|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236296|NCT04689347|Antidotes|antidotes|mesh-ancestor
139236297|NCT04689347|Protective Agents|protective agents|mesh-ancestor
139236298|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
139236299|NCT04689347|Vitamins|vitamins|mesh-ancestor
139236300|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
139236301|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139236302|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
139236303|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139236304|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
139236305|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236306|NCT02420795|TIC10 compound|tic10 compound|mesh-list
139236307|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236308|NCT02384759|Aflibercept|aflibercept|mesh-list
139236309|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139236310|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139236311|NCT02384759|Growth Substances|growth substances|mesh-ancestor
139236312|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236313|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
139236314|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236315|NCT05276687|Vancomycin|vancomycin|mesh-list
139236316|NCT05276687|Povidone-Iodine|povidone-iodine|mesh-list
139236317|NCT05276687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139236318|NCT05276687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139236319|NCT05276687|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139236320|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
139236321|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139236322|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236323|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139236324|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236325|NCT03332771|Metformin|metformin|mesh-list
139236326|NCT03332771|Glimepiride|glimepiride|mesh-list
139236327|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139236328|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139236329|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236330|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139236331|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139236332|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
139236333|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139236334|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236335|NCT03625830|Paclitaxel|paclitaxel|mesh-list
139236336|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139236337|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236338|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
139236339|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
139236341|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236342|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
139236343|NCT04108104|Prazosin|prazosin|mesh-list
139236344|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139236345|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139236346|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139236347|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139236348|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
139236349|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236350|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236351|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236352|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
139236353|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
139236354|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139236355|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139236356|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
139236357|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
139236358|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139236359|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
139236360|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139236361|NCT05304468|Cisplatin|cisplatin|mesh-list
139236362|NCT05304468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236363|NCT03039192|Esketamine|esketamine|mesh-list
139236364|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
139236365|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139236366|NCT03698279|Vaccines|vaccines|mesh-list
139236367|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
139236368|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236369|NCT03038880|Ranibizumab|ranibizumab|mesh-list
139236370|NCT03038880|Faricimab|faricimab|mesh-list
139236371|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139236372|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139236373|NCT03038880|Growth Substances|growth substances|mesh-ancestor
139236374|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236375|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
139236376|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236377|NCT03035916|Anesthetics|anesthetics|mesh-list
139236378|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139236379|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236380|NCT01702571|Trastuzumab|trastuzumab|mesh-list
139236381|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139236382|NCT01702571|Maytansine|maytansine|mesh-list
139236383|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139236384|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236385|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139236386|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
139236387|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
139236388|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
139236389|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236390|NCT01702571|Immunotoxins|immunotoxins|mesh-ancestor
139236391|NCT01702571|Immunoconjugates|immunoconjugates|mesh-ancestor
139236392|NCT01702571|Immunologic Factors|immunologic factors|mesh-ancestor
139236393|NCT01702571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236394|NCT01578239|Octreotide|octreotide|mesh-list
139236395|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139236396|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139236397|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139236398|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236399|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139236400|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236401|NCT05274893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139236402|NCT05274893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236403|NCT01220531|Cyclosporine|cyclosporine|mesh-list
139236404|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
139236405|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
139236406|NCT01220531|Prednisolone|prednisolone|mesh-list
139236407|NCT01220531|Tacrolimus|tacrolimus|mesh-list
139236408|NCT01220531|Cyclosporins|cyclosporins|mesh-list
139236409|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139236410|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
139236411|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139236412|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
139193014|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
139236413|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236414|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139236415|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236416|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236417|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
139236418|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139236419|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
139236420|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139236421|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139236422|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236423|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139236424|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
139236425|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139236426|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139236427|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
139236428|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
139236429|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236430|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139236431|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
139236432|NCT01220531|Hormones|hormones|mesh-ancestor
139236433|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236434|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139236435|NCT01220531|Protective Agents|protective agents|mesh-ancestor
139236436|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139236437|NCT05255471|Olaparib|olaparib|mesh-list
139236438|NCT05255471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139236439|NCT05255471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236440|NCT05255471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236441|NCT05255471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236442|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
139236443|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139236444|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236445|NCT03241927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139236446|NCT03241927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236447|NCT02941523|Carboplatin|carboplatin|mesh-list
139236448|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236449|NCT03666143|Tislelizumab|tislelizumab|mesh-list
139236450|NCT03666143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139236451|NCT03666143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236452|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
139236453|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139236454|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139236455|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139236456|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139236457|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139236458|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236459|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236460|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236461|NCT00360425|Hematinics|hematinics|mesh-ancestor
139236462|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139236463|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139236464|NCT02938585|Factor VIII|factor viii|mesh-list
139236465|NCT02938585|Coagulants|coagulants|mesh-ancestor
139236466|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139236467|NCT00233597|Hematinics|hematinics|mesh-ancestor
139236468|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139236469|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139236470|NCT04282811|Venetoclax|venetoclax|mesh-list
139236471|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236472|NCT03229759|Octenidine|octenidine|mesh-list
139236473|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139236474|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139236475|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
139236476|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139236477|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236478|NCT03476681|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139236479|NCT03476681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236480|NCT03620825|Indomethacin|indomethacin|mesh-list
139236481|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139236482|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139236483|NCT03620825|Analgesics|analgesics|mesh-ancestor
139236484|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
139236485|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236486|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236487|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139236488|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139236489|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
139236490|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
139236491|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139236492|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139236493|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236494|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236495|NCT01496118|Panobinostat|panobinostat|mesh-list
139236496|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236497|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139236498|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236499|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236500|NCT03329573|Paroxetine|paroxetine|mesh-list
139236501|NCT03329573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139236502|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139236503|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139236504|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236505|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236506|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
139236507|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236508|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139236509|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
139236510|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139236511|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139236512|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139236513|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236514|NCT00492349|Varenicline|varenicline|mesh-list
139236515|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139236516|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139236517|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
139236518|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236519|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236520|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236521|NCT03308825|Vaccines|vaccines|mesh-list
139236522|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
139236523|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236524|NCT04235855|Liver Extracts|liver extracts|mesh-list
139236525|NCT04235855|Hematinics|hematinics|mesh-ancestor
139236526|NCT03328325|Vaccines|vaccines|mesh-list
139236527|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
139236528|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236529|NCT03476603|Irbesartan|irbesartan|mesh-list
139236530|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139236531|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139236532|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139236533|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236534|NCT03476525|Fluoxetine|fluoxetine|mesh-list
139236535|NCT03476525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139236536|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139236537|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139236538|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236539|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236540|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
139236541|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236542|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139236543|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
139236544|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139236545|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139236546|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139236547|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236548|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
139236549|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139236550|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139236551|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236552|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139236553|NCT03665545|Poly I-C|poly i-c|mesh-list
139236554|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
139236555|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139236556|NCT03665545|Poly ICLC|poly iclc|mesh-list
139236557|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139236558|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236559|NCT03665545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139236560|NCT03665545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236561|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
139236562|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
139236563|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236564|NCT03665545|Laxatives|laxatives|mesh-ancestor
139236565|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139236566|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
139236567|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139236568|NCT03305081|Copper|copper|mesh-list
139236569|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
139236570|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139236571|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
139236572|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139236573|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236574|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139236575|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139236576|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139236577|NCT03305081|Trace Elements|trace elements|mesh-ancestor
139236578|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
139236579|NCT04079881|Insulin|insulin|mesh-list
139236580|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139236581|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139236582|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236583|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
139236584|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139236585|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
139236586|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236587|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
139236588|NCT03223909|Protective Agents|protective agents|mesh-ancestor
139236589|NCT03733925|Golimumab|golimumab|mesh-list
139236590|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139236591|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139236592|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139236593|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
139236594|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236595|NCT03649711|Aspirin|aspirin|mesh-list
139236596|NCT03649711|Clopidogrel|clopidogrel|mesh-list
139236597|NCT03649711|Ticagrelor|ticagrelor|mesh-list
139236598|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139236599|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139236600|NCT03649711|Analgesics|analgesics|mesh-ancestor
139236601|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
139236602|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171109|NCT01359488|Hormones|hormones|mesh-list
139236603|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236604|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139236605|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139236606|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139236607|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139236608|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236609|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139236610|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139236611|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236612|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
139236613|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139236614|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139236615|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139236616|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
139236617|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236618|NCT03273257|Riociguat|riociguat|mesh-list
139236619|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
139236620|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236621|NCT04270877|Naltrexone|naltrexone|mesh-list
139236622|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139236623|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139236624|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236625|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
139236626|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236627|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139236628|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139236629|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139236630|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139236631|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236632|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236633|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236634|NCT03271151|Analgesics|analgesics|mesh-ancestor
139236635|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
139236636|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236637|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
139236638|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139236639|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
139236640|NCT03301649|Ivermectin|ivermectin|mesh-list
139236641|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139236642|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139236643|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139236644|NCT01144416|Hormones|hormones|mesh-ancestor
139236645|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236646|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236647|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
139236648|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139236649|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
139236650|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
139236651|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236652|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236653|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236654|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139236655|NCT00335777|Analgesics|analgesics|mesh-ancestor
139236656|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
139236657|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236658|NCT03764137|Panitumumab|panitumumab|mesh-list
139236659|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139236660|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236661|NCT03625518|Oxytocin|oxytocin|mesh-list
139236662|NCT03625518|Dinoprostone|dinoprostone|mesh-list
139236663|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
139236664|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139236665|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236666|NCT00972738|Loratadine|loratadine|mesh-list
139236667|NCT00972738|Montelukast|montelukast|mesh-list
139236668|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139236669|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
139236670|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139236671|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
139236672|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236673|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236674|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139236675|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139236676|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236677|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
139236678|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
139236679|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139236680|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139236681|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139236682|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
139236683|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
139236684|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236685|NCT03452839|Meropenem|meropenem|mesh-list
139236686|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139236687|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139236688|NCT04701281|Capecitabine|capecitabine|mesh-list
139236689|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139236690|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
139236691|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236692|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236693|NCT03882918|Gaboxadol|gaboxadol|mesh-list
139236694|NCT03882918|Analgesics|analgesics|mesh-ancestor
139236695|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
139236696|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236697|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236698|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
139236699|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
139236700|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
139236701|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236702|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236703|NCT04180397|Furosemide|furosemide|mesh-list
139236704|NCT04180397|Diuretics|diuretics|mesh-ancestor
139236705|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
139236706|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236707|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139236708|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139236709|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236710|NCT03295721|Bupivacaine|bupivacaine|mesh-list
139236711|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
139236712|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
139236713|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139236714|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236715|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
139236716|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236717|NCT00803790|Vitamin D|vitamin d|mesh-list
139236718|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
139236719|NCT00803790|Cholecalciferol|cholecalciferol|mesh-list
139236720|NCT00803790|Alendronate|alendronate|mesh-list
139236721|NCT00803790|Vitamins|vitamins|mesh-list
139236722|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
139236723|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236724|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139236725|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139236726|NCT00442338|Aminophylline|aminophylline|mesh-list
139236727|NCT00442338|Theophylline|theophylline|mesh-list
139236728|NCT00442338|Montelukast|montelukast|mesh-list
139236729|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139236730|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
139236731|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139236732|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
139236733|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236734|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236735|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139236736|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139236737|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236738|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139236739|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
139236740|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236741|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139236742|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139236743|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236744|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139236745|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139236746|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
139236747|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236748|NCT00442338|Protective Agents|protective agents|mesh-ancestor
139236749|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
139236750|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139236751|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139236752|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236753|NCT02316834|Talazoparib|talazoparib|mesh-list
139236754|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139236755|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236756|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236757|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236758|NCT02879136|Methylphenidate|methylphenidate|mesh-list
139236759|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139236760|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139236761|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236762|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139236763|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139236764|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139236765|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236766|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
139236767|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236768|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139236769|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
139236770|NCT00250458|Rizatriptan|rizatriptan|mesh-list
139236771|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139236772|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
139236773|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236774|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236775|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236776|NCT01965132|Adalimumab|adalimumab|mesh-list
139236777|NCT01965132|Infliximab|infliximab|mesh-list
139236778|NCT01965132|Golimumab|golimumab|mesh-list
139236779|NCT01965132|Etanercept|etanercept|mesh-list
139236780|NCT01965132|Abatacept|abatacept|mesh-list
139236781|NCT01965132|Upadacitinib|upadacitinib|mesh-list
139236782|NCT01965132|Ustekinumab|ustekinumab|mesh-list
139236783|NCT01965132|Ixekizumab|ixekizumab|mesh-list
139236784|NCT01965132|Tofacitinib|tofacitinib|mesh-list
139236785|NCT01965132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139236786|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236788|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236789|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139236790|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139236791|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139236792|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
139236793|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139236794|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139236795|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139236796|NCT01965132|Analgesics|analgesics|mesh-ancestor
139236797|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
139236798|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236799|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139236800|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139236801|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236802|NCT01965132|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139236803|NCT01965132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139236804|NCT01965132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236805|NCT01667133|Ponatinib|ponatinib|mesh-list
139236806|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236807|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139236808|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236809|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236810|NCT01498770|Olanzapine|olanzapine|mesh-list
139236811|NCT01498770|Risperidone|risperidone|mesh-list
139236812|NCT01498770|Aripiprazole|aripiprazole|mesh-list
139236813|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139236814|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139236815|NCT01498770|Ziprasidone|ziprasidone|mesh-list
139236816|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139236817|NCT01498770|Clozapine|clozapine|mesh-list
139236818|NCT01498770|Asenapine|asenapine|mesh-list
139236819|NCT01498770|Amisulpride|amisulpride|mesh-list
139236820|NCT01498770|Iloperidone|iloperidone|mesh-list
139236821|NCT01498770|Sertindole|sertindole|mesh-list
139236822|NCT01498770|Zotepine|zotepine|mesh-list
139236823|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139236824|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
139236825|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236826|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236827|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236828|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139236829|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139236830|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139236831|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139236832|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139236833|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
139236834|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
139236835|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
139236836|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236837|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139236838|NCT01498770|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139236839|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139236840|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139236841|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
139236842|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
139236843|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139236844|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139236845|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139236846|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139236847|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139236848|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139236849|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139236850|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
139236851|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
139236852|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
139236853|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139236854|NCT00140946|Montelukast|montelukast|mesh-list
139236855|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236856|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236857|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
139236858|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139236859|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139236860|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
139236861|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236862|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139236863|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139236864|NCT00095004|Rizatriptan|rizatriptan|mesh-list
139236865|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236866|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236867|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236868|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139236869|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
139236870|NCT00967746|Etonogestrel|etonogestrel|mesh-list
139236871|NCT00967746|Desogestrel|desogestrel|mesh-list
139236872|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139236873|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
139236874|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139236875|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236876|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139236877|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139236878|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139236879|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139236880|NCT00967746|Progestins|progestins|mesh-ancestor
139236881|NCT00967746|Hormones|hormones|mesh-ancestor
139236882|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236883|NCT00092118|Montelukast|montelukast|mesh-list
139236884|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139236885|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
139236886|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139236887|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
139299631|NCT04302870|Amantadine|amantadine|mesh-list
139236888|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236889|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236890|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139236891|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139236892|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236893|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139236894|NCT00920634|Hormones|hormones|mesh-ancestor
139236895|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236896|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236897|NCT00092040|Alendronate|alendronate|mesh-list
139236898|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
139236899|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236900|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236901|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139236902|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139236903|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139236904|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139236905|NCT05224128|Imatinib Mesylate|imatinib mesylate|mesh-list
139236906|NCT05224128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236907|NCT05224128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139236908|NCT05224128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236909|NCT05224128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236910|NCT05416827|Dexamethasone|dexamethasone|mesh-list
139236911|NCT05416827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139236912|NCT05416827|Antiemetics|antiemetics|mesh-ancestor
139236913|NCT05416827|Autonomic Agents|autonomic agents|mesh-ancestor
139236914|NCT05416827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236915|NCT05416827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236916|NCT05416827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139236917|NCT05416827|Glucocorticoids|glucocorticoids|mesh-ancestor
139236918|NCT05416827|Hormones|hormones|mesh-ancestor
139236919|NCT05416827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139236920|NCT05416827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139236921|NCT05416827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236922|NCT05076513|Niraparib|niraparib|mesh-list
139236923|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139236924|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236925|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236926|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236927|NCT05418465|Dapagliflozin|dapagliflozin|mesh-list
139236928|NCT05418465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139236929|NCT05418465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236930|NCT05418465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139236931|NCT05418465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236932|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
139236933|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139236934|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139236935|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139236936|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139236937|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236938|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
139236939|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236940|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236941|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139236942|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236943|NCT05418309|Paclitaxel|paclitaxel|mesh-list
139236944|NCT05418309|Tislelizumab|tislelizumab|mesh-list
139236945|NCT05418309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139236946|NCT05418309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139236947|NCT05418309|Tubulin Modulators|tubulin modulators|mesh-ancestor
139236948|NCT05418309|Antimitotic Agents|antimitotic agents|mesh-ancestor
139236949|NCT05418309|Mitosis Modulators|mitosis modulators|mesh-ancestor
139236950|NCT05418309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236951|NCT05418309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139236952|NCT05137548|Tenofovir|tenofovir|mesh-list
139236953|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
139236954|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139236955|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139236956|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139236957|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236958|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236959|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139236960|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139236961|NCT05091294|Anesthetics|anesthetics|mesh-list
139236962|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
139236963|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139236964|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236965|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
139236966|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236967|NCT05320926|Aspirin|aspirin|mesh-list
139236968|NCT05320926|Clopidogrel|clopidogrel|mesh-list
139236969|NCT05320926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139236970|NCT05320926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139236971|NCT05320926|Analgesics|analgesics|mesh-ancestor
139236972|NCT05320926|Sensory System Agents|sensory system agents|mesh-ancestor
139236973|NCT05320926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236974|NCT05320926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139236975|NCT05320926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139236976|NCT05320926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139236977|NCT05320926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139236978|NCT05320926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139236979|NCT05320926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139236980|NCT05320926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139236981|NCT05320926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139236982|NCT05320926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139236983|NCT05320926|Antipyretics|antipyretics|mesh-ancestor
139236984|NCT05320926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139236985|NCT05320926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139236986|NCT05320926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139236987|NCT05320926|Purinergic Agents|purinergic agents|mesh-ancestor
139236988|NCT05320926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139236989|NCT05417997|Clarithromycin|clarithromycin|mesh-list
139236990|NCT05417997|Ceftriaxone|ceftriaxone|mesh-list
139236991|NCT05417997|Favipiravir|favipiravir|mesh-list
139236992|NCT05417997|Methylprednisolone|methylprednisolone|mesh-list
139236993|NCT05417997|Enoxaparin|enoxaparin|mesh-list
139236994|NCT05417997|Lansoprazole|lansoprazole|mesh-list
139236995|NCT05417997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139236996|NCT05417997|Antiemetics|antiemetics|mesh-ancestor
139236997|NCT05417997|Autonomic Agents|autonomic agents|mesh-ancestor
139236998|NCT05417997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139236999|NCT05417997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237000|NCT05417997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139237001|NCT05417997|Glucocorticoids|glucocorticoids|mesh-ancestor
139237002|NCT05417997|Hormones|hormones|mesh-ancestor
139237003|NCT05417997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139237004|NCT05417997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139193615|NCT04272775|Ixazomib|ixazomib|mesh-list
139237005|NCT05417997|Protective Agents|protective agents|mesh-ancestor
139237006|NCT05417997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139237007|NCT05417997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237008|NCT05417997|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139237009|NCT05417997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237010|NCT05417997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237011|NCT05417997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139237012|NCT05417997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139237013|NCT05417997|Anticoagulants|anticoagulants|mesh-ancestor
139237014|NCT05417997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139237015|NCT05417997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139237016|NCT05417997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139237017|NCT05417997|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139237018|NCT05417997|Antiviral Agents|antiviral agents|mesh-ancestor
139237019|NCT03856788|Bupivacaine|bupivacaine|mesh-list
139237020|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
139237021|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
139237022|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237023|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237024|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
139237025|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237026|NCT03242759|Pirfenidone|pirfenidone|mesh-list
139237027|NCT03242759|Nintedanib|nintedanib|mesh-list
139237028|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237029|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139237030|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237031|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237032|NCT03242759|Analgesics|analgesics|mesh-ancestor
139237033|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
139237034|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237035|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237036|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139237037|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139237038|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237039|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237040|NCT03625050|Celecoxib|celecoxib|mesh-list
139237041|NCT03625050|Esomeprazole|esomeprazole|mesh-list
139237042|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139237043|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139237044|NCT03625050|Analgesics|analgesics|mesh-ancestor
139237045|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
139237046|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237047|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237048|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237049|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237050|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139237051|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139237052|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237053|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237054|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139237055|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139237056|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139237057|NCT03257813|Timolol|timolol|mesh-list
139237058|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139237059|NCT03257813|Dorzolamide|dorzolamide|mesh-list
139237060|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139237061|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139237062|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
139237063|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237064|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237065|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237066|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139237067|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139237068|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139237069|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139237070|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139237071|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139237072|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237073|NCT03210259|Adalimumab|adalimumab|mesh-list
139237074|NCT03210259|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139237075|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237076|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139193684|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237077|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
139237078|NCT04319757|Fludarabine|fludarabine|mesh-list
139237079|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139237080|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
139237081|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237082|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237083|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139237084|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
139237085|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237086|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237087|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139237088|NCT05180461|Ivermectin|ivermectin|mesh-list
139237089|NCT05180461|Emodepside|emodepside|mesh-list
139237090|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139237091|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237092|NCT02496611|Exenatide|exenatide|mesh-list
139237093|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139237094|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237095|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139237096|NCT02496611|Incretins|incretins|mesh-ancestor
139237097|NCT02496611|Hormones|hormones|mesh-ancestor
139237098|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139237099|NCT03237481|Bupivacaine|bupivacaine|mesh-list
139237100|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
139237101|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
139237102|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237103|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237104|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
139237105|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237106|NCT03704220|Warfarin|warfarin|mesh-list
139237107|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
139237108|NCT03222349|Diazepam|diazepam|mesh-list
139237109|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139237110|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
139237111|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
139237112|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
139237113|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237114|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237115|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139237116|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139237117|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237118|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139237119|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139237120|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139237121|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139237122|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139237123|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139237124|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
139237125|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
139237126|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
139237127|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
139237128|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237129|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237130|NCT02927925|Daratumumab|daratumumab|mesh-list
139237131|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237132|NCT03208933|Pirfenidone|pirfenidone|mesh-list
139237133|NCT03208933|Analgesics|analgesics|mesh-ancestor
139237134|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
139237135|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237136|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237137|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139237138|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139237139|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237140|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237141|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237142|NCT02415036|Melphalan|melphalan|mesh-list
139237143|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139237144|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
139237145|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237146|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237147|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139237148|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139237149|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
139237150|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237151|NCT04752267|Clevudine|clevudine|mesh-list
139237152|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
139237153|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237154|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
139193758|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237155|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139237156|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
139237157|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237158|NCT02117700|Expectorants|expectorants|mesh-ancestor
139237159|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
139237160|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139237161|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
139237162|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237163|NCT02117700|Protective Agents|protective agents|mesh-ancestor
139237164|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237165|NCT02117700|Antidotes|antidotes|mesh-ancestor
139237166|NCT02932579|Acetaminophen|acetaminophen|mesh-list
139237167|NCT02932579|Ibuprofen|ibuprofen|mesh-list
139237168|NCT02932579|Oxycodone|oxycodone|mesh-list
139237169|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139237170|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139237171|NCT02932579|Analgesics|analgesics|mesh-ancestor
139237172|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
139237173|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237174|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237175|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237176|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237177|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139237178|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237179|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237180|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139237181|NCT02932579|Narcotics|narcotics|mesh-ancestor
139237182|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237183|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
139237184|NCT04748757|Annexin A5|annexin a5|mesh-list
139237185|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237186|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237187|NCT03207451|Aspirin|aspirin|mesh-list
139237188|NCT03207451|Clopidogrel|clopidogrel|mesh-list
139237189|NCT03207451|Vorapaxar|vorapaxar|mesh-list
139237190|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139237191|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139237192|NCT03207451|Analgesics|analgesics|mesh-ancestor
139237193|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
139237194|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237195|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237196|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237197|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237198|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139237199|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139237200|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237201|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139237202|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139237203|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237204|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
139237205|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139237206|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139237207|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139237208|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
139237209|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237210|NCT05089123|Vaccines|vaccines|mesh-list
139237211|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
139237212|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237213|NCT02361125|Methylphenidate|methylphenidate|mesh-list
139237214|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139237215|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237216|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139237217|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139237218|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139237219|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237220|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
139237221|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237222|NCT03701256|Atracurium|atracurium|mesh-list
139237223|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139237224|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139237225|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139237226|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237227|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237228|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139237229|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139237230|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
139237231|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237232|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237234|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
139237235|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139237236|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139237237|NCT04780581|Prednisolone|prednisolone|mesh-list
139237238|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
139237239|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139237240|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
139237241|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237242|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
139237243|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
139237244|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237245|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237246|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139237247|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
139237248|NCT04780581|Hormones|hormones|mesh-ancestor
139237249|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139237250|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139237251|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237252|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139237253|NCT04780581|Protective Agents|protective agents|mesh-ancestor
139237254|NCT01526135|Gemcitabine|gemcitabine|mesh-list
139237255|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139237256|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
139237257|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237258|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237259|NCT05417139|Immunomodulating Agents|immunomodulating agents|mesh-list
139237260|NCT05417139|Immunologic Factors|immunologic factors|mesh-ancestor
139237261|NCT05417139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237262|NCT03701022|Apatinib|apatinib|mesh-list
139237263|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237264|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139237265|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237266|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237267|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
139237268|NCT04221165|Narcotics|narcotics|mesh-ancestor
139237269|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237270|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237271|NCT04221165|Analgesics|analgesics|mesh-ancestor
139237272|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
139237273|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237274|NCT03255629|Glucagon|glucagon|mesh-list
139237275|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139237276|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139237277|NCT03255629|Hormones|hormones|mesh-ancestor
139237278|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139237279|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237280|NCT03255629|Incretins|incretins|mesh-ancestor
139237281|NCT01143779|Telbivudine|telbivudine|mesh-list
139237282|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
139237283|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237284|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139237285|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237286|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237287|NCT03703596|Docetaxel|docetaxel|mesh-list
139237288|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237289|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
139237290|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
139237291|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
139237292|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237293|NCT01137773|Insulin|insulin|mesh-list
139237294|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139237295|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139237296|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237297|NCT03698292|Metoclopramide|metoclopramide|mesh-list
139237298|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
139237299|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
139237300|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237301|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237302|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139237303|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139237304|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139237305|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
139237306|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237307|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237308|NCT04613271|Azithromycin|azithromycin|mesh-list
139237309|NCT04613271|Favipiravir|favipiravir|mesh-list
139237310|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139237311|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237312|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
139237313|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139237314|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139237315|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237316|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139237317|NCT03094611|Immunotoxins|immunotoxins|mesh-ancestor
139237318|NCT03094611|Immunoconjugates|immunoconjugates|mesh-ancestor
139237319|NCT03094611|Immunologic Factors|immunologic factors|mesh-ancestor
139237320|NCT03094611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237321|NCT03631953|Trametinib|trametinib|mesh-list
139237322|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237323|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139237324|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237325|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237326|NCT01030575|Inositol|inositol|mesh-list
139237327|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
139237328|NCT01030575|Vitamins|vitamins|mesh-ancestor
139237329|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
139237330|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237331|NCT04215471|Antibodies|antibodies|mesh-list
139237332|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
139237333|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
139237334|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237335|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
139237336|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139237337|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139237338|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
139237339|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237340|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237341|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237342|NCT03106987|Olaparib|olaparib|mesh-list
139237343|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139237344|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237345|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237346|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237347|NCT02932267|Adapalene|adapalene|mesh-list
139237348|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139237349|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139237350|NCT02932267|Analgesics|analgesics|mesh-ancestor
139237351|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
139237352|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237353|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237354|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237355|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237356|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
139237357|NCT03217591|Praliciguat|praliciguat|mesh-list
139237358|NCT03217591|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139237359|NCT03217591|Enzyme Activators|enzyme activators|mesh-ancestor
139237360|NCT03217591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237361|NCT03217591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139237362|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
139237363|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
139237364|NCT03697824|Fludarabine|fludarabine|mesh-list
139237365|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139237366|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
139237367|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237368|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237369|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139237370|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
139237371|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237372|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237373|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139237374|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139237375|NCT03697824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139237376|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139237377|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139237378|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237379|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139237380|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237381|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237382|NCT03697746|Acetaminophen|acetaminophen|mesh-list
139237384|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139237385|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139237386|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139237387|NCT03697746|Analgesics|analgesics|mesh-ancestor
139237388|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
139237389|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237390|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237391|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237392|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237393|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139237394|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237395|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237396|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
139237397|NCT03697668|Piperaquine|piperaquine|mesh-list
139237398|NCT03697668|Artenimol|artenimol|mesh-list
139237399|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
139237400|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237401|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139237402|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237403|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237404|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
139237405|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139237406|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139237407|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237408|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
139237409|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139237410|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
139237411|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237412|NCT03702738|Expectorants|expectorants|mesh-ancestor
139237413|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
139237414|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139237415|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
139237416|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237417|NCT03702738|Protective Agents|protective agents|mesh-ancestor
139237418|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237419|NCT03702738|Antidotes|antidotes|mesh-ancestor
139237420|NCT03697044|Irinotecan|irinotecan|mesh-list
139237421|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139237422|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139237423|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237424|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237425|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237426|NCT03699774|Firuglipel|firuglipel|mesh-list
139237427|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139237428|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139237429|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139237430|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
139237431|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237432|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139237433|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139237434|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237435|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139237436|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237437|NCT03699696|Propofol|propofol|mesh-list
139237438|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139237439|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237440|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237441|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139237442|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
139237443|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
139237444|NCT03702426|Norfloxacin|norfloxacin|mesh-list
139237445|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139237446|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237447|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139237448|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139237449|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237450|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237451|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237452|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139237453|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139237454|NCT00265941|Cetuximab|cetuximab|mesh-list
139237456|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139237457|NCT03699384|Azacitidine|azacitidine|mesh-list
139237458|NCT03699384|Avelumab|avelumab|mesh-list
139237459|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139237460|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
139237461|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237462|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237463|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237464|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139237465|NCT05378763|Docetaxel|docetaxel|mesh-list
139237466|NCT05378763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237467|NCT05378763|Tubulin Modulators|tubulin modulators|mesh-ancestor
139237468|NCT05378763|Antimitotic Agents|antimitotic agents|mesh-ancestor
139237469|NCT05378763|Mitosis Modulators|mitosis modulators|mesh-ancestor
139237470|NCT05378763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237471|NCT03201211|Vaccines|vaccines|mesh-list
139237472|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
139237473|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237474|NCT04472949|Carboplatin|carboplatin|mesh-list
139237475|NCT04472949|Etoposide|etoposide|mesh-list
139237476|NCT04472949|Durvalumab|durvalumab|mesh-list
139237477|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237478|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139237479|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139237480|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139237481|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237482|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237483|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139237484|NCT03696186|Phenobarbital|phenobarbital|mesh-list
139237485|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
139237486|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139237487|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237488|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237489|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139237490|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139237491|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237492|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237493|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
139237494|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
139237495|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139237496|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139237497|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139237498|NCT03698916|Celecoxib|celecoxib|mesh-list
139237499|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139237500|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139237501|NCT03698916|Analgesics|analgesics|mesh-ancestor
139237502|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
139237503|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237504|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237505|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237506|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237507|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139237508|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139237509|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237510|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237511|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
139237512|NCT03695952|Nivolumab|nivolumab|mesh-list
139237513|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139237514|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139237515|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237516|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237517|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
139237518|NCT03695640|Analgesics|analgesics|mesh-ancestor
139237519|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
139237520|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237521|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237522|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
139237523|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237524|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139237525|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
139237526|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139237527|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139237528|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237529|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139237530|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
139237531|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139237532|NCT03698682|Levofloxacin|levofloxacin|mesh-list
139237533|NCT03698682|Ofloxacin|ofloxacin|mesh-list
139237534|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139237535|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237536|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139237537|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139237538|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139237539|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237540|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237541|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237542|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139237543|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139237544|NCT03029832|Atezolizumab|atezolizumab|mesh-list
139237545|NCT03029832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139237546|NCT03029832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237547|NCT03029832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139237548|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237549|NCT05598567|Anesthetics|anesthetics|mesh-list
139237550|NCT05598567|Sevoflurane|sevoflurane|mesh-list
139237551|NCT05598567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237552|NCT05598567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237553|NCT05598567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139237554|NCT05598567|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139237555|NCT05598567|Anesthetics, General|anesthetics, general|mesh-ancestor
139237556|NCT03701880|Bisoprolol|bisoprolol|mesh-list
139237557|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139237558|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
139237559|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
139237560|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237561|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237562|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139237563|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139237564|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139237565|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
139237566|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237567|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237568|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
139237569|NCT03692754|Dexamethasone|dexamethasone|mesh-list
139237570|NCT03692754|Atorvastatin|atorvastatin|mesh-list
139237571|NCT03692754|Calcium|calcium|mesh-list
139237572|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237573|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
139237574|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
139237575|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237576|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237577|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139237578|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
139237579|NCT03692754|Hormones|hormones|mesh-ancestor
139237580|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139237581|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139237582|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237583|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139237584|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139237585|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139237586|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139237587|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
139237588|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237589|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139237590|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139237591|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237592|NCT04224558|Acetaminophen|acetaminophen|mesh-list
139237593|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
139237594|NCT04224558|Promethazine|promethazine|mesh-list
139237595|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
139237596|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139237597|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
139237598|NCT04224558|Fludarabine|fludarabine|mesh-list
139237599|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
139237600|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139237601|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
139237602|NCT04224558|Antibodies|antibodies|mesh-list
139237603|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
139237604|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139237605|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139237606|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139237607|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
139237608|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237609|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237610|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139237611|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
139237612|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237613|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237614|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139237615|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139237616|NCT04224558|Analgesics|analgesics|mesh-ancestor
139237617|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
139237618|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237619|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
139237620|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237621|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
139237622|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
139237623|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139237624|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
139237625|NCT04224558|Hormones|hormones|mesh-ancestor
139237626|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139237627|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139237628|NCT04224558|Protective Agents|protective agents|mesh-ancestor
139237629|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139237630|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139237631|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139237632|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237633|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
139237634|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
139237635|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139237636|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
139237637|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
139237638|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237639|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139237640|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
139237641|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
139237642|NCT05598411|Methylprednisolone|methylprednisolone|mesh-list
139237643|NCT05598411|Glucocorticoids|glucocorticoids|mesh-list
139237644|NCT05598411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237645|NCT05598411|Antiemetics|antiemetics|mesh-ancestor
139237646|NCT05598411|Autonomic Agents|autonomic agents|mesh-ancestor
139237647|NCT05598411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237648|NCT05598411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237649|NCT05598411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139237650|NCT05598411|Hormones|hormones|mesh-ancestor
139237651|NCT05598411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139237652|NCT05598411|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139237653|NCT05598411|Protective Agents|protective agents|mesh-ancestor
139237654|NCT03688230|Cetuximab|cetuximab|mesh-list
139237655|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139237656|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237657|NCT03694236|Durvalumab|durvalumab|mesh-list
139237658|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139237659|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237660|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
139237661|NCT03692286|Calcium|calcium|mesh-list
139237662|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139237663|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237664|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139237665|NCT03694080|Calcium|calcium|mesh-list
139237666|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139237667|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237668|NCT04203498|Nabiximols|nabiximols|mesh-list
139237669|NCT04203498|Analgesics|analgesics|mesh-ancestor
139237670|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
139237671|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237672|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237673|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
139237674|NCT03691896|Vitamin D|vitamin d|mesh-list
139237675|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139237676|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237677|NCT03691896|Vitamins|vitamins|mesh-ancestor
139237678|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
139237679|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139237681|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139237682|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139237683|NCT03691818|Analgesics|analgesics|mesh-ancestor
139237684|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
139237685|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237686|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237687|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139237688|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237689|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139237690|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237691|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237692|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139237693|NCT03687606|Menotropins|menotropins|mesh-list
139237694|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139237695|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237696|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139237697|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
139237698|NCT04059978|Remifentanil|remifentanil|mesh-list
139237699|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139237700|NCT04059978|Narcotics|narcotics|mesh-ancestor
139237701|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237702|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237703|NCT04059978|Analgesics|analgesics|mesh-ancestor
139237704|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
139237705|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237706|NCT03199963|Tamoxifen|tamoxifen|mesh-list
139237707|NCT03199963|Afimoxifene|afimoxifene|mesh-list
139237708|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139237709|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
139237710|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139237711|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237712|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139237713|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237714|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139237715|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139237716|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139237717|NCT03636685|Paclitaxel|paclitaxel|mesh-list
139237718|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139237719|NCT03636685|Carboplatin|carboplatin|mesh-list
139237720|NCT03636685|Pemetrexed|pemetrexed|mesh-list
139237721|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139237722|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237723|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
139237724|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
139237725|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
139237726|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237727|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237728|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139237729|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139237730|NCT03883581|Quinidine|quinidine|mesh-list
139237731|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
139237732|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
139237733|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
139237734|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
139237735|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139237736|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139237737|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237738|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237739|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237740|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139237741|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139237742|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
139237743|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139237744|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
139237745|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139237746|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139237747|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237748|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237749|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139237750|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139237751|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
139237752|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139237753|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139237754|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139237755|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139237756|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139237757|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
139237758|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139237759|NCT03824535|Fluorides|fluorides|mesh-list
139237760|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139237761|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237762|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
139237763|NCT03824535|Protective Agents|protective agents|mesh-ancestor
139237764|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237765|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
139237766|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
139237767|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237768|NCT03113643|Azacitidine|azacitidine|mesh-list
139237769|NCT03113643|Venetoclax|venetoclax|mesh-list
139237770|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139237771|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
139237772|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237773|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237774|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237775|NCT03091491|Nivolumab|nivolumab|mesh-list
139237776|NCT03091491|Ipilimumab|ipilimumab|mesh-list
139237777|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139237778|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237779|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139237780|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237781|NCT04733235|Progesterone|progesterone|mesh-list
139237782|NCT04733235|Hormones|hormones|mesh-ancestor
139237783|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139237784|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237785|NCT04733235|Progestins|progestins|mesh-ancestor
139237786|NCT05598177|Dexmedetomidine|dexmedetomidine|mesh-list
139237787|NCT05598177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139237788|NCT05598177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237789|NCT05598177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237790|NCT05598177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139237791|NCT05598177|Analgesics|analgesics|mesh-ancestor
139237792|NCT05598177|Sensory System Agents|sensory system agents|mesh-ancestor
139237793|NCT05598177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237794|NCT05598177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139237795|NCT05598177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139237796|NCT05598177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139237797|NCT05598177|Adrenergic Agents|adrenergic agents|mesh-ancestor
139237798|NCT05598177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237799|NCT05598177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237800|NCT03740529|Rituximab|rituximab|mesh-list
139237801|NCT03740529|Venetoclax|venetoclax|mesh-list
139237802|NCT03740529|Pirtobrutinib|pirtobrutinib|mesh-list
139237803|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139237804|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237805|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
139237806|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237807|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237808|NCT03740529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139237809|NCT03740529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237810|NCT03740529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237811|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
139237812|NCT03029208|Hematinics|hematinics|mesh-ancestor
139237813|NCT05212623|Vaccines|vaccines|mesh-list
139237814|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
139237815|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237816|NCT03693222|Morphine|morphine|mesh-list
139237817|NCT03693222|Tramadol|tramadol|mesh-list
139237818|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139237819|NCT03693222|Narcotics|narcotics|mesh-ancestor
139237820|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237821|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237822|NCT03693222|Analgesics|analgesics|mesh-ancestor
139237823|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
139237824|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237825|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
139237826|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139237827|NCT03693066|Disinfectants|disinfectants|mesh-list
139237828|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139237829|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237830|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
139237831|NCT03631641|Nivolumab|nivolumab|mesh-list
139237832|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139237833|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237834|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139237835|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237836|NCT03631875|Ketamine|ketamine|mesh-list
139237837|NCT03631875|Propofol|propofol|mesh-list
139237838|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139237839|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237840|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237841|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139237842|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
139237843|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
139237844|NCT03631875|Analgesics|analgesics|mesh-ancestor
139237845|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
139237846|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237847|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139237848|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139237849|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139237850|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237851|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237852|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139237853|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
139237854|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237855|NCT04941261|Vaccines|vaccines|mesh-list
139237856|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
139237857|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237858|NCT05597709|Insulin|insulin|mesh-list
139237859|NCT05597709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139237860|NCT05597709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237861|NCT02917629|Pioglitazone|pioglitazone|mesh-list
139237862|NCT02917629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139237863|NCT02917629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237864|NCT05417841|Insulin|insulin|mesh-list
139237865|NCT05417841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139237866|NCT05417841|Insulin Aspart|insulin aspart|mesh-list
139237867|NCT05417841|Insulin, Long-Acting|insulin, long-acting|mesh-list
139237868|NCT05417841|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139237869|NCT05417841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139237870|NCT05417841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237871|NCT03691038|Pregabalin|pregabalin|mesh-list
139237872|NCT03691038|Analgesics|analgesics|mesh-ancestor
139237873|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
139237874|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237875|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237876|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
139237877|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139237878|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139237879|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237880|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139237881|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139237882|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139237883|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237884|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139237885|NCT02927847|Nicotine|nicotine|mesh-list
139237886|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139237887|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
139237888|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237889|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237890|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139237891|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139237892|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
139237893|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237894|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299671|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237895|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139237896|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
139237897|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237898|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237899|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
139237900|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139237901|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139237902|NCT02886585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139237903|NCT02886585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237904|NCT01568853|Norepinephrine|norepinephrine|mesh-list
139237905|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139237906|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139237907|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
139237908|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237909|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237910|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237911|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
139237912|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
139237913|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237914|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139237915|NCT02960438|Quetmolimab|quetmolimab|mesh-list
139237916|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139237917|NCT03690414|Atropine|atropine|mesh-list
139237918|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139237919|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139237920|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139237921|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139237922|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139237923|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
139237924|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237925|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237926|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139237927|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
139237928|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
139237929|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
139237930|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139237931|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139237932|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
139237933|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237934|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237935|NCT02959970|Dapsone|dapsone|mesh-list
139237936|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237937|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
139237938|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139237939|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139237940|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139237941|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139237942|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237943|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
139237944|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139237945|NCT03681990|Ethanol|ethanol|mesh-list
139237946|NCT03681990|Chlorhexidine|chlorhexidine|mesh-list
139237947|NCT03681990|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139237948|NCT03681990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139237949|NCT03681990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139237950|NCT03681990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237951|NCT03681990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237952|NCT03681990|Disinfectants|disinfectants|mesh-ancestor
139237953|NCT03681990|Dermatologic Agents|dermatologic agents|mesh-ancestor
139237954|NCT02740335|Protein C|protein c|mesh-list
139237955|NCT02740335|Protein S|protein s|mesh-list
139237956|NCT02740335|Thrombin|thrombin|mesh-list
139237957|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
139237958|NCT02740335|Coagulants|coagulants|mesh-ancestor
139237959|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
139237960|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139237961|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139237962|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237963|NCT05351151|Lidocaine|lidocaine|mesh-list
139237964|NCT05351151|Anesthetics, Local|anesthetics, local|mesh-ancestor
139237965|NCT05351151|Anesthetics|anesthetics|mesh-ancestor
139237966|NCT05351151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237967|NCT05351151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237968|NCT05351151|Sensory System Agents|sensory system agents|mesh-ancestor
139237969|NCT05351151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139237970|NCT05351151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139237971|NCT05351151|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139237972|NCT05351151|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139237973|NCT05351151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139237974|NCT05351151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237975|NCT01568931|Coal Tar|coal tar|mesh-list
139237976|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
139237977|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
139237978|NCT04800367|Denosumab|denosumab|mesh-list
139194592|NCT03383068|Metformin|metformin|mesh-list
139237979|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139237980|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108091|NCT05426486|Carboplatin|carboplatin|mesh-list
139237981|NCT03713658|Risperidone|risperidone|mesh-list
139237982|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139237983|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139237984|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
139237985|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139237986|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139237987|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139237988|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139237989|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139237990|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139237991|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139237992|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139237993|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
139237994|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139237995|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139237996|NCT05475717|Alprostadil|alprostadil|mesh-list
139237997|NCT05475717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139237998|NCT05475717|Vasodilator Agents|vasodilator agents|mesh-ancestor
139237999|NCT05475717|Urological Agents|urological agents|mesh-ancestor
139238000|NCT05133687|Bupivacaine|bupivacaine|mesh-list
139238001|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
139238002|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
139238003|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238004|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238005|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
139238006|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238007|NCT03685032|Dexamethasone|dexamethasone|mesh-list
139238008|NCT03685032|Ondansetron|ondansetron|mesh-list
139238009|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139238010|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
139238011|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
139238012|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238013|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238014|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139238015|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
139238016|NCT03685032|Hormones|hormones|mesh-ancestor
139238017|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139238018|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139238019|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238020|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
139238021|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
139238022|NCT03685032|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139238023|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139238024|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
139238025|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238026|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238027|NCT02451111|Rituximab|rituximab|mesh-list
139238028|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238029|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238030|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
139238031|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238032|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139238033|NCT03689010|Azelaic acid|azelaic acid|mesh-list
139238034|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238035|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
139238036|NCT05451771|Dexamethasone|dexamethasone|mesh-list
139299678|NCT04280692|Lumefantrine|lumefantrine|mesh-list
139238037|NCT05451771|Dexamethasone acetate|dexamethasone acetate|mesh-list
139238038|NCT05451771|Venetoclax|venetoclax|mesh-list
139238039|NCT05451771|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139238040|NCT05451771|Daratumumab|daratumumab|mesh-list
139238041|NCT05451771|Pomalidomide|pomalidomide|mesh-list
139238042|NCT05451771|Ixazomib|ixazomib|mesh-list
139238043|NCT05451771|BB 1101|bb 1101|mesh-list
139238044|NCT05451771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139238045|NCT05451771|Antiemetics|antiemetics|mesh-ancestor
139238046|NCT05451771|Autonomic Agents|autonomic agents|mesh-ancestor
139238047|NCT05451771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238048|NCT05451771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238049|NCT05451771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139238050|NCT05451771|Glucocorticoids|glucocorticoids|mesh-ancestor
139238051|NCT05451771|Hormones|hormones|mesh-ancestor
139238052|NCT05451771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139238053|NCT05451771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139238054|NCT05451771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238055|NCT05451771|Protease Inhibitors|protease inhibitors|mesh-ancestor
139642462|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238056|NCT05451771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238057|NCT05451771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238058|NCT05451771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139238059|NCT05451771|Alkylating Agents|alkylating agents|mesh-ancestor
139238060|NCT05451771|Immunologic Factors|immunologic factors|mesh-ancestor
139238061|NCT05451771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139238062|NCT05451771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139238063|NCT05451771|Growth Substances|growth substances|mesh-ancestor
139238064|NCT05451771|Growth Inhibitors|growth inhibitors|mesh-ancestor
139238066|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139238067|NCT05387343|Vaccines|vaccines|mesh-list
139238068|NCT05387343|Immunologic Factors|immunologic factors|mesh-ancestor
139238069|NCT05387343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238070|NCT04220775|Atezolizumab|atezolizumab|mesh-list
139238071|NCT04220775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139238072|NCT04220775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238073|NCT04220775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238074|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238075|NCT01381887|Canagliflozin|canagliflozin|mesh-list
139238076|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139238077|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238078|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139238079|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238080|NCT04877379|Ceftibuten|ceftibuten|mesh-list
139238081|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139238082|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139238083|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
139238084|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238085|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238086|NCT03684330|Vitamin D|vitamin d|mesh-list
139238087|NCT03684330|Vitamins|vitamins|mesh-ancestor
139238088|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
139238089|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238090|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139238091|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
139238092|NCT01381809|Hematinics|hematinics|mesh-ancestor
139238093|NCT03677466|Tenecteplase|tenecteplase|mesh-list
139238094|NCT03677466|Streptokinase|streptokinase|mesh-list
139238095|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139238096|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139238097|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238098|NCT03447132|Fulvestrant|fulvestrant|mesh-list
139238099|NCT03447132|Goserelin|goserelin|mesh-list
139238100|NCT03447132|Palbociclib|palbociclib|mesh-list
139238101|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139238102|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238103|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139238104|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139238105|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
139238106|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139238107|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238108|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139238109|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238110|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238111|NCT04133623|Ibuprofen|ibuprofen|mesh-list
139238112|NCT04133623|Ketorolac|ketorolac|mesh-list
139238113|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139238114|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139238115|NCT04133623|Analgesics|analgesics|mesh-ancestor
139238116|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
139238117|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238118|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238119|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139238120|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139238121|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139238122|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238123|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238124|NCT03188185|Naltrexone|naltrexone|mesh-list
139238125|NCT03188185|Buprenorphine|buprenorphine|mesh-list
139238126|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139238127|NCT03188185|Narcotics|narcotics|mesh-ancestor
139238128|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238129|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238130|NCT03188185|Analgesics|analgesics|mesh-ancestor
139238131|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
139238132|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238134|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139238135|NCT03679182|Olanzapine|olanzapine|mesh-list
139238136|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
139238137|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
139238138|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238139|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238140|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139238141|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139238142|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139238143|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238144|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139238145|NCT03679182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139238146|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139238147|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139238148|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238149|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238150|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
139238151|NCT03184987|Albuterol|albuterol|mesh-list
139238152|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139238153|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
139238154|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238155|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238156|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139238157|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
139238158|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
139238159|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139238160|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139238161|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139238162|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139238163|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
139238164|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238165|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238166|NCT03026166|Nivolumab|nivolumab|mesh-list
139238167|NCT03026166|Ipilimumab|ipilimumab|mesh-list
139238168|NCT03026166|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
139238169|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238170|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238171|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139238172|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238173|NCT03026166|Immunoconjugates|immunoconjugates|mesh-ancestor
139238174|NCT03026166|Immunologic Factors|immunologic factors|mesh-ancestor
139238175|NCT03026166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238176|NCT03573648|Palbociclib|palbociclib|mesh-list
139238177|NCT03573648|Avelumab|avelumab|mesh-list
139238178|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238179|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139238180|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238181|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238182|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238183|NCT03026088|Bisoprolol|bisoprolol|mesh-list
139238184|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139238185|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
139238186|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
139238187|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238188|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238189|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139238190|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139238191|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139238192|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
139238193|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238194|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238195|NCT03678792|Morphine|morphine|mesh-list
139238196|NCT03678792|Buprenorphine|buprenorphine|mesh-list
139238197|NCT03678792|Tramadol|tramadol|mesh-list
139238198|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139238199|NCT03678792|Naloxone|naloxone|mesh-list
139238200|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139238201|NCT03678792|Narcotics|narcotics|mesh-ancestor
139238202|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238203|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238204|NCT03678792|Analgesics|analgesics|mesh-ancestor
139238205|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
139238206|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238207|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139238208|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139238209|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139238210|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139238211|NCT03181789|Interleukin-12|interleukin-12|mesh-list
139238213|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
139238214|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238215|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139238216|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139238217|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139238218|NCT03181789|Growth Substances|growth substances|mesh-ancestor
139238219|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
139238220|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238221|NCT03678090|Plasminogen|plasminogen|mesh-list
139238222|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139238223|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139238224|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139238225|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238226|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139238227|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139238228|NCT03678012|Hematinics|hematinics|mesh-ancestor
139238229|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139238230|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139238231|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139238232|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139238233|NCT03676296|Puerarin|puerarin|mesh-list
139238234|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
139238235|NCT03676140|Azithromycin|azithromycin|mesh-list
139238236|NCT03676140|Ivermectin|ivermectin|mesh-list
139238237|NCT03676140|Albendazole|albendazole|mesh-list
139238238|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
139238239|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139238240|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139238241|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139238242|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
139238243|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
139238244|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139238245|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139238246|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
139238247|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
139238248|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
139238249|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238250|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238251|NCT03676140|Filaricides|filaricides|mesh-ancestor
139238252|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
139238253|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139238254|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238255|NCT03504774|Immunomodulating Agents|immunomodulating agents|mesh-list
139238256|NCT03504774|Immunologic Factors|immunologic factors|mesh-ancestor
139238257|NCT03504774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238258|NCT04059198|Tenofovir|tenofovir|mesh-list
139238259|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
139238260|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139238261|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139238262|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139238263|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238264|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238265|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139238266|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139238267|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
139238268|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238269|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238270|NCT04058964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139238271|NCT04058964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238272|NCT03675594|Cobalt|cobalt|mesh-list
139238273|NCT03675594|Chromium|chromium|mesh-list
139238274|NCT03675594|Trace Elements|trace elements|mesh-ancestor
139238275|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
139238276|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238277|NCT03671538|Pemetrexed|pemetrexed|mesh-list
139238278|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238279|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238280|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238281|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139238283|NCT05420467|Paclitaxel|paclitaxel|mesh-list
139238284|NCT05420467|Docetaxel|docetaxel|mesh-list
139238285|NCT05420467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139238286|NCT05420467|Cyclophosphamide|cyclophosphamide|mesh-list
139238287|NCT05420467|Carboplatin|carboplatin|mesh-list
139238288|NCT05420467|Trastuzumab|trastuzumab|mesh-list
139238289|NCT05420467|Epirubicin|epirubicin|mesh-list
139238290|NCT05420467|Pertuzumab|pertuzumab|mesh-list
139238291|NCT05420467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139238292|NCT05420467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238293|NCT05420467|Tubulin Modulators|tubulin modulators|mesh-ancestor
139238294|NCT05420467|Antimitotic Agents|antimitotic agents|mesh-ancestor
139238295|NCT05420467|Mitosis Modulators|mitosis modulators|mesh-ancestor
139238296|NCT05420467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238297|NCT05420467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139238298|NCT05420467|Immunologic Factors|immunologic factors|mesh-ancestor
139238299|NCT05420467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238300|NCT05420467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139238301|NCT05420467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139238302|NCT05420467|Alkylating Agents|alkylating agents|mesh-ancestor
139238303|NCT05420467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139238304|NCT05420467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238305|NCT05420467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139238306|NCT05420467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139238307|NCT05420467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139238308|NCT05420467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238309|NCT03022578|Lomustine|lomustine|mesh-list
139238310|NCT03022578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139238311|NCT03022578|Alkylating Agents|alkylating agents|mesh-ancestor
139238312|NCT03022578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238313|NCT03022578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238314|NCT03671070|Epinephrine|epinephrine|mesh-list
139238315|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139238316|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139238317|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
139238318|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238319|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238320|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238321|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139238322|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139238323|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
139238324|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238325|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139238326|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
139238327|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
139238328|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
139238329|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139238330|NCT03670758|Protein S|protein s|mesh-list
139238331|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
139238332|NCT03674658|Propafenone|propafenone|mesh-list
139238333|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139238334|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139238335|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139238336|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139238337|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238338|NCT03623256|Fentanyl|fentanyl|mesh-list
139238339|NCT03623256|Bupivacaine|bupivacaine|mesh-list
139238340|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
139238341|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
139238342|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238343|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238344|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
139238345|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238346|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139238347|NCT03623256|Narcotics|narcotics|mesh-ancestor
139238348|NCT03623256|Analgesics|analgesics|mesh-ancestor
139238349|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139238350|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139238351|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
139238352|NCT03082014|Losartan|losartan|mesh-list
139238353|NCT03082014|Atenolol|atenolol|mesh-list
139238354|NCT03082014|Amlodipine|amlodipine|mesh-list
139238355|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139238356|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139238357|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139238358|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238359|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139238360|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238361|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
139238362|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139238363|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139238364|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139238365|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
139238366|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
139238367|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238368|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139238369|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139238370|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139238371|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
139238372|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238373|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
139238374|NCT03670212|Yohimbine|yohimbine|mesh-list
139238375|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139238376|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
139238377|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
139238378|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238379|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238380|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139238381|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139238382|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139238383|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
139238384|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238385|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238386|NCT03670212|Urological Agents|urological agents|mesh-ancestor
139238387|NCT03165955|Paclitaxel|paclitaxel|mesh-list
139238388|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139238389|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238390|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
139238391|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
139238392|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
139238393|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238394|NCT05263921|Ritonavir|ritonavir|mesh-list
139238395|NCT05263921|Nirmatrelvir|nirmatrelvir|mesh-list
139238396|NCT05263921|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139238397|NCT05263921|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139238398|NCT05263921|Protease Inhibitors|protease inhibitors|mesh-ancestor
139238399|NCT05263921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238400|NCT05263921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238401|NCT05263921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139238402|NCT05263921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139238403|NCT05263921|Antiviral Agents|antiviral agents|mesh-ancestor
139238404|NCT05263921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139238405|NCT05263921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139238406|NCT05263921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139238407|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139238408|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238409|NCT03673332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238410|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238411|NCT03048084|Levetiracetam|levetiracetam|mesh-list
139238412|NCT03048084|Valproic Acid|valproic acid|mesh-list
139238413|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
139238414|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
139238415|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238416|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238417|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
139238418|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238419|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238420|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
139238421|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139238422|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238423|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139238424|NCT03165721|Guadecitabine|guadecitabine|mesh-list
139238425|NCT03165721|Azacitidine|azacitidine|mesh-list
139238426|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238427|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139238428|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
139238429|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238430|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238431|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
139238432|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
139238434|NCT02224872|Tacrolimus|tacrolimus|mesh-list
139238435|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
139238436|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139238437|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
139238438|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238439|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139238440|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139238441|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
139238442|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238443|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238444|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139238445|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139238446|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238447|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139238448|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139238449|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
139238450|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139238451|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139238452|NCT02187198|Buprenorphine|buprenorphine|mesh-list
139238453|NCT02187198|Naloxone|naloxone|mesh-list
139238454|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139238455|NCT02187198|Narcotics|narcotics|mesh-ancestor
139238456|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238457|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238458|NCT02187198|Analgesics|analgesics|mesh-ancestor
139238459|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
139238460|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238461|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139238462|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
139238463|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139238464|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238465|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238466|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139238467|NCT04969705|Analgesics|analgesics|mesh-ancestor
139238468|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
139238469|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238470|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139238471|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139238472|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139238473|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
139238474|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238475|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238476|NCT03676374|Prucalopride|prucalopride|mesh-list
139238477|NCT03676374|Laxatives|laxatives|mesh-ancestor
139238478|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139238479|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139238480|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139238481|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
139238482|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238483|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238484|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238485|NCT01829958|Prednisone|prednisone|mesh-list
139238486|NCT01829958|Rituximab|rituximab|mesh-list
139238487|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238488|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238489|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
139238490|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238491|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139238492|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139238493|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
139238494|NCT01829958|Hormones|hormones|mesh-ancestor
139238495|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139238496|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139238497|NCT03021642|Tepotinib|tepotinib|mesh-list
139238498|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238499|NCT03023046|Prednisone|prednisone|mesh-list
139238500|NCT03023046|Cortisone|cortisone|mesh-list
139238501|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
139238502|NCT03023046|Rituximab|rituximab|mesh-list
139238503|NCT03023046|Doxorubicin|doxorubicin|mesh-list
139238504|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139238505|NCT03023046|Etoposide|etoposide|mesh-list
139238506|NCT03023046|Vincristine|vincristine|mesh-list
139195121|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
139238507|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
139238508|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
139238509|NCT03023046|Daunorubicin|daunorubicin|mesh-list
139238511|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
139238512|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139238513|NCT03023046|Antibodies|antibodies|mesh-list
139238514|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
139238515|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139238516|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139238517|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
139238518|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238519|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139238520|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139238521|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
139238522|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238523|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238524|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139238525|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139238526|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139238527|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139238528|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238529|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139238530|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
139238531|NCT03023046|Hormones|hormones|mesh-ancestor
139238532|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139238533|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139238534|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139238535|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
139238536|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
139238537|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
139238538|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139238539|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
139238540|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
139238541|NCT03668262|Atracurium|atracurium|mesh-list
139238542|NCT03668262|Cisatracurium|cisatracurium|mesh-list
139238543|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139238544|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139238545|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139238546|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238547|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238548|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139238549|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139238550|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
139238551|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238552|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238553|NCT03668964|Vitamin D|vitamin d|mesh-list
139238554|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
139238555|NCT03668964|Vitamins|vitamins|mesh-list
139238556|NCT03668964|Vitamin E|vitamin e|mesh-list
139238557|NCT03668964|Tocopherols|tocopherols|mesh-list
139238558|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
139238559|NCT03668964|Vitamin A|vitamin a|mesh-list
139238560|NCT03668964|Riboflavin|riboflavin|mesh-list
139238561|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
139238562|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
139238563|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238564|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139238565|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139238566|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
139238567|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238568|NCT03668964|Protective Agents|protective agents|mesh-ancestor
139238569|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139238570|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
139238571|NCT03668730|Paclitaxel|paclitaxel|mesh-list
139238572|NCT03668730|Fluorouracil|fluorouracil|mesh-list
139238573|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139238574|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238575|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
139238576|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
139238577|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
139238578|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238579|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
139238580|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139238581|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139238582|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
139195202|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
139238583|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238585|NCT03021018|Brivaracetam|brivaracetam|mesh-list
139238586|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
139238587|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
139238588|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
139238589|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238590|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238591|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139238592|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139238593|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238594|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139238595|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139238596|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139238597|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
139238598|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
139238599|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238600|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238601|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
139238602|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139238603|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238604|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238605|NCT02509507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139238606|NCT02509507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238607|NCT03175549|Apremilast|apremilast|mesh-list
139238608|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139238609|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139238610|NCT03175549|Analgesics|analgesics|mesh-ancestor
139238611|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
139238612|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238613|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238614|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139238615|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139299707|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
139238616|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139238617|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139238618|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238619|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238620|NCT01314937|Mebendazole|mebendazole|mesh-list
139238621|NCT01314937|Piperazine|piperazine|mesh-list
139238622|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
139238623|NCT01314937|DMP 777|dmp 777|mesh-list
139238624|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
139238625|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
139238626|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139238627|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139238628|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
139238629|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
139238630|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
139238631|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238632|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238633|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238634|NCT04718155|Atorvastatin|atorvastatin|mesh-list
139238635|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139238636|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139238637|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
139238638|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238639|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139238640|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139238641|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238642|NCT04668859|Midodrine|midodrine|mesh-list
139238643|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
139238644|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
139238645|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238646|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238647|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139238648|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139238649|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139238650|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139238651|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
139238652|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238653|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238654|NCT02924688|Fluticasone|fluticasone|mesh-list
139238655|NCT02924688|Albuterol|albuterol|mesh-list
139238656|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139238657|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139238658|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139238659|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139238660|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
139238661|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238662|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238663|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139238664|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
139238665|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
139238666|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139238667|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139238668|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139238669|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139238670|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
139238671|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238672|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238673|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
139238674|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139238675|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
139238676|NCT02924688|Hormones|hormones|mesh-ancestor
139238677|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139238678|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
139238679|NCT03668418|Camptothecin|camptothecin|mesh-list
139238680|NCT03668418|Docetaxel|docetaxel|mesh-list
139238681|NCT03668418|Gemcitabine|gemcitabine|mesh-list
139238682|NCT03668418|Fluorouracil|fluorouracil|mesh-list
139238683|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
139238684|NCT03668418|Irinotecan|irinotecan|mesh-list
139238685|NCT03668418|Epirubicin|epirubicin|mesh-list
139238686|NCT03668418|Taxane|taxane|mesh-list
139238687|NCT03668418|Antimetabolites|antimetabolites|mesh-list
139238688|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139238689|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238690|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
139238691|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
139238692|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
139238693|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238694|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139238695|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139238696|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
139238697|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238698|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139238699|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139238700|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238701|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139238702|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139238703|NCT03011892|Triamcinolone|triamcinolone|mesh-list
139238704|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139238705|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
139238706|NCT03011892|Hormones|hormones|mesh-ancestor
139238707|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139238708|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238709|NCT02125513|Paclitaxel|paclitaxel|mesh-list
139238710|NCT02125513|Carboplatin|carboplatin|mesh-list
139238711|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139238712|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238713|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
139238714|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
139238715|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
139238716|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238717|NCT03666546|Methamphetamine|methamphetamine|mesh-list
139238718|NCT03666546|Lactulose|lactulose|mesh-list
139238719|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139238720|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139238721|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238722|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
139238723|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
139238724|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238725|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
139238726|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238727|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238728|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
139238729|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139238730|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139238731|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139238732|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139238733|NCT03012828|Moxidectin|moxidectin|mesh-list
139238734|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
139238735|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139238736|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139238737|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
139238738|NCT03666390|Midazolam|midazolam|mesh-list
139238739|NCT03666390|Ketamine|ketamine|mesh-list
139238740|NCT03666390|Analgesics|analgesics|mesh-ancestor
139238741|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
139238742|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238743|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238744|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139238745|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139238746|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
139238747|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
139238748|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238749|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139238750|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139238751|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238752|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238753|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139238754|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139238755|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139238756|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139238757|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139238758|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
139238759|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
139238760|NCT03003390|Enoxaparin|enoxaparin|mesh-list
139238761|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
139238762|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139299715|NCT04276857|Vitamins|vitamins|mesh-ancestor
139238763|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139238764|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238765|NCT03003000|Ibuprofen|ibuprofen|mesh-list
139238766|NCT03003000|Caffeine|caffeine|mesh-list
139238767|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139238768|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139238769|NCT03003000|Analgesics|analgesics|mesh-ancestor
139238770|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
139238771|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238772|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238773|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139238774|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139238775|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139238776|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238777|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238778|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139238779|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139238780|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139238781|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139238782|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
139238783|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238784|NCT03665766|Cycloserine|cycloserine|mesh-list
139238785|NCT03665766|Tacrolimus|tacrolimus|mesh-list
139238786|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139238787|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
139238788|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238789|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139238790|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238791|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238792|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139238793|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139238794|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139238795|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
139238796|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139238797|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
139238798|NCT03637361|Methadone|methadone|mesh-list
139238799|NCT03637361|D-methadone|d-methadone|mesh-list
139238800|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139238801|NCT03637361|Narcotics|narcotics|mesh-ancestor
139238802|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238803|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238804|NCT03637361|Analgesics|analgesics|mesh-ancestor
139238805|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
139238806|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238807|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
139238808|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
139108926|NCT05418166|Evolocumab|evolocumab|mesh-list
139195423|NCT01172171|Melatonin|melatonin|mesh-list
139238809|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139238810|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
139238811|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238812|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139238813|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238814|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238815|NCT03254459|Morphine|morphine|mesh-list
139238816|NCT03254459|Oxycodone|oxycodone|mesh-list
139238817|NCT03254459|Buprenorphine|buprenorphine|mesh-list
139238818|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139238819|NCT03254459|Narcotics|narcotics|mesh-ancestor
139238820|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238821|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238822|NCT03254459|Analgesics|analgesics|mesh-ancestor
139238823|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
139238824|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238825|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139238826|NCT03620591|Lidocaine|lidocaine|mesh-list
139238827|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
139238828|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
139238829|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238830|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238831|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
139238832|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238833|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139238834|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139238835|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139238836|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139238837|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238838|NCT05178953|Zinc|zinc|mesh-list
139238839|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
139238840|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
139238841|NCT05178953|Trace Elements|trace elements|mesh-ancestor
139238842|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
139238843|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238844|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139238845|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238846|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238847|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139238848|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139238849|NCT05178953|Protective Agents|protective agents|mesh-ancestor
139238850|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
139238851|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139238852|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
139238853|NCT05178953|Astringents|astringents|mesh-ancestor
139238854|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
139238855|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
139238856|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238857|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238858|NCT03251963|Enoxaparin|enoxaparin|mesh-list
139238859|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
139238860|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
139238861|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139238862|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139238863|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238864|NCT03287219|Methylene Blue|methylene blue|mesh-list
139238865|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238866|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238867|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
139238868|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139238869|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238870|NCT03249935|Azithromycin|azithromycin|mesh-list
139238871|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139238872|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139238873|NCT03622073|Misoprostol|misoprostol|mesh-list
139238874|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139238875|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
139238876|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139238877|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238878|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139238879|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139238880|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
139238881|NCT03000348|Cysteamine|cysteamine|mesh-list
139238882|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
139642192|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139238883|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238884|NCT03664986|Bupivacaine|bupivacaine|mesh-list
139238885|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
139238886|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
139238887|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139238888|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238889|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
139238890|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238891|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
139238892|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238893|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238894|NCT03492918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139238895|NCT03492918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238896|NCT03247673|Bevacizumab|bevacizumab|mesh-list
139238897|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238898|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238899|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139238900|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139238901|NCT03247673|Growth Substances|growth substances|mesh-ancestor
139238902|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238903|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
139238904|NCT03665610|Ozanimod|ozanimod|mesh-list
139238905|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139238906|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238907|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139238908|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
139238909|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238910|NCT03664908|Antibodies|antibodies|mesh-list
139238911|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
139238912|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238913|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139238914|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139238915|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
139238916|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238917|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139238918|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139238919|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
139238920|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
139238921|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238922|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238923|NCT03664440|Nevirapine|nevirapine|mesh-list
139238924|NCT03664440|Rilpivirine|rilpivirine|mesh-list
139238925|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139238926|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139238927|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238928|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238929|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
139238930|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139238931|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139238932|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139238933|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139238934|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139238935|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139238936|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139238937|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139238938|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
139238939|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
139238940|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139238941|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139238942|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
139238943|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238944|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238945|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238946|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139238947|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139238948|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238949|NCT03240575|Fluticasone|fluticasone|mesh-list
139238950|NCT03240575|Xhance|xhance|mesh-list
139238951|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
139238952|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139238953|NCT03240575|Olodaterol|olodaterol|mesh-list
139238954|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139238955|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139238956|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
139109054|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238957|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238958|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238959|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139195570|NCT03381664|Quinidine|quinidine|mesh-list
139238960|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
139238962|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139238963|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
139238964|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139238965|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
139238966|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139238967|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238968|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139238969|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139238970|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139238971|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
139238972|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
139299737|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
139238973|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139238974|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238975|NCT04034225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139238976|NCT04034225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238977|NCT03690947|Ranibizumab|ranibizumab|mesh-list
139238978|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139238979|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139238980|NCT03690947|Growth Substances|growth substances|mesh-ancestor
139238981|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238982|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
139238983|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238984|NCT02999178|Nintedanib|nintedanib|mesh-list
139238985|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139238986|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139238987|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139238988|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139238989|NCT02999100|Oxytocin|oxytocin|mesh-list
139238990|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
139238991|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139238992|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139238993|NCT02749370|Etanercept|etanercept|mesh-list
139238994|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139238995|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139238996|NCT02749370|Analgesics|analgesics|mesh-ancestor
139238997|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
139238998|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139238999|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239000|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139239001|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139239002|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239003|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139239004|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
139239005|NCT03617900|Acetaminophen|acetaminophen|mesh-list
139239006|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139239007|NCT03617900|Analgesics|analgesics|mesh-ancestor
139239008|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
139239009|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239010|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239011|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
139239012|NCT05384366|Paclitaxel|paclitaxel|mesh-list
139239013|NCT05384366|Carboplatin|carboplatin|mesh-list
139239014|NCT05384366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139239015|NCT05384366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299979|NCT03875235|Durvalumab|durvalumab|mesh-list
139239016|NCT05384366|Tubulin Modulators|tubulin modulators|mesh-ancestor
139239017|NCT05384366|Antimitotic Agents|antimitotic agents|mesh-ancestor
139239018|NCT05384366|Mitosis Modulators|mitosis modulators|mesh-ancestor
139239019|NCT05384366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239020|NCT03616808|Hemostatics|hemostatics|mesh-list
139239021|NCT03616808|Coagulants|coagulants|mesh-ancestor
139239022|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
139239023|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139239024|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139239025|NCT03617510|Analgesics|analgesics|mesh-ancestor
139239026|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
139239027|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239028|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239029|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139642193|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239030|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139239031|NCT03617432|Prednisone|prednisone|mesh-list
139239032|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
139239033|NCT03617432|Doxorubicin|doxorubicin|mesh-list
139239034|NCT03617432|Etoposide|etoposide|mesh-list
139239035|NCT03617432|Vincristine|vincristine|mesh-list
139239037|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
139239038|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239039|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139239040|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139300061|NCT03793114|Cosyntropin|cosyntropin|mesh-list
139239041|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
139239042|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239043|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239044|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139239045|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139239046|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139239047|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139239048|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239049|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139239050|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
139239051|NCT03617432|Hormones|hormones|mesh-ancestor
139239052|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139239053|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139239054|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139239055|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
139239056|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
139239057|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
139239058|NCT02996682|Ribavirin|ribavirin|mesh-list
139239059|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139239060|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
139239061|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239062|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
139239063|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239064|NCT02873702|Lansoprazole|lansoprazole|mesh-list
139239065|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
139239066|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139239067|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239068|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139239069|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239070|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239071|NCT03616262|Lidocaine|lidocaine|mesh-list
139239072|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
139239073|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
139239074|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139239075|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239076|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
139239077|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239078|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139239079|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139239080|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139239081|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139239082|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239083|NCT03615950|Vitamin D|vitamin d|mesh-list
139239084|NCT03615950|Vitamins|vitamins|mesh-ancestor
139239085|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
139239086|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239087|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139239088|NCT02911116|Ustekinumab|ustekinumab|mesh-list
139239089|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
139239090|NCT03664050|Letrozole|letrozole|mesh-list
139239091|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239092|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139239093|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139239094|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239095|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239096|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139239097|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
139239098|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139239099|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239100|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139239101|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139239102|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
139239103|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139239104|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239105|NCT04494438|Rituximab|rituximab|mesh-list
139239106|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139239107|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239108|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
139239110|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139239111|NCT04057482|Dequalinium|dequalinium|mesh-list
139239112|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139239113|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239114|NCT03662412|Sirolimus|sirolimus|mesh-list
139239115|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139239116|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239117|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139239118|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239119|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
139239120|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139239121|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
139239122|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239123|NCT02870972|Berotralstat|berotralstat|mesh-list
139239124|NCT02870972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139239125|NCT02870972|Protease Inhibitors|protease inhibitors|mesh-ancestor
139239126|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239127|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239128|NCT03214367|Insulin|insulin|mesh-list
139239129|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139239130|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
139239131|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
139239132|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139239133|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239134|NCT03662958|Leuprolide|leuprolide|mesh-list
139239135|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139239136|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
139239137|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139239138|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239139|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139239140|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239141|NCT03231371|Adenosine|adenosine|mesh-list
139239142|NCT03231371|Analgesics|analgesics|mesh-ancestor
139239143|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
139239144|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239145|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239146|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139300327|NCT03401294|Antidotes|antidotes|mesh-ancestor
139239147|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
139239148|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139239149|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
139239150|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
139239151|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239152|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239153|NCT03663114|Lenvatinib|lenvatinib|mesh-list
139239154|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239155|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139239156|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239157|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239158|NCT03526679|Lenvatinib|lenvatinib|mesh-list
139239159|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239160|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139239161|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239162|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239163|NCT04057326|Pancreatin|pancreatin|mesh-list
139239164|NCT04057326|Pancrelipase|pancrelipase|mesh-list
139239165|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239166|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139300395|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
139239167|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139239168|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139239169|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
139239170|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239171|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239172|NCT05384210|Gabapentin|gabapentin|mesh-list
139239173|NCT05384210|Milnacipran|milnacipran|mesh-list
139239174|NCT05384210|Levomilnacipran|levomilnacipran|mesh-list
139239175|NCT05384210|Analgesics|analgesics|mesh-ancestor
139239176|NCT05384210|Sensory System Agents|sensory system agents|mesh-ancestor
139239177|NCT05384210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239178|NCT05384210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239179|NCT05384210|Anticonvulsants|anticonvulsants|mesh-ancestor
139239180|NCT05384210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139239181|NCT05384210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139239182|NCT05384210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195800|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
139239183|NCT05384210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139239184|NCT05384210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139239185|NCT05384210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139239186|NCT05384210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239187|NCT05384210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239188|NCT05384210|Antimanic Agents|antimanic agents|mesh-ancestor
139239189|NCT05384210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139239190|NCT05384210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139239191|NCT05384210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139239192|NCT05384210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139239193|NCT05384210|Antidepressive Agents|antidepressive agents|mesh-ancestor
139239194|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
139239195|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139239196|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
139239198|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139239199|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239200|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
139239201|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
139239202|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
139239203|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
139239204|NCT03239483|Dapivirine|dapivirine|mesh-list
139239205|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139239206|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139239207|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
139239208|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239209|NCT01068912|Favipiravir|favipiravir|mesh-list
139239210|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
139239211|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239212|NCT04056702|Ivacaftor|ivacaftor|mesh-list
139239213|NCT04056702|Elexacaftor|elexacaftor|mesh-list
139239214|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139239215|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139239216|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239217|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
139239218|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139239219|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139239220|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239221|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139239222|NCT03612440|Analgesics|analgesics|mesh-ancestor
139239223|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
139239224|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239225|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139239226|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139239227|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139239228|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
139239229|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239230|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239231|NCT03662724|Venetoclax|venetoclax|mesh-list
139239232|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239233|NCT03662568|Ritonavir|ritonavir|mesh-list
139239234|NCT03662568|Tenofovir|tenofovir|mesh-list
139239235|NCT03662568|Entecavir|entecavir|mesh-list
139239236|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139239237|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139239238|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
139239239|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239240|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239241|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139239242|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139239243|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
139239244|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300753|NCT01424982|Daunorubicin|daunorubicin|mesh-list
139239245|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139239246|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139239247|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139239248|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139239249|NCT02993250|Simeprevir|simeprevir|mesh-list
139239250|NCT02993250|Odalasvir|odalasvir|mesh-list
139239251|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
139239252|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239253|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
139239254|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239255|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239256|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139239257|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139239258|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139239259|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139239260|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239262|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239263|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239265|NCT05383820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139239266|NCT05383820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139239267|NCT05383820|Analgesics|analgesics|mesh-ancestor
139239268|NCT05383820|Sensory System Agents|sensory system agents|mesh-ancestor
139300894|NCT00606866|Sorafenib|sorafenib|mesh-list
139239269|NCT05383820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239270|NCT05383820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239271|NCT05383820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139239272|NCT05383820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139239273|NCT05383820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139239274|NCT05383820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239275|NCT05383820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239276|NCT03611504|Hemostatics|hemostatics|mesh-list
139239277|NCT03611504|Coagulants|coagulants|mesh-ancestor
139239278|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139239279|NCT02954510|Hematinics|hematinics|mesh-ancestor
139300963|NCT00157248|Dabigatran|dabigatran|mesh-list
139239280|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139239281|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139239282|NCT02032784|Octreotide|octreotide|mesh-list
139239283|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239284|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139239285|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239286|NCT03611426|Thrombin|thrombin|mesh-list
139239287|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
139239288|NCT03611426|Coagulants|coagulants|mesh-ancestor
139239289|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139239290|NCT03658746|Amoxicillin|amoxicillin|mesh-list
139239291|NCT03658746|Metronidazole|metronidazole|mesh-list
139239292|NCT03658746|Clarithromycin|clarithromycin|mesh-list
139239293|NCT03658746|Levofloxacin|levofloxacin|mesh-list
139239294|NCT03658746|Ofloxacin|ofloxacin|mesh-list
139239295|NCT03658746|Tetracycline|tetracycline|mesh-list
139239296|NCT03658746|Tinidazole|tinidazole|mesh-list
139239297|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139239298|NCT03658746|Furazolidone|furazolidone|mesh-list
139239299|NCT03658746|Bismuth|bismuth|mesh-list
139239300|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139239301|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239302|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
139239303|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139239304|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139239305|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139239306|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239307|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239308|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139239309|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139239310|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139239311|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139239312|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139239313|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239314|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139239315|NCT03658746|Antacids|antacids|mesh-ancestor
139239316|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239317|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139239318|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139239319|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139239320|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
139239321|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
139239322|NCT02990910|Narcotics|narcotics|mesh-ancestor
139239323|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139239324|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239325|NCT02990910|Analgesics|analgesics|mesh-ancestor
139239326|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
139239327|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239328|NCT04056000|Caffeine|caffeine|mesh-list
139239329|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139239330|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239331|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139239332|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239333|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195949|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
139239334|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139239335|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139239336|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
139239337|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239338|NCT03611348|Latanoprost|latanoprost|mesh-list
139239339|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139239340|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139239341|NCT02033018|Aflibercept|aflibercept|mesh-list
139239342|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139239343|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139239344|NCT02033018|Growth Substances|growth substances|mesh-ancestor
139239345|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239346|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
139239347|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239348|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
139239349|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301338|NCT01235754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139239350|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239351|NCT03658590|Dexamethasone|dexamethasone|mesh-list
139239352|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139239353|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
139239354|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
139239355|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239356|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239357|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239358|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
139239359|NCT03658590|Hormones|hormones|mesh-ancestor
139239360|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139239361|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139239362|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239363|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
139239364|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
139239365|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139239366|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139239367|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239368|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239369|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239370|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139239371|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
139239372|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239373|NCT03941093|Leucovorin|leucovorin|mesh-list
139239374|NCT03941093|Paclitaxel|paclitaxel|mesh-list
139239375|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139239376|NCT03941093|Gemcitabine|gemcitabine|mesh-list
139239377|NCT03941093|Irinotecan|irinotecan|mesh-list
139239378|NCT03941093|Fluorouracil|fluorouracil|mesh-list
139239379|NCT03941093|Folfirinox|folfirinox|mesh-list
139239380|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
139239381|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139239382|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239383|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
139239384|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
139239385|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
139239386|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239387|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139239388|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
139239389|NCT03941093|Antidotes|antidotes|mesh-ancestor
139239390|NCT03941093|Protective Agents|protective agents|mesh-ancestor
139239391|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239392|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
139239393|NCT03941093|Vitamins|vitamins|mesh-ancestor
139239394|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
139239395|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139239396|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139239397|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239398|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139239399|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
139239400|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139239401|NCT02033408|Amoxicillin|amoxicillin|mesh-list
139239402|NCT02033408|Metronidazole|metronidazole|mesh-list
139239403|NCT02033408|Vancomycin|vancomycin|mesh-list
139239404|NCT02033408|Doxycycline|doxycycline|mesh-list
139239405|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
139239406|NCT02033408|Gentamicins|gentamicins|mesh-list
139239407|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239408|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139239409|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139239410|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
139196025|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
139239411|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139239412|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139239413|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239414|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239415|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301652|NCT01281462|Cephalosporins|cephalosporins|mesh-list
139239416|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139239417|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139239418|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139239419|NCT03610880|Yimitasvir|yimitasvir|mesh-list
139239420|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
139239421|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239422|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
139239423|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139239424|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139239425|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139239426|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139239427|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239428|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
139239429|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239430|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239431|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139239432|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239433|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139239434|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139239435|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
139239436|NCT02560298|Paclitaxel|paclitaxel|mesh-list
139239437|NCT02560298|Cisplatin|cisplatin|mesh-list
139239438|NCT02560298|Carboplatin|carboplatin|mesh-list
139239439|NCT02560298|Capecitabine|capecitabine|mesh-list
139239440|NCT02560298|Fluorouracil|fluorouracil|mesh-list
139239441|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139239442|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139239443|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239444|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
139239445|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
139301785|NCT01009242|Methotrexate|methotrexate|mesh-list
139239446|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
139239447|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239448|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139239449|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
139239450|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139239451|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
139239452|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239453|NCT01330615|Lidocaine|lidocaine|mesh-list
139239454|NCT01330615|Prilocaine|prilocaine|mesh-list
139301834|NCT01007292|Rituximab|rituximab|mesh-list
139239455|NCT01330615|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139239456|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
139239457|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
139239458|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301904|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
139239459|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239460|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
139239461|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239462|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139239463|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139239464|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139239465|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139239466|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239467|NCT01330615|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139239468|NCT05034029|Metformin|metformin|mesh-list
139239469|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139239470|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239471|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139239472|NCT03237065|Hematinics|hematinics|mesh-ancestor
139239473|NCT03620461|Gemcitabine|gemcitabine|mesh-list
139239474|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139239475|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139239476|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
139239477|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239478|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239479|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
139239480|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139239481|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139302178|NCT04176848|Durvalumab|durvalumab|mesh-list
139239482|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
139239483|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239484|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239485|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239486|NCT01314781|Urological Agents|urological agents|mesh-ancestor
139239487|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139239488|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139239489|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139239490|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139239491|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239492|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
139239493|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239494|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239495|NCT02863328|Empagliflozin|empagliflozin|mesh-list
139239496|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139239497|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239498|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139239499|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239500|NCT03040141|Oseltamivir|oseltamivir|mesh-list
139302307|NCT00840840|Amoxicillin|amoxicillin|mesh-list
139239501|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
139239502|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239503|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302368|NCT00939276|Nepafenac|nepafenac|mesh-list
139239504|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239505|NCT02937701|Infliximab|infliximab|mesh-list
139239506|NCT02937701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139239507|NCT02937701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139239508|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
139239509|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239510|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139239511|NCT05186623|Ustekinumab|ustekinumab|mesh-list
139239512|NCT05186623|Vedolizumab|vedolizumab|mesh-list
139239513|NCT05186623|Tofacitinib|tofacitinib|mesh-list
139239514|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
139239515|NCT05186623|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139239516|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139239517|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239518|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239519|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239520|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
139239521|NCT04602845|Midazolam|midazolam|mesh-list
139239522|NCT04602845|Fentanyl|fentanyl|mesh-list
139239523|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139239524|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139239525|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139239526|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239527|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139239528|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139239529|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139239530|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139239531|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
139239532|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
139302580|NCT04037072|Mitomycin|mitomycin|mesh-list
139239533|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
139239534|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
139239535|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239536|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239537|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139239538|NCT04602845|Narcotics|narcotics|mesh-ancestor
139239539|NCT04602845|Analgesics|analgesics|mesh-ancestor
139239540|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
139239541|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239542|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139239543|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139239544|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139239545|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139239546|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139239547|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239548|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
139239549|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139239550|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239551|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139239552|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139239553|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239554|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239555|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239556|NCT03168919|Temozolomide|temozolomide|mesh-list
139239557|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139239558|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
139239559|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239560|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239561|NCT03205163|Factor VIII|factor viii|mesh-list
139239563|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
139239564|NCT03638947|Povidone|povidone|mesh-list
139239565|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
139239566|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
139239567|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139239568|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239569|NCT03502681|Avelumab|avelumab|mesh-list
139239570|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139239571|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239572|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
139239573|NCT04938817|Lenvatinib|lenvatinib|mesh-list
139239574|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139239575|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239576|NCT04938817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139239577|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239578|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139239579|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239580|NCT04485325|Etanercept|etanercept|mesh-list
139239581|NCT04485325|Tofacitinib|tofacitinib|mesh-list
139239582|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139239583|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139239584|NCT04485325|Analgesics|analgesics|mesh-ancestor
139239585|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
139239586|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239587|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239588|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139239589|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139239590|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239591|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139239592|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
139239593|NCT04485325|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139239594|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139239595|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239596|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239597|NCT03610178|Insulin|insulin|mesh-list
139239598|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139239599|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139239600|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239601|NCT02033798|Tamsulosin|tamsulosin|mesh-list
139239602|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139239603|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139239604|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139239605|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
139239606|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239607|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239608|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239609|NCT02033798|Urological Agents|urological agents|mesh-ancestor
139239610|NCT02887183|Valsartan|valsartan|mesh-list
139239611|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139239612|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139239613|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139239614|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139239615|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239616|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
139239617|NCT03660306|Anesthetics|anesthetics|mesh-list
139239618|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139239619|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239620|NCT03660306|Narcotics|narcotics|mesh-ancestor
139239621|NCT03660306|Analgesics|analgesics|mesh-ancestor
139239622|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
139239623|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239624|NCT01067352|Hormones|hormones|mesh-list
139239625|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139239626|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239627|NCT02920242|Rifaximin|rifaximin|mesh-list
139239628|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139239629|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239630|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239631|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139239632|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139196253|NCT01179503|Vitamins|vitamins|mesh-ancestor
139239633|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139239634|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139239635|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239636|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239637|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
139239638|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239639|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139239640|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139239641|NCT03203447|Triamcinolone|triamcinolone|mesh-list
139239642|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139239643|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139239644|NCT03203447|Bevacizumab|bevacizumab|mesh-list
139239645|NCT03203447|Ranibizumab|ranibizumab|mesh-list
139239646|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139239647|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139239648|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239649|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139239650|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139239651|NCT03203447|Growth Substances|growth substances|mesh-ancestor
139239652|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239653|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
139239654|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139239655|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
139239656|NCT03203447|Hormones|hormones|mesh-ancestor
139239657|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139239658|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139239659|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
139239660|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239661|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239662|NCT01068678|Insulin|insulin|mesh-list
139239663|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139239664|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
139239665|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139239666|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239667|NCT03202511|Tenofovir|tenofovir|mesh-list
139239668|NCT03202511|Emtricitabine|emtricitabine|mesh-list
139239669|NCT03202511|Probenecid|probenecid|mesh-list
139239670|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
139239671|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239672|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139239673|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139239674|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239675|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239676|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139239677|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139239678|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
139239679|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
139239680|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139239681|NCT03637049|Midazolam|midazolam|mesh-list
139239682|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139239683|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139239684|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139239685|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239686|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139239687|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139239688|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139239689|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139239690|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
139239691|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
139239692|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
139239693|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
139303453|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
139239694|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239695|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239696|NCT03636971|Mannitol|mannitol|mesh-list
139239697|NCT03636971|Sorbitol|sorbitol|mesh-list
139239698|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
139239699|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139239700|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
139239701|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239702|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
139239703|NCT03636971|Protective Agents|protective agents|mesh-ancestor
139239704|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139239705|NCT03636971|Diuretics|diuretics|mesh-ancestor
139239706|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
139239707|NCT03636971|Cathartics|cathartics|mesh-ancestor
139239708|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239709|NCT03610100|Gemcitabine|gemcitabine|mesh-list
139239710|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139239711|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
139239712|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239713|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239714|NCT03657966|Paclitaxel|paclitaxel|mesh-list
139239715|NCT03657966|Carboplatin|carboplatin|mesh-list
139239716|NCT03657966|Gemcitabine|gemcitabine|mesh-list
139239717|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139239718|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239719|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
139239720|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
139239721|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
139239722|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239723|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139239724|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
139239725|NCT03659292|Anesthetics|anesthetics|mesh-list
139303638|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
139239726|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139239727|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239728|NCT03659058|Colchicine|colchicine|mesh-list
139239729|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139239730|NCT03659058|Antioxidants|antioxidants|mesh-list
139239731|NCT03659058|Silymarin|silymarin|mesh-list
139239732|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
139239733|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139239734|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
139239735|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
139239736|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
139239737|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239738|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239739|NCT03659058|Protective Agents|protective agents|mesh-ancestor
139239740|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239741|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139239742|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239743|NCT03635905|Gabapentin|gabapentin|mesh-list
139239744|NCT03635905|Analgesics|analgesics|mesh-ancestor
139239745|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
139239746|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303846|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
139239747|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239748|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
139239749|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139239750|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139086477|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
139239751|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139239752|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139239753|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139239754|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139239755|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239756|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239757|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
139239758|NCT02960113|Scopolamine|scopolamine|mesh-list
139239759|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139239760|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139239761|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
139239762|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
139239763|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239764|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239765|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239766|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
139239767|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139239768|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
139086548|NCT03912740|Analgesics|analgesics|mesh-ancestor
139239769|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239770|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239771|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139239772|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
139239773|NCT04458324|Buspirone|buspirone|mesh-list
139239774|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139239775|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139239776|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139239777|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239778|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139239779|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139239780|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
139239781|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239782|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239783|NCT03657420|Dexamethasone|dexamethasone|mesh-list
139239784|NCT03657420|Pomalidomide|pomalidomide|mesh-list
139239785|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139239786|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
139239787|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
139239788|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239789|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239790|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239791|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
139239792|NCT03657420|Hormones|hormones|mesh-ancestor
139239793|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139239794|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139239795|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239796|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
139239797|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139239798|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139239799|NCT03657420|Growth Substances|growth substances|mesh-ancestor
139239800|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
139239801|NCT02984982|Anticoagulants|anticoagulants|mesh-list
139239802|NCT02984982|Atorvastatin|atorvastatin|mesh-list
139239803|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139239804|NCT02984982|Ezetimibe|ezetimibe|mesh-list
139239805|NCT02984982|Alirocumab|alirocumab|mesh-list
139239806|NCT02984982|Fenofibrate|fenofibrate|mesh-list
139239807|NCT02984982|Bezafibrate|bezafibrate|mesh-list
139239808|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139239809|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139239810|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
139239811|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239812|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139239813|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139239814|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239815|NCT02984982|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139239816|NCT02984982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139239817|NCT02984982|Protease Inhibitors|protease inhibitors|mesh-ancestor
139239818|NCT03656484|Metronidazole|metronidazole|mesh-list
139239819|NCT03656484|Tetracycline|tetracycline|mesh-list
139239820|NCT03656484|Melatonin|melatonin|mesh-list
139239821|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
139239822|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239823|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139239824|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139239825|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139239826|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
139239827|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239828|NCT03656484|Protective Agents|protective agents|mesh-ancestor
139239829|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239830|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139239831|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139239832|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
139239833|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
139239834|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139239835|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239836|NCT04309578|Capecitabine|capecitabine|mesh-list
139239837|NCT04309578|Trastuzumab|trastuzumab|mesh-list
139239838|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239839|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139239840|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
139239841|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239842|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139239843|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
139239844|NCT03656952|PF-06700841|pf-06700841|mesh-list
139239845|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139239846|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239847|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139239848|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139239849|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239850|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239851|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239852|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139239853|NCT02981472|Vitamin K|vitamin k|mesh-list
139239854|NCT02981472|Heparin|heparin|mesh-list
139239855|NCT02981472|Enoxaparin|enoxaparin|mesh-list
139239856|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139239857|NCT02981472|Tinzaparin|tinzaparin|mesh-list
139239858|NCT02981472|Dalteparin|dalteparin|mesh-list
139239859|NCT02981472|Warfarin|warfarin|mesh-list
139239860|NCT02981472|Apixaban|apixaban|mesh-list
139239861|NCT02981472|Vitamins|vitamins|mesh-ancestor
139239862|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
139239863|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087061|NCT03902522|Leronlimab|leronlimab|mesh-list
139239864|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
139239865|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139239866|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139239867|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239868|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139239869|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
139239870|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139239871|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
139239872|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239873|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139239874|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
139239875|NCT02981472|Coagulants|coagulants|mesh-ancestor
139239876|NCT03656172|Chrysarobin|chrysarobin|mesh-list
139087184|NCT03901118|Paclitaxel|paclitaxel|mesh-list
139239877|NCT03656172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139239878|NCT03656172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139239879|NCT03656172|Analgesics|analgesics|mesh-ancestor
139239880|NCT03656172|Sensory System Agents|sensory system agents|mesh-ancestor
139239881|NCT03656172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087252|NCT03905564|Vitamins|vitamins|mesh-ancestor
139239882|NCT03656172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239883|NCT03656172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139239884|NCT03656172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139239885|NCT03656094|Docetaxel|docetaxel|mesh-list
139239886|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
139239887|NCT03656094|Pemetrexed|pemetrexed|mesh-list
139239888|NCT03656094|Vinorelbine|vinorelbine|mesh-list
139239889|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087328|NCT01149746|Tamsulosin|tamsulosin|mesh-list
139239890|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
139239891|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
139239892|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
139239893|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239894|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139239895|NCT03656094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139239896|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239897|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139239898|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139239899|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139239900|NCT04298034|Labetalol|labetalol|mesh-list
139239901|NCT04298034|Nifedipine|nifedipine|mesh-list
139239902|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139239903|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087386|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139239904|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239905|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139239906|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239907|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
139239908|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
139239909|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139087448|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
139239910|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139239911|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139239912|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
139239913|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139239914|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139239915|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
139239916|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
139239917|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239918|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139087517|NCT03892148|Furosemide|furosemide|mesh-list
139239919|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139239920|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139239921|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
139239922|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139239923|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239924|NCT02982720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139239925|NCT02982720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239926|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
139239927|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239928|NCT00849667|Carboplatin|carboplatin|mesh-list
139239929|NCT00849667|Taxane|taxane|mesh-list
139239930|NCT00849667|Farletuzumab|farletuzumab|mesh-list
139239931|NCT00849667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239932|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139239933|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
139239934|NCT03201419|Coagulants|coagulants|mesh-ancestor
139239935|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139239936|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
139239937|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239938|NCT01764633|Evolocumab|evolocumab|mesh-list
139239939|NCT01764633|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139239940|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139239941|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139239942|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
139239943|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239944|NCT01764633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139239945|NCT01764633|Protease Inhibitors|protease inhibitors|mesh-ancestor
139239946|NCT01764633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239947|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139239948|NCT02924389|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139239949|NCT02924389|Dolutegravir|dolutegravir|mesh-list
139239950|NCT02924389|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
139239951|NCT02924389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139239952|NCT02924389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139239953|NCT02924389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239954|NCT02924389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239955|NCT02924389|Antiviral Agents|antiviral agents|mesh-ancestor
139239956|NCT02924389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139239957|NCT02924389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139239958|NCT02924389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139239959|NCT02924389|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139239960|NCT02924389|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139239961|NCT01315093|Heparin|heparin|mesh-list
139239962|NCT01315093|Calcium heparin|calcium heparin|mesh-list
139239963|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139239964|NCT01315093|Tinzaparin|tinzaparin|mesh-list
139239965|NCT01315093|Dalteparin|dalteparin|mesh-list
139239966|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
139239967|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139239968|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139239969|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239970|NCT01331707|Everolimus|everolimus|mesh-list
139239971|NCT01331707|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139239972|NCT01331707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139239973|NCT01331707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139239974|NCT01331707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139239975|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139239976|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
139239977|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239978|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239979|NCT03953807|Dexamethasone|dexamethasone|mesh-list
139239980|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139239981|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
139239982|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
139239983|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239984|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239985|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139239986|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
139239987|NCT03953807|Hormones|hormones|mesh-ancestor
139239988|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139239989|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139239990|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139239991|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
139239992|NCT03662711|Olodaterol|olodaterol|mesh-list
139239993|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
139239994|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139239995|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139239996|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139239997|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
139239998|NCT02923531|Nivolumab|nivolumab|mesh-list
139239999|NCT02923531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139240000|NCT02923531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240001|NCT02923531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139240002|NCT02923531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240003|NCT02934503|Carboplatin|carboplatin|mesh-list
139240004|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
139240005|NCT02934503|Etoposide|etoposide|mesh-list
139240006|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240007|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139240008|NCT02934503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139240009|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240010|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139240011|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139240012|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139240013|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240014|NCT04563247|Antibodies|antibodies|mesh-list
139240015|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
139110107|NCT05941806|Tamsulosin|tamsulosin|mesh-list
139196629|NCT01289327|Analgesics|analgesics|mesh-ancestor
139088246|NCT03882788|Fentanyl|fentanyl|mesh-list
139240016|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240017|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
139240018|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139240019|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139240020|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240021|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139240022|NCT01314209|Analgesics|analgesics|mesh-ancestor
139240023|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
139240024|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240025|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139240026|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139240027|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139240028|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
139240029|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240030|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240031|NCT05431075|Amoxicillin|amoxicillin|mesh-list
139240032|NCT05431075|Tetracycline|tetracycline|mesh-list
139240033|NCT05431075|Potassium Citrate|potassium citrate|mesh-list
139240034|NCT05431075|Esomeprazole|esomeprazole|mesh-list
139240035|NCT05431075|Bismuth|bismuth|mesh-list
139240036|NCT05431075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240037|NCT05431075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139240038|NCT05431075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240039|NCT05431075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139240040|NCT05431075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139240041|NCT05431075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139240042|NCT05431075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240043|NCT05431075|Antacids|antacids|mesh-ancestor
139240044|NCT05431075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139240045|NCT05431075|Diuretics|diuretics|mesh-ancestor
139240046|NCT05431075|Natriuretic Agents|natriuretic agents|mesh-ancestor
139240047|NCT05431075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240048|NCT05431075|Expectorants|expectorants|mesh-ancestor
139240049|NCT05431075|Respiratory System Agents|respiratory system agents|mesh-ancestor
139240050|NCT03636659|Amphotericin B|amphotericin b|mesh-list
139240051|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139240052|NCT03636659|Amebicides|amebicides|mesh-ancestor
139240053|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139240054|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139240055|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240056|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139240057|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
139240058|NCT04892173|Cetuximab|cetuximab|mesh-list
139240059|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139240060|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240061|NCT03198767|Licogliflozin|licogliflozin|mesh-list
139240062|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
139240063|NCT03198767|Psyllium|psyllium|mesh-list
139240064|NCT03198767|Calcium|calcium|mesh-list
139240065|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139240066|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240067|NCT03198767|Antacids|antacids|mesh-ancestor
139240068|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240069|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139240070|NCT03198767|Cathartics|cathartics|mesh-ancestor
139240071|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139240072|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139240073|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
139240074|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
139240075|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139240076|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
139240077|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240078|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240079|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139240080|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
139240081|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139240082|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139240083|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139240084|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
139240085|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240086|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240087|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139240088|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139240089|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139642194|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139240091|NCT01331785|Midodrine|midodrine|mesh-list
139240092|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
139240093|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
139240094|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240095|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240096|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139240097|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139240098|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139240099|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139240100|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
139240101|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240102|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240103|NCT01382589|Afamelanotide|afamelanotide|mesh-list
139240104|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
139240105|NCT03671759|Caffeine|caffeine|mesh-list
139240106|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139240107|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240108|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139240109|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240110|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240111|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139240112|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139240113|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
139240114|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240115|NCT01384227|Proflavine|proflavine|mesh-list
139240116|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139240117|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240118|NCT01382511|Simvastatin|simvastatin|mesh-list
139240119|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139240120|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139240121|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
139240122|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240123|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139240124|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139240125|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240126|NCT03684447|Propofol|propofol|mesh-list
139240127|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139240128|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139240129|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240130|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139240131|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
139240132|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
139240133|NCT04505059|Anesthetics|anesthetics|mesh-list
139088585|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240134|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139240135|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240136|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139240137|NCT04217135|Hydralazine|hydralazine|mesh-list
139240138|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139240139|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
139240140|NCT01337401|Cediranib|cediranib|mesh-list
139240141|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240142|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139240143|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240144|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240145|NCT04178603|Insulin|insulin|mesh-list
139240146|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139240147|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240148|NCT01333891|Nitroprusside|nitroprusside|mesh-list
139240149|NCT01333891|Phenylephrine|phenylephrine|mesh-list
139240150|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
139240151|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139240152|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
139240153|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
139240154|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240155|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240156|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
139240157|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139240158|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
139240159|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
139240160|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139240161|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139240162|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139240163|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
139240164|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110259|NCT05855395|Hormones|hormones|mesh-ancestor
139240165|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240166|NCT01333891|Protective Agents|protective agents|mesh-ancestor
139240167|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139240168|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
139240169|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139240170|NCT04853875|Amoxicillin|amoxicillin|mesh-list
139240171|NCT04853875|Metronidazole|metronidazole|mesh-list
139240172|NCT04853875|Clarithromycin|clarithromycin|mesh-list
139240173|NCT04853875|Tetracycline|tetracycline|mesh-list
139088684|NCT01281566|Cisapride|cisapride|mesh-list
139240174|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
139240175|NCT04853875|Bismuth|bismuth|mesh-list
139240176|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139240177|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240178|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139240179|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139240180|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139240181|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240182|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240183|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139240184|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139240185|NCT04853875|Antacids|antacids|mesh-ancestor
139240186|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139240187|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139240188|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139240189|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139240190|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240191|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
139240192|NCT03196505|Bupivacaine|bupivacaine|mesh-list
139240193|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
139240194|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
139240195|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139240196|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240197|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
139240198|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240199|NCT01334047|Vaccines|vaccines|mesh-list
139240200|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
139240201|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240202|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
139240203|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139240204|NCT03196349|Warfarin|warfarin|mesh-list
139240205|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
139240206|NCT03196349|Apixaban|apixaban|mesh-list
139240207|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
139240208|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139240209|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
139240210|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139240211|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
139240212|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088745|NCT00313313|Metformin|metformin|mesh-list
139240213|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240214|NCT01331941|Paclitaxel|paclitaxel|mesh-list
139240215|NCT01331941|Trebananib|trebananib|mesh-list
139240216|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139240217|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240218|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
139240219|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
139240220|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
139240221|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088775|NCT01268930|Coagulants|coagulants|mesh-ancestor
139240222|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139240223|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139240224|NCT01331941|Growth Substances|growth substances|mesh-ancestor
139240225|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240226|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
139240227|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
139240228|NCT02886715|Tazarotene|tazarotene|mesh-list
139240229|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
139240230|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
139240231|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
139240232|NCT02886715|Vitamins|vitamins|mesh-ancestor
139240233|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
139240234|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240235|NCT01337791|Telbivudine|telbivudine|mesh-list
139240236|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
139240237|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240238|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139240239|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240240|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642195|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
139240241|NCT01334203|Ranolazine|ranolazine|mesh-list
139240242|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139240243|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139240244|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240245|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
139240246|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139240247|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
139240248|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139240249|NCT01569165|Fluorides|fluorides|mesh-list
139240250|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
139240251|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
139240252|NCT01569165|Protective Agents|protective agents|mesh-ancestor
139240253|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240254|NCT02535091|Cenobamate|cenobamate|mesh-list
139240255|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
139240256|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139240257|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139240258|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139240259|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
139240260|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240261|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139240262|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139240263|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240264|NCT01382199|Lactoferrin|lactoferrin|mesh-list
139240265|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240266|NCT01381497|Naproxen|naproxen|mesh-list
139240267|NCT01381497|Sumatriptan|sumatriptan|mesh-list
139240268|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139240269|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139240270|NCT01381497|Analgesics|analgesics|mesh-ancestor
139240271|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
139240272|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240273|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240274|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139240275|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139240276|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
139240277|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139240278|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240279|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240280|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139240281|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139240282|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139240283|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
139240284|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240285|NCT03635827|Xenon|xenon|mesh-list
139240286|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139240287|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
139240288|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
139240289|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139240290|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240291|NCT01338103|Rituximab|rituximab|mesh-list
139240292|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139240293|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240294|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
139240295|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240296|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139240297|NCT03621761|Modafinil|modafinil|mesh-list
139240298|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139240299|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240300|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139240301|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139240302|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139240303|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240304|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
139240305|NCT03318861|Fludarabine|fludarabine|mesh-list
139240306|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139240307|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
139240308|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240309|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139240310|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139089055|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139240311|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
139240312|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240313|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240314|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139240315|NCT03084315|Nicotine|nicotine|mesh-list
139240316|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139240317|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
139240318|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240319|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240320|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139240321|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139240322|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
139240323|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240324|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240325|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
139240326|NCT03187301|Apomorphine|apomorphine|mesh-list
139240327|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139240328|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240329|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139240330|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139240331|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240332|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240333|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240334|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240335|NCT03187301|Emetics|emetics|mesh-ancestor
139240336|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
139240337|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240338|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139240339|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
139240340|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
139240341|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240342|NCT01381185|Aspirin|aspirin|mesh-list
139240343|NCT01381185|Clopidogrel|clopidogrel|mesh-list
139240344|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139240345|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139240346|NCT01381185|Analgesics|analgesics|mesh-ancestor
139240347|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
139240348|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240349|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240350|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139240351|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139240352|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139089164|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
139240353|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139240354|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240355|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139240356|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139240357|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240358|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
139240359|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139240360|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139240361|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139240362|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
139240363|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240364|NCT02946047|Ixazomib|ixazomib|mesh-list
139240365|NCT02946047|Glycine|glycine|mesh-list
139240366|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240367|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
139240368|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240369|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240370|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
139240371|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240372|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240373|NCT05421897|Cyclophosphamide|cyclophosphamide|mesh-list
139240374|NCT05421897|Temozolomide|temozolomide|mesh-list
139240375|NCT05421897|Irinotecan|irinotecan|mesh-list
139240376|NCT05421897|Topotecan|topotecan|mesh-list
139240377|NCT05421897|Dinutuximab|dinutuximab|mesh-list
139240378|NCT05421897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139240379|NCT05421897|Immunologic Factors|immunologic factors|mesh-ancestor
139240380|NCT05421897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240381|NCT05421897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139240382|NCT05421897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139240383|NCT05421897|Alkylating Agents|alkylating agents|mesh-ancestor
139240384|NCT05421897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240385|NCT05421897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240386|NCT05421897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139240387|NCT05421897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139240388|NCT05421897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139240389|NCT05421897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240390|NCT03077919|Ropivacaine|ropivacaine|mesh-list
139240391|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
139091580|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139091581|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091582|NCT04423718|Aflibercept|aflibercept|mesh-list
139091583|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139091584|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139091585|NCT04423718|Growth Substances|growth substances|mesh-ancestor
139091586|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089343|NCT03865160|Atropine|atropine|mesh-list
139091587|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
139091588|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091589|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
139091590|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139091591|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091592|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139091593|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091594|NCT04396873|11C-PS13|11c-ps13|mesh-list
139091595|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139091596|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091597|NCT04381936|Aspirin|aspirin|mesh-list
139091598|NCT04381936|Empagliflozin|empagliflozin|mesh-list
139091599|NCT04381936|Ritonavir|ritonavir|mesh-list
139091600|NCT04381936|Lopinavir|lopinavir|mesh-list
139091601|NCT04381936|Azithromycin|azithromycin|mesh-list
139091602|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
139091603|NCT04381936|Oseltamivir|oseltamivir|mesh-list
139091604|NCT04381936|Nirmatrelvir|nirmatrelvir|mesh-list
139091605|NCT04381936|Sotrovimab|sotrovimab|mesh-list
139091606|NCT04381936|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139091607|NCT04381936|Molnupiravir|molnupiravir|mesh-list
139091608|NCT04381936|Baloxavir|baloxavir|mesh-list
139091609|NCT04381936|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
139091610|NCT04381936|Dexamethasone|dexamethasone|mesh-list
139091611|NCT04381936|Dexamethasone acetate|dexamethasone acetate|mesh-list
139091612|NCT04381936|Colchicine|colchicine|mesh-list
139091613|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139091614|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139642196|NCT04392427|Ribavirin|ribavirin|mesh-list
139642197|NCT04392427|Ivermectin|ivermectin|mesh-list
139642198|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
139642199|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
139642200|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091615|NCT04381936|Antibodies|antibodies|mesh-list
138842207|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642201|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
139642202|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139642203|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139642204|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
139642205|NCT01457131|Fludarabine|fludarabine|mesh-list
139642206|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139642207|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
139642208|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642209|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139642210|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139642211|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
139642212|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642213|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642214|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139642215|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
139642216|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
139642217|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139642218|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139642219|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139642220|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139642221|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642222|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642223|NCT01455337|Prednisolone|prednisolone|mesh-list
139642224|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
139642225|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139642226|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
139642227|NCT01455337|Hormones|hormones|mesh-ancestor
139642228|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139642229|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642230|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139642231|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642232|NCT01455337|Protective Agents|protective agents|mesh-ancestor
139642233|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139642234|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240392|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
139240393|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139240394|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240395|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
139240396|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240397|NCT01380951|Telbivudine|telbivudine|mesh-list
139240398|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
139240399|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240400|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139240401|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240402|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240403|NCT01377597|Ranibizumab|ranibizumab|mesh-list
139240404|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139240405|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139240406|NCT01377597|Growth Substances|growth substances|mesh-ancestor
139240407|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240408|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
139240409|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240410|NCT03204695|Clopidogrel|clopidogrel|mesh-list
139089627|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
139240411|NCT03204695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139240412|NCT03204695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139240413|NCT03204695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139240414|NCT03204695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139240415|NCT03204695|Purinergic Agents|purinergic agents|mesh-ancestor
139240416|NCT03204695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240417|NCT03204695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240418|NCT03204695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240419|NCT03287375|Cisplatin|cisplatin|mesh-list
139240420|NCT03287375|Doxorubicin|doxorubicin|mesh-list
139240421|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
139240422|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240423|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139240424|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139240425|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139240426|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240427|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240428|NCT03881059|Ustekinumab|ustekinumab|mesh-list
139240429|NCT03881059|Deucravacitinib|deucravacitinib|mesh-list
139240430|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
139240431|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139240432|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240433|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240434|NCT01338337|Azacitidine|azacitidine|mesh-list
139240435|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139240436|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
139240437|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240438|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240439|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240440|NCT03083847|Chloroquine|chloroquine|mesh-list
139240441|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139240442|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
139240443|NCT03083847|Amebicides|amebicides|mesh-ancestor
139240444|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139240445|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139240446|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240447|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
139240448|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139240449|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139240450|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139240451|NCT03083847|Analgesics|analgesics|mesh-ancestor
139240452|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
139240453|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240454|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090029|NCT01180322|Cytarabine|cytarabine|mesh-list
139240455|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139240456|NCT03083847|Filaricides|filaricides|mesh-ancestor
139240457|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
139240458|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
139240459|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139240460|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240461|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240462|NCT03082677|Ixazomib|ixazomib|mesh-list
139240463|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240464|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
139240465|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240466|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240467|NCT03136055|Paclitaxel|paclitaxel|mesh-list
139240468|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
139240469|NCT03136055|Irinotecan|irinotecan|mesh-list
139240470|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139240471|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240472|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
139240473|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
139240474|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
139240475|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240476|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139240477|NCT03136055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139240478|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139240479|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139240480|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240481|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
139240482|NCT03221309|Narcotics|narcotics|mesh-ancestor
139240483|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139240484|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240485|NCT03221309|Analgesics|analgesics|mesh-ancestor
139240486|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
139240487|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240489|NCT03426657|Tremelimumab|tremelimumab|mesh-list
139240490|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139240491|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240492|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
139240493|NCT02858180|Ledipasvir|ledipasvir|mesh-list
139240494|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
139240495|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240496|NCT03609086|Melatonin|melatonin|mesh-list
139240497|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
139240498|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240499|NCT03609086|Protective Agents|protective agents|mesh-ancestor
139240500|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240501|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139240502|NCT00730717|Adalimumab|adalimumab|mesh-list
139240503|NCT00730717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139240504|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139240505|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139240506|NCT01332409|Fluticasone|fluticasone|mesh-list
139240507|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139240508|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139240509|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139240510|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139240511|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
139240512|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240513|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240514|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139240515|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
139240516|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
139240517|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139240518|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139240519|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139240520|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139240521|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
139240522|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240523|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240524|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
139240525|NCT01332409|Hormones|hormones|mesh-ancestor
139240526|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139240527|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
139240528|NCT03181451|Ferric maltol|ferric maltol|mesh-list
139240529|NCT03181451|Hematinics|hematinics|mesh-ancestor
139240530|NCT03495973|Ustekinumab|ustekinumab|mesh-list
139240531|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
139240532|NCT00480805|Losartan|losartan|mesh-list
139240533|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139240534|NCT00480805|Ramipril|ramipril|mesh-list
139240535|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139240536|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139240537|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139240538|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139240539|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240540|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240541|NCT00480805|Diuretics|diuretics|mesh-ancestor
139240542|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
139240543|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139240544|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139090559|NCT06125054|Ketamine|ketamine|mesh-list
139240545|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139240546|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
139240547|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240548|NCT00406783|Desloratadine|desloratadine|mesh-list
139240549|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139240550|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
139090650|NCT06047379|Paclitaxel|paclitaxel|mesh-list
139240551|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240552|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240553|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240554|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139240555|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139240556|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
139240557|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
139240558|NCT03179891|Diazepam|diazepam|mesh-list
139240559|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139090690|NCT06023862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139090691|NCT06023862|Dostarlimab|dostarlimab|mesh-list
139090692|NCT06023862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139240560|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
139240561|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
139240562|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
139240563|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240564|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240565|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139240566|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139240567|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139240568|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139240569|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139240570|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139240571|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139240572|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139240573|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139240574|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
139240575|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
139240576|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
139240577|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
139240578|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240579|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240580|NCT01334671|Atorvastatin|atorvastatin|mesh-list
139240581|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139240582|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139240583|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
139240584|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240585|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139240586|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139240587|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240588|NCT01332565|Dolutegravir|dolutegravir|mesh-list
139240589|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139240590|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139240591|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240592|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240593|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139240594|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139240595|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
139240596|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240597|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139240598|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139240599|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240600|NCT02736227|Everolimus|everolimus|mesh-list
139240601|NCT02736227|Tacrolimus|tacrolimus|mesh-list
139240602|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139240603|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
139240604|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240605|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139240606|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240607|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240608|NCT02736227|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139240609|NCT02736227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139240610|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240611|NCT01334905|Mirabegron|mirabegron|mesh-list
139240612|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139240613|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139240614|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139240615|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
139240616|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240617|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240618|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240619|NCT01334905|Urological Agents|urological agents|mesh-ancestor
139240620|NCT01335139|Immunomodulating Agents|immunomodulating agents|mesh-list
139240621|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
139240622|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240623|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
139240624|NCT05030129|Pyridoxal|pyridoxal|mesh-list
139240625|NCT05030129|Pyridoxine|pyridoxine|mesh-list
139240626|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
139240627|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
139240628|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
139240629|NCT05030129|Vitamins|vitamins|mesh-ancestor
139240630|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
139240631|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240632|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
139240633|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139240634|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
139240635|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139240636|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139240637|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139240638|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
139240639|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091061|NCT05582811|Riociguat|riociguat|mesh-list
139240640|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240641|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
139240642|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
139240643|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
139240644|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
139240645|NCT01339039|Plerixafor|plerixafor|mesh-list
139240646|NCT01339039|Bevacizumab|bevacizumab|mesh-list
139240647|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139240648|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240649|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139240650|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139240651|NCT01339039|Growth Substances|growth substances|mesh-ancestor
139240652|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240653|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
139240654|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139240655|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139240656|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
139240657|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240658|NCT03176459|Bupivacaine|bupivacaine|mesh-list
139240659|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
139240660|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
139240661|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139240662|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240663|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
139240664|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240665|NCT01332955|Ribavirin|ribavirin|mesh-list
139240666|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139240667|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
139240668|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240669|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
139240670|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240671|NCT05224895|Anesthetics|anesthetics|mesh-list
139240672|NCT05224895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139240673|NCT05224895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240674|NCT01335373|Metronidazole|metronidazole|mesh-list
139240675|NCT01335373|Miconazole|miconazole|mesh-list
139240676|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240677|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139240678|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139240679|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139240680|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
139240681|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139240682|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139240683|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240684|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240685|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139240686|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
139091251|NCT05073237|Hormones|hormones|mesh-ancestor
139240687|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139240688|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240689|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139240690|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139240691|NCT01333267|Hormones|hormones|mesh-list
139240692|NCT01333267|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
139240693|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
139240694|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
139240695|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
139240696|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
139240697|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139197302|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
139240698|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240699|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139240700|NCT01333267|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
139240702|NCT01335529|Ribavirin|ribavirin|mesh-list
139240703|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
139240704|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
139240705|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139240706|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240707|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
139240708|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240709|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
139240710|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240711|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
139240712|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240713|NCT00308347|Losartan|losartan|mesh-list
139240714|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139240715|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139240716|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139240717|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139240718|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240719|NCT02186834|Dexamethasone|dexamethasone|mesh-list
139240720|NCT02186834|Doxorubicin|doxorubicin|mesh-list
139240721|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139240722|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139240723|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
139240724|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
139240725|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240726|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240727|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139240728|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
139240729|NCT02186834|Hormones|hormones|mesh-ancestor
139240730|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139240731|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139240732|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240733|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139240734|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139240735|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139240736|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240737|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240738|NCT04335890|Vaccines|vaccines|mesh-list
139240739|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
139240740|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240741|NCT01379157|Imipenem|imipenem|mesh-list
139240742|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139240743|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240744|NCT01538966|Octreotide|octreotide|mesh-list
139240745|NCT01538966|Lanreotide|lanreotide|mesh-list
139240746|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139240747|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139240748|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240749|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
139240750|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139240751|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139240752|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240753|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240754|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139240755|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139240756|NCT01377285|Protective Agents|protective agents|mesh-ancestor
139240757|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240758|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
139240759|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139240760|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
139240761|NCT02905266|Nivolumab|nivolumab|mesh-list
139240762|NCT02905266|Ipilimumab|ipilimumab|mesh-list
139240763|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139240764|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303916|NCT02732912|Zopiclone|zopiclone|mesh-list
139240765|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139240766|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240767|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
139240768|NCT01380717|Calcium|calcium|mesh-list
139240769|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139240770|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139240771|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139240772|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240773|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139240774|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
139240775|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240776|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240777|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
139240778|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240779|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139240780|NCT03080493|Acetaminophen|acetaminophen|mesh-list
139240781|NCT03080493|Ibuprofen|ibuprofen|mesh-list
139240782|NCT03080493|Gabapentin|gabapentin|mesh-list
139240783|NCT03080493|Codeine|codeine|mesh-list
139240784|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139240785|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139240786|NCT03080493|Analgesics|analgesics|mesh-ancestor
139240787|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
139240788|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240789|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240790|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
139240791|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139240792|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139240793|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139240794|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139240795|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240796|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240797|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
139240798|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139240799|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139240800|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139240801|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139240802|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139240803|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139240804|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240805|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
139240806|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139240807|NCT03080493|Narcotics|narcotics|mesh-ancestor
139240808|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
139240809|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
139304229|NCT03422510|CXA-10|cxa-10|mesh-list
139240810|NCT03080493|Laxatives|laxatives|mesh-ancestor
139240811|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139240812|NCT01339910|Vidarabine|vidarabine|mesh-list
139240813|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
139240814|NCT01339910|Melphalan|melphalan|mesh-list
139240815|NCT01339910|Busulfan|busulfan|mesh-list
139240816|NCT01339910|Fludarabine|fludarabine|mesh-list
139240817|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
139240818|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139240819|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
139240820|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240821|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139240822|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139240823|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
139240824|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240825|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240826|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139240827|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139240828|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
139240829|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
139240830|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240831|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
139240832|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139240833|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
139240834|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240835|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240836|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139240837|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
139240838|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139110972|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139240839|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
139240840|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240841|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240842|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139240843|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
139240844|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
139240845|NCT03655392|Protective Agents|protective agents|mesh-ancestor
139240846|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
139240847|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139240848|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
139240849|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240850|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139240851|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139240852|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
139240853|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240854|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240855|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139240856|NCT04203290|Bupivacaine|bupivacaine|mesh-list
139240857|NCT04203290|Sevoflurane|sevoflurane|mesh-list
139240858|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
139240859|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
139240860|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139240861|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240862|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
139240863|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240864|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139240865|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139240866|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
139240867|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139240868|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
139240869|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139240870|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
139240871|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240872|NCT03654612|Apatinib|apatinib|mesh-list
139240873|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240874|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139240875|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240876|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240877|NCT01066104|Omalizumab|omalizumab|mesh-list
139240878|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139240879|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139304401|NCT03128216|Ropivacaine|ropivacaine|mesh-list
139240880|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139240881|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
139240882|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
139240883|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240884|NCT02736968|Auranofin|auranofin|mesh-list
139240885|NCT02736968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139240886|NCT03608306|Methamphetamine|methamphetamine|mesh-list
139240887|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139240888|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240889|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
139240890|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
139240891|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240892|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
139240893|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139240894|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240895|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
139240896|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139240897|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139240898|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139240899|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139240900|NCT03654144|Dienogest|dienogest|mesh-list
139240901|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
139240902|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
139240903|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139240904|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139240905|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240906|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139240907|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139240908|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139240909|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139240910|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
139642235|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240911|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139240912|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139240913|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240914|NCT02591615|Paclitaxel|paclitaxel|mesh-list
139240915|NCT02591615|Carboplatin|carboplatin|mesh-list
139240916|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
139240917|NCT02591615|Pemetrexed|pemetrexed|mesh-list
139240918|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139240919|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240920|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
139240921|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
139240922|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
139197534|NCT03636555|Oxytocin|oxytocin|mesh-list
139240923|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240924|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139240925|NCT02591615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139240926|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240927|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139240928|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139240929|NCT03077607|Itraconazole|itraconazole|mesh-list
139240930|NCT03077607|Rifampin|rifampin|mesh-list
139240931|NCT03077607|Talazoparib|talazoparib|mesh-list
139240932|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
139240933|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139240934|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139240935|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139240936|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240937|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240938|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139240939|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
139240940|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139240941|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240942|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139240943|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139240944|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
139240945|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139240946|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
139240947|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139240948|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139240949|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139240950|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139240951|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139240952|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139240953|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139240954|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139240955|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240956|NCT04215588|Hemostatics|hemostatics|mesh-list
139240957|NCT04215588|Coagulants|coagulants|mesh-ancestor
139240958|NCT01377051|Maleic acid|maleic acid|mesh-list
139240959|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240960|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240961|NCT03217175|Glucagon|glucagon|mesh-list
139240962|NCT03217175|Pancrelipase|pancrelipase|mesh-list
139240963|NCT03217175|Pancreatin|pancreatin|mesh-list
139240964|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240965|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139240966|NCT03217175|Hormones|hormones|mesh-ancestor
139240967|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139240968|NCT01379079|Aspirin|aspirin|mesh-list
139240969|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
139240970|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
139240971|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
139240972|NCT01379079|Calcium|calcium|mesh-list
139240973|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139240974|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139240975|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139240976|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139240977|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139240978|NCT01379079|Analgesics|analgesics|mesh-ancestor
139240979|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
139240980|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139240981|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139240982|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139240983|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139240984|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139240985|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240986|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139240987|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139240988|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240989|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
139240990|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
139240991|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139240992|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139240993|NCT01379001|Scopolamine|scopolamine|mesh-list
139240994|NCT01379001|Donepezil|donepezil|mesh-list
139240995|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139240996|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139240997|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139240998|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139240999|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
139241000|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241001|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241002|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
139241003|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139241004|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
139241005|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
139241006|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241007|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139241008|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
139304992|NCT00345618|Biotin|biotin|mesh-list
139241009|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139241010|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139241011|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
139241012|NCT03172325|Folic Acid|folic acid|mesh-list
139241013|NCT03172325|Prednisolone|prednisolone|mesh-list
139241014|NCT03172325|Adalimumab|adalimumab|mesh-list
139241015|NCT03172325|Methotrexate|methotrexate|mesh-list
139241016|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139241017|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
139241018|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139305118|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139241019|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241020|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139241021|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
139241022|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241023|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241024|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
139241025|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241026|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139241027|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139241028|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
139241029|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139241030|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139241031|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139241032|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
139241033|NCT03172325|Hormones|hormones|mesh-ancestor
139241034|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139241035|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139241036|NCT03172325|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139241037|NCT03172325|Hematinics|hematinics|mesh-ancestor
139241038|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
139241039|NCT03172325|Vitamins|vitamins|mesh-ancestor
139241040|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
139241041|NCT03653520|Diazepam|diazepam|mesh-list
139241042|NCT03653520|Tramadol|tramadol|mesh-list
139241043|NCT03653520|Ondansetron|ondansetron|mesh-list
139241044|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
139241045|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
139241046|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241047|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241048|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139241049|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
139241050|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
139241051|NCT03653520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139241052|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139241053|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
139241054|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241055|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305470|NCT03556917|Caffeine|caffeine|mesh-list
139241056|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139241057|NCT03653520|Narcotics|narcotics|mesh-ancestor
139241058|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139241059|NCT03653520|Analgesics|analgesics|mesh-ancestor
139111207|NCT01152372|Insulin|insulin|mesh-list
139305527|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139241060|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
139241061|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139241062|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
139241063|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139241064|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139241065|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139241066|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139241067|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139241068|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139241069|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139241070|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
139197686|NCT04503850|Mirabegron|mirabegron|mesh-list
139241071|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
139241072|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
139241073|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
139241074|NCT01208090|Ponesimod|ponesimod|mesh-list
139241075|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139241076|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241077|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139241078|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
139241079|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241080|NCT01380483|Doxycycline|doxycycline|mesh-list
139241081|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139241082|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139241083|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
139241084|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139241085|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139241086|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
139241087|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139241088|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139241089|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
139241090|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241091|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241092|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241093|NCT01378845|Bosentan|bosentan|mesh-list
139241094|NCT01378845|Alprostadil|alprostadil|mesh-list
139241095|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139241096|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139241097|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241098|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139241099|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
139241100|NCT01378845|Urological Agents|urological agents|mesh-ancestor
139241101|NCT04884399|Ranibizumab|ranibizumab|mesh-list
139241102|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139241103|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139241104|NCT04884399|Growth Substances|growth substances|mesh-ancestor
139241105|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241106|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
139241107|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241108|NCT04904549|Vaccines|vaccines|mesh-list
139241109|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
139241110|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241111|NCT03607916|Morphine|morphine|mesh-list
139241112|NCT03607916|Prilocaine|prilocaine|mesh-list
139241113|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139241114|NCT03607916|Narcotics|narcotics|mesh-ancestor
139241115|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139241116|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241117|NCT03607916|Analgesics|analgesics|mesh-ancestor
139241118|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
139241119|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241120|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
139241121|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
139241122|NCT01141712|Cytarabine|cytarabine|mesh-list
139241123|NCT01141712|Etoposide|etoposide|mesh-list
139241124|NCT01141712|Melphalan|melphalan|mesh-list
139241125|NCT01141712|Carmustine|carmustine|mesh-list
139241126|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139241127|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241128|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139241129|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139241130|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241131|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241132|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139241133|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
139241134|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
139642236|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139241135|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139241136|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139241137|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
139241138|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241139|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139241140|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
139241141|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139241142|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
139241143|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139241144|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
139241145|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091672|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139241146|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
139241147|NCT02034890|Protective Agents|protective agents|mesh-ancestor
139241148|NCT02015351|Bevacizumab|bevacizumab|mesh-list
139241149|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139241150|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241151|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139241152|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139241153|NCT02015351|Growth Substances|growth substances|mesh-ancestor
139241154|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241155|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
139241156|NCT03604796|Acetaminophen|acetaminophen|mesh-list
139306197|NCT05035745|Talazoparib|talazoparib|mesh-list
139241157|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139241158|NCT03604796|Analgesics|analgesics|mesh-ancestor
139241159|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
139241160|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241161|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241162|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
139241163|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
139241165|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139241166|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241167|NCT02237534|Antacids|antacids|mesh-ancestor
139241168|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241169|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139241170|NCT03606902|Fentanyl|fentanyl|mesh-list
139241171|NCT03606902|Bupivacaine|bupivacaine|mesh-list
139241172|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
139241173|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
139241174|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139241175|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241176|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
139241177|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241178|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139241179|NCT03606902|Narcotics|narcotics|mesh-ancestor
139241180|NCT03606902|Analgesics|analgesics|mesh-ancestor
139241181|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139241182|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139241183|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
139241184|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
139241185|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139241186|NCT03606824|Pitavastatin|pitavastatin|mesh-list
139241187|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139241188|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139241189|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139241190|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
139241191|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241192|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241193|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139241194|NCT03604016|Tenofovir|tenofovir|mesh-list
139241195|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
139241196|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139241197|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139241198|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139241199|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241200|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241201|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139241202|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139241203|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
139241204|NCT01064622|Gemcitabine|gemcitabine|mesh-list
139241205|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139241206|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
139241207|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241208|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241209|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139241210|NCT01063764|Levetiracetam|levetiracetam|mesh-list
139241211|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
139241212|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
139241214|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241215|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139241216|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241217|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241218|NCT01380249|Bromides|bromides|mesh-list
139241219|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
139241220|NCT04054518|Durvalumab|durvalumab|mesh-list
139241221|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139241222|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241223|NCT03652896|Liver Extracts|liver extracts|mesh-list
139241224|NCT03652896|Hematinics|hematinics|mesh-ancestor
139241225|NCT04565847|Albuterol|albuterol|mesh-list
139241226|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139241227|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
139241228|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241229|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241230|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139241231|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
139241232|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
139241233|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139241234|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139241235|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139241236|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139241237|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
139241238|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241239|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241240|NCT03075891|Doxycycline|doxycycline|mesh-list
139241242|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139241243|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139241244|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
139241245|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139241246|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139241247|NCT02013167|Blinatumomab|blinatumomab|mesh-list
139241248|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241249|NCT01378533|Paclitaxel|paclitaxel|mesh-list
139241250|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
139241251|NCT01378533|Carboplatin|carboplatin|mesh-list
139241252|NCT01378533|Epirubicin|epirubicin|mesh-list
139241253|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139241254|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241255|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
139241256|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
139241257|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
139307064|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241258|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241259|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139241260|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
139241261|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241262|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139241263|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139241264|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
139241265|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139241266|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139307200|NCT02095665|Acetaminophen|acetaminophen|mesh-list
139241267|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139241268|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139241269|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241270|NCT02630199|Paclitaxel|paclitaxel|mesh-list
139241271|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139241272|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241273|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
139241274|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
139241275|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
139241276|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241277|NCT02588781|Pemetrexed|pemetrexed|mesh-list
139241278|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241279|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241280|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241281|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139241282|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139241283|NCT01063062|Methotrexate|methotrexate|mesh-list
139241284|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139241285|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
139241286|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139241287|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241288|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139241290|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307338|NCT04337060|Analgesics|analgesics|mesh-ancestor
139241291|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241292|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
139241293|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241294|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139241295|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139241296|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
139241297|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139241298|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139241299|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
139241300|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
139241301|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
139241302|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139241303|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139241304|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
139241305|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
139241306|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241307|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241308|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241309|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139241310|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
139241311|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139241312|NCT04483115|Tadalafil|tadalafil|mesh-list
139241313|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
139241314|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139241315|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139241316|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241317|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241318|NCT04483115|Urological Agents|urological agents|mesh-ancestor
139241319|NCT04054362|Paclitaxel|paclitaxel|mesh-list
139241320|NCT04054362|Gemcitabine|gemcitabine|mesh-list
139307593|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139241321|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139241322|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139241323|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241324|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
139241325|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
139241326|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
139241327|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241328|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139241329|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
139241330|NCT04467281|Daratumumab|daratumumab|mesh-list
139241331|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241332|NCT01378143|Pentamidine|pentamidine|mesh-list
139241333|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
139241334|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139241335|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139241336|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139241337|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139241338|NCT02973048|Bupivacaine|bupivacaine|mesh-list
139241339|NCT02973048|Prilocaine|prilocaine|mesh-list
139241340|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
139241341|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
139241342|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139241343|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241344|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
139241345|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241346|NCT04054206|Ibudilast|ibudilast|mesh-list
139241347|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139241348|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
139241349|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241350|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241351|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139241352|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
139241353|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139241354|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241355|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241356|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139241357|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
139241358|NCT03603938|Losartan|losartan|mesh-list
139241359|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139241360|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139241361|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139241362|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139307848|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139241363|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241364|NCT03652116|Meperidine|meperidine|mesh-list
139241365|NCT03652116|Bupivacaine|bupivacaine|mesh-list
139241366|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
139241367|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
139241368|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139241369|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241370|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
139241371|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241372|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139241373|NCT03652116|Narcotics|narcotics|mesh-ancestor
139241374|NCT03652116|Analgesics|analgesics|mesh-ancestor
139241375|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139241376|NCT02232087|Fluticasone|fluticasone|mesh-list
139241377|NCT02232087|Xhance|xhance|mesh-list
139241378|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139241379|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139241380|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139241381|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139241382|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
139241383|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241384|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241385|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139241386|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
139241387|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
139241388|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139241389|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139241390|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139241391|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139241392|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
139241393|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241394|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241395|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
139241396|NCT02232087|Hormones|hormones|mesh-ancestor
139241397|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139241398|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
139241399|NCT01380015|Rosmarinic acid|rosmarinic acid|mesh-list
139241400|NCT01380015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139241401|NCT01380015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139241402|NCT01380015|Analgesics|analgesics|mesh-ancestor
139241403|NCT01380015|Sensory System Agents|sensory system agents|mesh-ancestor
139241404|NCT01380015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241405|NCT01380015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241406|NCT01380015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139241407|NCT01380015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139241408|NCT01380015|Antioxidants|antioxidants|mesh-ancestor
139241409|NCT01380015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241410|NCT01380015|Protective Agents|protective agents|mesh-ancestor
139241411|NCT01380015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139241412|NCT01380015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139241413|NCT01380015|Protease Inhibitors|protease inhibitors|mesh-ancestor
139241414|NCT01380015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241415|NCT03603626|Pregabalin|pregabalin|mesh-list
139241416|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241417|NCT03603626|Analgesics|analgesics|mesh-ancestor
139241418|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
139241419|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241420|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
139241421|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139241422|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139241423|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241424|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139241425|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139241426|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139241427|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139241428|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139241429|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
139241430|NCT02972502|Promethazine|promethazine|mesh-list
139241431|NCT02972502|Haloperidol|haloperidol|mesh-list
139241432|NCT02972502|Metoclopramide|metoclopramide|mesh-list
139241433|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
139241434|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139241435|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139241436|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139241437|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241438|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
139241439|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
139241440|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
139241441|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241442|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
139241443|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
139241444|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139241445|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139241446|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
139241447|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
139241448|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241449|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241450|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139241451|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
139241452|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
139241453|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139241454|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139241455|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139241456|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139241457|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
139241458|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139241459|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139241461|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241462|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139241463|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241464|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241465|NCT03163667|Everolimus|everolimus|mesh-list
139241466|NCT03163667|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139241467|NCT03163667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139241468|NCT03163667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241469|NCT03163667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241470|NCT03163667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139241471|NCT03163667|Immunologic Factors|immunologic factors|mesh-ancestor
139241472|NCT03163667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241473|NCT03163667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241474|NCT03603548|Tacrolimus|tacrolimus|mesh-list
139241475|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139241476|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
139241477|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241478|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139241479|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241480|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241481|NCT03954782|Nintedanib|nintedanib|mesh-list
139241482|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241483|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139241484|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241485|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241486|NCT03651726|Palmidrol|palmidrol|mesh-list
139241487|NCT03651726|Dronabinol|dronabinol|mesh-list
139241488|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
139241489|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241490|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139241491|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139241492|NCT03651726|Analgesics|analgesics|mesh-ancestor
139241493|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
139241494|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308644|NCT00325650|Rimonabant|rimonabant|mesh-list
139241495|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139241496|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139241497|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241498|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241499|NCT03651726|Hormones|hormones|mesh-ancestor
139241500|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139241501|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139241502|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139241503|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139241504|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
139241505|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139241506|NCT00107250|Paclitaxel|paclitaxel|mesh-list
139241507|NCT00107250|Carboplatin|carboplatin|mesh-list
139241508|NCT00107250|Capecitabine|capecitabine|mesh-list
139241509|NCT00107250|Cediranib|cediranib|mesh-list
139241510|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139241511|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241512|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
139241513|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
139241514|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
139241515|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308770|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
139241516|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139241517|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
139241518|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241519|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139241520|NCT03167411|Exenatide|exenatide|mesh-list
139241521|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
139241522|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139241523|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241524|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139091673|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
139241525|NCT03167411|Incretins|incretins|mesh-ancestor
139241526|NCT03167411|Hormones|hormones|mesh-ancestor
139241527|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139241528|NCT02237768|Dirithromycin|dirithromycin|mesh-list
139308963|NCT05458726|Paclitaxel|paclitaxel|mesh-list
139241529|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139241530|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139241531|NCT05461833|Octylonium|octylonium|mesh-list
139241532|NCT05461833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139241533|NCT05461833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139241534|NCT05461833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241535|NCT05461833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139241536|NCT05461833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241537|NCT05461833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139241538|NCT05461833|Parasympatholytics|parasympatholytics|mesh-ancestor
139241539|NCT05461833|Autonomic Agents|autonomic agents|mesh-ancestor
139309104|NCT00254904|Antimetabolites|antimetabolites|mesh-ancestor
139241540|NCT05461833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241541|NCT05461833|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139241542|NCT05461833|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139241543|NCT05461833|Cholinergic Agents|cholinergic agents|mesh-ancestor
139241544|NCT05461833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241545|NCT01560585|Isotretinoin|isotretinoin|mesh-list
139241546|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
139241547|NCT01376427|Dexamethasone|dexamethasone|mesh-list
139241548|NCT01376427|Methotrexate|methotrexate|mesh-list
139241549|NCT01376427|Vincristine|vincristine|mesh-list
139241550|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139241551|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
139241552|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
139241553|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241554|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241555|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139241556|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
139241557|NCT01376427|Hormones|hormones|mesh-ancestor
139241558|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139241559|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139241560|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241561|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139241562|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
139241563|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139241564|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139241565|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
139241566|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241567|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
139241568|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241569|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139241570|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139241571|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
139241572|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139241573|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139241574|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139241575|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
139241576|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
139241577|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
139241578|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139241579|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241580|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139241581|NCT05462535|Losartan|losartan|mesh-list
139241582|NCT05462535|Amlodipine|amlodipine|mesh-list
139241583|NCT05462535|Chlorthalidone|chlorthalidone|mesh-list
139241584|NCT05462535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139241585|NCT05462535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139241586|NCT05462535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139241587|NCT05462535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241588|NCT05462535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139241589|NCT05462535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241590|NCT05462535|Vasodilator Agents|vasodilator agents|mesh-ancestor
139241591|NCT05462535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139241592|NCT05462535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139241593|NCT05462535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139241594|NCT05462535|Diuretics|diuretics|mesh-ancestor
139241595|NCT05462535|Natriuretic Agents|natriuretic agents|mesh-ancestor
139309648|NCT03008382|Metoprolol|metoprolol|mesh-list
139241596|NCT05462535|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139241597|NCT05764317|Amlodipine|amlodipine|mesh-list
139241598|NCT05764317|Perindopril|perindopril|mesh-list
139241599|NCT05764317|Atorvastatin|atorvastatin|mesh-list
139241600|NCT05764317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139241601|NCT05764317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139241602|NCT05764317|Antimetabolites|antimetabolites|mesh-ancestor
139241603|NCT05764317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241604|NCT05764317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139241605|NCT05764317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139241606|NCT05764317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241607|NCT05764317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139241608|NCT05764317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139241609|NCT05764317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139241610|NCT05764317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139241611|NCT05764317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241612|NCT05764317|Vasodilator Agents|vasodilator agents|mesh-ancestor
139241613|NCT05764317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139241614|NCT05764317|Protease Inhibitors|protease inhibitors|mesh-ancestor
139241615|NCT05461365|Insulin|insulin|mesh-list
139241616|NCT05461365|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139241617|NCT05461365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139241618|NCT05461365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241619|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139241620|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241621|NCT02317991|Paclitaxel|paclitaxel|mesh-list
139241622|NCT02317991|Ramucirumab|ramucirumab|mesh-list
139241623|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139241624|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241625|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
139241626|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
139241627|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
139241628|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241629|NCT03602690|Ritonavir|ritonavir|mesh-list
139241630|NCT03602690|Darunavir|darunavir|mesh-list
139241631|NCT03602690|Dolutegravir|dolutegravir|mesh-list
139241632|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139241633|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139241634|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
139241635|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241636|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241637|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139241638|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139241639|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
139241640|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139241641|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139241642|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139241643|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139241644|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139241645|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139241646|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139241647|NCT02978495|Paclitaxel|paclitaxel|mesh-list
139241648|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
139241649|NCT02978495|Carboplatin|carboplatin|mesh-list
139241650|NCT02978495|Doxorubicin|doxorubicin|mesh-list
139241651|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139241652|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241653|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
139241654|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
139241655|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
139241656|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241657|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139241658|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
139241659|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241660|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139241661|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139241662|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
139241663|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139241664|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139241665|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139241666|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139241667|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241668|NCT02237690|Doxorubicin|doxorubicin|mesh-list
139241669|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139241670|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139241671|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241672|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139241673|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139241674|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198280|NCT01293149|Ropivacaine|ropivacaine|mesh-list
139309791|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
139241675|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241676|NCT04788017|Ziresovir|ziresovir|mesh-list
139241677|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
139241678|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139241679|NCT03600974|Domperidone|domperidone|mesh-list
139241680|NCT03600974|Citalopram|citalopram|mesh-list
139241681|NCT03600974|Esomeprazole|esomeprazole|mesh-list
139241682|NCT03600974|Omeprazole|omeprazole|mesh-list
139241683|NCT03600974|Rabeprazole|rabeprazole|mesh-list
139241684|NCT03600974|Pantoprazole|pantoprazole|mesh-list
139241685|NCT03600974|Lansoprazole|lansoprazole|mesh-list
139241686|NCT03600974|Mosapride|mosapride|mesh-list
139241687|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
139241688|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139310156|NCT02260947|Ibuprofen|ibuprofen|mesh-list
139241689|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139241690|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139241691|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241692|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241693|NCT03600974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139241694|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139310375|NCT05537584|Dopamine Agents|dopamine agents|mesh-ancestor
139241695|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139241696|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
139241697|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241698|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139241699|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
139241700|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139241701|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
139241702|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241703|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
139241704|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139241705|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
139241706|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139241707|NCT03075267|Budesonide|budesonide|mesh-list
139241708|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
139241709|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
139241710|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139241711|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139241712|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
139241713|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241714|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241715|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139241716|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
139241717|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
139241718|NCT03075267|Hormones|hormones|mesh-ancestor
139241719|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139241720|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139310865|NCT04680988|Paclitaxel|paclitaxel|mesh-list
139241721|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139241722|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139241723|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
139310942|NCT00446186|Montelukast|montelukast|mesh-list
139241724|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241725|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241726|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139241727|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139241728|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139241729|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
139241730|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
139241731|NCT03600506|Sympatholytics|sympatholytics|mesh-list
139241732|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139311162|NCT03387644|Pregabalin|pregabalin|mesh-list
139311219|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311292|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241733|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311368|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139241734|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241735|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139241736|NCT03600506|Analgesics|analgesics|mesh-ancestor
139311519|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
139241737|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
139241738|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241739|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139241740|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139241741|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138968538|NCT00787826|Vaccines|vaccines|mesh-list
139241742|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
139241743|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311811|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139241744|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241745|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
139241746|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
139241747|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139241748|NCT03074331|Velpatasvir|velpatasvir|mesh-list
139241749|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
139198356|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241750|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139241751|NCT02237924|Endostar protein|endostar protein|mesh-list
139241752|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139312180|NCT03374306|Atropine|atropine|mesh-list
139241753|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139241754|NCT02237924|Growth Substances|growth substances|mesh-ancestor
139241755|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241756|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
139241757|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241758|NCT03825302|Mannitol|mannitol|mesh-list
139241759|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
139241760|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139241761|NCT03825302|Diuretics|diuretics|mesh-ancestor
139241762|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
139241763|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241764|NCT03825302|Miotics|miotics|mesh-ancestor
139241765|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
139241766|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312764|NCT03375632|Dotinurad|dotinurad|mesh-list
139241767|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139241768|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139241769|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
139241770|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139241771|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139241772|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
139241773|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241774|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241775|NCT02238392|Adenosine|adenosine|mesh-list
139241776|NCT02238392|Analgesics|analgesics|mesh-ancestor
139241777|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
139241778|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241779|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241780|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139241781|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
139241782|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139241783|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
139241784|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
139241785|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241786|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313423|NCT05347654|Coccidiostats|coccidiostats|mesh-ancestor
139241787|NCT02260193|Glycine|glycine|mesh-list
139241788|NCT02260193|Glycine Agents|glycine agents|mesh-ancestor
139241789|NCT02260193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241790|NCT02260193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313497|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
139241791|NCT02260193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241792|NCT02849678|Lidocaine|lidocaine|mesh-list
139241793|NCT02849678|Ropivacaine|ropivacaine|mesh-list
139241794|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
139241795|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
139241796|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139241797|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313869|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
139241798|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
139241799|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241800|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139241801|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139241802|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139241803|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139241804|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241805|NCT04295577|Niraparib|niraparib|mesh-list
139241806|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139241807|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241808|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241809|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241810|NCT02238158|Ipratropium|ipratropium|mesh-list
139111945|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
139241811|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139241812|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
139241813|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241814|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241815|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139241816|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
139314165|NCT04506242|Apatinib|apatinib|mesh-list
139241817|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139241818|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
139241819|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241820|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241821|NCT02238314|Ritonavir|ritonavir|mesh-list
139241822|NCT02238314|Tipranavir|tipranavir|mesh-list
139241823|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139241824|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139241825|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139241826|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
139241827|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241828|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241829|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139241830|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139241831|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
139241832|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139241833|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139241834|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139241835|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139241836|NCT02238470|Warfarin|warfarin|mesh-list
139241837|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
139241838|NCT02238470|Dabigatran|dabigatran|mesh-list
139241839|NCT02238470|Apixaban|apixaban|mesh-list
139241840|NCT02238470|Anticoagulants|anticoagulants|mesh-list
139241841|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139241842|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
139314751|NCT03346538|Edaravone|edaravone|mesh-list
139241843|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139241844|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
139314816|NCT05512546|Aspirin|aspirin|mesh-list
139241845|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314888|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314964|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
139241846|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241847|NCT03586934|Acetaminophen|acetaminophen|mesh-list
139241848|NCT03586934|Celecoxib|celecoxib|mesh-list
139241849|NCT03586934|Ketorolac|ketorolac|mesh-list
139241850|NCT03586934|Meloxicam|meloxicam|mesh-list
139241851|NCT03586934|Morphine|morphine|mesh-list
139241852|NCT03586934|Oxycodone|oxycodone|mesh-list
139241853|NCT03586934|Tramadol|tramadol|mesh-list
139241854|NCT03586934|Hydrocodone|hydrocodone|mesh-list
139241855|NCT03586934|Ropivacaine|ropivacaine|mesh-list
139241856|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139241857|NCT03586934|Narcotics|narcotics|mesh-ancestor
139241858|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139241859|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241860|NCT03586934|Analgesics|analgesics|mesh-ancestor
139241861|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
139241862|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241863|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
139241864|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
139315556|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241865|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139241866|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
139241867|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139241868|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139241869|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139315777|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139241870|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139241871|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139241872|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315931|NCT02256033|Istradefylline|istradefylline|mesh-list
139241873|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241874|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
139241875|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
139241876|NCT03586154|Ketamine|ketamine|mesh-list
139241877|NCT03586154|Bupivacaine|bupivacaine|mesh-list
139241878|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
139241879|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
139316143|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
139241880|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139241881|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241882|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
139241883|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241884|NCT03586154|Analgesics|analgesics|mesh-ancestor
139241885|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139241886|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139642237|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139112014|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139241887|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
139241888|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139241889|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139241890|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241891|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241892|NCT03629847|Everolimus|everolimus|mesh-list
139241893|NCT03629847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139241894|NCT03629847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139241895|NCT03629847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316273|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
139316346|NCT03338426|Atorvastatin|atorvastatin|mesh-list
139241896|NCT03629847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241897|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139241898|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
139316509|NCT03332888|Rituximab|rituximab|mesh-list
139241899|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241900|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241901|NCT01314833|Paclitaxel|paclitaxel|mesh-list
139241902|NCT01314833|Docetaxel|docetaxel|mesh-list
139241903|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
139241904|NCT01314833|Fluorouracil|fluorouracil|mesh-list
139241905|NCT01314833|Epirubicin|epirubicin|mesh-list
139241906|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139241907|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241908|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
139316718|NCT03537807|Riluzole|riluzole|mesh-list
139241909|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
139241910|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
139241911|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241912|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139241913|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
139241914|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241915|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139241916|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139241917|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
139241918|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139241919|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
139241920|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139241921|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139241922|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139241923|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139241924|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139241925|NCT03579836|Gemcitabine|gemcitabine|mesh-list
139241926|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139241927|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
139241928|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241929|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241930|NCT02737826|Buprenorphine|buprenorphine|mesh-list
139241931|NCT02737826|Gabapentin|gabapentin|mesh-list
139241932|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139241933|NCT02737826|Narcotics|narcotics|mesh-ancestor
139241934|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139241935|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241936|NCT02737826|Analgesics|analgesics|mesh-ancestor
139241937|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
139241938|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241939|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139317459|NCT05946902|Mirabegron|mirabegron|mesh-list
139241940|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
139241941|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139241942|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139241943|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139241944|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139241945|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139241946|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241947|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241948|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
139241949|NCT03367715|Nivolumab|nivolumab|mesh-list
139241950|NCT03367715|Ipilimumab|ipilimumab|mesh-list
139241951|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317801|NCT04979377|Insulin|insulin|mesh-list
139241952|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139241953|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139241954|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241955|NCT04064931|Niacin|niacin|mesh-list
139241956|NCT04064931|Vitamins|vitamins|mesh-ancestor
139317947|NCT04641871|Irinotecan|irinotecan|mesh-list
139241957|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
139241958|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241959|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139241960|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
139642238|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
139318158|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
139241961|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241962|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139241963|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
139241964|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
139241965|NCT03577652|Ticagrelor|ticagrelor|mesh-list
139241966|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139241967|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139241968|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139241969|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139241970|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
139241971|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241972|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318532|NCT01495637|Sargramostim|sargramostim|mesh-list
139241973|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241974|NCT03620513|Lidocaine|lidocaine|mesh-list
139241975|NCT03620513|Phenylephrine|phenylephrine|mesh-list
139241976|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
139318674|NCT03326102|Paclitaxel|paclitaxel|mesh-list
139241977|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
139241978|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
139241980|NCT03620513|Anesthetics|anesthetics|mesh-list
139241981|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
139241982|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139318752|NCT02186145|Metronidazole|metronidazole|mesh-list
139241983|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139241984|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
139241985|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139241986|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139241987|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139241988|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139241989|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139241990|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139241991|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139241992|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139241993|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
139241994|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139241995|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
139241996|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
139241997|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139241998|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
139241999|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139242000|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
139318954|NCT02183415|Incretins|incretins|mesh-ancestor
139242001|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139242002|NCT03620513|Protective Agents|protective agents|mesh-ancestor
139242003|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139242004|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139242005|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139242006|NCT03585062|Paclitaxel|paclitaxel|mesh-list
139242007|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139319093|NCT03321110|Vitamins|vitamins|mesh-ancestor
139242008|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242009|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
139242010|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
139242011|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
139319237|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139242012|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242013|NCT03584360|Calcitriol|calcitriol|mesh-list
139242014|NCT03584360|Betamethasone|betamethasone|mesh-list
139242015|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
139319388|NCT00706004|Lubiprostone|lubiprostone|mesh-list
139242016|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139242017|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
139242018|NCT03584360|Calcipotriene|calcipotriene|mesh-list
139242019|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139242020|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139242021|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
139242022|NCT03584360|Hormones|hormones|mesh-ancestor
139242023|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242024|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242025|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139242026|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
139242027|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
139242028|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139242029|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139242030|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139242031|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242032|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139242033|NCT03584360|Vitamins|vitamins|mesh-ancestor
139242034|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
139319756|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
139242035|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139242037|NCT03579758|Capecitabine|capecitabine|mesh-list
139242038|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242039|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139242040|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
139242041|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242042|NCT03577574|Anesthetics|anesthetics|mesh-list
139242043|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139242044|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242045|NCT01330901|Ustekinumab|ustekinumab|mesh-list
139242046|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
139242047|NCT02428647|Zinc|zinc|mesh-list
139242048|NCT02428647|Trace Elements|trace elements|mesh-ancestor
139242049|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
139198656|NCT05583214|Antiemetics|antiemetics|mesh-ancestor
139320031|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
139242050|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242051|NCT01071395|Amantadine|amantadine|mesh-list
139242052|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139242053|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139242054|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
139242055|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139242056|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
139242057|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242058|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242059|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242060|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139242061|NCT01071395|Analgesics|analgesics|mesh-ancestor
139242062|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
139242063|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242064|NCT03577496|Peppermint oil|peppermint oil|mesh-list
139242065|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
139242066|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
139242067|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320618|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139242068|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320706|NCT02192229|Vitamin D|vitamin d|mesh-list
139242069|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139242070|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
139242071|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
139242072|NCT03582878|Sirolimus|sirolimus|mesh-list
139242073|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139242074|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242075|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139242076|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
139242077|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139242078|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139242079|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242080|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242081|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
139242082|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139242083|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
139242084|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242085|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
139242086|NCT02238704|Iron|iron|mesh-list
139242087|NCT02238704|Folic Acid|folic acid|mesh-list
139242088|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
139242089|NCT02238704|Calcium|calcium|mesh-list
139242090|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139242091|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242092|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139242093|NCT02238704|Trace Elements|trace elements|mesh-ancestor
139242094|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
139242095|NCT02238704|Hematinics|hematinics|mesh-ancestor
139242096|NCT02238704|Vitamins|vitamins|mesh-ancestor
139242097|NCT01331135|Sirolimus|sirolimus|mesh-list
139242098|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139242099|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139242100|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139242101|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242102|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
139242103|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139242104|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
139242105|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242106|NCT03577184|Metformin|metformin|mesh-list
139242107|NCT03577184|Vildagliptin|vildagliptin|mesh-list
139242108|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139242109|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242110|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139242111|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
139242112|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242113|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242115|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
139242116|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139242117|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
139242118|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242119|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139242120|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139242121|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
139242122|NCT02238860|Tenofovir|tenofovir|mesh-list
139242123|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
139242124|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139242125|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139242126|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139242127|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242128|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242129|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139242130|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139242131|NCT01333709|Folfirinox|folfirinox|mesh-list
139242132|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242133|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
139242134|NCT04869137|Lenvatinib|lenvatinib|mesh-list
139242135|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139242136|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242137|NCT04869137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139242138|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242139|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139242140|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242141|NCT00493961|Hormones|hormones|mesh-list
139242142|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242143|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242144|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139242145|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139242146|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139242147|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139242148|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242149|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242150|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242151|NCT02903238|Analgesics|analgesics|mesh-ancestor
139242152|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
139242153|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242154|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
139242155|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139242156|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
139242157|NCT01329809|Molgramostim|molgramostim|mesh-list
139242158|NCT01329809|Sargramostim|sargramostim|mesh-list
139242159|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
139242160|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242161|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242162|NCT02847260|Treprostinil|treprostinil|mesh-list
139242163|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139242164|NCT01331447|Exemestane|exemestane|mesh-list
139242165|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242166|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139242167|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139242168|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242169|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242170|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139242171|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
139242172|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242173|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242174|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
139242175|NCT02968563|Idelalisib|idelalisib|mesh-list
139242176|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139242177|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242178|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242179|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242180|NCT01329887|Ketanserin|ketanserin|mesh-list
139242181|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139242182|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139242183|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139242184|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
139242185|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139112318|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
139242186|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242187|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242188|NCT01334099|Tremelimumab|tremelimumab|mesh-list
139242189|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242190|NCT01331525|Ipilimumab|ipilimumab|mesh-list
139320830|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
139242191|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139242192|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242193|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139242194|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242195|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139242196|NCT01334177|Cetuximab|cetuximab|mesh-list
139242197|NCT01334177|Antibodies|antibodies|mesh-list
139242198|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
139242199|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139242200|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
139242201|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242202|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242203|NCT05762523|Vaccines|vaccines|mesh-list
139242204|NCT05762523|Immunologic Factors|immunologic factors|mesh-ancestor
139242205|NCT05762523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242206|NCT02796261|Eflornithine|eflornithine|mesh-list
139242207|NCT02796261|Lomustine|lomustine|mesh-list
139242208|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139242209|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
139242210|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242211|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242212|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139242213|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139242214|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139242215|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139242216|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139242217|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242218|NCT02904096|Lidocaine|lidocaine|mesh-list
139242219|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
139242220|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
139242221|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139242222|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242223|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
139242224|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242225|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139242226|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139242227|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139242228|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139242229|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242230|NCT02586675|Tamoxifen|tamoxifen|mesh-list
139242231|NCT02586675|Goserelin|goserelin|mesh-list
139242232|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139242233|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
139242234|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242235|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242236|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139242237|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242238|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139242239|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139242240|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139242241|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
139242242|NCT03648528|Vitamin D|vitamin d|mesh-list
139242243|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139242244|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242245|NCT03648528|Vitamins|vitamins|mesh-ancestor
139242246|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
139242247|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139242248|NCT03161405|Itraconazole|itraconazole|mesh-list
139242249|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242250|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242251|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
139242252|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139242253|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139242254|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139242255|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139242256|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
139642239|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139642240|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
139242257|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242258|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242259|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139242260|NCT01813929|Metformin|metformin|mesh-list
139242261|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139242262|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242263|NCT01502085|Dexamethasone|dexamethasone|mesh-list
139242264|NCT01502085|Vorinostat|vorinostat|mesh-list
139242265|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139242266|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
139242267|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
139242268|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242269|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242270|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139242271|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
139242272|NCT01502085|Hormones|hormones|mesh-ancestor
139198877|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
139242273|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242274|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139242275|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242276|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139242277|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242278|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242279|NCT03648684|Caffeine|caffeine|mesh-list
139242280|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139242281|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242282|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139242283|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242284|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242285|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139242286|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139242287|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
139242288|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242289|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139242290|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139242291|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242292|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242293|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139242294|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139242295|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242296|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
139242297|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242298|NCT02901054|Ondansetron|ondansetron|mesh-list
139242299|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
139242300|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
139242301|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242302|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242303|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139242304|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
139242305|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
139242306|NCT02901054|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139242307|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139242308|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
139242309|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242310|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242311|NCT03647670|Midazolam|midazolam|mesh-list
139242312|NCT03647670|Abrocitinib|abrocitinib|mesh-list
139242313|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139242314|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139242315|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139242316|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242317|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139242318|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139242319|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139242320|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139242321|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
139242322|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
139242323|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
139242324|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
139242325|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242326|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242327|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139242328|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242329|NCT02966340|Prazosin|prazosin|mesh-list
139242330|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139242331|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139242332|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139242333|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139242334|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
139242335|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242336|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242337|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242338|NCT05284734|Anesthetics|anesthetics|mesh-list
139242339|NCT05284734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139242340|NCT05284734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242341|NCT03629379|Ustekinumab|ustekinumab|mesh-list
139242342|NCT03629379|Vedolizumab|vedolizumab|mesh-list
139242343|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
139242344|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139242345|NCT05055999|Atezolizumab|atezolizumab|mesh-list
139242346|NCT05055999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139242347|NCT05055999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242348|NCT05055999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139242349|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242350|NCT05205837|Letrozole|letrozole|mesh-list
139242351|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242352|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139242353|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139242354|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242355|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242356|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139242357|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
139242358|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242359|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242360|NCT03578900|Citric Acid|citric acid|mesh-list
139242361|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
139242362|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
139242363|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139242364|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
139242365|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
139242366|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242367|NCT02550002|Aflibercept|aflibercept|mesh-list
139242368|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139242369|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139242370|NCT02550002|Growth Substances|growth substances|mesh-ancestor
139242371|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242372|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
139242373|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242374|NCT03574376|Bupivacaine|bupivacaine|mesh-list
139242375|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
139242376|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
139242377|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139242378|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242379|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
139242380|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242381|NCT03576794|Prednisolone|prednisolone|mesh-list
139242382|NCT03576794|Leflunomide|leflunomide|mesh-list
139242383|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139242384|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
139242385|NCT03576794|Hormones|hormones|mesh-ancestor
139242386|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242387|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242388|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139242389|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242390|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242391|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242392|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139242393|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
139242394|NCT03578822|Aspirin|aspirin|mesh-list
139242395|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139242396|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139242397|NCT03578822|Analgesics|analgesics|mesh-ancestor
139242398|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
139242399|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242400|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242401|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139242402|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139242403|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139242404|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139242405|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242406|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139242407|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139242408|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242409|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
139242410|NCT03576638|Levodopa|levodopa|mesh-list
139242411|NCT03576638|Carbidopa|carbidopa|mesh-list
139242412|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139242413|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139242414|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139242415|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
139242416|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242417|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242418|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242419|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139242420|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242421|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139199024|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139242422|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
139242423|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
139242424|NCT04284657|Citric Acid|citric acid|mesh-list
139242425|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
139242426|NCT04284657|Pravastatin|pravastatin|mesh-list
139242427|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
139242428|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139242429|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
139242430|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
139242431|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242432|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139242433|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139242434|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
139242435|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139242436|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139242437|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242438|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
139242439|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139242440|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242441|NCT03574220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139242442|NCT03574220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242443|NCT04876677|Beclomethasone|beclomethasone|mesh-list
139242444|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
139242445|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
139242446|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139242447|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
139242448|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242449|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242450|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139242451|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
139242452|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139242453|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139242454|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139242455|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
139242456|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242457|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242458|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139242459|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
139242460|NCT04876677|Hormones|hormones|mesh-ancestor
139242461|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242462|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139242463|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139242464|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139242465|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
139242466|NCT03578432|Everolimus|everolimus|mesh-list
139242467|NCT03578432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139242468|NCT03578432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139242469|NCT03578432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242470|NCT03578432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242471|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139242472|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
139242473|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242474|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242475|NCT03578354|Atenolol|atenolol|mesh-list
139242476|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
139242477|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139242478|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139242479|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
139242480|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
139242481|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242482|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242483|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139242484|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139242485|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139242486|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
139242487|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242488|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242489|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139242490|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139242491|NCT05204979|Misoprostol|misoprostol|mesh-list
139242492|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139242493|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
139242494|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139242495|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242497|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139242498|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
139242499|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139242500|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242501|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139242502|NCT02239952|Sunitinib|sunitinib|mesh-list
139242503|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242504|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139242505|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242506|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242507|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139242508|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139242509|NCT02239952|Growth Substances|growth substances|mesh-ancestor
139242510|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242511|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
139242512|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139242513|NCT03647280|Epirubicin|epirubicin|mesh-list
139242514|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242515|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242516|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139242517|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139242518|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139242519|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242520|NCT03578042|Losartan|losartan|mesh-list
139242521|NCT03578042|Amlodipine|amlodipine|mesh-list
139242522|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139242523|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139242524|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139242525|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139242526|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242527|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139242528|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242529|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
139242530|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139242531|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139242532|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139242533|NCT03578042|Diuretics|diuretics|mesh-ancestor
139242534|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
139242535|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139242536|NCT03646500|Remifentanil|remifentanil|mesh-list
139242537|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139242538|NCT03646500|Narcotics|narcotics|mesh-ancestor
139242539|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139242540|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242541|NCT03646500|Analgesics|analgesics|mesh-ancestor
139242542|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
139242543|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242544|NCT03574064|Glucagon|glucagon|mesh-list
139242545|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
139242546|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139242547|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139242548|NCT03574064|Hormones|hormones|mesh-ancestor
139242549|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242550|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242551|NCT03574064|Incretins|incretins|mesh-ancestor
139242552|NCT03573986|Bevacizumab|bevacizumab|mesh-list
139242553|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139242554|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242555|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139242556|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139242557|NCT03573986|Growth Substances|growth substances|mesh-ancestor
139242558|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242559|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
139242560|NCT03959592|Carotenoids|carotenoids|mesh-list
139242561|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
139242562|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242563|NCT03959592|Protective Agents|protective agents|mesh-ancestor
139242564|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242565|NCT04087395|Lidocaine|lidocaine|mesh-list
139242566|NCT04087395|Anesthetics|anesthetics|mesh-list
139242567|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
139242568|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139242569|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242570|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
139242571|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242572|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139242573|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139242574|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139242575|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139242576|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242577|NCT03573596|Dasatinib|dasatinib|mesh-list
139242578|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242579|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139242580|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242581|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242582|NCT03621618|Dobutamine|dobutamine|mesh-list
139242583|NCT03621618|Norepinephrine|norepinephrine|mesh-list
139242584|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139242585|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139242586|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
139242587|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242588|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242589|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242590|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
139242591|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
139242592|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242593|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139242594|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139242595|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139242596|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139242597|NCT03621618|Protective Agents|protective agents|mesh-ancestor
139242598|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
139242599|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139242600|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139242601|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
139242602|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139242603|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139242604|NCT01569945|Clomiphene|clomiphene|mesh-list
139242605|NCT01569945|Menotropins|menotropins|mesh-list
139242606|NCT01569945|Estradiol|estradiol|mesh-list
139242607|NCT01569945|Estrogens|estrogens|mesh-ancestor
139242608|NCT01569945|Hormones|hormones|mesh-ancestor
139242609|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242610|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242611|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139242612|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
139242613|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139242614|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139242615|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139242616|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139242617|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139242618|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
139242619|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139242620|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
139242621|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139242622|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139242623|NCT03645876|Capecitabine|capecitabine|mesh-list
139242624|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
139242625|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139242626|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
139112766|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139242627|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242628|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242629|NCT03646266|Bromides|bromides|mesh-list
139242630|NCT03646266|Rocuronium|rocuronium|mesh-list
139242631|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
139242632|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139242633|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139242634|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139242635|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242636|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242637|NCT04052178|Capsaicin|capsaicin|mesh-list
139242638|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
139242639|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
139242640|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
139242641|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242642|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242643|NCT03645642|Midodrine|midodrine|mesh-list
139242644|NCT03645642|Diuretics|diuretics|mesh-list
139242645|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
139242646|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242648|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
139242649|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242650|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139242651|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139242652|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139242653|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139242654|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
139242655|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242656|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242657|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139242658|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
139242659|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242660|NCT01345188|Ranolazine|ranolazine|mesh-list
139242661|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139242662|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139242663|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242664|NCT03852459|Ibuprofen|ibuprofen|mesh-list
139242665|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139242666|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139242667|NCT03852459|Analgesics|analgesics|mesh-ancestor
139242668|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
139242669|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242670|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242671|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139242672|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139242673|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139242674|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242675|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242676|NCT03580902|Buprenorphine|buprenorphine|mesh-list
139242677|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139242678|NCT03580902|Naloxone|naloxone|mesh-list
139242679|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139242680|NCT03580902|Narcotics|narcotics|mesh-ancestor
139242681|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139242682|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242683|NCT03580902|Analgesics|analgesics|mesh-ancestor
139242684|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
139242685|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242686|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139242687|NCT02896296|Buprenorphine|buprenorphine|mesh-list
139242688|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139242689|NCT02896296|Narcotics|narcotics|mesh-ancestor
139242690|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139242691|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242692|NCT02896296|Analgesics|analgesics|mesh-ancestor
139242693|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
139242694|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242695|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139242696|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
139242697|NCT03644706|Diuretics|diuretics|mesh-ancestor
139242698|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
139242699|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242700|NCT03644706|Expectorants|expectorants|mesh-ancestor
139642241|NCT03059316|Labetalol|labetalol|mesh-list
139642242|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
139112843|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139242701|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
139242702|NCT03740919|Insulin|insulin|mesh-list
139242703|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139242704|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
139242705|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
139242706|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139242707|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242708|NCT01335685|Prednisone|prednisone|mesh-list
139242709|NCT01335685|Melphalan|melphalan|mesh-list
139242710|NCT01335685|Ixazomib|ixazomib|mesh-list
139242711|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139242712|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
139242713|NCT01335685|Hormones|hormones|mesh-ancestor
139242714|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242715|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242716|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139242717|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242718|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139242719|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
139320994|NCT02205879|Pregabalin|pregabalin|mesh-list
139242720|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242721|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139242722|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139242723|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
139242724|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
139242725|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242726|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
139242727|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139242728|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242730|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139242731|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
139242732|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242733|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242734|NCT01339663|Aldesleukin|aldesleukin|mesh-list
139242735|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
139242736|NCT01339663|Interleukin-2|interleukin-2|mesh-list
139242737|NCT01339663|Vaccines|vaccines|mesh-list
139242738|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
139242739|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242740|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139242741|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139242742|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139242743|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
139242744|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242745|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242746|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139242747|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139242748|NCT01339663|Analgesics|analgesics|mesh-ancestor
139242749|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
139242750|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242751|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139242752|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139242753|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
139242754|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139242755|NCT00092599|Ezetimibe|ezetimibe|mesh-list
139242756|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139242757|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139242758|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
139242759|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242760|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139242761|NCT03737565|Tryptophan|tryptophan|mesh-list
139242762|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139242763|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
139242764|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139242765|NCT02889133|Iron|iron|mesh-list
139242766|NCT02889133|Dextrans|dextrans|mesh-list
139242767|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
139242768|NCT02889133|Trace Elements|trace elements|mesh-ancestor
139242769|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
139242770|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242771|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
139242772|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
139242773|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
139242774|NCT02889133|Hematinics|hematinics|mesh-ancestor
139242775|NCT01333423|Roscovitine|roscovitine|mesh-list
139242776|NCT01333423|Doxorubicin|doxorubicin|mesh-list
139242777|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139642243|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
139112916|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
139242778|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139242779|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242780|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139242781|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139242782|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242783|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242784|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
139242785|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139242786|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139242788|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139242789|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139242790|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139242791|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139242792|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139242793|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242794|NCT00092209|Diuretics|diuretics|mesh-ancestor
139242795|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
139199405|NCT02292758|Cetuximab|cetuximab|mesh-list
139242796|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242797|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139242798|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139242799|NCT01339741|Vitamin D|vitamin d|mesh-list
139242800|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
139242801|NCT01339741|Vitamins|vitamins|mesh-ancestor
139242802|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
139242803|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242804|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139242805|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139242806|NCT00003777|Fluorouracil|fluorouracil|mesh-list
139242807|NCT00003777|Amifostine|amifostine|mesh-list
139242808|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242809|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
139242810|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242811|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139242812|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139242813|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
139242814|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242815|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139242816|NCT00003777|Protective Agents|protective agents|mesh-ancestor
139242817|NCT01339819|Dabigatran|dabigatran|mesh-list
139242818|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
139242819|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
139242820|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139242821|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
139242822|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242823|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242824|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
139242825|NCT02963922|Liraglutide|liraglutide|mesh-list
139242826|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139242827|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242828|NCT02963922|Incretins|incretins|mesh-ancestor
139242829|NCT02963922|Hormones|hormones|mesh-ancestor
139242830|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242831|NCT00090181|Diclofenac|diclofenac|mesh-list
139242832|NCT00090181|Etoricoxib|etoricoxib|mesh-list
139242833|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139242834|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139242835|NCT00090181|Analgesics|analgesics|mesh-ancestor
139242836|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
139242837|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242838|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242839|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139242840|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139242841|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139242842|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242843|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242844|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139242845|NCT03619785|Acetaminophen|acetaminophen|mesh-list
139242846|NCT03619785|Ibuprofen|ibuprofen|mesh-list
139242847|NCT03619785|Ketorolac|ketorolac|mesh-list
139242848|NCT03619785|Fentanyl|fentanyl|mesh-list
139242849|NCT03619785|Ketamine|ketamine|mesh-list
139242850|NCT03619785|Morphine|morphine|mesh-list
139242851|NCT03619785|Gabapentin|gabapentin|mesh-list
139242852|NCT03619785|Hydromorphone|hydromorphone|mesh-list
139242853|NCT03619785|Hydrocodone|hydrocodone|mesh-list
139242854|NCT03619785|Bupivacaine|bupivacaine|mesh-list
139242855|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
139242856|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
139242857|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139242858|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242859|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
139242860|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242861|NCT03619785|Analgesics|analgesics|mesh-ancestor
139242862|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139242863|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139242864|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
139242865|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139242866|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139242867|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242868|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242869|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139242870|NCT03619785|Narcotics|narcotics|mesh-ancestor
139242871|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139242872|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139242873|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
139199474|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
139242874|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139242875|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139242876|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139242877|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139242878|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242879|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
139242880|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139242881|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139242882|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139242883|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
139242884|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
139242885|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
139242886|NCT02881567|Daclizumab|daclizumab|mesh-list
139242887|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139242888|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
139242889|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242890|NCT05184517|Cyclosporine|cyclosporine|mesh-list
139242891|NCT05184517|Cyclosporins|cyclosporins|mesh-list
139242892|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242893|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242894|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139242895|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
139242896|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242897|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
139242898|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139242899|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
139242900|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139242901|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139242902|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
139242903|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139242904|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139242905|NCT02962284|Prednisolone|prednisolone|mesh-list
139242906|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
139242907|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
139242908|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139242909|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
139242910|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139242911|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
139242912|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
139242913|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242914|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242915|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139242916|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
139242917|NCT02962284|Hormones|hormones|mesh-ancestor
139242918|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242919|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139242920|NCT02962284|Protective Agents|protective agents|mesh-ancestor
139242921|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139242922|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139242923|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139242924|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242925|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242926|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
139242927|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139242928|NCT03642600|Folic Acid|folic acid|mesh-list
139242929|NCT03642600|Inositol|inositol|mesh-list
139242930|NCT03642600|Liraglutide|liraglutide|mesh-list
139242931|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139242932|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242933|NCT03642600|Incretins|incretins|mesh-ancestor
139242934|NCT03642600|Hormones|hormones|mesh-ancestor
139242935|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139242936|NCT03642600|Hematinics|hematinics|mesh-ancestor
139242937|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
139242938|NCT03642600|Vitamins|vitamins|mesh-ancestor
139242939|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
139242940|NCT01069692|Ferric Compounds|ferric compounds|mesh-list
139242941|NCT01069692|Hematinics|hematinics|mesh-ancestor
139242942|NCT05183178|Ticagrelor|ticagrelor|mesh-list
139242943|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139242944|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139242945|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139242946|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139242947|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139242948|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
139242949|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242950|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242951|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242952|NCT03161093|Naproxen|naproxen|mesh-list
139242953|NCT03161093|Fasinumab|fasinumab|mesh-list
139242954|NCT03161093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139242955|NCT03161093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139242956|NCT03161093|Analgesics|analgesics|mesh-ancestor
139242957|NCT03161093|Sensory System Agents|sensory system agents|mesh-ancestor
139242958|NCT03161093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242959|NCT03161093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242960|NCT03161093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139242961|NCT03161093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139242962|NCT03161093|Gout Suppressants|gout suppressants|mesh-ancestor
139242963|NCT03161093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139242964|NCT03161093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242965|NCT03161093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242966|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
139242967|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139242968|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
139242969|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139242970|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242971|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139242972|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
139242973|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139242974|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
139242975|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242976|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242977|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139242978|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
139242979|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
139242980|NCT03573284|Protective Agents|protective agents|mesh-ancestor
139242981|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
139242982|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242983|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242984|NCT01334333|Tacrolimus|tacrolimus|mesh-list
139242985|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139242986|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
139242987|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242988|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139242989|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242990|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242991|NCT03573050|Rivastigmine|rivastigmine|mesh-list
139242992|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139242993|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139242994|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139242995|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
139242996|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139242997|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139242998|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139242999|NCT03573050|Protective Agents|protective agents|mesh-ancestor
139243000|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
139243001|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139243002|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139243003|NCT02847494|Dexamethasone|dexamethasone|mesh-list
139243004|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
139243005|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139243006|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139243008|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
139243009|NCT02847494|Metoclopramide|metoclopramide|mesh-list
139243010|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139243011|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
139243012|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139243013|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
139243014|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
139243015|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243016|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243017|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139243018|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
139243019|NCT02847494|Hormones|hormones|mesh-ancestor
139243020|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139243021|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139243022|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243023|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139243024|NCT02847494|Protective Agents|protective agents|mesh-ancestor
139243025|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139243026|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139243027|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
139243028|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139243029|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243030|NCT02554253|Ketamine|ketamine|mesh-list
139243031|NCT02554253|Propofol|propofol|mesh-list
139243032|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139243033|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139243034|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243035|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139243036|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
139243037|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
139243038|NCT02554253|Analgesics|analgesics|mesh-ancestor
139243039|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
139243040|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243041|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139243042|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139243043|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139243044|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139243045|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243046|NCT02239484|Tadalafil|tadalafil|mesh-list
139243047|NCT02239484|Tamsulosin|tamsulosin|mesh-list
139243048|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
139243049|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139243050|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139243051|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243052|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243053|NCT02239484|Urological Agents|urological agents|mesh-ancestor
139243054|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139243055|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139243056|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139243057|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
139243058|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139243059|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243060|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
139243061|NCT03575234|Nivolumab|nivolumab|mesh-list
139243062|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139243063|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
139243064|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243065|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139243066|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139243067|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
139243068|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243069|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243070|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139243071|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139243072|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139243073|NCT04508855|Heparin|heparin|mesh-list
139243074|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139243075|NCT04508855|Tinzaparin|tinzaparin|mesh-list
139243076|NCT04508855|Dalteparin|dalteparin|mesh-list
139243077|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
139243078|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139113217|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139243079|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139243080|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243081|NCT03575078|Olaparib|olaparib|mesh-list
139243082|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139243083|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243084|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243085|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243086|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
139243087|NCT03157583|Glycerol|glycerol|mesh-list
139243088|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139243089|NCT03157583|Protective Agents|protective agents|mesh-ancestor
139243090|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243091|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
139243092|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139243093|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
139243094|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139243095|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139243096|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243097|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
139243098|NCT03570710|Coagulants|coagulants|mesh-ancestor
139243099|NCT01337765|Dactolisib|dactolisib|mesh-list
139243100|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243101|NCT01307033|Losartan|losartan|mesh-list
139243102|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139243103|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139243104|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139243105|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139243106|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243107|NCT04475705|Propofol|propofol|mesh-list
139243108|NCT04475705|Sevoflurane|sevoflurane|mesh-list
139243109|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139243110|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139243111|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243112|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139243113|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
139243114|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
139243115|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139243116|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139243117|NCT03158311|Fluticasone|fluticasone|mesh-list
139243118|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
139243119|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139243120|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139243121|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139243122|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
139243123|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243124|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243125|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139243126|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
139243127|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
139243128|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139243129|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
139243130|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139243131|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
139243132|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139243133|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243134|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139243135|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139243136|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139243137|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
139243138|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139243139|NCT02244866|Hormones|hormones|mesh-ancestor
139243140|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139243141|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243142|NCT01334567|Tenofovir|tenofovir|mesh-list
139243143|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
139243144|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139243145|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139243146|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139243147|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243148|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243149|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139243150|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139642244|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139243151|NCT04398329|Bupivacaine|bupivacaine|mesh-list
139243152|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
139243153|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
139243154|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139243155|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243156|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
139243157|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243158|NCT00449111|Losartan|losartan|mesh-list
139243159|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139243160|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139243161|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139243162|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139243163|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243164|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
139243165|NCT03568916|Apixaban|apixaban|mesh-list
139243166|NCT03568916|Dabigatran|dabigatran|mesh-list
139243167|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139243168|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
139243169|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139243170|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
139243171|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243172|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243173|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
139243174|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
139243175|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
139243176|NCT01334645|Coagulants|coagulants|mesh-ancestor
139243177|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139243178|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139243179|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
139243180|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243181|NCT03571490|Ropivacaine|ropivacaine|mesh-list
139321109|NCT03203642|XL647|xl647|mesh-list
139243182|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
139243183|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
139243184|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139243185|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243186|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
139243187|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243188|NCT01331993|Naproxen|naproxen|mesh-list
139243189|NCT01331993|Esomeprazole|esomeprazole|mesh-list
139243190|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139243191|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139243192|NCT01331993|Analgesics|analgesics|mesh-ancestor
139243193|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
139243194|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243195|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243196|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139243197|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139243198|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
139243199|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139243200|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243201|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243202|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139243203|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139243204|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139243205|NCT01338077|Omeprazole|omeprazole|mesh-list
139243206|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139243207|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139243208|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139243209|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243210|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243211|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
139243212|NCT03570320|Narcotics|narcotics|mesh-ancestor
139243213|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139243214|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243215|NCT03570320|Analgesics|analgesics|mesh-ancestor
139243216|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
139243217|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243218|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
139243219|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139243220|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139243221|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243222|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139243223|NCT04266665|Analgesics|analgesics|mesh-ancestor
139243224|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
139243225|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243226|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139243227|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139243228|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139243229|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
139243230|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139243231|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243232|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
139243233|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139243234|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139243235|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139243236|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
139243237|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
139243238|NCT01338311|Albuterol|albuterol|mesh-list
139243239|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139243240|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
139243241|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243242|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243243|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139243244|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
139243245|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
139243246|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139243247|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139243248|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139243249|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139243250|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
139243251|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139243252|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243254|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139243255|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139243256|NCT01334879|Growth Substances|growth substances|mesh-ancestor
139243257|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243258|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
139243259|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243260|NCT01315795|Lanreotide|lanreotide|mesh-list
139243261|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243262|NCT03570164|Sevoflurane|sevoflurane|mesh-list
139243263|NCT03570164|Desflurane|desflurane|mesh-list
139243264|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139243265|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139243266|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
139243267|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
139243268|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139243269|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243270|NCT01315951|Petrolatum|petrolatum|mesh-list
139243271|NCT01315951|Emollients|emollients|mesh-ancestor
139243272|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
139243273|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
139243274|NCT05184049|Epalrestat|epalrestat|mesh-list
139243275|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
139243276|NCT05184049|Vitamins|vitamins|mesh-ancestor
139243277|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
139243278|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243279|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243280|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243281|NCT01336543|Cisplatin|cisplatin|mesh-list
139243282|NCT01336543|Gemcitabine|gemcitabine|mesh-list
139243283|NCT01336543|Etoposide|etoposide|mesh-list
139243284|NCT01336543|Pemetrexed|pemetrexed|mesh-list
139243285|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243286|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139243287|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
139243288|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243289|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139243290|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139243291|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139321188|NCT03482544|Analgesics|analgesics|mesh-ancestor
139243292|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243293|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139243294|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139243295|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139243296|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
139243297|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243298|NCT01336621|Ezogabine|ezogabine|mesh-list
139243299|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
139243300|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139243301|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243302|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
139243303|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
139243304|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139243305|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
139321270|NCT04542200|Antibodies|antibodies|mesh-list
139243306|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243307|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243308|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139243309|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
139243310|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139243311|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139243312|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139243313|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
139243314|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321320|NCT02723084|Ribavirin|ribavirin|mesh-list
139243315|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321381|NCT05783479|Estradiol|estradiol|mesh-list
139243316|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139243317|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
139243318|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139243319|NCT01340521|Clomiphene|clomiphene|mesh-list
139243320|NCT01340521|Enclomiphene|enclomiphene|mesh-list
139243321|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
139243322|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139243323|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
139243324|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139243325|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243326|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139243327|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
139243328|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139243329|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139243330|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139243331|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139243332|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
139243333|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243334|NCT01340599|Protective Agents|protective agents|mesh-ancestor
139243335|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243336|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139243337|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139243338|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243339|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139243340|NCT01335035|Deferasirox|deferasirox|mesh-list
139243341|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139243342|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
139243343|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
139243344|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243345|NCT01340677|Canagliflozin|canagliflozin|mesh-list
139243346|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139243347|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243348|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139243349|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243350|NCT05163535|Elsulfavirine|elsulfavirine|mesh-list
139243351|NCT05163535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139243352|NCT05163535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139243353|NCT05163535|Antiviral Agents|antiviral agents|mesh-ancestor
139243354|NCT05163535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139243355|NCT01340833|Dabrafenib|dabrafenib|mesh-list
139243356|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243357|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139243358|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243359|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243360|NCT01332383|Naratriptan|naratriptan|mesh-list
139243361|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139321873|NCT06094842|Fludarabine|fludarabine|mesh-list
139243362|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139243363|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139243364|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
139243365|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139243366|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243367|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243368|NCT01342237|Carboplatin|carboplatin|mesh-list
139243369|NCT01342237|Etoposide|etoposide|mesh-list
139243370|NCT01342237|Melphalan|melphalan|mesh-list
139243371|NCT01342237|Topotecan|topotecan|mesh-list
139243372|NCT01342237|Thiotepa|thiotepa|mesh-list
139243373|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243374|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139243375|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139243376|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139243377|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243378|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243379|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139243380|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
139243381|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139322157|NCT05810792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322158|NCT05796167|Pimavanserin|pimavanserin|mesh-list
139322159|NCT05796167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139322160|NCT05796167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139322161|NCT05796167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139322162|NCT05796167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139243382|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139243383|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
139243384|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243385|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139243387|NCT01337323|Xhance|xhance|mesh-list
139243388|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139243389|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139243390|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
139243391|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322366|NCT05423951|Rocuronium|rocuronium|mesh-list
139243392|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243393|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139243394|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
139243395|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
139243396|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139243397|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
139243398|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
139243399|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
139243400|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091674|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243401|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
139243402|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139243403|NCT04830943|Protective Agents|protective agents|mesh-ancestor
139243404|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243405|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
139243407|NCT03067610|Cisplatin|cisplatin|mesh-list
139243408|NCT03067610|Carboplatin|carboplatin|mesh-list
139243409|NCT03067610|Cetuximab|cetuximab|mesh-list
139243410|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139243411|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243412|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
139243413|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
139243414|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
138979414|NCT03440177|Ramipril|ramipril|mesh-list
139243415|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243416|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139243417|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
139243418|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
139243419|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139243420|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
139243421|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243422|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243423|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139243424|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
139243425|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139243426|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139243427|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139243428|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
139243429|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322711|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139243430|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243431|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139243432|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
139243433|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139243434|NCT05182957|Lenalidomide|lenalidomide|mesh-list
139243435|NCT05182957|Azacitidine|azacitidine|mesh-list
139243436|NCT05182957|Antibodies|antibodies|mesh-list
139243437|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
139243438|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139243439|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
139243440|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243441|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139243442|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139243443|NCT05182957|Growth Substances|growth substances|mesh-ancestor
139322924|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
139243444|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
139243445|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243446|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139243447|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
139323054|NCT04426591|Biotin|biotin|mesh-list
139243448|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243449|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243450|NCT00092651|Simvastatin|simvastatin|mesh-list
139243451|NCT00092651|Ezetimibe|ezetimibe|mesh-list
139243452|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
139243453|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139243454|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139243455|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
139243456|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243457|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139243458|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139243459|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243460|NCT04889599|Docetaxel|docetaxel|mesh-list
139243461|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243462|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
139243463|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
139243464|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
139243465|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243466|NCT01342627|Sorafenib|sorafenib|mesh-list
139243467|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243468|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139243469|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243470|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243471|NCT03160703|Fluorides|fluorides|mesh-list
139243472|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
139243473|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
139243474|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
139243475|NCT03160703|Protective Agents|protective agents|mesh-ancestor
139243476|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243478|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
139243479|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139243480|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139243481|NCT01332617|Prednisolone|prednisolone|mesh-list
139243482|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
139243483|NCT01332617|Diclofenac|diclofenac|mesh-list
139243484|NCT01332617|Bortezomib|bortezomib|mesh-list
139243485|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139243486|NCT01332617|Simvastatin|simvastatin|mesh-list
139323122|NCT04250064|Growth Substances|growth substances|mesh-ancestor
139243487|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139243488|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
139243489|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243490|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139243491|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
139243492|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
139243493|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243494|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243495|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139243496|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
139243497|NCT01332617|Hormones|hormones|mesh-ancestor
139243498|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139243499|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139243500|NCT01332617|Protective Agents|protective agents|mesh-ancestor
139243501|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139243502|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139243503|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139243504|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
139243505|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243506|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139243507|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139243508|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243509|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139243510|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139243511|NCT01332617|Analgesics|analgesics|mesh-ancestor
139243512|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
139243513|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139243514|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139243515|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139243516|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
139243517|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139243518|NCT03569696|Nivolumab|nivolumab|mesh-list
139323301|NCT03906669|Tamoxifen|tamoxifen|mesh-list
139243519|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139243520|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243521|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139243522|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243523|NCT00092573|Ezetimibe|ezetimibe|mesh-list
139243524|NCT00092573|Fenofibrate|fenofibrate|mesh-list
139243525|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139243526|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139243527|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
139243528|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243529|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139243530|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139243532|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139243533|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243534|NCT01342939|Hormones|hormones|mesh-ancestor
139243535|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139243536|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139243537|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
139243538|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243539|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243540|NCT03569540|Glyburide|glyburide|mesh-list
139243541|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139243542|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243543|NCT05708690|Tranexamic Acid|tranexamic acid|mesh-list
139243544|NCT05708690|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139243545|NCT05708690|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139323437|NCT03548454|Analgesics|analgesics|mesh-ancestor
139243546|NCT05708690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243547|NCT05708690|Hemostatics|hemostatics|mesh-ancestor
139243548|NCT05708690|Coagulants|coagulants|mesh-ancestor
139243549|NCT04851821|Quercetin|quercetin|mesh-list
139243550|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
139200148|NCT05216822|Racecadotril|racecadotril|mesh-list
139323517|NCT03199053|Hormones|hormones|mesh-ancestor
139243551|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243553|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243554|NCT03379727|Midostaurin|midostaurin|mesh-list
139243555|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243556|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139243557|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243558|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243559|NCT02247128|Aspirin|aspirin|mesh-list
139243560|NCT02247128|Clopidogrel|clopidogrel|mesh-list
139243561|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139243562|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139243563|NCT02247128|Analgesics|analgesics|mesh-ancestor
139243564|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
139243565|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243566|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243567|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139243568|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139243569|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139243570|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139243571|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243572|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139243573|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139243574|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243575|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
139243576|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139243577|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139243578|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139243579|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
139243580|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139243581|NCT01339481|Abatacept|abatacept|mesh-list
139243582|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139243583|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243584|NCT01339481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139243585|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243586|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139243587|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
139243588|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243589|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139243590|NCT01344031|Fulvestrant|fulvestrant|mesh-list
139243591|NCT01344031|Anastrozole|anastrozole|mesh-list
139243592|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139243593|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243594|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139243595|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139243596|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
139243597|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139243598|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243599|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139243600|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139243601|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243602|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243603|NCT01332929|Bevacizumab|bevacizumab|mesh-list
139243604|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139243605|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243606|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139243607|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139243608|NCT01332929|Growth Substances|growth substances|mesh-ancestor
139243609|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243610|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
139243611|NCT02247986|Methylphenidate|methylphenidate|mesh-list
139323808|NCT01397552|Hormones|hormones|mesh-ancestor
139243612|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139243613|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243614|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139243615|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139243616|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139243617|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243618|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
139243619|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139243621|NCT05708534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139243622|NCT05708534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243623|NCT05708534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139243624|NCT05708534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243625|NCT05708534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139243626|NCT05708534|Immunologic Factors|immunologic factors|mesh-ancestor
139243627|NCT05708534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243628|NCT05708534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139243629|NCT03000374|Leucovorin|leucovorin|mesh-list
139243630|NCT03000374|Fluorouracil|fluorouracil|mesh-list
139243631|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
139243632|NCT03000374|Panitumumab|panitumumab|mesh-list
139243633|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
139243634|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243635|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139243636|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243637|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139243638|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
139243639|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243640|NCT03000374|Antidotes|antidotes|mesh-ancestor
139243641|NCT03000374|Protective Agents|protective agents|mesh-ancestor
139243642|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
139243643|NCT03000374|Vitamins|vitamins|mesh-ancestor
139243644|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
139243645|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139243646|NCT03566576|Docetaxel|docetaxel|mesh-list
139243647|NCT03566576|Pemetrexed|pemetrexed|mesh-list
139243648|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243649|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
139243650|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
139243651|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
139243652|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243653|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243654|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139324071|NCT04311424|Hormones|hormones|mesh-ancestor
139243655|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139243656|NCT04377997|Heparin|heparin|mesh-list
139243657|NCT04377997|Calcium heparin|calcium heparin|mesh-list
139243658|NCT04377997|Enoxaparin|enoxaparin|mesh-list
139243659|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139243660|NCT04377997|Tinzaparin|tinzaparin|mesh-list
139243661|NCT04377997|Dalteparin|dalteparin|mesh-list
139243662|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
139243663|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139243664|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139243665|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243666|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
139243667|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139243668|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243669|NCT04758949|Nivolumab|nivolumab|mesh-list
139243670|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139243671|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243672|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139243673|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243674|NCT03566030|Tenofovir|tenofovir|mesh-list
139243675|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
139243676|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139243677|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139243678|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139243679|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243680|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243681|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139243682|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139243683|NCT01333085|Paclitaxel|paclitaxel|mesh-list
139243684|NCT01333085|Carboplatin|carboplatin|mesh-list
139243685|NCT01333085|Everolimus|everolimus|mesh-list
139243686|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139243687|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243688|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
139243689|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324345|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
139243690|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324401|NCT01802749|Gemcitabine|gemcitabine|mesh-list
139243691|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243692|NCT01333085|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139243693|NCT01333085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139243694|NCT01333085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243695|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139243696|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
139243697|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243698|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139243699|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139243700|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
139243701|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243702|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243703|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139243704|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
139243705|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139243706|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139243707|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139243708|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
139243709|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139243710|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243712|NCT03565406|Ipilimumab|ipilimumab|mesh-list
139243713|NCT03565406|Mocetinostat|mocetinostat|mesh-list
139243714|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139243715|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243716|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139243717|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243718|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139243719|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243720|NCT04734379|Fasudil|fasudil|mesh-list
139243721|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139243722|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139243723|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243724|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139243725|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243726|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
139243727|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139243728|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243729|NCT01339871|Vorinostat|vorinostat|mesh-list
139243730|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243731|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139243732|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243733|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243734|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
139243735|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139243736|NCT03564704|Cytarabine|cytarabine|mesh-list
139243737|NCT03564704|Dexamethasone|dexamethasone|mesh-list
139243738|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
139243739|NCT03564704|Methotrexate|methotrexate|mesh-list
139243740|NCT03564704|Etoposide|etoposide|mesh-list
139243741|NCT03564704|Vincristine|vincristine|mesh-list
139243742|NCT03564704|Doxorubicin|doxorubicin|mesh-list
139324904|NCT00735657|Iodine|iodine|mesh-list
139243743|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
139243744|NCT03564704|Idarubicin|idarubicin|mesh-list
139243745|NCT03564704|Pegaspargase|pegaspargase|mesh-list
139243746|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139243747|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
139324953|NCT03313856|Antacids|antacids|mesh-ancestor
139243748|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243749|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139243750|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139243751|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
139243752|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243753|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243755|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139243756|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
139243757|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
139243758|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243759|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139243760|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
139243761|NCT03564704|Hormones|hormones|mesh-ancestor
139243762|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139243763|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139243764|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139243765|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
139325230|NCT02736474|Naltrexone|naltrexone|mesh-list
139243766|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139243767|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139243768|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
139243769|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
139243770|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243771|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139243772|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139200375|NCT03818945|Listerine|listerine|mesh-list
139243773|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139243775|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139243776|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
139325300|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
139243777|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139243778|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
139243779|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
139325367|NCT01337115|Ropivacaine|ropivacaine|mesh-list
139243780|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
139243781|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139243782|NCT03564548|Morphine|morphine|mesh-list
139243783|NCT03564548|Oxycodone|oxycodone|mesh-list
139243784|NCT03564548|Hydromorphone|hydromorphone|mesh-list
139243785|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139243786|NCT03564548|Narcotics|narcotics|mesh-ancestor
139243787|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139243788|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243789|NCT03564548|Analgesics|analgesics|mesh-ancestor
139243790|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
139243791|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243792|NCT05353010|Tacrolimus|tacrolimus|mesh-list
139243793|NCT05353010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139243794|NCT05353010|Immunologic Factors|immunologic factors|mesh-ancestor
139243795|NCT05353010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243796|NCT05353010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139243797|NCT05353010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243798|NCT05353010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243799|NCT05352854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139243800|NCT05352854|Pilocarpine|pilocarpine|mesh-list
139243801|NCT05352854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139243802|NCT05352854|Miotics|miotics|mesh-ancestor
139243803|NCT05352854|Autonomic Agents|autonomic agents|mesh-ancestor
139243804|NCT05352854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243805|NCT05352854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243806|NCT05352854|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139243807|NCT05352854|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139243808|NCT05352854|Cholinergic Agents|cholinergic agents|mesh-ancestor
139243809|NCT05352854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139243810|NCT05352854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243811|NCT01841177|Milrinone|milrinone|mesh-list
139243812|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139243813|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139243814|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
139243815|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139243816|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139243817|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243818|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325559|NCT02723006|Nivolumab|nivolumab|mesh-list
139243819|NCT01841177|Protective Agents|protective agents|mesh-ancestor
139243820|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243821|NCT02838134|Rocuronium|rocuronium|mesh-list
139243822|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139243823|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139243824|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139243825|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243826|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243827|NCT03150589|Ranibizumab|ranibizumab|mesh-list
139243828|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139243829|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139243830|NCT03150589|Growth Substances|growth substances|mesh-ancestor
139243831|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243832|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
139243833|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243834|NCT05708300|Vaccines|vaccines|mesh-list
139243835|NCT05708300|Immunologic Factors|immunologic factors|mesh-ancestor
139243836|NCT05708300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243837|NCT05340452|Clarithromycin|clarithromycin|mesh-list
139243838|NCT05340452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139243839|NCT05340452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139243840|NCT05340452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139243841|NCT05340452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243842|NCT05340452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243843|NCT05340452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139243844|NCT05340452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139243845|NCT03145207|Lidocaine|lidocaine|mesh-list
139243846|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
139243847|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
139243848|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139243849|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325686|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139243850|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
139243851|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243852|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139243853|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139243854|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139243855|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139243856|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243858|NCT02836652|Warfarin|warfarin|mesh-list
139243859|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139243860|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139243861|NCT02836652|Analgesics|analgesics|mesh-ancestor
139243862|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
139243863|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243864|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243865|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139243866|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139243867|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139243868|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139243869|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243870|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139243871|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139243872|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243873|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
139243874|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
139243875|NCT02836496|Prednisone|prednisone|mesh-list
139243876|NCT02836496|Prednisolone|prednisolone|mesh-list
139243877|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139243878|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
139243879|NCT02836496|Hormones|hormones|mesh-ancestor
139325939|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
139243880|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139243881|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326011|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
139243882|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139243883|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243884|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
139243885|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139243886|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243887|NCT05250661|Propolis|propolis|mesh-list
139243888|NCT05250661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139243889|NCT04044781|BPN14770|bpn14770|mesh-list
139243890|NCT04044781|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139243891|NCT04044781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139243892|NCT04044781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243893|NCT04044781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243894|NCT01345279|Paclitaxel|paclitaxel|mesh-list
139243895|NCT01345279|Topotecan|topotecan|mesh-list
139243896|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139243897|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243898|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
139243899|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
139243900|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
139243901|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114045|NCT03182166|Golimumab|golimumab|mesh-list
139243902|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139243903|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139243904|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243905|NCT02833844|Evolocumab|evolocumab|mesh-list
139243906|NCT02833844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139243907|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139326357|NCT01493505|Paclitaxel|paclitaxel|mesh-list
139243908|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139243909|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
139243910|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243911|NCT02833844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139243912|NCT02833844|Protease Inhibitors|protease inhibitors|mesh-ancestor
139243913|NCT02833844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243914|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139243915|NCT01345357|Gemcitabine|gemcitabine|mesh-list
139243916|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243917|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139243918|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
139326427|NCT01280565|Dacarbazine|dacarbazine|mesh-list
139243919|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243920|NCT01333631|Valproic Acid|valproic acid|mesh-list
139243921|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
139243923|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243924|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
139243925|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326490|NCT01265901|Growth Substances|growth substances|mesh-ancestor
139243926|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243927|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
139243928|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139243929|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139243930|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139243931|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
139243932|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
139243933|NCT04611763|Analgesics|analgesics|mesh-ancestor
139326561|NCT00909597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139326562|NCT00909597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139326563|NCT00909597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326564|NCT00909597|Incretins|incretins|mesh-ancestor
139326565|NCT00909597|Hormones|hormones|mesh-ancestor
139326566|NCT00909597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139326567|NCT01077297|Tezosentan|tezosentan|mesh-list
139326568|NCT01077297|Vasodilator Agents|vasodilator agents|mesh-ancestor
139326569|NCT05653245|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
139326570|NCT05653245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326571|NCT05379855|Atropine|atropine|mesh-list
139326572|NCT05379855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139326577|NCT05379855|Autonomic Agents|autonomic agents|mesh-ancestor
139243934|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
139243935|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243936|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243937|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139243938|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139243939|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139243940|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139243941|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139243942|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243943|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243944|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
139243945|NCT01341782|Calcitriol|calcitriol|mesh-list
139243946|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
139243947|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139243948|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243949|NCT01341782|Vitamins|vitamins|mesh-ancestor
139243950|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
139243951|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139243952|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243953|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
139243954|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139243955|NCT01341782|Protective Agents|protective agents|mesh-ancestor
139243956|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139243957|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139243958|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243959|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139243960|NCT02250157|Irinotecan|irinotecan|mesh-list
139243961|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139243962|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139243963|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139243964|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243965|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243966|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
139243967|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139243968|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
139243969|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243970|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
139243971|NCT03564158|Meropenem|meropenem|mesh-list
139243972|NCT03564158|Vaborbactam|vaborbactam|mesh-list
139243973|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139243974|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139243975|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139243976|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139642245|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139243977|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326750|NCT05084508|Vaccines|vaccines|mesh-list
139243978|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243979|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243980|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139243981|NCT02677298|Botulinum Toxins|botulinum toxins|mesh-list
139326813|NCT01007097|Glimepiride|glimepiride|mesh-list
139243982|NCT02677298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139243983|NCT02677298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139243984|NCT02677298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139243985|NCT02677298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139243986|NCT02677298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139243987|NCT02677298|Cholinergic Agents|cholinergic agents|mesh-ancestor
139243988|NCT02677298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139243989|NCT02677298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243990|NCT02677298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139243991|NCT02677298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243992|NCT01345981|Lidocaine|lidocaine|mesh-list
139243993|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
139243994|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
139243995|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139326950|NCT00788541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139243996|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139243997|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
139243998|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139243999|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139244000|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139244001|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139244002|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139244003|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244004|NCT00871351|Atorvastatin|atorvastatin|mesh-list
139244005|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139244007|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139244008|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139244009|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
139244010|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244011|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139244012|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139244013|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244014|NCT04920331|Erenumab|erenumab|mesh-list
139244015|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139244016|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244017|NCT04920331|Analgesics|analgesics|mesh-ancestor
139244018|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
139244019|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244020|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244021|NCT02745080|Adalimumab|adalimumab|mesh-list
139244022|NCT02745080|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139244023|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244024|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139244025|NCT01346137|Meloxicam|meloxicam|mesh-list
139244026|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139244027|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139244028|NCT01346137|Analgesics|analgesics|mesh-ancestor
139244029|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
139244030|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244031|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244032|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244033|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139244034|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139244035|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139244036|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244037|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244038|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
139244039|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244040|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
139244041|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139244042|NCT00442897|Atorvastatin|atorvastatin|mesh-list
139244043|NCT00442897|Simvastatin|simvastatin|mesh-list
139244044|NCT00442897|Ezetimibe|ezetimibe|mesh-list
139244045|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139327575|NCT01963208|GABA Agents|gaba agents|mesh-ancestor
139244046|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139244047|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
139244048|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244049|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139642246|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
139244050|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139244051|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244052|NCT01346215|Heparin|heparin|mesh-list
139244053|NCT01346215|Calcium heparin|calcium heparin|mesh-list
139244054|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
139244055|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139244056|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139244057|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244058|NCT02834390|Cytarabine|cytarabine|mesh-list
139244059|NCT02834390|Daunorubicin|daunorubicin|mesh-list
139244060|NCT02834390|Idarubicin|idarubicin|mesh-list
139244061|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139244062|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
139244063|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244064|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244065|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
139244066|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244067|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139244068|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
139091675|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139244069|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244070|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139244071|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139244072|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139244073|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244075|NCT01317433|Cetuximab|cetuximab|mesh-list
139244076|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139244077|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244078|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139244079|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244080|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
139244081|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139244082|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139244083|NCT01317511|Caseins|caseins|mesh-list
139244084|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
139244085|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
139244086|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244087|NCT01356602|Triamcinolone|triamcinolone|mesh-list
139244088|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139244089|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139244090|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139244091|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139244092|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244093|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
139244094|NCT01356602|Hormones|hormones|mesh-ancestor
139244095|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139244096|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244097|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139244098|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
139244099|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244100|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244101|NCT01347853|Ketorolac|ketorolac|mesh-list
139244102|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139244103|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139244104|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139244105|NCT01347853|Analgesics|analgesics|mesh-ancestor
139244106|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
139244107|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244108|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244109|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328110|NCT02461004|Ezetimibe|ezetimibe|mesh-list
139244110|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139244111|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139244112|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244113|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244114|NCT01346917|Lidocaine|lidocaine|mesh-list
139244115|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
139244116|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
139328250|NCT03282110|Citalopram|citalopram|mesh-list
139244117|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139244118|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244119|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
139244120|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244121|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139244122|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139244123|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139244124|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139244125|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244126|NCT01348009|Cisplatin|cisplatin|mesh-list
139244127|NCT01348009|Capecitabine|capecitabine|mesh-list
139244128|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244129|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139244130|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
139244131|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244132|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
139328528|NCT00734253|Vitamins|vitamins|mesh-ancestor
139244133|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244134|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139244135|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244136|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244137|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
139244138|NCT01348243|Lidocaine|lidocaine|mesh-list
139244139|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
139244140|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
139244141|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139244142|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244143|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
139244144|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244145|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139244146|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139244147|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139244148|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139244149|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244150|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139244152|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139244153|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
139244154|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244155|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
139244156|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
139244157|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139244158|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329045|NCT00624351|Epratuzumab|epratuzumab|mesh-list
139244159|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139244160|NCT03772951|Clozapine|clozapine|mesh-list
139244161|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139244162|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
139244163|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244164|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244165|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244166|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139244167|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139244168|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139244169|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139244170|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
139244171|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
139244172|NCT01343329|Propranolol|propranolol|mesh-list
139244173|NCT01343329|Esmolol|esmolol|mesh-list
139244174|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139244175|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139244176|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
139244177|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244178|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244179|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244180|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139244181|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139244182|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
139244183|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139244184|NCT01317589|Fentanyl|fentanyl|mesh-list
139244185|NCT01317589|Methadone|methadone|mesh-list
139244186|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139244187|NCT01317589|Narcotics|narcotics|mesh-ancestor
139244188|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139244189|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244190|NCT01317589|Analgesics|analgesics|mesh-ancestor
139244191|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
139244192|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244193|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139244194|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139244195|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
139244196|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
139244197|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
139244198|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
139244199|NCT02825420|Trabectedin|trabectedin|mesh-list
139244200|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139244201|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
139244202|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244203|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244204|NCT02829944|Ketorolac|ketorolac|mesh-list
139244205|NCT02829944|Ropivacaine|ropivacaine|mesh-list
139244206|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
139244207|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
139329234|NCT00677079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244208|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139244209|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244210|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
139244211|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244212|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139244213|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139244214|NCT02829944|Analgesics|analgesics|mesh-ancestor
139244215|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244216|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139244217|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139244218|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244219|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244220|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
139244221|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139244222|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244223|NCT04014530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139244224|NCT04014530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244225|NCT03563534|Fluorides|fluorides|mesh-list
139244226|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
139244227|NCT03563534|Protective Agents|protective agents|mesh-ancestor
139244228|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244229|NCT03563144|Leucovorin|leucovorin|mesh-list
139244230|NCT03563144|Paclitaxel|paclitaxel|mesh-list
139244231|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
139244232|NCT03563144|Bevacizumab|bevacizumab|mesh-list
139244233|NCT03563144|Gemcitabine|gemcitabine|mesh-list
139244234|NCT03563144|Capecitabine|capecitabine|mesh-list
139244235|NCT03563144|Fluorouracil|fluorouracil|mesh-list
139244236|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
139244237|NCT03563144|Avelumab|avelumab|mesh-list
139329622|NCT04947059|Gemcitabine|gemcitabine|mesh-list
139244238|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139244239|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244240|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
139244241|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
139244242|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
139244243|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244244|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139244245|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
139244246|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244247|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139244248|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139244249|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
139244250|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139244251|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139244252|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139244253|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139244254|NCT03563144|Growth Substances|growth substances|mesh-ancestor
139244255|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
139244256|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139244257|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
139244258|NCT03563144|Antidotes|antidotes|mesh-ancestor
139244259|NCT03563144|Protective Agents|protective agents|mesh-ancestor
139244260|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
139244261|NCT03563144|Vitamins|vitamins|mesh-ancestor
139244262|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
139244263|NCT01338818|Methylphenidate|methylphenidate|mesh-list
139244264|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139244265|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244266|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139244267|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139244268|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139244269|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244270|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
139244271|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244272|NCT05310110|Lidocaine|lidocaine|mesh-list
139244273|NCT05310110|Propofol|propofol|mesh-list
139244274|NCT05310110|Cisatracurium|cisatracurium|mesh-list
139244275|NCT05310110|Atracurium|atracurium|mesh-list
139244276|NCT05310110|Anesthetics, Local|anesthetics, local|mesh-ancestor
139244277|NCT05310110|Anesthetics|anesthetics|mesh-ancestor
139244278|NCT05310110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139244279|NCT05310110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244280|NCT05310110|Sensory System Agents|sensory system agents|mesh-ancestor
139244281|NCT05310110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244282|NCT05310110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139244283|NCT05310110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139244284|NCT05310110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139244285|NCT05310110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139244286|NCT05310110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244287|NCT05310110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139244288|NCT05310110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139244289|NCT05310110|Anesthetics, General|anesthetics, general|mesh-ancestor
139244290|NCT05310110|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139244291|NCT05310110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139244292|NCT05310110|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139200911|NCT02500108|Domperidone|domperidone|mesh-list
139244293|NCT05310110|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139244294|NCT05310110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139244295|NCT05310110|Cholinergic Agents|cholinergic agents|mesh-ancestor
139244296|NCT05310110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244297|NCT02823470|Ivacaftor|ivacaftor|mesh-list
139244298|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139244299|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139244300|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244301|NCT03562754|Heparin|heparin|mesh-list
139244302|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
139244303|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244304|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139244305|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139244306|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
139244307|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
139244308|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
139244309|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244310|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244311|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
139244312|NCT01371656|Levofloxacin|levofloxacin|mesh-list
139244313|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139244314|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244315|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139244316|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139244317|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139244318|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244319|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244320|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244321|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139330088|NCT03234842|Paclitaxel|paclitaxel|mesh-list
139244322|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139244323|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139244324|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139244325|NCT01354964|Vitamin D|vitamin d|mesh-list
139244326|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
139244327|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
139244328|NCT01354964|Vitamins|vitamins|mesh-list
139244329|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
139244330|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244331|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139244332|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139244333|NCT02259998|Dipyridamole|dipyridamole|mesh-list
139244334|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139244335|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244336|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244337|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139244338|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
139244339|NCT02035904|Morphine|morphine|mesh-list
139244340|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
139244341|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139244342|NCT02035904|Narcotics|narcotics|mesh-ancestor
139244343|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330185|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
139244344|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244345|NCT02035904|Analgesics|analgesics|mesh-ancestor
139244346|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
139244347|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244348|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
139244349|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
139244350|NCT04110080|Anesthetics|anesthetics|mesh-list
139244351|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139244352|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244353|NCT02035982|Rivastigmine|rivastigmine|mesh-list
139244355|NCT02035982|Galantamine|galantamine|mesh-list
139244356|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
139330267|NCT03221816|Folic Acid|folic acid|mesh-list
139244357|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244358|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244359|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
139244360|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244361|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244362|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
139244363|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139244364|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
139244365|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244366|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139244367|NCT02035982|Protective Agents|protective agents|mesh-ancestor
139244368|NCT05707832|Amphotericin B|amphotericin b|mesh-list
139244369|NCT05707832|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139244370|NCT05707832|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
139244371|NCT05707832|Amebicides|amebicides|mesh-ancestor
139244372|NCT05707832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139244373|NCT05707832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139244374|NCT05707832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244375|NCT05707832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139244376|NCT05707832|Antifungal Agents|antifungal agents|mesh-ancestor
139244377|NCT05707832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139244378|NCT05707832|Protease Inhibitors|protease inhibitors|mesh-ancestor
139244379|NCT05707832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244380|NCT05707832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244381|NCT05707832|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139244382|NCT05707832|Protective Agents|protective agents|mesh-ancestor
139244383|NCT05707832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330320|NCT03232034|Calcium|calcium|mesh-list
139244384|NCT05707832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244385|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
139244386|NCT02822222|Cathartics|cathartics|mesh-ancestor
139244387|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139244388|NCT02821910|Metformin|metformin|mesh-list
139244389|NCT02821910|Empagliflozin|empagliflozin|mesh-list
139244390|NCT02821910|Linagliptin|linagliptin|mesh-list
139244391|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139330369|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
139244392|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244393|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139244394|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244395|NCT02821910|Incretins|incretins|mesh-ancestor
139244396|NCT02821910|Hormones|hormones|mesh-ancestor
139244397|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139244398|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139244399|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
139244400|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244401|NCT03819452|Vitamin D|vitamin d|mesh-list
139244402|NCT03819452|Vitamins|vitamins|mesh-ancestor
139244403|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
139244404|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244405|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139244406|NCT03138655|Vedolizumab|vedolizumab|mesh-list
139244407|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139244408|NCT05707520|Mycophenolic Acid|mycophenolic acid|mesh-list
139330502|NCT02424851|Thalidomide|thalidomide|mesh-list
139244409|NCT05707520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139244410|NCT05707520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244411|NCT05707520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139244412|NCT05707520|Antitubercular Agents|antitubercular agents|mesh-ancestor
139244413|NCT05707520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139244414|NCT05707520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244415|NCT05707520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244416|NCT05707520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244417|NCT04412785|Cyclosporine|cyclosporine|mesh-list
139244418|NCT04412785|Cyclosporins|cyclosporins|mesh-list
139244419|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244420|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244421|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139244422|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
139330566|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139244423|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244424|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
139244425|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244426|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
139244427|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139244428|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139244429|NCT01352611|Baclofen|baclofen|mesh-list
139244430|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139244431|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244432|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139244433|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244434|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139244435|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
139244436|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
139244437|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330625|NCT00562887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244438|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244439|NCT02819804|Nivolumab|nivolumab|mesh-list
139244440|NCT02819804|Dasatinib|dasatinib|mesh-list
139244441|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139244442|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244443|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139201057|NCT05863858|Contraceptive Agents|contraceptive agents|mesh-ancestor
139244444|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244445|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139244446|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244447|NCT02819726|Rituximab|rituximab|mesh-list
139244448|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139244449|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244450|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
139244451|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244452|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139244453|NCT02816138|Nicotine|nicotine|mesh-list
139244454|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139244455|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
139244456|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244457|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244458|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139244459|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139244460|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
139244461|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244462|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244463|NCT02036060|Prednisone|prednisone|mesh-list
139244464|NCT02036060|Docetaxel|docetaxel|mesh-list
139244465|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330752|NCT00468117|Analgesics|analgesics|mesh-ancestor
139244466|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
139244467|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
139244468|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
139244469|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244470|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244471|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
139244472|NCT02036060|Hormones|hormones|mesh-ancestor
139244473|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139244474|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244475|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139244476|NCT02036528|Doxycycline|doxycycline|mesh-list
139244477|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
139244478|NCT02036528|Gentamicins|gentamicins|mesh-list
139244479|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139244480|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244481|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
139244482|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139244483|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139244484|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139244485|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139244486|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244487|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244488|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244489|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139244490|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139244491|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139244492|NCT02880865|Vaccines|vaccines|mesh-list
139244493|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
139244494|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244495|NCT03635125|Metoprolol|metoprolol|mesh-list
139244496|NCT03635125|Nebivolol|nebivolol|mesh-list
139244497|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139244498|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139244499|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
139244500|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
139244501|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244502|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244503|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139244504|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139244505|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139244506|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
139244507|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244508|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244509|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
139244510|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139244511|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139244512|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139244514|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139244515|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139244516|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139244517|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
139244518|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244519|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244520|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244521|NCT02047838|Hormones|hormones|mesh-list
139244522|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139244523|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139244524|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244525|NCT01318681|Fluticasone|fluticasone|mesh-list
139244526|NCT01318681|Xhance|xhance|mesh-list
139244527|NCT01318681|Cetirizine|cetirizine|mesh-list
139244528|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244529|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139244530|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
139244531|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244532|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244533|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139244534|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
139244535|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
139244536|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139244537|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139244538|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139244539|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
139244540|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
139244541|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244542|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244543|NCT03604159|Buprenorphine|buprenorphine|mesh-list
139244544|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139244545|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139244546|NCT03604159|Narcotics|narcotics|mesh-ancestor
139331196|NCT00520923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244547|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139244548|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244549|NCT03604159|Analgesics|analgesics|mesh-ancestor
139244550|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
139244551|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244552|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139244553|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139244554|NCT01353235|Prednisolone|prednisolone|mesh-list
139244555|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244556|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
139244557|NCT01353235|Hormones|hormones|mesh-ancestor
139244558|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139244559|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244560|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139244561|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244562|NCT02048228|Clopidogrel|clopidogrel|mesh-list
139244563|NCT02048228|Ticagrelor|ticagrelor|mesh-list
139244564|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139244565|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139244566|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139244567|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139244568|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
139244569|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244570|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244571|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244572|NCT03046927|Vitamin D|vitamin d|mesh-list
139244573|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
139244574|NCT03046927|Vitamins|vitamins|mesh-ancestor
139244575|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
139244576|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244577|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139244578|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139244579|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
139244580|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139244581|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
139331445|NCT03207542|Daratumumab|daratumumab|mesh-list
139244582|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244583|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244584|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139244585|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
139244586|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139244587|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139244588|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139244589|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
139331585|NCT02712788|Milrinone|milrinone|mesh-list
139244590|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244591|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244592|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
139331665|NCT00406809|Navitoclax|navitoclax|mesh-list
139244593|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
139244594|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244595|NCT02048384|Metformin|metformin|mesh-list
139244596|NCT02048384|Sirolimus|sirolimus|mesh-list
139244597|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139244598|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244599|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139244600|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244601|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139244602|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244603|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
139244604|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139244605|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
139244606|NCT01353391|Metformin|metformin|mesh-list
139244607|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139244608|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244609|NCT01349335|Tolvaptan|tolvaptan|mesh-list
139244610|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139244611|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244612|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
139244613|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244614|NCT03009487|Amlodipine|amlodipine|mesh-list
139244615|NCT03009487|Olmesartan|olmesartan|mesh-list
139244616|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139244617|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
139244618|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139244619|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139244620|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139244621|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139331796|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244622|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244623|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139244624|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244625|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
139244626|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139244627|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139244628|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
139244629|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139244630|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139244631|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244632|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139244633|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139244634|NCT02048540|Bevacizumab|bevacizumab|mesh-list
139244635|NCT02048540|Docetaxel|docetaxel|mesh-list
139244636|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
139244637|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139244638|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244639|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139244640|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139244641|NCT02048540|Growth Substances|growth substances|mesh-ancestor
139244642|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244643|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
139244644|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
139244645|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
139244646|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
139244647|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244648|NCT01353469|Insulin|insulin|mesh-list
139244649|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139244650|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139244651|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244652|NCT03562130|Teduglutide|teduglutide|mesh-list
139244653|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139244654|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139244655|NCT03562130|Protective Agents|protective agents|mesh-ancestor
139244656|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244657|NCT02050178|Paclitaxel|paclitaxel|mesh-list
139244658|NCT02050178|Gemcitabine|gemcitabine|mesh-list
139244659|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139244660|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244661|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
139244662|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
139244663|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
139244664|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244665|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139244666|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
139244667|NCT02048852|Menthol|menthol|mesh-list
139244668|NCT02048852|Nicotine|nicotine|mesh-list
139244669|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139244670|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
139244671|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244672|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244673|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139244674|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139244675|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
139244676|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244677|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244678|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
139244679|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
139244680|NCT02048930|Budesonide|budesonide|mesh-list
139244681|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244682|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139244683|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
139331992|NCT02285751|Aspirin|aspirin|mesh-list
139244684|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244685|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244686|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139244687|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
139244688|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
139244689|NCT02048930|Hormones|hormones|mesh-ancestor
139244690|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139244691|NCT02049320|Remifentanil|remifentanil|mesh-list
139244692|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139244693|NCT02049320|Narcotics|narcotics|mesh-ancestor
139244694|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332025|NCT05114915|Docetaxel|docetaxel|mesh-list
139244695|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244696|NCT02049320|Analgesics|analgesics|mesh-ancestor
139244697|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
139244698|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244699|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
139244700|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139244701|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244702|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
139244703|NCT02050802|Macitentan|macitentan|mesh-list
139244704|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139244705|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244706|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139244707|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139244708|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244709|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244710|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244711|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139244712|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139244713|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139244714|NCT02051738|Mebendazole|mebendazole|mesh-list
139244715|NCT02051738|Piperazine|piperazine|mesh-list
139244716|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
139244717|NCT02051738|DMP 777|dmp 777|mesh-list
139244718|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
139244719|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
139244720|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139244721|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244722|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
139244723|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
139244724|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
139244725|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244726|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244727|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244728|NCT02050958|Ibuprofen|ibuprofen|mesh-list
139244729|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139244730|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139244731|NCT02050958|Analgesics|analgesics|mesh-ancestor
139244732|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
139244733|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244734|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244735|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244736|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139244737|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139244738|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244739|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244740|NCT02037464|Capsaicin|capsaicin|mesh-list
139244741|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
139244742|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
139244743|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
139244744|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244745|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244746|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
139244747|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139244748|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244749|NCT02051894|Dobutamine|dobutamine|mesh-list
139244750|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139332415|NCT02445404|Hormones|hormones|mesh-ancestor
139244751|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
139244752|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
139244753|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244754|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244755|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139244756|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139244757|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139244758|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
139244759|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244760|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244761|NCT02051894|Protective Agents|protective agents|mesh-ancestor
139244762|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139244763|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
139244764|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244765|NCT01357681|Protective Agents|protective agents|mesh-ancestor
139244766|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244767|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139244768|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139244769|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244770|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139244771|NCT01543633|Propofol|propofol|mesh-list
139244772|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139244773|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139244774|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244775|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139244776|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
139244777|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
139244778|NCT03561740|Capecitabine|capecitabine|mesh-list
139244779|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139244780|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
139244781|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244782|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244783|NCT01357759|Gimsilumab|gimsilumab|mesh-list
139244784|NCT01357759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244785|NCT01357759|Antiviral Agents|antiviral agents|mesh-ancestor
139244786|NCT01357759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244787|NCT02052128|Onapristone|onapristone|mesh-list
139244788|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244789|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139244790|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
139244791|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139244792|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244793|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
139244794|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139244795|NCT01349413|Esomeprazole|esomeprazole|mesh-list
139244796|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139244797|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139114952|NCT01191216|Docetaxel|docetaxel|mesh-list
139244798|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139244799|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244800|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244801|NCT01349647|Vaccines|vaccines|mesh-list
139244802|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
139244803|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244804|NCT02806232|Praziquantel|praziquantel|mesh-list
139244805|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
139244806|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139244807|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244808|NCT02908087|Liraglutide|liraglutide|mesh-list
139244809|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139244810|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244811|NCT02908087|Incretins|incretins|mesh-ancestor
139244812|NCT02908087|Hormones|hormones|mesh-ancestor
139244813|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139244814|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
139244815|NCT02053766|Propofol|propofol|mesh-list
139244816|NCT02053766|Sevoflurane|sevoflurane|mesh-list
139244817|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139244818|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139244819|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244820|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139244822|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
139244823|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244824|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139244825|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139244826|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139244827|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
139244828|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244829|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244830|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139244831|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
139244832|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
139244833|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139244834|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139244835|NCT02053922|Misoprostol|misoprostol|mesh-list
139244836|NCT02053922|Oxytocin|oxytocin|mesh-list
139244837|NCT02053922|Carbetocin|carbetocin|mesh-list
139244838|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139332635|NCT03196154|Insulin|insulin|mesh-list
139244839|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
139244840|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139244841|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244842|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139244843|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139244844|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
139244845|NCT02054000|Tirofiban|tirofiban|mesh-list
139244846|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139244847|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139244848|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244849|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139244850|NCT02054078|Bevacizumab|bevacizumab|mesh-list
139244851|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139244852|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244853|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139244854|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139332686|NCT00294320|Imiquimod|imiquimod|mesh-list
139244855|NCT02054078|Growth Substances|growth substances|mesh-ancestor
139244856|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244857|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
139244858|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
139244859|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139244860|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139244861|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139244862|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139244863|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244864|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
139244865|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244866|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244867|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139244868|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244870|NCT01336595|Triamcinolone|triamcinolone|mesh-list
139244871|NCT01336595|Trace Elements|trace elements|mesh-ancestor
139244872|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
139642247|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139244873|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244874|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244875|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
139244877|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139244878|NCT01336751|Insulin|insulin|mesh-list
139244879|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139244880|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
139244881|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
139244882|NCT01336751|Protamines|protamines|mesh-list
139244883|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139244884|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244885|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
139244886|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244887|NCT01336751|Coagulants|coagulants|mesh-ancestor
139244888|NCT01336829|Rilpivirine|rilpivirine|mesh-list
139244889|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139244890|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139244891|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244892|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244893|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
139244894|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244895|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139244896|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139244897|NCT02960490|Quetmolimab|quetmolimab|mesh-list
139244898|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139244899|NCT05184179|Olmesartan|olmesartan|mesh-list
139244900|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139244901|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139244902|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139244903|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139244904|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
139244905|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244906|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139244907|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139244908|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244909|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139244910|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139244911|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139244912|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139244913|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
139244914|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244915|NCT01065012|Udenafil|udenafil|mesh-list
139244916|NCT01065012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139244917|NCT01065012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139244918|NCT01065012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244919|NCT01065012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244920|NCT01315691|Amikacin|amikacin|mesh-list
139244921|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139244922|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244923|NCT05654090|Sulbactam|sulbactam|mesh-list
139244924|NCT05654090|Cefoperazone|cefoperazone|mesh-list
139244925|NCT05654090|Sulperazone|sulperazone|mesh-list
139244926|NCT05654090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139244927|NCT05654090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244928|NCT05654090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139244929|NCT05654090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333057|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244930|NCT05654090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244931|NCT05654090|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139244932|NCT02054468|Remifentanil|remifentanil|mesh-list
139244933|NCT02054468|Propofol|propofol|mesh-list
139244934|NCT02054468|Rocuronium|rocuronium|mesh-list
139244935|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139244936|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139244937|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244938|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138990084|NCT05351229|Morphine|morphine|mesh-list
139244939|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
139244940|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
139244941|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139244942|NCT02054468|Narcotics|narcotics|mesh-ancestor
139244943|NCT02054468|Analgesics|analgesics|mesh-ancestor
139244944|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
139244945|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244946|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139115104|NCT01097746|Paclitaxel|paclitaxel|mesh-list
139244947|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139244948|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139244949|NCT03640650|Triamcinolone|triamcinolone|mesh-list
139244950|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139244951|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139244952|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139244953|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139244954|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139244955|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139244956|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
139244957|NCT03640650|Hormones|hormones|mesh-ancestor
139244958|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139244959|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244960|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139244961|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
139244962|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244963|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244964|NCT05183555|Edotreotide|edotreotide|mesh-list
139244965|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139244966|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244967|NCT02052908|Naproxen|naproxen|mesh-list
139244968|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139244969|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139244970|NCT02052908|Analgesics|analgesics|mesh-ancestor
139244971|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
139244972|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139244973|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244974|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139244975|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139244976|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
139244977|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139244978|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244979|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244980|NCT01336985|Irinotecan|irinotecan|mesh-list
139244981|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139244982|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139244983|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139244984|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139244985|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139244986|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139244987|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
139244988|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
139244989|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139244990|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
139244991|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244992|NCT03635411|Niacinamide|niacinamide|mesh-list
139244993|NCT03635411|Niacin|niacin|mesh-list
139244994|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
139244995|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
139244996|NCT03635411|Vitamins|vitamins|mesh-ancestor
139244997|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
139244998|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139244999|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139245000|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
139245001|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245002|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139245003|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
139245004|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139245005|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245006|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
139245007|NCT02748512|Hormones|hormones|mesh-ancestor
139245008|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139245009|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245010|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
139245011|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
139245012|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
139245013|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245014|NCT02053142|Acyclovir|acyclovir|mesh-list
139245015|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
139245016|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245017|NCT01316549|Fludarabine|fludarabine|mesh-list
139245018|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245019|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139245020|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
139642248|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245021|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245023|NCT01341743|Adefovir|adefovir|mesh-list
139245024|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139245025|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
139245026|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245027|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139245028|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139245029|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245030|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245031|NCT01341275|Vaccines|vaccines|mesh-list
139245032|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
139245033|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245034|NCT01353937|Plerixafor|plerixafor|mesh-list
139245035|NCT01353937|Becaplermin|becaplermin|mesh-list
139245036|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139245037|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139245038|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
139245039|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245040|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
139245041|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
139245042|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139245043|NCT01353937|Growth Substances|growth substances|mesh-ancestor
139245044|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201658|NCT01808599|Rituximab|rituximab|mesh-list
139245045|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139245046|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139245047|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
139245048|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245049|NCT02053298|Timolol|timolol|mesh-list
139245050|NCT02053298|Dorzolamide|dorzolamide|mesh-list
139245051|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139245052|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139245053|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
139245054|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245055|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245056|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245057|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139245058|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139245059|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139245060|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245061|NCT02054936|Warfarin|warfarin|mesh-list
139245062|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
139245063|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
139245064|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139245065|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
139245066|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139245067|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
139245068|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245069|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245070|NCT04782791|Nivolumab|nivolumab|mesh-list
139245071|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139245072|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245073|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139245074|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245075|NCT01341353|Amiodarone|amiodarone|mesh-list
139245076|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
139245077|NCT01341353|Calcium|calcium|mesh-list
139245078|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139245079|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245080|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139245081|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
139245082|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139245083|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139245084|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245085|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139333951|NCT03180476|Apatinib|apatinib|mesh-list
139245086|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139245087|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139245088|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245089|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139245090|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139245091|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139245092|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
139245093|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139245094|NCT02056184|Adalimumab|adalimumab|mesh-list
139334070|NCT02419820|APD791|apd791|mesh-list
139245095|NCT02056184|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139245097|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245098|NCT02800928|Aticaprant|aticaprant|mesh-list
139245099|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139245100|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245101|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
139245102|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245103|NCT02056418|Prednisone|prednisone|mesh-list
139245104|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
139245105|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245106|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
139245107|NCT02056418|Hormones|hormones|mesh-ancestor
139472320|NCT02837263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245108|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139245109|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245110|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139245111|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245112|NCT02055014|Liraglutide|liraglutide|mesh-list
139245113|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139245114|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245115|NCT02055014|Incretins|incretins|mesh-ancestor
139245116|NCT02055014|Hormones|hormones|mesh-ancestor
139245117|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139245118|NCT02055170|Finasteride|finasteride|mesh-list
139091676|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139245119|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139245120|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139245121|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245122|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245123|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
139245124|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139245125|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245126|NCT02055170|Urological Agents|urological agents|mesh-ancestor
139245127|NCT04490993|Epirubicin|epirubicin|mesh-list
139245128|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139245129|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245130|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139245131|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139245132|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245133|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245134|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
139245135|NCT02055482|Hematinics|hematinics|mesh-ancestor
139245136|NCT02059460|Terlipressin|terlipressin|mesh-list
139245137|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139245138|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139245139|NCT02055716|Sulforaphane|sulforaphane|mesh-list
139245140|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139245141|NCT02055716|Protective Agents|protective agents|mesh-ancestor
139245142|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245143|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245144|NCT04739735|Anesthetics|anesthetics|mesh-list
139245145|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139245146|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245147|NCT02059616|Amlodipine|amlodipine|mesh-list
139245148|NCT02059616|Candesartan|candesartan|mesh-list
139245149|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
139245150|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139245151|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139245152|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139245153|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245154|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139245155|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245156|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
139245157|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139245158|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139245159|NCT02059694|Lidocaine|lidocaine|mesh-list
139245160|NCT02059694|Epinephrine|epinephrine|mesh-list
139245161|NCT02059694|Racepinephrine|racepinephrine|mesh-list
139245162|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
139245163|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
139245164|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
139245165|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139245166|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245167|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
139245168|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245169|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139245170|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139245171|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139245172|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139245173|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245174|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139245175|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139245176|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
139245177|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245178|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139245179|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139245180|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
139245181|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139245182|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
139245183|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
139245184|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
139245185|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139245186|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139245187|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
139245188|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245189|NCT02056730|Calcium|calcium|mesh-list
139245190|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139245191|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245192|NCT05162573|177Lu-PSMA-617|177lu-psma-617|mesh-list
139245193|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139245194|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245195|NCT01337219|Tobramycin|tobramycin|mesh-list
139245196|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139245197|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245198|NCT03560804|Olmesartan|olmesartan|mesh-list
139245199|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
139245200|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139245201|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139245202|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139245203|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245204|NCT03560804|Diuretics|diuretics|mesh-ancestor
139245205|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
139245206|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245207|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139245208|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139245209|NCT03150719|Ivacaftor|ivacaftor|mesh-list
139245210|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139245211|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139245212|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245213|NCT02059772|Ranibizumab|ranibizumab|mesh-list
139245214|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139245215|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139245216|NCT02059772|Growth Substances|growth substances|mesh-ancestor
139245217|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245218|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
139245219|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245220|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139245221|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139245222|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139245223|NCT01344083|Analgesics|analgesics|mesh-ancestor
139245224|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
139245225|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245226|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245227|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245228|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245229|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139245230|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139245231|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139245232|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
139245233|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
139245234|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245235|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245236|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
139245237|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139245238|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
139245239|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245240|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245241|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139245242|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
139245243|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245244|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245245|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139245246|NCT00982111|Pemetrexed|pemetrexed|mesh-list
139245247|NCT00982111|Necitumumab|necitumumab|mesh-list
139245248|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245249|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245250|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245251|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139245252|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139245253|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139245254|NCT02957682|Alirocumab|alirocumab|mesh-list
139245255|NCT02957682|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139245256|NCT02957682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139245257|NCT02957682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139245258|NCT02957682|Antimetabolites|antimetabolites|mesh-ancestor
139245259|NCT02957682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245260|NCT02957682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139245261|NCT02957682|Protease Inhibitors|protease inhibitors|mesh-ancestor
139245262|NCT02957682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245263|NCT02957682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139245264|NCT03057951|Empagliflozin|empagliflozin|mesh-list
139091677|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
139245265|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139245266|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245267|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139245268|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245269|NCT02060318|Infliximab|infliximab|mesh-list
139245270|NCT02060318|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139245271|NCT02060318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245272|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
139245273|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139245274|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245275|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
139245276|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139245277|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139245278|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
139245279|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245280|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245281|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245282|NCT01318837|Urological Agents|urological agents|mesh-ancestor
139245283|NCT01350037|Remifentanil|remifentanil|mesh-list
139245284|NCT01350037|Alfentanil|alfentanil|mesh-list
139245285|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139245286|NCT01350037|Narcotics|narcotics|mesh-ancestor
139245287|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139245288|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245289|NCT01350037|Analgesics|analgesics|mesh-ancestor
139245290|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
139245291|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245292|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139245293|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
139245294|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
139245295|NCT02060006|Meloxicam|meloxicam|mesh-list
139245296|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
139245297|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139245298|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139245299|NCT02060006|Analgesics|analgesics|mesh-ancestor
139245300|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
139245301|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245302|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245303|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245304|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245305|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139245306|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245307|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245308|NCT03620435|Atezolizumab|atezolizumab|mesh-list
139245309|NCT03620435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139245310|NCT03620435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245311|NCT03620435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139245312|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245313|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
139245314|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
139245315|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245316|NCT04686773|Vaccines|vaccines|mesh-list
139245317|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
139245318|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245319|NCT02956278|Allopurinol|allopurinol|mesh-list
139245320|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
139245321|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245322|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245323|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
139245324|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245325|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139245326|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
139245327|NCT02956278|Protective Agents|protective agents|mesh-ancestor
139245328|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245329|NCT02060396|Aspirin|aspirin|mesh-list
139245330|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139245331|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139245332|NCT02060396|Analgesics|analgesics|mesh-ancestor
139245333|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
139245334|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245335|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245336|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245337|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245338|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139245339|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139245340|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245341|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139245342|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139245343|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245344|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
139245345|NCT01358071|Doxorubicin|doxorubicin|mesh-list
139245346|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139245347|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139245348|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245349|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139245350|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139245351|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245352|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245353|NCT02058212|Vitamin E|vitamin e|mesh-list
139245354|NCT02058212|Selenium|selenium|mesh-list
139245355|NCT02058212|Vitamins|vitamins|mesh-ancestor
139245356|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
139245357|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245358|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
139245359|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245360|NCT02058212|Protective Agents|protective agents|mesh-ancestor
139245361|NCT02058212|Trace Elements|trace elements|mesh-ancestor
139245362|NCT02058446|Amlodipine|amlodipine|mesh-list
139245363|NCT02058446|Valsartan|valsartan|mesh-list
139245364|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
139245365|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139245366|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139245367|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139245368|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245369|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139245370|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245371|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
139245372|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139245373|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139245374|NCT01354405|Lanreotide|lanreotide|mesh-list
139245375|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245376|NCT03363035|Enoxaparin|enoxaparin|mesh-list
139245377|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
139245378|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139245379|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
139245380|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139245381|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
139245382|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245383|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245384|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
139245385|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139245386|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139245387|NCT02060552|Diacerein|diacerein|mesh-list
139245388|NCT02060552|Colchicine|colchicine|mesh-list
139245389|NCT02060552|Febuxostat|febuxostat|mesh-list
139245390|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
139245391|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245392|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
139245393|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
139245394|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
139245395|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245396|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245397|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245398|NCT05384574|Cholecalciferol|cholecalciferol|mesh-list
139245399|NCT05384574|Vitamin D|vitamin d|mesh-list
139245400|NCT05384574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139245401|NCT05384574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245402|NCT05384574|Vitamins|vitamins|mesh-ancestor
139245403|NCT05384574|Micronutrients|micronutrients|mesh-ancestor
139245404|NCT05384574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139245405|NCT04355585|Colchicine|colchicine|mesh-list
139245406|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
139245407|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245408|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
139245409|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
139245410|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
139245411|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245412|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245413|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139245414|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245415|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139245416|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245417|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245418|NCT04653389|Immunomodulating Agents|immunomodulating agents|mesh-list
139245419|NCT04653389|Immunologic Factors|immunologic factors|mesh-ancestor
139245420|NCT04653389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245421|NCT01344395|Ketorolac|ketorolac|mesh-list
139245422|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139245423|NCT01344395|Ropivacaine|ropivacaine|mesh-list
139245424|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
139245425|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
139245426|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139245427|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245428|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
139245429|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245430|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139245431|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139245432|NCT01344395|Analgesics|analgesics|mesh-ancestor
139245433|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245434|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245435|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139245436|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245437|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245438|NCT02291445|Peppermint oil|peppermint oil|mesh-list
139245439|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
139245440|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
139245441|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245442|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245443|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139245444|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
139245445|NCT02062112|Laxatives|laxatives|mesh-list
139245446|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139245447|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
139245448|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
139245449|NCT01342289|Fludarabine|fludarabine|mesh-list
139245450|NCT01342289|Tacrolimus|tacrolimus|mesh-list
139245451|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139245452|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
139245453|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245454|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245455|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139245456|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
139245457|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245458|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245459|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139245460|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139245461|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245462|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139245463|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139245464|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
139245465|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139245466|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245468|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
139245469|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245470|NCT02062190|Protective Agents|protective agents|mesh-ancestor
139245471|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245472|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245473|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139245474|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
139245475|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139245476|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139245477|NCT01354483|Prednisolone|prednisolone|mesh-list
139245478|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
139245479|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
139245480|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139245481|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
139245482|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245483|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
139245484|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
139245485|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245486|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245487|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139245488|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
139245489|NCT01354483|Hormones|hormones|mesh-ancestor
139245490|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139245491|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139245492|NCT01354483|Protective Agents|protective agents|mesh-ancestor
139245493|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139245494|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245495|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
139245496|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139245497|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245498|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245499|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
139245500|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139245501|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139245502|NCT03618264|Dexamethasone|dexamethasone|mesh-list
139245503|NCT03618264|Ropivacaine|ropivacaine|mesh-list
139245504|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245505|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
139245506|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
139334218|NCT02423096|Olanzapine|olanzapine|mesh-list
139245507|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245508|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245509|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139245510|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
139245511|NCT03618264|Hormones|hormones|mesh-ancestor
139245512|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139245513|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139245514|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245515|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
139245516|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
139245517|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139334426|NCT02415920|Oxytocin|oxytocin|mesh-list
139245518|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
139245519|NCT03617016|Domperidone|domperidone|mesh-list
139245520|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
139245521|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
139245522|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245523|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245524|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139245525|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139245526|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
139245527|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245528|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245529|NCT02060786|Clopidogrel|clopidogrel|mesh-list
139245530|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139245531|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139245532|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139245533|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139245534|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
139245535|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472321|NCT02616640|Dexamethasone|dexamethasone|mesh-list
139245536|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245537|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245538|NCT03153137|Macitentan|macitentan|mesh-list
139245539|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139245540|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139115702|NCT03668808|Insulin|insulin|mesh-list
139245541|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245542|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139245543|NCT03617484|Bortezomib|bortezomib|mesh-list
139245544|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245545|NCT01344473|Caseins|caseins|mesh-list
139245546|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
139245547|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
139245548|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245549|NCT03618108|Azithromycin|azithromycin|mesh-list
139245550|NCT03618108|Doxycycline|doxycycline|mesh-list
139245551|NCT03618108|Rifabutin|rifabutin|mesh-list
139245552|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139245553|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245554|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
139245555|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139245556|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139245557|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139245558|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
139245559|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139245560|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139245561|NCT02236728|Pramipexole|pramipexole|mesh-list
139245562|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
139245563|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245564|NCT02236728|Protective Agents|protective agents|mesh-ancestor
139245565|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245566|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139245567|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139245568|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
139245569|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
139245570|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245571|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139245572|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
139245573|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245575|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245576|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139245577|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245578|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245579|NCT01342835|Propofol|propofol|mesh-list
139245580|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139245581|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139245582|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245583|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139245584|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
139245585|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
139245586|NCT01344863|Trastuzumab|trastuzumab|mesh-list
139245587|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139245588|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245589|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
139245590|NCT03139279|Propofol|propofol|mesh-list
139245591|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139245592|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139245593|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245594|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139245595|NCT03139279|Analgesics|analgesics|mesh-ancestor
139245596|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
139245597|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245598|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139245599|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139245600|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139245601|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
139245602|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245603|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245604|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139245605|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
139245606|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
139245607|NCT02562599|Raltitrexed|raltitrexed|mesh-list
139245608|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245609|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139245610|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
139245611|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245612|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139245613|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245614|NCT03311958|Nivolumab|nivolumab|mesh-list
139245615|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139642249|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245616|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245617|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139335020|NCT03116282|Ethanol|ethanol|mesh-list
139245618|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245619|NCT01370642|Ribavirin|ribavirin|mesh-list
139245620|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
139245621|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245622|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
139245623|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245624|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
139245625|NCT03138967|Bromides|bromides|mesh-list
139245626|NCT03138967|Rocuronium|rocuronium|mesh-list
139245627|NCT03138967|Neostigmine|neostigmine|mesh-list
139245628|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
139245629|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139245630|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139245631|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139245632|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245633|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245634|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139245635|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245636|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245637|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
139245638|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245639|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139245640|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
139245641|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139245642|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139245643|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139245644|NCT01547117|Carbon Monoxide|carbon monoxide|mesh-list
139245645|NCT01547117|Antimetabolites|antimetabolites|mesh-ancestor
139245646|NCT01547117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245647|NCT01547117|Gasotransmitters|gasotransmitters|mesh-ancestor
139245648|NCT01547117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245649|NCT01547117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245650|NCT01358383|Naproxen|naproxen|mesh-list
139245651|NCT01358383|Esomeprazole|esomeprazole|mesh-list
139245652|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139245653|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139245654|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139245655|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245656|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245657|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139245658|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139245659|NCT01358383|Analgesics|analgesics|mesh-ancestor
139245660|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
139245661|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245662|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245663|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245664|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245665|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
139245666|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139245667|NCT03560336|Liraglutide|liraglutide|mesh-list
139245668|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139245669|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245670|NCT03560336|Incretins|incretins|mesh-ancestor
139245671|NCT03560336|Hormones|hormones|mesh-ancestor
139245672|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139245673|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
139245674|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139245675|NCT03615768|Clindamycin|clindamycin|mesh-list
139245676|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
139245677|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
139245678|NCT03615768|Adapalene|adapalene|mesh-list
139245679|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139245680|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245681|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139245682|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245683|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245684|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139245685|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139245686|NCT03615768|Analgesics|analgesics|mesh-ancestor
139245687|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
139245688|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245689|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245690|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245691|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245692|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
139245693|NCT02061644|Anesthetics|anesthetics|mesh-list
139245694|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139245695|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245696|NCT03793400|Bevacizumab|bevacizumab|mesh-list
139245697|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139245698|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245699|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139245700|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139245701|NCT03793400|Growth Substances|growth substances|mesh-ancestor
139245702|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245703|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
139245704|NCT01318369|Diazepam|diazepam|mesh-list
139245705|NCT01318369|Dronabinol|dronabinol|mesh-list
139245706|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
139245707|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245708|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139245709|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139245710|NCT01318369|Analgesics|analgesics|mesh-ancestor
139245711|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
139245712|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245713|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139245714|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139245715|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245716|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202337|NCT05014334|Bismuth|bismuth|mesh-list
139245717|NCT01318369|Hormones|hormones|mesh-ancestor
139472322|NCT02616640|Durvalumab|durvalumab|mesh-list
139472323|NCT02616640|Pomalidomide|pomalidomide|mesh-list
139245718|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139245719|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139245720|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
139245721|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
139245722|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
139245723|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139245724|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139335889|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139245725|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139245726|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139245727|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139245728|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139245729|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139245730|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139245731|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
139245732|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
139245733|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
139245734|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
139245735|NCT03479684|Warfarin|warfarin|mesh-list
139245736|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
139245737|NCT03614052|Tamsulosin|tamsulosin|mesh-list
139245738|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139245739|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139245740|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139336032|NCT02305485|Everolimus|everolimus|mesh-list
139245741|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
139245742|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245743|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245744|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245745|NCT03614052|Urological Agents|urological agents|mesh-ancestor
139245746|NCT02062892|Sirolimus|sirolimus|mesh-list
139245747|NCT02062892|Everolimus|everolimus|mesh-list
139245748|NCT02062892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139245749|NCT02062892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139245750|NCT02062892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245751|NCT02062892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245752|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139245753|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
139245754|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245755|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245756|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139245757|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245758|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139245759|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
139245760|NCT02063360|Ritonavir|ritonavir|mesh-list
139245761|NCT02063360|Darunavir|darunavir|mesh-list
139245762|NCT02063360|Fostemsavir|fostemsavir|mesh-list
139245763|NCT02063360|Etravirine|etravirine|mesh-list
139245764|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139336306|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
139245765|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139245766|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
139245767|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245768|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245769|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139245770|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139245771|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
139245772|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245773|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139245774|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139245775|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139245776|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139245777|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139245778|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139245779|NCT03614832|Clopidogrel|clopidogrel|mesh-list
139245780|NCT03614832|Ticagrelor|ticagrelor|mesh-list
139245781|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139245782|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139336579|NCT02307825|Azithromycin|azithromycin|mesh-list
139245783|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139245784|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139245785|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
139245786|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336660|NCT03943888|Atropine|atropine|mesh-list
139245787|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245788|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245789|NCT05210595|Clopidogrel|clopidogrel|mesh-list
139245790|NCT05210595|Ticagrelor|ticagrelor|mesh-list
139245791|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139245792|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139336724|NCT05356091|Sevoflurane|sevoflurane|mesh-list
139245793|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139245794|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139245795|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
139245796|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472324|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245797|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245798|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245799|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
139245800|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139245801|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
139245802|NCT02061800|Melphalan|melphalan|mesh-list
139245803|NCT02061800|Busulfan|busulfan|mesh-list
139245804|NCT02061800|Thiotepa|thiotepa|mesh-list
139245805|NCT02061800|Fludarabine|fludarabine|mesh-list
139245806|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
139245807|NCT02061800|Tacrolimus|tacrolimus|mesh-list
139245808|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139245809|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
139245810|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245811|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139245812|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139245813|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
139245814|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245815|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245816|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139245817|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139245818|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245819|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245820|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
139245821|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
139245822|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245823|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139245824|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
139245825|NCT02061800|Hormones|hormones|mesh-ancestor
139245826|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139245827|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139245828|NCT02061800|Protective Agents|protective agents|mesh-ancestor
139336989|NCT00647933|Lynestrenol|lynestrenol|mesh-list
139245829|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139245830|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139245831|NCT01350817|Docetaxel|docetaxel|mesh-list
139245832|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139245833|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245834|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
139245835|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
139245836|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
139472325|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
139245837|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245838|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139245839|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245840|NCT01986075|Amphetamine|amphetamine|mesh-list
139245841|NCT01986075|Adderall|adderall|mesh-list
139245842|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139245843|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245844|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
139245845|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
139245846|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245847|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
139245848|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245849|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245850|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
139245851|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139245852|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139245853|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139245854|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139245855|NCT02061878|Bexarotene|bexarotene|mesh-list
139245856|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245857|NCT00394355|Fluticasone|fluticasone|mesh-list
139245859|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
139245860|NCT00394355|Montelukast|montelukast|mesh-list
139245861|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245862|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139245863|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
139472326|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
139245864|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245865|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245866|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139245867|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
139245868|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
139245869|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139245870|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139245871|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
139245872|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139245873|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139245874|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139337626|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
139245875|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245876|NCT02797808|Sertraline|sertraline|mesh-list
139245877|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
139245878|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139245879|NCT02797808|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139245880|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139245881|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139245882|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245883|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245884|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
139245885|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245886|NCT02796560|Travoprost|travoprost|mesh-list
139245887|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139245888|NCT01316081|Vitamins|vitamins|mesh-list
139245889|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
139245890|NCT01316081|Vitamin E|vitamin e|mesh-list
139245891|NCT01316081|Tocopherols|tocopherols|mesh-list
139245892|NCT01316081|Tocotrienols|tocotrienols|mesh-list
139245893|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
139245894|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
139245895|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245896|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
139245897|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245898|NCT01316081|Protective Agents|protective agents|mesh-ancestor
139245899|NCT02062034|Vitamins|vitamins|mesh-list
139245900|NCT02062034|Vitamin E|vitamin e|mesh-list
139245901|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
139245902|NCT02062034|Ubiquinone|ubiquinone|mesh-list
139245903|NCT02062034|Antioxidants|antioxidants|mesh-list
139245904|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
139245905|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338039|NCT05112861|Growth Substances|growth substances|mesh-ancestor
139245906|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245907|NCT02062034|Protective Agents|protective agents|mesh-ancestor
139245908|NCT00344487|Ritonavir|ritonavir|mesh-list
139245909|NCT00344487|Lopinavir|lopinavir|mesh-list
139245910|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139245911|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139245912|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
139245913|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245914|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245915|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139245916|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139245917|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
139338181|NCT04703361|Vitamins|vitamins|mesh-ancestor
139245918|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245919|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139338249|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
139245920|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139245921|NCT03789968|Tenofovir|tenofovir|mesh-list
139245922|NCT03789968|Emtricitabine|emtricitabine|mesh-list
139338337|NCT03000673|Heparin|heparin|mesh-list
139245923|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139245924|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
139245925|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139338391|NCT04308837|Palonosetron|palonosetron|mesh-list
139245926|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139245927|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139245928|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245929|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245930|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139245931|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139245932|NCT05089643|Capecitabine|capecitabine|mesh-list
139245933|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139245934|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
139245935|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245936|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245937|NCT02871492|Acyclovir|acyclovir|mesh-list
139245938|NCT02871492|Pritelivir|pritelivir|mesh-list
139245939|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
139245940|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245941|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245942|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245943|NCT03613974|Lidocaine|lidocaine|mesh-list
139245944|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
139245945|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
139245946|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139245947|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245948|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
139245949|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245950|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139245951|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139245952|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139245953|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139245954|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245955|NCT01343225|Ritonavir|ritonavir|mesh-list
139245956|NCT01343225|Darunavir|darunavir|mesh-list
139245957|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
139245958|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139245959|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139245960|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139245961|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
139245962|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139245963|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245964|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139245965|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139245966|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
139245967|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139245968|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139245969|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139245970|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139245971|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139245972|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139245973|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139245974|NCT01370408|Dexamethasone|dexamethasone|mesh-list
139245975|NCT01370408|Ondansetron|ondansetron|mesh-list
139245976|NCT01370408|Palonosetron|palonosetron|mesh-list
139245977|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139245978|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
139245979|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
139245980|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139245981|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139245982|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139245983|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
139245984|NCT01370408|Hormones|hormones|mesh-ancestor
139245985|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139245986|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139338875|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
139245987|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245988|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
139245989|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
139245990|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139245991|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139245992|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
139245993|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139245994|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139245995|NCT04769388|Carboplatin|carboplatin|mesh-list
139245996|NCT04769388|Pemetrexed|pemetrexed|mesh-list
139245997|NCT04769388|Osimertinib|osimertinib|mesh-list
139245998|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139245999|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246000|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246001|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139246002|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139246003|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139246004|NCT03294109|Bupivacaine|bupivacaine|mesh-list
139246005|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
139246006|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
139246007|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246008|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246009|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
139246010|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246011|NCT01345643|Chrysarobin|chrysarobin|mesh-list
139246012|NCT01345643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139246013|NCT01345643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139246014|NCT01345643|Analgesics|analgesics|mesh-ancestor
139246015|NCT01345643|Sensory System Agents|sensory system agents|mesh-ancestor
139246016|NCT01345643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246017|NCT01345643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246018|NCT01345643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246019|NCT01345643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139246020|NCT02065466|Paclitaxel|paclitaxel|mesh-list
139246021|NCT02065466|Bevacizumab|bevacizumab|mesh-list
139246022|NCT02065466|Temozolomide|temozolomide|mesh-list
139246023|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139246024|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246025|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
139246026|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
139246027|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
139246028|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246029|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139246030|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139246031|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139246032|NCT02065466|Growth Substances|growth substances|mesh-ancestor
139246033|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246034|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
139246035|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139246036|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
139246037|NCT05208801|Morphine|morphine|mesh-list
139246038|NCT05208801|Bupivacaine|bupivacaine|mesh-list
139339259|NCT03680339|Misoprostol|misoprostol|mesh-list
139246039|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
139246040|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
139246041|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246042|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246043|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
139246044|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246045|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139246046|NCT05208801|Narcotics|narcotics|mesh-ancestor
139246047|NCT05208801|Analgesics|analgesics|mesh-ancestor
139246048|NCT02064140|Rocuronium|rocuronium|mesh-list
139246049|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139246050|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139246051|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139246052|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246053|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246054|NCT05190627|Loratadine|loratadine|mesh-list
139246055|NCT05190627|Sirolimus|sirolimus|mesh-list
139246056|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139246057|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339544|NCT05338450|Antipruritics|antipruritics|mesh-ancestor
139246058|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139246059|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339620|NCT05255770|Benzocaine|benzocaine|mesh-list
139246060|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
139246061|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139246062|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
139246063|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246064|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246065|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
139246066|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
139246067|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139246068|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139246069|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139246070|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
139246071|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
139246072|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339775|NCT05317624|Hormones|hormones|mesh-ancestor
139246073|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
139246075|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139339830|NCT03480321|Cilostazol|cilostazol|mesh-list
139246076|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139246077|NCT01343303|Analgesics|analgesics|mesh-ancestor
139246078|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
139246079|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246080|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246081|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246082|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139246083|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
139246084|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139246085|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246086|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246087|NCT01343381|Heparin|heparin|mesh-list
139246088|NCT01343381|Calcium heparin|calcium heparin|mesh-list
139246089|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
139246090|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139246091|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139246092|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202713|NCT03328234|Paclitaxel|paclitaxel|mesh-list
139246093|NCT03620149|Denosumab|denosumab|mesh-list
139246094|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139246095|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246096|NCT02064374|Metformin|metformin|mesh-list
139246097|NCT02064374|Dolutegravir|dolutegravir|mesh-list
139246098|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139246099|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246100|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139246101|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139246102|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246103|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246104|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139246105|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139246106|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
139246107|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139246108|NCT01355263|Vitamin A|vitamin a|mesh-list
139246109|NCT01355263|Vitamins|vitamins|mesh-ancestor
139246110|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
139246111|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246112|NCT03613428|Prednisone|prednisone|mesh-list
139246113|NCT03613428|Vincristine|vincristine|mesh-list
139246114|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246115|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
139246116|NCT03613428|Hormones|hormones|mesh-ancestor
139246117|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139246118|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246119|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139246120|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246121|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139246122|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
139246123|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
139246124|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
139246125|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340262|NCT03473613|Cabergoline|cabergoline|mesh-list
139246126|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
139246127|NCT02064530|Bupivacaine|bupivacaine|mesh-list
139246128|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
139246129|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
139246130|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246131|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246132|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
139246133|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246134|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139340403|NCT02390882|Tamsulosin|tamsulosin|mesh-list
139246135|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139246136|NCT02064530|Analgesics|analgesics|mesh-ancestor
139246137|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139246138|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139246139|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139246140|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
139246141|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246142|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246143|NCT04519437|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
139246144|NCT04519437|Antiviral Agents|antiviral agents|mesh-ancestor
139246145|NCT04519437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139246146|NCT01359085|Pregabalin|pregabalin|mesh-list
139246147|NCT01359085|Analgesics|analgesics|mesh-ancestor
139246148|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
139340608|NCT03059511|Analgesics|analgesics|mesh-ancestor
139246149|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246150|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246151|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
139246152|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139246153|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139246154|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340681|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139246155|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139246156|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139246157|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139340749|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
139246158|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246159|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139246160|NCT04322357|Prednisone|prednisone|mesh-list
139246161|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
139246162|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246163|NCT04322357|Hormones|hormones|mesh-ancestor
139246164|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139246165|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246166|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139246167|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246168|NCT01351285|Remifentanil|remifentanil|mesh-list
139246169|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139246170|NCT01351285|Narcotics|narcotics|mesh-ancestor
139246171|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246172|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246173|NCT01351285|Analgesics|analgesics|mesh-ancestor
139246174|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
139246175|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246176|NCT02032290|Clopidogrel|clopidogrel|mesh-list
139246177|NCT02032290|Ticagrelor|ticagrelor|mesh-list
139246178|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139246179|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139341038|NCT05622123|Exenatide|exenatide|mesh-list
139246180|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139246181|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139246182|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
139246183|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246184|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341098|NCT05390905|Analgesics|analgesics|mesh-ancestor
139246185|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246186|NCT03379428|Trastuzumab|trastuzumab|mesh-list
139246187|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139246188|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246189|NCT03628131|Carboplatin|carboplatin|mesh-list
139246190|NCT03628131|Etoposide|etoposide|mesh-list
139246191|NCT03628131|Ifosfamide|ifosfamide|mesh-list
139246192|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246193|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139246194|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139246195|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139246196|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246197|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246198|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139246199|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
139246200|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
139246201|NCT03560024|Growth Substances|growth substances|mesh-ancestor
139246202|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246203|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
139246204|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139341299|NCT04476277|Biotin|biotin|mesh-list
139246205|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246206|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139246207|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139246208|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
139246209|NCT03612492|Lidocaine|lidocaine|mesh-list
139246210|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
139246211|NCT03612492|Anesthetics|anesthetics|mesh-list
139246212|NCT03612492|Esmolol|esmolol|mesh-list
139246213|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116374|NCT03819348|Miconazole|miconazole|mesh-list
139341373|NCT04285346|Ganaxolone|ganaxolone|mesh-list
139246214|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246215|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
139246216|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246217|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139246218|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139246219|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139246220|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139246221|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246222|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139246223|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139246224|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
139246225|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472327|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246226|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139246227|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
139246228|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139341657|NCT01256398|Melphalan|melphalan|mesh-list
139246229|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139246230|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139246231|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
139246232|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139246233|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246234|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139246235|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139246236|NCT01351597|Docetaxel|docetaxel|mesh-list
139246237|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
139246238|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246239|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
139246240|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
139246241|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
139246242|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246243|NCT02793128|Mitomycins|mitomycins|mesh-list
139246244|NCT02793128|Mitomycin|mitomycin|mesh-list
139246245|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139246246|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246247|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
139246248|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246249|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139341870|NCT02673567|Antibodies|antibodies|mesh-list
139246250|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246251|NCT03612180|Metoprolol|metoprolol|mesh-list
139246252|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139246253|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139246254|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
139246255|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
139246256|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246257|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246258|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139246259|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139246260|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139246261|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
139246262|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246263|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246264|NCT04400799|Enoxaparin|enoxaparin|mesh-list
139246265|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
139246266|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139246267|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139472328|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246268|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246269|NCT01359241|Insulin|insulin|mesh-list
139246270|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139246271|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246272|NCT02068196|Ipilimumab|ipilimumab|mesh-list
139246273|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139342214|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
139246274|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246275|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139246276|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246277|NCT03142451|Minocycline|minocycline|mesh-list
139246278|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139246279|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139342296|NCT02372318|Nalmefene|nalmefene|mesh-list
139246280|NCT04065789|Dexamethasone|dexamethasone|mesh-list
139246281|NCT04065789|Lenalidomide|lenalidomide|mesh-list
139246282|NCT04065789|Daratumumab|daratumumab|mesh-list
139246283|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246284|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
139246285|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
139246286|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246287|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246288|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139246289|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
139246290|NCT04065789|Hormones|hormones|mesh-ancestor
139246291|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139246292|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139246293|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246294|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
139246295|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139246296|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139246297|NCT04065789|Growth Substances|growth substances|mesh-ancestor
139246298|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
139246299|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
139246300|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
139246301|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246302|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
139246303|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246304|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246305|NCT02064842|Ritonavir|ritonavir|mesh-list
139246306|NCT02064842|Simeprevir|simeprevir|mesh-list
139246307|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139246308|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139246309|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
139246310|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342633|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139246311|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246312|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139246313|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139246314|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
139091678|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246315|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139246316|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139246317|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139246319|NCT04192266|Estrogens|estrogens|mesh-ancestor
139246320|NCT04192266|Hormones|hormones|mesh-ancestor
139246321|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139246322|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246323|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
139246324|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139246325|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246326|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246327|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139342836|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
139246328|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139246329|NCT01359397|Bevacizumab|bevacizumab|mesh-list
139246330|NCT01359397|Trastuzumab|trastuzumab|mesh-list
139246331|NCT01359397|Docetaxel|docetaxel|mesh-list
139246332|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
139246333|NCT01359397|Capecitabine|capecitabine|mesh-list
139246334|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139246335|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246336|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139246337|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139246338|NCT01359397|Growth Substances|growth substances|mesh-ancestor
139246339|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246340|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
139246341|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
139246342|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
139246343|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
139246344|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246345|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139343115|NCT02510794|Ranibizumab|ranibizumab|mesh-list
139246346|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
139246347|NCT05250245|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139246348|NCT05250245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139246349|NCT05250245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139246350|NCT05250245|Cholinergic Agents|cholinergic agents|mesh-ancestor
139246351|NCT05250245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343179|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246352|NCT05250245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246353|NCT05250245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246354|NCT05250245|Urological Agents|urological agents|mesh-ancestor
139246355|NCT01347983|Methotrexate|methotrexate|mesh-list
139246356|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139246357|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
139246358|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139246359|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246360|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139246361|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
139246362|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246363|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246364|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
139246365|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246366|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139246367|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139343397|NCT02906917|Insulin|insulin|mesh-list
139246368|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
139246369|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139246370|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139246371|NCT05249933|Benzocaine|benzocaine|mesh-list
139246372|NCT05249933|Anesthetics, Local|anesthetics, local|mesh-ancestor
139246373|NCT05249933|Anesthetics|anesthetics|mesh-ancestor
139246374|NCT05249933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246375|NCT05249933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246376|NCT05249933|Sensory System Agents|sensory system agents|mesh-ancestor
139246377|NCT05249933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246378|NCT02032836|Iloprost|iloprost|mesh-list
139246379|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139246380|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
139246381|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
139246382|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
139246383|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
139343594|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139246384|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246385|NCT02465593|Capecitabine|capecitabine|mesh-list
139246386|NCT02465593|Fluorouracil|fluorouracil|mesh-list
139246387|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139246388|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
139343742|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139246389|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246390|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246391|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139343814|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
139246392|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
139246393|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246394|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139246395|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246396|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
139246397|NCT02424019|Hormones|hormones|mesh-ancestor
139246398|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139246399|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246400|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
139246401|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246402|NCT03611244|Benzocaine|benzocaine|mesh-list
139246403|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
139246404|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
139246405|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246406|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246407|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
139246408|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246409|NCT01359709|Nicotine|nicotine|mesh-list
139246410|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139246411|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
139246412|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246413|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246414|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139246415|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139246416|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
139246417|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246418|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246419|NCT02826486|Leucovorin|leucovorin|mesh-list
139246420|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
139246421|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139246422|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246423|NCT02826486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139246424|NCT02826486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246425|NCT02826486|Antidotes|antidotes|mesh-ancestor
139246426|NCT02826486|Protective Agents|protective agents|mesh-ancestor
139246427|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344243|NCT03645109|Vitamin D|vitamin d|mesh-list
139246428|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
139246429|NCT02826486|Vitamins|vitamins|mesh-ancestor
139246430|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
139246431|NCT02825940|Gemcitabine|gemcitabine|mesh-list
139246432|NCT02825940|Atezolizumab|atezolizumab|mesh-list
139246433|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344308|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
139246434|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139246435|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
139642250|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139246436|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246437|NCT02825940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139246438|NCT02825940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139246439|NCT02304991|Glycerol|glycerol|mesh-list
139246440|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139246441|NCT02304991|Protective Agents|protective agents|mesh-ancestor
139246442|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246443|NCT02069132|Warfarin|warfarin|mesh-list
139246444|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
139246445|NCT01352065|Bosentan|bosentan|mesh-list
139246446|NCT01352065|Ambrisentan|ambrisentan|mesh-list
139246447|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139246448|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139246449|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246450|NCT01356043|Niacin|niacin|mesh-list
139246451|NCT01356043|Amlodipine|amlodipine|mesh-list
139246452|NCT01356043|Telmisartan|telmisartan|mesh-list
139246453|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139246454|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139246455|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139344653|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139246456|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246457|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139246458|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246459|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
139246460|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139246461|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139246462|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139246463|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
139246464|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139344790|NCT03655535|PAZ320|paz320|mesh-list
139246465|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
139246466|NCT01356043|Vitamins|vitamins|mesh-ancestor
139246467|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
139246468|NCT02065388|Warfarin|warfarin|mesh-list
139246469|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
139246470|NCT01317563|Vitamin A|vitamin a|mesh-list
139246471|NCT01317563|Selenium|selenium|mesh-list
139246472|NCT01317563|Vitamins|vitamins|mesh-ancestor
139246473|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
139246474|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246475|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
139246476|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246477|NCT01317563|Protective Agents|protective agents|mesh-ancestor
139246478|NCT01317563|Trace Elements|trace elements|mesh-ancestor
139246479|NCT02067338|Morphine|morphine|mesh-list
139246480|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
139246481|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139246482|NCT02067338|Narcotics|narcotics|mesh-ancestor
139344856|NCT03468465|Urological Agents|urological agents|mesh-ancestor
139246483|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246484|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246485|NCT02067338|Analgesics|analgesics|mesh-ancestor
139246486|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
139246487|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246488|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
139246489|NCT02067338|Coagulants|coagulants|mesh-ancestor
139246490|NCT01352143|Thrombin|thrombin|mesh-list
139246491|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
139246492|NCT01352143|Coagulants|coagulants|mesh-ancestor
139246493|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
139246494|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
139246495|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
139246496|NCT05188495|Trastuzumab|trastuzumab|mesh-list
139246497|NCT05188495|Pertuzumab|pertuzumab|mesh-list
139246498|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139345142|NCT03719001|Analgesics|analgesics|mesh-ancestor
139246499|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246500|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
139246501|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246502|NCT01356121|Midazolam|midazolam|mesh-list
139246503|NCT01356121|Propofol|propofol|mesh-list
139246504|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139246505|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246506|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246507|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139246508|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
139246509|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
139246510|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139246511|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139246512|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139246513|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139246514|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
139246515|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
139246516|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246517|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246518|NCT01336608|Fluticasone|fluticasone|mesh-list
139246519|NCT01336608|Xhance|xhance|mesh-list
139246520|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246521|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139246522|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
139246523|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246524|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246525|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139246526|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
139246527|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
139246528|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139246529|NCT03628521|Carboplatin|carboplatin|mesh-list
139246530|NCT03628521|Gemcitabine|gemcitabine|mesh-list
139246531|NCT03628521|Pemetrexed|pemetrexed|mesh-list
139246532|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139246533|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246534|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139246535|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
139246536|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246537|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246538|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139246539|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139246540|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139246541|NCT05697003|Fluticasone|fluticasone|mesh-list
139246542|NCT05697003|Xhance|xhance|mesh-list
139246543|NCT05697003|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139246544|NCT05697003|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139246545|NCT05697003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139345700|NCT03432273|Nicotine|nicotine|mesh-list
139246546|NCT05697003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139246547|NCT05697003|Autonomic Agents|autonomic agents|mesh-ancestor
139246548|NCT05697003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246549|NCT05697003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246550|NCT05697003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139246551|NCT05697003|Respiratory System Agents|respiratory system agents|mesh-ancestor
139246552|NCT05697003|Dermatologic Agents|dermatologic agents|mesh-ancestor
139246553|NCT05697003|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139345867|NCT04941196|Ticagrelor|ticagrelor|mesh-list
139246554|NCT05697003|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139246555|NCT05697003|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139246556|NCT05697003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139246557|NCT05697003|Adrenergic Agents|adrenergic agents|mesh-ancestor
139246558|NCT05697003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246559|NCT05697003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246560|NCT05697003|Glucocorticoids|glucocorticoids|mesh-ancestor
139246561|NCT05697003|Hormones|hormones|mesh-ancestor
139345909|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
139246562|NCT05697003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139246563|NCT05697003|Sympathomimetics|sympathomimetics|mesh-ancestor
139246564|NCT02069522|Carotenoids|carotenoids|mesh-list
139246565|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
139246566|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246567|NCT02069522|Protective Agents|protective agents|mesh-ancestor
139246568|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246569|NCT01361425|Methyldopa|methyldopa|mesh-list
139246570|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139246571|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
139246572|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
139246573|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246574|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246575|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139246576|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139246577|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139246578|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
139246579|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246580|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246581|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139246582|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139246583|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139246584|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
139246585|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246586|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346109|NCT03422445|Temozolomide|temozolomide|mesh-list
139246587|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246588|NCT01356355|Urological Agents|urological agents|mesh-ancestor
139246589|NCT01356433|Vitamins|vitamins|mesh-list
139246590|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
139246591|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
139246592|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246593|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
139246594|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246595|NCT01356433|Protective Agents|protective agents|mesh-ancestor
139246596|NCT03691727|Tirofiban|tirofiban|mesh-list
139246597|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139246598|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139246599|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246600|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139246601|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139246602|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
139246603|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139246604|NCT01356511|Dexamethasone|dexamethasone|mesh-list
139246605|NCT01356511|Prednisone|prednisone|mesh-list
139246606|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246607|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
139246608|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
139246609|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246610|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246611|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139246612|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
139246613|NCT01356511|Hormones|hormones|mesh-ancestor
139003177|NCT00669617|Xhance|xhance|mesh-list
139246614|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139246615|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139246616|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246617|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
139246618|NCT02069990|Vitamin D|vitamin d|mesh-list
139246619|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139246620|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246621|NCT02069990|Vitamins|vitamins|mesh-ancestor
139246622|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
139246623|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139246624|NCT05076409|Fluconazole|fluconazole|mesh-list
139246625|NCT05076409|BI 425809|bi 425809|mesh-list
139246626|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
139246627|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139246628|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139246629|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139246630|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346590|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139246631|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246632|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139246633|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
139472329|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139246634|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139246635|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246636|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139246637|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139246638|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
139246639|NCT02076386|Dolutegravir|dolutegravir|mesh-list
139246640|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139246641|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139246642|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246643|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246644|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139246645|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139246646|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
139246647|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139246648|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
139246649|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139246650|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139246651|NCT02072330|Amlodipine|amlodipine|mesh-list
139246652|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139246653|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139246654|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139246655|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139246656|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139246657|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246658|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139246659|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246660|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
139246661|NCT02072330|Diuretics|diuretics|mesh-ancestor
139246662|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
139246663|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139246664|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139091623|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246665|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139246666|NCT02072408|Aflibercept|aflibercept|mesh-list
139246667|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139246668|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139246669|NCT02072408|Growth Substances|growth substances|mesh-ancestor
139246670|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246671|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
139246672|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246673|NCT02070458|Cytarabine|cytarabine|mesh-list
139246674|NCT02070458|Etoposide|etoposide|mesh-list
139246675|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
139246676|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
139246677|NCT02070458|Ixazomib|ixazomib|mesh-list
139246678|NCT02070458|Glycine|glycine|mesh-list
139246679|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
139246680|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139246681|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246682|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139246683|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139246684|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246685|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472330|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
139246686|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139246687|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
139246688|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
139246689|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139246690|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139246691|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
139246692|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246693|NCT02070458|Analgesics|analgesics|mesh-ancestor
139246694|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
139347204|NCT02354768|Lanreotide|lanreotide|mesh-list
139246695|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246696|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
139246697|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
139246698|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246700|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139246701|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246702|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139246703|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246704|NCT02077010|Milrinone|milrinone|mesh-list
139246705|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139246706|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139246707|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
139246708|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139246709|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139347416|NCT03612739|Azacitidine|azacitidine|mesh-list
139246710|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246711|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246712|NCT02077010|Protective Agents|protective agents|mesh-ancestor
139246713|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246714|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
139246715|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139246716|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
139246717|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246718|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
139246719|NCT01319461|Protective Agents|protective agents|mesh-ancestor
139246720|NCT02072720|Bevacizumab|bevacizumab|mesh-list
139246721|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139246722|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246723|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139246724|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139246725|NCT02072720|Growth Substances|growth substances|mesh-ancestor
139004391|NCT01095133|Amiloride|amiloride|mesh-list
139246726|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246727|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
139246728|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
139246729|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139246730|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
139246731|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
139246732|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246733|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246734|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139347697|NCT02031965|Hormones|hormones|mesh-ancestor
139246735|NCT01356745|Analgesics|analgesics|mesh-ancestor
139246736|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
139246737|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246738|NCT02072798|Cefuroxime|cefuroxime|mesh-list
139246739|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
139642251|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
139246740|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139246741|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139246742|NCT04943549|Bupivacaine|bupivacaine|mesh-list
139246743|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
139246744|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
139246745|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246746|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246747|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
139246748|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246749|NCT04252105|Antioxidants|antioxidants|mesh-list
139347899|NCT02346890|Sevelamer|sevelamer|mesh-list
139246750|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246751|NCT04252105|Protective Agents|protective agents|mesh-ancestor
139246752|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246753|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
139246754|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
139246755|NCT02077322|Coagulants|coagulants|mesh-ancestor
139246756|NCT02077400|Cefazolin|cefazolin|mesh-list
139246757|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139246758|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139246759|NCT02077478|Remifentanil|remifentanil|mesh-list
139246760|NCT02077478|Propofol|propofol|mesh-list
139246761|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139246762|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246763|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246764|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139246765|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
139246766|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
139246767|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139246768|NCT02077478|Narcotics|narcotics|mesh-ancestor
139348126|NCT02348528|Hormones|hormones|mesh-ancestor
139246769|NCT02077478|Analgesics|analgesics|mesh-ancestor
139246770|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
139246771|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246772|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
139246773|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
139246774|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139246776|NCT02077556|Everolimus|everolimus|mesh-list
139246777|NCT02077556|Tacrolimus|tacrolimus|mesh-list
139246778|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139246779|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
139246780|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246781|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139246782|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246783|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246784|NCT02077556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139246785|NCT02077556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139246786|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246787|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139246788|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139246789|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
139246790|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139246791|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139246792|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246793|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
139246794|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
139246795|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246796|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139246797|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
139246798|NCT02077556|Hormones|hormones|mesh-ancestor
139246799|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139246800|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139246801|NCT02077556|Protective Agents|protective agents|mesh-ancestor
139246802|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139246803|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
139246804|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139246805|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139246806|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246807|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
139246808|NCT02930941|Coagulants|coagulants|mesh-ancestor
139246809|NCT02077634|Prednisone|prednisone|mesh-list
139246810|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
139246811|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246812|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
139246813|NCT02077634|Hormones|hormones|mesh-ancestor
139246814|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139246815|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246816|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139642252|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
139246817|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246818|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139246819|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246820|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246821|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
139246822|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139246823|NCT01365403|Carbamazepine|carbamazepine|mesh-list
139246824|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
139246825|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
139246826|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139246827|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139472331|NCT02616640|Hormones|hormones|mesh-ancestor
139246828|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246829|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139246830|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139246831|NCT01365403|Analgesics|analgesics|mesh-ancestor
139246832|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
139246833|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246834|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139246835|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139246836|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246837|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139246838|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139246839|NCT01352663|Insulin|insulin|mesh-list
139246840|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
139246841|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139246842|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246843|NCT01362361|Nintedanib|nintedanib|mesh-list
139246844|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246845|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139246846|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203472|NCT01334502|Prednisone|prednisone|mesh-list
139246847|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246848|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
139246849|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139246850|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246851|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348996|NCT02327234|Analgesics|analgesics|mesh-ancestor
139246852|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139246853|NCT02077712|Analgesics|analgesics|mesh-ancestor
139246854|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
139246855|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349063|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
139246856|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139246857|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139246858|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139246859|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
139246860|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246861|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246862|NCT02073734|Dexamethasone|dexamethasone|mesh-list
139246863|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246864|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
139246865|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
139246866|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246867|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246868|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139246869|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
139246870|NCT02073734|Hormones|hormones|mesh-ancestor
139246871|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139246872|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139246873|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246874|NCT02071004|Aspirin|aspirin|mesh-list
139349272|NCT02326610|Hormones|hormones|mesh-list
139246875|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139246876|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139246877|NCT02071004|Analgesics|analgesics|mesh-ancestor
139246878|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
139246879|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246880|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246881|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246882|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139246883|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139246884|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139246885|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246886|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139246887|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139246888|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246889|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
139246890|NCT02071160|Melatonin|melatonin|mesh-list
139246891|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
139246892|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246893|NCT02071160|Protective Agents|protective agents|mesh-ancestor
139246894|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246895|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246896|NCT03131713|Acetaminophen|acetaminophen|mesh-list
139246897|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139246898|NCT03131713|Analgesics|analgesics|mesh-ancestor
139246899|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
139246900|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246901|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246902|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
139246903|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
139246904|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139246905|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246906|NCT03514121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139246907|NCT03514121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349602|NCT03608501|Thalidomide|thalidomide|mesh-list
139246908|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
139246909|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
139246910|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
139349671|NCT03386643|Clobetasol|clobetasol|mesh-list
139246911|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139246912|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139246913|NCT02930005|Analgesics|analgesics|mesh-ancestor
139349742|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
139246914|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
139349813|NCT02854631|Hormones|hormones|mesh-ancestor
139246915|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246916|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246917|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246918|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139203539|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139246920|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246921|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246922|NCT01349387|Metformin|metformin|mesh-list
139246923|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139246924|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246925|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
139246926|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
139246927|NCT01361269|Clindamycin|clindamycin|mesh-list
139246928|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
139246929|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
139246930|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
139246931|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139246932|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139246933|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139246934|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246935|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246936|NCT01353209|Letrozole|letrozole|mesh-list
139246937|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246938|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139246939|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139246940|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246941|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246942|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139246943|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
139246944|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139246945|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246946|NCT03637491|Avelumab|avelumab|mesh-list
139246947|NCT03637491|Talazoparib|talazoparib|mesh-list
139246948|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139246949|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246950|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139246951|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350085|NCT03252626|Alprostadil|alprostadil|mesh-list
139246952|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246953|NCT01363063|Ketorolac|ketorolac|mesh-list
139246954|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139246955|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139246956|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139246957|NCT01363063|Analgesics|analgesics|mesh-ancestor
139246958|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
139246959|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139246960|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350234|NCT02237495|Analgesics|analgesics|mesh-ancestor
139246961|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139246962|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139246963|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139246964|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139246965|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350294|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
139246967|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139246968|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139246969|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
139246970|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246971|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139246972|NCT01349699|Deferasirox|deferasirox|mesh-list
139246973|NCT01349699|Hematinics|hematinics|mesh-ancestor
139246974|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139246975|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
139246976|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
139246977|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246978|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139350444|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
139246979|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139246980|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
139246981|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246982|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246983|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246984|NCT03628443|Mitogens|mitogens|mesh-list
139246985|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
139246986|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139246987|NCT01365871|Anesthetics|anesthetics|mesh-list
139246988|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139246989|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139246990|NCT01349777|Clopidogrel|clopidogrel|mesh-list
139246991|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139246992|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139246993|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139246994|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139246995|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
139350654|NCT06042426|Morphine|morphine|mesh-list
139246996|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139246997|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350706|NCT06041711|Anesthetics|anesthetics|mesh-list
139246998|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247000|NCT03446157|Palbociclib|palbociclib|mesh-list
139247001|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139247002|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247003|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139247004|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247005|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247006|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
139247007|NCT04700007|Promethazine|promethazine|mesh-list
139247008|NCT04700007|Morphine|morphine|mesh-list
139247009|NCT04700007|Capsaicin|capsaicin|mesh-list
139247010|NCT04700007|Histamine|histamine|mesh-list
139247011|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-list
139247012|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139247013|NCT04700007|Narcotics|narcotics|mesh-ancestor
139247014|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139247015|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247016|NCT04700007|Analgesics|analgesics|mesh-ancestor
139247017|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
139247018|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247019|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
139247020|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
139247021|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139247022|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139247023|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
139247024|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
139247025|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
139247026|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
139247027|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139247028|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139247029|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
139247030|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247031|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247032|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139247033|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
139247034|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
139247035|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139247036|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247037|NCT01318655|Naloxegol|naloxegol|mesh-list
139247038|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139247039|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247040|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
139247041|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247042|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
139247043|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139247044|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
139247045|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139247047|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247048|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139247049|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139247050|NCT01350089|Ethanol|ethanol|mesh-list
139247051|NCT01350089|Caffeine|caffeine|mesh-list
139247052|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139247053|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247054|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139247055|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247056|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139247057|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139247058|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247059|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247060|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139247061|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139247062|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
139247063|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247064|NCT03137303|Albuterol|albuterol|mesh-list
139247065|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139247066|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
139247067|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247068|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247069|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139247070|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
139247072|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139247073|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139247074|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139247075|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139247076|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
139247077|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247078|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247079|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139247080|NCT03296553|Valganciclovir|valganciclovir|mesh-list
139247081|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
139247082|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247083|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
139247084|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139247085|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247086|NCT01370707|Metformin|metformin|mesh-list
139247087|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139351074|NCT05408559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247088|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247089|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139247090|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247091|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
139247092|NCT01363609|Liraglutide|liraglutide|mesh-list
139247093|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139247094|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247095|NCT01363609|Incretins|incretins|mesh-ancestor
139247096|NCT01363609|Hormones|hormones|mesh-ancestor
139247097|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139247098|NCT03060447|Vesatolimod|vesatolimod|mesh-list
139247099|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
139247100|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247101|NCT04623567|Metformin|metformin|mesh-list
139247102|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139247103|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247104|NCT01712789|Dexamethasone|dexamethasone|mesh-list
139247105|NCT01712789|Pomalidomide|pomalidomide|mesh-list
139247106|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139247107|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
139247108|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
139247109|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247110|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247111|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139247112|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
139247113|NCT01712789|Hormones|hormones|mesh-ancestor
139247114|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139247115|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139247116|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247117|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
139247118|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139247119|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139247120|NCT01712789|Growth Substances|growth substances|mesh-ancestor
139247121|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
139247122|NCT01350323|Bevacizumab|bevacizumab|mesh-list
139247123|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139247124|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247125|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139247126|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139247127|NCT01350323|Growth Substances|growth substances|mesh-ancestor
139247128|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247129|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
139247130|NCT03074318|Avelumab|avelumab|mesh-list
139247131|NCT03074318|Trabectedin|trabectedin|mesh-list
139247132|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139247133|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139247134|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247135|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139247136|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
139247137|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247138|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
139247139|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247140|NCT02071316|Esomeprazole|esomeprazole|mesh-list
139247141|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
139247142|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139247143|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139247144|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247145|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
139247146|NCT02071316|Coagulants|coagulants|mesh-ancestor
139247147|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139247148|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139247149|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139247150|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247151|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139247152|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139247153|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247154|NCT02074280|Rifaximin|rifaximin|mesh-list
139247155|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139247156|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247157|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139247158|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139247159|NCT02077946|Liraglutide|liraglutide|mesh-list
139247160|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139247161|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247162|NCT02077946|Incretins|incretins|mesh-ancestor
139247163|NCT02077946|Hormones|hormones|mesh-ancestor
139247164|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139247165|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139247166|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
139247167|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247168|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247169|NCT03559790|Tenofovir|tenofovir|mesh-list
139247170|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
139247171|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247172|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139247173|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139247174|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351605|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
139247175|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247176|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139247177|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139247178|NCT02079974|Pravastatin|pravastatin|mesh-list
139247179|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139247180|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139247181|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
139247182|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247183|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139247184|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139247185|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247186|NCT01353755|Immunomodulating Agents|immunomodulating agents|mesh-list
139247187|NCT01353755|Immunologic Factors|immunologic factors|mesh-ancestor
139247188|NCT01353755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247189|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139247190|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
139247191|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247192|NCT01317953|Protective Agents|protective agents|mesh-ancestor
139247193|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247194|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139247195|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139247196|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247197|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139247198|NCT02078336|Atropine|atropine|mesh-list
139247199|NCT02078336|Midazolam|midazolam|mesh-list
139247200|NCT02078336|Droperidol|droperidol|mesh-list
139247201|NCT02078336|Lorazepam|lorazepam|mesh-list
139247202|NCT02078336|Biperiden|biperiden|mesh-list
139247203|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139247204|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139247205|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139247206|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247207|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139247208|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139247209|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139247210|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139247211|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
139247212|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
139247213|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
139247214|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
139247215|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247216|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247217|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139247218|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139247219|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
139247220|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247221|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139247222|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
139247224|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
139247225|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139247226|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139247227|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
139247228|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
139247229|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
139247230|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139247231|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139247232|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139247233|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139247234|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139247235|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139247236|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
139247237|NCT01353833|Aldesleukin|aldesleukin|mesh-list
139247238|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247239|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139247240|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139247241|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
139247242|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247243|NCT03353675|Nivolumab|nivolumab|mesh-list
139247244|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139247245|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247246|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139247247|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247248|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
139247249|NCT01350713|Povidone|povidone|mesh-list
139247250|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
139247251|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
139247252|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139247253|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247254|NCT02075294|Entecavir|entecavir|mesh-list
139247255|NCT02075294|Adefovir|adefovir|mesh-list
139247256|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139247257|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
139247258|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247259|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139247260|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139247261|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247262|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247263|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139247264|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
139247265|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139247266|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139247267|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139247268|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139247269|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247270|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139247271|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139247272|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139247273|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139247274|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247275|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139247276|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139247277|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139247278|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
139247279|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247280|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247281|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139247282|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139247283|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
139247285|NCT01358045|Diclofenac|diclofenac|mesh-list
139247286|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139247287|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139247288|NCT01358045|Analgesics|analgesics|mesh-ancestor
139247289|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
139247290|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247291|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247292|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139247293|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139247294|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139247295|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247296|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247297|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139247298|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139247299|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139247300|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139247301|NCT01358045|Vitamins|vitamins|mesh-ancestor
139247302|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
139247303|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139247304|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
139247305|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139247306|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
139247307|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247308|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247309|NCT01357811|Digoxin|digoxin|mesh-list
139247310|NCT01357811|Eliglustat|eliglustat|mesh-list
139247311|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139247312|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139247313|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247314|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247315|NCT01357811|Protective Agents|protective agents|mesh-ancestor
139247316|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247317|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
139247318|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
139247319|NCT04300985|Anesthetics|anesthetics|mesh-list
139247320|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139247321|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247322|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139247323|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139247324|NCT04300985|Analgesics|analgesics|mesh-ancestor
139247325|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
139247326|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247327|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139247328|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139247329|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139247330|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
139247331|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247332|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247333|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139247334|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
139247335|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139247336|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139247337|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139247338|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
139247339|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139247340|NCT02079194|Aspirin|aspirin|mesh-list
139247341|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139247342|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139247343|NCT02079194|Analgesics|analgesics|mesh-ancestor
139247344|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
139247345|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247346|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247347|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139247348|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139247349|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139247350|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139247351|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247352|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139247353|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139247354|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247355|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
139247356|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
139247357|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139247358|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
139247359|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247360|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247361|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139247362|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
139247363|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139247364|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
139247365|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247366|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247367|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139247368|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
139247370|NCT01351493|Protective Agents|protective agents|mesh-ancestor
139247371|NCT01318187|Acetaminophen|acetaminophen|mesh-list
139247372|NCT01318187|Morphine|morphine|mesh-list
139247373|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139247374|NCT01318187|Narcotics|narcotics|mesh-ancestor
139247375|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139247376|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247377|NCT01318187|Analgesics|analgesics|mesh-ancestor
139247378|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
139247379|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247380|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139247381|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
139247382|NCT01358435|Insulin|insulin|mesh-list
139247383|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139247384|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
139247385|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
139247386|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
139247387|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139247388|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247389|NCT01318265|Ketoconazole|ketoconazole|mesh-list
139247390|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
139247391|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247392|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139247393|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139247394|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247395|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247396|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139247397|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
139247398|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139247399|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247400|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139247401|NCT01354457|Epratuzumab|epratuzumab|mesh-list
139247402|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139247403|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247404|NCT02079350|Polygeline|polygeline|mesh-list
139247405|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
139247406|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
139247407|NCT03062540|Cyclobenzaprine|cyclobenzaprine|mesh-list
139247408|NCT03062540|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139247409|NCT03062540|Antidepressive Agents|antidepressive agents|mesh-ancestor
139247410|NCT03062540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139247411|NCT03062540|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139247412|NCT03062540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247413|NCT03062540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139247414|NCT03062540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247415|NCT03062540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139247416|NCT03062540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139247417|NCT03060980|Empagliflozin|empagliflozin|mesh-list
139247418|NCT03060980|Glimepiride|glimepiride|mesh-list
139247419|NCT03060980|Exenatide|exenatide|mesh-list
139247420|NCT03060980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139247421|NCT03060980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247422|NCT03060980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139352571|NCT03277924|Doxorubicin|doxorubicin|mesh-list
139247423|NCT03060980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247424|NCT03060980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139247425|NCT03060980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139247426|NCT03060980|Immunologic Factors|immunologic factors|mesh-ancestor
139247427|NCT03060980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139247428|NCT03060980|Incretins|incretins|mesh-ancestor
139247429|NCT03060980|Hormones|hormones|mesh-ancestor
139247430|NCT03060980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139247431|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
139247432|NCT01358591|Calcium|calcium|mesh-list
139247433|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139247434|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247435|NCT01358591|Antacids|antacids|mesh-ancestor
139247436|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247437|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139247438|NCT02081144|Nicotine|nicotine|mesh-list
139247439|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139247440|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
139247441|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247442|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247443|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139247444|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139247445|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
139247446|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247447|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247449|NCT02083328|Caffeine|caffeine|mesh-list
139247450|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139247451|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247452|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139247453|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247454|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247455|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139247456|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139247457|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
139247458|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247459|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139247460|NCT02083328|Diuretics|diuretics|mesh-ancestor
139247461|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
139247462|NCT02079506|Candesartan|candesartan|mesh-list
139247463|NCT02079506|Candesartan cilexetil|candesartan cilexetil|mesh-list
139247464|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139247465|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139247466|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139247467|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
139247468|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247469|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139247470|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139247471|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247472|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139247473|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139247474|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139247475|NCT02940548|Amlodipine|amlodipine|mesh-list
139247476|NCT02940548|Nifedipine|nifedipine|mesh-list
139247477|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139247478|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139352657|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247479|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139247480|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247481|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139247482|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352796|NCT05708521|Hydromorphone|hydromorphone|mesh-list
139247483|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
139247484|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
139247485|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139247486|NCT01366183|Paclitaxel|paclitaxel|mesh-list
139247487|NCT01366183|Carboplatin|carboplatin|mesh-list
139247488|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139247489|NCT01366183|Lenograstim|lenograstim|mesh-list
139247490|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139247491|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247492|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
139247493|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
139247494|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
139247495|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247496|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139247497|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
139247498|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247499|NCT03134183|Misoprostol|misoprostol|mesh-list
139247500|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139247501|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
139247502|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139247503|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247504|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139247505|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139247506|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
139247507|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
139247508|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139247509|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247510|NCT02083484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139247511|NCT02083484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247512|NCT01354613|Amlodipine|amlodipine|mesh-list
139247513|NCT01354613|Dobutamine|dobutamine|mesh-list
139247514|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139247515|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139247516|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139204146|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
139247517|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247518|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139247519|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247520|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
139247521|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139247522|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
139247523|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
139247524|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247525|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139247526|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139247527|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139247528|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
139247529|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247530|NCT01354613|Protective Agents|protective agents|mesh-ancestor
139247531|NCT02083640|Palbociclib|palbociclib|mesh-list
139247532|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247533|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139247534|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247535|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247536|NCT01352039|Heparin|heparin|mesh-list
139247537|NCT01352039|Calcium heparin|calcium heparin|mesh-list
139247538|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
139247539|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139247540|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139247541|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247542|NCT04419337|Metformin|metformin|mesh-list
139247543|NCT04419337|Pioglitazone|pioglitazone|mesh-list
139247544|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139247545|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139247546|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247547|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247548|NCT01359059|Pregabalin|pregabalin|mesh-list
139247549|NCT01359059|Analgesics|analgesics|mesh-ancestor
139247550|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
139247551|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247552|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247553|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
139247554|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139247555|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139247556|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247557|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139247558|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139247559|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139247560|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139247561|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139247562|NCT05189093|Antibodies|antibodies|mesh-list
139247563|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139247564|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
139247565|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247566|NCT01371331|Tacrolimus|tacrolimus|mesh-list
139247567|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139247568|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
139247569|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247570|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139247571|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247572|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247573|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
139247574|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139247575|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247576|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
139247577|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247578|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
139247579|NCT03133793|Vitamins|vitamins|mesh-ancestor
139247580|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
139247581|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247582|NCT03133481|Ropivacaine|ropivacaine|mesh-list
139247583|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
139247584|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
139247585|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139247586|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247587|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
139247588|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247589|NCT01366651|Doripenem|doripenem|mesh-list
139247590|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139204225|NCT01313429|Celecoxib|celecoxib|mesh-list
139247591|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247592|NCT05124509|Vaccines|vaccines|mesh-list
139247593|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
139247594|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247595|NCT02864316|Nivolumab|nivolumab|mesh-list
139247596|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139247597|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247598|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139247599|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247600|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
139247601|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139247602|NCT02862600|Perhexiline|perhexiline|mesh-list
139247603|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139247604|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139247605|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247606|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139247607|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247608|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
139247609|NCT01354925|Insulin|insulin|mesh-list
139247610|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139247611|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247612|NCT03556345|Trastuzumab|trastuzumab|mesh-list
139247613|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139247614|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247615|NCT03610230|Iron|iron|mesh-list
139247616|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139247617|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
139247618|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139247619|NCT03610230|Trace Elements|trace elements|mesh-ancestor
139247620|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
139247621|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247622|NCT03610230|Hematinics|hematinics|mesh-ancestor
139247623|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
139247624|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
139247625|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247626|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247627|NCT05188859|Pemetrexed|pemetrexed|mesh-list
139247628|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247629|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247630|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247631|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139247632|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139247633|NCT02033538|Paclitaxel|paclitaxel|mesh-list
139247634|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139247635|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139353171|NCT04868877|Osimertinib|osimertinib|mesh-list
139247636|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247637|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
139247638|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
139247639|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
139117830|NCT04581148|Antibodies|antibodies|mesh-list
139353227|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139247640|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247641|NCT02792192|Atezolizumab|atezolizumab|mesh-list
139247642|NCT02792192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139247643|NCT02792192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247644|NCT02792192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139247645|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247646|NCT03609996|Ranibizumab|ranibizumab|mesh-list
139247647|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139247648|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139247649|NCT03609996|Growth Substances|growth substances|mesh-ancestor
139247650|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247651|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
139247652|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247653|NCT02088008|Valsartan|valsartan|mesh-list
139247654|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139247655|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139247656|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139247657|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247658|NCT01361789|Dexamethasone|dexamethasone|mesh-list
139247659|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
139247660|NCT01361789|Etoricoxib|etoricoxib|mesh-list
139247661|NCT01361789|Parecoxib|parecoxib|mesh-list
139247662|NCT01361789|Valdecoxib|valdecoxib|mesh-list
139247663|NCT01361789|BB 1101|bb 1101|mesh-list
139204298|NCT01313585|Albuterol|albuterol|mesh-list
139353380|NCT04174196|Cc-486|cc-486|mesh-list
139247664|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139247665|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
139247666|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
139247667|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247668|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247669|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139247670|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
139247671|NCT01361789|Hormones|hormones|mesh-ancestor
139247672|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139247673|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139247674|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247675|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
139247676|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247677|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247678|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139247679|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139247680|NCT01361789|Analgesics|analgesics|mesh-ancestor
139247681|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
139247682|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139247683|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139247684|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139247685|NCT02964507|Fulvestrant|fulvestrant|mesh-list
139247686|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139247687|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247688|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139247689|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139247690|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
139247691|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139247692|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247693|NCT02083874|Cannabidiol|cannabidiol|mesh-list
139247694|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
139247695|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
139247696|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139247697|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247698|NCT05188781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139247699|NCT05188781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247700|NCT03634735|Thiamine|thiamine|mesh-list
139247701|NCT03634735|Vitamins|vitamins|mesh-ancestor
139247702|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
139247703|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247704|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
139247705|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139247706|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
139247707|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139247708|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139247709|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247710|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
139247711|NCT02084342|Coagulants|coagulants|mesh-ancestor
139642253|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353464|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
139247712|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139247713|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
139247714|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247715|NCT01371487|Trametinib|trametinib|mesh-list
139247716|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247717|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139247718|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247719|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247720|NCT02084420|Pantoprazole|pantoprazole|mesh-list
139247721|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139247722|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139247723|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139247724|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247725|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247726|NCT01367431|Xanthohumol|xanthohumol|mesh-list
139247727|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247728|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139247729|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139247730|NCT01367431|Growth Substances|growth substances|mesh-ancestor
139247731|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247732|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
139247733|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
139247734|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139247735|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247736|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
139247737|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247738|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
139204361|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247740|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
139247741|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139247742|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139247743|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247744|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247745|NCT01364701|Urological Agents|urological agents|mesh-ancestor
139247746|NCT02440464|Fludarabine|fludarabine|mesh-list
139247747|NCT02440464|Bortezomib|bortezomib|mesh-list
139247748|NCT02440464|Melphalan|melphalan|mesh-list
139247749|NCT02440464|Ixazomib|ixazomib|mesh-list
139247750|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247751|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247752|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139247753|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
139247754|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247755|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139247756|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
139247757|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139247758|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
139247759|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247760|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
139247761|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139247762|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247763|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
139247764|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247765|NCT02088398|Ricolinostat|ricolinostat|mesh-list
139247766|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247767|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139247768|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247769|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247770|NCT02084576|Ketorolac|ketorolac|mesh-list
139247771|NCT02084576|Nepafenac|nepafenac|mesh-list
139247772|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139247773|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139247774|NCT02084576|Analgesics|analgesics|mesh-ancestor
139247775|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
139247776|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247777|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247778|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139247779|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139247780|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139247781|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247782|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353706|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353707|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353708|NCT02730546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139353709|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139353710|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353711|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139353712|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
139353713|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139010553|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
139353714|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139353715|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
139353716|NCT02730546|Antidotes|antidotes|mesh-ancestor
139353717|NCT02730546|Protective Agents|protective agents|mesh-ancestor
139353718|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
139247783|NCT03131453|Umibecestat|umibecestat|mesh-list
139247784|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247785|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247786|NCT02084654|Exenatide|exenatide|mesh-list
139247787|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139247788|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247789|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139247790|NCT02084654|Incretins|incretins|mesh-ancestor
139247791|NCT02084654|Hormones|hormones|mesh-ancestor
139247792|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139247793|NCT01367743|Epinephrine|epinephrine|mesh-list
139247794|NCT01367743|Norepinephrine|norepinephrine|mesh-list
139247795|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139247796|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139247797|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139247798|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
139247799|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247800|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247801|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247802|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139247803|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139247804|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
139247805|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247806|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139247807|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
139247808|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
139247809|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
139247810|NCT02084732|Sorafenib|sorafenib|mesh-list
139247811|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247812|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139247813|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247814|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247815|NCT02780401|Vaccines|vaccines|mesh-list
139247816|NCT02780401|Sargramostim|sargramostim|mesh-list
139247817|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
139247818|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247819|NCT02533232|Minocycline|minocycline|mesh-list
139247820|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139247821|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247822|NCT02673151|Edetic Acid|edetic acid|mesh-list
139247823|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139247824|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
139247825|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
139247826|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247827|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
139247828|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139247829|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139247830|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139247831|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
139247832|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139247833|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139247834|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247835|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139247836|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139247837|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
139247838|NCT05042947|Hormones|hormones|mesh-ancestor
139247839|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139247840|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247841|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247842|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247843|NCT02082236|Sufentanil|sufentanil|mesh-list
139247844|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139247845|NCT02082236|Narcotics|narcotics|mesh-ancestor
139247846|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139247847|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247848|NCT02082236|Analgesics|analgesics|mesh-ancestor
139247849|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
139247850|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247851|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139247852|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139247853|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
139247854|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
139247855|NCT03557996|Listerine|listerine|mesh-list
139247856|NCT03557996|Fluorides|fluorides|mesh-list
139247857|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
139247858|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
139247859|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
139247860|NCT03557996|Protective Agents|protective agents|mesh-ancestor
139247861|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091624|NCT04381936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139247862|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139247863|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247864|NCT02296801|Letrozole|letrozole|mesh-list
139247865|NCT02296801|Palbociclib|palbociclib|mesh-list
139247866|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247867|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139247868|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139247869|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247870|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247871|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139247872|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
139247873|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139247874|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247875|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139247876|NCT02859324|Nivolumab|nivolumab|mesh-list
139247877|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139247878|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247879|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139247880|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353763|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
139353764|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353765|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353766|NCT02589496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139353767|NCT02589496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353768|NCT02213575|Minocycline|minocycline|mesh-list
139353769|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139353770|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139353771|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
139353772|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139247881|NCT02085590|Vaccines|vaccines|mesh-list
139247882|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
139247883|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
139247884|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247885|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139247886|NCT02143063|Cocaine|cocaine|mesh-list
139247887|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
139247888|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
139247889|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139247890|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247891|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
139247892|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247893|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139247894|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139247895|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139247896|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139247897|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247898|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
139247899|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247900|NCT02088866|Lidocaine|lidocaine|mesh-list
139247901|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
139247902|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
139247903|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139247904|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247905|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
139247906|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247907|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139247908|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139247909|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139247910|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139247911|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247912|NCT02859246|Guaifenesin|guaifenesin|mesh-list
139247913|NCT02859246|Expectorants|expectorants|mesh-ancestor
139247914|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
139247915|NCT02088944|Infliximab|infliximab|mesh-list
139247916|NCT02088944|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139247917|NCT02088944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139247918|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
139247919|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139247920|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139247921|NCT02073097|Acyclovir|acyclovir|mesh-list
139247922|NCT02073097|Prednisone|prednisone|mesh-list
139247923|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
139247924|NCT02073097|Rituximab|rituximab|mesh-list
139247925|NCT02073097|Doxorubicin|doxorubicin|mesh-list
139247926|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139247927|NCT02073097|Vincristine|vincristine|mesh-list
139247928|NCT02073097|Lenograstim|lenograstim|mesh-list
139247929|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139247930|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
139247931|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247932|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139247933|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139247934|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
139642254|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139247935|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247936|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139247937|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139247938|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139247939|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139247940|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139247941|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139247942|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247943|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139247944|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
139247945|NCT02073097|Hormones|hormones|mesh-ancestor
139247946|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139247947|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139247948|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139247949|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
139247950|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
139247951|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
139247952|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139247953|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
139247954|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139247955|NCT02921997|Vaccines|vaccines|mesh-list
139247956|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
139247957|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247958|NCT02791490|Metformin|metformin|mesh-list
139247959|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139247960|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139247961|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247962|NCT02791490|Incretins|incretins|mesh-ancestor
139247963|NCT02791490|Hormones|hormones|mesh-ancestor
139247964|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139247965|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139247966|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
139247967|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247968|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247969|NCT02085824|Enoxaparin|enoxaparin|mesh-list
139247970|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
139247971|NCT02085824|Dabigatran|dabigatran|mesh-list
139247972|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139247973|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
139247974|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139247975|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
139247976|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247977|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247978|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
139247979|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139247980|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139247981|NCT01368445|Azelastine|azelastine|mesh-list
139247982|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139247983|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
139247984|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139247985|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139247986|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139247987|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
139247988|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139247989|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139247990|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139247991|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139247992|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139247993|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139247994|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
139247995|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
139247996|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139247997|NCT02085902|Ropivacaine|ropivacaine|mesh-list
139247998|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
139247999|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
139248000|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139248001|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248002|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
139248003|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248004|NCT01368757|Lenalidomide|lenalidomide|mesh-list
139248005|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
139248006|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248007|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139248008|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139248009|NCT01368757|Growth Substances|growth substances|mesh-ancestor
139118186|NCT03766074|Vitamin D|vitamin d|mesh-list
139248010|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
139248011|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248012|NCT02086292|Lidocaine|lidocaine|mesh-list
139248013|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
139248014|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
139248015|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139248016|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248017|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
139248018|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248019|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139248020|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139248021|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139248022|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139248023|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248024|NCT02425644|Teriflunomide|teriflunomide|mesh-list
139248025|NCT02425644|Ponesimod|ponesimod|mesh-list
139248026|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139248027|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139248028|NCT02425644|Analgesics|analgesics|mesh-ancestor
139248029|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
139248030|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248031|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248032|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139248033|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139354125|NCT03593707|Metformin|metformin|mesh-list
139248034|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139248035|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
139248036|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139248037|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248038|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
139248039|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139248040|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
139248041|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139248042|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
139248043|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248044|NCT02086526|Metformin|metformin|mesh-list
139248045|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139248046|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248047|NCT04180995|Axitinib|axitinib|mesh-list
139248048|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248049|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139248050|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248051|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248052|NCT02089178|Remifentanil|remifentanil|mesh-list
139248053|NCT02089178|Anesthetics|anesthetics|mesh-list
139248054|NCT02089178|Propofol|propofol|mesh-list
139248055|NCT02089178|Sevoflurane|sevoflurane|mesh-list
139248056|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139248057|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248058|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139248059|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139248060|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
139248061|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139248062|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139248063|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139248064|NCT02089178|Narcotics|narcotics|mesh-ancestor
139248065|NCT02089178|Analgesics|analgesics|mesh-ancestor
139248066|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
139248067|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248068|NCT02089256|Liraglutide|liraglutide|mesh-list
139248069|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139248070|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248071|NCT02089256|Incretins|incretins|mesh-ancestor
139248072|NCT02089256|Hormones|hormones|mesh-ancestor
139248073|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139248074|NCT02861664|Fluorides|fluorides|mesh-list
139248075|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
139248076|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
139248077|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
139248078|NCT02861664|Protective Agents|protective agents|mesh-ancestor
139248079|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248080|NCT02086838|Dextrans|dextrans|mesh-list
139248081|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
139248082|NCT02086838|Hematinics|hematinics|mesh-list
139248083|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
139248084|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
139642255|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139248085|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
139248086|NCT02236962|Pioglitazone|pioglitazone|mesh-list
139248087|NCT02236962|Ephedrine|ephedrine|mesh-list
139248088|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139248089|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248090|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139248091|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
139248092|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
139248093|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248094|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139248095|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
139248096|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139248097|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248098|NCT04431375|Tenofovir|tenofovir|mesh-list
139248099|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
139248100|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248101|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139248102|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139248103|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248104|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248105|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139248106|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139248107|NCT02086994|Misoprostol|misoprostol|mesh-list
139248108|NCT02086994|Carbetocin|carbetocin|mesh-list
139248109|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139248110|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
139248111|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139248112|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248113|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139248114|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139248115|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
139248116|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139248117|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139248118|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248119|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139248120|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248121|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248123|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139248124|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139248125|NCT02087384|Vaccines|vaccines|mesh-list
139248126|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
139248127|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248128|NCT02087462|Vitamins|vitamins|mesh-list
139248129|NCT02087462|Thiamine|thiamine|mesh-list
139248130|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
139248131|NCT02087462|Diclofenac|diclofenac|mesh-list
139248132|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
139248133|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248134|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139248135|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139248136|NCT02087462|Analgesics|analgesics|mesh-ancestor
139248137|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
139248138|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354318|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
139248139|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139248140|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139248141|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139354391|NCT02518503|Atorvastatin|atorvastatin|mesh-list
139248142|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248143|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248144|NCT02087540|Telmisartan|telmisartan|mesh-list
139248145|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139248146|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139248147|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139248148|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
139248149|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248150|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139248151|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139248152|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248153|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139248154|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139248155|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139248156|NCT03206463|Dronabinol|dronabinol|mesh-list
139354528|NCT03601091|Midazolam|midazolam|mesh-list
139248157|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
139248158|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248159|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139248160|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139248161|NCT03206463|Analgesics|analgesics|mesh-ancestor
139248162|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
139248163|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248164|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139248165|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139248166|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354663|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
139248167|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248168|NCT03206463|Hormones|hormones|mesh-ancestor
139248169|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139248170|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
139248171|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139248172|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
139248173|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248174|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
139248175|NCT02091674|Protective Agents|protective agents|mesh-ancestor
139248176|NCT01218555|Lenalidomide|lenalidomide|mesh-list
139248177|NCT01218555|Everolimus|everolimus|mesh-list
139248178|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
139248179|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248180|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139248181|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139248182|NCT01218555|Growth Substances|growth substances|mesh-ancestor
139248183|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
139248184|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248185|NCT01218555|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139248186|NCT01218555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139248187|NCT01218555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248188|NCT01218555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248189|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139248190|NCT02091830|Acetaminophen|acetaminophen|mesh-list
139248191|NCT02091830|Cortisone|cortisone|mesh-list
139248192|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139248193|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139248194|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139248195|NCT02091830|Analgesics|analgesics|mesh-ancestor
139248196|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
139248197|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248198|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248199|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
139248200|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139248201|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
139248202|NCT01111305|Reslizumab|reslizumab|mesh-list
139248203|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139248204|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
139354936|NCT04505943|Isoniazid|isoniazid|mesh-list
139248205|NCT01111305|Filaricides|filaricides|mesh-ancestor
139248206|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
139248207|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
139248208|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139248209|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248210|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139248211|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248212|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248213|NCT03752307|Prednisone|prednisone|mesh-list
139248214|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
139248215|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
139248216|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139248217|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
139248218|NCT03752307|Hormones|hormones|mesh-ancestor
139248219|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139248220|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248221|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139248222|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248223|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
139248224|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
139248225|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248226|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139248227|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139355280|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
139248228|NCT03752307|Protective Agents|protective agents|mesh-ancestor
139248229|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139248230|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139248231|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
139248232|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139248233|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248234|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
139248235|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
139248236|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
139248237|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139248238|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
139248239|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139248240|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248241|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248242|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
139248243|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139248244|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248245|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248247|NCT02091908|Vaccines|vaccines|mesh-list
139248248|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
139248249|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248250|NCT02091908|Cathartics|cathartics|mesh-ancestor
139248251|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139248252|NCT03627897|Bupivacaine|bupivacaine|mesh-list
139248253|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
139248254|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
139248255|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139248256|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248257|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
139248258|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248259|NCT01372111|Cisplatin|cisplatin|mesh-list
139248260|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248261|NCT03125941|Dexamethasone|dexamethasone|mesh-list
139248262|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139248263|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
139248264|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
139355692|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139248265|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248266|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248267|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139248268|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
139248270|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139248271|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139248272|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248273|NCT02092142|Vaccines|vaccines|mesh-list
139248274|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
139248275|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248276|NCT02095886|BMS-955176|bms-955176|mesh-list
139248277|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139248278|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139248279|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
139248280|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248281|NCT01372579|Carboplatin|carboplatin|mesh-list
139248282|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248283|NCT02090036|Lumefantrine|lumefantrine|mesh-list
139248284|NCT02090036|Artemether|artemether|mesh-list
139248285|NCT02090036|Primaquine|primaquine|mesh-list
139248286|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139248287|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
139248288|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139248289|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139248290|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248291|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139248292|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139248293|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248294|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
139248295|NCT02092376|Vitamin D|vitamin d|mesh-list
139355964|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248296|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139248297|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248298|NCT02092376|Vitamins|vitamins|mesh-ancestor
139248299|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
139248300|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139248301|NCT05452928|Valacyclovir|valacyclovir|mesh-list
139248302|NCT05452928|Acyclovir|acyclovir|mesh-list
139248303|NCT05452928|Antiviral Agents|antiviral agents|mesh-ancestor
139248304|NCT05452928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248305|NCT03125395|Ivacaftor|ivacaftor|mesh-list
139248306|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139248307|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139248308|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248309|NCT01369303|Tenofovir|tenofovir|mesh-list
139248310|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
139248311|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248312|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139248313|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139248314|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248315|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248316|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139248317|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139248318|NCT02092532|Aflibercept|aflibercept|mesh-list
139248319|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139248320|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139248321|NCT02092532|Growth Substances|growth substances|mesh-ancestor
139248322|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248323|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
139248324|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248325|NCT02092766|Artesunate|artesunate|mesh-list
139248326|NCT02092766|Quinine|quinine|mesh-list
139248327|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
139248328|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139248329|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139248330|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248331|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248332|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
139248333|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
139248334|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139248335|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
139248336|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139356145|NCT00708435|Protein S|protein s|mesh-list
139248337|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248338|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139248339|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248340|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139248341|NCT02092766|Analgesics|analgesics|mesh-ancestor
139248342|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
139248343|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139248344|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
139248345|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139248346|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
139248347|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248349|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139248350|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
139248351|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
139248352|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
139248353|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248354|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356356|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
139248355|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139248356|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139248357|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139248358|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139248359|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139248360|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139248361|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139356428|NCT04482686|Vitamin D|vitamin d|mesh-list
139248362|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139248363|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139248364|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
139248365|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
139248366|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
139248367|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
139248368|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139248369|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248370|NCT02093000|Bevacizumab|bevacizumab|mesh-list
139248371|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139248372|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248373|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139248374|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139248375|NCT02093000|Growth Substances|growth substances|mesh-ancestor
139356636|NCT02982668|Metoclopramide|metoclopramide|mesh-list
139248376|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248377|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
139248378|NCT00261807|Daptomycin|daptomycin|mesh-list
139248379|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139248380|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248381|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
139248382|NCT02090504|Oxazepam|oxazepam|mesh-list
139248383|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139248384|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139248385|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
139248386|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
139248387|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139248388|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248389|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139248390|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139248391|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139248392|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139091625|NCT04381936|Glucocorticoids|glucocorticoids|mesh-ancestor
139248393|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
139248394|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
139248395|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139248396|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248397|NCT01567059|Cytarabine|cytarabine|mesh-list
139248398|NCT01567059|Decitabine|decitabine|mesh-list
139248399|NCT01567059|Azacitidine|azacitidine|mesh-list
139248400|NCT01567059|Tosedostat|tosedostat|mesh-list
139248401|NCT01567059|Glycine|glycine|mesh-list
139248402|NCT01567059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139248403|NCT01567059|Antimetabolites|antimetabolites|mesh-ancestor
139248404|NCT01567059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248405|NCT01567059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248406|NCT01567059|Antiviral Agents|antiviral agents|mesh-ancestor
139248407|NCT01567059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248408|NCT01567059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139248409|NCT01567059|Immunologic Factors|immunologic factors|mesh-ancestor
139248410|NCT01567059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248411|NCT01567059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248412|NCT01567059|Glycine Agents|glycine agents|mesh-ancestor
139248413|NCT01567059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139248414|NCT02090738|Amoxicillin|amoxicillin|mesh-list
139248415|NCT02090738|Clarithromycin|clarithromycin|mesh-list
139248416|NCT02090738|Acetazolamide|acetazolamide|mesh-list
139248417|NCT02090738|Esomeprazole|esomeprazole|mesh-list
139248418|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139248419|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248420|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139248421|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139248422|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139248423|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357267|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139248424|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357336|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
139248425|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139248426|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139248427|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139248428|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
139248429|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139248430|NCT02090738|Diuretics|diuretics|mesh-ancestor
139248431|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
139248432|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248433|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
139248434|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139248435|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139248436|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139248437|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139248438|NCT03441555|Venetoclax|venetoclax|mesh-list
139248439|NCT03441555|Alvocidib|alvocidib|mesh-list
139248440|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248441|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
139248442|NCT03441555|Growth Substances|growth substances|mesh-ancestor
139248443|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357551|NCT03327987|Vaccines|vaccines|mesh-list
139248444|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139248445|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248446|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248447|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139248448|NCT03346239|Escitalopram|escitalopram|mesh-list
139248449|NCT03346239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139248450|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139248451|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139357689|NCT01362530|Aprepitant|aprepitant|mesh-list
139248452|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248453|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139248454|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
139248455|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248456|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
139248457|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139248458|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139248459|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248460|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139248461|NCT05218161|Analgesics|analgesics|mesh-ancestor
139248462|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
139248463|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248464|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139248465|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139248466|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139642256|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
139248467|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
139248468|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139248469|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248470|NCT02861586|Vaccines|vaccines|mesh-list
139248471|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
139248472|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248473|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139248474|NCT02099240|Amoxicillin|amoxicillin|mesh-list
139248475|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
139248476|NCT02099240|Azithromycin|azithromycin|mesh-list
139248477|NCT02099240|Vancomycin|vancomycin|mesh-list
139248478|NCT02099240|Clarithromycin|clarithromycin|mesh-list
139248479|NCT02099240|Doxycycline|doxycycline|mesh-list
139248480|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
139248481|NCT02099240|Levofloxacin|levofloxacin|mesh-list
139248482|NCT02099240|Ofloxacin|ofloxacin|mesh-list
139248483|NCT02099240|Minocycline|minocycline|mesh-list
139248484|NCT02099240|Rifampin|rifampin|mesh-list
139248485|NCT02099240|Clindamycin|clindamycin|mesh-list
139248486|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
139248487|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
139248488|NCT02099240|Gentamicins|gentamicins|mesh-list
139248489|NCT02099240|Isoniazid|isoniazid|mesh-list
139248490|NCT02099240|Meropenem|meropenem|mesh-list
139248491|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
139248492|NCT02099240|Tazobactam|tazobactam|mesh-list
139248493|NCT02099240|Linezolid|linezolid|mesh-list
139248494|NCT02099240|Cycloserine|cycloserine|mesh-list
139248495|NCT02099240|Piperacillin|piperacillin|mesh-list
139248496|NCT02099240|Metronidazole|metronidazole|mesh-list
139248497|NCT02099240|Penicillins|penicillins|mesh-list
139248498|NCT02099240|Imipenem|imipenem|mesh-list
139248499|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
139248500|NCT02099240|Amikacin|amikacin|mesh-list
139248501|NCT02099240|Erythromycin|erythromycin|mesh-list
139248502|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
139358127|NCT02489955|Tobramycin|tobramycin|mesh-list
139248503|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139248504|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
139248505|NCT02099240|Ceftazidime|ceftazidime|mesh-list
139248507|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139248508|NCT02099240|Ampicillin|ampicillin|mesh-list
139248509|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
139248510|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
139248511|NCT02099240|Mupirocin|mupirocin|mesh-list
139248512|NCT02099240|Rifapentine|rifapentine|mesh-list
139248513|NCT02099240|Rifabutin|rifabutin|mesh-list
139248514|NCT02099240|Cefepime|cefepime|mesh-list
139248515|NCT02099240|Cefuroxime|cefuroxime|mesh-list
139248516|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
139248517|NCT02099240|Fosfomycin|fosfomycin|mesh-list
139248518|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139248519|NCT02099240|Paromomycin|paromomycin|mesh-list
139248520|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
139248521|NCT02099240|Aztreonam|aztreonam|mesh-list
139248522|NCT02099240|Polymyxins|polymyxins|mesh-list
139248523|NCT02099240|Neomycin|neomycin|mesh-list
139248524|NCT02099240|Sulbactam|sulbactam|mesh-list
139248525|NCT02099240|Bacitracin|bacitracin|mesh-list
139248526|NCT02099240|Cefotaxime|cefotaxime|mesh-list
139248527|NCT02099240|Cefoxitin|cefoxitin|mesh-list
139248528|NCT02099240|Cefixime|cefixime|mesh-list
139248529|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
139248530|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
139248531|NCT02099240|Polymyxin B|polymyxin b|mesh-list
139248532|NCT02099240|Penicillin G|penicillin g|mesh-list
139248533|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139248534|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
139248535|NCT02099240|Cefdinir|cefdinir|mesh-list
139248536|NCT02099240|Norfloxacin|norfloxacin|mesh-list
139248537|NCT02099240|Cloxacillin|cloxacillin|mesh-list
139248538|NCT02099240|Cefprozil|cefprozil|mesh-list
139248539|NCT02099240|Cephalosporins|cephalosporins|mesh-list
139248540|NCT02099240|Oxacillin|oxacillin|mesh-list
139248541|NCT02099240|Streptomycin|streptomycin|mesh-list
139248542|NCT02099240|Nafcillin|nafcillin|mesh-list
139248543|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
139248544|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
139248545|NCT02099240|Ticarcillin|ticarcillin|mesh-list
139248546|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
139248547|NCT02099240|Ceftibuten|ceftibuten|mesh-list
139248548|NCT02099240|Sultamicillin|sultamicillin|mesh-list
139248549|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
139248550|NCT02099240|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
139248551|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
139248552|NCT02099240|Ethionamide|ethionamide|mesh-list
139248553|NCT02099240|Kanamycin|kanamycin|mesh-list
139248554|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
139248555|NCT02099240|Penicillin V|penicillin v|mesh-list
139248556|NCT02099240|Cefoperazone|cefoperazone|mesh-list
139248557|NCT02099240|Lincomycin|lincomycin|mesh-list
139248558|NCT02099240|Demeclocycline|demeclocycline|mesh-list
139248559|NCT02099240|Cefaclor|cefaclor|mesh-list
139248560|NCT02099240|Cefotetan|cefotetan|mesh-list
139248561|NCT02099240|Dirithromycin|dirithromycin|mesh-list
139248562|NCT02099240|Tobramycin|tobramycin|mesh-list
139248563|NCT02099240|Capreomycin|capreomycin|mesh-list
139248564|NCT02099240|Mafenide|mafenide|mesh-list
139248565|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
139358494|NCT03317847|Hormones|hormones|mesh-ancestor
139248566|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
139248567|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
139248568|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
139248569|NCT02099240|Netilmicin|netilmicin|mesh-list
139248570|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
139248571|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
139248572|NCT02099240|Virginiamycin|virginiamycin|mesh-list
139248573|NCT02099240|Enoxacin|enoxacin|mesh-list
139248574|NCT02099240|Novobiocin|novobiocin|mesh-list
139248575|NCT02099240|Methicillin|methicillin|mesh-list
139248576|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139248577|NCT02099240|Bacampicillin|bacampicillin|mesh-list
139248578|NCT02099240|Carbenicillin|carbenicillin|mesh-list
139248579|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
139248580|NCT02099240|Mezlocillin|mezlocillin|mesh-list
139248581|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
139248582|NCT02099240|Cefamandole|cefamandole|mesh-list
139248583|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
139248584|NCT02099240|Cefonicid|cefonicid|mesh-list
139248585|NCT02099240|Cefmetazole|cefmetazole|mesh-list
139248586|NCT02099240|Loracarbef|loracarbef|mesh-list
139248587|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
139248588|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
139248589|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
139248590|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
139248591|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
139248592|NCT02099240|Methacycline|methacycline|mesh-list
139248593|NCT02099240|Tetracycline|tetracycline|mesh-list
139248594|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
139248595|NCT02099240|Dalfopristin|dalfopristin|mesh-list
139248596|NCT02099240|Spectinomycin|spectinomycin|mesh-list
139248597|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139248598|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
139248599|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
139248600|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
139248601|NCT02099240|Methenamine|methenamine|mesh-list
139248602|NCT02099240|Sulperazone|sulperazone|mesh-list
139248603|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
139248604|NCT02099240|Cinoxacin|cinoxacin|mesh-list
139248605|NCT02099240|Trimethoprim|trimethoprim|mesh-list
139248606|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
139248607|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
139248608|NCT02099240|Procaine|procaine|mesh-list
139248609|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139248610|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139248611|NCT02099240|Cilastatin|cilastatin|mesh-list
139248612|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248613|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
139248614|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139248615|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139248616|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248617|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248618|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248619|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139248620|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
139248621|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139248622|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248623|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139248624|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139248625|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139248626|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139248627|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139248628|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139248629|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
139248630|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139248631|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139248632|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139248633|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139248634|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
139248635|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139248636|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139248637|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139248638|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139248639|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139358948|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139248640|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139642257|NCT01312389|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139248641|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139248642|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139248643|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139248644|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
139248645|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139248646|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139248647|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139248648|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139248649|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139248650|NCT02099240|Analgesics|analgesics|mesh-ancestor
139248651|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
139248652|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248653|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139248654|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139248655|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
139248656|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139248657|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139248658|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139248659|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
139248660|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
139248661|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
139248662|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139248663|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139248664|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139248665|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139248666|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139248667|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
139248668|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
139248669|NCT05215743|Antioxidants|antioxidants|mesh-list
139248670|NCT05215743|Deferoxamine|deferoxamine|mesh-list
139248671|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
139248672|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248674|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
139248675|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139248676|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248677|NCT05215743|Protective Agents|protective agents|mesh-ancestor
139248678|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248679|NCT05215743|Siderophores|siderophores|mesh-ancestor
139248680|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139248681|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
139248682|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
139248683|NCT02099396|Gemcitabine|gemcitabine|mesh-list
139248684|NCT02099396|Docetaxel|docetaxel|mesh-list
139248685|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139248686|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
139248687|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248688|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248689|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
139248690|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
139248691|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
139248692|NCT05215665|Lenvatinib|lenvatinib|mesh-list
139248693|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248694|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139248695|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359589|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
139248696|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248697|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
139248698|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139248699|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139248700|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
139248701|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248702|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139248703|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139248704|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248705|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248706|NCT05217069|Leucovorin|leucovorin|mesh-list
139248707|NCT05217069|Folic Acid|folic acid|mesh-list
139248708|NCT05217069|Irinotecan|irinotecan|mesh-list
139248709|NCT05217069|Cetuximab|cetuximab|mesh-list
139248710|NCT05217069|Avelumab|avelumab|mesh-list
139248711|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
139248712|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139248713|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139248714|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248715|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248716|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642258|NCT01312389|Immunologic Factors|immunologic factors|mesh-ancestor
139248717|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139248718|NCT05217069|Antidotes|antidotes|mesh-ancestor
139248719|NCT05217069|Protective Agents|protective agents|mesh-ancestor
139248720|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248721|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
139248722|NCT05217069|Vitamins|vitamins|mesh-ancestor
139248723|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
139248724|NCT05217069|Hematinics|hematinics|mesh-ancestor
139248725|NCT02065635|Propofol|propofol|mesh-list
139248726|NCT02065635|Sevoflurane|sevoflurane|mesh-list
139248727|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139248728|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139248729|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248730|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139248731|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
139248732|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
139248733|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139248734|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139248735|NCT03628053|Blinatumomab|blinatumomab|mesh-list
139248736|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139248737|NCT03628053|Tisagenlecleucel|tisagenlecleucel|mesh-list
139248738|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248739|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139248740|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139248741|NCT03628053|Immunotoxins|immunotoxins|mesh-ancestor
139248742|NCT03628053|Immunoconjugates|immunoconjugates|mesh-ancestor
139248743|NCT03628053|Immunologic Factors|immunologic factors|mesh-ancestor
139248744|NCT03628053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248745|NCT02100176|Dopamine|dopamine|mesh-list
139248746|NCT02100176|Rotigotine|rotigotine|mesh-list
139248747|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
139248748|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
139248749|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139248750|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360352|NCT04223648|Nivolumab|nivolumab|mesh-list
139248751|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248752|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139248753|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
139248754|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
139248755|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248756|NCT02100176|Protective Agents|protective agents|mesh-ancestor
139248757|NCT02250482|Factor VIII|factor viii|mesh-list
139248758|NCT02250482|Coagulants|coagulants|mesh-ancestor
139248759|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139248760|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139248761|NCT05189145|Hormones|hormones|mesh-list
139248762|NCT05189145|Estradiol|estradiol|mesh-list
139248763|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139248764|NCT05189145|Progesterone|progesterone|mesh-list
139248765|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
139248766|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139248767|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248768|NCT05189145|Estrogens|estrogens|mesh-ancestor
139248769|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139248770|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
139248771|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139360635|NCT04622865|Quercetin|quercetin|mesh-list
139248772|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139248773|NCT05189145|Progestins|progestins|mesh-ancestor
139248774|NCT04967079|Trametinib|trametinib|mesh-list
139248775|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248776|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139248777|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360696|NCT05283356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139248778|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248779|NCT03556592|Metoprolol|metoprolol|mesh-list
139248780|NCT03556592|Midazolam|midazolam|mesh-list
139248781|NCT03556592|Caffeine|caffeine|mesh-list
139248782|NCT03556592|Omeprazole|omeprazole|mesh-list
139248783|NCT03556592|Warfarin|warfarin|mesh-list
139248784|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139248785|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139248786|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139248787|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248788|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139248789|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139360914|NCT05137964|Vitamin D|vitamin d|mesh-list
139248790|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139248791|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139248792|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
139248793|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
139248794|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
139248795|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
139248796|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139248797|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248798|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
139248799|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139248800|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139248801|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248802|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139248803|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139248804|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
139248805|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139248806|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139248807|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139248808|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139248809|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139248810|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
139248811|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
139248812|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248813|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139248814|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139248815|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139248816|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
139248817|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
139248818|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139248819|NCT04964193|Cyproterone|cyproterone|mesh-list
139361406|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139248820|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
139248821|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139248822|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139248823|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139248824|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
139248825|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139248826|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248827|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139248828|NCT04964193|Estrogens|estrogens|mesh-ancestor
139248829|NCT04964193|Hormones|hormones|mesh-ancestor
139248830|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139248831|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
139248832|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
139248833|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248834|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139248835|NCT02100488|Insulin|insulin|mesh-list
139361695|NCT03308487|Vitamin D|vitamin d|mesh-list
139248836|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139248837|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139248838|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248839|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
139248840|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139248841|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248842|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139248843|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
139248844|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139248845|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248846|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361827|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248847|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248848|NCT04865497|Vaccines|vaccines|mesh-list
139248849|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
139248850|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248851|NCT05665725|Siltuximab|siltuximab|mesh-list
139248852|NCT05665725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139248853|NCT05665725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248854|NCT05665725|Immunologic Factors|immunologic factors|mesh-ancestor
139248855|NCT05665725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248856|NCT02098148|Xenon|xenon|mesh-list
139248857|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139361966|NCT02059759|Analgesics|analgesics|mesh-ancestor
139248858|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
139248859|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
139248860|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139248861|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248862|NCT05168527|Paclitaxel|paclitaxel|mesh-list
139248863|NCT05168527|Gemcitabine|gemcitabine|mesh-list
139248864|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139248865|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248866|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
139248867|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
139248868|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
139248869|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362100|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139248870|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139248871|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
139248872|NCT02098460|Cilostazol|cilostazol|mesh-list
139248873|NCT02098460|Atorvastatin|atorvastatin|mesh-list
139248874|NCT02098460|Probucol|probucol|mesh-list
139362178|NCT02786498|Vitamin D|vitamin d|mesh-list
139248875|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139248876|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139248877|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
139248878|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248879|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139362312|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139248880|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139248881|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248882|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139248883|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
139248884|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248885|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248886|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139248887|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
139248888|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139248889|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139248890|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139248891|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
139248892|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139248893|NCT02098460|Protective Agents|protective agents|mesh-ancestor
139248894|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139248895|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139248896|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
139248897|NCT02095574|Venetoclax|venetoclax|mesh-list
139248898|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248899|NCT02095730|Vitamins|vitamins|mesh-list
139248900|NCT02095730|Riboflavin|riboflavin|mesh-list
139248901|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
139248902|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
139248903|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248904|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139248905|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
139248906|NCT02102438|Paclitaxel|paclitaxel|mesh-list
139248907|NCT02102438|Carboplatin|carboplatin|mesh-list
139248908|NCT02102438|Trastuzumab|trastuzumab|mesh-list
139248909|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139248910|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248911|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
139248912|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
139248913|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
139248914|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248915|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139248916|NCT02098616|Asunaprevir|asunaprevir|mesh-list
139248917|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
139248918|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248919|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248920|NCT02102516|Ketorolac|ketorolac|mesh-list
139248921|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139248922|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139248923|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139248924|NCT02102516|Analgesics|analgesics|mesh-ancestor
139248925|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
139248926|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248927|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248928|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139248929|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139248930|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139248931|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248932|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248933|NCT02106182|Silodosin|silodosin|mesh-list
139362797|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139248934|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139248935|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139248936|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139248937|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
139248938|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139248939|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248940|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362966|NCT02796391|Nicotine|nicotine|mesh-list
139248941|NCT02106182|Urological Agents|urological agents|mesh-ancestor
139248942|NCT01369693|Lobeline|lobeline|mesh-list
139248943|NCT01369693|Nicotine|nicotine|mesh-list
139248944|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139248945|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
139248946|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248947|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248948|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139248949|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139248950|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
139248951|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139248952|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248953|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
139248954|NCT02102594|Bortezomib|bortezomib|mesh-list
139248955|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248956|NCT02102672|Trimetazidine|trimetazidine|mesh-list
139248957|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
139248958|NCT02106338|REP 3123|rep 3123|mesh-list
139248959|NCT02106338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139248960|NCT02106338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139248961|NCT04249323|Prednisone|prednisone|mesh-list
139248962|NCT04249323|Cortisone|cortisone|mesh-list
139248963|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139248964|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
139248965|NCT04249323|Hormones|hormones|mesh-ancestor
139248966|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139248967|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248968|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139248969|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139248970|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139248971|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139248972|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248973|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248974|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139248975|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
139248976|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139248977|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248978|NCT02102828|Aspirin|aspirin|mesh-list
139248979|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139248980|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139248981|NCT02102828|Analgesics|analgesics|mesh-ancestor
139248982|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
139248983|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139248984|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139248985|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139248986|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139248987|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139248988|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139248989|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248990|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139248991|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139248992|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139248993|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
139248994|NCT01372423|Lubiprostone|lubiprostone|mesh-list
139248995|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139248996|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139248997|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139248998|NCT02106650|Leucovorin|leucovorin|mesh-list
139248999|NCT02106650|Folic Acid|folic acid|mesh-list
139249000|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
139249001|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
139249002|NCT02106650|Vitamins|vitamins|mesh-ancestor
139249003|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
139249004|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249005|NCT02106650|Antidotes|antidotes|mesh-ancestor
139249006|NCT02106650|Protective Agents|protective agents|mesh-ancestor
139249007|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
139249008|NCT02106650|Hematinics|hematinics|mesh-ancestor
139249009|NCT05221437|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139249010|NCT05221437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249011|NCT01376011|Quercetin|quercetin|mesh-list
139249012|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
139249013|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249014|NCT01376011|Protective Agents|protective agents|mesh-ancestor
139249015|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249016|NCT02106806|Zinc|zinc|mesh-list
139249017|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
139249018|NCT02106806|Trace Elements|trace elements|mesh-ancestor
139249019|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
139249020|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249021|NCT02106806|Astringents|astringents|mesh-ancestor
139249022|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
139249023|NCT02966119|Aspirin|aspirin|mesh-list
139249024|NCT02966119|Clopidogrel|clopidogrel|mesh-list
139363965|NCT06126640|Trastuzumab|trastuzumab|mesh-list
139249025|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139249026|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139249027|NCT02966119|Analgesics|analgesics|mesh-ancestor
139249028|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
139249029|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249030|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249031|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249032|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139249033|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139249034|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139249035|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249036|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139249037|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139249038|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249039|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
139249040|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139249041|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139249042|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139249043|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
139364178|NCT06088147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139249044|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139249045|NCT02101892|Amitriptyline|amitriptyline|mesh-list
139249046|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139249047|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
139249048|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139249049|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139249050|NCT02101892|Analgesics|analgesics|mesh-ancestor
139249051|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
139249052|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249053|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249054|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139249055|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139249056|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139249057|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249058|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
139249059|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139249060|NCT03634111|Morphine|morphine|mesh-list
139249061|NCT03634111|Ropivacaine|ropivacaine|mesh-list
139249062|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139249063|NCT03634111|Narcotics|narcotics|mesh-ancestor
139249064|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139249065|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249066|NCT03634111|Analgesics|analgesics|mesh-ancestor
139249067|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
139249068|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249069|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
139249070|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
139249071|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139249072|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139249073|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139249074|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
139249075|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249076|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249077|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139249078|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139249079|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
139249080|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249081|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
139249082|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139249083|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
139249084|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139249085|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249086|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139249087|NCT02250794|Insulin|insulin|mesh-list
139249088|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139249089|NCT02250794|Metformin|metformin|mesh-list
139249090|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
139249091|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139249092|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
139249093|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139249094|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249095|NCT02250794|Incretins|incretins|mesh-ancestor
139249096|NCT02250794|Hormones|hormones|mesh-ancestor
139249097|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249098|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139249099|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
139249100|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249101|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249102|NCT02103374|Terbutaline|terbutaline|mesh-list
139249103|NCT02103374|Ipratropium|ipratropium|mesh-list
139249104|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139249105|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
139249106|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249107|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249108|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139249109|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
139249110|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139249111|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
139249112|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139249113|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249114|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
139249115|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
139249116|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139249117|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139249118|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139249119|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139249120|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
139249121|NCT05707221|Chlorhexidine|chlorhexidine|mesh-list
139249122|NCT05707221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139249123|NCT05707221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249124|NCT05707221|Disinfectants|disinfectants|mesh-ancestor
139249125|NCT03117361|Dexamethasone|dexamethasone|mesh-list
139249126|NCT03117361|Bortezomib|bortezomib|mesh-list
139249127|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249128|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
139249129|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
139249130|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249131|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364846|NCT05419466|Melatonin|melatonin|mesh-list
139364847|NCT05419466|Antioxidants|antioxidants|mesh-ancestor
139364848|NCT05419466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364849|NCT05419466|Protective Agents|protective agents|mesh-ancestor
139249132|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139205712|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139249133|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
139249134|NCT03117361|Hormones|hormones|mesh-ancestor
139364915|NCT05311085|Autonomic Agents|autonomic agents|mesh-ancestor
139249135|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249136|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139249137|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249138|NCT03053427|Gabapentin|gabapentin|mesh-list
139249139|NCT03053427|Analgesics|analgesics|mesh-ancestor
139249140|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
139249141|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249142|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249143|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
139249144|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139249145|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139249146|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139249147|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139249148|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139249149|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139249150|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139249151|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249152|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
139249153|NCT02107118|Complement Factor H|complement factor h|mesh-list
139249154|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139249155|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139249156|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
139249157|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249158|NCT05081089|Lumefantrine|lumefantrine|mesh-list
139249159|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
139249160|NCT05081089|Artemether|artemether|mesh-list
139249161|NCT05081089|Primaquine|primaquine|mesh-list
139249162|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
139249163|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139249164|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139249165|NCT05081089|Amodiaquine|amodiaquine|mesh-list
139249166|NCT05081089|Tafenoquine|tafenoquine|mesh-list
139249167|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
139249168|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139249169|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139249170|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139365198|NCT04947085|Ketamine|ketamine|mesh-list
139249171|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139249172|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249173|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249174|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139249175|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139249176|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139249177|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249178|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139249179|NCT03554408|Antibodies|antibodies|mesh-list
139249180|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
139249181|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139365336|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
139249182|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
139249183|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249184|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249185|NCT02103686|Pregabalin|pregabalin|mesh-list
139249186|NCT02103686|Analgesics|analgesics|mesh-ancestor
139249187|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
139249188|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249189|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249190|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
139249191|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139249192|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139249193|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249194|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139249195|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139249196|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139249197|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139249198|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139249199|NCT02110082|Cetuximab|cetuximab|mesh-list
139249200|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365610|NCT04291001|Etonogestrel|etonogestrel|mesh-list
139249201|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249202|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139249203|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
139249204|NCT02103764|Desogestrel|desogestrel|mesh-list
139249205|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139249206|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139249207|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139249208|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
139365752|NCT04062266|Venetoclax|venetoclax|mesh-list
139249209|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139249210|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365823|NCT03932643|TIC10 compound|tic10 compound|mesh-list
139249211|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139249212|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139249213|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139249214|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139365898|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
139249215|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249216|NCT02103764|Progestins|progestins|mesh-ancestor
139249217|NCT02103764|Hormones|hormones|mesh-ancestor
139249218|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249219|NCT02110316|Voriconazole|voriconazole|mesh-list
139365988|NCT03693014|Nivolumab|nivolumab|mesh-list
139249220|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
139249221|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249222|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139366036|NCT03548428|Atezolizumab|atezolizumab|mesh-list
139249223|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139249224|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249225|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249226|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139249227|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
139249228|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249229|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249230|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139249231|NCT02110394|Rituximab|rituximab|mesh-list
139249232|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139366177|NCT03104400|Adalimumab|adalimumab|mesh-list
139249233|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139249234|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249235|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
139249236|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249237|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139249238|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139249239|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
139249240|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249241|NCT02373241|Losartan|losartan|mesh-list
139249242|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139249243|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139366318|NCT02578368|Leucovorin|leucovorin|mesh-list
139642259|NCT01312389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249244|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139249245|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139249246|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366387|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139249248|NCT05656131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139249249|NCT05656131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249250|NCT05656131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249251|NCT05656131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249252|NCT02103998|Iodine|iodine|mesh-list
139249253|NCT02103998|Hormones|hormones|mesh-list
139249254|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249255|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366531|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139249256|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139249257|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249258|NCT02103998|Trace Elements|trace elements|mesh-ancestor
139366624|NCT01106534|Aspirin|aspirin|mesh-list
139249259|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
139249260|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
139249261|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139249262|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139249263|NCT01941589|Prednisolone|prednisolone|mesh-list
139249264|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
139249265|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
139249266|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139249267|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139249268|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139366752|NCT02084563|Cytarabine|cytarabine|mesh-list
139249269|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139249270|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
139249271|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249272|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
139249273|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
139249274|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249275|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249276|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139249277|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
139249278|NCT01941589|Hormones|hormones|mesh-ancestor
139249279|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249280|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139249281|NCT01941589|Protective Agents|protective agents|mesh-ancestor
139366888|NCT02085967|Bupropion|bupropion|mesh-list
139249282|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139249283|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249285|NCT01845649|Estrogens|estrogens|mesh-ancestor
139249286|NCT01845649|Hormones|hormones|mesh-ancestor
139249287|NCT01845649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249288|NCT01845649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249289|NCT01345929|Levofloxacin|levofloxacin|mesh-list
139249290|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139249291|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249292|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139249293|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139249294|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139249295|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249296|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249297|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249298|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139249299|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139249300|NCT02107742|Lidocaine|lidocaine|mesh-list
139249301|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
139249302|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
139249303|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139249304|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249305|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
139249306|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249307|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139249308|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139249309|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139249310|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139249311|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249312|NCT02250872|Cisplatin|cisplatin|mesh-list
139249313|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249314|NCT02110784|Piperaquine|piperaquine|mesh-list
139249315|NCT02110784|Artenimol|artenimol|mesh-list
139249316|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
139249317|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139249318|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139249319|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249320|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
139249321|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139249322|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139249324|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
139249325|NCT04988425|Antibodies|antibodies|mesh-list
139249326|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139249327|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139249328|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
139249329|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
139249330|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249331|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249332|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
139249333|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
139249334|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249335|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139249336|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
139249337|NCT04988425|Hormones|hormones|mesh-ancestor
139249338|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249339|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139249340|NCT04988425|Protective Agents|protective agents|mesh-ancestor
139249341|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139249342|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249343|NCT01343901|Bevacizumab|bevacizumab|mesh-list
139249344|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139249345|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249346|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139249347|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139249348|NCT01343901|Growth Substances|growth substances|mesh-ancestor
139249349|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249350|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
139249351|NCT05617521|Caffeine|caffeine|mesh-list
139249352|NCT05617521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139249353|NCT05617521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205938|NCT06209229|Quercetin|quercetin|mesh-list
139249354|NCT05617521|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139249355|NCT05617521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249356|NCT05617521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249357|NCT05617521|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139249358|NCT05617521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139249359|NCT05617521|Purinergic Agents|purinergic agents|mesh-ancestor
139249360|NCT05617521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139249361|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139249362|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139249363|NCT02104700|Tenofovir|tenofovir|mesh-list
139249364|NCT02104700|Emtricitabine|emtricitabine|mesh-list
139249365|NCT02104700|Rilpivirine|rilpivirine|mesh-list
139249366|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
139249367|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249368|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139249369|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139249370|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249371|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249372|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139249373|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139249374|NCT02104778|Dexamethasone|dexamethasone|mesh-list
139249375|NCT02104778|Epinephrine|epinephrine|mesh-list
139249376|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249377|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
139249378|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
139249379|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249380|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249381|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139249382|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
139249383|NCT02104778|Hormones|hormones|mesh-ancestor
139249384|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249385|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139249386|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249387|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139249388|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139249389|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
139249390|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139249391|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119548|NCT03745664|Hormones|hormones|mesh-ancestor
139249392|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139249393|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139249394|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139249395|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
139249396|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
139249397|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
139249398|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139249399|NCT02108366|Oseltamivir|oseltamivir|mesh-list
139249400|NCT02108366|Celecoxib|celecoxib|mesh-list
139249401|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139249402|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139249403|NCT02108366|Analgesics|analgesics|mesh-ancestor
139249404|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
139249405|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249406|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249407|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249408|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139249409|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139249410|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139249411|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249412|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249413|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
139249414|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249415|NCT05706207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139249416|NCT05706207|Antibodies|antibodies|mesh-list
139249417|NCT05706207|Immunoglobulins|immunoglobulins|mesh-list
139249418|NCT05706207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139249419|NCT05706207|Immunologic Factors|immunologic factors|mesh-ancestor
139249420|NCT05706207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249421|NCT05706207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249422|NCT02105090|Anesthetics|anesthetics|mesh-list
139249423|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
139249424|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139249425|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249426|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249427|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
139249428|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
139249429|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139249431|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139249432|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249433|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
139249434|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
139249435|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139249436|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
139249437|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139249438|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249439|NCT02112032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139249440|NCT02112032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249441|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
139249442|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249443|NCT01343823|Ecallantide|ecallantide|mesh-list
139249444|NCT01343823|Analgesics|analgesics|mesh-ancestor
139249445|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
139249446|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249447|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249448|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139249449|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139249450|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249451|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139249452|NCT02251184|Aspirin|aspirin|mesh-list
139249453|NCT02251184|Dipyridamole|dipyridamole|mesh-list
139249454|NCT02251184|Lansoprazole|lansoprazole|mesh-list
139249455|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
139249456|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
139249457|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139249458|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139249459|NCT02251184|Analgesics|analgesics|mesh-ancestor
139249460|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
139249461|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249462|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249463|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249464|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139249465|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139249466|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139642260|NCT01312389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139249467|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249468|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139368130|NCT02113891|Eculizumab|eculizumab|mesh-list
139249469|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139249470|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249471|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
139249472|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139249473|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139249474|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139249475|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139249476|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
139249477|NCT02108756|Pantoprazole|pantoprazole|mesh-list
139249478|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139249479|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139249480|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139249481|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249482|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249483|NCT05547399|Zanubrutinib|zanubrutinib|mesh-list
139249484|NCT05547399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249485|NCT05547399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139249486|NCT05547399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249487|NCT05547399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249488|NCT01318083|Glimepiride|glimepiride|mesh-list
139249489|NCT01318083|Alogliptin|alogliptin|mesh-list
139249490|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139249491|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139249492|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249493|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139249494|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
139249495|NCT01318083|Incretins|incretins|mesh-ancestor
139249496|NCT01318083|Hormones|hormones|mesh-ancestor
139249497|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249498|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139368321|NCT03553303|Valsartan|valsartan|mesh-list
139249499|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
139249500|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249501|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249502|NCT02105714|Formaldehyde|formaldehyde|mesh-list
139249503|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
139249504|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249505|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139249506|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139368450|NCT05016128|Ketamine|ketamine|mesh-list
139249507|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249509|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249510|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
139249511|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249512|NCT03817515|Sirolimus|sirolimus|mesh-list
139249513|NCT03817515|Temsirolimus|temsirolimus|mesh-list
139249514|NCT03817515|MTOR Inhibitors|mtor inhibitors|mesh-list
139249515|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139249516|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249517|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139249518|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249519|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
139249520|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139249521|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
139249522|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249523|NCT03817515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139249524|NCT03817515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249525|NCT03817515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249526|NCT02105870|Abciximab|abciximab|mesh-list
139249527|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
139249528|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139249529|NCT02112422|Dexamethasone|dexamethasone|mesh-list
139249530|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
139249531|NCT02112422|BB 1101|bb 1101|mesh-list
139249532|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249533|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
139249534|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
139249535|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249536|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249537|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139249538|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
139249539|NCT02112422|Hormones|hormones|mesh-ancestor
139249540|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249541|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139249542|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249543|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
139249544|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249545|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249546|NCT02106104|Glimepiride|glimepiride|mesh-list
139249547|NCT02106104|Linagliptin|linagliptin|mesh-list
139249548|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139249549|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139249550|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369083|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
139249551|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139249552|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
139249553|NCT02106104|Incretins|incretins|mesh-ancestor
139249554|NCT02106104|Hormones|hormones|mesh-ancestor
139249555|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249556|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139249557|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
139249558|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249559|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249560|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139249561|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139249562|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249563|NCT01376323|Incretins|incretins|mesh-ancestor
139249564|NCT01376323|Hormones|hormones|mesh-ancestor
139249565|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249566|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139249567|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
139249568|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249569|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249570|NCT02113904|Adalimumab|adalimumab|mesh-list
139249571|NCT02113904|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139369231|NCT03270033|Hormones|hormones|mesh-ancestor
139249572|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249573|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139249574|NCT05432115|Amoxicillin|amoxicillin|mesh-list
139249575|NCT05432115|Tetracycline|tetracycline|mesh-list
139249576|NCT05432115|Esomeprazole|esomeprazole|mesh-list
139249577|NCT05432115|Bismuth|bismuth|mesh-list
139206176|NCT06207799|Plerixafor|plerixafor|mesh-list
139249578|NCT05432115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139249579|NCT05432115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249580|NCT05432115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139249581|NCT05432115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139249582|NCT05432115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139249583|NCT05432115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249584|NCT05432115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249585|NCT05432115|Antacids|antacids|mesh-ancestor
139249586|NCT05432115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139249587|NCT02114528|Amiodarone|amiodarone|mesh-list
139249588|NCT02114528|Sotalol|sotalol|mesh-list
139249589|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139249590|NCT02114528|Mexiletine|mexiletine|mesh-list
139249591|NCT02114528|Procainamide|procainamide|mesh-list
139249592|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
139249593|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139249594|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139249595|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249596|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139249597|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139249598|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139249599|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249600|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139249601|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139249602|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139249603|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139249604|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139249605|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
139249606|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139249607|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249608|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
139369563|NCT02456740|Erenumab|erenumab|mesh-list
139249609|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
139249610|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249611|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139249612|NCT01376401|Prednisone|prednisone|mesh-list
139249613|NCT01376401|Bortezomib|bortezomib|mesh-list
139249614|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139249615|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249616|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
139249617|NCT01376401|Hormones|hormones|mesh-ancestor
139249618|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249619|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249620|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139249621|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249622|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139249623|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
139249624|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249625|NCT02119520|Atorvastatin|atorvastatin|mesh-list
139249626|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139249627|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139249628|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
139249629|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249630|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139249631|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139369763|NCT02128243|Leucovorin|leucovorin|mesh-list
139249632|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249633|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
139249634|NCT03961789|Narcotics|narcotics|mesh-ancestor
139249635|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139249636|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249637|NCT03961789|Analgesics|analgesics|mesh-ancestor
139249638|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
139249639|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249640|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139249641|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
139249642|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
139249643|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249644|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249645|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139249646|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139249647|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139249648|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
139249649|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249650|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139249651|NCT01376713|Dacarbazine|dacarbazine|mesh-list
139249652|NCT01376713|Ofatumumab|ofatumumab|mesh-list
139249653|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139369972|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
139249654|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139249655|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
139249656|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249657|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249658|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
139249659|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249660|NCT03728179|Aspirin|aspirin|mesh-list
139249661|NCT03728179|Celecoxib|celecoxib|mesh-list
139249662|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
139249663|NCT03728179|Nivolumab|nivolumab|mesh-list
139249664|NCT03728179|Ipilimumab|ipilimumab|mesh-list
139370109|NCT03074786|Tenofovir|tenofovir|mesh-list
139249665|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139249666|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
139249667|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249668|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139249669|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139249670|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
139249671|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249672|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249673|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139249674|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139249675|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139249676|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139249677|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139249678|NCT03728179|Analgesics|analgesics|mesh-ancestor
139249679|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
139249680|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249681|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249682|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139249683|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139249684|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139249685|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139370318|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
139249686|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249687|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
139249688|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139249689|NCT01368536|Amlodipine|amlodipine|mesh-list
139249690|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
139249691|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139249692|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139249693|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139249694|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249695|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139249696|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249697|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
139249698|NCT01368536|Diuretics|diuretics|mesh-ancestor
139249699|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
139249700|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139249701|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
139249702|NCT05103735|Remifentanil|remifentanil|mesh-list
139249703|NCT05103735|Propofol|propofol|mesh-list
139249704|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139249705|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139249706|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249707|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139249708|NCT05103735|Analgesics|analgesics|mesh-ancestor
139249709|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
139249710|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249711|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139249712|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139249713|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139249714|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
139370738|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
139249715|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139249716|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370817|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
139249717|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139249718|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
139249719|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
139249720|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139249721|NCT05103735|Narcotics|narcotics|mesh-ancestor
139249722|NCT01319929|CB2 receptor agonist LY2828360|cb2 receptor agonist ly2828360|mesh-list
139249723|NCT01319929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139249724|NCT01319929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139370880|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
139249725|NCT01319929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139249726|NCT01319929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249728|NCT01319929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249729|NCT01319929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249730|NCT03633565|Prednisolone|prednisolone|mesh-list
139249731|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139249732|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
139249733|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139249734|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
139249735|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
139249736|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139249737|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
139249738|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
139249739|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249740|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
139249741|NCT03633565|Hormones|hormones|mesh-ancestor
139249742|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249743|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249744|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139249745|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249746|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
139249747|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
139249748|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249749|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139371151|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
139249750|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139249751|NCT03633565|Protective Agents|protective agents|mesh-ancestor
139249752|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
139249753|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139371223|NCT02138929|Everolimus|everolimus|mesh-list
139249754|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249755|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249756|NCT03633565|Urological Agents|urological agents|mesh-ancestor
139249757|NCT02120066|Plasminogen|plasminogen|mesh-list
139249758|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139249759|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139249760|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139249761|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249762|NCT01373359|Misoprostol|misoprostol|mesh-list
139249763|NCT01373359|Oxytocin|oxytocin|mesh-list
139249764|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
139249765|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139642261|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
139249766|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249767|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139249768|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
139249769|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139249770|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139249771|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
139249772|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139249773|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249774|NCT02251964|Rituximab|rituximab|mesh-list
139249775|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139249776|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249777|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
139249778|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249779|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139249780|NCT04739995|Naltrexone|naltrexone|mesh-list
139249781|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139249782|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139249783|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249784|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
139249785|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249786|NCT02120612|Naloxone|naloxone|mesh-list
139249787|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139249788|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249789|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
139249790|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139249791|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
139249792|NCT02115152|Capecitabine|capecitabine|mesh-list
139249793|NCT02115152|Fluorouracil|fluorouracil|mesh-list
139249794|NCT02115152|Epirubicin|epirubicin|mesh-list
139249795|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139249796|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
139249797|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371412|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371413|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139371414|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371415|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
139371416|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139371417|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
139371418|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371419|NCT03568721|Acetaminophen|acetaminophen|mesh-list
139371420|NCT03568721|Ibuprofen|ibuprofen|mesh-list
139371421|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139371422|NCT03568721|Analgesics|analgesics|mesh-ancestor
139249798|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139249799|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139249800|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
139249801|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249802|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249803|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139249804|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139249805|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
139249806|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139249807|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139249808|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139249809|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249810|NCT02115464|Metformin|metformin|mesh-list
139249811|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139249812|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249813|NCT02858076|Aflibercept|aflibercept|mesh-list
139249814|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
139249815|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139249816|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139249817|NCT02858076|Growth Substances|growth substances|mesh-ancestor
139249818|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249819|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
139249820|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249821|NCT01319695|Hormones|hormones|mesh-list
139249822|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139249823|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249824|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249825|NCT04594759|Isotretinoin|isotretinoin|mesh-list
139249826|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
139249827|NCT02123498|Omeprazole|omeprazole|mesh-list
139249828|NCT02123498|Pantoprazole|pantoprazole|mesh-list
139249829|NCT02123498|Ranitidine|ranitidine|mesh-list
139249830|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139249831|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139249832|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139249833|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139249834|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371741|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249835|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249836|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139249837|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
139249838|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
139249839|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139249840|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249841|NCT02115776|Amoxicillin|amoxicillin|mesh-list
139249842|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
139249843|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
139249844|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
139249845|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139249846|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249847|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139249848|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
139249849|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139249850|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249851|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249852|NCT02123654|Asunaprevir|asunaprevir|mesh-list
139249853|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
139249854|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249855|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249856|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
139249857|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
139249858|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139372164|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
139249859|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249860|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139249861|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139249862|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
139249863|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139249864|NCT03609294|Linagliptin|linagliptin|mesh-list
139249865|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139372252|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
139249866|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249867|NCT03609294|Incretins|incretins|mesh-ancestor
139249868|NCT03609294|Hormones|hormones|mesh-ancestor
139372311|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249869|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249870|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139249871|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
139249872|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249873|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249874|NCT01917552|Capecitabine|capecitabine|mesh-list
139249875|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139249876|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
139249877|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249878|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249879|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
139249880|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
139249881|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139249882|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249883|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249884|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
139249885|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139249886|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139249887|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249888|NCT03119701|Interferons|interferons|mesh-list
139249889|NCT03119701|Interferon-beta|interferon-beta|mesh-list
139249890|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
139249891|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249892|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
139249893|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372543|NCT01651780|Heparin|heparin|mesh-list
139249894|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
139249895|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249896|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139249897|NCT03717129|Tenofovir|tenofovir|mesh-list
139249898|NCT03717129|Emtricitabine|emtricitabine|mesh-list
139372582|NCT05357612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139249899|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139249900|NCT03717129|Cobicistat|cobicistat|mesh-list
139249901|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139372649|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
139249902|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139249903|NCT03717129|Elvitegravir|elvitegravir|mesh-list
139249904|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
139249905|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249906|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139249907|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139249908|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249909|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249910|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139249911|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139249912|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139249913|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139120099|NCT04903210|Niacin|niacin|mesh-list
139249914|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139249915|NCT03627039|Metformin|metformin|mesh-list
139249916|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
139249917|NCT03627039|Empagliflozin|empagliflozin|mesh-list
139249918|NCT03627039|Canagliflozin|canagliflozin|mesh-list
139372928|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
139249919|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139249920|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249921|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139249922|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249923|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
139249924|NCT01374373|Hematinics|hematinics|mesh-ancestor
139249925|NCT02116556|Rifaximin|rifaximin|mesh-list
139249926|NCT02116556|Prednisone|prednisone|mesh-list
139249927|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249928|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
139249929|NCT02116556|Hormones|hormones|mesh-ancestor
139249930|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249931|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249932|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139249933|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249934|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139249935|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249936|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139249937|NCT03634345|Fluconazole|fluconazole|mesh-list
139249938|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
139249939|NCT03634345|Abrocitinib|abrocitinib|mesh-list
139249940|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
139249941|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249942|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139249943|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139249944|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139249945|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249946|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139249947|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
139373350|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139249948|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139249949|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249950|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139249951|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139249952|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139249953|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139249954|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139249955|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139249956|NCT03634345|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139249957|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139249958|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139249959|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139249960|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
139249961|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139249962|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
139249963|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139249964|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139249965|NCT03553238|Cytarabine|cytarabine|mesh-list
139249966|NCT03553238|Dexamethasone|dexamethasone|mesh-list
139249967|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
139249968|NCT03553238|Methotrexate|methotrexate|mesh-list
139249969|NCT03553238|Etoposide|etoposide|mesh-list
139249970|NCT03553238|Vincristine|vincristine|mesh-list
139249971|NCT03553238|Doxorubicin|doxorubicin|mesh-list
139249972|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
139249973|NCT03553238|Idarubicin|idarubicin|mesh-list
139249974|NCT03553238|Pegaspargase|pegaspargase|mesh-list
139249975|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139249976|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
139249977|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139249978|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139249979|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139249980|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
139249981|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139249982|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139249983|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139249984|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139249985|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
139249986|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
139249987|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642262|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139249988|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139249989|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
139249990|NCT03553238|Hormones|hormones|mesh-ancestor
139249991|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373903|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
139249992|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139249993|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139249994|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
139249995|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139249996|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139249997|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
139249998|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
139249999|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250000|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139250001|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139250002|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139374036|NCT02058173|Amebicides|amebicides|mesh-ancestor
139250003|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139250004|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139250005|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
139250006|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250007|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
139250008|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
139250009|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
139374178|NCT03560375|Empagliflozin|empagliflozin|mesh-list
139250010|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139250011|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
139250012|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139250013|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250014|NCT01373593|Lidocaine|lidocaine|mesh-list
139250015|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
139250016|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
139250017|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139250018|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250019|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
139250020|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250021|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139374328|NCT02064491|Paclitaxel|paclitaxel|mesh-list
139250022|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139250023|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139250024|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139250025|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250026|NCT02116712|Saracatinib|saracatinib|mesh-list
139250027|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250028|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250029|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250030|NCT02116790|Naproxen|naproxen|mesh-list
139250031|NCT02116790|Levodopa|levodopa|mesh-list
139250032|NCT02116790|Carbidopa|carbidopa|mesh-list
139250033|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139250034|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139250035|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139250036|NCT02116790|Analgesics|analgesics|mesh-ancestor
139250037|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
139250038|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250039|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250040|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139250041|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139250042|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
139250043|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139250044|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250045|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250046|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139250047|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139250048|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
139250049|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374384|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
139250050|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139250051|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139250052|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
139250053|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
139250054|NCT02859961|Leronlimab|leronlimab|mesh-list
139250055|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
139250056|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139250057|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139374430|NCT02065349|ASP8477|asp8477|mesh-list
139250058|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250059|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139250060|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139250061|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
139250062|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250063|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
139250064|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250065|NCT02124200|Nicotine|nicotine|mesh-list
139250066|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139250067|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
139250068|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250069|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250070|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139250071|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139250072|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
139250073|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250074|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250075|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
139250076|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
139250077|NCT04503993|Antibodies|antibodies|mesh-list
139250078|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
139250079|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
139250080|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374561|NCT02625974|Nifurtimox|nifurtimox|mesh-list
139250081|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
139250082|NCT02116868|Nicardipine|nicardipine|mesh-list
139250083|NCT02116868|Urapidil|urapidil|mesh-list
139250084|NCT02116868|Remifentanil|remifentanil|mesh-list
139250085|NCT02116868|Esmolol|esmolol|mesh-list
139250086|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139250087|NCT02116868|Narcotics|narcotics|mesh-ancestor
139250088|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139250089|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250090|NCT02116868|Analgesics|analgesics|mesh-ancestor
139250091|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
139250092|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250093|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139374685|NCT02076893|Analgesics|analgesics|mesh-ancestor
139250094|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139250095|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139250096|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
139250097|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139031650|NCT00986609|Poly I-C|poly i-c|mesh-list
139250098|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250099|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139250100|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139250101|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139250102|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
139250103|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139250104|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
139250105|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139250106|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139250107|NCT02679781|Midazolam|midazolam|mesh-list
139374899|NCT02080169|Midazolam|midazolam|mesh-list
139250108|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139250109|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139250110|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139250111|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250112|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139374975|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139250113|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139250114|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139250115|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139375048|NCT03241875|Pregabalin|pregabalin|mesh-list
139250116|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
139250117|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
139250118|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
139250119|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
139250120|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250121|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250122|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
139250123|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139250124|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250125|NCT04373031|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139250126|NCT04373031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250127|NCT02624869|Evolocumab|evolocumab|mesh-list
139250128|NCT02624869|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139250129|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139250130|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139250131|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
139250132|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250133|NCT02624869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139375254|NCT02453607|Infliximab|infliximab|mesh-list
139250134|NCT02624869|Protease Inhibitors|protease inhibitors|mesh-ancestor
139250135|NCT02624869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250136|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139250137|NCT02121782|Vaccines|vaccines|mesh-list
139250138|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
139250139|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250140|NCT03553082|Propofol|propofol|mesh-list
139250141|NCT03553082|Sevoflurane|sevoflurane|mesh-list
139250142|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139250143|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139250144|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250145|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139375461|NCT05234619|Analgesics|analgesics|mesh-ancestor
139250146|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
139250147|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
139250148|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139250149|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139250150|NCT03318393|Heparin|heparin|mesh-list
139250151|NCT03318393|Calcium heparin|calcium heparin|mesh-list
139250152|NCT03318393|Bivalirudin|bivalirudin|mesh-list
139250153|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
139250154|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139250155|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139250156|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250157|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
139250158|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139250159|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
139250160|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250161|NCT03110029|Efinaconazole|efinaconazole|mesh-list
139250162|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
139375527|NCT02792231|Ofatumumab|ofatumumab|mesh-list
139250163|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250164|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
139250165|NCT03552146|Propofol|propofol|mesh-list
139250166|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139250167|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139250168|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250169|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139250170|NCT03552146|Analgesics|analgesics|mesh-ancestor
139250171|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
139250172|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250173|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139250174|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139250175|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139250176|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
139250177|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250178|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250179|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139250180|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
139250181|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
139250182|NCT01374763|Oxycodone|oxycodone|mesh-list
139250183|NCT01374763|Naloxone|naloxone|mesh-list
139250184|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139250185|NCT01374763|Narcotics|narcotics|mesh-ancestor
139250186|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139250187|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250188|NCT01374763|Analgesics|analgesics|mesh-ancestor
139250189|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
139250190|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250191|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139250192|NCT03608514|Terlipressin|terlipressin|mesh-list
139250193|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139250194|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139250195|NCT02117726|Midazolam|midazolam|mesh-list
139250196|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
139250197|NCT02117726|Propofol|propofol|mesh-list
139250198|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139250199|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139250200|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250201|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139250202|NCT02117726|Analgesics|analgesics|mesh-ancestor
139375930|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
139250203|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
139250204|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250205|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139250206|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139250207|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139250208|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
139250209|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250210|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250211|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139250212|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
139250213|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
139250214|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139250215|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139250216|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139250217|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139250218|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
139250219|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
139250220|NCT02733432|Fluconazole|fluconazole|mesh-list
139250221|NCT02733432|Rezafungin|rezafungin|mesh-list
139250222|NCT02733432|Antifungal Agents|antifungal agents|mesh-ancestor
139250223|NCT02733432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250224|NCT02733432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139250225|NCT02733432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139250226|NCT02733432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250227|NCT02733432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250228|NCT02733432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139250229|NCT02733432|Hormone Antagonists|hormone antagonists|mesh-ancestor
139250230|NCT02733432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139250231|NCT02733432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376092|NCT04913402|Dsuvia|dsuvia|mesh-list
139250232|NCT02733432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139250233|NCT02733432|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139250234|NCT03634189|Cannabidiol|cannabidiol|mesh-list
139250235|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
139250236|NCT03608046|Irinotecan|irinotecan|mesh-list
139250237|NCT03608046|Cetuximab|cetuximab|mesh-list
139250238|NCT03608046|Avelumab|avelumab|mesh-list
139250239|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139250240|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139250241|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250242|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250243|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250244|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139250245|NCT02122484|Colchicine|colchicine|mesh-list
139250246|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
139250247|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139250248|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
139250249|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
139250250|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
139250251|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376327|NCT02140801|Ticagrelor|ticagrelor|mesh-list
139250252|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250253|NCT03606018|Insulin|insulin|mesh-list
139250254|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139250255|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
139250256|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139250257|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250258|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
139250259|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
139250260|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139250261|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139250262|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250263|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250264|NCT01373749|Urological Agents|urological agents|mesh-ancestor
139250265|NCT04045795|Dexamethasone|dexamethasone|mesh-list
139250266|NCT04045795|Pomalidomide|pomalidomide|mesh-list
139250267|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139250268|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139250269|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
139250270|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
139250271|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250272|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250273|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139250274|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
139250275|NCT04045795|Hormones|hormones|mesh-ancestor
139250276|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139250277|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139250278|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250279|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
139250280|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139250281|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139250282|NCT04045795|Growth Substances|growth substances|mesh-ancestor
139250283|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
139250284|NCT03605940|Methoxsalen|methoxsalen|mesh-list
139250285|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139250286|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
139250287|NCT03607734|Amoxicillin|amoxicillin|mesh-list
139250288|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139250289|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250294|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
139250295|NCT03602430|Vitamins|vitamins|mesh-ancestor
139250296|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
139250297|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250298|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139250299|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139250300|NCT02260544|Doxorubicin|doxorubicin|mesh-list
139250301|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139250302|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139250303|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250304|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139250305|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139250306|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250307|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250308|NCT05470647|Interleukin-4|interleukin-4|mesh-list
139250309|NCT05470647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139250310|NCT05470647|Immunologic Factors|immunologic factors|mesh-ancestor
139250311|NCT05470647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250312|NCT05470647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250313|NCT05470647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139250314|NCT04409665|Ketamine|ketamine|mesh-list
139250315|NCT04409665|Analgesics|analgesics|mesh-ancestor
139250316|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
139250317|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250318|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250319|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139250320|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139250321|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
139250322|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
139250323|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139377018|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
139250324|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139250325|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139250326|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250327|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250328|NCT02854800|Varenicline|varenicline|mesh-list
139250329|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139250330|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139250331|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
139250332|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250333|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250334|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250336|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139250337|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250338|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139250339|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139250340|NCT03552770|Growth Substances|growth substances|mesh-ancestor
139250341|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250342|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
139250347|NCT02931539|Valganciclovir|valganciclovir|mesh-list
139250348|NCT02931539|Ganciclovir|ganciclovir|mesh-list
139250349|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139250350|NCT02931539|Cidofovir|cidofovir|mesh-list
139250351|NCT02931539|Foscarnet|foscarnet|mesh-list
139250352|NCT02931539|Maribavir|maribavir|mesh-list
139250353|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
139250354|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250355|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139250356|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250357|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250358|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139250359|NCT03602118|Phenobarbital|phenobarbital|mesh-list
139250360|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
139250361|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139250362|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139250363|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250364|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139250365|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139250366|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250367|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250368|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
139250369|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
139250370|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139250371|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139250372|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139250373|NCT02125682|Atorvastatin|atorvastatin|mesh-list
139250374|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139250375|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139250376|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
139250377|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250378|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139250379|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139250380|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250381|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
139250382|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139250383|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139250384|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139250385|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250386|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
139250387|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250388|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250389|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139250390|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250391|NCT02131220|Tirofiban|tirofiban|mesh-list
139250392|NCT02131220|Saruplase|saruplase|mesh-list
139250393|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139250394|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139377554|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
139250395|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250396|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139250397|NCT04042077|Vancomycin|vancomycin|mesh-list
139250398|NCT04042077|Tazobactam|tazobactam|mesh-list
139250399|NCT04042077|Linezolid|linezolid|mesh-list
139377625|NCT02438397|Insulin|insulin|mesh-list
139250400|NCT04042077|Piperacillin|piperacillin|mesh-list
139250401|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139250402|NCT04042077|Tigecycline|tigecycline|mesh-list
139250403|NCT04042077|Delafloxacin|delafloxacin|mesh-list
139250404|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139377692|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
139250405|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250406|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139250407|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250408|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250409|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139250410|NCT03557359|Nivolumab|nivolumab|mesh-list
139250411|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139250412|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250413|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139250414|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250415|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139250416|NCT02127320|Ezetimibe|ezetimibe|mesh-list
139250417|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139250418|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139250419|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
139250420|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250421|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139250422|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139250423|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250424|NCT03522415|Methotrexate|methotrexate|mesh-list
139250425|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139250426|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
139250427|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139250428|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250429|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139250430|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
139250431|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250432|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250433|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
139250434|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250435|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139250436|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139250437|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
139250438|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139250439|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139250440|NCT04226833|Entrectinib|entrectinib|mesh-list
139250441|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139250442|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250443|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250444|NCT02131298|Itraconazole|itraconazole|mesh-list
139250445|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139250446|NCT02131298|Palbociclib|palbociclib|mesh-list
139250447|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
139250448|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250449|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139250450|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139250451|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250452|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250453|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139250454|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
139250455|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139250456|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250457|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139250458|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250459|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139250460|NCT01375387|Lacosamide|lacosamide|mesh-list
139250461|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
139250462|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139250463|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139250464|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139250465|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250466|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
139250467|NCT02853318|Bevacizumab|bevacizumab|mesh-list
139250468|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
139250469|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139250470|NCT02853318|Antibodies|antibodies|mesh-list
139250471|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
139250472|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139250473|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
139250474|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
139250475|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139250476|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
139250477|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250478|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139250479|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139250480|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
139250481|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250482|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250483|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139250484|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139250485|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139250486|NCT02853318|Growth Substances|growth substances|mesh-ancestor
139250487|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
139250488|NCT02853318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139250489|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
139250490|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139250491|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139250492|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
139250493|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
139250494|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139250495|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250496|NCT03604224|Canagliflozin|canagliflozin|mesh-list
139250497|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139250498|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250499|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139250500|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250501|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139250502|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
139250503|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250504|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139250505|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139250506|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250507|NCT02404155|Clozapine|clozapine|mesh-list
139378192|NCT02145637|Afatinib|afatinib|mesh-list
139250508|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139250509|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
139250510|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250511|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250512|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250513|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139250514|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139250515|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139250516|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139250518|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
139250519|NCT02127788|Micafungin|micafungin|mesh-list
139250520|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
139250521|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250522|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
139250523|NCT02131688|Analgesics|analgesics|mesh-ancestor
139250524|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
139250525|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250526|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250527|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250528|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139250529|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139250530|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250531|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250532|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139250533|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139250534|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
139250535|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250536|NCT02126462|Antacids|antacids|mesh-ancestor
139250537|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250538|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139250539|NCT03113071|Decitabine|decitabine|mesh-list
139250540|NCT03113071|Digoxin|digoxin|mesh-list
139250541|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139250542|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
139250543|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250544|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378614|NCT02086097|Ibuprofen|ibuprofen|mesh-list
139250545|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250546|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139250547|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139091679|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250548|NCT03113071|Protective Agents|protective agents|mesh-ancestor
139250549|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250550|NCT03050307|Lansoprazole|lansoprazole|mesh-list
139250551|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
139250552|NCT03050307|Bismuth|bismuth|mesh-list
139250553|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139250554|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139250555|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139250556|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250557|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250558|NCT03050307|Antacids|antacids|mesh-ancestor
139250559|NCT02127866|Beclomethasone|beclomethasone|mesh-list
139250560|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
139250561|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
139250562|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139250563|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
139250564|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250565|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250566|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139250567|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
139250568|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139250569|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139250570|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139250571|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
139250572|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250573|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250574|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139250575|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139250576|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139250577|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
139250578|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139250579|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
139250580|NCT02127866|Hormones|hormones|mesh-ancestor
139250581|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139250582|NCT03550508|Antibodies|antibodies|mesh-list
139250583|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139250584|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
139250585|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250586|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
139250587|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139250588|NCT03607578|Protective Agents|protective agents|mesh-ancestor
139250589|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250590|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
139250591|NCT05760079|Lactoferrin|lactoferrin|mesh-list
139250592|NCT05760079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250593|NCT03603834|Leucovorin|leucovorin|mesh-list
139250594|NCT03603834|Fluorouracil|fluorouracil|mesh-list
139250595|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
139250596|NCT03603834|Irinotecan|irinotecan|mesh-list
139250597|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
139378934|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
139250598|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250599|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139250600|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250601|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139250602|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
139250603|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250604|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139250605|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139250606|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250607|NCT03603834|Antidotes|antidotes|mesh-ancestor
139250608|NCT03603834|Protective Agents|protective agents|mesh-ancestor
139378975|NCT03046238|Analgesics|analgesics|mesh-ancestor
139250609|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
139250610|NCT03603834|Vitamins|vitamins|mesh-ancestor
139250611|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
139250612|NCT03601338|Bemiparin|bemiparin|mesh-list
139250613|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
139250614|NCT02128022|Glyburide|glyburide|mesh-list
139250615|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139250616|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250617|NCT03256045|Dexamethasone|dexamethasone|mesh-list
139250618|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
139250619|NCT03256045|Panobinostat|panobinostat|mesh-list
139250620|NCT03256045|Ichthammol|ichthammol|mesh-list
139250621|NCT03256045|BB 1101|bb 1101|mesh-list
139250622|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139250623|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
139250624|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
139250625|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250626|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250627|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139250628|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
139250629|NCT03256045|Hormones|hormones|mesh-ancestor
139250630|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139250631|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139250632|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250633|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
139250634|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250635|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250636|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139250637|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
139250638|NCT03603756|Paclitaxel|paclitaxel|mesh-list
139250639|NCT03603756|Irinotecan|irinotecan|mesh-list
139250640|NCT03603756|Apatinib|apatinib|mesh-list
139250641|NCT03603756|Nedaplatin|nedaplatin|mesh-list
139250642|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139250643|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250644|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
139250645|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
139250646|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
139379308|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139250647|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250648|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139250649|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139250650|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250651|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139250652|NCT02372409|Doxorubicin|doxorubicin|mesh-list
139250653|NCT02372409|Etoposide|etoposide|mesh-list
139250654|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
139379451|NCT02102633|Dabigatran|dabigatran|mesh-list
139250655|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139250656|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250657|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139379538|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
139250658|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139250659|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250660|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250661|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139250662|NCT03626259|Losartan|losartan|mesh-list
139250663|NCT03626259|Amlodipine|amlodipine|mesh-list
139250664|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139379659|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
139250665|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139250666|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139250667|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250668|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139250669|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250670|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
139250671|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139250672|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139250673|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139250674|NCT03601260|Allopurinol|allopurinol|mesh-list
139250675|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
139250676|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250677|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250678|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
139250679|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139250680|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139250681|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
139250682|NCT03601260|Protective Agents|protective agents|mesh-ancestor
139250683|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250684|NCT05193253|Liver Extracts|liver extracts|mesh-list
139250685|NCT05193253|Hematinics|hematinics|mesh-ancestor
139250686|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
139250687|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139250688|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250689|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
139250690|NCT03600948|Sirolimus|sirolimus|mesh-list
139250691|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139250692|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250693|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139250694|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250695|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
139250696|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139250697|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
139250698|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250699|NCT02132000|Tamoxifen|tamoxifen|mesh-list
139250700|NCT02132000|Toremifene|toremifene|mesh-list
139250701|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139250702|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
139250703|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139250704|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250705|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139250706|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250707|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139250708|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139250709|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139250710|NCT03118765|Bromides|bromides|mesh-list
139250711|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139250712|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
139250713|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139250714|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
139250715|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250716|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250717|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139250718|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
139250719|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
139250720|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139250721|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
139250722|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250723|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250724|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
139250725|NCT02128100|Leucovorin|leucovorin|mesh-list
139250726|NCT02128100|Fluorouracil|fluorouracil|mesh-list
139250727|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
139250728|NCT02128100|Irinotecan|irinotecan|mesh-list
139250729|NCT02128100|Folfirinox|folfirinox|mesh-list
139250730|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
139250731|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250732|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139250733|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250734|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139250735|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
139250736|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250737|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139250738|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139250739|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250740|NCT02128100|Antidotes|antidotes|mesh-ancestor
139250741|NCT02128100|Protective Agents|protective agents|mesh-ancestor
139250742|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
139250743|NCT02128100|Vitamins|vitamins|mesh-ancestor
139250744|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
139250745|NCT03603366|Aspirin|aspirin|mesh-list
139250746|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139250747|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139250748|NCT03603366|Analgesics|analgesics|mesh-ancestor
139250749|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
139250750|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250751|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250752|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139250753|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139250754|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139250755|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139250756|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250757|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139250758|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139250759|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250760|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
139250761|NCT02128178|Enoxaparin|enoxaparin|mesh-list
139250762|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
139250763|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
139250764|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139250765|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139250766|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250767|NCT03600870|Midodrine|midodrine|mesh-list
139250768|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
139250769|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
139250770|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250771|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250772|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139250773|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139250774|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139250775|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139250776|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
139250777|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250778|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250779|NCT02128334|Leuprolide|leuprolide|mesh-list
139250780|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139250781|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
139250782|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139250783|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250784|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139250785|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250786|NCT01375699|Doxorubicin|doxorubicin|mesh-list
139250787|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139250788|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
139250789|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139250790|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250791|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139250792|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139250793|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250794|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250795|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
139250796|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139250797|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139250798|NCT01375699|Urological Agents|urological agents|mesh-ancestor
139250799|NCT01373983|Ziconotide|ziconotide|mesh-list
139250800|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139250801|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139250802|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250803|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139250804|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250805|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139250806|NCT01373983|Protective Agents|protective agents|mesh-ancestor
139250807|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139250808|NCT01373983|Analgesics|analgesics|mesh-ancestor
139250809|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
139250810|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250811|NCT05812612|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139250812|NCT05812612|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139250813|NCT05812612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139250814|NCT05812521|Methylene Blue|methylene blue|mesh-list
139250815|NCT05812521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250816|NCT05812521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250817|NCT05812430|Paclitaxel|paclitaxel|mesh-list
139250818|NCT05812430|Cisplatin|cisplatin|mesh-list
139250819|NCT05812430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139250820|NCT05812430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250821|NCT05812430|Tubulin Modulators|tubulin modulators|mesh-ancestor
139250822|NCT05812430|Antimitotic Agents|antimitotic agents|mesh-ancestor
139250823|NCT05812430|Mitosis Modulators|mitosis modulators|mesh-ancestor
139250824|NCT05812430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250825|NCT05812404|Fexuprazan|fexuprazan|mesh-list
139250826|NCT05812404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139250827|NCT03607110|Fentanyl|fentanyl|mesh-list
139250828|NCT03607110|Ketamine|ketamine|mesh-list
139250829|NCT03607110|Analgesics|analgesics|mesh-ancestor
139250830|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
139250831|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250832|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250833|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139250834|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139250835|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
139250836|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
139250837|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139250838|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139379857|NCT04867226|Colchicine|colchicine|mesh-list
139250839|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139250840|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250841|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250842|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139250843|NCT03607110|Narcotics|narcotics|mesh-ancestor
139250844|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139250845|NCT05811793|Bevacizumab|bevacizumab|mesh-list
139250846|NCT05811793|Tislelizumab|tislelizumab|mesh-list
139250847|NCT05811793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139250848|NCT05811793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250849|NCT05811793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139250850|NCT05811793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139250851|NCT05811793|Growth Substances|growth substances|mesh-ancestor
139250852|NCT05811793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250853|NCT05811793|Growth Inhibitors|growth inhibitors|mesh-ancestor
139250854|NCT05811507|Testosterone|testosterone|mesh-list
139207452|NCT05840770|Cemiplimab|cemiplimab|mesh-list
139250855|NCT05811507|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139250856|NCT05811507|Androgens|androgens|mesh-ancestor
139250857|NCT05811507|Hormones|hormones|mesh-ancestor
139250858|NCT05811507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139250859|NCT05811507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250860|NCT05811507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139250861|NCT05811507|Immunologic Factors|immunologic factors|mesh-ancestor
139250862|NCT05811221|Anesthetics|anesthetics|mesh-list
139250863|NCT05811221|Esketamine|esketamine|mesh-list
139250864|NCT05811221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139250865|NCT05811221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250866|NCT05811221|Antidepressive Agents|antidepressive agents|mesh-ancestor
139250867|NCT05811221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139250868|NCT05811000|Donepezil|donepezil|mesh-list
139250869|NCT05811000|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139250870|NCT05811000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250871|NCT05811000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250872|NCT05811000|Cholinergic Agents|cholinergic agents|mesh-ancestor
139250873|NCT05811000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250874|NCT05811000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250875|NCT05811000|Nootropic Agents|nootropic agents|mesh-ancestor
139250876|NCT05810909|Calcium Carbonate|calcium carbonate|mesh-list
139250877|NCT05810909|Calcium|calcium|mesh-list
139250878|NCT05810909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139250879|NCT05810909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250880|NCT05810909|Antacids|antacids|mesh-ancestor
139250881|NCT05810909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250882|NCT05810909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139250883|NCT05810350|Pemetrexed|pemetrexed|mesh-list
139250884|NCT05810350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250885|NCT05810350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250886|NCT05810350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250887|NCT05810350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139250888|NCT05810350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139250889|NCT05807360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139250890|NCT05807360|Hyaluronic Acid|hyaluronic acid|mesh-list
139250891|NCT05807360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139250892|NCT05807360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139250893|NCT05807360|Immunologic Factors|immunologic factors|mesh-ancestor
139250894|NCT05807360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250895|NCT05807360|Viscosupplements|viscosupplements|mesh-ancestor
139250896|NCT05807360|Protective Agents|protective agents|mesh-ancestor
139250897|NCT05801224|Nitric Oxide|nitric oxide|mesh-list
139250898|NCT05801224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139250899|NCT05801224|Autonomic Agents|autonomic agents|mesh-ancestor
139250900|NCT05801224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250901|NCT05801224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250902|NCT05801224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139250903|NCT05801224|Respiratory System Agents|respiratory system agents|mesh-ancestor
139250904|NCT05801224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139250905|NCT05801224|Antioxidants|antioxidants|mesh-ancestor
139250906|NCT05801224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185257|NCT03448744|Entecavir|entecavir|mesh-list
139250907|NCT05801224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250908|NCT05801224|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139250909|NCT05801224|Vasodilator Agents|vasodilator agents|mesh-ancestor
139250910|NCT05801224|Gasotransmitters|gasotransmitters|mesh-ancestor
139250911|NCT05801224|Protective Agents|protective agents|mesh-ancestor
139250912|NCT05793489|Silybin|silybin|mesh-list
139250913|NCT05793489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139250914|NCT05793489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250915|NCT05793489|Protective Agents|protective agents|mesh-ancestor
139250916|NCT05793489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250917|NCT05754853|Paclitaxel|paclitaxel|mesh-list
139250918|NCT05754853|Docetaxel|docetaxel|mesh-list
139250919|NCT05754853|Gemcitabine|gemcitabine|mesh-list
139250920|NCT05754853|Pemetrexed|pemetrexed|mesh-list
139250921|NCT05754853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139250922|NCT05754853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250923|NCT05754853|Tubulin Modulators|tubulin modulators|mesh-ancestor
139250924|NCT05754853|Antimitotic Agents|antimitotic agents|mesh-ancestor
139250925|NCT05754853|Mitosis Modulators|mitosis modulators|mesh-ancestor
139250926|NCT05754853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250927|NCT05754853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139250928|NCT05754853|Antimetabolites|antimetabolites|mesh-ancestor
139250929|NCT05754853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250930|NCT05754853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139250931|NCT05754853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139250932|NCT05747625|Panitumumab|panitumumab|mesh-list
139250933|NCT05747625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139250934|NCT05747625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250935|NCT05742347|Protective Agents|protective agents|mesh-list
139250936|NCT05742347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250937|NCT05692869|Propranolol|propranolol|mesh-list
139250938|NCT05692869|Pseudoephedrine|pseudoephedrine|mesh-list
139250939|NCT05692869|Ephedrine|ephedrine|mesh-list
139250940|NCT05692869|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139250941|NCT05692869|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139250942|NCT05692869|Adrenergic Agents|adrenergic agents|mesh-ancestor
139250943|NCT05692869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139250944|NCT05692869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250945|NCT05692869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250946|NCT05692869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139250947|NCT05692869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139250948|NCT05692869|Vasodilator Agents|vasodilator agents|mesh-ancestor
139250949|NCT05692869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139250950|NCT05692869|Autonomic Agents|autonomic agents|mesh-ancestor
139250951|NCT05692869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250952|NCT05692869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139250953|NCT05692869|Respiratory System Agents|respiratory system agents|mesh-ancestor
139250954|NCT05692869|Nasal Decongestants|nasal decongestants|mesh-ancestor
139250955|NCT05692869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139250956|NCT05692869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139250957|NCT05692869|Sympathomimetics|sympathomimetics|mesh-ancestor
139250958|NCT05655468|Dronedarone|dronedarone|mesh-list
139250959|NCT05655468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139250960|NCT05644353|Mirikizumab|mirikizumab|mesh-list
139250961|NCT05644353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139250962|NCT05644353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139250963|NCT05644353|Analgesics|analgesics|mesh-ancestor
139250964|NCT05644353|Sensory System Agents|sensory system agents|mesh-ancestor
139250965|NCT05644353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250966|NCT05644353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250967|NCT05644353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139250968|NCT05644353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139250969|NCT05644353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139250970|NCT05644353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139250971|NCT05563389|Atorvastatin|atorvastatin|mesh-list
139250972|NCT05563389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139250973|NCT05563389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139250974|NCT05563389|Antimetabolites|antimetabolites|mesh-ancestor
139250975|NCT05563389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250976|NCT05563389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139379865|NCT04856852|Iodine|iodine|mesh-list
139250977|NCT05563389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139250978|NCT05563389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250979|NCT05548660|Analgesics|analgesics|mesh-list
139250980|NCT05548660|Sensory System Agents|sensory system agents|mesh-ancestor
139250981|NCT05548660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139250982|NCT05548660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139250983|NCT05539963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139250984|NCT05539963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139250985|NCT05525273|Trametinib|trametinib|mesh-list
139250986|NCT05525273|Dabrafenib|dabrafenib|mesh-list
139250987|NCT05525273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139250988|NCT05525273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139250989|NCT05525273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139250990|NCT05525273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250991|NCT05511766|Allopurinol|allopurinol|mesh-list
139250992|NCT05511766|Atorvastatin|atorvastatin|mesh-list
139250993|NCT05511766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139250994|NCT05511766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139250995|NCT05511766|Antimetabolites|antimetabolites|mesh-ancestor
139250996|NCT05511766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139250997|NCT05511766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139250998|NCT05511766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139250999|NCT05511766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251000|NCT05511766|Gout Suppressants|gout suppressants|mesh-ancestor
139251001|NCT05511766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139251002|NCT05511766|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139251003|NCT05511766|Antioxidants|antioxidants|mesh-ancestor
139251004|NCT05511766|Protective Agents|protective agents|mesh-ancestor
139251005|NCT05511766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251006|NCT05466734|Cilostazol|cilostazol|mesh-list
139251007|NCT05466734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139251008|NCT05466734|Autonomic Agents|autonomic agents|mesh-ancestor
139251009|NCT05466734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251010|NCT05466734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251011|NCT05466734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139251012|NCT05466734|Respiratory System Agents|respiratory system agents|mesh-ancestor
139251013|NCT05466734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139251014|NCT05466734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139251015|NCT05466734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251016|NCT05466734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139251017|NCT05466734|Vasodilator Agents|vasodilator agents|mesh-ancestor
139251018|NCT05466734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139251019|NCT05466734|Protective Agents|protective agents|mesh-ancestor
139251020|NCT05466734|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139251021|NCT05466734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139251022|NCT05466734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251023|NCT05420402|Propofol|propofol|mesh-list
139251024|NCT05420402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139251025|NCT05420402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251026|NCT05420402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251027|NCT05420402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139251028|NCT05420402|Anesthetics, General|anesthetics, general|mesh-ancestor
139251029|NCT05420402|Anesthetics|anesthetics|mesh-ancestor
139251030|NCT05417087|Vortioxetine|vortioxetine|mesh-list
139251031|NCT05417087|Antidepressive Agents|antidepressive agents|mesh-ancestor
139251032|NCT05417087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139251033|NCT05417087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139251034|NCT05417087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139251035|NCT05417087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251036|NCT05417087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251037|NCT05417087|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139251038|NCT05417087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139379870|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251039|NCT05417087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139251040|NCT05417087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251041|NCT05417087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251042|NCT05417087|Serotonin Agents|serotonin agents|mesh-ancestor
139251043|NCT05417087|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139251044|NCT05417087|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139251045|NCT05417087|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139251046|NCT05417087|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139251047|NCT05416957|Vortioxetine|vortioxetine|mesh-list
139251048|NCT05416957|Antidepressive Agents|antidepressive agents|mesh-ancestor
139251049|NCT05416957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139251050|NCT05416957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139251051|NCT05416957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139251052|NCT05416957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251053|NCT05416957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251054|NCT05416957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139251055|NCT05416957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139251056|NCT05416957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139251057|NCT05416957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251058|NCT05416957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251059|NCT05416957|Serotonin Agents|serotonin agents|mesh-ancestor
139251060|NCT05416957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139251061|NCT05416957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139251062|NCT05416957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139251063|NCT05416957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139251064|NCT05416762|Vortioxetine|vortioxetine|mesh-list
139251065|NCT05416762|Antidepressive Agents|antidepressive agents|mesh-ancestor
139251066|NCT05416762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139251067|NCT05416762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139251068|NCT05416762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139251069|NCT05416762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251070|NCT05416762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251071|NCT05416762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139251072|NCT05416762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139251073|NCT05416762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139251074|NCT05416762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251075|NCT05416762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251076|NCT05416762|Serotonin Agents|serotonin agents|mesh-ancestor
139251077|NCT05416762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139251078|NCT05416762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139251079|NCT05416762|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139251080|NCT05416762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139251081|NCT05365802|FAPI-46|fapi-46|mesh-list
139251082|NCT05365802|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139251083|NCT05365802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251084|NCT05358639|Olaparib|olaparib|mesh-list
139251085|NCT05358639|Navitoclax|navitoclax|mesh-list
139251086|NCT05358639|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139251087|NCT05358639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251088|NCT05358639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251089|NCT05358639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251090|NCT05330871|Vaccines|vaccines|mesh-list
139251091|NCT05330871|Immunologic Factors|immunologic factors|mesh-ancestor
139251092|NCT05330871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251093|NCT05327595|Midazolam|midazolam|mesh-list
139251094|NCT05327595|Atorvastatin|atorvastatin|mesh-list
139251095|NCT05327595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139251096|NCT05327595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139251097|NCT05327595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251098|NCT05327595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251099|NCT05327595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139251100|NCT05327595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139251101|NCT05327595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139251102|NCT05327595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139251103|NCT05327595|Anesthetics, General|anesthetics, general|mesh-ancestor
139251104|NCT05327595|Anesthetics|anesthetics|mesh-ancestor
139251105|NCT05327595|GABA Modulators|gaba modulators|mesh-ancestor
139251106|NCT05327595|GABA Agents|gaba agents|mesh-ancestor
139251107|NCT05327595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251108|NCT05327595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251109|NCT05327595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139251110|NCT05327595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139251111|NCT05327595|Antimetabolites|antimetabolites|mesh-ancestor
139251112|NCT05327595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139251113|NCT05327595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139251114|NCT05327595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251115|NCT05314153|Brexanolone|brexanolone|mesh-list
139251116|NCT05314153|Neurosteroids|neurosteroids|mesh-ancestor
139251117|NCT05314153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251118|NCT05314153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251119|NCT05314153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251120|NCT05314153|GABA Modulators|gaba modulators|mesh-ancestor
139251121|NCT05314153|GABA Agents|gaba agents|mesh-ancestor
139251122|NCT05283408|Dexmedetomidine|dexmedetomidine|mesh-list
139251123|NCT05283408|Esketamine|esketamine|mesh-list
139251124|NCT05283408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139251125|NCT05283408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251126|NCT05283408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251127|NCT05283408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139251128|NCT05283408|Analgesics|analgesics|mesh-ancestor
139251129|NCT05283408|Sensory System Agents|sensory system agents|mesh-ancestor
139251130|NCT05283408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251131|NCT05283408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139251132|NCT05283408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139251133|NCT05283408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139251134|NCT05283408|Adrenergic Agents|adrenergic agents|mesh-ancestor
139251135|NCT05283408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251136|NCT05283408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251137|NCT05283408|Antidepressive Agents|antidepressive agents|mesh-ancestor
139251138|NCT05283408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139251139|NCT05275400|Insulin|insulin|mesh-list
139251140|NCT05275400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139251141|NCT05275400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139251142|NCT05275400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251143|NCT05240755|Cannabidiol|cannabidiol|mesh-list
139251144|NCT05240755|Anticonvulsants|anticonvulsants|mesh-ancestor
139251145|NCT05229315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139251146|NCT05229315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251147|NCT05229315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139251148|NCT05229315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251149|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139251150|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139251151|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139251152|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251153|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251154|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139251155|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139251156|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139251157|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139251158|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
139251159|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251160|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251161|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139251162|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139251163|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
139251164|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139251165|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139251166|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
139251168|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
139251169|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
139251170|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251171|NCT05208931|Growth Substances|growth substances|mesh-ancestor
139251172|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251173|NCT05191862|Cilostazol|cilostazol|mesh-list
139251174|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139251175|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
139251176|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251177|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251178|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139251179|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
139251180|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139251181|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139251182|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251183|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139251184|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
139251185|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139251186|NCT05191862|Protective Agents|protective agents|mesh-ancestor
139251187|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139251188|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139251189|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251190|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
139251191|NCT05189704|Narcotics|narcotics|mesh-ancestor
139251192|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251193|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251194|NCT05189704|Analgesics|analgesics|mesh-ancestor
139251195|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
139251196|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251197|NCT05179421|Oxytocin|oxytocin|mesh-list
139251198|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
139251199|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139251200|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251201|NCT05100160|Gabapentin|gabapentin|mesh-list
139251202|NCT05100160|Analgesics|analgesics|mesh-ancestor
139251203|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
139251204|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251205|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251206|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
139251207|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139251208|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139251209|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251210|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139251211|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139251212|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139251213|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251214|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251215|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
139251216|NCT05052931|Paclitaxel|paclitaxel|mesh-list
139251217|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
139251218|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139251219|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251220|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
139251221|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
139251222|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
139251223|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251224|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
139251225|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139251226|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
139251227|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251228|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251229|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139251230|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
139251231|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139251232|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
139251233|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251234|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251235|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139251236|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
139251237|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
139251238|NCT05052229|Protective Agents|protective agents|mesh-ancestor
139251239|NCT05020769|Osimertinib|osimertinib|mesh-list
139251240|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251241|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139251242|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251243|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251244|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139251245|NCT05002738|Desogestrel|desogestrel|mesh-list
139251246|NCT05002738|Estradiol|estradiol|mesh-list
139251247|NCT05002738|Estrogens|estrogens|mesh-ancestor
139251248|NCT05002738|Hormones|hormones|mesh-ancestor
139251249|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139251250|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251251|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139251252|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
139251253|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139251254|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139251255|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139251256|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139251257|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139251258|NCT05002738|Progestins|progestins|mesh-ancestor
139251259|NCT04990284|Levodopa|levodopa|mesh-list
139251260|NCT04990284|Opicapone|opicapone|mesh-list
139251261|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139251262|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139251263|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
139251264|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251265|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251266|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251267|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139251268|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251269|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
139251270|NCT04955158|Ketamine|ketamine|mesh-list
139251271|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139251272|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251273|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251274|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139251275|NCT04955158|Analgesics|analgesics|mesh-ancestor
139251276|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
139251277|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251278|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139251279|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139251280|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139251281|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
139251282|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251283|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251284|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139251285|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139251286|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
139251287|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
139251288|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139251289|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139251290|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
139251291|NCT04928391|Nalbuphine|nalbuphine|mesh-list
139251292|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139251293|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251294|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251295|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139251296|NCT04928391|Analgesics|analgesics|mesh-ancestor
139251297|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
139251298|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251299|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139251300|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139251301|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139251302|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
139251303|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251304|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251305|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139251306|NCT04928391|Narcotics|narcotics|mesh-ancestor
139251307|NCT04928352|Bupivacaine|bupivacaine|mesh-list
139251308|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
139251309|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
139251310|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251311|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251312|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
139251313|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251314|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
139251315|NCT04928300|Ketamine|ketamine|mesh-list
139251316|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139251317|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251318|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251319|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139251320|NCT04928300|Analgesics|analgesics|mesh-ancestor
139251321|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
139251322|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251323|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139251324|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139251325|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139251326|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
139251327|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251328|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251329|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139251330|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139251331|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
139251332|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
139251333|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139251334|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139251335|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
139251336|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139251337|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139251338|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251339|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
139121567|NCT03727646|Niacin|niacin|mesh-list
139251340|NCT04910464|Coagulants|coagulants|mesh-ancestor
139251341|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
139251342|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139251343|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139251344|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251345|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
139251346|NCT04905901|Coagulants|coagulants|mesh-ancestor
139251347|NCT04901988|Nivolumab|nivolumab|mesh-list
139251348|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139251349|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251350|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139251351|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251352|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
139251353|NCT04899687|Fluoxetine|fluoxetine|mesh-list
139251354|NCT04899687|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139251355|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139251356|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139251357|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251358|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251359|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
139251360|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251361|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139251362|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
139251363|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139251364|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139251365|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139251366|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251367|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
139251368|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
139251369|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139251370|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139251371|NCT04823845|Adapalene|adapalene|mesh-list
139251372|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139251373|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139251375|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
139251376|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251377|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251378|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139251379|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139251380|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
139251381|NCT04792749|Metformin|metformin|mesh-list
139251382|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139251383|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251384|NCT04789070|Sirolimus|sirolimus|mesh-list
139251385|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139251386|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139251387|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139251388|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251389|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
139251390|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139251391|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
139251392|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251393|NCT04756427|Citric Acid|citric acid|mesh-list
139251394|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
139251395|NCT04756427|Anticoagulants|anticoagulants|mesh-list
139251396|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139251397|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
139251398|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
139251399|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251400|NCT04722601|Azacitidine|azacitidine|mesh-list
139251401|NCT04722601|Venetoclax|venetoclax|mesh-list
139251402|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
139251403|NCT04722601|Cc-486|cc-486|mesh-list
139251404|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139251405|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
139251406|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251407|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251408|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251409|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139251410|NCT04692844|Propranolol|propranolol|mesh-list
139251411|NCT04692844|Primidone|primidone|mesh-list
139251412|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139251413|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139251414|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
139642263|NCT04943952|Asparaginase|asparaginase|mesh-list
139251415|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251416|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251417|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251418|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139251419|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139251420|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
139251421|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
139251422|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
139251423|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
139251424|NCT04657003|Tirzepatide|tirzepatide|mesh-list
139251425|NCT04657003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139251426|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251427|NCT04657003|Incretins|incretins|mesh-ancestor
139251428|NCT04657003|Hormones|hormones|mesh-ancestor
139251429|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139251430|NCT04624906|Rituximab|rituximab|mesh-list
139251431|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139251432|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
139251433|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139251434|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251435|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
139251436|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251437|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139251438|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139251439|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
139251440|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251441|NCT04610320|Daratumumab|daratumumab|mesh-list
139251442|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251443|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
139251444|NCT04546399|Leucovorin|leucovorin|mesh-list
139251445|NCT04546399|Folic Acid|folic acid|mesh-list
139251446|NCT04546399|Cytarabine|cytarabine|mesh-list
139251447|NCT04546399|Dexamethasone|dexamethasone|mesh-list
139251448|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
139251449|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
139251450|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139251451|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139251452|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139251454|NCT04546399|Nivolumab|nivolumab|mesh-list
139251455|NCT04546399|Methotrexate|methotrexate|mesh-list
139251456|NCT04546399|Etoposide|etoposide|mesh-list
139251457|NCT04546399|Vincristine|vincristine|mesh-list
139251458|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
139251459|NCT04546399|Asparaginase|asparaginase|mesh-list
139251460|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
139251461|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
139251462|NCT04546399|Pegaspargase|pegaspargase|mesh-list
139251463|NCT04546399|Thioguanine|thioguanine|mesh-list
139251464|NCT04546399|Blinatumomab|blinatumomab|mesh-list
139251465|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139251466|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
139251467|NCT04546399|Antibodies|antibodies|mesh-list
139251468|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
139251469|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139251470|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139251471|NCT04546399|BB 1101|bb 1101|mesh-list
139251472|NCT04546399|Calcium|calcium|mesh-list
139251473|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
139251474|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
139251475|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139251476|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
139251477|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251478|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139251479|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139251480|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
139251481|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251482|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251483|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139251484|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139251485|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
139251486|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
139251487|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251488|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139251489|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
139251490|NCT04546399|Hormones|hormones|mesh-ancestor
139251491|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139251492|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139251493|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
139251494|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251495|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139251496|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139251497|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139251498|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139251499|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
139251500|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139251501|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139251503|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
139251504|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139251505|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139251506|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139251507|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139251508|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139251509|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
139251510|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139251511|NCT04546399|Antidotes|antidotes|mesh-ancestor
139251512|NCT04546399|Protective Agents|protective agents|mesh-ancestor
139251513|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
139251514|NCT04546399|Vitamins|vitamins|mesh-ancestor
139251515|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
139251516|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
139251517|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
139251518|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
139251519|NCT04546399|Hematinics|hematinics|mesh-ancestor
139251520|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
139251521|NCT04540120|Dapansutrile|dapansutrile|mesh-list
139251522|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139251523|NCT04480086|Navitoclax|navitoclax|mesh-list
139251524|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251525|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139251526|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139251527|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139251528|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139251529|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139251530|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251531|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251532|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139251533|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139251534|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139251535|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139251536|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
139251537|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251538|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251539|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139251540|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139251541|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
139251542|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139251543|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139251544|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
139251546|NCT04426825|Atezolizumab|atezolizumab|mesh-list
139251547|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139251548|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251549|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139251550|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139251551|NCT04426825|Growth Substances|growth substances|mesh-ancestor
139251552|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251553|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
139251554|NCT04426825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139251555|NCT04426825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251556|NCT04418479|Aspirin|aspirin|mesh-list
139251557|NCT04418479|Clopidogrel|clopidogrel|mesh-list
139251558|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139251559|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139251560|NCT04418479|Analgesics|analgesics|mesh-ancestor
139251561|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
139251562|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251563|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251564|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139251565|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139251566|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139251567|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139251568|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251569|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139251570|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139251571|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251572|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
139251573|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139251574|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139251575|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139251576|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
139251577|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251578|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139251579|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139251580|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251581|NCT04408508|Amoxicillin|amoxicillin|mesh-list
139251582|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139251583|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139251584|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
139251585|NCT04181515|Yohimbine|yohimbine|mesh-list
139251586|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139251587|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
139251588|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
139251589|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251590|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251591|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139251592|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139251593|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139251594|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
139251595|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251596|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251597|NCT04181515|Urological Agents|urological agents|mesh-ancestor
139251598|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
139251599|NCT04180969|Yohimbine|yohimbine|mesh-list
139251600|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139251601|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
139251602|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
139251603|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208205|NCT05428969|Venetoclax|venetoclax|mesh-list
139251604|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251605|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139251606|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139251607|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139251608|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
139251609|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251610|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251611|NCT04180969|Urological Agents|urological agents|mesh-ancestor
139251612|NCT04123470|Atezolizumab|atezolizumab|mesh-list
139251613|NCT04123470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139251614|NCT04123470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251615|NCT04123470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139251616|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251617|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
139251618|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139251619|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251620|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139251621|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251622|NCT04060108|Methamphetamine|methamphetamine|mesh-list
139251623|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139251624|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251625|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
139251626|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
139251627|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251628|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
139251629|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251630|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251631|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
139251632|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139251633|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139251634|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139251635|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139251637|NCT04017598|Trace Elements|trace elements|mesh-ancestor
139251638|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
139251639|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251640|NCT04014803|Aspirin|aspirin|mesh-list
139251641|NCT04014803|Clopidogrel|clopidogrel|mesh-list
139251642|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139251643|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139251644|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139251645|NCT04014803|Analgesics|analgesics|mesh-ancestor
139251646|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
139251647|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251648|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251649|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139251650|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139251651|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139251652|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139251653|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251654|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139251655|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139251656|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251657|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
139251658|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139251659|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139251660|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139251661|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
139251662|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251663|NCT03945903|Golimumab|golimumab|mesh-list
139251664|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139251665|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139251666|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139251667|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
139251668|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251669|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
139251670|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
139251671|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
139251672|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251673|NCT03937219|Nivolumab|nivolumab|mesh-list
139251674|NCT03937219|Ipilimumab|ipilimumab|mesh-list
139251675|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139251676|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251677|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139251678|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251680|NCT03869268|Ticagrelor|ticagrelor|mesh-list
139251681|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139251682|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139251683|NCT03869268|Analgesics|analgesics|mesh-ancestor
139251684|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
139251685|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251686|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251687|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139251688|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139251689|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139251690|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139251691|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251692|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139251693|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139251694|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251695|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
139251696|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139251697|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139251698|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139251699|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
139251700|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251701|NCT03843463|Dexetimide|dexetimide|mesh-list
139251702|NCT03843463|Citalopram|citalopram|mesh-list
139251703|NCT03843463|Escitalopram|escitalopram|mesh-list
139251704|NCT03843463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139251705|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139251706|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139251707|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251708|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251709|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
139251710|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251711|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139251712|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139251713|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
139251714|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
139251715|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251716|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139251717|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139251718|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
139251719|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139251720|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
139251721|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139251722|NCT03660930|Sirolimus|sirolimus|mesh-list
139251723|NCT03660930|Temsirolimus|temsirolimus|mesh-list
139251724|NCT03660930|MTOR Inhibitors|mtor inhibitors|mesh-list
139251725|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139251726|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139251727|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139251728|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251729|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
139251730|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139251731|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
139251732|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251733|NCT03660930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139251734|NCT03660930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251735|NCT03660930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251736|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
139251737|NCT03643796|Ketamine|ketamine|mesh-list
139251738|NCT03643796|Remifentanil|remifentanil|mesh-list
139251739|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139251740|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251741|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251742|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139251743|NCT03643796|Analgesics|analgesics|mesh-ancestor
139251744|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
139251745|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251746|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139251747|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139251748|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139251749|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
139251750|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251751|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251752|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139251753|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139251754|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
139251755|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
139251756|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139251757|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139251758|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139251759|NCT03643796|Narcotics|narcotics|mesh-ancestor
139251760|NCT03623854|Nivolumab|nivolumab|mesh-list
139251761|NCT03623854|Relatlimab|relatlimab|mesh-list
139251762|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
139251763|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
139251764|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139251765|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251766|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139251767|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251768|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
139251769|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251770|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139251771|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139251772|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251773|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
139251774|NCT03530215|Immunomodulating Agents|immunomodulating agents|mesh-list
139251775|NCT03530215|Immunologic Factors|immunologic factors|mesh-ancestor
139251776|NCT03530215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251777|NCT03475277|Ketamine|ketamine|mesh-list
139251778|NCT03475277|Analgesics|analgesics|mesh-ancestor
139251779|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
139251780|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251781|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251782|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139251783|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139251784|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
139251785|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
139251786|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251787|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139251788|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139251789|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251790|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251791|NCT03472274|Durvalumab|durvalumab|mesh-list
139251792|NCT03472274|Tremelimumab|tremelimumab|mesh-list
139251793|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251794|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091712|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251795|NCT03436433|Lacosamide|lacosamide|mesh-list
139251796|NCT03436433|Levetiracetam|levetiracetam|mesh-list
139251797|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
139251798|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
139251799|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139251800|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139251801|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139251802|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251803|NCT03405090|Fentanyl|fentanyl|mesh-list
139251804|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
139251805|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139251806|NCT03405090|Narcotics|narcotics|mesh-ancestor
139251807|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251808|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251809|NCT03405090|Analgesics|analgesics|mesh-ancestor
139251810|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
139251811|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251812|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139251813|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139251814|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
139251815|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
139251816|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
139251817|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139251818|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
139251819|NCT03284307|Midazolam|midazolam|mesh-list
139251820|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
139251821|NCT03284307|Ketamine|ketamine|mesh-list
139251822|NCT03284307|Propofol|propofol|mesh-list
139251823|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139251824|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251825|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251826|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139251827|NCT03284307|Analgesics|analgesics|mesh-ancestor
139251828|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
139251829|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251830|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139251831|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139251832|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139251833|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
139251834|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251835|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251836|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139251837|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
139251838|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
139251839|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139251840|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139251841|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139251842|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139251843|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139251844|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139251845|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139251846|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
139251847|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
139251848|NCT03279289|Leucovorin|leucovorin|mesh-list
139251849|NCT03279289|Folic Acid|folic acid|mesh-list
139251850|NCT03279289|Fluorouracil|fluorouracil|mesh-list
139251851|NCT03279289|Irinotecan|irinotecan|mesh-list
139251852|NCT03279289|Aflibercept|aflibercept|mesh-list
139251853|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
139251854|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
139251855|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251856|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139380016|NCT06099366|Antiemetics|antiemetics|mesh-ancestor
139251857|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251858|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139251859|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
139251860|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251861|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139251862|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139251863|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251864|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139251865|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139251866|NCT03279289|Growth Substances|growth substances|mesh-ancestor
139251867|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
139251868|NCT03279289|Antidotes|antidotes|mesh-ancestor
139251869|NCT03279289|Protective Agents|protective agents|mesh-ancestor
139642264|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642265|NCT01352637|Cycloserine|cycloserine|mesh-list
139251870|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
139251871|NCT03279289|Vitamins|vitamins|mesh-ancestor
139251872|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
139251873|NCT03279289|Hematinics|hematinics|mesh-ancestor
139251874|NCT03207867|Spartalizumab|spartalizumab|mesh-list
139251875|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139251876|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251877|NCT03207867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139251878|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251879|NCT03186456|Aspirin|aspirin|mesh-list
139251880|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139251881|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139251882|NCT03186456|Analgesics|analgesics|mesh-ancestor
139251883|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
139251884|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251885|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251886|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139251887|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139251888|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139251889|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139251890|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251891|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139251892|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139251893|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251894|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
139251895|NCT03184935|Decitabine|decitabine|mesh-list
139251896|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139251897|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
139251898|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251899|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251900|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251901|NCT03176498|Aspirin|aspirin|mesh-list
139251902|NCT03176498|Atorvastatin|atorvastatin|mesh-list
139251903|NCT03176498|Calcium|calcium|mesh-list
139251904|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139251905|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251906|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139251907|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139251908|NCT03176498|Analgesics|analgesics|mesh-ancestor
139251909|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
139251910|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251911|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139251912|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139251913|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139251914|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139251915|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251916|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139251917|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139251918|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251919|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
139251920|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139251921|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139251922|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
139251923|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139251924|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139251925|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
139251926|NCT03126591|Olaratumab|olaratumab|mesh-list
139251927|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139251928|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251929|NCT03126591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139251930|NCT03126591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251931|NCT03085004|Ethanol|ethanol|mesh-list
139251932|NCT03085004|Paclitaxel|paclitaxel|mesh-list
139251933|NCT03085004|Gemcitabine|gemcitabine|mesh-list
139251934|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139251935|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251936|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
139251937|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
139251938|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
139251939|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251940|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139251941|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
139251942|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139251943|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139251944|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251945|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251946|NCT03059862|Tryptophan|tryptophan|mesh-list
139251947|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139251948|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
139251949|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139251950|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139251951|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251952|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251953|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251954|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139251955|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
139251956|NCT02916862|Calcium|calcium|mesh-list
139251957|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139251958|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251959|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139251960|NCT02891447|Cisplatin|cisplatin|mesh-list
139251961|NCT02891447|Mitomycins|mitomycins|mesh-list
139251962|NCT02891447|Mitomycin|mitomycin|mesh-list
139251963|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251964|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139251965|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
139251966|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251967|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139251968|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139251969|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
139251970|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139251971|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139251972|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139251973|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
139251974|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139251975|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251976|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251977|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
139251978|NCT02680626|Ropivacaine|ropivacaine|mesh-list
139251979|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
139251980|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
139251981|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139251982|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139251983|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
139251984|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139251985|NCT02680626|Analgesics|analgesics|mesh-ancestor
139251986|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139251987|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
139251988|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139251989|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139251990|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139251991|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139251992|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
139251993|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139251994|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
139251995|NCT02494583|Capecitabine|capecitabine|mesh-list
139251996|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139251997|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139251998|NCT02494583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139251999|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252000|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139252001|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
139252002|NCT02359331|Amoxicillin|amoxicillin|mesh-list
139252003|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
139252004|NCT02359331|Metronidazole|metronidazole|mesh-list
139252005|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139252006|NCT02359331|Tetracycline|tetracycline|mesh-list
139252007|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
139252008|NCT02359331|Bismuth|bismuth|mesh-list
139252009|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139252010|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139252011|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139252012|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252013|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252014|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252015|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139252016|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139252017|NCT02359331|Antacids|antacids|mesh-ancestor
139252018|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139252019|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139252020|NCT02322814|Paclitaxel|paclitaxel|mesh-list
139252021|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139252022|NCT02322814|Atezolizumab|atezolizumab|mesh-list
139252023|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139252024|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252025|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
139252026|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
139252027|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
139252028|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252029|NCT02322814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139252030|NCT02322814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139252031|NCT01837862|Mebendazole|mebendazole|mesh-list
139252032|NCT01837862|Piperazine|piperazine|mesh-list
139252033|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
139252034|NCT01837862|Bevacizumab|bevacizumab|mesh-list
139252035|NCT01837862|Carboplatin|carboplatin|mesh-list
139252036|NCT01837862|Irinotecan|irinotecan|mesh-list
139252037|NCT01837862|Vincristine|vincristine|mesh-list
139252038|NCT01837862|Temozolomide|temozolomide|mesh-list
139252039|NCT01837862|DMP 777|dmp 777|mesh-list
139252040|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139252041|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252042|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139252043|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139252044|NCT01837862|Growth Substances|growth substances|mesh-ancestor
139252045|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252046|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
139252047|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139252048|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139252049|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252050|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252051|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139252052|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
139252053|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
139252054|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
139252055|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139252056|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
139252057|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
139252058|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
139252059|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139252060|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252061|NCT01675219|Mitomycins|mitomycins|mesh-list
139252062|NCT01675219|Mitomycin|mitomycin|mesh-list
139252063|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139252064|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252065|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
139252066|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252067|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139252068|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252069|NCT01333033|Leucovorin|leucovorin|mesh-list
139252070|NCT01333033|Paclitaxel|paclitaxel|mesh-list
139252071|NCT01333033|Carboplatin|carboplatin|mesh-list
139252072|NCT01333033|Fluorouracil|fluorouracil|mesh-list
139252073|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
139252074|NCT01333033|Calcium|calcium|mesh-list
139252075|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
139252076|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139252077|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252078|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
139252079|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
139252080|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
139252081|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252082|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139252083|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252084|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
139252085|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139252086|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139252087|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
139252088|NCT01333033|Antidotes|antidotes|mesh-ancestor
139252089|NCT01333033|Protective Agents|protective agents|mesh-ancestor
139252090|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
139252091|NCT01333033|Vitamins|vitamins|mesh-ancestor
139252092|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
139252093|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
139252094|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139252095|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252096|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252097|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139252098|NCT00778063|Analgesics|analgesics|mesh-ancestor
139252099|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
139252100|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252101|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139252102|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139252103|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139252104|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
139252105|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139252106|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252107|NCT00547196|Cyclosporine|cyclosporine|mesh-list
139252108|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
139252109|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
139252110|NCT00547196|Melphalan|melphalan|mesh-list
139252111|NCT00547196|Busulfan|busulfan|mesh-list
139252112|NCT00547196|Fludarabine|fludarabine|mesh-list
139252113|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
139252114|NCT00547196|Cyclosporins|cyclosporins|mesh-list
139252115|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139252116|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
139252117|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252118|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139252119|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139252120|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
139252121|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252122|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252123|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139252124|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139252125|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
139252126|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252127|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
139252128|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252129|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
139252130|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139208730|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
139252131|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139252132|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139252134|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139252135|NCT00330941|Lidocaine|lidocaine|mesh-list
139252136|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
139252137|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
139252138|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252139|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252140|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
139252141|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252142|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139252143|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139252144|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139252145|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139252146|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252147|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
139252148|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139252149|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
139252150|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252151|NCT03149107|Expectorants|expectorants|mesh-ancestor
139252152|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
139252153|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139252154|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
139252155|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252156|NCT03149107|Protective Agents|protective agents|mesh-ancestor
139252157|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252158|NCT03149107|Antidotes|antidotes|mesh-ancestor
139252159|NCT03135301|Metformin|metformin|mesh-list
139252160|NCT03135301|Letrozole|letrozole|mesh-list
139252161|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139252162|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252163|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252164|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139252165|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139252166|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252167|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252168|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139252169|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
139252170|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139252171|NCT03602898|Cyclosporine|cyclosporine|mesh-list
139252172|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
139252173|NCT03602898|Busulfan|busulfan|mesh-list
139252174|NCT03602898|Methotrexate|methotrexate|mesh-list
139252176|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
139252177|NCT03602898|Tacrolimus|tacrolimus|mesh-list
139252178|NCT03602898|Cyclosporins|cyclosporins|mesh-list
139252179|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139252180|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139252181|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
139252182|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252183|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139252184|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139252185|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
139252186|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252187|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252188|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139252189|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139252190|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
139252191|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139252192|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139252193|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
139252194|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
139252195|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252196|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139252197|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139252198|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139252199|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
139252200|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252201|NCT02983747|Loxoprofen|loxoprofen|mesh-list
139252202|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139252203|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139252204|NCT02983747|Analgesics|analgesics|mesh-ancestor
139252205|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
139252206|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252207|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252209|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139252210|NCT05759845|Topiramate|topiramate|mesh-list
139252211|NCT05759845|Amitriptyline|amitriptyline|mesh-list
139252212|NCT05759845|Anticonvulsants|anticonvulsants|mesh-ancestor
139252213|NCT05759845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139252214|NCT05759845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252215|NCT05759845|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139252216|NCT05759845|Antidepressive Agents|antidepressive agents|mesh-ancestor
139252217|NCT05759845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139252218|NCT05759845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139252219|NCT05759845|Analgesics|analgesics|mesh-ancestor
139252220|NCT05759845|Sensory System Agents|sensory system agents|mesh-ancestor
139252221|NCT05759845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252222|NCT05759845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139252223|NCT05759845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139252224|NCT05759845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139252225|NCT05759845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252226|NCT05759845|Adrenergic Agents|adrenergic agents|mesh-ancestor
139252227|NCT05759845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139252228|NCT03931291|Azacitidine|azacitidine|mesh-list
139252229|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139252230|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
139252231|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252232|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252233|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252234|NCT00799110|Imiquimod|imiquimod|mesh-list
139252235|NCT00799110|Vaccines|vaccines|mesh-list
139252236|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
139252237|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252238|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139252239|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252240|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
139252241|NCT05199727|Tadalafil|tadalafil|mesh-list
139252242|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
139252243|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139252244|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139252245|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252246|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252247|NCT05199727|Urological Agents|urological agents|mesh-ancestor
139252248|NCT02132234|Adalimumab|adalimumab|mesh-list
139252249|NCT02132234|Infliximab|infliximab|mesh-list
139252250|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
139252251|NCT02132234|Etanercept|etanercept|mesh-list
139252252|NCT02132234|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139252253|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139252254|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139252255|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
139252256|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139252257|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139252258|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139252259|NCT02132234|Analgesics|analgesics|mesh-ancestor
139252260|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
139252261|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252262|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252263|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139252264|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
139252265|NCT02132390|Toremifene|toremifene|mesh-list
139252266|NCT02132390|Goserelin|goserelin|mesh-list
139252267|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139252268|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252269|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139252270|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139252271|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
139252272|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139252273|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252274|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139252275|NCT02128646|Ketorolac|ketorolac|mesh-list
139252276|NCT02128646|Bupivacaine|bupivacaine|mesh-list
139252277|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
139252278|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
139252279|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252280|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252281|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
139252282|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252283|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139252284|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139252286|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139252287|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139252288|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139252289|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252290|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252291|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139252292|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
139252293|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
139252294|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252295|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139252296|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
139252297|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139252298|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252299|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
139252300|NCT05198947|Ivermectin|ivermectin|mesh-list
139252301|NCT05198947|Permethrin|permethrin|mesh-list
139252302|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139252303|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252304|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252305|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252306|NCT01367834|Hormones|hormones|mesh-list
139252307|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139252308|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252309|NCT03106753|Bupivacaine|bupivacaine|mesh-list
139252310|NCT03106753|Terbutaline|terbutaline|mesh-list
139252311|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
139252312|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
139252313|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252314|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252315|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
139252316|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252317|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139252318|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
139252319|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139252320|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
139252321|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
139252322|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
139252323|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139252324|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139252325|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139252326|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139252327|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
139252328|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139252329|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252330|NCT02133014|Fluorouracil|fluorouracil|mesh-list
139252331|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
139252332|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252333|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139252334|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252335|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139252336|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
139252337|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252338|NCT05759455|Vitamin D|vitamin d|mesh-list
139252339|NCT05759455|Vitamins|vitamins|mesh-ancestor
139252340|NCT05759455|Micronutrients|micronutrients|mesh-ancestor
139252341|NCT05759455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252342|NCT05759455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139252343|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139252344|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139252345|NCT02129114|Estradiol|estradiol|mesh-list
139252346|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139252347|NCT02129114|Estrogens|estrogens|mesh-ancestor
139252348|NCT02129114|Hormones|hormones|mesh-ancestor
139252349|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139252350|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252351|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139252352|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
139252353|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139252354|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139252355|NCT02136992|Pirfenidone|pirfenidone|mesh-list
139252356|NCT02136992|Analgesics|analgesics|mesh-ancestor
139252357|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
139252358|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252359|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252360|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139252361|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139252362|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139252363|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139252364|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252365|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
139252366|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139252367|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252368|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139252369|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139252370|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252371|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252372|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252373|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139252374|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139252375|NCT02129270|Lidocaine|lidocaine|mesh-list
139252376|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
139252377|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
139252378|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252379|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252380|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
139252381|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252382|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139252383|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139252384|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139252385|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139252386|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252387|NCT05370547|Cyclophosphamide|cyclophosphamide|mesh-list
139252388|NCT05370547|Fludarabine|fludarabine|mesh-list
139252389|NCT05370547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139252390|NCT05370547|Immunologic Factors|immunologic factors|mesh-ancestor
139252391|NCT05370547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252392|NCT05370547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139252393|NCT05370547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139252394|NCT05370547|Alkylating Agents|alkylating agents|mesh-ancestor
139252395|NCT05370547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252396|NCT05370547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252397|NCT05370547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139252398|NCT02133326|Acetaminophen|acetaminophen|mesh-list
139252399|NCT02133326|Ibuprofen|ibuprofen|mesh-list
139252400|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139252401|NCT02133326|Analgesics|analgesics|mesh-ancestor
139122546|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252402|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
139252403|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252404|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252405|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
139252406|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139252407|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139252408|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139252409|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139252410|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252411|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252412|NCT02137616|Olanzapine|olanzapine|mesh-list
139252413|NCT02137616|Risperidone|risperidone|mesh-list
139252414|NCT02137616|Aripiprazole|aripiprazole|mesh-list
139252415|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139252416|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139252417|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
139252418|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139252419|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252420|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252421|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139252422|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139252423|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252424|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139252425|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139252426|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
139252427|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
139252428|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
139252429|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252430|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139252431|NCT02137616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139252432|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139252433|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139252434|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
139252435|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
139252436|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139252437|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139252438|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139252439|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139252440|NCT02133638|Propofol|propofol|mesh-list
139252441|NCT02133638|Sevoflurane|sevoflurane|mesh-list
139252442|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139252443|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252444|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252445|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139252446|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
139252447|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
139252448|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139252449|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139252450|NCT02545283|Cytarabine|cytarabine|mesh-list
139252451|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139252452|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
139252453|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252454|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252455|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
139252456|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252457|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139252458|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
139252459|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252460|NCT02137928|Carboplatin|carboplatin|mesh-list
139252461|NCT02137928|Etoposide|etoposide|mesh-list
139252462|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
139252463|NCT02137928|Vincristine|vincristine|mesh-list
139252464|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252465|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139252466|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139252467|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139252468|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252469|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252470|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
139252471|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
139642266|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139252472|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
139252473|NCT02138084|Ritonavir|ritonavir|mesh-list
139252474|NCT02138084|Fostemsavir|fostemsavir|mesh-list
139252475|NCT02138084|Rifabutin|rifabutin|mesh-list
139252476|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139252477|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139252478|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
139252479|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252480|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252481|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139252482|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139252483|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
139252484|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252485|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139252486|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139252487|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139252488|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139252489|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
139252490|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139252491|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139252492|NCT02129582|Methotrexate|methotrexate|mesh-list
139252493|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
139252494|NCT02129582|Fludarabine|fludarabine|mesh-list
139252495|NCT02129582|Busulfan|busulfan|mesh-list
139252496|NCT02129582|Tacrolimus|tacrolimus|mesh-list
139252497|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
139252498|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139252499|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
139252500|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139252501|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
139252502|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139252503|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252504|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139252505|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
139209105|NCT04791761|Analgesics|analgesics|mesh-ancestor
139252506|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252507|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252508|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
139252509|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252510|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139252511|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139252512|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
139252513|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139252514|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139252515|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139252516|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
139252517|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139252518|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139252519|NCT02138396|Fentanyl|fentanyl|mesh-list
139252520|NCT02138396|Naltrexone|naltrexone|mesh-list
139252521|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139252522|NCT02138396|Narcotics|narcotics|mesh-ancestor
139252523|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252524|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252525|NCT02138396|Analgesics|analgesics|mesh-ancestor
139252526|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
139252527|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252528|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139252529|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139252530|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
139252531|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
139252532|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139252533|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139252534|NCT04560881|Vaccines|vaccines|mesh-list
139252535|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
139252536|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252537|NCT02875613|Avelumab|avelumab|mesh-list
139252538|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139252539|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252540|NCT02815267|Minocycline|minocycline|mesh-list
139252541|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139252542|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252543|NCT02130440|Resveratrol|resveratrol|mesh-list
139252544|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
139252545|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252546|NCT02130440|Protective Agents|protective agents|mesh-ancestor
139252547|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252548|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252549|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139091713|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139252551|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252552|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139252553|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139252554|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139252555|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139252556|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252557|NCT02138708|Adenosine|adenosine|mesh-list
139252558|NCT02138708|Acetylcholine|acetylcholine|mesh-list
139252559|NCT02138708|Analgesics|analgesics|mesh-ancestor
139252560|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
139252561|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252562|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252563|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139252564|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
139252565|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139252566|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
139252567|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
139252568|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139252569|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252570|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139252571|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
139252572|NCT03633175|Progesterone|progesterone|mesh-list
139252573|NCT03633175|Progestins|progestins|mesh-ancestor
139252574|NCT03633175|Hormones|hormones|mesh-ancestor
139252575|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139252576|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252577|NCT02539693|Lidocaine|lidocaine|mesh-list
139252578|NCT02539693|Clonidine|clonidine|mesh-list
139252579|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
139252580|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
139252581|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252582|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252583|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
139252584|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252585|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139252586|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139252587|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139252588|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139252589|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252590|NCT02539693|Analgesics|analgesics|mesh-ancestor
139252591|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139252592|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
139252593|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
139252594|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139252595|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139252596|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139252597|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
139252598|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139252599|NCT05062135|Progesterone|progesterone|mesh-list
139252600|NCT05062135|Progestins|progestins|mesh-ancestor
139252601|NCT05062135|Hormones|hormones|mesh-ancestor
139252602|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139252603|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252604|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139252605|NCT02134106|Polymyxins|polymyxins|mesh-list
139252606|NCT02134106|Doripenem|doripenem|mesh-list
139252607|NCT02134106|Polymyxin B|polymyxin b|mesh-list
139252608|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139252609|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252610|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
139252611|NCT01354301|Everolimus|everolimus|mesh-list
139252612|NCT01354301|Tacrolimus|tacrolimus|mesh-list
139252613|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
139252614|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139252615|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
139252616|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252617|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139252618|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252619|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252620|NCT01354301|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139252621|NCT01354301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139252622|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252623|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139642267|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252624|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139252625|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
139252626|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139252627|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252628|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
139252629|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139252630|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139252631|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
139252632|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252633|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139252634|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139252635|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
139252636|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252637|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252638|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139252639|NCT01343277|Dacarbazine|dacarbazine|mesh-list
139252640|NCT01343277|Trabectedin|trabectedin|mesh-list
139252641|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139252642|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
139252643|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252644|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252645|NCT04856293|Crizotinib|crizotinib|mesh-list
139252646|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252647|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139252648|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252649|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252650|NCT02253212|Carboplatin|carboplatin|mesh-list
139252651|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252652|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
139252653|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
139252654|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
139252655|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139252656|NCT01355939|Protective Agents|protective agents|mesh-ancestor
139252657|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252658|NCT01356017|Amlodipine|amlodipine|mesh-list
139252659|NCT01356017|Telmisartan|telmisartan|mesh-list
139252660|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139252661|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139252662|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139252663|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252664|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139252665|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252666|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
139252667|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139252668|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139252669|NCT02139098|Amitriptyline|amitriptyline|mesh-list
139252670|NCT02139098|Zolpidem|zolpidem|mesh-list
139252671|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139252672|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139252673|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252674|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252675|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139252676|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
139252677|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
139252678|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139252679|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252680|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139252681|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
139252682|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139252683|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139252684|NCT02139098|Analgesics|analgesics|mesh-ancestor
139252685|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
139252686|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252687|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139252688|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139252689|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139252690|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
139252691|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
139252692|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139252693|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252694|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
139252695|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
139252696|NCT02487979|Immunotoxins|immunotoxins|mesh-list
139252697|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139252698|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
139252699|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252700|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139037037|NCT00425438|Hormones|hormones|mesh-ancestor
139252701|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252702|NCT02130830|Lidocaine|lidocaine|mesh-list
139252703|NCT02130830|Prilocaine|prilocaine|mesh-list
139252704|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
139252705|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
139252706|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252707|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252708|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
139252709|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252710|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139252711|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139252712|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139252713|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139252714|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252715|NCT01360151|Ranibizumab|ranibizumab|mesh-list
139252716|NCT01360151|Verteporfin|verteporfin|mesh-list
139252717|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139252718|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139252719|NCT01360151|Growth Substances|growth substances|mesh-ancestor
139252720|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252721|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
139252722|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252723|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139252724|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
139252725|NCT01363037|Maraviroc|maraviroc|mesh-list
139252726|NCT01363037|Dapivirine|dapivirine|mesh-list
139252727|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139252728|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139252729|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252730|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139252731|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139252732|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
139252733|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252734|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139252736|NCT01363115|Calcium|calcium|mesh-list
139252737|NCT01363115|Vitamins|vitamins|mesh-ancestor
139252738|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
139252739|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252740|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139252741|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139252742|NCT01356329|Heparin|heparin|mesh-list
139252743|NCT01356329|Enoxaparin|enoxaparin|mesh-list
139252744|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
139252745|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139252746|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139252747|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252748|NCT05579522|Hyaluronic Acid|hyaluronic acid|mesh-list
139252749|NCT05579522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139252750|NCT05579522|Immunologic Factors|immunologic factors|mesh-ancestor
139252751|NCT05579522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252752|NCT05579522|Viscosupplements|viscosupplements|mesh-ancestor
139252753|NCT05579522|Protective Agents|protective agents|mesh-ancestor
139252754|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139252755|NCT01363193|Heparin|heparin|mesh-list
139252756|NCT01363193|Calcium heparin|calcium heparin|mesh-list
139252757|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
139252758|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139252759|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139252760|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252761|NCT01319279|Hydrocodone|hydrocodone|mesh-list
139252762|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139252763|NCT01319279|Narcotics|narcotics|mesh-ancestor
139252764|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252765|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252766|NCT01319279|Analgesics|analgesics|mesh-ancestor
139252767|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
139252768|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252769|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
139252770|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
139252771|NCT01363271|Vancomycin|vancomycin|mesh-list
139252772|NCT01363271|Linezolid|linezolid|mesh-list
139252773|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139252774|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252775|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139252776|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252777|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252778|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139252779|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252780|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139252781|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252782|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252783|NCT01360463|Methadone|methadone|mesh-list
139252784|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139252785|NCT01360463|Narcotics|narcotics|mesh-ancestor
139252786|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252787|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252788|NCT01360463|Analgesics|analgesics|mesh-ancestor
139252789|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
139252790|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252791|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
139252792|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
139252793|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139252794|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252795|NCT03103087|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139252796|NCT03103087|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139252797|NCT03103087|Norethindrone|norethindrone|mesh-list
139252798|NCT03103087|Norethindrone Acetate|norethindrone acetate|mesh-list
139252799|NCT03103087|Estradiol|estradiol|mesh-list
139252800|NCT03103087|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139252801|NCT03103087|Relugolix|relugolix|mesh-list
139252802|NCT03103087|Estrogens|estrogens|mesh-ancestor
139252803|NCT03103087|Hormones|hormones|mesh-ancestor
139252804|NCT03103087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139252805|NCT03103087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252806|NCT03103087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139252807|NCT03103087|Contraceptive Agents|contraceptive agents|mesh-ancestor
139252808|NCT03103087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139209407|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
139252809|NCT03103087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139252810|NCT03103087|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139252811|NCT03103087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139252812|NCT03103087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139252813|NCT03103087|Androgen Antagonists|androgen antagonists|mesh-ancestor
139252814|NCT03103087|Hormone Antagonists|hormone antagonists|mesh-ancestor
139252815|NCT05579288|Nitrous Oxide|nitrous oxide|mesh-list
139252816|NCT05579288|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139252817|NCT05579288|Anesthetics, General|anesthetics, general|mesh-ancestor
139252818|NCT05579288|Anesthetics|anesthetics|mesh-ancestor
139252819|NCT05579288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252820|NCT05579288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252821|NCT05579288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139252822|NCT05579288|Analgesics|analgesics|mesh-ancestor
139252823|NCT05579288|Sensory System Agents|sensory system agents|mesh-ancestor
139252824|NCT05579288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252825|NCT02134964|Dapansutrile|dapansutrile|mesh-list
139252826|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139252827|NCT01363583|Epoprostenol|epoprostenol|mesh-list
139252828|NCT01363583|Tezosentan|tezosentan|mesh-list
139252829|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139252830|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139252831|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
139252832|NCT02135120|Morphine|morphine|mesh-list
139252833|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252834|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252835|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139252836|NCT02135120|Narcotics|narcotics|mesh-ancestor
139252837|NCT02135120|Analgesics|analgesics|mesh-ancestor
139252838|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
139252839|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252840|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
139252841|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252842|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139252843|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252844|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380171|NCT05994378|Ganirelix|ganirelix|mesh-list
139252845|NCT01319357|Saxagliptin|saxagliptin|mesh-list
139252846|NCT01319357|Incretins|incretins|mesh-ancestor
139252847|NCT01319357|Hormones|hormones|mesh-ancestor
139252848|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139252849|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252850|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139252851|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
139252852|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252853|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252854|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139252856|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139252857|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252858|NCT02055053|Bupivacaine|bupivacaine|mesh-list
139252859|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
139252860|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
139252861|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252862|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252863|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
139252864|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252865|NCT02135510|Metoclopramide|metoclopramide|mesh-list
139252866|NCT02135510|Palonosetron|palonosetron|mesh-list
139252867|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
139252868|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
139252869|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252870|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252871|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139252872|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139252873|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139252874|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
139252875|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139252876|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252877|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139252878|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139252879|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
139252880|NCT03548714|Ethanol|ethanol|mesh-list
139252881|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139252882|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139252883|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252884|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252886|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139252887|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139252888|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139252889|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252890|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
139252891|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252892|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139252893|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139252894|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252895|NCT01363817|Dexamethasone|dexamethasone|mesh-list
139252896|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139252897|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
139252898|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
139252899|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252900|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252901|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139252902|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
139252903|NCT01363817|Hormones|hormones|mesh-ancestor
139252904|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139252905|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139252906|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252907|NCT02140268|Midazolam|midazolam|mesh-list
139252908|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139252909|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139252910|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252911|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252912|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139252913|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139252914|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139252915|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139252916|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
139252917|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
139252918|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
139252919|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
139252920|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139252921|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252922|NCT05578352|Insulin|insulin|mesh-list
139252923|NCT05578352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139252924|NCT05578352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252925|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
139252926|NCT03602508|Mirabegron|mirabegron|mesh-list
139252928|NCT03602508|Fesoterodine|fesoterodine|mesh-list
139252929|NCT03602508|Oxybutynin|oxybutynin|mesh-list
139252930|NCT03602508|Darifenacin|darifenacin|mesh-list
139252931|NCT03602508|Propiverine|propiverine|mesh-list
139252932|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139252933|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139252934|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
139252935|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139252936|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252937|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252938|NCT03602508|Urological Agents|urological agents|mesh-ancestor
139252939|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139252940|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139252941|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139252942|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
139252943|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
139252944|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
139252945|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252946|NCT03549728|Lenograstim|lenograstim|mesh-list
139252947|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139252948|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
139252949|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252950|NCT01356797|Fentanyl|fentanyl|mesh-list
139252951|NCT01356797|Bupivacaine|bupivacaine|mesh-list
139252952|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
139252953|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
139252954|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
139252955|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139252956|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252957|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
139252958|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252959|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139252960|NCT01356797|Narcotics|narcotics|mesh-ancestor
139252961|NCT01356797|Analgesics|analgesics|mesh-ancestor
139252962|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139252963|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139252964|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
139252965|NCT02238132|Ipratropium|ipratropium|mesh-list
139252966|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139252967|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
139252968|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252969|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252970|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139252971|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
139252972|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139252973|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
139252974|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139252975|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252976|NCT05200429|Ivacaftor|ivacaftor|mesh-list
139252977|NCT05200429|Elexacaftor|elexacaftor|mesh-list
139252978|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139252979|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139252980|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252981|NCT05578196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139252982|NCT02135822|Paclitaxel|paclitaxel|mesh-list
139252983|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139252984|NCT02135822|Gemcitabine|gemcitabine|mesh-list
139252985|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139252986|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139252987|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
139252988|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
139252989|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
139252990|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139252991|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139252992|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
139252993|NCT02238210|Ipratropium|ipratropium|mesh-list
139252994|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139252995|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
139252996|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139252997|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139252998|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139252999|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
139253000|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139253001|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
139253002|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123144|NCT01097811|Erythromycin|erythromycin|mesh-list
139253003|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253004|NCT05739955|Disinfectants|disinfectants|mesh-list
139253005|NCT05739955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253006|NCT02978456|Sirolimus|sirolimus|mesh-list
139253007|NCT02978456|Temsirolimus|temsirolimus|mesh-list
139253008|NCT02978456|MTOR Inhibitors|mtor inhibitors|mesh-list
139253009|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139253010|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253011|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139253012|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253013|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
139253014|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139253015|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
139253016|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253017|NCT02978456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139253018|NCT02978456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253019|NCT02978456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253020|NCT05736913|Vaccines|vaccines|mesh-list
139253021|NCT05736913|Immunologic Factors|immunologic factors|mesh-ancestor
139253022|NCT05736913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253023|NCT03598452|Ganciclovir|ganciclovir|mesh-list
139253024|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139253025|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
139253026|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253027|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139253028|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253029|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253030|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139253031|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139253032|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139253033|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139253034|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253035|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253036|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253037|NCT03549026|Analgesics|analgesics|mesh-ancestor
139253038|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
139253039|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253040|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
139253041|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139253042|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
139253043|NCT03101371|Iodine|iodine|mesh-list
139253044|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
139253045|NCT03101371|Povidone|povidone|mesh-list
139253046|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139253047|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253048|NCT03101371|Trace Elements|trace elements|mesh-ancestor
139253049|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
139253050|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253051|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
139253052|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
139253053|NCT03588078|Azacitidine|azacitidine|mesh-list
139253054|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139253055|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
139253056|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253057|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253058|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253059|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139253060|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
139253061|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139253062|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
139253063|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139253064|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253065|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139380176|NCT05986422|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139253066|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139253067|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253068|NCT05494190|Docetaxel|docetaxel|mesh-list
139253069|NCT05494190|Capecitabine|capecitabine|mesh-list
139253070|NCT05494190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253071|NCT05494190|Tubulin Modulators|tubulin modulators|mesh-ancestor
139253072|NCT05494190|Antimitotic Agents|antimitotic agents|mesh-ancestor
139253073|NCT05494190|Mitosis Modulators|mitosis modulators|mesh-ancestor
139253074|NCT05494190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253075|NCT05494190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139642268|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139253076|NCT05494190|Antimetabolites|antimetabolites|mesh-ancestor
139253077|NCT02850276|Bromides|bromides|mesh-list
139253078|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139253079|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
139253080|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139253081|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253082|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253083|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
139253084|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253085|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253086|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
139253087|NCT03862170|Cefazolin|cefazolin|mesh-list
139253088|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139253089|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253090|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139253091|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139253092|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253093|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253094|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253095|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139253096|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139253097|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139253098|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
139253099|NCT05577806|Dydrogesterone|dydrogesterone|mesh-list
139253100|NCT05577806|Progestins|progestins|mesh-ancestor
139253101|NCT05577806|Hormones|hormones|mesh-ancestor
139253102|NCT05577806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139253103|NCT05577806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253104|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
139253105|NCT03548948|Iron|iron|mesh-list
139253106|NCT03548948|Trace Elements|trace elements|mesh-ancestor
139253107|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
139253108|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209719|NCT04261439|Tislelizumab|tislelizumab|mesh-list
139253109|NCT02238444|Aspirin|aspirin|mesh-list
139253110|NCT02238444|Heparin|heparin|mesh-list
139253111|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139253113|NCT02238444|Dalteparin|dalteparin|mesh-list
139253114|NCT02238444|Dipyridamole|dipyridamole|mesh-list
139253115|NCT02238444|Warfarin|warfarin|mesh-list
139253116|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139253117|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139253118|NCT02238444|Analgesics|analgesics|mesh-ancestor
139253119|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
139253120|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253121|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253122|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139253123|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139253124|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139253125|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139253126|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253127|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139253128|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139253129|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253130|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
139253131|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
139253132|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139253133|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
139253134|NCT03131687|Dulaglutide|dulaglutide|mesh-list
139253135|NCT03131687|Tirzepatide|tirzepatide|mesh-list
139253136|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139253137|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253138|NCT03131687|Incretins|incretins|mesh-ancestor
139253139|NCT03131687|Hormones|hormones|mesh-ancestor
139253140|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139253141|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
139253142|NCT03579888|Fludarabine|fludarabine|mesh-list
139253143|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139253144|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
139253145|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253146|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139253147|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139253148|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
139253149|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253150|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253151|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139253152|NCT05344027|Mitotane|mitotane|mesh-list
139253153|NCT05344027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139253154|NCT05344027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253155|NCT05430698|Antibodies|antibodies|mesh-list
139253156|NCT05430698|Immunologic Factors|immunologic factors|mesh-ancestor
139253157|NCT05430698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253158|NCT03585894|Ketorolac|ketorolac|mesh-list
139253159|NCT03585894|Sumatriptan|sumatriptan|mesh-list
139253160|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139253161|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139253162|NCT03585894|Analgesics|analgesics|mesh-ancestor
139253163|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
139253164|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253165|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253166|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139253167|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139253168|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139253169|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253170|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253171|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139253172|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139253173|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139253174|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
139253175|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253176|NCT04912921|Palmidrol|palmidrol|mesh-list
139253177|NCT04912921|Curcumin|curcumin|mesh-list
139253178|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139253179|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139253180|NCT04912921|Analgesics|analgesics|mesh-ancestor
139253181|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
139253182|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253183|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253184|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139253185|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139253186|NCT04912921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253187|NCT04912921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253188|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253189|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
139253190|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253191|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139253192|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139253193|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253194|NCT04912921|Hormones|hormones|mesh-ancestor
139253195|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139253196|NCT05420324|Paclitaxel|paclitaxel|mesh-list
139253197|NCT05420324|Pembrolizumab|pembrolizumab|mesh-list
139253198|NCT05420324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139253199|NCT05420324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253200|NCT05420324|Tubulin Modulators|tubulin modulators|mesh-ancestor
139253201|NCT05420324|Antimitotic Agents|antimitotic agents|mesh-ancestor
139253202|NCT05420324|Mitosis Modulators|mitosis modulators|mesh-ancestor
139253203|NCT05420324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253204|NCT05420324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139253205|NCT05420324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139253206|NCT02238288|Acetaminophen|acetaminophen|mesh-list
139253207|NCT02238288|Lidocaine|lidocaine|mesh-list
139253208|NCT02238288|Epinephrine|epinephrine|mesh-list
139253209|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
139253210|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
139253211|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
139253212|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253213|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253214|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
139253215|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253216|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139253217|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139253218|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139253219|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139253220|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253221|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139253222|NCT02238288|Analgesics|analgesics|mesh-ancestor
139253223|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
139253224|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139253225|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139253226|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
139253227|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253228|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139253229|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139253230|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
139253231|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139253232|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
139253233|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
139253234|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
139253235|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139253236|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139253237|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139253238|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
139253239|NCT02238288|Coagulants|coagulants|mesh-ancestor
139253240|NCT01561040|Vitamin D|vitamin d|mesh-list
139253241|NCT01561040|Vitamin A|vitamin a|mesh-list
139253242|NCT01561040|Vitamins|vitamins|mesh-ancestor
139253243|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
139253244|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253245|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139253246|NCT03590496|Calcium|calcium|mesh-list
139253247|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139253248|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253249|NCT05577260|Dexmedetomidine|dexmedetomidine|mesh-list
139253250|NCT05577260|Bupivacaine|bupivacaine|mesh-list
139253251|NCT05577260|Anesthetics, Local|anesthetics, local|mesh-ancestor
139253252|NCT05577260|Anesthetics|anesthetics|mesh-ancestor
139253253|NCT05577260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253254|NCT05577260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253255|NCT05577260|Sensory System Agents|sensory system agents|mesh-ancestor
139253256|NCT05577260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253257|NCT05577260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139253258|NCT05577260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139253259|NCT05577260|Analgesics|analgesics|mesh-ancestor
139253260|NCT05577260|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139253261|NCT05577260|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139253262|NCT05577260|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139253263|NCT05577260|Adrenergic Agents|adrenergic agents|mesh-ancestor
139253264|NCT05577260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253265|NCT05577260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253266|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
139253267|NCT03760562|Hormones|hormones|mesh-ancestor
139253268|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139253269|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253270|NCT01357031|Amitriptyline|amitriptyline|mesh-list
139253271|NCT01357031|Melatonin|melatonin|mesh-list
139253272|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
139253273|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253274|NCT01357031|Protective Agents|protective agents|mesh-ancestor
139253275|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253276|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253277|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139253278|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
139253279|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139253280|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139253281|NCT01357031|Analgesics|analgesics|mesh-ancestor
139253282|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
139253283|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253284|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139253285|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139253286|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139253287|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
139253288|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253289|NCT01357109|Bosentan|bosentan|mesh-list
139253290|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139253291|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139253292|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253293|NCT02253446|Diclofenac|diclofenac|mesh-list
139253294|NCT02253446|Piroxicam|piroxicam|mesh-list
139253295|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139253296|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139253297|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139253298|NCT02253446|Analgesics|analgesics|mesh-ancestor
139253299|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
139253300|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253301|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253302|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139253303|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139253304|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139253305|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253306|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253308|NCT05417893|Everolimus|everolimus|mesh-list
139253309|NCT05417893|MTOR Inhibitors|mtor inhibitors|mesh-list
139253310|NCT05417893|Temsirolimus|temsirolimus|mesh-list
139253311|NCT05417893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139253312|NCT05417893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253313|NCT05417893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253314|NCT05417893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139253315|NCT05417893|Immunologic Factors|immunologic factors|mesh-ancestor
139253316|NCT05417893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253317|NCT05417893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253318|NCT05417893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139253319|NCT05417893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253320|NCT05417893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139253321|NCT05417893|Antifungal Agents|antifungal agents|mesh-ancestor
139253322|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
139253323|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139253324|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253325|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253326|NCT01563224|Baclofen|baclofen|mesh-list
139253327|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139253328|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253329|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139253330|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253331|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139253332|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
139253333|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
139253334|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253335|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253336|NCT01369979|Imidacloprid|imidacloprid|mesh-list
139253337|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
139253338|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253339|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253340|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253341|NCT03577860|Bupivacaine|bupivacaine|mesh-list
139253342|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
139253343|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
139253344|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253345|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253346|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
139253347|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253348|NCT03577782|Vedolizumab|vedolizumab|mesh-list
139253349|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139253350|NCT03432065|Buspirone|buspirone|mesh-list
139253351|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139253352|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139253353|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253354|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253355|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139253356|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139253357|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
139253358|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253359|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253360|NCT03577626|Hemay005|hemay005|mesh-list
139253361|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
139253362|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139253363|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139253364|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253365|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253366|NCT03412799|Paclitaxel|paclitaxel|mesh-list
139253367|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139253368|NCT03412799|Gemcitabine|gemcitabine|mesh-list
139253369|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139253370|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253371|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
139253372|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
139253373|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
139253374|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253375|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139253376|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
139253377|NCT03579732|Aspirin|aspirin|mesh-list
139253378|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139253379|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139253380|NCT03579732|Analgesics|analgesics|mesh-ancestor
139253381|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
139253382|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253383|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253384|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139253385|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139253386|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139253387|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139253388|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253389|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139253390|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139253391|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253392|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
139253393|NCT02259816|Amlodipine|amlodipine|mesh-list
139253394|NCT02259816|Telmisartan|telmisartan|mesh-list
139253395|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139253396|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139253397|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139253398|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253399|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139253400|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253401|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
139253402|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139253403|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139253404|NCT01567735|Simeprevir|simeprevir|mesh-list
139253405|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
139253406|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253407|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
139253408|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253409|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253410|NCT04631471|Ibudilast|ibudilast|mesh-list
139253411|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139253412|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
139253413|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253414|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253415|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139253416|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
139253417|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139253418|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253419|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253420|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139253421|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
139253422|NCT03577392|Capecitabine|capecitabine|mesh-list
139253423|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
139253424|NCT03577392|Endostatins|endostatins|mesh-list
139253425|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139253426|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
139253427|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253428|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253429|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139253430|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139253431|NCT03577392|Growth Substances|growth substances|mesh-ancestor
139253432|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253433|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
139253434|NCT03579576|Ribavirin|ribavirin|mesh-list
139253435|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
139253436|NCT03579576|Velpatasvir|velpatasvir|mesh-list
139253437|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
139253438|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253439|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
139253440|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253441|NCT01364519|Fluticasone|fluticasone|mesh-list
139253442|NCT01364519|Xhance|xhance|mesh-list
139253443|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139253444|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139253445|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
139253446|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253447|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253448|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139253449|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
139253450|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
139253451|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139253452|NCT03577158|Insulin|insulin|mesh-list
139253453|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139253454|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253455|NCT02253914|Ritonavir|ritonavir|mesh-list
139253456|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139253457|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139253458|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
139253459|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253460|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253461|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139253462|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139253463|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
139253464|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253465|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139253466|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139253467|NCT01364675|Metformin|metformin|mesh-list
139253468|NCT01364675|Enalapril|enalapril|mesh-list
139253469|NCT01364675|Simvastatin|simvastatin|mesh-list
139253470|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139253471|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253472|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139253473|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139253474|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
139253475|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253476|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139253477|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139253478|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253479|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139253480|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
139253481|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139253482|NCT02253758|Propofol|propofol|mesh-list
139253483|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139253484|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253485|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253486|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139253487|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
139253488|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
139253489|NCT03547232|Indomethacin|indomethacin|mesh-list
139253490|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139253491|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139253492|NCT03547232|Analgesics|analgesics|mesh-ancestor
139253493|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
139253494|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253495|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253496|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139253497|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139253498|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
139253499|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
139253500|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139253501|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139253502|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253503|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253504|NCT02250534|Nicotine|nicotine|mesh-list
139253505|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139253506|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
139253507|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253508|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253509|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139253510|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139253511|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
139253512|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253513|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253514|NCT01370135|Ranibizumab|ranibizumab|mesh-list
139253515|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139253516|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139253517|NCT01370135|Growth Substances|growth substances|mesh-ancestor
139253518|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253519|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
139253520|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253521|NCT05266586|Ezetimibe|ezetimibe|mesh-list
139253522|NCT05266586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139253523|NCT05266586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139253524|NCT05266586|Antimetabolites|antimetabolites|mesh-ancestor
139253525|NCT05266586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253526|NCT05266586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139253527|NCT01370291|Risperidone|risperidone|mesh-list
139253528|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139253529|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
139253530|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253531|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253532|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253533|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139253534|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139253535|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253536|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139380229|NCT05928741|Cholecalciferol|cholecalciferol|mesh-list
139253537|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139253538|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
139253540|NCT05575544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139253541|NCT05575544|Narcotics|narcotics|mesh-ancestor
139253542|NCT05575544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253543|NCT05575544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253544|NCT05575544|Analgesics|analgesics|mesh-ancestor
139253545|NCT05575544|Sensory System Agents|sensory system agents|mesh-ancestor
139253546|NCT05575544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253547|NCT05179772|Olanzapine|olanzapine|mesh-list
139253548|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
139253549|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
139253550|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253551|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253552|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139253553|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139253554|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139253555|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253556|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139253557|NCT05179772|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139253558|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139253559|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139253560|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253561|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253562|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
139253563|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
139253564|NCT01364987|Peficitinib|peficitinib|mesh-list
139253565|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139253566|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253567|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139253568|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
139253569|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139253570|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253571|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253572|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253573|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139253574|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
139253575|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253576|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
139253577|NCT01365923|Remifentanil|remifentanil|mesh-list
139253578|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139253579|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253580|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253581|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139253582|NCT01365923|Analgesics|analgesics|mesh-ancestor
139253583|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
139253584|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253585|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139253586|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139253587|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139253588|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
139253589|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253590|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253591|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139253592|NCT01365923|Narcotics|narcotics|mesh-ancestor
139253593|NCT01370915|Vitamins|vitamins|mesh-list
139253594|NCT01370915|Pregabalin|pregabalin|mesh-list
139253595|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
139253596|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253597|NCT01370915|Analgesics|analgesics|mesh-ancestor
139253598|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
139253599|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253600|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
139123743|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
139253601|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139253602|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139253603|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253604|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139253605|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139253606|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139253607|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253608|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139253609|NCT05574998|Paclitaxel|paclitaxel|mesh-list
139253610|NCT05574998|Cisplatin|cisplatin|mesh-list
139253611|NCT05574998|Carboplatin|carboplatin|mesh-list
139253612|NCT05574998|Pemetrexed|pemetrexed|mesh-list
139253613|NCT05574998|Endostar protein|endostar protein|mesh-list
139253614|NCT05574998|Endostatins|endostatins|mesh-list
139253615|NCT05574998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139253616|NCT05574998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253617|NCT05574998|Tubulin Modulators|tubulin modulators|mesh-ancestor
139253618|NCT05574998|Antimitotic Agents|antimitotic agents|mesh-ancestor
139253619|NCT05574998|Mitosis Modulators|mitosis modulators|mesh-ancestor
139253620|NCT05574998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253621|NCT05574998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253622|NCT05574998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139253623|NCT05574998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139253624|NCT05574998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139253625|NCT05574998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139253626|NCT05574998|Growth Substances|growth substances|mesh-ancestor
139253627|NCT05574998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253628|NCT05574998|Growth Inhibitors|growth inhibitors|mesh-ancestor
139253629|NCT03547778|Misoprostol|misoprostol|mesh-list
139253630|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139253631|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
139253632|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139253633|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253634|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139253635|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139253636|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
139253637|NCT03547700|Ixazomib|ixazomib|mesh-list
139253638|NCT03547700|Romidepsin|romidepsin|mesh-list
139253639|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253640|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
139253641|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253642|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253643|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139253644|NCT03547700|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139253645|NCT02239458|Saxagliptin|saxagliptin|mesh-list
139253646|NCT02239458|Incretins|incretins|mesh-ancestor
139253648|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139253649|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253650|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139253651|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
139253652|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253653|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253654|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139253655|NCT03578874|Capecitabine|capecitabine|mesh-list
139253656|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
139253657|NCT03578874|Sorafenib|sorafenib|mesh-list
139253658|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139253659|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
139253660|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253661|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253662|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139253663|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253664|NCT01366001|Buprenorphine|buprenorphine|mesh-list
139253665|NCT01366001|ALKS-33|alks-33|mesh-list
139253666|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139253667|NCT01366001|Narcotics|narcotics|mesh-ancestor
139253668|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253669|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253670|NCT01366001|Analgesics|analgesics|mesh-ancestor
139253671|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
139253672|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253673|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139253674|NCT01365065|Vorinostat|vorinostat|mesh-list
139253675|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642269|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
139253676|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139253677|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253678|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253679|NCT03576456|Alprazolam|alprazolam|mesh-list
139253680|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139253681|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253682|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253683|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139253684|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139253685|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139253686|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
139253687|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
139253688|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253689|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253690|NCT03576378|Prednisone|prednisone|mesh-list
139253691|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
139253692|NCT03576378|Etoposide|etoposide|mesh-list
139253693|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
139253694|NCT03576378|Procarbazine|procarbazine|mesh-list
139253695|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139253696|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
139253697|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253698|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139253699|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139253700|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
139253701|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253702|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253703|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139253704|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139253705|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
139253706|NCT03576378|Hormones|hormones|mesh-ancestor
139253707|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139253708|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139253709|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139253710|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139253711|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139253712|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253713|NCT03576378|Analgesics|analgesics|mesh-ancestor
139253714|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
139253715|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253716|NCT05572190|Hydrocodone|hydrocodone|mesh-list
139253717|NCT05572190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139253718|NCT05572190|Narcotics|narcotics|mesh-ancestor
139253719|NCT05572190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253720|NCT05572190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253721|NCT05572190|Analgesics|analgesics|mesh-ancestor
139253722|NCT05572190|Sensory System Agents|sensory system agents|mesh-ancestor
139253723|NCT05572190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253724|NCT05572190|Antitussive Agents|antitussive agents|mesh-ancestor
139253725|NCT05572190|Respiratory System Agents|respiratory system agents|mesh-ancestor
139253726|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139253727|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139253728|NCT05567588|Pembrolizumab|pembrolizumab|mesh-list
139253729|NCT05567588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139253730|NCT05567588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253731|NCT05567588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139253732|NCT05567588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253734|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139253735|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253736|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139253737|NCT03578640|Grazoprevir|grazoprevir|mesh-list
139253738|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
139253739|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253740|NCT04465916|Tenofovir|tenofovir|mesh-list
139253741|NCT04465916|Entecavir|entecavir|mesh-list
139253742|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
139253743|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253744|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139253745|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139253746|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253747|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253748|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139253749|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139253750|NCT01366235|Chloroquine|chloroquine|mesh-list
139253751|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139253752|NCT01366235|Amebicides|amebicides|mesh-ancestor
139253753|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139253754|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139253755|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253756|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
139253757|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139253758|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139253759|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139253760|NCT01366235|Analgesics|analgesics|mesh-ancestor
139253761|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
139253762|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253763|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253764|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139253765|NCT01366235|Filaricides|filaricides|mesh-ancestor
139253766|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
139253767|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
139253768|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
139253769|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139253770|NCT04871165|Antibodies|antibodies|mesh-list
139253771|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
139253772|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253773|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
139253774|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139253775|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253776|NCT04249739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139253777|NCT04249739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253778|NCT01366313|Acetaminophen|acetaminophen|mesh-list
139253779|NCT01366313|Morphine|morphine|mesh-list
139253780|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139253781|NCT01366313|Narcotics|narcotics|mesh-ancestor
139253782|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139253783|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253784|NCT01366313|Analgesics|analgesics|mesh-ancestor
139253785|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
139253786|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253787|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139253788|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
139253789|NCT02253524|Metoclopramide|metoclopramide|mesh-list
139253790|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
138837202|NCT02618733|Clopidogrel|clopidogrel|mesh-list
139253791|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
139253792|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
139253793|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253794|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253795|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139253796|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139253797|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139253798|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
139253799|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253800|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253801|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139253802|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
139253803|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
139253804|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139253805|NCT02253602|Hematinics|hematinics|mesh-ancestor
139253806|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139253807|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139253808|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
139253809|NCT03575520|Doxorubicin|doxorubicin|mesh-list
139253810|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139253811|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
139253812|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253813|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139253814|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139253815|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
139253816|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253817|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253818|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139253819|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139253820|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139253821|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139253822|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253823|NCT01366391|Metformin|metformin|mesh-list
139253824|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139253825|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253826|NCT04408586|Topiramate|topiramate|mesh-list
139253827|NCT04408586|Phentermine|phentermine|mesh-list
139253828|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
139253829|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139253830|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253831|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139253832|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
139253833|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139253834|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
139253835|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
139253836|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253837|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
139253838|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253839|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253840|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139253841|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
139253842|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
139253843|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253844|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139253845|NCT02239614|Antacids|antacids|mesh-ancestor
139253846|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253847|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139253848|NCT03572400|Gemcitabine|gemcitabine|mesh-list
139253849|NCT03572400|Durvalumab|durvalumab|mesh-list
139253850|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139253851|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
139253852|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253853|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253854|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139253855|NCT02253836|Ritonavir|ritonavir|mesh-list
139253856|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139253857|NCT02253836|Tipranavir|tipranavir|mesh-list
139253858|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139253859|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139253860|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
139253861|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253862|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253863|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139253864|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139253865|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
139253867|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139253868|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139253869|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139253870|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139253871|NCT02241018|Antibodies|antibodies|mesh-list
139253872|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139253873|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139253874|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
139253875|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253876|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253877|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253878|NCT04039022|Dextromethorphan|dextromethorphan|mesh-list
139253879|NCT04039022|Bupropion|bupropion|mesh-list
139253880|NCT04039022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139253881|NCT04039022|Antidepressive Agents|antidepressive agents|mesh-ancestor
139253882|NCT04039022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139253883|NCT04039022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139253884|NCT04039022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139253885|NCT04039022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139253886|NCT04039022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253887|NCT04039022|Dopamine Agents|dopamine agents|mesh-ancestor
139253888|NCT04039022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253889|NCT04039022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253890|NCT04039022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139253891|NCT04039022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139253892|NCT04039022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253893|NCT04039022|Antitussive Agents|antitussive agents|mesh-ancestor
139253894|NCT04039022|Respiratory System Agents|respiratory system agents|mesh-ancestor
139253895|NCT04039022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139253896|NCT04039022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139253897|NCT00109772|Lenalidomide|lenalidomide|mesh-list
139253898|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
139253899|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253900|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139253901|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139253902|NCT00109772|Growth Substances|growth substances|mesh-ancestor
139253903|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
139253904|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253905|NCT03572010|Fesoterodine|fesoterodine|mesh-list
139253906|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139253907|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139253908|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
139253909|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139253910|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253911|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253912|NCT03572010|Urological Agents|urological agents|mesh-ancestor
139253913|NCT01560104|Paclitaxel|paclitaxel|mesh-list
139253914|NCT01560104|Carboplatin|carboplatin|mesh-list
139253915|NCT01560104|Veliparib|veliparib|mesh-list
139253916|NCT01560104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139253917|NCT01560104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253918|NCT01560104|Tubulin Modulators|tubulin modulators|mesh-ancestor
139253919|NCT01560104|Antimitotic Agents|antimitotic agents|mesh-ancestor
139253920|NCT01560104|Mitosis Modulators|mitosis modulators|mesh-ancestor
139253921|NCT01560104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253922|NCT01560104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139253923|NCT01560104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253924|NCT00101972|Antibodies|antibodies|mesh-list
139253925|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139253926|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
139253927|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253928|NCT02245932|Resveratrol|resveratrol|mesh-list
139253929|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
139253930|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253931|NCT02245932|Protective Agents|protective agents|mesh-ancestor
139253932|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253933|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253934|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139253935|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139253936|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139253937|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253938|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253940|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139253941|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
139253942|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
139253943|NCT04944368|Paraproteins|paraproteins|mesh-list
139253944|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
139253945|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253946|NCT03546530|Interferons|interferons|mesh-list
139253947|NCT03546530|Resveratrol|resveratrol|mesh-list
139253948|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139253949|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
139253950|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253951|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
139253952|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253953|NCT03546530|Protective Agents|protective agents|mesh-ancestor
139253954|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253955|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253956|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139253957|NCT01366547|Lamivudine|lamivudine|mesh-list
139253958|NCT01366547|Abacavir|abacavir|mesh-list
139253959|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
139253960|NCT01366547|Dolutegravir|dolutegravir|mesh-list
139253961|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139253962|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139253963|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253964|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253965|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
139253966|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253967|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139253968|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139253969|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139253970|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139253971|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
139253972|NCT05190341|Ibuprofen|ibuprofen|mesh-list
139253973|NCT05190341|Ketorolac|ketorolac|mesh-list
139253974|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139253975|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139253976|NCT05190341|Analgesics|analgesics|mesh-ancestor
139253977|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
139253978|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139253979|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139253980|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139253981|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139253982|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139253983|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139253984|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253985|NCT04347239|Leronlimab|leronlimab|mesh-list
139253986|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139253987|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139253988|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139253989|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139253990|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139253991|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
139253992|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139253993|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
139253994|NCT00109928|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139253995|NCT00109928|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139253996|NCT00109928|Prednisolone|prednisolone|mesh-list
139253997|NCT00109928|Prednisolone acetate|prednisolone acetate|mesh-list
139253998|NCT00109928|Gemcitabine|gemcitabine|mesh-list
139253999|NCT00109928|Etoposide|etoposide|mesh-list
139254000|NCT00109928|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139254001|NCT00109928|Prednisolone phosphate|prednisolone phosphate|mesh-list
139254002|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254003|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139254004|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
139254005|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254006|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139254007|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139254008|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139254009|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254010|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139254011|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
139254012|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
139254013|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254014|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254015|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139254017|NCT00109928|Hormones|hormones|mesh-ancestor
139254018|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139254019|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139254020|NCT00109928|Protective Agents|protective agents|mesh-ancestor
139254021|NCT00109928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139254022|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
139254023|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254024|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
139254025|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254026|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254027|NCT00109850|Irinotecan|irinotecan|mesh-list
139254028|NCT00109850|Cetuximab|cetuximab|mesh-list
139254029|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254030|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139254031|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139254032|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254033|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254034|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139254035|NCT03318770|Dasatinib|dasatinib|mesh-list
139254036|NCT03318770|Blinatumomab|blinatumomab|mesh-list
139254037|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254038|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139254039|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254040|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254041|NCT01065519|Umirolimus|umirolimus|mesh-list
139254042|NCT01065519|Everolimus|everolimus|mesh-list
139254043|NCT01065519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139254044|NCT01065519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139254045|NCT01065519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254046|NCT01065519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254047|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139254048|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
139254049|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254050|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254051|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139254052|NCT01810016|Poly I-C|poly i-c|mesh-list
139254053|NCT01810016|Ipilimumab|ipilimumab|mesh-list
139254054|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139254055|NCT01810016|Vaccines|vaccines|mesh-list
139254056|NCT01810016|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139254057|NCT01810016|Poly ICLC|poly iclc|mesh-list
139254058|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
139254059|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254060|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139254061|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254062|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139254063|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254064|NCT01810016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139254065|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
139254066|NCT01810016|Laxatives|laxatives|mesh-ancestor
139254067|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139254068|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
139254069|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254070|NCT02254148|Metoprolol|metoprolol|mesh-list
139254071|NCT02254148|Digoxin|digoxin|mesh-list
139254072|NCT02254148|Midazolam|midazolam|mesh-list
139254073|NCT02254148|Caffeine|caffeine|mesh-list
139254074|NCT02254148|Omeprazole|omeprazole|mesh-list
139254075|NCT02254148|Warfarin|warfarin|mesh-list
139254076|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139254077|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139254078|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139254079|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254080|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139254081|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139254082|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139254083|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139254084|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
139254085|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
139254086|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
139254087|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
139254088|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254089|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254090|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
139254091|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139254092|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139254093|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254094|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139254095|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139254096|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
139254097|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139254098|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139254099|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139254100|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139254101|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139254102|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
139254103|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
139254104|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254105|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139254106|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139254107|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139254108|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
139254109|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139254110|NCT02254148|Protective Agents|protective agents|mesh-ancestor
139254111|NCT02842866|Vaccines|vaccines|mesh-list
139254112|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
139254113|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254114|NCT01316913|Bromides|bromides|mesh-list
139254115|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
139254116|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139254117|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
139254118|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254119|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254120|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139254121|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
139254122|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
139254123|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139254124|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
139254125|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254126|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254127|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
139254128|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
139254129|NCT02875067|Lenalidomide|lenalidomide|mesh-list
139254130|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139254131|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254132|NCT02875067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139254133|NCT02875067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254134|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
139254135|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254136|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139254137|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139254138|NCT02875067|Growth Substances|growth substances|mesh-ancestor
139254139|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
139254140|NCT03570294|Atosiban|atosiban|mesh-list
139254141|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
139254142|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139254143|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254144|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
139254145|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139254146|NCT02143622|Cetuximab|cetuximab|mesh-list
139254147|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139254148|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254149|NCT02781506|Nivolumab|nivolumab|mesh-list
139254150|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139254151|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254152|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139254153|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254154|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139254155|NCT03571230|Amoxicillin|amoxicillin|mesh-list
139254156|NCT03571230|Metronidazole|metronidazole|mesh-list
139254157|NCT03571230|Clarithromycin|clarithromycin|mesh-list
139254158|NCT03571230|Levofloxacin|levofloxacin|mesh-list
139254159|NCT03571230|Tetracycline|tetracycline|mesh-list
139254160|NCT03571230|Tinidazole|tinidazole|mesh-list
139254161|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139254162|NCT03571230|Furazolidone|furazolidone|mesh-list
139254163|NCT03571230|Bismuth|bismuth|mesh-list
139254164|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139254165|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254166|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
139254167|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139254168|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139254169|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139254170|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254171|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254172|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139254173|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139254174|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139254175|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139254176|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139254177|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254178|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139254179|NCT03571230|Antacids|antacids|mesh-ancestor
139254180|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139254181|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139254182|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139254183|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139254184|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
139254185|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139254186|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139254187|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
139254188|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254189|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254190|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139254191|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
139254192|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139254193|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139254194|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139254195|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
139254196|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254197|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254198|NCT02143934|Chloroquine|chloroquine|mesh-list
139254199|NCT02143934|Lumefantrine|lumefantrine|mesh-list
139254200|NCT02143934|Artemether|artemether|mesh-list
139254201|NCT02143934|Primaquine|primaquine|mesh-list
139254202|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139254203|NCT02143934|Amebicides|amebicides|mesh-ancestor
139254204|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139254205|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139254206|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254207|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
139254208|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139254209|NCT03096847|Letrozole|letrozole|mesh-list
139254210|NCT03096847|Goserelin|goserelin|mesh-list
139254211|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254212|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139254213|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139254214|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254215|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254216|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139254217|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
139254218|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139254219|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254220|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139254221|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
139254222|NCT03545516|Bupivacaine|bupivacaine|mesh-list
139254223|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
139254224|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
139254225|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139254226|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254227|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
139254228|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254229|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139254230|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139254231|NCT03545516|Analgesics|analgesics|mesh-ancestor
139254232|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139254233|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139254234|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139254235|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
139254236|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254237|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254238|NCT02846532|Aspirin|aspirin|mesh-list
139254239|NCT02846532|Rivaroxaban|rivaroxaban|mesh-list
139254240|NCT02846532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139254241|NCT02846532|Antithrombins|antithrombins|mesh-ancestor
139254242|NCT02846532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139254243|NCT02846532|Protease Inhibitors|protease inhibitors|mesh-ancestor
139254244|NCT02846532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254245|NCT02846532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254246|NCT02846532|Anticoagulants|anticoagulants|mesh-ancestor
139254247|NCT02846532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139254248|NCT02846532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139254249|NCT02846532|Analgesics|analgesics|mesh-ancestor
139254250|NCT02846532|Sensory System Agents|sensory system agents|mesh-ancestor
139254251|NCT02846532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254252|NCT02846532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254253|NCT02846532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139254254|NCT02846532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139254255|NCT02846532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139254256|NCT02846532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139254257|NCT02846532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139254258|NCT02846532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139254259|NCT02846532|Antipyretics|antipyretics|mesh-ancestor
139254260|NCT01371461|Paroxetine|paroxetine|mesh-list
139254261|NCT01371461|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139254262|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139254263|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139254264|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254265|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254266|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
139254267|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254268|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139254269|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
139254270|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139254271|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139254272|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139254273|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254274|NCT05324423|Colchicine|colchicine|mesh-list
139254275|NCT05324423|Febuxostat|febuxostat|mesh-list
139254276|NCT05324423|Gout Suppressants|gout suppressants|mesh-ancestor
139254277|NCT05324423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139254278|NCT05324423|Tubulin Modulators|tubulin modulators|mesh-ancestor
139254279|NCT05324423|Antimitotic Agents|antimitotic agents|mesh-ancestor
139254280|NCT05324423|Mitosis Modulators|mitosis modulators|mesh-ancestor
139254281|NCT05324423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254282|NCT05324423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254283|NCT00842348|Lanreotide|lanreotide|mesh-list
139254284|NCT00842348|Somatostatin|somatostatin|mesh-list
139254285|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254286|NCT00842348|Hormones|hormones|mesh-ancestor
139254287|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139254288|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254289|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
139254290|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139254291|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139254292|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139254293|NCT02144246|Norgestimate|norgestimate|mesh-list
139254294|NCT02144246|Norgestrel|norgestrel|mesh-list
139254295|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139254296|NCT02144246|Estradiol|estradiol|mesh-list
139254297|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139254298|NCT02144246|Estrogens|estrogens|mesh-ancestor
139254299|NCT02144246|Hormones|hormones|mesh-ancestor
139254300|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139254301|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254302|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139254303|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
139254304|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139254305|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139254306|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139254307|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139254308|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139254309|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139254310|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254311|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139254312|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139254313|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254314|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254315|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254316|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139254317|NCT03095521|Menthol|menthol|mesh-list
139254318|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
139254319|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
139254320|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
139254321|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139254322|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
139254323|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139254324|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
139254325|NCT03569046|Bupivacaine|bupivacaine|mesh-list
139254326|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
139254327|NCT03569046|Anesthetics|anesthetics|mesh-list
139254328|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
139254329|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139254330|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254331|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
139254332|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254333|NCT02935595|Ketamine|ketamine|mesh-list
139254334|NCT02935595|Analgesics|analgesics|mesh-ancestor
139254335|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
139254336|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254337|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254338|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139254339|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139254340|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
139254341|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
139254342|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139254343|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139254344|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139254345|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254346|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254347|NCT02817347|Tazobactam|tazobactam|mesh-list
139254348|NCT02817347|Piperacillin|piperacillin|mesh-list
139254349|NCT02817347|Dexamethasone|dexamethasone|mesh-list
139254350|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
139254351|NCT02817347|BB 1101|bb 1101|mesh-list
139254352|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139254353|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
139254354|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
139254355|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254356|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254357|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139254358|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
139254359|NCT02817347|Hormones|hormones|mesh-ancestor
139254360|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139254361|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139124501|NCT00059787|Paclitaxel|paclitaxel|mesh-list
139254362|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254363|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
139254364|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254365|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254366|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139254367|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254368|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139254369|NCT01373021|Fentanyl|fentanyl|mesh-list
139254370|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
139254371|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139254372|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139254373|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254374|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139254375|NCT01373021|Analgesics|analgesics|mesh-ancestor
139254376|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
139254377|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254378|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139254379|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139254380|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139254381|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
139254382|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254383|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380278|NCT05722886|Pertuzumab|pertuzumab|mesh-list
139254384|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139254385|NCT01373021|Narcotics|narcotics|mesh-ancestor
139254386|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139254387|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139254388|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
139254389|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
138837757|NCT04119921|Ketorolac|ketorolac|mesh-list
139254390|NCT03568578|Entecavir|entecavir|mesh-list
139254391|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
139254392|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254393|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
139254394|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139254395|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254396|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
139254397|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254398|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
139254399|NCT02140736|Hematinics|hematinics|mesh-ancestor
139254400|NCT05417035|Testosterone undecanoate|testosterone undecanoate|mesh-list
139254401|NCT05417035|Androgens|androgens|mesh-ancestor
139254402|NCT05417035|Hormones|hormones|mesh-ancestor
139254403|NCT05417035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139254404|NCT05417035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254405|NCT03095287|Factor VIII|factor viii|mesh-list
139254406|NCT03095287|Coagulants|coagulants|mesh-ancestor
139254407|NCT01335581|Tretinoin|tretinoin|mesh-list
139254408|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254409|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
139254410|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
139254411|NCT05204563|Imipenem|imipenem|mesh-list
139254412|NCT05204563|Relebactam|relebactam|mesh-list
139254413|NCT05204563|Cilastatin|cilastatin|mesh-list
139254414|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139254415|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254416|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
139254417|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254418|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254419|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139254420|NCT02140814|Niacinamide|niacinamide|mesh-list
139254422|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
139254423|NCT02140814|Vitamins|vitamins|mesh-ancestor
139254424|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
139254425|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254426|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
139254427|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139254428|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
139254429|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254430|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139254431|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
139254432|NCT03015090|Theophylline|theophylline|mesh-list
139254433|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139254434|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
139254435|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254436|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254437|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139642270|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139254438|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
139254439|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139254440|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254441|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254442|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
139254443|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139254444|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139254445|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
139254446|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254447|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
139254448|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139254449|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139254450|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254451|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
139254452|NCT02620748|Coagulants|coagulants|mesh-ancestor
139254453|NCT02144792|Verapamil|verapamil|mesh-list
139254454|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139254455|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139254456|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139254457|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254458|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139254459|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254460|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
139254461|NCT03566394|Gabapentin|gabapentin|mesh-list
139254462|NCT03566394|Analgesics|analgesics|mesh-ancestor
139254463|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
139254464|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254465|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254466|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
139254467|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139254468|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139254469|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139254470|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139254471|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139254472|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139254473|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254474|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254475|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
139254476|NCT00033293|Prednisone|prednisone|mesh-list
139254477|NCT00033293|Cortisone|cortisone|mesh-list
139254478|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
139254479|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
139254480|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139254481|NCT00033293|Antibodies|antibodies|mesh-list
139254482|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
139254483|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139254484|NCT00033293|Immunoglobulin G|immunoglobulin g|mesh-list
139254485|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139254486|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
139254487|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254488|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139254489|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139254490|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
139254491|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254492|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254493|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139254494|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139254495|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
139254496|NCT00033293|Hormones|hormones|mesh-ancestor
139254497|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139254498|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139254499|NCT03566316|Amlodipine|amlodipine|mesh-list
139254500|NCT03566316|Telmisartan|telmisartan|mesh-list
139254501|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139254502|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139254503|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139254504|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139254505|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139254506|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254507|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139254508|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254509|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
139254510|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139254511|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139124648|NCT03951285|Vitamins|vitamins|mesh-ancestor
139254512|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
139254513|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139254514|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139254515|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254516|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139254517|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139254518|NCT02145104|Valsartan|valsartan|mesh-list
139254519|NCT02145104|Cilnidipine|cilnidipine|mesh-list
139254520|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139254521|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139254522|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139254523|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254524|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139254525|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139254526|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139254527|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254528|NCT02145338|Trimethoprim|trimethoprim|mesh-list
139254529|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
139254530|NCT02145338|Cephalexin|cephalexin|mesh-list
139254531|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139254532|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254533|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
139254534|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139254535|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139254536|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139254537|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254538|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254539|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139254540|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139254541|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139254542|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139254543|NCT03565536|Sorafenib|sorafenib|mesh-list
139254544|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254545|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139254546|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254547|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254548|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
139254549|NCT03565458|Empagliflozin|empagliflozin|mesh-list
139254550|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139254551|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254552|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139254553|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254554|NCT03565302|Terbutaline|terbutaline|mesh-list
139254555|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
139254556|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139254557|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
139254558|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254559|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254560|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139254561|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
139254562|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139254563|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139254564|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139254565|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
139254566|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254567|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254568|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
139254569|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
139254570|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139254571|NCT01372007|Lanreotide|lanreotide|mesh-list
139254572|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254573|NCT01373411|Ticagrelor|ticagrelor|mesh-list
139254574|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139254575|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139254576|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139254577|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139254578|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
139254579|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254580|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254581|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254582|NCT03567408|Bivalirudin|bivalirudin|mesh-list
139642271|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
139254589|NCT05354076|Doxorubicin|doxorubicin|mesh-list
139254590|NCT05354076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139254591|NCT05354076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139254592|NCT05354076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254593|NCT05354076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139380307|NCT05565625|Dermatologic Agents|dermatologic agents|mesh-ancestor
139254594|NCT05354076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139254595|NCT05354076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254596|NCT05354076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254597|NCT05192681|Docetaxel|docetaxel|mesh-list
139254598|NCT05192681|Tislelizumab|tislelizumab|mesh-list
139254599|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254600|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
139254601|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
139254602|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
139254603|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254604|NCT05192681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139254612|NCT02039674|Paclitaxel|paclitaxel|mesh-list
139254613|NCT02039674|Bevacizumab|bevacizumab|mesh-list
139254614|NCT02039674|Carboplatin|carboplatin|mesh-list
139254615|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
139254616|NCT02039674|Pemetrexed|pemetrexed|mesh-list
139254617|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139254618|NCT02039674|Ipilimumab|ipilimumab|mesh-list
139254619|NCT02039674|Gefitinib|gefitinib|mesh-list
139254620|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139254621|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254622|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
139254623|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
139254624|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
139254625|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254626|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139254627|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139254628|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139254629|NCT02039674|Growth Substances|growth substances|mesh-ancestor
139254630|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254631|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
139254632|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139254633|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254634|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139254635|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139254636|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139254637|NCT03099187|Pirfenidone|pirfenidone|mesh-list
139254638|NCT03099187|Analgesics|analgesics|mesh-ancestor
139254639|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
139254640|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254641|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254642|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139254643|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139254644|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139254645|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139254646|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254647|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
139254648|NCT04162756|Fludarabine|fludarabine|mesh-list
139254649|NCT04162756|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
139254650|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139254651|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
139254652|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254653|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139254654|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139254655|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
139254656|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254657|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254658|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139254659|NCT04162756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139254661|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
139254662|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254663|NCT04895488|Vortioxetine|vortioxetine|mesh-list
139254664|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
139254665|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
139254666|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139254667|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139254668|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139254669|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139254670|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254671|NCT04895488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139254672|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139254673|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139254674|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254675|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254676|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
139254677|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139254678|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139254679|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139254680|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139254681|NCT01373333|Amifampridine|amifampridine|mesh-list
139254682|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139254683|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254684|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254685|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139254686|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139254687|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254688|NCT01368341|Amoxicillin|amoxicillin|mesh-list
139254689|NCT01368341|Doxycycline|doxycycline|mesh-list
139254690|NCT01368341|Penicillin V|penicillin v|mesh-list
139254691|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139254692|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254693|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
139254694|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139254695|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139254696|NCT01368419|Endostar protein|endostar protein|mesh-list
139254697|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139254698|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139254699|NCT01368419|Growth Substances|growth substances|mesh-ancestor
139254700|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254701|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
139254702|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254703|NCT04639219|Trastuzumab|trastuzumab|mesh-list
139254704|NCT04639219|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139254705|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139254706|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254707|NCT04639219|Immunoconjugates|immunoconjugates|mesh-ancestor
139254708|NCT04639219|Immunologic Factors|immunologic factors|mesh-ancestor
139254709|NCT04639219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254710|NCT04455100|Itraconazole|itraconazole|mesh-list
139254711|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
139254712|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254713|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139254714|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139254715|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254716|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254717|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139254718|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
139254719|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139254720|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254721|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139254722|NCT04439578|Rifampin|rifampin|mesh-list
139254723|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139254724|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
139254725|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139254726|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254727|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
139254728|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139254729|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254730|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254731|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139254732|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139254733|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139254734|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139254735|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139254736|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139254738|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139254739|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139254740|NCT03110848|Prednisolone|prednisolone|mesh-list
139254741|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
139254742|NCT03110848|Atorvastatin|atorvastatin|mesh-list
139254743|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139254744|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
139254745|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
139254746|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139254747|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139254748|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
139254749|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254750|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139254751|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139254752|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254753|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139254754|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
139254755|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
139254756|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254757|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254758|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139254759|NCT03110848|Hormones|hormones|mesh-ancestor
139254760|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139254761|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139254762|NCT03110848|Protective Agents|protective agents|mesh-ancestor
139254763|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139254764|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254765|NCT03139474|Hormones|hormones|mesh-list
139254766|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
139254767|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139254768|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254769|NCT01368887|Niacinamide|niacinamide|mesh-list
139254771|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
139254772|NCT01368887|Calcipotriene|calcipotriene|mesh-list
139254773|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
139254774|NCT01368887|Vitamins|vitamins|mesh-ancestor
139254775|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
139254776|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254777|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139254778|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
139254779|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254780|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139254781|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
139254782|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
139254783|NCT01369043|Vitamins|vitamins|mesh-list
139254784|NCT01369043|Vitamin E|vitamin e|mesh-list
139254785|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
139254786|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254787|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
139254788|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254789|NCT01369043|Protective Agents|protective agents|mesh-ancestor
139254790|NCT04477096|Emtricitabine|emtricitabine|mesh-list
139254791|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
139254792|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254793|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139254794|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139254795|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254796|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254797|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139254798|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139254799|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
139254800|NCT01369121|Hormones|hormones|mesh-ancestor
139254801|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139254802|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254803|NCT03868150|Amiodarone|amiodarone|mesh-list
139254804|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139254805|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
139254806|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139254807|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139380322|NCT05561387|Glucocorticoids|glucocorticoids|mesh-ancestor
139254808|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254810|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139254811|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139254812|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254813|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139254814|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139254815|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139254816|NCT03521687|Apremilast|apremilast|mesh-list
139254817|NCT03521687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139254818|NCT03521687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139254819|NCT03521687|Analgesics|analgesics|mesh-ancestor
139254820|NCT03521687|Sensory System Agents|sensory system agents|mesh-ancestor
139254821|NCT03521687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254822|NCT03521687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254823|NCT03521687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139254824|NCT03521687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139254825|NCT03521687|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139254826|NCT03521687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139254827|NCT03521687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254828|NCT03521687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254829|NCT03141658|Ketamine|ketamine|mesh-list
139254830|NCT03141658|Analgesics|analgesics|mesh-ancestor
139254831|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
139254832|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254833|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254834|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139254835|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139254836|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
139254837|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
139254838|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139254839|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139254840|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139254841|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254842|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254843|NCT03498131|Melatonin|melatonin|mesh-list
139254844|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
139254845|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254846|NCT03498131|Protective Agents|protective agents|mesh-ancestor
139254847|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254848|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139254849|NCT01319825|Milnacipran|milnacipran|mesh-list
139254850|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
139254851|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139254852|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139254853|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139254854|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254855|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254856|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254857|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139254858|NCT01319825|Analgesics|analgesics|mesh-ancestor
139254859|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
139254860|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254861|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
139254862|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139254863|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
139254864|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
139254865|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380336|NCT05511948|Hydroquinone|hydroquinone|mesh-list
139254866|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254867|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
139254868|NCT01369277|Vitamins|vitamins|mesh-ancestor
139254869|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
139254870|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254871|NCT02983006|Nivolumab|nivolumab|mesh-list
139254872|NCT02983006|DS-8273a|ds-8273a|mesh-list
139254873|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139254874|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254875|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139254876|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254878|NCT03811756|Vitamins|vitamins|mesh-ancestor
139254879|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
139254880|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254881|NCT03141268|Lactulose|lactulose|mesh-list
139254882|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139254883|NCT03316781|Adalimumab|adalimumab|mesh-list
139254884|NCT03316781|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139254885|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139254886|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139254887|NCT01319903|Antibodies|antibodies|mesh-list
139254888|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139380342|NCT05461092|Morphine|morphine|mesh-list
139254889|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
139254890|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254891|NCT02839200|Zolpidem|zolpidem|mesh-list
139254892|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139254893|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139254894|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139254895|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254896|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139254897|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
139254898|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
139254899|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254900|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254901|NCT01369667|Vitamin D|vitamin d|mesh-list
139254902|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
139254903|NCT01369667|Vitamins|vitamins|mesh-ancestor
139254904|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
139254905|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254906|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139254907|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139254908|NCT03564912|Capecitabine|capecitabine|mesh-list
139254909|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
139254910|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139254911|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
139254912|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254913|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254914|NCT03551626|Trametinib|trametinib|mesh-list
139254915|NCT03551626|Dabrafenib|dabrafenib|mesh-list
139254916|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254917|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139254918|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254919|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254920|NCT05760053|Cisplatin|cisplatin|mesh-list
139254921|NCT05760053|Carboplatin|carboplatin|mesh-list
139254922|NCT05760053|Etoposide|etoposide|mesh-list
139254923|NCT05760053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254924|NCT05760053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139254925|NCT05760053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139254926|NCT05760053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139254927|NCT05760053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254928|NCT05760053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254929|NCT03118739|Febuxostat|febuxostat|mesh-list
139254930|NCT03118739|Verinurad|verinurad|mesh-list
139254931|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
139254932|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139254933|NCT03181126|Venetoclax|venetoclax|mesh-list
139254934|NCT03181126|Navitoclax|navitoclax|mesh-list
139254935|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254936|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139254937|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254938|NCT04799548|Tislelizumab|tislelizumab|mesh-list
139254939|NCT04799548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139254940|NCT04799548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254941|NCT01375985|Radavirsen|radavirsen|mesh-list
139254942|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
139254943|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139254944|NCT02654080|Vaccines|vaccines|mesh-list
139254945|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
139254946|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254947|NCT03140332|Sorafenib|sorafenib|mesh-list
139254948|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254949|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139254950|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139254951|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254952|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
139254953|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139254954|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254955|NCT02835690|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139254956|NCT02835690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254957|NCT02832167|Nivolumab|nivolumab|mesh-list
139254958|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139254959|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254960|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139254961|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254962|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
139254963|NCT04941040|Anesthetics|anesthetics|mesh-list
139254964|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139254965|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254966|NCT04941040|Narcotics|narcotics|mesh-ancestor
139254967|NCT04941040|Analgesics|analgesics|mesh-ancestor
139254968|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
139254969|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139254970|NCT00913705|Carboplatin|carboplatin|mesh-list
139254971|NCT00913705|Paclitaxel|paclitaxel|mesh-list
139254972|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139254973|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139254974|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139254975|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
139254976|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
139254977|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
139254978|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254979|NCT04934410|Midazolam|midazolam|mesh-list
139254980|NCT04934410|Etomidate|etomidate|mesh-list
139254981|NCT04934410|Sevoflurane|sevoflurane|mesh-list
139254982|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139254983|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139254984|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139254985|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139254986|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139254987|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139254988|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139254989|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139254991|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
139254992|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
139380430|NCT05074940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380431|NCT05074940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380432|NCT05041257|Maytansine|maytansine|mesh-list
139254993|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
139254994|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139254995|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139254996|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139254997|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139254998|NCT02787239|Rituximab|rituximab|mesh-list
139254999|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139255000|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255001|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
139255002|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255003|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139255004|NCT03140956|Levodopa|levodopa|mesh-list
139255005|NCT03140956|Carbidopa|carbidopa|mesh-list
139255006|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139255007|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139255008|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
139255009|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255010|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255011|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255012|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139255013|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255014|NCT02681237|Olaparib|olaparib|mesh-list
139255015|NCT02681237|Cediranib|cediranib|mesh-list
139255016|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139255017|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255018|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255019|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255020|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139255021|NCT02674529|Escitalopram|escitalopram|mesh-list
139255022|NCT02674529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139255023|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139255024|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139255025|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255026|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255027|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
139255028|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255029|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139255030|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139255031|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255032|NCT03632317|Everolimus|everolimus|mesh-list
139255033|NCT03632317|Panobinostat|panobinostat|mesh-list
139255034|NCT03632317|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139255035|NCT03632317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139255036|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255037|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255038|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139255039|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
139255040|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255041|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255042|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139255043|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
139255044|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139255045|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255046|NCT02653963|Triamcinolone|triamcinolone|mesh-list
139255047|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139255048|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
139255049|NCT02653963|Hormones|hormones|mesh-ancestor
139255050|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255051|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255052|NCT03097861|Lubiprostone|lubiprostone|mesh-list
139255053|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139255054|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139255055|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255056|NCT01376141|Sumatriptan|sumatriptan|mesh-list
139255057|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139255058|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139255059|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139255060|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
139255061|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255062|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255063|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255064|NCT01816139|Estradiol|estradiol|mesh-list
139255065|NCT01816139|Estrogens|estrogens|mesh-ancestor
139255066|NCT01816139|Hormones|hormones|mesh-ancestor
139255067|NCT01816139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255068|NCT01816139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255069|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
139255070|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139255071|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139255072|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139255073|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139255074|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255075|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
139255076|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255077|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255078|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139255079|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255080|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
139255081|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139255082|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139255083|NCT05041673|Metformin|metformin|mesh-list
139255084|NCT05041673|Liraglutide|liraglutide|mesh-list
139255085|NCT05041673|Empagliflozin|empagliflozin|mesh-list
139255086|NCT05041673|Vildagliptin|vildagliptin|mesh-list
139255087|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139255088|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255089|NCT05041673|Incretins|incretins|mesh-ancestor
139255090|NCT05041673|Hormones|hormones|mesh-ancestor
139255091|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255092|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139255093|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255094|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139255095|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
139255096|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255097|NCT03907540|Belumosudil|belumosudil|mesh-list
139255098|NCT03907540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139255099|NCT03907540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255100|NCT03907540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255101|NCT05759429|Melatonin|melatonin|mesh-list
139255102|NCT05759429|Antioxidants|antioxidants|mesh-ancestor
139380478|NCT04984811|Atezolizumab|atezolizumab|mesh-list
139380479|NCT04984811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139380480|NCT04984811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380481|NCT04984811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380482|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380483|NCT04942067|Dexamethasone|dexamethasone|mesh-list
139255103|NCT05759429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255104|NCT05759429|Protective Agents|protective agents|mesh-ancestor
139255105|NCT05759429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255106|NCT05759429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139255107|NCT04005209|Ketamine|ketamine|mesh-list
139255108|NCT04005209|Analgesics|analgesics|mesh-ancestor
139255109|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
139255110|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255111|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255112|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139255113|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139255114|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
139255115|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
139255116|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139255117|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139255118|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139255119|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255120|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255121|NCT03904108|Ramucirumab|ramucirumab|mesh-list
139255122|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255123|NCT02833350|Folic Acid|folic acid|mesh-list
139255124|NCT02833350|Adalimumab|adalimumab|mesh-list
139255125|NCT02833350|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139255126|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139255127|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139255128|NCT02833350|Hematinics|hematinics|mesh-ancestor
139255129|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
139255130|NCT02833350|Vitamins|vitamins|mesh-ancestor
139255131|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
139255132|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255133|NCT03137134|Crizotinib|crizotinib|mesh-list
139255134|NCT03137134|Esomeprazole|esomeprazole|mesh-list
139255135|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139255136|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139255137|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139255138|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255139|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255140|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255141|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139255142|NCT03137368|Tamoxifen|tamoxifen|mesh-list
139255143|NCT03137368|Exemestane|exemestane|mesh-list
139255144|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139255145|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
139255146|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255147|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255148|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139255149|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255150|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139255151|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139255152|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139255153|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139255154|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139255155|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255156|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255157|NCT03138616|Vitamin D|vitamin d|mesh-list
139255158|NCT03138616|Vitamins|vitamins|mesh-ancestor
139255159|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
139255160|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255161|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139255162|NCT03137290|Neostigmine|neostigmine|mesh-list
139255163|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139255164|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255165|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255166|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
139255167|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255168|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255169|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139255170|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
139255171|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255172|NCT03782818|Olaparib|olaparib|mesh-list
139255173|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139255174|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255175|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255176|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255177|NCT05391724|Brincidofovir|brincidofovir|mesh-list
139255178|NCT05391724|Antiviral Agents|antiviral agents|mesh-ancestor
139255179|NCT05391724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139255180|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
139255181|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139255182|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139255183|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255184|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139255185|NCT03355534|Analgesics|analgesics|mesh-ancestor
139255186|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
139255187|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255188|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139255189|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139255190|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139255191|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
139255192|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255193|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255194|NCT05385562|Triamcinolone|triamcinolone|mesh-list
139255195|NCT05385562|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139255196|NCT05385562|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139255197|NCT05385562|Hyaluronic Acid|hyaluronic acid|mesh-list
139255198|NCT05385562|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139255199|NCT05385562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139255200|NCT05385562|Glucocorticoids|glucocorticoids|mesh-ancestor
139255201|NCT05385562|Hormones|hormones|mesh-ancestor
139255202|NCT05385562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255203|NCT05385562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255204|NCT05385562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139255205|NCT05385562|Immunologic Factors|immunologic factors|mesh-ancestor
139255206|NCT05385562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255207|NCT05385562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255208|NCT05385562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139255209|NCT05385562|Viscosupplements|viscosupplements|mesh-ancestor
139255210|NCT05385562|Protective Agents|protective agents|mesh-ancestor
139255211|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
139255213|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139255214|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
139255215|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255216|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139255217|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139255218|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
139255219|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255220|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255221|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139255222|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139255223|NCT03139708|Phenylephrine|phenylephrine|mesh-list
139255224|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
139255225|NCT03139708|Tropicamide|tropicamide|mesh-list
139255226|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139255227|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
139255228|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
139255229|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255230|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255231|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
139255232|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139255233|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
139255234|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
139255235|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139255236|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139255237|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139255238|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
139255239|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255240|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255241|NCT03139708|Protective Agents|protective agents|mesh-ancestor
139255242|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139255243|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139255244|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139255245|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139255246|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
139255247|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139255248|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139255249|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
139255250|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255251|NCT05330364|Cladribine|cladribine|mesh-list
139255252|NCT05330364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255253|NCT05330364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139255255|NCT05330364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255256|NCT05087368|Vaccines|vaccines|mesh-list
139255257|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
139255258|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255259|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139255260|NCT05087134|Choline|choline|mesh-list
139255261|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
139255262|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139255263|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
139255264|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255265|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139255266|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139255267|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
139255268|NCT03048747|Tolvaptan|tolvaptan|mesh-list
139255269|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139255270|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255271|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
139255272|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255273|NCT05086822|Irinotecan|irinotecan|mesh-list
139255274|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139255275|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139255276|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255277|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255278|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255279|NCT05354128|Fibrinolytic Agents|fibrinolytic agents|mesh-list
139255280|NCT05354128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139255281|NCT05354128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255282|NCT04051827|Midazolam|midazolam|mesh-list
139255283|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139255284|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139255285|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139255286|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255287|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139255288|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139255289|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139255290|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139255291|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
139255292|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
139255293|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
139255294|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
139255295|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255296|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255297|NCT05346874|Oxaliplatin|oxaliplatin|mesh-list
139255298|NCT05346874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255299|NCT02123823|Everolimus|everolimus|mesh-list
139255300|NCT02123823|Exemestane|exemestane|mesh-list
139255301|NCT02123823|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139255302|NCT02123823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139255303|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255304|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255305|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139255306|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
139255307|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255308|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255309|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139255310|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139255311|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139255312|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
139255313|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255314|NCT05085652|Anesthetics|anesthetics|mesh-list
139255315|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139255316|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255317|NCT03136510|Apixaban|apixaban|mesh-list
139255318|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139255319|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
139255320|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139255321|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
139255322|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255323|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255324|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
139255325|NCT05692245|Dexamethasone|dexamethasone|mesh-list
139255326|NCT05692245|Ondansetron|ondansetron|mesh-list
139255327|NCT05692245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139255328|NCT05692245|Antiemetics|antiemetics|mesh-ancestor
139255329|NCT05692245|Autonomic Agents|autonomic agents|mesh-ancestor
139255330|NCT05692245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255331|NCT05692245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255332|NCT05692245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139255333|NCT05692245|Glucocorticoids|glucocorticoids|mesh-ancestor
139255334|NCT05692245|Hormones|hormones|mesh-ancestor
139255335|NCT05692245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255336|NCT05692245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139255337|NCT05692245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255338|NCT05692245|Antipruritics|antipruritics|mesh-ancestor
139255339|NCT05692245|Dermatologic Agents|dermatologic agents|mesh-ancestor
139255340|NCT05692245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139255341|NCT05692245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139255342|NCT05692245|Serotonin Agents|serotonin agents|mesh-ancestor
139255343|NCT05692245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255344|NCT05692245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255345|NCT05085106|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
139255346|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139255347|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139255348|NCT05085106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139255349|NCT05085106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139255350|NCT05085106|Analgesics|analgesics|mesh-ancestor
139255351|NCT05085106|Sensory System Agents|sensory system agents|mesh-ancestor
139255352|NCT05085106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255353|NCT05085106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255354|NCT05085106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139255355|NCT05085106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139255356|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
139255357|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
139255358|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139255359|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139255360|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139255361|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255362|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255363|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139255364|NCT00159796|Olanzapine|olanzapine|mesh-list
139255365|NCT00159796|Asenapine|asenapine|mesh-list
139255366|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
139255367|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
139255368|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255369|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255370|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139255371|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139255372|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139255373|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139255374|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139255375|NCT00159796|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139255376|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139255377|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139255378|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255379|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255380|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
139255381|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139255382|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139255383|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255384|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
139255385|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139255386|NCT03327844|Metronidazole|metronidazole|mesh-list
139255387|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
139255388|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139255389|NCT03327844|Calcium|calcium|mesh-list
139255390|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139255391|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255392|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139255393|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139255394|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
139255395|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139255396|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139255397|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139255398|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139255399|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255400|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255402|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139255403|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139255404|NCT05008510|Camptothecin|camptothecin|mesh-list
139255405|NCT05008510|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139255406|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
139255407|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
139255408|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255409|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139255410|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255411|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139255412|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139255413|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255414|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255415|NCT05194995|Cetuximab|cetuximab|mesh-list
139255416|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139255417|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255418|NCT05187039|Anesthetics|anesthetics|mesh-list
139255419|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139255420|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255421|NCT03136666|Candesartan|candesartan|mesh-list
139255422|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
139255423|NCT03136666|Nifedipine|nifedipine|mesh-list
139255424|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139255425|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139255426|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139255427|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255428|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139255429|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139255430|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139255431|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255432|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
138838772|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
139255434|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139255435|NCT03255083|Osimertinib|osimertinib|mesh-list
139255436|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255437|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139255438|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255439|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255440|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
139255441|NCT03735537|Teriparatide|teriparatide|mesh-list
139255442|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139255443|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139255444|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255445|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139255446|NCT04531059|Metronidazole|metronidazole|mesh-list
139255447|NCT04531059|Minocycline|minocycline|mesh-list
139255448|NCT04531059|Tetracycline|tetracycline|mesh-list
139255449|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
139255450|NCT04531059|Esomeprazole|esomeprazole|mesh-list
139255451|NCT04531059|Bismuth|bismuth|mesh-list
139255452|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255453|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139255454|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139255455|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139255456|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139255457|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139255458|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139255459|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139255460|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255461|NCT04531059|Antacids|antacids|mesh-ancestor
139255462|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139255463|NCT04531059|Diuretics|diuretics|mesh-ancestor
139255464|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
139255465|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255466|NCT04531059|Expectorants|expectorants|mesh-ancestor
139255467|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
139255468|NCT05090176|Povidone|povidone|mesh-list
139255469|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
139255470|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
139255471|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
139255472|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139255473|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139255474|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255475|NCT04558294|Ketanserin|ketanserin|mesh-list
139255476|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139255477|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
139255478|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255479|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139255480|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139255481|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
139255482|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255483|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255484|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139255485|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139255486|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139255487|NCT03378466|Heparin|heparin|mesh-list
139255488|NCT03378466|Calcium heparin|calcium heparin|mesh-list
139255489|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
139255490|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139255491|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139255492|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255493|NCT05077540|Misoprostol|misoprostol|mesh-list
139255494|NCT05077540|Oxytocin|oxytocin|mesh-list
139255495|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
139255496|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139255497|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255498|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139255499|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
139255500|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139255501|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139255502|NCT03097315|Triamcinolone|triamcinolone|mesh-list
139255503|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139255504|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139255505|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138838848|NCT00817765|Posaconazole|posaconazole|mesh-list
139255506|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139255507|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
139255508|NCT03097315|Hormones|hormones|mesh-ancestor
139255509|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255510|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255511|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139255512|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
139255513|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255514|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255515|NCT05530707|Niacinamide|niacinamide|mesh-list
139255516|NCT05530707|Niacin|niacin|mesh-list
139255517|NCT05530707|Nicotinic Acids|nicotinic acids|mesh-list
139255518|NCT05530707|Vitamin B Complex|vitamin b complex|mesh-ancestor
139255519|NCT05530707|Vitamins|vitamins|mesh-ancestor
139255520|NCT05530707|Micronutrients|micronutrients|mesh-ancestor
139255521|NCT05530707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255522|NCT05530707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139255523|NCT05530707|Antimetabolites|antimetabolites|mesh-ancestor
139255524|NCT05530707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255525|NCT05530707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139255526|NCT05530707|Vasodilator Agents|vasodilator agents|mesh-ancestor
139255527|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139255528|NCT03093415|Grazoprevir|grazoprevir|mesh-list
139255529|NCT03093415|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139255530|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
139255531|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139255532|NCT01358526|Oxycodone|oxycodone|mesh-list
139255533|NCT01358526|Naloxone|naloxone|mesh-list
139255534|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139255535|NCT01358526|Narcotics|narcotics|mesh-ancestor
139255536|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139255537|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255538|NCT01358526|Analgesics|analgesics|mesh-ancestor
139255539|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
139255540|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255541|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139255542|NCT01310010|Dasatinib|dasatinib|mesh-list
139255543|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255544|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139255545|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255546|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255547|NCT02830776|Bimatoprost|bimatoprost|mesh-list
139255548|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139255549|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139255550|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139255551|NCT03563664|Danazol|danazol|mesh-list
139255552|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139255553|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
139255554|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139380552|NCT04827446|Methamphetamine|methamphetamine|mesh-list
139255555|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255556|NCT03041181|Gemcitabine|gemcitabine|mesh-list
139255557|NCT03041181|Docetaxel|docetaxel|mesh-list
139255558|NCT03041181|Nivolumab|nivolumab|mesh-list
139255559|NCT03041181|Pemetrexed|pemetrexed|mesh-list
139255560|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139255561|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
139255562|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255563|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255564|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
139255565|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
139255566|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
139255567|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139255568|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139255569|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255570|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139255571|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139255572|NCT02828124|Nivolumab|nivolumab|mesh-list
139255573|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139255574|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255575|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139255576|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255577|NCT02829996|Latanoprost|latanoprost|mesh-list
139255578|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139255579|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139255580|NCT05385549|Imatinib Mesylate|imatinib mesylate|mesh-list
139255581|NCT05385549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255582|NCT05385549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139255583|NCT05385549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255584|NCT05385549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255585|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139255586|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139255587|NCT05197062|Aticaprant|aticaprant|mesh-list
139255588|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139255589|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255590|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
139255591|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255592|NCT05000736|Fulvestrant|fulvestrant|mesh-list
139255593|NCT05000736|Palbociclib|palbociclib|mesh-list
139255594|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139255595|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139255596|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255597|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139255598|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139255599|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
139255600|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255601|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255602|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139255603|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255604|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255605|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139255606|NCT03828162|Anticoagulants|anticoagulants|mesh-list
139255607|NCT03563040|Methoxsalen|methoxsalen|mesh-list
139255608|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139255609|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
139255610|NCT03094416|Esomeprazole|esomeprazole|mesh-list
139255611|NCT03094416|Omeprazole|omeprazole|mesh-list
139255612|NCT03094416|Rabeprazole|rabeprazole|mesh-list
139255613|NCT03094416|Pantoprazole|pantoprazole|mesh-list
139255614|NCT03094416|Lansoprazole|lansoprazole|mesh-list
139255615|NCT03094416|Dexlansoprazole|dexlansoprazole|mesh-list
139255616|NCT03094416|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139255617|NCT03094416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139255618|NCT03094416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139255619|NCT03094416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255620|NCT03094416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255621|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
139255622|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139297249|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255623|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
139255624|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139255625|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255626|NCT01338870|Incretins|incretins|mesh-ancestor
139255627|NCT01338870|Hormones|hormones|mesh-ancestor
139255628|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255629|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139255630|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
139255631|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255632|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255633|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
139255634|NCT01338870|Vitamins|vitamins|mesh-ancestor
139255635|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
139255636|NCT02824224|Tamoxifen|tamoxifen|mesh-list
139255637|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139255638|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
139255639|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255640|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255641|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139255642|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255643|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139255644|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139255645|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139255646|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
139255647|NCT01338792|Pemetrexed|pemetrexed|mesh-list
139255648|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255649|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255650|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255651|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139255652|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139255653|NCT01314105|Carboplatin|carboplatin|mesh-list
139255654|NCT01314105|Nintedanib|nintedanib|mesh-list
139255655|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255656|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139255657|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255658|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839075|NCT00816673|Protective Agents|protective agents|mesh-ancestor
139255659|NCT01966471|Maytansine|maytansine|mesh-list
139255660|NCT01966471|Docetaxel|docetaxel|mesh-list
139255661|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139255662|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
139255663|NCT01966471|Doxorubicin|doxorubicin|mesh-list
139255664|NCT01966471|Fluorouracil|fluorouracil|mesh-list
139255665|NCT01966471|Trastuzumab|trastuzumab|mesh-list
139255666|NCT01966471|Epirubicin|epirubicin|mesh-list
139255667|NCT01966471|Pertuzumab|pertuzumab|mesh-list
139255668|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139255669|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255670|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
139255671|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
139255672|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
139255673|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255674|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139255675|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
139255676|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255677|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139255678|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139255679|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
139255680|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139255681|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139255682|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139255683|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139255684|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255685|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
139255686|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139255687|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139255688|NCT01966471|Immunotoxins|immunotoxins|mesh-ancestor
139255689|NCT01966471|Immunoconjugates|immunoconjugates|mesh-ancestor
139255690|NCT04188847|Apatinib|apatinib|mesh-list
139255691|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255692|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139255693|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255694|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255695|NCT05255107|Riboflavin|riboflavin|mesh-list
139255696|NCT05255107|Lubricant Eye Drops|lubricant eye drops|mesh-list
139255697|NCT05255107|Vitamin B Complex|vitamin b complex|mesh-ancestor
139255698|NCT05255107|Vitamins|vitamins|mesh-ancestor
139255699|NCT05255107|Micronutrients|micronutrients|mesh-ancestor
139255700|NCT05255107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255701|NCT05255107|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139255702|NCT05255107|Dermatologic Agents|dermatologic agents|mesh-ancestor
139255703|NCT05255107|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139255704|NCT05255107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139255705|NCT03227471|Ivacaftor|ivacaftor|mesh-list
139255706|NCT03227471|Elexacaftor|elexacaftor|mesh-list
139255707|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139255708|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139255709|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255710|NCT01354314|Fluconazole|fluconazole|mesh-list
139255711|NCT01354314|Paroxetine|paroxetine|mesh-list
139255712|NCT01354314|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139255713|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139255714|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139255715|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255716|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255717|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
139255718|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255719|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139255720|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
139255721|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139255722|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139255723|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139255724|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255725|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
139255726|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139255727|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139255728|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139255729|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
139255730|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255731|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139255732|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139255733|NCT04509336|Orphenadrine|orphenadrine|mesh-list
139255734|NCT04509336|Baclofen|baclofen|mesh-list
139255735|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139255736|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255737|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139255738|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255739|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139255740|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
139255741|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
139255742|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255743|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255744|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139255745|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139255746|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
139255747|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
139255748|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139255749|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139255750|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
139255751|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
139255752|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139255753|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255754|NCT03194321|Tacrolimus|tacrolimus|mesh-list
139255755|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139255756|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
139255757|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255758|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139255759|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255760|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255761|NCT01374581|Artesunate|artesunate|mesh-list
139255762|NCT01374581|Lumefantrine|lumefantrine|mesh-list
139255763|NCT01374581|Artemether|artemether|mesh-list
139255764|NCT01374581|Amodiaquine|amodiaquine|mesh-list
139255765|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139255766|NCT01374581|Quinine|quinine|mesh-list
139255767|NCT01374581|Clindamycin|clindamycin|mesh-list
139255768|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
139255769|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
139255770|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
139255771|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139255772|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139255773|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139255774|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255775|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
139255776|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
139255777|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139255778|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
139255779|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139255780|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139255781|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255782|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255783|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139255784|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255785|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139255786|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255787|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139255788|NCT01374581|Analgesics|analgesics|mesh-ancestor
139255789|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
139255790|NCT01354938|Clarithromycin|clarithromycin|mesh-list
139255791|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139255792|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139255793|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139255794|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255795|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255796|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139255797|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139255798|NCT03065556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139255799|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
139255800|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139255801|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139255802|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255803|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139255804|NCT01374737|Analgesics|analgesics|mesh-ancestor
139255805|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
139255806|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839145|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
139255807|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139255808|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139255809|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139255810|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
139255811|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255812|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255814|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
139255815|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255816|NCT01376453|Fluorouracil|fluorouracil|mesh-list
139255817|NCT01376453|Sorafenib|sorafenib|mesh-list
139255818|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
139255819|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255820|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139255821|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255822|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139255823|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
139255824|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255825|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139255826|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255827|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139255828|NCT01568125|Incretins|incretins|mesh-list
139255829|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255830|NCT01568125|Hormones|hormones|mesh-ancestor
139255831|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255832|NCT02288897|Temozolomide|temozolomide|mesh-list
139255833|NCT02288897|Dacarbazine|dacarbazine|mesh-list
139255834|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139255835|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139255836|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
139255837|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255838|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255839|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139255840|NCT05707572|Methylprednisolone|methylprednisolone|mesh-list
139255841|NCT05707572|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139255842|NCT05707572|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139255843|NCT05707572|Prednisolone|prednisolone|mesh-list
139255844|NCT05707572|Prednisolone acetate|prednisolone acetate|mesh-list
139255845|NCT05707572|Lidocaine|lidocaine|mesh-list
139255846|NCT05707572|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139255847|NCT05707572|Prednisolone phosphate|prednisolone phosphate|mesh-list
139255848|NCT05707572|Anesthetics, Local|anesthetics, local|mesh-ancestor
139255849|NCT05707572|Anesthetics|anesthetics|mesh-ancestor
139255850|NCT05707572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139255851|NCT05707572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255852|NCT05707572|Sensory System Agents|sensory system agents|mesh-ancestor
139255853|NCT05707572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255854|NCT05707572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139255855|NCT05707572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139255856|NCT05707572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139255857|NCT05707572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139255858|NCT05707572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255859|NCT05707572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139255860|NCT05707572|Antiemetics|antiemetics|mesh-ancestor
139255861|NCT05707572|Autonomic Agents|autonomic agents|mesh-ancestor
139255862|NCT05707572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139255863|NCT05707572|Glucocorticoids|glucocorticoids|mesh-ancestor
139255864|NCT05707572|Hormones|hormones|mesh-ancestor
139255865|NCT05707572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255866|NCT05707572|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139255867|NCT05707572|Protective Agents|protective agents|mesh-ancestor
139255868|NCT05707572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139255869|NCT05707572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255870|NCT02035800|Adalimumab|adalimumab|mesh-list
139255871|NCT02035800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139255872|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139255873|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139255874|NCT03993912|Dexamethasone|dexamethasone|mesh-list
139255875|NCT03993912|Lenalidomide|lenalidomide|mesh-list
139255876|NCT03993912|Daratumumab|daratumumab|mesh-list
139255877|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139255878|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
139255879|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
139255880|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255881|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255882|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139255883|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
139255884|NCT03993912|Hormones|hormones|mesh-ancestor
139255885|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255886|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139255887|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255888|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
139255889|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139255890|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139255891|NCT03993912|Growth Substances|growth substances|mesh-ancestor
139255892|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
139255893|NCT01568749|Acetaminophen|acetaminophen|mesh-list
139255894|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139255895|NCT01568749|Analgesics|analgesics|mesh-ancestor
139255896|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
139255897|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255898|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255899|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
139255900|NCT02819310|Laxatives|laxatives|mesh-list
139255901|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139255902|NCT03633773|Immunomodulating Agents|immunomodulating agents|mesh-list
139255903|NCT03633773|Immunologic Factors|immunologic factors|mesh-ancestor
139255904|NCT03633773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255905|NCT01375361|Albuterol|albuterol|mesh-list
139255906|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139255907|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
139255908|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255909|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255910|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139255911|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
139255912|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
139255913|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139255914|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139255915|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139255916|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139255917|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
139255918|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255919|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255921|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139255922|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
139255923|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255924|NCT01376765|Antacids|antacids|mesh-ancestor
139255925|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255926|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139255927|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
139255928|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
139255929|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139255930|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255931|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139255932|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255933|NCT01358201|Cytarabine|cytarabine|mesh-list
139255934|NCT01358201|Dexamethasone|dexamethasone|mesh-list
139255935|NCT01358201|Methotrexate|methotrexate|mesh-list
139255936|NCT01358201|Vincristine|vincristine|mesh-list
139255937|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139255938|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
139255939|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
139255940|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255941|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255942|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139255943|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
139255944|NCT01358201|Hormones|hormones|mesh-ancestor
139255945|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139255946|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139255947|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255948|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139255949|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
139255950|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139255951|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139255952|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
139255953|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255954|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
139255955|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139255956|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138839294|NCT00640393|Analgesics|analgesics|mesh-ancestor
139255957|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139091680|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139255958|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
139255959|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139255960|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139255961|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139255962|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
139255963|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
139255964|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
139255965|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
139255966|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139255968|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
139255969|NCT02951767|Atezolizumab|atezolizumab|mesh-list
139255970|NCT02951767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139255971|NCT02951767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255972|NCT02951767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139255973|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139255974|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139255975|NCT03091777|Metronidazole|metronidazole|mesh-list
139255976|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139255977|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139255978|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139255979|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139255980|NCT05392361|Gabapentin|gabapentin|mesh-list
139255981|NCT05392361|Baclofen|baclofen|mesh-list
139255982|NCT05392361|Analgesics|analgesics|mesh-ancestor
139255983|NCT05392361|Sensory System Agents|sensory system agents|mesh-ancestor
139255984|NCT05392361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139255985|NCT05392361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139255986|NCT05392361|Anticonvulsants|anticonvulsants|mesh-ancestor
139255987|NCT05392361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139255988|NCT05392361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139255989|NCT05392361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139255990|NCT05392361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139380713|NCT03862716|Insulin|insulin|mesh-list
139255991|NCT05392361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139255992|NCT05392361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139255993|NCT05392361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139255994|NCT05392361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139255995|NCT05392361|Antimanic Agents|antimanic agents|mesh-ancestor
139255996|NCT05392361|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139255997|NCT05392361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139255998|NCT05392361|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139255999|NCT05392361|GABA Agonists|gaba agonists|mesh-ancestor
139256000|NCT05392361|GABA Agents|gaba agents|mesh-ancestor
139256001|NCT05338541|Etoposide|etoposide|mesh-list
139256002|NCT05338541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139256003|NCT05338541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256004|NCT05338541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139256005|NCT05338541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139256006|NCT05338541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256007|NCT05338541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256008|NCT05335655|Dexmedetomidine|dexmedetomidine|mesh-list
139256009|NCT05335655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139256010|NCT05335655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139256011|NCT05335655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256012|NCT05335655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139256013|NCT05335655|Analgesics|analgesics|mesh-ancestor
139256014|NCT05335655|Sensory System Agents|sensory system agents|mesh-ancestor
139256015|NCT05335655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256016|NCT05335655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139256017|NCT05335655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139256018|NCT05335655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139256019|NCT05335655|Adrenergic Agents|adrenergic agents|mesh-ancestor
139256020|NCT05335655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256021|NCT05335655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256022|NCT04589351|Ezetimibe|ezetimibe|mesh-list
139256023|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139256024|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139256025|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
139256026|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256027|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139256028|NCT02818998|Aflibercept|aflibercept|mesh-list
139256029|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138839401|NCT00826657|Vitamins|vitamins|mesh-ancestor
139256030|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139256031|NCT02818998|Growth Substances|growth substances|mesh-ancestor
139256032|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256033|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
139256034|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256035|NCT02821416|Benralizumab|benralizumab|mesh-list
139256036|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139256037|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
139256038|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139256039|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139256040|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256041|NCT03108521|Incretins|incretins|mesh-ancestor
139256042|NCT03108521|Hormones|hormones|mesh-ancestor
139256043|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256044|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139256045|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
139256046|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256047|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256048|NCT04500509|Diclofenac|diclofenac|mesh-list
139256049|NCT04500509|Dinoprostone|dinoprostone|mesh-list
139256050|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139256051|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139256052|NCT04500509|Analgesics|analgesics|mesh-ancestor
139256053|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
139256054|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256055|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256056|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139256057|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139256058|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139256059|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256060|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256061|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
139256062|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139256063|NCT05760599|Bevacizumab|bevacizumab|mesh-list
139256064|NCT05760599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139256065|NCT05760599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256066|NCT05760599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139256067|NCT05760599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139256068|NCT05760599|Growth Substances|growth substances|mesh-ancestor
139256069|NCT05760599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256070|NCT05760599|Growth Inhibitors|growth inhibitors|mesh-ancestor
139256071|NCT04441073|Lidocaine|lidocaine|mesh-list
139256072|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
139256073|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
139256074|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139256075|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256076|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
139256077|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256078|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139256079|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139256080|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139256081|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139256082|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256083|NCT02817828|Drospirenone|drospirenone|mesh-list
139256084|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139256085|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
139256086|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256087|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256088|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139256089|NCT02817828|Diuretics|diuretics|mesh-ancestor
139256090|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
139256091|NCT03632681|Insulin|insulin|mesh-list
139256092|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139256093|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139256094|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256095|NCT05597995|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
139256096|NCT05597995|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139256097|NCT05597995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139256098|NCT03796650|Vancomycin|vancomycin|mesh-list
139256099|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139256100|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139256101|NCT05597527|Apatinib|apatinib|mesh-list
139256102|NCT05597527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256103|NCT05597527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139256105|NCT05597527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256106|NCT05198141|Letrozole|letrozole|mesh-list
139256107|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256108|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139256109|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139256110|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256111|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256112|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139256113|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
139256114|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256115|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256116|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
139256117|NCT02813694|Lefamulin|lefamulin|mesh-list
139256118|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139256119|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139256120|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139256121|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139256122|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256123|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256124|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256125|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
139256126|NCT03632161|Bupivacaine|bupivacaine|mesh-list
139256127|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
139256128|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
139256129|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139256130|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256131|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
139256132|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256133|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139256134|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139256135|NCT03632161|Analgesics|analgesics|mesh-ancestor
139256136|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139256137|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139256138|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139256139|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
139256140|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297250|NCT04153383|Protective Agents|protective agents|mesh-ancestor
139256141|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256142|NCT03103919|Rotigotine|rotigotine|mesh-list
139256143|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
139256144|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
139256145|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256146|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256147|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256148|NCT04173325|Nivolumab|nivolumab|mesh-list
139256149|NCT04173325|Irinotecan|irinotecan|mesh-list
139256150|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139256151|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256152|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139256153|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256154|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139256155|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139256156|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256157|NCT02810964|Sulforaphane|sulforaphane|mesh-list
139256158|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139256159|NCT02810964|Protective Agents|protective agents|mesh-ancestor
139256160|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256161|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256162|NCT04073147|Venetoclax|venetoclax|mesh-list
139256163|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
139256164|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256165|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139256166|NCT02707159|Paclitaxel|paclitaxel|mesh-list
139256167|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139256168|NCT02707159|Gemcitabine|gemcitabine|mesh-list
139256169|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139256170|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256171|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
139256172|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
139256173|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
139256174|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256175|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139256176|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
139256177|NCT04113187|Propranolol|propranolol|mesh-list
139256178|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139256179|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139256180|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
139256181|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256182|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256183|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256184|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139256185|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139256186|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
139256188|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
139256189|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139256190|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139256191|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139256192|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
139256193|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256194|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139256195|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139256196|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256197|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
139256198|NCT04011475|Olodaterol|olodaterol|mesh-list
139256199|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139256200|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
139256201|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256202|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256203|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139256204|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
139256205|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
139256206|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139256207|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
139256208|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256209|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256210|NCT03663335|Tacrolimus|tacrolimus|mesh-list
139256211|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139256212|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
139256213|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256214|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139256215|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256216|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256217|NCT03632915|Lacosamide|lacosamide|mesh-list
139256218|NCT03632915|Phenytoin|phenytoin|mesh-list
139256219|NCT03632915|Ketamine|ketamine|mesh-list
139256220|NCT03632915|Levetiracetam|levetiracetam|mesh-list
139256221|NCT03632915|Valproic Acid|valproic acid|mesh-list
139256222|NCT03632915|Phenobarbital|phenobarbital|mesh-list
139256223|NCT03632915|Analgesics|analgesics|mesh-ancestor
139256224|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
139256225|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256226|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256227|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139256228|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139256229|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
139256230|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
139256231|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139256232|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139256233|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139256234|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256235|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256236|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
139256237|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
139256238|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256239|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
139256240|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
139256241|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139256242|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139256243|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139256244|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139256245|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139256246|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139256247|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139256248|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139256249|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
139256250|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139256251|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139256252|NCT05649605|Methyltestosterone|methyltestosterone|mesh-list
139256253|NCT05649605|Testosterone|testosterone|mesh-list
139256254|NCT05649605|Testosterone undecanoate|testosterone undecanoate|mesh-list
139256255|NCT05649605|Testosterone enanthate|testosterone enanthate|mesh-list
139256256|NCT05649605|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139256257|NCT05649605|Androgens|androgens|mesh-ancestor
139256258|NCT05649605|Hormones|hormones|mesh-ancestor
139256259|NCT05649605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256260|NCT05649605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256261|NCT05649605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139256262|NCT05649605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256263|NCT05649605|Anabolic Agents|anabolic agents|mesh-ancestor
139256264|NCT05640479|Pregabalin|pregabalin|mesh-list
139256265|NCT05640479|Dexmedetomidine|dexmedetomidine|mesh-list
139256266|NCT05640479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139256267|NCT05640479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139256268|NCT05640479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256269|NCT05640479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139256270|NCT05640479|Analgesics|analgesics|mesh-ancestor
139256271|NCT05640479|Sensory System Agents|sensory system agents|mesh-ancestor
139256272|NCT05640479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256273|NCT05640479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139256274|NCT05640479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139256275|NCT05640479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139256276|NCT05640479|Adrenergic Agents|adrenergic agents|mesh-ancestor
139256277|NCT05640479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256278|NCT05640479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256279|NCT05640479|Anticonvulsants|anticonvulsants|mesh-ancestor
139256280|NCT05640479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139256281|NCT05640479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139256282|NCT05640479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139256283|NCT05640479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139256284|NCT05640479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139256285|NCT05640479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139256286|NCT05309525|Tranexamic Acid|tranexamic acid|mesh-list
139256287|NCT05309525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139256288|NCT05309525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139256289|NCT05309525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256290|NCT05309525|Hemostatics|hemostatics|mesh-ancestor
139256291|NCT05309525|Coagulants|coagulants|mesh-ancestor
139256292|NCT04905563|Acetaminophen|acetaminophen|mesh-list
139256293|NCT04905563|Ibuprofen|ibuprofen|mesh-list
139256294|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139256295|NCT04905563|Hydrocodone|hydrocodone|mesh-list
139256296|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139256297|NCT04905563|Analgesics|analgesics|mesh-ancestor
139256298|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
139256299|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256300|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256301|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
139256302|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139256303|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139256304|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139256305|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139256306|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256307|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256308|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139256309|NCT04905563|Narcotics|narcotics|mesh-ancestor
139256310|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139256311|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
139256312|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
139256313|NCT02810418|Paclitaxel|paclitaxel|mesh-list
139256314|NCT02810418|LMB-100|lmb-100|mesh-list
139256315|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139256316|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256317|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
139256318|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
139256319|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
139256320|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256321|NCT02810418|Immunoconjugates|immunoconjugates|mesh-ancestor
139256322|NCT02810418|Immunologic Factors|immunologic factors|mesh-ancestor
139256323|NCT02810418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256324|NCT02959541|Leucovorin|leucovorin|mesh-list
139256325|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
139256326|NCT02959541|Antidotes|antidotes|mesh-ancestor
138839673|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139256327|NCT02959541|Protective Agents|protective agents|mesh-ancestor
139256328|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256329|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
139256330|NCT02959541|Vitamins|vitamins|mesh-ancestor
139256331|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
139256332|NCT05705700|Dutasteride|dutasteride|mesh-list
139256333|NCT05705700|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139256334|NCT05705700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139256335|NCT05705700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256336|NCT05705700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256337|NCT05705700|Hormone Antagonists|hormone antagonists|mesh-ancestor
139256338|NCT05705700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256339|NCT05705700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256340|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
139256341|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139256342|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256343|NCT02260050|Epinastine|epinastine|mesh-list
139256344|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139256345|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
139256346|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
139256347|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256348|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256349|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256350|NCT02036736|Propofol|propofol|mesh-list
139256351|NCT02036736|Anesthetics|anesthetics|mesh-list
139256352|NCT02036736|Desflurane|desflurane|mesh-list
139256353|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139256354|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139256355|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256356|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139256357|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
139256358|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139256359|NCT05693688|Atosiban|atosiban|mesh-list
139256360|NCT05693688|Hormone Antagonists|hormone antagonists|mesh-ancestor
139256361|NCT05693688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256362|NCT05693688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256363|NCT05693688|Tocolytic Agents|tocolytic agents|mesh-ancestor
139256364|NCT05693688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139126528|NCT01103115|Vitamins|vitamins|mesh-ancestor
139256365|NCT02047422|Metolazone|metolazone|mesh-list
139256366|NCT02047422|Furosemide|furosemide|mesh-list
139256367|NCT02047422|Spironolactone|spironolactone|mesh-list
139256368|NCT02047422|Diuretics|diuretics|mesh-ancestor
139256369|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
139256370|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256371|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139256372|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139256373|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256374|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139256375|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
139256376|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256377|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139256378|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139256379|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139256380|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
139256381|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139256382|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139256383|NCT02048358|Prednisolone|prednisolone|mesh-list
139256384|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
139256385|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139256386|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
139256387|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139256388|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
139256389|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
139256390|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256391|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256392|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139256393|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
139256394|NCT02048358|Hormones|hormones|mesh-ancestor
139256395|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256396|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139256397|NCT02048358|Protective Agents|protective agents|mesh-ancestor
139256398|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139256399|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256400|NCT02928029|Dexamethasone|dexamethasone|mesh-list
139256401|NCT02928029|Bortezomib|bortezomib|mesh-list
139256402|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139256403|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139256404|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
139256405|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
139256406|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256407|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256408|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139256409|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
139256410|NCT02928029|Hormones|hormones|mesh-ancestor
139256411|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256412|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139256413|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256414|NCT02050074|Metformin|metformin|mesh-list
139256415|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139256416|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139380802|NCT03510468|Vitamins|vitamins|mesh-ancestor
139256417|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256418|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139256419|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139256420|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
139256421|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256422|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139256423|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
139256424|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139256425|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
139256426|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
139256427|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139256428|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256429|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139256430|NCT02050152|Analgesics|analgesics|mesh-ancestor
139256431|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
139256432|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256433|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
139256434|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
139256435|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139256436|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139256437|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
139642272|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256438|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256439|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
139256440|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139256441|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256442|NCT04717193|Epinephrine|epinephrine|mesh-list
139256443|NCT04717193|Racepinephrine|racepinephrine|mesh-list
139256444|NCT04717193|Bupivacaine|bupivacaine|mesh-list
139256445|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
139256446|NCT04717193|Anesthetics|anesthetics|mesh-list
139256447|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
139256448|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139256449|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256450|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
139256451|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256452|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139256453|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139256454|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
139256455|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256456|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256457|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139256458|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139256459|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
139256460|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139256461|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
139256462|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
139256463|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
139256464|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139256465|NCT05212025|Gemcitabine|gemcitabine|mesh-list
139256466|NCT05212025|Adavosertib|adavosertib|mesh-list
139256467|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139256468|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
139256469|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256470|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256471|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256472|NCT02051868|Paclitaxel|paclitaxel|mesh-list
139256473|NCT02051868|Carboplatin|carboplatin|mesh-list
139256474|NCT02051868|Fluorouracil|fluorouracil|mesh-list
139256475|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139256476|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256477|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
139256478|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
139256480|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256481|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
139256482|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139256483|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139256484|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
139256485|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256486|NCT04696757|Capecitabine|capecitabine|mesh-list
139256487|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139256488|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
139256489|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256490|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256491|NCT02049294|Omalizumab|omalizumab|mesh-list
139256492|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139256493|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139256494|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
139256495|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
139256496|NCT02051946|Diuretics|diuretics|mesh-ancestor
139256497|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
139256498|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256499|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256500|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256501|NCT02049606|Nabumetone|nabumetone|mesh-list
139256502|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139256503|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139256504|NCT02049606|Analgesics|analgesics|mesh-ancestor
139256505|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
139256506|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256507|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256508|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139256509|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139256510|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139256511|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139256512|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256513|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256514|NCT02037516|Neostigmine|neostigmine|mesh-list
139256515|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139256516|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256517|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256518|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
139256519|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256520|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256521|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139256522|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
139256523|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256524|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
139256525|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
139256526|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139256527|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139380848|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
139256528|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139256529|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139256530|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256531|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
139256532|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256533|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256534|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139256535|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256536|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139256537|NCT02037672|Metformin|metformin|mesh-list
139256538|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139256539|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256540|NCT02049762|Aspirin|aspirin|mesh-list
139256541|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139256542|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139256543|NCT02049762|Analgesics|analgesics|mesh-ancestor
139256544|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
139256545|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256546|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256547|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139256548|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139256549|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139256550|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138839898|NCT02847104|Insulin|insulin|mesh-list
139091681|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139256551|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256552|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139256553|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139256554|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256555|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
139256556|NCT03561558|Ibuprofen|ibuprofen|mesh-list
139256557|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139256558|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139256559|NCT03561558|Analgesics|analgesics|mesh-ancestor
139256560|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
139256561|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256562|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256563|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139256564|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139256565|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139256566|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256567|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256568|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
139256569|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139256570|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256571|NCT03099161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139256572|NCT03099161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256573|NCT04639115|Ozanimod|ozanimod|mesh-list
139256574|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139256575|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256576|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139256577|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
139256578|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256579|NCT04260659|Lidocaine|lidocaine|mesh-list
139256580|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
139256581|NCT04260659|Fentanyl|fentanyl|mesh-list
139256582|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
139256583|NCT04260659|Ketamine|ketamine|mesh-list
139256584|NCT04260659|Remifentanil|remifentanil|mesh-list
139380864|NCT02955082|Carboplatin|carboplatin|mesh-list
139380865|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380866|NCT02947750|Folic Acid|folic acid|mesh-list
139380867|NCT02947750|Hematinics|hematinics|mesh-ancestor
139380868|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
139380869|NCT02947750|Vitamins|vitamins|mesh-ancestor
139380870|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
139380871|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380872|NCT02891603|Sirolimus|sirolimus|mesh-list
139256585|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
139256586|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
139642273|NCT03058536|Progesterone|progesterone|mesh-list
139126755|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
139256587|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139256588|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256589|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
139256590|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256591|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139256592|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139256593|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139256594|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139256595|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256596|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139256597|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139256598|NCT04260659|Analgesics|analgesics|mesh-ancestor
139256599|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139256600|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139256601|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139256602|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
139256603|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256604|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139256605|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139256606|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
139256607|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139256608|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139256609|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139256610|NCT04260659|Narcotics|narcotics|mesh-ancestor
139256611|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139256612|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
139256613|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139256614|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139256615|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
139256616|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139256617|NCT05068661|Fentanyl|fentanyl|mesh-list
139256618|NCT05068661|Bupivacaine|bupivacaine|mesh-list
139256619|NCT05068661|Ropivacaine|ropivacaine|mesh-list
139256620|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139256621|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
139256622|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
139256623|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138839975|NCT00623779|Analgesics|analgesics|mesh-ancestor
139256624|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256625|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
139256626|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256628|NCT05068661|Narcotics|narcotics|mesh-ancestor
139256629|NCT05068661|Analgesics|analgesics|mesh-ancestor
139256630|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139256631|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139256632|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
139256633|NCT04148495|Acetaminophen|acetaminophen|mesh-list
139256634|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139256635|NCT04148495|Analgesics|analgesics|mesh-ancestor
139256636|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
139256637|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256638|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256639|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
139256640|NCT05060003|Atezolizumab|atezolizumab|mesh-list
139256641|NCT05060003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139256642|NCT05060003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256643|NCT05060003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139256644|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256645|NCT05051189|Fentanyl|fentanyl|mesh-list
139256646|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139256647|NCT05051189|Narcotics|narcotics|mesh-ancestor
139256648|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139256649|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256650|NCT05051189|Analgesics|analgesics|mesh-ancestor
139256651|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
139256652|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256653|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139256654|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139256655|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
139256656|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
139256657|NCT04172597|Loperamide|loperamide|mesh-list
139256658|NCT04172597|Antidiarrheals|antidiarrheals|mesh-list
139256659|NCT04172597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139256660|NCT00446225|Carboplatin|carboplatin|mesh-list
139256661|NCT00446225|Docetaxel|docetaxel|mesh-list
139642274|NCT03058536|Progestins|progestins|mesh-ancestor
139091715|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139256662|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139256664|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256665|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
139256666|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
139256667|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
139256668|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256669|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139256670|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256671|NCT00446225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139256672|NCT00446225|Antimetabolites|antimetabolites|mesh-ancestor
139256673|NCT03080935|Evolocumab|evolocumab|mesh-list
139256674|NCT03080935|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139256675|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139256676|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139256677|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
139256678|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256679|NCT03080935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139256680|NCT03080935|Protease Inhibitors|protease inhibitors|mesh-ancestor
139256681|NCT03080935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256682|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139256683|NCT04479449|Otaplimastat|otaplimastat|mesh-list
139256684|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139256685|NCT04479449|Protective Agents|protective agents|mesh-ancestor
139256686|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256687|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
139256688|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139256689|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256690|NCT03674567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139256691|NCT03674567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256692|NCT04986605|Methoxsalen|methoxsalen|mesh-list
139256693|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139256694|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
139256695|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
139256696|NCT01383655|Analgesics|analgesics|mesh-ancestor
139256697|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
139256698|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256699|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256700|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
139380897|NCT02839915|Folic Acid|folic acid|mesh-list
139256701|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139256702|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139256703|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
139256704|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139256705|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139256706|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256707|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139256708|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
139256709|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139256711|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139256712|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256713|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139256714|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139256715|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256716|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256717|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139256718|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
139256719|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256720|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256721|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
139256722|NCT02921789|Prednisone|prednisone|mesh-list
139256723|NCT02921789|Tacrolimus|tacrolimus|mesh-list
139256724|NCT02921789|Basiliximab|basiliximab|mesh-list
139256725|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139256726|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
139256727|NCT02921789|Hormones|hormones|mesh-ancestor
139256728|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256729|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256730|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139256731|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256732|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139256733|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
139256734|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139642275|NCT03058536|Hormones|hormones|mesh-ancestor
139256735|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256736|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256737|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139256738|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139256739|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
139256740|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139256741|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139256742|NCT01568333|Decitabine|decitabine|mesh-list
139256743|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139256744|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
139256745|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256746|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256747|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256748|NCT03437005|Ketoconazole|ketoconazole|mesh-list
139256749|NCT03437005|Desonide|desonide|mesh-list
139256750|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
139256751|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139256752|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139256753|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139256754|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380909|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139256755|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256756|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139256757|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
139256758|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256759|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256760|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139256761|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139256762|NCT03943823|Estrogens|estrogens|mesh-list
139256763|NCT03943823|Hormones|hormones|mesh-ancestor
139256764|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256765|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256766|NCT02419742|Paclitaxel|paclitaxel|mesh-list
139256767|NCT02419742|Docetaxel|docetaxel|mesh-list
139256768|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
139256769|NCT02419742|Carboplatin|carboplatin|mesh-list
139256770|NCT02419742|Doxorubicin|doxorubicin|mesh-list
139256771|NCT02419742|Trastuzumab|trastuzumab|mesh-list
139256772|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139256773|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256775|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
139256776|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
139256777|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256778|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139256779|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
139256780|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256781|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139256782|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139256783|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
139256784|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139256785|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139256786|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139256787|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139256788|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256789|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139256790|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
139256791|NCT02409290|Levofloxacin|levofloxacin|mesh-list
139256792|NCT02409290|Isoniazid|isoniazid|mesh-list
139256793|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
139256794|NCT02409290|Ethambutol|ethambutol|mesh-list
139256795|NCT02409290|Bedaquiline|bedaquiline|mesh-list
139256796|NCT02409290|Clofazimine|clofazimine|mesh-list
139256797|NCT02409290|Kanamycin|kanamycin|mesh-list
139256798|NCT02409290|Prothionamide|prothionamide|mesh-list
139256799|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139256800|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139256801|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139256802|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139256803|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256804|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256805|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256806|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139256807|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139256808|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139256809|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
139256810|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139256812|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
139256813|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139256814|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139256815|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
139256816|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139256817|NCT02898077|Paclitaxel|paclitaxel|mesh-list
139256818|NCT02898077|Ramucirumab|ramucirumab|mesh-list
139256819|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139256820|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256821|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
139256822|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
139256823|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
139256824|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256825|NCT02145884|Timolol|timolol|mesh-list
139256826|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256827|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139256828|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139256829|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
139256830|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256831|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256832|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139256833|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139256834|NCT03544814|Cisplatin|cisplatin|mesh-list
139256835|NCT03544814|Pemetrexed|pemetrexed|mesh-list
139256836|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256837|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256838|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256839|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139256840|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139256841|NCT03097133|Esketamine|esketamine|mesh-list
139256842|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
139256843|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139256844|NCT02148380|Carboplatin|carboplatin|mesh-list
139256845|NCT02148380|Pemetrexed|pemetrexed|mesh-list
139256846|NCT02148380|Gefitinib|gefitinib|mesh-list
139256847|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256848|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091682|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256849|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256850|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139256851|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139256852|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139256853|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139256854|NCT02146118|Silybin|silybin|mesh-list
139256855|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256856|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139256857|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256858|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256859|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139256860|NCT02146118|Protective Agents|protective agents|mesh-ancestor
139256861|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256862|NCT02142140|Methylphenidate|methylphenidate|mesh-list
139256863|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139256864|NCT02142140|Adderall|adderall|mesh-list
139256865|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
139256866|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
139256867|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139256868|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256869|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139256870|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139256871|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139256872|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256873|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
139256874|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256875|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139256876|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
139256877|NCT02142218|Nivolumab|nivolumab|mesh-list
139256878|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139256879|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256880|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139256881|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256882|NCT02142296|Aflibercept|aflibercept|mesh-list
139256883|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139256884|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139256885|NCT02142296|Growth Substances|growth substances|mesh-ancestor
139256886|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256887|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
139256888|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256889|NCT02142530|Belinostat|belinostat|mesh-list
139256890|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256891|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139256892|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256893|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256894|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
139256895|NCT01383343|Leucovorin|leucovorin|mesh-list
139256896|NCT01383343|Folic Acid|folic acid|mesh-list
139256897|NCT01383343|Bevacizumab|bevacizumab|mesh-list
139256898|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139256899|NCT01383343|Fluorouracil|fluorouracil|mesh-list
139256900|NCT01383343|Irinotecan|irinotecan|mesh-list
139256901|NCT01383343|Sorafenib|sorafenib|mesh-list
139256902|NCT01383343|Camptothecin|camptothecin|mesh-list
139256903|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
139256904|NCT01383343|Antibodies|antibodies|mesh-list
139256905|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
139256906|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139256907|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
139256908|NCT01383343|Calcium|calcium|mesh-list
139256909|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
139256910|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256911|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139256912|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139256913|NCT01383343|Growth Substances|growth substances|mesh-ancestor
139256914|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256915|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
139256916|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
139256917|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139256918|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139256919|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
139256920|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256921|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139256922|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139091683|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139256923|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139256924|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139256925|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139256926|NCT01383343|Antidotes|antidotes|mesh-ancestor
139256927|NCT01383343|Protective Agents|protective agents|mesh-ancestor
139256928|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
139256929|NCT01383343|Vitamins|vitamins|mesh-ancestor
139256930|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
139256931|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139256932|NCT01383343|Hematinics|hematinics|mesh-ancestor
139256933|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139256934|NCT03631147|Rifaximin|rifaximin|mesh-list
139256935|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139256936|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139256937|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139256938|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
139256939|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139256940|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139256941|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256942|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139256943|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256944|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139256945|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
139256946|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
139256947|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256948|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256949|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256950|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139256951|NCT05344495|Midazolam|midazolam|mesh-list
139256952|NCT05344495|Bupivacaine|bupivacaine|mesh-list
139256953|NCT05344495|Anesthetics, Local|anesthetics, local|mesh-ancestor
139256954|NCT05344495|Anesthetics|anesthetics|mesh-ancestor
139256955|NCT05344495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139256956|NCT05344495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256957|NCT05344495|Sensory System Agents|sensory system agents|mesh-ancestor
139256958|NCT05344495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139256959|NCT05344495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139256960|NCT05344495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139256961|NCT05344495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139256962|NCT05344495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139256963|NCT05344495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139256964|NCT05344495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139256965|NCT05344495|Anesthetics, General|anesthetics, general|mesh-ancestor
139256966|NCT05344495|GABA Modulators|gaba modulators|mesh-ancestor
139256967|NCT05344495|GABA Agents|gaba agents|mesh-ancestor
139256968|NCT05344495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139256969|NCT05344495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256970|NCT01593241|Carboplatin|carboplatin|mesh-list
139256971|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139256972|NCT05960565|Glucagon|glucagon|mesh-list
139256973|NCT05960565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139256974|NCT05960565|Hormones|hormones|mesh-ancestor
139256975|NCT05960565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256976|NCT05960565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256977|NCT05960227|Dextrans|dextrans|mesh-list
139256978|NCT05960227|Iron-Dextran Complex|iron-dextran complex|mesh-list
139256979|NCT05960227|Anticoagulants|anticoagulants|mesh-ancestor
139256980|NCT05960227|Plasma Substitutes|plasma substitutes|mesh-ancestor
139256981|NCT05960227|Blood Substitutes|blood substitutes|mesh-ancestor
139256982|NCT05960227|Hematinics|hematinics|mesh-ancestor
139256983|NCT05960110|Fluorides|fluorides|mesh-list
139256984|NCT05960110|Fluorides, Topical|fluorides, topical|mesh-list
139256985|NCT05960110|Cariostatic Agents|cariostatic agents|mesh-ancestor
139256986|NCT05960110|Protective Agents|protective agents|mesh-ancestor
139256987|NCT05960110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256988|NCT05959889|Montelukast|montelukast|mesh-list
139256989|NCT05959889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139256990|NCT05959889|Respiratory System Agents|respiratory system agents|mesh-ancestor
139256991|NCT05959889|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139256992|NCT05959889|Hormone Antagonists|hormone antagonists|mesh-ancestor
139256993|NCT05959889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139256994|NCT05959889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139256995|NCT05959889|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139256996|NCT05959889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139256997|NCT05959889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139256998|NCT05959863|Captopril|captopril|mesh-list
139256999|NCT05959863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139257000|NCT05959863|Protease Inhibitors|protease inhibitors|mesh-ancestor
139257001|NCT05959863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257002|NCT05959863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257003|NCT05959863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139257004|NCT05959759|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139257005|NCT05959759|Dermatologic Agents|dermatologic agents|mesh-ancestor
139257006|NCT05959759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139257007|NCT05959759|Immunologic Factors|immunologic factors|mesh-ancestor
139257008|NCT05959759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257009|NCT05959616|Ciprofloxacin|ciprofloxacin|mesh-list
139257010|NCT05959616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139257011|NCT05959616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257012|NCT05959616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139381037|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139257013|NCT05959616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139257014|NCT05959616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257015|NCT05959616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257016|NCT05959616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257017|NCT05959616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139257018|NCT05959616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139257019|NCT05959603|Vancomycin|vancomycin|mesh-list
139257020|NCT05959603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139257021|NCT05959603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257022|NCT05959447|Dabigatran|dabigatran|mesh-list
139257023|NCT05959447|Gemfibrozil|gemfibrozil|mesh-list
139257024|NCT05959447|Antithrombins|antithrombins|mesh-ancestor
139257025|NCT05959447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139257026|NCT05959447|Protease Inhibitors|protease inhibitors|mesh-ancestor
139257027|NCT05959447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257028|NCT05959447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257029|NCT05959447|Anticoagulants|anticoagulants|mesh-ancestor
139257030|NCT05959447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139257031|NCT05959447|Antimetabolites|antimetabolites|mesh-ancestor
139257032|NCT05959447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139257033|NCT05959447|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139257034|NCT05959447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139257035|NCT05958914|Calcitonin|calcitonin|mesh-list
139257036|NCT05958914|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139257037|NCT05958914|Katacalcin|katacalcin|mesh-list
139257038|NCT05958914|Enkephalins|enkephalins|mesh-list
139257039|NCT05958914|Vasodilator Agents|vasodilator agents|mesh-ancestor
139257040|NCT05958914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139257041|NCT05958914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257042|NCT05958914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139257043|NCT05958914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139257044|NCT05958914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257045|NCT05958810|Lumefantrine|lumefantrine|mesh-list
139257046|NCT05958810|Artemether|artemether|mesh-list
139257047|NCT05958810|Primaquine|primaquine|mesh-list
139257048|NCT05958810|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139257049|NCT05958810|Antimalarials|antimalarials|mesh-ancestor
139257050|NCT05958810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139257051|NCT05958810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139257052|NCT05958810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257053|NCT05958797|Chloroquine|chloroquine|mesh-list
139257054|NCT05958797|Primaquine|primaquine|mesh-list
139257055|NCT05958797|Amebicides|amebicides|mesh-ancestor
139257056|NCT05958797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139257057|NCT05958797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139257058|NCT05958797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257059|NCT05958797|Antimalarials|antimalarials|mesh-ancestor
139257060|NCT05958797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139257061|NCT05958758|Psilocybin|psilocybin|mesh-list
139257062|NCT05958758|Hallucinogens|hallucinogens|mesh-ancestor
139257063|NCT05958758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257064|NCT05958758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139257065|NCT05958719|Azacitidine|azacitidine|mesh-list
139257066|NCT05958719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139257067|NCT05958719|Antimetabolites|antimetabolites|mesh-ancestor
139257068|NCT05958719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257069|NCT05958719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257070|NCT05958719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257071|NCT05958290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139257072|NCT05958290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257073|NCT05955885|Flurbiprofen|flurbiprofen|mesh-list
139257074|NCT05955885|Benzydamine|benzydamine|mesh-list
139257075|NCT05955885|Analgesics|analgesics|mesh-ancestor
139257076|NCT05955885|Sensory System Agents|sensory system agents|mesh-ancestor
139257077|NCT05955885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257078|NCT05955885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257079|NCT05955885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139257080|NCT05955885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139257081|NCT05955885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139257082|NCT05955885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139257083|NCT05955885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139257084|NCT05955885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257085|NCT05955885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257087|NCT05952752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139257088|NCT05952752|Antiemetics|antiemetics|mesh-ancestor
139257089|NCT05952752|Autonomic Agents|autonomic agents|mesh-ancestor
139257090|NCT05952752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257091|NCT05952752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257092|NCT05952752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139257093|NCT05952752|Glucocorticoids|glucocorticoids|mesh-ancestor
139257094|NCT05952752|Hormones|hormones|mesh-ancestor
139257095|NCT05952752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257096|NCT05952752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139257097|NCT05952752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257098|NCT05949125|Cyclophosphamide|cyclophosphamide|mesh-list
139257099|NCT05949125|Fludarabine|fludarabine|mesh-list
139257100|NCT05949125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139257101|NCT05949125|Immunologic Factors|immunologic factors|mesh-ancestor
139257102|NCT05949125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257103|NCT05949125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139257104|NCT05949125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139257105|NCT05949125|Alkylating Agents|alkylating agents|mesh-ancestor
139257106|NCT05949125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257107|NCT05949125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257108|NCT05949125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139257109|NCT05914857|Dapagliflozin|dapagliflozin|mesh-list
139257110|NCT05914857|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139257111|NCT05914857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257112|NCT05914857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139257113|NCT05914857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257114|NCT05909696|Rocuronium|rocuronium|mesh-list
139257115|NCT05909696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139257116|NCT05909696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139257117|NCT05909696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139257118|NCT05909696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257119|NCT05909696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257120|NCT05908331|Sirolimus|sirolimus|mesh-list
139257121|NCT05908331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139257122|NCT05908331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257123|NCT05908331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139257124|NCT05908331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257125|NCT05908331|Antifungal Agents|antifungal agents|mesh-ancestor
139257126|NCT05908331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139257127|NCT05908331|Immunologic Factors|immunologic factors|mesh-ancestor
139257128|NCT05908331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257129|NCT05907811|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
139257130|NCT05907811|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139257131|NCT05907811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381058|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139257132|NCT05907811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257133|NCT05903352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139257134|NCT05903352|Anti-Infective Agents|anti-infective agents|mesh-list
139257135|NCT05902780|Dexmedetomidine|dexmedetomidine|mesh-list
139257136|NCT05902780|Bupivacaine|bupivacaine|mesh-list
139257137|NCT05902780|Anesthetics, Local|anesthetics, local|mesh-ancestor
139257138|NCT05902780|Anesthetics|anesthetics|mesh-ancestor
139257139|NCT05902780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257140|NCT05902780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257141|NCT05902780|Sensory System Agents|sensory system agents|mesh-ancestor
139257142|NCT05902780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257143|NCT05902780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139257144|NCT05902780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139257145|NCT05902780|Analgesics|analgesics|mesh-ancestor
139257146|NCT05902780|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139257147|NCT05902780|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139257148|NCT05902780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139257149|NCT05902780|Adrenergic Agents|adrenergic agents|mesh-ancestor
139257150|NCT05902780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139257151|NCT05902780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257152|NCT05901350|Levodopa|levodopa|mesh-list
139257153|NCT05901350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139257154|NCT05901350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139257155|NCT05901350|Dopamine Agents|dopamine agents|mesh-ancestor
139257156|NCT05901350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139257157|NCT05901350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257158|NCT05901350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257159|NCT05894018|Fluzoparib|fluzoparib|mesh-list
139257160|NCT05894018|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139257161|NCT05894018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257162|NCT05894018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257163|NCT05894018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257164|NCT05822440|Itraconazole|itraconazole|mesh-list
139257165|NCT05822440|Antifungal Agents|antifungal agents|mesh-ancestor
139257166|NCT05822440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257167|NCT05822440|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139257168|NCT05822440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139257169|NCT05822440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257170|NCT05822440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257171|NCT05822440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139257172|NCT05822440|Hormone Antagonists|hormone antagonists|mesh-ancestor
139257173|NCT05822440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257174|NCT05822440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257175|NCT05822440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139257176|NCT05805839|Corticosterone|corticosterone|mesh-list
139257177|NCT05805839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139257178|NCT05790252|Buprenorphine|buprenorphine|mesh-list
139257179|NCT05790252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139257180|NCT05790252|Narcotics|narcotics|mesh-ancestor
139257181|NCT05790252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257182|NCT05790252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257183|NCT05790252|Analgesics|analgesics|mesh-ancestor
139257184|NCT05790252|Sensory System Agents|sensory system agents|mesh-ancestor
139257185|NCT05790252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257186|NCT05790252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139257188|NCT05757999|Analgesics|analgesics|mesh-ancestor
139257189|NCT05757999|Sensory System Agents|sensory system agents|mesh-ancestor
139257190|NCT05757999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257191|NCT05757999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257192|NCT05757999|Anesthetics|anesthetics|mesh-ancestor
139257193|NCT05757999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257194|NCT05757999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139257195|NCT05757999|Anticonvulsants|anticonvulsants|mesh-ancestor
139257196|NCT05757999|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139257197|NCT05757999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139257198|NCT05757999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257199|NCT05757999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139257200|NCT05757999|Tocolytic Agents|tocolytic agents|mesh-ancestor
139257201|NCT05757999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139257202|NCT05729646|Oxaliplatin|oxaliplatin|mesh-list
139257203|NCT05729646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257204|NCT05557136|Ether|ether|mesh-list
139257205|NCT05557136|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139257206|NCT05557136|Anesthetics, General|anesthetics, general|mesh-ancestor
139257207|NCT05557136|Anesthetics|anesthetics|mesh-ancestor
139257208|NCT05557136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257209|NCT05557136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257210|NCT05502081|Remdesivir|remdesivir|mesh-list
139257211|NCT05502081|Favipiravir|favipiravir|mesh-list
139257212|NCT05502081|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
139257213|NCT05502081|Antimetabolites|antimetabolites|mesh-ancestor
139257214|NCT05502081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257215|NCT05502081|Antiviral Agents|antiviral agents|mesh-ancestor
139257216|NCT05502081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257217|NCT05494385|Gabapentin|gabapentin|mesh-list
139257218|NCT05494385|Analgesics|analgesics|mesh-ancestor
139257219|NCT05494385|Sensory System Agents|sensory system agents|mesh-ancestor
139257220|NCT05494385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257221|NCT05494385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257222|NCT05494385|Anticonvulsants|anticonvulsants|mesh-ancestor
139091684|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139257224|NCT05494385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139257225|NCT05494385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257226|NCT05494385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139257227|NCT05494385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139257228|NCT05494385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139257229|NCT05494385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139257230|NCT05494385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257231|NCT05494385|Antimanic Agents|antimanic agents|mesh-ancestor
139257232|NCT05455294|Decitabine|decitabine|mesh-list
139257233|NCT05455294|Venetoclax|venetoclax|mesh-list
139257234|NCT05455294|Navitoclax|navitoclax|mesh-list
139257235|NCT05455294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139257236|NCT05455294|Antimetabolites|antimetabolites|mesh-ancestor
139257237|NCT05455294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257238|NCT05455294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257239|NCT05455294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257240|NCT05437796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139257241|NCT05437796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257242|NCT05437796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257243|NCT05396014|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139257244|NCT05396014|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139257245|NCT05396014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139257246|NCT05396014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139257247|NCT05396014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257248|NCT05396014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139257249|NCT05396014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257250|NCT05396014|Analgesics|analgesics|mesh-ancestor
139257251|NCT05396014|Sensory System Agents|sensory system agents|mesh-ancestor
139257252|NCT05396014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257253|NCT05396014|Antidepressive Agents|antidepressive agents|mesh-ancestor
139257254|NCT05396014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139257255|NCT05396014|Dopamine Agents|dopamine agents|mesh-ancestor
139257256|NCT05263557|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139257257|NCT05263557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139257258|NCT05263557|Immunologic Factors|immunologic factors|mesh-ancestor
139257259|NCT05263557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257260|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139257261|NCT05201300|Propofol|propofol|mesh-list
139257262|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139257263|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257264|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257265|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139257266|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
139257267|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
139257268|NCT05119439|Misoprostol|misoprostol|mesh-list
139257269|NCT05119439|Mifepristone|mifepristone|mesh-list
139257270|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139257271|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
139257272|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139257273|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257274|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139257275|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139257276|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
139257277|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139257278|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139257279|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139257280|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139257281|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
139257282|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139257283|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139257284|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
139257285|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257286|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
139257287|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139257288|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139257289|NCT05020392|Vidarabine|vidarabine|mesh-list
139257290|NCT05020392|Fludarabine|fludarabine|mesh-list
139257291|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
139257292|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257293|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139257294|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
139257295|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257296|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139257297|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
139257298|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257299|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
139257300|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257301|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139257302|NCT04992468|Hormones|hormones|mesh-ancestor
139257303|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257304|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257305|NCT04975100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139257306|NCT04975100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139257307|NCT04975100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139257308|NCT04975100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257309|NCT04975100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139257310|NCT04975100|Serotonin Agents|serotonin agents|mesh-ancestor
139257311|NCT04975100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257312|NCT04970342|Alprazolam|alprazolam|mesh-list
139257313|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257314|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139257315|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139257316|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257317|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139257318|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257319|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139257320|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139257321|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
139257322|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
139257323|NCT04959981|Osimertinib|osimertinib|mesh-list
139257324|NCT04959981|Sotorasib|sotorasib|mesh-list
139257325|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257326|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139257327|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257328|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257329|NCT04959981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139257330|NCT04959981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139257332|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139257333|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139257334|NCT04901377|Estradiol|estradiol|mesh-list
139257335|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139257336|NCT04901377|Estrogens|estrogens|mesh-ancestor
139257337|NCT04901377|Hormones|hormones|mesh-ancestor
139257338|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257339|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257340|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139257341|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
139257342|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139257343|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139257344|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139257345|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139257346|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139257347|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
139257348|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139257349|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257350|NCT04795245|Afatinib|afatinib|mesh-list
139257351|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257352|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139257353|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257354|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257355|NCT04742101|Azacitidine|azacitidine|mesh-list
139257356|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139257357|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
139257358|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257359|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257360|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257361|NCT04738422|Glycine|glycine|mesh-list
139257362|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
139257363|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139257364|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257365|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257366|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
139257367|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
139257368|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257369|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
139257370|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139257371|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257373|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139257374|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
139257375|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
139257376|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257377|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257378|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139257379|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
139257380|NCT04654507|Hormones|hormones|mesh-ancestor
139257381|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257382|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139257383|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257384|NCT04646655|Enoxaparin|enoxaparin|mesh-list
139257385|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
139257386|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139257387|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139257388|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257389|NCT04629443|Azacitidine|azacitidine|mesh-list
139257390|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139257391|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
139257392|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257393|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257394|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257395|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
139257396|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139257397|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
139257398|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257399|NCT04627922|Expectorants|expectorants|mesh-ancestor
139257400|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
139257401|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139257402|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
139257403|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257404|NCT04627922|Protective Agents|protective agents|mesh-ancestor
139257405|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257406|NCT04627922|Antidotes|antidotes|mesh-ancestor
139257407|NCT04577716|Listerine|listerine|mesh-list
139257408|NCT04577716|Fluorides|fluorides|mesh-list
139257409|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
139257410|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
139257411|NCT04577716|Protective Agents|protective agents|mesh-ancestor
139257412|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257413|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139257414|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257415|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
139257416|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139257417|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257418|NCT04521413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139257419|NCT04521413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257420|NCT04516057|Nabilone|nabilone|mesh-list
139257421|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
139257422|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
139257423|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257424|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257425|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139257426|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139257427|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139257428|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257429|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139257430|NCT04424641|Antibodies|antibodies|mesh-list
139257431|NCT04424641|Immunoglobulins|immunoglobulins|mesh-list
139257432|NCT04424641|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139257433|NCT04424641|Immunoglobulin G|immunoglobulin g|mesh-list
139257434|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139257435|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
139257436|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257437|NCT04393103|Atropine|atropine|mesh-list
139257438|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139257439|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139257440|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139257441|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139257442|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
139257443|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257444|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257445|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139257446|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
139257447|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
139257448|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
139257449|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139257450|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139257451|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
139257452|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139257453|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257454|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139257455|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139257456|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139257457|NCT04334629|Ibuprofen|ibuprofen|mesh-list
139257458|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139257459|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139257460|NCT04334629|Analgesics|analgesics|mesh-ancestor
139257461|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
139257462|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257463|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257464|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139257465|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139257466|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139257467|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257468|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257469|NCT04296890|Maytansine|maytansine|mesh-list
139257470|NCT04296890|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139257471|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139257472|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257473|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
139257474|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
139257475|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
139257476|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257477|NCT04296890|Immunoconjugates|immunoconjugates|mesh-ancestor
139257478|NCT04296890|Immunologic Factors|immunologic factors|mesh-ancestor
139257479|NCT04296890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257480|NCT04276090|Dexamethasone|dexamethasone|mesh-list
139257481|NCT04276090|Floxuridine|floxuridine|mesh-list
139257482|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139257483|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
139257484|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
139257485|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257486|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257487|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139257488|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
139257489|NCT04276090|Hormones|hormones|mesh-ancestor
139257490|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257491|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139257492|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257493|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139257494|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
139257495|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257496|NCT04273139|Venetoclax|venetoclax|mesh-list
139257497|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257498|NCT04081688|Atezolizumab|atezolizumab|mesh-list
139257499|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139257500|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
139257501|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
139257502|NCT04081688|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139257503|NCT04081688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257504|NCT04081688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139257505|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257506|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
139257507|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257508|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
139257509|NCT04064814|Flunarizine|flunarizine|mesh-list
139257510|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
139257511|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257512|NCT04064814|Protective Agents|protective agents|mesh-ancestor
139257513|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257514|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
139257515|NCT04064814|Vitamins|vitamins|mesh-ancestor
139257516|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
139257517|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
139091685|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
139257518|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139257519|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139257520|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139257521|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139257522|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
139257523|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
139257524|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139257525|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
139257526|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
139257527|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139257528|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257529|NCT03846388|Hormones|hormones|mesh-list
139257530|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139257531|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257532|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257533|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139257534|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139257535|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257536|NCT03675815|Ritonavir|ritonavir|mesh-list
139257537|NCT03675815|Darunavir|darunavir|mesh-list
139257538|NCT03675815|Tenofovir|tenofovir|mesh-list
139257539|NCT03675815|Lamivudine|lamivudine|mesh-list
139257540|NCT03675815|Emtricitabine|emtricitabine|mesh-list
139257541|NCT03675815|Dolutegravir|dolutegravir|mesh-list
139257542|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139257543|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139257544|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139257545|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
139257546|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257547|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257548|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139257549|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139257550|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
139257551|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257552|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139257553|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139257554|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139257555|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139257556|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139257557|NCT03672695|Venetoclax|venetoclax|mesh-list
139257558|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257559|NCT03669133|Vitamin E|vitamin e|mesh-list
139257560|NCT03669133|Vitamins|vitamins|mesh-ancestor
139257561|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
139257562|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257563|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
139257564|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257565|NCT03669133|Protective Agents|protective agents|mesh-ancestor
139257566|NCT03647969|Nivolumab|nivolumab|mesh-list
139257567|NCT03647969|Ipilimumab|ipilimumab|mesh-list
139257568|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139257569|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257570|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139257571|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257572|NCT03644186|Paclitaxel|paclitaxel|mesh-list
139257573|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139257574|NCT03644186|Trastuzumab|trastuzumab|mesh-list
139257575|NCT03644186|Letrozole|letrozole|mesh-list
139257576|NCT03644186|Palbociclib|palbociclib|mesh-list
139257577|NCT03644186|Pertuzumab|pertuzumab|mesh-list
139257578|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139257579|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257580|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
139257581|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
139257582|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
139257583|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257584|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139257585|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139257586|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139257587|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257588|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139257589|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
139257590|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257591|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840947|NCT05660135|Amlodipine|amlodipine|mesh-list
139257592|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139257594|NCT03593759|Prednisolone|prednisolone|mesh-list
139257595|NCT03593759|Methotrexate|methotrexate|mesh-list
139257596|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139257597|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
139257598|NCT03593759|Hormones|hormones|mesh-ancestor
139257599|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257600|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257601|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139257602|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257603|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139257604|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
139257605|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139257606|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139257607|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
139257608|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257609|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
139257610|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257611|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139257612|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139257613|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
139257614|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139257615|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139257616|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139257617|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
139257618|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139257619|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257620|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257621|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139257622|NCT03457701|Iron|iron|mesh-list
139257623|NCT03457701|Trace Elements|trace elements|mesh-ancestor
139257624|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
139257625|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257626|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
139257627|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139257628|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257629|NCT03347292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139257633|NCT03182426|Etanercept|etanercept|mesh-list
139257634|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
139257635|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139257636|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139257637|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257638|NCT03182426|Incretins|incretins|mesh-ancestor
139257639|NCT03182426|Hormones|hormones|mesh-ancestor
139257640|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257641|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139257642|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139257643|NCT03182426|Analgesics|analgesics|mesh-ancestor
139257644|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
139257645|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257646|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139257647|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139257648|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139257649|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139381311|NCT04847024|Parecoxib|parecoxib|mesh-list
139257650|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
139257651|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139257652|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257653|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139257654|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139257655|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
139257656|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257657|NCT03078946|Midazolam|midazolam|mesh-list
139257658|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
139257659|NCT03078946|Morphine|morphine|mesh-list
139257660|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139257661|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257662|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257663|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139257664|NCT03078946|Analgesics|analgesics|mesh-ancestor
139257665|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
139257666|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257667|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139257668|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139257669|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139257670|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
139257671|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139257672|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257673|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139257674|NCT03078946|Narcotics|narcotics|mesh-ancestor
139257675|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139257676|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139257677|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139257678|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139257679|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139257680|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
139257681|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
139257682|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
139257683|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
139257684|NCT02974621|Bevacizumab|bevacizumab|mesh-list
139257685|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139257687|NCT02974621|Cediranib|cediranib|mesh-list
139257688|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
139257689|NCT02974621|Antibodies|antibodies|mesh-list
139257690|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
139257691|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139257692|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
139257693|NCT02974621|Maleic acid|maleic acid|mesh-list
139257694|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257695|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139257696|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139257697|NCT02974621|Growth Substances|growth substances|mesh-ancestor
139257698|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257699|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
139257700|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
139257701|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257702|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139257703|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257704|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139257712|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257713|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139257715|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139257716|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139257717|NCT02663518|Rituximab|rituximab|mesh-list
139257718|NCT02663518|Nivolumab|nivolumab|mesh-list
139257719|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
139257720|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139257721|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257722|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
139257723|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257724|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139257725|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139257726|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257727|NCT02563002|Bevacizumab|bevacizumab|mesh-list
139257728|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
139257729|NCT02563002|Cetuximab|cetuximab|mesh-list
139257730|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139257731|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257732|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139257733|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139257734|NCT02563002|Growth Substances|growth substances|mesh-ancestor
139257735|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257736|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
139257737|NCT02563002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139257738|NCT02563002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257739|NCT02454933|Durvalumab|durvalumab|mesh-list
139257740|NCT02454933|Osimertinib|osimertinib|mesh-list
138841099|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139257741|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139257742|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257743|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139257744|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257745|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257746|NCT02430480|Goserelin|goserelin|mesh-list
139257747|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139257748|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257749|NCT02207439|Nelfinavir|nelfinavir|mesh-list
139257750|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139257751|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139257752|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
139257753|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257754|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257755|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139257756|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139257757|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
139257758|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257759|NCT01796197|Paclitaxel|paclitaxel|mesh-list
139257760|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
139257761|NCT01796197|Doxorubicin|doxorubicin|mesh-list
139257762|NCT01796197|Trastuzumab|trastuzumab|mesh-list
139257763|NCT01796197|Pertuzumab|pertuzumab|mesh-list
139257764|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139257765|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257766|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
139257767|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
139257768|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
139257769|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257770|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139257771|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
139257772|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257773|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139257774|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139257775|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
139257776|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139257777|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139257778|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139257779|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139257780|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257781|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139257782|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
139257783|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139257784|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257785|NCT01205048|Lidocaine|lidocaine|mesh-list
139257786|NCT01205048|Anesthetics, Local|anesthetics, local|mesh-ancestor
139257787|NCT01205048|Anesthetics|anesthetics|mesh-ancestor
139257788|NCT01205048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257789|NCT01205048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257790|NCT01205048|Sensory System Agents|sensory system agents|mesh-ancestor
139257791|NCT01205048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257792|NCT01205048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139257793|NCT01205048|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139257794|NCT01205048|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139257795|NCT01205048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139381317|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257796|NCT01205048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257797|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139257798|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139257799|NCT01052779|Hematinics|hematinics|mesh-ancestor
139257800|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139257801|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139257802|NCT00785525|Lenograstim|lenograstim|mesh-list
139257803|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139257804|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
139257805|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257806|NCT00591370|Temozolomide|temozolomide|mesh-list
139257807|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139257808|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
139257809|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257810|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257811|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139257812|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139257813|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257814|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
139257815|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138841164|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
139257817|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257818|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
139257819|NCT02782676|Protective Agents|protective agents|mesh-ancestor
139257820|NCT03033095|Etanercept|etanercept|mesh-list
139257821|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139257822|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139257823|NCT03033095|Analgesics|analgesics|mesh-ancestor
139257824|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
139257825|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257826|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257827|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139257828|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139257829|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139257830|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139257831|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
139257832|NCT02142920|Gedatolisib|gedatolisib|mesh-list
139257833|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139257834|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257835|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257836|NCT01383785|Abciximab|abciximab|mesh-list
139257837|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
139257838|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139257839|NCT02146976|Propofol|propofol|mesh-list
139257840|NCT02146976|Sevoflurane|sevoflurane|mesh-list
139257841|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139257842|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257843|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257844|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139257845|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
139257846|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
139257847|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139257848|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139257849|NCT02147054|Rocuronium|rocuronium|mesh-list
139257850|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139257851|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139257852|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139257853|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257854|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257855|NCT00107978|Vancomycin|vancomycin|mesh-list
139257856|NCT00107978|Telavancin|telavancin|mesh-list
139257857|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139257858|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257859|NCT02781818|Triamcinolone|triamcinolone|mesh-list
139257860|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139257861|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139257862|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139257863|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139257864|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
139257865|NCT02781818|Hormones|hormones|mesh-ancestor
139257866|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257867|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257868|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139257869|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
139257870|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257871|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257872|NCT02149628|Propofol|propofol|mesh-list
139257873|NCT02149628|Desflurane|desflurane|mesh-list
139257874|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139257875|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257876|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257877|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139257878|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
139257879|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
139257880|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139257881|NCT02927873|Vaccines|vaccines|mesh-list
139257882|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
139257883|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257884|NCT02460419|Capecitabine|capecitabine|mesh-list
139257885|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139257886|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
139257887|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257888|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139257889|NCT01568411|Itraconazole|itraconazole|mesh-list
139257890|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
139257891|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257892|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139257893|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139257894|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257895|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257896|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139257897|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
139257898|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257899|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257900|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139257901|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
139257902|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
139257903|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
139257904|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257905|NCT03631901|Diazepam|diazepam|mesh-list
139257906|NCT03631901|Melatonin|melatonin|mesh-list
139257907|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
139257908|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257909|NCT03631901|Protective Agents|protective agents|mesh-ancestor
139257910|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257911|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257912|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139257913|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
139257914|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
139257915|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
139257916|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257917|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139257918|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139257919|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139257920|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139257921|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139257922|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139257923|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139257924|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139257925|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
139257926|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
139257927|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
139257928|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
139257929|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139257930|NCT01383395|Cilostazol|cilostazol|mesh-list
139257931|NCT01383395|Simvastatin|simvastatin|mesh-list
139257932|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139257933|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139257934|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
139257935|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257936|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139257937|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139257938|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257939|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139257940|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
139257941|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257942|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257943|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139257944|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
139257945|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139257946|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139257947|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139257948|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
139257949|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139257950|NCT01383395|Protective Agents|protective agents|mesh-ancestor
139257951|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139257952|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139257953|NCT05084651|Itraconazole|itraconazole|mesh-list
139257954|NCT05084651|Lumefantrine|lumefantrine|mesh-list
139257955|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
139257956|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139257957|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139257958|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139257959|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257960|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257961|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139257962|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
139257963|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139257964|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257965|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139257966|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
139257967|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139257968|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139257969|NCT02781584|Firsocostat|firsocostat|mesh-list
139257970|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139257971|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139257972|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
139257973|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139257974|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
139257975|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257976|NCT02147678|Remifentanil|remifentanil|mesh-list
139257977|NCT02147678|Propofol|propofol|mesh-list
139257978|NCT02147678|Etomidate|etomidate|mesh-list
139257979|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
139257980|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139257981|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257982|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139257983|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139257984|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
139257985|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139257986|NCT02147678|Narcotics|narcotics|mesh-ancestor
139257987|NCT02147678|Analgesics|analgesics|mesh-ancestor
139257988|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
139257989|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139257990|NCT02151344|Vaccines|vaccines|mesh-list
139257991|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
139257992|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257993|NCT02155634|Lenalidomide|lenalidomide|mesh-list
139257994|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
139257995|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139257996|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139257997|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139257998|NCT02155634|Growth Substances|growth substances|mesh-ancestor
139257999|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
139258000|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258001|NCT02151812|Paclitaxel|paclitaxel|mesh-list
139258002|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139258003|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139258004|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258005|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
139258006|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
139258007|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
139258008|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258010|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
139258011|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139258012|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258013|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
139258014|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258015|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139258016|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
139258017|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139258018|NCT02255084|Menthol|menthol|mesh-list
139258019|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
139258020|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
139258021|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139258022|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139258023|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
139258024|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258025|NCT02255162|Cytarabine|cytarabine|mesh-list
139258026|NCT02255162|Lenalidomide|lenalidomide|mesh-list
139258027|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139258028|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
139258029|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258030|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258031|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
139258032|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258033|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139258034|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
139258035|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258036|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139258037|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139258038|NCT02255162|Growth Substances|growth substances|mesh-ancestor
139258039|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
139258040|NCT02152514|Sufentanil|sufentanil|mesh-list
139258041|NCT02152514|Morphine|morphine|mesh-list
139258042|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139258043|NCT02152514|Narcotics|narcotics|mesh-ancestor
139258044|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139258045|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258046|NCT02152514|Analgesics|analgesics|mesh-ancestor
139258047|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
139258048|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258049|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139258050|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139258051|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
139258052|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
139258053|NCT02261090|Pramipexole|pramipexole|mesh-list
139258054|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
139258055|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258056|NCT02261090|Protective Agents|protective agents|mesh-ancestor
139258057|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258058|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139258059|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139258060|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
139258061|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
139258062|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258063|NCT01307423|Thalidomide|thalidomide|mesh-list
139258064|NCT01307423|Apremilast|apremilast|mesh-list
139258065|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139258066|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139258067|NCT01307423|Analgesics|analgesics|mesh-ancestor
139258068|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
139258069|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258070|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258071|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258072|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139258073|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139258074|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139258075|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258076|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258077|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139258078|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
139258079|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
139381338|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
139258080|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139258081|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258082|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139258105|NCT03542240|Analgesics|analgesics|mesh-ancestor
139258106|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
139258107|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258108|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258109|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258110|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139258111|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258112|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258113|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258114|NCT00911183|Prednisone|prednisone|mesh-list
139258115|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
139258116|NCT00911183|Rituximab|rituximab|mesh-list
139258117|NCT00911183|Doxorubicin|doxorubicin|mesh-list
139258119|NCT00911183|Vincristine|vincristine|mesh-list
139258120|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139258121|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
139258122|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258123|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139258124|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139258125|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
139258126|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258127|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258128|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139258129|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139258130|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139258131|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139258132|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139258133|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258134|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258135|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
139258136|NCT00911183|Hormones|hormones|mesh-ancestor
139258137|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258138|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139258139|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139258140|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
139258141|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
139258142|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
139258143|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
139258144|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139258145|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258146|NCT05420441|Chitosan|chitosan|mesh-list
139258147|NCT05420441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139258148|NCT05420441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139258149|NCT05420441|Antimetabolites|antimetabolites|mesh-ancestor
139258150|NCT05420441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258151|NCT05420441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139258152|NCT05420441|Chelating Agents|chelating agents|mesh-ancestor
139258153|NCT05420441|Sequestering Agents|sequestering agents|mesh-ancestor
139258154|NCT05420441|Hemostatics|hemostatics|mesh-ancestor
139258155|NCT05420441|Coagulants|coagulants|mesh-ancestor
139258156|NCT05598593|Cytarabine|cytarabine|mesh-list
139258157|NCT05598593|Fludarabine|fludarabine|mesh-list
139258158|NCT05598593|Busulfan|busulfan|mesh-list
139258159|NCT05598593|Thiotepa|thiotepa|mesh-list
139258160|NCT05598593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258161|NCT05598593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139258162|NCT05598593|Antimetabolites|antimetabolites|mesh-ancestor
139258163|NCT05598593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258164|NCT05598593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139258165|NCT05598593|Immunologic Factors|immunologic factors|mesh-ancestor
139258166|NCT05598593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258167|NCT05598593|Antiviral Agents|antiviral agents|mesh-ancestor
139258168|NCT05598593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258169|NCT05598593|Alkylating Agents|alkylating agents|mesh-ancestor
139258170|NCT05598593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139258171|NCT05598593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139258172|NCT05337449|Fluorides|fluorides|mesh-list
139258173|NCT05337449|Cariostatic Agents|cariostatic agents|mesh-ancestor
139258174|NCT05337449|Protective Agents|protective agents|mesh-ancestor
139381343|NCT02430363|Dactolisib|dactolisib|mesh-list
139258175|NCT05337449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258176|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
139258177|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139258178|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139258179|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139258180|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258181|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
139258182|NCT02150720|Coagulants|coagulants|mesh-ancestor
139258183|NCT02153060|Dexamethasone|dexamethasone|mesh-list
139258184|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
139258185|NCT02153060|BB 1101|bb 1101|mesh-list
139258186|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258187|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
139258188|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
139258189|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258190|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258191|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139258192|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
139258193|NCT02153060|Hormones|hormones|mesh-ancestor
138841543|NCT02836002|Atovaquone|atovaquone|mesh-list
139091686|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139258194|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258195|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139258196|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258198|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258199|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258200|NCT02156570|Ribavirin|ribavirin|mesh-list
139258201|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
139258202|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
139258203|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258204|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
139258205|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258206|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
139258207|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139258208|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258209|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
139258210|NCT02156726|Fludarabine|fludarabine|mesh-list
139258211|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139258212|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
139258213|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258214|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139258215|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139258216|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
139258217|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258218|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258219|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139258220|NCT02153450|Metformin|metformin|mesh-list
139258221|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139258222|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258223|NCT05598281|Sotorasib|sotorasib|mesh-list
139258224|NCT05598281|Digoxin|digoxin|mesh-list
139258225|NCT05598281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139258226|NCT05598281|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139258227|NCT05598281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258228|NCT05598281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258229|NCT05598281|Protective Agents|protective agents|mesh-ancestor
139258230|NCT05598281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258231|NCT05598281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139258232|NCT05598281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139258233|NCT05598281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258234|NCT03092375|Ribavirin|ribavirin|mesh-list
139258235|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
139258236|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258237|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
139258238|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258239|NCT01995513|Prednisone|prednisone|mesh-list
139258240|NCT01995513|Prednisolone|prednisolone|mesh-list
139258241|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
139258242|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258243|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
139258244|NCT01995513|Hormones|hormones|mesh-ancestor
139258245|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258246|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258247|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139258248|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258249|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139258250|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258251|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258252|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
139258253|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139258254|NCT03180359|Vaccines|vaccines|mesh-list
139258255|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
139258256|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258257|NCT01304511|Ganirelix|ganirelix|mesh-list
139258258|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
139258259|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258260|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258261|NCT00103610|Plerixafor|plerixafor|mesh-list
139258262|NCT00103610|Lenograstim|lenograstim|mesh-list
139258263|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139258264|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
139258265|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258266|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139258267|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139258268|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
139258269|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258270|NCT02156960|Denosumab|denosumab|mesh-list
139258271|NCT02156960|Teriparatide|teriparatide|mesh-list
139258272|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139258273|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258274|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139258275|NCT02153606|Glycerol|glycerol|mesh-list
139258276|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139258277|NCT02153606|Protective Agents|protective agents|mesh-ancestor
139258278|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258279|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
139258280|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139258281|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139258282|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139258283|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258284|NCT04687631|Bevacizumab|bevacizumab|mesh-list
139258285|NCT04687631|Cetuximab|cetuximab|mesh-list
139258286|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139258287|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258288|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139258289|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139258290|NCT04687631|Growth Substances|growth substances|mesh-ancestor
139258291|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258292|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
139258293|NCT04833023|Olanzapine|olanzapine|mesh-list
139258294|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
139258295|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
139258296|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258297|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258298|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139258299|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139258300|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139258301|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139258302|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139258303|NCT04833023|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139258304|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139258305|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139258306|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258307|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258308|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
139258309|NCT03091439|Dalbavancin|dalbavancin|mesh-list
139128481|NCT01221831|Dienogest|dienogest|mesh-list
139258310|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139258311|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258312|NCT03631823|Temozolomide|temozolomide|mesh-list
139258313|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139258314|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
139258315|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258316|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258317|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
139258318|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139258319|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
139258320|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139258321|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
139258322|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258323|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258324|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
139258325|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
139258326|NCT02154074|Isoflurane|isoflurane|mesh-list
139258327|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
139258328|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139258329|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258330|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139258331|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139258332|NCT02154074|Analgesics|analgesics|mesh-ancestor
139258333|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
139258334|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258335|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139258336|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139258337|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139258338|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
139258339|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258340|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258341|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139258342|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
139258344|NCT05460455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139258345|NCT05460455|Immunologic Factors|immunologic factors|mesh-ancestor
139258346|NCT05460455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258347|NCT03104413|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139258348|NCT03104413|Immunologic Factors|immunologic factors|mesh-ancestor
139258349|NCT03104413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258350|NCT01382147|Daunorubicin|daunorubicin|mesh-list
139258351|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
139258352|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139258353|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258354|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139258355|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139258356|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258357|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258358|NCT01382147|Analgesics|analgesics|mesh-ancestor
139258359|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
139258360|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258361|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258362|NCT01381835|Simeprevir|simeprevir|mesh-list
139258363|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
139258364|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258365|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
139258366|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258367|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258368|NCT04429685|Ketamine|ketamine|mesh-list
139258369|NCT04429685|Analgesics|analgesics|mesh-ancestor
139258370|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
139258371|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258372|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258373|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139258374|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139258375|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
139258376|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
139258377|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139258378|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139258379|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139258380|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258381|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258382|NCT01384279|Metformin|metformin|mesh-list
139258383|NCT01384279|Topiramate|topiramate|mesh-list
139642463|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139258384|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139258385|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258386|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
139258387|NCT01381601|Bevacizumab|bevacizumab|mesh-list
139258388|NCT01381601|Sunitinib|sunitinib|mesh-list
139258389|NCT01381601|Sorafenib|sorafenib|mesh-list
139258390|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139258391|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258392|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139258393|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139258394|NCT01381601|Growth Substances|growth substances|mesh-ancestor
139258395|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258396|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
139258397|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139258398|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258399|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258400|NCT02823353|Fenofibrate|fenofibrate|mesh-list
139258401|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139258402|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
139258403|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258404|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139258405|NCT04509193|Warfarin|warfarin|mesh-list
139258406|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
139258407|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
139258408|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139258409|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
139258410|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139258411|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
139258412|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841767|NCT00837655|Calcium|calcium|mesh-list
139258413|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258414|NCT02697383|Dexamethasone|dexamethasone|mesh-list
139258415|NCT02697383|Ixazomib|ixazomib|mesh-list
139258416|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258417|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
139258419|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258420|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258421|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139258422|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
139258423|NCT02697383|Hormones|hormones|mesh-ancestor
139258424|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258425|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139258426|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258427|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
139258428|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258429|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258430|NCT04173949|Ramipril|ramipril|mesh-list
139258431|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139258432|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
139258433|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258434|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258435|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139258436|NCT01382017|Lacosamide|lacosamide|mesh-list
139258437|NCT01382017|Carbamazepine|carbamazepine|mesh-list
139258438|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
139258439|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139258440|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139258441|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139258442|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258443|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
139258444|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139258445|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139258446|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258447|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139258448|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139258449|NCT01382017|Analgesics|analgesics|mesh-ancestor
139258450|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
139258451|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258452|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139258453|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139258454|NCT01381523|Naproxen|naproxen|mesh-list
139258455|NCT01381523|Sumatriptan|sumatriptan|mesh-list
139258456|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139258457|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139258458|NCT01381523|Analgesics|analgesics|mesh-ancestor
139258459|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
139258460|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258461|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258462|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258463|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139258464|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
139258465|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139258466|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258467|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258468|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139258469|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139258470|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139258471|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
139258472|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258473|NCT04233047|Fostemsavir|fostemsavir|mesh-list
139258474|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139258475|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139258476|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
139258477|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258478|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139258479|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139258480|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258481|NCT01381445|Clobetasol|clobetasol|mesh-list
139258482|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258483|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
139258484|NCT01381445|Hormones|hormones|mesh-ancestor
139258485|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258486|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258487|NCT03083639|Esomeprazole|esomeprazole|mesh-list
139258488|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139258489|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138841836|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258490|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139258491|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258492|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258493|NCT02927431|Oseltamivir|oseltamivir|mesh-list
139258494|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
139258495|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258496|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258497|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258498|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
139258499|NCT05027893|Cefixime|cefixime|mesh-list
139258500|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139258501|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258502|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139258503|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139258504|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258505|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258506|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258507|NCT04113083|Dehydrocholesterols|dehydrocholesterols|mesh-list
139258508|NCT04113083|Provitamins|provitamins|mesh-ancestor
139258509|NCT04113083|Vitamins|vitamins|mesh-ancestor
139258510|NCT04113083|Micronutrients|micronutrients|mesh-ancestor
139258511|NCT04113083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258512|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139258513|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
139258514|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258515|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
139258516|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139258517|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
139258518|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258519|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
139258520|NCT04989361|Protective Agents|protective agents|mesh-ancestor
139258521|NCT01381289|Ivacaftor|ivacaftor|mesh-list
139258522|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139258523|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139258524|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258525|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139258526|NCT04899193|Hormones|hormones|mesh-ancestor
139258527|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258528|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258529|NCT01381705|Rituximab|rituximab|mesh-list
139258530|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139258531|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258532|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
139258533|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258534|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139258536|NCT04401709|Capecitabine|capecitabine|mesh-list
139258537|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139258538|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
139258539|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258540|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258541|NCT04497987|Bamlanivimab|bamlanivimab|mesh-list
139258542|NCT04497987|Antiviral Agents|antiviral agents|mesh-ancestor
139258543|NCT04497987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258544|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
139258545|NCT01381627|Remifentanil|remifentanil|mesh-list
139258546|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139258547|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139258548|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258549|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139258550|NCT01381627|Analgesics|analgesics|mesh-ancestor
139258551|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
139258552|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258553|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139258554|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139258555|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139258556|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
139258557|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258558|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258559|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139258560|NCT01381627|Narcotics|narcotics|mesh-ancestor
139258561|NCT00974571|Cetirizine|cetirizine|mesh-list
139258562|NCT00974571|Montelukast|montelukast|mesh-list
139258563|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139258564|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
139258565|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139258566|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
139258567|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258568|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258569|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139258570|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139258571|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258572|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139258573|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139258574|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139258575|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
139258576|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
139258577|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258578|NCT02766608|Budesonide|budesonide|mesh-list
139258579|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
139258580|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139258581|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258582|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139258583|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
139258584|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258585|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258586|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139258587|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
139258588|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
139258589|NCT02766608|Hormones|hormones|mesh-ancestor
139258590|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258591|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139258592|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139258593|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139258594|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
139258595|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258596|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258597|NCT01382407|Cetuximab|cetuximab|mesh-list
139258598|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139258599|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258600|NCT02235857|Dextrans|dextrans|mesh-list
139258601|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
139258602|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
139258603|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
139258604|NCT03317119|Trifluridine|trifluridine|mesh-list
139258605|NCT03317119|Trametinib|trametinib|mesh-list
139258606|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258607|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139258608|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258609|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258610|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
139258611|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
139258612|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258613|NCT04356495|Ciclesonide|ciclesonide|mesh-list
139258614|NCT04356495|Interferons|interferons|mesh-list
139258615|NCT04356495|Interferon-beta|interferon-beta|mesh-list
139258616|NCT04356495|Telmisartan|telmisartan|mesh-list
139258617|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
139258618|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258619|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258620|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
139258621|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258622|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139258623|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139258624|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139258625|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258626|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
139258627|NCT04356495|Hormones|hormones|mesh-ancestor
139258628|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258629|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139258630|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
139258631|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139258632|NCT02154230|Calcium|calcium|mesh-list
139258633|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139258634|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258635|NCT04200963|Nivolumab|nivolumab|mesh-list
139258636|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139258637|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841987|NCT00838357|Plerixafor|plerixafor|mesh-list
139258638|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139258639|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258640|NCT02157428|Flumazenil|flumazenil|mesh-list
139258641|NCT02157428|Antidotes|antidotes|mesh-ancestor
139258642|NCT02157428|Protective Agents|protective agents|mesh-ancestor
139258643|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258644|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
139258645|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
139258646|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258647|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258648|NCT00960141|Loratadine|loratadine|mesh-list
139258649|NCT00960141|Montelukast|montelukast|mesh-list
139258650|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139258651|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
139258652|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139258653|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
139258654|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258655|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258656|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139258657|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139258658|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258659|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
139258660|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
139258661|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139258662|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139258663|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139258664|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
139258665|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
139258666|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258667|NCT00759655|Factor VIII|factor viii|mesh-list
139258668|NCT00759655|Coagulants|coagulants|mesh-ancestor
139258669|NCT02255006|Glyburide|glyburide|mesh-list
139258670|NCT02255006|Celecoxib|celecoxib|mesh-list
139258671|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139258672|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139258673|NCT02255006|Analgesics|analgesics|mesh-ancestor
139258674|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
139258675|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258676|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258677|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258678|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139258679|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139258680|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139258681|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258682|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258683|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139258684|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
139258685|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139258686|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258687|NCT03396471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139258688|NCT03396471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258689|NCT00103142|Sargramostim|sargramostim|mesh-list
139258690|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
139258691|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258692|NCT00943683|Montelukast|montelukast|mesh-list
139258693|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139258694|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
139258695|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139258696|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
139258697|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258698|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258699|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139258700|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139258701|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258702|NCT03542006|Brinzolamide|brinzolamide|mesh-list
139258703|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139258704|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258705|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258706|NCT02154464|Acetaminophen|acetaminophen|mesh-list
139258707|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139258708|NCT02154464|Analgesics|analgesics|mesh-ancestor
139258709|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
139258710|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258711|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258712|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
139258713|NCT00911547|Beclomethasone|beclomethasone|mesh-list
139258714|NCT00911547|Montelukast|montelukast|mesh-list
139258715|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139258716|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
139258717|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139258718|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
139258719|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258720|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258721|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139258722|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139258723|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258724|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258725|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
139258727|NCT02159690|Prednisone|prednisone|mesh-list
139258728|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
139258729|NCT02159690|Dutasteride|dutasteride|mesh-list
139258730|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258731|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
139258732|NCT02159690|Hormones|hormones|mesh-ancestor
139258733|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258734|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258735|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139258736|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258737|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139258738|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258739|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258740|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
139258741|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139258742|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139258743|NCT02157818|Midazolam|midazolam|mesh-list
139258744|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
139258745|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139258746|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139258747|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258748|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139258749|NCT02157818|Analgesics|analgesics|mesh-ancestor
139258750|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
139258751|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258752|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139258753|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139258754|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139258755|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
139258756|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258757|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258758|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139258759|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139258760|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139258761|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139258762|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139258763|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
139258764|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
139258765|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
139258766|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
139258767|NCT00899379|Rizatriptan|rizatriptan|mesh-list
139258768|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139258769|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
139258770|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258771|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258772|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258773|NCT04326439|Cytarabine|cytarabine|mesh-list
139258774|NCT04326439|Etoposide|etoposide|mesh-list
139258775|NCT04326439|Daunorubicin|daunorubicin|mesh-list
139258776|NCT04326439|Sorafenib|sorafenib|mesh-list
139258777|NCT04326439|Asparaginase|asparaginase|mesh-list
139258778|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
139258779|NCT04326439|Calicheamicins|calicheamicins|mesh-list
139258780|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139258781|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258782|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139258783|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139258784|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258785|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842140|NCT02843984|Lactoferrin|lactoferrin|mesh-list
139258786|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139258788|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
139258789|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258790|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139258791|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
139258792|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258793|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139258794|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139258795|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139258796|NCT04326439|Immunotoxins|immunotoxins|mesh-ancestor
139258797|NCT04326439|Immunoconjugates|immunoconjugates|mesh-ancestor
139258798|NCT03541928|Valacyclovir|valacyclovir|mesh-list
139258799|NCT03541928|Leuprolide|leuprolide|mesh-list
139258800|NCT03541928|Bicalutamide|bicalutamide|mesh-list
139258801|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139258802|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
139258803|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139258804|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258805|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139258806|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258807|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
139258808|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
139258809|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258810|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
139258811|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258812|NCT00145795|Ritonavir|ritonavir|mesh-list
139258813|NCT00145795|Lopinavir|lopinavir|mesh-list
139258814|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139258815|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139258816|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
139258817|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258818|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258819|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139258820|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139258821|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
139258822|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258823|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139258824|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139258825|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139258826|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
139258827|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258828|NCT00898677|Sumatriptan|sumatriptan|mesh-list
139258830|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139258831|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139258832|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139258833|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
139258834|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258835|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258836|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258837|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
139258838|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139258839|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258840|NCT02154776|Letrozole|letrozole|mesh-list
139258841|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258842|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139258843|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139258844|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258845|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258846|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139258847|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
139258848|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258849|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258850|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139258851|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
139258852|NCT03388749|Annamycin|annamycin|mesh-list
139258853|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139258854|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258855|NCT02770820|Aldesleukin|aldesleukin|mesh-list
139258856|NCT02770820|Interleukin-2|interleukin-2|mesh-list
139258857|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258858|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139258859|NCT02770820|Analgesics|analgesics|mesh-ancestor
139258860|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
139258861|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258862|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258863|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139258864|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139258865|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
139258866|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258868|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139258869|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
139258870|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258871|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139258872|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258873|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258874|NCT02160080|Interferons|interferons|mesh-list
139258875|NCT02160080|Ribavirin|ribavirin|mesh-list
139258876|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
139258877|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258878|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
139258879|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139258880|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
139258881|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258882|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
139258883|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258884|NCT05422183|Lenvatinib|lenvatinib|mesh-list
139258885|NCT05422183|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139258886|NCT05422183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258887|NCT05422183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139258888|NCT05422183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258889|NCT05422183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258890|NCT02160158|Fesoterodine|fesoterodine|mesh-list
139258891|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139258892|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139258893|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
139258894|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258895|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258896|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258897|NCT02160158|Urological Agents|urological agents|mesh-ancestor
139258898|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139258899|NCT02160236|Tenoxicam|tenoxicam|mesh-list
139258900|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139258901|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139258902|NCT02160236|Analgesics|analgesics|mesh-ancestor
139258903|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
139258904|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258905|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258906|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258907|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139258908|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139258909|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258910|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258911|NCT02154932|Misoprostol|misoprostol|mesh-list
139258912|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139258913|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
139258914|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139258915|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258916|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139258917|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139258918|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
139258919|NCT02158286|Acetaminophen|acetaminophen|mesh-list
139258920|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139258921|NCT02158286|Analgesics|analgesics|mesh-ancestor
139258922|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
139258923|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258924|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258925|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
139258926|NCT01377415|Bupivacaine|bupivacaine|mesh-list
139258927|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
139258928|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
139258929|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139258930|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258931|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
139258932|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258933|NCT02155088|Paclitaxel|paclitaxel|mesh-list
139258934|NCT02155088|Gemcitabine|gemcitabine|mesh-list
139258935|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139258936|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139258937|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
139258938|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
139258939|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
139258940|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258941|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139258942|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
139258944|NCT02160548|Albuterol|albuterol|mesh-list
139258945|NCT02160548|Pralidoxime|pralidoxime|mesh-list
139258946|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139258947|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139258948|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139258949|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
139258950|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258951|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258952|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139258953|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
139258954|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
139258955|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
139258956|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139258957|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139258958|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
139258959|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139258960|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258961|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
139258962|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139258963|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139258964|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139258965|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139258966|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
139258967|NCT02160548|Antidotes|antidotes|mesh-ancestor
139258968|NCT02160548|Protective Agents|protective agents|mesh-ancestor
139258969|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
139258970|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
139258971|NCT02158598|Vitamin D|vitamin d|mesh-list
139258972|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
139258973|NCT02158598|Cholecalciferol|cholecalciferol|mesh-list
139258974|NCT02158598|Vitamins|vitamins|mesh-list
139258975|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
139258976|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258977|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139258978|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139258979|NCT03082729|Apremilast|apremilast|mesh-list
139258980|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139258981|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139258982|NCT03082729|Analgesics|analgesics|mesh-ancestor
139258983|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
139258984|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139258985|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258986|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139258987|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139258988|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139258989|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139258990|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139258991|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139258992|NCT02160704|Enclomiphene|enclomiphene|mesh-list
139258993|NCT02160704|Clomiphene|clomiphene|mesh-list
139258994|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
139258995|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139258996|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
139258997|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139258998|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139258999|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139259000|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
139259001|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139259002|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139259003|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139259004|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
139259005|NCT03542552|Nifedipine|nifedipine|mesh-list
139259006|NCT03542552|Analgesics|analgesics|mesh-ancestor
139259007|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
139259008|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259009|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842360|NCT02840006|Anesthetics|anesthetics|mesh-list
139259010|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
139259011|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259012|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139259013|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
139259014|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139259015|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139259016|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381397|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
139259017|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139259018|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
139259019|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139259020|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
139259021|NCT02155166|Ibuprofen|ibuprofen|mesh-list
139259022|NCT02155166|Lidocaine|lidocaine|mesh-list
139259023|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
139259024|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
139259025|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259026|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259027|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
139259028|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259029|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139259030|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139259031|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139259032|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139259033|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259034|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139259035|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139259036|NCT02155166|Analgesics|analgesics|mesh-ancestor
139259037|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139259038|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139259039|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139259040|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259041|NCT00398931|Alendronate|alendronate|mesh-list
139259042|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259043|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139259044|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139259045|NCT00920361|Hormones|hormones|mesh-ancestor
139259046|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139259047|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259048|NCT00651807|Etonogestrel|etonogestrel|mesh-list
139259049|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139259050|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
139259051|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139091717|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
139259052|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259053|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139259054|NCT02158910|Donepezil|donepezil|mesh-list
139259055|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139259056|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259057|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259058|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
139259059|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259060|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259061|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
139259062|NCT03077659|Paclitaxel|paclitaxel|mesh-list
139259063|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139259064|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259065|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
139259066|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
139259067|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
139259068|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259069|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
139259070|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139259071|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259072|NCT05052723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139259073|NCT05052723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259074|NCT02807883|Blinatumomab|blinatumomab|mesh-list
139259075|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259076|NCT04051047|Gemcitabine|gemcitabine|mesh-list
139259077|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139259078|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
139259079|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259080|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259081|NCT00102440|Allopurinol|allopurinol|mesh-list
139259082|NCT00102440|Febuxostat|febuxostat|mesh-list
138842434|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139259083|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
139259084|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259085|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259086|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
139259087|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139259088|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139259089|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
139259090|NCT00102440|Protective Agents|protective agents|mesh-ancestor
139259091|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259092|NCT05224167|Melatonin|melatonin|mesh-list
139259093|NCT05224167|Hydroxyzine|hydroxyzine|mesh-list
139259094|NCT05224167|Antioxidants|antioxidants|mesh-ancestor
139259095|NCT05224167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259096|NCT05224167|Protective Agents|protective agents|mesh-ancestor
139259097|NCT05224167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259098|NCT05224167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259099|NCT05224167|Antipruritics|antipruritics|mesh-ancestor
139259100|NCT05224167|Dermatologic Agents|dermatologic agents|mesh-ancestor
139259101|NCT05224167|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139259102|NCT05224167|Histamine Antagonists|histamine antagonists|mesh-ancestor
139259103|NCT05224167|Histamine Agents|histamine agents|mesh-ancestor
139259104|NCT05224167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259105|NCT01377259|Anesthetics|anesthetics|mesh-list
139259106|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259107|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259108|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139259109|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139259110|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139259111|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259112|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259113|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139259114|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139259115|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259116|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
139259117|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259118|NCT03909607|Ketamine|ketamine|mesh-list
139259119|NCT03909607|Analgesics|analgesics|mesh-ancestor
139259120|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
139259121|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259122|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642276|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139259131|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259132|NCT03902509|Pirfenidone|pirfenidone|mesh-list
139259133|NCT03902509|Analgesics|analgesics|mesh-ancestor
139259134|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
139259135|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259136|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259137|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139259138|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139259139|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139259140|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139259141|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259142|NCT02166632|Bupivacaine|bupivacaine|mesh-list
139259143|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
139259144|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
139259145|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259146|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259147|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
139259148|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259149|NCT02161952|Pirfenidone|pirfenidone|mesh-list
139259150|NCT02161952|Analgesics|analgesics|mesh-ancestor
139259151|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
139259152|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259153|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259154|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139259155|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138842508|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259157|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139259158|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259170|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139259171|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139259172|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259173|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259174|NCT04784559|Remdesivir|remdesivir|mesh-list
139259175|NCT04784559|Favipiravir|favipiravir|mesh-list
139259176|NCT04784559|Dexamethasone|dexamethasone|mesh-list
139259177|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139259178|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
139259179|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
139259180|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259181|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259182|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139259183|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
139259184|NCT04784559|Hormones|hormones|mesh-ancestor
139259185|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139259186|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139259187|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259188|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
139259189|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259190|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
139259191|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139259192|NCT03704181|Colchicine|colchicine|mesh-list
139259193|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
139259194|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139259195|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
139642277|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259196|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
139259197|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
139259198|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259199|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259201|NCT03625011|Analgesics|analgesics|mesh-ancestor
139259202|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
139259203|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259204|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259205|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
139259206|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139259207|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139259208|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259209|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139259210|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139259211|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139259212|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259213|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259214|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
139259215|NCT03625167|Petrolatum|petrolatum|mesh-list
139259216|NCT03625167|Emollients|emollients|mesh-ancestor
139259217|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
139259218|NCT04718727|Olanzapine|olanzapine|mesh-list
139259219|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
139259220|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
139259221|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259222|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259223|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139259224|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139259225|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139259226|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259227|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139259228|NCT04718727|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139259229|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139259230|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139259231|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259232|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259233|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
139259234|NCT03701529|Anesthetics|anesthetics|mesh-list
139259236|NCT03701529|Sevoflurane|sevoflurane|mesh-list
139259237|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259238|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259239|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139259240|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139259241|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
139259242|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139259243|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139259244|NCT04553133|Letrozole|letrozole|mesh-list
139259245|NCT04553133|Fulvestrant|fulvestrant|mesh-list
139259246|NCT04553133|Palbociclib|palbociclib|mesh-list
139259247|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259248|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139259249|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139259250|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259251|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259252|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139259253|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
139259254|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139259255|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259256|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139259257|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139259258|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139259259|NCT03701451|Decitabine|decitabine|mesh-list
139259260|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139259261|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
139259262|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259263|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259264|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259265|NCT03703089|Paclitaxel|paclitaxel|mesh-list
139259266|NCT03703089|Gemcitabine|gemcitabine|mesh-list
139259267|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139259268|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259269|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
139259270|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
139259271|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
139259272|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259273|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139259274|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
139259275|NCT02807844|Spartalizumab|spartalizumab|mesh-list
139259276|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139259277|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259278|NCT02807844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139259279|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259280|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
139259281|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139259282|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139259283|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139259284|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259285|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
139259286|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259287|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259288|NCT02052180|Bupivacaine|bupivacaine|mesh-list
139259289|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
139259290|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
139259291|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259292|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259293|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
139259294|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259295|NCT03561402|Teriflunomide|teriflunomide|mesh-list
139259296|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139259297|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139259298|NCT03561402|Analgesics|analgesics|mesh-ancestor
139259299|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
139259300|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259301|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259302|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139259303|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139259304|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139259305|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
139259306|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
139259307|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139259308|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259309|NCT04694781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139259310|NCT04694781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259311|NCT02805972|Naloxone|naloxone|mesh-list
139259312|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139259313|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259314|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
139259315|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259316|NCT02052258|Oxytocin|oxytocin|mesh-list
139259317|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
139259318|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139259319|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259320|NCT02053818|Sufentanil|sufentanil|mesh-list
139259321|NCT02053818|Remifentanil|remifentanil|mesh-list
139259322|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139259323|NCT02053818|Narcotics|narcotics|mesh-ancestor
139259324|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259325|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259326|NCT02053818|Analgesics|analgesics|mesh-ancestor
139259327|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
139259328|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259329|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139259330|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139259331|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
139259332|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
139259333|NCT03702387|Anesthetics|anesthetics|mesh-list
139259334|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259335|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259336|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
139259337|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
139259338|NCT03031899|Coagulants|coagulants|mesh-ancestor
139259339|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
139259340|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259341|NCT03700905|Nivolumab|nivolumab|mesh-list
139259342|NCT03700905|Ipilimumab|ipilimumab|mesh-list
139259343|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139259344|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259345|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139259346|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259347|NCT03700749|Iodine|iodine|mesh-list
139259348|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
139259349|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139259350|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
139259351|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
139259352|NCT03700749|Povidone|povidone|mesh-list
139259353|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139259354|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139259355|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
139259356|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
139259357|NCT03700749|Trace Elements|trace elements|mesh-ancestor
139259358|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
139259359|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259360|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
139259361|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
139259362|NCT03086369|Paclitaxel|paclitaxel|mesh-list
139259363|NCT03086369|Gemcitabine|gemcitabine|mesh-list
139259364|NCT03086369|Olaratumab|olaratumab|mesh-list
139259365|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139259366|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259367|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
139259368|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
139259369|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
139259370|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259371|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139259372|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
139259373|NCT00101582|Cisplatin|cisplatin|mesh-list
139259374|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259375|NCT05326373|Fluorides|fluorides|mesh-list
139259376|NCT05326373|Tin Fluorides|tin fluorides|mesh-list
139259377|NCT05326373|Cariostatic Agents|cariostatic agents|mesh-ancestor
139259378|NCT05326373|Protective Agents|protective agents|mesh-ancestor
139259379|NCT05326373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259380|NCT02166944|Tamoxifen|tamoxifen|mesh-list
139259381|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139259382|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
139259383|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139259384|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259385|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139259386|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259387|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139259388|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139259389|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139259391|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139259392|NCT02162264|Donepezil|donepezil|mesh-list
139259393|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139259394|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259395|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259396|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
139259397|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259398|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259399|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
139259400|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
139259401|NCT03700515|Hematinics|hematinics|mesh-ancestor
139259402|NCT03700359|Etoposide|etoposide|mesh-list
139259403|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139259404|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259405|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139259406|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139259407|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259408|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259409|NCT02167178|Polygeline|polygeline|mesh-list
139259410|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
139259411|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
139259412|NCT03625089|Atorvastatin|atorvastatin|mesh-list
139259413|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139259414|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139259415|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
139259416|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259417|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139259418|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139259419|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259420|NCT01378949|Morphine|morphine|mesh-list
139259421|NCT01378949|Bupivacaine|bupivacaine|mesh-list
139259422|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
139259423|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
139642278|NCT01314417|Methotrexate|methotrexate|mesh-list
139129623|NCT01135641|Rituximab|rituximab|mesh-list
139259424|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259425|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259426|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
139259427|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259428|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139259429|NCT01378949|Narcotics|narcotics|mesh-ancestor
139259430|NCT01378949|Analgesics|analgesics|mesh-ancestor
139259431|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
139259432|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139259433|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259434|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259435|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139259436|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139259437|NCT01381055|Protective Agents|protective agents|mesh-ancestor
139259438|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259439|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
139259440|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139259441|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
139259442|NCT03122613|Curcumin|curcumin|mesh-list
139259443|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139259444|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139259445|NCT03122613|Analgesics|analgesics|mesh-ancestor
139259446|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
139259447|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259448|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259449|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139259450|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139259451|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259452|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259453|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259454|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
139259455|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139259456|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139259457|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259459|NCT03540368|Coagulants|coagulants|mesh-ancestor
139259460|NCT02255396|Estradiol|estradiol|mesh-list
139259461|NCT02255396|Estrogens|estrogens|mesh-ancestor
139259462|NCT02255396|Hormones|hormones|mesh-ancestor
139259463|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139259464|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259465|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
139259466|NCT02163980|Ropivacaine|ropivacaine|mesh-list
139259467|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139259468|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259469|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259470|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139259471|NCT02163980|Analgesics|analgesics|mesh-ancestor
139259472|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
139259473|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259474|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139259475|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139259476|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139259477|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
139259478|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259479|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259480|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
139259481|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
139259482|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139259483|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139259484|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
139259485|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259486|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259487|NCT01569035|Warfarin|warfarin|mesh-list
139259488|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
139259489|NCT03841565|Dexamethasone|dexamethasone|mesh-list
139259490|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
139259491|NCT03841565|Daratumumab|daratumumab|mesh-list
139259492|NCT03841565|Pomalidomide|pomalidomide|mesh-list
139259493|NCT03841565|Ichthammol|ichthammol|mesh-list
139259494|NCT03841565|BB 1101|bb 1101|mesh-list
139259495|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139259496|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
139259497|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
139259498|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642279|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139129694|NCT03739671|Vitamin D|vitamin d|mesh-list
139259499|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259500|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139259501|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
139259502|NCT03841565|Hormones|hormones|mesh-ancestor
139259503|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139259504|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139259505|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259506|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
139259507|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259508|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259509|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
139259510|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139259511|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139259512|NCT03841565|Growth Substances|growth substances|mesh-ancestor
139259513|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
139259514|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
139259515|NCT02162966|Colistin|colistin|mesh-list
139259516|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139259517|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139259518|NCT01595321|Leucovorin|leucovorin|mesh-list
139259519|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
139259520|NCT01595321|Fluorouracil|fluorouracil|mesh-list
139259521|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
139381420|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381421|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
139381422|NCT04851548|Protective Agents|protective agents|mesh-ancestor
139259522|NCT01595321|Irinotecan|irinotecan|mesh-list
139259523|NCT01595321|Folfirinox|folfirinox|mesh-list
139259524|NCT01595321|Vaccines|vaccines|mesh-list
139259525|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
139259526|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259527|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139259528|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139259529|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139259530|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
139259531|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259532|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259533|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139259535|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139259536|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139259537|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139259538|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259539|NCT01595321|Antidotes|antidotes|mesh-ancestor
139259540|NCT01595321|Protective Agents|protective agents|mesh-ancestor
139259541|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
139259542|NCT01595321|Vitamins|vitamins|mesh-ancestor
139259543|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
139259544|NCT02164214|Etanercept|etanercept|mesh-list
139259545|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139259546|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139259547|NCT02164214|Analgesics|analgesics|mesh-ancestor
139259548|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
139259549|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259550|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259551|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139259552|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139259553|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139259554|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139259555|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
139259556|NCT03722849|Adenosine|adenosine|mesh-list
139259557|NCT03722849|Capsaicin|capsaicin|mesh-list
139259558|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
139259559|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
139259560|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
139259561|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259562|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259563|NCT03722849|Analgesics|analgesics|mesh-ancestor
139259564|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139259565|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
139259566|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139259567|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
139259568|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
139259569|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259570|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259571|NCT02170844|Dabigatran|dabigatran|mesh-list
139259572|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
139259573|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139259574|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
139259575|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642280|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
139129765|NCT01136421|Bromides|bromides|mesh-list
139259576|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259577|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
139259578|NCT02170922|Dabigatran|dabigatran|mesh-list
139259579|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
139259580|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139259581|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
139259582|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259583|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259584|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
139259585|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
139259586|NCT02167958|Fludarabine|fludarabine|mesh-list
139259587|NCT02167958|Tacrolimus|tacrolimus|mesh-list
139259588|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139259589|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
139259590|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259591|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139259592|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139259593|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
139259594|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259595|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259596|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139259597|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139259598|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259599|NCT01384331|NuvaRing|nuvaring|mesh-list
139259600|NCT01384331|Desogestrel|desogestrel|mesh-list
139259601|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139259602|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
139259603|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139259604|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259605|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139259606|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139259607|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139259608|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139259609|NCT01384331|Progestins|progestins|mesh-ancestor
139259610|NCT01384331|Hormones|hormones|mesh-ancestor
139259611|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139259612|NCT03699423|Atropine|atropine|mesh-list
139259613|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139259614|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139259615|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139259616|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139259617|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139259618|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
139259619|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259620|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259621|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139259622|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
139259623|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
139259624|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
139259625|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139259626|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139259627|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
139259628|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259629|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259630|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
139259631|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139259632|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259633|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259634|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139259635|NCT02164448|Analgesics|analgesics|mesh-ancestor
139259636|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
139259637|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259638|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139259639|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139259640|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139259641|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
139259642|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259643|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259644|NCT03612713|Oxycodone|oxycodone|mesh-list
139259645|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139259646|NCT03612713|Narcotics|narcotics|mesh-ancestor
139259647|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259648|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381442|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139381443|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381444|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381445|NCT04851392|Dronabinol|dronabinol|mesh-list
139642281|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139259649|NCT03612713|Analgesics|analgesics|mesh-ancestor
139259650|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
139259651|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259652|NCT01380509|Metronidazole|metronidazole|mesh-list
139259653|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139259654|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139259655|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139259656|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139259657|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139259658|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139259659|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139259660|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
139259661|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259662|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139259663|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139259664|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259665|NCT00976131|Ubiquinone|ubiquinone|mesh-list
139259666|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
139259667|NCT00976131|Cyclophosphamide|cyclophosphamide|mesh-list
139259668|NCT00976131|Doxorubicin|doxorubicin|mesh-list
139259669|NCT00976131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139259670|NCT00976131|Immunologic Factors|immunologic factors|mesh-ancestor
139259671|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259672|NCT00976131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139259673|NCT00976131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139259674|NCT00976131|Alkylating Agents|alkylating agents|mesh-ancestor
139259675|NCT00976131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259676|NCT00976131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259677|NCT00976131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139259678|NCT00976131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139259679|NCT00976131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139259680|NCT00976131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139259681|NCT00976131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259682|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
139259683|NCT00976131|Vitamins|vitamins|mesh-ancestor
139259684|NCT01384253|Trastuzumab|trastuzumab|mesh-list
139259685|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139259686|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259687|NCT03631277|Calcium|calcium|mesh-list
139259688|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139259689|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259690|NCT02171000|Dabigatran|dabigatran|mesh-list
139259691|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
139259692|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139259693|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
139259694|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259695|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259696|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
139259697|NCT02164604|Ranibizumab|ranibizumab|mesh-list
139259698|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139259699|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139259700|NCT02164604|Growth Substances|growth substances|mesh-ancestor
139259701|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259702|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
139259703|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259704|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
139259705|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139259706|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
139259707|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259708|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139259709|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139259710|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
139259711|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259712|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259713|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139259714|NCT04571645|Heparin|heparin|mesh-list
139259715|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
139259716|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139259717|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139259718|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259719|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
139259720|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139259721|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
139259722|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
139259723|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259724|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129907|NCT01234935|Gemcitabine|gemcitabine|mesh-list
139259725|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139259726|NCT04050267|Analgesics|analgesics|mesh-ancestor
139259727|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
139259728|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259729|NCT02759120|Doxycycline|doxycycline|mesh-list
139259730|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139259731|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139259732|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
139259733|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
139259734|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139259735|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139259736|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139259737|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
139259738|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139259739|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
139259740|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139259741|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
139259742|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139259743|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
139259744|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139259745|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259746|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139259747|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139259748|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139259749|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139259750|NCT01569113|Estrogens|estrogens|mesh-ancestor
139259751|NCT01569113|Hormones|hormones|mesh-ancestor
139259752|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139259753|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139259754|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
139259755|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139259756|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139259757|NCT03699033|Paclitaxel|paclitaxel|mesh-list
139259758|NCT03699033|Carboplatin|carboplatin|mesh-list
139259759|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139259760|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259761|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
139259762|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
139259763|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
139259764|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259765|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
139259766|NCT03697239|Paclitaxel|paclitaxel|mesh-list
139259767|NCT03697239|Gemcitabine|gemcitabine|mesh-list
139259768|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139259769|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139259770|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259771|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
139259772|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
139259773|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
139259774|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259775|NCT03697239|Vitamins|vitamins|mesh-ancestor
139259776|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
139259777|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259778|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139259779|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
139259780|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
139259781|NCT03697239|Protective Agents|protective agents|mesh-ancestor
139259782|NCT01380431|Lisinopril|lisinopril|mesh-list
139259783|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139259784|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
139259785|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259786|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259787|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139259788|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139259789|NCT01380431|Protective Agents|protective agents|mesh-ancestor
139381465|NCT02429193|Hormones|hormones|mesh-ancestor
139259790|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259791|NCT03697161|Gaboxadol|gaboxadol|mesh-list
139259792|NCT03697161|Analgesics|analgesics|mesh-ancestor
139259793|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
139259794|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259795|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259796|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
139259797|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
139642282|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259798|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
139259799|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259800|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259801|NCT02171156|Nintedanib|nintedanib|mesh-list
139259802|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259803|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139259804|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259805|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259806|NCT01380353|Diclofenac|diclofenac|mesh-list
139259807|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
139259808|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139259809|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139259810|NCT01380353|Analgesics|analgesics|mesh-ancestor
139259811|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
139259812|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259813|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259814|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139259815|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139259816|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139259817|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259818|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259819|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
139259820|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139259821|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
139259822|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259823|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
139259824|NCT02168426|Protective Agents|protective agents|mesh-ancestor
139259825|NCT01380275|Docetaxel|docetaxel|mesh-list
139259826|NCT01380275|Irinotecan|irinotecan|mesh-list
139259827|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259828|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
139259829|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
139259830|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
139259831|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259832|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139259833|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139259834|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843196|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
139259835|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
139259836|NCT02171390|Testosterone|testosterone|mesh-list
139259837|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
139259838|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
139259839|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139259840|NCT02171390|Androgens|androgens|mesh-ancestor
139259841|NCT02171390|Hormones|hormones|mesh-ancestor
139259842|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139259843|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259844|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139259845|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259846|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
139259847|NCT01378481|Vorinostat|vorinostat|mesh-list
139259848|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259849|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139259850|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259851|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259852|NCT02171468|Dabigatran|dabigatran|mesh-list
139259853|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
139259854|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139259855|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
139259856|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259857|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259858|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
139259859|NCT03502031|Losartan|losartan|mesh-list
139259860|NCT03502031|Valsartan|valsartan|mesh-list
139259861|NCT03502031|Enalapril|enalapril|mesh-list
139259862|NCT03502031|Enalaprilat|enalaprilat|mesh-list
139259863|NCT03502031|Lisinopril|lisinopril|mesh-list
139259864|NCT03502031|Perindopril|perindopril|mesh-list
139259865|NCT03502031|Spironolactone|spironolactone|mesh-list
139259866|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139259867|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139259868|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139259869|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259870|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139259871|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139259872|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
139259873|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139259874|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259875|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139259877|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
139259878|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139259879|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
139259880|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259881|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139259882|NCT03502031|Protective Agents|protective agents|mesh-ancestor
139259883|NCT02171546|Fexofenadine|fexofenadine|mesh-list
139259884|NCT02171546|Quinidine|quinidine|mesh-list
139259885|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
139259886|NCT02171546|Dabigatran|dabigatran|mesh-list
139259887|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
139259888|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139259889|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
139259890|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259891|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259892|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
139259893|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139259894|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139259895|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139259896|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
139259897|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
139259898|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259899|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259900|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139259901|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139259902|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
139259903|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139259904|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
139259905|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139259906|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139259907|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138843269|NCT04622904|Lidocaine|lidocaine|mesh-list
139259908|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139259909|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139259910|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
139259911|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139259912|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139259913|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139259914|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139259915|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139259916|NCT02171624|Quinidine|quinidine|mesh-list
139259917|NCT02171624|Dabigatran|dabigatran|mesh-list
139259918|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
139259919|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139259920|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
139259921|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259922|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259923|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
139259924|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139259925|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139259926|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
139259927|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139259928|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259929|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139259930|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
139259931|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139259932|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139259933|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139259934|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139259935|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139259936|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
139259937|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139259938|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139259939|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139259940|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139259941|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139259942|NCT03705351|Temozolomide|temozolomide|mesh-list
139259943|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139259944|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
139259945|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259946|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259947|NCT03705195|Gliclazide|gliclazide|mesh-list
139259948|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139259949|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259950|NCT00101192|Cetuximab|cetuximab|mesh-list
139259951|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259952|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139259953|NCT03688269|Dexamethasone|dexamethasone|mesh-list
139259954|NCT03688269|Ropivacaine|ropivacaine|mesh-list
139259955|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139259956|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
139259957|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
139259958|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259959|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259960|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139259961|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
139259962|NCT03688269|Hormones|hormones|mesh-ancestor
139259963|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139259964|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139259965|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259966|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
139259967|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
139259968|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259969|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
139259970|NCT03688191|Sirolimus|sirolimus|mesh-list
139259971|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139259972|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139259973|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139259974|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259975|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
139259976|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139259977|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
139259978|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259979|NCT02164838|Axitinib|axitinib|mesh-list
139259980|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259981|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139259982|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259983|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259984|NCT02171702|Afatinib|afatinib|mesh-list
139259985|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139259987|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259988|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259989|NCT02171780|Olodaterol|olodaterol|mesh-list
139259990|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139259991|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
139259992|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139259993|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259994|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139259995|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
139259996|NCT02172014|Midazolam|midazolam|mesh-list
139259997|NCT02172014|Fentanyl|fentanyl|mesh-list
139259998|NCT02172014|Citric Acid|citric acid|mesh-list
139259999|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
139260000|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139260001|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139260002|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139260003|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260004|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139260005|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139260006|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139260007|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139260008|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
139260009|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
139260010|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
139260011|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
139260012|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260013|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260014|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139260015|NCT02172014|Narcotics|narcotics|mesh-ancestor
139260016|NCT02172014|Analgesics|analgesics|mesh-ancestor
139260017|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
139260018|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260019|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
139260020|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139260021|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
139260022|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
139260023|NCT02172170|Empagliflozin|empagliflozin|mesh-list
139260024|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139260025|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260026|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139260027|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260028|NCT02255942|Zinc|zinc|mesh-list
139260029|NCT02255942|Iron|iron|mesh-list
139260030|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
139260031|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
139260032|NCT02255942|Trace Elements|trace elements|mesh-ancestor
139260033|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
139260034|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260035|NCT02255942|Astringents|astringents|mesh-ancestor
139260036|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
139260037|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
139260038|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139260039|NCT02255942|Protective Agents|protective agents|mesh-ancestor
139260040|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
139260041|NCT03029247|Hematinics|hematinics|mesh-ancestor
139260042|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
139260043|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139260044|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139260045|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260046|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139260047|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139260048|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260049|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260050|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260051|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139260052|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
139260053|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139260054|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260055|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139260056|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139260057|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139260058|NCT03624309|Docetaxel|docetaxel|mesh-list
139260059|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260060|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
139260061|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
139260062|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
139260063|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260064|NCT03692013|Losartan|losartan|mesh-list
139260065|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139260066|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139260067|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139260068|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139260069|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260070|NCT03695835|Immunomodulating Agents|immunomodulating agents|mesh-list
139260071|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
139260072|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260073|NCT03687255|Tazobactam|tazobactam|mesh-list
139260074|NCT03687255|Piperacillin|piperacillin|mesh-list
139260075|NCT03687255|Cefepime|cefepime|mesh-list
139260076|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139260077|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
139260078|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139260079|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260080|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139260081|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260082|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260083|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
139260084|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139260085|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
139260086|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260087|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
139260088|NCT03691467|Protective Agents|protective agents|mesh-ancestor
139260089|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
139260090|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260091|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260092|NCT02165930|Naltrexone|naltrexone|mesh-list
139260093|NCT02165930|Oxycodone|oxycodone|mesh-list
139260094|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139260095|NCT02165930|Narcotics|narcotics|mesh-ancestor
139260096|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139260097|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260098|NCT02165930|Analgesics|analgesics|mesh-ancestor
139260099|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
139260100|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260101|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139260102|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139260103|NCT03694977|Spartalizumab|spartalizumab|mesh-list
139260104|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139260105|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260106|NCT03694977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139260107|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260108|NCT02172248|Metformin|metformin|mesh-list
139260109|NCT02172248|Empagliflozin|empagliflozin|mesh-list
139260110|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139260111|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260112|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139260113|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260114|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
139260115|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139260116|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
139260117|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260118|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260119|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139260120|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
139260121|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
139260122|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139260123|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
139260124|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260125|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260126|NCT02169596|Ticagrelor|ticagrelor|mesh-list
139260127|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139260128|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139260129|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139260130|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139260131|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
139260132|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260133|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260134|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260135|NCT02169752|Ambrisentan|ambrisentan|mesh-list
139260136|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139260138|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139260139|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
139260140|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260141|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260142|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139260143|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
139260144|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139260145|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
139260146|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260147|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260148|NCT00109538|Lonafarnib|lonafarnib|mesh-list
139260149|NCT00109538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260150|NCT00109538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260151|NCT02172482|Bromides|bromides|mesh-list
139260152|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
139260153|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139260154|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
139260155|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260156|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260157|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139260158|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
139260159|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
139260160|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139260161|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
139260162|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260163|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260164|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
139260165|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
139260166|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139260167|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
139260168|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260169|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260170|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139260171|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
139260172|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
139260173|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139260174|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
139260175|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260176|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260177|NCT00106808|Pioglitazone|pioglitazone|mesh-list
139260178|NCT00106808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139260179|NCT00106808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260180|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
139260181|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139260182|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
139260183|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260184|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
139260185|NCT02166554|Protective Agents|protective agents|mesh-ancestor
139260186|NCT03687021|Progesterone|progesterone|mesh-list
139260187|NCT03687021|Progestins|progestins|mesh-ancestor
139260188|NCT03687021|Hormones|hormones|mesh-ancestor
139260189|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139260190|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260191|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
139260192|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139260193|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139260194|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
139260195|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260196|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260197|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139260198|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
139260199|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
139260200|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139260201|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
139260202|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260203|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381497|NCT02429505|Miltefosine|miltefosine|mesh-list
139260204|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139260205|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139260206|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139260207|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
139260208|NCT02174900|Lumefantrine|lumefantrine|mesh-list
139260209|NCT02174900|Artemether|artemether|mesh-list
139260210|NCT02174900|Primaquine|primaquine|mesh-list
139260211|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139260213|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139260214|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139260215|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260216|NCT02170610|Pantoprazole|pantoprazole|mesh-list
139260217|NCT02170610|Dabigatran|dabigatran|mesh-list
139260218|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139260219|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139260220|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139260221|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260222|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260223|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
139260224|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139260225|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
139260226|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
139260227|NCT02173106|Cyclosporine|cyclosporine|mesh-list
139260228|NCT02173106|Cyclosporins|cyclosporins|mesh-list
139260229|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260230|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260231|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139260232|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
139260233|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260234|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
139260235|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260236|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
139260237|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139260238|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139260239|NCT03932721|Evolocumab|evolocumab|mesh-list
139260240|NCT03932721|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139260241|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139260242|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139260243|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
139260244|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260245|NCT03932721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139260246|NCT03932721|Protease Inhibitors|protease inhibitors|mesh-ancestor
139260247|NCT03932721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260248|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139260249|NCT00106340|Metformin|metformin|mesh-list
139260250|NCT00106340|Glimepiride|glimepiride|mesh-list
139260251|NCT00106340|Vildagliptin|vildagliptin|mesh-list
139260252|NCT00106340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139260253|NCT00106340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260254|NCT00106340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139260255|NCT00106340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139260256|NCT00106340|Immunologic Factors|immunologic factors|mesh-ancestor
139260257|NCT00106340|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139260258|NCT00106340|Protease Inhibitors|protease inhibitors|mesh-ancestor
139260259|NCT00106340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260260|NCT00106340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260261|NCT03538496|Bupivacaine|bupivacaine|mesh-list
139260262|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
139260263|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
139260264|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139260265|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260266|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
139260267|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260268|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
139260269|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139260270|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139260271|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260272|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
139260273|NCT03686787|Coagulants|coagulants|mesh-ancestor
139260274|NCT03694587|Ibuprofen|ibuprofen|mesh-list
139260275|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139260276|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139260277|NCT03694587|Analgesics|analgesics|mesh-ancestor
139260278|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
139381501|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139260279|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260280|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260281|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139260282|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139260283|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139260284|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843633|NCT00962585|Equol|equol|mesh-list
139260285|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260287|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139260288|NCT02170766|Pantoprazole|pantoprazole|mesh-list
139260289|NCT02170766|Dabigatran|dabigatran|mesh-list
139260290|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139260291|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139260292|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139260293|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260294|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260295|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
139260296|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139260297|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
139260298|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
139260299|NCT04156659|Tisagenlecleucel|tisagenlecleucel|mesh-list
139260300|NCT04156659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139260301|NCT04156659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260302|NCT03694119|Phenelzine|phenelzine|mesh-list
139260303|NCT03694119|Ozanimod|ozanimod|mesh-list
139260304|NCT03694119|Tyramine|tyramine|mesh-list
139260305|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139260306|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260307|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139260308|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
139260309|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260310|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
139260311|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139260312|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139260313|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260314|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
139260315|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
139260316|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260317|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139260318|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139260319|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139260320|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
139260321|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260322|NCT02178254|Fosfomycin|fosfomycin|mesh-list
139260323|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139260324|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260325|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
139260326|NCT02173262|Lenograstim|lenograstim|mesh-list
139260327|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139260328|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
139260329|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260330|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139260331|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260332|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139260333|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139260334|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260335|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260336|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260337|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139260338|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139260339|NCT02173418|Ropivacaine|ropivacaine|mesh-list
139260340|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
139260341|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
139260342|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139260343|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260344|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
139260345|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260346|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
139260347|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260348|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
139260349|NCT02178488|Vitamin D|vitamin d|mesh-list
139260350|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139260351|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260352|NCT02178488|Vitamins|vitamins|mesh-ancestor
139260353|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
139260354|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139260355|NCT02173652|Linagliptin|linagliptin|mesh-list
139260356|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139260357|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843705|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260358|NCT02173652|Incretins|incretins|mesh-ancestor
139260359|NCT02173652|Hormones|hormones|mesh-ancestor
139260360|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139260361|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139260363|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260364|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260365|NCT02173730|Pantoprazole|pantoprazole|mesh-list
139260366|NCT02173730|Dabigatran|dabigatran|mesh-list
139260367|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139260368|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139260369|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139260370|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260371|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260372|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
139260373|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139260374|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
139260375|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
139260376|NCT02175446|Bevacizumab|bevacizumab|mesh-list
139260377|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139260378|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260379|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139260380|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139260381|NCT02175446|Growth Substances|growth substances|mesh-ancestor
139260382|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260383|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
139260384|NCT02178644|Capecitabine|capecitabine|mesh-list
139260385|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139260386|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
139260387|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260388|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260389|NCT03686163|Mitogens|mitogens|mesh-list
139260390|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
139260391|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260392|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
139260393|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
139260394|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139260395|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
139260396|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139260397|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260398|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139260399|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139260400|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139260401|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139260402|NCT02173886|Bupropion|bupropion|mesh-list
139260403|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139260404|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
139260405|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139260406|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139260407|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139260408|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139260409|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260410|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
139260411|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260412|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260413|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139260414|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139260415|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260416|NCT02173964|Pinaverium|pinaverium|mesh-list
139260417|NCT02173964|Bromides|bromides|mesh-list
139260418|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
139260419|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139260420|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139260421|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260422|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139260423|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260424|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
139260425|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
139260426|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260427|NCT02175602|Sertraline|sertraline|mesh-list
139260428|NCT02175602|Escitalopram|escitalopram|mesh-list
139260429|NCT02175602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139260430|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138843784|NCT00630149|Pemetrexed|pemetrexed|mesh-list
139260431|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139260432|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260433|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260434|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
139260435|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260436|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
139260437|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139260438|NCT03686085|Dinoprostone|dinoprostone|mesh-list
139260439|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
139260440|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139260441|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260442|NCT03693885|Oxytocin|oxytocin|mesh-list
139260443|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
139260444|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139260445|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260446|NCT02174120|Propofol|propofol|mesh-list
139260447|NCT02174120|Etomidate|etomidate|mesh-list
139260448|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139260449|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139260450|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260451|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139260452|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
139260453|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
139260454|NCT02175914|Erythromycin|erythromycin|mesh-list
139260455|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
139260456|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139260457|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
139260458|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139260459|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260460|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139260461|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139260462|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260463|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260464|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
139260465|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139260466|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139260467|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260468|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
139260469|NCT02753816|Coagulants|coagulants|mesh-ancestor
139260470|NCT02179034|Menthol|menthol|mesh-list
139260471|NCT02179034|Nicotine|nicotine|mesh-list
139260472|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139260473|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
139260474|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260475|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260477|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139260478|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
139260479|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260480|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260481|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
139260482|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
139260483|NCT02174588|Midazolam|midazolam|mesh-list
139260484|NCT02174588|Propofol|propofol|mesh-list
139260485|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139260486|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139260487|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260488|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139260489|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
139260490|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
139260491|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139038368|NCT00372996|Exemestane|exemestane|mesh-list
139260492|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139260493|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139260494|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139260495|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
139260496|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
139260497|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260498|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260499|NCT03693573|Bevacizumab|bevacizumab|mesh-list
139260500|NCT03693573|Atezolizumab|atezolizumab|mesh-list
139260501|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139260502|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260503|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139260504|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139260505|NCT03693573|Growth Substances|growth substances|mesh-ancestor
139260506|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260507|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
139260508|NCT03693573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139260509|NCT03693573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260510|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139260512|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139260513|NCT02176304|Prednisolone|prednisolone|mesh-list
139260514|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
139260515|NCT02176304|Lidocaine|lidocaine|mesh-list
139260516|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139260517|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
139260518|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
139260519|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
139260520|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139260521|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260522|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
139260523|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260524|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139260525|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139260526|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139260527|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139260528|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260529|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139260530|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
139260531|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
139260532|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139260533|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
139260534|NCT02176304|Hormones|hormones|mesh-ancestor
139260535|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139260536|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139260537|NCT02176304|Protective Agents|protective agents|mesh-ancestor
139260538|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139260539|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260540|NCT02176460|Colchicine|colchicine|mesh-list
139260541|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
139260542|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139260543|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
139260544|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
139260545|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
139260546|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260547|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260548|NCT02256254|Simvastatin|simvastatin|mesh-list
139260549|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139260550|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139260551|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
139260552|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260553|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139260554|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139260555|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260556|NCT02182076|Nintedanib|nintedanib|mesh-list
139260557|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260558|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139260559|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260560|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260561|NCT02179268|Sertraline|sertraline|mesh-list
139260562|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139260563|NCT02179268|Citalopram|citalopram|mesh-list
139260564|NCT02179268|Reboxetine|reboxetine|mesh-list
139260565|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
139260566|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139260567|NCT02179268|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139260568|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139260569|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139260570|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260571|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260572|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
139260573|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260574|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139260575|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139260576|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139260577|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
139260578|NCT02182154|Nintedanib|nintedanib|mesh-list
139260579|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260580|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139260581|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260582|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260583|NCT02182232|Paclitaxel|paclitaxel|mesh-list
139260584|NCT02182232|Carboplatin|carboplatin|mesh-list
139260585|NCT02182232|Nintedanib|nintedanib|mesh-list
139260586|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139260587|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260588|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
139260589|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
139260590|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
139260591|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260592|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139260593|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260594|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
139260595|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139260596|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260597|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139260598|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139260599|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260600|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260601|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260602|NCT02176850|Telmisartan|telmisartan|mesh-list
139260603|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139260604|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139260605|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139260606|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260607|NCT03537326|Budesonide|budesonide|mesh-list
139260608|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139260609|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139260610|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
139260611|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260612|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260613|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139260614|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
139260615|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
139260616|NCT03537326|Hormones|hormones|mesh-ancestor
139260617|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139260618|NCT02182544|Ketotifen|ketotifen|mesh-list
139260619|NCT02182544|Epinastine|epinastine|mesh-list
139260620|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
139260621|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
139260622|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139260623|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
139260624|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
139260625|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260626|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260627|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260628|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139260629|NCT02179658|Vancomycin|vancomycin|mesh-list
139260630|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
139260631|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139260632|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260633|NCT02177318|Bromides|bromides|mesh-list
139260634|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
139260635|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139260636|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
139260637|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260638|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260639|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139260640|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
139260641|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
139260642|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139260643|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
139260644|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260645|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260646|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
139260647|NCT02177396|Valsartan|valsartan|mesh-list
139260648|NCT02177396|Telmisartan|telmisartan|mesh-list
139260649|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139260650|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139260651|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139260652|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260653|NCT02030054|Atorvastatin|atorvastatin|mesh-list
139260654|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139260655|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139260656|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139260657|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
139260658|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260659|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139260660|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139260661|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260662|NCT02182622|Prednisone|prednisone|mesh-list
139260663|NCT02182622|Docetaxel|docetaxel|mesh-list
139260664|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260665|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
139260666|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
139260667|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
139260668|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260669|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139260670|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
139260671|NCT02182622|Hormones|hormones|mesh-ancestor
139260672|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139260673|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260674|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139260675|NCT02182700|Bromides|bromides|mesh-list
139260676|NCT02182700|Albuterol|albuterol|mesh-list
139260677|NCT02182700|Ipratropium|ipratropium|mesh-list
139260678|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
139260679|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139260680|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
139260681|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260682|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260683|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139260684|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
139260685|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
139260686|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139260687|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139260688|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139260689|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139260690|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
139260691|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260692|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260693|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139260694|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
139260695|NCT02182778|Cisplatin|cisplatin|mesh-list
139260696|NCT02182778|Gemcitabine|gemcitabine|mesh-list
139260697|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260698|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139260699|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
139260700|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260701|NCT03688971|Ketoconazole|ketoconazole|mesh-list
139260702|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
139260703|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260704|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139260705|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139260706|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260707|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260708|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139260709|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
139260710|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139260711|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260712|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139260713|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
139260714|NCT02179814|Promethazine|promethazine|mesh-list
139260715|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139260716|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139260717|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139260718|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260719|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
139260720|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
139260721|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
139260722|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260723|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
139260724|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
139260725|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139260726|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139260727|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
139260728|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
139260729|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260730|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260731|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139260732|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
139260733|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
139260734|NCT02179970|Plerixafor|plerixafor|mesh-list
139260735|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139260736|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139260737|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
139260738|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260739|NCT03537950|Cannabidiol|cannabidiol|mesh-list
139260740|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
139260741|NCT02182856|Bromides|bromides|mesh-list
139260742|NCT02182856|Albuterol|albuterol|mesh-list
139260743|NCT02182856|Ipratropium|ipratropium|mesh-list
139260744|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
139260745|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139260746|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
139260747|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260748|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260749|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139260750|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
139260751|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
139260752|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139260753|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139260754|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139260755|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139260756|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
139260757|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260758|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260759|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139260760|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
139260761|NCT02183012|Ibuprofen|ibuprofen|mesh-list
139260762|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139260763|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139260764|NCT02183012|Analgesics|analgesics|mesh-ancestor
139260765|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
139260766|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260767|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260768|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139260769|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139260770|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139260771|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260772|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260773|NCT02180048|Caffeine|caffeine|mesh-list
139260774|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139260775|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260776|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139381523|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
139260777|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260778|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260779|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139260780|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139260781|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
139260782|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260784|NCT03688659|Gentamicins|gentamicins|mesh-list
139260785|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139260786|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260787|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139260788|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260789|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260790|NCT03683043|Leuprolide|leuprolide|mesh-list
139260791|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139260792|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
139260793|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139260794|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260795|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139260796|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260797|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139260798|NCT02180204|Tenecteplase|tenecteplase|mesh-list
139260799|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139260800|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139260801|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260802|NCT02183090|Meloxicam|meloxicam|mesh-list
139260803|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139260804|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139260805|NCT02183090|Analgesics|analgesics|mesh-ancestor
139260806|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
139260807|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260808|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260809|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139260810|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139260811|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139260812|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139260813|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260814|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260815|NCT02177552|Carboplatin|carboplatin|mesh-list
139260816|NCT02177552|Docetaxel|docetaxel|mesh-list
139260817|NCT02177552|Capecitabine|capecitabine|mesh-list
139260818|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
139260819|NCT02177552|Epirubicin|epirubicin|mesh-list
139260820|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260821|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
139260822|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
139260823|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
139260824|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260825|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139260826|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
139260827|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139260828|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139260829|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139260830|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260831|NCT03682653|Azithromycin|azithromycin|mesh-list
139260832|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139260833|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260834|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
139260835|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139260836|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139260837|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139260838|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
139260839|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
139260840|NCT04062279|Autoantibodies|autoantibodies|mesh-list
139260841|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
139260842|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260843|NCT02183246|Porfiromycin|porfiromycin|mesh-list
139260844|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139260845|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260846|NCT02183324|Linagliptin|linagliptin|mesh-list
139260847|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139260848|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260849|NCT02183324|Incretins|incretins|mesh-ancestor
139260850|NCT02183324|Hormones|hormones|mesh-ancestor
139381527|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260851|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139260852|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139260854|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260855|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260856|NCT02183402|Linagliptin|linagliptin|mesh-list
139260857|NCT02183402|Digoxin|digoxin|mesh-list
139260858|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139260859|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139260860|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260861|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260862|NCT02183402|Protective Agents|protective agents|mesh-ancestor
139260863|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260864|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139260865|NCT02183402|Incretins|incretins|mesh-ancestor
139260866|NCT02183402|Hormones|hormones|mesh-ancestor
139260867|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139260868|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139260869|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
139260870|NCT02183480|Linagliptin|linagliptin|mesh-list
139260871|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139260872|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260873|NCT02183480|Incretins|incretins|mesh-ancestor
139260874|NCT02183480|Hormones|hormones|mesh-ancestor
139260875|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139260876|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139260877|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
139260878|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260879|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260880|NCT05141864|Lidocaine|lidocaine|mesh-list
139260882|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
139260883|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139260884|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260885|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
139260886|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260887|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139260888|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139260889|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139260890|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139260891|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260892|NCT02180516|Meloxicam|meloxicam|mesh-list
139260893|NCT02180516|Etodolac|etodolac|mesh-list
139260894|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139260895|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139260896|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139260897|NCT02180516|Analgesics|analgesics|mesh-ancestor
139260898|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
139260899|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260900|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260901|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139260902|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139260903|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139260904|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260905|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260906|NCT02183636|Pioglitazone|pioglitazone|mesh-list
139260907|NCT02183636|Linagliptin|linagliptin|mesh-list
139260908|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139260909|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260910|NCT02183636|Incretins|incretins|mesh-ancestor
139260911|NCT02183636|Hormones|hormones|mesh-ancestor
139260912|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139260913|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139260914|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
139260915|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260916|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260917|NCT02183948|Oxytocin|oxytocin|mesh-list
139260918|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
139260919|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139260920|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260921|NCT02184104|Caffeine|caffeine|mesh-list
139260922|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139260923|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260924|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139260925|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260926|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260927|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139260928|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139260929|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
139260930|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260931|NCT02184260|Dipyrone|dipyrone|mesh-list
139260932|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139260933|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139260934|NCT02184260|Analgesics|analgesics|mesh-ancestor
139260935|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
139260936|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260937|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260938|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139260939|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139260940|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
139260941|NCT03684837|Vitamin D|vitamin d|mesh-list
139260942|NCT03684837|Vitamins|vitamins|mesh-ancestor
139260943|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
139260944|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260945|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139260946|NCT03808155|Tamsulosin|tamsulosin|mesh-list
139260947|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139260948|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139260949|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139260950|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
139260951|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139260952|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844311|NCT00859183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260953|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260954|NCT03808155|Urological Agents|urological agents|mesh-ancestor
139260955|NCT02752958|Fluorides|fluorides|mesh-list
139260956|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
139260957|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
139260958|NCT02752958|Protective Agents|protective agents|mesh-ancestor
139260959|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260960|NCT02181218|Dexamethasone|dexamethasone|mesh-list
139260961|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
139260962|NCT02181218|Gemcitabine|gemcitabine|mesh-list
139260963|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
139260964|NCT02181218|Romidepsin|romidepsin|mesh-list
139260965|NCT02181218|BB 1101|bb 1101|mesh-list
139260966|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139260967|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
139260968|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
139260969|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260970|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260971|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139260972|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
139260973|NCT02181218|Hormones|hormones|mesh-ancestor
139260974|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139260975|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139260976|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260977|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
139260978|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139260979|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260980|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139260981|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
139260982|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139260983|NCT02181218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139260984|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139260985|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
139260986|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139260987|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
139260988|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139260989|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260990|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139260991|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139260992|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139260993|NCT03682497|Spironolactone|spironolactone|mesh-list
139260994|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139260995|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
139260996|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139260997|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139260998|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139261000|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
139261001|NCT02185898|Menthol|menthol|mesh-list
139261002|NCT02185898|Nicotine|nicotine|mesh-list
139261003|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139261004|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
139261005|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261006|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261007|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139261008|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139261009|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
139261010|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261011|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261012|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
139261013|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
139261014|NCT02805660|Durvalumab|durvalumab|mesh-list
139261015|NCT02805660|Mocetinostat|mocetinostat|mesh-list
139261016|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139261017|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261018|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139261019|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261020|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261021|NCT02186132|Atropine|atropine|mesh-list
139261022|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139261023|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139261024|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139261025|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
139261026|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261027|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261028|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139261029|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
139261030|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
139261031|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
139261032|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139261033|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139261034|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
139261035|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261036|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261037|NCT03536780|Gemcitabine|gemcitabine|mesh-list
139261038|NCT03536780|Avelumab|avelumab|mesh-list
139261039|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139261040|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
139261041|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261042|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261043|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139261044|NCT02052336|Clarithromycin|clarithromycin|mesh-list
139261045|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139261046|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139261047|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139261048|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261049|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261050|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139261051|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139261052|NCT02181920|Dipyrone|dipyrone|mesh-list
139261053|NCT02181920|Diclofenac|diclofenac|mesh-list
139261054|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139261055|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139261056|NCT02181920|Analgesics|analgesics|mesh-ancestor
139261057|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
139261058|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261059|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261060|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139261061|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139261062|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139261063|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261064|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261065|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
139261066|NCT02185118|Sevoflurane|sevoflurane|mesh-list
139261067|NCT02185118|Isoflurane|isoflurane|mesh-list
139261068|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139261069|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139261070|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
139261071|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
139261072|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131268|NCT03590626|Dulaglutide|dulaglutide|mesh-list
139261073|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261075|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139261076|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139261077|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139261078|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261079|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139261080|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139261081|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
139261082|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261083|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261084|NCT02053974|Spironolactone|spironolactone|mesh-list
139261085|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139261086|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
139261087|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139261088|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261089|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139261090|NCT02053974|Diuretics|diuretics|mesh-ancestor
139261091|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
139261092|NCT02185196|Vitamin D|vitamin d|mesh-list
139261093|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
139261094|NCT02185196|Vitamins|vitamins|mesh-ancestor
139261095|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
139261096|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261097|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139261098|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139261099|NCT02052492|Vitamin D|vitamin d|mesh-list
139261100|NCT02052492|Vitamins|vitamins|mesh-ancestor
139261101|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
139261102|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844465|NCT05977868|Amoxicillin|amoxicillin|mesh-list
139261103|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139261104|NCT02181998|Heparin|heparin|mesh-list
139261105|NCT02181998|Enoxaparin|enoxaparin|mesh-list
139261106|NCT02181998|Tenecteplase|tenecteplase|mesh-list
139261107|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
139261108|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139261109|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139261110|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261111|NCT02054052|Bevacizumab|bevacizumab|mesh-list
139261112|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139261113|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261114|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139261115|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139261116|NCT02054052|Growth Substances|growth substances|mesh-ancestor
139261117|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261118|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
139261119|NCT02185352|Cisplatin|cisplatin|mesh-list
139261120|NCT02185352|Etoposide|etoposide|mesh-list
139261121|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261122|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139261123|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139261124|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139261125|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261126|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261127|NCT02052726|Vaccines|vaccines|mesh-list
139261128|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
139261129|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261130|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
139261131|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139261132|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139261133|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261134|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139261135|NCT02185430|Analgesics|analgesics|mesh-ancestor
139261136|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
139261137|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261138|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139261139|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139261140|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139261141|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
139261142|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261143|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261144|NCT03536390|Methylphenidate|methylphenidate|mesh-list
139642283|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139261145|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139261146|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261147|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139261148|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139261149|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139261150|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261151|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
139261152|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261153|NCT03561870|Olaparib|olaparib|mesh-list
139261154|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139261155|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261156|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261157|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261158|NCT02186990|Propofol|propofol|mesh-list
139261159|NCT02186990|Etomidate|etomidate|mesh-list
139261160|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139261161|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139261162|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261163|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139261164|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
139261165|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
139261166|NCT05657028|Lidocaine|lidocaine|mesh-list
139261167|NCT05657028|Dexmedetomidine|dexmedetomidine|mesh-list
139261168|NCT05657028|Anesthetics, Local|anesthetics, local|mesh-ancestor
139261169|NCT05657028|Anesthetics|anesthetics|mesh-ancestor
139261170|NCT05657028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139261171|NCT05657028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261172|NCT05657028|Sensory System Agents|sensory system agents|mesh-ancestor
139261173|NCT05657028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261174|NCT05657028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139261175|NCT05657028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139261176|NCT05657028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138844612|NCT05602519|Anesthetics|anesthetics|mesh-ancestor
139261177|NCT05657028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139261178|NCT05657028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261179|NCT05657028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139261180|NCT05657028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139261181|NCT05657028|Analgesics|analgesics|mesh-ancestor
139261182|NCT05657028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139261183|NCT05657028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139261184|NCT05657028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139261185|NCT05657028|Adrenergic Agents|adrenergic agents|mesh-ancestor
139261186|NCT05657028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261187|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
139261188|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139261189|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139261190|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261191|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139261192|NCT02187068|Analgesics|analgesics|mesh-ancestor
139261193|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
139261194|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261195|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139261196|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139261197|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139261198|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
139261199|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261200|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261201|NCT02054442|Methotrexate|methotrexate|mesh-list
139261202|NCT02054442|Cetuximab|cetuximab|mesh-list
139261203|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139261204|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
139261205|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139261206|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261207|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139261208|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
139261209|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261210|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261211|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
139261212|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261213|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139261214|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139261215|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
139261216|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139261217|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139261218|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139261219|NCT02054676|Ibuprofen|ibuprofen|mesh-list
139261220|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139261221|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139261222|NCT02054676|Analgesics|analgesics|mesh-ancestor
139261223|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
139261224|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261225|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261226|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139261227|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139261228|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139261229|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261230|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261231|NCT02256956|Amitriptyline|amitriptyline|mesh-list
139261232|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139261233|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139261234|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
139261235|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139261236|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139261237|NCT02256956|Analgesics|analgesics|mesh-ancestor
139261238|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
139261239|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261240|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261241|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139261242|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139261243|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139261244|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261245|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
139261246|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261247|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139261248|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139261249|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
139261250|NCT02256956|Urological Agents|urological agents|mesh-ancestor
139261251|NCT02187536|Telmisartan|telmisartan|mesh-list
139261252|NCT02187536|Simvastatin|simvastatin|mesh-list
139261253|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139261254|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139261255|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
139261256|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261257|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139261258|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139261259|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261260|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139261261|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139261262|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139261263|NCT02256722|Propranolol|propranolol|mesh-list
139261264|NCT02256722|Bisoprolol|bisoprolol|mesh-list
139261265|NCT02256722|Acipimox|acipimox|mesh-list
139261266|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139261267|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139261268|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
139261269|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261270|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261271|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139261272|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
139261273|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139261274|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139261275|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139261276|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
139261277|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261278|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261279|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139261280|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139261281|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139261282|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139261283|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
139261284|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
139261285|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139261286|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139261287|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
139261288|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139261289|NCT02187614|Acetaminophen|acetaminophen|mesh-list
139261290|NCT02187614|Diclofenac|diclofenac|mesh-list
139261291|NCT02187614|Morphine|morphine|mesh-list
139261292|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139261293|NCT02187614|Narcotics|narcotics|mesh-ancestor
139261294|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139261295|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261296|NCT02187614|Analgesics|analgesics|mesh-ancestor
139261297|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
139261298|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261299|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139261300|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
139261301|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139261302|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139261303|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139261304|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139261305|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261306|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261307|NCT02030678|Irinotecan|irinotecan|mesh-list
139261308|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139261309|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139261310|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261311|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261312|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261313|NCT02054988|Caffeine|caffeine|mesh-list
139261314|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139261315|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261316|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139261317|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261318|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261319|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139261320|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139261321|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
139261322|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261323|NCT02191124|Mirtazapine|mirtazapine|mesh-list
139261324|NCT02191124|Paroxetine|paroxetine|mesh-list
139261325|NCT02191124|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139261326|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139261327|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139261328|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261329|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261330|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
139261331|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261332|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139261333|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
139261334|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139261335|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139261336|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139261337|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261338|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139261339|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
139261340|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
139261341|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139261342|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139261343|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139261344|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139261345|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139261346|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139261347|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
139261348|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139261349|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139261350|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139261351|NCT02193698|Dexamethasone|dexamethasone|mesh-list
139261352|NCT02193698|Lenalidomide|lenalidomide|mesh-list
139261353|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139261354|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
139261355|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
139261356|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261357|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261358|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139261359|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
139261360|NCT02193698|Hormones|hormones|mesh-ancestor
139261361|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139261362|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139261363|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261364|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
139261365|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139261366|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139261367|NCT02193698|Growth Substances|growth substances|mesh-ancestor
139261368|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
139261369|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139261370|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139261371|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261372|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261373|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
139261374|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139261375|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139261376|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139261377|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139261378|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139261379|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261380|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261381|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261382|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
139261383|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139261384|NCT02191280|Quercetin|quercetin|mesh-list
139261385|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
139261386|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261387|NCT02191280|Protective Agents|protective agents|mesh-ancestor
139261388|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261389|NCT02055378|Atropine|atropine|mesh-list
139261390|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139261391|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139261392|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139261393|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
139261394|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844765|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
139261395|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261396|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139261397|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
139261398|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
139261399|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
139261400|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139261401|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139261402|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
139261403|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261404|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261405|NCT04558190|Ubiquinone|ubiquinone|mesh-list
139261406|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139261407|NCT04558190|Albuterol|albuterol|mesh-list
139381555|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
139261408|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139261409|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
139261410|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261411|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261412|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139261413|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
139261414|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
139261415|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139261416|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139261417|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139261418|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139261419|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
139261420|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261421|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261422|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139261423|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139261424|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139261425|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
139261426|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139261427|NCT03676959|Antibodies|antibodies|mesh-list
139261428|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
139261429|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139261430|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
139261431|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261432|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261433|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139261434|NCT03755973|Hormones|hormones|mesh-ancestor
139642284|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
139261435|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139261436|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261437|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139261438|NCT02056938|Basiliximab|basiliximab|mesh-list
139261439|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
139261440|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261441|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139261442|NCT02191670|Tenecteplase|tenecteplase|mesh-list
139261443|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139261444|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139261445|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261446|NCT02057094|Caseins|caseins|mesh-list
139261447|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
139261448|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
139261449|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261450|NCT02917941|Dexamethasone|dexamethasone|mesh-list
139261451|NCT02917941|Lenalidomide|lenalidomide|mesh-list
139261452|NCT02917941|Ixazomib|ixazomib|mesh-list
139261453|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139261454|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
139261455|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
139261456|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261457|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261458|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139261459|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
139261460|NCT02917941|Hormones|hormones|mesh-ancestor
139261461|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139261462|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139261463|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261464|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
139261465|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139261466|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139261467|NCT02917941|Growth Substances|growth substances|mesh-ancestor
139261468|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
139261469|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
139261470|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261471|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261472|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
139261473|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139261474|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261475|NCT02191748|Triamcinolone|triamcinolone|mesh-list
139261476|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139261477|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
139381559|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139261479|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139261480|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261481|NCT02191826|Tolcapone|tolcapone|mesh-list
139261482|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139261483|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139261484|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139261485|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261486|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261487|NCT01333956|Pregabalin|pregabalin|mesh-list
139261488|NCT01333956|Analgesics|analgesics|mesh-ancestor
139261489|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
139261490|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261491|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261492|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
139261493|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139261494|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139261495|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261496|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139261497|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139261498|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139261499|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139261500|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139261501|NCT02057328|Telmisartan|telmisartan|mesh-list
139261502|NCT02057328|Nebivolol|nebivolol|mesh-list
139261503|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139261504|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139261505|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139261506|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261507|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
139261508|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139261509|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139261510|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139261511|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
139261512|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261513|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261514|NCT02057484|Tacrolimus|tacrolimus|mesh-list
139261515|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139261516|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
139261517|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261518|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139261519|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261520|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261521|NCT02192060|Triclosan|triclosan|mesh-list
139261522|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139261523|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139261524|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139261525|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139261526|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
139261527|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261528|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139261529|NCT02188394|Bupivacaine|bupivacaine|mesh-list
139261530|NCT02188394|Anesthetics|anesthetics|mesh-list
139261531|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
139261532|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139261533|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261534|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
139261535|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261536|NCT01333722|Acetaminophen|acetaminophen|mesh-list
139261537|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139261538|NCT01333722|Hydrocodone|hydrocodone|mesh-list
139261539|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139261540|NCT01333722|Analgesics|analgesics|mesh-ancestor
139261541|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
139261542|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261543|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261545|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139261546|NCT01333722|Narcotics|narcotics|mesh-ancestor
139261547|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139261548|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
139261549|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
139261550|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139261551|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139261552|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139261553|NCT02188472|Trimethoprim|trimethoprim|mesh-list
139261554|NCT02188472|Penicillins|penicillins|mesh-list
139261555|NCT02188472|Penicillin V|penicillin v|mesh-list
139261556|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139261557|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139261558|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
139261559|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139261560|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139261561|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139261562|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261563|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261564|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139261565|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139261566|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139261567|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139261568|NCT02188550|Everolimus|everolimus|mesh-list
139261569|NCT02188550|Letrozole|letrozole|mesh-list
139261570|NCT02188550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139261571|NCT02188550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139261572|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261573|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261574|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139261575|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
139261576|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261577|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261578|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139261579|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139261580|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139261581|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
139261582|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139261583|NCT02059590|Isavuconazole|isavuconazole|mesh-list
139261584|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
139261585|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139261586|NCT02057796|Efavirenz|efavirenz|mesh-list
139261587|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139261588|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139261589|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139261590|NCT02057796|Rifampin|rifampin|mesh-list
139261591|NCT02057796|Isoniazid|isoniazid|mesh-list
139261592|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
139261593|NCT02057796|Ethambutol|ethambutol|mesh-list
139261594|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139261595|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139261596|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261597|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261598|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
139261599|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139261600|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139261601|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139261602|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139261603|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139261604|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139261605|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139261606|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139261607|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139261608|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139261609|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
139261610|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139261611|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
139261612|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139261613|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139261614|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139261615|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139261616|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139261617|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
139261618|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139261620|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139261621|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
139261622|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
139261623|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139261624|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139261625|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261626|NCT03560856|Fulvestrant|fulvestrant|mesh-list
139261627|NCT03560856|Palbociclib|palbociclib|mesh-list
139261628|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139261629|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261630|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139261631|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139261632|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
139261633|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139261634|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261635|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139261636|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261637|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261638|NCT03676413|Fluticasone|fluticasone|mesh-list
139261639|NCT03676413|Xhance|xhance|mesh-list
139261640|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139261641|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139261642|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139261643|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139261644|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
139261645|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261646|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261647|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139261648|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
139261649|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
139261650|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139261651|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139261652|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139261653|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139261654|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
139261655|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261656|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261657|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
139131856|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261658|NCT03676413|Hormones|hormones|mesh-ancestor
139261659|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139261660|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
139261661|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139261662|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139261663|NCT01370694|Prednisolone|prednisolone|mesh-list
139261664|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
139261665|NCT01370694|Vincristine|vincristine|mesh-list
139261666|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139261667|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
139261668|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261669|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139261670|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139261671|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
139261672|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261673|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261674|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139261675|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139261676|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
139261677|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
139261678|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
139261679|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139261680|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
139261681|NCT01370694|Hormones|hormones|mesh-ancestor
139261682|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139261683|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139261684|NCT02256878|Amitriptyline|amitriptyline|mesh-list
139261685|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139261686|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
139261687|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845062|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139261688|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139261689|NCT02256878|Analgesics|analgesics|mesh-ancestor
139261690|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
139261691|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261692|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261693|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139261694|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139261695|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139261696|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261697|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
139261698|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261699|NCT02058186|Vitamin D|vitamin d|mesh-list
139261700|NCT02058186|Vitamins|vitamins|mesh-ancestor
139261701|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
139261702|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261703|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139261704|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
139261705|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139261706|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139261707|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261708|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
139261709|NCT03676023|Coagulants|coagulants|mesh-ancestor
139261710|NCT02260206|Colchicine|colchicine|mesh-list
139261711|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
139261712|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139261713|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
139261714|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
139261715|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
139261716|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261717|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261718|NCT02058576|Tamsulosin|tamsulosin|mesh-list
139261719|NCT02058576|Dutasteride|dutasteride|mesh-list
139261720|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139261721|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139261722|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139261723|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
139261724|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261725|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261726|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261727|NCT02058576|Urological Agents|urological agents|mesh-ancestor
139261728|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139642285|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131932|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139261729|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139261730|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261731|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
139261732|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139261733|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139261734|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
139261735|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
139261736|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261737|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261738|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139261739|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139261740|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139261741|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
139261742|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139261743|NCT03675555|Dexamethasone|dexamethasone|mesh-list
139261744|NCT03675555|Mirtazapine|mirtazapine|mesh-list
139261745|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139261746|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139261747|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
139261748|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
139261749|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261750|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261751|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139261752|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
139261754|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139261755|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139261756|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261757|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
139261758|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139261759|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139261760|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
139261761|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
138845140|NCT02803788|Dexamethasone|dexamethasone|mesh-list
139261762|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261763|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261764|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139261765|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139261766|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139261767|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139261768|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139261769|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139261770|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
139261771|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139261772|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139261773|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
139261774|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139261775|NCT02194166|Paclitaxel|paclitaxel|mesh-list
139261776|NCT02194166|Docetaxel|docetaxel|mesh-list
139261777|NCT02194166|Trastuzumab|trastuzumab|mesh-list
139261778|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139261779|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261780|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
139261781|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
139261782|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
139261783|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261784|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139261785|NCT02194322|Olcegepant|olcegepant|mesh-list
139261786|NCT02194322|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139261787|NCT02194322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261788|NCT02194322|Analgesics|analgesics|mesh-ancestor
139261789|NCT02194322|Sensory System Agents|sensory system agents|mesh-ancestor
139261790|NCT02194322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261791|NCT02194322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261792|NCT02193308|Amlodipine|amlodipine|mesh-list
139261793|NCT02193308|Telmisartan|telmisartan|mesh-list
139261794|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139261795|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139261796|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139261797|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139261798|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642286|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132008|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261799|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139261800|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261801|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
139261802|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139261803|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139261805|NCT02060604|Ranibizumab|ranibizumab|mesh-list
139261806|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139261807|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139261808|NCT02060604|Growth Substances|growth substances|mesh-ancestor
139261809|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261810|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
139261811|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261812|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139261813|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139261814|NCT02060604|Analgesics|analgesics|mesh-ancestor
139261815|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
139261816|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261817|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139261818|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139261819|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139261820|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261821|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261822|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
139261823|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139261824|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261825|NCT03315143|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139261826|NCT03315143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139261827|NCT03315143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261828|NCT03315143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139261829|NCT03315143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261830|NCT02194556|Gemcitabine|gemcitabine|mesh-list
139261831|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139261832|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
139261833|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261834|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261835|NCT02030912|Amoxicillin|amoxicillin|mesh-list
139261836|NCT02030912|Minocycline|minocycline|mesh-list
139261837|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139261838|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139261839|NCT02060916|PAZ320|paz320|mesh-list
139261840|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139261841|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261842|NCT02797080|Interferons|interferons|mesh-list
139261843|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
139261844|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261845|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
139261846|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139261847|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
139261848|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139261849|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
139261850|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261851|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261852|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139261853|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
139261854|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
139261855|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139261856|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
139261857|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261858|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261859|NCT02915835|Riociguat|riociguat|mesh-list
139261860|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
139261861|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261862|NCT01370616|Amoxicillin|amoxicillin|mesh-list
139261863|NCT01370616|Tazobactam|tazobactam|mesh-list
139261864|NCT01370616|Piperacillin|piperacillin|mesh-list
139261865|NCT01370616|Ertapenem|ertapenem|mesh-list
139261866|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139261867|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139261868|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139261869|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139642287|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
139261870|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261871|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261872|NCT02688881|Sirolimus|sirolimus|mesh-list
139261873|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139261874|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139261875|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139261876|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261877|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
139261878|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139261879|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
139261880|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261881|NCT02197286|Vitamin D|vitamin d|mesh-list
139261882|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
139261883|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
139261884|NCT02197286|Vitamins|vitamins|mesh-list
139261885|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
139261886|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261887|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139261888|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139261889|NCT02197442|Valsartan|valsartan|mesh-list
139261890|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139261891|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139261892|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139261893|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261894|NCT03534674|Vitamin D|vitamin d|mesh-list
139261895|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
139261896|NCT03534674|Vitamins|vitamins|mesh-ancestor
139261897|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
139261898|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261899|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139261900|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139261901|NCT02063334|Vitamin D|vitamin d|mesh-list
139261902|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
139261903|NCT02063334|Vitamins|vitamins|mesh-ancestor
139261904|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
139261905|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845303|NCT00959699|Ribavirin|ribavirin|mesh-list
139261906|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139261907|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139261909|NCT02916927|Analgesics|analgesics|mesh-ancestor
139261910|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
139261911|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261912|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261913|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139261914|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139261915|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
139261916|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
139261917|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139261918|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139261919|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139261920|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261921|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261922|NCT02197598|Nalmefene|nalmefene|mesh-list
139261923|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139261924|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261925|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
139261926|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261927|NCT02196662|Mesalamine|mesalamine|mesh-list
139261928|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139261929|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139261930|NCT02196662|Analgesics|analgesics|mesh-ancestor
139261931|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
139261932|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261933|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261934|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139261935|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139261936|NCT02195180|Leucovorin|leucovorin|mesh-list
139261937|NCT02195180|Gemcitabine|gemcitabine|mesh-list
139261938|NCT02195180|Fluorouracil|fluorouracil|mesh-list
139261939|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
139261940|NCT02195180|Asparaginase|asparaginase|mesh-list
139261941|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139261942|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
139261943|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261944|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261945|NCT02195180|Antidotes|antidotes|mesh-ancestor
139261946|NCT02195180|Protective Agents|protective agents|mesh-ancestor
139261947|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261948|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
139261949|NCT02195180|Vitamins|vitamins|mesh-ancestor
139261950|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
139261951|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139261952|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
139261953|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
139261954|NCT03623529|Giapreza|giapreza|mesh-list
139261955|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
139261956|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139261957|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139261958|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
139261959|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139261960|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261961|NCT02197676|Guadecitabine|guadecitabine|mesh-list
139261962|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261963|NCT02916693|Mirabegron|mirabegron|mesh-list
139381586|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
139261964|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139261965|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139261966|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139261967|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
139261968|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261969|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261970|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261971|NCT02916693|Urological Agents|urological agents|mesh-ancestor
139261972|NCT02195336|Paclitaxel|paclitaxel|mesh-list
139261973|NCT02195336|Bevacizumab|bevacizumab|mesh-list
139261974|NCT02195336|Carboplatin|carboplatin|mesh-list
139261975|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139261976|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139261977|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
139261978|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
139261979|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
138845364|NCT05550636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139261980|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261981|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139261982|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139261983|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139261984|NCT02195336|Growth Substances|growth substances|mesh-ancestor
139261985|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261986|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
139261987|NCT03679065|Acetaminophen|acetaminophen|mesh-list
139261988|NCT03679065|Dexamethasone|dexamethasone|mesh-list
139261989|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
139261990|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139261991|NCT03679065|BB 1101|bb 1101|mesh-list
139261992|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139261993|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
139261994|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
139261995|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139261996|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139261997|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139261998|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
139261999|NCT03679065|Hormones|hormones|mesh-ancestor
139262000|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139262001|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139262002|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262003|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
139262004|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262005|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262006|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139262007|NCT03679065|Analgesics|analgesics|mesh-ancestor
139262008|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
139262009|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
139262010|NCT02196740|Metronidazole|metronidazole|mesh-list
139262011|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
139262012|NCT02196740|Clindamycin|clindamycin|mesh-list
139262013|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
139262014|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
139262015|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
139262016|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262017|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139262018|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139262019|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139262020|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139262021|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139262022|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262023|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262024|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262025|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139262026|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139262027|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139262028|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139262029|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139262031|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
139262032|NCT02195492|Protective Agents|protective agents|mesh-ancestor
139262033|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262034|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
139262035|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139262036|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262037|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139262038|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
139262039|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139262040|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262041|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262042|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262043|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
139262044|NCT02919345|Glyburide|glyburide|mesh-list
139262045|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139262046|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262047|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139262048|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262049|NCT02195804|Ranitidine|ranitidine|mesh-list
139262050|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139262051|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139262052|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139262053|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139262054|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
139262055|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
138845436|NCT02798172|Incretins|incretins|mesh-ancestor
139262056|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139262057|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262058|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262059|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
139262060|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
139262061|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
139262062|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139262063|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262064|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
139262065|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262066|NCT03674463|Immunomodulating Agents|immunomodulating agents|mesh-list
139262067|NCT03674463|Immunologic Factors|immunologic factors|mesh-ancestor
139262068|NCT03674463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262069|NCT03674385|Vitamin E|vitamin e|mesh-list
139262070|NCT03674385|Metformin|metformin|mesh-list
139262071|NCT03674385|Clomiphene|clomiphene|mesh-list
139262072|NCT03674385|Enclomiphene|enclomiphene|mesh-list
139262073|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
139262074|NCT03674385|Vitamins|vitamins|mesh-ancestor
139262075|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
139262076|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262077|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139262078|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262079|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
139262080|NCT03674385|Protective Agents|protective agents|mesh-ancestor
139262081|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139262082|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
139262083|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139262084|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139262085|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
139262086|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139262087|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139262088|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139262089|NCT02574455|Gemcitabine|gemcitabine|mesh-list
139262090|NCT02574455|Capecitabine|capecitabine|mesh-list
139262091|NCT02574455|Vinorelbine|vinorelbine|mesh-list
139262092|NCT02574455|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139262093|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139262094|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
139262095|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262096|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262097|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139262098|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
139262099|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
139262100|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
139262101|NCT02574455|Immunoconjugates|immunoconjugates|mesh-ancestor
139262102|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
139262103|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262104|NCT02197988|Fentanyl|fentanyl|mesh-list
139262105|NCT02197988|Bupivacaine|bupivacaine|mesh-list
139262106|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
139262107|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
139262108|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139262109|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262110|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
139262111|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262112|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139262113|NCT02197988|Narcotics|narcotics|mesh-ancestor
139262114|NCT02197988|Analgesics|analgesics|mesh-ancestor
139262115|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139262116|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139262117|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
139262118|NCT03672357|Liver Extracts|liver extracts|mesh-list
139262119|NCT03672357|Hematinics|hematinics|mesh-ancestor
139262120|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139262121|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
139262122|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262123|NCT03674073|Vaccines|vaccines|mesh-list
139262124|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
139262125|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262126|NCT03673995|Inositol|inositol|mesh-list
139262127|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
139262128|NCT03673995|Vitamins|vitamins|mesh-ancestor
139262129|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
139262130|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262131|NCT01378091|Prednisone|prednisone|mesh-list
139262132|NCT01378091|Docetaxel|docetaxel|mesh-list
139262133|NCT01378091|Lenalidomide|lenalidomide|mesh-list
139262134|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262135|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
139262136|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
139262137|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
139262138|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262139|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139262140|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
139262141|NCT01378091|Hormones|hormones|mesh-ancestor
139262142|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139262143|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262144|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139262145|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
139262146|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139262147|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139262148|NCT01378091|Growth Substances|growth substances|mesh-ancestor
139262149|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
139262150|NCT02794974|Anesthetics|anesthetics|mesh-list
139262151|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139262152|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262153|NCT02063568|Oxytocin|oxytocin|mesh-list
139262154|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
139262155|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139262156|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262157|NCT02257502|Aflibercept|aflibercept|mesh-list
139262158|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139262159|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139262160|NCT02257502|Growth Substances|growth substances|mesh-ancestor
139262161|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262162|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
139262163|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262164|NCT02450123|Sunitinib|sunitinib|mesh-list
139262165|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262166|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139262167|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139262168|NCT02450123|Growth Substances|growth substances|mesh-ancestor
139262169|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262170|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
139262171|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139262172|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262173|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262174|NCT02063802|Metformin|metformin|mesh-list
139262175|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139262176|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262177|NCT03672045|Carbetocin|carbetocin|mesh-list
139262178|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
139262179|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139262180|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262181|NCT02198300|Clopidogrel|clopidogrel|mesh-list
139262182|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139262183|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139262184|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139262185|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139262186|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
139262187|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139262188|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262189|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262190|NCT03560232|Clindamycin|clindamycin|mesh-list
139262191|NCT03560232|Gentamicins|gentamicins|mesh-list
139262192|NCT03560232|Cefazolin|cefazolin|mesh-list
139262193|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
139262194|NCT03560232|Tazobactam|tazobactam|mesh-list
139262195|NCT03560232|Piperacillin|piperacillin|mesh-list
139262196|NCT03560232|Ampicillin|ampicillin|mesh-list
139262197|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139262198|NCT03560232|Sulbactam|sulbactam|mesh-list
139262199|NCT03560232|Sultamicillin|sultamicillin|mesh-list
139262200|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139262201|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262202|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139262203|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262204|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262205|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139262206|NCT02201342|Udenafil|udenafil|mesh-list
139262207|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139262208|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139262209|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262210|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262211|NCT02201576|Bortezomib|bortezomib|mesh-list
139262212|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
139262213|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139262214|NCT02201576|Antibodies|antibodies|mesh-list
139262215|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
139262216|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139262217|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262218|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
139262219|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262220|NCT02198378|Acetaminophen|acetaminophen|mesh-list
139262221|NCT02198378|Morphine|morphine|mesh-list
139262222|NCT02198378|Entonox|entonox|mesh-list
139262223|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139262224|NCT02198378|Narcotics|narcotics|mesh-ancestor
139262225|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139262226|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262227|NCT02198378|Analgesics|analgesics|mesh-ancestor
139262228|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
139262229|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262230|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139262231|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
139262232|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139262233|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
139262234|NCT02063100|Losartan|losartan|mesh-list
139262235|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139262236|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139262237|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139262238|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139262239|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262240|NCT02198846|Insulin|insulin|mesh-list
139262241|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139262242|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262243|NCT02198924|Celecoxib|celecoxib|mesh-list
139262244|NCT02198924|Parecoxib|parecoxib|mesh-list
139262245|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139262246|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139262247|NCT02198924|Analgesics|analgesics|mesh-ancestor
139262248|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
139262249|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262250|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262251|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139262252|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139262253|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139262254|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139262255|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381597|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139262256|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262257|NCT05462093|Liver Extracts|liver extracts|mesh-list
139262258|NCT05462093|Hematinics|hematinics|mesh-ancestor
139262259|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
139262260|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139262261|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262262|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139262263|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139262264|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262265|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262266|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262267|NCT02202200|Palbociclib|palbociclib|mesh-list
139262268|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262269|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139262270|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262271|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262272|NCT02064504|Fluticasone|fluticasone|mesh-list
139262273|NCT02064504|Xhance|xhance|mesh-list
139262274|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139262275|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139262276|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
139262277|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262278|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262279|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139262280|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
139262281|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
139262282|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139262283|NCT02067936|Remifentanil|remifentanil|mesh-list
139262284|NCT02067936|Propofol|propofol|mesh-list
139262285|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139262286|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139262287|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262288|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139262289|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
139262290|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
139262291|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139262292|NCT02067936|Narcotics|narcotics|mesh-ancestor
139262293|NCT02067936|Analgesics|analgesics|mesh-ancestor
139262294|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
139262295|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262296|NCT01377545|Anesthetics|anesthetics|mesh-list
139262297|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
139262298|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139262299|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262300|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
139262301|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262302|NCT01379807|Docetaxel|docetaxel|mesh-list
139262303|NCT01379807|Panitumumab|panitumumab|mesh-list
139262304|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262305|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
139262306|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
139262307|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
139262308|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262309|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139262310|NCT02202512|Naproxen|naproxen|mesh-list
139262311|NCT02202512|Cimetidine|cimetidine|mesh-list
139262312|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139262313|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139262314|NCT02202512|Analgesics|analgesics|mesh-ancestor
139262315|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
139262316|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262317|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262318|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139262319|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139262320|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
139262321|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139262322|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262323|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262324|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139262325|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139262326|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139262327|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
139262328|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
139262329|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139262330|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139262331|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139262332|NCT02065752|Metformin|metformin|mesh-list
139262333|NCT02065752|Canagliflozin|canagliflozin|mesh-list
139262334|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139262335|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262336|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139262337|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262338|NCT02206490|Naltrexone|naltrexone|mesh-list
139262339|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
139262340|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139262341|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139262342|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262343|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
139262344|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262345|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
139262346|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
139262347|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139262348|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139262349|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139262350|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262351|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
139262352|NCT02068170|Azithromycin|azithromycin|mesh-list
139262353|NCT02068170|Clarithromycin|clarithromycin|mesh-list
139262354|NCT02068170|Levofloxacin|levofloxacin|mesh-list
139262355|NCT02068170|Erythromycin|erythromycin|mesh-list
139262356|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
139262357|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139262358|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
139262359|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139262360|NCT02068170|Itraconazole|itraconazole|mesh-list
139262361|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139262362|NCT02068170|Fluconazole|fluconazole|mesh-list
139262363|NCT02068170|Ketoconazole|ketoconazole|mesh-list
139262364|NCT02068170|Voriconazole|voriconazole|mesh-list
139262365|NCT02068170|Sunitinib|sunitinib|mesh-list
139262366|NCT02068170|Methadone|methadone|mesh-list
139262367|NCT02068170|Haloperidol|haloperidol|mesh-list
139262368|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
139262369|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139262370|NCT02068170|Tacrolimus|tacrolimus|mesh-list
139262371|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139262372|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
139262373|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262374|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139262375|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262376|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262377|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139262378|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262379|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139262380|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139262381|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262382|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139262383|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
139262384|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139262385|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139262386|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139262387|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139262388|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139262389|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139262390|NCT02068170|Growth Substances|growth substances|mesh-ancestor
139262391|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
139262392|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139262393|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139262394|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139262395|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139262396|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
139262397|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139262398|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139262399|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
139262400|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139262401|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139262402|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139262403|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139262404|NCT02068170|Narcotics|narcotics|mesh-ancestor
139262405|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139262406|NCT02068170|Analgesics|analgesics|mesh-ancestor
139262407|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
139262408|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139262409|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
139262410|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
139262411|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139262412|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139262413|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
139262414|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
139262415|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139262416|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139262417|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139262418|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139262419|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139262420|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
139262421|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139262422|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139262423|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
139262424|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139262425|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139262426|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
139262427|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
139262428|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139262429|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262430|NCT02206646|Tenecteplase|tenecteplase|mesh-list
139262431|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139262432|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139262433|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262434|NCT02419417|Nivolumab|nivolumab|mesh-list
139262435|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139262436|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139262437|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139262438|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262439|NCT02068404|Nifedipine|nifedipine|mesh-list
139262440|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139262441|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139262442|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262443|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139262444|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262445|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
139262447|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139262448|NCT02068482|Rifaximin|rifaximin|mesh-list
139262449|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139262450|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262451|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139262452|NCT02206802|Minoxidil|minoxidil|mesh-list
139262453|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139262454|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
139262455|NCT02065986|Tenofovir|tenofovir|mesh-list
139262456|NCT02065986|Emtricitabine|emtricitabine|mesh-list
139262457|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139262458|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
139262459|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139262460|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139262461|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139262462|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139262463|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139262464|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139262465|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139262466|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139262467|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
139262468|NCT02068560|Coagulants|coagulants|mesh-ancestor
139262469|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139262470|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
139262471|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139262472|NCT01377103|Testosterone|testosterone|mesh-list
139262473|NCT01377103|Androgens|androgens|mesh-ancestor
139476025|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139476026|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
139476027|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139476028|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139476029|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139476030|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
139476031|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139476032|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139476033|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139476034|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139476035|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
139476036|NCT04718740|Coagulants|coagulants|mesh-ancestor
139476037|NCT04718740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139476038|NCT04718740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476039|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139476040|NCT04647916|Camptothecin|camptothecin|mesh-list
139476041|NCT04647916|Irinotecan|irinotecan|mesh-list
139476042|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
139476043|NCT04647916|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139476044|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
139476045|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476046|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139476047|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476048|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139476049|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139476050|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476051|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476052|NCT04590248|Adavosertib|adavosertib|mesh-list
139476053|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476054|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476055|NCT04586231|Lenvatinib|lenvatinib|mesh-list
139476056|NCT04586231|Belzutifan|belzutifan|mesh-list
139476057|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476058|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139476059|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476060|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476061|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
139476062|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
139476063|NCT04560816|Choline|choline|mesh-list
139476064|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139476065|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476066|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139476067|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139476068|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476069|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476070|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476071|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476072|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
139476073|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139476074|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
139476075|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139476076|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139476077|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
139476078|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
139476079|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
139476080|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139476081|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139476082|NCT04560816|Growth Substances|growth substances|mesh-ancestor
139476083|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
139476084|NCT04511013|Nivolumab|nivolumab|mesh-list
139262818|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
139476085|NCT04511013|Ipilimumab|ipilimumab|mesh-list
139476086|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476087|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476088|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139476089|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476090|NCT04504318|Enoxaparin|enoxaparin|mesh-list
139476091|NCT04504318|Apixaban|apixaban|mesh-list
139476092|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
139476093|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139476094|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139002261|NCT00771251|Golimumab|golimumab|mesh-list
139476095|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476096|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139476097|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
139476098|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139476099|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
139476100|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476101|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
139476102|NCT04468061|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139476103|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476104|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476105|NCT04468061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139476106|NCT04468061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476107|NCT04468061|Immunoconjugates|immunoconjugates|mesh-ancestor
139476108|NCT04468061|Immunologic Factors|immunologic factors|mesh-ancestor
139476109|NCT04468061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476110|NCT04417517|Azacitidine|azacitidine|mesh-list
139476111|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139476112|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
139476113|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476114|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476115|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476116|NCT04337177|Temozolomide|temozolomide|mesh-list
139476117|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139476118|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
139002282|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476119|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476120|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476121|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
139476122|NCT04205968|Leucovorin|leucovorin|mesh-list
139476123|NCT04205968|Folic Acid|folic acid|mesh-list
139476124|NCT04205968|Paclitaxel|paclitaxel|mesh-list
139476125|NCT04205968|Camptothecin|camptothecin|mesh-list
139476126|NCT04205968|Fluorouracil|fluorouracil|mesh-list
139476127|NCT04205968|Irinotecan|irinotecan|mesh-list
139476128|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139476129|NCT04205968|Ramucirumab|ramucirumab|mesh-list
139002296|NCT00068419|Tamoxifen|tamoxifen|mesh-list
139476130|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139476131|NCT04205968|Antibodies|antibodies|mesh-list
139476132|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
139476133|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139476134|NCT04205968|Lexatumumab|lexatumumab|mesh-list
139476135|NCT04205968|Calcium|calcium|mesh-list
139476136|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
139476137|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139476138|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476139|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
139476140|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
139476141|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
139476142|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002310|NCT00068419|Analgesics|analgesics|mesh-ancestor
139476143|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
139476144|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476145|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139476146|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139476147|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
139476148|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139476149|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139476150|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139476151|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139476152|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476153|NCT04205968|Antidotes|antidotes|mesh-ancestor
139476154|NCT04205968|Protective Agents|protective agents|mesh-ancestor
139476155|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
139476156|NCT04205968|Vitamins|vitamins|mesh-ancestor
139476157|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
139476158|NCT04205968|Hematinics|hematinics|mesh-ancestor
139476159|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
139476160|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139476161|NCT04141020|Sirolimus|sirolimus|mesh-list
139476162|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139476163|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476164|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139476165|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476166|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
139476167|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139476168|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
139476169|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476171|NCT04071457|Daratumumab|daratumumab|mesh-list
139476172|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
139476173|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476174|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139476175|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139476176|NCT04071457|Growth Substances|growth substances|mesh-ancestor
139476177|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
139476178|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476179|NCT04060719|Rifampin|rifampin|mesh-list
139476180|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139476181|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
139476182|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139476183|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476184|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
139476185|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139476186|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476187|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476188|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139476189|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139476190|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139476191|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139476192|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139476193|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139476194|NCT03877406|Empagliflozin|empagliflozin|mesh-list
139476195|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139002354|NCT00398866|Hylan|hylan|mesh-list
139476196|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139476197|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476198|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476199|NCT03746106|Thiamine|thiamine|mesh-list
139476200|NCT03746106|Metformin|metformin|mesh-list
139476201|NCT03746106|Trimethoprim|trimethoprim|mesh-list
139476202|NCT03746106|Vitamins|vitamins|mesh-ancestor
139476203|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
139476204|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476205|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139476206|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
139476207|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139476208|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476209|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
139476210|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139476211|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139476212|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139476213|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476214|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476215|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139476216|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139476217|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139476218|NCT03737461|Lidocaine|lidocaine|mesh-list
139476219|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
139476220|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
139476221|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139476222|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476223|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
139476224|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139476225|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139476226|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139476227|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139002380|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139476228|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139476229|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476230|NCT03722173|Itraconazole|itraconazole|mesh-list
139476231|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
139476232|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476233|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139476234|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139476235|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476236|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476237|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139476238|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
139476239|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139476240|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476241|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139476242|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
139476243|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139476244|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476245|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139002403|NCT00398632|Analgesics|analgesics|mesh-ancestor
139476246|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476247|NCT03695380|Atezolizumab|atezolizumab|mesh-list
139476248|NCT03695380|Niraparib|niraparib|mesh-list
139476249|NCT03695380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139476250|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476251|NCT03695380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476252|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476253|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139476254|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476255|NCT03678025|Prednisone|prednisone|mesh-list
139476256|NCT03678025|Cortisone|cortisone|mesh-list
139476257|NCT03678025|Docetaxel|docetaxel|mesh-list
139476258|NCT03678025|Leuprolide|leuprolide|mesh-list
139476259|NCT03678025|Goserelin|goserelin|mesh-list
139476260|NCT03678025|Bicalutamide|bicalutamide|mesh-list
139476261|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139476262|NCT03678025|Flutamide|flutamide|mesh-list
139476263|NCT03678025|Nilutamide|nilutamide|mesh-list
139476264|NCT03678025|Tryptophan|tryptophan|mesh-list
139476265|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476266|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
139476267|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
139476268|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
139476269|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476270|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139476271|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
139476272|NCT03678025|Hormones|hormones|mesh-ancestor
139476273|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139476274|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476275|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139476276|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139476277|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
139476278|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139476279|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
139476280|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
139476281|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
139476282|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139476283|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
139476284|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139476285|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139476286|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
139476287|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139476288|NCT03636256|Docetaxel|docetaxel|mesh-list
139476289|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476290|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
139476291|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
139476292|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
139476293|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476294|NCT03451331|Carboplatin|carboplatin|mesh-list
139476295|NCT03451331|Gemcitabine|gemcitabine|mesh-list
139476296|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
139476297|NCT03451331|Nivolumab|nivolumab|mesh-list
139476298|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476299|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139476300|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
139476301|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476302|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476303|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139476304|NCT03418961|Carvedilol|carvedilol|mesh-list
139476305|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139476306|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139476307|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
139476308|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139476309|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476310|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476311|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139476313|NCT03418961|Protective Agents|protective agents|mesh-ancestor
139476314|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139476315|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139476316|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139476317|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
139476318|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139476319|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139476320|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
139476321|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476322|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476323|NCT03386357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139476324|NCT03386357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476325|NCT03293784|Infliximab|infliximab|mesh-list
139476326|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
139476327|NCT03293784|Nivolumab|nivolumab|mesh-list
139476328|NCT03293784|Ipilimumab|ipilimumab|mesh-list
139476329|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476330|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476331|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139476332|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476333|NCT03293784|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139476334|NCT03293784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139476335|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
139476336|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139476337|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139476338|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139476339|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
139476340|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476341|NCT03013218|Paclitaxel|paclitaxel|mesh-list
139476342|NCT03013218|Rituximab|rituximab|mesh-list
139476343|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
139476344|NCT03013218|Trastuzumab|trastuzumab|mesh-list
139476345|NCT03013218|Ramucirumab|ramucirumab|mesh-list
139476346|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139476347|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476348|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
139476349|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
139476350|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
139476351|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476352|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476353|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
139476354|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476355|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139476356|NCT03013218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139476357|NCT02996487|Vancomycin|vancomycin|mesh-list
139476358|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139476359|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476360|NCT02980276|Metformin|metformin|mesh-list
139476361|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139476362|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476363|NCT02614794|Capecitabine|capecitabine|mesh-list
139476364|NCT02614794|Trastuzumab|trastuzumab|mesh-list
139476365|NCT02614794|Tucatinib|tucatinib|mesh-list
139476366|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139476367|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
139002524|NCT00779129|Doxorubicin|doxorubicin|mesh-list
139476368|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476369|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476370|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476371|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139476372|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476373|NCT02495896|Paclitaxel|paclitaxel|mesh-list
139476374|NCT02495896|Docetaxel|docetaxel|mesh-list
139476375|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139476376|NCT02495896|Cisplatin|cisplatin|mesh-list
139476377|NCT02495896|Gemcitabine|gemcitabine|mesh-list
139476378|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139476379|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476380|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
139476381|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
139476382|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
139476383|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476384|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139476385|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
139476386|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
139476387|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139476389|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
139476390|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139476391|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476392|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476393|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
139476394|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
139476395|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139476396|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
139476397|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139476398|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
139476399|NCT01782443|Aflibercept|aflibercept|mesh-list
139476400|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139476401|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139476402|NCT01782443|Growth Substances|growth substances|mesh-ancestor
139476403|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476404|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
139476405|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476406|NCT01712815|Clevudine|clevudine|mesh-list
139476407|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
139476408|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476409|NCT01555632|Atorvastatin|atorvastatin|mesh-list
139476410|NCT01555632|Calcium|calcium|mesh-list
139476411|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139476412|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476413|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139476414|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139476415|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
139476416|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476417|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139476418|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139476419|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476420|NCT01274026|Verapamil|verapamil|mesh-list
139476421|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139476422|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139476423|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139476424|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476425|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139476426|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476427|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
139476428|NCT01186029|Aprepitant|aprepitant|mesh-list
139476429|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
139476430|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
139476431|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139476432|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476433|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139476434|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139476435|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139476436|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476437|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139476438|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
139476439|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476440|NCT00896012|Sirolimus|sirolimus|mesh-list
139476441|NCT00896012|Tacrolimus|tacrolimus|mesh-list
139476442|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139476443|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
139476444|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476445|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139476446|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476447|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476448|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139476449|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476450|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139476451|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476452|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
139476453|NCT00876226|Citalopram|citalopram|mesh-list
139476454|NCT00876226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139476455|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139476456|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139476457|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476458|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139476459|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
139476460|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476461|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139476462|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
139002629|NCT00539006|Xhance|xhance|mesh-list
139476463|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139476464|NCT00816413|Cyclosporine|cyclosporine|mesh-list
139476465|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
139476466|NCT00816413|Pentostatin|pentostatin|mesh-list
139476467|NCT00816413|Cyclosporins|cyclosporins|mesh-list
139476468|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476469|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476470|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139476471|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
139476472|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476473|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
139476474|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476475|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
139476476|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139476477|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139476478|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139476479|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476480|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139476481|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
139476482|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139476483|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139476484|NCT05916937|Omalizumab|omalizumab|mesh-list
139476485|NCT05916937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139476486|NCT05916937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139476487|NCT05916937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139476488|NCT05916937|Respiratory System Agents|respiratory system agents|mesh-ancestor
139476489|NCT05916937|Immunologic Factors|immunologic factors|mesh-ancestor
139476490|NCT05916937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476491|NCT02342977|Lacosamide|lacosamide|mesh-list
139476492|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
139476493|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139476494|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139476495|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139002660|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
139476496|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476497|NCT05916781|Mycophenolic Acid|mycophenolic acid|mesh-list
139476498|NCT05916781|Tacrolimus|tacrolimus|mesh-list
139476499|NCT05916781|Glucocorticoids|glucocorticoids|mesh-list
139476500|NCT05916781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139476501|NCT05916781|Immunologic Factors|immunologic factors|mesh-ancestor
139476502|NCT05916781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476503|NCT05916781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139476504|NCT05916781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476505|NCT05916781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476506|NCT05916781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139476507|NCT05916781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476508|NCT05916781|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139476509|NCT05916781|Antitubercular Agents|antitubercular agents|mesh-ancestor
139476510|NCT05916781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139476511|NCT05916781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476512|NCT05916781|Hormones|hormones|mesh-ancestor
139476513|NCT05916781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139476514|NCT05916755|Cyclophosphamide|cyclophosphamide|mesh-list
139476515|NCT05916755|Carboplatin|carboplatin|mesh-list
139476516|NCT05916755|Pembrolizumab|pembrolizumab|mesh-list
139476517|NCT05916755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139476518|NCT05916755|Immunologic Factors|immunologic factors|mesh-ancestor
139476519|NCT05916755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476520|NCT05916755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139476521|NCT05916755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139476522|NCT05916755|Alkylating Agents|alkylating agents|mesh-ancestor
139476523|NCT05916755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476524|NCT05916755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476525|NCT05916755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139476526|NCT05916755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476527|NCT05916755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139476528|NCT05916742|Dipyrone|dipyrone|mesh-list
139476529|NCT05916742|Amoxicillin|amoxicillin|mesh-list
139476530|NCT05916742|Chlorhexidine|chlorhexidine|mesh-list
139476531|NCT05916742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139476532|NCT05916742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476533|NCT05916742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139476534|NCT05916742|Disinfectants|disinfectants|mesh-ancestor
139476535|NCT05916742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139476536|NCT05916742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139476537|NCT05916742|Analgesics|analgesics|mesh-ancestor
139476538|NCT05916742|Sensory System Agents|sensory system agents|mesh-ancestor
139476539|NCT05916742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139476540|NCT05916742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476541|NCT05916742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139476542|NCT05916742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139476543|NCT05916742|Antipyretics|antipyretics|mesh-ancestor
139476544|NCT05916729|Miconazole|miconazole|mesh-list
139476545|NCT05916729|Antifungal Agents|antifungal agents|mesh-ancestor
139476546|NCT05916729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476547|NCT05916729|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139476548|NCT05916729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139476549|NCT05916729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476550|NCT05916729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476551|NCT05916729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139476552|NCT05916729|Hormone Antagonists|hormone antagonists|mesh-ancestor
139476553|NCT05916729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139476554|NCT05916729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476555|NCT05916729|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139476556|NCT05916729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139476557|NCT05916716|Dipyrone|dipyrone|mesh-list
139476558|NCT05916716|Amoxicillin|amoxicillin|mesh-list
139476559|NCT05916716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139476560|NCT05916716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476561|NCT05916716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139476562|NCT05916716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139476563|NCT05916716|Analgesics|analgesics|mesh-ancestor
139476564|NCT05916716|Sensory System Agents|sensory system agents|mesh-ancestor
139476565|NCT05916716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139476566|NCT05916716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476567|NCT05916716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139476568|NCT05916716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139476569|NCT05916716|Antipyretics|antipyretics|mesh-ancestor
139476570|NCT05916521|Fluorides|fluorides|mesh-list
139476571|NCT05916521|Tin Fluorides|tin fluorides|mesh-list
139476572|NCT05916521|Fluorophosphate|fluorophosphate|mesh-list
139476573|NCT05916521|Cariostatic Agents|cariostatic agents|mesh-ancestor
139476574|NCT05916521|Protective Agents|protective agents|mesh-ancestor
139476575|NCT05916521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476576|NCT05916508|Fluorides|fluorides|mesh-list
139476577|NCT05916508|Tin Fluorides|tin fluorides|mesh-list
139476578|NCT05916508|Fluorophosphate|fluorophosphate|mesh-list
139476579|NCT05916508|Cariostatic Agents|cariostatic agents|mesh-ancestor
139476580|NCT05916508|Protective Agents|protective agents|mesh-ancestor
139476581|NCT05916508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476582|NCT05916469|Levonorgestrel|levonorgestrel|mesh-list
139476583|NCT05916469|Norethindrone|norethindrone|mesh-list
139476584|NCT05916469|Norethindrone Acetate|norethindrone acetate|mesh-list
139476585|NCT05916469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139476586|NCT05916469|Contraceptive Agents|contraceptive agents|mesh-ancestor
139476587|NCT05916469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139476588|NCT05916469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476589|NCT05916469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139476590|NCT05916469|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139476591|NCT05916469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139476592|NCT05916469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139476593|NCT05916339|Methylphenidate|methylphenidate|mesh-list
139476594|NCT05916339|Amphetamine|amphetamine|mesh-list
139476595|NCT05916339|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
139476596|NCT05916339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476597|NCT05916339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139476598|NCT05916339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139476599|NCT05916339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139476600|NCT05916339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476601|NCT05916339|Dopamine Agents|dopamine agents|mesh-ancestor
139476602|NCT05916339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139476603|NCT05916339|Sympathomimetics|sympathomimetics|mesh-ancestor
139476604|NCT05916339|Autonomic Agents|autonomic agents|mesh-ancestor
139476605|NCT05916339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139476606|NCT05916339|Adrenergic Agents|adrenergic agents|mesh-ancestor
139476607|NCT05916339|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139476608|NCT05916105|Ciprofloxacin|ciprofloxacin|mesh-list
139263369|NCT01378741|Propofol|propofol|mesh-list
139476609|NCT05916105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139476610|NCT05916105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476611|NCT05916105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139476612|NCT05916105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139476613|NCT05916105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476614|NCT05916105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476615|NCT05916105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476616|NCT05916105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139476617|NCT05916105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139476618|NCT05916066|Niacinamide|niacinamide|mesh-list
139476619|NCT05916066|Niacin|niacin|mesh-list
139476620|NCT05916066|Nicotinic Acids|nicotinic acids|mesh-list
139476621|NCT05916066|Vitamin B Complex|vitamin b complex|mesh-ancestor
139476622|NCT05916066|Vitamins|vitamins|mesh-ancestor
139476623|NCT05916066|Micronutrients|micronutrients|mesh-ancestor
139476624|NCT05916066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476625|NCT05916066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139476626|NCT05916066|Antimetabolites|antimetabolites|mesh-ancestor
139476627|NCT05916066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476628|NCT05916066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139476629|NCT05916066|Vasodilator Agents|vasodilator agents|mesh-ancestor
139476630|NCT05915871|Clarithromycin|clarithromycin|mesh-list
139476631|NCT05915871|Bismuth|bismuth|mesh-list
139476632|NCT05915871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139476633|NCT05915871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139002810|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139476634|NCT05915871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139476635|NCT05915871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476636|NCT05915871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476637|NCT05915871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139476638|NCT05915871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139476639|NCT05915871|Antacids|antacids|mesh-ancestor
139476640|NCT05915871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139476641|NCT05915676|Immunoglobulins|immunoglobulins|mesh-list
139476642|NCT05915676|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139476643|NCT05915676|Antibodies|antibodies|mesh-list
139476644|NCT05915676|Immunologic Factors|immunologic factors|mesh-ancestor
139476645|NCT05915676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476646|NCT05915520|Pantoprazole|pantoprazole|mesh-list
139476647|NCT05915520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139476648|NCT05915520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139476649|NCT05915520|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139476650|NCT05915520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476651|NCT05915520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476652|NCT05915481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139476653|NCT05915481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476654|NCT05915481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476655|NCT05915481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476656|NCT05915286|Chlorthalidone|chlorthalidone|mesh-list
139476657|NCT05915286|Furosemide|furosemide|mesh-list
139476658|NCT05915286|Diuretics|diuretics|mesh-ancestor
139476659|NCT05915286|Natriuretic Agents|natriuretic agents|mesh-ancestor
139476660|NCT05915286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476661|NCT05915286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139476662|NCT05915286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139476663|NCT05915286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476664|NCT05915286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139476665|NCT05915286|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139476666|NCT05915260|Adenosine|adenosine|mesh-list
139476667|NCT05915260|Analgesics|analgesics|mesh-ancestor
139476668|NCT05915260|Sensory System Agents|sensory system agents|mesh-ancestor
139476669|NCT05915260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139476670|NCT05915260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476671|NCT05915260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139476672|NCT05915260|Vasodilator Agents|vasodilator agents|mesh-ancestor
139476673|NCT05915260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139476674|NCT05915260|Purinergic Agonists|purinergic agonists|mesh-ancestor
139476675|NCT05915260|Purinergic Agents|purinergic agents|mesh-ancestor
139476676|NCT05915260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139476677|NCT05915260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476678|NCT05915169|Chrysarobin|chrysarobin|mesh-list
139476679|NCT05915169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139476680|NCT05915169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139476681|NCT05915169|Analgesics|analgesics|mesh-ancestor
139476682|NCT05915169|Sensory System Agents|sensory system agents|mesh-ancestor
139476683|NCT05915169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139476684|NCT05915169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476685|NCT05915169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139476686|NCT05915169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139476687|NCT05915013|Ketamine|ketamine|mesh-list
139476688|NCT05915013|Analgesics|analgesics|mesh-ancestor
139476689|NCT05915013|Sensory System Agents|sensory system agents|mesh-ancestor
139476690|NCT05915013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139476691|NCT05915013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476692|NCT05915013|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139476693|NCT05915013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139476694|NCT05915013|Anesthetics, General|anesthetics, general|mesh-ancestor
139476695|NCT05915013|Anesthetics|anesthetics|mesh-ancestor
139476696|NCT05915013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139476697|NCT05915013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139476698|NCT05915013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139476699|NCT05915013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139476700|NCT05915013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476701|NCT05914805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139476702|NCT05914753|Cyclophosphamide|cyclophosphamide|mesh-list
139476703|NCT05914753|Docetaxel|docetaxel|mesh-list
139476704|NCT05914753|Epirubicin|epirubicin|mesh-list
139476705|NCT05914753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139476706|NCT05914753|Immunologic Factors|immunologic factors|mesh-ancestor
139476707|NCT05914753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476708|NCT05914753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139476709|NCT05914753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139476710|NCT05914753|Alkylating Agents|alkylating agents|mesh-ancestor
139476711|NCT05914753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476712|NCT05914753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476713|NCT05914753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139476714|NCT05914753|Tubulin Modulators|tubulin modulators|mesh-ancestor
139476715|NCT05914753|Antimitotic Agents|antimitotic agents|mesh-ancestor
139476716|NCT05914753|Mitosis Modulators|mitosis modulators|mesh-ancestor
139476717|NCT05914753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139476718|NCT05914753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139476719|NCT05914753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139476720|NCT05914753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476721|NCT05914701|Letermovir|letermovir|mesh-list
139476722|NCT05914701|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139476723|NCT05914701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476724|NCT05914701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476725|NCT05914701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476726|NCT05914701|Antiviral Agents|antiviral agents|mesh-ancestor
139476727|NCT05914701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476728|NCT05914675|Letermovir|letermovir|mesh-list
139476729|NCT05914675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139476730|NCT05914675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476731|NCT05914675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476732|NCT05914675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476733|NCT05914675|Antiviral Agents|antiviral agents|mesh-ancestor
139476734|NCT05914675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476735|NCT05914662|Rituximab|rituximab|mesh-list
139476736|NCT05914662|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139476737|NCT05914662|Zanubrutinib|zanubrutinib|mesh-list
139476738|NCT05914662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476739|NCT05914662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476740|NCT05914662|Immunologic Factors|immunologic factors|mesh-ancestor
139476741|NCT05914662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476742|NCT05914662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139476743|NCT05914662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139476744|NCT05914662|Alkylating Agents|alkylating agents|mesh-ancestor
139476745|NCT05914662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476746|NCT05914662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139476747|NCT05914662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476748|NCT05914610|Oxaliplatin|oxaliplatin|mesh-list
139476749|NCT05914610|Tegafur|tegafur|mesh-list
139476750|NCT05914610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476751|NCT05914610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139476752|NCT05914610|Antimetabolites|antimetabolites|mesh-ancestor
139476753|NCT05914610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476754|NCT05914545|Immunoconjugates|immunoconjugates|mesh-list
139476755|NCT05914545|Immunologic Factors|immunologic factors|mesh-ancestor
139476756|NCT05914545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476757|NCT05914454|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139476758|NCT05914454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139476759|NCT05914350|Methylprednisolone|methylprednisolone|mesh-list
139476760|NCT05914350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139476761|NCT05914350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139476762|NCT05914350|Prednisolone|prednisolone|mesh-list
139476763|NCT05914350|Prednisolone acetate|prednisolone acetate|mesh-list
139476764|NCT05914350|Lidocaine|lidocaine|mesh-list
139476765|NCT05914350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139476766|NCT05914350|Prednisolone phosphate|prednisolone phosphate|mesh-list
139476767|NCT05914350|Anesthetics, Local|anesthetics, local|mesh-ancestor
139476768|NCT05914350|Anesthetics|anesthetics|mesh-ancestor
139476769|NCT05914350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139476770|NCT05914350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476771|NCT05914350|Sensory System Agents|sensory system agents|mesh-ancestor
139476772|NCT05914350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139476773|NCT05914350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139476774|NCT05914350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139476775|NCT05914350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139476776|NCT05914350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139476777|NCT05914350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476778|NCT05914350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139476779|NCT05914350|Antiemetics|antiemetics|mesh-ancestor
139476780|NCT05914350|Autonomic Agents|autonomic agents|mesh-ancestor
139476781|NCT05914350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139476782|NCT05914350|Glucocorticoids|glucocorticoids|mesh-ancestor
139476783|NCT05914350|Hormones|hormones|mesh-ancestor
139476784|NCT05914350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139476785|NCT05914350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139476786|NCT05914350|Protective Agents|protective agents|mesh-ancestor
139476787|NCT05914350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139476788|NCT05914350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476789|NCT05914285|Albuterol|albuterol|mesh-list
139476790|NCT05914285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139476791|NCT05914285|Autonomic Agents|autonomic agents|mesh-ancestor
139476792|NCT05914285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139476793|NCT05914285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476794|NCT05914285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139476795|NCT05914285|Respiratory System Agents|respiratory system agents|mesh-ancestor
139476796|NCT05914285|Tocolytic Agents|tocolytic agents|mesh-ancestor
139476797|NCT05914285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139476798|NCT05914285|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139476799|NCT05914285|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139476800|NCT05914285|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139476801|NCT05914285|Adrenergic Agents|adrenergic agents|mesh-ancestor
139476802|NCT05914285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002966|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139476803|NCT05914285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476804|NCT05914129|Liver Extracts|liver extracts|mesh-list
139476805|NCT05914129|Hematinics|hematinics|mesh-ancestor
139476806|NCT05913947|Cariprazine|cariprazine|mesh-list
139476807|NCT05913947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139476808|NCT05913947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139476809|NCT05913947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139476810|NCT05913947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476811|NCT05913947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139476812|NCT05913856|Chlorhexidine|chlorhexidine|mesh-list
139476813|NCT05913856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139476814|NCT05913856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476815|NCT05913856|Disinfectants|disinfectants|mesh-ancestor
139476816|NCT05913661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139476817|NCT05913661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476818|NCT05913661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476819|NCT05913661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476820|NCT05913596|Daratumumab|daratumumab|mesh-list
139476821|NCT05913596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476822|NCT05913583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139476823|NCT05913583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476824|NCT05913583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476825|NCT05913583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476826|NCT05913570|Antibodies|antibodies|mesh-list
139476827|NCT05913570|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139476828|NCT05913570|Immunologic Factors|immunologic factors|mesh-ancestor
139263569|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139476829|NCT05913570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476830|NCT05913466|Tranexamic Acid|tranexamic acid|mesh-list
139476831|NCT05913466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139476832|NCT05913466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139476833|NCT05913466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476834|NCT05913466|Hemostatics|hemostatics|mesh-ancestor
139476835|NCT05913466|Coagulants|coagulants|mesh-ancestor
139476836|NCT05913427|Cisplatin|cisplatin|mesh-list
139476837|NCT05913427|Doxorubicin|doxorubicin|mesh-list
139476838|NCT05913427|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139476839|NCT05913427|Etoposide|etoposide|mesh-list
139476840|NCT05913427|Etoposide phosphate|etoposide phosphate|mesh-list
139476841|NCT05913427|Megestrol|megestrol|mesh-list
139476842|NCT05913427|Megestrol Acetate|megestrol acetate|mesh-list
139476843|NCT05913427|Mitotane|mitotane|mesh-list
139476844|NCT05913427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476845|NCT05913427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139476846|NCT05913427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139476847|NCT05913427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139476848|NCT05913427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476849|NCT05913427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476850|NCT05913427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139476851|NCT05913427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139476852|NCT05913427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139476853|NCT05913427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139476854|NCT05913427|Contraceptive Agents|contraceptive agents|mesh-ancestor
139476855|NCT05913427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139476856|NCT05913427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476857|NCT05913427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139476858|NCT05913427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139476859|NCT05913427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139476860|NCT05913427|Appetite Stimulants|appetite stimulants|mesh-ancestor
139476861|NCT05913427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139476862|NCT05913414|Iron|iron|mesh-list
139476863|NCT05913414|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139003046|NCT00057811|Vitamins|vitamins|mesh-ancestor
139476864|NCT05913414|Ferric Compounds|ferric compounds|mesh-list
139476865|NCT05913414|Trace Elements|trace elements|mesh-ancestor
139476866|NCT05913414|Micronutrients|micronutrients|mesh-ancestor
139476867|NCT05913414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476868|NCT05913414|Hematinics|hematinics|mesh-ancestor
139476869|NCT05913180|Ascorbic Acid|ascorbic acid|mesh-list
139476870|NCT05913180|Vitamins|vitamins|mesh-ancestor
139476871|NCT05913180|Micronutrients|micronutrients|mesh-ancestor
139476872|NCT05913180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476873|NCT05913180|Antioxidants|antioxidants|mesh-ancestor
139476874|NCT05913180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476875|NCT05913180|Protective Agents|protective agents|mesh-ancestor
139476876|NCT05913115|Bemarituzumab|bemarituzumab|mesh-list
139476877|NCT05913115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476878|NCT05913115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476879|NCT05912816|Tislelizumab|tislelizumab|mesh-list
139476880|NCT05912816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476881|NCT05912816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476882|NCT05912712|Infliximab|infliximab|mesh-list
139476883|NCT05912712|Mesalamine|mesalamine|mesh-list
139476884|NCT05912712|Thrombin|thrombin|mesh-list
139476885|NCT05912712|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139476886|NCT05912712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139476887|NCT05912712|Dermatologic Agents|dermatologic agents|mesh-ancestor
139476888|NCT05912712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139476889|NCT05912712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139476890|NCT05912712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139476891|NCT05912712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139476892|NCT05912712|Analgesics|analgesics|mesh-ancestor
139476893|NCT05912712|Sensory System Agents|sensory system agents|mesh-ancestor
139476894|NCT05912712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139476895|NCT05912712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476896|NCT05912712|Hemostatics|hemostatics|mesh-ancestor
139476897|NCT05912712|Coagulants|coagulants|mesh-ancestor
139476898|NCT05912686|Atorvastatin|atorvastatin|mesh-list
139476899|NCT05912686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139476900|NCT05912686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139476901|NCT05912686|Antimetabolites|antimetabolites|mesh-ancestor
139476902|NCT05912686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476903|NCT05912686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139476904|NCT05912686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139476905|NCT05912686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476906|NCT05912621|Tirzepatide|tirzepatide|mesh-list
139263641|NCT02220296|Insulin|insulin|mesh-list
139476907|NCT05912621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139476908|NCT05912621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476909|NCT05912621|Incretins|incretins|mesh-ancestor
139476910|NCT05912621|Hormones|hormones|mesh-ancestor
139476911|NCT05912621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139476912|NCT05912387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139476913|NCT05912387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139476914|NCT05912387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139476915|NCT05912387|Antimetabolites|antimetabolites|mesh-ancestor
139476916|NCT05912387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476917|NCT05912387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139476918|NCT05912387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139476919|NCT05912387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476920|NCT05912335|Anesthetics|anesthetics|mesh-list
139476921|NCT05912335|Anesthetics, Local|anesthetics, local|mesh-list
139476922|NCT05912335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139476923|NCT05912335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476924|NCT05912335|Sensory System Agents|sensory system agents|mesh-ancestor
139476925|NCT05912335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139476926|NCT05912205|Disitamab vedotin|disitamab vedotin|mesh-list
139476927|NCT05912205|Immunoconjugates|immunoconjugates|mesh-ancestor
139476928|NCT05912205|Immunologic Factors|immunologic factors|mesh-ancestor
139476929|NCT05912205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476930|NCT05912192|Mometasone Furoate|mometasone furoate|mesh-list
139476931|NCT05912192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139476932|NCT05912192|Dermatologic Agents|dermatologic agents|mesh-ancestor
139476933|NCT05912192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139476934|NCT05912179|Liver Extracts|liver extracts|mesh-list
139476935|NCT05912179|Hematinics|hematinics|mesh-ancestor
139476936|NCT05912114|Mannitol|mannitol|mesh-list
139476937|NCT05912114|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139476938|NCT05912114|Diuretics|diuretics|mesh-ancestor
139476939|NCT05912114|Natriuretic Agents|natriuretic agents|mesh-ancestor
139476940|NCT05912114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476941|NCT05912075|Capecitabine|capecitabine|mesh-list
139476942|NCT05912075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139476943|NCT05912075|Antimetabolites|antimetabolites|mesh-ancestor
139476944|NCT05912075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476945|NCT05912075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476946|NCT05911828|Ferroquine|ferroquine|mesh-list
139476947|NCT05911828|Antimalarials|antimalarials|mesh-ancestor
139476948|NCT05911828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139476949|NCT05911828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139476950|NCT05911828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476951|NCT05911659|Ticagrelor|ticagrelor|mesh-list
139476952|NCT05911659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139476953|NCT05911659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139476954|NCT05911659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139476955|NCT05911659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139476956|NCT05911659|Purinergic Agents|purinergic agents|mesh-ancestor
139476957|NCT05911659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139476958|NCT05911659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476959|NCT05911659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476960|NCT05911503|Ganciclovir|ganciclovir|mesh-list
139476961|NCT05911503|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139476962|NCT05911503|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139476963|NCT05911503|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139476964|NCT05911503|Antiviral Agents|antiviral agents|mesh-ancestor
139476965|NCT05911503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476966|NCT05911503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139476967|NCT05911503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476968|NCT05911503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476969|NCT05911438|Epoetin Alfa|epoetin alfa|mesh-list
139476970|NCT05911438|Hematinics|hematinics|mesh-ancestor
139476971|NCT05911347|Psyllium|psyllium|mesh-list
139476972|NCT05911347|Cathartics|cathartics|mesh-ancestor
139476973|NCT05911347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139476974|NCT05911308|Paclitaxel|paclitaxel|mesh-list
139476975|NCT05911308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139476976|NCT05911308|Carboplatin|carboplatin|mesh-list
139476977|NCT05911308|Pemetrexed|pemetrexed|mesh-list
139476978|NCT05911308|Durvalumab|durvalumab|mesh-list
139476979|NCT05911308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139263712|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139476980|NCT05911308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139476981|NCT05911308|Tubulin Modulators|tubulin modulators|mesh-ancestor
139476982|NCT05911308|Antimitotic Agents|antimitotic agents|mesh-ancestor
139476983|NCT05911308|Mitosis Modulators|mitosis modulators|mesh-ancestor
139476984|NCT05911308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476985|NCT05911308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476986|NCT05911308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139476987|NCT05911308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139476988|NCT05911308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139476989|NCT05911282|Acetylcysteine|acetylcysteine|mesh-list
139476990|NCT05911282|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139476991|NCT05911282|Antiviral Agents|antiviral agents|mesh-ancestor
139476992|NCT05911282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139476993|NCT05911282|Expectorants|expectorants|mesh-ancestor
139476994|NCT05911282|Respiratory System Agents|respiratory system agents|mesh-ancestor
139476995|NCT05911282|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139476996|NCT05911282|Antioxidants|antioxidants|mesh-ancestor
139476997|NCT05911282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476998|NCT05911282|Protective Agents|protective agents|mesh-ancestor
139003155|NCT00570713|Gemcitabine|gemcitabine|mesh-list
139476999|NCT05911282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477000|NCT05911282|Antidotes|antidotes|mesh-ancestor
139477001|NCT05911022|Colchicine|colchicine|mesh-list
139477002|NCT05911022|Gout Suppressants|gout suppressants|mesh-ancestor
139477003|NCT05911022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139477004|NCT05911022|Tubulin Modulators|tubulin modulators|mesh-ancestor
139477005|NCT05911022|Antimitotic Agents|antimitotic agents|mesh-ancestor
139477006|NCT05911022|Mitosis Modulators|mitosis modulators|mesh-ancestor
139477007|NCT05911022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477008|NCT05911022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477009|NCT05907655|Nitroglycerin|nitroglycerin|mesh-list
139477010|NCT05907655|Vasodilator Agents|vasodilator agents|mesh-ancestor
139477011|NCT05907512|Endostar protein|endostar protein|mesh-list
139477012|NCT05907512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139477013|NCT05907512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139477014|NCT05907512|Growth Substances|growth substances|mesh-ancestor
139477015|NCT05907512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477016|NCT05907512|Growth Inhibitors|growth inhibitors|mesh-ancestor
139477017|NCT05907512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477018|NCT05906056|Zoledronic Acid|zoledronic acid|mesh-list
139477019|NCT05906056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139477020|NCT05906056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477021|NCT05905770|Alemtuzumab|alemtuzumab|mesh-list
139477022|NCT05905770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477023|NCT05905770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477024|NCT05905510|Anesthetics|anesthetics|mesh-list
139477025|NCT05905510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477026|NCT05905510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477027|NCT05904964|Disitamab vedotin|disitamab vedotin|mesh-list
139477028|NCT05904964|Immunoconjugates|immunoconjugates|mesh-ancestor
139477029|NCT05904964|Immunologic Factors|immunologic factors|mesh-ancestor
139003215|NCT00777413|Minocycline|minocycline|mesh-list
139477030|NCT05904964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477031|NCT05904353|Zoledronic Acid|zoledronic acid|mesh-list
139477032|NCT05904353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139477033|NCT05904353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477034|NCT05903014|Acetylcysteine|acetylcysteine|mesh-list
139477035|NCT05903014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139477036|NCT05903014|Antiviral Agents|antiviral agents|mesh-ancestor
139477037|NCT05903014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139477038|NCT05903014|Expectorants|expectorants|mesh-ancestor
139477039|NCT05903014|Respiratory System Agents|respiratory system agents|mesh-ancestor
139477040|NCT05903014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139477041|NCT05903014|Antioxidants|antioxidants|mesh-ancestor
139477042|NCT05903014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477043|NCT05903014|Protective Agents|protective agents|mesh-ancestor
139477044|NCT05903014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477045|NCT05903014|Antidotes|antidotes|mesh-ancestor
139477046|NCT05874492|Dermatologic Agents|dermatologic agents|mesh-list
139477047|NCT05823896|Ritonavir|ritonavir|mesh-list
139477048|NCT05823896|Nirmatrelvir|nirmatrelvir|mesh-list
139477049|NCT05823896|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139477050|NCT05823896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139477051|NCT05823896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139477052|NCT05823896|Protease Inhibitors|protease inhibitors|mesh-ancestor
139477053|NCT05823896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477054|NCT05823896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477055|NCT05823896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139477056|NCT05823896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139477057|NCT05823896|Antiviral Agents|antiviral agents|mesh-ancestor
139477058|NCT05823896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139477059|NCT05823896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139477060|NCT05823896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139477061|NCT05821088|Carboplatin|carboplatin|mesh-list
139477062|NCT05821088|Etoposide|etoposide|mesh-list
139477063|NCT05821088|Lenalidomide|lenalidomide|mesh-list
139477064|NCT05821088|Etoposide phosphate|etoposide phosphate|mesh-list
139477065|NCT05821088|Ifosfamide|ifosfamide|mesh-list
139477066|NCT05821088|Isophosphamide mustard|isophosphamide mustard|mesh-list
139477067|NCT05821088|Podophyllotoxin|podophyllotoxin|mesh-list
139477068|NCT05821088|Immunoglobulins|immunoglobulins|mesh-list
139477069|NCT05821088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477070|NCT05821088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139477071|NCT05821088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139477072|NCT05821088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139477073|NCT05821088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477074|NCT05821088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477075|NCT05821088|Immunologic Factors|immunologic factors|mesh-ancestor
139477076|NCT05821088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477077|NCT05821088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139477078|NCT05821088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139477079|NCT05821088|Growth Substances|growth substances|mesh-ancestor
139477080|NCT05821088|Growth Inhibitors|growth inhibitors|mesh-ancestor
139477081|NCT05821088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139477082|NCT05821088|Alkylating Agents|alkylating agents|mesh-ancestor
139477083|NCT05821088|Keratolytic Agents|keratolytic agents|mesh-ancestor
139477084|NCT05821088|Dermatologic Agents|dermatologic agents|mesh-ancestor
139477085|NCT05821088|Tubulin Modulators|tubulin modulators|mesh-ancestor
139477086|NCT05821088|Antimitotic Agents|antimitotic agents|mesh-ancestor
139477087|NCT05821088|Mitosis Modulators|mitosis modulators|mesh-ancestor
139477088|NCT05794581|Liraglutide|liraglutide|mesh-list
139477089|NCT05794581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139477090|NCT05794581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477091|NCT05794581|Incretins|incretins|mesh-ancestor
139477092|NCT05794581|Hormones|hormones|mesh-ancestor
139477093|NCT05794581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139477094|NCT05767944|Anesthetics|anesthetics|mesh-list
139477095|NCT05767944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477096|NCT05767944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477097|NCT05751265|Paclitaxel|paclitaxel|mesh-list
139477098|NCT05751265|Tislelizumab|tislelizumab|mesh-list
139477099|NCT05751265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139477100|NCT05751265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477101|NCT05751265|Tubulin Modulators|tubulin modulators|mesh-ancestor
139477102|NCT05751265|Antimitotic Agents|antimitotic agents|mesh-ancestor
139477103|NCT05751265|Mitosis Modulators|mitosis modulators|mesh-ancestor
139477104|NCT05751265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477105|NCT05751265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477106|NCT05716854|Moxifloxacin|moxifloxacin|mesh-list
139477107|NCT05716854|Clarithromycin|clarithromycin|mesh-list
139477108|NCT05716854|Cobicistat|cobicistat|mesh-list
139477109|NCT05716854|Pimozide|pimozide|mesh-list
139477110|NCT05716854|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139477111|NCT05716854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139477112|NCT05716854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139477113|NCT05716854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139477114|NCT05716854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139477115|NCT05716854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477116|NCT05716854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477117|NCT05716854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477118|NCT05716854|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139477119|NCT05716854|Contraceptive Agents|contraceptive agents|mesh-ancestor
139477120|NCT05716854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139477121|NCT05716854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477122|NCT05716854|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139477123|NCT05716854|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139477124|NCT05716854|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139477125|NCT05716854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139477126|NCT05716854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139477127|NCT05716854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139477128|NCT05716854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139477129|NCT05716854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139477130|NCT05716854|Antiviral Agents|antiviral agents|mesh-ancestor
139477131|NCT05716854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139263861|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139477132|NCT05716854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139477133|NCT05716854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477134|NCT05716854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139477135|NCT05716854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139477136|NCT05716854|Dopamine Agents|dopamine agents|mesh-ancestor
139477137|NCT05716854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139477138|NCT05716854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139477139|NCT05714553|Leucovorin|leucovorin|mesh-list
139477140|NCT05714553|Docetaxel|docetaxel|mesh-list
139477141|NCT05714553|Pembrolizumab|pembrolizumab|mesh-list
139477142|NCT05714553|Levoleucovorin|levoleucovorin|mesh-list
139477143|NCT05714553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477144|NCT05714553|Tubulin Modulators|tubulin modulators|mesh-ancestor
139477145|NCT05714553|Antimitotic Agents|antimitotic agents|mesh-ancestor
139477146|NCT05714553|Mitosis Modulators|mitosis modulators|mesh-ancestor
139477147|NCT05714553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477148|NCT05714553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477149|NCT05714553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139477150|NCT05714553|Antidotes|antidotes|mesh-ancestor
139477151|NCT05714553|Protective Agents|protective agents|mesh-ancestor
139477152|NCT05714553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477153|NCT05714553|Vitamin B Complex|vitamin b complex|mesh-ancestor
139477154|NCT05714553|Vitamins|vitamins|mesh-ancestor
139477155|NCT05714553|Micronutrients|micronutrients|mesh-ancestor
139477156|NCT05713760|Tirbanibulin|tirbanibulin|mesh-list
139477157|NCT05713760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477158|NCT05713760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477159|NCT05701488|Durvalumab|durvalumab|mesh-list
139477160|NCT05701488|Tremelimumab|tremelimumab|mesh-list
139477161|NCT05701488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477162|NCT05701488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477163|NCT05685407|Caffeine|caffeine|mesh-list
139477164|NCT05685407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139477165|NCT05685407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477166|NCT05685407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139477167|NCT05685407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477168|NCT05685407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477169|NCT05685407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139477170|NCT05685407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139477171|NCT05685407|Purinergic Agents|purinergic agents|mesh-ancestor
139477172|NCT05685407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139477173|NCT05684276|Paclitaxel|paclitaxel|mesh-list
139477174|NCT05684276|Carboplatin|carboplatin|mesh-list
139477175|NCT05684276|Nivolumab|nivolumab|mesh-list
139477176|NCT05684276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139477177|NCT05684276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477178|NCT05684276|Tubulin Modulators|tubulin modulators|mesh-ancestor
139477179|NCT05684276|Antimitotic Agents|antimitotic agents|mesh-ancestor
139477180|NCT05684276|Mitosis Modulators|mitosis modulators|mesh-ancestor
139477181|NCT05684276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477182|NCT05684276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477183|NCT05684276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139477184|NCT05669820|Antisecretory factor|antisecretory factor|mesh-list
139477185|NCT05669820|Antidiarrheals|antidiarrheals|mesh-ancestor
139477186|NCT05669820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139477187|NCT05641051|Metoclopramide|metoclopramide|mesh-list
139477188|NCT05641051|Antiemetics|antiemetics|mesh-ancestor
139477189|NCT05641051|Autonomic Agents|autonomic agents|mesh-ancestor
139477190|NCT05641051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477191|NCT05641051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477192|NCT05641051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139477193|NCT05641051|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139477194|NCT05641051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139003375|NCT00778349|Metformin|metformin|mesh-list
139477195|NCT05641051|Dopamine Agents|dopamine agents|mesh-ancestor
139477196|NCT05641051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139477197|NCT05641051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477198|NCT05631626|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
139477199|NCT05631626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139477200|NCT05631626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477201|NCT05631626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139477202|NCT05631626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139477203|NCT05631626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139477204|NCT05631626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477205|NCT05631626|Dopamine Agents|dopamine agents|mesh-ancestor
139477206|NCT05631626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139477207|NCT05618366|Venetoclax|venetoclax|mesh-list
139477208|NCT05618366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477209|NCT05587998|Morphine|morphine|mesh-list
139477210|NCT05587998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139477211|NCT05587998|Narcotics|narcotics|mesh-ancestor
139477212|NCT05587998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477213|NCT05587998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477214|NCT05587998|Analgesics|analgesics|mesh-ancestor
139477215|NCT05587998|Sensory System Agents|sensory system agents|mesh-ancestor
139477216|NCT05587998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477217|NCT05585398|Botulinum Toxins|botulinum toxins|mesh-list
139477218|NCT05585398|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139477219|NCT05585398|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139477220|NCT05585398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139477221|NCT05585398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139477222|NCT05585398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139477223|NCT05585398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477224|NCT05585398|Cholinergic Agents|cholinergic agents|mesh-ancestor
139477225|NCT05585398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139477226|NCT05585398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477227|NCT05585398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139477228|NCT05585398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477229|NCT05571735|Vaccines|vaccines|mesh-list
139477230|NCT05571735|Immunologic Factors|immunologic factors|mesh-ancestor
139477231|NCT05571735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477232|NCT05554237|Ceftibuten|ceftibuten|mesh-list
139477233|NCT05554237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139477234|NCT05554237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139477235|NCT05550870|Fenugreek seed meal|fenugreek seed meal|mesh-list
139477236|NCT05550870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139477237|NCT05550870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477238|NCT05544695|Hyaluronic Acid|hyaluronic acid|mesh-list
139477239|NCT05544695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139477240|NCT05544695|Immunologic Factors|immunologic factors|mesh-ancestor
139477241|NCT05544695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477242|NCT05544695|Viscosupplements|viscosupplements|mesh-ancestor
139477243|NCT05544695|Protective Agents|protective agents|mesh-ancestor
139477244|NCT05538312|Itraconazole|itraconazole|mesh-list
139477245|NCT05538312|Antifungal Agents|antifungal agents|mesh-ancestor
139477246|NCT05538312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139477247|NCT05538312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139477248|NCT05538312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139477249|NCT05538312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477250|NCT05538312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477251|NCT05538312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139477252|NCT05538312|Hormone Antagonists|hormone antagonists|mesh-ancestor
139477253|NCT05538312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139477254|NCT05538312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477255|NCT05538312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139477256|NCT05507476|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139477257|NCT05507476|Epinephrine|epinephrine|mesh-list
139477258|NCT05507476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139477259|NCT05507476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139477260|NCT05507476|Adrenergic Agents|adrenergic agents|mesh-ancestor
139477261|NCT05507476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139477262|NCT05507476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477263|NCT05507476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477264|NCT05507476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139477265|NCT05507476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139477266|NCT05507476|Autonomic Agents|autonomic agents|mesh-ancestor
139477267|NCT05507476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477268|NCT05507476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139477269|NCT05507476|Respiratory System Agents|respiratory system agents|mesh-ancestor
139477270|NCT05507476|Mydriatics|mydriatics|mesh-ancestor
139477271|NCT05507476|Sympathomimetics|sympathomimetics|mesh-ancestor
139477272|NCT05507476|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139477273|NCT05507476|Hemostatics|hemostatics|mesh-ancestor
139477274|NCT05507476|Coagulants|coagulants|mesh-ancestor
139477275|NCT05507476|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139477276|NCT05507476|Natriuretic Agents|natriuretic agents|mesh-ancestor
139477277|NCT05494125|Ropivacaine|ropivacaine|mesh-list
139477278|NCT05494125|Anesthetics, Local|anesthetics, local|mesh-ancestor
139477279|NCT05494125|Anesthetics|anesthetics|mesh-ancestor
138505679|NCT00018447|Fluorides|fluorides|mesh-list
139477280|NCT05494125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477281|NCT05494125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477282|NCT05494125|Sensory System Agents|sensory system agents|mesh-ancestor
139477283|NCT05494125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477284|NCT05484401|Ibuprofen|ibuprofen|mesh-list
139477285|NCT05484401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139477286|NCT05484401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139477287|NCT05484401|Analgesics|analgesics|mesh-ancestor
139477288|NCT05484401|Sensory System Agents|sensory system agents|mesh-ancestor
139477289|NCT05484401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477290|NCT05484401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477291|NCT05484401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139477292|NCT05484401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139477293|NCT05484401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139477294|NCT05484401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477295|NCT05484401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477296|NCT05447676|4-Aminopyridine|4-aminopyridine|mesh-list
139477297|NCT05447676|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139477298|NCT05447676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139477299|NCT05447676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477300|NCT05442580|Cyclophosphamide|cyclophosphamide|mesh-list
138754242|NCT01079949|Cetrorelix|cetrorelix|mesh-list
139477301|NCT05442580|Fludarabine|fludarabine|mesh-list
139477302|NCT05442580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139477303|NCT05442580|Immunologic Factors|immunologic factors|mesh-ancestor
139477304|NCT05442580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477305|NCT05442580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139477306|NCT05442580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139477307|NCT05442580|Alkylating Agents|alkylating agents|mesh-ancestor
139477308|NCT05442580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477309|NCT05442580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477310|NCT05442580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139477311|NCT05423340|Nicotine|nicotine|mesh-list
139477312|NCT05423340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139477313|NCT05423340|Autonomic Agents|autonomic agents|mesh-ancestor
139477314|NCT05423340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477315|NCT05423340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477316|NCT05423340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139477317|NCT05423340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139477318|NCT05423340|Cholinergic Agents|cholinergic agents|mesh-ancestor
139477319|NCT05423340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139477320|NCT05423340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477321|NCT05418582|Carbamazepine|carbamazepine|mesh-list
139477322|NCT05418582|Anticonvulsants|anticonvulsants|mesh-ancestor
139477323|NCT05418582|Antimanic Agents|antimanic agents|mesh-ancestor
139477324|NCT05418582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139477325|NCT05418582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477326|NCT05418582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477327|NCT05418582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139477328|NCT05418582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139477329|NCT05418582|Analgesics|analgesics|mesh-ancestor
139477330|NCT05418582|Sensory System Agents|sensory system agents|mesh-ancestor
139477331|NCT05418582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477332|NCT05418582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139477333|NCT05418582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139477334|NCT05418582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477335|NCT05418582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139477336|NCT05418582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139477337|NCT05417425|Lidocaine|lidocaine|mesh-list
139477338|NCT05417425|Protective Agents|protective agents|mesh-list
139477339|NCT05417425|Anesthetics, Local|anesthetics, local|mesh-ancestor
139477340|NCT05417425|Anesthetics|anesthetics|mesh-ancestor
139477341|NCT05417425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477342|NCT05417425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477343|NCT05417425|Sensory System Agents|sensory system agents|mesh-ancestor
139477344|NCT05417425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477345|NCT05417425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139477346|NCT05417425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139477347|NCT05417425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139477348|NCT05417425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139477349|NCT05417425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477350|NCT05394103|Pembrolizumab|pembrolizumab|mesh-list
139477351|NCT05394103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477352|NCT05394103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477353|NCT05394103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139477354|NCT05394103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477355|NCT05388474|Ibalizumab|ibalizumab|mesh-list
139477356|NCT05388474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139477357|NCT05388474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139477358|NCT05388474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139477359|NCT05388474|Antiviral Agents|antiviral agents|mesh-ancestor
139477360|NCT05388474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139477361|NCT05388474|Immunologic Factors|immunologic factors|mesh-ancestor
139477362|NCT05388474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477363|NCT05372744|Antidepressive Agents|antidepressive agents|mesh-list
139477364|NCT05372744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139477365|NCT05347771|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139477366|NCT05347771|Immunologic Factors|immunologic factors|mesh-ancestor
139477367|NCT05347771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477368|NCT05342844|Dexmedetomidine|dexmedetomidine|mesh-list
139477369|NCT05342844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139477370|NCT05342844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477371|NCT05342844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477372|NCT05342844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139477373|NCT05342844|Analgesics|analgesics|mesh-ancestor
139477374|NCT05342844|Sensory System Agents|sensory system agents|mesh-ancestor
139477375|NCT05342844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477376|NCT05342844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139477377|NCT05342844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139477378|NCT05342844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139477379|NCT05342844|Adrenergic Agents|adrenergic agents|mesh-ancestor
139477380|NCT05342844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139477381|NCT05342844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477382|NCT05339087|Riociguat|riociguat|mesh-list
139477383|NCT05339087|Enzyme Activators|enzyme activators|mesh-ancestor
139477384|NCT05339087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477385|NCT05323617|Cyclosporine|cyclosporine|mesh-list
139477386|NCT05323617|Cyclosporins|cyclosporins|mesh-list
139477387|NCT05323617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139477388|NCT05323617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477389|NCT05323617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477390|NCT05323617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139477391|NCT05323617|Immunologic Factors|immunologic factors|mesh-ancestor
139477392|NCT05323617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477393|NCT05323617|Antifungal Agents|antifungal agents|mesh-ancestor
139477394|NCT05323617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139477395|NCT05323617|Dermatologic Agents|dermatologic agents|mesh-ancestor
139477396|NCT05323617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139477397|NCT05323617|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139477398|NCT05229965|Acetaminophen|acetaminophen|mesh-list
139477399|NCT05229965|Codeine|codeine|mesh-list
139477400|NCT05229965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139477401|NCT05229965|Analgesics|analgesics|mesh-ancestor
139477402|NCT05229965|Sensory System Agents|sensory system agents|mesh-ancestor
139477403|NCT05229965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477404|NCT05229965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477405|NCT05229965|Antipyretics|antipyretics|mesh-ancestor
139477406|NCT05229965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139477407|NCT05229965|Narcotics|narcotics|mesh-ancestor
139477408|NCT05229965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477409|NCT05229965|Antitussive Agents|antitussive agents|mesh-ancestor
139477410|NCT05229965|Respiratory System Agents|respiratory system agents|mesh-ancestor
139477411|NCT05227391|Letrozole|letrozole|mesh-list
139477412|NCT05227391|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139477413|NCT05227391|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139477414|NCT05227391|Estradiol|estradiol|mesh-list
139477415|NCT05227391|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139477416|NCT05227391|Estrogens|estrogens|mesh-ancestor
139477417|NCT05227391|Hormones|hormones|mesh-ancestor
139477418|NCT05227391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139477419|NCT05227391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477420|NCT05227391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139477421|NCT05227391|Contraceptive Agents|contraceptive agents|mesh-ancestor
139477422|NCT05227391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139477423|NCT05227391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139477424|NCT05227391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477425|NCT05227391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139003629|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
139477426|NCT05227391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139477427|NCT05227391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139264163|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477428|NCT05227391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477429|NCT05227391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139477430|NCT05227391|Hormone Antagonists|hormone antagonists|mesh-ancestor
139477432|NCT05207709|Letrozole|letrozole|mesh-list
139477433|NCT05207709|Fulvestrant|fulvestrant|mesh-list
139477434|NCT05207709|Tislelizumab|tislelizumab|mesh-list
139477435|NCT05207709|Palbociclib|palbociclib|mesh-list
139477436|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139477437|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477438|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
139477439|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
139477440|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
139477441|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477442|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139477443|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139477444|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477445|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139477446|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
139477447|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139477448|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003647|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139477449|NCT05207709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139477450|NCT05207709|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139477451|NCT05207709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477452|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139477453|NCT05203276|Endostar protein|endostar protein|mesh-list
139477454|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139477455|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139477456|NCT05203276|Growth Substances|growth substances|mesh-ancestor
139477457|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477458|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
139477459|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477460|NCT05201066|Azacitidine|azacitidine|mesh-list
139477461|NCT05201066|Decitabine|decitabine|mesh-list
139477462|NCT05201066|Venetoclax|venetoclax|mesh-list
139477463|NCT05201066|Spartalizumab|spartalizumab|mesh-list
139477464|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139477465|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
139477466|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477467|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477468|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477469|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139477470|NCT05201066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477471|NCT05167487|Cisplatin|cisplatin|mesh-list
139477472|NCT05167487|Carboplatin|carboplatin|mesh-list
139477473|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477474|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
139477475|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477476|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477477|NCT05159778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139477478|NCT05159778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477479|NCT05159050|Paclitaxel|paclitaxel|mesh-list
139477480|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139477481|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477482|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
139477483|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
139477484|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
139477485|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477486|NCT05152888|Evolocumab|evolocumab|mesh-list
139477487|NCT05152888|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139477488|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139477489|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139477490|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
139477491|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003692|NCT00785603|Tramadol|tramadol|mesh-list
139477492|NCT05152888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139477493|NCT05152888|Protease Inhibitors|protease inhibitors|mesh-ancestor
139477494|NCT05152888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477495|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139477496|NCT05151484|Alendronate|alendronate|mesh-list
139477497|NCT05151484|Teriparatide|teriparatide|mesh-list
139477498|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139477499|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477500|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139477501|NCT05113537|177Lu-PSMA-617|177lu-psma-617|mesh-list
139477502|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477503|NCT05113537|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139477504|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139477506|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139477507|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
139477508|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139477509|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477510|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139477511|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139477512|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477513|NCT05104554|Folic Acid|folic acid|mesh-list
139477514|NCT05104554|Micronutrients|micronutrients|mesh-list
139477515|NCT05104554|Trace Elements|trace elements|mesh-list
139477516|NCT05104554|Hematinics|hematinics|mesh-ancestor
139477517|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
139477518|NCT05104554|Vitamins|vitamins|mesh-ancestor
139477519|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477520|NCT05088252|Propofol|propofol|mesh-list
139477521|NCT05088252|Desflurane|desflurane|mesh-list
139477522|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139477523|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477524|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477525|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139477526|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
139477527|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
139477528|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139477529|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
139477530|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139477531|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
139003729|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477532|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477533|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
139477534|NCT05073575|Protective Agents|protective agents|mesh-ancestor
139477535|NCT05069298|Silybin|silybin|mesh-list
139477536|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139477537|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477538|NCT05069298|Protective Agents|protective agents|mesh-ancestor
139477539|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477540|NCT05047640|Vaccines|vaccines|mesh-list
139477541|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
139477542|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477543|NCT05043714|Nivolumab|nivolumab|mesh-list
139477544|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477545|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477546|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139477547|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477548|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139477549|NCT05039073|Nivolumab|nivolumab|mesh-list
139477550|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139477551|NCT05039073|Antibodies|antibodies|mesh-list
139477552|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
139477553|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139477554|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
139477555|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
139477556|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477557|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477558|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139477559|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477560|NCT05039073|Immunotoxins|immunotoxins|mesh-ancestor
139477561|NCT05029999|Doxorubicin|doxorubicin|mesh-list
139477562|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139477563|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139477564|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477565|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139477566|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139477567|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477568|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477569|NCT05023967|Metformin|metformin|mesh-list
139477570|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139477571|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477572|NCT05012254|Paclitaxel|paclitaxel|mesh-list
139477573|NCT05012254|Cisplatin|cisplatin|mesh-list
139477574|NCT05012254|Carboplatin|carboplatin|mesh-list
139477575|NCT05012254|Nivolumab|nivolumab|mesh-list
139477576|NCT05012254|Pemetrexed|pemetrexed|mesh-list
139477577|NCT05012254|Ipilimumab|ipilimumab|mesh-list
139477578|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139477579|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477580|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
139477581|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
139477582|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
139477583|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972674|NCT00893724|Niacin|niacin|mesh-list
139477584|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477585|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139477586|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477587|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139477588|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139477589|NCT04995978|Pioglitazone|pioglitazone|mesh-list
139477590|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139477591|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477592|NCT04987294|Rasburicase|rasburicase|mesh-list
139477593|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
139477594|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139477595|NCT04987242|Rasburicase|rasburicase|mesh-list
139477596|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
139477597|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139477598|NCT04976192|Omalizumab|omalizumab|mesh-list
139477599|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139477600|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139477601|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
139477602|NCT04958486|Trastuzumab|trastuzumab|mesh-list
139477603|NCT04958486|Azacitidine|azacitidine|mesh-list
139477604|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477605|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003810|NCT00783653|Sunitinib|sunitinib|mesh-list
139477606|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139477607|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
139477608|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477609|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477610|NCT04942210|Vaccines|vaccines|mesh-list
139477611|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
139477612|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477613|NCT04940767|Minocycline|minocycline|mesh-list
139477614|NCT04940767|Isotretinoin|isotretinoin|mesh-list
139477615|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139477616|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139477617|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
139477618|NCT04913805|Niacinamide|niacinamide|mesh-list
139477619|NCT04913805|Niacin|niacin|mesh-list
139477620|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
139477621|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
139477622|NCT04913805|Vitamins|vitamins|mesh-ancestor
139477623|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
139477624|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477625|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139477626|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
139477627|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477628|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139477629|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
139477630|NCT04907968|Carboplatin|carboplatin|mesh-list
139477631|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477632|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
139477633|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139477634|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139477635|NCT04900220|Prednisolone|prednisolone|mesh-list
139477636|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
139477637|NCT04900220|Betamethasone|betamethasone|mesh-list
139477638|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139477639|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
139477640|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139477641|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
139477642|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
139477643|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477644|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477645|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139477646|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
139477647|NCT04900220|Hormones|hormones|mesh-ancestor
139477648|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139477649|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139477650|NCT04900220|Protective Agents|protective agents|mesh-ancestor
139477651|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139477652|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003843|NCT00783731|Midazolam|midazolam|mesh-list
139477653|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139477654|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
139477655|NCT04896320|Tucatinib|tucatinib|mesh-list
139477656|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477657|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139477658|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477659|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477660|NCT04887259|Interleukin-2|interleukin-2|mesh-list
139477661|NCT04887259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477662|NCT04887259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139477663|NCT04887259|Analgesics|analgesics|mesh-ancestor
139477664|NCT04887259|Sensory System Agents|sensory system agents|mesh-ancestor
139477665|NCT04887259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477666|NCT04887259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477667|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
139477668|NCT04877613|Fludarabine|fludarabine|mesh-list
139477669|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139477670|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
139477671|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477672|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139477673|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139477674|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
139477675|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477676|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477677|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139477678|NCT04871607|Cytarabine|cytarabine|mesh-list
139477679|NCT04871607|Etoposide|etoposide|mesh-list
139477680|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
139477681|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
139477682|NCT04871607|Carmustine|carmustine|mesh-list
139477683|NCT04871607|Basiliximab|basiliximab|mesh-list
139477684|NCT04871607|Lenograstim|lenograstim|mesh-list
139477685|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139477686|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477687|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139477688|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139477689|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477690|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477691|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139477692|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
139477693|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
139477694|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139477695|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139477696|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
139477697|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477698|NCT04871607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139477699|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139477700|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
139477701|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
139477702|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
139477703|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
139477704|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
139477705|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
139477706|NCT04865042|Gabapentin|gabapentin|mesh-list
139477707|NCT04865042|Analgesics|analgesics|mesh-ancestor
139477708|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
139477709|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477710|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477711|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
139477712|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139477713|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139477714|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477715|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139477716|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139477717|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139477718|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139477719|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477720|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
139477721|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139477722|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139477723|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
139477724|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477725|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477726|NCT04830592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139477727|NCT04830592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477728|NCT04824131|Tenofovir|tenofovir|mesh-list
139477729|NCT04824131|Emtricitabine|emtricitabine|mesh-list
139477730|NCT04824131|Cabotegravir|cabotegravir|mesh-list
139477731|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
139477732|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139477733|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139477734|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139477735|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477736|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477737|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139477738|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139477739|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139477740|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139477741|NCT04776447|Carboplatin|carboplatin|mesh-list
139477742|NCT04776447|Atezolizumab|atezolizumab|mesh-list
139477743|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477744|NCT04776447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139477745|NCT04776447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477746|NCT04776447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139003953|NCT00391222|Olanzapine|olanzapine|mesh-list
139477747|NCT04768504|Tofacitinib|tofacitinib|mesh-list
139477748|NCT04768504|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139477749|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139477750|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477751|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477752|NCT04748172|Antibodies|antibodies|mesh-list
139477753|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
139477754|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477755|NCT04736823|Paclitaxel|paclitaxel|mesh-list
139477756|NCT04736823|Docetaxel|docetaxel|mesh-list
139477757|NCT04736823|Carboplatin|carboplatin|mesh-list
139477758|NCT04736823|Pemetrexed|pemetrexed|mesh-list
139477759|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139477760|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477761|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
139477762|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
139477763|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
139477764|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477765|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477766|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139477767|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139477768|NCT04729621|Denosumab|denosumab|mesh-list
139477769|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139477770|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477771|NCT04664023|Vaccines|vaccines|mesh-list
139477772|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
139477773|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477774|NCT04633889|Deferoxamine|deferoxamine|mesh-list
139477775|NCT04633889|Siderophores|siderophores|mesh-ancestor
139477776|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139477777|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
139477778|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
139003989|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
139477779|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477780|NCT04630886|Lidocaine|lidocaine|mesh-list
139477781|NCT04630886|Epinephrine|epinephrine|mesh-list
139477782|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
139477783|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
139477784|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
139477785|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477786|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477787|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
139477788|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477789|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139003991|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139477790|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139477791|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139477792|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139477793|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477794|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139477795|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139477796|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
139477797|NCT04630886|Coagulants|coagulants|mesh-ancestor
139477798|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139477799|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139477800|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
139477801|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139477802|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139477803|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139477804|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
139477805|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139477806|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
139477807|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
139264531|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139477808|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
139477809|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139477810|NCT04619316|Trametinib|trametinib|mesh-list
139477811|NCT04619316|Dabrafenib|dabrafenib|mesh-list
139477812|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477813|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139477814|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477815|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477816|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
139477817|NCT04610528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139477818|NCT04610528|Immunologic Factors|immunologic factors|mesh-ancestor
139477819|NCT04610528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477820|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477821|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477822|NCT04609111|Aspirin|aspirin|mesh-list
139477823|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139477824|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139477825|NCT04609111|Analgesics|analgesics|mesh-ancestor
139477826|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
139477827|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004021|NCT05254808|Nitrofurantoin|nitrofurantoin|mesh-list
139477828|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477829|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139477830|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139477831|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139477832|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139477833|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477834|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139477835|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139477836|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477837|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
139477838|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139477839|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477840|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477841|NCT04590196|Curcumin|curcumin|mesh-list
139477842|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139477843|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139477844|NCT04590196|Analgesics|analgesics|mesh-ancestor
139477845|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
139477846|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477847|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477848|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139477849|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139477850|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477851|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477852|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477853|NCT04589208|Ketamine|ketamine|mesh-list
139477854|NCT04589208|Analgesics|analgesics|mesh-ancestor
139477855|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
139477856|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477857|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477858|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139477859|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139477860|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
139477861|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
139477862|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477863|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139477864|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139477865|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139477866|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477867|NCT04566328|Dexamethasone|dexamethasone|mesh-list
139477868|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
139477869|NCT04566328|Lenalidomide|lenalidomide|mesh-list
139477870|NCT04566328|Bortezomib|bortezomib|mesh-list
139477871|NCT04566328|Daratumumab|daratumumab|mesh-list
139477872|NCT04566328|Ichthammol|ichthammol|mesh-list
139477873|NCT04566328|BB 1101|bb 1101|mesh-list
139477874|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139477875|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139477876|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
139477877|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
139477878|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477879|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477880|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139477881|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
139477882|NCT04566328|Hormones|hormones|mesh-ancestor
139477883|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139477884|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139477885|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477886|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
139477887|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477888|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477889|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
139477890|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139477891|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139477892|NCT04566328|Growth Substances|growth substances|mesh-ancestor
139477893|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
139477894|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
139477895|NCT04559139|Cisplatin|cisplatin|mesh-list
139477896|NCT04559139|Gemcitabine|gemcitabine|mesh-list
139477897|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477898|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139477899|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
139477900|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477901|NCT04551222|Probenecid|probenecid|mesh-list
139477902|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
139477903|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
139477904|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139477905|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
139477906|NCT04527549|Trametinib|trametinib|mesh-list
139477907|NCT04527549|Dabrafenib|dabrafenib|mesh-list
139477908|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139477909|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
139477910|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139477911|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139477912|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139477913|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477914|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477915|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139477916|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477917|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139477918|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139477919|NCT04527549|Protective Agents|protective agents|mesh-ancestor
139477920|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477921|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139477922|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
139477923|NCT04512430|Bevacizumab|bevacizumab|mesh-list
139477924|NCT04512430|Atezolizumab|atezolizumab|mesh-list
139477925|NCT04512430|Carboplatin|carboplatin|mesh-list
139477926|NCT04512430|Pemetrexed|pemetrexed|mesh-list
139477927|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477928|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477929|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139477930|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139477931|NCT04512430|Growth Substances|growth substances|mesh-ancestor
139477932|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477933|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
139477934|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477935|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477936|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139477937|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139477938|NCT04512430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139477939|NCT04502433|Poractant alfa|poractant alfa|mesh-list
139477940|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139477941|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
139477942|NCT04484818|Leuprolide|leuprolide|mesh-list
139477943|NCT04484818|Goserelin|goserelin|mesh-list
139477944|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139477945|NCT04484818|Tryptophan|tryptophan|mesh-list
139477946|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
139004153|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139477947|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139477948|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477949|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139477950|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
139477951|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139477952|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139477953|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477954|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
139477955|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139477956|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
139477957|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139004159|NCT01044394|Laxatives|laxatives|mesh-ancestor
139477958|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139477959|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
139477960|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139477961|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
139264678|NCT04908592|Dexamethasone|dexamethasone|mesh-list
139477962|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
139477963|NCT04484012|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139477964|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477965|NCT04484012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139477966|NCT04484012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477967|NCT04484012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477968|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
139477969|NCT04477200|Temozolomide|temozolomide|mesh-list
139477970|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139477971|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
139477972|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477973|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477974|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139477975|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139477976|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
139477977|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139477978|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139477979|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139477980|NCT04455802|Morphine|morphine|mesh-list
139477981|NCT04455802|Buprenorphine|buprenorphine|mesh-list
139477982|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139477983|NCT04455802|Narcotics|narcotics|mesh-ancestor
139477984|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139477985|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139477986|NCT04455802|Analgesics|analgesics|mesh-ancestor
139477987|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
139477988|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139477989|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139477990|NCT04443088|Pembrolizumab|pembrolizumab|mesh-list
139477991|NCT04443088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139477992|NCT04443088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139477993|NCT04443088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139477994|NCT04443088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139477995|NCT04426890|Omalizumab|omalizumab|mesh-list
139477996|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139477997|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139477998|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139477999|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
139478000|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
139478001|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478002|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
139478003|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
139478004|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139478005|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478006|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478007|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478008|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139478009|NCT04411836|Primaquine|primaquine|mesh-list
139478010|NCT04411836|Tafenoquine|tafenoquine|mesh-list
139478011|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
139478012|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139478013|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139478014|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478015|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139478016|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
139478017|NCT04364048|Cisplatin|cisplatin|mesh-list
139478018|NCT04364048|Carboplatin|carboplatin|mesh-list
139478019|NCT04364048|Etoposide|etoposide|mesh-list
139478020|NCT04364048|Pemetrexed|pemetrexed|mesh-list
139478021|NCT04364048|Durvalumab|durvalumab|mesh-list
139478022|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139478023|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478024|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139478025|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139478026|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139478027|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478028|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478029|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139478030|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139478031|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478032|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
139478033|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478034|NCT04328727|Cyclosporine|cyclosporine|mesh-list
139478035|NCT04328727|Cyclosporins|cyclosporins|mesh-list
139478036|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139478037|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
139478038|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478039|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478040|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139478042|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478043|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
139478044|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478045|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
139478046|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139478047|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139478048|NCT04311580|Mitomycins|mitomycins|mesh-list
139478049|NCT04311580|Mitomycin|mitomycin|mesh-list
139478050|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139478051|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478052|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
139478053|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478054|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139478055|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478056|NCT04301492|Vortioxetine|vortioxetine|mesh-list
139478057|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
139478058|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139478059|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139478060|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139478061|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139478062|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478063|NCT04301492|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139478064|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139478065|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139478066|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478067|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139478068|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
139478069|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139478070|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139478071|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139478072|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139478073|NCT04290039|Atropine|atropine|mesh-list
139478074|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139478075|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139478076|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139478077|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139478078|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139478079|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
139478080|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139478081|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478082|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139478083|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
139478084|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
139478085|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
139478086|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139478087|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139478088|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
139478089|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139478090|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478091|NCT04266249|Paclitaxel|paclitaxel|mesh-list
139478092|NCT04266249|Maytansine|maytansine|mesh-list
139478093|NCT04266249|Docetaxel|docetaxel|mesh-list
139478094|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139478095|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139478096|NCT04266249|Trastuzumab|trastuzumab|mesh-list
139478097|NCT04266249|Pertuzumab|pertuzumab|mesh-list
139478098|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139478099|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139478100|NCT04266249|Antibodies|antibodies|mesh-list
139478101|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
139478102|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139478103|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
139478104|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139478105|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478106|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
139478107|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
139478108|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
139478109|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478110|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
139478111|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478112|NCT04266249|Immunotoxins|immunotoxins|mesh-ancestor
139478113|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
139478114|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478115|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478116|NCT04260126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139478117|NCT04260126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478118|NCT04233112|Melatonin|melatonin|mesh-list
139478119|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
139478120|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478121|NCT04233112|Protective Agents|protective agents|mesh-ancestor
139478122|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478123|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139478124|NCT04217954|Bevacizumab|bevacizumab|mesh-list
139478125|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478126|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478127|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139478128|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139478129|NCT04217954|Growth Substances|growth substances|mesh-ancestor
139478130|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478131|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
139478132|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139478133|NCT04210427|Laxatives|laxatives|mesh-ancestor
139478134|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139478135|NCT04194034|Flucytosine|flucytosine|mesh-list
139478136|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
139478137|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478138|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
139478139|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478140|NCT04191135|Carboplatin|carboplatin|mesh-list
139478141|NCT04191135|Gemcitabine|gemcitabine|mesh-list
139478142|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
139478143|NCT04191135|Olaparib|olaparib|mesh-list
139478144|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478145|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139478146|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
139478147|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478148|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478149|NCT04191135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139478150|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139478151|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478152|NCT04356170|Docetaxel|docetaxel|mesh-list
139478153|NCT04356170|Fluorouracil|fluorouracil|mesh-list
139478154|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478155|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
139478156|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
139478157|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
139478158|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478159|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
139478160|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139478161|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139478162|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
139478163|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478164|NCT04166318|Capecitabine|capecitabine|mesh-list
139478165|NCT04166318|Fluorouracil|fluorouracil|mesh-list
139478166|NCT04166318|Mitomycins|mitomycins|mesh-list
139478167|NCT04166318|Mitomycin|mitomycin|mesh-list
139478168|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139478169|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
139478170|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478171|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478172|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139478173|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
139478174|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478175|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139478176|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
139478177|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139478178|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478179|NCT04150614|Dexamethasone|dexamethasone|mesh-list
139478180|NCT04150614|Ondansetron|ondansetron|mesh-list
139478181|NCT04150614|Granisetron|granisetron|mesh-list
139478182|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139478183|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
139478184|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
139478185|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139478186|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478187|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139478188|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
139478189|NCT04150614|Hormones|hormones|mesh-ancestor
139478190|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139478191|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139478192|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478193|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
139478194|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
139478195|NCT04150614|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139478196|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139478197|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
139478198|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139478199|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478200|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
139478201|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
139478202|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139478203|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139478204|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478205|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004410|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
139478206|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478207|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139478208|NCT04126096|Lactams|lactams|mesh-list
139478209|NCT04126096|beta-Lactams|beta-lactams|mesh-list
139478210|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139478211|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478212|NCT04125836|Octreotide|octreotide|mesh-list
139478213|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139478214|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139478215|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478216|NCT04121455|Bevacizumab|bevacizumab|mesh-list
139478217|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
139478218|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478219|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478220|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139478221|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139478222|NCT04121455|Growth Substances|growth substances|mesh-ancestor
139478223|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478224|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
139478225|NCT04121455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139478226|NCT04121455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478227|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
139478228|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
139478229|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139478230|NCT04115631|Cytarabine|cytarabine|mesh-list
139478231|NCT04115631|Rituximab|rituximab|mesh-list
139478232|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139478233|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139478234|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
139478235|NCT04115631|Antibodies|antibodies|mesh-list
139478236|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
139478237|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139478238|NCT04115631|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139478239|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
139478240|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478241|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478242|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139478243|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139478244|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
139478245|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478246|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
139478247|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478248|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139478249|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139478250|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
139478251|NCT04115631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139478252|NCT04115631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478253|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
139478254|NCT04109482|Fludarabine|fludarabine|mesh-list
139004460|NCT00665561|Maraviroc|maraviroc|mesh-list
139478255|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139478256|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
139478257|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478258|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139478259|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139478260|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
139478261|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478262|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478263|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139478264|NCT04094584|Naltrexone|naltrexone|mesh-list
139478265|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139478266|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139478267|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478268|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
139478269|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139478271|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139478272|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139478273|NCT04047472|Growth Substances|growth substances|mesh-ancestor
139478274|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478275|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
139478276|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478277|NCT04047355|Propranolol|propranolol|mesh-list
139478278|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139478279|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139478280|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
139478281|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139478282|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478283|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478284|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139478285|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139478286|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
139478287|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
139478288|NCT04020341|Gepotidacin|gepotidacin|mesh-list
139478289|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139478290|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478291|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139004499|NCT00791141|Cetuximab|cetuximab|mesh-list
139478292|NCT04020341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139478293|NCT04020341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478294|NCT04020341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478295|NCT04020341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478296|NCT04011280|Varenicline|varenicline|mesh-list
139478297|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139478298|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139478299|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
139478300|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139478301|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478302|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478303|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
139478304|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139478305|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139478306|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
139478307|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139478308|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478309|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139478310|NCT03987711|Warfarin|warfarin|mesh-list
139478311|NCT03987711|Apixaban|apixaban|mesh-list
139478312|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
139478313|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139478314|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
139478315|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139478316|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
139478317|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478318|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478319|NCT03937635|Dexamethasone|dexamethasone|mesh-list
139004528|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
139478320|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
139478321|NCT03937635|Lenalidomide|lenalidomide|mesh-list
139478322|NCT03937635|Daratumumab|daratumumab|mesh-list
139478323|NCT03937635|Ichthammol|ichthammol|mesh-list
139478324|NCT03937635|BB 1101|bb 1101|mesh-list
139478325|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139478326|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
139478327|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
139478328|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139478329|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478330|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139478331|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
139478332|NCT03937635|Hormones|hormones|mesh-ancestor
139478333|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139478334|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139478335|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478336|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
139478337|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139478338|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139478339|NCT03937635|Growth Substances|growth substances|mesh-ancestor
139478340|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
139478341|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
139478343|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478344|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
139478345|NCT03892044|Nivolumab|nivolumab|mesh-list
139478346|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478347|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478348|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139478349|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478350|NCT03891953|Spartalizumab|spartalizumab|mesh-list
139478351|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139478352|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478353|NCT03891953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478354|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478355|NCT03867851|Heparin|heparin|mesh-list
139478356|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
139478357|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139478358|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139478359|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478360|NCT03809780|Dexamethasone|dexamethasone|mesh-list
139478361|NCT03809780|Lenalidomide|lenalidomide|mesh-list
139478362|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139478363|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
139478364|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
139478365|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139478366|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478367|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139478368|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
139478369|NCT03809780|Hormones|hormones|mesh-ancestor
139478370|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139478371|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139478372|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478373|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
139478374|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139478375|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139478376|NCT03809780|Growth Substances|growth substances|mesh-ancestor
139478377|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
139478378|NCT03802604|Atezolizumab|atezolizumab|mesh-list
139478379|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139478380|NCT03802604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139478381|NCT03802604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478382|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478383|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478384|NCT03785873|Leucovorin|leucovorin|mesh-list
139478385|NCT03785873|Fluorouracil|fluorouracil|mesh-list
139478386|NCT03785873|Nivolumab|nivolumab|mesh-list
139478387|NCT03785873|Irinotecan|irinotecan|mesh-list
139478388|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
139478389|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478390|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139478391|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478392|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139478393|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
139478394|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478395|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478396|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139478397|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139478398|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139004597|NCT00660179|Macitentan|macitentan|mesh-list
139478399|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478400|NCT03785873|Antidotes|antidotes|mesh-ancestor
139478401|NCT03785873|Protective Agents|protective agents|mesh-ancestor
139478402|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
139478403|NCT03785873|Vitamins|vitamins|mesh-ancestor
139478404|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
139478405|NCT03782064|Nivolumab|nivolumab|mesh-list
139478406|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478407|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478408|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139478409|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478410|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
139478411|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139478412|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478413|NCT03764293|Sorafenib|sorafenib|mesh-list
139478414|NCT03764293|Apatinib|apatinib|mesh-list
139478415|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478416|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139478417|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478418|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478419|NCT03747042|Letrozole|letrozole|mesh-list
139478420|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478421|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139478422|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139478423|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478424|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478425|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139478426|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
139478427|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139478428|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478429|NCT03739112|Vaccines|vaccines|mesh-list
139478430|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
139478431|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478432|NCT03724071|Flucytosine|flucytosine|mesh-list
139478433|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
139478434|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478435|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
139478436|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478437|NCT03709446|Leflunomide|leflunomide|mesh-list
139478438|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478439|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478440|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139478441|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
139478442|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478443|NCT03671525|Nimodipine|nimodipine|mesh-list
139478444|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139478445|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139004621|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
139478446|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139478447|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478448|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139478449|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478450|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
139478451|NCT03648437|Acetaminophen|acetaminophen|mesh-list
139478452|NCT03648437|Ibuprofen|ibuprofen|mesh-list
139478453|NCT03648437|Indomethacin|indomethacin|mesh-list
139478454|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139478455|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139478456|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139478457|NCT03648437|Analgesics|analgesics|mesh-ancestor
139478458|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
139478459|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139478460|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478461|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139478462|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139478463|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139478464|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478465|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478466|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
139478467|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
139478468|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
139478469|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139478470|NCT03646058|Buprenorphine|buprenorphine|mesh-list
139478471|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139478472|NCT03646058|Narcotics|narcotics|mesh-ancestor
139478473|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139478474|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478475|NCT03646058|Analgesics|analgesics|mesh-ancestor
139478476|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
139478477|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139478478|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139478479|NCT03622593|Aflibercept|aflibercept|mesh-list
139478480|NCT03622593|Faricimab|faricimab|mesh-list
139478481|NCT03622593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139478482|NCT03622593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139478483|NCT03622593|Growth Substances|growth substances|mesh-ancestor
139478484|NCT03622593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509935|NCT03270501|Golimumab|golimumab|mesh-list
139478485|NCT03622593|Growth Inhibitors|growth inhibitors|mesh-ancestor
139478486|NCT03622593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478487|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
139478488|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
139265203|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
139478489|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
139478497|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139478498|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478499|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478500|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139478501|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139478502|NCT03572530|Azacitidine|azacitidine|mesh-list
139478503|NCT03572530|Decitabine|decitabine|mesh-list
139478504|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139478505|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
139478506|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478507|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478508|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478515|NCT03558087|Gemcitabine|gemcitabine|mesh-list
139478516|NCT03558087|Nivolumab|nivolumab|mesh-list
139478517|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478518|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139478519|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
139478520|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478521|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478522|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139478523|NCT03542695|Alendronate|alendronate|mesh-list
139478524|NCT03542695|Copper|copper|mesh-list
139478525|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139478526|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478527|NCT03542695|Trace Elements|trace elements|mesh-ancestor
139478528|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
139478529|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139478530|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
139478531|NCT03512405|Blinatumomab|blinatumomab|mesh-list
139478532|NCT03512405|Antibodies|antibodies|mesh-list
139478533|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
139478534|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139478535|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
139478536|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139478537|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
139478538|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004734|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478539|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478540|NCT03512405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139478541|NCT03512405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478542|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139478543|NCT03458416|Cannabidiol|cannabidiol|mesh-list
139478544|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
139478545|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
139478546|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139478547|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478548|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478549|NCT03430219|Calcium|calcium|mesh-list
139478550|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139478551|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478552|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
139478553|NCT03419234|Prednisone|prednisone|mesh-list
139478554|NCT03419234|Cortisone|cortisone|mesh-list
139478555|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
139478556|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
139478557|NCT03419234|Hormones|hormones|mesh-list
139478558|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139478559|NCT03419234|Androgens|androgens|mesh-list
139478560|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
139478561|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139478562|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
139478563|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139478564|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478565|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139478566|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478567|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139478568|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478569|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478570|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
139478571|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139478572|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
139478573|NCT03419234|Protective Agents|protective agents|mesh-ancestor
139478574|NCT03419234|Vitamins|vitamins|mesh-ancestor
139478575|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
139478576|NCT03419234|Estrogens|estrogens|mesh-ancestor
139478577|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
139478578|NCT03267433|Rituximab|rituximab|mesh-list
139478579|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478580|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478581|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
139478582|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478583|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139478584|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
139478585|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139478586|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
139478587|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478588|NCT03238300|Expectorants|expectorants|mesh-ancestor
139004787|NCT00792779|Propofol|propofol|mesh-list
139478589|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
139478590|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139478591|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
139478592|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478593|NCT03238300|Protective Agents|protective agents|mesh-ancestor
139478594|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478595|NCT03238300|Antidotes|antidotes|mesh-ancestor
139478596|NCT03215511|Selitrectinib|selitrectinib|mesh-list
139478597|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478598|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478599|NCT03214003|Cisplatin|cisplatin|mesh-list
139478600|NCT03214003|Etoposide|etoposide|mesh-list
139478601|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
139478602|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478603|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139478604|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139478605|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139478606|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478607|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478608|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
139478609|NCT03139370|Fludarabine|fludarabine|mesh-list
139478610|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139478611|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
139004813|NCT00792857|Vitamins|vitamins|mesh-ancestor
139478612|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478613|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139478614|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139478615|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
139478616|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478617|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478618|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139478619|NCT03133221|Idelalisib|idelalisib|mesh-list
139478620|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478621|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478622|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478623|NCT03113500|Prednisone|prednisone|mesh-list
139478624|NCT03113500|Cortisone|cortisone|mesh-list
139478625|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
139478626|NCT03113500|Doxorubicin|doxorubicin|mesh-list
139478627|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139478628|NCT03113500|Etoposide|etoposide|mesh-list
139478629|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
139478630|NCT03113500|Daunorubicin|daunorubicin|mesh-list
139478631|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139478632|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
139478633|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139478634|NCT03113500|Antibodies|antibodies|mesh-list
139478635|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
139478636|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139478637|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
139478638|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139478639|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
139478640|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478641|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139478642|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139478643|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
139004841|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
139478644|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478645|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478646|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139478647|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139478648|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139478649|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139478650|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478651|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139478652|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
139478653|NCT03113500|Hormones|hormones|mesh-ancestor
139478654|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139478655|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139478656|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139478657|NCT03113500|Immunotoxins|immunotoxins|mesh-ancestor
139478658|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
139478659|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
139478660|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
139478661|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
139478662|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
139478663|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
139478664|NCT03089203|Fludarabine|fludarabine|mesh-list
139478665|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139478666|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
139478667|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478668|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139478669|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139478670|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
139478671|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478672|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478673|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139478674|NCT03049540|Tadalafil|tadalafil|mesh-list
139478675|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
139478676|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139478677|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139478678|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478679|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478680|NCT03049540|Urological Agents|urological agents|mesh-ancestor
139478681|NCT03012880|Dexamethasone|dexamethasone|mesh-list
139478682|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
139478683|NCT03012880|Lenalidomide|lenalidomide|mesh-list
139478684|NCT03012880|Daratumumab|daratumumab|mesh-list
139478685|NCT03012880|Ixazomib|ixazomib|mesh-list
139478686|NCT03012880|Ichthammol|ichthammol|mesh-list
139478687|NCT03012880|BB 1101|bb 1101|mesh-list
139478688|NCT03012880|Glycine|glycine|mesh-list
139478689|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139478690|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
139478691|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
139478692|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139478693|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478694|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139478695|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
139478696|NCT03012880|Hormones|hormones|mesh-ancestor
139478697|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139478698|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139478699|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478700|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
139478701|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139478702|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139478703|NCT03012880|Growth Substances|growth substances|mesh-ancestor
139478704|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
139478705|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478706|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
139478707|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478708|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
139478709|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
139478710|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139478711|NCT02999087|Cetuximab|cetuximab|mesh-list
139478712|NCT02999087|Avelumab|avelumab|mesh-list
139478713|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478714|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478715|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
139478716|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
139478717|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139478718|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139265424|NCT02269202|Midazolam|midazolam|mesh-list
139478719|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478720|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478721|NCT02983461|Urological Agents|urological agents|mesh-ancestor
139478722|NCT02936102|Spartalizumab|spartalizumab|mesh-list
139478723|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139478724|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478725|NCT02936102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478726|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478727|NCT02924727|Valsartan|valsartan|mesh-list
139478728|NCT02924727|Ramipril|ramipril|mesh-list
139478729|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139478730|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139478731|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139478732|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139478733|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478734|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139478735|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
139478736|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478737|NCT02905110|Methotrexate|methotrexate|mesh-list
139478738|NCT02905110|Etoposide|etoposide|mesh-list
139478739|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139478740|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
139478741|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139478742|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478743|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139478744|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
139478745|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478746|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478747|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
139478748|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478749|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139478750|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139478751|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
139478752|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139478753|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139478754|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139478755|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139478756|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139478757|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
139478758|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139478759|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139478760|NCT02798523|Prednisolone|prednisolone|mesh-list
139478761|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
139004967|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139478762|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
139478763|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139478764|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
139478765|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139478766|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
139478767|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
139478768|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139478769|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478770|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139478771|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
139478772|NCT02798523|Hormones|hormones|mesh-ancestor
139478773|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139478774|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139478775|NCT02798523|Protective Agents|protective agents|mesh-ancestor
139478776|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139478777|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478778|NCT02797977|Gemcitabine|gemcitabine|mesh-list
139478779|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478780|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139478781|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
139478782|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478783|NCT02772588|Leuprolide|leuprolide|mesh-list
139478784|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139478785|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
139478786|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139478787|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478788|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139478789|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478790|NCT02766582|Paclitaxel|paclitaxel|mesh-list
139478791|NCT02766582|Carboplatin|carboplatin|mesh-list
139478792|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
139265498|NCT06091553|Gabapentin|gabapentin|mesh-list
139478796|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
139478797|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
139478798|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478799|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478800|NCT02766582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139478801|NCT02720692|Meloxicam|meloxicam|mesh-list
139478802|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139478803|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139478804|NCT02720692|Analgesics|analgesics|mesh-ancestor
139478805|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
139478806|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139478807|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478808|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139478809|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139478810|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139478811|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139478812|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478813|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478814|NCT02712151|Ropivacaine|ropivacaine|mesh-list
139478815|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
139478816|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
139478817|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139478818|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478819|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
139478820|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139478821|NCT02707484|Thalidomide|thalidomide|mesh-list
139478822|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139478823|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
139478824|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478825|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
139478826|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139478827|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478828|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139478829|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139478830|NCT02707484|Growth Substances|growth substances|mesh-ancestor
139478831|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
139478832|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478836|NCT02646683|Vedolizumab|vedolizumab|mesh-list
139478837|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139478838|NCT02628626|Clonidine|clonidine|mesh-list
139478839|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139478840|NCT02628626|Analgesics|analgesics|mesh-ancestor
139478841|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
139478842|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139478843|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478844|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139478845|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
139478846|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
139478847|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139478848|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139478849|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139478850|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
139478851|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139478852|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478853|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139478854|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139478855|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
139478856|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139478857|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139478858|NCT02616965|Romidepsin|romidepsin|mesh-list
139005048|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139478859|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478860|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478861|NCT02616965|Immunotoxins|immunotoxins|mesh-ancestor
139478862|NCT02616965|Immunoconjugates|immunoconjugates|mesh-ancestor
139478863|NCT02616965|Immunologic Factors|immunologic factors|mesh-ancestor
139478864|NCT02616965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478865|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139478866|NCT02616965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139478867|NCT02616965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478868|NCT02616965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478869|NCT02554812|Avelumab|avelumab|mesh-list
139478870|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478871|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478872|NCT02527707|Ritonavir|ritonavir|mesh-list
139478873|NCT02527707|Lonafarnib|lonafarnib|mesh-list
139478874|NCT02527707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139478875|NCT02527707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139478876|NCT02527707|Protease Inhibitors|protease inhibitors|mesh-ancestor
139478877|NCT02527707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478878|NCT02527707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478879|NCT02527707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139478880|NCT02527707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139478881|NCT02527707|Antiviral Agents|antiviral agents|mesh-ancestor
139478882|NCT02527707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478883|NCT02527707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139478884|NCT02527707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139478885|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139478886|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139478887|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478888|NCT02367924|Trabectedin|trabectedin|mesh-list
139478889|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139478890|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
139478891|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478892|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478893|NCT02352090|Dienogest|dienogest|mesh-list
139478894|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139478895|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139478896|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139478897|NCT02352090|Estradiol|estradiol|mesh-list
139478898|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139478899|NCT02352090|Nandrolone|nandrolone|mesh-list
139005104|NCT00803309|Ribavirin|ribavirin|mesh-list
139478900|NCT02352090|Estrogens|estrogens|mesh-ancestor
139478901|NCT02352090|Hormones|hormones|mesh-ancestor
139478902|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139478903|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478904|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139478905|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
139478906|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139478907|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139478908|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139478909|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139478910|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139478911|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
139478912|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139478913|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478914|NCT02352090|Androgens|androgens|mesh-ancestor
139478915|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
139478916|NCT02135107|Rabeprazole|rabeprazole|mesh-list
139478917|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139478918|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139478919|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139478920|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478921|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478922|NCT01982448|Paclitaxel|paclitaxel|mesh-list
139478923|NCT01982448|Cisplatin|cisplatin|mesh-list
139478924|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139478925|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478926|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
139478927|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
139478928|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
139478929|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478930|NCT01809041|Remifentanil|remifentanil|mesh-list
139478931|NCT01809041|Propofol|propofol|mesh-list
139478932|NCT01809041|Sevoflurane|sevoflurane|mesh-list
139478933|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139478934|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139478935|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139478936|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139478937|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
139478938|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
139478939|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139478940|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139478941|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139478942|NCT01809041|Narcotics|narcotics|mesh-ancestor
139478943|NCT01809041|Analgesics|analgesics|mesh-ancestor
139478944|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
139478945|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139478946|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
139478947|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139478948|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478949|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
139478950|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139478951|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478952|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
139478953|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139478954|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478955|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
139478956|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139478957|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005166|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478958|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
139478959|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139478960|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478961|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
139478962|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139478963|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478964|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
139478965|NCT01593254|Dasatinib|dasatinib|mesh-list
139478966|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478967|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139478968|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478969|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478970|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139478971|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478972|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
139478973|NCT01525394|Lenvatinib|lenvatinib|mesh-list
139478974|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139478975|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139478976|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139478977|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139478978|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478979|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478980|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478981|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139478982|NCT01454934|Gemcitabine|gemcitabine|mesh-list
139478983|NCT01454934|Docetaxel|docetaxel|mesh-list
139478984|NCT01454934|Pemetrexed|pemetrexed|mesh-list
139478985|NCT01454934|Vinorelbine|vinorelbine|mesh-list
139478986|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139478987|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
139478988|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139478989|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139478990|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
139478991|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
139478992|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
139478993|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139478994|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139478995|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139478996|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139478997|NCT01442246|Leuprolide|leuprolide|mesh-list
139478998|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139478999|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
139479000|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139479001|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479002|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139479003|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479004|NCT01439282|Capecitabine|capecitabine|mesh-list
139479005|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139479006|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
139479007|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479008|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479009|NCT01326312|Leuprolide|leuprolide|mesh-list
139479010|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139479011|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
139479012|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139479013|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479014|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139265733|NCT06087510|Esketamine|esketamine|mesh-list
139479015|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479016|NCT01321554|Lenvatinib|lenvatinib|mesh-list
139479017|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479018|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139005226|NCT00656513|Miotics|miotics|mesh-ancestor
139479019|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479020|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479021|NCT01308437|Insulin|insulin|mesh-list
139479022|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139479023|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
139479024|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139479025|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479026|NCT01268293|Lenvatinib|lenvatinib|mesh-list
139479027|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479028|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139479029|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479030|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479031|NCT01267175|Insulin|insulin|mesh-list
139479032|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139479033|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479034|NCT01231841|Cyclosporine|cyclosporine|mesh-list
139479035|NCT01231841|Cyclosporins|cyclosporins|mesh-list
139479036|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
139479037|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139479038|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
139479039|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479040|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479041|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139479042|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
139479043|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479044|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
139479045|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479046|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
139479047|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139479048|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139479049|NCT01133756|Carboplatin|carboplatin|mesh-list
139479050|NCT01133756|Gemcitabine|gemcitabine|mesh-list
139479051|NCT01133756|Lenvatinib|lenvatinib|mesh-list
139479052|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479053|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139479054|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
139479055|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479056|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139479057|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479058|NCT01126736|Pemetrexed|pemetrexed|mesh-list
139479059|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479060|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479061|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479062|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139479063|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139479064|NCT01111461|Lenvatinib|lenvatinib|mesh-list
139479065|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479066|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139479067|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005281|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
139479068|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479069|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139479070|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479071|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139479072|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479073|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479074|NCT01067287|Pidilizumab|pidilizumab|mesh-list
139479075|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139479076|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479077|NCT00796263|Dolutegravir|dolutegravir|mesh-list
139479078|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139479079|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139479080|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479081|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479082|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139479083|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139479084|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
139479085|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479086|NCT00715442|Sunitinib|sunitinib|mesh-list
139479087|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479088|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139479089|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139479090|NCT00715442|Growth Substances|growth substances|mesh-ancestor
139479091|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479092|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
139005301|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139479093|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139479094|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479095|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479096|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
139479098|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139479099|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479100|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139479101|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139479102|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479103|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479104|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
139479105|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139479106|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
139479107|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479108|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139479109|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139479110|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
139479111|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479112|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479113|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139479114|NCT00244933|Gemcitabine|gemcitabine|mesh-list
139479115|NCT00244933|Genistein|genistein|mesh-list
139479116|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139479117|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
139479118|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479119|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479120|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139479121|NCT00244933|Protective Agents|protective agents|mesh-ancestor
139479122|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479123|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139479124|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479125|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
139479126|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139479127|NCT00244933|Estrogens|estrogens|mesh-ancestor
139479128|NCT00244933|Hormones|hormones|mesh-ancestor
139479129|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139479130|NCT00121719|Lenvatinib|lenvatinib|mesh-list
139479131|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479132|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139479133|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479134|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479135|NCT00053209|Gemcitabine|gemcitabine|mesh-list
139479136|NCT00053209|Pemetrexed|pemetrexed|mesh-list
139479137|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139479138|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
139479139|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479140|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479141|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479142|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139479143|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139479144|NCT00039429|Atrasentan|atrasentan|mesh-list
139479145|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479146|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139479147|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139005366|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479148|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479149|NCT00014508|Cyclosporine|cyclosporine|mesh-list
139479150|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
139479151|NCT00014508|Melphalan|melphalan|mesh-list
139479152|NCT00014508|Fludarabine|fludarabine|mesh-list
139479153|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
139479154|NCT00014508|Cyclosporins|cyclosporins|mesh-list
139479155|NCT00014508|Sargramostim|sargramostim|mesh-list
139479156|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139479157|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
139479158|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479159|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139479160|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139479161|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
139479162|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479163|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479164|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139479165|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139479166|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
139479167|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479168|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
139479169|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479170|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
139479171|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139479172|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
139479173|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
139479174|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139479175|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
139479176|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479177|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139479178|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139479179|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
139479180|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479181|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479182|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139479183|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139479184|NCT00005962|Cytarabine|cytarabine|mesh-list
139479185|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
139479186|NCT00005962|Daunorubicin|daunorubicin|mesh-list
139479187|NCT00005962|Topotecan|topotecan|mesh-list
139479188|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
139479189|NCT00005962|Sargramostim|sargramostim|mesh-list
139479190|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139479191|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
139479192|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479193|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139005395|NCT00655499|Panitumumab|panitumumab|mesh-list
139479194|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139479195|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
139479196|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479197|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479198|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139479199|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139479200|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
139479201|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
139479202|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479203|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139479204|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139479205|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139479206|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005432|NCT00807521|Dexamethasone|dexamethasone|mesh-list
139479207|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139479208|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139479209|NCT00005962|Immunotoxins|immunotoxins|mesh-ancestor
139479210|NCT00005962|Immunoconjugates|immunoconjugates|mesh-ancestor
139479211|NCT00005847|Interferons|interferons|mesh-list
139479212|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
139479213|NCT00005847|Paclitaxel|paclitaxel|mesh-list
139479214|NCT00005847|Vinorelbine|vinorelbine|mesh-list
139479215|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
139479216|NCT00005847|Estramustine|estramustine|mesh-list
139479217|NCT00005847|Isotretinoin|isotretinoin|mesh-list
139479218|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139479219|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479220|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
139479221|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
139479222|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
139479223|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479224|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
139479225|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479226|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
139479227|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479228|NCT00005847|Analgesics|analgesics|mesh-ancestor
139479229|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
139479230|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139479231|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139479232|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139479233|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479234|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
139479235|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139479236|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
139479237|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139265948|NCT05702463|Aspirin|aspirin|mesh-list
139479238|NCT00005644|Paclitaxel|paclitaxel|mesh-list
139479239|NCT00005644|Gemcitabine|gemcitabine|mesh-list
139479240|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139479241|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479243|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
139479244|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
139479245|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479246|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139479247|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
139479248|NCT00003871|Vaccines|vaccines|mesh-list
139479249|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
139479250|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479251|NCT00003809|Cetuximab|cetuximab|mesh-list
139479252|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479253|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139479254|NCT00003808|Theophylline|theophylline|mesh-list
138976744|NCT04041362|UB-421|ub-421|mesh-list
139479255|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139479256|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
139479257|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139479258|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479259|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139479260|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
139479261|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139479262|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479263|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479264|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
139479265|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139479266|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139479267|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
139479268|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139479269|NCT00003592|Paclitaxel|paclitaxel|mesh-list
139479270|NCT00003592|Methotrexate|methotrexate|mesh-list
139479271|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139479272|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479273|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
139479274|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
139479275|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
139005499|NCT00807755|Carboplatin|carboplatin|mesh-list
139479276|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479277|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139479278|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
139479279|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139479280|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479281|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139479282|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
139479283|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
139479284|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479285|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139479286|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139479287|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
139479288|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139479289|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139479290|NCT00003518|Paclitaxel|paclitaxel|mesh-list
139479291|NCT00003518|Gemcitabine|gemcitabine|mesh-list
139479292|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139479293|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479294|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
139479295|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
139479296|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
139479297|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479298|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139479299|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
139479300|NCT00003444|Interferons|interferons|mesh-list
139479301|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
139479302|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479303|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
139479304|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479305|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
139479306|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479307|NCT00003388|Cytarabine|cytarabine|mesh-list
139479308|NCT00003388|Prednisone|prednisone|mesh-list
139479309|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
139479310|NCT00003388|Doxorubicin|doxorubicin|mesh-list
139479311|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139479312|NCT00003388|Methotrexate|methotrexate|mesh-list
139479313|NCT00003388|Vincristine|vincristine|mesh-list
139479314|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139479315|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
139479316|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479317|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139479318|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139479319|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
139479320|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479321|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479322|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139479323|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139479324|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139479325|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139479326|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479327|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139479328|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
139479329|NCT00003388|Hormones|hormones|mesh-ancestor
139479330|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139479331|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139005562|NCT00811031|Prednisone|prednisone|mesh-list
139479332|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139479333|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
139479334|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139479335|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139479336|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
139479337|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
139479338|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139479339|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139479340|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
139479341|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479342|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139479343|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
139479344|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
139479345|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
139479346|NCT00003376|Paclitaxel|paclitaxel|mesh-list
139479347|NCT00003376|Vinblastine|vinblastine|mesh-list
139479348|NCT00003376|Carboplatin|carboplatin|mesh-list
139479349|NCT00003376|Doxorubicin|doxorubicin|mesh-list
139479350|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139479351|NCT00003376|Methotrexate|methotrexate|mesh-list
139479352|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139005583|NCT02552537|Diuretics|diuretics|mesh-ancestor
139479353|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479354|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
139479355|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
139479356|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
139479357|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479358|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139479359|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139479360|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139479361|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479362|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139479363|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
139479364|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139479365|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479366|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139479367|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
139479368|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
139479369|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139479370|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139479371|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
139479372|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139479373|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139479374|NCT00003353|Melphalan|melphalan|mesh-list
139479375|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
139479376|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479377|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139479378|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
139479379|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479380|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479381|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139479382|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139479383|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
139479384|NCT00003309|Etoposide|etoposide|mesh-list
139479385|NCT00003309|Vincristine|vincristine|mesh-list
139479386|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139479387|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
139479388|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479389|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139479390|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139479391|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
139266094|NCT05556512|Tirzepatide|tirzepatide|mesh-list
139479392|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479393|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479394|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139479395|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139479396|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139479397|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139479398|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479399|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
139479400|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
139479401|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
139479403|NCT00003237|Cisplatin|cisplatin|mesh-list
139005626|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
139479404|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139479405|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479406|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
139479407|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
139479408|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
139479409|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479410|NCT00003129|Valrubicin|valrubicin|mesh-list
139479411|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479412|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139479413|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139479414|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479415|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479416|NCT00003027|Interferons|interferons|mesh-list
139479417|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
139479418|NCT00003027|Aldesleukin|aldesleukin|mesh-list
139479419|NCT00003027|Dacarbazine|dacarbazine|mesh-list
139479420|NCT00003027|Vinblastine|vinblastine|mesh-list
139479421|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479422|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
139479423|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479424|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
139479425|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479426|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139479427|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139479428|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139479429|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
139479430|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479431|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139479432|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
139479433|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
139479434|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
139479435|NCT00002914|Piritrexim|piritrexim|mesh-list
139479436|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479437|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139479438|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479439|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479440|NCT00002872|Doxycycline|doxycycline|mesh-list
139479441|NCT00002872|Bleomycin|bleomycin|mesh-list
139479442|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139479443|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479444|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
139479445|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139479446|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139479447|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139479448|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479449|NCT00002868|Interferons|interferons|mesh-list
139479450|NCT00002868|Cytarabine|cytarabine|mesh-list
139479451|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
139479452|NCT00002868|Etoposide|etoposide|mesh-list
139479453|NCT00002868|Idarubicin|idarubicin|mesh-list
139479454|NCT00002868|Busulfan|busulfan|mesh-list
139479455|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
139479456|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139479457|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479458|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139479459|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139479460|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479461|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479462|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
139479463|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479464|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139479465|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
139479466|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139479467|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
139479468|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479469|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
139479470|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139479471|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139479472|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139479473|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
139479474|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139479475|NCT00002650|Folic Acid|folic acid|mesh-list
139479476|NCT00002650|Hematinics|hematinics|mesh-ancestor
139479477|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
139479478|NCT00002650|Vitamins|vitamins|mesh-ancestor
139479479|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
139479480|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479481|NCT03078725|Metformin|metformin|mesh-list
139479482|NCT03078725|Glyburide|glyburide|mesh-list
139479483|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139479484|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479485|NCT02341963|Ketamine|ketamine|mesh-list
139479486|NCT02341963|Analgesics|analgesics|mesh-ancestor
139479487|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
139479488|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139479489|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479490|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139479491|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139479492|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
139479493|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
139479494|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139479495|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139479496|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139479497|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139479498|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479499|NCT05014685|Amoxicillin|amoxicillin|mesh-list
139479500|NCT05014685|Metronidazole|metronidazole|mesh-list
139479501|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
139479502|NCT05014685|Rabeprazole|rabeprazole|mesh-list
139479503|NCT05014685|Bismuth|bismuth|mesh-list
139479504|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479505|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139479506|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479507|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139479508|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139479509|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139479510|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139479511|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139479512|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479513|NCT05014685|Antacids|antacids|mesh-ancestor
139479514|NCT05014685|Diuretics|diuretics|mesh-ancestor
139479515|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
139479516|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479517|NCT05014685|Expectorants|expectorants|mesh-ancestor
139479518|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
139479519|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
139479520|NCT03111901|Interleukin-2|interleukin-2|mesh-list
139479521|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139479522|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479523|NCT03111901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139479524|NCT03111901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479525|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139479526|NCT03111901|Analgesics|analgesics|mesh-ancestor
139479527|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
139479528|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139479529|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479530|NCT05014607|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139479531|NCT05014607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139479532|NCT05014607|Immunologic Factors|immunologic factors|mesh-ancestor
139479533|NCT05014607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479534|NCT02341729|Ticagrelor|ticagrelor|mesh-list
139479535|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139479536|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139479537|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139479538|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139479539|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
139479540|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139479541|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139266247|NCT05170334|Belinostat|belinostat|mesh-list
139479542|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479543|NCT05014373|Favipiravir|favipiravir|mesh-list
139479544|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
139479545|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479546|NCT04762459|Pemetrexed|pemetrexed|mesh-list
139479547|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479548|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479549|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479550|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139479551|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139479552|NCT03078569|Testosterone|testosterone|mesh-list
139479553|NCT03078569|Androgens|androgens|mesh-ancestor
139479554|NCT03078569|Hormones|hormones|mesh-ancestor
139479555|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139479556|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479557|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139479558|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
139479559|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139479560|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
139479561|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479562|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479563|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139479564|NCT03078257|Aspirin|aspirin|mesh-list
139479565|NCT03078257|Tirofiban|tirofiban|mesh-list
139479566|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
139479567|NCT03078257|Clopidogrel|clopidogrel|mesh-list
139479568|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139479569|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139479570|NCT03078257|Analgesics|analgesics|mesh-ancestor
139479571|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
139479572|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139479573|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479574|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139479575|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139479576|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139479577|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139479578|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479579|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139479580|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139479581|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479582|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
139005804|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
139479583|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139479584|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139479585|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139479586|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
139479587|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139479588|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
139479589|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139479590|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
139479591|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
139479592|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139479593|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479594|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
139479595|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139479596|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139479597|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479598|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139479599|NCT05005715|Analgesics|analgesics|mesh-ancestor
139479600|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
139479601|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139479602|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139479603|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139479604|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139479605|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
139479606|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139479607|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479608|NCT02345707|Cabotegravir|cabotegravir|mesh-list
139479609|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139479610|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139479611|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479612|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479613|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139479614|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139479615|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
139479616|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479617|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
139479618|NCT05005637|Prednisone|prednisone|mesh-list
139479619|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139479620|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
139479621|NCT05005637|Hormones|hormones|mesh-ancestor
139479622|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139479623|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479624|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139479625|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479626|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139479627|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479628|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139479629|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139479630|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479631|NCT02336659|Incretins|incretins|mesh-ancestor
139479632|NCT02336659|Hormones|hormones|mesh-ancestor
139479633|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139479634|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139479635|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
139479636|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479637|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479638|NCT03081923|Durvalumab|durvalumab|mesh-list
139479639|NCT03081923|Tremelimumab|tremelimumab|mesh-list
139005852|NCT01097941|Vaccines|vaccines|mesh-list
139479640|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139479641|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479642|NCT02341105|Amiodarone|amiodarone|mesh-list
139479643|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139479644|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
139479645|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139479646|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139479647|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479648|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139479649|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139479650|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139479651|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479652|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139479653|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139479654|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139479655|NCT03078101|Empagliflozin|empagliflozin|mesh-list
139479656|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139479657|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479658|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139479659|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479660|NCT02345239|Pantoprazole|pantoprazole|mesh-list
139479661|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139005895|NCT00061633|Vancomycin|vancomycin|mesh-list
139479662|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139479663|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139479664|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479665|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479666|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
139479667|NCT04688203|Labetalol|labetalol|mesh-list
139479668|NCT04688203|Analgesics|analgesics|mesh-ancestor
139479669|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
139479670|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139479671|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479672|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
139479673|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139479674|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139479675|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
139479676|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139479677|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139479678|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005910|NCT02550977|Gestodene|gestodene|mesh-list
139479679|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139479680|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
139479681|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139479682|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139479683|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139479684|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
139479685|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139479686|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139479687|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
139479688|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
139479689|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139266398|NCT04975308|Exemestane|exemestane|mesh-list
139479690|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139479691|NCT05254561|Immunomodulating Agents|immunomodulating agents|mesh-list
139479692|NCT05254561|Immunologic Factors|immunologic factors|mesh-ancestor
139479693|NCT05254561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479694|NCT04509973|Dexamethasone|dexamethasone|mesh-list
139479695|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139479696|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
139479697|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
139479698|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139479699|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479700|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139479701|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
139479703|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139479704|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139479705|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479706|NCT02336347|Quinidine|quinidine|mesh-list
139479707|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
139479708|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
139479709|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
139479710|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139479711|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139479712|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139479713|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479714|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479715|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139479716|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139479717|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
139479718|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139479719|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
139479720|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139479721|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139479722|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005957|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139005958|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139005959|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005960|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
139005961|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139005962|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005963|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139005964|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005965|NCT00365716|Vaccines|vaccines|mesh-list
139479723|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479724|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139479725|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139479726|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
139479727|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139479728|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139479729|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139479730|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139479731|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139479732|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
139479733|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
139479734|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139479735|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479736|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139479737|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139479738|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139479739|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139479740|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
139479741|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
139479742|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139479743|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479744|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479745|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
139479746|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139479747|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139479748|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479749|NCT02340481|Simethicone|simethicone|mesh-list
139479750|NCT02340481|Loperamide|loperamide|mesh-list
139479751|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
139479752|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139479753|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
139479754|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479755|NCT02340481|Emollients|emollients|mesh-ancestor
139479756|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
139479757|NCT03077633|Progesterone|progesterone|mesh-list
139479758|NCT03077633|Progestins|progestins|mesh-ancestor
139479759|NCT03077633|Hormones|hormones|mesh-ancestor
139479760|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139479761|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479762|NCT05253781|Aspirin|aspirin|mesh-list
139479763|NCT05253781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139479764|NCT05253781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139479765|NCT05253781|Analgesics|analgesics|mesh-ancestor
139479766|NCT05253781|Sensory System Agents|sensory system agents|mesh-ancestor
139479767|NCT05253781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139479768|NCT05253781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479769|NCT05253781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139479770|NCT05253781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139479771|NCT05253781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139479772|NCT05253781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139479773|NCT05253781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479774|NCT05253781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139479775|NCT05253781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139479776|NCT05253781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479777|NCT05253781|Antipyretics|antipyretics|mesh-ancestor
139479778|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
139479779|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139479780|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139479781|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139479782|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479783|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479784|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139479785|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139479786|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139479787|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139479788|NCT02340247|Cathartics|cathartics|mesh-ancestor
139479789|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139479790|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
139479791|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139479792|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139479793|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139479794|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
139479795|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139479796|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479797|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139479798|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139479799|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139006029|NCT00058825|Cyclosporine|cyclosporine|mesh-list
139479800|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139479801|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479802|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
139479803|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
139479804|NCT05178823|Fluorides|fluorides|mesh-list
139479805|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
139479806|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
139479807|NCT05178823|Protective Agents|protective agents|mesh-ancestor
139479808|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479809|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139479810|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479811|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
139479812|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
139479813|NCT03105583|Vitamins|vitamins|mesh-list
139479814|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
139479815|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479816|NCT03105115|Fentanyl|fentanyl|mesh-list
139479817|NCT03105115|Bupivacaine|bupivacaine|mesh-list
139479818|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
139479819|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
139479820|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139479821|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479822|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
139479823|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139479824|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139479825|NCT03105115|Narcotics|narcotics|mesh-ancestor
139479826|NCT03105115|Analgesics|analgesics|mesh-ancestor
139479827|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139479828|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139479829|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
139479830|NCT03105349|Ribavirin|ribavirin|mesh-list
139479831|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
139479832|NCT03105349|Grazoprevir|grazoprevir|mesh-list
139479833|NCT03105349|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139479834|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
139479835|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479836|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
139266541|NCT04670432|Troxerutin|troxerutin|mesh-list
139479837|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479838|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139479839|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139479840|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139479841|NCT03077555|Estradiol|estradiol|mesh-list
139479842|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139479843|NCT03077555|Estrogens|estrogens|mesh-ancestor
139479844|NCT03077555|Hormones|hormones|mesh-ancestor
139479845|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139479846|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479847|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139479848|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
139479849|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139479850|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139479851|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139479852|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139479853|NCT02335255|Naftifine|naftifine|mesh-list
139479854|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
139479855|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479856|NCT05012033|Prednisolone|prednisolone|mesh-list
139479857|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139479858|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
139479859|NCT05012033|Hormones|hormones|mesh-ancestor
139479860|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139479861|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479862|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139479863|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479864|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
139479865|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139479866|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479867|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139479868|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139479869|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479870|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479871|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479872|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
139479873|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139479874|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139479875|NCT02334475|Prednisolone|prednisolone|mesh-list
139479876|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
139479877|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139479878|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
139479879|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139479880|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
139479881|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
139479882|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139479883|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479884|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139479885|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
139479886|NCT02334475|Hormones|hormones|mesh-ancestor
139479887|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139479888|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139479889|NCT02334475|Protective Agents|protective agents|mesh-ancestor
139479890|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139479891|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479892|NCT02334631|Simethicone|simethicone|mesh-list
139479893|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
139479894|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479895|NCT02334631|Emollients|emollients|mesh-ancestor
139479896|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
139479897|NCT02338531|Nirogacestat|nirogacestat|mesh-list
139479898|NCT02338531|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139479899|NCT02338531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479900|NCT02338531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479901|NCT02332135|Vitamin D|vitamin d|mesh-list
139479902|NCT02332135|Vitamins|vitamins|mesh-ancestor
139479903|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
139479904|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479905|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139479906|NCT02334163|Metronidazole|metronidazole|mesh-list
139479907|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
139479908|NCT02334163|Lactulose|lactulose|mesh-list
139479909|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479910|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139479911|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139479912|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139479913|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139479914|NCT02332057|Diclofenac|diclofenac|mesh-list
139479915|NCT02332057|Lidocaine|lidocaine|mesh-list
139479916|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
139479917|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
139479918|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139479919|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479920|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
139479921|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139479922|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139479923|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139479924|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139479925|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139479926|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479927|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139479928|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139479929|NCT02332057|Analgesics|analgesics|mesh-ancestor
139006136|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
139479930|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139479931|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139479932|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139479933|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479934|NCT02331745|Lenograstim|lenograstim|mesh-list
139479935|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139479936|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
139479937|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479938|NCT02638259|GP2015|gp2015|mesh-list
139479939|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
139479940|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
139479941|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139479942|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
139479943|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139479944|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
139479945|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479946|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479947|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
139479948|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
139479949|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139479950|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479951|NCT02334007|Dalteparin|dalteparin|mesh-list
139479952|NCT02334007|Tinzaparin|tinzaparin|mesh-list
139479953|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139479954|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
139479955|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139479956|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139479957|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479958|NCT02637323|Triamcinolone|triamcinolone|mesh-list
139479959|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139479960|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139479961|NCT02637323|FX006|fx006|mesh-list
139479962|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139479963|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139479964|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
139479965|NCT02637323|Hormones|hormones|mesh-ancestor
139479966|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139479967|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479968|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139479969|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
139479970|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479971|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479972|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
139479973|NCT02331823|Isoniazid|isoniazid|mesh-list
139479974|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
139479975|NCT02331823|Ethambutol|ethambutol|mesh-list
139479976|NCT02331823|Rifabutin|rifabutin|mesh-list
139479977|NCT02331823|Streptomycin|streptomycin|mesh-list
139479978|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139479979|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139479980|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139479981|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139479982|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139479983|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479984|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139479985|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139479986|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
139479987|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139479988|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139479989|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
139479990|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139479991|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139479992|NCT02890459|Denatonium|denatonium|mesh-list
139479994|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139479995|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
139479996|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139479997|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
139479998|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139479999|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
139480000|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139480001|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
139480002|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480003|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
139480004|NCT03077009|Protective Agents|protective agents|mesh-ancestor
139480005|NCT04477525|Bupivacaine|bupivacaine|mesh-list
139480006|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
139480007|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
139480008|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480009|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480010|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
139480011|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480012|NCT03079973|Calcipotriene|calcipotriene|mesh-list
139480013|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
139480014|NCT05004545|Propofol|propofol|mesh-list
139480015|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139480016|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480017|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480018|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139480019|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
139480020|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
139480021|NCT03079895|Nicotine|nicotine|mesh-list
139480022|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139480023|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
139480024|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480025|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480026|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139480027|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139480028|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
139480029|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480030|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480031|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
139480032|NCT05003765|Buprenorphine|buprenorphine|mesh-list
139480033|NCT05003765|Bupivacaine|bupivacaine|mesh-list
139480034|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139480035|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
139480036|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
139480037|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480038|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480039|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
139006276|NCT00463047|Fentanyl|fentanyl|mesh-list
139480040|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480041|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139480042|NCT05003765|Narcotics|narcotics|mesh-ancestor
139480043|NCT05003765|Analgesics|analgesics|mesh-ancestor
139480044|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139480045|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139480046|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
139480047|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139480048|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139480049|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480050|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139480051|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
139480052|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139480053|NCT02337283|BI 425809|bi 425809|mesh-list
139480054|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
139480055|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
139480056|NCT02333305|Vitamins|vitamins|mesh-ancestor
139480057|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
139480058|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480059|NCT02326987|Pregabalin|pregabalin|mesh-list
139480060|NCT02326987|Analgesics|analgesics|mesh-ancestor
139480061|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
139480062|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480063|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480064|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
139480065|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139266768|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
139480066|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139480067|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480068|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139480069|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139480070|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139006294|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
139480071|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480072|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139480073|NCT02331511|Aspirin|aspirin|mesh-list
139480074|NCT02331511|Clopidogrel|clopidogrel|mesh-list
139480075|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139480076|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139480077|NCT02331511|Analgesics|analgesics|mesh-ancestor
139480078|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
139480079|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480080|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480081|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139480082|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139480083|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139480084|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139480085|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480086|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139480087|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139480088|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480089|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
139480090|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139480091|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139480092|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139480093|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
139480094|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480095|NCT02326441|KX2-361|kx2-361|mesh-list
139480096|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139480097|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480098|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480099|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
139480100|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
139480101|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
139480102|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480103|NCT02039791|Paclitaxel|paclitaxel|mesh-list
139480104|NCT02039791|Carboplatin|carboplatin|mesh-list
139480105|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
139480106|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139480107|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480108|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
139480109|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
139480110|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
139480111|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480112|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139480113|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
139480114|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139480115|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
139480116|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480117|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480118|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139480119|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
139480120|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139480121|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139480122|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139480123|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
139480124|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480125|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480126|NCT03111511|JNJ-56136379|jnj-56136379|mesh-list
139480127|NCT03111511|Drospirenone|drospirenone|mesh-list
139480128|NCT03111511|Midazolam|midazolam|mesh-list
139480129|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139480130|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139480131|NCT03111511|Betadex|betadex|mesh-list
139480132|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139480133|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139480134|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480135|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480136|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139480137|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139480138|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139480139|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139480140|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
139480141|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
139480142|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
139480143|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
139480144|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480145|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480146|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139480147|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139480148|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139480149|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
139480150|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139480151|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139480152|NCT03111511|Estrogens|estrogens|mesh-ancestor
139480153|NCT03111511|Hormones|hormones|mesh-ancestor
139480154|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139480155|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139480156|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
139480157|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139480158|NCT03111511|Diuretics|diuretics|mesh-ancestor
139480159|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
139480160|NCT03111511|Antiviral Agents|antiviral agents|mesh-ancestor
139480161|NCT03111511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139480162|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
139480163|NCT03144115|Oxytocin|oxytocin|mesh-list
139480164|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
139480165|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139480166|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480167|NCT02326285|Docetaxel|docetaxel|mesh-list
139480168|NCT02326285|Gefitinib|gefitinib|mesh-list
139480169|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006408|NCT01047202|Vaccines|vaccines|mesh-list
139480170|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
139480171|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
139480172|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
139480173|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480174|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139480175|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480176|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
139480177|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139480178|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139480179|NCT02332603|Prednisolone|prednisolone|mesh-list
139480180|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
139480181|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139480182|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
139480183|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139480184|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
139480185|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
139480186|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480187|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480188|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139480189|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
139480190|NCT02332603|Hormones|hormones|mesh-ancestor
139480191|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139480192|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139480193|NCT02332603|Protective Agents|protective agents|mesh-ancestor
139480194|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139480195|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480196|NCT02332447|Naloxone|naloxone|mesh-list
139480197|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139480198|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480199|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
139480200|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480201|NCT05077813|Vitamin D|vitamin d|mesh-list
139480202|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
139480203|NCT05077813|Cholecalciferol|cholecalciferol|mesh-list
139480204|NCT05077813|Vitamins|vitamins|mesh-list
139480205|NCT05077813|Minocycline|minocycline|mesh-list
139480206|NCT05077813|Tretinoin|tretinoin|mesh-list
139480207|NCT05077813|Alitretinoin|alitretinoin|mesh-list
139480208|NCT05077813|Isotretinoin|isotretinoin|mesh-list
139480209|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
139480210|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480211|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139480212|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139480213|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139480214|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139480215|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480216|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
139480217|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
139480218|NCT02326051|Enoxaparin|enoxaparin|mesh-list
139480219|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
139480220|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
139480221|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139480222|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139480223|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480225|NCT05076955|Tobramycin|tobramycin|mesh-list
139480226|NCT05076955|Itraconazole|itraconazole|mesh-list
139480227|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139480228|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139480229|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
139480230|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139480231|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139480232|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480233|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480234|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139480235|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
139480236|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139480237|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480238|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139480239|NCT05077111|Anesthetics|anesthetics|mesh-list
139480240|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480241|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480242|NCT05075863|Letrozole|letrozole|mesh-list
139480243|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480244|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139480245|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139480246|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480247|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480248|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139480249|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
139480250|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139480251|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480252|NCT02330419|Naltrexone|naltrexone|mesh-list
139480253|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139480254|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139480255|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480256|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
139480257|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480258|NCT05068141|Paclitaxel|paclitaxel|mesh-list
139480259|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139480260|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480261|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
139480262|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
139480263|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
139480264|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480265|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
139480266|NCT03142165|Promethazine|promethazine|mesh-list
139480267|NCT03142165|Famotidine|famotidine|mesh-list
139480268|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139480269|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139480270|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480271|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480272|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
139480273|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
139480274|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
139480275|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480276|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
139480277|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
139480278|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139480279|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139480280|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
139480281|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
139480282|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480283|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480284|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139480285|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
139480286|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
139480287|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139480288|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139480289|NCT02330029|Pinaverium|pinaverium|mesh-list
139480290|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139480291|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139480292|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480293|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139480294|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480295|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
139480296|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
139006540|NCT00641147|Curcumin|curcumin|mesh-list
139480297|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480298|NCT04988971|Corticosterone|corticosterone|mesh-list
139480299|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
139480300|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139480301|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139480302|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
139480303|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
139480304|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480305|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480306|NCT02329795|Temozolomide|temozolomide|mesh-list
139480307|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139480308|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
139480309|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480310|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480311|NCT02329561|Tramadol|tramadol|mesh-list
139480312|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139480313|NCT02329561|Narcotics|narcotics|mesh-ancestor
139480314|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480315|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480316|NCT02329561|Analgesics|analgesics|mesh-ancestor
139480317|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
139480318|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480319|NCT03143491|Paclitaxel|paclitaxel|mesh-list
139480320|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139480321|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480322|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
139480323|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
139480324|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
139480325|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480326|NCT05002673|Anesthetics|anesthetics|mesh-list
139480327|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480328|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480329|NCT03076151|Tacrolimus|tacrolimus|mesh-list
139480330|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139480331|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
139480332|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480333|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139480334|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006597|NCT02551133|Hormones|hormones|mesh-ancestor
139480335|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480336|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
139480337|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139480338|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139480339|NCT05002517|Prednisolone|prednisolone|mesh-list
139480340|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
139480341|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139480342|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
139480343|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139480344|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
139480345|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
139480346|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480347|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480348|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139480349|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
139480350|NCT05002517|Hormones|hormones|mesh-ancestor
139480351|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139480352|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139480353|NCT05002517|Protective Agents|protective agents|mesh-ancestor
139480354|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139480355|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480356|NCT05002361|Dexamethasone|dexamethasone|mesh-list
139480357|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139480358|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
139480359|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
139480360|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480361|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480362|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139480363|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
139480364|NCT05002361|Hormones|hormones|mesh-ancestor
139480365|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139480366|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139480367|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480368|NCT02329405|Rifampin|rifampin|mesh-list
139480369|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139480370|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
139480371|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139480372|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139480373|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
139480374|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139480375|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480376|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480377|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139480378|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139480379|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139480380|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139480381|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139480382|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139480383|NCT02329171|Imiquimod|imiquimod|mesh-list
139480384|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139480385|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
139480386|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480387|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480388|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
139480389|NCT04498741|Midazolam|midazolam|mesh-list
139480390|NCT04498741|Dabigatran|dabigatran|mesh-list
139480391|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139480392|NCT04498741|Tacrolimus|tacrolimus|mesh-list
139480393|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139480394|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
139480395|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480396|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139480397|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480398|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480399|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139480400|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139480401|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480402|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139480403|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139480404|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139480405|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139480406|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
139480407|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
139480408|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
139480409|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
139480410|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480411|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139480412|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139480413|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
139480414|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139006660|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
139480415|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139480416|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
139480417|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139480418|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
139480419|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
139480420|NCT03551743|Edoxaban|edoxaban|mesh-list
139480421|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139480422|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
139480423|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139480424|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
139480425|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480426|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480427|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
139480428|NCT04654429|Ondansetron|ondansetron|mesh-list
139480429|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
139480430|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
139480431|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480432|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480433|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139480434|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
139480435|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
139480436|NCT04654429|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139480437|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139480438|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
139480439|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480440|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480441|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
139480442|NCT03111121|Neostigmine|neostigmine|mesh-list
139480443|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139480444|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480445|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480446|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
139480447|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480448|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480449|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139480450|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
139480451|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480452|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139480453|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139480454|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139480455|NCT02328469|Doxycycline|doxycycline|mesh-list
139480456|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
139480457|NCT02328469|Acyclovir|acyclovir|mesh-list
139480458|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139480459|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139480460|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
139480461|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139480462|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139480463|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
139480464|NCT04998071|Bupivacaine|bupivacaine|mesh-list
139480465|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
139480466|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
139480467|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480468|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480469|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
139480470|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480471|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139480472|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480473|NCT03073343|Betaine|betaine|mesh-list
139480474|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139480475|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
139480476|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139480477|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
139480478|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480479|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139480480|NCT03073265|Apixaban|apixaban|mesh-list
139480481|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139480482|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
139480483|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139480484|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
139480485|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480486|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480487|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
139480488|NCT04997837|Capecitabine|capecitabine|mesh-list
139480489|NCT04997837|Tegafur|tegafur|mesh-list
139480490|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
139480491|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139480492|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139480493|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
139480494|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006751|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139480495|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480496|NCT04997837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139480497|NCT04202263|Minocycline|minocycline|mesh-list
139480498|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139480499|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139480500|NCT04996979|Ropivacaine|ropivacaine|mesh-list
139480501|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
139480502|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
139480503|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480504|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480505|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
139480506|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480507|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
139480508|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480509|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139480510|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480511|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480512|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
139480513|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139480514|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480515|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139480516|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
139480517|NCT04997291|Razoxane|razoxane|mesh-list
139480518|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480519|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139480520|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139480521|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139480522|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480523|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480524|NCT04997291|Protective Agents|protective agents|mesh-ancestor
139480525|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480526|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
139480527|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
139480528|NCT02328079|Acyclovir|acyclovir|mesh-list
139480529|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
139480530|NCT02328079|Prednisolone|prednisolone|mesh-list
139480531|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139480532|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
139480533|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139480534|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
139480535|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139480536|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
139480537|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139480538|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
139480539|NCT02328079|Hormones|hormones|mesh-ancestor
139480540|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139480541|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480542|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139480543|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480544|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
139480545|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
139480546|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480547|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139480548|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139480549|NCT02328079|Protective Agents|protective agents|mesh-ancestor
139480550|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139480551|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
139480552|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139480553|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139480554|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
139480555|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480556|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480557|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480558|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
139480559|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
139480560|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480561|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
139480562|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139480563|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
139480564|NCT02578069|Sirolimus|sirolimus|mesh-list
139480565|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139480566|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139480567|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139480568|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480569|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
139480570|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139480571|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
139480572|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480573|NCT03074825|Chiauranib|chiauranib|mesh-list
139480574|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480575|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139480576|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480577|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480578|NCT03072485|Metformin|metformin|mesh-list
139480579|NCT03072485|Sirolimus|sirolimus|mesh-list
139480580|NCT03072485|Diclofenac|diclofenac|mesh-list
139480581|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139480582|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480583|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139480584|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139480585|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139480586|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480587|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
139480588|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139480589|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
139480590|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480591|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480592|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139480593|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139480594|NCT03072485|Analgesics|analgesics|mesh-ancestor
139480595|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
139267302|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
139480596|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480597|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139480598|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139480599|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139480600|NCT05080543|Terlipressin|terlipressin|mesh-list
139480601|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139480602|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139480603|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
139480604|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139480605|NCT03074591|Hematinics|hematinics|mesh-ancestor
139480606|NCT03111433|Ubiquinone|ubiquinone|mesh-list
139480607|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
139480608|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480609|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
139480610|NCT03111433|Vitamins|vitamins|mesh-ancestor
139480611|NCT03143023|Fluorides|fluorides|mesh-list
139480612|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
139480613|NCT03143023|Protective Agents|protective agents|mesh-ancestor
139480614|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480615|NCT03074435|Ivermectin|ivermectin|mesh-list
139480616|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139480617|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139480618|NCT03142789|Cerivastatin|cerivastatin|mesh-list
139480619|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139480620|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139480621|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139480622|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
139480623|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480624|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480625|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139480626|NCT03072329|Bupivacaine|bupivacaine|mesh-list
139480627|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
139006892|NCT00450801|Cytarabine|cytarabine|mesh-list
139480628|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
139480629|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480630|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480631|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
139480632|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480633|NCT02327689|Emtricitabine|emtricitabine|mesh-list
139480634|NCT02327689|Adefovir|adefovir|mesh-list
139480635|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139480636|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
139480637|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139480638|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139480639|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139480640|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480641|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480642|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139480643|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139480644|NCT02327923|Ketorolac|ketorolac|mesh-list
139480645|NCT02327923|Lidocaine|lidocaine|mesh-list
139480646|NCT02327923|Atropine|atropine|mesh-list
139480647|NCT02327923|Ephedrine|ephedrine|mesh-list
139480648|NCT02327923|Fentanyl|fentanyl|mesh-list
139480649|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
139480650|NCT02327923|Morphine|morphine|mesh-list
139480651|NCT02327923|Tramadol|tramadol|mesh-list
139480652|NCT02327923|Ondansetron|ondansetron|mesh-list
139480653|NCT02327923|Bupivacaine|bupivacaine|mesh-list
139480654|NCT02327923|Propofol|propofol|mesh-list
139480655|NCT02327923|Neostigmine|neostigmine|mesh-list
139480656|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
139480657|NCT02327923|Esmolol|esmolol|mesh-list
139480658|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
139480659|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
139480660|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480661|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480662|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
139480663|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480664|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139480665|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139480666|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139480667|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139480668|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480669|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139480670|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139480671|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
139480672|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139480673|NCT02327923|Narcotics|narcotics|mesh-ancestor
139480674|NCT02327923|Analgesics|analgesics|mesh-ancestor
139480675|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139480676|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139480677|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
139480678|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
139480679|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139480680|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
139480681|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
139480682|NCT02327923|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139480683|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139480684|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
139480685|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480686|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139480687|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139480688|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139480689|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139480690|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480691|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139480692|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139480693|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
139480694|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
139480695|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
139480696|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139480697|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139480698|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
139480699|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139480700|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139480701|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139480702|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139480703|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139480704|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
139480705|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139480706|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
139480707|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139480708|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139480709|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139480710|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139480711|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139480712|NCT04991207|Bosentan|bosentan|mesh-list
139480713|NCT04991207|Zamicastat|zamicastat|mesh-list
139480714|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139480715|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139480716|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480717|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480718|NCT03072173|Xylometazoline|xylometazoline|mesh-list
139480719|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
139480720|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139480721|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
139480722|NCT03074123|Cosyntropin|cosyntropin|mesh-list
139480723|NCT03074123|Hormones|hormones|mesh-ancestor
139480724|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139480725|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480726|NCT02327299|Fesoterodine|fesoterodine|mesh-list
139480727|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139480728|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139480729|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
139480730|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480731|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480732|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480733|NCT02327299|Urological Agents|urological agents|mesh-ancestor
139480734|NCT03494569|Fludarabine|fludarabine|mesh-list
139480735|NCT03494569|Melphalan|melphalan|mesh-list
139480736|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
139480737|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139480738|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480739|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480740|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139480741|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
139480742|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480743|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139480744|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
139480745|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139480746|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
139480747|NCT03071549|Salicylates|salicylates|mesh-list
139480748|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139480749|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
139480750|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
139480751|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
139480752|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139480753|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139480754|NCT03071549|Analgesics|analgesics|mesh-ancestor
139007016|NCT01023867|Donepezil|donepezil|mesh-list
139480755|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
139480756|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480757|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480758|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139480759|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139480760|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139480761|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480762|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480763|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
139480764|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139480765|NCT04994951|Triamcinolone|triamcinolone|mesh-list
139480766|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139480767|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139480768|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139480769|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139480770|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
139480771|NCT04994951|Hormones|hormones|mesh-ancestor
139480772|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139007031|NCT00815399|Pioglitazone|pioglitazone|mesh-list
139480773|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480774|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139480775|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
139480776|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480777|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480778|NCT03073889|Ropivacaine|ropivacaine|mesh-list
139480779|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
139480780|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
139480781|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480782|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480783|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
139480784|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480785|NCT03071705|Metformin|metformin|mesh-list
139480786|NCT03071705|Gefitinib|gefitinib|mesh-list
139480787|NCT03071705|Afatinib|afatinib|mesh-list
139480788|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139480789|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480790|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480791|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139480792|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480793|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480794|NCT03351439|Celecoxib|celecoxib|mesh-list
139480795|NCT03351439|Naproxen|naproxen|mesh-list
139480796|NCT03351439|Gabapentin|gabapentin|mesh-list
139480797|NCT03351439|Zopiclone|zopiclone|mesh-list
139480798|NCT03351439|Analgesics|analgesics|mesh-ancestor
139480799|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
139480800|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480801|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480802|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
139480803|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139480804|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139007066|NCT00820547|Growth Substances|growth substances|mesh-ancestor
139480805|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480806|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139480807|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139480808|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139480809|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480810|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480811|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
139480812|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139480813|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139480814|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139480815|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139480816|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139480817|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139480818|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480819|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
139480820|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139480821|NCT03139747|Everolimus|everolimus|mesh-list
139480822|NCT03139747|Lenvatinib|lenvatinib|mesh-list
139480823|NCT03139747|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139480824|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139480825|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007079|NCT00815945|Carboplatin|carboplatin|mesh-list
139480826|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267520|NCT01312454|Travoprost|travoprost|mesh-list
139480827|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139480828|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
139480829|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480830|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480831|NCT02037919|Etonogestrel|etonogestrel|mesh-list
139480832|NCT02037919|Desogestrel|desogestrel|mesh-list
139480833|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139480834|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
139480835|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139480836|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480837|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139480838|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139480839|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139480840|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139480841|NCT02037919|Progestins|progestins|mesh-ancestor
139480842|NCT02037919|Hormones|hormones|mesh-ancestor
139480843|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139480844|NCT03139591|Dexamethasone|dexamethasone|mesh-list
139480845|NCT03139591|Lidocaine|lidocaine|mesh-list
139480846|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139480847|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
139480848|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
139480849|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007110|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
139480850|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480851|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139480852|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
139480853|NCT03139591|Hormones|hormones|mesh-ancestor
139480854|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139480855|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139480856|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480857|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
139480858|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
139480859|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139480860|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
139480861|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139480862|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139480863|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139480864|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139480865|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480866|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139480867|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139480868|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139480869|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139480870|NCT03139513|Vemurafenib|vemurafenib|mesh-list
139480871|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480872|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139480873|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480874|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480875|NCT04986995|Opicapone|opicapone|mesh-list
139480876|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139480877|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480878|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480879|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139480880|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139480881|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139480882|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139480883|NCT03971929|Diuretics|diuretics|mesh-ancestor
139480884|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
139480885|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480886|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139480887|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139480888|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480889|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
139480890|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139480891|NCT04986371|Niraparib|niraparib|mesh-list
139480892|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139480893|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480894|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480895|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480896|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
139480897|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139480898|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139480899|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480901|NCT03070847|Coagulants|coagulants|mesh-ancestor
139480902|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
139480903|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139480904|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139480905|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139480906|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139480907|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480908|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
139480909|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480910|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480911|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139480912|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480913|NCT04989257|Clopidogrel|clopidogrel|mesh-list
139480914|NCT04989257|Ticagrelor|ticagrelor|mesh-list
139480915|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139480916|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139480917|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139480918|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139480919|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
139480920|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480921|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480922|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480923|NCT04892069|Insulin|insulin|mesh-list
139480924|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
139480925|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139480926|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480927|NCT03140449|Calcitriol|calcitriol|mesh-list
139480928|NCT03140449|Sirolimus|sirolimus|mesh-list
139480929|NCT03140449|Temsirolimus|temsirolimus|mesh-list
139480930|NCT03140449|MTOR Inhibitors|mtor inhibitors|mesh-list
139480931|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139480932|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007178|NCT00821483|Frovatriptan|frovatriptan|mesh-list
139480933|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139480934|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480935|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
139480936|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139480937|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
139480938|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480939|NCT03140449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139480940|NCT03140449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139480941|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480942|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139480943|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139480944|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139480945|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139480946|NCT03140449|Vitamins|vitamins|mesh-ancestor
139480947|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
139480948|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139480949|NCT02659813|Copper|copper|mesh-list
139480950|NCT02659813|Nickel|nickel|mesh-list
139480951|NCT02659813|Trace Elements|trace elements|mesh-ancestor
139480952|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
139480953|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480954|NCT04985435|Adalimumab|adalimumab|mesh-list
139480955|NCT04985435|Etanercept|etanercept|mesh-list
139480956|NCT04985435|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139480957|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139480958|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139480959|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139480960|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139480961|NCT04985435|Analgesics|analgesics|mesh-ancestor
139480962|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
139480963|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139480964|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480965|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139480966|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139480967|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
139480968|NCT03070613|Lectins|lectins|mesh-list
139480969|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
139480970|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
139480971|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480972|NCT03070613|Coagulants|coagulants|mesh-ancestor
139480973|NCT03441139|Analgesics|analgesics|mesh-list
139480974|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
139480975|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267669|NCT02249910|Metformin|metformin|mesh-list
139480976|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480978|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139480979|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139480980|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
139480981|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
139480982|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
139480983|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480984|NCT04985669|Prucalopride|prucalopride|mesh-list
139480985|NCT04985669|Laxatives|laxatives|mesh-ancestor
139480986|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139480987|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139480988|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139480989|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
139480990|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139480991|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139480992|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480993|NCT04753957|Progesterone|progesterone|mesh-list
139480994|NCT04753957|Progestins|progestins|mesh-ancestor
139480995|NCT04753957|Hormones|hormones|mesh-ancestor
139480996|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139480997|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139480998|NCT03070379|Lidocaine|lidocaine|mesh-list
139480999|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
139481000|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
139481001|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481002|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481003|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
139481004|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481005|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139481006|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139481007|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139481008|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139481009|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481010|NCT03227263|Bevacizumab|bevacizumab|mesh-list
139481011|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481012|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481013|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139481014|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139481015|NCT03227263|Growth Substances|growth substances|mesh-ancestor
139481016|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481017|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
139481018|NCT04985201|Irinotecan|irinotecan|mesh-list
139481019|NCT04985201|Simvastatin|simvastatin|mesh-list
139481020|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139481021|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139481022|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481023|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481024|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481025|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139481026|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139481027|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
139481028|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139481029|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139481030|NCT02031601|Carboplatin|carboplatin|mesh-list
139481031|NCT02031601|Docetaxel|docetaxel|mesh-list
139481032|NCT02031601|Pemetrexed|pemetrexed|mesh-list
139481033|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139481034|NCT02031601|Gefitinib|gefitinib|mesh-list
139481035|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481036|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
139481037|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
139481038|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
139007291|NCT00449163|Antidotes|antidotes|mesh-ancestor
139481039|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481040|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481041|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139481042|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139481043|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139481044|NCT04984577|Edaravone|edaravone|mesh-list
139481045|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139481046|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
139481047|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481048|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139481049|NCT04984577|Protective Agents|protective agents|mesh-ancestor
139481050|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481052|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139481053|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139481054|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
139481055|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481056|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139481057|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139481058|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481059|NCT03068429|Sertraline|sertraline|mesh-list
139481060|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
139007340|NCT00447057|Pemetrexed|pemetrexed|mesh-list
139481061|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139481062|NCT03068429|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139481063|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139481064|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139481065|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481066|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481067|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
139481068|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481069|NCT03068351|Daratumumab|daratumumab|mesh-list
139481070|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481071|NCT03140293|Lidocaine|lidocaine|mesh-list
139481072|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
139481073|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
139481074|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
139481075|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481076|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481077|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
139481078|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481079|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139481080|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139481081|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139481082|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139481083|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481084|NCT04982861|Cefixime|cefixime|mesh-list
139481085|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139481086|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481087|NCT04572217|Topiramate|topiramate|mesh-list
139481088|NCT04572217|Phentermine|phentermine|mesh-list
139481089|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
139481090|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139481091|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481092|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139481093|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
139481094|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139481095|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
139481096|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
139481097|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481098|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
139481099|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481100|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481101|NCT05635955|Propofol|propofol|mesh-list
139481102|NCT05635955|Esketamine|esketamine|mesh-list
139481103|NCT05635955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139481104|NCT05635955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481105|NCT05635955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481106|NCT05635955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139481107|NCT05635955|Anesthetics, General|anesthetics, general|mesh-ancestor
139481108|NCT05635955|Anesthetics|anesthetics|mesh-ancestor
139481109|NCT05635955|Antidepressive Agents|antidepressive agents|mesh-ancestor
139481110|NCT05635955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139481111|NCT03137017|Acetaminophen|acetaminophen|mesh-list
139481112|NCT03137017|Hydrocodone|hydrocodone|mesh-list
139481113|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139481114|NCT03137017|Analgesics|analgesics|mesh-ancestor
139481115|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
139481116|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481117|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481118|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
139481119|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139481120|NCT03137017|Narcotics|narcotics|mesh-ancestor
139481121|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481122|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
139481123|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
139481124|NCT03013933|Cyclosporine|cyclosporine|mesh-list
139481125|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139481126|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139481127|NCT03013933|Verapamil|verapamil|mesh-list
139481128|NCT03013933|Antibodies|antibodies|mesh-list
139481129|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
139481130|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139481131|NCT03013933|Cyclosporins|cyclosporins|mesh-list
139481132|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
139481133|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
139481134|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481135|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481136|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481137|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481138|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139481139|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
139481140|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481141|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
139481142|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139481143|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139481144|NCT03013933|Immunotoxins|immunotoxins|mesh-ancestor
139481145|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139481146|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139481147|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139481148|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139481149|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
139481150|NCT05635253|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139481151|NCT05635253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139481152|NCT05635253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481153|NCT04262479|Vitamin D|vitamin d|mesh-list
139481154|NCT04262479|Vitamins|vitamins|mesh-ancestor
139481155|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
139481156|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481157|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139481158|NCT04133311|Latanoprost|latanoprost|mesh-list
139481159|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139481160|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139481161|NCT03217825|Losartan|losartan|mesh-list
139481162|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139481163|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139481164|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139481165|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139481166|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481167|NCT00157963|Losartan|losartan|mesh-list
139481168|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139481169|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139481170|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139481171|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139481172|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139481173|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481174|NCT00157963|Diuretics|diuretics|mesh-ancestor
139481175|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
139481176|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481177|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139481178|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139481179|NCT05087797|Nicorandil|nicorandil|mesh-list
139481180|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139481181|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139481182|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
139481183|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
139481184|NCT05087797|Vitamins|vitamins|mesh-ancestor
139481185|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
139481186|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481187|NCT03867799|Nivolumab|nivolumab|mesh-list
139481188|NCT03867799|Relatlimab|relatlimab|mesh-list
139481189|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481190|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481191|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139481192|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481193|NCT04873297|Metoclopramide|metoclopramide|mesh-list
139481194|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
139481195|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
139481196|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139267893|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139481197|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481198|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139481199|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139481200|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139481201|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
139481202|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481203|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481204|NCT05634473|Methacholine Chloride|methacholine chloride|mesh-list
139481205|NCT05634473|Miotics|miotics|mesh-ancestor
139481206|NCT05634473|Autonomic Agents|autonomic agents|mesh-ancestor
139481207|NCT05634473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481208|NCT05634473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481209|NCT05634473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139481210|NCT05634473|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139481211|NCT05634473|Respiratory System Agents|respiratory system agents|mesh-ancestor
139481212|NCT05634473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139481213|NCT05634473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139481214|NCT05634473|Cholinergic Agents|cholinergic agents|mesh-ancestor
139481215|NCT05634473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481216|NCT05634473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481217|NCT04858711|Lidocaine|lidocaine|mesh-list
139481218|NCT04858711|Fentanyl|fentanyl|mesh-list
139481219|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
139481220|NCT04858711|Ketamine|ketamine|mesh-list
139481221|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
139481222|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
139481223|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481224|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481225|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
139481226|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481227|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139481228|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139481229|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139481230|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139481231|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481232|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139481233|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139481234|NCT04858711|Analgesics|analgesics|mesh-ancestor
139481235|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139481236|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139481237|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139481238|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
139481239|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481240|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139481241|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139481242|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
139481243|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139481244|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139481245|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139481246|NCT04858711|Narcotics|narcotics|mesh-ancestor
139481247|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139481248|NCT03068975|Alvimopan|alvimopan|mesh-list
139481249|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139481250|NCT02034331|Acetylcholine|acetylcholine|mesh-list
139481251|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481252|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
139481253|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139481254|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
139481255|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481256|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481257|NCT03067883|Ritonavir|ritonavir|mesh-list
139481258|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139481259|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139481260|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
139481261|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481262|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481263|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139481264|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139481265|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
139481266|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481267|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139481268|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139481269|NCT03285763|Atezolizumab|atezolizumab|mesh-list
139481270|NCT03285763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139481271|NCT03285763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139267966|NCT01281254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139481272|NCT03285763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481274|NCT05393011|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139481275|NCT05393011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139481276|NCT05393011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481277|NCT03085771|Deferoxamine|deferoxamine|mesh-list
139481278|NCT03085771|Siderophores|siderophores|mesh-ancestor
139481279|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139481280|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
139481281|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
139481282|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481283|NCT05619965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139481284|NCT05619965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481285|NCT05619965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481286|NCT04659629|Pembrolizumab|pembrolizumab|mesh-list
139481287|NCT04659629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481288|NCT04659629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481289|NCT04659629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139481290|NCT04659629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481291|NCT02985619|Triamcinolone|triamcinolone|mesh-list
139481292|NCT02985619|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139481293|NCT02985619|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139481294|NCT02985619|Bevacizumab|bevacizumab|mesh-list
139481295|NCT02985619|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139481296|NCT02985619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481297|NCT02985619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481298|NCT02985619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139481299|NCT02985619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139481300|NCT02985619|Growth Substances|growth substances|mesh-ancestor
139481301|NCT02985619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481302|NCT02985619|Growth Inhibitors|growth inhibitors|mesh-ancestor
139481303|NCT02985619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139481304|NCT02985619|Glucocorticoids|glucocorticoids|mesh-ancestor
139481305|NCT02985619|Hormones|hormones|mesh-ancestor
139481306|NCT02985619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139481307|NCT02985619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139481308|NCT02985619|Immunologic Factors|immunologic factors|mesh-ancestor
139007577|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481309|NCT02985619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481310|NCT02985619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481311|NCT03110653|Remifentanil|remifentanil|mesh-list
139481312|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139481313|NCT03110653|Narcotics|narcotics|mesh-ancestor
139481314|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481315|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481316|NCT03110653|Analgesics|analgesics|mesh-ancestor
139481317|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
139481318|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481319|NCT05392387|Antiviral Agents|antiviral agents|mesh-list
139481320|NCT05392387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481321|NCT04450199|Vitamin D|vitamin d|mesh-list
139481322|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
139481323|NCT04450199|Cholecalciferol|cholecalciferol|mesh-list
139481324|NCT04450199|Vitamins|vitamins|mesh-list
139481325|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
139481326|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481327|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139481328|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139481329|NCT01884259|Docetaxel|docetaxel|mesh-list
139481330|NCT01884259|Fluorouracil|fluorouracil|mesh-list
139481331|NCT01884259|Cetuximab|cetuximab|mesh-list
139007613|NCT04429152|Tenofovir|tenofovir|mesh-list
139481332|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481333|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
139481334|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
139481335|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
139481336|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481337|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
139481338|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139481339|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139481340|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
139481341|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481342|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481343|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
139481344|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139481345|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481346|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139481347|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481348|NCT03067727|Dinoprostone|dinoprostone|mesh-list
139481349|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
139481350|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139481351|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481352|NCT01794793|Cabergoline|cabergoline|mesh-list
139481353|NCT01794793|Pasireotide|pasireotide|mesh-list
139481354|NCT01794793|Somatostatin|somatostatin|mesh-list
139481355|NCT01794793|Hormones|hormones|mesh-ancestor
139481356|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139481357|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481358|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139481359|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139481360|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
139481361|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
139481362|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481363|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481364|NCT03067103|Ketamine|ketamine|mesh-list
139481365|NCT03067103|Tramadol|tramadol|mesh-list
139481366|NCT03067103|Analgesics|analgesics|mesh-ancestor
139481367|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
139481368|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481369|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481370|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139481371|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139481372|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
139481373|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
139481374|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481375|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139481376|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139481377|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481378|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481379|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139481380|NCT03067103|Narcotics|narcotics|mesh-ancestor
139481381|NCT01398319|Ethanol|ethanol|mesh-list
139481382|NCT01398319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139481383|NCT01398319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481384|NCT01398319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481385|NCT01398319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481386|NCT01305889|Sertraline|sertraline|mesh-list
139481387|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
139007640|NCT01047982|Folic Acid|folic acid|mesh-list
139481388|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139481389|NCT01305889|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139481390|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139481391|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139481392|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481393|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481394|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
139481395|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481396|NCT00223171|Androgens|androgens|mesh-list
139481397|NCT00223171|Hormones|hormones|mesh-ancestor
139481398|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139481399|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481400|NCT03138031|Ethanol|ethanol|mesh-list
139481401|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139481402|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481403|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481404|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481405|NCT05431283|Tofacitinib|tofacitinib|mesh-list
139481406|NCT05431283|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139481407|NCT05431283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139481408|NCT05431283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481409|NCT05431283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481410|NCT03208985|Ulipristal acetate|ulipristal acetate|mesh-list
139481411|NCT03208985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139481412|NCT03208985|Contraceptive Agents|contraceptive agents|mesh-ancestor
139481413|NCT03208985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139481414|NCT03208985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481415|NCT03208985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139481416|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
139481417|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481418|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
139481419|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481420|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481421|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139481422|NCT03630835|Annexin A5|annexin a5|mesh-list
139481423|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481424|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481425|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
139481426|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139481427|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481428|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139481429|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481430|NCT05391451|Anesthetics|anesthetics|mesh-list
139481431|NCT05391451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481432|NCT05391451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481433|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
139481434|NCT03110341|Hematinics|hematinics|mesh-ancestor
139481435|NCT04537897|Midazolam|midazolam|mesh-list
139481436|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139481437|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139481438|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481439|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481440|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139481441|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139481442|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139481443|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139481444|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
139481445|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
139481446|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
139481447|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
139481448|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481449|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481450|NCT04405063|Paclitaxel|paclitaxel|mesh-list
139481451|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139481452|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481453|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
139481454|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
139481455|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
139481456|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481457|NCT05090449|Losartan|losartan|mesh-list
139481458|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
139481459|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139481460|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139481461|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139481462|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139481463|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481464|NCT05090449|Diuretics|diuretics|mesh-ancestor
139481465|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
139481466|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481467|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139481468|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139481469|NCT05090137|Diuretics|diuretics|mesh-list
139481470|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
139481471|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481472|NCT03067415|Latanoprost|latanoprost|mesh-list
139481473|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139481474|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139481475|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
139481476|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139481477|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
139481478|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481479|NCT05089981|Expectorants|expectorants|mesh-ancestor
139481480|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
139481481|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139481482|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
139481483|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481484|NCT05089981|Protective Agents|protective agents|mesh-ancestor
139481485|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481486|NCT05089981|Antidotes|antidotes|mesh-ancestor
139481487|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
139481488|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139481489|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481490|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481491|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139481492|NCT04206059|Analgesics|analgesics|mesh-ancestor
139481493|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
139481494|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481495|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139481497|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139481498|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
139481499|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481500|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481501|NCT05431049|Anesthetics|anesthetics|mesh-list
139481502|NCT05431049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481503|NCT05431049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481504|NCT04132817|Paclitaxel|paclitaxel|mesh-list
139481505|NCT04132817|Nivolumab|nivolumab|mesh-list
139481506|NCT04132817|Ipilimumab|ipilimumab|mesh-list
139481507|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139481508|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481509|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
139481510|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
139481511|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
139481512|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481513|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481514|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139481515|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
139481516|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139481517|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139481518|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139481519|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139481520|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481521|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
139481522|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481523|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481524|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139481525|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481526|NCT03136237|Cyclosporine|cyclosporine|mesh-list
139481527|NCT03136237|Digoxin|digoxin|mesh-list
139481528|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139481529|NCT03136237|Cyclosporins|cyclosporins|mesh-list
139481530|NCT03136237|Berotralstat|berotralstat|mesh-list
139481531|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481532|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481533|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139481534|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
139481535|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481536|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
139481537|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481538|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
139481539|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139481540|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139481541|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139481542|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139481543|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
139481544|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139481545|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139481546|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139481547|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139481548|NCT03136237|Protective Agents|protective agents|mesh-ancestor
139481549|NCT03136237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139481550|NCT03136237|Protease Inhibitors|protease inhibitors|mesh-ancestor
139481551|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
139481552|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139481553|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
139481554|NCT04021381|Cathartics|cathartics|mesh-ancestor
139481555|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139481556|NCT03066791|Curcumin|curcumin|mesh-list
139481557|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139481558|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139481559|NCT03066791|Analgesics|analgesics|mesh-ancestor
139481560|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
139481561|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481562|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481563|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139481564|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139481565|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481566|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481567|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481568|NCT05729555|Diphenhydramine|diphenhydramine|mesh-list
139481569|NCT05729555|Promethazine|promethazine|mesh-list
139481570|NCT05729555|Ibuprofen|ibuprofen|mesh-list
139481571|NCT05729555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139481572|NCT05729555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139481573|NCT05729555|Analgesics|analgesics|mesh-ancestor
139481574|NCT05729555|Sensory System Agents|sensory system agents|mesh-ancestor
139481575|NCT05729555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481576|NCT05729555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481577|NCT05729555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139481578|NCT05729555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139481579|NCT05729555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139481580|NCT05729555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481581|NCT05729555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007844|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
139481582|NCT05729555|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139481583|NCT05729555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139481584|NCT05729555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481585|NCT05729555|Anesthetics, Local|anesthetics, local|mesh-ancestor
139481586|NCT05729555|Anesthetics|anesthetics|mesh-ancestor
139481587|NCT05729555|Antiemetics|antiemetics|mesh-ancestor
139481588|NCT05729555|Autonomic Agents|autonomic agents|mesh-ancestor
139481589|NCT05729555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139481590|NCT05729555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139481591|NCT05729555|Histamine Antagonists|histamine antagonists|mesh-ancestor
139481592|NCT05729555|Histamine Agents|histamine agents|mesh-ancestor
139481593|NCT05729555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481594|NCT05729555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139481595|NCT05729555|Antipruritics|antipruritics|mesh-ancestor
139481596|NCT05729555|Dermatologic Agents|dermatologic agents|mesh-ancestor
139481597|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139481598|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139481599|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481600|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481601|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139481602|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139481603|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481604|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
139481605|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481606|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139481607|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139481608|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139481609|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139007887|NCT00379834|Timolol|timolol|mesh-list
139481610|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
139481611|NCT03136003|Coagulants|coagulants|mesh-ancestor
139481612|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139481613|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
139481614|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481615|NCT05410847|Paclitaxel|paclitaxel|mesh-list
139481616|NCT05410847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139481617|NCT05410847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481618|NCT05410847|Tubulin Modulators|tubulin modulators|mesh-ancestor
139481619|NCT05410847|Antimitotic Agents|antimitotic agents|mesh-ancestor
139481620|NCT05410847|Mitosis Modulators|mitosis modulators|mesh-ancestor
139481621|NCT05410847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481622|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
139481623|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139481624|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139481625|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139481626|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139481627|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481628|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
139481629|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481630|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481631|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139481632|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481633|NCT03726749|Prednisone|prednisone|mesh-list
139481634|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
139481635|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139481636|NCT03726749|Hormones|hormones|mesh-ancestor
139481637|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139481638|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481639|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139481640|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481641|NCT03821077|Immunomodulating Agents|immunomodulating agents|mesh-list
139481642|NCT03821077|Immunologic Factors|immunologic factors|mesh-ancestor
139481643|NCT03821077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481644|NCT03136705|Niacinamide|niacinamide|mesh-list
139481645|NCT03136705|Niacin|niacin|mesh-list
139481646|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
139481647|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
139481648|NCT03136705|Vitamins|vitamins|mesh-ancestor
139481649|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
139481650|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481651|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139481652|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
139007916|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
139481653|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481654|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139481655|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
139481656|NCT03066557|Apatinib|apatinib|mesh-list
139481657|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
139481658|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481659|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139481660|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481661|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481662|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139481663|NCT03066557|Estrogens|estrogens|mesh-ancestor
139481664|NCT03066557|Hormones|hormones|mesh-ancestor
139481665|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139481666|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481667|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139481668|NCT05737303|Paclitaxel|paclitaxel|mesh-list
139481669|NCT05737303|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139481670|NCT05737303|Carboplatin|carboplatin|mesh-list
139481671|NCT05737303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139481672|NCT05737303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481673|NCT05737303|Tubulin Modulators|tubulin modulators|mesh-ancestor
139481674|NCT05737303|Antimitotic Agents|antimitotic agents|mesh-ancestor
139481675|NCT05737303|Mitosis Modulators|mitosis modulators|mesh-ancestor
139481676|NCT05737303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481677|NCT03066089|Fenugreek seed meal|fenugreek seed meal|mesh-list
139481678|NCT03066089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139481679|NCT03066089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481680|NCT05188313|Paclitaxel|paclitaxel|mesh-list
139481681|NCT05188313|Carboplatin|carboplatin|mesh-list
139481682|NCT05188313|Trastuzumab|trastuzumab|mesh-list
139481683|NCT05188313|Pertuzumab|pertuzumab|mesh-list
139481684|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139481685|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481686|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
139481687|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
139481688|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
139481689|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481690|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481691|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139481692|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481693|NCT03066011|Voriconazole|voriconazole|mesh-list
139481694|NCT03066011|Posaconazole|posaconazole|mesh-list
139481695|NCT03066011|Isavuconazole|isavuconazole|mesh-list
139481696|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
139481697|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481698|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139481699|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139481700|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481701|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481702|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139481703|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
139481704|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139481705|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481706|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139481707|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139481708|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139481709|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139481710|NCT03135769|Avelumab|avelumab|mesh-list
139481711|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481712|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481713|NCT03123211|Veliparib|veliparib|mesh-list
139481714|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139481715|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481716|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481717|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481718|NCT05520749|Luspatercept|luspatercept|mesh-list
139481719|NCT05520749|Hematinics|hematinics|mesh-ancestor
139268487|NCT04059003|Taxane|taxane|mesh-list
139481720|NCT03073525|Atezolizumab|atezolizumab|mesh-list
139481721|NCT03073525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139481722|NCT03073525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481723|NCT03073525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481724|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481725|NCT02563015|Vitamin D|vitamin d|mesh-list
139481726|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
139481727|NCT02563015|Vitamins|vitamins|mesh-ancestor
139481728|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
139481729|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481730|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139481731|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139481732|NCT02382445|Anesthetics|anesthetics|mesh-list
139481733|NCT02382445|Propofol|propofol|mesh-list
139481734|NCT02382445|Sevoflurane|sevoflurane|mesh-list
139481735|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481736|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481737|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139481738|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139481739|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
139481740|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139481741|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139481742|NCT05736757|Plasminogen|plasminogen|mesh-list
139481743|NCT05736757|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139481744|NCT05736757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139481745|NCT05736757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139481746|NCT05736757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481747|NCT05091775|Mesalamine|mesalamine|mesh-list
139481748|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139481749|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139481750|NCT05091775|Analgesics|analgesics|mesh-ancestor
139481751|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
139481752|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481753|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481754|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139481755|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139481756|NCT04821869|Albuterol|albuterol|mesh-list
139481757|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139481758|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
139481759|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481760|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481761|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139481762|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
139481763|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139481764|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139481765|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139481766|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
139481767|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481768|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481769|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
139481770|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139481771|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
139481772|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139481773|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
139481774|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481775|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
139481776|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139481777|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139481778|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
139481779|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139481780|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139481781|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139481782|NCT02631551|Analgesics|analgesics|mesh-ancestor
139481783|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
139481784|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481785|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481786|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139481787|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139481788|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139481789|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
139481790|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
139481791|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481792|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481793|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
139481794|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139481795|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481796|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481797|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139481798|NCT05091151|Analgesics|analgesics|mesh-ancestor
139481799|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
139481800|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481801|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139481802|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139481803|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139481804|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
139481805|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481806|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481807|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
139481808|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139481809|NCT04447235|Ivermectin|ivermectin|mesh-list
139481810|NCT04447235|Losartan|losartan|mesh-list
139481811|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139481812|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139481813|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139481814|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139481815|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481816|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139008102|NCT01646814|Aspirin|aspirin|mesh-list
139481817|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481818|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
139481819|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481820|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481821|NCT01700569|Leucovorin|leucovorin|mesh-list
139481822|NCT01700569|Folic Acid|folic acid|mesh-list
139481823|NCT01700569|Temozolomide|temozolomide|mesh-list
139481824|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
139481825|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481826|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139481827|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
139481828|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481829|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481830|NCT01700569|Antidotes|antidotes|mesh-ancestor
139481831|NCT01700569|Protective Agents|protective agents|mesh-ancestor
139481832|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
139481833|NCT01700569|Vitamins|vitamins|mesh-ancestor
139481834|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
139481835|NCT01700569|Hematinics|hematinics|mesh-ancestor
139481836|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
139481837|NCT05090761|Buprenorphine|buprenorphine|mesh-list
139481838|NCT05090761|Bupivacaine|bupivacaine|mesh-list
139481839|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139481840|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
139481841|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
139481842|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481843|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481844|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
139481845|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481846|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139481847|NCT05090761|Narcotics|narcotics|mesh-ancestor
139481848|NCT05090761|Analgesics|analgesics|mesh-ancestor
139481849|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139481850|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139481851|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
139481852|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139481853|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139481854|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481855|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139481856|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
139481857|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139481858|NCT03065309|Remifentanil|remifentanil|mesh-list
139481859|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139481860|NCT03065309|Narcotics|narcotics|mesh-ancestor
139481861|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481862|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481863|NCT03065309|Analgesics|analgesics|mesh-ancestor
139481864|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
139481865|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481866|NCT02819479|Bevacizumab|bevacizumab|mesh-list
139481867|NCT02819479|Mannitol|mannitol|mesh-list
139268568|NCT00882440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481868|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481869|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481870|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139481871|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139481872|NCT02819479|Growth Substances|growth substances|mesh-ancestor
139481873|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481874|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
139481875|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139481877|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
139481878|NCT05376943|Antiviral Agents|antiviral agents|mesh-list
139481879|NCT05376943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481880|NCT04074785|Bevacizumab|bevacizumab|mesh-list
139481881|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481882|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481883|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139481884|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139481885|NCT04074785|Growth Substances|growth substances|mesh-ancestor
139481886|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481887|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
139481888|NCT04533841|Propranolol|propranolol|mesh-list
139481889|NCT04533841|Misoprostol|misoprostol|mesh-list
139481890|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139481891|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
139481892|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139481893|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481894|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139481895|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139481896|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
139481897|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139481898|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139481899|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
139481900|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481901|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481902|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139481903|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139481904|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
139481905|NCT04536805|Metformin|metformin|mesh-list
139481906|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139481907|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481908|NCT05376865|Vitamin D|vitamin d|mesh-list
139481909|NCT05376865|Vitamins|vitamins|mesh-ancestor
139481910|NCT05376865|Micronutrients|micronutrients|mesh-ancestor
139481911|NCT05376865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008176|NCT00995826|Laninamivir|laninamivir|mesh-list
139481912|NCT05376865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139481913|NCT04064411|Abaloparatide|abaloparatide|mesh-list
139481914|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
139481915|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139481916|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481917|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139481918|NCT04012931|Rilpivirine|rilpivirine|mesh-list
139481919|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139481920|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139481921|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481922|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481923|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
139481924|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481925|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139481926|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139481927|NCT03063359|Fentanyl|fentanyl|mesh-list
139481928|NCT03063359|Morphine|morphine|mesh-list
139481929|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139481930|NCT03063359|Narcotics|narcotics|mesh-ancestor
139481931|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481932|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481933|NCT03063359|Analgesics|analgesics|mesh-ancestor
139481934|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
139481935|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481936|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139481937|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139481938|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
139481939|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
139481940|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
139481941|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
139481942|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139481943|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139481944|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139481945|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139481946|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481947|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
139481948|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139481949|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481950|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139481951|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139481952|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
139481953|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
139481954|NCT02660359|Coagulants|coagulants|mesh-ancestor
139481955|NCT05067985|Anesthetics|anesthetics|mesh-list
139481956|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139481957|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481959|NCT04262869|Carboplatin|carboplatin|mesh-list
139481960|NCT04262869|Pemetrexed|pemetrexed|mesh-list
139481961|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139481962|NCT04262869|Durvalumab|durvalumab|mesh-list
139481963|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
139481964|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139481965|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
139481966|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139481967|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481968|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
139481969|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
139481970|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
139481971|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481972|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008253|NCT05162196|Niraparib|niraparib|mesh-list
139481973|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139481974|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139481975|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139481976|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
139481977|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481978|NCT05092165|Methylene Blue|methylene blue|mesh-list
139481979|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481980|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481981|NCT03062813|Entecavir|entecavir|mesh-list
139481982|NCT03062813|Tacrolimus|tacrolimus|mesh-list
139481983|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139481984|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
139481985|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139481986|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139481987|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481988|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481989|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
139481990|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139481991|NCT04582981|Raltitrexed|raltitrexed|mesh-list
139481992|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139481993|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
139481994|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139481995|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139481996|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139481997|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139481998|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
139481999|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139482000|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
139482001|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482002|NCT04531579|Valproic Acid|valproic acid|mesh-list
139482003|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139482004|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
139482005|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482006|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482007|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
139482008|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482009|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482010|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
139482011|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139482012|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139482013|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139482014|NCT03839459|Denosumab|denosumab|mesh-list
139482015|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139482016|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482017|NCT05097781|Antibodies|antibodies|mesh-list
139482018|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
139482019|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
139482020|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482021|NCT01117441|Cytarabine|cytarabine|mesh-list
139482022|NCT01117441|Dexamethasone|dexamethasone|mesh-list
139482023|NCT01117441|Prednisone|prednisone|mesh-list
139482024|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
139482025|NCT01117441|Ifosfamide|ifosfamide|mesh-list
139482026|NCT01117441|Doxorubicin|doxorubicin|mesh-list
139482027|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139482028|NCT01117441|Methotrexate|methotrexate|mesh-list
139482029|NCT01117441|Fludarabine|fludarabine|mesh-list
139482030|NCT01117441|Etoposide|etoposide|mesh-list
139482031|NCT01117441|Vincristine|vincristine|mesh-list
139482032|NCT01117441|Daunorubicin|daunorubicin|mesh-list
139482033|NCT01117441|Asparaginase|asparaginase|mesh-list
139482034|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
139482035|NCT01117441|Thioguanine|thioguanine|mesh-list
139482036|NCT01117441|Pegaspargase|pegaspargase|mesh-list
139482037|NCT01117441|Vindesine|vindesine|mesh-list
139482038|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139482039|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
139482040|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482041|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139482042|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139482043|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
139482044|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482045|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482046|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139482047|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139482048|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
139482049|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
139482050|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482051|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482052|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
139482053|NCT01117441|Hormones|hormones|mesh-ancestor
139482054|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139482055|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139482056|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139482057|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139482058|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139008326|NCT01001364|Hormones|hormones|mesh-ancestor
139482059|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482060|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139482061|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
139482062|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139482063|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139482064|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
139482065|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
139482066|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139482067|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139482068|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139482069|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
139482070|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139482071|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
139482072|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
139482073|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
139482074|NCT01101451|Cisplatin|cisplatin|mesh-list
139482075|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482076|NCT03656627|Nivolumab|nivolumab|mesh-list
139482077|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139482078|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482079|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139482080|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482081|NCT04759703|Pramipexole|pramipexole|mesh-list
139482082|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
139482083|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482084|NCT04759703|Protective Agents|protective agents|mesh-ancestor
139482085|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482086|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139482087|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139482088|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
139482089|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
139482090|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482091|NCT05026801|Azithromycin|azithromycin|mesh-list
139482092|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
139482093|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139482094|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139482095|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
138520275|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
139482096|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139482097|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139482098|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482099|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482144|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482145|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482146|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139482147|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139482148|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139482149|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139482150|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139482151|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139482152|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008387|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
139482153|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482154|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
139482155|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139482156|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139482157|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139482158|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139482159|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139482160|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139482161|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139482162|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139482163|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139482164|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
139482165|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
139482166|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139482167|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
139482168|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139482169|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139482170|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139482171|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
139482172|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139482173|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
139482174|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
139482175|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139268873|NCT00840866|Cefprozil|cefprozil|mesh-list
139482176|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139482177|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139482178|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
139482179|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
139008415|NCT00369382|Cyclosporine|cyclosporine|mesh-list
139482180|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
139482181|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139482182|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139482183|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139482184|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139482185|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
139482187|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139482188|NCT01938430|Ledipasvir|ledipasvir|mesh-list
139482189|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
139482190|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139482191|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
139482192|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
139482193|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139482194|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139482195|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482196|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
139482197|NCT04625530|Coagulants|coagulants|mesh-ancestor
139482198|NCT04625530|Hematinics|hematinics|mesh-ancestor
139482199|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139482200|NCT01916824|Mirtazapine|mirtazapine|mesh-list
139482201|NCT01916824|Citalopram|citalopram|mesh-list
139482202|NCT01916824|Bupropion|bupropion|mesh-list
139482203|NCT01916824|Fluoxetine|fluoxetine|mesh-list
139482204|NCT01916824|Paroxetine|paroxetine|mesh-list
139482205|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139482206|NCT01916824|Sertraline|sertraline|mesh-list
139482207|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
139482208|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139482209|NCT01916824|Escitalopram|escitalopram|mesh-list
139482210|NCT01916824|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139482211|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139482212|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139482213|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482214|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482215|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
139008444|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482216|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482217|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482218|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139482219|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139482220|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139482221|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
139482222|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139482223|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139482224|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482225|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139482226|NCT01916824|Analgesics|analgesics|mesh-ancestor
139482227|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
139482228|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139482229|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
139008465|NCT00436917|Letrozole|letrozole|mesh-list
139482230|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
139482231|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139482232|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139482233|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139482234|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139482235|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139482236|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139482237|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
139482238|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139482239|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139482240|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139482241|NCT01915732|Clindamycin|clindamycin|mesh-list
139482242|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
139482243|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
139482244|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139482245|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139482246|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139482247|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482248|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482249|NCT01936870|Fesoterodine|fesoterodine|mesh-list
139482250|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139482251|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139482252|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
139482253|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008492|NCT01028781|Growth Substances|growth substances|mesh-ancestor
139482254|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482255|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482256|NCT01936870|Urological Agents|urological agents|mesh-ancestor
139482258|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
139482259|NCT01618708|Protective Agents|protective agents|mesh-ancestor
139482260|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482261|NCT02229149|Paclitaxel|paclitaxel|mesh-list
139482262|NCT02229149|Vinorelbine|vinorelbine|mesh-list
139482263|NCT02229149|Docetaxel|docetaxel|mesh-list
139482264|NCT02229149|Capecitabine|capecitabine|mesh-list
139482265|NCT02229149|Trastuzumab|trastuzumab|mesh-list
139482266|NCT02229149|Pertuzumab|pertuzumab|mesh-list
139482267|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139482268|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482269|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
139482270|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
139482271|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
139482272|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482273|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139482274|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
139482275|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139482276|NCT04440371|Betamethasone|betamethasone|mesh-list
139482277|NCT04440371|Calcipotriene|calcipotriene|mesh-list
139482278|NCT04440371|Tacrolimus|tacrolimus|mesh-list
139482279|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139482280|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
139482281|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482282|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139482283|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482284|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482285|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139482286|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
139482287|NCT04440371|Hormones|hormones|mesh-ancestor
139482288|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139482289|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139482290|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
139008535|NCT00375934|Diclofenac|diclofenac|mesh-list
139482291|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
139482292|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
139482293|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482294|NCT04982549|Paclitaxel|paclitaxel|mesh-list
139482295|NCT04982549|Carboplatin|carboplatin|mesh-list
139482296|NCT04982549|Pemetrexed|pemetrexed|mesh-list
139482297|NCT04982549|Durvalumab|durvalumab|mesh-list
139482298|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139482299|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482300|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
139482301|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
139482302|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
139482303|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482304|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482305|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139482306|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139482307|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139482308|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
139482309|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
139482310|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139482311|NCT00790933|Vedolizumab|vedolizumab|mesh-list
139482312|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482313|NCT04981457|Misoprostol|misoprostol|mesh-list
139482314|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139482315|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
139482316|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139482317|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482318|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139482319|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482320|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
139482321|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139482322|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
139482323|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482324|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
139482325|NCT04981379|Favipiravir|favipiravir|mesh-list
139482326|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
139482327|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139482328|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139482329|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139482330|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482331|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482332|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139482333|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
139482334|NCT04389775|Glucagon|glucagon|mesh-list
139482335|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139482336|NCT04389775|Incretins|incretins|mesh-ancestor
139482337|NCT04389775|Hormones|hormones|mesh-ancestor
139008564|NCT01050322|Vinorelbine|vinorelbine|mesh-list
139482338|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139482339|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482340|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482341|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
139482342|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482343|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
139482344|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482345|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482346|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139482347|NCT02102789|Leucovorin|leucovorin|mesh-list
139482348|NCT02102789|Dexamethasone|dexamethasone|mesh-list
139482349|NCT02102789|Fluorouracil|fluorouracil|mesh-list
139482350|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
139482351|NCT02102789|Floxuridine|floxuridine|mesh-list
139482352|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139482353|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
139482354|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
139482355|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482356|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482357|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482358|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
139482359|NCT02102789|Hormones|hormones|mesh-ancestor
139482360|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139482361|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139482362|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482363|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482364|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
139482365|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139482366|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139482367|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
139482368|NCT02102789|Antidotes|antidotes|mesh-ancestor
139482369|NCT02102789|Protective Agents|protective agents|mesh-ancestor
139482370|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
139482371|NCT02102789|Vitamins|vitamins|mesh-ancestor
139482372|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
139482373|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
139482374|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139482375|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139482376|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482377|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
139482378|NCT02926651|Coagulants|coagulants|mesh-ancestor
139482379|NCT04305145|Prednisone|prednisone|mesh-list
139482380|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
139482381|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139482382|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139482383|NCT04305145|Prednisolone|prednisolone|mesh-list
139482384|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
139482385|NCT04305145|Infliximab|infliximab|mesh-list
139482386|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139482387|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
139482388|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139482389|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
139482390|NCT04305145|Hormones|hormones|mesh-ancestor
139482391|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139482392|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482393|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139482394|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482395|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
139482396|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
139482397|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482398|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482399|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139482400|NCT04305145|Protective Agents|protective agents|mesh-ancestor
139482401|NCT04305145|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139482402|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
139482403|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139482404|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
139482405|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
139482406|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482407|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482408|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482409|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
139482410|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
139482411|NCT04188145|Bevacizumab|bevacizumab|mesh-list
139482412|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139482413|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482414|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139482415|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139482416|NCT04188145|Growth Substances|growth substances|mesh-ancestor
139482417|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482418|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
139482419|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
139482420|NCT03063983|Methotrexate|methotrexate|mesh-list
139482421|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139482422|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
139482423|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482424|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139482425|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139482426|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
139482427|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482428|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482429|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139482430|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139482431|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
139482432|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139482433|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139482434|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
139482435|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
139482436|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482437|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139482438|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139482439|NCT03945721|Niraparib|niraparib|mesh-list
139482440|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139482441|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482442|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482443|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482444|NCT01876355|Clonidine|clonidine|mesh-list
139482445|NCT01876355|Analgesics|analgesics|mesh-ancestor
139482446|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
139482447|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482448|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482449|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139482450|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
139482451|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
139482452|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139482453|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139482454|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139482455|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
139482456|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482457|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482458|NCT02747407|Vaccines|vaccines|mesh-list
139482459|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
139482460|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482461|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
139482462|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139482463|NCT01870193|Glycine|glycine|mesh-list
139482464|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
139482465|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139482466|NCT01870193|Expectorants|expectorants|mesh-ancestor
139482467|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
139482468|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139482469|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
139482470|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482471|NCT01870193|Protective Agents|protective agents|mesh-ancestor
139482472|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482473|NCT01870193|Antidotes|antidotes|mesh-ancestor
139482474|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
139482475|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482476|NCT03063905|Buprenorphine|buprenorphine|mesh-list
139482477|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139482478|NCT03063905|Narcotics|narcotics|mesh-ancestor
139482479|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139482480|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482481|NCT03063905|Analgesics|analgesics|mesh-ancestor
139482482|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
139482483|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482484|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139482485|NCT04432415|Fluorides|fluorides|mesh-list
139482486|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
139482487|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
139482488|NCT04432415|Protective Agents|protective agents|mesh-ancestor
139482489|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482490|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
139482491|NCT03063671|Ketamine|ketamine|mesh-list
139482492|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139482493|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139482494|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482495|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139482496|NCT03063671|Analgesics|analgesics|mesh-ancestor
139482497|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
139482498|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482499|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139482500|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139482501|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139008742|NCT00817271|Glucagon|glucagon|mesh-list
139482502|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
139482503|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482504|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482505|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139482506|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139482507|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
139482508|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
139482509|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139482510|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139482511|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139482512|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139482513|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139482514|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482515|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482516|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139482517|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139482518|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482519|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
139482520|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482521|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
139482522|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139482523|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
139482524|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482525|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482526|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139482527|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139482528|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139482529|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
139482530|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139482531|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
139482532|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139482533|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482534|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139482535|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139482536|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482537|NCT02958709|Rifampin|rifampin|mesh-list
139482538|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139482539|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
139482540|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139482541|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139482542|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
139482543|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139482544|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008762|NCT01002690|Etoricoxib|etoricoxib|mesh-list
139482545|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482546|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139482547|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139482548|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139482549|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139482550|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139482551|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139482552|NCT04979663|Gemcitabine|gemcitabine|mesh-list
139482553|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
139482554|NCT04979663|Tislelizumab|tislelizumab|mesh-list
139482555|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139008798|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
139269235|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
139482556|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
139482557|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482558|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482559|NCT04979663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139482560|NCT04979585|Paclitaxel|paclitaxel|mesh-list
139482561|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139482562|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482563|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
139482564|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
139482565|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
139482566|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482567|NCT05103397|Prednisolone|prednisolone|mesh-list
139482568|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139482569|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
139482570|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139482571|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
139482572|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139482573|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
139482574|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139482575|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
139482576|NCT05103397|Hormones|hormones|mesh-ancestor
139482577|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139482578|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482579|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139482580|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482581|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
139482582|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
139482583|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482584|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482585|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139482586|NCT05103397|Protective Agents|protective agents|mesh-ancestor
139482587|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
139482588|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139482589|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482590|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139482591|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
139482592|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139482593|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139482594|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482595|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482596|NCT05101291|Bupivacaine|bupivacaine|mesh-list
139482597|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
139482598|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
139482599|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139482600|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482601|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
139482602|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482603|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
139482604|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
139482605|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139482606|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139482607|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139482608|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482609|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482610|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139482611|NCT04979273|Epinephrine|epinephrine|mesh-list
139482612|NCT04979273|Racepinephrine|racepinephrine|mesh-list
139482613|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
139482614|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139482615|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139482616|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
139482617|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008850|NCT00530946|Amlodipine|amlodipine|mesh-list
139482618|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482619|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482620|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139482621|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139482622|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
139482623|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482624|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139482625|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
139482626|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
139482627|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
139482628|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139482629|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
139482630|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139482631|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139482632|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482633|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
139482634|NCT05092555|Coagulants|coagulants|mesh-ancestor
139482635|NCT05036473|Levodopa|levodopa|mesh-list
139482636|NCT05036473|Carbidopa|carbidopa|mesh-list
139482637|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139482638|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139482639|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139482640|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
139482641|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482642|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482643|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482644|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139482645|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482646|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139482647|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
139482648|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
139482649|NCT04985851|Durvalumab|durvalumab|mesh-list
139482650|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139482651|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139482652|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482653|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
139482654|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482655|NCT05099575|Oxytocin|oxytocin|mesh-list
139482656|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
139482657|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139482658|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482659|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139482660|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139008906|NCT00530088|Trioxsalen|trioxsalen|mesh-list
139482661|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482662|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482663|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
139482664|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482665|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482666|NCT04973579|Anesthetics|anesthetics|mesh-list
139482667|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139482668|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482669|NCT04834063|Selenium|selenium|mesh-list
139482670|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
139482671|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482672|NCT04834063|Protective Agents|protective agents|mesh-ancestor
139482673|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482674|NCT04834063|Trace Elements|trace elements|mesh-ancestor
139482675|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
139482676|NCT04794205|Caryophyllene|caryophyllene|mesh-list
139482677|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139482678|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139482679|NCT04794205|Analgesics|analgesics|mesh-ancestor
139482680|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
139482681|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482682|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482683|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139482684|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139482685|NCT04973033|Tofacitinib|tofacitinib|mesh-list
139482686|NCT04973033|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139482687|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139482688|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482689|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482690|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
139482691|NCT02660281|Melphalan|melphalan|mesh-list
139482692|NCT02660281|Busulfan|busulfan|mesh-list
139482693|NCT02660281|Thiotepa|thiotepa|mesh-list
139482694|NCT02660281|Fludarabine|fludarabine|mesh-list
139482696|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139482697|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
139482698|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482699|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139482700|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139482701|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
139482702|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139269382|NCT02683018|Hormones|hormones|mesh-ancestor
139482703|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482704|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139482705|NCT02660281|Protective Agents|protective agents|mesh-ancestor
139482706|NCT02438995|Cetuximab|cetuximab|mesh-list
139482707|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139482708|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482709|NCT01669811|Esomeprazole|esomeprazole|mesh-list
139482710|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139482711|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482712|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139482713|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482714|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482715|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139482716|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139482717|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139482718|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482719|NCT04437017|Dexamethasone|dexamethasone|mesh-list
139482720|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
139482721|NCT04437017|Olanzapine|olanzapine|mesh-list
139482722|NCT04437017|Serotonin|serotonin|mesh-list
139482723|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139482724|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
139482725|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
139482726|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482727|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482728|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482729|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
139482730|NCT04437017|Hormones|hormones|mesh-ancestor
139482731|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139482732|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139482733|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482734|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139482735|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139008982|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139482736|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139482737|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139482738|NCT04437017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139482739|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139482740|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139482741|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482742|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482743|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
139482744|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139482745|NCT03061253|Nicotine|nicotine|mesh-list
139482746|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139482747|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
139482748|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008999|NCT00626639|Cisplatin|cisplatin|mesh-list
139482749|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482750|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139482751|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139482752|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
139482753|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482754|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482755|NCT05107063|Pravastatin|pravastatin|mesh-list
139482756|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139482757|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139482758|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
139482759|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482760|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139482761|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139482762|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482763|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
139482764|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139482765|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
139482766|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482767|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
139482768|NCT05106751|Protective Agents|protective agents|mesh-ancestor
139482769|NCT04977557|Thiamine|thiamine|mesh-list
139482770|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
139482771|NCT04977557|Vitamins|vitamins|mesh-ancestor
139482772|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
139482773|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482774|NCT04316143|Zamicastat|zamicastat|mesh-list
139482775|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482776|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482777|NCT05104801|Tislelizumab|tislelizumab|mesh-list
139482778|NCT05104801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139482779|NCT05104801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482780|NCT04530877|Infliximab|infliximab|mesh-list
139482781|NCT04530877|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139482782|NCT04530877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139482783|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
139482784|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482785|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139482786|NCT04971239|Methotrexate|methotrexate|mesh-list
139482787|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139482788|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
139482789|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139482790|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482791|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139482792|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
139009015|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
139482793|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482794|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482795|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
139482796|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482797|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139482798|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139482799|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
139482800|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139482801|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139482802|NCT04903093|Famotidine|famotidine|mesh-list
139482803|NCT04903093|Abrocitinib|abrocitinib|mesh-list
139482804|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139482805|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482806|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139482807|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
139482808|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
139482809|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482810|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482811|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482812|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139482813|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482814|NCT04529785|Ethanol|ethanol|mesh-list
139482815|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139482816|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139482817|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139482818|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482819|NCT04271293|Edoxaban|edoxaban|mesh-list
139482820|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139009060|NCT00830843|Propofol|propofol|mesh-list
139482821|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
139482822|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139482823|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
139482824|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482825|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482826|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
139482827|NCT03059849|Adalimumab|adalimumab|mesh-list
139482828|NCT03059849|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139482829|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139482830|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139482831|NCT04970693|Aflutinib|aflutinib|mesh-list
139482832|NCT04970693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139482833|NCT04970693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482834|NCT04970693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482835|NCT04970303|Methylphenidate|methylphenidate|mesh-list
139482836|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139482837|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482838|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139482839|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139482840|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139482841|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482842|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
139482843|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482844|NCT04432259|Dexamethasone|dexamethasone|mesh-list
139482845|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139482846|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
139482847|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
139482848|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482849|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482850|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482851|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
139482852|NCT04432259|Hormones|hormones|mesh-ancestor
139482853|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139482854|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139482855|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482857|NCT04964219|Esketamine|esketamine|mesh-list
139482858|NCT04964219|Analgesics|analgesics|mesh-ancestor
139482859|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
139482860|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482861|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482862|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139482863|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139482864|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
139482865|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
139482866|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139482867|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139482868|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139482869|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482870|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482871|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
139482872|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139482873|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
139482874|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139482875|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
139482876|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482877|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
139482878|NCT04975373|Protective Agents|protective agents|mesh-ancestor
139482879|NCT04974827|Carboplatin|carboplatin|mesh-list
139482880|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482881|NCT04963595|Vinorelbine|vinorelbine|mesh-list
139482882|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139482883|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482884|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
139482885|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
139482886|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
139482887|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482888|NCT04962425|Trastuzumab|trastuzumab|mesh-list
139482889|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139482890|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482891|NCT03060707|Bromides|bromides|mesh-list
139482892|NCT03060707|Rocuronium|rocuronium|mesh-list
139482893|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
139482894|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139482895|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139482896|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139482897|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482898|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482899|NCT03060005|Dextrans|dextrans|mesh-list
139482900|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
139482901|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
139482902|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
139482903|NCT04210141|Antivenins|antivenins|mesh-list
139482904|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
139482905|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482906|NCT04418531|Antibodies|antibodies|mesh-list
139482907|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
139482908|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139482909|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
139482910|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482911|NCT02555293|Rifaximin|rifaximin|mesh-list
139482912|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139482913|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139482914|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482915|NCT05104255|Anesthetics|anesthetics|mesh-list
139482916|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139482917|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482918|NCT03293017|Diazepam|diazepam|mesh-list
139482919|NCT03293017|Baclofen|baclofen|mesh-list
139482920|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139482921|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482922|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139482923|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482924|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139482925|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
139482926|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
139482927|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482928|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482929|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139482930|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
139482931|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
139482932|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
139482933|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139482934|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139482935|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139482936|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139482937|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139482938|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139482939|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139482940|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
139482941|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
139482942|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
139482943|NCT03198559|Vorinostat|vorinostat|mesh-list
139482944|NCT03198559|Disulfiram|disulfiram|mesh-list
139482945|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482946|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139482947|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482948|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482949|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139482950|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139482951|NCT02625623|Paclitaxel|paclitaxel|mesh-list
139482952|NCT02625623|Irinotecan|irinotecan|mesh-list
139482953|NCT02625623|Avelumab|avelumab|mesh-list
139482954|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139482955|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139482956|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
139482957|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
139482958|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
139482959|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482960|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139482961|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139482962|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482963|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139482964|NCT02749513|Itraconazole|itraconazole|mesh-list
139482965|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
139482966|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139482967|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139482968|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139482969|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139482970|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482971|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139482972|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
139482973|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139482974|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482975|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139482976|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
139482977|NCT05110339|Ropivacaine|ropivacaine|mesh-list
139482978|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139482979|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139482980|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482981|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139482982|NCT05110339|Analgesics|analgesics|mesh-ancestor
139482983|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
139482984|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139482985|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139482986|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139482987|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139482988|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
139482989|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139482990|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139482991|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
139482992|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
139482993|NCT04965545|Copper|copper|mesh-list
139482994|NCT04965545|Trace Elements|trace elements|mesh-ancestor
139482995|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
139482996|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139482997|NCT05105347|Prednisone|prednisone|mesh-list
139482998|NCT05105347|Adalimumab|adalimumab|mesh-list
139482999|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139483000|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
139483001|NCT05105347|Hormones|hormones|mesh-ancestor
139483002|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483003|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483004|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139483005|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139269689|NCT05202821|Fluorides|fluorides|mesh-list
139483006|NCT05105347|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139483007|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139483008|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
139483009|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
139483010|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139483011|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139483012|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483013|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483014|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483015|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139483017|NCT03060785|Emtricitabine|emtricitabine|mesh-list
139483018|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
139483019|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483020|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139483021|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139483022|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483023|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483024|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139483025|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139483026|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
139483027|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
139483028|NCT04952207|Grazoprevir|grazoprevir|mesh-list
139483029|NCT04952207|Ledipasvir|ledipasvir|mesh-list
139483030|NCT04952207|Velpatasvir|velpatasvir|mesh-list
139483031|NCT04952207|Asunaprevir|asunaprevir|mesh-list
139483032|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483033|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
139483034|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483035|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483036|NCT04632589|Losartan|losartan|mesh-list
139483037|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139483038|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139483039|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139483040|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139483041|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483042|NCT05108545|Amphotericin B|amphotericin b|mesh-list
139483043|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139483044|NCT05108545|Amebicides|amebicides|mesh-ancestor
139483045|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139483046|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139483047|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483048|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139483049|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
139483050|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
139483051|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139483052|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139483053|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483054|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
139483055|NCT05102695|Coagulants|coagulants|mesh-ancestor
139483056|NCT05007769|Atezolizumab|atezolizumab|mesh-list
139483057|NCT05007769|Ramucirumab|ramucirumab|mesh-list
139483058|NCT05007769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139483059|NCT05007769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483060|NCT05007769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139483061|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483062|NCT04952051|Folic Acid|folic acid|mesh-list
139483063|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
139483064|NCT04952051|Amlodipine|amlodipine|mesh-list
139483065|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139483066|NCT04952051|Enalapril|enalapril|mesh-list
139483067|NCT04952051|Enalaprilat|enalaprilat|mesh-list
139483068|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139483069|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139483070|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139483071|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483072|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139483073|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483074|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
139483075|NCT04952051|Hematinics|hematinics|mesh-ancestor
139483076|NCT04952051|Vitamins|vitamins|mesh-ancestor
139483077|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
139483078|NCT04952051|Diuretics|diuretics|mesh-ancestor
139269757|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
139483079|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
139483080|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139483081|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139483082|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
139483083|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483084|NCT04960943|Trastuzumab|trastuzumab|mesh-list
139483085|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139483086|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483087|NCT04431713|Exenatide|exenatide|mesh-list
139483088|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139483089|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483090|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139483091|NCT04431713|Incretins|incretins|mesh-ancestor
139483092|NCT04431713|Hormones|hormones|mesh-ancestor
139483093|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483094|NCT05104333|Vaccines|vaccines|mesh-list
139483095|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
139483096|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483097|NCT03059615|Doxorubicin|doxorubicin|mesh-list
139483098|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139483099|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483100|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138983094|NCT00524589|Hormones|hormones|mesh-ancestor
139483101|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139483102|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483103|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483104|NCT04951505|Cefepime|cefepime|mesh-list
139483105|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139483106|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483107|NCT04951349|Petrolatum|petrolatum|mesh-list
139483108|NCT04951349|Emollients|emollients|mesh-ancestor
139483109|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
139483110|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
139483111|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139483112|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483113|NCT02658019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139483114|NCT02658019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483115|NCT03059303|Simeprevir|simeprevir|mesh-list
139483116|NCT03059303|Odalasvir|odalasvir|mesh-list
139483117|NCT03059303|Omeprazole|omeprazole|mesh-list
139483118|NCT03059303|Lansoprazole|lansoprazole|mesh-list
139483119|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
139483120|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139483121|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139483122|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139483123|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483124|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483125|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
139483126|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483127|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
139483128|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139483129|NCT03059537|Cathartics|cathartics|mesh-ancestor
139483130|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139483131|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
139483132|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
139483133|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
139483134|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483135|NCT04428775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139483136|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139483137|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139483138|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
139483139|NCT04950569|Simendan|simendan|mesh-list
139483140|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139483141|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
139483142|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139483143|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139483144|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483145|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483146|NCT04950569|Protective Agents|protective agents|mesh-ancestor
139483147|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483148|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
139483149|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
139483150|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
139483151|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483152|NCT04436419|Protective Agents|protective agents|mesh-ancestor
139009375|NCT04736953|Sirolimus|sirolimus|mesh-list
139483153|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139269830|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483154|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
139483155|NCT04436419|Vitamins|vitamins|mesh-ancestor
139483156|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
139483157|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
139483158|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483159|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
139483160|NCT01675765|Cisplatin|cisplatin|mesh-list
139483161|NCT01675765|Pemetrexed|pemetrexed|mesh-list
139483162|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
139483163|NCT01675765|Immunomodulating Agents|immunomodulating agents|mesh-list
139483164|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139483165|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483166|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139483167|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139483168|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
139483169|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483170|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483171|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139483172|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483173|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139483174|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139483175|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
139483176|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139483177|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483178|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139483179|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139483180|NCT04943237|Analgesics|analgesics|mesh-ancestor
139483181|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
139483182|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483183|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483184|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139483185|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139483186|NCT04285255|Lidocaine|lidocaine|mesh-list
139483187|NCT04285255|Fentanyl|fentanyl|mesh-list
139483188|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
139483189|NCT04285255|Ketamine|ketamine|mesh-list
139483190|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
139483191|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
139483192|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483193|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483194|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
139483195|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483196|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139483197|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139483198|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139483199|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139009445|NCT04468776|Trazodone|trazodone|mesh-list
138983164|NCT02478255|Xenon|xenon|mesh-list
139483200|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483201|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139483202|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139483203|NCT04285255|Analgesics|analgesics|mesh-ancestor
139483204|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139483205|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139483206|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139483207|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
139483208|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139483209|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139483210|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139483211|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
139483212|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139483213|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139483214|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139483215|NCT04285255|Narcotics|narcotics|mesh-ancestor
139483216|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139483217|NCT04121299|Amlodipine|amlodipine|mesh-list
139483218|NCT04121299|Carvedilol|carvedilol|mesh-list
139483219|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139483220|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139483221|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139483222|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483223|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139483224|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483225|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
139483226|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139483227|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139483228|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
139483229|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139483230|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
139483231|NCT04121299|Protective Agents|protective agents|mesh-ancestor
139483232|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139483233|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139483235|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
139483236|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483237|NCT04942769|Protective Agents|protective agents|mesh-ancestor
139483238|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483239|NCT04942769|Trace Elements|trace elements|mesh-ancestor
139483240|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
139483241|NCT04942301|Endostar protein|endostar protein|mesh-list
139483242|NCT04942301|Endostatins|endostatins|mesh-list
139483243|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139483244|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139483245|NCT04942301|Growth Substances|growth substances|mesh-ancestor
139483246|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483247|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
139483248|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483249|NCT03057899|Fenugreek seed meal|fenugreek seed meal|mesh-list
139483250|NCT03057899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139483251|NCT03057899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483252|NCT04434001|Thrombin|thrombin|mesh-list
139483253|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
139483254|NCT04434001|Coagulants|coagulants|mesh-ancestor
139483255|NCT03540901|Acetazolamide|acetazolamide|mesh-list
139483256|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
139483257|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139483258|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483259|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483260|NCT03540901|Diuretics|diuretics|mesh-ancestor
139483261|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
139483262|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483263|NCT03517735|Remifentanil|remifentanil|mesh-list
139483264|NCT03517735|Propofol|propofol|mesh-list
139483265|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139483266|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483267|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483268|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139483269|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
139483270|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
139483271|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139483272|NCT03517735|Narcotics|narcotics|mesh-ancestor
139483273|NCT03517735|Analgesics|analgesics|mesh-ancestor
139483274|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
139483275|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483276|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
139483277|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139483278|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
139483279|NCT04941131|Povidone|povidone|mesh-list
139483280|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139483281|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483282|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
139483283|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
139483284|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
139483285|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
139483286|NCT03400501|Insulin|insulin|mesh-list
139483287|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139483288|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
139483289|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139483290|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483291|NCT04940273|Remifentanil|remifentanil|mesh-list
139483292|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139483293|NCT04940273|Narcotics|narcotics|mesh-ancestor
139483294|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483295|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483296|NCT04940273|Analgesics|analgesics|mesh-ancestor
139483297|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
139483298|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483299|NCT04948385|Propofol|propofol|mesh-list
139483300|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139483301|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483302|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483303|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139483304|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
139483305|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
139483306|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139483307|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139483308|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483309|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
139270011|NCT03632759|Golimumab|golimumab|mesh-list
139483310|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
139483311|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139483312|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139483313|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483314|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483315|NCT04948151|Urological Agents|urological agents|mesh-ancestor
139483316|NCT02633293|Treprostinil|treprostinil|mesh-list
139483317|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139483318|NCT04938713|Ketamine|ketamine|mesh-list
139483319|NCT04938713|Esketamine|esketamine|mesh-list
139483320|NCT04938713|Analgesics|analgesics|mesh-ancestor
139483321|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
139483322|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483323|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483324|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139483325|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139483326|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
139483327|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
139483328|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483329|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139483330|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139483331|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139483332|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483333|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
139483334|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139483335|NCT04938011|Progesterone|progesterone|mesh-list
139483336|NCT04938011|Progestins|progestins|mesh-ancestor
139483337|NCT04938011|Hormones|hormones|mesh-ancestor
139483338|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483339|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483340|NCT03057509|Octreotide|octreotide|mesh-list
139483341|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139483342|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139483343|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483344|NCT03572413|Bromides|bromides|mesh-list
139483345|NCT03572413|Rocuronium|rocuronium|mesh-list
139483346|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
139483347|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139483348|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139483349|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139483350|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483351|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483352|NCT04956419|Fluconazole|fluconazole|mesh-list
139483353|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
139483354|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483355|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139483356|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139483357|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483358|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483359|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139483360|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
139483361|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483362|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483363|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139483364|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139483365|NCT04946669|Abatacept|abatacept|mesh-list
139483366|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139483367|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483368|NCT04946669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139483369|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483370|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139483371|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
139483372|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483373|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139483374|NCT03219775|Nivolumab|nivolumab|mesh-list
139483375|NCT03219775|Ipilimumab|ipilimumab|mesh-list
139483376|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139483377|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483378|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139483379|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483380|NCT03100045|Artesunate|artesunate|mesh-list
139483381|NCT03100045|Artemisinins|artemisinins|mesh-list
139483382|NCT03100045|Artemisinin|artemisinin|mesh-list
139483383|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
139483384|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139270065|NCT02281058|Abatacept|abatacept|mesh-list
139483386|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483387|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483388|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
139483389|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
139483390|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139483391|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
139483392|NCT04946123|Selenium|selenium|mesh-list
139483393|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
139009664|NCT03735563|Narcotics|narcotics|mesh-ancestor
139483394|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483395|NCT04946123|Protective Agents|protective agents|mesh-ancestor
139483396|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483397|NCT04946123|Trace Elements|trace elements|mesh-ancestor
139483398|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
139483399|NCT04945577|Vitamin D|vitamin d|mesh-list
139483400|NCT04945577|Vitamins|vitamins|mesh-ancestor
139483401|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
139483402|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483403|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139483404|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
139483405|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139483406|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139483407|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139483408|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483409|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
139483410|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139483411|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483412|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139483413|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483414|NCT02655679|Ether|ether|mesh-list
139483415|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139483416|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
139483417|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
139483418|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483419|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483420|NCT04936295|Fulvestrant|fulvestrant|mesh-list
139483421|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139483422|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483423|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139483424|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139483425|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
139483426|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483427|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483428|NCT05114239|Timolol|timolol|mesh-list
139483429|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139483430|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139483431|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139483432|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139483433|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
139483434|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139483435|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483436|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483437|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139483438|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139483439|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139483440|NCT04418999|Dexamethasone|dexamethasone|mesh-list
139483441|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139483442|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
139483443|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
139483444|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483445|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483446|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139483447|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
139483448|NCT04418999|Hormones|hormones|mesh-ancestor
139483449|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483450|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139483451|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483452|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139483453|NCT05113459|Disitamab vedotin|disitamab vedotin|mesh-list
139483454|NCT05113459|Immunoconjugates|immunoconjugates|mesh-ancestor
139483455|NCT05113459|Immunologic Factors|immunologic factors|mesh-ancestor
139483456|NCT05113459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483457|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139483458|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483459|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139483460|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139483461|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139483462|NCT04935515|Anticoagulants|anticoagulants|mesh-list
139483463|NCT04935515|Coagulants|coagulants|mesh-list
139483464|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
139483465|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139483466|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483467|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
139483468|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
139483469|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009740|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
139483470|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483471|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483472|NCT04376281|Norepinephrine|norepinephrine|mesh-list
139483473|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139483474|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139483475|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
139483476|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139483477|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483478|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483479|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
139483480|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
139483481|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483482|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139483483|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
139483484|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139483485|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
139483486|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483487|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
139483488|NCT04332445|Protective Agents|protective agents|mesh-ancestor
139483489|NCT03890887|Itraconazole|itraconazole|mesh-list
139483490|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
139483491|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483492|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139483493|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139483494|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483495|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483496|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139483497|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
139483498|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483499|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483500|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139483501|NCT05015335|Adalimumab|adalimumab|mesh-list
139483502|NCT05015335|Methotrexate|methotrexate|mesh-list
139483503|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139483504|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
139483505|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139483506|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483507|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139483508|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
139483509|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483510|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483511|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
139483512|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483513|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139483514|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139483515|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
139483516|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139483517|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139483518|NCT05015335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139483519|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139009784|NCT03039413|Copper|copper|mesh-list
139483520|NCT03056261|Anesthetics|anesthetics|mesh-list
139483521|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483522|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483523|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
139483524|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139483525|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483526|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
139483527|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483528|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139483529|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139483530|NCT04574479|Morphine|morphine|mesh-list
139483531|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139483532|NCT04574479|Narcotics|narcotics|mesh-ancestor
139483533|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483534|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483535|NCT04574479|Analgesics|analgesics|mesh-ancestor
139483536|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
139483537|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483538|NCT02195947|Hormones|hormones|mesh-list
139483539|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483540|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483541|NCT01698307|Adalimumab|adalimumab|mesh-list
139483542|NCT01698307|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139483543|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139483544|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139483545|NCT04954339|Bevacizumab|bevacizumab|mesh-list
139483546|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139483547|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483548|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139483549|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139483550|NCT04954339|Growth Substances|growth substances|mesh-ancestor
139483551|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483552|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
139483553|NCT01966263|Epinephrine|epinephrine|mesh-list
139483554|NCT01966263|Racepinephrine|racepinephrine|mesh-list
139483555|NCT01966263|Ropivacaine|ropivacaine|mesh-list
139483556|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
139483557|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
139483558|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
139483559|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483560|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483561|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
139009848|NCT02735707|Cysteamine|cysteamine|mesh-list
139483562|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483563|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139483564|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139483565|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
139483566|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139483567|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483568|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139483569|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139483570|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
139483571|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139483572|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
139483573|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
139483574|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
139483575|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139483576|NCT04400201|Propofol|propofol|mesh-list
139009857|NCT02735707|Hormones|hormones|mesh-ancestor
139009870|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139483577|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139483578|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483579|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483580|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139483581|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
139483582|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
139483583|NCT04423107|Acetaminophen|acetaminophen|mesh-list
139483584|NCT04423107|Ibuprofen|ibuprofen|mesh-list
139483585|NCT04423107|Oxycodone|oxycodone|mesh-list
139483586|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139483587|NCT04423107|Analgesics|analgesics|mesh-ancestor
139483588|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
139483589|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983730|NCT04989348|Progestins|progestins|mesh-list
139483590|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483591|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
139483592|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139483593|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139483594|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139483595|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139483596|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483597|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483598|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139483599|NCT04423107|Narcotics|narcotics|mesh-ancestor
139483600|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483601|NCT01675531|Oxycodone|oxycodone|mesh-list
139483602|NCT01675531|Naloxone|naloxone|mesh-list
139483603|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139483604|NCT01675531|Narcotics|narcotics|mesh-ancestor
139483605|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483606|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483607|NCT01675531|Analgesics|analgesics|mesh-ancestor
139483608|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
139483609|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483610|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139483611|NCT05406999|Prednisolone|prednisolone|mesh-list
139483612|NCT05406999|Abiraterone Acetate|abiraterone acetate|mesh-list
139483613|NCT05406999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139483614|NCT05406999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139483615|NCT05406999|Glucocorticoids|glucocorticoids|mesh-ancestor
139483616|NCT05406999|Hormones|hormones|mesh-ancestor
139483617|NCT05406999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483618|NCT05406999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483619|NCT05406999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139483620|NCT05406999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483621|NCT05406999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139483622|NCT05406999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483623|NCT05406999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483624|NCT05406999|Hormone Antagonists|hormone antagonists|mesh-ancestor
139483625|NCT05406999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139483626|NCT04930211|Dexamethasone|dexamethasone|mesh-list
139483627|NCT04930211|Lidocaine|lidocaine|mesh-list
139483628|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139483629|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
139483630|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
139483631|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483632|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483633|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139483634|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
139483635|NCT04930211|Hormones|hormones|mesh-ancestor
139483636|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483637|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139483638|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483639|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
139483640|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
139483641|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483642|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
139483643|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139483644|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139009918|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
139483645|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139483646|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139483647|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483648|NCT04912271|Dexamethasone|dexamethasone|mesh-list
139483649|NCT04912271|Aprepitant|aprepitant|mesh-list
139483650|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
139483651|NCT04912271|Palonosetron|palonosetron|mesh-list
139483652|NCT04912271|Granisetron|granisetron|mesh-list
139483653|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139483654|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
139483655|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
139483656|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483657|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483658|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139483659|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
139483660|NCT04912271|Hormones|hormones|mesh-ancestor
139483661|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483662|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139483663|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483664|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139483665|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139483666|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483667|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139483668|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139483669|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
139483670|NCT02807779|Dexamethasone|dexamethasone|mesh-list
139483671|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139483672|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
139483673|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
139483674|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483675|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483676|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139483677|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
139483678|NCT02807779|Hormones|hormones|mesh-ancestor
139483679|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483680|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139483681|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483682|NCT04912193|Antithrombins|antithrombins|mesh-list
139483683|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
139483684|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139483685|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
139483686|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483687|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483688|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
139483689|NCT02680561|Fluticasone|fluticasone|mesh-list
139483690|NCT02680561|Xhance|xhance|mesh-list
139483691|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139483692|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139483693|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139483694|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139483695|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
139483696|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483697|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483698|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139483699|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
139483700|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
139483701|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139483702|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139483703|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139483704|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139483705|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
139483706|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139483707|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483708|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
139483709|NCT02680561|Hormones|hormones|mesh-ancestor
139483710|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483711|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
139483712|NCT05025163|Fluorides|fluorides|mesh-list
139483713|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
139483714|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
139483715|NCT05025163|Protective Agents|protective agents|mesh-ancestor
139483716|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483717|NCT02592031|Goserelin|goserelin|mesh-list
139483718|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139483719|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483720|NCT04784299|Lidocaine|lidocaine|mesh-list
139483721|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
139483722|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
139483723|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483724|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483725|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
139483726|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483727|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139483728|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139483729|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139483730|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139483731|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483732|NCT02333149|Melatonin|melatonin|mesh-list
139483733|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
139483734|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483735|NCT02333149|Protective Agents|protective agents|mesh-ancestor
139483736|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483737|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483738|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
139483739|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139483740|NCT03807817|Ethanol|ethanol|mesh-list
139483741|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139483742|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483743|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483744|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483745|NCT05122117|Methylene Blue|methylene blue|mesh-list
139483746|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483747|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483748|NCT05116345|Dexamethasone|dexamethasone|mesh-list
139483749|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
139483750|NCT05116345|BB 1101|bb 1101|mesh-list
139483751|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139483752|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
139483753|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
139483754|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483755|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483756|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139483757|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
139483758|NCT05116345|Hormones|hormones|mesh-ancestor
139483759|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483760|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139483761|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483762|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
139483763|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483764|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483765|NCT05076097|Rituximab|rituximab|mesh-list
139483766|NCT05076097|Lenalidomide|lenalidomide|mesh-list
139483767|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139483768|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483769|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
139483770|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483771|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139483772|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139483773|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139483774|NCT05076097|Growth Substances|growth substances|mesh-ancestor
139483775|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
139483776|NCT04513639|Dexamethasone|dexamethasone|mesh-list
139483777|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
139483778|NCT04513639|Daratumumab|daratumumab|mesh-list
139483779|NCT04513639|BB 1101|bb 1101|mesh-list
139483780|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139483781|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139483782|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
139483783|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
139483784|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483785|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483786|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139483787|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
139483788|NCT04513639|Hormones|hormones|mesh-ancestor
139010067|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
139483789|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139483790|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139483791|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483792|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
139483793|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483794|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483795|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
139483796|NCT05229913|Esketamine|esketamine|mesh-list
139483797|NCT05229913|Antidepressive Agents|antidepressive agents|mesh-ancestor
139483798|NCT05229913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139483799|NCT05108155|Tacrine|tacrine|mesh-list
139483800|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139483801|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483802|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483803|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
139483804|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139483805|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483806|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139483807|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
139483808|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483809|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
139483810|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139483811|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
139483812|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139483813|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139483814|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139483815|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483816|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483817|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139483818|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139483819|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139483820|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
139483821|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139483822|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483823|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139483824|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139483825|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
139483826|NCT05228743|Paclitaxel|paclitaxel|mesh-list
139483827|NCT05228743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139483828|NCT05228743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483829|NCT05228743|Tubulin Modulators|tubulin modulators|mesh-ancestor
139483830|NCT05228743|Antimitotic Agents|antimitotic agents|mesh-ancestor
139483831|NCT05228743|Mitosis Modulators|mitosis modulators|mesh-ancestor
139483832|NCT05228743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483833|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
139483834|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139483835|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483836|NCT04990921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139483837|NCT04990921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483838|NCT04507477|Rituximab|rituximab|mesh-list
139483839|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139483840|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010103|NCT00357994|Levodopa|levodopa|mesh-list
139483841|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
139483842|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483843|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139483844|NCT01675141|Lenalidomide|lenalidomide|mesh-list
139483845|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
139483846|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483847|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139483848|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139483849|NCT01675141|Growth Substances|growth substances|mesh-ancestor
139483850|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
139483851|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483852|NCT05102149|Vildagliptin|vildagliptin|mesh-list
139483853|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139483854|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483855|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139483856|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
139483857|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483858|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483859|NCT04412395|Lactoferrin|lactoferrin|mesh-list
139483860|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483861|NCT04987099|Choline|choline|mesh-list
139483862|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
139483863|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139483864|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
139483865|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483866|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139483867|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139483868|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
139483869|NCT03906721|Oxycodone|oxycodone|mesh-list
139010144|NCT02550119|Dexamethasone|dexamethasone|mesh-list
139483870|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139483871|NCT03906721|Narcotics|narcotics|mesh-ancestor
139483872|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483873|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483874|NCT03906721|Analgesics|analgesics|mesh-ancestor
139483875|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
139483876|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483877|NCT04663711|Anesthetics|anesthetics|mesh-list
139483878|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483879|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483880|NCT04529863|Abatacept|abatacept|mesh-list
139483881|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139483882|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483883|NCT04529863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139483884|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483885|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139483886|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
139483887|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483888|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139483889|NCT04582591|Cannabidiol|cannabidiol|mesh-list
139483890|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
139483891|NCT04497883|Maribavir|maribavir|mesh-list
139483892|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
139483893|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139483894|NCT03688633|Candesartan|candesartan|mesh-list
139483895|NCT03688633|Candesartan cilexetil|candesartan cilexetil|mesh-list
139483896|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139483897|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139483898|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139483899|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483900|NCT03963895|Thrombin|thrombin|mesh-list
139483901|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
139483902|NCT03963895|Coagulants|coagulants|mesh-ancestor
139483903|NCT03662815|Molgramostim|molgramostim|mesh-list
139483904|NCT03662815|Sargramostim|sargramostim|mesh-list
139483905|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
139483906|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483907|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483908|NCT03490903|Midazolam|midazolam|mesh-list
139483909|NCT03490903|Fentanyl|fentanyl|mesh-list
139483910|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139483911|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139483912|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139483913|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483914|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139483915|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139483916|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139483917|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139483918|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
139483919|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
139483920|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
139483921|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
139483922|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010201|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483923|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483924|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139483925|NCT03490903|Narcotics|narcotics|mesh-ancestor
139483926|NCT03490903|Analgesics|analgesics|mesh-ancestor
139483927|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
139483928|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139483929|NCT03954613|Memantine|memantine|mesh-list
139483930|NCT03954613|Donepezil|donepezil|mesh-list
139483931|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139483932|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483933|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483934|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
139483935|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139483936|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483937|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
139483938|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139483939|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139483940|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
139483941|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139483942|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139483943|NCT03367819|Cemiplimab|cemiplimab|mesh-list
139483944|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139483945|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483946|NCT04875871|Copper|copper|mesh-list
139483947|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139483948|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139483949|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483950|NCT04875871|Trace Elements|trace elements|mesh-ancestor
139483951|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
139483952|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483953|NCT04781725|Cisplatin|cisplatin|mesh-list
139483954|NCT04781725|Vinblastine|vinblastine|mesh-list
139483955|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483956|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139483957|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
139483958|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
139483959|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
139010224|NCT00622739|Ziprasidone|ziprasidone|mesh-list
139483960|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483961|NCT03554707|Bevacizumab|bevacizumab|mesh-list
139483962|NCT03554707|Irinotecan|irinotecan|mesh-list
139483963|NCT03554707|Temozolomide|temozolomide|mesh-list
139483964|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139483965|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139483966|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139483967|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139483968|NCT03554707|Growth Substances|growth substances|mesh-ancestor
139483969|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139483970|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
139483971|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139483972|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139483973|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483974|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483975|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139483976|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
139483977|NCT04264663|Furazolidone|furazolidone|mesh-list
139483978|NCT04264663|Tinidazole|tinidazole|mesh-list
139483979|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139483980|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010262|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139483981|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139483982|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139483983|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139483984|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139483985|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139483986|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139483987|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139483988|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
139483989|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139483990|NCT04563559|Prednisolone|prednisolone|mesh-list
139483991|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139483992|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
139483993|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139483994|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
139483995|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139483996|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
139483997|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139483998|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
139483999|NCT04563559|Hormones|hormones|mesh-ancestor
139484000|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139484001|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484002|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139484003|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484004|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
139484005|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
139484006|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484007|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484008|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139484009|NCT04563559|Protective Agents|protective agents|mesh-ancestor
139484010|NCT02124187|Nicotine|nicotine|mesh-list
139484011|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139484012|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
139484013|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484014|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484015|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139484016|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139484017|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
139484018|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484019|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484020|NCT02002819|Levetiracetam|levetiracetam|mesh-list
139484021|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
139484022|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
139484023|NCT01597193|Fulvestrant|fulvestrant|mesh-list
139484024|NCT01597193|Anastrozole|anastrozole|mesh-list
139484025|NCT01597193|Exemestane|exemestane|mesh-list
139484026|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139484027|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484028|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139484029|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139484030|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
139484031|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139484032|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484033|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139010334|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
139484034|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139484035|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484036|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484037|NCT04930133|Afatinib|afatinib|mesh-list
139484038|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484039|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139484040|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484041|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484042|NCT03057041|Fentanyl|fentanyl|mesh-list
139484043|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139484044|NCT03057041|Narcotics|narcotics|mesh-ancestor
139484045|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139484046|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484047|NCT03057041|Analgesics|analgesics|mesh-ancestor
139484048|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
139484049|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484050|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139484051|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139484052|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
139484053|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
139484054|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139484055|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484056|NCT05123287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139484057|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484058|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
139484059|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139484060|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139484061|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484062|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
139484064|NCT02622113|Canagliflozin|canagliflozin|mesh-list
139484065|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139484066|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484067|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139484068|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484069|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
139484070|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139484071|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139484072|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484073|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
139484074|NCT04430777|Coagulants|coagulants|mesh-ancestor
139484075|NCT04910477|Atropine|atropine|mesh-list
139484076|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
139484077|NCT04910477|Neostigmine|neostigmine|mesh-list
139484078|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139484079|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139484080|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484081|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139484082|NCT04910477|Analgesics|analgesics|mesh-ancestor
139484083|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
139484084|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484085|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139484086|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139484087|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139484088|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
139484089|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484090|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484091|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139484092|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139484093|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139484094|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
139484095|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139484096|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
139484097|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
139484098|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
139484099|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139484100|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139484101|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
139484102|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139484103|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484104|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139484105|NCT03843151|Itraconazole|itraconazole|mesh-list
139484106|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
139484107|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484108|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139484109|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139484110|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484111|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484112|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139484113|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
139484114|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139010407|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139010408|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
139010409|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
139484115|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484116|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139484117|NCT04929509|Listerine|listerine|mesh-list
139484118|NCT04929509|Fluorides|fluorides|mesh-list
139484119|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
139484120|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
139484121|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
139484122|NCT04929509|Protective Agents|protective agents|mesh-ancestor
139484123|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484124|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139484125|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484126|NCT03054467|Amlodipine|amlodipine|mesh-list
139484127|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139484128|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139484129|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139484130|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484131|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139484132|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484133|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
139484134|NCT04910165|Ropivacaine|ropivacaine|mesh-list
139484135|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
139484136|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
139484137|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139484138|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484139|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
139484140|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484142|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139484143|NCT02730325|Antibodies|antibodies|mesh-list
139484144|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
139484145|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484146|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
139484147|NCT04928495|Bromhexine|bromhexine|mesh-list
139484148|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139484149|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484150|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
139484151|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484152|NCT04928495|Protective Agents|protective agents|mesh-ancestor
139484153|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
139484154|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484155|NCT04928495|Expectorants|expectorants|mesh-ancestor
139484156|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
139484157|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139484158|NCT04928495|Antidotes|antidotes|mesh-ancestor
139484159|NCT01573429|Bisphenol A|bisphenol a|mesh-list
139484160|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139484161|NCT01573429|Estrogens|estrogens|mesh-ancestor
139484162|NCT01573429|Hormones|hormones|mesh-ancestor
139484163|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139484164|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484165|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139484166|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
139484167|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484168|NCT01573429|Protective Agents|protective agents|mesh-ancestor
139484169|NCT04909931|Vitamin D|vitamin d|mesh-list
139484170|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
139484171|NCT04909931|Vitamins|vitamins|mesh-ancestor
139484172|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
139484173|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484174|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139484175|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139484176|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
139484177|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139484178|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139484179|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484180|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
139484181|NCT04918589|Coagulants|coagulants|mesh-ancestor
139484182|NCT04101643|Evolocumab|evolocumab|mesh-list
139484183|NCT04101643|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139484184|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139484185|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139484186|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
139484187|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484188|NCT04101643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139484189|NCT04101643|Protease Inhibitors|protease inhibitors|mesh-ancestor
139484190|NCT04101643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484191|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139484192|NCT02620787|Tedizolid|tedizolid|mesh-list
139484193|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139484194|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484195|NCT04909619|Anesthetics|anesthetics|mesh-list
139484196|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
139484197|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139484198|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484199|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
139484200|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484201|NCT03520231|Vitamin D|vitamin d|mesh-list
139484202|NCT03520231|Denosumab|denosumab|mesh-list
139484203|NCT03520231|Carboplatin|carboplatin|mesh-list
139484204|NCT03520231|Gemcitabine|gemcitabine|mesh-list
139484205|NCT03520231|Calcium|calcium|mesh-list
139484206|NCT03520231|Vitamins|vitamins|mesh-ancestor
139484207|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
139484208|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484209|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484210|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139484211|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
139484212|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484213|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139484214|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139484215|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
139484216|NCT04927481|Analgesics|analgesics|mesh-ancestor
139484217|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
139484218|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484219|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484220|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484221|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139484222|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139484223|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484224|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484225|NCT03056495|Vorinostat|vorinostat|mesh-list
139484226|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484227|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139484228|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484229|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484230|NCT03171805|Propranolol|propranolol|mesh-list
139484231|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139484232|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139484233|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
139484234|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484235|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484236|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484237|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139484238|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139484239|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
139484240|NCT04918433|Anesthetics|anesthetics|mesh-list
139484241|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139484242|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484243|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139484244|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139484245|NCT03053219|Abivertinib|abivertinib|mesh-list
139484246|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139484247|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484248|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484249|NCT03055793|Budesonide|budesonide|mesh-list
139484250|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
139484251|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139484252|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139484253|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
139484254|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484255|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484256|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139484257|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
139484258|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
139484259|NCT03055793|Hormones|hormones|mesh-ancestor
139484260|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139484261|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139484262|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139484263|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139484264|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
139484265|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484266|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484267|NCT04926155|Metformin|metformin|mesh-list
139484268|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139484269|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484270|NCT04909775|Gemcitabine|gemcitabine|mesh-list
139484271|NCT04909775|Tislelizumab|tislelizumab|mesh-list
139484272|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484273|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139484274|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
139484275|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484276|NCT04909775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139484277|NCT04925141|Dasatinib|dasatinib|mesh-list
139484278|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484279|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139484280|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484281|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484282|NCT02651155|Lubiprostone|lubiprostone|mesh-list
139484283|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139484284|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139484285|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484286|NCT04925063|Metformin|metformin|mesh-list
139484287|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138761225|NCT04297839|Heparin|heparin|mesh-list
139484288|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484289|NCT04909151|Methamphetamine|methamphetamine|mesh-list
139484290|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139484291|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484292|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
139484293|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
139484294|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484295|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
139484296|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484297|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484298|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
139484299|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139484300|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139484301|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139484302|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139484303|NCT05132413|Bevacizumab|bevacizumab|mesh-list
139484304|NCT05132413|Cisplatin|cisplatin|mesh-list
139484305|NCT05132413|Carboplatin|carboplatin|mesh-list
139484306|NCT05132413|Pemetrexed|pemetrexed|mesh-list
139484307|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139484308|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484309|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139484310|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139484311|NCT05132413|Growth Substances|growth substances|mesh-ancestor
139484312|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484313|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
139484314|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484315|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484316|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139484317|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139484318|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139484319|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
139484320|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139484321|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139484322|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139484323|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139484324|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139484325|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484326|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
139484327|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484328|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484329|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139484330|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484331|NCT04917497|Simendan|simendan|mesh-list
139484332|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139484333|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
139484334|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139484335|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139484336|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484337|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484338|NCT04917497|Protective Agents|protective agents|mesh-ancestor
139484339|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484340|NCT03933007|Fexofenadine|fexofenadine|mesh-list
139484341|NCT03933007|Colchicine|colchicine|mesh-list
139484342|NCT03933007|Midazolam|midazolam|mesh-list
139484343|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139484344|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139484345|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139484346|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484347|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139484348|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139484349|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139484350|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139484351|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
139484352|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
139484353|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
139484354|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
139484355|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484356|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484357|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
139484358|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139484359|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
139484360|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
139271030|NCT02090244|Teriparatide|teriparatide|mesh-list
139484362|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484363|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139484364|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139484365|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139484366|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
139484367|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
139484368|NCT04907747|Amoxicillin|amoxicillin|mesh-list
139484369|NCT04907747|Furazolidone|furazolidone|mesh-list
139484370|NCT04907747|Esomeprazole|esomeprazole|mesh-list
139484371|NCT04907747|Bismuth|bismuth|mesh-list
139484372|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139484373|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484374|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139484375|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484376|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139484377|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484378|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484379|NCT04907747|Antacids|antacids|mesh-ancestor
139484380|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139484381|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139484382|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139484383|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139484384|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139484385|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139484386|NCT03052673|Fentanyl|fentanyl|mesh-list
139484387|NCT03052673|Ketamine|ketamine|mesh-list
139484388|NCT03052673|Analgesics|analgesics|mesh-ancestor
139484389|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
139484390|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484391|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484392|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139484393|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139484394|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
139484395|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
139484396|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139484397|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139484398|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139484399|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484400|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484401|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139484402|NCT03052673|Narcotics|narcotics|mesh-ancestor
139484403|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139484404|NCT04907123|Diuretics|diuretics|mesh-list
139484405|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
139484406|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484407|NCT05030857|Midazolam|midazolam|mesh-list
139484408|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139484409|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139484410|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139484411|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484412|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139484413|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139484414|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139484415|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139484416|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
139484417|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
139484418|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
139484419|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
139484420|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484421|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484422|NCT03319459|Trastuzumab|trastuzumab|mesh-list
139484423|NCT03319459|Cetuximab|cetuximab|mesh-list
139484424|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139484425|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484426|NCT04430933|Paclitaxel|paclitaxel|mesh-list
139484427|NCT04430933|Docetaxel|docetaxel|mesh-list
139484428|NCT04430933|Carboplatin|carboplatin|mesh-list
139484429|NCT04430933|Pemetrexed|pemetrexed|mesh-list
139484430|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139484431|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484432|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
139484433|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
139484434|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
139484435|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484436|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484437|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139484438|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139484439|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
139484440|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139484441|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139484442|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139484443|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
139484444|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484445|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484446|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484447|NCT03055091|Sorbitol|sorbitol|mesh-list
139484448|NCT03055091|Cathartics|cathartics|mesh-ancestor
139484449|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484450|NCT02648581|Ustekinumab|ustekinumab|mesh-list
139484451|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
139484452|NCT02609815|Metformin|metformin|mesh-list
139484453|NCT02609815|Glimepiride|glimepiride|mesh-list
139484454|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139484455|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484456|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139484457|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139484458|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
139484459|NCT05132023|Metformin|metformin|mesh-list
139484460|NCT05132023|Empagliflozin|empagliflozin|mesh-list
139484461|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139484462|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484463|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139484464|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484465|NCT05131711|Immunomodulating Agents|immunomodulating agents|mesh-list
139484466|NCT05131711|Immunologic Factors|immunologic factors|mesh-ancestor
139484467|NCT05131711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484468|NCT02619617|Pasireotide|pasireotide|mesh-list
139484469|NCT02619617|Hormones|hormones|mesh-ancestor
139484470|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139484471|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484472|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
139484473|NCT04012957|Hematinics|hematinics|mesh-ancestor
139484474|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
139010770|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
139484475|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139484476|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139484477|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484478|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
139484479|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139484480|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
139484481|NCT05125627|Progesterone|progesterone|mesh-list
139484482|NCT05125627|Progestins|progestins|mesh-ancestor
139484483|NCT05125627|Hormones|hormones|mesh-ancestor
139484484|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139484485|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484486|NCT05125549|Clopidogrel|clopidogrel|mesh-list
139484487|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139484488|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139484489|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139484490|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139484491|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
139484492|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484493|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484494|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484495|NCT04903847|Tenofovir|tenofovir|mesh-list
139484496|NCT04903847|Lamivudine|lamivudine|mesh-list
139484497|NCT04903847|Dolutegravir|dolutegravir|mesh-list
139484498|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
139484499|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484500|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139484501|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139484502|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484503|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484504|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139484505|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139484506|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139484507|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139484508|NCT04905953|Neostigmine|neostigmine|mesh-list
139484509|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139484510|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484511|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484512|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
139484513|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484514|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484515|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139484516|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
139484517|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484518|NCT04916093|Metformin|metformin|mesh-list
139484519|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139484520|NCT04916093|Vildagliptin|vildagliptin|mesh-list
139484521|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139484522|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484523|NCT04916093|Incretins|incretins|mesh-ancestor
139484524|NCT04916093|Hormones|hormones|mesh-ancestor
139484525|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139484526|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139484527|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
139484528|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484529|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484530|NCT03512119|Ivacaftor|ivacaftor|mesh-list
139484531|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139484532|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139484533|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484534|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
139484535|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139484536|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484537|NCT02642809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139484538|NCT02642809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484539|NCT03052361|Ondansetron|ondansetron|mesh-list
139484540|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
139484541|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
139484542|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484543|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484544|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484545|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
139484546|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
139484547|NCT03052361|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139484548|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139484549|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
139484550|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484551|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484552|NCT02370589|Vaccines|vaccines|mesh-list
139484553|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
139484554|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484555|NCT04949113|Nivolumab|nivolumab|mesh-list
139484556|NCT04949113|Ipilimumab|ipilimumab|mesh-list
139484557|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139484558|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484559|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139484560|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484561|NCT05057845|Lenvatinib|lenvatinib|mesh-list
139484562|NCT05057845|Tislelizumab|tislelizumab|mesh-list
139484563|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484564|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139484565|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484566|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484567|NCT05057845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139484568|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
139484569|NCT05109949|Empagliflozin|empagliflozin|mesh-list
139484570|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139484571|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484572|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139484573|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484574|NCT04901663|Amoxicillin|amoxicillin|mesh-list
139484575|NCT04901663|Clarithromycin|clarithromycin|mesh-list
139484576|NCT04901663|Omeprazole|omeprazole|mesh-list
139484577|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139484578|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484579|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139484580|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484581|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139484582|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484583|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484584|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139484585|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139484586|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139271249|NCT00529178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484587|NCT05134519|Trastuzumab|trastuzumab|mesh-list
139484588|NCT05134519|Antibodies|antibodies|mesh-list
139484589|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139484590|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
139484591|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484592|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139484593|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484594|NCT04394663|Omeprazole|omeprazole|mesh-list
139484595|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139484596|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484597|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139484598|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484599|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484600|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139484601|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139484602|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010887|NCT05416476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139484603|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
139484604|NCT04901117|Amoxicillin|amoxicillin|mesh-list
139484605|NCT04901117|Metronidazole|metronidazole|mesh-list
139484606|NCT04901117|Clarithromycin|clarithromycin|mesh-list
139484607|NCT04901117|Tetracycline|tetracycline|mesh-list
139484608|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
139484609|NCT04901117|Bismuth|bismuth|mesh-list
139484610|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484611|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139484612|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484613|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139484614|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139484615|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139484616|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484617|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139484618|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139484619|NCT04901117|Antacids|antacids|mesh-ancestor
139484620|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484621|NCT04901117|Diuretics|diuretics|mesh-ancestor
139484622|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
139484623|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484624|NCT04901117|Expectorants|expectorants|mesh-ancestor
139484625|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
139484626|NCT05121571|Sorafenib|sorafenib|mesh-list
139484627|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484628|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139484629|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484630|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484631|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
139484632|NCT03051269|Calcium|calcium|mesh-list
139484633|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139484634|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484635|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139484636|NCT04576663|Phenylephrine|phenylephrine|mesh-list
139484637|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
139484638|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139484639|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
139484640|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
139484641|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484642|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484643|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
139484644|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139484645|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
139484646|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
139484647|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139484648|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139484649|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139484650|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
139484651|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484652|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484653|NCT04576663|Protective Agents|protective agents|mesh-ancestor
139484654|NCT05281549|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139484655|NCT05281549|Tenecteplase|tenecteplase|mesh-list
139484656|NCT05281549|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139484657|NCT05281549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139484658|NCT05281549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484659|NCT05191225|Rituximab|rituximab|mesh-list
139484660|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139484661|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484662|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
139271326|NCT00117650|Etoposide|etoposide|mesh-list
139484663|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484664|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139484665|NCT03909217|Dexetimide|dexetimide|mesh-list
139484666|NCT03909217|Citalopram|citalopram|mesh-list
139484667|NCT03909217|Escitalopram|escitalopram|mesh-list
139484668|NCT03909217|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139484669|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139484670|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139484671|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484672|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484673|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
139484674|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484675|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139484676|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139484677|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
139484678|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
139484679|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484680|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139484681|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139484682|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
139484683|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139484684|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
139484685|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139484686|NCT02650921|Lidocaine|lidocaine|mesh-list
139484687|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
139484688|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
139484689|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139484690|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484691|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
139484692|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484693|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139484694|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139484695|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139484696|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139484697|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484698|NCT04913987|Cimetidine|cimetidine|mesh-list
139484699|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139484700|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484701|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139484702|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
139484703|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
139484704|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484705|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484706|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484707|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139484708|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139484709|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484710|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
139484711|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139484712|NCT01596335|Antibodies|antibodies|mesh-list
139484713|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
139484714|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484715|NCT04891679|Misoprostol|misoprostol|mesh-list
139484716|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139484717|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
139484718|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139484719|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484720|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139484721|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484722|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
139484723|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
139484724|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139484725|NCT04913831|Protective Agents|protective agents|mesh-ancestor
139484726|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484727|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
139484728|NCT04900415|Vitamin A|vitamin a|mesh-list
139484729|NCT04900415|Vitamins|vitamins|mesh-ancestor
139484730|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
139484731|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484732|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
139484733|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139484734|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484735|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139484736|NCT04891211|Vitamin D|vitamin d|mesh-list
139484737|NCT04891211|Vitamins|vitamins|mesh-ancestor
139271400|NCT02099604|Vitamin D|vitamin d|mesh-list
139484738|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
139484739|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484740|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139484741|NCT03050957|Menthol|menthol|mesh-list
139484742|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
139484743|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
139484744|NCT04885049|Racecadotril|racecadotril|mesh-list
139484745|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
139011028|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484746|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484747|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
139484748|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484749|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484750|NCT04430621|Hormones|hormones|mesh-list
139484751|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139484752|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139484753|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484754|NCT04884503|Clonazepam|clonazepam|mesh-list
139484755|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
139484756|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
139484757|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
139484758|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484759|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484760|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484761|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
139484762|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484763|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139484764|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484765|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484766|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
139484767|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139484768|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484769|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139484770|NCT04898699|Tenofovir|tenofovir|mesh-list
139484771|NCT04898699|Emtricitabine|emtricitabine|mesh-list
139484772|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139484773|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
139484774|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484775|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139484776|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139484777|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484778|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484779|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139484780|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139484781|NCT04888715|Pirfenidone|pirfenidone|mesh-list
139484782|NCT04888715|Nintedanib|nintedanib|mesh-list
139484783|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484784|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139484785|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484786|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484787|NCT04888715|Analgesics|analgesics|mesh-ancestor
139484788|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
139484789|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484790|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484791|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139484792|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139484793|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139484794|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139484795|NCT04888403|Paclitaxel|paclitaxel|mesh-list
139271473|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139271474|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139271475|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
139271476|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139271477|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139271478|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139271479|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
139271480|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271481|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271482|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139271483|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139271484|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271485|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
139271486|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
139271490|NCT03530462|Hormones|hormones|mesh-ancestor
139484796|NCT04888403|Nedaplatin|nedaplatin|mesh-list
139484797|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139484798|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484799|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
139484800|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
139484801|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
139484802|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484803|NCT03050177|Gefitinib|gefitinib|mesh-list
139484804|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484805|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139484806|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484807|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484808|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139484809|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139484810|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484811|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139484812|NCT03050411|Apatinib|apatinib|mesh-list
139484813|NCT03050411|Gefitinib|gefitinib|mesh-list
139484814|NCT03050411|Osimertinib|osimertinib|mesh-list
139484815|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484816|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139484817|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011144|NCT00851513|Lidocaine|lidocaine|mesh-list
139484818|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484819|NCT04887311|Tempol|tempol|mesh-list
139484820|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
139484821|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484822|NCT04887311|Protective Agents|protective agents|mesh-ancestor
139484823|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484824|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139484825|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484826|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139484827|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139484828|NCT03051503|Fentanyl|fentanyl|mesh-list
139484829|NCT03051503|Morphine|morphine|mesh-list
139484830|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139484831|NCT03051503|Narcotics|narcotics|mesh-ancestor
139484832|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139484833|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484834|NCT03051503|Analgesics|analgesics|mesh-ancestor
139484835|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
139484836|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484837|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139484838|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139484839|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
139484840|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
139484841|NCT04896125|Bimatoprost|bimatoprost|mesh-list
139484842|NCT04896125|Latanoprost|latanoprost|mesh-list
139484843|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139484844|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139484845|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139484846|NCT04895657|Tazobactam|tazobactam|mesh-list
139011157|NCT00841841|Dipyrone|dipyrone|mesh-list
139484847|NCT04895657|Piperacillin|piperacillin|mesh-list
139484848|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139484849|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139484850|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484851|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139484852|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484853|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484854|NCT04895423|Cyclosporine|cyclosporine|mesh-list
139484855|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
139484856|NCT04895423|Methotrexate|methotrexate|mesh-list
139271562|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
139271563|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139271564|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
139271565|NCT02100852|Chlorambucil|chlorambucil|mesh-list
139271566|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139271567|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139271568|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139271569|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
139271570|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139271571|NCT00057980|Celecoxib|celecoxib|mesh-list
139271572|NCT00057980|Epirubicin|epirubicin|mesh-list
139271573|NCT00057980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139271574|NCT00057980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139271575|NCT00057980|Analgesics|analgesics|mesh-ancestor
139271576|NCT00057980|Sensory System Agents|sensory system agents|mesh-ancestor
139271580|NCT00057980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139484857|NCT04895423|Cyclosporins|cyclosporins|mesh-list
139484858|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139484859|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
139484860|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139484861|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484862|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139484863|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
139484864|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484865|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484866|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
139484867|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484868|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139484869|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139484870|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
139484871|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139484872|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139484873|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
139484874|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484875|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139484876|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139484877|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139484878|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
139484879|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139484880|NCT04882163|Dexamethasone|dexamethasone|mesh-list
139484881|NCT04882163|Rituximab|rituximab|mesh-list
139484882|NCT04882163|Gemcitabine|gemcitabine|mesh-list
139484883|NCT04882163|Lenalidomide|lenalidomide|mesh-list
139484884|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139484885|NCT04882163|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139484886|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139484887|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
139484888|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
139484889|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484890|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484891|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484892|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
139484893|NCT04882163|Hormones|hormones|mesh-ancestor
139484894|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139484895|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139484896|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484897|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139484898|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
139484899|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139484900|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139484901|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
139484902|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484903|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139484904|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139484905|NCT04882163|Growth Substances|growth substances|mesh-ancestor
139484906|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
139011257|NCT02546843|Rocuronium|rocuronium|mesh-list
139484907|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139484908|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
139484909|NCT04882163|Immunoconjugates|immunoconjugates|mesh-ancestor
139484910|NCT04885751|Rebamipide|rebamipide|mesh-list
139484911|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139484912|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484913|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
139484914|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484915|NCT04885751|Protective Agents|protective agents|mesh-ancestor
139484916|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484917|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484918|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
139484919|NCT03049163|Propoxycaine|propoxycaine|mesh-list
139484920|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
139484921|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139484922|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484923|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
139484924|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
139484925|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484926|NCT04881851|Folic Acid|folic acid|mesh-list
139484927|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
139484928|NCT04881851|Inositol|inositol|mesh-list
139484929|NCT04881851|Hematinics|hematinics|mesh-ancestor
139484930|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
139484931|NCT04881851|Vitamins|vitamins|mesh-ancestor
139484932|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
139484933|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484934|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
139484935|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484936|NCT04881851|Protective Agents|protective agents|mesh-ancestor
139484937|NCT04871633|Azithromycin|azithromycin|mesh-list
139484938|NCT04871633|Remdesivir|remdesivir|mesh-list
139484939|NCT04871633|Dexamethasone|dexamethasone|mesh-list
139484940|NCT04871633|Prednisolone|prednisolone|mesh-list
139484941|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139484942|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139484943|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
139484944|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
139484945|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484946|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484947|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484948|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
139484949|NCT04871633|Hormones|hormones|mesh-ancestor
139570299|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484950|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139484951|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139484952|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484953|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484954|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139484955|NCT04871633|Protective Agents|protective agents|mesh-ancestor
139484956|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139484957|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139484958|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
139484959|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
139484960|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
139484961|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139484962|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484963|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139484964|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484965|NCT03046979|Apatinib|apatinib|mesh-list
139484966|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139484967|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139484968|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139484969|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484970|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139484971|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139011309|NCT00621023|Vitamins|vitamins|mesh-ancestor
139484972|NCT04676399|Diuretics|diuretics|mesh-ancestor
139484973|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
139484974|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484975|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139484976|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139484977|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484978|NCT03047057|Lidocaine|lidocaine|mesh-list
139484979|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
139484980|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
139484981|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139484982|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484983|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
139484984|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139484985|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139011338|NCT00852371|Artenimol|artenimol|mesh-list
139484986|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139484987|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139484988|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139484989|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484990|NCT04550195|Famotidine|famotidine|mesh-list
139484991|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139484992|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139484993|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139484994|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
139484995|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
139484996|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139484997|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139484998|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139484999|NCT04525391|Durvalumab|durvalumab|mesh-list
139485000|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139485001|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485002|NCT04879511|Metformin|metformin|mesh-list
139485003|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139485004|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485005|NCT03046901|Vancomycin|vancomycin|mesh-list
139485006|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139485007|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139485008|NCT03871049|Dexamethasone|dexamethasone|mesh-list
139485009|NCT03871049|Bupivacaine|bupivacaine|mesh-list
139485010|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139485011|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
139485012|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
139485013|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485014|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485015|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139485016|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
139485017|NCT03871049|Hormones|hormones|mesh-ancestor
139485018|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139485019|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139485020|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485021|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
139485022|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
139485023|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485024|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
139485025|NCT04870541|Nefopam|nefopam|mesh-list
139485026|NCT04870541|Ondansetron|ondansetron|mesh-list
139485027|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
139485028|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
139485029|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485030|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485031|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139485032|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
139485033|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
139485034|NCT04870541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139485035|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139485036|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
139485037|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139485038|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485039|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139485040|NCT04870541|Analgesics|analgesics|mesh-ancestor
139485041|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
139485042|NCT04870073|Mannitol|mannitol|mesh-list
139485043|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139485044|NCT04870073|Diuretics|diuretics|mesh-ancestor
139485045|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
139485046|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485047|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139485048|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139485049|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139485050|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
139485051|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139485052|NCT04878497|Warfarin|warfarin|mesh-list
139485053|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
139485054|NCT04878497|Dabigatran|dabigatran|mesh-list
139485055|NCT04878497|Apixaban|apixaban|mesh-list
139485056|NCT04878497|Edoxaban|edoxaban|mesh-list
139485057|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
139485058|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139485059|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
139011408|NCT00848939|Treprostinil|treprostinil|mesh-list
139485060|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139485061|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
139485062|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485063|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485064|NCT03257033|Paclitaxel|paclitaxel|mesh-list
139485065|NCT03257033|Gemcitabine|gemcitabine|mesh-list
139485066|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139485067|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485068|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
139485069|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
139485070|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
139485071|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485072|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139485073|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
139485074|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
139485075|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139485076|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485077|NCT02614859|Metformin|metformin|mesh-list
139485078|NCT02614859|Bicalutamide|bicalutamide|mesh-list
139485079|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139485080|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485081|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
139485082|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
139485083|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139485084|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485085|NCT04876859|Anesthetics|anesthetics|mesh-list
139485086|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485087|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485088|NCT04876313|Paclitaxel|paclitaxel|mesh-list
139485089|NCT04876313|Nivolumab|nivolumab|mesh-list
139485090|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139485091|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485092|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
139485093|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
139485094|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
139485095|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485096|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139485097|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139485098|NCT03049085|Aspirin|aspirin|mesh-list
139485099|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485100|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139485101|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139485102|NCT03049085|Analgesics|analgesics|mesh-ancestor
139485103|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
139011453|NCT00527826|Xhance|xhance|mesh-list
139485104|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485105|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139485106|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139485107|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139485108|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139485109|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485110|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139485111|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139485112|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485113|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
139485114|NCT04875611|Nivolumab|nivolumab|mesh-list
139485115|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139485116|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485117|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139485118|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485119|NCT05256953|Anesthetics|anesthetics|mesh-list
139485120|NCT05256953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485121|NCT05256953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485122|NCT04874675|Acetaminophen|acetaminophen|mesh-list
139485123|NCT04874675|Ibuprofen|ibuprofen|mesh-list
139485124|NCT04874675|Diclofenac|diclofenac|mesh-list
139485125|NCT04874675|Codeine|codeine|mesh-list
139485126|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139485127|NCT04874675|Analgesics|analgesics|mesh-ancestor
139485128|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
139485129|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485130|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485131|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
139485132|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139485133|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139485134|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139485135|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139485136|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485137|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485138|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139485139|NCT04874675|Narcotics|narcotics|mesh-ancestor
139485140|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485141|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
139485142|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
139485143|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
139485144|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139485145|NCT04868513|Fluorides|fluorides|mesh-list
139485146|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
139485147|NCT04868513|Protective Agents|protective agents|mesh-ancestor
139485148|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485149|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139485150|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139485151|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
139485152|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
139485153|NCT03047837|Aspirin|aspirin|mesh-list
139485154|NCT03047837|Metformin|metformin|mesh-list
139485155|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139485156|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485157|NCT03047837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139485158|NCT03047837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139485159|NCT03047837|Analgesics|analgesics|mesh-ancestor
139485160|NCT03047837|Sensory System Agents|sensory system agents|mesh-ancestor
139485161|NCT03047837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485163|NCT03047837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139485164|NCT03047837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139485165|NCT03047837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139485166|NCT03047837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485167|NCT03047837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139485168|NCT03047837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139485169|NCT03047837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485170|NCT03047837|Antipyretics|antipyretics|mesh-ancestor
139485171|NCT05256173|Melatonin|melatonin|mesh-list
139485172|NCT05256173|Antioxidants|antioxidants|mesh-ancestor
139485173|NCT05256173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485174|NCT05256173|Protective Agents|protective agents|mesh-ancestor
139485175|NCT05256173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485176|NCT05256173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485177|NCT02648347|Darbepoetin alfa|darbepoetin alfa|mesh-list
139485178|NCT02648347|Hematinics|hematinics|mesh-ancestor
139485179|NCT02614703|Acetic Acid|acetic acid|mesh-list
139485180|NCT02614703|Retinol acetate|retinol acetate|mesh-list
139485181|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139485182|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139485183|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139485184|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
139485185|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485186|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139485187|NCT02614703|Protective Agents|protective agents|mesh-ancestor
139485188|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485189|NCT01669343|Letrozole|letrozole|mesh-list
139485190|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485191|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139485192|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139485193|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485194|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485195|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139485196|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
139485197|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139485198|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485199|NCT03126643|Nivolumab|nivolumab|mesh-list
139485200|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139485201|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485202|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139485203|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485204|NCT04617067|Paclitaxel|paclitaxel|mesh-list
139485205|NCT04617067|Gemcitabine|gemcitabine|mesh-list
139485206|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139485207|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485208|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
139485209|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
139485210|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
139485211|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485212|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139485213|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
139485214|NCT01594931|Artesunate|artesunate|mesh-list
139485215|NCT01594931|Pyronaridine|pyronaridine|mesh-list
139485216|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
139485217|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139485218|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139485219|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139485220|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485221|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
139485222|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
139485223|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139485224|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
139485225|NCT03045185|Metronidazole|metronidazole|mesh-list
139485226|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
139485227|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139485228|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139485229|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139485230|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139485231|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139485232|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139485233|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485234|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485235|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485236|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139011581|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485237|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139485238|NCT04969237|Vitamin D|vitamin d|mesh-list
139485239|NCT04969237|Vitamins|vitamins|mesh-ancestor
139485240|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
139485241|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485242|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139485243|NCT04341467|Olanzapine|olanzapine|mesh-list
139485244|NCT04341467|Amisulpride|amisulpride|mesh-list
139485245|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
139485246|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
139485247|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485248|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485249|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139485250|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139485251|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139485252|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485253|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138984916|NCT04840511|Lidocaine|lidocaine|mesh-list
139485254|NCT04341467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139485255|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139485256|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139485257|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485258|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139485259|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
139485260|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139485261|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
139485262|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139485263|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
139485264|NCT04872881|Fentanyl|fentanyl|mesh-list
139485265|NCT04872881|Propofol|propofol|mesh-list
139485266|NCT04872881|Rocuronium|rocuronium|mesh-list
139485267|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139485268|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485269|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485270|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139485271|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
139485272|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
139485273|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139485274|NCT04872881|Narcotics|narcotics|mesh-ancestor
139485275|NCT04872881|Analgesics|analgesics|mesh-ancestor
139485276|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
139485277|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485278|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139485279|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139485280|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139485281|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139485282|NCT03044873|Deucravacitinib|deucravacitinib|mesh-list
139485283|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139485284|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139485285|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139485286|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
139485287|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485288|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139485289|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139485290|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485291|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
139011628|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
139485292|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139485293|NCT03044795|Veliparib|veliparib|mesh-list
139485294|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139485295|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485296|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485297|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485298|NCT04865705|Paclitaxel|paclitaxel|mesh-list
139485299|NCT04865705|Cisplatin|cisplatin|mesh-list
139485300|NCT04865705|Carboplatin|carboplatin|mesh-list
139485301|NCT04865705|Tislelizumab|tislelizumab|mesh-list
139485302|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139485303|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485304|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
139485305|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
139485306|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
139485307|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485308|NCT04865705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139272000|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
139485309|NCT04858997|Palbociclib|palbociclib|mesh-list
139485310|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485312|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485313|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485314|NCT05135143|Antioxidants|antioxidants|mesh-list
139485315|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485316|NCT05135143|Protective Agents|protective agents|mesh-ancestor
139485317|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485318|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139485319|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139485320|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
139485321|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485322|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139485323|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139485324|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
139485325|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139485326|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485327|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139485328|NCT05305183|Alendronate|alendronate|mesh-list
139485329|NCT05305183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139485330|NCT05305183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485331|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
139485332|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
139485333|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139485334|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485335|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485336|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
139485337|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
139485338|NCT05304559|Ketamine|ketamine|mesh-list
139485339|NCT05304559|Esketamine|esketamine|mesh-list
139485340|NCT05304559|Analgesics|analgesics|mesh-ancestor
139485341|NCT05304559|Sensory System Agents|sensory system agents|mesh-ancestor
139485342|NCT05304559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485343|NCT05304559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011687|NCT03998592|Vaccines|vaccines|mesh-list
139485344|NCT05304559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139485345|NCT05304559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139485346|NCT05304559|Anesthetics, General|anesthetics, general|mesh-ancestor
139485347|NCT05304559|Anesthetics|anesthetics|mesh-ancestor
139485348|NCT05304559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485349|NCT05304559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139485350|NCT05304559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139485351|NCT05304559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139485352|NCT05304559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485353|NCT05304559|Antidepressive Agents|antidepressive agents|mesh-ancestor
139485354|NCT05304559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139485355|NCT02613221|Panitumumab|panitumumab|mesh-list
139485356|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139485357|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485358|NCT05304169|Leuprolide|leuprolide|mesh-list
139485359|NCT05304169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139485360|NCT05304169|Fertility Agents|fertility agents|mesh-ancestor
139485361|NCT05304169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139485362|NCT05304169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485363|NCT05304169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139485364|NCT05304169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485365|NCT04858841|Levetiracetam|levetiracetam|mesh-list
139485366|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
139485367|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
139485368|NCT04682743|Acetaminophen|acetaminophen|mesh-list
139485369|NCT04682743|Ondansetron|ondansetron|mesh-list
139485370|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139485371|NCT04682743|Analgesics|analgesics|mesh-ancestor
139485372|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
139485373|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485374|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485375|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
139485376|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
139485377|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
139485378|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139485379|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
139485380|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
139485381|NCT04682743|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139485382|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139485383|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
139485384|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139272077|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
139485385|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485386|NCT03472573|Dexamethasone|dexamethasone|mesh-list
139485387|NCT03472573|Palbociclib|palbociclib|mesh-list
139485388|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139485389|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
139485390|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
139485391|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485392|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485393|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139485394|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
139485395|NCT03472573|Hormones|hormones|mesh-ancestor
139485396|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139485397|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139485398|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485399|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139485400|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485401|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485402|NCT04636333|Vaccines|vaccines|mesh-list
139485403|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
139485404|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485405|NCT03103009|Pasireotide|pasireotide|mesh-list
139485406|NCT03103009|Hormones|hormones|mesh-ancestor
139485407|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139485408|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485409|NCT03020875|Acetaminophen|acetaminophen|mesh-list
139485410|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139485411|NCT03020875|Analgesics|analgesics|mesh-ancestor
139485412|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
139011764|NCT00519636|Xhance|xhance|mesh-list
139485413|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485414|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485415|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
139485416|NCT02996305|Gaboxadol|gaboxadol|mesh-list
139485417|NCT02996305|Analgesics|analgesics|mesh-ancestor
139485418|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
139485419|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485420|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485421|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
139485422|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
139485423|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
139485424|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139485425|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485426|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
139485427|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139485428|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485429|NCT04866485|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139485430|NCT04866485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485431|NCT02888041|Dinoprostone|dinoprostone|mesh-list
139485432|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
139485433|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139485434|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485435|NCT02838745|Pemetrexed|pemetrexed|mesh-list
139485436|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485437|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485438|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485439|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139485440|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139485441|NCT00136435|Leucovorin|leucovorin|mesh-list
139485442|NCT00136435|Cytarabine|cytarabine|mesh-list
139485443|NCT00136435|Dexamethasone|dexamethasone|mesh-list
139485444|NCT00136435|Prednisone|prednisone|mesh-list
139485445|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
139485446|NCT00136435|Doxorubicin|doxorubicin|mesh-list
139485447|NCT00136435|Methotrexate|methotrexate|mesh-list
139485448|NCT00136435|Vincristine|vincristine|mesh-list
139485449|NCT00136435|Asparaginase|asparaginase|mesh-list
139485450|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
139485451|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139485452|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
139485453|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
139485454|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485455|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485456|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139485457|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
139485458|NCT00136435|Hormones|hormones|mesh-ancestor
139272148|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139485459|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139485460|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139485461|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485462|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139485463|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139485464|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139485465|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485466|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485467|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139485468|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
139485469|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139485470|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139485471|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
139485472|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
139485473|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139485474|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139485475|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
139485476|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139485477|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139485478|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
139485479|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139485480|NCT00136435|Antidotes|antidotes|mesh-ancestor
139485481|NCT00136435|Protective Agents|protective agents|mesh-ancestor
139485482|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
139485483|NCT00136435|Vitamins|vitamins|mesh-ancestor
139485484|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
139485485|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139485486|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
139485487|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
139485488|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
139485489|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139485490|NCT04864379|Molgramostim|molgramostim|mesh-list
139485491|NCT04864379|Sargramostim|sargramostim|mesh-list
139485492|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485493|NCT04864379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139485494|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485495|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
139485496|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485497|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
139485498|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485499|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
139485500|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139485501|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139485502|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485503|NCT03044561|Urological Agents|urological agents|mesh-ancestor
139485504|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
139485505|NCT02455141|Carboplatin|carboplatin|mesh-list
139485506|NCT02455141|Epirubicin|epirubicin|mesh-list
139485508|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139485509|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
139485510|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485511|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139485512|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139485513|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
139485514|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485515|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485516|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139485517|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139485518|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139485519|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139485520|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485521|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
139485522|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139485523|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139485524|NCT02439385|Curcumin|curcumin|mesh-list
139485525|NCT02439385|Bevacizumab|bevacizumab|mesh-list
139485526|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139485527|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485528|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139485529|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139485530|NCT02439385|Growth Substances|growth substances|mesh-ancestor
139485531|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485532|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
139485533|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139485534|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139272239|NCT03656679|Iodine|iodine|mesh-list
139485535|NCT02439385|Analgesics|analgesics|mesh-ancestor
139485536|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
139485537|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485538|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139485539|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139485540|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485541|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485542|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
139485543|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139485544|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
139485545|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139485546|NCT03104959|Expectorants|expectorants|mesh-ancestor
139485547|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
139485548|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139485549|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
139485550|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485551|NCT03104959|Protective Agents|protective agents|mesh-ancestor
139485552|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485553|NCT03104959|Antidotes|antidotes|mesh-ancestor
139485554|NCT03044171|Listerine|listerine|mesh-list
139485555|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139485556|NCT03044171|Fluorides|fluorides|mesh-list
139485557|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
139485558|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
139485559|NCT03044171|Protective Agents|protective agents|mesh-ancestor
139485560|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485561|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139485562|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139485563|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
139485564|NCT04856969|Olmesartan|olmesartan|mesh-list
139485565|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139485566|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485567|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139485568|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485569|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139485570|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139485571|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139485572|NCT04856111|Pirfenidone|pirfenidone|mesh-list
139485573|NCT04856111|Nintedanib|nintedanib|mesh-list
139485574|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485575|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139485576|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485577|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485578|NCT04856111|Analgesics|analgesics|mesh-ancestor
139485579|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
139485580|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485581|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485582|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139485583|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139485584|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139485585|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139485586|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
139485587|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139485588|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485589|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139485590|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
139485591|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139485592|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139485593|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139485594|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485595|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485596|NCT01799629|Glycerol|glycerol|mesh-list
139485597|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139485598|NCT01799629|Protective Agents|protective agents|mesh-ancestor
139485599|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485600|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139485601|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139485602|NCT03044093|Misoprostol|misoprostol|mesh-list
139485603|NCT03044093|Mifepristone|mifepristone|mesh-list
139485604|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139485605|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
139485606|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139485607|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485608|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139485609|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139485610|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
139485611|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139485612|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139485613|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139485614|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139485615|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
139485616|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139485617|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139485618|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
139485619|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139485620|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
139485621|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139485622|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139485623|NCT01553071|Fenretinide|fenretinide|mesh-list
139485624|NCT01553071|Safingol|safingol|mesh-list
139485625|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485626|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139485627|NCT01553071|Protective Agents|protective agents|mesh-ancestor
139485628|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485629|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485630|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485631|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
139485632|NCT01506973|Gemcitabine|gemcitabine|mesh-list
139485633|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139485634|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139485635|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
139011977|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
139485636|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485637|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485638|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
139485639|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139485640|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139485641|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139485642|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485643|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139485644|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139485645|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139485646|NCT04848467|Vaccines|vaccines|mesh-list
139485647|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
139485648|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485649|NCT03104335|Apatinib|apatinib|mesh-list
139485650|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485651|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139485652|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485653|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485654|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139485655|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139485656|NCT00484471|Valproic Acid|valproic acid|mesh-list
139485657|NCT00484471|Aripiprazole|aripiprazole|mesh-list
139485658|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
139485659|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139485660|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139485661|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139485662|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485663|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485664|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
139485665|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
139485666|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139485667|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485668|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139485669|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139485670|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
139485671|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139485672|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139485673|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139485674|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139485675|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
139485676|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485677|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
139485678|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
139485679|NCT05430841|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139485680|NCT05430841|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139485681|NCT05430841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485682|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
139485683|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139485684|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139272376|NCT02108106|Mitapivat|mitapivat|mesh-list
139485686|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
139485687|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139485688|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
139485689|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139485690|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
139485691|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
139485692|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485693|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485694|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139485695|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
139485696|NCT04847687|Hormones|hormones|mesh-ancestor
139485697|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139485698|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139485699|NCT04847687|Protective Agents|protective agents|mesh-ancestor
139485700|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139485701|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485702|NCT01729455|Belimumab|belimumab|mesh-list
139485703|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139485704|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
139485705|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485706|NCT03103867|Insulin|insulin|mesh-list
139485707|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139485708|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485709|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139485710|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
139485711|NCT04737343|Azathioprine|azathioprine|mesh-list
139485712|NCT04737343|Leflunomide|leflunomide|mesh-list
139485713|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
139485714|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485715|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139485716|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485717|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139485718|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
139485719|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485720|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139485721|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485722|NCT02609399|Oseltamivir|oseltamivir|mesh-list
139485723|NCT02609399|Peramivir|peramivir|mesh-list
139485724|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
139485725|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139485726|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485727|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485728|NCT05430217|Buspirone|buspirone|mesh-list
139485729|NCT05430217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139485730|NCT05430217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139485731|NCT05430217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485732|NCT05430217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485733|NCT05430217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139485734|NCT05430217|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139485735|NCT05430217|Serotonin Agents|serotonin agents|mesh-ancestor
139485736|NCT05430217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139485737|NCT05430217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485738|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
139485739|NCT03103555|Bortezomib|bortezomib|mesh-list
139485740|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139485741|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
139485742|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485743|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139485744|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139485745|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
139485746|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485747|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485748|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139485749|NCT02720185|Dasatinib|dasatinib|mesh-list
139485750|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485751|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139485752|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485753|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485754|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
139485755|NCT04846673|Pregabalin|pregabalin|mesh-list
139485756|NCT04846673|Analgesics|analgesics|mesh-ancestor
139485757|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
139485758|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485759|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139272454|NCT02108808|Clopidogrel|clopidogrel|mesh-list
139485760|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
139485761|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139485762|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139485763|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485764|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139485765|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139485766|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139485767|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485768|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139485769|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
139485770|NCT04846673|Protective Agents|protective agents|mesh-ancestor
139485771|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
139485772|NCT04846673|Vitamins|vitamins|mesh-ancestor
139485773|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
139485774|NCT04498273|Aspirin|aspirin|mesh-list
139485775|NCT04498273|Apixaban|apixaban|mesh-list
139485776|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139012122|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
139485777|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139485778|NCT04498273|Analgesics|analgesics|mesh-ancestor
139485779|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
139485780|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485781|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485782|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139485783|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139485784|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139485785|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139485786|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485787|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139485788|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139485789|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485790|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
139485791|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139485792|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
139485793|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139485794|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
139485795|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
139485796|NCT04853615|Empagliflozin|empagliflozin|mesh-list
139485797|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139485798|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485799|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139485800|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485801|NCT05573607|Chromium|chromium|mesh-list
139485802|NCT05573607|Trace Elements|trace elements|mesh-ancestor
139485803|NCT05573607|Micronutrients|micronutrients|mesh-ancestor
139485804|NCT05573607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485805|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
139485806|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485807|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139485808|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
139485809|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139485810|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485811|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485812|NCT03040817|Esomeprazole|esomeprazole|mesh-list
139485813|NCT03040817|Mosapride|mosapride|mesh-list
139485814|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485815|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139485816|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139485817|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139485818|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485819|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139485820|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
139485821|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139485822|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485823|NCT04853069|Estradiol|estradiol|mesh-list
139485824|NCT04853069|Estrogens|estrogens|mesh-ancestor
139485825|NCT04853069|Hormones|hormones|mesh-ancestor
139485826|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139485827|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485828|NCT05244811|Contraceptive Agents|contraceptive agents|mesh-list
139485829|NCT05244811|Contraceptives, Oral|contraceptives, oral|mesh-list
139485830|NCT05244811|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139485831|NCT05244811|Progestins|progestins|mesh-list
139485832|NCT05244811|Estradiol|estradiol|mesh-list
139485833|NCT05244811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139485834|NCT05244811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485835|NCT05244811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139485853|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485854|NCT05392959|Dapagliflozin|dapagliflozin|mesh-list
139485855|NCT05392959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139485856|NCT05392959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485857|NCT05392959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139485858|NCT05392959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485859|NCT04851977|Vaccines|vaccines|mesh-list
139485860|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
139485861|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485862|NCT05370417|Fluorides|fluorides|mesh-list
139485863|NCT05370417|Cariostatic Agents|cariostatic agents|mesh-ancestor
139485864|NCT05370417|Protective Agents|protective agents|mesh-ancestor
139485865|NCT05370417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485866|NCT04423185|Atezolizumab|atezolizumab|mesh-list
139485867|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
139485868|NCT04423185|Palbociclib|palbociclib|mesh-list
139485869|NCT04423185|Niraparib|niraparib|mesh-list
139485870|NCT04423185|Vemurafenib|vemurafenib|mesh-list
139485871|NCT04423185|Crizotinib|crizotinib|mesh-list
139485872|NCT04423185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139485873|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485874|NCT04423185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139485875|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485876|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139485877|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485878|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139485879|NCT04850885|Dexamethasone|dexamethasone|mesh-list
139485880|NCT04850885|Lidocaine|lidocaine|mesh-list
139485881|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139485882|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
139485883|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
139485884|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485885|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485886|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139485887|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
139485888|NCT04850885|Hormones|hormones|mesh-ancestor
139485889|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139485890|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139485891|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485892|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
139485893|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
139485894|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485895|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
139485896|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139485897|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139485898|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139485899|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139485900|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485901|NCT04850417|Aspirin|aspirin|mesh-list
139485902|NCT04850417|Clopidogrel|clopidogrel|mesh-list
139485903|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139485904|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139485905|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139485906|NCT04850417|Analgesics|analgesics|mesh-ancestor
139485907|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
139485908|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485909|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485910|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139485911|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139485912|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139485913|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139485914|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485915|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139485916|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139485917|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485918|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
139485919|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139485920|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139485921|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139485922|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
139485923|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139485924|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139485925|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
139485926|NCT04843943|Bevacizumab|bevacizumab|mesh-list
139485927|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139485928|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485929|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139485930|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139485931|NCT04843943|Growth Substances|growth substances|mesh-ancestor
139485932|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485933|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
139485934|NCT04850261|Nafarelin|nafarelin|mesh-list
139485935|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139485936|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
139485937|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139485938|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485939|NCT04843553|Niacinamide|niacinamide|mesh-list
139485940|NCT04843553|Niacin|niacin|mesh-list
139485941|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
139485942|NCT04843553|Vitamins|vitamins|mesh-ancestor
139485943|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
139485944|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485945|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
139485946|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139485947|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
139485948|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485949|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139485950|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
139485951|NCT02684461|Paclitaxel|paclitaxel|mesh-list
139485952|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
139485953|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139485954|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139485955|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
139485956|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
139485957|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
139485958|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485959|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139485960|NCT02684461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139485961|NCT03040193|Lidocaine|lidocaine|mesh-list
139485962|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
139485963|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
139485964|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139485965|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485966|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
139485967|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139485968|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139012313|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
139485969|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139485970|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139485971|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139485972|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485973|NCT03039101|Montelukast|montelukast|mesh-list
139485974|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139485975|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
139485976|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139485977|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
139485978|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139485979|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485980|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139485981|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139485982|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485983|NCT03103399|Levodopa|levodopa|mesh-list
139485984|NCT03103399|Carbidopa|carbidopa|mesh-list
139485985|NCT03103399|Entacapone|entacapone|mesh-list
139485986|NCT03103399|Benserazide|benserazide|mesh-list
139485987|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
139485988|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
139485989|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139485990|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139485991|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
139485992|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139485993|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139485994|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139485995|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139485996|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139485997|NCT03043157|Rocuronium|rocuronium|mesh-list
139485998|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139485999|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139486000|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139486001|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486002|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486003|NCT05339113|FAPI-46|fapi-46|mesh-list
139486004|NCT05339113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139486005|NCT05339113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486006|NCT05332795|Metformin|metformin|mesh-list
139486007|NCT05332795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139486008|NCT05332795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486009|NCT03042923|Mannitol|mannitol|mesh-list
139486010|NCT03042923|Lactulose|lactulose|mesh-list
139486011|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139486012|NCT03042923|Diuretics|diuretics|mesh-ancestor
139486013|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
139486014|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486015|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486016|NCT04429295|Vaccines|vaccines|mesh-list
139486017|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
139486018|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486019|NCT05258851|Ceftazidime|ceftazidime|mesh-list
139486020|NCT05258851|Colistin|colistin|mesh-list
139486021|NCT05258851|Avibactam|avibactam|mesh-list
139486022|NCT05258851|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
139486023|NCT05258851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139486024|NCT05258851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486025|NCT05258851|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139486026|NCT05258851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486027|NCT05258851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486028|NCT03043001|Memantine|memantine|mesh-list
139486029|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139486030|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139486031|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
139486032|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486033|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486034|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486035|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139486036|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139486037|NCT04843007|Pemetrexed|pemetrexed|mesh-list
139486038|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486039|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486040|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486041|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139486042|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139486043|NCT04840745|Leuprolide|leuprolide|mesh-list
139486044|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139486045|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
139486046|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139486047|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486048|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139486049|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486050|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
139486051|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139486052|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
139486053|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486054|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
139486055|NCT05072899|Protective Agents|protective agents|mesh-ancestor
139486056|NCT04839653|Vancomycin|vancomycin|mesh-list
139486057|NCT04839653|Gentamicins|gentamicins|mesh-list
139486058|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
139486059|NCT04839653|Polymyxins|polymyxins|mesh-list
139486060|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139486061|NCT04839653|Cefotaxime|cefotaxime|mesh-list
139486062|NCT04839653|Cefoxitin|cefoxitin|mesh-list
139486063|NCT04839653|Polymyxin B|polymyxin b|mesh-list
139486064|NCT04839653|Amphotericin B|amphotericin b|mesh-list
139486065|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139486066|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486067|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139486068|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486069|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486070|NCT04839653|Amebicides|amebicides|mesh-ancestor
139486071|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139486072|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139486073|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
139486074|NCT04842383|Peppermint oil|peppermint oil|mesh-list
139486075|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
139486076|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
139486077|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486078|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486079|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486080|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
139486081|NCT04884139|Tenofovir|tenofovir|mesh-list
139486082|NCT04884139|Lamivudine|lamivudine|mesh-list
139486083|NCT04884139|Emtricitabine|emtricitabine|mesh-list
139486084|NCT04884139|Dolutegravir|dolutegravir|mesh-list
139486085|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
139486086|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486087|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139486088|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139486089|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486090|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486091|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139486092|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139486093|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139486094|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139486095|NCT04860167|Diclofenac|diclofenac|mesh-list
139486096|NCT04860167|Lidocaine|lidocaine|mesh-list
139486097|NCT04860167|Propofol|propofol|mesh-list
139486098|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139486099|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139486100|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486101|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139486102|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
139486103|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
139486104|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139486105|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139486106|NCT04860167|Analgesics|analgesics|mesh-ancestor
139486107|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
139486108|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486109|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486110|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139486111|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139486112|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486113|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486114|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
139486115|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139486116|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139486117|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139486118|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139486119|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
139486120|NCT02514031|Paclitaxel|paclitaxel|mesh-list
139486121|NCT02514031|Gemcitabine|gemcitabine|mesh-list
139486122|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139486123|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486124|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
139486125|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
139486126|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
139486127|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486128|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139486129|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
139486130|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486131|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139486132|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139486133|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486134|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
139486135|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
139486136|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139486137|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139486138|NCT04622917|Prednisolone|prednisolone|mesh-list
139486139|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
139486140|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139486141|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
139486142|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486143|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
139486144|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
139486145|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486146|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486147|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486148|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
139486150|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139486151|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139486152|NCT04622917|Protective Agents|protective agents|mesh-ancestor
139486153|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139486154|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486155|NCT03038477|Durvalumab|durvalumab|mesh-list
139486156|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139486157|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486158|NCT03038243|Vaccines|vaccines|mesh-list
139486159|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
139486160|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486161|NCT03038321|Levofloxacin|levofloxacin|mesh-list
139486162|NCT03038321|Lornoxicam|lornoxicam|mesh-list
139486163|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139486164|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486165|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139486166|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139486167|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139486168|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486169|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486170|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486171|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139486172|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139486173|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139486174|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139486175|NCT03038321|Analgesics|analgesics|mesh-ancestor
139486176|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
139486177|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486178|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486179|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486180|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139486181|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139486182|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
139486183|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486184|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
139486185|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139486186|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139486187|NCT03042377|Calcium|calcium|mesh-list
139486188|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139486189|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486190|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139486191|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486192|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
139486193|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
139486194|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139486195|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486196|NCT04859777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139486197|NCT04859777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486198|NCT05562609|Tranexamic Acid|tranexamic acid|mesh-list
139486199|NCT05562609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139486200|NCT05562609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139486201|NCT05562609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486202|NCT05562609|Hemostatics|hemostatics|mesh-ancestor
139486203|NCT05562609|Coagulants|coagulants|mesh-ancestor
139486204|NCT05071339|Ganirelix|ganirelix|mesh-list
139486205|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
139486206|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139486207|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486208|NCT02606279|Valsartan|valsartan|mesh-list
139486209|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139486210|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139486211|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139486212|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486213|NCT04859621|Vitamin D|vitamin d|mesh-list
139486214|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
139486215|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
139486216|NCT04859621|Vitamins|vitamins|mesh-list
139486217|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139486218|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
139486219|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486220|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139486221|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139486222|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486223|NCT03039491|Vaccines|vaccines|mesh-list
139486224|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139486225|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
139486226|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486227|NCT03037775|Nicotine|nicotine|mesh-list
139486228|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139486229|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
139486230|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486231|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486232|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139486233|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139486234|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
139486235|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486236|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486237|NCT03039257|Vitamin A|vitamin a|mesh-list
139486238|NCT03039257|Vitamins|vitamins|mesh-ancestor
139486239|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
139486240|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486241|NCT03038009|Pantoprazole|pantoprazole|mesh-list
139486242|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139486243|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486244|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139486245|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486246|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486247|NCT03466801|Prednisone|prednisone|mesh-list
139486248|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
139486249|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139486250|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486251|NCT03466801|Hormones|hormones|mesh-ancestor
139486252|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139486253|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486254|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139486255|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486256|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
139486257|NCT05069779|Diazepam|diazepam|mesh-list
139486258|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139486259|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
139486260|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
139486261|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
139486262|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486263|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486264|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486265|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139486266|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139486267|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139486268|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139486269|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139486270|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139486271|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139486272|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139486273|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
139486274|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
139486275|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
139486276|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
139486277|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486278|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486279|NCT03251911|Ivacaftor|ivacaftor|mesh-list
139486280|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139486281|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139486282|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486283|NCT02643355|Clonidine|clonidine|mesh-list
139486284|NCT02643355|Olanzapine|olanzapine|mesh-list
139486285|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
139486286|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
139486287|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139272986|NCT02120118|Docetaxel|docetaxel|mesh-list
139486289|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486290|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139486291|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139486292|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139486293|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139486294|NCT02643355|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139486295|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139486296|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139486297|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486298|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486299|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
139486300|NCT02643355|Analgesics|analgesics|mesh-ancestor
139486301|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
139486302|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139486303|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
139486304|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139486305|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139486306|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139486307|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
139486308|NCT03036605|Dexamethasone|dexamethasone|mesh-list
139486309|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
139486310|NCT03036605|Bupivacaine|bupivacaine|mesh-list
139486311|NCT03036605|BB 1101|bb 1101|mesh-list
139486312|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486313|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
139486314|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
139486315|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486316|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486317|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486318|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
139486319|NCT03036605|Hormones|hormones|mesh-ancestor
139486320|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139486321|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139486322|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486323|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
139486324|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486325|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486326|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
139486327|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
139486328|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139486329|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
139486330|NCT03098875|Remifentanil|remifentanil|mesh-list
139486331|NCT03098875|Propofol|propofol|mesh-list
139486332|NCT03098875|Sevoflurane|sevoflurane|mesh-list
139486333|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139486334|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139486335|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486336|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139486337|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
139486338|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
139486339|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139486340|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139486341|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139486342|NCT03098875|Narcotics|narcotics|mesh-ancestor
139486343|NCT03098875|Analgesics|analgesics|mesh-ancestor
139486344|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
139486345|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486346|NCT03099031|Tinzaparin|tinzaparin|mesh-list
139486347|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139486348|NCT03099031|Dalteparin|dalteparin|mesh-list
139486349|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
139486350|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139486351|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139486352|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486353|NCT03101137|Dexamethasone|dexamethasone|mesh-list
139486354|NCT03101137|Bupivacaine|bupivacaine|mesh-list
139486355|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486356|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
139486357|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
139486358|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486359|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486360|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139273053|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139486361|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
139486362|NCT03101137|Hormones|hormones|mesh-ancestor
139486363|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139486364|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139486365|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486366|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
139486367|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
139486368|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139486369|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
139486370|NCT04833257|Tislelizumab|tislelizumab|mesh-list
139486371|NCT04833257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139486372|NCT04833257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486373|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139486374|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139486375|NCT04833101|Vaccines|vaccines|mesh-list
139486376|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
139486377|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486378|NCT00794599|Cetirizine|cetirizine|mesh-list
139486379|NCT00794599|Desloratadine|desloratadine|mesh-list
139486380|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139486381|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139486382|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139486383|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
139486384|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
139486385|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486386|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486387|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486388|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139486389|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
139486390|NCT00783133|Fexofenadine|fexofenadine|mesh-list
139486391|NCT00783133|Desloratadine|desloratadine|mesh-list
139486392|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139486393|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
139486394|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486395|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486396|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486397|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139486398|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139486399|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
139486400|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
139486401|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139486402|NCT03098407|Buprenorphine|buprenorphine|mesh-list
139486403|NCT03098407|Methadone|methadone|mesh-list
139486404|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139486405|NCT03098407|Narcotics|narcotics|mesh-ancestor
139012740|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
139486406|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139486407|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486408|NCT03098407|Analgesics|analgesics|mesh-ancestor
139486409|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
139486410|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486411|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139486412|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
139486413|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
139486414|NCT04836143|Mitogens|mitogens|mesh-list
139486415|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
139486416|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
139486417|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486418|NCT04836143|Growth Substances|growth substances|mesh-ancestor
139486419|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486420|NCT05068453|Antibodies|antibodies|mesh-list
139486421|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139486422|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
139486423|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486424|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
139486425|NCT00751075|Amoxicillin|amoxicillin|mesh-list
139486426|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139486427|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486428|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486429|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
139486430|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139486431|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
139486432|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486433|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
139486434|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139486435|NCT04836299|Ivermectin|ivermectin|mesh-list
139486436|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139486437|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486438|NCT00651391|Simvastatin|simvastatin|mesh-list
139486439|NCT00651391|Ezetimibe|ezetimibe|mesh-list
139486440|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139486441|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139486442|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
139486443|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486444|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139486445|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139486446|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486447|NCT00650689|Atorvastatin|atorvastatin|mesh-list
139486448|NCT00650689|Ezetimibe|ezetimibe|mesh-list
139486449|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139486450|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139486451|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
139486452|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486453|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139486454|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139486455|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486456|NCT05067517|Nintedanib|nintedanib|mesh-list
139486457|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486458|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139486459|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486460|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486461|NCT03100513|Lactulose|lactulose|mesh-list
139486462|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486463|NCT00552097|Simvastatin|simvastatin|mesh-list
139486464|NCT00552097|Ezetimibe|ezetimibe|mesh-list
139486465|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139486466|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139486467|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
139486468|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486469|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139486470|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139486471|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486472|NCT00396175|Finasteride|finasteride|mesh-list
139486473|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486474|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486475|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139486476|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139486477|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486478|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
139486479|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139486480|NCT00396175|Urological Agents|urological agents|mesh-ancestor
139486481|NCT02603393|Fluticasone|fluticasone|mesh-list
139486482|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
139486483|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139486484|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486485|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139486486|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
139486487|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486488|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486489|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139486490|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
139486491|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
139486492|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139486493|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
139486494|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139486495|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
139486496|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486497|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486498|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139486499|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139486500|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139486501|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
139486502|NCT04832945|Ivermectin|ivermectin|mesh-list
139486503|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139486504|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486505|NCT02642653|Lovastatin|lovastatin|mesh-list
139486506|NCT02642653|L 647318|l 647318|mesh-list
139486507|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
139486508|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139486509|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139486510|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
139570300|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486511|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486512|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139486513|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139486514|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486515|NCT01659567|Interferons|interferons|mesh-list
139486516|NCT01659567|Ribavirin|ribavirin|mesh-list
139486517|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
139486518|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
139486519|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139486520|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486521|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
139486522|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486523|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
139486524|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486525|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
139486526|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486527|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
139486528|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139486529|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486530|NCT03036995|Apremilast|apremilast|mesh-list
139486531|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139486532|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139486533|NCT03036995|Analgesics|analgesics|mesh-ancestor
139486534|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
139486535|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486536|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486537|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486538|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139486539|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139486540|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139486541|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486542|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486543|NCT05066035|Neostigmine|neostigmine|mesh-list
139486544|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139486545|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486546|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486547|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
139486548|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486549|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486550|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139486551|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
139486552|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486553|NCT04822415|Carticaine|carticaine|mesh-list
139486554|NCT04822415|Mepivacaine|mepivacaine|mesh-list
139486555|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
139486556|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
139486557|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139486558|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486559|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
139486560|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486561|NCT05065177|Vaccines|vaccines|mesh-list
139486562|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
139486563|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486564|NCT04821947|Bupivacaine|bupivacaine|mesh-list
139486565|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
139486566|NCT04821947|Anesthetics|anesthetics|mesh-list
139486567|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139486568|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486569|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
139486570|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486571|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139486572|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139486573|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139486574|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139486575|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486576|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486577|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486578|NCT03037073|Analgesics|analgesics|mesh-ancestor
139486579|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
139486580|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486581|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
139486582|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139486583|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
139486584|NCT04470973|Amikacin|amikacin|mesh-list
139486585|NCT04470973|Cefuroxime|cefuroxime|mesh-list
139486586|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
139486587|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139486588|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486589|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
139486591|NCT05046457|Vitamins|vitamins|mesh-ancestor
139486592|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
139486593|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486594|NCT05063071|Tenofovir|tenofovir|mesh-list
139486595|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
139486596|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486597|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139486598|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139486599|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486600|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486601|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139486602|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139486603|NCT05062681|Dexamethasone|dexamethasone|mesh-list
139486604|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
139486605|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139486606|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139486607|NCT05062681|Prednisolone|prednisolone|mesh-list
139486608|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
139486609|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139486610|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
139486611|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486612|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
139486613|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
139486614|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486615|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486616|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486617|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
139486618|NCT05062681|Hormones|hormones|mesh-ancestor
139486619|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139486620|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139486621|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486622|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139486623|NCT05062681|Protective Agents|protective agents|mesh-ancestor
139486624|NCT05056519|Vaccines|vaccines|mesh-list
139486625|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
139486626|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486627|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139486628|NCT05045053|Lifitegrast|lifitegrast|mesh-list
139486629|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139486630|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139486631|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
139486632|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486633|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486634|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486635|NCT05060809|Vitamin K|vitamin k|mesh-list
139486636|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
139486637|NCT05060809|Vitamins|vitamins|mesh-ancestor
139486638|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
139486639|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486640|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139486641|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139486642|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486643|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
139486644|NCT05060809|Coagulants|coagulants|mesh-ancestor
139486645|NCT05060419|Meropenem|meropenem|mesh-list
139486646|NCT05060419|Tazobactam|tazobactam|mesh-list
139486647|NCT05060419|Piperacillin|piperacillin|mesh-list
139486648|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139486649|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139486650|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486651|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139486652|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486653|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486654|NCT03097003|Apremilast|apremilast|mesh-list
139486655|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139486656|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139486657|NCT03097003|Analgesics|analgesics|mesh-ancestor
139486658|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
139486659|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486660|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486661|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486662|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139486663|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139486664|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139486665|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486666|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486667|NCT02605967|Spartalizumab|spartalizumab|mesh-list
139486668|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139486669|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486670|NCT02605967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139486671|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486672|NCT03036059|Ivermectin|ivermectin|mesh-list
139486673|NCT03036059|Albendazole|albendazole|mesh-list
139486674|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139486675|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486676|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
139486677|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
139486678|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139486679|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139486680|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
139486681|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
139486682|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
139486683|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486684|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486685|NCT04834427|Ketamine|ketamine|mesh-list
139486686|NCT04834427|Esketamine|esketamine|mesh-list
139486687|NCT04834427|Analgesics|analgesics|mesh-ancestor
139486688|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
139486689|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486690|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486691|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139486692|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139486693|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
139486694|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
139486695|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139486696|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139486697|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139486698|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486699|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486700|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
139486701|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139486702|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139486703|NCT05035849|Acarbose|acarbose|mesh-list
139486704|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139486705|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486706|NCT05035849|Incretins|incretins|mesh-ancestor
139486707|NCT05035849|Hormones|hormones|mesh-ancestor
139486708|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139486709|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139486710|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
139486711|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486712|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486713|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139486714|NCT05035381|Leucovorin|leucovorin|mesh-list
139486715|NCT05035381|Bevacizumab|bevacizumab|mesh-list
139486716|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
139486717|NCT05035381|Fluorouracil|fluorouracil|mesh-list
139486718|NCT05035381|Irinotecan|irinotecan|mesh-list
139486719|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139486720|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139486721|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486722|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139486723|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139486724|NCT05035381|Growth Substances|growth substances|mesh-ancestor
139486725|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486726|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
139486727|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486728|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
139486729|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139486730|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139486731|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
139486732|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139486733|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139486734|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486735|NCT05035381|Antidotes|antidotes|mesh-ancestor
139486736|NCT05035381|Protective Agents|protective agents|mesh-ancestor
139486737|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
139486738|NCT05035381|Vitamins|vitamins|mesh-ancestor
139486739|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
139273427|NCT04973020|Efavirenz|efavirenz|mesh-list
139486740|NCT04821323|Indomethacin|indomethacin|mesh-list
139486741|NCT04821323|Mannitol|mannitol|mesh-list
139486742|NCT04821323|Lactulose|lactulose|mesh-list
139486743|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139486744|NCT04821323|Diuretics|diuretics|mesh-ancestor
139486745|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
139486746|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486747|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139486748|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139486749|NCT04821323|Analgesics|analgesics|mesh-ancestor
139486750|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
139486751|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486752|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486753|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139486754|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
139486755|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
139486756|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139486757|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139486758|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486759|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486760|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486761|NCT05035069|Propofol|propofol|mesh-list
139486762|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139486763|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139486764|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486765|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139486766|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
139486767|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
139486768|NCT05035147|Paclitaxel|paclitaxel|mesh-list
139486769|NCT05035147|Gemcitabine|gemcitabine|mesh-list
139486770|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139486771|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139486772|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486773|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
139486774|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
139486775|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
139486776|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486777|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139486778|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
139486779|NCT04834115|Ivermectin|ivermectin|mesh-list
139486780|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139486781|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486782|NCT01505465|Melatonin|melatonin|mesh-list
139486783|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
139486784|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486785|NCT01505465|Protective Agents|protective agents|mesh-ancestor
139486786|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486787|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139486788|NCT04831229|Menthol|menthol|mesh-list
139486789|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
139486790|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
139486791|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
139486792|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139486793|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139486794|NCT04816253|Prednisolone|prednisolone|mesh-list
139486795|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
139486796|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139486797|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
139486798|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
139486799|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486800|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
139486801|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
139486802|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486803|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486804|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486805|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
139486806|NCT04816253|Hormones|hormones|mesh-ancestor
139486807|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139486808|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139486809|NCT04816253|Protective Agents|protective agents|mesh-ancestor
139486810|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139486811|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486812|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139486813|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
139486814|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
139486815|NCT04816097|Dexamethasone|dexamethasone|mesh-list
139486816|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139486817|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486818|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
139486819|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
139486820|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486821|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486822|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486823|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
139486824|NCT04816097|Hormones|hormones|mesh-ancestor
139486825|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139486826|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139486827|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486828|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
139486829|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139486830|NCT02600351|Ledipasvir|ledipasvir|mesh-list
139486831|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
139486832|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486833|NCT04829435|Rasburicase|rasburicase|mesh-list
139486834|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
139486835|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139486836|NCT05042635|Ixekizumab|ixekizumab|mesh-list
139486837|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
139486838|NCT04815395|Oxytocin|oxytocin|mesh-list
139486839|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
139486840|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139486841|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486842|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
139486843|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486844|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
139486845|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
139486846|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
139486847|NCT05034055|Atezolizumab|atezolizumab|mesh-list
139486848|NCT05034055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139486849|NCT05034055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486850|NCT05034055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139486851|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486852|NCT05042245|Silymarin|silymarin|mesh-list
139486853|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
139486854|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
139486855|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486856|NCT05042245|Protective Agents|protective agents|mesh-ancestor
139486857|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486858|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
139486859|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139486860|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486861|NCT03095209|Paclitaxel|paclitaxel|mesh-list
139486862|NCT03095209|Carboplatin|carboplatin|mesh-list
139486863|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139486864|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486865|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
139486866|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
139486867|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
139013204|NCT00879983|Azithromycin|azithromycin|mesh-list
139486868|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486869|NCT05034133|Cisplatin|cisplatin|mesh-list
139486870|NCT05034133|Etoposide|etoposide|mesh-list
139486871|NCT05034133|Durvalumab|durvalumab|mesh-list
139486872|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486873|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139486874|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139486875|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139486876|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486877|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486878|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139486879|NCT03096457|Paromomycin|paromomycin|mesh-list
139486880|NCT03096457|Pentamidine|pentamidine|mesh-list
139486881|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139486882|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486883|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139486884|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139486885|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
139486886|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139486887|NCT03096223|KHK4083|khk4083|mesh-list
139486888|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
139486889|NCT04814303|Morphine|morphine|mesh-list
139486890|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139486891|NCT04814303|Narcotics|narcotics|mesh-ancestor
139486892|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139273577|NCT00228176|Hormones|hormones|mesh-ancestor
139486893|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486894|NCT04814303|Analgesics|analgesics|mesh-ancestor
139486895|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
139486896|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486897|NCT05053009|Ibuprofen|ibuprofen|mesh-list
139486898|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139013234|NCT01007630|Rasagiline|rasagiline|mesh-list
139486899|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139486900|NCT05053009|Analgesics|analgesics|mesh-ancestor
139486901|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
139486902|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486903|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486904|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486905|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139486906|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139486907|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486908|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486909|NCT04813913|Bevacizumab|bevacizumab|mesh-list
139486910|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139486911|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486912|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139486913|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139486914|NCT04813913|Growth Substances|growth substances|mesh-ancestor
139486915|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486916|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
139486917|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
139486918|NCT04814381|Ketamine|ketamine|mesh-list
139486919|NCT04814381|Analgesics|analgesics|mesh-ancestor
139486920|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
139486921|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486922|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486923|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139486924|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139486925|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
139486926|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
139486927|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139486928|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139013272|NCT05883124|Rivastigmine|rivastigmine|mesh-list
139486929|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139486930|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486931|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486932|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139486933|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
139486934|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139486935|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139486936|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139486937|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
139486938|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139486939|NCT04819217|Charcoal|charcoal|mesh-list
139486940|NCT04819217|Antidotes|antidotes|mesh-ancestor
139486941|NCT04819217|Protective Agents|protective agents|mesh-ancestor
139486942|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486943|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139486944|NCT05052619|Cefmetazole|cefmetazole|mesh-list
139486945|NCT05052619|Sulperazone|sulperazone|mesh-list
139486946|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486947|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139486948|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
139486949|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139486950|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486951|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
139486952|NCT04813523|Cisplatin|cisplatin|mesh-list
139486953|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
139486954|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486955|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139486956|NCT04813523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139486957|NCT04813523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486958|NCT05032261|Norepinephrine|norepinephrine|mesh-list
139486959|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139486960|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139486961|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
139486962|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139486963|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486964|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486965|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
139486966|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
139486967|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486968|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139486969|NCT05619341|Psyllium|psyllium|mesh-list
139486970|NCT05619341|Cathartics|cathartics|mesh-ancestor
139486971|NCT05619341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486973|NCT04814069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139486974|NCT04814069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139486975|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
139486976|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
139486977|NCT05051137|Infliximab|infliximab|mesh-list
139486978|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
139486979|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139486980|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139486981|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139486982|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139486983|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139486984|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139486985|NCT05051137|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139486986|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139486987|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
139486988|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486989|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139486990|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139486991|NCT05051137|Analgesics|analgesics|mesh-ancestor
139486992|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
139486993|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139486994|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139486995|NCT05038969|Esomeprazole|esomeprazole|mesh-list
139486996|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139486997|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139486998|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139486999|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487000|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487001|NCT05038657|Atezolizumab|atezolizumab|mesh-list
139487002|NCT05038657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139487003|NCT05038657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487004|NCT05038657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139487005|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487006|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
139487007|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139487008|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487009|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487010|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139487011|NCT05038111|Analgesics|analgesics|mesh-ancestor
139487012|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
139487013|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487014|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139487015|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139487016|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139487017|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
139487018|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487019|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487020|NCT05030077|Carboplatin|carboplatin|mesh-list
139487021|NCT05030077|Gemcitabine|gemcitabine|mesh-list
139487022|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487023|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139487024|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
139487025|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487026|NCT05029531|Immunomodulating Agents|immunomodulating agents|mesh-list
139487027|NCT05029531|Immunologic Factors|immunologic factors|mesh-ancestor
139487028|NCT05029531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487029|NCT05029453|Apatinib|apatinib|mesh-list
139487030|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487031|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139487032|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487033|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487034|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
139487035|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
139487036|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487037|NCT05037253|Vitamin D|vitamin d|mesh-list
139487038|NCT05037253|Vitamins|vitamins|mesh-ancestor
139487039|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
139487040|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487041|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139487042|NCT05029297|Capsaicin|capsaicin|mesh-list
139487043|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
139487044|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
139273735|NCT05468840|Ketamine|ketamine|mesh-list
139487045|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
139487046|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487047|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487048|NCT05028907|Tocopherols|tocopherols|mesh-list
139487049|NCT05028907|Vitamin E|vitamin e|mesh-list
139487050|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
139487051|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
139487052|NCT05028907|Dexamethasone|dexamethasone|mesh-list
139487053|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
139487054|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
139487055|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139487056|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
139487057|NCT05028907|BB 1101|bb 1101|mesh-list
139487058|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139487059|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
139487060|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
139487061|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487062|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487063|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139487064|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
139487065|NCT05028907|Hormones|hormones|mesh-ancestor
139487066|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139487067|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139487068|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487069|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139487070|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
139487071|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
139487072|NCT05028907|Protective Agents|protective agents|mesh-ancestor
139487073|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
139487074|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487075|NCT05028907|Vitamins|vitamins|mesh-ancestor
139487076|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
139487077|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
139487078|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487079|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139487080|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487081|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139487082|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139487083|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139487084|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
139487085|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
139487086|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139487087|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
139487088|NCT05028049|Sufentanil|sufentanil|mesh-list
139487089|NCT05028049|Remifentanil|remifentanil|mesh-list
139487091|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139487092|NCT05028049|Narcotics|narcotics|mesh-ancestor
139487093|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487094|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487095|NCT05028049|Analgesics|analgesics|mesh-ancestor
139487096|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
139487097|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487098|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139487099|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139487100|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
139487101|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
139487102|NCT05023915|Dexamethasone|dexamethasone|mesh-list
139487103|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
139487104|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139487105|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
139487106|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
139487107|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487108|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487109|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139487110|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
139487111|NCT05023915|Hormones|hormones|mesh-ancestor
139487112|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139487113|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139487114|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487115|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
139487116|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139487117|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
139487118|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487119|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
139487120|NCT05027581|Protective Agents|protective agents|mesh-ancestor
139487121|NCT05027191|Sevoflurane|sevoflurane|mesh-list
139487122|NCT05027191|Desflurane|desflurane|mesh-list
139487123|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139487124|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139487125|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
139487126|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
139487127|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487128|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487129|NCT03094507|Dolutegravir|dolutegravir|mesh-list
139487130|NCT03094507|Darunavir|darunavir|mesh-list
139487131|NCT03094507|Cobicistat|cobicistat|mesh-list
139487132|NCT03094507|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139487133|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139487134|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139487135|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487136|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487137|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139487138|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139487139|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
139487140|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487141|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139487142|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139487143|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
139487144|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139487145|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139487146|NCT02528253|Tramadol|tramadol|mesh-list
139487147|NCT02528253|Tanezumab|tanezumab|mesh-list
139487148|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139487149|NCT02528253|Narcotics|narcotics|mesh-ancestor
139487150|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487151|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487152|NCT02528253|Analgesics|analgesics|mesh-ancestor
139487153|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
139487154|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487155|NCT03093103|Empagliflozin|empagliflozin|mesh-list
139487156|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139487157|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487158|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139487159|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487160|NCT03093805|Calcipotriene|calcipotriene|mesh-list
139487161|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
139487162|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139487163|NCT03093883|Hematinics|hematinics|mesh-ancestor
139487164|NCT05023759|Cannabidiol|cannabidiol|mesh-list
139487165|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
139487166|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
139487167|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139487168|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139487169|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487170|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139487171|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
139487172|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139487173|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487174|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487175|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487176|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
139487177|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487178|NCT05047393|Vitamin D|vitamin d|mesh-list
139487179|NCT05047393|Vitamins|vitamins|mesh-ancestor
139487180|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
139487181|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487182|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139487183|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139487184|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487185|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139487186|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139487187|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139487188|NCT05021887|Fluticasone|fluticasone|mesh-list
139487190|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139487191|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139487192|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
139487193|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487194|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487195|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139487196|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
139487197|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
139487198|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139487199|NCT05021731|Rifampin|rifampin|mesh-list
139487200|NCT05021731|Rifapentine|rifapentine|mesh-list
139487201|NCT05021731|Isoniazid|isoniazid|mesh-list
139487202|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139487203|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
139487204|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139487205|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487206|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
139487207|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139487208|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487209|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487210|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139487211|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139487212|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139487213|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139487214|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139487215|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139487216|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139487217|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139487218|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
139487219|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139487220|NCT05009953|Leucovorin|leucovorin|mesh-list
139487221|NCT05009953|Fluorouracil|fluorouracil|mesh-list
139487222|NCT05009953|Irinotecan|irinotecan|mesh-list
139487223|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
139487224|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487225|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139487226|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487227|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139487228|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
139487229|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487230|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139487231|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139487232|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487233|NCT05009953|Antidotes|antidotes|mesh-ancestor
139487234|NCT05009953|Protective Agents|protective agents|mesh-ancestor
139487235|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
139487236|NCT05009953|Vitamins|vitamins|mesh-ancestor
139487237|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
139487238|NCT03079453|Dexamethasone|dexamethasone|mesh-list
139013581|NCT05846906|Clomiphene|clomiphene|mesh-list
139487239|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139487240|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
139487241|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
139487242|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487243|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487244|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139487245|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
139487246|NCT03079453|Hormones|hormones|mesh-ancestor
139487247|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139487248|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139487249|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487250|NCT05009017|Bevacizumab|bevacizumab|mesh-list
139487251|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139487252|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487253|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139487254|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139487255|NCT05009017|Growth Substances|growth substances|mesh-ancestor
139487256|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487257|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
139487258|NCT05008939|Sevoflurane|sevoflurane|mesh-list
139487259|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139487260|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139487261|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
139487262|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
139487263|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487264|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487265|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
139487266|NCT05008861|Nivolumab|nivolumab|mesh-list
139487267|NCT05008861|Durvalumab|durvalumab|mesh-list
139487268|NCT05008861|Tislelizumab|tislelizumab|mesh-list
139487269|NCT05008861|Antibodies|antibodies|mesh-list
139487270|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139487271|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
139487272|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487273|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139487274|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139273945|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
139487275|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139487276|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487277|NCT05016973|Disitamab vedotin|disitamab vedotin|mesh-list
139487278|NCT05016973|Immunoconjugates|immunoconjugates|mesh-ancestor
139487279|NCT05016973|Immunologic Factors|immunologic factors|mesh-ancestor
139487280|NCT05016973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487281|NCT03091699|Nicotine|nicotine|mesh-list
139487282|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139487283|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
139487284|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487285|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487286|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139487287|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139487288|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
139487289|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487290|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487291|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
139487292|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487293|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487294|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
139487295|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487296|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487297|NCT04253457|Triamcinolone|triamcinolone|mesh-list
139487298|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139487299|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
139487300|NCT04253457|Hormones|hormones|mesh-ancestor
139487301|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139487302|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487303|NCT05380947|Rabeprazole|rabeprazole|mesh-list
139487304|NCT05380947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139487305|NCT05380947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139487306|NCT05380947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139487307|NCT05380947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487308|NCT05380947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487309|NCT02525133|Bupivacaine|bupivacaine|mesh-list
139487310|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
139487311|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
139570301|NCT00983931|Cyclosporine|cyclosporine|mesh-list
139487312|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487313|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487314|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
139487315|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487316|NCT05602311|Anesthetics|anesthetics|mesh-list
139487317|NCT05602311|Anesthetics, General|anesthetics, general|mesh-list
139487318|NCT05602311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487319|NCT05602311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487320|NCT05016349|Tamoxifen|tamoxifen|mesh-list
139487321|NCT05016349|Tocopherols|tocopherols|mesh-list
139487322|NCT05016349|Tretinoin|tretinoin|mesh-list
139487323|NCT05016349|Alitretinoin|alitretinoin|mesh-list
139487324|NCT05016349|Cannabidiol|cannabidiol|mesh-list
139487325|NCT05016349|Isotretinoin|isotretinoin|mesh-list
139487326|NCT05016349|Mifepristone|mifepristone|mesh-list
139487327|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139487328|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
139487329|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139487330|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487331|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139487332|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487333|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139487334|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139487335|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139487336|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
139487337|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
139487338|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
139487339|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139487340|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
139487341|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139487342|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139487343|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139487344|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139487345|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
139487346|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139487347|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139487348|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
139487349|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139487350|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139487351|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
139487352|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487353|NCT05016349|Protective Agents|protective agents|mesh-ancestor
139487354|NCT05016349|Vitamins|vitamins|mesh-ancestor
139487355|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
139487356|NCT05380635|Hypericin|hypericin|mesh-list
139487357|NCT05380635|Antidepressive Agents|antidepressive agents|mesh-ancestor
139487358|NCT05380635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139487359|NCT05380635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487360|NCT05380635|Antiviral Agents|antiviral agents|mesh-ancestor
139487361|NCT05380635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487362|NCT05380635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487363|NCT05380635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487364|NCT05380635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139487365|NCT05380635|Immunologic Factors|immunologic factors|mesh-ancestor
139487366|NCT05380635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487367|NCT05538819|Glimepiride|glimepiride|mesh-list
139487368|NCT05538819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139487369|NCT05538819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139487370|NCT05538819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487371|NCT05538819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139487372|NCT05538819|Immunologic Factors|immunologic factors|mesh-ancestor
139487373|NCT03079219|Dexamethasone|dexamethasone|mesh-list
139487374|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
139487375|NCT03079219|Ondansetron|ondansetron|mesh-list
139487376|NCT03079219|Olanzapine|olanzapine|mesh-list
139487377|NCT03079219|Aprepitant|aprepitant|mesh-list
139487378|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
139487379|NCT03079219|BB 1101|bb 1101|mesh-list
139487380|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139487381|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
139487382|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
139487383|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487384|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487385|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139487386|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
139487387|NCT03079219|Hormones|hormones|mesh-ancestor
139487388|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139487389|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139487390|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487391|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
139487392|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487393|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487394|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
139487395|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
139487396|NCT03079219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139487397|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139487398|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
139487399|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487400|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139487401|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139487402|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487403|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139487404|NCT03079219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139487405|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139487406|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139487407|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139487408|NCT03078829|Leuprolide|leuprolide|mesh-list
139487409|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139487410|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
139487411|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139487412|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487413|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139487414|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487415|NCT05008237|Docetaxel|docetaxel|mesh-list
139487416|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487417|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
139487418|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
139487419|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
139487420|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487421|NCT05014711|Fentanyl|fentanyl|mesh-list
139487422|NCT05014711|Remifentanil|remifentanil|mesh-list
139274097|NCT04313608|Gemcitabine|gemcitabine|mesh-list
139487423|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139487424|NCT05014711|Narcotics|narcotics|mesh-ancestor
139487425|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487426|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487427|NCT05014711|Analgesics|analgesics|mesh-ancestor
139487428|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
139487429|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487430|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139487431|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139487432|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
139013803|NCT05606692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139013806|NCT05606692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139487433|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
139487434|NCT05018923|Metronidazole|metronidazole|mesh-list
139487435|NCT05018923|Doxycycline|doxycycline|mesh-list
139487436|NCT05018923|Tetracycline|tetracycline|mesh-list
139487437|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
139487438|NCT05018923|Rabeprazole|rabeprazole|mesh-list
139487439|NCT05018923|Bismuth|bismuth|mesh-list
139487440|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487441|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487442|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139487443|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139487444|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139487445|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
139487446|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139487447|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139487448|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139487449|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487450|NCT05018923|Antacids|antacids|mesh-ancestor
139487451|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139487452|NCT05018923|Diuretics|diuretics|mesh-ancestor
139487453|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
139487454|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487455|NCT05018923|Expectorants|expectorants|mesh-ancestor
139487456|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
139487457|NCT03086473|Caffeine|caffeine|mesh-list
139487458|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
139487459|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487460|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139487461|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487462|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139487463|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487464|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139487465|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139487466|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
139487467|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487468|NCT03086005|Metformin|metformin|mesh-list
139487469|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139487470|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487471|NCT03079141|Eplerenone|eplerenone|mesh-list
139487472|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139487473|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
139487474|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139487475|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487476|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139487477|NCT03079141|Diuretics|diuretics|mesh-ancestor
139487478|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
139487479|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139487480|NCT03085849|Durvalumab|durvalumab|mesh-list
139487481|NCT03085849|Tremelimumab|tremelimumab|mesh-list
139487482|NCT03085849|Guadecitabine|guadecitabine|mesh-list
139487483|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139487484|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487485|NCT05001529|Antibodies|antibodies|mesh-list
139487486|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
139487487|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487488|NCT05001061|Misoprostol|misoprostol|mesh-list
139487489|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139487490|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
139487491|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139487492|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487493|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139487494|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139487495|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
139487496|NCT05531955|Pirfenidone|pirfenidone|mesh-list
139487497|NCT05531955|Analgesics|analgesics|mesh-ancestor
139487498|NCT05531955|Sensory System Agents|sensory system agents|mesh-ancestor
139487499|NCT05531955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487500|NCT05531955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487501|NCT05531955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139487502|NCT05531955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139487503|NCT05531955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139487504|NCT05531955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139487505|NCT05531955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487506|NCT05006911|Bromfenac|bromfenac|mesh-list
139487507|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139487508|NCT05006911|Phenylephrine|phenylephrine|mesh-list
139487509|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
139487510|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
139487511|NCT05006911|Pilocarpine|pilocarpine|mesh-list
139487512|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139487513|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
138764583|NCT04208581|Xhance|xhance|mesh-list
139487514|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487515|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
139487516|NCT05006911|Protective Agents|protective agents|mesh-ancestor
139487517|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139487518|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139487519|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139487520|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139487521|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
139487522|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487523|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487524|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
139487525|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
139487526|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487527|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
139487528|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139487529|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
139487530|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139487531|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
139487532|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139487533|NCT05006911|Miotics|miotics|mesh-ancestor
139487534|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139487535|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139487536|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
139487537|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139487538|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139487539|NCT05006911|Analgesics|analgesics|mesh-ancestor
139487540|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
139487541|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139487542|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139487543|NCT05339295|Levofloxacin|levofloxacin|mesh-list
139487544|NCT05339295|Ofloxacin|ofloxacin|mesh-list
139487545|NCT05339295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139487546|NCT05339295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487547|NCT05339295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139487548|NCT05339295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139487549|NCT05339295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139487550|NCT05339295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487551|NCT05339295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487552|NCT05339295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487553|NCT05339295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139487554|NCT05339295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139487555|NCT02637037|Metformin|metformin|mesh-list
139487556|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
139487557|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139487558|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487559|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139487560|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487561|NCT05307081|Lubricant Eye Drops|lubricant eye drops|mesh-list
139487562|NCT05307081|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139487563|NCT05307081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139487564|NCT05306535|Salicylic Acid|salicylic acid|mesh-list
139487565|NCT05306535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487566|NCT05306535|Antifungal Agents|antifungal agents|mesh-ancestor
139487567|NCT05306535|Keratolytic Agents|keratolytic agents|mesh-ancestor
139487568|NCT05306535|Dermatologic Agents|dermatologic agents|mesh-ancestor
139487569|NCT02637895|Vortioxetine|vortioxetine|mesh-list
139487570|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
139487571|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139487572|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139487573|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139487574|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487575|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487576|NCT02637895|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139487577|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139487578|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139487579|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487580|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487581|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
139487582|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139487583|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139487584|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139487585|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139487586|NCT05013697|Paclitaxel|paclitaxel|mesh-list
139487587|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139487588|NCT05013697|Cisplatin|cisplatin|mesh-list
139487589|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139487590|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487591|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
139487592|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
139487593|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
139487594|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487595|NCT05305911|Dapagliflozin|dapagliflozin|mesh-list
139487596|NCT05305911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139487597|NCT05305911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487598|NCT05305911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139487599|NCT05305911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487600|NCT05349435|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139487601|NCT05349435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487602|NCT05007223|Doxycycline|doxycycline|mesh-list
139487603|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139487604|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487605|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
139487606|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139487607|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139487608|NCT05000281|Ibuprofen|ibuprofen|mesh-list
139487609|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139487610|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139487611|NCT05000281|Analgesics|analgesics|mesh-ancestor
139487612|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
139487613|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487614|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487615|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139487616|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139487617|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139487618|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487619|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487620|NCT03081949|Selenium|selenium|mesh-list
139487621|NCT03081949|Selenious Acid|selenious acid|mesh-list
139487622|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
139487623|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
139487624|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487625|NCT03081949|Protective Agents|protective agents|mesh-ancestor
139487626|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487627|NCT03081949|Trace Elements|trace elements|mesh-ancestor
139487628|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
139274318|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
139274319|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139274320|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139274321|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139274322|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139274323|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
139274324|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139274325|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274348|NCT05193968|Nitroprusside|nitroprusside|mesh-list
139274349|NCT05193968|Norepinephrine|norepinephrine|mesh-list
139274350|NCT05193968|Acetylcholine|acetylcholine|mesh-list
139274351|NCT05193968|Terbutaline|terbutaline|mesh-list
139274352|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139274353|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139274354|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
139274355|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139274356|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139274357|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139274358|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
139274359|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
139274360|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139274361|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139014000|NCT06013540|Glucocorticoids|glucocorticoids|mesh-ancestor
139274363|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
139487630|NCT05347173|Nalbuphine|nalbuphine|mesh-list
139487631|NCT05347173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139487632|NCT05347173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487633|NCT05347173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487634|NCT05347173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139487635|NCT05347173|Analgesics|analgesics|mesh-ancestor
139487636|NCT05347173|Sensory System Agents|sensory system agents|mesh-ancestor
139487637|NCT05347173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487638|NCT05347173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139487639|NCT05347173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139487640|NCT05347173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139487641|NCT05347173|Adrenergic Agents|adrenergic agents|mesh-ancestor
139487642|NCT05347173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487643|NCT05347173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487644|NCT05347173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139487645|NCT05347173|Narcotics|narcotics|mesh-ancestor
139487646|NCT05006287|Warfarin|warfarin|mesh-list
139487647|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
139487648|NCT05006287|Dabigatran|dabigatran|mesh-list
139487649|NCT05006287|Apixaban|apixaban|mesh-list
139487650|NCT05006287|Anticoagulants|anticoagulants|mesh-list
139487651|NCT05006287|Edoxaban|edoxaban|mesh-list
139487652|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139487653|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
139487654|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139487655|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
139487656|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487657|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487658|NCT05013151|Castor Oil|castor oil|mesh-list
139487659|NCT05013151|Cathartics|cathartics|mesh-ancestor
139487660|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139487661|NCT05006209|Calcium|calcium|mesh-list
139487662|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139487663|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487664|NCT05335629|Dapagliflozin|dapagliflozin|mesh-list
139487665|NCT05335629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139487666|NCT05335629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487667|NCT05335629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139487668|NCT05335629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487669|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
139487670|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139487671|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487672|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487673|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139487674|NCT03076099|Analgesics|analgesics|mesh-ancestor
139487675|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
139487676|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487677|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139487678|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139487679|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139487680|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
139487681|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487682|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487683|NCT05554965|Propofol|propofol|mesh-list
139487684|NCT05554965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139487685|NCT05554965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487686|NCT05554965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487687|NCT05554965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139487688|NCT05554965|Anesthetics, General|anesthetics, general|mesh-ancestor
139487689|NCT05554965|Anesthetics|anesthetics|mesh-ancestor
139487690|NCT05331573|Apomorphine|apomorphine|mesh-list
139487691|NCT05331573|Emetics|emetics|mesh-ancestor
139487692|NCT05331573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487693|NCT05331573|Autonomic Agents|autonomic agents|mesh-ancestor
139487694|NCT05331573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487695|NCT05331573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139487696|NCT05331573|Dopamine Agonists|dopamine agonists|mesh-ancestor
139487697|NCT05331573|Dopamine Agents|dopamine agents|mesh-ancestor
139487698|NCT05331573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487699|NCT05331573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487700|NCT05260359|Ethanol|ethanol|mesh-list
139487701|NCT05260359|Sunscreening Agents|sunscreening agents|mesh-list
139487702|NCT05260359|Petrolatum|petrolatum|mesh-list
139487703|NCT05260359|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139487704|NCT05260359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487705|NCT05260359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487706|NCT05260359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487707|NCT05260359|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139487708|NCT05260359|Protective Agents|protective agents|mesh-ancestor
139487709|NCT05260359|Dermatologic Agents|dermatologic agents|mesh-ancestor
139487710|NCT05260359|Emollients|emollients|mesh-ancestor
139487711|NCT05294835|Ketamine|ketamine|mesh-list
139487712|NCT05294835|Analgesics|analgesics|mesh-ancestor
139014112|NCT05631886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139014113|NCT05631886|Paclitaxel|paclitaxel|mesh-list
139014114|NCT05631886|Antibodies|antibodies|mesh-list
139014115|NCT05631886|Immunoglobulins|immunoglobulins|mesh-list
139487713|NCT05294835|Sensory System Agents|sensory system agents|mesh-ancestor
139487714|NCT05294835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487715|NCT05294835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487716|NCT05294835|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139487717|NCT05294835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139487718|NCT05294835|Anesthetics, General|anesthetics, general|mesh-ancestor
139487719|NCT05294835|Anesthetics|anesthetics|mesh-ancestor
139487720|NCT05294835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487721|NCT05294835|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139487722|NCT05294835|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139487723|NCT05294835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487724|NCT05294835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487725|NCT02522325|Cocaine|cocaine|mesh-list
139487726|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
139487727|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
139487728|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
139487729|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487730|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487731|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
139487732|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487733|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139487734|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139487735|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139487736|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139487737|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487738|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
139487739|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487740|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139014147|NCT05368207|Pembrolizumab|pembrolizumab|mesh-list
139014148|NCT05368207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014149|NCT05368207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014150|NCT05368207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139014151|NCT05368207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487741|NCT01659021|Ofatumumab|ofatumumab|mesh-list
139487742|NCT01659021|Idelalisib|idelalisib|mesh-list
139487743|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487744|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487745|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487746|NCT05012137|Ropivacaine|ropivacaine|mesh-list
139487747|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
139487748|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
139487749|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487750|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487751|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
139487752|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487753|NCT06163170|Nivolumab|nivolumab|mesh-list
139487754|NCT06163170|Ipilimumab|ipilimumab|mesh-list
139487755|NCT06163170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139487756|NCT06163170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487757|NCT06163170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139487758|NCT06163170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487759|NCT06163053|Immunomodulating Agents|immunomodulating agents|mesh-list
139487760|NCT06163053|Immunologic Factors|immunologic factors|mesh-ancestor
139487761|NCT06163053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487762|NCT06163040|Dexamethasone|dexamethasone|mesh-list
139487763|NCT06163040|Dexamethasone acetate|dexamethasone acetate|mesh-list
139487764|NCT06163040|Lenalidomide|lenalidomide|mesh-list
139487765|NCT06163040|Pomalidomide|pomalidomide|mesh-list
139487766|NCT06163040|Elotuzumab|elotuzumab|mesh-list
139487767|NCT06163040|BB 1101|bb 1101|mesh-list
139487768|NCT06163040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139487769|NCT06163040|Antiemetics|antiemetics|mesh-ancestor
139487770|NCT06163040|Autonomic Agents|autonomic agents|mesh-ancestor
139487771|NCT06163040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487772|NCT06163040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487773|NCT06163040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139487774|NCT06163040|Glucocorticoids|glucocorticoids|mesh-ancestor
139487775|NCT06163040|Hormones|hormones|mesh-ancestor
139487776|NCT06163040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139487777|NCT06163040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139487778|NCT06163040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139274470|NCT05136508|Propofol|propofol|mesh-list
139487779|NCT06163040|Protease Inhibitors|protease inhibitors|mesh-ancestor
139487780|NCT06163040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487781|NCT06163040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487782|NCT06163040|Immunologic Factors|immunologic factors|mesh-ancestor
139487783|NCT06163040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139487784|NCT06163040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139487785|NCT06163040|Growth Substances|growth substances|mesh-ancestor
139487786|NCT06163040|Growth Inhibitors|growth inhibitors|mesh-ancestor
139487787|NCT06162832|Becaplermin|becaplermin|mesh-list
139487788|NCT06162832|Anticoagulants|anticoagulants|mesh-ancestor
139487789|NCT06162832|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
139487790|NCT06162832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139487791|NCT06162832|Growth Substances|growth substances|mesh-ancestor
139014177|NCT05104047|Lobeline|lobeline|mesh-list
139487792|NCT06162832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487793|NCT06162715|Tirzepatide|tirzepatide|mesh-list
139487794|NCT06162715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139487795|NCT06162715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487796|NCT06162715|Incretins|incretins|mesh-ancestor
139487797|NCT06162715|Hormones|hormones|mesh-ancestor
139487798|NCT06162715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139487799|NCT06162663|Suvorexant|suvorexant|mesh-list
139487800|NCT06162663|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139487801|NCT06162663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139487802|NCT06162663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487803|NCT06162663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487804|NCT06162663|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139487805|NCT06162663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487806|NCT06162663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487807|NCT06162572|Cemiplimab|cemiplimab|mesh-list
139487808|NCT06162572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139487809|NCT06162572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487810|NCT06162468|Paclitaxel|paclitaxel|mesh-list
139487811|NCT06162468|Gemcitabine|gemcitabine|mesh-list
139487812|NCT06162468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139487813|NCT06162468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487814|NCT06162468|Tubulin Modulators|tubulin modulators|mesh-ancestor
138986235|NCT00712049|Niacin|niacin|mesh-list
139487815|NCT06162468|Antimitotic Agents|antimitotic agents|mesh-ancestor
139487816|NCT06162468|Mitosis Modulators|mitosis modulators|mesh-ancestor
139487817|NCT06162468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487818|NCT06162468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139487819|NCT06162468|Antimetabolites|antimetabolites|mesh-ancestor
139487820|NCT06162455|Nitric Oxide|nitric oxide|mesh-list
139487821|NCT06162455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139487822|NCT06162455|Autonomic Agents|autonomic agents|mesh-ancestor
139487823|NCT06162455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487824|NCT06162455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487825|NCT06162455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139487826|NCT06162455|Respiratory System Agents|respiratory system agents|mesh-ancestor
139487827|NCT06162455|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139487828|NCT06162455|Antioxidants|antioxidants|mesh-ancestor
139487829|NCT06162455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487830|NCT06162455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487831|NCT06162455|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139487832|NCT06162455|Vasodilator Agents|vasodilator agents|mesh-ancestor
139487833|NCT06162455|Gasotransmitters|gasotransmitters|mesh-ancestor
139487834|NCT06162455|Protective Agents|protective agents|mesh-ancestor
139487835|NCT06162442|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139487836|NCT06162442|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139487837|NCT06162390|Remifentanil|remifentanil|mesh-list
139487838|NCT06162390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139487839|NCT06162390|Narcotics|narcotics|mesh-ancestor
139487840|NCT06162390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487841|NCT06162390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487842|NCT06162390|Analgesics|analgesics|mesh-ancestor
139487843|NCT06162390|Sensory System Agents|sensory system agents|mesh-ancestor
139014235|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
139487844|NCT06162390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487845|NCT06162286|Moxifloxacin|moxifloxacin|mesh-list
139487846|NCT06162286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139487847|NCT06162286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487848|NCT06162286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139487849|NCT06162286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139487850|NCT06162286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487851|NCT06162286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487852|NCT06162286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487853|NCT06162169|Itraconazole|itraconazole|mesh-list
139487854|NCT06162169|Rifampin|rifampin|mesh-list
139487855|NCT06162169|Digoxin|digoxin|mesh-list
139487856|NCT06162169|Midazolam|midazolam|mesh-list
139487857|NCT06162169|Omeprazole|omeprazole|mesh-list
139487858|NCT06162169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139487859|NCT06162169|Calcium|calcium|mesh-list
139487860|NCT06162169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139487861|NCT06162169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487862|NCT06162169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139487863|NCT06162169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139487864|NCT06162169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487865|NCT06162169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139487866|NCT06162169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139487867|NCT06162169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139487868|NCT06162169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139487869|NCT06162169|Anesthetics, General|anesthetics, general|mesh-ancestor
139487870|NCT06162169|Anesthetics|anesthetics|mesh-ancestor
139487871|NCT06162169|GABA Modulators|gaba modulators|mesh-ancestor
139487872|NCT06162169|GABA Agents|gaba agents|mesh-ancestor
139487873|NCT06162169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487874|NCT06162169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487875|NCT06162169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139487876|NCT06162169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139487877|NCT06162169|Antimetabolites|antimetabolites|mesh-ancestor
139487878|NCT06162169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139487879|NCT06162169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139487880|NCT06162169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487881|NCT06162169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139487882|NCT06162169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139487883|NCT06162169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139487884|NCT06162169|Antifungal Agents|antifungal agents|mesh-ancestor
139487885|NCT06162169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487886|NCT06162169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139487887|NCT06162169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139487888|NCT06162169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139487889|NCT06162169|Hormone Antagonists|hormone antagonists|mesh-ancestor
139487890|NCT06162169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139487891|NCT06162169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139487892|NCT06162169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139487893|NCT06162169|Antitubercular Agents|antitubercular agents|mesh-ancestor
139487894|NCT06162169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139487895|NCT06162169|Leprostatic Agents|leprostatic agents|mesh-ancestor
139487896|NCT06162169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139487897|NCT06162169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139487898|NCT06162169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139487899|NCT06162169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139487900|NCT06162169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139487901|NCT06162169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139487902|NCT06162169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139014284|NCT04361708|Irinotecan|irinotecan|mesh-list
139487903|NCT06162169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139487904|NCT06162169|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139487905|NCT06162169|Protective Agents|protective agents|mesh-ancestor
139487906|NCT06162065|Oxybutynin|oxybutynin|mesh-list
139487907|NCT06162065|Parasympatholytics|parasympatholytics|mesh-ancestor
139487908|NCT06162065|Autonomic Agents|autonomic agents|mesh-ancestor
139487909|NCT06162065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487910|NCT06162065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487911|NCT06162065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139487912|NCT06162065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139487913|NCT06162065|Cholinergic Agents|cholinergic agents|mesh-ancestor
139487914|NCT06162065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487915|NCT06162065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487916|NCT06162065|Urological Agents|urological agents|mesh-ancestor
139487917|NCT06161870|Vancomycin|vancomycin|mesh-list
139487918|NCT06161870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139487919|NCT06161870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487920|NCT06161766|Terlipressin|terlipressin|mesh-list
139487921|NCT06161766|Norepinephrine|norepinephrine|mesh-list
139487922|NCT06161766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139487923|NCT06161766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139487924|NCT06161766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139487925|NCT06161766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139487926|NCT06161766|Adrenergic Agents|adrenergic agents|mesh-ancestor
139487927|NCT06161766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487928|NCT06161766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487929|NCT06161766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487930|NCT06161766|Sympathomimetics|sympathomimetics|mesh-ancestor
139487931|NCT06161766|Autonomic Agents|autonomic agents|mesh-ancestor
139487932|NCT06161766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487933|NCT06161714|Lidocaine|lidocaine|mesh-list
139487934|NCT06161714|Carticaine|carticaine|mesh-list
139487935|NCT06161714|Anesthetics, Local|anesthetics, local|mesh-ancestor
139487936|NCT06161714|Anesthetics|anesthetics|mesh-ancestor
139487937|NCT06161714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487938|NCT06161714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487939|NCT06161714|Sensory System Agents|sensory system agents|mesh-ancestor
139487940|NCT06161714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487941|NCT06161714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139487942|NCT06161714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139487943|NCT06161714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139487944|NCT06161714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139487945|NCT06161714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487946|NCT06161493|Niraparib|niraparib|mesh-list
139487947|NCT06161493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139487948|NCT06161493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487949|NCT06161493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487950|NCT06161493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139487951|NCT06160492|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139487952|NCT06160492|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139487953|NCT06160492|Dermatologic Agents|dermatologic agents|mesh-ancestor
139487954|NCT06155773|Methamphetamine|methamphetamine|mesh-list
139487955|NCT06155773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139487956|NCT06155773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487957|NCT06155773|Sympathomimetics|sympathomimetics|mesh-ancestor
139487958|NCT06155773|Autonomic Agents|autonomic agents|mesh-ancestor
139487959|NCT06155773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487960|NCT06155773|Dopamine Agents|dopamine agents|mesh-ancestor
139487961|NCT06155773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487962|NCT06155773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487963|NCT06155773|Adrenergic Agents|adrenergic agents|mesh-ancestor
139487964|NCT06155773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139487965|NCT06155773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139014343|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
139487966|NCT06155773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139487967|NCT06155773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139487968|NCT06154720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139487969|NCT06154720|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139487970|NCT06154720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139487971|NCT06154720|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139487972|NCT06154720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139487973|NCT06154720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487974|NCT06154434|Chlorpromazine|chlorpromazine|mesh-list
139487975|NCT06154434|Antiemetics|antiemetics|mesh-ancestor
139487976|NCT06154434|Autonomic Agents|autonomic agents|mesh-ancestor
139487977|NCT06154434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139487978|NCT06154434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487979|NCT06154434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139487980|NCT06154434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139487981|NCT06154434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139487982|NCT06154434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139487983|NCT06154434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139487984|NCT06154434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139487985|NCT06154434|Dopamine Agents|dopamine agents|mesh-ancestor
139487986|NCT06154434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139487987|NCT06154434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487988|NCT06153004|Antidepressive Agents|antidepressive agents|mesh-list
139487989|NCT06153004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139487990|NCT06147518|Metformin|metformin|mesh-list
139487991|NCT06147518|Dapagliflozin|dapagliflozin|mesh-list
139487992|NCT06147518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139487993|NCT06147518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139487994|NCT06147518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139487995|NCT06147518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139487996|NCT06147518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139487997|NCT06147518|Incretins|incretins|mesh-ancestor
139487998|NCT06147518|Hormones|hormones|mesh-ancestor
139487999|NCT06147518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139488000|NCT06147518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139488001|NCT06147518|Protease Inhibitors|protease inhibitors|mesh-ancestor
139488003|NCT06143059|Ethanol|ethanol|mesh-list
139488004|NCT06143059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139488005|NCT06143059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488006|NCT06143059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139488007|NCT06143059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488008|NCT06141239|Calcitriol|calcitriol|mesh-list
139488009|NCT06141239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139488010|NCT06141239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488011|NCT06141239|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139488012|NCT06141239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139488013|NCT06141239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488014|NCT06141239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139488015|NCT06141239|Vitamins|vitamins|mesh-ancestor
139488016|NCT06141239|Micronutrients|micronutrients|mesh-ancestor
139488017|NCT06141239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139488018|NCT06140108|Metformin|metformin|mesh-list
139488019|NCT06140108|Empagliflozin|empagliflozin|mesh-list
139488020|NCT06140108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139488021|NCT06140108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488022|NCT06140108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139488023|NCT06140108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488024|NCT06112392|Antiparkinson Agents|antiparkinson agents|mesh-list
139488025|NCT06112392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139488026|NCT06106009|Midazolam|midazolam|mesh-list
139488027|NCT06106009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139488028|NCT06106009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139488029|NCT06106009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139488030|NCT06106009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488031|NCT06106009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139488032|NCT06106009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139488033|NCT06106009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139488034|NCT06106009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139488035|NCT06106009|Anesthetics, General|anesthetics, general|mesh-ancestor
139488036|NCT06106009|Anesthetics|anesthetics|mesh-ancestor
139488037|NCT06106009|GABA Modulators|gaba modulators|mesh-ancestor
139488038|NCT06106009|GABA Agents|gaba agents|mesh-ancestor
139488039|NCT06106009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139488040|NCT06106009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488041|NCT06087237|Pentoxifylline|pentoxifylline|mesh-list
139488042|NCT06087237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139488043|NCT06087237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488044|NCT06087237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488045|NCT06087237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139488046|NCT06087237|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139488047|NCT06087237|Protective Agents|protective agents|mesh-ancestor
139488048|NCT06087237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488049|NCT06087237|Vasodilator Agents|vasodilator agents|mesh-ancestor
139488050|NCT06087237|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139488051|NCT06087237|Antioxidants|antioxidants|mesh-ancestor
139488052|NCT06074315|Triamcinolone|triamcinolone|mesh-list
139488053|NCT06074315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139488054|NCT06074315|Glucocorticoids|glucocorticoids|mesh-ancestor
139488055|NCT06074315|Hormones|hormones|mesh-ancestor
139488056|NCT06074315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139488057|NCT06074315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488058|NCT06067958|Dexmedetomidine|dexmedetomidine|mesh-list
139488059|NCT06067958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139488060|NCT06067958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139488061|NCT06067958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488062|NCT06067958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139488063|NCT06067958|Analgesics|analgesics|mesh-ancestor
139488064|NCT06067958|Sensory System Agents|sensory system agents|mesh-ancestor
139488065|NCT06067958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488066|NCT06067958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139488067|NCT06067958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139488068|NCT06067958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139488069|NCT06067958|Adrenergic Agents|adrenergic agents|mesh-ancestor
139488070|NCT06067958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139488071|NCT06067958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488072|NCT06004752|Cyclosporine|cyclosporine|mesh-list
139488073|NCT06004752|Cyclosporins|cyclosporins|mesh-list
139274771|NCT02130804|Analgesics|analgesics|mesh-ancestor
139488074|NCT06004752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488075|NCT06004752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488076|NCT06004752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139488077|NCT06004752|Immunologic Factors|immunologic factors|mesh-ancestor
139488078|NCT06004752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488079|NCT06004752|Antifungal Agents|antifungal agents|mesh-ancestor
139488080|NCT06004752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488081|NCT06004752|Dermatologic Agents|dermatologic agents|mesh-ancestor
139488082|NCT06004752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139488083|NCT06004752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139488084|NCT05998239|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
139488085|NCT05998239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488086|NCT05998239|Immunologic Factors|immunologic factors|mesh-ancestor
139488087|NCT05998239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488088|NCT05987124|Defibrotide|defibrotide|mesh-list
139488089|NCT05987124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139488090|NCT05987124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139488091|NCT05987124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488092|NCT05987124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139488093|NCT05971602|Rifampin|rifampin|mesh-list
139488094|NCT05971602|Isoniazid|isoniazid|mesh-list
139488095|NCT05971602|Pyrazinamide|pyrazinamide|mesh-list
139488096|NCT05971602|Ethambutol|ethambutol|mesh-list
139488097|NCT05971602|Bedaquiline|bedaquiline|mesh-list
139488098|NCT05971602|Diarylquinolines|diarylquinolines|mesh-list
139488099|NCT05971602|Oxazolidinones|oxazolidinones|mesh-list
139488100|NCT05971602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139488101|NCT05971602|Antitubercular Agents|antitubercular agents|mesh-ancestor
139488102|NCT05971602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139488103|NCT05971602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488104|NCT05971602|Leprostatic Agents|leprostatic agents|mesh-ancestor
139488105|NCT05971602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139488106|NCT05971602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488107|NCT05971602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488108|NCT05971602|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139488109|NCT05971602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139488110|NCT05971602|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139488111|NCT05971602|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139488112|NCT05971602|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139488113|NCT05971602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139488114|NCT05971602|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139488115|NCT05971602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139488116|NCT05971602|Antimetabolites|antimetabolites|mesh-ancestor
139488117|NCT05971602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139488118|NCT05971602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139488119|NCT05971485|Melatonin|melatonin|mesh-list
139488120|NCT05971485|Antioxidants|antioxidants|mesh-ancestor
139488121|NCT05971485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488122|NCT05971485|Protective Agents|protective agents|mesh-ancestor
139488123|NCT05971485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488124|NCT05971485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139488125|NCT05946603|Fluorophosphate|fluorophosphate|mesh-list
139488126|NCT05946603|Cariostatic Agents|cariostatic agents|mesh-ancestor
139488127|NCT05946603|Protective Agents|protective agents|mesh-ancestor
139488128|NCT05946603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488129|NCT05928039|Adalimumab|adalimumab|mesh-list
139488130|NCT05928039|Infliximab|infliximab|mesh-list
139488131|NCT05928039|Interleukin-12|interleukin-12|mesh-list
139488132|NCT05928039|Interleukin-23|interleukin-23|mesh-list
139488133|NCT05928039|Ustekinumab|ustekinumab|mesh-list
139488134|NCT05928039|Vedolizumab|vedolizumab|mesh-list
139488135|NCT05928039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139488136|NCT05928039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139488137|NCT05928039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139488138|NCT05928039|Dermatologic Agents|dermatologic agents|mesh-ancestor
139488139|NCT05928039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139488140|NCT05928039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139488141|NCT05928039|Immunologic Factors|immunologic factors|mesh-ancestor
139488142|NCT05928039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488143|NCT05928039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139488144|NCT05928039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139488145|NCT05928039|Growth Substances|growth substances|mesh-ancestor
139488146|NCT05928039|Growth Inhibitors|growth inhibitors|mesh-ancestor
139488147|NCT05928039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488148|NCT05918328|Paclitaxel|paclitaxel|mesh-list
139488149|NCT05918328|Docetaxel|docetaxel|mesh-list
139488150|NCT05918328|Carboplatin|carboplatin|mesh-list
139488151|NCT05918328|Trastuzumab|trastuzumab|mesh-list
139488152|NCT05918328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139488153|NCT05918328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488154|NCT05918328|Tubulin Modulators|tubulin modulators|mesh-ancestor
139488155|NCT05918328|Antimitotic Agents|antimitotic agents|mesh-ancestor
139488156|NCT05918328|Mitosis Modulators|mitosis modulators|mesh-ancestor
139488157|NCT05918328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488158|NCT05918328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488159|NCT05903040|Lasmiditan|lasmiditan|mesh-list
139488160|NCT05903040|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139488161|NCT05903040|Serotonin Agents|serotonin agents|mesh-ancestor
139488162|NCT05903040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139488163|NCT05903040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488164|NCT05903040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488165|NCT05878249|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139488166|NCT05878249|Eusol|eusol|mesh-list
139488167|NCT05878249|Edetic Acid|edetic acid|mesh-list
139488168|NCT05878249|Pentetic Acid|pentetic acid|mesh-list
139488169|NCT05878249|Disinfectants|disinfectants|mesh-ancestor
139488170|NCT05878249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488171|NCT05878249|Anticoagulants|anticoagulants|mesh-ancestor
139488172|NCT05878249|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139488173|NCT05878249|Chelating Agents|chelating agents|mesh-ancestor
139488174|NCT05878249|Sequestering Agents|sequestering agents|mesh-ancestor
139488175|NCT05878249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488176|NCT05878249|Antidotes|antidotes|mesh-ancestor
139488177|NCT05878249|Protective Agents|protective agents|mesh-ancestor
138848499|NCT00375830|Listerine|listerine|mesh-list
139488178|NCT05878249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488179|NCT05878249|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139488180|NCT05820256|Caseins|caseins|mesh-list
139488181|NCT05820256|Chelating Agents|chelating agents|mesh-ancestor
139488182|NCT05820256|Sequestering Agents|sequestering agents|mesh-ancestor
139488183|NCT05820256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488184|NCT05750459|Artesunate|artesunate|mesh-list
139488185|NCT05750459|Antimalarials|antimalarials|mesh-ancestor
139488186|NCT05750459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139488187|NCT05750459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139488188|NCT05750459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488189|NCT05750459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488190|NCT05750459|Antiviral Agents|antiviral agents|mesh-ancestor
139488191|NCT05750459|Schistosomicides|schistosomicides|mesh-ancestor
139488192|NCT05750459|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139488193|NCT05750459|Anthelmintics|anthelmintics|mesh-ancestor
139488194|NCT05681039|Carboplatin|carboplatin|mesh-list
139488195|NCT05681039|Atezolizumab|atezolizumab|mesh-list
139488196|NCT05681039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488197|NCT05681039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139488198|NCT05681039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488199|NCT05681039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488200|NCT05654467|Vaccines|vaccines|mesh-list
139488201|NCT05654467|Immunologic Factors|immunologic factors|mesh-ancestor
139488202|NCT05654467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488203|NCT05610072|Acetylcysteine|acetylcysteine|mesh-list
139488204|NCT05610072|Hydromorphone|hydromorphone|mesh-list
139488205|NCT05610072|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139488206|NCT05610072|Antiviral Agents|antiviral agents|mesh-ancestor
139488207|NCT05610072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488208|NCT05610072|Expectorants|expectorants|mesh-ancestor
139488209|NCT05610072|Respiratory System Agents|respiratory system agents|mesh-ancestor
139488210|NCT05610072|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139488211|NCT05610072|Antioxidants|antioxidants|mesh-ancestor
139488212|NCT05610072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488213|NCT05610072|Protective Agents|protective agents|mesh-ancestor
139488214|NCT05610072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488215|NCT05610072|Antidotes|antidotes|mesh-ancestor
139488216|NCT05610072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139488217|NCT05610072|Narcotics|narcotics|mesh-ancestor
139488218|NCT05610072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139488219|NCT05610072|Analgesics|analgesics|mesh-ancestor
139488220|NCT05610072|Sensory System Agents|sensory system agents|mesh-ancestor
139488221|NCT05610072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488222|NCT05608291|Pembrolizumab|pembrolizumab|mesh-list
139488223|NCT05608291|Cemiplimab|cemiplimab|mesh-list
139488224|NCT05608291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488225|NCT05608291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488226|NCT05608291|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139488227|NCT05608291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488228|NCT05604300|Vitamin E|vitamin e|mesh-list
139274920|NCT05579418|Evolocumab|evolocumab|mesh-list
139488229|NCT05604300|Vitamins|vitamins|mesh-ancestor
139488230|NCT05604300|Micronutrients|micronutrients|mesh-ancestor
139488231|NCT05604300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488232|NCT05604300|Antioxidants|antioxidants|mesh-ancestor
139488233|NCT05604300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488234|NCT05604300|Protective Agents|protective agents|mesh-ancestor
139488235|NCT05603884|Cytarabine|cytarabine|mesh-list
139488236|NCT05603884|Azacitidine|azacitidine|mesh-list
139488237|NCT05603884|Venetoclax|venetoclax|mesh-list
139488238|NCT05603884|Mitoxantrone|mitoxantrone|mesh-list
139488239|NCT05603884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139488240|NCT05603884|Antimetabolites|antimetabolites|mesh-ancestor
139488241|NCT05603884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488242|NCT05603884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488243|NCT05603884|Antiviral Agents|antiviral agents|mesh-ancestor
139488244|NCT05603884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488245|NCT05603884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139488246|NCT05603884|Immunologic Factors|immunologic factors|mesh-ancestor
139488247|NCT05603884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488248|NCT05603884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488249|NCT05603884|Analgesics|analgesics|mesh-ancestor
139488250|NCT05603884|Sensory System Agents|sensory system agents|mesh-ancestor
139488251|NCT05603884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488252|NCT05603884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139488253|NCT05603884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139488254|NCT05597150|Magnesium citrate|magnesium citrate|mesh-list
139488255|NCT05597150|Cathartics|cathartics|mesh-ancestor
139488256|NCT05597150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139488257|NCT05596214|Curcumin|curcumin|mesh-list
139488258|NCT05596214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139488259|NCT05596214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139488260|NCT05596214|Analgesics|analgesics|mesh-ancestor
139488261|NCT05596214|Sensory System Agents|sensory system agents|mesh-ancestor
139488262|NCT05596214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488263|NCT05596214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488264|NCT05596214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139488265|NCT05596214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139488266|NCT05596214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488267|NCT05596214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488268|NCT05596214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488269|NCT05568797|Vaccines|vaccines|mesh-list
139488270|NCT05568797|Immunologic Factors|immunologic factors|mesh-ancestor
139488271|NCT05568797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488272|NCT05565105|Cyclophosphamide|cyclophosphamide|mesh-list
139488273|NCT05565105|Melphalan|melphalan|mesh-list
139488274|NCT05565105|Busulfan|busulfan|mesh-list
139488275|NCT05565105|Thiotepa|thiotepa|mesh-list
139488276|NCT05565105|Fludarabine|fludarabine|mesh-list
139488277|NCT05565105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139488278|NCT05565105|Immunologic Factors|immunologic factors|mesh-ancestor
139488279|NCT05565105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488280|NCT05565105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139488281|NCT05565105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139488282|NCT05565105|Alkylating Agents|alkylating agents|mesh-ancestor
139488283|NCT05565105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488284|NCT05565105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488285|NCT05565105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139488286|NCT05536154|Cytarabine|cytarabine|mesh-list
139488287|NCT05536154|Etoposide|etoposide|mesh-list
139488288|NCT05536154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139488289|NCT05536154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488290|NCT05536154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139488291|NCT05536154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139488292|NCT05536154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488293|NCT05536154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488294|NCT05536154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139488295|NCT05536154|Antimetabolites|antimetabolites|mesh-ancestor
139488296|NCT05536154|Antiviral Agents|antiviral agents|mesh-ancestor
139488297|NCT05536154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488298|NCT05536154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139488299|NCT05536154|Immunologic Factors|immunologic factors|mesh-ancestor
139488300|NCT05536154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488301|NCT05519254|Lactoferrin|lactoferrin|mesh-list
139488302|NCT05519254|Muramidase|muramidase|mesh-list
139488303|NCT05519254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488304|NCT05442216|Azacitidine|azacitidine|mesh-list
139488305|NCT05442216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139488306|NCT05442216|Antimetabolites|antimetabolites|mesh-ancestor
139488307|NCT05442216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488308|NCT05442216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488309|NCT05442216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488310|NCT05419050|Denosumab|denosumab|mesh-list
139488311|NCT05419050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139488312|NCT05419050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488313|NCT05418907|Exenatide|exenatide|mesh-list
139488314|NCT05418907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139488315|NCT05418907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488316|NCT05418907|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139488317|NCT05418907|Incretins|incretins|mesh-ancestor
139488318|NCT05418907|Hormones|hormones|mesh-ancestor
139488319|NCT05418907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139488320|NCT05361395|Carboplatin|carboplatin|mesh-list
139488321|NCT05361395|Etoposide|etoposide|mesh-list
139488322|NCT05361395|Atezolizumab|atezolizumab|mesh-list
139488323|NCT05361395|Durvalumab|durvalumab|mesh-list
139488324|NCT05361395|AMG 757|amg 757|mesh-list
139488325|NCT05361395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488326|NCT05361395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139488327|NCT05361395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139488328|NCT05361395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139488329|NCT05361395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488330|NCT05361395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488331|NCT05361395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139488332|NCT05361395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488333|NCT05353257|Carboplatin|carboplatin|mesh-list
139488334|NCT05353257|Etoposide|etoposide|mesh-list
139488335|NCT05353257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488336|NCT05353257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139488337|NCT05353257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139488338|NCT05353257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139488339|NCT05353257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488340|NCT05353257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488341|NCT05345132|Magnesium Sulfate|magnesium sulfate|mesh-list
139488342|NCT05345132|Nifedipine|nifedipine|mesh-list
139488343|NCT05345132|Analgesics|analgesics|mesh-ancestor
139488344|NCT05345132|Sensory System Agents|sensory system agents|mesh-ancestor
139488345|NCT05345132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488346|NCT05345132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488347|NCT05345132|Anesthetics|anesthetics|mesh-ancestor
139488348|NCT05345132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139488349|NCT05345132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139488350|NCT05345132|Anticonvulsants|anticonvulsants|mesh-ancestor
139488351|NCT05345132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139488352|NCT05345132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139488353|NCT05345132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488354|NCT05345132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139488355|NCT05345132|Tocolytic Agents|tocolytic agents|mesh-ancestor
139488356|NCT05345132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139488357|NCT05345132|Vasodilator Agents|vasodilator agents|mesh-ancestor
139488358|NCT05343806|Magnesium Sulfate|magnesium sulfate|mesh-list
139488359|NCT05343806|Nifedipine|nifedipine|mesh-list
139488360|NCT05343806|Analgesics|analgesics|mesh-ancestor
139488361|NCT05343806|Sensory System Agents|sensory system agents|mesh-ancestor
139488362|NCT05343806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488363|NCT05343806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848691|NCT05275686|Xhance|xhance|mesh-list
139488364|NCT05343806|Anesthetics|anesthetics|mesh-ancestor
139488365|NCT05343806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139488366|NCT05343806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139488367|NCT05343806|Anticonvulsants|anticonvulsants|mesh-ancestor
139488368|NCT05343806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139488369|NCT05343806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139488370|NCT05343806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488371|NCT05343806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139488372|NCT05343806|Tocolytic Agents|tocolytic agents|mesh-ancestor
139488373|NCT05343806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139488374|NCT05343806|Vasodilator Agents|vasodilator agents|mesh-ancestor
139488375|NCT05343312|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139488376|NCT05343312|Antimalarials|antimalarials|mesh-ancestor
139488377|NCT05343312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139488378|NCT05343312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139488379|NCT05343312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139275082|NCT05479578|Hormones|hormones|mesh-ancestor
139488380|NCT05326308|Obinutuzumab|obinutuzumab|mesh-list
139488381|NCT05326308|Zanubrutinib|zanubrutinib|mesh-list
139488382|NCT05326308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488383|NCT05326308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488384|NCT05326308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139488385|NCT05326308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570302|NCT00983931|Colchicine|colchicine|mesh-list
139488386|NCT05326308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488387|NCT05315700|Carboplatin|carboplatin|mesh-list
139488388|NCT05315700|Pemetrexed|pemetrexed|mesh-list
139488389|NCT05315700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488390|NCT05315700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488391|NCT05315700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488392|NCT05315700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139488393|NCT05315700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139488394|NCT05313256|Lidocaine|lidocaine|mesh-list
139488395|NCT05313256|Epinephrine|epinephrine|mesh-list
139488396|NCT05313256|Racepinephrine|racepinephrine|mesh-list
139488397|NCT05313256|Epinephryl borate|epinephryl borate|mesh-list
139488398|NCT05313256|Anesthetics, Local|anesthetics, local|mesh-ancestor
139488399|NCT05313256|Anesthetics|anesthetics|mesh-ancestor
139488400|NCT05313256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139488401|NCT05313256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488402|NCT05313256|Sensory System Agents|sensory system agents|mesh-ancestor
139488403|NCT05313256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488404|NCT05313256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139488405|NCT05313256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139488406|NCT05313256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139488407|NCT05313256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139488408|NCT05313256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488409|NCT05313256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139488410|NCT05313256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139488411|NCT05313256|Adrenergic Agents|adrenergic agents|mesh-ancestor
139488412|NCT05313256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139488413|NCT05313256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139488414|NCT05313256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139488415|NCT05313256|Autonomic Agents|autonomic agents|mesh-ancestor
139488416|NCT05313256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139488417|NCT05313256|Respiratory System Agents|respiratory system agents|mesh-ancestor
139488418|NCT05313256|Mydriatics|mydriatics|mesh-ancestor
139488419|NCT05313256|Sympathomimetics|sympathomimetics|mesh-ancestor
139488420|NCT05313256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139488421|NCT05305859|Azacitidine|azacitidine|mesh-list
139488422|NCT05305859|Venetoclax|venetoclax|mesh-list
139488423|NCT05305859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139488424|NCT05305859|Antimetabolites|antimetabolites|mesh-ancestor
139488425|NCT05305859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488426|NCT05305859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488427|NCT05305859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488428|NCT05302271|Prednisone|prednisone|mesh-list
139488429|NCT05302271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139488430|NCT05302271|Glucocorticoids|glucocorticoids|mesh-ancestor
139488431|NCT05302271|Hormones|hormones|mesh-ancestor
139488432|NCT05302271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139488433|NCT05302271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488434|NCT05302271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139488435|NCT05302271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488436|NCT05280314|Pembrolizumab|pembrolizumab|mesh-list
139488437|NCT05280314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488438|NCT05280314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488439|NCT05280314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139488440|NCT05280314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488441|NCT05269381|Cyclophosphamide|cyclophosphamide|mesh-list
139488442|NCT05269381|Pembrolizumab|pembrolizumab|mesh-list
139488443|NCT05269381|Sargramostim|sargramostim|mesh-list
139488444|NCT05269381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139488445|NCT05269381|Immunologic Factors|immunologic factors|mesh-ancestor
139488446|NCT05269381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488447|NCT05269381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139488448|NCT05269381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139488449|NCT05269381|Alkylating Agents|alkylating agents|mesh-ancestor
139488450|NCT05269381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488451|NCT05269381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488452|NCT05269381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139488453|NCT05269381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488454|NCT05269381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139488455|NCT05223582|Prednisone|prednisone|mesh-list
139488456|NCT05223582|Abiraterone Acetate|abiraterone acetate|mesh-list
139488458|NCT05223582|Androgens|androgens|mesh-list
139488459|NCT05223582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139488460|NCT05223582|Glucocorticoids|glucocorticoids|mesh-ancestor
139488461|NCT05223582|Hormones|hormones|mesh-ancestor
139488462|NCT05223582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139488463|NCT05223582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488464|NCT05223582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139488465|NCT05223582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488466|NCT05223582|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139488467|NCT05223582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488468|NCT05223582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488469|NCT05223582|Hormone Antagonists|hormone antagonists|mesh-ancestor
139488470|NCT05223582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139488471|NCT05223582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139488472|NCT05206448|Letrozole|letrozole|mesh-list
139488473|NCT05206448|Clomiphene|clomiphene|mesh-list
139488474|NCT05206448|Enclomiphene|enclomiphene|mesh-list
139488475|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
139488476|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570303|NCT00983931|Cyclosporins|cyclosporins|mesh-list
139488477|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488478|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139488479|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139488480|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488481|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139488482|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
139488483|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139488484|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488485|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139488486|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
139488487|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139488488|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139488489|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139488490|NCT05193604|Paclitaxel|paclitaxel|mesh-list
139488491|NCT05193604|Gemcitabine|gemcitabine|mesh-list
139488492|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139488493|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488494|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
139488495|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
139488496|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
139488497|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488498|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139488499|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
139488500|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
139488501|NCT05146245|Risperidone|risperidone|mesh-list
139488502|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139488503|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
139488504|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139488505|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488506|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488507|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139488508|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139488509|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139488510|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139488511|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139488512|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
139488513|NCT05040217|Mitogens|mitogens|mesh-list
139488514|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
139488515|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488516|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
139488517|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139488518|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
139488519|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488520|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
139488521|NCT05025865|Protective Agents|protective agents|mesh-ancestor
139488522|NCT05012618|Cetuximab|cetuximab|mesh-list
139488523|NCT05012618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488524|NCT05012618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488525|NCT04978675|Fluorides|fluorides|mesh-list
139488526|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
139488527|NCT04978675|Protective Agents|protective agents|mesh-ancestor
139488528|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488529|NCT04976855|Buprenorphine|buprenorphine|mesh-list
139275215|NCT03523754|Misoprostol|misoprostol|mesh-list
139488530|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139488532|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139488533|NCT04976855|Narcotics|narcotics|mesh-ancestor
139488534|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139488535|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488536|NCT04976855|Analgesics|analgesics|mesh-ancestor
139488537|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
139488538|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488539|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139488540|NCT04919226|Leucovorin|leucovorin|mesh-list
139488541|NCT04919226|Folic Acid|folic acid|mesh-list
139488542|NCT04919226|Capecitabine|capecitabine|mesh-list
139488543|NCT04919226|Fluorouracil|fluorouracil|mesh-list
139488544|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
139488545|NCT04919226|Everolimus|everolimus|mesh-list
139488546|NCT04919226|Temozolomide|temozolomide|mesh-list
139488547|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139488548|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
139488549|NCT04919226|Edotreotide|edotreotide|mesh-list
139488550|NCT04919226|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
139488551|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139488552|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
139488553|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488554|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488555|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139488556|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
139488557|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488558|NCT04919226|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139488559|NCT04919226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139488560|NCT04919226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488561|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139488562|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
139488563|NCT04919226|Antidotes|antidotes|mesh-ancestor
139488564|NCT04919226|Protective Agents|protective agents|mesh-ancestor
139488565|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
139488566|NCT04919226|Vitamins|vitamins|mesh-ancestor
139488567|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
139488568|NCT04919226|Hematinics|hematinics|mesh-ancestor
139488569|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139488570|NCT04904692|Dimercaprol|dimercaprol|mesh-list
138849015|NCT05339646|Ritonavir|ritonavir|mesh-list
139488571|NCT04904692|Chelating Agents|chelating agents|mesh-ancestor
139488572|NCT04904692|Sequestering Agents|sequestering agents|mesh-ancestor
139488573|NCT04904692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488574|NCT04865978|Warfarin|warfarin|mesh-list
139488575|NCT04865978|Apixaban|apixaban|mesh-list
139488576|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
139488577|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139488578|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
139488579|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139488580|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
139488581|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488582|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488583|NCT04861558|Fluorouracil|fluorouracil|mesh-list
139488584|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
139488585|NCT04861558|Irinotecan|irinotecan|mesh-list
139488586|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
139488587|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488588|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139488589|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488590|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139488591|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
139488592|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488593|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139488594|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139488595|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488596|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139488597|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
139488598|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488599|NCT04840862|Rifabutin|rifabutin|mesh-list
139275287|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
139488600|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139488601|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488602|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139488603|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
139488604|NCT04840615|Ipilimumab|ipilimumab|mesh-list
139488605|NCT04840615|LMB-100|lmb-100|mesh-list
139488606|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488607|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488608|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139488609|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488610|NCT04840615|Immunoconjugates|immunoconjugates|mesh-ancestor
139488611|NCT04840615|Immunologic Factors|immunologic factors|mesh-ancestor
139488612|NCT04840615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488613|NCT04778410|Cytarabine|cytarabine|mesh-list
139488614|NCT04778410|Etoposide|etoposide|mesh-list
139488615|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
139488616|NCT04778410|Azacitidine|azacitidine|mesh-list
139488617|NCT04778410|Venetoclax|venetoclax|mesh-list
139488618|NCT04778410|Cc-486|cc-486|mesh-list
139488619|NCT04778410|Magrolimab|magrolimab|mesh-list
139488620|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139488621|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488622|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139488623|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139488624|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488625|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488626|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139488627|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
139488628|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
139488629|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488630|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139488631|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
139488632|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488633|NCT04778410|Analgesics|analgesics|mesh-ancestor
139488634|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
139570304|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488635|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488636|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488637|NCT04772521|Nicotine|nicotine|mesh-list
139488638|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139488639|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
139488640|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488641|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488642|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139488643|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139488644|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
139488645|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139488646|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488647|NCT04755322|Aspirin|aspirin|mesh-list
139488648|NCT04755322|Folic Acid|folic acid|mesh-list
139488649|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
139488650|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139488651|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139488652|NCT04755322|Analgesics|analgesics|mesh-ancestor
139488653|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
139488654|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488655|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488656|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139488657|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139488658|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139488659|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139488660|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488661|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139488662|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139488663|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488664|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
139488665|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
139488666|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139488667|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139488668|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488669|NCT04755322|Hematinics|hematinics|mesh-ancestor
139488670|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
139488671|NCT04755322|Vitamins|vitamins|mesh-ancestor
139488672|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
139488673|NCT04721795|Pyrazinamide|pyrazinamide|mesh-list
139488674|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
139488675|NCT04721795|Atorvastatin|atorvastatin|mesh-list
139488676|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138849189|NCT00879541|Factor VIII|factor viii|mesh-list
139488677|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139488678|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
139488679|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488680|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139488681|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139488682|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488683|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139488684|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488686|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
139488687|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139488688|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
139488689|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139488690|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488691|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
139488692|NCT04644016|Cyclosporine|cyclosporine|mesh-list
139488693|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
139488694|NCT04644016|Fludarabine|fludarabine|mesh-list
139488695|NCT04644016|Busulfan|busulfan|mesh-list
139488696|NCT04644016|Clofarabine|clofarabine|mesh-list
139488697|NCT04644016|Cyclosporins|cyclosporins|mesh-list
139488698|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488699|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139488700|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
139488701|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488702|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139488703|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
139488704|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488705|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488706|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
139488707|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488708|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
139488709|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139488710|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139488711|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139488712|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139488713|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
139488714|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139488715|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
139488716|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139488717|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139488718|NCT04615910|Exenatide|exenatide|mesh-list
139488719|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139488720|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488721|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139488722|NCT04615910|Incretins|incretins|mesh-ancestor
139488723|NCT04615910|Hormones|hormones|mesh-ancestor
139488724|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139488725|NCT04603924|Niclosamide|niclosamide|mesh-list
139488726|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
139488727|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139488728|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
139488729|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139488730|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488731|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
139488732|NCT04596657|Vitamin D|vitamin d|mesh-list
139488733|NCT04596657|Vitamins|vitamins|mesh-ancestor
139488734|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
139488735|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488736|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139488737|NCT04585958|Trastuzumab|trastuzumab|mesh-list
139488738|NCT04585958|Olaparib|olaparib|mesh-list
139488739|NCT04585958|Camptothecin|camptothecin|mesh-list
139488740|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139488741|NCT04585958|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139488742|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
139488743|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488744|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488745|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488746|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849351|NCT02778360|Methylphenidate|methylphenidate|mesh-list
139488747|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
139488748|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488749|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139488750|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139488751|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139488752|NCT04528082|Apremilast|apremilast|mesh-list
139488753|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139488754|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139488755|NCT04528082|Analgesics|analgesics|mesh-ancestor
139488756|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
139488757|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488758|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488759|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139488760|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139488761|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139488762|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139488763|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488764|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488765|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
139488766|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488767|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488768|NCT04513067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139488769|NCT04513067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488770|NCT04505410|Infliximab|infliximab|mesh-list
139488771|NCT04505410|Ustekinumab|ustekinumab|mesh-list
139488772|NCT04505410|Tofacitinib|tofacitinib|mesh-list
139488773|NCT04505410|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139488774|NCT04505410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139488775|NCT04505410|Dermatologic Agents|dermatologic agents|mesh-ancestor
139488776|NCT04505410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139488777|NCT04505410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139488778|NCT04505410|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139488779|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139488780|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488781|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488782|NCT04478266|Letrozole|letrozole|mesh-list
139488783|NCT04478266|Palbociclib|palbociclib|mesh-list
139488784|NCT04478266|Goserelin|goserelin|mesh-list
139488785|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488786|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139488787|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139488788|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488789|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488790|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139488791|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
139488792|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139488793|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488794|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139488795|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139488796|NCT04426968|Interferons|interferons|mesh-list
139488797|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488798|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
139488799|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488800|NCT04356352|Lidocaine|lidocaine|mesh-list
139488801|NCT04356352|Esmolol|esmolol|mesh-list
139488802|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
139488803|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
139488804|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139488805|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488806|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
139488807|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488808|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139488809|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139488810|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139488811|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139488812|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488813|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139488814|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139488815|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139488816|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
139488817|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139488818|NCT04350463|Nivolumab|nivolumab|mesh-list
139488819|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
139488820|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488821|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488822|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139488823|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488824|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488825|NCT04286295|Nicotine|nicotine|mesh-list
139488826|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139488827|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
139488828|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488829|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488830|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139488831|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139488832|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
139488833|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139488834|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488835|NCT04286087|Anesthetics|anesthetics|mesh-list
139488836|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139488837|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488838|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139488839|NCT04285671|Trastuzumab|trastuzumab|mesh-list
139488840|NCT04285671|Necitumumab|necitumumab|mesh-list
139488841|NCT04285671|Osimertinib|osimertinib|mesh-list
139488842|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139488843|NCT04285671|Antibodies|antibodies|mesh-list
139488844|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
139488845|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139488846|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
139488847|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488848|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488849|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488850|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139488851|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488852|NCT04233216|Islatravir|islatravir|mesh-list
139488853|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
139488854|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139488855|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488856|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488857|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139488858|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139488859|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139488860|NCT04218409|Oxycodone|oxycodone|mesh-list
139488861|NCT04218409|Oxytocin|oxytocin|mesh-list
139488862|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
139488863|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139488864|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488865|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139488866|NCT04218409|Narcotics|narcotics|mesh-ancestor
139488867|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139488868|NCT04218409|Analgesics|analgesics|mesh-ancestor
139488869|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
139488870|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488871|NCT04173507|Avelumab|avelumab|mesh-list
139488872|NCT04173507|Talazoparib|talazoparib|mesh-list
139488873|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139488874|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488875|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488876|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139488877|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488878|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488879|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
139488880|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488881|NCT04157348|Benralizumab|benralizumab|mesh-list
139488882|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139488883|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
139488884|NCT04121260|Daratumumab|daratumumab|mesh-list
139488885|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488886|NCT04074330|Rituximab|rituximab|mesh-list
139488887|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488888|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488889|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
139488890|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488891|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139488892|NCT04007874|Vitamin E|vitamin e|mesh-list
139488893|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
139488894|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139488895|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139488896|NCT04007874|Vitamins|vitamins|mesh-ancestor
139488897|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
139488898|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488899|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
139488900|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488901|NCT04007874|Protective Agents|protective agents|mesh-ancestor
139488902|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139488903|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
139488904|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139488905|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139488906|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139488907|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139488908|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139488909|NCT04007874|Estrogens|estrogens|mesh-ancestor
139488910|NCT04007874|Hormones|hormones|mesh-ancestor
139488911|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139488912|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139488913|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
139488914|NCT03978624|Entinostat|entinostat|mesh-list
139488915|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139488916|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488917|NCT03978624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139488918|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488919|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139488920|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488921|NCT03971474|Gemcitabine|gemcitabine|mesh-list
139488922|NCT03971474|Docetaxel|docetaxel|mesh-list
139488923|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
139488924|NCT03971474|Pemetrexed|pemetrexed|mesh-list
139488925|NCT03971474|Ramucirumab|ramucirumab|mesh-list
139488926|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139488927|NCT03971474|Antibodies|antibodies|mesh-list
139488928|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
139488929|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139488930|NCT03971474|Lexatumumab|lexatumumab|mesh-list
139488931|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
139488932|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488933|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139488934|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
139488935|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488936|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488937|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
139488938|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
139488939|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
139488940|NCT03971474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139488941|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139488942|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139488943|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139488944|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
139488945|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139488946|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139488947|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488948|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
139488949|NCT03954314|Coagulants|coagulants|mesh-ancestor
139488950|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
139488951|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139488952|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488953|NCT03926130|Mirikizumab|mirikizumab|mesh-list
139488954|NCT03926130|Ustekinumab|ustekinumab|mesh-list
139488955|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
139488956|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139488957|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139488958|NCT03926130|Analgesics|analgesics|mesh-ancestor
139488959|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
139488960|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488961|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488962|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139488963|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139488964|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139488965|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139488966|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
139488967|NCT03919526|Fludarabine|fludarabine|mesh-list
139488968|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139488969|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
139488970|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488971|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139488972|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139488973|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
139488974|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488975|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139488976|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139488977|NCT03905798|Lorazepam|lorazepam|mesh-list
139488978|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
139488979|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
139488980|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
139488981|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139488982|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488983|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139488984|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139488985|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139275661|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139488986|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139488987|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139488989|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
139488990|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
139488991|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139488992|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139488993|NCT03881696|Omalizumab|omalizumab|mesh-list
139488994|NCT03881696|Immunomodulating Agents|immunomodulating agents|mesh-list
139488995|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
139488996|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139488997|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139488998|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139488999|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139489000|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
139489001|NCT03845296|Rucaparib|rucaparib|mesh-list
139489002|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139489003|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489004|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489005|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489006|NCT03819296|Prednisone|prednisone|mesh-list
139489007|NCT03819296|Infliximab|infliximab|mesh-list
139489008|NCT03819296|Cortisone|cortisone|mesh-list
139489009|NCT03819296|Vedolizumab|vedolizumab|mesh-list
139489010|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
139489011|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
139489012|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139489013|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
139489014|NCT03819296|Hormones|hormones|mesh-ancestor
139489015|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139489016|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489017|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139489018|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489019|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
139489020|NCT03819296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138849777|NCT02774460|Lisinopril|lisinopril|mesh-list
139489021|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
139489022|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139489023|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139489024|NCT03805581|Defibrotide|defibrotide|mesh-list
139489025|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139489026|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139489027|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489028|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139489029|NCT03769766|Curcumin|curcumin|mesh-list
139489030|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139489031|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139489032|NCT03769766|Analgesics|analgesics|mesh-ancestor
139489033|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
139489034|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489035|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489036|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139489037|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139489038|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489039|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489040|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489041|NCT03715933|Carboplatin|carboplatin|mesh-list
139489042|NCT03715933|Fluorouracil|fluorouracil|mesh-list
139489043|NCT03715933|Irinotecan|irinotecan|mesh-list
139489044|NCT03715933|Pemetrexed|pemetrexed|mesh-list
139489045|NCT03715933|Temozolomide|temozolomide|mesh-list
139489046|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849800|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139489047|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
139489048|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489049|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139489050|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139489051|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
139489052|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489053|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139489054|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139489055|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489056|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139489057|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139489058|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139489059|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
139489060|NCT03713580|Venetoclax|venetoclax|mesh-list
139489061|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489062|NCT03703856|Memantine|memantine|mesh-list
139489063|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139489064|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139489065|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
139489066|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139489067|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489068|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489069|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138849853|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139489070|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139489071|NCT03699540|Ethanol|ethanol|mesh-list
139489072|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139489073|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139489074|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489075|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489076|NCT03691714|Cetuximab|cetuximab|mesh-list
139489077|NCT03691714|Durvalumab|durvalumab|mesh-list
139489078|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139489079|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489080|NCT03656718|Nivolumab|nivolumab|mesh-list
139489081|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139489082|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489083|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139489084|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489085|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
139489086|NCT03645928|Nivolumab|nivolumab|mesh-list
139489087|NCT03645928|Ipilimumab|ipilimumab|mesh-list
139489088|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139489089|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489090|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139489091|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489092|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
139489093|NCT03577431|Everolimus|everolimus|mesh-list
139489094|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139489095|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
139489096|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489097|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139489098|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139489099|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
139489100|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489101|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489102|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139489103|NCT03577431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139489104|NCT03577431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139489105|NCT03577431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489106|NCT03528642|Temozolomide|temozolomide|mesh-list
139489107|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139489108|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
139489109|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489110|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489111|NCT03407144|Prednisone|prednisone|mesh-list
139489112|NCT03407144|Prednisolone|prednisolone|mesh-list
139489113|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
139489114|NCT03407144|Dacarbazine|dacarbazine|mesh-list
139489115|NCT03407144|Doxorubicin|doxorubicin|mesh-list
139489116|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
139489117|NCT03407144|Etoposide|etoposide|mesh-list
139489118|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
139489119|NCT03407144|Vincristine|vincristine|mesh-list
139489120|NCT03407144|Bleomycin|bleomycin|mesh-list
139489121|NCT03407144|Vinblastine|vinblastine|mesh-list
139489122|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139489123|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
139489124|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489125|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139489126|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139489127|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
139489128|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489129|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489130|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139489131|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139489132|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139489133|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139489134|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489135|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139489136|NCT03407144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139489137|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138849952|NCT04783194|Hormones|hormones|mesh-ancestor
139489138|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
139489139|NCT03407144|Hormones|hormones|mesh-ancestor
139489149|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489150|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489152|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
139489153|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489154|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139489155|NCT03360916|Atorvastatin|atorvastatin|mesh-list
139489156|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139489157|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139489158|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
139489159|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489160|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139489161|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139489162|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489163|NCT03351998|Atorvastatin|atorvastatin|mesh-list
139489164|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139489165|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139489166|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
139489167|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489168|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139489169|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139489170|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489180|NCT03211741|Bevacizumab|bevacizumab|mesh-list
139489181|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139489182|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489183|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139489184|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139489185|NCT03211741|Growth Substances|growth substances|mesh-ancestor
139489186|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489187|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
139489188|NCT03203525|Leucovorin|leucovorin|mesh-list
139489189|NCT03203525|Sirolimus|sirolimus|mesh-list
139489190|NCT03203525|Bevacizumab|bevacizumab|mesh-list
139489191|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139489192|NCT03203525|Doxorubicin|doxorubicin|mesh-list
139489193|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139489194|NCT03203525|Fluorouracil|fluorouracil|mesh-list
139489195|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
139489196|NCT03203525|Temsirolimus|temsirolimus|mesh-list
139489197|NCT03203525|MTOR Inhibitors|mtor inhibitors|mesh-list
139489198|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
139489199|NCT03203525|Antibodies|antibodies|mesh-list
139489200|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
139489201|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139489202|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
139489203|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489204|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139489205|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139489206|NCT03203525|Growth Substances|growth substances|mesh-ancestor
139489207|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489208|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
139489209|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
139489210|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139489211|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139489212|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139489213|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489214|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489216|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139489217|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139489218|NCT03203525|Antidotes|antidotes|mesh-ancestor
139489219|NCT03203525|Protective Agents|protective agents|mesh-ancestor
139489220|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
139489221|NCT03203525|Vitamins|vitamins|mesh-ancestor
139489222|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
139489223|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139489224|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139489225|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
139489226|NCT03203525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139489227|NCT03182192|Exenatide|exenatide|mesh-list
139489228|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139489229|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489230|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139489231|NCT03182192|Incretins|incretins|mesh-ancestor
139489232|NCT03182192|Hormones|hormones|mesh-ancestor
139489233|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139489234|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139489235|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139489236|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489237|NCT03137771|Gemcitabine|gemcitabine|mesh-list
139489238|NCT03137771|Docetaxel|docetaxel|mesh-list
139489239|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
139489240|NCT03137771|Pemetrexed|pemetrexed|mesh-list
139489241|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139489242|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139489243|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
139489244|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489245|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489246|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
139489247|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
139489248|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
139489249|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139489250|NCT03137771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139489251|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489252|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139489253|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139489254|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139489255|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
139489256|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139489257|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
139489258|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139489259|NCT03083184|Ethanol|ethanol|mesh-list
139489260|NCT03083184|Enoxaparin|enoxaparin|mesh-list
139489261|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
139489262|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139489263|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139489264|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489265|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139489266|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139489267|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489268|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489269|NCT03023631|Vaccines|vaccines|mesh-list
139489270|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
139489271|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489272|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
139489273|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139489274|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139489275|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489276|NCT02965716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139489277|NCT02965716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489278|NCT02876328|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139489279|NCT02876328|Antiviral Agents|antiviral agents|mesh-ancestor
139489280|NCT02876328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139489281|NCT02875223|Itraconazole|itraconazole|mesh-list
139489282|NCT02875223|Rifampin|rifampin|mesh-list
139489283|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
139489284|NCT02875223|Antifungal Agents|antifungal agents|mesh-ancestor
139489285|NCT02875223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139489286|NCT02875223|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139489287|NCT02875223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139275955|NCT05830799|Anesthetics|anesthetics|mesh-ancestor
139489288|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489289|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489290|NCT02875223|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139489291|NCT02875223|Hormone Antagonists|hormone antagonists|mesh-ancestor
139489292|NCT02875223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139489293|NCT02875223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489294|NCT02875223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139489295|NCT02875223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139489296|NCT02875223|Antitubercular Agents|antitubercular agents|mesh-ancestor
139489297|NCT02875223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139489298|NCT02875223|Leprostatic Agents|leprostatic agents|mesh-ancestor
139489299|NCT02875223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139489300|NCT02875223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139489301|NCT02875223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139489302|NCT02875223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139489303|NCT02875223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139489304|NCT02875223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139489305|NCT02875223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139489306|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489308|NCT02870920|Tremelimumab|tremelimumab|mesh-list
139489309|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139489310|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489311|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
139489312|NCT02869217|Fludarabine|fludarabine|mesh-list
139489313|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139489314|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
139489315|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489316|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139489317|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139489318|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
139489319|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489320|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489321|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139489322|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
139489323|NCT02697630|Entinostat|entinostat|mesh-list
139489324|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139489325|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489326|NCT02697630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139489327|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489328|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139489329|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489330|NCT02639806|Lidocaine|lidocaine|mesh-list
139489331|NCT02639806|Sevoflurane|sevoflurane|mesh-list
139489332|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
139489333|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
139489334|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489335|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489336|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
139489337|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489338|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139489339|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139489340|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139489341|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139489342|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489343|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139489344|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139489345|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
139489346|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
139489347|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489348|NCT02468232|Enalapril|enalapril|mesh-list
139489349|NCT02468232|Enalaprilat|enalaprilat|mesh-list
139489350|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139489351|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139489352|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
139489353|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489354|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489355|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139489356|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139489357|NCT02262780|Telmisartan|telmisartan|mesh-list
139489358|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139489359|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139489360|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139489361|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489362|NCT02210117|Bevacizumab|bevacizumab|mesh-list
139489363|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139489364|NCT02210117|Nivolumab|nivolumab|mesh-list
139489365|NCT02210117|Ipilimumab|ipilimumab|mesh-list
139489366|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
139489367|NCT02210117|Antibodies|antibodies|mesh-list
139489368|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
139489369|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139489370|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
139489371|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489372|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139489373|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139489374|NCT02210117|Growth Substances|growth substances|mesh-ancestor
139489375|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489376|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
139489377|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
139489378|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139489379|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489380|NCT01803555|Budesonide|budesonide|mesh-list
139489381|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
139489382|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139489383|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139489384|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139489385|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
138850451|NCT00887107|Sorafenib|sorafenib|mesh-list
139489386|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489387|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489388|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139489389|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
139489390|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
139489391|NCT01803555|Hormones|hormones|mesh-ancestor
139489392|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139489393|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139489394|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139489395|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139489396|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
139489397|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139489398|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489399|NCT01297764|Dexamethasone|dexamethasone|mesh-list
139489400|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
139489401|NCT01297764|Lenalidomide|lenalidomide|mesh-list
139489402|NCT01297764|Vorinostat|vorinostat|mesh-list
139489403|NCT01297764|BB 1101|bb 1101|mesh-list
139489404|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139489405|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
139489406|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
139489407|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489408|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489409|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139489410|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
139489411|NCT01297764|Hormones|hormones|mesh-ancestor
139489412|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139489413|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139489414|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489415|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
139489416|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489417|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489418|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
139489419|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139489420|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139489421|NCT01297764|Growth Substances|growth substances|mesh-ancestor
139489422|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
139489423|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139489424|NCT01245179|Panobinostat|panobinostat|mesh-list
139489425|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489426|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139489427|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489428|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489429|NCT01112306|Selexipag|selexipag|mesh-list
139489430|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139489431|NCT00242814|Amlodipine|amlodipine|mesh-list
139489432|NCT00242814|Telmisartan|telmisartan|mesh-list
139489433|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139489435|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139489436|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489437|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139489438|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489439|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
139489440|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139489441|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139489442|NCT00168857|Losartan|losartan|mesh-list
139489443|NCT00168857|Telmisartan|telmisartan|mesh-list
139489444|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139489445|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139489446|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139489447|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139489448|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489449|NCT04925167|Heparin|heparin|mesh-list
139489450|NCT04925167|Calcium heparin|calcium heparin|mesh-list
139489451|NCT04925167|Argatroban|argatroban|mesh-list
139489452|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
139489453|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139489454|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139489455|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489456|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
139489457|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139489458|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
139489459|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489460|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139489461|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139489462|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139489463|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139489464|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489465|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489466|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139489467|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139489468|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139489469|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139489470|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
139489471|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139489472|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489473|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139489474|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139489475|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
139489476|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139489477|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139489478|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
139489479|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
139489480|NCT02524665|Salicylates|salicylates|mesh-list
139489481|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139489482|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139489483|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
139489484|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
139489485|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
139489486|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139489487|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139489488|NCT02524665|Analgesics|analgesics|mesh-ancestor
139489489|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
139489490|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489491|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489492|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139489493|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139489494|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139489495|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489496|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489497|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139489498|NCT04998253|Propofol|propofol|mesh-list
139489499|NCT04998253|Sevoflurane|sevoflurane|mesh-list
139489500|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139489501|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489502|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489503|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139489504|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
139489505|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
139276182|NCT04447911|Empagliflozin|empagliflozin|mesh-list
139489506|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139489507|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139489509|NCT02638129|Bupropion|bupropion|mesh-list
139489510|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139489511|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139489512|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489513|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
139489514|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489515|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139489516|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
139489517|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139489518|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139489519|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139489520|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139489521|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489522|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
139489523|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139489524|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139489525|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139489526|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489527|NCT03079687|Olaparib|olaparib|mesh-list
139489528|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139489529|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489530|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489531|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489532|NCT04997707|Propofol|propofol|mesh-list
139489533|NCT04997707|Sevoflurane|sevoflurane|mesh-list
139489534|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139489535|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489536|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489537|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139489538|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
139489539|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
139489540|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139489541|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139489542|NCT05010499|Bupivacaine|bupivacaine|mesh-list
139489543|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
139489544|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
139489545|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
139489546|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489547|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489548|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
139489549|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489550|NCT03075241|Zolpidem|zolpidem|mesh-list
139489551|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139489552|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139489553|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489554|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489555|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139489556|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
139489557|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
139489558|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139489559|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489560|NCT04994119|Warfarin|warfarin|mesh-list
139489561|NCT04994119|Zamicastat|zamicastat|mesh-list
139489562|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
139489563|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489564|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489565|NCT01658943|Fluorouracil|fluorouracil|mesh-list
139489566|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
139489567|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
139489568|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489569|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139489570|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489571|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139489572|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
139489573|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489574|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139489575|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139489576|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139489577|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
139489578|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139489579|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139489580|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139489581|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139489582|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
139489583|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489584|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139489585|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139489586|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489587|NCT04996459|Tislelizumab|tislelizumab|mesh-list
139489588|NCT04996459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139489589|NCT04996459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489590|NCT03074773|Dexamethasone|dexamethasone|mesh-list
139489591|NCT03074773|Bupivacaine|bupivacaine|mesh-list
139489592|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139489593|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
139489594|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
139489595|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489596|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489597|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139489598|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
139489599|NCT03074773|Hormones|hormones|mesh-ancestor
139489600|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139489601|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139489602|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489603|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
139489604|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
139489605|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489606|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
139489607|NCT03077581|Anesthetics|anesthetics|mesh-list
139489608|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489609|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489610|NCT03077503|Fentanyl|fentanyl|mesh-list
139489611|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
139489612|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139489613|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489614|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489615|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139489616|NCT03077503|Analgesics|analgesics|mesh-ancestor
139489617|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
139489618|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489619|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139489620|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139489621|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139489622|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
139489623|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139489624|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489625|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139489626|NCT03077503|Narcotics|narcotics|mesh-ancestor
139489627|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139489628|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139489629|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
139489630|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
139489631|NCT05518695|Antibodies, Blocking|antibodies, blocking|mesh-list
139489632|NCT05518695|Immunologic Factors|immunologic factors|mesh-ancestor
139489633|NCT05518695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489634|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
139489635|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139489636|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489637|NCT03073057|Budesonide|budesonide|mesh-list
139489638|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
139489639|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139489640|NCT03073057|Charcoal|charcoal|mesh-list
139489641|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139489642|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139489643|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
139489644|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489645|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489646|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139489647|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
139489648|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
139489649|NCT03073057|Hormones|hormones|mesh-ancestor
139489650|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139489651|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139489652|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139489653|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139489654|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
139489655|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139489656|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489657|NCT03073057|Antidotes|antidotes|mesh-ancestor
139489658|NCT03073057|Protective Agents|protective agents|mesh-ancestor
139489659|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
139489660|NCT03073369|Vitamin D|vitamin d|mesh-list
139489661|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139489662|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489663|NCT03073369|Vitamins|vitamins|mesh-ancestor
139489664|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
139489665|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139489666|NCT04433611|Lidocaine|lidocaine|mesh-list
139489667|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
139489668|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
139489669|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489670|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489671|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
139489672|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489673|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139489674|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139489675|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139489676|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139489677|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489678|NCT04992481|Fluorides|fluorides|mesh-list
139489679|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
139489680|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
139489681|NCT04992481|Protective Agents|protective agents|mesh-ancestor
139489682|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489683|NCT02597933|Nintedanib|nintedanib|mesh-list
139489684|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489685|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139489686|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489687|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489688|NCT04995133|Colistin|colistin|mesh-list
139489689|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139489690|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139489691|NCT04360889|Tocopherols|tocopherols|mesh-list
139489692|NCT04360889|Vitamin E|vitamin e|mesh-list
139489693|NCT04360889|Tocotrienols|tocotrienols|mesh-list
139489694|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
139489695|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
139489696|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489697|NCT04360889|Protective Agents|protective agents|mesh-ancestor
139489698|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489699|NCT04360889|Vitamins|vitamins|mesh-ancestor
139489700|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
139489701|NCT03072589|Regadenoson|regadenoson|mesh-list
139489702|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139489703|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139489704|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
139489705|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
139489706|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139489707|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489708|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489709|NCT04994743|Cortisone|cortisone|mesh-list
139489710|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139489711|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139489712|NCT04807829|Nabilone|nabilone|mesh-list
139489713|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
139489714|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
139489715|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489716|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489717|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139489718|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139489719|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139489720|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489721|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139489722|NCT03072511|Nicotine|nicotine|mesh-list
139489723|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139489724|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
139489725|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489726|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489727|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139489728|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139489729|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
139489730|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139489731|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489733|NCT03072121|Metoprolol|metoprolol|mesh-list
139489734|NCT03072121|Isosorbide|isosorbide|mesh-list
139489735|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139489736|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139489737|NCT03072121|Trimetazidine|trimetazidine|mesh-list
139489738|NCT03072121|Clopidogrel|clopidogrel|mesh-list
139489739|NCT03072121|Atorvastatin|atorvastatin|mesh-list
139489740|NCT03072121|Calcium|calcium|mesh-list
139489741|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139489742|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489743|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139489744|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139489745|NCT03072121|Analgesics|analgesics|mesh-ancestor
139489746|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
139489747|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489748|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139489749|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139489750|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139489751|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139489752|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489753|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139489754|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139489755|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489756|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
139489757|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139489758|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139489759|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
139489760|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139489761|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139489762|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139489763|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139489764|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139489765|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
139489766|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139489767|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139489768|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139489769|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
139489770|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
139489771|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138850765|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
139489772|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139489773|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139489774|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
139489775|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139489776|NCT03072121|Diuretics|diuretics|mesh-ancestor
139489777|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
139489778|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
139489779|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139489780|NCT02597855|Aflibercept|aflibercept|mesh-list
139489781|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139489782|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139489783|NCT02597855|Growth Substances|growth substances|mesh-ancestor
139489784|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489785|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
139489786|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489787|NCT04987567|Antioxidants|antioxidants|mesh-list
139489788|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489789|NCT04987567|Protective Agents|protective agents|mesh-ancestor
139489790|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489791|NCT03072199|Rituximab|rituximab|mesh-list
139489792|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139489793|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489794|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
139489795|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489796|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139489797|NCT04806737|Teriflunomide|teriflunomide|mesh-list
139489798|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139489799|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139489800|NCT04806737|Analgesics|analgesics|mesh-ancestor
139489801|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
139489802|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489803|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489804|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139489805|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138850796|NCT02760888|Diclofenac|diclofenac|mesh-list
139489806|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139489807|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
139489808|NCT04991155|Zamicastat|zamicastat|mesh-list
139489809|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489810|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489811|NCT04462315|Cobalt|cobalt|mesh-list
139489812|NCT04462315|Chromium|chromium|mesh-list
139489813|NCT04462315|Everolimus|everolimus|mesh-list
139489814|NCT04462315|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139489815|NCT04462315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139489816|NCT04462315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489817|NCT04462315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489818|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139489819|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
139489820|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489821|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489822|NCT04462315|Trace Elements|trace elements|mesh-ancestor
139489823|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
139489824|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139489825|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139489826|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139489827|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139489828|NCT03071731|Bromides|bromides|mesh-list
139489829|NCT03071731|Ipratropium|ipratropium|mesh-list
139489830|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
139489831|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
139489832|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
139489833|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489834|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489835|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139489836|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
139489837|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139489838|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489839|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139489840|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
139489841|NCT04809935|Ethanol|ethanol|mesh-list
139489842|NCT04809935|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139489843|NCT04809935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139489844|NCT04809935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489845|NCT04809935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489846|NCT04255927|Triclosan|triclosan|mesh-list
139489847|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139489848|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139489849|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139489850|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139489851|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
139489852|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489853|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139489854|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139489855|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139489856|NCT03069781|Estradiol|estradiol|mesh-list
139489857|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139489858|NCT03069781|Estrogens|estrogens|mesh-ancestor
139489859|NCT03069781|Hormones|hormones|mesh-ancestor
139489860|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139489861|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489862|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139489863|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
139489864|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139489865|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139489866|NCT03071575|Vaccines|vaccines|mesh-list
139489867|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
139489868|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489869|NCT04798391|Dexamethasone|dexamethasone|mesh-list
139489870|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139489871|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
139489872|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
139489873|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489874|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489875|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139489876|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
139489877|NCT04798391|Hormones|hormones|mesh-ancestor
139489878|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139489879|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139489880|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489881|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
139489882|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
139489883|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139489884|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
139489885|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139489886|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489887|NCT05616455|Nitroglycerin|nitroglycerin|mesh-list
139489888|NCT05616455|Vasodilator Agents|vasodilator agents|mesh-ancestor
139489889|NCT04986319|Vitamin D|vitamin d|mesh-list
139489890|NCT04986319|Vitamins|vitamins|mesh-ancestor
139489891|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
139489892|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489893|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139489894|NCT02593097|Metformin|metformin|mesh-list
139489895|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139489896|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489897|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139489898|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
139489899|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489900|NCT01657461|Plasminogen|plasminogen|mesh-list
139489901|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139489902|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139489903|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139489904|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489905|NCT05001919|Mitogens|mitogens|mesh-list
139489906|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
139489907|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489908|NCT05001763|Prucalopride|prucalopride|mesh-list
139489909|NCT05001763|Laxatives|laxatives|mesh-ancestor
139489910|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139489911|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139489912|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139489913|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
139489914|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139489915|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489916|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489917|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
139489918|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489919|NCT02592551|Durvalumab|durvalumab|mesh-list
139489920|NCT02592551|Tremelimumab|tremelimumab|mesh-list
139489921|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139489922|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489923|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139489924|NCT04989127|Penicillins|penicillins|mesh-list
139489925|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139489926|NCT04989127|Analgesics|analgesics|mesh-list
139489927|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139489928|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
139489929|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
139489930|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489931|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489932|NCT04982809|Dexamethasone|dexamethasone|mesh-list
139489933|NCT04982809|Prednisolone|prednisolone|mesh-list
139489934|NCT04982809|Betamethasone|betamethasone|mesh-list
139489935|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139489936|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
139489937|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
139489938|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489939|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489940|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139489941|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
139489942|NCT04982809|Hormones|hormones|mesh-ancestor
139489943|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139489944|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139489945|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489946|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139489947|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
139489948|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
139489949|NCT03068533|Calcium|calcium|mesh-list
139489950|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139489951|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489952|NCT03068533|Antacids|antacids|mesh-ancestor
139489953|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489954|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139489955|NCT05281341|Hormones|hormones|mesh-list
139489956|NCT05281341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139489957|NCT05281341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489958|NCT04808687|Paclitaxel|paclitaxel|mesh-list
139489959|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139489960|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139489961|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
139489962|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
139489963|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
139489964|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489965|NCT05279703|Epinephrine|epinephrine|mesh-list
139489966|NCT05279703|Racepinephrine|racepinephrine|mesh-list
139489967|NCT05279703|Epinephryl borate|epinephryl borate|mesh-list
139489968|NCT05279703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139489969|NCT05279703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139489970|NCT05279703|Adrenergic Agents|adrenergic agents|mesh-ancestor
139489971|NCT05279703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139489972|NCT05279703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489973|NCT05279703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489974|NCT05279703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139489975|NCT05279703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139489976|NCT05279703|Autonomic Agents|autonomic agents|mesh-ancestor
139489977|NCT05279703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489978|NCT05279703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139489979|NCT05279703|Respiratory System Agents|respiratory system agents|mesh-ancestor
139489980|NCT05279703|Mydriatics|mydriatics|mesh-ancestor
139489981|NCT05279703|Sympathomimetics|sympathomimetics|mesh-ancestor
139489982|NCT05279703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139489983|NCT05392933|Lidocaine|lidocaine|mesh-list
139489984|NCT05392933|Anesthetics, Local|anesthetics, local|mesh-ancestor
139489985|NCT05392933|Anesthetics|anesthetics|mesh-ancestor
139489986|NCT05392933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139489987|NCT05392933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139489988|NCT05392933|Sensory System Agents|sensory system agents|mesh-ancestor
139489989|NCT05392933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139489990|NCT05392933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139489991|NCT05392933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139489992|NCT05392933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139489993|NCT05392933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139489994|NCT05392933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139489995|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
139489996|NCT04796675|Fludarabine|fludarabine|mesh-list
139489997|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139489998|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
139489999|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490000|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139490001|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139490002|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
139490003|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490004|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490005|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139490006|NCT04785755|Etilefrine|etilefrine|mesh-list
139490007|NCT04785755|Furosemide|furosemide|mesh-list
139490008|NCT04785755|Spironolactone|spironolactone|mesh-list
139490009|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139490010|NCT04785755|Diuretics|diuretics|mesh-list
139490011|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
139490012|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490013|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139490014|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139490015|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490016|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139490017|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
139490018|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139490019|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139490020|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139490021|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139490022|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
139490023|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490024|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139490025|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
139490026|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
139490027|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490028|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139490029|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139490030|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139490031|NCT04785755|Protective Agents|protective agents|mesh-ancestor
139490032|NCT04785911|Antiemetics|antiemetics|mesh-list
139490034|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
139490035|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
139490036|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490037|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490038|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490039|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
139490040|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490041|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139490042|NCT04243941|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139490043|NCT04243941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139490044|NCT04243941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490045|NCT05314101|Bevacizumab|bevacizumab|mesh-list
139490046|NCT05314101|Tislelizumab|tislelizumab|mesh-list
139490047|NCT05314101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139490048|NCT05314101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490049|NCT05314101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139490050|NCT05314101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139490051|NCT05314101|Growth Substances|growth substances|mesh-ancestor
139490052|NCT05314101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490053|NCT05314101|Growth Inhibitors|growth inhibitors|mesh-ancestor
139490054|NCT02595749|Oxytocin|oxytocin|mesh-list
139490055|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
139490056|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139490057|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490058|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
139490059|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139490060|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
139490061|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490062|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
139490063|NCT04426721|Protective Agents|protective agents|mesh-ancestor
139490064|NCT05221359|Insulin Aspart|insulin aspart|mesh-list
139490065|NCT05221359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139490066|NCT05221359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490067|NCT04794413|Pimavanserin|pimavanserin|mesh-list
139490068|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139490069|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139490070|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139490071|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139490072|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490073|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490074|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139490075|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139490076|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138851112|NCT04035889|Melatonin|melatonin|mesh-list
139490077|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
139490078|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490079|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490080|NCT04988191|Bevacizumab|bevacizumab|mesh-list
139490081|NCT04988191|Irinotecan|irinotecan|mesh-list
139490082|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139490083|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490084|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139490085|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139490086|NCT04988191|Growth Substances|growth substances|mesh-ancestor
139490087|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490088|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
139490089|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139490090|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139490091|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490092|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490093|NCT03069001|Ribavirin|ribavirin|mesh-list
139490094|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
139490095|NCT03069001|Simeprevir|simeprevir|mesh-list
139490096|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
139490097|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490098|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
139490099|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139490100|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
139490101|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490102|NCT03070405|Tenofovir|tenofovir|mesh-list
139490103|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
139490104|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
139490105|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139490106|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139490107|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139490108|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490109|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490110|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139490111|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139490112|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
139490113|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139490114|NCT03068065|Metformin|metformin|mesh-list
139490115|NCT03068065|Liraglutide|liraglutide|mesh-list
139490116|NCT03068065|Gliclazide|gliclazide|mesh-list
139490117|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139490118|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490119|NCT03068065|Incretins|incretins|mesh-ancestor
139490120|NCT03068065|Hormones|hormones|mesh-ancestor
138787903|NCT04293822|Cetirizine|cetirizine|mesh-list
139490121|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139490122|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
139490123|NCT05161611|Astringents|astringents|mesh-ancestor
139490124|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490125|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
139490126|NCT03660475|Naltrexone|naltrexone|mesh-list
139490127|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139490128|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139490129|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490130|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
139490131|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490132|NCT05211609|Methyldopa|methyldopa|mesh-list
139490133|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139490134|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
139490135|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
139490136|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490137|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490138|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139490139|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139490140|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139490141|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
139490142|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490143|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490144|NCT05615987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139490145|NCT05615987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139490146|NCT05615987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139490147|NCT05615987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490148|NCT05615987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851355|NCT00896077|Analgesics|analgesics|mesh-ancestor
139490149|NCT05615987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139490150|NCT05615987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139490151|NCT05615987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490152|NCT05615987|Cholinergic Agents|cholinergic agents|mesh-ancestor
139490153|NCT05615987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490154|NCT02594735|Abatacept|abatacept|mesh-list
139490155|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139490156|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490157|NCT02594735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139490158|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490159|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139490160|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
139490161|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490162|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139490163|NCT04793243|Vitamin D|vitamin d|mesh-list
139490164|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
139490165|NCT04793243|Vitamins|vitamins|mesh-ancestor
139490166|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
139490167|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490168|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139490169|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139490170|NCT04793399|Atezolizumab|atezolizumab|mesh-list
139490171|NCT04793399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139490172|NCT04793399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490173|NCT04793399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139490174|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490175|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
139490176|NCT05157711|Phenylephrine|phenylephrine|mesh-list
139490177|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
139490178|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
139490179|NCT05157711|Bismuth|bismuth|mesh-list
139490180|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139490181|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
139490182|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
139490183|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490184|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490185|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
139490186|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139490187|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
139490188|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
139490189|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139490190|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139490191|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139490192|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
139490193|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490194|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490195|NCT05157711|Protective Agents|protective agents|mesh-ancestor
139490196|NCT05157711|Antacids|antacids|mesh-ancestor
139490197|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139490198|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
139490199|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
139490200|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139490201|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139490202|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
139490203|NCT05157711|Coagulants|coagulants|mesh-ancestor
139490204|NCT05105997|Dexamethasone|dexamethasone|mesh-list
139490205|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139490206|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
139490207|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
139490208|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490209|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490210|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139490211|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
139490212|NCT05105997|Hormones|hormones|mesh-ancestor
139490213|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139490214|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139490215|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490216|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
139490217|NCT04801511|Vitamins|vitamins|mesh-ancestor
139490218|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
139490219|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490220|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
139490221|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490222|NCT04801511|Protective Agents|protective agents|mesh-ancestor
139490223|NCT05471687|Adenosine|adenosine|mesh-list
139490224|NCT05471687|Analgesics|analgesics|mesh-ancestor
139490225|NCT05471687|Sensory System Agents|sensory system agents|mesh-ancestor
139490226|NCT05471687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490227|NCT05471687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490228|NCT05471687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139490229|NCT05471687|Vasodilator Agents|vasodilator agents|mesh-ancestor
139490230|NCT05471687|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139490231|NCT05471687|Purinergic Agonists|purinergic agonists|mesh-ancestor
139490232|NCT05471687|Purinergic Agents|purinergic agents|mesh-ancestor
139490233|NCT05471687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490234|NCT05471687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490235|NCT05370729|Acetylcysteine|acetylcysteine|mesh-list
139490236|NCT05370729|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139490237|NCT05370729|Antiviral Agents|antiviral agents|mesh-ancestor
139490238|NCT05370729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139490239|NCT05370729|Expectorants|expectorants|mesh-ancestor
139490240|NCT05370729|Respiratory System Agents|respiratory system agents|mesh-ancestor
139490241|NCT05370729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139490242|NCT05370729|Antioxidants|antioxidants|mesh-ancestor
139490243|NCT05370729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490244|NCT05370729|Protective Agents|protective agents|mesh-ancestor
139490245|NCT05370729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490246|NCT05370729|Antidotes|antidotes|mesh-ancestor
139490247|NCT05471531|Vaccines|vaccines|mesh-list
139490248|NCT05471531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139490249|NCT05471531|Immunologic Factors|immunologic factors|mesh-ancestor
139490250|NCT05471531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490251|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139490252|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139490253|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490254|NCT04801199|Incretins|incretins|mesh-ancestor
139490255|NCT04801199|Hormones|hormones|mesh-ancestor
139490256|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139490257|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139490258|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
139276919|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
139490259|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490260|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490262|NCT05445791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139490263|NCT05445791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490264|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139490265|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
139490266|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139490267|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139490268|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
139490269|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490270|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490271|NCT04799639|Paclitaxel|paclitaxel|mesh-list
139490272|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139490273|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490274|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
139490275|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
139490276|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
139490277|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490278|NCT04798703|Paclitaxel|paclitaxel|mesh-list
139490279|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
139490280|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139490281|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490282|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
139490283|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
139490284|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
139490285|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490286|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139490287|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
139490288|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490289|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
139490290|NCT04798703|Protective Agents|protective agents|mesh-ancestor
139490291|NCT04798313|Denosumab|denosumab|mesh-list
139490292|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139490293|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490294|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
139490295|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
139490296|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
139490297|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490298|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490299|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
139490300|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490301|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139490302|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139490303|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490304|NCT05092581|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
139490305|NCT05092581|Antiviral Agents|antiviral agents|mesh-ancestor
139490306|NCT05092581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139490307|NCT04338659|Antibodies|antibodies|mesh-list
139490308|NCT04338659|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139490309|NCT04338659|Immunologic Factors|immunologic factors|mesh-ancestor
139490310|NCT04338659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490311|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
139490312|NCT05089461|Analgesics|analgesics|mesh-ancestor
139490313|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
139490314|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490315|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490316|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490317|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139490318|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139490319|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490320|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490321|NCT05730439|Lobeline|lobeline|mesh-list
139490322|NCT05730439|Nicotine|nicotine|mesh-list
139490323|NCT05730439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139490324|NCT05730439|Autonomic Agents|autonomic agents|mesh-ancestor
139490325|NCT05730439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490326|NCT05730439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490327|NCT05730439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139490328|NCT05730439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139490329|NCT05730439|Cholinergic Agents|cholinergic agents|mesh-ancestor
139490330|NCT05730439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851766|NCT00790647|Bortezomib|bortezomib|mesh-list
139490331|NCT05730439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139276997|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
139490332|NCT05730439|Respiratory System Agents|respiratory system agents|mesh-ancestor
139490333|NCT04805515|Nicotine|nicotine|mesh-list
139490334|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139490335|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
139490336|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490337|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490338|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139490339|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139490340|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
139490341|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490342|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490343|NCT05170919|Olanzapine|olanzapine|mesh-list
139490344|NCT05170919|Mirtazapine|mirtazapine|mesh-list
139490345|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
139490346|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
139490347|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490348|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490349|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139490350|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139490351|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139490352|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490353|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139490354|NCT05170919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139490355|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138851816|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490356|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139490357|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490358|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490359|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
139490360|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
139490361|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139490362|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
139490363|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
139490364|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139490365|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139490366|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139490367|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139490368|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
139490369|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139490370|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139490371|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139490372|NCT05613491|Insulin|insulin|mesh-list
139490373|NCT05613491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139490374|NCT05613491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139490375|NCT05613491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490376|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
139490377|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139490378|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139490379|NCT03066427|Sunitinib|sunitinib|mesh-list
139490380|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490381|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139490382|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139490383|NCT03066427|Growth Substances|growth substances|mesh-ancestor
138851866|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139490384|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490385|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
139490386|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139490387|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490388|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490389|NCT05177133|Capecitabine|capecitabine|mesh-list
139490390|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
139490391|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139490392|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
139490393|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490394|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490395|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
139490396|NCT02866643|Etonogestrel|etonogestrel|mesh-list
139490397|NCT02866643|Desogestrel|desogestrel|mesh-list
139490398|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139490399|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490400|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139490401|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139490402|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139490403|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139490404|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139490405|NCT02866643|Progestins|progestins|mesh-ancestor
139490406|NCT02866643|Hormones|hormones|mesh-ancestor
139490407|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139490409|NCT05176821|Furazolidone|furazolidone|mesh-list
139490410|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
139490411|NCT05176821|Esomeprazole|esomeprazole|mesh-list
139490412|NCT05176821|Bismuth|bismuth|mesh-list
139490413|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490414|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139490415|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139490416|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139490417|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139490418|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139490419|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490420|NCT05176821|Antacids|antacids|mesh-ancestor
139490421|NCT05176821|Diuretics|diuretics|mesh-ancestor
139490422|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
139490423|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490424|NCT05176821|Expectorants|expectorants|mesh-ancestor
139490425|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
139490426|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139490427|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139490428|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139490429|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139490430|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139490431|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139490432|NCT05555641|Nafamostat|nafamostat|mesh-list
139490433|NCT05555641|Heparin|heparin|mesh-list
139490434|NCT05555641|Calcium heparin|calcium heparin|mesh-list
139490435|NCT05555641|Anticoagulants|anticoagulants|mesh-ancestor
139490436|NCT05555641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139490437|NCT05555641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139490438|NCT05555641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490439|NCT05555641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139490440|NCT05555641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139490441|NCT05555641|Analgesics|analgesics|mesh-ancestor
139490442|NCT05555641|Sensory System Agents|sensory system agents|mesh-ancestor
139490443|NCT05555641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490444|NCT05555641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490445|NCT05555641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139490446|NCT05555641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139490447|NCT05555641|Protease Inhibitors|protease inhibitors|mesh-ancestor
139490448|NCT05555641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490449|NCT05555641|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139490450|NCT05555641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139490451|NCT05555641|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139490452|NCT05555641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139490453|NCT05555641|Immunologic Factors|immunologic factors|mesh-ancestor
139490454|NCT01672801|Nimodipine|nimodipine|mesh-list
139490455|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139490456|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139490457|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139490458|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490459|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139490460|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490461|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
139490462|NCT05613335|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139490463|NCT05613335|Hemostatics|hemostatics|mesh-ancestor
139490464|NCT05613335|Coagulants|coagulants|mesh-ancestor
139490465|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139490466|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
139490467|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
139490468|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
139490469|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490470|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490471|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
139490472|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490473|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139490474|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139490475|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
139490476|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490477|NCT05078463|Protective Agents|protective agents|mesh-ancestor
139490478|NCT05170113|Caffeine|caffeine|mesh-list
139490479|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139490480|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490481|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138852007|NCT02602509|Rifampin|rifampin|mesh-list
139490482|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490483|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490484|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139490485|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139490486|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
139490487|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490489|NCT05611463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490490|NCT05611463|Tubulin Modulators|tubulin modulators|mesh-ancestor
139490491|NCT05611463|Antimitotic Agents|antimitotic agents|mesh-ancestor
139490492|NCT05611463|Mitosis Modulators|mitosis modulators|mesh-ancestor
139490493|NCT05611463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490494|NCT05611385|Amphetamine|amphetamine|mesh-list
139490495|NCT05611385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139490496|NCT05611385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490497|NCT05611385|Sympathomimetics|sympathomimetics|mesh-ancestor
139490498|NCT05611385|Autonomic Agents|autonomic agents|mesh-ancestor
139490499|NCT05611385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490500|NCT05611385|Dopamine Agents|dopamine agents|mesh-ancestor
139490501|NCT05611385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490502|NCT05611385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490503|NCT05611385|Adrenergic Agents|adrenergic agents|mesh-ancestor
139490504|NCT05611385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139490505|NCT05611385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139490506|NCT05611385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139490507|NCT05611385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139490508|NCT05475041|Liver Extracts|liver extracts|mesh-list
139490509|NCT05475041|Hematinics|hematinics|mesh-ancestor
139490510|NCT02631577|Lenalidomide|lenalidomide|mesh-list
139490511|NCT02631577|Atezolizumab|atezolizumab|mesh-list
139490512|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
139490513|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
139490514|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490515|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139490516|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139490517|NCT02631577|Growth Substances|growth substances|mesh-ancestor
139490518|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
139490519|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490520|NCT02631577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139490521|NCT02631577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490522|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139490523|NCT01667081|Grazoprevir|grazoprevir|mesh-list
139490524|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
139490525|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139490526|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
139490527|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139490528|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139490529|NCT03067753|Prednisolone|prednisolone|mesh-list
139490530|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
139490531|NCT03067753|Hormones|hormones|mesh-list
139490532|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139490533|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
139490534|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139490535|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490536|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139490537|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
139490538|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
139490539|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490540|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139490541|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
139490542|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139490543|NCT03067753|Protective Agents|protective agents|mesh-ancestor
139490544|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139490545|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490546|NCT04331639|Vitamin D|vitamin d|mesh-list
139490547|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
139490548|NCT04331639|Vitamins|vitamins|mesh-ancestor
139490549|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
139490550|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490551|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139490552|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139490553|NCT03067597|Dinoprostone|dinoprostone|mesh-list
139277220|NCT05881486|Antipruritics|antipruritics|mesh-ancestor
139277221|NCT05881486|Dermatologic Agents|dermatologic agents|mesh-ancestor
139277222|NCT05881486|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139490554|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
138852139|NCT02852681|Diuretics|diuretics|mesh-ancestor
139490555|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139490556|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490557|NCT02518971|Tamsulosin|tamsulosin|mesh-list
139490558|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139490559|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139490560|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139490561|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
139490562|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490563|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490564|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490565|NCT02518971|Urological Agents|urological agents|mesh-ancestor
139490566|NCT04733963|Bevacizumab|bevacizumab|mesh-list
139490567|NCT04733963|Capecitabine|capecitabine|mesh-list
139490568|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139490569|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490570|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139490571|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139490572|NCT04733963|Growth Substances|growth substances|mesh-ancestor
139490573|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490574|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
139490575|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139490576|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
139490577|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490578|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
139490579|NCT03066115|Ketorolac|ketorolac|mesh-list
139490580|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139490581|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139490582|NCT03066115|Analgesics|analgesics|mesh-ancestor
138852203|NCT00898573|Lapatinib|lapatinib|mesh-list
139490583|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
139490584|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490585|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490586|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139490587|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139490588|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139490589|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490590|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490591|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
139490592|NCT03066115|Protective Agents|protective agents|mesh-ancestor
139490593|NCT03066115|Vitamins|vitamins|mesh-ancestor
139490594|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
139490595|NCT04212039|Bupivacaine|bupivacaine|mesh-list
139490596|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
139490597|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
139490598|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490599|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490600|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
139490601|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490602|NCT05048589|Vaccines|vaccines|mesh-list
139490603|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
139490604|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490605|NCT04447651|Immunomodulating Agents|immunomodulating agents|mesh-list
139490606|NCT04447651|Immunologic Factors|immunologic factors|mesh-ancestor
138852232|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139490607|NCT04447651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490608|NCT01364727|Amrubicin|amrubicin|mesh-list
139490609|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490610|NCT04990869|Niacinamide|niacinamide|mesh-list
139490611|NCT04990869|Niacin|niacin|mesh-list
139490612|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
139490613|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
139490614|NCT04990869|Vitamins|vitamins|mesh-ancestor
139490615|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
139490616|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490617|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139490618|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
139490619|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490620|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139490621|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
139490622|NCT01364649|Vortioxetine|vortioxetine|mesh-list
139490623|NCT01364649|Escitalopram|escitalopram|mesh-list
139490624|NCT01364649|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139490625|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139490626|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139490627|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490628|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490629|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
139490630|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490631|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
139490632|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139490633|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139490634|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139490635|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490636|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139490637|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139490638|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139490639|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139490640|NCT03065569|Bupivacaine|bupivacaine|mesh-list
139490641|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
139490642|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
139490643|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490644|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490645|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
139490646|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490647|NCT05723419|Anesthetics|anesthetics|mesh-list
139490648|NCT05723419|Anesthetics, Local|anesthetics, local|mesh-list
138852334|NCT02695758|Bupivacaine|bupivacaine|mesh-list
139490649|NCT05723419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490650|NCT05723419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490651|NCT05723419|Sensory System Agents|sensory system agents|mesh-ancestor
139490652|NCT05723419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490653|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139490654|NCT02588261|Gefitinib|gefitinib|mesh-list
139490655|NCT02588261|Naquotinib|naquotinib|mesh-list
139490656|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490657|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139490658|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490659|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490660|NCT04426487|Progesterone|progesterone|mesh-list
139490661|NCT04426487|Progestins|progestins|mesh-ancestor
139490662|NCT04426487|Hormones|hormones|mesh-ancestor
139490663|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139490664|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490665|NCT04988217|Interferons|interferons|mesh-list
139490666|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
139490667|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
138852394|NCT05660720|Moxifloxacin|moxifloxacin|mesh-list
139490668|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490669|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
139490670|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139490671|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
139490672|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490673|NCT01672723|Naltrexone|naltrexone|mesh-list
139490674|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139490675|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139490676|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490677|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
139490678|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490679|NCT04443673|Glycine|glycine|mesh-list
139490680|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
139490681|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490682|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490683|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490684|NCT05031975|Irinotecan|irinotecan|mesh-list
139490685|NCT05031975|Temozolomide|temozolomide|mesh-list
139490686|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139490687|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139490688|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490689|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490690|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490691|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139490692|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
139490693|NCT02632747|Empagliflozin|empagliflozin|mesh-list
139490694|NCT02632747|Ramipril|ramipril|mesh-list
138852445|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
139490695|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139490696|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490697|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139490698|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490699|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139490700|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
139490701|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490702|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139490703|NCT04216797|Diazepam|diazepam|mesh-list
139277372|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
139490704|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139490706|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
139490707|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
139490708|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490709|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490710|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139490711|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139490712|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490713|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139490714|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139490715|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139490716|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139490717|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139490718|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139490719|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
139490720|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
139490721|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
139490722|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
139490723|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490724|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490725|NCT05029401|Ibogaine|ibogaine|mesh-list
139490726|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
139490727|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490728|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139490729|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139490730|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139490731|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490732|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490733|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
139490734|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139490735|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490736|NCT05025813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139490737|NCT05025813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490738|NCT04033237|Nicotine|nicotine|mesh-list
139490739|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139490740|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
139490741|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490742|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490743|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139490744|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139490745|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
139490746|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490747|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490748|NCT04421547|Letrozole|letrozole|mesh-list
139490749|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490750|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139490751|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139490752|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490753|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490754|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139490755|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
139490756|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139490757|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490758|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
139490759|NCT03066817|Vitamin D|vitamin d|mesh-list
139490760|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139490761|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490762|NCT03066817|Vitamins|vitamins|mesh-ancestor
139490763|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
139490764|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139490765|NCT05060913|Lidocaine|lidocaine|mesh-list
139490766|NCT05060913|Prilocaine|prilocaine|mesh-list
139490767|NCT05060913|Benzocaine|benzocaine|mesh-list
139490768|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139490769|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
139490770|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
139490771|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490772|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490773|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
139490774|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490775|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139490776|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139490777|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139490778|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139490779|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490780|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139490781|NCT05165251|Amlodipine|amlodipine|mesh-list
139490782|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
139490783|NCT05165251|Atorvastatin|atorvastatin|mesh-list
139490784|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139490785|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139490786|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
139490787|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490788|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139490789|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139490790|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490791|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139490792|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139490793|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139490794|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139490795|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490796|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
139490797|NCT04209075|Metformin|metformin|mesh-list
139490798|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139490799|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490800|NCT05023473|Morphine|morphine|mesh-list
139490801|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139490802|NCT05023473|Narcotics|narcotics|mesh-ancestor
139490803|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490804|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490805|NCT05023473|Analgesics|analgesics|mesh-ancestor
139490806|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
139490807|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490808|NCT03066661|Entrectinib|entrectinib|mesh-list
139490809|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139490810|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490811|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490812|NCT03775629|Tramadol|tramadol|mesh-list
139490813|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139490814|NCT03775629|Narcotics|narcotics|mesh-ancestor
139490815|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490816|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490817|NCT03775629|Analgesics|analgesics|mesh-ancestor
139490818|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
139490819|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490820|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
139490821|NCT01671319|Docetaxel|docetaxel|mesh-list
139490822|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139490823|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
139490824|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490825|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139490826|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139490827|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
139490828|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490829|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490830|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139490831|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
139490832|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
139490833|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
139490834|NCT03763305|Fentanyl|fentanyl|mesh-list
139490835|NCT03763305|Remifentanil|remifentanil|mesh-list
139490836|NCT03763305|Propofol|propofol|mesh-list
139490837|NCT03763305|Sevoflurane|sevoflurane|mesh-list
139490838|NCT03763305|Desflurane|desflurane|mesh-list
139490839|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139490840|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139490841|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490842|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490843|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139490844|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
139490845|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
139490846|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139490847|NCT03763305|Narcotics|narcotics|mesh-ancestor
139490848|NCT03763305|Analgesics|analgesics|mesh-ancestor
139490849|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
139490850|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490851|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139490852|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139277521|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139490853|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139490855|NCT05054361|Lactulose|lactulose|mesh-list
139490856|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139490857|NCT05054361|Diuretics|diuretics|mesh-ancestor
139490858|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
139490859|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490860|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139490861|NCT04906213|Empagliflozin|empagliflozin|mesh-list
139490862|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138852747|NCT00915915|Estrogens|estrogens|mesh-ancestor
139490863|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490864|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139490865|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490866|NCT01670539|Triamcinolone|triamcinolone|mesh-list
139490867|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139490868|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
139490869|NCT01670539|Hormones|hormones|mesh-ancestor
139490870|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139490871|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490872|NCT04431895|Tofacitinib|tofacitinib|mesh-list
139490873|NCT04431895|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139490874|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139490875|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490876|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490877|NCT03064633|Dexamethasone|dexamethasone|mesh-list
139490878|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
139490879|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
139490880|NCT03064633|Bupivacaine|bupivacaine|mesh-list
139490881|NCT03064633|BB 1101|bb 1101|mesh-list
139490882|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139490883|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
139490884|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
139490885|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490886|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490887|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139490888|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
139490889|NCT03064633|Hormones|hormones|mesh-ancestor
139490890|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139490891|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139490892|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490893|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
139490894|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490895|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490896|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
139490897|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
139490898|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490899|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
139490900|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139490901|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139490902|NCT03064633|Analgesics|analgesics|mesh-ancestor
139490903|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139490904|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139490905|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139490906|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
139490907|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490908|NCT02589665|Mirikizumab|mirikizumab|mesh-list
139490909|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139490910|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139490911|NCT02589665|Analgesics|analgesics|mesh-ancestor
139490912|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
139490913|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490914|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490915|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139490916|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139490917|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139490918|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139490919|NCT04426409|Ofloxacin|ofloxacin|mesh-list
139490920|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139490921|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139490922|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139490923|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139490924|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139490925|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490926|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490927|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139490928|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139490929|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139490930|NCT04426097|Iodine|iodine|mesh-list
139490931|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139490932|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139490933|NCT04426097|Trace Elements|trace elements|mesh-ancestor
139490934|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
139490935|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490936|NCT05556083|Sildenafil Citrate|sildenafil citrate|mesh-list
139490937|NCT05556083|Vasodilator Agents|vasodilator agents|mesh-ancestor
139490938|NCT05556083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139490939|NCT05556083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139490940|NCT05556083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139490941|NCT05556083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490942|NCT05556083|Urological Agents|urological agents|mesh-ancestor
139490943|NCT05556005|Trimetazidine|trimetazidine|mesh-list
139490944|NCT05556005|Vasodilator Agents|vasodilator agents|mesh-ancestor
139490945|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
139490946|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
139490947|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139490948|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138852863|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139490949|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490950|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
139490951|NCT04373603|Coagulants|coagulants|mesh-ancestor
139490952|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139490953|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
139490954|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490955|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
139490956|NCT04373603|Protective Agents|protective agents|mesh-ancestor
139490957|NCT02519595|Ketamine|ketamine|mesh-list
139490958|NCT02519595|Analgesics|analgesics|mesh-ancestor
139490959|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
139490960|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490961|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490962|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139490963|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139490964|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
139490965|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
139490966|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490967|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139490968|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139490969|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139490970|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139490971|NCT04278755|Drospirenone|drospirenone|mesh-list
139490972|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139490973|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139490974|NCT04278755|Estradiol|estradiol|mesh-list
139490975|NCT04278755|Estrogens|estrogens|mesh-ancestor
139490976|NCT04278755|Hormones|hormones|mesh-ancestor
139490977|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139490978|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490979|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139490980|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
139490981|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139490982|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138852910|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138852911|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139490983|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139490984|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139490985|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139490986|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
139490987|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139490988|NCT04278755|Diuretics|diuretics|mesh-ancestor
139490989|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
139490990|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
139490991|NCT04277975|Narcotics|narcotics|mesh-ancestor
139490992|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139490993|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139490994|NCT04277975|Analgesics|analgesics|mesh-ancestor
139490995|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
139490996|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139490997|NCT04062695|Tofacitinib|tofacitinib|mesh-list
139490998|NCT04062695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139490999|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139277668|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
139491000|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491001|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491002|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
139491003|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139491004|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491005|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139491006|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491007|NCT00660673|Levodopa|levodopa|mesh-list
139491008|NCT00660673|Carbidopa|carbidopa|mesh-list
139491009|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139491010|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139491011|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139491012|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
139491013|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139491014|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491015|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491016|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139491017|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491018|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139491019|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
139491020|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
139491021|NCT03644381|Immunomodulating Agents|immunomodulating agents|mesh-list
139491022|NCT03644381|Immunologic Factors|immunologic factors|mesh-ancestor
139491023|NCT03644381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491024|NCT05612711|Dronabinol|dronabinol|mesh-list
139491025|NCT05612711|Hallucinogens|hallucinogens|mesh-ancestor
139491026|NCT05612711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491027|NCT05612711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139491028|NCT05612711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139491029|NCT05612711|Analgesics|analgesics|mesh-ancestor
139491030|NCT05612711|Sensory System Agents|sensory system agents|mesh-ancestor
139491031|NCT05612711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491032|NCT05612711|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139491033|NCT05612711|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139491034|NCT05612711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139491035|NCT05612711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491036|NCT05612711|Hormones|hormones|mesh-ancestor
139491037|NCT05612711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139491038|NCT04807309|Danazol|danazol|mesh-list
139491039|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139491040|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
139491041|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139491042|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491043|NCT04744649|Fluorouracil|fluorouracil|mesh-list
139491044|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
139491045|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491046|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139491047|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491048|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139491049|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
139491050|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491051|NCT04426955|Paclitaxel|paclitaxel|mesh-list
139491052|NCT04426955|Cisplatin|cisplatin|mesh-list
139491053|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139491054|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491055|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
139491056|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
139491057|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
139491058|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491059|NCT02630563|Cyclosporine|cyclosporine|mesh-list
139491060|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
139491061|NCT02630563|Cyclosporins|cyclosporins|mesh-list
139491062|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491063|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491064|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139491065|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
139491066|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491067|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
139491068|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491069|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
139491070|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139491071|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139491072|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139491073|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491074|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139491075|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
139491076|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139491077|NCT05700695|Lactulose|lactulose|mesh-list
139491078|NCT05700695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139491079|NCT05555147|Ropivacaine|ropivacaine|mesh-list
139491080|NCT05555147|Anesthetics, Local|anesthetics, local|mesh-ancestor
139491081|NCT05555147|Anesthetics|anesthetics|mesh-ancestor
139491082|NCT05555147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139491083|NCT05555147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491084|NCT05555147|Sensory System Agents|sensory system agents|mesh-ancestor
139491085|NCT05555147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491086|NCT02587247|Antibodies|antibodies|mesh-list
139491087|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
139491088|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491089|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
139491090|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139491091|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
139491092|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139491093|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
139491094|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853092|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139491095|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491096|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
139491097|NCT02521415|Acetaminophen|acetaminophen|mesh-list
139491098|NCT02521415|Ibuprofen|ibuprofen|mesh-list
139491099|NCT02521415|Fentanyl|fentanyl|mesh-list
139491100|NCT02521415|Ketamine|ketamine|mesh-list
139491101|NCT02521415|Analgesics|analgesics|mesh-list
139491102|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
139491103|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491104|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491105|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139491106|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139491107|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
139491108|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
139491109|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139491110|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139491111|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139491112|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139491113|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491114|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139491115|NCT02521415|Narcotics|narcotics|mesh-ancestor
139491116|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139491117|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139491118|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
139491119|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139491120|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139491121|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139491122|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139491123|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491124|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
139491125|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
139491126|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491127|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
139491128|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491129|NCT02588339|Sirolimus|sirolimus|mesh-list
139491130|NCT02588339|Panobinostat|panobinostat|mesh-list
139491131|NCT02588339|Tacrolimus|tacrolimus|mesh-list
139491132|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139491133|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
139491134|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491135|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139491136|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491137|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491138|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139491139|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491140|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139491141|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491142|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
139491143|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139491144|NCT05554055|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139491145|NCT05554055|Dalteparin|dalteparin|mesh-list
139491146|NCT05554055|Anticoagulants|anticoagulants|mesh-ancestor
139491147|NCT05554055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139491148|NCT05554055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139491149|NCT05554055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491150|NCT05700617|Dobutamine|dobutamine|mesh-list
139277818|NCT01430572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139491151|NCT05700617|Milrinone|milrinone|mesh-list
139491152|NCT05700617|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139491153|NCT05700617|Sympathomimetics|sympathomimetics|mesh-ancestor
139491154|NCT05700617|Autonomic Agents|autonomic agents|mesh-ancestor
139491155|NCT05700617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491156|NCT05700617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491157|NCT05700617|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139491158|NCT05700617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139491159|NCT05700617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139491160|NCT05700617|Adrenergic Agents|adrenergic agents|mesh-ancestor
139491161|NCT05700617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139491162|NCT05700617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491163|NCT05700617|Protective Agents|protective agents|mesh-ancestor
139491164|NCT05700617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139491165|NCT05700617|Vasodilator Agents|vasodilator agents|mesh-ancestor
139491166|NCT05700617|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139491167|NCT05700617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139491168|NCT05700617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491169|NCT02629159|Adalimumab|adalimumab|mesh-list
139491170|NCT02629159|Upadacitinib|upadacitinib|mesh-list
139491171|NCT02629159|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139491172|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139491173|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139491174|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139491175|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139491176|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491177|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491178|NCT02628769|Solithromycin|solithromycin|mesh-list
139491179|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139491180|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491181|NCT05552807|Paclitaxel|paclitaxel|mesh-list
139491182|NCT05552807|Docetaxel|docetaxel|mesh-list
139491183|NCT05552807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139491184|NCT05552807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491185|NCT05552807|Tubulin Modulators|tubulin modulators|mesh-ancestor
139491186|NCT05552807|Antimitotic Agents|antimitotic agents|mesh-ancestor
139491187|NCT05552807|Mitosis Modulators|mitosis modulators|mesh-ancestor
139491188|NCT05552807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491189|NCT05552729|Vitamin D|vitamin d|mesh-list
139491190|NCT05552729|Ergocalciferols|ergocalciferols|mesh-list
139491191|NCT05552729|Cholecalciferol|cholecalciferol|mesh-list
139491192|NCT05552729|Vitamins|vitamins|mesh-list
139491193|NCT05552729|Micronutrients|micronutrients|mesh-ancestor
139491194|NCT05552729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491195|NCT05552729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139491196|NCT05552729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139491197|NCT05552651|Paclitaxel|paclitaxel|mesh-list
139491198|NCT05552651|Carboplatin|carboplatin|mesh-list
139491199|NCT05552651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139491200|NCT05552651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138853222|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
139491201|NCT05552651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491202|NCT05552651|Tubulin Modulators|tubulin modulators|mesh-ancestor
139491203|NCT05552651|Antimitotic Agents|antimitotic agents|mesh-ancestor
139491204|NCT05552651|Mitosis Modulators|mitosis modulators|mesh-ancestor
139491205|NCT05552651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491206|NCT04981327|Apixaban|apixaban|mesh-list
139491207|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139491208|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
139491209|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139491210|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
139491211|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491212|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491213|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
139491214|NCT05547659|Acetaminophen|acetaminophen|mesh-list
139491215|NCT05547659|Celecoxib|celecoxib|mesh-list
139491216|NCT05547659|Pregabalin|pregabalin|mesh-list
139491217|NCT05547659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139491218|NCT05547659|Analgesics|analgesics|mesh-ancestor
139491219|NCT05547659|Sensory System Agents|sensory system agents|mesh-ancestor
139491220|NCT05547659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491221|NCT05547659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491222|NCT05547659|Antipyretics|antipyretics|mesh-ancestor
139491223|NCT05547659|Anticonvulsants|anticonvulsants|mesh-ancestor
139491224|NCT05547659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139491225|NCT05547659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139491226|NCT05547659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139277901|NCT02301494|Hormones|hormones|mesh-ancestor
138853247|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
139491227|NCT05547659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139491228|NCT05547659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139491229|NCT05547659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139491230|NCT05547659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139491231|NCT05547659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139491232|NCT05547659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139491233|NCT05547659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139491234|NCT05547659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139491235|NCT05547659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139491236|NCT05547659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139491237|NCT05547659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491238|NCT05541419|Budesonide|budesonide|mesh-list
139491239|NCT05541419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139491240|NCT05541419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138853295|NCT00908167|Cytarabine|cytarabine|mesh-list
139491241|NCT05541419|Autonomic Agents|autonomic agents|mesh-ancestor
139491242|NCT05541419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491243|NCT05541419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491244|NCT05541419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139491245|NCT05541419|Respiratory System Agents|respiratory system agents|mesh-ancestor
139491246|NCT05541419|Glucocorticoids|glucocorticoids|mesh-ancestor
139491247|NCT05541419|Hormones|hormones|mesh-ancestor
139491248|NCT05541419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139491249|NCT05541185|Naproxen|naproxen|mesh-list
139491250|NCT05541185|Lidocaine|lidocaine|mesh-list
139491251|NCT05541185|Anesthetics, Local|anesthetics, local|mesh-ancestor
139491252|NCT05541185|Anesthetics|anesthetics|mesh-ancestor
139491253|NCT05541185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139491254|NCT05541185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491255|NCT05541185|Sensory System Agents|sensory system agents|mesh-ancestor
139491256|NCT05541185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491257|NCT05541185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139491258|NCT05541185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139491259|NCT05541185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139491260|NCT05541185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139491261|NCT05541185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491262|NCT05541185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139491263|NCT05541185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139491264|NCT05541185|Analgesics|analgesics|mesh-ancestor
139491265|NCT05541185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139491266|NCT05541185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139491267|NCT05541185|Gout Suppressants|gout suppressants|mesh-ancestor
139491268|NCT05541185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139491269|NCT05541185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491270|NCT02518113|Dexamethasone|dexamethasone|mesh-list
139491271|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139491272|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
139491273|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
139491274|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491275|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491276|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139491277|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
139491278|NCT02518113|Hormones|hormones|mesh-ancestor
139491279|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139491280|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139491281|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491282|NCT05541107|Amphotericin B|amphotericin b|mesh-list
139491283|NCT05541107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139491284|NCT05541107|Amebicides|amebicides|mesh-ancestor
139491285|NCT05541107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139491286|NCT05541107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139491287|NCT05541107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491288|NCT05541107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139491289|NCT05541107|Antifungal Agents|antifungal agents|mesh-ancestor
139491290|NCT03062839|Melatonin|melatonin|mesh-list
139491291|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
139491292|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491293|NCT03062839|Protective Agents|protective agents|mesh-ancestor
139491294|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787976|NCT00641680|Hormones|hormones|mesh-ancestor
139491295|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139491296|NCT05540951|Bevacizumab|bevacizumab|mesh-list
139491297|NCT05540951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139491298|NCT05540951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491299|NCT05540951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139491300|NCT05540951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139491301|NCT05540951|Growth Substances|growth substances|mesh-ancestor
139277974|NCT02301806|Hormones|hormones|mesh-ancestor
139491302|NCT05540951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491303|NCT05540951|Growth Inhibitors|growth inhibitors|mesh-ancestor
139491304|NCT04981093|Dexamethasone|dexamethasone|mesh-list
139491305|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
139491306|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139491307|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
139491308|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
139491309|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491310|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491311|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139491312|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
139491313|NCT04981093|Hormones|hormones|mesh-ancestor
139491314|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139491315|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139491316|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491317|NCT05551247|Endostatins|endostatins|mesh-list
139491318|NCT05551247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491319|NCT05551247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139491320|NCT05551247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139491321|NCT05551247|Growth Substances|growth substances|mesh-ancestor
139491322|NCT05551247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491323|NCT05551247|Growth Inhibitors|growth inhibitors|mesh-ancestor
139491324|NCT05540483|Disitamab vedotin|disitamab vedotin|mesh-list
139491325|NCT05540483|Immunoconjugates|immunoconjugates|mesh-ancestor
139491326|NCT05540483|Immunologic Factors|immunologic factors|mesh-ancestor
139491327|NCT05540483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491328|NCT02629861|Calcitonin|calcitonin|mesh-list
139491329|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139491330|NCT02629861|Katacalcin|katacalcin|mesh-list
139491331|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139491332|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491333|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139491334|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
139491335|NCT02513823|Vitamin D|vitamin d|mesh-list
139491336|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
139491337|NCT02513823|Vitamins|vitamins|mesh-ancestor
139491338|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
139491339|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491340|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138853579|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
139491341|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139491342|NCT05545475|Heparin|heparin|mesh-list
139491343|NCT05545475|Enoxaparin|enoxaparin|mesh-list
139491344|NCT05545475|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139491345|NCT05545475|Tinzaparin|tinzaparin|mesh-list
139491346|NCT05545475|Dalteparin|dalteparin|mesh-list
139491347|NCT05545475|Nadroparin|nadroparin|mesh-list
139491348|NCT05545475|Warfarin|warfarin|mesh-list
139491349|NCT05545475|Anticoagulants|anticoagulants|mesh-ancestor
139491350|NCT05545475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139491351|NCT05545475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139491352|NCT05545475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491353|NCT05545397|Propofol|propofol|mesh-list
139491354|NCT05545397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139491355|NCT05545397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139491356|NCT05545397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491357|NCT05545397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139491358|NCT05545397|Anesthetics, General|anesthetics, general|mesh-ancestor
139491359|NCT05545397|Anesthetics|anesthetics|mesh-ancestor
139491360|NCT04952727|Vaccines|vaccines|mesh-list
139491361|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
139491362|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491363|NCT04433143|Minocycline|minocycline|mesh-list
139491364|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139491365|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491366|NCT01665911|Listerine|listerine|mesh-list
139491367|NCT01665911|Fluorides|fluorides|mesh-list
139491368|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
139491369|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
139491370|NCT01665911|Protective Agents|protective agents|mesh-ancestor
139491371|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491372|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139491373|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491374|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
139491375|NCT03063073|Bupivacaine|bupivacaine|mesh-list
139491376|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
139491377|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
139491378|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139491379|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491380|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
139491381|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491382|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139491383|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139491385|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139491386|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139491387|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139491388|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
139491389|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139491390|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491391|NCT04620733|Seladelpar|seladelpar|mesh-list
139491392|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139491393|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
139491394|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491395|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139491396|NCT02476617|Ritonavir|ritonavir|mesh-list
139491397|NCT02476617|Ribavirin|ribavirin|mesh-list
139491398|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139491399|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139491400|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
139491401|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491402|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491403|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139491404|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139491405|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
139491406|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491407|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139491408|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139491409|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
139491410|NCT04428307|Artemisinins|artemisinins|mesh-list
139491411|NCT04428307|Artemisinin|artemisinin|mesh-list
139491412|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
139491413|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139491414|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139491415|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491416|NCT05535725|Vancomycin|vancomycin|mesh-list
139491417|NCT05535725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139491418|NCT05535725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491419|NCT05535569|Paclitaxel|paclitaxel|mesh-list
139491420|NCT05535569|Nivolumab|nivolumab|mesh-list
139491421|NCT05535569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139491422|NCT05535569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491423|NCT05535569|Tubulin Modulators|tubulin modulators|mesh-ancestor
139491424|NCT05535569|Antimitotic Agents|antimitotic agents|mesh-ancestor
139491425|NCT05535569|Mitosis Modulators|mitosis modulators|mesh-ancestor
139491426|NCT05535569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491427|NCT05535569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139491428|NCT05535569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139491429|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139491430|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139491431|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491432|NCT03064165|Epinephrine|epinephrine|mesh-list
139491433|NCT03064165|Bupivacaine|bupivacaine|mesh-list
139491434|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
139491435|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
139491436|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139491437|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491438|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
139491439|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491440|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139491441|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139491442|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
139491443|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139491444|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491445|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139491446|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139491447|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
139491448|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139491449|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
139491450|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
139491451|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
139491452|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139491453|NCT05535413|Capecitabine|capecitabine|mesh-list
139491454|NCT05535413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139491455|NCT05535413|Antimetabolites|antimetabolites|mesh-ancestor
139278120|NCT02143362|Remifentanil|remifentanil|mesh-list
139491456|NCT05535413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491457|NCT05535413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491458|NCT03813199|Methotrexate|methotrexate|mesh-list
139491459|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139491460|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
139491461|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139491462|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491463|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139491464|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
139491465|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491466|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491467|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
139491468|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491469|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139491470|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139491471|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
139491472|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139491473|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139491474|NCT05699135|Avelumab|avelumab|mesh-list
139491475|NCT05699135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139491476|NCT05699135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491477|NCT03791593|Evolocumab|evolocumab|mesh-list
139491478|NCT03791593|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139491479|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139491480|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139491481|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
139491482|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491483|NCT03791593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139491484|NCT03791593|Protease Inhibitors|protease inhibitors|mesh-ancestor
139491485|NCT03791593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491486|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139491487|NCT03064243|Apatinib|apatinib|mesh-list
139491488|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491489|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139491490|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491491|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491492|NCT03765619|Aspirin|aspirin|mesh-list
139491493|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139491494|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139491495|NCT03765619|Analgesics|analgesics|mesh-ancestor
139491496|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
139491497|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491498|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491499|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139491500|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139491501|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139491502|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139491503|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491504|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139491505|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139491506|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491507|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
139491508|NCT05543603|Chlorhexidine|chlorhexidine|mesh-list
139491509|NCT05543603|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139491510|NCT05543603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139491511|NCT05543603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491512|NCT05543603|Disinfectants|disinfectants|mesh-ancestor
139491513|NCT05543603|Dermatologic Agents|dermatologic agents|mesh-ancestor
139491514|NCT04979923|Lidocaine|lidocaine|mesh-list
139491515|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
139491516|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
139491517|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139491518|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491519|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
139491520|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491521|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139491522|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139491523|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139491524|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139491525|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491526|NCT03706885|Efavirenz|efavirenz|mesh-list
139491527|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139491528|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139278192|NCT05073640|Protective Agents|protective agents|mesh-ancestor
139491529|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491530|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491531|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
139491532|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491533|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139491534|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139491535|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139491536|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139491537|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139491538|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139491539|NCT01665599|Testosterone|testosterone|mesh-list
139491540|NCT01665599|Androgens|androgens|mesh-ancestor
139491542|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139491543|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491544|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
139491545|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
139491546|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
139491547|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139491548|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139491549|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
139491550|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
139491551|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139491552|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491553|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491554|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139491555|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
139491556|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139491557|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
139491558|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
139491559|NCT03063775|Coagulants|coagulants|mesh-ancestor
139491560|NCT03063541|Aspirin|aspirin|mesh-list
139491561|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139491562|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139491563|NCT03063541|Analgesics|analgesics|mesh-ancestor
139491564|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
139491565|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491566|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491567|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139491568|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139491569|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139491570|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139491571|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491572|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139491573|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139491574|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491575|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
139491576|NCT04978597|Opicapone|opicapone|mesh-list
139491577|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139491578|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491579|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491580|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139491581|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139491582|NCT03490513|Anastrozole|anastrozole|mesh-list
139491583|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139491584|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491585|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139491586|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139491587|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491588|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491589|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139491590|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
139491591|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139491592|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491593|NCT04977661|Vitamin E|vitamin e|mesh-list
139491594|NCT04977661|Tocopherols|tocopherols|mesh-list
139491595|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
139491596|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
139491597|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139491598|NCT04977661|Vitamins|vitamins|mesh-ancestor
139491599|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
139491600|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491601|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
139491602|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491603|NCT04977661|Protective Agents|protective agents|mesh-ancestor
139491604|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139491605|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491606|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139491607|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139491608|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
139491609|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138854141|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
139491610|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139491611|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139491612|NCT04977427|Prednisolone|prednisolone|mesh-list
139491613|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139491614|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
139491615|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139491616|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
139491617|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139491618|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
139491619|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139491620|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
139491622|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139491623|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491624|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139491625|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491626|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
139491627|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
139491628|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491629|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139491630|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139491631|NCT04977427|Protective Agents|protective agents|mesh-ancestor
139491632|NCT04224415|Irinotecan|irinotecan|mesh-list
139491633|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138854215|NCT00928837|Naproxen|naproxen|mesh-list
139491634|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139491635|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491636|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491637|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491638|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
139491639|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139491640|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491641|NCT03239899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139491642|NCT03239899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491643|NCT03061981|Metformin|metformin|mesh-list
139491644|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139491645|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491646|NCT02510001|Crizotinib|crizotinib|mesh-list
139491647|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491648|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139491649|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491650|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491651|NCT02452047|Imipenem|imipenem|mesh-list
139491652|NCT02452047|Relebactam|relebactam|mesh-list
139491653|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
139491654|NCT02452047|Cilastatin|cilastatin|mesh-list
139491655|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139491656|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491657|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
139491658|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491659|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491660|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139491661|NCT02475369|Pancrelipase|pancrelipase|mesh-list
139491662|NCT02475369|Pancreatin|pancreatin|mesh-list
139491663|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139491664|NCT02474589|Tecovirimat|tecovirimat|mesh-list
139491665|NCT02474589|Antiviral Agents|antiviral agents|mesh-ancestor
139491666|NCT02474589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491667|NCT02474355|Osimertinib|osimertinib|mesh-list
139491668|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491669|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139491670|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491671|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491672|NCT02474199|Acetaminophen|acetaminophen|mesh-list
139491673|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
139491674|NCT02474199|Promethazine|promethazine|mesh-list
139491675|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139491676|NCT02474199|Analgesics|analgesics|mesh-ancestor
139491677|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
139491678|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491679|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491680|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
139491681|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139491682|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139491683|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139491684|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
139491685|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
139491686|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
139491687|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
139491688|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139491689|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139491690|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
139491691|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
139491692|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139491693|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491694|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139491695|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
139491696|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
139491697|NCT02450487|Piroxicam|piroxicam|mesh-list
139491698|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139491699|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139491700|NCT02450487|Analgesics|analgesics|mesh-ancestor
139491701|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
139491702|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491703|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491704|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139491705|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139491706|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139491707|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854335|NCT02739906|Insulin|insulin|mesh-list
139491708|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491709|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
139491710|NCT02506881|Hematinics|hematinics|mesh-ancestor
139491711|NCT02506257|Biguanides|biguanides|mesh-list
139491712|NCT02506257|Polihexanide|polihexanide|mesh-list
139491713|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139491714|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491715|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
139491716|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491717|NCT02505945|Omeprazole|omeprazole|mesh-list
139491718|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139491719|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139491720|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139491721|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491722|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491723|NCT04213885|Riboflavin|riboflavin|mesh-list
139491724|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
139491725|NCT04213885|Vitamins|vitamins|mesh-ancestor
139491726|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
139491727|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491728|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139491729|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
139491730|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
139491731|NCT02448771|Palbociclib|palbociclib|mesh-list
139491732|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491733|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138854392|NCT05788393|Sensory System Agents|sensory system agents|mesh-ancestor
138854393|NCT05788393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854394|NCT05788393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138854395|NCT05788393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138854396|NCT05788393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138854397|NCT05788393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138854398|NCT05788393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854399|NCT05788393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138854400|NCT05788393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138854401|NCT05788393|Analgesics|analgesics|mesh-ancestor
138854407|NCT05788159|Lacosamide|lacosamide|mesh-list
139491734|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491735|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491736|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139491737|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139491738|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
139491739|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139491740|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491741|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139491742|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
139491743|NCT02504541|Testosterone|testosterone|mesh-list
139491744|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
139491745|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
139491746|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139491747|NCT02504541|Androgens|androgens|mesh-ancestor
139491748|NCT02504541|Hormones|hormones|mesh-ancestor
139491749|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139491750|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491751|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139491752|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491753|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
139491754|NCT04924257|Esketamine|esketamine|mesh-list
138854444|NCT05787535|Cyclophosphamide|cyclophosphamide|mesh-list
139491756|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139491757|NCT04924179|Tislelizumab|tislelizumab|mesh-list
139491758|NCT04924179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139491759|NCT04924179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491760|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
139491761|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139491762|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491763|NCT03063307|Fluorides|fluorides|mesh-list
139491764|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
139491765|NCT03063307|Protective Agents|protective agents|mesh-ancestor
139491766|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491767|NCT04874935|Lansoprazole|lansoprazole|mesh-list
139491768|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
139491769|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139491770|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139491771|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139491772|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491773|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491774|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
139491775|NCT02961361|Ropivacaine|ropivacaine|mesh-list
139491776|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139491777|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139491778|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491779|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139491780|NCT02961361|Analgesics|analgesics|mesh-ancestor
139491781|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
139491782|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491783|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139491784|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139491785|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139491786|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
139491787|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139491788|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491789|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
139491790|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
139491791|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
139491792|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
139491793|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491794|NCT02426281|Paclitaxel|paclitaxel|mesh-list
139491795|NCT02426281|Gemcitabine|gemcitabine|mesh-list
139491796|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139491797|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491798|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
139491799|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
139491800|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
139491801|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491802|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139491803|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
139491804|NCT02448537|Gemcitabine|gemcitabine|mesh-list
139491805|NCT02448537|Doxorubicin|doxorubicin|mesh-list
139491806|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139491807|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139491808|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
139491809|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491810|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491811|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139491812|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139491813|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139491814|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491815|NCT03060265|Acetaminophen|acetaminophen|mesh-list
139491816|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139491817|NCT03060265|Analgesics|analgesics|mesh-ancestor
139491818|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
139491819|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491820|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491821|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
139491822|NCT02504151|Cannabidiol|cannabidiol|mesh-list
139491823|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
139491824|NCT02448381|Hypericin|hypericin|mesh-list
139491825|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
139491826|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139491827|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491828|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
139491829|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491830|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491831|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491832|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139491833|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
139491834|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491835|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
139491836|NCT02448225|Fluorides|fluorides|mesh-list
139491837|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139491838|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
139491839|NCT02448225|Protective Agents|protective agents|mesh-ancestor
139491840|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491841|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139491842|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491843|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
139491844|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
139491845|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491846|NCT02447991|Rizatriptan|rizatriptan|mesh-list
139491847|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139491848|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
139491849|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139491850|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491851|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491852|NCT02586155|Atorvastatin|atorvastatin|mesh-list
139491853|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139491854|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139491855|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139491856|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
139491857|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491858|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139491859|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139491860|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491861|NCT05536661|Lubricant Eye Drops|lubricant eye drops|mesh-list
139491862|NCT05536661|Hyaluronic Acid|hyaluronic acid|mesh-list
139491863|NCT05536661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139491864|NCT05536661|Immunologic Factors|immunologic factors|mesh-ancestor
139491865|NCT05536661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491866|NCT05536661|Viscosupplements|viscosupplements|mesh-ancestor
139491867|NCT05536661|Protective Agents|protective agents|mesh-ancestor
139491868|NCT05536661|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139491869|NCT05536661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139491870|NCT05536271|Bisoprolol|bisoprolol|mesh-list
139491871|NCT05536271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139491872|NCT05536271|Sympatholytics|sympatholytics|mesh-ancestor
139491873|NCT05536271|Autonomic Agents|autonomic agents|mesh-ancestor
139491874|NCT05536271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491875|NCT05536271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491876|NCT05536271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139491877|NCT05536271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139491878|NCT05536271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139491879|NCT05536271|Adrenergic Agents|adrenergic agents|mesh-ancestor
139491880|NCT05536271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139491881|NCT05536271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491882|NCT05536193|Metformin|metformin|mesh-list
139491883|NCT05536193|Salicylic Acid|salicylic acid|mesh-list
139491884|NCT05536193|Salicylates|salicylates|mesh-list
139491885|NCT05536193|Mitogens|mitogens|mesh-list
139491886|NCT05536193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139491887|NCT05536193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491888|NCT05536193|Mitosis Modulators|mitosis modulators|mesh-ancestor
139491889|NCT05536193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491890|NCT05536193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491891|NCT05536193|Antifungal Agents|antifungal agents|mesh-ancestor
139491892|NCT05536193|Keratolytic Agents|keratolytic agents|mesh-ancestor
139491893|NCT05536193|Dermatologic Agents|dermatologic agents|mesh-ancestor
139491894|NCT05536193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139491895|NCT05536193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139491896|NCT05536193|Analgesics|analgesics|mesh-ancestor
139491897|NCT05536193|Sensory System Agents|sensory system agents|mesh-ancestor
139491898|NCT05536193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491899|NCT05536193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139491900|NCT05536193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139491901|NCT05536193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139491902|NCT05536193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491903|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
139491904|NCT04425707|Ivermectin|ivermectin|mesh-list
139491905|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
139491906|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139491907|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139491908|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491909|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491910|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491911|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139491913|NCT05697185|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139491914|NCT05697185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139491915|NCT05697185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139491916|NCT05697185|Antimetabolites|antimetabolites|mesh-ancestor
139491917|NCT05697185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491918|NCT05697185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138854825|NCT04557215|Rifaximin|rifaximin|mesh-list
139491919|NCT05697185|Protease Inhibitors|protease inhibitors|mesh-ancestor
139491920|NCT05697185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491921|NCT05697185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139491922|NCT02581163|Ritonavir|ritonavir|mesh-list
139491923|NCT02581163|Ribavirin|ribavirin|mesh-list
139491924|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139491925|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139491926|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
139491927|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491928|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491929|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139491930|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139491931|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
139491932|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491933|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139491934|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139491935|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
138854863|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854864|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854865|NCT04395001|Analgesics|analgesics|mesh-ancestor
138854866|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
138854867|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139491936|NCT01938547|Clevidipine|clevidipine|mesh-list
139491937|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139491938|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139491939|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491940|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139491941|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491942|NCT05695625|Anesthetics|anesthetics|mesh-list
139491943|NCT05695625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139491944|NCT05695625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491945|NCT05586737|Rituximab|rituximab|mesh-list
139491946|NCT05586737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139491947|NCT05586737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491948|NCT05586737|Immunologic Factors|immunologic factors|mesh-ancestor
138854923|NCT03988933|Rifampin|rifampin|mesh-list
139491949|NCT05586737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491950|NCT05586737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139491951|NCT05678933|Prednisone|prednisone|mesh-list
139491952|NCT05678933|Cyclophosphamide|cyclophosphamide|mesh-list
139491953|NCT05678933|Vincristine|vincristine|mesh-list
139491954|NCT05678933|Azacitidine|azacitidine|mesh-list
139491955|NCT05678933|Epirubicin|epirubicin|mesh-list
139491956|NCT05678933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139491957|NCT05678933|Immunologic Factors|immunologic factors|mesh-ancestor
139491958|NCT05678933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491959|NCT05678933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139491960|NCT05678933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139491961|NCT05678933|Alkylating Agents|alkylating agents|mesh-ancestor
139491962|NCT05678933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491963|NCT05678933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491964|NCT05678933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139491965|NCT05678933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139491966|NCT05678933|Glucocorticoids|glucocorticoids|mesh-ancestor
139491967|NCT05678933|Hormones|hormones|mesh-ancestor
139491968|NCT05678933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139491969|NCT05678933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139491970|NCT05678933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139491971|NCT05678933|Tubulin Modulators|tubulin modulators|mesh-ancestor
139491972|NCT05678933|Antimitotic Agents|antimitotic agents|mesh-ancestor
139491973|NCT05678933|Mitosis Modulators|mitosis modulators|mesh-ancestor
139491974|NCT05678933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139491975|NCT05678933|Antimetabolites|antimetabolites|mesh-ancestor
139491976|NCT05678933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491977|NCT05678933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139491978|NCT05678933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139491979|NCT05678933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139491980|NCT05678621|Amoxicillin|amoxicillin|mesh-list
139491981|NCT05678621|Ciprofloxacin|ciprofloxacin|mesh-list
139491982|NCT05678621|Clavulanic Acids|clavulanic acids|mesh-list
139491983|NCT05678621|Clavulanic Acid|clavulanic acid|mesh-list
139491984|NCT05678621|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139491985|NCT05678621|Trimethoprim|trimethoprim|mesh-list
139491986|NCT05678621|Sulfamethoxazole|sulfamethoxazole|mesh-list
139491987|NCT05678621|Immunoglobulins|immunoglobulins|mesh-list
139491988|NCT05678621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139491989|NCT05678621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139491990|NCT05678621|Immunologic Factors|immunologic factors|mesh-ancestor
139491991|NCT05678621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139491992|NCT05678621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139491993|NCT05678621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139491994|NCT05678621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139491995|NCT05678621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139491996|NCT05678621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139491997|NCT05678621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139491998|NCT05678621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139491999|NCT05678621|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139492000|NCT05678621|Antimalarials|antimalarials|mesh-ancestor
139492001|NCT05678621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139492002|NCT05678621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139492003|NCT05678621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139492004|NCT05678621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139492005|NCT05678621|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138855032|NCT03070886|Docetaxel|docetaxel|mesh-list
139492006|NCT05678621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139492007|NCT02627677|Ponatinib|ponatinib|mesh-list
139492008|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492009|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139492010|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492011|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492012|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
139492013|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139492014|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492015|NCT04964479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139492016|NCT04964479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492017|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
139492018|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139492019|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139492020|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
139492021|NCT02585999|Ortho Evra|ortho evra|mesh-list
139492022|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139492023|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855076|NCT02821754|Durvalumab|durvalumab|mesh-list
139492024|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139492025|NCT05696951|Tranylcypromine|tranylcypromine|mesh-list
139492026|NCT05696951|Antidepressive Agents|antidepressive agents|mesh-ancestor
139492027|NCT05696951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139492028|NCT05696951|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139492029|NCT05696951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492030|NCT05696951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492031|NCT05696951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139492032|NCT05696951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139492033|NCT05696951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492034|NCT05696951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492035|NCT05674253|Hydrocortisone|hydrocortisone|mesh-list
139492036|NCT05674253|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139492037|NCT05674253|Dexmedetomidine|dexmedetomidine|mesh-list
139492038|NCT05674253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139492039|NCT05674253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492040|NCT05674253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492041|NCT05674253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139492042|NCT05674253|Analgesics|analgesics|mesh-ancestor
139492043|NCT05674253|Sensory System Agents|sensory system agents|mesh-ancestor
139492044|NCT05674253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492045|NCT05674253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139492046|NCT05674253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139492047|NCT05674253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139492048|NCT05674253|Adrenergic Agents|adrenergic agents|mesh-ancestor
139492049|NCT05674253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492050|NCT05674253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492051|NCT05674253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492052|NCT02500641|Naproxen|naproxen|mesh-list
139492053|NCT02500641|Colchicine|colchicine|mesh-list
139492054|NCT02500641|Allopurinol|allopurinol|mesh-list
139278725|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492056|NCT02500641|Omeprazole|omeprazole|mesh-list
139492057|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139492058|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139492059|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139492060|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492061|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492062|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139492063|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139492064|NCT02500641|Analgesics|analgesics|mesh-ancestor
139492065|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
139492066|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492067|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492068|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492069|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139492070|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
139492071|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139492072|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
139492073|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
139492074|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
139492075|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492076|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
139492077|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139492078|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
139492079|NCT02500641|Protective Agents|protective agents|mesh-ancestor
139492080|NCT04973293|Bevacizumab|bevacizumab|mesh-list
139492081|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139492082|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492083|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139492084|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139492085|NCT04973293|Growth Substances|growth substances|mesh-ancestor
139492086|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492087|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
139492088|NCT04962451|Ticagrelor|ticagrelor|mesh-list
139492089|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138855237|NCT02807870|Methylphenidate|methylphenidate|mesh-list
139492090|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139492091|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139492092|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139492093|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
139492094|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492095|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492096|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492097|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139492098|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492099|NCT03059719|Exenatide|exenatide|mesh-list
139492100|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139492101|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492102|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139492103|NCT03059719|Incretins|incretins|mesh-ancestor
139492104|NCT03059719|Hormones|hormones|mesh-ancestor
139492105|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139492106|NCT03060031|Oxytocin|oxytocin|mesh-list
139492107|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
139492108|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139492109|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492110|NCT02499783|Adalimumab|adalimumab|mesh-list
139492111|NCT02499783|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139492112|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492113|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139492114|NCT04972045|Curcumin|curcumin|mesh-list
139492115|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139492116|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139492117|NCT04972045|Analgesics|analgesics|mesh-ancestor
139492118|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
139492119|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492120|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492121|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492122|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139492123|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492124|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492125|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492126|NCT03059017|Albuterol|albuterol|mesh-list
139492127|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139492128|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
139492129|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492130|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492131|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139492132|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
139492133|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
139492134|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138855403|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492135|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139492136|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139492137|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139492138|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
139492139|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492140|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492141|NCT04425655|Fludarabine|fludarabine|mesh-list
139492142|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492143|NCT04970719|Remdesivir|remdesivir|mesh-list
139492144|NCT04970719|Dexamethasone|dexamethasone|mesh-list
139492145|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139492146|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492147|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
139492148|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
139492149|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492150|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492151|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139492152|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
139492153|NCT04970719|Hormones|hormones|mesh-ancestor
139492154|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139492155|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139492156|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492157|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
139492158|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492159|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
139492160|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139492161|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139492162|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492163|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139492164|NCT02466399|Latanoprost|latanoprost|mesh-list
139492165|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139492166|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
139492167|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139492168|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492169|NCT04970251|Aflibercept|aflibercept|mesh-list
139492170|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139492171|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139492172|NCT04970251|Growth Substances|growth substances|mesh-ancestor
139492173|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492174|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
139492175|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492176|NCT04970329|Dextrans|dextrans|mesh-list
139492177|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
139492178|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
139492179|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
139492180|NCT04960657|Glyburide|glyburide|mesh-list
139492181|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
139492182|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139492183|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492184|NCT04960657|Growth Substances|growth substances|mesh-ancestor
139492185|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
139492186|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492187|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492188|NCT02464059|Vitamin D|vitamin d|mesh-list
139492189|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
139492190|NCT02464059|Vitamins|vitamins|mesh-ancestor
139492191|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
139492192|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492193|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139492194|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139492195|NCT02463357|Metformin|metformin|mesh-list
139492196|NCT02463357|Nifedipine|nifedipine|mesh-list
139492197|NCT02463357|Methazolamide|methazolamide|mesh-list
139492198|NCT02463357|Quercetin|quercetin|mesh-list
139492199|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139492200|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492201|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139492202|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139492203|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492204|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139492205|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
139492206|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
139492207|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139492208|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
139492209|NCT02463357|Protective Agents|protective agents|mesh-ancestor
139492210|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139492211|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492212|NCT02463357|Diuretics|diuretics|mesh-ancestor
139492213|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
139492214|NCT04959721|Triamcinolone|triamcinolone|mesh-list
139492215|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139492216|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139492217|NCT04959721|Bupivacaine|bupivacaine|mesh-list
139492218|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139492219|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
139492220|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
139492221|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492222|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492223|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
139492224|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492225|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492226|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
139492228|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139492229|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139492230|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
139492231|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492232|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492233|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
139492234|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492235|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492236|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
139492237|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492238|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492239|NCT04676555|Ofatumumab|ofatumumab|mesh-list
139492240|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
139492241|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492242|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
139492243|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492244|NCT04314167|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139492245|NCT04314167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139492246|NCT04314167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139492247|NCT04314167|Antimetabolites|antimetabolites|mesh-ancestor
139492248|NCT04314167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492249|NCT04314167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139492250|NCT04314167|Protease Inhibitors|protease inhibitors|mesh-ancestor
139492251|NCT04314167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492252|NCT04314167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139492253|NCT05575427|Levofloxacin|levofloxacin|mesh-list
139492254|NCT05575427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139492255|NCT05575427|Minocycline|minocycline|mesh-list
139492256|NCT05575427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139492257|NCT05575427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139492258|NCT05575427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139492259|NCT05575427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139492260|NCT05575427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139492261|NCT05575427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492262|NCT05575427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492263|NCT05575427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492264|NCT05575427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139492265|NCT05575427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139492266|NCT05575427|Antimalarials|antimalarials|mesh-ancestor
139492267|NCT05575427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139492268|NCT05575427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139492269|NCT04959253|Psilocybin|psilocybin|mesh-list
139492270|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
139492271|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492272|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139492273|NCT02499159|Bupivacaine|bupivacaine|mesh-list
139492274|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
139492275|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
139492276|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492277|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492278|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
139492279|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139278953|NCT05055544|Fosfomycin|fosfomycin|mesh-list
139492281|NCT01664039|Travoprost|travoprost|mesh-list
139492282|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139492283|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139492284|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139492285|NCT05645705|Listerine|listerine|mesh-list
139492286|NCT05645705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139492287|NCT05645705|Sodium Fluoride|sodium fluoride|mesh-list
139492288|NCT05645705|Cariostatic Agents|cariostatic agents|mesh-ancestor
139492289|NCT05645705|Protective Agents|protective agents|mesh-ancestor
139492290|NCT05645705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492291|NCT05645705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139492292|NCT02445339|Naltrexone|naltrexone|mesh-list
139492293|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139492294|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139492295|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492296|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
139492297|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492298|NCT04959409|Tetracaine|tetracaine|mesh-list
139492299|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
139492300|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
139492301|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492302|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492303|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
139492304|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492305|NCT03058939|Tamoxifen|tamoxifen|mesh-list
139492306|NCT03058939|Paclitaxel|paclitaxel|mesh-list
139492307|NCT03058939|Carboplatin|carboplatin|mesh-list
139492308|NCT03058939|Trastuzumab|trastuzumab|mesh-list
139492309|NCT03058939|Letrozole|letrozole|mesh-list
139492310|NCT03058939|Pertuzumab|pertuzumab|mesh-list
139492311|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139492312|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492313|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
139492314|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
139492315|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
139492316|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492317|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139492318|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139492319|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139492320|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492321|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139492322|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
139492323|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138855697|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139492324|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492325|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139492326|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139492327|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139492328|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139492329|NCT03058471|Methotrexate|methotrexate|mesh-list
139492330|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139492331|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
139492332|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139492333|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492334|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139492335|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
139492336|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492337|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492338|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
139492339|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492340|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139492341|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139492342|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
139492343|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139492344|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139492345|NCT02579603|Pirfenidone|pirfenidone|mesh-list
139492346|NCT02579603|Nintedanib|nintedanib|mesh-list
139492347|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492348|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139492349|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492350|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492351|NCT02579603|Analgesics|analgesics|mesh-ancestor
139492352|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
139492353|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492354|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492355|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139492356|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139492357|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492358|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139492359|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
139492360|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139492361|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139492362|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492363|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
139492364|NCT03060889|Coagulants|coagulants|mesh-ancestor
139492365|NCT05546957|Aspirin|aspirin|mesh-list
139492366|NCT05546957|Rivaroxaban|rivaroxaban|mesh-list
139492367|NCT05546957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139492368|NCT05546957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139492369|NCT05546957|Analgesics|analgesics|mesh-ancestor
139492370|NCT05546957|Sensory System Agents|sensory system agents|mesh-ancestor
139492371|NCT05546957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492372|NCT05546957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492373|NCT05546957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492374|NCT05546957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139492375|NCT05546957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139492376|NCT05546957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139492377|NCT05546957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492378|NCT05546957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139492379|NCT05546957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139492380|NCT05546957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492381|NCT05546957|Antipyretics|antipyretics|mesh-ancestor
139492382|NCT05546957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139492383|NCT05546957|Antithrombins|antithrombins|mesh-ancestor
139492384|NCT05546957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139492385|NCT05546957|Protease Inhibitors|protease inhibitors|mesh-ancestor
139492386|NCT05546957|Anticoagulants|anticoagulants|mesh-ancestor
138855779|NCT02738502|Ritonavir|ritonavir|mesh-list
139492387|NCT04950205|Sevoflurane|sevoflurane|mesh-list
139492388|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139492389|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139492390|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
139492391|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
139492392|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492393|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492394|NCT02625259|Lansoprazole|lansoprazole|mesh-list
139492395|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
139492396|NCT02625259|Serabelisib|serabelisib|mesh-list
139492397|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139492398|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139492399|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139492400|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492401|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492402|NCT02577107|Ranibizumab|ranibizumab|mesh-list
139492403|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139492404|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139492405|NCT02577107|Growth Substances|growth substances|mesh-ancestor
139492406|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492407|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
139492408|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492409|NCT04958473|Axitinib|axitinib|mesh-list
139492410|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492411|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139492412|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492413|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492414|NCT04957927|Fluticasone|fluticasone|mesh-list
139492415|NCT04957927|Xhance|xhance|mesh-list
139492416|NCT04957927|Montelukast|montelukast|mesh-list
139492417|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492418|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139492419|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
139492420|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492421|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492422|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139492423|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
139492424|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
139492425|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139492426|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139492427|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
138855861|NCT05906433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492428|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139279092|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
139492429|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139492430|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139492431|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492432|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
139492433|NCT04950049|Dexamethasone|dexamethasone|mesh-list
139492434|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
139492435|NCT04950049|BB 1101|bb 1101|mesh-list
139492436|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492437|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
139492438|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
139492439|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492440|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492441|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139492442|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
139492443|NCT04950049|Hormones|hormones|mesh-ancestor
139492444|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139492445|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138855914|NCT05905757|Anesthetics|anesthetics|mesh-ancestor
139492446|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492447|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
139492448|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492449|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492450|NCT05587673|Methylprednisolone|methylprednisolone|mesh-list
139492451|NCT05587673|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139492452|NCT05587673|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139492453|NCT05587673|Prednisolone|prednisolone|mesh-list
139492454|NCT05587673|Prednisolone acetate|prednisolone acetate|mesh-list
139492455|NCT05587673|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139492456|NCT05587673|Prednisolone phosphate|prednisolone phosphate|mesh-list
139492457|NCT05587673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492458|NCT05587673|Antiemetics|antiemetics|mesh-ancestor
139492459|NCT05587673|Autonomic Agents|autonomic agents|mesh-ancestor
139492460|NCT05587673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492461|NCT05587673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492462|NCT05587673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139492463|NCT05587673|Glucocorticoids|glucocorticoids|mesh-ancestor
139492464|NCT05587673|Hormones|hormones|mesh-ancestor
139492465|NCT05587673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139492466|NCT05587673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139492467|NCT05587673|Protective Agents|protective agents|mesh-ancestor
139492468|NCT05587673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139492469|NCT05587673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492470|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
139492471|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492472|NCT04966429|Maraviroc|maraviroc|mesh-list
139492473|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139492474|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139492475|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492476|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139492477|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139492478|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
139492479|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139492480|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139492481|NCT04949347|Glycerol|glycerol|mesh-list
139492482|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139492483|NCT04949347|Protective Agents|protective agents|mesh-ancestor
139492484|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492485|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
139492486|NCT04948957|Esmolol|esmolol|mesh-list
139492487|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
139492488|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139492489|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139492490|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138855974|NCT05838703|Anticonvulsants|anticonvulsants|mesh-ancestor
139492491|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
139492492|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492493|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492494|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492495|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
139492496|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139492497|NCT04948801|Velpatasvir|velpatasvir|mesh-list
139492498|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
139492499|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139492500|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
139492501|NCT04948567|Analgesics|analgesics|mesh-ancestor
139492502|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
139492503|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492504|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492505|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
139492506|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492507|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139492508|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
139492509|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139492510|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139492511|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492512|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139492513|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
139492514|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139492515|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139492516|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
139492517|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492518|NCT04946929|Heparin|heparin|mesh-list
139492519|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139492520|NCT04946929|Tinzaparin|tinzaparin|mesh-list
139492521|NCT04946929|Dalteparin|dalteparin|mesh-list
139492522|NCT04946929|Ticagrelor|ticagrelor|mesh-list
139492523|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
139492524|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139492525|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139492526|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492527|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139492528|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139492529|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139492530|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139492531|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
139492532|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492533|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492534|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
139492535|NCT03058237|Baclofen|baclofen|mesh-list
139492536|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139492537|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492538|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139492539|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492540|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139492541|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
139492542|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
139492543|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492544|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492545|NCT04947241|Gemcitabine|gemcitabine|mesh-list
139492546|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139492547|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492548|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139492549|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
139492550|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492551|NCT04947241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139492552|NCT04933279|Iodine|iodine|mesh-list
139492553|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
139492554|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139492555|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139492556|NCT04933279|Trace Elements|trace elements|mesh-ancestor
139492557|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
139492558|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492559|NCT02577029|Interferons|interferons|mesh-list
139492560|NCT02577029|Tenofovir|tenofovir|mesh-list
139492561|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
139492562|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
139492563|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139492564|NCT02577029|Entecavir|entecavir|mesh-list
139492565|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
139492566|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139492567|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492568|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
139492569|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139492570|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139492571|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139492572|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492573|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492574|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139492575|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139492576|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
139492577|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492578|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
139492579|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492580|NCT04946383|Dasatinib|dasatinib|mesh-list
139279262|NCT02432209|Orlistat|orlistat|mesh-list
139492582|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492583|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138856194|NCT04352205|Bortezomib|bortezomib|mesh-list
139492584|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492585|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492586|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
139492587|NCT04946383|Protective Agents|protective agents|mesh-ancestor
139492588|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492589|NCT04943653|Paclitaxel|paclitaxel|mesh-list
139492590|NCT04943653|Capecitabine|capecitabine|mesh-list
139492591|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
139492592|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139492593|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492594|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
139492595|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
139492596|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
139492597|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492598|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139492599|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
139492600|NCT04943029|Paclitaxel|paclitaxel|mesh-list
139492601|NCT04943029|Carboplatin|carboplatin|mesh-list
139492602|NCT04943029|Pemetrexed|pemetrexed|mesh-list
139492603|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139492604|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492605|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
139492606|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
139492607|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
139492608|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492609|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492610|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139492611|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139492612|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
139492613|NCT03660059|Peficitinib|peficitinib|mesh-list
139492614|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492615|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492616|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139492617|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
139492618|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492619|NCT04946227|Paclitaxel|paclitaxel|mesh-list
139492620|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
139492621|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139492622|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492623|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
139492624|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
139492625|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
139492626|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492627|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139492628|NCT04946227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139492629|NCT04932187|Capecitabine|capecitabine|mesh-list
139492630|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139492631|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
139492632|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492633|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492634|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139492635|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
139492636|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492637|NCT03597347|Molgramostim|molgramostim|mesh-list
139492638|NCT03597347|Sargramostim|sargramostim|mesh-list
139492639|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492640|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
139492641|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492642|NCT04930627|Empagliflozin|empagliflozin|mesh-list
139492643|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139492644|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492645|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139492646|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492647|NCT03057769|Indomethacin|indomethacin|mesh-list
139492648|NCT03057769|Epinephrine|epinephrine|mesh-list
139492649|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139492650|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139492651|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
139492652|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492653|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492654|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492655|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139492656|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139492657|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
139492658|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492659|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139492660|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
139492661|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
139492662|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
139492663|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138856334|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
139492664|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139492665|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139492666|NCT03057769|Analgesics|analgesics|mesh-ancestor
139492667|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
139492668|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492669|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139492670|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
139492671|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
139492672|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139492673|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139492674|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492675|NCT04633577|Lidocaine|lidocaine|mesh-list
139492676|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
139492677|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
139492678|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492679|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492680|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
139492681|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492682|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139492683|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139492684|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139492685|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139492686|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492687|NCT04941625|Cystatins|cystatins|mesh-list
138856375|NCT03634228|Cytarabine|cytarabine|mesh-list
139492688|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139492689|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
139492690|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492691|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492692|NCT04922047|Tislelizumab|tislelizumab|mesh-list
139492693|NCT04922047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139492694|NCT04922047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492695|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139492696|NCT04921657|Simvastatin|simvastatin|mesh-list
139492697|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139492698|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139492699|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
139492700|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492701|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139492702|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139492703|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492704|NCT04930471|Metformin|metformin|mesh-list
139492705|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139492706|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492707|NCT05530811|Dexamethasone|dexamethasone|mesh-list
139492708|NCT05530811|Bupivacaine|bupivacaine|mesh-list
139492709|NCT05530811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492710|NCT05530811|Antiemetics|antiemetics|mesh-ancestor
139492711|NCT05530811|Autonomic Agents|autonomic agents|mesh-ancestor
139492712|NCT05530811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492713|NCT05530811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492714|NCT05530811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139492715|NCT05530811|Glucocorticoids|glucocorticoids|mesh-ancestor
139492716|NCT05530811|Hormones|hormones|mesh-ancestor
139492717|NCT05530811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139492718|NCT05530811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139492719|NCT05530811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492720|NCT05530811|Anesthetics, Local|anesthetics, local|mesh-ancestor
139492721|NCT05530811|Anesthetics|anesthetics|mesh-ancestor
139492722|NCT05530811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492723|NCT05530811|Sensory System Agents|sensory system agents|mesh-ancestor
139492724|NCT04940845|Denosumab|denosumab|mesh-list
139492725|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139492726|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492727|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
139492728|NCT04921111|Vaccines|vaccines|mesh-list
139492729|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
139279414|NCT02146638|Fentanyl|fentanyl|mesh-list
139492730|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492731|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139492732|NCT04921111|Antacids|antacids|mesh-ancestor
139492733|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492734|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139492735|NCT03057145|Olaparib|olaparib|mesh-list
139492736|NCT03057145|Prexasertib|prexasertib|mesh-list
139492737|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139492738|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492739|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492740|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492741|NCT03057145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139492742|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
139492743|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139492744|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139492745|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139492746|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139492747|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492748|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
139492749|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492750|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492751|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139492752|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492753|NCT04939675|Lamotrigine|lamotrigine|mesh-list
139492754|NCT04939675|Zonisamide|zonisamide|mesh-list
139492755|NCT04939675|Levetiracetam|levetiracetam|mesh-list
139492756|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
139492757|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
139492758|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139492759|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138856524|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
139492760|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492761|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139492762|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492763|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139492764|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139492765|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492766|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139492767|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139492768|NCT03055663|Midazolam|midazolam|mesh-list
139492769|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139492770|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139492771|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492772|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492773|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139492774|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139492775|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139492776|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139492777|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
139492778|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
139492779|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
139492780|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
139492781|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492782|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492783|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
139492784|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139492785|NCT04928365|Antibodies|antibodies|mesh-list
139492786|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139492787|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
139492788|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492789|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
139492790|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139492791|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139492792|NCT04938037|Prednisolone|prednisolone|mesh-list
139492793|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
139492794|NCT04938037|Bupivacaine|bupivacaine|mesh-list
139492795|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139492796|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
139492797|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
139492798|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
139492799|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492800|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492801|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
139492802|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492803|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492804|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
139492805|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
139492807|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
139492808|NCT04938037|Hormones|hormones|mesh-ancestor
139492809|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139492810|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139492811|NCT04938037|Protective Agents|protective agents|mesh-ancestor
139492812|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139492813|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492814|NCT04937569|Ivermectin|ivermectin|mesh-list
139492815|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139492816|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139492817|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
139492818|NCT04937101|Codeine|codeine|mesh-list
139492819|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139492820|NCT04937101|Narcotics|narcotics|mesh-ancestor
139492821|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492822|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492823|NCT04937101|Analgesics|analgesics|mesh-ancestor
139492824|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
139492825|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492826|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
139492827|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
139492828|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
139492829|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
139492830|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139492831|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
139492832|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
139492833|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492834|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492835|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139492836|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139492837|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139492838|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139492839|NCT04936711|Bupivacaine|bupivacaine|mesh-list
139492840|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
139492841|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
139492842|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492843|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492844|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
139492845|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492846|NCT04431349|Clopidogrel|clopidogrel|mesh-list
139492847|NCT04431349|Ticagrelor|ticagrelor|mesh-list
139492848|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139492849|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139492850|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139492851|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139492852|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
139492853|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492854|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492855|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492856|NCT03055741|Donepezil|donepezil|mesh-list
139492857|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139492858|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492859|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492860|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
139492861|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492862|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492863|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
139492864|NCT04927039|Iloprost|iloprost|mesh-list
139492865|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139492866|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
139492867|NCT02443155|Liraglutide|liraglutide|mesh-list
139492868|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139492869|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492870|NCT02443155|Incretins|incretins|mesh-ancestor
139492871|NCT02443155|Hormones|hormones|mesh-ancestor
139492872|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139492873|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
139492874|NCT04935541|Remifentanil|remifentanil|mesh-list
139492875|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139492876|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139492877|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492878|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139492879|NCT04935541|Analgesics|analgesics|mesh-ancestor
139492880|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
139492881|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492882|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139492883|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139492884|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139492885|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
139492886|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139492887|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492888|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139492889|NCT04935541|Narcotics|narcotics|mesh-ancestor
139492890|NCT04935073|Cetrorelix|cetrorelix|mesh-list
139492891|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139492892|NCT04935073|Hormones|hormones|mesh-ancestor
139492893|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139492894|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492895|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139492896|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
139492897|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139492898|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
139492899|NCT04917757|Dexamethasone|dexamethasone|mesh-list
139492900|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492901|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
139492902|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
139492903|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139492904|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492905|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139492906|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
139492907|NCT04917757|Hormones|hormones|mesh-ancestor
139492908|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139492909|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139492910|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492911|NCT04916899|Rifampin|rifampin|mesh-list
139492912|NCT04916899|Isoniazid|isoniazid|mesh-list
139492913|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
139492914|NCT04916899|Ethambutol|ethambutol|mesh-list
139492915|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139492916|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
139492917|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139492918|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139492919|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
139492920|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139492921|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492922|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492923|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139492924|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139492925|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139492926|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139492927|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139492928|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139492929|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139492930|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139492931|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
139492932|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139492933|NCT04916821|Propolis|propolis|mesh-list
139492934|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139492935|NCT04916665|Teduglutide|teduglutide|mesh-list
139492936|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139492937|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139492938|NCT04916665|Protective Agents|protective agents|mesh-ancestor
139492939|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492940|NCT04916353|Triamcinolone|triamcinolone|mesh-list
139492941|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139492942|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139492943|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139492944|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139492945|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
139492946|NCT04916353|Hormones|hormones|mesh-ancestor
139492947|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139492948|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492949|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139492950|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
139492951|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492952|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492953|NCT03056599|Interferons|interferons|mesh-list
139492954|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
139492955|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
139492957|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
139492958|NCT03056599|Gemcitabine|gemcitabine|mesh-list
139492959|NCT03056599|Docetaxel|docetaxel|mesh-list
139492960|NCT03056599|Doxorubicin|doxorubicin|mesh-list
139492961|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
139492962|NCT03056599|Nivolumab|nivolumab|mesh-list
139492963|NCT03056599|Bortezomib|bortezomib|mesh-list
139492964|NCT03056599|Ipilimumab|ipilimumab|mesh-list
139492965|NCT03056599|Atezolizumab|atezolizumab|mesh-list
139492966|NCT03056599|Durvalumab|durvalumab|mesh-list
139492967|NCT03056599|Avelumab|avelumab|mesh-list
139492968|NCT03056599|Trabectedin|trabectedin|mesh-list
139492969|NCT03056599|Olaratumab|olaratumab|mesh-list
139492970|NCT03056599|Entrectinib|entrectinib|mesh-list
139492971|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139492972|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
139492973|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139492974|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139492975|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
139492976|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
139492977|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
139492978|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139492979|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139492980|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139492981|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139492982|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139492983|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139492984|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
139492985|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139492986|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
139492987|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492988|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139492989|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139492990|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139492991|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
139492992|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139492993|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
139492994|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139492995|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139492996|NCT04915963|Vitamin D|vitamin d|mesh-list
139492997|NCT04915963|Vitamins|vitamins|mesh-ancestor
139492998|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
139492999|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856908|NCT00004860|Leucovorin|leucovorin|mesh-list
139493000|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139493001|NCT04915807|Paclitaxel|paclitaxel|mesh-list
139493002|NCT04915807|Irinotecan|irinotecan|mesh-list
139493003|NCT04915807|Ramucirumab|ramucirumab|mesh-list
139493004|NCT04915807|Taxane|taxane|mesh-list
139493005|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139493006|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493007|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
139493008|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
139493009|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
139493010|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493011|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139493012|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139493013|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493014|NCT01360021|Budesonide|budesonide|mesh-list
139493015|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139493016|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139493017|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139493018|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
139493019|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493020|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493021|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139493022|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
139493023|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
139493024|NCT01360021|Hormones|hormones|mesh-ancestor
139493025|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139493026|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139493027|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
139493028|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493029|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139493030|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139493031|NCT02497287|Sertraline|sertraline|mesh-list
139493032|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
139493033|NCT02497287|Esketamine|esketamine|mesh-list
139493034|NCT02497287|Escitalopram|escitalopram|mesh-list
139493035|NCT02497287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139493036|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139493037|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139493038|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493039|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493040|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
139493041|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493042|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493043|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139493044|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139493045|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139493046|NCT02497287|Analgesics|analgesics|mesh-ancestor
139493047|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
139493048|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
139493049|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139493050|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139493051|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139493052|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
139493053|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493054|NCT02458287|Bococizumab|bococizumab|mesh-list
139493055|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139493056|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139493057|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
139493058|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493059|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139493060|NCT03056053|Zolpidem|zolpidem|mesh-list
139493061|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139493062|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139493063|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493064|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493065|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139493066|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
139493067|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
139493068|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493069|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493070|NCT02496039|Quinidine|quinidine|mesh-list
139493071|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
139493072|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
139493073|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
139493074|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139493075|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139493076|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857050|NCT00002996|Flecainide|flecainide|mesh-list
139493077|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493078|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493079|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139493080|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139493081|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
139493082|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139493083|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
139493084|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139493085|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139493086|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139493087|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493088|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139493089|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139493090|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
139493091|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139493092|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139493093|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139493094|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139493095|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139493096|NCT04922359|Lidocaine|lidocaine|mesh-list
139493097|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
139493098|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
139493099|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493100|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857104|NCT00609557|Analgesics|analgesics|mesh-ancestor
139493101|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
139493102|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493103|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139493104|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139493105|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139279771|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493106|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139493107|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493109|NCT02495883|Propranolol|propranolol|mesh-list
139493110|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139493111|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139493112|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
139493113|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493114|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493115|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493116|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139493117|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139493118|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
139493119|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139493120|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139493121|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493122|NCT04910347|Nivolumab|nivolumab|mesh-list
139493123|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139493124|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493125|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139493126|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493127|NCT02439957|Valganciclovir|valganciclovir|mesh-list
139493128|NCT02439957|Brincidofovir|brincidofovir|mesh-list
139493129|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
139493130|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139493131|NCT02457195|Granisetron|granisetron|mesh-list
139493132|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
139493133|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
139493134|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493135|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493136|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139493137|NCT02457195|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139493138|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139493139|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
139493140|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493141|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493142|NCT04913779|Immunomodulating Agents|immunomodulating agents|mesh-list
139493143|NCT04913779|Immunologic Factors|immunologic factors|mesh-ancestor
139493144|NCT04913779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493145|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
139493146|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139493147|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139493148|NCT03054259|Prednisolone|prednisolone|mesh-list
139493149|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
139493150|NCT03054259|Rituximab|rituximab|mesh-list
139493151|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139493152|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
139493153|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139493154|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493155|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
139493156|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493157|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139493158|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139493159|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
139493160|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
139493161|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493162|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139493163|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
139493164|NCT03054259|Hormones|hormones|mesh-ancestor
139493165|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139493166|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139493167|NCT03054259|Protective Agents|protective agents|mesh-ancestor
139493168|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139493169|NCT01653327|Ketamine|ketamine|mesh-list
139493170|NCT01653327|Analgesics|analgesics|mesh-ancestor
139493171|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
139493172|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493173|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493174|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139493175|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139493176|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
139493177|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
139493178|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493179|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139493180|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139493181|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493182|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493183|NCT03053869|Diazepam|diazepam|mesh-list
139493184|NCT03053869|Lorazepam|lorazepam|mesh-list
139493185|NCT03053869|Alprazolam|alprazolam|mesh-list
139493186|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
139493187|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
139493188|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
139493189|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493190|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493191|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139493192|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139493193|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493194|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139493195|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139493196|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139493197|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
139493198|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
139493199|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493200|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493201|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139493202|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139493203|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139493204|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139493205|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
139493206|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
139493207|NCT03053947|Ketamine|ketamine|mesh-list
139493208|NCT03053947|Analgesics|analgesics|mesh-ancestor
139493209|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
139493210|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493211|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493212|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139493213|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139493214|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
139493215|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
139493216|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493217|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139493218|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139493219|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493220|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493221|NCT04893733|Folic Acid|folic acid|mesh-list
139493222|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
139493223|NCT04893733|Vitamins|vitamins|mesh-ancestor
139493224|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
139493225|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493226|NCT04893733|Hematinics|hematinics|mesh-ancestor
139493227|NCT02493855|Ritonavir|ritonavir|mesh-list
139493228|NCT02493855|Ribavirin|ribavirin|mesh-list
139493229|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139493230|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139493231|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
139493232|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493233|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493234|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139493235|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139493236|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
139493237|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139493238|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139493239|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139493240|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
139493241|NCT04892563|Morphine|morphine|mesh-list
139493242|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139493243|NCT04892563|Narcotics|narcotics|mesh-ancestor
139493244|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493245|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493246|NCT04892563|Analgesics|analgesics|mesh-ancestor
139493247|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
139493248|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493249|NCT04909255|Mirabegron|mirabegron|mesh-list
139493250|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
139493251|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139493252|NCT04909255|Oxybutynin|oxybutynin|mesh-list
139493253|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139279921|NCT01525316|Lactoferrin|lactoferrin|mesh-list
139493254|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139493255|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139493256|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
139493257|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493258|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493259|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493260|NCT04909255|Urological Agents|urological agents|mesh-ancestor
139493261|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139493262|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139493263|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
139493264|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
139493265|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
139493266|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493267|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
139493268|NCT04891861|Apixaban|apixaban|mesh-list
139493269|NCT04891861|Edoxaban|edoxaban|mesh-list
139493270|NCT04891861|Dabigatran|dabigatran|mesh-list
139493271|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139493272|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
139493273|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139493274|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
139493275|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493276|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493277|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
139493278|NCT03053167|Irinotecan|irinotecan|mesh-list
139493279|NCT03053167|Raltitrexed|raltitrexed|mesh-list
139493280|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139493281|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139493282|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493283|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493284|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493285|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139493286|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
139493287|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139493288|NCT04901923|Itraconazole|itraconazole|mesh-list
139493289|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
139493290|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
139493291|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139493292|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139493293|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139493294|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493295|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493296|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139493297|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
139493298|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139493299|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493300|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139493301|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493302|NCT03050905|Ritonavir|ritonavir|mesh-list
139493303|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139493304|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139493305|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
139493306|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493307|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493308|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139493309|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139493310|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
139493311|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139493312|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139493313|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139493314|NCT03050827|Oxybutynin|oxybutynin|mesh-list
139493315|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
139493316|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
139493317|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493318|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493319|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139493320|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139493321|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
139493322|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493323|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493324|NCT03050827|Urological Agents|urological agents|mesh-ancestor
139493325|NCT02438787|Golimumab|golimumab|mesh-list
139493326|NCT02438787|Ustekinumab|ustekinumab|mesh-list
139493327|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
139493328|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139493329|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139493330|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139279993|NCT02152410|Analgesics|analgesics|mesh-ancestor
139493331|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
139493332|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493334|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
139493335|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
139493336|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493337|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493338|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
139493339|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493340|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139493341|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139493342|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139493343|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138857541|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493344|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493345|NCT02493777|Methylphenidate|methylphenidate|mesh-list
139493346|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139493347|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493348|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139493349|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139493350|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139493351|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493352|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
139493353|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493354|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139493355|NCT04906915|Ketamine|ketamine|mesh-list
139493356|NCT04906915|Analgesics|analgesics|mesh-ancestor
139493357|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
139493358|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493359|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493360|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139493361|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139493362|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
139493363|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
139493364|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493365|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139493366|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139493367|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493368|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493369|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
139493370|NCT04900129|Diclofenac|diclofenac|mesh-list
139493371|NCT04900129|Salicylates|salicylates|mesh-list
139493372|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
139493373|NCT04900129|Menthol|menthol|mesh-list
139493374|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139493375|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138857585|NCT02725398|Scopolamine|scopolamine|mesh-list
139493376|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139493377|NCT04900129|Analgesics|analgesics|mesh-ancestor
139493378|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
139493379|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493380|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493381|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139493382|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139493383|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139493384|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493385|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493386|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
139493387|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
139493388|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
139493389|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139493390|NCT04900129|Expectorants|expectorants|mesh-ancestor
139493391|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
139493392|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139493393|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
139493394|NCT04900129|Protective Agents|protective agents|mesh-ancestor
139493395|NCT04900129|Antidotes|antidotes|mesh-ancestor
139493396|NCT02616601|Fluorouracil|fluorouracil|mesh-list
139493397|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
139493398|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493399|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139493400|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493401|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139493402|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
139493403|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493404|NCT02492997|Glycerol|glycerol|mesh-list
139493405|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139493406|NCT02492997|Protective Agents|protective agents|mesh-ancestor
139493407|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493409|NCT04393207|Dexamethasone acetate|dexamethasone acetate|mesh-list
139493410|NCT04393207|Methylprednisolone|methylprednisolone|mesh-list
139493411|NCT04393207|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139493412|NCT04393207|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139493413|NCT04393207|Prednisolone|prednisolone|mesh-list
139493414|NCT04393207|Prednisolone acetate|prednisolone acetate|mesh-list
139493415|NCT04393207|Bupivacaine|bupivacaine|mesh-list
139493416|NCT04393207|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139493417|NCT04393207|Prednisolone phosphate|prednisolone phosphate|mesh-list
139493418|NCT04393207|BB 1101|bb 1101|mesh-list
139493419|NCT04393207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139493420|NCT04393207|Antiemetics|antiemetics|mesh-ancestor
139493421|NCT04393207|Autonomic Agents|autonomic agents|mesh-ancestor
139493422|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493423|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493424|NCT04393207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139493425|NCT04393207|Glucocorticoids|glucocorticoids|mesh-ancestor
139493426|NCT04393207|Hormones|hormones|mesh-ancestor
138857674|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139493427|NCT04393207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139493428|NCT04393207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139493429|NCT04393207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493430|NCT04393207|Protease Inhibitors|protease inhibitors|mesh-ancestor
139493431|NCT04393207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493432|NCT04393207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493433|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
139493434|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
139493435|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493436|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
139493437|NCT04393207|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139493438|NCT04393207|Protective Agents|protective agents|mesh-ancestor
139493439|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
139493440|NCT02492841|Calcium|calcium|mesh-list
139493441|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139493442|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493443|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139493444|NCT04814875|Carboplatin|carboplatin|mesh-list
139493445|NCT04814875|Doxorubicin|doxorubicin|mesh-list
139493446|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139493447|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493448|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139493449|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139493450|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139493451|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493452|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493453|NCT02492763|Metformin|metformin|mesh-list
139493454|NCT02492763|Liraglutide|liraglutide|mesh-list
139493455|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139493456|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493457|NCT02492763|Incretins|incretins|mesh-ancestor
139493458|NCT02492763|Hormones|hormones|mesh-ancestor
138857781|NCT00938821|Analgesics|analgesics|mesh-ancestor
139493459|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139493460|NCT04899817|Granisetron|granisetron|mesh-list
139493461|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
139493462|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
139493463|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493464|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493465|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139493466|NCT04899817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139493467|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139493468|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
139493469|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493470|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493471|NCT04905667|Trastuzumab|trastuzumab|mesh-list
139493472|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139493473|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493474|NCT04397107|Aldesleukin|aldesleukin|mesh-list
139493475|NCT04397107|Interleukin-2|interleukin-2|mesh-list
139493476|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493477|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139493478|NCT04397107|Analgesics|analgesics|mesh-ancestor
139493479|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
139493480|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493481|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493482|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139493483|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139493484|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
139493485|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139493486|NCT02453841|Phenylephrine|phenylephrine|mesh-list
139493487|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
139493488|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139493489|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139493490|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
139493491|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493492|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857899|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139493493|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493494|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
139493495|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
139493496|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493497|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
139493498|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139493499|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
139493500|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139493501|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
139493502|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139493503|NCT02453841|Protective Agents|protective agents|mesh-ancestor
139493504|NCT04888663|Paclitaxel|paclitaxel|mesh-list
139493505|NCT04888663|Trastuzumab|trastuzumab|mesh-list
139493506|NCT04888663|Ramucirumab|ramucirumab|mesh-list
139493507|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139493508|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493509|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
139493510|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
139493511|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
139493512|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493513|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139493514|NCT04899427|Tislelizumab|tislelizumab|mesh-list
139493515|NCT04899427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139493516|NCT04899427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493517|NCT02453685|Insulin|insulin|mesh-list
139493518|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139493519|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
139493520|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
139493521|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
139493522|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139493523|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
139493524|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139493525|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139493526|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493527|NCT03051841|Dexamethasone|dexamethasone|mesh-list
139493528|NCT03051841|Bortezomib|bortezomib|mesh-list
139493529|NCT03051841|CKD-581|ckd-581|mesh-list
139493530|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138858020|NCT00940069|Pemetrexed|pemetrexed|mesh-list
139493531|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
139493532|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
139493533|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493534|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493535|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139493536|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
139493537|NCT03051841|Hormones|hormones|mesh-ancestor
139493538|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139493539|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139493540|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493541|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493542|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493543|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139493544|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
139493545|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493546|NCT02436759|Phenylephrine|phenylephrine|mesh-list
139493547|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
139493548|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139493549|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139493550|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139493551|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139493552|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
139493553|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493554|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493555|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493556|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
139493557|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
139493558|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493559|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
139493560|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139493561|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
139493562|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139493563|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
139493564|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139493565|NCT02436759|Protective Agents|protective agents|mesh-ancestor
139493566|NCT04888819|Fexuprazan|fexuprazan|mesh-list
139493567|NCT04888819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139493568|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
139493569|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
139493570|NCT04904185|Fludarabine|fludarabine|mesh-list
139493571|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
139493572|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139493573|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
139493574|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493575|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139493576|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139493577|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
139493578|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493579|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493580|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139493581|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139493582|NCT04904185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139493583|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139493584|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
139493585|NCT04887961|Trabectedin|trabectedin|mesh-list
139493586|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139493587|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
139493588|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493589|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493590|NCT04887649|Morphine|morphine|mesh-list
139493591|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139493592|NCT04887649|Narcotics|narcotics|mesh-ancestor
139493593|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493594|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493595|NCT04887649|Analgesics|analgesics|mesh-ancestor
139493596|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
139493597|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493598|NCT03050437|Pemetrexed|pemetrexed|mesh-list
139493599|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493600|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493601|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493602|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139493603|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139493604|NCT02436135|Idelalisib|idelalisib|mesh-list
139493605|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493606|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493607|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493608|NCT02435277|Metformin|metformin|mesh-list
139493609|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139493610|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493611|NCT02420223|Propranolol|propranolol|mesh-list
139493612|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139493613|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139493614|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
139493615|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493616|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493617|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493618|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139493619|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139493620|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
139493621|NCT02433483|Cytarabine|cytarabine|mesh-list
139493622|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
139493623|NCT02433483|Methotrexate|methotrexate|mesh-list
139493624|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139493625|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
139493626|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139493627|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493628|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139493629|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
139493630|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493631|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493632|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
139493633|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493634|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139493635|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139493636|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
139493637|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139493638|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139493639|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
139493640|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139493641|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139493642|NCT02419755|Cytarabine|cytarabine|mesh-list
139493643|NCT02419755|Dexamethasone|dexamethasone|mesh-list
139493644|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
139493645|NCT02419755|Doxorubicin|doxorubicin|mesh-list
139493646|NCT02419755|Methotrexate|methotrexate|mesh-list
139493647|NCT02419755|Bortezomib|bortezomib|mesh-list
139493648|NCT02419755|Asparaginase|asparaginase|mesh-list
139493649|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
139493650|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
139493651|NCT02419755|Vorinostat|vorinostat|mesh-list
139493652|NCT02419755|Pegaspargase|pegaspargase|mesh-list
139493653|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139493654|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
139493655|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
139493656|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493657|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493658|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139493659|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
139493660|NCT02419755|Hormones|hormones|mesh-ancestor
139493661|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139493662|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139493663|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493664|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139493665|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139493666|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139493667|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493668|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493669|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139493670|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
139493671|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139493672|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139493673|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
139493674|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
139493675|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139493676|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139493677|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
139493678|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139493679|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139493680|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
139493681|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139493682|NCT02419755|Analgesics|analgesics|mesh-ancestor
139493683|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
139493684|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139493685|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
139493686|NCT04913025|Nivolumab|nivolumab|mesh-list
139493687|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139493688|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493689|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139493690|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493691|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
139493692|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493693|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
139493694|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493695|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493696|NCT04887493|Alprostadil|alprostadil|mesh-list
139493697|NCT04887493|Misoprostol|misoprostol|mesh-list
139493698|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139493699|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
139493700|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139493701|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493702|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139493703|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139493704|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
139280364|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
139493705|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139493706|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
139493707|NCT04887493|Urological Agents|urological agents|mesh-ancestor
139493708|NCT02486757|Estradiol|estradiol|mesh-list
139493709|NCT02486757|Progesterone|progesterone|mesh-list
139493710|NCT02486757|Estrogens|estrogens|mesh-ancestor
139493711|NCT02486757|Hormones|hormones|mesh-ancestor
139493712|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139493713|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493714|NCT02486757|Progestins|progestins|mesh-ancestor
139493715|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139493716|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
139493717|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139493718|NCT03051529|Anesthetics|anesthetics|mesh-list
139493719|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493720|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493721|NCT04886869|Caffeine|caffeine|mesh-list
139493722|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139493723|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493724|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139493725|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493726|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493727|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139493728|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139493729|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
139493730|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493731|NCT04897477|Azacitidine|azacitidine|mesh-list
139493732|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139493733|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139493734|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
139493735|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493736|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493737|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493738|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139493739|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
139493740|NCT02576639|Umibecestat|umibecestat|mesh-list
139493741|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493742|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493743|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139493744|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139493745|NCT02418585|Sertraline|sertraline|mesh-list
139493746|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
139493747|NCT02418585|Esketamine|esketamine|mesh-list
139493748|NCT02418585|Escitalopram|escitalopram|mesh-list
139493749|NCT02418585|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139493750|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139493751|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139493752|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493753|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493754|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
139493755|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493756|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493757|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139493758|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139493759|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139493760|NCT02418585|Analgesics|analgesics|mesh-ancestor
139493761|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
139493762|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
139493763|NCT05529875|Propofol|propofol|mesh-list
139493764|NCT05529875|Sevoflurane|sevoflurane|mesh-list
139493765|NCT05529875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139493766|NCT05529875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493767|NCT05529875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493768|NCT05529875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139493769|NCT05529875|Anesthetics, General|anesthetics, general|mesh-ancestor
139493770|NCT05529875|Anesthetics|anesthetics|mesh-ancestor
139493771|NCT05529875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139493772|NCT05529875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139493773|NCT03051451|Metformin|metformin|mesh-list
139493774|NCT03051451|Fluoxetine|fluoxetine|mesh-list
139493775|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139493776|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493777|NCT03051451|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139493778|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139493779|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139493780|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493781|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493782|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
139493783|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139493784|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
139493785|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139493786|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139493787|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139493788|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493790|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139493791|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
139493792|NCT04883125|Pioglitazone|pioglitazone|mesh-list
139493793|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139493794|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493795|NCT05474183|Dexmedetomidine|dexmedetomidine|mesh-list
139493796|NCT05474183|Ketamine|ketamine|mesh-list
139493797|NCT05474183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139493798|NCT05474183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493799|NCT05474183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493800|NCT05474183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139493801|NCT05474183|Analgesics|analgesics|mesh-ancestor
139493802|NCT05474183|Sensory System Agents|sensory system agents|mesh-ancestor
139493803|NCT05474183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858639|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
139493804|NCT05474183|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139493805|NCT05474183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139493806|NCT05474183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139493807|NCT05474183|Adrenergic Agents|adrenergic agents|mesh-ancestor
139493808|NCT05474183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493809|NCT05474183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493810|NCT05474183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139493811|NCT05474183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139493812|NCT05474183|Anesthetics, General|anesthetics, general|mesh-ancestor
139493813|NCT05474183|Anesthetics|anesthetics|mesh-ancestor
139493814|NCT05474183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139493815|NCT05474183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139493816|NCT04885777|Lidocaine|lidocaine|mesh-list
139493817|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
139493818|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
139493819|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493820|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493821|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
139493822|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493823|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139493824|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139493825|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139493826|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139493827|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493828|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
139493829|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
139493830|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139493831|NCT02632721|Decitabine|decitabine|mesh-list
139493832|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139493833|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
139493834|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493835|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493836|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493837|NCT05529095|Apomorphine|apomorphine|mesh-list
139493838|NCT05529095|Emetics|emetics|mesh-ancestor
139493839|NCT05529095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493840|NCT05529095|Autonomic Agents|autonomic agents|mesh-ancestor
139493841|NCT05529095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493842|NCT05529095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139493843|NCT05529095|Dopamine Agonists|dopamine agonists|mesh-ancestor
139493844|NCT05529095|Dopamine Agents|dopamine agents|mesh-ancestor
139493845|NCT05529095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493846|NCT05529095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493847|NCT01596127|Rituximab|rituximab|mesh-list
139493848|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139493849|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493850|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
139493851|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493852|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139493853|NCT03051373|Paclitaxel|paclitaxel|mesh-list
139493854|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139493855|NCT03051373|Gemcitabine|gemcitabine|mesh-list
139493856|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139493857|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493858|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
139493859|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
139493860|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
139493861|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493862|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139493863|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
139493864|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139493865|NCT04895059|Ezetimibe|ezetimibe|mesh-list
139493866|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139493867|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139493868|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
139493869|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493870|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139493871|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139493872|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493873|NCT05467475|Esomeprazole|esomeprazole|mesh-list
139493874|NCT05467475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139493875|NCT05467475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139493876|NCT05467475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139493877|NCT05467475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493878|NCT05467475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493879|NCT05534165|Tecovirimat|tecovirimat|mesh-list
139493880|NCT05534165|Antiviral Agents|antiviral agents|mesh-ancestor
139493881|NCT05534165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139493882|NCT01595581|Methyltestosterone|methyltestosterone|mesh-list
139493883|NCT01595581|Testosterone|testosterone|mesh-list
139493884|NCT01595581|Testosterone undecanoate|testosterone undecanoate|mesh-list
139493885|NCT01595581|Testosterone enanthate|testosterone enanthate|mesh-list
139493886|NCT01595581|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139493887|NCT01595581|Androgens|androgens|mesh-ancestor
139493888|NCT01595581|Hormones|hormones|mesh-ancestor
139493889|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139493890|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493891|NCT01595581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139493892|NCT01595581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493893|NCT01595581|Anabolic Agents|anabolic agents|mesh-ancestor
139493894|NCT04885153|Fenofibrate|fenofibrate|mesh-list
139493895|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139493896|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
139493897|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493898|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139493899|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139493900|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139493901|NCT04884997|Temozolomide|temozolomide|mesh-list
139493902|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139493903|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
139493904|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493905|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493906|NCT04885075|Midazolam|midazolam|mesh-list
139493907|NCT04885075|Diazepam|diazepam|mesh-list
139493908|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139493909|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139493910|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493911|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493912|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139493913|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139493914|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139493915|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139493916|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
139493917|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
139493918|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
139493919|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
139493920|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139493921|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493922|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
139493923|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
139493924|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
139493925|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493926|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139493927|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139493928|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139493929|NCT01610687|Nabiximols|nabiximols|mesh-list
139493930|NCT01610687|Analgesics|analgesics|mesh-ancestor
138859121|NCT05367687|Apatinib|apatinib|mesh-list
139493931|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
139280597|NCT05038072|Hormones|hormones|mesh-ancestor
139493932|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493933|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493935|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139493936|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139493937|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
139493938|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493939|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139493940|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
139493941|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
139493942|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
139493943|NCT04884919|Coagulants|coagulants|mesh-ancestor
139493944|NCT04878835|Ranibizumab|ranibizumab|mesh-list
139493945|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139493946|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139493947|NCT04878835|Growth Substances|growth substances|mesh-ancestor
139493948|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493949|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
139493950|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493951|NCT04872283|Aspirin|aspirin|mesh-list
139493952|NCT04872283|Acetaminophen|acetaminophen|mesh-list
139493953|NCT04872283|Ketorolac|ketorolac|mesh-list
139493954|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139493955|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139493956|NCT04872283|Oxycodone|oxycodone|mesh-list
139493957|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139493958|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139493959|NCT04872283|Analgesics|analgesics|mesh-ancestor
139493960|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
139493961|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139493962|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493963|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139493964|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139493965|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139493966|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139493967|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493968|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139493969|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139493970|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139493971|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
139493972|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139493973|NCT04872283|Narcotics|narcotics|mesh-ancestor
139493974|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139493975|NCT05182385|Venetoclax|venetoclax|mesh-list
139493976|NCT05182385|Blinatumomab|blinatumomab|mesh-list
139493977|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493978|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
139493979|NCT04389073|Bevacizumab|bevacizumab|mesh-list
139493980|NCT04389073|Capecitabine|capecitabine|mesh-list
139493981|NCT04389073|Vinorelbine|vinorelbine|mesh-list
139493982|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139493983|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
139493984|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139493985|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139493986|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139493987|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
139493988|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139493989|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139493990|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139493991|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139493992|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139493993|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139493994|NCT04389073|Growth Substances|growth substances|mesh-ancestor
139493995|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
139493996|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139493997|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
139493998|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139493999|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
139494000|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
139494001|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
139494002|NCT04371445|Dexamethasone|dexamethasone|mesh-list
139494003|NCT04371445|Prednisolone|prednisolone|mesh-list
139494004|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139494005|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
139494006|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139494007|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
139280667|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
139494008|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139494009|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
139494010|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494011|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
139494012|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
139494013|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494014|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494015|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139494016|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
139494017|NCT04371445|Hormones|hormones|mesh-ancestor
139494018|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139494019|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139494020|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494021|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139494022|NCT04371445|Protective Agents|protective agents|mesh-ancestor
139494023|NCT03049267|Apremilast|apremilast|mesh-list
139494024|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139494025|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139494026|NCT03049267|Analgesics|analgesics|mesh-ancestor
139494027|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
139494028|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494029|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494030|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494031|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494032|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139494033|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139494034|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494035|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494036|NCT05524259|Folic Acid|folic acid|mesh-list
139494037|NCT05524259|Vitamin B Complex|vitamin b complex|mesh-list
139494038|NCT05524259|Inositol|inositol|mesh-list
139494039|NCT05524259|Hematinics|hematinics|mesh-ancestor
139494040|NCT05524259|Vitamins|vitamins|mesh-ancestor
139494041|NCT05524259|Micronutrients|micronutrients|mesh-ancestor
139494042|NCT05524259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494043|NCT04112095|Norgestrel|norgestrel|mesh-list
139494044|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139494045|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139494046|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139494047|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
139494048|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139494049|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494050|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139494051|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139494052|NCT05257993|Paclitaxel|paclitaxel|mesh-list
139494053|NCT05257993|Gemcitabine|gemcitabine|mesh-list
139494054|NCT05257993|Folfirinox|folfirinox|mesh-list
139494055|NCT05257993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139494056|NCT05257993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494057|NCT05257993|Tubulin Modulators|tubulin modulators|mesh-ancestor
139494058|NCT05257993|Antimitotic Agents|antimitotic agents|mesh-ancestor
139494059|NCT05257993|Mitosis Modulators|mitosis modulators|mesh-ancestor
139494060|NCT05257993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494061|NCT05257993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139494062|NCT05257993|Antimetabolites|antimetabolites|mesh-ancestor
139494063|NCT05533073|Etoricoxib|etoricoxib|mesh-list
139494064|NCT05533073|Tramadol|tramadol|mesh-list
139494065|NCT05533073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139494066|NCT05533073|Narcotics|narcotics|mesh-ancestor
139494067|NCT05533073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139494068|NCT05533073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494069|NCT05533073|Analgesics|analgesics|mesh-ancestor
139494070|NCT05533073|Sensory System Agents|sensory system agents|mesh-ancestor
139494071|NCT05533073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494072|NCT05533073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139494073|NCT05533073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139494074|NCT05533073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494075|NCT05533073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494076|NCT05533073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139494077|NCT05533073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139494078|NCT05533073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494079|NCT05533073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494080|NCT04050553|Tirzepatide|tirzepatide|mesh-list
139494081|NCT04050553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139280745|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
139494082|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494083|NCT04050553|Incretins|incretins|mesh-ancestor
139494084|NCT04050553|Hormones|hormones|mesh-ancestor
139494085|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139494087|NCT03946891|Diuretics|diuretics|mesh-ancestor
139494088|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
139494089|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494090|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139494091|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139494092|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494093|NCT03849625|Aspirin|aspirin|mesh-list
139494094|NCT03849625|Acetaminophen|acetaminophen|mesh-list
139494095|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139494096|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139494097|NCT03849625|Analgesics|analgesics|mesh-ancestor
139494098|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
139494099|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494100|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494101|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494102|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494103|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139494104|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139494105|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494106|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139494107|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139494108|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494109|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
139494110|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139494111|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
139494112|NCT03049345|Methylene Blue|methylene blue|mesh-list
139494113|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859625|NCT02755597|Bortezomib|bortezomib|mesh-list
139494114|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494115|NCT05526911|Tenofovir|tenofovir|mesh-list
139494116|NCT05526911|Lamivudine|lamivudine|mesh-list
139494117|NCT05526911|Dolutegravir|dolutegravir|mesh-list
139494118|NCT05526911|Digoxin|digoxin|mesh-list
139494119|NCT05526911|Midazolam|midazolam|mesh-list
139494120|NCT05526911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139494121|NCT05526911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139494122|NCT05526911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139494123|NCT05526911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494124|NCT05526911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139494125|NCT05526911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139494126|NCT05526911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139494127|NCT05526911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139494128|NCT05526911|Anesthetics, General|anesthetics, general|mesh-ancestor
139494129|NCT05526911|Anesthetics|anesthetics|mesh-ancestor
139494130|NCT05526911|GABA Modulators|gaba modulators|mesh-ancestor
139494131|NCT05526911|GABA Agents|gaba agents|mesh-ancestor
139494132|NCT05526911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139494133|NCT05526911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494134|NCT05526911|Antiviral Agents|antiviral agents|mesh-ancestor
139494135|NCT05526911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494136|NCT05526911|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139494137|NCT05526911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139494138|NCT05526911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494139|NCT05526911|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139494140|NCT05526911|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139494141|NCT05526911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138859691|NCT02033993|Paclitaxel|paclitaxel|mesh-list
139494142|NCT05526911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139494143|NCT05526911|Protective Agents|protective agents|mesh-ancestor
139494144|NCT05526911|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139494145|NCT05526911|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139494146|NCT04870489|Isotretinoin|isotretinoin|mesh-list
139494147|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
139494148|NCT05231941|Lidocaine|lidocaine|mesh-list
139494149|NCT05231941|Ropivacaine|ropivacaine|mesh-list
139494150|NCT05231941|Anesthetics, Local|anesthetics, local|mesh-ancestor
139494151|NCT05231941|Anesthetics|anesthetics|mesh-ancestor
139494152|NCT05231941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139494153|NCT05231941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494154|NCT05231941|Sensory System Agents|sensory system agents|mesh-ancestor
139494155|NCT05231941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494156|NCT05231941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139494157|NCT05231941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139494158|NCT05231941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139494159|NCT05231941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139494160|NCT05231941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494162|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
139494163|NCT04877509|Vitamin D|vitamin d|mesh-list
139494164|NCT04877509|Vitamin A|vitamin a|mesh-list
139494165|NCT04877509|Selenium|selenium|mesh-list
139494166|NCT04877509|Copper|copper|mesh-list
139494167|NCT04877509|Vitamins|vitamins|mesh-ancestor
139494168|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
139494169|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494170|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
139494171|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494172|NCT04877509|Protective Agents|protective agents|mesh-ancestor
139494173|NCT04877509|Trace Elements|trace elements|mesh-ancestor
139494174|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139494175|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
139494176|NCT03044743|Fludarabine|fludarabine|mesh-list
139494177|NCT03044743|Interleukin-2|interleukin-2|mesh-list
139494178|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139494179|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
138859795|NCT00668642|Dutasteride|dutasteride|mesh-list
139494180|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494181|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494182|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139494183|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
139494184|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494185|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494186|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139494187|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139494188|NCT03044743|Analgesics|analgesics|mesh-ancestor
139494189|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
139494190|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494191|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139494192|NCT03044665|Ezetimibe|ezetimibe|mesh-list
139494193|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139494194|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139494195|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
139494196|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494197|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139494198|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139494199|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494200|NCT05525351|Dexmedetomidine|dexmedetomidine|mesh-list
139494201|NCT05525351|Alfentanil|alfentanil|mesh-list
139494202|NCT05525351|Propofol|propofol|mesh-list
139494203|NCT05525351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139494204|NCT05525351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139494205|NCT05525351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494206|NCT05525351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139494207|NCT05525351|Analgesics|analgesics|mesh-ancestor
139494208|NCT05525351|Sensory System Agents|sensory system agents|mesh-ancestor
139494209|NCT05525351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494210|NCT05525351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139494211|NCT05525351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139494212|NCT05525351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139494213|NCT05525351|Adrenergic Agents|adrenergic agents|mesh-ancestor
139494214|NCT05525351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139494215|NCT05525351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494216|NCT05525351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139494217|NCT05525351|Anesthetics, General|anesthetics, general|mesh-ancestor
139494218|NCT05525351|Anesthetics|anesthetics|mesh-ancestor
139494219|NCT05525351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139494220|NCT05525351|Narcotics|narcotics|mesh-ancestor
139494221|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
139494222|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494223|NCT05521763|Vaccines|vaccines|mesh-list
139494224|NCT05521763|Immunologic Factors|immunologic factors|mesh-ancestor
139494225|NCT05521763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494226|NCT04865185|Ethanol|ethanol|mesh-list
139494227|NCT04865185|Lidocaine|lidocaine|mesh-list
139494228|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139494229|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494230|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139494231|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494232|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
139494233|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
139494234|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
139494235|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494236|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139494237|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138859911|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859912|NCT04258007|Neostigmine|neostigmine|mesh-list
138859913|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138859914|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859915|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859916|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
138859917|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139494238|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139494239|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139494240|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494241|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
139494242|NCT04876807|Omeprazole|omeprazole|mesh-list
139494243|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139494244|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139494245|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139494246|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494247|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494248|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494249|NCT05518409|Donepezil|donepezil|mesh-list
139494250|NCT05518409|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139494251|NCT05518409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494252|NCT05518409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494253|NCT05518409|Cholinergic Agents|cholinergic agents|mesh-ancestor
139494254|NCT05518409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139494255|NCT05518409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494256|NCT05518409|Nootropic Agents|nootropic agents|mesh-ancestor
139494257|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
139494258|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
139494259|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
139494260|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139494261|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139494262|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
139494263|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
139494264|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139494265|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494266|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494267|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139494268|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
139494269|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139494270|NCT04864717|Doxycycline|doxycycline|mesh-list
139494271|NCT04864717|Isotretinoin|isotretinoin|mesh-list
139494272|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139494273|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494274|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
139494275|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139494276|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139494277|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
139494278|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
139494279|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494280|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
139494281|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494282|NCT04876261|Protective Agents|protective agents|mesh-ancestor
139494283|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859993|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
139494284|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139494285|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
139494286|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139494287|NCT02613871|Ledipasvir|ledipasvir|mesh-list
139494288|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
139494289|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494290|NCT04869709|Betamethasone|betamethasone|mesh-list
139494291|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
139494292|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139494293|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
139494294|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139494295|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494296|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
139494297|NCT04869709|Hormones|hormones|mesh-ancestor
139494298|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139494299|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494300|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139494301|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
139494302|NCT02612077|Bevacizumab|bevacizumab|mesh-list
139494303|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139494304|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494305|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139494306|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139494307|NCT02612077|Growth Substances|growth substances|mesh-ancestor
139494308|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494309|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
139494310|NCT04622735|Acetaminophen|acetaminophen|mesh-list
139494311|NCT04622735|Nefopam|nefopam|mesh-list
139494312|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139494314|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
139494315|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494316|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494317|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
139494318|NCT05048615|Itraconazole|itraconazole|mesh-list
139494319|NCT05048615|Azacitidine|azacitidine|mesh-list
139494320|NCT05048615|Venetoclax|venetoclax|mesh-list
139494321|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139494322|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
139494323|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494324|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494325|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494326|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
139494327|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494328|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139494329|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139494330|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139494331|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
139494332|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139494333|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494334|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139494335|NCT05531435|Anesthetics|anesthetics|mesh-list
139494336|NCT05531435|Anesthetics, Local|anesthetics, local|mesh-list
139494337|NCT05531435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139494338|NCT05531435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494339|NCT05531435|Sensory System Agents|sensory system agents|mesh-ancestor
139494340|NCT05531435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494341|NCT05517239|Gemcitabine|gemcitabine|mesh-list
139494342|NCT05517239|Oxaliplatin|oxaliplatin|mesh-list
139494343|NCT05517239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139494344|NCT05517239|Antimetabolites|antimetabolites|mesh-ancestor
139494345|NCT05517239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494346|NCT05517239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494347|NCT05519813|Metformin|metformin|mesh-list
139494348|NCT05519813|Pioglitazone|pioglitazone|mesh-list
139494349|NCT05519813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138860160|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
139494350|NCT05519813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494351|NCT02613403|Ribavirin|ribavirin|mesh-list
139494352|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
139494353|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
139494354|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494355|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
139494356|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494357|NCT05002127|Paclitaxel|paclitaxel|mesh-list
139494358|NCT05002127|Trastuzumab|trastuzumab|mesh-list
139494359|NCT05002127|Ramucirumab|ramucirumab|mesh-list
138860208|NCT02783846|Analgesics|analgesics|mesh-ancestor
139494360|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139494361|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494362|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
139494363|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
139494364|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
139494365|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494366|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139494367|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
139494368|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
139494369|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139494370|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139494371|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494372|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494373|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494374|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494375|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
139494376|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139494377|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139494378|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494379|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
139494380|NCT03044041|Coagulants|coagulants|mesh-ancestor
139494381|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139494382|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139494383|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860337|NCT05133518|Analgesics|analgesics|mesh-ancestor
139494384|NCT05516303|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139494385|NCT05516303|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139494386|NCT05516303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494387|NCT05516303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139494388|NCT05516303|Immunologic Factors|immunologic factors|mesh-ancestor
139494389|NCT05516303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494390|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
139494391|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139494392|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494393|NCT04863079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139494394|NCT04863079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494395|NCT05512325|Bevacizumab|bevacizumab|mesh-list
139494396|NCT05512325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139494397|NCT05512325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860409|NCT02600247|Celecoxib|celecoxib|mesh-list
139494398|NCT05512325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139494399|NCT05512325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139494400|NCT05512325|Growth Substances|growth substances|mesh-ancestor
139494401|NCT05512325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494402|NCT05512325|Growth Inhibitors|growth inhibitors|mesh-ancestor
139494403|NCT04868227|Vitamin D|vitamin d|mesh-list
139494404|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
139494405|NCT04868227|Vitamins|vitamins|mesh-ancestor
139494406|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
139494407|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494408|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139494409|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139494410|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139494411|NCT04873531|Neostigmine|neostigmine|mesh-list
139494412|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139494413|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494414|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494415|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
139494416|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139494417|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494418|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139494419|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
139494420|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494421|NCT04862845|Pregabalin|pregabalin|mesh-list
139494422|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139494423|NCT04862845|Analgesics|analgesics|mesh-ancestor
139494424|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
139494425|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494426|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494427|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
139494428|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139494429|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139494430|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494431|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139494432|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139494433|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139494434|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139494435|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139494436|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139494437|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139494438|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139494439|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
139494440|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
139494441|NCT04862377|Budesonide|budesonide|mesh-list
139494442|NCT04862377|Poractant alfa|poractant alfa|mesh-list
139494443|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494444|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139494445|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
138860518|NCT05340530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494446|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494447|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494448|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139494449|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
139494450|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
139494451|NCT04862377|Hormones|hormones|mesh-ancestor
139494452|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139494453|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139494454|NCT04867993|Amikacin|amikacin|mesh-list
139494455|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139494456|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494457|NCT04872985|Paclitaxel|paclitaxel|mesh-list
139494458|NCT04872985|Docetaxel|docetaxel|mesh-list
139494459|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
139494460|NCT04872985|Doxorubicin|doxorubicin|mesh-list
139494461|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139494463|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139494464|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494465|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
139494466|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
139494467|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
139494468|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494469|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139494470|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
139494471|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494472|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494473|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139494474|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
139494475|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139494476|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139494477|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139494478|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139494479|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494480|NCT04872907|Fluorides|fluorides|mesh-list
139494481|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
139494482|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
139494483|NCT04872907|Protective Agents|protective agents|mesh-ancestor
139494484|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494485|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
139494486|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
139494487|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139494488|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
139494489|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494490|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494491|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139494492|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
139494493|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
139494494|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139494495|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
139494496|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139494497|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494498|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139494499|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139494500|NCT05507411|Immunomodulating Agents|immunomodulating agents|mesh-list
139494501|NCT05507411|Immunologic Factors|immunologic factors|mesh-ancestor
139494502|NCT05507411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494503|NCT04894643|Paclitaxel|paclitaxel|mesh-list
139494504|NCT04894643|Gemcitabine|gemcitabine|mesh-list
139494505|NCT04894643|Capecitabine|capecitabine|mesh-list
139494506|NCT04894643|Pancrelipase|pancrelipase|mesh-list
139494507|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139494508|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494509|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
139494510|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
139494511|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
138860729|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139494512|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494513|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139494514|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
139494515|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139494516|NCT05506865|Tiotropium Bromide|tiotropium bromide|mesh-list
139494517|NCT05506865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139494518|NCT05506865|Autonomic Agents|autonomic agents|mesh-ancestor
139494519|NCT05506865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494520|NCT05506865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494521|NCT05506865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139494522|NCT05506865|Respiratory System Agents|respiratory system agents|mesh-ancestor
139494523|NCT05506865|Parasympatholytics|parasympatholytics|mesh-ancestor
139494524|NCT05506865|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139494525|NCT05506865|Cholinergic Agents|cholinergic agents|mesh-ancestor
139494526|NCT05506865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139494527|NCT05506865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494528|NCT05506319|Vasopressins|vasopressins|mesh-list
139494529|NCT05506319|Arginine Vasopressin|arginine vasopressin|mesh-list
139494530|NCT05506319|Norepinephrine|norepinephrine|mesh-list
139494531|NCT05506319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139494532|NCT05506319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139494533|NCT05506319|Adrenergic Agents|adrenergic agents|mesh-ancestor
139494534|NCT05506319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281188|NCT00102960|Abacavir|abacavir|mesh-list
139494535|NCT05506319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494537|NCT05506319|Sympathomimetics|sympathomimetics|mesh-ancestor
139494538|NCT05506319|Autonomic Agents|autonomic agents|mesh-ancestor
139494539|NCT05506319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494540|NCT05506319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139494541|NCT05506319|Hemostatics|hemostatics|mesh-ancestor
139494542|NCT05506319|Coagulants|coagulants|mesh-ancestor
139494543|NCT05506319|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139494544|NCT05506319|Natriuretic Agents|natriuretic agents|mesh-ancestor
139494545|NCT05505539|Fluorouracil|fluorouracil|mesh-list
139494546|NCT05505539|Antimetabolites|antimetabolites|mesh-ancestor
139494547|NCT05505539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494548|NCT05505539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139494549|NCT05505539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494550|NCT05505539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139494551|NCT05505539|Immunologic Factors|immunologic factors|mesh-ancestor
139494552|NCT05505539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494553|NCT05505461|Antibodies|antibodies|mesh-list
139494554|NCT05505461|Immunologic Factors|immunologic factors|mesh-ancestor
139494555|NCT05505461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494556|NCT05514275|Capecitabine|capecitabine|mesh-list
139494557|NCT05514275|Endostatins|endostatins|mesh-list
139494558|NCT05514275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139494559|NCT05514275|Antimetabolites|antimetabolites|mesh-ancestor
139494560|NCT05514275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494561|NCT05514275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860794|NCT02708160|Fluorides|fluorides|mesh-list
139494562|NCT05514275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139494563|NCT05514275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139494564|NCT05514275|Growth Substances|growth substances|mesh-ancestor
139494565|NCT05514275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494566|NCT05514275|Growth Inhibitors|growth inhibitors|mesh-ancestor
139494567|NCT05514041|Varenicline|varenicline|mesh-list
139494568|NCT05514041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139494569|NCT05514041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139494570|NCT05514041|Cholinergic Agents|cholinergic agents|mesh-ancestor
139494571|NCT05514041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139494572|NCT05514041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494573|NCT05514041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494574|NCT02570711|Paclitaxel|paclitaxel|mesh-list
139494575|NCT02570711|Gemcitabine|gemcitabine|mesh-list
139494576|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
139494577|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139494578|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494579|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
139494580|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
139494581|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
139494582|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494583|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139494584|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
139494585|NCT05513729|Pioglitazone|pioglitazone|mesh-list
139494586|NCT05513729|Canagliflozin|canagliflozin|mesh-list
139494587|NCT05513729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139494588|NCT05513729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494589|NCT05513729|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139494590|NCT05513729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494591|NCT05504603|Rituximab|rituximab|mesh-list
139494592|NCT05504603|Zanubrutinib|zanubrutinib|mesh-list
139494593|NCT05504603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139494594|NCT05504603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494595|NCT05504603|Immunologic Factors|immunologic factors|mesh-ancestor
139494596|NCT05504603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494597|NCT05504603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494598|NCT05504603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139494599|NCT05504603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494600|NCT05504603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494601|NCT05504213|Fulvestrant|fulvestrant|mesh-list
139494602|NCT05504213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139494603|NCT05504213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494604|NCT05504213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139494605|NCT05504213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139494606|NCT05504213|Hormone Antagonists|hormone antagonists|mesh-ancestor
139494607|NCT05504213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139494608|NCT05504213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494609|NCT05510219|Obinutuzumab|obinutuzumab|mesh-list
139494610|NCT05510219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139494611|NCT05510219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494612|NCT02564471|Doxycycline|doxycycline|mesh-list
139494613|NCT02564471|Chloroquine|chloroquine|mesh-list
139494614|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139494615|NCT02564471|Atovaquone|atovaquone|mesh-list
139494616|NCT02564471|Proguanil|proguanil|mesh-list
139494617|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139494618|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494619|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
139494620|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139494621|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139494622|NCT02564471|Amebicides|amebicides|mesh-ancestor
139494623|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494624|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139494625|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139494626|NCT02564471|Analgesics|analgesics|mesh-ancestor
139494627|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
139494628|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860926|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494629|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494630|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494631|NCT02564471|Filaricides|filaricides|mesh-ancestor
139494632|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
139494633|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
139494634|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494635|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494636|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
139494637|NCT05503667|Bevacizumab|bevacizumab|mesh-list
139494638|NCT05503667|Aflutinib|aflutinib|mesh-list
139494639|NCT05503667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139494640|NCT05503667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494641|NCT05503667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139494642|NCT05503667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139494643|NCT05503667|Growth Substances|growth substances|mesh-ancestor
139494644|NCT05503667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494645|NCT05503667|Growth Inhibitors|growth inhibitors|mesh-ancestor
139494646|NCT05503667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139494647|NCT05503667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494648|NCT05503667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494649|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
139494650|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
139494651|NCT02563067|Growth Substances|growth substances|mesh-ancestor
139494652|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494653|NCT02568683|Vincristine|vincristine|mesh-list
139494654|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139494655|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494656|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
139494657|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
139494658|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
139494659|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494660|NCT05502731|Adalimumab|adalimumab|mesh-list
139494661|NCT05502731|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139494662|NCT05502731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494663|NCT05502731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494664|NCT05503043|Lidocaine|lidocaine|mesh-list
139494665|NCT05503043|Anesthetics, Local|anesthetics, local|mesh-ancestor
139494666|NCT05503043|Anesthetics|anesthetics|mesh-ancestor
139494667|NCT05503043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139494668|NCT05503043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494669|NCT05503043|Sensory System Agents|sensory system agents|mesh-ancestor
139494670|NCT05503043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494671|NCT05503043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138861107|NCT04962152|Nalbuphine|nalbuphine|mesh-list
139494672|NCT05503043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139494673|NCT05503043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139494674|NCT05503043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139494675|NCT05503043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494676|NCT02563925|Durvalumab|durvalumab|mesh-list
139494677|NCT02563925|Tremelimumab|tremelimumab|mesh-list
139494678|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139494679|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494680|NCT01663727|Paclitaxel|paclitaxel|mesh-list
139494681|NCT01663727|Bevacizumab|bevacizumab|mesh-list
139494682|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139494683|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494684|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
139494685|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
139494686|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
139494687|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494688|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139494689|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139494690|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139494691|NCT01663727|Growth Substances|growth substances|mesh-ancestor
139494692|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494693|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
139494694|NCT03042325|Alogliptin|alogliptin|mesh-list
139494695|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139494696|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494697|NCT03042325|Incretins|incretins|mesh-ancestor
139494698|NCT03042325|Hormones|hormones|mesh-ancestor
139494699|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139494700|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139494701|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
139494702|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494703|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494704|NCT01594333|Methotrexate|methotrexate|mesh-list
139494705|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139494706|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
139494707|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139494708|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494709|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139494710|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
139494711|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494712|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494713|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
139494714|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494715|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139494716|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139494717|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
139494718|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494719|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139494720|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
139494721|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
139494722|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139494723|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139494724|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494725|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861340|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139494726|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494727|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494728|NCT03043495|Dexamethasone|dexamethasone|mesh-list
139494729|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494730|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
139494731|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
139494732|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494733|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494734|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139494735|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
139494736|NCT03043495|Hormones|hormones|mesh-ancestor
139494737|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139494738|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139494739|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494740|NCT03043027|Bupivacaine|bupivacaine|mesh-list
139494741|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
139494742|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
139494743|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139494744|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494745|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
139494746|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494747|NCT04861207|Cladribine|cladribine|mesh-list
139494748|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494749|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139494750|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
139494751|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494752|NCT04858087|Lumefantrine|lumefantrine|mesh-list
139494753|NCT04858087|Artemether|artemether|mesh-list
139494754|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139494755|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
139494756|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139281410|NCT05004142|Letrozole|letrozole|mesh-list
139494757|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139494758|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494759|NCT03041935|Acetaminophen|acetaminophen|mesh-list
139494760|NCT03041935|Dexamethasone|dexamethasone|mesh-list
139494761|NCT03041935|Ketorolac|ketorolac|mesh-list
139494762|NCT03041935|Morphine|morphine|mesh-list
139494763|NCT03041935|Remifentanil|remifentanil|mesh-list
139494764|NCT03041935|Ondansetron|ondansetron|mesh-list
139494765|NCT03041935|Propofol|propofol|mesh-list
139494766|NCT03041935|Ropivacaine|ropivacaine|mesh-list
139494767|NCT03041935|Sevoflurane|sevoflurane|mesh-list
139494768|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494769|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
139494770|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
139494771|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494772|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494773|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139494774|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
139494775|NCT03041935|Hormones|hormones|mesh-ancestor
139494776|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139494777|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139494778|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494779|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139494780|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139494781|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139494782|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
139494783|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
139494784|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139494785|NCT03041935|Narcotics|narcotics|mesh-ancestor
139494786|NCT03041935|Analgesics|analgesics|mesh-ancestor
139494787|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
139494788|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
139494789|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139494790|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
139494791|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139494792|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138861531|NCT05260554|Fosfomycin|fosfomycin|mesh-list
139494793|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
139494794|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
139494795|NCT03041935|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139494796|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139494797|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
139494798|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139494799|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494800|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139494801|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494802|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139494803|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494804|NCT03042013|Naquotinib|naquotinib|mesh-list
139494805|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494806|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139494807|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494808|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494809|NCT03042871|Ranibizumab|ranibizumab|mesh-list
139494810|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139494811|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139494812|NCT03042871|Growth Substances|growth substances|mesh-ancestor
139494813|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494814|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
139494815|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494816|NCT03042637|Tacrolimus|tacrolimus|mesh-list
139494817|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139494818|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
139494819|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494820|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139494821|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494822|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494823|NCT03045133|Morphine|morphine|mesh-list
139494824|NCT03045133|Methadone|methadone|mesh-list
139494825|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139494826|NCT03045133|Narcotics|narcotics|mesh-ancestor
139494827|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139494828|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494829|NCT03045133|Analgesics|analgesics|mesh-ancestor
139494830|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
139494831|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494832|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
139494833|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
139494834|NCT02609659|Ritonavir|ritonavir|mesh-list
139494835|NCT02609659|Ribavirin|ribavirin|mesh-list
139494836|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139494837|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139494838|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
139494839|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494840|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494841|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139494842|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139494843|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
139494844|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494845|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139494846|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139494847|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
139494848|NCT04429711|Ivermectin|ivermectin|mesh-list
139494849|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139494850|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494851|NCT04429633|Candesartan|candesartan|mesh-list
139494852|NCT04429633|Candesartan cilexetil|candesartan cilexetil|mesh-list
139494853|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139494854|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139494855|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139494856|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494857|NCT03042091|Metronidazole|metronidazole|mesh-list
139494858|NCT03042091|Ethanol|ethanol|mesh-list
139494859|NCT03042091|Neomycin|neomycin|mesh-list
139494860|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494861|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139494862|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139494863|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139494864|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139494865|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139494866|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494867|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139494868|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494869|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494870|NCT04859569|Denosumab|denosumab|mesh-list
139494871|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139494872|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861822|NCT00924287|Mesna|mesna|mesh-list
139494873|NCT04856371|Letrozole|letrozole|mesh-list
139494874|NCT04856371|Fulvestrant|fulvestrant|mesh-list
139494875|NCT04856371|Palbociclib|palbociclib|mesh-list
139494876|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494877|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139494878|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139494879|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494880|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494881|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139494882|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
139494883|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139494884|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861864|NCT02773316|Analgesics|analgesics|mesh-ancestor
139494885|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139494886|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139494887|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139494888|NCT03041779|Acetaminophen|acetaminophen|mesh-list
139494889|NCT03041779|Diclofenac|diclofenac|mesh-list
139494890|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139494891|NCT03041779|Analgesics|analgesics|mesh-ancestor
139494892|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
139494893|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494894|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494895|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
139494896|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139494897|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494898|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494899|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139494900|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494901|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494902|NCT02612779|Dexamethasone|dexamethasone|mesh-list
139494903|NCT02612779|Nivolumab|nivolumab|mesh-list
139494904|NCT02612779|Pomalidomide|pomalidomide|mesh-list
139494905|NCT02612779|Elotuzumab|elotuzumab|mesh-list
139494906|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494907|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
139494908|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
139494909|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494910|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494911|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139494912|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
139494913|NCT02612779|Hormones|hormones|mesh-ancestor
139494914|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139494915|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139494916|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494917|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139494918|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138861925|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
139494919|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494920|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
139494921|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139494922|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139494923|NCT02612779|Growth Substances|growth substances|mesh-ancestor
139494924|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
139494925|NCT04866355|Ibuprofen|ibuprofen|mesh-list
139494926|NCT04866355|Scopolamine|scopolamine|mesh-list
139494927|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139494928|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139494929|NCT04866355|Analgesics|analgesics|mesh-ancestor
139494930|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
139494931|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494932|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494933|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494934|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494935|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139494936|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494937|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494938|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139494939|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
139494940|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
139494941|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139494942|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
139494943|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139494944|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
139494945|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139494946|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139494947|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139494948|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139494949|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494950|NCT02607865|Incretins|incretins|mesh-ancestor
139494951|NCT02607865|Hormones|hormones|mesh-ancestor
139494952|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139494953|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139494954|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
139494955|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494956|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494957|NCT04856137|Paclitaxel|paclitaxel|mesh-list
139494958|NCT04856137|Rituximab|rituximab|mesh-list
139494959|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139494960|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494961|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
139494962|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
139494963|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
139494964|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494965|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139494966|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
139494967|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494968|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139494969|NCT04855279|Listerine|listerine|mesh-list
139494970|NCT04855279|Fluorides|fluorides|mesh-list
139494971|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
139494972|NCT04855279|Glycerol|glycerol|mesh-list
139494973|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
139494974|NCT04855279|Protective Agents|protective agents|mesh-ancestor
139494975|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494976|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139494977|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139494978|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139494979|NCT04848259|Dexamethasone|dexamethasone|mesh-list
139494980|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
139494981|NCT04848259|BB 1101|bb 1101|mesh-list
139494982|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139494983|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
139494984|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
139494985|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139494986|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139494987|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139494988|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
139494989|NCT04848259|Hormones|hormones|mesh-ancestor
139494990|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139494991|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139494992|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139494993|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
139494994|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139494995|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139494996|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139494997|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
139494998|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139494999|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
139495000|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139495001|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495002|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139495003|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139495004|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495005|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
139495006|NCT04848181|Finasteride|finasteride|mesh-list
139495007|NCT04848181|Cyproterone|cyproterone|mesh-list
139495008|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139495009|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139495010|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495011|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495012|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
139495013|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139495014|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495015|NCT04848181|Urological Agents|urological agents|mesh-ancestor
139495016|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
139495017|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495018|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139495019|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
139495020|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139495021|NCT04847791|Lactoferrin|lactoferrin|mesh-list
139495022|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495023|NCT04375813|Sirolimus|sirolimus|mesh-list
139495024|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139495025|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495026|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139495027|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495028|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
139495029|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139495030|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
139495031|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495032|NCT04847245|Pregabalin|pregabalin|mesh-list
139495033|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139495034|NCT04847245|Esketamine|esketamine|mesh-list
139495035|NCT04847245|Analgesics|analgesics|mesh-ancestor
139495036|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
139495037|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862532|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
139495038|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495039|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
139495040|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139495041|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139495042|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495043|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139495044|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139495045|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139495046|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495047|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139495048|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139495049|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139495050|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495051|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
139495052|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
139495053|NCT04839913|Antibodies|antibodies|mesh-list
139495054|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
139495055|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495056|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
139495057|NCT04846621|Calcium|calcium|mesh-list
139495058|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139495059|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495060|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139495061|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495062|NCT04854577|Anesthetics|anesthetics|mesh-list
139495063|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495064|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495065|NCT04839445|Anesthetics|anesthetics|mesh-list
139495066|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495067|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495068|NCT04845607|Amiodarone|amiodarone|mesh-list
139495069|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139495070|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
139495071|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139495072|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139495073|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495074|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139495075|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139495076|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139495077|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495078|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139495079|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139495080|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139495081|NCT04853797|Calcium|calcium|mesh-list
139495082|NCT04853797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139495083|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495084|NCT03040531|Vitamin D|vitamin d|mesh-list
139495085|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
139495086|NCT03040531|Alendronate|alendronate|mesh-list
139495087|NCT03040531|Genistein|genistein|mesh-list
139495088|NCT03040531|Calcium|calcium|mesh-list
139495089|NCT03040531|Vitamins|vitamins|mesh-ancestor
139495090|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
139495091|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495092|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139495093|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139495094|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139495095|NCT03040531|Protective Agents|protective agents|mesh-ancestor
139495096|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495097|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139495098|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495099|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495100|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
139495101|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139495102|NCT03040531|Estrogens|estrogens|mesh-ancestor
139495103|NCT03040531|Hormones|hormones|mesh-ancestor
139495104|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139495105|NCT04838665|Phenylephrine|phenylephrine|mesh-list
139495106|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
139495107|NCT04838665|Tropicamide|tropicamide|mesh-list
139495108|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
139495109|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139495110|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
139495111|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
139495112|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495113|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495114|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
139495115|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139495116|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
139495117|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
139495118|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139495119|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139495120|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139495121|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
139495122|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495123|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495124|NCT04838665|Protective Agents|protective agents|mesh-ancestor
139495125|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139495126|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139495127|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
139495128|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
139495129|NCT04845061|Nebivolol|nebivolol|mesh-list
139495130|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139495131|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
139495132|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139495133|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139495134|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139495135|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
139495136|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139281788|NCT06203275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495137|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495138|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495139|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
139495140|NCT03040765|Denosumab|denosumab|mesh-list
139495141|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138862829|NCT04171791|Venetoclax|venetoclax|mesh-list
139495142|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495143|NCT01668667|Gabapentin|gabapentin|mesh-list
139495144|NCT01668667|Analgesics|analgesics|mesh-ancestor
139495145|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
139495146|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495147|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495148|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
139495149|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139495150|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139495151|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495152|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139495153|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139495154|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139495155|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495156|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495157|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
139495158|NCT03040219|Folic Acid|folic acid|mesh-list
139495159|NCT03040219|Hematinics|hematinics|mesh-ancestor
139495160|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
139495161|NCT03040219|Vitamins|vitamins|mesh-ancestor
139495162|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
139495163|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495164|NCT03038503|Terlipressin|terlipressin|mesh-list
139495165|NCT03038503|Methylene Blue|methylene blue|mesh-list
139495166|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495167|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495168|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139495169|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139495170|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
139495171|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139495172|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495173|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
139495174|NCT04852315|Caffeine|caffeine|mesh-list
139495175|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139495176|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495177|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139495178|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495179|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495180|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139495181|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139495182|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
139495183|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495184|NCT03038425|Ropivacaine|ropivacaine|mesh-list
139495185|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
139495186|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
139495187|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495188|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495189|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
139495190|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495191|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139495192|NCT04851769|Alirocumab|alirocumab|mesh-list
139495193|NCT04851769|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139495194|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139495195|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139495196|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
139495197|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495198|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495199|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138862916|NCT00648297|Diuretics|diuretics|mesh-ancestor
139495200|NCT04851769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139495201|NCT04851769|Protease Inhibitors|protease inhibitors|mesh-ancestor
139495202|NCT04843267|Tislelizumab|tislelizumab|mesh-list
139281863|NCT06202911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139281864|NCT06202911|Antioxidants|antioxidants|mesh-ancestor
139281865|NCT06202911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139281866|NCT06202911|Protective Agents|protective agents|mesh-ancestor
139281867|NCT06202911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139281868|NCT06202911|Antidotes|antidotes|mesh-ancestor
139281869|NCT06202885|Immunomodulating Agents|immunomodulating agents|mesh-list
139281870|NCT06202885|Immunologic Factors|immunologic factors|mesh-ancestor
139281871|NCT06202885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495203|NCT04843267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139495204|NCT04843267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495205|NCT04852081|Tamoxifen|tamoxifen|mesh-list
139495206|NCT04852081|Letrozole|letrozole|mesh-list
139495207|NCT04852081|Fulvestrant|fulvestrant|mesh-list
139495208|NCT04852081|Palbociclib|palbociclib|mesh-list
139495209|NCT04852081|Anastrozole|anastrozole|mesh-list
139495210|NCT04852081|Exemestane|exemestane|mesh-list
139495211|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495212|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139495213|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139495214|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495215|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495216|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139495217|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
139495218|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139495219|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495220|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139495221|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139495222|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139495223|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139495224|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139495225|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139495226|NCT02608099|Apixaban|apixaban|mesh-list
139495227|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139495228|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
139495229|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139495230|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
139495231|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495232|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495233|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
139495234|NCT04850755|Nivolumab|nivolumab|mesh-list
139495235|NCT04850755|Ipilimumab|ipilimumab|mesh-list
139495236|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139495237|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495238|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139495239|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495240|NCT04842487|Prednisone|prednisone|mesh-list
139495241|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
139495242|NCT04842487|Rituximab|rituximab|mesh-list
139495243|NCT04842487|Vincristine|vincristine|mesh-list
139495244|NCT04842487|Lenalidomide|lenalidomide|mesh-list
139495245|NCT04842487|Doxorubicin|doxorubicin|mesh-list
139495246|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139495247|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139495248|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
139495249|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495250|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139495251|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139495252|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
139495253|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495254|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495255|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139495256|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139495257|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139495258|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
139495259|NCT04842487|Hormones|hormones|mesh-ancestor
139495260|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139495261|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139495262|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139495263|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
139495264|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
139495265|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
139495266|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139495267|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139495268|NCT04842487|Growth Substances|growth substances|mesh-ancestor
139495269|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
139495270|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139495271|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139495272|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139495273|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495274|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139281939|NCT06191263|Venetoclax|venetoclax|mesh-list
139281940|NCT06191263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139281943|NCT06190665|Estrogens|estrogens|mesh-ancestor
139495275|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139495276|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495277|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
139495278|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139495279|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495280|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
139495281|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139495282|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
139495283|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495284|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495285|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139495286|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
139495287|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139495288|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
139495289|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495290|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495291|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139495292|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
139495293|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
139495294|NCT04312243|Protective Agents|protective agents|mesh-ancestor
139495295|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
139495296|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139495297|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139495298|NCT04837651|Antibodies|antibodies|mesh-list
139495299|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
139495300|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495301|NCT03039205|Clopidogrel|clopidogrel|mesh-list
139495302|NCT03039205|Ticagrelor|ticagrelor|mesh-list
139495303|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139495304|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139495305|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139495306|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139495307|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
139495308|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495309|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495310|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495311|NCT04837261|Propranolol|propranolol|mesh-list
139495312|NCT04837261|Amiodarone|amiodarone|mesh-list
139495313|NCT04837261|Flecainide|flecainide|mesh-list
139495314|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139495315|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139495316|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
139495317|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495318|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495319|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495320|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139495321|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139495322|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
139495323|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139495324|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139495325|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139495326|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139495327|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139495328|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495329|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139495330|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139495331|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139495332|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139495333|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
139495334|NCT04824937|Talazoparib|talazoparib|mesh-list
139495335|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139495336|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495337|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495338|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495339|NCT03036085|Epinephrine|epinephrine|mesh-list
139495340|NCT03036085|Bupivacaine|bupivacaine|mesh-list
139495341|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
139495342|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
139495343|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495344|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495345|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
139495346|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495347|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139282015|NCT06114628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139495348|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139495349|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
139495350|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495351|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495352|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139495353|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139495354|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
139495355|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139495356|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
139495357|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
139495358|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
139495359|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139495360|NCT04831255|Triamcinolone|triamcinolone|mesh-list
139495361|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139495362|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139495363|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139495364|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139495365|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
139495367|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139495368|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495369|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139495370|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
139495371|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495372|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495373|NCT02431533|Calcium|calcium|mesh-list
139495374|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139495375|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495376|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
138863165|NCT02704494|Losartan|losartan|mesh-list
139495377|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139495378|NCT02413593|Ledipasvir|ledipasvir|mesh-list
139495379|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
139495380|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495381|NCT01652703|Evolocumab|evolocumab|mesh-list
139495382|NCT01652703|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139495383|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139495384|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139495385|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
139495386|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495387|NCT01652703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139495388|NCT01652703|Protease Inhibitors|protease inhibitors|mesh-ancestor
139495389|NCT01652703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495390|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139495391|NCT01652469|Docetaxel|docetaxel|mesh-list
139495392|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139495393|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495394|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
139495395|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
139495396|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
139495397|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495398|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139495399|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495400|NCT02429427|Celecoxib|celecoxib|mesh-list
139495401|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139495402|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139495403|NCT02429427|Analgesics|analgesics|mesh-ancestor
139495404|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
139495405|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495406|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495407|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139495408|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139495409|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139495410|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139495411|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495412|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495413|NCT02412657|Dexamethasone|dexamethasone|mesh-list
139495414|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139495415|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
139495416|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
139495417|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495418|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495419|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138863214|NCT02759666|Fluzoparib|fluzoparib|mesh-list
139495420|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
139495421|NCT02412657|Hormones|hormones|mesh-ancestor
139495422|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139495423|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139495425|NCT02412111|Ivacaftor|ivacaftor|mesh-list
139495426|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139495427|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139495428|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495429|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
139495430|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139495431|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495432|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139495433|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495434|NCT02484651|Rocuronium|rocuronium|mesh-list
139495435|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139495436|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139495437|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139495438|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495439|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495440|NCT02410551|Fludarabine|fludarabine|mesh-list
139495441|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
139495442|NCT02410551|Busulfan|busulfan|mesh-list
139495443|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495444|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139495445|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
139495446|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495447|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139495448|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
139495449|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495450|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
138863240|NCT02756312|Anesthetics|anesthetics|mesh-list
139495451|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139495452|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139495453|NCT02424591|Ketamine|ketamine|mesh-list
139495454|NCT02424591|Analgesics|analgesics|mesh-ancestor
139495455|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
139495456|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495457|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495458|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139495459|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139495460|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
139495461|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
139495462|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495463|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139495464|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139495465|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495466|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495467|NCT02408523|Lacosamide|lacosamide|mesh-list
139495468|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139495469|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
139495470|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139495471|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139495472|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139495473|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495474|NCT04822909|Thalidomide|thalidomide|mesh-list
139495475|NCT04822909|Apremilast|apremilast|mesh-list
139495476|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139495477|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139495478|NCT04822909|Analgesics|analgesics|mesh-ancestor
139495479|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
139495480|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495481|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495482|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139495483|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139495484|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139495485|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139495486|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495487|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495488|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139495489|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
139495490|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
139495491|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139495492|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495493|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139282167|NCT05955365|Aspirin|aspirin|mesh-list
139495494|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139495495|NCT04822909|Growth Substances|growth substances|mesh-ancestor
139495496|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
139495497|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495498|NCT04831099|Testosterone|testosterone|mesh-list
139495499|NCT04831099|Androgens|androgens|mesh-ancestor
139495501|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139495502|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495503|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
139495504|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139495505|NCT02603419|Avelumab|avelumab|mesh-list
139495506|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139495507|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139495508|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495509|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
139495510|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495511|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
139495512|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139495513|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495514|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495515|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139495516|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139495517|NCT04367935|Protective Agents|protective agents|mesh-ancestor
139495518|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495519|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
139495520|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139495521|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
139495522|NCT04829773|Midazolam|midazolam|mesh-list
139495523|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139495524|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139495525|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495526|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495527|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139495528|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139495529|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139495530|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139495531|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
139495532|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
139495533|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
139495534|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
139495535|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495536|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495537|NCT04829695|Artesunate|artesunate|mesh-list
139495538|NCT04829695|Lumefantrine|lumefantrine|mesh-list
139495539|NCT04829695|Artemether|artemether|mesh-list
139495540|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139495541|NCT04829695|Amodiaquine|amodiaquine|mesh-list
139495542|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
139495543|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139495544|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139495545|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495546|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495547|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
139495548|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
139495549|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139495550|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
139495551|NCT03035695|Hemostatics|hemostatics|mesh-list
139495552|NCT03035695|Coagulants|coagulants|mesh-ancestor
139495553|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
139495554|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139495555|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
139495556|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
139495557|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495558|NCT04828525|Dexamethasone|dexamethasone|mesh-list
139495559|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139495560|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
139495561|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
139495562|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495563|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495564|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139495565|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
139282238|NCT05826990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495566|NCT04828525|Hormones|hormones|mesh-ancestor
139495567|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139495568|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139495569|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495570|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
139495571|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139495572|NCT04821193|Disinfectants|disinfectants|mesh-list
139495573|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139495574|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139495575|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495576|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
139495577|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
139495578|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139495579|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495580|NCT04827667|Dimercaprol|dimercaprol|mesh-list
139495581|NCT04827667|Chelating Agents|chelating agents|mesh-ancestor
139495582|NCT04827667|Sequestering Agents|sequestering agents|mesh-ancestor
139495583|NCT04827667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495584|NCT04360135|Acetaminophen|acetaminophen|mesh-list
139495585|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139495586|NCT04360135|Analgesics|analgesics|mesh-ancestor
139495587|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
139495588|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495589|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495590|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
139495591|NCT02605837|Budesonide|budesonide|mesh-list
139495592|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139495593|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139495594|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
139495595|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495596|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495597|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139495598|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
139495599|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
139495600|NCT02605837|Hormones|hormones|mesh-ancestor
139495601|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139495602|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
139495603|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139495604|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495605|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495606|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139495607|NCT04820101|Analgesics|analgesics|mesh-ancestor
139495608|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
139495609|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495610|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139495611|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139495612|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139495613|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
139495614|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495615|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495616|NCT04819867|Propolis|propolis|mesh-list
139495617|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495618|NCT02423343|Nivolumab|nivolumab|mesh-list
139495619|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139495620|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495621|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139495622|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495623|NCT04909515|Isotretinoin|isotretinoin|mesh-list
139495624|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
139495625|NCT05617729|Povidone-Iodine|povidone-iodine|mesh-list
139495626|NCT05617729|Povidone|povidone|mesh-list
139495627|NCT05617729|Plasma Substitutes|plasma substitutes|mesh-ancestor
139495628|NCT05617729|Blood Substitutes|blood substitutes|mesh-ancestor
139495629|NCT05617729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139495630|NCT05617729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495631|NCT04818931|Cefazolin|cefazolin|mesh-list
139495632|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139495633|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495634|NCT02406261|Midazolam|midazolam|mesh-list
139495635|NCT02406261|Donepezil|donepezil|mesh-list
139495636|NCT02406261|Simvastatin|simvastatin|mesh-list
139495637|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139495638|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139495639|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495640|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495641|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139495642|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139495643|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139495644|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139495645|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
139495646|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
139495647|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
139495648|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
139495649|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495650|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495651|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139495652|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139495653|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
139495654|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139495655|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139495656|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495657|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139495658|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
139495659|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
139495660|NCT02485353|Cytarabine|cytarabine|mesh-list
139495661|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139495662|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
139495663|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495664|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495665|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
139495666|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495667|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139495668|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
139495669|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495670|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139495671|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495672|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495673|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
139495674|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495675|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139495676|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139495677|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139495678|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139495679|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
139495680|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139495681|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
139495682|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495683|NCT04826497|Nicorandil|nicorandil|mesh-list
139495684|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139495685|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139495686|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
139495687|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
139495688|NCT04826497|Vitamins|vitamins|mesh-ancestor
139495689|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
139495690|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495691|NCT04819243|Atezolizumab|atezolizumab|mesh-list
139495692|NCT04819243|Talazoparib|talazoparib|mesh-list
139495693|NCT04819243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139495694|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495695|NCT04819243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139495696|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495697|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139495698|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495699|NCT02604589|Hydromorphone|hydromorphone|mesh-list
139495700|NCT02604589|Bupivacaine|bupivacaine|mesh-list
139495701|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
139495702|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
139495703|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495704|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495705|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
139495706|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495707|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139495708|NCT02604589|Narcotics|narcotics|mesh-ancestor
139495709|NCT02604589|Analgesics|analgesics|mesh-ancestor
139495710|NCT04818151|Warfarin|warfarin|mesh-list
139495711|NCT04818151|Apixaban|apixaban|mesh-list
139495712|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
139495713|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139495714|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
139495715|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139495716|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
139495717|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495718|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495719|NCT04817527|Edaravone|edaravone|mesh-list
139495720|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139495721|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
139495722|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495723|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139495724|NCT04817527|Protective Agents|protective agents|mesh-ancestor
139495725|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495726|NCT04357795|Cyclosporine|cyclosporine|mesh-list
139495727|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139495728|NCT04357795|Cyclosporins|cyclosporins|mesh-list
139495729|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495730|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495731|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139495732|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
139495733|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495734|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
139495735|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495736|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
139495737|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139495738|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139495739|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139495741|NCT02604199|Entecavir|entecavir|mesh-list
139495742|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
139495743|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139495744|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
139495745|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495746|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139495747|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139495748|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495749|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495750|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139495751|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139495752|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
139495753|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495754|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495755|NCT04807543|Castor Oil|castor oil|mesh-list
139495756|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
139495757|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
139495758|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139495759|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
139495760|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139495761|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495762|NCT04807543|Progestins|progestins|mesh-ancestor
139495763|NCT04807543|Hormones|hormones|mesh-ancestor
139495764|NCT04807543|Cathartics|cathartics|mesh-ancestor
139495765|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139495766|NCT04797949|Aspirin|aspirin|mesh-list
139495767|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139495768|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139495769|NCT04797949|Analgesics|analgesics|mesh-ancestor
139495770|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
139495771|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495772|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495773|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139495774|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139495775|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139495776|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139495777|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495778|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139495779|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139495780|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495781|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
139495782|NCT04797793|Adapalene|adapalene|mesh-list
139495783|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139495784|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139495785|NCT04797793|Analgesics|analgesics|mesh-ancestor
139495786|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
139495787|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495788|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495789|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139495790|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139495791|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
139495792|NCT04796857|Lenalidomide|lenalidomide|mesh-list
139495793|NCT04796857|Tislelizumab|tislelizumab|mesh-list
139495794|NCT04796857|Antibodies|antibodies|mesh-list
139495795|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
139495796|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495797|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139495798|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139495799|NCT04796857|Growth Substances|growth substances|mesh-ancestor
139495801|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495802|NCT04796857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139495803|NCT04796623|Fulvestrant|fulvestrant|mesh-list
139495804|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139495805|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495806|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139495807|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139495808|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
138863623|NCT04433858|Psilocybin|psilocybin|mesh-list
139495809|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139495810|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495811|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
139495812|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139495813|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495814|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495815|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139495816|NCT04815265|Analgesics|analgesics|mesh-ancestor
139495817|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
139495818|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495819|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139495820|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139495821|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139495822|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
139495823|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495824|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495825|NCT04815187|Montelukast|montelukast|mesh-list
139495826|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139495827|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
139495828|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139495829|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
139495830|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139495831|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495832|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139495833|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139495834|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495835|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
139495836|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
139495837|NCT04805827|Gabapentin|gabapentin|mesh-list
139495838|NCT04805827|Analgesics|analgesics|mesh-ancestor
139495839|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
139495840|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495841|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495842|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
139495843|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139495844|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139495845|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495846|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139495847|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138863680|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
139495848|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139495849|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495850|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495851|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
139495852|NCT02596711|Nicotine|nicotine|mesh-list
139495853|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
139495854|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139495855|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
139495856|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495857|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495858|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139495859|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139495860|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
139495861|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495862|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495863|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
139495864|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
139495865|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
139495866|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
139495867|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139495868|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495869|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495870|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
139495871|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139495872|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495873|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495874|NCT04814485|Paclitaxel|paclitaxel|mesh-list
139495875|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139495876|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139495877|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495878|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
139495879|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
139495880|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
139495881|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495882|NCT04804423|Listerine|listerine|mesh-list
139495883|NCT04804423|Fluorides|fluorides|mesh-list
139495884|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
139495885|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
139495886|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
139495887|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
139495888|NCT04804423|Protective Agents|protective agents|mesh-ancestor
139495889|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495890|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139495891|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139495892|NCT04794049|Lactulose|lactulose|mesh-list
139495893|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139495894|NCT04794127|Pioglitazone|pioglitazone|mesh-list
139495895|NCT04794127|Trabectedin|trabectedin|mesh-list
139495896|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139495897|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495898|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139495899|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
139495900|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495901|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495902|NCT04804267|Linaclotide|linaclotide|mesh-list
139495903|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139495904|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
139495905|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495906|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139495907|NCT04813471|Folic Acid|folic acid|mesh-list
139495908|NCT04813471|Nicorandil|nicorandil|mesh-list
139495909|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
139495910|NCT04813471|Atorvastatin|atorvastatin|mesh-list
139495911|NCT04813471|Vitamins|vitamins|mesh-ancestor
139495912|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
139495913|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495914|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139495915|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139495916|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
139495917|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495918|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139495919|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139495920|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495921|NCT04813471|Hematinics|hematinics|mesh-ancestor
139495922|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139495923|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139495924|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
139495925|NCT04803175|Valsartan|valsartan|mesh-list
139495926|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139495927|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139495928|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139495929|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139495930|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495931|NCT04792723|Aspirin|aspirin|mesh-list
138863745|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495932|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139495933|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139495934|NCT04792723|Analgesics|analgesics|mesh-ancestor
139495935|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
139495936|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495937|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495938|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139495939|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139495940|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139495941|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139495942|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495943|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139495944|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139282609|NCT05351593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139495946|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
139495947|NCT04792333|Firibastat|firibastat|mesh-list
139495948|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139495949|NCT04802785|Aspirin|aspirin|mesh-list
139495950|NCT04802785|Domperidone|domperidone|mesh-list
139495951|NCT04802785|Melatonin|melatonin|mesh-list
139495952|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139495953|NCT04802785|Simethicone|simethicone|mesh-list
139495954|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139495955|NCT04802785|Citric Acid|citric acid|mesh-list
139495956|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
139495957|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
139495958|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139495959|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
139495960|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
139495961|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495962|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
139495963|NCT04802785|Protective Agents|protective agents|mesh-ancestor
139495964|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139495965|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139495966|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139495967|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139495968|NCT04802785|Analgesics|analgesics|mesh-ancestor
139495969|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
139495970|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495971|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139495972|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139495973|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139495974|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139495975|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139495976|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139495977|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495978|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
139495979|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
139495980|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
139495981|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139495982|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139495983|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
139495984|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139495985|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
139495986|NCT04802785|Emollients|emollients|mesh-ancestor
139495987|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
139495988|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
139495989|NCT04802785|Antacids|antacids|mesh-ancestor
139495990|NCT02598193|Pirfenidone|pirfenidone|mesh-list
139495991|NCT02598193|Nintedanib|nintedanib|mesh-list
139495992|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139495993|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139495994|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139495995|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139495996|NCT02598193|Analgesics|analgesics|mesh-ancestor
139495997|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
139495998|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139495999|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496000|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139496001|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139496002|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139496003|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139496004|NCT04802083|Eculizumab|eculizumab|mesh-list
139496005|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139496006|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139496007|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
139496008|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496009|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
139496010|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
139496011|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139496012|NCT04790383|Protective Agents|protective agents|mesh-ancestor
139496013|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496014|NCT02388165|Vaccines|vaccines|mesh-list
139496015|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
139496016|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496017|NCT04811911|Methotrexate|methotrexate|mesh-list
139496018|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139282686|NCT05282550|Serotonin Agents|serotonin agents|mesh-ancestor
139496019|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
139496020|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139496021|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496022|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139496023|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
139496024|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496025|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496026|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
139496027|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496028|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139496029|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139496030|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
139496031|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139496032|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139496033|NCT04788979|Melatonin|melatonin|mesh-list
139496034|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
139496035|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496036|NCT04788979|Protective Agents|protective agents|mesh-ancestor
139496037|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496038|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139496039|NCT04811209|Analgesics|analgesics|mesh-list
139496040|NCT04811209|Anesthetics|anesthetics|mesh-list
139496041|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139496042|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496043|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
139496044|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496045|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
139496046|NCT04788355|Apixaban|apixaban|mesh-list
139496047|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
139496048|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139496049|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139496050|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496051|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496052|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496053|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139496054|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139496055|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
139496056|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139496057|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
139496058|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
139496059|NCT04799743|Resveratrol|resveratrol|mesh-list
139496060|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
139496061|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496062|NCT04799743|Protective Agents|protective agents|mesh-ancestor
139496063|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496064|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496065|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139496066|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
139496067|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139496068|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139496069|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496070|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
139496071|NCT04788121|Coagulants|coagulants|mesh-ancestor
139496072|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
139496073|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139496074|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139496075|NCT04810819|Prednisolone|prednisolone|mesh-list
139496076|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
139496077|NCT04810819|Dyphylline|dyphylline|mesh-list
139496078|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139496079|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
139496080|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139496081|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
139496082|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
139496083|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496084|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496085|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139496086|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
139496087|NCT04810819|Hormones|hormones|mesh-ancestor
138863907|NCT05322564|Narcotics|narcotics|mesh-ancestor
139496088|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139496089|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139496090|NCT04810819|Protective Agents|protective agents|mesh-ancestor
139496091|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139496092|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496093|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139496094|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139496095|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
139496096|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139282758|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139496097|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496098|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496099|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
139496100|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139496101|NCT04810507|Anagliptin|anagliptin|mesh-list
139496102|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138863933|NCT04218500|Vitamins|vitamins|mesh-ancestor
139496103|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496104|NCT04810507|Incretins|incretins|mesh-ancestor
139496105|NCT04810507|Hormones|hormones|mesh-ancestor
139496106|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139496107|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139496108|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
139496109|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496110|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496111|NCT04810585|Aflibercept|aflibercept|mesh-list
139496112|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139496113|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139496114|NCT04810585|Growth Substances|growth substances|mesh-ancestor
139496115|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496116|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
139496117|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496118|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
139496119|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496120|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
139496121|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
139496122|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
139496123|NCT04809649|Itraconazole|itraconazole|mesh-list
139496124|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
139496125|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496126|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139496127|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139496128|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496129|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496130|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139496131|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
139496132|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139496133|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496134|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139496135|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139496136|NCT04786795|Pancreatin|pancreatin|mesh-list
139496137|NCT04786795|Pancrelipase|pancrelipase|mesh-list
139496138|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139496139|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139496140|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
139496141|NCT02596945|Hematinics|hematinics|mesh-ancestor
139496142|NCT04786327|Edetic Acid|edetic acid|mesh-list
139496143|NCT04786327|Mitogens|mitogens|mesh-list
139496144|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
139496145|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
139496146|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496147|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
139496148|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139496149|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
139496150|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
139496151|NCT04786327|Antidotes|antidotes|mesh-ancestor
139496152|NCT04786327|Protective Agents|protective agents|mesh-ancestor
138863994|NCT04218734|Metformin|metformin|mesh-list
139496153|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496154|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139496155|NCT04153435|Calcium|calcium|mesh-list
139496156|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139496157|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496158|NCT01667419|Vemurafenib|vemurafenib|mesh-list
139496159|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496160|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139496161|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496162|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496163|NCT04808791|Trifluridine|trifluridine|mesh-list
139496164|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
139496165|NCT04808791|Irinotecan|irinotecan|mesh-list
139496166|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496167|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139496168|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139496169|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496170|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496171|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
139496172|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
139496173|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496174|NCT03843853|Bevacizumab|bevacizumab|mesh-list
139496175|NCT03843853|Pemetrexed|pemetrexed|mesh-list
139496176|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139496177|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496178|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139496179|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139496180|NCT03843853|Growth Substances|growth substances|mesh-ancestor
139496181|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496182|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
139496183|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496184|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496185|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139496186|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139496187|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
139496188|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139496189|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
139496190|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496191|NCT05054179|Ropivacaine|ropivacaine|mesh-list
139496192|NCT05054179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139496193|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
139496194|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
139496195|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139496196|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496197|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
139496198|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496199|NCT04789057|Atorvastatin|atorvastatin|mesh-list
139496200|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139496201|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139496202|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
139496203|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496204|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139496205|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139496206|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496207|NCT05611645|Bevacizumab|bevacizumab|mesh-list
139496208|NCT05611645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139496209|NCT05611645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496210|NCT05611645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139496211|NCT05611645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139496212|NCT05611645|Growth Substances|growth substances|mesh-ancestor
139496213|NCT05611645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496214|NCT05611645|Growth Inhibitors|growth inhibitors|mesh-ancestor
139496215|NCT02835079|Tamoxifen|tamoxifen|mesh-list
139496216|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139496217|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
139496218|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139496219|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496220|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139496221|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864055|NCT03355157|Letrozole|letrozole|mesh-list
139496222|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139496223|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139496224|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139496225|NCT01667107|Posaconazole|posaconazole|mesh-list
139496226|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
139496227|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496228|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139496229|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139496230|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139496231|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139496232|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139496233|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496234|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496235|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139496236|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
139496237|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139496238|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496239|NCT05240131|Atezolizumab|atezolizumab|mesh-list
139496240|NCT05240131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139496241|NCT05240131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496242|NCT05240131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139496243|NCT05240131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139282908|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
139496245|NCT05188339|Citric Acid|citric acid|mesh-list
139496246|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
139496247|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
139496248|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139496249|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
139496250|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
139496251|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496252|NCT05188339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139496253|NCT05188339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139496254|NCT05614765|Ezetimibe|ezetimibe|mesh-list
139496255|NCT05614765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139496256|NCT05614765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139496257|NCT05614765|Antimetabolites|antimetabolites|mesh-ancestor
139496258|NCT05614765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496259|NCT05614765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139496260|NCT02590003|Paclitaxel|paclitaxel|mesh-list
139496261|NCT02590003|Carboplatin|carboplatin|mesh-list
139496262|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139496263|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496264|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
139496265|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
139496266|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
139496267|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496268|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
139496269|NCT04134325|Nivolumab|nivolumab|mesh-list
139496270|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139496271|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496272|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139496273|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496274|NCT05474053|Ticagrelor|ticagrelor|mesh-list
139496275|NCT05474053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139496276|NCT05474053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139496277|NCT05474053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139496278|NCT05474053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139496279|NCT05474053|Purinergic Agents|purinergic agents|mesh-ancestor
139496280|NCT05474053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139496281|NCT05474053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496282|NCT05474053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496283|NCT05473819|Anesthetics|anesthetics|mesh-list
139496284|NCT05473819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139496285|NCT05473819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496286|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
139496287|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
139496288|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496289|NCT04762771|Colchicine|colchicine|mesh-list
139496290|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
139496291|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139496292|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
139496293|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
139496294|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
139496295|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496296|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496297|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139496298|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139496299|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139496300|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139496301|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496302|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
139496303|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139496304|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496305|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496306|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139496307|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139496308|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496309|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
139496310|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139496311|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
139496312|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139496313|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
139496314|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496315|NCT04481035|Expectorants|expectorants|mesh-ancestor
139496316|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
139496317|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139496318|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
139496319|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496320|NCT04481035|Protective Agents|protective agents|mesh-ancestor
139496321|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496322|NCT04481035|Antidotes|antidotes|mesh-ancestor
139496323|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
139496324|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139496325|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
139496326|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496327|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
139496328|NCT03032107|Trastuzumab|trastuzumab|mesh-list
139496329|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139496330|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139496331|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496332|NCT03032107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139496333|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496334|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
139496335|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
139496336|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
139496337|NCT03032107|Immunotoxins|immunotoxins|mesh-ancestor
139496338|NCT03032107|Immunoconjugates|immunoconjugates|mesh-ancestor
139496339|NCT03032107|Immunologic Factors|immunologic factors|mesh-ancestor
139496340|NCT03032107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496341|NCT05388175|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139496342|NCT05388175|Respiratory System Agents|respiratory system agents|mesh-ancestor
139496343|NCT05700955|Pembrolizumab|pembrolizumab|mesh-list
139496344|NCT05700955|Temozolomide|temozolomide|mesh-list
139496345|NCT05700955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139496346|NCT05700955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496347|NCT05700955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139496348|NCT05700955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496349|NCT05700955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139496350|NCT05700955|Alkylating Agents|alkylating agents|mesh-ancestor
139496351|NCT01650519|Ibuprofen|ibuprofen|mesh-list
139496352|NCT01650519|Ketorolac|ketorolac|mesh-list
139496353|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139496354|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139496355|NCT01650519|Analgesics|analgesics|mesh-ancestor
139496356|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
139496357|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496358|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496359|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139496360|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139496361|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139496362|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496363|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496364|NCT02197039|Esomeprazole|esomeprazole|mesh-list
139496365|NCT02197039|Pantoprazole|pantoprazole|mesh-list
139496366|NCT02197039|Hemostatics|hemostatics|mesh-list
139496367|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139496368|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139496369|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139496370|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496371|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496372|NCT02197039|Coagulants|coagulants|mesh-ancestor
139496373|NCT05557903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139496374|NCT05557903|Alemtuzumab|alemtuzumab|mesh-list
139496375|NCT05557903|Antibodies|antibodies|mesh-list
139496376|NCT05557903|Immunoglobulins|immunoglobulins|mesh-list
139496377|NCT05557903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139496378|NCT05557903|Immunologic Factors|immunologic factors|mesh-ancestor
139496379|NCT05557903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496380|NCT05557903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496381|NCT02386839|Mecasermin|mecasermin|mesh-list
139496382|NCT02386839|Growth Substances|growth substances|mesh-ancestor
139496383|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496384|NCT05347459|Dapagliflozin|dapagliflozin|mesh-list
139496385|NCT05347459|Empagliflozin|empagliflozin|mesh-list
139496386|NCT05347459|Canagliflozin|canagliflozin|mesh-list
139496387|NCT05347459|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139496388|NCT05347459|Linagliptin|linagliptin|mesh-list
139496389|NCT05347459|Vildagliptin|vildagliptin|mesh-list
139496390|NCT05347459|Saxagliptin|saxagliptin|mesh-list
139496391|NCT05347459|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139496392|NCT05347459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496393|NCT05347459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139496394|NCT05347459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496395|NCT05347459|Incretins|incretins|mesh-ancestor
139496396|NCT05347459|Hormones|hormones|mesh-ancestor
139496397|NCT05347459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139496398|NCT05347459|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139496399|NCT05347459|Protease Inhibitors|protease inhibitors|mesh-ancestor
139496400|NCT05347459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496401|NCT05346445|Fluoxetine|fluoxetine|mesh-list
139496402|NCT05346445|Citalopram|citalopram|mesh-list
139496403|NCT05346445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139496404|NCT05346445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139496405|NCT05346445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139496406|NCT05346445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496407|NCT05346445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139496408|NCT05346445|Serotonin Agents|serotonin agents|mesh-ancestor
139496409|NCT05346445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496410|NCT05346445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139496411|NCT05346445|Antidepressive Agents|antidepressive agents|mesh-ancestor
139496412|NCT05346445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139496413|NCT05346445|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139496414|NCT05346445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139496415|NCT05346445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496416|NCT01649271|Trastuzumab|trastuzumab|mesh-list
139496417|NCT01649271|Afatinib|afatinib|mesh-list
139496418|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139496419|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496420|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139496421|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496422|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496423|NCT02385669|Ipilimumab|ipilimumab|mesh-list
139496424|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139496425|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864228|NCT04216550|Apatinib|apatinib|mesh-list
139496426|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139496427|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496428|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
139496429|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139496430|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139496431|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496432|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
139496433|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
139496434|NCT02400333|Ticagrelor|ticagrelor|mesh-list
139496435|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139496436|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139496437|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139496438|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139496439|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
139496440|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139496441|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496442|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496443|NCT02399475|Hormones|hormones|mesh-list
139496444|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
139496445|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139496446|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496447|NCT02399163|Fluorides|fluorides|mesh-list
139496448|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
139496449|NCT02399163|Protective Agents|protective agents|mesh-ancestor
139496450|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496451|NCT02397837|Pramipexole|pramipexole|mesh-list
139496452|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
139496453|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496454|NCT02397837|Protective Agents|protective agents|mesh-ancestor
139496455|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496456|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139496457|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139496458|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
139496459|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
139496460|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139496461|NCT05549167|Sirolimus|sirolimus|mesh-list
139496462|NCT05549167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139496463|NCT05549167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496464|NCT05549167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139496465|NCT05549167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864264|NCT00911807|Donepezil|donepezil|mesh-list
139496466|NCT05549167|Antifungal Agents|antifungal agents|mesh-ancestor
139496467|NCT05549167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139496468|NCT05549167|Immunologic Factors|immunologic factors|mesh-ancestor
139496469|NCT05549167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496470|NCT05548465|Sufentanil|sufentanil|mesh-list
139496471|NCT05548465|Remifentanil|remifentanil|mesh-list
139496472|NCT05548465|Dsuvia|dsuvia|mesh-list
139496473|NCT05548465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139496474|NCT05548465|Narcotics|narcotics|mesh-ancestor
139496475|NCT05548465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139496476|NCT05548465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496477|NCT05548465|Analgesics|analgesics|mesh-ancestor
139496478|NCT05548465|Sensory System Agents|sensory system agents|mesh-ancestor
139496479|NCT05548465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496480|NCT05548465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139496481|NCT05548465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139496482|NCT05548465|Anesthetics, General|anesthetics, general|mesh-ancestor
139496483|NCT05548465|Anesthetics|anesthetics|mesh-ancestor
139496484|NCT05554003|Temozolomide|temozolomide|mesh-list
139496485|NCT05554003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139496486|NCT05554003|Alkylating Agents|alkylating agents|mesh-ancestor
139496487|NCT05554003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496488|NCT05554003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496489|NCT05541757|Heparin|heparin|mesh-list
139496490|NCT05541757|Anticoagulants|anticoagulants|mesh-ancestor
139496491|NCT05541757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139496492|NCT05541757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139496493|NCT05541757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496494|NCT05700565|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139496495|NCT05700565|Immunomodulating Agents|immunomodulating agents|mesh-list
139496496|NCT05700565|Immunologic Factors|immunologic factors|mesh-ancestor
139496497|NCT05700565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496498|NCT05541445|Pembrolizumab|pembrolizumab|mesh-list
139496499|NCT05541445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139496500|NCT05541445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496501|NCT05541445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139496502|NCT05541445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496503|NCT05540977|Donepezil|donepezil|mesh-list
139496504|NCT05540977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139496505|NCT05540977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496506|NCT05540977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496507|NCT05540977|Cholinergic Agents|cholinergic agents|mesh-ancestor
139496508|NCT05540977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139496509|NCT05540977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496510|NCT05540977|Nootropic Agents|nootropic agents|mesh-ancestor
139496511|NCT05547685|Methylene Blue|methylene blue|mesh-list
139496512|NCT05547685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496513|NCT05547685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496514|NCT05540587|Warfarin|warfarin|mesh-list
139496515|NCT05540587|Edoxaban|edoxaban|mesh-list
139496516|NCT05540587|Anticoagulants|anticoagulants|mesh-ancestor
139496517|NCT05540587|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139496518|NCT05540587|Antithrombins|antithrombins|mesh-ancestor
139496519|NCT05540587|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139496520|NCT05540587|Protease Inhibitors|protease inhibitors|mesh-ancestor
139496521|NCT05540587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496522|NCT05540587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496523|NCT05540431|Charcoal|charcoal|mesh-list
139496524|NCT05540431|Antidotes|antidotes|mesh-ancestor
139496525|NCT05540431|Protective Agents|protective agents|mesh-ancestor
139496526|NCT05540431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496527|NCT05553067|Antibodies|antibodies|mesh-list
139496528|NCT05553067|Immunologic Factors|immunologic factors|mesh-ancestor
139496529|NCT05553067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496530|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
139496531|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139496532|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139496533|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139496534|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139496535|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496536|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
139496537|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139496538|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496539|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139496540|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496541|NCT01666951|Tacrolimus|tacrolimus|mesh-list
139496542|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139496543|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
139496544|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496545|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139496546|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496547|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496548|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139496549|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
139496550|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496551|NCT05550415|Simvastatin|simvastatin|mesh-list
139496552|NCT05550415|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139496553|NCT05550415|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139496554|NCT05550415|Antimetabolites|antimetabolites|mesh-ancestor
139496555|NCT05550415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496556|NCT05550415|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139496557|NCT05550415|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139496558|NCT05550415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496559|NCT05550025|Apatinib|apatinib|mesh-list
139496560|NCT05550025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496561|NCT05550025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139496562|NCT05550025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496563|NCT05550025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496564|NCT05700253|Hyaluronic Acid|hyaluronic acid|mesh-list
139496565|NCT05700253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139496566|NCT05700253|Immunologic Factors|immunologic factors|mesh-ancestor
139496567|NCT05700253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496568|NCT05700253|Viscosupplements|viscosupplements|mesh-ancestor
139496569|NCT05700253|Protective Agents|protective agents|mesh-ancestor
139496570|NCT05544253|Mitomycins|mitomycins|mesh-list
139496571|NCT05544253|Mitomycin|mitomycin|mesh-list
139496572|NCT05544253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139496573|NCT05544253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496574|NCT05544253|Alkylating Agents|alkylating agents|mesh-ancestor
139496575|NCT05544253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496576|NCT05544253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139496577|NCT05544253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496578|NCT05535517|Emollients|emollients|mesh-list
139496579|NCT05535517|Dermatologic Agents|dermatologic agents|mesh-ancestor
139496580|NCT05543941|Povidone-Iodine|povidone-iodine|mesh-list
139496581|NCT05543941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139496582|NCT05543941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496583|NCT02580877|Insulin|insulin|mesh-list
139496584|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139496585|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
139496586|NCT02580877|Methamphetamine|methamphetamine|mesh-list
139496587|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138864355|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139496588|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496589|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139496590|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
139496591|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
139496592|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496593|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
139496594|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139496595|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496596|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
139496597|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139496598|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139496599|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139496600|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139496601|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
139496602|NCT01905631|Promethazine|promethazine|mesh-list
139496603|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139496604|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139496605|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139496606|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496607|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
139496608|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
139496609|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
139496610|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496611|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
139496612|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
139496613|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139496614|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139496615|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
139496616|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
139283284|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
139496617|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139496618|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496619|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139496620|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
139496621|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
139496622|NCT05679037|Thioctic Acid|thioctic acid|mesh-list
139496623|NCT05679037|Antioxidants|antioxidants|mesh-ancestor
139496624|NCT05679037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496625|NCT05679037|Protective Agents|protective agents|mesh-ancestor
139496626|NCT05679037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496627|NCT05679037|Vitamin B Complex|vitamin b complex|mesh-ancestor
139496628|NCT05679037|Vitamins|vitamins|mesh-ancestor
139496629|NCT05679037|Micronutrients|micronutrients|mesh-ancestor
139496630|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
139496631|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139496632|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139496633|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496634|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139496635|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139496636|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
139496637|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496638|NCT02582749|Bicalutamide|bicalutamide|mesh-list
139496639|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139496640|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
139496641|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
139496642|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139496643|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496644|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496645|NCT05461261|Prednisolone|prednisolone|mesh-list
139496646|NCT05461261|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139496647|NCT05461261|Methylprednisolone|methylprednisolone|mesh-list
139496648|NCT05461261|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139496649|NCT05461261|Prednisolone acetate|prednisolone acetate|mesh-list
139496650|NCT05461261|Docetaxel|docetaxel|mesh-list
139496651|NCT05461261|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139496652|NCT05461261|Prednisolone phosphate|prednisolone phosphate|mesh-list
139496653|NCT05461261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496654|NCT05461261|Tubulin Modulators|tubulin modulators|mesh-ancestor
139496655|NCT05461261|Antimitotic Agents|antimitotic agents|mesh-ancestor
139496656|NCT05461261|Mitosis Modulators|mitosis modulators|mesh-ancestor
139496657|NCT05461261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496658|NCT05461261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139496659|NCT05461261|Glucocorticoids|glucocorticoids|mesh-ancestor
139496660|NCT05461261|Hormones|hormones|mesh-ancestor
139496661|NCT05461261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139496662|NCT05461261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496663|NCT05461261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139496664|NCT05461261|Antiemetics|antiemetics|mesh-ancestor
139496665|NCT05461261|Autonomic Agents|autonomic agents|mesh-ancestor
139496666|NCT05461261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496667|NCT05461261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139496668|NCT05461261|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139496669|NCT05461261|Protective Agents|protective agents|mesh-ancestor
139496670|NCT05678413|Paclitaxel|paclitaxel|mesh-list
139496671|NCT05678413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139496672|NCT05678413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496673|NCT05678413|Tubulin Modulators|tubulin modulators|mesh-ancestor
139496674|NCT05678413|Antimitotic Agents|antimitotic agents|mesh-ancestor
139496675|NCT05678413|Mitosis Modulators|mitosis modulators|mesh-ancestor
139496676|NCT05678413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496677|NCT05678335|Hydroxychloroquine|hydroxychloroquine|mesh-list
139496678|NCT05678335|Tacrolimus|tacrolimus|mesh-list
139496679|NCT05678335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139496680|NCT05678335|Immunologic Factors|immunologic factors|mesh-ancestor
139496681|NCT05678335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496682|NCT05678335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139496683|NCT05678335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496684|NCT05678335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496685|NCT05678335|Antimalarials|antimalarials|mesh-ancestor
139496686|NCT05678335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139496687|NCT05678335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139496688|NCT05678335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496689|NCT05678335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139496690|NCT02582671|Ritonavir|ritonavir|mesh-list
139496691|NCT02582671|Ribavirin|ribavirin|mesh-list
139496692|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139496693|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139496694|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
139496695|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496696|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496698|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139496699|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
139496700|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496701|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139496702|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139496703|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
139496704|NCT02585713|Dalteparin|dalteparin|mesh-list
139496705|NCT02585713|Tinzaparin|tinzaparin|mesh-list
139496706|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139496707|NCT02585713|Apixaban|apixaban|mesh-list
139496708|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139496709|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
139496710|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139496711|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
139496712|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496713|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496714|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
139496715|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139496716|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139496717|NCT05078671|Cobicistat|cobicistat|mesh-list
139496718|NCT05078671|Olaparib|olaparib|mesh-list
139496719|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139496720|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496721|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496722|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496723|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138864457|NCT02741024|Amodiaquine|amodiaquine|mesh-list
139496724|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139496725|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
139496726|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496727|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139496728|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139496729|NCT02579863|Dexamethasone|dexamethasone|mesh-list
139496730|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
139496731|NCT02579863|Lenalidomide|lenalidomide|mesh-list
139496732|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139496733|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
139496734|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
139496735|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496736|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496737|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139496738|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
139496739|NCT02579863|Hormones|hormones|mesh-ancestor
139496740|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139496741|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139496742|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496743|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139496744|NCT02579863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139496745|NCT02579863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496746|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
139496747|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139496748|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139496749|NCT02579863|Growth Substances|growth substances|mesh-ancestor
139496750|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
139496751|NCT05677945|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139496752|NCT05677945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139496753|NCT05677945|Simvastatin|simvastatin|mesh-list
139496754|NCT05677945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496755|NCT05677945|Antitubercular Agents|antitubercular agents|mesh-ancestor
139496756|NCT05677945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139496757|NCT05677945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139496758|NCT05677945|Antimetabolites|antimetabolites|mesh-ancestor
139496759|NCT05677945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496760|NCT05677945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139496761|NCT05677945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139496762|NCT05677945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496763|NCT02582515|Cycloserine|cycloserine|mesh-list
139496764|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139496765|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496766|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139496767|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
139496768|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139496769|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
139496770|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496771|NCT02579629|Ropivacaine|ropivacaine|mesh-list
139496772|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
139496773|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
139496774|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139496775|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496776|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
139496777|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496778|NCT05677555|Colchicine|colchicine|mesh-list
139496779|NCT05677555|Gout Suppressants|gout suppressants|mesh-ancestor
139496780|NCT05677555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139496781|NCT05677555|Tubulin Modulators|tubulin modulators|mesh-ancestor
139496782|NCT05677555|Antimitotic Agents|antimitotic agents|mesh-ancestor
139496783|NCT05677555|Mitosis Modulators|mitosis modulators|mesh-ancestor
139496784|NCT05677555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496785|NCT05677555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496786|NCT02343939|Cytarabine|cytarabine|mesh-list
139496787|NCT02343939|Azacitidine|azacitidine|mesh-list
139496788|NCT02343939|Decitabine|decitabine|mesh-list
139496789|NCT02343939|Daunorubicin|daunorubicin|mesh-list
139496790|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139496791|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
139496792|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496793|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496794|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
139496795|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496796|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139496797|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
139496798|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496799|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496800|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139496801|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139496802|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139496803|NCT02343549|Bevacizumab|bevacizumab|mesh-list
139496804|NCT02343549|Temozolomide|temozolomide|mesh-list
139496805|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139496806|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496807|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139496808|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139496809|NCT02343549|Growth Substances|growth substances|mesh-ancestor
139496810|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496811|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
139496812|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139496813|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
139496814|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496815|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139496816|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
139496817|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139496818|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
139496819|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496820|NCT02395653|Fentanyl|fentanyl|mesh-list
139496821|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139496822|NCT02395653|Narcotics|narcotics|mesh-ancestor
139496823|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139496824|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496825|NCT02395653|Analgesics|analgesics|mesh-ancestor
139496826|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
139496827|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496828|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139496829|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139496830|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
139496831|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
139496832|NCT01664923|Bicalutamide|bicalutamide|mesh-list
139496833|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
139496834|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
139496835|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139496836|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496837|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496838|NCT04403347|Losartan|losartan|mesh-list
139496839|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
139496840|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139496841|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138864560|NCT02690987|Incretins|incretins|mesh-ancestor
139496842|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139496843|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496844|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139496845|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496846|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139496847|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496848|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496849|NCT05673655|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139496850|NCT05673655|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139496851|NCT05673655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139496852|NCT05673655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496853|NCT05673655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496854|NCT05673655|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139496855|NCT05673655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139496856|NCT05673655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496857|NCT05673655|Cholinergic Agents|cholinergic agents|mesh-ancestor
139496858|NCT05673655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139496859|NCT05692297|Denosumab|denosumab|mesh-list
139496860|NCT05692297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139496861|NCT05692297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496862|NCT05696509|Anesthetics|anesthetics|mesh-list
139496863|NCT05696509|Propofol|propofol|mesh-list
139496864|NCT05696509|Sevoflurane|sevoflurane|mesh-list
139496865|NCT05696509|Isoflurane|isoflurane|mesh-list
139496866|NCT05696509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139496867|NCT05696509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496868|NCT05696509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139496869|NCT05696509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139496870|NCT05696509|Anesthetics, General|anesthetics, general|mesh-ancestor
139496871|NCT05696509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139496872|NCT05696509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139496873|NCT02584855|Ixekizumab|ixekizumab|mesh-list
139496874|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
139496875|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
139496876|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
139496877|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139496878|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139496879|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864605|NCT04247867|Psyllium|psyllium|mesh-list
139496880|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496881|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496882|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139496883|NCT02581345|Adalimumab|adalimumab|mesh-list
139496884|NCT02581345|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139496885|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139496886|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139496887|NCT05579509|Midazolam|midazolam|mesh-list
139496888|NCT05579509|Fentanyl|fentanyl|mesh-list
139496889|NCT05579509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139496890|NCT05579509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139496891|NCT05579509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139496892|NCT05579509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496893|NCT05579509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139496894|NCT05579509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139496895|NCT05579509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139496896|NCT05579509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139496897|NCT05579509|Anesthetics, General|anesthetics, general|mesh-ancestor
139496898|NCT05579509|Anesthetics|anesthetics|mesh-ancestor
139496899|NCT05579509|GABA Modulators|gaba modulators|mesh-ancestor
139496900|NCT05579509|GABA Agents|gaba agents|mesh-ancestor
139496901|NCT05579509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139496902|NCT05579509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496903|NCT05579509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139496904|NCT05579509|Narcotics|narcotics|mesh-ancestor
139496905|NCT05579509|Analgesics|analgesics|mesh-ancestor
139496906|NCT05579509|Sensory System Agents|sensory system agents|mesh-ancestor
139496907|NCT05579509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496908|NCT05696431|Fluorides|fluorides|mesh-list
139496909|NCT05696431|Cariostatic Agents|cariostatic agents|mesh-ancestor
139496910|NCT05696431|Protective Agents|protective agents|mesh-ancestor
139496911|NCT05696431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496912|NCT05575219|Clonidine|clonidine|mesh-list
139496913|NCT05575219|Analgesics|analgesics|mesh-ancestor
139496914|NCT05575219|Sensory System Agents|sensory system agents|mesh-ancestor
139496915|NCT05575219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496916|NCT05575219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496917|NCT05575219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139496918|NCT05575219|Sympatholytics|sympatholytics|mesh-ancestor
139496919|NCT05575219|Autonomic Agents|autonomic agents|mesh-ancestor
139496920|NCT05575219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139496921|NCT05575219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139496922|NCT05575219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139496923|NCT05575219|Adrenergic Agents|adrenergic agents|mesh-ancestor
139496924|NCT05575219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139496925|NCT05575219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496926|NCT05568745|Misoprostol|misoprostol|mesh-list
139496927|NCT05568745|Oxytocin|oxytocin|mesh-list
139496928|NCT05568745|Oxytocics|oxytocics|mesh-ancestor
139496929|NCT05568745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139496930|NCT05568745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496931|NCT05568745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139496932|NCT05568745|Abortifacient Agents|abortifacient agents|mesh-ancestor
139496933|NCT05568745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139496934|NCT05568745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139496935|NCT02581189|Ritonavir|ritonavir|mesh-list
139496936|NCT02581189|Ribavirin|ribavirin|mesh-list
139496937|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139496938|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139496939|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
139496940|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496941|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496942|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139496943|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139496944|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
139496945|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496946|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139496947|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139496948|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
139496949|NCT05569681|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139496950|NCT05569681|Bemiparin|bemiparin|mesh-list
139496951|NCT05569681|Anticoagulants|anticoagulants|mesh-ancestor
139496952|NCT05569681|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139496953|NCT05569681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138864669|NCT03695510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139496954|NCT05569681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496955|NCT02576977|Dexamethasone|dexamethasone|mesh-list
139496956|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
139496957|NCT02576977|Pomalidomide|pomalidomide|mesh-list
139496958|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139496959|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
139496960|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
139496961|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139496962|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496963|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139496964|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
139496965|NCT02576977|Hormones|hormones|mesh-ancestor
139496966|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139496967|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139496968|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139496969|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139496970|NCT02576977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139496971|NCT02576977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496972|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
139496973|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139496974|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139496975|NCT02576977|Growth Substances|growth substances|mesh-ancestor
139496976|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
139496977|NCT05867212|Cabotegravir|cabotegravir|mesh-list
139496978|NCT05867212|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139496979|NCT05867212|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139496980|NCT05867212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496981|NCT05867212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496982|NCT05867212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139496983|NCT05867212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139496984|NCT05867212|Antiviral Agents|antiviral agents|mesh-ancestor
139496985|NCT05867212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139496986|NCT05866848|Caffeine|caffeine|mesh-list
139496987|NCT05866848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139496988|NCT05866848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496989|NCT05866848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139496990|NCT05866848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139496991|NCT05866848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139496992|NCT05866848|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139496993|NCT05866848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139496994|NCT05866848|Purinergic Agents|purinergic agents|mesh-ancestor
139283667|NCT03608241|Estradiol|estradiol|mesh-list
139496995|NCT05866848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139496997|NCT05866614|Immunologic Factors|immunologic factors|mesh-ancestor
139496998|NCT05866614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139496999|NCT05866588|Coal Tar|coal tar|mesh-list
139497000|NCT05866588|Keratolytic Agents|keratolytic agents|mesh-ancestor
139497001|NCT05866588|Dermatologic Agents|dermatologic agents|mesh-ancestor
139497002|NCT05866575|Vortioxetine|vortioxetine|mesh-list
139497003|NCT05866575|Escitalopram|escitalopram|mesh-list
139497004|NCT05866575|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139497005|NCT05866575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139497006|NCT05866575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139497007|NCT05866575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497008|NCT05866575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497009|NCT05866575|Serotonin Agents|serotonin agents|mesh-ancestor
139497010|NCT05866575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497011|NCT05866575|Antidepressive Agents|antidepressive agents|mesh-ancestor
139497012|NCT05866575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139497013|NCT05866575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139497014|NCT05866575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139497015|NCT05866575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139497016|NCT05866575|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139497017|NCT05866575|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139497018|NCT05866575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139497019|NCT05866575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139497020|NCT05866172|Zoledronic Acid|zoledronic acid|mesh-list
139497021|NCT05866172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139497022|NCT05866172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497023|NCT05866068|Clomiphene|clomiphene|mesh-list
139497024|NCT05866068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139497025|NCT05866068|Hormone Antagonists|hormone antagonists|mesh-ancestor
139497026|NCT05866068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139497027|NCT05866068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497028|NCT05866068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139497029|NCT05866068|Fertility Agents|fertility agents|mesh-ancestor
139497030|NCT05866068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139497031|NCT05866068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139497032|NCT05866068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139497033|NCT05865925|Irinotecan|irinotecan|mesh-list
139497034|NCT05865925|Floxuridine|floxuridine|mesh-list
139497035|NCT05865925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139497036|NCT05865925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139497037|NCT05865925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497038|NCT05865925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497039|NCT05865925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497040|NCT05865925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139497041|NCT05865925|Antimetabolites|antimetabolites|mesh-ancestor
139497042|NCT05865548|Aspirin|aspirin|mesh-list
139497043|NCT05865548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139497044|NCT05865548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139497045|NCT05865548|Analgesics|analgesics|mesh-ancestor
139497046|NCT05865548|Sensory System Agents|sensory system agents|mesh-ancestor
139497047|NCT05865548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497048|NCT05865548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864796|NCT02728934|Infliximab|infliximab|mesh-list
139497049|NCT05865548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139497050|NCT05865548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139497051|NCT05865548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139497052|NCT05865548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139497053|NCT05865548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497054|NCT05865548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139497055|NCT05865548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139497056|NCT05865548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497057|NCT05865548|Antipyretics|antipyretics|mesh-ancestor
139497058|NCT05861440|Antitubercular Agents|antitubercular agents|mesh-list
139497059|NCT05861440|Prednisolone|prednisolone|mesh-list
139497060|NCT05861440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139497061|NCT05861440|Glucocorticoids|glucocorticoids|mesh-ancestor
139497062|NCT05861440|Hormones|hormones|mesh-ancestor
139497063|NCT05861440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139497064|NCT05861440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497065|NCT05861440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139497066|NCT05861440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497067|NCT05861440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139283732|NCT03607071|Hormones|hormones|mesh-ancestor
139497068|NCT05861440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139497069|NCT05866029|Denosumab|denosumab|mesh-list
139497070|NCT05866029|Teriparatide|teriparatide|mesh-list
139497071|NCT05866029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139497072|NCT05866029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497073|NCT05866029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139497074|NCT05740618|Mannitol|mannitol|mesh-list
139497075|NCT05740618|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139497076|NCT05740618|Diuretics|diuretics|mesh-ancestor
139497077|NCT05740618|Natriuretic Agents|natriuretic agents|mesh-ancestor
139497078|NCT05740618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497079|NCT05677295|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139497080|NCT05677295|Imipramine|imipramine|mesh-list
139497081|NCT05677295|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139497082|NCT05677295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138864842|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
139497083|NCT05677295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139497084|NCT05677295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497085|NCT05677295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497086|NCT05677295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497087|NCT05677295|Analgesics|analgesics|mesh-ancestor
139497088|NCT05677295|Sensory System Agents|sensory system agents|mesh-ancestor
139497089|NCT05677295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497090|NCT05677295|Antidepressive Agents|antidepressive agents|mesh-ancestor
139497091|NCT05677295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139497092|NCT05677295|Dopamine Agents|dopamine agents|mesh-ancestor
139497093|NCT05677295|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139497094|NCT05677295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139497095|NCT05677295|Adrenergic Agents|adrenergic agents|mesh-ancestor
139497096|NCT05664750|Immunoglobulins|immunoglobulins|mesh-list
139497097|NCT05664750|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139497098|NCT05664750|Antibodies|antibodies|mesh-list
139497099|NCT05664750|Immunologic Factors|immunologic factors|mesh-ancestor
139497100|NCT05664750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497101|NCT05476991|Aspirin|aspirin|mesh-list
139497102|NCT05476991|Colchicine|colchicine|mesh-list
139497103|NCT05476991|Ticagrelor|ticagrelor|mesh-list
139497104|NCT05476991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139497105|NCT05476991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139497106|NCT05476991|Analgesics|analgesics|mesh-ancestor
139497107|NCT05476991|Sensory System Agents|sensory system agents|mesh-ancestor
139497108|NCT05476991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497109|NCT05476991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497110|NCT05476991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139497111|NCT05476991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139497112|NCT05476991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139497113|NCT05476991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139497114|NCT05476991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497115|NCT05476991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139497116|NCT05476991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139497117|NCT05476991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497118|NCT05476991|Antipyretics|antipyretics|mesh-ancestor
139497119|NCT05476991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139497120|NCT05476991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139497121|NCT05476991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139497122|NCT05476991|Purinergic Agents|purinergic agents|mesh-ancestor
139497123|NCT05476991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497124|NCT05476991|Gout Suppressants|gout suppressants|mesh-ancestor
139497125|NCT05476991|Tubulin Modulators|tubulin modulators|mesh-ancestor
139497126|NCT05476991|Antimitotic Agents|antimitotic agents|mesh-ancestor
139497127|NCT05476991|Mitosis Modulators|mitosis modulators|mesh-ancestor
139497128|NCT05476991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497129|NCT05465226|Analgesics, Opioid|analgesics, opioid|mesh-list
139497130|NCT05465226|Narcotics|narcotics|mesh-ancestor
139497131|NCT05465226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139497132|NCT05465226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497133|NCT05465226|Analgesics|analgesics|mesh-ancestor
139497134|NCT05465226|Sensory System Agents|sensory system agents|mesh-ancestor
139497135|NCT05465226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497136|NCT05382806|Flumazenil|flumazenil|mesh-list
139497137|NCT05382806|Antidotes|antidotes|mesh-ancestor
139497138|NCT05382806|Protective Agents|protective agents|mesh-ancestor
139497139|NCT05382806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497140|NCT05382806|GABA Modulators|gaba modulators|mesh-ancestor
139497141|NCT05382806|GABA Agents|gaba agents|mesh-ancestor
139497142|NCT05382806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497143|NCT05382806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497145|NCT05379972|Olaparib|olaparib|mesh-list
139497146|NCT05379972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497147|NCT05379972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497148|NCT05379972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139497149|NCT05379972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497150|NCT05379972|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139497151|NCT05379972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497152|NCT05312008|Oxytocin|oxytocin|mesh-list
139497153|NCT05312008|Oxytocics|oxytocics|mesh-ancestor
139497154|NCT05312008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139497155|NCT05312008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497156|NCT05163496|Psilocybin|psilocybin|mesh-list
139497157|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
139497158|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497159|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139497160|NCT05162443|Adagrasib|adagrasib|mesh-list
139497161|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497162|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139497163|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139497164|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139497165|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497166|NCT04952402|Vaccines|vaccines|mesh-list
139497167|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
139497168|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497169|NCT04941144|Vaccines|vaccines|mesh-list
139497170|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
139497171|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497172|NCT04842045|Midazolam|midazolam|mesh-list
139497173|NCT04842045|Psilocybin|psilocybin|mesh-list
139497174|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139497175|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139497176|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864979|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
139497177|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497178|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139497179|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139497180|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139497181|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139497182|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
139497183|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
139497184|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
139497185|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
139497186|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497187|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497188|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
139497189|NCT04754945|Dexamethasone|dexamethasone|mesh-list
139497190|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
139497191|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
139497192|NCT04754945|Bortezomib|bortezomib|mesh-list
139497193|NCT04754945|Ichthammol|ichthammol|mesh-list
139497194|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139497195|NCT04754945|BB 1101|bb 1101|mesh-list
139497196|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139497197|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
139497198|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497199|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139497200|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139497201|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
139497202|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497203|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497204|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139497205|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139497206|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
139497207|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
139497208|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497209|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139497210|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
139497211|NCT04754945|Hormones|hormones|mesh-ancestor
139497212|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139497213|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139497214|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
139497215|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497216|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
139497217|NCT04580498|Paclitaxel|paclitaxel|mesh-list
139497218|NCT04580498|Carboplatin|carboplatin|mesh-list
139497219|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139497220|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497221|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
139497222|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
139497223|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
139497224|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497225|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139497226|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139497227|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497228|NCT04428385|Artemisinins|artemisinins|mesh-list
139497229|NCT04428385|Artemisinin|artemisinin|mesh-list
139497230|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
139497231|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139497232|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139497233|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139497234|NCT04074161|Liraglutide|liraglutide|mesh-list
139497235|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139497236|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497237|NCT04074161|Incretins|incretins|mesh-ancestor
139497239|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139497240|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
139497241|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497242|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139497243|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497244|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497245|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
139497246|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
139497247|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139497248|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
139497249|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497250|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139497251|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139497252|NCT03843528|Azacitidine|azacitidine|mesh-list
139497253|NCT03843528|Vorinostat|vorinostat|mesh-list
139497254|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139497255|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
139497256|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497257|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497258|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497259|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139497260|NCT03779789|Vortioxetine|vortioxetine|mesh-list
139497261|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
139497262|NCT03779789|Citalopram|citalopram|mesh-list
139497263|NCT03779789|Fluoxetine|fluoxetine|mesh-list
139497264|NCT03779789|Paroxetine|paroxetine|mesh-list
139497265|NCT03779789|Sertraline|sertraline|mesh-list
139497266|NCT03779789|Escitalopram|escitalopram|mesh-list
139497267|NCT03779789|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139497268|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139497269|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139497270|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497271|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497272|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
139497273|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497274|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139497275|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
139497276|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139497277|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139497278|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139497279|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497280|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139497281|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139497282|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139497283|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139497284|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139497285|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139497286|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139497287|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139497288|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139497289|NCT03733210|Panitumumab|panitumumab|mesh-list
139497290|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497291|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497292|NCT03733132|Metformin|metformin|mesh-list
139497293|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139497294|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497295|NCT03667820|Osimertinib|osimertinib|mesh-list
139497297|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139497298|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497299|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497300|NCT03627468|Bromides|bromides|mesh-list
139497301|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
139497302|NCT03613116|Vitamin D|vitamin d|mesh-list
139497303|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
139497304|NCT03613116|Vitamins|vitamins|mesh-ancestor
139497305|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
139497306|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497307|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139497308|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139497309|NCT03588039|Paclitaxel|paclitaxel|mesh-list
139497310|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
139497311|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139497312|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497313|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
139497314|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
139497315|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
139497316|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497317|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497318|NCT03588039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139497319|NCT03553004|Niraparib|niraparib|mesh-list
139497320|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139497321|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497322|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497323|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497324|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
139497325|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497326|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497327|NCT03488667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139497328|NCT03488667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497329|NCT03406247|Nivolumab|nivolumab|mesh-list
139497330|NCT03406247|Ipilimumab|ipilimumab|mesh-list
139497331|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497332|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497333|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139497334|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497335|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139497336|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
139497337|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497338|NCT03317535|Anesthetics|anesthetics|mesh-list
139497339|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139497340|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497341|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
139497342|NCT03313206|Lenvatinib|lenvatinib|mesh-list
139497343|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497344|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497345|NCT03313206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139497346|NCT03313206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497347|NCT03313206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139497348|NCT03313206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497349|NCT03250377|Brivaracetam|brivaracetam|mesh-list
139497350|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
139497351|NCT03052816|Hydromorphone|hydromorphone|mesh-list
139497352|NCT03052816|Analgesics|analgesics|mesh-ancestor
139497353|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
139497354|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497355|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497356|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139497357|NCT03052816|Narcotics|narcotics|mesh-ancestor
139497358|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139497359|NCT02955940|Capecitabine|capecitabine|mesh-list
139497360|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139497361|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
139497362|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497363|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497364|NCT02393625|Nivolumab|nivolumab|mesh-list
139497365|NCT02393625|Ceritinib|ceritinib|mesh-list
139497366|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497367|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497368|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139284031|NCT02163954|Clopidogrel|clopidogrel|mesh-list
139497369|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497370|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139497371|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497372|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139497373|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
139497374|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497375|NCT02168829|Aspirin|aspirin|mesh-list
139497376|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
139497377|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139497378|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139497379|NCT02168829|Analgesics|analgesics|mesh-ancestor
139497380|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
139497381|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497382|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497383|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139497384|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139497385|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139497386|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139497387|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497388|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139497389|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139497390|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497391|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
139497392|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139497393|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
139497394|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139497395|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
139497396|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
139497397|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139497398|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
139497399|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497400|NCT01433289|Protective Agents|protective agents|mesh-ancestor
139497401|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497402|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139497403|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139497404|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497405|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139497406|NCT00995475|Fluticasone|fluticasone|mesh-list
139497407|NCT00995475|Xhance|xhance|mesh-list
139497408|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139497409|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139497410|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
139497411|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497412|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497413|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139497414|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
139497415|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
139497416|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139497417|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
139497418|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139497419|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
139497420|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497421|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497422|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139497423|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
139497424|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139497425|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
139497426|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497427|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497428|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139497429|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
139497430|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
139497431|NCT00945529|Protective Agents|protective agents|mesh-ancestor
139497432|NCT00921115|Fulvestrant|fulvestrant|mesh-list
139497433|NCT00921115|Anastrozole|anastrozole|mesh-list
139497434|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139497435|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497436|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139497437|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139497438|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
139497439|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139497440|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497441|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139497442|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139284104|NCT02167620|Metformin|metformin|mesh-list
139497443|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497444|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497445|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
139497446|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139497447|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
139497448|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497449|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497450|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139497451|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
139497452|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139497453|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139497454|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139497455|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
139497456|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865237|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139497457|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497458|NCT04425187|Bevacizumab|bevacizumab|mesh-list
139497459|NCT04425187|Gefitinib|gefitinib|mesh-list
139497460|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497461|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497462|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139497463|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139497464|NCT04425187|Growth Substances|growth substances|mesh-ancestor
139497465|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497466|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
139497467|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139497468|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497469|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497470|NCT05519839|Vaccines|vaccines|mesh-list
139497471|NCT05519839|Immunologic Factors|immunologic factors|mesh-ancestor
139497472|NCT05519839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497473|NCT05529667|Paclitaxel|paclitaxel|mesh-list
139497474|NCT05529667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139497475|NCT05529667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497476|NCT05529667|Tubulin Modulators|tubulin modulators|mesh-ancestor
139497477|NCT05529667|Antimitotic Agents|antimitotic agents|mesh-ancestor
139497478|NCT05529667|Mitosis Modulators|mitosis modulators|mesh-ancestor
139497479|NCT05529667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497480|NCT03571633|Paclitaxel|paclitaxel|mesh-list
139497481|NCT03571633|Trastuzumab|trastuzumab|mesh-list
139497482|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139497483|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497484|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
139497485|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
139497486|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
139497487|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497488|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497490|NCT05533255|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139497491|NCT05533255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139497492|NCT05533255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497493|NCT05533255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497494|NCT05533255|Hormone Antagonists|hormone antagonists|mesh-ancestor
139497495|NCT05533255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139497496|NCT05533255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497497|NCT05529355|Tegafur|tegafur|mesh-list
139497498|NCT05529355|Endostar protein|endostar protein|mesh-list
139497499|NCT05529355|Endostatins|endostatins|mesh-list
139497500|NCT05529355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139497501|NCT05529355|Antimetabolites|antimetabolites|mesh-ancestor
139497502|NCT05529355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497503|NCT05529355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497504|NCT05529355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139497505|NCT05529355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139497506|NCT05529355|Growth Substances|growth substances|mesh-ancestor
139497507|NCT05529355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497508|NCT05529355|Growth Inhibitors|growth inhibitors|mesh-ancestor
139497509|NCT05528887|Cyclophosphamide|cyclophosphamide|mesh-list
139497510|NCT05528887|Fludarabine|fludarabine|mesh-list
139497511|NCT05528887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139497512|NCT05528887|Immunologic Factors|immunologic factors|mesh-ancestor
139497513|NCT05528887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497514|NCT05528887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139497515|NCT05528887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139497516|NCT05528887|Alkylating Agents|alkylating agents|mesh-ancestor
139497517|NCT05528887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497518|NCT05528887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497519|NCT05528887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139497520|NCT03009019|Celecoxib|celecoxib|mesh-list
139497521|NCT03009019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139497522|NCT03009019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139497523|NCT03009019|Analgesics|analgesics|mesh-ancestor
139497524|NCT03009019|Sensory System Agents|sensory system agents|mesh-ancestor
139497525|NCT03009019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497526|NCT03009019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497527|NCT03009019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139497528|NCT03009019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139497529|NCT03009019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139497530|NCT03009019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139497531|NCT03009019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497532|NCT03009019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497533|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
139497534|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497535|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497536|NCT02575807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139497537|NCT02575807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497538|NCT02813785|Docetaxel|docetaxel|mesh-list
139497539|NCT02813785|Atezolizumab|atezolizumab|mesh-list
139497540|NCT02813785|Antibodies|antibodies|mesh-list
139497541|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
139497542|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497543|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865317|NCT04189094|Etoposide|etoposide|mesh-list
139497544|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
139497545|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
139497546|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
139497547|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497548|NCT02813785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139497549|NCT02813785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497550|NCT04302181|Ropivacaine|ropivacaine|mesh-list
139497551|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
139497552|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
139497553|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139497554|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497555|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
139497556|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497557|NCT05527795|Oxymetazoline|oxymetazoline|mesh-list
139497558|NCT05527795|Immunomodulating Agents|immunomodulating agents|mesh-list
139497559|NCT05527795|Immunologic Factors|immunologic factors|mesh-ancestor
139497560|NCT05527795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497561|NCT05527795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139497562|NCT05527795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139497563|NCT05527795|Adrenergic Agents|adrenergic agents|mesh-ancestor
139497564|NCT05527795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497565|NCT05527795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497566|NCT05527795|Sympathomimetics|sympathomimetics|mesh-ancestor
139497567|NCT05527795|Autonomic Agents|autonomic agents|mesh-ancestor
139497568|NCT05527795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497569|NCT05527795|Nasal Decongestants|nasal decongestants|mesh-ancestor
139497570|NCT05527795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139497571|NCT05527795|Respiratory System Agents|respiratory system agents|mesh-ancestor
139497572|NCT05532085|Analgesics|analgesics|mesh-list
139497573|NCT05532085|Anesthetics|anesthetics|mesh-list
139497574|NCT05532085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139497575|NCT05532085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497576|NCT05532085|Sensory System Agents|sensory system agents|mesh-ancestor
139497577|NCT05532085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497578|NCT02303119|Rituximab|rituximab|mesh-list
139497579|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497580|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497581|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
139497582|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497583|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139497584|NCT02575339|Sorafenib|sorafenib|mesh-list
139497585|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497586|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139497587|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497588|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284247|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
139497589|NCT01640587|Artesunate|artesunate|mesh-list
139497590|NCT01640587|Piperaquine|piperaquine|mesh-list
139497591|NCT01640587|Artenimol|artenimol|mesh-list
139497592|NCT01640587|Mefloquine|mefloquine|mesh-list
139497593|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
139497594|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139497595|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139497596|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139497597|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497598|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
139497599|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
139497600|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139497601|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
139497602|NCT01610713|Nabiximols|nabiximols|mesh-list
139497603|NCT01610713|Analgesics|analgesics|mesh-ancestor
139497604|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
139497605|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497606|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497607|NCT01606189|Nabiximols|nabiximols|mesh-list
139497608|NCT01606189|Analgesics|analgesics|mesh-ancestor
139497609|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
139497610|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497611|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497612|NCT01663987|Bromides|bromides|mesh-list
139497613|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
139497614|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139497615|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
139497616|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497617|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497618|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139497619|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
139497620|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
139497621|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139497622|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
139497623|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497624|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497625|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
139497626|NCT05305651|Sotrovimab|sotrovimab|mesh-list
139497627|NCT05305651|Antiviral Agents|antiviral agents|mesh-ancestor
139497628|NCT05305651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139497629|NCT02380287|Antibodies|antibodies|mesh-list
139497630|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139497631|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
139497632|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497633|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
139497634|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139497635|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
139497636|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497637|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
139497638|NCT02342223|Protective Agents|protective agents|mesh-ancestor
139497639|NCT02393547|Varenicline|varenicline|mesh-list
139497640|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139497641|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139497642|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
139497643|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865422|NCT00650637|Nelfinavir|nelfinavir|mesh-list
139497644|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497645|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497646|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139497647|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
139497648|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497649|NCT05531383|Memantine|memantine|mesh-list
139497650|NCT05531383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139497651|NCT05531383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139497652|NCT05531383|Dopamine Agents|dopamine agents|mesh-ancestor
139497653|NCT05531383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497654|NCT05531383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497655|NCT05531383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497656|NCT05531383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139497657|NCT05531383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139497658|NCT02392611|Fulvestrant|fulvestrant|mesh-list
139497659|NCT02392611|Exemestane|exemestane|mesh-list
139497660|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139497661|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497662|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139497663|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139497664|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
139497665|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139497666|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497667|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139497668|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139497669|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497670|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497672|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139497673|NCT02378961|Velpatasvir|velpatasvir|mesh-list
139497674|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
139497675|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139497676|NCT05518513|Bupivacaine|bupivacaine|mesh-list
139497677|NCT05518513|Anesthetics, Local|anesthetics, local|mesh-ancestor
139497678|NCT05518513|Anesthetics|anesthetics|mesh-ancestor
139497679|NCT05518513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139497680|NCT05518513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497681|NCT05518513|Sensory System Agents|sensory system agents|mesh-ancestor
139497682|NCT05518513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497683|NCT05518279|Tranexamic Acid|tranexamic acid|mesh-list
139497684|NCT05518279|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139497685|NCT05518279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139497686|NCT05518279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497687|NCT05518279|Hemostatics|hemostatics|mesh-ancestor
139497688|NCT05518279|Coagulants|coagulants|mesh-ancestor
139497689|NCT05523037|Sevoflurane|sevoflurane|mesh-list
139497690|NCT05523037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139497691|NCT05523037|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139497692|NCT05523037|Anesthetics, General|anesthetics, general|mesh-ancestor
139497693|NCT05523037|Anesthetics|anesthetics|mesh-ancestor
139497694|NCT05523037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139497695|NCT05523037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497696|NCT04625647|Sotorasib|sotorasib|mesh-list
139497697|NCT04625647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139497698|NCT04625647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497699|NCT04625647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497700|NCT04625647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497701|NCT05122741|Aspirin|aspirin|mesh-list
139497702|NCT05122741|Clopidogrel|clopidogrel|mesh-list
139497703|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139497704|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139497705|NCT05122741|Analgesics|analgesics|mesh-ancestor
139497706|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
139497707|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497708|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497709|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139497710|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139497711|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139497712|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139497713|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497714|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139497715|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139497716|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497717|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
139497718|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139497719|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139497720|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139497721|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
139497722|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497723|NCT05525767|Bevacizumab|bevacizumab|mesh-list
139497724|NCT05525767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497725|NCT05525767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865496|NCT00910767|Insulin|insulin|mesh-list
139497726|NCT05525767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139497727|NCT05525767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139497728|NCT05525767|Growth Substances|growth substances|mesh-ancestor
139497729|NCT05525767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497730|NCT05525767|Growth Inhibitors|growth inhibitors|mesh-ancestor
139497731|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139497732|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497733|NCT05025085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497734|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497735|NCT05522491|Olaparib|olaparib|mesh-list
139497736|NCT05522491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139497737|NCT05522491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497738|NCT05522491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139284404|NCT06160180|Hormones|hormones|mesh-ancestor
139497739|NCT05522491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497740|NCT02340975|Durvalumab|durvalumab|mesh-list
139497741|NCT02340975|Tremelimumab|tremelimumab|mesh-list
139497742|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139497743|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497744|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497745|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
139497746|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497747|NCT02392377|Leucovorin|leucovorin|mesh-list
139497748|NCT02392377|Paclitaxel|paclitaxel|mesh-list
139497749|NCT02392377|Carboplatin|carboplatin|mesh-list
139497750|NCT02392377|Fluorouracil|fluorouracil|mesh-list
139497751|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
139497752|NCT02392377|Calcium|calcium|mesh-list
139497753|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
139497754|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139497755|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497756|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
139497757|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
139497758|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
139497759|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497760|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139497761|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497762|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
139497763|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139497764|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139497765|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
138865545|NCT02694146|Hylan|hylan|mesh-list
139497766|NCT02392377|Antidotes|antidotes|mesh-ancestor
139497767|NCT02392377|Protective Agents|protective agents|mesh-ancestor
139497768|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
139497769|NCT02392377|Vitamins|vitamins|mesh-ancestor
139497770|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
139497771|NCT02340819|Teduglutide|teduglutide|mesh-list
139497772|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139497773|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139497774|NCT02340819|Protective Agents|protective agents|mesh-ancestor
139497775|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497776|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139497777|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139497778|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497779|NCT04903509|Acetaminophen|acetaminophen|mesh-list
139497780|NCT04903509|Liraglutide|liraglutide|mesh-list
139497781|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139497782|NCT04903509|Analgesics|analgesics|mesh-ancestor
139497783|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
139497784|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497785|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497786|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
139497787|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139497788|NCT04903509|Incretins|incretins|mesh-ancestor
139497789|NCT04903509|Hormones|hormones|mesh-ancestor
139497790|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139497791|NCT05517499|Dexamethasone|dexamethasone|mesh-list
139497792|NCT05517499|Dexamethasone acetate|dexamethasone acetate|mesh-list
139497793|NCT05517499|BB 1101|bb 1101|mesh-list
139497794|NCT05517499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139497795|NCT05517499|Antiemetics|antiemetics|mesh-ancestor
139497796|NCT05517499|Autonomic Agents|autonomic agents|mesh-ancestor
139497797|NCT05517499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497798|NCT05517499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497799|NCT05517499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139497800|NCT05517499|Glucocorticoids|glucocorticoids|mesh-ancestor
139497801|NCT05517499|Hormones|hormones|mesh-ancestor
139497802|NCT05517499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139497803|NCT05517499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139497804|NCT05517499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497805|NCT05517499|Protease Inhibitors|protease inhibitors|mesh-ancestor
139497806|NCT05517499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497807|NCT05517499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497808|NCT05512351|Bevacizumab|bevacizumab|mesh-list
139497809|NCT05512351|Tislelizumab|tislelizumab|mesh-list
139497810|NCT05512351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497811|NCT05512351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497812|NCT05512351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139497813|NCT05512351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139497814|NCT05512351|Growth Substances|growth substances|mesh-ancestor
139497815|NCT05512351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497816|NCT05512351|Growth Inhibitors|growth inhibitors|mesh-ancestor
139497818|NCT02569957|Topotecan|topotecan|mesh-list
139497819|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139497820|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139497821|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139497822|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497823|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497824|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497825|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
139497826|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139497827|NCT02569957|Expectorants|expectorants|mesh-ancestor
139497828|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
139497829|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139497830|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
139497831|NCT02569957|Protective Agents|protective agents|mesh-ancestor
139497832|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497833|NCT02569957|Antidotes|antidotes|mesh-ancestor
139497834|NCT01649427|Tacrolimus|tacrolimus|mesh-list
139497835|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139497836|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
139497837|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497838|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139497839|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497840|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497841|NCT05521633|Metformin|metformin|mesh-list
139497842|NCT05521633|Pioglitazone|pioglitazone|mesh-list
139497843|NCT05521633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139497844|NCT05521633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497845|NCT02336607|Metoprolol|metoprolol|mesh-list
139497846|NCT02336607|Felodipine|felodipine|mesh-list
139497847|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139497848|NCT02336607|Lisinopril|lisinopril|mesh-list
139497849|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139497850|NCT02336607|Diuretics|diuretics|mesh-ancestor
139497851|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
139497852|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497853|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139497854|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139497855|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497856|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139497857|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
139497858|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
139497859|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497860|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139497861|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139497862|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139497863|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
139497864|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497865|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139497866|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
139497867|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497868|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139497869|NCT02336607|Protective Agents|protective agents|mesh-ancestor
139497870|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138865711|NCT02643147|Furosemide|furosemide|mesh-list
139497871|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139497872|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
139497873|NCT02569801|Fulvestrant|fulvestrant|mesh-list
139497874|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139497875|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497876|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139497877|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139497878|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
139497879|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139497880|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497881|NCT02573311|Tamsulosin|tamsulosin|mesh-list
139497882|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139497883|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139497884|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139497885|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
139497886|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497887|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497888|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497889|NCT02573311|Urological Agents|urological agents|mesh-ancestor
139497890|NCT05520853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139497891|NCT05520853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497892|NCT05520853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497894|NCT05516251|Topiramate|topiramate|mesh-list
139497895|NCT05516251|Anticonvulsants|anticonvulsants|mesh-ancestor
139497896|NCT05516251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139497897|NCT05516251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497898|NCT02571049|Sumatriptan|sumatriptan|mesh-list
139497899|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139497900|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139497901|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139497902|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
139497903|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497904|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497905|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497906|NCT04295941|Trazodone|trazodone|mesh-list
139497907|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139497908|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139497909|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139497910|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497911|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139497912|NCT04295941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139497913|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139497914|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139497915|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497916|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497917|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
139497918|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139497919|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
139497920|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
139497921|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139497922|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
139497923|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497924|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497925|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139497926|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
139497927|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
139497928|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139497929|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
139497930|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139497931|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497932|NCT05515471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139497933|NCT05515471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139497934|NCT05515315|Paclitaxel|paclitaxel|mesh-list
139497935|NCT05515315|Tislelizumab|tislelizumab|mesh-list
139497936|NCT05515315|Nedaplatin|nedaplatin|mesh-list
139497937|NCT05515315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139497938|NCT05515315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497939|NCT05515315|Tubulin Modulators|tubulin modulators|mesh-ancestor
139497940|NCT05515315|Antimitotic Agents|antimitotic agents|mesh-ancestor
139497941|NCT05515315|Mitosis Modulators|mitosis modulators|mesh-ancestor
139497942|NCT05515315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497943|NCT05515315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497944|NCT05519371|Propofol|propofol|mesh-list
139497945|NCT05519371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139497946|NCT05519371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139497947|NCT05519371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497948|NCT05519371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139497949|NCT05519371|Anesthetics, General|anesthetics, general|mesh-ancestor
139497950|NCT05519371|Anesthetics|anesthetics|mesh-ancestor
139497951|NCT04847947|Vitamin D|vitamin d|mesh-list
139497952|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
139497953|NCT04847947|Vitamins|vitamins|mesh-ancestor
139497954|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
139497955|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497956|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139497957|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139497958|NCT05514925|Bevacizumab|bevacizumab|mesh-list
139497959|NCT05514925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139497960|NCT05514925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497961|NCT05514925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139497962|NCT05514925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139497963|NCT05514925|Growth Substances|growth substances|mesh-ancestor
139497964|NCT05514925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497965|NCT05514925|Growth Inhibitors|growth inhibitors|mesh-ancestor
139497966|NCT05514847|Aspirin|aspirin|mesh-list
139497967|NCT05514847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139497968|NCT05514847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139497969|NCT05514847|Analgesics|analgesics|mesh-ancestor
139497970|NCT05514847|Sensory System Agents|sensory system agents|mesh-ancestor
139497971|NCT05514847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139497972|NCT05514847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497973|NCT05514847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139497974|NCT05514847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139497975|NCT05514847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139497976|NCT05514847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138865844|NCT02641899|Incretins|incretins|mesh-ancestor
139497977|NCT05514847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497978|NCT05514847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139497979|NCT05514847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139497980|NCT05514847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139497981|NCT05514847|Antipyretics|antipyretics|mesh-ancestor
139497982|NCT05510323|Prednisolone|prednisolone|mesh-list
139497983|NCT05510323|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139497984|NCT05510323|Methylprednisolone|methylprednisolone|mesh-list
139497985|NCT05510323|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139497986|NCT05510323|Prednisolone acetate|prednisolone acetate|mesh-list
139497987|NCT05510323|Cyclophosphamide|cyclophosphamide|mesh-list
139497988|NCT05510323|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139497989|NCT05510323|Prednisolone phosphate|prednisolone phosphate|mesh-list
139497990|NCT05510323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139497991|NCT05510323|Immunologic Factors|immunologic factors|mesh-ancestor
139497992|NCT05510323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139497993|NCT05510323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139497994|NCT05510323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139497995|NCT05510323|Alkylating Agents|alkylating agents|mesh-ancestor
139497996|NCT05510323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139497997|NCT05510323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139497998|NCT05510323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139497999|NCT05510323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139498000|NCT05510323|Glucocorticoids|glucocorticoids|mesh-ancestor
139498001|NCT05510323|Hormones|hormones|mesh-ancestor
139498002|NCT05510323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138865875|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139498003|NCT05510323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139498004|NCT05510323|Antiemetics|antiemetics|mesh-ancestor
139498005|NCT05510323|Autonomic Agents|autonomic agents|mesh-ancestor
139498006|NCT05510323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498007|NCT05510323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139498008|NCT05510323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139498009|NCT05510323|Protective Agents|protective agents|mesh-ancestor
139498010|NCT05507671|BCG Vaccine|bcg vaccine|mesh-list
139498011|NCT05507671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139498012|NCT05507671|Immunologic Factors|immunologic factors|mesh-ancestor
139498013|NCT05507671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498014|NCT02568397|Dabigatran|dabigatran|mesh-list
139498015|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
139498016|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139498017|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
139498018|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498019|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498020|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
139498021|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
139498022|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139498023|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
139498024|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139498025|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
139498026|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498027|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498028|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
139498029|NCT05513131|Azacitidine|azacitidine|mesh-list
139498030|NCT05513131|Venetoclax|venetoclax|mesh-list
139498031|NCT05513131|Homoharringtonine|homoharringtonine|mesh-list
139498032|NCT05513131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139498033|NCT05513131|Antimetabolites|antimetabolites|mesh-ancestor
139498034|NCT05513131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498035|NCT05513131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498036|NCT05513131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498037|NCT05513131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139284713|NCT05645380|Docetaxel|docetaxel|mesh-list
139498038|NCT05513131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139498040|NCT05506501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498041|NCT05506501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498042|NCT05509153|Acetylcysteine|acetylcysteine|mesh-list
139498043|NCT05509153|Antiviral Agents|antiviral agents|mesh-ancestor
139498044|NCT05509153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498045|NCT05509153|Expectorants|expectorants|mesh-ancestor
139498046|NCT05509153|Respiratory System Agents|respiratory system agents|mesh-ancestor
139498047|NCT05509153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139498048|NCT05509153|Antioxidants|antioxidants|mesh-ancestor
139498049|NCT05509153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498050|NCT05509153|Protective Agents|protective agents|mesh-ancestor
139498051|NCT05509153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498052|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139498053|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139498054|NCT05505877|Tislelizumab|tislelizumab|mesh-list
139498055|NCT05505877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139498056|NCT05505877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498057|NCT02336451|Ceritinib|ceritinib|mesh-list
139498058|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498059|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139498060|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498061|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498062|NCT01648101|Ezogabine|ezogabine|mesh-list
139498063|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
139498064|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139498065|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498066|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
139498067|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498068|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
139498069|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498070|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498071|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139498072|NCT02372799|Fluoxetine|fluoxetine|mesh-list
139498073|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
139498074|NCT02372799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139498075|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139498076|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139498077|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498078|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498079|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
139498080|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498081|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138865956|NCT02709590|Analgesics|analgesics|mesh-ancestor
139498082|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
139498083|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139498084|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139498085|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139498086|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498087|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139498088|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139498089|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
139498090|NCT02566993|Doxorubicin|doxorubicin|mesh-list
139498091|NCT02566993|Vincristine|vincristine|mesh-list
139498092|NCT02566993|Topotecan|topotecan|mesh-list
139498093|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139498094|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
139498095|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498096|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139498097|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139498098|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
139498099|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498100|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498101|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139498102|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139498103|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139498104|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139498105|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498106|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139498107|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
139498108|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
139498109|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
139498110|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139498111|NCT02311881|Acetaminophen|acetaminophen|mesh-list
139498112|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139498113|NCT02311881|Analgesics|analgesics|mesh-ancestor
139498114|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
139498115|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498116|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498117|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
139498118|NCT02565511|Umibecestat|umibecestat|mesh-list
139498119|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498120|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498121|NCT04549051|Anesthetics|anesthetics|mesh-list
139498122|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
139498123|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498124|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498125|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
139498126|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498127|NCT05505253|Alfacalcidol|alfacalcidol|mesh-list
139498128|NCT05505253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139498129|NCT05505253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139498130|NCT05505253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498131|NCT05505253|Vitamins|vitamins|mesh-ancestor
138866039|NCT02693210|Methotrexate|methotrexate|mesh-list
139498132|NCT05505253|Micronutrients|micronutrients|mesh-ancestor
139498133|NCT05507983|Tranexamic Acid|tranexamic acid|mesh-list
139498134|NCT05507983|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139498135|NCT05507983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139498136|NCT05507983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498137|NCT05507983|Hemostatics|hemostatics|mesh-ancestor
139498138|NCT05507983|Coagulants|coagulants|mesh-ancestor
139498139|NCT02335983|Dexamethasone|dexamethasone|mesh-list
139498140|NCT02335983|Lenalidomide|lenalidomide|mesh-list
139498141|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139498142|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
139498143|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
139498144|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498145|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498146|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139498147|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
139498148|NCT02335983|Hormones|hormones|mesh-ancestor
139498149|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139498150|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139498151|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498152|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
139498153|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139498154|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139498155|NCT02335983|Growth Substances|growth substances|mesh-ancestor
139498156|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
139498157|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
139498158|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
138866100|NCT03781544|Diclofenac|diclofenac|mesh-list
139498159|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139498160|NCT04578691|Protective Agents|protective agents|mesh-ancestor
139498161|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498162|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
139498163|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139498164|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
139498165|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139498166|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139498167|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139498168|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139498169|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498170|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
139498171|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498172|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498173|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139498174|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498175|NCT02310789|Ivacaftor|ivacaftor|mesh-list
139498176|NCT02310789|Pilocarpine|pilocarpine|mesh-list
139498177|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
139498178|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139498179|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139498180|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498181|NCT02310789|Miotics|miotics|mesh-ancestor
139498182|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
139498183|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498184|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139284850|NCT05334485|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139498185|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139498186|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139498187|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
139498188|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498189|NCT02372253|Verapamil|verapamil|mesh-list
139498190|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139498191|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139498192|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139498193|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498194|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139498195|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498196|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
139498197|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
139498198|NCT02371629|Bromides|bromides|mesh-list
139498199|NCT02371629|Albuterol|albuterol|mesh-list
139498200|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
139498201|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139498202|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
139498203|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498204|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498205|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139498206|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
139498207|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
139498208|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139498209|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139498210|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139498211|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139498212|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
139498213|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498214|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498215|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139498216|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139498217|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139498218|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
139498219|NCT02559817|Linaclotide|linaclotide|mesh-list
139498220|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139498221|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
139498222|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498223|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139498224|NCT04577443|Adenosine|adenosine|mesh-list
139498225|NCT04577443|Analgesics|analgesics|mesh-ancestor
139498226|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
139498227|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498228|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498229|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139498230|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
139498231|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139498232|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
139498233|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
139498234|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498235|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498236|NCT04411537|Capecitabine|capecitabine|mesh-list
139498237|NCT04411537|Irinotecan|irinotecan|mesh-list
139498238|NCT04411537|Antibodies|antibodies|mesh-list
139498239|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
139498240|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866189|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
139498241|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139498242|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
139498243|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498244|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498245|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139498246|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139498247|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498248|NCT04630171|Anesthetics|anesthetics|mesh-list
139498249|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498250|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498251|NCT05503147|Nabiximols|nabiximols|mesh-list
139498252|NCT05503147|Analgesics|analgesics|mesh-ancestor
139498253|NCT05503147|Sensory System Agents|sensory system agents|mesh-ancestor
139498254|NCT05503147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498255|NCT05503147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498256|NCT04619095|Psyllium|psyllium|mesh-list
139498257|NCT04619095|Cathartics|cathartics|mesh-ancestor
139498258|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139498259|NCT05502991|Bevacizumab|bevacizumab|mesh-list
139498260|NCT05502991|Tislelizumab|tislelizumab|mesh-list
139498261|NCT05502991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139498262|NCT05502991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498263|NCT05502991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139498264|NCT05502991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139498265|NCT05502991|Growth Substances|growth substances|mesh-ancestor
139498266|NCT05502991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498267|NCT05502991|Growth Inhibitors|growth inhibitors|mesh-ancestor
139498269|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498270|NCT05499481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139498271|NCT05499481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498272|NCT05497765|Silybin|silybin|mesh-list
139498273|NCT05497765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139498274|NCT05497765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498275|NCT05497765|Protective Agents|protective agents|mesh-ancestor
139498276|NCT05497765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498277|NCT04424875|Melatonin|melatonin|mesh-list
139498278|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
139498279|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498280|NCT04424875|Protective Agents|protective agents|mesh-ancestor
139498281|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498282|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498283|NCT04277845|Dexamethasone|dexamethasone|mesh-list
139498284|NCT04277845|Dexamethasone acetate|dexamethasone acetate|mesh-list
139498285|NCT04277845|Lenalidomide|lenalidomide|mesh-list
139498286|NCT04277845|Bortezomib|bortezomib|mesh-list
139498287|NCT04277845|BB 1101|bb 1101|mesh-list
139498288|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139498289|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
139498290|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
139498291|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498292|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498293|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139498294|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
139498295|NCT04277845|Hormones|hormones|mesh-ancestor
139498296|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139498297|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139498298|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498299|NCT04277845|Protease Inhibitors|protease inhibitors|mesh-ancestor
139498300|NCT04277845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498301|NCT04277845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498302|NCT04277845|Immunologic Factors|immunologic factors|mesh-ancestor
139498303|NCT04277845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139498304|NCT04277845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139498305|NCT04277845|Growth Substances|growth substances|mesh-ancestor
139498306|NCT04277845|Growth Inhibitors|growth inhibitors|mesh-ancestor
139498307|NCT02559505|Vaccines|vaccines|mesh-list
139498308|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
139498309|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498310|NCT05497063|Pyrimethamine|pyrimethamine|mesh-list
139498311|NCT05497063|Sulfadoxine|sulfadoxine|mesh-list
139498312|NCT05497063|Antimalarials|antimalarials|mesh-ancestor
139498313|NCT05497063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139498314|NCT05497063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139498315|NCT05497063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498316|NCT05497063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139498317|NCT05497063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498318|NCT05497063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498319|NCT05497063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139498320|NCT05560945|Listerine|listerine|mesh-list
139498321|NCT05560945|Fluorides|fluorides|mesh-list
139498322|NCT05560945|Sodium Fluoride|sodium fluoride|mesh-list
139498323|NCT05560945|Cariostatic Agents|cariostatic agents|mesh-ancestor
139498324|NCT05560945|Protective Agents|protective agents|mesh-ancestor
139498325|NCT05560945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498326|NCT05560945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139498327|NCT05560945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498328|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
139498329|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139498330|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139498331|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498332|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
139498333|NCT04424563|Coagulants|coagulants|mesh-ancestor
139498334|NCT05495893|Mycophenolic Acid|mycophenolic acid|mesh-list
139498335|NCT05495893|Cyclophosphamide|cyclophosphamide|mesh-list
139498336|NCT05495893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139498337|NCT05495893|Immunologic Factors|immunologic factors|mesh-ancestor
138868504|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
139498338|NCT05495893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498339|NCT05495893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139498340|NCT05495893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139498341|NCT05495893|Alkylating Agents|alkylating agents|mesh-ancestor
139498342|NCT05495893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498343|NCT05495893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498344|NCT05495893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139498345|NCT05495893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139498346|NCT05495893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139498347|NCT05495893|Antitubercular Agents|antitubercular agents|mesh-ancestor
139498348|NCT05495893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139498349|NCT05495893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498350|NCT05495893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498351|NCT03542461|Nivolumab|nivolumab|mesh-list
139498352|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139498353|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498354|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139498355|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498356|NCT02556307|Ribavirin|ribavirin|mesh-list
139498357|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139498358|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
139498359|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498360|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
139498361|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498362|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
139498363|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139498364|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498365|NCT05494645|Bupivacaine|bupivacaine|mesh-list
139498366|NCT05494645|Anesthetics, Local|anesthetics, local|mesh-ancestor
139498367|NCT05494645|Anesthetics|anesthetics|mesh-ancestor
139498368|NCT05494645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498369|NCT05494645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498370|NCT05494645|Sensory System Agents|sensory system agents|mesh-ancestor
139498371|NCT05494645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498372|NCT05494567|Tadalafil|tadalafil|mesh-list
139498373|NCT05494567|Tamsulosin|tamsulosin|mesh-list
139498374|NCT05494567|Solifenacin Succinate|solifenacin succinate|mesh-list
139498375|NCT05494567|Vasodilator Agents|vasodilator agents|mesh-ancestor
139498376|NCT05494567|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139498377|NCT05494567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139498378|NCT05494567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498379|NCT05494567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498380|NCT05494567|Urological Agents|urological agents|mesh-ancestor
139498381|NCT05494567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139498382|NCT05494567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139498383|NCT05494567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139498384|NCT05494567|Adrenergic Agents|adrenergic agents|mesh-ancestor
139498385|NCT05494567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498386|NCT05494567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498387|NCT05494567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139498388|NCT05494567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139498389|NCT05494567|Cholinergic Agents|cholinergic agents|mesh-ancestor
139498390|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
139498391|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
139498392|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498393|NCT05494411|Mitomycins|mitomycins|mesh-list
139498394|NCT05494411|Mitomycin|mitomycin|mesh-list
139498395|NCT05494411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139498396|NCT05494411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498397|NCT05494411|Alkylating Agents|alkylating agents|mesh-ancestor
139498398|NCT05494411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498399|NCT05494411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139498400|NCT05494411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498401|NCT04080895|Lumefantrine|lumefantrine|mesh-list
139498402|NCT04080895|Artemether|artemether|mesh-list
139498403|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139498404|NCT04080895|Amodiaquine|amodiaquine|mesh-list
139498405|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
139498406|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139498407|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139498408|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498409|NCT04251169|Paclitaxel|paclitaxel|mesh-list
139498410|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
139498411|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139498412|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285082|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
139498413|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
139498414|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
139498415|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
139498416|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498417|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139498418|NCT04251169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139498419|NCT04279561|Edetic Acid|edetic acid|mesh-list
139498420|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139498421|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
139498422|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
139498423|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498424|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
139498425|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139498426|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139498427|NCT01662895|Deferoxamine|deferoxamine|mesh-list
139498428|NCT01662895|Siderophores|siderophores|mesh-ancestor
139498429|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139498430|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
139498431|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
139498432|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498433|NCT05498857|Ephedrine|ephedrine|mesh-list
139498434|NCT05498857|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139498435|NCT05498857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498436|NCT05498857|Sympathomimetics|sympathomimetics|mesh-ancestor
139498437|NCT05498857|Autonomic Agents|autonomic agents|mesh-ancestor
139498438|NCT05498857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498439|NCT05498857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139498440|NCT05498857|Adrenergic Agents|adrenergic agents|mesh-ancestor
139498441|NCT05498857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498442|NCT05498857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498443|NCT05498467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139498444|NCT05498467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139498445|NCT04139395|Citric Acid|citric acid|mesh-list
139498446|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
139498447|NCT04139395|Gallium citrate|gallium citrate|mesh-list
139498448|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
139498449|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139498450|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
139498451|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
139498452|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498453|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139498454|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139498455|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
139498456|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139498457|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
139498458|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498459|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
139498460|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
139498461|NCT02555683|Growth Substances|growth substances|mesh-ancestor
139498462|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498463|NCT02554981|Cyclosporine|cyclosporine|mesh-list
139498464|NCT02554981|Cyclosporins|cyclosporins|mesh-list
139498465|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498466|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498467|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139498468|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
139498469|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498470|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
139498471|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498472|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
139498473|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139498474|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139498475|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
139498476|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139498477|NCT02556775|Antibodies|antibodies|mesh-list
139498478|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
139498479|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139498480|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
139498481|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498482|NCT05485207|Botulinum Toxins|botulinum toxins|mesh-list
139498483|NCT05485207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139498484|NCT05485207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139498485|NCT05485207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139498486|NCT05485207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139285158|NCT04359823|Lovastatin|lovastatin|mesh-list
139498487|NCT05485207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498488|NCT05485207|Cholinergic Agents|cholinergic agents|mesh-ancestor
139498489|NCT05485207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498490|NCT05485207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498491|NCT05485207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139498492|NCT05485207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498493|NCT03879109|Folfirinox|folfirinox|mesh-list
139498494|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498495|NCT05488327|Lenalidomide|lenalidomide|mesh-list
139498496|NCT05488327|Immunologic Factors|immunologic factors|mesh-ancestor
139498497|NCT05488327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498498|NCT05488327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139498499|NCT05488327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139498500|NCT05488327|Growth Substances|growth substances|mesh-ancestor
139498501|NCT05488327|Growth Inhibitors|growth inhibitors|mesh-ancestor
139498502|NCT05488327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498503|NCT05488171|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139498504|NCT05488171|Hallucinogens|hallucinogens|mesh-ancestor
139498505|NCT05488171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498506|NCT05488171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139498507|NCT05488171|Serotonin Agents|serotonin agents|mesh-ancestor
139498508|NCT05488171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498509|NCT05488171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498510|NCT05488171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139498511|NCT05488171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139498512|NCT05488171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139498513|NCT05488171|Adrenergic Agents|adrenergic agents|mesh-ancestor
139498514|NCT05485051|Chlorhexidine|chlorhexidine|mesh-list
139498515|NCT05485051|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139498516|NCT05485051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139498517|NCT05485051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498518|NCT05485051|Disinfectants|disinfectants|mesh-ancestor
139498519|NCT05485051|Dermatologic Agents|dermatologic agents|mesh-ancestor
139498520|NCT05484817|Hormones|hormones|mesh-list
139498521|NCT05484817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139498522|NCT05484817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498523|NCT05484583|Carboplatin|carboplatin|mesh-list
139498524|NCT05484583|Etoposide|etoposide|mesh-list
139498525|NCT05484583|Durvalumab|durvalumab|mesh-list
139498526|NCT05484583|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139498527|NCT05484583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498528|NCT05484583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139498529|NCT05484583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139498530|NCT05484583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139498531|NCT05484583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498532|NCT05484583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498533|NCT05484583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139498534|NCT05484583|Immunologic Factors|immunologic factors|mesh-ancestor
139498535|NCT05484583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498536|NCT05479747|Analgesics|analgesics|mesh-list
139498537|NCT05479747|Sensory System Agents|sensory system agents|mesh-ancestor
139498538|NCT05479747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498539|NCT05479747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498540|NCT05487469|Thymalfasin|thymalfasin|mesh-list
139498541|NCT05487469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139498542|NCT05487469|Immunologic Factors|immunologic factors|mesh-ancestor
139498543|NCT05487469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498544|NCT05479357|Oxytocin|oxytocin|mesh-list
139498545|NCT05479357|Carbetocin|carbetocin|mesh-list
139498546|NCT05479357|Oxytocics|oxytocics|mesh-ancestor
139498547|NCT05479357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139498548|NCT05479357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498549|NCT05487391|Paclitaxel|paclitaxel|mesh-list
139498550|NCT05487391|Vinorelbine|vinorelbine|mesh-list
139498551|NCT05487391|Carboplatin|carboplatin|mesh-list
139498552|NCT05487391|Pemetrexed|pemetrexed|mesh-list
139498553|NCT05487391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139498554|NCT05487391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498555|NCT05487391|Tubulin Modulators|tubulin modulators|mesh-ancestor
139498556|NCT05487391|Antimitotic Agents|antimitotic agents|mesh-ancestor
139498557|NCT05487391|Mitosis Modulators|mitosis modulators|mesh-ancestor
139498558|NCT05487391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498559|NCT05487391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498560|NCT05487391|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139498561|NCT05487391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139285223|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498562|NCT05484193|Progesterone|progesterone|mesh-list
139498563|NCT05484193|Progestins|progestins|mesh-ancestor
139498564|NCT05484193|Hormones|hormones|mesh-ancestor
139498565|NCT05484193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139498566|NCT05484193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498567|NCT03796195|Bupivacaine|bupivacaine|mesh-list
139498568|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
139498569|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
139498570|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498571|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498572|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
139498573|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498574|NCT04268407|Amoxicillin|amoxicillin|mesh-list
139498575|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
139498576|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
139498577|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139498578|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139498579|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498580|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139498581|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498582|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498583|NCT05487001|Dexamethasone|dexamethasone|mesh-list
139498584|NCT05487001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139498585|NCT05487001|Antiemetics|antiemetics|mesh-ancestor
139498586|NCT05487001|Autonomic Agents|autonomic agents|mesh-ancestor
139498587|NCT05487001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498588|NCT05487001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498589|NCT05487001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139498590|NCT05487001|Glucocorticoids|glucocorticoids|mesh-ancestor
139498591|NCT05487001|Hormones|hormones|mesh-ancestor
139498592|NCT05487001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139498593|NCT05487001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139498594|NCT05487001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498595|NCT05483647|Anesthetics|anesthetics|mesh-list
139498596|NCT05483647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498597|NCT05483647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498598|NCT05475379|Vaccines|vaccines|mesh-list
139498599|NCT05475379|Immunologic Factors|immunologic factors|mesh-ancestor
139498600|NCT05475379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498601|NCT05475223|Carbon Monoxide|carbon monoxide|mesh-list
139498602|NCT05475223|Antimetabolites|antimetabolites|mesh-ancestor
139498603|NCT05475223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498604|NCT05475223|Gasotransmitters|gasotransmitters|mesh-ancestor
139498605|NCT05475223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498606|NCT05475223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498607|NCT04424017|Antibodies|antibodies|mesh-list
139498608|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
139498609|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498610|NCT05477797|Lenalidomide|lenalidomide|mesh-list
139498611|NCT05477797|Ixazomib|ixazomib|mesh-list
139498612|NCT05477797|Immunologic Factors|immunologic factors|mesh-ancestor
139498613|NCT05477797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498614|NCT05477797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139498615|NCT05477797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139498616|NCT05477797|Growth Substances|growth substances|mesh-ancestor
139498617|NCT05477797|Growth Inhibitors|growth inhibitors|mesh-ancestor
139498618|NCT05477797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498619|NCT05477797|Protease Inhibitors|protease inhibitors|mesh-ancestor
139498620|NCT05477797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498621|NCT05477797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498622|NCT05472259|Leucovorin|leucovorin|mesh-list
139498623|NCT05472259|Fluorouracil|fluorouracil|mesh-list
139498624|NCT05472259|Oxaliplatin|oxaliplatin|mesh-list
139498625|NCT05472259|Irinotecan|irinotecan|mesh-list
139498626|NCT05472259|Antimetabolites|antimetabolites|mesh-ancestor
139498627|NCT05472259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498628|NCT05472259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139498629|NCT05472259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498630|NCT05472259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139498631|NCT05472259|Immunologic Factors|immunologic factors|mesh-ancestor
139498632|NCT05472259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498633|NCT05472259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139498634|NCT05472259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139498635|NCT05472259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498636|NCT05472259|Antidotes|antidotes|mesh-ancestor
139498637|NCT05472259|Protective Agents|protective agents|mesh-ancestor
139498638|NCT05472259|Vitamin B Complex|vitamin b complex|mesh-ancestor
139498639|NCT05472259|Vitamins|vitamins|mesh-ancestor
139498640|NCT05472259|Micronutrients|micronutrients|mesh-ancestor
139498641|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
139498642|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139498643|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498644|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498645|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139498646|NCT04266145|Analgesics|analgesics|mesh-ancestor
139498647|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
139498648|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498649|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139498650|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139498651|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139498652|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
139498653|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498654|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498655|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139498656|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
139498657|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498658|NCT05477017|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139498659|NCT05477017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498660|NCT05477017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139498661|NCT05477017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498662|NCT02554903|Macitentan|macitentan|mesh-list
139498663|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139498664|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139498665|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498666|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139498667|NCT02332707|Ribavirin|ribavirin|mesh-list
139498668|NCT02332707|Grazoprevir|grazoprevir|mesh-list
139498669|NCT02332707|Ruzasvir|ruzasvir|mesh-list
139498670|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
139498671|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
139498672|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498673|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
139498674|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498675|NCT02370615|Itraconazole|itraconazole|mesh-list
139498676|NCT02370615|Digoxin|digoxin|mesh-list
139498677|NCT02370615|Midazolam|midazolam|mesh-list
139498678|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
139498679|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139498680|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139498681|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498682|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498683|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139498684|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139498685|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139498686|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139498687|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
139498688|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
139498689|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
139498690|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
139498691|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498692|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498693|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
139498694|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498695|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139498696|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139498697|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498698|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139498699|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
139498700|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139498701|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139498702|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139498703|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139498704|NCT02370615|Protective Agents|protective agents|mesh-ancestor
139498705|NCT02307513|Apremilast|apremilast|mesh-list
139498706|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139498707|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139498708|NCT02307513|Analgesics|analgesics|mesh-ancestor
139498709|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
139498710|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498711|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498712|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139498713|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139498714|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139498715|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139498716|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866591|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138866592|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
138866593|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866594|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138866595|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138866596|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
138866597|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866598|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866599|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139498717|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498718|NCT02328105|Paclitaxel|paclitaxel|mesh-list
139498719|NCT02328105|Carboplatin|carboplatin|mesh-list
139498720|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139498721|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139498722|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498723|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
139498724|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
139498725|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
139498726|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498727|NCT02305797|Lorazepam|lorazepam|mesh-list
139498728|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
139498729|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
139498730|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
139498731|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498732|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498733|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139498734|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139498735|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498736|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139498737|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139498738|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139498739|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
139498740|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
139498741|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498742|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498743|NCT01646073|Adalimumab|adalimumab|mesh-list
139498744|NCT01646073|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139498745|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139498746|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139498747|NCT02551159|Carboplatin|carboplatin|mesh-list
139498748|NCT02551159|Fluorouracil|fluorouracil|mesh-list
139498749|NCT02551159|Cetuximab|cetuximab|mesh-list
139498750|NCT02551159|Durvalumab|durvalumab|mesh-list
139498751|NCT02551159|Tremelimumab|tremelimumab|mesh-list
139498752|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139498753|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498754|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
139498755|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498756|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139498757|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139498758|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
139498759|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498760|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139498761|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
139498762|NCT04539379|Analgesics|analgesics|mesh-ancestor
139498763|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
139498764|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498765|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498766|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
139498767|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498768|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139498769|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
139498770|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139498771|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139498772|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498773|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139498774|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
139498775|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139498776|NCT05470075|Tramadol|tramadol|mesh-list
139498777|NCT05470075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139498778|NCT05470075|Narcotics|narcotics|mesh-ancestor
139498779|NCT05470075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498780|NCT05470075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498781|NCT05470075|Analgesics|analgesics|mesh-ancestor
139498782|NCT05470075|Sensory System Agents|sensory system agents|mesh-ancestor
139498783|NCT05470075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498784|NCT05481619|Vedolizumab|vedolizumab|mesh-list
139498785|NCT05481619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139498786|NCT02305563|Cytarabine|cytarabine|mesh-list
139498787|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139498788|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
139498789|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498790|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498791|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
139498792|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498793|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139498794|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
139498795|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498796|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
139498797|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
139498798|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139498799|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139498800|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866677|NCT02630511|Miotics|miotics|mesh-ancestor
139498801|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498802|NCT02304705|Urological Agents|urological agents|mesh-ancestor
139498803|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
139498804|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139498805|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498806|NCT02553499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139498807|NCT02553499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285522|NCT03314935|Fluorouracil|fluorouracil|mesh-list
139285523|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
139285524|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139285525|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285526|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
139285527|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
139285528|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
139285529|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139285530|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139285531|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
139285532|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139285533|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
139285534|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139285535|NCT03314935|Antidotes|antidotes|mesh-ancestor
139285536|NCT03314935|Protective Agents|protective agents|mesh-ancestor
139285537|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
139285538|NCT03314935|Vitamins|vitamins|mesh-ancestor
139285539|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
139285540|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139285541|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
139285542|NCT03255174|Coagulants|coagulants|mesh-ancestor
139285543|NCT03181100|Paclitaxel|paclitaxel|mesh-list
139285544|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139285545|NCT03181100|Bevacizumab|bevacizumab|mesh-list
139285546|NCT03181100|Atezolizumab|atezolizumab|mesh-list
139285547|NCT03181100|Vemurafenib|vemurafenib|mesh-list
139285548|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139498808|NCT02553265|Carbidopa|carbidopa|mesh-list
139285549|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
139285550|NCT03181100|Antibodies|antibodies|mesh-list
139285551|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
139498809|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139498810|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139498811|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
139498812|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498813|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498814|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498815|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139498816|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498817|NCT03215095|Durvalumab|durvalumab|mesh-list
139498818|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139498819|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498820|NCT01663103|Rilonacept|rilonacept|mesh-list
139498821|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139498822|NCT05501639|Tiotropium Bromide|tiotropium bromide|mesh-list
139498823|NCT05501639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139498824|NCT05501639|Autonomic Agents|autonomic agents|mesh-ancestor
139498825|NCT05501639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498826|NCT05501639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498827|NCT05501639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139498828|NCT05501639|Respiratory System Agents|respiratory system agents|mesh-ancestor
139498829|NCT05501639|Parasympatholytics|parasympatholytics|mesh-ancestor
139498830|NCT05501639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139498831|NCT05501639|Cholinergic Agents|cholinergic agents|mesh-ancestor
139498832|NCT05501639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139498833|NCT05501639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498835|NCT04577963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139498836|NCT04577963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498837|NCT04532645|Olaparib|olaparib|mesh-list
139498838|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139498839|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498840|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498841|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498842|NCT02560025|Cytarabine|cytarabine|mesh-list
139498843|NCT02560025|Daunorubicin|daunorubicin|mesh-list
139498844|NCT02560025|Idarubicin|idarubicin|mesh-list
139498845|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139498846|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
139498847|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498848|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498849|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
139498850|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498851|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139498852|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
139498853|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498854|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139498855|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139498856|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139498857|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498858|NCT05500937|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139498859|NCT05500937|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139498860|NCT05500937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139498861|NCT04524455|Dexamethasone|dexamethasone|mesh-list
139498862|NCT04524455|Blinatumomab|blinatumomab|mesh-list
139498863|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139498864|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
139498865|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
139498866|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498867|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498868|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139498869|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
139498870|NCT04524455|Hormones|hormones|mesh-ancestor
139498871|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139498872|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139498873|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498874|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
139498875|NCT04411901|Vitamin D|vitamin d|mesh-list
139498876|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139498877|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498878|NCT04411901|Vitamins|vitamins|mesh-ancestor
139498879|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
139498880|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139498881|NCT05508737|Trifluridine|trifluridine|mesh-list
139498882|NCT05508737|Pembrolizumab|pembrolizumab|mesh-list
139498883|NCT05508737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139498884|NCT05508737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498885|NCT05508737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139498886|NCT05508737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498887|NCT05508737|Antimetabolites|antimetabolites|mesh-ancestor
139498888|NCT05508737|Antiviral Agents|antiviral agents|mesh-ancestor
139498889|NCT05508737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139642367|NCT01452451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139642368|NCT04951128|Anesthetics|anesthetics|mesh-list
139642369|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
139642370|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
139642371|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642372|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642373|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139642374|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139642375|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642376|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
139642377|NCT04951128|Coagulants|coagulants|mesh-ancestor
139642378|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
139642379|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642380|NCT01458301|Leuprolide|leuprolide|mesh-list
139642381|NCT01458301|Relugolix|relugolix|mesh-list
139642382|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139642383|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
139642384|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139642385|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498890|NCT05508035|Valsartan|valsartan|mesh-list
139498891|NCT05508035|Ramipril|ramipril|mesh-list
139498892|NCT05508035|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139498893|NCT05508035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139498894|NCT05508035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139498895|NCT05508035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139498896|NCT05508035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498897|NCT05508035|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139498898|NCT05508035|Protease Inhibitors|protease inhibitors|mesh-ancestor
139498899|NCT05508035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498900|NCT02566889|Infliximab|infliximab|mesh-list
139498901|NCT02566889|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139498902|NCT02566889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139498903|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
139498904|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139498905|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139498906|NCT05507957|Chlorhexidine|chlorhexidine|mesh-list
139498907|NCT05507957|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139498908|NCT05507957|Ethanol|ethanol|mesh-list
139498909|NCT05507957|Povidone-Iodine|povidone-iodine|mesh-list
139498910|NCT05507957|Disinfectants|disinfectants|mesh-list
139498911|NCT05507957|Povidone|povidone|mesh-list
139498912|NCT05507957|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139498913|NCT05507957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498914|NCT05507957|Dermatologic Agents|dermatologic agents|mesh-ancestor
139498915|NCT05507957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498916|NCT05507957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498917|NCT05507957|Plasma Substitutes|plasma substitutes|mesh-ancestor
139498918|NCT05507957|Blood Substitutes|blood substitutes|mesh-ancestor
139498919|NCT05563571|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139498920|NCT05563571|Methylprednisolone|methylprednisolone|mesh-list
139498921|NCT05563571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139498922|NCT05563571|Prednisolone|prednisolone|mesh-list
139498923|NCT05563571|Prednisolone acetate|prednisolone acetate|mesh-list
139498924|NCT05563571|Lidocaine|lidocaine|mesh-list
139498925|NCT05563571|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139498926|NCT05563571|Prednisolone phosphate|prednisolone phosphate|mesh-list
139498927|NCT05563571|Anesthetics, Local|anesthetics, local|mesh-ancestor
139498928|NCT05563571|Anesthetics|anesthetics|mesh-ancestor
139498929|NCT05563571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139498930|NCT05563571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498931|NCT05563571|Sensory System Agents|sensory system agents|mesh-ancestor
139498932|NCT05563571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139498933|NCT05563571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139498934|NCT05563571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139498935|NCT05563571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139498936|NCT05563571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139498937|NCT05563571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498938|NCT05563571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139498939|NCT05563571|Antiemetics|antiemetics|mesh-ancestor
139498940|NCT05563571|Autonomic Agents|autonomic agents|mesh-ancestor
139498941|NCT05563571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139498942|NCT05563571|Glucocorticoids|glucocorticoids|mesh-ancestor
139498943|NCT05563571|Hormones|hormones|mesh-ancestor
139498944|NCT05563571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139498945|NCT05563571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139498946|NCT05563571|Protective Agents|protective agents|mesh-ancestor
139498947|NCT05563571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139498948|NCT05563571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498949|NCT02489903|Paclitaxel|paclitaxel|mesh-list
139498950|NCT02489903|Etoposide|etoposide|mesh-list
139498951|NCT02489903|Vinorelbine|vinorelbine|mesh-list
139498952|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139498953|NCT02489903|Carboplatin|carboplatin|mesh-list
139498954|NCT02489903|Gemcitabine|gemcitabine|mesh-list
139498955|NCT02489903|Irinotecan|irinotecan|mesh-list
139498956|NCT02489903|Pemetrexed|pemetrexed|mesh-list
139498957|NCT02489903|Taxane|taxane|mesh-list
139498958|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139498959|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498960|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
139498961|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
139498962|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
139498963|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498964|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139498965|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
139498966|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139498967|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139498968|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498969|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139498970|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139498971|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139498973|NCT01174199|Vorinostat|vorinostat|mesh-list
139498974|NCT01174199|Temsirolimus|temsirolimus|mesh-list
139498975|NCT01174199|MTOR Inhibitors|mtor inhibitors|mesh-list
139498976|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139498977|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139498978|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139498979|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498980|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
139498981|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139498982|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
139498983|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498984|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139498985|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139498986|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498987|NCT01174199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139498988|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139498989|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139498990|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498991|NCT05562869|Abatacept|abatacept|mesh-list
139498992|NCT05562869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139498993|NCT05562869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139498994|NCT05562869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139498995|NCT05562869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139498996|NCT05562869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139498997|NCT05562869|Immunologic Factors|immunologic factors|mesh-ancestor
139498998|NCT05562869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139498999|NCT05562869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499000|NCT04085237|Ropivacaine|ropivacaine|mesh-list
139499001|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
139499002|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
139499003|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139499004|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499005|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
139499006|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499007|NCT04080869|Vitamin A|vitamin a|mesh-list
139499008|NCT04080869|Tretinoin|tretinoin|mesh-list
139499009|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
139499010|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499011|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
139499012|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
139499013|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
138866812|NCT03481556|Dexamethasone|dexamethasone|mesh-list
139499014|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499015|NCT04080869|Protective Agents|protective agents|mesh-ancestor
139499016|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499017|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139499018|NCT04080869|Vitamins|vitamins|mesh-ancestor
139499019|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
139499020|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
139499021|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
139499022|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
139499023|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
139499024|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499025|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499026|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139499027|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139499028|NCT00560495|Growth Substances|growth substances|mesh-ancestor
139499029|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499030|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
139499031|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499032|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139499033|NCT02559713|Vedolizumab|vedolizumab|mesh-list
139499034|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139499035|NCT05499065|Cetuximab|cetuximab|mesh-list
139499036|NCT05499065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139499037|NCT05499065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499038|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
139499039|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
139499040|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139499041|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139499042|NCT04038437|Venetoclax|venetoclax|mesh-list
139499043|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499044|NCT05491343|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139499045|NCT05491343|Medroxyprogesterone|medroxyprogesterone|mesh-list
139499046|NCT05491343|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139499047|NCT05491343|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139499048|NCT05491343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139499049|NCT05491343|Contraceptive Agents|contraceptive agents|mesh-ancestor
139499050|NCT05491343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139499051|NCT05491343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499052|NCT05491343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139499053|NCT05491343|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139499054|NCT05491343|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138866814|NCT03481556|Bortezomib|bortezomib|mesh-list
139499055|NCT05491343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139499056|NCT05491343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499057|NCT05485883|Lenvatinib|lenvatinib|mesh-list
139499058|NCT05485883|Tislelizumab|tislelizumab|mesh-list
139499059|NCT05485883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499060|NCT05485883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139499061|NCT05485883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499062|NCT05485883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499063|NCT05485883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139499064|NCT04273607|Heparin|heparin|mesh-list
139499065|NCT04273607|Calcium heparin|calcium heparin|mesh-list
139499066|NCT04273607|Enoxaparin|enoxaparin|mesh-list
139499067|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
139499068|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139499069|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139499070|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499071|NCT05476081|Aspirin|aspirin|mesh-list
139499072|NCT05476081|Clopidogrel|clopidogrel|mesh-list
139499073|NCT05476081|Ticagrelor|ticagrelor|mesh-list
139499074|NCT05476081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139499075|NCT05476081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499076|NCT05476081|Analgesics|analgesics|mesh-ancestor
139499077|NCT05476081|Sensory System Agents|sensory system agents|mesh-ancestor
139499078|NCT05476081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499079|NCT05476081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499080|NCT05476081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499081|NCT05476081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499082|NCT05476081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139499083|NCT05476081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139499084|NCT05476081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499085|NCT05476081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139499086|NCT05476081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139499087|NCT05476081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499088|NCT05476081|Antipyretics|antipyretics|mesh-ancestor
139499089|NCT05476081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139499090|NCT05476081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139499091|NCT05476081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139499092|NCT05476081|Purinergic Agents|purinergic agents|mesh-ancestor
139499093|NCT05476081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499094|NCT05476003|Midazolam|midazolam|mesh-list
139499095|NCT05476003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139499096|NCT05476003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139499097|NCT05476003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139499098|NCT05476003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499099|NCT05476003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139499100|NCT05476003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139499101|NCT05476003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139499102|NCT05476003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139499103|NCT05476003|Anesthetics, General|anesthetics, general|mesh-ancestor
139499104|NCT05476003|Anesthetics|anesthetics|mesh-ancestor
139499105|NCT05476003|GABA Modulators|gaba modulators|mesh-ancestor
139499106|NCT05476003|GABA Agents|gaba agents|mesh-ancestor
139499107|NCT05476003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499108|NCT05476003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499109|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139499110|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
139499111|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499112|NCT02535715|Insulin|insulin|mesh-list
139499113|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139499114|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139499115|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499116|NCT02336815|Dexamethasone|dexamethasone|mesh-list
139499117|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499118|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
139499119|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
139499120|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499121|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499122|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139499123|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
139499124|NCT02336815|Hormones|hormones|mesh-ancestor
139499125|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139499126|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139499127|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499128|NCT05434039|Diclofenac|diclofenac|mesh-list
139499129|NCT05434039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139499130|NCT05434039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499131|NCT05434039|Analgesics|analgesics|mesh-ancestor
139499132|NCT05434039|Sensory System Agents|sensory system agents|mesh-ancestor
139499133|NCT05434039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499134|NCT05434039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499135|NCT05434039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499136|NCT05434039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499137|NCT05434039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139499138|NCT05434039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499139|NCT05434039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499140|NCT05466175|Prednisone|prednisone|mesh-list
139499141|NCT05466175|Vincristine|vincristine|mesh-list
139499142|NCT05466175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499143|NCT05466175|Glucocorticoids|glucocorticoids|mesh-ancestor
139499144|NCT05466175|Hormones|hormones|mesh-ancestor
139499145|NCT05466175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139499146|NCT05466175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499147|NCT05466175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139499148|NCT05466175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499149|NCT05466175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139499150|NCT05466175|Tubulin Modulators|tubulin modulators|mesh-ancestor
139499151|NCT05466175|Antimitotic Agents|antimitotic agents|mesh-ancestor
139499152|NCT05466175|Mitosis Modulators|mitosis modulators|mesh-ancestor
139499153|NCT05466175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499154|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139499155|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139499156|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139499157|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
139499158|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499159|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139499160|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139499161|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499162|NCT02545933|Aspirin|aspirin|mesh-list
139499163|NCT02545933|Ticagrelor|ticagrelor|mesh-list
139499164|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139499165|NCT02545933|Vorapaxar|vorapaxar|mesh-list
139499166|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139499167|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499168|NCT02545933|Analgesics|analgesics|mesh-ancestor
139499169|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
139499170|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499171|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499172|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499173|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499174|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139499175|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139499176|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499177|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139499178|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139499179|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499180|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
139499181|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139499182|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139499183|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139499184|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
139499185|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499186|NCT02545075|Ipilimumab|ipilimumab|mesh-list
139499187|NCT02545075|Dacarbazine|dacarbazine|mesh-list
139499188|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139499189|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139285876|NCT02161770|Osimertinib|osimertinib|mesh-list
139499190|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139499191|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499192|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139499193|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
139499194|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
139499195|NCT03007537|Hematinics|hematinics|mesh-ancestor
139499196|NCT03004183|Valacyclovir|valacyclovir|mesh-list
139499197|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
139499198|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139499199|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499200|NCT03004183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139499201|NCT03004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499202|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
139499203|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139499204|NCT02544763|Cannabidiol|cannabidiol|mesh-list
139499205|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
139499206|NCT02556203|Aspirin|aspirin|mesh-list
139499207|NCT02556203|Vitamin K|vitamin k|mesh-list
139499208|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
139499209|NCT02556203|Clopidogrel|clopidogrel|mesh-list
139499210|NCT02556203|Vitamins|vitamins|mesh-ancestor
139499211|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
139499212|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499213|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139499214|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139499215|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139499216|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139499217|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
139499218|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499219|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499220|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139499221|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
139499222|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139499223|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
139499224|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499225|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
139499226|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139499227|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499228|NCT02556203|Analgesics|analgesics|mesh-ancestor
139499229|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
139499230|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499231|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499232|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499233|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139499234|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139499235|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139499236|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
139499237|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139499238|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
139499239|NCT02556203|Coagulants|coagulants|mesh-ancestor
139499240|NCT05485571|Methotrexate|methotrexate|mesh-list
139499241|NCT05485571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139499242|NCT05485571|Abortifacient Agents|abortifacient agents|mesh-ancestor
139499243|NCT05485571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139499244|NCT05485571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499245|NCT05485571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139499246|NCT05485571|Antimetabolites|antimetabolites|mesh-ancestor
139499247|NCT05485571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499248|NCT05485571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499249|NCT05485571|Dermatologic Agents|dermatologic agents|mesh-ancestor
139499250|NCT05485571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499251|NCT05485571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139499252|NCT05485571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139499253|NCT05485571|Immunologic Factors|immunologic factors|mesh-ancestor
139499254|NCT05485571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499255|NCT05485571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139499256|NCT05496725|Micafungin|micafungin|mesh-list
139499257|NCT05496725|Antifungal Agents|antifungal agents|mesh-ancestor
139499258|NCT05496725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139499259|NCT05490719|Cisplatin|cisplatin|mesh-list
139499260|NCT05490719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499261|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
139285949|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
139499262|NCT04424459|Narcotics|narcotics|mesh-ancestor
139499263|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139499264|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499265|NCT04424459|Analgesics|analgesics|mesh-ancestor
139499266|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
139499267|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499268|NCT05485259|Thioctic Acid|thioctic acid|mesh-list
139499269|NCT05485259|Antioxidants|antioxidants|mesh-ancestor
139499270|NCT05485259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499271|NCT05485259|Protective Agents|protective agents|mesh-ancestor
139499272|NCT05485259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499273|NCT05485259|Vitamin B Complex|vitamin b complex|mesh-ancestor
139499275|NCT05485259|Micronutrients|micronutrients|mesh-ancestor
139499276|NCT05490407|Carboplatin|carboplatin|mesh-list
139499277|NCT05490407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499278|NCT05490095|Everolimus|everolimus|mesh-list
139499279|NCT05490095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139499280|NCT05490095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139499281|NCT05490095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499282|NCT05490095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499283|NCT05490095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139499284|NCT05490095|Immunologic Factors|immunologic factors|mesh-ancestor
139499285|NCT05490095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499286|NCT05490095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499287|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
139499288|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139499289|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
139499290|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139499291|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
139499292|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499293|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499294|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
139499295|NCT05496179|Metoclopramide|metoclopramide|mesh-list
139499296|NCT05496179|Prucalopride|prucalopride|mesh-list
139499297|NCT05496179|Antiemetics|antiemetics|mesh-ancestor
139499298|NCT05496179|Autonomic Agents|autonomic agents|mesh-ancestor
139499299|NCT05496179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499300|NCT05496179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499301|NCT05496179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139499302|NCT05496179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139499303|NCT05496179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139499304|NCT05496179|Dopamine Agents|dopamine agents|mesh-ancestor
139499305|NCT05496179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499306|NCT05496179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499307|NCT05496179|Laxatives|laxatives|mesh-ancestor
139499308|NCT05496179|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139499309|NCT05496179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139499310|NCT05496179|Serotonin Agents|serotonin agents|mesh-ancestor
139499311|NCT05489939|Salicylates|salicylates|mesh-list
139499312|NCT05489939|Methyl salicylate|methyl salicylate|mesh-list
139499313|NCT05489939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139499314|NCT05489939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499315|NCT05489939|Analgesics|analgesics|mesh-ancestor
139499316|NCT05489939|Sensory System Agents|sensory system agents|mesh-ancestor
139499317|NCT05489939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499318|NCT05489939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499319|NCT05489939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499320|NCT05489939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499321|NCT05489939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139499322|NCT05489939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499323|NCT05489939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499324|NCT05483543|Pamiparib|pamiparib|mesh-list
139499325|NCT05483543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139499326|NCT05483543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499327|NCT05483543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499328|NCT05483543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499329|NCT04139213|Naltrexone|naltrexone|mesh-list
139499330|NCT04139213|Buprenorphine|buprenorphine|mesh-list
138867068|NCT02046434|Glycerol|glycerol|mesh-list
139499331|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139499332|NCT04139213|Naloxone|naloxone|mesh-list
139499333|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139499334|NCT04139213|Narcotics|narcotics|mesh-ancestor
139499335|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139499336|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499337|NCT04139213|Analgesics|analgesics|mesh-ancestor
139499338|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
139499339|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499340|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139499341|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139499342|NCT05494775|Mitogens|mitogens|mesh-list
139499343|NCT05494775|Endothelial Growth Factors|endothelial growth factors|mesh-list
139499344|NCT05494775|Mitosis Modulators|mitosis modulators|mesh-ancestor
139499345|NCT05494775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499346|NCT05494775|Growth Substances|growth substances|mesh-ancestor
139499347|NCT05494775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499348|NCT05488925|Vitamin E|vitamin e|mesh-list
139499349|NCT05488925|Diclofenac|diclofenac|mesh-list
139499350|NCT05488925|Piroxicam|piroxicam|mesh-list
139499351|NCT05488925|Tramadol|tramadol|mesh-list
139499352|NCT05488925|Vitamins|vitamins|mesh-ancestor
139499353|NCT05488925|Micronutrients|micronutrients|mesh-ancestor
139499354|NCT05488925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499355|NCT05488925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139499356|NCT05488925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499357|NCT05488925|Analgesics|analgesics|mesh-ancestor
139499358|NCT05488925|Sensory System Agents|sensory system agents|mesh-ancestor
139499359|NCT05488925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499360|NCT05488925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499361|NCT05488925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499362|NCT05488925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139499363|NCT05488925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867095|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499364|NCT05488925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499365|NCT05488925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139499366|NCT05488925|Narcotics|narcotics|mesh-ancestor
139499367|NCT05488925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139499368|NCT05488925|Antioxidants|antioxidants|mesh-ancestor
139499369|NCT05488925|Protective Agents|protective agents|mesh-ancestor
139499370|NCT05482763|Itraconazole|itraconazole|mesh-list
139499371|NCT05482763|Terbinafine|terbinafine|mesh-list
139499372|NCT05482763|Ciclopirox|ciclopirox|mesh-list
139499373|NCT05482763|Amorolfine|amorolfine|mesh-list
139499374|NCT05482763|Antifungal Agents|antifungal agents|mesh-ancestor
139499375|NCT05482763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139499376|NCT05482763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139499377|NCT05482763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139499378|NCT05482763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499379|NCT05482763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499380|NCT05482763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139499381|NCT05482763|Hormone Antagonists|hormone antagonists|mesh-ancestor
139499382|NCT05482763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139499383|NCT05482763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499384|NCT05482763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139499385|NCT05482373|Oleuropein|oleuropein|mesh-list
139499386|NCT05482373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139499387|NCT05482373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139499388|NCT05482373|Vasodilator Agents|vasodilator agents|mesh-ancestor
139499389|NCT05482295|Vaccines|vaccines|mesh-list
139499390|NCT05482295|Immunologic Factors|immunologic factors|mesh-ancestor
139499391|NCT05482295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499392|NCT05494307|Terbutaline|terbutaline|mesh-list
139499393|NCT05494307|Danazol|danazol|mesh-list
139499394|NCT05494307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139499395|NCT05494307|Autonomic Agents|autonomic agents|mesh-ancestor
139499396|NCT05494307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499397|NCT05494307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499398|NCT05494307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139499399|NCT05494307|Respiratory System Agents|respiratory system agents|mesh-ancestor
139499400|NCT05494307|Sympathomimetics|sympathomimetics|mesh-ancestor
139499401|NCT05494307|Tocolytic Agents|tocolytic agents|mesh-ancestor
139499402|NCT05494307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139499403|NCT05494307|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139499404|NCT05494307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139499405|NCT05494307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139499406|NCT05494307|Adrenergic Agents|adrenergic agents|mesh-ancestor
139499407|NCT05494307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499408|NCT05494307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499409|NCT05494307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139499410|NCT05494307|Hormone Antagonists|hormone antagonists|mesh-ancestor
139499411|NCT05494307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139499412|NCT05487521|Methylprednisolone|methylprednisolone|mesh-list
139499413|NCT05487521|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139499414|NCT05487521|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139499415|NCT05487521|Prednisolone|prednisolone|mesh-list
139499416|NCT05487521|Prednisolone acetate|prednisolone acetate|mesh-list
139499417|NCT05487521|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139499418|NCT05487521|Prednisolone phosphate|prednisolone phosphate|mesh-list
139499419|NCT05487521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499420|NCT05487521|Antiemetics|antiemetics|mesh-ancestor
139499421|NCT05487521|Autonomic Agents|autonomic agents|mesh-ancestor
139499422|NCT05487521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499423|NCT05487521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499424|NCT05487521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139499425|NCT05487521|Glucocorticoids|glucocorticoids|mesh-ancestor
139499426|NCT05487521|Hormones|hormones|mesh-ancestor
139499427|NCT05487521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139499428|NCT05487521|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139499429|NCT05487521|Protective Agents|protective agents|mesh-ancestor
139499430|NCT05487521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139499431|NCT05487521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499432|NCT05481281|Dexmedetomidine|dexmedetomidine|mesh-list
139499433|NCT05481281|Ketamine|ketamine|mesh-list
139499434|NCT05481281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139499435|NCT05481281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139499436|NCT05481281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499437|NCT05481281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499438|NCT05481281|Analgesics|analgesics|mesh-ancestor
139499439|NCT05481281|Sensory System Agents|sensory system agents|mesh-ancestor
139499440|NCT05481281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499441|NCT05481281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139499442|NCT05481281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139499443|NCT05481281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139499444|NCT05481281|Adrenergic Agents|adrenergic agents|mesh-ancestor
139499445|NCT05481281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499446|NCT05481281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499447|NCT05481281|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139499448|NCT05481281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139499449|NCT05481281|Anesthetics, General|anesthetics, general|mesh-ancestor
139499450|NCT05481281|Anesthetics|anesthetics|mesh-ancestor
139499451|NCT05481281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139499452|NCT05481281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139499453|NCT05487443|Gemcitabine|gemcitabine|mesh-list
139499454|NCT05487443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139499455|NCT05487443|Antimetabolites|antimetabolites|mesh-ancestor
139499456|NCT05487443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499457|NCT05487443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499458|NCT02558231|Selexipag|selexipag|mesh-list
139499459|NCT02558231|Tadalafil|tadalafil|mesh-list
139499460|NCT02558231|Macitentan|macitentan|mesh-list
139499461|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
139499462|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139499463|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139499464|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499465|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499466|NCT02558231|Urological Agents|urological agents|mesh-ancestor
139499467|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139499468|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139499469|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139499470|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139499471|NCT05486819|Propofol|propofol|mesh-list
139499472|NCT05486819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139499473|NCT05486819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139499474|NCT05486819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499475|NCT05486819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139499476|NCT05486819|Anesthetics, General|anesthetics, general|mesh-ancestor
139499477|NCT05486819|Anesthetics|anesthetics|mesh-ancestor
139499478|NCT05492669|Lidocaine|lidocaine|mesh-list
139499479|NCT05492669|Anesthetics, Local|anesthetics, local|mesh-ancestor
139499480|NCT05492669|Anesthetics|anesthetics|mesh-ancestor
139499481|NCT05492669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139499482|NCT05492669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499483|NCT05492669|Sensory System Agents|sensory system agents|mesh-ancestor
139499484|NCT05492669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867215|NCT02703272|Dexamethasone|dexamethasone|mesh-list
139499485|NCT05492669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139499486|NCT05492669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139499487|NCT05492669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139499488|NCT05492669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139499489|NCT05492669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499490|NCT02554721|Aspirin|aspirin|mesh-list
139499491|NCT02554721|Cilostazol|cilostazol|mesh-list
139286168|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
139499492|NCT02554721|Clopidogrel|clopidogrel|mesh-list
139499493|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139499494|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139499495|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139499496|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139499497|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
139499498|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499499|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499500|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499501|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139499502|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499503|NCT02554721|Analgesics|analgesics|mesh-ancestor
139499504|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
139499505|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499506|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499507|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499508|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139499509|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139499510|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139499511|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499512|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
139499513|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139499514|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
139499515|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139499516|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
139499517|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
139499518|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139499519|NCT02554721|Protective Agents|protective agents|mesh-ancestor
139499520|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139499521|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139499522|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
139499523|NCT03810911|Hematinics|hematinics|mesh-ancestor
139499524|NCT02552225|Amitriptyline|amitriptyline|mesh-list
139499525|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139499526|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
139499527|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139499528|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499529|NCT02552225|Analgesics|analgesics|mesh-ancestor
139499530|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
139499531|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499532|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499533|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139499534|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139499535|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139499536|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499537|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
139499538|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499539|NCT02552147|Nicotine|nicotine|mesh-list
139499540|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139499541|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
139499542|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499543|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499544|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139499545|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139499546|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
139499547|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499548|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499549|NCT05479487|Apatinib|apatinib|mesh-list
139499550|NCT05479487|Fluzoparib|fluzoparib|mesh-list
139499551|NCT05479487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499552|NCT05479487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139499553|NCT05479487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499554|NCT05479487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499555|NCT05479487|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139499556|NCT05479175|Ibuprofen|ibuprofen|mesh-list
139499557|NCT05479175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139499558|NCT05479175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499559|NCT05479175|Analgesics|analgesics|mesh-ancestor
139499560|NCT05479175|Sensory System Agents|sensory system agents|mesh-ancestor
139499561|NCT05479175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499562|NCT05479175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499563|NCT05479175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499564|NCT05479175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139286245|NCT03068260|Ibuprofen|ibuprofen|mesh-list
139499565|NCT05479175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139499566|NCT05479175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499567|NCT05479175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499568|NCT02534935|Vaccines|vaccines|mesh-list
139499569|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
139499570|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499571|NCT02544451|Ivacaftor|ivacaftor|mesh-list
139499572|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139499573|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139499574|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499575|NCT02551991|Leucovorin|leucovorin|mesh-list
139499576|NCT02551991|Fluorouracil|fluorouracil|mesh-list
139499577|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
139499578|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
139499579|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499580|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139499581|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499582|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139499583|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
139499584|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499585|NCT02551991|Antidotes|antidotes|mesh-ancestor
139499586|NCT02551991|Protective Agents|protective agents|mesh-ancestor
139499587|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
139499588|NCT02551991|Vitamins|vitamins|mesh-ancestor
139499589|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
139499590|NCT05491811|Bevacizumab|bevacizumab|mesh-list
139499591|NCT05491811|Ensartinib|ensartinib|mesh-list
139499592|NCT05491811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139499593|NCT05491811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499594|NCT05491811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139499595|NCT05491811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139499596|NCT05491811|Growth Substances|growth substances|mesh-ancestor
139499597|NCT05491811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499598|NCT05491811|Growth Inhibitors|growth inhibitors|mesh-ancestor
139499599|NCT05491811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139499600|NCT05491811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499601|NCT05491811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499602|NCT05478785|Cisplatin|cisplatin|mesh-list
139499603|NCT05478785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499604|NCT02865551|Anesthetics|anesthetics|mesh-list
139499605|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139499606|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499607|NCT05478083|Leuprolide|leuprolide|mesh-list
139499608|NCT05478083|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138867385|NCT02698514|Desflurane|desflurane|mesh-list
139499609|NCT05478083|Fertility Agents|fertility agents|mesh-ancestor
139499610|NCT05478083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139499611|NCT05478083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499612|NCT05478083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139499613|NCT05478083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499614|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
139499615|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
139499616|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499617|NCT02544217|Protective Agents|protective agents|mesh-ancestor
139499618|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499619|NCT05427565|Caffeine|caffeine|mesh-list
139499620|NCT05427565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139499621|NCT05427565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499622|NCT05427565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139499623|NCT05427565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499624|NCT05427565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499625|NCT05427565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139499626|NCT05427565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139499627|NCT05427565|Purinergic Agents|purinergic agents|mesh-ancestor
139499628|NCT05427565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499629|NCT02533453|Exenatide|exenatide|mesh-list
139499630|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139499631|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499632|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139499633|NCT02533453|Incretins|incretins|mesh-ancestor
139499634|NCT02533453|Hormones|hormones|mesh-ancestor
139499635|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139499636|NCT05424835|Capecitabine|capecitabine|mesh-list
139499637|NCT05424835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139499638|NCT05424835|Antimetabolites|antimetabolites|mesh-ancestor
139286318|NCT02166450|Nystatin|nystatin|mesh-list
139499639|NCT05424835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499640|NCT05424835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499641|NCT02533375|Adalimumab|adalimumab|mesh-list
139499642|NCT02533375|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139499643|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499644|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499645|NCT02551055|Paclitaxel|paclitaxel|mesh-list
139499646|NCT02551055|Docetaxel|docetaxel|mesh-list
139499647|NCT02551055|Serabelisib|serabelisib|mesh-list
139499648|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139499649|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499650|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
139499651|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
139499652|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
139499653|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499654|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499655|NCT05470673|Metronidazole|metronidazole|mesh-list
139499656|NCT05470673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139499657|NCT05470673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139499658|NCT05470673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139499659|NCT05470673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139499660|NCT05459285|Dulaglutide|dulaglutide|mesh-list
139499661|NCT05459285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139499662|NCT05459285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499663|NCT02542943|Fluorides|fluorides|mesh-list
139499664|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
139499665|NCT02542943|Protective Agents|protective agents|mesh-ancestor
139499666|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499667|NCT03284957|Everolimus|everolimus|mesh-list
139499668|NCT03284957|Palbociclib|palbociclib|mesh-list
139499669|NCT03284957|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139499670|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139499671|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499672|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499673|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139499674|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
139499675|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499676|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499677|NCT02542631|Insulin|insulin|mesh-list
139499678|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139499679|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139499680|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499681|NCT05477615|Carboplatin|carboplatin|mesh-list
139499682|NCT05477615|Pemetrexed|pemetrexed|mesh-list
139499683|NCT05477615|Lazertinib|lazertinib|mesh-list
139499684|NCT05477615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499685|NCT05477615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499686|NCT05477615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499687|NCT05477615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139499688|NCT05477615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139499689|NCT05477615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139499690|NCT02529553|LY3076226|ly3076226|mesh-list
139499691|NCT02529553|Immunoconjugates|immunoconjugates|mesh-ancestor
139499692|NCT02529553|Immunologic Factors|immunologic factors|mesh-ancestor
139499693|NCT02529553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499694|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
139499695|NCT02547935|Saxagliptin|saxagliptin|mesh-list
139499696|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139499697|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499698|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139499699|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499700|NCT02547935|Incretins|incretins|mesh-ancestor
139499701|NCT02547935|Hormones|hormones|mesh-ancestor
138867445|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
139499702|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139499703|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139499704|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
139499705|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499706|NCT04258111|Antibodies|antibodies|mesh-list
139499707|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
139499708|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
139499709|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499710|NCT02327169|Paclitaxel|paclitaxel|mesh-list
139499711|NCT02327169|Irinotecan|irinotecan|mesh-list
139286400|NCT02174718|Vitamin D|vitamin d|mesh-list
139499712|NCT02327169|Cetuximab|cetuximab|mesh-list
139499713|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139499714|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499715|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
139499716|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
139499717|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
139499718|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499719|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139499720|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139499721|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499722|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139499723|NCT02327013|Vortioxetine|vortioxetine|mesh-list
139499724|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
139499725|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139499726|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139499727|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139499728|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139499729|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499730|NCT02327013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139499731|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139499732|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139499733|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499734|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499735|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
139499736|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139499737|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139499738|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139499739|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139499740|NCT02301975|Fluticasone|fluticasone|mesh-list
139499741|NCT02301975|Xhance|xhance|mesh-list
139499742|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139499743|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499744|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139499745|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
139499746|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499747|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499748|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139499749|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
139499750|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
139499751|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139499752|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139499753|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139499754|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139499755|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
139499756|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499757|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499758|NCT04882839|Psilocybin|psilocybin|mesh-list
139499759|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
139499760|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499761|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139499762|NCT02300259|Itraconazole|itraconazole|mesh-list
139499763|NCT02300259|Diltiazem|diltiazem|mesh-list
139499764|NCT02300259|Tadalafil|tadalafil|mesh-list
139499765|NCT02300259|Simvastatin|simvastatin|mesh-list
139499766|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139499767|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139499768|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
139499769|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499770|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139499771|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139499772|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499773|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
139499774|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139499775|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139499776|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139499777|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139499778|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
139499779|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139499780|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499781|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139499782|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
139499783|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139499784|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139499785|NCT02300259|Urological Agents|urological agents|mesh-ancestor
139499786|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139499787|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139499788|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139499789|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139499791|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139499792|NCT02300103|Velpatasvir|velpatasvir|mesh-list
139499793|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
139499794|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139499795|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
139499796|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139499797|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139499798|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139499799|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
139499800|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
139499801|NCT02299635|Nirogacestat|nirogacestat|mesh-list
139499802|NCT02299635|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139499803|NCT02299635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499804|NCT02299635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499805|NCT02366091|Methotrexate|methotrexate|mesh-list
139499806|NCT02366091|Colchicine|colchicine|mesh-list
139499807|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139499808|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
139499809|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139499810|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499811|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139499812|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
139499813|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499814|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499815|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
139499816|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499817|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139499818|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139499819|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
139499820|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499821|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139499822|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
139499823|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
139499824|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
139499825|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
139499826|NCT05476679|Celecoxib|celecoxib|mesh-list
139499827|NCT05476679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139499828|NCT05476679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499829|NCT05476679|Analgesics|analgesics|mesh-ancestor
139499830|NCT05476679|Sensory System Agents|sensory system agents|mesh-ancestor
139499831|NCT05476679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499832|NCT05476679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499833|NCT05476679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499834|NCT05476679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499835|NCT05476679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139499836|NCT05476679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139499837|NCT05476679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499838|NCT05476679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499839|NCT02546765|Acetaminophen|acetaminophen|mesh-list
138867612|NCT02698124|Decitabine|decitabine|mesh-list
139499840|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
139499841|NCT02546765|Propofol|propofol|mesh-list
139499842|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139499843|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139499844|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499845|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499846|NCT02546765|Analgesics|analgesics|mesh-ancestor
139499847|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
139499848|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499849|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139499850|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139499851|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139499852|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
139499853|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499854|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499855|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139499856|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
139499857|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
139499858|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
139499859|NCT02553629|Rocuronium|rocuronium|mesh-list
139286540|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139286541|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
139286542|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286544|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
139499860|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139499861|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139499862|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139499863|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499864|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499865|NCT03029351|Exenatide|exenatide|mesh-list
139499866|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139499867|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499868|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139499869|NCT03029351|Incretins|incretins|mesh-ancestor
139499870|NCT03029351|Hormones|hormones|mesh-ancestor
139499871|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139499872|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139499873|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
139499874|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499875|NCT02365233|Insulin|insulin|mesh-list
139499876|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139499877|NCT02365233|Pioglitazone|pioglitazone|mesh-list
139499878|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139499879|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
139499880|NCT02365233|Saxagliptin|saxagliptin|mesh-list
139499881|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139499882|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139499883|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499884|NCT02365233|Incretins|incretins|mesh-ancestor
139499885|NCT02365233|Hormones|hormones|mesh-ancestor
139499886|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139499887|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
139499888|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867681|NCT03170882|Pomalidomide|pomalidomide|mesh-list
139499889|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499890|NCT02364999|Paclitaxel|paclitaxel|mesh-list
139499891|NCT02364999|Bevacizumab|bevacizumab|mesh-list
139499892|NCT02364999|Carboplatin|carboplatin|mesh-list
139499893|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139499894|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499895|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
139499896|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
139499897|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
139499898|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499899|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139499900|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139499901|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139499902|NCT02364999|Growth Substances|growth substances|mesh-ancestor
139499903|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499904|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
139499905|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
139499906|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
139499907|NCT02363283|Immunotoxins|immunotoxins|mesh-list
139499908|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139499909|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
139499910|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499911|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139499912|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499913|NCT02321319|Hydromorphone|hydromorphone|mesh-list
139499914|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139499915|NCT02321319|Narcotics|narcotics|mesh-ancestor
139499916|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139499917|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499918|NCT02321319|Analgesics|analgesics|mesh-ancestor
139499919|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
139499920|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499921|NCT02088541|Cytarabine|cytarabine|mesh-list
139499922|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
139499923|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139499924|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
139499925|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499926|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139499927|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
139499928|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139499929|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139499930|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
139499931|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499932|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
139499933|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139286616|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499934|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139499935|NCT02294019|Ibuprofen|ibuprofen|mesh-list
139499936|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139499937|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499938|NCT02294019|Analgesics|analgesics|mesh-ancestor
139499939|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
139499940|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499941|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499942|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499943|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499944|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139499945|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499946|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499947|NCT02320149|Sarecycline|sarecycline|mesh-list
139499948|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139499949|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139499950|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
139499951|NCT05405725|Denosumab|denosumab|mesh-list
139499952|NCT05405725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139499953|NCT05405725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499954|NCT02293863|Oseltamivir|oseltamivir|mesh-list
139499955|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
139499956|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139499957|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499958|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499959|NCT02293395|Aspirin|aspirin|mesh-list
139499960|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
139499961|NCT02293395|Clopidogrel|clopidogrel|mesh-list
139499962|NCT02293395|Ticagrelor|ticagrelor|mesh-list
139499963|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139499964|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139499965|NCT02293395|Analgesics|analgesics|mesh-ancestor
139499966|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
139499967|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139499968|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499969|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139499970|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139499971|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139499972|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139499973|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139499974|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139091753|NCT04165772|Capecitabine|capecitabine|mesh-list
139499975|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139499976|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139499977|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
139499978|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139499979|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139499980|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139499981|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
139499982|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139499983|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139499984|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
139499985|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139499986|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
139499987|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
139499988|NCT05447065|Vitamin D|vitamin d|mesh-list
139499989|NCT05447065|Vitamins|vitamins|mesh-ancestor
139499990|NCT05447065|Micronutrients|micronutrients|mesh-ancestor
139499991|NCT05447065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139499992|NCT05447065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139499993|NCT05401357|Bimatoprost|bimatoprost|mesh-list
139499994|NCT05401357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139499995|NCT05401357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139499996|NCT05401357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139499997|NCT05401279|Gemcitabine|gemcitabine|mesh-list
139499998|NCT05401279|Tislelizumab|tislelizumab|mesh-list
139499999|NCT05401279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500000|NCT05401279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139500001|NCT05401279|Antimetabolites|antimetabolites|mesh-ancestor
139500002|NCT05401279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500003|NCT05401279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139500004|NCT05451095|Ketamine|ketamine|mesh-list
139500005|NCT05451095|Analgesics|analgesics|mesh-ancestor
139500006|NCT05451095|Sensory System Agents|sensory system agents|mesh-ancestor
139500007|NCT05451095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500008|NCT05451095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500009|NCT05451095|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139500010|NCT05451095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139500011|NCT05451095|Anesthetics, General|anesthetics, general|mesh-ancestor
139500012|NCT05451095|Anesthetics|anesthetics|mesh-ancestor
139500013|NCT05451095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500014|NCT05451095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139500015|NCT05451095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139500016|NCT05451095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500017|NCT05451095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500018|NCT02954081|Apremilast|apremilast|mesh-list
139500019|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139500020|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139500021|NCT02954081|Analgesics|analgesics|mesh-ancestor
139500022|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
139500023|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500024|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500025|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139500026|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139500027|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139500028|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139500029|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500030|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500031|NCT02532283|Oseltamivir|oseltamivir|mesh-list
139500032|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
139500033|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139500034|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500035|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500036|NCT05398705|Cepharanthine|cepharanthine|mesh-list
139500037|NCT05398705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139500038|NCT05398705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139500039|NCT05398705|Analgesics|analgesics|mesh-ancestor
139500040|NCT05398705|Sensory System Agents|sensory system agents|mesh-ancestor
139500041|NCT05398705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500042|NCT05398705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500043|NCT05398705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139500044|NCT05398705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139500045|NCT05398705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139500046|NCT05398705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500047|NCT05398705|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139500048|NCT05398705|Protective Agents|protective agents|mesh-ancestor
139500049|NCT05415865|Lidocaine|lidocaine|mesh-list
139500050|NCT05415865|Anesthetics, Local|anesthetics, local|mesh-ancestor
139500051|NCT05415865|Anesthetics|anesthetics|mesh-ancestor
139500052|NCT05415865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500053|NCT05415865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500054|NCT05415865|Sensory System Agents|sensory system agents|mesh-ancestor
139500055|NCT05415865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500056|NCT05415865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139500057|NCT05415865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139500058|NCT05415865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139500059|NCT05415865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139500060|NCT05415865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500061|NCT02552303|Modafinil|modafinil|mesh-list
139500062|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139500063|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500064|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139500065|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139500066|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139500067|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500068|NCT01660711|Leucovorin|leucovorin|mesh-list
139500069|NCT01660711|Fluorouracil|fluorouracil|mesh-list
139500070|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
139500071|NCT01660711|Irinotecan|irinotecan|mesh-list
139500072|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
139500073|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500074|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139500075|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500076|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139500077|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
139500078|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500079|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139500080|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139500081|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500082|NCT01660711|Antidotes|antidotes|mesh-ancestor
139500083|NCT01660711|Protective Agents|protective agents|mesh-ancestor
139500084|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
139500085|NCT01660711|Vitamins|vitamins|mesh-ancestor
139091871|NCT03728673|Dexetimide|dexetimide|mesh-list
139500086|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
139500087|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
139500088|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139500089|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
139500090|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500091|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139500092|NCT02538965|Lenalidomide|lenalidomide|mesh-list
139500093|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
139500094|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500095|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139500096|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139500097|NCT02538965|Growth Substances|growth substances|mesh-ancestor
139500098|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
139500099|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500100|NCT02543801|Ketorolac|ketorolac|mesh-list
139500101|NCT02543801|Clonidine|clonidine|mesh-list
139500102|NCT02543801|Epinephrine|epinephrine|mesh-list
139500103|NCT02543801|Bupivacaine|bupivacaine|mesh-list
139500104|NCT02543801|Ropivacaine|ropivacaine|mesh-list
139500105|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
139500106|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
139500107|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500108|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500109|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
139500110|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500111|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139500112|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139500113|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
139500114|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500115|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500116|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139500117|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139500118|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
139091899|NCT03727061|Trioxsalen|trioxsalen|mesh-list
139500119|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139500120|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
139500121|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
139500122|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
139500123|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139500124|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139500125|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139500126|NCT02543801|Analgesics|analgesics|mesh-ancestor
139500127|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139500128|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139500129|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139500130|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500131|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139500132|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
139500133|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139500134|NCT02481635|Paclitaxel|paclitaxel|mesh-list
139500135|NCT02481635|Gemcitabine|gemcitabine|mesh-list
139500136|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139500137|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500138|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
139500139|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
139500140|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
139500141|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500142|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139500143|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
139500144|NCT05411159|Analgesics, Opioid|analgesics, opioid|mesh-list
139500145|NCT05411159|Anesthetics|anesthetics|mesh-list
139500146|NCT05411159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500147|NCT05411159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500148|NCT05411159|Narcotics|narcotics|mesh-ancestor
139500149|NCT05411159|Analgesics|analgesics|mesh-ancestor
139500150|NCT05411159|Sensory System Agents|sensory system agents|mesh-ancestor
139500151|NCT05411159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500152|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
139500153|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139500154|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
139500155|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139500156|NCT02362425|Expectorants|expectorants|mesh-ancestor
139500157|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
139500158|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139500159|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
139500160|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500161|NCT02362425|Protective Agents|protective agents|mesh-ancestor
139500162|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500163|NCT02362425|Antidotes|antidotes|mesh-ancestor
139500164|NCT02362269|Vitamin D|vitamin d|mesh-list
139500165|NCT02362269|Vitamins|vitamins|mesh-ancestor
139500166|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
139500167|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500168|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139500169|NCT02529995|Osimertinib|osimertinib|mesh-list
139500170|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500171|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139500172|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500173|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500174|NCT02319759|Ustekinumab|ustekinumab|mesh-list
139500175|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
139500176|NCT02318667|Golimumab|golimumab|mesh-list
139500177|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139500178|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139500179|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139500180|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
139500181|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500182|NCT02292771|Vasotocin|vasotocin|mesh-list
139500183|NCT02292771|Atosiban|atosiban|mesh-list
139500184|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
139500185|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139500186|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500187|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
139500188|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139500189|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
139500190|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139500191|NCT02291913|Tamoxifen|tamoxifen|mesh-list
139500192|NCT02291913|Everolimus|everolimus|mesh-list
139500193|NCT02291913|Letrozole|letrozole|mesh-list
139500194|NCT02291913|Fulvestrant|fulvestrant|mesh-list
139500195|NCT02291913|Anastrozole|anastrozole|mesh-list
139500196|NCT02291913|Exemestane|exemestane|mesh-list
139500197|NCT02291913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139500198|NCT02291913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139500199|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500200|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500201|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139500202|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
139500203|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500204|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500205|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139500206|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139500207|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139500208|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
139091976|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500209|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139500210|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139500211|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139500212|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139500213|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139500214|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139500215|NCT02291679|Linaclotide|linaclotide|mesh-list
139500216|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139500217|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
139500218|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500219|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139500220|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
139500221|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139500222|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139500223|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139500224|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
139500225|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
139500226|NCT02360475|Vaccines|vaccines|mesh-list
139500227|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
139500228|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500229|NCT02360397|Ranolazine|ranolazine|mesh-list
139500230|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139500231|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139500232|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500233|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139500234|NCT02317809|Hormones|hormones|mesh-ancestor
139500235|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139500236|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500237|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
139500238|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139500239|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500240|NCT02359851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139500241|NCT02359851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500243|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139500244|NCT01607905|Analgesics|analgesics|mesh-ancestor
139500245|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
139500246|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500247|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500248|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
139500249|NCT02389543|Dexamethasone|dexamethasone|mesh-list
139500250|NCT02389543|Lenalidomide|lenalidomide|mesh-list
139500251|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139500252|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
139500253|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
139500254|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500255|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500256|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139500257|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
139500258|NCT02389543|Hormones|hormones|mesh-ancestor
139500259|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139500260|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139500261|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500262|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
139500263|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139500264|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139500265|NCT02389543|Growth Substances|growth substances|mesh-ancestor
139500266|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
139500267|NCT05441605|Chlorhexidine|chlorhexidine|mesh-list
139500268|NCT05441605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139500269|NCT05441605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139500270|NCT05441605|Disinfectants|disinfectants|mesh-ancestor
139500271|NCT00843037|Sunitinib|sunitinib|mesh-list
139500272|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500273|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139500274|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139500275|NCT00843037|Growth Substances|growth substances|mesh-ancestor
139500276|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500277|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
139500278|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139500279|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500280|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500281|NCT05441527|Muramidase|muramidase|mesh-list
139500282|NCT05441527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139500283|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139500284|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139500285|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500286|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139500287|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500288|NCT05004805|Methylene Blue|methylene blue|mesh-list
139500289|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500290|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500291|NCT04261387|LUT014|lut014|mesh-list
139500292|NCT04261387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139500293|NCT04261387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500294|NCT04261387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500295|NCT05411965|Pioglitazone|pioglitazone|mesh-list
139500296|NCT05411965|Dapagliflozin|dapagliflozin|mesh-list
139500297|NCT05411965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139500298|NCT05411965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500299|NCT05411965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139500300|NCT05411965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500301|NCT04261075|Durvalumab|durvalumab|mesh-list
139500302|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139500303|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500304|NCT05436769|Clarithromycin|clarithromycin|mesh-list
139500305|NCT05436769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139500306|NCT05436769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139500307|NCT05436769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139500308|NCT05436769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500309|NCT05436769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500310|NCT05436769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139500311|NCT05436769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139500312|NCT01659853|Azelaic acid|azelaic acid|mesh-list
139500313|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139500314|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139500315|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139500316|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139500317|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139500318|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
139500319|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500320|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500321|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500322|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500323|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
139500324|NCT05576389|Fluzoparib|fluzoparib|mesh-list
139500325|NCT05576389|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139500326|NCT05576389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500327|NCT05576389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500328|NCT05576389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500329|NCT05341609|Ritonavir|ritonavir|mesh-list
139500330|NCT05341609|Nirmatrelvir|nirmatrelvir|mesh-list
139500331|NCT05341609|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139500332|NCT05341609|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139500333|NCT05341609|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139500334|NCT05341609|Protease Inhibitors|protease inhibitors|mesh-ancestor
139500335|NCT05341609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500336|NCT05341609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500337|NCT05341609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139500338|NCT05341609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139500339|NCT05341609|Antiviral Agents|antiviral agents|mesh-ancestor
139500340|NCT05341609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139500341|NCT05341609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139500342|NCT05341609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139500343|NCT05371015|Ropivacaine|ropivacaine|mesh-list
139500344|NCT05371015|Anesthetics, Local|anesthetics, local|mesh-ancestor
139500345|NCT05371015|Anesthetics|anesthetics|mesh-ancestor
139500346|NCT05371015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500347|NCT05371015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500348|NCT05371015|Sensory System Agents|sensory system agents|mesh-ancestor
139500349|NCT05371015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500350|NCT02531113|Ozanimod|ozanimod|mesh-list
139500351|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139500352|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500353|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139500354|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
139500355|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500356|NCT04248595|Azacitidine|azacitidine|mesh-list
139500357|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
139500358|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139500359|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
139500360|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500361|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500362|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500363|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139500364|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139500365|NCT05334277|Bevacizumab|bevacizumab|mesh-list
139500366|NCT05334277|Carboplatin|carboplatin|mesh-list
139500367|NCT05334277|Pemetrexed|pemetrexed|mesh-list
139500368|NCT05334277|Aflutinib|aflutinib|mesh-list
139500369|NCT05334277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139500370|NCT05334277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500371|NCT05334277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139500372|NCT05334277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139500373|NCT05334277|Growth Substances|growth substances|mesh-ancestor
139500374|NCT05334277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500375|NCT05334277|Growth Inhibitors|growth inhibitors|mesh-ancestor
139500376|NCT05334277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500377|NCT05334277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500378|NCT05334277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139500379|NCT05334277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139500380|NCT05334277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139500381|NCT05332717|Melatonin|melatonin|mesh-list
139287063|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
139500382|NCT05332717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500383|NCT05332717|Antioxidants|antioxidants|mesh-ancestor
139500384|NCT05332717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500385|NCT05332717|Protective Agents|protective agents|mesh-ancestor
139500386|NCT05332717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500387|NCT05300269|Capecitabine|capecitabine|mesh-list
139500388|NCT05300269|Oxaliplatin|oxaliplatin|mesh-list
139500389|NCT05300269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139500390|NCT05300269|Antimetabolites|antimetabolites|mesh-ancestor
139500391|NCT05300269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500392|NCT05300269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500393|NCT05353933|Pantoprazole|pantoprazole|mesh-list
139500394|NCT05353933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139500395|NCT05353933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139500396|NCT05353933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139500397|NCT05353933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500398|NCT05353933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500399|NCT05352685|Propofol|propofol|mesh-list
139500400|NCT05352685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139500401|NCT05352685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500402|NCT05352685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500403|NCT05352685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139500404|NCT05352685|Anesthetics, General|anesthetics, general|mesh-ancestor
139500405|NCT05352685|Anesthetics|anesthetics|mesh-ancestor
139500406|NCT05321875|Candesartan|candesartan|mesh-list
139500407|NCT05321875|Candesartan cilexetil|candesartan cilexetil|mesh-list
139500408|NCT05321875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139500409|NCT05321875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139500410|NCT05321875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139500411|NCT05321875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500412|NCT02522767|Mesalamine|mesalamine|mesh-list
139500413|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139500414|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139500415|NCT02522767|Analgesics|analgesics|mesh-ancestor
139500416|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
139500417|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500418|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500419|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139500420|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139500421|NCT02522377|Midazolam|midazolam|mesh-list
139500422|NCT02522377|Ketamine|ketamine|mesh-list
139500423|NCT02522377|Analgesics|analgesics|mesh-ancestor
139500424|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
139500425|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500426|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092141|NCT02143401|Sorafenib|sorafenib|mesh-list
139500427|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139500428|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139500429|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
139500430|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
139500431|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500432|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139500433|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139500434|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500435|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500436|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139500437|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139500438|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139500439|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139500440|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139500441|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
139500442|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
139500443|NCT05267743|Lansoprazole|lansoprazole|mesh-list
139500444|NCT05267743|Dexlansoprazole|dexlansoprazole|mesh-list
139500445|NCT05267743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139500446|NCT05267743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139500447|NCT05267743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139500448|NCT05267743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500449|NCT05267743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500450|NCT05291845|Vaccines|vaccines|mesh-list
139500451|NCT05291845|Immunologic Factors|immunologic factors|mesh-ancestor
139500452|NCT05291845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500453|NCT05314621|Fluticasone|fluticasone|mesh-list
139500454|NCT05314621|Xhance|xhance|mesh-list
139500455|NCT05314621|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139500456|NCT05314621|Dextrans|dextrans|mesh-list
139500457|NCT05314621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139500458|NCT05314621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139500459|NCT05314621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139500460|NCT05314621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139500461|NCT05314621|Autonomic Agents|autonomic agents|mesh-ancestor
139500462|NCT05314621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500463|NCT05314621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500464|NCT05314621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139500465|NCT05314621|Respiratory System Agents|respiratory system agents|mesh-ancestor
139500466|NCT05314621|Dermatologic Agents|dermatologic agents|mesh-ancestor
139500467|NCT05314621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139500468|NCT05314621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139092172|NCT01972919|Gemcitabine|gemcitabine|mesh-list
139500469|NCT05314621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139500470|NCT05314621|Analgesics|analgesics|mesh-ancestor
139500471|NCT05314621|Sensory System Agents|sensory system agents|mesh-ancestor
139500472|NCT05314621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139500473|NCT05314621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139500474|NCT05314621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139500475|NCT05314621|Histamine Antagonists|histamine antagonists|mesh-ancestor
139500476|NCT05314621|Histamine Agents|histamine agents|mesh-ancestor
139500477|NCT05314621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500478|NCT05314621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500479|NCT05314621|Anticoagulants|anticoagulants|mesh-ancestor
139500480|NCT05314621|Plasma Substitutes|plasma substitutes|mesh-ancestor
139500481|NCT05314621|Blood Substitutes|blood substitutes|mesh-ancestor
139500482|NCT05263609|Pembrolizumab|pembrolizumab|mesh-list
139500483|NCT05263609|Axitinib|axitinib|mesh-list
139500484|NCT05263609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139500485|NCT05263609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500486|NCT05263609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139500487|NCT05263609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500488|NCT05263609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139500489|NCT05263609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500490|NCT05313997|Diclofenac|diclofenac|mesh-list
139500491|NCT05313997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139500492|NCT05313997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139500493|NCT05313997|Analgesics|analgesics|mesh-ancestor
139500494|NCT05313997|Sensory System Agents|sensory system agents|mesh-ancestor
139500495|NCT05313997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500496|NCT05313997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500497|NCT05313997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139500498|NCT05313997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139500499|NCT05313997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139500500|NCT05313997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500501|NCT05313997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500502|NCT05259241|Thrombin|thrombin|mesh-list
139500503|NCT05259241|Hemostatics|hemostatics|mesh-ancestor
139500504|NCT05259241|Coagulants|coagulants|mesh-ancestor
139500505|NCT01657903|Listerine|listerine|mesh-list
139500506|NCT01657903|Fluorides|fluorides|mesh-list
139500507|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
139500508|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
139500509|NCT01657903|Protective Agents|protective agents|mesh-ancestor
139500510|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500511|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139500512|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139500513|NCT05256823|Celecoxib|celecoxib|mesh-list
139500514|NCT05256823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139500515|NCT05256823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139500516|NCT05256823|Analgesics|analgesics|mesh-ancestor
139500517|NCT05256823|Sensory System Agents|sensory system agents|mesh-ancestor
139500518|NCT05256823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500519|NCT05256823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500520|NCT05256823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139500521|NCT05256823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139500522|NCT05256823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139500523|NCT05256823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139500524|NCT05256823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500525|NCT05256823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500526|NCT05253937|Epinephrine|epinephrine|mesh-list
139500527|NCT05253937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139500528|NCT05253937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139500529|NCT05253937|Adrenergic Agents|adrenergic agents|mesh-ancestor
139500530|NCT05253937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500531|NCT05253937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500532|NCT05253937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500533|NCT05253937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139500534|NCT05253937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139500535|NCT05253937|Autonomic Agents|autonomic agents|mesh-ancestor
139500536|NCT05253937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500537|NCT05253937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139500538|NCT05253937|Respiratory System Agents|respiratory system agents|mesh-ancestor
139500539|NCT05253937|Mydriatics|mydriatics|mesh-ancestor
139500540|NCT05253937|Sympathomimetics|sympathomimetics|mesh-ancestor
139500541|NCT05253937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139500542|NCT05218603|Bortezomib|bortezomib|mesh-list
139500543|NCT05218603|Daratumumab|daratumumab|mesh-list
139500544|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500545|NCT05214001|Almotriptan|almotriptan|mesh-list
139500546|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139500547|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
139500548|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500549|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500550|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500551|NCT05277337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139500552|NCT05277337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139500553|NCT05277337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500554|NCT05277337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500555|NCT05277337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139500556|NCT05277337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139500557|NCT05277337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500558|NCT05277337|Cholinergic Agents|cholinergic agents|mesh-ancestor
139500559|NCT05277337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500560|NCT05248945|Carbamazepine|carbamazepine|mesh-list
139500561|NCT05248945|Anticonvulsants|anticonvulsants|mesh-ancestor
139500562|NCT05248945|Antimanic Agents|antimanic agents|mesh-ancestor
139500563|NCT05248945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139500564|NCT05248945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500565|NCT05248945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500566|NCT05248945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139500567|NCT05248945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139500568|NCT05248945|Analgesics|analgesics|mesh-ancestor
139500569|NCT05248945|Sensory System Agents|sensory system agents|mesh-ancestor
139500570|NCT05248945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500571|NCT05248945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139500572|NCT05248945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139500573|NCT05248945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500574|NCT05248945|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139500575|NCT05248945|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139500576|NCT04239313|Vaccines|vaccines|mesh-list
139092218|NCT01722266|Liraglutide|liraglutide|mesh-list
139500577|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
139500578|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500579|NCT05209711|Lidocaine|lidocaine|mesh-list
139500580|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
139500581|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
139500582|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500583|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500584|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
139500585|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500586|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139500587|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139500588|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139500589|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139500590|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500591|NCT05272969|Vitamin D|vitamin d|mesh-list
139500592|NCT05272969|Calcium|calcium|mesh-list
139500593|NCT05272969|Vitamins|vitamins|mesh-ancestor
139500594|NCT05272969|Micronutrients|micronutrients|mesh-ancestor
139500595|NCT05272969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500596|NCT05272969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139500597|NCT05272969|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139500598|NCT05206747|Methamphetamine|methamphetamine|mesh-list
139500599|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139500600|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500601|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
139500602|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
139500603|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500604|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
139500605|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500606|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500608|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139500609|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139500610|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139500611|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139500612|NCT05205811|Zonisamide|zonisamide|mesh-list
139500613|NCT05205811|Bupropion|bupropion|mesh-list
139500614|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139500615|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
139500616|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139500617|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139500618|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139500619|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139500620|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500621|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
139500622|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500623|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092234|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139500624|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139500625|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139500626|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500627|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
139500628|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139500629|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139500630|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139500631|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
139500632|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500633|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139500634|NCT05166343|Epinephrine|epinephrine|mesh-list
139500635|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139500636|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139500637|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
139500638|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500639|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500640|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500641|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139500642|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139500643|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
139500644|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500645|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139500646|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
139500647|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
139500648|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
139500649|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139500650|NCT01656733|Nicotine|nicotine|mesh-list
139500651|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139500652|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
139500653|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500654|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500655|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139500656|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139500657|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
139500658|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500659|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500660|NCT05236543|Itraconazole|itraconazole|mesh-list
139500661|NCT05236543|Antifungal Agents|antifungal agents|mesh-ancestor
139500662|NCT05236543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139500663|NCT05236543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139500664|NCT05236543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139500665|NCT05236543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500666|NCT05236543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500667|NCT05236543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139092273|NCT00673816|Sunitinib|sunitinib|mesh-list
139500668|NCT05236543|Hormone Antagonists|hormone antagonists|mesh-ancestor
139500669|NCT05236543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139500670|NCT05236543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500671|NCT05236543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139500672|NCT05157841|Bupivacaine|bupivacaine|mesh-list
139500673|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
139500674|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
139500675|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500676|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500677|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
139287369|NCT02172534|Bromides|bromides|mesh-list
139500678|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500680|NCT05225155|Anticoagulants|anticoagulants|mesh-ancestor
139500681|NCT05225155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139500682|NCT05225155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139500683|NCT05225155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500684|NCT05190445|Paclitaxel|paclitaxel|mesh-list
139500685|NCT05190445|Ramucirumab|ramucirumab|mesh-list
139500686|NCT05190445|Tucatinib|tucatinib|mesh-list
139500687|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139500688|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500689|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
139500690|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
139500691|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
139500692|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500693|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139500694|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500695|NCT05148949|Vaccines|vaccines|mesh-list
139500696|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
139500697|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500698|NCT05107999|Doxepin|doxepin|mesh-list
139500699|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
139500700|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
139500701|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139500702|NCT05107999|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139500703|NCT05107999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139500704|NCT05107999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500705|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500706|NCT05107999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139500707|NCT05107999|Histamine Antagonists|histamine antagonists|mesh-ancestor
139500708|NCT05107999|Histamine Agents|histamine agents|mesh-ancestor
139500709|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500710|NCT05186545|Fulvestrant|fulvestrant|mesh-list
139500711|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139500712|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500713|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139500714|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139500715|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
139500716|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139500717|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500718|NCT05107765|Pioglitazone|pioglitazone|mesh-list
139500719|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139500720|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500721|NCT05094427|Anesthetics|anesthetics|mesh-list
139500722|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
139500723|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500724|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500725|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
139500726|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500727|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
139500728|NCT05175781|Ketamine|ketamine|mesh-list
139500729|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139500730|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500731|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500732|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139500733|NCT05175781|Analgesics|analgesics|mesh-ancestor
139500734|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
139500735|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500736|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139500737|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139500738|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139500739|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
139500740|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500741|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500742|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139500743|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139500744|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
139500745|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
139500746|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139500747|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139500748|NCT04421911|Diclofenac|diclofenac|mesh-list
139500749|NCT04421911|Ketoprofen|ketoprofen|mesh-list
139500750|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139287435|NCT05588284|Antithrombins|antithrombins|mesh-ancestor
139500752|NCT04421911|Analgesics|analgesics|mesh-ancestor
139500753|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
139500754|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092337|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
139500755|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500756|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139500757|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139500758|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139500759|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500760|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500761|NCT05174611|Vitamin D|vitamin d|mesh-list
139500762|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
139500763|NCT05174611|Vitamins|vitamins|mesh-ancestor
139500764|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
139500765|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500766|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139500767|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139500768|NCT05133817|Norepinephrine|norepinephrine|mesh-list
139500769|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139500770|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139500771|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139500772|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
139500773|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500774|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500775|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500776|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
139500777|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
139500778|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500779|NCT05171335|Lenvatinib|lenvatinib|mesh-list
139500780|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500781|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139500782|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500783|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500784|NCT02522299|Nemiralisib|nemiralisib|mesh-list
139500785|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139500786|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500787|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500788|NCT01365091|Metformin|metformin|mesh-list
139500789|NCT01365091|Saxagliptin|saxagliptin|mesh-list
139500790|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139500791|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500792|NCT01365091|Incretins|incretins|mesh-ancestor
139500793|NCT01365091|Hormones|hormones|mesh-ancestor
139500794|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139500795|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139500796|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
139500797|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500798|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500799|NCT05079763|Monolaurin|monolaurin|mesh-list
139500800|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
139500801|NCT05079763|Protective Agents|protective agents|mesh-ancestor
139500802|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500803|NCT05050981|Hormones|hormones|mesh-list
139500804|NCT05050981|Serotonin|serotonin|mesh-list
139500805|NCT05050981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139500806|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139500807|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500808|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139500809|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
139500810|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500811|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500812|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139500813|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139500814|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139500815|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
139500816|NCT01364467|Guaifenesin|guaifenesin|mesh-list
139500817|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139500818|NCT01364467|Expectorants|expectorants|mesh-ancestor
139500819|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
139500820|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139500821|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139500822|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
139500823|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500824|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500825|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500826|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
139500827|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139500828|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
139500829|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
139500830|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500831|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
139500832|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139500833|NCT05110417|Bromides|bromides|mesh-list
139500834|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139500835|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
139500836|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139500837|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092396|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139500838|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500839|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
139500840|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500841|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500842|NCT05031481|Butoconazole|butoconazole|mesh-list
139500843|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
139500844|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139500845|NCT05057767|Midazolam|midazolam|mesh-list
139500846|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139500847|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139500848|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500849|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500850|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139500851|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139500852|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139500853|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139500854|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
139500855|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
139500856|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
139500857|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
139500858|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500859|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500860|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
139500861|NCT04997317|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
139500862|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
139500863|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
139500864|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500865|NCT04997317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139500866|NCT04997239|Vaccines|vaccines|mesh-list
139500867|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
139500868|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500869|NCT04216693|Digoxin|digoxin|mesh-list
139500870|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139500871|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139500872|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500873|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500874|NCT04216693|Protective Agents|protective agents|mesh-ancestor
139500875|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500876|NCT01364389|Prednisone|prednisone|mesh-list
139500877|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139500878|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
139500879|NCT01364389|Hormones|hormones|mesh-ancestor
139500880|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139500881|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500882|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139500883|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500884|NCT05054881|Iodine|iodine|mesh-list
139500885|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139500886|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139500887|NCT05054881|Trace Elements|trace elements|mesh-ancestor
139500888|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
139500889|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500890|NCT04949425|Adavosertib|adavosertib|mesh-list
139500891|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500892|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500893|NCT04421209|Propranolol|propranolol|mesh-list
139500894|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139500895|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139500896|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
139500897|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500898|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500899|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500900|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139500901|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139500902|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
139500904|NCT04983121|Mitogens|mitogens|mesh-list
139500905|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
139500906|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
139500907|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500908|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
139500909|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500910|NCT02291289|Bevacizumab|bevacizumab|mesh-list
139500911|NCT02291289|Trastuzumab|trastuzumab|mesh-list
139500912|NCT02291289|Cetuximab|cetuximab|mesh-list
139500913|NCT02291289|Atezolizumab|atezolizumab|mesh-list
139500914|NCT02291289|Pertuzumab|pertuzumab|mesh-list
139500915|NCT02291289|Capecitabine|capecitabine|mesh-list
139500916|NCT02291289|Fluorouracil|fluorouracil|mesh-list
139500917|NCT02291289|Vemurafenib|vemurafenib|mesh-list
139500918|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139500919|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500920|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139500921|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139500922|NCT02291289|Growth Substances|growth substances|mesh-ancestor
139500923|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500924|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
139500925|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139500926|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
139500927|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500928|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139500929|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
139500930|NCT02291289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139500931|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139500932|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500933|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
139500934|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139500935|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500936|NCT02289963|Alirocumab|alirocumab|mesh-list
139500937|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139500938|NCT02289963|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139500939|NCT02289963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139500940|NCT02289963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139500941|NCT02289963|Antimetabolites|antimetabolites|mesh-ancestor
139500942|NCT02289963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500943|NCT02289963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139500944|NCT02289963|Protease Inhibitors|protease inhibitors|mesh-ancestor
139500945|NCT02289963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500946|NCT02289963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139500947|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
139500948|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500949|NCT02358369|Timolol|timolol|mesh-list
139500950|NCT02358369|Bimatoprost|bimatoprost|mesh-list
139500951|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139500952|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139500953|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139500954|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139500955|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
139500956|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139500957|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500958|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500959|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139500960|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139500961|NCT02316171|Mitomycins|mitomycins|mesh-list
139500962|NCT02316171|Mitomycin|mitomycin|mesh-list
139500963|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139500964|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500965|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
139500966|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500967|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139500968|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500969|NCT02315625|Everolimus|everolimus|mesh-list
139500970|NCT02315625|Sunitinib|sunitinib|mesh-list
139500971|NCT02315625|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139500972|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139500973|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139500974|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139500975|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139500977|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500978|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139500979|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139500980|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139500981|NCT02315625|Growth Substances|growth substances|mesh-ancestor
139500982|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
139500983|NCT02357979|Fluorides|fluorides|mesh-list
139500984|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
139500985|NCT02357979|Protective Agents|protective agents|mesh-ancestor
139500986|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500987|NCT02357901|Buprenorphine|buprenorphine|mesh-list
139500988|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139500989|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139500990|NCT02357901|Narcotics|narcotics|mesh-ancestor
139500991|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139500992|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139500993|NCT02357901|Analgesics|analgesics|mesh-ancestor
139500994|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
139500995|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139500996|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139500997|NCT01601847|Vitamin D|vitamin d|mesh-list
139500998|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
139500999|NCT01601847|Vitamins|vitamins|mesh-ancestor
139501000|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
139501001|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501002|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139501003|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139501004|NCT02515279|Ribavirin|ribavirin|mesh-list
139501005|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139501006|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
139501007|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501008|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
139501009|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501010|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
139501011|NCT02515045|Prednisolone|prednisolone|mesh-list
139501012|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139501013|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
139501014|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139501015|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
139501016|NCT02515045|Nepafenac|nepafenac|mesh-list
139501017|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139501018|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
139501019|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501020|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
139501021|NCT02515045|Hormones|hormones|mesh-ancestor
139501022|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501023|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501024|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139501025|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501026|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
139501027|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
139501028|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501029|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139501030|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139501031|NCT02515045|Protective Agents|protective agents|mesh-ancestor
139501032|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139501033|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501034|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139501035|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139501036|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501037|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501038|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139501039|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139501040|NCT02515045|Analgesics|analgesics|mesh-ancestor
139501041|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
139501042|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139501043|NCT02513485|Levodopa|levodopa|mesh-list
139501044|NCT02513485|Carbidopa|carbidopa|mesh-list
139501045|NCT02513485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139501046|NCT02513485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139501047|NCT02513485|Dopamine Agents|dopamine agents|mesh-ancestor
139501048|NCT02513485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139287744|NCT04437654|Apixaban|apixaban|mesh-list
139501049|NCT02513485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501050|NCT02513485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501051|NCT02513485|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139501052|NCT02513485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501054|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139501055|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139501056|NCT02289417|Analgesics|analgesics|mesh-ancestor
139501057|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
139501058|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501059|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501060|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501061|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139501062|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139501063|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139501064|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501065|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501066|NCT02512861|Bupivacaine|bupivacaine|mesh-list
139501067|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
139501068|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
139501069|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139501070|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501071|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
139501072|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501073|NCT04979065|Vitamin D|vitamin d|mesh-list
139501074|NCT04979065|Vitamins|vitamins|mesh-ancestor
139501075|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
139501076|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501077|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139501078|NCT02288325|Milnacipran|milnacipran|mesh-list
139501079|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
139501080|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139501081|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139501082|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139501083|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501084|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139501085|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501086|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
139501087|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139501088|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139501089|NCT02288325|Analgesics|analgesics|mesh-ancestor
139501090|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
139501091|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501092|NCT04978051|Icatibant|icatibant|mesh-list
139501093|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139501094|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139501095|NCT04978051|Analgesics|analgesics|mesh-ancestor
139501096|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
139501097|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501098|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501099|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501100|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139501101|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
139501102|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
139501103|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501104|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139501105|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139501106|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
139501107|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139501108|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139501109|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501110|NCT05010421|Clobetasol|clobetasol|mesh-list
139501111|NCT05010421|Emollients|emollients|mesh-list
139501112|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501113|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
139501114|NCT05010421|Hormones|hormones|mesh-ancestor
139092574|NCT01094964|Epirubicin|epirubicin|mesh-list
139501115|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501116|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501117|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
139501118|NCT02504827|Ceftazidime|ceftazidime|mesh-list
139501119|NCT02504827|Avibactam|avibactam|mesh-list
139501120|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
139501121|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139501122|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501123|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139501125|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501126|NCT02504671|Folic Acid|folic acid|mesh-list
139501127|NCT02504671|Hematinics|hematinics|mesh-ancestor
139501128|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
139501129|NCT02504671|Vitamins|vitamins|mesh-ancestor
139501130|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
139501131|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501132|NCT02314143|Trametinib|trametinib|mesh-list
139501133|NCT02314143|Dabrafenib|dabrafenib|mesh-list
139501134|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501135|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139501136|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501137|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501138|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
139501139|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139501140|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501141|NCT05007613|Atezolizumab|atezolizumab|mesh-list
139501142|NCT05007613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139501143|NCT05007613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501144|NCT05007613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139501145|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501146|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
139501147|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139501148|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139501149|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139501150|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139501151|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139501152|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501153|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
139501154|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139501155|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501156|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139501157|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501158|NCT02501629|Reslizumab|reslizumab|mesh-list
139501159|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139501160|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
139501161|NCT02501473|Rituximab|rituximab|mesh-list
139501162|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
139501163|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139501164|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501165|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
139501166|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501167|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139501168|NCT02501473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139501169|NCT02501473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501170|NCT02501161|Insulin|insulin|mesh-list
139501171|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139501172|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
139501173|NCT02501161|Liraglutide|liraglutide|mesh-list
139501174|NCT02501161|Xultophy|xultophy|mesh-list
139501175|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139501176|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501177|NCT02501161|Incretins|incretins|mesh-ancestor
139501178|NCT02501161|Hormones|hormones|mesh-ancestor
139501179|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501180|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
139501181|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139501182|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139501183|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501184|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139501185|NCT04205539|Analgesics|analgesics|mesh-ancestor
139501186|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
139501187|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501188|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139501189|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139501190|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139501191|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
139501192|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139501193|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501194|NCT02313909|Aspirin|aspirin|mesh-list
139501195|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
139501196|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139501197|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139501198|NCT02313909|Analgesics|analgesics|mesh-ancestor
139501199|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
139501200|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501201|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501202|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501203|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139501204|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139501205|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139501206|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501207|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139501208|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139501209|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501210|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
139501211|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139501212|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
139501213|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139501214|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
139501215|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
139501216|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
139501217|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139501218|NCT02287467|Antibodies|antibodies|mesh-list
139501219|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
139501220|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139501221|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
139501222|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501223|NCT02287233|Cytarabine|cytarabine|mesh-list
139501224|NCT02287233|Venetoclax|venetoclax|mesh-list
139501225|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139501226|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
139501227|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501228|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501229|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
139501230|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501231|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139501232|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
139501233|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501234|NCT01646385|Etanercept|etanercept|mesh-list
139501235|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
139501236|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139501237|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139501238|NCT01646385|Analgesics|analgesics|mesh-ancestor
139501239|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
139501240|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501241|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501242|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501243|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139501244|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139501245|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
139501246|NCT02286843|Trastuzumab|trastuzumab|mesh-list
139501247|NCT02286843|Pertuzumab|pertuzumab|mesh-list
139501248|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139501249|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501250|NCT02281773|BI 409306|bi 409306|mesh-list
139501251|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139501252|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501253|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501254|NCT02354235|Canagliflozin|canagliflozin|mesh-list
139501255|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139501256|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501257|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139501258|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501259|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
139501260|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139501261|NCT02284893|Saxagliptin|saxagliptin|mesh-list
139501262|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139501263|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501264|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139501265|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501266|NCT02284893|Incretins|incretins|mesh-ancestor
139501267|NCT02284893|Hormones|hormones|mesh-ancestor
139501268|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501269|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139501270|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
139501271|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501272|NCT02483611|Lidocaine|lidocaine|mesh-list
139501273|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
139501274|NCT02483611|Cisatracurium|cisatracurium|mesh-list
139501275|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
139501276|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
139501277|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139501278|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501279|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
139501280|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501281|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139501282|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139501283|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139501284|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139092704|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
139501285|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501286|NCT02483611|Analgesics|analgesics|mesh-ancestor
139501287|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
139501288|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139501289|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139501290|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
139501291|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139501292|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139501293|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139501294|NCT02482129|Dexamethasone|dexamethasone|mesh-list
139501295|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139501296|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139501297|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501298|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
139501299|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
139501300|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501301|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501302|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139501303|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
139501304|NCT02482129|Hormones|hormones|mesh-ancestor
139501305|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501306|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139501307|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501308|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
139501309|NCT02495857|Viscosupplements|viscosupplements|mesh-list
139501310|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139501311|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
139501312|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501313|NCT02495857|Protective Agents|protective agents|mesh-ancestor
139501314|NCT02495389|Mirabegron|mirabegron|mesh-list
139501315|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139501316|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139501317|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139501318|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
139501319|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139501320|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501321|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501322|NCT02495389|Urological Agents|urological agents|mesh-ancestor
139501323|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139501324|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501325|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139501326|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501327|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501328|NCT02495077|Acetaminophen|acetaminophen|mesh-list
139501329|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
139501330|NCT02495077|Promethazine|promethazine|mesh-list
139501331|NCT02495077|Loratadine|loratadine|mesh-list
139501332|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
139501333|NCT02495077|Prednisone|prednisone|mesh-list
139501334|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
139501335|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139501336|NCT02495077|Infliximab|infliximab|mesh-list
139501337|NCT02495077|Tacrolimus|tacrolimus|mesh-list
139501338|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
139501339|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139501340|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501341|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
139501342|NCT02495077|Hormones|hormones|mesh-ancestor
139501343|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501344|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501345|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139501346|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501347|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139501348|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
139501349|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139501350|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501351|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501353|NCT02495077|Analgesics|analgesics|mesh-ancestor
139501354|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
139501355|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501356|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
139501357|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139501358|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139501359|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
139501360|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139501361|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501362|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
139501363|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
139501364|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139501365|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139501366|NCT02495077|Protective Agents|protective agents|mesh-ancestor
139501367|NCT02495077|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139501368|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
139501369|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139501370|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139501371|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139501372|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139501373|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
139501374|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
139501375|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139501376|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
139501377|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
139501378|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139501379|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139501380|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
139501381|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139501382|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
139501383|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
139501384|NCT02278341|Hematinics|hematinics|mesh-ancestor
139501385|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
139501386|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139501387|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139501388|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501389|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
139501390|NCT02278263|Coagulants|coagulants|mesh-ancestor
139501391|NCT02494921|Prednisone|prednisone|mesh-list
139501392|NCT02494921|Docetaxel|docetaxel|mesh-list
139501393|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501394|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
139501395|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
139501396|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
139501397|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501398|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501399|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
139501400|NCT02494921|Hormones|hormones|mesh-ancestor
139501401|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501402|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501403|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139501404|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
139501405|NCT01653847|Everolimus|everolimus|mesh-list
139501406|NCT01653847|Tacrolimus|tacrolimus|mesh-list
139501407|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139501408|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
139501409|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501410|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139501411|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501412|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501413|NCT01653847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139501414|NCT01653847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139501415|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501416|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139501417|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139501418|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
139501419|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139501420|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501421|NCT02493751|Avelumab|avelumab|mesh-list
139501422|NCT02493751|Axitinib|axitinib|mesh-list
139501423|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139501424|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501425|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139501426|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501427|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501429|NCT02493517|Somatostatin|somatostatin|mesh-list
139501430|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501431|NCT02493517|Hormones|hormones|mesh-ancestor
139501432|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501433|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501434|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
139501435|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139501436|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501437|NCT02493361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139501438|NCT02493361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501439|NCT04959799|Dalbavancin|dalbavancin|mesh-list
139501440|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139501441|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501442|NCT02478463|Cabotegravir|cabotegravir|mesh-list
139501443|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139501444|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139501445|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501446|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501447|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139501448|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139501449|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
139501450|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501451|NCT02491411|Dexamethasone|dexamethasone|mesh-list
139501452|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
139501453|NCT02491411|Ichthammol|ichthammol|mesh-list
139501454|NCT02491411|BB 1101|bb 1101|mesh-list
139501455|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501456|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
139501457|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
139501458|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501459|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501460|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139501461|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
139501462|NCT02491411|Hormones|hormones|mesh-ancestor
139501463|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501464|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139501465|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092827|NCT02459392|Prednisolone|prednisolone|mesh-list
139501466|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
139501467|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501468|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501469|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
139501470|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
139501471|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139501472|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
139501473|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139501474|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501475|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139501476|NCT02490475|Docetaxel|docetaxel|mesh-list
139501477|NCT02490475|Pertuzumab|pertuzumab|mesh-list
139501478|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501479|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
139501480|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
139501481|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
139501482|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501483|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139501484|NCT02477839|Lacosamide|lacosamide|mesh-list
139501485|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
139501486|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139501487|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139501488|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139501489|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501490|NCT04939987|Acetaminophen|acetaminophen|mesh-list
139501491|NCT04939987|Ketorolac|ketorolac|mesh-list
139501492|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139501493|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139501494|NCT04939987|Ketamine|ketamine|mesh-list
139501495|NCT04939987|Oxycodone|oxycodone|mesh-list
139501496|NCT04939987|Gabapentin|gabapentin|mesh-list
139501497|NCT04939987|Tramadol|tramadol|mesh-list
139501498|NCT04939987|Hydrocodone|hydrocodone|mesh-list
139501499|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
139501500|NCT04939987|Analgesics|analgesics|mesh-ancestor
139501501|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
139501502|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501503|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501504|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139501505|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139501507|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
139501508|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139501509|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139501510|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139501511|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139501512|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501513|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139501514|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
139501515|NCT04939987|Narcotics|narcotics|mesh-ancestor
139501516|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
139501517|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139501518|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139501519|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139501520|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
139501521|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139501522|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501523|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139501524|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139501525|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501526|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
139501527|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
139501528|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139501529|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139501530|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139501531|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
139501532|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501533|NCT02477215|Dexamethasone|dexamethasone|mesh-list
139501534|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139501535|NCT02477215|Ixazomib|ixazomib|mesh-list
139501536|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501537|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
139501538|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
139501539|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501540|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501541|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139501542|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
139501543|NCT02477215|Hormones|hormones|mesh-ancestor
139501544|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501545|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139501546|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501547|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139501548|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
139501549|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501550|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
139501551|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501552|NCT02487199|Ritonavir|ritonavir|mesh-list
139501553|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139501554|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139501555|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
139501556|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501557|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501558|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139501559|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139501560|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
139501561|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501562|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139501563|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139501564|NCT02475733|Metronidazole|metronidazole|mesh-list
139501565|NCT02475733|Meropenem|meropenem|mesh-list
139501566|NCT02475733|Ceftazidime|ceftazidime|mesh-list
139501567|NCT02475733|Avibactam|avibactam|mesh-list
139501568|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
139501569|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501570|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139501571|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139501572|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139501573|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139501574|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501575|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501576|NCT02486653|Tamsulosin|tamsulosin|mesh-list
139501577|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139501578|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139501579|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139501580|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
139501581|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139501582|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501583|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501584|NCT02486653|Urological Agents|urological agents|mesh-ancestor
139501585|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
139501586|NCT02475265|Estradiol|estradiol|mesh-list
139501587|NCT02475265|Estrogens|estrogens|mesh-ancestor
139501588|NCT02475265|Hormones|hormones|mesh-ancestor
139501589|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501590|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501591|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139501592|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
139501593|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139501594|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139501595|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139501596|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139501597|NCT02450539|Docetaxel|docetaxel|mesh-list
139501598|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501599|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
139501600|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
139501601|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
139501602|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501603|NCT02449915|Bupivacaine|bupivacaine|mesh-list
139501604|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
139501605|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
139501606|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139501607|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501608|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
139501609|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501610|NCT02472847|Dronabinol|dronabinol|mesh-list
139501611|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
139501612|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501613|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139501614|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139501615|NCT02472847|Analgesics|analgesics|mesh-ancestor
139501616|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
139501617|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501618|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139501619|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139501620|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139501621|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501622|NCT02472847|Hormones|hormones|mesh-ancestor
139501623|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501624|NCT02472145|Decitabine|decitabine|mesh-list
139501625|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139501626|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
139501627|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501628|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501629|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501630|NCT02448043|Bimatoprost|bimatoprost|mesh-list
139501631|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139501632|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
139501633|NCT02447887|Ixazomib|ixazomib|mesh-list
139501634|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501635|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
139501636|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501637|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501638|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
139501639|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501640|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139501641|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
139501642|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139501643|NCT02417935|Pregabalin|pregabalin|mesh-list
139501644|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139501645|NCT02417935|Analgesics|analgesics|mesh-ancestor
139501646|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
139501647|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501648|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501649|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
139501650|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139288336|NCT03701503|Hormones|hormones|mesh-list
139501651|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139501652|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501653|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139501654|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139501655|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139501656|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139501657|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139501658|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139501659|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139501660|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139501661|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
139501662|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
139501663|NCT02447029|Lidocaine|lidocaine|mesh-list
139501664|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
139501665|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
139501666|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139501667|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501668|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
139501669|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501670|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139501671|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139501672|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139501673|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139501674|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501675|NCT02416453|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139501676|NCT02416453|Antiviral Agents|antiviral agents|mesh-ancestor
139501677|NCT02416453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501678|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
139501679|NCT02469961|Propofol|propofol|mesh-list
139501680|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139501681|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139501682|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501683|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139501684|NCT02469961|Analgesics|analgesics|mesh-ancestor
139501685|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
139501686|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501687|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139501688|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139501689|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139501690|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
139501691|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139501692|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501693|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139501694|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
139501695|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
139501696|NCT02415595|BMS-955176|bms-955176|mesh-list
139501697|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139501698|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139501699|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
139501700|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501701|NCT02446717|Ribavirin|ribavirin|mesh-list
139501702|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
139501703|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501704|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
139501705|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501706|NCT02469415|Azacitidine|azacitidine|mesh-list
139501707|NCT02469415|Decitabine|decitabine|mesh-list
139501708|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139501709|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
139501710|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501711|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501712|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501713|NCT02446171|Naloxegol|naloxegol|mesh-list
139501714|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139501715|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501716|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
139501717|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501718|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139501719|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
139501720|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139501721|NCT02415127|Interferons|interferons|mesh-list
139501722|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
139501723|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139288413|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139501724|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
139501725|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501726|NCT02468557|Paclitaxel|paclitaxel|mesh-list
139501727|NCT02468557|Idelalisib|idelalisib|mesh-list
139501728|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139501729|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501730|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
139501731|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
139501732|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
139501733|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501734|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501735|NCT02413489|Daratumumab|daratumumab|mesh-list
139501736|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501737|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
139501738|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139501739|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
139501740|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501741|NCT02444533|Bupivacaine|bupivacaine|mesh-list
139501742|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
139501743|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
139501744|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139501745|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501746|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
139501747|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501748|NCT01651039|Dexamethasone|dexamethasone|mesh-list
139501749|NCT01651039|Lenalidomide|lenalidomide|mesh-list
139501750|NCT01651039|Panobinostat|panobinostat|mesh-list
139501751|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501752|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
139501753|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
139501754|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501755|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501756|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139501757|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
139501758|NCT01651039|Hormones|hormones|mesh-ancestor
139501759|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501760|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139501761|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501762|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
139501763|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139501764|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139501765|NCT01651039|Growth Substances|growth substances|mesh-ancestor
139501766|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
139501767|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139501768|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501769|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501770|NCT02349633|Palbociclib|palbociclib|mesh-list
139501771|NCT02349633|Avelumab|avelumab|mesh-list
139501772|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501773|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139501774|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501775|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501776|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139501777|NCT02275611|Oxytocin|oxytocin|mesh-list
139501778|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
139501779|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139501780|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501781|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
139501782|NCT04875585|Lenvatinib|lenvatinib|mesh-list
139501783|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139501784|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501785|NCT04875585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139501786|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501787|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139501788|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501789|NCT02273973|Letrozole|letrozole|mesh-list
139501790|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501791|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139501792|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139501793|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501794|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501795|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139501796|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
139288504|NCT02187822|Taxane|taxane|mesh-list
139501797|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501798|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501799|NCT05649111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139501800|NCT05649111|Difluprednate|difluprednate|mesh-list
139501801|NCT05649111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139501802|NCT05649111|Glucocorticoids|glucocorticoids|mesh-ancestor
139501803|NCT05649111|Hormones|hormones|mesh-ancestor
139501804|NCT05649111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501805|NCT05649111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501806|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
139501807|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139501808|NCT02465515|Incretins|incretins|mesh-ancestor
139501809|NCT02465515|Hormones|hormones|mesh-ancestor
139501810|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501811|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501812|NCT05561361|Spironolactone|spironolactone|mesh-list
139501813|NCT05561361|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139501814|NCT05561361|Hormone Antagonists|hormone antagonists|mesh-ancestor
139501815|NCT05561361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501816|NCT05561361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501817|NCT05561361|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139501818|NCT05561361|Diuretics|diuretics|mesh-ancestor
139501819|NCT05561361|Natriuretic Agents|natriuretic agents|mesh-ancestor
139501820|NCT02412631|Varenicline|varenicline|mesh-list
139501821|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139501822|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139501823|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
139501824|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139501825|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501826|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501827|NCT02272803|Dexamethasone|dexamethasone|mesh-list
139501828|NCT02272803|Lenalidomide|lenalidomide|mesh-list
139501829|NCT02272803|Elotuzumab|elotuzumab|mesh-list
139501830|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501831|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
139501832|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
139501833|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501834|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501835|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139501836|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
139501837|NCT02272803|Hormones|hormones|mesh-ancestor
139501838|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501839|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139501840|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501841|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
139501842|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139093050|NCT04728646|Dexamethasone|dexamethasone|mesh-list
139501843|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139501844|NCT02272803|Growth Substances|growth substances|mesh-ancestor
139501845|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
139501846|NCT02272725|Ibuprofen|ibuprofen|mesh-list
139501847|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139501848|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139501849|NCT02272725|Analgesics|analgesics|mesh-ancestor
139501850|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
139501851|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501852|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501853|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501854|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139501855|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139501856|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501857|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501858|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
139501859|NCT01650805|Ponatinib|ponatinib|mesh-list
139501860|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501861|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139501862|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501863|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501864|NCT02442349|Osimertinib|osimertinib|mesh-list
139501865|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501866|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139501867|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501868|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501869|NCT02442271|Ritonavir|ritonavir|mesh-list
139501870|NCT02442271|Ribavirin|ribavirin|mesh-list
139501871|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139501872|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139501873|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
139501874|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139501875|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501876|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139501877|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139501878|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
139501879|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501880|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139501881|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139501882|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
139501883|NCT02463409|Theophylline|theophylline|mesh-list
139501884|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139501885|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
139501886|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501887|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501888|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139501889|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
139501890|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139501891|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093086|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
139501892|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501893|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
139501894|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139501895|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139501896|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
139501897|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139501898|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
139501899|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139501900|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501901|NCT02528357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139501902|NCT02528357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501903|NCT04910503|Dexamethasone|dexamethasone|mesh-list
139501904|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139501905|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501906|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
139501907|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
139501908|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501909|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501910|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139501911|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
139501912|NCT04910503|Hormones|hormones|mesh-ancestor
139501913|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501914|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139501915|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501916|NCT04910425|Fluorides|fluorides|mesh-list
139501917|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
139501918|NCT04910425|Protective Agents|protective agents|mesh-ancestor
139501919|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501920|NCT02463331|Chloroquine|chloroquine|mesh-list
139501921|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139501922|NCT02463331|Prednisone|prednisone|mesh-list
139501923|NCT02463331|Azathioprine|azathioprine|mesh-list
139501924|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139501925|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
139501926|NCT02463331|Hormones|hormones|mesh-ancestor
139501927|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139501928|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501929|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139501930|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139501931|NCT02463331|Amebicides|amebicides|mesh-ancestor
139501932|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139501933|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139501934|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139501935|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
139501936|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139501937|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139501938|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139501939|NCT02463331|Analgesics|analgesics|mesh-ancestor
139501940|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
139501941|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501942|NCT02463331|Filaricides|filaricides|mesh-ancestor
139501943|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
139501944|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
139501945|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
139501946|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501947|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139288634|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
139501948|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139501949|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
139501950|NCT02463097|Insulin|insulin|mesh-list
139501951|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139501952|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501953|NCT05427149|Magnesium Sulfate|magnesium sulfate|mesh-list
139501954|NCT05427149|Analgesics|analgesics|mesh-ancestor
139501955|NCT05427149|Sensory System Agents|sensory system agents|mesh-ancestor
139501956|NCT05427149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501957|NCT05427149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501958|NCT05427149|Anesthetics|anesthetics|mesh-ancestor
139501959|NCT05427149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139501960|NCT05427149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139501961|NCT05427149|Anticonvulsants|anticonvulsants|mesh-ancestor
139501962|NCT05427149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139501963|NCT05427149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139501964|NCT05427149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501965|NCT05427149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139501966|NCT05427149|Tocolytic Agents|tocolytic agents|mesh-ancestor
139501967|NCT05427149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139501968|NCT02462473|Olanzapine|olanzapine|mesh-list
139501969|NCT02462473|Risperidone|risperidone|mesh-list
139093147|NCT03242434|Mannitol|mannitol|mesh-list
139501970|NCT02462473|Aripiprazole|aripiprazole|mesh-list
139501971|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139501972|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139501973|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139501974|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
139501975|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139501976|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139501977|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139501978|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139501979|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139501980|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139501981|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139501982|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139501983|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
139501984|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
139501985|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
139501986|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139501987|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139501988|NCT02462473|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139501989|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139501990|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139501991|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
139501992|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
139501993|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139501994|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139501995|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139501996|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139501997|NCT02440789|Sirolimus|sirolimus|mesh-list
139501998|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139501999|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502000|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139502001|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502002|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
139502003|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139502004|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
139502005|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502006|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
139502007|NCT02538107|Hematinics|hematinics|mesh-ancestor
139502008|NCT02272413|Bevacizumab|bevacizumab|mesh-list
139502009|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139502010|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502011|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139502012|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139502013|NCT02272413|Growth Substances|growth substances|mesh-ancestor
139502014|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502015|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
139502016|NCT05648799|Molnupiravir|molnupiravir|mesh-list
139502017|NCT05648799|Antiviral Agents|antiviral agents|mesh-ancestor
139502018|NCT05648799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139288717|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
139502019|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
139502020|NCT02120807|Pemetrexed|pemetrexed|mesh-list
139502021|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502022|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502023|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502024|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139502025|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139502026|NCT02120807|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139502027|NCT02120807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139502028|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139502029|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
139502030|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502031|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139502032|NCT02532647|Midazolam|midazolam|mesh-list
139502033|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139502034|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139502035|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139502036|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502037|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139502038|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139502039|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139502040|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139502041|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
139502042|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
139502043|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
139502044|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
139502045|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502046|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502047|NCT02537015|Bimatoprost|bimatoprost|mesh-list
139502048|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139502049|NCT01660763|Sufentanil|sufentanil|mesh-list
139502050|NCT01660763|Dsuvia|dsuvia|mesh-list
139502051|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139502052|NCT01660763|Narcotics|narcotics|mesh-ancestor
139502053|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139502054|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093222|NCT01192724|Aspirin|aspirin|mesh-list
139502055|NCT01660763|Analgesics|analgesics|mesh-ancestor
139502056|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
139502057|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502058|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139502059|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139502060|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
139502061|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
139502062|NCT01937117|Trastuzumab|trastuzumab|mesh-list
139502063|NCT01937117|Pertuzumab|pertuzumab|mesh-list
139502064|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139502065|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502066|NCT02268045|Rituximab|rituximab|mesh-list
139502067|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139502068|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502069|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
139502070|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502071|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139502072|NCT02267187|Anesthetics|anesthetics|mesh-list
139502073|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139502074|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502075|NCT01641939|Trastuzumab|trastuzumab|mesh-list
139502076|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139502077|NCT01641939|Maytansine|maytansine|mesh-list
139502078|NCT01641939|Taxane|taxane|mesh-list
139502079|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139502080|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502081|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139502082|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
139502083|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
139502084|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
139502085|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502086|NCT01641939|Immunotoxins|immunotoxins|mesh-ancestor
139502087|NCT01641939|Immunoconjugates|immunoconjugates|mesh-ancestor
139502088|NCT01641939|Immunologic Factors|immunologic factors|mesh-ancestor
139502089|NCT01641939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502090|NCT02409355|Carboplatin|carboplatin|mesh-list
139502091|NCT02409355|Gemcitabine|gemcitabine|mesh-list
139502092|NCT02409355|Atezolizumab|atezolizumab|mesh-list
139502093|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502094|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139502095|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
139502096|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502097|NCT02409355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139502098|NCT02409355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139502099|NCT02438371|Indomethacin|indomethacin|mesh-list
139502100|NCT02438371|Nifedipine|nifedipine|mesh-list
139502101|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139502102|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139502103|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502104|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139502105|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502106|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
139502107|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
139502108|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139502109|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139502110|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139502111|NCT02438371|Analgesics|analgesics|mesh-ancestor
139502112|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
139502113|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502114|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139502115|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139502116|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
139502117|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139502118|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502119|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139502120|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
139502121|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139502122|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
139502123|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502124|NCT04920565|Polymyxins|polymyxins|mesh-list
139502125|NCT04920565|Polymyxin B|polymyxin b|mesh-list
139502126|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139502127|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502128|NCT04909021|Vaccines|vaccines|mesh-list
139502129|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
139502130|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502131|NCT02460991|Sorafenib|sorafenib|mesh-list
139502132|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502133|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139502134|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502135|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502136|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139502137|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139502138|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502139|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139502140|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502141|NCT02436889|Mirabegron|mirabegron|mesh-list
139502142|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139502143|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139502144|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139502145|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139502146|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
139502147|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502148|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502149|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502150|NCT02436889|Urological Agents|urological agents|mesh-ancestor
139502151|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139502152|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139502153|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
139502154|NCT02436577|Ticagrelor|ticagrelor|mesh-list
139502155|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139502156|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139502157|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139502158|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139502159|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
139502160|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502161|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502162|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502163|NCT02459665|Metronidazole|metronidazole|mesh-list
139502164|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502165|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139502166|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139502167|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139502168|NCT02265237|Ritonavir|ritonavir|mesh-list
139502169|NCT02265237|Ribavirin|ribavirin|mesh-list
139502170|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139502171|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139502172|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
139502173|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502174|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502175|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139502176|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139502177|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
139502178|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502179|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139502180|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139502181|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
139502182|NCT04874025|Palbociclib|palbociclib|mesh-list
139502183|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502184|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139502185|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502186|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502188|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
139502189|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139502190|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
139502191|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139502192|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139502193|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139502194|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139502195|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502196|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
139502197|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502198|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502199|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139502200|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502201|NCT02260791|Adalimumab|adalimumab|mesh-list
139502202|NCT02260791|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139502203|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139502204|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139502205|NCT02260635|Evacetrapib|evacetrapib|mesh-list
139502206|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139502207|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139502208|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
139502209|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502210|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139502211|NCT02259231|Nivolumab|nivolumab|mesh-list
139502212|NCT02259231|Ipilimumab|ipilimumab|mesh-list
139502213|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139502214|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502215|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139502216|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502217|NCT02258529|Rituximab|rituximab|mesh-list
139502218|NCT02258529|Idelalisib|idelalisib|mesh-list
139502219|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139502220|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502221|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
139502222|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502223|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139093366|NCT01296074|Hormones|hormones|mesh-ancestor
139502224|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502225|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502226|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
139502227|NCT02256969|Prednisolone|prednisolone|mesh-list
139502228|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139502229|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
139502230|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139502231|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
139502232|NCT02256969|Mineral Oil|mineral oil|mesh-list
139502233|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139502234|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
139502235|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139502236|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
139502237|NCT02256969|Hormones|hormones|mesh-ancestor
139502238|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139502239|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502240|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139502241|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502242|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
139502243|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
139502244|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502245|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139502246|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139502247|NCT02256969|Protective Agents|protective agents|mesh-ancestor
139502248|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139502249|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502250|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139502251|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139502253|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
139502254|NCT02256267|Rifampin|rifampin|mesh-list
139502255|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139502256|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
139502257|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139502258|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502259|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
139502260|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139502261|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502262|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502263|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139502264|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139502265|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139502266|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139502267|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139502268|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139502269|NCT05429463|Paclitaxel|paclitaxel|mesh-list
139502270|NCT05429463|Carboplatin|carboplatin|mesh-list
139502271|NCT05429463|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139502272|NCT05429463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139502273|NCT05429463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502274|NCT05429463|Tubulin Modulators|tubulin modulators|mesh-ancestor
139502275|NCT05429463|Antimitotic Agents|antimitotic agents|mesh-ancestor
139502276|NCT05429463|Mitosis Modulators|mitosis modulators|mesh-ancestor
139502277|NCT05429463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502278|NCT02255565|Methylphenidate|methylphenidate|mesh-list
139502279|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139502280|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502281|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139502282|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139502283|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139502284|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502285|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
139502286|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502287|NCT01640301|Aldesleukin|aldesleukin|mesh-list
139502288|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
139502289|NCT01640301|Fludarabine|fludarabine|mesh-list
139502290|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
139502291|NCT01640301|Interleukin-2|interleukin-2|mesh-list
139502292|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139502293|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
139502294|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502295|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139502296|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139502297|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
139502298|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502299|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502300|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139502301|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139502302|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
139502303|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139502304|NCT01640301|Analgesics|analgesics|mesh-ancestor
139502305|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
139502306|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502307|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139502308|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139502309|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
139502310|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502311|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
139502312|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
139502313|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139502314|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139502315|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093411|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
139502316|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502317|NCT01642407|Urological Agents|urological agents|mesh-ancestor
139502318|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
139502319|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139502320|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502321|NCT02255097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139502322|NCT02255097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502324|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502325|NCT05640375|Methylprednisolone|methylprednisolone|mesh-list
139502326|NCT05640375|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139502327|NCT05640375|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139502328|NCT05640375|Prednisolone|prednisolone|mesh-list
139502329|NCT05640375|Prednisolone acetate|prednisolone acetate|mesh-list
139502330|NCT05640375|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139502331|NCT05640375|Prednisolone phosphate|prednisolone phosphate|mesh-list
139502332|NCT05640375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139502333|NCT05640375|Antiemetics|antiemetics|mesh-ancestor
139502334|NCT05640375|Autonomic Agents|autonomic agents|mesh-ancestor
139502335|NCT05640375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502336|NCT05640375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502337|NCT05640375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139502338|NCT05640375|Glucocorticoids|glucocorticoids|mesh-ancestor
139502339|NCT05640375|Hormones|hormones|mesh-ancestor
139502340|NCT05640375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139502341|NCT05640375|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139502342|NCT05640375|Protective Agents|protective agents|mesh-ancestor
139502343|NCT05640375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139502344|NCT05640375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502345|NCT01641237|Listerine|listerine|mesh-list
139502346|NCT01641237|Fluorides|fluorides|mesh-list
139502347|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
139502348|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
139502349|NCT01641237|Protective Agents|protective agents|mesh-ancestor
139502350|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502351|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139502352|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502353|NCT05617209|Thrombin|thrombin|mesh-list
139502354|NCT05617209|Hemostatics|hemostatics|mesh-ancestor
139502355|NCT05617209|Coagulants|coagulants|mesh-ancestor
139502356|NCT01639833|Hemostatics|hemostatics|mesh-list
139502357|NCT01639833|Coagulants|coagulants|mesh-ancestor
139502358|NCT01639131|Gemcitabine|gemcitabine|mesh-list
139502359|NCT01639131|Docetaxel|docetaxel|mesh-list
139502360|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139502361|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
139502362|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502363|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502364|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
139502365|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
139502366|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
139502367|NCT01641159|Buspirone|buspirone|mesh-list
139502368|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139502369|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139502370|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139502371|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502372|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139502373|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139502374|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
139502375|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502376|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502377|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
139502378|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139502379|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
139502380|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502381|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502382|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139502383|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
139502384|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139502385|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139502386|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139502387|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
139502388|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502389|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502390|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
139502391|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139502392|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139502393|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502394|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
139502395|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
139502396|NCT05369481|Minoxidil|minoxidil|mesh-list
139502397|NCT05369481|Sildenafil Citrate|sildenafil citrate|mesh-list
139502398|NCT05369481|Vasodilator Agents|vasodilator agents|mesh-ancestor
139502399|NCT05369481|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139502400|NCT05369481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139502401|NCT05369481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502402|NCT05369481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502403|NCT05369481|Urological Agents|urological agents|mesh-ancestor
139502404|NCT05369481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139502405|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
139502406|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139502407|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
139502408|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502409|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
139502410|NCT04853589|Protective Agents|protective agents|mesh-ancestor
139502411|NCT01638429|Rifaximin|rifaximin|mesh-list
139502412|NCT01638429|Neomycin|neomycin|mesh-list
139502413|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139502414|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502415|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139502416|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139502417|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502418|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502419|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139502420|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139502421|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502422|NCT04853355|Spironolactone|spironolactone|mesh-list
139502423|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139502424|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
139502425|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139502426|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502427|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139502428|NCT04853355|Diuretics|diuretics|mesh-ancestor
139502429|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
139502430|NCT05369091|Simvastatin|simvastatin|mesh-list
139502431|NCT05369091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139502432|NCT05369091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139502433|NCT05369091|Antimetabolites|antimetabolites|mesh-ancestor
139502434|NCT05369091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502435|NCT05369091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139502436|NCT05369091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139502437|NCT05369091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502438|NCT01601535|Irinotecan|irinotecan|mesh-list
139502439|NCT01601535|Temozolomide|temozolomide|mesh-list
139502440|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139502441|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139502442|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502443|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502444|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502445|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139502446|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
139502447|NCT05422365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139502448|NCT05422365|Immunoglobulins|immunoglobulins|mesh-list
139502449|NCT05422365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139502450|NCT05422365|Antibodies|antibodies|mesh-list
139502451|NCT05422365|gamma-Globulins|gamma-globulins|mesh-list
139502452|NCT05422365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139502453|NCT05422365|Immunologic Factors|immunologic factors|mesh-ancestor
139502454|NCT05422365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502455|NCT04641273|Pregabalin|pregabalin|mesh-list
139502456|NCT04641273|Analgesics|analgesics|mesh-ancestor
139502457|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
139502458|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502459|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502460|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
139502461|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139502462|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139502463|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502464|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139502465|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139502466|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139502467|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139502468|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139502469|NCT04586985|Midazolam|midazolam|mesh-list
139502470|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139502471|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139502472|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139502473|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502474|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139502475|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139502476|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139502477|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139502478|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
139502479|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
139502480|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
139502481|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
139502482|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502483|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502484|NCT05408403|Anesthetics|anesthetics|mesh-list
139502485|NCT05408403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139502486|NCT05408403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502487|NCT04830735|Dasatinib|dasatinib|mesh-list
139502488|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502489|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139502490|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502491|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502492|NCT05335317|Hormones|hormones|mesh-list
139502493|NCT05335317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139502494|NCT05335317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502495|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139502496|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502497|NCT04419441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139093530|NCT01198106|Cinnarizine|cinnarizine|mesh-list
139502498|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502499|NCT05329779|Pregnanolone|pregnanolone|mesh-list
139502500|NCT05329779|Brexanolone|brexanolone|mesh-list
139502501|NCT05329779|Anesthetics|anesthetics|mesh-ancestor
139502502|NCT05329779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139502503|NCT05329779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502504|NCT05329779|Neurosteroids|neurosteroids|mesh-ancestor
139502505|NCT05329779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502506|NCT05329779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502507|NCT05329779|GABA Modulators|gaba modulators|mesh-ancestor
139502508|NCT05329779|GABA Agents|gaba agents|mesh-ancestor
139502509|NCT04850937|Esketamine|esketamine|mesh-list
139502510|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
139502511|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139502512|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139502513|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139502514|NCT04411329|Dexamethasone|dexamethasone|mesh-list
139502515|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
139502516|NCT04411329|Bupivacaine|bupivacaine|mesh-list
139502517|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139502518|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
139502519|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
139502520|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502521|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502522|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139502523|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
139502524|NCT04411329|Hormones|hormones|mesh-ancestor
139502525|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139502526|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139502527|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502528|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
139502529|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
139502530|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139502531|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
139502532|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139093562|NCT03850652|Iron|iron|mesh-list
139502533|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139502534|NCT04411329|Analgesics|analgesics|mesh-ancestor
139502535|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139502536|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139502537|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139502538|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
139502539|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502540|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502541|NCT05171673|Diclofenac|diclofenac|mesh-list
139502542|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
139502543|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139502544|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139502545|NCT05171673|Analgesics|analgesics|mesh-ancestor
139289233|NCT04622995|Diazepam|diazepam|mesh-list
139502546|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
139502547|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502548|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502549|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139502550|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139502551|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139502552|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502553|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502554|NCT05147415|Metoprolol|metoprolol|mesh-list
139502555|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139502556|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139502557|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
139502558|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
139502559|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502560|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502561|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139502562|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139502563|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139502564|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
139502565|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502566|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502567|NCT04390581|Lidocaine|lidocaine|mesh-list
139502568|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
139502569|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
139502570|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139502571|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502572|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
139502573|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502574|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139502575|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139502576|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139502577|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139502578|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502579|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139502580|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502581|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502582|NCT04225767|Calcium|calcium|mesh-list
139502583|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139502584|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502585|NCT04820673|Sarecycline|sarecycline|mesh-list
139502586|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139502587|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502588|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
139502589|NCT04114539|Ecopipam|ecopipam|mesh-list
139502590|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139502591|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139502592|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139502593|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502594|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139502595|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139502596|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
139502597|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502598|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502599|NCT03256149|Dexamethasone|dexamethasone|mesh-list
139502600|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139502601|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
139502602|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
139502603|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502604|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502605|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139502606|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
139502607|NCT03256149|Hormones|hormones|mesh-ancestor
139502608|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139502609|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139502610|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502611|NCT03253263|Mecasermin|mecasermin|mesh-list
139502612|NCT03253263|Growth Substances|growth substances|mesh-ancestor
139502613|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502614|NCT01636947|Dexamethasone|dexamethasone|mesh-list
139502615|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
139502616|NCT01636947|Ondansetron|ondansetron|mesh-list
139502617|NCT01636947|Aprepitant|aprepitant|mesh-list
139502618|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
139289297|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139502619|NCT01636947|Metoclopramide|metoclopramide|mesh-list
139502620|NCT01636947|Granisetron|granisetron|mesh-list
139502621|NCT01636947|Tropisetron|tropisetron|mesh-list
139502622|NCT01636947|Dolasetron|dolasetron|mesh-list
139502623|NCT01636947|Alizapride|alizapride|mesh-list
139502624|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139502625|NCT01636947|BB 1101|bb 1101|mesh-list
139502626|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139502627|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
139502628|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
139502629|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502630|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502631|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139502632|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
139502633|NCT01636947|Hormones|hormones|mesh-ancestor
139502634|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139502635|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139502636|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093684|NCT03846284|Bupivacaine|bupivacaine|mesh-list
139502637|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
139502638|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502639|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502640|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
139502641|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
139502642|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139502643|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139502644|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
139502645|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502646|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139502647|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139502648|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139502649|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
139502650|NCT03052725|Reslizumab|reslizumab|mesh-list
139502651|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139502652|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
139502653|NCT04793919|Tretinoin|tretinoin|mesh-list
139502654|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
139502655|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
139502656|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502657|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
139502658|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
139502659|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139502660|NCT04793919|Immunotoxins|immunotoxins|mesh-ancestor
139502661|NCT04793919|Immunoconjugates|immunoconjugates|mesh-ancestor
139502662|NCT04793919|Immunologic Factors|immunologic factors|mesh-ancestor
139502663|NCT04793919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502664|NCT02817633|Carboplatin|carboplatin|mesh-list
139502665|NCT02817633|Docetaxel|docetaxel|mesh-list
139502666|NCT02817633|Nivolumab|nivolumab|mesh-list
139502667|NCT02817633|Pemetrexed|pemetrexed|mesh-list
139502668|NCT02817633|Dostarlimab|dostarlimab|mesh-list
139502669|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502670|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
139502671|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
139502672|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
139502673|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502674|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139502675|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139502676|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502677|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139093723|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139502678|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139502679|NCT04791969|Naltrexone|naltrexone|mesh-list
139502680|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139502681|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139502682|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502683|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
139502684|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502685|NCT05651373|Hydroxychloroquine|hydroxychloroquine|mesh-list
139502686|NCT05651373|Prednisone|prednisone|mesh-list
139502687|NCT05651373|Certolizumab Pegol|certolizumab pegol|mesh-list
139502688|NCT05651373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139289390|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
139502689|NCT05651373|Glucocorticoids|glucocorticoids|mesh-ancestor
139502690|NCT05651373|Hormones|hormones|mesh-ancestor
139502691|NCT05651373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139502692|NCT05651373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502693|NCT05651373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139502694|NCT05651373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502695|NCT05651373|Antimalarials|antimalarials|mesh-ancestor
139502696|NCT05651373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139502697|NCT05651373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139502698|NCT05651373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502699|NCT05651373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502700|NCT05651373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502701|NCT05651373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139502702|NCT05651373|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139502703|NCT05651373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139502704|NCT05651373|Immunologic Factors|immunologic factors|mesh-ancestor
139502705|NCT03905889|Sunitinib|sunitinib|mesh-list
139502706|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502707|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139502708|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139502709|NCT03905889|Growth Substances|growth substances|mesh-ancestor
139502710|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502711|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
139502712|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139502713|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502714|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502715|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139502716|NCT03846765|Phenylephrine|phenylephrine|mesh-list
139502717|NCT03846765|Dobutamine|dobutamine|mesh-list
139502718|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
139502719|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139502720|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
139502721|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
139502722|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502723|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502724|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
139093768|NCT01566734|Cefazolin|cefazolin|mesh-list
139502725|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139502726|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
139502727|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
139502728|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139502729|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139502730|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139502731|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
139502732|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502733|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502734|NCT03846765|Protective Agents|protective agents|mesh-ancestor
139502735|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139502736|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139502737|NCT05163405|Bortezomib|bortezomib|mesh-list
139502738|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502739|NCT01635153|Micronutrients|micronutrients|mesh-list
139502740|NCT01635153|Trace Elements|trace elements|mesh-list
139502741|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502742|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139502743|NCT04446039|Vortioxetine|vortioxetine|mesh-list
139502744|NCT04446039|Mirtazapine|mirtazapine|mesh-list
139093835|NCT01202084|Xhance|xhance|mesh-list
139502745|NCT04446039|Bupropion|bupropion|mesh-list
139502746|NCT04446039|Fluoxetine|fluoxetine|mesh-list
139502747|NCT04446039|Paroxetine|paroxetine|mesh-list
139502748|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139502749|NCT04446039|Sertraline|sertraline|mesh-list
139502750|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139502751|NCT04446039|Tianeptine|tianeptine|mesh-list
139502752|NCT04446039|Escitalopram|escitalopram|mesh-list
139502753|NCT04446039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139502754|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139502755|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139502756|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502757|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502758|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
139502759|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502760|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502761|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139502762|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
139502763|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139502764|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139502765|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
139502766|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139502767|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139502768|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502769|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139502770|NCT04446039|Analgesics|analgesics|mesh-ancestor
139502771|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
139502772|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139502773|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139502774|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139502775|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139502776|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139502777|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139502778|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139502779|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139502780|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
139502781|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
139502782|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139502783|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139502784|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139502785|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
139502786|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139502787|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139502788|NCT03591861|Carmustine|carmustine|mesh-list
139502789|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139502790|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
139502791|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502792|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502793|NCT01600053|Lenalidomide|lenalidomide|mesh-list
139502794|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
139502795|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502796|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139502797|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139502798|NCT01600053|Growth Substances|growth substances|mesh-ancestor
139502799|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
139502800|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502801|NCT03569241|Androgens|androgens|mesh-list
139502802|NCT03569241|Hormones|hormones|mesh-ancestor
139093883|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502803|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139502804|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502805|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
139502806|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
139502807|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139502808|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502809|NCT01068249|Everolimus|everolimus|mesh-list
139502810|NCT01068249|Letrozole|letrozole|mesh-list
139502811|NCT01068249|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139502812|NCT01068249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139502813|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502814|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502815|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139502816|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
139502817|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502818|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502819|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139502820|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139502821|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139502822|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
139502823|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139502824|NCT01035099|Letrozole|letrozole|mesh-list
139502825|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502826|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139502827|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139502828|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502829|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502830|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139502831|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
139502832|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139502833|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502834|NCT03560349|Lidocaine|lidocaine|mesh-list
139502835|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
139502836|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
139502837|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139502838|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502839|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
139502840|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502841|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139502842|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139502843|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139502844|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139642386|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139502845|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502847|NCT04435431|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139502848|NCT04435431|Dopamine Agents|dopamine agents|mesh-ancestor
139502849|NCT04435431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502850|NCT04435431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502851|NCT04435431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502852|NCT02246673|Febuxostat|febuxostat|mesh-list
139502853|NCT02246673|Verinurad|verinurad|mesh-list
139502854|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
139502855|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139502856|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139502857|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139502858|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139502859|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502860|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502861|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
139502862|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502863|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139502864|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139502865|NCT04191447|Budesonide|budesonide|mesh-list
139502866|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
139502867|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139502868|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139502869|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139502870|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
139502871|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093968|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139502872|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502873|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139502874|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
139502875|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
139502876|NCT04191447|Hormones|hormones|mesh-ancestor
139502877|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139502878|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139502879|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139502880|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139502881|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
139502882|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502883|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502884|NCT02243631|Probenecid|probenecid|mesh-list
139502885|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
139502886|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
139502887|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139502888|NCT02242305|Scopolamine|scopolamine|mesh-list
139502889|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139502890|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139502891|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
139502892|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
139502893|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502894|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502895|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139502896|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
139502897|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139502898|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
139502899|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502900|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502901|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139502902|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
139502903|NCT02240121|Rifaximin|rifaximin|mesh-list
139502904|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139502905|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502906|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139502907|NCT02238483|AZD7624|azd7624|mesh-list
139502908|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139502909|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502910|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502911|NCT01632891|Ritonavir|ritonavir|mesh-list
139502912|NCT01632891|Lopinavir|lopinavir|mesh-list
139502913|NCT01632891|Tenofovir|tenofovir|mesh-list
139502914|NCT01632891|Emtricitabine|emtricitabine|mesh-list
139502915|NCT01632891|Nevirapine|nevirapine|mesh-list
139502916|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139502917|NCT01632891|Efavirenz|efavirenz|mesh-list
139502918|NCT01632891|Trimethoprim|trimethoprim|mesh-list
139502919|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
139502920|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139502921|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139502922|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
139502923|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502924|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502925|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139502926|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139502927|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
139094059|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
139502928|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502929|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139502930|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139502931|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139502932|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139502933|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139502934|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139502935|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139502936|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139502937|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139502938|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139502939|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
139502940|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139502941|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139502942|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139502943|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139502944|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139502945|NCT02208843|Afatinib|afatinib|mesh-list
139502946|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502947|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139502948|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139502949|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502950|NCT02208063|Vancomycin|vancomycin|mesh-list
139502951|NCT02208063|Cefazolin|cefazolin|mesh-list
139502952|NCT02208063|Daptomycin|daptomycin|mesh-list
139502953|NCT02208063|Penicillins|penicillins|mesh-list
139502954|NCT02208063|Cloxacillin|cloxacillin|mesh-list
139502955|NCT02208063|Oxacillin|oxacillin|mesh-list
139502956|NCT02208063|Telavancin|telavancin|mesh-list
139502957|NCT02208063|Nafcillin|nafcillin|mesh-list
139502958|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139502959|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502960|NCT02207907|Listerine|listerine|mesh-list
139502961|NCT02207907|Fluorides|fluorides|mesh-list
139502962|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
139502963|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
139502964|NCT02207907|Protective Agents|protective agents|mesh-ancestor
139502965|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502966|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139502967|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139502968|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
139502969|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139502970|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
139502971|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139502972|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502973|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139502974|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
139502975|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
139502976|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139502977|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
139502978|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502979|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502980|NCT02237157|Gemcitabine|gemcitabine|mesh-list
139502981|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139502982|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
139502983|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139502984|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502985|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
139502986|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139502987|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139502988|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139502989|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
139502990|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139502991|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094173|NCT01066403|Pergolide|pergolide|mesh-list
139502992|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139502993|NCT02233803|Budesonide|budesonide|mesh-list
139502994|NCT02233803|Albuterol|albuterol|mesh-list
139642387|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139502995|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139502996|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139502997|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139502998|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
139502999|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503000|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503001|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139503002|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
139503003|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
139503004|NCT02233803|Hormones|hormones|mesh-ancestor
139503005|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503006|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
139503007|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139503008|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139503009|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139503010|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139503011|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
139503012|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503013|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503014|NCT02233647|Cocaine|cocaine|mesh-list
139503015|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
139503016|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
139503017|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139503018|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503019|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
139503020|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503021|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139503022|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139503023|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139503024|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139503025|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503026|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
139503027|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503028|NCT01632579|Celecoxib|celecoxib|mesh-list
139503029|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139503030|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139503031|NCT01632579|Analgesics|analgesics|mesh-ancestor
139503032|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
139503033|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503034|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503035|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139503036|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139503037|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139503038|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139503039|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503040|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503041|NCT01632345|Efavirenz|efavirenz|mesh-list
139503042|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139503043|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139503044|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139503045|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503046|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503047|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
139503048|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503049|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139503050|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139503051|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139503052|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139503053|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139503054|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139503055|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139503056|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139503057|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
139503058|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
139503059|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139503060|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139503061|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503062|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503063|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503064|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139503065|NCT02205333|Rituximab|rituximab|mesh-list
139503066|NCT02205333|Durvalumab|durvalumab|mesh-list
139503067|NCT02205333|Tremelimumab|tremelimumab|mesh-list
139503068|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139503069|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094230|NCT01297166|Vitamins|vitamins|mesh-ancestor
139503070|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
139503071|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503072|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139503073|NCT04776369|Lidocaine|lidocaine|mesh-list
139503074|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
139503075|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
139503076|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
139503077|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139503078|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503079|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
139503080|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503081|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139503082|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139503083|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139503084|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139503085|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503086|NCT04776369|Analgesics|analgesics|mesh-ancestor
139503087|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
139503088|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139503089|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139503090|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
139503091|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139503092|NCT02230527|Clopidogrel|clopidogrel|mesh-list
139503093|NCT02230527|Ticagrelor|ticagrelor|mesh-list
139503094|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139503095|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139503096|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139503097|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139503098|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
139503099|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503100|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503101|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503102|NCT03155061|Nivolumab|nivolumab|mesh-list
139503103|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139503104|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503105|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139503106|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503107|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
139503108|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139503109|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503110|NCT02203149|Grazoprevir|grazoprevir|mesh-list
139503111|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
139503112|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503113|NCT02202837|Etanercept|etanercept|mesh-list
139094251|NCT05667818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139503114|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139503115|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139503116|NCT02202837|Analgesics|analgesics|mesh-ancestor
139503117|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
139503118|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503119|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503120|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139503121|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139503122|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139503123|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139503124|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
139503125|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
139503126|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139503127|NCT02226549|Ledipasvir|ledipasvir|mesh-list
139503128|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
139503129|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503130|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139503131|NCT02226003|Glimepiride|glimepiride|mesh-list
139503132|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
139503133|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139503134|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503135|NCT02226003|Incretins|incretins|mesh-ancestor
139503136|NCT02226003|Hormones|hormones|mesh-ancestor
139503137|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503138|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139503139|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
139503140|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139289818|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
139503141|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503142|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139503143|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139503144|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
139503145|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139503146|NCT02469519|Dexamethasone|dexamethasone|mesh-list
139503147|NCT02469519|Betamethasone|betamethasone|mesh-list
139503148|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139503149|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
139503150|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
139094281|NCT01205360|Fentanyl|fentanyl|mesh-list
139503151|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503152|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503153|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139503154|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
139503155|NCT02469519|Hormones|hormones|mesh-ancestor
139503156|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503157|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139503158|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503159|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139503160|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
139503161|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
139503162|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139503163|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
139503164|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503165|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503166|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139503167|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
139503168|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
139503169|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139503170|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
139503171|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503172|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503173|NCT02404441|Spartalizumab|spartalizumab|mesh-list
139503174|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139503175|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503176|NCT02404441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139503177|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503178|NCT02101281|Mitogens|mitogens|mesh-list
139503179|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
139503180|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503181|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
139503182|NCT02224599|Imiquimod|imiquimod|mesh-list
139503183|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139503184|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
139503185|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503186|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139503187|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139503188|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
139503189|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503190|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503191|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139503192|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139503193|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
139503194|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
139503195|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139503196|NCT02201901|Velpatasvir|velpatasvir|mesh-list
139503197|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
139094323|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
139503198|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503199|NCT02224053|Osimertinib|osimertinib|mesh-list
139503200|NCT02224053|Omeprazole|omeprazole|mesh-list
139503201|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139503202|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139503203|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139503204|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503205|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503206|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503207|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139503208|NCT04774107|Ribavirin|ribavirin|mesh-list
139503209|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
139503210|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503211|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
139503212|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503213|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
139503214|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139289889|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
139503215|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139503216|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503217|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503218|NCT02434939|Ketamine|ketamine|mesh-list
139503219|NCT02434939|Morphine|morphine|mesh-list
139503220|NCT02434939|Analgesics|analgesics|mesh-ancestor
139503221|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
139503222|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503223|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503224|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139503225|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139503226|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
139503227|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
139503228|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139503229|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139503230|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139503231|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503232|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503233|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139503234|NCT02434939|Narcotics|narcotics|mesh-ancestor
139503235|NCT02457325|Carticaine|carticaine|mesh-list
139503236|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
139503237|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
139503238|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139503239|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503240|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
139503241|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503242|NCT02434081|Nivolumab|nivolumab|mesh-list
139503243|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139503244|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503245|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139503246|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503247|NCT02222493|Infliximab|infliximab|mesh-list
139503248|NCT02222493|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139503249|NCT02222493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139503250|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
139503251|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139503252|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139503253|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139503254|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
139503255|NCT01439997|Coagulants|coagulants|mesh-ancestor
139503256|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139503257|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
139503258|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503259|NCT02403271|Durvalumab|durvalumab|mesh-list
139503260|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139503261|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503262|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
139503263|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139503264|NCT02219685|Ledipasvir|ledipasvir|mesh-list
139503265|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
139503266|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503267|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
139503268|NCT02457247|Antacids|antacids|mesh-ancestor
139503269|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503270|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139503271|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139503272|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139503273|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503274|NCT02198235|Dexamethasone|dexamethasone|mesh-list
139503275|NCT02198235|Buprenorphine|buprenorphine|mesh-list
139503276|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139503277|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
139503278|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
139503279|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503280|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503281|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139503282|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
139503283|NCT02198235|Hormones|hormones|mesh-ancestor
139503284|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503285|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139503286|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503287|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139503288|NCT02198235|Narcotics|narcotics|mesh-ancestor
139503289|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139503290|NCT02198235|Analgesics|analgesics|mesh-ancestor
139503291|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
139503292|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139503293|NCT00346125|Doxorubicin|doxorubicin|mesh-list
139503294|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139503295|NCT00346125|Ifosfamide|ifosfamide|mesh-list
139503296|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139503297|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139503298|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503299|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139503300|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139503301|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503302|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503303|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139503304|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
139503305|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139503306|NCT02217501|Aspirin|aspirin|mesh-list
139503307|NCT02217501|Clopidogrel|clopidogrel|mesh-list
139503308|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139503309|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139503310|NCT02217501|Analgesics|analgesics|mesh-ancestor
139503311|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
139503312|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503313|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503314|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139503315|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139503316|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139503317|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139503318|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503319|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139503320|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139503321|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503322|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
139503323|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139503324|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139503325|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139503326|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
139503327|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503328|NCT01649869|Valganciclovir|valganciclovir|mesh-list
139503329|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
139503330|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503331|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
139503332|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139503333|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503334|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
139503335|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
139503336|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
139503337|NCT02399449|Hematinics|hematinics|mesh-ancestor
139503338|NCT02217345|Hormones|hormones|mesh-list
139503339|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503340|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503341|NCT02428855|Dasatinib|dasatinib|mesh-list
139503342|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503343|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139503344|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503345|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503346|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
139503347|NCT02428699|Liver Extracts|liver extracts|mesh-list
139503348|NCT02428699|Hematinics|hematinics|mesh-ancestor
139503349|NCT02428699|Vitamins|vitamins|mesh-ancestor
139503350|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
139503351|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503352|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139503353|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
139503354|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139503355|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
139503356|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503357|NCT02397889|Midazolam|midazolam|mesh-list
139503358|NCT02397889|Ketamine|ketamine|mesh-list
139503359|NCT02397889|Analgesics|analgesics|mesh-ancestor
139503360|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
139503361|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503362|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503363|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139503364|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139503365|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
139503366|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
139503367|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139503368|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139503369|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139503370|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503371|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503372|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139503373|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139503374|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139503375|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139503376|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139503377|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
139503378|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
139503380|NCT02396953|Somatostatin|somatostatin|mesh-list
139503381|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503382|NCT02396953|Hormones|hormones|mesh-ancestor
139503383|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503384|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503385|NCT02387983|Posaconazole|posaconazole|mesh-list
139503386|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
139503387|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503388|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139503389|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139503390|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139503391|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139503392|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139503393|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503394|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503395|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139503396|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
139503397|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503398|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503399|NCT02395627|Tamoxifen|tamoxifen|mesh-list
139503400|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
139503401|NCT02395627|Vorinostat|vorinostat|mesh-list
139503402|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139503403|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503404|NCT02395627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139503405|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503406|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139503407|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
139503408|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503409|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503410|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139503411|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139503412|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139503413|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139503414|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139503415|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503416|NCT02395081|Vitamin D|vitamin d|mesh-list
139503417|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
139503418|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
139503419|NCT02395081|Vitamins|vitamins|mesh-list
139503420|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
139503421|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503422|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139503423|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139503424|NCT02425111|Vedolizumab|vedolizumab|mesh-list
139503425|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139503426|NCT02393755|Capecitabine|capecitabine|mesh-list
139503427|NCT02393755|Nintedanib|nintedanib|mesh-list
139503428|NCT02393755|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139503429|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139503430|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
139503431|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503432|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503433|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139503434|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503435|NCT02393209|Docetaxel|docetaxel|mesh-list
139503436|NCT02393209|Serabelisib|serabelisib|mesh-list
139503437|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503438|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
139503439|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
139503440|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
139290119|NCT02220348|Linaclotide|linaclotide|mesh-list
139503441|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503442|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503443|NCT02424097|Listerine|listerine|mesh-list
139503444|NCT02424097|Fluorides|fluorides|mesh-list
139503445|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
139503446|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
139503447|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
139503448|NCT02424097|Protective Agents|protective agents|mesh-ancestor
139503449|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503450|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139503451|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503452|NCT02392507|Paclitaxel|paclitaxel|mesh-list
139503453|NCT02392507|Carboplatin|carboplatin|mesh-list
139503454|NCT02392507|Necitumumab|necitumumab|mesh-list
139503455|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139503456|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503457|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
139503458|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
139503459|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
139503460|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503461|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139503462|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
139503463|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139503464|NCT04904341|Protective Agents|protective agents|mesh-ancestor
139503465|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503466|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
139503467|NCT02385799|Sertraline|sertraline|mesh-list
139503468|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
139503469|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139503470|NCT02385799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139503471|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139503472|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139503473|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503474|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503475|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
139503476|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503477|NCT02422303|Ketamine|ketamine|mesh-list
139503478|NCT02422303|Analgesics|analgesics|mesh-ancestor
139503479|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
139503480|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503481|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503482|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139503483|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139503484|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
139503485|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
139503486|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139503487|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139503488|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139503489|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503490|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503491|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
139503492|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139503493|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139503494|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503495|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139503496|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139503497|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503498|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139503499|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503500|NCT02384395|Lamivudine|lamivudine|mesh-list
139503501|NCT02384395|Abacavir|abacavir|mesh-list
139503502|NCT02384395|Dolutegravir|dolutegravir|mesh-list
139503503|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139503504|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139503505|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503506|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503507|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
139503508|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503509|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139503510|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139503511|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139503512|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139503513|NCT02391337|Digoxin|digoxin|mesh-list
139503515|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139503516|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139503517|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503518|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503519|NCT02391337|Protective Agents|protective agents|mesh-ancestor
139503520|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503521|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139503522|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
139503523|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
139503524|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503525|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139503526|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139503527|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139503528|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
139503529|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503530|NCT01649791|Lenalidomide|lenalidomide|mesh-list
139503531|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
139503532|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503533|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139503534|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139503535|NCT01649791|Growth Substances|growth substances|mesh-ancestor
139503536|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
139503537|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503538|NCT02347657|Ivacaftor|ivacaftor|mesh-list
139503539|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139503540|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139503541|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503542|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
139503543|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139503544|NCT02346721|Velpatasvir|velpatasvir|mesh-list
139503545|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
139503546|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503547|NCT02388997|Omalizumab|omalizumab|mesh-list
139503548|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139503549|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139503550|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
139503551|NCT02345161|Budesonide|budesonide|mesh-list
139503552|NCT02345161|Albuterol|albuterol|mesh-list
139503553|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
139503554|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139503555|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139503556|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139503557|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
139503558|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503559|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503560|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139503561|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
139503562|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
139503563|NCT02345161|Hormones|hormones|mesh-ancestor
139503564|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503565|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139503566|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139503567|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139503568|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
139503569|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503570|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503571|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
139503572|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139503573|NCT02251275|Tolvaptan|tolvaptan|mesh-list
139503574|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139503575|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503576|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
139503577|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503578|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
139503579|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139503580|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
139503581|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503582|NCT02379637|Expectorants|expectorants|mesh-ancestor
139503583|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
139503584|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139503585|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
139503586|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139290267|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503587|NCT02379637|Protective Agents|protective agents|mesh-ancestor
139503588|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503589|NCT02379637|Antidotes|antidotes|mesh-ancestor
139503590|NCT02195583|Zinc|zinc|mesh-list
139503591|NCT02195583|Listerine|listerine|mesh-list
139503592|NCT02195583|Fluorides|fluorides|mesh-list
139503593|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
139503594|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
139503595|NCT02195583|Protective Agents|protective agents|mesh-ancestor
139503596|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503597|NCT02195583|Trace Elements|trace elements|mesh-ancestor
139503598|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
139503599|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139503600|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503601|NCT02379091|Leucovorin|leucovorin|mesh-list
139503602|NCT02379091|Folic Acid|folic acid|mesh-list
139503603|NCT02379091|Methotrexate|methotrexate|mesh-list
139503604|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
139503605|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139503606|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
139503607|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139503608|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503609|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139503610|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
139503611|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503612|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503613|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
139503614|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503615|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139503616|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139503617|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
139503618|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139503619|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139503620|NCT02379091|Antidotes|antidotes|mesh-ancestor
139503621|NCT02379091|Protective Agents|protective agents|mesh-ancestor
139503622|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
139503623|NCT02379091|Vitamins|vitamins|mesh-ancestor
139503624|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
139503625|NCT02379091|Hematinics|hematinics|mesh-ancestor
139503626|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
139503627|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139503628|NCT02378935|Velpatasvir|velpatasvir|mesh-list
139503629|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
139503630|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503631|NCT02250651|Timolol|timolol|mesh-list
139503632|NCT02250651|Bimatoprost|bimatoprost|mesh-list
139503633|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139503634|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139503635|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
139503636|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503637|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503638|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503639|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139503640|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139503641|NCT02214225|Vaccines|vaccines|mesh-list
139503642|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
139503643|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503644|NCT02249949|Efatutazone|efatutazone|mesh-list
139503645|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503646|NCT02249091|Cytarabine|cytarabine|mesh-list
139503647|NCT02249091|Idarubicin|idarubicin|mesh-list
139503648|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139503649|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
139503650|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503651|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503652|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
139503653|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503654|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139503655|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
139503656|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503657|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139503658|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139503659|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139503660|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503661|NCT02213055|Permethrin|permethrin|mesh-list
139503662|NCT02213055|Malathion|malathion|mesh-list
139503663|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503664|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503665|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139503666|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
139503667|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503668|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503669|NCT02309515|Lenalidomide|lenalidomide|mesh-list
139503670|NCT02309515|Vaccines|vaccines|mesh-list
139503671|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
139503672|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503673|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139503674|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139503675|NCT02309515|Growth Substances|growth substances|mesh-ancestor
139503676|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
139503677|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503678|NCT02309359|Methotrexate|methotrexate|mesh-list
139503679|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139503680|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
139503681|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139503682|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503683|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139503684|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
139503685|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503686|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503687|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
139503688|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503689|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139503690|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139503691|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
139503692|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139503693|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139503694|NCT02375971|Ranibizumab|ranibizumab|mesh-list
139503695|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139503696|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139503697|NCT02375971|Growth Substances|growth substances|mesh-ancestor
139503698|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503699|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
139503700|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503701|NCT02212197|Leuprolide|leuprolide|mesh-list
139503702|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139503703|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
139503704|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139503705|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503706|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139503707|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503708|NCT02193165|Triclosan|triclosan|mesh-list
139503709|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
139503710|NCT02193165|Fluorides|fluorides|mesh-list
139503711|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
139503712|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
139503713|NCT02193165|Protective Agents|protective agents|mesh-ancestor
139503714|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503715|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139503716|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503717|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139503718|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139503719|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
139503720|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503721|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139503722|NCT01617460|Aripiprazole|aripiprazole|mesh-list
139503723|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
139503724|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139503725|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139503726|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139503727|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139503728|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503729|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
139503730|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
139503731|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503732|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503733|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139503734|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139503735|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
139503736|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139503737|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139503738|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139503739|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139503740|NCT01889602|Topiramate|topiramate|mesh-list
139503741|NCT01889602|Lorazepam|lorazepam|mesh-list
139503742|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
139503743|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139503744|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503745|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
139503746|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
139503747|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503748|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139503749|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139503750|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139503751|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139503752|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139503753|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139503754|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
139503755|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
139503756|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503757|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503758|NCT01935700|Colchicine|colchicine|mesh-list
139503759|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
139503760|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139503761|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
139503762|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
139503763|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
139094798|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
139503764|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503765|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503766|NCT01618162|Liraglutide|liraglutide|mesh-list
139503767|NCT01618162|Xultophy|xultophy|mesh-list
139503768|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139503769|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503770|NCT01618162|Incretins|incretins|mesh-ancestor
139503771|NCT01618162|Hormones|hormones|mesh-ancestor
139503772|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503773|NCT04771767|Ketamine|ketamine|mesh-list
139503774|NCT04771767|Analgesics|analgesics|mesh-ancestor
139503775|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
139503776|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503777|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503778|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139503779|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139503780|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
139503781|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
139503782|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139503783|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139503784|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139503785|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503786|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503787|NCT02341417|Cinacalcet|cinacalcet|mesh-list
139503788|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139503789|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503790|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139503791|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
139503792|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503793|NCT02340949|Leucovorin|leucovorin|mesh-list
139503794|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
139503795|NCT02340949|Aflibercept|aflibercept|mesh-list
139503796|NCT02340949|Fluorouracil|fluorouracil|mesh-list
139503797|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503798|NCT02340949|Antidotes|antidotes|mesh-ancestor
139503799|NCT02340949|Protective Agents|protective agents|mesh-ancestor
139503800|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503801|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
139503802|NCT02340949|Vitamins|vitamins|mesh-ancestor
139503803|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
139503804|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139503805|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139503806|NCT02340949|Growth Substances|growth substances|mesh-ancestor
139503807|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
139094834|NCT01300676|Estradiol|estradiol|mesh-list
139503808|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
139503809|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503810|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139503811|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139503812|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
139503813|NCT02374957|Cilostazol|cilostazol|mesh-list
139503814|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139503815|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
139290516|NCT02226978|Ritonavir|ritonavir|mesh-list
139503816|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503817|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503818|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139503819|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
139503820|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139503821|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139503822|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503823|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139503824|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
139503825|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139503826|NCT02374957|Protective Agents|protective agents|mesh-ancestor
139503827|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139503828|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139503829|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503830|NCT02308033|Metronidazole|metronidazole|mesh-list
139503831|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503832|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139503833|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139503834|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139503835|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
139503836|NCT02339155|Promethazine|promethazine|mesh-list
139503837|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139503838|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139503839|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139503840|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503841|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
139503842|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
139503843|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
139503844|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503845|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
139503846|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
139094867|NCT03814616|Artesunate|artesunate|mesh-list
139503847|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139503848|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139503849|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
139503850|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
139503851|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503852|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503853|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139503854|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
139503855|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
139503856|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139503857|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
139503858|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139503859|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139503860|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139503861|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503862|NCT02210091|Factor VIII|factor viii|mesh-list
139503863|NCT02210091|BAX 855|bax 855|mesh-list
139503864|NCT02210091|Coagulants|coagulants|mesh-ancestor
139503865|NCT02338999|Pioglitazone|pioglitazone|mesh-list
139503866|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139503867|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503868|NCT02169219|Prednisone|prednisone|mesh-list
139503869|NCT02169219|Rituximab|rituximab|mesh-list
139503870|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
139503871|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139503872|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503873|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
139503874|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503875|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139503876|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139503877|NCT02169219|Hormones|hormones|mesh-ancestor
139503878|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503879|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139503880|NCT02191137|Riociguat|riociguat|mesh-list
139503881|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
139503882|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503883|NCT02168439|Midazolam|midazolam|mesh-list
139503884|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
139503885|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139503886|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139503887|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503888|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139503889|NCT02168439|Analgesics|analgesics|mesh-ancestor
139503890|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
139503891|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503892|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139642388|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
139503893|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139503894|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139503895|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
139503896|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139503897|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503898|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139503899|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139503900|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139503901|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139503902|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139503903|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
139503904|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
139503905|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
139503906|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
139503907|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
139503908|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139503909|NCT02135445|Relugolix|relugolix|mesh-list
139503910|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
139503911|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
139503912|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503913|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503914|NCT02374099|Azacitidine|azacitidine|mesh-list
139503915|NCT02374099|Fulvestrant|fulvestrant|mesh-list
139503916|NCT02374099|Cc-486|cc-486|mesh-list
139503917|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139503918|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
139503919|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503920|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503921|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503922|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139503923|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139094934|NCT00302003|Hormones|hormones|mesh-ancestor
139503924|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139503925|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
139503926|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139503927|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503928|NCT02134977|Leuprolide|leuprolide|mesh-list
139503929|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139503930|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
139503931|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139503932|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503933|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139503934|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503935|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
139503936|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
139503937|NCT02374021|Adalimumab|adalimumab|mesh-list
139503938|NCT02374021|Etanercept|etanercept|mesh-list
139503939|NCT02374021|Methotrexate|methotrexate|mesh-list
139503940|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139503941|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
139503942|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139503943|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503944|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139503945|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
139503946|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503947|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139503948|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
139503949|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503950|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139503951|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139503952|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
139503953|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139503954|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139503955|NCT02374021|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139503956|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139503957|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
139503958|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139503959|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139503960|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503961|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139503962|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139503963|NCT02374021|Analgesics|analgesics|mesh-ancestor
139503964|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
139503965|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503966|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139503967|NCT02372383|Azithromycin|azithromycin|mesh-list
139503968|NCT02372383|Rifampin|rifampin|mesh-list
139503969|NCT02372383|Ethambutol|ethambutol|mesh-list
139503970|NCT02372383|Pancrelipase|pancrelipase|mesh-list
139503971|NCT02372383|Pancreatin|pancreatin|mesh-list
139503972|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139503973|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139503974|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139503975|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
139503976|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
139503977|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139503978|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139503979|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139503980|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139503981|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139503982|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139503983|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139503984|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139503985|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139503986|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139503987|NCT01648699|Hydromorphone|hydromorphone|mesh-list
139503988|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139503989|NCT01648699|Narcotics|narcotics|mesh-ancestor
139503990|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139503991|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139503992|NCT01648699|Analgesics|analgesics|mesh-ancestor
139503993|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
139503994|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139503995|NCT02134353|Mannitol|mannitol|mesh-list
139503996|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139503997|NCT02134353|Diuretics|diuretics|mesh-ancestor
139503998|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
139503999|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504000|NCT01646125|Docetaxel|docetaxel|mesh-list
139504001|NCT01646125|Pemetrexed|pemetrexed|mesh-list
139504002|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504003|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
139504004|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
139504005|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
139504006|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504007|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504008|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139504009|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139504010|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
139504011|NCT01362790|Pentostatin|pentostatin|mesh-list
139504012|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139504013|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139504014|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
139504015|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504016|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139504017|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139504018|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
139504019|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504020|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504021|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139504022|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139504023|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504024|NCT02167893|Leuprolide|leuprolide|mesh-list
139504025|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139504026|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
139504027|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139504028|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504029|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139504030|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504031|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
139504032|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139504033|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139504034|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
139504035|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504036|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504037|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504038|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139504039|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139504040|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139504041|NCT01615198|Olmesartan|olmesartan|mesh-list
139504042|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139504043|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139504044|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139504045|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139504046|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504048|NCT02337907|BI 409306|bi 409306|mesh-list
139504049|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139504050|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504051|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504052|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
139504053|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504054|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504055|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
139504056|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139504057|NCT01913470|Losartan|losartan|mesh-list
139504058|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139504059|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139504060|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139504061|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139504062|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504063|NCT02166333|Vitamin D|vitamin d|mesh-list
139504064|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
139504065|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
139504066|NCT02166333|Vitamins|vitamins|mesh-list
139504067|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
139504068|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504069|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139504070|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139504071|NCT02132949|Paclitaxel|paclitaxel|mesh-list
139504072|NCT02132949|Docetaxel|docetaxel|mesh-list
139504073|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
139504074|NCT02132949|Doxorubicin|doxorubicin|mesh-list
139504075|NCT02132949|Fluorouracil|fluorouracil|mesh-list
139504076|NCT02132949|Trastuzumab|trastuzumab|mesh-list
139504077|NCT02132949|Epirubicin|epirubicin|mesh-list
139504078|NCT02132949|Pertuzumab|pertuzumab|mesh-list
139504079|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139504080|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504081|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
139504082|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
139504083|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
139504084|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504085|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139504086|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
139504087|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504088|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139504089|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139504090|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
139504091|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139504092|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139504093|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139504094|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139504095|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504096|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
139504097|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139504098|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139504099|NCT02165397|Rituximab|rituximab|mesh-list
139504100|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139504101|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504102|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
139504103|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504104|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139504105|NCT02132637|Insulin|insulin|mesh-list
139504106|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139504107|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
139504108|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139504109|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504110|NCT02164929|Acetaminophen|acetaminophen|mesh-list
139504111|NCT02164929|Dexamethasone|dexamethasone|mesh-list
139504112|NCT02164929|Lidocaine|lidocaine|mesh-list
139504113|NCT02164929|Epinephrine|epinephrine|mesh-list
139504114|NCT02164929|Midazolam|midazolam|mesh-list
139504115|NCT02164929|Hydromorphone|hydromorphone|mesh-list
139504116|NCT02164929|Ropivacaine|ropivacaine|mesh-list
139504117|NCT02164929|Propofol|propofol|mesh-list
139504118|NCT02164929|Sevoflurane|sevoflurane|mesh-list
139504119|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139504120|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
139504121|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
139504122|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504123|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504124|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139504125|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
139504126|NCT02164929|Hormones|hormones|mesh-ancestor
139504127|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504128|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139504129|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504130|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
139504131|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
139504132|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504133|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
139504134|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139504135|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139504136|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139504137|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139504138|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504139|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139095110|NCT03954756|Apatinib|apatinib|mesh-list
139504140|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139504141|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
139504142|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139504143|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139504144|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139504145|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139504146|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
139504147|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
139504148|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504149|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139504150|NCT02164929|Analgesics|analgesics|mesh-ancestor
139504151|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
139504152|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139504153|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139504154|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139504155|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139504156|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
139504157|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139504158|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139504159|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139504160|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
139504161|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
139504162|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
139504163|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139504164|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139504165|NCT02164929|Narcotics|narcotics|mesh-ancestor
139504166|NCT01888432|Everolimus|everolimus|mesh-list
139504167|NCT01888432|Tacrolimus|tacrolimus|mesh-list
139504168|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139504169|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
139504170|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504171|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139504172|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504173|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504174|NCT01888432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139504175|NCT01888432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139504176|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504177|NCT02188719|Acetaminophen|acetaminophen|mesh-list
139504178|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
139504179|NCT02188719|Promethazine|promethazine|mesh-list
139504180|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
139504181|NCT02188719|Valganciclovir|valganciclovir|mesh-list
139504182|NCT02188719|Ganciclovir|ganciclovir|mesh-list
139504183|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
139504184|NCT02188719|Prednisone|prednisone|mesh-list
139504185|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139504186|NCT02188719|Everolimus|everolimus|mesh-list
139504187|NCT02188719|Liver Extracts|liver extracts|mesh-list
139504188|NCT02188719|Tacrolimus|tacrolimus|mesh-list
139504189|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
139504190|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139504191|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139504192|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
139504193|NCT02188719|Hormones|hormones|mesh-ancestor
139504194|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504195|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504196|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139504197|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504198|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139504199|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
139504200|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139504201|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504202|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504203|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139504204|NCT02188719|Analgesics|analgesics|mesh-ancestor
139504205|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
139504206|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504207|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
139504208|NCT02188719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139504209|NCT02188719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139504210|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139504211|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139504212|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
139504213|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139504214|NCT02188719|Hematinics|hematinics|mesh-ancestor
139504215|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139504216|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139504217|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504218|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
139504219|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
139504220|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
139504221|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
139504222|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139504223|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139504224|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
139504225|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
139504226|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504227|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139504228|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
139504229|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
139504230|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
139504231|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139504232|NCT02188719|Protective Agents|protective agents|mesh-ancestor
139504233|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139504234|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139504235|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504236|NCT01933672|Incretins|incretins|mesh-ancestor
139504237|NCT01933672|Hormones|hormones|mesh-ancestor
139504238|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504239|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139504240|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
139504241|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504242|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504243|NCT02132247|Diclofenac|diclofenac|mesh-list
139504244|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
139504245|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139504246|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139504247|NCT02132247|Analgesics|analgesics|mesh-ancestor
139504248|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
139095207|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
139504249|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504250|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504251|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139504252|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139504253|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139504254|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504255|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504256|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
139504257|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139504258|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
139504259|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139504260|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
139504261|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504262|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504263|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
139504264|NCT05269017|Vitamin D|vitamin d|mesh-list
139504265|NCT05269017|Cholecalciferol|cholecalciferol|mesh-list
139504266|NCT05269017|Budesonide|budesonide|mesh-list
139504267|NCT05269017|Vitamins|vitamins|mesh-ancestor
139504268|NCT05269017|Micronutrients|micronutrients|mesh-ancestor
139504269|NCT05269017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504270|NCT05269017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139504271|NCT05269017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139504272|NCT05269017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139290943|NCT05590234|Bupivacaine|bupivacaine|mesh-list
139504273|NCT05269017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139504274|NCT05269017|Autonomic Agents|autonomic agents|mesh-ancestor
139504275|NCT05269017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504276|NCT05269017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139504277|NCT05269017|Respiratory System Agents|respiratory system agents|mesh-ancestor
139504278|NCT05269017|Glucocorticoids|glucocorticoids|mesh-ancestor
139504279|NCT05269017|Hormones|hormones|mesh-ancestor
139504280|NCT05269017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504281|NCT01628913|Everolimus|everolimus|mesh-list
139504282|NCT01628913|Dactolisib|dactolisib|mesh-list
139504283|NCT01628913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139504284|NCT01628913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139504285|NCT01628913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504286|NCT01628913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504287|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139504288|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
139504289|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504290|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504291|NCT02164383|Nicotine|nicotine|mesh-list
139504292|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139504293|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
139504294|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504295|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504296|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139504297|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139504298|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
139504299|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504300|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504301|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
139504302|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139504303|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139504304|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139504305|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
139504306|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139504307|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139504308|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139504309|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504310|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504311|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139504312|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139504313|NCT02131155|Afatinib|afatinib|mesh-list
139504314|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504315|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139504316|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504317|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504318|NCT01933594|Romidepsin|romidepsin|mesh-list
139504319|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139504320|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504321|NCT01933594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139504322|NCT01933594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504323|NCT01933594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504324|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139504325|NCT02305849|Methotrexate|methotrexate|mesh-list
139504326|NCT02305849|Peficitinib|peficitinib|mesh-list
139504327|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139504328|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
139504329|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139504330|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504331|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139504332|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
139504333|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504334|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504335|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
139504336|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504337|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139504338|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139504339|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
139504340|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139504341|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139504342|NCT02371759|Anesthetics|anesthetics|mesh-list
139504343|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504344|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504345|NCT02531633|Prednisone|prednisone|mesh-list
139504346|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139504347|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139504348|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
139504349|NCT02531633|Hormones|hormones|mesh-ancestor
139504350|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504351|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504352|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139504353|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504354|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
139504355|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
139504356|NCT02536313|Velpatasvir|velpatasvir|mesh-list
139504357|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
139504358|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139504359|NCT02187861|Rituximab|rituximab|mesh-list
139504360|NCT02187861|Venetoclax|venetoclax|mesh-list
139504361|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139504362|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139504363|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504364|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
139504365|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504366|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139504367|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139504368|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
139095328|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139504369|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504370|NCT05379179|Fentanyl|fentanyl|mesh-list
139504371|NCT05379179|Ketamine|ketamine|mesh-list
139504372|NCT05379179|Analgesics|analgesics|mesh-ancestor
139504373|NCT05379179|Sensory System Agents|sensory system agents|mesh-ancestor
139504374|NCT05379179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504375|NCT05379179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504376|NCT05379179|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139504377|NCT05379179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139504378|NCT05379179|Anesthetics, General|anesthetics, general|mesh-ancestor
139504379|NCT05379179|Anesthetics|anesthetics|mesh-ancestor
139504380|NCT05379179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504381|NCT05379179|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139504382|NCT05379179|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139504383|NCT05379179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504384|NCT05379179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504385|NCT05379179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139504386|NCT05379179|Narcotics|narcotics|mesh-ancestor
139504387|NCT05379179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139504388|NCT05383001|Durvalumab|durvalumab|mesh-list
139504389|NCT05383001|Tremelimumab|tremelimumab|mesh-list
139504390|NCT05383001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139504391|NCT05383001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504392|NCT02527421|Betamethasone|betamethasone|mesh-list
139504393|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139504394|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
139504395|NCT02527421|Hormones|hormones|mesh-ancestor
139504396|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504397|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504398|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139504399|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
139504400|NCT05610371|Lidocaine|lidocaine|mesh-list
139504401|NCT05610371|Anesthetics, Local|anesthetics, local|mesh-ancestor
139504402|NCT05610371|Anesthetics|anesthetics|mesh-ancestor
139504403|NCT05610371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504404|NCT05610371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504405|NCT05610371|Sensory System Agents|sensory system agents|mesh-ancestor
139504406|NCT05610371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504407|NCT05610371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139504408|NCT05610371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139504409|NCT05610371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139504410|NCT05610371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139504411|NCT05610371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504412|NCT02163759|Adalimumab|adalimumab|mesh-list
139504413|NCT02163759|Etrolizumab|etrolizumab|mesh-list
139504414|NCT02163759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138845949|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
139504415|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139504416|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139504417|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139504418|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
139504419|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504420|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
139504421|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139642389|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
139504422|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504423|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
139504424|NCT02163447|Piperaquine|piperaquine|mesh-list
139504425|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
139504426|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139504427|NCT02163447|Artenimol|artenimol|mesh-list
139504428|NCT02163447|Artemisinins|artemisinins|mesh-list
139504429|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
139504430|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139504431|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139504432|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139504433|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139504434|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504435|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504436|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139504437|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
139504438|NCT01887418|Testosterone|testosterone|mesh-list
139504439|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
139504440|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
139504441|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139504442|NCT01887418|Androgens|androgens|mesh-ancestor
139504443|NCT01887418|Hormones|hormones|mesh-ancestor
139504444|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504445|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504446|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139504447|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504448|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
139504449|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139504450|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139504451|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139504452|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139504453|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504454|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504455|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504456|NCT01912612|Analgesics|analgesics|mesh-ancestor
139504457|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
139504458|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504459|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
139504460|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139504461|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
139504462|NCT02302807|Paclitaxel|paclitaxel|mesh-list
139504463|NCT02302807|Docetaxel|docetaxel|mesh-list
139504464|NCT02302807|Atezolizumab|atezolizumab|mesh-list
139504465|NCT02302807|Antibodies|antibodies|mesh-list
139504466|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139504467|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504468|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
139504469|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
139504470|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
139504471|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504472|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
139504473|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504474|NCT02302807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139095436|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504475|NCT02302807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139504476|NCT01931566|Pioglitazone|pioglitazone|mesh-list
139504477|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139504478|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504479|NCT05372939|Adalimumab|adalimumab|mesh-list
139504480|NCT05372939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139504481|NCT05372939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139504482|NCT05372939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139504483|NCT01912456|Complement C1s|complement c1s|mesh-list
139504484|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139504485|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
139504486|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
139504487|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504488|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139504489|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139504490|NCT04251065|Daratumumab|daratumumab|mesh-list
139504491|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504492|NCT01885936|Albuterol|albuterol|mesh-list
139504493|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139504494|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
139504495|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504496|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504497|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139504498|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
139504499|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
139504500|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139504501|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139504502|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139504503|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139504504|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
139504505|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504506|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504507|NCT05368415|Norepinephrine|norepinephrine|mesh-list
139504508|NCT05368415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139504509|NCT05368415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139504510|NCT05368415|Adrenergic Agents|adrenergic agents|mesh-ancestor
139504511|NCT05368415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504512|NCT05368415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095474|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
139504513|NCT05368415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504514|NCT05368415|Sympathomimetics|sympathomimetics|mesh-ancestor
139504515|NCT05368415|Autonomic Agents|autonomic agents|mesh-ancestor
139504516|NCT05368415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504517|NCT05368415|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139504518|NCT05529173|Povidone-Iodine|povidone-iodine|mesh-list
139504519|NCT05529173|Povidone|povidone|mesh-list
139504520|NCT05529173|Plasma Substitutes|plasma substitutes|mesh-ancestor
139504521|NCT05529173|Blood Substitutes|blood substitutes|mesh-ancestor
139504522|NCT05529173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139504523|NCT05529173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139504524|NCT05335109|Xenon|xenon|mesh-list
139504525|NCT05335109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139504526|NCT05335109|Anesthetics, General|anesthetics, general|mesh-ancestor
139504527|NCT05335109|Anesthetics|anesthetics|mesh-ancestor
139504528|NCT05335109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504529|NCT05335109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504530|NCT05333237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139504531|NCT01912222|Ixazomib|ixazomib|mesh-list
139504532|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504533|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
139504534|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504535|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504536|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139504537|NCT05500703|Dexmedetomidine|dexmedetomidine|mesh-list
139504538|NCT05500703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139504539|NCT05500703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504540|NCT05500703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504541|NCT05500703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139504542|NCT05500703|Analgesics|analgesics|mesh-ancestor
139504543|NCT05500703|Sensory System Agents|sensory system agents|mesh-ancestor
139504544|NCT05500703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504545|NCT05500703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139504546|NCT05500703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139504547|NCT05500703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139504548|NCT05500703|Adrenergic Agents|adrenergic agents|mesh-ancestor
139504549|NCT05500703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504550|NCT05500703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504551|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
139504552|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139504553|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504554|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504555|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139504556|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139504557|NCT02524847|Methoxsalen|methoxsalen|mesh-list
139504558|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139504559|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
139504560|NCT04422275|Budesonide|budesonide|mesh-list
139504561|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139504562|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139504563|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
139504564|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504565|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504566|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139504567|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
139504568|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
139504569|NCT04422275|Hormones|hormones|mesh-ancestor
139504570|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504571|NCT05361941|Tobramycin|tobramycin|mesh-list
139504572|NCT05361941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139504573|NCT05361941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139504574|NCT05324735|Pentoxifylline|pentoxifylline|mesh-list
139504575|NCT05324735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139504576|NCT05324735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504577|NCT05324735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504578|NCT05324735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139504579|NCT05324735|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139504580|NCT05324735|Protective Agents|protective agents|mesh-ancestor
139504581|NCT05324735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504582|NCT05324735|Vasodilator Agents|vasodilator agents|mesh-ancestor
139504583|NCT05324735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139504584|NCT05324735|Antioxidants|antioxidants|mesh-ancestor
139504585|NCT05359055|Itraconazole|itraconazole|mesh-list
139504586|NCT05359055|Rifampin|rifampin|mesh-list
139504587|NCT05359055|Antifungal Agents|antifungal agents|mesh-ancestor
139504588|NCT05359055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139504589|NCT05359055|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139504590|NCT05359055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139095550|NCT03365362|Varenicline|varenicline|mesh-list
139504591|NCT05359055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504592|NCT05359055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504593|NCT05359055|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139504594|NCT05359055|Hormone Antagonists|hormone antagonists|mesh-ancestor
139504595|NCT05359055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504596|NCT05359055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504597|NCT05359055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139504598|NCT05359055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139504599|NCT05359055|Antitubercular Agents|antitubercular agents|mesh-ancestor
139504600|NCT05359055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139504601|NCT05359055|Leprostatic Agents|leprostatic agents|mesh-ancestor
139504602|NCT05359055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139504603|NCT05359055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139504604|NCT05359055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139504605|NCT05359055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139504606|NCT05359055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139504607|NCT05359055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139504608|NCT05359055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139504609|NCT02524379|Glyburide|glyburide|mesh-list
139504610|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139504611|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504612|NCT02524145|Isoproterenol|isoproterenol|mesh-list
139504613|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
139504614|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
139504615|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139504616|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504617|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504618|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139504619|NCT02524145|Analgesics|analgesics|mesh-ancestor
139504620|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
139504621|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504622|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139504623|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139504624|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139504625|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
139504626|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504627|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504628|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139095578|NCT03201562|Tropicamide|tropicamide|mesh-list
139504629|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139504630|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139504631|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
139504632|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139504633|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139504634|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
139504635|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139504636|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
139504637|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139504638|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
139504639|NCT02524145|Protective Agents|protective agents|mesh-ancestor
139504640|NCT05357417|Bevacizumab|bevacizumab|mesh-list
139504641|NCT05357417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139504642|NCT05357417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504643|NCT05357417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139504644|NCT05357417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139504645|NCT05357417|Growth Substances|growth substances|mesh-ancestor
139504646|NCT05357417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504647|NCT05357417|Growth Inhibitors|growth inhibitors|mesh-ancestor
139504648|NCT01658813|Interferons|interferons|mesh-list
139504649|NCT01658813|Fluorouracil|fluorouracil|mesh-list
139504650|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
139504651|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504652|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139504653|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504654|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139504655|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
139504656|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504657|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
139504658|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139504659|NCT02187471|Pregabalin|pregabalin|mesh-list
139504660|NCT02187471|Analgesics|analgesics|mesh-ancestor
139504661|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
139504662|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504663|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504664|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
139504665|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139504666|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139504667|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504668|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139504669|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139504670|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139095654|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504671|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504672|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139504673|NCT02525471|RNS60|rns60|mesh-list
139504674|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139504675|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139504676|NCT02525471|Analgesics|analgesics|mesh-ancestor
139504677|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
139504678|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504679|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504680|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139504681|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139504682|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139504683|NCT05284409|Acetaminophen|acetaminophen|mesh-list
139504684|NCT05284409|Dexamethasone|dexamethasone|mesh-list
139504685|NCT05284409|Meperidine|meperidine|mesh-list
139504686|NCT05284409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139504687|NCT05284409|Antiemetics|antiemetics|mesh-ancestor
139504688|NCT05284409|Autonomic Agents|autonomic agents|mesh-ancestor
139504689|NCT05284409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504690|NCT05284409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504691|NCT05284409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139504692|NCT05284409|Glucocorticoids|glucocorticoids|mesh-ancestor
139504693|NCT05284409|Hormones|hormones|mesh-ancestor
139504694|NCT05284409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504695|NCT05284409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139504696|NCT05284409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504697|NCT05284409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139504698|NCT05284409|Analgesics|analgesics|mesh-ancestor
139504699|NCT05284409|Sensory System Agents|sensory system agents|mesh-ancestor
139504700|NCT05284409|Antipyretics|antipyretics|mesh-ancestor
139504701|NCT05284409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139504702|NCT05284409|Narcotics|narcotics|mesh-ancestor
139504703|NCT05284409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504704|NCT05284409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139504705|NCT02523599|Bupivacaine|bupivacaine|mesh-list
139504706|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
139504707|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
139504708|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504709|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504710|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
139504711|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504712|NCT05354999|Caffeine|caffeine|mesh-list
139504713|NCT05354999|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139504714|NCT05354999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504715|NCT05354999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139504716|NCT05354999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504717|NCT05354999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504718|NCT05354999|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139504719|NCT05354999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139504720|NCT05354999|Purinergic Agents|purinergic agents|mesh-ancestor
139504721|NCT05354999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504722|NCT02187159|Pregabalin|pregabalin|mesh-list
139504723|NCT02187159|Analgesics|analgesics|mesh-ancestor
139504724|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
139504725|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504726|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504727|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
139504728|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139504729|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139504730|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504731|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139504732|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139504733|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139504734|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504735|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139504736|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
139504737|NCT02335411|Capecitabine|capecitabine|mesh-list
139504738|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504739|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139504740|NCT02335411|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139504741|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504742|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139504743|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
139504744|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139504745|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504746|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139504747|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504748|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504749|NCT02161731|Warfarin|warfarin|mesh-list
139504750|NCT02161731|Evacetrapib|evacetrapib|mesh-list
139504751|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
139504752|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139504753|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139504754|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
139504755|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504756|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139504757|NCT02124759|Sevelamer|sevelamer|mesh-list
139504758|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
139504759|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
139504760|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504761|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
139504762|NCT02302339|Nivolumab|nivolumab|mesh-list
139504763|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
139504764|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139504765|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139504766|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504767|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139504768|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504769|NCT02302339|Immunoconjugates|immunoconjugates|mesh-ancestor
139504770|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
139504771|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504772|NCT04895917|Daratumumab|daratumumab|mesh-list
139504773|NCT04895917|Pomalidomide|pomalidomide|mesh-list
139504774|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504775|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
139504776|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504777|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139504778|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139504779|NCT04895917|Growth Substances|growth substances|mesh-ancestor
139504780|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
139504781|NCT02161575|Ranibizumab|ranibizumab|mesh-list
139504782|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139504783|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139504784|NCT02161575|Growth Substances|growth substances|mesh-ancestor
139504785|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504786|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
139504787|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504788|NCT02161185|Midazolam|midazolam|mesh-list
139504789|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139504790|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139504791|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504792|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504793|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139504794|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139504795|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139504796|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139504797|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
139504798|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
139504799|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
139504800|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
139504801|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504802|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504803|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
139504804|NCT02159469|Testosterone|testosterone|mesh-list
139504805|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
139504806|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
139504807|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139504808|NCT02159469|Androgens|androgens|mesh-ancestor
139504809|NCT02159469|Hormones|hormones|mesh-ancestor
139504810|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504811|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504812|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139504813|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504814|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
139504815|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
139504816|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139504817|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
139504818|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139504819|NCT02123511|Expectorants|expectorants|mesh-ancestor
139504820|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
139504821|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139504822|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
139504823|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504824|NCT02123511|Protective Agents|protective agents|mesh-ancestor
139504825|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504826|NCT02123511|Antidotes|antidotes|mesh-ancestor
139504827|NCT04746339|Apixaban|apixaban|mesh-list
139504828|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139504829|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
139504830|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139504831|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
139504832|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504833|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504834|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
139504835|NCT02301403|Nicotine|nicotine|mesh-list
139504836|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139504837|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
139504838|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504839|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504840|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139504841|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139504842|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
139504843|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504844|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504845|NCT02333383|Adalimumab|adalimumab|mesh-list
139504846|NCT02333383|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139504847|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139504848|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139504849|NCT02369341|Vaccines|vaccines|mesh-list
139504850|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
139504851|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504852|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139504853|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
139504854|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139504855|NCT02158533|Naltrexone|naltrexone|mesh-list
139504856|NCT02158533|Buprenorphine|buprenorphine|mesh-list
139504857|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139504858|NCT02158533|Narcotics|narcotics|mesh-ancestor
139504859|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504860|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504861|NCT02158533|Analgesics|analgesics|mesh-ancestor
139504862|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
139504863|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504864|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139504865|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139504866|NCT02120469|Everolimus|everolimus|mesh-list
139504867|NCT02120469|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139504868|NCT02120469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139504869|NCT02120469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504870|NCT02120469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504871|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139504872|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
139504873|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504874|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504875|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
139504876|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139504877|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504878|NCT02180061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139504879|NCT02180061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504880|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
139504881|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
139504882|NCT02120157|Busulfan|busulfan|mesh-list
139504883|NCT02120157|Tacrolimus|tacrolimus|mesh-list
139504884|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139504885|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
139504886|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504887|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139504888|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139504889|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
139504890|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504891|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504892|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139504893|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139504894|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504895|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139504896|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139504897|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
139504898|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139504899|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139504900|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139504901|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
139504902|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504903|NCT02155881|Ciclesonide|ciclesonide|mesh-list
139504904|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
139504905|NCT02155881|Hormones|hormones|mesh-ancestor
139504906|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504907|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504908|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139504909|NCT05279807|Amlodipine|amlodipine|mesh-list
139504910|NCT05279807|Zofenopril|zofenopril|mesh-list
139504911|NCT05279807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139504912|NCT05279807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139504913|NCT05279807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139504914|NCT05279807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504915|NCT05279807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139504916|NCT05279807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504917|NCT05279807|Vasodilator Agents|vasodilator agents|mesh-ancestor
139096018|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139504918|NCT05279807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139504919|NCT05279807|Protease Inhibitors|protease inhibitors|mesh-ancestor
139504920|NCT05279807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504921|NCT05319431|Lenvatinib|lenvatinib|mesh-list
139504922|NCT05319431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504923|NCT05319431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139504924|NCT05319431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504925|NCT05319431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504926|NCT05276531|Progesterone|progesterone|mesh-list
139504927|NCT05276531|Progestins|progestins|mesh-ancestor
139504928|NCT05276531|Hormones|hormones|mesh-ancestor
139504929|NCT05276531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504930|NCT05276531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504931|NCT01658579|Insulin|insulin|mesh-list
139504932|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139504933|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
139504934|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139504935|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504936|NCT05561309|Ropivacaine|ropivacaine|mesh-list
139504937|NCT05561309|Anesthetics, Local|anesthetics, local|mesh-ancestor
139504938|NCT05561309|Anesthetics|anesthetics|mesh-ancestor
139504939|NCT05561309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504940|NCT05561309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504941|NCT05561309|Sensory System Agents|sensory system agents|mesh-ancestor
139504942|NCT05561309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504943|NCT05268497|Antidepressive Agents|antidepressive agents|mesh-list
139504944|NCT05268497|Esketamine|esketamine|mesh-list
139504945|NCT05268497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139504946|NCT05266859|Calcium|calcium|mesh-list
139504947|NCT05266859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139504948|NCT05266859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504949|NCT05346731|Dexamethasone|dexamethasone|mesh-list
139504950|NCT05346731|Ondansetron|ondansetron|mesh-list
139504951|NCT05346731|Olanzapine|olanzapine|mesh-list
139504952|NCT05346731|Aprepitant|aprepitant|mesh-list
139504953|NCT05346731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139504954|NCT05346731|Antiemetics|antiemetics|mesh-ancestor
139504955|NCT05346731|Autonomic Agents|autonomic agents|mesh-ancestor
139504956|NCT05346731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139504957|NCT05346731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139504958|NCT05346731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139504959|NCT05346731|Glucocorticoids|glucocorticoids|mesh-ancestor
139504960|NCT05346731|Hormones|hormones|mesh-ancestor
139504961|NCT05346731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139504962|NCT05346731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139504963|NCT05346731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504964|NCT05346731|Antipruritics|antipruritics|mesh-ancestor
139504965|NCT05346731|Dermatologic Agents|dermatologic agents|mesh-ancestor
139504966|NCT05346731|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139504967|NCT05346731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139504968|NCT05346731|Serotonin Agents|serotonin agents|mesh-ancestor
139504969|NCT05346731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139504970|NCT05346731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096141|NCT05150782|Vitamins|vitamins|mesh-ancestor
139504971|NCT05346731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139504972|NCT05346731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139504973|NCT05346731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139504974|NCT05346731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139504975|NCT05346731|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139504976|NCT05346731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139504977|NCT05346731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139504978|NCT05346731|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139504979|NCT02118597|Interferons|interferons|mesh-list
139504980|NCT02118597|Ribavirin|ribavirin|mesh-list
139504981|NCT02118597|Simeprevir|simeprevir|mesh-list
139504982|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504983|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
139504984|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139504985|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
139504986|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504987|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
139504988|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139504989|NCT05218889|Paclitaxel|paclitaxel|mesh-list
139504990|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139504991|NCT05218889|Gemcitabine|gemcitabine|mesh-list
139504992|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139504993|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139504994|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
139504995|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
139504996|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
139504997|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139504998|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139504999|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
139505000|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139505001|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139505002|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
139505003|NCT02117349|Coagulants|coagulants|mesh-ancestor
139505004|NCT02177175|Carvedilol|carvedilol|mesh-list
139505005|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139505006|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139505007|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
139505008|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505009|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505010|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505011|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139505012|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
139505013|NCT02177175|Protective Agents|protective agents|mesh-ancestor
139505014|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139505015|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139505016|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139505017|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
139505018|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139505019|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139505020|NCT01657877|Calcium|calcium|mesh-list
139505021|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139505022|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505023|NCT05254925|Sunscreening Agents|sunscreening agents|mesh-list
139505024|NCT05254925|Petrolatum|petrolatum|mesh-list
139096225|NCT01316848|Tivozanib|tivozanib|mesh-list
139505025|NCT05254925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139505026|NCT05254925|Protective Agents|protective agents|mesh-ancestor
139505027|NCT05254925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505028|NCT05254925|Dermatologic Agents|dermatologic agents|mesh-ancestor
139505029|NCT05254925|Emollients|emollients|mesh-ancestor
139505030|NCT05205473|Lidocaine|lidocaine|mesh-list
139505031|NCT05205473|Anesthetics|anesthetics|mesh-list
139505032|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
139505033|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139505034|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505035|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
139505036|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505037|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139505038|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139505039|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139505040|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139505041|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505042|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139505043|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139505044|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139505045|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505046|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505047|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139505048|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139505049|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505050|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
139505051|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505052|NCT02175771|Fluticasone|fluticasone|mesh-list
139505053|NCT02175771|Xhance|xhance|mesh-list
139505054|NCT02175771|Albuterol|albuterol|mesh-list
139505055|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139505056|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139505057|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
139505058|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139505059|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139505060|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
139505061|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505062|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505063|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139505064|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
139505065|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
139505066|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139505067|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139505068|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139505069|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
139505070|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505071|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505072|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
139505073|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139505074|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
139505075|NCT02175771|Hormones|hormones|mesh-ancestor
139505076|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505077|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
139505078|NCT01657799|Veliparib|veliparib|mesh-list
139505079|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139505080|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505081|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505082|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505083|NCT02116803|Fulvestrant|fulvestrant|mesh-list
139505084|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139505085|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505086|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139505087|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139505088|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
139505089|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505090|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505091|NCT02115321|Grazoprevir|grazoprevir|mesh-list
139505092|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
139505093|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505094|NCT05248841|Insulin Glargine|insulin glargine|mesh-list
139505095|NCT05248841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139505096|NCT05248841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505097|NCT05248139|Prednisolone|prednisolone|mesh-list
139505098|NCT05248139|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139505099|NCT05248139|Methylprednisolone|methylprednisolone|mesh-list
139505100|NCT05248139|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139505101|NCT05248139|Prednisolone acetate|prednisolone acetate|mesh-list
139505102|NCT05248139|Triamcinolone|triamcinolone|mesh-list
139505103|NCT05248139|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139505104|NCT05248139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139505105|NCT05248139|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139505106|NCT05248139|Prednisolone phosphate|prednisolone phosphate|mesh-list
139505107|NCT05248139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139505108|NCT05248139|Glucocorticoids|glucocorticoids|mesh-ancestor
139505109|NCT05248139|Hormones|hormones|mesh-ancestor
139505110|NCT05248139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505111|NCT05248139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505112|NCT05248139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139505113|NCT05248139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505114|NCT05248139|Antiemetics|antiemetics|mesh-ancestor
139505115|NCT05248139|Autonomic Agents|autonomic agents|mesh-ancestor
139505116|NCT05248139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505117|NCT05248139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139505118|NCT05248139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139505119|NCT05248139|Protective Agents|protective agents|mesh-ancestor
139505120|NCT05248139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139505121|NCT05248139|Immunologic Factors|immunologic factors|mesh-ancestor
139505122|NCT05248139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139505123|NCT05247125|Melatonin|melatonin|mesh-list
139505124|NCT05247125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505125|NCT05247125|Antioxidants|antioxidants|mesh-ancestor
139505126|NCT05247125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505127|NCT05247125|Protective Agents|protective agents|mesh-ancestor
139505128|NCT05247125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139505129|NCT05154383|Vaccines|vaccines|mesh-list
139505130|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
139505131|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505132|NCT05245877|Enoxaparin|enoxaparin|mesh-list
139505133|NCT05245877|Dalteparin|dalteparin|mesh-list
139505134|NCT05245877|Tinzaparin|tinzaparin|mesh-list
139505135|NCT05245877|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139505136|NCT05245877|Anticoagulants|anticoagulants|mesh-ancestor
139505137|NCT05245877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139505138|NCT05245877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139505139|NCT05245877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505140|NCT02367781|Paclitaxel|paclitaxel|mesh-list
139505141|NCT02367781|Carboplatin|carboplatin|mesh-list
139505142|NCT02367781|Pemetrexed|pemetrexed|mesh-list
139096545|NCT00279305|Rituximab|rituximab|mesh-list
139505143|NCT02367781|Atezolizumab|atezolizumab|mesh-list
139505144|NCT02367781|Antibodies|antibodies|mesh-list
139505145|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139505146|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139505147|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505148|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
139505149|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
139505150|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
139505151|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505152|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
139505153|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505154|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505155|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139505156|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139505157|NCT02367781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139505158|NCT02367781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139505159|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
139505160|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139505161|NCT04242173|Cemiplimab|cemiplimab|mesh-list
139505162|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139505163|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505164|NCT02152371|Metformin|metformin|mesh-list
139505165|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
139505166|NCT02152371|Dulaglutide|dulaglutide|mesh-list
139505167|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139505168|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505169|NCT02332291|Bupropion|bupropion|mesh-list
139505170|NCT02332291|Escitalopram|escitalopram|mesh-list
139505171|NCT02332291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139505172|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139291852|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
139505173|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139505174|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505175|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505176|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
139505177|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505178|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139505179|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
139505180|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139505181|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139505182|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
139505183|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139505184|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139505185|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505186|NCT01656395|Montelukast|montelukast|mesh-list
139505187|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139505188|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
139505189|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139505190|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
139505191|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505192|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505193|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139505194|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139505195|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505196|NCT02114931|Adalimumab|adalimumab|mesh-list
139096785|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505197|NCT02114931|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139505198|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139505199|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139505200|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
139505201|NCT05185739|Lenvatinib|lenvatinib|mesh-list
139505202|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139505203|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505204|NCT05185739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139505205|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505206|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139505207|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505208|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139505209|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139505210|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096852|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139505211|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139505212|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139505213|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139505214|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505215|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
139505216|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505217|NCT05181605|Folfirinox|folfirinox|mesh-list
139505218|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505219|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
139505220|NCT02300311|Capsaicin|capsaicin|mesh-list
139505221|NCT02300311|Nonivamide|nonivamide|mesh-list
139505222|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
139505223|NCT02300311|Vitamins|vitamins|mesh-ancestor
139505224|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
139505225|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505226|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
139505227|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505228|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
139505229|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
139505230|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139505231|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505232|NCT05140499|Bupivacaine|bupivacaine|mesh-list
139505233|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
139505234|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
139505235|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096913|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505236|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505237|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
139505238|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505239|NCT04229381|Coal Tar|coal tar|mesh-list
139505240|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
139505241|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
139505242|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139505243|NCT05178485|Bupivacaine|bupivacaine|mesh-list
139505244|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
139505245|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
139505246|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139505247|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505248|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
139505249|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505250|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139505251|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
139505253|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505254|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139505255|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
139505256|NCT05228951|Trastuzumab|trastuzumab|mesh-list
139505257|NCT05228951|Letrozole|letrozole|mesh-list
139505258|NCT05228951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139505259|NCT05228951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505260|NCT05228951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139097027|NCT01308320|Narcotics|narcotics|mesh-ancestor
139505261|NCT05228951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139505262|NCT05228951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505263|NCT05228951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505264|NCT05228951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139505265|NCT05228951|Hormone Antagonists|hormone antagonists|mesh-ancestor
139505266|NCT05228951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505267|NCT05228951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505268|NCT05174039|Miglustat|miglustat|mesh-list
139505269|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505270|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505271|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139505272|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139505273|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
139505274|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505275|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139505276|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139505277|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505278|NCT02175225|Deferoxamine|deferoxamine|mesh-list
139505279|NCT02175225|Siderophores|siderophores|mesh-ancestor
139505280|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139505281|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
139505282|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
139505283|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505284|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139505285|NCT05170841|Tramadol|tramadol|mesh-list
139505286|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139505287|NCT05170841|Narcotics|narcotics|mesh-ancestor
139505288|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139505289|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505290|NCT05170841|Analgesics|analgesics|mesh-ancestor
139505291|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
139505292|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505293|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139505294|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139505295|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139505296|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139505297|NCT05135273|Vaccines|vaccines|mesh-list
139505298|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
139505299|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505300|NCT02299375|Albuterol|albuterol|mesh-list
139505301|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139505302|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
139505303|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505304|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505305|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139097280|NCT05401058|Droperidol|droperidol|mesh-list
139505306|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
139505307|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
139505308|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139505309|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139505310|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139505311|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139505312|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
139505313|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505314|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505315|NCT02151591|Varenicline|varenicline|mesh-list
139097346|NCT01344304|Aprepitant|aprepitant|mesh-list
139505316|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139505317|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139505318|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
139505319|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505320|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505321|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505322|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139505323|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139505324|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139505325|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139505326|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505327|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139505328|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139505329|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139505330|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139505331|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
139505332|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505333|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505334|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139097415|NCT00338260|Atenolol|atenolol|mesh-list
139505335|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139505337|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139505338|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139505339|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
139505340|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139505341|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139505342|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505343|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
139505344|NCT02114385|Vaccines|vaccines|mesh-list
139505345|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
139505346|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505347|NCT05098457|Lidocaine|lidocaine|mesh-list
139505348|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
139505349|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
139505350|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139505351|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505352|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
139505353|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097474|NCT01320254|Cisplatin|cisplatin|mesh-list
139505354|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139505355|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139505356|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139505357|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139505358|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505359|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
139505360|NCT02114151|Simeprevir|simeprevir|mesh-list
139505361|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
139505362|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505363|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
139505364|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505365|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505366|NCT05220293|Betamethasone|betamethasone|mesh-list
139505367|NCT05220293|Betamethasone Valerate|betamethasone valerate|mesh-list
139505368|NCT05220293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139505369|NCT05220293|Betamethasone benzoate|betamethasone benzoate|mesh-list
139505370|NCT05220293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139505371|NCT05220293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139505372|NCT05220293|Glucocorticoids|glucocorticoids|mesh-ancestor
139505373|NCT05220293|Hormones|hormones|mesh-ancestor
139505374|NCT05220293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505375|NCT05220293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505376|NCT05220293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139505377|NCT05220293|Respiratory System Agents|respiratory system agents|mesh-ancestor
139505378|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
139505379|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139505380|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
139505381|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139505382|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139505383|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505384|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
139505385|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505386|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505387|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139505388|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
139505389|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
139505390|NCT02297503|Protective Agents|protective agents|mesh-ancestor
139505391|NCT02366767|Insulin|insulin|mesh-list
139505392|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139505393|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505394|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
139505395|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
139505396|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139505397|NCT02149875|Protective Agents|protective agents|mesh-ancestor
139097639|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
139505398|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505399|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
139505400|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139505401|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
139505402|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139505403|NCT05124899|Protective Agents|protective agents|mesh-ancestor
139505404|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505405|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
139505406|NCT02112045|Melphalan|melphalan|mesh-list
139505407|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139505408|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
139505409|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505410|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505411|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139505412|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139505413|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
139505414|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505415|NCT02147691|Azelaic acid|azelaic acid|mesh-list
139505416|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139505417|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139505418|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139505419|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139505420|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139505421|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
139505422|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505423|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505424|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505425|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505426|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
139505427|NCT01655693|Doxorubicin|doxorubicin|mesh-list
139505428|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139505429|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139505430|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097770|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
139505431|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139505432|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139505433|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505434|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505435|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
139505436|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139505437|NCT05090657|Methylene Blue|methylene blue|mesh-list
139505438|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139505439|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505440|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
139505441|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
139505442|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505443|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505444|NCT05048849|Somatomedin B|somatomedin b|mesh-list
139505445|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139505446|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139505447|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
139505448|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505449|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505450|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139505451|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
139505452|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139505453|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
139505454|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139505455|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505456|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139505457|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139505458|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505459|NCT04751877|Dexamethasone|dexamethasone|mesh-list
139505460|NCT04751877|Lenalidomide|lenalidomide|mesh-list
139505461|NCT04751877|Bortezomib|bortezomib|mesh-list
139505462|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139505463|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
139505464|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
139505465|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097953|NCT03777644|Analgesics|analgesics|mesh-ancestor
139505466|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505467|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139505468|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
139505469|NCT04751877|Hormones|hormones|mesh-ancestor
139505470|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505471|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139505472|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505473|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
139505474|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139505475|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139505476|NCT04751877|Growth Substances|growth substances|mesh-ancestor
139505477|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
139505478|NCT02147067|Ranolazine|ranolazine|mesh-list
139505479|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139505480|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139505481|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505482|NCT02107131|Ranibizumab|ranibizumab|mesh-list
139505483|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139505484|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139505485|NCT02107131|Growth Substances|growth substances|mesh-ancestor
139505486|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505487|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
139505488|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505489|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
139505490|NCT02106975|Vitamins|vitamins|mesh-ancestor
139505491|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
139505492|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505493|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
139505494|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505495|NCT02106975|Protective Agents|protective agents|mesh-ancestor
139505496|NCT05133765|Insulin|insulin|mesh-list
139505497|NCT05133765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139505498|NCT05133765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505499|NCT02520011|Cytarabine|cytarabine|mesh-list
139505500|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
139505501|NCT02520011|Alvocidib|alvocidib|mesh-list
139505502|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139505503|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
139505504|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505505|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505506|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
139505507|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505508|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139505509|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
139505510|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505511|NCT02520011|Analgesics|analgesics|mesh-ancestor
139505512|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
139505513|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505514|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139505515|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139505516|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505517|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
139505518|NCT02520011|Growth Substances|growth substances|mesh-ancestor
139505519|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139505520|NCT05037539|Fentanyl|fentanyl|mesh-list
139505521|NCT05037539|Morphine|morphine|mesh-list
139505522|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139505523|NCT05037539|Narcotics|narcotics|mesh-ancestor
139505524|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139505525|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505526|NCT05037539|Analgesics|analgesics|mesh-ancestor
139505527|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
139505528|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505529|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139505530|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139505531|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
139505532|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
139505533|NCT02519231|Naproxen|naproxen|mesh-list
139505534|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139505535|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139505536|NCT02519231|Analgesics|analgesics|mesh-ancestor
139505537|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
139098063|NCT03770000|Romidepsin|romidepsin|mesh-list
139505538|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505539|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505540|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139505541|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139505542|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
139505543|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139505544|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505545|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505546|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
139505547|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139505548|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139505549|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139505550|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139505551|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505552|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
139505553|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505554|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505555|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139505556|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505557|NCT02075073|Trastuzumab|trastuzumab|mesh-list
139505558|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139505559|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505560|NCT04738149|Bimatoprost|bimatoprost|mesh-list
139505561|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139505562|NCT05060627|Dexamethasone|dexamethasone|mesh-list
139505563|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139505564|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
139505565|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
139505566|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505567|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505568|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139505569|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
139505570|NCT05060627|Hormones|hormones|mesh-ancestor
139505571|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505572|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139505573|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505574|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139505575|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
139505576|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505577|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139505578|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139505579|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
139505580|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505581|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505582|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139505583|NCT05024747|Nicotine|nicotine|mesh-list
139505584|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139505585|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
139505586|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505587|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505588|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139505589|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139505590|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
139505591|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505592|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505593|NCT05056883|Ivermectin|ivermectin|mesh-list
139505594|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139505595|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505596|NCT04991597|Lidocaine|lidocaine|mesh-list
139505597|NCT04991597|Epinephrine|epinephrine|mesh-list
139505598|NCT04991597|Racepinephrine|racepinephrine|mesh-list
139505599|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
139505600|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
139505601|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
139505602|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139505603|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505604|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
139505605|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505606|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139505607|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139505608|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139505609|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139505610|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505611|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139505612|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139505613|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
139505614|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505615|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139505616|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139505617|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
139505618|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139505619|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
139505620|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
139505621|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
139505622|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139505623|NCT04949867|Glucagon|glucagon|mesh-list
139505624|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139505625|NCT04949867|Hormones|hormones|mesh-ancestor
139505626|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505627|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505628|NCT05018117|Nicotine|nicotine|mesh-list
139505629|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139098262|NCT01352572|Milnacipran|milnacipran|mesh-list
139505630|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
139505631|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505632|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505633|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139505634|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139505635|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
139505636|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505637|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505638|NCT05016869|Capecitabine|capecitabine|mesh-list
139505639|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139505640|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
139505641|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505642|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505643|NCT02141997|Adalimumab|adalimumab|mesh-list
139505644|NCT02141997|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139505645|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139505646|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139505647|NCT04411433|Azithromycin|azithromycin|mesh-list
139505648|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
139505649|NCT04411433|Favipiravir|favipiravir|mesh-list
139505650|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139505651|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505652|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
139505653|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139505654|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139505655|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505656|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505657|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139505658|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
139505659|NCT04987463|Sirolimus|sirolimus|mesh-list
139505660|NCT04987463|Vigabatrin|vigabatrin|mesh-list
139505661|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139505662|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505663|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139505664|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505665|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
139505666|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139505667|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
139505668|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505669|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505670|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505671|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
139505672|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
139505673|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505674|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
139505675|NCT05012735|Provitamins|provitamins|mesh-list
139505676|NCT05012735|Vitamins|vitamins|mesh-ancestor
139505677|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
139505678|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505679|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
139505680|NCT02519777|Dolutegravir|dolutegravir|mesh-list
139505681|NCT02519777|Maraviroc|maraviroc|mesh-list
139505682|NCT02519777|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139505683|NCT02519777|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139505684|NCT02519777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505685|NCT02519777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505686|NCT02519777|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139505687|NCT02519777|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139505688|NCT02519777|Antiviral Agents|antiviral agents|mesh-ancestor
139505689|NCT02519777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505690|NCT02519777|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139505691|NCT02519777|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139505692|NCT02519777|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139505693|NCT05008913|Adavosertib|adavosertib|mesh-list
139505694|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505695|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505696|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139505697|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139505698|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505699|NCT04982705|Incretins|incretins|mesh-ancestor
139505700|NCT04982705|Hormones|hormones|mesh-ancestor
139505701|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505702|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139505703|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
139505704|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505705|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505706|NCT04944095|Antibodies|antibodies|mesh-list
139505707|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
139505708|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505709|NCT02141295|Leucovorin|leucovorin|mesh-list
139505710|NCT02141295|Folic Acid|folic acid|mesh-list
139505711|NCT02141295|Bevacizumab|bevacizumab|mesh-list
139505712|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
139505713|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
139505714|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139505715|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505716|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139505717|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139505718|NCT02141295|Growth Substances|growth substances|mesh-ancestor
139505719|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505720|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
139505721|NCT02141295|Antidotes|antidotes|mesh-ancestor
139505722|NCT02141295|Protective Agents|protective agents|mesh-ancestor
139505723|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
139505724|NCT02141295|Vitamins|vitamins|mesh-ancestor
139505725|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
139505726|NCT02141295|Hematinics|hematinics|mesh-ancestor
139505727|NCT02514551|Paclitaxel|paclitaxel|mesh-list
139505728|NCT02514551|Ramucirumab|ramucirumab|mesh-list
139505729|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139505730|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505731|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
139505732|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
139505733|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
139505734|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505735|NCT02141217|Amoxicillin|amoxicillin|mesh-list
139505736|NCT02141217|Clindamycin|clindamycin|mesh-list
139505737|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
139505738|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
139505739|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
139505740|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
139505741|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139505742|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139098368|NCT03767036|Tramadol|tramadol|mesh-list
139505743|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505744|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139505745|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505746|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505747|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139505748|NCT02514473|Ivacaftor|ivacaftor|mesh-list
139505749|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139505750|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139505751|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505752|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139505753|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139505754|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505755|NCT02513771|Incretins|incretins|mesh-ancestor
139505756|NCT02513771|Hormones|hormones|mesh-ancestor
139505757|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505758|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139505759|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
139505760|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505761|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505762|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139505763|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
139505764|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505765|NCT02069379|Metformin|metformin|mesh-list
139505766|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139505767|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505768|NCT02511431|Ritonavir|ritonavir|mesh-list
139505769|NCT02511431|Lonafarnib|lonafarnib|mesh-list
139505770|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139505771|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139505772|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
139505773|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505774|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505775|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139505776|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139505777|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
139505778|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505779|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139505780|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139505781|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139505782|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139505783|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
139505784|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
139505785|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139505786|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139505787|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
139505788|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505789|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505790|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505791|NCT01655069|Urological Agents|urological agents|mesh-ancestor
139505792|NCT01654601|Clozapine|clozapine|mesh-list
139505793|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139505794|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
139505795|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505796|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505797|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505798|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139505799|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139505800|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139505801|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139505802|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
139505803|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
139505804|NCT04978649|Amlodipine|amlodipine|mesh-list
139505805|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139505806|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139505807|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139098467|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505808|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505809|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139505810|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505811|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
139505812|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139505813|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139505814|NCT02508935|Narcotics|narcotics|mesh-ancestor
139505815|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139505816|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505817|NCT02508935|Analgesics|analgesics|mesh-ancestor
139505818|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
139505819|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505820|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139505821|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139505822|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139505823|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139505824|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139505825|NCT02507375|Pertuzumab|pertuzumab|mesh-list
139505826|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505827|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139505828|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505829|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505830|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139505831|NCT02507219|Ibuprofen|ibuprofen|mesh-list
139505832|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139505833|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139505834|NCT02507219|Analgesics|analgesics|mesh-ancestor
139505835|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
139505836|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505837|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505838|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139505839|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139505840|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139505841|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505842|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505843|NCT02483975|Albuterol|albuterol|mesh-list
139505844|NCT02483975|Montelukast|montelukast|mesh-list
139505845|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139505846|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
139505847|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139505848|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
139505849|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505850|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505851|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139505852|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139505853|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505854|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139505855|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
139505856|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505857|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
139505858|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139505859|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139505860|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139505861|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139505862|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
139505863|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505864|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139505865|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139505867|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139505868|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505869|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139505870|NCT02483585|Erenumab|erenumab|mesh-list
139505871|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139505872|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505873|NCT02483585|Analgesics|analgesics|mesh-ancestor
139505874|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
139505875|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505876|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505877|NCT02101983|Cytarabine|cytarabine|mesh-list
139505878|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139505879|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
139505880|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505881|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505882|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
139505883|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139505884|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139505885|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
139505886|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505887|NCT04974281|Lenvatinib|lenvatinib|mesh-list
139505888|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505889|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139505890|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505891|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505892|NCT02503865|Orlistat|orlistat|mesh-list
139505893|NCT02503865|Diltiazem|diltiazem|mesh-list
139505894|NCT02503865|Atorvastatin|atorvastatin|mesh-list
139505895|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139505896|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139505897|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
139505898|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505899|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139505900|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139505901|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505902|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139505903|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139505904|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139505905|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139505906|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505907|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
139505908|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139505909|NCT02481947|Laxatives|laxatives|mesh-list
139505910|NCT02481947|Lubiprostone|lubiprostone|mesh-list
139505911|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139505912|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139505913|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505914|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139505915|NCT02503085|Ibuprofen|ibuprofen|mesh-list
139505916|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139505917|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139505918|NCT02503085|Analgesics|analgesics|mesh-ancestor
139505919|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
139505920|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505921|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505922|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139505923|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139505924|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139505925|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505926|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505927|NCT02502149|Factor VIII|factor viii|mesh-list
139505928|NCT02502149|Coagulants|coagulants|mesh-ancestor
139505929|NCT02480621|Bupivacaine|bupivacaine|mesh-list
139505930|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
139505931|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
139505932|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139505933|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505934|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
139505935|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505936|NCT02046603|Methotrexate|methotrexate|mesh-list
139505937|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139505938|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
139505939|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139505940|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505941|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139505942|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
139505943|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505944|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139505945|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
139505946|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139505947|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139505948|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139505949|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
139505950|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139505951|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139505952|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139505953|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139505954|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139505955|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139505956|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505957|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139505958|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139505959|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139505960|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139505961|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
139505962|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505963|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505964|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139505965|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139505966|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
139505967|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139505968|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139505969|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
139505971|NCT02101359|Tropicamide|tropicamide|mesh-list
139505972|NCT02101359|Mydriatics|mydriatics|mesh-list
139505973|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
139505974|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
139505975|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139505976|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505977|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
139505978|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139505979|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
139505980|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139505981|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139505982|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
139505983|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505984|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505985|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
139505986|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
139505987|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139505988|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139505989|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
139505990|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139505991|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139505992|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139505993|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139505994|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139505995|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139505996|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
139505997|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139505998|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139505999|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506000|NCT01883362|Midostaurin|midostaurin|mesh-list
139506001|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506002|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139506003|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506004|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506005|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
139506006|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
139506007|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
139506008|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506009|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506010|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139506011|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139506012|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
139506013|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
139506014|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506015|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506016|NCT02045979|Adalimumab|adalimumab|mesh-list
139506017|NCT02045979|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139506018|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506019|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139506020|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
139506021|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
139506022|NCT04734405|Fluconazole|fluconazole|mesh-list
139506023|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
139506024|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506025|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139506026|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139506027|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506028|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506029|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139506030|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
139506031|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506032|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506033|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139506034|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139506035|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139506036|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139506037|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139506038|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139506039|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506040|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139506041|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139506042|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139506043|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139506044|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
139506045|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098597|NCT00045942|Midostaurin|midostaurin|mesh-list
139506046|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506047|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139506048|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139506049|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
139506050|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139506051|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139506052|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
139506053|NCT01928758|Nicotine|nicotine|mesh-list
139506054|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139506055|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
139506056|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506057|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506058|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139506059|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139506060|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
139506061|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506062|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506063|NCT01614886|Rivastigmine|rivastigmine|mesh-list
139506064|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139506065|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506066|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506067|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
139506068|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506069|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506070|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139506071|NCT01614886|Protective Agents|protective agents|mesh-ancestor
139506072|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
139506073|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139506074|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139506075|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139506076|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139506077|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139506078|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506079|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
139506080|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506081|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506082|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139506083|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506084|NCT04171726|Edoxaban|edoxaban|mesh-list
139506085|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139506086|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
139506087|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139506088|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
139506089|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506090|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506091|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
139506092|NCT02100657|Dexamethasone|dexamethasone|mesh-list
139506093|NCT02100657|Bortezomib|bortezomib|mesh-list
139506094|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506095|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
139506096|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
139506097|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506098|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506099|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139506100|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
139506101|NCT02100657|Hormones|hormones|mesh-ancestor
139506102|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506103|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139506104|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506105|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
139506106|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139506107|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
139506108|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139506109|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506110|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139506111|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139506112|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139506113|NCT01909804|Ribavirin|ribavirin|mesh-list
139506114|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
139506115|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506116|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
139506117|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506118|NCT01880086|Clomiphene|clomiphene|mesh-list
139506119|NCT01880086|Enclomiphene|enclomiphene|mesh-list
139506120|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
139506121|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139506122|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
139506123|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506124|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506125|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139506126|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
139506127|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139506128|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139506129|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139506130|NCT01879618|Dalteparin|dalteparin|mesh-list
139506131|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
139506132|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139506133|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139506134|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506135|NCT01926886|Trastuzumab|trastuzumab|mesh-list
139506136|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139506137|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506138|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139506139|NCT01925950|Beclomethasone|beclomethasone|mesh-list
139506140|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139292838|NCT06015126|Vinorelbine|vinorelbine|mesh-list
139506141|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
139506142|NCT01925950|Hormones|hormones|mesh-ancestor
139098724|NCT00003702|Dactinomycin|dactinomycin|mesh-list
139506143|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506144|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506145|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139506146|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
139506147|NCT04415320|Ensartinib|ensartinib|mesh-list
139506148|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506149|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139506150|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506151|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506152|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
139506153|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
139506154|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139506155|NCT01878292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139506156|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139506157|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139506158|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506159|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506160|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
139506161|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506162|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139506163|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139506164|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139506165|NCT01907854|Liraglutide|liraglutide|mesh-list
139506166|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139506167|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506168|NCT01907854|Incretins|incretins|mesh-ancestor
139506169|NCT01907854|Hormones|hormones|mesh-ancestor
139506170|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506171|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139506172|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
139506173|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506174|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506175|NCT02480153|Adalimumab|adalimumab|mesh-list
139506176|NCT02480153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139506177|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506178|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139506179|NCT04972253|Infigratinib|infigratinib|mesh-list
139506180|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506181|NCT02500979|Insulin|insulin|mesh-list
139506182|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139506183|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
139506184|NCT02500979|Pramlintide|pramlintide|mesh-list
139506185|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
139506186|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139506187|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506188|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
139506189|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139506190|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
139098806|NCT00238433|Melphalan|melphalan|mesh-list
139506191|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506192|NCT02500901|Niraparib|niraparib|mesh-list
139506193|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139506194|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506195|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506196|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506197|NCT01877668|Adalimumab|adalimumab|mesh-list
139506198|NCT01877668|Tofacitinib|tofacitinib|mesh-list
139506199|NCT01877668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139506200|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506201|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139506202|NCT01877668|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139506203|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139506204|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506205|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506206|NCT01906372|Hormones|hormones|mesh-list
139506207|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139506208|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139506209|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
139506210|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506211|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506212|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506213|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139292909|NCT05887843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139506214|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
139506215|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139506216|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506217|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
139506218|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139506219|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
139506220|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506221|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139506222|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139506223|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139506224|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506225|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
139506226|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
139506227|NCT01876732|Vitamins|vitamins|mesh-ancestor
139506228|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
139506229|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506230|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
139506231|NCT01876732|Hematinics|hematinics|mesh-ancestor
139506232|NCT01905592|Niraparib|niraparib|mesh-list
139506233|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139506234|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506235|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506236|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506237|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
139506238|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139506239|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506240|NCT02500121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139506241|NCT02500121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506242|NCT01875250|Metronidazole|metronidazole|mesh-list
139506243|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506244|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139506245|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139506246|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139506247|NCT01904032|Vitamin D|vitamin d|mesh-list
139506248|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
139506249|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
139506250|NCT01904032|Vitamins|vitamins|mesh-list
139506251|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
139506252|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506253|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139506254|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139506255|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139506256|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139506257|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139506258|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139506259|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506260|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
139506261|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506262|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506263|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139506264|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506265|NCT02325739|Spartalizumab|spartalizumab|mesh-list
139506266|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139506267|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506268|NCT02325739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139506269|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506270|NCT01903720|Dexamethasone|dexamethasone|mesh-list
139506271|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506272|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
139098888|NCT03139240|Oxycodone|oxycodone|mesh-list
139506273|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
139506274|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506275|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506276|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139506277|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
139506278|NCT01903720|Hormones|hormones|mesh-ancestor
139506279|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506280|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139506281|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506282|NCT02366689|Triclosan|triclosan|mesh-list
139506283|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
139506284|NCT02366689|Fluorides|fluorides|mesh-list
139506285|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
139506286|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
139506287|NCT02366689|Protective Agents|protective agents|mesh-ancestor
139506288|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506289|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139506290|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506291|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139506292|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139506293|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
139506294|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506295|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139506297|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139506298|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139506299|NCT01903252|Analgesics|analgesics|mesh-ancestor
139506300|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
139506301|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506302|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506303|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506304|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139506305|NCT01613716|Dexamethasone|dexamethasone|mesh-list
139506306|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506307|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
139506308|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
139506309|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506310|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506311|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139506312|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
139506313|NCT01613716|Hormones|hormones|mesh-ancestor
139506314|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506315|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139506316|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506317|NCT01872910|Celecoxib|celecoxib|mesh-list
139506318|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139506319|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139506320|NCT01872910|Analgesics|analgesics|mesh-ancestor
139506321|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
139506322|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506323|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506324|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506325|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139506326|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139506327|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139506328|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506329|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506330|NCT01920568|Vitamin D|vitamin d|mesh-list
139506331|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
139506332|NCT01920568|Denosumab|denosumab|mesh-list
139506333|NCT01920568|Calcium|calcium|mesh-list
139506334|NCT01920568|Vitamins|vitamins|mesh-ancestor
139506335|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
139506336|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506337|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139506338|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139506339|NCT01901848|Bupropion|bupropion|mesh-list
139506340|NCT01901848|Nicotine|nicotine|mesh-list
139506341|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139506342|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
139506343|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506344|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506345|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139506346|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139506347|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
139506348|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506349|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506350|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139506351|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
139506352|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139506353|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139506354|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139506355|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139506356|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
139506357|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139506358|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139506359|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506360|NCT01901614|Anesthetics|anesthetics|mesh-list
139506361|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139506362|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506364|NCT02499575|Ropivacaine|ropivacaine|mesh-list
139506365|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
139506366|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
139506367|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139506368|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506369|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
139506370|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506371|NCT02065791|Canagliflozin|canagliflozin|mesh-list
139506372|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139506373|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506374|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139506375|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506376|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
139506377|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139506378|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
139506379|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506380|NCT02499029|Expectorants|expectorants|mesh-ancestor
139506381|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
139506382|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139506383|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
139506384|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506385|NCT02499029|Protective Agents|protective agents|mesh-ancestor
139506386|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506387|NCT02499029|Antidotes|antidotes|mesh-ancestor
139506388|NCT02065713|Golimumab|golimumab|mesh-list
139506389|NCT02065713|Methotrexate|methotrexate|mesh-list
139506390|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139506391|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
139506392|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139506393|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506394|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139506395|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
139506396|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506397|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506398|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
139506399|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506400|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139506401|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139506402|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
139506403|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139506404|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139506405|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139506406|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506407|NCT02497781|Ceftazidime|ceftazidime|mesh-list
139506408|NCT02497781|Cefepime|cefepime|mesh-list
139506409|NCT02497781|Avibactam|avibactam|mesh-list
139506410|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
139506411|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139506412|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506413|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139506414|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506415|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506416|NCT02497469|Adalimumab|adalimumab|mesh-list
139506417|NCT02497469|Vedolizumab|vedolizumab|mesh-list
139506418|NCT02497469|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139506419|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506420|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139506421|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139506422|NCT02497391|Evacetrapib|evacetrapib|mesh-list
139506423|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139506424|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139506425|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
139506426|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506427|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139506428|NCT02476175|Mirabegron|mirabegron|mesh-list
139506429|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139506430|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139506431|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139506432|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
139506433|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506434|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506435|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506436|NCT02476175|Urological Agents|urological agents|mesh-ancestor
139506437|NCT02065557|Adalimumab|adalimumab|mesh-list
139506438|NCT02065557|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139506439|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506440|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139506441|NCT02065245|Penicillins|penicillins|mesh-list
139506442|NCT02065245|Streptomycin|streptomycin|mesh-list
139506443|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139506444|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506445|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139506446|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506447|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506448|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
139506449|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139506450|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139506451|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
139506452|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
139506453|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139506454|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506455|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139506456|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139506457|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
139506458|NCT04182555|Bilirubin|bilirubin|mesh-list
139506459|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
139506460|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506461|NCT04182555|Protective Agents|protective agents|mesh-ancestor
139506462|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506463|NCT02366143|Paclitaxel|paclitaxel|mesh-list
139506464|NCT02366143|Bevacizumab|bevacizumab|mesh-list
139506465|NCT02366143|Carboplatin|carboplatin|mesh-list
139506466|NCT02366143|Atezolizumab|atezolizumab|mesh-list
139506467|NCT02366143|Antibodies|antibodies|mesh-list
139506468|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139506469|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139506470|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506471|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
139506472|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
139506473|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
139506474|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506475|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139506476|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139506477|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139506478|NCT02366143|Growth Substances|growth substances|mesh-ancestor
139506479|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506480|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
139506481|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
139506482|NCT02366143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139506483|NCT02098395|Liraglutide|liraglutide|mesh-list
139506484|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139506485|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506486|NCT02098395|Incretins|incretins|mesh-ancestor
139506487|NCT02098395|Hormones|hormones|mesh-ancestor
139506488|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506489|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139506490|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139506491|NCT02096835|Dexamethasone|dexamethasone|mesh-list
139506492|NCT02096835|Tropisetron|tropisetron|mesh-list
139506493|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506494|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
139506495|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
139506496|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506497|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506498|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139506499|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
139506500|NCT02096835|Hormones|hormones|mesh-ancestor
139506501|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506502|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139506503|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506504|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139506505|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139506506|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
139506507|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506508|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506509|NCT02294773|Letrozole|letrozole|mesh-list
139506510|NCT02294773|Clomiphene|clomiphene|mesh-list
139506511|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506512|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139293209|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
139506513|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139506514|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506515|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506516|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139506517|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
139506518|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506519|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506520|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139506521|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
139506522|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139506523|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139506524|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139506525|NCT02365285|Heparin|heparin|mesh-list
139506526|NCT02365285|Galantamine|galantamine|mesh-list
139506527|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139506528|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
139506529|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139506530|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139506531|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506532|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139099077|NCT01357876|Metformin|metformin|mesh-list
139506533|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139506534|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139506535|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139506536|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506537|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
139506538|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506539|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506540|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139506541|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
139506542|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506543|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
139506544|NCT02041299|Deferiprone|deferiprone|mesh-list
139506545|NCT02041299|Deferoxamine|deferoxamine|mesh-list
139506546|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139506547|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
139506548|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
139506549|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506550|NCT02041299|Siderophores|siderophores|mesh-ancestor
139506551|NCT01645735|Vancomycin|vancomycin|mesh-list
139506552|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
139506553|NCT01645735|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139506554|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139506555|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506556|NCT01645111|Clevidipine|clevidipine|mesh-list
139506557|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139506558|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139506559|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506560|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139506561|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506562|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
139506563|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139506564|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506565|NCT01919164|Mitogens|mitogens|mesh-list
139506566|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
139099112|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
139506567|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506568|NCT01901224|Metformin|metformin|mesh-list
139506569|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139506570|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506571|NCT01901146|Paclitaxel|paclitaxel|mesh-list
139506572|NCT01901146|Trastuzumab|trastuzumab|mesh-list
139506573|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139506574|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506575|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
139506576|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
139506577|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
139506578|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506579|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139506580|NCT01644643|Metronidazole|metronidazole|mesh-list
139506581|NCT01644643|Ceftazidime|ceftazidime|mesh-list
139506582|NCT01644643|Avibactam|avibactam|mesh-list
139506583|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506584|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139506585|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139506586|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139506587|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139506588|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506589|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506590|NCT01864174|Metformin|metformin|mesh-list
139506591|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139506592|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506593|NCT01900444|Vaccines|vaccines|mesh-list
139506594|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
139506595|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506596|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
139506597|NCT02496221|Incretins|incretins|mesh-ancestor
139506598|NCT02496221|Hormones|hormones|mesh-ancestor
139506599|NCT02496221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506600|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506601|NCT02475629|Ibalizumab|ibalizumab|mesh-list
139506602|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139506603|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139506604|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
139506605|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506606|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139506607|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139506608|NCT01653743|Hormones|hormones|mesh-ancestor
139506609|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506610|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506611|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139506612|NCT02293993|Guadecitabine|guadecitabine|mesh-list
139506613|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506614|NCT02322775|Benralizumab|benralizumab|mesh-list
139506615|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139506616|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
139506617|NCT01646827|Aripiprazole|aripiprazole|mesh-list
139506618|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
139506619|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139506620|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139506621|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139506622|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139506623|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506624|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
139506625|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
139506626|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506627|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506628|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139506629|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139506630|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
139506631|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139506632|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139506633|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139506634|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139506635|NCT02360995|Triclosan|triclosan|mesh-list
139506636|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
139506637|NCT02360995|Fluorides|fluorides|mesh-list
139506638|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
139506639|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
139506640|NCT02360995|Protective Agents|protective agents|mesh-ancestor
139506641|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506642|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139506643|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506644|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139506645|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139506646|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
139506647|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506648|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139506649|NCT02359903|Infliximab|infliximab|mesh-list
139506650|NCT02359903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139506651|NCT02359903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506652|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
139506653|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139506654|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139506655|NCT02291419|Aspirin|aspirin|mesh-list
139506656|NCT02291419|Ticagrelor|ticagrelor|mesh-list
139506657|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139506658|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139506659|NCT02291419|Analgesics|analgesics|mesh-ancestor
139506660|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
139506661|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506662|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506663|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506664|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139506665|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139506666|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139506667|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506668|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139506669|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139506670|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506671|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
139506672|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139506673|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139506674|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139506675|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
139506676|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506677|NCT02319031|Ribavirin|ribavirin|mesh-list
139506678|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
139506679|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
139506680|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506681|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
139099308|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
139506682|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506683|NCT02359435|Amoxicillin|amoxicillin|mesh-list
139506684|NCT02359435|Metronidazole|metronidazole|mesh-list
139506685|NCT02359435|Clarithromycin|clarithromycin|mesh-list
139506686|NCT02359435|Pantoprazole|pantoprazole|mesh-list
139506687|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139506688|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506689|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139506690|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139506691|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139506692|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506693|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506694|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139506695|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139506696|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139506697|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139506698|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139506699|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
139506700|NCT04599868|Analgesics|analgesics|mesh-ancestor
139506701|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
139506702|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506703|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506704|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
139506705|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139506706|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139506707|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
139506708|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139506709|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139506710|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506711|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139506712|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
139506713|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139506714|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
139506715|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139506716|NCT01612156|Lidocaine|lidocaine|mesh-list
139506717|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
139506718|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
139506719|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139506720|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506721|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
139506722|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506723|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139506724|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139506725|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139506726|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139506727|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506728|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
139506729|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139506730|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
139506731|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506732|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506733|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139506734|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
139506735|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
139506736|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139293438|NCT03837899|Durvalumab|durvalumab|mesh-list
139506737|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
139506738|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099377|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
139506739|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506740|NCT01615822|Artefenomel|artefenomel|mesh-list
139506741|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
139506742|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139506743|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139506744|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506745|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
139506746|NCT01613326|Albuterol|albuterol|mesh-list
139506747|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
139506748|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139506749|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
139506750|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506751|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506752|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139506753|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
139506754|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
139506755|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139506756|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
139506757|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506758|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506759|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
139506760|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139506761|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139506762|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139506763|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139506764|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
139506765|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139506766|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139506767|NCT01898806|Triamcinolone|triamcinolone|mesh-list
139506768|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139506769|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139506770|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139506771|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506772|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
139506773|NCT01898806|Hormones|hormones|mesh-ancestor
139506774|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506775|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506776|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139506777|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
139506778|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506779|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506780|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139506781|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
139506782|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506783|NCT02290873|Midazolam|midazolam|mesh-list
139506784|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139506785|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139506786|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139506787|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506788|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139506789|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139506790|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139506791|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139506792|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
139506793|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
139506794|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
139506795|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
139506796|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506797|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506798|NCT02358343|Sertraline|sertraline|mesh-list
139506799|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
139506800|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139506801|NCT02358343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139506802|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139506803|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139506804|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506805|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506806|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
139506807|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506808|NCT02318095|Paclitaxel|paclitaxel|mesh-list
139506809|NCT02318095|Gemcitabine|gemcitabine|mesh-list
139506810|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139506811|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506812|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
139506813|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
139506814|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
139506815|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506816|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139506817|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
139506818|NCT02317627|Belumosudil|belumosudil|mesh-list
139506819|NCT02317627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139506820|NCT02317627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506821|NCT02317627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506822|NCT02517905|Bupivacaine|bupivacaine|mesh-list
139506823|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
139506824|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
139506825|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139506826|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506827|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
139506828|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506830|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
139506831|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506832|NCT02473913|Protective Agents|protective agents|mesh-ancestor
139506833|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506834|NCT02316847|Diazepam|diazepam|mesh-list
139506835|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139506836|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
139506837|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
139506838|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
139506839|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506840|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506841|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139506842|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139506843|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139506844|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139506845|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139506846|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139506847|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139506848|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139506849|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139506850|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
139506851|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
139506852|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
139506853|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
139506854|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506855|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506856|NCT02473445|Cysteamine|cysteamine|mesh-list
139506857|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
139506858|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506859|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
139506860|NCT02473367|Antacids|antacids|mesh-list
139506861|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139506862|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139506863|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
139506864|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506865|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139506866|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139506867|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506868|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506869|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139506870|NCT02316613|Rituximab|rituximab|mesh-list
139506871|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139506872|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506873|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
139506874|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506875|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139506876|NCT02492165|Vaccines|vaccines|mesh-list
139506877|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
139506878|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506879|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139506880|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
139506881|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506882|NCT02286895|Vaccines|vaccines|mesh-list
139506883|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
139506884|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506885|NCT02472977|Nivolumab|nivolumab|mesh-list
139506886|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139506887|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506888|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139506889|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506890|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
139506891|NCT02060487|Citric Acid|citric acid|mesh-list
139506892|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
139506893|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
139506894|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139506895|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
139506896|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
139506897|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506898|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
139506899|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139506900|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139506901|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506902|NCT02060487|Urological Agents|urological agents|mesh-ancestor
139506903|NCT02059239|Cytarabine|cytarabine|mesh-list
139506904|NCT02059239|Rituximab|rituximab|mesh-list
139506905|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
139506906|NCT02059239|Etoposide|etoposide|mesh-list
139506907|NCT02059239|Melphalan|melphalan|mesh-list
139506908|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139506909|NCT02059239|Carmustine|carmustine|mesh-list
139506910|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139506911|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506912|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
139506913|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506914|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139506915|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139506916|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139506917|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139506918|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506919|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506920|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139506921|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
139506922|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
139506923|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139506924|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139506925|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139506926|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
139506927|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139506928|NCT02059161|Insulin|insulin|mesh-list
139506929|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139506930|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
139506931|NCT02059161|MK-1293|mk-1293|mesh-list
139506932|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139506933|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506934|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139506935|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
139506936|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506937|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139506938|NCT01897714|Dexamethasone|dexamethasone|mesh-list
139506939|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506940|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
139506941|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
139506942|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506943|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506944|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139506945|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
139506946|NCT01897714|Hormones|hormones|mesh-ancestor
139506947|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506948|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139506949|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506950|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
139506951|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139506952|NCT01860976|Abatacept|abatacept|mesh-list
139506953|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139506954|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506955|NCT01860976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139506956|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506957|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139506958|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
139506959|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506960|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139506961|NCT01860040|Gemcitabine|gemcitabine|mesh-list
139506962|NCT01860040|Pemetrexed|pemetrexed|mesh-list
139506963|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139506964|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139506966|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506967|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139506968|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139506969|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139506970|NCT04618744|Insulin|insulin|mesh-list
139506971|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139506972|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139506973|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506974|NCT01896934|Sertraline|sertraline|mesh-list
139506975|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
139506976|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139506977|NCT01896934|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139506978|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139506979|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139506980|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139506981|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139506982|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
139506983|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506984|NCT02039505|Vedolizumab|vedolizumab|mesh-list
139506985|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139506986|NCT02095197|Triamcinolone|triamcinolone|mesh-list
139506987|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506988|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
139506989|NCT02095197|Hormones|hormones|mesh-ancestor
139506990|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139506991|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506992|NCT02039427|Dexamethasone|dexamethasone|mesh-list
139506993|NCT02039427|Ketorolac|ketorolac|mesh-list
139506994|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139506995|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
139506996|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
139506997|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139506998|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139506999|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139507000|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
139507001|NCT02039427|Hormones|hormones|mesh-ancestor
139507002|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139507003|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139507004|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507005|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139507006|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139507007|NCT02039427|Analgesics|analgesics|mesh-ancestor
139507008|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
139507009|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139507010|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139507011|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507012|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507013|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139507014|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
139507015|NCT02094885|Coagulants|coagulants|mesh-ancestor
139507016|NCT01896856|Trifluridine|trifluridine|mesh-list
139507017|NCT01896856|Irinotecan|irinotecan|mesh-list
139507018|NCT01896856|Guadecitabine|guadecitabine|mesh-list
139507019|NCT01896856|Azacitidine|azacitidine|mesh-list
139507020|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139507021|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139507022|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507023|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507024|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507025|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
139507026|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
139507027|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507028|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139507029|NCT01896700|Methylphenidate|methylphenidate|mesh-list
139507030|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139507031|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507032|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139507033|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139507034|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139507035|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507036|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
139507037|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507038|NCT01896232|Cinacalcet|cinacalcet|mesh-list
139507039|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139507040|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507041|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139507042|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
139507043|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139507044|NCT02460224|Spartalizumab|spartalizumab|mesh-list
139507045|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139507046|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507047|NCT02460224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139507048|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507049|NCT02058537|Bethanechol|bethanechol|mesh-list
139507050|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139507051|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
139507052|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507053|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507054|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139507055|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139507056|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
139507057|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507058|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507059|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
139507060|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
139507061|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
139507062|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507063|NCT01612000|Coagulants|coagulants|mesh-ancestor
139507064|NCT02409680|Aspirin|aspirin|mesh-list
139507065|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139507066|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139507067|NCT02409680|Analgesics|analgesics|mesh-ancestor
139507068|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
139507069|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507070|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507071|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139507072|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139507073|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139507074|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139507075|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507076|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139507077|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139507078|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507079|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
139507080|NCT01894984|Risperidone|risperidone|mesh-list
139507081|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
139507082|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139507083|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
139507084|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507085|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507086|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507087|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139507088|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139507089|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139507090|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139507091|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
139507092|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
139507093|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139507094|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507095|NCT02375672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139507096|NCT02375672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507097|NCT02491463|Vaccines|vaccines|mesh-list
139507098|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
139507099|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507100|NCT02038881|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139507101|NCT02038881|Antiviral Agents|antiviral agents|mesh-ancestor
139507102|NCT02038881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507103|NCT01857622|Edoxaban|edoxaban|mesh-list
139507104|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139507105|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
139507106|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139507107|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
139507108|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507109|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507110|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
139507111|NCT01857310|Folic Acid|folic acid|mesh-list
139507112|NCT01857310|Hematinics|hematinics|mesh-ancestor
139507113|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
139507114|NCT01857310|Vitamins|vitamins|mesh-ancestor
139507115|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
139507116|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507117|NCT02472353|Metformin|metformin|mesh-list
139507118|NCT02472353|Doxorubicin|doxorubicin|mesh-list
139507119|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139507120|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507121|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139507122|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507123|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139507124|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139507125|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507126|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507127|NCT02314117|Capecitabine|capecitabine|mesh-list
139507128|NCT02314117|Fluorouracil|fluorouracil|mesh-list
139507129|NCT02314117|Ramucirumab|ramucirumab|mesh-list
139507130|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507131|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139507132|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
139507133|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507134|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139507135|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
139507136|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507137|NCT02058147|Insulin|insulin|mesh-list
139507138|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139507139|NCT02058147|Metformin|metformin|mesh-list
139507140|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
139507141|NCT02058147|Lixisenatide|lixisenatide|mesh-list
139507142|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139507143|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507144|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
139507145|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139507146|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
139507147|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507148|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507149|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139507150|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
139507151|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
139507152|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139507153|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
139507154|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507155|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507156|NCT02471183|Selexipag|selexipag|mesh-list
139507157|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139507158|NCT01855828|Paclitaxel|paclitaxel|mesh-list
139507159|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
139507160|NCT01855828|Fluorouracil|fluorouracil|mesh-list
139507161|NCT01855828|Trastuzumab|trastuzumab|mesh-list
139507162|NCT01855828|Epirubicin|epirubicin|mesh-list
139507163|NCT01855828|Pertuzumab|pertuzumab|mesh-list
139507164|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139507165|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507166|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
139507167|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
139507168|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
139507169|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507170|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139507171|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
139099969|NCT06024928|Insulin|insulin|mesh-list
139507172|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507173|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139507174|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139507175|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
139507176|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139507177|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
139507178|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139507179|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139507180|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139507181|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139507182|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139507183|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507184|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
139507185|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139507186|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
139507187|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507188|NCT02351167|Nicotine|nicotine|mesh-list
139507189|NCT02351167|Varenicline|varenicline|mesh-list
139507190|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139507191|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
139507192|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507193|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507194|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139507195|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139507196|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
139507197|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507198|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507199|NCT02350309|Lemborexant|lemborexant|mesh-list
139507200|NCT02350309|Flurazepam|flurazepam|mesh-list
139507201|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139507202|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507203|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507204|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139507205|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139507206|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139507207|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507208|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139507209|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139507210|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139507211|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
139507212|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
139507213|NCT02038647|Paclitaxel|paclitaxel|mesh-list
139507214|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139507215|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507216|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
139507217|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
139507218|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
139507219|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507220|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
139507221|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139507222|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507223|NCT02037477|Esomeprazole|esomeprazole|mesh-list
139507224|NCT02037477|Rabeprazole|rabeprazole|mesh-list
139507225|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139507226|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139507227|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139507228|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507229|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507230|NCT02057523|Hormones|hormones|mesh-list
139507231|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139507232|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139507233|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
139507234|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139507235|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507236|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507237|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507238|NCT02037165|Celecoxib|celecoxib|mesh-list
139507239|NCT02037165|Pregabalin|pregabalin|mesh-list
139507240|NCT02037165|Analgesics|analgesics|mesh-ancestor
139507241|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
139507242|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507243|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507244|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
139507245|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139507246|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139507247|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507248|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139507249|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139507250|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139507251|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139507252|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139507253|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139507254|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139507255|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139507256|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139507257|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139507258|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139507259|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507260|NCT02470403|Licogliflozin|licogliflozin|mesh-list
139507261|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139507262|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507263|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139293960|NCT04455464|Midodrine|midodrine|mesh-list
139507264|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507265|NCT01855750|Prednisone|prednisone|mesh-list
139507266|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
139507267|NCT01855750|Rituximab|rituximab|mesh-list
139507268|NCT01855750|Doxorubicin|doxorubicin|mesh-list
139507269|NCT01855750|Vincristine|vincristine|mesh-list
139507270|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139507271|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
139507272|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507273|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139507274|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139507275|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
139507276|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507277|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507278|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139507279|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139507280|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139507281|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139507282|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139507283|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507284|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139507285|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
139507286|NCT01855750|Hormones|hormones|mesh-ancestor
139507287|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139507288|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139507289|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139507290|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
139507291|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
139507292|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
139507293|NCT04963439|Macitentan|macitentan|mesh-list
139507294|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139507295|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139507296|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507297|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139507298|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
139507299|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
139507300|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139507301|NCT01622673|Antacids|antacids|mesh-list
139507302|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
139507303|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
139507304|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
139507305|NCT01622673|TEMPO|tempo|mesh-list
139507306|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507307|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139100132|NCT05850455|Analgesics|analgesics|mesh-ancestor
139507308|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139507309|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
139507310|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507311|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139507312|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139507313|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507314|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507315|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139507316|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139507317|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
139507318|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
139507319|NCT01622673|Protective Agents|protective agents|mesh-ancestor
139507320|NCT02469077|Morphine|morphine|mesh-list
139507321|NCT02469077|Naloxone|naloxone|mesh-list
139507322|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139507323|NCT02469077|Narcotics|narcotics|mesh-ancestor
139507324|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139507325|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507326|NCT02469077|Analgesics|analgesics|mesh-ancestor
139507327|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
139507328|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507329|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139507330|NCT02486627|Levofloxacin|levofloxacin|mesh-list
139507331|NCT02486627|Meropenem|meropenem|mesh-list
139507332|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139507333|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139100167|NCT05752305|Prednisolone|prednisolone|mesh-list
139507334|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139507335|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139507336|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139507337|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507338|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507339|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507340|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139507341|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139507342|NCT02282293|Piperaquine|piperaquine|mesh-list
139507343|NCT02282293|Trimethoprim|trimethoprim|mesh-list
139507344|NCT02282293|Artenimol|artenimol|mesh-list
139507345|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
139507346|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
139507347|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139507348|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139507349|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507350|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139507351|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139507352|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507353|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507354|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139507355|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139507356|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139507357|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
139507358|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
139507359|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139507360|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
139507361|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507362|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507363|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139507364|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
139507365|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139507366|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139507367|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139507368|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
139507369|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507370|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507371|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139507372|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139507373|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139507374|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
139507375|NCT01892020|Insulin|insulin|mesh-list
139507376|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139507377|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
139507378|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
139507379|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139507380|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507381|NCT02485691|Prednisone|prednisone|mesh-list
139507382|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
139507383|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139507384|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
139507385|NCT02485691|Hormones|hormones|mesh-ancestor
139507386|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139507387|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507388|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139507389|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507390|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139507391|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507392|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507393|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
139507394|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139507395|NCT02517515|Ritonavir|ritonavir|mesh-list
139507396|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139507397|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139507398|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
139507399|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507400|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507401|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139507402|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139507403|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
139507404|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507405|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139507406|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139507407|NCT01891864|Etanercept|etanercept|mesh-list
139507408|NCT01891864|GP2015|gp2015|mesh-list
139507409|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139507410|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139507411|NCT01891864|Analgesics|analgesics|mesh-ancestor
139507412|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
139507413|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507414|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507415|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139507416|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139507417|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139507418|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139507419|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
139507420|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
139507421|NCT02484911|Dexamethasone|dexamethasone|mesh-list
139507422|NCT02484911|Olanzapine|olanzapine|mesh-list
139507423|NCT02484911|Aprepitant|aprepitant|mesh-list
139507424|NCT02484911|Palonosetron|palonosetron|mesh-list
139507425|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139507426|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
139507427|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
139507428|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507429|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507430|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139507431|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
139507432|NCT02484911|Hormones|hormones|mesh-ancestor
139507433|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139507434|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139507435|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507436|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139507437|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139507438|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139507439|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139507440|NCT02484911|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139507441|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139507442|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139507443|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507444|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507445|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
139507446|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139507447|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139507448|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139507449|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
139507450|NCT04306367|Olaparib|olaparib|mesh-list
139507451|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139507452|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507453|NCT04306367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139507454|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507455|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139507456|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507457|NCT04616014|Insulin|insulin|mesh-list
139507458|NCT04616014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139507459|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139507460|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507461|NCT02451917|Insulin|insulin|mesh-list
139507462|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139507463|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
139507464|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
139507465|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
139507466|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
139507467|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139507468|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507469|NCT02349451|Adalimumab|adalimumab|mesh-list
139507470|NCT02349451|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139507471|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139507472|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139507473|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
139507474|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139507475|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507476|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139507477|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507478|NCT02409368|Nivolumab|nivolumab|mesh-list
139507479|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139507480|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507481|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139100408|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
139507482|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507483|NCT04891484|Ondansetron|ondansetron|mesh-list
139507484|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
139507485|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
139507486|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507487|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139294183|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
139507488|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139507490|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
139507491|NCT04891484|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139507492|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139507493|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
139507494|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507495|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507496|NCT01853644|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139507497|NCT01853644|Tivozanib|tivozanib|mesh-list
139507498|NCT01853644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139507499|NCT01853644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507500|NCT01853644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507501|NCT01853254|Ribavirin|ribavirin|mesh-list
139507502|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139507503|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
139507504|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507505|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
139507506|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507507|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139507508|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139507509|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507510|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139507511|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
139507512|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507513|NCT01853176|Bupivacaine|bupivacaine|mesh-list
139507514|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
139507515|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
139100442|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507516|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139507517|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507518|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
139507519|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507520|NCT01852942|Losartan|losartan|mesh-list
139507521|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139507522|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139507523|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139507524|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139507525|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507526|NCT01852162|Dabigatran|dabigatran|mesh-list
139507527|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
139507528|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139507529|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
139507530|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507531|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507532|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
139507533|NCT01835470|Abatacept|abatacept|mesh-list
139507534|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139507535|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507536|NCT01835470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139507537|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507538|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139507539|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
139507540|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507541|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139507542|NCT02451137|Insulin|insulin|mesh-list
139507543|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139507544|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
139507545|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
139507546|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139507547|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507548|NCT02372006|Afatinib|afatinib|mesh-list
139507549|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507550|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139507551|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507552|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507553|NCT02406248|Ticagrelor|ticagrelor|mesh-list
139507554|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139507555|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139507556|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139507557|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139507558|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
139507559|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139294263|NCT03050866|Histamine|histamine|mesh-list
139507560|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507561|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507562|NCT02450903|Ceritinib|ceritinib|mesh-list
139507563|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507564|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139507565|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507566|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507567|NCT02371616|Listerine|listerine|mesh-list
139507568|NCT02371616|Calcium|calcium|mesh-list
139507569|NCT02371616|Fluorides|fluorides|mesh-list
139507570|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
139507571|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
139507572|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139507573|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507574|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
139507575|NCT02371616|Protective Agents|protective agents|mesh-ancestor
139507576|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139507577|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507578|NCT01835158|Sunitinib|sunitinib|mesh-list
139507579|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507580|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139507581|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139507582|NCT01835158|Growth Substances|growth substances|mesh-ancestor
139507583|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507584|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
139507585|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139507586|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507587|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507588|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
139507589|NCT01833832|Antidotes|antidotes|mesh-ancestor
139507590|NCT01833832|Protective Agents|protective agents|mesh-ancestor
139507591|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507592|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
139507593|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507594|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
139507595|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139507596|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507597|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
139507598|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
139507599|NCT01850602|Sevelamer|sevelamer|mesh-list
139507600|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
139507601|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
139507602|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507603|NCT02405780|Adalimumab|adalimumab|mesh-list
139507604|NCT02405780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139507605|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139507606|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139507607|NCT02369510|Epinephrine|epinephrine|mesh-list
139507608|NCT02369510|Racepinephrine|racepinephrine|mesh-list
139507609|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
139507610|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139507611|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139507612|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
139507613|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507614|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507615|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507616|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139507617|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139507618|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
139507619|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507620|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139507621|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
139507622|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
139507623|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
139507624|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139507625|NCT01650194|Prednisone|prednisone|mesh-list
139507626|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
139507627|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139507628|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
139507629|NCT01650194|Hormones|hormones|mesh-ancestor
139507630|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139507631|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507632|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139507633|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877841|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
139507634|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139507635|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507636|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507637|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
139507638|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139507639|NCT02404220|Dexamethasone|dexamethasone|mesh-list
139507640|NCT02404220|Vincristine|vincristine|mesh-list
139507641|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139507642|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
139507643|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
139507644|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507645|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507646|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139507647|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
139507648|NCT02404220|Hormones|hormones|mesh-ancestor
139507649|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139507650|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139507651|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507652|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139507653|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
139507654|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
139507655|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
139507656|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507657|NCT02366468|Ranibizumab|ranibizumab|mesh-list
139507658|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139507659|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139507660|NCT02366468|Growth Substances|growth substances|mesh-ancestor
139507661|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507662|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
139507663|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507664|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139507665|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139507666|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139507667|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139507668|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507669|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507670|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507671|NCT02335346|Analgesics|analgesics|mesh-ancestor
139507672|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
139507673|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507674|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
139507675|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139507676|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
139507677|NCT02401256|Efavirenz|efavirenz|mesh-list
139507678|NCT02401256|Bupropion|bupropion|mesh-list
139507679|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139507680|NCT02401256|Montelukast|montelukast|mesh-list
139507681|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139507682|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139507683|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
139507684|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507685|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139507686|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139507687|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507688|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139507689|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
139507690|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139507691|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139507692|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139507693|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139507694|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
139507695|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507696|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507697|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139507698|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139507699|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139507700|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
139507701|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139507702|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
139507703|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139507704|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139507705|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139507706|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139507707|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139507708|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
139507709|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507710|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139507711|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139507712|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139507713|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139507715|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
139507716|NCT04877587|Gemcitabine|gemcitabine|mesh-list
139507717|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139507718|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
139507719|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507720|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507721|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
139507722|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139507723|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139507724|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507725|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139507726|NCT02284243|Analgesics|analgesics|mesh-ancestor
139507727|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
139507728|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507729|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139507730|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139507731|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139507732|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
139507733|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507734|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507735|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
139507736|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507737|NCT02284009|Incretins|incretins|mesh-ancestor
139507738|NCT02284009|Hormones|hormones|mesh-ancestor
139507739|NCT02284009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139507740|NCT02400476|Budesonide|budesonide|mesh-list
139507741|NCT02400476|Loperamide|loperamide|mesh-list
139507742|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
139507743|NCT02400476|Colestipol|colestipol|mesh-list
139507744|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139507745|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139507746|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
139507747|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507748|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507749|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139507750|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
139507751|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
139507752|NCT02400476|Hormones|hormones|mesh-ancestor
139100731|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
139507753|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139507754|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139507755|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139507756|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
139507757|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507758|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139507759|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
139507760|NCT02363738|Infliximab|infliximab|mesh-list
139507761|NCT02363738|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139507762|NCT02363738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139507763|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
139507764|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139507765|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139507766|NCT02331680|Tolvaptan|tolvaptan|mesh-list
139507767|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139507768|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507769|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
139507770|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507771|NCT02349061|Ustekinumab|ustekinumab|mesh-list
139507772|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
139507773|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
139507774|NCT02331368|Lenalidomide|lenalidomide|mesh-list
139507775|NCT02331368|Melphalan|melphalan|mesh-list
139507776|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139507777|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507778|NCT02331368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138877990|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507779|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507780|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
139507781|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507782|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139507783|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139507784|NCT02331368|Growth Substances|growth substances|mesh-ancestor
139507785|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
139100768|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139507786|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139507787|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
139507788|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139507789|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139507791|NCT02280421|Cyclosporins|cyclosporins|mesh-list
139507792|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507793|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507794|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139507795|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
139507796|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507797|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
139507798|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507799|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
139507800|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139507801|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139507802|NCT04906382|Paclitaxel|paclitaxel|mesh-list
139507803|NCT04906382|Carboplatin|carboplatin|mesh-list
139507804|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139507805|NCT04906382|Tislelizumab|tislelizumab|mesh-list
139507806|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139507807|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507808|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
139507809|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
139507810|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
139507811|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100807|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139507812|NCT04906382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139507813|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139507814|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
139507815|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139507816|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139507817|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139507818|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139507819|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507820|NCT02347813|Pioglitazone|pioglitazone|mesh-list
139507821|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139507822|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507823|NCT02359994|Hemostatics|hemostatics|mesh-list
139507824|NCT02359994|Coagulants|coagulants|mesh-ancestor
139507825|NCT04905446|Niacinamide|niacinamide|mesh-list
139507826|NCT04905446|Niacin|niacin|mesh-list
139507827|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
139507828|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
139507829|NCT04905446|Vitamins|vitamins|mesh-ancestor
139507830|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
139507831|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507832|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139507833|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
139507834|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507835|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139507836|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
139507837|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
139507838|NCT02326298|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139507839|NCT02326298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139507840|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139507841|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
139507842|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507843|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139507844|NCT02279719|Sorafenib|sorafenib|mesh-list
139507845|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507846|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139507847|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507848|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507849|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
139507850|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139507851|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507852|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139507853|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507854|NCT02326220|Alirocumab|alirocumab|mesh-list
139507855|NCT02326220|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139507856|NCT02326220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139507857|NCT02326220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139507858|NCT02326220|Antimetabolites|antimetabolites|mesh-ancestor
139507859|NCT02326220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507860|NCT02326220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139507861|NCT02326220|Protease Inhibitors|protease inhibitors|mesh-ancestor
139507862|NCT02326220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507863|NCT02326220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139100930|NCT03742921|Romidepsin|romidepsin|mesh-list
139507865|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139507866|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507867|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
139507868|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139507869|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139507870|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507871|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
139507872|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
139507873|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139507874|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139507875|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139507876|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
139507877|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507878|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507879|NCT05650099|Cimetidine|cimetidine|mesh-list
139507880|NCT05650099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139507881|NCT05650099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139507882|NCT05650099|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139507883|NCT05650099|Histamine Antagonists|histamine antagonists|mesh-ancestor
139507884|NCT05650099|Histamine Agents|histamine agents|mesh-ancestor
139507885|NCT05650099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507886|NCT05650099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507887|NCT05650099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507888|NCT05650099|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139507889|NCT05650099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139507890|NCT05650099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507891|NCT02278471|Losartan|losartan|mesh-list
139507892|NCT02278471|Amlodipine|amlodipine|mesh-list
139507893|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139507894|NCT02278471|Atorvastatin|atorvastatin|mesh-list
139507895|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139507896|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139507897|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
139507898|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507899|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139507900|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139507901|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507902|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139507903|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139507904|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139507905|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139507906|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507907|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
139507908|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139507909|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139507910|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139507911|NCT02278471|Diuretics|diuretics|mesh-ancestor
139507912|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
139507913|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139507914|NCT05565235|Nalbuphine|nalbuphine|mesh-list
139507915|NCT05565235|Bupivacaine|bupivacaine|mesh-list
139507916|NCT05565235|Anesthetics, Local|anesthetics, local|mesh-ancestor
139507917|NCT05565235|Anesthetics|anesthetics|mesh-ancestor
139507918|NCT05565235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139507919|NCT05565235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507920|NCT05565235|Sensory System Agents|sensory system agents|mesh-ancestor
139507921|NCT05565235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507922|NCT05565235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139507923|NCT05565235|Narcotics|narcotics|mesh-ancestor
139507924|NCT05565235|Analgesics|analgesics|mesh-ancestor
139507925|NCT02278003|Propofol|propofol|mesh-list
139507926|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139507927|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139507928|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507929|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139507930|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
139507932|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139507933|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
139507934|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507935|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139507936|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139507937|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139507938|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507939|NCT02395172|Docetaxel|docetaxel|mesh-list
139507940|NCT02395172|Avelumab|avelumab|mesh-list
139507941|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507942|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
139507943|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
139507944|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
139507945|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507946|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139507947|NCT04876027|Dulaglutide|dulaglutide|mesh-list
139507948|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139507949|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507950|NCT02358044|Ribavirin|ribavirin|mesh-list
139507951|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
139507952|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139507953|NCT02358044|Grazoprevir|grazoprevir|mesh-list
139507954|NCT02358044|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139507955|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
139507956|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507957|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
139507958|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507959|NCT05649241|Nicotine|nicotine|mesh-list
139507960|NCT05649241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139507961|NCT05649241|Autonomic Agents|autonomic agents|mesh-ancestor
139507962|NCT05649241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139507963|NCT05649241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139507964|NCT05649241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139507965|NCT05649241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139507966|NCT05649241|Cholinergic Agents|cholinergic agents|mesh-ancestor
139101087|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
139101088|NCT03321643|Rituximab|rituximab|mesh-list
139101089|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139101090|NCT03321643|Atezolizumab|atezolizumab|mesh-list
139101091|NCT03321643|Gemcitabine|gemcitabine|mesh-list
139101092|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
139101093|NCT03321643|Antibodies|antibodies|mesh-list
139101094|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
139101095|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139101096|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
139101099|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139507967|NCT05649241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139507968|NCT05649241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507969|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
139507970|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507971|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139507972|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507973|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507974|NCT02357810|Topotecan|topotecan|mesh-list
139507975|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139507976|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139507977|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507978|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507979|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139507980|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139507981|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139507982|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139507983|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139507984|NCT01850446|Oseltamivir|oseltamivir|mesh-list
139507985|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
139507986|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139507987|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507988|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507989|NCT01644175|Alirocumab|alirocumab|mesh-list
139507990|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139507991|NCT01644175|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139507992|NCT01644175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139507993|NCT01644175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139507994|NCT01644175|Antimetabolites|antimetabolites|mesh-ancestor
139507995|NCT01644175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139507996|NCT01644175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139507997|NCT01644175|Protease Inhibitors|protease inhibitors|mesh-ancestor
139507998|NCT01644175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139507999|NCT01644175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139508000|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
139508001|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508002|NCT04856761|Capecitabine|capecitabine|mesh-list
139508003|NCT04856761|Tegafur|tegafur|mesh-list
139508004|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139508005|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
139508006|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508007|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508008|NCT01832038|Lacosamide|lacosamide|mesh-list
139508009|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
139508010|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139508011|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139508012|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139508013|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508014|NCT01849588|Sorafenib|sorafenib|mesh-list
139508015|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508016|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139508017|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508018|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508019|NCT02357342|Sirolimus|sirolimus|mesh-list
139508020|NCT02357342|Aflibercept|aflibercept|mesh-list
139508021|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508022|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139508023|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139508024|NCT02357342|Growth Substances|growth substances|mesh-ancestor
139508025|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508026|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
139508027|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139508028|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508029|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139508030|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
139508031|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139508032|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
139508033|NCT02325518|Timolol|timolol|mesh-list
139508034|NCT02325518|Dorzolamide|dorzolamide|mesh-list
139508035|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139508036|NCT02325518|Maleic acid|maleic acid|mesh-list
139508037|NCT02325518|Brinzolamide|brinzolamide|mesh-list
139508038|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139508039|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508040|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508041|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139508042|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139101333|NCT02476825|Xhance|xhance|mesh-list
139508043|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
139508044|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508045|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508046|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139508047|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139508048|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139508049|NCT02270983|Linaclotide|linaclotide|mesh-list
139508050|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139508051|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
139508052|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508053|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139508054|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139508055|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139508056|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508057|NCT02324270|Diclofenac|diclofenac|mesh-list
139508058|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
139508059|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139508060|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139508061|NCT02324270|Analgesics|analgesics|mesh-ancestor
139508062|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
139508063|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508064|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508065|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139508066|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139508067|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139508068|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508069|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508070|NCT05648071|Pemetrexed|pemetrexed|mesh-list
139508071|NCT05648071|Nedaplatin|nedaplatin|mesh-list
139508072|NCT05648071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508073|NCT05648071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508074|NCT05648071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508075|NCT05648071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139508076|NCT05648071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139508077|NCT01849276|Metformin|metformin|mesh-list
139508078|NCT01849276|Cytarabine|cytarabine|mesh-list
139508079|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139294776|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
139508080|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508081|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139508082|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
139101507|NCT01495676|Cisplatin|cisplatin|mesh-list
139508083|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508084|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508085|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
139508086|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508087|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139508088|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
139508089|NCT02465489|Deferiprone|deferiprone|mesh-list
139508090|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139508091|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
139508092|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
139101586|NCT05626140|Diclofenac|diclofenac|mesh-list
139508093|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508094|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
139508095|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139508096|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508097|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139508098|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139508099|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508100|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508101|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508102|NCT01601821|Sirolimus|sirolimus|mesh-list
139508103|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139101665|NCT00233987|Melphalan|melphalan|mesh-list
139508104|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508105|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139508106|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508107|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
139508108|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139508109|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
139508110|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508111|NCT01846624|Decitabine|decitabine|mesh-list
139508112|NCT01846624|Azacitidine|azacitidine|mesh-list
139508113|NCT01846624|Midostaurin|midostaurin|mesh-list
139508114|NCT01846624|Staurosporine|staurosporine|mesh-list
139101699|NCT04623242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139508115|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139508116|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
139508117|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508118|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508119|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508120|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139508121|NCT01827670|Fluorides|fluorides|mesh-list
139508122|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
139508123|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
139508124|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
139508125|NCT01827670|Protective Agents|protective agents|mesh-ancestor
139508126|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508127|NCT01844830|Phenylephrine|phenylephrine|mesh-list
139508128|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
139508129|NCT01844830|Tetracaine|tetracaine|mesh-list
139508130|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
139508131|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
139508132|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139508133|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508134|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
139508135|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508136|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139508137|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139508138|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
139508139|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508140|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508141|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
139508142|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
139508143|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
139508144|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139508145|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
139508146|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139508147|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
139508148|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139508149|NCT01844830|Protective Agents|protective agents|mesh-ancestor
139508150|NCT02323334|Itraconazole|itraconazole|mesh-list
139508151|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
139508152|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508153|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139508154|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139508155|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139294855|NCT03562143|Iron|iron|mesh-list
139508156|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508157|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139508158|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
139508159|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139508160|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508161|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139508162|NCT02322866|Sarecycline|sarecycline|mesh-list
139508163|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139508164|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508165|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
139508166|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139508167|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139508168|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139508169|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508170|NCT02356562|Ritonavir|ritonavir|mesh-list
139508171|NCT02356562|Ribavirin|ribavirin|mesh-list
139508172|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
139508173|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139508174|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139508175|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
139508176|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508177|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508178|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139508179|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139508180|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
139508181|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508182|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139508183|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139508184|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
139508185|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
139508186|NCT02354690|Fludarabine|fludarabine|mesh-list
139508187|NCT02354690|Interleukin-2|interleukin-2|mesh-list
139508188|NCT02354690|Vemurafenib|vemurafenib|mesh-list
139508189|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139508190|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
139508191|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508192|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139508193|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139508194|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
139508195|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508196|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508197|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139508198|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139508199|NCT02354690|Analgesics|analgesics|mesh-ancestor
139508200|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
139508201|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508202|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139508203|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508204|NCT02354222|Canagliflozin|canagliflozin|mesh-list
139508205|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139508206|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508207|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139508208|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508209|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
139508210|NCT02351960|Lansoprazole|lansoprazole|mesh-list
139508211|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139508212|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139508213|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139508214|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508215|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508216|NCT02351180|Beclomethasone|beclomethasone|mesh-list
139508217|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139508218|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
139508219|NCT02351180|Hormones|hormones|mesh-ancestor
139508220|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139508221|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508222|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139508223|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
139508224|NCT02350478|Linagliptin|linagliptin|mesh-list
139508225|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139508226|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508227|NCT02350478|Incretins|incretins|mesh-ancestor
139508228|NCT02350478|Hormones|hormones|mesh-ancestor
139508229|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139508230|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139508231|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
139508232|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102038|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508233|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508234|NCT02349542|Bupivacaine|bupivacaine|mesh-list
139508235|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
139508236|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
139508237|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139508238|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508239|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
139508240|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508241|NCT02321930|Tofacitinib|tofacitinib|mesh-list
139508242|NCT02321930|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139508243|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139508244|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508245|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508246|NCT02264821|Morphine|morphine|mesh-list
139508247|NCT02264821|Ropivacaine|ropivacaine|mesh-list
139508248|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
139508249|NCT02264821|Anesthetics|anesthetics|mesh-list
139508250|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139508251|NCT02264821|Narcotics|narcotics|mesh-ancestor
139508252|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139508253|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508254|NCT02264821|Analgesics|analgesics|mesh-ancestor
139508255|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
139508256|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508257|NCT04854889|Decitabine|decitabine|mesh-list
139508258|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139508259|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
139102157|NCT03972683|Atropine|atropine|mesh-list
139508260|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508261|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508262|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508263|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
139508264|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139508265|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139508266|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139508267|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139508268|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508269|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
139508270|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508271|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102220|NCT01358344|Vorapaxar|vorapaxar|mesh-list
139508272|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139508273|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508274|NCT05341843|Sertraline|sertraline|mesh-list
139508275|NCT05341843|Antidepressive Agents|antidepressive agents|mesh-ancestor
139508276|NCT05341843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139508277|NCT05341843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139508278|NCT05341843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139508279|NCT05341843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139508280|NCT05341843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508281|NCT05341843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508282|NCT05341843|Serotonin Agents|serotonin agents|mesh-ancestor
139508283|NCT05341843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508284|NCT02320058|Nivolumab|nivolumab|mesh-list
139508285|NCT02320058|Ipilimumab|ipilimumab|mesh-list
139508286|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139508287|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508288|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139508289|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508290|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
139508291|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139508292|NCT02319668|Listerine|listerine|mesh-list
139508293|NCT02319668|Fluorides|fluorides|mesh-list
139508294|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
139508295|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
139508296|NCT02319668|Protective Agents|protective agents|mesh-ancestor
139508297|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508298|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139508299|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508300|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
139508301|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
139508302|NCT02092467|Adalimumab|adalimumab|mesh-list
139508303|NCT02092467|Etanercept|etanercept|mesh-list
139508304|NCT02092467|Tofacitinib|tofacitinib|mesh-list
139508305|NCT02092467|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139508306|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139508307|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139508308|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139508309|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139508310|NCT02092467|Analgesics|analgesics|mesh-ancestor
139508311|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
139508312|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508313|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508314|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139508315|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139508316|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
139508317|NCT02092467|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139508318|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139508319|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102406|NCT01371526|Cosyntropin|cosyntropin|mesh-list
139508320|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508321|NCT04420871|Capecitabine|capecitabine|mesh-list
139508322|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139508323|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
139508324|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508325|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508326|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139508327|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139508328|NCT02349386|Estradiol|estradiol|mesh-list
139508329|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139508330|NCT02349386|Estrogens|estrogens|mesh-ancestor
139508331|NCT02349386|Hormones|hormones|mesh-ancestor
139508332|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139102463|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
139508333|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508334|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139508335|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
139508336|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139508337|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139508338|NCT04892888|Vaccines|vaccines|mesh-list
139508339|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
139508340|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508341|NCT02036775|Ambroxol|ambroxol|mesh-list
139508342|NCT02036775|Expectorants|expectorants|mesh-ancestor
139508343|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
139508344|NCT02034591|Apixaban|apixaban|mesh-list
139508345|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139508346|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
139508347|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139508348|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
139508349|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102516|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
139508350|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508351|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
139508352|NCT02091921|Ticagrelor|ticagrelor|mesh-list
139508353|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139508354|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139508355|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139508356|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139508357|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
139508358|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508359|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508360|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508361|NCT02034513|Insulin|insulin|mesh-list
139508362|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139508363|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
139508364|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
139508365|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139508366|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508367|NCT02461745|Ribavirin|ribavirin|mesh-list
139508368|NCT02461745|Ritonavir|ritonavir|mesh-list
139508369|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
139102576|NCT00867178|Vorinostat|vorinostat|mesh-list
139508370|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508371|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
139508372|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508373|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139508374|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139508375|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
139508376|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508377|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139508378|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139508379|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139508380|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139508381|NCT02034435|Amlodipine|amlodipine|mesh-list
139508382|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139508383|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139508384|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139508385|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508386|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139508387|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508388|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
139508389|NCT02033889|Insulin|insulin|mesh-list
139508390|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139508391|NCT02033889|Metformin|metformin|mesh-list
139508392|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
139508393|NCT02033889|Glimepiride|glimepiride|mesh-list
139508394|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
139508395|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
139508396|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139508397|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508398|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139508399|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139508400|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
139508401|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139508402|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508403|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
139508404|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139508405|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508406|NCT02447003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139508407|NCT02447003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508408|NCT04594018|Minoxidil|minoxidil|mesh-list
139508409|NCT04594018|Finasteride|finasteride|mesh-list
139508410|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139508411|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
139508412|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139508413|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139508414|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508415|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508416|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
139508417|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139508418|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508419|NCT04594018|Urological Agents|urological agents|mesh-ancestor
139508420|NCT02054481|Ustekinumab|ustekinumab|mesh-list
139508421|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139508422|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
139508423|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
139508424|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508425|NCT02054325|Polidocanol|polidocanol|mesh-list
139508426|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139508427|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139508428|NCT02091375|Cannabidiol|cannabidiol|mesh-list
139508429|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
139508430|NCT02032875|Ribavirin|ribavirin|mesh-list
139508431|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
139508432|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
139508433|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508434|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
139508435|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508436|NCT02032407|Dapsone|dapsone|mesh-list
139508437|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508438|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
139508439|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139508440|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139508441|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139508442|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508443|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508444|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
139508445|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139508446|NCT01843660|Acetaminophen|acetaminophen|mesh-list
139508447|NCT01843660|Tramadol|tramadol|mesh-list
139508448|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139508449|NCT01843660|Analgesics|analgesics|mesh-ancestor
139508450|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
139508451|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508452|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508453|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
139508454|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139508455|NCT01843660|Narcotics|narcotics|mesh-ancestor
139508456|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139295158|NCT02748057|Ezetimibe|ezetimibe|mesh-list
139508457|NCT02032173|Ranibizumab|ranibizumab|mesh-list
139508458|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139508459|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139508460|NCT02032173|Growth Substances|growth substances|mesh-ancestor
139508461|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508462|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
139508463|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508464|NCT02461589|Liraglutide|liraglutide|mesh-list
139508465|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139508466|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508467|NCT02461589|Incretins|incretins|mesh-ancestor
139508468|NCT02461589|Hormones|hormones|mesh-ancestor
139508469|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139508470|NCT02089737|Panitumumab|panitumumab|mesh-list
139508471|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139508472|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508473|NCT02089347|Vaccines|vaccines|mesh-list
139508474|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
139508475|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508476|NCT02419469|Cytarabine|cytarabine|mesh-list
139508477|NCT02419469|Dexamethasone|dexamethasone|mesh-list
139508478|NCT02419469|Prednisone|prednisone|mesh-list
139508479|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
139508480|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
139508481|NCT02419469|Rituximab|rituximab|mesh-list
139508482|NCT02419469|Doxorubicin|doxorubicin|mesh-list
139508483|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139508484|NCT02419469|Methotrexate|methotrexate|mesh-list
139508485|NCT02419469|Vincristine|vincristine|mesh-list
139508486|NCT02419469|Daunorubicin|daunorubicin|mesh-list
139508487|NCT02419469|Asparaginase|asparaginase|mesh-list
139508488|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
139508489|NCT02419469|Ofatumumab|ofatumumab|mesh-list
139508490|NCT02419469|Pegaspargase|pegaspargase|mesh-list
139508491|NCT02419469|Thioguanine|thioguanine|mesh-list
139508492|NCT02419469|BB 1101|bb 1101|mesh-list
139508493|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139508494|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
139508495|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508496|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139103048|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508497|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139508498|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
139508499|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508500|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508501|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139508502|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139508503|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
139508504|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
139508505|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508506|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139508507|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
139508508|NCT02419469|Hormones|hormones|mesh-ancestor
139508509|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139508510|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139508511|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139508512|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139508513|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139103109|NCT01115712|Pioglitazone|pioglitazone|mesh-list
139508514|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139508515|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508516|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139508517|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
139508518|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139508519|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139508520|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
139508521|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
139508522|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139508523|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139508524|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
139508525|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508526|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139508527|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
139508528|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
139508529|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
139508530|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
139508531|NCT04687761|Cytarabine|cytarabine|mesh-list
139508532|NCT04687761|Azacitidine|azacitidine|mesh-list
139508533|NCT04687761|Venetoclax|venetoclax|mesh-list
139508534|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139508535|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
139508536|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508537|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508538|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
139508539|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508540|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139508541|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
139103168|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
139508542|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508543|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508544|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139508545|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139508546|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508547|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508548|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139508549|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139508550|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508551|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
139508552|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508553|NCT04730193|Caffeine|caffeine|mesh-list
139508554|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139508555|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508556|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139508557|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508558|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508559|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139508560|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139508561|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
139508562|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508563|NCT02088957|Phenytoin|phenytoin|mesh-list
139508564|NCT02088957|Brivaracetam|brivaracetam|mesh-list
139508565|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139508566|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
139508567|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139508568|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139508569|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139508570|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508571|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139103275|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
139508572|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139508573|NCT02088177|Naltrexone|naltrexone|mesh-list
139508574|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139508575|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139508576|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508577|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
139508578|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508579|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
139508580|NCT02030535|Olodaterol|olodaterol|mesh-list
139508581|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139508582|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
139508583|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508584|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508585|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139508586|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
139508587|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
139508588|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139508589|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
139508590|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508591|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508592|NCT02029989|Chrysarobin|chrysarobin|mesh-list
139508593|NCT02029989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139508594|NCT02029989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139508595|NCT02029989|Analgesics|analgesics|mesh-ancestor
139508596|NCT02029989|Sensory System Agents|sensory system agents|mesh-ancestor
139508597|NCT02029989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508598|NCT02029989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508599|NCT02029989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139508600|NCT02029989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139508601|NCT02048241|Guanfacine|guanfacine|mesh-list
139508602|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139508603|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139508604|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139508605|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139508606|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
139508607|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139295311|NCT04387942|Aldesleukin|aldesleukin|mesh-list
139508608|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508609|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508611|NCT02087943|Apremilast|apremilast|mesh-list
139508612|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139508613|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139508614|NCT02087943|Analgesics|analgesics|mesh-ancestor
139508615|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
139508616|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508617|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508618|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139508619|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139508620|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139508621|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139508622|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508623|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508624|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139508625|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
139508626|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
139508627|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139508628|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508629|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139508630|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139508631|NCT02087943|Growth Substances|growth substances|mesh-ancestor
139508632|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
139508633|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508634|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139508635|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139508636|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508637|NCT04709211|Bupivacaine|bupivacaine|mesh-list
139508638|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
139508639|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
139508640|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139508641|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508642|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
139508643|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508644|NCT02443883|Ramucirumab|ramucirumab|mesh-list
139508645|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508646|NCT02087241|Carboplatin|carboplatin|mesh-list
139508647|NCT02087241|Pemetrexed|pemetrexed|mesh-list
139508648|NCT02087241|Adavosertib|adavosertib|mesh-list
139508649|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508650|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508651|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508652|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139508653|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139508654|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139508655|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139508656|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139508657|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139508658|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139508659|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
139508660|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508661|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508662|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508663|NCT02443337|Necitumumab|necitumumab|mesh-list
139508664|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139508665|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508666|NCT02443103|Guanabenz|guanabenz|mesh-list
139508667|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139508668|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139508669|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139508670|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139508671|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
139508672|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508673|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508674|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508675|NCT02022657|Tenofovir|tenofovir|mesh-list
139508676|NCT02022657|Emtricitabine|emtricitabine|mesh-list
139508677|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139508678|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
139508679|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139295382|NCT02061267|Niacin|niacin|mesh-list
139508680|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139508681|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139508682|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508683|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508684|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139508685|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139508686|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
139508687|NCT02021643|Ribavirin|ribavirin|mesh-list
139508688|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
139508689|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508690|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
139508691|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508692|NCT02415959|Pancrelipase|pancrelipase|mesh-list
139508693|NCT02415959|Pancreatin|pancreatin|mesh-list
139508694|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139508695|NCT02021331|Cimetidine|cimetidine|mesh-list
139508696|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139508697|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139508698|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139508699|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
139508700|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
139508701|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508702|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508703|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508704|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139508705|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139508706|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508707|NCT02441309|Ifosfamide|ifosfamide|mesh-list
139508708|NCT02441309|Mifamurtide|mifamurtide|mesh-list
139508709|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139508710|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
139508711|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508712|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508713|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139508714|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
139508715|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508716|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139508717|NCT01652729|Exenatide|exenatide|mesh-list
139508718|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139508719|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508720|NCT01652729|Incretins|incretins|mesh-ancestor
139508721|NCT01652729|Hormones|hormones|mesh-ancestor
139508722|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139508723|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139508724|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
139103656|NCT01121016|Montelukast|montelukast|mesh-list
139508725|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508726|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508727|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139508728|NCT02083965|Factor VIII|factor viii|mesh-list
139508729|NCT02083965|Coagulants|coagulants|mesh-ancestor
139508730|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
139508731|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139508732|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139508733|NCT02458469|Buspirone|buspirone|mesh-list
139508734|NCT02458469|Trazodone|trazodone|mesh-list
139508735|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139508736|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139508737|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139508738|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508739|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139508740|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139508741|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
139508742|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508743|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508744|NCT02458469|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139508745|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139508746|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139508747|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139508748|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
139508749|NCT01843348|Cyclosporine|cyclosporine|mesh-list
139508750|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
139508751|NCT01843348|Everolimus|everolimus|mesh-list
139508752|NCT01843348|Tacrolimus|tacrolimus|mesh-list
139508753|NCT01843348|Cyclosporins|cyclosporins|mesh-list
139508754|NCT01843348|Basiliximab|basiliximab|mesh-list
139295456|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139508755|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139508756|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
139508757|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508758|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139508759|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508760|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508761|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
139508762|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508763|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
139508764|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139508765|NCT01843348|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139508766|NCT01843348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139508767|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508768|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139508769|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139508770|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
139508771|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139508772|NCT01825876|Warfarin|warfarin|mesh-list
139508773|NCT01825876|Evacetrapib|evacetrapib|mesh-list
139508774|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
139508775|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139103760|NCT03932916|Donepezil|donepezil|mesh-list
139508776|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139508777|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
139508778|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508779|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139508780|NCT01825798|Metformin|metformin|mesh-list
139508781|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139508782|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508783|NCT02412761|Amlodipine|amlodipine|mesh-list
139508784|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139508785|NCT02412761|Lisinopril|lisinopril|mesh-list
139508786|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
139508787|NCT02412761|Diuretics|diuretics|mesh-list
139508788|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
139508789|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139508790|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139508791|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139508792|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508793|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139508794|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139508795|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103812|NCT01220154|Paclitaxel|paclitaxel|mesh-list
139508796|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
139508797|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
139508798|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
139508799|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139508800|NCT02412761|Protective Agents|protective agents|mesh-ancestor
139508801|NCT01842334|Nicotine|nicotine|mesh-list
139508802|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139508803|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
139508804|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508805|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508806|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139508807|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139508808|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
139508809|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508810|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508811|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
139508812|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139508813|NCT02457611|Ledipasvir|ledipasvir|mesh-list
139508814|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
139508815|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508816|NCT02083653|Capecitabine|capecitabine|mesh-list
139508817|NCT02083653|Fluorouracil|fluorouracil|mesh-list
139508818|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139508819|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139508820|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
139508821|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508822|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508823|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139508824|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
139508825|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508826|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
139508827|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
139508828|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139508829|NCT02436239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139295531|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
139508830|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139508831|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139508832|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508833|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508834|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
139508835|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508836|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139508837|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139508838|NCT02026011|Naltrexone|naltrexone|mesh-list
139508839|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139508840|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139508841|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508842|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
139508843|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508844|NCT02456909|Morphine|morphine|mesh-list
139508845|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139508846|NCT02456909|Narcotics|narcotics|mesh-ancestor
139508847|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139508848|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508849|NCT02456909|Analgesics|analgesics|mesh-ancestor
139508850|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
139508851|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508852|NCT02025621|Simendan|simendan|mesh-list
139508853|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139508854|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
139508855|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139508856|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139508857|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508858|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508859|NCT02025621|Protective Agents|protective agents|mesh-ancestor
139508860|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508861|NCT04729023|Temazepam|temazepam|mesh-list
139508862|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139508863|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139508864|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508865|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139508866|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139508867|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139508868|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
139508869|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
139508870|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139508871|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508872|NCT02020941|Dexamethasone|dexamethasone|mesh-list
139508873|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139508874|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
139508875|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
139508876|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508877|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508878|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139508879|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
139508880|NCT02020941|Hormones|hormones|mesh-ancestor
139104018|NCT01376440|Eusol|eusol|mesh-list
139508881|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139508882|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139508883|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508884|NCT01823224|Acetaminophen|acetaminophen|mesh-list
139508885|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139508886|NCT01823224|Analgesics|analgesics|mesh-ancestor
139508887|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
139508888|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508889|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508890|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
139508891|NCT01840228|Progesterone|progesterone|mesh-list
139508892|NCT01840228|Progestins|progestins|mesh-ancestor
139508893|NCT01840228|Hormones|hormones|mesh-ancestor
139508894|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139508895|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508896|NCT01823146|Oxytocin|oxytocin|mesh-list
139508897|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
139508898|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139508899|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508900|NCT02083185|Leuprolide|leuprolide|mesh-list
139508901|NCT02083185|Relugolix|relugolix|mesh-list
139508902|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139508903|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
139508904|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139295607|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
139508906|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139508907|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508908|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
139508909|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
139508910|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139508911|NCT02412371|Paclitaxel|paclitaxel|mesh-list
139508912|NCT02412371|Carboplatin|carboplatin|mesh-list
139508913|NCT02412371|Veliparib|veliparib|mesh-list
139508914|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139508915|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508916|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
139508917|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
139508918|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
139508919|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508920|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139508921|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508922|NCT01822756|Paclitaxel|paclitaxel|mesh-list
139508923|NCT01822756|Gemcitabine|gemcitabine|mesh-list
139508924|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139508925|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508926|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
139508927|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
139508928|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
139508929|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508930|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139508931|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
139508932|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139508933|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
139508934|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139508935|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139508936|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139508937|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508938|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
139508939|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
139508940|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139508941|NCT01611298|Vaccines|vaccines|mesh-list
139508942|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
139508943|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508944|NCT01822132|Naltrexone|naltrexone|mesh-list
139508945|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139508946|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139508947|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508948|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
139508949|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508950|NCT01821898|Budesonide|budesonide|mesh-list
139508951|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139104315|NCT01127880|Clindamycin|clindamycin|mesh-list
139508952|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139508953|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
139508954|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508955|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508956|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139508957|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
139508958|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
139508959|NCT01821898|Hormones|hormones|mesh-ancestor
139508960|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139508961|NCT02411591|Necitumumab|necitumumab|mesh-list
139508962|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139508963|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139508964|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139508965|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
139508966|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
139508967|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508968|NCT01838044|Celecoxib|celecoxib|mesh-list
139508969|NCT01838044|Pregabalin|pregabalin|mesh-list
139508970|NCT01838044|Analgesics|analgesics|mesh-ancestor
139508971|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
139508972|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139508973|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508974|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
139508975|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139508976|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139508977|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139508978|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139508979|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139508980|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139508981|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139508982|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139508983|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139508984|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139508985|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139508986|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139508987|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139508988|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139508989|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139508990|NCT02435147|Denosumab|denosumab|mesh-list
139508991|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139508992|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508993|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139508994|NCT02435069|Glycerol|glycerol|mesh-list
139508995|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139508996|NCT02435069|Protective Agents|protective agents|mesh-ancestor
139508997|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139508998|NCT04917731|Botulinum Toxins|botulinum toxins|mesh-list
139508999|NCT04917731|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139509000|NCT04917731|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139509001|NCT04917731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139509002|NCT04917731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139509003|NCT04917731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509004|NCT04917731|Cholinergic Agents|cholinergic agents|mesh-ancestor
139509005|NCT04917731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509006|NCT04917731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509007|NCT04917731|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139509008|NCT04917731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509009|NCT01820572|Cyclosporine|cyclosporine|mesh-list
139509010|NCT01820572|Abatacept|abatacept|mesh-list
139509011|NCT01820572|Tacrolimus|tacrolimus|mesh-list
139509012|NCT01820572|Cyclosporins|cyclosporins|mesh-list
139509013|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139509014|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
139509015|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509016|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139509017|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509018|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509019|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
139509020|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509021|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
139509022|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139509023|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139104534|NCT03923010|Itraconazole|itraconazole|mesh-list
139509024|NCT01820572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139509025|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509026|NCT01610596|Halobetasol|halobetasol|mesh-list
139509027|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139509028|NCT01818700|Buprenorphine|buprenorphine|mesh-list
139509029|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139509030|NCT01818700|Narcotics|narcotics|mesh-ancestor
139509031|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139509032|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509033|NCT01818700|Analgesics|analgesics|mesh-ancestor
139509034|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
139509035|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509036|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139509037|NCT01817764|Fluticasone|fluticasone|mesh-list
139509038|NCT01817764|Xhance|xhance|mesh-list
139509039|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139509040|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509041|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139509042|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
139509043|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509044|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509045|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139509046|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
139509047|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
139509048|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139509049|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139509050|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139509051|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139509052|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
139509053|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104593|NCT01131546|Amlodipine|amlodipine|mesh-list
139509054|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509056|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139509057|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
139509058|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
139509059|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139509060|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509061|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139509062|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139509063|NCT01817530|Norethindrone|norethindrone|mesh-list
139509064|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
139509065|NCT01817530|Estradiol|estradiol|mesh-list
139509066|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139509067|NCT01817530|Estrogens|estrogens|mesh-ancestor
139509068|NCT01817530|Hormones|hormones|mesh-ancestor
139509069|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139509070|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509071|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139509072|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
139509073|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139509074|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139509075|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139509076|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139509077|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139509078|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139509079|NCT01816984|Cetuximab|cetuximab|mesh-list
139509080|NCT01816984|Antibodies|antibodies|mesh-list
139509081|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
139509082|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139509083|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
139509084|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509085|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509086|NCT01816594|Paclitaxel|paclitaxel|mesh-list
139509087|NCT01816594|Trastuzumab|trastuzumab|mesh-list
139509088|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139509089|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509090|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
139509091|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
139509092|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
139509093|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509094|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139509095|NCT02453711|Liraglutide|liraglutide|mesh-list
139509096|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139509097|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509098|NCT02453711|Incretins|incretins|mesh-ancestor
139509099|NCT02453711|Hormones|hormones|mesh-ancestor
139509100|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139509101|NCT02453555|Empagliflozin|empagliflozin|mesh-list
139509102|NCT02453555|Linagliptin|linagliptin|mesh-list
139509103|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139509104|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509105|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139509106|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509107|NCT02453555|Incretins|incretins|mesh-ancestor
139509108|NCT02453555|Hormones|hormones|mesh-ancestor
139509109|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139509110|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139509111|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
139509112|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509113|NCT02453321|Bupivacaine|bupivacaine|mesh-list
139509114|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
139509115|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
139509116|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139509117|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509118|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
139509119|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509120|NCT01610284|Fulvestrant|fulvestrant|mesh-list
139509121|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139509122|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509123|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139509124|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139509125|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
139509126|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139104663|NCT03925818|Antacids|antacids|mesh-ancestor
139509127|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509128|NCT02452463|Durvalumab|durvalumab|mesh-list
139509129|NCT02452463|Nintedanib|nintedanib|mesh-list
139509130|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
139509131|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139509132|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
139509133|NCT02452463|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139509134|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139509135|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509136|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
139509137|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509138|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139509139|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509140|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509141|NCT03628391|Haloperidol|haloperidol|mesh-list
139509142|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
139509143|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
139509144|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
139509145|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509146|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509147|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139509148|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139509149|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139509150|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139509151|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139509152|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139509153|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
139509154|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509155|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509156|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139509157|NCT01610206|Gemcitabine|gemcitabine|mesh-list
139509158|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139509159|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
139509160|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509161|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509162|NCT01816048|Listerine|listerine|mesh-list
139509163|NCT01816048|Fluorides|fluorides|mesh-list
139509164|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
139509165|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
139509166|NCT01816048|Protective Agents|protective agents|mesh-ancestor
139509167|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509168|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139509169|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509170|NCT01612858|Metformin|metformin|mesh-list
139509171|NCT01612858|Pioglitazone|pioglitazone|mesh-list
139509172|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139509173|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509174|NCT01612702|Dexamethasone|dexamethasone|mesh-list
139509175|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509176|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
139509177|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
139104825|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
139509178|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509179|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509180|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139509181|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
139509182|NCT01612702|Hormones|hormones|mesh-ancestor
139509183|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139509184|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139509185|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509186|NCT02431559|Doxorubicin|doxorubicin|mesh-list
139509187|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139509188|NCT02431559|Durvalumab|durvalumab|mesh-list
139509189|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139509190|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509191|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139509192|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139509193|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509194|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509195|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139509196|NCT01652573|Calcitonin|calcitonin|mesh-list
139509197|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
139509198|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139509199|NCT01652573|Katacalcin|katacalcin|mesh-list
139509200|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139509201|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509202|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139509203|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
139509204|NCT02388191|Naproxen|naproxen|mesh-list
139509205|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139509206|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139509207|NCT02388191|Analgesics|analgesics|mesh-ancestor
139509208|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
139509209|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509210|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509211|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509212|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139509213|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
139509214|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139509215|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509216|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509217|NCT01815736|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139509218|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
139509219|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509220|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139509221|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139509222|NCT02387957|Bevacizumab|bevacizumab|mesh-list
139509223|NCT02387957|Ranibizumab|ranibizumab|mesh-list
139509224|NCT02387957|Aflibercept|aflibercept|mesh-list
139509225|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139509226|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509227|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139509228|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139509229|NCT02387957|Growth Substances|growth substances|mesh-ancestor
139509230|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509231|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
139509232|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139509233|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139509234|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139509235|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139509236|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509237|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509238|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
139509239|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509240|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139509241|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139509242|NCT01799590|Topiramate|topiramate|mesh-list
139509243|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
139509244|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139509245|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509246|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139509247|NCT04902131|Menotropins|menotropins|mesh-list
139509248|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139509249|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
139509250|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139509251|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509252|NCT01815424|Tofacitinib|tofacitinib|mesh-list
139509253|NCT01815424|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139105039|NCT05401032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139509254|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139509255|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509256|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509257|NCT02431247|Tenofovir|tenofovir|mesh-list
139509258|NCT02431247|Emtricitabine|emtricitabine|mesh-list
139509259|NCT02431247|Darunavir|darunavir|mesh-list
139509260|NCT02431247|Cobicistat|cobicistat|mesh-list
139509261|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139509262|NCT02431247|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139509263|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
139509264|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509265|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139509266|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139509267|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509268|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509269|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139105130|NCT03917628|Adalimumab|adalimumab|mesh-list
139509270|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139509271|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139509272|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139509273|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
139509274|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139295981|NCT02232672|Choline|choline|mesh-list
139509275|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139509276|NCT01814878|Acetaminophen|acetaminophen|mesh-list
139509277|NCT01814878|Tramadol|tramadol|mesh-list
139509278|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139509279|NCT01814878|Analgesics|analgesics|mesh-ancestor
139509280|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
139509281|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509282|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509283|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
139509284|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139509285|NCT01814878|Narcotics|narcotics|mesh-ancestor
139509286|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139509287|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
139509288|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
139509289|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509290|NCT02407223|Ustekinumab|ustekinumab|mesh-list
139509291|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
139509292|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
139509293|NCT04602754|Empagliflozin|empagliflozin|mesh-list
139509294|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139509295|NCT04602754|Calcium|calcium|mesh-list
139509296|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139509297|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509298|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139509299|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139509300|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139509301|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
139509302|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509303|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139509304|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139509305|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509306|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139509307|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139509308|NCT01813474|Olaparib|olaparib|mesh-list
139509309|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139509310|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509311|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509312|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509313|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
139509314|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139509315|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509316|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
139509317|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139509318|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139509319|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139509320|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139105214|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139509321|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509322|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
139509323|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509324|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509325|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139509326|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509327|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
139509328|NCT02383589|Rituximab|rituximab|mesh-list
139509329|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139509330|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509331|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
139509332|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509333|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139105275|NCT04751604|Niacin|niacin|mesh-list
139509334|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139509335|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139509336|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
139509337|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139509338|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509339|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509340|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509341|NCT01810432|Evacetrapib|evacetrapib|mesh-list
139509342|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139509343|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139509344|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
139509345|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509346|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139509347|NCT02404805|Dolutegravir|dolutegravir|mesh-list
139509348|NCT02404805|Simeprevir|simeprevir|mesh-list
139509349|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139509350|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139509351|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509352|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509353|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139509354|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139509355|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
139509356|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509357|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
139509358|NCT02430311|Paclitaxel|paclitaxel|mesh-list
139509359|NCT02430311|Olaparib|olaparib|mesh-list
139509360|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139509361|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509362|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
139509363|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
139509364|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
139509365|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509366|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139105367|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
139509367|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509368|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
139509369|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139509370|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139509371|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
139509372|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509373|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139509374|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139509375|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509376|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509377|NCT02404493|Decanoic acid|decanoic acid|mesh-list
139509378|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
139509379|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509380|NCT02379221|Lidocaine|lidocaine|mesh-list
139509381|NCT02379221|Epinephrine|epinephrine|mesh-list
139509382|NCT02379221|Benzocaine|benzocaine|mesh-list
139509383|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
139509384|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
139509385|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139509386|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509387|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
139509388|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509389|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139509390|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139509391|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139509392|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139509393|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509394|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139509395|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139509396|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
139509397|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509398|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139509399|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139509400|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
139509401|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139509402|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
139509403|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
139509404|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
139509405|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139509406|NCT02404103|Flunisolide|flunisolide|mesh-list
139509407|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509408|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139509409|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
139509410|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
139509411|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
139509412|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509413|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139509414|NCT02403635|Midazolam|midazolam|mesh-list
139509415|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139509416|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139509417|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139509418|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509419|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139509420|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139509421|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139509422|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139509423|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
139509424|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
139296132|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139509425|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
139509426|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
139509427|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509428|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509429|NCT02402933|Glucagon|glucagon|mesh-list
139509430|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139509431|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139509432|NCT02402933|Hormones|hormones|mesh-ancestor
139509433|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139509434|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509435|NCT02402933|Incretins|incretins|mesh-ancestor
139509436|NCT01796470|Idelalisib|idelalisib|mesh-list
139105523|NCT05849220|Dapagliflozin|dapagliflozin|mesh-list
139509437|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509438|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509439|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509440|NCT04414852|Apatinib|apatinib|mesh-list
139509441|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509442|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139509443|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509444|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509445|NCT01810042|Ranibizumab|ranibizumab|mesh-list
139509446|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139509447|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139509448|NCT01810042|Growth Substances|growth substances|mesh-ancestor
139509449|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509450|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
139509451|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509452|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
139509453|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
139509454|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509455|NCT01867294|Doxycycline|doxycycline|mesh-list
139509456|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
139509457|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139509458|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139509459|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139509460|NCT01867294|Spironolactone|spironolactone|mesh-list
139509461|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
139509462|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509463|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139509464|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509465|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
139509466|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139509467|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139509468|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139509469|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
139509470|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139509471|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509472|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139509473|NCT01867294|Diuretics|diuretics|mesh-ancestor
139105578|NCT05848336|Caseins|caseins|mesh-list
139509474|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
139509475|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139509476|NCT01867294|Protective Agents|protective agents|mesh-ancestor
139509477|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
139509478|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139509479|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139509480|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509481|NCT02423291|Immunotoxins|immunotoxins|mesh-ancestor
139509482|NCT02423291|Immunoconjugates|immunoconjugates|mesh-ancestor
139509483|NCT02423291|Immunologic Factors|immunologic factors|mesh-ancestor
139509484|NCT02423291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509485|NCT02401529|Acetaminophen|acetaminophen|mesh-list
139509486|NCT02401529|Dexamethasone|dexamethasone|mesh-list
139509487|NCT02401529|Prednisolone|prednisolone|mesh-list
139509488|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509489|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
139509490|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
139509491|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509492|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509493|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139509494|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
139509495|NCT02401529|Hormones|hormones|mesh-ancestor
139509496|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139509497|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139509498|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509499|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139509500|NCT02401529|Analgesics|analgesics|mesh-ancestor
139509501|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
139509503|NCT01866826|Rifaximin|rifaximin|mesh-list
139509504|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139509505|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509506|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139509507|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139509508|NCT01865812|Cathartics|cathartics|mesh-ancestor
139509509|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139509510|NCT01808092|Meropenem|meropenem|mesh-list
139509511|NCT01808092|Ceftazidime|ceftazidime|mesh-list
139509512|NCT01808092|Avibactam|avibactam|mesh-list
139509513|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
139509514|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139509515|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509516|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139509517|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509518|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509519|NCT01807234|Ketorolac|ketorolac|mesh-list
139509520|NCT01807234|Sumatriptan|sumatriptan|mesh-list
139509521|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139509522|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139509523|NCT01807234|Analgesics|analgesics|mesh-ancestor
139509524|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
139509525|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509526|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509527|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509528|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139509529|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139509530|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509531|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509532|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139509533|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139509534|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139509535|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
139509536|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509537|NCT02421887|Antioxidants|antioxidants|mesh-list
139509538|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509539|NCT02421887|Protective Agents|protective agents|mesh-ancestor
139509540|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509541|NCT01789606|Ibuprofen|ibuprofen|mesh-list
139509542|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139509543|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139509544|NCT01789606|Analgesics|analgesics|mesh-ancestor
139509545|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
139509546|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509547|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509548|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509549|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139509550|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139509551|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509552|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509553|NCT01788358|Candesartan|candesartan|mesh-list
139509554|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
139509555|NCT01788358|Nifedipine|nifedipine|mesh-list
139509556|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139509557|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139509558|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139509559|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509560|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139509561|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139509562|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139509563|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509564|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
139509565|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
139509566|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139509567|NCT01773070|Ritonavir|ritonavir|mesh-list
139509568|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139509569|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139509570|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
139509571|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509572|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509573|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139509574|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139509575|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
139509576|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509577|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139509578|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139509579|NCT01772368|Fluticasone|fluticasone|mesh-list
139509580|NCT01772368|Xhance|xhance|mesh-list
139509581|NCT01772368|Albuterol|albuterol|mesh-list
139509582|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139509583|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139509584|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
139509585|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509586|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139509587|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
139509588|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509589|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509590|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139509591|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
139509592|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
139509593|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139509594|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139509595|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139509596|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
139509597|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509598|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509599|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
139509600|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139509601|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
139509602|NCT01772368|Hormones|hormones|mesh-ancestor
139509603|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139509604|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
139509605|NCT01806298|Hormones|hormones|mesh-list
139509606|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139509607|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509608|NCT01772134|Fluticasone|fluticasone|mesh-list
139509609|NCT01772134|Xhance|xhance|mesh-list
139509610|NCT01772134|Bromides|bromides|mesh-list
139509611|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139509612|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509613|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139509614|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
139509615|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509616|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509617|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139509618|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
139509619|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
139509620|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139509621|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139509622|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139509623|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139509624|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
139509625|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509626|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509627|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
139509628|NCT02017899|Vaccines|vaccines|mesh-list
139509629|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
139509630|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509631|NCT01993329|Mitomycin|mitomycin|mesh-list
139509632|NCT01993329|Cisplatin|cisplatin|mesh-list
139509633|NCT01993329|Ifosfamide|ifosfamide|mesh-list
139509634|NCT01993329|Mesna|mesna|mesh-list
139509635|NCT01993329|Protective Agents|protective agents|mesh-ancestor
139509636|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509637|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
139106121|NCT05388773|Carboplatin|carboplatin|mesh-list
139509638|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509639|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139509640|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509641|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139509642|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509643|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139509644|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139509645|NCT02016183|Candesartan|candesartan|mesh-list
139509646|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
139509647|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139509648|NCT02016183|Diuretics|diuretics|mesh-ancestor
139509649|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
139509650|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509651|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139509652|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139509653|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509654|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139509655|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139509656|NCT02421419|Dexamethasone|dexamethasone|mesh-list
139509657|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
139509658|NCT02421419|Lidocaine|lidocaine|mesh-list
139509659|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139509660|NCT02421419|BB 1101|bb 1101|mesh-list
139509661|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509662|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
139509663|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
139509664|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509665|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509666|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139509667|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
139509668|NCT02421419|Hormones|hormones|mesh-ancestor
139509669|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139509670|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139509671|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509672|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
139509673|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
139509674|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139509675|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
139509676|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139509677|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139509678|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139509679|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139509680|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509681|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
139509682|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509683|NCT02016105|Adalimumab|adalimumab|mesh-list
139509684|NCT02016105|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139509685|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509686|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139509687|NCT02400749|Apremilast|apremilast|mesh-list
139509688|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139106341|NCT05074992|Ipilimumab|ipilimumab|mesh-list
139509689|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139509690|NCT02400749|Analgesics|analgesics|mesh-ancestor
139509691|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
139509692|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509693|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509694|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509695|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139509696|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139509697|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139509698|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106384|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139509699|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509700|NCT02420327|Galantamine|galantamine|mesh-list
139509701|NCT02420327|Nicotine|nicotine|mesh-list
139509702|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139509703|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
139509704|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509705|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509706|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139509707|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139509708|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
139509709|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509710|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509711|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139509712|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509713|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139509714|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
139509715|NCT02374853|Vancomycin|vancomycin|mesh-list
139509716|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139509717|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509718|NCT02015793|Adalimumab|adalimumab|mesh-list
139509719|NCT02015793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139509720|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509721|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139509722|NCT02347631|Dipivefrin|dipivefrin|mesh-list
139509723|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139509724|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
139509725|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509726|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509727|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509728|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
139509729|NCT02015637|Delafloxacin|delafloxacin|mesh-list
139509730|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139509731|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509732|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
139509733|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
139509734|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139509735|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
139509736|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509737|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509738|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139509739|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
139509740|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139509741|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139509742|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139509743|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
139509744|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509745|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509746|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139509747|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139509748|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139509749|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
139509750|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139509751|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139509752|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139509753|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139509754|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509755|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106531|NCT04786873|Clonidine|clonidine|mesh-list
139509756|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509757|NCT01621191|Analgesics|analgesics|mesh-ancestor
139509758|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
139509759|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509760|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
139509761|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139509762|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
139509763|NCT02343263|Bupivacaine|bupivacaine|mesh-list
139509764|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139509765|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
139509766|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
139509767|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139509768|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509769|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
139509770|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509771|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
139509772|NCT02343263|Coagulants|coagulants|mesh-ancestor
139509773|NCT02342639|Rifaximin|rifaximin|mesh-list
139509774|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139509775|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509776|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139509777|NCT01625091|Naltrexone|naltrexone|mesh-list
139509778|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139509779|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139509780|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509781|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
139509782|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509783|NCT02396537|Lidocaine|lidocaine|mesh-list
139509784|NCT02396537|Midazolam|midazolam|mesh-list
139509785|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
139509786|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
139509787|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139509788|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509789|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
139509790|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509791|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139509792|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139509793|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139509794|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139509795|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509796|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139509797|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139509798|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139509799|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139509800|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139509801|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139509802|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
139509803|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
139509804|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
139509805|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509806|NCT01624467|Necitumumab|necitumumab|mesh-list
139509807|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139509808|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509809|NCT01624233|Ixekizumab|ixekizumab|mesh-list
139509810|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
139509811|NCT01993017|Bupropion|bupropion|mesh-list
139509812|NCT01993017|Sertraline|sertraline|mesh-list
139509813|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
139509814|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139509815|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139509816|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139509817|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139509818|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139509819|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509820|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
139509821|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509822|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509823|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139509824|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139509825|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509826|NCT01993017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139509827|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
139509828|NCT01988493|Sorafenib|sorafenib|mesh-list
139509829|NCT01988493|Tepotinib|tepotinib|mesh-list
139509830|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509831|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139509832|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509833|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509834|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
139509835|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139509836|NCT02081079|Ledipasvir|ledipasvir|mesh-list
139509837|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
139509838|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509839|NCT02081001|Glucagon|glucagon|mesh-list
139509840|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139509841|NCT02081001|Hormones|hormones|mesh-ancestor
139509842|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139509843|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509844|NCT02080221|Leucovorin|leucovorin|mesh-list
139509845|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
139509846|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509847|NCT02080221|Antidotes|antidotes|mesh-ancestor
139509848|NCT02080221|Protective Agents|protective agents|mesh-ancestor
139509849|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509850|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
139509851|NCT02080221|Vitamins|vitamins|mesh-ancestor
139509852|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
139509853|NCT02014467|Vitamin D|vitamin d|mesh-list
139509854|NCT02014467|Denosumab|denosumab|mesh-list
139509855|NCT02014467|Calcium|calcium|mesh-list
139509856|NCT02014467|Vitamins|vitamins|mesh-ancestor
139509857|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
139509858|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509859|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139509860|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139509861|NCT02013765|Trastuzumab|trastuzumab|mesh-list
139509862|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139509863|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509864|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
139509865|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
139509866|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509867|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509868|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509869|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
139509870|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
139509871|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
139509872|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
139509873|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509874|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509875|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509876|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
139509877|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
139509878|NCT01988103|Thalidomide|thalidomide|mesh-list
139509879|NCT01988103|Apremilast|apremilast|mesh-list
139509880|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139509881|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139509882|NCT01988103|Analgesics|analgesics|mesh-ancestor
139509883|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
139509884|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509885|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509886|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509887|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139509888|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139509889|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139509890|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509891|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509892|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139509893|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
139509894|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
139509895|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139509896|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509897|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139509898|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139509899|NCT01988103|Growth Substances|growth substances|mesh-ancestor
139509900|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
139509901|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509902|NCT02013375|Sirolimus|sirolimus|mesh-list
139509903|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
139509904|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
139509905|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139509906|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
139509907|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509908|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139509909|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139509910|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
139509911|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509912|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509913|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139509914|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139509915|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139509916|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139509917|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
139509918|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139509919|NCT02079519|Bevacizumab|bevacizumab|mesh-list
139509920|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139509921|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509922|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139509923|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139509924|NCT02079519|Growth Substances|growth substances|mesh-ancestor
139509925|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509926|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
139509927|NCT02078817|Ketamine|ketamine|mesh-list
139509928|NCT02078817|Analgesics|analgesics|mesh-ancestor
139509929|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
139509930|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509931|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509932|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139509933|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139509934|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
139509935|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
139509936|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139509937|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139509938|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139509939|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139509940|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509941|NCT02011113|Dexamethasone|dexamethasone|mesh-list
139509942|NCT02011113|Pomalidomide|pomalidomide|mesh-list
139509943|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139509944|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
139509945|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
139509946|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139509947|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509948|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139509949|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
139509950|NCT02011113|Hormones|hormones|mesh-ancestor
139509951|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139509952|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139509953|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509954|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
139509955|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139509956|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139509957|NCT02011113|Growth Substances|growth substances|mesh-ancestor
139509958|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
139509959|NCT01807156|Tivozanib|tivozanib|mesh-list
139509960|NCT01807156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139509961|NCT01807156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509962|NCT01807156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509963|NCT01987479|Methotrexate|methotrexate|mesh-list
139509964|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139509965|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
139509966|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139509967|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509968|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139509969|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
139509970|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509971|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509972|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
139509973|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509974|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139509975|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139509976|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
139509977|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139509978|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139509979|NCT01620489|Liraglutide|liraglutide|mesh-list
139509980|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139509981|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139509982|NCT01620489|Incretins|incretins|mesh-ancestor
139509983|NCT01620489|Hormones|hormones|mesh-ancestor
139509984|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139509985|NCT02010567|Capecitabine|capecitabine|mesh-list
139509986|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139509987|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
139509988|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509989|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509990|NCT01806064|Axitinib|axitinib|mesh-list
139509991|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139509992|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139509993|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139509994|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139509995|NCT01787188|Meloxicam|meloxicam|mesh-list
139509996|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139509997|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139509998|NCT01787188|Analgesics|analgesics|mesh-ancestor
139509999|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
139510000|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510001|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510002|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139510003|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139510004|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139510005|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139510006|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510007|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510008|NCT01787032|Ketoconazole|ketoconazole|mesh-list
139510009|NCT01787032|Voriconazole|voriconazole|mesh-list
139510010|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
139510011|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139510012|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139510013|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139510014|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510015|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510016|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139510017|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
139510018|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139107061|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
139510019|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510020|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139510021|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139510022|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
139510023|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139510024|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139510025|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139510026|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139510027|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510028|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
139510029|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139510030|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510031|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139510032|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139510033|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510034|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139510035|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
139510036|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510037|NCT01768858|Adalimumab|adalimumab|mesh-list
139510038|NCT01768858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139510039|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139510040|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139510041|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
139510042|NCT01736254|Evacetrapib|evacetrapib|mesh-list
139510043|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139510044|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
139510045|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510046|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139510047|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139510048|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139510049|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510050|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139510051|NCT01785472|Olmesartan|olmesartan|mesh-list
139510052|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139510053|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139510054|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139510055|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139510056|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139510057|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510058|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
139510059|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139510060|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139510061|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
139510062|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139510063|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139510064|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139510065|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510066|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510067|NCT01736176|Levodopa|levodopa|mesh-list
139510068|NCT01736176|Carbidopa|carbidopa|mesh-list
139510069|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139510070|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139510071|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139510072|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
139510073|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139510074|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510075|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510076|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139510077|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510078|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139510079|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
139510080|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
139510081|NCT01735630|Inositol|inositol|mesh-list
139510082|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
139510083|NCT01735630|Vitamins|vitamins|mesh-ancestor
139510084|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
139510085|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510086|NCT04575922|Nivolumab|nivolumab|mesh-list
139510087|NCT04575922|Ipilimumab|ipilimumab|mesh-list
139510088|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510089|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510090|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139510091|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510092|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
139510093|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510094|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139510095|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510096|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510097|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
139510098|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510099|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510100|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139510101|NCT01734850|Busulfan|busulfan|mesh-list
139510102|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
139107426|NCT03057847|Velpatasvir|velpatasvir|mesh-list
139510103|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510104|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139510105|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
139510106|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510107|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139510108|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510109|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139510110|NCT01766050|Abatacept|abatacept|mesh-list
139510111|NCT01766050|Losartan|losartan|mesh-list
139510112|NCT01766050|Midazolam|midazolam|mesh-list
139510113|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
139510114|NCT01766050|Caffeine|caffeine|mesh-list
139510115|NCT01766050|Omeprazole|omeprazole|mesh-list
139510116|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139510117|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139510118|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139510119|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510120|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139510121|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139510122|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139510123|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139510124|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
139510125|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
139510126|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
139510127|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
139510128|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139107616|NCT02368652|Amlodipine|amlodipine|mesh-list
139510129|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510130|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139510131|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139510132|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139510133|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139510134|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139510135|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139510136|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107688|NCT02297139|Dasatinib|dasatinib|mesh-list
139510137|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139510138|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139510139|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
139510140|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139510141|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139510142|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139510143|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
139510144|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
139510145|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139510146|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139510147|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139510148|NCT01766050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510149|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510150|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139510151|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
139510152|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139510153|NCT02341625|Nivolumab|nivolumab|mesh-list
139510154|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510155|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510156|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139510157|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510158|NCT02370095|Treprostinil|treprostinil|mesh-list
139510159|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139510160|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139510161|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
139510162|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
139510163|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139510164|NCT01734772|Dabigatran|dabigatran|mesh-list
139510165|NCT01734772|Ticagrelor|ticagrelor|mesh-list
139510166|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139510167|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139510168|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139510169|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139510170|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
139510171|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139510172|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510173|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510174|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
139510175|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139510176|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
139510177|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510179|NCT02340221|Fulvestrant|fulvestrant|mesh-list
139510180|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139510181|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510182|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139510183|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139510184|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
139510185|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510186|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510187|NCT02395055|Adalimumab|adalimumab|mesh-list
139510188|NCT02395055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139510189|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139510190|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139510191|NCT02369159|Oseltamivir|oseltamivir|mesh-list
139510192|NCT02369159|Peramivir|peramivir|mesh-list
139510193|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
139510194|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139510195|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510196|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510197|NCT02394665|Temozolomide|temozolomide|mesh-list
139510198|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139510199|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
139510200|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510201|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510202|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
139510203|NCT02367833|NuvaRing|nuvaring|mesh-list
139510204|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
139510205|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139108008|NCT05794919|Phenol|phenol|mesh-list
139510206|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139510207|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510208|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139510209|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139510210|NCT02338193|Metformin|metformin|mesh-list
139510211|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
139510212|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139510213|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510214|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139510215|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510216|NCT01783444|Capecitabine|capecitabine|mesh-list
139510217|NCT01783444|Everolimus|everolimus|mesh-list
139510218|NCT01783444|Exemestane|exemestane|mesh-list
139510219|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139510220|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
139510221|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510222|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510223|NCT01783444|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139510224|NCT01783444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139510225|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510226|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139510227|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
139510228|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510229|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139510230|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139510231|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139510232|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
139510233|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510234|NCT02367131|Empagliflozin|empagliflozin|mesh-list
139510235|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139510236|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510237|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139510238|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510239|NCT01608724|Saxagliptin|saxagliptin|mesh-list
139510240|NCT01608724|Incretins|incretins|mesh-ancestor
139510241|NCT01608724|Hormones|hormones|mesh-ancestor
139510242|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510243|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510244|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139510245|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
139510246|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510247|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510248|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139510249|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139510250|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510251|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510252|NCT04905251|Misoprostol|misoprostol|mesh-list
139510253|NCT04905251|Mifepristone|mifepristone|mesh-list
139108169|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510254|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139510255|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
139510256|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139510257|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510258|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139510259|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139510260|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
139510261|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139510262|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139510263|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139510264|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139510265|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
139510266|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139510267|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139510268|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
139510269|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510270|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
139510271|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139510272|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139510273|NCT02364947|Nalmefene|nalmefene|mesh-list
139510274|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139510275|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510276|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
139510277|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510278|NCT02337491|Bevacizumab|bevacizumab|mesh-list
139510279|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
139510280|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510281|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510282|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139510283|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139510284|NCT02337491|Growth Substances|growth substances|mesh-ancestor
139510285|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510286|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
139510287|NCT02337491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139510288|NCT02337491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510289|NCT01765582|Leucovorin|leucovorin|mesh-list
139510290|NCT01765582|Folic Acid|folic acid|mesh-list
139510291|NCT01765582|Bevacizumab|bevacizumab|mesh-list
139510292|NCT01765582|Capecitabine|capecitabine|mesh-list
139510293|NCT01765582|Fluorouracil|fluorouracil|mesh-list
139510294|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
139510295|NCT01765582|Irinotecan|irinotecan|mesh-list
139510296|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
139510297|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510298|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510299|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139510300|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139510301|NCT01765582|Growth Substances|growth substances|mesh-ancestor
139510302|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510303|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
139510304|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139510305|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
139510306|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510307|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139510308|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
139510309|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139510310|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139510311|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510312|NCT01765582|Antidotes|antidotes|mesh-ancestor
139510313|NCT01765582|Protective Agents|protective agents|mesh-ancestor
139510314|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
139510315|NCT01765582|Vitamins|vitamins|mesh-ancestor
139510316|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
139510317|NCT01765582|Hematinics|hematinics|mesh-ancestor
139510318|NCT04413838|Nivolumab|nivolumab|mesh-list
139510319|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510320|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510321|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139108389|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139510322|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297028|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
139510323|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139510324|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
139510325|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510326|NCT01648283|Methadone|methadone|mesh-list
139510327|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139510328|NCT01648283|Narcotics|narcotics|mesh-ancestor
139510329|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139510330|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510331|NCT01648283|Analgesics|analgesics|mesh-ancestor
139510332|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
139510333|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510334|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
139108461|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
139510335|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
139510336|NCT01649297|Empagliflozin|empagliflozin|mesh-list
139510337|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139510338|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510339|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139510340|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510341|NCT01648205|Ranolazine|ranolazine|mesh-list
139510342|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139510343|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139510344|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510345|NCT02362451|Vaccines|vaccines|mesh-list
139510346|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
139510347|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510348|NCT01765270|Saxagliptin|saxagliptin|mesh-list
139510349|NCT01765270|Incretins|incretins|mesh-ancestor
139510350|NCT01765270|Hormones|hormones|mesh-ancestor
139510351|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510352|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510353|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139510354|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
139510355|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510356|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510357|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139510358|NCT01733758|Liraglutide|liraglutide|mesh-list
139510359|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
139510360|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139510361|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139510362|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510363|NCT01733758|Incretins|incretins|mesh-ancestor
139510364|NCT01733758|Hormones|hormones|mesh-ancestor
139510365|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510366|NCT01607554|Irinotecan|irinotecan|mesh-list
139510367|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139510368|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139510369|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510370|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510371|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510372|NCT01607476|Corticosterone|corticosterone|mesh-list
139510373|NCT01607476|Flutemetamol|flutemetamol|mesh-list
139510374|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139510375|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139510376|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510377|NCT01765192|Montelukast|montelukast|mesh-list
139510378|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139510379|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
139510380|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139510381|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
139510382|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510383|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108597|NCT05282940|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139510384|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139510385|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139510386|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510387|NCT01733680|Amiloride|amiloride|mesh-list
139510388|NCT01733680|Diuretics|diuretics|mesh-ancestor
139510389|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
139510390|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510391|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139510392|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139510393|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139510394|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297103|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
139510395|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139510396|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139510397|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139510398|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510399|NCT04892498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510400|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510401|NCT02336165|Bevacizumab|bevacizumab|mesh-list
139510402|NCT02336165|Durvalumab|durvalumab|mesh-list
139510403|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510404|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510405|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139510406|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139510407|NCT02336165|Growth Substances|growth substances|mesh-ancestor
139510408|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510409|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
139510410|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
139510411|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139510412|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
139510413|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510414|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139510415|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139510416|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
139510417|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510418|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510419|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139510420|NCT02319044|Durvalumab|durvalumab|mesh-list
139510421|NCT02319044|Tremelimumab|tremelimumab|mesh-list
139510422|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139510423|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510424|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510425|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
139510426|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510427|NCT01649765|Belimumab|belimumab|mesh-list
139510428|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139510429|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
139510430|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510431|NCT02317016|Osimertinib|osimertinib|mesh-list
139510432|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139510433|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139510434|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139510435|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
139510436|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510437|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139510438|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139510439|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510440|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510441|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139510443|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
139510444|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139510445|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510446|NCT02311478|Trace Elements|trace elements|mesh-ancestor
139510447|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
139510448|NCT02281760|Trametinib|trametinib|mesh-list
139510449|NCT02281760|Dabrafenib|dabrafenib|mesh-list
139510450|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139510451|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510452|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139510453|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510454|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510455|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139510456|NCT02281760|Protective Agents|protective agents|mesh-ancestor
139510457|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510458|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139510459|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
139510460|NCT02390531|Bevacizumab|bevacizumab|mesh-list
139510461|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510462|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510463|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139510464|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139510465|NCT02390531|Growth Substances|growth substances|mesh-ancestor
139510466|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297173|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139510467|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
139510468|NCT02390219|Ivacaftor|ivacaftor|mesh-list
139510469|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139510470|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139108649|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139510471|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510472|NCT02334215|Methadone|methadone|mesh-list
139510473|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139510474|NCT02334215|Narcotics|narcotics|mesh-ancestor
139510475|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139510476|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510477|NCT02334215|Analgesics|analgesics|mesh-ancestor
139510478|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
139510479|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510480|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
139510481|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
139510482|NCT02359877|Interferons|interferons|mesh-list
139510483|NCT02359877|Interferon-beta|interferon-beta|mesh-list
139510484|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
139510485|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510486|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
139510487|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139510488|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
139510489|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510490|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139510491|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
139510492|NCT02389829|Promethazine|promethazine|mesh-list
139510493|NCT02389829|Hydromorphone|hydromorphone|mesh-list
139510494|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
139510495|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139510496|NCT02389829|Narcotics|narcotics|mesh-ancestor
139510497|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139108687|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139510498|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510499|NCT02389829|Analgesics|analgesics|mesh-ancestor
139510500|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
139510501|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510502|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139510503|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139510504|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
139510505|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
139510506|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
139510507|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
139510508|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139510509|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139510510|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
139510511|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
139510512|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139510513|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510514|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139510515|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
139510516|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
139510517|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139510518|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139510519|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139510520|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139510521|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
139510522|NCT02358863|Leucovorin|leucovorin|mesh-list
139510523|NCT02358863|Cisplatin|cisplatin|mesh-list
139510524|NCT02358863|Docetaxel|docetaxel|mesh-list
139510525|NCT02358863|Capecitabine|capecitabine|mesh-list
139510526|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
139510527|NCT02358863|Irinotecan|irinotecan|mesh-list
139510528|NCT02358863|Epirubicin|epirubicin|mesh-list
139510529|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510530|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
139510531|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
139510532|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
139510533|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510534|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139510535|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
139510536|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139510537|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139510538|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510539|NCT02358863|Antidotes|antidotes|mesh-ancestor
139510540|NCT02358863|Protective Agents|protective agents|mesh-ancestor
139510541|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510542|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
139510543|NCT02358863|Vitamins|vitamins|mesh-ancestor
139510544|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
139510545|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139510546|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139510547|NCT02358473|Docetaxel|docetaxel|mesh-list
139510548|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
139510549|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510550|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
139510551|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
139510552|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
139510553|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510554|NCT02357459|Triamcinolone|triamcinolone|mesh-list
139510555|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139510556|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139510557|NCT02357459|FX006|fx006|mesh-list
139510558|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139510559|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139510560|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
139510561|NCT02357459|Hormones|hormones|mesh-ancestor
139510562|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510563|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510564|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139510565|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
139510566|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510567|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510568|NCT02332889|Decitabine|decitabine|mesh-list
139510569|NCT02332889|Poly ICLC|poly iclc|mesh-list
139510570|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139510571|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
139510572|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510573|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510574|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510575|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
139510576|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
139108969|NCT01142622|Ropivacaine|ropivacaine|mesh-list
139510577|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510578|NCT02357147|Pemetrexed|pemetrexed|mesh-list
139510579|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510580|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510581|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510582|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139510583|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139510584|NCT02332655|Cannabidiol|cannabidiol|mesh-list
139510585|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
139510586|NCT02388737|Lansoprazole|lansoprazole|mesh-list
139510587|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
139510588|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139510589|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139510590|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139510591|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510592|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510593|NCT02355665|Nicotine|nicotine|mesh-list
139510594|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139510595|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
139510596|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510597|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510598|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139510599|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139510600|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
139510601|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139510602|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510603|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
139510604|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139510605|NCT02010255|Ledipasvir|ledipasvir|mesh-list
139510606|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
139510607|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139510608|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
139510609|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139510610|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510611|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139510612|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139510613|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
139510614|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139510615|NCT01620177|Ethanol|ethanol|mesh-list
139510616|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139510617|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139510618|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139510619|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510620|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
139510621|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139510622|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510623|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139510624|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510625|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
139510626|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139510627|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139510628|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139510629|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139510630|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510631|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
139510632|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139510633|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510634|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139510635|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510636|NCT02009397|Ipilimumab|ipilimumab|mesh-list
139510637|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510638|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510639|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139510640|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510641|NCT02312219|Folic Acid|folic acid|mesh-list
139510642|NCT02312219|Methotrexate|methotrexate|mesh-list
139510643|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139510644|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
139510645|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139510646|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510647|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139510648|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
139510649|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510650|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510651|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
139510652|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510653|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139510654|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139510655|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
139510656|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139510657|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139510658|NCT02312219|Hematinics|hematinics|mesh-ancestor
139510659|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
139510660|NCT02312219|Vitamins|vitamins|mesh-ancestor
139510661|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
139510662|NCT01986231|Glucagon|glucagon|mesh-list
139510663|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139510664|NCT01986231|Hormones|hormones|mesh-ancestor
139510665|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510666|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510667|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139510668|NCT02312063|Glimepiride|glimepiride|mesh-list
139510669|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139510670|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510671|NCT02312063|Incretins|incretins|mesh-ancestor
139510672|NCT02312063|Hormones|hormones|mesh-ancestor
139510673|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510674|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139510675|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
139510676|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510677|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510678|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139510679|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139510680|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
139510681|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
139510682|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139510683|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139510684|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510685|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139510686|NCT02353169|Analgesics|analgesics|mesh-ancestor
139510687|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
139510688|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510689|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139510690|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139510691|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139510692|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
139510693|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139510694|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510695|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139109333|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
139510696|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139510697|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510698|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139510699|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139510700|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139510701|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510702|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
139510703|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139510704|NCT01983969|Pyridoxine|pyridoxine|mesh-list
139510705|NCT01983969|Dexamethasone|dexamethasone|mesh-list
139510706|NCT01983969|Rituximab|rituximab|mesh-list
139510707|NCT01983969|Gemcitabine|gemcitabine|mesh-list
139510708|NCT01983969|Azacitidine|azacitidine|mesh-list
139510709|NCT01983969|Melphalan|melphalan|mesh-list
139510710|NCT01983969|Busulfan|busulfan|mesh-list
139510711|NCT01983969|Vorinostat|vorinostat|mesh-list
139510712|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139510713|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
139510714|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
139510715|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510716|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510717|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139510718|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
139510719|NCT01983969|Hormones|hormones|mesh-ancestor
139510720|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510721|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139510722|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510723|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510724|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
139510725|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139510726|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139510727|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
139510728|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510729|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510730|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139510731|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
139510732|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139510733|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139510734|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139510735|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
139510736|NCT01983969|Vitamins|vitamins|mesh-ancestor
139510737|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
139510738|NCT02008773|Valacyclovir|valacyclovir|mesh-list
139510739|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
139510740|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139510741|NCT02257567|Rituximab|rituximab|mesh-list
139510742|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
139510743|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139510744|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139510745|NCT02257567|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139510746|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
139510747|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510748|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510749|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
139510750|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510751|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139510752|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139510753|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
139510754|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510755|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
139510756|NCT01642615|Lansoprazole|lansoprazole|mesh-list
139510757|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139510758|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139510759|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139510760|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510761|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510762|NCT02311361|Durvalumab|durvalumab|mesh-list
139510763|NCT02311361|Tremelimumab|tremelimumab|mesh-list
139510764|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510765|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510766|NCT02329223|Omalizumab|omalizumab|mesh-list
139510767|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139510768|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139510769|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
139510770|NCT05302297|Cemiplimab|cemiplimab|mesh-list
139510771|NCT05302297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510772|NCT05302297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510773|NCT02310581|Buprenorphine|buprenorphine|mesh-list
139297469|NCT03158389|Sirolimus|sirolimus|mesh-list
139510774|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139510775|NCT02310581|Narcotics|narcotics|mesh-ancestor
139510776|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139510777|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510778|NCT02310581|Analgesics|analgesics|mesh-ancestor
139510779|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
139510780|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510781|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139510782|NCT04892693|Talazoparib|talazoparib|mesh-list
139510783|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139510784|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510785|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510786|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510787|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
139510788|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139510789|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
139510790|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139510791|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
139510792|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510793|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510794|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
139510795|NCT02008227|Docetaxel|docetaxel|mesh-list
139510796|NCT02008227|Atezolizumab|atezolizumab|mesh-list
139510797|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510798|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
139510799|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
139510800|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
139510801|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510802|NCT02008227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139510803|NCT02008227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510804|NCT02348723|Warfarin|warfarin|mesh-list
139510805|NCT02348723|Dabigatran|dabigatran|mesh-list
139510806|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
139510807|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
139510808|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139510809|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
139510810|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510811|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510812|NCT02006667|Gemcitabine|gemcitabine|mesh-list
139510813|NCT02006667|Trastuzumab|trastuzumab|mesh-list
139510814|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510815|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139510816|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
139510817|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510818|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510819|NCT01983111|Acetaminophen|acetaminophen|mesh-list
139510820|NCT01983111|Buprenorphine|buprenorphine|mesh-list
139510821|NCT01983111|Tramadol|tramadol|mesh-list
139510822|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139510823|NCT01983111|Analgesics|analgesics|mesh-ancestor
139510824|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
139510825|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510826|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510827|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
139510828|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139510829|NCT01983111|Narcotics|narcotics|mesh-ancestor
139510830|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139510831|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139510832|NCT02348489|Guadecitabine|guadecitabine|mesh-list
139510833|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510834|NCT01966107|Bromides|bromides|mesh-list
139510835|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
139510836|NCT01982331|Vaccines|vaccines|mesh-list
139510837|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
139510838|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510839|NCT02326025|Doxorubicin|doxorubicin|mesh-list
139510840|NCT02326025|Olaratumab|olaratumab|mesh-list
139510841|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139510842|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510843|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139510844|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139510845|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510846|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510847|NCT01619865|Edotreotide|edotreotide|mesh-list
139510848|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139510849|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510850|NCT02006121|Apomorphine|apomorphine|mesh-list
139510851|NCT02006121|Emetics|emetics|mesh-ancestor
139510852|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510853|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
139510854|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510855|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139510856|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
139510857|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
139510858|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139510859|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510860|NCT02005887|Letrozole|letrozole|mesh-list
139510861|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139510862|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510863|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139510864|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139510865|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510866|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510867|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139510868|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
139510869|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510870|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510871|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
139510872|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139510873|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
139510874|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139510875|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139510876|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139510877|NCT01981473|Infliximab|infliximab|mesh-list
139510878|NCT01981473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139510879|NCT01981473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139510880|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
139510881|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139510882|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139510883|NCT02005029|Erythromycin|erythromycin|mesh-list
139510884|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
139510885|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139510886|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
139510887|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139510888|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139510889|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139510890|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139510891|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510892|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510893|NCT04416399|Budesonide|budesonide|mesh-list
139510894|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139510895|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139510896|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
139510897|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510898|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510899|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139510900|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
139510901|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
139510902|NCT04416399|Hormones|hormones|mesh-ancestor
139510903|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510904|NCT02282345|Talazoparib|talazoparib|mesh-list
139510905|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139510906|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510907|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510908|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510909|NCT01732822|Clopidogrel|clopidogrel|mesh-list
139510910|NCT01732822|Ticagrelor|ticagrelor|mesh-list
139109773|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
139510911|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139510912|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139510913|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139510914|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139510915|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
139510916|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139510917|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510918|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510919|NCT02004093|Paclitaxel|paclitaxel|mesh-list
139510920|NCT02004093|Carboplatin|carboplatin|mesh-list
139510921|NCT02004093|Gemcitabine|gemcitabine|mesh-list
139510922|NCT02004093|Pertuzumab|pertuzumab|mesh-list
139510923|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139510924|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510925|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
139510926|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
139510927|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
139510928|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510929|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139510931|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139510932|NCT01641367|Tenofovir|tenofovir|mesh-list
139510933|NCT01641367|Emtricitabine|emtricitabine|mesh-list
139510934|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
139570305|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510935|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139510936|NCT01641367|Darunavir|darunavir|mesh-list
139510937|NCT01641367|Etravirine|etravirine|mesh-list
139510938|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139510939|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
139510940|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
139510941|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139510942|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139510943|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139510944|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510945|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510946|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139510947|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139510948|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139510949|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139510950|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139510951|NCT02325713|Praziquantel|praziquantel|mesh-list
139510952|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
139510953|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139510954|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139510955|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
139510956|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139510957|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139510958|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510959|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139510960|NCT04877639|Analgesics|analgesics|mesh-ancestor
139510961|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
139510962|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139510963|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139510964|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139510965|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139510966|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
139510967|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139510968|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510969|NCT02325401|Metformin|metformin|mesh-list
139510970|NCT02325401|Cisplatin|cisplatin|mesh-list
139510971|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510972|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139510973|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510974|NCT02324699|Prednisone|prednisone|mesh-list
139510975|NCT02324699|Vedolizumab|vedolizumab|mesh-list
139510976|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139510977|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
139510978|NCT02324699|Hormones|hormones|mesh-ancestor
139510979|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139510980|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139510981|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139510982|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510983|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139510984|NCT01979523|Trametinib|trametinib|mesh-list
139510985|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510986|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139510987|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510988|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510989|NCT02255461|Palbociclib|palbociclib|mesh-list
139510990|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510991|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139510992|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139510993|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139510994|NCT01764022|Paclitaxel|paclitaxel|mesh-list
139510995|NCT01764022|Trastuzumab|trastuzumab|mesh-list
139510996|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139510997|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139510998|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
139510999|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
139297699|NCT01059071|Etoposide|etoposide|mesh-list
139511000|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
139570306|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139511001|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511002|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139511004|NCT02003391|Travoprost|travoprost|mesh-list
139511005|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139511006|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139511007|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139511008|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139511009|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
139511010|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139511011|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511012|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511013|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139511014|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139511015|NCT02254681|Gemcitabine|gemcitabine|mesh-list
139511016|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511017|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139511018|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
139511019|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511020|NCT01965327|Interferons|interferons|mesh-list
139511021|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
139511022|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511023|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
139511024|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139511025|NCT01639729|Sufentanil|sufentanil|mesh-list
139511026|NCT01639729|Dsuvia|dsuvia|mesh-list
139511027|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139511028|NCT01639729|Narcotics|narcotics|mesh-ancestor
139511029|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511030|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511031|NCT01639729|Analgesics|analgesics|mesh-ancestor
139511032|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
139511033|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511034|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139511035|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139511036|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
139511037|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
139511038|NCT02002221|Metformin|metformin|mesh-list
139511039|NCT02002221|Vildagliptin|vildagliptin|mesh-list
139511040|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139511041|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511042|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139511043|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
139511044|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511045|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511046|NCT05650723|Venetoclax|venetoclax|mesh-list
139511047|NCT05650723|Obinutuzumab|obinutuzumab|mesh-list
139511048|NCT05650723|Zanubrutinib|zanubrutinib|mesh-list
139511049|NCT05650723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511050|NCT05650723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139511051|NCT05650723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139511052|NCT05650723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511053|NCT05650723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511054|NCT05247697|Mirtazapine|mirtazapine|mesh-list
139511055|NCT05247697|Antidepressive Agents|antidepressive agents|mesh-ancestor
139511056|NCT05247697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139511057|NCT05247697|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139511058|NCT05247697|Histamine Antagonists|histamine antagonists|mesh-ancestor
139511059|NCT05247697|Histamine Agents|histamine agents|mesh-ancestor
139511060|NCT05247697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139511061|NCT05247697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511062|NCT05247697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511063|NCT05247697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139511064|NCT05247697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139511065|NCT05247697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511066|NCT05247697|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139511067|NCT05247697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139511068|NCT05247697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139511069|NCT05247697|Adrenergic Agents|adrenergic agents|mesh-ancestor
139511070|NCT05247697|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139511071|NCT05247697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139511072|NCT05247697|Serotonin Agents|serotonin agents|mesh-ancestor
139511073|NCT05247697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139511074|NCT02001987|Methotrexate|methotrexate|mesh-list
139511075|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139511076|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
139511077|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139511078|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511079|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139511080|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
139511081|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511082|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511083|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
139511084|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511085|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139511086|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139511087|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
139511088|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139511089|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139511091|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139511092|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
139511093|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511094|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511095|NCT01782742|Bexarotene|bexarotene|mesh-list
139511096|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511097|NCT01732588|Artefenomel|artefenomel|mesh-list
139511098|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
139511099|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139511100|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139511101|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139511102|NCT01639339|Belimumab|belimumab|mesh-list
139511103|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139511104|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
139511105|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511106|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139511107|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
139511108|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511109|NCT04419259|Erenumab|erenumab|mesh-list
139511110|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139511111|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511112|NCT04419259|Analgesics|analgesics|mesh-ancestor
139511113|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
139511114|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511115|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511116|NCT02000427|Blinatumomab|blinatumomab|mesh-list
139511117|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511118|NCT04845217|Peppermint oil|peppermint oil|mesh-list
139511119|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
139511120|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
139511121|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511122|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511123|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139110041|NCT01257360|Panitumumab|panitumumab|mesh-list
139511124|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
139511125|NCT05359393|Tislelizumab|tislelizumab|mesh-list
139511126|NCT05359393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139511127|NCT05359393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511128|NCT01600885|Guanfacine|guanfacine|mesh-list
139511129|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139511130|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139511131|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139511132|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139511133|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
139511134|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139511135|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511136|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511137|NCT04625257|Antibodies|antibodies|mesh-list
139511138|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
139511139|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511140|NCT05369377|Zanubrutinib|zanubrutinib|mesh-list
139511141|NCT05369377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511142|NCT05369377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139511143|NCT05369377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511144|NCT05369377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511145|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
139511146|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139511147|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139511148|NCT04832269|Prednisolone|prednisolone|mesh-list
139511149|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
139511150|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139511151|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
139511152|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139511153|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
139511154|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
139511155|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511156|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511157|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139511158|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
139511159|NCT04832269|Hormones|hormones|mesh-ancestor
139570307|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
139511160|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139511161|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139511162|NCT04832269|Protective Agents|protective agents|mesh-ancestor
139511163|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139511164|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511165|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
139511166|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139511167|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511168|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511169|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139511170|NCT04608331|Analgesics|analgesics|mesh-ancestor
139511171|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
139511172|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511173|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139511174|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139511175|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139511176|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
139511177|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139511178|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511179|NCT01637077|Pregabalin|pregabalin|mesh-list
139511180|NCT01637077|Analgesics|analgesics|mesh-ancestor
139511181|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
139511182|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511183|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511184|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
139511185|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139511186|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139511187|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511188|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139511189|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139511190|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139511191|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511192|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139511193|NCT02308163|Etanercept|etanercept|mesh-list
139511194|NCT02308163|Peficitinib|peficitinib|mesh-list
139511195|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139110116|NCT05941637|Axitinib|axitinib|mesh-list
139511196|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139511197|NCT02308163|Analgesics|analgesics|mesh-ancestor
139511198|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
139511199|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511200|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511201|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139511202|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139511203|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139511204|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139511205|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
139511206|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511207|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511208|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
139511209|NCT04001647|Nitroprusside|nitroprusside|mesh-list
139511210|NCT04001647|Acetylcholine|acetylcholine|mesh-list
139511211|NCT04001647|Vitamins|vitamins|mesh-ancestor
139511212|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
139511213|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511214|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
139511215|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511216|NCT04001647|Protective Agents|protective agents|mesh-ancestor
139511217|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139511218|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
139511219|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139511220|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139511221|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
139511222|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139511223|NCT01999335|Dexamethasone|dexamethasone|mesh-list
139511225|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139511226|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
139511227|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
139511228|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511229|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511230|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139511231|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
139511232|NCT01999335|Hormones|hormones|mesh-ancestor
139511233|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139511234|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139511235|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511236|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
139511237|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139511238|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139511239|NCT01999335|Growth Substances|growth substances|mesh-ancestor
139511240|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
139511241|NCT01999179|Heparin|heparin|mesh-list
139511242|NCT01999179|Enoxaparin|enoxaparin|mesh-list
139511243|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139511244|NCT01999179|Tinzaparin|tinzaparin|mesh-list
139511245|NCT01999179|Dalteparin|dalteparin|mesh-list
139511246|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
139511247|NCT01999179|Dabigatran|dabigatran|mesh-list
139511248|NCT01999179|Apixaban|apixaban|mesh-list
139511249|NCT01999179|Anticoagulants|anticoagulants|mesh-list
139511250|NCT01999179|Edoxaban|edoxaban|mesh-list
139511251|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139511252|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139511253|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511254|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139511255|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
139511256|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139511257|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
139511258|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511259|NCT01977729|Sertraline|sertraline|mesh-list
139511260|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
139511261|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139511262|NCT01977729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139511263|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139511264|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139511265|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511266|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139511267|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
139511268|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511269|NCT01998399|Ticagrelor|ticagrelor|mesh-list
139511270|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139511271|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139511272|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139511273|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139511274|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
139511275|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139511276|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511277|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511278|NCT01731886|Dexamethasone|dexamethasone|mesh-list
139511279|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
139511280|NCT01731886|Melphalan|melphalan|mesh-list
139511281|NCT01731886|Lenalidomide|lenalidomide|mesh-list
139511282|NCT01731886|Lenograstim|lenograstim|mesh-list
139511283|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139511284|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
139511285|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511286|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139511287|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139511288|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
139511289|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511290|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511291|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139511292|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139511293|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
139511294|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
139511295|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511296|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139511297|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
139511298|NCT01731886|Hormones|hormones|mesh-ancestor
139511299|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139511300|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139511301|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139511302|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139511303|NCT01731886|Growth Substances|growth substances|mesh-ancestor
139511304|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
139511305|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139511306|NCT01759420|Ondansetron|ondansetron|mesh-list
139511307|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
139511308|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
139511309|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511310|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511311|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139511312|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
139511313|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
139511314|NCT01759420|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139511315|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139511316|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
139511317|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139511318|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511319|NCT01781026|Vemurafenib|vemurafenib|mesh-list
139511320|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511321|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139511322|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511323|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511325|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139511326|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511327|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139511328|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139511329|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511330|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139511331|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
139511332|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511333|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
139511334|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139511335|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
139511336|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511337|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139511338|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139511339|NCT01975701|Infigratinib|infigratinib|mesh-list
139511340|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511341|NCT01962987|Diclofenac|diclofenac|mesh-list
139511342|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139511343|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139511344|NCT01962987|Analgesics|analgesics|mesh-ancestor
139511345|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
139511346|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511347|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511348|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139511349|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139511350|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139511351|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511352|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511353|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
139511354|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
139511355|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139511356|NCT01638013|Peficitinib|peficitinib|mesh-list
139511357|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511358|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511359|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139511360|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
139511361|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511362|NCT01637623|Allopurinol|allopurinol|mesh-list
139511363|NCT01637623|Losartan|losartan|mesh-list
139511364|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139511365|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139511366|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139511367|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139110371|NCT05484154|Protein C|protein c|mesh-list
139511368|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511369|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
139511370|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511371|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
139511372|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139511373|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139511374|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
139511375|NCT01637623|Protective Agents|protective agents|mesh-ancestor
139511376|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511377|NCT01995825|Lamotrigine|lamotrigine|mesh-list
139511378|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
139511379|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139511380|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139511381|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511382|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139511383|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511384|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139511385|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139511386|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511387|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139511388|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139511389|NCT04267081|Venetoclax|venetoclax|mesh-list
139511390|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511391|NCT04792567|Siponimod|siponimod|mesh-list
139511392|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139511393|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511394|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139511395|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
139511396|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511397|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
139511398|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139511399|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
139511400|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139511401|NCT04419025|Expectorants|expectorants|mesh-ancestor
139511402|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
139511403|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139511404|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
139511405|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511406|NCT04419025|Protective Agents|protective agents|mesh-ancestor
139511407|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511408|NCT04419025|Antidotes|antidotes|mesh-ancestor
139511409|NCT05259787|Propofol|propofol|mesh-list
139511410|NCT05259787|Etomidate|etomidate|mesh-list
139511411|NCT05259787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139511412|NCT05259787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511413|NCT05259787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511414|NCT05259787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139511415|NCT05259787|Anesthetics, General|anesthetics, general|mesh-ancestor
139511416|NCT05259787|Anesthetics|anesthetics|mesh-ancestor
139511417|NCT05226325|Dexmedetomidine|dexmedetomidine|mesh-list
139511418|NCT05226325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139110436|NCT05119920|Miotics|miotics|mesh-ancestor
139511419|NCT05226325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511420|NCT05226325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511421|NCT05226325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139511422|NCT05226325|Analgesics|analgesics|mesh-ancestor
139511423|NCT05226325|Sensory System Agents|sensory system agents|mesh-ancestor
139511424|NCT05226325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511425|NCT05226325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139511426|NCT05226325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139511427|NCT05226325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139511428|NCT05226325|Adrenergic Agents|adrenergic agents|mesh-ancestor
139511429|NCT05226325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139511430|NCT05226325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511431|NCT05221021|Mirabegron|mirabegron|mesh-list
139511432|NCT05221021|Estradiol|estradiol|mesh-list
139511433|NCT05221021|Estrogens|estrogens|mesh-list
139511434|NCT05221021|Hormones|hormones|mesh-ancestor
139511435|NCT05221021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139511436|NCT05221021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511437|NCT05221021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139511438|NCT05221021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139511439|NCT05221021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139511440|NCT05221021|Adrenergic Agents|adrenergic agents|mesh-ancestor
139511441|NCT05221021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139511442|NCT05221021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511443|NCT05221021|Urological Agents|urological agents|mesh-ancestor
139511444|NCT03164473|Rituximab|rituximab|mesh-list
139298146|NCT06150560|Losartan|losartan|mesh-list
139511445|NCT03164473|Azathioprine|azathioprine|mesh-list
139511446|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139511447|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511448|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
139511449|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511450|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139511451|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
139511452|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511453|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139511454|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139511455|NCT05218915|Dulaglutide|dulaglutide|mesh-list
139511456|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139511457|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511458|NCT01995201|Methotrexate|methotrexate|mesh-list
139511459|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139511460|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
139511461|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139511462|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511463|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139511464|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
139511465|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511466|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511467|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
139511468|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511469|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139511470|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139511471|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
139511472|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139511473|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139511474|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139511475|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
139110490|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
139511476|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511477|NCT05165641|Anesthetics|anesthetics|mesh-list
139511478|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511479|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511480|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139511481|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139511482|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511483|NCT05814432|Amphotericin B|amphotericin b|mesh-list
139511484|NCT05814432|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139511485|NCT05814432|Amebicides|amebicides|mesh-ancestor
139511486|NCT05814432|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139511487|NCT05814432|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139511488|NCT05814432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139511489|NCT05814432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139511490|NCT05814432|Antifungal Agents|antifungal agents|mesh-ancestor
139511491|NCT05814302|Acetaminophen|acetaminophen|mesh-list
139511492|NCT05814302|Ibuprofen|ibuprofen|mesh-list
139511493|NCT05814302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139511494|NCT05814302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139511495|NCT05814302|Analgesics|analgesics|mesh-ancestor
139511496|NCT05814302|Sensory System Agents|sensory system agents|mesh-ancestor
139511497|NCT05814302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511498|NCT05814302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511499|NCT05814302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139511500|NCT05814302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139511501|NCT05814302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139511502|NCT05814302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511503|NCT05814302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511504|NCT05814302|Antipyretics|antipyretics|mesh-ancestor
139511505|NCT05814068|Antihypertensive Agents|antihypertensive agents|mesh-list
139511506|NCT05813951|Linezolid|linezolid|mesh-list
139511507|NCT05813951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139511508|NCT05813951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139511509|NCT05813951|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139511510|NCT05813951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511511|NCT05813951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511512|NCT05813821|Anti-Infective Agents|anti-infective agents|mesh-list
139511513|NCT05813821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139511514|NCT05813691|Antibodies|antibodies|mesh-list
139511515|NCT05813691|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
139511516|NCT05813691|Immunologic Factors|immunologic factors|mesh-ancestor
139511517|NCT05813691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511518|NCT05813665|Denosumab|denosumab|mesh-list
139110601|NCT03997266|Ampicillin|ampicillin|mesh-list
139511519|NCT05813665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139511520|NCT05813665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511521|NCT05813600|Ritonavir|ritonavir|mesh-list
139298219|NCT06149767|Tubulin Modulators|tubulin modulators|mesh-ancestor
139511522|NCT05813600|Nirmatrelvir|nirmatrelvir|mesh-list
139511523|NCT05813600|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139511524|NCT05813600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139511525|NCT05813600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139511526|NCT05813600|Protease Inhibitors|protease inhibitors|mesh-ancestor
139511527|NCT05813600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511528|NCT05813600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511529|NCT05813600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139511530|NCT05813600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139511531|NCT05813600|Antiviral Agents|antiviral agents|mesh-ancestor
139511532|NCT05813600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139511533|NCT05813600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139511534|NCT05813600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139511535|NCT05813561|Fexuprazan|fexuprazan|mesh-list
139511536|NCT05813561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139511537|NCT05813522|Aflutinib|aflutinib|mesh-list
139511538|NCT05813522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139511539|NCT05813522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511540|NCT05813522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511541|NCT05813496|Thioctic Acid|thioctic acid|mesh-list
139511542|NCT05813496|Antioxidants|antioxidants|mesh-ancestor
139511543|NCT05813496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511544|NCT05813496|Protective Agents|protective agents|mesh-ancestor
139511545|NCT05813496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511546|NCT05813496|Vitamin B Complex|vitamin b complex|mesh-ancestor
139511547|NCT05813496|Vitamins|vitamins|mesh-ancestor
139511548|NCT05813496|Micronutrients|micronutrients|mesh-ancestor
139511549|NCT05813470|Omalizumab|omalizumab|mesh-list
139511550|NCT05813470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139511551|NCT05813470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139511552|NCT05813470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139511553|NCT05813470|Respiratory System Agents|respiratory system agents|mesh-ancestor
139511554|NCT05813470|Immunologic Factors|immunologic factors|mesh-ancestor
139511555|NCT05813470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511556|NCT05813405|Antihypertensive Agents|antihypertensive agents|mesh-list
139511557|NCT05813366|Vitamin B 6|vitamin b 6|mesh-list
139511558|NCT05813366|Pyridoxal|pyridoxal|mesh-list
139511559|NCT05813366|Pyridoxine|pyridoxine|mesh-list
139511560|NCT05813366|Tryptophan|tryptophan|mesh-list
139511561|NCT05813366|Vitamins|vitamins|mesh-ancestor
139511562|NCT05813366|Micronutrients|micronutrients|mesh-ancestor
139511563|NCT05813366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511564|NCT05813366|Vitamin B Complex|vitamin b complex|mesh-ancestor
139511565|NCT05813366|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139511566|NCT05813366|Antidepressive Agents|antidepressive agents|mesh-ancestor
139511567|NCT05813366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139511568|NCT05813249|Tocopherols|tocopherols|mesh-list
139511569|NCT05813249|Vitamin E|vitamin e|mesh-list
139511570|NCT05813249|Tocotrienols|tocotrienols|mesh-list
139511571|NCT05813249|alpha-Tocopherol|alpha-tocopherol|mesh-list
139511572|NCT05813249|Antioxidants|antioxidants|mesh-ancestor
139511573|NCT05813249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511574|NCT05813249|Protective Agents|protective agents|mesh-ancestor
139511575|NCT05813249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511576|NCT05813249|Vitamins|vitamins|mesh-ancestor
139511577|NCT05813249|Micronutrients|micronutrients|mesh-ancestor
139511578|NCT05813184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139511579|NCT05813184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139511580|NCT05813145|Fenofibrate|fenofibrate|mesh-list
139511581|NCT05813145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139511582|NCT05813145|Antimetabolites|antimetabolites|mesh-ancestor
139511583|NCT05813145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511584|NCT05813145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139511585|NCT05813106|Dexmedetomidine|dexmedetomidine|mesh-list
139511586|NCT05813106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139511587|NCT05813106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511588|NCT05813106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511589|NCT05813106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139511590|NCT05813106|Analgesics|analgesics|mesh-ancestor
139511591|NCT05813106|Sensory System Agents|sensory system agents|mesh-ancestor
139511592|NCT05813106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511593|NCT05813106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139511594|NCT05813106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139511595|NCT05813106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139511596|NCT05813106|Adrenergic Agents|adrenergic agents|mesh-ancestor
139511597|NCT05813106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139298293|NCT06136351|Rituximab|rituximab|mesh-list
139511598|NCT05813106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511599|NCT05813015|Docetaxel|docetaxel|mesh-list
139511600|NCT05813015|Tegafur|tegafur|mesh-list
139511601|NCT05813015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511602|NCT05813015|Tubulin Modulators|tubulin modulators|mesh-ancestor
139511603|NCT05813015|Antimitotic Agents|antimitotic agents|mesh-ancestor
139511604|NCT05813015|Mitosis Modulators|mitosis modulators|mesh-ancestor
139511605|NCT05813015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511606|NCT05813015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139511607|NCT05813015|Antimetabolites|antimetabolites|mesh-ancestor
139511608|NCT05808582|Fulvestrant|fulvestrant|mesh-list
139511609|NCT05808582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139511610|NCT05808582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511611|NCT05808582|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139511612|NCT05808582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139511613|NCT05808582|Hormone Antagonists|hormone antagonists|mesh-ancestor
139511614|NCT05808582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139511615|NCT05808582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511616|NCT05796804|Anesthetics|anesthetics|mesh-list
139511617|NCT05796804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511618|NCT05796804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511619|NCT05788874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139511620|NCT05788874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139511621|NCT05788874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511622|NCT05788289|Lenalidomide|lenalidomide|mesh-list
139511623|NCT05788289|Immunologic Factors|immunologic factors|mesh-ancestor
139511624|NCT05788289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511625|NCT05788289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139511626|NCT05788289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139511627|NCT05788289|Growth Substances|growth substances|mesh-ancestor
139511628|NCT05788289|Growth Inhibitors|growth inhibitors|mesh-ancestor
139511629|NCT05788289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511630|NCT05775887|Vaccines|vaccines|mesh-list
139511631|NCT05775887|Immunologic Factors|immunologic factors|mesh-ancestor
139511632|NCT05775887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511633|NCT05757388|Acetaminophen|acetaminophen|mesh-list
139511634|NCT05757388|Parecoxib|parecoxib|mesh-list
139511635|NCT05757388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139511636|NCT05757388|Analgesics|analgesics|mesh-ancestor
139511637|NCT05757388|Sensory System Agents|sensory system agents|mesh-ancestor
139511638|NCT05757388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511639|NCT05757388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511640|NCT05757388|Antipyretics|antipyretics|mesh-ancestor
139511641|NCT05757388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139511642|NCT05757388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139511643|NCT05757388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511644|NCT05757388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511645|NCT05757388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139511646|NCT05757388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139511647|NCT05757388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139511648|NCT05755334|Ropivacaine|ropivacaine|mesh-list
139511649|NCT05755334|Anesthetics, Local|anesthetics, local|mesh-ancestor
139511650|NCT05755334|Anesthetics|anesthetics|mesh-ancestor
139511651|NCT05755334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511652|NCT05755334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511653|NCT05755334|Sensory System Agents|sensory system agents|mesh-ancestor
139511654|NCT05755334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511655|NCT05688735|Isosorbide|isosorbide|mesh-list
139511656|NCT05688735|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139511657|NCT05688735|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139511658|NCT05688735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139511659|NCT05688735|Diuretics|diuretics|mesh-ancestor
139511660|NCT05688735|Natriuretic Agents|natriuretic agents|mesh-ancestor
139511661|NCT05688735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511662|NCT05688735|Vasodilator Agents|vasodilator agents|mesh-ancestor
139511663|NCT05688735|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139511664|NCT05688735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511665|NCT05627596|Nicotine|nicotine|mesh-list
139511666|NCT05627596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139511667|NCT05627596|Autonomic Agents|autonomic agents|mesh-ancestor
139511668|NCT05627596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110974|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
139511669|NCT05627596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511670|NCT05627596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139511671|NCT05627596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139511672|NCT05627596|Cholinergic Agents|cholinergic agents|mesh-ancestor
139511673|NCT05627596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138881883|NCT02753855|Telavancin|telavancin|mesh-list
139511674|NCT05627596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511675|NCT05582798|Protease Inhibitors|protease inhibitors|mesh-list
139511676|NCT05582798|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139511677|NCT05582798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511678|NCT05582798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511679|NCT05582798|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139511680|NCT05582798|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139511682|NCT05552196|Ponesimod|ponesimod|mesh-list
139511683|NCT05552196|Anticonvulsants|anticonvulsants|mesh-ancestor
139511684|NCT05552196|Antimanic Agents|antimanic agents|mesh-ancestor
139511685|NCT05552196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139511686|NCT05552196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511687|NCT05552196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511688|NCT05552196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139511689|NCT05552196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139511690|NCT05552196|Analgesics|analgesics|mesh-ancestor
139511691|NCT05552196|Sensory System Agents|sensory system agents|mesh-ancestor
139511692|NCT05552196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511693|NCT05552196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139511694|NCT05552196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139511695|NCT05552196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111040|NCT01257828|Riluzole|riluzole|mesh-list
139511696|NCT05552196|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139511697|NCT05552196|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139511698|NCT05552196|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139511699|NCT05552196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139511700|NCT05552196|Immunologic Factors|immunologic factors|mesh-ancestor
139511701|NCT05538247|Indomethacin|indomethacin|mesh-list
139511702|NCT05538247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139511703|NCT05538247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139511704|NCT05538247|Analgesics|analgesics|mesh-ancestor
139511705|NCT05538247|Sensory System Agents|sensory system agents|mesh-ancestor
139511706|NCT05538247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511707|NCT05538247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511708|NCT05538247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139511709|NCT05538247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139511710|NCT05538247|Gout Suppressants|gout suppressants|mesh-ancestor
139511711|NCT05538247|Tocolytic Agents|tocolytic agents|mesh-ancestor
139511712|NCT05538247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139511713|NCT05538247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139511714|NCT05538247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511715|NCT05538247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511716|NCT05496192|Nivolumab|nivolumab|mesh-list
139511717|NCT05496192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139511718|NCT05496192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511719|NCT05496192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139511720|NCT05496192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511721|NCT05472623|Nivolumab|nivolumab|mesh-list
139511722|NCT05472623|Adagrasib|adagrasib|mesh-list
139511723|NCT05472623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139511724|NCT05472623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511725|NCT05472623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139511726|NCT05472623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511727|NCT05438394|Melphalan|melphalan|mesh-list
139511728|NCT05438394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139511729|NCT05438394|Alkylating Agents|alkylating agents|mesh-ancestor
139511730|NCT05438394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511731|NCT05438394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511732|NCT05438394|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139511733|NCT05438394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139511734|NCT05438394|Immunologic Factors|immunologic factors|mesh-ancestor
139511735|NCT05438394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511736|NCT05386030|Lidocaine|lidocaine|mesh-list
139511737|NCT05386030|Anesthetics, Local|anesthetics, local|mesh-ancestor
139511738|NCT05386030|Anesthetics|anesthetics|mesh-ancestor
139511739|NCT05386030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511740|NCT05386030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511741|NCT05386030|Sensory System Agents|sensory system agents|mesh-ancestor
139511742|NCT05386030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511743|NCT05386030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139511744|NCT05386030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139511745|NCT05386030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139511746|NCT05386030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139511747|NCT05386030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511748|NCT05287191|Magnesium Sulfate|magnesium sulfate|mesh-list
139511749|NCT05287191|Digoxin|digoxin|mesh-list
139511750|NCT05287191|Amiodarone|amiodarone|mesh-list
139511751|NCT05287191|Analgesics|analgesics|mesh-ancestor
139111208|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139511752|NCT05287191|Sensory System Agents|sensory system agents|mesh-ancestor
139511753|NCT05287191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511754|NCT05287191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511755|NCT05287191|Anesthetics|anesthetics|mesh-ancestor
139511756|NCT05287191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511757|NCT05287191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139511758|NCT05287191|Anticonvulsants|anticonvulsants|mesh-ancestor
139511759|NCT05287191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139511760|NCT05287191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139511761|NCT05287191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511762|NCT05287191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139511763|NCT05287191|Tocolytic Agents|tocolytic agents|mesh-ancestor
139511764|NCT05287191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139511765|NCT05287191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139511766|NCT05287191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511767|NCT05287191|Protective Agents|protective agents|mesh-ancestor
139511768|NCT05287191|Vasodilator Agents|vasodilator agents|mesh-ancestor
139511769|NCT05287191|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139511770|NCT05287191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139511771|NCT05287191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139511772|NCT05287191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139511773|NCT05287191|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139511774|NCT05287191|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139511775|NCT05287191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139511776|NCT05259046|Vitamin K 2|vitamin k 2|mesh-list
139511777|NCT05259046|Vitamin K|vitamin k|mesh-list
139511778|NCT05259046|Menaquinone 7|menaquinone 7|mesh-list
139511779|NCT05259046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139511780|NCT05259046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139511781|NCT05259046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511782|NCT05259046|Hemostatics|hemostatics|mesh-ancestor
139511783|NCT05259046|Coagulants|coagulants|mesh-ancestor
139511784|NCT05259046|Vitamins|vitamins|mesh-ancestor
139511785|NCT05259046|Micronutrients|micronutrients|mesh-ancestor
139511786|NCT05259046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511787|NCT05206682|Leuprolide|leuprolide|mesh-list
139511788|NCT05206682|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139511789|NCT05206682|Fertility Agents|fertility agents|mesh-ancestor
139511790|NCT05206682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139511791|NCT05206682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511792|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139511793|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511794|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
139511795|NCT05129748|Mannitol|mannitol|mesh-list
139511796|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139511797|NCT05129748|Diuretics|diuretics|mesh-ancestor
139511798|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
139511799|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511800|NCT05129748|Antidotes|antidotes|mesh-ancestor
139511801|NCT05129748|Protective Agents|protective agents|mesh-ancestor
139511802|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
139511803|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511804|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
139511805|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139511806|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139511807|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
139511808|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
139511809|NCT05127746|Donepezil|donepezil|mesh-list
139511810|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139511811|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511812|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511813|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
139511814|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139511815|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511816|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
139511817|NCT04930887|Bupivacaine|bupivacaine|mesh-list
139511818|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
139511819|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
139511820|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511821|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511823|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511824|NCT04863248|Docetaxel|docetaxel|mesh-list
139511825|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511826|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
139511827|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
139511828|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
139511829|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511830|NCT04815902|Losartan|losartan|mesh-list
139511831|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139511832|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139511833|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139511834|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139511835|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511836|NCT04807140|Paclitaxel|paclitaxel|mesh-list
139511837|NCT04807140|Carboplatin|carboplatin|mesh-list
139511838|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139511839|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511840|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
139511841|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
139511842|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
139511843|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511844|NCT04759248|Trastuzumab|trastuzumab|mesh-list
139511845|NCT04759248|Atezolizumab|atezolizumab|mesh-list
139511846|NCT04759248|Vinorelbine|vinorelbine|mesh-list
139511847|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139511848|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511849|NCT04759248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139511850|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511851|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139511852|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
139511853|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
139511854|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
139511855|NCT04756726|Dexamethasone|dexamethasone|mesh-list
139511856|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139511857|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
139511858|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
139511859|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511860|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511861|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139511862|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
139511863|NCT04756726|Hormones|hormones|mesh-ancestor
139511864|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139511865|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139511866|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511867|NCT04704505|Androgens|androgens|mesh-list
139511868|NCT04704505|Hormones|hormones|mesh-ancestor
139511869|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139511870|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511871|NCT04529278|Liraglutide|liraglutide|mesh-list
139511872|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139511873|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511874|NCT04529278|Incretins|incretins|mesh-ancestor
139511875|NCT04529278|Hormones|hormones|mesh-ancestor
139511876|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139511877|NCT04503148|Propofol|propofol|mesh-list
139511878|NCT04503148|Anesthetics|anesthetics|mesh-list
139511879|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
139511880|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
139511881|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139511882|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511883|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511884|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139511885|NCT04429516|Morphine|morphine|mesh-list
139511886|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139511887|NCT04429516|Narcotics|narcotics|mesh-ancestor
139511888|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511889|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511890|NCT04429516|Analgesics|analgesics|mesh-ancestor
139511891|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
139511892|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511893|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
139511894|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139511895|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511896|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511897|NCT04357951|Cycloserine|cycloserine|mesh-list
139511898|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139511899|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139511900|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139511901|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
139511902|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139511903|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
139511904|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511905|NCT04285229|Ixekizumab|ixekizumab|mesh-list
139511906|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
139511907|NCT04282668|Tretinoin|tretinoin|mesh-list
139511908|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511909|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
139511910|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
139511911|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
139511912|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
139511913|NCT04259060|Hematinics|hematinics|mesh-ancestor
139511914|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
139511915|NCT04259060|Vitamins|vitamins|mesh-ancestor
139511916|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
139511917|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511918|NCT04218240|Lofexidine|lofexidine|mesh-list
139511919|NCT04218240|Pregabalin|pregabalin|mesh-list
139511920|NCT04218240|Analgesics|analgesics|mesh-ancestor
139511921|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
139511922|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139511923|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511924|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
139511925|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139511926|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139511927|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511928|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139511929|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139511930|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139511931|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511932|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139511933|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139511934|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139511935|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139111558|NCT01263834|Growth Substances|growth substances|mesh-ancestor
139511936|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139511937|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139511938|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
139511939|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139511940|NCT04212793|Bevacizumab|bevacizumab|mesh-list
139511941|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139511942|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511943|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139511944|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139511945|NCT04212793|Growth Substances|growth substances|mesh-ancestor
139511946|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511947|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
139511948|NCT04084951|Nivolumab|nivolumab|mesh-list
139511949|NCT04084951|Ipilimumab|ipilimumab|mesh-list
139511950|NCT04084951|Atezolizumab|atezolizumab|mesh-list
139511951|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139511952|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511953|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139511954|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511955|NCT04083898|Prednisone|prednisone|mesh-list
139511956|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139511957|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139511958|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
139511959|NCT04083898|Hormones|hormones|mesh-ancestor
139511960|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139511961|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511962|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139111598|NCT03886662|LB100|lb100|mesh-list
139511963|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511964|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139511965|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
139511966|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511967|NCT04035837|Interferons|interferons|mesh-list
139511968|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
139511969|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511970|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
139511971|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139511973|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511974|NCT04022135|Folic Acid|folic acid|mesh-list
139511975|NCT04022135|Hematinics|hematinics|mesh-ancestor
139511976|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
139511977|NCT04022135|Vitamins|vitamins|mesh-ancestor
139511978|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
139511979|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511980|NCT04001777|Osimertinib|osimertinib|mesh-list
139511981|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511982|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139511983|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139511984|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511985|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
139511986|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139511987|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511988|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
139511989|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139511990|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139511991|NCT03983668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139511992|NCT03983668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139511993|NCT03977012|Buprenorphine|buprenorphine|mesh-list
139511994|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139511995|NCT03977012|Narcotics|narcotics|mesh-ancestor
139511996|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139511997|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139511998|NCT03977012|Analgesics|analgesics|mesh-ancestor
139511999|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
139512000|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512001|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139512002|NCT03915964|Adalimumab|adalimumab|mesh-list
139512003|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139512004|NCT03915964|Etanercept|etanercept|mesh-list
139512005|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139512006|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139512007|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139512008|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139512009|NCT03915964|Analgesics|analgesics|mesh-ancestor
139512010|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
139512011|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512012|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512013|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139512014|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139512015|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
139512016|NCT03907423|Metformin|metformin|mesh-list
139512017|NCT03907423|Glimepiride|glimepiride|mesh-list
139512018|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139512019|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139512020|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512021|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139512022|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139512023|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
139512024|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512025|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139512026|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139512027|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512028|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139512029|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139512030|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
139512031|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
139512032|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139512033|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139512034|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512035|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
139512036|NCT03897621|Coagulants|coagulants|mesh-ancestor
139512037|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
139512038|NCT03809884|Diuretics|diuretics|mesh-ancestor
139512039|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
139512040|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512041|NCT03809884|Expectorants|expectorants|mesh-ancestor
139512042|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
139512043|NCT03768427|Atorvastatin|atorvastatin|mesh-list
139512044|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139512045|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139512046|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
139512047|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512048|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139512049|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139512050|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512051|NCT03758781|Nivolumab|nivolumab|mesh-list
139111734|NCT01266252|Analgesics|analgesics|mesh-ancestor
139512052|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139512053|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512054|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139512055|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512056|NCT03746080|Plerixafor|plerixafor|mesh-list
139512057|NCT03746080|Temozolomide|temozolomide|mesh-list
139512058|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139512059|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
139512060|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512061|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512062|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139512063|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139512064|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
139512065|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512066|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139512067|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139512068|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
139512069|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512070|NCT03572933|Pregnanolone|pregnanolone|mesh-list
139512071|NCT03572933|Ganaxolone|ganaxolone|mesh-list
139512072|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
139512073|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512074|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512075|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512076|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
139512077|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
139512078|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
139512079|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139512080|NCT03558152|Vedolizumab|vedolizumab|mesh-list
139512081|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139512082|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139512083|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
139512084|NCT03461406|Coagulants|coagulants|mesh-ancestor
139512085|NCT03431974|Aminopterin|aminopterin|mesh-list
139512086|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139512087|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512088|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512089|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
139512090|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139512091|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512092|NCT03416335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139512093|NCT03416335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512094|NCT03311308|Metformin|metformin|mesh-list
139512095|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
139512096|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139512097|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512098|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139512099|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512100|NCT03311308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139512101|NCT03311308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111844|NCT01162746|Dexamethasone|dexamethasone|mesh-list
139512102|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139512103|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139512104|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512105|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139512106|NCT03179449|Hematinics|hematinics|mesh-ancestor
139512107|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139512108|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139512109|NCT02915744|Paclitaxel|paclitaxel|mesh-list
139512110|NCT02915744|Vinorelbine|vinorelbine|mesh-list
139512111|NCT02915744|Docetaxel|docetaxel|mesh-list
139512112|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139512113|NCT02915744|Gemcitabine|gemcitabine|mesh-list
139512114|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
139512115|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139512116|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512117|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
139512118|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
139512119|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
139512120|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512121|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139512122|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
139512123|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139512124|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139512125|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512127|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139512128|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139512129|NCT02782949|Analgesics|analgesics|mesh-ancestor
139512130|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
139111939|NCT01158846|Clopidogrel|clopidogrel|mesh-list
139512131|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512132|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512133|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139512134|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139512135|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512136|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512137|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512138|NCT02736656|Viloxazine|viloxazine|mesh-list
139512139|NCT02736656|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139512140|NCT02736656|Antidepressive Agents|antidepressive agents|mesh-ancestor
139512141|NCT02736656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139512142|NCT02736656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139512143|NCT02736656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139512144|NCT02736656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139512145|NCT02736656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512146|NCT02736656|Adrenergic Agents|adrenergic agents|mesh-ancestor
139512147|NCT02736656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512148|NCT02736656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512149|NCT02506933|Vaccines|vaccines|mesh-list
139512150|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
139512151|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512152|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
139512153|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139512154|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139512155|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512156|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139512157|NCT02409810|Analgesics|analgesics|mesh-ancestor
139512158|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
139512159|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512160|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139512161|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139512162|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139512163|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
139512164|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512165|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512166|NCT02206815|Aspirin|aspirin|mesh-list
139512167|NCT02206815|Warfarin|warfarin|mesh-list
139512168|NCT02206815|Clopidogrel|clopidogrel|mesh-list
139512169|NCT02206815|Ticagrelor|ticagrelor|mesh-list
139512170|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139512171|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139512172|NCT02206815|Analgesics|analgesics|mesh-ancestor
139512173|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
139512174|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512175|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512176|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139512177|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139512178|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139512179|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139512180|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512181|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139512182|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139512183|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512184|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
139512185|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139512186|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139512187|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139512188|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
139512189|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512190|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
139512191|NCT02175680|Leronlimab|leronlimab|mesh-list
139512192|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139512193|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139512194|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297138|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139512195|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139512196|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139512197|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
139512198|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512199|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139512201|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139512202|NCT01983462|Diuretics|diuretics|mesh-ancestor
139512203|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
139512204|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512205|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139512206|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139512207|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512208|NCT01983462|Analgesics|analgesics|mesh-ancestor
139512209|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
139512210|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512211|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
139512212|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
139512213|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139512214|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139512215|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139512216|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
139512217|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512218|NCT01779375|Metformin|metformin|mesh-list
139512219|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
139512220|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139512221|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512222|NCT01559935|Clarithromycin|clarithromycin|mesh-list
139512223|NCT01559935|Dexamethasone|dexamethasone|mesh-list
139512224|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
139512225|NCT01559935|Lenalidomide|lenalidomide|mesh-list
139512226|NCT01559935|BB 1101|bb 1101|mesh-list
139512227|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139512228|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
139512229|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
139512230|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512231|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512232|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139512233|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
139512234|NCT01559935|Hormones|hormones|mesh-ancestor
139512235|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139512236|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139512237|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512238|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
139512239|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512240|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512241|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
139512242|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139512243|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139512244|NCT01559935|Growth Substances|growth substances|mesh-ancestor
139512245|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
139512246|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139512247|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512248|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139512249|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139512250|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139512251|NCT00981058|Gemcitabine|gemcitabine|mesh-list
139512252|NCT00981058|Necitumumab|necitumumab|mesh-list
139512253|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512254|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139512255|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
139512256|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112135|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139512257|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139512258|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139512259|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
139512260|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139512261|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
139512262|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139512263|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512264|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139512265|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139512266|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512267|NCT00565851|Paclitaxel|paclitaxel|mesh-list
139512268|NCT00565851|Docetaxel|docetaxel|mesh-list
139512269|NCT00565851|Bevacizumab|bevacizumab|mesh-list
139512270|NCT00565851|Carboplatin|carboplatin|mesh-list
139512271|NCT00565851|Gemcitabine|gemcitabine|mesh-list
139512272|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139512273|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139512274|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
139512276|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
139512277|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139512278|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
139512279|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139512280|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512281|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
139512282|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
139512283|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
139112232|NCT01164774|Ramipril|ramipril|mesh-list
139512284|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512285|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139512286|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139512287|NCT00565851|Growth Substances|growth substances|mesh-ancestor
139512288|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512289|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
139512290|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
139512291|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139512292|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
139512293|NCT00238563|Triamcinolone|triamcinolone|mesh-list
139512294|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139512295|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
139512296|NCT00238563|Hormones|hormones|mesh-ancestor
139512297|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139512298|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512299|NCT04499677|Ritonavir|ritonavir|mesh-list
139512300|NCT04499677|Lopinavir|lopinavir|mesh-list
139512301|NCT04499677|Favipiravir|favipiravir|mesh-list
139512302|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139512303|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139512304|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
139512305|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512306|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512307|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139512308|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139512309|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
139512310|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512311|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139512312|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139512313|NCT05652751|Mitogens|mitogens|mesh-list
139512314|NCT05652751|Mitosis Modulators|mitosis modulators|mesh-ancestor
139512315|NCT05652751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512316|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
139512317|NCT02909335|Prednisone|prednisone|mesh-list
139512318|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
139512319|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139512320|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139512321|NCT02909335|Prednisolone|prednisolone|mesh-list
139512322|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
139512323|NCT02909335|Everolimus|everolimus|mesh-list
139512324|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139512325|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
139512326|NCT02909335|Tacrolimus|tacrolimus|mesh-list
139512327|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139512328|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
139512329|NCT02909335|Hormones|hormones|mesh-ancestor
139512330|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139512331|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512332|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139512333|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512334|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139512335|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
139512336|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139512337|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512338|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512339|NCT02909335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139512340|NCT02909335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139512341|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139512342|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139512343|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
139112493|NCT05834231|Memantine|memantine|mesh-list
139512344|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139512345|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512346|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
139512347|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
139512348|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512349|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139512350|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139512351|NCT02909335|Protective Agents|protective agents|mesh-ancestor
139512353|NCT05652517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139512354|NCT05652517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512355|NCT05652517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139512356|NCT05652517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512357|NCT03998293|Somatostatin|somatostatin|mesh-list
139512358|NCT03998293|Hormones|hormones|mesh-ancestor
139512359|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139512360|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512361|NCT01606306|Fluticasone|fluticasone|mesh-list
139512362|NCT01606306|Xhance|xhance|mesh-list
139512363|NCT01606306|Montelukast|montelukast|mesh-list
139512364|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139512365|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139512366|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
139512367|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512368|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512369|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139512370|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
139512371|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
139512372|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139512373|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139512374|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
139512375|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139512376|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139512377|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139512378|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512379|NCT01753570|Interferon-beta|interferon-beta|mesh-list
139512380|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512381|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
139512382|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512383|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
139512384|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512385|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
139512386|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139512387|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139512388|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139512389|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139112588|NCT05699811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139512390|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512391|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
139512392|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512393|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512394|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139512395|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512396|NCT01777282|Biguanides|biguanides|mesh-list
139512397|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
139512398|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
139512399|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
139512400|NCT01777282|Incretins|incretins|mesh-ancestor
139512401|NCT01777282|Hormones|hormones|mesh-ancestor
139512402|NCT01777282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139512403|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512404|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139512405|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512406|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512407|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
139512408|NCT04571632|Ipilimumab|ipilimumab|mesh-list
139512409|NCT04571632|Avelumab|avelumab|mesh-list
139512410|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139512411|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512412|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139512413|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512414|NCT01975389|Bococizumab|bococizumab|mesh-list
139512415|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139512416|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139512417|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
139112642|NCT05625347|Sensory System Agents|sensory system agents|mesh-ancestor
139512418|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512419|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139512420|NCT01974141|Dapsone|dapsone|mesh-list
139512421|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512422|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
139512423|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139512424|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139512425|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139112692|NCT05325593|Dexamethasone|dexamethasone|mesh-list
139512426|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512427|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512428|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
139512429|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139512430|NCT01945593|Factor VIII|factor viii|mesh-list
139512432|NCT01945593|Coagulants|coagulants|mesh-ancestor
139512433|NCT01945281|Amphotericin B|amphotericin b|mesh-list
139512434|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139512435|NCT01945281|Caspofungin|caspofungin|mesh-list
139512436|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
139512437|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
139512438|NCT01945281|Amebicides|amebicides|mesh-ancestor
139512439|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139512440|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139512441|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512442|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139512443|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
139512444|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512445|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512446|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139512447|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139512448|NCT01961349|Propofol|propofol|mesh-list
139512449|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139512450|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139512451|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139512452|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512453|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139512454|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
139512455|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
139512456|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139512457|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139512458|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139512459|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
139512460|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
139512461|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512462|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512463|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512464|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
139512465|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
139512466|NCT04661397|Tenofovir|tenofovir|mesh-list
139512467|NCT04661397|Emtricitabine|emtricitabine|mesh-list
139512468|NCT04661397|Darunavir|darunavir|mesh-list
139512469|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139512470|NCT04661397|Cobicistat|cobicistat|mesh-list
139512471|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139512472|NCT04661397|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139512473|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
139512474|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512475|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139512476|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139512477|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512478|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512479|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139512480|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139512481|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139512482|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139512483|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
139512484|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139512485|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139512486|NCT01973439|Abacavir|abacavir|mesh-list
139512487|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
139512488|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139512489|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139512490|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512491|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297139|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
139512492|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
139512493|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512494|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139512495|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139512496|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
139512497|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139512498|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
139512499|NCT01973283|Escitalopram|escitalopram|mesh-list
139112875|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
139512500|NCT01973283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139512501|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139512502|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139512503|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512504|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512505|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
139512506|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512507|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512508|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139512509|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139512510|NCT01973283|Analgesics|analgesics|mesh-ancestor
139512511|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
139512512|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
139512513|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
139512514|NCT01972659|Analgesics|analgesics|mesh-ancestor
139512515|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
139512516|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512517|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512518|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
139512519|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139512520|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139512521|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
139512522|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139512523|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139512524|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512525|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139512526|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
139113016|NCT02969837|Dexamethasone|dexamethasone|mesh-list
139512527|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139512528|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
139512529|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
139512530|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512531|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512532|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512533|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
139512534|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
139512535|NCT01774786|Capecitabine|capecitabine|mesh-list
139512536|NCT01774786|Fluorouracil|fluorouracil|mesh-list
139512537|NCT01774786|Trastuzumab|trastuzumab|mesh-list
139512538|NCT01774786|Pertuzumab|pertuzumab|mesh-list
139512539|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512540|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139512541|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
139512542|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512543|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139512544|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
139512545|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113073|NCT02656511|Tenofovir|tenofovir|mesh-list
139512546|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139512547|NCT01942161|Aripiprazole|aripiprazole|mesh-list
139512548|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
139512549|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139512550|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139512551|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139512552|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139512553|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512554|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
139512555|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
139512556|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512557|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512558|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139512559|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139512560|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
139512561|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139512562|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139512563|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139512564|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139512565|NCT01971645|Dexamethasone|dexamethasone|mesh-list
139512566|NCT01971645|Ropivacaine|ropivacaine|mesh-list
139512567|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139512568|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
139512569|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
139512570|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512571|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512572|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139512573|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
139512574|NCT01971645|Hormones|hormones|mesh-ancestor
139512575|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139512576|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139512577|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512578|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
139512579|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
139512580|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139512581|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
139512582|NCT01941537|Fezakinumab|fezakinumab|mesh-list
139512583|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
139512584|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
139512585|NCT01960413|Montelukast|montelukast|mesh-list
139512586|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139512587|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
139512588|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139512589|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
139512590|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139512591|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512592|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139512593|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139512594|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512595|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512596|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
139512597|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512598|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139512599|NCT01970475|Adalimumab|adalimumab|mesh-list
139512600|NCT01970475|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139512601|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139512602|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139512603|NCT01939977|Calcifediol|calcifediol|mesh-list
139512604|NCT01939977|Vitamins|vitamins|mesh-ancestor
139512605|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
139512606|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512607|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139512608|NCT01939899|Ixazomib|ixazomib|mesh-list
139512609|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512610|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
139512611|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512612|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512613|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
139512614|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139512615|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
139512616|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512617|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
139512618|NCT01970397|Protective Agents|protective agents|mesh-ancestor
139512619|NCT01970241|Insulin|insulin|mesh-list
139512620|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139512621|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139512622|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512623|NCT01728376|Daptomycin|daptomycin|mesh-list
139512624|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139512625|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512626|NCT02217709|Phenelzine|phenelzine|mesh-list
139512627|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
139512628|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139512629|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139512630|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512631|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512632|NCT04791553|Cenobamate|cenobamate|mesh-list
139512633|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
139512634|NCT05651347|Melatonin|melatonin|mesh-list
139512635|NCT05651347|Antioxidants|antioxidants|mesh-ancestor
139512636|NCT05651347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512637|NCT05651347|Protective Agents|protective agents|mesh-ancestor
139512638|NCT05651347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512639|NCT05651347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139512640|NCT05651269|Gemcitabine|gemcitabine|mesh-list
139512641|NCT05651269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139512642|NCT05651269|Antimetabolites|antimetabolites|mesh-ancestor
139512643|NCT05651269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299348|NCT04824092|Hormones|hormones|mesh-ancestor
139512644|NCT05651269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512645|NCT01707004|Vidarabine|vidarabine|mesh-list
139512646|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
139512647|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
139512648|NCT01707004|Busulfan|busulfan|mesh-list
139512649|NCT01707004|Fludarabine|fludarabine|mesh-list
139512650|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
139512651|NCT01707004|Azacitidine|azacitidine|mesh-list
139512652|NCT01707004|Decitabine|decitabine|mesh-list
139512653|NCT01707004|Tacrolimus|tacrolimus|mesh-list
139512654|NCT01707004|Lenograstim|lenograstim|mesh-list
139512655|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139512656|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
139512657|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512658|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139512659|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139512660|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
139512661|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512662|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512663|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139512664|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139512665|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
139512666|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
139512667|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512668|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139512669|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139512670|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512671|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139512672|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139512673|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
139512674|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139512675|NCT01939197|Ritonavir|ritonavir|mesh-list
139512676|NCT01939197|Ribavirin|ribavirin|mesh-list
139512677|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139512678|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139512679|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
139512680|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512681|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512682|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139512683|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139512684|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
139512685|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512686|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139512687|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139512688|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
139512689|NCT01969851|Lacosamide|lacosamide|mesh-list
139512690|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
139512691|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139512692|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139512693|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139512694|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512695|NCT01938573|Sirolimus|sirolimus|mesh-list
139512696|NCT01938573|Cisplatin|cisplatin|mesh-list
139512697|NCT01938573|Gemcitabine|gemcitabine|mesh-list
139512698|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512699|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139512700|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
139512701|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512702|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139512703|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512704|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139512705|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
139512706|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139512707|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
139512708|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512709|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
139512710|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139512711|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
139512712|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139512713|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
139512714|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512715|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512716|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
139512717|NCT01937871|Tadalafil|tadalafil|mesh-list
139512718|NCT01937871|Tamsulosin|tamsulosin|mesh-list
139512719|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
139299414|NCT04725812|Eculizumab|eculizumab|mesh-list
139512720|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139512721|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139512722|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512723|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512724|NCT01937871|Urological Agents|urological agents|mesh-ancestor
139512725|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139512726|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139512727|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139512728|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
139512729|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512730|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512732|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139512733|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139512734|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139512735|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
139512736|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512737|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139512738|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139512739|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512740|NCT01287091|Rabeprazole|rabeprazole|mesh-list
139512741|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139512742|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139512743|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139512744|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512745|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512746|NCT01269463|Methylphenidate|methylphenidate|mesh-list
139512747|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139512748|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512749|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139512750|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139512751|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139512752|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512753|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
139512754|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512755|NCT02539459|Everolimus|everolimus|mesh-list
139512756|NCT02539459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139512757|NCT02539459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139512758|NCT02539459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512759|NCT02539459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512760|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139512761|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
139512762|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512763|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512764|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
139114052|NCT03193216|Antacids|antacids|mesh-ancestor
139512765|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139512766|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139512767|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
139512768|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512769|NCT01634113|Bromides|bromides|mesh-list
139512770|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
139512771|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139512772|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
139512773|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512774|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512775|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139512776|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
139512777|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
139512778|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139512779|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
139512780|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512781|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512782|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
139512783|NCT01937715|Bevacizumab|bevacizumab|mesh-list
139512784|NCT01937715|Gedatolisib|gedatolisib|mesh-list
139512785|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139114173|NCT03751098|Protective Agents|protective agents|mesh-ancestor
139512786|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512787|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139512788|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139512789|NCT01937715|Growth Substances|growth substances|mesh-ancestor
139512790|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512791|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
139512792|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139512793|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512794|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512795|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
139512796|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139512797|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139512798|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512799|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
139512800|NCT01937559|Coagulants|coagulants|mesh-ancestor
139512801|NCT01918371|Ranibizumab|ranibizumab|mesh-list
139512802|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139512803|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139512804|NCT01918371|Growth Substances|growth substances|mesh-ancestor
139512805|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512806|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
139114239|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
139512807|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512808|NCT01916967|Desloratadine|desloratadine|mesh-list
139512809|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139512810|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
139512811|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512812|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512813|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512814|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139512815|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139512816|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
139512817|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
139512818|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139512819|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139512820|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139512821|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139512822|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139512823|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139512824|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139114363|NCT01181310|Donepezil|donepezil|mesh-list
139512825|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
139512826|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512827|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512828|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512829|NCT01916109|Carboplatin|carboplatin|mesh-list
139512830|NCT01916109|Gemcitabine|gemcitabine|mesh-list
139512831|NCT01916109|Panitumumab|panitumumab|mesh-list
139512832|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512833|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139512834|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
139512835|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512836|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139512837|NCT01958619|Artefenomel|artefenomel|mesh-list
139512838|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
139512839|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139512840|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139512841|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512842|NCT01726270|Tamsulosin|tamsulosin|mesh-list
139512843|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139512844|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139512845|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139512846|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
139512847|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512848|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114513|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
139512849|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512850|NCT01726270|Urological Agents|urological agents|mesh-ancestor
139512851|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139512852|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139512853|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139512854|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139512855|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512856|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139512857|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139512858|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139512859|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139512860|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
139512861|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512862|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512863|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139512864|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139512865|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
139512866|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139512867|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139512868|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
139512869|NCT01545271|Xenon|xenon|mesh-list
139512870|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139512871|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
139512872|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
139512873|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139512874|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512875|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139512876|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139512877|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512878|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512879|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139512880|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139114554|NCT01188174|Clofarabine|clofarabine|mesh-list
139512881|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512882|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
139512883|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512884|NCT01617447|Aripiprazole|aripiprazole|mesh-list
139512885|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
139512886|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139512887|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139114603|NCT01182246|Genistein|genistein|mesh-list
139512888|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139512889|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139512890|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512891|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
139512892|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
139512893|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512894|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512895|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139512896|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139512897|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
139512898|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139512899|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139512900|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139512901|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139512902|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
139512903|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139512904|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512905|NCT04797325|Prednisolone|prednisolone|mesh-list
139512906|NCT04797325|Infliximab|infliximab|mesh-list
139512907|NCT04797325|Vedolizumab|vedolizumab|mesh-list
139512908|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139512909|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
139512910|NCT04797325|Hormones|hormones|mesh-ancestor
139512911|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139512912|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512913|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139512914|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512915|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139512916|NCT04797325|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139512917|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
139512918|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139512919|NCT02246647|Mannitol|mannitol|mesh-list
139512920|NCT02246647|Lactulose|lactulose|mesh-list
139512921|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139512922|NCT02246647|Diuretics|diuretics|mesh-ancestor
139512923|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
139512924|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114785|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139512925|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139512926|NCT02244619|Acetaminophen|acetaminophen|mesh-list
139512927|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139512928|NCT02244619|Analgesics|analgesics|mesh-ancestor
139512929|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
139512930|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512931|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512932|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
139512933|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
139512934|NCT02243371|Nivolumab|nivolumab|mesh-list
139512935|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
139512936|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512937|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139512938|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139512939|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139512940|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
139512941|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512942|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139512943|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139512944|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139512945|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139512946|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139114919|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
139512947|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139512948|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139512949|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139512950|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512951|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512952|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512953|NCT01931475|Analgesics|analgesics|mesh-ancestor
139512954|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
139512955|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512956|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
139512957|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139512958|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
139512959|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139512960|NCT04630821|Eusol|eusol|mesh-list
139512961|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
139512962|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139512963|NCT01646177|Etanercept|etanercept|mesh-list
139512964|NCT01646177|Ixekizumab|ixekizumab|mesh-list
139512965|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139512966|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139512967|NCT01646177|Analgesics|analgesics|mesh-ancestor
139512968|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
139512969|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139512970|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512971|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139512972|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139512973|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139512974|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139512975|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
139512976|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
139512977|NCT01929135|Atorvastatin|atorvastatin|mesh-list
139512978|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139512979|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139512980|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
139512981|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115048|NCT01293162|Vitamins|vitamins|mesh-ancestor
139512982|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139512983|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139512984|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139512985|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139512986|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139512987|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139512988|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139512989|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139512990|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139512991|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139512992|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139512993|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139512994|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
139512995|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139512996|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139512997|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139512998|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139512999|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
139513000|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139513001|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139513002|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
139513003|NCT02324153|Riboflavin|riboflavin|mesh-list
139513004|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
139513005|NCT02324153|Vitamins|vitamins|mesh-ancestor
139513006|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
139513007|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513008|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139513009|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
139513010|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139513011|NCT02280473|Laxatives|laxatives|mesh-ancestor
139513012|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139513013|NCT02308007|Metronidazole|metronidazole|mesh-list
139513014|NCT02308007|Terconazole|terconazole|mesh-list
139513015|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513016|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139297140|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
139513017|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139513018|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139513019|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
139513020|NCT01910181|Vemurafenib|vemurafenib|mesh-list
139513021|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513022|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139513023|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513024|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513025|NCT04885907|Vaccines|vaccines|mesh-list
139513026|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
139513027|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513028|NCT01957215|Indomethacin|indomethacin|mesh-list
139513029|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139513030|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139513031|NCT01957215|Analgesics|analgesics|mesh-ancestor
139513032|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
139513033|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513034|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513035|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139513036|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139513037|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
139513038|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
139513039|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139513040|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139513041|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513042|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513043|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
139513044|NCT01928433|Finafloxacin|finafloxacin|mesh-list
139513045|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
139513046|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139513047|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513048|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139513049|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139513050|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513051|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513052|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513053|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139513054|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139513055|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139513056|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139513057|NCT02322281|Paclitaxel|paclitaxel|mesh-list
139513058|NCT02322281|Docetaxel|docetaxel|mesh-list
139513059|NCT02322281|Gemcitabine|gemcitabine|mesh-list
139513060|NCT02322281|Pemetrexed|pemetrexed|mesh-list
139513061|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139513062|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513063|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
139513064|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
139513065|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
139513066|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513067|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139513068|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
139513069|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513070|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139513071|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139513072|NCT02243293|Ribavirin|ribavirin|mesh-list
139513073|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
139513074|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513075|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
139513076|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513077|NCT02322047|Prazosin|prazosin|mesh-list
139513078|NCT02322047|Naltrexone|naltrexone|mesh-list
139513079|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139513080|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139513081|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513082|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
139513083|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513084|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139513085|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139115402|NCT03846180|Octreotide|octreotide|mesh-list
139513086|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139513087|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139513088|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
139513089|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513090|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299793|NCT04120805|Hemostatics|hemostatics|mesh-list
139513091|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139513092|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139513093|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513094|NCT02254291|Incretins|incretins|mesh-ancestor
139513095|NCT02254291|Hormones|hormones|mesh-ancestor
139513096|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139513097|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139513098|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
139513099|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570308|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513100|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513101|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139513102|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
139513103|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513104|NCT02320721|Insulin|insulin|mesh-list
139513105|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139513106|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
139513107|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139513108|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513109|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139513110|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
139513111|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139513112|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
139513113|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513114|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513115|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139513116|NCT04197089|Vitamin D|vitamin d|mesh-list
139513117|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
139513118|NCT04197089|Vitamins|vitamins|mesh-ancestor
139513119|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
139513120|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513121|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139513122|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139513123|NCT02252965|Metformin|metformin|mesh-list
139513124|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139513125|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513126|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
139513127|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139513128|NCT02251717|Ledipasvir|ledipasvir|mesh-list
139513129|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
139513130|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513131|NCT02242201|Ketorolac|ketorolac|mesh-list
139513132|NCT02242201|Epinephrine|epinephrine|mesh-list
139513133|NCT02242201|Bupivacaine|bupivacaine|mesh-list
139513134|NCT02242201|Ropivacaine|ropivacaine|mesh-list
139513135|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
139513136|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
139513137|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139513138|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513139|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
139513140|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513141|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139513142|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139513143|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
139513144|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513145|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513146|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139513147|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139513148|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
139513149|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139513150|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
139513151|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
139513152|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
139513153|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139570309|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
139513154|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139513155|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139513156|NCT02242201|Analgesics|analgesics|mesh-ancestor
139513157|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139513158|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139513159|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139513160|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513161|NCT02242045|Idelalisib|idelalisib|mesh-list
139513162|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513163|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513164|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513165|NCT02241889|Pancrelipase|pancrelipase|mesh-list
139513166|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139513167|NCT02241187|Cetuximab|cetuximab|mesh-list
139513168|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139513169|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513171|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513172|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
139513173|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
139513174|NCT02238379|Oxytocin|oxytocin|mesh-list
139513175|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
139513176|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139513177|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513178|NCT02207491|Timolol|timolol|mesh-list
139513179|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139513180|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139513181|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513182|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139513183|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139513184|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
139513185|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513186|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513187|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139513188|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139513189|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139513190|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
139513191|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
139513192|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513193|NCT02207413|Vaccines|vaccines|mesh-list
139513194|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
139513195|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513196|NCT02276027|Ceritinib|ceritinib|mesh-list
139513197|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513198|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139513199|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513200|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513201|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
139513202|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139513203|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139513204|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139513205|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
139513206|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513207|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513208|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513209|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
139513210|NCT04761133|Povidone|povidone|mesh-list
139513211|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
139513212|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
139513213|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139513214|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513215|NCT02233309|Anesthetics|anesthetics|mesh-list
139513216|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139513217|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513218|NCT02280044|Rifaximin|rifaximin|mesh-list
139513219|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139513220|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513221|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139513222|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
139513223|NCT02308748|Lidocaine|lidocaine|mesh-list
139513224|NCT02308748|Mexiletine|mexiletine|mesh-list
139513225|NCT02308748|Dofetilide|dofetilide|mesh-list
139513226|NCT02308748|Diltiazem|diltiazem|mesh-list
139513227|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
139513228|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
139513229|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139513230|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513231|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
139513232|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513233|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139513234|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139115802|NCT01203306|Octreotide|octreotide|mesh-list
139513235|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139513236|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139513237|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513238|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139513239|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513240|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139513241|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139513242|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513243|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513244|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139513245|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139513246|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139513247|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
139513248|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139513249|NCT04745689|Carboplatin|carboplatin|mesh-list
139513251|NCT04745689|Durvalumab|durvalumab|mesh-list
139513252|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513253|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139513254|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139513255|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139513256|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513257|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513258|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139513259|NCT02308124|Midodrine|midodrine|mesh-list
139513260|NCT02308124|Bromides|bromides|mesh-list
139513261|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139513262|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
139513263|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
139513264|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
139513265|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513266|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513267|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139513268|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139513269|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139513270|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139513271|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
139513272|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513273|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513274|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139513275|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513276|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
139513277|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139513278|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139513279|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513280|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139513281|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
139513282|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513283|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
139513284|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
139513285|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139513286|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
139513287|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513288|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513289|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139513290|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
139513291|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
139513292|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139513293|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
139513294|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513295|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513296|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139513297|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139513298|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139513299|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
139513300|NCT02308046|Terconazole|terconazole|mesh-list
139513301|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
139513302|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513303|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139513304|NCT02318693|Glyburide|glyburide|mesh-list
139513305|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139513306|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513307|NCT02318693|Incretins|incretins|mesh-ancestor
139513308|NCT02318693|Hormones|hormones|mesh-ancestor
139513309|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139513310|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139513311|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
139513312|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513313|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513314|NCT02230891|Carvedilol|carvedilol|mesh-list
139513315|NCT02230891|Spironolactone|spironolactone|mesh-list
139300025|NCT03829410|Bevacizumab|bevacizumab|mesh-list
139513316|NCT02230891|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139513317|NCT02230891|Hormone Antagonists|hormone antagonists|mesh-ancestor
139513318|NCT02230891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139513319|NCT02230891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513320|NCT02230891|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139513321|NCT02230891|Diuretics|diuretics|mesh-ancestor
139513322|NCT02230891|Natriuretic Agents|natriuretic agents|mesh-ancestor
139513323|NCT02230891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139116045|NCT02155920|Everolimus|everolimus|mesh-list
139513324|NCT02230891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139513325|NCT02230891|Adrenergic Agents|adrenergic agents|mesh-ancestor
139513326|NCT02230891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513327|NCT02230891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513328|NCT02230891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139513329|NCT02230891|Antioxidants|antioxidants|mesh-ancestor
139513330|NCT02230891|Protective Agents|protective agents|mesh-ancestor
139513331|NCT02230891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139513332|NCT02230891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139513333|NCT02230891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139513334|NCT02230891|Vasodilator Agents|vasodilator agents|mesh-ancestor
139513335|NCT02230891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139513336|NCT02230891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139513337|NCT02302859|Nicotine|nicotine|mesh-list
139513338|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139513339|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
139513340|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513341|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513342|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139513343|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139513344|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
139513345|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513346|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513347|NCT02274311|Clomiphene|clomiphene|mesh-list
139513348|NCT02274311|Enclomiphene|enclomiphene|mesh-list
139513349|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
139513350|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139513351|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
139513352|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139513353|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513354|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139513355|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
139513356|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139513357|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139513358|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139513359|NCT02316353|Complement C1s|complement c1s|mesh-list
139513360|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139513361|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
139513362|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
139513363|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513364|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139513365|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139513366|NCT02279732|Paclitaxel|paclitaxel|mesh-list
139513367|NCT02279732|Carboplatin|carboplatin|mesh-list
139513368|NCT02279732|Ipilimumab|ipilimumab|mesh-list
139513369|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139513370|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513371|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
139513372|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
139513373|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
139513374|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513375|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139513376|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139513377|NCT04876430|Meropenem|meropenem|mesh-list
139513378|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139513379|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513380|NCT02304926|Simvastatin|simvastatin|mesh-list
139513381|NCT02304926|Ezetimibe|ezetimibe|mesh-list
139513382|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
139513383|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139513384|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139513385|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
139513386|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513387|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139513388|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139513389|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513390|NCT01646255|Levodopa|levodopa|mesh-list
139513392|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139513393|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139513394|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
139513395|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513396|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513397|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513398|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
139513399|NCT02203591|Ethanol|ethanol|mesh-list
139513400|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
139513401|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139513402|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139513403|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513404|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139513405|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513406|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
139513407|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
139513408|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
139513409|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139513410|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139513411|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
139513412|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513413|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513414|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513415|NCT01642277|Urological Agents|urological agents|mesh-ancestor
139513416|NCT02230189|Methacholine Chloride|methacholine chloride|mesh-list
139513417|NCT02230189|Miotics|miotics|mesh-ancestor
139513418|NCT02230189|Autonomic Agents|autonomic agents|mesh-ancestor
139513419|NCT02230189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513420|NCT02230189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513421|NCT02230189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139513422|NCT02230189|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139513423|NCT02230189|Respiratory System Agents|respiratory system agents|mesh-ancestor
139513424|NCT02230189|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139513425|NCT02230189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139513426|NCT02230189|Cholinergic Agents|cholinergic agents|mesh-ancestor
139513427|NCT02230189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513428|NCT02230189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513429|NCT02304302|Memantine|memantine|mesh-list
139513430|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139513431|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139513432|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
139513433|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513434|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513435|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513436|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139513437|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139513438|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139513439|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139513440|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139513441|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
139513442|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513443|NCT02301143|Paclitaxel|paclitaxel|mesh-list
139513444|NCT02301143|Gemcitabine|gemcitabine|mesh-list
139513445|NCT02301143|Capecitabine|capecitabine|mesh-list
139513446|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139513447|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513448|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
139513449|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
139513450|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
139513451|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513452|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139513453|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
139513454|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
139513455|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
139513456|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139513457|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
139513458|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513459|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513460|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139513461|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
139513462|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
139513463|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139116435|NCT01303536|Ondansetron|ondansetron|mesh-list
139300174|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
139513464|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
139513465|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513466|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513467|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139513468|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139513469|NCT02275052|Albuterol|albuterol|mesh-list
139513470|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139513471|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
139513472|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513473|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513474|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139513475|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
139513476|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
139116493|NCT03799536|Sotalol|sotalol|mesh-list
139513477|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139513478|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139513479|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139513480|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139513481|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
139513482|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513483|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513484|NCT05649020|Prilocaine|prilocaine|mesh-list
139513485|NCT05649020|Anesthetics, Local|anesthetics, local|mesh-ancestor
139513486|NCT05649020|Anesthetics|anesthetics|mesh-ancestor
139513487|NCT05649020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139513488|NCT05649020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513489|NCT05649020|Sensory System Agents|sensory system agents|mesh-ancestor
139513490|NCT05649020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513491|NCT04869488|Prednisone|prednisone|mesh-list
139513492|NCT04869488|Apatinib|apatinib|mesh-list
139513493|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
139513494|NCT04869488|Fluzoparib|fluzoparib|mesh-list
139513495|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139513496|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
139513497|NCT04869488|Hormones|hormones|mesh-ancestor
139513498|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139513499|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513500|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139513501|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513502|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139513503|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513504|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513505|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139513506|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
139513507|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139513508|NCT04869488|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139513509|NCT02274038|Pemetrexed|pemetrexed|mesh-list
139513510|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513511|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513512|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513513|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139513514|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139513515|NCT01646021|Sirolimus|sirolimus|mesh-list
139513516|NCT01646021|Temsirolimus|temsirolimus|mesh-list
139513517|NCT01646021|MTOR Inhibitors|mtor inhibitors|mesh-list
139513518|NCT01646021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139513519|NCT01646021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513520|NCT01646021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513521|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139513522|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
139513523|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513524|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513525|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139513526|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513527|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139513528|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
139513529|NCT01750918|Fluorouracil|fluorouracil|mesh-list
139513530|NCT01750918|Panitumumab|panitumumab|mesh-list
139513531|NCT01750918|Trametinib|trametinib|mesh-list
139513532|NCT01750918|Dabrafenib|dabrafenib|mesh-list
139513533|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
139513534|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513535|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139513536|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513537|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139513538|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
139513539|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513540|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139513541|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139513542|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116664|NCT03798522|Nalbuphine|nalbuphine|mesh-list
139513544|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139513545|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139513546|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139513547|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
139513548|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
139513549|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513550|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513551|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513552|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139513553|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139513554|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513555|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139513556|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139513557|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139513558|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139513559|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513560|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139513561|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139513562|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139513563|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
139513564|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513565|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513566|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139513567|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139513568|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
139513569|NCT02269943|Azacitidine|azacitidine|mesh-list
139513570|NCT02269943|Cc-486|cc-486|mesh-list
139513571|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139513572|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
139513573|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513574|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513575|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513576|NCT01605370|Metoprolol|metoprolol|mesh-list
139513577|NCT01605370|Nebivolol|nebivolol|mesh-list
139513578|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139513579|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139513580|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
139513581|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
139513582|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513583|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513584|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139513585|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139513586|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139513587|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
139513588|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513589|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513590|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
139513591|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139513592|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139513593|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139513594|NCT01605136|Afamelanotide|afamelanotide|mesh-list
139513595|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
139513596|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
139513597|NCT01706146|Apixaban|apixaban|mesh-list
139513598|NCT01706146|Dabigatran|dabigatran|mesh-list
139513599|NCT01706146|Anticoagulants|anticoagulants|mesh-list
139513600|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139513601|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
139513602|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139513603|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
139513604|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513605|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513606|NCT02269241|Drospirenone|drospirenone|mesh-list
139513607|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139513608|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
139513609|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139513610|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513611|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139513612|NCT02269241|Diuretics|diuretics|mesh-ancestor
139513613|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
139513614|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
139513615|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139513616|NCT01750294|Diuretics|diuretics|mesh-ancestor
139513617|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
139513618|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513619|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139513620|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139513621|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513622|NCT01749982|Choline|choline|mesh-list
139513623|NCT01749982|Betaine|betaine|mesh-list
139513624|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
139513625|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139513626|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
139513627|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513628|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139513629|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139513630|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
139513631|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
139513632|NCT02269163|Antibodies|antibodies|mesh-list
139513633|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
139513634|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139513635|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139513636|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
139513637|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
139513638|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513639|NCT01749826|Morphine|morphine|mesh-list
139513640|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139513641|NCT01749826|Narcotics|narcotics|mesh-ancestor
139513642|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139513643|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513644|NCT01749826|Analgesics|analgesics|mesh-ancestor
139513645|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
139513646|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513647|NCT01724866|Cyclophosphamide|cyclophosphamide|mesh-list
139513648|NCT01724866|Docetaxel|docetaxel|mesh-list
139513649|NCT01724866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139513650|NCT01724866|Immunologic Factors|immunologic factors|mesh-ancestor
139513651|NCT01724866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513652|NCT01724866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139513653|NCT01724866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139513654|NCT01724866|Alkylating Agents|alkylating agents|mesh-ancestor
139513655|NCT01724866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513656|NCT01724866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513657|NCT01724866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139513658|NCT01724866|Tubulin Modulators|tubulin modulators|mesh-ancestor
139513659|NCT01724866|Antimitotic Agents|antimitotic agents|mesh-ancestor
139513660|NCT01724866|Mitosis Modulators|mitosis modulators|mesh-ancestor
139513661|NCT02266433|Dexamethasone|dexamethasone|mesh-list
139513662|NCT02266433|Ketorolac|ketorolac|mesh-list
139513663|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139513664|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
139513665|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
139513666|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513667|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513668|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139513669|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
139513670|NCT02266433|Hormones|hormones|mesh-ancestor
139513671|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139513672|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139513673|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513674|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139513675|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139513676|NCT02266433|Analgesics|analgesics|mesh-ancestor
139513677|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
139513678|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139513679|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139513680|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513681|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513682|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
139513683|NCT02273726|Hematinics|hematinics|mesh-ancestor
139513684|NCT01723228|Rasagiline|rasagiline|mesh-list
139513685|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139513686|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513687|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513688|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139513689|NCT01723228|Protective Agents|protective agents|mesh-ancestor
139513690|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513691|NCT02273180|Insulin|insulin|mesh-list
139513692|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139513693|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
139513694|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
139513695|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139513696|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513697|NCT01745380|Phenylephrine|phenylephrine|mesh-list
139513698|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
139513699|NCT01745380|Tetracaine|tetracaine|mesh-list
139513700|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
139513701|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
139513702|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139513703|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117111|NCT03077698|Hormones|hormones|mesh-ancestor
139513704|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
139513705|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513706|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139513707|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139513708|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
139513709|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513710|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513711|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
139513712|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
139513713|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
139513714|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139513715|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
139513716|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139513717|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
139513718|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139513719|NCT01745380|Protective Agents|protective agents|mesh-ancestor
139513720|NCT04550104|Olaparib|olaparib|mesh-list
139513721|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139513722|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513723|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513724|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513725|NCT05648318|Lactulose|lactulose|mesh-list
139513726|NCT05648318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139513727|NCT02203513|Prexasertib|prexasertib|mesh-list
139513728|NCT02203513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139513729|NCT02203513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513730|NCT02203513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513731|NCT01703260|Pioglitazone|pioglitazone|mesh-list
139513732|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139513733|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513734|NCT02299388|Liraglutide|liraglutide|mesh-list
139513735|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139513736|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513737|NCT02299388|Incretins|incretins|mesh-ancestor
139513738|NCT02299388|Hormones|hormones|mesh-ancestor
139513739|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139513740|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
139513741|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
139513742|NCT02202577|Povidone|povidone|mesh-list
139513743|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139513744|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513745|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
139513746|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
139513747|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
139513748|NCT01723072|Omalizumab|omalizumab|mesh-list
139513749|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139513750|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139513751|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139513752|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
139513753|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
139513754|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513755|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139513756|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139513757|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513758|NCT02169505|Immunotoxins|immunotoxins|mesh-ancestor
139513759|NCT02169505|Immunoconjugates|immunoconjugates|mesh-ancestor
139513760|NCT02169505|Immunologic Factors|immunologic factors|mesh-ancestor
139513761|NCT02169505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300476|NCT02780128|Ceritinib|ceritinib|mesh-list
139513762|NCT01909791|Aflibercept|aflibercept|mesh-list
139513763|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139513764|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139513765|NCT01909791|Growth Substances|growth substances|mesh-ancestor
139513766|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513767|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
139513768|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513769|NCT02202499|Varenicline|varenicline|mesh-list
139513770|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139513771|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139513772|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
139513773|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513774|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513775|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513776|NCT02227849|Canagliflozin|canagliflozin|mesh-list
139513777|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139513778|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513779|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139117339|NCT03781596|Omeprazole|omeprazole|mesh-list
139513780|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513781|NCT02169271|Aspirin|aspirin|mesh-list
139513782|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139513783|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139513784|NCT02169271|Analgesics|analgesics|mesh-ancestor
139513785|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
139513786|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513787|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513788|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139513789|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139513790|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139513791|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139513792|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513793|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139513794|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139117391|NCT05494866|Cobicistat|cobicistat|mesh-list
139513795|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513796|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
139513797|NCT01644188|Ezetimibe|ezetimibe|mesh-list
139513798|NCT01644188|Alirocumab|alirocumab|mesh-list
139513799|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139513800|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139513801|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139513802|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
139513803|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513804|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139513805|NCT01644188|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139513806|NCT01644188|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139513807|NCT01644188|Protease Inhibitors|protease inhibitors|mesh-ancestor
139513808|NCT01644188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513809|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
139513810|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513811|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
139513812|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
139513813|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513814|NCT02271854|Diclofenac|diclofenac|mesh-list
139513815|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139513816|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139513817|NCT02271854|Analgesics|analgesics|mesh-ancestor
139513818|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
139513819|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139513820|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513821|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139513822|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139513823|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139513824|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513825|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513826|NCT02296892|Midazolam|midazolam|mesh-list
139513827|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139513828|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139513829|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139513830|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513831|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139513832|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139513833|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139513834|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139513835|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
139513836|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
139513837|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
139513838|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
139513839|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139513840|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513841|NCT02168803|Evacetrapib|evacetrapib|mesh-list
139300552|NCT02457442|Narcotics|narcotics|mesh-ancestor
139513842|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139513843|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139513844|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
139513845|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513846|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139513847|NCT02201329|Azacitidine|azacitidine|mesh-list
139513848|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139513849|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
139513850|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513851|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513852|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513853|NCT01927419|Nivolumab|nivolumab|mesh-list
139513854|NCT01927419|Ipilimumab|ipilimumab|mesh-list
139513855|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139513856|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513857|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139513858|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513859|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
139513860|NCT02168491|Lixisenatide|lixisenatide|mesh-list
139513861|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139513862|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513863|NCT01721746|Paclitaxel|paclitaxel|mesh-list
139513864|NCT01721746|Carboplatin|carboplatin|mesh-list
139513865|NCT01721746|Nivolumab|nivolumab|mesh-list
139513866|NCT01721746|Dacarbazine|dacarbazine|mesh-list
139513867|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139513868|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513869|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
139513870|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
139513871|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
139513872|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513873|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139513874|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139513875|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139513876|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
139513877|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
139513878|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139513879|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
139513880|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513881|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139513882|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139513883|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
139513884|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513885|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513886|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139513887|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139513888|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
139513889|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513890|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139513891|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
139513892|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513893|NCT02296190|Etripamil|etripamil|mesh-list
139513894|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139513895|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139117746|NCT05191264|Analgesics|analgesics|mesh-list
139513896|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513897|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139513898|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513899|NCT04875026|Fluorouracil|fluorouracil|mesh-list
139513900|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
139513901|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513902|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139513903|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513904|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139513905|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
139513906|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513907|NCT02296112|Trametinib|trametinib|mesh-list
139513908|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513909|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139513910|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513911|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513912|NCT02269670|Tamoxifen|tamoxifen|mesh-list
139513913|NCT02269670|Everolimus|everolimus|mesh-list
139513914|NCT02269670|Letrozole|letrozole|mesh-list
139513915|NCT02269670|Fulvestrant|fulvestrant|mesh-list
139513916|NCT02269670|Anastrozole|anastrozole|mesh-list
139513917|NCT02269670|Megestrol|megestrol|mesh-list
139513918|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
139513919|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513920|NCT02269670|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139513921|NCT02269670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139513922|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513923|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139513924|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
139513925|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513926|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513927|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139513928|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139513929|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139513930|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
139513931|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139513932|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139513933|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139513934|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139513935|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139513936|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139513937|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139513938|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139513939|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139513940|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
139513941|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139513942|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139513943|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139513944|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
139513945|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139513946|NCT02225353|Progesterone|progesterone|mesh-list
139513947|NCT02225353|Progestins|progestins|mesh-ancestor
139513948|NCT02225353|Hormones|hormones|mesh-ancestor
139513949|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139513950|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513951|NCT01641926|Interferons|interferons|mesh-list
139513952|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
139513953|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
139513954|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139513955|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139513956|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513957|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
139513958|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139513959|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
139513960|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513961|NCT02294786|Capecitabine|capecitabine|mesh-list
139513962|NCT02294786|Lapatinib|lapatinib|mesh-list
139513963|NCT02294786|Octreotide|octreotide|mesh-list
139513964|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139513965|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
139513966|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513967|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513968|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139513969|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513970|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139513971|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139513972|NCT04880876|Eluxadoline|eluxadoline|mesh-list
139513973|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139513974|NCT01927341|Panitumumab|panitumumab|mesh-list
139513975|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139513976|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513977|NCT02294474|Insulin|insulin|mesh-list
139513978|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139513979|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
139513980|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
139513981|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139513982|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513983|NCT02168101|Ixazomib|ixazomib|mesh-list
139513984|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139513985|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
139513986|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139513987|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513988|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139513989|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
139513990|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139513991|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
139513992|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139513994|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139513995|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139513996|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139513997|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
139513998|NCT02298023|Coagulants|coagulants|mesh-ancestor
139513999|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
139514000|NCT02296931|Analgesics|analgesics|mesh-ancestor
139514001|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
139514002|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117930|NCT03771768|Triamcinolone|triamcinolone|mesh-list
139514003|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514004|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
139514005|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139514006|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139514007|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
139514008|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139514009|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139514010|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514011|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139514012|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
139514013|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139514014|NCT02166697|Candesartan|candesartan|mesh-list
139514015|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
139514016|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139514017|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139514018|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139514019|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514020|NCT02197897|Tamoxifen|tamoxifen|mesh-list
139514021|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139514022|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
139514023|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139514024|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514025|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139514026|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514027|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139514028|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139514029|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139514030|NCT02196259|Ketamine|ketamine|mesh-list
139514031|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
139514032|NCT02196259|Anesthetics|anesthetics|mesh-list
139514033|NCT02196259|Analgesics|analgesics|mesh-ancestor
139514034|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
139514035|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514036|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514037|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139514038|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
139514039|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139514040|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139514041|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139514042|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139514043|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514044|NCT02294396|Mirabegron|mirabegron|mesh-list
139514045|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
139514046|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139514047|NCT02294396|Propiverine|propiverine|mesh-list
139514048|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139514049|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139514050|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139514051|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
139514052|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139514053|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514054|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514055|NCT02294396|Urological Agents|urological agents|mesh-ancestor
139514056|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139514057|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139514058|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
139514059|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
139514060|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
139514061|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514062|NCT02164981|Nitroprusside|nitroprusside|mesh-list
139514063|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139300798|NCT01415752|Rituximab|rituximab|mesh-list
139514064|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
139514065|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139514066|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514067|NCT01908699|Beraprost|beraprost|mesh-list
139514068|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139514069|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
139514070|NCT01363011|Darunavir|darunavir|mesh-list
139514071|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139514072|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139514073|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139514074|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
139514075|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514076|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514077|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139514078|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139514079|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
139514080|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514081|NCT02263547|Teriflunomide|teriflunomide|mesh-list
139514082|NCT02263547|Colestipol|colestipol|mesh-list
139514083|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139514084|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139514085|NCT02263547|Analgesics|analgesics|mesh-ancestor
139514086|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
139514087|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514088|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514089|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514090|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514091|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139514092|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
139514093|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139514094|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
139514095|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514096|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139514097|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
139514098|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
139514099|NCT01925703|Hematinics|hematinics|mesh-ancestor
139514100|NCT01617681|Valsartan|valsartan|mesh-list
139514101|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139514102|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139514103|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139514104|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514105|NCT02263079|Interferons|interferons|mesh-list
139514106|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
139514107|NCT02263079|Lamivudine|lamivudine|mesh-list
139514108|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
139514109|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139514110|NCT02263079|Entecavir|entecavir|mesh-list
139514111|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514112|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
139514113|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514114|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
139514115|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514116|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139514117|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139514118|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514119|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514120|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139514121|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139514122|NCT02260817|Choline|choline|mesh-list
139514123|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
139514124|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139514125|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
139514126|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514127|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139514128|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139514129|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
139514130|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139514131|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514132|NCT01642589|Vaccines|vaccines|mesh-list
139514133|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
139514134|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514135|NCT01954251|Vaccines|vaccines|mesh-list
139514136|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
139514137|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514138|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139514139|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139514140|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514142|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
139514143|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139514144|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
139514145|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514146|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514147|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139514148|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
139514149|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
139514150|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139514151|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
139514152|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139514153|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514154|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
139514155|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139514156|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139514157|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139514158|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139514159|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
139514160|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139514161|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
139514162|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514163|NCT01645280|Methotrexate|methotrexate|mesh-list
139514164|NCT01645280|Ustekinumab|ustekinumab|mesh-list
139514165|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139514166|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
139514167|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139514168|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514169|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139514170|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
139514171|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514172|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514173|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
139514174|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514175|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139514176|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139514177|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
139514178|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514179|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139514180|NCT01629589|Vaccines|vaccines|mesh-list
139514181|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
139514182|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514183|NCT04188223|Vaccines|vaccines|mesh-list
139514184|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
139514185|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514186|NCT02220907|Canagliflozin|canagliflozin|mesh-list
139514187|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139514188|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514189|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139514190|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514191|NCT01601873|Heparin|heparin|mesh-list
139514192|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
139514193|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139514194|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139514195|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514196|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
139514197|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
139514198|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139514199|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514200|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514201|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
139514202|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
139514203|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
139514204|NCT04420247|Chloroquine|chloroquine|mesh-list
139514205|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
139514206|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139514207|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139514208|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514209|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514210|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514211|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514212|NCT04420247|Amebicides|amebicides|mesh-ancestor
139514213|NCT01644890|Paclitaxel|paclitaxel|mesh-list
139514214|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139514215|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514216|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
139514217|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
139514218|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
139514219|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514221|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
139514222|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514223|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
139514224|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514225|NCT01628965|Rotigotine|rotigotine|mesh-list
139514226|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
139514227|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
139514228|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139514229|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514230|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514231|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
139514232|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139514233|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
139514234|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514235|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514236|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139514237|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
139514238|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
139514239|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139514240|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
139514241|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139514242|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514243|NCT02255279|Vaccines|vaccines|mesh-list
139514244|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
139514245|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514246|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139514247|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139514248|NCT02266706|Tazobactam|tazobactam|mesh-list
139514249|NCT02266706|Ceftolozane|ceftolozane|mesh-list
139514250|NCT02266706|Cephalosporins|cephalosporins|mesh-list
139514251|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
139514252|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
139514253|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139514254|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514255|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139514256|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514257|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514258|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139514259|NCT02292719|Ritonavir|ritonavir|mesh-list
139514260|NCT02292719|Ribavirin|ribavirin|mesh-list
139514261|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
139514262|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139514263|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139514264|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
139514265|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514266|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514267|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139514268|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139514269|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
139514270|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514271|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139514272|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139514273|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
139514274|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
139514275|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514276|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
139514277|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139514278|NCT02264990|Paclitaxel|paclitaxel|mesh-list
139514279|NCT02264990|Carboplatin|carboplatin|mesh-list
139514280|NCT02264990|Pemetrexed|pemetrexed|mesh-list
139514281|NCT02264990|Veliparib|veliparib|mesh-list
139514282|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139514283|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514284|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
139514285|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
139514286|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
139514287|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514288|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514289|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139514290|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139514291|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139514293|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139514294|NCT02289833|Maytansine|maytansine|mesh-list
139514295|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139514296|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514297|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139514298|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
139514299|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
139514300|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
139514301|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514302|NCT02289833|Immunotoxins|immunotoxins|mesh-ancestor
139514303|NCT02289833|Immunoconjugates|immunoconjugates|mesh-ancestor
139514304|NCT02289833|Immunologic Factors|immunologic factors|mesh-ancestor
139514305|NCT02289833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514306|NCT01702558|Capecitabine|capecitabine|mesh-list
139514307|NCT01702558|Trastuzumab|trastuzumab|mesh-list
139514308|NCT01702558|Maytansine|maytansine|mesh-list
139514309|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139514310|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139514311|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
139514312|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514313|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514314|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139514315|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139514316|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
139514317|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
139514318|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
139514319|NCT01702558|Immunotoxins|immunotoxins|mesh-ancestor
139514320|NCT01702558|Immunoconjugates|immunoconjugates|mesh-ancestor
139514321|NCT01702558|Immunologic Factors|immunologic factors|mesh-ancestor
139514322|NCT01702558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514323|NCT02194465|Spironolactone|spironolactone|mesh-list
139514324|NCT02194465|Tadalafil|tadalafil|mesh-list
139514325|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139514326|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
139514327|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
139514328|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139514329|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139514330|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118673|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139514331|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514332|NCT02194465|Urological Agents|urological agents|mesh-ancestor
139514333|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
139514334|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139514335|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514336|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139514337|NCT02194465|Diuretics|diuretics|mesh-ancestor
139514338|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
139514339|NCT02194465|Hormones|hormones|mesh-ancestor
139514340|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139514341|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139514342|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514343|NCT01720264|Incretins|incretins|mesh-ancestor
139514344|NCT01720264|Hormones|hormones|mesh-ancestor
139514345|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139514346|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139514347|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
139514348|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514349|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514350|NCT04564846|Insulin|insulin|mesh-list
139514351|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139514352|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514353|NCT01702246|Simvastatin|simvastatin|mesh-list
139514354|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139514355|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139514356|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
139514357|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514358|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139514359|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139514360|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514361|NCT01631227|Eprosartan|eprosartan|mesh-list
139514362|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139514363|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
139514364|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139514365|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514366|NCT05645861|Benzocaine|benzocaine|mesh-list
139514367|NCT05645861|Anesthetics, Local|anesthetics, local|mesh-ancestor
139514368|NCT05645861|Anesthetics|anesthetics|mesh-ancestor
139514369|NCT05645861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139514370|NCT05645861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514371|NCT05645861|Sensory System Agents|sensory system agents|mesh-ancestor
139514372|NCT05645861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514373|NCT01719172|Hemostatics|hemostatics|mesh-list
139118844|NCT03754842|Niacin|niacin|mesh-list
139514374|NCT01719172|Coagulants|coagulants|mesh-ancestor
139514375|NCT02285855|Metformin|metformin|mesh-list
139514376|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139514377|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514378|NCT02285153|Aspirin|aspirin|mesh-list
139514379|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
139514380|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139514381|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139514382|NCT02285153|Analgesics|analgesics|mesh-ancestor
139514383|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
139514384|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514385|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514386|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514387|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514388|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139514389|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139514390|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514391|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139514392|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139514393|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514394|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
139514395|NCT01632241|Belimumab|belimumab|mesh-list
139514396|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139514397|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
139514398|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514399|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
139514400|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139514401|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139514402|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514403|NCT02263508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139514404|NCT02263508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514405|NCT01741792|Blinatumomab|blinatumomab|mesh-list
139514406|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514407|NCT02289950|Farletuzumab|farletuzumab|mesh-list
139514408|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514409|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139514410|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
139514411|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139514412|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139514413|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139570310|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514414|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514415|NCT01740388|Besifloxacin|besifloxacin|mesh-list
139514416|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139514417|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514418|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139514419|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139514420|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514421|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514422|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514423|NCT01740154|Sunitinib|sunitinib|mesh-list
139514424|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514425|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139514426|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139514427|NCT01740154|Growth Substances|growth substances|mesh-ancestor
139514428|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514429|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
139514430|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139514431|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514432|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514433|NCT02287610|Prednisone|prednisone|mesh-list
139514434|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514435|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
139514436|NCT02287610|Hormones|hormones|mesh-ancestor
139514437|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139301153|NCT01554696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514438|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514439|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139514440|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514442|NCT02262728|Simeprevir|simeprevir|mesh-list
139514443|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
139514444|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514445|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
139119067|NCT03999554|Vaccines|vaccines|mesh-list
139514446|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514447|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514448|NCT01717768|Testosterone|testosterone|mesh-list
139514449|NCT01717768|Androgens|androgens|mesh-ancestor
139514450|NCT01717768|Hormones|hormones|mesh-ancestor
139514451|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139514452|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514453|NCT02260934|Acetaminophen|acetaminophen|mesh-list
139514454|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
139514455|NCT02260934|Promethazine|promethazine|mesh-list
139514456|NCT02260934|Prednisone|prednisone|mesh-list
139514457|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
139514458|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139514459|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139514460|NCT02260934|Prednisolone|prednisolone|mesh-list
139514461|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
139514462|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
139514463|NCT02260934|Rituximab|rituximab|mesh-list
139514464|NCT02260934|Belimumab|belimumab|mesh-list
139514465|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139514466|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
139514467|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139514468|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
139514469|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514470|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139570311|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
139514471|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139514472|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
139514473|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514474|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514475|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139514476|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139514477|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514478|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
139514479|NCT02260934|Hormones|hormones|mesh-ancestor
139514480|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139514481|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139514482|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139514483|NCT02260934|Analgesics|analgesics|mesh-ancestor
139514484|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
139514485|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514486|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
139514487|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
139514488|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
139514489|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139514490|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139514491|NCT02260934|Protective Agents|protective agents|mesh-ancestor
139514492|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139514493|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139514494|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139514495|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
139514496|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
139514497|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139514498|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
139514499|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
139514500|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139514501|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139514502|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
139514503|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
139514504|NCT02260388|Mexiletine|mexiletine|mesh-list
139514505|NCT02260388|Pregabalin|pregabalin|mesh-list
139514506|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139514507|NCT02260388|Nortriptyline|nortriptyline|mesh-list
139514508|NCT02260388|Analgesics|analgesics|mesh-ancestor
139514509|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
139514510|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514511|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301240|NCT01516086|Xhance|xhance|mesh-list
139514512|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
139514513|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139514514|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139514515|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514516|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139514517|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139514518|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139514519|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139514520|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139514521|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139514522|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139514523|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139514524|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
139514525|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
139570312|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514526|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139514527|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139514528|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
139514529|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139514530|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139514531|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139514532|NCT02260154|Mebeverine|mebeverine|mesh-list
139514533|NCT02260154|Alverine|alverine|mesh-list
139514534|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
139514535|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
139514536|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
139514537|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514538|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514539|NCT01643408|Asparaginase|asparaginase|mesh-list
139514540|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514541|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
139514542|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139514543|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139514544|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514545|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139514546|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139514547|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514548|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514549|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514550|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
139514551|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139514552|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139514553|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139514554|NCT01739764|Vemurafenib|vemurafenib|mesh-list
139514555|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514556|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139514557|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514558|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514559|NCT01700530|Simvastatin|simvastatin|mesh-list
139514560|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139514561|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139514562|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139514563|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
139514564|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514565|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139514566|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514567|NCT01717456|Loperamide|loperamide|mesh-list
139514568|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
139514569|NCT01717456|Laxatives|laxatives|mesh-list
139514570|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139514571|NCT01716754|Omalizumab|omalizumab|mesh-list
139514572|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139514573|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139514574|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
139514575|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139514576|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139514577|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139514578|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139514579|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139514580|NCT01698814|Analgesics|analgesics|mesh-ancestor
139514581|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
139514582|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514583|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514584|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514585|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514586|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139514587|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139301301|NCT02266056|Rocuronium|rocuronium|mesh-list
139514588|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139514589|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
139514590|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
139514591|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139514592|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514594|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139514595|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514596|NCT01738594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139514597|NCT01738594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514598|NCT01738594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514599|NCT01697956|Beclomethasone|beclomethasone|mesh-list
139514600|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514601|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
139514602|NCT01697956|Hormones|hormones|mesh-ancestor
139514603|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139514604|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514605|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139514606|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
139514607|NCT01697800|Tadalafil|tadalafil|mesh-list
139514608|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
139514609|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139514610|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139514611|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514612|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514613|NCT01697800|Urological Agents|urological agents|mesh-ancestor
139514614|NCT01644500|Glimepiride|glimepiride|mesh-list
139514615|NCT01644500|Dulaglutide|dulaglutide|mesh-list
139514616|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139514617|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139514618|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514619|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139514620|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
139514621|NCT01604824|Alirocumab|alirocumab|mesh-list
139514622|NCT01604824|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139514623|NCT01604824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139514624|NCT01604824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139119963|NCT03745586|Hormones|hormones|mesh-ancestor
139514625|NCT01604824|Antimetabolites|antimetabolites|mesh-ancestor
139514626|NCT01604824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514627|NCT01604824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139514628|NCT01604824|Protease Inhibitors|protease inhibitors|mesh-ancestor
139514629|NCT01604824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514630|NCT01604824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139514631|NCT01716052|Ibuprofen|ibuprofen|mesh-list
139514632|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139514633|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139514634|NCT01716052|Analgesics|analgesics|mesh-ancestor
139514635|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
139514636|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514637|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514638|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514639|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514640|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139514641|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514642|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514643|NCT01641692|Albuterol|albuterol|mesh-list
139514644|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139514645|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
139514646|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514647|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514648|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139514649|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
139514650|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
139514651|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139514652|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139514653|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139514654|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139514655|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
139514656|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139514657|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514658|NCT01682512|Rituximab|rituximab|mesh-list
139514659|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139514660|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514661|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
139514662|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514664|NCT04863716|Fentanyl|fentanyl|mesh-list
139514665|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139514666|NCT04863716|Narcotics|narcotics|mesh-ancestor
139514667|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139514668|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514669|NCT04863716|Analgesics|analgesics|mesh-ancestor
139514670|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
139514671|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514672|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139514673|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139514674|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
139514675|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
139514676|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
139514677|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139514678|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514679|NCT04135352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139514680|NCT04135352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514681|NCT01715896|Golimumab|golimumab|mesh-list
139514682|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
139514683|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139514684|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514685|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139514686|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
139514687|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514688|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514689|NCT05642702|Vitamins|vitamins|mesh-list
139514690|NCT05642702|Ascorbic Acid|ascorbic acid|mesh-list
139514691|NCT05642702|Niacinamide|niacinamide|mesh-list
139514692|NCT05642702|Niacin|niacin|mesh-list
139514693|NCT05642702|Nicotinic Acids|nicotinic acids|mesh-list
139514694|NCT05642702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139514695|NCT05642702|Micronutrients|micronutrients|mesh-ancestor
139514696|NCT05642702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514697|NCT05642702|Antioxidants|antioxidants|mesh-ancestor
139120185|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
139514698|NCT05642702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514699|NCT05642702|Protective Agents|protective agents|mesh-ancestor
139514700|NCT05642702|Vitamin B Complex|vitamin b complex|mesh-ancestor
139514701|NCT05642702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139514702|NCT05642702|Antimetabolites|antimetabolites|mesh-ancestor
139514703|NCT05642702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139514704|NCT05642702|Vasodilator Agents|vasodilator agents|mesh-ancestor
139514705|NCT02254772|Ipilimumab|ipilimumab|mesh-list
139514706|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139514707|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514708|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139514709|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514710|NCT01682044|Rituximab|rituximab|mesh-list
139514711|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139514712|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514713|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
139514714|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514715|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514716|NCT05640596|Betamethasone|betamethasone|mesh-list
139514717|NCT05640596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514718|NCT05640596|Glucocorticoids|glucocorticoids|mesh-ancestor
139514719|NCT05640596|Hormones|hormones|mesh-ancestor
139514720|NCT05640596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139514721|NCT05640596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514722|NCT05640596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139514723|NCT05640596|Respiratory System Agents|respiratory system agents|mesh-ancestor
139514724|NCT05651126|Psilocybin|psilocybin|mesh-list
139514725|NCT05651126|Hallucinogens|hallucinogens|mesh-ancestor
139514726|NCT05651126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514727|NCT05651126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139514728|NCT01696942|Mesalamine|mesalamine|mesh-list
139514729|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514730|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514731|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514732|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139514733|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139514734|NCT01696942|Analgesics|analgesics|mesh-ancestor
139514735|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
139514736|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514737|NCT04871204|Octreotide|octreotide|mesh-list
139301454|NCT01314222|Pregabalin|pregabalin|mesh-list
139514738|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139514739|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139514740|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514741|NCT05650268|Vitamin D|vitamin d|mesh-list
139514742|NCT05650268|Ergocalciferols|ergocalciferols|mesh-list
139514743|NCT05650268|Cholecalciferol|cholecalciferol|mesh-list
139514744|NCT05650268|Vitamins|vitamins|mesh-list
139514745|NCT05650268|Micronutrients|micronutrients|mesh-ancestor
139514746|NCT05650268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514747|NCT05650268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139514748|NCT05650268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139514749|NCT04835870|Prednisone|prednisone|mesh-list
139514750|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
139514751|NCT04835870|Rituximab|rituximab|mesh-list
139514752|NCT04835870|Doxorubicin|doxorubicin|mesh-list
139514753|NCT04835870|Vincristine|vincristine|mesh-list
139514754|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
139514755|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139514756|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
139514757|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514758|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514759|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139514760|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
139514761|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514762|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514763|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139514764|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139514765|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139514766|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139514767|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139514768|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514769|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514770|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
139514771|NCT04835870|Hormones|hormones|mesh-ancestor
139514772|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139514773|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139120403|NCT05609656|Pembrolizumab|pembrolizumab|mesh-list
139514774|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139514775|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
139514776|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
139514777|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
139514778|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139514779|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139514780|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
139514781|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514782|NCT04834310|Clindamycin|clindamycin|mesh-list
139514783|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
139514784|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
139514785|NCT04834310|Cefazolin|cefazolin|mesh-list
139514786|NCT04834310|Cephalexin|cephalexin|mesh-list
139514787|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139514788|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514789|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139514790|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514791|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514792|NCT05372198|Immunomodulating Agents|immunomodulating agents|mesh-list
139514793|NCT05372198|Immunologic Factors|immunologic factors|mesh-ancestor
139514794|NCT05372198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514795|NCT05359406|Tislelizumab|tislelizumab|mesh-list
139514796|NCT05359406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139514797|NCT05359406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514798|NCT04654208|Palbociclib|palbociclib|mesh-list
139514799|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514800|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139514801|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514802|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514803|NCT04844216|Lidocaine|lidocaine|mesh-list
139514804|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
139514805|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
139514806|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
139514807|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139514808|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514809|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
139514810|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514811|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139301529|NCT01166412|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139514812|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139514813|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139514814|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139514815|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514816|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139514817|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
139514818|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
139514819|NCT04844216|Protective Agents|protective agents|mesh-ancestor
139514821|NCT05345678|Tremelimumab|tremelimumab|mesh-list
139514822|NCT05345678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139514823|NCT05345678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514824|NCT05327738|Atezolizumab|atezolizumab|mesh-list
139514825|NCT05327738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139514826|NCT05327738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139514827|NCT05327738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514828|NCT05327738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139514829|NCT05327738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514830|NCT05327738|Immunologic Factors|immunologic factors|mesh-ancestor
139514831|NCT05327738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514832|NCT04419662|Phenylephrine|phenylephrine|mesh-list
139514833|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
139514834|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139514835|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
139514836|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
139514837|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514838|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514839|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
139514840|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139514841|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
139514842|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
139514843|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139514844|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139514845|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139514846|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
139514847|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139514848|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514849|NCT04419662|Protective Agents|protective agents|mesh-ancestor
139514850|NCT04589546|Niacinamide|niacinamide|mesh-list
139514851|NCT04589546|Niacin|niacin|mesh-list
139514852|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
139514853|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
139514854|NCT04589546|Vitamins|vitamins|mesh-ancestor
139120699|NCT00823342|Tenofovir|tenofovir|mesh-list
139514855|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
139514856|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514857|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139514858|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
139514859|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514860|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139514861|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
139514862|NCT02164513|Fluticasone|fluticasone|mesh-list
139514863|NCT02164513|Xhance|xhance|mesh-list
139514864|NCT02164513|Bromides|bromides|mesh-list
139514865|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514866|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139514867|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
139514868|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514869|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514870|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139514871|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
139514872|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
139514873|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139514874|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
139514875|NCT04513184|Dexamethasone|dexamethasone|mesh-list
139514876|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
139514877|NCT04513184|BB 1101|bb 1101|mesh-list
139514878|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514879|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
139514880|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
139514881|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514882|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514883|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139514884|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
139514885|NCT04513184|Hormones|hormones|mesh-ancestor
139514886|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139514887|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139514888|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514889|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
139514890|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514891|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514892|NCT04756531|Nirmatrelvir|nirmatrelvir|mesh-list
139514893|NCT04756531|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139514894|NCT04756531|Protease Inhibitors|protease inhibitors|mesh-ancestor
139514895|NCT04756531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514896|NCT04756531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514897|NCT04756531|Antiviral Agents|antiviral agents|mesh-ancestor
139514898|NCT04756531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514899|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139514900|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139514901|NCT01713946|Everolimus|everolimus|mesh-list
139514902|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
139514903|NCT01713946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139514904|NCT01713946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139514905|NCT01713946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514906|NCT01713946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514907|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139514908|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
139514909|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514910|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514911|NCT04464512|Sufentanil|sufentanil|mesh-list
139514912|NCT04464512|Buprenorphine|buprenorphine|mesh-list
139514913|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139514914|NCT04464512|Narcotics|narcotics|mesh-ancestor
139514915|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139514916|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514917|NCT04464512|Analgesics|analgesics|mesh-ancestor
139514918|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
139514919|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514920|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139514921|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139514922|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139514923|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
139514924|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
139514925|NCT02191579|Topiramate|topiramate|mesh-list
139514926|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
139514927|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139514928|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139514929|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139514930|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139514931|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514932|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
139514933|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139514934|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514935|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139514936|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514937|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
139514938|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139514939|NCT05324462|Xultophy|xultophy|mesh-list
139514940|NCT05324462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139514941|NCT05324462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514942|NCT05324462|Incretins|incretins|mesh-ancestor
139514943|NCT05324462|Hormones|hormones|mesh-ancestor
139120920|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
139514944|NCT05324462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139514945|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139514946|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139514947|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139514948|NCT01363700|Epinastine|epinastine|mesh-list
139514949|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139514950|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139514951|NCT01363700|Analgesics|analgesics|mesh-ancestor
139514952|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
139514953|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514954|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514955|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514956|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139514957|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139514958|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139514959|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139514960|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
139514961|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
139514962|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139514963|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514964|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
139514965|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139514966|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514967|NCT04372706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139514968|NCT04372706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514970|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
139514971|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139514972|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514973|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139514974|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139514975|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139514976|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139514977|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
139514978|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
139514979|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139514980|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139514981|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
139514982|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139514983|NCT04327934|Testosterone|testosterone|mesh-list
139514984|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
139514985|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
139514986|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139514987|NCT04327934|Hormones|hormones|mesh-ancestor
139514988|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139514989|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139514990|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139514991|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139514992|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
139514993|NCT04327934|Androgens|androgens|mesh-ancestor
139514994|NCT04791566|Dexamethasone|dexamethasone|mesh-list
139514995|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139514996|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
139514997|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
139514998|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139514999|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515000|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139515001|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
139515002|NCT04791566|Hormones|hormones|mesh-ancestor
139515003|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515004|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139515005|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515006|NCT04129736|Teriflunomide|teriflunomide|mesh-list
139515007|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139515008|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139515009|NCT04129736|Analgesics|analgesics|mesh-ancestor
139515010|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
139515011|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515012|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515013|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139121102|NCT00071799|Cytarabine|cytarabine|mesh-list
139515014|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139515015|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139515016|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
139515017|NCT01637402|Prednisone|prednisone|mesh-list
139515018|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
139515019|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515020|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
139515021|NCT01637402|Hormones|hormones|mesh-ancestor
139515022|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515023|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515024|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139515025|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515026|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139515027|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515028|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515029|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
139515030|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139515031|NCT04419038|Mitomycins|mitomycins|mesh-list
139515032|NCT04419038|Mitomycin|mitomycin|mesh-list
139515033|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139515034|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515035|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
139515036|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515037|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139515038|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515039|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
139515040|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139515041|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515042|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139515043|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139515044|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
139515045|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515046|NCT04818944|Tirofiban|tirofiban|mesh-list
139515047|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139515048|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139515049|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515050|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139515051|NCT02189941|Deferiprone|deferiprone|mesh-list
139515052|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139515053|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
139515054|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
139121198|NCT03731468|Hormones|hormones|mesh-ancestor
139515055|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515056|NCT01601132|Colchicine|colchicine|mesh-list
139515057|NCT01601132|Theophylline|theophylline|mesh-list
139515058|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
139515059|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139515060|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
139515061|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
139515062|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
139515063|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515064|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515065|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139515066|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
139515067|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515068|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515069|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139515070|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
139515071|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139515072|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515073|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
139515074|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139515075|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139515076|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
139515077|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139515078|NCT04836962|Dexamethasone|dexamethasone|mesh-list
139515079|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515080|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
139515081|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
139515082|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515083|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515084|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139515085|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
139515086|NCT04836962|Hormones|hormones|mesh-ancestor
139515087|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515088|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139515089|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515090|NCT05289440|Esketamine|esketamine|mesh-list
139515091|NCT05289440|Antidepressive Agents|antidepressive agents|mesh-ancestor
139515092|NCT05289440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139515093|NCT04809974|Niacinamide|niacinamide|mesh-list
139515094|NCT04809974|Vitamins|vitamins|mesh-ancestor
139515095|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
139515096|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515097|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
139515098|NCT04691960|Metformin|metformin|mesh-list
139515099|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139515100|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515101|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
139515102|NCT04809038|Analgesics|analgesics|mesh-ancestor
139515103|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
139515104|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515105|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515106|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
139515107|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139515108|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139515109|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
139515110|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139515111|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139515112|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515113|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139301830|NCT05628558|Coagulants|coagulants|mesh-ancestor
139515114|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
139515115|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139515116|NCT05221190|Lidocaine|lidocaine|mesh-list
139515117|NCT05221190|Anesthetics, Local|anesthetics, local|mesh-ancestor
139515118|NCT05221190|Anesthetics|anesthetics|mesh-ancestor
139515119|NCT05221190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139515120|NCT05221190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515121|NCT05221190|Sensory System Agents|sensory system agents|mesh-ancestor
139515122|NCT05221190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515123|NCT05221190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139515124|NCT05221190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139515125|NCT05221190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139515126|NCT05221190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139515127|NCT05221190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515128|NCT04816682|Silymarin|silymarin|mesh-list
139515129|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
139515130|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515131|NCT04816682|Protective Agents|protective agents|mesh-ancestor
139515132|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515133|NCT02162719|Paclitaxel|paclitaxel|mesh-list
139515134|NCT02162719|Ipatasertib|ipatasertib|mesh-list
139515135|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139515136|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515137|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
139515138|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
139515139|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
139515140|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515141|NCT02162719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139515142|NCT02162719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515143|NCT04808882|Tinzaparin|tinzaparin|mesh-list
139515144|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139515145|NCT04808882|Dalteparin|dalteparin|mesh-list
139515146|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
139121528|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
139515147|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139515148|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139515149|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515150|NCT05652374|Nitrofurantoin|nitrofurantoin|mesh-list
139515151|NCT05652374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139515152|NCT05652374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515153|NCT05652374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139515154|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139515155|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139515156|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
139515157|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515158|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515159|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139515160|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
139515161|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139515162|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139515163|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139515164|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
139515165|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139515166|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515167|NCT03029000|Lenograstim|lenograstim|mesh-list
139515168|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139515169|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
139515170|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515171|NCT03783182|Betamethasone|betamethasone|mesh-list
139515172|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
139515173|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139515174|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
139515175|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139515176|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
139515177|NCT03783182|Hormones|hormones|mesh-ancestor
139515178|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515179|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515180|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515181|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139515182|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
139515183|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
139515184|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139515185|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515186|NCT05651750|Fluticasone|fluticasone|mesh-list
139515187|NCT05651750|Xhance|xhance|mesh-list
139515188|NCT05651750|Montelukast|montelukast|mesh-list
139515189|NCT05651750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515191|NCT05651750|Autonomic Agents|autonomic agents|mesh-ancestor
139515192|NCT05651750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515193|NCT05651750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515194|NCT05651750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139515195|NCT05651750|Respiratory System Agents|respiratory system agents|mesh-ancestor
139515196|NCT05651750|Dermatologic Agents|dermatologic agents|mesh-ancestor
139121711|NCT03724838|Esomeprazole|esomeprazole|mesh-list
139515197|NCT05651750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139515198|NCT05651750|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139515199|NCT05651750|Hormone Antagonists|hormone antagonists|mesh-ancestor
139515200|NCT05651750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515201|NCT05651750|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139515202|NCT05651750|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139515203|NCT05651750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515204|NCT02160145|Tolvaptan|tolvaptan|mesh-list
139515205|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139515206|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515207|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
139515208|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515209|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
139515210|NCT02216071|Dexamethasone|dexamethasone|mesh-list
139515211|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
139515212|NCT02216071|BB 1101|bb 1101|mesh-list
139515213|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515214|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
139515215|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
139121772|NCT00086385|Bupropion|bupropion|mesh-list
139515216|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515217|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515218|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139515219|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
139515220|NCT02216071|Hormones|hormones|mesh-ancestor
139515221|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515222|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139515223|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515224|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
139515225|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121822|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139515226|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515227|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139515228|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515229|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139515230|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139515231|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139515232|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139515233|NCT01681576|Valsartan|valsartan|mesh-list
139515234|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139515235|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139515236|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139515237|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139515238|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515239|NCT02188459|Bupropion|bupropion|mesh-list
139515240|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139515241|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
139515242|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139515243|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139515244|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139515245|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139515246|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515247|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
139515248|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139515249|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515250|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139515251|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139515252|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515253|NCT02743364|Simvastatin|simvastatin|mesh-list
139515254|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139515255|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139515256|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
139515257|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515258|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139301979|NCT01117584|Metformin|metformin|mesh-list
139515259|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139515261|NCT02214121|Ticagrelor|ticagrelor|mesh-list
139515262|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139515263|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139515264|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139515265|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139515266|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
139515267|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139515268|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515269|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515270|NCT01681186|Lansoprazole|lansoprazole|mesh-list
139515271|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
139515272|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139515273|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139515274|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139515275|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515276|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515277|NCT01695772|Bevacizumab|bevacizumab|mesh-list
139515278|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139515279|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515280|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139515281|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139515282|NCT01695772|Growth Substances|growth substances|mesh-ancestor
139515283|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515284|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
139515285|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139515286|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139515287|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139515288|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515289|NCT01636934|Minocycline|minocycline|mesh-list
139515290|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139515291|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515292|NCT01712854|Budesonide|budesonide|mesh-list
139515293|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139515294|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515295|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139515296|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
139515297|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515298|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515299|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139515300|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
139515301|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
139515302|NCT01712854|Hormones|hormones|mesh-ancestor
139515303|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515304|NCT02986594|Aspirin|aspirin|mesh-list
139515305|NCT02986594|Heparin|heparin|mesh-list
139515306|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139515307|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139515308|NCT02986594|Analgesics|analgesics|mesh-ancestor
139515309|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
139515310|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515311|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515312|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515313|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139515314|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139515315|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139570313|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139515316|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515317|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139515318|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139515319|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515320|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
139515321|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
139515322|NCT02159365|Dexamethasone|dexamethasone|mesh-list
139515323|NCT02159365|Lenalidomide|lenalidomide|mesh-list
139515324|NCT02159365|Elotuzumab|elotuzumab|mesh-list
139515325|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515326|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
139515327|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
139515328|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515329|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515330|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139515331|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
139515332|NCT02159365|Hormones|hormones|mesh-ancestor
139515333|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515334|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139515335|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515336|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
139515337|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139515338|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139515339|NCT02159365|Growth Substances|growth substances|mesh-ancestor
139515340|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
139515341|NCT02072200|Prednisone|prednisone|mesh-list
139515342|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515343|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
139515344|NCT02072200|Hormones|hormones|mesh-ancestor
139515345|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515346|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515347|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139515348|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515349|NCT01691794|Ritonavir|ritonavir|mesh-list
139515350|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139515351|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139515352|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139515353|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
139515354|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515355|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515356|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139515357|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139515358|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
139515359|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515360|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139515361|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139515362|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139515363|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
139515364|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515365|NCT02158975|Ixazomib|ixazomib|mesh-list
139515366|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515367|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
139515368|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515369|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515370|NCT02158039|Ethanol|ethanol|mesh-list
139515371|NCT02158039|Lidocaine|lidocaine|mesh-list
139515372|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
139515373|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
139515374|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139515375|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515376|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
139515377|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515378|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139515379|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139515380|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139515381|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139515382|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515383|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139515384|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515385|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139515386|NCT03563222|SMOFlipid|smoflipid|mesh-list
139515387|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139515388|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139515389|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139515390|NCT02490800|Lisavanbulin|lisavanbulin|mesh-list
139515391|NCT02490800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139515392|NCT02490800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515393|NCT02490800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139515394|NCT02490800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515395|NCT01635764|Adalimumab|adalimumab|mesh-list
139515396|NCT01635764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139515397|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515398|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139515399|NCT04810598|Venetoclax|venetoclax|mesh-list
139515400|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515401|NCT02158052|Tacrolimus|tacrolimus|mesh-list
139515402|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139515403|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139515404|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
139515405|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515406|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139515407|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515408|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515409|NCT01635218|Fluoxetine|fluoxetine|mesh-list
139515410|NCT01635218|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139515411|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139515412|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139515413|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515414|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139515415|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
139515416|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515417|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139515418|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
139515419|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139515420|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139515421|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139515422|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515423|NCT05351684|Dolutegravir|dolutegravir|mesh-list
139515424|NCT05351684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139515425|NCT05351684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139515426|NCT05351684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515427|NCT05351684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515428|NCT05351684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139515429|NCT05351684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139515430|NCT05351684|Antiviral Agents|antiviral agents|mesh-ancestor
139515431|NCT05351684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515432|NCT02049866|Denosumab|denosumab|mesh-list
139515433|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139515434|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515435|NCT04274894|Testosterone|testosterone|mesh-list
139515436|NCT04274894|Androgens|androgens|mesh-ancestor
139515437|NCT04274894|Hormones|hormones|mesh-ancestor
139515438|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515439|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515440|NCT04786964|Folic Acid|folic acid|mesh-list
139515441|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
139515442|NCT04786964|Dexamethasone|dexamethasone|mesh-list
139515443|NCT04786964|Carboplatin|carboplatin|mesh-list
139515444|NCT04786964|Pemetrexed|pemetrexed|mesh-list
139515445|NCT04786964|Vitamins|vitamins|mesh-ancestor
139515446|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
139515447|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515448|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515449|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
139515450|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
139515451|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515452|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139515453|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
139515454|NCT04786964|Hormones|hormones|mesh-ancestor
139515455|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515456|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139515457|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515458|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515459|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515460|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139515461|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139515462|NCT04786964|Hematinics|hematinics|mesh-ancestor
139515463|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
139515464|NCT02213263|Rituximab|rituximab|mesh-list
139515465|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139515466|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515467|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
139515468|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515469|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139515470|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
139515471|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139515472|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515473|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
139515474|NCT04216784|Furosemide|furosemide|mesh-list
139515475|NCT04216784|Diuretics|diuretics|mesh-ancestor
139515476|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
139515477|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515478|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139515479|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139515480|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515481|NCT01975064|Propofol|propofol|mesh-list
139515483|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139515484|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139515485|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515486|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139515487|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
139515488|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
139122523|NCT03673956|Levofloxacin|levofloxacin|mesh-list
139515489|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139515490|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139515491|NCT02210689|Clindamycin|clindamycin|mesh-list
139515492|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
139515493|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
139515494|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139515495|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515496|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139515497|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515498|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515499|NCT02209597|Bupropion|bupropion|mesh-list
139515500|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139515501|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
139122598|NCT01311050|Bevacizumab|bevacizumab|mesh-list
139515502|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139515503|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139515504|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139515505|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139515506|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515507|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
139515508|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139515509|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515510|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139515511|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139515512|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515513|NCT01469156|Ranibizumab|ranibizumab|mesh-list
139515514|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139515515|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139515516|NCT01469156|Growth Substances|growth substances|mesh-ancestor
139515517|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515518|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
139515519|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515520|NCT04191434|Budesonide|budesonide|mesh-list
139515521|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
139515522|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139515523|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515524|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139515525|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
139515526|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515527|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515528|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139515529|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
139515530|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
139515531|NCT04191434|Hormones|hormones|mesh-ancestor
139515532|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515533|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139515534|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139515535|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139515536|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
139515537|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139515538|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515539|NCT03835676|Treprostinil|treprostinil|mesh-list
139515540|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139515541|NCT03651128|Dexamethasone|dexamethasone|mesh-list
139515542|NCT03651128|Lenalidomide|lenalidomide|mesh-list
139515543|NCT03651128|Bortezomib|bortezomib|mesh-list
139515544|NCT03651128|Daratumumab|daratumumab|mesh-list
139515545|NCT03651128|Pomalidomide|pomalidomide|mesh-list
139515546|NCT03651128|Ixazomib|ixazomib|mesh-list
139515547|NCT03651128|Elotuzumab|elotuzumab|mesh-list
139515548|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515549|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
139515550|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
139515551|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515552|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515553|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139302273|NCT00841698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515554|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
139515555|NCT03651128|Hormones|hormones|mesh-ancestor
139515556|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515557|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139515558|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515559|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
139122765|NCT03619330|Hormones|hormones|mesh-ancestor
139515560|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139515561|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139515562|NCT03651128|Growth Substances|growth substances|mesh-ancestor
139515563|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
139515564|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
139515565|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515566|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515567|NCT00664898|Bortezomib|bortezomib|mesh-list
139515568|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515569|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139515570|NCT04776980|Hematinics|hematinics|mesh-ancestor
139515571|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139515572|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139515573|NCT02187055|Adalimumab|adalimumab|mesh-list
139515574|NCT02187055|Methotrexate|methotrexate|mesh-list
139515575|NCT02187055|Tofacitinib|tofacitinib|mesh-list
139515576|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139515577|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
139515578|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139515579|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515580|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139515581|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
139515582|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515583|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515584|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
139515585|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515586|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139515587|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139515588|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
139515589|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139515590|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139515591|NCT02187055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139515592|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515593|NCT02187055|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139515594|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139515595|NCT00119366|Iodine|iodine|mesh-list
139515596|NCT00119366|Cyclosporine|cyclosporine|mesh-list
139515597|NCT00119366|Mycophenolic Acid|mycophenolic acid|mesh-list
139515598|NCT00119366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139515599|NCT00119366|Fludarabine|fludarabine|mesh-list
139515600|NCT00119366|Fludarabine phosphate|fludarabine phosphate|mesh-list
139515601|NCT00119366|Antibodies|antibodies|mesh-list
139515602|NCT00119366|Immunoglobulins|immunoglobulins|mesh-list
139515603|NCT00119366|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139515604|NCT00119366|Cyclosporins|cyclosporins|mesh-list
139515605|NCT00119366|Immunologic Factors|immunologic factors|mesh-ancestor
139515606|NCT00119366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515607|NCT00119366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515608|NCT00119366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139515609|NCT00119366|Antimetabolites|antimetabolites|mesh-ancestor
139515610|NCT00119366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515611|NCT00119366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139515612|NCT00119366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515613|NCT00119366|Antifungal Agents|antifungal agents|mesh-ancestor
139515614|NCT00119366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515615|NCT00119366|Dermatologic Agents|dermatologic agents|mesh-ancestor
139515616|NCT00119366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139515617|NCT00119366|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139515618|NCT00119366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139515619|NCT00119366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139515620|NCT00119366|Antitubercular Agents|antitubercular agents|mesh-ancestor
139515621|NCT00119366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139515622|NCT00119366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139515623|NCT00119366|Trace Elements|trace elements|mesh-ancestor
139515624|NCT00119366|Micronutrients|micronutrients|mesh-ancestor
139515625|NCT02246660|Resveratrol|resveratrol|mesh-list
139515626|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
139515627|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515628|NCT02246660|Protective Agents|protective agents|mesh-ancestor
139515629|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515630|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515631|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139515632|NCT02246582|Insulin|insulin|mesh-list
139515633|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139515634|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515635|NCT02137369|Dexetimide|dexetimide|mesh-list
139515636|NCT02137369|Citalopram|citalopram|mesh-list
139515637|NCT02137369|Sertraline|sertraline|mesh-list
139515638|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
139515639|NCT02137369|Escitalopram|escitalopram|mesh-list
139515640|NCT02137369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139515641|NCT02137369|Serotonin|serotonin|mesh-list
139515642|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139515643|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139515644|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515645|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139515646|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
139515647|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515648|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139515649|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139515650|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
139515651|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
139515652|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122978|NCT03692416|Analgesics|analgesics|mesh-ancestor
139515653|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139515654|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139515655|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
139515656|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139515657|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139515658|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139515659|NCT02155309|Scopolamine|scopolamine|mesh-list
139515660|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139515661|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139515662|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
139515663|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
139515664|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515665|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515666|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139515667|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
139515668|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139515669|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
139515670|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139515671|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515672|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139515673|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
139515674|NCT02186821|Ceritinib|ceritinib|mesh-list
139515675|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515676|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139515677|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515678|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515679|NCT01710358|Adalimumab|adalimumab|mesh-list
139515680|NCT01710358|Methotrexate|methotrexate|mesh-list
139515681|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139515682|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
139515683|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139515684|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515685|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139515686|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
139515687|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515688|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515689|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
139515690|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515691|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139515692|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139515693|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
139515694|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139123093|NCT03029650|Scopolamine|scopolamine|mesh-list
139515695|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139515696|NCT01710358|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139515697|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515698|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
139515699|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139515700|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
139515701|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139515702|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515703|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139515704|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
139515705|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302422|NCT03512756|Sirolimus|sirolimus|mesh-list
139515706|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139515707|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139515708|NCT03455270|Palbociclib|palbociclib|mesh-list
139515709|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515710|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139515711|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515712|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515714|NCT01691482|Ipratropium|ipratropium|mesh-list
139515715|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139515716|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
139515717|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515718|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515719|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139515720|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
139515721|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
139515722|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139515723|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139515724|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139515725|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139515726|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
139515727|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139515728|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515729|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139515730|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
139515731|NCT01710046|Tofacitinib|tofacitinib|mesh-list
139515732|NCT01710046|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139515733|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139515734|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515735|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515736|NCT02154529|Trastuzumab|trastuzumab|mesh-list
139515737|NCT02154529|XL647|xl647|mesh-list
139515738|NCT02154529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139515739|NCT02154529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570314|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
139515740|NCT02154529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139515741|NCT02154529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515742|NCT02154529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515743|NCT02154139|Leuprolide|leuprolide|mesh-list
139515744|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139515745|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
139515746|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139515747|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515748|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139515749|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515750|NCT02154061|Metronidazole|metronidazole|mesh-list
139515751|NCT02154061|Vancomycin|vancomycin|mesh-list
139515752|NCT02154061|Neomycin|neomycin|mesh-list
139515753|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515754|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139515755|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139515756|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139515757|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139515758|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515759|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515760|NCT01907217|Methohexital|methohexital|mesh-list
139515761|NCT01907217|Succinylcholine|succinylcholine|mesh-list
139515762|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139515763|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139515764|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139515765|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515766|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515767|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139515768|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
139515769|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
139515770|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139515771|NCT01953783|Ixazomib|ixazomib|mesh-list
139515772|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515773|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
139515774|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515775|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515776|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139515777|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515778|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139515779|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302495|NCT05349006|Azathioprine|azathioprine|mesh-list
139515780|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515782|NCT04619979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139515783|NCT04619979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515784|NCT01630135|Fluticasone|fluticasone|mesh-list
139515785|NCT01630135|Xhance|xhance|mesh-list
139515786|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515787|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139515788|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
139515789|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515790|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515791|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139515792|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
139515793|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
139515794|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139515795|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
139515796|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139515797|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515798|NCT01924767|Empagliflozin|empagliflozin|mesh-list
139515799|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139515800|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515801|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139515802|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515803|NCT01691092|Ketamine|ketamine|mesh-list
139515804|NCT01691092|Analgesics|analgesics|mesh-ancestor
139515805|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
139515806|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570315|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
139515807|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515808|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139515809|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139515810|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
139515811|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
139515812|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139515813|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139515814|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139515815|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139515816|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515817|NCT02133001|Esketamine|esketamine|mesh-list
139515818|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
139515819|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139515820|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
139515821|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
139515822|NCT01709578|Methotrexate|methotrexate|mesh-list
139515823|NCT01709578|Leflunomide|leflunomide|mesh-list
139515824|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139515825|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
139515826|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139515827|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515828|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139515829|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
139515830|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515831|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515832|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
139515833|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515834|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139515835|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139515836|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
139515837|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139515838|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139515839|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
139515840|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139515841|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139515842|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123523|NCT03624010|Simendan|simendan|mesh-list
139515843|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139515844|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139515845|NCT01709578|Analgesics|analgesics|mesh-ancestor
139515846|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
139515847|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515848|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515849|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139515850|NCT02132767|Digoxin|digoxin|mesh-list
139515851|NCT02132767|Amiodarone|amiodarone|mesh-list
139515852|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
139302579|NCT04037072|Mitomycins|mitomycins|mesh-list
139515853|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139515854|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515855|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139515856|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139515857|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515858|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515859|NCT02132767|Protective Agents|protective agents|mesh-ancestor
139515860|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
139515861|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139515862|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139515863|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139515864|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139515865|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139515866|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139570316|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
139515867|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139515868|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139515869|NCT02153905|Aldesleukin|aldesleukin|mesh-list
139515870|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
139515871|NCT02153905|Fludarabine|fludarabine|mesh-list
139515872|NCT02153905|Interleukin-2|interleukin-2|mesh-list
139515873|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139515874|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
139515875|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515876|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139515877|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139515878|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
139515879|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515880|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515881|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139515882|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139515883|NCT02153905|Analgesics|analgesics|mesh-ancestor
139515884|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
139515885|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515886|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139515887|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139515888|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
139515889|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515890|NCT04752631|Tenecteplase|tenecteplase|mesh-list
139515891|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139515892|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139515893|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515894|NCT02244944|Ezetimibe|ezetimibe|mesh-list
139515895|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139515896|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139515897|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
139515898|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515899|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139515900|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139515901|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
139515902|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515903|NCT01591096|Plasminogen|plasminogen|mesh-list
139515904|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139515905|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139515906|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139515907|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515908|NCT01953003|Capecitabine|capecitabine|mesh-list
139515909|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139515910|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
139515911|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515912|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515913|NCT01709500|Atorvastatin|atorvastatin|mesh-list
139515914|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139515915|NCT01709500|Simvastatin|simvastatin|mesh-list
139515916|NCT01709500|Alirocumab|alirocumab|mesh-list
139515917|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139515918|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139515919|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
139515920|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515921|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139515922|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139515923|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515924|NCT01709500|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139515925|NCT01709500|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139515926|NCT01709500|Protease Inhibitors|protease inhibitors|mesh-ancestor
139302641|NCT05617690|Anesthetics|anesthetics|mesh-ancestor
139515927|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
139515928|NCT01599806|Ceftazidime|ceftazidime|mesh-list
139515929|NCT01599806|Avibactam|avibactam|mesh-list
139515930|NCT01599806|Doripenem|doripenem|mesh-list
139515931|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139515932|NCT01599806|Trimethoprim|trimethoprim|mesh-list
139515933|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
139515934|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139515935|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515936|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139515937|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139515938|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515939|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515940|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515941|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139515942|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139515943|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139515944|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
139515945|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139515946|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139515947|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139515948|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139515949|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139515950|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139515951|NCT01599325|Azacitidine|azacitidine|mesh-list
139515952|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139515953|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
139515954|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515955|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515956|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515957|NCT01924299|Fluconazole|fluconazole|mesh-list
139515958|NCT01924299|Ketoconazole|ketoconazole|mesh-list
139515959|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
139515960|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515961|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139515962|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139515963|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139515964|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515965|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139515966|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
139515967|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139515968|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515969|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139515970|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139515971|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139515972|NCT02182999|Ropivacaine|ropivacaine|mesh-list
139515973|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
139515974|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
139515975|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139515976|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515977|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
139515978|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139515979|NCT01598311|Vancomycin|vancomycin|mesh-list
139515980|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139515981|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139515982|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
139515983|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139515984|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139515985|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139515986|NCT02978222|Molgramostim|molgramostim|mesh-list
139515987|NCT02978222|Sargramostim|sargramostim|mesh-list
139124138|NCT02915302|Vaccines|vaccines|mesh-list
139515988|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
139515989|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515990|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139515991|NCT02181673|Golimumab|golimumab|mesh-list
139515992|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139515993|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139515994|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139515995|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
139515996|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139515997|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
139515998|NCT02152345|Abatacept|abatacept|mesh-list
139515999|NCT02152345|Tacrolimus|tacrolimus|mesh-list
139516000|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139516001|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
139516002|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139516004|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516005|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139516006|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516007|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516008|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516009|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139516010|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
139516011|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
139516012|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516013|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139516014|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
139516015|NCT02152345|Hormones|hormones|mesh-ancestor
139516016|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139516017|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139516018|NCT02152345|Protective Agents|protective agents|mesh-ancestor
139516019|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139516020|NCT02152345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139516021|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139516022|NCT02180659|Buprenorphine|buprenorphine|mesh-list
139516023|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139516024|NCT02180659|Narcotics|narcotics|mesh-ancestor
139516025|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516026|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516027|NCT02180659|Analgesics|analgesics|mesh-ancestor
139516028|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
139516029|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516030|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139516031|NCT02207816|Vaccines|vaccines|mesh-list
139516032|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
139516033|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516034|NCT02241512|Ibuprofen|ibuprofen|mesh-list
139516035|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139516036|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139516037|NCT02241512|Analgesics|analgesics|mesh-ancestor
139516038|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
139516039|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516040|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516041|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139516042|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139516043|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139516044|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516045|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516046|NCT01709110|Vitamin D|vitamin d|mesh-list
139516047|NCT01709110|Teriparatide|teriparatide|mesh-list
139516048|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
139516049|NCT01709110|Calcium|calcium|mesh-list
139516050|NCT01709110|Vitamins|vitamins|mesh-ancestor
139516051|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
139516052|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516053|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139516054|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139516055|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139516056|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139516057|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516058|NCT02240108|Rifaximin|rifaximin|mesh-list
139516059|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139516060|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516061|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139516062|NCT01590082|Doxycycline|doxycycline|mesh-list
139516063|NCT01590082|Temozolomide|temozolomide|mesh-list
139516064|NCT01590082|Ipilimumab|ipilimumab|mesh-list
139516065|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139516066|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
139516067|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516068|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516069|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139516070|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139516071|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139516072|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516073|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
139124513|NCT01099839|Miglitol|miglitol|mesh-list
139516074|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139516075|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139516076|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139516077|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139516078|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139516079|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516080|NCT02179177|Apixaban|apixaban|mesh-list
139516081|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139516082|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
139516083|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139516084|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
139516085|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516086|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516087|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
139516088|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139516089|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139516090|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139516091|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516092|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516093|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139516094|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139516095|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139516096|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139516097|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
139516098|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516099|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516100|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139516101|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139516102|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
139516103|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139516104|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139516105|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
139516106|NCT02129647|Axitinib|axitinib|mesh-list
139516107|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516108|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139516109|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516110|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516111|NCT02238626|Ibudilast|ibudilast|mesh-list
139516112|NCT02238626|Riluzole|riluzole|mesh-list
139516113|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
139516114|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139516115|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139516116|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516117|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516118|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516119|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139516120|NCT02238626|Protective Agents|protective agents|mesh-ancestor
139516121|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139516122|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
139516123|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516124|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139516125|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
139516126|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139516127|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516128|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139516129|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
139516130|NCT02151643|Iron|iron|mesh-list
139516131|NCT02151643|Trace Elements|trace elements|mesh-ancestor
139516132|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
139516133|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516134|NCT02203838|Risperidone|risperidone|mesh-list
139516135|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139516136|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
139516137|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516138|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516139|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516140|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139516141|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139516142|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516143|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139516144|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139516145|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
139516146|NCT02178709|Leucovorin|leucovorin|mesh-list
139516147|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
139516148|NCT02178709|Irinotecan|irinotecan|mesh-list
139516149|NCT02178709|Folfirinox|folfirinox|mesh-list
139516150|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516151|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139516152|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139516153|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516154|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516155|NCT02178709|Antidotes|antidotes|mesh-ancestor
139516156|NCT02178709|Protective Agents|protective agents|mesh-ancestor
139516157|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516158|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
139516159|NCT02178709|Vitamins|vitamins|mesh-ancestor
139516160|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
139516161|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
139516162|NCT02238080|Hematinics|hematinics|mesh-ancestor
139516163|NCT02178553|Bupivacaine|bupivacaine|mesh-list
139124733|NCT03540030|Celecoxib|celecoxib|mesh-list
139516164|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
139516165|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
139516166|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516167|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516168|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
139516169|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516170|NCT01627327|Fluticasone|fluticasone|mesh-list
139516171|NCT01627327|Xhance|xhance|mesh-list
139516172|NCT01627327|Bromides|bromides|mesh-list
139516173|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
139516174|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139516175|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139516176|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
139516177|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516178|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516179|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139516180|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
139516181|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
139516182|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139516183|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
139516184|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139516185|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
139516186|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516187|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516188|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
139516189|NCT01627249|Bevacizumab|bevacizumab|mesh-list
139516190|NCT01627249|Ranibizumab|ranibizumab|mesh-list
139516191|NCT01627249|Aflibercept|aflibercept|mesh-list
139516192|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139516193|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516194|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139516195|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139516196|NCT01627249|Growth Substances|growth substances|mesh-ancestor
139516197|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516198|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
139516199|NCT01688830|Dabigatran|dabigatran|mesh-list
139516200|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
139516201|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139516202|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
139516203|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516204|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516205|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
139516206|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
139516207|NCT01604278|Bromides|bromides|mesh-list
139516208|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
139516209|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139516210|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139516211|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139516212|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
139516213|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516214|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516215|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516216|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
139516217|NCT01687270|Ribavirin|ribavirin|mesh-list
139516218|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
139516219|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516220|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
139124884|NCT00046839|Celecoxib|celecoxib|mesh-list
139516221|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516222|NCT01588990|Leucovorin|leucovorin|mesh-list
139516223|NCT01588990|Bevacizumab|bevacizumab|mesh-list
139516224|NCT01588990|Capecitabine|capecitabine|mesh-list
139516225|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
139516226|NCT01588990|Irinotecan|irinotecan|mesh-list
139302942|NCT00719550|Epirubicin|epirubicin|mesh-list
139516227|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139516228|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516229|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139516230|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139516231|NCT01588990|Growth Substances|growth substances|mesh-ancestor
139516232|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516233|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
139516234|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139124944|NCT00006489|Naltrexone|naltrexone|mesh-list
139516235|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
139516236|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516237|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139516238|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139516239|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516240|NCT01588990|Antidotes|antidotes|mesh-ancestor
139516241|NCT01588990|Protective Agents|protective agents|mesh-ancestor
139516242|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
139516243|NCT01588990|Vitamins|vitamins|mesh-ancestor
139516244|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
139516245|NCT02126839|Albuterol|albuterol|mesh-list
139516246|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139516247|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
139516248|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516249|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516250|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139516251|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
139516252|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
139516253|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139516254|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139516255|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139516256|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139516257|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
139516258|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516259|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516260|NCT02125279|Calcitriol|calcitriol|mesh-list
139516261|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139516262|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516263|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139516264|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139516265|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516266|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139516267|NCT02125279|Vitamins|vitamins|mesh-ancestor
139516268|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
139516269|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139516270|NCT02124811|Minocycline|minocycline|mesh-list
139516271|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139516272|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516273|NCT02148445|Nicotine|nicotine|mesh-list
139516274|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139516275|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
139516276|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516277|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516278|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139516279|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139516280|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
139516281|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516282|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516283|NCT02147587|Tofacitinib|tofacitinib|mesh-list
139516284|NCT02147587|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139516285|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139516286|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516287|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516288|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
139516289|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139516290|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
139516291|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139516292|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516293|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139516294|NCT04751929|Atezolizumab|atezolizumab|mesh-list
139516295|NCT04751929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139516296|NCT04751929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516297|NCT04751929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139516298|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516299|NCT02176291|Buprenorphine|buprenorphine|mesh-list
139516300|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139516301|NCT02176291|Narcotics|narcotics|mesh-ancestor
139516302|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516303|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516304|NCT02176291|Analgesics|analgesics|mesh-ancestor
139516305|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
139516306|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516307|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139516308|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
139516309|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
139516310|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516311|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516312|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516313|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
139516314|NCT02175277|Hematinics|hematinics|mesh-ancestor
139516315|NCT01568866|Dexamethasone|dexamethasone|mesh-list
139516317|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139516318|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
139516319|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
139516320|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516321|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516322|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139516323|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
139516324|NCT01568866|Hormones|hormones|mesh-ancestor
139570317|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
139516325|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139516326|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139516327|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516328|NCT01567852|Ketamine|ketamine|mesh-list
139516329|NCT01567852|Methohexital|methohexital|mesh-list
139516330|NCT01567852|Analgesics|analgesics|mesh-ancestor
139516331|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
139516332|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516333|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516334|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139516335|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139516336|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
139516337|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
139125290|NCT05974501|Celecoxib|celecoxib|mesh-list
139516338|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516339|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139516340|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139516341|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516342|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516343|NCT01587274|Acetaminophen|acetaminophen|mesh-list
139516344|NCT01587274|Naproxen|naproxen|mesh-list
139516345|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139516346|NCT01587274|Oxycodone|oxycodone|mesh-list
139516347|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
139516348|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139516349|NCT01587274|Analgesics|analgesics|mesh-ancestor
139516350|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
139516351|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516352|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516353|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
139516354|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139516355|NCT01587274|Narcotics|narcotics|mesh-ancestor
139516356|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516357|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139516358|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139516359|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139516360|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
139516361|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139516362|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516363|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516364|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139516365|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
139516366|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139516367|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139516368|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139516369|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139516370|NCT01587118|Asenapine|asenapine|mesh-list
139516371|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139516372|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139516373|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516374|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516375|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139516376|NCT01905657|Docetaxel|docetaxel|mesh-list
139516377|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
139516378|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516379|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
139516380|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
139516381|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
139516382|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516383|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139516384|NCT01905657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139516386|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
139516387|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516388|NCT01952145|Insulin|insulin|mesh-list
139516389|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139516390|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
139516391|NCT01952145|Liraglutide|liraglutide|mesh-list
139516392|NCT01952145|Xultophy|xultophy|mesh-list
139516393|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139516394|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516395|NCT01952145|Incretins|incretins|mesh-ancestor
139516396|NCT01952145|Hormones|hormones|mesh-ancestor
139516397|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139516398|NCT01923363|Tazobactam|tazobactam|mesh-list
139516399|NCT01923363|Piperacillin|piperacillin|mesh-list
139516400|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139516401|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139516402|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516403|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139516404|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516405|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516406|NCT01904721|Bimatoprost|bimatoprost|mesh-list
139516407|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139516408|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139516409|NCT01922739|Hydrocodone|hydrocodone|mesh-list
139516410|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139516411|NCT01922739|Narcotics|narcotics|mesh-ancestor
139516412|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516413|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516414|NCT01922739|Analgesics|analgesics|mesh-ancestor
139516415|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
139516416|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516417|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
139516418|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
139516419|NCT02236988|Thalidomide|thalidomide|mesh-list
139516420|NCT02236988|Apremilast|apremilast|mesh-list
139516421|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139516422|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139516423|NCT02236988|Analgesics|analgesics|mesh-ancestor
139516424|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
139516425|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516426|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516427|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139516428|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139516429|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139516430|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139516431|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516432|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516433|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139516434|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
139516435|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
139516436|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139516437|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516438|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139125435|NCT05805761|Anti-Infective Agents|anti-infective agents|mesh-list
139516439|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139516440|NCT02236988|Growth Substances|growth substances|mesh-ancestor
139516441|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
139516442|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516443|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
139516444|NCT02236520|Spironolactone|spironolactone|mesh-list
139516445|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139516446|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
139516447|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139516448|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516449|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139516450|NCT02236520|Diuretics|diuretics|mesh-ancestor
139516451|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
139516452|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139516453|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139516454|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139516455|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516456|NCT04769414|Gemcitabine|gemcitabine|mesh-list
139516457|NCT04769414|Fluorouracil|fluorouracil|mesh-list
139516458|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139516459|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
139516460|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516461|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516462|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139516463|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
139516464|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516465|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
139516466|NCT01922271|Albuterol|albuterol|mesh-list
139516467|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
139516468|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139516469|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
139516470|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516471|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516472|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139516473|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
139516474|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
139516475|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139516476|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
139516477|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516478|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516479|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
139516480|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139516481|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139516482|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139516483|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139516484|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
139516485|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139516486|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139516487|NCT02236130|Acetaminophen|acetaminophen|mesh-list
139516488|NCT02236130|Morphine|morphine|mesh-list
139516489|NCT02236130|Hydrocodone|hydrocodone|mesh-list
139516490|NCT02236130|Analgesics|analgesics|mesh-list
139516491|NCT02236130|Anesthetics|anesthetics|mesh-list
139516492|NCT02236130|Ropivacaine|ropivacaine|mesh-list
139516493|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
139516494|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516495|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516496|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139516497|NCT02236130|Narcotics|narcotics|mesh-ancestor
139516498|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
139516499|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516500|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139516501|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
139516502|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
139516503|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
139516504|NCT01641809|Tenofovir|tenofovir|mesh-list
139516505|NCT01641809|Lamivudine|lamivudine|mesh-list
139516506|NCT01641809|Emtricitabine|emtricitabine|mesh-list
139516507|NCT01641809|Efavirenz|efavirenz|mesh-list
139516508|NCT01641809|Abacavir|abacavir|mesh-list
139516509|NCT01641809|Rilpivirine|rilpivirine|mesh-list
139516510|NCT01641809|Cabotegravir|cabotegravir|mesh-list
139516511|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
139516512|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516513|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139516514|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139516515|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516516|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516517|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139516518|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139516519|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139516520|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139516521|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139516522|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139516523|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139516524|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139516525|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139516526|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139516527|NCT01632566|Celecoxib|celecoxib|mesh-list
139516528|NCT01632566|Simvastatin|simvastatin|mesh-list
139516529|NCT01632566|LY3031207|ly3031207|mesh-list
139516530|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139516531|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139516532|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
139516533|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516534|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139516535|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139516536|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516537|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139516538|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139516539|NCT01632566|Analgesics|analgesics|mesh-ancestor
139516540|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
139516541|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516542|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516543|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139516544|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139516545|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139516546|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139516547|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
139516548|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
139516549|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139516550|NCT02254304|Interferons|interferons|mesh-list
139516551|NCT02254304|Interferon-beta|interferon-beta|mesh-list
139516552|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
139516553|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516554|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
139516555|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516556|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
139516557|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516558|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139516559|NCT05650151|Vitamin D|vitamin d|mesh-list
139516560|NCT05650151|Vitamins|vitamins|mesh-ancestor
139516561|NCT05650151|Micronutrients|micronutrients|mesh-ancestor
139516562|NCT05650151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516563|NCT05650151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139516564|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
139516565|NCT02174731|Hematinics|hematinics|mesh-ancestor
139516566|NCT01922037|Omalizumab|omalizumab|mesh-list
139516567|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139516568|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139516569|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
139516570|NCT02282813|Calcitriol|calcitriol|mesh-list
139516571|NCT02282813|Calcifediol|calcifediol|mesh-list
139125823|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139125825|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139516572|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
139516573|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139516574|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516575|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139516576|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139516577|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516578|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139516579|NCT02282813|Vitamins|vitamins|mesh-ancestor
139516580|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
139516581|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139516582|NCT05638529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139516583|NCT05638529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139516584|NCT05638529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516585|NCT02121847|Cyclosporine|cyclosporine|mesh-list
139516586|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139516587|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139516588|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
139516589|NCT02121847|Cyclosporins|cyclosporins|mesh-list
139516590|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516591|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516592|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139516593|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
139516594|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516595|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
139516596|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516597|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
139516598|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139516599|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139516600|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139516601|NCT02121847|Laxatives|laxatives|mesh-ancestor
139516602|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139516603|NCT01586806|Dexamethasone|dexamethasone|mesh-list
139516604|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
139516605|NCT01586806|Bupivacaine|bupivacaine|mesh-list
139516606|NCT01586806|BB 1101|bb 1101|mesh-list
139516607|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139516608|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
139516609|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
139516610|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516611|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516612|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139516613|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
139516614|NCT01586806|Hormones|hormones|mesh-ancestor
139570318|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516615|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139516616|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139516617|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516618|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
139516619|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516620|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516621|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
139516622|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
139516623|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516624|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
139516625|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139516626|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139516627|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139516628|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
139516629|NCT02143843|Bimatoprost|bimatoprost|mesh-list
139516630|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139516631|NCT01586338|Hylan|hylan|mesh-list
139516632|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
139125905|NCT02969798|Metformin|metformin|mesh-list
139516633|NCT01586338|Protective Agents|protective agents|mesh-ancestor
139516634|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516635|NCT02143141|Morphine|morphine|mesh-list
139516636|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139516637|NCT02143141|Narcotics|narcotics|mesh-ancestor
139516638|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516639|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516640|NCT02143141|Analgesics|analgesics|mesh-ancestor
139516641|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
139516642|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516643|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
139516644|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139516645|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139516646|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139125964|NCT01936532|Dexamethasone|dexamethasone|mesh-list
139516647|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
139516648|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516649|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516650|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516651|NCT05497583|Factor VIII|factor viii|mesh-list
139516652|NCT05497583|Coagulants|coagulants|mesh-ancestor
139516653|NCT02253992|Nivolumab|nivolumab|mesh-list
139516654|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139516655|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516656|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139516657|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516658|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
139516659|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139516660|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516661|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
139516662|NCT01585558|Tamoxifen|tamoxifen|mesh-list
139516663|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139516664|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
139516665|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139516666|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516667|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139516668|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516669|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139516670|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139516671|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139516672|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
139516673|NCT01585246|Urological Agents|urological agents|mesh-ancestor
139516674|NCT01585168|Memantine|memantine|mesh-list
139516675|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139516676|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139516677|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
139516678|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516679|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516680|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516681|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139303388|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
139516682|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139516684|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
139516685|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516686|NCT02231918|Protective Agents|protective agents|mesh-ancestor
139516687|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516688|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139516689|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139516690|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
139516691|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
139516692|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516693|NCT02199314|Desflurane|desflurane|mesh-list
139516694|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139516695|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
139516696|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
139516697|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516698|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516699|NCT02197520|Insulin|insulin|mesh-list
139516700|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139516701|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
139516702|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
139516703|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139516704|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516705|NCT02230904|Rotigotine|rotigotine|mesh-list
139516706|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
139516707|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
139516708|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516709|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516710|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516711|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
139516712|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
139516713|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516714|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516715|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516716|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
139516717|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
139516718|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
139516719|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139516720|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
139516721|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139516722|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139516723|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
139516724|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516725|NCT02228096|Tisagenlecleucel|tisagenlecleucel|mesh-list
139516726|NCT02228096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139516727|NCT02228096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516728|NCT01683994|Prednisone|prednisone|mesh-list
139516729|NCT01683994|Docetaxel|docetaxel|mesh-list
139516730|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516731|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
139516732|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
139516733|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
139516734|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516735|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139516736|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
139516737|NCT01683994|Hormones|hormones|mesh-ancestor
139516738|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139516739|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516740|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139516741|NCT02247440|Interferons|interferons|mesh-list
139516742|NCT02247440|Ribavirin|ribavirin|mesh-list
139516743|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516744|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
139126189|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
139516745|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516746|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
139516747|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516748|NCT04857203|Vitamin D|vitamin d|mesh-list
139516749|NCT04857203|Vitamins|vitamins|mesh-ancestor
139516750|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
139516751|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516752|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139516753|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
139516754|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139516755|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139516756|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339478|NCT01347060|Xhance|xhance|mesh-list
139516757|NCT04660643|Tirzepatide|tirzepatide|mesh-list
139516758|NCT04660643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139516759|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516761|NCT04660643|Hormones|hormones|mesh-ancestor
139516762|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139516763|NCT04659317|Oxycodone|oxycodone|mesh-list
139516764|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139516765|NCT04659317|Narcotics|narcotics|mesh-ancestor
139516766|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516767|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516768|NCT04659317|Analgesics|analgesics|mesh-ancestor
139516769|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
139516770|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516771|NCT03602261|Calcifediol|calcifediol|mesh-list
139516772|NCT03602261|Vitamins|vitamins|mesh-ancestor
139516773|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
139516774|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516775|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139516776|NCT02141659|Relugolix|relugolix|mesh-list
139516777|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
139516778|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
139516779|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139516780|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516781|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139516782|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139516783|NCT05422703|Analgesics|analgesics|mesh-list
139516784|NCT05422703|Sensory System Agents|sensory system agents|mesh-ancestor
139516785|NCT05422703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516786|NCT05422703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516787|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
139516788|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139516789|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516790|NCT02120833|Decanoic acid|decanoic acid|mesh-list
139516791|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
139516792|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516793|NCT04615949|Cannabidiol|cannabidiol|mesh-list
139516794|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
139516795|NCT02170207|Lansoprazole|lansoprazole|mesh-list
139516796|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
139516797|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139516798|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139516799|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139516800|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516801|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516802|NCT02227784|Atorvastatin|atorvastatin|mesh-list
139516803|NCT02227784|Ezetimibe|ezetimibe|mesh-list
139516804|NCT02227784|Evacetrapib|evacetrapib|mesh-list
139516805|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139516806|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139516807|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
139516808|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516809|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139516810|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139516811|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516812|NCT04577417|Methylphenidate|methylphenidate|mesh-list
139516813|NCT04577417|Amphetamine|amphetamine|mesh-list
139516814|NCT04577417|Adderall|adderall|mesh-list
139516815|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
139516816|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
139516817|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139516818|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516819|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139516820|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139516821|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139516822|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516823|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
139516824|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516825|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
139516826|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
139516827|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139516828|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
139516829|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139516830|NCT01683058|Aripiprazole|aripiprazole|mesh-list
139516831|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
139516832|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139516833|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139516834|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139516835|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139516836|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516837|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
139516838|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
139516839|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516840|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516841|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139516842|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139516843|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
139516844|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139516845|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139516846|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139516847|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139516848|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
139516849|NCT02193776|Rifampin|rifampin|mesh-list
139516850|NCT02193776|Isoniazid|isoniazid|mesh-list
139516851|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
139516852|NCT02193776|Ethambutol|ethambutol|mesh-list
139516853|NCT02193776|Bedaquiline|bedaquiline|mesh-list
139516854|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139516855|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516856|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139516857|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139516858|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516859|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516860|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516861|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139516862|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
139516863|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
139516864|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139516865|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139516866|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139516867|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139516868|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139516869|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139516870|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139516871|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139516872|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139516873|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
139516874|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139516875|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139516876|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
139516877|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139516878|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139516879|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139516880|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516881|NCT02169830|Topiramate|topiramate|mesh-list
139516882|NCT02169830|Nortriptyline|nortriptyline|mesh-list
139516883|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
139516884|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139516885|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516886|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139516887|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
139516888|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139516889|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139516890|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139516891|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139516892|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516893|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
139516894|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139516895|NCT04536467|Goserelin|goserelin|mesh-list
139516896|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139516897|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516898|NCT05341349|Pembrolizumab|pembrolizumab|mesh-list
139516899|NCT05341349|Nivolumab|nivolumab|mesh-list
139516900|NCT05341349|Ipilimumab|ipilimumab|mesh-list
139516901|NCT05341349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139516902|NCT05341349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516903|NCT05341349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139516904|NCT05341349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516905|NCT04525547|Nintedanib|nintedanib|mesh-list
139516906|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516907|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139303636|NCT04827472|Fexuprazan|fexuprazan|mesh-list
139516908|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516909|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126388|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
139516910|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139516911|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516912|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139516913|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516914|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516915|NCT02119819|Metformin|metformin|mesh-list
139516916|NCT02119819|Exenatide|exenatide|mesh-list
139516917|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139516918|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516919|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139516920|NCT02119819|Incretins|incretins|mesh-ancestor
139516921|NCT02119819|Hormones|hormones|mesh-ancestor
139516922|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139516923|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
139516924|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139516925|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
139516926|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516927|NCT04766450|Expectorants|expectorants|mesh-ancestor
139516928|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
139516929|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139516930|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
139516931|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516932|NCT04766450|Protective Agents|protective agents|mesh-ancestor
139516933|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516934|NCT04766450|Antidotes|antidotes|mesh-ancestor
139516935|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
139516936|NCT02168816|Metronidazole|metronidazole|mesh-list
139516937|NCT02168816|Vancomycin|vancomycin|mesh-list
139516938|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
139516939|NCT02168816|Clindamycin|clindamycin|mesh-list
139516940|NCT02168816|Meropenem|meropenem|mesh-list
139516941|NCT02168816|Tazobactam|tazobactam|mesh-list
139516942|NCT02168816|Linezolid|linezolid|mesh-list
139516943|NCT02168816|Piperacillin|piperacillin|mesh-list
139516944|NCT02168816|Daptomycin|daptomycin|mesh-list
139516945|NCT02168816|Cefepime|cefepime|mesh-list
139516946|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139516947|NCT02168816|Aztreonam|aztreonam|mesh-list
139516948|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139516949|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139516950|NCT02168816|Trimethoprim|trimethoprim|mesh-list
139516951|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
139516952|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139516953|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139516954|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139126572|NCT00003645|Leuprolide|leuprolide|mesh-list
139516955|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516956|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516957|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516958|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139516959|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139516960|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139516961|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139516962|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139516963|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139516964|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139516965|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
139516966|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139516967|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139516968|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139516969|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
139516970|NCT01584232|Dulaglutide|dulaglutide|mesh-list
139516971|NCT01584232|Biguanides|biguanides|mesh-list
139516972|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139516973|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139516974|NCT02119663|Capecitabine|capecitabine|mesh-list
139516975|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139516976|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
139516977|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516978|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516979|NCT04481009|Paclitaxel|paclitaxel|mesh-list
139516980|NCT04481009|Gemcitabine|gemcitabine|mesh-list
139516981|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139516982|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516983|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
139516984|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
139516985|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
139516986|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516987|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139516989|NCT05327231|Docetaxel|docetaxel|mesh-list
139516990|NCT05327231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139516991|NCT05327231|Tubulin Modulators|tubulin modulators|mesh-ancestor
139516992|NCT05327231|Antimitotic Agents|antimitotic agents|mesh-ancestor
139516993|NCT05327231|Mitosis Modulators|mitosis modulators|mesh-ancestor
139516994|NCT05327231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516995|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
139516996|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139516997|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139516998|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
139516999|NCT01628107|Hematinics|hematinics|mesh-ancestor
139517000|NCT04745377|Antibodies|antibodies|mesh-list
139517001|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
139517002|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517003|NCT01583530|Belimumab|belimumab|mesh-list
139517004|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139517005|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
139517006|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517007|NCT01639001|Carboplatin|carboplatin|mesh-list
139517008|NCT01639001|Pemetrexed|pemetrexed|mesh-list
139517009|NCT01639001|Crizotinib|crizotinib|mesh-list
139517010|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517011|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517012|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517013|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139517014|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139517015|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139517016|NCT02167256|Saracatinib|saracatinib|mesh-list
139517017|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517018|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517019|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517020|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139517021|NCT02166476|Levofloxacin|levofloxacin|mesh-list
139517022|NCT02166476|Meropenem|meropenem|mesh-list
139517023|NCT02166476|Tazobactam|tazobactam|mesh-list
139517024|NCT02166476|Piperacillin|piperacillin|mesh-list
139517025|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139517026|NCT02166476|Vaborbactam|vaborbactam|mesh-list
139517027|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
139517028|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126740|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139517029|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139517030|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139517031|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139517032|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517033|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517034|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517035|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139517036|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139517037|NCT02224274|Clopidogrel|clopidogrel|mesh-list
139517038|NCT02224274|Ticagrelor|ticagrelor|mesh-list
139517039|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139517040|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139517041|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139517042|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139517043|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
139517044|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517045|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517046|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517047|NCT05219669|Nalmefene|nalmefene|mesh-list
139517048|NCT05219669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139517049|NCT05219669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517050|NCT05219669|Sensory System Agents|sensory system agents|mesh-ancestor
139517051|NCT05219669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517052|NCT04763252|Coal Tar|coal tar|mesh-list
139517053|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
139517054|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
139517055|NCT05369039|Prednisolone|prednisolone|mesh-list
139517056|NCT05369039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139517057|NCT05369039|Glucocorticoids|glucocorticoids|mesh-ancestor
139517058|NCT05369039|Hormones|hormones|mesh-ancestor
139517059|NCT05369039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139517060|NCT05369039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517061|NCT05369039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139517062|NCT05369039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517063|NCT04373369|Atezolizumab|atezolizumab|mesh-list
139517064|NCT04373369|Vorolanib|vorolanib|mesh-list
139517065|NCT04373369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139517066|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517067|NCT04373369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139517068|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517069|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139517070|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517071|NCT04791059|Sufentanil|sufentanil|mesh-list
139517072|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
139517073|NCT04791059|Ketamine|ketamine|mesh-list
139517074|NCT04791059|Esketamine|esketamine|mesh-list
139517075|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139517076|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139517077|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517078|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139517079|NCT04791059|Analgesics|analgesics|mesh-ancestor
139517080|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
139517081|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517082|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139517083|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139517084|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139517085|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
139517086|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517087|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517088|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139126828|NCT03652714|Anesthetics|anesthetics|mesh-list
139517089|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139517090|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
139517091|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
139517092|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139517093|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139517094|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139517095|NCT04791059|Narcotics|narcotics|mesh-ancestor
139517096|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139517097|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
139517098|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139517099|NCT05398913|Rimonabant|rimonabant|mesh-list
139517100|NCT05398913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139517101|NCT05398913|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
139517102|NCT05398913|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139517103|NCT05398913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517104|NCT05398913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517105|NCT05398913|Hormones|hormones|mesh-ancestor
139517106|NCT05398913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139517107|NCT05398913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517108|NCT01583374|Thalidomide|thalidomide|mesh-list
139517109|NCT01583374|Apremilast|apremilast|mesh-list
139517110|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139517111|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139517112|NCT01583374|Analgesics|analgesics|mesh-ancestor
139517113|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
139517114|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517115|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126930|NCT01327521|Cisplatin|cisplatin|mesh-list
139517116|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139517117|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139517118|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139517119|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139517120|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517121|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517122|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139517123|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
139517124|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
139517125|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139517126|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139517127|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139517128|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139517129|NCT01583374|Growth Substances|growth substances|mesh-ancestor
139517130|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
139517131|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517132|NCT02222714|Protein C|protein c|mesh-list
139517133|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
139303833|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139517134|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139517135|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139517136|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517137|NCT04145219|Immunomodulating Agents|immunomodulating agents|mesh-list
139517138|NCT04145219|Immunologic Factors|immunologic factors|mesh-ancestor
139517139|NCT04145219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517140|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139517141|NCT02164916|Cetuximab|cetuximab|mesh-list
139517142|NCT02164916|Irinotecan|irinotecan|mesh-list
139517143|NCT02164916|Camptothecin|camptothecin|mesh-list
139517144|NCT02164916|Vemurafenib|vemurafenib|mesh-list
139517145|NCT02164916|Antibodies|antibodies|mesh-list
139517146|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
139517147|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139517148|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
139517149|NCT02164916|Mitogens|mitogens|mesh-list
139517150|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
139517151|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517152|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517153|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139517154|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139517155|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517156|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517157|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
139517158|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139517159|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139517160|NCT04091867|Cetuximab|cetuximab|mesh-list
139517161|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139517162|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517163|NCT05651789|Propranolol|propranolol|mesh-list
139517164|NCT05651789|Carvedilol|carvedilol|mesh-list
139517165|NCT05651789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139517166|NCT05651789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139517167|NCT05651789|Adrenergic Agents|adrenergic agents|mesh-ancestor
139517168|NCT05651789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517169|NCT05651789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517170|NCT05651789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517171|NCT05651789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139517172|NCT05651789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139517173|NCT05651789|Vasodilator Agents|vasodilator agents|mesh-ancestor
139517174|NCT05651789|Antioxidants|antioxidants|mesh-ancestor
139517175|NCT05651789|Protective Agents|protective agents|mesh-ancestor
139517176|NCT05651789|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139517177|NCT05651789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139517178|NCT05651789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139517179|NCT05651789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139517180|NCT05651789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139517181|NCT02999477|Paclitaxel|paclitaxel|mesh-list
139517182|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
139517183|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139517184|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517185|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
139517186|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
139517187|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
139517188|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570319|NCT00983853|Ribavirin|ribavirin|mesh-list
139517189|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139517190|NCT02999477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139517191|NCT02222558|Testosterone|testosterone|mesh-list
139517192|NCT02222558|Androgens|androgens|mesh-ancestor
139517193|NCT02222558|Hormones|hormones|mesh-ancestor
139517194|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139517195|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517196|NCT02975999|Vasopressins|vasopressins|mesh-list
139517197|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
139517198|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
139517199|NCT02975999|Coagulants|coagulants|mesh-ancestor
139517200|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139517201|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139517202|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
139127075|NCT03650998|Ropivacaine|ropivacaine|mesh-list
139517203|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517204|NCT02188784|Iron|iron|mesh-list
139517205|NCT02188784|Trace Elements|trace elements|mesh-ancestor
139517206|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
139517207|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517208|NCT02222246|Morphine|morphine|mesh-list
139517209|NCT02222246|Hydromorphone|hydromorphone|mesh-list
139517210|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139517211|NCT02222246|Narcotics|narcotics|mesh-ancestor
139297141|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139517212|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139517213|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517214|NCT02222246|Analgesics|analgesics|mesh-ancestor
139517215|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
139517216|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517217|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139517218|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139517220|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
139517221|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139517222|NCT02220920|Canagliflozin|canagliflozin|mesh-list
139517223|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139517224|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127127|NCT01106547|Prednisolone|prednisolone|mesh-list
139517225|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139517226|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517227|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
139517228|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
139517229|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
139517230|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517231|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517232|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139517233|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139517234|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139517235|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139517236|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139517237|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139517238|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
139517239|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517240|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517241|NCT04790279|Amlodipine|amlodipine|mesh-list
139517242|NCT04790279|Nifedipine|nifedipine|mesh-list
139517243|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139517244|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139517245|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139517246|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517247|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139570320|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139517248|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517249|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
139517250|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
139517251|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139517252|NCT03877289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139517253|NCT03877289|Oxybutynin|oxybutynin|mesh-list
139517254|NCT03877289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139517255|NCT03877289|Parasympatholytics|parasympatholytics|mesh-ancestor
139517256|NCT03877289|Autonomic Agents|autonomic agents|mesh-ancestor
139517257|NCT03877289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517258|NCT03877289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517259|NCT03877289|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139517260|NCT03877289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139517261|NCT03877289|Cholinergic Agents|cholinergic agents|mesh-ancestor
139517262|NCT03877289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517263|NCT03877289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517264|NCT03877289|Urological Agents|urological agents|mesh-ancestor
139517265|NCT05554679|Metformin|metformin|mesh-list
139517266|NCT05554679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139517267|NCT05554679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517268|NCT05494619|Immunoglobulins|immunoglobulins|mesh-list
139517269|NCT05494619|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139517270|NCT05494619|Antibodies|antibodies|mesh-list
139517271|NCT05494619|gamma-Globulins|gamma-globulins|mesh-list
139517272|NCT05494619|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139517273|NCT05494619|Immunologic Factors|immunologic factors|mesh-ancestor
139517274|NCT05494619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517275|NCT01634555|Leucovorin|leucovorin|mesh-list
139517276|NCT01634555|Folic Acid|folic acid|mesh-list
139517277|NCT01634555|Fluorouracil|fluorouracil|mesh-list
139517278|NCT01634555|Irinotecan|irinotecan|mesh-list
139517279|NCT01634555|Ramucirumab|ramucirumab|mesh-list
139517280|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
139517281|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
139517282|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570321|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
139517283|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139517284|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517285|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139517286|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
139517287|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517288|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139517289|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139517290|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517291|NCT01634555|Antidotes|antidotes|mesh-ancestor
139517292|NCT01634555|Protective Agents|protective agents|mesh-ancestor
139517293|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
139517294|NCT01634555|Vitamins|vitamins|mesh-ancestor
139517295|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
139517296|NCT01634555|Hematinics|hematinics|mesh-ancestor
139517297|NCT05355155|Bevacizumab|bevacizumab|mesh-list
139517298|NCT05355155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139517299|NCT05355155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517300|NCT05355155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139517301|NCT05355155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139517302|NCT05355155|Growth Substances|growth substances|mesh-ancestor
139517303|NCT05355155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517304|NCT05355155|Growth Inhibitors|growth inhibitors|mesh-ancestor
139517305|NCT01634243|Rotigotine|rotigotine|mesh-list
139517306|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
139517307|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
139517308|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517309|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517310|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517311|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
139517312|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139517313|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139517314|NCT04814615|Daratumumab|daratumumab|mesh-list
139517315|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517316|NCT04814537|Bupivacaine|bupivacaine|mesh-list
139517317|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
139517318|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
139517319|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139517320|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517321|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
139517322|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517323|NCT01582282|Psyllium|psyllium|mesh-list
139517324|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
139517325|NCT01582282|Cathartics|cathartics|mesh-ancestor
139517326|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139517327|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
139517328|NCT01599650|Ranibizumab|ranibizumab|mesh-list
139517329|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139517330|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139517331|NCT01599650|Growth Substances|growth substances|mesh-ancestor
139517332|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517333|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
139517334|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517335|NCT03774875|Apremilast|apremilast|mesh-list
139517336|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139517337|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139517338|NCT03774875|Analgesics|analgesics|mesh-ancestor
139517339|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
139517340|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517341|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517342|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139517343|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139127315|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
139517344|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139517345|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139517346|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517347|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517348|NCT01563172|Listerine|listerine|mesh-list
139517349|NCT01563172|Fluorides|fluorides|mesh-list
139517350|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
139517351|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
139517352|NCT01563172|Protective Agents|protective agents|mesh-ancestor
139517353|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517354|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139517355|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139517356|NCT04755764|Atenolol|atenolol|mesh-list
139517357|NCT04755764|Labetalol|labetalol|mesh-list
139517358|NCT04755764|Nifedipine|nifedipine|mesh-list
139517359|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139517360|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139086620|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139517361|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517362|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139517363|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517364|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
139517365|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
139517366|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139517367|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139517368|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139517369|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
139517370|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
139517371|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517372|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139517373|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139517374|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139517375|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
139517376|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517377|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
139517378|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139517379|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139517381|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
139517382|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
139517383|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517384|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517385|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139517386|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139517387|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139517388|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139517389|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139517390|NCT02161718|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139517391|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139517392|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139517393|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517394|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517395|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
139517396|NCT04813991|Ibuprofen|ibuprofen|mesh-list
139517397|NCT04813991|Oxycodone|oxycodone|mesh-list
139517398|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139517399|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139517400|NCT04813991|Analgesics|analgesics|mesh-ancestor
139517401|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
139517402|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517403|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517404|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139517405|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139517406|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139517407|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517408|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517409|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139517410|NCT04813991|Narcotics|narcotics|mesh-ancestor
139517411|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139517412|NCT02218736|Aticaprant|aticaprant|mesh-list
139517413|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
139517414|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127415|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
139517415|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
139517416|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517417|NCT01580488|Calcitriol|calcitriol|mesh-list
139517418|NCT01580488|Calcipotriene|calcipotriene|mesh-list
139517419|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139517420|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
139517421|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139517422|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517423|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139517424|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139517425|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517426|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139517427|NCT01580488|Vitamins|vitamins|mesh-ancestor
139517428|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
139517429|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139517430|NCT01580020|Dexamethasone|dexamethasone|mesh-list
139517431|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139517432|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
139517433|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
139517434|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517435|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517436|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139517438|NCT01580020|Hormones|hormones|mesh-ancestor
139517439|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139517440|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139517441|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517442|NCT01579318|Interleukin-12|interleukin-12|mesh-list
139517443|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139127455|NCT01328145|Aspirin|aspirin|mesh-list
139517444|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
139517445|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517446|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139517447|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139517448|NCT01579318|Growth Substances|growth substances|mesh-ancestor
139517449|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
139517450|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517451|NCT01578850|Etanercept|etanercept|mesh-list
139517452|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139517453|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139517454|NCT01578850|Analgesics|analgesics|mesh-ancestor
139517455|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
139517456|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517457|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517458|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139517459|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139517460|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139517461|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139517462|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
139517463|NCT01539538|Sufentanil|sufentanil|mesh-list
139517464|NCT01539538|Morphine|morphine|mesh-list
139517465|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139517466|NCT01539538|Narcotics|narcotics|mesh-ancestor
139517467|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139517468|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517469|NCT01539538|Analgesics|analgesics|mesh-ancestor
139517470|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
139517471|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517472|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139517473|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139517474|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
139517475|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
139517476|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
139517477|NCT01562548|Guaifenesin|guaifenesin|mesh-list
139517478|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139517479|NCT01562548|Expectorants|expectorants|mesh-ancestor
139517480|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
139517481|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139517482|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139517483|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
139517484|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139127544|NCT01113489|Beclomethasone|beclomethasone|mesh-list
139517485|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517486|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517487|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
139517488|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139517489|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
139517490|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
139517491|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517492|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
139517493|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139517494|NCT03027934|Ticagrelor|ticagrelor|mesh-list
139517495|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139517496|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139517497|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139517498|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139517499|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139517500|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
139517501|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517502|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517503|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517504|NCT01562314|Cannabidiol|cannabidiol|mesh-list
139517505|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
139517506|NCT01539226|Dapivirine|dapivirine|mesh-list
139517507|NCT01539226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139517508|NCT01539226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139127603|NCT01211457|Venetoclax|venetoclax|mesh-list
139517509|NCT01539226|Antiviral Agents|antiviral agents|mesh-ancestor
139517510|NCT01539226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139517511|NCT01537120|Vildagliptin|vildagliptin|mesh-list
139086795|NCT03908372|Docetaxel|docetaxel|mesh-list
139517512|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139517513|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517514|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139517515|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
139517516|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517517|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517518|NCT01537042|Rotigotine|rotigotine|mesh-list
139517519|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
139517520|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
139517521|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517522|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517523|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517524|NCT01536574|Ropinirole|ropinirole|mesh-list
139517525|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139517526|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139517527|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
139517528|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
139517529|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517530|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517531|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517532|NCT04410094|Itraconazole|itraconazole|mesh-list
139517533|NCT04410094|Rifampin|rifampin|mesh-list
139517534|NCT04410094|Lazertinib|lazertinib|mesh-list
139517535|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
139517536|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139517537|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139517538|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139517539|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517540|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517541|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139517542|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
139517543|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139517544|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517545|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139517546|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139517547|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
139517548|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139517549|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
139517550|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139517551|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139517552|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139517553|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139517554|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139517555|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139517556|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139517557|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139517558|NCT01576042|Amiodarone|amiodarone|mesh-list
139517559|NCT01576042|Sotalol|sotalol|mesh-list
139517560|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139517561|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
139517562|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139517563|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139517564|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517565|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139517566|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139517567|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139517568|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517569|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139517570|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139517571|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139517572|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139517573|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139517574|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
139517575|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517576|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517577|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
139517578|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
139517579|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517580|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
139517581|NCT01536262|Olodaterol|olodaterol|mesh-list
139517582|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139086848|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139517583|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
139517584|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127738|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
139517585|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517586|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139517587|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
139517588|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
139517589|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139517590|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
139517591|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517592|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517593|NCT04102618|Trastuzumab|trastuzumab|mesh-list
139517594|NCT04102618|Atezolizumab|atezolizumab|mesh-list
139517595|NCT04102618|Letrozole|letrozole|mesh-list
139517596|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139517597|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517598|NCT04102618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139517599|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517600|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139517601|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139517602|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517603|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139517604|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
139517605|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139517606|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517607|NCT01575028|Bupivacaine|bupivacaine|mesh-list
139517608|NCT01575028|Ropivacaine|ropivacaine|mesh-list
139517609|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
139517610|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
139517611|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139517612|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517613|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
139517614|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517615|NCT04443569|Lidocaine|lidocaine|mesh-list
139517616|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
139517617|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
139517618|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139517619|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517620|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
139517621|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517622|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139517623|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139517624|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139517625|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139517626|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517627|NCT03508895|Caseins|caseins|mesh-list
139517628|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
139517629|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
139517630|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517631|NCT01574716|Gemcitabine|gemcitabine|mesh-list
139517632|NCT01574716|Docetaxel|docetaxel|mesh-list
139517633|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139517634|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
139517635|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517636|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517637|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
139517638|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
139517639|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
139517640|NCT02161562|Omalizumab|omalizumab|mesh-list
139517641|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139517642|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139517643|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139517644|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
139517645|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
139517646|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517647|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
139517648|NCT01559116|Olodaterol|olodaterol|mesh-list
139517649|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139517650|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
139517651|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517652|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517653|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139517654|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
139517655|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
139517656|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139517657|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
139517658|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517659|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517660|NCT01574326|Sevelamer|sevelamer|mesh-list
139517661|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
139517662|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
139517663|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517664|NCT01574248|Icatibant|icatibant|mesh-list
139517665|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139517666|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139517667|NCT01574248|Analgesics|analgesics|mesh-ancestor
139517668|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
139517669|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517670|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517671|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139517672|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139517673|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
139517674|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
139128083|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
139517675|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517676|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139517677|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139517678|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
139517679|NCT04761094|Insulin|insulin|mesh-list
139517680|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139517681|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517682|NCT01557946|Citalopram|citalopram|mesh-list
139517683|NCT01557946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139517684|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139517685|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139517686|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517687|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517688|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
139517689|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517690|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139517691|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
139517692|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139517693|NCT01534078|Doxorubicin|doxorubicin|mesh-list
139517694|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139517695|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139517696|NCT01534078|Dacarbazine|dacarbazine|mesh-list
139517697|NCT01534078|Vinblastine|vinblastine|mesh-list
139517698|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139517699|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517700|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139517701|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139517702|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517703|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517704|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139517705|NCT01534078|Immunotoxins|immunotoxins|mesh-ancestor
139517706|NCT01534078|Immunoconjugates|immunoconjugates|mesh-ancestor
139517707|NCT01534078|Immunologic Factors|immunologic factors|mesh-ancestor
139517708|NCT01534078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517709|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139517710|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
139517711|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139517712|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
139517713|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
139517714|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
139517715|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
139517716|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139517717|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139517718|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
139517719|NCT02161406|Abatacept|abatacept|mesh-list
139517720|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139517721|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517722|NCT02161406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139517723|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517724|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139517725|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
139517726|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517727|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139517728|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
139517729|NCT01573000|Antibodies|antibodies|mesh-list
139517730|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
139517731|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
139517732|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517733|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517734|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
139517735|NCT01572844|Antidotes|antidotes|mesh-ancestor
139517736|NCT01572844|Protective Agents|protective agents|mesh-ancestor
139517737|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517738|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
139517739|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517740|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
139517741|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139517742|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139517743|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
139517744|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
139517745|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
139517746|NCT01533922|Olodaterol|olodaterol|mesh-list
139517747|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139517748|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
139517749|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517750|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517751|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139517752|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
139517753|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
139517754|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139517755|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
139517756|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517757|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517758|NCT01533688|Bisacodyl|bisacodyl|mesh-list
139517759|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139517760|NCT01533688|Cathartics|cathartics|mesh-ancestor
139517761|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139517762|NCT01533688|Laxatives|laxatives|mesh-ancestor
139517763|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
139517764|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
139517765|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139517766|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139517767|NCT02217878|Morphine|morphine|mesh-list
139517768|NCT02217878|Ticagrelor|ticagrelor|mesh-list
139517769|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139517770|NCT02217878|Narcotics|narcotics|mesh-ancestor
139517771|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139517772|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517773|NCT02217878|Analgesics|analgesics|mesh-ancestor
139517774|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
139517775|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517776|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139517777|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139517778|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139517779|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139517780|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
139517781|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517782|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517783|NCT02217566|Prednisone|prednisone|mesh-list
139517784|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
139517785|NCT02217566|Androgens|androgens|mesh-list
139517786|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139517787|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
139517788|NCT02217566|Hormones|hormones|mesh-ancestor
139517789|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139517790|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517791|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139517792|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517793|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139517794|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517795|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517796|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
139517797|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139517798|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
139517799|NCT02217410|Tacrolimus|tacrolimus|mesh-list
139517800|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139517801|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
139517802|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517803|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139517804|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517805|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517806|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139517807|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517808|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139517809|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
139517810|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139517811|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139517812|NCT02217332|Pramipexole|pramipexole|mesh-list
139517813|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
139517814|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517815|NCT02217332|Protective Agents|protective agents|mesh-ancestor
139517816|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517817|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139517818|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139517819|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
139517820|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
139517821|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517823|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
139517824|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517825|NCT02181842|Pioglitazone|pioglitazone|mesh-list
139517826|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139517827|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517828|NCT01632020|Metformin|metformin|mesh-list
139517829|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139517830|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517831|NCT02181296|Ropivacaine|ropivacaine|mesh-list
139517832|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
139517833|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
139517834|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139517835|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517836|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
139517837|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517838|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
139517839|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
139517840|NCT02158442|Ticarcillin|ticarcillin|mesh-list
139517841|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139517842|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517843|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517844|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139517845|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139517846|NCT02158364|Vaccines|vaccines|mesh-list
139517847|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
139517848|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517849|NCT02180672|Fluticasone|fluticasone|mesh-list
139517850|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139517851|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139517852|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
139517853|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517854|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517855|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139517856|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
139517857|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
139517858|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139517859|NCT01920711|Valsartan|valsartan|mesh-list
139517860|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139128574|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
139517861|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139517862|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139517863|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139517864|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517865|NCT02180438|Tenofovir|tenofovir|mesh-list
139517866|NCT02180438|Emtricitabine|emtricitabine|mesh-list
139517867|NCT02180438|Cobicistat|cobicistat|mesh-list
139517868|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139517869|NCT02180438|Elvitegravir|elvitegravir|mesh-list
139517870|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
139517871|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139517872|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139517873|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139517874|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517875|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517876|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139517877|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139517878|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139517879|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139517880|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139517881|NCT02157116|Docetaxel|docetaxel|mesh-list
139517882|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517884|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
139517885|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
139517886|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517887|NCT01920555|Midazolam|midazolam|mesh-list
139517888|NCT01920555|Ketamine|ketamine|mesh-list
139517889|NCT01920555|Analgesics|analgesics|mesh-ancestor
139517890|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
139517891|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517892|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517893|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139517894|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139517895|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
139517896|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
139517897|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139517898|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139517899|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139517900|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517901|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517902|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139517903|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139517904|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139517905|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139517906|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139517907|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
139517908|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
139517909|NCT02156804|Nivolumab|nivolumab|mesh-list
139517910|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139517911|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517912|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139517913|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517914|NCT02156492|Atorvastatin|atorvastatin|mesh-list
139517915|NCT02156492|Simvastatin|simvastatin|mesh-list
139517916|NCT02156492|Evacetrapib|evacetrapib|mesh-list
139517917|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139517918|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139517919|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
139517920|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128751|NCT03923829|Astringents|astringents|mesh-ancestor
139517921|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139517922|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139517923|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517924|NCT01920477|Ofatumumab|ofatumumab|mesh-list
139517925|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517926|NCT04641195|Vitamin D|vitamin d|mesh-list
139517927|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
139517928|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
139517929|NCT04641195|Vitamins|vitamins|mesh-list
139517930|NCT04641195|Zinc|zinc|mesh-list
139517931|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
139517932|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517933|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139517934|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139517935|NCT04641195|Trace Elements|trace elements|mesh-ancestor
139517936|NCT02213042|Trastuzumab|trastuzumab|mesh-list
139517937|NCT02213042|Lapatinib|lapatinib|mesh-list
139517938|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139517939|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139517940|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517941|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139517942|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139517943|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517944|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139128866|NCT03646006|Bupivacaine|bupivacaine|mesh-list
139517945|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139517946|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
139517947|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139517948|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517949|NCT04418180|Fenofibrate|fenofibrate|mesh-list
139517950|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139517951|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
139517952|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517953|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139517954|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
139517955|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139517956|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517958|NCT02212730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517959|NCT02178956|Paclitaxel|paclitaxel|mesh-list
139517960|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139517961|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517962|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
139517963|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
139517964|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
139517965|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517966|NCT02211638|Candesartan|candesartan|mesh-list
139517967|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
139517968|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139517969|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139517970|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139517971|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517972|NCT02178566|Treprostinil|treprostinil|mesh-list
139517973|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139517974|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
139517975|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139517976|NCT01631864|Amlodipine|amlodipine|mesh-list
139517977|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139517978|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139517979|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139517980|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139517981|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517982|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139517983|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517984|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
139517985|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139517986|NCT01557244|Fesoterodine|fesoterodine|mesh-list
139517987|NCT01557244|Oxybutynin|oxybutynin|mesh-list
139517988|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139517989|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139517990|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
139517991|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139517992|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139517993|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139517994|NCT01557244|Urological Agents|urological agents|mesh-ancestor
139517995|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
139517996|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
139517997|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139517998|NCT02177942|Micronutrients|micronutrients|mesh-list
139517999|NCT02177942|Trace Elements|trace elements|mesh-list
139518000|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518001|NCT02155322|Interferons|interferons|mesh-list
139518002|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
139518003|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
139518004|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139518005|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518006|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
139518007|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518008|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
139518009|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518010|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139518011|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139518012|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139518013|NCT02209454|Analgesics|analgesics|mesh-ancestor
139518014|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
139518015|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518016|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518017|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139518018|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139518019|NCT01557166|Liraglutide|liraglutide|mesh-list
139518020|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139518021|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518022|NCT01557166|Incretins|incretins|mesh-ancestor
139518023|NCT01557166|Hormones|hormones|mesh-ancestor
139518024|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139518025|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
139518026|NCT01556932|Promethazine|promethazine|mesh-list
139518027|NCT01556932|Lorazepam|lorazepam|mesh-list
139518028|NCT01556932|Haloperidol|haloperidol|mesh-list
139518029|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139518030|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139518031|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139518032|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518033|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
139518034|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
139518035|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
139518036|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518037|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
139518038|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
139518039|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139518040|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139518041|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
139518042|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
139518043|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518044|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518045|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139518046|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
139518047|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
139518048|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139518049|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139518050|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139518051|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139518052|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
139518053|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139518054|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
139518055|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139518056|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
139518057|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
139518058|NCT02985736|Desoximetasone|desoximetasone|mesh-list
139518059|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139518060|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
139518061|NCT02985736|Hormones|hormones|mesh-ancestor
139518062|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139129349|NCT02528877|Sirolimus|sirolimus|mesh-list
139518063|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518064|NCT02985658|Cisplatin|cisplatin|mesh-list
139518065|NCT02985658|Vinorelbine|vinorelbine|mesh-list
139518066|NCT02985658|Veliparib|veliparib|mesh-list
139518067|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518068|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139518069|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
139518070|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
139518071|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
139518072|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518073|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139518074|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518075|NCT02177786|Selonsertib|selonsertib|mesh-list
139518076|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139518077|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518078|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518079|NCT02153918|Metronidazole|metronidazole|mesh-list
139518080|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518081|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139518082|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139129410|NCT03920397|Vitamins|vitamins|mesh-ancestor
139518083|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139518084|NCT04752566|Eculizumab|eculizumab|mesh-list
139518085|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139518086|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139518087|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
139518088|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518089|NCT01571362|Naltrexone|naltrexone|mesh-list
139518090|NCT01571362|Oxycodone|oxycodone|mesh-list
139518091|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139518092|NCT01571362|Narcotics|narcotics|mesh-ancestor
139518093|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139518094|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518095|NCT01571362|Analgesics|analgesics|mesh-ancestor
139518096|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
139518097|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518098|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139518099|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139518100|NCT01571284|Aflibercept|aflibercept|mesh-list
139518101|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139129463|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
139518102|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139518103|NCT01571284|Growth Substances|growth substances|mesh-ancestor
139518104|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518105|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
139518106|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087372|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
139518107|NCT02137772|Letermovir|letermovir|mesh-list
139518108|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139518110|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518111|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518112|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
139518113|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518114|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139518115|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139518116|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
139518117|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518118|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518119|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139518120|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
139518121|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139518122|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139518123|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139518124|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
139518125|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518126|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518127|NCT02137226|Adalimumab|adalimumab|mesh-list
139518128|NCT02137226|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139518129|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139518130|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139518131|NCT01530334|Gefitinib|gefitinib|mesh-list
139518132|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518133|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139518134|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518135|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518136|NCT01570192|Vancomycin|vancomycin|mesh-list
139518137|NCT01570192|Gentamicins|gentamicins|mesh-list
139518138|NCT01570192|Meropenem|meropenem|mesh-list
139518139|NCT01570192|Linezolid|linezolid|mesh-list
139518140|NCT01570192|Tobramycin|tobramycin|mesh-list
139518141|NCT01570192|Amikacin|amikacin|mesh-list
139518142|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139518143|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518144|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139518145|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129570|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
139518146|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518147|NCT02136914|Amantadine|amantadine|mesh-list
139518148|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139518149|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139518150|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
139518151|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518152|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
139518153|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518154|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518155|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518156|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139518157|NCT02136914|Analgesics|analgesics|mesh-ancestor
139518158|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
139518159|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518160|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
139518161|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139518162|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139518163|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139518164|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
139518165|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518166|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518167|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518168|NCT01554514|Rituximab|rituximab|mesh-list
139518169|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139518170|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518171|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
139518172|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518173|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139518174|NCT01553188|Prednisone|prednisone|mesh-list
139518175|NCT01553188|Trebananib|trebananib|mesh-list
139518176|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139518177|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
139518178|NCT01553188|Hormones|hormones|mesh-ancestor
139518179|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139518180|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518181|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139087450|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
139518182|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518183|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139518184|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139518185|NCT01553188|Growth Substances|growth substances|mesh-ancestor
139518186|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
139518187|NCT02175758|Ribavirin|ribavirin|mesh-list
139518188|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
139518189|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
139518190|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518191|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
139518192|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518193|NCT01599104|Olmesartan|olmesartan|mesh-list
139518194|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139518195|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139518196|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139518197|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139518198|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518199|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
139518200|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139518201|NCT01518244|Timolol|timolol|mesh-list
139518202|NCT01518244|Brinzolamide|brinzolamide|mesh-list
139518203|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518204|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518205|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139518206|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139129750|NCT01138137|Antidotes|antidotes|mesh-ancestor
139518207|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
139518208|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518209|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518210|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139518211|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139518212|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139518213|NCT01552408|Ranibizumab|ranibizumab|mesh-list
139518214|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139518215|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139518216|NCT01552408|Growth Substances|growth substances|mesh-ancestor
139518217|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518218|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
139518219|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518220|NCT02174276|Tenofovir|tenofovir|mesh-list
139518221|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
139518222|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518223|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139518224|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139518225|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518226|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518227|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139518228|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139518229|NCT01527682|Dorzolamide|dorzolamide|mesh-list
139518230|NCT01527682|Latanoprost|latanoprost|mesh-list
139518231|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139518232|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139518233|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139518234|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139518235|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518236|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518237|NCT01516216|Vitamin D|vitamin d|mesh-list
139518238|NCT01516216|Leucovorin|leucovorin|mesh-list
139518239|NCT01516216|Bevacizumab|bevacizumab|mesh-list
139518240|NCT01516216|Fluorouracil|fluorouracil|mesh-list
139518241|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
139518242|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139518243|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518244|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139518245|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139518246|NCT01516216|Growth Substances|growth substances|mesh-ancestor
139518247|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518248|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
139518249|NCT01516216|Vitamins|vitamins|mesh-ancestor
139518250|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
139518251|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139518252|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
139297142|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518253|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518254|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139129853|NCT05280717|Sotrovimab|sotrovimab|mesh-list
139518255|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139518256|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
139518258|NCT01516216|Protective Agents|protective agents|mesh-ancestor
139518259|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
139518260|NCT01950819|Cyclosporine|cyclosporine|mesh-list
139518261|NCT01950819|Prednisone|prednisone|mesh-list
139518262|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
139518263|NCT01950819|Tacrolimus|tacrolimus|mesh-list
139518264|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
139518265|NCT01950819|Cyclosporins|cyclosporins|mesh-list
139518266|NCT01950819|Basiliximab|basiliximab|mesh-list
139518267|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139518268|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
139518269|NCT01950819|Hormones|hormones|mesh-ancestor
139518270|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139518271|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518272|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139518273|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518274|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
139518275|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
139518276|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518277|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139518278|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139518279|NCT01950819|Protective Agents|protective agents|mesh-ancestor
139518280|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139518281|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
139518282|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139518283|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518284|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518285|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518286|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
139518287|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
139518288|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139518289|NCT01514422|Minocycline|minocycline|mesh-list
139518290|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139518291|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518292|NCT01524796|Pregabalin|pregabalin|mesh-list
139518293|NCT01524796|Analgesics|analgesics|mesh-ancestor
139518294|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
139518295|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518296|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518297|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
139518298|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139518299|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139518300|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518301|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139518302|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139518303|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139518304|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139518305|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139518306|NCT01547728|Antithrombins|antithrombins|mesh-list
139129954|NCT01139463|Olanzapine|olanzapine|mesh-list
139518307|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
139518308|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139518309|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
139518310|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518311|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518312|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
139518313|NCT01523392|Clopidogrel|clopidogrel|mesh-list
139518314|NCT01523392|Ticagrelor|ticagrelor|mesh-list
139518315|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139518316|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139518317|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139518318|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139518319|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
139518320|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518321|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518322|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518323|NCT01512160|Ibuprofen|ibuprofen|mesh-list
139518324|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139518325|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139518326|NCT01512160|Analgesics|analgesics|mesh-ancestor
139518327|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
139518328|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518329|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518330|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139087594|NCT03890510|Anesthetics|anesthetics|mesh-list
139518331|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139518332|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139518333|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518334|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518336|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139518337|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139518338|NCT01950741|Growth Substances|growth substances|mesh-ancestor
139518339|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518340|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
139518341|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518342|NCT01950273|Rituximab|rituximab|mesh-list
139518343|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139518344|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518345|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
139518346|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518347|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139518348|NCT01919229|Letrozole|letrozole|mesh-list
139518349|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518350|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139518351|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139518352|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518353|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518354|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139518355|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
139518356|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139518357|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518358|NCT01511536|Prednisone|prednisone|mesh-list
139518359|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
139518360|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139518361|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
139518362|NCT01511536|Hormones|hormones|mesh-ancestor
139518363|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139518364|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518365|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139518366|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518367|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139518368|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518369|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518370|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
139518371|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139518372|NCT01510912|Diclofenac|diclofenac|mesh-list
139518373|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139518374|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139518375|NCT01510912|Analgesics|analgesics|mesh-ancestor
139518376|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
139518377|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518378|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518379|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139518380|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139518381|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139518382|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518383|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518384|NCT01510756|Sorafenib|sorafenib|mesh-list
139518385|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518386|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139518387|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518388|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518389|NCT01522456|Tretinoin|tretinoin|mesh-list
139518390|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
139518391|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518392|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
139518393|NCT01521364|Clarithromycin|clarithromycin|mesh-list
139518394|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139518395|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518396|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139518397|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518398|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518399|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139518400|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139518401|NCT01545388|Metformin|metformin|mesh-list
139518402|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139087679|NCT01153880|Mupirocin|mupirocin|mesh-list
139518403|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139518404|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518405|NCT01545388|Incretins|incretins|mesh-ancestor
139518406|NCT01545388|Hormones|hormones|mesh-ancestor
139518407|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139518408|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139518409|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
139518410|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518411|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518412|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
139518413|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
139518414|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518415|NCT01544920|Interferons|interferons|mesh-list
139518416|NCT01544920|Ribavirin|ribavirin|mesh-list
139518417|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
139518418|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
139518419|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139518420|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518421|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
139518422|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139130151|NCT02868892|Pemetrexed|pemetrexed|mesh-list
139518423|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
139518424|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518425|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
139518426|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518427|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139518428|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
139518429|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
139518430|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518431|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
139518432|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518433|NCT01543204|Etanercept|etanercept|mesh-list
139518434|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139518435|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139518436|NCT01543204|Analgesics|analgesics|mesh-ancestor
139518437|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
139518438|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518439|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518440|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139518441|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139518442|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139518443|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139518444|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
139518445|NCT01518946|Midodrine|midodrine|mesh-list
139518446|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
139518447|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
139518448|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518449|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518450|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139518451|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139518452|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139518453|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139518454|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
139518455|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518456|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518457|NCT01507246|Morphine|morphine|mesh-list
139518458|NCT01507246|Bupivacaine|bupivacaine|mesh-list
139518459|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
139518460|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
139518461|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139518462|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518463|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
139518464|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518465|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139518466|NCT01507246|Narcotics|narcotics|mesh-ancestor
139518467|NCT01507246|Analgesics|analgesics|mesh-ancestor
139518468|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
139518469|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
139518470|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518471|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
139518472|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518473|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518474|NCT02073448|Adapalene|adapalene|mesh-list
139518475|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139518476|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
139518477|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139518478|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139518479|NCT02073448|Analgesics|analgesics|mesh-ancestor
139518480|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
139518481|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518482|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518483|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139518484|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139518485|NCT01487200|Triamcinolone|triamcinolone|mesh-list
139518486|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139518487|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139518489|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139518490|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139518491|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
139518492|NCT01487200|Hormones|hormones|mesh-ancestor
139518493|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139518494|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518495|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139518496|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
139518497|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518498|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518499|NCT01486966|Insulin|insulin|mesh-list
139518500|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139518501|NCT01486966|Metformin|metformin|mesh-list
139518502|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
139518503|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
139518504|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
139518505|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
139518506|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
139518507|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139518508|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518509|NCT04080076|Tacrolimus|tacrolimus|mesh-list
139518510|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139518511|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
139518512|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518513|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139518514|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518515|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518516|NCT01900431|Leucovorin|leucovorin|mesh-list
139518517|NCT01900431|Folic Acid|folic acid|mesh-list
139518518|NCT01900431|Prednisone|prednisone|mesh-list
139518519|NCT01900431|Methotrexate|methotrexate|mesh-list
139518520|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
139518521|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139518522|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
139518523|NCT01900431|Hormones|hormones|mesh-ancestor
139518524|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139518525|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518526|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139518527|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518528|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139518529|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
139518530|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139518531|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139518532|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
139518533|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518534|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
139518535|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518536|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139518537|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139518538|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
139518539|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139518540|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139518541|NCT01900431|Antidotes|antidotes|mesh-ancestor
139518542|NCT01900431|Protective Agents|protective agents|mesh-ancestor
139518543|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
139518544|NCT01900431|Vitamins|vitamins|mesh-ancestor
139518545|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
139518546|NCT01900431|Hematinics|hematinics|mesh-ancestor
139518547|NCT01948791|Rivastigmine|rivastigmine|mesh-list
139518548|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139518549|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518550|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518551|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
139518552|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518553|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518554|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139087821|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139518555|NCT01948791|Protective Agents|protective agents|mesh-ancestor
139518556|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
139518558|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
139518559|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518560|NCT01898091|Protective Agents|protective agents|mesh-ancestor
139518561|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518562|NCT01898091|Vitamins|vitamins|mesh-ancestor
139518563|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
139518564|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139518565|NCT01947855|Empagliflozin|empagliflozin|mesh-list
139518566|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139518567|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518568|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139518569|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518570|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
139518571|NCT01888497|Promethazine|promethazine|mesh-list
139518572|NCT01888497|Triazolam|triazolam|mesh-list
139518573|NCT01888497|Gabapentin|gabapentin|mesh-list
139518574|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518575|NCT01888497|Analgesics|analgesics|mesh-ancestor
139518576|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
139518577|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518578|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518579|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
139518580|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139518581|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139518582|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139518583|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139518584|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139518585|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139518586|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518587|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
139518588|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139518589|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139518590|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
139518591|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
139518592|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
139518593|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
139518594|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139518595|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139518596|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
139518597|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
139518598|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139518599|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
139518600|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
139518601|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139518602|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
139518603|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
139518604|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
139518605|NCT01485796|Antibodies|antibodies|mesh-list
139518606|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
139518607|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139518608|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139518609|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
139518610|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518611|NCT01897233|Ivacaftor|ivacaftor|mesh-list
139518612|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139518613|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139518614|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518615|NCT01887717|Sorafenib|sorafenib|mesh-list
139518616|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518617|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139518618|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518619|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518620|NCT01463098|Zolpidem|zolpidem|mesh-list
139518621|NCT01463098|Lemborexant|lemborexant|mesh-list
139518622|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139518623|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139518624|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139518625|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518626|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139518627|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
139518628|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
139518629|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087895|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518630|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518631|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139518632|NCT01462942|Bromides|bromides|mesh-list
139518633|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
139518634|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139518635|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
139518636|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518637|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518638|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139518639|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
139518640|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139518641|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139518642|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139518643|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
139518644|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518645|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518646|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
139518647|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139518648|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139518649|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518650|NCT01504204|Adapalene|adapalene|mesh-list
139518651|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
139518652|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139518653|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
139518654|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139518655|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139518656|NCT01504204|Analgesics|analgesics|mesh-ancestor
139518657|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
139518658|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518659|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518660|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139518661|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139518662|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139518663|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139518664|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139518665|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139518666|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518667|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139518668|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139518669|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139130636|NCT03609970|Vitamin D|vitamin d|mesh-list
139518670|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139518671|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
139518672|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518673|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518674|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139518675|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139518676|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
139518677|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139518678|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139518679|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
139518680|NCT02118961|Vaccines|vaccines|mesh-list
139518681|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
139518682|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518683|NCT02140645|Linagliptin|linagliptin|mesh-list
139518684|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139518685|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518686|NCT02140645|Incretins|incretins|mesh-ancestor
139518687|NCT02140645|Hormones|hormones|mesh-ancestor
139518688|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139518689|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139518690|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
139518691|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518692|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518693|NCT02140411|Ranibizumab|ranibizumab|mesh-list
139518694|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139518695|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139518696|NCT02140411|Growth Substances|growth substances|mesh-ancestor
139518697|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518698|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
139518699|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518700|NCT02139943|Canagliflozin|canagliflozin|mesh-list
139518701|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139130676|NCT05383300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139518702|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518703|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139518704|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518705|NCT01485172|Ropinirole|ropinirole|mesh-list
139518706|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139518707|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139518708|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
139518709|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
139518710|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518711|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518712|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518713|NCT02105701|Ribavirin|ribavirin|mesh-list
139518714|NCT02105701|Grazoprevir|grazoprevir|mesh-list
139518715|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
139518716|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518717|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
139518718|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518719|NCT04411225|Cannabidiol|cannabidiol|mesh-list
139518720|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
139518721|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139518722|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139518723|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518724|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518725|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139518726|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139518727|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518728|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
139518729|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518730|NCT01502644|Morphine|morphine|mesh-list
139518731|NCT01502644|Oxycodone|oxycodone|mesh-list
139518732|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139518733|NCT01502644|Narcotics|narcotics|mesh-ancestor
139518734|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130777|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
139518735|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518736|NCT01502644|Analgesics|analgesics|mesh-ancestor
139518737|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
139518738|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518739|NCT01462318|Vitamin K|vitamin k|mesh-list
139518740|NCT01462318|Midazolam|midazolam|mesh-list
139518741|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
139518742|NCT01462318|Caffeine|caffeine|mesh-list
139518743|NCT01462318|Omeprazole|omeprazole|mesh-list
139518744|NCT01462318|Warfarin|warfarin|mesh-list
139518745|NCT01462318|Daclizumab|daclizumab|mesh-list
139518746|NCT01462318|Vitamins|vitamins|mesh-ancestor
139518747|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
139518748|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518749|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139518750|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139518751|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139518752|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139518753|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139518754|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139518755|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139130847|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
139518756|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
139518757|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
139518758|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
139518759|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
139518760|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518761|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518762|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
139518763|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139518764|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139518765|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518766|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139518767|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139518768|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
139518769|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139518770|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139518771|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139518772|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139130892|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
139518773|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139518774|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
139518775|NCT01462318|Coagulants|coagulants|mesh-ancestor
139518776|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
139518777|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
139518778|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139518779|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139518780|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139518781|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
139518783|NCT01485094|Analgesics|analgesics|mesh-ancestor
139518784|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
139518785|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518786|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518787|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
139518788|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139518789|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139518790|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518791|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139518792|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139518793|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139518794|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139518795|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139518796|NCT04079686|Cefazolin|cefazolin|mesh-list
139518797|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139518798|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518799|NCT01502410|Sorafenib|sorafenib|mesh-list
139518800|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518801|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139518802|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518803|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518804|NCT02132312|Phenylephrine|phenylephrine|mesh-list
139518805|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
139518806|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139518807|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
139518808|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
139518809|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518810|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518811|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
139518812|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139518813|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
139518814|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
139518815|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139518816|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139518817|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139518818|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
139518819|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518820|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518821|NCT02132312|Protective Agents|protective agents|mesh-ancestor
139518822|NCT02150954|Oxytocin|oxytocin|mesh-list
139518823|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
139518824|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139518825|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518826|NCT04188392|Pimavanserin|pimavanserin|mesh-list
139518827|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139518828|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139518829|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139518830|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139518831|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139518832|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518833|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139518834|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139518835|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139518836|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
139518837|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518838|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518839|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139518840|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139518841|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518842|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139518843|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139518844|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139518845|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518846|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
139518847|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518848|NCT02131064|Carboplatin|carboplatin|mesh-list
139518849|NCT02131064|Docetaxel|docetaxel|mesh-list
139518850|NCT02131064|Trastuzumab|trastuzumab|mesh-list
139518851|NCT02131064|Pertuzumab|pertuzumab|mesh-list
139518852|NCT02131064|Maytansine|maytansine|mesh-list
139518853|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139518854|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518855|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
139518856|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
139518858|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518859|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139518860|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139518861|NCT02131064|Immunotoxins|immunotoxins|mesh-ancestor
139518862|NCT02131064|Immunoconjugates|immunoconjugates|mesh-ancestor
139518863|NCT02131064|Immunologic Factors|immunologic factors|mesh-ancestor
139518864|NCT02131064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518865|NCT02130284|Insulin|insulin|mesh-list
139518866|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139518867|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139518868|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518869|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139518870|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
139518871|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518872|NCT04748822|Ethanol|ethanol|mesh-list
139518873|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139518874|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518875|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139518876|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518877|NCT04739150|Nintedanib|nintedanib|mesh-list
139518878|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518879|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139518880|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518881|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518882|NCT02147132|Nicotine|nicotine|mesh-list
139518883|NCT02147132|Varenicline|varenicline|mesh-list
139518884|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139518885|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
139518886|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518887|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518888|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139518889|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139518890|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
139518891|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518892|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518893|NCT02146430|Pregabalin|pregabalin|mesh-list
139518894|NCT02146430|Analgesics|analgesics|mesh-ancestor
139518895|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
139518896|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518897|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518898|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
139518899|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139518900|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139518901|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518902|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139518903|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139518904|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139518905|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139518906|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139518907|NCT02129192|Amlodipine|amlodipine|mesh-list
139518908|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139518909|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139518910|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139518911|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518912|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139518913|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518914|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
139518915|NCT02128490|Naproxen|naproxen|mesh-list
139518916|NCT02128490|Colchicine|colchicine|mesh-list
139518917|NCT02128490|Febuxostat|febuxostat|mesh-list
139518918|NCT02128490|Lansoprazole|lansoprazole|mesh-list
139518919|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
139518920|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139518921|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139518922|NCT02128490|Analgesics|analgesics|mesh-ancestor
139518923|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
139518924|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139518925|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518926|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139518927|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139518928|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
139518929|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139518930|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518931|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518932|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
139518933|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
139518934|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
139518935|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518936|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139518937|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139518938|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139518939|NCT02105636|Docetaxel|docetaxel|mesh-list
139518940|NCT02105636|Nivolumab|nivolumab|mesh-list
139518941|NCT02105636|Methotrexate|methotrexate|mesh-list
139518942|NCT02105636|Cetuximab|cetuximab|mesh-list
139518943|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518944|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
139518945|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
139518946|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
139518947|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518948|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139518949|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139518950|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139518951|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
139518952|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139518953|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518954|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139518955|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
139518956|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
139518957|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139518958|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139518959|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139518960|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
139131232|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
139518961|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139518962|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139518963|NCT01626872|Risperidone|risperidone|mesh-list
139518964|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139518965|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
139518966|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139518967|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518968|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518969|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139518970|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139518971|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139518972|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139518973|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139518974|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
139518975|NCT01598090|Ribavirin|ribavirin|mesh-list
139518976|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139518977|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
139518978|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518979|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
139518980|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139518981|NCT02145182|Eculizumab|eculizumab|mesh-list
139518982|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139518983|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139518984|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
139518985|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139518986|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
139518987|NCT02145026|Hematinics|hematinics|mesh-ancestor
139518988|NCT02144012|Docetaxel|docetaxel|mesh-list
139518989|NCT02144012|Trastuzumab|trastuzumab|mesh-list
139518990|NCT02144012|Maytansine|maytansine|mesh-list
139518991|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139518992|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139518993|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
139518994|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
139518995|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
139518996|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139518997|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139518998|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139518999|NCT02144012|Immunotoxins|immunotoxins|mesh-ancestor
139519000|NCT02144012|Immunoconjugates|immunoconjugates|mesh-ancestor
139519001|NCT02144012|Immunologic Factors|immunologic factors|mesh-ancestor
139519002|NCT02144012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519003|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139519004|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519005|NCT02141672|Cyclosporine|cyclosporine|mesh-list
139519006|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
139088268|NCT03876704|Vitamins|vitamins|mesh-list
139519007|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519009|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519010|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519011|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139519012|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
139519013|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519014|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139519015|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139519016|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
139519017|NCT01628120|Hematinics|hematinics|mesh-ancestor
139519018|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139519019|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
139519020|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139519021|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
139519022|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519023|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
139519024|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139519025|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519026|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519027|NCT02123966|Sirolimus|sirolimus|mesh-list
139519028|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139519029|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519030|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139519031|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519032|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
139519033|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139519034|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
139519035|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519036|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
139519037|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139519038|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519039|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519040|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139519041|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139519042|NCT02123576|Protective Agents|protective agents|mesh-ancestor
139519043|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519044|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
139519045|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139519046|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
139519047|NCT05235347|Sotrovimab|sotrovimab|mesh-list
139519048|NCT05235347|Antiviral Agents|antiviral agents|mesh-ancestor
139519049|NCT05235347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519050|NCT02140970|Ibuprofen|ibuprofen|mesh-list
139519051|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139519052|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139519053|NCT02140970|Analgesics|analgesics|mesh-ancestor
139519054|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
139519055|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519056|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519057|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139519058|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139519059|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139519060|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519061|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519062|NCT02101112|Apixaban|apixaban|mesh-list
139519063|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139519064|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
139519065|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139519066|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
139519067|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519068|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519069|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
139519070|NCT02139644|Fluticasone|fluticasone|mesh-list
139519071|NCT02139644|Xhance|xhance|mesh-list
139519072|NCT02139644|Beclomethasone|beclomethasone|mesh-list
139519073|NCT02139644|Albuterol|albuterol|mesh-list
139519074|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139519075|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
139519076|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139519077|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139519078|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
139519079|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519080|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519081|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139519082|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
139519083|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
139519084|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139519085|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139519086|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139519087|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
139519088|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519089|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519090|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
139519091|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139519092|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
139519093|NCT02139644|Hormones|hormones|mesh-ancestor
139519094|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519095|NCT02100644|Lamotrigine|lamotrigine|mesh-list
139519096|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
139519097|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139519098|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139519099|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519100|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139519101|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519102|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139519103|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139519104|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139519105|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139519106|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139519107|NCT02074982|Ustekinumab|ustekinumab|mesh-list
139519108|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139519109|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
139519110|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519111|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
139519112|NCT04150913|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139519113|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139519114|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139519115|NCT04150913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139519116|NCT04150913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519117|NCT04798001|Vaccines|vaccines|mesh-list
139519118|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
139519119|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519120|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
139519121|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
139519122|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519123|NCT02099708|Lansoprazole|lansoprazole|mesh-list
139519124|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
139519125|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139519126|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139519127|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139519128|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519129|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519130|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
139519131|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139519132|NCT02073656|Ledipasvir|ledipasvir|mesh-list
139519133|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
139519134|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519135|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
139519136|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139519137|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519138|NCT02209181|Acetaminophen|acetaminophen|mesh-list
139519139|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139519140|NCT02209181|Analgesics|analgesics|mesh-ancestor
139519141|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
139519142|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519143|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519144|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
139519145|NCT02242487|Levodopa|levodopa|mesh-list
139519146|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139519147|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139519148|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
139519149|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519150|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131791|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
139519151|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519152|NCT02241785|Natalizumab|natalizumab|mesh-list
139519153|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
139519154|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519155|NCT02241551|Paclitaxel|paclitaxel|mesh-list
139519156|NCT02241551|Gemcitabine|gemcitabine|mesh-list
139519157|NCT02241551|Fluorouracil|fluorouracil|mesh-list
139519158|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
139519159|NCT02241551|Irinotecan|irinotecan|mesh-list
139519160|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139519161|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519162|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
139519163|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
139519164|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
139519165|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519166|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139519167|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
139519168|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139519169|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
139519170|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519171|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139519172|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139519173|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519174|NCT02207621|Timolol|timolol|mesh-list
139519175|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139519176|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139519177|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519178|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139519179|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139519180|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
139519181|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519182|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519183|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139519184|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139519185|NCT02240693|BI 409306|bi 409306|mesh-list
139519186|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139519187|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519188|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519189|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139519190|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139519191|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
139519192|NCT02072096|Metformin|metformin|mesh-list
139519193|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
139519194|NCT02072096|Pioglitazone|pioglitazone|mesh-list
139131976|NCT03708458|Antidotes|antidotes|mesh-ancestor
139519195|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139519196|NCT02072096|Liraglutide|liraglutide|mesh-list
139519197|NCT02072096|Exenatide|exenatide|mesh-list
139519198|NCT02072096|Glimepiride|glimepiride|mesh-list
139519199|NCT02072096|Linagliptin|linagliptin|mesh-list
139519200|NCT02072096|Acarbose|acarbose|mesh-list
139519201|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139519202|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519203|NCT02072096|Incretins|incretins|mesh-ancestor
139519204|NCT02072096|Hormones|hormones|mesh-ancestor
139519205|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519206|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139519207|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
139519208|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519209|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519210|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139519211|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139519212|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139519213|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
139519214|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139519215|NCT01631825|Rotigotine|rotigotine|mesh-list
139519216|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
139519217|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
139519218|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519219|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519220|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519221|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139519222|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139519223|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139519224|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
139519225|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519226|NCT02123108|Mycophenolic Acid|mycophenolic acid|mesh-list
139519227|NCT02123108|Tacrolimus|tacrolimus|mesh-list
139519228|NCT02123108|Basiliximab|basiliximab|mesh-list
139519229|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139519230|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
139519231|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519232|NCT02123108|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139519233|NCT02123108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519234|NCT02123108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519235|NCT02123108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139519236|NCT02123108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519237|NCT02123108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139519238|NCT02123108|Antitubercular Agents|antitubercular agents|mesh-ancestor
139519239|NCT02123108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139519240|NCT02123108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519241|NCT02121392|Bupivacaine|bupivacaine|mesh-list
139519242|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
139519243|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
139519244|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139519245|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519246|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
139519247|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519248|NCT02097056|Donepezil|donepezil|mesh-list
139519249|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139519250|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519251|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519252|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
139519253|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519254|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519255|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
139519256|NCT02121002|Diclofenac|diclofenac|mesh-list
139519257|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139519258|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139519259|NCT02121002|Analgesics|analgesics|mesh-ancestor
139519260|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
139519261|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519262|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519263|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139519264|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139519265|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139519266|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519267|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519268|NCT02096900|Midazolam|midazolam|mesh-list
139519269|NCT02096900|Zolpidem|zolpidem|mesh-list
139519270|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139519271|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139519272|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139519273|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519274|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139519275|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139519276|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139519277|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139132123|NCT03910803|Brodalumab|brodalumab|mesh-list
139519278|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
139519279|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
139519280|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
139519281|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
139519282|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519283|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519284|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139519285|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139519286|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
139519287|NCT02120924|Azelaic acid|azelaic acid|mesh-list
139519288|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519289|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
139519290|NCT02096744|Clonidine|clonidine|mesh-list
139519291|NCT02096744|Analgesics|analgesics|mesh-ancestor
139519292|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
139519293|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519294|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519295|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139519296|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
139519297|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
139519298|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139519299|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139519300|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139519301|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
139519302|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519303|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519304|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
139519305|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
139088566|NCT01163396|Leucovorin|leucovorin|mesh-list
139519306|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519307|NCT02069366|Dronabinol|dronabinol|mesh-list
139519308|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
139519309|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519310|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139519311|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139519312|NCT02069366|Analgesics|analgesics|mesh-ancestor
139519313|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
139519314|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519315|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139519316|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139519317|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519318|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519319|NCT02069366|Hormones|hormones|mesh-ancestor
139519320|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519321|NCT04732208|Mydriatics|mydriatics|mesh-list
139519322|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
139519323|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519324|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519325|NCT02068508|Pioglitazone|pioglitazone|mesh-list
139519326|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139519327|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519328|NCT02207231|Adalimumab|adalimumab|mesh-list
139519329|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139519330|NCT02207231|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139519331|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139519332|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139519333|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
139519334|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519335|NCT02206685|Methadone|methadone|mesh-list
139519336|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139519337|NCT02206685|Narcotics|narcotics|mesh-ancestor
139519338|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139519339|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519340|NCT02206685|Analgesics|analgesics|mesh-ancestor
139519341|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
139519342|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519343|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
139519344|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
139519345|NCT02095106|Calpastatin|calpastatin|mesh-list
139519346|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139519347|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
139519348|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519349|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519350|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
139519351|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139519352|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519353|NCT02235311|Pantoprazole|pantoprazole|mesh-list
139519354|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139519355|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139519356|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139519357|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519358|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519359|NCT02235077|Spironolactone|spironolactone|mesh-list
139519360|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139519361|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
139519362|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519363|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519364|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139519365|NCT02235077|Diuretics|diuretics|mesh-ancestor
139519366|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
139519367|NCT02234141|Selonsertib|selonsertib|mesh-list
139519368|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139519369|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519370|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519371|NCT01896531|Leucovorin|leucovorin|mesh-list
139519372|NCT01896531|Fluorouracil|fluorouracil|mesh-list
139519373|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
139519374|NCT01896531|Ipatasertib|ipatasertib|mesh-list
139519375|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
139519376|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519377|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139519378|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519379|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139519380|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
139519381|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519382|NCT01896531|Antidotes|antidotes|mesh-ancestor
139519383|NCT01896531|Protective Agents|protective agents|mesh-ancestor
139519384|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
139519385|NCT01896531|Vitamins|vitamins|mesh-ancestor
139519386|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
139519387|NCT01896531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139519388|NCT01896531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519389|NCT01618305|Lamivudine|lamivudine|mesh-list
139519390|NCT01618305|Zidovudine|zidovudine|mesh-list
139519391|NCT01618305|Efavirenz|efavirenz|mesh-list
139519392|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139519393|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
139519394|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139519395|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139519396|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519397|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519398|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
139519399|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519400|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139519401|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139519402|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
139519403|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139519404|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139519405|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139519406|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139519407|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139519408|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139519409|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139519410|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139519411|NCT01896297|Dabigatran|dabigatran|mesh-list
139519412|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
139519413|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139519414|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
139519415|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519416|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519417|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
139519418|NCT01884675|Ambrisentan|ambrisentan|mesh-list
139519419|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139519420|NCT01884597|Ranibizumab|ranibizumab|mesh-list
139519421|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139519422|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139519423|NCT01884597|Growth Substances|growth substances|mesh-ancestor
139519424|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519425|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
139519426|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519427|NCT01864005|Clopidogrel|clopidogrel|mesh-list
139519428|NCT01864005|Ticagrelor|ticagrelor|mesh-list
139519429|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139519430|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139519431|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139519432|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139519433|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
139519434|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519435|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519436|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519437|NCT01863771|Golimumab|golimumab|mesh-list
139519438|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139519439|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139519440|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139519441|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
139519442|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132281|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
139519443|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139519444|NCT01894581|Hormones|hormones|mesh-ancestor
139519445|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519446|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519447|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
139519448|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139519449|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139519450|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139519451|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139519452|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139519453|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519454|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
139519455|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088714|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519456|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519458|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519459|NCT01862991|Digoxin|digoxin|mesh-list
139519460|NCT01862991|Misoprostol|misoprostol|mesh-list
139519461|NCT01862991|Mifepristone|mifepristone|mesh-list
139519462|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139519463|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
139519464|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139519465|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519466|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139519467|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139519468|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
139519469|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139519470|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139519471|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519472|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519473|NCT01862991|Protective Agents|protective agents|mesh-ancestor
139132307|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519474|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139519475|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139519476|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139519477|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139519478|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
139519479|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139519480|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139519481|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
139519482|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519483|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
139519484|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139519485|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139519486|NCT02202551|Amantadine|amantadine|mesh-list
139519487|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139519488|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139519489|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
139519490|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519491|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
139519492|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519493|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519494|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519495|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139519496|NCT02202551|Analgesics|analgesics|mesh-ancestor
139519497|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
139519498|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519499|NCT02118337|Nivolumab|nivolumab|mesh-list
139519500|NCT02118337|Durvalumab|durvalumab|mesh-list
139519501|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139519502|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519503|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139519504|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519505|NCT02105467|Grazoprevir|grazoprevir|mesh-list
139519506|NCT02105467|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139519507|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
139519508|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519509|NCT02202161|Metformin|metformin|mesh-list
139519510|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139519511|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139519512|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519513|NCT02202161|Incretins|incretins|mesh-ancestor
139519514|NCT02202161|Hormones|hormones|mesh-ancestor
139519515|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519516|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139519517|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
139519518|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519519|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519520|NCT03109847|Metformin|metformin|mesh-list
139519521|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139519522|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519523|NCT01461928|Rituximab|rituximab|mesh-list
139519524|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139519525|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519526|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
139519527|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519528|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139519529|NCT02623205|Escitalopram|escitalopram|mesh-list
139519530|NCT02623205|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139519531|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139519532|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139519533|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519534|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519535|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
139519536|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519538|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139519539|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139519540|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139519541|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139519542|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
139519543|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519544|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519545|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519546|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139519547|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139519548|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519549|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139519550|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139519551|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
139519552|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519553|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519554|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519555|NCT01500382|Urological Agents|urological agents|mesh-ancestor
139519556|NCT02137837|Everolimus|everolimus|mesh-list
139519557|NCT02137837|Fulvestrant|fulvestrant|mesh-list
139519558|NCT02137837|Anastrozole|anastrozole|mesh-list
139519559|NCT02137837|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139519560|NCT02137837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139519561|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519562|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519563|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139519564|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
139519565|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519566|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519567|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139519568|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139519569|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139519570|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
139519571|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519572|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139519573|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139519574|NCT01483690|Dexamethasone|dexamethasone|mesh-list
139519575|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
139519576|NCT01483690|Methotrexate|methotrexate|mesh-list
139519577|NCT01483690|Vincristine|vincristine|mesh-list
139519578|NCT01483690|Decitabine|decitabine|mesh-list
139519579|NCT01483690|Asparaginase|asparaginase|mesh-list
139519580|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
139519581|NCT01483690|Vorinostat|vorinostat|mesh-list
139519582|NCT01483690|Pegaspargase|pegaspargase|mesh-list
139519583|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139519584|NCT01483690|BB 1101|bb 1101|mesh-list
139132493|NCT03899337|Prednisolone|prednisolone|mesh-list
139519585|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139519586|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
139519587|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
139519588|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519589|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519590|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139519591|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
139519592|NCT01483690|Hormones|hormones|mesh-ancestor
139519593|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519594|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139519595|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519596|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
139519597|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519598|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519599|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139297143|NCT04479241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139519600|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
139519601|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139519602|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139519603|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
139519604|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
139519605|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139519606|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139519607|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
139519608|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139519609|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139519610|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139519611|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
139519612|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
139519613|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
139519614|NCT01483690|Analgesics|analgesics|mesh-ancestor
139132537|NCT01256775|Aspirin|aspirin|mesh-list
139519615|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
139519616|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139519617|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139519618|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139519619|NCT01483144|Eflornithine|eflornithine|mesh-list
139519620|NCT01483144|Sulindac|sulindac|mesh-list
139519621|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519622|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139519623|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139519624|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139519625|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519626|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139519627|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519628|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519629|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139519630|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139519631|NCT01483144|Analgesics|analgesics|mesh-ancestor
139519632|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
139519633|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519634|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519635|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139519636|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139519637|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139519638|NCT01881789|Dexamethasone|dexamethasone|mesh-list
139519639|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
139519640|NCT01881789|Lenalidomide|lenalidomide|mesh-list
139519641|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139519642|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
139519643|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519644|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139519645|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139519646|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
139519647|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132646|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139519648|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519649|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139519650|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139519651|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
139519652|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
139519653|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519654|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139519655|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
139519656|NCT01881789|Hormones|hormones|mesh-ancestor
139519657|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519658|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139519659|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139519660|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139519661|NCT01881789|Growth Substances|growth substances|mesh-ancestor
139519662|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
139519663|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
139519664|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139519665|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
139519666|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519667|NCT01892163|Dexamethasone|dexamethasone|mesh-list
139519668|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139519669|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
139519670|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
139519671|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519672|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519673|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139519674|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
139519675|NCT01892163|Hormones|hormones|mesh-ancestor
139519676|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519677|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139519678|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519679|NCT01500226|Dexamethasone|dexamethasone|mesh-list
139519680|NCT01500226|Granisetron|granisetron|mesh-list
139519681|NCT01500226|Rolapitant|rolapitant|mesh-list
139519682|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139519683|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
139519684|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
139519685|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519686|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519687|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139519688|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
139519689|NCT01500226|Hormones|hormones|mesh-ancestor
139519690|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519691|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139519692|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519693|NCT01500226|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139519694|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139519695|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
139519696|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519697|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519698|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139519699|NCT02075047|Ziprasidone|ziprasidone|mesh-list
139519700|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139519701|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
139519702|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519703|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519704|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519705|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139519706|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139519707|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139519708|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139519709|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139519710|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
139519711|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139519712|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139519713|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519714|NCT01859793|Incretins|incretins|mesh-ancestor
139519715|NCT01859793|Hormones|hormones|mesh-ancestor
139519716|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519717|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139519718|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
139519719|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519720|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519721|NCT01859715|Oxycodone|oxycodone|mesh-list
139519722|NCT01859715|Hydrocodone|hydrocodone|mesh-list
139519723|NCT01859715|Ondansetron|ondansetron|mesh-list
139519724|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139519725|NCT01859715|Narcotics|narcotics|mesh-ancestor
139519726|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139519727|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519728|NCT01859715|Analgesics|analgesics|mesh-ancestor
139519729|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
139519730|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519731|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
139519732|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
139519733|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139519734|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
139519735|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
139519736|NCT01859715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139132857|NCT01312376|Growth Substances|growth substances|mesh-ancestor
139519737|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139519738|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
139519739|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519740|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519741|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
139519742|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
139519743|NCT04590495|Cannabidiol|cannabidiol|mesh-list
139519744|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
139519745|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139519746|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139519747|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139519748|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519749|NCT01461538|Immunotoxins|immunotoxins|mesh-ancestor
139519750|NCT01461538|Immunoconjugates|immunoconjugates|mesh-ancestor
139519751|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
139519752|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519753|NCT02117479|Capecitabine|capecitabine|mesh-list
139519754|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139519755|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
139519756|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519757|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519758|NCT01482910|Aflibercept|aflibercept|mesh-list
139519759|NCT01482910|Verteporfin|verteporfin|mesh-list
139519760|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139519761|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139519762|NCT01482910|Growth Substances|growth substances|mesh-ancestor
139519763|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519764|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
139519765|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519766|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139519767|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
139519768|NCT04077190|Cortisone|cortisone|mesh-list
139519769|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139519770|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139519771|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
139519772|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519773|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
139519774|NCT02229539|Promethazine|promethazine|mesh-list
139519775|NCT02229539|Lidocaine|lidocaine|mesh-list
139519776|NCT02229539|Doxepin|doxepin|mesh-list
139519777|NCT02229539|Antacids|antacids|mesh-list
139519778|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
139519779|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
139519780|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139519781|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519782|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
139519783|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519784|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139519785|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139519786|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139519787|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139519788|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519789|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139519790|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139519791|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
139519792|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
139519793|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139519794|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139519795|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
139519796|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
139519797|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519798|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139519799|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
139519800|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
139519801|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139519802|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
139519803|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139519804|NCT01835223|Tivozanib|tivozanib|mesh-list
139519805|NCT01835223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139519806|NCT01835223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519807|NCT01835223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519808|NCT02229383|Exenatide|exenatide|mesh-list
139519809|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139519810|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519811|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139519812|NCT02229383|Incretins|incretins|mesh-ancestor
139519813|NCT02229383|Hormones|hormones|mesh-ancestor
139519814|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519815|NCT01499368|Omeprazole|omeprazole|mesh-list
139519816|NCT01499368|Famotidine|famotidine|mesh-list
139519817|NCT01499368|Lafutidine|lafutidine|mesh-list
139519818|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139519819|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139519820|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139519821|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519822|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519823|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139519824|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
139519825|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
139519826|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519827|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519828|NCT01835145|Temozolomide|temozolomide|mesh-list
139519829|NCT01835145|Dacarbazine|dacarbazine|mesh-list
139519830|NCT01835145|Imidazole|imidazole|mesh-list
139519831|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139519832|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
139133068|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139519833|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519834|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519835|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519837|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
139519838|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
139519839|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
139519840|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139519841|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519842|NCT02229227|Incretins|incretins|mesh-ancestor
139519843|NCT02229227|Hormones|hormones|mesh-ancestor
139519844|NCT02229227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139519845|NCT01499290|Metronidazole|metronidazole|mesh-list
139519846|NCT01499290|Meropenem|meropenem|mesh-list
139519847|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519848|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139519849|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139519850|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139519851|NCT01833897|Cycloserine|cycloserine|mesh-list
139519852|NCT01833897|Ketamine|ketamine|mesh-list
139519853|NCT01833897|Olanzapine|olanzapine|mesh-list
139519854|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139519855|NCT01833897|Fluoxetine|fluoxetine|mesh-list
139519856|NCT01833897|Analgesics|analgesics|mesh-ancestor
139519857|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
139519858|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519859|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519860|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139519861|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139519862|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
139519863|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
139519864|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139519865|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139519866|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139519867|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519868|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519869|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
139519870|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
139519871|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139519872|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139519873|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139519874|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139519875|NCT01833897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139519876|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139519877|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139519878|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
139519879|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
139519880|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139519881|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139519882|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139519883|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519884|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139519885|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519886|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139519887|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
139519888|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139519889|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
139519890|NCT02226653|Evacetrapib|evacetrapib|mesh-list
139519891|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139519892|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139519893|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
139519894|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519895|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139519896|NCT02201771|Aspirin|aspirin|mesh-list
139519897|NCT02201771|Ticagrelor|ticagrelor|mesh-list
139519898|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139519899|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139519900|NCT02201771|Analgesics|analgesics|mesh-ancestor
139519901|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
139519902|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519903|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519904|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139089160|NCT03349268|Anesthetics, General|anesthetics, general|mesh-ancestor
139519905|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139519906|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139519907|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139519908|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519909|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139519910|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139519911|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519912|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
139519913|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139519914|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139519915|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139519916|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
139519917|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519918|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
139519919|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139519920|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139519921|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139519922|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139519923|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519924|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519925|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139519927|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139519928|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139519929|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139519930|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519931|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139133355|NCT01266681|Amiodarone|amiodarone|mesh-list
139519932|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
139519933|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139519934|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139519935|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139519936|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139519937|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519938|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
139519939|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519940|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519941|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139519942|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519943|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
139519944|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
139519945|NCT01459666|Coagulants|coagulants|mesh-ancestor
139519946|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139519947|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
139519948|NCT01645475|Coagulants|coagulants|mesh-ancestor
139519949|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139519950|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
139519951|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519952|NCT04767113|Heparin|heparin|mesh-list
139519953|NCT04767113|Calcium heparin|calcium heparin|mesh-list
139519954|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
139519955|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139519956|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139519957|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519958|NCT02199509|Levetiracetam|levetiracetam|mesh-list
139519959|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
139519960|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
139519961|NCT01458574|Tofacitinib|tofacitinib|mesh-list
139519962|NCT01458574|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139519963|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139519964|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139519965|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519966|NCT02224703|Cannabidiol|cannabidiol|mesh-list
139519967|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
139519968|NCT01458106|Factor VIII|factor viii|mesh-list
139519969|NCT01458106|Coagulants|coagulants|mesh-ancestor
139519970|NCT01457950|Denosumab|denosumab|mesh-list
139519971|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139519972|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519973|NCT01499134|Metoprolol|metoprolol|mesh-list
139519974|NCT01499134|Nebivolol|nebivolol|mesh-list
139519975|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139519976|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139519977|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
139519978|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
139519979|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139519980|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139519981|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139519982|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139519983|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139519984|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
139519985|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139519986|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139519987|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
139519988|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139519989|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139519990|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139519991|NCT02198651|Adalimumab|adalimumab|mesh-list
139519992|NCT02198651|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139519993|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139519994|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139519995|NCT03026842|Cytarabine|cytarabine|mesh-list
139519996|NCT03026842|Decitabine|decitabine|mesh-list
139519997|NCT03026842|Daunorubicin|daunorubicin|mesh-list
139519998|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
139519999|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
139520000|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139520001|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
139520002|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520003|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133497|NCT03883347|Remifentanil|remifentanil|mesh-list
139520004|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
139520005|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520006|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520007|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
139520008|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520009|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139520010|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139520011|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139520012|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520013|NCT03026842|Analgesics|analgesics|mesh-ancestor
139520014|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
139520015|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520016|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139520017|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
139520018|NCT01498822|Levetiracetam|levetiracetam|mesh-list
139520019|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
139520020|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
139520021|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139520022|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139520023|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139520024|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520025|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139520026|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139520027|NCT01498120|Rotigotine|rotigotine|mesh-list
139520028|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
139520029|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
139520030|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520031|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133619|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139520032|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520033|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139520034|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139520035|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520036|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520037|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
139520038|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520039|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
139520040|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139520041|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139520042|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520043|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
139520044|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
139520045|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139520046|NCT02197247|Rifampin|rifampin|mesh-list
139520047|NCT02197247|Osimertinib|osimertinib|mesh-list
139520048|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139520049|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
139520050|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139520051|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520052|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
139520053|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139520054|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520055|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520056|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139089306|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
139520057|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139520058|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139520059|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139520060|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139520061|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139520062|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520063|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139520064|NCT02224157|Budesonide|budesonide|mesh-list
139520065|NCT02224157|Terbutaline|terbutaline|mesh-list
139520066|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
139520067|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139520068|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139520069|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
139520070|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520071|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520072|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139520073|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
139520074|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
139520075|NCT02224157|Hormones|hormones|mesh-ancestor
139520076|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139520077|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139520078|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139520079|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139520080|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
139520081|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520082|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520083|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
139520084|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
139520085|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139520086|NCT02196701|Adalimumab|adalimumab|mesh-list
139520087|NCT02196701|Methotrexate|methotrexate|mesh-list
139520088|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139520089|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
139520090|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139520091|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520092|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139520093|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
139520094|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520095|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520096|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
139520097|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520098|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139520099|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520100|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
139520101|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139520102|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139520103|NCT02196701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139520104|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139520105|NCT01481116|Glimepiride|glimepiride|mesh-list
139520106|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139520107|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139520108|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520109|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520110|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
139520111|NCT02222207|Ranibizumab|ranibizumab|mesh-list
139520112|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139520113|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139520114|NCT02222207|Growth Substances|growth substances|mesh-ancestor
139520115|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520116|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
139520117|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520118|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
139520119|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139520120|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139520121|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139520122|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139520123|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520124|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
139520125|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520126|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520127|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139520128|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520129|NCT02252081|Metformin|metformin|mesh-list
139520130|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139520131|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520133|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139520134|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139520135|NCT01623752|Analgesics|analgesics|mesh-ancestor
139520136|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
139520137|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520138|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520139|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139520140|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139520141|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139520142|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520143|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
139520144|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139520145|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139520146|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520147|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520148|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
139520149|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520150|NCT02219477|Ritonavir|ritonavir|mesh-list
139520151|NCT02219477|Ribavirin|ribavirin|mesh-list
139520152|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139520153|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139520154|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
139520155|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520156|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520157|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139520158|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139520159|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
139520160|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520161|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139520162|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139520163|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
139520164|NCT02093390|Fluconazole|fluconazole|mesh-list
139520165|NCT02093390|Atorvastatin|atorvastatin|mesh-list
139520166|NCT02093390|Relugolix|relugolix|mesh-list
139520167|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139520168|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139520169|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
139520170|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520171|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139520172|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139520173|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520174|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
139520175|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520176|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139520177|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139520178|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139520179|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
139520180|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139133785|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
139520181|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520182|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139520183|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139520184|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
139520185|NCT02219087|Bupivacaine|bupivacaine|mesh-list
139520186|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
139520187|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
139520188|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139520189|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520190|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
139520191|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520192|NCT02248961|Losartan|losartan|mesh-list
139520193|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139520194|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139520195|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139520196|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139520197|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520198|NCT02219009|Aripiprazole|aripiprazole|mesh-list
139520199|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
139520200|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139520201|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139520202|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139089459|NCT05275270|Oxytocin|oxytocin|mesh-list
139520203|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139520204|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520206|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
139520207|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133822|NCT01156779|Incretins|incretins|mesh-ancestor
139520208|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520209|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139520210|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139520211|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
139520212|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139520213|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139520214|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139520215|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139520216|NCT01456936|Bupropion|bupropion|mesh-list
139520217|NCT01456936|Nicotine|nicotine|mesh-list
139520218|NCT01456936|Varenicline|varenicline|mesh-list
139520219|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139520220|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
139520221|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520222|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520223|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139520224|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139520225|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
139520226|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520227|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520228|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139133870|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
139520229|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
139520230|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139520231|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139520232|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139520233|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139520234|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
139520235|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139520236|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139520237|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520238|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139520239|NCT01456780|Tobramycin|tobramycin|mesh-list
139520240|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
139520241|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139520242|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520243|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139520244|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139520245|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139520246|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139520247|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
139520248|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520249|NCT01479868|Interferons|interferons|mesh-list
139520250|NCT01479868|Ribavirin|ribavirin|mesh-list
139520251|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
139520252|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
139520253|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139520254|NCT01479868|Simeprevir|simeprevir|mesh-list
139520255|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520256|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
139520257|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520258|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
139520259|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520260|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
139520261|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520262|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
139520263|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520264|NCT01455220|Natalizumab|natalizumab|mesh-list
139520265|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
139520266|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520267|NCT01454596|Aldesleukin|aldesleukin|mesh-list
139520268|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
139520269|NCT01454596|Fludarabine|fludarabine|mesh-list
139520270|NCT01454596|Mitogens|mitogens|mesh-list
139520271|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520272|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
139520273|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520274|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139520275|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139520276|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
139520277|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520278|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520279|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139520280|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
139520281|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139520282|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139520283|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
139520284|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520285|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
139520286|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139520287|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520288|NCT04541290|Tacrolimus|tacrolimus|mesh-list
139520289|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520290|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
139520291|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520292|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139520293|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520294|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520295|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139520296|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
139520297|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520298|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139520299|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139520300|NCT01495000|Denosumab|denosumab|mesh-list
139520301|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139520302|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520303|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139520304|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139520305|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
139520306|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520307|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520308|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139520309|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
139520310|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
139520311|NCT01494610|Hormones|hormones|mesh-ancestor
139520312|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139520313|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
139520314|NCT02116777|Temozolomide|temozolomide|mesh-list
139520315|NCT02116777|Talazoparib|talazoparib|mesh-list
139520316|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139520317|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
139520318|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520319|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520320|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139520321|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520322|NCT01494532|Ropinirole|ropinirole|mesh-list
139520323|NCT01494532|Levodopa|levodopa|mesh-list
139520324|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
139520325|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
139520326|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520327|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520328|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520329|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139520330|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139520331|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
139520332|NCT02191397|Dexetimide|dexetimide|mesh-list
139520333|NCT02191397|Citalopram|citalopram|mesh-list
139520334|NCT02191397|Bupropion|bupropion|mesh-list
139520335|NCT02191397|Escitalopram|escitalopram|mesh-list
139520336|NCT02191397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139520337|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139520338|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139134272|NCT03563170|Paclitaxel|paclitaxel|mesh-list
139520339|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520340|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520341|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
139520342|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520343|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139520344|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139520345|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
139520346|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
139520347|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520348|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139520349|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139520350|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
139520351|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139520352|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
139520353|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139520354|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139520355|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
139520356|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139520357|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139520358|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520359|NCT01630811|Quinidine|quinidine|mesh-list
139520360|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
139520361|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
139520362|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
139520363|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139520364|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139520365|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520366|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520367|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520368|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139520369|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139520370|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
139520371|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139520372|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
139520373|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139520374|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139520375|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520376|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520377|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139520378|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139520379|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
139520380|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139520381|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139520382|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139520383|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139520384|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139520385|NCT02169791|Ixazomib|ixazomib|mesh-list
139520386|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520387|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
139520388|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520389|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520390|NCT02216357|Ifetroban|ifetroban|mesh-list
139520391|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139520392|NCT01492426|Ribavirin|ribavirin|mesh-list
139520393|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139520394|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
139520395|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520396|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
139520397|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520398|NCT01453348|Vaccines|vaccines|mesh-list
139520399|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
139520400|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520401|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
139520402|NCT01475734|Incretins|incretins|mesh-ancestor
139520403|NCT01475734|Hormones|hormones|mesh-ancestor
139520404|NCT01475734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139520405|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520406|NCT02189837|Atorvastatin|atorvastatin|mesh-list
139520407|NCT02189837|Evolocumab|evolocumab|mesh-list
139520408|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139520409|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139520410|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139520411|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
139520412|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520413|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139520414|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139520415|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520416|NCT02189837|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139520417|NCT02189837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139520418|NCT02189837|Protease Inhibitors|protease inhibitors|mesh-ancestor
139520419|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
139520420|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520421|NCT02216123|Chloroquine|chloroquine|mesh-list
139520422|NCT02216123|Primaquine|primaquine|mesh-list
139520423|NCT02216123|Tafenoquine|tafenoquine|mesh-list
139520424|NCT02216123|Amebicides|amebicides|mesh-ancestor
139520425|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139520426|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139520427|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520429|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139520430|NCT01490866|Leucovorin|leucovorin|mesh-list
139520431|NCT01490866|Bevacizumab|bevacizumab|mesh-list
139520432|NCT01490866|Fluorouracil|fluorouracil|mesh-list
139520433|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
139520434|NCT01490866|Axitinib|axitinib|mesh-list
139520435|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139520436|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520437|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139520438|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139520439|NCT01490866|Growth Substances|growth substances|mesh-ancestor
139520440|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520441|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
139520442|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
139520443|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520444|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139520445|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520446|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
139520447|NCT01490866|Antidotes|antidotes|mesh-ancestor
139520448|NCT01490866|Protective Agents|protective agents|mesh-ancestor
139520449|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
139520450|NCT01490866|Vitamins|vitamins|mesh-ancestor
139520451|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
139520452|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139520453|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520454|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
139520455|NCT02215967|Fludarabine|fludarabine|mesh-list
139520456|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520457|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
139520458|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520459|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139520460|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139520461|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
139520462|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520463|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520464|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139520465|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
139520466|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139520467|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
139520468|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520469|NCT02168387|Expectorants|expectorants|mesh-ancestor
139520470|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
139520471|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139520472|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
139520473|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520474|NCT02168387|Protective Agents|protective agents|mesh-ancestor
139520475|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520476|NCT02168387|Antidotes|antidotes|mesh-ancestor
139520477|NCT04418219|Interferons|interferons|mesh-list
139520478|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
139520479|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
139520480|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
139520481|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
139520482|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520483|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
139520484|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520485|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139520486|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139520487|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
139134571|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139520488|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520489|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520490|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139520491|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139520492|NCT04418219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139520493|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
139520494|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520495|NCT02167451|Maraviroc|maraviroc|mesh-list
139520496|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139520497|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139520498|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520499|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139520500|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139520501|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
139520502|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520503|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139520504|NCT02167139|Adalimumab|adalimumab|mesh-list
139520505|NCT02167139|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139520506|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139520507|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139520509|NCT02116309|Epinephrine|epinephrine|mesh-list
139520510|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139520511|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139520512|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
139520513|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520514|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520515|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520516|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139520517|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139520518|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
139520519|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520520|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139520521|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
139520522|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
139520523|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
139520524|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139520525|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139520526|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139520527|NCT02116309|Analgesics|analgesics|mesh-ancestor
139520528|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
139520529|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139520530|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139520531|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
139520532|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
139520533|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139520534|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139520535|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520536|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
139520537|NCT01474486|Thiamine|thiamine|mesh-list
139520538|NCT01474486|Micronutrients|micronutrients|mesh-list
139520539|NCT01474486|Trace Elements|trace elements|mesh-list
139520540|NCT01474486|Vitamins|vitamins|mesh-ancestor
139520541|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520542|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
139520543|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139520544|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139520545|NCT01451398|Insulin|insulin|mesh-list
139520546|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139520547|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520548|NCT02073565|Everolimus|everolimus|mesh-list
139520549|NCT02073565|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139520550|NCT02073565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139520551|NCT02073565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520552|NCT02073565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520553|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520554|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
139520555|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520556|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520557|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139520558|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
139520559|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139520560|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
139520561|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520562|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520563|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139520564|NCT01450696|Capecitabine|capecitabine|mesh-list
139520565|NCT01450696|Trastuzumab|trastuzumab|mesh-list
139520566|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520567|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139520568|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
139520569|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520570|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139520571|NCT02070991|Macitentan|macitentan|mesh-list
139520572|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139520573|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139520574|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520575|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139520576|NCT01490086|Aripiprazole|aripiprazole|mesh-list
139520577|NCT01490086|RP5063|rp5063|mesh-list
139520578|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
139520579|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139520581|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139520582|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139520583|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520584|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
139520585|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
139520586|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520587|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520588|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139520589|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139520590|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
139520591|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139520592|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139520593|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139520594|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139520595|NCT02113579|Fluorides|fluorides|mesh-list
139520596|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
139520597|NCT02113579|Protective Agents|protective agents|mesh-ancestor
139520598|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520599|NCT01474018|Bromocriptine|bromocriptine|mesh-list
139520600|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139520601|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139520602|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
139520603|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139520604|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520605|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
139520606|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
139520607|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520608|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520609|NCT02100475|Insulin|insulin|mesh-list
139520610|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139520611|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
139520612|NCT02100475|Liraglutide|liraglutide|mesh-list
139520613|NCT02100475|Xultophy|xultophy|mesh-list
139520614|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139520615|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520616|NCT02100475|Incretins|incretins|mesh-ancestor
139520617|NCT02100475|Hormones|hormones|mesh-ancestor
139520618|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139520619|NCT04075240|Aspirin|aspirin|mesh-list
139520620|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
139520621|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139520622|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139520623|NCT04075240|Analgesics|analgesics|mesh-ancestor
139520624|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
139520625|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520626|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520627|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139520628|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139520629|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139520630|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139135033|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139520631|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520632|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139520633|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139520634|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520635|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
139520636|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139520637|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
139520638|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139520639|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
139520640|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
139520641|NCT02070757|Meropenem|meropenem|mesh-list
139520642|NCT02070757|Tazobactam|tazobactam|mesh-list
139520643|NCT02070757|Ceftolozane|ceftolozane|mesh-list
139520644|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
139520645|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139520646|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520647|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139520648|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520649|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135091|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139520650|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139520651|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139520652|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139520653|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139520654|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520655|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
139520656|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139520657|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520658|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520659|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139520660|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139520661|NCT01625845|Protective Agents|protective agents|mesh-ancestor
139520662|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520663|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
139520664|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139520665|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
139520666|NCT01473940|Gemcitabine|gemcitabine|mesh-list
139520667|NCT01473940|Ipilimumab|ipilimumab|mesh-list
139520668|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139520669|NCT01473940|Antibodies|antibodies|mesh-list
139520670|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
139520671|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139520672|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
139520673|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520674|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139520675|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
139520676|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520677|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520678|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139520679|NCT01832727|Dexamethasone|dexamethasone|mesh-list
139520680|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139520681|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
139520682|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
139520683|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520684|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520685|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139520686|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
139520687|NCT01832727|Hormones|hormones|mesh-ancestor
139520688|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139520689|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139520690|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520691|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
139520692|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
139520693|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139520694|NCT01473394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139520695|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139520696|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139520697|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520698|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520699|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
139520700|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520701|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139520702|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139520703|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
139520704|NCT04408144|Progestins|progestins|mesh-ancestor
139520705|NCT04408144|Hormones|hormones|mesh-ancestor
139520706|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139520707|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520708|NCT01449682|Dexamethasone|dexamethasone|mesh-list
139520709|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
139520710|NCT01449682|BB 1101|bb 1101|mesh-list
139520711|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139520712|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
139520713|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
139520714|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520715|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520716|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139520717|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
139520718|NCT01449682|Hormones|hormones|mesh-ancestor
139520719|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139520720|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139520721|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520722|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
139520723|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520724|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520725|NCT01831791|Dutasteride|dutasteride|mesh-list
139520726|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139520727|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139520728|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135315|NCT02036008|Liver Extracts|liver extracts|mesh-list
139520729|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520730|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
139520731|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139520732|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520733|NCT01857531|Nicotine|nicotine|mesh-list
139520734|NCT01857531|Ganaxolone|ganaxolone|mesh-list
139520735|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139520736|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
139520737|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520738|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520739|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139520740|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139520741|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
139520742|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520743|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520744|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
139520745|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
139520746|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
139520747|NCT02166047|Vesatolimod|vesatolimod|mesh-list
139520748|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
139520749|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520750|NCT01831089|Paclitaxel|paclitaxel|mesh-list
139520751|NCT01831089|Bevacizumab|bevacizumab|mesh-list
139135426|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
139520752|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139520753|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520754|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
139520755|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
139520756|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
139520757|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520758|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139520759|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139520760|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139520761|NCT01831089|Growth Substances|growth substances|mesh-ancestor
139520762|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520763|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
139520764|NCT02111785|Dexamethasone|dexamethasone|mesh-list
139520765|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139520766|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
139520767|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
139520768|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520769|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520770|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139520771|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
139520772|NCT02111785|Hormones|hormones|mesh-ancestor
139520773|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139520774|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139520775|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520776|NCT02068495|Amlodipine|amlodipine|mesh-list
139520777|NCT02068495|Candesartan|candesartan|mesh-list
139520778|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
139520779|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139520780|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139520781|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139520782|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520783|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139520784|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520785|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
139520786|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139520787|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139520788|NCT02097823|Olanzapine|olanzapine|mesh-list
139520789|NCT02097823|Aprepitant|aprepitant|mesh-list
139520790|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
139520791|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
139520792|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520793|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520794|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139520795|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139520796|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139520797|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139520798|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139520799|NCT02097823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139520800|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139520801|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139520802|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520803|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520804|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
139520805|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139520806|NCT01857063|Montelukast|montelukast|mesh-list
139520807|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139520808|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
139520809|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139520810|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
139520811|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139520812|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520813|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139520814|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139520815|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520816|NCT01856907|Metformin|metformin|mesh-list
139520817|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139520818|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139520819|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520820|NCT01856907|Incretins|incretins|mesh-ancestor
139520821|NCT01856907|Hormones|hormones|mesh-ancestor
139520822|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139520823|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139520824|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
139520825|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520826|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520827|NCT02097745|Rituximab|rituximab|mesh-list
139520828|NCT02097745|Methotrexate|methotrexate|mesh-list
139520829|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139520830|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520831|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
139520832|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520833|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139520834|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139520835|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
139520836|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139520837|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139520838|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
139520839|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520840|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
139520841|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520842|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139520843|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520844|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139520845|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
139520846|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139520847|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520848|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
139520849|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139520850|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
139520851|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139520852|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520853|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139520854|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
139520855|NCT02212379|Etravirine|etravirine|mesh-list
139520856|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139520857|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139520858|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
139520859|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520860|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139520861|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139520862|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520863|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520864|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139520865|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139520866|NCT02187809|Clobazam|clobazam|mesh-list
139520867|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
139520868|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139520869|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139520870|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139520871|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520872|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139520873|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139520874|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
139520875|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
139520876|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520877|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520878|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
139520879|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139520880|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139520881|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139520882|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139520883|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520884|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520885|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520886|NCT02162771|Prednisone|prednisone|mesh-list
139520887|NCT02162771|Prednisolone|prednisolone|mesh-list
139520888|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
139520889|NCT02162771|Rituximab|rituximab|mesh-list
139520890|NCT02162771|Vincristine|vincristine|mesh-list
139520891|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520892|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
139520893|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520894|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139520895|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139520896|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
139520897|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520898|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520899|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139520900|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139520901|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139520902|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
139520903|NCT02162771|Hormones|hormones|mesh-ancestor
139135727|NCT05986318|Hormones|hormones|mesh-ancestor
139520904|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139520905|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139520906|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139520907|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
139520908|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
139520909|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
139520910|NCT02160041|Infigratinib|infigratinib|mesh-list
139520911|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520912|NCT02186873|Golimumab|golimumab|mesh-list
139520913|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139520914|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139520915|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139520916|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
139520917|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520918|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139520919|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
139520920|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520921|NCT01830543|Aspirin|aspirin|mesh-list
139520922|NCT01830543|Vitamin K|vitamin k|mesh-list
139520923|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
139520924|NCT01830543|Clopidogrel|clopidogrel|mesh-list
139520925|NCT01830543|Ticagrelor|ticagrelor|mesh-list
139520926|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139520927|NCT01830543|Vitamins|vitamins|mesh-ancestor
139520928|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
139520929|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520930|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139520931|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139520932|NCT01830543|Analgesics|analgesics|mesh-ancestor
139520933|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
139520934|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520935|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139520936|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139520937|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139520938|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139520939|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520940|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139520941|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139520942|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520943|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
139520944|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139520945|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139520946|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139520947|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
139090206|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
139520948|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520949|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139520950|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
139135852|NCT05773365|Anesthetics|anesthetics|mesh-list
139520951|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139520952|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
139520953|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
139520954|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139520955|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
139520956|NCT01830543|Coagulants|coagulants|mesh-ancestor
139520957|NCT02109445|Paclitaxel|paclitaxel|mesh-list
139520958|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139520959|NCT02109445|Gemcitabine|gemcitabine|mesh-list
139520960|NCT02109445|Nirogacestat|nirogacestat|mesh-list
139520961|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139520962|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139520963|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
139520964|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
139520965|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
139520966|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520967|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139520968|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
139520969|NCT02109445|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139520970|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520971|NCT02109133|Rocuronium|rocuronium|mesh-list
139520972|NCT02109133|Atracurium|atracurium|mesh-list
139520973|NCT02109133|Neostigmine|neostigmine|mesh-list
139520974|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139520975|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139520976|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139520977|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520978|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520979|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139520980|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139520981|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139520982|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
139520983|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139520984|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139520985|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
139520986|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139520987|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139520988|NCT01623271|Gabapentin|gabapentin|mesh-list
139135897|NCT05372315|BB 1101|bb 1101|mesh-list
139520989|NCT01623271|Analgesics|analgesics|mesh-ancestor
139520990|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
139520991|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139520992|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139520993|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
139520994|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139520995|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139520996|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139520997|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139520998|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139520999|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139521000|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521001|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521002|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
139521003|NCT02095951|Ethanol|ethanol|mesh-list
139521004|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139521005|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521006|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139521007|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521008|NCT02095873|Resveratrol|resveratrol|mesh-list
139521009|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
139521010|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521011|NCT02095873|Protective Agents|protective agents|mesh-ancestor
139521012|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521013|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521014|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139521015|NCT02094937|Fluticasone|fluticasone|mesh-list
139521016|NCT02094937|Xhance|xhance|mesh-list
139521017|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521018|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139135939|NCT05104983|Sirolimus|sirolimus|mesh-list
139521019|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
139521020|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521021|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090280|NCT06193486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521022|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139521023|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
139521024|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
139521025|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139521026|NCT04724629|Aldesleukin|aldesleukin|mesh-list
139521027|NCT04724629|Colchicine|colchicine|mesh-list
139521028|NCT04724629|Ixekizumab|ixekizumab|mesh-list
139521029|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521030|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139521031|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139521032|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
139521033|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521034|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
139521035|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521036|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
139521037|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
139521038|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
139521039|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521040|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
139521041|NCT02186015|Vitamin D|vitamin d|mesh-list
139521042|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
139521043|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
139521044|NCT02186015|Vitamins|vitamins|mesh-list
139521045|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
139521046|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521047|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139521048|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139521049|NCT02066389|Upadacitinib|upadacitinib|mesh-list
139521050|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139521051|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139521052|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521053|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521054|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521055|NCT02106403|Disinfectants|disinfectants|mesh-list
139521056|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521057|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
139521058|NCT02133131|Grazoprevir|grazoprevir|mesh-list
139521059|NCT02133131|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139521060|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
139521061|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521062|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
139521063|NCT02106325|Promethazine|promethazine|mesh-list
139521064|NCT02106325|Ketamine|ketamine|mesh-list
139521065|NCT02106325|Analgesics|analgesics|mesh-ancestor
138896626|NCT00696956|Paclitaxel|paclitaxel|mesh-list
139521066|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
139521067|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521068|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521069|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139521070|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139521071|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
139521072|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
139521073|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139521074|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139521075|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139521076|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521077|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521078|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139521079|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139521080|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
139521081|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
139521082|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
139521083|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139521084|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139521085|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
139521086|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
139521087|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139521088|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
139521089|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
139521090|NCT02184611|Bromides|bromides|mesh-list
139521091|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
139521092|NCT02066311|Nelfinavir|nelfinavir|mesh-list
139521093|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139521094|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139521095|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
139521096|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521097|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090353|NCT06192420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139090354|NCT06192420|Analgesics|analgesics|mesh-ancestor
139521098|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139521099|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139521100|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
139521101|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521102|NCT01625611|Naltrexone|naltrexone|mesh-list
139521103|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139521104|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139521105|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521106|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
139521107|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521108|NCT02159807|Fentanyl|fentanyl|mesh-list
139521109|NCT02159807|Bupivacaine|bupivacaine|mesh-list
139521110|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
139521111|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
139521112|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139521113|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521114|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
139521115|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521116|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139521117|NCT02159807|Narcotics|narcotics|mesh-ancestor
139521118|NCT02159807|Analgesics|analgesics|mesh-ancestor
139521119|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139521120|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139521121|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
139521122|NCT02183675|Amlodipine|amlodipine|mesh-list
139521123|NCT02183675|Telmisartan|telmisartan|mesh-list
139521124|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139521125|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139521126|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139521127|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139521128|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139521129|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521130|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139521131|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521132|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
139521133|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139521134|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139521135|NCT02183675|Diuretics|diuretics|mesh-ancestor
139521136|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
139521137|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139521138|NCT02183519|Capsaicin|capsaicin|mesh-list
139521139|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
139521140|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
139521141|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
139521142|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521143|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521144|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139521145|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139521146|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
139521147|NCT02132195|Hormones|hormones|mesh-ancestor
139521148|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139521149|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521150|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136092|NCT04494529|Hormones|hormones|mesh-ancestor
139521151|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521152|NCT02182895|Saxagliptin|saxagliptin|mesh-list
139521153|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139521154|NCT02182895|Incretins|incretins|mesh-ancestor
139521155|NCT02182895|Hormones|hormones|mesh-ancestor
139521156|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139521157|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521158|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
139521159|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521160|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521161|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139521162|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
139521163|NCT01625377|Everolimus|everolimus|mesh-list
139521164|NCT01625377|Tacrolimus|tacrolimus|mesh-list
139521165|NCT01625377|Basiliximab|basiliximab|mesh-list
139521166|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139521167|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
139521168|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521169|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139521170|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521171|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521172|NCT01625377|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139090428|NCT06191744|Doxorubicin|doxorubicin|mesh-list
139521173|NCT01625377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139521174|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521175|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139521176|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139521177|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
139521178|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139521179|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521180|NCT02132117|Phenylephrine|phenylephrine|mesh-list
139521181|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
139521182|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139521183|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139521184|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
139521185|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521186|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521187|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521188|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
139521189|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
139521190|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521191|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
139521192|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139521193|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
139521194|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139521195|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
139521196|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139521197|NCT02132117|Protective Agents|protective agents|mesh-ancestor
139521198|NCT02047045|Prucalopride|prucalopride|mesh-list
139521199|NCT02047045|Serotonin|serotonin|mesh-list
139521200|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139521201|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
139521202|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521203|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521204|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521205|NCT02047045|Laxatives|laxatives|mesh-ancestor
139521206|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139521207|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139521208|NCT02131259|Afatinib|afatinib|mesh-list
139521209|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521210|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139521211|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521212|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521213|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
139521214|NCT01829295|Prednisone|prednisone|mesh-list
139521215|NCT01829295|Methotrexate|methotrexate|mesh-list
139521216|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521217|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
139521218|NCT01829295|Hormones|hormones|mesh-ancestor
139521219|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139521220|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521221|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139521222|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521223|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139521224|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
139521225|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139521226|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139521227|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
139521228|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521229|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
139521230|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521231|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139521232|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139521233|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
139521234|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521235|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139521236|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139521237|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139521238|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
139521239|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139521240|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521241|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
139521242|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139136244|NCT03681639|Cobalt|cobalt|mesh-list
139521243|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139521244|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
139521245|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521246|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521247|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139521248|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
139521249|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139521250|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139521251|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139521252|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
139521253|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521254|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521255|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
139521256|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139521257|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
139521258|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521259|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521260|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139521261|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139521262|NCT01623115|Alirocumab|alirocumab|mesh-list
139521263|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139521264|NCT01623115|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139521265|NCT01623115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139521266|NCT01623115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139521267|NCT01623115|Antimetabolites|antimetabolites|mesh-ancestor
139521268|NCT01623115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521269|NCT01623115|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139521270|NCT01623115|Protease Inhibitors|protease inhibitors|mesh-ancestor
139521271|NCT01623115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521272|NCT01623115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139521273|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
139521274|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521275|NCT02092285|Golimumab|golimumab|mesh-list
139521276|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139521277|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521278|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139521279|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
139521280|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521281|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
139521282|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139521283|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139521284|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139521285|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139521286|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139521287|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521288|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
139521289|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521290|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521291|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139521292|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521293|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
139521294|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
139521295|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139521296|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
139521297|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521298|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521299|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139521300|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
139521301|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139521302|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139521303|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139521304|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
139521305|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521306|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136309|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136310|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139521307|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521308|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
139521309|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139521310|NCT01827267|Sirolimus|sirolimus|mesh-list
139521311|NCT01827267|Temsirolimus|temsirolimus|mesh-list
139521312|NCT01827267|MTOR Inhibitors|mtor inhibitors|mesh-list
139521313|NCT01827267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139521314|NCT01827267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521315|NCT01827267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521316|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139521317|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
139521318|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521319|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521320|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139521321|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521322|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139136373|NCT00662740|Tiotropium Bromide|tiotropium bromide|mesh-list
139136374|NCT00662740|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139136375|NCT00662740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139136376|NCT00662740|Autonomic Agents|autonomic agents|mesh-ancestor
139136377|NCT00662740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136378|NCT00662740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136379|NCT00662740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139136380|NCT00662740|Respiratory System Agents|respiratory system agents|mesh-ancestor
139136381|NCT00662740|Parasympatholytics|parasympatholytics|mesh-ancestor
139136382|NCT00662740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139136383|NCT00662740|Cholinergic Agents|cholinergic agents|mesh-ancestor
139136384|NCT00662740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136385|NCT00662740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521323|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
139521324|NCT01827111|Paclitaxel|paclitaxel|mesh-list
139521325|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139521326|NCT01827111|Ipilimumab|ipilimumab|mesh-list
139521327|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139521328|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521329|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
139521330|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
139521331|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
139521332|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521333|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139521334|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139521335|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
139521336|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139521337|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
139521338|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139521339|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
139521340|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521341|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521342|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
139521343|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
139521344|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521345|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139521346|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521347|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521348|NCT01854645|Bromides|bromides|mesh-list
139521349|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
139521350|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139521351|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
139521352|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521353|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521354|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139521355|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
139521356|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
139521357|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139521358|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
139521359|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521360|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521361|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
139521362|NCT04418089|Simvastatin|simvastatin|mesh-list
139521363|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139521364|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139521365|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
139521366|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521367|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139521368|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139521369|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521370|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
139521371|NCT01825941|Promethazine|promethazine|mesh-list
139521372|NCT01825941|Metoclopramide|metoclopramide|mesh-list
139521373|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139521374|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139521375|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139521376|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521377|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
139521378|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
139521379|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
139521380|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521381|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
139521382|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
139521383|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139521384|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139521385|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
139521386|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
138899073|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
139521387|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521388|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521389|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139521390|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
139521391|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
139521392|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139521393|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139521394|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
139521395|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
139521396|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139521397|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521398|NCT02180165|Voriconazole|voriconazole|mesh-list
139521399|NCT02180165|Posaconazole|posaconazole|mesh-list
139521400|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
139521401|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136509|NCT01182129|Nicotine|nicotine|mesh-list
139521402|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139521403|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139521404|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521405|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521406|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139521407|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
139521408|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139521409|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521410|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139521411|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139521412|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139521413|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139521414|NCT02155985|Aspirin|aspirin|mesh-list
139521415|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139521416|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139521417|NCT02155985|Analgesics|analgesics|mesh-ancestor
139521418|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
139521419|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521420|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521421|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521422|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521423|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139521424|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139521425|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521426|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139521427|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139521428|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521429|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
139521430|NCT02155829|Riluzole|riluzole|mesh-list
139521431|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
139521432|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139521433|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139521434|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136624|NCT01186653|Hormones|hormones|mesh-ancestor
139521435|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521436|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521437|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139521438|NCT02155829|Protective Agents|protective agents|mesh-ancestor
139521439|NCT02178995|Methylphenidate|methylphenidate|mesh-list
139521440|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139521441|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521442|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139521443|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139521444|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139521445|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521446|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
139521447|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521448|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
139521449|NCT02154425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139521450|NCT02154425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521451|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139136678|NCT01289301|Sirolimus|sirolimus|mesh-list
139521452|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
139521453|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521454|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521455|NCT02154347|Mitiglinide|mitiglinide|mesh-list
139521456|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139521457|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521458|NCT01627067|Metformin|metformin|mesh-list
139521459|NCT01627067|Everolimus|everolimus|mesh-list
139521460|NCT01627067|Exemestane|exemestane|mesh-list
139521461|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139521462|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521463|NCT01627067|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139521464|NCT01627067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139521465|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521466|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521467|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139521468|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
139521469|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521470|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139136730|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
139521471|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139521472|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139521473|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
139521474|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139521475|NCT02178059|Terbutaline|terbutaline|mesh-list
139521476|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139521477|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
139521478|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521479|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521480|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139521481|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
139521482|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
139521483|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
139521484|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139521485|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139521486|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139521487|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139521488|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
139521489|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521490|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521491|NCT02128217|Ribavirin|ribavirin|mesh-list
139521492|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
139521493|NCT02128217|Ledipasvir|ledipasvir|mesh-list
139521494|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139521495|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
139521496|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521497|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
139521498|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521499|NCT01628549|Sarecycline|sarecycline|mesh-list
139521500|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139521501|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521502|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
139521503|NCT02127125|Sevelamer|sevelamer|mesh-list
139521504|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
139521505|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
139521506|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521507|NCT02090413|Aspirin|aspirin|mesh-list
139521508|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139521509|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139521510|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139521511|NCT02090413|Analgesics|analgesics|mesh-ancestor
139521512|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
139521513|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521514|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521515|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521516|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521517|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139521518|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139521519|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521520|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139521521|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139521522|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521523|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
139521524|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
139521525|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139521526|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
139521527|NCT02125877|Deferasirox|deferasirox|mesh-list
139521528|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139521529|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
139521530|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
139521531|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521532|NCT01598987|Cyclosporine|cyclosporine|mesh-list
139521533|NCT01598987|Everolimus|everolimus|mesh-list
139521534|NCT01598987|Tacrolimus|tacrolimus|mesh-list
139521535|NCT01598987|Cyclosporins|cyclosporins|mesh-list
139521536|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139521537|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
139521538|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521539|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139521540|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521541|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521542|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
139521543|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521544|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
139090803|NCT05851547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139521545|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521546|NCT01598987|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139521547|NCT01598987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139521548|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521549|NCT02062879|Ketamine|ketamine|mesh-list
139521550|NCT02062879|Hydromorphone|hydromorphone|mesh-list
139521551|NCT02062879|Analgesics|analgesics|mesh-ancestor
139521552|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
139521553|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521554|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521555|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139521556|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139521557|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
139521558|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
139521559|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139521560|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139521561|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139521562|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521563|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137079|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
139521564|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139521565|NCT02062879|Narcotics|narcotics|mesh-ancestor
139521566|NCT02062645|Amlodipine|amlodipine|mesh-list
139521567|NCT02062645|Valsartan|valsartan|mesh-list
139521568|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
139521569|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139521570|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139521571|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139521572|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521573|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139521574|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521575|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
139521576|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139521577|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139521578|NCT04700839|Metformin|metformin|mesh-list
139521579|NCT04700839|Canagliflozin|canagliflozin|mesh-list
139521580|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139521581|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139521582|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521583|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521584|NCT02043301|Bococizumab|bococizumab|mesh-list
139521585|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139521586|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139521587|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
139521588|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521589|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139521590|NCT01598753|Tramadol|tramadol|mesh-list
139521591|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139521592|NCT01598753|Narcotics|narcotics|mesh-ancestor
139521593|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139521594|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521595|NCT01598753|Analgesics|analgesics|mesh-ancestor
139521596|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
139521597|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521598|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
139521599|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
139521600|NCT01824693|Melphalan|melphalan|mesh-list
139521601|NCT01824693|Busulfan|busulfan|mesh-list
139521602|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
139521603|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139521604|NCT01824693|Fludarabine|fludarabine|mesh-list
139521605|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
139521606|NCT01824693|Tacrolimus|tacrolimus|mesh-list
139521607|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139521608|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
139521609|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521610|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521611|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139521612|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
139521613|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521614|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521615|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139521616|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139521617|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
139521618|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139521619|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521620|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139521621|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139521622|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
139521623|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139521624|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521625|NCT02176655|Aspirin|aspirin|mesh-list
139521626|NCT02176655|Sumatriptan|sumatriptan|mesh-list
139521627|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139521628|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139521629|NCT02176655|Analgesics|analgesics|mesh-ancestor
139521630|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
139521631|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521632|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521633|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521634|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521635|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139521636|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139521637|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521638|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139521639|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139521640|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521641|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
139521642|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139521643|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139521644|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139521645|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
139521646|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521647|NCT01622569|Fluticasone|fluticasone|mesh-list
139521648|NCT01622569|Xhance|xhance|mesh-list
139521649|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521650|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139521651|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
139521652|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521653|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521654|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139521655|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
139521656|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
139521657|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139521658|NCT04747301|Dinoprostone|dinoprostone|mesh-list
139521659|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
139521660|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139521661|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521662|NCT02152163|Ibuprofen|ibuprofen|mesh-list
139137223|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
139521663|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139521664|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139521665|NCT02152163|Analgesics|analgesics|mesh-ancestor
139521666|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
139521667|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521668|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521669|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521670|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521671|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139521672|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521673|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521674|NCT02152007|Sirolimus|sirolimus|mesh-list
139521675|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139521676|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521677|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139521678|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521679|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
139521680|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139521681|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
139521682|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521683|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
139521684|NCT02151851|Methotrexate|methotrexate|mesh-list
139521685|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139521686|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
139521687|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139521688|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521689|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139521690|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
139521691|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521692|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521693|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
139521694|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521695|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139521696|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090951|NCT05643066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139521697|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
139521698|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521699|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139521700|NCT02151851|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139521701|NCT02151851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521702|NCT02176421|Lidocaine|lidocaine|mesh-list
139521703|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
139521704|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
139521705|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139521706|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521707|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
139521708|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521709|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139521710|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139521711|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139521712|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139521713|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521714|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
139521715|NCT02042443|Leucovorin|leucovorin|mesh-list
139521716|NCT02042443|Folic Acid|folic acid|mesh-list
139521717|NCT02042443|Capecitabine|capecitabine|mesh-list
139521718|NCT02042443|Fluorouracil|fluorouracil|mesh-list
139521719|NCT02042443|Trametinib|trametinib|mesh-list
139521720|NCT02042443|Calcium|calcium|mesh-list
139521721|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
139521722|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139521723|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521724|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139521725|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139521726|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
139521727|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521728|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521729|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139521730|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
139521731|NCT02042443|Antidotes|antidotes|mesh-ancestor
139521732|NCT02042443|Protective Agents|protective agents|mesh-ancestor
139521733|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
139521734|NCT02042443|Vitamins|vitamins|mesh-ancestor
139521735|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
139521736|NCT02042443|Hematinics|hematinics|mesh-ancestor
139521737|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139521738|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521739|NCT02118896|Tacrolimus|tacrolimus|mesh-list
139521740|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139521741|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
139521742|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521743|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139521744|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521745|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521746|NCT02124707|Paclitaxel|paclitaxel|mesh-list
139521747|NCT02124707|Carboplatin|carboplatin|mesh-list
139521748|NCT02124707|Cetuximab|cetuximab|mesh-list
139521749|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139521750|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521751|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
139521752|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
139521753|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
139521754|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521755|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139521756|NCT02092220|Pancrelipase|pancrelipase|mesh-list
139521757|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139521758|NCT02066402|Linezolid|linezolid|mesh-list
139521759|NCT02066402|Tedizolid|tedizolid|mesh-list
139521760|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
139521761|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139521762|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521763|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139521764|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521765|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521766|NCT02060383|Metformin|metformin|mesh-list
139521767|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139521768|NCT02060383|Liraglutide|liraglutide|mesh-list
139521769|NCT02060383|Pasireotide|pasireotide|mesh-list
139521770|NCT02060383|Somatostatin|somatostatin|mesh-list
139521771|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139521772|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521773|NCT02060383|Incretins|incretins|mesh-ancestor
139521774|NCT02060383|Hormones|hormones|mesh-ancestor
139521775|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139521776|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139521777|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
139521778|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521779|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521780|NCT02086591|Doxycycline|doxycycline|mesh-list
139521781|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139521782|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521783|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
139521784|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139521785|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139521786|NCT02065622|Adalimumab|adalimumab|mesh-list
139521787|NCT02065622|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139521788|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521789|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521790|NCT02117648|Clarithromycin|clarithromycin|mesh-list
139521791|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139521792|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521793|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139521794|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521795|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521796|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139521797|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139521798|NCT02124161|Vaccines|vaccines|mesh-list
139521799|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139521800|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
139521801|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521802|NCT02117570|Vaccines|vaccines|mesh-list
139521803|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
139521804|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521805|NCT02123459|Cephalexin|cephalexin|mesh-list
139521806|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139521807|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521808|NCT01853475|Artefenomel|artefenomel|mesh-list
139521809|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
139521810|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139521811|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139521812|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521813|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
139521814|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521815|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
139521816|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521817|NCT04411160|Protective Agents|protective agents|mesh-ancestor
139521818|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139521819|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
139521820|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521821|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139521822|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
139521823|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139521824|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521825|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139521826|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
139521827|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
139521828|NCT02151773|Vaccines|vaccines|mesh-list
139521829|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
139521830|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521831|NCT02151461|Metformin|metformin|mesh-list
139521832|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139521833|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521834|NCT02091986|Budesonide|budesonide|mesh-list
139521835|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139521836|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521837|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139521838|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
139521839|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521840|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521841|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139521842|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
139521843|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
139521844|NCT02091986|Hormones|hormones|mesh-ancestor
139521845|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139521846|NCT02117024|Paclitaxel|paclitaxel|mesh-list
139521847|NCT02117024|Vinorelbine|vinorelbine|mesh-list
139521848|NCT02117024|Docetaxel|docetaxel|mesh-list
139521849|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
139091099|NCT05508074|Riluzole|riluzole|mesh-list
139521850|NCT02117024|Gemcitabine|gemcitabine|mesh-list
139521851|NCT02117024|Pemetrexed|pemetrexed|mesh-list
139521852|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139521853|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139521854|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521855|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
139521856|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
139521857|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
139521858|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521859|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139521860|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
139521861|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521862|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521863|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139521864|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
139521865|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139521866|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139521867|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
139521868|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521869|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139521870|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139521871|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139521872|NCT02064920|Donepezil|donepezil|mesh-list
139521873|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139521874|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521875|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521876|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
139521877|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521878|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521879|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
139521880|NCT02151149|Paclitaxel|paclitaxel|mesh-list
139521881|NCT02151149|Carboplatin|carboplatin|mesh-list
139521882|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139521883|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521884|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
139521885|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
139521886|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
139521887|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521888|NCT02150213|Dexamethasone|dexamethasone|mesh-list
139521889|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139521890|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
139521891|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
139521892|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521893|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521894|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139521895|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
139521896|NCT02150213|Hormones|hormones|mesh-ancestor
139521897|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139521898|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139521899|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521900|NCT02091362|Metformin|metformin|mesh-list
139521901|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139521902|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521903|NCT02091206|Cannabidiol|cannabidiol|mesh-list
139137733|NCT03842631|Timolol|timolol|mesh-list
139521904|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
139521905|NCT02062658|Ketamine|ketamine|mesh-list
139521906|NCT02062658|Analgesics|analgesics|mesh-ancestor
139521907|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
139521908|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139521909|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521910|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139521911|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139521912|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
139521913|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
139521914|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139521915|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139521916|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139521917|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521918|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521919|NCT02115308|Regadenoson|regadenoson|mesh-list
139521920|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139521921|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139521922|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
139521923|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
139521924|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139521925|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521926|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521927|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
139521928|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139521929|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139521930|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139521931|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139521932|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521933|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521934|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521935|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
139521936|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
139521937|NCT02090114|Testosterone|testosterone|mesh-list
139521938|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
139521939|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
139521940|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139521941|NCT02090114|Androgens|androgens|mesh-ancestor
139521942|NCT02090114|Hormones|hormones|mesh-ancestor
139521943|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139521944|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521945|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139521946|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521947|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
139521948|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139521949|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521950|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521951|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
139521952|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139521953|NCT04742036|Paclitaxel|paclitaxel|mesh-list
139521954|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139521955|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521956|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
139521957|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
139521958|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
139521959|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521960|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
139521961|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139521962|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
139521963|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139521964|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
139521965|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521966|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521967|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
139521968|NCT02111096|Metformin|metformin|mesh-list
139521969|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139521970|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139137837|NCT03930615|Letermovir|letermovir|mesh-list
139521971|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521972|NCT02111096|Incretins|incretins|mesh-ancestor
139521973|NCT02111096|Hormones|hormones|mesh-ancestor
139521974|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139521975|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139521976|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
139521977|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139521978|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521979|NCT02110706|Rituximab|rituximab|mesh-list
139521980|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139521981|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139521982|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
139521983|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521984|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139521985|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
139521986|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139521987|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
139521988|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139521989|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
139521990|NCT02110238|Protective Agents|protective agents|mesh-ancestor
139521991|NCT02107898|Alirocumab|alirocumab|mesh-list
139521992|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139521993|NCT02107898|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139521994|NCT02107898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139521995|NCT02107898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139521996|NCT02107898|Antimetabolites|antimetabolites|mesh-ancestor
139521997|NCT02107898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139521998|NCT02107898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139521999|NCT02107898|Protease Inhibitors|protease inhibitors|mesh-ancestor
139091249|NCT05073237|Estrogens|estrogens|mesh-list
139522000|NCT02107898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522001|NCT02107898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139522002|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
139522003|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522004|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
139522005|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139522006|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139522007|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139522008|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522009|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
139522010|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522011|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522012|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139522013|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522015|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139522016|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139522017|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
139522018|NCT02173769|Olodaterol|olodaterol|mesh-list
139522019|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139522020|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
139522021|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522022|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522023|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139522024|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
139522025|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
139522026|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139522027|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
139522028|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522029|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522030|NCT02121509|Metformin|metformin|mesh-list
139522031|NCT02121509|Linagliptin|linagliptin|mesh-list
139522032|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139522033|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522034|NCT02121509|Incretins|incretins|mesh-ancestor
139522035|NCT02121509|Hormones|hormones|mesh-ancestor
139522036|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139522037|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139522038|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
139137888|NCT01202487|Epinephrine|epinephrine|mesh-list
139522039|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522040|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522041|NCT02149199|Budesonide|budesonide|mesh-list
139522042|NCT02149199|Terbutaline|terbutaline|mesh-list
139522043|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
139522044|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139522045|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139522046|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
139522047|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522048|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522049|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139522050|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
139522051|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
139522052|NCT02149199|Hormones|hormones|mesh-ancestor
139522053|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139137962|NCT03292016|Emetics|emetics|mesh-ancestor
139522054|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139522055|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139522056|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139522057|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
139522058|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522059|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522060|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
139522061|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
139522062|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139522063|NCT02120417|Capecitabine|capecitabine|mesh-list
139522064|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139522065|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
139522066|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522067|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522068|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
139522069|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139522070|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139522071|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139522072|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139091336|NCT05006794|Docetaxel|docetaxel|mesh-list
139522073|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522074|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
139522075|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522076|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138073|NCT05281419|Hormones|hormones|mesh-ancestor
139522077|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139522078|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522079|NCT02058368|Tamsulosin|tamsulosin|mesh-list
139522080|NCT02058368|Dutasteride|dutasteride|mesh-list
139522081|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139522082|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139522083|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139522084|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
139522085|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522086|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522087|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522088|NCT02058368|Urological Agents|urological agents|mesh-ancestor
139522089|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139522090|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139522091|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522092|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
139522093|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139522094|NCT02058290|Morphine|morphine|mesh-list
139522095|NCT02058290|Bupivacaine|bupivacaine|mesh-list
139522096|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
139522097|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
139522098|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522099|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522100|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
139522101|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522102|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139522103|NCT02058290|Narcotics|narcotics|mesh-ancestor
139522104|NCT02058290|Analgesics|analgesics|mesh-ancestor
139522105|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
139522106|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139522107|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139522108|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522109|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522110|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139522111|NCT04718480|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139522112|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139522113|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139522114|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522115|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522116|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
139522117|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139522118|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
139522119|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139522120|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139522121|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522122|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139522123|NCT02106884|Paclitaxel|paclitaxel|mesh-list
139522124|NCT02106884|Gemcitabine|gemcitabine|mesh-list
139522125|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139522126|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522127|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
139522128|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
139522129|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
139522130|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522131|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139522132|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
139522133|NCT02081690|Macitentan|macitentan|mesh-list
139522134|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139522135|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139522136|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522137|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139522138|NCT01625000|Risperidone|risperidone|mesh-list
139522139|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139522140|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
139522141|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522142|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522143|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522144|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139522145|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139522146|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522147|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139522148|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139522149|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
139522150|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139522151|NCT02057198|Metronidazole|metronidazole|mesh-list
139522152|NCT02057198|Vancomycin|vancomycin|mesh-list
139522153|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
139522154|NCT02057198|Amebicides|amebicides|mesh-list
139522155|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139522156|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139522157|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139522158|NCT02056340|Atorvastatin|atorvastatin|mesh-list
139522159|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139522160|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139522161|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
139522162|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522163|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139522164|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139522165|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522166|NCT02046122|Cytarabine|cytarabine|mesh-list
139522167|NCT02046122|Idarubicin|idarubicin|mesh-list
139522168|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139522169|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
139522170|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522171|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522172|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
139522173|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139522174|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139522175|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
139522176|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522177|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139522178|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139522179|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139522180|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522181|NCT02080832|Dexetimide|dexetimide|mesh-list
139522182|NCT02080832|Citalopram|citalopram|mesh-list
139522183|NCT02080832|Escitalopram|escitalopram|mesh-list
139522184|NCT02080832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139522185|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139522186|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139522187|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522188|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522189|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
139522190|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522191|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139522192|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
139522193|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139522194|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139522195|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139522196|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
139522197|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
139522198|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522199|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139522200|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139522201|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
139522202|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
139522203|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139522204|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522205|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139522206|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522207|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522208|NCT02078102|Meloxicam|meloxicam|mesh-list
139522209|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522210|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139522211|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139522212|NCT02078102|Analgesics|analgesics|mesh-ancestor
139522213|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
139522214|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522215|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139522216|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139091469|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139522217|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139522218|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139522219|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522220|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522222|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
139522223|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
139522224|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139522225|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139522226|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139522227|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522228|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522229|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
139522230|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
139522231|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522232|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522233|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139522234|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139522235|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
139138524|NCT05577117|Narcotics|narcotics|mesh-ancestor
139522236|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139522237|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139522238|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139522239|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139522240|NCT02044094|Buprenorphine|buprenorphine|mesh-list
139522241|NCT02044094|Hydromorphone|hydromorphone|mesh-list
139522242|NCT02044094|Naloxone|naloxone|mesh-list
139522243|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139522244|NCT02044094|Narcotics|narcotics|mesh-ancestor
139522245|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522246|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522247|NCT02044094|Analgesics|analgesics|mesh-ancestor
139522248|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
139522249|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522250|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139522251|NCT02053610|Rituximab|rituximab|mesh-list
139522252|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
139522253|NCT02053610|Chlorambucil|chlorambucil|mesh-list
139522254|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522255|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522256|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
139522257|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522258|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139522259|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139522260|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
139522261|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522262|NCT02075606|Lanreotide|lanreotide|mesh-list
139522263|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522264|NCT04701008|Ketamine|ketamine|mesh-list
139522265|NCT04701008|Analgesics|analgesics|mesh-ancestor
139522266|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
139522267|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522268|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522269|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139522270|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139522271|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
139522272|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
139522273|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522274|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139522275|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139522276|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522277|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522278|NCT02052440|Baclofen|baclofen|mesh-list
139522279|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139522280|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522281|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139522282|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522283|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139522284|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
139522285|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
139522286|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522287|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522288|NCT02049944|Cefazolin|cefazolin|mesh-list
139522289|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139522290|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139522291|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
139522292|NCT01621880|Bevacizumab|bevacizumab|mesh-list
139522293|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522294|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522295|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139522296|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139522297|NCT01621880|Growth Substances|growth substances|mesh-ancestor
139522298|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522299|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
139522300|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139522301|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
139522302|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
139522303|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522304|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139522305|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
139522306|NCT01621880|Hormones|hormones|mesh-ancestor
139522307|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139522308|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139522309|NCT01621880|Protective Agents|protective agents|mesh-ancestor
139522310|NCT02041429|Paclitaxel|paclitaxel|mesh-list
139522311|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139522312|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522313|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
139522314|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
139522315|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
139522316|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522317|NCT02083783|Amphetamine|amphetamine|mesh-list
139522318|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139522319|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522320|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
139522321|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
139522322|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522323|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
139522324|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522325|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522326|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
139522327|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139522328|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139522329|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139138679|NCT03800667|Vitamins|vitamins|mesh-ancestor
139522330|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139522331|NCT02059135|Antithrombins|antithrombins|mesh-list
139522332|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
139522333|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139522334|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
139522335|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522336|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522337|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
139522338|NCT04695769|Ribavirin|ribavirin|mesh-list
139522339|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
139522340|NCT04695769|Velpatasvir|velpatasvir|mesh-list
139522341|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139522342|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
139522343|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522344|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
139522345|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139522346|NCT02038933|Nivolumab|nivolumab|mesh-list
139522347|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522348|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522349|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139522350|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522351|NCT02081599|Insulin|insulin|mesh-list
139522352|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139522353|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522354|NCT02038153|Lenalidomide|lenalidomide|mesh-list
139522355|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
139522356|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522357|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139522358|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139522359|NCT02038153|Growth Substances|growth substances|mesh-ancestor
139522360|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
139522361|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522362|NCT02079805|Telmisartan|telmisartan|mesh-list
139522363|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139522364|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139522365|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139522366|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139522367|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522368|NCT02037295|Vancomycin|vancomycin|mesh-list
139522369|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139522370|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139522371|NCT02079649|Dexamethasone|dexamethasone|mesh-list
139522372|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139522373|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139522374|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139522375|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
139522376|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
139522377|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522378|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522379|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139522380|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
139522381|NCT02079649|Hormones|hormones|mesh-ancestor
139522382|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139522383|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139522384|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522385|NCT02036515|Metformin|metformin|mesh-list
139522386|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138889299|NCT02544308|Hormones|hormones|mesh-ancestor
139522387|NCT02036515|Glimepiride|glimepiride|mesh-list
139522388|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
139522389|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139522390|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522391|NCT02036515|Incretins|incretins|mesh-ancestor
139522392|NCT02036515|Hormones|hormones|mesh-ancestor
139522393|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139522394|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139522395|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
139522396|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522397|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522398|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139522399|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139522400|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
139522401|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139522402|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
139522403|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139522404|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522405|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
139522406|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139522407|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139522408|NCT05887375|Glycopyrrolate|glycopyrrolate|mesh-list
139522409|NCT05887375|Bromides|bromides|mesh-list
139522410|NCT05887375|Rocuronium|rocuronium|mesh-list
139522411|NCT05887375|Neostigmine|neostigmine|mesh-list
139522412|NCT05887375|Anticonvulsants|anticonvulsants|mesh-ancestor
139522413|NCT05887375|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139522414|NCT05887375|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139522415|NCT05887375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139522416|NCT05887375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522417|NCT05887375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522418|NCT05887375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139522419|NCT05887375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522420|NCT05887375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522421|NCT05887375|Cholinergic Agents|cholinergic agents|mesh-ancestor
139522422|NCT05887375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522423|NCT05887375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139522424|NCT05887375|Autonomic Agents|autonomic agents|mesh-ancestor
139522425|NCT05887375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139522426|NCT05887375|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139522427|NCT05887375|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139522428|NCT05887258|Analgesics, Opioid|analgesics, opioid|mesh-list
139522429|NCT05887258|Anesthetics|anesthetics|mesh-list
139522430|NCT05887258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522431|NCT05887258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522432|NCT05887258|Narcotics|narcotics|mesh-ancestor
139522433|NCT05887258|Analgesics|analgesics|mesh-ancestor
139522434|NCT05887258|Sensory System Agents|sensory system agents|mesh-ancestor
139522435|NCT05887258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522436|NCT05887219|Azelaic acid|azelaic acid|mesh-list
139522437|NCT05887219|Tranexamic Acid|tranexamic acid|mesh-list
139522438|NCT05887219|Hydroquinone|hydroquinone|mesh-list
139522439|NCT05887219|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139304049|NCT02074137|Hormones|hormones|mesh-ancestor
139522440|NCT05887219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139138882|NCT02048644|Hormones|hormones|mesh-ancestor
139522441|NCT05887219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522442|NCT05887219|Hemostatics|hemostatics|mesh-ancestor
139522443|NCT05887219|Coagulants|coagulants|mesh-ancestor
139522444|NCT05887219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522445|NCT05887219|Dermatologic Agents|dermatologic agents|mesh-ancestor
139522446|NCT05887219|Antioxidants|antioxidants|mesh-ancestor
139522447|NCT05887219|Protective Agents|protective agents|mesh-ancestor
139522448|NCT05887219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522449|NCT05887219|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139522451|NCT05886998|Anticoagulants|anticoagulants|mesh-ancestor
139522452|NCT05886998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139522453|NCT05886998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139522454|NCT05886998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522455|NCT05886933|Fexuprazan|fexuprazan|mesh-list
139522456|NCT05886933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139522457|NCT05886829|Chlorpheniramine|chlorpheniramine|mesh-list
139522458|NCT05886829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522459|NCT05886829|Antipruritics|antipruritics|mesh-ancestor
139522460|NCT05886829|Dermatologic Agents|dermatologic agents|mesh-ancestor
139522461|NCT05886829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139522462|NCT05886829|Histamine Antagonists|histamine antagonists|mesh-ancestor
139522463|NCT05886829|Histamine Agents|histamine agents|mesh-ancestor
139522464|NCT05886829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522465|NCT05886829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138902|NCT02051842|Metadoxine|metadoxine|mesh-list
139522466|NCT05886829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139522467|NCT05886790|Vaccines|vaccines|mesh-list
139522468|NCT05886790|Immunologic Factors|immunologic factors|mesh-ancestor
139522469|NCT05886790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522470|NCT05886660|Scopolamine|scopolamine|mesh-list
139522471|NCT05886660|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139522472|NCT05886660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139522473|NCT05886660|Antiemetics|antiemetics|mesh-ancestor
139522474|NCT05886660|Autonomic Agents|autonomic agents|mesh-ancestor
139522475|NCT05886660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522476|NCT05886660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522477|NCT05886660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139522478|NCT05886660|Mydriatics|mydriatics|mesh-ancestor
139522479|NCT05886660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139522480|NCT05886660|Cholinergic Agents|cholinergic agents|mesh-ancestor
139522481|NCT05886660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522482|NCT05886660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522483|NCT05886660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139522484|NCT05886660|Parasympatholytics|parasympatholytics|mesh-ancestor
139522485|NCT05886465|Bevacizumab|bevacizumab|mesh-list
139522486|NCT05886465|Atezolizumab|atezolizumab|mesh-list
139522487|NCT05886465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522488|NCT05886465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522489|NCT05886465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139522490|NCT05886465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139522491|NCT05886465|Growth Substances|growth substances|mesh-ancestor
139522492|NCT05886465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522493|NCT05886465|Growth Inhibitors|growth inhibitors|mesh-ancestor
139522494|NCT05886465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139522495|NCT05886465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522496|NCT05886439|Pembrolizumab|pembrolizumab|mesh-list
139522497|NCT05886439|Durvalumab|durvalumab|mesh-list
139522498|NCT05886439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522499|NCT05886439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522500|NCT05886439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139522501|NCT05886439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522502|NCT05886257|Bevacizumab|bevacizumab|mesh-list
139522503|NCT05886257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522504|NCT05886257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522505|NCT05886257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139522506|NCT05886257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139522507|NCT05886257|Growth Substances|growth substances|mesh-ancestor
139522508|NCT05886257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522509|NCT05886257|Growth Inhibitors|growth inhibitors|mesh-ancestor
139522510|NCT05886192|Vasopressins|vasopressins|mesh-list
139522511|NCT05886192|Arginine Vasopressin|arginine vasopressin|mesh-list
139522512|NCT05886192|Norepinephrine|norepinephrine|mesh-list
139522513|NCT05886192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139522514|NCT05886192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139522515|NCT05886192|Adrenergic Agents|adrenergic agents|mesh-ancestor
139522516|NCT05886192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522517|NCT05886192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522518|NCT05886192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522519|NCT05886192|Sympathomimetics|sympathomimetics|mesh-ancestor
139522520|NCT05886192|Autonomic Agents|autonomic agents|mesh-ancestor
139522521|NCT05886192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522522|NCT05886192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139522523|NCT05886192|Hemostatics|hemostatics|mesh-ancestor
139522524|NCT05886192|Coagulants|coagulants|mesh-ancestor
139522525|NCT05886192|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139522526|NCT05886192|Natriuretic Agents|natriuretic agents|mesh-ancestor
139522527|NCT05886127|Hemostatics|hemostatics|mesh-list
139522528|NCT05886127|Coagulants|coagulants|mesh-ancestor
139522529|NCT05886088|Dapagliflozin|dapagliflozin|mesh-list
139522530|NCT05886088|Linagliptin|linagliptin|mesh-list
139522531|NCT05886088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139522532|NCT05886088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522533|NCT05886088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139522534|NCT05886088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522535|NCT05886088|Incretins|incretins|mesh-ancestor
139522536|NCT05886088|Hormones|hormones|mesh-ancestor
139522537|NCT05886088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139522538|NCT05886088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139522539|NCT05886088|Protease Inhibitors|protease inhibitors|mesh-ancestor
139522540|NCT05886088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522541|NCT05885919|Edaravone|edaravone|mesh-list
139522542|NCT05885919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139522543|NCT05885919|Antioxidants|antioxidants|mesh-ancestor
139522544|NCT05885919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522545|NCT05885919|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139522546|NCT05885919|Protective Agents|protective agents|mesh-ancestor
139522547|NCT05885919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522548|NCT05885802|Anesthetics|anesthetics|mesh-list
139522549|NCT05885802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522550|NCT05885802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522551|NCT05885776|Trastuzumab|trastuzumab|mesh-list
139522552|NCT05885776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522553|NCT05885776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522554|NCT05884372|Vitamin D|vitamin d|mesh-list
139522555|NCT05884372|Denosumab|denosumab|mesh-list
139522556|NCT05884372|Eldecalcitol|eldecalcitol|mesh-list
139522557|NCT05884372|Calcium|calcium|mesh-list
139522558|NCT05884372|Vitamins|vitamins|mesh-ancestor
139522559|NCT05884372|Micronutrients|micronutrients|mesh-ancestor
139522560|NCT05884372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522561|NCT05884372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139139097|NCT04639011|Serotonin|serotonin|mesh-list
139522562|NCT05884372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139522563|NCT05794477|Paclitaxel|paclitaxel|mesh-list
139522564|NCT05794477|Carboplatin|carboplatin|mesh-list
139522565|NCT05794477|Pemetrexed|pemetrexed|mesh-list
139522566|NCT05794477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139522567|NCT05794477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522568|NCT05794477|Tubulin Modulators|tubulin modulators|mesh-ancestor
139522569|NCT05794477|Antimitotic Agents|antimitotic agents|mesh-ancestor
139522570|NCT05794477|Mitosis Modulators|mitosis modulators|mesh-ancestor
139522571|NCT05794477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522572|NCT05794477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522573|NCT05794477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139522574|NCT05794477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139522575|NCT05789381|Magnesium Sulfate|magnesium sulfate|mesh-list
139522576|NCT05789381|Analgesics|analgesics|mesh-ancestor
139522577|NCT05789381|Sensory System Agents|sensory system agents|mesh-ancestor
139522578|NCT05789381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522579|NCT05789381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522580|NCT05789381|Anesthetics|anesthetics|mesh-ancestor
139522581|NCT05789381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522582|NCT05789381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139522583|NCT05789381|Anticonvulsants|anticonvulsants|mesh-ancestor
139522584|NCT05789381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139522585|NCT05789381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139522586|NCT05789381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522587|NCT05789381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139522588|NCT05789381|Tocolytic Agents|tocolytic agents|mesh-ancestor
139522589|NCT05789381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139522590|NCT05745701|Cyclosporine|cyclosporine|mesh-list
139522591|NCT05745701|Itraconazole|itraconazole|mesh-list
139522592|NCT05745701|Cyclosporins|cyclosporins|mesh-list
139522593|NCT05745701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522594|NCT05745701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522595|NCT05745701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139522596|NCT05745701|Immunologic Factors|immunologic factors|mesh-ancestor
139522597|NCT05745701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522598|NCT05745701|Antifungal Agents|antifungal agents|mesh-ancestor
139522599|NCT05745701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139522600|NCT05745701|Dermatologic Agents|dermatologic agents|mesh-ancestor
139522601|NCT05745701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139522602|NCT05745701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139522603|NCT05745701|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139522604|NCT05745701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139522605|NCT05745701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139522606|NCT05745701|Hormone Antagonists|hormone antagonists|mesh-ancestor
139522607|NCT05745701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139522608|NCT05745701|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139522609|NCT05742594|Lazertinib|lazertinib|mesh-list
139522610|NCT05742594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139522611|NCT05742594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522612|NCT05742594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522613|NCT05741086|Atorvastatin|atorvastatin|mesh-list
139522614|NCT05741086|Evolocumab|evolocumab|mesh-list
139522615|NCT05741086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139522616|NCT05741086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139522617|NCT05741086|Antimetabolites|antimetabolites|mesh-ancestor
139522618|NCT05741086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522619|NCT05741086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139522620|NCT05741086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139522621|NCT05741086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522622|NCT05741086|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139522623|NCT05741086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139522624|NCT05741086|Protease Inhibitors|protease inhibitors|mesh-ancestor
139570322|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570323|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
139522625|NCT05722262|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
139522626|NCT05722262|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139522627|NCT05722262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522628|NCT05722262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139522629|NCT05722262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522630|NCT05710887|Nitrous Oxide|nitrous oxide|mesh-list
139522631|NCT05710887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139522632|NCT05710887|Anesthetics, General|anesthetics, general|mesh-ancestor
139522633|NCT05710887|Anesthetics|anesthetics|mesh-ancestor
139522634|NCT05710887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522635|NCT05710887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522636|NCT05710887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139522637|NCT05710887|Analgesics|analgesics|mesh-ancestor
139522638|NCT05710887|Sensory System Agents|sensory system agents|mesh-ancestor
139522639|NCT05710887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522640|NCT05657041|Clopidogrel|clopidogrel|mesh-list
139522641|NCT05657041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139522642|NCT05657041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139522643|NCT05657041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139522644|NCT05657041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139522645|NCT05657041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139522646|NCT05657041|Purinergic Agents|purinergic agents|mesh-ancestor
139522647|NCT05657041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522648|NCT05657041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522649|NCT05657041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522650|NCT05607420|Alemtuzumab|alemtuzumab|mesh-list
139522651|NCT05607420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522652|NCT05607420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522653|NCT05607316|Metformin|metformin|mesh-list
139522654|NCT05607316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139522655|NCT05607316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522656|NCT05605587|Leflunomide|leflunomide|mesh-list
139522657|NCT05605587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522658|NCT05605587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522659|NCT05605587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139522660|NCT05605587|Immunologic Factors|immunologic factors|mesh-ancestor
139522661|NCT05605587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522662|NCT05582993|Factor VIII|factor viii|mesh-list
139139389|NCT03788733|Melatonin|melatonin|mesh-list
139522663|NCT05582993|Coagulants|coagulants|mesh-ancestor
139522664|NCT05581758|Sotorasib|sotorasib|mesh-list
139522665|NCT05581758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139522666|NCT05581758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522667|NCT05581758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522668|NCT05581758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522669|NCT05554146|Dronabinol|dronabinol|mesh-list
139522670|NCT05554146|Hallucinogens|hallucinogens|mesh-ancestor
139522671|NCT05554146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522672|NCT05554146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139522673|NCT05554146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139522674|NCT05554146|Analgesics|analgesics|mesh-ancestor
139522675|NCT05554146|Sensory System Agents|sensory system agents|mesh-ancestor
139522676|NCT05554146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522677|NCT05554146|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139522678|NCT05554146|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139522679|NCT05554146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522680|NCT05554146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522681|NCT05554146|Hormones|hormones|mesh-ancestor
139570324|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139522682|NCT05554146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139522683|NCT05553301|Vaccines|vaccines|mesh-list
139522684|NCT05553301|Immunologic Factors|immunologic factors|mesh-ancestor
139522685|NCT05553301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522686|NCT05535738|Fluticasone|fluticasone|mesh-list
139522688|NCT05535738|Adalimumab|adalimumab|mesh-list
139522689|NCT05535738|Triamcinolone|triamcinolone|mesh-list
139522690|NCT05535738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139522691|NCT05535738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139522692|NCT05535738|Betamethasone|betamethasone|mesh-list
139522693|NCT05535738|Betamethasone Valerate|betamethasone valerate|mesh-list
139522694|NCT05535738|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139522695|NCT05535738|Betamethasone benzoate|betamethasone benzoate|mesh-list
139522696|NCT05535738|Ustekinumab|ustekinumab|mesh-list
139522697|NCT05535738|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139522698|NCT05535738|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
139522699|NCT05535738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139522700|NCT05535738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139522701|NCT05535738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139522702|NCT05535738|Autonomic Agents|autonomic agents|mesh-ancestor
139522703|NCT05535738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522704|NCT05535738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522705|NCT05535738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139522706|NCT05535738|Respiratory System Agents|respiratory system agents|mesh-ancestor
139522707|NCT05535738|Dermatologic Agents|dermatologic agents|mesh-ancestor
139522708|NCT05535738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139522709|NCT05535738|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139522710|NCT05535738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139522711|NCT05535738|Glucocorticoids|glucocorticoids|mesh-ancestor
139522712|NCT05535738|Hormones|hormones|mesh-ancestor
139522713|NCT05535738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139522714|NCT05535738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139522715|NCT05535738|Immunologic Factors|immunologic factors|mesh-ancestor
139522716|NCT05535738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522717|NCT05535738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522718|NCT05535738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139522719|NCT05518110|Hydroxychloroquine|hydroxychloroquine|mesh-list
139522720|NCT05518110|Trametinib|trametinib|mesh-list
139522721|NCT05518110|Antimalarials|antimalarials|mesh-ancestor
139522722|NCT05518110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139522723|NCT05518110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139522724|NCT05518110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139522725|NCT05518110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522726|NCT05518110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522727|NCT05518110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139522728|NCT05518110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522729|NCT05518110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139522730|NCT05351489|Dexmedetomidine|dexmedetomidine|mesh-list
139522731|NCT05351489|Bupivacaine|bupivacaine|mesh-list
139522732|NCT05351489|Anesthetics, Local|anesthetics, local|mesh-ancestor
139522733|NCT05351489|Anesthetics|anesthetics|mesh-ancestor
139522734|NCT05351489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522735|NCT05351489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522736|NCT05351489|Sensory System Agents|sensory system agents|mesh-ancestor
139522737|NCT05351489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522738|NCT05351489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139522739|NCT05351489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139522740|NCT05351489|Analgesics|analgesics|mesh-ancestor
139522741|NCT05351489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139304346|NCT04449224|Analgesics|analgesics|mesh-ancestor
139522742|NCT05351489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139522743|NCT05351489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139522744|NCT05351489|Adrenergic Agents|adrenergic agents|mesh-ancestor
139522745|NCT05351489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522746|NCT05351489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522747|NCT05345717|Abatacept|abatacept|mesh-list
139522748|NCT05345717|Proteasome Inhibitors|proteasome inhibitors|mesh-list
139522749|NCT05345717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139522750|NCT05345717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522751|NCT05345717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522752|NCT05345717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522753|NCT05345717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139522754|NCT05345717|Immunologic Factors|immunologic factors|mesh-ancestor
139522755|NCT05345717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522756|NCT05345717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139522757|NCT05345717|Protease Inhibitors|protease inhibitors|mesh-ancestor
139522758|NCT05345717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522759|NCT05327127|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
139522760|NCT05327127|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139522761|NCT05327127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522762|NCT05327127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139522763|NCT05327127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522764|NCT05245968|Sunitinib|sunitinib|mesh-list
139522765|NCT05245968|Imatinib Mesylate|imatinib mesylate|mesh-list
139522766|NCT05245968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522767|NCT05245968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139522768|NCT05245968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139522769|NCT05245968|Growth Substances|growth substances|mesh-ancestor
139522770|NCT05245968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522771|NCT05245968|Growth Inhibitors|growth inhibitors|mesh-ancestor
139522772|NCT05245968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139522773|NCT05245968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522774|NCT05245968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522775|NCT05220514|PK 11195|pk 11195|mesh-list
139522776|NCT05220514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522777|NCT05194969|Petrolatum|petrolatum|mesh-list
139522778|NCT05194969|Emollients|emollients|mesh-ancestor
139522779|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
139522780|NCT05166239|Lenvatinib|lenvatinib|mesh-list
139522781|NCT05166239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139522782|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522783|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139522784|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522785|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522786|NCT05166239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522787|NCT05145296|Daratumumab|daratumumab|mesh-list
139522788|NCT05145296|Abatacept|abatacept|mesh-list
139522789|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522790|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139522791|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522792|NCT05145296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522793|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139522794|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
139522795|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522796|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139522797|NCT05122767|Dolutegravir|dolutegravir|mesh-list
139522798|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139522799|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139522800|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522801|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522802|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139522803|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139522804|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
139522805|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139522806|NCT05100654|Doxycycline|doxycycline|mesh-list
139522807|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
139522808|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139522809|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139522810|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139522811|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139522812|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
139297144|NCT04479241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522813|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139522814|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139522815|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139522816|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139522817|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522818|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522819|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522820|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139522821|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139522822|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139522823|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139522825|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
139522826|NCT05095922|Calcium|calcium|mesh-list
139522827|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139522828|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522829|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139522830|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139522831|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139522832|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522833|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
139522834|NCT05095922|Coagulants|coagulants|mesh-ancestor
139522835|NCT05062980|Docetaxel|docetaxel|mesh-list
139522836|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
139522837|NCT05062980|Ramucirumab|ramucirumab|mesh-list
139522838|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522839|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
139522840|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
139522841|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
139522842|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522843|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522844|NCT05062980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139522845|NCT04907253|Quercetin|quercetin|mesh-list
139522846|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
139522847|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522848|NCT04907253|Protective Agents|protective agents|mesh-ancestor
139522849|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522850|NCT04875715|Hydroquinone|hydroquinone|mesh-list
139522851|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
139522852|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522853|NCT04875715|Protective Agents|protective agents|mesh-ancestor
139522854|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522855|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139522856|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
139522857|NCT04836429|Trioxsalen|trioxsalen|mesh-list
139522858|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522859|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
139522860|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139522861|NCT04822467|Ethanol|ethanol|mesh-list
139522862|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139522863|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139522864|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522865|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522866|NCT04769713|Ropivacaine|ropivacaine|mesh-list
139522867|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
139522868|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
139522869|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522870|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522871|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
139522872|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522873|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139522874|NCT04728581|Mirtazapine|mirtazapine|mesh-list
139522875|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
139522876|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139522877|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139522878|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139522879|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522880|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522881|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139522882|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
139522883|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
139522884|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522885|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522886|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139522887|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139522888|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139522889|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139522890|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
139522891|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139522892|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139522893|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
139522894|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139522895|NCT04677543|Azithromycin|azithromycin|mesh-list
139522896|NCT04677543|Amikacin|amikacin|mesh-list
139522897|NCT04677543|Ethambutol|ethambutol|mesh-list
139522898|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139522899|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139522900|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
139522901|NCT04662840|Anesthetics|anesthetics|mesh-list
139522902|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
139522903|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139522904|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522905|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
139522906|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522907|NCT04544293|Molgramostim|molgramostim|mesh-list
139522908|NCT04544293|Sargramostim|sargramostim|mesh-list
139522909|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
139522910|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522911|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522912|NCT04413201|Osimertinib|osimertinib|mesh-list
139522913|NCT04413201|Afatinib|afatinib|mesh-list
139522914|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522915|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139522916|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522917|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522918|NCT04254627|Etanercept|etanercept|mesh-list
139522919|NCT04254627|Mifepristone|mifepristone|mesh-list
139522920|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139522921|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139522922|NCT04254627|Analgesics|analgesics|mesh-ancestor
139522923|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
139522924|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139522925|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522926|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139522927|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139522928|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139522929|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139522930|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
139522931|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139522932|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
139522933|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139522934|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139522935|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139522936|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139522937|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
139522938|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139522939|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139522940|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
139522941|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139522942|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
139522943|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139522944|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139522945|NCT04139902|Dostarlimab|dostarlimab|mesh-list
139522946|NCT04139902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522947|NCT04136366|Methotrexate|methotrexate|mesh-list
139522948|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139522949|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
139522950|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139522951|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522952|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139522953|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
139522954|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522955|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522956|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
139522957|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522958|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139522959|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139304573|NCT00532038|Ketoprofen|ketoprofen|mesh-list
139522960|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
139522961|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139522962|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139522963|NCT03811847|Methylphenidate|methylphenidate|mesh-list
139522964|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139522965|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522966|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139522967|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139522968|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139522969|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522970|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
139522971|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139522972|NCT03809000|Leuprolide|leuprolide|mesh-list
139522973|NCT03809000|Goserelin|goserelin|mesh-list
139522974|NCT03809000|Bicalutamide|bicalutamide|mesh-list
139522975|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139522976|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139522977|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139522978|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
139522979|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139522980|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139522981|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522982|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
139522983|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
139522984|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
139522985|NCT03590054|Abexinostat|abexinostat|mesh-list
139522986|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522987|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522988|NCT03590054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139522989|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139522990|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139522991|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139522992|NCT03568097|Avelumab|avelumab|mesh-list
139522993|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522994|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522995|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
139522996|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139522997|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139522998|NCT03546582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138907515|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
139522999|NCT03546582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523000|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
139523001|NCT03226249|Doxorubicin|doxorubicin|mesh-list
139523002|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139523003|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
139523004|NCT03226249|Dacarbazine|dacarbazine|mesh-list
139523005|NCT03226249|Vinblastine|vinblastine|mesh-list
139523006|NCT03226249|Imidazole|imidazole|mesh-list
139523007|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139523008|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139523009|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523010|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139523011|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139523012|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912268|NCT04117919|Triamcinolone|triamcinolone|mesh-list
139523013|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523014|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139523015|NCT03226249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139523016|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139523017|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139523018|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
139523019|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139523020|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
139523021|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
139523022|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
139523023|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
139523024|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
139523025|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139523026|NCT03184155|Nicardipine|nicardipine|mesh-list
139523027|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139523028|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139523029|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139523030|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523031|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139523032|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523033|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
139297145|NCT04366050|Ramipril|ramipril|mesh-list
139523034|NCT03172624|Nivolumab|nivolumab|mesh-list
139523035|NCT03172624|Ipilimumab|ipilimumab|mesh-list
139523036|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139523037|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523038|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139523039|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523040|NCT03063944|Azacitidine|azacitidine|mesh-list
139523041|NCT03063944|Decitabine|decitabine|mesh-list
139523042|NCT03063944|Venetoclax|venetoclax|mesh-list
139523043|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139523044|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
139523045|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523046|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523047|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523048|NCT03062631|Amifampridine|amifampridine|mesh-list
139523049|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139523050|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523051|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523052|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139523053|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139523054|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523055|NCT02849548|Suvorexant|suvorexant|mesh-list
139523056|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139523057|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139523058|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139523059|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523060|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139523061|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523062|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523063|NCT02780310|Lenvatinib|lenvatinib|mesh-list
139523064|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140176|NCT01320579|Tacrolimus|tacrolimus|mesh-list
139523065|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139523066|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523067|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523068|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
139523069|NCT02758431|Anastrozole|anastrozole|mesh-list
139523070|NCT02758431|Testosterone|testosterone|mesh-list
139523071|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
139523072|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
139523073|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139523074|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139523075|NCT02758431|Acyline|acyline|mesh-list
139523076|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
139523077|NCT02758431|Hormones|hormones|mesh-ancestor
139523078|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139523079|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523080|NCT02758431|Androgens|androgens|mesh-ancestor
139523081|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139523082|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523083|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
139523084|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139523085|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523086|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523087|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139523088|NCT02756000|Dobutamine|dobutamine|mesh-list
139523089|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139523090|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
139523091|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
139523092|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523093|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523094|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139523095|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139523096|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139523097|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
139523098|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523099|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523100|NCT02756000|Protective Agents|protective agents|mesh-ancestor
139523101|NCT02601365|Molgramostim|molgramostim|mesh-list
139523102|NCT02601365|Sargramostim|sargramostim|mesh-list
139523103|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
139523104|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523105|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304719|NCT00392574|Prulifloxacin|prulifloxacin|mesh-list
139523106|NCT02583893|Cytarabine|cytarabine|mesh-list
139523107|NCT02583893|Sirolimus|sirolimus|mesh-list
139523108|NCT02583893|Etoposide|etoposide|mesh-list
139523109|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
139523110|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
139523111|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139523112|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523113|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139523114|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139523115|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523116|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523117|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139523118|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
139523119|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
139523120|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139523121|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139523122|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
139523123|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523124|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139523125|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139523126|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
139523127|NCT02583893|Analgesics|analgesics|mesh-ancestor
139523128|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
139523129|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523130|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139523131|NCT02411448|Gefitinib|gefitinib|mesh-list
139523132|NCT02411448|Osimertinib|osimertinib|mesh-list
139523133|NCT02411448|Ramucirumab|ramucirumab|mesh-list
139523134|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523135|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139523136|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523137|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523138|NCT02107144|Trimetazidine|trimetazidine|mesh-list
139523139|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
139523140|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
139523141|NCT01860170|Bortezomib|bortezomib|mesh-list
139523142|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139523143|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
139523144|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523145|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139523146|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139523147|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
139523148|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523149|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523150|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139523151|NCT01847274|Niraparib|niraparib|mesh-list
139523152|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139523153|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523154|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523155|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523156|NCT01330446|Modafinil|modafinil|mesh-list
139523157|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139523158|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523159|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139523160|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139523161|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139523162|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523163|NCT00866554|Tamoxifen|tamoxifen|mesh-list
139523164|NCT00866554|Bicalutamide|bicalutamide|mesh-list
139523165|NCT00866554|Dutasteride|dutasteride|mesh-list
139523166|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139523167|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
139523168|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139523169|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523170|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139523171|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523172|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139523173|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139523174|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139523175|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
139523176|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139523177|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139523178|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523179|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523180|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139523181|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139523182|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523184|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
139523185|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
139523186|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139523187|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523188|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
139523189|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139523190|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
139523191|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523192|NCT00442104|Ganaxolone|ganaxolone|mesh-list
139523193|NCT00442104|Neurosteroids|neurosteroids|mesh-ancestor
139523194|NCT00442104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523195|NCT00442104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523196|NCT00442104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523197|NCT00442104|GABA Modulators|gaba modulators|mesh-ancestor
139523198|NCT00442104|GABA Agents|gaba agents|mesh-ancestor
139523199|NCT00441896|Ganaxolone|ganaxolone|mesh-list
139523200|NCT00441896|Neurosteroids|neurosteroids|mesh-ancestor
139523201|NCT00441896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523202|NCT00441896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523203|NCT00441896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523204|NCT00441896|GABA Modulators|gaba modulators|mesh-ancestor
139523205|NCT00441896|GABA Agents|gaba agents|mesh-ancestor
139523206|NCT00202800|Gemcitabine|gemcitabine|mesh-list
139523207|NCT00202800|Etoposide|etoposide|mesh-list
139523208|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139523209|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
139523210|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523211|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523212|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139523213|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139523214|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139523215|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523216|NCT00194714|Vaccines|vaccines|mesh-list
139523217|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
139523218|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523219|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139523220|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
139523221|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523222|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139523223|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
139523224|NCT02034799|Coagulants|coagulants|mesh-ancestor
139523225|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139523226|NCT02057575|Latanoprost|latanoprost|mesh-list
139523227|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139523228|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139523229|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
139523230|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523231|NCT02034565|Apixaban|apixaban|mesh-list
139523232|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139523233|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
139523234|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139523235|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
139523236|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523237|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523238|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
139523239|NCT02075515|Vaccines|vaccines|mesh-list
139523240|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
139523241|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523242|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
139523243|NCT04682587|Avelumab|avelumab|mesh-list
139523244|NCT04682587|Axitinib|axitinib|mesh-list
139570325|NCT05604261|Rabeprazole|rabeprazole|mesh-list
139523245|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139523246|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523247|NCT04682587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139523248|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523249|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139523250|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523251|NCT04417543|Memantine|memantine|mesh-list
139523252|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139523253|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139523254|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
139523255|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523256|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523257|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304861|NCT02604550|Narcotics|narcotics|mesh-ancestor
139523258|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139523259|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139523261|NCT02021318|Hematinics|hematinics|mesh-ancestor
139523262|NCT02020616|Metformin|metformin|mesh-list
139523263|NCT02020616|Exenatide|exenatide|mesh-list
139523264|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139523265|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523266|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139523267|NCT02020616|Incretins|incretins|mesh-ancestor
139523268|NCT02020616|Hormones|hormones|mesh-ancestor
139523269|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139523270|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139523271|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139570326|NCT05604261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139523272|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523273|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139523274|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
139523275|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523276|NCT01622660|Gemcitabine|gemcitabine|mesh-list
139523277|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139523278|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
139523279|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523280|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523281|NCT04697498|Anesthetics|anesthetics|mesh-list
139523282|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139523283|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523284|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
139523285|NCT02019602|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139523286|NCT02019602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139523287|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139523288|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
139523289|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523290|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139523291|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139523292|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
139523293|NCT02040428|Coagulants|coagulants|mesh-ancestor
139523294|NCT02018822|Urethane|urethane|mesh-list
139523295|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523296|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139523297|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
139523298|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
139523299|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139523300|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523301|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
139523302|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
139523303|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523304|NCT02022007|Metformin|metformin|mesh-list
139523305|NCT02022007|Saxagliptin|saxagliptin|mesh-list
139523306|NCT02022007|Biguanides|biguanides|mesh-list
139523307|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139523308|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139523309|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523310|NCT02022007|Incretins|incretins|mesh-ancestor
139523311|NCT02022007|Hormones|hormones|mesh-ancestor
139523312|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139523313|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
139523314|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523315|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523316|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
139523317|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139523318|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
139523319|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139523320|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
139523321|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523322|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523323|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
139523324|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139523325|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139523326|NCT02053753|Denosumab|denosumab|mesh-list
139523327|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139523328|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523329|NCT02019979|Metformin|metformin|mesh-list
139523330|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139523331|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304938|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139523332|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
139523334|NCT02019667|Protective Agents|protective agents|mesh-ancestor
139523335|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523336|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
139523337|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
139523338|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138510759|NCT00065455|Vitamin A|vitamin a|mesh-list
139523339|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523340|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
139523341|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
139523342|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139523343|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139523344|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523345|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
139523346|NCT02030821|Coagulants|coagulants|mesh-ancestor
139523347|NCT02052739|Brexanolone|brexanolone|mesh-list
139523348|NCT02052739|Neurosteroids|neurosteroids|mesh-ancestor
139523349|NCT02052739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523350|NCT02052739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523351|NCT02052739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523352|NCT02052739|GABA Modulators|gaba modulators|mesh-ancestor
139523353|NCT02052739|GABA Agents|gaba agents|mesh-ancestor
139523354|NCT02019277|Paclitaxel|paclitaxel|mesh-list
139523355|NCT02019277|Docetaxel|docetaxel|mesh-list
139523356|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139523357|NCT02019277|Trastuzumab|trastuzumab|mesh-list
139523358|NCT02019277|Pertuzumab|pertuzumab|mesh-list
139523359|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139523360|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523361|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
139523362|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
139523363|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
139523364|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523365|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139523366|NCT01823835|Palbociclib|palbociclib|mesh-list
139523367|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523368|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139523369|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523370|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523371|NCT01823679|Capecitabine|capecitabine|mesh-list
139523372|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139523373|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
139570327|NCT05604261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139523374|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523375|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523376|NCT01823289|Itraconazole|itraconazole|mesh-list
139523377|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
139523378|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139523379|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139523380|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139523381|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523382|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523383|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139523384|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
139523385|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139523386|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523387|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139523388|NCT01822899|Fluticasone|fluticasone|mesh-list
139523389|NCT01822899|Xhance|xhance|mesh-list
139523390|NCT01822899|Bromides|bromides|mesh-list
139523391|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139523392|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139523393|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139523394|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
139523395|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523396|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523397|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139523398|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
139523399|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
139523400|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139523401|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139523402|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139523403|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139523404|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
139523405|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511046|NCT00068029|Octreotide|octreotide|mesh-list
139523406|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523407|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
139523408|NCT01822821|Acetaminophen|acetaminophen|mesh-list
139523409|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139523410|NCT01822821|Analgesics|analgesics|mesh-ancestor
139523411|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
139523412|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523413|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523414|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
139523415|NCT01822665|Acetaminophen|acetaminophen|mesh-list
139523416|NCT01822665|Ibuprofen|ibuprofen|mesh-list
139523417|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139523418|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139523419|NCT01822665|Analgesics|analgesics|mesh-ancestor
139523420|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
139523421|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523422|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523423|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139523424|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139523425|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139523426|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523427|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523428|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
139523429|NCT01822587|Propranolol|propranolol|mesh-list
139523430|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139523431|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139523432|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
139523433|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523434|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523435|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523436|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139523437|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139523438|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
139523439|NCT01821963|Interferons|interferons|mesh-list
139523440|NCT01821963|Ribavirin|ribavirin|mesh-list
139523441|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
139523442|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
139523443|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139523444|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523445|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
139523446|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139523447|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
139523448|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523449|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
139523450|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523451|NCT01821729|Leucovorin|leucovorin|mesh-list
139523452|NCT01821729|Fluorouracil|fluorouracil|mesh-list
139523453|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
139523454|NCT01821729|Folfirinox|folfirinox|mesh-list
139523455|NCT01821729|Losartan|losartan|mesh-list
139523456|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
139523457|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523458|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139523459|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523460|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139523461|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
139523462|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523463|NCT01821729|Antidotes|antidotes|mesh-ancestor
139523464|NCT01821729|Protective Agents|protective agents|mesh-ancestor
139523465|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
139523466|NCT01821729|Vitamins|vitamins|mesh-ancestor
139523467|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
139523468|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139523469|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139523470|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139523471|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139523472|NCT01820637|Paclitaxel|paclitaxel|mesh-list
139523473|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139523474|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523475|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
139523476|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
139523477|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
139523478|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523479|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
139523480|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139523481|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
139523482|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139523483|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139523484|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
139523485|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139523486|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139523487|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139523488|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523489|NCT02171429|Adalimumab|adalimumab|mesh-list
139523490|NCT02171429|Etrolizumab|etrolizumab|mesh-list
139523491|NCT02171429|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139523492|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139523493|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139523494|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139523495|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
139523496|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523497|NCT01818141|Vancomycin|vancomycin|mesh-list
139523498|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
139523499|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139523500|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139523501|NCT01849497|Evolocumab|evolocumab|mesh-list
139523502|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139523503|NCT01849497|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139523504|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139523505|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139523506|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
139523507|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523508|NCT01849497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139523509|NCT01849497|Protease Inhibitors|protease inhibitors|mesh-ancestor
139523510|NCT01849497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523511|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139523512|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
139523513|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523514|NCT04170465|Metformin|metformin|mesh-list
139523515|NCT04170465|Paclitaxel|paclitaxel|mesh-list
139523516|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
139523517|NCT04170465|Doxorubicin|doxorubicin|mesh-list
139523518|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139523519|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523520|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
139523521|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
139523522|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
139523523|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523524|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139523525|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
139523526|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523527|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139523528|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139523529|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
139523530|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139523531|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139523532|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139523533|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139523534|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139523535|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523536|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139523537|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523538|NCT01847313|Liraglutide|liraglutide|mesh-list
139523539|NCT01847313|Glucagon|glucagon|mesh-list
139523540|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139523541|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139523542|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523543|NCT01847313|Incretins|incretins|mesh-ancestor
139523544|NCT01847313|Hormones|hormones|mesh-ancestor
139523545|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139523546|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139523547|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139523548|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
139523549|NCT02117687|Glycerol|glycerol|mesh-list
139523550|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139523551|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
139523552|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523553|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
139523554|NCT02117687|Protective Agents|protective agents|mesh-ancestor
139523555|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139523556|NCT02117687|Laxatives|laxatives|mesh-ancestor
139523557|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139305164|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
139523558|NCT02141633|Fluticasone|fluticasone|mesh-list
139523559|NCT02141633|Xhance|xhance|mesh-list
139523560|NCT02141633|Albuterol|albuterol|mesh-list
139523561|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139523562|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139523563|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
139523564|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523565|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523566|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139523567|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
139523568|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
139523569|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139523570|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
139523571|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139523572|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139523573|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139523574|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139523575|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
139523576|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523577|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523578|NCT01846611|Dexamethasone|dexamethasone|mesh-list
139523579|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139523580|NCT01846611|Doxorubicin|doxorubicin|mesh-list
139523581|NCT01846611|Trabectedin|trabectedin|mesh-list
139523582|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139523583|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
139523584|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
139523585|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523586|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523587|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139523588|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
139523589|NCT01846611|Hormones|hormones|mesh-ancestor
139523590|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139523591|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139523592|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523593|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139523594|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139523595|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139523596|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523597|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141366|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
139523598|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139523599|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
139523600|NCT01846299|Ranibizumab|ranibizumab|mesh-list
139523601|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139523602|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139523603|NCT01846299|Growth Substances|growth substances|mesh-ancestor
139523604|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523605|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
139523606|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523607|NCT01628393|Ozanimod|ozanimod|mesh-list
139523608|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139523609|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523610|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139523611|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
139523612|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523613|NCT01846221|Clonidine|clonidine|mesh-list
139523614|NCT01846221|Fentanyl|fentanyl|mesh-list
139523615|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139523616|NCT01846221|Narcotics|narcotics|mesh-ancestor
139523617|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139523618|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523619|NCT01846221|Analgesics|analgesics|mesh-ancestor
139523620|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
139523621|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523622|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139523623|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139523624|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
139523625|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
139523626|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139523627|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
139523628|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
139523629|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139523630|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139523631|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139523632|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
139523633|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523634|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523635|NCT01845831|Metformin|metformin|mesh-list
139523636|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
139523637|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139523638|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139523639|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523640|NCT01845831|Incretins|incretins|mesh-ancestor
139523641|NCT01845831|Hormones|hormones|mesh-ancestor
139523642|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139523643|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139523644|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
139523645|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523646|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523647|NCT01844895|Abatacept|abatacept|mesh-list
139523648|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139523649|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523650|NCT01844895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139523651|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523652|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139523653|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
139523654|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523655|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139523656|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
139523657|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139523658|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139523659|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139523660|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139523661|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523662|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
139523663|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523664|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523665|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139523666|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523667|NCT04594239|Lidocaine|lidocaine|mesh-list
139523668|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
139523669|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
139523670|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
139523671|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139523672|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523673|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
139523674|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523675|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139523676|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139523677|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139523678|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139523679|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523680|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139523681|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
139523682|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
139523683|NCT04594239|Protective Agents|protective agents|mesh-ancestor
139523684|NCT01814553|Afatinib|afatinib|mesh-list
139523685|NCT01814553|Loperamide|loperamide|mesh-list
139523686|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
139523687|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523688|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139523689|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523690|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523691|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139523692|NCT02116205|Vaccines|vaccines|mesh-list
139523693|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
139523694|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523695|NCT01844583|Rifampin|rifampin|mesh-list
139523696|NCT01844583|Esomeprazole|esomeprazole|mesh-list
139523697|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139523698|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139523699|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139523700|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523701|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523702|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139523703|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
139523704|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139523705|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139523706|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
139523707|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139523708|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139523709|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139523710|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139523711|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139523712|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139523713|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139523714|NCT02115113|Everolimus|everolimus|mesh-list
139523715|NCT02115113|Tacrolimus|tacrolimus|mesh-list
139523716|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139523717|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
139523718|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523719|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139523720|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523721|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523722|NCT02115113|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139523723|NCT02115113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139523724|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523725|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
139523726|NCT02114177|Simeprevir|simeprevir|mesh-list
139523727|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
139523728|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139523729|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
139523730|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141915|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139523731|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523732|NCT02138825|Riociguat|riociguat|mesh-list
139523733|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
139523734|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523735|NCT02138747|Mirabegron|mirabegron|mesh-list
139523736|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139523737|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139523738|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139523739|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139523740|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
139523741|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523742|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523743|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523744|NCT02138747|Urological Agents|urological agents|mesh-ancestor
139523745|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139523746|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139523747|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
139523748|NCT02105285|Carteolol|carteolol|mesh-list
139523749|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139523750|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139523751|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139523752|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139523753|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
139523754|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523755|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523756|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523757|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139523758|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139523759|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
139523760|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
139523761|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523762|NCT01621490|Nivolumab|nivolumab|mesh-list
139523763|NCT01621490|Ipilimumab|ipilimumab|mesh-list
139523764|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139141991|NCT02086942|Hormones|hormones|mesh-ancestor
139523765|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523766|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139523767|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523768|NCT02030041|Vitamin D|vitamin d|mesh-list
139523769|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
139523770|NCT02030041|Simvastatin|simvastatin|mesh-list
139523771|NCT02030041|Vitamins|vitamins|mesh-ancestor
139523772|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
139523773|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523774|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139523775|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139523776|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139523777|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139523778|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
139523779|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523780|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139523781|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139523782|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523783|NCT01994720|Aspirin|aspirin|mesh-list
139523784|NCT01994720|Ticagrelor|ticagrelor|mesh-list
139523785|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139523786|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139523787|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139523788|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139523789|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
139523790|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142074|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
139523791|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523792|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523793|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139523794|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139523795|NCT01994720|Analgesics|analgesics|mesh-ancestor
139523796|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
139523797|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523798|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139523799|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139523800|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139523801|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139523802|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139523803|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523804|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
139523805|NCT01814397|Letrozole|letrozole|mesh-list
139523806|NCT01814397|Anastrozole|anastrozole|mesh-list
139523807|NCT01814397|Exemestane|exemestane|mesh-list
139523808|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523809|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139523810|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139523811|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523812|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523813|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139523814|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
139523815|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139523816|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523817|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139523818|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
139523819|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
139523820|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139523821|NCT01844115|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139523822|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139523823|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139523824|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523825|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523826|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
139523827|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523828|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139523829|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139523830|NCT02018042|Abatacept|abatacept|mesh-list
139523831|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139523832|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523833|NCT02018042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139523834|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523835|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139523836|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
139523837|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523838|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139523839|NCT02017171|Allopurinol|allopurinol|mesh-list
139523840|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
139523841|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523842|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523843|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
139523844|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139523845|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139523846|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
139523847|NCT02017171|Protective Agents|protective agents|mesh-ancestor
139523848|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523849|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
139523850|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139523851|NCT02029417|Cytarabine|cytarabine|mesh-list
139523852|NCT02029417|Decitabine|decitabine|mesh-list
139523853|NCT02029417|Azacitidine|azacitidine|mesh-list
139523854|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
139523855|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139305464|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
139523856|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
139523857|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523859|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
139523860|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139523861|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139523862|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
139523863|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523864|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523865|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139523866|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139523867|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139523868|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
139523869|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523870|NCT02050321|Vemurafenib|vemurafenib|mesh-list
139523871|NCT02050321|Acitretin|acitretin|mesh-list
139523872|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523873|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139523874|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523875|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523876|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
139523877|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
139523878|NCT02017015|Paclitaxel|paclitaxel|mesh-list
139523879|NCT02017015|Gemcitabine|gemcitabine|mesh-list
139523880|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139523881|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523882|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
139523883|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
139523884|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
139523885|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523886|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139523887|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
139523888|NCT02016625|Cyclosporine|cyclosporine|mesh-list
139523889|NCT02016625|Tacrolimus|tacrolimus|mesh-list
139523890|NCT02016625|Cyclosporins|cyclosporins|mesh-list
139523891|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139523892|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
139523893|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523894|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139523895|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523896|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523897|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
139523898|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139523899|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
139523900|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139523901|NCT02016482|Adalimumab|adalimumab|mesh-list
139523902|NCT02016482|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139523903|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139523904|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139523905|NCT02028871|Insulin|insulin|mesh-list
139523906|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139523907|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523908|NCT02028715|Acetaminophen|acetaminophen|mesh-list
139523909|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139523910|NCT02028715|Analgesics|analgesics|mesh-ancestor
139523911|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
139523912|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523913|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523914|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
139523915|NCT02016170|Ticagrelor|ticagrelor|mesh-list
139142559|NCT02102698|Ecopipam|ecopipam|mesh-list
139523916|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139523917|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139523918|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139523919|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139523920|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139523921|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
139523922|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523923|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523924|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523925|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
139523926|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
139523927|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139523928|NCT02015546|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139523929|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139523930|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139523931|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523933|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
139142619|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523934|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523935|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139523936|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139523937|NCT02038790|Buprenorphine|buprenorphine|mesh-list
139523938|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139523939|NCT02038790|Naloxone|naloxone|mesh-list
139523940|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139523941|NCT02038790|Narcotics|narcotics|mesh-ancestor
139523942|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139523943|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523944|NCT02038790|Analgesics|analgesics|mesh-ancestor
139523945|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
139523946|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523947|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139523948|NCT02027311|Midazolam|midazolam|mesh-list
139523949|NCT02027311|Meperidine|meperidine|mesh-list
139523950|NCT02027311|Etomidate|etomidate|mesh-list
139523951|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139523952|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139523953|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139523954|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523955|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139523956|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139523957|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139523958|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139523959|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
139523960|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
139523961|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
139523962|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
139523963|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523964|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523965|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139523966|NCT02027311|Narcotics|narcotics|mesh-ancestor
139523967|NCT02027311|Analgesics|analgesics|mesh-ancestor
139523968|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
139523969|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523970|NCT02047903|Afatinib|afatinib|mesh-list
139523971|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139523972|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139523973|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139523974|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523975|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
139523976|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139523977|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139523978|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523979|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139523980|NCT02026141|Analgesics|analgesics|mesh-ancestor
139523981|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
139523982|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523983|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139523984|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139523985|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139523986|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
139523987|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139523988|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523989|NCT02025907|Canagliflozin|canagliflozin|mesh-list
139523990|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139523991|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139523992|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139523993|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523994|NCT02025751|Metoclopramide|metoclopramide|mesh-list
139523995|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
139523996|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
139523997|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139523998|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139523999|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139524000|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139524001|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139524002|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
139524003|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305614|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
139524004|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524005|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139524006|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139524007|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
139524008|NCT02024971|Metformin|metformin|mesh-list
139524009|NCT02024971|Pioglitazone|pioglitazone|mesh-list
139524010|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139524011|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524012|NCT01843023|Naltrexone|naltrexone|mesh-list
139524013|NCT01843023|Buprenorphine|buprenorphine|mesh-list
139524014|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139524015|NCT01843023|Narcotics|narcotics|mesh-ancestor
139524016|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139524017|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524018|NCT01843023|Analgesics|analgesics|mesh-ancestor
139524019|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
139524020|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524021|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139524022|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139524023|NCT01812759|Fentanyl|fentanyl|mesh-list
139524024|NCT01812759|Hydromorphone|hydromorphone|mesh-list
139524025|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139524026|NCT01812759|Narcotics|narcotics|mesh-ancestor
139524027|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139524028|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524029|NCT01812759|Analgesics|analgesics|mesh-ancestor
139524030|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
139524031|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524032|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139524033|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139524034|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
139524035|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
139524036|NCT01812057|Dexamethasone|dexamethasone|mesh-list
139524037|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139524038|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
139524039|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
139524040|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524041|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524042|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139524043|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
139524044|NCT01812057|Hormones|hormones|mesh-ancestor
139524045|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139524046|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139524047|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524048|NCT01842633|Acetaminophen|acetaminophen|mesh-list
139524049|NCT01842633|Ibuprofen|ibuprofen|mesh-list
139524050|NCT01842633|Caffeine|caffeine|mesh-list
139524051|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139524052|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139524053|NCT01842633|Analgesics|analgesics|mesh-ancestor
139524054|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
139524055|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524056|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524057|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139524058|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139524059|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139524060|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524061|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524062|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
139524063|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139524064|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139524065|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139524066|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139524067|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
139524068|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524069|NCT01841697|Metformin|metformin|mesh-list
139524070|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139524071|NCT01841697|Glimepiride|glimepiride|mesh-list
139524072|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139524073|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524074|NCT01841697|Incretins|incretins|mesh-ancestor
139524075|NCT01841697|Hormones|hormones|mesh-ancestor
139524076|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139524077|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139524078|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
139524079|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524080|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524081|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139524082|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139524083|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
139524084|NCT01809327|Metformin|metformin|mesh-list
139524085|NCT01809327|Canagliflozin|canagliflozin|mesh-list
139524086|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139524087|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524088|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139524089|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524090|NCT03272139|Bupivacaine|bupivacaine|mesh-list
139524091|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
139524092|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
139524093|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139524094|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524095|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
139524096|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524097|NCT01808313|Ambrisentan|ambrisentan|mesh-list
139524098|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139524099|NCT01840605|Ketotifen|ketotifen|mesh-list
139524100|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
139524101|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
139524102|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
139524103|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139524104|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
139524105|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
139524106|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524107|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524108|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524109|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139524110|NCT02023879|Alirocumab|alirocumab|mesh-list
139524111|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139524112|NCT02023879|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139524113|NCT02023879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139524114|NCT02023879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139524115|NCT02023879|Antimetabolites|antimetabolites|mesh-ancestor
139142957|NCT01331824|Amrubicin|amrubicin|mesh-list
139524116|NCT02023879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524117|NCT02023879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139524118|NCT02023879|Protease Inhibitors|protease inhibitors|mesh-ancestor
139524119|NCT02023879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524120|NCT02023879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139524121|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
139524122|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524123|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139524124|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139524125|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524126|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
139524127|NCT02013817|Rituximab|rituximab|mesh-list
139524128|NCT02013817|Fludarabine|fludarabine|mesh-list
139524129|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139524130|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
139524131|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524132|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139524133|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139524134|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
139524135|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524136|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524137|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139524138|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139524139|NCT02023099|Ritonavir|ritonavir|mesh-list
139524140|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139524141|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139524142|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
139143013|NCT02108002|Vorinostat|vorinostat|mesh-list
139524143|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524144|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524145|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139524146|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139524147|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
139524148|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139524149|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139524150|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139524151|NCT02013037|Eculizumab|eculizumab|mesh-list
139524152|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139524153|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139524154|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
139524155|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524156|NCT04416607|Menotropins|menotropins|mesh-list
139524157|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139524158|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
139524159|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139524160|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524161|NCT01967173|Fluticasone|fluticasone|mesh-list
139524162|NCT01967173|Xhance|xhance|mesh-list
139524163|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139524164|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139524165|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
139524166|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524167|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524168|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139524169|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
139524170|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
139524171|NCT01967173|Hormones|hormones|mesh-ancestor
139524172|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139524173|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
139524174|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139524175|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
139524176|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139524177|NCT01993927|Voglibose|voglibose|mesh-list
139524178|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139524179|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524180|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139524181|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524182|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524183|NCT02012959|Tolvaptan|tolvaptan|mesh-list
139524184|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139524185|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524186|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
139524187|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524188|NCT02012491|Misoprostol|misoprostol|mesh-list
139524189|NCT02012491|Mifepristone|mifepristone|mesh-list
139524190|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139524191|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
139524192|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139524193|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524194|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139524195|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139524196|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
139524197|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139524198|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139524199|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139143200|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
139524200|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139524201|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
139524202|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139524203|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139524204|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
139524205|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139524206|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
139524207|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139524208|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139524209|NCT02038010|Trastuzumab|trastuzumab|mesh-list
139524210|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139524211|NCT02038010|Maytansine|maytansine|mesh-list
139524212|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
139524213|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
139524214|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139524215|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524216|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139524217|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
139524218|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
139524219|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
139524220|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524221|NCT02038010|Immunotoxins|immunotoxins|mesh-ancestor
139524222|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
139524223|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524224|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524225|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
139524226|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524227|NCT01989572|Sargramostim|sargramostim|mesh-list
139524228|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
139524229|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524231|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
139524232|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524233|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524234|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
139524235|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139524236|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139524237|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
139524238|NCT01988402|Protective Agents|protective agents|mesh-ancestor
139524239|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524240|NCT01988090|Vitamin D|vitamin d|mesh-list
139524241|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
139524242|NCT01988090|Cholecalciferol|cholecalciferol|mesh-list
139524243|NCT01988090|Vitamins|vitamins|mesh-list
139524244|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
139524245|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524246|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139524247|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139524248|NCT02011945|Nivolumab|nivolumab|mesh-list
139524249|NCT02011945|Dasatinib|dasatinib|mesh-list
139524250|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139524251|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524252|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139524253|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524254|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139524255|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524256|NCT02013830|Bevacizumab|bevacizumab|mesh-list
139524257|NCT02013830|Capecitabine|capecitabine|mesh-list
139524258|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139524259|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524260|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139524261|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139524262|NCT02013830|Growth Substances|growth substances|mesh-ancestor
139524263|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524264|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
139524265|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139524266|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
139524267|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524268|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
139524269|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139524270|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139524271|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139524272|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139524273|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524274|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
139524275|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524276|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524277|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139524278|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524279|NCT01619059|Metformin|metformin|mesh-list
139524280|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
139524281|NCT01619059|Saxagliptin|saxagliptin|mesh-list
139524282|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139524283|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524284|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139524285|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524286|NCT01619059|Incretins|incretins|mesh-ancestor
139524287|NCT01619059|Hormones|hormones|mesh-ancestor
139524288|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139524289|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139524290|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
139524291|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524292|NCT04691804|Prednisone|prednisone|mesh-list
139524293|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
139524294|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139524295|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
139524296|NCT04691804|Hormones|hormones|mesh-ancestor
139524297|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139524298|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524299|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139524300|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524301|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139524302|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305920|NCT05777226|Epalrestat|epalrestat|mesh-list
139524303|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524305|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139524306|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139524307|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524308|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139524309|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524310|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524311|NCT01807923|Ivacaftor|ivacaftor|mesh-list
139524312|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139524313|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139524314|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524315|NCT01966003|Paclitaxel|paclitaxel|mesh-list
139524316|NCT01966003|Bevacizumab|bevacizumab|mesh-list
139524317|NCT01966003|Carboplatin|carboplatin|mesh-list
139524318|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139524319|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524320|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
139524321|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
139524322|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
139524323|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524324|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139524325|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139524326|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139524327|NCT01966003|Growth Substances|growth substances|mesh-ancestor
139524328|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524329|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
139524330|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
139524331|NCT01839279|Tizanidine|tizanidine|mesh-list
139524332|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139524333|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139524334|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139524335|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139524336|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524337|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524338|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524339|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524340|NCT01839279|Analgesics|analgesics|mesh-ancestor
139524341|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
139524342|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524343|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
139524344|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139524345|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139524346|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
139524347|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
139524348|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139524349|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139524350|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139524351|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
139524352|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524353|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
139524354|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139524355|NCT01965535|Ledipasvir|ledipasvir|mesh-list
139524356|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
139143632|NCT02113150|Narcotics|narcotics|mesh-ancestor
139524357|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139524358|NCT01964755|Leucovorin|leucovorin|mesh-list
139524359|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
139524360|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
139524361|NCT01964755|Zidovudine|zidovudine|mesh-list
139524362|NCT01964755|Rituximab|rituximab|mesh-list
139524363|NCT01964755|Doxorubicin|doxorubicin|mesh-list
139524364|NCT01964755|Methotrexate|methotrexate|mesh-list
139524365|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
139524366|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
139524367|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139524368|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524369|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
139524370|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524371|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139524372|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139524373|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139524374|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139524375|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524376|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305985|NCT05635851|Nitroglycerin|nitroglycerin|mesh-list
139524377|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139524378|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
139524379|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139524380|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139524381|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
139524382|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
139524383|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139524384|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139524385|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139524387|NCT01964755|Protective Agents|protective agents|mesh-ancestor
139524388|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
139524389|NCT01964755|Vitamins|vitamins|mesh-ancestor
139524390|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
139524391|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139524392|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
139524393|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139524394|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139524395|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139524396|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
139524397|NCT01991743|Bupivacaine|bupivacaine|mesh-list
139524398|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
139524399|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
139524400|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143747|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
139524401|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524402|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
139524403|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524404|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139524405|NCT01991197|Gliclazide|gliclazide|mesh-list
139524406|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139524407|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524408|NCT01991197|Incretins|incretins|mesh-ancestor
139524409|NCT01991197|Hormones|hormones|mesh-ancestor
139524410|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139524411|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139524412|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
139524413|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524414|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524415|NCT01990573|Methadone|methadone|mesh-list
139524416|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139524417|NCT01990573|Narcotics|narcotics|mesh-ancestor
139524418|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139524419|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524420|NCT01990573|Analgesics|analgesics|mesh-ancestor
139524421|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
139524422|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524423|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
139524424|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
139524425|NCT01990339|Lansoprazole|lansoprazole|mesh-list
139524426|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
139524427|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139524428|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139524429|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139524430|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524431|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524432|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139524433|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139524434|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139524435|NCT02007577|Analgesics|analgesics|mesh-ancestor
139524436|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
139524437|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524438|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524439|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139524440|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139524441|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139524442|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524443|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139524444|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524445|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524446|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
139524447|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139524448|NCT01962493|Listerine|listerine|mesh-list
139524449|NCT01962493|Fluorides|fluorides|mesh-list
139524450|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
139524451|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
139143982|NCT02125630|Hormones|hormones|mesh-list
139524452|NCT01962493|Protective Agents|protective agents|mesh-ancestor
139524453|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524454|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139524455|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139524456|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
139524457|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
139524458|NCT01989169|Midazolam|midazolam|mesh-list
139524459|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139524460|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139524461|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139524462|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144047|NCT03550534|Calcium|calcium|mesh-list
139524463|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139524464|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139524465|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139524466|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139524467|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
139524468|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
139524469|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
139524470|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
139524471|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524472|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524473|NCT01988779|Levofloxacin|levofloxacin|mesh-list
139524474|NCT01988779|Ofloxacin|ofloxacin|mesh-list
139524475|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139524476|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139524477|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139524478|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139524479|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139524480|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524481|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524482|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524483|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139524484|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139524485|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139524486|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139524487|NCT01987232|Carboplatin|carboplatin|mesh-list
139524488|NCT01987232|Etoposide|etoposide|mesh-list
139144106|NCT06148649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139524489|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524490|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139524491|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139524492|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139524493|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524494|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524495|NCT04676204|Teriflunomide|teriflunomide|mesh-list
139524496|NCT04676204|Cladribine|cladribine|mesh-list
139524497|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139524498|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139524499|NCT04676204|Ozanimod|ozanimod|mesh-list
139524500|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524501|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139524502|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
139524503|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524504|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139524505|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524506|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
139144156|NCT06148103|Propofol|propofol|mesh-list
139524507|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139524508|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139524509|NCT04676204|Analgesics|analgesics|mesh-ancestor
139524510|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
139524511|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524512|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139524513|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139524514|NCT02010632|Clopidogrel|clopidogrel|mesh-list
139524515|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139524516|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139144223|NCT06134284|Rituximab|rituximab|mesh-list
139524517|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139524518|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139524519|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
139524520|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524521|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524522|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524523|NCT01986062|Amphetamine|amphetamine|mesh-list
139524524|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139524525|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524526|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
139524527|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
139524528|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524529|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
139524530|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524531|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524532|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
139144281|NCT06116201|Contraceptive Agents|contraceptive agents|mesh-ancestor
139524533|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139524534|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139524535|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139524536|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139524538|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
139524539|NCT01985126|Promethazine|promethazine|mesh-list
139524540|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
139524541|NCT01985126|Daratumumab|daratumumab|mesh-list
139524542|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139524543|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139524544|NCT01985126|Analgesics|analgesics|mesh-ancestor
139524545|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
139524546|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524547|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524548|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
139524549|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139524550|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
139524551|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
139524552|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139524553|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
139524554|NCT01985126|Hormones|hormones|mesh-ancestor
139524555|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139524556|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139524557|NCT01985126|Protective Agents|protective agents|mesh-ancestor
139524558|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524559|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
139524560|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139524561|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139524562|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139524563|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
139524564|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
139524565|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139524566|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
139524567|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
139524568|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524569|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524570|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139524571|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
139524572|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
139524573|NCT01984892|Poly ICLC|poly iclc|mesh-list
139524574|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
139524575|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
139524576|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524577|NCT01807221|Eplerenone|eplerenone|mesh-list
139524578|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139524579|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
139144393|NCT05986773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144394|NCT05986773|Anticonvulsants|anticonvulsants|mesh-ancestor
139144395|NCT05986773|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139144396|NCT05986773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144397|NCT05986773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139144398|NCT05986773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139144407|NCT05962424|Ketamine|ketamine|mesh-list
139144421|NCT05934409|Niacin|niacin|mesh-list
139524580|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139524581|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524582|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139524583|NCT01807221|Diuretics|diuretics|mesh-ancestor
139524584|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
139524585|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139524586|NCT02031458|Atezolizumab|atezolizumab|mesh-list
139524587|NCT02031458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139524588|NCT02031458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524589|NCT02031458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139524590|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524591|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139524592|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
139524593|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524594|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
139524595|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139524596|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
139524597|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524598|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524599|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139524600|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
139524601|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
139524602|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139524603|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
139524604|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524605|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524606|NCT04687514|Dulaglutide|dulaglutide|mesh-list
139524607|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139524608|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524609|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
139524610|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
139524611|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524612|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524613|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524614|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
139524615|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
139524616|NCT01984424|Atorvastatin|atorvastatin|mesh-list
139524618|NCT01984424|Evolocumab|evolocumab|mesh-list
139524619|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139524620|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139524621|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139524622|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
139524623|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524624|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139524625|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139524626|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524627|NCT01984424|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139524628|NCT01984424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139524629|NCT01984424|Protease Inhibitors|protease inhibitors|mesh-ancestor
139524630|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
139524631|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524632|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139524633|NCT01837719|Cobicistat|cobicistat|mesh-list
139524634|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139524635|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139524636|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
139524637|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524638|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524639|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139524640|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139524641|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
139524642|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139524643|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139524644|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139524645|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139524646|NCT01984268|Hormones|hormones|mesh-ancestor
139524647|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139524648|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524649|NCT02009384|Ipilimumab|ipilimumab|mesh-list
139524650|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139524651|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524652|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139524653|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524654|NCT01805037|Rituximab|rituximab|mesh-list
139524655|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139524656|NCT01805037|Antibodies|antibodies|mesh-list
139524657|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
139524658|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139524659|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
139524660|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
139524661|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524662|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139524663|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144533|NCT05656170|Anesthetics|anesthetics|mesh-ancestor
139524664|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139524665|NCT01805037|Immunotoxins|immunotoxins|mesh-ancestor
139524666|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139524667|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139524668|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139524669|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139524670|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524671|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524672|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524673|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
139524674|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139524675|NCT01836549|Imetelstat|imetelstat|mesh-list
139524676|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
139524677|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524678|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524679|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139524680|NCT01836471|Fluticasone|fluticasone|mesh-list
139524681|NCT01836471|Xhance|xhance|mesh-list
139524682|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
139524683|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139524684|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139524685|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
139524686|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524687|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524688|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139524689|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
139524690|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
139524691|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139524692|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
139524693|NCT01836471|Growth Substances|growth substances|mesh-ancestor
139524694|NCT02030600|Insulin|insulin|mesh-list
139524695|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139144598|NCT05553184|Vitamins|vitamins|mesh-ancestor
139524696|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
139524697|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139524698|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524699|NCT01802775|Aspirin|aspirin|mesh-list
139524700|NCT01802775|Edoxaban|edoxaban|mesh-list
139524701|NCT01802775|Clopidogrel|clopidogrel|mesh-list
139524702|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139524703|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139524704|NCT01802775|Analgesics|analgesics|mesh-ancestor
139524705|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
139524706|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524707|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524708|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139524709|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139524710|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139524711|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139524712|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524713|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139524714|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139524715|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524716|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
139524717|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139524718|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139524719|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139524720|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
139144629|NCT05514899|Hormones|hormones|mesh-ancestor
139524721|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524722|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139524723|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
139524724|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139524725|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
139524726|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
139524727|NCT01802385|Sertraline|sertraline|mesh-list
139524728|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
139524729|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139524730|NCT01802385|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139524731|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139524732|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139524733|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524734|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524735|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
139524736|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524737|NCT01773993|Pregabalin|pregabalin|mesh-list
139524738|NCT01773993|Analgesics|analgesics|mesh-ancestor
139144679|NCT05418556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144680|NCT05418556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144681|NCT05418556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139144682|NCT05418556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139524739|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
139524740|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524741|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524742|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
139524743|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139524744|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139524745|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524746|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139524747|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139524748|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139524749|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139524750|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139524751|NCT01802073|Vancomycin|vancomycin|mesh-list
139524752|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139524753|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139524754|NCT01607073|Verapamil|verapamil|mesh-list
139524755|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139524756|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139524757|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139524758|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524759|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139524760|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524761|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
139524762|NCT01801917|Siponimod|siponimod|mesh-list
139524763|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139524764|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524765|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139144740|NCT05284812|Vaccines|vaccines|mesh-list
139524766|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
139524767|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524768|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139524769|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
139524770|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524771|NCT01772823|Tenofovir|tenofovir|mesh-list
139524772|NCT01772823|Emtricitabine|emtricitabine|mesh-list
139524773|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139524774|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
139524775|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139524776|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139524777|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139524778|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524779|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524780|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139524781|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139524782|NCT04177082|Riboflavin|riboflavin|mesh-list
139524783|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
139524784|NCT04177082|Vitamins|vitamins|mesh-ancestor
139524785|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
139524786|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144781|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144785|NCT05092945|Vitamins|vitamins|mesh-ancestor
139524787|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139524788|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
139524789|NCT01982942|Ibudilast|ibudilast|mesh-list
139524790|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139524791|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
139524792|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524793|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524794|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139524795|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
139524796|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139524797|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524798|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524799|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139524800|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
138895364|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
139144851|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139144852|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144853|NCT04946864|Palbociclib|palbociclib|mesh-list
139144854|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144855|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139144856|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144857|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144858|NCT04940572|Valproic Acid|valproic acid|mesh-list
139144859|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
139144860|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144861|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144862|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
139144863|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524801|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139524802|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139524803|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139524804|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524805|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524806|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
139524807|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139524808|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139524809|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139524810|NCT01769391|Paclitaxel|paclitaxel|mesh-list
139524811|NCT01769391|Carboplatin|carboplatin|mesh-list
139524812|NCT01769391|Necitumumab|necitumumab|mesh-list
139524813|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139524814|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524815|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
139524816|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
139524817|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
139524818|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524819|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139524820|NCT01767987|Ranolazine|ranolazine|mesh-list
139524821|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139524822|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306442|NCT04170738|Amphetamine|amphetamine|mesh-list
139524823|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524825|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139524826|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139524827|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524828|NCT02029274|Siponimod|siponimod|mesh-list
139524829|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139524830|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524831|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139524832|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
139524833|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524834|NCT02008370|Bupivacaine|bupivacaine|mesh-list
139524835|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
139524836|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
139524837|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139524838|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524839|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
139524840|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524841|NCT01981616|Vedolizumab|vedolizumab|mesh-list
139524842|NCT01981616|Vaccines|vaccines|mesh-list
139524843|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
139524844|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524845|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139524846|NCT01962103|Paclitaxel|paclitaxel|mesh-list
139524847|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139524848|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139524849|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145083|NCT04599933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145084|NCT04599933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524850|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
139524851|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
139524852|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
139524853|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524854|NCT01961323|Nebivolol|nebivolol|mesh-list
139524855|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139524856|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
139524857|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139524858|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139524859|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139524860|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
139524861|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524862|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524863|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524864|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
139524865|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
139524866|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524867|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524868|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524869|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
139524870|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
139524871|NCT01960855|Upadacitinib|upadacitinib|mesh-list
139524872|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139524873|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139524874|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524875|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524876|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139524877|NCT02007434|Loratadine|loratadine|mesh-list
139524878|NCT02007434|Ibuprofen|ibuprofen|mesh-list
139524879|NCT02007434|Lidocaine|lidocaine|mesh-list
139524880|NCT02007434|Epinephrine|epinephrine|mesh-list
139524881|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
139524882|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
139524883|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
139524884|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139524885|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524886|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
139524887|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139524888|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139524889|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139524890|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139524891|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139524892|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524893|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139524894|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139524895|NCT02007434|Analgesics|analgesics|mesh-ancestor
139524896|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139524897|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139524898|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139524899|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139524900|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139524901|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139524902|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
139524903|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524904|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139524905|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139524906|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
139524907|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139524908|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
139524909|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
139524910|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
139524911|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139524912|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
139524913|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
139524914|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139524915|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139524916|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139524917|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
139524918|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
139524919|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139524920|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139524921|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
139524922|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139524923|NCT01987453|Ledipasvir|ledipasvir|mesh-list
139524924|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
139524925|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139524926|NCT02006641|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
139524927|NCT02006641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139524928|NCT02006641|Serotonin Agents|serotonin agents|mesh-ancestor
139524929|NCT02006641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524930|NCT02006641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524931|NCT02006641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524932|NCT01959919|Factor VIII|factor viii|mesh-list
139524933|NCT01959919|Coagulants|coagulants|mesh-ancestor
139524934|NCT01986907|Ranibizumab|ranibizumab|mesh-list
139524935|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139524936|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139524937|NCT01986907|Growth Substances|growth substances|mesh-ancestor
139524938|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524939|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
139524940|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524941|NCT01959841|Valacyclovir|valacyclovir|mesh-list
139524942|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
139524943|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139524944|NCT02005627|Immunomodulating Agents|immunomodulating agents|mesh-list
139524945|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
139524946|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524947|NCT02073929|Liraglutide|liraglutide|mesh-list
139524948|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139524949|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524950|NCT02073929|Incretins|incretins|mesh-ancestor
139524951|NCT02073929|Hormones|hormones|mesh-ancestor
139524952|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139524953|NCT02113007|Rituximab|rituximab|mesh-list
139145434|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139145435|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
139145436|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
139145441|NCT03332316|Hormones|hormones|mesh-ancestor
139524954|NCT02113007|Temozolomide|temozolomide|mesh-list
139524955|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139524956|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139524957|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
139524958|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524959|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139524960|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139524961|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
139524962|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524963|NCT02104505|Tocopherols|tocopherols|mesh-list
139524964|NCT02104505|Vitamin E|vitamin e|mesh-list
139524965|NCT02104505|Tocotrienols|tocotrienols|mesh-list
139524966|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
139524967|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
139524968|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
139306589|NCT03507699|Nivolumab|nivolumab|mesh-list
139524969|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524970|NCT02104505|Protective Agents|protective agents|mesh-ancestor
139524971|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524972|NCT02104505|Vitamins|vitamins|mesh-ancestor
139524973|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
139524974|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139524975|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139524976|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139524977|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
139524978|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524979|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139524980|NCT02111369|Propranolol|propranolol|mesh-list
139524981|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
139524982|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139524983|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139524984|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139524985|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
139524986|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139524987|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139524988|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139524989|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139524990|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
139524991|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139524992|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139524993|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
139524994|NCT02069093|Dexamethasone|dexamethasone|mesh-list
139524995|NCT02069093|Everolimus|everolimus|mesh-list
139524996|NCT02069093|Exemestane|exemestane|mesh-list
139524997|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139524998|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
139524999|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
139525000|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525001|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525002|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139525003|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
139525004|NCT02069093|Hormones|hormones|mesh-ancestor
139525005|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139525006|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139525007|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525008|NCT02069093|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139525009|NCT02069093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139525010|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525011|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525012|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139525013|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
139525014|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139525015|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139525016|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139525017|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
139525018|NCT02109029|Insulin|insulin|mesh-list
139525019|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139525020|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525021|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525022|NCT02007278|Metformin|metformin|mesh-list
139525023|NCT02007278|Glimepiride|glimepiride|mesh-list
139525024|NCT02007278|Vildagliptin|vildagliptin|mesh-list
139525025|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525026|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525027|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139525028|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139525029|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
139525030|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139525031|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
139525032|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525033|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525034|NCT02028338|Dapivirine|dapivirine|mesh-list
139525035|NCT02028338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139525036|NCT02028338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139525037|NCT02028338|Antiviral Agents|antiviral agents|mesh-ancestor
139525038|NCT02028338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525039|NCT01625897|Risperidone|risperidone|mesh-list
139525040|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139525041|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
139525042|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525043|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525044|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525045|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139306653|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
139525046|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139525047|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139525048|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139525049|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139525050|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
139525051|NCT02106923|Metformin|metformin|mesh-list
139525052|NCT02106923|Empagliflozin|empagliflozin|mesh-list
139525053|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525054|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525055|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139525056|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525057|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
139525058|NCT02006732|Olodaterol|olodaterol|mesh-list
139525059|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139525060|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
139525061|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525062|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525063|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139525064|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
139525065|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
139145627|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139145628|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145632|NCT02804126|Narcotics|narcotics|mesh-ancestor
139525066|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139525067|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
139525068|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525069|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525070|NCT02098733|Pioglitazone|pioglitazone|mesh-list
139525071|NCT02098733|Glimepiride|glimepiride|mesh-list
139525072|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525073|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525074|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139525075|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139525076|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
139525077|NCT02098109|Plerixafor|plerixafor|mesh-list
139525078|NCT02098109|Lenograstim|lenograstim|mesh-list
139525079|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139525080|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
139525081|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145689|NCT02287129|Paclitaxel|paclitaxel|mesh-list
139145690|NCT02287129|Carboplatin|carboplatin|mesh-list
139145691|NCT02287129|Capecitabine|capecitabine|mesh-list
139145692|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
139145693|NCT02287129|Epirubicin|epirubicin|mesh-list
139145694|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139145695|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525082|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139525083|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139525084|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
139525085|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525086|NCT02097719|Timolol|timolol|mesh-list
139525087|NCT02097719|Bimatoprost|bimatoprost|mesh-list
139525088|NCT02097719|Travoprost|travoprost|mesh-list
139525089|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525090|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139525091|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139525092|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
139525093|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525094|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525095|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139525096|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139145744|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
139145745|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145746|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139145747|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139145748|NCT02142803|Growth Substances|growth substances|mesh-ancestor
139145749|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896256|NCT00694694|Lumefantrine|lumefantrine|mesh-list
139145751|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
139525097|NCT01449370|Serabelisib|serabelisib|mesh-list
139525098|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525099|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525100|NCT02066129|Fluticasone|fluticasone|mesh-list
139525101|NCT02066129|Xhance|xhance|mesh-list
139525102|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139525103|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139525104|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
139525105|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525106|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525107|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139525108|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
139525109|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
139525110|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139525111|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139525112|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139525113|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525114|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
139525115|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139525116|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139525117|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525118|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139525119|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525120|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139525121|NCT02006654|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
139525122|NCT02006654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139525123|NCT02006654|Serotonin Agents|serotonin agents|mesh-ancestor
139525124|NCT02006654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525125|NCT02006654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525126|NCT02006654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525127|NCT01448824|Ketoconazole|ketoconazole|mesh-list
139525128|NCT01448824|Evacetrapib|evacetrapib|mesh-list
139525129|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
139525130|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525131|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139525132|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139525133|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525134|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525135|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139525136|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
139525137|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139525138|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525139|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139525140|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139525141|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139525142|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
139145871|NCT02252614|Naproxen|naproxen|mesh-list
139525143|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139525144|NCT02005562|Cyclosporine|cyclosporine|mesh-list
139525145|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
139525146|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
139525147|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139525148|NCT02005562|Cyclosporins|cyclosporins|mesh-list
139525149|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525150|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525151|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139525152|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
139525153|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525154|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
139525155|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525156|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
139525157|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139525158|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139525159|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139525160|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525161|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139525162|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
139525163|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139525164|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139525165|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
139525166|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
139525167|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525168|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139525169|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
139525170|NCT02005562|Hormones|hormones|mesh-ancestor
139525171|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139525172|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139525173|NCT02005562|Protective Agents|protective agents|mesh-ancestor
139525174|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139525175|NCT01448044|Interferons|interferons|mesh-list
139525176|NCT01448044|Ribavirin|ribavirin|mesh-list
139525177|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
139525178|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
139525179|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139525180|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525181|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
139525182|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525183|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
139525184|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525185|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
139525186|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525187|NCT01472380|Efavirenz|efavirenz|mesh-list
139525188|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
139525189|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139525190|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139525191|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525192|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525193|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
139525194|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525195|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139525196|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139525198|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139525199|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139525200|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139525201|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139525202|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139525203|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
139525204|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139525205|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
139525206|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139525207|NCT01447420|Ribavirin|ribavirin|mesh-list
139525208|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139525209|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
139525210|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525211|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
139525212|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525213|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
139525214|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139525215|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525216|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
139525217|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
139525218|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
139525219|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139525220|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525221|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139525222|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139525223|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
139525224|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139525225|NCT01438840|Maleic acid|maleic acid|mesh-list
139525226|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525227|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525228|NCT01471054|Dexamethasone|dexamethasone|mesh-list
139525229|NCT01471054|Bevacizumab|bevacizumab|mesh-list
139525230|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139525231|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525232|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139525233|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139525234|NCT01471054|Growth Substances|growth substances|mesh-ancestor
139525235|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525236|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
139525237|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139525238|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
139525239|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
139525240|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525241|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139525242|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
139525243|NCT01471054|Hormones|hormones|mesh-ancestor
139525244|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139525245|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139525246|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
139525247|NCT01978184|Gemcitabine|gemcitabine|mesh-list
139525248|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139525249|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139525250|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
139525251|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525252|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525253|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
139525254|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139525255|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139525256|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525257|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525258|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139525259|NCT01445548|Sirolimus|sirolimus|mesh-list
139525260|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139525261|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525262|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139525263|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525264|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
139525265|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139525266|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
139525267|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525268|NCT01977794|Amlodipine|amlodipine|mesh-list
139525269|NCT01977794|Bisoprolol|bisoprolol|mesh-list
139525270|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139525271|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139525272|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139525273|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525274|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139525275|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525276|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
139525277|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
139525278|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
139525279|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525280|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139525281|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139525282|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139525283|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
139525284|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525285|NCT02005484|Trastuzumab|trastuzumab|mesh-list
139525286|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139525287|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525289|NCT01597973|Colistin|colistin|mesh-list
139525290|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139525291|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525292|NCT02047253|Acyclovir|acyclovir|mesh-list
139525293|NCT02047253|Dexamethasone|dexamethasone|mesh-list
139525294|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139525295|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
139525296|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
139525297|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525298|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525299|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139525300|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
139525301|NCT02047253|Hormones|hormones|mesh-ancestor
139525302|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139525303|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139525304|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525305|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
139525306|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525307|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
139525308|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139525309|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525310|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525311|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525312|NCT02096003|Morphine|morphine|mesh-list
139525313|NCT02096003|Hydromorphone|hydromorphone|mesh-list
139525314|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139525315|NCT02096003|Narcotics|narcotics|mesh-ancestor
139525316|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139525317|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525318|NCT02096003|Analgesics|analgesics|mesh-ancestor
139525319|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
139525320|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525321|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
139525322|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139525323|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139525324|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525325|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
139525326|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
139525327|NCT02059187|Insulin|insulin|mesh-list
139525328|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139525329|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
139525330|NCT02059187|MK-1293|mk-1293|mesh-list
139525331|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525332|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525333|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139525334|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
139525335|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525336|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139525337|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139525338|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525339|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525340|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525341|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139525342|NCT01622231|Fluticasone|fluticasone|mesh-list
139525343|NCT01622231|Xhance|xhance|mesh-list
139525344|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139525345|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139525346|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
139525347|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525348|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525349|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139525350|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
139525351|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
139525352|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139525353|NCT02042183|Lubiprostone|lubiprostone|mesh-list
139525354|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139525355|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139525356|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525357|NCT02058095|Tadalafil|tadalafil|mesh-list
139525358|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
139525359|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139525360|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139525361|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525362|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525363|NCT02058095|Urological Agents|urological agents|mesh-ancestor
139525364|NCT02023112|Ritonavir|ritonavir|mesh-list
139525365|NCT02023112|Ribavirin|ribavirin|mesh-list
139525366|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139525367|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139525368|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
139525369|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525370|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525371|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139525372|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139525373|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
139525374|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525375|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139525376|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139525377|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
139525378|NCT04670666|Metformin|metformin|mesh-list
139525379|NCT04670666|Empagliflozin|empagliflozin|mesh-list
139525380|NCT04670666|Linagliptin|linagliptin|mesh-list
139525381|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525382|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525383|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139525384|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525385|NCT04670666|Incretins|incretins|mesh-ancestor
139525386|NCT04670666|Hormones|hormones|mesh-ancestor
139146285|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139525387|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139525388|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139525389|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
139525390|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525391|NCT01976624|Timolol|timolol|mesh-list
139525392|NCT01976624|Bimatoprost|bimatoprost|mesh-list
139525393|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139525394|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139525395|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
139525396|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525397|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525398|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146373|NCT00129545|Warfarin|warfarin|mesh-list
139525399|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139525400|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139525401|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139525402|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
139525403|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525404|NCT04717973|Vitamin D|vitamin d|mesh-list
139525405|NCT04717973|Vitamins|vitamins|mesh-list
139525406|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
139525407|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
139525408|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
139525409|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525410|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139525411|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
139525412|NCT04717973|Hematinics|hematinics|mesh-ancestor
139525413|NCT02057549|Haloperidol|haloperidol|mesh-list
139525414|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
139525415|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
139525416|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
139525417|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525418|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525419|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139525420|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139525421|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139525422|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139525423|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139525424|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139525425|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
139525426|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525427|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525428|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139525429|NCT02057393|Methylene Blue|methylene blue|mesh-list
139525430|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525431|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525432|NCT02040779|Beclomethasone|beclomethasone|mesh-list
139525433|NCT02040779|Albuterol|albuterol|mesh-list
139525434|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
139525435|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
139525436|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525437|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525438|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139525439|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
139525440|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
139525441|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139525442|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139525443|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139525444|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139525445|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
139525446|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525447|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525448|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139525449|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
139525450|NCT02040779|Hormones|hormones|mesh-ancestor
139525451|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139525452|NCT02056301|Morphine|morphine|mesh-list
139525453|NCT02056301|Hydromorphone|hydromorphone|mesh-list
139525454|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139525455|NCT02056301|Narcotics|narcotics|mesh-ancestor
139525456|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139525457|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525458|NCT02056301|Analgesics|analgesics|mesh-ancestor
139525459|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
139525460|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525461|NCT01967576|Axitinib|axitinib|mesh-list
139525462|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525463|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139525464|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525465|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525466|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139525467|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139525468|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139525469|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139525470|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139525471|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
139525472|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525473|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525474|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525475|NCT01976312|Ranibizumab|ranibizumab|mesh-list
139525476|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139525477|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139525478|NCT01976312|Growth Substances|growth substances|mesh-ancestor
139525479|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525480|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
139146643|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
139525481|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525482|NCT02053493|Isosorbide|isosorbide|mesh-list
139525483|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139525484|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139525485|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139525486|NCT02053493|Diuretics|diuretics|mesh-ancestor
139525487|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
139525488|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525489|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
139525490|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139525491|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525492|NCT02003144|Eculizumab|eculizumab|mesh-list
139525493|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139525494|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139525495|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
139525496|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525497|NCT02038907|Vaccines|vaccines|mesh-list
139307111|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139525498|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
139525499|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525500|NCT02052011|Ranolazine|ranolazine|mesh-list
139525501|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139525502|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139525503|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525504|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
139525505|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139525506|NCT02051933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139525507|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139525508|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139525509|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525510|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
139525511|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525512|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525513|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139525514|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525515|NCT02035553|Pimavanserin|pimavanserin|mesh-list
139525516|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139525517|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139525518|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139525519|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139525520|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139525521|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525522|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139525523|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139525524|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139525525|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
139525526|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525527|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525528|NCT01445080|Sorafenib|sorafenib|mesh-list
139525529|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525530|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139525531|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525532|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525533|NCT04709471|Nicotine|nicotine|mesh-list
139525534|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139525535|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
139525536|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525537|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525538|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139525539|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139525540|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
139525541|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525542|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525543|NCT01959529|Insulin|insulin|mesh-list
139525544|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139525545|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
139525546|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525547|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525548|NCT02033369|Pramipexole|pramipexole|mesh-list
139525549|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
139525550|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525551|NCT02033369|Protective Agents|protective agents|mesh-ancestor
139525552|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525553|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139525554|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139525555|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
139525556|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
139525557|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525558|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
139525559|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
139525560|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525561|NCT04681469|Niraparib|niraparib|mesh-list
139525562|NCT04681469|Dostarlimab|dostarlimab|mesh-list
139525563|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139525564|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525565|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525566|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525567|NCT01986751|Clonidine|clonidine|mesh-list
139525568|NCT01986751|Ropivacaine|ropivacaine|mesh-list
139525569|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
139525570|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
139525571|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139525572|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307182|NCT02101047|Phenylephrine|phenylephrine|mesh-list
139525573|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
139525574|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525575|NCT01986751|Analgesics|analgesics|mesh-ancestor
139525576|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139525577|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
139525578|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
139525579|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139525580|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139525581|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139525582|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
139525583|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525584|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525585|NCT01438060|Aripiprazole|aripiprazole|mesh-list
139525586|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
139525587|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139525588|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139525589|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139525590|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139525591|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525592|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
139525593|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
139525594|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525595|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525596|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139525597|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139525598|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
139525599|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139525600|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139525601|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139525602|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139525603|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
139525604|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139525605|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139525606|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525607|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
139525608|NCT01443364|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139525609|NCT01443364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139525610|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139525611|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
139525612|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525613|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139525615|NCT02020577|Afatinib|afatinib|mesh-list
139525616|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139525617|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525618|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139525619|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525620|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525621|NCT02020031|Vancomycin|vancomycin|mesh-list
139525622|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139525623|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525624|NCT02030405|Ixazomib|ixazomib|mesh-list
139525625|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
139525626|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525627|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
139525628|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525629|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525630|NCT01975376|Bococizumab|bococizumab|mesh-list
139525631|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139525632|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139525633|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
139525634|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525635|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139525636|NCT01443130|Chloroquine|chloroquine|mesh-list
139525637|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
139525638|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
139525639|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139525640|NCT01443130|Amebicides|amebicides|mesh-ancestor
139525641|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139525642|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139525643|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525644|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
139525645|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139307262|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
139147158|NCT00108082|Carvedilol|carvedilol|mesh-list
139525646|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139525647|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525648|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525649|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139525650|NCT01436500|Ifetroban|ifetroban|mesh-list
139525651|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139525652|NCT01958827|Adalimumab|adalimumab|mesh-list
139525653|NCT01958827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139525654|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139525655|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139525656|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
139525657|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139525658|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
139525659|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139525660|NCT01436110|Fluticasone|fluticasone|mesh-list
139525661|NCT01436110|Xhance|xhance|mesh-list
139525662|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139525663|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139525664|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
139525665|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525666|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525667|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139525668|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
139525669|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
139525670|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139525671|NCT01619852|Lidocaine|lidocaine|mesh-list
139525672|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
139525673|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
139525674|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139525675|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525676|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
139525677|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147270|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139525678|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139525679|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139525680|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139525681|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139525682|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525683|NCT04069936|Nivolumab|nivolumab|mesh-list
139525684|NCT04069936|Tadalafil|tadalafil|mesh-list
139525685|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139525686|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147346|NCT00104728|Gefitinib|gefitinib|mesh-list
139525687|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139525688|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525689|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
139525690|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139525691|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139525692|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525693|NCT04069936|Urological Agents|urological agents|mesh-ancestor
139525694|NCT02000882|Capecitabine|capecitabine|mesh-list
139525695|NCT02000882|Trastuzumab|trastuzumab|mesh-list
139147400|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
139525696|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139525697|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
139525698|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525699|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525700|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139525701|NCT04666129|Prednisone|prednisone|mesh-list
139525702|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
139525703|NCT04666129|Docetaxel|docetaxel|mesh-list
139525704|NCT04666129|Relugolix|relugolix|mesh-list
139525705|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525706|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
139525707|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
139525708|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
139525709|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525710|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139525711|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
139525712|NCT04666129|Hormones|hormones|mesh-ancestor
139525713|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139525714|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525715|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139525716|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
139525717|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
139525718|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307337|NCT04337060|Narcotics|narcotics|mesh-ancestor
139525719|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139525720|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139525721|NCT04666129|Protective Agents|protective agents|mesh-ancestor
139525722|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
139525723|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
139147470|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
139525724|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139525725|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
139525726|NCT04666051|Coagulants|coagulants|mesh-ancestor
139525727|NCT01965704|Ondansetron|ondansetron|mesh-list
139525728|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
139525729|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
139525730|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525731|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525732|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139525733|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
139525734|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
139525735|NCT01965704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139525736|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139525737|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
139525738|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525739|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525740|NCT02003365|Triamcinolone|triamcinolone|mesh-list
139525741|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139525742|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139525743|NCT02003365|FX006|fx006|mesh-list
139525744|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139525745|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139525746|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
139525747|NCT02003365|Hormones|hormones|mesh-ancestor
139525748|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139525749|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525750|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139525751|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
139525752|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525753|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525754|NCT01975220|Metformin|metformin|mesh-list
139525755|NCT01975220|Empagliflozin|empagliflozin|mesh-list
139525756|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525757|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525758|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139525759|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525760|NCT01974752|Dacarbazine|dacarbazine|mesh-list
139525761|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139525762|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
139525763|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525764|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525765|NCT01999946|Naltrexone|naltrexone|mesh-list
139525766|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139525767|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139525768|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525769|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
139525770|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525771|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
139525772|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139525773|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
139525774|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525775|NCT02002975|Pioglitazone|pioglitazone|mesh-list
139525776|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525777|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525778|NCT02001181|Tofacitinib|tofacitinib|mesh-list
139525779|NCT02001181|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139525780|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139525781|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525782|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525783|NCT04176055|Haloperidol|haloperidol|mesh-list
139525784|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
139525785|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
139525786|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
139525787|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525788|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525789|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139525790|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139525791|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139525792|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139525793|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139525794|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139147616|NCT01079819|BMS 708163|bms 708163|mesh-list
139525795|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
139525796|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525797|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525798|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139525799|NCT04659278|Peppermint oil|peppermint oil|mesh-list
139525800|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
139525801|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
139525802|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525803|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525804|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139525805|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
139525806|NCT01999868|Abatacept|abatacept|mesh-list
139525807|NCT01999868|Ustekinumab|ustekinumab|mesh-list
139525808|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
139525809|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
139147665|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139525810|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525811|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139525812|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525813|NCT01999868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139525814|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525815|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139525816|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139525817|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
139525818|NCT03511963|Bevacizumab|bevacizumab|mesh-list
139525819|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139525820|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525821|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139525822|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139525823|NCT03511963|Growth Substances|growth substances|mesh-ancestor
139525824|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525825|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
139525826|NCT01999322|Insulin|insulin|mesh-list
139525827|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139525828|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
139525829|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
139525830|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139525831|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525832|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525833|NCT01964924|Trametinib|trametinib|mesh-list
139525834|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525835|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139525836|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525837|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525838|NCT01964378|Morphine|morphine|mesh-list
139525839|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139525840|NCT01964378|Narcotics|narcotics|mesh-ancestor
139525841|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139525842|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525843|NCT01964378|Analgesics|analgesics|mesh-ancestor
139525844|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
139525845|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525846|NCT01442038|Ranolazine|ranolazine|mesh-list
139525847|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139525848|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139525849|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525850|NCT01998919|Carboplatin|carboplatin|mesh-list
139525851|NCT01998919|Gemcitabine|gemcitabine|mesh-list
139525852|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139525853|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525854|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139525855|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
139525856|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525857|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139525858|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525859|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139525860|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
139525861|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525862|NCT01972724|Metformin|metformin|mesh-list
139525863|NCT01972724|Pioglitazone|pioglitazone|mesh-list
139525864|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139147887|NCT00119015|Xhance|xhance|mesh-list
139525865|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525866|NCT01441960|Rocuronium|rocuronium|mesh-list
139525867|NCT01441960|Succinylcholine|succinylcholine|mesh-list
139525868|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139525869|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139525870|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139525871|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139525872|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525873|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139147907|NCT01079351|Carbamazepine|carbamazepine|mesh-list
139525875|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
139525876|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525877|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
139525878|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
139525879|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
139525880|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139525881|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139525882|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525883|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525884|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525885|NCT01955161|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
139525886|NCT01955161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139525887|NCT01955161|Serotonin Agents|serotonin agents|mesh-ancestor
139525888|NCT01955161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525889|NCT01955161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147966|NCT01761890|Dasatinib|dasatinib|mesh-list
139525890|NCT01955161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525891|NCT01441414|Axitinib|axitinib|mesh-list
139525892|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525893|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139525894|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525895|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525896|NCT01954927|Gabapentin|gabapentin|mesh-list
139525897|NCT01954927|Analgesics|analgesics|mesh-ancestor
139525898|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
139525899|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148018|NCT02160184|Pancrelipase|pancrelipase|mesh-list
139525900|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525901|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
139525902|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139525903|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139525904|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139525905|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139525906|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139525907|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139525908|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139525909|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525910|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
139525911|NCT01953913|Afatinib|afatinib|mesh-list
139525912|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525913|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139525914|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525915|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525916|NCT01970540|Doxorubicin|doxorubicin|mesh-list
139525917|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139525918|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525919|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139525920|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139525921|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525922|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525923|NCT01996826|Bevacizumab|bevacizumab|mesh-list
139525924|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139525925|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139525926|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525927|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139525928|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139525929|NCT01996826|Growth Substances|growth substances|mesh-ancestor
139148209|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525930|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525931|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
139525932|NCT01996826|Laxatives|laxatives|mesh-ancestor
139525933|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139525934|NCT01621178|Insulin|insulin|mesh-list
139525935|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139525936|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
139525937|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
139525938|NCT01621178|Dulaglutide|dulaglutide|mesh-list
139525939|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525940|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525941|NCT01962974|Golimumab|golimumab|mesh-list
139525942|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139525943|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139525944|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139525945|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
139307551|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
139525946|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525947|NCT01962896|Sirolimus|sirolimus|mesh-list
139525948|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139525949|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139525950|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139525951|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525952|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525953|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139525954|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525955|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139525956|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
139525957|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139525958|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
139525959|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525960|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139525961|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525962|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525963|NCT01970462|Incretins|incretins|mesh-ancestor
139525964|NCT01970462|Hormones|hormones|mesh-ancestor
139525965|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139525966|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139148284|NCT03022292|Aflibercept|aflibercept|mesh-list
139525967|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
139525968|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525969|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525970|NCT01958671|Metformin|metformin|mesh-list
139525971|NCT01958671|Glimepiride|glimepiride|mesh-list
139525972|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
139525973|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139525974|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139525975|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139525976|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139525977|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
139525978|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139525979|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525980|NCT01995266|Asunaprevir|asunaprevir|mesh-list
139525981|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
139525982|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139525983|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525984|NCT01969058|Isotretinoin|isotretinoin|mesh-list
139525985|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
139525986|NCT01968980|Bococizumab|bococizumab|mesh-list
139525987|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139525988|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139525989|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
139525990|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139525991|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139525992|NCT01968434|Carbocysteine|carbocysteine|mesh-list
139525993|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139525994|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139525995|NCT01968434|Expectorants|expectorants|mesh-ancestor
139525996|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
139525997|NCT01946438|Vaccines|vaccines|mesh-list
139525998|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
139525999|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526000|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
139526001|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
139526002|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139526003|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139526004|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526005|NCT01917656|Metformin|metformin|mesh-list
139526006|NCT01917656|Liraglutide|liraglutide|mesh-list
139526007|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139526008|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526009|NCT01917656|Incretins|incretins|mesh-ancestor
139526010|NCT01917656|Hormones|hormones|mesh-ancestor
139526011|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139526012|NCT02017535|Fluoxetine|fluoxetine|mesh-list
139526013|NCT02017535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139526014|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139526015|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139526016|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526017|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526018|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
139526019|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526020|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139526021|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
139526022|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139526023|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139526024|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139526025|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526027|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
139526028|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
139526029|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139526030|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526031|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
139526032|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526033|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139526034|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139526035|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139526036|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139526037|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526038|NCT01943552|Bromides|bromides|mesh-list
139526039|NCT01943552|Ipratropium|ipratropium|mesh-list
139526040|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
139526041|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139526042|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
139526043|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526044|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526045|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139526046|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
139526047|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139526048|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
139526049|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526050|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526051|NCT01915940|Timolol|timolol|mesh-list
139526052|NCT01915940|Bimatoprost|bimatoprost|mesh-list
139526053|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139526054|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139526055|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139526056|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139526057|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
139526058|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526059|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526060|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526061|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139526062|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139526063|NCT01914926|Metoprolol|metoprolol|mesh-list
139526064|NCT01914926|Diltiazem|diltiazem|mesh-list
139526065|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139526066|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139526067|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
139526068|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
139526069|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526070|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148456|NCT03731091|Calcitriol|calcitriol|mesh-list
139526071|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139526072|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139526073|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139526074|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
139526075|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526076|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526077|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139526078|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139526079|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139526080|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
139526081|NCT05119166|Niacinamide|niacinamide|mesh-list
139526082|NCT05119166|Niacin|niacin|mesh-list
139526083|NCT05119166|Nicotinic Acids|nicotinic acids|mesh-list
139526084|NCT05119166|Azithromycin|azithromycin|mesh-list
139526085|NCT05119166|Vitamins|vitamins|mesh-ancestor
139526086|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
139526087|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526088|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139526089|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526090|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
139526091|NCT05119166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139526092|NCT05119166|Antimetabolites|antimetabolites|mesh-ancestor
139526093|NCT05119166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526094|NCT05119166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139526095|NCT05119166|Vasodilator Agents|vasodilator agents|mesh-ancestor
139526097|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
139526098|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139526099|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139526100|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139526101|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139526102|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526103|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
139526104|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
139526105|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526106|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526107|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139526108|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139526109|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
139526110|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139526111|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139526112|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139526113|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139526114|NCT02030015|Miglustat|miglustat|mesh-list
139526115|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526116|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526117|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139526118|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139526119|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
139526120|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526121|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139526122|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139526123|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526124|NCT02029235|Acetaminophen|acetaminophen|mesh-list
139526125|NCT02029235|Ibuprofen|ibuprofen|mesh-list
139526126|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139526127|NCT02029235|Hydrocodone|hydrocodone|mesh-list
139526128|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139526129|NCT02029235|Analgesics|analgesics|mesh-ancestor
139526130|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
139526131|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526132|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526133|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
139526134|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139526135|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139526136|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139526137|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139526138|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526139|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526140|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139526141|NCT02029235|Narcotics|narcotics|mesh-ancestor
139526142|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139526143|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
139526144|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
139526145|NCT01617434|Liraglutide|liraglutide|mesh-list
139526146|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139526147|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526148|NCT01617434|Incretins|incretins|mesh-ancestor
139526149|NCT01617434|Hormones|hormones|mesh-ancestor
139526150|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139526151|NCT01940900|Ranibizumab|ranibizumab|mesh-list
139526152|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139526153|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139526154|NCT01940900|Growth Substances|growth substances|mesh-ancestor
139526155|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526156|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
139526157|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526158|NCT01911260|Chelating Agents|chelating agents|mesh-list
139526159|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
139526160|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526161|NCT02015819|Leucovorin|leucovorin|mesh-list
139148676|NCT03726021|Irinotecan|irinotecan|mesh-list
139526162|NCT02015819|Flucytosine|flucytosine|mesh-list
139526163|NCT02015819|Calcium|calcium|mesh-list
139526164|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
139526165|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139526166|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526167|NCT02015819|Antidotes|antidotes|mesh-ancestor
139307777|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
139526168|NCT02015819|Protective Agents|protective agents|mesh-ancestor
139526169|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
139526170|NCT02015819|Vitamins|vitamins|mesh-ancestor
139526171|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
139526172|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
139526173|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526174|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
139526175|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526176|NCT01939496|Canagliflozin|canagliflozin|mesh-list
139526177|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139526178|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526179|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139526180|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526181|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139526182|NCT01938716|Gemcitabine|gemcitabine|mesh-list
139526183|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139526184|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
139526185|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526186|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526187|NCT01937390|Bromides|bromides|mesh-list
139526188|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
139526189|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139526190|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
139526191|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526192|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526193|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139526194|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
139526195|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
139526196|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139526197|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
139526198|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526199|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526200|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
139526201|NCT02028767|Metformin|metformin|mesh-list
139526202|NCT02028767|Empagliflozin|empagliflozin|mesh-list
139526203|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139526204|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526205|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139526206|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526207|NCT04683965|Bevacizumab|bevacizumab|mesh-list
139526208|NCT04683965|Pemetrexed|pemetrexed|mesh-list
139526209|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139526210|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526211|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139526212|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139526213|NCT04683965|Growth Substances|growth substances|mesh-ancestor
139526214|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526215|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
139526216|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526217|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526218|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139526219|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139526220|NCT02015195|Ethanol|ethanol|mesh-list
139526221|NCT02015195|Acetic Acid|acetic acid|mesh-list
139526222|NCT02015195|Retinol acetate|retinol acetate|mesh-list
139526223|NCT02015195|Lidocaine|lidocaine|mesh-list
139526224|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
139526225|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
139526226|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139526227|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526228|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
139526229|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526230|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139526231|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139526232|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139526233|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139526234|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526235|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139526236|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526237|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139526238|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139526239|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
139526240|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139526241|NCT02015195|Protective Agents|protective agents|mesh-ancestor
139526242|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526243|NCT02025725|Metoclopramide|metoclopramide|mesh-list
139526244|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
139526245|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
139526246|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526247|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526248|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139526249|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139526250|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139526251|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
139526252|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526253|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526254|NCT02025179|Teriparatide|teriparatide|mesh-list
139526255|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139526256|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526257|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139526258|NCT02013791|Cyclosporine|cyclosporine|mesh-list
139526259|NCT02013791|Cyclosporins|cyclosporins|mesh-list
139526260|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526261|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526262|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139526263|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
139526264|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526265|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
139526266|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526267|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
139526268|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139526269|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139526270|NCT02024867|Trimethoprim|trimethoprim|mesh-list
139526271|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139526272|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
139526273|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139526274|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526275|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
139526276|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139526277|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139526278|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139526279|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526280|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526281|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139526282|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139526283|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139526284|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139526285|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139526286|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526287|NCT01951417|Adapalene|adapalene|mesh-list
139526288|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139526289|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
139526290|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139526291|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139526292|NCT01951417|Analgesics|analgesics|mesh-ancestor
139526293|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
139526294|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526295|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526296|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139526297|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139526298|NCT02023151|Omalizumab|omalizumab|mesh-list
139526299|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139526300|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139526301|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
139526302|NCT01979185|Simvastatin|simvastatin|mesh-list
139526303|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139526304|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139526305|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
139526306|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526307|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139526308|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139526309|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526310|NCT01946425|Vaccines|vaccines|mesh-list
139526311|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
139526312|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526313|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139526314|NCT01937312|Travoprost|travoprost|mesh-list
139526315|NCT01937312|Brinzolamide|brinzolamide|mesh-list
139526316|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139526317|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139526318|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139526319|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139526320|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
139526321|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526322|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526323|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526324|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139526325|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526326|NCT01935128|Everolimus|everolimus|mesh-list
139526327|NCT01935128|Tacrolimus|tacrolimus|mesh-list
139526328|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139526329|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
139526330|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526331|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139526332|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526333|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526334|NCT01935128|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139526335|NCT01935128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139526336|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526337|NCT01934972|Cycloserine|cycloserine|mesh-list
139526338|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139526339|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526340|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139526341|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
139526342|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139526343|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
139526344|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526345|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139526346|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139526347|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139526348|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139526349|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139526350|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139526351|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139526352|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
139526353|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526354|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526355|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526356|NCT01977937|Gabapentin|gabapentin|mesh-list
139526357|NCT01977937|Analgesics|analgesics|mesh-ancestor
139526358|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
139526359|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526360|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526361|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
139526362|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139526363|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139526364|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139526365|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139526366|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139526367|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139526368|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526369|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526370|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
139526371|NCT02015663|Tobramycin|tobramycin|mesh-list
139526372|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139526373|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526374|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139526375|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
139526376|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526377|NCT01951105|Naproxen|naproxen|mesh-list
139526378|NCT01951105|Levodopa|levodopa|mesh-list
139526379|NCT01951105|Carbidopa|carbidopa|mesh-list
139526380|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139148978|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
139526381|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139526382|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139526383|NCT01951105|Analgesics|analgesics|mesh-ancestor
139526384|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
139526385|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526386|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526387|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139526388|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139526389|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
139308005|NCT03554109|Protective Agents|protective agents|mesh-ancestor
139526390|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139526391|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526392|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526393|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139526394|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139526395|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
139526396|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526397|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139526398|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139526399|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
139526400|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
139526402|NCT01958918|Aflibercept|aflibercept|mesh-list
139526403|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139526404|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139526405|NCT01958918|Growth Substances|growth substances|mesh-ancestor
139526406|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526407|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
139526408|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526409|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
139526410|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139526411|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139526412|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139526413|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139526414|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526415|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
139526416|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526417|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526418|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139526419|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526420|NCT01934894|Lapatinib|lapatinib|mesh-list
139526421|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526422|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139526423|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526424|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526425|NCT01950169|Vitamin D|vitamin d|mesh-list
139526426|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
139526427|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
139526428|NCT01950169|Diphosphonates|diphosphonates|mesh-list
139526429|NCT01950169|Calcium|calcium|mesh-list
139526430|NCT01950169|Vitamins|vitamins|mesh-ancestor
139526431|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
139526432|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526433|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139526434|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139526435|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139526436|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139526437|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526438|NCT01909466|Aripiprazole|aripiprazole|mesh-list
139526439|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
139526440|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139526441|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139526442|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139526443|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139526444|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526445|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
139526446|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
139526447|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526448|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526449|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139526450|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139526451|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
139526452|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139526453|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139526454|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139526455|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139526456|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139526457|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139526458|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526459|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139526460|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139526461|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139308082|NCT02114073|Cyclosporine|cyclosporine|mesh-list
139526462|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526463|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
139526464|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526465|NCT01995071|Ribavirin|ribavirin|mesh-list
139526466|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
139526467|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526468|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
139526469|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526470|NCT01994837|Venetoclax|venetoclax|mesh-list
139526471|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526472|NCT02010593|Dapivirine|dapivirine|mesh-list
139526473|NCT02010593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139526474|NCT02010593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139526475|NCT02010593|Antiviral Agents|antiviral agents|mesh-ancestor
139526476|NCT02010593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526477|NCT01994291|Ranibizumab|ranibizumab|mesh-list
139526478|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139526479|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139526480|NCT01994291|Growth Substances|growth substances|mesh-ancestor
139526481|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526482|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
139526483|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526484|NCT01993823|Clotrimazole|clotrimazole|mesh-list
139526485|NCT01993823|Miconazole|miconazole|mesh-list
139526486|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139526487|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526488|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
139526489|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139526490|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139526491|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526492|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526493|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139526494|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
139526495|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139526496|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526497|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139526498|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139526499|NCT01993667|Acetazolamide|acetazolamide|mesh-list
139526500|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
139526501|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139526502|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526503|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526504|NCT01993667|Diuretics|diuretics|mesh-ancestor
139526505|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
139526506|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526507|NCT01934192|Metoclopramide|metoclopramide|mesh-list
139526508|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
139526509|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
139526510|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526511|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526512|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139526513|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139526514|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139526515|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
139526516|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526517|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526518|NCT01933880|Methylphenidate|methylphenidate|mesh-list
139526519|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139526520|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526521|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139526522|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139526523|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139526524|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526525|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
139526526|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526527|NCT02008877|Sirolimus|sirolimus|mesh-list
139526528|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139526529|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526530|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139526531|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526532|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
139526533|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139526534|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
139526535|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526536|NCT01933334|Pirfenidone|pirfenidone|mesh-list
139526537|NCT01933334|Analgesics|analgesics|mesh-ancestor
139526538|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
139526539|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526540|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526541|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139526542|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139526543|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139526544|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139526545|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526546|NCT01908140|Fluticasone|fluticasone|mesh-list
139526547|NCT01908140|Bromides|bromides|mesh-list
139526548|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
139526549|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139526550|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139526551|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139526552|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
139526553|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526554|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526555|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139526556|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
139526557|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
139526558|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139526559|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139526560|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139526561|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139526562|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
139526563|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526564|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526565|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
139526566|NCT02008565|Loperamide|loperamide|mesh-list
139526567|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
139526568|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139526569|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139526570|NCT01931150|Dapsone|dapsone|mesh-list
139526571|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526572|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
139526573|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139526574|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139526575|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139526576|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526577|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526578|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
139526579|NCT01906346|Cocaine|cocaine|mesh-list
139526580|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
139526581|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
139526582|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139526583|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526584|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
139526585|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526586|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139526587|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139526588|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139526589|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139526590|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526591|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
139526592|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526593|NCT04645004|Aspirin|aspirin|mesh-list
139526594|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139526595|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139526596|NCT04645004|Analgesics|analgesics|mesh-ancestor
139526597|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
139526598|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526599|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526600|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139526601|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139526602|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139526603|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139526604|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526605|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139526606|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139526607|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526608|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
139526609|NCT01929980|Bortezomib|bortezomib|mesh-list
139526610|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526611|NCT01363076|Ketorolac|ketorolac|mesh-list
139526612|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139526613|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139526614|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139526615|NCT01363076|Analgesics|analgesics|mesh-ancestor
139526616|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
139526617|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526618|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526619|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139526620|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139526621|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139526622|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526623|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526624|NCT01929044|Anisodamine|anisodamine|mesh-list
139526625|NCT01929044|Scopolamine|scopolamine|mesh-list
139526626|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139526627|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139526628|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
139526629|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
139526630|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526631|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526632|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139526633|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
139526634|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139526635|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
139526636|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526637|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526638|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139526639|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
139526640|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139526641|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139526642|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
139526643|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139526644|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139526645|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139526646|NCT01929044|Analgesics|analgesics|mesh-ancestor
139149258|NCT02172586|Losartan|losartan|mesh-list
139526647|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
139526648|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139526649|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139526650|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139526651|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
139526652|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139526653|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
139526654|NCT01929044|Protective Agents|protective agents|mesh-ancestor
139526655|NCT01957202|Levocabastine|levocabastine|mesh-list
139526656|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139526657|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139526658|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
139526659|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
139526660|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526661|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526662|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526663|NCT01616654|Tazarotene|tazarotene|mesh-list
139526664|NCT01616654|Trifarotene|trifarotene|mesh-list
139526665|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
139526666|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
139526667|NCT01902290|Brodalumab|brodalumab|mesh-list
139526668|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
139526669|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
139526670|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139526671|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
139526672|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526673|NCT01467466|Expectorants|expectorants|mesh-ancestor
139526674|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
139526675|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139526676|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
139526677|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526678|NCT01467466|Protective Agents|protective agents|mesh-ancestor
139526679|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526680|NCT01467466|Antidotes|antidotes|mesh-ancestor
139526681|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
139526682|NCT01441180|Ribavirin|ribavirin|mesh-list
139526683|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
139526684|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526685|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
139526686|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526687|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
139526688|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
139526689|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
139526690|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139526691|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139526692|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526693|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526694|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526695|NCT04061980|Nivolumab|nivolumab|mesh-list
139526696|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139526697|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526698|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139526699|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526700|NCT01467076|Alprostadil|alprostadil|mesh-list
139526701|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139526702|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
139526703|NCT01467076|Urological Agents|urological agents|mesh-ancestor
139526704|NCT01466062|Palivizumab|palivizumab|mesh-list
139526705|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
139526706|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526707|NCT04504864|Aspirin|aspirin|mesh-list
139526708|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139526709|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139526710|NCT04504864|Analgesics|analgesics|mesh-ancestor
139526711|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
139526712|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149336|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
139526713|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526714|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139526715|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139526716|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139526717|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139526718|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526719|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139526720|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139526721|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526722|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
139526723|NCT04060342|Paclitaxel|paclitaxel|mesh-list
139526724|NCT04060342|Gemcitabine|gemcitabine|mesh-list
139526725|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
139526726|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139526727|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526728|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
139526729|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
139526730|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
139526731|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526732|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139526733|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
139526734|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139526735|NCT04060342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139526736|NCT01435018|Tenofovir|tenofovir|mesh-list
139526737|NCT01435018|Emtricitabine|emtricitabine|mesh-list
139526738|NCT01435018|Efavirenz|efavirenz|mesh-list
139526739|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139526740|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139526741|NCT01435018|Paclitaxel|paclitaxel|mesh-list
139526742|NCT01435018|Etoposide|etoposide|mesh-list
139526743|NCT01435018|Vincristine|vincristine|mesh-list
139526744|NCT01435018|Bleomycin|bleomycin|mesh-list
139526745|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139526746|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526747|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
139526748|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
139526749|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
139526750|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526751|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139526752|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139526753|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526754|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
139526755|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526756|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139526757|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139526758|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139526759|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139526760|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139526761|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139308393|NCT02118051|Ganirelix|ganirelix|mesh-list
139526762|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139526763|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139526764|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139526765|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139526766|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139526768|NCT01419184|Daptomycin|daptomycin|mesh-list
139526769|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139526770|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139526771|NCT01417156|Nintedanib|nintedanib|mesh-list
139526772|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526773|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139526774|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526775|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526776|NCT01417078|Diazepam|diazepam|mesh-list
139526777|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139526778|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
139526779|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
139526780|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
139526781|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526782|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526783|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139526784|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139526785|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139526786|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139526787|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139526788|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139526789|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139526790|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139526791|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139526792|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
139526793|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
139526794|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
139526795|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
139526796|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526797|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526798|NCT01954394|Alirocumab|alirocumab|mesh-list
139526799|NCT01954394|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139526800|NCT01954394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139526801|NCT01954394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139526802|NCT01954394|Antimetabolites|antimetabolites|mesh-ancestor
139526803|NCT01954394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526804|NCT01954394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139526805|NCT01954394|Protease Inhibitors|protease inhibitors|mesh-ancestor
139526806|NCT01954394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881547|NCT02768519|OTS167|ots167|mesh-list
139526807|NCT01954394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139526808|NCT01464424|Bimatoprost|bimatoprost|mesh-list
139526809|NCT01464424|Travoprost|travoprost|mesh-list
139526810|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139526811|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139526812|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139526813|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139526814|NCT01902134|Tramadol|tramadol|mesh-list
139526815|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139526816|NCT01902134|Narcotics|narcotics|mesh-ancestor
139526817|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139526818|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526819|NCT01902134|Analgesics|analgesics|mesh-ancestor
139526820|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
139526821|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526822|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139526823|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139526824|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139526825|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139526826|NCT01954082|Inositol|inositol|mesh-list
139526827|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
139526828|NCT01954082|Vitamins|vitamins|mesh-ancestor
139526829|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
139526830|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526831|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
139526832|NCT01417000|Pancrelipase|pancrelipase|mesh-list
139526833|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139526834|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
139526835|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526836|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139526837|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139526838|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
139526839|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149506|NCT02182258|Nintedanib|nintedanib|mesh-list
139526840|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526841|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139526842|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139526843|NCT01415986|Temoporfin|temoporfin|mesh-list
139526844|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526845|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139526846|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
139526847|NCT01415518|Budesonide|budesonide|mesh-list
139526848|NCT01415518|Theophylline|theophylline|mesh-list
139526849|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
139526850|NCT01415518|Ipratropium|ipratropium|mesh-list
139526851|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139526852|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139526853|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139526854|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
139526855|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526856|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526857|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139526858|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
139526859|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
139526860|NCT01415518|Hormones|hormones|mesh-ancestor
139526861|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139526862|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139526863|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139526864|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139526865|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
139526866|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526867|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526868|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139526869|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
139526870|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139526871|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526872|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
139526873|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139526874|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139526875|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
139526876|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
139526877|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139526878|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139526879|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139526880|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526881|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
139526882|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526883|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526884|NCT04767178|Acetaminophen|acetaminophen|mesh-list
139526885|NCT04767178|Ibuprofen|ibuprofen|mesh-list
139526886|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139526887|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139526888|NCT04767178|Analgesics|analgesics|mesh-ancestor
139526889|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
139526890|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526891|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526892|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139526893|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139526894|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139526895|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139526896|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526897|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
139526898|NCT01432600|Dexamethasone|dexamethasone|mesh-list
139526899|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
139526900|NCT01432600|Pomalidomide|pomalidomide|mesh-list
139526901|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139526902|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
139526903|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526904|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139526905|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139526906|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
139526907|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526908|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139526909|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139526910|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139526911|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
139526912|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
139526913|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526914|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139526916|NCT01432600|Hormones|hormones|mesh-ancestor
139526917|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139526918|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139526919|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139526920|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139526921|NCT01432600|Growth Substances|growth substances|mesh-ancestor
139526922|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
139526923|NCT01432444|Aripiprazole|aripiprazole|mesh-list
139526924|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
139526925|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139526926|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139526927|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139526928|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139526929|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526930|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
139526931|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
139526932|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526933|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526934|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139526935|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139526936|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
139526937|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139526938|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139526939|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139526940|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139526941|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139526942|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139526943|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526944|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139526945|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139526946|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139526947|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526948|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
139526949|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526950|NCT01932788|Vitamin D|vitamin d|mesh-list
139526951|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
139526952|NCT01932788|Vitamins|vitamins|mesh-list
139526953|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
139526954|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526955|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139526956|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139526957|NCT01431976|Lamotrigine|lamotrigine|mesh-list
139526958|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
139526959|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139526960|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139526961|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526962|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139526963|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526964|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139526965|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139526966|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139526967|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139149649|NCT02752906|Vaccines|vaccines|mesh-list
139526968|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139526969|NCT01413958|Loratadine|loratadine|mesh-list
139526970|NCT01413958|Phenylephrine|phenylephrine|mesh-list
139526971|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
139526972|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139526973|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
139526974|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
139526975|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139526976|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139526977|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
139526978|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139526979|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
139526980|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
139526981|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139526982|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139526983|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139526984|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
139526985|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139526986|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139526987|NCT01413958|Protective Agents|protective agents|mesh-ancestor
139526988|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
139526989|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
139526990|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139526991|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139526992|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139526993|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
139526994|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
139526995|NCT01413178|Melphalan|melphalan|mesh-list
139526996|NCT01413178|Busulfan|busulfan|mesh-list
139526997|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139526998|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
139526999|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527000|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527001|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139527002|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139527003|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
139527004|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527005|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139527006|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
139527007|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527008|NCT03025906|Valproic Acid|valproic acid|mesh-list
139527009|NCT03025906|Phenobarbital|phenobarbital|mesh-list
139527010|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
139527011|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527012|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527013|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
139527014|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527015|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527016|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
139527017|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139527018|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139527019|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139527020|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139527021|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139527022|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139527023|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
139527024|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139527025|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139527026|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139527027|NCT04053712|Glucagon|glucagon|mesh-list
139527028|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139527029|NCT04053712|Hormones|hormones|mesh-ancestor
139527030|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139527031|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527032|NCT01798485|Docetaxel|docetaxel|mesh-list
139527033|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527034|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
139527035|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
139527036|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
139527037|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527038|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
139527039|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
139527040|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139527041|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139527042|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139527043|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139527044|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527045|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
139527046|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527047|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527048|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139527049|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527050|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139527051|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139527052|NCT01767519|Urological Agents|urological agents|mesh-ancestor
139527053|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
139527054|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139527055|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139527056|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139527057|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139527058|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527059|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
139527060|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527061|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527062|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139527063|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527064|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139527065|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527066|NCT01765569|Vemurafenib|vemurafenib|mesh-list
139527067|NCT01765569|Digoxin|digoxin|mesh-list
139149800|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
139527068|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139527069|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139527070|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527071|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527072|NCT01765569|Protective Agents|protective agents|mesh-ancestor
139527073|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527074|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527075|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139527076|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139527077|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
139527078|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527079|NCT01609023|Rituximab|rituximab|mesh-list
139527080|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527081|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527082|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
139527083|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527084|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527085|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
139527086|NCT01765179|Testosterone|testosterone|mesh-list
139527087|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
139527088|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
139527089|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139527090|NCT01765179|Androgens|androgens|mesh-ancestor
139527091|NCT01765179|Hormones|hormones|mesh-ancestor
139527092|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139527093|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527094|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139527095|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527096|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
139527097|NCT01793883|Laninamivir|laninamivir|mesh-list
139527098|NCT01793883|Zanamivir|zanamivir|mesh-list
139527099|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
139527100|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527101|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527102|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527103|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
139527104|NCT01953692|Lenalidomide|lenalidomide|mesh-list
139527105|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527106|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527107|NCT01953692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139527108|NCT01953692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527109|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
139527110|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527111|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139527112|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139527113|NCT01953692|Growth Substances|growth substances|mesh-ancestor
139527114|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
139527115|NCT01791153|Prednisone|prednisone|mesh-list
139527116|NCT01791153|Methotrexate|methotrexate|mesh-list
139527117|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139527118|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
139527119|NCT01791153|Hormones|hormones|mesh-ancestor
139527120|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139527121|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527122|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139527123|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149831|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
139527124|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139527125|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
139527126|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139527127|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139527128|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
139527129|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527130|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
139527131|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527132|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139527133|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139527134|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
139527135|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527136|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139527137|NCT01926782|Alirocumab|alirocumab|mesh-list
139527138|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139527139|NCT01926782|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139527140|NCT01926782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139527141|NCT01926782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139527142|NCT01926782|Antimetabolites|antimetabolites|mesh-ancestor
139527143|NCT01926782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527144|NCT01926782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139527145|NCT01926782|Protease Inhibitors|protease inhibitors|mesh-ancestor
139527146|NCT01926782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527147|NCT01926782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139527148|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
139527149|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527150|NCT01926626|Moclobemide|moclobemide|mesh-list
139527151|NCT01926626|Nicotine|nicotine|mesh-list
139527152|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139527153|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
139527154|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527155|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527156|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139527157|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139527158|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
139527159|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527160|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527161|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
139527162|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139527163|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139527164|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527165|NCT01900730|Valproic Acid|valproic acid|mesh-list
139527166|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
139527167|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149850|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527168|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527169|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
139527170|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527171|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527172|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
139527173|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139527174|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139527175|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139527176|NCT01952834|Vancomycin|vancomycin|mesh-list
139527177|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139527178|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527179|NCT01952054|Denosumab|denosumab|mesh-list
139527180|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139527181|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527182|NCT01925768|Apremilast|apremilast|mesh-list
139527183|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139527184|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139527185|NCT01925768|Analgesics|analgesics|mesh-ancestor
139527186|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
139527187|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527188|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527189|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139527190|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527191|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139527192|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139527193|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527194|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527195|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
139527196|NCT01431274|Olodaterol|olodaterol|mesh-list
139527197|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139527198|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
139527199|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527200|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527201|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139527202|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
139527203|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
139527204|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139527205|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
139527206|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527207|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527208|NCT01991795|Ticagrelor|ticagrelor|mesh-list
139308833|NCT05473858|Phentolamine|phentolamine|mesh-list
139527209|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139527210|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139527211|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139527213|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
139527214|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527215|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527216|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527217|NCT02076100|Ruzasvir|ruzasvir|mesh-list
139527218|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
139527219|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527220|NCT01411774|Cycloserine|cycloserine|mesh-list
139527221|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139527222|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527223|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139527224|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
139527225|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139527226|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
139527227|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527228|NCT01410604|Metformin|metformin|mesh-list
139527229|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139527230|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527231|NCT01410448|Cyclosporine|cyclosporine|mesh-list
139527232|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
139527233|NCT01410448|Everolimus|everolimus|mesh-list
139527234|NCT01410448|Cyclosporins|cyclosporins|mesh-list
139527235|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527236|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527237|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139527238|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
139527239|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149972|NCT02185768|Idarubicin|idarubicin|mesh-list
139527240|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
139527241|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527242|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
139527243|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527244|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139527245|NCT01410448|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139527246|NCT01410448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139527247|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527248|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139527249|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139527250|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
139527251|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139527252|NCT01430104|Teriparatide|teriparatide|mesh-list
139527253|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139527254|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527255|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139527256|NCT01990859|Ipilimumab|ipilimumab|mesh-list
139527257|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527258|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527259|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139527260|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527261|NCT02093897|Factor VIII|factor viii|mesh-list
139527262|NCT02093897|Coagulants|coagulants|mesh-ancestor
139527263|NCT01976845|Midazolam|midazolam|mesh-list
139527264|NCT01976845|Propofol|propofol|mesh-list
139527265|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139527266|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139527267|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527268|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139527269|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
139527270|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
139527271|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139527272|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139527273|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139527274|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139527275|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
139527276|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
139527277|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527278|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527279|NCT01989689|Etanercept|etanercept|mesh-list
139527280|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139527281|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139527282|NCT01989689|Analgesics|analgesics|mesh-ancestor
139527283|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
139527284|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527285|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527286|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139527287|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527288|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139527289|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139527290|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
139527291|NCT01942993|Vemurafenib|vemurafenib|mesh-list
139527292|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527293|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139527294|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527295|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527296|NCT01989455|Deferiprone|deferiprone|mesh-list
139527297|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139527298|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
139527299|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
139527300|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527302|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
139527303|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139527304|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527305|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139527306|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527307|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527308|NCT01618669|Regadenoson|regadenoson|mesh-list
139527309|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139527310|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139527311|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
139527312|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
139527313|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527314|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527315|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527316|NCT01390948|Bevacizumab|bevacizumab|mesh-list
139527317|NCT01390948|Temozolomide|temozolomide|mesh-list
139527318|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527319|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527320|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139527321|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139527322|NCT01390948|Growth Substances|growth substances|mesh-ancestor
139527323|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527324|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
139527325|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139527326|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
139527327|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527328|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
139527329|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139527330|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
139527331|NCT01429792|Ribavirin|ribavirin|mesh-list
139527332|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139527333|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
139527334|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527335|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
139527336|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527337|NCT01940887|Bevacizumab|bevacizumab|mesh-list
139527338|NCT01940887|Aflibercept|aflibercept|mesh-list
139527339|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527340|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527341|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139527342|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139527343|NCT01940887|Growth Substances|growth substances|mesh-ancestor
139527344|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527345|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
139527346|NCT01925612|Prednisone|prednisone|mesh-list
139527347|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
139527348|NCT01925612|Rituximab|rituximab|mesh-list
139527349|NCT01925612|Doxorubicin|doxorubicin|mesh-list
139527350|NCT01925612|Vincristine|vincristine|mesh-list
139527351|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139527352|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139527353|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139527354|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
139527355|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527356|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527357|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139527358|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
139527359|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527360|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527361|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139527362|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527363|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139527364|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139527365|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139527366|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527367|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139527368|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
139527370|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150234|NCT02187250|Incretins|incretins|mesh-ancestor
139527371|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139527372|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139527373|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
139527374|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
139527375|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
139527376|NCT01925612|Immunotoxins|immunotoxins|mesh-ancestor
139527377|NCT01925612|Immunoconjugates|immunoconjugates|mesh-ancestor
139527378|NCT02093663|Mesalamine|mesalamine|mesh-list
139527379|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139527380|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139527381|NCT02093663|Analgesics|analgesics|mesh-ancestor
139527382|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
139527383|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527384|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527385|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139527386|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527387|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139527388|NCT01408888|Dulaglutide|dulaglutide|mesh-list
139527389|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139527390|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527391|NCT01408888|Incretins|incretins|mesh-ancestor
139527392|NCT01408888|Hormones|hormones|mesh-ancestor
139150278|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139527393|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139527394|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139527395|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
139527396|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527397|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527398|NCT01918033|Desloratadine|desloratadine|mesh-list
139527399|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139527400|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
139527401|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527402|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527403|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527404|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139527405|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139527406|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
139527407|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
139527408|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
139527409|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139527410|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139527411|NCT01390402|Aldesleukin|aldesleukin|mesh-list
139527412|NCT01390402|Methotrexate|methotrexate|mesh-list
139527413|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
139527414|NCT01390402|Fludarabine|fludarabine|mesh-list
139527415|NCT01390402|Busulfan|busulfan|mesh-list
139527416|NCT01390402|Interleukin-2|interleukin-2|mesh-list
139527417|NCT01390402|Tacrolimus|tacrolimus|mesh-list
139527418|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
139527419|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139527420|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139527421|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
139527422|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139527423|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527424|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139527425|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
139527426|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527427|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527428|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
139527429|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527430|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139527431|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139527432|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
139527433|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527434|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139527435|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
139527436|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527437|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139527438|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
139527439|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139527440|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139527441|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139527442|NCT01390402|Analgesics|analgesics|mesh-ancestor
139527443|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
139527444|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527445|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139527446|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139527447|NCT01428076|Polidocanol|polidocanol|mesh-list
139527448|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139527449|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139527450|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139527451|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527452|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139527453|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527454|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527455|NCT02093351|Tamoxifen|tamoxifen|mesh-list
139527456|NCT02093351|Letrozole|letrozole|mesh-list
139527457|NCT02093351|Olaparib|olaparib|mesh-list
139527458|NCT02093351|Anastrozole|anastrozole|mesh-list
139527459|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527460|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139527461|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139527462|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527463|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527464|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139527465|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
139527466|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139527467|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527468|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139527469|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139527470|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139527471|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139527472|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139527473|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139527474|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139527475|NCT02078284|Protective Agents|protective agents|mesh-ancestor
139527476|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527477|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139527478|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
139527479|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527480|NCT02092961|Adalimumab|adalimumab|mesh-list
139527481|NCT02092961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139150489|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
139527482|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139527483|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527484|NCT01940497|Paclitaxel|paclitaxel|mesh-list
139527485|NCT01940497|Docetaxel|docetaxel|mesh-list
139527486|NCT01940497|Doxorubicin|doxorubicin|mesh-list
139527487|NCT01940497|Trastuzumab|trastuzumab|mesh-list
139527488|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139527489|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527490|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
139527491|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
139527492|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
139527493|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527494|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139527495|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139527496|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139527497|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527498|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527499|NCT01987505|Rituximab|rituximab|mesh-list
139527500|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527501|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527502|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
139527503|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527504|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527505|NCT01923896|Cycloserine|cycloserine|mesh-list
139527506|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139527507|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527508|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139527509|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
139527510|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139527511|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
139527512|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527513|NCT01938625|Cyclosporine|cyclosporine|mesh-list
139527514|NCT01938625|Ribavirin|ribavirin|mesh-list
139527515|NCT01938625|Simeprevir|simeprevir|mesh-list
139527516|NCT01938625|Tacrolimus|tacrolimus|mesh-list
139527517|NCT01938625|Cyclosporins|cyclosporins|mesh-list
139527518|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139527519|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
139527520|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527521|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139527522|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527523|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527524|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
139527525|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527526|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
139527527|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527528|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
139527529|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
139527530|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
139527531|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
139150592|NCT02031016|Fentanyl|fentanyl|mesh-list
139527532|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
139527533|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527534|NCT01975285|Dexamethasone|dexamethasone|mesh-list
139527535|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139527536|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
139527537|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
139527538|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527539|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527540|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139527541|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
139527542|NCT01975285|Hormones|hormones|mesh-ancestor
139527543|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139527544|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139527545|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527546|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139527547|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
139527548|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527549|NCT04624399|Atezolizumab|atezolizumab|mesh-list
139527550|NCT04624399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139527551|NCT04624399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527552|NCT04624399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527553|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527554|NCT01915849|Licogliflozin|licogliflozin|mesh-list
139527555|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139527556|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527557|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139527558|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527559|NCT01915303|Cabergoline|cabergoline|mesh-list
139527560|NCT01915303|Pasireotide|pasireotide|mesh-list
139527561|NCT01915303|Hormones|hormones|mesh-ancestor
139527562|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139527563|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527564|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139527565|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139527566|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
139527567|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
139527568|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527569|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527570|NCT01987427|Phentermine|phentermine|mesh-list
139527571|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139527572|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527573|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
139527574|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139527575|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
139527576|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
139527577|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527578|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
139527579|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527580|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527581|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139527582|NCT01937299|Travoprost|travoprost|mesh-list
139527583|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139527584|NCT01937299|Brinzolamide|brinzolamide|mesh-list
139527585|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139527586|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139527587|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139527588|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139527589|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139527590|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
139527591|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527592|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527593|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527594|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139527595|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527596|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139527597|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
139527598|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527599|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
139527600|NCT01597557|Analgesics|analgesics|mesh-ancestor
139527601|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
139527602|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527603|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527604|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
139527605|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139527606|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139527607|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
139527608|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139527609|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139527610|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527611|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139527612|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
139527613|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139527614|NCT01914757|Benralizumab|benralizumab|mesh-list
139527615|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139527616|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
139527618|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139527619|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
139527620|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527621|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527622|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527623|NCT01789281|Everolimus|everolimus|mesh-list
139527624|NCT01789281|Octreotide|octreotide|mesh-list
139527625|NCT01789281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139527626|NCT01789281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139527627|NCT01789281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527628|NCT01789281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527629|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139527630|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
139527631|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527632|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527633|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139527634|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139527635|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
139527636|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139527637|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527638|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139527639|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139527640|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527641|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527642|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527643|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139527644|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139527645|NCT01789047|Topiramate|topiramate|mesh-list
139527646|NCT01789047|Amantadine|amantadine|mesh-list
139527647|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
139527648|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139527649|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527650|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139527651|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139527652|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
139527653|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527654|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
139527655|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527656|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527657|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139527658|NCT01789047|Analgesics|analgesics|mesh-ancestor
139309282|NCT02260557|Selexipag|selexipag|mesh-list
139527659|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
139527660|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527661|NCT01617187|Olanzapine|olanzapine|mesh-list
139527662|NCT01617187|Asenapine|asenapine|mesh-list
139527663|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
139527664|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
139527665|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527666|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527667|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139527668|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139527669|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139527670|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139527671|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139527672|NCT01617187|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139527673|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139527674|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139527675|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527676|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527677|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
139527678|NCT01759407|Epinephrine|epinephrine|mesh-list
139527679|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139527680|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139527681|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
139527682|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527683|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527684|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527685|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139527686|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139527687|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
139527688|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527689|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139527690|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
139527691|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
139527692|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
139150825|NCT02203552|Minocycline|minocycline|mesh-list
139527693|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139527694|NCT01787331|Itraconazole|itraconazole|mesh-list
139527695|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
139527696|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527697|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139527698|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139527699|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527700|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527701|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139527702|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
139527703|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139527704|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527705|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139527706|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
139527707|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139527708|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139527709|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
139527710|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527711|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527712|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139527713|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
139527714|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139527715|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139527716|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139527717|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
139527718|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527719|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527720|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139527721|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139527722|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527723|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139527724|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
139527725|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527726|NCT01786707|Metformin|metformin|mesh-list
139527727|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139527728|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527729|NCT01786551|Eplerenone|eplerenone|mesh-list
139527730|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139527731|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
139527732|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139527733|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527734|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139527735|NCT01786551|Diuretics|diuretics|mesh-ancestor
139527736|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
139527737|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139527738|NCT01973569|Denosumab|denosumab|mesh-list
139527739|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139527740|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527741|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
139527742|NCT01951586|Denosumab|denosumab|mesh-list
139527743|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139527744|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527745|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139527746|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527747|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
139527748|NCT04641728|Olaparib|olaparib|mesh-list
139527749|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139150987|NCT02221414|Metformin|metformin|mesh-list
139527750|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527751|NCT04641728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139527752|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527753|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139527754|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527755|NCT01756833|Doxycycline|doxycycline|mesh-list
139527756|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139527757|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527758|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
139527759|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139527760|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139527761|NCT01785615|Atorvastatin|atorvastatin|mesh-list
139527762|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139527763|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139527764|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
139527765|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527766|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139527767|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139527768|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527769|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
139527770|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
139527771|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139527772|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139527773|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139527774|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527775|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527776|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527777|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
139527778|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139527779|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527780|NCT01783821|Budesonide|budesonide|mesh-list
139527781|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
139527782|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139527783|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139527784|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
139527785|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527786|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527787|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139527788|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
139527789|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
139527790|NCT01783821|Hormones|hormones|mesh-ancestor
139527791|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139527792|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139527793|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139527794|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139527795|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
139527796|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527797|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527798|NCT01608087|Bevacizumab|bevacizumab|mesh-list
139527799|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527800|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527801|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139527802|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139527803|NCT01608087|Growth Substances|growth substances|mesh-ancestor
139527804|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527805|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
139527806|NCT01912963|Trastuzumab|trastuzumab|mesh-list
139527807|NCT01912963|Pertuzumab|pertuzumab|mesh-list
139527808|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527809|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527810|NCT01912807|Ondansetron|ondansetron|mesh-list
139527811|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
139527812|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
139527813|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527814|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527815|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139527816|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
139527817|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
139527818|NCT01912807|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139527819|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139527820|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
139527821|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527822|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527823|NCT01782885|Acetaminophen|acetaminophen|mesh-list
139527824|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139527825|NCT01782885|Analgesics|analgesics|mesh-ancestor
139527826|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
139527827|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527828|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527829|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
139527830|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139527831|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139527832|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139527833|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139570328|NCT05604261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139527834|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527835|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527836|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527837|NCT01754493|Analgesics|analgesics|mesh-ancestor
139527838|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
139527839|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527840|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
139527841|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139527842|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
139527843|NCT01972789|Ranibizumab|ranibizumab|mesh-list
139527844|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139527845|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139527846|NCT01972789|Growth Substances|growth substances|mesh-ancestor
139527847|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527848|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
139527849|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527850|NCT01910389|Tadalafil|tadalafil|mesh-list
139527851|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
139527852|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139527853|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139527854|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527855|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527856|NCT01910389|Urological Agents|urological agents|mesh-ancestor
139527857|NCT01970995|Menthol|menthol|mesh-list
139527858|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
139527859|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
139527860|NCT01970527|Ipilimumab|ipilimumab|mesh-list
139527861|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527862|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527863|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139527864|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527865|NCT01408576|Epratuzumab|epratuzumab|mesh-list
139527866|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527867|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527868|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
139527869|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
139527870|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139527871|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139527872|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527873|NCT01427608|Olanzapine|olanzapine|mesh-list
139527874|NCT01427608|Sertraline|sertraline|mesh-list
139527875|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
139527876|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
139527877|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527878|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527879|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139527880|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139527881|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139527882|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139527883|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139527884|NCT01427608|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139527885|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139527886|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139527887|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527888|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527889|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
139527890|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
139527891|NCT01408030|Bevacizumab|bevacizumab|mesh-list
139527892|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
139527893|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
139527894|NCT01408030|Estrogens|estrogens|mesh-list
139527895|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139527896|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527897|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139527898|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139527899|NCT01408030|Growth Substances|growth substances|mesh-ancestor
139527900|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527901|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
139527902|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139527903|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139527904|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527905|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
139527906|NCT01408030|Coagulants|coagulants|mesh-ancestor
139527907|NCT01408030|Hormones|hormones|mesh-ancestor
139527908|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139527909|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139527910|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139527911|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527912|NCT01897532|Linagliptin|linagliptin|mesh-list
139527913|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139527914|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527915|NCT01897532|Incretins|incretins|mesh-ancestor
139527916|NCT01897532|Hormones|hormones|mesh-ancestor
139527917|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139527918|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139527919|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
139527920|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527921|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527922|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
139527923|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527924|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139527925|NCT04641026|Protective Agents|protective agents|mesh-ancestor
139527926|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527927|NCT01896128|Modafinil|modafinil|mesh-list
139527928|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139527929|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527930|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139527931|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139527932|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139527933|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527934|NCT01949870|Gemcitabine|gemcitabine|mesh-list
139527935|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527936|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139527937|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
139527938|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527939|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
139527940|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
139527941|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527942|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527943|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527944|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
139527945|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
139527946|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139527947|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
139527948|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527949|NCT01405924|Dexamethasone|dexamethasone|mesh-list
139527950|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
139527951|NCT01405924|Aprepitant|aprepitant|mesh-list
139309583|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527953|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
139527954|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
139527955|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527956|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527957|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139527958|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
139527959|NCT01405924|Hormones|hormones|mesh-ancestor
139527960|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139527961|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139527962|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139527963|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139527964|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139527965|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527966|NCT01426438|Aspirin|aspirin|mesh-list
139527967|NCT01426438|Niacin|niacin|mesh-list
139527968|NCT01426438|Fenofibrate|fenofibrate|mesh-list
139527969|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139527970|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139527971|NCT01426438|Analgesics|analgesics|mesh-ancestor
139527972|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
139527973|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139527974|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139527975|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139527976|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139527977|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139527978|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139527979|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527980|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139527981|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139527982|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527983|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
139527984|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139527985|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
139527986|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139527987|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
139527988|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
139527989|NCT01426438|Vitamins|vitamins|mesh-ancestor
139527990|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
139527991|NCT01782495|Ritonavir|ritonavir|mesh-list
139527992|NCT01782495|Ribavirin|ribavirin|mesh-list
139527993|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139527994|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139527995|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
139527996|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139527997|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139527998|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139527999|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139528000|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
139528001|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528002|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139528003|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139528004|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
139528005|NCT01922102|Ranibizumab|ranibizumab|mesh-list
139528006|NCT01922102|Verteporfin|verteporfin|mesh-list
139528007|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139528008|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139528009|NCT01922102|Growth Substances|growth substances|mesh-ancestor
139528010|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528011|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
139528012|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528013|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139528014|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
139528015|NCT01405768|Lidocaine|lidocaine|mesh-list
139528016|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
139528017|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
139528018|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139528019|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528020|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
139528021|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528022|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139528023|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139528024|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139528025|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139309662|NCT02137239|Prednisone|prednisone|mesh-list
139528026|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528027|NCT01913353|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139528028|NCT01913353|Antiviral Agents|antiviral agents|mesh-ancestor
139528029|NCT01913353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528030|NCT01754259|Ranolazine|ranolazine|mesh-list
139528031|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139528032|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139528033|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528034|NCT01405456|Eplerenone|eplerenone|mesh-list
139528035|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139528036|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
139528037|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528038|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528039|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139528040|NCT01405456|Diuretics|diuretics|mesh-ancestor
139528041|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
139528042|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139528043|NCT01404208|Cycloserine|cycloserine|mesh-list
139528044|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139528045|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528046|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139528047|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
139528048|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139528049|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
139528050|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528051|NCT01617668|Paclitaxel|paclitaxel|mesh-list
139528052|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139528053|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528054|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
139528055|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
139528056|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
139528057|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528058|NCT01895270|Isradipine|isradipine|mesh-list
139528059|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139528060|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139528061|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139528062|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528063|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139528064|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528065|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
139528066|NCT01424644|Vaccines|vaccines|mesh-list
139528067|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
139528068|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528069|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
139528070|NCT01403116|Testosterone|testosterone|mesh-list
139528071|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
139528072|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
139528073|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139528074|NCT01403116|Androgens|androgens|mesh-ancestor
139528075|NCT01403116|Hormones|hormones|mesh-ancestor
139528076|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528077|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528078|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139528079|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528080|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
139528081|NCT01753401|Prednisone|prednisone|mesh-list
139528082|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139528083|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139528084|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
139528085|NCT01753401|Hormones|hormones|mesh-ancestor
139528086|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528087|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528088|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139528089|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528090|NCT01894568|Insulin|insulin|mesh-list
139528091|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139528092|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
139528093|NCT01894568|Pioglitazone|pioglitazone|mesh-list
139528094|NCT01894568|Biguanides|biguanides|mesh-list
139528095|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139528096|NCT01894568|Meglitinide|meglitinide|mesh-list
139528097|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309729|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139528098|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
139528099|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139528100|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
139528101|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528102|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
139528103|NCT01920152|Protective Agents|protective agents|mesh-ancestor
139528104|NCT01752933|Guadecitabine|guadecitabine|mesh-list
139528105|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528106|NCT01752855|Adalimumab|adalimumab|mesh-list
139528107|NCT01752855|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139528108|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139528109|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139528110|NCT01402492|Naltrexone|naltrexone|mesh-list
139528111|NCT01402492|Buprenorphine|buprenorphine|mesh-list
139528112|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139528113|NCT01402492|Naloxone|naloxone|mesh-list
139528114|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139528115|NCT01402492|Narcotics|narcotics|mesh-ancestor
139528116|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139528117|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528118|NCT01402492|Analgesics|analgesics|mesh-ancestor
139528119|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
139528120|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528121|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139528122|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139528123|NCT01894256|Olaparib|olaparib|mesh-list
139528124|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139528125|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528126|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528127|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528128|NCT01780935|Ranibizumab|ranibizumab|mesh-list
139528129|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139528130|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139528131|NCT01780935|Growth Substances|growth substances|mesh-ancestor
139528132|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528133|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
139528134|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528135|NCT01422538|Mannitol|mannitol|mesh-list
139528136|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139528137|NCT01422538|Diuretics|diuretics|mesh-ancestor
139528138|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
139528139|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528140|NCT01422382|Diltiazem|diltiazem|mesh-list
139528141|NCT01422382|Pitavastatin|pitavastatin|mesh-list
139528142|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139528143|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139528144|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139528145|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570329|NCT05604261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528146|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139528147|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528148|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
139528149|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139528150|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139528151|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139528152|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
139528153|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528154|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139528155|NCT01401322|Lenalidomide|lenalidomide|mesh-list
139528156|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
139528157|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528158|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139528159|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139528160|NCT01401322|Growth Substances|growth substances|mesh-ancestor
139528161|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
139528162|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528163|NCT01401010|Doripenem|doripenem|mesh-list
139528164|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139528165|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528166|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139528167|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
139528168|NCT01890746|Cytarabine|cytarabine|mesh-list
139528169|NCT01890746|Daunorubicin|daunorubicin|mesh-list
139528170|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139528171|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
139528172|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309803|NCT01666444|Doxorubicin|doxorubicin|mesh-list
139528173|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528174|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
139528175|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528176|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139528177|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
139528178|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528179|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139528180|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139528181|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139528182|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528183|NCT01422304|Atropine|atropine|mesh-list
139528184|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
139528185|NCT01422304|Neostigmine|neostigmine|mesh-list
139528186|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139528187|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139528188|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139528189|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
139528190|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528191|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528192|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139528193|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
139528194|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
139528195|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
139528196|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139528197|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139528198|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
139528199|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528200|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528201|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139151872|NCT02230228|Vitamins|vitamins|mesh-ancestor
139528202|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528203|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139528204|NCT01387516|Nicotine|nicotine|mesh-list
139528205|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139528206|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
139528207|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528208|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528209|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139528210|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139528211|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
139528212|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528213|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528214|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139528215|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139528216|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139528217|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139528218|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528219|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139528220|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139528221|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139528222|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139528223|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
139528224|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528225|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528226|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139528227|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139528228|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
139528229|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139528230|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139528231|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
139528232|NCT01894022|Ambrisentan|ambrisentan|mesh-list
139528233|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139528234|NCT01386970|Lamivudine|lamivudine|mesh-list
139528235|NCT01386970|Zidovudine|zidovudine|mesh-list
139528236|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139528237|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139528238|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139528239|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528240|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528241|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
139528242|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528243|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139528244|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139528245|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
139528246|NCT01385566|Vaccines|vaccines|mesh-list
139528247|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
139528248|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528249|NCT05365984|Carbon Monoxide|carbon monoxide|mesh-list
139528250|NCT05365984|Antimetabolites|antimetabolites|mesh-ancestor
139528251|NCT05365984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528252|NCT05365984|Gasotransmitters|gasotransmitters|mesh-ancestor
139528253|NCT05365984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528254|NCT05365984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528255|NCT01780545|Docetaxel|docetaxel|mesh-list
139528256|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528257|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
139528258|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
139528259|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
139528260|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528261|NCT01780389|Milnacipran|milnacipran|mesh-list
139528262|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
139528263|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139528264|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139528265|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139528266|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528267|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528268|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528269|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139528270|NCT01780389|Analgesics|analgesics|mesh-ancestor
139528271|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
139528272|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528273|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
139528274|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139528275|NCT01778985|Estrogens|estrogens|mesh-list
139528276|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139528277|NCT01778985|Hormones|hormones|mesh-ancestor
139528278|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528279|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528280|NCT01865084|Tadalafil|tadalafil|mesh-list
139528281|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
139528282|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139528283|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139528284|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528285|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528286|NCT01865084|Urological Agents|urological agents|mesh-ancestor
139528287|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
139528288|NCT01385098|Vitamin D|vitamin d|mesh-list
139528289|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
139528290|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
139528291|NCT01385098|Vitamins|vitamins|mesh-list
139528292|NCT01385098|Calcium|calcium|mesh-list
139528293|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
139528294|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528295|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139528296|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139528297|NCT01398514|Escitalopram|escitalopram|mesh-list
139528298|NCT01398514|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139528299|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139528300|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139528301|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528302|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528303|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
139528304|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528305|NCT03025282|Betamethasone|betamethasone|mesh-list
139528306|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
139528307|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139152140|NCT01093937|Varenicline|varenicline|mesh-list
139528308|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139528309|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
139528310|NCT03025282|Hormones|hormones|mesh-ancestor
139528311|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528312|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528313|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139528314|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
139528315|NCT01778049|Empagliflozin|empagliflozin|mesh-list
139528316|NCT01778049|Linagliptin|linagliptin|mesh-list
139528317|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139528318|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528319|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139528320|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528321|NCT01778049|Incretins|incretins|mesh-ancestor
139528322|NCT01778049|Hormones|hormones|mesh-ancestor
139309953|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
139528323|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528324|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139528325|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
139528326|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528327|NCT01777581|Milnacipran|milnacipran|mesh-list
139528328|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
139528329|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139528330|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139528331|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139528332|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528333|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528334|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528335|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139528336|NCT01777581|Analgesics|analgesics|mesh-ancestor
139528337|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
139528338|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528339|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
139528340|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139528341|NCT01864148|Interferons|interferons|mesh-list
139528342|NCT01864148|Interferon-beta|interferon-beta|mesh-list
139528343|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
139528344|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528345|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
139528346|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528347|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
139528348|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528349|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139528350|NCT01890122|Metformin|metformin|mesh-list
139528351|NCT01890122|Alogliptin|alogliptin|mesh-list
139528352|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139528353|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528354|NCT01890122|Incretins|incretins|mesh-ancestor
139528355|NCT01890122|Hormones|hormones|mesh-ancestor
139528356|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528357|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139528358|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
139528359|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528360|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528361|NCT01397890|Budesonide|budesonide|mesh-list
139528362|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
139528363|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
139528364|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139528365|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139528366|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139528367|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
139528368|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528369|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528370|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139528371|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
139528372|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
139528373|NCT01397890|Hormones|hormones|mesh-ancestor
139528374|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528375|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139528376|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139528377|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139528378|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
139528379|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528380|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528381|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
139528382|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139528383|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
139528384|NCT01777269|Tamsulosin|tamsulosin|mesh-list
139528385|NCT01777269|Dutasteride|dutasteride|mesh-list
139528386|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139528387|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139528388|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139528389|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
139528390|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528391|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528392|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528393|NCT01777269|Urological Agents|urological agents|mesh-ancestor
139528394|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139528395|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139528396|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528397|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
139528398|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528399|NCT01777191|Ixekizumab|ixekizumab|mesh-list
139528400|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
139528401|NCT01896050|Tamoxifen|tamoxifen|mesh-list
139528402|NCT01896050|Letrozole|letrozole|mesh-list
139528403|NCT01896050|Anastrozole|anastrozole|mesh-list
139528404|NCT01896050|Exemestane|exemestane|mesh-list
139528405|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528406|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139528407|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139528408|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528409|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528410|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139528411|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
139528412|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528413|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528414|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139528415|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139528416|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139528417|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139528418|NCT01775787|Menthol|menthol|mesh-list
139528419|NCT01775787|Nicotine|nicotine|mesh-list
139528420|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139528421|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
139528422|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528423|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528424|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139528425|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139528426|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
139528427|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528428|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528429|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
139528430|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
139528431|NCT01775475|Prednisone|prednisone|mesh-list
139528432|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
139528433|NCT01775475|Lomustine|lomustine|mesh-list
139528434|NCT01775475|Doxorubicin|doxorubicin|mesh-list
139528435|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139528436|NCT01775475|Etoposide|etoposide|mesh-list
139528437|NCT01775475|Vincristine|vincristine|mesh-list
139528438|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
139528439|NCT01775475|Procarbazine|procarbazine|mesh-list
139528440|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139528441|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
139152305|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
139528442|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528443|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139528444|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139528445|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
139528446|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528447|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528448|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139528449|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139528450|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139528451|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139528452|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528453|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139528454|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
139528455|NCT01775475|Hormones|hormones|mesh-ancestor
139528456|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528457|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139528458|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139528459|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
139528460|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
139528461|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
139528462|NCT01774929|Fentanyl|fentanyl|mesh-list
139528463|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139528464|NCT01774929|Narcotics|narcotics|mesh-ancestor
139528465|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139528466|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528467|NCT01774929|Analgesics|analgesics|mesh-ancestor
139528468|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
139528469|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528470|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139528471|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139528472|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
139528473|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
139528474|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
139528475|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139528476|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139528477|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528478|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139528479|NCT01774305|Analgesics|analgesics|mesh-ancestor
139528480|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
139528481|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528482|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139528483|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139528484|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139528485|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
139528486|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528487|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528488|NCT01397422|Amantadine|amantadine|mesh-list
139528489|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139152397|NCT01095575|Narcotics|narcotics|mesh-ancestor
139528490|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139528491|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
139528492|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528493|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
139528494|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528495|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528496|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528497|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139528498|NCT01397422|Analgesics|analgesics|mesh-ancestor
139528499|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
139528500|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528501|NCT01736475|Factor VIII|factor viii|mesh-list
139528502|NCT01736475|BAX 855|bax 855|mesh-list
139528503|NCT01736475|Coagulants|coagulants|mesh-ancestor
139528504|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139528505|NCT01863680|Hormones|hormones|mesh-list
139528506|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139528507|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528508|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528509|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139528510|NCT01747629|Albuterol|albuterol|mesh-list
139528511|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139528512|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
139152477|NCT00064337|Melphalan|melphalan|mesh-list
139528513|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528514|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528515|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139528516|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
139528517|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
139528518|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139528519|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139528520|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139528521|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139528522|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
139528523|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528524|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528525|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139528526|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
139528527|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139528528|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139528529|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139528530|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139528531|NCT01886690|Laxatives|laxatives|mesh-ancestor
139528532|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139528533|NCT01885208|Exenatide|exenatide|mesh-list
139528534|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139528535|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528536|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139528537|NCT01885208|Incretins|incretins|mesh-ancestor
139528538|NCT01885208|Hormones|hormones|mesh-ancestor
139528539|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528540|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
139528541|NCT01859702|Dexamethasone|dexamethasone|mesh-list
139528542|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139528543|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139528544|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
139528545|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
139528546|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528547|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528548|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139528549|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
139528550|NCT01859702|Hormones|hormones|mesh-ancestor
139528551|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528552|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139528553|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528554|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139528555|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139528556|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528557|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139528558|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139528559|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528560|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528561|NCT01747551|Leucovorin|leucovorin|mesh-list
139528562|NCT01747551|Fluorouracil|fluorouracil|mesh-list
139528563|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
139528564|NCT01747551|Aflibercept|aflibercept|mesh-list
139528565|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
139528566|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528567|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139528568|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528569|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139528570|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
139528571|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528572|NCT01747551|Antidotes|antidotes|mesh-ancestor
139528573|NCT01747551|Protective Agents|protective agents|mesh-ancestor
139528574|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
139528575|NCT01747551|Vitamins|vitamins|mesh-ancestor
139528576|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
139528577|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139528578|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139528579|NCT01747551|Growth Substances|growth substances|mesh-ancestor
139528580|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
139528581|NCT01859390|Antioxidants|antioxidants|mesh-list
139528582|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528583|NCT01859390|Protective Agents|protective agents|mesh-ancestor
139528584|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528585|NCT01858766|Ribavirin|ribavirin|mesh-list
139528586|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
139528587|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528588|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
139528589|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528590|NCT01745367|Paclitaxel|paclitaxel|mesh-list
139528591|NCT01745367|Tivozanib|tivozanib|mesh-list
139528592|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139528593|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528594|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
139528595|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
139528596|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
139528597|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528598|NCT01745367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139528599|NCT01745367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528600|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
139528601|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139528602|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139528603|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139528604|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528605|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
139528606|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528607|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528608|NCT01383928|Dexamethasone|dexamethasone|mesh-list
139528609|NCT01383928|Lenalidomide|lenalidomide|mesh-list
139528610|NCT01383928|Ixazomib|ixazomib|mesh-list
139528611|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139528612|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
139528613|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
139528614|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528615|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528616|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139528617|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
139528618|NCT01383928|Hormones|hormones|mesh-ancestor
139528619|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528620|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139528621|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528622|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
139528623|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139528624|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139528625|NCT01383928|Growth Substances|growth substances|mesh-ancestor
139528626|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
139528627|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
139528628|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528629|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528630|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139528631|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528632|NCT05892705|Dexmedetomidine|dexmedetomidine|mesh-list
139528633|NCT05892705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139528634|NCT05892705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139528635|NCT05892705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528636|NCT05892705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139528637|NCT05892705|Analgesics|analgesics|mesh-ancestor
139528638|NCT05892705|Sensory System Agents|sensory system agents|mesh-ancestor
139528639|NCT05892705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528640|NCT05892705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139528641|NCT05892705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139528642|NCT05892705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139528643|NCT05892705|Adrenergic Agents|adrenergic agents|mesh-ancestor
139528644|NCT05892705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528645|NCT05892705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528646|NCT05892471|Propofol|propofol|mesh-list
139528647|NCT05892471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139528648|NCT05892471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139528649|NCT05892471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528650|NCT05892471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139528651|NCT05892471|Anesthetics, General|anesthetics, general|mesh-ancestor
139528652|NCT05892471|Anesthetics|anesthetics|mesh-ancestor
139528653|NCT05892068|Tucatinib|tucatinib|mesh-list
139528654|NCT05892068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528655|NCT05892068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139528656|NCT05892068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528657|NCT05892068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528658|NCT05892042|Rivaroxaban|rivaroxaban|mesh-list
139528659|NCT05892042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139528660|NCT05892042|Antithrombins|antithrombins|mesh-ancestor
139528661|NCT05892042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139528662|NCT05892042|Protease Inhibitors|protease inhibitors|mesh-ancestor
139528663|NCT05892042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528664|NCT05892042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528665|NCT05892042|Anticoagulants|anticoagulants|mesh-ancestor
139528666|NCT05891561|Pertuzumab|pertuzumab|mesh-list
139528667|NCT05891561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139528668|NCT05891561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528669|NCT05889949|Sorafenib|sorafenib|mesh-list
139528670|NCT05889949|Lenvatinib|lenvatinib|mesh-list
139528671|NCT05889949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528672|NCT05889949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139528673|NCT05889949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528674|NCT05889949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528675|NCT05887804|Triamcinolone|triamcinolone|mesh-list
139528676|NCT05887804|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139528677|NCT05887804|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139528678|NCT05887804|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139528679|NCT05887804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139528680|NCT05887804|Glucocorticoids|glucocorticoids|mesh-ancestor
139528681|NCT05887804|Hormones|hormones|mesh-ancestor
139528682|NCT05887804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528683|NCT05887804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528684|NCT05887804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139528685|NCT05887804|Immunologic Factors|immunologic factors|mesh-ancestor
139528686|NCT05887804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528687|NCT05887804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528688|NCT05808725|Amlodipine|amlodipine|mesh-list
139528689|NCT05808725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139528690|NCT05808725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139528691|NCT05808725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139528692|NCT05808725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139528693|NCT05808725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528694|NCT05808725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139528695|NCT05808725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528696|NCT05808725|Vasodilator Agents|vasodilator agents|mesh-ancestor
139528697|NCT05792540|Dapagliflozin|dapagliflozin|mesh-list
139528698|NCT05792540|Fluoxetine|fluoxetine|mesh-list
139528699|NCT05792540|Atorvastatin|atorvastatin|mesh-list
139528700|NCT05792540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139528701|NCT05792540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139528702|NCT05792540|Antimetabolites|antimetabolites|mesh-ancestor
139528703|NCT05792540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528704|NCT05792540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139528705|NCT05792540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139528706|NCT05792540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528707|NCT05792540|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139528708|NCT05792540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139528709|NCT05792540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528710|NCT05792540|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139528711|NCT05792540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139528712|NCT05792540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139528713|NCT05792540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528714|NCT05792540|Serotonin Agents|serotonin agents|mesh-ancestor
139528715|NCT05792540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139528716|NCT05792540|Antidepressive Agents|antidepressive agents|mesh-ancestor
139528717|NCT05792540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139528718|NCT05792540|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139528719|NCT05792540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139528720|NCT05780307|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139528721|NCT05780307|Immunologic Factors|immunologic factors|mesh-ancestor
139528722|NCT05780307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528723|NCT05700214|Lidocaine|lidocaine|mesh-list
139528724|NCT05700214|Ropivacaine|ropivacaine|mesh-list
139528725|NCT05700214|Anesthetics, Local|anesthetics, local|mesh-ancestor
139528726|NCT05700214|Anesthetics|anesthetics|mesh-ancestor
139152732|NCT01416064|Molindone|molindone|mesh-list
139528727|NCT05700214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139528728|NCT05700214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528729|NCT05700214|Sensory System Agents|sensory system agents|mesh-ancestor
139528730|NCT05700214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528731|NCT05700214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139528732|NCT05700214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139528733|NCT05700214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139528734|NCT05700214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139528735|NCT05700214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528736|NCT05600686|Prednisone|prednisone|mesh-list
139528737|NCT05600686|Cortisone|cortisone|mesh-list
139528738|NCT05600686|Cyclophosphamide|cyclophosphamide|mesh-list
139528739|NCT05600686|Rituximab|rituximab|mesh-list
139528740|NCT05600686|Doxorubicin|doxorubicin|mesh-list
139528741|NCT05600686|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139528742|NCT05600686|Etoposide|etoposide|mesh-list
139528743|NCT05600686|Vincristine|vincristine|mesh-list
139528744|NCT05600686|Etoposide phosphate|etoposide phosphate|mesh-list
139528745|NCT05600686|Daunorubicin|daunorubicin|mesh-list
139528746|NCT05600686|Podophyllotoxin|podophyllotoxin|mesh-list
139528747|NCT05600686|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139528748|NCT05600686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139528749|NCT05600686|Antibodies|antibodies|mesh-list
139528750|NCT05600686|Immunoglobulins|immunoglobulins|mesh-list
139528751|NCT05600686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139528752|NCT05600686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139528753|NCT05600686|Immunologic Factors|immunologic factors|mesh-ancestor
139528754|NCT05600686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528755|NCT05600686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139528756|NCT05600686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139528757|NCT05600686|Alkylating Agents|alkylating agents|mesh-ancestor
139528758|NCT05600686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528759|NCT05600686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528760|NCT05600686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139528761|NCT05600686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139528762|NCT05600686|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139528763|NCT05600686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139528764|NCT05600686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528765|NCT05600686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139528766|NCT05600686|Glucocorticoids|glucocorticoids|mesh-ancestor
139528767|NCT05600686|Hormones|hormones|mesh-ancestor
139528768|NCT05600686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528769|NCT05600686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139528770|NCT05600686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139528771|NCT05600686|Tubulin Modulators|tubulin modulators|mesh-ancestor
139528772|NCT05600686|Antimitotic Agents|antimitotic agents|mesh-ancestor
139528773|NCT05600686|Mitosis Modulators|mitosis modulators|mesh-ancestor
139528774|NCT05600686|Keratolytic Agents|keratolytic agents|mesh-ancestor
139528775|NCT05600686|Dermatologic Agents|dermatologic agents|mesh-ancestor
139528776|NCT05564338|Tislelizumab|tislelizumab|mesh-list
139528777|NCT05564338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139528778|NCT05564338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528779|NCT05536284|Bisoprolol|bisoprolol|mesh-list
139528780|NCT05536284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139528781|NCT05536284|Sympatholytics|sympatholytics|mesh-ancestor
139528782|NCT05536284|Autonomic Agents|autonomic agents|mesh-ancestor
139528783|NCT05536284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528784|NCT05536284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528785|NCT05536284|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139528786|NCT05536284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139528787|NCT05536284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139528788|NCT05536284|Adrenergic Agents|adrenergic agents|mesh-ancestor
139528789|NCT05536284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528790|NCT05536284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528791|NCT05409391|Insulin|insulin|mesh-list
139528792|NCT05409391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139528793|NCT05409391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528794|NCT05367063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139528795|NCT05367063|Canagliflozin|canagliflozin|mesh-list
139528796|NCT05367063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139528797|NCT05367063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528798|NCT05367063|Incretins|incretins|mesh-ancestor
139528799|NCT05367063|Hormones|hormones|mesh-ancestor
139528800|NCT05367063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528801|NCT05367063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139528802|NCT05367063|Protease Inhibitors|protease inhibitors|mesh-ancestor
139528803|NCT05367063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528804|NCT05367063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528805|NCT05367063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139528806|NCT05358548|Paclitaxel|paclitaxel|mesh-list
139528807|NCT05358548|Carboplatin|carboplatin|mesh-list
139528808|NCT05358548|Pembrolizumab|pembrolizumab|mesh-list
139528809|NCT05358548|Fluorouracil|fluorouracil|mesh-list
139528810|NCT05358548|Pemetrexed|pemetrexed|mesh-list
139528811|NCT05358548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139528812|NCT05358548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528813|NCT05358548|Tubulin Modulators|tubulin modulators|mesh-ancestor
139528814|NCT05358548|Antimitotic Agents|antimitotic agents|mesh-ancestor
139528815|NCT05358548|Mitosis Modulators|mitosis modulators|mesh-ancestor
139528816|NCT05358548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528817|NCT05358548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139528818|NCT05358548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139528819|NCT05358548|Antimetabolites|antimetabolites|mesh-ancestor
139528820|NCT05358548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139528821|NCT05358548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139528822|NCT05358548|Immunologic Factors|immunologic factors|mesh-ancestor
139528823|NCT05358548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528824|NCT05358548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528825|NCT05358548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139528826|NCT05358548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139528827|NCT05274477|4-Aminopyridine|4-aminopyridine|mesh-list
139528828|NCT05274477|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139528829|NCT05274477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139528830|NCT05274477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528831|NCT05262556|Nivolumab|nivolumab|mesh-list
139528832|NCT05262556|Ipilimumab|ipilimumab|mesh-list
139528833|NCT05262556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139528834|NCT05262556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528835|NCT05262556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139528836|NCT05262556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528837|NCT05244070|Cyclophosphamide|cyclophosphamide|mesh-list
139528838|NCT05244070|Fludarabine|fludarabine|mesh-list
139528839|NCT05244070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139528840|NCT05244070|Immunologic Factors|immunologic factors|mesh-ancestor
139528841|NCT05244070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528842|NCT05244070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139528843|NCT05244070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139528844|NCT05244070|Alkylating Agents|alkylating agents|mesh-ancestor
139528845|NCT05244070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528846|NCT05244070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528847|NCT05244070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139528848|NCT05236777|Natalizumab|natalizumab|mesh-list
139528849|NCT05236777|Immunologic Factors|immunologic factors|mesh-ancestor
139528850|NCT05236777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528851|NCT05222607|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139528852|NCT05222607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139528853|NCT05222607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528854|NCT05222607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528855|NCT05222607|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139528856|NCT05222607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139528857|NCT05222607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528858|NCT05222607|Cholinergic Agents|cholinergic agents|mesh-ancestor
139528859|NCT05222607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528860|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
139528861|NCT05167409|Cetuximab|cetuximab|mesh-list
139528862|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139528863|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528864|NCT05167409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139528865|NCT05167409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528866|NCT05096117|ASP8062|asp8062|mesh-list
139152863|NCT02263924|Vitamin E|vitamin e|mesh-list
139528867|NCT05096117|Analgesics|analgesics|mesh-ancestor
139528868|NCT05096117|Sensory System Agents|sensory system agents|mesh-ancestor
139528869|NCT05096117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528870|NCT05096117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528871|NCT05096117|GABA Modulators|gaba modulators|mesh-ancestor
139528872|NCT05096117|GABA Agents|gaba agents|mesh-ancestor
139528873|NCT05096117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528874|NCT05096117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528875|NCT05072093|Tenofovir|tenofovir|mesh-list
139528876|NCT05072093|Emtricitabine|emtricitabine|mesh-list
139528877|NCT05072093|Cabotegravir|cabotegravir|mesh-list
139528878|NCT05072093|Doxycycline|doxycycline|mesh-list
139528879|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
139528880|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528881|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139528882|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139528883|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528884|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528885|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139528886|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139528887|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139528888|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
139528889|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139528890|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139528891|NCT05072093|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139528892|NCT05072093|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139528893|NCT05047718|Vaccines|vaccines|mesh-list
139528894|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
139528895|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528896|NCT05027633|Carboplatin|carboplatin|mesh-list
139528897|NCT05027633|Docetaxel|docetaxel|mesh-list
139528898|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
139528899|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528900|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
139528901|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
139528902|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
139528903|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528904|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139528905|NCT05027633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139528906|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139528907|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139528908|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528909|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139528910|NCT04851613|Fulvestrant|fulvestrant|mesh-list
139528911|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139528912|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528913|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139152949|NCT02264236|Vaccines|vaccines|mesh-list
139528914|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139528915|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
139528916|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528917|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528918|NCT04628026|Venetoclax|venetoclax|mesh-list
139310547|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139528919|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528920|NCT04605861|Liraglutide|liraglutide|mesh-list
139528921|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139528922|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528923|NCT04605861|Incretins|incretins|mesh-ancestor
139528924|NCT04605861|Hormones|hormones|mesh-ancestor
139528925|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528926|NCT04564443|Calcium|calcium|mesh-list
139528927|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139528928|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528929|NCT04530630|Emtricitabine|emtricitabine|mesh-list
139528930|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
139528931|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528932|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139528933|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139528934|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528935|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528936|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139528937|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139528938|NCT04469764|Letrozole|letrozole|mesh-list
139528939|NCT04469764|Anastrozole|anastrozole|mesh-list
139528940|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139528941|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139528942|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139528943|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528944|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528945|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139528946|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
139528947|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139528948|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528949|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139528950|NCT04416737|Insulin|insulin|mesh-list
139528951|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139528952|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528953|NCT04364607|Neostigmine|neostigmine|mesh-list
139153064|NCT02268370|Dasatinib|dasatinib|mesh-list
139528954|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139528955|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528956|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528957|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
139528958|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528959|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528960|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139528961|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
139528962|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139528963|NCT04348383|Defibrotide|defibrotide|mesh-list
139528964|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139528965|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139528966|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528967|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139528968|NCT04263792|Trimethoprim|trimethoprim|mesh-list
139528969|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139528970|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139528971|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
139528972|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139528973|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139528974|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139528975|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528976|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528977|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139528978|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139528979|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139528980|NCT04230564|Azacitidine|azacitidine|mesh-list
139528981|NCT04230564|Venetoclax|venetoclax|mesh-list
139528982|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139528983|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
139528984|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139528985|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153118|NCT03953729|Ibuprofen|ibuprofen|mesh-list
139528986|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139528987|NCT04085172|Guanfacine|guanfacine|mesh-list
139528988|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139528989|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139528990|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139528991|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139528992|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310624|NCT03524274|Antibodies|antibodies|mesh-list
139528993|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
139528994|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139528995|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139528996|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139528997|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139528998|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139528999|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139529000|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
139529001|NCT04081545|Analgesics|analgesics|mesh-list
139529002|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
139529003|NCT04081545|Anesthetics|anesthetics|mesh-list
139529004|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529005|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529006|NCT04081545|Narcotics|narcotics|mesh-ancestor
139529007|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
139529008|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529009|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139529010|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139529011|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139529012|NCT04064697|Valganciclovir|valganciclovir|mesh-list
139529013|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
139529014|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529015|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139529016|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
139529017|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529018|NCT03896230|Ketamine|ketamine|mesh-list
139529019|NCT03896230|Analgesics|analgesics|mesh-ancestor
139529020|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
139529021|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529022|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529023|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139529024|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139529025|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
139529026|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
139529027|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529028|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139529029|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139529030|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529031|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529032|NCT03878316|Oxytocin|oxytocin|mesh-list
139529033|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
139529034|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139529035|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529036|NCT03854929|Azithromycin|azithromycin|mesh-list
139529037|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
139529038|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139529039|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529040|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139529041|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139529042|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529043|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529044|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529045|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139529046|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139529047|NCT03852628|Naltrexone|naltrexone|mesh-list
139529048|NCT03852628|Buprenorphine|buprenorphine|mesh-list
139529049|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139529050|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139529051|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529052|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
139529053|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529054|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139529055|NCT03852628|Narcotics|narcotics|mesh-ancestor
139529056|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529057|NCT03852628|Analgesics|analgesics|mesh-ancestor
139529058|NCT03826524|Epinephrine|epinephrine|mesh-list
139529059|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139529060|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139529061|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
139529062|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529063|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529064|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529065|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139529066|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139529067|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
139529068|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529070|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
139529071|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
139529072|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
139529073|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139529074|NCT03741426|Durvalumab|durvalumab|mesh-list
139529075|NCT03741426|Olaparib|olaparib|mesh-list
139529076|NCT03741426|Cediranib|cediranib|mesh-list
139529077|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139529078|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529079|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139529080|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529081|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529082|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139529083|NCT03623633|Denosumab|denosumab|mesh-list
139529084|NCT03623633|Alendronate|alendronate|mesh-list
139529085|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139529086|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139529087|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529088|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139529089|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
139529090|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139529091|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139529092|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139529093|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139529094|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139529095|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139529096|NCT03554174|Psilocybin|psilocybin|mesh-list
139529097|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
139529098|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529099|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139529100|NCT03508440|Prednisone|prednisone|mesh-list
139529101|NCT03508440|Prednisolone|prednisolone|mesh-list
139529102|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139529103|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
139529104|NCT03508440|Hormones|hormones|mesh-ancestor
139529105|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139529106|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529107|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139529108|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529109|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139153358|NCT02269540|Citalopram|citalopram|mesh-list
139529110|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139529111|NCT03422861|Nabilone|nabilone|mesh-list
139529112|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
139529113|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
139529114|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529115|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529116|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139529117|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139529118|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139529119|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529120|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139529121|NCT03421496|Cannabidiol|cannabidiol|mesh-list
139529122|NCT03421496|Vigabatrin|vigabatrin|mesh-list
139529123|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
139529124|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529125|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529126|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
139529127|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529128|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153417|NCT02261662|Ribavirin|ribavirin|mesh-list
139529129|NCT03278106|Trifluridine|trifluridine|mesh-list
139529130|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
139529131|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529132|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
139529133|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529134|NCT03255252|Cisplatin|cisplatin|mesh-list
139529135|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529136|NCT03192215|Aspirin|aspirin|mesh-list
139529137|NCT03192215|Apixaban|apixaban|mesh-list
139529138|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139529139|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139529140|NCT03192215|Analgesics|analgesics|mesh-ancestor
139529141|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
139310783|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
139529142|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529143|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529144|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139529145|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139529146|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139529147|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139529148|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529149|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139529150|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139529151|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529153|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139529154|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
139529155|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139529156|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
139529157|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
139529158|NCT03052608|Crizotinib|crizotinib|mesh-list
139529159|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529160|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139529161|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529162|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529163|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139529164|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139529165|NCT02865018|Cetirizine|cetirizine|mesh-list
139529166|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139529167|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139529168|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139153465|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
139529169|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
139529170|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
139529171|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529172|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529173|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529174|NCT02795143|Isotretinoin|isotretinoin|mesh-list
139529175|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
139529176|NCT02790736|Propranolol|propranolol|mesh-list
139529177|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139529178|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139529179|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
139529180|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529181|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529182|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529183|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139529184|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139529185|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
139529186|NCT02704208|Nicotine|nicotine|mesh-list
139529187|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139529188|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
139529189|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529190|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529191|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139529192|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139529193|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
139529194|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529195|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529196|NCT02516670|Vitamins|vitamins|mesh-list
139529197|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
139529198|NCT02516670|Docetaxel|docetaxel|mesh-list
139529199|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
139529200|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529201|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529202|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
139529203|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
139529204|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
139529205|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529206|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
139529207|NCT02516670|Protective Agents|protective agents|mesh-ancestor
139529208|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139529209|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139529210|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139529211|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529212|NCT02280525|Cytarabine|cytarabine|mesh-list
139529213|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
139529214|NCT02280525|Rituximab|rituximab|mesh-list
139529215|NCT02280525|Fludarabine|fludarabine|mesh-list
139529216|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
139529217|NCT02280525|Lenalidomide|lenalidomide|mesh-list
139529218|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139529219|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
139529220|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529221|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139529222|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139529223|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
139529224|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529225|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529226|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139529227|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139529228|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139529229|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
139529230|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
139529231|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529232|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139529233|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139529234|NCT02280525|Growth Substances|growth substances|mesh-ancestor
139529235|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
139529237|NCT02157883|Osimertinib|osimertinib|mesh-list
139529238|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
139529239|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529240|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139529241|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139529242|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529243|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529244|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139529245|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
139529246|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139529247|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529248|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139529249|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529250|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139529251|NCT02091141|Trastuzumab|trastuzumab|mesh-list
139529252|NCT02091141|Atezolizumab|atezolizumab|mesh-list
139529253|NCT02091141|Pertuzumab|pertuzumab|mesh-list
139529254|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139529255|NCT02091141|Vemurafenib|vemurafenib|mesh-list
139529256|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139529257|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529258|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139529259|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529260|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529261|NCT02091141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139529262|NCT02066181|Sorafenib|sorafenib|mesh-list
139529263|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529264|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139529265|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529266|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529267|NCT01970865|Crizotinib|crizotinib|mesh-list
139529268|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529269|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139529270|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529271|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529272|NCT01928576|Nivolumab|nivolumab|mesh-list
139529273|NCT01928576|Azacitidine|azacitidine|mesh-list
139529274|NCT01928576|Entinostat|entinostat|mesh-list
139529275|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139529276|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529277|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139529278|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529279|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139529280|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
139529281|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529282|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139529283|NCT01869114|Sirolimus|sirolimus|mesh-list
139529284|NCT01869114|Azacitidine|azacitidine|mesh-list
139529285|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139529286|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
139529287|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529288|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153641|NCT00906334|Glycine|glycine|mesh-list
139529289|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529290|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139529291|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529292|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139529293|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
139529294|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139529295|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
139529296|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529297|NCT01843751|Buprenorphine|buprenorphine|mesh-list
139529298|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139529299|NCT01843751|Naloxone|naloxone|mesh-list
139529300|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139529301|NCT01843751|Narcotics|narcotics|mesh-ancestor
139529302|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529303|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529304|NCT01843751|Analgesics|analgesics|mesh-ancestor
139529305|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
139529306|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529307|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139529308|NCT01756248|Aflibercept|aflibercept|mesh-list
139529309|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139529310|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139529311|NCT01756248|Growth Substances|growth substances|mesh-ancestor
139529312|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529313|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
139529314|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529315|NCT01744652|Dasatinib|dasatinib|mesh-list
139529316|NCT01744652|Crizotinib|crizotinib|mesh-list
139529317|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529318|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139529319|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529320|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529321|NCT01711541|Paclitaxel|paclitaxel|mesh-list
139529322|NCT01711541|Cisplatin|cisplatin|mesh-list
139529323|NCT01711541|Carboplatin|carboplatin|mesh-list
139529324|NCT01711541|Fluorouracil|fluorouracil|mesh-list
139529325|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139529326|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
139529327|NCT01711541|Veliparib|veliparib|mesh-list
139529328|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139529329|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529330|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
139529331|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
139529332|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
139529333|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529334|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
139529335|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139529336|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139529337|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
139529338|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529339|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
139529340|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529341|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139529342|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139529343|NCT01370512|Droxidopa|droxidopa|mesh-list
139529344|NCT01370512|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139529345|NCT01370512|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139529346|NCT01370512|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139529347|NCT01370512|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139529348|NCT01370512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529349|NCT01370512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529350|NCT01370512|Cholinergic Agents|cholinergic agents|mesh-ancestor
139529351|NCT01370512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529352|NCT01370512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529353|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
139529354|NCT00215813|Poly I-C|poly i-c|mesh-list
139529355|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
139529356|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529357|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
139529358|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
139529359|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529360|NCT00179465|Tiagabine|tiagabine|mesh-list
139529361|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
139529362|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139529363|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529364|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529365|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139529366|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
139529367|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
139529368|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139529369|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139529370|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529372|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529373|NCT00134030|Interferons|interferons|mesh-list
139529374|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
139529375|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
139529376|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139529377|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139529378|NCT00134030|Cisplatin|cisplatin|mesh-list
139529379|NCT00134030|Doxorubicin|doxorubicin|mesh-list
139529380|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139529381|NCT00134030|Methotrexate|methotrexate|mesh-list
139529382|NCT00134030|Etoposide|etoposide|mesh-list
139529383|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
139529384|NCT00134030|Ifosfamide|ifosfamide|mesh-list
139529385|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
139529386|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
139529387|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529388|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139529389|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139529390|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139529391|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529392|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529393|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139529394|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
139529395|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139529396|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529397|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139529398|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
139529399|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
139529400|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139529401|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139529402|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
139529403|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139529404|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139529405|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139529406|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
139529407|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529408|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139529409|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
139529410|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
139153837|NCT00886600|Losartan|losartan|mesh-list
139529411|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
139529412|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
139529413|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
139529414|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
139529415|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139529416|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139529417|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529418|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
139529419|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
139529420|NCT01381900|Metformin|metformin|mesh-list
139529421|NCT01381900|Canagliflozin|canagliflozin|mesh-list
139529422|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139529423|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529424|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139529425|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529426|NCT01744197|Lidocaine|lidocaine|mesh-list
139529427|NCT01744197|Tetracaine|tetracaine|mesh-list
139529428|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
139529429|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
139529430|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529431|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529432|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
139529433|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529434|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139529435|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139529436|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139529437|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139529438|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529439|NCT04565301|Dexamethasone|dexamethasone|mesh-list
139529440|NCT04565301|Neostigmine|neostigmine|mesh-list
139529441|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139529442|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
139529443|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
139529444|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529446|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139529447|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
139529448|NCT04565301|Hormones|hormones|mesh-ancestor
139529449|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139529450|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139153862|NCT03952481|Lifitegrast|lifitegrast|mesh-list
139529451|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529452|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139529453|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529454|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529455|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
139529456|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529457|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139529458|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139529459|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139529460|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139529461|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139529462|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139529463|NCT01743027|Analgesics|analgesics|mesh-ancestor
139529464|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
139529465|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529466|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529467|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139529468|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139529469|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139529470|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139529471|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139529472|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
139529473|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
139529474|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529475|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529476|NCT01380730|Evolocumab|evolocumab|mesh-list
139529477|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139529478|NCT01380730|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139529479|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139529480|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139529481|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
139529482|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529483|NCT01380730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139529484|NCT01380730|Protease Inhibitors|protease inhibitors|mesh-ancestor
139529485|NCT01380730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529486|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139529487|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
139529488|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529489|NCT04010968|Venetoclax|venetoclax|mesh-list
139529490|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529491|NCT01395784|Pioglitazone|pioglitazone|mesh-list
139529492|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139529493|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529494|NCT01380184|Sirolimus|sirolimus|mesh-list
139529495|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139529496|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529497|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139529498|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529499|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
139529500|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139529501|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
139529502|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529503|NCT00002826|Paclitaxel|paclitaxel|mesh-list
139529504|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139529505|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529506|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
139529507|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
139529508|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
139153943|NCT03135106|Fluconazole|fluconazole|mesh-list
139529509|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529510|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
139529511|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139529512|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529513|NCT04331938|Anesthetics|anesthetics|mesh-list
139529514|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529515|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529516|NCT01731951|Imetelstat|imetelstat|mesh-list
139529517|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
139529518|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529519|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529520|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139529521|NCT01741545|Interferons|interferons|mesh-list
139529522|NCT01741545|Ribavirin|ribavirin|mesh-list
139529523|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529524|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
139529525|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529526|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
139529527|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529528|NCT01884350|Apixaban|apixaban|mesh-list
139529529|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139529530|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
139529531|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139529532|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
139529533|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529534|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529535|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
139529536|NCT01614795|Sirolimus|sirolimus|mesh-list
139529537|NCT01614795|Temsirolimus|temsirolimus|mesh-list
139529538|NCT01614795|MTOR Inhibitors|mtor inhibitors|mesh-list
139529539|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139529540|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139529541|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529542|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139529543|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529544|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
139529545|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139529546|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
139529547|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529548|NCT01614795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139529549|NCT01614795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529550|NCT01614795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529551|NCT01834586|Anesthetics|anesthetics|mesh-list
139529552|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529553|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529554|NCT01614093|Oxytocin|oxytocin|mesh-list
139529555|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
139529556|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139529557|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529558|NCT01834274|Metformin|metformin|mesh-list
139529559|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139529560|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139529561|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529562|NCT01834274|Incretins|incretins|mesh-ancestor
139529563|NCT01834274|Hormones|hormones|mesh-ancestor
139529564|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139529565|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139529566|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
139529567|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529568|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529569|NCT01739595|Enclomiphene|enclomiphene|mesh-list
139529570|NCT01739595|Clomiphene|clomiphene|mesh-list
139529571|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
139529572|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139529573|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
139154021|NCT00934180|Autonomic Agents|autonomic agents|mesh-ancestor
139529574|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139529575|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529576|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139529577|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
139529578|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139529579|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139529580|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139529581|NCT01738971|Progestins|progestins|mesh-list
139529582|NCT01738971|Hormones|hormones|mesh-ancestor
139529583|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139529584|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529585|NCT01738503|Buprenorphine|buprenorphine|mesh-list
139529586|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139529587|NCT01738503|Narcotics|narcotics|mesh-ancestor
139529588|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529589|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529590|NCT01738503|Analgesics|analgesics|mesh-ancestor
139529591|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
139529592|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529593|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139311258|NCT05172518|Taxane|taxane|mesh-list
139529594|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139529595|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139529596|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139529597|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138924268|NCT00712335|Xhance|xhance|mesh-list
139529598|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529599|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
139529600|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529601|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529602|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
139529603|NCT01737879|Hematinics|hematinics|mesh-ancestor
139529604|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
139529605|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139529606|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139529607|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529608|NCT01726335|Risperidone|risperidone|mesh-list
139529609|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139529610|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
139529611|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529612|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529613|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529614|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139529615|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139529616|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529617|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139529618|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139529619|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
139529620|NCT01726023|Metronidazole|metronidazole|mesh-list
139529621|NCT01726023|Meropenem|meropenem|mesh-list
139529622|NCT01726023|Ceftazidime|ceftazidime|mesh-list
139529623|NCT01726023|Avibactam|avibactam|mesh-list
139529624|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
139529625|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529626|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139529627|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139529628|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139529629|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139529630|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154112|NCT05095064|Irinotecan|irinotecan|mesh-list
139529631|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529632|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
139529633|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529634|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
139529635|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139529636|NCT04609761|Antibodies|antibodies|mesh-list
139529637|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
139529638|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139529639|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
139529640|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529641|NCT01858532|Atrasentan|atrasentan|mesh-list
139529642|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529643|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139529644|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139529645|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529646|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
139529647|NCT04613960|Analgesics|analgesics|mesh-ancestor
139529648|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
139529649|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529650|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529651|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
139529652|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529653|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139529654|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
139529655|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139529656|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139529657|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529658|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139529659|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
139529660|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139529661|NCT01857206|Vaccines|vaccines|mesh-list
139529662|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
139529663|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529664|NCT01882088|Psyllium|psyllium|mesh-list
139529665|NCT01882088|Cathartics|cathartics|mesh-ancestor
139529666|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139529667|NCT01722669|Quercetin|quercetin|mesh-list
139529668|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
139311317|NCT02291094|Lidocaine|lidocaine|mesh-list
139529669|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529670|NCT01722669|Protective Agents|protective agents|mesh-ancestor
139529671|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529672|NCT01707147|Linagliptin|linagliptin|mesh-list
139529673|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139529674|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529675|NCT01707147|Incretins|incretins|mesh-ancestor
139529676|NCT01707147|Hormones|hormones|mesh-ancestor
139529677|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154136|NCT00920764|Atrasentan|atrasentan|mesh-list
139529678|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139529679|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
139529680|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529681|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529682|NCT01876251|Docetaxel|docetaxel|mesh-list
139529683|NCT01876251|Nirogacestat|nirogacestat|mesh-list
139529684|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529685|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
139529686|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
139529687|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
139529688|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529689|NCT01876251|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139529690|NCT01876251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529691|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
139529692|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139529693|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139529694|NCT01875237|Prednisolone|prednisolone|mesh-list
139529695|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
139529696|NCT01875237|Methotrexate|methotrexate|mesh-list
139529697|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
139529698|NCT01875237|Fludarabine|fludarabine|mesh-list
139529699|NCT01875237|Melphalan|melphalan|mesh-list
139529700|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
139529701|NCT01875237|Tacrolimus|tacrolimus|mesh-list
139529702|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139529703|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
139529704|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139529705|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
139529706|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139529707|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529708|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139529709|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
139529710|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529711|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529712|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
139529713|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529714|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139529715|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139529716|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
139529717|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139529718|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139529719|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139529720|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139529721|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
139529722|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
139529723|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529724|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139529725|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
139529726|NCT01875237|Hormones|hormones|mesh-ancestor
139529727|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139529728|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139529729|NCT01875237|Protective Agents|protective agents|mesh-ancestor
139529730|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139529731|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139529732|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
139529733|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139529734|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139529735|NCT01874535|Esomeprazole|esomeprazole|mesh-list
139529736|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139529737|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139529738|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139529739|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529740|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529741|NCT01722045|Aflibercept|aflibercept|mesh-list
139529742|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139529743|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139529744|NCT01722045|Growth Substances|growth substances|mesh-ancestor
139529745|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529746|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
139529747|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529748|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139529749|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139529750|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139529751|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
139154224|NCT00838630|Autonomic Agents|autonomic agents|mesh-ancestor
139529752|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529753|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
139529754|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
139529755|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139529756|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
139529757|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529758|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139529759|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139529760|NCT04415385|Apatinib|apatinib|mesh-list
139529761|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529762|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139529763|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529764|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529765|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
139529766|NCT01720797|Anesthetics|anesthetics|mesh-list
139529767|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
139529768|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529769|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529770|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139529771|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529772|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
139529773|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
139529774|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529775|NCT01831466|Tofacitinib|tofacitinib|mesh-list
139529776|NCT01831466|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139529777|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139529778|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529779|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529780|NCT01881230|Paclitaxel|paclitaxel|mesh-list
139529781|NCT01881230|Carboplatin|carboplatin|mesh-list
139529782|NCT01881230|Gemcitabine|gemcitabine|mesh-list
139529783|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139529784|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529785|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
139529786|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
139529787|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
139529788|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529789|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139529790|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
139529791|NCT01856114|Fentanyl|fentanyl|mesh-list
139529792|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139529793|NCT01856114|Narcotics|narcotics|mesh-ancestor
139529794|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529795|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529796|NCT01856114|Analgesics|analgesics|mesh-ancestor
139529797|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
139529798|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529799|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139529800|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139529801|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
139529802|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
139529803|NCT01614470|Ivacaftor|ivacaftor|mesh-list
139154262|NCT03134638|Carboplatin|carboplatin|mesh-list
139529804|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139529805|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139529806|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529807|NCT01880528|Lisinopril|lisinopril|mesh-list
139529808|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139529809|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
139529810|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529811|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529812|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139529813|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139529814|NCT01880528|Protective Agents|protective agents|mesh-ancestor
139529815|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529816|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
139529817|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
139529818|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529819|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529820|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529822|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
139529823|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
139529824|NCT01854710|Loxapine|loxapine|mesh-list
139529825|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139529826|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529827|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139529828|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139529829|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529830|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529831|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529832|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529833|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139529834|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139529835|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139529836|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139529837|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139529838|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
139529839|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529840|NCT01828034|Gemcitabine|gemcitabine|mesh-list
139529841|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529842|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139529843|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
139529844|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529845|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139529846|NCT01853696|Prednisolone|prednisolone|mesh-list
139529847|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139529848|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
139529849|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139529850|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
139529851|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139529852|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
139529853|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139529854|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
139529855|NCT01853696|Hormones|hormones|mesh-ancestor
139529856|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139529857|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529858|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139529859|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529860|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
139529861|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
139529862|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529863|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139529864|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139529865|NCT01853696|Protective Agents|protective agents|mesh-ancestor
139529866|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139529867|NCT01719861|Desipramine|desipramine|mesh-list
139529868|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139529869|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
139529870|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139529871|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529872|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529873|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139529874|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139529875|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139529876|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
139529877|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139529878|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529879|NCT01853618|Tremelimumab|tremelimumab|mesh-list
139529880|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529881|NCT01719783|Vaccines|vaccines|mesh-list
139529882|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
139529883|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529884|NCT01878890|Efavirenz|efavirenz|mesh-list
139529885|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139529886|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139529887|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529888|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529889|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
139529890|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529891|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139311520|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
139529892|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139154307|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139529893|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139529894|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139529895|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139529896|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139529897|NCT01827332|Oxytocin|oxytocin|mesh-list
139529898|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
139529899|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139529900|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529901|NCT01719003|Metformin|metformin|mesh-list
139529902|NCT01719003|Empagliflozin|empagliflozin|mesh-list
139529903|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139529904|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529905|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139529906|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529907|NCT01853228|Cytarabine|cytarabine|mesh-list
139529908|NCT01853228|Decitabine|decitabine|mesh-list
139529909|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139529910|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
139529911|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529912|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529913|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
139529914|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529915|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139529916|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
139529917|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529918|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529919|NCT01705587|Teriparatide|teriparatide|mesh-list
139529920|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139529921|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529922|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139529923|NCT01705509|Ranolazine|ranolazine|mesh-list
139529924|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139529925|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139529926|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529927|NCT01853072|Prednisolone|prednisolone|mesh-list
139529928|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139529929|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
139529930|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139529931|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
139529932|NCT01853072|Nepafenac|nepafenac|mesh-list
139529933|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139529934|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
139529935|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139529936|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
139529937|NCT01853072|Hormones|hormones|mesh-ancestor
139529938|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139529939|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946061|NCT00742092|Miglustat|miglustat|mesh-list
139529940|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139529941|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529942|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
139529943|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
139529944|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139529945|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139529946|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139529947|NCT01853072|Protective Agents|protective agents|mesh-ancestor
139529948|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139529949|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139529950|NCT01853072|Analgesics|analgesics|mesh-ancestor
139529951|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
139529952|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139529953|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
139529954|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139529955|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139529956|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
139529957|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139529958|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139529959|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139529960|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529961|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529962|NCT01827254|Sunitinib|sunitinib|mesh-list
139529963|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529964|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139529965|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139311590|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
139529966|NCT01827254|Growth Substances|growth substances|mesh-ancestor
139529967|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529968|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
139529969|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139529970|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529971|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529972|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139529973|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
139529974|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139529975|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139529976|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139529977|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529978|NCT01704651|Alvimopan|alvimopan|mesh-list
139529979|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139529980|NCT01876082|Methotrexate|methotrexate|mesh-list
139529981|NCT01876082|Vinblastine|vinblastine|mesh-list
139529982|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139529983|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
139529984|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139529985|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139529986|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139529987|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
139529988|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139529989|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139529990|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
139529991|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139529992|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139529993|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139529994|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
139529995|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139529996|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139529997|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139529998|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
139529999|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
139530000|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
139530001|NCT01716585|Ribavirin|ribavirin|mesh-list
139530002|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
139530003|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530004|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
139530005|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530006|NCT01852292|Paclitaxel|paclitaxel|mesh-list
139530007|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139530008|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530009|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
139530010|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
139530011|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
139530012|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530013|NCT01715805|Cariprazine|cariprazine|mesh-list
139530014|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
139530015|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139530016|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139530017|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139530018|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139530019|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530020|NCT01852214|Ticagrelor|ticagrelor|mesh-list
139530021|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139530022|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139530023|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139530024|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139530025|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139530026|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
139530027|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530028|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530029|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530030|NCT01393990|Tamoxifen|tamoxifen|mesh-list
139530031|NCT01393990|Midazolam|midazolam|mesh-list
139530032|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139530033|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139530034|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139530035|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530036|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139530037|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139530038|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139530039|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139530040|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
139530041|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
139530042|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
139530043|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
139530044|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530045|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530046|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139530047|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
139530048|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530049|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139530050|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530051|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139530052|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139530053|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139530055|NCT00210184|Fluorouracil|fluorouracil|mesh-list
139530056|NCT00210184|Irinotecan|irinotecan|mesh-list
139530057|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
139530058|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530059|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139530060|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530061|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139530062|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
139530063|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530064|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139530065|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139530066|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530067|NCT00210184|Antidotes|antidotes|mesh-ancestor
139530068|NCT00210184|Protective Agents|protective agents|mesh-ancestor
139530069|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
139530070|NCT00210184|Vitamins|vitamins|mesh-ancestor
139530071|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
139530072|NCT00210964|Linezolid|linezolid|mesh-list
139530073|NCT00210964|Ceftazidime|ceftazidime|mesh-list
139530074|NCT00210964|Ceftobiprole|ceftobiprole|mesh-list
139530075|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
139530076|NCT00210964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139530077|NCT00210964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530078|NCT00210964|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139530079|NCT00210964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530080|NCT00210964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530081|NCT03593434|Xenon|xenon|mesh-list
139530082|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139530083|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
139530084|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
139530085|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139530086|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530087|NCT03792958|Vorolanib|vorolanib|mesh-list
139530088|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139530089|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530090|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530091|NCT03989362|Ipilimumab|ipilimumab|mesh-list
139530092|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139530093|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530094|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139530095|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530096|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
139530097|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
139530098|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139530099|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
139530100|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139530101|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139530102|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530103|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139530104|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530105|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530106|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139530107|NCT04407130|Doxycycline|doxycycline|mesh-list
139530108|NCT04407130|Ivermectin|ivermectin|mesh-list
139530109|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139530110|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530111|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
139530112|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139530113|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139530114|NCT03599284|Clopidogrel|clopidogrel|mesh-list
139530115|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139530116|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139530117|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139530118|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139530119|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
139530120|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530121|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530122|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530123|NCT03024814|Acetaminophen|acetaminophen|mesh-list
139530124|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139530125|NCT03024814|Analgesics|analgesics|mesh-ancestor
139530126|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
139530127|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530128|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530129|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
139530130|NCT03024502|Clotrimazole|clotrimazole|mesh-list
139530131|NCT03024502|Miconazole|miconazole|mesh-list
139530132|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139530133|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530134|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
139530135|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139530136|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139530137|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530138|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530139|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139530140|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
139530141|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530142|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530143|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139530144|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139530145|NCT03024580|Tamoxifen|tamoxifen|mesh-list
139530146|NCT03024580|Letrozole|letrozole|mesh-list
139530147|NCT03024580|Fulvestrant|fulvestrant|mesh-list
139530148|NCT03024580|Anastrozole|anastrozole|mesh-list
139530149|NCT03024580|Exemestane|exemestane|mesh-list
139530150|NCT03024580|Megestrol|megestrol|mesh-list
139530151|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
139530152|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530153|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139530154|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139530155|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530156|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530157|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139530158|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
139530159|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530160|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530161|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139530162|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139530163|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139530164|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139530165|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139530166|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139530167|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139530168|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139530169|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
139530170|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139530171|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139530172|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139530173|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
139530174|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139530175|NCT01851590|Terbinafine|terbinafine|mesh-list
139530176|NCT01851590|Amorolfine|amorolfine|mesh-list
139530177|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
139530178|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530179|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530180|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530181|NCT03598816|Durvalumab|durvalumab|mesh-list
139530182|NCT03598816|Tremelimumab|tremelimumab|mesh-list
139530183|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139530184|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530185|NCT05633758|Metolazone|metolazone|mesh-list
139530186|NCT05633758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139530187|NCT05633758|Diuretics|diuretics|mesh-ancestor
139530188|NCT05633758|Natriuretic Agents|natriuretic agents|mesh-ancestor
139530189|NCT05633758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530190|NCT05633758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139530191|NCT05633758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139530192|NCT05633758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530193|NCT03598738|Esomeprazole|esomeprazole|mesh-list
139530194|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139530195|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139530196|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139530197|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530198|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530199|NCT03594214|Vitamin D|vitamin d|mesh-list
139530200|NCT03594214|Vitamins|vitamins|mesh-ancestor
139530201|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
139530202|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530203|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139530204|NCT04003948|Ibogaine|ibogaine|mesh-list
139530205|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
139530206|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530207|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139530208|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139530209|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139530210|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530211|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530212|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
139530213|NCT03598582|Hematinics|hematinics|mesh-ancestor
139530214|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
139530215|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139530216|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139530217|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139530218|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139530219|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530220|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
139530221|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530222|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530223|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139154538|NCT00829504|Ropinirole|ropinirole|mesh-list
139530224|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530225|NCT03593668|Metformin|metformin|mesh-list
139530226|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139530227|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530228|NCT03598348|Capecitabine|capecitabine|mesh-list
139530229|NCT03598348|Apatinib|apatinib|mesh-list
139530230|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139530231|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
139530232|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530233|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530234|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139530235|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530236|NCT03598192|Sufentanil|sufentanil|mesh-list
139530237|NCT03598192|Dsuvia|dsuvia|mesh-list
139530238|NCT03598192|Ropivacaine|ropivacaine|mesh-list
139530239|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
139530240|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
139530241|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139530242|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530243|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
139530244|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530245|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139530246|NCT03598192|Narcotics|narcotics|mesh-ancestor
139530247|NCT03598192|Analgesics|analgesics|mesh-ancestor
139530248|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139530249|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139530250|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
139530251|NCT04003246|Durvalumab|durvalumab|mesh-list
139530252|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139530253|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139530254|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530255|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
139530256|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530257|NCT00218296|Lobeline|lobeline|mesh-list
139530258|NCT00218296|Nicotine|nicotine|mesh-list
139530259|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139530260|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
139530261|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530262|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530263|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139311891|NCT03375398|PAZ320|paz320|mesh-list
139530264|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139530265|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
139530266|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530267|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530268|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
139530269|NCT00217672|Bevacizumab|bevacizumab|mesh-list
139530270|NCT00217672|Docetaxel|docetaxel|mesh-list
139530271|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139530272|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530273|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139530274|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139530275|NCT00217672|Growth Substances|growth substances|mesh-ancestor
139530276|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530277|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
139530278|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
139530279|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
139530280|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
139530281|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530282|NCT00216736|Dexamethasone|dexamethasone|mesh-list
139530283|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139530284|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
139530285|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
139530286|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530287|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530288|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139530289|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
139530290|NCT00216736|Hormones|hormones|mesh-ancestor
139530291|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530292|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139530293|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530294|NCT01850030|Progesterone|progesterone|mesh-list
139530295|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
139530296|NCT01850030|Progestins|progestins|mesh-ancestor
139530297|NCT01850030|Hormones|hormones|mesh-ancestor
139530298|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530299|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530300|NCT00215644|Capecitabine|capecitabine|mesh-list
139530301|NCT00215644|Epirubicin|epirubicin|mesh-list
139530302|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530303|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139530304|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
139530305|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530306|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139530307|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139530308|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139530309|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530310|NCT00213148|Anastrozole|anastrozole|mesh-list
139530311|NCT00213148|Citric Acid|citric acid|mesh-list
139530312|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
139530313|NCT00213148|Clomiphene|clomiphene|mesh-list
139530314|NCT00213148|Enclomiphene|enclomiphene|mesh-list
139530315|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
139530316|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
139530317|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139530318|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
139530319|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
139530320|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530321|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139530322|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530323|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139530324|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139530325|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530326|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139530327|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
139530328|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530329|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530330|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139530331|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
139530332|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139530333|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139530334|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139530335|NCT01704261|Metformin|metformin|mesh-list
139530336|NCT01704261|Glimepiride|glimepiride|mesh-list
139530337|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139530338|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530339|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139530340|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139311964|NCT02149407|Glycerol|glycerol|mesh-list
139530341|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
139530342|NCT00212758|Hormones|hormones|mesh-list
139530343|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530344|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530345|NCT01824290|Tadalafil|tadalafil|mesh-list
139530346|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
139530347|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139530348|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139530349|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530350|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530351|NCT01824290|Urological Agents|urological agents|mesh-ancestor
139530352|NCT03592342|Clobetasol|clobetasol|mesh-list
139530353|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139530354|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
139530355|NCT03592342|Hormones|hormones|mesh-ancestor
139530356|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530357|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530358|NCT01715415|Ribavirin|ribavirin|mesh-list
139530359|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
139530360|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530361|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
139530362|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530363|NCT00211510|Insulin|insulin|mesh-list
139530364|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139530365|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530366|NCT04198636|Denosumab|denosumab|mesh-list
139530367|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139530368|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530369|NCT04414995|Acetaminophen|acetaminophen|mesh-list
139530370|NCT04414995|Ibuprofen|ibuprofen|mesh-list
139530371|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139530372|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139530373|NCT04414995|Analgesics|analgesics|mesh-ancestor
139530374|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
139530375|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530376|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530377|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139530378|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139530379|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139530380|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530381|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530382|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
139530383|NCT01869699|Acetaminophen|acetaminophen|mesh-list
139530384|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139530385|NCT01869699|Analgesics|analgesics|mesh-ancestor
139530386|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
139530387|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530388|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530389|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
139530390|NCT01875848|Buprenorphine|buprenorphine|mesh-list
139530391|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139530392|NCT01875848|Naloxone|naloxone|mesh-list
139530393|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139530394|NCT01875848|Narcotics|narcotics|mesh-ancestor
139530395|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139530396|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530397|NCT01875848|Analgesics|analgesics|mesh-ancestor
139530398|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
139530399|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530400|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139530401|NCT03591172|Propolis|propolis|mesh-list
139530402|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530403|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139530404|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139530405|NCT04197622|Diuretics|diuretics|mesh-ancestor
139530406|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
139530407|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530408|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139530409|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139530410|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530411|NCT03595930|Fluticasone|fluticasone|mesh-list
139530412|NCT03595930|Xhance|xhance|mesh-list
139530413|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138885145|NCT00993343|Cyclosporine|cyclosporine|mesh-list
139530414|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139530415|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
139530416|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530417|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530418|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139530419|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
139530420|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
139530421|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139530422|NCT03595852|Cefazolin|cefazolin|mesh-list
139530423|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139530424|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530425|NCT04191382|Letrozole|letrozole|mesh-list
139530426|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530427|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139530428|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139530429|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530430|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530431|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139530432|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
139530433|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530434|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530435|NCT01703091|Docetaxel|docetaxel|mesh-list
139530436|NCT01703091|Ramucirumab|ramucirumab|mesh-list
139530437|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530438|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
139530439|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
139530440|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
139530441|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530442|NCT04196998|Tenofovir|tenofovir|mesh-list
139530443|NCT04196998|Entecavir|entecavir|mesh-list
139530444|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
139530445|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530446|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139530447|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139530448|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530449|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530450|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139530451|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139530452|NCT04196452|Ipilimumab|ipilimumab|mesh-list
139530453|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139530454|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530455|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139530456|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530457|NCT01867671|Immunomodulating Agents|immunomodulating agents|mesh-list
139530458|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
139530459|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530460|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
139530461|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139530462|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530463|NCT04196608|Tazobactam|tazobactam|mesh-list
139530464|NCT04196608|Imipenem|imipenem|mesh-list
139530465|NCT04196608|Ceftolozane|ceftolozane|mesh-list
139530466|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
139530467|NCT04196608|Relebactam|relebactam|mesh-list
139530468|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139530469|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530470|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139530471|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530472|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530473|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139530474|NCT04022200|Paclitaxel|paclitaxel|mesh-list
139530475|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139530476|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530477|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
139530478|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
139530479|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
139530480|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530481|NCT04552743|Plerixafor|plerixafor|mesh-list
139530482|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139530483|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139530484|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
139530485|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530486|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
139530487|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139530488|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139530489|NCT03590080|Prednisolone|prednisolone|mesh-list
139530490|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
139530491|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139530492|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
139530493|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139530494|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
139530495|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
139530496|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530497|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530498|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139530499|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
139530500|NCT03590080|Hormones|hormones|mesh-ancestor
139530501|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530502|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139530503|NCT03590080|Protective Agents|protective agents|mesh-ancestor
139530504|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139530505|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530506|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
139530507|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139530508|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530509|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530510|NCT03594058|Solabegron|solabegron|mesh-list
139530511|NCT03594058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139530512|NCT03594058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139530513|NCT03594058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139530514|NCT03594058|Adrenergic Agents|adrenergic agents|mesh-ancestor
139530515|NCT03594058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530516|NCT03594058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530517|NCT03594058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530518|NCT04194658|Letrozole|letrozole|mesh-list
139530519|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530520|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139530521|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139530522|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530523|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530524|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139530525|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
139530526|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530527|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530528|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139530529|NCT04028518|Plasminogen|plasminogen|mesh-list
139530530|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139530531|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139530532|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530533|NCT04747678|Ivermectin|ivermectin|mesh-list
139530534|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139530535|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530536|NCT04191928|Apixaban|apixaban|mesh-list
139530537|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139530538|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
139530539|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139530540|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
139530541|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530542|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530543|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
139530544|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139530545|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530546|NCT04027192|Midazolam|midazolam|mesh-list
139530547|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139530548|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139530549|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139530550|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530551|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139530552|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139530553|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139530554|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139530555|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
139530556|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
139530557|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
139530558|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
139530559|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530560|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530561|NCT04406506|Erythromycin|erythromycin|mesh-list
139530562|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
139530563|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139530564|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
139530565|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139530566|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530567|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139530568|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139530569|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530570|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530571|NCT04191694|Ondansetron|ondansetron|mesh-list
139530572|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
139530573|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
139530574|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530575|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530576|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139530577|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
139530578|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
139155011|NCT01104337|Analgesics|analgesics|mesh-ancestor
139530579|NCT04191694|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139530580|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139530581|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
139530582|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530583|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530585|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139530586|NCT04026022|Narcotics|narcotics|mesh-ancestor
139530587|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139530588|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530589|NCT04026022|Analgesics|analgesics|mesh-ancestor
139530590|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
139530591|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530592|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139530593|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139155051|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139530594|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
139530595|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
139530596|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139530597|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530598|NCT04020328|Prednisone|prednisone|mesh-list
139530599|NCT04020328|Leflunomide|leflunomide|mesh-list
139530600|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139530601|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
139530602|NCT04020328|Hormones|hormones|mesh-ancestor
139530603|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530604|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530605|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139530606|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530607|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530608|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530609|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139530610|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
139530611|NCT04020094|Atezolizumab|atezolizumab|mesh-list
139530612|NCT04020094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139530613|NCT04020094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530614|NCT04020094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139530615|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530616|NCT02080468|Norgestimate|norgestimate|mesh-list
139530617|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139530618|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
139530619|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139530620|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530621|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139530622|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139530623|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139530624|NCT04020016|Nalbuphine|nalbuphine|mesh-list
139530625|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139530626|NCT04020016|Narcotics|narcotics|mesh-ancestor
139530627|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139530628|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530629|NCT04020016|Analgesics|analgesics|mesh-ancestor
139530630|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
138905602|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
139530631|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530632|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139530633|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139530634|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139530635|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
139530636|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530637|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530638|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139530639|NCT01874054|Immunotoxins|immunotoxins|mesh-ancestor
139530640|NCT01874054|Immunoconjugates|immunoconjugates|mesh-ancestor
139155141|NCT01333982|Gentamicins|gentamicins|mesh-list
139312268|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139530641|NCT01874054|Immunologic Factors|immunologic factors|mesh-ancestor
139530642|NCT01874054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530644|NCT04029610|Epinephrine|epinephrine|mesh-list
139530645|NCT04029610|Racepinephrine|racepinephrine|mesh-list
139530646|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
139530647|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
139530648|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
139530649|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139530650|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530651|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
139530652|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530653|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139530654|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139530655|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139530656|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139530657|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530658|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139530659|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139530660|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
139530661|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530662|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139530663|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139530664|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
139530665|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139530666|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
139530667|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
139530668|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
139530669|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139530670|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
139530671|NCT04026880|Testosterone|testosterone|mesh-list
139530672|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
139530673|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
139530674|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139530675|NCT04026880|Androgens|androgens|mesh-ancestor
139530676|NCT04026880|Hormones|hormones|mesh-ancestor
139530677|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530678|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530679|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139530680|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530681|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
139530682|NCT04024384|Daratumumab|daratumumab|mesh-list
139530683|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530684|NCT04023760|Apixaban|apixaban|mesh-list
139530685|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139530686|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
139530687|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139530688|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
139530689|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155315|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530690|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530691|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
139530692|NCT04020718|Nicotine|nicotine|mesh-list
139530693|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139530694|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
139530695|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530696|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530697|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139530698|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139530699|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
139530700|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530701|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530702|NCT04027348|Dexamethasone|dexamethasone|mesh-list
139530703|NCT04027348|Octreotide|octreotide|mesh-list
139530704|NCT04027348|Metoclopramide|metoclopramide|mesh-list
139530705|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139530706|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
139530707|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
139530708|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530709|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530710|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139530711|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
139530712|NCT04027348|Hormones|hormones|mesh-ancestor
139530713|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530714|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139530715|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530716|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139530717|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139530718|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
139530719|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530720|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530721|NCT04195204|Tropisetron|tropisetron|mesh-list
139530722|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
139530723|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
139155436|NCT02280772|Cathartics|cathartics|mesh-ancestor
139530724|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530725|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530726|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139530727|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139530728|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139530729|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
139530730|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530731|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530732|NCT04023292|Tamoxifen|tamoxifen|mesh-list
139530733|NCT04023292|Letrozole|letrozole|mesh-list
139530734|NCT04023292|Exemestane|exemestane|mesh-list
139530735|NCT04023292|Anastrozole|anastrozole|mesh-list
139530736|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530737|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139530738|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139530739|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530740|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530741|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139530742|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
139530743|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530744|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530745|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139530746|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139530747|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139530748|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139530749|NCT03022240|Ondansetron|ondansetron|mesh-list
139530750|NCT03022240|Propofol|propofol|mesh-list
139530751|NCT03022240|Sevoflurane|sevoflurane|mesh-list
139530752|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139530753|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139530754|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530755|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139530756|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
139530757|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
139530758|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139530759|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139530760|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
139530761|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
139530762|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530763|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139530764|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
139530765|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
139530766|NCT03022240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139530767|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139530768|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
139530769|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530770|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530771|NCT02704390|Methylphenidate|methylphenidate|mesh-list
139530772|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138906126|NCT00679679|Metformin|metformin|mesh-list
139530773|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530774|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139530775|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139530776|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139530777|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530778|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
139530779|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530780|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
139530781|NCT04147390|Tacrolimus|tacrolimus|mesh-list
139530782|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139530783|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
139530784|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530785|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139530786|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530787|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530788|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139530789|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530790|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139530791|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
139530792|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139530793|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530794|NCT02708680|Atezolizumab|atezolizumab|mesh-list
139530795|NCT02708680|Entinostat|entinostat|mesh-list
139155728|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139530796|NCT02708680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139530797|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530798|NCT02708680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139530799|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530800|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139530801|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530802|NCT03931642|Blinatumomab|blinatumomab|mesh-list
139530803|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530804|NCT04021420|Nivolumab|nivolumab|mesh-list
139530805|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139530806|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530807|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139530808|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530809|NCT04144582|Docetaxel|docetaxel|mesh-list
139530810|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530811|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
139530812|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
139530813|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
139530814|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530815|NCT01611974|Maribavir|maribavir|mesh-list
139530816|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
139530817|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530818|NCT01871870|Pancrelipase|pancrelipase|mesh-list
139530819|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139530820|NCT02080780|Clarithromycin|clarithromycin|mesh-list
139530821|NCT02080780|Diltiazem|diltiazem|mesh-list
139530822|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139530823|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530824|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139530825|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530826|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530827|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139530828|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139530829|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139530830|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139530831|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139530832|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139530833|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530834|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
139530835|NCT01871558|Metformin|metformin|mesh-list
139530836|NCT01871558|Vildagliptin|vildagliptin|mesh-list
139530837|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139530838|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530839|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139530840|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
139530841|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530842|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530843|NCT01711359|Folic Acid|folic acid|mesh-list
139530844|NCT01711359|Methotrexate|methotrexate|mesh-list
139530845|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139530846|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
139530847|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139530848|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530849|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139530850|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
139530851|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530852|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530853|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
139155982|NCT00580216|Biotin|biotin|mesh-list
139530854|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530855|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139530856|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139530857|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
139530858|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139530859|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139530860|NCT01711359|Hematinics|hematinics|mesh-ancestor
139530861|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
139530862|NCT01711359|Vitamins|vitamins|mesh-ancestor
139530863|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
139530864|NCT04140136|Tocotrienols|tocotrienols|mesh-list
139530865|NCT04140136|Vitamin E|vitamin e|mesh-list
139312489|NCT02158689|Letrozole|letrozole|mesh-list
139530866|NCT04140136|Tocopherols|tocopherols|mesh-list
139530867|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
139530868|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530869|NCT04140136|Protective Agents|protective agents|mesh-ancestor
139530870|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530871|NCT04140136|Vitamins|vitamins|mesh-ancestor
139530872|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
139530873|NCT04146532|Aspirin|aspirin|mesh-list
139530874|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139530875|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139530876|NCT04146532|Analgesics|analgesics|mesh-ancestor
139530877|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
139530878|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530879|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530880|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139530881|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139530882|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139530883|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139530884|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530885|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139530886|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139530887|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530888|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
139530889|NCT03929224|Bacitracin|bacitracin|mesh-list
139530890|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139530891|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530892|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139530893|NCT04146610|Antibodies|antibodies|mesh-list
139530894|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
139530895|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
139530896|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530897|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
139530898|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139530899|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139530900|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530901|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
139530902|NCT04146376|Coagulants|coagulants|mesh-ancestor
139530903|NCT01710657|Lacosamide|lacosamide|mesh-list
139530904|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
139530905|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139530906|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139530907|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139530908|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530909|NCT03021772|Dexamethasone|dexamethasone|mesh-list
139530910|NCT03021772|Neostigmine|neostigmine|mesh-list
139530911|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139530912|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
139530913|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
139530914|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530915|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530916|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139530917|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
139530918|NCT03021772|Hormones|hormones|mesh-ancestor
139530919|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139530920|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139530921|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530922|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139530923|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156213|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139530924|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530925|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
139530926|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139530927|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139530928|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
139530929|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139530930|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530931|NCT05581420|Ferrous fumarate|ferrous fumarate|mesh-list
139530932|NCT05581420|Trace Elements|trace elements|mesh-ancestor
139530933|NCT05581420|Micronutrients|micronutrients|mesh-ancestor
139530934|NCT05581420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530935|NCT03904498|Tolcapone|tolcapone|mesh-list
139530936|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139530937|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139530938|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139530939|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530940|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530941|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
139530942|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139530943|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139530944|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530945|NCT04405960|Vitamins|vitamins|mesh-ancestor
139530946|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
139530947|NCT03945604|Apatinib|apatinib|mesh-list
139530948|NCT03945604|Fluzoparib|fluzoparib|mesh-list
139530949|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530950|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139530951|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530952|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530953|NCT03945604|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139530954|NCT03944356|Trametinib|trametinib|mesh-list
139530955|NCT03944356|Dabrafenib|dabrafenib|mesh-list
139530956|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530957|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139530958|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139530959|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530960|NCT01701063|Ribavirin|ribavirin|mesh-list
139530961|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139530962|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
139530963|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530964|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
139530965|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530966|NCT03920722|Rituximab|rituximab|mesh-list
139530967|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139156266|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
139530968|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530969|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
139530970|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530971|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139530972|NCT05580094|Anesthetics|anesthetics|mesh-list
139530973|NCT05580094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139530974|NCT05580094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530975|NCT05586100|Cetuximab|cetuximab|mesh-list
139530976|NCT05586100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139530977|NCT05586100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530978|NCT05585086|Peppermint oil|peppermint oil|mesh-list
139530979|NCT05585086|Antiemetics|antiemetics|mesh-ancestor
139530980|NCT05585086|Autonomic Agents|autonomic agents|mesh-ancestor
139530981|NCT05585086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139530982|NCT05585086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530983|NCT05585086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139530984|NCT05585086|Parasympatholytics|parasympatholytics|mesh-ancestor
139530985|NCT01710501|Interferons|interferons|mesh-list
139530986|NCT01710501|Ribavirin|ribavirin|mesh-list
139530987|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
139530988|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
139530989|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139530990|NCT01710501|Grazoprevir|grazoprevir|mesh-list
139530991|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139530992|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
139530993|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139530994|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
139530995|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139530996|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
139530997|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139530998|NCT05583058|Hormones|hormones|mesh-list
139530999|NCT05583058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139531000|NCT05583058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531001|NCT01700829|Midazolam|midazolam|mesh-list
139531002|NCT01700829|Ketamine|ketamine|mesh-list
139531003|NCT01700829|Analgesics|analgesics|mesh-ancestor
139531004|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
139531005|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531006|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531007|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139531008|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139531009|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
139531010|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
139531011|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531012|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139531013|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139531014|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531015|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531016|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139531017|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139531018|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139531019|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139531020|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139531021|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
139531022|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
139531023|NCT04143880|Progesterone|progesterone|mesh-list
139531024|NCT04143880|Progestins|progestins|mesh-ancestor
139156408|NCT00361582|Sensory System Agents|sensory system agents|mesh-ancestor
139531026|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139531027|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531028|NCT04144192|Lidocaine|lidocaine|mesh-list
139531029|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
139531030|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
139531031|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531032|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531033|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
139531034|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531035|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139531036|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139531037|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139531038|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139531039|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531040|NCT01710345|Sufentanil|sufentanil|mesh-list
139531041|NCT01710345|Dsuvia|dsuvia|mesh-list
139531042|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139531043|NCT01710345|Narcotics|narcotics|mesh-ancestor
139531044|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531045|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531046|NCT01710345|Analgesics|analgesics|mesh-ancestor
139531047|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
139531048|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531049|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139531050|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139531051|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
139531052|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
139531053|NCT03022006|Grazoprevir|grazoprevir|mesh-list
139531054|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
139156535|NCT00345748|Immunologic Factors|immunologic factors|mesh-ancestor
139531055|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139531056|NCT04143256|Menthol|menthol|mesh-list
139531057|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
139531058|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
139531059|NCT04143412|Ramipril|ramipril|mesh-list
139531060|NCT04143412|Eplerenone|eplerenone|mesh-list
139531061|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139531062|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
139531063|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531064|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531065|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139531066|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139531067|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
139531068|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139531069|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531070|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139531071|NCT04143412|Diuretics|diuretics|mesh-ancestor
139531072|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
139531073|NCT05582278|Lenvatinib|lenvatinib|mesh-list
139531074|NCT05582278|Tislelizumab|tislelizumab|mesh-list
139531075|NCT05582278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139531076|NCT05582278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531077|NCT05582278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139531078|NCT05582278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531079|NCT05582278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531080|NCT05582278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139531081|NCT01710033|Tofacitinib|tofacitinib|mesh-list
139531082|NCT01710033|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139531083|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139156647|NCT05982197|Curcumin|curcumin|mesh-list
139531084|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531085|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531086|NCT01822496|Paclitaxel|paclitaxel|mesh-list
139531087|NCT01822496|Etoposide|etoposide|mesh-list
139531088|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
139531089|NCT01822496|Cisplatin|cisplatin|mesh-list
139531090|NCT01822496|Carboplatin|carboplatin|mesh-list
139531091|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139531092|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
139531093|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139531094|NCT01822496|Crizotinib|crizotinib|mesh-list
139531095|NCT01822496|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139531096|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139531097|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531098|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
139531099|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
139531100|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
139531101|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531102|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139531103|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139531104|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531105|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139531106|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
139531107|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
139531108|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139531109|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
139531110|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531111|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531112|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
139531113|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139531114|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531115|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531116|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139531117|NCT03588988|Analgesics|analgesics|mesh-ancestor
139531118|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
139531119|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531120|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139531121|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139531122|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139531123|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
139531124|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531125|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531127|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139531128|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139531129|NCT01821560|Baclofen|baclofen|mesh-list
139531130|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139531131|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531132|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139531133|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531134|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139531135|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
139531136|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
139531137|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531138|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531139|NCT05580328|Hematoporphyrins|hematoporphyrins|mesh-list
139531140|NCT05580328|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139531141|NCT05580328|Dermatologic Agents|dermatologic agents|mesh-ancestor
139531142|NCT03588676|Melatonin|melatonin|mesh-list
139531143|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
139531144|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531145|NCT03588676|Protective Agents|protective agents|mesh-ancestor
139531146|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531147|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531148|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139531149|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139531150|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
139531151|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531152|NCT01709721|Hydromorphone|hydromorphone|mesh-list
139531153|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139531154|NCT01709721|Narcotics|narcotics|mesh-ancestor
139531155|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531156|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531157|NCT01709721|Analgesics|analgesics|mesh-ancestor
139531158|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
139531159|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531160|NCT01866657|Phenylephrine|phenylephrine|mesh-list
139531161|NCT01866657|Dopamine|dopamine|mesh-list
139531162|NCT01866657|Ephedrine|ephedrine|mesh-list
139531163|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139531164|NCT01866657|Propofol|propofol|mesh-list
139531165|NCT01866657|Sevoflurane|sevoflurane|mesh-list
139156947|NCT06098625|Hormones|hormones|mesh-ancestor
139531166|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
139531167|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531168|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312794|NCT03366584|Vitamin D|vitamin d|mesh-list
139531169|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139531170|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139531171|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
139531172|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139531173|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139531174|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139531175|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
139531176|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
139531177|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531178|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
139531179|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
139531180|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
139531181|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139531182|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139531183|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139531184|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
139531185|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531186|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531187|NCT01866657|Protective Agents|protective agents|mesh-ancestor
139531188|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139531189|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
139531190|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
139531191|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
139531192|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531193|NCT03589690|Protective Agents|protective agents|mesh-ancestor
139531194|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531195|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
139531196|NCT03589690|Vitamins|vitamins|mesh-ancestor
139531197|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
139531198|NCT03587194|Apremilast|apremilast|mesh-list
139531199|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139531200|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139531201|NCT03587194|Analgesics|analgesics|mesh-ancestor
139531202|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
139531203|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531204|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531205|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531206|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139531207|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139531208|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139531209|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531210|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531211|NCT01699815|Acetaminophen|acetaminophen|mesh-list
139531212|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139531213|NCT01699815|Analgesics|analgesics|mesh-ancestor
139531214|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
139531215|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531216|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531217|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
139531218|NCT03589222|Dexamethasone|dexamethasone|mesh-list
139531219|NCT03589222|Bortezomib|bortezomib|mesh-list
139531220|NCT03589222|Daratumumab|daratumumab|mesh-list
139531221|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531222|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
139531223|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
139531224|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531225|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531226|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139531227|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
139531228|NCT03589222|Hormones|hormones|mesh-ancestor
139531229|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139531230|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139531231|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531232|NCT01846208|Immunomodulating Agents|immunomodulating agents|mesh-list
139531233|NCT01846208|Immunologic Factors|immunologic factors|mesh-ancestor
139531234|NCT01846208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531235|NCT03589066|Rotigotine|rotigotine|mesh-list
139531236|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
139531237|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
139531238|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531239|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531240|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312877|NCT03505008|Adalimumab|adalimumab|mesh-list
139531241|NCT03020368|Diclofenac|diclofenac|mesh-list
139531242|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139531243|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139531244|NCT03020368|Analgesics|analgesics|mesh-ancestor
139531245|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
139531246|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531247|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531248|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531249|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139531250|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139531251|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531252|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531253|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139531254|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139531255|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531256|NCT05702944|Phenoxybenzamine|phenoxybenzamine|mesh-list
139531257|NCT05702944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139531258|NCT05702944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139531259|NCT05702944|Adrenergic Agents|adrenergic agents|mesh-ancestor
139531260|NCT05702944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531261|NCT05702944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531262|NCT05702944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531263|NCT05702944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139531264|NCT05702944|Vasodilator Agents|vasodilator agents|mesh-ancestor
139531265|NCT03580876|Azathioprine|azathioprine|mesh-list
139531266|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
139531267|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531268|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139531269|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531270|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139531271|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
139531272|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531273|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139531274|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
139531275|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139531276|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531277|NCT03586024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139531278|NCT03586024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531279|NCT03585556|Prednisolone|prednisolone|mesh-list
139531280|NCT03585556|Ranibizumab|ranibizumab|mesh-list
139531281|NCT03585556|Aflibercept|aflibercept|mesh-list
138907924|NCT00851552|Rituximab|rituximab|mesh-list
139531282|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531283|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139531284|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139531285|NCT03585556|Growth Substances|growth substances|mesh-ancestor
139531286|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531287|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
139531288|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531289|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
139531290|NCT03585556|Hormones|hormones|mesh-ancestor
139531291|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139531292|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139531293|NCT05702398|Vitamins|vitamins|mesh-list
139531294|NCT05702398|Vitamin A|vitamin a|mesh-list
139531295|NCT05702398|Niacin|niacin|mesh-list
139531296|NCT05702398|Niacinamide|niacinamide|mesh-list
139531297|NCT05702398|Nicotinic Acids|nicotinic acids|mesh-list
139531298|NCT05702398|Micronutrients|micronutrients|mesh-ancestor
139531299|NCT05702398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531300|NCT05702398|Vitamin B Complex|vitamin b complex|mesh-ancestor
139531301|NCT05702398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531302|NCT05702398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139531303|NCT05702398|Antimetabolites|antimetabolites|mesh-ancestor
139531304|NCT05702398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139531305|NCT05702398|Vasodilator Agents|vasodilator agents|mesh-ancestor
139531306|NCT01709409|Poractant alfa|poractant alfa|mesh-list
139531307|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139531308|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
139531309|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
139531310|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139531311|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157536|NCT06216886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157537|NCT06216886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139157538|NCT06216886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139531312|NCT01698879|Immunotoxins|immunotoxins|mesh-ancestor
139531313|NCT01698879|Immunoconjugates|immunoconjugates|mesh-ancestor
139531314|NCT01698879|Immunologic Factors|immunologic factors|mesh-ancestor
139531315|NCT01698879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531316|NCT02335294|Morphine|morphine|mesh-list
139531317|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139531318|NCT02335294|Narcotics|narcotics|mesh-ancestor
139531319|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531320|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531321|NCT02335294|Analgesics|analgesics|mesh-ancestor
139531322|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
139531323|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531324|NCT01698801|Dexamethasone|dexamethasone|mesh-list
139531325|NCT01698801|Lenalidomide|lenalidomide|mesh-list
139531326|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531327|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
139531328|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
139531329|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531330|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531331|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139531332|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
139531333|NCT01698801|Hormones|hormones|mesh-ancestor
139531334|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139531335|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139531336|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531337|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
139531338|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139531339|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139531340|NCT01698801|Growth Substances|growth substances|mesh-ancestor
139531341|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
139531342|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139531343|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139531344|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
139531345|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
139531346|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139531347|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139531348|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157658|NCT06215989|Mitosis Modulators|mitosis modulators|mesh-ancestor
139157659|NCT06215989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157660|NCT06215989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157661|NCT06215976|Metformin|metformin|mesh-list
139157662|NCT06215976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139157663|NCT06215976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157664|NCT06215859|Tramadol|tramadol|mesh-list
139157665|NCT06215859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139157666|NCT06215859|Narcotics|narcotics|mesh-ancestor
139157669|NCT06215859|Analgesics|analgesics|mesh-ancestor
139531349|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
139531350|NCT03580018|Coagulants|coagulants|mesh-ancestor
139531351|NCT03584854|Carboprost|carboprost|mesh-list
139531352|NCT03584854|Dinoprost|dinoprost|mesh-list
139531353|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
139531354|NCT03584854|Methylergonovine|methylergonovine|mesh-list
139531355|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139531356|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
139531357|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139531358|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531359|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
139531360|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
139531361|NCT03584698|Misoprostol|misoprostol|mesh-list
139531362|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139531363|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
139531364|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139531365|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531366|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139157714|NCT06215651|Lenvatinib|lenvatinib|mesh-list
139531367|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139531368|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
139531369|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139531370|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139531371|NCT03584698|Analgesics|analgesics|mesh-ancestor
139531372|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
139531373|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531374|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531375|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139531376|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139531377|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
139531378|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531379|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139531380|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
139531381|NCT01682031|Selenium|selenium|mesh-list
139531382|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
139531383|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531384|NCT01682031|Protective Agents|protective agents|mesh-ancestor
139531385|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531386|NCT01682031|Trace Elements|trace elements|mesh-ancestor
139531387|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
139531388|NCT03020134|Ritonavir|ritonavir|mesh-list
139531389|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139531390|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139531391|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
139531392|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531393|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531394|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139531395|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139531396|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
139531397|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139531398|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139531399|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139531400|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139531401|NCT03020056|Antioxidants|antioxidants|mesh-list
139531402|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139531403|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531404|NCT03020056|Protective Agents|protective agents|mesh-ancestor
139531405|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531407|NCT03584074|Pregabalin|pregabalin|mesh-list
139531408|NCT03584074|Analgesics|analgesics|mesh-ancestor
139531409|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
139531410|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531411|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531412|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
139531413|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139531414|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139531415|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531416|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139531417|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139531418|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139531419|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157892|NCT06093191|Tobramycin|tobramycin|mesh-list
139531420|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139531421|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139531422|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139531423|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531424|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139531425|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139531426|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139531427|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531428|NCT03583138|Buprenorphine|buprenorphine|mesh-list
139531429|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139531430|NCT03583138|Narcotics|narcotics|mesh-ancestor
139531431|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531432|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531433|NCT03583138|Analgesics|analgesics|mesh-ancestor
139531434|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
139531435|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531436|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139157966|NCT06038539|Docetaxel|docetaxel|mesh-list
139531437|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
139531438|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139531439|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531440|NCT03020602|Ubiquinone|ubiquinone|mesh-list
139531441|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
139531442|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
139531443|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531444|NCT03020602|Vitamins|vitamins|mesh-ancestor
139531445|NCT01567527|Aripiprazole|aripiprazole|mesh-list
139531446|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
139531447|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139531448|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139531449|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139531450|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531451|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531452|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
139531453|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
139531454|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531455|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531456|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139531457|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139531458|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
139531459|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139531460|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139531461|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139531462|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139531463|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
139531464|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139531465|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
139531466|NCT03159598|Urethane|urethane|mesh-list
139531467|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531468|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139531469|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
139313088|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139531470|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
139158000|NCT05909995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158021|NCT05903859|Probenecid|probenecid|mesh-list
139158022|NCT05903859|Uricosuric Agents|uricosuric agents|mesh-ancestor
139158023|NCT05903859|Gout Suppressants|gout suppressants|mesh-ancestor
139158024|NCT05903859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139158025|NCT05901467|Hormones|hormones|mesh-list
139158026|NCT05901467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139158027|NCT05901467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158028|NCT05878769|Astegolimab|astegolimab|mesh-list
139158029|NCT05878769|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139158030|NCT05878769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139158031|NCT05878769|Antiviral Agents|antiviral agents|mesh-ancestor
139158032|NCT05878769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158033|NCT05861999|Risdiplam|risdiplam|mesh-list
139158034|NCT05861999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139158035|NCT05861999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139158036|NCT05861999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158037|NCT05809830|Doxorubicin|doxorubicin|mesh-list
139531471|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531472|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531473|NCT01818752|Prednisone|prednisone|mesh-list
139531474|NCT01818752|Bortezomib|bortezomib|mesh-list
139531475|NCT01818752|Melphalan|melphalan|mesh-list
139531476|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531477|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
139531478|NCT01818752|Hormones|hormones|mesh-ancestor
139531479|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139531480|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531481|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139531482|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531483|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139531484|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
139531485|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158043|NCT05809830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158044|NCT05809830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158045|NCT05803382|Capecitabine|capecitabine|mesh-list
139158046|NCT05803382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139531486|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139531487|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139531488|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
139531489|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
139531490|NCT03582280|Calcium|calcium|mesh-list
139531491|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139531492|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531493|NCT03582280|Antacids|antacids|mesh-ancestor
139531494|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531495|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139531496|NCT05701384|Lazertinib|lazertinib|mesh-list
139531497|NCT05701384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139531498|NCT05701384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531499|NCT05701384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531500|NCT01362608|Triamcinolone|triamcinolone|mesh-list
139158099|NCT05607550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158100|NCT05607550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158101|NCT05605639|Bupivacaine|bupivacaine|mesh-list
139158102|NCT05605639|Anesthetics, Local|anesthetics, local|mesh-ancestor
139158103|NCT05605639|Anesthetics|anesthetics|mesh-ancestor
139158104|NCT05605639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139158105|NCT05605639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158116|NCT05600426|Cyclosporine|cyclosporine|mesh-list
139531501|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139531502|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139531503|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139531504|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531505|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
139531506|NCT01362608|Hormones|hormones|mesh-ancestor
139531507|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139531508|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531509|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139531510|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
139531511|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531512|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531513|NCT03581968|Pancrelipase|pancrelipase|mesh-list
139531514|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139531515|NCT03158584|Morphine|morphine|mesh-list
139531516|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139531517|NCT03158584|Narcotics|narcotics|mesh-ancestor
139531518|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531519|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531520|NCT03158584|Analgesics|analgesics|mesh-ancestor
139158159|NCT05591339|BCG Vaccine|bcg vaccine|mesh-list
139158160|NCT05591339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139158209|NCT05556616|Bortezomib|bortezomib|mesh-list
139531521|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
139531522|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531523|NCT04765228|Doxorubicin|doxorubicin|mesh-list
139531524|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139531525|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139531526|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531527|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139531528|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139531529|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531530|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531531|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139531532|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139531533|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139531534|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
139531535|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139531536|NCT03156322|Fentanyl|fentanyl|mesh-list
139531537|NCT03156322|Bupivacaine|bupivacaine|mesh-list
139531538|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
139531539|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
139531540|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531541|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531542|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
139531543|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313166|NCT03506802|Aldesleukin|aldesleukin|mesh-list
139531544|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139531545|NCT03156322|Narcotics|narcotics|mesh-ancestor
139531546|NCT03156322|Analgesics|analgesics|mesh-ancestor
139531547|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139531548|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139531549|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
139531550|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
139531551|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531552|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531553|NCT04140058|Ondansetron|ondansetron|mesh-list
139531554|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
139531555|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
139531556|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531557|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531558|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139531559|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
139531560|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
139531561|NCT04140058|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139531562|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139531563|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
139531564|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531565|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531566|NCT02899078|Nivolumab|nivolumab|mesh-list
139531567|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139531568|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531569|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139531570|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531571|NCT01670734|Alirocumab|alirocumab|mesh-list
139531572|NCT01670734|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139531573|NCT01670734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139531574|NCT01670734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139531575|NCT01670734|Antimetabolites|antimetabolites|mesh-ancestor
139531576|NCT01670734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531577|NCT01670734|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139531578|NCT01670734|Protease Inhibitors|protease inhibitors|mesh-ancestor
139531579|NCT01670734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531580|NCT01670734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139531581|NCT01670890|Cisplatin|cisplatin|mesh-list
139531582|NCT01670890|Temozolomide|temozolomide|mesh-list
139531583|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531584|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139531585|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
139531586|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531587|NCT04551196|Acetaminophen|acetaminophen|mesh-list
139531588|NCT04551196|Ibuprofen|ibuprofen|mesh-list
139531589|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139531590|NCT04551196|Analgesics|analgesics|mesh-ancestor
139531591|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
139531592|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531593|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531594|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
139531595|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139531596|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531597|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139531598|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139531599|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531600|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531601|NCT01923298|Estradiol|estradiol|mesh-list
139531602|NCT01923298|Estrogens|estrogens|mesh-ancestor
139531603|NCT01923298|Hormones|hormones|mesh-ancestor
139531604|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139531605|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531606|NCT03154918|Dexamethasone|dexamethasone|mesh-list
139531607|NCT03154918|Gemcitabine|gemcitabine|mesh-list
139531608|NCT03154918|Etoposide|etoposide|mesh-list
139531609|NCT03154918|Ifosfamide|ifosfamide|mesh-list
139531610|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531611|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
139531612|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
139531613|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531614|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531615|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139531616|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
139531617|NCT03154918|Hormones|hormones|mesh-ancestor
139531618|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139531619|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139531620|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531621|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531622|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531623|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139531624|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
139531625|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139531626|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139531627|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139531628|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139531629|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
139531630|NCT01671904|Rituximab|rituximab|mesh-list
139531631|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
139531632|NCT01671904|Venetoclax|venetoclax|mesh-list
139531633|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139158619|NCT04981509|Sodium Fluoride|sodium fluoride|mesh-list
139531634|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139531635|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531636|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
139531637|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531638|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139531639|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139531640|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
139531641|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531642|NCT04040452|Ketorolac|ketorolac|mesh-list
139531643|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139531644|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139531645|NCT04040452|Analgesics|analgesics|mesh-ancestor
139531646|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
139531647|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531648|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531649|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531650|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139531651|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139531652|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531653|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531654|NCT04027894|Rifamycins|rifamycins|mesh-list
139531655|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
139531656|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139531657|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139531658|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139531659|NCT03154528|Vitamin D|vitamin d|mesh-list
139531660|NCT03154528|Vitamins|vitamins|mesh-ancestor
139531661|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
139531662|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531663|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139531664|NCT03154372|Metronidazole|metronidazole|mesh-list
139531665|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139531666|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139531667|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139531668|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139531669|NCT01676506|Ranibizumab|ranibizumab|mesh-list
139531670|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139531671|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139531672|NCT01676506|Growth Substances|growth substances|mesh-ancestor
139531673|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531674|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
139531675|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531676|NCT03154294|Paclitaxel|paclitaxel|mesh-list
139531677|NCT03154294|Serabelisib|serabelisib|mesh-list
139531678|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139531679|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531680|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
139531681|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
139531682|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
139531683|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531684|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531685|NCT03154606|Calcium|calcium|mesh-list
139531686|NCT03154606|Caseins|caseins|mesh-list
139531687|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139531688|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531689|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
139531690|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
139531691|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531692|NCT01672450|Ipilimumab|ipilimumab|mesh-list
139313316|NCT01796002|Romidepsin|romidepsin|mesh-list
139531693|NCT01672450|Interleukin-2|interleukin-2|mesh-list
139531694|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139531695|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531696|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139531697|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531698|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139531699|NCT01672450|Analgesics|analgesics|mesh-ancestor
139531700|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
139531701|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531702|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531703|NCT01854268|Capsaicin|capsaicin|mesh-list
139531704|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
139531705|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
139531706|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
139531707|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531708|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531709|NCT01672606|Rocuronium|rocuronium|mesh-list
139531710|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139531711|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139531712|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139531713|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531714|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531715|NCT01594281|Ranibizumab|ranibizumab|mesh-list
139531716|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139531717|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139531718|NCT01594281|Growth Substances|growth substances|mesh-ancestor
139531719|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531720|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
139531721|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531722|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
139531723|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139531724|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
139531725|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531726|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531727|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139531728|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139531729|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139531730|NCT04964050|Diuretics|diuretics|mesh-ancestor
139531731|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
139531732|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531733|NCT03526900|Atezolizumab|atezolizumab|mesh-list
139158943|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531734|NCT03526900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139531735|NCT03526900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531736|NCT03526900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139531737|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531738|NCT03420742|Midazolam|midazolam|mesh-list
139531739|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139531740|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139531741|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531742|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531743|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139531744|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139531745|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139531746|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139531747|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
139531748|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
139531749|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
139531750|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
139531751|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531752|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531753|NCT01818284|Plerixafor|plerixafor|mesh-list
139531754|NCT01818284|Lenograstim|lenograstim|mesh-list
139531755|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139531756|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
139531757|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531758|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139531759|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139531760|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
139531761|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139531762|NCT02081014|Glucagon|glucagon|mesh-list
139531763|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139531764|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139531765|NCT02081014|Hormones|hormones|mesh-ancestor
139531766|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139531767|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313386|NCT02308644|Growth Substances|growth substances|mesh-ancestor
139531769|NCT03025594|Ketorolac|ketorolac|mesh-list
139531770|NCT03025594|Epinephrine|epinephrine|mesh-list
139531771|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
139531772|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139531773|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139531774|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
139531775|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531776|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531777|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159117|NCT04195399|Imidazole|imidazole|mesh-list
139531778|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139531779|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139531780|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
139531781|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531782|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139531783|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
139531784|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
139531785|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
139531786|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139531787|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139531788|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139531789|NCT03025594|Analgesics|analgesics|mesh-ancestor
139531790|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
139531791|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531792|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139531793|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139531794|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159168|NCT04000529|Spartalizumab|spartalizumab|mesh-list
139531795|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
139531796|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
139531797|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531798|NCT04404946|Phenylephrine|phenylephrine|mesh-list
139531799|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
139531800|NCT04404946|Norepinephrine|norepinephrine|mesh-list
139531801|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139531802|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
139531803|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
139531804|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531805|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531806|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
139531807|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139531808|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
139531809|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
139531810|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139531811|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139531812|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139531813|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
139531814|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531815|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531816|NCT04404946|Protective Agents|protective agents|mesh-ancestor
139531817|NCT01673542|Lidocaine|lidocaine|mesh-list
139531818|NCT01673542|Prilocaine|prilocaine|mesh-list
139531819|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139531820|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
139531821|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
139531822|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531823|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531824|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
139531825|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531826|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139531827|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139531828|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139531829|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139531830|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531831|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139531832|NCT04804540|Vedolizumab|vedolizumab|mesh-list
139531833|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139531834|NCT01610492|Belimumab|belimumab|mesh-list
139531835|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139531836|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
139531837|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531838|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139531839|NCT01817582|Cyclosporine|cyclosporine|mesh-list
139531840|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139531841|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
139531842|NCT01817582|Cyclosporins|cyclosporins|mesh-list
139531843|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531844|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531845|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139531847|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531848|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
139531849|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139531850|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
139531851|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139531852|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139531853|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139159371|NCT03533582|Cisplatin|cisplatin|mesh-list
139531854|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139531855|NCT01594125|Nintedanib|nintedanib|mesh-list
139531856|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531857|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139531858|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531859|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531860|NCT01592409|Dronabinol|dronabinol|mesh-list
139531861|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
139531862|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531863|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139531864|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139531865|NCT01592409|Analgesics|analgesics|mesh-ancestor
139531866|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
139531867|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531868|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139531869|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139531870|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531871|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531872|NCT01592409|Hormones|hormones|mesh-ancestor
139531873|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139531874|NCT02081638|Aspirin|aspirin|mesh-list
139531875|NCT02081638|Atorvastatin|atorvastatin|mesh-list
139531876|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139531877|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139531878|NCT02081638|Analgesics|analgesics|mesh-ancestor
139531879|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
139159500|NCT03126916|Dinutuximab|dinutuximab|mesh-list
139531880|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531881|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531882|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139531883|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139531884|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139531885|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139531886|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531887|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139531888|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139531889|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531890|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
139531891|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139531892|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139531893|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
139531894|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139531895|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139531896|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
139531897|NCT04603508|Empagliflozin|empagliflozin|mesh-list
139531898|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139531899|NCT04603508|Calcium|calcium|mesh-list
139531900|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139531901|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531902|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139531903|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139531904|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139531905|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
139531906|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531907|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139531908|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139531909|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159651|NCT02981628|Leucovorin|leucovorin|mesh-list
139531910|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139531911|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139531912|NCT01674166|Prucalopride|prucalopride|mesh-list
139531913|NCT01674166|Laxatives|laxatives|mesh-ancestor
139531914|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139531915|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139313536|NCT03356054|Immunoconjugates|immunoconjugates|mesh-ancestor
139531916|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139531917|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
139531918|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531919|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531920|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531921|NCT02235688|Gemcitabine|gemcitabine|mesh-list
139531922|NCT02235688|Doxorubicin|doxorubicin|mesh-list
139531923|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139531924|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
139531925|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531926|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531927|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139531928|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139531929|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139531930|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531931|NCT03152578|Capsaicin|capsaicin|mesh-list
139531932|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
139531933|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
139531934|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
139531935|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531936|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531937|NCT01065532|Paclitaxel|paclitaxel|mesh-list
139531938|NCT01065532|Everolimus|everolimus|mesh-list
139531939|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139531940|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139531941|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159769|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139159770|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139159771|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159772|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159773|NCT02470091|Denosumab|denosumab|mesh-list
139159774|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139159775|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159776|NCT02451943|Doxorubicin|doxorubicin|mesh-list
139159777|NCT02451943|Olaratumab|olaratumab|mesh-list
139159778|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139159779|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159780|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139159781|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139159782|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159783|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159784|NCT02329860|Apatinib|apatinib|mesh-list
139531942|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
139531943|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
139531944|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531945|NCT01065532|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139531946|NCT01065532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139531947|NCT01065532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531948|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139531949|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
139531950|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531951|NCT04764916|Bupivacaine|bupivacaine|mesh-list
139531952|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
139531953|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
139531954|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139531955|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531956|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
139531957|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531958|NCT01674868|Fluoxetine|fluoxetine|mesh-list
139531959|NCT01674868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139531960|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139531961|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139531962|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531963|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531964|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
139531965|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531966|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139531967|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
139531968|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139531969|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139531970|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139531971|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139531972|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139531973|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
139531974|NCT01674946|Cathartics|cathartics|mesh-ancestor
139531975|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139531976|NCT01675024|Rotigotine|rotigotine|mesh-list
139531977|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
139531978|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
139531979|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139531980|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531981|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531982|NCT02081950|Enoxaparin|enoxaparin|mesh-list
139531983|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
139531984|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
139531985|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139531986|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139531987|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139531988|NCT01675648|Lofexidine|lofexidine|mesh-list
139531989|NCT01675648|Clonidine|clonidine|mesh-list
139531990|NCT01675648|Diazepam|diazepam|mesh-list
139531991|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139531993|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
139531994|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
139531995|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139531996|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139531997|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139531998|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139531999|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139532000|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139532001|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139532002|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139532003|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139532004|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139532005|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139532006|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
139532007|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
139532008|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
139532009|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
139532010|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532011|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532012|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139532013|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139532014|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
139532015|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139532016|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139532017|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139532018|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
139532019|NCT01675648|Analgesics|analgesics|mesh-ancestor
139532020|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
139532021|NCT01566435|Paclitaxel|paclitaxel|mesh-list
139532022|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139532023|NCT01566435|Fluorouracil|fluorouracil|mesh-list
139532024|NCT01566435|Cetuximab|cetuximab|mesh-list
139532025|NCT01566435|Antibodies|antibodies|mesh-list
139532026|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139532027|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139532028|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532029|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
139532030|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
139532031|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
139532032|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532033|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
139532034|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532035|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
139532036|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139532037|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139532038|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139532039|NCT01675804|Methylphenidate|methylphenidate|mesh-list
139532040|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139532041|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532042|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139532043|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139532044|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139532045|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532046|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
139532047|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160136|NCT05544968|Antibodies|antibodies|mesh-list
139532048|NCT01696695|Capecitabine|capecitabine|mesh-list
139532049|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139532050|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
139532051|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532052|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532053|NCT05261386|Betadex|betadex|mesh-list
139532054|NCT05261386|Sequestering Agents|sequestering agents|mesh-ancestor
139532055|NCT05261386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532056|NCT03861988|Ketamine|ketamine|mesh-list
139532057|NCT03861988|Analgesics|analgesics|mesh-ancestor
139532058|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
139160179|NCT05543122|Dopamine Agents|dopamine agents|mesh-ancestor
139532059|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532060|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532061|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139532062|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139532063|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
139532064|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
139313688|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139532065|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139532066|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139532067|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139532068|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532069|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532070|NCT03755440|Antibodies|antibodies|mesh-list
139532071|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
139532072|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532073|NCT01565889|Ritonavir|ritonavir|mesh-list
139532074|NCT01565889|Ribavirin|ribavirin|mesh-list
139532075|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139532076|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139532077|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
139532078|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532079|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532080|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139532081|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139532082|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
139532083|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139532084|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139532085|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139532086|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
139532087|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
139532088|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139532089|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
139532090|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532091|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532092|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139532093|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
139532094|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
139532095|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139532096|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
139532097|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532098|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532099|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
139532100|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139532101|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139532102|NCT01591785|Retapamulin|retapamulin|mesh-list
139532103|NCT01591785|Petrolatum|petrolatum|mesh-list
139532104|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139532105|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139532106|NCT01591785|Emollients|emollients|mesh-ancestor
139532107|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
139532108|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
139532109|NCT03654040|Everolimus|everolimus|mesh-list
139532110|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139532111|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
139532112|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532113|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139532114|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139532115|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
139532116|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532117|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532118|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139532119|NCT03654040|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139532120|NCT03654040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139532121|NCT03654040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532122|NCT03833440|Docetaxel|docetaxel|mesh-list
139532123|NCT03833440|Durvalumab|durvalumab|mesh-list
139532124|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532125|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
139532126|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
139532127|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
139532128|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532129|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139532130|NCT01677442|Anesthetics|anesthetics|mesh-list
139532131|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139532132|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532133|NCT01695135|Prednisone|prednisone|mesh-list
139532134|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
139532135|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139532136|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
139532137|NCT01695135|Hormones|hormones|mesh-ancestor
139532138|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139532139|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313769|NCT03355352|Sufentanil|sufentanil|mesh-list
139532140|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139532141|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532142|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139532143|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532144|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532145|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
139532146|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139532147|NCT03749902|Misoprostol|misoprostol|mesh-list
139532148|NCT03749902|Oxytocin|oxytocin|mesh-list
139532149|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
139532150|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139532151|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532152|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139532153|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
139532154|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139532155|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139532156|NCT01590771|Metformin|metformin|mesh-list
139532157|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139532158|NCT01590771|Glimepiride|glimepiride|mesh-list
139532159|NCT01590771|Gliclazide|gliclazide|mesh-list
139532160|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139532161|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532162|NCT01590771|Incretins|incretins|mesh-ancestor
139532163|NCT01590771|Hormones|hormones|mesh-ancestor
139532164|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139532165|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139532166|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
139532167|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532168|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532169|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139532170|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139532171|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
139532172|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
139532173|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139532174|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139532175|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
139532176|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532177|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532178|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
139532179|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
139532180|NCT03735316|Vitamins|vitamins|mesh-ancestor
139532181|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
139532182|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532183|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
139532184|NCT03735316|Hematinics|hematinics|mesh-ancestor
139532185|NCT01694433|Vitamin D|vitamin d|mesh-list
139532186|NCT01694433|Calcitriol|calcitriol|mesh-list
139532187|NCT01694433|Calcipotriene|calcipotriene|mesh-list
139532188|NCT01694433|Vitamins|vitamins|mesh-ancestor
139532189|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
139532190|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532191|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139532192|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
139532193|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139160649|NCT04651348|Antibodies|antibodies|mesh-list
139160650|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139160651|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
139160652|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160653|NCT04642365|Atezolizumab|atezolizumab|mesh-list
139160654|NCT04642365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139532194|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139532195|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139532196|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532197|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139532198|NCT01693185|Midazolam|midazolam|mesh-list
139532199|NCT01693185|Meperidine|meperidine|mesh-list
139532200|NCT01693185|Remifentanil|remifentanil|mesh-list
139532201|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139532202|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139532203|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139532204|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532205|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139532206|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139532207|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139532208|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139532209|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
139532210|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
139532211|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
139532212|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
139532213|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532214|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532215|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139532216|NCT01693185|Narcotics|narcotics|mesh-ancestor
139532218|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
139532219|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532220|NCT03630640|Nivolumab|nivolumab|mesh-list
139532221|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139532222|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532223|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139532224|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532225|NCT03625726|Thrombin|thrombin|mesh-list
139532226|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
139532227|NCT03625726|Coagulants|coagulants|mesh-ancestor
139532228|NCT03814954|Epinephrine|epinephrine|mesh-list
139532229|NCT03814954|Albuterol|albuterol|mesh-list
139532230|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139532231|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139532232|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
139532233|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532234|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532235|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532236|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139532237|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139532238|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
139532239|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532240|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139532241|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
139532242|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
139532243|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
139532244|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139532245|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
139532246|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139532247|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139532248|NCT03813160|Dronabinol|dronabinol|mesh-list
139532249|NCT03813160|Lenabasum|lenabasum|mesh-list
139532250|NCT03813160|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139532251|NCT03813160|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139532252|NCT03813160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532253|NCT03813160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532254|NCT03813160|Hormones|hormones|mesh-ancestor
139532255|NCT03813160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139532256|NCT03813160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532257|NCT03813160|Hallucinogens|hallucinogens|mesh-ancestor
139532258|NCT03813160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139532259|NCT03813160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139532260|NCT03813160|Analgesics|analgesics|mesh-ancestor
139532261|NCT03813160|Sensory System Agents|sensory system agents|mesh-ancestor
139532262|NCT03813160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532263|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139532264|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139532265|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
139532266|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532267|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139532268|NCT03807856|Dabigatran|dabigatran|mesh-list
139532269|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
139532270|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139532271|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
139532272|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532273|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532274|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
139532275|NCT03806530|Gabapentin|gabapentin|mesh-list
139532276|NCT03806530|Ropinirole|ropinirole|mesh-list
139532277|NCT03806530|Analgesics|analgesics|mesh-ancestor
139532278|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
139532279|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532280|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532281|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
139532282|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139532283|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139532284|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139532285|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139532286|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139532287|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139532288|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532289|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532290|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
139532291|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139532292|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139532293|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
139532294|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
139532295|NCT00003820|Rituximab|rituximab|mesh-list
139532296|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139532297|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532298|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
139532299|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532300|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139532301|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
139532302|NCT01693029|Hematinics|hematinics|mesh-ancestor
139532303|NCT01589445|Metformin|metformin|mesh-list
139532304|NCT01589445|Pioglitazone|pioglitazone|mesh-list
139532305|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139532306|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532307|NCT01561989|Vitamin D|vitamin d|mesh-list
139532308|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
139532309|NCT01561989|Vaccines|vaccines|mesh-list
139532310|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
139532311|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532312|NCT01561989|Vitamins|vitamins|mesh-ancestor
139532313|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
139532314|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139532315|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139532316|NCT00004054|Paclitaxel|paclitaxel|mesh-list
139532317|NCT00004054|Etoposide|etoposide|mesh-list
139532318|NCT00004054|Bicalutamide|bicalutamide|mesh-list
139532319|NCT00004054|Flutamide|flutamide|mesh-list
139532320|NCT00004054|Estramustine|estramustine|mesh-list
139532321|NCT00004054|Warfarin|warfarin|mesh-list
139532322|NCT00004054|Hormones|hormones|mesh-list
139532323|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139532324|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139532325|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532326|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
139532327|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
139532328|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
139532329|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532330|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139532331|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139532332|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532333|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139532334|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532335|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
139532336|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
139532337|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
139161116|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532338|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139532339|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139532340|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
139532341|NCT01587885|Omeprazole|omeprazole|mesh-list
139532342|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139532343|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139532344|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139532345|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532346|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532347|NCT01587651|Ticagrelor|ticagrelor|mesh-list
139532348|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139532349|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139532350|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139532351|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139532352|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139532353|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
139532354|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532355|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532356|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532357|NCT04763434|Dexamethasone|dexamethasone|mesh-list
139532358|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
139532359|NCT04763434|Ropivacaine|ropivacaine|mesh-list
139532360|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139532361|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
139532362|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
139532363|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532364|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532365|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139532366|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
139532367|NCT04763434|Hormones|hormones|mesh-ancestor
139642472|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139313992|NCT05528146|Psyllium|psyllium|mesh-list
139532368|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139532369|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139532370|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532371|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139532372|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139532373|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139532374|NCT04763434|Analgesics|analgesics|mesh-ancestor
139532375|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
139532376|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139532377|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139532378|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139532379|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
139532380|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532381|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532382|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
139532383|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
139532384|NCT04762966|Metformin|metformin|mesh-list
139532385|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139532386|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532387|NCT03602560|Seladelpar|seladelpar|mesh-list
139532388|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139532389|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
139532390|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532391|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139532392|NCT00779116|Cetirizine|cetirizine|mesh-list
139532393|NCT00779116|Desloratadine|desloratadine|mesh-list
139532394|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139532395|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139532396|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139532397|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
139532398|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
139532399|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532400|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532401|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532402|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139532403|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
139532404|NCT01691781|Lisinopril|lisinopril|mesh-list
139532405|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139532406|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
139532407|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532408|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532409|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139532410|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139532411|NCT01691781|Protective Agents|protective agents|mesh-ancestor
139532412|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532413|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
139532414|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139532415|NCT01561755|Antibodies|antibodies|mesh-list
139532416|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
139532417|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139532418|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
139532419|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532420|NCT03789214|Suvorexant|suvorexant|mesh-list
139532421|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139532422|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139532423|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139532424|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532425|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139532426|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532427|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532428|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
139532429|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139532430|NCT04124367|Protective Agents|protective agents|mesh-ancestor
139532431|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532432|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
139532433|NCT01560507|Bupropion|bupropion|mesh-list
139532434|NCT01560507|Nicotine|nicotine|mesh-list
139532435|NCT01560507|Varenicline|varenicline|mesh-list
139532436|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139532437|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
139532438|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532439|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532440|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139532441|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139532442|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
139532443|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532444|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532445|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139532446|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
139532447|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139532448|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139532449|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139532450|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139532451|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
139532452|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139532453|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139532454|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532456|NCT03684538|Trace Elements|trace elements|mesh-ancestor
139532457|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
139532458|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532459|NCT03682978|Baclofen|baclofen|mesh-list
139532460|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139532461|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532462|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139532463|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532464|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139532465|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
139532466|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
139532467|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532468|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532469|NCT03676192|Bevacizumab|bevacizumab|mesh-list
139532470|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139532471|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532472|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139532473|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139161369|NCT02254031|Immunotoxins|immunotoxins|mesh-ancestor
139532474|NCT03676192|Growth Substances|growth substances|mesh-ancestor
139532475|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532476|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
139532477|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
139532478|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139532479|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139532480|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139532481|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139532482|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532483|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
139532484|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532485|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532486|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139532487|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532488|NCT03580408|Nivolumab|nivolumab|mesh-list
139532489|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139532490|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532491|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139532492|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532493|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
139532494|NCT03766750|Linagliptin|linagliptin|mesh-list
139532495|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139532496|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532497|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139532498|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532499|NCT03766750|Incretins|incretins|mesh-ancestor
139532500|NCT03766750|Hormones|hormones|mesh-ancestor
139532501|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139532502|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139532503|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
139532504|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532505|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
139532506|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
139532507|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139532508|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
139532509|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532510|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139532511|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139532512|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
139532513|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532514|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532515|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139532516|NCT04762810|Hormones|hormones|mesh-ancestor
139532517|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139532518|NCT03674242|Carboplatin|carboplatin|mesh-list
139532519|NCT03674242|Gemcitabine|gemcitabine|mesh-list
139532520|NCT03674242|Asparaginase|asparaginase|mesh-list
139532521|NCT03674242|Eryaspase|eryaspase|mesh-list
139532522|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532523|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139532524|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
139532525|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532526|NCT04761952|Infliximab|infliximab|mesh-list
139532527|NCT04761952|Azathioprine|azathioprine|mesh-list
139532528|NCT04761952|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139161522|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
139532529|NCT04761952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139532530|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
139532531|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139532532|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139532533|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
139532534|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532535|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139532536|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532537|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139532538|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
139532539|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532540|NCT03673072|Gemcitabine|gemcitabine|mesh-list
139532541|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532542|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139532543|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
139532544|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532545|NCT01690299|Etanercept|etanercept|mesh-list
139532546|NCT01690299|Apremilast|apremilast|mesh-list
139532547|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139532548|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139532549|NCT01690299|Analgesics|analgesics|mesh-ancestor
139532550|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
139532551|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532552|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532553|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139532554|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139532555|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139532556|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139532557|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
139532558|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139532559|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139532560|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532561|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532562|NCT03570814|Azithromycin|azithromycin|mesh-list
139532563|NCT03570814|Ivermectin|ivermectin|mesh-list
139532564|NCT03570814|Albendazole|albendazole|mesh-list
139532565|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139532566|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139532567|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139532568|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
139532569|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
139532570|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139532571|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139532572|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
139532573|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
139532574|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
139532575|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532576|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532577|NCT00723736|Desloratadine|desloratadine|mesh-list
139532578|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139532579|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
139532580|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532581|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532582|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532583|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139532584|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139532585|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
139532586|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
139532587|NCT00305344|Vaccines|vaccines|mesh-list
139532588|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
139532589|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532590|NCT01690143|Melphalan|melphalan|mesh-list
139532591|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139532592|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
139161635|NCT00888459|Nicotine|nicotine|mesh-list
139532593|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532594|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532595|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139532596|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139532597|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
139532598|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532599|NCT05347498|Febuxostat|febuxostat|mesh-list
139532600|NCT05347498|Gout Suppressants|gout suppressants|mesh-ancestor
139532601|NCT05347498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139532602|NCT01677364|Oxytocin|oxytocin|mesh-list
139532603|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
139532604|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139532605|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532606|NCT03563248|Nivolumab|nivolumab|mesh-list
139532607|NCT03563248|Folfirinox|folfirinox|mesh-list
139532608|NCT03563248|Losartan|losartan|mesh-list
139532609|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139532610|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532611|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139532612|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532613|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139532614|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139532615|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139532616|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139532617|NCT04403776|Tofacitinib|tofacitinib|mesh-list
139532618|NCT04403776|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139532619|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139532620|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532621|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532622|NCT03559348|Leucovorin|leucovorin|mesh-list
139532623|NCT03559348|Gemcitabine|gemcitabine|mesh-list
139532624|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139532625|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
139532626|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532627|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532628|NCT03559348|Antidotes|antidotes|mesh-ancestor
139532629|NCT03559348|Protective Agents|protective agents|mesh-ancestor
139532630|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532631|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
139532632|NCT03559348|Vitamins|vitamins|mesh-ancestor
139532633|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
139532634|NCT04762030|Paclitaxel|paclitaxel|mesh-list
139532635|NCT04762030|Carboplatin|carboplatin|mesh-list
139532636|NCT04762030|Durvalumab|durvalumab|mesh-list
139532637|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139532638|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532639|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
139532640|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
139532641|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
139532642|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532643|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139532644|NCT01559259|Acetaminophen|acetaminophen|mesh-list
139532645|NCT01559259|Ibuprofen|ibuprofen|mesh-list
139532646|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139532647|NCT01559259|Analgesics|analgesics|mesh-ancestor
139532648|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
139532649|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532650|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532651|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
139532652|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139532653|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139532654|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139532655|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139532656|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532657|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532658|NCT03088306|Acetaminophen|acetaminophen|mesh-list
139532659|NCT03088306|Fentanyl|fentanyl|mesh-list
139532660|NCT03088306|Ketamine|ketamine|mesh-list
139532661|NCT03088306|Gabapentin|gabapentin|mesh-list
139532662|NCT03088306|Hydromorphone|hydromorphone|mesh-list
139532663|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
139532664|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139532665|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314290|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
139532666|NCT03088306|Analgesics|analgesics|mesh-ancestor
139532667|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
139532668|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532669|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139532670|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139532671|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
139532672|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139532673|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139532674|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139161902|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
139532675|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532676|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139532677|NCT03088306|Narcotics|narcotics|mesh-ancestor
139532678|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139532679|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139532680|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
139532681|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
139532682|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139532683|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139532684|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139532685|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
139532686|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
139532687|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139532688|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532689|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139532690|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532691|NCT03088384|Ketamine|ketamine|mesh-list
139532692|NCT03088384|Analgesics|analgesics|mesh-ancestor
139532693|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
139532694|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532695|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532696|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139532697|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139532698|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
139532699|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
139532700|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139532701|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139532702|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139532703|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532704|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532705|NCT01677598|Ustekinumab|ustekinumab|mesh-list
139532706|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
139532707|NCT01677754|Memantine|memantine|mesh-list
139532708|NCT01677754|Rivastigmine|rivastigmine|mesh-list
139532709|NCT01677754|Donepezil|donepezil|mesh-list
139532710|NCT01677754|Galantamine|galantamine|mesh-list
139532711|NCT01677754|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139532712|NCT01677754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532713|NCT01677754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532714|NCT01677754|Cholinergic Agents|cholinergic agents|mesh-ancestor
139532715|NCT01677754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532716|NCT01677754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532717|NCT01677754|Nootropic Agents|nootropic agents|mesh-ancestor
139532718|NCT01677754|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139532719|NCT01677754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139532720|NCT01677754|Dopamine Agents|dopamine agents|mesh-ancestor
139532721|NCT01677754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139532722|NCT01677754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139532723|NCT01677754|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139532724|NCT01677754|Autonomic Agents|autonomic agents|mesh-ancestor
139532725|NCT01677754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532726|NCT01677754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139532727|NCT01677754|Protective Agents|protective agents|mesh-ancestor
139532728|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
139532729|NCT01670500|Cisplatin|cisplatin|mesh-list
139532730|NCT01670500|Doxorubicin|doxorubicin|mesh-list
139532731|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139532732|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
139532733|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532734|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139532735|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139532736|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
139532737|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532738|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532739|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139532740|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139532741|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139532742|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139532743|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532744|NCT01678612|Copper|copper|mesh-list
139532745|NCT01678612|Trace Elements|trace elements|mesh-ancestor
139532746|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
139532747|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532748|NCT03525574|Ivacaftor|ivacaftor|mesh-list
139532749|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139532750|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139532751|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532752|NCT02405260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139532753|NCT02405260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139532754|NCT02405260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532755|NCT02405260|Incretins|incretins|mesh-ancestor
139532756|NCT02405260|Hormones|hormones|mesh-ancestor
139162258|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139532757|NCT02405260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139532758|NCT02405260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139532759|NCT02405260|Protease Inhibitors|protease inhibitors|mesh-ancestor
139532760|NCT02405260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532761|NCT02405260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532762|NCT03519646|Eliglustat|eliglustat|mesh-list
139532763|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532764|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532765|NCT02984722|Metformin|metformin|mesh-list
139532766|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139532767|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532768|NCT02401750|Naltrexone|naltrexone|mesh-list
139532769|NCT02401750|Oxycodone|oxycodone|mesh-list
139532770|NCT02401750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139532771|NCT02401750|Narcotics|narcotics|mesh-ancestor
139532772|NCT02401750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139532773|NCT02401750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532774|NCT02401750|Analgesics|analgesics|mesh-ancestor
139532775|NCT02401750|Sensory System Agents|sensory system agents|mesh-ancestor
139532776|NCT02401750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532777|NCT02401750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139532778|NCT02401750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139532779|NCT01689519|Vemurafenib|vemurafenib|mesh-list
139532780|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532781|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139532782|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532783|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532784|NCT01689363|Histamine|histamine|mesh-list
139532785|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
139532786|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
139532787|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139532788|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532789|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532790|NCT03455140|BCT-100|bct-100|mesh-list
139532791|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532792|NCT01689207|Aztreonam|aztreonam|mesh-list
139532793|NCT01689207|Avibactam|avibactam|mesh-list
139532794|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139532795|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139532796|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139532797|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532798|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532799|NCT00089284|Rituximab|rituximab|mesh-list
139532800|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
139532801|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139532802|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532803|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
139532804|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532805|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139532806|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139532807|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
139532808|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139532809|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532810|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139532811|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532812|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532813|NCT00087646|Ribavirin|ribavirin|mesh-list
139532814|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139532815|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
139532816|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
139532817|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532819|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139532820|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
139532821|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532822|NCT03492658|Methotrexate|methotrexate|mesh-list
139532823|NCT03492658|Abatacept|abatacept|mesh-list
139532824|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139532825|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
139532826|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139532827|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532828|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139532829|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
139532830|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532831|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532832|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
139532833|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532834|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139532835|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139532836|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
139532837|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139532838|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139532839|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139532840|NCT03492658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139532841|NCT03085654|Oxytocin|oxytocin|mesh-list
139532842|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
139532843|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139532844|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532845|NCT00087568|Ribavirin|ribavirin|mesh-list
139532846|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139532847|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
139162548|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139532848|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532849|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
139532850|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139532851|NCT04402762|Enoxaparin|enoxaparin|mesh-list
139532852|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
139532853|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
139532854|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139532855|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139532856|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532857|NCT00085540|Romidepsin|romidepsin|mesh-list
139532858|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139532859|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532860|NCT00085540|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139162618|NCT00110422|Irbesartan|irbesartan|mesh-list
139532861|NCT00085540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532862|NCT00085540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532863|NCT01688739|Erenumab|erenumab|mesh-list
139532864|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139532865|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532866|NCT01688739|Analgesics|analgesics|mesh-ancestor
139532867|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
139532868|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532869|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532870|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
139532871|NCT00084838|Leucovorin|leucovorin|mesh-list
139532872|NCT00084838|Cytarabine|cytarabine|mesh-list
139532873|NCT00084838|Dactinomycin|dactinomycin|mesh-list
139532874|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
139532875|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139532876|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139532877|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139532878|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
139532879|NCT00084838|Temozolomide|temozolomide|mesh-list
139532880|NCT00084838|Cisplatin|cisplatin|mesh-list
139532881|NCT00084838|Doxorubicin|doxorubicin|mesh-list
139532882|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139532883|NCT00084838|Methotrexate|methotrexate|mesh-list
139532884|NCT00084838|Etoposide|etoposide|mesh-list
139532885|NCT00084838|Vincristine|vincristine|mesh-list
139532886|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
139532887|NCT00084838|Razoxane|razoxane|mesh-list
139532888|NCT00084838|Lenograstim|lenograstim|mesh-list
139532889|NCT00084838|Calcium|calcium|mesh-list
139532890|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
139532891|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139532892|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
139532893|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162744|NCT02285374|Emtricitabine|emtricitabine|mesh-list
139532894|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139314520|NCT05515120|Aspirin|aspirin|mesh-list
139532895|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139532896|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
139532897|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532898|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532899|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139532900|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139532901|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139532902|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139532903|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532904|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139532905|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139532906|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139532907|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
139532908|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139532909|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139532911|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
139532912|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139532913|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139532914|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139532915|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
139532916|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139532917|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139532918|NCT00084838|Antidotes|antidotes|mesh-ancestor
139532919|NCT00084838|Protective Agents|protective agents|mesh-ancestor
139532920|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
139532921|NCT00084838|Vitamins|vitamins|mesh-ancestor
139532922|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
139532923|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
139532924|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
139532925|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
139532926|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139532927|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139532928|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139532929|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139532930|NCT01558089|Etanercept|etanercept|mesh-list
139532931|NCT01558089|Methotrexate|methotrexate|mesh-list
139532932|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139532933|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
139532934|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139532935|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532936|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139532937|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
139532938|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532939|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532940|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
139532941|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532942|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139532943|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139532944|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
139532945|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139532946|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139532947|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139532948|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139532949|NCT01558089|Analgesics|analgesics|mesh-ancestor
139532950|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
139532951|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139532952|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139532953|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139532954|NCT00084682|Romidepsin|romidepsin|mesh-list
139532955|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139532956|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532957|NCT00084682|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139532958|NCT00084682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532959|NCT00084682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532960|NCT01556997|Amlodipine|amlodipine|mesh-list
139532961|NCT01556997|Perindopril|perindopril|mesh-list
139532962|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139532963|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139532964|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139532965|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532966|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139532967|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532968|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
139532969|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139532970|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
139532971|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532972|NCT00082888|Tipifarnib|tipifarnib|mesh-list
139532973|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532974|NCT03085186|Crizotinib|crizotinib|mesh-list
139532975|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532976|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139532977|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139532978|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532979|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
139532980|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139532981|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139532982|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139532983|NCT00082810|Fulvestrant|fulvestrant|mesh-list
139532984|NCT00082810|Tipifarnib|tipifarnib|mesh-list
139532985|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139532986|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532987|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139532988|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139532989|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
139532990|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139532991|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532992|NCT03085030|Antioxidants|antioxidants|mesh-list
139532993|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139532994|NCT03085030|Protective Agents|protective agents|mesh-ancestor
139532995|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139532996|NCT03443128|Vinorelbine|vinorelbine|mesh-list
139532997|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139532998|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139532999|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
139533000|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
139533001|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
139533002|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533003|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
139533004|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139533005|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139533006|NCT03437746|Prednisolone|prednisolone|mesh-list
139533007|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
139533008|NCT03437746|Anesthetics|anesthetics|mesh-list
139533009|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139533010|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
139533011|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139533012|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
139533013|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
139533014|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533015|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533016|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139533017|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
139533018|NCT03437746|Hormones|hormones|mesh-ancestor
139533019|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139533020|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139533021|NCT03437746|Protective Agents|protective agents|mesh-ancestor
139533022|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139533023|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533024|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533025|NCT03084250|Tenofovir|tenofovir|mesh-list
139533026|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139533027|NCT03084250|Entecavir|entecavir|mesh-list
139533028|NCT03084250|Adefovir|adefovir|mesh-list
139163040|NCT03147248|Infliximab|infliximab|mesh-list
139533029|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
139533030|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533031|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139533032|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139533033|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533034|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533035|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139533036|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139533037|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
139533038|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139533039|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139533040|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139533041|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533042|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
139533043|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139533044|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533045|NCT03084328|Vitamin D|vitamin d|mesh-list
139533046|NCT03084328|Vitamins|vitamins|mesh-ancestor
139533047|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
139533048|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533049|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139533050|NCT01678690|Gemcitabine|gemcitabine|mesh-list
139533051|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139533052|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
139533053|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533054|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533055|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
139533056|NCT01679080|Teriparatide|teriparatide|mesh-list
139533057|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139533058|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533059|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139533060|NCT03083782|Cyclosporine|cyclosporine|mesh-list
139533061|NCT03083782|Apixaban|apixaban|mesh-list
139533062|NCT03083782|Tacrolimus|tacrolimus|mesh-list
139533063|NCT03083782|Cyclosporins|cyclosporins|mesh-list
139533064|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139533065|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
139533066|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533067|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139533068|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533069|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533070|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
139533071|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533072|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
139533073|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139533074|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139533075|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
139533076|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139533077|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
139533078|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
139533079|NCT03471442|Bupivacaine|bupivacaine|mesh-list
139533080|NCT03471442|Ropivacaine|ropivacaine|mesh-list
139533081|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
139533082|NCT03471442|Anesthetics|anesthetics|mesh-list
139533083|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
139533084|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533085|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533086|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
139533087|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533088|NCT01679392|Ropivacaine|ropivacaine|mesh-list
139533089|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
139533090|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
139163347|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533091|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533092|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533093|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
139533094|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533095|NCT03083080|Epinephrine|epinephrine|mesh-list
139533096|NCT03083080|Ropivacaine|ropivacaine|mesh-list
139533097|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
139533098|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
139533099|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533100|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533101|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
139533102|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533103|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139533104|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139533105|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
139533106|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139533107|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533108|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139533109|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139533110|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
139533111|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139533112|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
139533113|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
139533114|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
139533115|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139533116|NCT03082300|Naquotinib|naquotinib|mesh-list
139533117|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533118|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139533119|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533120|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533121|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
139533122|NCT01679860|Immunomodulating Agents|immunomodulating agents|mesh-list
139533123|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
139533124|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533125|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139163533|NCT01213849|Xhance|xhance|mesh-list
139533126|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533127|NCT05346952|Carboplatin|carboplatin|mesh-list
139533128|NCT05346952|Pemetrexed|pemetrexed|mesh-list
139533129|NCT05346952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533130|NCT05346952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533131|NCT05346952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533132|NCT05346952|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139533133|NCT05346952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139533134|NCT03081442|Misoprostol|misoprostol|mesh-list
139533135|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
139533136|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139533137|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
139533138|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139533139|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533140|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139533141|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139533142|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
139533143|NCT03431194|Midodrine|midodrine|mesh-list
139533144|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
139533145|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
139533146|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533147|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533148|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139533149|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139533150|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139533151|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139533152|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
139533153|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139533154|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533155|NCT03080740|Metronidazole|metronidazole|mesh-list
139533156|NCT03080740|Clindamycin|clindamycin|mesh-list
139533157|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
139533158|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
139533159|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533160|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139533161|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139533162|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139533163|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139533164|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533165|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533166|NCT03081832|Oxytocin|oxytocin|mesh-list
139533167|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
139533168|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139533169|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533170|NCT05345938|Mitoxantrone|mitoxantrone|mesh-list
139533171|NCT05345938|Analgesics|analgesics|mesh-ancestor
139533172|NCT05345938|Sensory System Agents|sensory system agents|mesh-ancestor
139533173|NCT05345938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533174|NCT05345938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533175|NCT05345938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533176|NCT05345938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139533177|NCT05345938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139163646|NCT01122121|Leuprolide|leuprolide|mesh-list
139533178|NCT05345938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533179|NCT05345938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533180|NCT03080350|Fentanyl|fentanyl|mesh-list
139533181|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139533182|NCT03080350|Narcotics|narcotics|mesh-ancestor
139533183|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533184|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533185|NCT03080350|Analgesics|analgesics|mesh-ancestor
139533186|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
139163694|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139533187|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533188|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139533189|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139533190|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
139533191|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
139533192|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139533193|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139533194|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139314818|NCT05512546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139533195|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533196|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533197|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139533198|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139533199|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139533200|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
139533201|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163783|NCT01116193|Hormones|hormones|mesh-ancestor
139533202|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533203|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139533204|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139533205|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
139533207|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533208|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139533209|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533210|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533211|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
139533212|NCT03323866|Budesonide|budesonide|mesh-list
139533213|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139533214|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139533215|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
139533216|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163828|NCT01116583|Gabapentin|gabapentin|mesh-list
139533217|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533218|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139533219|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
139533220|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
139533221|NCT03323866|Hormones|hormones|mesh-ancestor
139533222|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139533223|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
139533224|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139533225|NCT05688670|Ropivacaine|ropivacaine|mesh-list
139533226|NCT05688670|Anesthetics|anesthetics|mesh-ancestor
139533227|NCT05688670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533228|NCT05688670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533229|NCT05688670|Anesthetics, Local|anesthetics, local|mesh-ancestor
139533230|NCT05688670|Sensory System Agents|sensory system agents|mesh-ancestor
139533231|NCT05688670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533232|NCT05684848|Resveratrol|resveratrol|mesh-list
139533233|NCT05684848|Antioxidants|antioxidants|mesh-ancestor
139533234|NCT05684848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533235|NCT05684848|Protective Agents|protective agents|mesh-ancestor
139533236|NCT05684848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533237|NCT05684848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163878|NCT03939871|Vinorelbine|vinorelbine|mesh-list
139163880|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533238|NCT05684848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139533239|NCT03366298|Epinephrine|epinephrine|mesh-list
139533240|NCT03366298|Racepinephrine|racepinephrine|mesh-list
139533241|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
139533242|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139533243|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139533244|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
139533245|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139533246|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533247|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533248|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139533249|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139533250|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
139533251|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533252|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139533253|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
139533254|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
139533255|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
139533256|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139533257|NCT01842620|Metformin|metformin|mesh-list
139163942|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
139163943|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139163944|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139163945|NCT04467892|Prednisolone|prednisolone|mesh-list
139163946|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
139163947|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139163948|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
139163949|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139163950|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
139163951|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
139533258|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139533259|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533260|NCT04760704|Antibodies|antibodies|mesh-list
139533261|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
139533262|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533263|NCT01931839|Ivacaftor|ivacaftor|mesh-list
139533264|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139533265|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139533266|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533267|NCT01842308|Melphalan|melphalan|mesh-list
139533268|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
139533269|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139533270|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139533271|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
139533272|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533273|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163989|NCT03524950|Analgesics|analgesics|mesh-ancestor
139163990|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
139163991|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163992|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139163993|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139533274|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139533275|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139533276|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
139533277|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533278|NCT01931059|Risperidone|risperidone|mesh-list
139533279|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139533280|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
139533281|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139533282|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533283|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533284|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139533285|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139533286|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533287|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139164047|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
139533288|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139533289|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
139533290|NCT01841762|Macitentan|macitentan|mesh-list
139533291|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139533292|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139533293|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533294|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139533295|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
139533296|NCT03301636|Nivolumab|nivolumab|mesh-list
139533297|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139533298|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533299|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139533300|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533301|NCT04602494|Varenicline|varenicline|mesh-list
139533302|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139533303|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139533304|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
139533305|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139533306|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533307|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533308|NCT05640232|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139533309|NCT05640232|Parasympatholytics|parasympatholytics|mesh-ancestor
139533310|NCT05640232|Autonomic Agents|autonomic agents|mesh-ancestor
139533311|NCT05640232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533312|NCT05640232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533313|NCT05640232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139533314|NCT05640232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139533315|NCT05640232|Cholinergic Agents|cholinergic agents|mesh-ancestor
139164166|NCT03936205|Analgesics|analgesics|mesh-ancestor
139533316|NCT05640232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139533317|NCT05640232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533318|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139533319|NCT01970371|Meropenem|meropenem|mesh-list
139533320|NCT01970371|Colistin|colistin|mesh-list
139533321|NCT01970371|Tigecycline|tigecycline|mesh-list
139533322|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533323|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139533324|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533325|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533326|NCT05604742|Belimumab|belimumab|mesh-list
139533327|NCT05604742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139533328|NCT05604742|Immunologic Factors|immunologic factors|mesh-ancestor
139533329|NCT05604742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533330|NCT03350386|Oxaprozin|oxaprozin|mesh-list
139533331|NCT03350386|Dotinurad|dotinurad|mesh-list
139533332|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
139533333|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
139533334|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139533335|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139533336|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139533337|NCT03350386|Analgesics|analgesics|mesh-ancestor
139533338|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
139533339|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533340|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533341|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139533342|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139314980|NCT02511704|Nicotine|nicotine|mesh-list
139533343|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533344|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533345|NCT05567458|Luspatercept|luspatercept|mesh-list
139533346|NCT05567458|Hematinics|hematinics|mesh-ancestor
139533347|NCT03344692|Alirocumab|alirocumab|mesh-list
139533348|NCT03344692|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139533349|NCT03344692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139533350|NCT03344692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139533351|NCT03344692|Antimetabolites|antimetabolites|mesh-ancestor
139533352|NCT03344692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533353|NCT03344692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139533354|NCT03344692|Protease Inhibitors|protease inhibitors|mesh-ancestor
139533355|NCT03344692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533356|NCT03344692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139533357|NCT05305924|Fulvestrant|fulvestrant|mesh-list
139533358|NCT05305924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139533359|NCT05305924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533360|NCT05305924|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139533361|NCT05305924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139533362|NCT05305924|Hormone Antagonists|hormone antagonists|mesh-ancestor
139533363|NCT05305924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139533364|NCT05305924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533365|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139533366|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
139533367|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533368|NCT05223088|Oxaliplatin|oxaliplatin|mesh-list
139533369|NCT05223088|Apatinib|apatinib|mesh-list
139533370|NCT05223088|Tislelizumab|tislelizumab|mesh-list
139533371|NCT05223088|Tegafur|tegafur|mesh-list
139533372|NCT05223088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533373|NCT05223088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139533374|NCT05223088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533375|NCT05223088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533376|NCT05223088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139164396|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139533377|NCT05223088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139533378|NCT05223088|Antimetabolites|antimetabolites|mesh-ancestor
139533379|NCT01838876|Cariprazine|cariprazine|mesh-list
139533380|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
139533381|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139533382|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139533383|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139533384|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533385|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533386|NCT03279250|Prednisone|prednisone|mesh-list
139533387|NCT03279250|Cortisone|cortisone|mesh-list
139533388|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
139533389|NCT03279250|Hormones|hormones|mesh-list
139533390|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139533391|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139533392|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
139533393|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139533394|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533395|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139533396|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533397|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139533398|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533399|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533400|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
139533401|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139533402|NCT01838642|Ponatinib|ponatinib|mesh-list
139533403|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533404|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139533405|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533406|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533407|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139533408|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139533409|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
139533410|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139533411|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139533412|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533413|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
139533414|NCT01813058|Coagulants|coagulants|mesh-ancestor
139533415|NCT05491330|Ritonavir|ritonavir|mesh-list
139533416|NCT05491330|Nirmatrelvir|nirmatrelvir|mesh-list
139533417|NCT05491330|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139533418|NCT05491330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139533419|NCT05491330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139533420|NCT05491330|Protease Inhibitors|protease inhibitors|mesh-ancestor
139533421|NCT05491330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164529|NCT02456012|Esomeprazole|esomeprazole|mesh-list
139533422|NCT05491330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533423|NCT05491330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139533424|NCT05491330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139533425|NCT05491330|Antiviral Agents|antiviral agents|mesh-ancestor
139533426|NCT05491330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533427|NCT05491330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139533428|NCT05491330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139533429|NCT01811732|Vancomycin|vancomycin|mesh-list
139533430|NCT01811732|Aztreonam|aztreonam|mesh-list
139533431|NCT01811732|Delafloxacin|delafloxacin|mesh-list
139533432|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139533433|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533434|NCT05139004|Fludarabine|fludarabine|mesh-list
139533435|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
139533436|NCT05139004|Melphalan|melphalan|mesh-list
139533437|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
139533438|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139533439|NCT05139004|Basiliximab|basiliximab|mesh-list
139533440|NCT05139004|Mitogens|mitogens|mesh-list
139533441|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
139533442|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533443|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139533444|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
139533445|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533446|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139533447|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
139533448|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533449|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139533450|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
139533451|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139533452|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
139533453|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
139533454|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
139533455|NCT01811186|Oxycodone|oxycodone|mesh-list
139533456|NCT01811186|Naloxone|naloxone|mesh-list
139533457|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139533458|NCT01811186|Narcotics|narcotics|mesh-ancestor
139533459|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533460|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533461|NCT01811186|Analgesics|analgesics|mesh-ancestor
139533462|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
139533463|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533464|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139533465|NCT01866098|Naltrexone|naltrexone|mesh-list
139533466|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139533467|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139533468|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533469|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
139533470|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533471|NCT04885972|Triamcinolone|triamcinolone|mesh-list
139533472|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139533473|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139533474|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139533475|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139533476|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
139533477|NCT04885972|Hormones|hormones|mesh-ancestor
139533478|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139533479|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533480|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139533481|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
139533482|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533483|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533484|NCT03985540|Methamphetamine|methamphetamine|mesh-list
139533485|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139533486|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164697|NCT06128278|Equol|equol|mesh-list
139533487|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
139533488|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
139533489|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533490|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
139533491|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139533492|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533493|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
139533494|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139533495|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139533496|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139533497|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139533498|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139533499|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
139533500|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
139533501|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533502|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533503|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
139533504|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533505|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139533506|NCT01865552|Etanercept|etanercept|mesh-list
139533507|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139533508|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139533509|NCT01865552|Analgesics|analgesics|mesh-ancestor
139533510|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
139533511|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533512|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533513|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139533514|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139164778|NCT06126068|Tocolytic Agents|tocolytic agents|mesh-ancestor
139533515|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139533516|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139533517|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
139533518|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
139533519|NCT01809314|Hematinics|hematinics|mesh-ancestor
139533520|NCT01808690|Metformin|metformin|mesh-list
139533521|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139533522|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533523|NCT04583618|Vaccines|vaccines|mesh-list
139533524|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139533525|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
139533526|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533527|NCT04413734|Cisplatin|cisplatin|mesh-list
139533528|NCT04413734|Gemcitabine|gemcitabine|mesh-list
139533529|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533530|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139533531|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
139533532|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533533|NCT03229798|Sumatriptan|sumatriptan|mesh-list
139533534|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139533535|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139533536|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139533537|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
139533538|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139533539|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533540|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533541|NCT04805944|Dolutegravir|dolutegravir|mesh-list
139533542|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139533543|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139533544|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533545|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164899|NCT05867329|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139164900|NCT05867329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139164909|NCT05736224|Sunscreening Agents|sunscreening agents|mesh-list
139164910|NCT05736224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139164911|NCT05736224|Protective Agents|protective agents|mesh-ancestor
139164912|NCT05736224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164913|NCT05736224|Dermatologic Agents|dermatologic agents|mesh-ancestor
139164914|NCT05733923|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139533546|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139533547|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139533548|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
139533549|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533550|NCT03906292|Niacinamide|niacinamide|mesh-list
139533551|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
139533552|NCT03906292|Dasatinib|dasatinib|mesh-list
139164967|NCT05608252|Fulvestrant|fulvestrant|mesh-list
139533553|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533554|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139533555|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533556|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533557|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
139533558|NCT03906292|Vitamins|vitamins|mesh-ancestor
139533559|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
139533560|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533561|NCT03229174|Droxidopa|droxidopa|mesh-list
139533562|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139533563|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139533564|NCT03227926|Panitumumab|panitumumab|mesh-list
139165027|NCT05232344|Progestins|progestins|mesh-ancestor
139533565|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139533566|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533567|NCT03615742|Budesonide|budesonide|mesh-list
139533568|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139533569|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139533570|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
139533571|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533572|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533573|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139533574|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
139533575|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
139533576|NCT03615742|Hormones|hormones|mesh-ancestor
139533577|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139533578|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139533579|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139533580|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533581|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139533582|NCT01363297|Immunotoxins|immunotoxins|mesh-ancestor
139533583|NCT01363297|Immunoconjugates|immunoconjugates|mesh-ancestor
139533584|NCT01363297|Immunologic Factors|immunologic factors|mesh-ancestor
139533585|NCT01363297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533586|NCT04756804|Ethanol|ethanol|mesh-list
139533587|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
139533588|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139533589|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139533590|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533591|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533592|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533593|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
139533594|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
139533595|NCT03199924|Diclofenac|diclofenac|mesh-list
139533596|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139533597|NCT03199924|Lidocaine|lidocaine|mesh-list
139533598|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
139533599|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
139533600|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
139533601|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533602|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533603|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
139533604|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533605|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139533606|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139533607|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139533608|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139533609|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533610|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139533611|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139533612|NCT03199924|Analgesics|analgesics|mesh-ancestor
139533613|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139533614|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139533615|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533616|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
139533617|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139533618|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139533619|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
139533620|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139533621|NCT04746430|Dexamethasone|dexamethasone|mesh-list
139533622|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139533623|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
139533624|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
139533625|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533626|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533627|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139533628|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
139533629|NCT04746430|Hormones|hormones|mesh-ancestor
139533630|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139533631|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139533632|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533633|NCT03197662|Oxytocin|oxytocin|mesh-list
139533634|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
139533635|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139533636|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533637|NCT03247582|Edoxaban|edoxaban|mesh-list
139533638|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139533639|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
139533640|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139533641|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
139533642|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533643|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533644|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
139533645|NCT01808612|Fluoxetine|fluoxetine|mesh-list
139533646|NCT01808612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139533647|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139533648|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139533649|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533650|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139533651|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
139533652|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533653|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139533654|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
139533655|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139533656|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139533657|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139533658|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533660|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
139533661|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139533662|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139533663|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139533664|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
139533665|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139533666|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533667|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533668|NCT01908829|Urological Agents|urological agents|mesh-ancestor
139533669|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139533670|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139533671|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
139533672|NCT01773122|Dapsone|dapsone|mesh-list
139533673|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533674|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
139533675|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139533676|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139533677|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139533678|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533679|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533680|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
139533681|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139533682|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
139533683|NCT01808534|Ifosfamide|ifosfamide|mesh-list
139533684|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139533685|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
139533686|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533687|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533688|NCT03218800|Ertapenem|ertapenem|mesh-list
139533689|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139533690|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533691|NCT01802216|Minocycline|minocycline|mesh-list
139533692|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139533693|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533694|NCT03621904|Tamoxifen|tamoxifen|mesh-list
139533695|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
139533696|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
139533697|NCT03621904|Progesterone|progesterone|mesh-list
139533698|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139533699|NCT03621904|Progestins|progestins|mesh-ancestor
139533700|NCT03621904|Hormones|hormones|mesh-ancestor
139533701|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139533702|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533703|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139533704|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
139533705|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139533706|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139533707|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139533708|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139533709|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533710|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533711|NCT01808144|Febuxostat|febuxostat|mesh-list
139533712|NCT01808144|Lesinurad|lesinurad|mesh-list
139533713|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
139533714|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139533715|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
139533716|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
139533717|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139533718|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315354|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
139533719|NCT02085070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139533720|NCT02085070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533721|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139533722|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
139533723|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533724|NCT01801436|Bortezomib|bortezomib|mesh-list
139533725|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533726|NCT01771250|Insulin|insulin|mesh-list
139533727|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139533728|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
139533729|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139533730|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533731|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139533732|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139533733|NCT03568708|Estradiol|estradiol|mesh-list
139533734|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139533735|NCT03568708|Estrogens|estrogens|mesh-list
139533736|NCT03568708|Hormones|hormones|mesh-ancestor
139533737|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139533738|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533739|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139533740|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
139533741|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139533742|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139533743|NCT04305106|Bevacizumab|bevacizumab|mesh-list
139533744|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139533745|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533746|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139533747|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139533748|NCT04305106|Growth Substances|growth substances|mesh-ancestor
139533749|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533750|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
139533751|NCT01770392|Rifampin|rifampin|mesh-list
139533752|NCT01770392|Nintedanib|nintedanib|mesh-list
139533753|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139533754|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
139533755|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139533756|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533757|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
139533758|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139533759|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533760|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533761|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139533762|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139533763|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139533764|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139533765|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139533766|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139533767|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533768|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139533769|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
139533770|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139533771|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139533772|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139533773|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139533774|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533775|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
139533776|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165668|NCT03680092|Methotrexate|methotrexate|mesh-list
139533777|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533778|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139533779|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533780|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
139533781|NCT03492112|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139533782|NCT03492112|Velpatasvir|velpatasvir|mesh-list
139533783|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
139533784|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533785|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
139533786|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139533787|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533788|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533789|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139533790|NCT01576575|Rifampin|rifampin|mesh-list
139533791|NCT01576575|Ketoconazole|ketoconazole|mesh-list
139533792|NCT01576575|Buprenorphine|buprenorphine|mesh-list
139533793|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139533794|NCT01576575|Narcotics|narcotics|mesh-ancestor
139533795|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533796|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533797|NCT01576575|Analgesics|analgesics|mesh-ancestor
139533798|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
139533799|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533800|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139533801|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139533802|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
139533803|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139533804|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533805|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
139533806|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139533807|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533808|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533809|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139533810|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139533811|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139533812|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139533813|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139533814|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139533815|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
139533816|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139533817|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139533818|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139533819|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
139533820|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139533821|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139533822|NCT05051566|Esomeprazole|esomeprazole|mesh-list
139533823|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139533824|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139533825|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139533826|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533827|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533828|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
139533829|NCT01576341|Hematinics|hematinics|mesh-ancestor
139533830|NCT04398004|Clarithromycin|clarithromycin|mesh-list
139533831|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139533832|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533833|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139533834|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533835|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533836|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139533837|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139533838|NCT01687413|Cisplatin|cisplatin|mesh-list
139533839|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533840|NCT01555671|Meperidine|meperidine|mesh-list
139533841|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139533842|NCT01555671|Narcotics|narcotics|mesh-ancestor
139533843|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139165950|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139533844|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533845|NCT01555671|Analgesics|analgesics|mesh-ancestor
139533846|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
139533847|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533848|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139533849|NCT03226756|Nivolumab|nivolumab|mesh-list
139533850|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139533851|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533852|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139533853|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533854|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139533855|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
139533856|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139533857|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533858|NCT01807598|Immunotoxins|immunotoxins|mesh-ancestor
139533859|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
139533860|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533861|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
139533862|NCT01801280|Pantoprazole|pantoprazole|mesh-list
139533863|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139533864|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533865|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139533866|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
139533867|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139533868|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533869|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533870|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533871|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139533872|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139533873|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139533874|NCT01769456|Tenofovir|tenofovir|mesh-list
139533875|NCT01769456|Emtricitabine|emtricitabine|mesh-list
139533876|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139533877|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
139533878|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533879|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139533880|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139533881|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533882|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533883|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139533884|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139533885|NCT01769378|Glimepiride|glimepiride|mesh-list
139533886|NCT01769378|Dulaglutide|dulaglutide|mesh-list
139533887|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139533888|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139533889|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166054|NCT04808245|Imiquimod|imiquimod|mesh-list
139533890|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139533891|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
139533892|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139533893|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
139533894|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533895|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139533896|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
139533897|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533898|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139533899|NCT01768286|Ledipasvir|ledipasvir|mesh-list
139166120|NCT04443309|Lenvatinib|lenvatinib|mesh-list
139533900|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
139533901|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533902|NCT01800968|Liraglutide|liraglutide|mesh-list
139533903|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139533904|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533905|NCT01800968|Incretins|incretins|mesh-ancestor
139533906|NCT01800968|Hormones|hormones|mesh-ancestor
139533907|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139533908|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
139533909|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
139533910|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533911|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139533912|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
139533913|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
139533914|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533915|NCT01687101|Menthol|menthol|mesh-list
139533916|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
139533917|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
139533918|NCT01968967|Bococizumab|bococizumab|mesh-list
139533919|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139166182|NCT04211168|Lenvatinib|lenvatinib|mesh-list
139533920|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139533921|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
139533922|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533923|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139533924|NCT01806662|Ustekinumab|ustekinumab|mesh-list
139533925|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
139533926|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
139533927|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
139533928|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139533929|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139533930|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
139533931|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533932|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139533933|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139533934|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139533935|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166233|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166234|NCT04155632|Antidotes|antidotes|mesh-ancestor
139166235|NCT04073134|Evolocumab|evolocumab|mesh-list
139166236|NCT04073134|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139166237|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139166238|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139166239|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
139166242|NCT04073134|Protease Inhibitors|protease inhibitors|mesh-ancestor
139533936|NCT01930045|Antacids|antacids|mesh-ancestor
139533937|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139533938|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
139533939|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139533940|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
139533941|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533942|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
139533943|NCT04631263|Protective Agents|protective agents|mesh-ancestor
139533944|NCT01929343|Lidocaine|lidocaine|mesh-list
139533945|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
139533946|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
139533947|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139533948|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533949|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
139533950|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139533951|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139533952|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139533953|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139533954|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139533955|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533956|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139533957|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
139533958|NCT01806584|Coagulants|coagulants|mesh-ancestor
139533959|NCT01798706|Lixisenatide|lixisenatide|mesh-list
139533960|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139533961|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533962|NCT01767194|Sirolimus|sirolimus|mesh-list
139533963|NCT01767194|Irinotecan|irinotecan|mesh-list
139533964|NCT01767194|Camptothecin|camptothecin|mesh-list
139533965|NCT01767194|Temozolomide|temozolomide|mesh-list
139533966|NCT01767194|Temsirolimus|temsirolimus|mesh-list
139533967|NCT01767194|Dinutuximab|dinutuximab|mesh-list
139533968|NCT01767194|MTOR Inhibitors|mtor inhibitors|mesh-list
139533969|NCT01767194|Sargramostim|sargramostim|mesh-list
139533970|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139533971|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139533972|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166297|NCT03626064|Nicotine|nicotine|mesh-list
139533973|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533974|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139533975|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139533976|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
139533977|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139533978|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139533979|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139533980|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
139533981|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139533982|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
139533983|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533984|NCT01767194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139533985|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139533986|NCT01575873|Denosumab|denosumab|mesh-list
139533987|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139533988|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533989|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
139533990|NCT04276636|Antacids|antacids|mesh-ancestor
139533991|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139533992|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139533993|NCT00002644|Tamoxifen|tamoxifen|mesh-list
139533994|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139533995|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
139533996|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139533997|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139533998|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139533999|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534000|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139534001|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139534002|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139534003|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139534004|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139534005|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139534006|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139534007|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534008|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139534009|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139534010|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139534011|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139534012|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
139534013|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139534014|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534015|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139534016|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139534017|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
139534018|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139534019|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139534020|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
139534021|NCT04397770|Temozolomide|temozolomide|mesh-list
139534022|NCT04397770|Apatinib|apatinib|mesh-list
139534023|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139534024|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
139534025|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534026|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534027|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139534028|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534029|NCT03082846|Temozolomide|temozolomide|mesh-list
139534030|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139534031|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
139534032|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534033|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534034|NCT01609790|Bevacizumab|bevacizumab|mesh-list
139534035|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139534036|NCT01609790|Trebananib|trebananib|mesh-list
139534037|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
139534038|NCT01609790|Antibodies|antibodies|mesh-list
139534039|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
139534040|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139534041|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
139534042|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534043|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139534044|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139534045|NCT01609790|Growth Substances|growth substances|mesh-ancestor
139534046|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534047|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
139534048|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
139534049|NCT01767116|Ribavirin|ribavirin|mesh-list
139534050|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
139534051|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534052|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
139534053|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139534054|NCT01574703|Bupropion|bupropion|mesh-list
139534055|NCT01574703|Nicotine|nicotine|mesh-list
139534056|NCT01574703|Varenicline|varenicline|mesh-list
139534057|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139534058|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
139534059|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534060|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534061|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139534062|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139534063|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
139534064|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139534065|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534066|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139534067|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
139534068|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139534069|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139534070|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139534071|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139534072|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
139534073|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139534074|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139534075|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534076|NCT01686633|Fluticasone|fluticasone|mesh-list
139534078|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139534079|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139534080|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
139534081|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534082|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534083|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139534084|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
139534085|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
139534086|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139534087|NCT03141424|Fluticasone|fluticasone|mesh-list
139534088|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
139534089|NCT03141424|Ciclesonide|ciclesonide|mesh-list
139534090|NCT03141424|Budesonide|budesonide|mesh-list
139534091|NCT03141424|Beclomethasone|beclomethasone|mesh-list
139534092|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139534093|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139534094|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
139534095|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534096|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534097|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139534098|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
139534099|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
139534100|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139534101|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
139534103|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139534104|NCT03614494|Piroxicam|piroxicam|mesh-list
139534105|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
139534106|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139534107|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
139166688|NCT02291536|Dronabinol|dronabinol|mesh-list
139534108|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139534109|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534110|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139534111|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139534112|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139534113|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139534114|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139534115|NCT03614494|Analgesics|analgesics|mesh-ancestor
139534116|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
139534117|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534118|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139534119|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534120|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139534121|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166725|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534122|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534123|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
139534124|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534125|NCT05245708|Oxytocin|oxytocin|mesh-list
139534126|NCT05245708|Oxytocics|oxytocics|mesh-ancestor
139534127|NCT05245708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139534128|NCT05245708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534129|NCT01922596|Ropivacaine|ropivacaine|mesh-list
139534130|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
139534131|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
139534132|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139534133|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534134|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
139534135|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534136|NCT01573767|Fluticasone|fluticasone|mesh-list
139534137|NCT01573767|Xhance|xhance|mesh-list
139534138|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139534139|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139534140|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
139534141|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534142|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534143|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139534144|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
139534145|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
139534146|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139534147|NCT03133546|Bevacizumab|bevacizumab|mesh-list
139534148|NCT03133546|Osimertinib|osimertinib|mesh-list
139534149|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534150|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534151|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139534152|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139534153|NCT03133546|Growth Substances|growth substances|mesh-ancestor
139534154|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534155|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
139534156|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139534157|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534158|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534159|NCT01551303|Oxytocin|oxytocin|mesh-list
139534160|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
139534161|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139534162|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534163|NCT01685073|Zolpidem|zolpidem|mesh-list
139534164|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139534165|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139534166|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139534167|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534168|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139534169|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
139534170|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
139534171|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139534172|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534173|NCT05241028|Ensartinib|ensartinib|mesh-list
139534174|NCT05241028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534175|NCT05241028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139534176|NCT05241028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534177|NCT05241028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534178|NCT01572675|Celecoxib|celecoxib|mesh-list
139534179|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139534180|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139534181|NCT01572675|Analgesics|analgesics|mesh-ancestor
139534182|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
139534183|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534184|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534185|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139534186|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534187|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139534188|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139534189|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534190|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534191|NCT05929937|Analgesics, Opioid|analgesics, opioid|mesh-list
139534192|NCT05929937|Narcotics|narcotics|mesh-ancestor
139534193|NCT05929937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139534194|NCT05929937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534195|NCT05929937|Analgesics|analgesics|mesh-ancestor
139534196|NCT05929937|Sensory System Agents|sensory system agents|mesh-ancestor
139534197|NCT05929937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534198|NCT05929794|Metronidazole|metronidazole|mesh-list
139534199|NCT05929794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139534200|NCT05929794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139534201|NCT05929794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139534202|NCT05929794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139534203|NCT05929755|Methylprednisolone|methylprednisolone|mesh-list
139534204|NCT05929755|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139534205|NCT05929755|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139534206|NCT05929755|Prednisolone|prednisolone|mesh-list
139534207|NCT05929755|Prednisolone acetate|prednisolone acetate|mesh-list
139534208|NCT05929755|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139534209|NCT05929755|Prednisolone phosphate|prednisolone phosphate|mesh-list
139534210|NCT05929755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139534211|NCT05929755|Antiemetics|antiemetics|mesh-ancestor
139534212|NCT05929755|Autonomic Agents|autonomic agents|mesh-ancestor
139534213|NCT05929755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534214|NCT05929755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534215|NCT05929755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139534216|NCT05929755|Glucocorticoids|glucocorticoids|mesh-ancestor
139534217|NCT05929755|Hormones|hormones|mesh-ancestor
139534218|NCT05929755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139534219|NCT05929755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139534220|NCT05929755|Protective Agents|protective agents|mesh-ancestor
139167031|NCT01130311|Vitamin D|vitamin d|mesh-list
139534221|NCT05929755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139534222|NCT05929755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534223|NCT05929456|Cetuximab|cetuximab|mesh-list
139534224|NCT05929456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534225|NCT05929456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534226|NCT05929339|Oxytocin|oxytocin|mesh-list
139534227|NCT05929339|Oxytocics|oxytocics|mesh-ancestor
139534228|NCT05929339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139534229|NCT05929339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534230|NCT05928988|Itraconazole|itraconazole|mesh-list
139534231|NCT05928988|Antifungal Agents|antifungal agents|mesh-ancestor
139534232|NCT05928988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139534233|NCT05928988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139534234|NCT05928988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139534235|NCT05928988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534236|NCT05928988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534237|NCT05928988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139534238|NCT05928988|Hormone Antagonists|hormone antagonists|mesh-ancestor
139534239|NCT05928988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139534240|NCT05928988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534241|NCT05928988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139534242|NCT05928780|Fluzoparib|fluzoparib|mesh-list
139534243|NCT05928780|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139534244|NCT05928780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534245|NCT05928780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534246|NCT05928780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534247|NCT05928728|Colchicine|colchicine|mesh-list
139534248|NCT05928728|Gout Suppressants|gout suppressants|mesh-ancestor
139534249|NCT05928728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534250|NCT05928728|Tubulin Modulators|tubulin modulators|mesh-ancestor
139534251|NCT05928728|Antimitotic Agents|antimitotic agents|mesh-ancestor
139534252|NCT05928728|Mitosis Modulators|mitosis modulators|mesh-ancestor
139534253|NCT05928728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534254|NCT05928728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534255|NCT05928546|Quercetin|quercetin|mesh-list
139534256|NCT05928546|Antioxidants|antioxidants|mesh-ancestor
139534257|NCT05928546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534258|NCT05928546|Protective Agents|protective agents|mesh-ancestor
139534259|NCT05928546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534260|NCT05928000|Tenofovir|tenofovir|mesh-list
139534261|NCT05928000|Entecavir|entecavir|mesh-list
139534262|NCT05928000|Antiviral Agents|antiviral agents|mesh-ancestor
139534263|NCT05928000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139534264|NCT05928000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139534265|NCT05928000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139534266|NCT05928000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534267|NCT05928000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534268|NCT05928000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139534269|NCT05928000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139534270|NCT05927233|Methylprednisolone|methylprednisolone|mesh-list
139534271|NCT05927233|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139534272|NCT05927233|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139534273|NCT05927233|Prednisolone|prednisolone|mesh-list
139534274|NCT05927233|Prednisolone acetate|prednisolone acetate|mesh-list
139534275|NCT05927233|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139534276|NCT05927233|Prednisolone phosphate|prednisolone phosphate|mesh-list
139534277|NCT05927233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139534278|NCT05927233|Antiemetics|antiemetics|mesh-ancestor
139534279|NCT05927233|Autonomic Agents|autonomic agents|mesh-ancestor
139534280|NCT05927233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534281|NCT05927233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534282|NCT05927233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139534283|NCT05927233|Glucocorticoids|glucocorticoids|mesh-ancestor
139534284|NCT05927233|Hormones|hormones|mesh-ancestor
139534285|NCT05927233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139534286|NCT05927233|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139534287|NCT05927233|Protective Agents|protective agents|mesh-ancestor
139534288|NCT05927233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139534289|NCT05927233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534290|NCT05873218|Ephedrine|ephedrine|mesh-list
139534291|NCT05873218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139534292|NCT05873218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534293|NCT05873218|Sympathomimetics|sympathomimetics|mesh-ancestor
139534294|NCT05873218|Autonomic Agents|autonomic agents|mesh-ancestor
139534295|NCT05873218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534296|NCT05873218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139534297|NCT05873218|Adrenergic Agents|adrenergic agents|mesh-ancestor
139534298|NCT05873218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139534299|NCT05873218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534300|NCT05839158|Mupirocin|mupirocin|mesh-list
139534301|NCT05839158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139534302|NCT05839158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139534303|NCT05839158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139534304|NCT05839158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534305|NCT05839158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534306|NCT05827549|Blinatumomab|blinatumomab|mesh-list
139534307|NCT05827549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534308|NCT05441280|Pimavanserin|pimavanserin|mesh-list
139534309|NCT05441280|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139534310|NCT05441280|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139534311|NCT05441280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139534312|NCT05441280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139534313|NCT05441280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139534314|NCT05441280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534315|NCT05441280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139534316|NCT05441280|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139534317|NCT05441280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139534318|NCT05441280|Serotonin Agents|serotonin agents|mesh-ancestor
139534319|NCT05441280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139534320|NCT05441280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534321|NCT05413161|Omalizumab|omalizumab|mesh-list
139534322|NCT05413161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139534323|NCT05413161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139534324|NCT05413161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139534325|NCT05413161|Respiratory System Agents|respiratory system agents|mesh-ancestor
139534326|NCT05413161|Immunologic Factors|immunologic factors|mesh-ancestor
139534327|NCT05413161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534328|NCT05378750|Diuretics|diuretics|mesh-list
139534329|NCT05378750|Natriuretic Agents|natriuretic agents|mesh-ancestor
139534330|NCT05378750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534331|NCT05362955|Fluorouracil|fluorouracil|mesh-list
139534332|NCT05362955|Antimetabolites|antimetabolites|mesh-ancestor
139534333|NCT05362955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534334|NCT05362955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139534335|NCT05362955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534336|NCT05362955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139534337|NCT05362955|Immunologic Factors|immunologic factors|mesh-ancestor
139534338|NCT05362955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534339|NCT05343169|Naloxone|naloxone|mesh-list
139534340|NCT05343169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139534341|NCT05343169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534342|NCT05343169|Sensory System Agents|sensory system agents|mesh-ancestor
139534343|NCT05343169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534344|NCT05228314|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139534345|NCT05228314|Vaccines|vaccines|mesh-list
139534346|NCT05228314|Aluminum sulfate|aluminum sulfate|mesh-list
139534347|NCT05228314|Immunologic Factors|immunologic factors|mesh-ancestor
139534348|NCT05228314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534349|NCT05228314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139534350|NCT05228314|Antacids|antacids|mesh-ancestor
139534351|NCT05228314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534352|NCT05228314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139534353|NCT05183854|Vaccines|vaccines|mesh-list
139534354|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139534355|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
139534356|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534357|NCT05167760|Apraclonidine|apraclonidine|mesh-list
139534358|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139534359|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139534360|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139534361|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
139534362|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139534363|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534364|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534365|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
139534366|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534367|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534368|NCT05127590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139167382|NCT06140914|Calcium|calcium|mesh-list
139534369|NCT05127590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534370|NCT05116891|Leucovorin|leucovorin|mesh-list
139534371|NCT05116891|Cisplatin|cisplatin|mesh-list
139534372|NCT05116891|Gemcitabine|gemcitabine|mesh-list
139534373|NCT05116891|Docetaxel|docetaxel|mesh-list
139534374|NCT05116891|Fluorouracil|fluorouracil|mesh-list
139534375|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
139534376|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534377|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139534378|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
139534379|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534380|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
139534381|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
139534382|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
139534383|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139534384|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
139534385|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534386|NCT05116891|Antidotes|antidotes|mesh-ancestor
139534387|NCT05116891|Protective Agents|protective agents|mesh-ancestor
139534388|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
139534389|NCT05116891|Vitamins|vitamins|mesh-ancestor
139534390|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
139534391|NCT05069038|Palbociclib|palbociclib|mesh-list
139534392|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534393|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139534395|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534396|NCT04983030|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139534397|NCT04983030|Antiviral Agents|antiviral agents|mesh-ancestor
139534398|NCT04983030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139534399|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
139534400|NCT04973566|Etanercept|etanercept|mesh-list
139534401|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
139534402|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139534403|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139534404|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139534405|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167497|NCT06017895|Histamine Agents|histamine agents|mesh-ancestor
139534406|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534407|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534408|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139534409|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139534410|NCT04973566|Analgesics|analgesics|mesh-ancestor
139534411|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
139534412|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534413|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534414|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139534415|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139534416|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139534417|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
139534418|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
139534419|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534420|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534421|NCT04856189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139534422|NCT04856189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534423|NCT04855929|Ipilimumab|ipilimumab|mesh-list
139534424|NCT04855929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534425|NCT04855929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534426|NCT04855929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139534427|NCT04855929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534428|NCT04760496|Oxytocin|oxytocin|mesh-list
139534429|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
139534430|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139534431|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534432|NCT04722822|Vaccines|vaccines|mesh-list
139534433|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
139534434|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534435|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
139534436|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534437|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534438|NCT04682431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139534439|NCT04682431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534440|NCT04563507|Letrozole|letrozole|mesh-list
139534441|NCT04563507|Palbociclib|palbociclib|mesh-list
139534442|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534443|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139534444|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139534445|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534446|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534447|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139534448|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
139534449|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139534450|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534451|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139534452|NCT04515641|Islatravir|islatravir|mesh-list
139534453|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
139534454|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139534455|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534456|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534457|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139534458|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139534459|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139534460|NCT04474366|Ropivacaine|ropivacaine|mesh-list
139534461|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
139534462|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
139534463|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139534464|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534465|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
139534466|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534467|NCT04465643|Nivolumab|nivolumab|mesh-list
139534468|NCT04465643|Ipilimumab|ipilimumab|mesh-list
139534469|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534470|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534471|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139534472|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534473|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
139534474|NCT04422431|Choline|choline|mesh-list
139534475|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
139534476|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139534477|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
139534478|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534479|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139167811|NCT05384678|Serotonin Agents|serotonin agents|mesh-ancestor
139534480|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139534481|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
139534482|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
139534483|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
139534484|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534485|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139534486|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139534487|NCT04422431|Growth Substances|growth substances|mesh-ancestor
139534488|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534489|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
139534490|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534491|NCT04416451|Rituximab|rituximab|mesh-list
139534492|NCT04416451|Venetoclax|venetoclax|mesh-list
139534493|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534494|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534495|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
139534496|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534497|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534498|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
139534499|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139534500|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
139534501|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
139534502|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139534503|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534504|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534505|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139534506|NCT04406649|Analgesics|analgesics|mesh-ancestor
139534507|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
139534508|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534509|NCT04316390|Vitamins|vitamins|mesh-list
139534510|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
139534511|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
139534512|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534513|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
139534514|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534515|NCT04316390|Protective Agents|protective agents|mesh-ancestor
139534516|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
139534517|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139534518|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139534519|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
139534520|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
139534521|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534522|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534523|NCT04152863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139534524|NCT04152863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534525|NCT04129554|Tenofovir|tenofovir|mesh-list
139534526|NCT04129554|Entecavir|entecavir|mesh-list
139534527|NCT04129554|JNJ-56136379|jnj-56136379|mesh-list
139534528|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
139534529|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139534530|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139534531|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139534532|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534533|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534534|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139534535|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139534536|NCT04109729|Nivolumab|nivolumab|mesh-list
139534537|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534538|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316179|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
139534539|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139534540|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534542|NCT04049513|Fludarabine|fludarabine|mesh-list
139534543|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139534544|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
139534545|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534546|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534547|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139534548|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
139534549|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534550|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534551|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139534552|NCT04002180|Vedolizumab|vedolizumab|mesh-list
139534553|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139534554|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
139534555|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534556|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534557|NCT03968419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139534558|NCT03968419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534559|NCT03924986|Tislelizumab|tislelizumab|mesh-list
139534560|NCT03924986|Gemcitabine|gemcitabine|mesh-list
139534561|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534562|NCT03924986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534563|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139534564|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
139534565|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534566|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
139534567|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139534568|NCT03866577|Antibodies|antibodies|mesh-list
139534569|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
139534570|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139534571|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
139534572|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534573|NCT03810807|Osimertinib|osimertinib|mesh-list
139534574|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534575|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139534576|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534577|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534578|NCT03684980|Leucovorin|leucovorin|mesh-list
139534579|NCT03684980|Rituximab|rituximab|mesh-list
139534580|NCT03684980|Methotrexate|methotrexate|mesh-list
139534581|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534582|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534583|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
139534584|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534585|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534586|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139534587|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
139534588|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139534589|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139534590|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
139534591|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534592|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
139534593|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534594|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139534595|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139168289|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139168290|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168292|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139534596|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139534597|NCT03684980|Antidotes|antidotes|mesh-ancestor
139534598|NCT03684980|Protective Agents|protective agents|mesh-ancestor
139534599|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
139534600|NCT03684980|Vitamins|vitamins|mesh-ancestor
139534601|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
139534602|NCT03666559|Azacitidine|azacitidine|mesh-list
139534603|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139534604|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
139534605|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534606|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534607|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534608|NCT03662022|Rifampin|rifampin|mesh-list
139534609|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139534610|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
139534611|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139534612|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139534613|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
139534614|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139534615|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534616|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534617|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139534618|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139534619|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139534620|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139534621|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139168419|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
139534622|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139534623|NCT03648996|Allopurinol|allopurinol|mesh-list
139534624|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
139534625|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534626|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534627|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
139534628|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534629|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139534630|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
139534631|NCT03648996|Protective Agents|protective agents|mesh-ancestor
139534632|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534633|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
139534634|NCT03585465|Capecitabine|capecitabine|mesh-list
139534635|NCT03585465|Nivolumab|nivolumab|mesh-list
139534636|NCT03585465|Vinblastine|vinblastine|mesh-list
139534637|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139534638|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
139534639|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534640|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534641|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139534642|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
139168479|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139534643|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534644|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534645|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139534646|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139534647|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
139534648|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534649|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139534650|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139534651|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
139534652|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
139534653|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
139534654|NCT03523312|Capecitabine|capecitabine|mesh-list
139534655|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139534656|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
139534657|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534658|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534659|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
139534660|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
139534661|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534662|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534663|NCT03449238|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139534664|NCT03449238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534665|NCT03439293|Dexamethasone|dexamethasone|mesh-list
139534666|NCT03439293|Daratumumab|daratumumab|mesh-list
139534667|NCT03439293|Ixazomib|ixazomib|mesh-list
139534668|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139534669|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
139534670|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
139534671|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534672|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534673|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139534674|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
139534675|NCT03439293|Hormones|hormones|mesh-ancestor
139534676|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139534677|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139534678|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534679|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
139534680|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534681|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534682|NCT03423979|Paclitaxel|paclitaxel|mesh-list
139534683|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139534684|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534685|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
139534686|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
139534687|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
139534688|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534689|NCT03239210|Ondansetron|ondansetron|mesh-list
139534690|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
139534691|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
139534692|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534693|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534694|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139534695|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
139534696|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
139534697|NCT03239210|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139534698|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139534699|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
139534700|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139534701|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534702|NCT03196466|Topiramate|topiramate|mesh-list
139534703|NCT03196466|Pregabalin|pregabalin|mesh-list
139534704|NCT03196466|Lamotrigine|lamotrigine|mesh-list
139534705|NCT03196466|Zonisamide|zonisamide|mesh-list
139534706|NCT03196466|Lacosamide|lacosamide|mesh-list
139534707|NCT03196466|Carbamazepine|carbamazepine|mesh-list
139534708|NCT03196466|Phenytoin|phenytoin|mesh-list
139534709|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
139534710|NCT03196466|Rufinamide|rufinamide|mesh-list
139534711|NCT03196466|Cannabidiol|cannabidiol|mesh-list
139534712|NCT03196466|Levetiracetam|levetiracetam|mesh-list
139534713|NCT03196466|Valproic Acid|valproic acid|mesh-list
139534714|NCT03196466|Brivaracetam|brivaracetam|mesh-list
139534715|NCT03196466|Phenobarbital|phenobarbital|mesh-list
139534716|NCT03196466|Clobazam|clobazam|mesh-list
139534717|NCT03196466|Ethosuximide|ethosuximide|mesh-list
139534718|NCT03196466|Stiripentol|stiripentol|mesh-list
139534719|NCT03196466|Tiagabine|tiagabine|mesh-list
139534720|NCT03196466|Primidone|primidone|mesh-list
139534721|NCT03196466|Felbamate|felbamate|mesh-list
139534722|NCT03196466|Analgesics|analgesics|mesh-ancestor
139534723|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
139534724|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534725|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534726|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
139534727|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139534728|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139534729|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534730|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139534731|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139534732|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139534733|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139534734|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139534735|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139534736|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
139534737|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139534738|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139534739|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534740|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
139534741|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139534742|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
139534743|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139534744|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139534745|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139534746|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139534747|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139534748|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139534749|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139534750|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139534751|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
139534752|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139534753|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139534754|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
139534755|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
139534756|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139534757|NCT03184870|Leucovorin|leucovorin|mesh-list
139534758|NCT03184870|Paclitaxel|paclitaxel|mesh-list
139534759|NCT03184870|Gemcitabine|gemcitabine|mesh-list
139534760|NCT03184870|Fluorouracil|fluorouracil|mesh-list
139534761|NCT03184870|Nivolumab|nivolumab|mesh-list
139534762|NCT03184870|Irinotecan|irinotecan|mesh-list
139534763|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139534764|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534765|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
139534766|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
139534767|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
139534768|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534769|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139534770|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
139534771|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139534772|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
139534773|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534774|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534775|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139534776|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139534777|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139534778|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534779|NCT03184870|Antidotes|antidotes|mesh-ancestor
139534780|NCT03184870|Protective Agents|protective agents|mesh-ancestor
139534781|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
139534782|NCT03184870|Vitamins|vitamins|mesh-ancestor
139534783|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
139534784|NCT03122522|Nivolumab|nivolumab|mesh-list
139534785|NCT03122522|Ipilimumab|ipilimumab|mesh-list
139534786|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534787|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534788|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139534789|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534790|NCT03108846|Escitalopram|escitalopram|mesh-list
139534791|NCT03108846|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139534792|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139534793|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139534794|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534795|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139534796|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
139534797|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534798|NCT03086343|Abatacept|abatacept|mesh-list
139534799|NCT03086343|Upadacitinib|upadacitinib|mesh-list
139534800|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139534801|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534802|NCT03086343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534803|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534804|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139534805|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
139534806|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534807|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534808|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139534809|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139534810|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534811|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
139534812|NCT02904226|Nivolumab|nivolumab|mesh-list
139534813|NCT02904226|Ipilimumab|ipilimumab|mesh-list
139534814|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534815|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534816|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139169013|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
139534817|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534818|NCT02775695|Doxycycline|doxycycline|mesh-list
139534819|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139534820|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139534821|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
139534822|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139534823|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139534824|NCT02679040|Trastuzumab|trastuzumab|mesh-list
139534825|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534826|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534827|NCT02610075|Adavosertib|adavosertib|mesh-list
139534828|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534829|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534830|NCT02599454|Atezolizumab|atezolizumab|mesh-list
139534831|NCT02599454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139534832|NCT02599454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169122|NCT03923803|Katacalcin|katacalcin|mesh-list
139534833|NCT02599454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139534834|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534835|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
139534836|NCT02559856|Apixaban|apixaban|mesh-list
139534837|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139534838|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
139534839|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139534840|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
139534841|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534842|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534843|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
139534844|NCT02482311|Adavosertib|adavosertib|mesh-list
139534845|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534846|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534847|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
139534848|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139534849|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
139534850|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139534851|NCT02338609|Everolimus|everolimus|mesh-list
139534852|NCT02338609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139534853|NCT02338609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139534854|NCT02338609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534855|NCT02338609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534856|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139534857|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
139534858|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534859|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534860|NCT01466686|Temozolomide|temozolomide|mesh-list
139534861|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139534862|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
139534863|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534864|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534865|NCT01093196|Dexamethasone|dexamethasone|mesh-list
139534866|NCT01093196|Prednisone|prednisone|mesh-list
139534867|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
139534868|NCT01093196|Melphalan|melphalan|mesh-list
139534869|NCT01093196|Lenalidomide|lenalidomide|mesh-list
139534870|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139534871|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
139534872|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534873|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534874|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139534875|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
139534876|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534877|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534878|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139169237|NCT02299882|Vancomycin|vancomycin|mesh-list
139534879|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139534880|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
139534881|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
139534882|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534883|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139534884|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
139534885|NCT01093196|Hormones|hormones|mesh-ancestor
139534886|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139534887|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139534888|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139534889|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139534890|NCT01093196|Growth Substances|growth substances|mesh-ancestor
139534891|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
139534892|NCT01091831|Dexamethasone|dexamethasone|mesh-list
139534893|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
139534894|NCT01091831|Melphalan|melphalan|mesh-list
139534895|NCT01091831|Lenalidomide|lenalidomide|mesh-list
139534896|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139534897|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
139169293|NCT01355354|Digoxin|digoxin|mesh-list
139534898|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534899|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534900|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139534901|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
139534902|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534903|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534904|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139534905|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139534906|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
139534907|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
139534908|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534909|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139534910|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
139534911|NCT01091831|Hormones|hormones|mesh-ancestor
139534912|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139534913|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139534914|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139534915|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139534916|NCT01091831|Growth Substances|growth substances|mesh-ancestor
139534917|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
139534918|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
139534919|NCT00093834|Doxorubicin|doxorubicin|mesh-list
139534920|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139534921|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139534922|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
139534923|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534924|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534925|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139534926|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
139169404|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
139534927|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534928|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534929|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139534930|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139534931|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139534932|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139534933|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534934|NCT01550289|Vaccines|vaccines|mesh-list
139534935|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
139534936|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534937|NCT01968031|Istradefylline|istradefylline|mesh-list
139534938|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
139169473|NCT01356212|Ketorolac|ketorolac|mesh-list
139534939|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139534940|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139534941|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
139534942|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139534943|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534944|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534945|NCT01684215|Letrozole|letrozole|mesh-list
139534946|NCT01684215|Palbociclib|palbociclib|mesh-list
139534947|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534948|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139534949|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139534950|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534951|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534952|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139534953|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
139534954|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139534955|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534956|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139534957|NCT01908205|Oxytocin|oxytocin|mesh-list
139534958|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
139534959|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139534960|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534961|NCT01549041|Asenapine|asenapine|mesh-list
139534962|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139534963|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139534964|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169578|NCT04464850|Iron|iron|mesh-list
139534965|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534966|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139534967|NCT01907815|Trametinib|trametinib|mesh-list
139534968|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534969|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139534970|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139534971|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534972|NCT01548573|Thalidomide|thalidomide|mesh-list
139534973|NCT01548573|Dexamethasone|dexamethasone|mesh-list
139534974|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
139534975|NCT01548573|Melphalan|melphalan|mesh-list
139534976|NCT01548573|Doxorubicin|doxorubicin|mesh-list
139534977|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139534978|NCT01548573|Etoposide|etoposide|mesh-list
139534979|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
139534980|NCT01548573|Bortezomib|bortezomib|mesh-list
139534981|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139534982|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
139534983|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139534984|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139534985|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139534986|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
139534987|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139534988|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139534989|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139534990|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139534991|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
139534992|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
139534993|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139534994|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139534995|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
139534996|NCT01548573|Hormones|hormones|mesh-ancestor
139534997|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139534998|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139534999|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139535000|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139535001|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139535002|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535003|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139535004|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
139535005|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139535006|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535007|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139535008|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139535009|NCT01548573|Growth Substances|growth substances|mesh-ancestor
139535010|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
139535011|NCT01570491|Anesthetics|anesthetics|mesh-list
139535012|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535013|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535014|NCT01518153|Methotrexate|methotrexate|mesh-list
139535015|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
139535016|NCT01518153|Fludarabine|fludarabine|mesh-list
139535017|NCT01518153|Melphalan|melphalan|mesh-list
139535018|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
139535019|NCT01518153|Tacrolimus|tacrolimus|mesh-list
139535020|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139535021|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
139535022|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139535023|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535024|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139535025|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
139535026|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535027|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535028|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
139535029|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535030|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139535031|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139535032|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
139535033|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535034|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139535035|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139535036|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139535037|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
139535038|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139535039|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139535040|NCT04620343|Anesthetics|anesthetics|mesh-list
139535041|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535042|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535043|NCT01517373|Glimepiride|glimepiride|mesh-list
139535044|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139535045|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139535046|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535047|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139535048|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
139535049|NCT01517295|Hydrocodone|hydrocodone|mesh-list
139535050|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139535051|NCT01517295|Narcotics|narcotics|mesh-ancestor
139169874|NCT01230463|Ketorolac|ketorolac|mesh-list
139535052|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535053|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535054|NCT01517295|Analgesics|analgesics|mesh-ancestor
139535055|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
139535056|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535057|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
139535058|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
139535059|NCT01548417|Mifepristone|mifepristone|mesh-list
139535060|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139535061|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
139535062|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139535063|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535064|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139535065|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139535066|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139535067|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
139535068|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139535069|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139535070|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
139535071|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139535073|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139535074|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139535075|NCT01546857|Gabapentin|gabapentin|mesh-list
139535076|NCT01546857|Analgesics|analgesics|mesh-ancestor
139535077|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
139535078|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535079|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535080|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
139535081|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139535082|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139535083|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535084|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139535085|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139535086|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139535087|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535088|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535089|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
139535090|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139535091|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535092|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139535093|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139535094|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139535095|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139535096|NCT00637000|Buprenorphine|buprenorphine|mesh-list
139535097|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139535098|NCT00637000|Naloxone|naloxone|mesh-list
139535099|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139535100|NCT00637000|Narcotics|narcotics|mesh-ancestor
139535101|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535102|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535103|NCT00637000|Analgesics|analgesics|mesh-ancestor
139535104|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
139535105|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535106|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139535107|NCT01515189|Ipilimumab|ipilimumab|mesh-list
139535108|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139535109|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535110|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139170128|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
139535111|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535112|NCT01546623|Leuprolide|leuprolide|mesh-list
139535113|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139535114|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
139535115|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139535116|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535117|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139535118|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535119|NCT00636610|Bevacizumab|bevacizumab|mesh-list
139535120|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139535121|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535122|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139535123|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139535124|NCT00636610|Growth Substances|growth substances|mesh-ancestor
139535125|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535126|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
139535127|NCT00635050|Paclitaxel|paclitaxel|mesh-list
139535128|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
139535129|NCT00635050|Bevacizumab|bevacizumab|mesh-list
139535130|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139535131|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535132|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
139535133|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
139535134|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
139535135|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535136|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139535137|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
139535138|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535139|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535140|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139535141|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
139535142|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139316785|NCT02491970|Xhance|xhance|mesh-list
139535143|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139535145|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139535146|NCT00635050|Growth Substances|growth substances|mesh-ancestor
139535147|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
139535148|NCT05240404|Immunomodulating Agents|immunomodulating agents|mesh-list
139535149|NCT05240404|Immunologic Factors|immunologic factors|mesh-ancestor
139535150|NCT05240404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535151|NCT01923376|Lactulose|lactulose|mesh-list
139535152|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139535153|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139535154|NCT01923376|Laxatives|laxatives|mesh-ancestor
139535155|NCT05245786|Copper|copper|mesh-list
139535156|NCT05245786|Antibodies|antibodies|mesh-list
139535157|NCT05245786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139535158|NCT05245786|Immunologic Factors|immunologic factors|mesh-ancestor
139535159|NCT05245786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535160|NCT05245786|Trace Elements|trace elements|mesh-ancestor
139535161|NCT05245786|Micronutrients|micronutrients|mesh-ancestor
139535162|NCT00634504|Leucovorin|leucovorin|mesh-list
139535163|NCT00634504|Methotrexate|methotrexate|mesh-list
139535164|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
139535165|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139535166|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
139535167|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139535168|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535169|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139535170|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
139535171|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535172|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535173|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
139535174|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535175|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139535176|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139535177|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
139535178|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535179|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139535180|NCT00634504|Antidotes|antidotes|mesh-ancestor
139535181|NCT00634504|Protective Agents|protective agents|mesh-ancestor
139535182|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
139535183|NCT00634504|Vitamins|vitamins|mesh-ancestor
139535184|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
139535185|NCT03101254|Vemurafenib|vemurafenib|mesh-list
139535186|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535187|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139535188|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535189|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535190|NCT00634114|Esomeprazole|esomeprazole|mesh-list
139535191|NCT00634114|Omeprazole|omeprazole|mesh-list
139535192|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139535193|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139170418|NCT03504280|Vitamin D|vitamin d|mesh-list
139535194|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139535195|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535196|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535197|NCT00634036|Pioglitazone|pioglitazone|mesh-list
139535198|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139535199|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535200|NCT05241496|Lidocaine|lidocaine|mesh-list
139535201|NCT05241496|Anesthetics, Local|anesthetics, local|mesh-ancestor
139535202|NCT05241496|Anesthetics|anesthetics|mesh-ancestor
139535203|NCT05241496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535204|NCT05241496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535205|NCT05241496|Sensory System Agents|sensory system agents|mesh-ancestor
139535206|NCT05241496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535207|NCT05241496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139535208|NCT05241496|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139170475|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
139535209|NCT05241496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139535210|NCT05241496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139535211|NCT05241496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535212|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139535213|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
139535214|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535215|NCT01539837|Deferiprone|deferiprone|mesh-list
139535216|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139535217|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
139535218|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
139535219|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535221|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139535222|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535223|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535224|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139535225|NCT01923844|Beractant|beractant|mesh-list
139535226|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
139535227|NCT01924000|Minoxidil|minoxidil|mesh-list
139535228|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139535229|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
139535230|NCT01924078|Capecitabine|capecitabine|mesh-list
139535231|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139535232|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139535233|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
139535234|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535235|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535236|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139535237|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535238|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139535239|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
139535240|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139535241|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535242|NCT00630994|Decitabine|decitabine|mesh-list
139535243|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139535244|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
139535245|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535246|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535247|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535248|NCT01924234|Morphine|morphine|mesh-list
139535249|NCT01924234|Remifentanil|remifentanil|mesh-list
139535250|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139535251|NCT01924234|Narcotics|narcotics|mesh-ancestor
139535252|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535253|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535254|NCT01924234|Analgesics|analgesics|mesh-ancestor
139535255|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
139535256|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535257|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
139535258|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
139535259|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139535260|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139535261|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
139535262|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535263|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
139535264|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535265|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535266|NCT01927198|Verinurad|verinurad|mesh-list
139535267|NCT01927198|Gout Suppressants|gout suppressants|mesh-ancestor
139535268|NCT01927198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535269|NCT01924468|Haloperidol|haloperidol|mesh-list
139535270|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
139535271|NCT01924468|Methylphenidate|methylphenidate|mesh-list
139535272|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139535273|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535274|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139170733|NCT02306278|Gabapentin|gabapentin|mesh-list
139535275|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139535276|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139535277|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535278|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
139535279|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535280|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
139535281|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
139535282|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535283|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139535284|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139535285|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139535286|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535287|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139535288|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139535289|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139535290|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
139535291|NCT01923064|Polidocanol|polidocanol|mesh-list
139535292|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316926|NCT02256423|Ibuprofen|ibuprofen|mesh-list
139535293|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139535294|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139535296|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139535297|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
139535298|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535299|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
139535300|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139535301|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535302|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139170834|NCT02316496|Irinotecan|irinotecan|mesh-list
139535303|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139535304|NCT01924624|Growth Substances|growth substances|mesh-ancestor
139535305|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
139535306|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535307|NCT01929382|Interferons|interferons|mesh-list
139535308|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
139535309|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535310|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
139535311|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535312|NCT00989950|Methylphenidate|methylphenidate|mesh-list
139535313|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139535314|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535315|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139535316|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139535317|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139535318|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535319|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
139535320|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535321|NCT01925092|Mifepristone|mifepristone|mesh-list
139535322|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139535323|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
139535324|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139535325|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535326|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139535327|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139535328|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139535329|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
139535330|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139535331|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139535332|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
139535333|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139535334|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
139535335|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139535336|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139535337|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
139535338|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139535339|NCT01905943|Chlorambucil|chlorambucil|mesh-list
139535340|NCT01905943|Fludarabine|fludarabine|mesh-list
139535341|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
139535342|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139535343|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
139535344|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535345|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535346|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139535347|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
139535348|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535349|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535350|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139535351|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139535352|NCT01929031|Ibuprofen|ibuprofen|mesh-list
139535353|NCT01929031|Caffeine|caffeine|mesh-list
139535354|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139535355|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139535356|NCT01929031|Analgesics|analgesics|mesh-ancestor
139535357|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
139535358|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535359|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535360|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139535361|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535362|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139535363|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535364|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535365|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139535366|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139535367|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139535368|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139535369|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
139535370|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535372|NCT00989092|Hematinics|hematinics|mesh-ancestor
139535373|NCT00988858|Pemetrexed|pemetrexed|mesh-list
139535374|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535375|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535376|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535377|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139535378|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139535379|NCT01920334|Zolpidem|zolpidem|mesh-list
139171133|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139535380|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139535381|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139535382|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535383|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535384|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139535385|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
139535386|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
139535387|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535388|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535389|NCT00986986|Niacin|niacin|mesh-list
139535390|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139535391|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
139535392|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535393|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139535394|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
139535395|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
139535396|NCT00986986|Vitamins|vitamins|mesh-ancestor
139535397|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
139535398|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535399|NCT01928719|Nicotine|nicotine|mesh-list
139535400|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139535401|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
139535402|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535403|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535404|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139535405|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139535406|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
139535407|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535408|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535409|NCT00986674|Paclitaxel|paclitaxel|mesh-list
139535410|NCT00986674|Carboplatin|carboplatin|mesh-list
139535411|NCT00986674|Cetuximab|cetuximab|mesh-list
139535412|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139535413|NCT00986674|Antibodies|antibodies|mesh-list
139535414|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
139535415|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139535416|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139535417|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535418|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
139535419|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
139535420|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
139535421|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535422|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
139535423|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535424|NCT00986440|Efatutazone|efatutazone|mesh-list
139535425|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535426|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139535427|NCT01904149|Tramadol|tramadol|mesh-list
139535428|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139535429|NCT01904149|Narcotics|narcotics|mesh-ancestor
139171312|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535430|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535431|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535432|NCT01904149|Analgesics|analgesics|mesh-ancestor
139535433|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
139535434|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535435|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139535436|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139535437|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139535438|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535439|NCT01925638|Ketoconazole|ketoconazole|mesh-list
139535440|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
139535441|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535442|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139171366|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
139535443|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139535444|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535445|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535446|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139535447|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
139535448|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139535449|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171428|NCT03467360|Diuretics|diuretics|mesh-ancestor
139535450|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139535451|NCT00985738|Dutasteride|dutasteride|mesh-list
139535452|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139535453|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139535454|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535455|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535456|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
139535457|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139535458|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535459|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139535460|NCT00985504|Escitalopram|escitalopram|mesh-list
139535461|NCT00985504|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139535462|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139535463|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139535464|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535465|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535466|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
139171496|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
139535467|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535468|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535469|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
139535470|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139535471|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139535472|NCT00985504|Analgesics|analgesics|mesh-ancestor
139535473|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
139535474|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
139535475|NCT01921192|Folic Acid|folic acid|mesh-list
139535476|NCT01921192|Hematinics|hematinics|mesh-ancestor
139535477|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
139535478|NCT01921192|Vitamins|vitamins|mesh-ancestor
139535479|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
139535480|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535481|NCT04275388|Interferons|interferons|mesh-list
139535482|NCT04275388|Ritonavir|ritonavir|mesh-list
139535483|NCT04275388|Lopinavir|lopinavir|mesh-list
139535484|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
139535485|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139535486|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535487|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
139535488|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535489|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139535490|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139535491|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
139535492|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535493|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535494|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139535495|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139535496|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139535497|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139535498|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
139535499|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171688|NCT02320240|Citalopram|citalopram|mesh-list
139535500|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
139535501|NCT01921426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139535502|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
139535503|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535504|NCT01921426|Protective Agents|protective agents|mesh-ancestor
139535505|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535506|NCT01921582|Methylphenidate|methylphenidate|mesh-list
139535507|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139535508|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535509|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139535510|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139535511|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139535512|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535513|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
139171749|NCT01238965|Leucovorin|leucovorin|mesh-list
139535514|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535515|NCT00985426|Vaccines|vaccines|mesh-list
139535516|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
139535517|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535518|NCT00985192|Everolimus|everolimus|mesh-list
139535519|NCT00985192|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139535520|NCT00985192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139535521|NCT00985192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535522|NCT00985192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535523|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139535524|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
139535525|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535526|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535527|NCT03390010|Misoprostol|misoprostol|mesh-list
139535528|NCT03390010|Carboprost|carboprost|mesh-list
139535529|NCT03390010|Oxytocin|oxytocin|mesh-list
139535530|NCT03390010|Carboprost tromethamine|carboprost tromethamine|mesh-list
139535531|NCT03390010|Methylergonovine|methylergonovine|mesh-list
139535532|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139535533|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
139535534|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139535535|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535536|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139535537|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139535538|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
139535539|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
139535540|NCT00984568|Prednisolone|prednisolone|mesh-list
139535541|NCT00984568|Infliximab|infliximab|mesh-list
139535542|NCT00984568|Mesalamine|mesalamine|mesh-list
139535543|NCT00984568|Azathioprine|azathioprine|mesh-list
139535544|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139535545|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
139535546|NCT00984568|Hormones|hormones|mesh-ancestor
139535547|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139535548|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535549|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139535550|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535551|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535552|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139535553|NCT00984568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139535554|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
139535555|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535556|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
139535557|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535558|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139535559|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139535560|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
139535561|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139535562|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139535563|NCT00984568|Analgesics|analgesics|mesh-ancestor
139535564|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
139535565|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
139535566|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139535567|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535568|NCT02984176|Simethicone|simethicone|mesh-list
139535569|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
139535570|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535571|NCT02984176|Emollients|emollients|mesh-ancestor
139535572|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
139535573|NCT01921738|Azithromycin|azithromycin|mesh-list
139535574|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139535575|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535576|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
139535577|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139535578|NCT00984256|Atovaquone|atovaquone|mesh-list
139535579|NCT00984256|Proguanil|proguanil|mesh-list
139535580|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
139535581|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535582|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
139535583|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139535584|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139535585|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535586|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535587|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
139535588|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139535589|NCT00984022|Laxatives|laxatives|mesh-ancestor
139535590|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139535591|NCT01890265|Pirfenidone|pirfenidone|mesh-list
139535592|NCT01890265|Nintedanib|nintedanib|mesh-list
139535594|NCT01890265|Antibodies|antibodies|mesh-list
139535595|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
139535596|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139535597|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
139535598|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535599|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535600|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139535601|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535602|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535603|NCT01890265|Analgesics|analgesics|mesh-ancestor
139535604|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
139535605|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535606|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139535607|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139535608|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139535609|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535610|NCT01926652|Amlodipine|amlodipine|mesh-list
139535611|NCT01926652|Candesartan|candesartan|mesh-list
139535612|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
139535613|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139535614|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139535615|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139535616|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535617|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139535618|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535619|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
139535620|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139535621|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139535622|NCT01928329|Exenatide|exenatide|mesh-list
139535623|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139535624|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535625|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139535626|NCT01928329|Incretins|incretins|mesh-ancestor
139535627|NCT01928329|Hormones|hormones|mesh-ancestor
139535628|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139535629|NCT01890109|Erenumab|erenumab|mesh-list
139535630|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139535631|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535632|NCT01890109|Analgesics|analgesics|mesh-ancestor
139535633|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
139535634|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535635|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535636|NCT03069976|Metronidazole|metronidazole|mesh-list
139172107|NCT00807859|Trebananib|trebananib|mesh-list
139535637|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535638|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139535639|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139535640|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139535641|NCT00982930|Tobramycin|tobramycin|mesh-list
139535642|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139535643|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535644|NCT01903993|Docetaxel|docetaxel|mesh-list
139535645|NCT01903993|Atezolizumab|atezolizumab|mesh-list
139535646|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535647|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
139535648|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
139535649|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
139535650|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535651|NCT01903993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139535652|NCT01903993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139535653|NCT00980044|Tramadol|tramadol|mesh-list
139535654|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139535655|NCT00980044|Narcotics|narcotics|mesh-ancestor
139535656|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535657|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535658|NCT00980044|Analgesics|analgesics|mesh-ancestor
139535659|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
139535660|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535661|NCT01927588|Prednisone|prednisone|mesh-list
139535662|NCT01927588|Everolimus|everolimus|mesh-list
139535663|NCT01927588|Tacrolimus|tacrolimus|mesh-list
139535664|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139535665|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
139535666|NCT01927588|Hormones|hormones|mesh-ancestor
139535667|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139535668|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535669|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139535671|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139535672|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
139535673|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139535674|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535675|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535676|NCT01927588|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139535677|NCT01927588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139535678|NCT05601466|Cytarabine|cytarabine|mesh-list
139535679|NCT05601466|Cyclophosphamide|cyclophosphamide|mesh-list
139535680|NCT05601466|Fludarabine|fludarabine|mesh-list
139535681|NCT05601466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139535682|NCT05601466|Immunologic Factors|immunologic factors|mesh-ancestor
139535683|NCT05601466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535684|NCT05601466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172260|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139535685|NCT05601466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139535686|NCT05601466|Alkylating Agents|alkylating agents|mesh-ancestor
139535687|NCT05601466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535688|NCT05601466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535689|NCT05601466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139535690|NCT05601466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139535691|NCT05601466|Antimetabolites|antimetabolites|mesh-ancestor
139535692|NCT05601466|Antiviral Agents|antiviral agents|mesh-ancestor
139535693|NCT05601466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535694|NCT01903837|Naltrexone|naltrexone|mesh-list
139535695|NCT01903837|Olanzapine|olanzapine|mesh-list
139535696|NCT01903837|ALKS-33|alks-33|mesh-list
139535697|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
139535698|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
139535699|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535700|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535701|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139535702|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139535703|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139535704|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535705|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139535706|NCT01903837|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139535707|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139535708|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139535709|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535710|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535711|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
139535712|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139535713|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139535714|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
139535715|NCT00982696|Analgesics, Opioid|analgesics, opioid|mesh-list
139535716|NCT00982696|Mitogens|mitogens|mesh-list
139535717|NCT00982696|Enkephalins|enkephalins|mesh-list
139535718|NCT00982696|Opioid Peptides|opioid peptides|mesh-list
139535719|NCT00982696|Narcotics|narcotics|mesh-ancestor
139535720|NCT00982696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535721|NCT00982696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535722|NCT00982696|Analgesics|analgesics|mesh-ancestor
139535723|NCT00982696|Sensory System Agents|sensory system agents|mesh-ancestor
139535724|NCT00982696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535725|NCT00982696|Mitosis Modulators|mitosis modulators|mesh-ancestor
139535726|NCT00982696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535727|NCT00982696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535728|NCT00981526|Telmisartan|telmisartan|mesh-list
139535729|NCT00981526|Olanzapine|olanzapine|mesh-list
139535730|NCT00981526|Clozapine|clozapine|mesh-list
139535731|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
139535732|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
139535733|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535734|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535735|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139535736|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139535737|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139535738|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535739|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139535740|NCT00981526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139535741|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139535742|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139535743|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535744|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535745|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
139535746|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139535747|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139535748|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139535749|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139535750|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
139535751|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
139535752|NCT04274920|Calcium|calcium|mesh-list
139535753|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139535754|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535755|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
139535756|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139535757|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139535758|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139535759|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139535760|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535761|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
139535762|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535763|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535764|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139535765|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535766|NCT05607940|Chrysarobin|chrysarobin|mesh-list
139535767|NCT05607940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139535768|NCT05607940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139535769|NCT05607940|Analgesics|analgesics|mesh-ancestor
139535770|NCT05607940|Sensory System Agents|sensory system agents|mesh-ancestor
139535771|NCT05607940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535772|NCT05607940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535773|NCT05607940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139535774|NCT05607940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535775|NCT04394728|Trabectedin|trabectedin|mesh-list
139535776|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139535777|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
139535778|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535779|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535780|NCT05600608|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
139535781|NCT05600608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535782|NCT01616173|Dexamethasone|dexamethasone|mesh-list
139535783|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
139535784|NCT01616173|BB 1101|bb 1101|mesh-list
139535785|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139535786|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
139535787|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
139535788|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535789|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535790|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139535791|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
139535792|NCT01616173|Hormones|hormones|mesh-ancestor
139535793|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139535794|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139535795|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535796|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
139535797|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535798|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535799|NCT05609500|Warfarin|warfarin|mesh-list
139535800|NCT05609500|Anticoagulants|anticoagulants|mesh-ancestor
139535801|NCT03044314|Nitric Oxide|nitric oxide|mesh-list
139535802|NCT03044314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139535803|NCT03044314|Autonomic Agents|autonomic agents|mesh-ancestor
139535804|NCT03044314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535805|NCT03044314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535806|NCT03044314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139535807|NCT03044314|Respiratory System Agents|respiratory system agents|mesh-ancestor
139535808|NCT03044314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139535809|NCT03044314|Antioxidants|antioxidants|mesh-ancestor
139535810|NCT03044314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535811|NCT03044314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535812|NCT03044314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139535813|NCT03044314|Vasodilator Agents|vasodilator agents|mesh-ancestor
139535814|NCT03044314|Gasotransmitters|gasotransmitters|mesh-ancestor
139535815|NCT03044314|Protective Agents|protective agents|mesh-ancestor
139535816|NCT05608642|Prednisolone|prednisolone|mesh-list
139535817|NCT05608642|Lidocaine|lidocaine|mesh-list
139535818|NCT05608642|Anesthetics, Local|anesthetics, local|mesh-ancestor
139535819|NCT05608642|Anesthetics|anesthetics|mesh-ancestor
139535820|NCT05608642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535821|NCT05608642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535822|NCT05608642|Sensory System Agents|sensory system agents|mesh-ancestor
139535823|NCT05608642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535824|NCT05608642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139535825|NCT05608642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139535826|NCT05608642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139535827|NCT05608642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139535828|NCT05608642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535829|NCT05608642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139535830|NCT05608642|Glucocorticoids|glucocorticoids|mesh-ancestor
139535831|NCT05608642|Hormones|hormones|mesh-ancestor
139535832|NCT05608642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139535833|NCT05608642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139535834|NCT05608642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535835|NCT05608564|Amoxicillin|amoxicillin|mesh-list
139535836|NCT05608564|Metronidazole|metronidazole|mesh-list
139535837|NCT05608564|Tazobactam|tazobactam|mesh-list
139535838|NCT05608564|Piperacillin|piperacillin|mesh-list
139535839|NCT05608564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139535840|NCT05608564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535841|NCT05608564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139535842|NCT05608564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139535843|NCT05608564|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139535844|NCT05608564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535845|NCT05608564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535846|NCT03036904|Prednisone|prednisone|mesh-list
139535847|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
139535848|NCT03036904|Rituximab|rituximab|mesh-list
139535849|NCT03036904|Doxorubicin|doxorubicin|mesh-list
139535850|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139535851|NCT03036904|Etoposide|etoposide|mesh-list
139535852|NCT03036904|Vincristine|vincristine|mesh-list
139535853|NCT03036904|Venetoclax|venetoclax|mesh-list
139535854|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139535855|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
139535856|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535857|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535858|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139535859|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
139535860|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535861|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535862|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139535863|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139535864|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139535865|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139535866|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139535867|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535868|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139535869|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
139535870|NCT03036904|Hormones|hormones|mesh-ancestor
139535871|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139535872|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139535873|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139535874|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
139535875|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
139535876|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
139535877|NCT05604898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139535878|NCT05604898|Antibodies|antibodies|mesh-list
139535879|NCT05604898|Immunoglobulins|immunoglobulins|mesh-list
139535880|NCT05604898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139535881|NCT05604898|Immunologic Factors|immunologic factors|mesh-ancestor
139535882|NCT05604898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535883|NCT05604898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535884|NCT04392700|Tenofovir|tenofovir|mesh-list
139535885|NCT04392700|Entecavir|entecavir|mesh-list
139535886|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
139535887|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535888|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139535889|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139535890|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535891|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317524|NCT05776888|Ofatumumab|ofatumumab|mesh-list
139535892|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139172942|NCT01374308|Interferons|interferons|mesh-list
139535893|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139535894|NCT03828058|Tacrolimus|tacrolimus|mesh-list
139535895|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139535896|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
139535897|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535898|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139535899|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535900|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535901|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139535902|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
139535903|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535904|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139535905|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139535906|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139535907|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535908|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535909|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139535910|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139535911|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535912|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
139535913|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535914|NCT03827200|Ambrisentan|ambrisentan|mesh-list
139535915|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139535916|NCT02983630|Penicillins|penicillins|mesh-list
139535917|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139535918|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535919|NCT03827278|Itraconazole|itraconazole|mesh-list
139535920|NCT03827278|Voriconazole|voriconazole|mesh-list
139535921|NCT03827278|Amphotericin B|amphotericin b|mesh-list
139535922|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
139535923|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139535924|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139535925|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139535926|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535927|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535928|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139535929|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
139535930|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139535931|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535932|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139535933|NCT03827278|Amebicides|amebicides|mesh-ancestor
139535934|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139535935|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139535936|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139535937|NCT01513473|Insulin|insulin|mesh-list
139535938|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139535939|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
139535940|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
139535941|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139535942|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535943|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
139173114|NCT03135262|Rituximab|rituximab|mesh-list
139535944|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139535945|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535946|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535947|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139535948|NCT03109990|Analgesics|analgesics|mesh-ancestor
139535949|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
139535950|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535951|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139535952|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139535953|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139535954|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
139173180|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535955|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139535956|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535957|NCT01513317|Siltuximab|siltuximab|mesh-list
139535958|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535959|NCT03825328|Paclitaxel|paclitaxel|mesh-list
139535960|NCT03825328|Gemcitabine|gemcitabine|mesh-list
139535961|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
139535962|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139535963|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139535964|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139535965|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
139535966|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
139535967|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
139535968|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535969|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139535970|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
139535971|NCT03825016|Diclofenac|diclofenac|mesh-list
139535972|NCT03825016|Lidocaine|lidocaine|mesh-list
139535973|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
139535974|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
139535975|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139535976|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139535977|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
139535978|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139535979|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139535980|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139535981|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139535982|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139535983|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139535984|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139535985|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139535986|NCT03825016|Analgesics|analgesics|mesh-ancestor
139535987|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139535988|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139535989|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139535990|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139535991|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
139535992|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139535993|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139535994|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
139535995|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139535996|NCT03043924|Estradiol|estradiol|mesh-list
139535997|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139535998|NCT03043924|Cyproterone|cyproterone|mesh-list
139535999|NCT03043924|Estrogens|estrogens|mesh-ancestor
139536000|NCT03043924|Hormones|hormones|mesh-ancestor
139536001|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536002|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536003|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139536004|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
139536005|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139536006|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139536007|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139536008|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139536009|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139536010|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
139536011|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
139536012|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536013|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139536014|NCT03824314|Midazolam|midazolam|mesh-list
139536015|NCT03824314|Fentanyl|fentanyl|mesh-list
139536016|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139536017|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139536018|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139536019|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536020|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139536021|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139536022|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139536023|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139536024|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
139536025|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
139536026|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
139536027|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
139536028|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139536029|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536030|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139536031|NCT03824314|Narcotics|narcotics|mesh-ancestor
139536032|NCT03824314|Analgesics|analgesics|mesh-ancestor
139536033|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
139173408|NCT03531840|Olaparib|olaparib|mesh-list
139536034|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536035|NCT03824002|Insulin|insulin|mesh-list
139536036|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139536037|NCT03824002|Metformin|metformin|mesh-list
139536038|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
139536039|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
139536040|NCT03824002|Dulaglutide|dulaglutide|mesh-list
139536041|NCT03824002|Repaglinide|repaglinide|mesh-list
139536042|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
139536043|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139536044|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139536045|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536046|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
139536047|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
139536048|NCT03823846|Parecoxib|parecoxib|mesh-list
139536049|NCT03823846|Dezocine|dezocine|mesh-list
139536050|NCT03823846|Analgesics|analgesics|mesh-ancestor
139536051|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
139536052|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536053|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173461|NCT03109756|Gaboxadol|gaboxadol|mesh-list
139536054|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139536055|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139536056|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536057|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139536058|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139536059|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536060|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536061|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139536062|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139536063|NCT03823846|Narcotics|narcotics|mesh-ancestor
139536064|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139536065|NCT02908750|Fexofenadine|fexofenadine|mesh-list
139536066|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536067|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139536068|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139536069|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139536070|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
139536071|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
139536072|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139536073|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536074|NCT03823612|Calcium|calcium|mesh-list
139536075|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139536076|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536077|NCT02810704|Aspirin|aspirin|mesh-list
139536078|NCT02810704|Warfarin|warfarin|mesh-list
139536079|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
139536080|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139536081|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139536082|NCT02810704|Analgesics|analgesics|mesh-ancestor
139536083|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
139536084|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536085|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536086|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536087|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139536088|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139536089|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139536090|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536091|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139536092|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139536093|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536094|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
139536095|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
139536096|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139536097|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
139536098|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139536099|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
139536100|NCT02926222|Lomustine|lomustine|mesh-list
139536101|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139536102|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
139536103|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536104|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536105|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
139536106|NCT04273282|Dexamethasone|dexamethasone|mesh-list
139536107|NCT04273282|Prednisolone|prednisolone|mesh-list
139536108|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139536109|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
139536110|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139536111|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
139536112|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139536113|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
139536114|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536115|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
139536116|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
139536117|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536118|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536119|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139536120|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
139536121|NCT04273282|Hormones|hormones|mesh-ancestor
139536122|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536123|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139536124|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536125|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139536126|NCT04273282|Protective Agents|protective agents|mesh-ancestor
139536127|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139536128|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536129|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139536130|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139536131|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536132|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536133|NCT01454440|Eptifibatide|eptifibatide|mesh-list
139536134|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139536135|NCT01454518|Anesthetics|anesthetics|mesh-list
139536136|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
139536137|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139536138|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536139|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
139536140|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536141|NCT02983084|Copper|copper|mesh-list
139536142|NCT02983084|Nickel|nickel|mesh-list
139536143|NCT02983084|Trace Elements|trace elements|mesh-ancestor
139536144|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
139536145|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536146|NCT01455142|Insulin|insulin|mesh-list
139536147|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
139536148|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139536149|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536150|NCT01455532|Carboplatin|carboplatin|mesh-list
139536151|NCT01455532|Gemcitabine|gemcitabine|mesh-list
139536152|NCT01455532|Doxorubicin|doxorubicin|mesh-list
139536153|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139536154|NCT01455532|Iniparib|iniparib|mesh-list
139536155|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536156|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139536157|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
139536158|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536159|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139536160|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139536161|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139536162|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536163|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139536164|NCT01455922|Glimepiride|glimepiride|mesh-list
139536165|NCT01455922|Exenatide|exenatide|mesh-list
139536166|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139536167|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139536168|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536169|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139173798|NCT05626387|Hormones|hormones|mesh-ancestor
139536170|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
139536171|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139536172|NCT01455922|Incretins|incretins|mesh-ancestor
139536173|NCT01455922|Hormones|hormones|mesh-ancestor
139536174|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536175|NCT01456234|Oseltamivir|oseltamivir|mesh-list
139536176|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
139536177|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536178|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536179|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536180|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139536181|NCT01456312|Entecavir|entecavir|mesh-list
139173861|NCT01148173|Ifosfamide|ifosfamide|mesh-list
139536182|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
139536183|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536184|NCT01456468|Tretinoin|tretinoin|mesh-list
139536185|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536186|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
139536187|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
139536188|NCT01456546|Proguanil|proguanil|mesh-list
139536189|NCT01456546|Clopidogrel|clopidogrel|mesh-list
139536190|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139536191|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139536192|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139536193|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139536194|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
139536195|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139536196|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173918|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139536197|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536198|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
139536199|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139536200|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139536201|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536202|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
139536203|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
139536204|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139536205|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536206|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
139536207|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139536208|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536209|NCT01457716|Budesonide|budesonide|mesh-list
139536210|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
139536211|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536212|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139536213|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
139536214|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173979|NCT03493386|Glycine|glycine|mesh-list
139536215|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536216|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139536217|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
139536218|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
139536219|NCT01457716|Hormones|hormones|mesh-ancestor
139536220|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536221|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139536222|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139536223|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139536224|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
139536225|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139536226|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536227|NCT02880982|Vitamin D|vitamin d|mesh-list
139536228|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
139536229|NCT02880982|Vitamins|vitamins|mesh-ancestor
139536230|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
139536231|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536232|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139536233|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139536234|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139536235|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
139536236|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139536237|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139536238|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139536239|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139536240|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536241|NCT01459198|Vaccines|vaccines|mesh-list
139536242|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
139536243|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536244|NCT02490904|Eplerenone|eplerenone|mesh-list
139536245|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139536246|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
139536247|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536248|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536249|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139536250|NCT02490904|Diuretics|diuretics|mesh-ancestor
139536251|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
139536252|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139536253|NCT04390984|Apatinib|apatinib|mesh-list
139536254|NCT04390984|Gefitinib|gefitinib|mesh-list
139536255|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536256|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139536257|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536258|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536259|NCT02873806|Tobramycin|tobramycin|mesh-list
139536260|NCT02873806|Dexamethasone|dexamethasone|mesh-list
139536261|NCT02873806|Travoprost|travoprost|mesh-list
139536262|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536263|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
139536264|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
139536265|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536266|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536267|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139536268|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
139317899|NCT04749797|Bupivacaine|bupivacaine|mesh-list
139536269|NCT02873806|Hormones|hormones|mesh-ancestor
139536270|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536271|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139536272|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536273|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139536274|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139536275|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536276|NCT01890772|Vitamin D|vitamin d|mesh-list
139536277|NCT01890772|Ribavirin|ribavirin|mesh-list
139536278|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139536279|NCT01890772|Vitamins|vitamins|mesh-ancestor
139536280|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
139536281|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536282|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139536283|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
139536284|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536285|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
139536286|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536287|NCT01891084|Acetaminophen|acetaminophen|mesh-list
139536288|NCT01891084|Ibuprofen|ibuprofen|mesh-list
139536289|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139536290|NCT01891084|Analgesics|analgesics|mesh-ancestor
139536291|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
139536292|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536293|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536294|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
139536295|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139536296|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536297|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139536298|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139536299|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536300|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536301|NCT01891708|Bevacizumab|bevacizumab|mesh-list
139536302|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139536303|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536304|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139536305|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139536306|NCT01891708|Growth Substances|growth substances|mesh-ancestor
139536307|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536308|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
139536309|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
139536310|NCT01892098|Astringents|astringents|mesh-ancestor
139536311|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536312|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
139536313|NCT01892176|Ubiquinone|ubiquinone|mesh-list
139536314|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
138959756|NCT00678080|Metformin|metformin|mesh-list
139536315|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
139536316|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536317|NCT01892176|Vitamins|vitamins|mesh-ancestor
139536318|NCT01892254|Metformin|metformin|mesh-list
139536319|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139536320|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536321|NCT01892332|Lidocaine|lidocaine|mesh-list
139536322|NCT01892332|Fentanyl|fentanyl|mesh-list
139536323|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
139536324|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
139536325|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139536326|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536327|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
139536328|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536329|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139536330|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139536331|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139536332|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139536333|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536334|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139536335|NCT01892332|Narcotics|narcotics|mesh-ancestor
139536336|NCT01892332|Analgesics|analgesics|mesh-ancestor
139536337|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139536338|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139536339|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
139536340|NCT01892488|Sultamicillin|sultamicillin|mesh-list
139536341|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
139536342|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139536343|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536344|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317973|NCT04523493|Lenvatinib|lenvatinib|mesh-list
139536345|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536346|NCT01892644|Deferasirox|deferasirox|mesh-list
139536347|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139536348|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
139536349|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
139536350|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536351|NCT01901653|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
139536352|NCT01901653|Immunoconjugates|immunoconjugates|mesh-ancestor
139536353|NCT01901653|Immunologic Factors|immunologic factors|mesh-ancestor
139536354|NCT01901653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536355|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
139536356|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139536357|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536358|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
139536359|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
139536360|NCT02798536|Paclitaxel|paclitaxel|mesh-list
139536361|NCT02798536|LMB-100|lmb-100|mesh-list
139536362|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139536363|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536364|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
139536365|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
139536366|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
139536367|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536368|NCT02798536|Immunoconjugates|immunoconjugates|mesh-ancestor
139536369|NCT02798536|Immunologic Factors|immunologic factors|mesh-ancestor
139536370|NCT02798536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536371|NCT04758286|Anesthetics|anesthetics|mesh-list
139536372|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139536373|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536374|NCT01615939|Bupivacaine|bupivacaine|mesh-list
139536375|NCT01615939|Ropivacaine|ropivacaine|mesh-list
139536376|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
139536377|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
139536378|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139536379|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536380|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
139536381|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536382|NCT02789878|Prednisone|prednisone|mesh-list
139536383|NCT02789878|Goserelin|goserelin|mesh-list
139536384|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536385|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
139536386|NCT02789878|Hormones|hormones|mesh-ancestor
139536387|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536388|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536389|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139536390|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536391|NCT01901185|Etanercept|etanercept|mesh-list
139536392|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139536393|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139536394|NCT01901185|Analgesics|analgesics|mesh-ancestor
139536395|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
139536396|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536397|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536398|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536399|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139536400|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139536401|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139536402|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
139536403|NCT01893424|Dronabinol|dronabinol|mesh-list
139536404|NCT01893424|Nabiximols|nabiximols|mesh-list
139536405|NCT01893424|Cannabidiol|cannabidiol|mesh-list
139536406|NCT01893424|Piperine|piperine|mesh-list
139536407|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
139536408|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
139536409|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536410|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139536411|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139536412|NCT01893424|Analgesics|analgesics|mesh-ancestor
139536413|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
139536414|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536415|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139536416|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139536417|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139536418|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536419|NCT01893424|Hormones|hormones|mesh-ancestor
139536420|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536421|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139536422|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536423|NCT02788708|Paclitaxel|paclitaxel|mesh-list
139536424|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139536425|NCT02788708|Lenvatinib|lenvatinib|mesh-list
139536426|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139536427|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536428|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
139536429|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
139536430|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
139536431|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536432|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139536433|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536434|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
139536435|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139536436|NCT01888003|Hematinics|hematinics|mesh-ancestor
139536437|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
139536438|NCT02773732|Etoposide|etoposide|mesh-list
139536439|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139536440|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536441|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139536442|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139536443|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536444|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536445|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139536446|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536447|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139536448|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139536449|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
139536450|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139536451|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536452|NCT02769520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139536453|NCT02769520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536454|NCT02735122|Acetaminophen|acetaminophen|mesh-list
139536455|NCT02735122|Ibuprofen|ibuprofen|mesh-list
139536456|NCT02735122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139536457|NCT02735122|Analgesics|analgesics|mesh-ancestor
139536458|NCT02735122|Sensory System Agents|sensory system agents|mesh-ancestor
139536459|NCT02735122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536460|NCT02735122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536461|NCT02735122|Antipyretics|antipyretics|mesh-ancestor
139536462|NCT02735122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139536463|NCT02735122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536464|NCT02735122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139536465|NCT02735122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139536466|NCT02735122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536467|NCT02735122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536468|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139536469|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139536470|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139536471|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139536472|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536473|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
139536474|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139536475|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536476|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139536477|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536478|NCT01893658|Omalizumab|omalizumab|mesh-list
139536479|NCT01893658|Prednisone|prednisone|mesh-list
139536480|NCT01893658|Prednisolone|prednisolone|mesh-list
139536481|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536482|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
139536483|NCT01893658|Hormones|hormones|mesh-ancestor
139536484|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536485|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536486|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139536487|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536488|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139536489|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139536490|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
139536491|NCT02688556|Cyclosporine|cyclosporine|mesh-list
139536492|NCT02688556|Cyclosporins|cyclosporins|mesh-list
139536493|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536494|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536495|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139536496|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
139536497|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536498|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
139536499|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536500|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
139536501|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139536502|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139536503|NCT02684032|Letrozole|letrozole|mesh-list
139536504|NCT02684032|Fulvestrant|fulvestrant|mesh-list
139536505|NCT02684032|Palbociclib|palbociclib|mesh-list
139536506|NCT02684032|Gedatolisib|gedatolisib|mesh-list
139536507|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536508|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139536509|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139536510|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536511|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536512|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139536513|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
139174535|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139536514|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536515|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536516|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139536517|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139536518|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139536519|NCT02388178|Fluorides|fluorides|mesh-list
139536520|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
139536521|NCT02388178|Protective Agents|protective agents|mesh-ancestor
139536522|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536523|NCT02384668|Vitamin D|vitamin d|mesh-list
139536524|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
139536525|NCT02384668|Vitamins|vitamins|mesh-ancestor
139536526|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
139536527|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536528|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139536529|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139536530|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139536531|NCT01898923|Laxatives|laxatives|mesh-ancestor
139536532|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139536533|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139536534|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139536535|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536536|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139536537|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139536538|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139536539|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536540|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
139536541|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139536542|NCT01886287|Octreotide|octreotide|mesh-list
139536543|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139536544|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139536545|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536546|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
139536547|NCT02707588|Cetuximab|cetuximab|mesh-list
139536548|NCT02707588|Antibodies|antibodies|mesh-list
139536549|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
139536550|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
139536551|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536552|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139536553|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536554|NCT02707588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139536555|NCT02707588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536556|NCT05602480|Vaccines|vaccines|mesh-list
139536557|NCT05602480|Immunologic Factors|immunologic factors|mesh-ancestor
139536558|NCT05602480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536559|NCT05604586|Acetylcysteine|acetylcysteine|mesh-list
139536560|NCT05604586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139536561|NCT05604586|Antiviral Agents|antiviral agents|mesh-ancestor
139536562|NCT05604586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536563|NCT05604586|Expectorants|expectorants|mesh-ancestor
139536564|NCT05604586|Respiratory System Agents|respiratory system agents|mesh-ancestor
139536565|NCT05604586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139536566|NCT05604586|Antioxidants|antioxidants|mesh-ancestor
139536567|NCT05604586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536568|NCT05604586|Protective Agents|protective agents|mesh-ancestor
139174568|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
139536569|NCT05604586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536570|NCT05604586|Antidotes|antidotes|mesh-ancestor
139536571|NCT05604118|Aspirin|aspirin|mesh-list
139536572|NCT05604118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139536573|NCT05604118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139536574|NCT05604118|Analgesics|analgesics|mesh-ancestor
139536575|NCT05604118|Sensory System Agents|sensory system agents|mesh-ancestor
139536576|NCT05604118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536577|NCT05604118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536578|NCT05604118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536579|NCT05604118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139536580|NCT05604118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139536581|NCT05604118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139536582|NCT05604118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536583|NCT05604118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139536584|NCT05604118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139536585|NCT05604118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536586|NCT05604118|Antipyretics|antipyretics|mesh-ancestor
139536587|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139536588|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
139536589|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
139536590|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536591|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
139536592|NCT04393792|Povidone|povidone|mesh-list
139536593|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
139536594|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
139536595|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139536596|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536597|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
139536598|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139536599|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139536600|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139536601|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139536602|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139536603|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536604|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
139536605|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139536606|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536607|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139536608|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536609|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139536610|NCT02315872|Hormones|hormones|mesh-ancestor
139536611|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536612|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536613|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
139536614|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139536615|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139536616|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536617|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139536618|NCT04127500|Analgesics|analgesics|mesh-ancestor
139536619|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
139536620|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536621|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139536622|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139536623|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139536624|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
139536625|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139536626|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536627|NCT03017326|Carboplatin|carboplatin|mesh-list
139536628|NCT03017326|Gemcitabine|gemcitabine|mesh-list
139536629|NCT03017326|Doxorubicin|doxorubicin|mesh-list
139536630|NCT03017326|Fluorouracil|fluorouracil|mesh-list
139536631|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
139536632|NCT03017326|Irinotecan|irinotecan|mesh-list
139536633|NCT03017326|Etoposide|etoposide|mesh-list
139536634|NCT03017326|Vincristine|vincristine|mesh-list
139536635|NCT03017326|Sorafenib|sorafenib|mesh-list
139536636|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536637|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139536638|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
139536639|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536640|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139536641|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139536642|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139536643|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536644|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139536645|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
139536646|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536647|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139536648|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139536649|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
139536650|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
139536651|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
139536652|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139536653|NCT04126330|Vitamin D|vitamin d|mesh-list
139536654|NCT04126330|Vitamins|vitamins|mesh-ancestor
139536655|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
139536656|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536657|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139536658|NCT04126720|Vitamin E|vitamin e|mesh-list
139536659|NCT04126720|Vitamins|vitamins|mesh-ancestor
139536660|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
139536661|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536662|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
139536663|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536664|NCT04126720|Protective Agents|protective agents|mesh-ancestor
139536665|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
139536666|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536667|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
139536668|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139536669|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139536670|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536671|NCT04126252|Urological Agents|urological agents|mesh-ancestor
139536672|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
139536673|NCT03007732|Prednisone|prednisone|mesh-list
139536674|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
139536675|NCT03007732|Leuprolide|leuprolide|mesh-list
139536676|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
139536677|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
139536678|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139536679|NCT03007732|Androgens|androgens|mesh-list
139536680|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139536681|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536682|NCT03007732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139536683|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536684|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536685|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
139536686|NCT03007732|Hormones|hormones|mesh-ancestor
139536687|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536688|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536689|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139536690|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139536691|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
139536692|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139536693|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139536694|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536695|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
139536696|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139536697|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
139536698|NCT03007732|Protective Agents|protective agents|mesh-ancestor
139536699|NCT03007732|Vitamins|vitamins|mesh-ancestor
139536700|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
139536701|NCT03007732|Estrogens|estrogens|mesh-ancestor
139536702|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
139536703|NCT03007420|Lidocaine|lidocaine|mesh-list
139536704|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
139536705|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
139536706|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139536707|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536708|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
139536709|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536710|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139536711|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139536712|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139536713|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139536714|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536715|NCT04125706|Metronidazole|metronidazole|mesh-list
139536716|NCT04125706|Minocycline|minocycline|mesh-list
139536717|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536718|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139536719|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139536720|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139536721|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139536722|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139536723|NCT04125082|Insulin|insulin|mesh-list
139536724|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139536725|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139536726|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536727|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
139536728|NCT04393246|Ambrisentan|ambrisentan|mesh-list
139536729|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139536730|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536731|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139536732|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536733|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139536734|NCT04124302|Insulin|insulin|mesh-list
139536735|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139536736|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
139536737|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
139536738|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
139536739|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139536740|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536741|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139536742|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139536743|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536744|NCT04411069|Droperidol|droperidol|mesh-list
139536745|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139536746|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
139536747|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
139536748|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536749|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536750|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139536751|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139536752|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139174609|NCT01149577|Olanzapine|olanzapine|mesh-list
139536753|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139536754|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139536755|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139536756|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139536757|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
139536758|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139536759|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536760|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
139536761|NCT01884571|Prednisone|prednisone|mesh-list
139536762|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
139536763|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139536764|NCT01884571|Tacrolimus|tacrolimus|mesh-list
139536765|NCT01884571|Basiliximab|basiliximab|mesh-list
139536766|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536767|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
139536768|NCT01884571|Hormones|hormones|mesh-ancestor
139536769|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536770|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536771|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139536772|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536773|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139536774|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
139536775|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139536776|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536777|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536778|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139536779|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139536780|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
139536781|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139536782|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536783|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
139536784|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
139536785|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536786|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139536787|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139536788|NCT01884571|Protective Agents|protective agents|mesh-ancestor
139536789|NCT01884337|Apixaban|apixaban|mesh-list
139536790|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139536791|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
139536792|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139536793|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
139536794|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536795|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536796|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
139536797|NCT04123288|ACT-709478|act-709478|mesh-list
139536798|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139536799|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139536800|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536801|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139536802|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536803|NCT04123210|Vitamin A|vitamin a|mesh-list
139536804|NCT04123210|Vitamins|vitamins|mesh-ancestor
139536805|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
139536806|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536807|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139536808|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139536809|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536810|NCT04121416|Sufentanil|sufentanil|mesh-list
139536811|NCT04121416|Oxycodone|oxycodone|mesh-list
139536812|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139536813|NCT04121416|Narcotics|narcotics|mesh-ancestor
139536814|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139536815|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536816|NCT04121416|Analgesics|analgesics|mesh-ancestor
139536817|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
139174741|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
139536818|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536819|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139536820|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139536821|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
139536822|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
139536823|NCT04121338|Bupivacaine|bupivacaine|mesh-list
139536824|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
139536825|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
139536826|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139536827|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536828|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
139536829|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536830|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
139536831|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
139536832|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536833|NCT01922011|Vancomycin|vancomycin|mesh-list
139536834|NCT01922011|Daptomycin|daptomycin|mesh-list
139536835|NCT01922011|Nafcillin|nafcillin|mesh-list
139536836|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139536837|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536838|NCT04127968|Vitamin A|vitamin a|mesh-list
139536839|NCT04127968|Vitamins|vitamins|mesh-ancestor
139536840|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
139536841|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536842|NCT01921387|Cytarabine|cytarabine|mesh-list
139536843|NCT01921387|Etoposide|etoposide|mesh-list
139536844|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
139536845|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
139536846|NCT01921387|Melphalan|melphalan|mesh-list
139536847|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
139536848|NCT01921387|Carmustine|carmustine|mesh-list
139536849|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139536850|NCT01921387|Antibodies|antibodies|mesh-list
139536851|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139536852|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
139536853|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536854|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139536855|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536856|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139536857|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139536858|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536859|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536860|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139536861|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
139536862|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
139536863|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536864|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139536865|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139536866|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
139536867|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139536868|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
139536869|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
139536870|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
139536871|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
139536872|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
139536873|NCT04129996|Paclitaxel|paclitaxel|mesh-list
139536874|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139536875|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536876|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
139536877|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
139318498|NCT01660971|Dasatinib|dasatinib|mesh-list
139536878|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
139536879|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536880|NCT04129216|Tamoxifen|tamoxifen|mesh-list
139536881|NCT04129216|Letrozole|letrozole|mesh-list
139536882|NCT04129216|Exemestane|exemestane|mesh-list
139536883|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536884|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536885|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139536886|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139536887|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536888|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139536889|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
139536890|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536891|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536892|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139536893|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139536894|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139536895|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139536896|NCT01895335|Teriflunomide|teriflunomide|mesh-list
139536897|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139536898|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139536899|NCT01895335|Analgesics|analgesics|mesh-ancestor
139536900|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
139536901|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536902|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536903|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536904|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139536905|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139536906|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
139536907|NCT03829696|Misoprostol|misoprostol|mesh-list
139536908|NCT03829696|Mifepristone|mifepristone|mesh-list
139536909|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
139536910|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139536911|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
139536912|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139536913|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536914|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139536915|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139536916|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
139536917|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139536918|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139536919|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139536920|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139536921|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
139536922|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139536923|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139536924|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
139536925|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536926|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
139536927|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139536928|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139536929|NCT03829774|Acetaminophen|acetaminophen|mesh-list
139536930|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139536931|NCT03829774|Analgesics|analgesics|mesh-ancestor
139536932|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
139536933|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536934|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536935|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
139536937|NCT02974738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536938|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
139536939|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139536940|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
139536941|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536942|NCT02972398|Expectorants|expectorants|mesh-ancestor
139536943|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
139536944|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139536945|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
139536946|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536947|NCT02972398|Protective Agents|protective agents|mesh-ancestor
139536948|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536949|NCT02972398|Antidotes|antidotes|mesh-ancestor
139536950|NCT01617655|Alirocumab|alirocumab|mesh-list
139536951|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139536952|NCT01617655|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139536953|NCT01617655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139536954|NCT01617655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139536955|NCT01617655|Antimetabolites|antimetabolites|mesh-ancestor
139536956|NCT01617655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536957|NCT01617655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139536958|NCT01617655|Protease Inhibitors|protease inhibitors|mesh-ancestor
139536959|NCT01617655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536960|NCT01617655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139536961|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
139536962|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536963|NCT02965768|Naltrexone|naltrexone|mesh-list
139536964|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139536965|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139536966|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536967|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
139536968|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139536969|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
139536970|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139536971|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139536972|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536973|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
139536974|NCT01895101|Coagulants|coagulants|mesh-ancestor
139536975|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
139536976|NCT03828682|Prednisone|prednisone|mesh-list
139536977|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
139536978|NCT03828682|Tacrolimus|tacrolimus|mesh-list
139536979|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
139536980|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139536981|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139536982|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
139536983|NCT03828682|Hormones|hormones|mesh-ancestor
139536984|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139536985|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139536986|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139536987|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139536988|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139536989|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
139536990|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139536991|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139536992|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139536993|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139536994|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139536995|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
139536996|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139536997|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139536998|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
139536999|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
139537000|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537001|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139537002|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139537003|NCT03828682|Protective Agents|protective agents|mesh-ancestor
139537004|NCT03483649|Bevacizumab|bevacizumab|mesh-list
139537005|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139537006|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537007|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139537008|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139537009|NCT03483649|Growth Substances|growth substances|mesh-ancestor
139537010|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537011|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
139537012|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
139537013|NCT03822520|Celecoxib|celecoxib|mesh-list
139537014|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139537015|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537016|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139537017|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139537018|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537019|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537020|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537021|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537022|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139537023|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139537024|NCT03822520|Analgesics|analgesics|mesh-ancestor
139537025|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
139537026|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537027|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537028|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139537029|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139537030|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139537031|NCT01894477|Fludarabine|fludarabine|mesh-list
139318647|NCT05464394|Hemostatics|hemostatics|mesh-ancestor
139537033|NCT01894477|Treosulfan|treosulfan|mesh-list
139537034|NCT01894477|Busulfan|busulfan|mesh-list
139537035|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537036|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139537037|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
139537038|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537039|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139537040|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
139537041|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537042|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139537043|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
139537044|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139537045|NCT04391998|Metronidazole|metronidazole|mesh-list
139537046|NCT04391998|Albendazole|albendazole|mesh-list
139537047|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537048|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139537049|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139537050|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139537051|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
139537052|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
139537053|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139537054|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
139537055|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
139537056|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
139537057|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537058|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537059|NCT03820180|Fluticasone|fluticasone|mesh-list
139537060|NCT03820180|Xhance|xhance|mesh-list
139537061|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139537062|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139537063|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537064|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139537065|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
139537066|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537067|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537068|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139537069|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
139537070|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
139537071|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139537072|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139537073|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139537074|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139537075|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
139537076|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139537077|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537078|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
139537079|NCT03820180|Hormones|hormones|mesh-ancestor
139175610|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139537080|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537081|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
139537082|NCT01894243|Olaparib|olaparib|mesh-list
139537083|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139537084|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537085|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537086|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537087|NCT01450384|Pemetrexed|pemetrexed|mesh-list
139537088|NCT01450384|Sorafenib|sorafenib|mesh-list
139537089|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537090|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537091|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537092|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139537093|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139175662|NCT01159639|Clopidogrel|clopidogrel|mesh-list
139537094|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139537095|NCT01450462|Vitamin D|vitamin d|mesh-list
139537096|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
139537097|NCT01450462|Vitamins|vitamins|mesh-ancestor
139537098|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
139537099|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537100|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139537101|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139537102|NCT01450774|Beclomethasone|beclomethasone|mesh-list
139537103|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
139537104|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139537105|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
139537106|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537107|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537108|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139537109|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
139537110|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139537111|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139537112|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139537113|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
139537114|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139537115|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537116|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537117|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
139537118|NCT01450774|Hormones|hormones|mesh-ancestor
139537119|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537120|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
139537121|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139537122|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139537123|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139537124|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537125|NCT01451086|Vaccines|vaccines|mesh-list
139537126|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
139537127|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537128|NCT01451710|Prednisone|prednisone|mesh-list
139537129|NCT01451710|Prednisolone|prednisolone|mesh-list
139537130|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139537131|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
139537132|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139175791|NCT00075725|Hormones|hormones|mesh-ancestor
139537133|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
139537134|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139537135|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
139537136|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537137|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
139537138|NCT01451710|Hormones|hormones|mesh-ancestor
139537139|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537140|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537141|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139537142|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537143|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
139537144|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
139537145|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537146|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139537147|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139537148|NCT01451710|Protective Agents|protective agents|mesh-ancestor
139537149|NCT01451788|Thrombin|thrombin|mesh-list
139537150|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
139537151|NCT01451788|Coagulants|coagulants|mesh-ancestor
139537152|NCT01452100|Prednisone|prednisone|mesh-list
139537153|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537154|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
139537155|NCT01452100|Hormones|hormones|mesh-ancestor
139537156|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537157|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537158|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139537159|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537160|NCT01452334|BMS-936559|bms-936559|mesh-list
139537161|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139537162|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537163|NCT01452568|Aspirin|aspirin|mesh-list
139537164|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
139537165|NCT01452568|Salicylates|salicylates|mesh-list
139537166|NCT01452568|Warfarin|warfarin|mesh-list
139537167|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139537168|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139537169|NCT01452568|Analgesics|analgesics|mesh-ancestor
139537170|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
139537171|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537172|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537173|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537174|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139537175|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139537176|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139537177|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537178|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139537179|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139537180|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537181|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
139318804|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
139176020|NCT03406260|Lasmiditan|lasmiditan|mesh-list
139537182|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
139537183|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537184|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
139537185|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
139537186|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
139537188|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
139537189|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139537190|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139537191|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139537192|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537193|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537194|NCT01452880|Remifentanil|remifentanil|mesh-list
139537195|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139537196|NCT01452880|Narcotics|narcotics|mesh-ancestor
139537197|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139537198|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537199|NCT01452880|Analgesics|analgesics|mesh-ancestor
139537200|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
139537201|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537202|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
139537203|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139537204|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139537205|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
139537206|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537207|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139537208|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139537209|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537210|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537211|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139537212|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
139537213|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139537214|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
139537215|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537216|NCT01453504|Everolimus|everolimus|mesh-list
139537217|NCT01453504|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139537218|NCT01453504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139537219|NCT01453504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537220|NCT01453504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537221|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139537222|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
139537223|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537224|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537225|NCT01453582|Propolis|propolis|mesh-list
139537226|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537227|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
139537228|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139537229|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139537230|NCT04847752|Aspirin|aspirin|mesh-list
139537231|NCT04847752|Warfarin|warfarin|mesh-list
139537232|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
139537233|NCT04847752|Dabigatran|dabigatran|mesh-list
139537234|NCT04847752|Anticoagulants|anticoagulants|mesh-list
139537235|NCT04847752|Clopidogrel|clopidogrel|mesh-list
139537236|NCT04847752|Atorvastatin|atorvastatin|mesh-list
139537237|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139537238|NCT04847752|Evolocumab|evolocumab|mesh-list
139537239|NCT04847752|Alirocumab|alirocumab|mesh-list
139537240|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139537241|NCT04847752|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139537242|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139537243|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139537244|NCT04847752|Analgesics|analgesics|mesh-ancestor
139537245|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
139537246|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537247|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537248|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537249|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139537250|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139537251|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139537252|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537253|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139537254|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139537255|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537256|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
139537257|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139537258|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139537259|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
139537260|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139537261|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139537262|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139537263|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139537264|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
139537265|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139537266|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139537267|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
139537268|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139537269|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
139537270|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139537271|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
139537272|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
139537273|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537274|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139537275|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
139537276|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139537277|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537278|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139537279|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139537280|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139537281|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
139537282|NCT02864914|Empagliflozin|empagliflozin|mesh-list
139537283|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139176278|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
139537284|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139537285|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537286|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139537287|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537288|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
139537289|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537290|NCT02849470|Complement Factor H|complement factor h|mesh-list
139537291|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139537292|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139537293|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
139537294|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537295|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139537296|NCT05024188|Metronidazole|metronidazole|mesh-list
139537297|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
139537298|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537299|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139537300|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139537301|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139537302|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139537303|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537304|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537305|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537306|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139537307|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139537308|NCT04390594|Nafamostat|nafamostat|mesh-list
139537309|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139537310|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139537311|NCT04390594|Analgesics|analgesics|mesh-ancestor
139537312|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
139537313|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537314|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537315|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537316|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139537317|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
139537318|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
139537319|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537320|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537321|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139537322|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139537323|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139537324|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139537325|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
139537326|NCT05024422|Pyridoxine|pyridoxine|mesh-list
139537327|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
139537328|NCT05024422|Cabergoline|cabergoline|mesh-list
139537329|NCT05024422|Vitamins|vitamins|mesh-ancestor
139537330|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
139537331|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537332|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
139537333|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139537334|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139537335|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
139537336|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
139537337|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139537338|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537339|NCT02819596|Durvalumab|durvalumab|mesh-list
139537340|NCT02819596|Tremelimumab|tremelimumab|mesh-list
139537341|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139537342|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537343|NCT02818894|Lidocaine|lidocaine|mesh-list
139537344|NCT02818894|Bupivacaine|bupivacaine|mesh-list
139537345|NCT02818894|Anesthetics, Local|anesthetics, local|mesh-ancestor
139537346|NCT02818894|Anesthetics|anesthetics|mesh-ancestor
139537347|NCT02818894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139537348|NCT02818894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537349|NCT02818894|Sensory System Agents|sensory system agents|mesh-ancestor
139537350|NCT02818894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537351|NCT02818894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139537352|NCT02818894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139537353|NCT02818894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139537354|NCT02818894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139537355|NCT02818894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537356|NCT05586568|Itraconazole|itraconazole|mesh-list
139537357|NCT05586568|Rifampin|rifampin|mesh-list
139537358|NCT05586568|Esomeprazole|esomeprazole|mesh-list
139537359|NCT05586568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139537360|NCT05586568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139537361|NCT05586568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139537362|NCT05586568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537363|NCT05586568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176489|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
139537364|NCT05586568|Antifungal Agents|antifungal agents|mesh-ancestor
139537365|NCT05586568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537366|NCT05586568|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139537367|NCT05586568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139537368|NCT05586568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139537369|NCT05586568|Hormone Antagonists|hormone antagonists|mesh-ancestor
139537370|NCT05586568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537371|NCT05586568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537372|NCT05586568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139537373|NCT05586568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139537374|NCT05586568|Antitubercular Agents|antitubercular agents|mesh-ancestor
139537375|NCT05586568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139537376|NCT05586568|Leprostatic Agents|leprostatic agents|mesh-ancestor
139537377|NCT05586568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139537378|NCT05586568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139537379|NCT05586568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139537380|NCT05586568|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139537381|NCT05586568|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139537382|NCT05586568|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139537383|NCT05586568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139537384|NCT02624908|Canagliflozin|canagliflozin|mesh-list
139537385|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139537386|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537387|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139537388|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537389|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
139537390|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139537391|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
139537392|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139537393|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537394|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139537395|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
139537396|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139537397|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537398|NCT02556424|Dexamethasone|dexamethasone|mesh-list
139537399|NCT02556424|Triamcinolone|triamcinolone|mesh-list
139537400|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537401|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
139537402|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
139537403|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537404|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537405|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139537406|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
139537407|NCT02556424|Hormones|hormones|mesh-ancestor
139537408|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537409|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139537410|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537411|NCT02543944|Clonidine|clonidine|mesh-list
139537412|NCT02543944|Naltrexone|naltrexone|mesh-list
139537413|NCT02543944|Buprenorphine|buprenorphine|mesh-list
139537414|NCT02543944|Gabapentin|gabapentin|mesh-list
139537415|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139537416|NCT02543944|Narcotics|narcotics|mesh-ancestor
139537417|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139537418|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537419|NCT02543944|Analgesics|analgesics|mesh-ancestor
139537420|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
139537421|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537422|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139537423|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
139537424|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139537425|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139537426|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139537427|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139537428|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139537429|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139537430|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537431|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
139537432|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139537433|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139537434|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
139537435|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
139537436|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139537437|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139537438|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139537439|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
139537440|NCT02531308|Metformin|metformin|mesh-list
139537441|NCT02531308|Prednisone|prednisone|mesh-list
139537442|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
139537443|NCT02531308|Rituximab|rituximab|mesh-list
139537444|NCT02531308|Doxorubicin|doxorubicin|mesh-list
139537445|NCT02531308|Vincristine|vincristine|mesh-list
139537446|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139537447|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
139537448|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537449|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139537450|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139537451|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
139537452|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537453|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537454|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139537455|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139537456|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139537457|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139537458|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139537459|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139537460|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537461|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537462|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
139537463|NCT02531308|Hormones|hormones|mesh-ancestor
139537464|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537465|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139537466|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139537467|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
139537468|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
139537469|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
139537470|NCT02523976|Cytarabine|cytarabine|mesh-list
139537471|NCT02523976|Dexamethasone|dexamethasone|mesh-list
139537472|NCT02523976|Prednisone|prednisone|mesh-list
139537473|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
139537474|NCT02523976|Methotrexate|methotrexate|mesh-list
139537475|NCT02523976|Etoposide|etoposide|mesh-list
139537476|NCT02523976|Vincristine|vincristine|mesh-list
139537477|NCT02523976|Daunorubicin|daunorubicin|mesh-list
139537478|NCT02523976|Dasatinib|dasatinib|mesh-list
139537479|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
139537480|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
139537481|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139537482|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
139537483|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176839|NCT01169935|Dextrans|dextrans|mesh-list
139537484|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139537485|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139537486|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
139537487|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537488|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537489|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139537490|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537491|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
139537492|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
139176887|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537493|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537494|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139537495|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
139537496|NCT02523976|Hormones|hormones|mesh-ancestor
139537497|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537498|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139537499|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139537500|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
139537501|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139537502|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139537503|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
139537504|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
139537505|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537506|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139537507|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139537508|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139537509|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139537510|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139537511|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
139537512|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537513|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
139537514|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
139537515|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
139537516|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139537517|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139537518|NCT02523976|Analgesics|analgesics|mesh-ancestor
139537519|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
139537520|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139537521|NCT02493322|Olmesartan|olmesartan|mesh-list
139537522|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139537523|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
139537524|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139537525|NCT02493322|Diuretics|diuretics|mesh-ancestor
139537526|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
139537527|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537528|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139537529|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139537530|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537531|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139537532|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139537533|NCT04757974|Fostemsavir|fostemsavir|mesh-list
139537534|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139537535|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139537536|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
139537537|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537538|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139537539|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139537540|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537541|NCT04757506|Naltrexone|naltrexone|mesh-list
139537542|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139537543|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139537544|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537545|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
139537546|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537547|NCT02477644|Olaparib|olaparib|mesh-list
139537548|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139537549|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537550|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537551|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537552|NCT02466334|Calcitonin|calcitonin|mesh-list
139537553|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
139537554|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139537555|NCT02466334|Katacalcin|katacalcin|mesh-list
139537556|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139537557|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537558|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139537559|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
139537560|NCT02460874|Glyburide|glyburide|mesh-list
139537561|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138727191|NCT04513717|Leuprolide|leuprolide|mesh-list
139537562|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537563|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
139537564|NCT02443324|Ramucirumab|ramucirumab|mesh-list
139537565|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139537566|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537567|NCT02443324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139537568|NCT02443324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537569|NCT01894048|Beclomethasone|beclomethasone|mesh-list
139537570|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537571|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
139537572|NCT01894048|Hormones|hormones|mesh-ancestor
139537573|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537574|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537575|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139537576|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
139537577|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
139537578|NCT02420314|Paclitaxel|paclitaxel|mesh-list
139537579|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139537580|NCT02420314|Carboplatin|carboplatin|mesh-list
139537581|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139537582|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537583|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
139537584|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
139537585|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
139537586|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537587|NCT02420314|Vitamins|vitamins|mesh-ancestor
139537588|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
139537589|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537590|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
139537591|NCT02420314|Protective Agents|protective agents|mesh-ancestor
139537592|NCT01539291|Idelalisib|idelalisib|mesh-list
139537593|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537594|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537595|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537596|NCT04746040|Fluticasone|fluticasone|mesh-list
139537597|NCT04746040|Xhance|xhance|mesh-list
139537598|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139537599|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139537600|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537601|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139537602|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
139537603|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537604|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537605|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139537606|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
139537607|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
139177378|NCT01178047|Rasagiline|rasagiline|mesh-list
139537608|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139537609|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139537610|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139537611|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139537612|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
139537613|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139537614|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537615|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
139537616|NCT04746040|Hormones|hormones|mesh-ancestor
139537617|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537618|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
139537619|NCT02400814|Atezolizumab|atezolizumab|mesh-list
139537620|NCT02400814|Antibodies|antibodies|mesh-list
139537621|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139537622|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
139537623|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537624|NCT02400814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139537625|NCT02400814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537626|NCT02400814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139537627|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537628|NCT02398240|Rituximab|rituximab|mesh-list
139537629|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139537630|NCT02398240|Doxorubicin|doxorubicin|mesh-list
139537631|NCT02398240|Vincristine|vincristine|mesh-list
139537632|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139537633|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537634|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
139537635|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537636|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139537637|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139537638|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139537639|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139537640|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537641|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537642|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139537643|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
139537644|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
139537645|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
139537646|NCT02398240|Immunotoxins|immunotoxins|mesh-ancestor
139537647|NCT02398240|Immunoconjugates|immunoconjugates|mesh-ancestor
139537648|NCT02022280|Lansoprazole|lansoprazole|mesh-list
139537649|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
139537650|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139537651|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139537652|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139537653|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537654|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537655|NCT01511445|Silicon|silicon|mesh-list
139537656|NCT01511445|Trace Elements|trace elements|mesh-ancestor
139537657|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
139537658|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537659|NCT02344186|Liraglutide|liraglutide|mesh-list
139537660|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139537661|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537662|NCT02344186|Incretins|incretins|mesh-ancestor
139537663|NCT02344186|Hormones|hormones|mesh-ancestor
139537664|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537665|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
139537666|NCT01537887|Evacetrapib|evacetrapib|mesh-list
139537667|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139537668|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537669|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139537670|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139537671|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537672|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537673|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537674|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139537675|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139537676|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
139537677|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139537678|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139537679|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139537680|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537681|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
139537682|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139537683|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177608|NCT01288495|Psyllium|psyllium|mesh-list
139537684|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139537685|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
139537686|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139537687|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537688|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537689|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537690|NCT01928056|Montelukast|montelukast|mesh-list
139537691|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139537692|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
139537693|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139537694|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
139537695|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537696|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537697|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139537698|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139537699|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537700|NCT05585866|Anesthetics|anesthetics|mesh-list
139537701|NCT05585866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139177732|NCT05619887|Sensory System Agents|sensory system agents|mesh-ancestor
139537702|NCT05585866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537703|NCT01992952|Fulvestrant|fulvestrant|mesh-list
139537704|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139537705|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537706|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139537707|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139537708|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
139642473|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139537709|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537710|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537711|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
139537712|NCT01928134|Calcium|calcium|mesh-list
139537713|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139537714|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537715|NCT01928134|Antacids|antacids|mesh-ancestor
139537716|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537717|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139537718|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139537719|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139537720|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139537721|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139537722|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537723|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
139537724|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139537725|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537726|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139537727|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537728|NCT04756492|Cyclosporine|cyclosporine|mesh-list
139537729|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
139537730|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537731|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
139537732|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177854|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
139537733|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537734|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139537735|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
139537736|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537737|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139537738|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139537739|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
139537740|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139537741|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537742|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139537743|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139537744|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537745|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177910|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
139537746|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537747|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
139537748|NCT04767633|Analgesics|analgesics|mesh-ancestor
139537749|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
139537750|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537751|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537752|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
139537753|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139537754|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139537755|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
139537756|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139177972|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537757|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139537758|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537759|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139537760|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
139537761|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139537762|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
139537763|NCT01928914|Tafenoquine|tafenoquine|mesh-list
139537764|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139537765|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537766|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139537767|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139537768|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537769|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537770|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537771|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
139537772|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139537773|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139537774|NCT02249104|Adapalene|adapalene|mesh-list
139537775|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
139537776|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139537777|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
139537778|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139537779|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139537780|NCT02249104|Analgesics|analgesics|mesh-ancestor
139537781|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
139537782|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537783|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537784|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537786|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139537787|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139537788|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139537789|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
139537790|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537791|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139537792|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139537793|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537794|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
139537795|NCT01536561|Antibodies|antibodies|mesh-list
139537796|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139537797|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
139537798|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
139537799|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537800|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537801|NCT02236312|Botulinum Toxins|botulinum toxins|mesh-list
139537802|NCT02236312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139537803|NCT02236312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139537804|NCT02236312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139537805|NCT02236312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139537806|NCT02236312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537807|NCT02236312|Cholinergic Agents|cholinergic agents|mesh-ancestor
139537808|NCT02236312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139537809|NCT02236312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537810|NCT02236312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139537811|NCT02236312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537812|NCT01916278|Lidocaine|lidocaine|mesh-list
139537813|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
139537814|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
139537815|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139537816|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537817|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
139537818|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537819|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139537820|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139537821|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139537822|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139537823|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537824|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
139537825|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139537826|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537827|NCT03084640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139537828|NCT03084640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537829|NCT04409691|Sirolimus|sirolimus|mesh-list
139537830|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139537831|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537832|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139537833|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537834|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
139537835|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139537836|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
139537837|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537838|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
139537839|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139537840|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139537841|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139537842|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537843|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
139537844|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
139537845|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139537846|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537847|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139537848|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537849|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537850|NCT01516606|Clarithromycin|clarithromycin|mesh-list
139537851|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139537852|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139537853|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139537854|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537855|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537856|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139537857|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139537859|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
139537860|NCT02209636|Vitamins|vitamins|mesh-ancestor
139537861|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
139537862|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537863|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
139537864|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537865|NCT02209636|Protective Agents|protective agents|mesh-ancestor
139537866|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
139537867|NCT01508325|Metoprolol|metoprolol|mesh-list
139537868|NCT01508325|Bisoprolol|bisoprolol|mesh-list
139537869|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139537870|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139537871|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
139537872|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
139537873|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537874|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537875|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139537876|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139537877|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139537878|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
139537879|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139537880|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537881|NCT01514344|Rituximab|rituximab|mesh-list
139178282|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537882|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139537883|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537884|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
139537885|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537886|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139537887|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
139537888|NCT02191930|Doxorubicin|doxorubicin|mesh-list
139537889|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139537890|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139537891|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139537892|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
139537893|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537894|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139537895|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139537896|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
139537897|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537898|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537899|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139537900|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139537901|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139537902|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139537903|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537904|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139537905|NCT02191930|Immunotoxins|immunotoxins|mesh-ancestor
139537906|NCT02191930|Immunoconjugates|immunoconjugates|mesh-ancestor
139537907|NCT01536015|Rotigotine|rotigotine|mesh-list
139537908|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
139537909|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
139537910|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139537911|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537912|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537913|NCT01484691|Budesonide|budesonide|mesh-list
139537914|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537915|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139537916|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
139537917|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537918|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537919|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139537920|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
139537921|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
139537922|NCT01484691|Hormones|hormones|mesh-ancestor
139537923|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537924|NCT01464034|Dexamethasone|dexamethasone|mesh-list
139537925|NCT01464034|Pomalidomide|pomalidomide|mesh-list
139537926|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139178490|NCT03852979|Paclitaxel|paclitaxel|mesh-list
139537927|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
139537928|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
139537929|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537930|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537931|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139537932|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
139537933|NCT01464034|Hormones|hormones|mesh-ancestor
139537934|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139537935|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139537936|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537937|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
139537938|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139537939|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139537940|NCT01464034|Growth Substances|growth substances|mesh-ancestor
139537941|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
139537942|NCT01535235|Lisinopril|lisinopril|mesh-list
139537943|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139537944|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
139537945|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537946|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537947|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139537948|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139537949|NCT01535235|Protective Agents|protective agents|mesh-ancestor
139537950|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537951|NCT02317744|Naltrexone|naltrexone|mesh-list
139537952|NCT02317744|Bupropion|bupropion|mesh-list
139537953|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139537954|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139537955|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537956|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
139537957|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139537958|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139537959|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
139537960|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139537961|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139537962|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139537963|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139537964|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537965|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
139537966|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139537967|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139537968|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139537969|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537970|NCT05577442|Trastuzumab|trastuzumab|mesh-list
139537971|NCT05577442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139537972|NCT05577442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537973|NCT01895764|Adalimumab|adalimumab|mesh-list
139537974|NCT01895764|Methotrexate|methotrexate|mesh-list
139537975|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139537976|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
139537977|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139537978|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537979|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139537980|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
139537981|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139537982|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139537983|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
139537984|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139537985|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139537986|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139537987|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
139537988|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139537989|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139537990|NCT01895764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139537991|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537992|NCT01894360|Belimumab|belimumab|mesh-list
139537993|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139537994|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
139178707|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139537995|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139537996|NCT01483599|Adalimumab|adalimumab|mesh-list
139537997|NCT01483599|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139537998|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139537999|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139538000|NCT01407562|Paclitaxel|paclitaxel|mesh-list
139538001|NCT01407562|Carboplatin|carboplatin|mesh-list
139538002|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139538003|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538004|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
139538005|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
139538006|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
139538007|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538008|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139538009|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
139538010|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538011|NCT01393522|Milnacipran|milnacipran|mesh-list
139538012|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
139538013|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139538014|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139538015|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139538016|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538017|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538018|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538019|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139538020|NCT01393522|Analgesics|analgesics|mesh-ancestor
139538021|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
139538022|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538023|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
139538024|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139538025|NCT02086786|Risperidone|risperidone|mesh-list
139538026|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139538027|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
139538028|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538029|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538030|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538031|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139538032|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139538033|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139538034|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139538035|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139538036|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
139538037|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
139538038|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139538039|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139538040|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139538041|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139538042|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538043|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
139538044|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538045|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538046|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139538047|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538048|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139538049|NCT01895218|Hematinics|hematinics|mesh-ancestor
139538050|NCT01895998|Albuterol|albuterol|mesh-list
139538051|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139538052|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
139538053|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538054|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538055|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139538056|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
139538057|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
139538058|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139538059|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139538060|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139538061|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139538062|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
139538063|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538064|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538065|NCT01895296|Pasireotide|pasireotide|mesh-list
139538066|NCT01895296|Hormones|hormones|mesh-ancestor
139538067|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139538068|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538069|NCT01276600|Tenofovir|tenofovir|mesh-list
139538070|NCT01276600|Emtricitabine|emtricitabine|mesh-list
139538071|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
139538072|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139538073|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139538074|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139538075|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538076|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538078|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139538079|NCT04755868|Talazoparib|talazoparib|mesh-list
139538080|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139538081|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538082|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538083|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538084|NCT01621906|Alovudine|alovudine|mesh-list
139538085|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
139538086|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139538087|NCT01615510|Tapentadol|tapentadol|mesh-list
139538088|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139538089|NCT01615510|Narcotics|narcotics|mesh-ancestor
139538090|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139538091|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538092|NCT01615510|Analgesics|analgesics|mesh-ancestor
139538093|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
139538094|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538095|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139538096|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139538097|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139538098|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538099|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
139538100|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538101|NCT00530062|Albuterol|albuterol|mesh-list
139538102|NCT00530062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139538103|NCT00530062|Autonomic Agents|autonomic agents|mesh-ancestor
139538104|NCT00530062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538105|NCT00530062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179040|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
139538106|NCT00530062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139538107|NCT00530062|Respiratory System Agents|respiratory system agents|mesh-ancestor
139538108|NCT00530062|Tocolytic Agents|tocolytic agents|mesh-ancestor
139538109|NCT00530062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139538110|NCT00530062|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139538111|NCT00530062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139538112|NCT00530062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139538113|NCT00530062|Adrenergic Agents|adrenergic agents|mesh-ancestor
139538114|NCT00530062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538115|NCT00530062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538116|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
139538117|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139538118|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139538119|NCT01209364|Prednisolone|prednisolone|mesh-list
139538120|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
139179103|NCT03849235|Glucagon|glucagon|mesh-list
139538121|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139538122|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
139538123|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139538124|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
139538125|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
139538126|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538127|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538128|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139538129|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
139538130|NCT01209364|Hormones|hormones|mesh-ancestor
139538131|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139538132|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139538133|NCT01209364|Protective Agents|protective agents|mesh-ancestor
139538134|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139538135|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538136|NCT05080192|Fenofibrate|fenofibrate|mesh-list
139538137|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139538138|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
139538139|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538140|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139538141|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139538142|NCT00472966|Tretinoin|tretinoin|mesh-list
139538143|NCT00472966|Glycolic acid|glycolic acid|mesh-list
139538144|NCT00472966|Hydroquinone|hydroquinone|mesh-list
139538145|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538146|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
139538147|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
139538148|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139538149|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
139538150|NCT00472966|Hormones|hormones|mesh-ancestor
139538151|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139538152|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538154|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538155|NCT00472966|Protective Agents|protective agents|mesh-ancestor
139179213|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
139538156|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139538157|NCT01573780|Gemcitabine|gemcitabine|mesh-list
139538158|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139538159|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
139538160|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538161|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538162|NCT01547260|Gemcitabine|gemcitabine|mesh-list
139538163|NCT01547260|Lenalidomide|lenalidomide|mesh-list
139538164|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139538165|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
139538166|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538167|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538168|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
139538169|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538170|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139538171|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139538172|NCT01547260|Growth Substances|growth substances|mesh-ancestor
139538173|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
139538174|NCT01896388|Ifenprodil|ifenprodil|mesh-list
139538175|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139538176|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139538177|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
139538178|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538179|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538180|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538181|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
139538182|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139538183|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139538184|NCT01125436|Vitamin D|vitamin d|mesh-list
139538185|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
139538186|NCT01125436|Vitamins|vitamins|mesh-ancestor
139538187|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
139538188|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538189|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139538190|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139538191|NCT00436540|Clobetasol|clobetasol|mesh-list
139179274|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
139538192|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139538193|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
139538194|NCT00436540|Hormones|hormones|mesh-ancestor
139538195|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139538196|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538197|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139538198|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139538199|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139538200|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139538201|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538202|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538203|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538204|NCT00425230|Analgesics|analgesics|mesh-ancestor
139538205|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
139538206|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538207|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
139538208|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139538209|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
139538210|NCT04634578|Bevacizumab|bevacizumab|mesh-list
139538211|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139538212|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538213|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139538214|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139538215|NCT04634578|Growth Substances|growth substances|mesh-ancestor
139538216|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538217|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
139538218|NCT01066858|Tenofovir|tenofovir|mesh-list
139538219|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
139538220|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139538221|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139538222|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139538223|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319867|NCT02660034|Pamiparib|pamiparib|mesh-list
139538224|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538225|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139538226|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139538227|NCT04777552|Diazepam|diazepam|mesh-list
139538228|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139538229|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
139538230|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
139538231|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
139538232|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538233|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538234|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139538235|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139538236|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139538237|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139538238|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139538239|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139538240|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139538241|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139538242|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139538243|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
139538244|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
139538245|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
139538246|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
139538247|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538248|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538249|NCT01506609|Paclitaxel|paclitaxel|mesh-list
139538250|NCT01506609|Carboplatin|carboplatin|mesh-list
139538251|NCT01506609|Temozolomide|temozolomide|mesh-list
139538252|NCT01506609|Veliparib|veliparib|mesh-list
139538253|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139538254|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538255|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
139538256|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
139538257|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
139538258|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538259|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139538260|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
139538261|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139538262|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538263|NCT04777162|Tislelizumab|tislelizumab|mesh-list
139538264|NCT04777162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139538265|NCT04777162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538266|NCT03027219|Alprostadil|alprostadil|mesh-list
139538267|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139538268|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
139538269|NCT03027219|Urological Agents|urological agents|mesh-ancestor
139538270|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
139538271|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
139538272|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538273|NCT01506453|Gabapentin|gabapentin|mesh-list
139538274|NCT01506453|Analgesics|analgesics|mesh-ancestor
139538275|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
139538276|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538277|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538278|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
139538279|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139538280|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139538281|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139538282|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139538283|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139179459|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139538284|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139538285|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538286|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538287|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
139538288|NCT04389580|Tamoxifen|tamoxifen|mesh-list
139538289|NCT04389580|Isotretinoin|isotretinoin|mesh-list
139538290|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139538291|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
139538292|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139538293|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538294|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139538295|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319938|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538296|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139538297|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139538298|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139538299|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
139538300|NCT00199108|Dexamethasone|dexamethasone|mesh-list
139538301|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139538302|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
139538303|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
139538304|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538305|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538306|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139538307|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
139538308|NCT00199108|Hormones|hormones|mesh-ancestor
139538309|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139538310|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139538311|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538312|NCT01504971|Rabeprazole|rabeprazole|mesh-list
139538313|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139538314|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139538315|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139538316|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538317|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538318|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
139538319|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
139538320|NCT04753918|Trioxsalen|trioxsalen|mesh-list
139538321|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179567|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179568|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139179569|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139179570|NCT01102595|Growth Substances|growth substances|mesh-ancestor
139179571|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179572|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
139179573|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139179574|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
139179575|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739742|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
139538322|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
139538323|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139538324|NCT04161664|Paclitaxel|paclitaxel|mesh-list
139538325|NCT04161664|Carboplatin|carboplatin|mesh-list
139538326|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139538327|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538328|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
139179625|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
139538329|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
139538330|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
139538331|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538332|NCT00936832|Leucovorin|leucovorin|mesh-list
139538333|NCT00936832|Fluorouracil|fluorouracil|mesh-list
139538334|NCT00936832|Irinotecan|irinotecan|mesh-list
139538335|NCT00936832|Sunitinib|sunitinib|mesh-list
139538336|NCT00936832|Calcium|calcium|mesh-list
139538337|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
139538338|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139538339|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538340|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
139538341|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538342|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139538343|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538344|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139538345|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
139538346|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139538347|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139538348|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538349|NCT00936832|Antidotes|antidotes|mesh-ancestor
139538350|NCT00936832|Protective Agents|protective agents|mesh-ancestor
139538351|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
139538352|NCT00936832|Vitamins|vitamins|mesh-ancestor
139538353|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
139538354|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139538355|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139538356|NCT00936832|Growth Substances|growth substances|mesh-ancestor
139538357|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
139538358|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139538359|NCT01479621|Fluticasone|fluticasone|mesh-list
139538360|NCT01479621|Xhance|xhance|mesh-list
139538361|NCT01479621|Albuterol|albuterol|mesh-list
139538362|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
139538363|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139538364|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139538365|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
139538366|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538367|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538368|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139179760|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
139538369|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
139538370|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
139538371|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139538372|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
139538373|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139538374|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139538375|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139538376|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
139538377|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538378|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538379|NCT04776226|Citalopram|citalopram|mesh-list
139538380|NCT04776226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139538381|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139538382|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139538383|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538384|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538385|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
139538386|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538387|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139538388|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
139538389|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139538390|NCT02319304|Leucovorin|leucovorin|mesh-list
139538391|NCT02319304|Fluorouracil|fluorouracil|mesh-list
139538392|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
139538393|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
139538394|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538395|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139538396|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538397|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139538398|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
139538399|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538400|NCT02319304|Antidotes|antidotes|mesh-ancestor
139538401|NCT02319304|Protective Agents|protective agents|mesh-ancestor
139538402|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
139538403|NCT02319304|Vitamins|vitamins|mesh-ancestor
139538404|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
139538405|NCT00885664|Ritonavir|ritonavir|mesh-list
139538406|NCT00885664|Lopinavir|lopinavir|mesh-list
139538407|NCT00885664|Tenofovir|tenofovir|mesh-list
139538408|NCT00885664|Emtricitabine|emtricitabine|mesh-list
139538409|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139538410|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139538411|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139538412|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
139538413|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538414|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538415|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139538416|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139538417|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
139538418|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139538419|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139538420|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139538421|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139538422|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139538423|NCT04784104|Epinephrine|epinephrine|mesh-list
139538424|NCT04784104|Racepinephrine|racepinephrine|mesh-list
139538425|NCT04784104|Bupivacaine|bupivacaine|mesh-list
139538426|NCT04784104|Prilocaine|prilocaine|mesh-list
139538427|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139538428|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
139538429|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
139538430|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
139538431|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139538432|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538433|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
139538434|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538435|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139538436|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139538437|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
139538438|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538439|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538440|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139538441|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139538442|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
139538443|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139538444|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
139538445|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
139538446|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
139538447|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139538448|NCT00880594|Desipramine|desipramine|mesh-list
139538449|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139538450|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
139320089|NCT03534297|Dapansutrile|dapansutrile|mesh-list
139538451|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139538452|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538453|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538454|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139538455|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139538456|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139538457|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
139538458|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538459|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538460|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
139538461|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139538462|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538463|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139538464|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538465|NCT04783636|Leuprolide|leuprolide|mesh-list
139538466|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139538467|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
139538468|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139538469|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538470|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139538471|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538472|NCT00820846|Vaccines|vaccines|mesh-list
139538473|NCT00820846|Immunologic Factors|immunologic factors|mesh-ancestor
139538474|NCT00820846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538475|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139538476|NCT03364348|Trastuzumab|trastuzumab|mesh-list
139538477|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139538478|NCT03364348|Maytansine|maytansine|mesh-list
139180155|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139180156|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180157|NCT01208441|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139180158|NCT03718377|Anesthetics|anesthetics|mesh-list
139180161|NCT01197469|Tadalafil|tadalafil|mesh-list
139538479|NCT03364348|Antibodies|antibodies|mesh-list
139538480|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
139538481|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139538482|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
139538483|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
139538484|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
139538485|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538486|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538487|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139538488|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
139538489|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
139538490|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
139180220|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
139180221|NCT03940391|Midazolam|midazolam|mesh-list
139180222|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139180223|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139180224|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180225|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180226|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139538491|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538492|NCT03364348|Immunotoxins|immunotoxins|mesh-ancestor
139538493|NCT04782622|Apatinib|apatinib|mesh-list
139538494|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538495|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139538496|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538497|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538498|NCT04775212|Sevoflurane|sevoflurane|mesh-list
139538499|NCT04775212|Desflurane|desflurane|mesh-list
139538500|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139538501|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139538502|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
139538503|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
139538504|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139538505|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538506|NCT04774822|Mydriatics|mydriatics|mesh-list
139538507|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
139538508|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538509|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538510|NCT04782388|Alprazolam|alprazolam|mesh-list
139538511|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139538512|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139538513|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538514|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139538515|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139538516|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139538517|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
139538518|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
139538519|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538520|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538521|NCT04782076|Dabigatran|dabigatran|mesh-list
139538522|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
139538523|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139538524|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
139538525|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642474|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139538526|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538528|NCT04782310|Pregabalin|pregabalin|mesh-list
139538529|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139538530|NCT04782310|Analgesics|analgesics|mesh-ancestor
139538531|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
139538532|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538533|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538534|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
139538535|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139538536|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139538537|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538538|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139538539|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139538540|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139538541|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139538542|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139538543|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139538544|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139538545|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538546|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
139538547|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
139538548|NCT03300544|Leucovorin|leucovorin|mesh-list
139538549|NCT03300544|Capecitabine|capecitabine|mesh-list
139538550|NCT03300544|Fluorouracil|fluorouracil|mesh-list
139538551|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
139538552|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139538553|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139538554|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
139538555|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538556|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538557|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139538558|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
139538559|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538560|NCT03300544|Antidotes|antidotes|mesh-ancestor
139538561|NCT03300544|Protective Agents|protective agents|mesh-ancestor
139538562|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
139538563|NCT03300544|Vitamins|vitamins|mesh-ancestor
139538564|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
139538565|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139538566|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
139538567|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139538568|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139538569|NCT03249844|Prednisolone|prednisolone|mesh-list
139538570|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
139538571|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139538572|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
139538573|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139538574|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
139538575|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
139538576|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538577|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538578|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139538579|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
139538580|NCT03249844|Hormones|hormones|mesh-ancestor
139180439|NCT06106789|Tobramycin|tobramycin|mesh-list
139538581|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139538582|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139538583|NCT03249844|Protective Agents|protective agents|mesh-ancestor
139538584|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139538585|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538586|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
139538587|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139538588|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
139538589|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139538590|NCT00637624|Expectorants|expectorants|mesh-ancestor
139538591|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
139538592|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139538593|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
139538594|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538595|NCT00637624|Protective Agents|protective agents|mesh-ancestor
139538596|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538597|NCT00637624|Antidotes|antidotes|mesh-ancestor
139538598|NCT01479465|Leucovorin|leucovorin|mesh-list
139538599|NCT01479465|Fluorouracil|fluorouracil|mesh-list
139538600|NCT01479465|Irinotecan|irinotecan|mesh-list
139538601|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
139538602|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538603|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139538605|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139538606|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
139538607|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538608|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139538609|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139538610|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538611|NCT01479465|Antidotes|antidotes|mesh-ancestor
139538612|NCT01479465|Protective Agents|protective agents|mesh-ancestor
139538613|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
139538614|NCT01479465|Vitamins|vitamins|mesh-ancestor
139538615|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
139538616|NCT04781686|Docetaxel|docetaxel|mesh-list
139538617|NCT04781686|Apatinib|apatinib|mesh-list
139538618|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538619|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
139538620|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
139538621|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
139538622|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538623|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139538624|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538625|NCT04780750|Docetaxel|docetaxel|mesh-list
139538626|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538627|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
139538628|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
139538629|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
139538630|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538631|NCT04780984|Bromides|bromides|mesh-list
139180658|NCT05945485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180659|NCT05935553|Baclofen|baclofen|mesh-list
139180660|NCT05935553|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139180662|NCT05935553|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139538632|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
139538633|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139538634|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
139538635|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538636|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538637|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139538638|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
139538639|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
139538640|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139538641|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
139538642|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538643|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538644|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
139538645|NCT02090374|Vitamin D|vitamin d|mesh-list
139538646|NCT02090374|Poly ICLC|poly iclc|mesh-list
139538647|NCT02090374|Vitamins|vitamins|mesh-ancestor
139538648|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
139538649|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538650|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139538651|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
139538652|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
139538653|NCT02222740|Hydrocodone|hydrocodone|mesh-list
139538654|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139180724|NCT05872854|Hypericin|hypericin|mesh-list
138747642|NCT01228734|Leucovorin|leucovorin|mesh-list
139180735|NCT05797740|Cladribine|cladribine|mesh-list
139538655|NCT02222740|Narcotics|narcotics|mesh-ancestor
139538656|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139538657|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538658|NCT02222740|Analgesics|analgesics|mesh-ancestor
139538659|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
139538660|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538661|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
139538662|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
139538663|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
139538664|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139538665|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538666|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139538667|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538668|NCT04779892|Infliximab|infliximab|mesh-list
139180774|NCT05653193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538669|NCT04779892|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139538670|NCT04779892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139538671|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
139538672|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139538673|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139538674|NCT04389424|Tamoxifen|tamoxifen|mesh-list
139538675|NCT04389424|Anastrozole|anastrozole|mesh-list
139538676|NCT04389424|Exemestane|exemestane|mesh-list
139538677|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139538678|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
139538679|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139538680|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538681|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139538682|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538683|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139538684|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139538685|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139538686|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139538687|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139538688|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538689|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538690|NCT04771390|Selitrectinib|selitrectinib|mesh-list
139538691|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538692|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538693|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
139538694|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139538695|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139538696|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139538697|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
139538698|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
139538699|NCT05411380|Capecitabine|capecitabine|mesh-list
139538700|NCT05411380|Letrozole|letrozole|mesh-list
139538701|NCT05411380|Fulvestrant|fulvestrant|mesh-list
139538702|NCT05411380|Anastrozole|anastrozole|mesh-list
139538703|NCT05411380|Exemestane|exemestane|mesh-list
139538704|NCT05411380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139538705|NCT05411380|Antimetabolites|antimetabolites|mesh-ancestor
139538706|NCT05411380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538707|NCT05411380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538708|NCT05411380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139538709|NCT05411380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139538710|NCT05411380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538711|NCT05411380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139538712|NCT05411380|Hormone Antagonists|hormone antagonists|mesh-ancestor
139538713|NCT05411380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139538714|NCT05411380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538715|NCT05411380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139538716|NCT05411380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139538717|NCT04779580|Anesthetics|anesthetics|mesh-list
139538718|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
139538719|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139538720|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538721|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
139538722|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538723|NCT04770688|Osimertinib|osimertinib|mesh-list
139538724|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538725|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139538726|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538727|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538728|NCT05390476|Capecitabine|capecitabine|mesh-list
139538729|NCT05390476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139538730|NCT05390476|Antimetabolites|antimetabolites|mesh-ancestor
139538731|NCT05390476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538732|NCT05390476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538733|NCT05324332|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139538734|NCT05324332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139538735|NCT05324332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538736|NCT04769908|Lenvatinib|lenvatinib|mesh-list
139538737|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538738|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139538739|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538740|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538741|NCT00054028|Suramin|suramin|mesh-list
139538742|NCT00054028|Paclitaxel|paclitaxel|mesh-list
139538743|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139538744|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538745|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
139538746|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
139538747|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
139538748|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538749|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
139538750|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
139538751|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139538752|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139538753|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139538754|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139538755|NCT00058240|Alvocidib|alvocidib|mesh-list
139538756|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538757|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
139538758|NCT00058240|Growth Substances|growth substances|mesh-ancestor
139538759|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538760|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139538761|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538762|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538763|NCT03026907|Azathioprine|azathioprine|mesh-list
139538764|NCT03026907|Alitretinoin|alitretinoin|mesh-list
139538765|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538766|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
139538767|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
139538768|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538769|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139538770|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139538771|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
139538772|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538773|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139538774|NCT00060424|Cyclosporine|cyclosporine|mesh-list
139538775|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
139538776|NCT00060424|Fludarabine|fludarabine|mesh-list
139538777|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
139538778|NCT00060424|Cyclosporins|cyclosporins|mesh-list
139538779|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538780|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139538781|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
139538782|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538783|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139538784|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
139538785|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538786|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538787|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
139538788|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139538789|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
139538790|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139538791|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139538792|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139538793|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139538794|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
139538795|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139538796|NCT00062764|Pioglitazone|pioglitazone|mesh-list
139538797|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139538798|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538799|NCT00063232|Metformin|metformin|mesh-list
139538800|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139181016|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
139538801|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538802|NCT00063622|Vitamin E|vitamin e|mesh-list
139538803|NCT00063622|Pioglitazone|pioglitazone|mesh-list
139538804|NCT00063622|Vitamins|vitamins|mesh-ancestor
139538805|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
139538806|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538807|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139538808|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
139538809|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538810|NCT00063622|Protective Agents|protective agents|mesh-ancestor
139538811|NCT00153166|Pioglitazone|pioglitazone|mesh-list
139538812|NCT00153166|Atorvastatin|atorvastatin|mesh-list
139538813|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139538814|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139538815|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
139538816|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538817|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139538818|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139538819|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538820|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139538821|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538822|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
139538823|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139538824|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139538825|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139538826|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139538827|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538828|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
139538829|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538830|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538831|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139538832|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538833|NCT01475721|Fluticasone|fluticasone|mesh-list
139538834|NCT01475721|Xhance|xhance|mesh-list
139538835|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139538836|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139538837|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
139538838|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538839|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538840|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139538841|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
139538842|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
139538843|NCT01475721|Hormones|hormones|mesh-ancestor
139538844|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139538845|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
139538846|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139538847|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
139538848|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139538849|NCT00065806|Atorvastatin|atorvastatin|mesh-list
139538850|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139538851|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139538852|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
139538853|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538854|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139538855|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139538856|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538857|NCT00068770|Celecoxib|celecoxib|mesh-list
139538858|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139538859|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139538860|NCT00068770|Analgesics|analgesics|mesh-ancestor
139538861|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
139538862|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538863|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538864|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139538865|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139538866|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139538867|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139538868|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538869|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538870|NCT01475331|Ethanol|ethanol|mesh-list
139538871|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139538872|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139538873|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139538874|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538875|NCT01500213|Dexamethasone|dexamethasone|mesh-list
139538876|NCT01500213|Granisetron|granisetron|mesh-list
139538877|NCT01500213|Rolapitant|rolapitant|mesh-list
139538878|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139538879|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
139538880|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
139538881|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538882|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538883|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139538884|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
139538885|NCT01500213|Hormones|hormones|mesh-ancestor
139538886|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139538887|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139538888|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538889|NCT01500213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139538890|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139538891|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
139538892|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538893|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538894|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139538895|NCT00069160|Docetaxel|docetaxel|mesh-list
139538896|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
139538897|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538898|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
139538899|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
139538900|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
139538901|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538902|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139538903|NCT00071890|Aldesleukin|aldesleukin|mesh-list
139538904|NCT00071890|Interleukin-2|interleukin-2|mesh-list
139538905|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538906|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139538907|NCT00071890|Analgesics|analgesics|mesh-ancestor
139538908|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
139538909|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538910|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538911|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139538912|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139538913|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
139538914|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139538915|NCT01475253|Lidocaine|lidocaine|mesh-list
139538916|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
139538917|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
139538918|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139538919|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538920|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
139538921|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538922|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139538923|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139538924|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139538925|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139538926|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538927|NCT00072514|Dexamethasone|dexamethasone|mesh-list
139538928|NCT00072514|Rituximab|rituximab|mesh-list
139538929|NCT00072514|Carboplatin|carboplatin|mesh-list
139538930|NCT00072514|Gemcitabine|gemcitabine|mesh-list
139538931|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139538932|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
139538933|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
139538934|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139538935|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538936|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139538937|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
139538938|NCT00072514|Hormones|hormones|mesh-ancestor
139538939|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139538940|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139538941|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538942|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139538943|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
139538944|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139538945|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139538946|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
139538947|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538948|NCT00074308|Bevacizumab|bevacizumab|mesh-list
139538949|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139538950|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
139538951|NCT00074308|Antibodies|antibodies|mesh-list
139538952|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
139538953|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139538954|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538955|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139538956|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139538957|NCT00074308|Growth Substances|growth substances|mesh-ancestor
139538958|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538959|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
139538960|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
139538961|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139538962|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538963|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538964|NCT00166036|Atorvastatin|atorvastatin|mesh-list
139538965|NCT00166036|Pravastatin|pravastatin|mesh-list
139538966|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139538967|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139538968|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
139538969|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538970|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139181444|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139538971|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139538972|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538973|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
139538974|NCT00167206|Fludarabine|fludarabine|mesh-list
139538975|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139538976|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
139320614|NCT02880540|Morphine|morphine|mesh-list
139538977|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538978|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139538979|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139538980|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
139538981|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538982|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538983|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139538984|NCT01474551|Vemurafenib|vemurafenib|mesh-list
139538985|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139538986|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139538987|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139538988|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538989|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139538990|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139538991|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139538992|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139538993|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
139538994|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139538995|NCT00168298|Dexamethasone|dexamethasone|mesh-list
139538996|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
139538997|NCT00168298|BB 1101|bb 1101|mesh-list
139538998|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139538999|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
139539000|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
139539001|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539002|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539003|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139539004|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
139539005|NCT00168298|Hormones|hormones|mesh-ancestor
139539006|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139539007|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139539008|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539009|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
139539010|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539011|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539012|NCT00076258|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139181621|NCT00007670|Lamotrigine|lamotrigine|mesh-list
139539013|NCT00076258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139539014|NCT00076258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139539015|NCT00076258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539016|NCT00076258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539017|NCT00076258|Serotonin Agents|serotonin agents|mesh-ancestor
139539018|NCT00076258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539019|NCT00078286|Sertraline|sertraline|mesh-list
139539020|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
139539021|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139539022|NCT00078286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139539023|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139539024|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139539025|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539026|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539027|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
139539028|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539029|NCT00078754|Valproic Acid|valproic acid|mesh-list
139539030|NCT00078754|Fluoxetine|fluoxetine|mesh-list
139539031|NCT00078754|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139539032|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139539033|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139539034|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539035|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539036|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
139539037|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539038|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139539039|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
139539040|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139181744|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
139539041|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139539042|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139539043|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539044|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
139539045|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
139539046|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
139320694|NCT02209701|Porfiromycin|porfiromycin|mesh-list
139539047|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139539048|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139539049|NCT00081328|Metformin|metformin|mesh-list
139539050|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
139539051|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139539052|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539053|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
139539054|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139539055|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539056|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139539057|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
139539058|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139539059|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539060|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539061|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539062|NCT00083122|Cisplatin|cisplatin|mesh-list
139539063|NCT00083122|Alvocidib|alvocidib|mesh-list
139539064|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539065|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
139539066|NCT00083122|Growth Substances|growth substances|mesh-ancestor
139539067|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539068|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139539069|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539070|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539071|NCT01474239|Bevacizumab|bevacizumab|mesh-list
139539072|NCT01474239|Fotemustine|fotemustine|mesh-list
139539073|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539074|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539075|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139539076|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139539077|NCT01474239|Growth Substances|growth substances|mesh-ancestor
139539078|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539079|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
139539080|NCT01473381|Dexetimide|dexetimide|mesh-list
139539081|NCT01473381|Citalopram|citalopram|mesh-list
139539082|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
139539083|NCT01473381|Escitalopram|escitalopram|mesh-list
139539084|NCT01473381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139539085|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139539086|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139539087|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539088|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539089|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
139539090|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539091|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139539092|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
139539093|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139539094|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139539095|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139539096|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
139539097|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
139539098|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539099|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139539100|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139539101|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
139539102|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139539103|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139181931|NCT01214291|Toremifene|toremifene|mesh-list
139539104|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
139539105|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139539106|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139539107|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139539108|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139539109|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539110|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
139539111|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539112|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539113|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139539114|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539115|NCT01499277|Vancomycin|vancomycin|mesh-list
139539116|NCT01499277|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139539117|NCT01499277|Aztreonam|aztreonam|mesh-list
139539118|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139539119|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539120|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
139539121|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
139539122|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
139539123|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539124|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539125|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139539126|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139539127|NCT00176800|Growth Substances|growth substances|mesh-ancestor
139539128|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539129|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
139539130|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539132|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
139539133|NCT00176878|Busulfan|busulfan|mesh-list
139539134|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139539135|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539136|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139539137|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
139539138|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539139|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539140|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
139539141|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539142|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
139539143|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139539144|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139539145|NCT01898182|Kinetin|kinetin|mesh-list
139539146|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
139539147|NCT01898182|Growth Substances|growth substances|mesh-ancestor
139539148|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539149|NCT01499199|Dolutegravir|dolutegravir|mesh-list
139539150|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139539151|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139539152|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539153|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539154|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139539155|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139539156|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
139539157|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539158|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139539159|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
139539160|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139539161|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
139539162|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139539163|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539164|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139539165|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139539166|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539167|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139539168|NCT01897012|Romidepsin|romidepsin|mesh-list
139539169|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539170|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139539171|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539172|NCT01897012|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139539173|NCT01897012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539174|NCT01897012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539175|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139539176|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139539177|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539178|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539179|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
139539180|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539181|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
139539182|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139539183|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539184|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139539185|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539186|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139539187|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
139539188|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
139539189|NCT01527357|Coagulants|coagulants|mesh-ancestor
139539190|NCT00181714|Methylphenidate|methylphenidate|mesh-list
139539191|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139539192|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539193|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139539194|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139539195|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139539196|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539197|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
139539198|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539199|NCT01472835|Midazolam|midazolam|mesh-list
139539200|NCT01472835|Fentanyl|fentanyl|mesh-list
139539201|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139539202|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139539203|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139539204|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539205|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139539206|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139539207|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139539208|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139539209|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
139539210|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
139539211|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
139539212|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
139539213|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539214|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539215|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139539216|NCT01472835|Narcotics|narcotics|mesh-ancestor
139539217|NCT01472835|Analgesics|analgesics|mesh-ancestor
139539218|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
139539219|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539220|NCT00185692|Acetaminophen|acetaminophen|mesh-list
139539221|NCT00185692|Cyclosporine|cyclosporine|mesh-list
139539222|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
139539223|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
139539224|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139539225|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139539226|NCT00185692|Prednisolone|prednisolone|mesh-list
139539227|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
139539228|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
139539229|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139539230|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139539231|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139539232|NCT00185692|Cyclosporins|cyclosporins|mesh-list
139539233|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139539234|NCT00185692|Lenograstim|lenograstim|mesh-list
139539235|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139539236|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
139539237|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539238|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539239|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539240|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
139539241|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539242|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
139539243|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539244|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
139539245|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539246|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139539247|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139539248|NCT00185692|Analgesics|analgesics|mesh-ancestor
139539249|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
139539250|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539251|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
139539252|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139539253|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539254|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139539255|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
139539256|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139539257|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139539258|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
139539259|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
139539260|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139539261|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
139539262|NCT00185692|Hormones|hormones|mesh-ancestor
139539263|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139539264|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139539265|NCT00185692|Protective Agents|protective agents|mesh-ancestor
139539266|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139539267|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139539268|NCT01526733|Insulin|insulin|mesh-list
139320915|NCT02205489|Protective Agents|protective agents|mesh-ancestor
139539269|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139539270|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
139539271|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
139539272|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139539273|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539274|NCT00094900|Rilonacept|rilonacept|mesh-list
139539275|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139539276|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
139539277|NCT00096460|Carmustine|carmustine|mesh-list
139539278|NCT00096460|Rituximab|rituximab|mesh-list
139539279|NCT00096460|Methotrexate|methotrexate|mesh-list
139539280|NCT00096460|Fludarabine|fludarabine|mesh-list
139539281|NCT00096460|Etoposide|etoposide|mesh-list
139539282|NCT00096460|Tacrolimus|tacrolimus|mesh-list
139539283|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539284|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
139539285|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539286|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539287|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139539288|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
139539289|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539290|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539291|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139539292|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539293|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139539294|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
139539295|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139539296|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139182260|NCT01201213|Anesthetics|anesthetics|mesh-list
139539297|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
139539298|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
139539299|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539300|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139539301|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139539302|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139539303|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139539304|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139539305|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139539306|NCT00006178|Sirolimus|sirolimus|mesh-list
139539307|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
139539308|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139539309|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539310|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139539311|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539312|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
139539313|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539314|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
139539315|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539316|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
139539317|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139539318|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139539319|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539320|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139539321|NCT00098956|Topotecan|topotecan|mesh-list
139539322|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
139539323|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139539324|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139539325|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539326|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539327|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539328|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139539329|NCT02197156|Acetaminophen|acetaminophen|mesh-list
139539330|NCT02197156|Hydrocodone|hydrocodone|mesh-list
139539331|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139539332|NCT02197156|Analgesics|analgesics|mesh-ancestor
139539333|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
139539334|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539335|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539336|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
139539337|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139539338|NCT02197156|Narcotics|narcotics|mesh-ancestor
139539339|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139539340|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
139539341|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
139539342|NCT00187720|Metformin|metformin|mesh-list
139539343|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139539344|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539345|NCT00006244|Interferons|interferons|mesh-list
139539346|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
139539347|NCT00006244|Aldesleukin|aldesleukin|mesh-list
139539348|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
139539349|NCT00006244|Melphalan|melphalan|mesh-list
139539351|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539352|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
139539353|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539354|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139539355|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
139539356|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539357|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139539358|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539359|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
139539360|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539361|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139539362|NCT00006244|Analgesics|analgesics|mesh-ancestor
139539363|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
139539364|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539365|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139539366|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139539367|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
139539368|NCT01525875|Antacids|antacids|mesh-ancestor
139539369|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539370|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139539371|NCT01525641|Pramipexole|pramipexole|mesh-list
139539372|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
139539373|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539374|NCT01525641|Protective Agents|protective agents|mesh-ancestor
139539375|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539376|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139539377|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139539378|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
139539379|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
139539380|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539381|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
139539382|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539383|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
139539384|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539385|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539386|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139539387|NCT01496469|Febuxostat|febuxostat|mesh-list
139539388|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
139539389|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539390|NCT00189436|Budesonide|budesonide|mesh-list
139539391|NCT00189436|Albuterol|albuterol|mesh-list
139539392|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139539393|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139539394|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
139539395|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539396|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539397|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139539398|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
139539399|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
139539400|NCT00189436|Hormones|hormones|mesh-ancestor
139539401|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139539402|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
139539403|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139539404|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139539405|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139539406|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139539407|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
139539408|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539409|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539410|NCT01471353|Capecitabine|capecitabine|mesh-list
139539411|NCT01471353|Sorafenib|sorafenib|mesh-list
139539412|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139539413|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
139539414|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539415|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539416|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139539417|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539418|NCT01525407|Atorvastatin|atorvastatin|mesh-list
139539419|NCT01525407|Calcium|calcium|mesh-list
139539420|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139539421|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539422|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139539423|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139539424|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
139539425|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539426|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139539427|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139539428|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539429|NCT01471197|Pemetrexed|pemetrexed|mesh-list
139539430|NCT01471197|Ipilimumab|ipilimumab|mesh-list
139539431|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539432|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539433|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539434|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139539435|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139539436|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539437|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139539438|NCT04408989|Bevacizumab|bevacizumab|mesh-list
139539439|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539440|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539441|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139539442|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139539443|NCT04408989|Growth Substances|growth substances|mesh-ancestor
139539444|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539445|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
139539446|NCT00011986|Paclitaxel|paclitaxel|mesh-list
139539447|NCT00011986|Carboplatin|carboplatin|mesh-list
139539448|NCT00011986|Gemcitabine|gemcitabine|mesh-list
139539449|NCT00011986|Doxorubicin|doxorubicin|mesh-list
139539450|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139539451|NCT00011986|Topotecan|topotecan|mesh-list
139539452|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139539453|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539454|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
139539455|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
139539456|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
139539457|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539458|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139539459|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
139539460|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139539461|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139539462|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139539463|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539464|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139539465|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139539466|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139539467|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
139539468|NCT01524783|Everolimus|everolimus|mesh-list
139539469|NCT01524783|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139539470|NCT01524783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139539471|NCT01524783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539472|NCT01524783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539473|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539474|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
139539475|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539476|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539477|NCT01494987|Glimepiride|glimepiride|mesh-list
139539478|NCT01494987|Ranolazine|ranolazine|mesh-list
139539479|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139539480|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139539481|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539482|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539483|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
139539484|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139539485|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139539486|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539487|NCT04409769|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139539488|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
139539489|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
139539490|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139539491|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539492|NCT01524627|Varenicline|varenicline|mesh-list
139539493|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139539494|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139539495|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
139539496|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539497|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539498|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539499|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
139539500|NCT01469637|Mesalamine|mesalamine|mesh-list
139539501|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539502|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139539503|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139539504|NCT01469637|Analgesics|analgesics|mesh-ancestor
139539505|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
139539506|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539507|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539508|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139539509|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539510|NCT04409223|Sunitinib|sunitinib|mesh-list
139539511|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539512|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139539513|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139539514|NCT04409223|Growth Substances|growth substances|mesh-ancestor
139539515|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539516|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
139539517|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139539518|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539519|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539520|NCT00012298|Rituximab|rituximab|mesh-list
139539521|NCT00012298|Oprelvekin|oprelvekin|mesh-list
139539522|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139539523|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539524|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539525|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
139539526|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539527|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539528|NCT00193258|Bevacizumab|bevacizumab|mesh-list
139539529|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139539530|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
139539531|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539532|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539533|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139539534|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139539535|NCT00193258|Growth Substances|growth substances|mesh-ancestor
139539536|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539537|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
139539538|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139539539|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539540|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539541|NCT00029536|Progesterone|progesterone|mesh-list
139539542|NCT00029536|Progestins|progestins|mesh-ancestor
139539543|NCT00029536|Hormones|hormones|mesh-ancestor
139539544|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139539545|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539546|NCT00193492|Bevacizumab|bevacizumab|mesh-list
139539547|NCT00193492|Rituximab|rituximab|mesh-list
139539548|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539549|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539550|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139539551|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139539552|NCT00193492|Growth Substances|growth substances|mesh-ancestor
139539553|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539554|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
139539555|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
139539556|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539557|NCT00194116|Valproic Acid|valproic acid|mesh-list
139539558|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
139539559|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539560|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539561|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
139539562|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139182522|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
139539563|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539564|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
139539565|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139539566|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139539567|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139539568|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
139539569|NCT02096458|Lansoprazole|lansoprazole|mesh-list
139539570|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139539571|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139539572|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139539573|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539574|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539575|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
139539576|NCT00194896|Glyburide|glyburide|mesh-list
139539577|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139539578|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539579|NCT04348474|Azithromycin|azithromycin|mesh-list
139539580|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
139539581|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139539582|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539583|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
139539584|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139539585|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139539586|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182555|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139539587|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539588|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539589|NCT00107536|Lapatinib|lapatinib|mesh-list
139539590|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539591|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139539592|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539593|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539594|NCT00108550|Gabapentin|gabapentin|mesh-list
139539595|NCT00108550|Analgesics|analgesics|mesh-ancestor
139539596|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
139539597|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539598|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539599|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
139539600|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139539601|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139539602|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182605|NCT03955211|Ibuprofen|ibuprofen|mesh-list
139182606|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139182607|NCT03955211|Analgesics|analgesics|mesh-ancestor
139182608|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
139182609|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182610|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182611|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
139182612|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139182613|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139539603|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139539604|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139539605|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139539606|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539607|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539608|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
139539609|NCT02093962|Pemetrexed|pemetrexed|mesh-list
139539610|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539611|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539612|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539613|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139539614|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139539615|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139539616|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139539617|NCT00200902|Escitalopram|escitalopram|mesh-list
139539618|NCT00200902|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139539619|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139539620|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139539621|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539622|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539623|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
139539624|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539625|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539626|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139539627|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
139539628|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139539629|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139539630|NCT00200902|Analgesics|analgesics|mesh-ancestor
139539631|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
139539632|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
139539633|NCT00201448|Vaccines|vaccines|mesh-list
139539634|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
139539635|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539636|NCT00201760|Gemcitabine|gemcitabine|mesh-list
139539637|NCT00201760|Trastuzumab|trastuzumab|mesh-list
139539638|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539639|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139539640|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
139539641|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539642|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539643|NCT00201838|Etanercept|etanercept|mesh-list
139539644|NCT00201838|Gemcitabine|gemcitabine|mesh-list
139539645|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139539646|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
139539647|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539648|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321289|NCT02227173|Analgesics|analgesics|mesh-ancestor
139539649|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139539650|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139539651|NCT00201838|Analgesics|analgesics|mesh-ancestor
139539652|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
139539653|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539654|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539655|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139539656|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539657|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139539658|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539659|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
139539660|NCT00040846|Cyclosporine|cyclosporine|mesh-list
139539661|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
139539662|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139539663|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
139539664|NCT00040846|Fludarabine|fludarabine|mesh-list
139539665|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
139539666|NCT00040846|Antibodies|antibodies|mesh-list
139539667|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
139539668|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139539669|NCT00040846|Cyclosporins|cyclosporins|mesh-list
139539670|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
139539671|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539672|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539673|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139539674|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
139539675|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539676|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539677|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539678|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
139539679|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539680|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
139539681|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539682|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139539683|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139539684|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139539685|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
139539686|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139539687|NCT00041938|Aspirin|aspirin|mesh-list
139539688|NCT00041938|Warfarin|warfarin|mesh-list
139539689|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139539690|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139539691|NCT00041938|Analgesics|analgesics|mesh-ancestor
139539692|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
139539693|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539694|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539695|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139539696|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539697|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139539698|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139539699|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539700|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139539701|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139539702|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539703|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
139539704|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
139539705|NCT00202930|Rituximab|rituximab|mesh-list
139539706|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539707|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539708|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
139539709|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539710|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539711|NCT00044044|Haloperidol|haloperidol|mesh-list
139539712|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
139539713|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139539714|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
139539715|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
139539716|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539717|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539718|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139539719|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139539720|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139539721|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139539722|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139539723|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139539724|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
139539725|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539726|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539727|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139539728|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139539729|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139539730|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139539731|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
139539732|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139539733|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139539734|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
139539735|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139539737|NCT00112918|Bevacizumab|bevacizumab|mesh-list
139539738|NCT00112918|Capecitabine|capecitabine|mesh-list
139539739|NCT00112918|Fluorouracil|fluorouracil|mesh-list
139539740|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
139539741|NCT00112918|Calcium|calcium|mesh-list
139539742|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
139539743|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539744|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539745|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139539746|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139539747|NCT00112918|Growth Substances|growth substances|mesh-ancestor
139539748|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539749|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
139539750|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139539751|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139539752|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
139539753|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539754|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539755|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
139539756|NCT00112918|Antidotes|antidotes|mesh-ancestor
139539757|NCT00112918|Protective Agents|protective agents|mesh-ancestor
139539758|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
139539759|NCT00112918|Vitamins|vitamins|mesh-ancestor
139539760|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
139539761|NCT00046228|Reteplase|reteplase|mesh-list
139539762|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139539763|NCT00046228|Abciximab|abciximab|mesh-list
139539764|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
139539765|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139539766|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139539767|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139539768|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539769|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
139539770|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139539771|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139539772|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
139539773|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139539774|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539775|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139539776|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139539777|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139539778|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139539779|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539780|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139539781|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139539782|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539783|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539784|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539785|NCT00113230|Bevacizumab|bevacizumab|mesh-list
139539786|NCT00113230|Capecitabine|capecitabine|mesh-list
139539787|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539788|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539789|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139539790|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139539791|NCT00113230|Growth Substances|growth substances|mesh-ancestor
139539792|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539793|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
139539794|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139539795|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
139539796|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539797|NCT00049036|Prednisone|prednisone|mesh-list
139539798|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
139539799|NCT00049036|Rituximab|rituximab|mesh-list
139539800|NCT00049036|Doxorubicin|doxorubicin|mesh-list
139539801|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139539803|NCT00049036|Vincristine|vincristine|mesh-list
139539804|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
139539805|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539806|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
139539807|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539808|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539809|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139539810|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
139539811|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539812|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539813|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139539814|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539815|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139539816|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139539817|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139539818|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539819|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139539820|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
139539821|NCT00049036|Hormones|hormones|mesh-ancestor
139539822|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139539823|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139539824|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139539825|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
139539826|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
139539827|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
139539828|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
139539829|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
139539830|NCT00049504|Fludarabine|fludarabine|mesh-list
139539831|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
139539832|NCT00049504|Tacrolimus|tacrolimus|mesh-list
139539833|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539834|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
139539835|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539836|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539837|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139539838|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
139539839|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539840|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539841|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139539842|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139539843|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
139539844|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139539845|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539846|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139539847|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139539848|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
139539849|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139539850|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539851|NCT00050986|Temozolomide|temozolomide|mesh-list
139539852|NCT00050986|Tipifarnib|tipifarnib|mesh-list
139539853|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139539854|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
139539855|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539856|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539857|NCT00118144|Bortezomib|bortezomib|mesh-list
139539858|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539859|NCT00118378|Modafinil|modafinil|mesh-list
139539860|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139539861|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539862|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139539863|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139539864|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139539865|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539866|NCT00217438|Melphalan|melphalan|mesh-list
139539867|NCT00217438|Amifostine|amifostine|mesh-list
139539868|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139539869|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
139539870|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539871|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539872|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139539873|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139539874|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
139539875|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539876|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139539878|NCT04480450|Rituximab|rituximab|mesh-list
139539879|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539880|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539881|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
139539882|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539883|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539884|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
139539885|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539886|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539887|NCT00052078|Sertraline|sertraline|mesh-list
139539888|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
139539889|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139539890|NCT00052078|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139539891|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139539892|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139539893|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539894|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539895|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
139539896|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539897|NCT05820048|Lansoprazole|lansoprazole|mesh-list
139539898|NCT05820048|Dexlansoprazole|dexlansoprazole|mesh-list
139539899|NCT05820048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139539900|NCT05820048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139539901|NCT05820048|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139539902|NCT05820048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539903|NCT05820048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539904|NCT05819983|Ivermectin|ivermectin|mesh-list
139539905|NCT05819983|Permethrin|permethrin|mesh-list
139539906|NCT05819983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139539907|NCT05819983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539908|NCT05819983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539909|NCT05819983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539910|NCT05819970|Allyl sulfide|allyl sulfide|mesh-list
139539911|NCT05819970|Antioxidants|antioxidants|mesh-ancestor
139539912|NCT05819970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539913|NCT05819970|Protective Agents|protective agents|mesh-ancestor
139539914|NCT05819970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539915|NCT05819970|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139539916|NCT05819970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539917|NCT05819970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139539918|NCT05819970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539919|NCT05819632|Curcumin|curcumin|mesh-list
139539920|NCT05819632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139539921|NCT05819632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139539922|NCT05819632|Analgesics|analgesics|mesh-ancestor
139539923|NCT05819632|Sensory System Agents|sensory system agents|mesh-ancestor
139539924|NCT05819632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139539925|NCT05819632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539926|NCT05819632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139539927|NCT05819632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139539928|NCT05819632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539929|NCT05819632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539930|NCT05819632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539931|NCT05819229|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139539932|NCT05819229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539933|NCT05819060|Bevacizumab|bevacizumab|mesh-list
139539934|NCT05819060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539935|NCT05819060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539936|NCT05819060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139539937|NCT05819060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139539938|NCT05819060|Growth Substances|growth substances|mesh-ancestor
139539939|NCT05819060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539940|NCT05819060|Growth Inhibitors|growth inhibitors|mesh-ancestor
139539941|NCT05818995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139539942|NCT05818995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139539943|NCT05818995|Calcium Channel Blockers|calcium channel blockers|mesh-list
139539944|NCT05818995|Angiotensin II|angiotensin ii|mesh-list
139539945|NCT05818995|Giapreza|giapreza|mesh-list
139539946|NCT05818995|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139539947|NCT05818995|Angiotensinogen|angiotensinogen|mesh-list
139321588|NCT05527314|Anesthetics|anesthetics|mesh-ancestor
139539948|NCT05818995|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139539949|NCT05818995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139539950|NCT05818995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139539951|NCT05818995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539952|NCT05818995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539953|NCT05818995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139539954|NCT05818995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139539955|NCT05818995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139539956|NCT05818995|Protease Inhibitors|protease inhibitors|mesh-ancestor
139539957|NCT05818995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139539958|NCT05818982|Irinotecan|irinotecan|mesh-list
139539959|NCT05818982|Afatinib|afatinib|mesh-list
139539960|NCT05818982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139539961|NCT05818982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139539962|NCT05818982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539963|NCT05818982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539964|NCT05818982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539965|NCT05818982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139539966|NCT05818670|Tadalafil|tadalafil|mesh-list
139539967|NCT05818670|Tamsulosin|tamsulosin|mesh-list
139539968|NCT05818670|Vasodilator Agents|vasodilator agents|mesh-ancestor
139539969|NCT05818670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139539970|NCT05818670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139539971|NCT05818670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139539972|NCT05818670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539973|NCT05818670|Urological Agents|urological agents|mesh-ancestor
139539974|NCT05818670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139539975|NCT05818670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139539976|NCT05818670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139539977|NCT05818670|Adrenergic Agents|adrenergic agents|mesh-ancestor
139539978|NCT05818670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139539979|NCT05818670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139539980|NCT05816512|Chlorhexidine|chlorhexidine|mesh-list
139539981|NCT05816512|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139539982|NCT05816512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139539983|NCT05816512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139539984|NCT05816512|Disinfectants|disinfectants|mesh-ancestor
139539985|NCT05816512|Dermatologic Agents|dermatologic agents|mesh-ancestor
139539986|NCT05816499|Docetaxel|docetaxel|mesh-list
139539987|NCT05816499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539988|NCT05816499|Tubulin Modulators|tubulin modulators|mesh-ancestor
139539989|NCT05816499|Antimitotic Agents|antimitotic agents|mesh-ancestor
139539990|NCT05816499|Mitosis Modulators|mitosis modulators|mesh-ancestor
139539991|NCT05816499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539992|NCT05815927|Pembrolizumab|pembrolizumab|mesh-list
139539993|NCT05815927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139539994|NCT05815927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139539995|NCT05815927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139539996|NCT05815927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139539997|NCT05815901|Febuxostat|febuxostat|mesh-list
139539998|NCT05815901|Gout Suppressants|gout suppressants|mesh-ancestor
139539999|NCT05815901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139540000|NCT05815784|Atropine|atropine|mesh-list
139540001|NCT05815784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139540002|NCT05815784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139540003|NCT05815784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139540004|NCT05815784|Autonomic Agents|autonomic agents|mesh-ancestor
139540005|NCT05815784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540006|NCT05815784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540007|NCT05815784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139540008|NCT05815784|Respiratory System Agents|respiratory system agents|mesh-ancestor
139540009|NCT05815784|Mydriatics|mydriatics|mesh-ancestor
139540010|NCT05815784|Parasympatholytics|parasympatholytics|mesh-ancestor
139540011|NCT05815784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139540012|NCT05815784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139540013|NCT05815784|Cholinergic Agents|cholinergic agents|mesh-ancestor
139183123|NCT01126229|Resveratrol|resveratrol|mesh-list
139540014|NCT05815784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540015|NCT05815784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540016|NCT05815719|Hormones|hormones|mesh-list
139540017|NCT05815719|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139540018|NCT05815719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540019|NCT05815719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540020|NCT05815654|Analgesics|analgesics|mesh-list
139540021|NCT05815654|Sensory System Agents|sensory system agents|mesh-ancestor
139540022|NCT05815654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540023|NCT05815654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540024|NCT05815303|Capecitabine|capecitabine|mesh-list
139540025|NCT05815303|Oxaliplatin|oxaliplatin|mesh-list
139540026|NCT05815303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139540027|NCT05815303|Antimetabolites|antimetabolites|mesh-ancestor
139540028|NCT05815303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540029|NCT05815303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540030|NCT05814874|Selenium|selenium|mesh-list
139540031|NCT05814874|Antioxidants|antioxidants|mesh-ancestor
139540032|NCT05814874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540033|NCT05814874|Protective Agents|protective agents|mesh-ancestor
139540034|NCT05814874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540035|NCT05814874|Trace Elements|trace elements|mesh-ancestor
139540036|NCT05814874|Micronutrients|micronutrients|mesh-ancestor
139540037|NCT05814770|Spironolactone|spironolactone|mesh-list
139540038|NCT05814770|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139540039|NCT05814770|Hormone Antagonists|hormone antagonists|mesh-ancestor
139540040|NCT05814770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540041|NCT05814770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540042|NCT05814770|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139540043|NCT05814770|Diuretics|diuretics|mesh-ancestor
139540044|NCT05814770|Natriuretic Agents|natriuretic agents|mesh-ancestor
139540045|NCT05814731|Cytarabine|cytarabine|mesh-list
139540046|NCT05814731|Cyclophosphamide|cyclophosphamide|mesh-list
139540047|NCT05814731|Busulfan|busulfan|mesh-list
139540048|NCT05814731|Semustine|semustine|mesh-list
139540049|NCT05814731|Mitoxantrone|mitoxantrone|mesh-list
139540050|NCT05814731|Thymoglobulin|thymoglobulin|mesh-list
139540051|NCT05814731|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139540052|NCT05814731|Immunoglobulins|immunoglobulins|mesh-list
139540053|NCT05814731|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139540054|NCT05814731|Antibodies|antibodies|mesh-list
139540055|NCT05814731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139540056|NCT05814731|Immunologic Factors|immunologic factors|mesh-ancestor
139540057|NCT05814731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540058|NCT05814731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139540059|NCT05814731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139540060|NCT05814731|Alkylating Agents|alkylating agents|mesh-ancestor
139540061|NCT05814731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540062|NCT05814731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540063|NCT05814731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139540064|NCT05814731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139540065|NCT05814731|Antimetabolites|antimetabolites|mesh-ancestor
139540066|NCT05814731|Antiviral Agents|antiviral agents|mesh-ancestor
139540067|NCT05814731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540068|NCT05814731|Analgesics|analgesics|mesh-ancestor
139540069|NCT05814731|Sensory System Agents|sensory system agents|mesh-ancestor
139540070|NCT05814731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540071|NCT05814731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139540072|NCT05814731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139540073|NCT05814731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540074|NCT05814718|Cytarabine|cytarabine|mesh-list
139540075|NCT05814718|Etoposide|etoposide|mesh-list
139540076|NCT05814718|Mitoxantrone|mitoxantrone|mesh-list
139540077|NCT05814718|Etoposide phosphate|etoposide phosphate|mesh-list
139540078|NCT05814718|Melphalan|melphalan|mesh-list
139540079|NCT05814718|Carmustine|carmustine|mesh-list
139540080|NCT05814718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139540081|NCT05814718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540082|NCT05814718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139540083|NCT05814718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139540084|NCT05814718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540085|NCT05814718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540086|NCT05814718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139540087|NCT05814718|Antimetabolites|antimetabolites|mesh-ancestor
139540088|NCT05814718|Antiviral Agents|antiviral agents|mesh-ancestor
139540089|NCT05814718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540090|NCT05814718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139540091|NCT05814718|Immunologic Factors|immunologic factors|mesh-ancestor
139540092|NCT05814718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540093|NCT05814718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139540094|NCT05814718|Alkylating Agents|alkylating agents|mesh-ancestor
139540095|NCT05814718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139540096|NCT05814718|Analgesics|analgesics|mesh-ancestor
139540097|NCT05814718|Sensory System Agents|sensory system agents|mesh-ancestor
139540098|NCT05814718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540099|NCT05814601|Norepinephrine|norepinephrine|mesh-list
139540100|NCT05814601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139540101|NCT05814601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139540102|NCT05814601|Adrenergic Agents|adrenergic agents|mesh-ancestor
139540103|NCT05814601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540104|NCT05814601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540105|NCT05814601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540106|NCT05814601|Sympathomimetics|sympathomimetics|mesh-ancestor
139540107|NCT05814601|Autonomic Agents|autonomic agents|mesh-ancestor
139540108|NCT05814601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540109|NCT05814601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139540110|NCT05797662|Propranolol|propranolol|mesh-list
139540111|NCT05797662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139540112|NCT05797662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139540113|NCT05797662|Adrenergic Agents|adrenergic agents|mesh-ancestor
139540114|NCT05797662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540115|NCT05797662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540116|NCT05797662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540117|NCT05797662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139540118|NCT05797662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139540119|NCT05797662|Vasodilator Agents|vasodilator agents|mesh-ancestor
139540120|NCT05795257|Dimercaprol|dimercaprol|mesh-list
139540121|NCT05795257|Chelating Agents|chelating agents|mesh-ancestor
139540122|NCT05795257|Sequestering Agents|sequestering agents|mesh-ancestor
139540123|NCT05795257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540124|NCT05786378|Anesthetics|anesthetics|mesh-list
139540125|NCT05786378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139540126|NCT05786378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540127|NCT05779241|Risperidone|risperidone|mesh-list
139540128|NCT05779241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139540129|NCT05779241|Serotonin Agents|serotonin agents|mesh-ancestor
139540130|NCT05779241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183213|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540131|NCT05779241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540132|NCT05779241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540133|NCT05779241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139540134|NCT05779241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139540135|NCT05779241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139540136|NCT05779241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139540137|NCT05779241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139540138|NCT05779241|Dopamine Agents|dopamine agents|mesh-ancestor
139540139|NCT05766358|Tirzepatide|tirzepatide|mesh-list
139540140|NCT05766358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139540141|NCT05766358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540142|NCT05766358|Incretins|incretins|mesh-ancestor
139540143|NCT05766358|Hormones|hormones|mesh-ancestor
139540144|NCT05766358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540145|NCT05757557|Nitric Oxide|nitric oxide|mesh-list
139540146|NCT05757557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139540147|NCT05757557|Autonomic Agents|autonomic agents|mesh-ancestor
139540148|NCT05757557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540149|NCT05757557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540150|NCT05757557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139540151|NCT05757557|Respiratory System Agents|respiratory system agents|mesh-ancestor
139540152|NCT05757557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139540153|NCT05757557|Antioxidants|antioxidants|mesh-ancestor
139540154|NCT05757557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540155|NCT05757557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540156|NCT05757557|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139540157|NCT05757557|Vasodilator Agents|vasodilator agents|mesh-ancestor
139540158|NCT05757557|Gasotransmitters|gasotransmitters|mesh-ancestor
139540159|NCT05757557|Protective Agents|protective agents|mesh-ancestor
139540160|NCT05751317|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139540161|NCT05751317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540162|NCT05716984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139540163|NCT05716984|Natriuretic Agents|natriuretic agents|mesh-ancestor
139540164|NCT05716984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540165|NCT05688904|Imipramine|imipramine|mesh-list
139540166|NCT05688904|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139540167|NCT05688904|Antidepressive Agents|antidepressive agents|mesh-ancestor
139540168|NCT05688904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139540169|NCT05688904|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139540170|NCT05688904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139540171|NCT05688904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139540172|NCT05688904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540174|NCT05688904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540175|NCT05688904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540176|NCT05687357|Paclitaxel|paclitaxel|mesh-list
139540177|NCT05687357|Oxaliplatin|oxaliplatin|mesh-list
139540178|NCT05687357|Tislelizumab|tislelizumab|mesh-list
139540179|NCT05687357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139540180|NCT05687357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540181|NCT05687357|Tubulin Modulators|tubulin modulators|mesh-ancestor
139540182|NCT05687357|Antimitotic Agents|antimitotic agents|mesh-ancestor
139540183|NCT05687357|Mitosis Modulators|mitosis modulators|mesh-ancestor
139540184|NCT05687357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540185|NCT05687357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139540186|NCT05675943|Antibodies|antibodies|mesh-list
139540187|NCT05675943|Immunologic Factors|immunologic factors|mesh-ancestor
139540188|NCT05675943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540189|NCT05604222|Mirabegron|mirabegron|mesh-list
139540190|NCT05604222|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139540191|NCT05604222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139540192|NCT05604222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139540193|NCT05604222|Adrenergic Agents|adrenergic agents|mesh-ancestor
139540194|NCT05604222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540195|NCT05604222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540196|NCT05604222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540197|NCT05604222|Urological Agents|urological agents|mesh-ancestor
139540198|NCT05565222|Meropenem|meropenem|mesh-list
139540199|NCT05565222|Tazobactam|tazobactam|mesh-list
139540200|NCT05565222|Piperacillin|piperacillin|mesh-list
139540201|NCT05565222|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139540202|NCT05565222|Temocillin|temocillin|mesh-list
139540203|NCT05565222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139540204|NCT05565222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540205|NCT05565222|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139540206|NCT05565222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540207|NCT05565222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540208|NCT05482789|Exenatide|exenatide|mesh-list
139540209|NCT05482789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139540210|NCT05482789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540211|NCT05482789|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139540212|NCT05482789|Incretins|incretins|mesh-ancestor
139540213|NCT05482789|Hormones|hormones|mesh-ancestor
139540214|NCT05482789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540215|NCT05474950|Minocycline|minocycline|mesh-list
139540216|NCT05474950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139540217|NCT05474950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540218|NCT05461404|Emollients|emollients|mesh-list
139540219|NCT05461404|Dermatologic Agents|dermatologic agents|mesh-ancestor
139540220|NCT05445076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139540221|NCT05445076|Antibodies|antibodies|mesh-list
139540222|NCT05445076|Immunoglobulins|immunoglobulins|mesh-list
139540223|NCT05445076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139540224|NCT05445076|Immunologic Factors|immunologic factors|mesh-ancestor
139540225|NCT05445076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540226|NCT05445076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540227|NCT05389722|Itraconazole|itraconazole|mesh-list
139540228|NCT05389722|Rifampin|rifampin|mesh-list
139540229|NCT05389722|Digoxin|digoxin|mesh-list
139540230|NCT05389722|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139540231|NCT05389722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139540232|NCT05389722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139540233|NCT05389722|Antimetabolites|antimetabolites|mesh-ancestor
139540234|NCT05389722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540235|NCT05389722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139540236|NCT05389722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139540237|NCT05389722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540238|NCT05389722|Antifungal Agents|antifungal agents|mesh-ancestor
139540239|NCT05389722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540240|NCT05389722|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139540241|NCT05389722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139540242|NCT05389722|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139540243|NCT05389722|Hormone Antagonists|hormone antagonists|mesh-ancestor
139540244|NCT05389722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540245|NCT05389722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540246|NCT05389722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139540247|NCT05389722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139540248|NCT05389722|Antitubercular Agents|antitubercular agents|mesh-ancestor
139540249|NCT05389722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139540250|NCT05389722|Leprostatic Agents|leprostatic agents|mesh-ancestor
139540251|NCT05389722|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139540252|NCT05389722|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139540253|NCT05389722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139540254|NCT05389722|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139540255|NCT05389722|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139540256|NCT05389722|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139540257|NCT05389722|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139540258|NCT05389722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139540259|NCT05389722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139540260|NCT05389722|Protective Agents|protective agents|mesh-ancestor
139540261|NCT05373680|Metformin|metformin|mesh-list
139540262|NCT05373680|Empagliflozin|empagliflozin|mesh-list
139540263|NCT05373680|Biguanides|biguanides|mesh-list
139540264|NCT05373680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139540265|NCT05373680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540266|NCT05373680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139540267|NCT05373680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540268|NCT05353348|Iron|iron|mesh-list
139540269|NCT05353348|Ascorbic Acid|ascorbic acid|mesh-list
139540270|NCT05353348|Epoetin Alfa|epoetin alfa|mesh-list
139540271|NCT05353348|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139540272|NCT05353348|Trace Elements|trace elements|mesh-ancestor
139540273|NCT05353348|Micronutrients|micronutrients|mesh-ancestor
139540274|NCT05353348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540275|NCT05353348|Antioxidants|antioxidants|mesh-ancestor
139540276|NCT05353348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540277|NCT05353348|Protective Agents|protective agents|mesh-ancestor
139540278|NCT05353348|Vitamins|vitamins|mesh-ancestor
139540279|NCT05353348|Hematinics|hematinics|mesh-ancestor
139540280|NCT05304520|Natalizumab|natalizumab|mesh-list
139540281|NCT05304520|Immunologic Factors|immunologic factors|mesh-ancestor
139540282|NCT05304520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540283|NCT05294263|Varenicline|varenicline|mesh-list
139540284|NCT05294263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139540285|NCT05294263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139540286|NCT05294263|Cholinergic Agents|cholinergic agents|mesh-ancestor
139540287|NCT05294263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540288|NCT05294263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540289|NCT05294263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540290|NCT05261594|Caffeine|caffeine|mesh-list
139540291|NCT05261594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139540292|NCT05261594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540293|NCT05261594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139540294|NCT05261594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540295|NCT05261594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540296|NCT05261594|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139540297|NCT05261594|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139540298|NCT05261594|Purinergic Agents|purinergic agents|mesh-ancestor
139540299|NCT05261594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540300|NCT05220748|Pembrolizumab|pembrolizumab|mesh-list
139540301|NCT05220748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139540302|NCT05220748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540303|NCT05220748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139540304|NCT05220748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540305|NCT05180357|Benralizumab|benralizumab|mesh-list
139540306|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139540307|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
139540308|NCT05141708|Talazoparib|talazoparib|mesh-list
139540309|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139540310|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540311|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540312|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540313|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139540314|NCT05137119|Vancomycin|vancomycin|mesh-list
139540315|NCT05137119|Clindamycin|clindamycin|mesh-list
139540316|NCT05137119|Cefazolin|cefazolin|mesh-list
139540317|NCT05137119|Daptomycin|daptomycin|mesh-list
139540318|NCT05137119|Penicillins|penicillins|mesh-list
139540319|NCT05137119|Penicillin G|penicillin g|mesh-list
139540320|NCT05137119|Lincomycin|lincomycin|mesh-list
139540321|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540322|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139540323|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540324|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540325|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139540326|NCT05085808|Trazodone|trazodone|mesh-list
139540327|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
139540328|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139540329|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139540330|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139540331|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139540332|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540333|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139540334|NCT05085808|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139540335|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139540336|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139540337|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540338|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540339|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
139540340|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139540341|NCT05078944|Donepezil|donepezil|mesh-list
139540342|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139540343|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540344|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540345|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
139540346|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540347|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540348|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
139540349|NCT05076019|Atorvastatin|atorvastatin|mesh-list
139540350|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139183463|NCT01218893|Chloroquine|chloroquine|mesh-list
139540351|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139540352|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
139540353|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540354|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139540355|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139540356|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540357|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
139540358|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
139540359|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540360|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
139540361|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540362|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540363|NCT05036005|Pertuzumab|pertuzumab|mesh-list
139540364|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139540365|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540366|NCT05033769|Paclitaxel|paclitaxel|mesh-list
139540367|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139540368|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139540369|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540370|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
139540371|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
139540372|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
139540373|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540374|NCT05019846|Bicalutamide|bicalutamide|mesh-list
139540375|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139540376|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
139540377|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
139540378|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540379|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540380|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540381|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
139540382|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139540383|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
139540384|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139540385|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139540386|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139540387|NCT05004025|Nivolumab|nivolumab|mesh-list
139540388|NCT05004025|Ipilimumab|ipilimumab|mesh-list
139540389|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139540390|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540391|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139540392|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540393|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
139540394|NCT04998240|Paraproteins|paraproteins|mesh-list
139540395|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
139540396|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540397|NCT04984759|Primaquine|primaquine|mesh-list
139540398|NCT04984759|Tafenoquine|tafenoquine|mesh-list
139540399|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
139540400|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139540401|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139540402|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540403|NCT04952324|Folic Acid|folic acid|mesh-list
139540404|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
139540405|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
139540406|NCT04952324|Vitamins|vitamins|mesh-ancestor
139540407|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
139540408|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540409|NCT04952324|Hematinics|hematinics|mesh-ancestor
139540410|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
139540411|NCT04951726|Neostigmine|neostigmine|mesh-list
139540412|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139540413|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540414|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540415|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
139540416|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540417|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540418|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139540419|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
139540420|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540421|NCT04948892|Anesthetics|anesthetics|mesh-list
139540422|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139540423|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540424|NCT04926571|Dexamethasone|dexamethasone|mesh-list
139540425|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139540426|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
139540427|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
139540428|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540429|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540430|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139540431|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
139540432|NCT04926571|Hormones|hormones|mesh-ancestor
139540433|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540434|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139540435|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540436|NCT04918823|Cyclosporine|cyclosporine|mesh-list
139540437|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139540438|NCT04918823|Cyclosporins|cyclosporins|mesh-list
139540439|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540440|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540441|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139540442|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
139540443|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540444|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
139540445|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540446|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
139540447|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139540448|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139540449|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139540450|NCT04909073|Afatinib|afatinib|mesh-list
139540451|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540452|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139540453|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540454|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540455|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
139540456|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139540457|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139540458|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540459|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
139540460|NCT04785651|Coagulants|coagulants|mesh-ancestor
139540461|NCT04780204|Tenofovir|tenofovir|mesh-list
139540462|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
139540463|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540464|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139540465|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139540466|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540467|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540468|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139540469|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139540470|NCT04748588|Sotrovimab|sotrovimab|mesh-list
139540471|NCT04748588|Bamlanivimab|bamlanivimab|mesh-list
139540472|NCT04748588|Antiviral Agents|antiviral agents|mesh-ancestor
139540473|NCT04748588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540474|NCT04735510|Cyclosporine|cyclosporine|mesh-list
139540476|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540477|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540478|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139540479|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
139540480|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540481|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
139540482|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540483|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
139540484|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139540485|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139540486|NCT04696523|Xenon|xenon|mesh-list
139540487|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139540488|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
139540489|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
139540490|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139540491|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540492|NCT04655222|Interferons|interferons|mesh-list
139540493|NCT04655222|Interferon-beta|interferon-beta|mesh-list
139540494|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540495|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
139540496|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540497|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
139540498|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540499|NCT04652440|Tislelizumab|tislelizumab|mesh-list
139540500|NCT04652440|Antibodies|antibodies|mesh-list
139540501|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139540502|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
139540503|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540504|NCT04652440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139540505|NCT04652440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540506|NCT04612725|Benralizumab|benralizumab|mesh-list
139540507|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139540508|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
139540509|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
139540510|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540511|NCT04585711|Etanercept|etanercept|mesh-list
139540512|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139540513|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139540514|NCT04585711|Analgesics|analgesics|mesh-ancestor
139540515|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
139540516|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540517|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540518|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139540519|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139540520|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139540521|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139540522|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
139540523|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139540524|NCT04551495|Letrozole|letrozole|mesh-list
139540525|NCT04551495|Goserelin|goserelin|mesh-list
139540526|NCT04551495|Entrectinib|entrectinib|mesh-list
139540527|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540528|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139540529|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139540530|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540531|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540532|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139540533|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
139540534|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540535|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540536|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139540537|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139540538|NCT04501718|Etoposide|etoposide|mesh-list
139540539|NCT04501718|Temozolomide|temozolomide|mesh-list
139540540|NCT04501718|Apatinib|apatinib|mesh-list
139540541|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139540542|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540543|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139540544|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139540545|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183770|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139540546|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540547|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139540548|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
139540549|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139540550|NCT04501705|Apatinib|apatinib|mesh-list
139540551|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540552|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139540554|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540555|NCT04463394|Vasopressins|vasopressins|mesh-list
139540556|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
139540557|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
139540558|NCT04463394|Coagulants|coagulants|mesh-ancestor
139540559|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139540560|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139540561|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
139540562|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540563|NCT04454905|Apatinib|apatinib|mesh-list
139540564|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540565|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139540566|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540567|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540568|NCT04436601|Lactulose|lactulose|mesh-list
139540569|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139540570|NCT04373785|Temozolomide|temozolomide|mesh-list
139540571|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138773620|NCT00879775|Caffeine|caffeine|mesh-list
139540572|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
139540573|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540574|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540575|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
139540576|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
139540577|NCT04309552|Alovudine|alovudine|mesh-list
139540578|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
139540579|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540580|NCT04275180|Argatroban|argatroban|mesh-list
139540581|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
139540582|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139540583|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
139540584|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540585|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540586|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
139540587|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139540588|NCT04271332|Baclofen|baclofen|mesh-list
139540589|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139540590|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540591|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139540592|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540593|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139540594|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
139540595|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
139540596|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540597|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540598|NCT04267978|Irinotecan|irinotecan|mesh-list
139540599|NCT04267978|Temozolomide|temozolomide|mesh-list
139540600|NCT04267978|Endostatins|endostatins|mesh-list
139540601|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139540602|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139540603|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540604|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540605|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540606|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139540607|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
139540608|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139540609|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139540610|NCT04267978|Growth Substances|growth substances|mesh-ancestor
139540611|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540612|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
139540613|NCT04230252|Acetaminophen|acetaminophen|mesh-list
139540614|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139540615|NCT04230252|Analgesics|analgesics|mesh-ancestor
139540616|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
139540617|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540618|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540619|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
139540620|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139540621|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139540622|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540623|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540624|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139540625|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
139540626|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540627|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540628|NCT04117178|Memantine|memantine|mesh-list
139540629|NCT04117178|Donepezil|donepezil|mesh-list
139540630|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139540631|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540632|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540633|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
139540634|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540635|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540636|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
139540637|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139540638|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139540639|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
139540640|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139540641|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139540642|NCT04094961|Dexamethasone|dexamethasone|mesh-list
139540643|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
139540644|NCT04094961|Pomalidomide|pomalidomide|mesh-list
139540645|NCT04094961|Ixazomib|ixazomib|mesh-list
139540646|NCT04094961|BB 1101|bb 1101|mesh-list
139540647|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139540648|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
139540649|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
139540650|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540651|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540652|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139540653|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
139540654|NCT04094961|Hormones|hormones|mesh-ancestor
139540655|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540656|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139540657|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540658|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
139540659|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540660|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540661|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
139540662|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139540663|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139540664|NCT04094961|Growth Substances|growth substances|mesh-ancestor
139540665|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
139540666|NCT03991936|Triamcinolone|triamcinolone|mesh-list
139540667|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139540668|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139540669|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139540670|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139540671|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
139540672|NCT03991936|Hormones|hormones|mesh-ancestor
139540673|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540674|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540675|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139540676|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
139540677|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540678|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540679|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
139540680|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
139540681|NCT03979599|Analgesics|analgesics|mesh-ancestor
139540682|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
139540683|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540684|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540685|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
139540686|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139540687|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139540688|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
139540689|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139540690|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139183943|NCT01225523|Capecitabine|capecitabine|mesh-list
139540691|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540692|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139540693|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
139540694|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139540695|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
139540696|NCT03946514|Losartan|losartan|mesh-list
139540697|NCT03946514|Amlodipine|amlodipine|mesh-list
139540698|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139540699|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139540700|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139540701|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139540702|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540703|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139540704|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540705|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
139540706|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139540707|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139540708|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139540709|NCT03946514|Diuretics|diuretics|mesh-ancestor
139540710|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
139540711|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139540712|NCT03935958|Curcumin|curcumin|mesh-list
139540713|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139540714|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139540715|NCT03935958|Analgesics|analgesics|mesh-ancestor
139540716|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
139540717|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540718|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540719|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139540720|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139540721|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540722|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540723|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540724|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139540725|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139540726|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139540727|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139540728|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540729|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
139540730|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540731|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540732|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139540733|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540734|NCT03915444|Paclitaxel|paclitaxel|mesh-list
139540735|NCT03915444|Gemcitabine|gemcitabine|mesh-list
139540736|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139540737|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540738|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
139540739|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
139540740|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
139540741|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540742|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139540743|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
139540744|NCT03892785|Prednisone|prednisone|mesh-list
139540745|NCT03892785|Methotrexate|methotrexate|mesh-list
139540746|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139540747|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
139540748|NCT03892785|Hormones|hormones|mesh-ancestor
139540749|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540750|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540751|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139540752|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540753|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139540754|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
139540755|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139540756|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139540757|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
139540758|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540759|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
139540760|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540761|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139540762|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139540763|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
139540764|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139540765|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139540766|NCT03869034|Leucovorin|leucovorin|mesh-list
139540767|NCT03869034|Fluorouracil|fluorouracil|mesh-list
139540768|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
139540769|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
139540770|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540771|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139540772|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540773|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139540774|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
139540775|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540776|NCT03869034|Antidotes|antidotes|mesh-ancestor
139540777|NCT03869034|Protective Agents|protective agents|mesh-ancestor
139540778|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
139540779|NCT03869034|Vitamins|vitamins|mesh-ancestor
139540780|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
139540781|NCT03841097|Tacrolimus|tacrolimus|mesh-list
139540782|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139540783|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
139540784|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540785|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139540786|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540787|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540788|NCT03831425|Ubiquinone|ubiquinone|mesh-list
139540789|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
139540790|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
139540791|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540792|NCT03831425|Vitamins|vitamins|mesh-ancestor
139540793|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
139540794|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139540795|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540796|NCT03804944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139540797|NCT03804944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540798|NCT03790111|Cisplatin|cisplatin|mesh-list
139540799|NCT03790111|Gemcitabine|gemcitabine|mesh-list
139540800|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540801|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139540802|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
139540803|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540804|NCT03780543|Tenofovir|tenofovir|mesh-list
139540805|NCT03780543|Entecavir|entecavir|mesh-list
139540806|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139540807|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
139540808|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540809|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139540810|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540811|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540812|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139540813|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139540814|NCT03772314|Modafinil|modafinil|mesh-list
139540815|NCT03772314|Amphetamine|amphetamine|mesh-list
139540816|NCT03772314|Adderall|adderall|mesh-list
139540817|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
139540818|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139540819|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540820|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139540821|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139540822|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139540823|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540824|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
139540825|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
139540826|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540827|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
139540828|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540829|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
139540830|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139540831|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139540832|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139540833|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139540834|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
139540835|NCT03760575|Pemetrexed|pemetrexed|mesh-list
139540836|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540837|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139540838|NCT03760575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139540839|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540840|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540841|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139540842|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139540843|NCT03720522|Adenosine|adenosine|mesh-list
139540844|NCT03720522|Analgesics|analgesics|mesh-ancestor
139540845|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
139540846|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540847|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540848|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139540849|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
139540850|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139540851|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
139540852|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
139540853|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540854|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540855|NCT03699631|Methotrexate|methotrexate|mesh-list
139540856|NCT03699631|Tacrolimus|tacrolimus|mesh-list
139540857|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139540858|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
139540859|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139540860|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540861|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139540862|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
139540863|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540864|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540865|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
139540866|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540867|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139540868|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139540869|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
139540870|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139540871|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139540872|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139540873|NCT03686150|Vitamin D|vitamin d|mesh-list
139540874|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
139540875|NCT03686150|Vitamins|vitamins|mesh-ancestor
139540876|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
139540877|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777622|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
139540878|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139540879|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139540880|NCT03678233|Testosterone|testosterone|mesh-list
139540881|NCT03678233|Androgens|androgens|mesh-ancestor
139540882|NCT03678233|Hormones|hormones|mesh-ancestor
139540883|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540884|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540885|NCT03617718|Glycine|glycine|mesh-list
139540886|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
139540887|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540888|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540889|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540890|NCT03610061|Durvalumab|durvalumab|mesh-list
139540891|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139540892|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540893|NCT03606642|Clopidogrel|clopidogrel|mesh-list
139540894|NCT03606642|Ticagrelor|ticagrelor|mesh-list
139540895|NCT03606642|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139540896|NCT03606642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540897|NCT03606642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540898|NCT03606642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139184293|NCT01303549|Amphotericin B|amphotericin b|mesh-list
139540899|NCT03606642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139540900|NCT03606642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139540901|NCT03606642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139540902|NCT03606642|Purinergic Agents|purinergic agents|mesh-ancestor
139540903|NCT03606642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540904|NCT03527043|Escitalopram|escitalopram|mesh-list
139540905|NCT03527043|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139540906|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139540907|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139540908|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540909|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139540910|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
139540911|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540912|NCT03458221|Itraconazole|itraconazole|mesh-list
139540913|NCT03458221|Everolimus|everolimus|mesh-list
139540914|NCT03458221|Letrozole|letrozole|mesh-list
139540915|NCT03458221|Bicalutamide|bicalutamide|mesh-list
139540916|NCT03458221|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139540917|NCT03458221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139540918|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540919|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540920|NCT03458221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139540921|NCT03458221|Immunologic Factors|immunologic factors|mesh-ancestor
139540922|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540923|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540924|NCT03458221|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139540925|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139540926|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139540927|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
139540928|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139540929|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
139540930|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540931|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139540932|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139540933|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139540934|NCT03458221|Androgen Antagonists|androgen antagonists|mesh-ancestor
139540935|NCT03451487|Acetaminophen|acetaminophen|mesh-list
139540936|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139540937|NCT03451487|Analgesics|analgesics|mesh-ancestor
139540938|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
139540939|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540940|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540941|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
139540942|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
139540943|NCT03410030|Paclitaxel|paclitaxel|mesh-list
139540944|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139540945|NCT03410030|Cisplatin|cisplatin|mesh-list
139540946|NCT03410030|Gemcitabine|gemcitabine|mesh-list
139540947|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139540948|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540949|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
139540950|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
139540951|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
139540952|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540953|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138779679|NCT01192178|Xhance|xhance|mesh-list
139540954|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
139540955|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
139540956|NCT03410030|Protective Agents|protective agents|mesh-ancestor
139540957|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540958|NCT03410030|Vitamins|vitamins|mesh-ancestor
139540959|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
139540960|NCT03382301|Cyclosporine|cyclosporine|mesh-list
139540961|NCT03382301|Cyclosporins|cyclosporins|mesh-list
139540962|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540963|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540964|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139540965|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
139540966|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540967|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
139540968|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139540969|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
139540970|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139540971|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139540972|NCT03290391|Naltrexone|naltrexone|mesh-list
139540973|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139540974|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
139540975|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139540976|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139540977|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139540978|NCT03280030|Midostaurin|midostaurin|mesh-list
139540979|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540980|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139540981|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139540982|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540983|NCT03194867|Cemiplimab|cemiplimab|mesh-list
139540984|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139540985|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540986|NCT03138720|Paclitaxel|paclitaxel|mesh-list
139540987|NCT03138720|Cisplatin|cisplatin|mesh-list
139540988|NCT03138720|Gemcitabine|gemcitabine|mesh-list
139540989|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139540990|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139540991|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139540992|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
139540993|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
139540994|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
139540995|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139540996|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139540997|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
139540998|NCT03131726|Simvastatin|simvastatin|mesh-list
139540999|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139322654|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
139541001|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
139541002|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541003|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139541004|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139541005|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541006|NCT03112590|Interferons|interferons|mesh-list
139541007|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
139541008|NCT03112590|Paclitaxel|paclitaxel|mesh-list
139541009|NCT03112590|Trastuzumab|trastuzumab|mesh-list
139541010|NCT03112590|Pertuzumab|pertuzumab|mesh-list
139541011|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139541012|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541013|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
139541014|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
139541015|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
139184547|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
139541016|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541017|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541018|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
139541019|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139541020|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
139541021|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139541022|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139541023|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541024|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
139541025|NCT03085394|Coagulants|coagulants|mesh-ancestor
139541026|NCT03065621|Palbociclib|palbociclib|mesh-list
139541027|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541028|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139541029|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541030|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541031|NCT03060434|Acetaminophen|acetaminophen|mesh-list
139541032|NCT03060434|Ibuprofen|ibuprofen|mesh-list
139541033|NCT03060434|Pregabalin|pregabalin|mesh-list
139541034|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
139541035|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139541036|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139541037|NCT03060434|Analgesics|analgesics|mesh-ancestor
139541038|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
139541039|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541040|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541041|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139541042|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139184603|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541043|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139541044|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541045|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541046|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
139541047|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139541048|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139541049|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139541050|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139541051|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139541052|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541053|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139541054|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
139541055|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139541056|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139541057|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139541058|NCT03060434|Protective Agents|protective agents|mesh-ancestor
139541059|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
139541060|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139541061|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
139541062|NCT03021486|Haloperidol|haloperidol|mesh-list
139541063|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
139541064|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
139541065|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
139541066|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
139541067|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541068|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541069|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139541070|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139541071|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139541072|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541073|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139541074|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139541075|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
139541076|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541077|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541078|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139541079|NCT02949128|Ravulizumab|ravulizumab|mesh-list
139541080|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139541081|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139541082|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
139541083|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541084|NCT02944617|Micronutrients|micronutrients|mesh-list
139541085|NCT02944617|Trace Elements|trace elements|mesh-list
139541086|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541087|NCT02923115|Enoxaparin|enoxaparin|mesh-list
139541088|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
139541089|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139541090|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139541091|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541092|NCT02910583|Venetoclax|venetoclax|mesh-list
139541093|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541094|NCT02820857|Bevacizumab|bevacizumab|mesh-list
139541095|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541096|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541097|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139541098|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139541099|NCT02820857|Growth Substances|growth substances|mesh-ancestor
139541100|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541101|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
139541102|NCT02790710|Propranolol|propranolol|mesh-list
139541103|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139541104|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139541105|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
139541106|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541107|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541108|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541109|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139541110|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139541111|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
139541112|NCT02648477|Doxorubicin|doxorubicin|mesh-list
139541113|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139541114|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
139541115|NCT02648477|Letrozole|letrozole|mesh-list
139541116|NCT02648477|Anastrozole|anastrozole|mesh-list
139541117|NCT02648477|Exemestane|exemestane|mesh-list
139541118|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139541119|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541120|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139541121|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139541122|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541123|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541124|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541125|NCT02648477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139541126|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139541127|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139541128|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139541129|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
139541130|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139541131|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541132|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139541133|NCT02604732|Aspirin|aspirin|mesh-list
139541134|NCT02604732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139541135|NCT02604732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139541136|NCT02604732|Analgesics|analgesics|mesh-ancestor
139541137|NCT02604732|Sensory System Agents|sensory system agents|mesh-ancestor
139541138|NCT02604732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541139|NCT02604732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541140|NCT02604732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139541141|NCT02604732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139541142|NCT02604732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139541143|NCT02604732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139541144|NCT02604732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541145|NCT02604732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139541146|NCT02604732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139541147|NCT02604732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541148|NCT02604732|Antipyretics|antipyretics|mesh-ancestor
139322806|NCT04864067|Leucovorin|leucovorin|mesh-list
139541149|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
139541150|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139541151|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139541152|NCT02444429|Prednisolone|prednisolone|mesh-list
139541153|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
139541154|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139541155|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
139541156|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139541157|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
139541158|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
139541159|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541160|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541161|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139541162|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
139541163|NCT02444429|Hormones|hormones|mesh-ancestor
139541164|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139541165|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139541166|NCT02444429|Protective Agents|protective agents|mesh-ancestor
139541167|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139541168|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541169|NCT02318342|Warfarin|warfarin|mesh-list
139541170|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
139541171|NCT02134184|Vaccines|vaccines|mesh-list
139541172|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
139541173|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541174|NCT02029846|Metformin|metformin|mesh-list
139541175|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139541176|NCT02029846|Incretins|incretins|mesh-list
139541177|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139541178|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541179|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
139541180|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541181|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541182|NCT02029846|Hormones|hormones|mesh-ancestor
139541183|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139541184|NCT06018623|Anesthetics|anesthetics|mesh-list
139541185|NCT06018623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185049|NCT03776812|Paclitaxel|paclitaxel|mesh-list
139541186|NCT06018623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541187|NCT06018597|Sevoflurane|sevoflurane|mesh-list
139541188|NCT06018597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139541189|NCT06018597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139541190|NCT06018597|Anesthetics, General|anesthetics, general|mesh-ancestor
139541191|NCT06018597|Anesthetics|anesthetics|mesh-ancestor
139541192|NCT06018597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541193|NCT06018597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541194|NCT06018207|Midazolam|midazolam|mesh-list
139541195|NCT06018207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139541196|NCT06018207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139541197|NCT06018207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541198|NCT06018207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541199|NCT06018207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139541200|NCT06018207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139541201|NCT06018207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139541202|NCT06018207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139541203|NCT06018207|Anesthetics, General|anesthetics, general|mesh-ancestor
139541204|NCT06018207|Anesthetics|anesthetics|mesh-ancestor
139541205|NCT06018207|GABA Modulators|gaba modulators|mesh-ancestor
139541206|NCT06018207|GABA Agents|gaba agents|mesh-ancestor
139541207|NCT06018207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185179|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541208|NCT06018207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541209|NCT06018025|Antibodies|antibodies|mesh-list
139541210|NCT06018025|Immunologic Factors|immunologic factors|mesh-ancestor
139541211|NCT06018025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541212|NCT06017921|Eszopiclone|eszopiclone|mesh-list
139541213|NCT06017921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139541214|NCT06017921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541215|NCT06017921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541216|NCT06017726|Insulin|insulin|mesh-list
139541217|NCT06017726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139541218|NCT06017726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541219|NCT06017167|Dexamethasone|dexamethasone|mesh-list
139541220|NCT06017167|Dexamethasone acetate|dexamethasone acetate|mesh-list
139541221|NCT06017167|Dexmedetomidine|dexmedetomidine|mesh-list
139541222|NCT06017167|Ondansetron|ondansetron|mesh-list
139541223|NCT06017167|BB 1101|bb 1101|mesh-list
139541224|NCT06017167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139541225|NCT06017167|Antiemetics|antiemetics|mesh-ancestor
139541226|NCT06017167|Autonomic Agents|autonomic agents|mesh-ancestor
139541227|NCT06017167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541228|NCT06017167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541229|NCT06017167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139541230|NCT06017167|Glucocorticoids|glucocorticoids|mesh-ancestor
139541231|NCT06017167|Hormones|hormones|mesh-ancestor
139541232|NCT06017167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139541233|NCT06017167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139541234|NCT06017167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541235|NCT06017167|Protease Inhibitors|protease inhibitors|mesh-ancestor
139541236|NCT06017167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541237|NCT06017167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541238|NCT06017167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139541239|NCT06017167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541240|NCT06017167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139541241|NCT06017167|Analgesics|analgesics|mesh-ancestor
139541242|NCT06017167|Sensory System Agents|sensory system agents|mesh-ancestor
139541243|NCT06017167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139541244|NCT06017167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139541245|NCT06017167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139541246|NCT06017167|Adrenergic Agents|adrenergic agents|mesh-ancestor
139541247|NCT06017167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541248|NCT06017167|Antipruritics|antipruritics|mesh-ancestor
139541249|NCT06017167|Dermatologic Agents|dermatologic agents|mesh-ancestor
139541250|NCT06017167|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139541251|NCT06017167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139541252|NCT06017167|Serotonin Agents|serotonin agents|mesh-ancestor
139541253|NCT06017141|Fentanyl|fentanyl|mesh-list
139541254|NCT06017141|Propofol|propofol|mesh-list
139541255|NCT06017141|Sevoflurane|sevoflurane|mesh-list
139541256|NCT06017141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139541257|NCT06017141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541258|NCT06017141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185358|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139541259|NCT06017141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139541260|NCT06017141|Anesthetics, General|anesthetics, general|mesh-ancestor
139541261|NCT06017141|Anesthetics|anesthetics|mesh-ancestor
139541262|NCT06017141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139541263|NCT06017141|Narcotics|narcotics|mesh-ancestor
139541264|NCT06017141|Analgesics|analgesics|mesh-ancestor
139541265|NCT06017141|Sensory System Agents|sensory system agents|mesh-ancestor
139541266|NCT06017141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541267|NCT06017141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139541268|NCT06017141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139541269|NCT06017141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139541270|NCT06017037|Citalopram|citalopram|mesh-list
139185426|NCT05401019|Pramipexole|pramipexole|mesh-list
139541271|NCT06017037|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139541272|NCT06017037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139541273|NCT06017037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139541274|NCT06017037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541275|NCT06017037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541276|NCT06017037|Serotonin Agents|serotonin agents|mesh-ancestor
139541277|NCT06017037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541278|NCT06017037|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139541279|NCT06017037|Antidepressive Agents|antidepressive agents|mesh-ancestor
139541280|NCT06017037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139541281|NCT06016985|Caffeine|caffeine|mesh-list
139541282|NCT06016985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139541283|NCT06016985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541284|NCT06016985|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139541285|NCT06016985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541286|NCT06016985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541287|NCT06016985|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139541288|NCT06016985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139541289|NCT06016985|Purinergic Agents|purinergic agents|mesh-ancestor
139541290|NCT06016985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541291|NCT06016855|Copper|copper|mesh-list
139541292|NCT06016855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139541293|NCT06016855|Trace Elements|trace elements|mesh-ancestor
139541294|NCT06016855|Micronutrients|micronutrients|mesh-ancestor
139541295|NCT06016855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541296|NCT06016855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139541297|NCT06016855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541298|NCT06011330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139541299|NCT06011330|Antibodies|antibodies|mesh-list
139322943|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
139541300|NCT06011330|Immunologic Factors|immunologic factors|mesh-ancestor
139541301|NCT06011330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541302|NCT06011330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541303|NCT06011330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541304|NCT06011330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541305|NCT06007391|Niacinamide|niacinamide|mesh-list
139541306|NCT06007391|Niacin|niacin|mesh-list
139541307|NCT06007391|Nicotinic Acids|nicotinic acids|mesh-list
139541308|NCT06007391|Vitamin B Complex|vitamin b complex|mesh-ancestor
139541309|NCT06007391|Vitamins|vitamins|mesh-ancestor
139541310|NCT06007391|Micronutrients|micronutrients|mesh-ancestor
139541311|NCT06007391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541312|NCT06007391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139541313|NCT06007391|Antimetabolites|antimetabolites|mesh-ancestor
139541314|NCT06007391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541315|NCT06007391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139541316|NCT06007391|Vasodilator Agents|vasodilator agents|mesh-ancestor
139541317|NCT05997563|Progesterone|progesterone|mesh-list
139541318|NCT05997563|Progestins|progestins|mesh-ancestor
139541319|NCT05997563|Hormones|hormones|mesh-ancestor
139185677|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139541320|NCT05997563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139541321|NCT05997563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541322|NCT05980572|Triamcinolone|triamcinolone|mesh-list
139541323|NCT05980572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139541324|NCT05980572|Aceclofenac|aceclofenac|mesh-list
139541325|NCT05980572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139541326|NCT05980572|Glucocorticoids|glucocorticoids|mesh-ancestor
139541327|NCT05980572|Hormones|hormones|mesh-ancestor
139541328|NCT05980572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139541329|NCT05980572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541330|NCT05980572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139541331|NCT05980572|Analgesics|analgesics|mesh-ancestor
139541332|NCT05980572|Sensory System Agents|sensory system agents|mesh-ancestor
139541333|NCT05980572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541334|NCT05980572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139541335|NCT05936606|Clopidogrel|clopidogrel|mesh-list
139541336|NCT05936606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139541337|NCT05936606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139541338|NCT05936606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139541339|NCT05936606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139541340|NCT05936606|Purinergic Agents|purinergic agents|mesh-ancestor
139541341|NCT05936606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541342|NCT05936606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541343|NCT05936606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541344|NCT05936086|Cyclosporine|cyclosporine|mesh-list
139541345|NCT05936086|Dexamethasone|dexamethasone|mesh-list
139541346|NCT05936086|Etoposide|etoposide|mesh-list
139541347|NCT05936086|Cyclophosphamide|cyclophosphamide|mesh-list
139541348|NCT05936086|Cyclosporins|cyclosporins|mesh-list
139541349|NCT05936086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139541350|NCT05936086|Antiemetics|antiemetics|mesh-ancestor
139541351|NCT05936086|Autonomic Agents|autonomic agents|mesh-ancestor
139541352|NCT05936086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541353|NCT05936086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541354|NCT05936086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139541355|NCT05936086|Glucocorticoids|glucocorticoids|mesh-ancestor
139541356|NCT05936086|Hormones|hormones|mesh-ancestor
139541357|NCT05936086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139541358|NCT05936086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139541359|NCT05936086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541360|NCT05936086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139541361|NCT05936086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139541362|NCT05936086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139541363|NCT05936086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541364|NCT05936086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541365|NCT05936086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139541366|NCT05936086|Immunologic Factors|immunologic factors|mesh-ancestor
139541367|NCT05936086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139541368|NCT05936086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139541369|NCT05936086|Alkylating Agents|alkylating agents|mesh-ancestor
139541370|NCT05936086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139541371|NCT05936086|Antifungal Agents|antifungal agents|mesh-ancestor
139541372|NCT05936086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139541373|NCT05936086|Dermatologic Agents|dermatologic agents|mesh-ancestor
139541374|NCT05936086|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139541375|NCT05932511|Ascorbic Acid|ascorbic acid|mesh-list
139541376|NCT05932511|Antioxidants|antioxidants|mesh-ancestor
139541377|NCT05932511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541378|NCT05932511|Protective Agents|protective agents|mesh-ancestor
139541379|NCT05932511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541380|NCT05932511|Vitamins|vitamins|mesh-ancestor
139541381|NCT05932511|Micronutrients|micronutrients|mesh-ancestor
139541382|NCT05882903|Betamethasone|betamethasone|mesh-list
139541383|NCT05882903|Betamethasone Valerate|betamethasone valerate|mesh-list
139541384|NCT05882903|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139541385|NCT05882903|Betamethasone benzoate|betamethasone benzoate|mesh-list
139541386|NCT05882903|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139541387|NCT05882903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139541388|NCT05882903|Glucocorticoids|glucocorticoids|mesh-ancestor
139541389|NCT05882903|Hormones|hormones|mesh-ancestor
139541390|NCT05882903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139541391|NCT05882903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541392|NCT05882903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139541393|NCT05882903|Respiratory System Agents|respiratory system agents|mesh-ancestor
139541394|NCT05873712|Cyclophosphamide|cyclophosphamide|mesh-list
139541395|NCT05873712|Fludarabine|fludarabine|mesh-list
139541396|NCT05873712|Zanubrutinib|zanubrutinib|mesh-list
139541397|NCT05873712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139541398|NCT05873712|Immunologic Factors|immunologic factors|mesh-ancestor
139541399|NCT05873712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541400|NCT05873712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139541401|NCT05873712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139541402|NCT05873712|Alkylating Agents|alkylating agents|mesh-ancestor
139541403|NCT05873712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541404|NCT05873712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541405|NCT05873712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139541406|NCT05873712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139541407|NCT05873712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541408|NCT05872451|Bromides|bromides|mesh-list
139541409|NCT05872451|Rocuronium|rocuronium|mesh-list
139541410|NCT05872451|Anticonvulsants|anticonvulsants|mesh-ancestor
139541411|NCT05872451|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139541412|NCT05872451|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139541413|NCT05872451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139541414|NCT05872451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541415|NCT05872451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541416|NCT05861921|Lithium Carbonate|lithium carbonate|mesh-list
139541417|NCT05861921|Antidepressive Agents|antidepressive agents|mesh-ancestor
139541418|NCT05861921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139541419|NCT05861921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541420|NCT05861921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541421|NCT05861921|Antimanic Agents|antimanic agents|mesh-ancestor
139541422|NCT05861921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139541423|NCT05861921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541424|NCT05861921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541425|NCT05854498|Bevacizumab|bevacizumab|mesh-list
139541426|NCT05854498|Irinotecan|irinotecan|mesh-list
139541427|NCT05854498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541428|NCT05854498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541429|NCT05854498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139541430|NCT05854498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139541431|NCT05854498|Growth Substances|growth substances|mesh-ancestor
139541432|NCT05854498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541433|NCT05854498|Growth Inhibitors|growth inhibitors|mesh-ancestor
139541434|NCT05854498|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139541435|NCT05854498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139541436|NCT05854498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541437|NCT05854498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541438|NCT05841472|Carboplatin|carboplatin|mesh-list
139541439|NCT05841472|Pemetrexed|pemetrexed|mesh-list
139541440|NCT05841472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541441|NCT05841472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541442|NCT05841472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541443|NCT05841472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139541444|NCT05841472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139541445|NCT05831449|Ropivacaine|ropivacaine|mesh-list
139541446|NCT05831449|Anesthetics, Local|anesthetics, local|mesh-list
139541447|NCT05831449|Anesthetics|anesthetics|mesh-list
139541448|NCT05831449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541449|NCT05831449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185921|NCT05107193|Afatinib|afatinib|mesh-list
139541450|NCT05831449|Sensory System Agents|sensory system agents|mesh-ancestor
139541451|NCT05831449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541452|NCT05821725|Hyaluronic Acid|hyaluronic acid|mesh-list
139541453|NCT05821725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139541454|NCT05821725|Immunologic Factors|immunologic factors|mesh-ancestor
139541455|NCT05821725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541456|NCT05821725|Viscosupplements|viscosupplements|mesh-ancestor
139541457|NCT05821725|Protective Agents|protective agents|mesh-ancestor
139541458|NCT05818124|Oseltamivir|oseltamivir|mesh-list
139541459|NCT05818124|Molnupiravir|molnupiravir|mesh-list
139541460|NCT05818124|Antiviral Agents|antiviral agents|mesh-ancestor
139541461|NCT05818124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139541462|NCT05818124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541463|NCT05818124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541464|NCT05813847|Anesthetics|anesthetics|mesh-list
139541465|NCT05813847|Anesthetics, Local|anesthetics, local|mesh-list
139541466|NCT05813847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541467|NCT05813847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541468|NCT05813847|Sensory System Agents|sensory system agents|mesh-ancestor
139541469|NCT05813847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541470|NCT05810233|Ascorbic Acid|ascorbic acid|mesh-list
139541471|NCT05810233|Vitamins|vitamins|mesh-ancestor
139541472|NCT05810233|Micronutrients|micronutrients|mesh-ancestor
139541473|NCT05810233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541474|NCT05810233|Antioxidants|antioxidants|mesh-ancestor
139541475|NCT05810233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541476|NCT05810233|Protective Agents|protective agents|mesh-ancestor
139541477|NCT05805891|Bortezomib|bortezomib|mesh-list
139541478|NCT05805891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541479|NCT06133764|Ethanol|ethanol|mesh-list
139541480|NCT06133764|Acetic Acid|acetic acid|mesh-list
139541481|NCT06133764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139541482|NCT06133764|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139541483|NCT06133764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139541484|NCT06133764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541485|NCT06133764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541486|NCT06133764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139541487|NCT06133686|Tenofovir|tenofovir|mesh-list
139541488|NCT06133686|Emtricitabine|emtricitabine|mesh-list
139541489|NCT06133686|Cabotegravir|cabotegravir|mesh-list
139541490|NCT06133686|Antiviral Agents|antiviral agents|mesh-ancestor
139541491|NCT06133686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139541492|NCT06133686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139541493|NCT06133686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139541494|NCT06133686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541495|NCT06133686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541496|NCT06133686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139541497|NCT06133686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139541498|NCT06133686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139541499|NCT06133686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139541500|NCT06133517|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139541501|NCT06133517|Immunoconjugates|immunoconjugates|mesh-ancestor
139541502|NCT06133517|Immunologic Factors|immunologic factors|mesh-ancestor
139541503|NCT06133517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541504|NCT06133231|Micronutrients|micronutrients|mesh-list
139541505|NCT06133231|Trace Elements|trace elements|mesh-list
139541506|NCT06133231|Antioxidants|antioxidants|mesh-list
139541507|NCT06133231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541508|NCT06133231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541509|NCT06133231|Protective Agents|protective agents|mesh-ancestor
139541510|NCT06133088|Gossypol acetic acid|gossypol acetic acid|mesh-list
139541511|NCT06133088|Gossypol|gossypol|mesh-list
139541512|NCT06133088|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139541513|NCT06133088|Contraceptive Agents|contraceptive agents|mesh-ancestor
139541514|NCT06133088|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139541515|NCT06133088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541516|NCT06133088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139541517|NCT06133088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541518|NCT06133088|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139541519|NCT06133088|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
139541520|NCT06133088|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
139541521|NCT06133049|Ozanimod|ozanimod|mesh-list
139541522|NCT06133049|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139323170|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139541523|NCT06133049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541524|NCT06133049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139541525|NCT06133049|Immunologic Factors|immunologic factors|mesh-ancestor
139541526|NCT06133049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541527|NCT06132945|Nivolumab|nivolumab|mesh-list
139541528|NCT06132945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541529|NCT06132945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541530|NCT06132945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139541531|NCT06132945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541532|NCT06132815|Astringents|astringents|mesh-list
139541533|NCT06132815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541534|NCT06132815|Dermatologic Agents|dermatologic agents|mesh-ancestor
139541535|NCT06132451|Antihypertensive Agents|antihypertensive agents|mesh-list
139541536|NCT06132308|Bupivacaine|bupivacaine|mesh-list
139541537|NCT06132308|Anesthetics, Local|anesthetics, local|mesh-ancestor
139541538|NCT06132308|Anesthetics|anesthetics|mesh-ancestor
139541539|NCT06132308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186220|NCT00602576|Sorafenib|sorafenib|mesh-list
139541540|NCT06132308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541541|NCT06132308|Sensory System Agents|sensory system agents|mesh-ancestor
139541542|NCT06132308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541543|NCT06132191|Cemiplimab|cemiplimab|mesh-list
139541544|NCT06132191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541545|NCT06132191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541546|NCT06132165|Deoxycholic Acid|deoxycholic acid|mesh-list
139541547|NCT06132165|Polidocanol|polidocanol|mesh-list
139541548|NCT06132165|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139541549|NCT06132165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139186272|NCT04341454|Fexuprazan|fexuprazan|mesh-list
139541550|NCT06132165|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139541551|NCT06132165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139541552|NCT06132035|Aflibercept|aflibercept|mesh-list
139541553|NCT06132035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139541554|NCT06132035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139541555|NCT06132035|Growth Substances|growth substances|mesh-ancestor
139541556|NCT06132035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541557|NCT06132035|Growth Inhibitors|growth inhibitors|mesh-ancestor
139541558|NCT06132035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541559|NCT06131957|Fluorides|fluorides|mesh-list
139541560|NCT06131957|Fluorides, Topical|fluorides, topical|mesh-list
139541561|NCT06131957|Cariostatic Agents|cariostatic agents|mesh-ancestor
139541562|NCT06131957|Protective Agents|protective agents|mesh-ancestor
139541563|NCT06131957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541564|NCT06129188|Propofol|propofol|mesh-list
139541565|NCT06129188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139541566|NCT06129188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541567|NCT06129188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541568|NCT06129188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139541569|NCT06129188|Anesthetics, General|anesthetics, general|mesh-ancestor
139541570|NCT06129188|Anesthetics|anesthetics|mesh-ancestor
139541571|NCT06128330|Tranexamic Acid|tranexamic acid|mesh-list
139541572|NCT06128330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139541573|NCT06128330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139541574|NCT06128330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541575|NCT06128330|Hemostatics|hemostatics|mesh-ancestor
139541576|NCT06128330|Coagulants|coagulants|mesh-ancestor
139541577|NCT06042257|Guanfacine|guanfacine|mesh-list
139541578|NCT06042257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139541579|NCT06042257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139541580|NCT06042257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139541581|NCT06042257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139541582|NCT06042257|Adrenergic Agents|adrenergic agents|mesh-ancestor
139541583|NCT06042257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541584|NCT06042257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541585|NCT06042257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541586|NCT06039774|Chitosan|chitosan|mesh-list
139541587|NCT06039774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139541588|NCT06039774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139541589|NCT06039774|Antimetabolites|antimetabolites|mesh-ancestor
139541590|NCT06039774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541591|NCT06039774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139541592|NCT06039774|Chelating Agents|chelating agents|mesh-ancestor
139541593|NCT06039774|Sequestering Agents|sequestering agents|mesh-ancestor
139541594|NCT06039774|Hemostatics|hemostatics|mesh-ancestor
139541595|NCT06039774|Coagulants|coagulants|mesh-ancestor
139541596|NCT06037980|Paclitaxel|paclitaxel|mesh-list
139541597|NCT06037980|Gemcitabine|gemcitabine|mesh-list
139541598|NCT06037980|Capecitabine|capecitabine|mesh-list
139541599|NCT06037980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139541600|NCT06037980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541601|NCT06037980|Tubulin Modulators|tubulin modulators|mesh-ancestor
139541602|NCT06037980|Antimitotic Agents|antimitotic agents|mesh-ancestor
139541603|NCT06037980|Mitosis Modulators|mitosis modulators|mesh-ancestor
139541604|NCT06037980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541605|NCT06037980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139541606|NCT06037980|Antimetabolites|antimetabolites|mesh-ancestor
139541608|NCT06023602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139541609|NCT06023602|Fertility Agents|fertility agents|mesh-ancestor
139541610|NCT06023602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139541611|NCT06023602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541612|NCT06023602|Hormone Antagonists|hormone antagonists|mesh-ancestor
139541613|NCT06023602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139541614|NCT06014385|Scopolamine|scopolamine|mesh-list
139541615|NCT06014385|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139541616|NCT06014385|LSN3172176|lsn3172176|mesh-list
139541617|NCT06014385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139541618|NCT06014385|Antiemetics|antiemetics|mesh-ancestor
139541619|NCT06014385|Autonomic Agents|autonomic agents|mesh-ancestor
139541620|NCT06014385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541621|NCT06014385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541622|NCT06014385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139541623|NCT06014385|Mydriatics|mydriatics|mesh-ancestor
139186379|NCT01309633|Bevacizumab|bevacizumab|mesh-list
139541624|NCT06014385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139541625|NCT06014385|Cholinergic Agents|cholinergic agents|mesh-ancestor
139541626|NCT06014385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541627|NCT06014385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541628|NCT06014385|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139541629|NCT06014385|Parasympatholytics|parasympatholytics|mesh-ancestor
139541630|NCT06014385|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139541631|NCT06006286|Bevacizumab|bevacizumab|mesh-list
139541632|NCT06006286|Atezolizumab|atezolizumab|mesh-list
139541633|NCT06006286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541634|NCT06006286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541635|NCT06006286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139541636|NCT06006286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139541637|NCT06006286|Growth Substances|growth substances|mesh-ancestor
139541638|NCT06006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541639|NCT06006286|Growth Inhibitors|growth inhibitors|mesh-ancestor
139541640|NCT06006286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139541641|NCT06006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541642|NCT06004115|Lorazepam|lorazepam|mesh-list
139541643|NCT06004115|Anticonvulsants|anticonvulsants|mesh-ancestor
139541644|NCT06004115|Antiemetics|antiemetics|mesh-ancestor
139186418|NCT02949024|Hormones|hormones|mesh-ancestor
139541645|NCT06004115|Autonomic Agents|autonomic agents|mesh-ancestor
139541646|NCT06004115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541647|NCT06004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541648|NCT06004115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139541649|NCT06004115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139541650|NCT06004115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541651|NCT06004115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139541652|NCT06004115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139541653|NCT06004115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139541654|NCT06004115|GABA Modulators|gaba modulators|mesh-ancestor
139541655|NCT06004115|GABA Agents|gaba agents|mesh-ancestor
139541656|NCT06004115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541657|NCT06004115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541658|NCT05968690|Propranolol|propranolol|mesh-list
139541659|NCT05968690|Naltrexone|naltrexone|mesh-list
139541660|NCT05968690|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139541661|NCT05968690|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139541662|NCT05968690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541663|NCT05968690|Sensory System Agents|sensory system agents|mesh-ancestor
139541664|NCT05968690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541665|NCT05968690|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139541666|NCT05968690|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139541667|NCT05968690|Adrenergic Agents|adrenergic agents|mesh-ancestor
139541668|NCT05968690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541669|NCT05968690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541670|NCT05968690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139541671|NCT05968690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139541672|NCT05968690|Vasodilator Agents|vasodilator agents|mesh-ancestor
139541673|NCT05963048|Rituximab|rituximab|mesh-list
139541674|NCT05963048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541675|NCT05963048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323317|NCT03906669|Progestins|progestins|mesh-ancestor
139541676|NCT05963048|Immunologic Factors|immunologic factors|mesh-ancestor
139541677|NCT05963048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541678|NCT05963048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139541679|NCT05959356|Leucovorin|leucovorin|mesh-list
139541680|NCT05959356|Oxaliplatin|oxaliplatin|mesh-list
139541681|NCT05959356|Irinotecan|irinotecan|mesh-list
139541682|NCT05959356|Cetuximab|cetuximab|mesh-list
139541683|NCT05959356|Levoleucovorin|levoleucovorin|mesh-list
139541684|NCT05959356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541685|NCT05959356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139541686|NCT05959356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139541687|NCT05959356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541688|NCT05959356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541689|NCT05959356|Antidotes|antidotes|mesh-ancestor
139541690|NCT05959356|Protective Agents|protective agents|mesh-ancestor
139541691|NCT05959356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541692|NCT05959356|Vitamin B Complex|vitamin b complex|mesh-ancestor
139541693|NCT05959356|Vitamins|vitamins|mesh-ancestor
139541694|NCT05959356|Micronutrients|micronutrients|mesh-ancestor
139541695|NCT05959356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541696|NCT05935579|Durvalumab|durvalumab|mesh-list
139541697|NCT05935579|Lenvatinib|lenvatinib|mesh-list
139541698|NCT05935579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541699|NCT05935579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541700|NCT05935579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139541701|NCT05935579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186524|NCT01309789|Hormones|hormones|mesh-ancestor
139541702|NCT05935579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541703|NCT05902208|Antiviral Agents|antiviral agents|mesh-list
139541704|NCT05902208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139541705|NCT05876377|Vaccines|vaccines|mesh-list
139541706|NCT05876377|Immunologic Factors|immunologic factors|mesh-ancestor
139541707|NCT05876377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541708|NCT05839470|Leucovorin|leucovorin|mesh-list
139541709|NCT05839470|Oxaliplatin|oxaliplatin|mesh-list
139541710|NCT05839470|Irinotecan|irinotecan|mesh-list
139541711|NCT05839470|Levoleucovorin|levoleucovorin|mesh-list
139541712|NCT05839470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541713|NCT05839470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139541714|NCT05839470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139541715|NCT05839470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541716|NCT05839470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541717|NCT05839470|Antidotes|antidotes|mesh-ancestor
139541718|NCT05839470|Protective Agents|protective agents|mesh-ancestor
139541719|NCT05839470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541720|NCT05839470|Vitamin B Complex|vitamin b complex|mesh-ancestor
139541721|NCT05839470|Vitamins|vitamins|mesh-ancestor
139541722|NCT05839470|Micronutrients|micronutrients|mesh-ancestor
139541723|NCT05767749|Lidocaine|lidocaine|mesh-list
139541724|NCT05767749|Epinephrine|epinephrine|mesh-list
139541725|NCT05767749|Racepinephrine|racepinephrine|mesh-list
139541726|NCT05767749|Bupivacaine|bupivacaine|mesh-list
139541727|NCT05767749|Ropivacaine|ropivacaine|mesh-list
139541728|NCT05767749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139541729|NCT05767749|Epinephryl borate|epinephryl borate|mesh-list
139541730|NCT05767749|Anesthetics, Local|anesthetics, local|mesh-ancestor
139541731|NCT05767749|Anesthetics|anesthetics|mesh-ancestor
139541732|NCT05767749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541733|NCT05767749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541734|NCT05767749|Sensory System Agents|sensory system agents|mesh-ancestor
139541735|NCT05767749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541736|NCT05767749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139541737|NCT05767749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139541738|NCT05767749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139541739|NCT05767749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139541740|NCT05767749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541741|NCT05767749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139541742|NCT05767749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139541743|NCT05767749|Adrenergic Agents|adrenergic agents|mesh-ancestor
139541744|NCT05767749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541745|NCT05767749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139541746|NCT05767749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139541747|NCT05767749|Autonomic Agents|autonomic agents|mesh-ancestor
139541748|NCT05767749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139541749|NCT05767749|Respiratory System Agents|respiratory system agents|mesh-ancestor
139541750|NCT05767749|Mydriatics|mydriatics|mesh-ancestor
139541751|NCT05767749|Sympathomimetics|sympathomimetics|mesh-ancestor
139541752|NCT05767749|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139541753|NCT05725837|Paroxetine|paroxetine|mesh-list
139541754|NCT05725837|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139541755|NCT05725837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139541756|NCT05725837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139541757|NCT05725837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541758|NCT05725837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139186670|NCT04447118|Docetaxel|docetaxel|mesh-list
139541759|NCT05725837|Serotonin Agents|serotonin agents|mesh-ancestor
139541760|NCT05725837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541761|NCT05725837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139541762|NCT05725837|Antidepressive Agents|antidepressive agents|mesh-ancestor
139541763|NCT05725837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139541764|NCT05725837|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139541765|NCT05725837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139541766|NCT05725837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541767|NCT05716516|Estradiol|estradiol|mesh-list
139541768|NCT05716516|Estrogens|estrogens|mesh-ancestor
139541769|NCT05716516|Hormones|hormones|mesh-ancestor
139541770|NCT05716516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139541771|NCT05716516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541772|NCT05711667|Acetic Acid|acetic acid|mesh-list
139541773|NCT05711667|Letermovir|letermovir|mesh-list
139541774|NCT05711667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139541775|NCT05711667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139541776|NCT05711667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541777|NCT05711667|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139541778|NCT05711667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541779|NCT05711667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541780|NCT05711667|Antiviral Agents|antiviral agents|mesh-ancestor
139541781|NCT05676749|Pembrolizumab|pembrolizumab|mesh-list
139541782|NCT05676749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541783|NCT05676749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541784|NCT05676749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139541785|NCT05676749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541786|NCT05658484|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139541787|NCT05658484|Dermatologic Agents|dermatologic agents|mesh-ancestor
139541788|NCT05658484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139541789|NCT05658484|Immunologic Factors|immunologic factors|mesh-ancestor
139186812|NCT04305249|Nivolumab|nivolumab|mesh-list
139541790|NCT05658484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541791|NCT05653882|Pembrolizumab|pembrolizumab|mesh-list
139541792|NCT05653882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541793|NCT05653882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541794|NCT05653882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139541795|NCT05653882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541796|NCT05650476|Talazoparib|talazoparib|mesh-list
139541797|NCT05650476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139541798|NCT05650476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541799|NCT05650476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541800|NCT05650476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541801|NCT05598723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139541802|NCT05598723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139541803|NCT05598723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139541804|NCT05598723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139541805|NCT05598723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541806|NCT05598723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541807|NCT05598723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139541808|NCT05598723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139541809|NCT05598723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541810|NCT05598723|Cholinergic Agents|cholinergic agents|mesh-ancestor
139541811|NCT05598723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541812|NCT05577000|Cyclophosphamide|cyclophosphamide|mesh-list
139541813|NCT05577000|Fludarabine|fludarabine|mesh-list
139541814|NCT05577000|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
139541815|NCT05577000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139541816|NCT05577000|Immunologic Factors|immunologic factors|mesh-ancestor
139541817|NCT05577000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541818|NCT05577000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139541819|NCT05577000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139541820|NCT05577000|Alkylating Agents|alkylating agents|mesh-ancestor
139541821|NCT05577000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541822|NCT05577000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541823|NCT05577000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139541824|NCT05577000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541825|NCT05543629|Paclitaxel|paclitaxel|mesh-list
139541826|NCT05543629|Docetaxel|docetaxel|mesh-list
139541827|NCT05543629|Carboplatin|carboplatin|mesh-list
139541828|NCT05543629|Nivolumab|nivolumab|mesh-list
139541829|NCT05543629|Taxane|taxane|mesh-list
139541830|NCT05543629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139541831|NCT05543629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541832|NCT05543629|Tubulin Modulators|tubulin modulators|mesh-ancestor
139541833|NCT05543629|Antimitotic Agents|antimitotic agents|mesh-ancestor
139541834|NCT05543629|Mitosis Modulators|mitosis modulators|mesh-ancestor
139541835|NCT05543629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186887|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541836|NCT05543629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541837|NCT05543629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139541838|NCT05517265|Acalabrutinib|acalabrutinib|mesh-list
139541839|NCT05517265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541840|NCT05515978|Metformin|metformin|mesh-list
139541841|NCT05515978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139541842|NCT05515978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541843|NCT05469165|Cyproheptadine|cyproheptadine|mesh-list
139541844|NCT05469165|Antipruritics|antipruritics|mesh-ancestor
139541845|NCT05469165|Dermatologic Agents|dermatologic agents|mesh-ancestor
139541846|NCT05469165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139541847|NCT05469165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139541848|NCT05469165|Histamine Antagonists|histamine antagonists|mesh-ancestor
139541849|NCT05469165|Histamine Agents|histamine agents|mesh-ancestor
139541850|NCT05469165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541851|NCT05469165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541852|NCT05469165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541853|NCT05469165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139541854|NCT05469165|Serotonin Agents|serotonin agents|mesh-ancestor
139541855|NCT05469165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139541856|NCT05466578|Abrocitinib|abrocitinib|mesh-list
139541857|NCT05466578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139541858|NCT05466578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541859|NCT05466578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541860|NCT05458102|Voriconazole|voriconazole|mesh-list
139541861|NCT05458102|Cobicistat|cobicistat|mesh-list
139541862|NCT05458102|Rifabutin|rifabutin|mesh-list
139541863|NCT05458102|Vesatolimod|vesatolimod|mesh-list
139541864|NCT05458102|Antifungal Agents|antifungal agents|mesh-ancestor
139541865|NCT05458102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139186952|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
139541866|NCT05458102|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139541867|NCT05458102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139541868|NCT05458102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541869|NCT05458102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541870|NCT05458102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139541871|NCT05458102|Hormone Antagonists|hormone antagonists|mesh-ancestor
139541872|NCT05458102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139541873|NCT05458102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541874|NCT05458102|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139541875|NCT05458102|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139541876|NCT05458102|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139541877|NCT05458102|Antiviral Agents|antiviral agents|mesh-ancestor
139541878|NCT05458102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139541879|NCT05458102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139541880|NCT05458102|Antitubercular Agents|antitubercular agents|mesh-ancestor
139541881|NCT05450718|Buprenorphine|buprenorphine|mesh-list
139541882|NCT05450718|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139541883|NCT05450718|Naloxone|naloxone|mesh-list
139541884|NCT05450718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139541885|NCT05450718|Narcotics|narcotics|mesh-ancestor
139541886|NCT05450718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186999|NCT03464968|Leucovorin|leucovorin|mesh-list
139541887|NCT05450718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541888|NCT05450718|Analgesics|analgesics|mesh-ancestor
139541889|NCT05450718|Sensory System Agents|sensory system agents|mesh-ancestor
139541890|NCT05450718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541891|NCT05450718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139541892|NCT05431413|Phosphocreatine|phosphocreatine|mesh-list
139541893|NCT05431413|Fluoxetine|fluoxetine|mesh-list
139541894|NCT05431413|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139541895|NCT05431413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139541896|NCT05431413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139541897|NCT05431413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541898|NCT05431413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541899|NCT05431413|Serotonin Agents|serotonin agents|mesh-ancestor
139541900|NCT05431413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541901|NCT05431413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139541902|NCT05431413|Antidepressive Agents|antidepressive agents|mesh-ancestor
139541903|NCT05431413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139541904|NCT05431413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139541905|NCT05431413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139541906|NCT05431413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541907|NCT05431413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139541908|NCT05431413|Protective Agents|protective agents|mesh-ancestor
139541909|NCT05395507|Interferons|interferons|mesh-list
139541910|NCT05395507|Interferon-alpha|interferon-alpha|mesh-list
139541911|NCT05395507|Interferon alpha-2|interferon alpha-2|mesh-list
139541912|NCT05395507|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139541913|NCT05395507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541914|NCT05395507|Antiviral Agents|antiviral agents|mesh-ancestor
139541915|NCT05395507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139541916|NCT05395507|Immunologic Factors|immunologic factors|mesh-ancestor
139541917|NCT05395507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541918|NCT05337566|Azithromycin|azithromycin|mesh-list
139541919|NCT05337566|Cefuroxime|cefuroxime|mesh-list
139541920|NCT05337566|Cefuroxime axetil|cefuroxime axetil|mesh-list
139541921|NCT05337566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139541922|NCT05337566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139541923|NCT05279417|Methotrexate|methotrexate|mesh-list
139187126|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
139541924|NCT05279417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139541925|NCT05279417|Abortifacient Agents|abortifacient agents|mesh-ancestor
139541926|NCT05279417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139541927|NCT05279417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541928|NCT05279417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139541929|NCT05279417|Antimetabolites|antimetabolites|mesh-ancestor
139541930|NCT05279417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541931|NCT05279417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541932|NCT05279417|Dermatologic Agents|dermatologic agents|mesh-ancestor
139541933|NCT05279417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541934|NCT05279417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139541935|NCT05279417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139541936|NCT05279417|Immunologic Factors|immunologic factors|mesh-ancestor
139541937|NCT05279417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139541938|NCT05279417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139541939|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
139541940|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139541941|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139541942|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187169|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
139541943|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139541944|NCT05215158|Analgesics|analgesics|mesh-ancestor
139541945|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
139541946|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541947|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139541948|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139541949|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139541950|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
139541951|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139541952|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541953|NCT05168813|Vaccines|vaccines|mesh-list
139541954|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
139541955|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541956|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
139541957|NCT05165225|Docetaxel|docetaxel|mesh-list
139541958|NCT05165225|Epirubicin|epirubicin|mesh-list
139541959|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139541960|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
139541961|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541962|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139541963|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139541964|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
139541965|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541966|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541967|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139541968|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
139541969|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
139541970|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
139541971|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139541972|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139541973|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139541974|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139541975|NCT05145400|Dexamethasone|dexamethasone|mesh-list
139541976|NCT05145400|Lenalidomide|lenalidomide|mesh-list
139541977|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139541979|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
139541980|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139541981|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139541982|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139541983|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
139541984|NCT05145400|Hormones|hormones|mesh-ancestor
139541985|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139541986|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139541987|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541988|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
139541989|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139187291|NCT04452370|Etoposide|etoposide|mesh-list
139541990|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139541991|NCT05145400|Growth Substances|growth substances|mesh-ancestor
139541992|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
139541993|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139541994|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139541995|NCT05142709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139541996|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139541997|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
139541998|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139541999|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
139542000|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139542001|NCT05114941|Antibodies|antibodies|mesh-list
139542002|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
139542003|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139542004|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
139542005|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542006|NCT05012371|Everolimus|everolimus|mesh-list
139542007|NCT05012371|Lenvatinib|lenvatinib|mesh-list
139542008|NCT05012371|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139542009|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139542010|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542011|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187329|NCT01235273|Hormones|hormones|mesh-list
139542012|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542013|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
139542014|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542015|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542016|NCT05002816|Elotuzumab|elotuzumab|mesh-list
139542017|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542018|NCT04999332|Leucovorin|leucovorin|mesh-list
139542019|NCT04999332|Docetaxel|docetaxel|mesh-list
139542020|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
139542021|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
139542022|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542023|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
139542024|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
139542025|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
139542026|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542027|NCT04999332|Antidotes|antidotes|mesh-ancestor
139542028|NCT04999332|Protective Agents|protective agents|mesh-ancestor
139542029|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542030|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
139542031|NCT04999332|Vitamins|vitamins|mesh-ancestor
139542032|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
139542033|NCT04874194|Venetoclax|venetoclax|mesh-list
139542034|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
139542035|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542036|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139542037|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139542038|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542039|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542040|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
139187375|NCT05488613|Midostaurin|midostaurin|mesh-list
139542041|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542042|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542043|NCT04862455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542044|NCT04862455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542045|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139542046|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139542047|NCT04837209|Niraparib|niraparib|mesh-list
139542048|NCT04837209|Dostarlimab|dostarlimab|mesh-list
139542049|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139542050|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542051|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542052|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542053|NCT04797767|Cytarabine|cytarabine|mesh-list
139542054|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
139542056|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
139542057|NCT04797767|Cladribine|cladribine|mesh-list
139542058|NCT04797767|Lenograstim|lenograstim|mesh-list
139542059|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542060|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
139542061|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542062|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542063|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
139542064|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139542065|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542066|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
139542067|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542068|NCT04797767|Analgesics|analgesics|mesh-ancestor
139542069|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
139542070|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139542071|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139542072|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139542073|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542074|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139542075|NCT04784715|Trastuzumab|trastuzumab|mesh-list
139542076|NCT04784715|Pertuzumab|pertuzumab|mesh-list
139542077|NCT04784715|Taxane|taxane|mesh-list
139542078|NCT04784715|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139542079|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542080|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542081|NCT04784715|Immunoconjugates|immunoconjugates|mesh-ancestor
139542082|NCT04784715|Immunologic Factors|immunologic factors|mesh-ancestor
139542083|NCT04784715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542084|NCT04752163|Leucovorin|leucovorin|mesh-list
139542085|NCT04752163|Cytarabine|cytarabine|mesh-list
139542086|NCT04752163|Voriconazole|voriconazole|mesh-list
139542087|NCT04752163|Posaconazole|posaconazole|mesh-list
139542088|NCT04752163|Dexamethasone|dexamethasone|mesh-list
139542089|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
139542090|NCT04752163|Prednisone|prednisone|mesh-list
139542091|NCT04752163|Cortisone|cortisone|mesh-list
139542092|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
139542093|NCT04752163|Rituximab|rituximab|mesh-list
139542094|NCT04752163|Methotrexate|methotrexate|mesh-list
139542095|NCT04752163|Vincristine|vincristine|mesh-list
139542096|NCT04752163|Azacitidine|azacitidine|mesh-list
139542097|NCT04752163|Venetoclax|venetoclax|mesh-list
139542098|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139542099|NCT04752163|Antibodies|antibodies|mesh-list
139542100|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
139542101|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139542102|NCT04752163|Lenograstim|lenograstim|mesh-list
139542103|NCT04752163|BB 1101|bb 1101|mesh-list
139542104|NCT04752163|Mesna|mesna|mesh-list
139542105|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542106|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
139542107|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542108|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139542109|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139542110|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
139542111|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542112|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542113|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139542114|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139542115|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
139542116|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
139542117|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139542118|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139542119|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
139542120|NCT04752163|Hormones|hormones|mesh-ancestor
139542121|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139542122|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139542123|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
139542124|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542125|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139542126|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
139542127|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139542128|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542129|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
139542130|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
139542131|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139542132|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139542133|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
139542134|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139542135|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139542136|NCT04752163|Antidotes|antidotes|mesh-ancestor
139542137|NCT04752163|Protective Agents|protective agents|mesh-ancestor
139542138|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
139542139|NCT04752163|Vitamins|vitamins|mesh-ancestor
139542140|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
139542141|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139542142|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
139542143|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
139542144|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
139542145|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
139542146|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139542147|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139542148|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139542149|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
139542150|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139542151|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139542152|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139542153|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139542154|NCT04732598|Paclitaxel|paclitaxel|mesh-list
139542155|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139542156|NCT04732598|Bevacizumab|bevacizumab|mesh-list
139542157|NCT04732598|Atezolizumab|atezolizumab|mesh-list
139542158|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139542159|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542160|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
139542161|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
139542162|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
139542163|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542164|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542165|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139542166|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139542167|NCT04732598|Growth Substances|growth substances|mesh-ancestor
139542168|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542169|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
139542170|NCT04732598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542171|NCT04731467|Paclitaxel|paclitaxel|mesh-list
139542172|NCT04731467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139542173|NCT04731467|Gemcitabine|gemcitabine|mesh-list
139542174|NCT04731467|Nivolumab|nivolumab|mesh-list
139542175|NCT04731467|Fluorouracil|fluorouracil|mesh-list
139542176|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139542177|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542178|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
139542179|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
139542180|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
139542181|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542182|NCT04731467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542183|NCT04731467|Antimetabolites|antimetabolites|mesh-ancestor
139542184|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542185|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542186|NCT04731467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542187|NCT04731467|Immunologic Factors|immunologic factors|mesh-ancestor
139542188|NCT04731467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542189|NCT04667078|Cangrelor|cangrelor|mesh-list
139542190|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139542191|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139542192|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139542193|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139542194|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
139542195|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139542196|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542197|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542198|NCT04630808|Latanoprost|latanoprost|mesh-list
139542199|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139542200|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139542201|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
139542202|NCT04539808|Leucovorin|leucovorin|mesh-list
139542203|NCT04539808|Folic Acid|folic acid|mesh-list
139542204|NCT04539808|Capecitabine|capecitabine|mesh-list
139542205|NCT04539808|Fluorouracil|fluorouracil|mesh-list
139542206|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
139542207|NCT04539808|Irinotecan|irinotecan|mesh-list
139323847|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
139542208|NCT04539808|Camptothecin|camptothecin|mesh-list
139542209|NCT04539808|Losartan|losartan|mesh-list
139542210|NCT04539808|Calcium|calcium|mesh-list
139542211|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
139542212|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139542213|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542214|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139542215|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542216|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
139542217|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542218|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542219|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542220|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
139542221|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139542222|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139542223|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542224|NCT04539808|Antidotes|antidotes|mesh-ancestor
139542225|NCT04539808|Protective Agents|protective agents|mesh-ancestor
139542226|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
139542227|NCT04539808|Vitamins|vitamins|mesh-ancestor
139542228|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
139542229|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139542230|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139542231|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139542232|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139542233|NCT04539808|Hematinics|hematinics|mesh-ancestor
139542234|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139542235|NCT04530487|Cyclosporine|cyclosporine|mesh-list
139542236|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
139542237|NCT04530487|Fludarabine|fludarabine|mesh-list
139542238|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
139542239|NCT04530487|Etoposide|etoposide|mesh-list
139542240|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
139542241|NCT04530487|Melphalan|melphalan|mesh-list
139542242|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
139542243|NCT04530487|Thiotepa|thiotepa|mesh-list
139542244|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
139542245|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139542246|NCT04530487|Tacrolimus|tacrolimus|mesh-list
139542247|NCT04530487|Cyclosporins|cyclosporins|mesh-list
139542248|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
139542249|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139542250|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
139542251|NCT04530487|Antibodies|antibodies|mesh-list
139542252|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
139542253|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139542254|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139542255|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542256|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542257|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
139542258|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542259|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542260|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
139542261|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542262|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139542263|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139542264|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139542265|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542266|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139542267|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
139542268|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139542269|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
139542270|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139542271|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139542272|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139542273|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
139542274|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139542275|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139542276|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
139542277|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139542278|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
139542279|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
139542280|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
139542281|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
139542282|NCT04528680|Paclitaxel|paclitaxel|mesh-list
139542283|NCT04528680|Carboplatin|carboplatin|mesh-list
139542284|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139542285|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139542286|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187888|NCT03318315|Vaccines|vaccines|mesh-list
139542287|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
139542288|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
139542289|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
139542290|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542291|NCT04513808|Anesthetics|anesthetics|mesh-list
139542292|NCT04513808|Propofol|propofol|mesh-list
139542293|NCT04513808|Sevoflurane|sevoflurane|mesh-list
139542294|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139542295|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542296|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139542297|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139542298|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
139542299|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139542300|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139542301|NCT04478734|Thiamine|thiamine|mesh-list
139542303|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
139542304|NCT04478734|Vitamins|vitamins|mesh-ancestor
139542305|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
139542306|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542307|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
139542308|NCT04478292|Cisplatin|cisplatin|mesh-list
139542309|NCT04478292|Carboplatin|carboplatin|mesh-list
139542310|NCT04478292|Doxorubicin|doxorubicin|mesh-list
139542311|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139542312|NCT04478292|Fluorouracil|fluorouracil|mesh-list
139542313|NCT04478292|Irinotecan|irinotecan|mesh-list
139542314|NCT04478292|Vincristine|vincristine|mesh-list
139542315|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542316|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139542317|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139542318|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139542319|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542320|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542321|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
139542322|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542323|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542324|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
139542325|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542326|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139542327|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139542328|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
139542329|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
139542330|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
139542331|NCT04478292|Antidotes|antidotes|mesh-ancestor
139542332|NCT04478292|Protective Agents|protective agents|mesh-ancestor
139542333|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
139542334|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
139542335|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139542336|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139542337|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
139542338|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
139542339|NCT04474470|Cetuximab|cetuximab|mesh-list
139542340|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542341|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542342|NCT04464174|Carboplatin|carboplatin|mesh-list
139542343|NCT04464174|Gemcitabine|gemcitabine|mesh-list
139542344|NCT04464174|Capecitabine|capecitabine|mesh-list
139542345|NCT04464174|Ipatasertib|ipatasertib|mesh-list
139542346|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542347|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542348|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
139542349|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542350|NCT04464174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139542351|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542352|NCT04459117|Acetaminophen|acetaminophen|mesh-list
139542353|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139542354|NCT04459117|Analgesics|analgesics|mesh-ancestor
139542355|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
139542356|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139542357|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542358|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
139542359|NCT04407754|Inositol|inositol|mesh-list
139542360|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
139542361|NCT04407754|Vitamins|vitamins|mesh-ancestor
139542362|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
139542363|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542364|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
139542365|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139542366|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139542367|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542368|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
139542369|NCT04387305|Coagulants|coagulants|mesh-ancestor
139542370|NCT04351555|Carboplatin|carboplatin|mesh-list
139542371|NCT04351555|Pemetrexed|pemetrexed|mesh-list
139542372|NCT04351555|Osimertinib|osimertinib|mesh-list
139542373|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542374|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542375|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542376|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139542377|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139542378|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139542379|NCT04297254|Lenvatinib|lenvatinib|mesh-list
139542380|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542381|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139542382|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188095|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139542383|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542384|NCT04244981|Thrombin|thrombin|mesh-list
139542385|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
139542386|NCT04244981|Coagulants|coagulants|mesh-ancestor
139542387|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
139542388|NCT04198922|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139542389|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542390|NCT04198922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139542391|NCT04198922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542392|NCT04198922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542393|NCT04182373|Antithrombins|antithrombins|mesh-list
139542394|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
139542395|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139542396|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
139542397|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542398|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542399|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
139542400|NCT04180085|Abatacept|abatacept|mesh-list
139542401|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542402|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542403|NCT04180085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542404|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542405|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542406|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
139542407|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542408|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139542409|NCT04140305|Ozanimod|ozanimod|mesh-list
139542410|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139542411|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542412|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542413|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
139542414|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542415|NCT04133948|Nivolumab|nivolumab|mesh-list
139542416|NCT04133948|Ipilimumab|ipilimumab|mesh-list
139542417|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542418|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542419|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542420|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542421|NCT04071756|Tazarotene|tazarotene|mesh-list
139542422|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
139542423|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
139542424|NCT04068610|Bevacizumab|bevacizumab|mesh-list
139542425|NCT04068610|Durvalumab|durvalumab|mesh-list
139542426|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542427|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542428|NCT04068610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139542429|NCT04068610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139542430|NCT04068610|Growth Substances|growth substances|mesh-ancestor
139542431|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542432|NCT04068610|Growth Inhibitors|growth inhibitors|mesh-ancestor
139542433|NCT04005690|Olaparib|olaparib|mesh-list
139542434|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139542435|NCT04005690|Onvansertib|onvansertib|mesh-list
139542436|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542437|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542438|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542439|NCT04005690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139542440|NCT03997370|Carboplatin|carboplatin|mesh-list
139542441|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542442|NCT03961971|Spartalizumab|spartalizumab|mesh-list
139324073|NCT04301765|Testosterone|testosterone|mesh-list
139542443|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542444|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542445|NCT03961971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542446|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542447|NCT03879135|Factor VIII|factor viii|mesh-list
139542448|NCT03879135|Coagulants|coagulants|mesh-ancestor
139542449|NCT03874936|Dexamethasone|dexamethasone|mesh-list
139542450|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139542451|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139542452|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
139542453|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
139542454|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139542455|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542456|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139542457|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
139542458|NCT03874936|Hormones|hormones|mesh-ancestor
139188322|NCT03430024|Estrogens|estrogens|mesh-list
139188323|NCT03430024|Hormones|hormones|mesh-ancestor
139542459|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139542460|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139542461|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542462|NCT03860844|Cytarabine|cytarabine|mesh-list
139542463|NCT03860844|Dexamethasone|dexamethasone|mesh-list
139542464|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
139542465|NCT03860844|Doxorubicin|doxorubicin|mesh-list
139542466|NCT03860844|Methotrexate|methotrexate|mesh-list
139542467|NCT03860844|Fludarabine|fludarabine|mesh-list
139542468|NCT03860844|Etoposide|etoposide|mesh-list
139542469|NCT03860844|Vincristine|vincristine|mesh-list
139542470|NCT03860844|Daunorubicin|daunorubicin|mesh-list
139542471|NCT03860844|Asparaginase|asparaginase|mesh-list
139542472|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
139542473|NCT03860844|Idarubicin|idarubicin|mesh-list
139542474|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
139542475|NCT03860844|Pegaspargase|pegaspargase|mesh-list
139542476|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542477|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
139542478|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542479|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139542480|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139542481|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
139542482|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542483|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542484|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139542485|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139542486|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
139542487|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
139542488|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139542489|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139542490|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
139542491|NCT03860844|Hormones|hormones|mesh-ancestor
139542492|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139542493|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139542494|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139542495|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139542496|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139542497|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542498|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139542499|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
139542500|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139542501|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542502|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
139542503|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
139542504|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139542505|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139542506|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139542507|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
139542508|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139542509|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
139542510|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
139542511|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
139542512|NCT03860844|Analgesics|analgesics|mesh-ancestor
139542513|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
139542514|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
139542515|NCT03853304|Folic Acid|folic acid|mesh-list
139542516|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
139542517|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
139542518|NCT03853304|Vitamins|vitamins|mesh-ancestor
139542519|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
139542520|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542521|NCT03853304|Hematinics|hematinics|mesh-ancestor
139542523|NCT03787264|Venetoclax|venetoclax|mesh-list
139542524|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139542525|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
139542526|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
139542527|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542528|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139542529|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
139542530|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542531|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542532|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
139542533|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542534|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542535|NCT03732950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542536|NCT03732950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542537|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
139542538|NCT03721068|Fludarabine|fludarabine|mesh-list
139542539|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542540|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
139542541|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542542|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139542543|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139542544|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
139542545|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542546|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188532|NCT04449718|Vitamins|vitamins|mesh-ancestor
139542547|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139542548|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
139542549|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139542550|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
139542551|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139542552|NCT03707951|Expectorants|expectorants|mesh-ancestor
139542553|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
139542554|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139542555|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
139542556|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542557|NCT03707951|Protective Agents|protective agents|mesh-ancestor
139542558|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542559|NCT03707951|Antidotes|antidotes|mesh-ancestor
139542560|NCT03691493|Tamoxifen|tamoxifen|mesh-list
139542561|NCT03691493|Letrozole|letrozole|mesh-list
139542562|NCT03691493|Fulvestrant|fulvestrant|mesh-list
139542563|NCT03691493|Palbociclib|palbociclib|mesh-list
139542564|NCT03691493|Anastrozole|anastrozole|mesh-list
139542565|NCT03691493|Exemestane|exemestane|mesh-list
139542566|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542567|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139542568|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139542569|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542570|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542571|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139542572|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
139542573|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139542574|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542575|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139542576|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139542577|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139542578|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139542579|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139542580|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139542581|NCT03529422|Durvalumab|durvalumab|mesh-list
139542582|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542583|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542584|NCT03501368|Trametinib|trametinib|mesh-list
139542585|NCT03501368|Ceritinib|ceritinib|mesh-list
139542586|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542587|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139542588|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542589|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542590|NCT03493685|Irbesartan|irbesartan|mesh-list
139542591|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139542592|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139542593|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139542594|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542595|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
139542596|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542597|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542598|NCT03486197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542599|NCT03486197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542600|NCT03459846|Durvalumab|durvalumab|mesh-list
139542601|NCT03459846|Olaparib|olaparib|mesh-list
139542602|NCT03459846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542603|NCT03459846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542604|NCT03459846|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139542605|NCT03459846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542606|NCT03459846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542607|NCT03370406|Fluorouracil|fluorouracil|mesh-list
139542608|NCT03370406|Imiquimod|imiquimod|mesh-list
139542609|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
139542610|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542611|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542612|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542613|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542614|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
139542615|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542616|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139542617|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
139542618|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
139542619|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542620|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542621|NCT03362060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542622|NCT03362060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542623|NCT03298984|Cytarabine|cytarabine|mesh-list
139542624|NCT03298984|Daunorubicin|daunorubicin|mesh-list
139542625|NCT03298984|Alvocidib|alvocidib|mesh-list
139542626|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542627|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
139542628|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542629|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542630|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
139542631|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139542632|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139188676|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
139542633|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
139542634|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542635|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139542636|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139542637|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139542638|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542639|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
139542640|NCT03298984|Growth Substances|growth substances|mesh-ancestor
139542641|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139542642|NCT03248492|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139542643|NCT03248492|Immunoconjugates|immunoconjugates|mesh-ancestor
139542644|NCT03248492|Immunologic Factors|immunologic factors|mesh-ancestor
139542645|NCT03248492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542646|NCT03219528|Rifaximin|rifaximin|mesh-list
139542647|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139542648|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139542649|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139542650|NCT03149003|Bevacizumab|bevacizumab|mesh-list
139542651|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542652|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542653|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139542654|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139542655|NCT03149003|Growth Substances|growth substances|mesh-ancestor
139542656|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542657|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
139542658|NCT03148275|Trametinib|trametinib|mesh-list
139542659|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542660|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139542661|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542662|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542663|NCT03103750|Calcitriol|calcitriol|mesh-list
139542664|NCT03103750|Amphetamine|amphetamine|mesh-list
139542665|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
139542666|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139542667|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542668|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139542669|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139324325|NCT02214381|Paclitaxel|paclitaxel|mesh-list
139542670|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542671|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139542672|NCT03103750|Vitamins|vitamins|mesh-ancestor
139542673|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
139542674|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139542675|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139542676|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
139188862|NCT00458003|Phenylephrine|phenylephrine|mesh-list
139542677|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
139542678|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139542679|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
139542680|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139542681|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
139542682|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139542683|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139542684|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139542685|NCT03089606|Pembrolizumab|pembrolizumab|mesh-list
139542686|NCT03089606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542687|NCT03089606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542688|NCT03089606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542689|NCT03089606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542690|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
139542691|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139542692|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
139542693|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139542694|NCT03055377|Expectorants|expectorants|mesh-ancestor
139542695|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
139542696|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139542697|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
139542698|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542699|NCT03055377|Protective Agents|protective agents|mesh-ancestor
139542700|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542701|NCT03055377|Antidotes|antidotes|mesh-ancestor
139542702|NCT02993731|Paclitaxel|paclitaxel|mesh-list
139542703|NCT02993731|Gemcitabine|gemcitabine|mesh-list
139542704|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139542705|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542706|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
139542707|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
139542708|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
139542709|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542710|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542711|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
139542712|NCT02977052|Nivolumab|nivolumab|mesh-list
139542713|NCT02977052|Ipilimumab|ipilimumab|mesh-list
139542714|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542715|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542716|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542717|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542718|NCT02934529|Leucovorin|leucovorin|mesh-list
139542719|NCT02934529|Folic Acid|folic acid|mesh-list
139542720|NCT02934529|Bevacizumab|bevacizumab|mesh-list
139542721|NCT02934529|Cetuximab|cetuximab|mesh-list
139542722|NCT02934529|Capecitabine|capecitabine|mesh-list
139542723|NCT02934529|Fluorouracil|fluorouracil|mesh-list
139542724|NCT02934529|Irinotecan|irinotecan|mesh-list
139189045|NCT02913612|Timolol|timolol|mesh-list
139542725|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
139542726|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542727|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542728|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139542729|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139542730|NCT02934529|Growth Substances|growth substances|mesh-ancestor
139542731|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542732|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
139542733|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542734|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
139542735|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542736|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542737|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
139542738|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139542739|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139542740|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542741|NCT02934529|Antidotes|antidotes|mesh-ancestor
139542742|NCT02934529|Protective Agents|protective agents|mesh-ancestor
139542743|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
139542744|NCT02934529|Vitamins|vitamins|mesh-ancestor
139542745|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
139542746|NCT02934529|Hematinics|hematinics|mesh-ancestor
139542748|NCT02903368|Leuprolide|leuprolide|mesh-list
139542749|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
139542750|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139542751|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
139542752|NCT02903368|Hormones|hormones|mesh-ancestor
139542753|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139542754|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542755|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139542756|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542757|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139542758|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
139542759|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139542760|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139542761|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542762|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542763|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
139542764|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139542765|NCT02841839|Fluorides|fluorides|mesh-list
139542766|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
139189217|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
139542767|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
139542768|NCT02841839|Protective Agents|protective agents|mesh-ancestor
139542769|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542770|NCT02826161|Paclitaxel|paclitaxel|mesh-list
139542771|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139542772|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542773|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
139542774|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
139542775|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
139542776|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542777|NCT02799901|Nivolumab|nivolumab|mesh-list
139542778|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542779|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542780|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542781|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542782|NCT02753127|Leucovorin|leucovorin|mesh-list
139542783|NCT02753127|Bevacizumab|bevacizumab|mesh-list
139542784|NCT02753127|Fluorouracil|fluorouracil|mesh-list
139542785|NCT02753127|Irinotecan|irinotecan|mesh-list
139542786|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542787|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542788|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139542789|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139542790|NCT02753127|Growth Substances|growth substances|mesh-ancestor
139189277|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542791|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542792|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
139542793|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
139542794|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542795|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542796|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542797|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
139542798|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139542799|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139542800|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542801|NCT02753127|Antidotes|antidotes|mesh-ancestor
139542802|NCT02753127|Protective Agents|protective agents|mesh-ancestor
139542803|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
139542804|NCT02753127|Vitamins|vitamins|mesh-ancestor
139542805|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
139542806|NCT02752685|Paclitaxel|paclitaxel|mesh-list
139542807|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
139542808|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139189327|NCT03764527|Artesunate|artesunate|mesh-list
139542809|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542810|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
139542811|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
139542812|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
139542813|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542814|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542815|NCT02752685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542816|NCT02746796|Capecitabine|capecitabine|mesh-list
139542817|NCT02746796|Tegafur|tegafur|mesh-list
139542818|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
139542819|NCT02746796|Nivolumab|nivolumab|mesh-list
139542820|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542821|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
139324447|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542822|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542823|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542824|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542825|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542826|NCT02735928|Doxorubicin|doxorubicin|mesh-list
139542827|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542828|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139542829|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139542830|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139542831|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542832|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542833|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
139542834|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542835|NCT02580604|Calcium|calcium|mesh-list
139542836|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139542837|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542838|NCT02577406|Cytarabine|cytarabine|mesh-list
139542839|NCT02577406|Azacitidine|azacitidine|mesh-list
139542840|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542841|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
139542842|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542843|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542844|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
139542845|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139542846|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542847|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
139542848|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542849|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542850|NCT02527434|Durvalumab|durvalumab|mesh-list
139542851|NCT02527434|Tremelimumab|tremelimumab|mesh-list
139542852|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139542853|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542854|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542855|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
139542856|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542857|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
139542858|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139542859|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542860|NCT02320292|Rituximab|rituximab|mesh-list
139542861|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139542862|NCT02320292|Antibodies|antibodies|mesh-list
139542863|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
139542864|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139542865|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
139542866|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542867|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542868|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139542869|NCT02315534|Temozolomide|temozolomide|mesh-list
139542870|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139542871|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
139542872|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542873|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542874|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
139542875|NCT02278887|Fludarabine|fludarabine|mesh-list
139542876|NCT02278887|Ipilimumab|ipilimumab|mesh-list
139542877|NCT02278887|Interleukin-2|interleukin-2|mesh-list
139542878|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542879|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
139542880|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542881|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139542882|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139542883|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
139542884|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542885|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542886|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139542887|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542888|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542889|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139542890|NCT02278887|Analgesics|analgesics|mesh-ancestor
139542891|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
139542892|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139542893|NCT02231749|Nivolumab|nivolumab|mesh-list
139542894|NCT02231749|Ipilimumab|ipilimumab|mesh-list
139542895|NCT02231749|Sunitinib|sunitinib|mesh-list
139542896|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542897|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542898|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139542899|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542900|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139542901|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139542902|NCT02231749|Growth Substances|growth substances|mesh-ancestor
139542903|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542904|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
139542905|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139542906|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542907|NCT02188745|Letrozole|letrozole|mesh-list
139542908|NCT02188745|Anastrozole|anastrozole|mesh-list
139542909|NCT02188745|Exemestane|exemestane|mesh-list
139542910|NCT02188745|Estradiol|estradiol|mesh-list
139542911|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139542912|NCT02188745|Estrogens|estrogens|mesh-ancestor
139542913|NCT02188745|Hormones|hormones|mesh-ancestor
139542914|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139542915|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542916|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542917|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139542918|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542919|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542920|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139542921|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
139542922|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139542923|NCT02024607|Leucovorin|leucovorin|mesh-list
139542924|NCT02024607|Bevacizumab|bevacizumab|mesh-list
139542925|NCT02024607|Capecitabine|capecitabine|mesh-list
139542926|NCT02024607|Fluorouracil|fluorouracil|mesh-list
139542927|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
139542928|NCT02024607|Irinotecan|irinotecan|mesh-list
139542929|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542930|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542931|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139542932|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139542933|NCT02024607|Growth Substances|growth substances|mesh-ancestor
139542934|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542935|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
139542936|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542937|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
139542938|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542939|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139542940|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
139542941|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139542942|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139542943|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542944|NCT02024607|Antidotes|antidotes|mesh-ancestor
139542945|NCT02024607|Protective Agents|protective agents|mesh-ancestor
139542946|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
139542947|NCT02024607|Vitamins|vitamins|mesh-ancestor
139542948|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
139542949|NCT01938248|Aspirin|aspirin|mesh-list
139542950|NCT01938248|Apixaban|apixaban|mesh-list
139542951|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139542952|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139542953|NCT01938248|Analgesics|analgesics|mesh-ancestor
139542954|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
139542955|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139542956|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542957|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139542958|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139542959|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139542960|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139542961|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542962|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139542963|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139542964|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139542965|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
139542966|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139542967|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
139542968|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139542969|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
139542970|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
139542971|NCT01776307|Capecitabine|capecitabine|mesh-list
139542972|NCT01776307|Cetuximab|cetuximab|mesh-list
139542973|NCT01776307|Panitumumab|panitumumab|mesh-list
139542974|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139542975|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
139542976|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542977|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542978|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139542979|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
139542980|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139542981|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
139542982|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
139542983|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139542984|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139542985|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139542986|NCT01622322|Analgesics|analgesics|mesh-ancestor
139189997|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
139542987|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
139542988|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139542989|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139542990|NCT01325441|Paclitaxel|paclitaxel|mesh-list
139542991|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139542992|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139542993|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
139542994|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
139542995|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
139542996|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139542997|NCT00742807|Alfentanil|alfentanil|mesh-list
139542998|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139542999|NCT00742807|Narcotics|narcotics|mesh-ancestor
139543000|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543001|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543002|NCT00742807|Analgesics|analgesics|mesh-ancestor
139543003|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
139543004|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543005|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139543006|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
139543007|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
139543008|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139543009|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
139190033|NCT04631536|Hematinics|hematinics|mesh-ancestor
139543010|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543011|NCT05803083|Hyaluronic Acid|hyaluronic acid|mesh-list
139543012|NCT05803083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139543013|NCT05803083|Immunologic Factors|immunologic factors|mesh-ancestor
139543014|NCT05803083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543015|NCT05803083|Viscosupplements|viscosupplements|mesh-ancestor
139543016|NCT05803083|Protective Agents|protective agents|mesh-ancestor
139543017|NCT05783648|Tranexamic Acid|tranexamic acid|mesh-list
139543018|NCT05783648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139543019|NCT05783648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139543020|NCT05783648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543021|NCT05783648|Hemostatics|hemostatics|mesh-ancestor
139543022|NCT05783648|Coagulants|coagulants|mesh-ancestor
139543023|NCT05761951|Pembrolizumab|pembrolizumab|mesh-list
139543024|NCT05761951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543025|NCT05761951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190088|NCT04447378|PENTA|penta|mesh-list
139543026|NCT05761951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543027|NCT05761951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543028|NCT05761405|Ceftriaxone|ceftriaxone|mesh-list
139543029|NCT05761405|Amikacin|amikacin|mesh-list
139543030|NCT05761405|Mannitol|mannitol|mesh-list
139543031|NCT05761405|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139543032|NCT05761405|Diuretics|diuretics|mesh-ancestor
139543033|NCT05761405|Natriuretic Agents|natriuretic agents|mesh-ancestor
139543034|NCT05761405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543035|NCT05761405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139543036|NCT05761405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543037|NCT05739474|Vaccines|vaccines|mesh-list
139543038|NCT05739474|Immunologic Factors|immunologic factors|mesh-ancestor
139543039|NCT05739474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543040|NCT05736562|Vitamins|vitamins|mesh-list
139543041|NCT05736562|Micronutrients|micronutrients|mesh-ancestor
139543042|NCT05736562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543043|NCT05690698|Haloperidol|haloperidol|mesh-list
139543044|NCT05690698|Haloperidol decanoate|haloperidol decanoate|mesh-list
139543045|NCT05690698|Antiemetics|antiemetics|mesh-ancestor
139543046|NCT05690698|Autonomic Agents|autonomic agents|mesh-ancestor
139543047|NCT05690698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543048|NCT05690698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190158|NCT03755947|Venetoclax|venetoclax|mesh-list
139543049|NCT05690698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139543050|NCT05690698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139543051|NCT05690698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139543052|NCT05690698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543053|NCT05690698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139543054|NCT05690698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139543055|NCT05690698|Dopamine Agents|dopamine agents|mesh-ancestor
139543056|NCT05690698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139543057|NCT05690698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543058|NCT05690698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139543059|NCT05636189|Anesthetics|anesthetics|mesh-list
139190195|NCT03256695|Albuterol|albuterol|mesh-list
139543060|NCT05636189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543061|NCT05636189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543062|NCT05626998|Dexmedetomidine|dexmedetomidine|mesh-list
139543063|NCT05626998|Gabapentin|gabapentin|mesh-list
139543064|NCT05626998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139543065|NCT05626998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543066|NCT05626998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543067|NCT05626998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139543068|NCT05626998|Analgesics|analgesics|mesh-ancestor
139543069|NCT05626998|Sensory System Agents|sensory system agents|mesh-ancestor
139543070|NCT05626998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543071|NCT05626998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139543072|NCT05626998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139543073|NCT05626998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139543074|NCT05626998|Adrenergic Agents|adrenergic agents|mesh-ancestor
139543075|NCT05626998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139543076|NCT05626998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543077|NCT05626998|Anticonvulsants|anticonvulsants|mesh-ancestor
139543078|NCT05626998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139543079|NCT05626998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139543080|NCT05626998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139543081|NCT05626998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139543082|NCT05626998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139543083|NCT05626998|Antimanic Agents|antimanic agents|mesh-ancestor
139543084|NCT05597839|Nivolumab|nivolumab|mesh-list
139543085|NCT05597839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543086|NCT05597839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543087|NCT05597839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543088|NCT05597839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543089|NCT05582174|Esomeprazole|esomeprazole|mesh-list
139543090|NCT05582174|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139543091|NCT05582174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139543092|NCT05582174|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139543093|NCT05582174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543094|NCT05582174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543095|NCT05578664|Pembrolizumab|pembrolizumab|mesh-list
139543096|NCT05578664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543097|NCT05578664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190379|NCT05239390|Hormones|hormones|mesh-ancestor
139543098|NCT05578664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543099|NCT05578664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543100|NCT05555901|Bevacizumab|bevacizumab|mesh-list
139543101|NCT05555901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543102|NCT05555901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543103|NCT05555901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139543104|NCT05555901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139543105|NCT05555901|Growth Substances|growth substances|mesh-ancestor
139543106|NCT05555901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543107|NCT05555901|Growth Inhibitors|growth inhibitors|mesh-ancestor
139543108|NCT05521828|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139543109|NCT05521828|Dydrogesterone|dydrogesterone|mesh-list
139543110|NCT05521828|Hormones|hormones|mesh-ancestor
139543111|NCT05521828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139543112|NCT05521828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543113|NCT05521828|Progestins|progestins|mesh-ancestor
139543114|NCT05447026|Anti-Infective Agents|anti-infective agents|mesh-list
139543115|NCT05447026|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139543116|NCT05418972|Nivolumab|nivolumab|mesh-list
139543117|NCT05418972|Relatlimab|relatlimab|mesh-list
139543118|NCT05418972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543119|NCT05418972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543120|NCT05418972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543121|NCT05418972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543122|NCT05399173|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139543123|NCT05399173|Hemostatics|hemostatics|mesh-ancestor
139543124|NCT05399173|Coagulants|coagulants|mesh-ancestor
139543125|NCT05399173|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139543126|NCT05399173|Natriuretic Agents|natriuretic agents|mesh-ancestor
139543127|NCT05399173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543129|NCT05388877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543130|NCT05388877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139543131|NCT05388877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190488|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139543132|NCT05388877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543133|NCT05371899|Chiauranib|chiauranib|mesh-list
139543134|NCT05371899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543135|NCT05371899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139543136|NCT05371899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543137|NCT05371899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543138|NCT05322707|Budesonide|budesonide|mesh-list
139543139|NCT05322707|Formoterol Fumarate|formoterol fumarate|mesh-list
139543140|NCT05322707|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139543141|NCT05322707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139543142|NCT05322707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139543143|NCT05322707|Autonomic Agents|autonomic agents|mesh-ancestor
139543144|NCT05322707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543145|NCT05322707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543146|NCT05322707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139543147|NCT05322707|Respiratory System Agents|respiratory system agents|mesh-ancestor
139543148|NCT05322707|Glucocorticoids|glucocorticoids|mesh-ancestor
139543149|NCT05322707|Hormones|hormones|mesh-ancestor
139543150|NCT05322707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139543151|NCT05322707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139543152|NCT05322707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139543153|NCT05322707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139543154|NCT05322707|Adrenergic Agents|adrenergic agents|mesh-ancestor
139543155|NCT05322707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139543156|NCT05322707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543157|NCT05316233|Hyaluronic Acid|hyaluronic acid|mesh-list
139543158|NCT05316233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139543159|NCT05316233|Immunologic Factors|immunologic factors|mesh-ancestor
139543160|NCT05316233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543161|NCT05316233|Viscosupplements|viscosupplements|mesh-ancestor
139543162|NCT05316233|Protective Agents|protective agents|mesh-ancestor
139543163|NCT05251636|Aflibercept|aflibercept|mesh-list
139543164|NCT05251636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139190633|NCT02813200|Hormones|hormones|mesh-ancestor
139543165|NCT05251636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139543166|NCT05251636|Growth Substances|growth substances|mesh-ancestor
139543167|NCT05251636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543168|NCT05251636|Growth Inhibitors|growth inhibitors|mesh-ancestor
139543169|NCT05251636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543170|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139543171|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
139543172|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543173|NCT05191797|Atezolizumab|atezolizumab|mesh-list
139543174|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
139543175|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139543176|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
139543177|NCT05191797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543178|NCT05191797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190679|NCT01481272|Antidotes|antidotes|mesh-ancestor
139543179|NCT05191797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543180|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543181|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
139543182|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543183|NCT05163522|Midazolam|midazolam|mesh-list
139543184|NCT05163522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139543185|NCT05163522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139543186|NCT05163522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543187|NCT05163522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190726|NCT03171480|Isosorbide|isosorbide|mesh-list
139543188|NCT05163522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139543189|NCT05163522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139543190|NCT05163522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139543191|NCT05163522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139543192|NCT05163522|Anesthetics, General|anesthetics, general|mesh-ancestor
139543193|NCT05163522|Anesthetics|anesthetics|mesh-ancestor
139543194|NCT05163522|GABA Modulators|gaba modulators|mesh-ancestor
139543195|NCT05163522|GABA Agents|gaba agents|mesh-ancestor
139543196|NCT05163522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139543197|NCT05163522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543198|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
139543199|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139543200|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
139543201|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543202|NCT05142735|Expectorants|expectorants|mesh-ancestor
139190795|NCT04732260|Letermovir|letermovir|mesh-list
139543203|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
139543204|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139543205|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
139543206|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543207|NCT05142735|Protective Agents|protective agents|mesh-ancestor
139543208|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543209|NCT05142735|Antidotes|antidotes|mesh-ancestor
139543210|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
139543211|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139543212|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543213|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543214|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139543215|NCT05134363|Analgesics|analgesics|mesh-ancestor
139543216|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
139543217|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543218|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139543219|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139543220|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139543221|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
139543222|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139543223|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543224|NCT05020899|Nicotine|nicotine|mesh-list
139543225|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139543226|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
139543227|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543228|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543229|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139543230|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139543231|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
139543232|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139543233|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543234|NCT04954287|Vaccines|vaccines|mesh-list
139543235|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
139543236|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543237|NCT04934748|Phenylephrine|phenylephrine|mesh-list
139543238|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
139543239|NCT04934748|Norepinephrine|norepinephrine|mesh-list
139543240|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139543241|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
139543242|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
139543243|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543244|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543245|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
139543246|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139543247|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
139543248|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
139543249|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139543250|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139543251|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139543252|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
139543253|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139543254|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543255|NCT04934748|Protective Agents|protective agents|mesh-ancestor
139543256|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139543257|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543258|NCT04830813|Chiauranib|chiauranib|mesh-list
139543259|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543260|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139543261|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543262|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543263|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
139543264|NCT04788108|Progestins|progestins|mesh-ancestor
139543265|NCT04788108|Hormones|hormones|mesh-ancestor
139543266|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139543267|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543268|NCT04741438|Nivolumab|nivolumab|mesh-list
139543269|NCT04741438|Ipilimumab|ipilimumab|mesh-list
139543270|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543271|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543272|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543273|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543274|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139543275|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139543276|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139543277|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543278|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543279|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139543280|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139191025|NCT03077438|Vaccines|vaccines|mesh-list
139543281|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543282|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
139543283|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139543284|NCT04648540|Acetaminophen|acetaminophen|mesh-list
139543285|NCT04648540|Celecoxib|celecoxib|mesh-list
139543286|NCT04648540|Ketorolac|ketorolac|mesh-list
139543287|NCT04648540|Lidocaine|lidocaine|mesh-list
139543288|NCT04648540|Pregabalin|pregabalin|mesh-list
139543289|NCT04648540|Fentanyl|fentanyl|mesh-list
139543290|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
139543291|NCT04648540|Morphine|morphine|mesh-list
139543292|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
139543293|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
139543294|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543295|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543296|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
139543297|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543298|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139543299|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139543300|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139543301|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139543302|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543303|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139543304|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139543305|NCT04648540|Analgesics|analgesics|mesh-ancestor
139543306|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139543307|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139543308|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139543309|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
139543310|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139543311|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139543312|NCT04648540|Narcotics|narcotics|mesh-ancestor
139543313|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139543314|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139543315|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
139543316|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
139543317|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
139543318|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139543319|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139543320|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139543321|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139543322|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139543323|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139543324|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139543325|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139543326|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139543327|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139543328|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543329|NCT04645823|Lidocaine|lidocaine|mesh-list
139543330|NCT04645823|Fentanyl|fentanyl|mesh-list
139543331|NCT04645823|Citric Acid|citric acid|mesh-list
139543332|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
139543333|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
139543334|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
139543335|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543336|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543337|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
139543338|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543339|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139191233|NCT03075410|GSK656|gsk656|mesh-list
139543340|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139543341|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139543342|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139543343|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543344|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139543345|NCT04645823|Narcotics|narcotics|mesh-ancestor
139543346|NCT04645823|Analgesics|analgesics|mesh-ancestor
139543347|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139543348|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139543349|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
139543350|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
139543351|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139543352|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
139543353|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
139543354|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
139543356|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543357|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543358|NCT04594382|Analgesics|analgesics|mesh-ancestor
139543359|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
139543360|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543361|NCT04558112|Levodopa|levodopa|mesh-list
139543362|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139543363|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139543364|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
139543365|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191318|NCT01378286|Chloroquine|chloroquine|mesh-list
139543366|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543367|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543368|NCT04546230|Anesthetics|anesthetics|mesh-list
139543369|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543370|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543371|NCT04473482|Ethanol|ethanol|mesh-list
139543372|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139543373|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543374|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191369|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139543375|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543376|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
139543377|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139543378|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139543379|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139543380|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139543381|NCT04440735|Atezolizumab|atezolizumab|mesh-list
139543382|NCT04440735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543383|NCT04440735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543384|NCT04440735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543385|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543386|NCT04422392|Paclitaxel|paclitaxel|mesh-list
139543387|NCT04422392|Carboplatin|carboplatin|mesh-list
139543388|NCT04422392|Pemetrexed|pemetrexed|mesh-list
139543389|NCT04422392|Antibodies|antibodies|mesh-list
139191434|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139543390|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139543391|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543392|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
139543393|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
139543394|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
139543395|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543396|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
139543397|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543398|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543399|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139543400|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139543401|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139543402|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
139543403|NCT04414761|Cetrorelix|cetrorelix|mesh-list
139543404|NCT04414761|Progesterone|progesterone|mesh-list
139543405|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
139543406|NCT04414761|Ganirelix|ganirelix|mesh-list
139543407|NCT04414761|Progestins|progestins|mesh-ancestor
139543408|NCT04414761|Hormones|hormones|mesh-ancestor
139543409|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139543410|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543411|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139543412|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139543413|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139543414|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
139543415|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139543416|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139543417|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139543418|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139543419|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139543420|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543421|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
139543422|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139543423|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
139543424|NCT04400994|Rituximab|rituximab|mesh-list
139543425|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543426|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543427|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
139543429|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139543430|NCT04367688|Tenofovir|tenofovir|mesh-list
139543431|NCT04367688|Emtricitabine|emtricitabine|mesh-list
139543432|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
139543433|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543434|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139543435|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139543436|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543437|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543438|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139543439|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139543440|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
139543441|NCT04318678|Rituximab|rituximab|mesh-list
139543442|NCT04318678|Fludarabine|fludarabine|mesh-list
139543443|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139543444|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
139543445|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543446|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139543447|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139543448|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
139543449|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543450|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543451|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139543452|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543453|NCT04307238|Anesthetics|anesthetics|mesh-list
139543454|NCT04307238|Propofol|propofol|mesh-list
139543455|NCT04307238|Sevoflurane|sevoflurane|mesh-list
139543456|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543457|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543458|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139543459|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139543460|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
139543461|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139543462|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139543463|NCT04224571|Rituximab|rituximab|mesh-list
139543464|NCT04224571|Bortezomib|bortezomib|mesh-list
139543465|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543466|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543467|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
139543468|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543469|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139543470|NCT04222062|Carmustine|carmustine|mesh-list
139543471|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139543472|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
139543473|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543474|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543475|NCT04186598|Nifedipine|nifedipine|mesh-list
139543476|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139543477|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139543478|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543479|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139543480|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543481|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
139543482|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
139543483|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139543484|NCT04103398|Sorafenib|sorafenib|mesh-list
139543485|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
139543486|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543487|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139543488|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543489|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543490|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139543491|NCT04103398|Estrogens|estrogens|mesh-ancestor
139543492|NCT04103398|Hormones|hormones|mesh-ancestor
139543493|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139543494|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543495|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139543496|NCT04067726|Vitamin D|vitamin d|mesh-list
139543497|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
139543498|NCT04067726|Denosumab|denosumab|mesh-list
139543499|NCT04067726|Calcium|calcium|mesh-list
139543500|NCT04067726|Vitamins|vitamins|mesh-ancestor
139543501|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
139543502|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543503|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139543504|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139543505|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139543506|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
139543507|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139543508|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
139543509|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139543510|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543511|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139543512|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139543513|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543515|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543516|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543517|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543518|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543519|NCT04042740|Ribavirin|ribavirin|mesh-list
139543520|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
139191609|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
139543521|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543522|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
139543523|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543524|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
139543525|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543526|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543527|NCT04007744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543528|NCT04007744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543529|NCT03934814|Rituximab|rituximab|mesh-list
139543530|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
139543531|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543532|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543533|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
139543534|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543535|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139543536|NCT03934814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543537|NCT03934814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543538|NCT03919799|Belumosudil|belumosudil|mesh-list
139543539|NCT03919799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139543540|NCT03919799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543541|NCT03919799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543542|NCT03866837|Micronutrients|micronutrients|mesh-list
139543543|NCT03866837|Trace Elements|trace elements|mesh-list
139543544|NCT03866837|Lactoferrin|lactoferrin|mesh-list
139543545|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543546|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543547|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
139543548|NCT03809624|Antibodies|antibodies|mesh-list
139543549|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
139543550|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191723|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139543551|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543552|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543553|NCT03809624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543554|NCT03809624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543555|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139543556|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139543557|NCT03691649|Timolol|timolol|mesh-list
139543558|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139543559|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139543560|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191783|NCT00882050|Exenatide|exenatide|mesh-list
139543561|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139543562|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139543563|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
139543564|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139543565|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543566|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139543567|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139543568|NCT03689946|Listerine|listerine|mesh-list
139543569|NCT03689946|Evolocumab|evolocumab|mesh-list
139543570|NCT03689946|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139543571|NCT03689946|Fluorides|fluorides|mesh-list
139543572|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
139543573|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
139543574|NCT03689946|Protective Agents|protective agents|mesh-ancestor
139543575|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191850|NCT04707534|Hormones|hormones|mesh-ancestor
139543576|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139543577|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543578|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139543579|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139543580|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
139543581|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543582|NCT03689946|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139543583|NCT03689946|Protease Inhibitors|protease inhibitors|mesh-ancestor
139543584|NCT03689946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543585|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139543586|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
139543587|NCT03655002|Nivolumab|nivolumab|mesh-list
139543588|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139543589|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
139543590|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543591|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139543592|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139543593|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
139543594|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543595|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543596|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139543597|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543598|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543599|NCT03606980|Dexamethasone|dexamethasone|mesh-list
139543600|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
139543601|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139543602|NCT03606980|BB 1101|bb 1101|mesh-list
139543603|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139543604|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
139543605|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
139543606|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543607|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543608|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139543609|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
139543610|NCT03606980|Hormones|hormones|mesh-ancestor
139543611|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139543612|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139543613|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543614|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
139191956|NCT01148147|Adenosine|adenosine|mesh-list
139543615|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543616|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543617|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
139543618|NCT03596424|Ketamine|ketamine|mesh-list
139543619|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139543620|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543621|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543622|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139543623|NCT03596424|Analgesics|analgesics|mesh-ancestor
139543624|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
139543625|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543626|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139543627|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139543628|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139543629|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
139543630|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139543631|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543632|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139543633|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139543634|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
139543635|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
139543636|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139543637|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139543638|NCT03531918|Cytarabine|cytarabine|mesh-list
139543639|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
139543640|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
139543641|NCT03531918|Cladribine|cladribine|mesh-list
139543642|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
139543643|NCT03531918|Calicheamicins|calicheamicins|mesh-list
139543644|NCT03531918|Lenograstim|lenograstim|mesh-list
139543645|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139543646|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
139543647|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543648|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543649|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
139543650|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543651|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139325271|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
139543652|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
139543653|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543655|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
139543656|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543657|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139543658|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139543659|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543660|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139543661|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543662|NCT03531918|Immunotoxins|immunotoxins|mesh-ancestor
139543663|NCT03531918|Immunoconjugates|immunoconjugates|mesh-ancestor
139543664|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139543665|NCT03531645|Fulvestrant|fulvestrant|mesh-list
139543666|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139543667|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543668|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139543669|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139543670|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
139543671|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139543672|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543673|NCT03499704|Metformin|metformin|mesh-list
139543674|NCT03499704|Pioglitazone|pioglitazone|mesh-list
139543675|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
139543676|NCT03499704|Alogliptin|alogliptin|mesh-list
139543677|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139543678|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543679|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139543680|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543681|NCT03499704|Incretins|incretins|mesh-ancestor
139543682|NCT03499704|Hormones|hormones|mesh-ancestor
139543683|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139543684|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139543685|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
139543686|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543687|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
139543688|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543689|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543690|NCT03498612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543691|NCT03498612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543692|NCT03362515|Furosemide|furosemide|mesh-list
139543693|NCT03362515|Diuretics|diuretics|mesh-ancestor
139543694|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
139543695|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543696|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139543697|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139543698|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543699|NCT03292926|Dexamethasone|dexamethasone|mesh-list
139543700|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
139543701|NCT03292926|Bupivacaine|bupivacaine|mesh-list
139543702|NCT03292926|BB 1101|bb 1101|mesh-list
139543703|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139543704|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
139543705|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
139543706|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543707|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543708|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139543709|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
139543710|NCT03292926|Hormones|hormones|mesh-ancestor
139543711|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139543712|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139543713|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543714|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
139543715|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543716|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543717|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
139543718|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
139543719|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543720|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
139543721|NCT03288324|Tofacitinib|tofacitinib|mesh-list
139543722|NCT03288324|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139543723|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139543724|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325358|NCT00702650|Hormones|hormones|mesh-ancestor
139543725|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543726|NCT03245151|Everolimus|everolimus|mesh-list
139543727|NCT03245151|Lenvatinib|lenvatinib|mesh-list
139543728|NCT03245151|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139543729|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139543730|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543731|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543732|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139543733|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
139543734|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543735|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543736|NCT03216343|Chiauranib|chiauranib|mesh-list
139543737|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543738|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139543739|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543740|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543741|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
139543742|NCT03096275|Hormones|hormones|mesh-ancestor
139543743|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139543744|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543745|NCT03070223|Pitavastatin|pitavastatin|mesh-list
139543746|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139543747|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139543748|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139543749|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
139543750|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543751|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543752|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139543753|NCT03012321|Prednisone|prednisone|mesh-list
139543754|NCT03012321|Olaparib|olaparib|mesh-list
139543755|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
139543756|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139543757|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
139543758|NCT03012321|Hormones|hormones|mesh-ancestor
139543759|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139543760|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543761|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139543762|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543763|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139543764|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543765|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543766|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139543767|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
139543768|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139543769|NCT02985593|KHK4083|khk4083|mesh-list
139543770|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
139543771|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
139543772|NCT02858921|Trametinib|trametinib|mesh-list
139543773|NCT02858921|Dabrafenib|dabrafenib|mesh-list
139543774|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543775|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543776|NCT02858921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139543777|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543778|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139543779|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543780|NCT02645149|Trametinib|trametinib|mesh-list
139543781|NCT02645149|Ceritinib|ceritinib|mesh-list
139543782|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543783|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139543784|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543785|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543786|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139543787|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543788|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543789|NCT02588651|Immunotoxins|immunotoxins|mesh-ancestor
139543790|NCT02588651|Immunoconjugates|immunoconjugates|mesh-ancestor
139543791|NCT02588651|Immunologic Factors|immunologic factors|mesh-ancestor
139543792|NCT02588651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543793|NCT02523859|Propofol|propofol|mesh-list
139543794|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139543795|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139543796|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543797|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139543798|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
139543799|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
139543800|NCT02370329|Interferons|interferons|mesh-list
139543801|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
139543802|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
139543803|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139543804|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139543805|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543806|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
139543807|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543808|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
139543809|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543810|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
139543811|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139543812|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543813|NCT02227199|Carboplatin|carboplatin|mesh-list
139543814|NCT02227199|Etoposide|etoposide|mesh-list
139543815|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
139543816|NCT02227199|Ifosfamide|ifosfamide|mesh-list
139543817|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
139543818|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139543819|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
139543820|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139543821|NCT02227199|Antibodies|antibodies|mesh-list
139543822|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
139543823|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139543824|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
139543825|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
139543826|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543827|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543828|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139543829|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139543830|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139543831|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543832|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543833|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139543834|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
139543835|NCT02227199|Immunotoxins|immunotoxins|mesh-ancestor
139543836|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
139543837|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
139543838|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
139543839|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
139543840|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
139543841|NCT02087865|Donepezil|donepezil|mesh-list
139192508|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
139543842|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139543843|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543844|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543845|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
139543846|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139543847|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543848|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
139543849|NCT01980823|Metformin|metformin|mesh-list
139543850|NCT01980823|Atorvastatin|atorvastatin|mesh-list
139543851|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139543852|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543853|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139543854|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139543855|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
139543856|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543857|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139543858|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139543859|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543860|NCT01972347|Trametinib|trametinib|mesh-list
139543861|NCT01972347|Dabrafenib|dabrafenib|mesh-list
139543862|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543863|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139543864|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543865|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543866|NCT01889992|Sirolimus|sirolimus|mesh-list
139543867|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139543868|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543869|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139543870|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543871|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
139543872|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139543873|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
139543874|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543875|NCT01858740|Methotrexate|methotrexate|mesh-list
139543876|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
139543878|NCT01858740|Thiotepa|thiotepa|mesh-list
139543879|NCT01858740|Tacrolimus|tacrolimus|mesh-list
139543880|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139543881|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
139543882|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139543883|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543884|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139543885|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
139543886|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543887|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543888|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
139543889|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543890|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139543891|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139543892|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
139543893|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139543894|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139543895|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139543896|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139543897|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
139543898|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139543899|NCT01839734|Lubiprostone|lubiprostone|mesh-list
139543900|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139543901|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139543902|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543903|NCT01682083|Trametinib|trametinib|mesh-list
139543904|NCT01682083|Dabrafenib|dabrafenib|mesh-list
139543905|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543906|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139543907|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543908|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543909|NCT01511068|Sargramostim|sargramostim|mesh-list
139543910|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
139543911|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543912|NCT01180790|Interferons|interferons|mesh-list
139543913|NCT01180790|Ribavirin|ribavirin|mesh-list
139543914|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
139543915|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
139543916|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139543917|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543918|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
139543919|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543920|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
139543921|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543922|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
139543923|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543924|NCT00721526|Disulfiram|disulfiram|mesh-list
139543925|NCT00721526|Lorazepam|lorazepam|mesh-list
139543926|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
139543927|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
139543928|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
139543929|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543930|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543931|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139543932|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139543933|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139192706|NCT01152047|Oxytocin|oxytocin|mesh-list
139543934|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139543935|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139543936|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139543937|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
139543938|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
139543939|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139543940|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543941|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139543942|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139543943|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543944|NCT00679042|Exenatide|exenatide|mesh-list
139543945|NCT00679042|Sirolimus|sirolimus|mesh-list
139543946|NCT00679042|Etanercept|etanercept|mesh-list
139543947|NCT00679042|Tacrolimus|tacrolimus|mesh-list
139543948|NCT00679042|Basiliximab|basiliximab|mesh-list
139543949|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139543950|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
139543951|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543952|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139543953|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543954|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543955|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139543956|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543957|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139543958|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139543959|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
139543960|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139543961|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139543963|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
139543964|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139543965|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139543966|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139543967|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139543968|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139543969|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139543970|NCT00679042|Incretins|incretins|mesh-ancestor
139543971|NCT00679042|Hormones|hormones|mesh-ancestor
139543972|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139543973|NCT00505063|Vaccines|vaccines|mesh-list
139543974|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139543975|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
139543976|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139543977|NCT00350272|Tenofovir|tenofovir|mesh-list
139543978|NCT00350272|Lamivudine|lamivudine|mesh-list
139543979|NCT00350272|Efavirenz|efavirenz|mesh-list
139543980|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
139543981|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
139543982|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139543983|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139543984|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139543985|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139543986|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139543987|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139543988|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139543989|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139543990|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139543991|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139543992|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139543993|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139543994|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139543995|NCT02020694|Vitamin D|vitamin d|mesh-list
139543996|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
139543997|NCT02020694|Cholecalciferol|cholecalciferol|mesh-list
139543998|NCT02020694|Vitamins|vitamins|mesh-list
139543999|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
139544000|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544001|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139544002|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139544003|NCT02019875|Clarithromycin|clarithromycin|mesh-list
139544004|NCT02019875|Rifampin|rifampin|mesh-list
139544005|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139544006|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544007|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139544008|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544009|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544010|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139544011|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139544012|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139544013|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
139544014|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
139544015|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139544016|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139544017|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139544018|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139544019|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139544020|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139544021|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139544022|NCT01907009|Melphalan|melphalan|mesh-list
139544023|NCT01907009|Lenograstim|lenograstim|mesh-list
139544024|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139544025|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
139325642|NCT02264847|Enclomiphene|enclomiphene|mesh-list
139544026|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544027|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544028|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139544029|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544030|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
139544031|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544032|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139544033|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
139544034|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544035|NCT01686126|Metformin|metformin|mesh-list
139544036|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
139544037|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139544038|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544039|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139544040|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
139544041|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139544042|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139544043|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139544044|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139544045|NCT01531582|Minocycline|minocycline|mesh-list
139544046|NCT01531582|Tetracycline|tetracycline|mesh-list
139544047|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139544048|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544049|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139544050|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544051|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544052|NCT01512888|Busulfan|busulfan|mesh-list
139544053|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
139544054|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544055|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544056|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
139544057|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544058|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139544059|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544060|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139544061|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
139544062|NCT01493453|Fludarabine|fludarabine|mesh-list
139544063|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544064|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
139544065|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544066|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139544067|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139544068|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
139544069|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544070|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544071|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139544072|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139544073|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544074|NCT00460486|Formaldehyde|formaldehyde|mesh-list
139544075|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
139544076|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544077|NCT00378105|Dexamethasone|dexamethasone|mesh-list
139544078|NCT00378105|Lenalidomide|lenalidomide|mesh-list
139544079|NCT00378105|Bortezomib|bortezomib|mesh-list
139544080|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139544081|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
139544082|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
139544083|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544084|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544085|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139544086|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
139544087|NCT00378105|Hormones|hormones|mesh-ancestor
139544088|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139544089|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139544090|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544091|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
139544092|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139544093|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139544094|NCT00378105|Growth Substances|growth substances|mesh-ancestor
139544095|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
139544096|NCT00139477|Metformin|metformin|mesh-list
139544097|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139544098|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544099|NCT00004935|Trastuzumab|trastuzumab|mesh-list
139544100|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544101|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544103|NCT00119158|Xhance|xhance|mesh-list
139544104|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
139544105|NCT00119158|Tacrolimus|tacrolimus|mesh-list
139544106|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139544107|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139544108|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
139544109|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544110|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544111|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139544112|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
139544113|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
139544114|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139544115|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139544116|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139544117|NCT00119158|Analgesics|analgesics|mesh-ancestor
139193186|NCT03884465|Treprostinil|treprostinil|mesh-list
139544118|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
139544119|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139544120|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544121|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
139544122|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139544123|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544124|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544125|NCT00119392|Cyclosporine|cyclosporine|mesh-list
139544126|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
139544127|NCT00119392|Rituximab|rituximab|mesh-list
139544128|NCT00119392|Fludarabine|fludarabine|mesh-list
139544129|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
139544130|NCT00119392|Cyclosporins|cyclosporins|mesh-list
139544131|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139544132|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544133|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544134|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
139544135|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544136|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139193247|NCT01262729|Xenon|xenon|mesh-list
139544137|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139544138|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
139544139|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544140|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544141|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544142|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
139544143|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544144|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
139544145|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139544146|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139544147|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139544148|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
139544149|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139544150|NCT00218062|Modafinil|modafinil|mesh-list
139544151|NCT00218062|Amphetamine|amphetamine|mesh-list
139544152|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
139544153|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139544154|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544155|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139544156|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139193295|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
139544157|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139544158|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544159|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
139544160|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
139544161|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544162|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
139544163|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544164|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
139544165|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139544166|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139544167|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139544168|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139544169|NCT00121186|Methotrexate|methotrexate|mesh-list
139544170|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
139544171|NCT00121186|Fludarabine|fludarabine|mesh-list
139544172|NCT00121186|Melphalan|melphalan|mesh-list
139544173|NCT00121186|Tacrolimus|tacrolimus|mesh-list
139544174|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139544175|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
139544176|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139544177|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544178|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139544179|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
139544180|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544181|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544182|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
139544183|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544184|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139544185|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544186|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
139544187|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139544188|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139544189|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139544190|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139544191|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
139544192|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139544193|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
139544195|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139544196|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139544197|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544198|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139544199|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
139544200|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139544201|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544202|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544203|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544204|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
139544205|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544206|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
139544207|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544208|NCT00053014|Cyclosporine|cyclosporine|mesh-list
139544209|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
139544210|NCT00053014|Fludarabine|fludarabine|mesh-list
139544211|NCT00053014|Cyclosporins|cyclosporins|mesh-list
139544212|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544213|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544214|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544215|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
139544216|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544217|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544218|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
139544219|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544220|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
139544221|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139544222|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139544223|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139544224|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139544225|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
139544226|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139544227|NCT00123604|Metoprolol|metoprolol|mesh-list
139544228|NCT00123604|Carvedilol|carvedilol|mesh-list
139544229|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139544230|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139544231|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
139544232|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
139544233|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544234|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544235|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139544236|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139544237|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139544238|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
139544239|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544240|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544241|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
139544242|NCT00123604|Protective Agents|protective agents|mesh-ancestor
139544243|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139544244|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139544245|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139544246|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
139544247|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139544248|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139544249|NCT00221338|Gabapentin|gabapentin|mesh-list
139544250|NCT00221338|Analgesics|analgesics|mesh-ancestor
139325867|NCT03130842|Alprazolam|alprazolam|mesh-list
139544251|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
139544252|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544253|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544254|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
139544255|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139544256|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139544257|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139544258|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139544259|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139544260|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139544261|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544262|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544263|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
139544265|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139544266|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544267|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139544268|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544269|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
139544270|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544271|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
139544272|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544273|NCT00053482|Vaccines|vaccines|mesh-list
139544274|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
139544275|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544276|NCT00130780|Bevacizumab|bevacizumab|mesh-list
139544277|NCT00130780|Docetaxel|docetaxel|mesh-list
139544278|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544279|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544280|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139544281|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139544282|NCT00130780|Growth Substances|growth substances|mesh-ancestor
139544283|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544284|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
139544285|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
139544286|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
139544287|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
139544288|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544289|NCT00225784|Gemcitabine|gemcitabine|mesh-list
139544290|NCT00225784|Cetuximab|cetuximab|mesh-list
139544291|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139544292|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
139193682|NCT01163435|Levofloxacin|levofloxacin|mesh-list
139544293|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544294|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544295|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544296|NCT02092168|Opicapone|opicapone|mesh-list
139544297|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139544298|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544299|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544300|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139544301|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139544302|NCT00133978|Selenium|selenium|mesh-list
139544303|NCT00133978|Antioxidants|antioxidants|mesh-list
139544304|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544305|NCT00133978|Protective Agents|protective agents|mesh-ancestor
139544306|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544307|NCT00133978|Trace Elements|trace elements|mesh-ancestor
139544308|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
139544309|NCT01897324|Hormones|hormones|mesh-list
139544310|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139544311|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544312|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
139544313|NCT00254410|Rituximab|rituximab|mesh-list
139544314|NCT00254410|Fludarabine|fludarabine|mesh-list
139544315|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
139544316|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544317|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
139544318|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544319|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139544320|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139544321|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
139544322|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544323|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544324|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139544325|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544326|NCT00254410|Analgesics|analgesics|mesh-ancestor
139544327|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
139544328|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544329|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139544330|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139544331|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544332|NCT00254488|Valproic Acid|valproic acid|mesh-list
139544333|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139544334|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544335|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544336|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
139544337|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139544338|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139544339|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544340|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
139544341|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
139544342|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544343|NCT01899118|Capecitabine|capecitabine|mesh-list
139544344|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
139544345|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
139544346|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139544347|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
139544348|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544349|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544350|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544351|NCT00231868|Paclitaxel|paclitaxel|mesh-list
139544352|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139544353|NCT00231868|Carboplatin|carboplatin|mesh-list
139544354|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139544355|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544356|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
139544357|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
139544358|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
139544359|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544360|NCT00257686|Pravastatin|pravastatin|mesh-list
139544361|NCT00257686|Pitavastatin|pitavastatin|mesh-list
139544362|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139544363|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139544364|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
139544365|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544366|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139544367|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139544368|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544369|NCT01469013|Methotrexate|methotrexate|mesh-list
139193979|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
139544370|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139544371|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
139544372|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139544373|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544374|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139544375|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
139544376|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544377|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544378|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
139544379|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544380|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139544381|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544382|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
139544383|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139544384|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139544385|NCT01493427|Travoprost|travoprost|mesh-list
139194037|NCT03330249|Cisplatin|cisplatin|mesh-list
139544386|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139544387|NCT01523457|Folfirinox|folfirinox|mesh-list
139544388|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544389|NCT01523301|Rotigotine|rotigotine|mesh-list
139544390|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
139544391|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
139544392|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544393|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544394|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544395|NCT01766336|Inositol|inositol|mesh-list
139544396|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
139544397|NCT01766336|Vitamins|vitamins|mesh-ancestor
139544398|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
139544399|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544400|NCT01797302|Vitamin D|vitamin d|mesh-list
139544401|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
139544402|NCT01797302|Vitamins|vitamins|mesh-ancestor
139544403|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
139544404|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544405|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139544406|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139544407|NCT01804946|Oseltamivir|oseltamivir|mesh-list
139544408|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
139544409|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544410|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544411|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544412|NCT01795898|Fentanyl|fentanyl|mesh-list
139544413|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139544414|NCT01795898|Narcotics|narcotics|mesh-ancestor
139544415|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139544416|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544417|NCT01795898|Analgesics|analgesics|mesh-ancestor
139544418|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
139544419|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544420|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139544421|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139544422|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
139544423|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
139544424|NCT01736696|Tofacitinib|tofacitinib|mesh-list
139544425|NCT01736696|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139544426|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139544427|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544428|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544429|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
139544430|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139544431|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
139544432|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139544433|NCT01764464|Gabapentin|gabapentin|mesh-list
139544434|NCT01764464|Analgesics|analgesics|mesh-ancestor
139544435|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
139544436|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194142|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
139544437|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544438|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
139544439|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139544440|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139544441|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139544442|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139544443|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139544444|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139544445|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544446|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544447|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
139544448|NCT01763918|Evolocumab|evolocumab|mesh-list
139544449|NCT01763918|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139544450|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139544451|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139544452|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
139544453|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544454|NCT01763918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139544455|NCT01763918|Protease Inhibitors|protease inhibitors|mesh-ancestor
139544456|NCT01763918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544457|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139544458|NCT01606748|Gemcitabine|gemcitabine|mesh-list
139544459|NCT01606748|Necitumumab|necitumumab|mesh-list
139544460|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544461|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139544462|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
139544463|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544464|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544465|NCT01597622|Belimumab|belimumab|mesh-list
139544466|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544467|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
139544468|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544469|NCT01761266|Sorafenib|sorafenib|mesh-list
139544470|NCT01761266|Lenvatinib|lenvatinib|mesh-list
139544471|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544472|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139544473|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194325|NCT02526953|Capecitabine|capecitabine|mesh-list
139544474|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544475|NCT01759862|Aminophylline|aminophylline|mesh-list
139544476|NCT01759862|Theophylline|theophylline|mesh-list
139544477|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139544478|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
139544479|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544480|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544481|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139544482|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
139544483|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139544484|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544485|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544486|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
139544487|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139544488|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139544489|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
139544490|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544491|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139544492|NCT01759862|Protective Agents|protective agents|mesh-ancestor
139544493|NCT01790828|Factor VIII|factor viii|mesh-list
139544494|NCT01790828|Coagulants|coagulants|mesh-ancestor
139544495|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
139544496|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
139544497|NCT01790594|Abatacept|abatacept|mesh-list
139544498|NCT01790594|Tacrolimus|tacrolimus|mesh-list
139544499|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
139544500|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139544501|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544502|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
139544503|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544504|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139544505|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544506|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544507|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139544508|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544509|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139544510|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
139194449|NCT03387826|Ticagrelor|ticagrelor|mesh-list
139544511|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139544512|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544513|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139544514|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
139544515|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
139544516|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544517|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139544518|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
139544519|NCT01790594|Hormones|hormones|mesh-ancestor
139544520|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139544521|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139544522|NCT01790594|Protective Agents|protective agents|mesh-ancestor
139544523|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139544524|NCT01790594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544525|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139544526|NCT01790516|Cetuximab|cetuximab|mesh-list
139544527|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544528|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544529|NCT01790438|Insulin|insulin|mesh-list
139544530|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139544531|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
139544532|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
139544533|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
139544534|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139544535|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544536|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139544537|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139544538|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544539|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139544540|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544541|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
139544542|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139544543|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
139544544|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139544545|NCT01734902|Scopolamine|scopolamine|mesh-list
139544546|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139544547|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139544548|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
139544549|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
139544550|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544551|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544552|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139544553|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
139544554|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139544555|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
139544556|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544557|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544558|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139544559|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
139544560|NCT01789970|Hydrocodone|hydrocodone|mesh-list
139544561|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139544562|NCT01789970|Narcotics|narcotics|mesh-ancestor
139544563|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139544564|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544565|NCT01789970|Analgesics|analgesics|mesh-ancestor
139544566|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
139544567|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194563|NCT01281605|Insulin|insulin|mesh-list
139544568|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
139544569|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
139544570|NCT01788566|Gemcitabine|gemcitabine|mesh-list
139544571|NCT01788566|Necitumumab|necitumumab|mesh-list
139544572|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544573|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139544574|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
139544575|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544576|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544577|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139544578|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
139544579|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139544580|NCT01732796|Ribavirin|ribavirin|mesh-list
139544581|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
139544582|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544583|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
139544584|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544585|NCT01732640|Paclitaxel|paclitaxel|mesh-list
139544586|NCT01732640|Cisplatin|cisplatin|mesh-list
139544587|NCT01732640|Carboplatin|carboplatin|mesh-list
139544588|NCT01732640|Afatinib|afatinib|mesh-list
139544589|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139544590|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544591|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
139544592|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
139544593|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
139544594|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544595|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139544596|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544597|NCT04560686|Atezolizumab|atezolizumab|mesh-list
139544598|NCT04560686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139544599|NCT04560686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544600|NCT04560686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544601|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544602|NCT01757288|Paclitaxel|paclitaxel|mesh-list
139544603|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139544604|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139544605|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544606|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
139544607|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
139544608|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
139544609|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544610|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139544611|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
139544612|NCT01731938|Coagulants|coagulants|mesh-ancestor
139544613|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139544614|NCT01731002|Latanoprost|latanoprost|mesh-list
139544615|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139544616|NCT01783886|Aflibercept|aflibercept|mesh-list
139544617|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139544618|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139544619|NCT01783886|Growth Substances|growth substances|mesh-ancestor
139544620|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544621|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
139544622|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544623|NCT01609556|Maytansine|maytansine|mesh-list
139544624|NCT01609556|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139544625|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139544626|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544627|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
139544628|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
139544629|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
139544630|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544631|NCT01609556|Immunoconjugates|immunoconjugates|mesh-ancestor
139544632|NCT01609556|Immunologic Factors|immunologic factors|mesh-ancestor
139194785|NCT01170845|Sivelestat|sivelestat|mesh-list
139544633|NCT01609556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544635|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
139544636|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139544637|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
139544638|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139544639|NCT00259090|Fulvestrant|fulvestrant|mesh-list
139544640|NCT00259090|Anastrozole|anastrozole|mesh-list
139544641|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139544642|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544643|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139544644|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139544645|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
139194833|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544646|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139544647|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544648|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139544649|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139544650|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544651|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544652|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
139544653|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139544654|NCT00236938|Hematinics|hematinics|mesh-ancestor
139544655|NCT01898728|Iodine|iodine|mesh-list
139544656|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
139544657|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
139544658|NCT01898728|Povidone|povidone|mesh-list
139544659|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139544660|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139544661|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139544662|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544663|NCT01898728|Trace Elements|trace elements|mesh-ancestor
139544664|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
139544665|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544666|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
139544667|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
139544668|NCT00260962|Olanzapine|olanzapine|mesh-list
139544669|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
139544670|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
139544671|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544672|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544673|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139544674|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139544675|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139544676|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139544677|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139544678|NCT00260962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139544679|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139544680|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139544681|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544682|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544683|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
139544684|NCT00237718|Vitamin E|vitamin e|mesh-list
139544685|NCT00237718|Tocopherols|tocopherols|mesh-list
139544686|NCT00237718|Tocotrienols|tocotrienols|mesh-list
139544687|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
139544688|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
139544689|NCT00237718|Vitamins|vitamins|mesh-ancestor
139544690|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
139544691|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544692|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
139544693|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544694|NCT00237718|Protective Agents|protective agents|mesh-ancestor
139544695|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
139544696|NCT00238108|Melatonin|melatonin|mesh-list
139544697|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
139544698|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544699|NCT00238108|Protective Agents|protective agents|mesh-ancestor
139544700|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544701|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139544702|NCT00266110|Trastuzumab|trastuzumab|mesh-list
139544703|NCT00266110|Vinorelbine|vinorelbine|mesh-list
139544704|NCT00266110|Sargramostim|sargramostim|mesh-list
139544705|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544706|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544707|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139544708|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
139544709|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
139544710|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
139544711|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544712|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
139544713|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544714|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
139544715|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139544716|NCT00240526|Antibodies|antibodies|mesh-list
139544717|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
139544718|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544719|NCT00242632|Memantine|memantine|mesh-list
139544720|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139544721|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139544722|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
139544723|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544724|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544725|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544726|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139544727|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139544728|NCT01899430|Metformin|metformin|mesh-list
139544729|NCT01899430|Liraglutide|liraglutide|mesh-list
139544730|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139544731|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544732|NCT01899430|Incretins|incretins|mesh-ancestor
139544733|NCT01899430|Hormones|hormones|mesh-ancestor
139544734|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139544735|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
139544736|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139544737|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195128|NCT01171547|Daptomycin|daptomycin|mesh-list
139544738|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544739|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139544740|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139544741|NCT00267670|Protective Agents|protective agents|mesh-ancestor
139544742|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544743|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
139544744|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139544745|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
139544746|NCT00247624|Eszopiclone|eszopiclone|mesh-list
139544747|NCT00247624|Fluoxetine|fluoxetine|mesh-list
139544748|NCT00247624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139544749|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139544750|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139544751|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544752|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544753|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
139544754|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544755|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139544756|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
139544757|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139544758|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139544759|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139544760|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544761|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139544762|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139544763|NCT00248560|Gemcitabine|gemcitabine|mesh-list
139544764|NCT00248560|Docetaxel|docetaxel|mesh-list
139544765|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139544766|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
139544767|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544768|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195261|NCT03745105|Piroxicam|piroxicam|mesh-list
139544769|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
139544770|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
139544771|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
139544772|NCT00268762|Argatroban|argatroban|mesh-list
139544773|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
139544774|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139544775|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
139544776|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544777|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544778|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
139544779|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139544780|NCT00270634|Tacrolimus|tacrolimus|mesh-list
139544781|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544782|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
139544783|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544784|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139544785|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544786|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544787|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
139544788|NCT04110340|Gentamicins|gentamicins|mesh-list
139544789|NCT04110340|Streptomycin|streptomycin|mesh-list
139195300|NCT03744247|Antibodies|antibodies|mesh-list
139544790|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139544791|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544792|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139544793|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139544794|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544795|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544796|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544797|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139544798|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139544799|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139544800|NCT00270790|Carboplatin|carboplatin|mesh-list
139544801|NCT00270790|Amifostine|amifostine|mesh-list
139544802|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544803|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139544804|NCT00270790|Protective Agents|protective agents|mesh-ancestor
139544805|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544806|NCT00271570|Infliximab|infliximab|mesh-list
139544807|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
139544808|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139544809|NCT00271570|Antibodies|antibodies|mesh-list
139544810|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
139544811|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139544812|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
139544813|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544814|NCT00271570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139544815|NCT00271570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139544816|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
139544817|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139544818|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139544819|NCT05237596|Acetaminophen|acetaminophen|mesh-list
139544820|NCT05237596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139544821|NCT05237596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139544822|NCT05237596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139544823|NCT05237596|Analgesics|analgesics|mesh-ancestor
139544824|NCT05237596|Sensory System Agents|sensory system agents|mesh-ancestor
139544825|NCT05237596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544826|NCT05237596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544827|NCT05237596|Antipyretics|antipyretics|mesh-ancestor
139544828|NCT05237596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139544829|NCT02102932|Metformin|metformin|mesh-list
139544830|NCT02102932|Empagliflozin|empagliflozin|mesh-list
139544831|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139544832|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544833|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139544834|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544835|NCT00273754|Caffeine|caffeine|mesh-list
139544836|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139544837|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544838|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139544839|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544840|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544841|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139544842|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139544843|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
139544844|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544845|NCT04751344|Bupivacaine|bupivacaine|mesh-list
139544846|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
139544847|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
139544848|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139544849|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544850|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
139544851|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544852|NCT05211232|Tislelizumab|tislelizumab|mesh-list
139544853|NCT05211232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544854|NCT05211232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544855|NCT00273910|Imiquimod|imiquimod|mesh-list
139544856|NCT00273910|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139544857|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139544858|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
139544859|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544860|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544861|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
139544862|NCT00274768|Capecitabine|capecitabine|mesh-list
139544863|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139195603|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
139544864|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
139544865|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544866|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544867|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
139544868|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
139544869|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139544870|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139544871|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139544872|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139544873|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544874|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
139544875|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544876|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544877|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139544878|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544879|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139544880|NCT01763996|Febuxostat|febuxostat|mesh-list
139544881|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
139544882|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139544883|NCT01790464|Lidocaine|lidocaine|mesh-list
139544884|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
139544885|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
139544886|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139544887|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544888|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
139544889|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544890|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139544891|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139544892|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139544893|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139195715|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
139544894|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544895|NCT01790542|Iron|iron|mesh-list
139544896|NCT01790542|Trace Elements|trace elements|mesh-ancestor
139544897|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
139544898|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544899|NCT01899820|Lumefantrine|lumefantrine|mesh-list
139544900|NCT01899820|Artemether|artemether|mesh-list
139544901|NCT01899820|Piperaquine|piperaquine|mesh-list
139544902|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139544903|NCT01899820|Artenimol|artenimol|mesh-list
139544904|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
139544905|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139544906|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139544907|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544908|NCT02100748|Morphine|morphine|mesh-list
139544909|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139544910|NCT02100748|Narcotics|narcotics|mesh-ancestor
139544911|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139544912|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544913|NCT02100748|Analgesics|analgesics|mesh-ancestor
139544914|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
139195791|NCT03375034|Clonazepam|clonazepam|mesh-list
139544915|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544916|NCT00283504|Omalizumab|omalizumab|mesh-list
139544917|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139544918|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139544919|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
139544920|NCT00283816|Metformin|metformin|mesh-list
139544921|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
139544922|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
139544923|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139544924|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139544925|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544926|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139544927|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139544928|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
139544929|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139544930|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139544931|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139544932|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139326555|NCT01098435|ALKS-33|alks-33|mesh-list
139544933|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544934|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
139544935|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544936|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544937|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139544938|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544939|NCT04339426|Azithromycin|azithromycin|mesh-list
139544940|NCT04339426|Atovaquone|atovaquone|mesh-list
139544941|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139544942|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544943|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
139544944|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139544945|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139544946|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544947|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544948|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
139544949|NCT00287716|Pirfenidone|pirfenidone|mesh-list
139544950|NCT00287716|Analgesics|analgesics|mesh-ancestor
139544951|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
139544952|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139544953|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544954|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139544955|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139544956|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139544957|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139544958|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544959|NCT00287872|Thalidomide|thalidomide|mesh-list
139544960|NCT00287872|Bortezomib|bortezomib|mesh-list
139544961|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544962|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139544963|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
139195964|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
139544964|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544965|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
139544966|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139544967|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544968|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139544969|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139544970|NCT00287872|Growth Substances|growth substances|mesh-ancestor
139544971|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
139544972|NCT00288574|Fluoxetine|fluoxetine|mesh-list
139544973|NCT00288574|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139544974|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139544975|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139544976|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544977|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139544978|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
139544979|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139544980|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139544981|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
139544982|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139544983|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139544984|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139196013|NCT04597320|Midazolam|midazolam|mesh-list
139544985|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544986|NCT04061590|Cisplatin|cisplatin|mesh-list
139544987|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
139544988|NCT04061590|Pemetrexed|pemetrexed|mesh-list
139544989|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139544990|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139544991|NCT04061590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139544992|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139544993|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139544994|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139544995|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139544996|NCT01791088|Sirolimus|sirolimus|mesh-list
139196067|NCT03123952|ABT-414|abt-414|mesh-list
139544997|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139544998|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139544999|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139545000|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545001|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
139545002|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139545003|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
139545004|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545005|NCT00291226|Glycine|glycine|mesh-list
139545006|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
139545007|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545008|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545009|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545010|NCT01791166|Antibodies|antibodies|mesh-list
139545011|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
139545012|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545013|NCT00291694|Celecoxib|celecoxib|mesh-list
139545014|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139545015|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139545016|NCT00291694|Analgesics|analgesics|mesh-ancestor
139545017|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
139545018|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545019|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545020|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139545021|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139545022|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139545023|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139545024|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545025|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545026|NCT00292162|Metoprolol|metoprolol|mesh-list
139545027|NCT00292162|Carvedilol|carvedilol|mesh-list
139545028|NCT00292162|Ramipril|ramipril|mesh-list
139545029|NCT00292162|Enalapril|enalapril|mesh-list
139545030|NCT00292162|Lisinopril|lisinopril|mesh-list
139545031|NCT00292162|Bisoprolol|bisoprolol|mesh-list
139545032|NCT00292162|Perindopril|perindopril|mesh-list
139545033|NCT00292162|Captopril|captopril|mesh-list
139545034|NCT00292162|Spironolactone|spironolactone|mesh-list
139545035|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139545036|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139545037|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139545038|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139545039|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139545040|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
139545041|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
139545042|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545043|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545044|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139545045|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139545046|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
139545047|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545048|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545049|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
139545050|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139545051|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139545052|NCT00292162|Diuretics|diuretics|mesh-ancestor
139545053|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
139545054|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
139545055|NCT00292162|Protective Agents|protective agents|mesh-ancestor
139545056|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139545057|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139545058|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139545059|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
139545060|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139545061|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139545062|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
139545063|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545064|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139545065|NCT00296296|Cyclosporine|cyclosporine|mesh-list
139545066|NCT00296296|Tacrolimus|tacrolimus|mesh-list
139545067|NCT00296296|Cyclosporins|cyclosporins|mesh-list
139545068|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139545069|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
139545070|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545071|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139545072|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545073|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545074|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
139545075|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139545076|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
139545077|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139545078|NCT01791400|Sumatriptan|sumatriptan|mesh-list
139545079|NCT01791400|Metoclopramide|metoclopramide|mesh-list
139545080|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
139545081|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
139545082|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545083|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545084|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139545085|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139545086|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139545087|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
139545088|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545089|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545090|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139545091|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139545092|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139545093|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
139545094|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
139545095|NCT00300430|Atorvastatin|atorvastatin|mesh-list
139545096|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139545097|NCT00300430|Simvastatin|simvastatin|mesh-list
139545098|NCT00300430|Fenofibrate|fenofibrate|mesh-list
139545099|NCT00300430|Calcium|calcium|mesh-list
139196356|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139545100|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139545101|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545102|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139545103|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139545104|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139545105|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
139545106|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545107|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139545108|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139545109|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545110|NCT02104414|Epinephrine|epinephrine|mesh-list
139545111|NCT02104414|Bupivacaine|bupivacaine|mesh-list
139545112|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
139545113|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
139545114|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139545115|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545116|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
139545117|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196406|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
139545118|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139545119|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139545120|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
139545121|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545122|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545123|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139545124|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139545125|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
139545126|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139545127|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
139545128|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
139545129|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
139545130|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139545131|NCT02100826|Cephalexin|cephalexin|mesh-list
139545132|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139545133|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139545134|NCT02101918|Aflibercept|aflibercept|mesh-list
139545135|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
139545136|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139545137|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139545138|NCT02101918|Growth Substances|growth substances|mesh-ancestor
139545139|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545140|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
139545141|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545142|NCT00300742|Topiramate|topiramate|mesh-list
139545143|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
139545144|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139545145|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545146|NCT00301756|Belinostat|belinostat|mesh-list
139545147|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545148|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139545149|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545150|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545151|NCT00302068|Sertraline|sertraline|mesh-list
139545152|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
139545153|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139545154|NCT00302068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139545155|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139545156|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139545157|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545158|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545159|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
139545160|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545161|NCT00302848|Drospirenone|drospirenone|mesh-list
139545162|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
139545163|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
139545164|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
139545165|NCT00302848|Progestins|progestins|mesh-list
139545166|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139545167|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545168|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139545169|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139545170|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139545171|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139545172|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
139545173|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139545174|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139545175|NCT00302848|Diuretics|diuretics|mesh-ancestor
139545176|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
139545177|NCT00302848|Hormones|hormones|mesh-ancestor
139545178|NCT00303862|Cediranib|cediranib|mesh-list
139545179|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545180|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545181|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545182|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139545183|NCT00304096|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139545184|NCT00304096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139545185|NCT00304096|Immunologic Factors|immunologic factors|mesh-ancestor
139545186|NCT00304096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545187|NCT05267392|Durvalumab|durvalumab|mesh-list
139545188|NCT05267392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139545189|NCT05267392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545190|NCT00142168|Rituximab|rituximab|mesh-list
139545191|NCT00142168|Lenalidomide|lenalidomide|mesh-list
139545192|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139545193|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545194|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
139545195|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545196|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139545197|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139545198|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139545199|NCT00142168|Growth Substances|growth substances|mesh-ancestor
139545200|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
139545201|NCT02501434|Heparin|heparin|mesh-list
139545202|NCT02501434|Calcium heparin|calcium heparin|mesh-list
139545203|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
139545204|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139545205|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139545206|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545207|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139545208|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139545209|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139545210|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545211|NCT00148798|Cisplatin|cisplatin|mesh-list
139545212|NCT00148798|Cetuximab|cetuximab|mesh-list
139545213|NCT00148798|Vinorelbine|vinorelbine|mesh-list
139545214|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545215|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139196618|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
139545216|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139545217|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
139545218|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
139545219|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
139545220|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545221|NCT00149734|Ondansetron|ondansetron|mesh-list
139545222|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
139545223|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
139545224|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545225|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545226|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139545227|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
139545228|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
139545229|NCT00149734|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139545230|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139545231|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
139545232|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545233|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545234|NCT00198328|Bleomycin|bleomycin|mesh-list
139545235|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139545236|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545237|NCT00305578|Memantine|memantine|mesh-list
139545238|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139545239|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139545240|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
139545241|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545242|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545243|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545244|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139545245|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139545246|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
139545247|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545248|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139545249|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139545250|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545251|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545252|NCT01468311|Daclizumab|daclizumab|mesh-list
139545253|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139545254|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
139545255|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545256|NCT00306202|Dasatinib|dasatinib|mesh-list
139545257|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545258|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139545259|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545260|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545261|NCT00325078|Infliximab|infliximab|mesh-list
139545262|NCT00325078|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139545263|NCT00325078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139545264|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
139545265|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139545266|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139545267|NCT00325780|Pitavastatin|pitavastatin|mesh-list
139545268|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139545269|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139545270|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139545271|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
139545272|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545273|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545274|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139545275|NCT00326170|Azacitidine|azacitidine|mesh-list
139545276|NCT00326170|Tretinoin|tretinoin|mesh-list
139545277|NCT00326170|Valproic Acid|valproic acid|mesh-list
139545278|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139545279|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
139545280|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545281|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545282|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545283|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
139545284|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
139545285|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
139545286|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
139545287|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545288|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545289|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
139545290|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139545291|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139545292|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139545293|NCT00326872|Cediranib|cediranib|mesh-list
139545294|NCT00326872|Maleic acid|maleic acid|mesh-list
139545295|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545296|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545297|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545298|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139545299|NCT05266690|Dextrans|dextrans|mesh-list
139545300|NCT05266690|Anticoagulants|anticoagulants|mesh-ancestor
139545301|NCT05266690|Plasma Substitutes|plasma substitutes|mesh-ancestor
139545302|NCT05266690|Blood Substitutes|blood substitutes|mesh-ancestor
139545303|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
139545304|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139545305|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545306|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139545307|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326928|NCT01001715|Fasinumab|fasinumab|mesh-list
139545308|NCT05266534|Terlipressin|terlipressin|mesh-list
139545309|NCT05266534|Carbetocin|carbetocin|mesh-list
139196887|NCT03733561|Rotigotine|rotigotine|mesh-list
139545310|NCT05266534|Oxytocics|oxytocics|mesh-ancestor
139545311|NCT05266534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139545312|NCT05266534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545313|NCT05266534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139545314|NCT05266534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139545315|NCT01730378|Vaccines|vaccines|mesh-list
139545316|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
139545317|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545318|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
139545319|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139545320|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
139545321|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545322|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139545323|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139545324|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545325|NCT01790308|Liraglutide|liraglutide|mesh-list
139545326|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139004340|NCT01094821|ATI 7505|ati 7505|mesh-list
139545327|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545328|NCT01790308|Incretins|incretins|mesh-ancestor
139545329|NCT01790308|Hormones|hormones|mesh-ancestor
139545330|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139545331|NCT01609010|Interferons|interferons|mesh-list
139545332|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
139545333|NCT01609010|Rituximab|rituximab|mesh-list
139545334|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139545335|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545336|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
139545337|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545338|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139545339|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
139545340|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139545341|NCT01608308|Acetaminophen|acetaminophen|mesh-list
139545342|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139545343|NCT01608308|Analgesics|analgesics|mesh-ancestor
139545344|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
139545345|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545346|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545347|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
139545348|NCT00332644|Bupropion|bupropion|mesh-list
139545349|NCT00332644|Nicotine|nicotine|mesh-list
139545350|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139545351|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
139545352|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545353|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545354|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139545355|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139545356|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
139545357|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545358|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545359|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139545360|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
139545361|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139545362|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139545363|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139545364|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139545365|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
139545366|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139545367|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139545368|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545369|NCT01755416|Insulin|insulin|mesh-list
139545370|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139545371|NCT01755416|Liraglutide|liraglutide|mesh-list
139545372|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139545373|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545374|NCT01755416|Incretins|incretins|mesh-ancestor
139545375|NCT01755416|Hormones|hormones|mesh-ancestor
139545376|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139545377|NCT01755026|Cefazolin|cefazolin|mesh-list
139545378|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139545379|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139545380|NCT00333814|Dexamethasone|dexamethasone|mesh-list
139545381|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
139545382|NCT00333814|BB 1101|bb 1101|mesh-list
139545383|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139327000|NCT04061252|Brodalumab|brodalumab|mesh-list
139545384|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
139545385|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
139545386|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545387|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545388|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139545389|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
139545390|NCT00333814|Hormones|hormones|mesh-ancestor
139545391|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139545392|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139545393|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545394|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
139545395|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545396|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545397|NCT01728584|Bromides|bromides|mesh-list
139545398|NCT01728584|Rocuronium|rocuronium|mesh-list
139545399|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
139545400|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139545401|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139545402|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139545403|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545404|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545405|NCT00315328|Atropine|atropine|mesh-list
139545406|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139009049|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
139545407|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139545408|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139545409|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
139545410|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545411|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545412|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139545413|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
139545414|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
139545415|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
139545416|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139545417|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139545418|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
139545419|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545420|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545421|NCT01522443|Prednisone|prednisone|mesh-list
139545422|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
139545423|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139545424|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
139545425|NCT01522443|Hormones|hormones|mesh-ancestor
139545426|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139545427|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545428|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139545429|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545430|NCT01522443|Analgesics|analgesics|mesh-ancestor
139545431|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
139545432|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545433|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139545434|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139545435|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545436|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545437|NCT00336700|Gemcitabine|gemcitabine|mesh-list
139545438|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139545439|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139545440|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
139545441|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545442|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545443|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139545444|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545445|NCT01468233|Adalimumab|adalimumab|mesh-list
139545446|NCT01468233|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139545447|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139545448|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139545449|NCT01754402|Dexamethasone|dexamethasone|mesh-list
139545450|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139545451|NCT01754402|Pomalidomide|pomalidomide|mesh-list
139545452|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139545453|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
139545454|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
139545455|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545456|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545457|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139545458|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
139545459|NCT01754402|Hormones|hormones|mesh-ancestor
139545460|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139327127|NCT04537689|Ixekizumab|ixekizumab|mesh-list
139545461|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139545462|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545463|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139545464|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
139545465|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545466|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
139545467|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139545468|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139545469|NCT01754402|Growth Substances|growth substances|mesh-ancestor
139545470|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
139545471|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139545472|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
139545473|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545474|NCT01782872|Ropivacaine|ropivacaine|mesh-list
139545475|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
139545476|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
139545477|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139545478|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545479|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
139545480|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545481|NCT01490697|Cycloserine|cycloserine|mesh-list
139545482|NCT01490697|Mifepristone|mifepristone|mesh-list
139545483|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139545484|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
139545485|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139545486|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545487|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139545488|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139545489|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139545490|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
139010516|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
139545491|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139545492|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139545493|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
139545494|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139545495|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
139545496|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139545497|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139545498|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139545499|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139545500|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139545501|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
139545502|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139545503|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
139545504|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545505|NCT01728194|Escitalopram|escitalopram|mesh-list
139545506|NCT01728194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139545507|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139545508|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138525765|NCT04733066|Teduglutide|teduglutide|mesh-list
139545509|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545510|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545511|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
139545512|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545513|NCT04408911|Midazolam|midazolam|mesh-list
139545514|NCT04408911|Lormetazepam|lormetazepam|mesh-list
139545515|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139545516|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139545517|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139545518|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545519|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139545520|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139545521|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139545522|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139545523|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
139545524|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
139545525|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
139545526|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
139545527|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545528|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545529|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
139545530|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139545531|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139545532|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139545533|NCT01466673|Desogestrel|desogestrel|mesh-list
139545534|NCT01466673|Norgestimate|norgestimate|mesh-list
139545535|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139545536|NCT01466673|Estradiol|estradiol|mesh-list
139545537|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139545538|NCT01466673|Estrogens|estrogens|mesh-ancestor
139545539|NCT01466673|Hormones|hormones|mesh-ancestor
139545540|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139545541|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545542|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139545543|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
139545544|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139545545|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139545546|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139545547|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139545548|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139545549|NCT01466673|Progestins|progestins|mesh-ancestor
139545550|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139545551|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139545552|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139545553|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139545554|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545555|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545556|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545557|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139545558|NCT01753856|Vitamin D|vitamin d|mesh-list
139545559|NCT01753856|Denosumab|denosumab|mesh-list
139545560|NCT01753856|Teriparatide|teriparatide|mesh-list
139545561|NCT01753856|Tetracycline|tetracycline|mesh-list
139545562|NCT01753856|Demeclocycline|demeclocycline|mesh-list
139545563|NCT01753856|Calcium|calcium|mesh-list
139545564|NCT01753856|Vitamins|vitamins|mesh-ancestor
139545565|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
139545566|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545567|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139545568|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139545569|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139545570|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139545571|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139545572|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013095|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139545573|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545574|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
139545575|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139545576|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139545577|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139545578|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139545579|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545580|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
139545581|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545582|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545583|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139545584|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545585|NCT01521117|Donepezil|donepezil|mesh-list
139545586|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139545587|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545588|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545589|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
139545590|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545591|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545592|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
139545593|NCT01466595|Rifaximin|rifaximin|mesh-list
139545594|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138529266|NCT00398814|Sorafenib|sorafenib|mesh-list
139545595|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139545596|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139545597|NCT02073747|Albuterol|albuterol|mesh-list
139545598|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139545599|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
139545600|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545601|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545602|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139545603|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
139545604|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
139545605|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139545606|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139545607|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139327223|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
139545608|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139545609|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
139545610|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545611|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545612|NCT01465659|Temozolomide|temozolomide|mesh-list
139545613|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139545614|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
139545615|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545616|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545617|NCT01462929|Bromides|bromides|mesh-list
139545618|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
139545619|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139545620|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
139545621|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545622|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545623|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139545624|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
139545625|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
139545626|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139545627|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
139545628|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545629|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545630|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
139545631|NCT01462695|Sunitinib|sunitinib|mesh-list
139545632|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545633|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139545634|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139545635|NCT01462695|Growth Substances|growth substances|mesh-ancestor
139545636|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545637|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
139545638|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139545639|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545640|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545641|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
139545642|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
139545643|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545644|NCT01465347|Protective Agents|protective agents|mesh-ancestor
139545645|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545646|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139545647|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545648|NCT01465191|Morphine|morphine|mesh-list
139545649|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139545650|NCT01465191|Narcotics|narcotics|mesh-ancestor
139545651|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139545652|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545653|NCT01465191|Analgesics|analgesics|mesh-ancestor
139545654|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
139545655|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545656|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
139545657|NCT01519947|Hematinics|hematinics|mesh-ancestor
139545658|NCT01462227|Naltrexone|naltrexone|mesh-list
139545659|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139545660|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139545661|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545662|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
139545663|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545664|NCT01464879|Testosterone|testosterone|mesh-list
139545665|NCT01464879|Androgens|androgens|mesh-ancestor
139545666|NCT01464879|Hormones|hormones|mesh-ancestor
139545667|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139545668|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545669|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
139545670|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139545671|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139545672|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
139545673|NCT01519791|Methotrexate|methotrexate|mesh-list
139545674|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139545675|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
139545676|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139545677|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545678|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139545679|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
139545680|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327303|NCT00979251|Amantadine|amantadine|mesh-list
139545681|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545682|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
139545683|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545684|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139545685|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139545686|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
139545687|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139545688|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139545689|NCT01519791|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139545690|NCT01519791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139545691|NCT01439373|Interferons|interferons|mesh-list
139545692|NCT01439373|Ribavirin|ribavirin|mesh-list
139545693|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
139545694|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
139545695|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139545696|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545697|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
139545698|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139545699|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
139545700|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545701|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
139545702|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545703|NCT01461369|Diclofenac|diclofenac|mesh-list
139545704|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139545705|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139545706|NCT01461369|Analgesics|analgesics|mesh-ancestor
139545707|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
139545708|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545709|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545710|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139545711|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139545712|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139545713|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545714|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545715|NCT01727258|Fluorides|fluorides|mesh-list
139545716|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
139545717|NCT01727258|Protective Agents|protective agents|mesh-ancestor
139545718|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545719|NCT01781234|Insulin|insulin|mesh-list
139545720|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139545721|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545722|NCT01752842|Fenofibrate|fenofibrate|mesh-list
139545723|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139545724|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
139545725|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545726|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139545727|NCT01461057|Capecitabine|capecitabine|mesh-list
139545728|NCT01461057|Trastuzumab|trastuzumab|mesh-list
139545729|NCT01461057|Pertuzumab|pertuzumab|mesh-list
139545730|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545731|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139545732|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
139545733|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545734|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139545735|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139545736|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139545737|NCT01519635|Diuretics|diuretics|mesh-ancestor
139545738|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
139545739|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545740|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139545741|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139545742|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545743|NCT01519323|Vemurafenib|vemurafenib|mesh-list
139545744|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545745|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139545746|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014857|NCT04992624|Hormones|hormones|mesh-ancestor
139545747|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545748|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
139545749|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139545750|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139545751|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545752|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
139545753|NCT01519245|Coagulants|coagulants|mesh-ancestor
139545754|NCT01519167|Midazolam|midazolam|mesh-list
139545755|NCT01519167|Fentanyl|fentanyl|mesh-list
139545756|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
139545757|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139545758|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139545759|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545761|NCT01519167|Analgesics|analgesics|mesh-ancestor
139545762|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
139545763|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545764|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139545765|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139014930|NCT04902625|Bupropion|bupropion|mesh-list
139545766|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139545767|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
139545768|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545769|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545770|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139545771|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139545772|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139545773|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139545774|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139545775|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
139545776|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
139545777|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
139545778|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
139545779|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139545780|NCT01519167|Narcotics|narcotics|mesh-ancestor
139545781|NCT00318136|Paclitaxel|paclitaxel|mesh-list
139545782|NCT00318136|Bevacizumab|bevacizumab|mesh-list
139545783|NCT00318136|Carboplatin|carboplatin|mesh-list
139015041|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
139545784|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139545785|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545786|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
139545787|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
139545788|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
139545789|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545790|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139545791|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139545792|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139545793|NCT00318136|Growth Substances|growth substances|mesh-ancestor
139545794|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545795|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
139545796|NCT00318292|Epinephrine|epinephrine|mesh-list
139545797|NCT00318292|Bupivacaine|bupivacaine|mesh-list
139545798|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
139545799|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
139545800|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139545801|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545802|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
139545803|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545804|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139545805|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139545806|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
139545807|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545808|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545809|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139545810|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139545811|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
139545812|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139545813|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
139545814|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
139545815|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
139545816|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139545817|NCT01791868|Valproic Acid|valproic acid|mesh-list
139545818|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
139545819|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545820|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545821|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
139545822|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139545823|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545824|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
139545825|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139545826|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139545827|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139545828|NCT00348946|Androgens|androgens|mesh-list
139545829|NCT00348946|Oxandrolone|oxandrolone|mesh-list
139545830|NCT00348946|Hormones|hormones|mesh-ancestor
139327445|NCT05497570|Tenoxicam|tenoxicam|mesh-list
139327458|NCT00963885|Lactams|lactams|mesh-list
139545831|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139545832|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545833|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
139545834|NCT00349336|Bevacizumab|bevacizumab|mesh-list
139545835|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139545836|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545837|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139545838|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139545839|NCT00349336|Growth Substances|growth substances|mesh-ancestor
139545840|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545841|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
139545842|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139545843|NCT04751188|Bezafibrate|bezafibrate|mesh-list
139545844|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139545845|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139545846|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139545847|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
139545848|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545849|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139545850|NCT00352612|Clindamycin|clindamycin|mesh-list
139545851|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
139545852|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
139545853|NCT00352612|Cephalexin|cephalexin|mesh-list
139545854|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139545855|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139545856|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139545857|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545858|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545859|NCT00323362|Gemcitabine|gemcitabine|mesh-list
139545860|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
139545861|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139545862|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
139545863|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545864|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545865|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139545866|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545867|NCT00390364|Everolimus|everolimus|mesh-list
139545868|NCT00390364|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139545869|NCT00390364|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139545870|NCT00390364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139545871|NCT00390364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545872|NCT00390364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545873|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139545874|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
139545875|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545876|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545877|NCT00354640|Anastrozole|anastrozole|mesh-list
139545878|NCT00354640|Simvastatin|simvastatin|mesh-list
139545879|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139545880|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139545881|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
139545882|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545883|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139545884|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139545885|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545886|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139545887|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545888|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139545889|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139545890|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139545891|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
139545892|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139545893|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545894|NCT00392392|Paclitaxel|paclitaxel|mesh-list
139545895|NCT00392392|Bevacizumab|bevacizumab|mesh-list
139545896|NCT00392392|Trastuzumab|trastuzumab|mesh-list
139545897|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139545898|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545899|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
139545900|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
139545901|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
139545902|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545903|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139545904|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139545905|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139545907|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545908|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
139545909|NCT01519089|Tofacitinib|tofacitinib|mesh-list
139545910|NCT01519089|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139545911|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139545912|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015386|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
139015387|NCT03146962|Vitamins|vitamins|mesh-ancestor
139015388|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
139015389|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015390|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
139015391|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015392|NCT03146962|Protective Agents|protective agents|mesh-ancestor
139015393|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
139015394|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
139545913|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545914|NCT00392704|Paclitaxel|paclitaxel|mesh-list
139545915|NCT00392704|Bevacizumab|bevacizumab|mesh-list
139545916|NCT00392704|Fluorouracil|fluorouracil|mesh-list
139545917|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139545918|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139545919|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545920|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
139545921|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
139545922|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
139545923|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545924|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139545925|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139545926|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139545927|NCT00392704|Growth Substances|growth substances|mesh-ancestor
139545928|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545929|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
139545930|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
139545931|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139545932|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139545933|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
139545934|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139545935|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545936|NCT00392782|Fludarabine|fludarabine|mesh-list
139545937|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
139545938|NCT00392782|Thiotepa|thiotepa|mesh-list
139545939|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139545940|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545941|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139545942|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
139545943|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545944|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139015437|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
139015438|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139015439|NCT02824276|Morphine|morphine|mesh-list
139015440|NCT02824276|Oxycodone|oxycodone|mesh-list
139015441|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139015442|NCT02824276|Narcotics|narcotics|mesh-ancestor
139015443|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015444|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015445|NCT02824276|Analgesics|analgesics|mesh-ancestor
139015446|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
139015447|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139545945|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
139545946|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545947|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139545948|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
139545949|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139545950|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
139545951|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139545952|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139545953|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139545954|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139545955|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139545956|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545957|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545958|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015473|NCT02813135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139545959|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139545960|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
139545961|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139545962|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545963|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139545964|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139545965|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139545966|NCT01518309|Pimavanserin|pimavanserin|mesh-list
139545967|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139545968|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139545969|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139545970|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139545971|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139545972|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545973|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139545974|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139545975|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139545976|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
139545977|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327595|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139545978|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545979|NCT01419717|Denosumab|denosumab|mesh-list
139545980|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139545981|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545982|NCT01458951|Tofacitinib|tofacitinib|mesh-list
139545983|NCT01458951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139545984|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139545985|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139545986|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139545987|NCT01458639|Xenon|xenon|mesh-list
139545988|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139545989|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
139545990|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
139545991|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139545992|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545993|NCT00393796|Sunitinib|sunitinib|mesh-list
139545994|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139545995|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139545996|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139545997|NCT00393796|Growth Substances|growth substances|mesh-ancestor
139545998|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139545999|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
139546000|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139546001|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546002|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546003|NCT00393874|Prazosin|prazosin|mesh-list
139546004|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139546005|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139546006|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139546007|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139546008|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
139546009|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139015576|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
139546010|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546011|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546012|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
139546013|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
139546014|NCT01458171|Antibodies|antibodies|mesh-list
139546015|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
139546016|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139546017|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139546018|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
139546019|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546020|NCT00395044|Gabapentin|gabapentin|mesh-list
139015636|NCT01025089|Cetuximab|cetuximab|mesh-list
139546021|NCT00395044|Analgesics|analgesics|mesh-ancestor
139546022|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
139546023|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546024|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546025|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
139546026|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139546027|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139546028|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139546029|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139546030|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139546031|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139546032|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546033|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546034|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
139546035|NCT01457703|Letrozole|letrozole|mesh-list
139546036|NCT01457703|Cetrorelix|cetrorelix|mesh-list
139546037|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139546038|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546039|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139546040|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139546041|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546042|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546043|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139546044|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
139546045|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139546046|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546047|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139546048|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
139546049|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139546050|NCT01457703|Hormones|hormones|mesh-ancestor
139546051|NCT02076321|Acetaminophen|acetaminophen|mesh-list
139546052|NCT02076321|Ibuprofen|ibuprofen|mesh-list
139546053|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139546054|NCT02076321|Analgesics|analgesics|mesh-ancestor
139546055|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
139015783|NCT00530270|Hormones|hormones|mesh-ancestor
139546056|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546057|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546058|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
139546059|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139546060|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139546061|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139546062|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139546063|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546064|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546065|NCT00358462|Azithromycin|azithromycin|mesh-list
139546066|NCT00358462|Doxycycline|doxycycline|mesh-list
139546067|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139546068|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139546069|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
139546070|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139546071|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139546072|NCT01437267|Vaccines|vaccines|mesh-list
139546073|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139546074|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
139546075|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546076|NCT01437111|Vitamin D|vitamin d|mesh-list
139546077|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
139546078|NCT01437111|Alendronate|alendronate|mesh-list
139546079|NCT01437111|Vitamins|vitamins|mesh-ancestor
139546080|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
139015888|NCT03999008|Budesonide|budesonide|mesh-list
139546081|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546082|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139546083|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139546084|NCT04065555|Cetuximab|cetuximab|mesh-list
139546085|NCT04065555|Avelumab|avelumab|mesh-list
139546086|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139546087|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139546088|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546089|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
139546090|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546091|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139015940|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
139546092|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139546093|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139546094|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139546095|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546096|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546097|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546098|NCT00360724|Analgesics|analgesics|mesh-ancestor
139546099|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
139546100|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546101|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
139546102|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139546103|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
139546104|NCT00398398|Capecitabine|capecitabine|mesh-list
139546105|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
139546106|NCT00398398|Cetuximab|cetuximab|mesh-list
139546107|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139546108|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
139546109|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016010|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
139546110|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546111|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139546112|NCT00398476|Fluticasone|fluticasone|mesh-list
139546113|NCT00398476|Xhance|xhance|mesh-list
139546114|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139546115|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139546116|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
139546117|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546118|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546119|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139546120|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
139546121|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
139546122|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139546123|NCT01436643|Fluoxetine|fluoxetine|mesh-list
139546124|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139546125|NCT01436643|Citalopram|citalopram|mesh-list
139546126|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139546127|NCT01436643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139546128|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139546129|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139546130|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546131|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546133|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546134|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139546135|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
139546136|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139546137|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139546138|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139546139|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546140|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139546141|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139546142|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139546143|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
139546144|NCT00361972|Lansoprazole|lansoprazole|mesh-list
139546145|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
139546146|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139546147|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139546148|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139546149|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546150|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546151|NCT00362440|Metformin|metformin|mesh-list
139546152|NCT00362440|Pioglitazone|pioglitazone|mesh-list
139546153|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139546154|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546155|NCT02109640|Oxycodone|oxycodone|mesh-list
139546156|NCT02109640|Naloxone|naloxone|mesh-list
139546157|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139546158|NCT02109640|Narcotics|narcotics|mesh-ancestor
139546159|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139546160|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546161|NCT02109640|Analgesics|analgesics|mesh-ancestor
139546162|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
139546163|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546164|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139546165|NCT01454739|Factor VIII|factor viii|mesh-list
139546166|NCT01454739|Coagulants|coagulants|mesh-ancestor
139546167|NCT00366106|Dexamethasone|dexamethasone|mesh-list
139546168|NCT00366106|Doxorubicin|doxorubicin|mesh-list
139546169|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139546170|NCT00366106|Bortezomib|bortezomib|mesh-list
139546171|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139546172|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
139546173|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
139546174|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546175|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546176|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139546177|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
139546178|NCT00366106|Hormones|hormones|mesh-ancestor
139546179|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139546180|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139546181|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546182|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139546183|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139546184|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139546185|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546186|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546187|NCT00368290|Modafinil|modafinil|mesh-list
139546188|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139546189|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546190|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139546191|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139546192|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139546193|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546194|NCT00369226|Methotrexate|methotrexate|mesh-list
139546195|NCT00369226|Bortezomib|bortezomib|mesh-list
139546196|NCT00369226|Tacrolimus|tacrolimus|mesh-list
139546197|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139546198|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
139546199|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139546200|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546201|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139546202|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
139546203|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546204|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546205|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
139546206|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546207|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139546208|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139546209|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
139546210|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139546211|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139546212|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139546213|NCT01416441|Aripiprazole|aripiprazole|mesh-list
139546214|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
139546215|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139546216|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139546217|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139546218|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139546219|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546220|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
139546221|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
139546222|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546223|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546224|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139546225|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139546226|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
139546227|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139546228|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139546229|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139546230|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139546231|NCT00406276|Docetaxel|docetaxel|mesh-list
139546232|NCT00406276|Everolimus|everolimus|mesh-list
139546233|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546234|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
139546235|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
139546236|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
139546237|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016473|NCT02541383|BB 1101|bb 1101|mesh-list
139546238|NCT00406276|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139546239|NCT00406276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139546240|NCT00406276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546241|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139546242|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
139546243|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546244|NCT00408070|Paclitaxel|paclitaxel|mesh-list
139546245|NCT00408070|Bevacizumab|bevacizumab|mesh-list
139546246|NCT00408070|Carboplatin|carboplatin|mesh-list
139546247|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139546248|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546249|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
139546250|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
139546251|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
139546252|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546253|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139546254|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139546255|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139546256|NCT00408070|Growth Substances|growth substances|mesh-ancestor
139546257|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546258|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
139546259|NCT00408460|Paclitaxel|paclitaxel|mesh-list
139546260|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
139546261|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139546262|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546263|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
139546264|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
139546265|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
139546266|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546267|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139546268|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546269|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
139546270|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139546271|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546272|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
139546273|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139546274|NCT02111746|Bupivacaine|bupivacaine|mesh-list
139546275|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
139546276|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
139546277|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139546278|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546279|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
139546280|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546281|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
139546282|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139546283|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546284|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546285|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139546286|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139546287|NCT01793272|Protective Agents|protective agents|mesh-ancestor
139546288|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546289|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
139546290|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139546291|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
139546292|NCT00410488|Dexamethasone|dexamethasone|mesh-list
139546293|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
139546294|NCT00410488|Doxorubicin|doxorubicin|mesh-list
139546295|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139546296|NCT00410488|Vincristine|vincristine|mesh-list
139546297|NCT00410488|Ifosfamide|ifosfamide|mesh-list
139546298|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
139546299|NCT00410488|Palonosetron|palonosetron|mesh-list
139546300|NCT00410488|BB 1101|bb 1101|mesh-list
139546301|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139546302|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
139546303|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
139546304|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546305|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546306|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139546307|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
139546308|NCT00410488|Hormones|hormones|mesh-ancestor
139546309|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139546310|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139546311|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546312|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
139546313|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546314|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546315|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139546316|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139546317|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139546318|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139546319|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
139546320|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
139546321|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
139546322|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139546323|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
139546324|NCT00410488|Protective Agents|protective agents|mesh-ancestor
139546325|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139546326|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139546327|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
139546328|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546329|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139546330|NCT01793350|Benphothiamine|benphothiamine|mesh-list
139546331|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139546332|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
139546333|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546334|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
139546335|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
139546336|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546337|NCT00416494|Bevacizumab|bevacizumab|mesh-list
139546338|NCT00416494|Capecitabine|capecitabine|mesh-list
139546339|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
139546340|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139546341|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546342|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139546343|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139546344|NCT00416494|Growth Substances|growth substances|mesh-ancestor
139546345|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546346|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
139546347|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139546348|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
139546349|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546350|NCT00417274|Quinacrine|quinacrine|mesh-list
139546351|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
139546352|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139546353|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
139546355|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139546356|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
139546357|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139546358|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
139546359|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546360|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546361|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546362|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139546363|NCT04749940|Laxatives|laxatives|mesh-ancestor
139546364|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139546365|NCT05286346|Tenofovir|tenofovir|mesh-list
139546366|NCT05286346|Antiviral Agents|antiviral agents|mesh-ancestor
139546367|NCT05286346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139546368|NCT05286346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139546369|NCT05286346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139546370|NCT05286346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546371|NCT05286346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546372|NCT05286346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139546373|NCT05286346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139546374|NCT05286268|Plasminogen|plasminogen|mesh-list
139546375|NCT05286268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139546376|NCT05286268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139546377|NCT05286268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546378|NCT00422032|Clofarabine|clofarabine|mesh-list
139546379|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139546380|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
139546381|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546382|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546383|NCT01388920|Tesamorelin|tesamorelin|mesh-list
139546384|NCT01388920|Growth Substances|growth substances|mesh-ancestor
139546385|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546386|NCT00423358|Vitamin D|vitamin d|mesh-list
139546387|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
139546388|NCT00423358|Vitamins|vitamins|mesh-ancestor
139546389|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
139546390|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546391|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139546392|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139546393|NCT00424840|Bevacizumab|bevacizumab|mesh-list
139546394|NCT00424840|Carboplatin|carboplatin|mesh-list
139546395|NCT00424840|Bortezomib|bortezomib|mesh-list
139546396|NCT00424840|Docetaxel|docetaxel|mesh-list
139546397|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139546398|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546399|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139546400|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139546401|NCT00424840|Growth Substances|growth substances|mesh-ancestor
139546402|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546403|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
139546404|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
139546405|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
139546406|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
139546407|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546408|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139546409|NCT00425386|Sunitinib|sunitinib|mesh-list
139546410|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546411|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139546412|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546413|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546414|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139546415|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139546416|NCT00425386|Growth Substances|growth substances|mesh-ancestor
139546417|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546418|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
139546419|NCT01164202|Sunitinib|sunitinib|mesh-list
139546420|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546421|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139546422|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139546423|NCT01164202|Growth Substances|growth substances|mesh-ancestor
139546424|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328043|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
139546425|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
139546426|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139546427|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546428|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546429|NCT02112370|Epinephrine|epinephrine|mesh-list
139546430|NCT02112370|Racepinephrine|racepinephrine|mesh-list
139546431|NCT02112370|Ropivacaine|ropivacaine|mesh-list
139546432|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
139546433|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
139546434|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
139546435|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139546436|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546437|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
139546438|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546439|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139546440|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139546441|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
139546442|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546443|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546444|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139546445|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139546446|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
139546447|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139546448|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
139546449|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
139546450|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
139546451|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139546452|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
139546453|NCT00427336|Fludarabine|fludarabine|mesh-list
139546454|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
139546455|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
139546456|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139546457|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139546458|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
139546459|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546460|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139546461|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139546462|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
139546463|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546464|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546465|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139546466|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139546467|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
139546468|NCT00371176|Cycloserine|cycloserine|mesh-list
139546469|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139546470|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139546471|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139546472|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
139546473|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139546474|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
139546475|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546476|NCT00428584|Interferons|interferons|mesh-list
139546477|NCT00428584|Interferon-beta|interferon-beta|mesh-list
139546478|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
139546479|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546480|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
139546481|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139546482|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
139546483|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546484|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139546485|NCT05187286|Apixaban|apixaban|mesh-list
139546486|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139546487|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
139546488|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139546489|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
139546490|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546491|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546492|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
139546493|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
139546494|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139546495|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139546496|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139546497|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139546498|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546499|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
139546500|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546501|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546502|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139546503|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546505|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139546506|NCT00455650|Mecamylamine|mecamylamine|mesh-list
139546507|NCT00455650|Varenicline|varenicline|mesh-list
139546508|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139546509|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139546510|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
139546511|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546512|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546513|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546514|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139546515|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
139546516|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
139546517|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546518|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139546519|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139546520|NCT00431626|Dutasteride|dutasteride|mesh-list
139546521|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139546522|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139546523|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546524|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546525|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
139546526|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139546527|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546528|NCT00455962|Estradiol|estradiol|mesh-list
139546529|NCT00455962|Progesterone|progesterone|mesh-list
139546530|NCT00455962|Estrogens|estrogens|mesh-ancestor
139546531|NCT00455962|Hormones|hormones|mesh-ancestor
139546532|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139546533|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546534|NCT00455962|Progestins|progestins|mesh-ancestor
139546535|NCT00434356|Paclitaxel|paclitaxel|mesh-list
139546536|NCT00434356|Bevacizumab|bevacizumab|mesh-list
139546537|NCT00434356|Sunitinib|sunitinib|mesh-list
139546538|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139546539|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546540|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
139546541|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
139546542|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
139546543|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546544|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139546545|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139546546|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139546547|NCT00434356|Growth Substances|growth substances|mesh-ancestor
139546548|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546549|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
139546550|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139546551|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546552|NCT00376948|Gemcitabine|gemcitabine|mesh-list
139546553|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139546554|NCT00376948|Genistein|genistein|mesh-list
139546555|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139546556|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
139546557|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546558|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546559|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139546560|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546561|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139546562|NCT00376948|Protective Agents|protective agents|mesh-ancestor
139546563|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546564|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
139546565|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139546566|NCT00376948|Estrogens|estrogens|mesh-ancestor
139546567|NCT00376948|Hormones|hormones|mesh-ancestor
139546568|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139546569|NCT00438100|Capecitabine|capecitabine|mesh-list
139546570|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139546571|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
139546572|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546573|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546574|NCT00456508|Ecallantide|ecallantide|mesh-list
139546575|NCT00456508|Analgesics|analgesics|mesh-ancestor
139546576|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
139546577|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328201|NCT03287180|Naloxone|naloxone|mesh-list
139546578|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546579|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139546580|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139546581|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139546582|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139546583|NCT00457366|Lorazepam|lorazepam|mesh-list
139546584|NCT00457366|Haloperidol|haloperidol|mesh-list
139546585|NCT00457366|Benztropine|benztropine|mesh-list
139546586|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139546587|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
139546588|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
139546589|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139546590|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139546591|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139546592|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139546593|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546594|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
139546595|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
139546596|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546597|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139546598|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139546599|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
139546600|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139017035|NCT06158841|Bortezomib|bortezomib|mesh-list
139546601|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546602|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139546603|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
139546604|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139546605|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139546606|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
139546607|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
139546608|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139546609|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
139546610|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139546611|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139546612|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
139546613|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139546614|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139546615|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139546616|NCT00458848|Prednisone|prednisone|mesh-list
139546617|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
139546618|NCT00458848|Methotrexate|methotrexate|mesh-list
139546619|NCT00458848|Etoposide|etoposide|mesh-list
139546620|NCT00458848|Vincristine|vincristine|mesh-list
139546621|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
139546622|NCT00458848|Daunorubicin|daunorubicin|mesh-list
139546623|NCT00458848|Asparaginase|asparaginase|mesh-list
139546624|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
139546625|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
139546626|NCT00458848|Idarubicin|idarubicin|mesh-list
139546627|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139546628|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
139546629|NCT00458848|Hormones|hormones|mesh-ancestor
139546630|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139546631|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546632|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139546633|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546634|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139546635|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
139546636|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139546637|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139546638|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
139546639|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546640|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
139546641|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546642|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139546643|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139546644|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
139546645|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139546646|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139546647|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139546648|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139546649|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139546650|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
139546651|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
139546652|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
139546653|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
139546654|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
139017146|NCT06083571|Anesthetics|anesthetics|mesh-ancestor
139546655|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546656|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139546657|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139546658|NCT00458848|Protective Agents|protective agents|mesh-ancestor
139546659|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139546660|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139546661|NCT00458848|Analgesics|analgesics|mesh-ancestor
139546662|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
139546663|NCT00438802|Alefacept|alefacept|mesh-list
139546664|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
139546665|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
139546666|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546667|NCT00377572|Omalizumab|omalizumab|mesh-list
139546668|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139546669|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139546670|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139546671|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
139546672|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
139546673|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546674|NCT00438880|Rituximab|rituximab|mesh-list
139546675|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139546676|NCT00438880|Antibodies|antibodies|mesh-list
139546677|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
139546678|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139546679|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
139546680|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546681|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546682|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139546683|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
139546684|NCT00378352|Hematinics|hematinics|mesh-ancestor
139546685|NCT00462280|Lovastatin|lovastatin|mesh-list
139546686|NCT00462280|L 647318|l 647318|mesh-list
139546687|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
139546688|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139546689|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139546690|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
139546691|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546692|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139546693|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139546694|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546695|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
139546696|NCT00381004|Rituximab|rituximab|mesh-list
139546697|NCT00381004|Fludarabine|fludarabine|mesh-list
139546698|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
139546699|NCT00381004|Sargramostim|sargramostim|mesh-list
139546700|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139546701|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
139546702|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546703|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139546704|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139546705|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
139546706|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546707|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546708|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139546709|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139546710|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139546711|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
139546712|NCT00381550|Fludarabine|fludarabine|mesh-list
139546713|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
139546714|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546715|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139546716|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
139546717|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546718|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139546719|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
139546720|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546721|NCT00440830|Nicotine|nicotine|mesh-list
139017353|NCT05817656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139017354|NCT05808764|Risdiplam|risdiplam|mesh-list
138534889|NCT00130936|Epirubicin|epirubicin|mesh-list
138768077|NCT04178863|Timolol|timolol|mesh-list
139017379|NCT05763875|Ezetimibe|ezetimibe|mesh-list
139546722|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139546723|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
139546724|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546725|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546726|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139546727|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139546728|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
139546729|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546730|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546731|NCT00427804|Calcitriol|calcitriol|mesh-list
139546732|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139546733|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546734|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139546735|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139546736|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546737|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139546738|NCT00427804|Vitamins|vitamins|mesh-ancestor
139546739|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
139017448|NCT05695573|Cystatins|cystatins|mesh-list
139546740|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139546741|NCT00381862|Leucovorin|leucovorin|mesh-list
139546742|NCT00381862|Dexamethasone|dexamethasone|mesh-list
139546743|NCT00381862|Fluorouracil|fluorouracil|mesh-list
139546744|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
139546745|NCT00381862|Irinotecan|irinotecan|mesh-list
139546746|NCT00381862|Camptothecin|camptothecin|mesh-list
139546747|NCT00381862|Aprepitant|aprepitant|mesh-list
139546748|NCT00381862|Palonosetron|palonosetron|mesh-list
139546749|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
139546750|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139546751|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
139546752|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
139546753|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017501|NCT05645432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139017502|NCT05645432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546754|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546755|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139546756|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
139546757|NCT00381862|Hormones|hormones|mesh-ancestor
139546758|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139546759|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139546760|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546761|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
139546762|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546763|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139017572|NCT05516498|Dapagliflozin|dapagliflozin|mesh-list
139017573|NCT05516498|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139017574|NCT05516498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017575|NCT05516498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139017576|NCT05516498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017577|NCT05505214|Mometasone Furoate|mometasone furoate|mesh-list
139017578|NCT05505214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139017579|NCT05505214|Dermatologic Agents|dermatologic agents|mesh-ancestor
139017580|NCT05505214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139017581|NCT05493566|Aldesleukin|aldesleukin|mesh-list
139017582|NCT05493566|Pembrolizumab|pembrolizumab|mesh-list
139017583|NCT05493566|Interleukin-2|interleukin-2|mesh-list
139017584|NCT05493566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017585|NCT05493566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017597|NCT05488678|Ceftibuten|ceftibuten|mesh-list
139546764|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139546765|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
139546766|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139546767|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139546768|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546769|NCT00381862|Antidotes|antidotes|mesh-ancestor
139546770|NCT00381862|Protective Agents|protective agents|mesh-ancestor
139546771|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
139546772|NCT00381862|Vitamins|vitamins|mesh-ancestor
139546773|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
139546774|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139546775|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546776|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139546777|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139546778|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
139546779|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139546780|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139546781|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139546782|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139546783|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139546784|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546785|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546786|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017632|NCT05462613|Aspirin|aspirin|mesh-list
139017633|NCT05462613|Bevacizumab|bevacizumab|mesh-list
139017634|NCT05462613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139546787|NCT00464698|Analgesics|analgesics|mesh-ancestor
139546788|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
139546789|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546790|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
139546791|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139546792|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
139546793|NCT00465088|Niacin|niacin|mesh-list
139546794|NCT00465088|Niacinamide|niacinamide|mesh-list
139546795|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
139546796|NCT00465088|Atorvastatin|atorvastatin|mesh-list
139546797|NCT00465088|Simvastatin|simvastatin|mesh-list
139546798|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139546799|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139546800|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
139546801|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546802|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139546803|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139546804|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546805|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
139546806|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
139546807|NCT00465088|Vitamins|vitamins|mesh-ancestor
139546808|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
139546809|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768370|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
139546811|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139546812|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
139546813|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546814|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546815|NCT00466960|Paclitaxel|paclitaxel|mesh-list
139546816|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139546817|NCT00466960|Sargramostim|sargramostim|mesh-list
139546818|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139546819|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546820|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
139546821|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
139546822|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
139546823|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546824|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
139546825|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546826|NCT00383266|Carboplatin|carboplatin|mesh-list
139546827|NCT00383266|Pemetrexed|pemetrexed|mesh-list
139546828|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546829|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017734|NCT05309655|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139546830|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546831|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139546832|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139546833|NCT00384670|Vaccines|vaccines|mesh-list
139546834|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
139546835|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546836|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139546837|NCT00467350|Laxatives|laxatives|mesh-ancestor
139546838|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139546839|NCT00444028|Loxapine|loxapine|mesh-list
139546840|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139546841|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139546842|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139546843|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546844|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139546845|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139546846|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
139546847|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546848|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546849|NCT00444964|Hormones|hormones|mesh-list
139546850|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139546851|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546852|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139546853|NCT00445588|Sorafenib|sorafenib|mesh-list
139546854|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546855|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139546856|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546857|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546858|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
139546859|NCT00445744|Busulfan|busulfan|mesh-list
139546860|NCT00445744|Methotrexate|methotrexate|mesh-list
139546861|NCT00445744|Tacrolimus|tacrolimus|mesh-list
139546862|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139546863|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
139546864|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546865|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139546866|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139546867|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
139546868|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546869|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546870|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139546871|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139546872|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
139546873|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139546874|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139546875|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
139546876|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
139546877|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546878|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139546879|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139546880|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139546881|NCT00468208|Abatacept|abatacept|mesh-list
139546882|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139546883|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546884|NCT00468208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139546886|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139546887|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
139546888|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546889|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139546890|NCT00385138|Clopidogrel|clopidogrel|mesh-list
139546891|NCT00385138|Cangrelor|cangrelor|mesh-list
139546892|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139546893|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139546894|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139546895|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139546896|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
139546897|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546898|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546899|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546900|NCT00446290|Docetaxel|docetaxel|mesh-list
139546901|NCT00446290|Capecitabine|capecitabine|mesh-list
139546902|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
139546903|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546904|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
139546905|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
139546906|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
139546907|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546908|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139546909|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
139546910|NCT00385216|Nicotine|nicotine|mesh-list
139546911|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139546912|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
139546913|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546914|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546915|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139546916|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139546917|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
139546918|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546919|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546920|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139546921|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546922|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139546923|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546924|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546925|NCT00470392|Clobetasol|clobetasol|mesh-list
139546926|NCT00470392|Imiquimod|imiquimod|mesh-list
139546927|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139546928|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
139546929|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546930|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546931|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
139546932|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139546933|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
139546934|NCT00470392|Hormones|hormones|mesh-ancestor
139546935|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139546936|NCT00470548|Paclitaxel|paclitaxel|mesh-list
139546937|NCT00470548|Pemetrexed|pemetrexed|mesh-list
139546938|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139546939|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139546940|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546941|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
139546942|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
139546943|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
139017955|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139546944|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546945|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546946|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139546947|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139546948|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139546949|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139546950|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139546951|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139546952|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546953|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139546954|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546955|NCT00388414|Analgesics|analgesics|mesh-ancestor
139546956|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
139018011|NCT04792385|Diuretics|diuretics|mesh-ancestor
139546957|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139546958|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
139546959|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139546960|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
139546961|NCT00475150|Cediranib|cediranib|mesh-list
139546962|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546963|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546964|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546965|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139546966|NCT00451048|Sunitinib|sunitinib|mesh-list
139546967|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546968|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139546969|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139546970|NCT00451048|Growth Substances|growth substances|mesh-ancestor
139546971|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546972|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
139546973|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139546974|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139546975|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139546976|NCT00388804|Leuprolide|leuprolide|mesh-list
139546977|NCT00388804|Goserelin|goserelin|mesh-list
139546978|NCT00388804|Flutamide|flutamide|mesh-list
139546979|NCT00388804|Bicalutamide|bicalutamide|mesh-list
139546980|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139546981|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
139546982|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139546983|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546984|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139546985|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139546986|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
139546987|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
139546988|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139546989|NCT00389818|Prednisone|prednisone|mesh-list
139546990|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
139546991|NCT00389818|Rituximab|rituximab|mesh-list
139546992|NCT00389818|Doxorubicin|doxorubicin|mesh-list
139546993|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139546994|NCT00389818|Vincristine|vincristine|mesh-list
139546995|NCT00389818|Sargramostim|sargramostim|mesh-list
139546996|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139546997|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
139546998|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139546999|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139547000|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139547001|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
139547002|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547003|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547004|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139547005|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139547006|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139547007|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139547008|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139547009|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547010|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547011|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
139547012|NCT00389818|Hormones|hormones|mesh-ancestor
139547013|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547014|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139547015|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139547016|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
139547017|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
139547018|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
139547019|NCT00452374|Cytarabine|cytarabine|mesh-list
139547020|NCT00452374|Rituximab|rituximab|mesh-list
139547021|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
139547022|NCT00452374|Fludarabine|fludarabine|mesh-list
139547023|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
139547024|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139547025|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547026|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
139547027|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547028|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139547029|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139547030|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
139547031|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547032|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139547033|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
139547034|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547035|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
139547036|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139547037|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547038|NCT03286114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139547039|NCT03286114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547040|NCT00476242|Naltrexone|naltrexone|mesh-list
139547041|NCT00476242|Memantine|memantine|mesh-list
139547042|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139547043|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139547044|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
139547045|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547046|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547047|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547048|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139547049|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139547050|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139547051|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139547052|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
139547053|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547054|NCT00476788|Insulin|insulin|mesh-list
139547055|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139547056|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139547057|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547058|NCT01795144|Glucagon|glucagon|mesh-list
139547059|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139547060|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139547061|NCT01795144|Hormones|hormones|mesh-ancestor
139018277|NCT04239794|Propofol|propofol|mesh-list
139547062|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547063|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547064|NCT01795144|Incretins|incretins|mesh-ancestor
139547065|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139547066|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
139547067|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139547068|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139547069|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547070|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139547071|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139547072|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139547073|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547074|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
139547075|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547076|NCT00453388|Cyclosporine|cyclosporine|mesh-list
139547077|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
139547078|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
139547079|NCT00453388|Fludarabine|fludarabine|mesh-list
139547080|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
139547081|NCT00453388|Cyclosporins|cyclosporins|mesh-list
139547082|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139547083|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
139547084|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547085|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139547086|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139547087|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
139547088|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547089|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547090|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139547091|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139547092|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
139547093|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547094|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
139547095|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547096|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
139547097|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139547098|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139547099|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139547100|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
139547101|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139547102|NCT00389974|Sunitinib|sunitinib|mesh-list
139547103|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547104|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139547105|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139547106|NCT00389974|Growth Substances|growth substances|mesh-ancestor
139547107|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547108|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
139547109|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139547110|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547111|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547112|NCT01453725|Golimumab|golimumab|mesh-list
139547113|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139547114|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547115|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139547116|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
139547117|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547118|NCT00454324|Paclitaxel|paclitaxel|mesh-list
139547119|NCT00454324|Carboplatin|carboplatin|mesh-list
139547120|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139547121|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139547122|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547123|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
139547124|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
139547125|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
139547126|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547127|NCT02110264|Naltrexone|naltrexone|mesh-list
139547128|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139547129|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139547130|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547131|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
139547132|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547133|NCT01795222|Midazolam|midazolam|mesh-list
139547134|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139547135|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139547136|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139547137|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547138|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139547139|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139547140|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139547141|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139547142|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
139547143|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
139547144|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
139547145|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
139547146|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547147|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547148|NCT01415349|Omeprazole|omeprazole|mesh-list
139547149|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139547150|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139547151|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139547152|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547153|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547154|NCT00528190|Itraconazole|itraconazole|mesh-list
139547155|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
139547156|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547157|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139547158|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139547159|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547160|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547161|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139547162|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
139547163|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547164|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547165|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139547166|NCT02334813|Dexamethasone|dexamethasone|mesh-list
139547167|NCT02334813|Prednisone|prednisone|mesh-list
139547168|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547169|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
139547170|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
139547171|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547172|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547173|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139547174|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
139547175|NCT02334813|Hormones|hormones|mesh-ancestor
139547176|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547177|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139547178|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547179|NCT00478036|Prednisolone|prednisolone|mesh-list
139547180|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
139547181|NCT00478036|Ketorolac|ketorolac|mesh-list
139547182|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139547183|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139547184|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547185|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
139547186|NCT00478036|Hormones|hormones|mesh-ancestor
139547187|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547188|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547189|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139018470|NCT03530683|Hormones|hormones|mesh-ancestor
139547190|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547191|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547192|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139547193|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139547194|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139547195|NCT00478036|Analgesics|analgesics|mesh-ancestor
139547196|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
139547197|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139547198|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139547199|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547200|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547201|NCT00478036|Laxatives|laxatives|mesh-ancestor
139547202|NCT04048863|Imidacloprid|imidacloprid|mesh-list
139547203|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
139547204|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547205|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547206|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547207|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
139547208|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547209|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
139547210|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547211|NCT01453023|Fluticasone|fluticasone|mesh-list
139547212|NCT01453023|Xhance|xhance|mesh-list
139547213|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547214|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139018502|NCT03424005|SGN-LIV1A|sgn-liv1a|mesh-list
139547215|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
139547216|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547217|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547218|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139547219|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
139547220|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
139547221|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139547222|NCT01452789|Morphine|morphine|mesh-list
139547223|NCT01452789|Buprenorphine|buprenorphine|mesh-list
139547224|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139547225|NCT01452789|Narcotics|narcotics|mesh-ancestor
139547226|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139547227|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547228|NCT01452789|Analgesics|analgesics|mesh-ancestor
139547229|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
139547230|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547231|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139547232|NCT00478192|Conivaptan|conivaptan|mesh-list
139547233|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139547234|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547235|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
139547236|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547237|NCT01414257|Methotrexate|methotrexate|mesh-list
139547238|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139547239|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
139547240|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139547241|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547242|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139547243|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
139547244|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547245|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547246|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
139547247|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547248|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139547249|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139547250|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
139018551|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018552|NCT03117972|Leucovorin|leucovorin|mesh-list
139018553|NCT03117972|Bevacizumab|bevacizumab|mesh-list
139018554|NCT03117972|Capecitabine|capecitabine|mesh-list
139018555|NCT03117972|Fluorouracil|fluorouracil|mesh-list
139018556|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
139018557|NCT03117972|Irinotecan|irinotecan|mesh-list
139018558|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
139018559|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139547251|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139547252|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139547253|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139547254|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547255|NCT00528580|Simvastatin|simvastatin|mesh-list
139547256|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139547257|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139547258|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
139547259|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547260|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139547261|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139547262|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547263|NCT00529126|Epinephrine|epinephrine|mesh-list
139547264|NCT00529126|Bupivacaine|bupivacaine|mesh-list
139547265|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
139547266|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
139547267|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139018599|NCT02937818|Carboplatin|carboplatin|mesh-list
139547268|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547269|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
139547270|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547271|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139547272|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139547273|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
139547274|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547275|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547276|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139547277|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139547278|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
139547279|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139547280|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
139547281|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
139547282|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
139547283|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139547284|NCT00529204|Exenatide|exenatide|mesh-list
139547285|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139547286|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547287|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139547288|NCT00529204|Incretins|incretins|mesh-ancestor
139547289|NCT00529204|Hormones|hormones|mesh-ancestor
139547290|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547291|NCT01451541|Ciclesonide|ciclesonide|mesh-list
139547292|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
139547293|NCT01451541|Hormones|hormones|mesh-ancestor
139547294|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139018656|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
139547295|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547296|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139547297|NCT00530764|Nabiximols|nabiximols|mesh-list
139547298|NCT00530764|Dronabinol|dronabinol|mesh-list
139547299|NCT00530764|Cannabidiol|cannabidiol|mesh-list
139547300|NCT00530764|Analgesics|analgesics|mesh-ancestor
139547301|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
139547302|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547303|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547304|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
139547305|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
139547306|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139547307|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139547308|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139547309|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139547310|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547311|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547312|NCT00530764|Hormones|hormones|mesh-ancestor
139547313|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547314|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139547315|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139547316|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139547317|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139547318|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547319|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547320|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547321|NCT00532480|Analgesics|analgesics|mesh-ancestor
139547322|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
139547323|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547324|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
139547325|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139547326|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
139547327|NCT00483262|Bortezomib|bortezomib|mesh-list
139547328|NCT00483262|Temsirolimus|temsirolimus|mesh-list
139547329|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547330|NCT00483262|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139547331|NCT00483262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139547332|NCT00483262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547333|NCT00483262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547334|NCT00483262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139547335|NCT00483262|Immunologic Factors|immunologic factors|mesh-ancestor
139547336|NCT00483262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547337|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
139547338|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
139547339|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139547340|NCT00483496|Protective Agents|protective agents|mesh-ancestor
139547341|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547342|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
139547343|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139547344|NCT00485836|Ranibizumab|ranibizumab|mesh-list
139547345|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139547346|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139547347|NCT00485836|Growth Substances|growth substances|mesh-ancestor
139547348|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547349|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
139547350|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547351|NCT00488488|Tigecycline|tigecycline|mesh-list
139547352|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139547353|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547354|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139547355|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547356|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547357|NCT01450761|Carboplatin|carboplatin|mesh-list
139547358|NCT01450761|Etoposide|etoposide|mesh-list
139547359|NCT01450761|Ipilimumab|ipilimumab|mesh-list
139547360|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547361|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139547362|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139547363|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139547364|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547365|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547366|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139547367|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139547368|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
139547369|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547370|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
139547371|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139547372|NCT00538642|Ziprasidone|ziprasidone|mesh-list
139547373|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139547374|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
139547375|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547376|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547377|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547378|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139547379|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139547380|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139547381|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139547382|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139547383|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
139547384|NCT01433991|Lenvatinib|lenvatinib|mesh-list
139547385|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547386|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139547387|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547388|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547389|NCT01450683|Itraconazole|itraconazole|mesh-list
139547390|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
139547391|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547392|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139547393|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139547394|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547395|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547396|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139547397|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
139547398|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547399|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547400|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139547401|NCT01433055|Minocycline|minocycline|mesh-list
139547402|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139547403|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547404|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
139547405|NCT01450137|Hormones|hormones|mesh-ancestor
139329037|NCT02281305|Colchicine|colchicine|mesh-list
139547406|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547407|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547408|NCT01412229|Paclitaxel|paclitaxel|mesh-list
139547409|NCT01412229|Carboplatin|carboplatin|mesh-list
139547410|NCT01412229|Cetuximab|cetuximab|mesh-list
139547411|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139547412|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547413|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
139547414|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
139547415|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
139547416|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547417|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139547418|NCT01432275|Insulin|insulin|mesh-list
139547419|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139547420|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547421|NCT01411995|Lidocaine|lidocaine|mesh-list
139547422|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
139547423|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
139547424|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139547425|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547426|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
139547427|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547428|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139547429|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139547430|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139547431|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139547432|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547433|NCT01411215|Etanercept|etanercept|mesh-list
139547434|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139547435|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139547436|NCT01411215|Analgesics|analgesics|mesh-ancestor
139547437|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
139547438|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547439|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547440|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139018952|NCT06044805|Filaricides|filaricides|mesh-ancestor
139547441|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139547442|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139547443|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139547444|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
139547445|NCT01449279|Ipilimumab|ipilimumab|mesh-list
139547446|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139547447|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547448|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139547449|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547450|NCT01431963|Lamotrigine|lamotrigine|mesh-list
139547451|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
139547452|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139547453|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139547454|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547455|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139547456|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547457|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139018998|NCT06038981|Tranexamic Acid|tranexamic acid|mesh-list
139547458|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139547459|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139547460|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139547461|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139547462|NCT01447407|Vaccines|vaccines|mesh-list
139547463|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
139547464|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
139547465|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547466|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139547467|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139547468|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
139547469|NCT00540982|Vinorelbine|vinorelbine|mesh-list
139547470|NCT00540982|Lidocaine|lidocaine|mesh-list
139547471|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
139547472|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
139547473|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139547474|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547475|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
139547476|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547477|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139329095|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
139547478|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139547479|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139547480|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139547481|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547482|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139547483|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547484|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
139547485|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
139547486|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
139547487|NCT00542620|Insulin|insulin|mesh-list
139547488|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139547489|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
139547490|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
139547491|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139547492|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
139547493|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139547494|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547495|NCT00543400|Heparin|heparin|mesh-list
139547496|NCT00543400|Calcium heparin|calcium heparin|mesh-list
139547497|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
139547498|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139547499|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139547500|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547501|NCT01796938|Lacosamide|lacosamide|mesh-list
139547502|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
139547503|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139547504|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139547505|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139547506|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547507|NCT00492544|Vaccines|vaccines|mesh-list
139547508|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
139547509|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547510|NCT00492622|Omeprazole|omeprazole|mesh-list
139547511|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139547512|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139547513|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139547514|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547515|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547516|NCT00494494|Nepafenac|nepafenac|mesh-list
139547517|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139547518|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139547519|NCT00494494|Analgesics|analgesics|mesh-ancestor
139547520|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
139547521|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547522|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547523|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547524|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139547525|NCT03145558|Doxorubicin|doxorubicin|mesh-list
139547526|NCT03145558|Tirapazamine|tirapazamine|mesh-list
139547527|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139547528|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547529|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139547530|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139547531|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547532|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547533|NCT00497770|Pemetrexed|pemetrexed|mesh-list
139547534|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547535|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547536|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547537|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139547538|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139547539|NCT00498550|Clozapine|clozapine|mesh-list
139547540|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139547541|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
139547542|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547543|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547544|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547545|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139547546|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139547547|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139547548|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139547549|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
139547550|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
139547551|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139547552|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
139547553|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139547554|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139547555|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139547556|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139019125|NCT05572229|Lenalidomide|lenalidomide|mesh-list
139547557|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547558|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139547559|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139547560|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547561|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547562|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139547563|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
139547564|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547565|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547566|NCT00499408|Vitamin D|vitamin d|mesh-list
139547567|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
139547568|NCT00499408|Vitamins|vitamins|mesh-ancestor
139547569|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
139547570|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547571|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139547572|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139547573|NCT03019666|Niacinamide|niacinamide|mesh-list
139547574|NCT03019666|Niacin|niacin|mesh-list
139547575|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
139547576|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
139547577|NCT03019666|Vitamins|vitamins|mesh-ancestor
139547578|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
139547579|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547580|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139547581|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
139547582|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547583|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139547584|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
139547585|NCT00500578|Ribavirin|ribavirin|mesh-list
139547586|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
139547587|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547588|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
139547589|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547590|NCT01430559|Meloxicam|meloxicam|mesh-list
139547591|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139547592|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139547593|NCT01430559|Analgesics|analgesics|mesh-ancestor
139547594|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
139547595|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547596|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547597|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547598|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139547599|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139547600|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139547601|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019292|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547602|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547603|NCT00500656|Icatibant|icatibant|mesh-list
139547604|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
139547605|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139547606|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139547607|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547608|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
139547609|NCT00500656|Coagulants|coagulants|mesh-ancestor
139547610|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139547611|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139547612|NCT00500656|Analgesics|analgesics|mesh-ancestor
139547613|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
139547614|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547615|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547616|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547617|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139547618|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
139547619|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
139547620|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139547621|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139547622|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
139547623|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
139547624|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139547625|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547626|NCT01445847|Lidocaine|lidocaine|mesh-list
139547627|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
139547628|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
139547629|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139547630|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547631|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
139547632|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547633|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139547634|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139547635|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139547636|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139547637|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547638|NCT00502216|Naltrexone|naltrexone|mesh-list
139547639|NCT00502216|Varenicline|varenicline|mesh-list
139547640|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139547641|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139547642|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547643|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
139547644|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547645|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139547646|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139547647|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
139547648|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547649|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547650|NCT00545662|Choline|choline|mesh-list
139547651|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139547652|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
139547653|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139547654|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
139547655|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547656|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139547657|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139547658|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
139547659|NCT00545974|Memantine|memantine|mesh-list
139547660|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139547661|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139547662|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
139547663|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547664|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547665|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547666|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139547667|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139547668|NCT00548470|Varenicline|varenicline|mesh-list
139547669|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139547670|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139547671|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
139547672|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547673|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547674|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547675|NCT00509002|Gefitinib|gefitinib|mesh-list
139547676|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547677|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139547678|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547679|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547680|NCT00887380|Anastrozole|anastrozole|mesh-list
139547681|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139547682|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547683|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139547684|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139547685|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547686|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547687|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139547688|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
139547689|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547690|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547691|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139547692|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547693|NCT00557284|Montelukast|montelukast|mesh-list
139547694|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139547695|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
139547696|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139547697|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
139547698|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547699|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547700|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139547701|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139547702|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547703|NCT00557362|Voriconazole|voriconazole|mesh-list
139547704|NCT00557362|Natamycin|natamycin|mesh-list
139547705|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
139547706|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547707|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139547708|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139547709|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547710|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547711|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139547712|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
139547713|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547714|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547715|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139547716|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139547717|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139547718|NCT00512278|Infliximab|infliximab|mesh-list
139547719|NCT00512278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139547720|NCT00512278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547721|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
139547722|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139547723|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139547724|NCT01445535|Prednisone|prednisone|mesh-list
139547725|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
139547726|NCT01445535|Rituximab|rituximab|mesh-list
139547727|NCT01445535|Doxorubicin|doxorubicin|mesh-list
139547728|NCT01445535|Etoposide|etoposide|mesh-list
139547729|NCT01445535|Vincristine|vincristine|mesh-list
139547730|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139547731|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
139547732|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547733|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139547734|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139547735|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
139547736|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547737|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547738|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139547739|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139547740|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139547741|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139547742|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139547743|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547744|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547745|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
139547746|NCT01445535|Hormones|hormones|mesh-ancestor
139547747|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547748|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139547749|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139547750|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
139547751|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
139547752|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
139547753|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
139547754|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
139547755|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139547756|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139547757|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547758|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547759|NCT01409031|Urological Agents|urological agents|mesh-ancestor
139547760|NCT01430403|Fluticasone|fluticasone|mesh-list
139547761|NCT01430403|Xhance|xhance|mesh-list
139547762|NCT01430403|Omalizumab|omalizumab|mesh-list
139547763|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139547764|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547765|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139547766|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
139547767|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547768|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547769|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139019452|NCT04493151|Imipenem|imipenem|mesh-list
139547770|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
139547771|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
139547772|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139547773|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
139547774|NCT01408641|Topiramate|topiramate|mesh-list
139547775|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
139547776|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139547777|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547778|NCT01429077|Levodopa|levodopa|mesh-list
139547779|NCT01429077|Carbidopa|carbidopa|mesh-list
139547780|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139547781|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139547782|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
139547783|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547784|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547785|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547786|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139547787|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547788|NCT01408563|Fludarabine|fludarabine|mesh-list
139547789|NCT01408563|Melphalan|melphalan|mesh-list
139547790|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547791|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547792|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139547793|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
139547794|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547795|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139547796|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
139547797|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139547798|NCT01442493|Methadone|methadone|mesh-list
139547799|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139547800|NCT01442493|Narcotics|narcotics|mesh-ancestor
139547801|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139547802|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547803|NCT01442493|Analgesics|analgesics|mesh-ancestor
139547804|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
139547805|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547806|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
139547807|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
139547808|NCT04407975|Betamethasone|betamethasone|mesh-list
139547809|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547810|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
139547811|NCT04407975|Hormones|hormones|mesh-ancestor
139547812|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547813|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547814|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139547815|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
139547816|NCT01428063|Interferons|interferons|mesh-list
139547817|NCT01428063|Ribavirin|ribavirin|mesh-list
139547818|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
139547819|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
139547820|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139547821|NCT01428063|Asunaprevir|asunaprevir|mesh-list
139547822|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547823|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
139547824|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547825|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
139547826|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547827|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
139547828|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547829|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
139547830|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547831|NCT00513292|Paclitaxel|paclitaxel|mesh-list
139547832|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
139547833|NCT00513292|Trastuzumab|trastuzumab|mesh-list
139547834|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139547835|NCT00513292|Epirubicin|epirubicin|mesh-list
139547836|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139547837|NCT00513292|Antibodies|antibodies|mesh-list
139547838|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
139547839|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139547840|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139547841|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547842|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
139547843|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
139547844|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
139547845|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547846|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139547847|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
139547848|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547849|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139329458|NCT03243500|Lidocaine|lidocaine|mesh-list
139547850|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139547851|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
139547852|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139547853|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139547854|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139547855|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139547856|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547857|NCT00513370|Adalimumab|adalimumab|mesh-list
139547858|NCT00513370|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139547859|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547860|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139547861|NCT00559468|Bromides|bromides|mesh-list
139547862|NCT00559468|Propofol|propofol|mesh-list
139547863|NCT00559468|Sevoflurane|sevoflurane|mesh-list
139547864|NCT00559468|Rocuronium|rocuronium|mesh-list
139547865|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139547866|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139547867|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547868|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139547869|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
139547870|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
139547871|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139547872|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139547873|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
139547874|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139547875|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139547876|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139547877|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547878|NCT00561418|Vorinostat|vorinostat|mesh-list
139547879|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547880|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139547881|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547882|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547883|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139547884|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
139547885|NCT00514852|Glycerol|glycerol|mesh-list
139547886|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139547887|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139547888|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139547889|NCT00514852|Protective Agents|protective agents|mesh-ancestor
139547890|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547891|NCT00514852|Laxatives|laxatives|mesh-ancestor
139547892|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139547893|NCT00555880|Midodrine|midodrine|mesh-list
139547894|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
139547895|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
139547896|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139547897|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547898|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139547899|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139019615|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139547900|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139547901|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139547902|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
139547903|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139547904|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547905|NCT00563290|Dasatinib|dasatinib|mesh-list
139547906|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547907|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139547908|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547909|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547910|NCT00556504|Ribavirin|ribavirin|mesh-list
139547911|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139547912|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139547913|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
139547914|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547915|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
139547916|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547917|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
139547918|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139547919|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547920|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139547921|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139547922|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
139547923|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547924|NCT00520234|Caspofungin|caspofungin|mesh-list
139547925|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
139329534|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
139547926|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547927|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547928|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547930|NCT00520468|Prednisone|prednisone|mesh-list
139547931|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
139547932|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
139547933|NCT00520468|Cyclosporins|cyclosporins|mesh-list
139547934|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139547935|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
139547936|NCT00520468|Hormones|hormones|mesh-ancestor
139019716|NCT06082388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547937|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547938|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547939|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139547940|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547941|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547942|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547943|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139547944|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
139547945|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
139547946|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547947|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
139547948|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139547949|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139547950|NCT00520468|Hematinics|hematinics|mesh-ancestor
139547951|NCT05559268|Denosumab|denosumab|mesh-list
139547952|NCT05559268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139547953|NCT05559268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547954|NCT02121418|Cytarabine|cytarabine|mesh-list
139547955|NCT02121418|Decitabine|decitabine|mesh-list
139547956|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139547957|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
139547958|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547959|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547960|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
139547961|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139547962|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139547963|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
139547964|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547965|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139547966|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139547967|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139547968|NCT01441635|Norethindrone|norethindrone|mesh-list
139547969|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
139547970|NCT01441635|Estradiol|estradiol|mesh-list
139547971|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139547972|NCT01441635|Progesterone|progesterone|mesh-list
139547973|NCT01441635|Estrogens|estrogens|mesh-ancestor
139547974|NCT01441635|Hormones|hormones|mesh-ancestor
139547975|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139547976|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547977|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139547978|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
139547979|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139547980|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139547981|NCT01441635|Progestins|progestins|mesh-ancestor
139547982|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139547983|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139547984|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139547985|NCT01427907|Calcium|calcium|mesh-list
139547986|NCT01427907|Sevelamer|sevelamer|mesh-list
139547987|NCT01427907|Calcium acetate|calcium acetate|mesh-list
139547988|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139547989|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139547990|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
139547991|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
139547992|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139547993|NCT02985333|Dexamethasone|dexamethasone|mesh-list
139547994|NCT02985333|Paclitaxel|paclitaxel|mesh-list
139547995|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
139547996|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139547997|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139547998|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
139547999|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
139548000|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
139548001|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548002|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139548003|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
139548004|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548005|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139548006|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139548007|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
139548008|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139548009|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139548010|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
139548011|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
139548012|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548013|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139548014|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
139548015|NCT02985333|Hormones|hormones|mesh-ancestor
139548016|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548017|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139548018|NCT01427751|Dexamethasone|dexamethasone|mesh-list
139548019|NCT01427751|Ranibizumab|ranibizumab|mesh-list
139548020|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139548021|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
139548022|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
139548023|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548024|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548025|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139548026|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
139548027|NCT01427751|Hormones|hormones|mesh-ancestor
139548028|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548029|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139548030|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548031|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139548032|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139548033|NCT01427751|Growth Substances|growth substances|mesh-ancestor
139548034|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
139548035|NCT01920061|Docetaxel|docetaxel|mesh-list
139548036|NCT01920061|Gedatolisib|gedatolisib|mesh-list
139548037|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548038|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
139548039|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
139548040|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
139548041|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548042|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139548043|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548044|NCT01426347|Vitamin D|vitamin d|mesh-list
139548045|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
139548046|NCT01426347|Vitamins|vitamins|mesh-ancestor
139548047|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
139019998|NCT06012175|Melatonin|melatonin|mesh-list
139548048|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548049|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139548050|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139548051|NCT04612309|Immunomodulating Agents|immunomodulating agents|mesh-list
139548052|NCT04612309|Immunologic Factors|immunologic factors|mesh-ancestor
139548053|NCT04612309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548054|NCT04415983|Metronidazole|metronidazole|mesh-list
139548055|NCT04415983|Clarithromycin|clarithromycin|mesh-list
139548056|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
139548057|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139548058|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548059|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139548060|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139548061|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139548062|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139548063|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548064|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548065|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139548066|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139548067|NCT01426269|Metronidazole|metronidazole|mesh-list
139548068|NCT01426269|Doxycycline|doxycycline|mesh-list
139548069|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548070|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139548071|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139548072|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139548073|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
139548074|NCT01426113|Timolol|timolol|mesh-list
139548075|NCT01426113|Bimatoprost|bimatoprost|mesh-list
139548076|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139548077|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139548078|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139329683|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
139548079|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139020046|NCT05938959|Ropivacaine|ropivacaine|mesh-list
139548081|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548082|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548083|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548084|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139548085|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139548086|NCT01393899|Tofacitinib|tofacitinib|mesh-list
139548087|NCT01393899|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139548088|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139548089|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548090|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548091|NCT02078193|Abatacept|abatacept|mesh-list
139548092|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139548093|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548094|NCT02078193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139548095|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548096|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139548097|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
139548098|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548099|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139548100|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139548101|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139548102|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548103|NCT01405911|Incretins|incretins|mesh-ancestor
139548104|NCT01405911|Hormones|hormones|mesh-ancestor
139548105|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548106|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139548107|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
139548108|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548109|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548110|NCT01425801|Albuterol|albuterol|mesh-list
139548111|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139548112|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
139548113|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548114|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548115|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139548116|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
139548117|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
139548118|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139548119|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139548120|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139548121|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139548122|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
139548123|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548124|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548125|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
139548126|NCT02076243|Paclitaxel|paclitaxel|mesh-list
139548127|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139548128|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548129|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
139548130|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
139548131|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
139548132|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548133|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
139548134|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139548135|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139548136|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139548137|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139548138|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548139|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
139548140|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548141|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548142|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139548143|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548144|NCT01392573|Insulin|insulin|mesh-list
139548145|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139548146|NCT01392573|Liraglutide|liraglutide|mesh-list
139548147|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
139548148|NCT01392573|Xultophy|xultophy|mesh-list
139548149|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139548150|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548151|NCT01392573|Incretins|incretins|mesh-ancestor
139548152|NCT01392573|Hormones|hormones|mesh-ancestor
139548153|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548154|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
139548155|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548156|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139548157|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548158|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548159|NCT01405053|Rufinamide|rufinamide|mesh-list
139548160|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
139548161|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139548162|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139548163|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139548164|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020239|NCT05476094|Antimetabolites|antimetabolites|mesh-ancestor
139548165|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139548166|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
139548167|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548168|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
139548169|NCT01392183|Sirolimus|sirolimus|mesh-list
139548170|NCT01392183|Temsirolimus|temsirolimus|mesh-list
139548171|NCT01392183|MTOR Inhibitors|mtor inhibitors|mesh-list
139548172|NCT01392183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139548173|NCT01392183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548174|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548175|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139548176|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
139548177|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548178|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548179|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139548180|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548181|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139548182|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
139548183|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139548184|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139548185|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139548186|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
139548187|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
139548188|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
139548189|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548190|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
139548191|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
139548192|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139548193|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139548194|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
139548195|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
139548196|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548197|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139548198|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
139548199|NCT01402947|Mesalamine|mesalamine|mesh-list
139548200|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139548201|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548202|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139548203|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139548204|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548205|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548206|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548207|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139548208|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139548209|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139548210|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139548211|NCT01402947|Analgesics|analgesics|mesh-ancestor
139548212|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
139548213|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548214|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548215|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139548216|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139548217|NCT03025893|Sunitinib|sunitinib|mesh-list
139548218|NCT03025893|Lomustine|lomustine|mesh-list
139548219|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548220|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139548221|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139548222|NCT03025893|Growth Substances|growth substances|mesh-ancestor
139548223|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548224|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
139548225|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139548226|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548227|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548228|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139548229|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
139548230|NCT01402869|Lidocaine|lidocaine|mesh-list
139548231|NCT01402869|Epinephrine|epinephrine|mesh-list
139548232|NCT01402869|Prilocaine|prilocaine|mesh-list
139548233|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
139548234|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
139548235|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139548236|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548237|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
139548238|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548239|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139548240|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139548241|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139548242|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139548243|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548244|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139548245|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139548246|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
139548247|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548248|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139548249|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139548250|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
139548251|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139548252|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
139548253|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
139548254|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
139548255|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139548256|NCT01391793|Dexamethasone|dexamethasone|mesh-list
139548257|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139548258|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
139548259|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
139548260|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548261|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548262|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139548263|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
139548264|NCT01391793|Hormones|hormones|mesh-ancestor
139548265|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548266|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139548267|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548268|NCT01422915|Colestipol|colestipol|mesh-list
139548269|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139548270|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
139548271|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548272|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139548273|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
139548274|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
139548275|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139548276|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
139548277|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548278|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548279|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139548280|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
139548281|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
139548282|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139548283|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
138541467|NCT00408226|Pemetrexed|pemetrexed|mesh-list
139548284|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548285|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548286|NCT01422213|Vortioxetine|vortioxetine|mesh-list
139548287|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
139548288|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139548289|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139548290|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139548291|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139548292|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548293|NCT01422213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139548294|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139548295|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139548296|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548297|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548298|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
139548299|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139329936|NCT03709355|Hormones|hormones|mesh-ancestor
139548300|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139548301|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139548302|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139548304|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
139548305|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548306|NCT01725386|Capecitabine|capecitabine|mesh-list
139548307|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139548308|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
139548309|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548310|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548311|NCT01402011|Lidocaine|lidocaine|mesh-list
139548312|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
139548313|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
139020560|NCT04330690|Hormones|hormones|mesh-ancestor
139548314|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139548315|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548316|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
139548317|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548318|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139548319|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139548320|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139548321|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139548322|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548323|NCT01421667|Rituximab|rituximab|mesh-list
139548324|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139548325|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139548326|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548327|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
139548328|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548329|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139548330|NCT01421667|Immunotoxins|immunotoxins|mesh-ancestor
139548331|NCT01421667|Immunoconjugates|immunoconjugates|mesh-ancestor
139548332|NCT01891669|PF-06263507|pf-06263507|mesh-list
139548333|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139548334|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548335|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
139548336|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
139548337|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548338|NCT01421511|Linezolid|linezolid|mesh-list
139548339|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139548340|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548341|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139548342|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548343|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548344|NCT01891357|Paclitaxel|paclitaxel|mesh-list
139548345|NCT01891357|Trastuzumab|trastuzumab|mesh-list
139548346|NCT01891357|Lapatinib|lapatinib|mesh-list
139548347|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139548348|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548349|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
139548350|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
139548351|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
139548352|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548353|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139548354|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139548355|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548356|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
139548357|NCT01420965|Antibodies|antibodies|mesh-list
139548358|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
139548359|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139548360|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
139548361|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548362|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139020605|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
139548363|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139548364|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
139548365|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548366|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548367|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139548368|NCT04033575|Listerine|listerine|mesh-list
139548369|NCT04033575|Fluorides|fluorides|mesh-list
139548370|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
139548371|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
139548372|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
139548373|NCT04033575|Protective Agents|protective agents|mesh-ancestor
139548374|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548375|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139548376|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548377|NCT01390389|Ubiquinone|ubiquinone|mesh-list
139548378|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
139548379|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
139548380|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548381|NCT01390389|Vitamins|vitamins|mesh-ancestor
139548382|NCT03835533|Nivolumab|nivolumab|mesh-list
139548383|NCT03835533|Poly ICLC|poly iclc|mesh-list
139548384|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139548385|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548386|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139548387|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548388|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
139548389|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
139548390|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548391|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
139548392|NCT01401465|Ciclesonide|ciclesonide|mesh-list
139548393|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139548394|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
139548395|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139548396|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
139548397|NCT01401465|Hormones|hormones|mesh-ancestor
139548398|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548399|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548400|NCT01890967|Atorvastatin|atorvastatin|mesh-list
139548401|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139548402|NCT01890967|Simvastatin|simvastatin|mesh-list
139548403|NCT01890967|Ezetimibe|ezetimibe|mesh-list
139548404|NCT01890967|Pravastatin|pravastatin|mesh-list
139548405|NCT01890967|Pitavastatin|pitavastatin|mesh-list
139548406|NCT01890967|Lovastatin|lovastatin|mesh-list
139548407|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139548408|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139548409|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
139548410|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548411|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139548412|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139548413|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548414|NCT01863667|Glimepiride|glimepiride|mesh-list
139548415|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139548416|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139548417|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548418|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139548419|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
139548420|NCT01614769|Glimepiride|glimepiride|mesh-list
139548421|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139548422|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139548423|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548424|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139548425|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
139548426|NCT01614457|Ivacaftor|ivacaftor|mesh-list
139548427|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139548428|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139548429|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548430|NCT01835431|Insulin|insulin|mesh-list
139548431|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139548432|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
139548433|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
139548434|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139548435|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
139548436|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139548437|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548438|NCT01880593|Ketamine|ketamine|mesh-list
139548439|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
139548440|NCT01880593|Analgesics|analgesics|mesh-ancestor
139548441|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
139548442|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548443|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548444|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139548445|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139548446|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
139548447|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
139548448|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330064|NCT02966093|Lenvatinib|lenvatinib|mesh-list
139548449|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139548450|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139548451|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548452|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548453|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
139548454|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139548455|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548456|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
139548457|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139548459|NCT01400451|Vemurafenib|vemurafenib|mesh-list
139548460|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139548461|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548462|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139020707|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139548463|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548464|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139548465|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548466|NCT01400139|Hydrocodone|hydrocodone|mesh-list
139548467|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139548468|NCT01400139|Narcotics|narcotics|mesh-ancestor
139548469|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139548470|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548471|NCT01400139|Analgesics|analgesics|mesh-ancestor
139548472|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
139548473|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548474|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
139548475|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
139548476|NCT01399905|Carbidopa|carbidopa|mesh-list
139548477|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139548478|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139548479|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
139548480|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548481|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548482|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548483|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139548484|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548485|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139548486|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
139548487|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139548488|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139548489|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139548490|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139548491|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548492|NCT01724528|Allopurinol|allopurinol|mesh-list
139548493|NCT01724528|Febuxostat|febuxostat|mesh-list
139548494|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
139548495|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548496|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548497|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
139548498|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139548499|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139548500|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
139548501|NCT01724528|Protective Agents|protective agents|mesh-ancestor
139020756|NCT03164928|Denosumab|denosumab|mesh-list
139548502|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548503|NCT01750268|Topiramate|topiramate|mesh-list
139548504|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
139548505|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139548506|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548507|NCT01880437|Cytarabine|cytarabine|mesh-list
139548508|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139548509|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
139548510|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548511|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548512|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
139548513|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548514|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139548515|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
139548516|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548517|NCT01861717|Lanreotide|lanreotide|mesh-list
139548518|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548519|NCT01834729|Alfuzosin|alfuzosin|mesh-list
139548520|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139548521|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139548522|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139548523|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
139548524|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548525|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548526|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548527|NCT01834729|Urological Agents|urological agents|mesh-ancestor
139548528|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
139548529|NCT01860703|Deferiprone|deferiprone|mesh-list
139548530|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139548531|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548532|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139548533|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139548534|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548535|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548536|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548537|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139548538|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
139548539|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
139548540|NCT01399593|Eculizumab|eculizumab|mesh-list
139548541|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139548542|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139548543|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
139548544|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548545|NCT01388985|Vaccines|vaccines|mesh-list
139548546|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
139548547|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548548|NCT01388361|Insulin|insulin|mesh-list
139548549|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139548550|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
139548551|NCT01388361|Liraglutide|liraglutide|mesh-list
139548552|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139548553|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548554|NCT01388361|Incretins|incretins|mesh-ancestor
139548555|NCT01388361|Hormones|hormones|mesh-ancestor
139548556|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548557|NCT05368935|Nitazoxanide|nitazoxanide|mesh-list
139548558|NCT05368935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139548559|NCT05368935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548560|NCT01399125|Rivastigmine|rivastigmine|mesh-list
139548561|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139548562|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548563|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548564|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
139548565|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548566|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548567|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139548568|NCT01399125|Protective Agents|protective agents|mesh-ancestor
139548569|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
139548570|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139548571|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548572|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139548573|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
139548574|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139548575|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548576|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548577|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548578|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139548579|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139548580|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
139548581|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139548582|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139548583|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548584|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139548585|NCT04040439|Analgesics|analgesics|mesh-ancestor
139548586|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
139548587|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548588|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139548589|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139548590|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139548591|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
139548592|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548593|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548594|NCT04012827|Doxorubicin|doxorubicin|mesh-list
139548595|NCT04012827|Apatinib|apatinib|mesh-list
139548596|NCT04012827|Ifosfamide|ifosfamide|mesh-list
139548597|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139548598|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548599|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139548600|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139548601|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330206|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139548602|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548603|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139548604|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139548605|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
139548607|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139548608|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548609|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
139548610|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139548611|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
139548612|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548613|NCT01386645|Expectorants|expectorants|mesh-ancestor
139548614|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
139548615|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139548616|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
139548617|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548618|NCT01386645|Protective Agents|protective agents|mesh-ancestor
139548619|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548620|NCT01386645|Antidotes|antidotes|mesh-ancestor
139548621|NCT01831765|Insulin|insulin|mesh-list
139548622|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139548623|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
139548624|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
139548625|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139548626|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
139548627|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139548628|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548629|NCT01830595|Lactoferrin|lactoferrin|mesh-list
139548630|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548631|NCT01748162|Fluticasone|fluticasone|mesh-list
139548632|NCT01748162|Prednisolone|prednisolone|mesh-list
139548633|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139548634|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139548635|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
139548636|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548637|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548638|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139548639|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
139548640|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
139548641|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139548642|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
139548643|NCT01748162|Hormones|hormones|mesh-ancestor
139548644|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548645|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139548646|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548647|NCT01723904|Rotigotine|rotigotine|mesh-list
139548648|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
139548649|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
139548650|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548651|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548652|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548653|NCT01830127|Ribavirin|ribavirin|mesh-list
139548654|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
139548655|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548656|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
139548657|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548658|NCT01614067|Ganirelix|ganirelix|mesh-list
139548659|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
139548660|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548661|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548662|NCT01397409|Ranibizumab|ranibizumab|mesh-list
139548663|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139548664|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139548665|NCT01397409|Growth Substances|growth substances|mesh-ancestor
139548666|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548667|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
139548668|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548669|NCT04766775|Fluorides|fluorides|mesh-list
139548670|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
139548671|NCT04766775|Protective Agents|protective agents|mesh-ancestor
139548672|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542449|NCT00186706|Selenium|selenium|mesh-list
139548673|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
139548674|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139548675|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
139548676|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330282|NCT03226340|Niacin|niacin|mesh-list
139548677|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548678|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139548679|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
139548680|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
139548681|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139548682|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
139548683|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548684|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548685|NCT03024879|Erythromycin|erythromycin|mesh-list
139548686|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
139548687|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139548688|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
139548689|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139548690|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548691|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139548692|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139548693|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548694|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548695|NCT01383993|Voriconazole|voriconazole|mesh-list
139548696|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
139548697|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548698|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139548699|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139548700|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548701|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548702|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139548703|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
139548704|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548705|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548706|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139548707|NCT01396395|Nicorandil|nicorandil|mesh-list
139548708|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139548709|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139548710|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
139548711|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
139548712|NCT01396395|Vitamins|vitamins|mesh-ancestor
139548713|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
139548714|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548715|NCT01396083|Dexamethasone|dexamethasone|mesh-list
139548716|NCT01396083|Ranibizumab|ranibizumab|mesh-list
139548717|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139548718|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
139548719|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
139548720|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020924|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
139548721|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548722|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139548723|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
139548724|NCT01396083|Hormones|hormones|mesh-ancestor
139548725|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548726|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139548727|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548728|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139548729|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139548730|NCT01396083|Growth Substances|growth substances|mesh-ancestor
139548731|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
139548732|NCT01776008|Anastrozole|anastrozole|mesh-list
139548733|NCT01776008|Goserelin|goserelin|mesh-list
139548734|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139548735|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548736|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139548737|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139548738|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548739|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548740|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139548741|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
139548742|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548743|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548744|NCT01858363|Paclitaxel|paclitaxel|mesh-list
139548745|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139548746|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548747|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
139548748|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
139548749|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
139330362|NCT03225326|Carticaine|carticaine|mesh-list
139548750|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548751|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
139548752|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
139548753|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548754|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139548755|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139548756|NCT01396005|Buprenorphine|buprenorphine|mesh-list
139548757|NCT01396005|Methadone|methadone|mesh-list
139020950|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
139548758|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139548759|NCT01396005|Naloxone|naloxone|mesh-list
139548760|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139548761|NCT01396005|Narcotics|narcotics|mesh-ancestor
139548762|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139548763|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548764|NCT01396005|Analgesics|analgesics|mesh-ancestor
139548765|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
139548766|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548767|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139548768|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
139548769|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
139548770|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
139548771|NCT03024957|Morphine|morphine|mesh-list
139548772|NCT03024957|Bupivacaine|bupivacaine|mesh-list
139548773|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
139548774|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
139548775|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139548776|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548777|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
139548778|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548779|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139548780|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139548781|NCT03024957|Analgesics|analgesics|mesh-ancestor
139548782|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139548783|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139548784|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139548785|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
139548786|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548787|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548788|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139548789|NCT03024957|Narcotics|narcotics|mesh-ancestor
139548790|NCT03025113|Ketoprofen|ketoprofen|mesh-list
139548791|NCT03025113|Amitriptyline|amitriptyline|mesh-list
139548792|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
139548793|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139548794|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139548795|NCT03025113|Analgesics|analgesics|mesh-ancestor
139548796|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
139548797|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548798|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548799|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139548800|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139548801|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139548802|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548803|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548804|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139548805|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
139548806|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139548807|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139548808|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139548809|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139548810|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139548811|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139548812|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139548813|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139548814|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
139548815|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548816|NCT01877083|Lenvatinib|lenvatinib|mesh-list
139548817|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548818|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139548819|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548820|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548821|NCT01380327|Immunomodulating Agents|immunomodulating agents|mesh-list
139548822|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
139548823|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548824|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139548825|NCT01829425|Oxybutynin|oxybutynin|mesh-list
139548826|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139548827|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139548828|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
139548829|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548830|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548831|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548832|NCT01829425|Urological Agents|urological agents|mesh-ancestor
139548833|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
139548834|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
139548835|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021020|NCT03944434|Leuprolide|leuprolide|mesh-list
139548836|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
139548837|NCT01394991|Hematinics|hematinics|mesh-ancestor
139548838|NCT01394523|Bupivacaine|bupivacaine|mesh-list
139548839|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
139548840|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
139548841|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139548842|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548843|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
139548844|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548845|NCT01857583|PENTA|penta|mesh-list
139548846|NCT01857583|Edoxaban|edoxaban|mesh-list
139548847|NCT01857583|Fondaparinux|fondaparinux|mesh-list
139548848|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139548849|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
139548850|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139548851|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
139548852|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548853|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548854|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
139548855|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139548856|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139548857|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139548858|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
139548859|NCT00211185|Prednisone|prednisone|mesh-list
139548860|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
139548861|NCT00211185|Doxorubicin|doxorubicin|mesh-list
139548862|NCT00211185|Vincristine|vincristine|mesh-list
139548863|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
139548864|NCT00211185|Lenograstim|lenograstim|mesh-list
139548865|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139548866|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
139548867|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548868|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139548869|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139548870|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
139548871|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548872|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548873|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139548874|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139548875|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139548876|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139548877|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548878|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139548879|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
139548880|NCT00211185|Hormones|hormones|mesh-ancestor
139548881|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548882|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139548883|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139548884|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
139548885|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
139548886|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
139548887|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139548888|NCT00219297|Epothilone B|epothilone b|mesh-list
139548889|NCT00219297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548890|NCT00219297|Tubulin Modulators|tubulin modulators|mesh-ancestor
139548891|NCT00219297|Antimitotic Agents|antimitotic agents|mesh-ancestor
139548892|NCT00219297|Mitosis Modulators|mitosis modulators|mesh-ancestor
139548893|NCT00219297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548894|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139548895|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548896|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139548897|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548898|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548899|NCT01721486|Acetaminophen|acetaminophen|mesh-list
139548900|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139548901|NCT01721486|Analgesics|analgesics|mesh-ancestor
139548902|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
139548903|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548904|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548905|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
139548906|NCT01721408|Imipenem|imipenem|mesh-list
139548907|NCT01721408|Tigecycline|tigecycline|mesh-list
139548908|NCT01721408|Cilastatin|cilastatin|mesh-list
139548909|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139548910|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548911|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139548912|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548913|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548914|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
139548915|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139548916|NCT03998709|Somatostatin|somatostatin|mesh-list
139548917|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548918|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139548919|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139548920|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139548921|NCT03998709|Hormones|hormones|mesh-ancestor
139548922|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548923|NCT01744496|Rotigotine|rotigotine|mesh-list
139548924|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
139548925|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
139548926|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548927|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548928|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548929|NCT01721330|Naltrexone|naltrexone|mesh-list
139548930|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139548931|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139548932|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548933|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
139548934|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548935|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
139548936|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139548937|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548938|NCT03592407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139548939|NCT03592407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548940|NCT03595371|Dapansutrile|dapansutrile|mesh-list
139548941|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139548942|NCT01828021|Margetuximab|margetuximab|mesh-list
139548943|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548944|NCT03784599|Trastuzumab|trastuzumab|mesh-list
139548945|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139548946|NCT03784599|Osimertinib|osimertinib|mesh-list
139548947|NCT03784599|Maytansine|maytansine|mesh-list
139548948|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139548949|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548950|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139548951|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548952|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548953|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139548954|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
139548955|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
139548956|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
139548957|NCT03784599|Immunotoxins|immunotoxins|mesh-ancestor
139548958|NCT03784599|Immunoconjugates|immunoconjugates|mesh-ancestor
139548959|NCT03784599|Immunologic Factors|immunologic factors|mesh-ancestor
139548960|NCT03784599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548961|NCT01827943|Sirolimus|sirolimus|mesh-list
139548962|NCT01827943|Temsirolimus|temsirolimus|mesh-list
139548963|NCT01827943|MTOR Inhibitors|mtor inhibitors|mesh-list
139548964|NCT01827943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139548965|NCT01827943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139548966|NCT01827943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548967|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139548968|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
139548969|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548970|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548971|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139548972|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139548973|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139548974|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
139548975|NCT02985255|Docetaxel|docetaxel|mesh-list
139548976|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139548977|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
139548978|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
139548979|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
139548980|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548981|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139548982|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139548983|NCT00217971|Dronabinol|dronabinol|mesh-list
139548984|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
139548985|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139548986|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139548987|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139548988|NCT00217971|Analgesics|analgesics|mesh-ancestor
139548989|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
139548990|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139548991|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139548992|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139548993|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139548994|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139548995|NCT00217971|Hormones|hormones|mesh-ancestor
139548996|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139548997|NCT00217581|Bevacizumab|bevacizumab|mesh-list
139548998|NCT00217581|Docetaxel|docetaxel|mesh-list
139548999|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
139549000|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139549001|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549002|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139549003|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139549004|NCT00217581|Growth Substances|growth substances|mesh-ancestor
139549005|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549006|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
139549007|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
139549008|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
139549009|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
139549010|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549011|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
139549012|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
139549013|NCT01856257|Abatacept|abatacept|mesh-list
139549014|NCT01856257|Tacrolimus|tacrolimus|mesh-list
139549015|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
139549016|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139549017|NCT01856257|Basiliximab|basiliximab|mesh-list
139549018|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139549019|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
139549020|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549021|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139549022|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549023|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549024|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139549025|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549026|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139549027|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
139549028|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139549029|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549030|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549031|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
139549032|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
139549033|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549034|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139549035|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
139549036|NCT01856257|Hormones|hormones|mesh-ancestor
139549037|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139549038|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139549039|NCT01856257|Protective Agents|protective agents|mesh-ancestor
139549040|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139549041|NCT01856257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139549042|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549043|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
139549044|NCT00215943|Thalidomide|thalidomide|mesh-list
139549045|NCT00215943|Dexamethasone|dexamethasone|mesh-list
139549046|NCT00215943|Doxorubicin|doxorubicin|mesh-list
139549047|NCT00215943|Vincristine|vincristine|mesh-list
139549048|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139549049|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549050|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
139549051|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
139549052|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549053|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549054|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139549055|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
139549057|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139549058|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139549059|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549060|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139549061|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139549062|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139549063|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549064|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549065|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139549066|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
139549067|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
139549068|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
139549069|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139549070|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
139549071|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
139549072|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139549073|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549074|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139549075|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139549076|NCT00215943|Growth Substances|growth substances|mesh-ancestor
139549077|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
139549078|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139549079|NCT01827163|Paclitaxel|paclitaxel|mesh-list
139549080|NCT01827163|Trastuzumab|trastuzumab|mesh-list
139549081|NCT01827163|Lapatinib|lapatinib|mesh-list
139549082|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139549083|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549084|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
139549085|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
139549086|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
139549087|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549088|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139549089|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139549090|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549091|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139549092|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
139549093|NCT00214461|Vaccines|vaccines|mesh-list
139549094|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
139549095|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549096|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
139549097|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139549098|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139549099|NCT00211887|Interferons|interferons|mesh-list
139549100|NCT00211887|Interferon-beta|interferon-beta|mesh-list
139549101|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
139549102|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
139549103|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
139549104|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549105|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
139549106|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549107|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
139549108|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549109|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139549110|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139549111|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549112|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139549113|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549114|NCT03592485|Acetaminophen|acetaminophen|mesh-list
139549115|NCT03592485|Oxycodone|oxycodone|mesh-list
139549116|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139549117|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549118|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139549119|NCT03592485|Analgesics|analgesics|mesh-ancestor
139549120|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
139549121|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549122|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
139549123|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139549124|NCT03592485|Narcotics|narcotics|mesh-ancestor
139549125|NCT04199013|Fentanyl|fentanyl|mesh-list
139549126|NCT04199013|Ropivacaine|ropivacaine|mesh-list
139549127|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
139549128|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
139549129|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139549130|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549132|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549133|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139549134|NCT04199013|Narcotics|narcotics|mesh-ancestor
139549135|NCT04199013|Analgesics|analgesics|mesh-ancestor
139549136|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139549137|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139549138|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
139549139|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
139549140|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139549141|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
139549142|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549143|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
139549144|NCT04198467|Protective Agents|protective agents|mesh-ancestor
139549145|NCT03599427|Lidocaine|lidocaine|mesh-list
139549146|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
139549147|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
139549148|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139549149|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549150|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
139549151|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549152|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139549153|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139549154|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139549155|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139549156|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549157|NCT01855789|Methotrexate|methotrexate|mesh-list
139549158|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139549159|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
139549160|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139549161|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549162|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139549163|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
139549164|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549165|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549166|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
139549167|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549168|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139549169|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139549170|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
139549171|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549172|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139549173|NCT04198233|Diazepam|diazepam|mesh-list
139549174|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139549175|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
139549176|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
139549177|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
139549178|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549179|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549180|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139549181|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139549182|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139549183|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139549184|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139549185|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139549186|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139549187|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139549188|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139549189|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
139549190|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
139549191|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
139549192|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
139549193|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139549194|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549195|NCT03591471|Prednisone|prednisone|mesh-list
139549196|NCT03591471|Benazepril|benazepril|mesh-list
139549197|NCT03591471|Heparin|heparin|mesh-list
139549198|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139549199|NCT03591471|Tinzaparin|tinzaparin|mesh-list
139549200|NCT03591471|Dalteparin|dalteparin|mesh-list
139549201|NCT03591471|Calcium heparin|calcium heparin|mesh-list
139549202|NCT03591471|Dipyridamole|dipyridamole|mesh-list
139330800|NCT02451098|Ezetimibe|ezetimibe|mesh-list
139021346|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
139549203|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549204|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549205|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
139549206|NCT03591471|Hormones|hormones|mesh-ancestor
139549207|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139549209|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549210|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
139549211|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139549212|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139549213|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549214|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139549215|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549216|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139549217|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
139549218|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139549219|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
139549220|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139549221|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139549222|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
139549223|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549224|NCT01876381|Tolvaptan|tolvaptan|mesh-list
139549225|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139549226|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549227|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
139549228|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549229|NCT03591003|Antibodies|antibodies|mesh-list
139549230|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
139549231|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
139021367|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139549232|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549233|NCT01875991|Etanercept|etanercept|mesh-list
139549234|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139549235|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139549236|NCT01875991|Analgesics|analgesics|mesh-ancestor
139549237|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
139549238|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549239|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549240|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549241|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549242|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139549243|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139549244|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
139549245|NCT04203927|Empagliflozin|empagliflozin|mesh-list
139549246|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139549247|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549248|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139549249|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549250|NCT01855243|Insulin|insulin|mesh-list
139549251|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139549252|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139549253|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549254|NCT04196829|Fluorides|fluorides|mesh-list
139549255|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
139549256|NCT04196829|Protective Agents|protective agents|mesh-ancestor
139549257|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549258|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139549259|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
139549260|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139549261|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139549262|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139549263|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549264|NCT01854697|Interferons|interferons|mesh-list
139549265|NCT01854697|Ribavirin|ribavirin|mesh-list
139549266|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
139549267|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
139549268|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139549269|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549270|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
139549271|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549272|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
139549273|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549274|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
139549275|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549276|NCT01824823|Afatinib|afatinib|mesh-list
139549277|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549278|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139549279|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021413|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139549280|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549281|NCT03598725|Prednisone|prednisone|mesh-list
139549282|NCT03598725|Rituximab|rituximab|mesh-list
139549283|NCT03598725|Factor VIII|factor viii|mesh-list
139549284|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139549285|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549286|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
139549287|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549288|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549289|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549290|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
139549291|NCT03598725|Hormones|hormones|mesh-ancestor
139549292|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139549293|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139549294|NCT03598725|Coagulants|coagulants|mesh-ancestor
139549295|NCT04766307|Interleukin-2|interleukin-2|mesh-list
139549296|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549297|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139549298|NCT04766307|Analgesics|analgesics|mesh-ancestor
139549299|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
139549300|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549301|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549302|NCT01875367|Trastuzumab|trastuzumab|mesh-list
139549303|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139549304|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549305|NCT04194957|Capecitabine|capecitabine|mesh-list
139549306|NCT04194957|Fluorouracil|fluorouracil|mesh-list
139549307|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139549308|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
139549309|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549310|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549311|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139549312|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
139549313|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549314|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
139549315|NCT04194255|Trace Elements|trace elements|mesh-ancestor
139549316|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
139549317|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549318|NCT04406883|Simvastatin|simvastatin|mesh-list
139549319|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139549320|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139549321|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
139549322|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549323|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139549324|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139549325|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549326|NCT03597867|Diclofenac|diclofenac|mesh-list
139549327|NCT03597867|Indomethacin|indomethacin|mesh-list
139549328|NCT03597867|Nepafenac|nepafenac|mesh-list
139549329|NCT03597867|Bromfenac|bromfenac|mesh-list
139549330|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139549331|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139549332|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139549333|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139549334|NCT03597867|Analgesics|analgesics|mesh-ancestor
139549335|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
139549336|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549337|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549338|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549339|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549340|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139549341|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549342|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549343|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
139549344|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
139549345|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139549346|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
139549347|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139549348|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139549349|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549350|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139330957|NCT05459194|Hormones|hormones|mesh-ancestor
139549351|NCT03597477|Analgesics|analgesics|mesh-ancestor
139549352|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
139549353|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549354|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139549355|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139549356|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139549357|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
139549358|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139549359|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549360|NCT04193319|Fluconazole|fluconazole|mesh-list
139549361|NCT04193319|Fluzoparib|fluzoparib|mesh-list
139549362|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
139549363|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549364|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139549365|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139549366|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549367|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549368|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139549369|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
139549370|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139549371|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549372|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139549373|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139549374|NCT04193319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139549375|NCT04193319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549376|NCT04192617|Methotrexate|methotrexate|mesh-list
139549377|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139549378|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
139549379|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139549380|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549381|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139549382|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
139549383|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549384|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549385|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
139549386|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549387|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139549388|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139549389|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
139549390|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549391|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139549392|NCT01874665|Ponatinib|ponatinib|mesh-list
139549393|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549394|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139549395|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549396|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549397|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
139549398|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
139549399|NCT04028739|Curcumin|curcumin|mesh-list
139549400|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139549401|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139549402|NCT04028739|Analgesics|analgesics|mesh-ancestor
139549403|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
139549404|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549405|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549406|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549407|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549408|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549409|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549410|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549411|NCT04028505|Terlipressin|terlipressin|mesh-list
139549412|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139549413|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139549414|NCT04190745|Paclitaxel|paclitaxel|mesh-list
139549415|NCT04190745|Apatinib|apatinib|mesh-list
139549416|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139549417|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549418|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
139549419|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
139549420|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
139549421|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549422|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139549423|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549424|NCT04028349|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139549425|NCT04028349|Antiviral Agents|antiviral agents|mesh-ancestor
139331020|NCT00658047|Immunologic Factors|immunologic factors|mesh-ancestor
139549426|NCT04028349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549427|NCT01873729|Naltrexone|naltrexone|mesh-list
139549428|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139549429|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139549430|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549431|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
139549432|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549433|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
139549434|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139549435|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549436|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139549437|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549438|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549439|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
139549440|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
139549441|NCT04027959|Vitamins|vitamins|mesh-ancestor
139549442|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
139549443|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549444|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
139549445|NCT04027959|Hematinics|hematinics|mesh-ancestor
139549446|NCT04344951|Chloroquine|chloroquine|mesh-list
139549447|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139549448|NCT04344951|Amebicides|amebicides|mesh-ancestor
139549449|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139549450|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139549451|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549452|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
139549453|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549454|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139549455|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139549456|NCT04344951|Analgesics|analgesics|mesh-ancestor
139549457|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
139549458|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549459|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021535|NCT00359632|Linezolid|linezolid|mesh-list
139549460|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549461|NCT04344951|Filaricides|filaricides|mesh-ancestor
139549462|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
139549463|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
139549464|NCT01822561|Eplerenone|eplerenone|mesh-list
139549465|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139549466|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
139549467|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139549468|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549469|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139549470|NCT01822561|Diuretics|diuretics|mesh-ancestor
139549471|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
139549472|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139549473|NCT02080455|Atorvastatin|atorvastatin|mesh-list
139549474|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139549475|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139549476|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
139549477|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549478|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139549479|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139549480|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549481|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139549482|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
139549483|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549484|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
139549485|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139549486|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139549487|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549488|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
139549489|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139549490|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139549491|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139549492|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139549493|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549494|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
139549495|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139549496|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549497|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139549498|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549499|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139549500|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139549501|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139549502|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139549503|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549504|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
139549505|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139549506|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549507|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139549508|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549509|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
139549510|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139549511|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139549512|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549513|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
139549514|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
139549515|NCT04199169|Vaccines|vaccines|mesh-list
139549516|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
139549517|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549518|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
139549519|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139549520|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139549521|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139549522|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
139549523|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139549524|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139549525|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139549526|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
139549527|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139549528|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
139549529|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139549530|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
139549531|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549532|NCT01872715|Doxycycline|doxycycline|mesh-list
139549533|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139549534|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549535|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
139549536|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139549537|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139549538|NCT01613599|Rituximab|rituximab|mesh-list
139549539|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139549540|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549541|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
139549542|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549543|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549544|NCT03930771|Capecitabine|capecitabine|mesh-list
139549545|NCT03930771|Temozolomide|temozolomide|mesh-list
139549546|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139549547|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
139549548|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549549|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549550|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139549551|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
139549552|NCT04024683|Ropivacaine|ropivacaine|mesh-list
139549553|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
139549554|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
139549555|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139549556|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549557|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
139549558|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549559|NCT04024527|Amoxicillin|amoxicillin|mesh-list
139549560|NCT04024527|Metronidazole|metronidazole|mesh-list
139549561|NCT04024527|Esomeprazole|esomeprazole|mesh-list
139549562|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139549563|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549564|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139549565|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139549566|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139549567|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139549568|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139549569|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549570|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549571|NCT06061835|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
139549572|NCT06061835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139549573|NCT06061835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139549574|NCT06061835|Analgesics|analgesics|mesh-ancestor
139549575|NCT06061835|Sensory System Agents|sensory system agents|mesh-ancestor
139549576|NCT06061835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549577|NCT06061835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549578|NCT06061835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549579|NCT06061835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549580|NCT06061718|Travoprost|travoprost|mesh-list
139549581|NCT06061718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139549582|NCT06061666|Glycerol|glycerol|mesh-list
139549583|NCT06061666|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139549584|NCT06061666|Protective Agents|protective agents|mesh-ancestor
139549585|NCT06061666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549586|NCT06061484|Amoxicillin|amoxicillin|mesh-list
139549587|NCT06061484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139549588|NCT06061484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549589|NCT06061445|Antibodies|antibodies|mesh-list
139549590|NCT06061445|Immunologic Factors|immunologic factors|mesh-ancestor
139549591|NCT06061445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549592|NCT06061315|Silicon|silicon|mesh-list
139549593|NCT06061315|Trace Elements|trace elements|mesh-ancestor
139549594|NCT06061315|Micronutrients|micronutrients|mesh-ancestor
139549595|NCT06061315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549596|NCT06061276|Lenvatinib|lenvatinib|mesh-list
139549597|NCT06061276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549598|NCT06061276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139549599|NCT06061276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549600|NCT06061276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549601|NCT06061094|Imatinib Mesylate|imatinib mesylate|mesh-list
139549602|NCT06061094|Blinatumomab|blinatumomab|mesh-list
139549603|NCT06061094|Ponatinib|ponatinib|mesh-list
139549604|NCT06061094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549605|NCT06061094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139549606|NCT06061094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549607|NCT06061094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549608|NCT06060990|Trace Elements|trace elements|mesh-list
139549609|NCT06060990|Micronutrients|micronutrients|mesh-list
139549610|NCT06060990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549611|NCT06060886|Aripiprazole|aripiprazole|mesh-list
139549612|NCT06060886|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139549613|NCT06060886|Antidepressive Agents|antidepressive agents|mesh-ancestor
139549614|NCT06060886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139549615|NCT06060886|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139549616|NCT06060886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139549617|NCT06060886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139549618|NCT06060886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549619|NCT06060886|Dopamine Agonists|dopamine agonists|mesh-ancestor
139549620|NCT06060886|Dopamine Agents|dopamine agents|mesh-ancestor
139549621|NCT06060886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139549622|NCT06060886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549623|NCT06060886|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139549624|NCT06060886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139549625|NCT06060886|Serotonin Agents|serotonin agents|mesh-ancestor
139549626|NCT06060886|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139549627|NCT06060886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139549628|NCT06060886|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139549629|NCT06060886|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139549630|NCT06060782|Cytarabine|cytarabine|mesh-list
139549631|NCT06060782|Cyclophosphamide|cyclophosphamide|mesh-list
139549632|NCT06060782|Thiotepa|thiotepa|mesh-list
139549633|NCT06060782|Cladribine|cladribine|mesh-list
139549634|NCT06060782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139549635|NCT06060782|Immunologic Factors|immunologic factors|mesh-ancestor
139549636|NCT06060782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549637|NCT06060782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549638|NCT06060782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139549639|NCT06060782|Alkylating Agents|alkylating agents|mesh-ancestor
139549640|NCT06060782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549641|NCT06060782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549642|NCT06060782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139549643|NCT06060782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139549644|NCT06060782|Antimetabolites|antimetabolites|mesh-ancestor
139549645|NCT06060782|Antiviral Agents|antiviral agents|mesh-ancestor
139549646|NCT06060782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549647|NCT06060743|Insulin|insulin|mesh-list
139549648|NCT06060743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139549649|NCT06060743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549650|NCT06060340|Propolis|propolis|mesh-list
139549651|NCT06060340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549652|NCT06060327|Misoprostol|misoprostol|mesh-list
139549653|NCT06060327|Tranexamic Acid|tranexamic acid|mesh-list
139331242|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549654|NCT06060327|Oxytocin|oxytocin|mesh-list
139549655|NCT06060327|Carbetocin|carbetocin|mesh-list
139549656|NCT06060327|Oxytocics|oxytocics|mesh-ancestor
139549657|NCT06060327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139549658|NCT06060327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549659|NCT06060327|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139549660|NCT06060327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139549661|NCT06060327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549662|NCT06060327|Hemostatics|hemostatics|mesh-ancestor
139549663|NCT06060327|Coagulants|coagulants|mesh-ancestor
139549664|NCT06060327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139549665|NCT06060327|Abortifacient Agents|abortifacient agents|mesh-ancestor
139549666|NCT06060327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139549667|NCT06060327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139549668|NCT06060301|Sulfasalazine|sulfasalazine|mesh-list
139549669|NCT06060301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549670|NCT06060301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139549671|NCT06060301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139549672|NCT06060301|Analgesics|analgesics|mesh-ancestor
139549673|NCT06060301|Sensory System Agents|sensory system agents|mesh-ancestor
139549674|NCT06060301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549675|NCT06060301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549676|NCT06060301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549677|NCT06060301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549678|NCT06060301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139549679|NCT06060132|Arsenic Trioxide|arsenic trioxide|mesh-list
139549680|NCT06060132|Sodium arsenite|sodium arsenite|mesh-list
139549681|NCT06060132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549682|NCT06060132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549683|NCT06060132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549684|NCT06060080|Lenograstim|lenograstim|mesh-list
139549685|NCT06060080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139549686|NCT06060080|Immunologic Factors|immunologic factors|mesh-ancestor
139549687|NCT06060080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549688|NCT06060015|Bupivacaine|bupivacaine|mesh-list
139549689|NCT06060015|Anesthetics, Local|anesthetics, local|mesh-ancestor
139549690|NCT06060015|Anesthetics|anesthetics|mesh-ancestor
139549691|NCT06060015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139549692|NCT06060015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549693|NCT06060015|Sensory System Agents|sensory system agents|mesh-ancestor
139549694|NCT06060015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549695|NCT06059989|Folic Acid|folic acid|mesh-list
139549696|NCT06059989|Infliximab|infliximab|mesh-list
139549697|NCT06059989|Methotrexate|methotrexate|mesh-list
139549698|NCT06059989|Mercaptopurine|mercaptopurine|mesh-list
139549699|NCT06059989|Azathioprine|azathioprine|mesh-list
139549700|NCT06059989|Thioguanine|thioguanine|mesh-list
139549701|NCT06059989|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139549702|NCT06059989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139549703|NCT06059989|Abortifacient Agents|abortifacient agents|mesh-ancestor
139549704|NCT06059989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139549705|NCT06059989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549706|NCT06059989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139549707|NCT06059989|Antimetabolites|antimetabolites|mesh-ancestor
139549708|NCT06059989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549709|NCT06059989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549710|NCT06059989|Dermatologic Agents|dermatologic agents|mesh-ancestor
139549711|NCT06059989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549712|NCT06059989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139549713|NCT06059989|Immunologic Factors|immunologic factors|mesh-ancestor
139549714|NCT06059989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549715|NCT06059989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139549716|NCT06059989|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139549717|NCT06059989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549718|NCT06059989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139549719|NCT06059989|Hematinics|hematinics|mesh-ancestor
139549720|NCT06059989|Vitamin B Complex|vitamin b complex|mesh-ancestor
139549721|NCT06059989|Vitamins|vitamins|mesh-ancestor
139549722|NCT06059989|Micronutrients|micronutrients|mesh-ancestor
139549723|NCT06059885|Tislelizumab|tislelizumab|mesh-list
139549724|NCT06059885|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139549725|NCT06059885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139549726|NCT06059885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549727|NCT06059885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139549728|NCT06059885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549729|NCT06059885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549730|NCT06057896|Inositol|inositol|mesh-list
139549731|NCT06057896|Phytoestrogens|phytoestrogens|mesh-list
139549732|NCT06057896|Vitamin B Complex|vitamin b complex|mesh-ancestor
139549734|NCT06057896|Micronutrients|micronutrients|mesh-ancestor
139549735|NCT06057896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549736|NCT06057896|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139549737|NCT06057896|Estrogens|estrogens|mesh-ancestor
139549738|NCT06057896|Hormones|hormones|mesh-ancestor
139549739|NCT06057896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139549740|NCT06057610|Docetaxel|docetaxel|mesh-list
139549741|NCT06057610|Trastuzumab|trastuzumab|mesh-list
139549742|NCT06057610|Pertuzumab|pertuzumab|mesh-list
139549743|NCT06057610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549744|NCT06057610|Tubulin Modulators|tubulin modulators|mesh-ancestor
139021693|NCT03991312|Itraconazole|itraconazole|mesh-list
139549745|NCT06057610|Antimitotic Agents|antimitotic agents|mesh-ancestor
139549746|NCT06057610|Mitosis Modulators|mitosis modulators|mesh-ancestor
139549747|NCT06057610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549748|NCT06057610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139549749|NCT06057545|Tacrolimus|tacrolimus|mesh-list
139549750|NCT06057545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139549751|NCT06057545|Immunologic Factors|immunologic factors|mesh-ancestor
139549752|NCT06057545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549753|NCT06057545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139549754|NCT06057545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549755|NCT06057545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549756|NCT06057519|Rifampin|rifampin|mesh-list
139549757|NCT06057519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139549758|NCT06057519|Antitubercular Agents|antitubercular agents|mesh-ancestor
139549759|NCT06057519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139549760|NCT06057519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549761|NCT06057519|Leprostatic Agents|leprostatic agents|mesh-ancestor
139549762|NCT06057519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139549763|NCT06057519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549764|NCT06057519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549765|NCT06057519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139549766|NCT06057519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139549767|NCT06057519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139549768|NCT06057519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139549769|NCT06057519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139549770|NCT06057519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139549771|NCT06057194|Letermovir|letermovir|mesh-list
139549772|NCT06057194|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139549773|NCT06057194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549774|NCT06057194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549775|NCT06057194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549776|NCT06057194|Antiviral Agents|antiviral agents|mesh-ancestor
139549777|NCT06057194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549778|NCT06057168|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139549779|NCT06057168|Chelating Agents|chelating agents|mesh-ancestor
139549780|NCT06057168|Sequestering Agents|sequestering agents|mesh-ancestor
139549781|NCT06057168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549782|NCT06057103|Oseltamivir|oseltamivir|mesh-list
139021728|NCT01057498|RNS60|rns60|mesh-list
139549783|NCT06057103|Antiviral Agents|antiviral agents|mesh-ancestor
139549784|NCT06057103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549785|NCT06057103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549786|NCT06057103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549787|NCT06056570|Allopurinol|allopurinol|mesh-list
139549788|NCT06056570|Dotinurad|dotinurad|mesh-list
139549789|NCT06056570|Antimetabolites|antimetabolites|mesh-ancestor
139549790|NCT06056570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549791|NCT06056570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549792|NCT06056570|Gout Suppressants|gout suppressants|mesh-ancestor
139549793|NCT06056570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549794|NCT06056570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139549795|NCT06056570|Antioxidants|antioxidants|mesh-ancestor
139549796|NCT06056570|Protective Agents|protective agents|mesh-ancestor
139549797|NCT06056570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549798|NCT06056570|Uricosuric Agents|uricosuric agents|mesh-ancestor
139549799|NCT06056492|Nitrous Oxide|nitrous oxide|mesh-list
139549800|NCT06056492|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139549801|NCT06056492|Anesthetics, General|anesthetics, general|mesh-ancestor
139549802|NCT06056492|Anesthetics|anesthetics|mesh-ancestor
139549803|NCT06056492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139331395|NCT00429429|Immunomodulating Agents|immunomodulating agents|mesh-list
139549804|NCT06056492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549805|NCT06056492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139549806|NCT06056492|Analgesics|analgesics|mesh-ancestor
139549807|NCT06056492|Sensory System Agents|sensory system agents|mesh-ancestor
139549808|NCT06056492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549809|NCT06056336|Paclitaxel|paclitaxel|mesh-list
139549810|NCT06056336|Carboplatin|carboplatin|mesh-list
139549811|NCT06056336|Tislelizumab|tislelizumab|mesh-list
139549812|NCT06056336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139549813|NCT06056336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139549814|NCT06056336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549815|NCT06056336|Tubulin Modulators|tubulin modulators|mesh-ancestor
139549816|NCT06056336|Antimitotic Agents|antimitotic agents|mesh-ancestor
139549817|NCT06056336|Mitosis Modulators|mitosis modulators|mesh-ancestor
139549818|NCT06056336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549819|NCT06056336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139549820|NCT06056167|Insulin|insulin|mesh-list
139549821|NCT06056167|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139549822|NCT06056167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549823|NCT06056115|Tislelizumab|tislelizumab|mesh-list
139549824|NCT06056115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139549825|NCT06056115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549826|NCT06056089|Amoxicillin|amoxicillin|mesh-list
139549827|NCT06056089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139549828|NCT06056089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549829|NCT06055907|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139549830|NCT06055907|Dalteparin|dalteparin|mesh-list
139549831|NCT06055907|Anticoagulants|anticoagulants|mesh-ancestor
139549832|NCT06055907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139549833|NCT06055907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139549834|NCT06055907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549835|NCT06055829|Insulin|insulin|mesh-list
139549836|NCT06055829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139549837|NCT06055829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549838|NCT06055816|Endostar protein|endostar protein|mesh-list
139549839|NCT06055816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139549840|NCT06055816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139549841|NCT06055816|Growth Substances|growth substances|mesh-ancestor
139549842|NCT06055816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549843|NCT06055816|Growth Inhibitors|growth inhibitors|mesh-ancestor
139549844|NCT06055816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549845|NCT06055777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139549846|NCT06055777|beta-Lactams|beta-lactams|mesh-list
139549847|NCT06055777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549848|NCT06055738|Paclitaxel|paclitaxel|mesh-list
139549849|NCT06055738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139549850|NCT06055738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139549851|NCT06055738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549852|NCT06055738|Tubulin Modulators|tubulin modulators|mesh-ancestor
139549853|NCT06055738|Antimitotic Agents|antimitotic agents|mesh-ancestor
139549854|NCT06055738|Mitosis Modulators|mitosis modulators|mesh-ancestor
139549855|NCT06055738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549856|NCT06053385|Melatonin|melatonin|mesh-list
139549857|NCT06053385|Antioxidants|antioxidants|mesh-ancestor
139549858|NCT06053385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549859|NCT06053385|Protective Agents|protective agents|mesh-ancestor
139549860|NCT06053385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549861|NCT06053385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139549862|NCT06052956|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139549863|NCT06052956|Methylene Blue|methylene blue|mesh-list
139549864|NCT06052956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549865|NCT06052956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549866|NCT06052956|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139549867|NCT06052956|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139549868|NCT06052956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139549869|NCT06052787|Amantadine|amantadine|mesh-list
139549870|NCT06052787|Cerebrolysin|cerebrolysin|mesh-list
139549871|NCT06052787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139549872|NCT06052787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139549873|NCT06052787|Antiviral Agents|antiviral agents|mesh-ancestor
139549874|NCT06052787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549875|NCT06052787|Dopamine Agents|dopamine agents|mesh-ancestor
139549876|NCT06052787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139549877|NCT06052787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549878|NCT06052787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549879|NCT06052787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139549880|NCT06052787|Analgesics|analgesics|mesh-ancestor
139549881|NCT06052787|Sensory System Agents|sensory system agents|mesh-ancestor
139549882|NCT06052787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549883|NCT06052787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139549884|NCT06052787|Protective Agents|protective agents|mesh-ancestor
139549885|NCT06052787|Nootropic Agents|nootropic agents|mesh-ancestor
139549886|NCT06052020|Atorvastatin|atorvastatin|mesh-list
139549887|NCT06052020|Alirocumab|alirocumab|mesh-list
139549888|NCT06052020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139549889|NCT06052020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139549890|NCT06052020|Antimetabolites|antimetabolites|mesh-ancestor
139549891|NCT06052020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549892|NCT06052020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139549893|NCT06052020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139549894|NCT06052020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549895|NCT06052020|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139549896|NCT06052020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139549897|NCT06052020|Protease Inhibitors|protease inhibitors|mesh-ancestor
139549898|NCT06051487|Titanium dioxide|titanium dioxide|mesh-list
139549899|NCT06051487|Sunscreening Agents|sunscreening agents|mesh-ancestor
139549900|NCT06051487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139549901|NCT06051487|Protective Agents|protective agents|mesh-ancestor
139549902|NCT06051487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549903|NCT06051487|Dermatologic Agents|dermatologic agents|mesh-ancestor
139549904|NCT06051487|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139549905|NCT06051253|Infliximab|infliximab|mesh-list
139549906|NCT06051253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139549907|NCT06051253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549908|NCT06051253|Dermatologic Agents|dermatologic agents|mesh-ancestor
139549909|NCT06051253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139549910|NCT06051253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139549911|NCT06045351|Vitamin D|vitamin d|mesh-list
139549912|NCT06045351|Vitamins|vitamins|mesh-ancestor
139549913|NCT06045351|Micronutrients|micronutrients|mesh-ancestor
139549914|NCT06045351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549915|NCT06045351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139549916|NCT06044558|Mycophenolic Acid|mycophenolic acid|mesh-list
139549917|NCT06044558|Voriconazole|voriconazole|mesh-list
139549918|NCT06044558|Caspofungin|caspofungin|mesh-list
139549919|NCT06044558|Methylprednisolone|methylprednisolone|mesh-list
139549920|NCT06044558|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139549921|NCT06044558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139549922|NCT06044558|Prednisolone|prednisolone|mesh-list
139549923|NCT06044558|Prednisolone acetate|prednisolone acetate|mesh-list
139549924|NCT06044558|Tacrolimus|tacrolimus|mesh-list
139549925|NCT06044558|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139549926|NCT06044558|Prednisolone phosphate|prednisolone phosphate|mesh-list
139549927|NCT06044558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139549928|NCT06044558|Immunologic Factors|immunologic factors|mesh-ancestor
139549929|NCT06044558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549930|NCT06044558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139549931|NCT06044558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139549932|NCT06044558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549933|NCT06044558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139549934|NCT06044558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549935|NCT06044558|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139549936|NCT06044558|Antitubercular Agents|antitubercular agents|mesh-ancestor
139549937|NCT06044558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139549938|NCT06044558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139549939|NCT06044558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549940|NCT06044558|Antiemetics|antiemetics|mesh-ancestor
139549941|NCT06044558|Autonomic Agents|autonomic agents|mesh-ancestor
139549942|NCT06044558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549943|NCT06044558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139549944|NCT06044558|Glucocorticoids|glucocorticoids|mesh-ancestor
139549945|NCT06044558|Hormones|hormones|mesh-ancestor
139549946|NCT06044558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139549947|NCT06044558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139549948|NCT06044558|Protective Agents|protective agents|mesh-ancestor
139549949|NCT06044558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139549950|NCT06044558|Antifungal Agents|antifungal agents|mesh-ancestor
139549951|NCT06044558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139549952|NCT06044558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139549953|NCT06044558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139549954|NCT06044558|Hormone Antagonists|hormone antagonists|mesh-ancestor
139549955|NCT06044558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139549956|NCT06043063|Lidocaine|lidocaine|mesh-list
139549957|NCT06043063|Bupivacaine|bupivacaine|mesh-list
139549958|NCT06043063|Anesthetics, Local|anesthetics, local|mesh-list
139549959|NCT06043063|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139549960|NCT06043063|Anesthetics|anesthetics|mesh-list
139549961|NCT06043063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139549962|NCT06043063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549963|NCT06043063|Sensory System Agents|sensory system agents|mesh-ancestor
139549964|NCT06043063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549965|NCT06043063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139549966|NCT06043063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139549967|NCT06043063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139549968|NCT06043063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139549969|NCT06043063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549970|NCT06043063|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139549971|NCT06034821|Ketamine|ketamine|mesh-list
139549972|NCT06034821|Analgesics|analgesics|mesh-ancestor
139549973|NCT06034821|Sensory System Agents|sensory system agents|mesh-ancestor
139549974|NCT06034821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549975|NCT06034821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549976|NCT06034821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139549977|NCT06034821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139549978|NCT06034821|Anesthetics, General|anesthetics, general|mesh-ancestor
139549979|NCT06034821|Anesthetics|anesthetics|mesh-ancestor
139549980|NCT06034821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139549981|NCT06034821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139549982|NCT06034821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139549983|NCT06034821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139549984|NCT06034821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139549985|NCT06016465|Dexamethasone|dexamethasone|mesh-list
139549986|NCT06016465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139549987|NCT06016465|Antiemetics|antiemetics|mesh-ancestor
139549988|NCT06016465|Autonomic Agents|autonomic agents|mesh-ancestor
139549989|NCT06016465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139549990|NCT06016465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139549991|NCT06016465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139549992|NCT06016465|Glucocorticoids|glucocorticoids|mesh-ancestor
139549993|NCT06016465|Hormones|hormones|mesh-ancestor
139549994|NCT06016465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139549995|NCT06016465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139549996|NCT06016465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139549997|NCT06007547|Poractant alfa|poractant alfa|mesh-list
139549998|NCT06007547|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139549999|NCT06007547|Respiratory System Agents|respiratory system agents|mesh-ancestor
139550000|NCT06006117|Rituximab|rituximab|mesh-list
139550001|NCT06006117|Lenalidomide|lenalidomide|mesh-list
139550002|NCT06006117|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139550003|NCT06006117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550004|NCT06006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550005|NCT06006117|Immunologic Factors|immunologic factors|mesh-ancestor
139550006|NCT06006117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550007|NCT06006117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139550008|NCT06006117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139550009|NCT06006117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139550010|NCT06006117|Growth Substances|growth substances|mesh-ancestor
139550011|NCT06006117|Growth Inhibitors|growth inhibitors|mesh-ancestor
139550012|NCT06006117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139550013|NCT06006117|Alkylating Agents|alkylating agents|mesh-ancestor
139550014|NCT06006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550015|NCT05985590|Drospirenone|drospirenone|mesh-list
139550016|NCT05985590|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139550017|NCT05985590|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139550018|NCT05985590|Estradiol|estradiol|mesh-list
139550019|NCT05985590|Estrogens|estrogens|mesh-ancestor
139550020|NCT05985590|Hormones|hormones|mesh-ancestor
139550021|NCT05985590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139550022|NCT05985590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550023|NCT05985590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139550024|NCT05985590|Contraceptive Agents|contraceptive agents|mesh-ancestor
139550025|NCT05985590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139550026|NCT05985590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139550027|NCT05985590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139550028|NCT05985590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139550029|NCT05985590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139550030|NCT05985590|Hormone Antagonists|hormone antagonists|mesh-ancestor
139550031|NCT05985590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139550033|NCT05985590|Natriuretic Agents|natriuretic agents|mesh-ancestor
139550034|NCT05979493|Bupivacaine|bupivacaine|mesh-list
139550035|NCT05979493|Anesthetics, Local|anesthetics, local|mesh-ancestor
139550036|NCT05979493|Anesthetics|anesthetics|mesh-ancestor
139550037|NCT05979493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550038|NCT05979493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550039|NCT05979493|Sensory System Agents|sensory system agents|mesh-ancestor
139550040|NCT05979493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550041|NCT05976828|Vaccines|vaccines|mesh-list
139550042|NCT05976828|Immunologic Factors|immunologic factors|mesh-ancestor
139550043|NCT05976828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550044|NCT05939765|Antipsychotic Agents|antipsychotic agents|mesh-list
139550045|NCT05939765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139550046|NCT05939765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550047|NCT05939765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550048|NCT05939765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139550049|NCT05928806|Nivolumab|nivolumab|mesh-list
139550050|NCT05928806|Ipilimumab|ipilimumab|mesh-list
139550051|NCT05928806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550052|NCT05928806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550053|NCT05928806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550054|NCT05928806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550055|NCT05926336|Anesthetics|anesthetics|mesh-list
139550056|NCT05926336|Propofol|propofol|mesh-list
139550057|NCT05926336|Sevoflurane|sevoflurane|mesh-list
139550058|NCT05926336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550059|NCT05926336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550060|NCT05926336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139021908|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
139550061|NCT05926336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139550062|NCT05926336|Anesthetics, General|anesthetics, general|mesh-ancestor
139550063|NCT05926336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139550064|NCT05926336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139550065|NCT05912062|Paclitaxel|paclitaxel|mesh-list
139550066|NCT05912062|Trastuzumab|trastuzumab|mesh-list
139550067|NCT05912062|Pertuzumab|pertuzumab|mesh-list
139550068|NCT05912062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139550069|NCT05912062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550070|NCT05912062|Tubulin Modulators|tubulin modulators|mesh-ancestor
139550071|NCT05912062|Antimitotic Agents|antimitotic agents|mesh-ancestor
139550072|NCT05912062|Mitosis Modulators|mitosis modulators|mesh-ancestor
139550073|NCT05912062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550074|NCT05912062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550075|NCT05904028|Faricimab|faricimab|mesh-list
139550076|NCT05904028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139550077|NCT05904028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139550078|NCT05904028|Growth Substances|growth substances|mesh-ancestor
139550079|NCT05904028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550080|NCT05904028|Growth Inhibitors|growth inhibitors|mesh-ancestor
139550081|NCT05904028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550082|NCT05886335|Cyclophosphamide|cyclophosphamide|mesh-list
139550083|NCT05886335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139550084|NCT05886335|Immunologic Factors|immunologic factors|mesh-ancestor
139550085|NCT05886335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550086|NCT05886335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139550087|NCT05886335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139021942|NCT00516074|Exenatide|exenatide|mesh-list
139550088|NCT05886335|Alkylating Agents|alkylating agents|mesh-ancestor
139550089|NCT05886335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550090|NCT05886335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550091|NCT05886335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139550092|NCT05880394|Copper|copper|mesh-list
139550093|NCT05880394|Trace Elements|trace elements|mesh-ancestor
139550094|NCT05880394|Micronutrients|micronutrients|mesh-ancestor
139550095|NCT05880394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550096|NCT05876572|Naloxone|naloxone|mesh-list
139550097|NCT05876572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139550098|NCT05876572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550099|NCT05876572|Sensory System Agents|sensory system agents|mesh-ancestor
139550100|NCT05876572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550101|NCT05867056|Cysteamine|cysteamine|mesh-list
139550102|NCT05867056|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
139550103|NCT05867056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550104|NCT05866471|Psilocybin|psilocybin|mesh-list
139550105|NCT05866471|Hallucinogens|hallucinogens|mesh-ancestor
139550106|NCT05866471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550107|NCT05866471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139550108|NCT05857007|Glucocorticoids|glucocorticoids|mesh-list
139550109|NCT05857007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550110|NCT05857007|Hormones|hormones|mesh-ancestor
139550111|NCT05857007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139550112|NCT05854992|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
139550113|NCT05854992|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139550114|NCT05854992|Serotonin Agents|serotonin agents|mesh-ancestor
139550115|NCT05854992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550116|NCT05854992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550117|NCT05854992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550118|NCT05837897|Vedolizumab|vedolizumab|mesh-list
139550119|NCT05837897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139550120|NCT05813132|Cytarabine|cytarabine|mesh-list
139550121|NCT05813132|Carboplatin|carboplatin|mesh-list
139550122|NCT05813132|Etoposide|etoposide|mesh-list
139550123|NCT05813132|Etoposide phosphate|etoposide phosphate|mesh-list
139550124|NCT05813132|Melphalan|melphalan|mesh-list
139550125|NCT05813132|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139550126|NCT05813132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021981|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
139550127|NCT05813132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139550128|NCT05813132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139550129|NCT05813132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139550130|NCT05813132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550131|NCT05813132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550132|NCT05813132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139550133|NCT05813132|Antimetabolites|antimetabolites|mesh-ancestor
139550134|NCT05813132|Antiviral Agents|antiviral agents|mesh-ancestor
139550135|NCT05813132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550136|NCT05813132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139550137|NCT05813132|Immunologic Factors|immunologic factors|mesh-ancestor
139550138|NCT05813132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550139|NCT05813132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139550140|NCT05813132|Alkylating Agents|alkylating agents|mesh-ancestor
139550141|NCT05813132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139550142|NCT05800834|Lidocaine|lidocaine|mesh-list
139550143|NCT05800834|Morphine|morphine|mesh-list
139550144|NCT05800834|Anesthetics, Local|anesthetics, local|mesh-ancestor
139550145|NCT05800834|Anesthetics|anesthetics|mesh-ancestor
139550146|NCT05800834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550147|NCT05800834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550148|NCT05800834|Sensory System Agents|sensory system agents|mesh-ancestor
139550149|NCT05800834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550150|NCT05800834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139550151|NCT05800834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139550152|NCT05800834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139550153|NCT05800834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139550154|NCT05800834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550155|NCT05800834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139550156|NCT05800834|Narcotics|narcotics|mesh-ancestor
139550157|NCT05800834|Analgesics|analgesics|mesh-ancestor
139550158|NCT05793905|Lidocaine|lidocaine|mesh-list
139550159|NCT05793905|Anesthetics, Local|anesthetics, local|mesh-ancestor
139550160|NCT05793905|Anesthetics|anesthetics|mesh-ancestor
139550161|NCT05793905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550162|NCT05793905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550163|NCT05793905|Sensory System Agents|sensory system agents|mesh-ancestor
139550164|NCT05793905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550165|NCT05793905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139550166|NCT05793905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139550167|NCT05793905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139550168|NCT05793905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139550169|NCT05793905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550170|NCT05793099|Propolis|propolis|mesh-list
139550171|NCT05793099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550172|NCT05785819|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139550173|NCT05785819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550174|NCT05784844|Meropenem|meropenem|mesh-list
139550175|NCT05784844|Micafungin|micafungin|mesh-list
139550176|NCT05784844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139550177|NCT05784844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550178|NCT05784844|Antifungal Agents|antifungal agents|mesh-ancestor
139550179|NCT05783661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139331775|NCT03913091|Bupivacaine|bupivacaine|mesh-list
139550180|NCT05783661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550181|NCT05781711|Metformin|metformin|mesh-list
139550182|NCT05781711|Levodopa|levodopa|mesh-list
139550183|NCT05781711|Carbidopa|carbidopa|mesh-list
139550184|NCT05781711|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139022030|NCT01033305|Cyclosporine|cyclosporine|mesh-list
139550185|NCT05781711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139550186|NCT05781711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550187|NCT05781711|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139550188|NCT05781711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139550189|NCT05781711|Dopamine Agents|dopamine agents|mesh-ancestor
139550190|NCT05781711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550191|NCT05781711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550192|NCT05781711|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139550193|NCT05781711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550194|NCT05781711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139550195|NCT05781711|Immunologic Factors|immunologic factors|mesh-ancestor
139550196|NCT05781711|Dopamine Agonists|dopamine agonists|mesh-ancestor
139550197|NCT05778591|Buprenorphine|buprenorphine|mesh-list
139550198|NCT05778591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139550199|NCT05778591|Narcotics|narcotics|mesh-ancestor
139550200|NCT05778591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550201|NCT05778591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550202|NCT05778591|Analgesics|analgesics|mesh-ancestor
139550203|NCT05778591|Sensory System Agents|sensory system agents|mesh-ancestor
139550204|NCT05778591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550205|NCT05778591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139550206|NCT05766683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139550207|NCT05766683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139550208|NCT05766683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139550209|NCT05766683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550210|NCT05766683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550211|NCT05766683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139550212|NCT05766683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139550213|NCT05766683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550214|NCT05766683|Cholinergic Agents|cholinergic agents|mesh-ancestor
139550215|NCT05766683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550216|NCT05753787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139550217|NCT05753787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139550218|NCT05743400|Thymoglobulin|thymoglobulin|mesh-list
139550219|NCT05743400|Immunologic Factors|immunologic factors|mesh-ancestor
139550220|NCT05743400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550221|NCT05743400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139022042|NCT00514904|Vaccines|vaccines|mesh-list
139550222|NCT05734807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139550223|NCT05734807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139550224|NCT05734807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550225|NCT05734807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550226|NCT05734807|Antiviral Agents|antiviral agents|mesh-ancestor
139550227|NCT05734807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550228|NCT05732077|Dopamine|dopamine|mesh-list
139550229|NCT05732077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139550230|NCT05732077|Sympathomimetics|sympathomimetics|mesh-ancestor
139550231|NCT05732077|Autonomic Agents|autonomic agents|mesh-ancestor
139550232|NCT05732077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550233|NCT05732077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550234|NCT05732077|Dopamine Agents|dopamine agents|mesh-ancestor
139550235|NCT05732077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550236|NCT05732077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550237|NCT05732077|Protective Agents|protective agents|mesh-ancestor
139550238|NCT05717062|Varespladib methyl|varespladib methyl|mesh-list
139550239|NCT05717062|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
139550240|NCT05717062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550241|NCT05717062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550242|NCT05709301|Donepezil|donepezil|mesh-list
139550243|NCT05709301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139550244|NCT05709301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550245|NCT05709301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550246|NCT05709301|Cholinergic Agents|cholinergic agents|mesh-ancestor
139550247|NCT05709301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550248|NCT05709301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550249|NCT05709301|Nootropic Agents|nootropic agents|mesh-ancestor
139550250|NCT05662202|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139550251|NCT05662202|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139550252|NCT05662202|Dermatologic Agents|dermatologic agents|mesh-ancestor
139550253|NCT05649059|Cannabidiol|cannabidiol|mesh-list
139550254|NCT05649059|Anticonvulsants|anticonvulsants|mesh-ancestor
139550255|NCT05638620|Bupivacaine|bupivacaine|mesh-list
139550256|NCT05638620|Anesthetics, Local|anesthetics, local|mesh-ancestor
139550257|NCT05638620|Anesthetics|anesthetics|mesh-ancestor
139550258|NCT05638620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550259|NCT05638620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550260|NCT05638620|Sensory System Agents|sensory system agents|mesh-ancestor
139550261|NCT05638620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550262|NCT05637606|Etilefrine|etilefrine|mesh-list
139550263|NCT05637606|Norepinephrine|norepinephrine|mesh-list
139550264|NCT05637606|Ephedrine|ephedrine|mesh-list
139550265|NCT05637606|Pseudoephedrine|pseudoephedrine|mesh-list
139550266|NCT05637606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139550267|NCT05637606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139550268|NCT05637606|Adrenergic Agents|adrenergic agents|mesh-ancestor
139550269|NCT05637606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550270|NCT05637606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550271|NCT05637606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550272|NCT05637606|Sympathomimetics|sympathomimetics|mesh-ancestor
139550273|NCT05637606|Autonomic Agents|autonomic agents|mesh-ancestor
139550274|NCT05637606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550275|NCT05637606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139550276|NCT05637606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139550277|NCT05637606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139550278|NCT05637606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139550279|NCT05637606|Respiratory System Agents|respiratory system agents|mesh-ancestor
139550280|NCT05637606|Nasal Decongestants|nasal decongestants|mesh-ancestor
139550281|NCT05637606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139550282|NCT05637606|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139550283|NCT05637606|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139550284|NCT05637606|Protective Agents|protective agents|mesh-ancestor
139550285|NCT05623774|Imatinib Mesylate|imatinib mesylate|mesh-list
139550286|NCT05623774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550287|NCT05623774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139550288|NCT05623774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550289|NCT05623774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550290|NCT05623059|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139550291|NCT05623059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139550292|NCT05623059|Immunologic Factors|immunologic factors|mesh-ancestor
139550293|NCT05623059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550294|NCT05582538|Paclitaxel|paclitaxel|mesh-list
139550295|NCT05582538|Durvalumab|durvalumab|mesh-list
139550296|NCT05582538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139022145|NCT00521586|Vaccines|vaccines|mesh-list
139550297|NCT05582538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550298|NCT05582538|Tubulin Modulators|tubulin modulators|mesh-ancestor
139550299|NCT05582538|Antimitotic Agents|antimitotic agents|mesh-ancestor
139550300|NCT05582538|Mitosis Modulators|mitosis modulators|mesh-ancestor
139550301|NCT05582538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550302|NCT05582538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550303|NCT05570305|Dapagliflozin|dapagliflozin|mesh-list
139550304|NCT05570305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139550305|NCT05570305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550306|NCT05570305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139550307|NCT05570305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550308|NCT05562518|Estrogens|estrogens|mesh-list
139550309|NCT05562518|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139550310|NCT05562518|Hormones|hormones|mesh-ancestor
139550311|NCT05562518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139550312|NCT05562518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550313|NCT05562518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139550314|NCT05562518|Immunologic Factors|immunologic factors|mesh-ancestor
139550315|NCT05556356|Acetaminophen|acetaminophen|mesh-list
139550316|NCT05556356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139550317|NCT05556356|Analgesics|analgesics|mesh-ancestor
139550318|NCT05556356|Sensory System Agents|sensory system agents|mesh-ancestor
139550319|NCT05556356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550320|NCT05556356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550321|NCT05556356|Antipyretics|antipyretics|mesh-ancestor
139550322|NCT05553522|Capecitabine|capecitabine|mesh-list
139550323|NCT05553522|Trastuzumab|trastuzumab|mesh-list
139550324|NCT05553522|Tucatinib|tucatinib|mesh-list
139550325|NCT05553522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139550326|NCT05553522|Antimetabolites|antimetabolites|mesh-ancestor
139550327|NCT05553522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550328|NCT05553522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331921|NCT00299325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550329|NCT05553522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550330|NCT05553522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139550331|NCT05553522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550332|NCT05553132|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139550334|NCT05553132|Coagulants|coagulants|mesh-ancestor
139550335|NCT05549297|Pembrolizumab|pembrolizumab|mesh-list
139550336|NCT05549297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550337|NCT05549297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550338|NCT05549297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550339|NCT05549297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550340|NCT05544734|Acetaminophen|acetaminophen|mesh-list
139550341|NCT05544734|Ibuprofen|ibuprofen|mesh-list
139550342|NCT05544734|Hydrocodone|hydrocodone|mesh-list
139550343|NCT05544734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139550344|NCT05544734|Analgesics|analgesics|mesh-ancestor
139550345|NCT05544734|Sensory System Agents|sensory system agents|mesh-ancestor
139550346|NCT05544734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550347|NCT05544734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550348|NCT05544734|Antipyretics|antipyretics|mesh-ancestor
139550349|NCT05544734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139550350|NCT05544734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139550351|NCT05544734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139550352|NCT05544734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139550353|NCT05544734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550354|NCT05544734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550355|NCT05544734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139550356|NCT05544734|Narcotics|narcotics|mesh-ancestor
139550357|NCT05544734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550358|NCT05544734|Antitussive Agents|antitussive agents|mesh-ancestor
139550359|NCT05544734|Respiratory System Agents|respiratory system agents|mesh-ancestor
139550360|NCT05515939|Insulin|insulin|mesh-list
139550361|NCT05515939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139550362|NCT05515939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550363|NCT05515029|Cyclophosphamide|cyclophosphamide|mesh-list
139550364|NCT05515029|Abatacept|abatacept|mesh-list
139550365|NCT05515029|Vedolizumab|vedolizumab|mesh-list
139550366|NCT05515029|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139550367|NCT05515029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139550368|NCT05515029|Immunologic Factors|immunologic factors|mesh-ancestor
139550369|NCT05515029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550370|NCT05515029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139550371|NCT05515029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139550372|NCT05515029|Alkylating Agents|alkylating agents|mesh-ancestor
139550373|NCT05515029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550374|NCT05515029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550375|NCT05515029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139550376|NCT05515029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550377|NCT05515029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550378|NCT05515029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139550379|NCT05515029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550380|NCT05514483|Ondansetron|ondansetron|mesh-list
139550381|NCT05514483|Antiemetics|antiemetics|mesh-ancestor
139550382|NCT05514483|Autonomic Agents|autonomic agents|mesh-ancestor
139550383|NCT05514483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550384|NCT05514483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022188|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
139550385|NCT05514483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139550386|NCT05514483|Antipruritics|antipruritics|mesh-ancestor
139550387|NCT05514483|Dermatologic Agents|dermatologic agents|mesh-ancestor
139550388|NCT05514483|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139550389|NCT05514483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139550390|NCT05514483|Serotonin Agents|serotonin agents|mesh-ancestor
139550391|NCT05514483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550392|NCT05514483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550393|NCT05499052|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139550394|NCT05499052|Hormones|hormones|mesh-ancestor
139550395|NCT05499052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139550396|NCT05499052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550397|NCT05484557|Enoxaparin|enoxaparin|mesh-list
139550398|NCT05484557|Enoxaparin sodium|enoxaparin sodium|mesh-list
139550399|NCT05484557|Apixaban|apixaban|mesh-list
139550400|NCT05484557|Anticoagulants|anticoagulants|mesh-ancestor
139550401|NCT05484557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139550402|NCT05484557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139550403|NCT05484557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550404|NCT05484557|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139550405|NCT05484557|Antithrombins|antithrombins|mesh-ancestor
139550406|NCT05484557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139550407|NCT05484557|Protease Inhibitors|protease inhibitors|mesh-ancestor
139550408|NCT05484557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550409|NCT05480800|Vaccines|vaccines|mesh-list
139550410|NCT05480800|Immunologic Factors|immunologic factors|mesh-ancestor
139550411|NCT05480800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550412|NCT05477823|Androgens|androgens|mesh-list
139550413|NCT05477823|Hormones|hormones|mesh-ancestor
139550414|NCT05477823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139550415|NCT05477823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550416|NCT05459701|Dapagliflozin|dapagliflozin|mesh-list
139022217|NCT00404235|Paclitaxel|paclitaxel|mesh-list
139550417|NCT05459701|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139550418|NCT05459701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550419|NCT05459701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139550420|NCT05459701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550421|NCT05459389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139550422|NCT05459389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550423|NCT05430828|Evolocumab|evolocumab|mesh-list
139550424|NCT05430828|Alirocumab|alirocumab|mesh-list
139550425|NCT05430828|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139550426|NCT05430828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139550427|NCT05430828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139550428|NCT05430828|Antimetabolites|antimetabolites|mesh-ancestor
139550429|NCT05430828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550430|NCT05430828|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139550431|NCT05430828|Protease Inhibitors|protease inhibitors|mesh-ancestor
139550432|NCT05430828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550433|NCT05430828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139550434|NCT05428488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139550435|NCT05428488|Abatacept|abatacept|mesh-list
139550436|NCT05428488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550437|NCT05428488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550438|NCT05428488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550439|NCT05428488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550440|NCT05428488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139550441|NCT05428488|Immunologic Factors|immunologic factors|mesh-ancestor
139550442|NCT05428488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550443|NCT05428488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139550444|NCT05428488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139550445|NCT05428007|Nivolumab|nivolumab|mesh-list
139550446|NCT05428007|Ipilimumab|ipilimumab|mesh-list
139550447|NCT05428007|Relatlimab|relatlimab|mesh-list
139550448|NCT05428007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550449|NCT05428007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550450|NCT05428007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550451|NCT05428007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550452|NCT05400031|Propolis|propolis|mesh-list
139550453|NCT05400031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550454|NCT05393674|Nivolumab|nivolumab|mesh-list
139550455|NCT05393674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550456|NCT05393674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550457|NCT05393674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550458|NCT05393674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550459|NCT05383352|Leucovorin|leucovorin|mesh-list
139550460|NCT05383352|Folic Acid|folic acid|mesh-list
139550461|NCT05383352|Fluorouracil|fluorouracil|mesh-list
139550462|NCT05383352|Irinotecan|irinotecan|mesh-list
139550463|NCT05383352|Camptothecin|camptothecin|mesh-list
139550464|NCT05383352|Levoleucovorin|levoleucovorin|mesh-list
139550465|NCT05383352|Antimetabolites|antimetabolites|mesh-ancestor
139550466|NCT05383352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550467|NCT05383352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139550468|NCT05383352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550469|NCT05383352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139550470|NCT05383352|Immunologic Factors|immunologic factors|mesh-ancestor
139550471|NCT05383352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550472|NCT05383352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139550473|NCT05383352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139550474|NCT05383352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550475|NCT05383352|Antidotes|antidotes|mesh-ancestor
139550476|NCT05383352|Protective Agents|protective agents|mesh-ancestor
139550477|NCT05383352|Vitamin B Complex|vitamin b complex|mesh-ancestor
139550478|NCT05383352|Vitamins|vitamins|mesh-ancestor
139550479|NCT05383352|Micronutrients|micronutrients|mesh-ancestor
139550480|NCT05383352|Hematinics|hematinics|mesh-ancestor
139550481|NCT05383352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139550482|NCT05379790|Irinotecan|irinotecan|mesh-list
139550483|NCT05379790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139550484|NCT05379790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139550485|NCT05379790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550486|NCT05379790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550487|NCT05379790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550488|NCT05374538|Sotorasib|sotorasib|mesh-list
139550489|NCT05374538|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550490|NCT05374538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550491|NCT05374538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550492|NCT05374538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550493|NCT05373264|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139550494|NCT05373264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139550495|NCT05373264|Diuretics|diuretics|mesh-ancestor
139550496|NCT05373264|Natriuretic Agents|natriuretic agents|mesh-ancestor
139550497|NCT05373264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550498|NCT05373264|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139550499|NCT05373264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139550500|NCT05373264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550501|NCT05370040|Vaccines|vaccines|mesh-list
139550502|NCT05370040|Immunologic Factors|immunologic factors|mesh-ancestor
139550503|NCT05370040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550504|NCT05368376|Metoprolol|metoprolol|mesh-list
139550505|NCT05368376|Labetalol|labetalol|mesh-list
139550506|NCT05368376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139550507|NCT05368376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139550508|NCT05368376|Sympatholytics|sympatholytics|mesh-ancestor
139550509|NCT05368376|Autonomic Agents|autonomic agents|mesh-ancestor
139550510|NCT05368376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550511|NCT05368376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550512|NCT05368376|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139550513|NCT05368376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139550514|NCT05368376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139550515|NCT05368376|Adrenergic Agents|adrenergic agents|mesh-ancestor
139550516|NCT05368376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550517|NCT05368376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550518|NCT05368376|Sympathomimetics|sympathomimetics|mesh-ancestor
139550519|NCT05368376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139550520|NCT05368376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139550521|NCT05327270|Nivolumab|nivolumab|mesh-list
139550522|NCT05327270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550523|NCT05327270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550524|NCT05327270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550525|NCT05327270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550526|NCT05317806|Metformin|metformin|mesh-list
139550527|NCT05317806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139550528|NCT05317806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550529|NCT05309928|Amoxicillin|amoxicillin|mesh-list
139550530|NCT05309928|Probenecid|probenecid|mesh-list
139550531|NCT05309928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139550532|NCT05309928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550533|NCT05309928|Uricosuric Agents|uricosuric agents|mesh-ancestor
139550534|NCT05309928|Gout Suppressants|gout suppressants|mesh-ancestor
139550535|NCT05309928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139550536|NCT05309421|Pembrolizumab|pembrolizumab|mesh-list
139550537|NCT05309421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550538|NCT05309421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550539|NCT05309421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550540|NCT05309421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550541|NCT05290727|Hyaluronic Acid|hyaluronic acid|mesh-list
139550542|NCT05290727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139550543|NCT05290727|Immunologic Factors|immunologic factors|mesh-ancestor
139550544|NCT05290727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550545|NCT05290727|Viscosupplements|viscosupplements|mesh-ancestor
139550546|NCT05290727|Protective Agents|protective agents|mesh-ancestor
139550547|NCT05271604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139550548|NCT05271604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550549|NCT05271604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550550|NCT05271604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550551|NCT05255302|Pembrolizumab|pembrolizumab|mesh-list
139550552|NCT05255302|Pemetrexed|pemetrexed|mesh-list
139550553|NCT05255302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139332149|NCT05724381|Phenol|phenol|mesh-list
139550554|NCT05255302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550555|NCT05255302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550556|NCT05255302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550557|NCT05255302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550558|NCT05255302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139550559|NCT05255302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139550560|NCT05243550|Mitomycins|mitomycins|mesh-list
139550561|NCT05243550|Mitomycin|mitomycin|mesh-list
139550562|NCT05243550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139550563|NCT05243550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550564|NCT05243550|Alkylating Agents|alkylating agents|mesh-ancestor
139550565|NCT05243550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550566|NCT05243550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139550567|NCT05243550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550568|NCT05243290|Niacinamide|niacinamide|mesh-list
139550569|NCT05243290|Niacin|niacin|mesh-list
139550570|NCT05243290|Nicotinic Acids|nicotinic acids|mesh-list
139550571|NCT05243290|Vitamin B Complex|vitamin b complex|mesh-ancestor
139550572|NCT05243290|Vitamins|vitamins|mesh-ancestor
139550573|NCT05243290|Micronutrients|micronutrients|mesh-ancestor
139550574|NCT05243290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550575|NCT05243290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139550576|NCT05243290|Antimetabolites|antimetabolites|mesh-ancestor
139550577|NCT05243290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550578|NCT05243290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139550579|NCT05243290|Vasodilator Agents|vasodilator agents|mesh-ancestor
139550580|NCT05239546|Dostarlimab|dostarlimab|mesh-list
139550581|NCT05239546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550582|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
139550583|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
139550584|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550585|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139550586|NCT05174832|Paclitaxel|paclitaxel|mesh-list
139550587|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
139550588|NCT05174832|Olaparib|olaparib|mesh-list
139550589|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139550590|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550591|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
139550592|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
139550593|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
139550594|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550595|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550596|NCT05174832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550597|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139550598|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550599|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139550600|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
139550601|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550602|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
139550603|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139550604|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550605|NCT05128630|Durvalumab|durvalumab|mesh-list
139550606|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550607|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550608|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
139550609|NCT05109429|Narcotics|narcotics|mesh-ancestor
139550610|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550611|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550612|NCT05109429|Analgesics|analgesics|mesh-ancestor
139550613|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
139550614|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550615|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
139550616|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139550617|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139550618|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550619|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
139550620|NCT05082142|Coagulants|coagulants|mesh-ancestor
139550621|NCT05080803|Bevacizumab|bevacizumab|mesh-list
139550622|NCT05080803|Ranibizumab|ranibizumab|mesh-list
139550623|NCT05080803|Aflibercept|aflibercept|mesh-list
139550624|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550625|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550626|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139550627|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139550628|NCT05080803|Growth Substances|growth substances|mesh-ancestor
139550629|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550630|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
139550631|NCT05065970|Felzartamab|felzartamab|mesh-list
139550632|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550633|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
139550634|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550635|NCT05065801|Folfirinox|folfirinox|mesh-list
139550636|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550637|NCT05055830|Acetaminophen|acetaminophen|mesh-list
139550638|NCT05055830|Milrinone|milrinone|mesh-list
139550639|NCT05055830|Methadone|methadone|mesh-list
139550640|NCT05055830|Caffeine|caffeine|mesh-list
139550641|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139550642|NCT05055830|Analgesics|analgesics|mesh-ancestor
139550643|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
139550644|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550645|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550646|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
139550647|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139550648|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139550649|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550650|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550651|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139550652|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139550653|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
139550654|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550655|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139550656|NCT05055830|Narcotics|narcotics|mesh-ancestor
139550657|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550658|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
139550659|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
139550660|NCT05055830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139550661|NCT05055830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139550662|NCT05055830|Vasodilator Agents|vasodilator agents|mesh-ancestor
139550663|NCT05055830|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139550664|NCT05055830|Protective Agents|protective agents|mesh-ancestor
139550665|NCT05053971|Entinostat|entinostat|mesh-list
139550666|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139550667|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550668|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550669|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550670|NCT05048069|Rebamipide|rebamipide|mesh-list
139550671|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139022430|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
139550672|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139550673|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
139550674|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550675|NCT05048069|Protective Agents|protective agents|mesh-ancestor
139550676|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550677|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550678|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
139550679|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139550680|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
139550681|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139550682|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
139550683|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550684|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550685|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
139550686|NCT04994808|Fludarabine|fludarabine|mesh-list
139550687|NCT04994808|Clofarabine|clofarabine|mesh-list
139550688|NCT04994808|Treosulfan|treosulfan|mesh-list
139550689|NCT04994808|Busulfan|busulfan|mesh-list
139550690|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550691|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139550692|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
139550693|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550694|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139550695|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
139550696|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550697|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139550698|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
139550699|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139550700|NCT04991402|Dolutegravir|dolutegravir|mesh-list
139550701|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139550702|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139550703|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139550704|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550705|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550706|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139550707|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
139550708|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550709|NCT04954781|Tislelizumab|tislelizumab|mesh-list
139550710|NCT04954781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550711|NCT04954781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550712|NCT04936685|Vaccines|vaccines|mesh-list
139550713|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
139550714|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550715|NCT04921371|Listerine|listerine|mesh-list
139550716|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139550717|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550718|NCT04893096|Felzartamab|felzartamab|mesh-list
139550719|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550720|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
139550721|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550722|NCT04888741|Cyclosporine|cyclosporine|mesh-list
139550723|NCT04888741|Sirolimus|sirolimus|mesh-list
139550724|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
139550725|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
139550726|NCT04888741|Cyclosporins|cyclosporins|mesh-list
139550727|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
139550728|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139550729|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
139550730|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550731|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139550732|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139550733|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
139550734|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550735|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550736|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139550737|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550738|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
139550739|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550740|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
139550741|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139550742|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139550743|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139550744|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
139550745|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139550746|NCT04869358|Ofatumumab|ofatumumab|mesh-list
139550747|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550748|NCT04825223|Vaccines|vaccines|mesh-list
139550749|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
139550750|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550751|NCT04822649|Adenosine|adenosine|mesh-list
139550752|NCT04822649|Analgesics|analgesics|mesh-ancestor
139550753|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
139550754|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550755|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550756|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139550757|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
139550758|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139550759|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
139550760|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
139550761|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550762|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550763|NCT04753372|Aspirin|aspirin|mesh-list
139550764|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
139550765|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139550766|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
139550767|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139550768|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
139550769|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550770|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550771|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
139550772|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139550773|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139550774|NCT04753372|Analgesics|analgesics|mesh-ancestor
139550775|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
139550776|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550777|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550778|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139550779|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139550780|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139550781|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139550782|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139550783|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139550784|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
139550785|NCT04748042|Prednisone|prednisone|mesh-list
139550786|NCT04748042|Olaparib|olaparib|mesh-list
139550787|NCT04748042|Androgens|androgens|mesh-list
139550788|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139550789|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
139550790|NCT04748042|Hormones|hormones|mesh-ancestor
139550791|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139550792|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550793|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139550794|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550795|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139550796|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550797|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550798|NCT04733040|Felzartamab|felzartamab|mesh-list
139550799|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550800|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
139550801|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550802|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
139550803|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139550804|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550805|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550806|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139550807|NCT04730609|Analgesics|analgesics|mesh-ancestor
139550808|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
139550809|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550810|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139550811|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139550812|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139550813|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
139550814|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550815|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550816|NCT04713176|Remdesivir|remdesivir|mesh-list
139550817|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
139550818|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550819|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
139550820|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550821|NCT04703621|Daratumumab|daratumumab|mesh-list
139550822|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550823|NCT04696146|Complement C1s|complement c1s|mesh-list
139550824|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139550825|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
139550826|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
139550827|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550828|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139550829|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139550830|NCT04669665|Ketamine|ketamine|mesh-list
139550831|NCT04669665|Analgesics|analgesics|mesh-ancestor
139550832|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
139550833|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550834|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550835|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139550836|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139550837|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
139550838|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
139550839|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550840|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139550841|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139550842|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550843|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550844|NCT04661007|Lenalidomide|lenalidomide|mesh-list
139550845|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
139550846|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550847|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139550848|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139550849|NCT04661007|Growth Substances|growth substances|mesh-ancestor
139550850|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
139550851|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550852|NCT04588233|Melatonin|melatonin|mesh-list
139550853|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
139550854|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550855|NCT04588233|Protective Agents|protective agents|mesh-ancestor
139550856|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550857|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550859|NCT04567615|Relatlimab|relatlimab|mesh-list
139550860|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550861|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550862|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550863|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550864|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
139550865|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
139550866|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139550867|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139550868|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
139550869|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550870|NCT04538378|Durvalumab|durvalumab|mesh-list
139550871|NCT04538378|Olaparib|olaparib|mesh-list
139550872|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550873|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550874|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139550875|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550876|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550877|NCT04534153|Fexofenadine|fexofenadine|mesh-list
139550878|NCT04534153|Terfenadine|terfenadine|mesh-list
139550879|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139550880|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139550881|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139550882|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
139550883|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
139550884|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550885|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550886|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550887|NCT04525014|Irinotecan|irinotecan|mesh-list
139550888|NCT04525014|Temozolomide|temozolomide|mesh-list
139550889|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139550890|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139550891|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550892|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550893|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550894|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139550895|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
139550896|NCT04524611|Ustekinumab|ustekinumab|mesh-list
139550897|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139550898|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
139550899|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
139550900|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550901|NCT04515147|Vaccines|vaccines|mesh-list
139550902|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139550903|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
139550904|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550905|NCT04491877|Vaccines|vaccines|mesh-list
139550906|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
139550907|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550908|NCT04471818|Ketamine|ketamine|mesh-list
139550909|NCT04471818|Analgesics|analgesics|mesh-ancestor
139550910|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
139550911|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139550912|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550913|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139550914|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139550915|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
139550916|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
139550917|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139550918|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139550919|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139550920|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139550921|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550922|NCT04454658|Navitoclax|navitoclax|mesh-list
139550923|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550924|NCT04434482|Temozolomide|temozolomide|mesh-list
139550925|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139550926|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
139550927|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550928|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022621|NCT00896519|Prednisone|prednisone|mesh-list
139550929|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
139550930|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139332523|NCT05707169|Anesthetics|anesthetics|mesh-ancestor
139550931|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139550932|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
139550933|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139550934|NCT04419909|Tisagenlecleucel|tisagenlecleucel|mesh-list
139550935|NCT04419909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550936|NCT04419909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550938|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550939|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139550940|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550941|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550942|NCT04387227|Carboplatin|carboplatin|mesh-list
139550943|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
139550944|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550945|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550946|NCT04387227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550947|NCT04387227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550948|NCT04364776|Durvalumab|durvalumab|mesh-list
139550949|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550950|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550951|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
139550952|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
139550953|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139550954|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550955|NCT04338529|Vitamins|vitamins|mesh-ancestor
139550956|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
139550957|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139550958|NCT04338529|Antacids|antacids|mesh-ancestor
139550959|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550960|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139550961|NCT04266795|Azacitidine|azacitidine|mesh-list
139550962|NCT04266795|Venetoclax|venetoclax|mesh-list
139550963|NCT04266795|Pevonedistat|pevonedistat|mesh-list
139550964|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139550965|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
139550966|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550967|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550968|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550969|NCT04262466|Pembrolizumab|pembrolizumab|mesh-list
139550970|NCT04262466|Atezolizumab|atezolizumab|mesh-list
139550971|NCT04262466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139550972|NCT04262466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550973|NCT04262466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139550974|NCT04262466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550975|NCT04259944|Capecitabine|capecitabine|mesh-list
139550976|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139550977|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
139550978|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550979|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550980|NCT04256941|Letrozole|letrozole|mesh-list
139550981|NCT04256941|Fulvestrant|fulvestrant|mesh-list
139550982|NCT04256941|Palbociclib|palbociclib|mesh-list
139550983|NCT04256941|Anastrozole|anastrozole|mesh-list
139550984|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139550985|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139550986|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139550987|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139550988|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139550989|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139550990|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
139550991|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139550992|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139550993|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139550994|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139022695|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
139550995|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139550996|NCT04254692|Bupivacaine|bupivacaine|mesh-list
139550997|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
139550998|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
139550999|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139551000|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551001|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
139551002|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551003|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
139551004|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551005|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551006|NCT04234113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551007|NCT04234113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551008|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139551009|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139551010|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139551011|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
139551012|NCT04216472|Paclitaxel|paclitaxel|mesh-list
139551013|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139551014|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
139551015|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139551016|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551017|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
139551018|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
139551019|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
139551020|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551021|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551022|NCT04212364|Naloxone|naloxone|mesh-list
139551023|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139551024|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551025|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
139551026|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551027|NCT04205643|Infliximab|infliximab|mesh-list
139551028|NCT04205643|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139551029|NCT04205643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139551030|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
139551031|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139551032|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139551033|NCT04195945|Cytarabine|cytarabine|mesh-list
139551034|NCT04195945|Daunorubicin|daunorubicin|mesh-list
139551035|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
139551036|NCT04195945|Cladribine|cladribine|mesh-list
139551037|NCT04195945|Lenograstim|lenograstim|mesh-list
139551038|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139551039|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
139551040|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551041|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551042|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
139551043|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139551044|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139551045|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
139551046|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551047|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139551048|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139551049|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139551050|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551051|NCT04195945|Analgesics|analgesics|mesh-ancestor
139551052|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
139551053|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551054|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139551055|NCT04166604|Trifluridine|trifluridine|mesh-list
139551056|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
139551057|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551058|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
139551059|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139551060|NCT04145440|Felzartamab|felzartamab|mesh-list
139551061|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551062|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
139551063|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551064|NCT04127227|Gemcitabine|gemcitabine|mesh-list
139551065|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
139551066|NCT04127227|Pegaspargase|pegaspargase|mesh-list
139551067|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139551068|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
139551069|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551070|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551071|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
139551072|NCT04106219|Topotecan|topotecan|mesh-list
139551073|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139551074|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
139551075|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551076|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139551077|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139551078|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
139022758|NCT00342628|Vaccines|vaccines|mesh-list
139551079|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332674|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
139551080|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551081|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139551082|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139551083|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139551084|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551085|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
139551086|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139551087|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139551088|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551089|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
139551090|NCT04089865|Coagulants|coagulants|mesh-ancestor
139551091|NCT04074512|Copper|copper|mesh-list
139551092|NCT04074512|Trace Elements|trace elements|mesh-ancestor
139551093|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
139551094|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551095|NCT04062708|Durvalumab|durvalumab|mesh-list
139551096|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551097|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551098|NCT04057131|Icatibant|icatibant|mesh-list
139551099|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139551100|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139551101|NCT04057131|Analgesics|analgesics|mesh-ancestor
139551102|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
139551103|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551104|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551105|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139551106|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139551107|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
139551108|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
139551109|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551110|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139551111|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139551112|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
139551113|NCT04036435|Deucravacitinib|deucravacitinib|mesh-list
139551114|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
139551115|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139551116|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551117|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551118|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
139551119|NCT04033107|Metformin|metformin|mesh-list
139551120|NCT04033107|Vitamins|vitamins|mesh-ancestor
139551121|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
139551122|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551123|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139551124|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
139551125|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551126|NCT04033107|Protective Agents|protective agents|mesh-ancestor
139551127|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139551128|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139551129|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551130|NCT04017832|Incretins|incretins|mesh-ancestor
139551131|NCT04017832|Hormones|hormones|mesh-ancestor
139551132|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139551133|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139551134|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
139551135|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551136|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551137|NCT04006262|Nivolumab|nivolumab|mesh-list
139551138|NCT04006262|Ipilimumab|ipilimumab|mesh-list
139551139|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551140|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551141|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551142|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551143|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
139551144|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551145|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139551146|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551147|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551148|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
139551149|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139551150|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551151|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139551152|NCT03994627|Olaratumab|olaratumab|mesh-list
139551153|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551154|NCT03978611|Ipilimumab|ipilimumab|mesh-list
139551155|NCT03978611|Relatlimab|relatlimab|mesh-list
139551156|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551157|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551158|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551159|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551160|NCT03973333|Atezolizumab|atezolizumab|mesh-list
139551161|NCT03973333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551162|NCT03973333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551163|NCT03973333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551164|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551165|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
139551166|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139551167|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139551168|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139551169|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139551170|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551171|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
139551172|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139551173|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551174|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139551175|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551176|NCT03944577|Evolocumab|evolocumab|mesh-list
139551177|NCT03944577|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139551178|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139551179|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139551180|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
139551181|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551182|NCT03944577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139551183|NCT03944577|Protease Inhibitors|protease inhibitors|mesh-ancestor
139551184|NCT03944577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551185|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139551186|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
139551187|NCT03925025|Nimodipine|nimodipine|mesh-list
139551188|NCT03925025|Analgesics|analgesics|mesh-ancestor
139551189|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
139551190|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551191|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551192|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
139551193|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139551194|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139551195|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
139551196|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139551197|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139551198|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551199|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139551200|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
139551201|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139551202|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139551203|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
139551204|NCT03924947|Pancrelipase|pancrelipase|mesh-list
139551205|NCT03924947|Pancreatin|pancreatin|mesh-list
139551206|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139551207|NCT03919292|Valproic Acid|valproic acid|mesh-list
139551208|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
139551209|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551210|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551211|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
139551212|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139551213|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551214|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
139551215|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139551216|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139551217|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139551218|NCT03914118|Modafinil|modafinil|mesh-list
139551219|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139551220|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551221|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139551222|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139551223|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139551224|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551225|NCT03911973|Talazoparib|talazoparib|mesh-list
139551226|NCT03911973|Gedatolisib|gedatolisib|mesh-list
139551227|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139551228|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551229|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551230|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551231|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139551232|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
139551233|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139551234|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139551235|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139551236|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139551237|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551238|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
139551239|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139551240|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551241|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139551242|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551243|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
139551244|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139551245|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139551246|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551247|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139551248|NCT03892928|Analgesics|analgesics|mesh-ancestor
139551249|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
139551250|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551251|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139551252|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139551253|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139551254|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
139551255|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139551256|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551257|NCT03864094|Phenylephrine|phenylephrine|mesh-list
139551258|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
139551259|NCT03864094|Norepinephrine|norepinephrine|mesh-list
139551260|NCT03864094|Ephedrine|ephedrine|mesh-list
139551261|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
139551262|NCT03864094|Remifentanil|remifentanil|mesh-list
139551263|NCT03864094|Propofol|propofol|mesh-list
139551264|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139551265|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139551266|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551267|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139551268|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
139551269|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
139551270|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139551271|NCT03864094|Narcotics|narcotics|mesh-ancestor
139551272|NCT03864094|Analgesics|analgesics|mesh-ancestor
139551273|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
139551274|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551275|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139551276|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
139551277|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
139551278|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
139551279|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139551280|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
139551281|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
139551282|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139551283|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139551284|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139551285|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
139551286|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139551287|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551288|NCT03864094|Protective Agents|protective agents|mesh-ancestor
139551289|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139551290|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139551291|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139551292|NCT03863184|Rituximab|rituximab|mesh-list
139551293|NCT03863184|Lenalidomide|lenalidomide|mesh-list
139551294|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
139551295|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551296|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551297|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
139551298|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551299|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139551300|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139551301|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139332900|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
139551302|NCT03863184|Growth Substances|growth substances|mesh-ancestor
139551303|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
139551304|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
139551305|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139551306|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
139551307|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
139551308|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139551309|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551310|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139551311|NCT03826693|Analgesics|analgesics|mesh-ancestor
139551312|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
139551313|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551314|NCT03768349|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139551315|NCT03768349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139551316|NCT03768349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551317|NCT03765983|Trastuzumab|trastuzumab|mesh-list
139551318|NCT03765983|GDC-0084|gdc-0084|mesh-list
139551319|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551320|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551321|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551322|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551323|NCT03761225|Prednisone|prednisone|mesh-list
139551324|NCT03761225|Docetaxel|docetaxel|mesh-list
139551325|NCT03761225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551326|NCT03761225|Tubulin Modulators|tubulin modulators|mesh-ancestor
139551327|NCT03761225|Antimitotic Agents|antimitotic agents|mesh-ancestor
139551328|NCT03761225|Mitosis Modulators|mitosis modulators|mesh-ancestor
139551329|NCT03761225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551330|NCT03761225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139551331|NCT03761225|Glucocorticoids|glucocorticoids|mesh-ancestor
139551332|NCT03761225|Hormones|hormones|mesh-ancestor
139551333|NCT03761225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139551334|NCT03761225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551335|NCT03761225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139551336|NCT03755804|Prednisone|prednisone|mesh-list
139551337|NCT03755804|Prednisolone|prednisolone|mesh-list
139551338|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
139551339|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139551340|NCT03755804|Dacarbazine|dacarbazine|mesh-list
139551341|NCT03755804|Doxorubicin|doxorubicin|mesh-list
139551342|NCT03755804|Etoposide|etoposide|mesh-list
139551343|NCT03755804|Vincristine|vincristine|mesh-list
139551344|NCT03755804|Bleomycin|bleomycin|mesh-list
139551345|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139551346|NCT03755804|Vinblastine|vinblastine|mesh-list
139551347|NCT03755804|Imidazole|imidazole|mesh-list
139551348|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139551349|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
139551350|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551351|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139551352|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139551353|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
139551354|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551355|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551356|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139551357|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139551358|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139551359|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139551360|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551361|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139551362|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
139551363|NCT03755804|Hormones|hormones|mesh-ancestor
139551364|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139551365|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139551366|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139551367|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
139551368|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
139022862|NCT04035707|Rocuronium|rocuronium|mesh-list
139551369|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
139551370|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551371|NCT03755804|Immunotoxins|immunotoxins|mesh-ancestor
139551372|NCT03755804|Immunoconjugates|immunoconjugates|mesh-ancestor
139551373|NCT03699475|Cyclophosphamide|cyclophosphamide|mesh-list
139551374|NCT03699475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139551375|NCT03699475|Immunologic Factors|immunologic factors|mesh-ancestor
139551376|NCT03699475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332977|NCT02438852|Ropivacaine|ropivacaine|mesh-list
139551377|NCT03699475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139551378|NCT03699475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139551380|NCT03699475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551381|NCT03699475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551382|NCT03699475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139551383|NCT03674424|Avelumab|avelumab|mesh-list
139551384|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551385|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551386|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139551387|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
139551388|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551389|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
139551390|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139551391|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139551392|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
139551393|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
139551394|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139551395|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551396|NCT03571308|Prednisolone|prednisolone|mesh-list
139551397|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
139551398|NCT03571308|Doxorubicin|doxorubicin|mesh-list
139551399|NCT03571308|Vincristine|vincristine|mesh-list
139551400|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
139551401|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139551402|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
139551403|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551404|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139551405|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139551406|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
139551407|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551408|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551409|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139551410|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139551411|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139551412|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139551413|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551414|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139551415|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
139551416|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
139551417|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
139551418|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139551419|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
139551420|NCT03571308|Hormones|hormones|mesh-ancestor
139551421|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139551422|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139551423|NCT03554473|Temozolomide|temozolomide|mesh-list
139551424|NCT03554473|Topotecan|topotecan|mesh-list
139551425|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139551426|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
139551427|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551428|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551429|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139551430|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139551431|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551432|NCT03539731|Piperazine|piperazine|mesh-list
139551433|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
139551434|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
139551435|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139551436|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139551437|NCT03529448|Temozolomide|temozolomide|mesh-list
139551438|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139551439|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
139551440|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551441|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551442|NCT03526250|Palbociclib|palbociclib|mesh-list
139551443|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551444|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139551445|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551446|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551447|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
139551448|NCT03519412|Temozolomide|temozolomide|mesh-list
139551449|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551450|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551451|NCT03519412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139333050|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551452|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551453|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139551454|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
139551455|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
139551456|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551457|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551458|NCT03514017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551459|NCT03514017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551460|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
139551461|NCT03513406|Neostigmine|neostigmine|mesh-list
139551462|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139551463|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551464|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551465|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
139551466|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139551467|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551468|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139551469|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
139551470|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551471|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139551472|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139551473|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139551474|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
139551475|NCT03504163|BCG Vaccine|bcg vaccine|mesh-list
139551476|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551477|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551478|NCT03504163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551479|NCT03504163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551480|NCT03504163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139551481|NCT03504163|Immunologic Factors|immunologic factors|mesh-ancestor
139551482|NCT03504163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551483|NCT03469960|Nivolumab|nivolumab|mesh-list
139551484|NCT03469960|Ipilimumab|ipilimumab|mesh-list
139551485|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551486|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551487|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551488|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551489|NCT03435952|Doxycycline|doxycycline|mesh-list
139551490|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
139022884|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
139551491|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551492|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551493|NCT03435952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551494|NCT03435952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551495|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139551496|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139551497|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
139551498|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139551499|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139551500|NCT03418779|Prednisolone|prednisolone|mesh-list
139551501|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
139551502|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139551503|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
139551504|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551505|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139551506|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139551507|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
139551508|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551509|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551510|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139551511|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139551512|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
139551513|NCT03418779|Hormones|hormones|mesh-ancestor
139551514|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139551515|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139551516|NCT03418038|Vitamins|vitamins|mesh-list
139551517|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
139551518|NCT03418038|Cytarabine|cytarabine|mesh-list
139551519|NCT03418038|Dexamethasone|dexamethasone|mesh-list
139551520|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
139551521|NCT03418038|Rituximab|rituximab|mesh-list
139551522|NCT03418038|Cisplatin|cisplatin|mesh-list
139551523|NCT03418038|Carboplatin|carboplatin|mesh-list
139551524|NCT03418038|Gemcitabine|gemcitabine|mesh-list
139551525|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
139551526|NCT03418038|Etoposide|etoposide|mesh-list
139551527|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
139551528|NCT03418038|Ifosfamide|ifosfamide|mesh-list
139551529|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
139551530|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
139551531|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139551532|NCT03418038|Antibodies|antibodies|mesh-list
139551533|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
139551534|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139551535|NCT03418038|BB 1101|bb 1101|mesh-list
139551536|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
139551537|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551538|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
139551539|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139551540|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
139551541|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
139551542|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551543|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139551544|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
139551545|NCT03418038|Hormones|hormones|mesh-ancestor
139551546|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139551547|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139551548|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551549|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
139551550|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551551|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551552|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139551553|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139551554|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
139022902|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
139551555|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139551556|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139551557|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139551558|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
139551559|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139551560|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139551561|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
139551562|NCT03418038|Protective Agents|protective agents|mesh-ancestor
139551563|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139551564|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
139551565|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
139551566|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
139551567|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
139551568|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
139551569|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
139551570|NCT03409588|Riociguat|riociguat|mesh-list
139551571|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
139551572|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551573|NCT03387085|Leucovorin|leucovorin|mesh-list
139551574|NCT03387085|Paclitaxel|paclitaxel|mesh-list
139551575|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
139551576|NCT03387085|Bevacizumab|bevacizumab|mesh-list
139551577|NCT03387085|Capecitabine|capecitabine|mesh-list
139551578|NCT03387085|Fluorouracil|fluorouracil|mesh-list
139551579|NCT03387085|Avelumab|avelumab|mesh-list
139551580|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139551581|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551582|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
139551583|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
139551584|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
139551585|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551586|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139551587|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
139551588|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551589|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139551590|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139551591|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
139551592|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139551593|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551594|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139551595|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139551596|NCT03387085|Growth Substances|growth substances|mesh-ancestor
139551597|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
139551598|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139551599|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
139551600|NCT03387085|Antidotes|antidotes|mesh-ancestor
139551601|NCT03387085|Protective Agents|protective agents|mesh-ancestor
139551602|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
139551603|NCT03387085|Vitamins|vitamins|mesh-ancestor
139551604|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
139551605|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
139551606|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139551607|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139551608|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551610|NCT03385928|Coagulants|coagulants|mesh-ancestor
139551611|NCT03374254|Leucovorin|leucovorin|mesh-list
139551612|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
139551613|NCT03374254|Fluorouracil|fluorouracil|mesh-list
139551614|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
139551615|NCT03374254|Irinotecan|irinotecan|mesh-list
139551616|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551617|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551618|NCT03374254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551619|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551620|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551621|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
139551622|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139551623|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139551624|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
139551625|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139551626|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139551627|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551628|NCT03374254|Antidotes|antidotes|mesh-ancestor
139551629|NCT03374254|Protective Agents|protective agents|mesh-ancestor
139551630|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
139551631|NCT03374254|Vitamins|vitamins|mesh-ancestor
139551632|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
139551633|NCT03354728|Vaccines|vaccines|mesh-list
139551634|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
139551635|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551636|NCT03350126|Nivolumab|nivolumab|mesh-list
139551637|NCT03350126|Ipilimumab|ipilimumab|mesh-list
139551638|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551639|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551640|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551641|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551642|NCT03347929|Naproxen|naproxen|mesh-list
139551643|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139551644|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139551645|NCT03347929|Analgesics|analgesics|mesh-ancestor
139551646|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
139551647|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551648|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551649|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139551650|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139551651|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
139551652|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139551653|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551654|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551655|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
139551656|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551657|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551658|NCT03248570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551659|NCT03248570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551660|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
139551661|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139551662|NCT03233204|Olaparib|olaparib|mesh-list
139551663|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139551664|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551665|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551666|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551667|NCT03216525|Alvimopan|alvimopan|mesh-list
139551668|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139551669|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139551670|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139551671|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551672|NCT03190915|Trametinib|trametinib|mesh-list
139551673|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551674|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139551675|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551676|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551677|NCT03143270|Nivolumab|nivolumab|mesh-list
139551678|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551679|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551680|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551681|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551682|NCT03117751|Cytarabine|cytarabine|mesh-list
139551683|NCT03117751|Dexamethasone|dexamethasone|mesh-list
139551684|NCT03117751|Prednisone|prednisone|mesh-list
139551685|NCT03117751|Prednisolone|prednisolone|mesh-list
139551686|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
139551687|NCT03117751|Doxorubicin|doxorubicin|mesh-list
139551688|NCT03117751|Methotrexate|methotrexate|mesh-list
139551689|NCT03117751|Etoposide|etoposide|mesh-list
139551690|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
139551691|NCT03117751|Vincristine|vincristine|mesh-list
139551692|NCT03117751|Bortezomib|bortezomib|mesh-list
139551693|NCT03117751|Daunorubicin|daunorubicin|mesh-list
139551694|NCT03117751|Asparaginase|asparaginase|mesh-list
139551695|NCT03117751|Dasatinib|dasatinib|mesh-list
139551696|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
139551697|NCT03117751|Vorinostat|vorinostat|mesh-list
139551698|NCT03117751|Idarubicin|idarubicin|mesh-list
139551699|NCT03117751|Clofarabine|clofarabine|mesh-list
139551700|NCT03117751|Pegaspargase|pegaspargase|mesh-list
139551701|NCT03117751|Thioguanine|thioguanine|mesh-list
139551702|NCT03117751|Blinatumomab|blinatumomab|mesh-list
139551703|NCT03117751|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
139551704|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139551705|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
139551706|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551707|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139551708|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139551709|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
139551710|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551711|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551712|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139551713|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139551714|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
139551715|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
139551716|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551717|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139551718|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
139551719|NCT03117751|Hormones|hormones|mesh-ancestor
139551720|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139551721|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139551722|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139551723|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139551724|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139551725|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551726|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139551727|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
139551728|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139551729|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139551730|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
139551731|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
139551732|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139551733|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139551734|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139551735|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
139551736|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139551737|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
139551738|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
139551739|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
139551740|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139551741|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139551742|NCT03113968|Ketamine|ketamine|mesh-list
139551743|NCT03113968|Analgesics|analgesics|mesh-ancestor
139551744|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
139551745|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551746|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551747|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139551748|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139551749|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
139551750|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
139551751|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139551752|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139551753|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139333354|NCT04466241|Ritonavir|ritonavir|mesh-list
139551754|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139551755|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551756|NCT03112174|Venetoclax|venetoclax|mesh-list
139551757|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551758|NCT03047135|Olaparib|olaparib|mesh-list
139551759|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139551760|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551761|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551762|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551763|NCT03028857|Choline|choline|mesh-list
139551764|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
139551765|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139551766|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
139551767|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551768|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139551769|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139551770|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
139551771|NCT02994576|Atezolizumab|atezolizumab|mesh-list
139551772|NCT02994576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551773|NCT02994576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551774|NCT02994576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551775|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551776|NCT02973789|Docetaxel|docetaxel|mesh-list
139551777|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139551778|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551779|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
139551780|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
139551781|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
139551782|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551783|NCT02973789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551784|NCT02906007|Bedaquiline|bedaquiline|mesh-list
139551785|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
139551786|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139551787|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139551788|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
139551789|NCT02883049|Leucovorin|leucovorin|mesh-list
139551790|NCT02883049|Folic Acid|folic acid|mesh-list
139551791|NCT02883049|Cytarabine|cytarabine|mesh-list
139551792|NCT02883049|Dexamethasone|dexamethasone|mesh-list
139551793|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
139551794|NCT02883049|Prednisone|prednisone|mesh-list
139551795|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
139551796|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139551797|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139551798|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139551799|NCT02883049|Cortisone|cortisone|mesh-list
139551800|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
139551801|NCT02883049|Doxorubicin|doxorubicin|mesh-list
139551802|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139551803|NCT02883049|Methotrexate|methotrexate|mesh-list
139551804|NCT02883049|Etoposide|etoposide|mesh-list
139551805|NCT02883049|Vincristine|vincristine|mesh-list
139551806|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
139551807|NCT02883049|Daunorubicin|daunorubicin|mesh-list
139551808|NCT02883049|Asparaginase|asparaginase|mesh-list
139551809|NCT02883049|Dasatinib|dasatinib|mesh-list
139551810|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
139551811|NCT02883049|Clofarabine|clofarabine|mesh-list
139551812|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
139551813|NCT02883049|Pegaspargase|pegaspargase|mesh-list
139551814|NCT02883049|Thioguanine|thioguanine|mesh-list
139551815|NCT02883049|BB 1101|bb 1101|mesh-list
139551816|NCT02883049|Calcium|calcium|mesh-list
139551817|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
139551818|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
139551819|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139551820|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
139551821|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551822|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139551823|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139551824|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
139551825|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551826|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551827|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139551828|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139551829|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
139551830|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
139551831|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551832|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139551833|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
139551834|NCT02883049|Hormones|hormones|mesh-ancestor
139551835|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139551836|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139551837|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
139551838|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551839|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139551840|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139551841|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139551842|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139551843|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139551844|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139551845|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
139551846|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139551847|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139551848|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
139551849|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
139551850|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139551851|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139551852|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139551853|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
139551854|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139551855|NCT02883049|Antidotes|antidotes|mesh-ancestor
139551856|NCT02883049|Protective Agents|protective agents|mesh-ancestor
139551857|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
139551858|NCT02883049|Vitamins|vitamins|mesh-ancestor
139551859|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
139551860|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
139551861|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
139551862|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
139551863|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139551864|NCT02883049|Hematinics|hematinics|mesh-ancestor
139551865|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
139551866|NCT02864251|Carboplatin|carboplatin|mesh-list
139551867|NCT02864251|Nivolumab|nivolumab|mesh-list
139551868|NCT02864251|Pemetrexed|pemetrexed|mesh-list
139551869|NCT02864251|Ipilimumab|ipilimumab|mesh-list
139551870|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551871|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551872|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551873|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551874|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551875|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139551876|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139551877|NCT02822092|Risperidone|risperidone|mesh-list
139551878|NCT02822092|Aripiprazole|aripiprazole|mesh-list
139551879|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139551880|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
139551881|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139551882|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551883|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551884|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139551885|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139023102|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
139551886|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139551887|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139551888|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139551889|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
139551890|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
139551891|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
139551892|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139551893|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139551894|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139551895|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139551896|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
139551897|NCT02816021|Azacitidine|azacitidine|mesh-list
139551898|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551899|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551900|NCT02816021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551901|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551902|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139551903|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
139551904|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551905|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
139551906|NCT02779751|Anastrozole|anastrozole|mesh-list
139551907|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551908|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551909|NCT02779751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551910|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551911|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139333501|NCT02435654|Olanzapine|olanzapine|mesh-list
139551912|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139551913|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139551914|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551915|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139551916|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
139551917|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139551918|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551919|NCT02774148|Acetaminophen|acetaminophen|mesh-list
139551920|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139551921|NCT02774148|Analgesics|analgesics|mesh-ancestor
139551922|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
139551923|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551924|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551925|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
139551926|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
139551927|NCT02771197|Fludarabine|fludarabine|mesh-list
139551928|NCT02771197|Melphalan|melphalan|mesh-list
139551929|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551930|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551931|NCT02771197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139551932|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551933|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139551934|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
139551935|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551936|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139551937|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
139551938|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139551939|NCT02722421|Efavirenz|efavirenz|mesh-list
139551940|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
139551941|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139551942|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139551943|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551944|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551945|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
139551946|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139551947|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139023122|NCT00904085|Oxymorphone|oxymorphone|mesh-list
139551948|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139551949|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139551950|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139551951|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139551952|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139551953|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139551954|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
139551955|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139551956|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551957|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139551958|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139551959|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139551960|NCT02693184|Vitamin D|vitamin d|mesh-list
139551961|NCT02693184|Calcium|calcium|mesh-list
139551962|NCT02693184|Vitamins|vitamins|mesh-ancestor
139551963|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
139551964|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551965|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139551966|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139551967|NCT02659241|Adavosertib|adavosertib|mesh-list
139551968|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139551969|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551970|NCT02647385|Lidocaine|lidocaine|mesh-list
139551971|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
139551972|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
139551973|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139551974|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551975|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
139551976|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139551977|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139551978|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139551979|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139551980|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139551981|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551982|NCT02588677|Riluzole|riluzole|mesh-list
139551983|NCT02588677|Anticonvulsants|anticonvulsants|mesh-ancestor
139551984|NCT02588677|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139551985|NCT02588677|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139551986|NCT02588677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139551987|NCT02588677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551988|NCT02588677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139551989|NCT02588677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139551990|NCT02588677|Protective Agents|protective agents|mesh-ancestor
139551991|NCT02565914|Ivacaftor|ivacaftor|mesh-list
139551992|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139551993|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139551994|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139551995|NCT02535078|Durvalumab|durvalumab|mesh-list
139551996|NCT02535078|Tremelimumab|tremelimumab|mesh-list
139551997|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139551998|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139551999|NCT02520791|Antibodies|antibodies|mesh-list
139552000|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139552001|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
139552002|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552003|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
139552004|NCT02338518|Etoposide|etoposide|mesh-list
139552005|NCT02338518|Epirubicin|epirubicin|mesh-list
139552006|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552007|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139552008|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139552009|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139552010|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552011|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552012|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139552013|NCT02286687|Talazoparib|talazoparib|mesh-list
139552014|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139552015|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552016|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552017|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552018|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
139552019|NCT02248701|Finasteride|finasteride|mesh-list
139552020|NCT02248701|Testosterone|testosterone|mesh-list
139552021|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
139552022|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
139552023|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139552024|NCT02248701|Androgens|androgens|mesh-ancestor
139552025|NCT02248701|Hormones|hormones|mesh-ancestor
139552026|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552027|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552028|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139552029|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552030|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
139552031|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139552032|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139552033|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552034|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552035|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
139552036|NCT02248701|Urological Agents|urological agents|mesh-ancestor
139552037|NCT02204982|Rituximab|rituximab|mesh-list
139552038|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139552039|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552040|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
139552041|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552042|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552043|NCT02086175|Rituximab|rituximab|mesh-list
139552044|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139552045|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552046|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
139552047|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552048|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552049|NCT02073838|Ribavirin|ribavirin|mesh-list
139552050|NCT02073838|Decitabine|decitabine|mesh-list
139552051|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
139552052|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552053|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
139552054|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552055|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139552056|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552057|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552058|NCT02068443|Metformin|metformin|mesh-list
139552059|NCT02068443|Alogliptin|alogliptin|mesh-list
139552060|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139552061|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552063|NCT02068443|Hormones|hormones|mesh-ancestor
139552064|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552065|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139552066|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
139552067|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552068|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552069|NCT02021006|Amoxicillin|amoxicillin|mesh-list
139552070|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
139552071|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
139552072|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139552073|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
139552074|NCT02021006|Cefixime|cefixime|mesh-list
139552075|NCT02021006|Trimethoprim|trimethoprim|mesh-list
139552076|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
139552077|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139552078|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552079|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139552080|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
139552081|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139552082|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139552083|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139552084|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023189|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
139552085|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552086|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139552087|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139552088|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139552089|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139552090|NCT02018861|Rituximab|rituximab|mesh-list
139552091|NCT02018861|Carboplatin|carboplatin|mesh-list
139552092|NCT02018861|Etoposide|etoposide|mesh-list
139552093|NCT02018861|Ifosfamide|ifosfamide|mesh-list
139552094|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139552095|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552096|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
139552097|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552098|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552099|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139552100|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139552101|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139552102|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552103|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552104|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139552105|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
139552106|NCT01995578|Azacitidine|azacitidine|mesh-list
139552107|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139552108|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
139552109|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552110|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552111|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552112|NCT01949337|Prednisone|prednisone|mesh-list
139552113|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139552114|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
139552115|NCT01949337|Hormones|hormones|mesh-ancestor
139552116|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552117|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552118|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139552119|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552120|NCT01827384|Carboplatin|carboplatin|mesh-list
139552121|NCT01827384|Everolimus|everolimus|mesh-list
139552122|NCT01827384|Temozolomide|temozolomide|mesh-list
139552123|NCT01827384|Trametinib|trametinib|mesh-list
139552124|NCT01827384|Veliparib|veliparib|mesh-list
139552125|NCT01827384|Adavosertib|adavosertib|mesh-list
139552126|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552127|NCT01827384|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139552128|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139552129|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552130|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552131|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139552132|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
139552133|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552134|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139552135|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
139552136|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139552137|NCT01585194|Nivolumab|nivolumab|mesh-list
139552138|NCT01585194|Ipilimumab|ipilimumab|mesh-list
139552139|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139552140|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552141|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139552142|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552143|NCT01560663|Carboplatin|carboplatin|mesh-list
139552144|NCT01560663|Docetaxel|docetaxel|mesh-list
139552145|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552146|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
139552147|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
139552148|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
139552149|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552150|NCT01463371|Azithromycin|azithromycin|mesh-list
139552151|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139552152|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552153|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139552154|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139552155|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552156|NCT01377389|Ipilimumab|ipilimumab|mesh-list
139552157|NCT01377389|Leuprolide|leuprolide|mesh-list
139552158|NCT01377389|Goserelin|goserelin|mesh-list
139552159|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139552160|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552161|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139552162|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552163|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139552164|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
139552165|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139552166|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552167|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139552168|NCT01194271|Ipilimumab|ipilimumab|mesh-list
139552169|NCT01194271|Leuprolide|leuprolide|mesh-list
139552170|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139552171|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552172|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139552173|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552174|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139552175|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
139552176|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139552177|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552178|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139552179|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
139552180|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
139552181|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139552182|NCT01172418|Daclizumab|daclizumab|mesh-list
139552183|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
139552184|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552185|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139552186|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139552187|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552188|NCT01119508|Temozolomide|temozolomide|mesh-list
139552189|NCT01119508|Ipilimumab|ipilimumab|mesh-list
139552190|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139552191|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
139023245|NCT00603941|Paclitaxel|paclitaxel|mesh-list
139552192|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552193|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552194|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139552195|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139552196|NCT00958737|Capecitabine|capecitabine|mesh-list
139552197|NCT00958737|Fluorouracil|fluorouracil|mesh-list
139552198|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
139552199|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139552200|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
139552201|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552202|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552203|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139552204|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
139552205|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552206|NCT00917592|Amoxicillin|amoxicillin|mesh-list
139552207|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
139552208|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
139552209|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139333818|NCT02428322|Vitamin D|vitamin d|mesh-list
139552210|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552211|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552212|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552213|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139552215|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139552216|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
139552217|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139552218|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552219|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552220|NCT00752154|Curcumin|curcumin|mesh-list
139552221|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139552222|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139552223|NCT00752154|Analgesics|analgesics|mesh-ancestor
139552224|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
139552225|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552226|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552227|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139552228|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552229|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552230|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552231|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552232|NCT00745134|Curcumin|curcumin|mesh-list
139552233|NCT00745134|Capecitabine|capecitabine|mesh-list
139552234|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139552235|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
139552236|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552237|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552238|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139552239|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139552240|NCT00745134|Analgesics|analgesics|mesh-ancestor
139552241|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
139552242|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552243|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552244|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139552245|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552246|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552247|NCT00673010|Iodine|iodine|mesh-list
139552248|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139552249|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552250|NCT00673010|Trace Elements|trace elements|mesh-ancestor
139552251|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
139552252|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552253|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
139552254|NCT00610883|Methotrexate|methotrexate|mesh-list
139552255|NCT00610883|Asparaginase|asparaginase|mesh-list
139552256|NCT00610883|Daunorubicin|daunorubicin|mesh-list
139552257|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139552258|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
139552259|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552260|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552261|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139552262|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
139552263|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552264|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552265|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139552266|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139552267|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
139552268|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139552269|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139552270|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
139552271|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
139552272|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552273|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139552274|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139552275|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139552276|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139552277|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139552278|NCT00574496|Cyclosporine|cyclosporine|mesh-list
139552279|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
139552280|NCT00574496|Prednisone|prednisone|mesh-list
139552281|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
139552282|NCT00574496|Melphalan|melphalan|mesh-list
139552283|NCT00574496|Ifosfamide|ifosfamide|mesh-list
139552284|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
139552285|NCT00574496|Gemcitabine|gemcitabine|mesh-list
139552286|NCT00574496|Methotrexate|methotrexate|mesh-list
139552287|NCT00574496|Fludarabine|fludarabine|mesh-list
139552288|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
139552289|NCT00574496|Vincristine|vincristine|mesh-list
139552290|NCT00574496|Vinorelbine|vinorelbine|mesh-list
139552291|NCT00574496|Procarbazine|procarbazine|mesh-list
139552292|NCT00574496|Cyclosporins|cyclosporins|mesh-list
139552293|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139552294|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
139552295|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552296|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552297|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139552298|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
139552299|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552300|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552301|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139552302|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139552303|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
139552304|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139552305|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
139552306|NCT00574496|Hormones|hormones|mesh-ancestor
139552307|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552308|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139552309|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139552310|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
139552311|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139552312|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
139552313|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552314|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139552315|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139552316|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139552317|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
139552318|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
139552319|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
139552320|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
139552321|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552322|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139552323|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139552324|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139552325|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
139552326|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139552327|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
139552328|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139552329|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552330|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139552331|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
139552332|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139552333|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552334|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552335|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552336|NCT00499083|Tamoxifen|tamoxifen|mesh-list
139552337|NCT00499083|Paclitaxel|paclitaxel|mesh-list
139552338|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
139552339|NCT00499083|Doxorubicin|doxorubicin|mesh-list
139552340|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139552341|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139552342|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139552343|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552344|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
139552345|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
139552346|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
139552347|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552348|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139552349|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
139552350|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552351|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552352|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139552353|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
139552354|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139552355|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139552356|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139552357|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139552358|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552359|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139552360|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
139552361|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552362|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139552363|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139552364|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139552365|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139552366|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139552368|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552369|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552370|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552371|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139552372|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139552373|NCT00089024|Leucovorin|leucovorin|mesh-list
139552374|NCT00089024|Folic Acid|folic acid|mesh-list
139552375|NCT00089024|Gemcitabine|gemcitabine|mesh-list
139552376|NCT00089024|Fluorouracil|fluorouracil|mesh-list
139552377|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
139552378|NCT00089024|Calcium|calcium|mesh-list
139552379|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
139552380|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139552381|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
139552382|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552383|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552384|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139552385|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552386|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139552387|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
139552388|NCT00089024|Antidotes|antidotes|mesh-ancestor
139552389|NCT00089024|Protective Agents|protective agents|mesh-ancestor
139552390|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
139552391|NCT00089024|Vitamins|vitamins|mesh-ancestor
139552392|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
139552393|NCT00089024|Hematinics|hematinics|mesh-ancestor
139552394|NCT01819129|Insulin|insulin|mesh-list
139552395|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139552396|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
139552397|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
139552398|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
139552399|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139552400|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139552401|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552402|NCT04025775|Insulin|insulin|mesh-list
139552403|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139552404|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552405|NCT04022811|Tobramycin|tobramycin|mesh-list
139552406|NCT04022811|Dexamethasone|dexamethasone|mesh-list
139552407|NCT04022811|Bromfenac|bromfenac|mesh-list
139552408|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
139552409|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139552410|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
139552411|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
139552412|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552413|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552414|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139552415|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
139552416|NCT04022811|Hormones|hormones|mesh-ancestor
139552417|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552418|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139552419|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552420|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139552421|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
139552422|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
139552423|NCT04022811|Protective Agents|protective agents|mesh-ancestor
139552424|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139552425|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552426|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139552427|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139552428|NCT04022811|Analgesics|analgesics|mesh-ancestor
139552429|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
139552430|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552431|NCT04145583|Voriconazole|voriconazole|mesh-list
139552432|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
139552433|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552434|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139552435|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139334025|NCT02423642|Heparin|heparin|mesh-list
139552436|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552437|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552438|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139552439|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
139552440|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552441|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552442|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139552443|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
139552444|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
139552445|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139552446|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139552447|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552448|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552449|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552450|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552451|NCT04145193|Leucovorin|leucovorin|mesh-list
139552452|NCT04145193|Fluorouracil|fluorouracil|mesh-list
139552453|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
139552454|NCT04145193|Durvalumab|durvalumab|mesh-list
139552455|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139552456|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
139552457|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552458|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139552459|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552460|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139552461|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
139552462|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552463|NCT04145193|Antidotes|antidotes|mesh-ancestor
139552464|NCT04145193|Protective Agents|protective agents|mesh-ancestor
139552465|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
139552466|NCT04145193|Vitamins|vitamins|mesh-ancestor
139552467|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
139552468|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139552469|NCT04147845|Triamcinolone|triamcinolone|mesh-list
139552470|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139552471|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139552472|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139552473|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139552474|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
139552475|NCT04147845|Hormones|hormones|mesh-ancestor
139552476|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552477|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552478|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139552479|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
139552480|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552481|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552482|NCT01849783|Thalidomide|thalidomide|mesh-list
139023552|NCT00336856|Irinotecan|irinotecan|mesh-list
139552483|NCT01849783|Dexamethasone|dexamethasone|mesh-list
139552484|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
139552485|NCT01849783|Melphalan|melphalan|mesh-list
139552486|NCT01849783|Doxorubicin|doxorubicin|mesh-list
139552487|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139552488|NCT01849783|Etoposide|etoposide|mesh-list
139552489|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
139552490|NCT01849783|Bortezomib|bortezomib|mesh-list
139552491|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139552492|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
139552493|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552494|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552495|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139552496|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
139552497|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552498|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552499|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139552500|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139552501|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
139552502|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
139552503|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552504|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139552505|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
139552506|NCT01849783|Hormones|hormones|mesh-ancestor
139552507|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552508|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139552509|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139552510|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139552511|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139552512|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552513|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139552514|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
139552515|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139552516|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552517|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139552518|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139552519|NCT01849783|Growth Substances|growth substances|mesh-ancestor
139552520|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
139552521|NCT01611883|Ezetimibe|ezetimibe|mesh-list
139552522|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139552523|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139552524|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
139552525|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552526|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139552527|NCT04170517|Progesterone|progesterone|mesh-list
139552528|NCT04170517|Progestins|progestins|mesh-ancestor
139552529|NCT04170517|Hormones|hormones|mesh-ancestor
139552530|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552531|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552532|NCT01848457|Methotrexate|methotrexate|mesh-list
139552533|NCT01848457|Pantoprazole|pantoprazole|mesh-list
139552534|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139552535|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
139552536|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139552537|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552538|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139552539|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
139552540|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552541|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552542|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
139552543|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552544|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139552545|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139552546|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
139552547|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552548|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139552549|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139552550|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139552551|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139552552|NCT01870999|Aripiprazole|aripiprazole|mesh-list
139552553|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
139552554|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139552555|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139552556|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139552557|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139552558|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552559|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
139552560|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
139552561|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139552562|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552563|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139552564|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139552565|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
139552566|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139552567|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139552568|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139552569|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139552570|NCT01870921|Ticagrelor|ticagrelor|mesh-list
139552571|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139552572|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139552573|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139552574|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139552575|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
139552576|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139552577|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552578|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552579|NCT00526474|Vorapaxar|vorapaxar|mesh-list
139552580|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139552581|NCT01848145|Ofatumumab|ofatumumab|mesh-list
139552582|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552583|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139552584|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139552585|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
139552586|NCT00527644|Hormones|hormones|mesh-ancestor
139552587|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552588|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552589|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139552590|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552591|NCT01847443|Nicotine|nicotine|mesh-list
139552592|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139552593|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
139552594|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552595|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552596|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139552597|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139552598|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
139552599|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139552600|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552601|NCT00527878|Ranitidine|ranitidine|mesh-list
139552602|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139552603|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139552604|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139552605|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139552606|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
139552607|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
139552608|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139552609|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552610|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552611|NCT05558878|Ambroxol|ambroxol|mesh-list
139552612|NCT05558878|Expectorants|expectorants|mesh-ancestor
139552613|NCT05558878|Respiratory System Agents|respiratory system agents|mesh-ancestor
139552614|NCT05621434|Maleic acid|maleic acid|mesh-list
139552615|NCT05621434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552616|NCT05621434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552617|NCT01870843|Escitalopram|escitalopram|mesh-list
139023630|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
139552618|NCT01870843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139552619|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139552620|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139552621|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552622|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139552623|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
139552624|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552625|NCT01816477|Ropivacaine|ropivacaine|mesh-list
139552626|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
139552627|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
139552628|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139552629|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552630|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
139552631|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552632|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
139552633|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139552634|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139552635|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552636|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
139552637|NCT01846507|Coagulants|coagulants|mesh-ancestor
139552638|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
139552639|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139552640|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
139552641|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552642|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
139552643|NCT01846039|Protective Agents|protective agents|mesh-ancestor
139552644|NCT01610167|Listerine|listerine|mesh-list
139552645|NCT01610167|Fluorides|fluorides|mesh-list
139552646|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
139552647|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
139552648|NCT01610167|Protective Agents|protective agents|mesh-ancestor
139552649|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552650|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139552651|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552652|NCT04478500|Minocycline|minocycline|mesh-list
139552653|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139552654|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552655|NCT01816243|Fentanyl|fentanyl|mesh-list
139552656|NCT01816243|Morphine|morphine|mesh-list
139552657|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139552658|NCT01816243|Narcotics|narcotics|mesh-ancestor
139552659|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139552660|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552661|NCT01816243|Analgesics|analgesics|mesh-ancestor
139552662|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
139334262|NCT05691959|Calcium|calcium|mesh-list
139552663|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552664|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139023660|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
139552665|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139552666|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
139552667|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
139552668|NCT05576896|Hydroxychloroquine|hydroxychloroquine|mesh-list
139552669|NCT05576896|Cetuximab|cetuximab|mesh-list
139552670|NCT05576896|Panitumumab|panitumumab|mesh-list
139552671|NCT05576896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139552672|NCT05576896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552673|NCT05576896|Antimalarials|antimalarials|mesh-ancestor
139552674|NCT05576896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139552675|NCT05576896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139552676|NCT05576896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552677|NCT05576896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552678|NCT05576896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552679|NCT05576896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552680|NCT01845805|Azacitidine|azacitidine|mesh-list
139552681|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139552682|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
139552683|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552684|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552685|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552686|NCT05575804|Capecitabine|capecitabine|mesh-list
139552687|NCT05575804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139552688|NCT05575804|Antimetabolites|antimetabolites|mesh-ancestor
139552689|NCT05575804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552690|NCT05575804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552691|NCT01845025|Fluticasone|fluticasone|mesh-list
139552692|NCT01845025|Xhance|xhance|mesh-list
139552693|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
139552694|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139552695|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139552696|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
139552697|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552698|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552699|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139552700|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
139552701|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
139552702|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139552703|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139552704|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139552705|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139552706|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
139552707|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139552708|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552709|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139552710|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139552711|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552712|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552713|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139552714|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139552715|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552716|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
139552717|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139552718|NCT04847440|Tenofovir|tenofovir|mesh-list
139552719|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
139552720|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552721|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139552722|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139552723|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552724|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552725|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139552726|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139552727|NCT01870297|Liraglutide|liraglutide|mesh-list
139552728|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139552729|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552730|NCT01870297|Incretins|incretins|mesh-ancestor
139552731|NCT01870297|Hormones|hormones|mesh-ancestor
139552732|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552733|NCT01814761|Bimatoprost|bimatoprost|mesh-list
139552734|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139552735|NCT01798030|Vitamin D|vitamin d|mesh-list
139552736|NCT01798030|Vitamins|vitamins|mesh-ancestor
139552737|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
139334330|NCT03669601|Gemcitabine|gemcitabine|mesh-list
139552738|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552739|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139552740|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
139552741|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139552742|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552743|NCT03329950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139552744|NCT03329950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552745|NCT01814371|Mupirocin|mupirocin|mesh-list
139552746|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139552747|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552748|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139552749|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552750|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552751|NCT03232138|Sulforaphane|sulforaphane|mesh-list
139552752|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139552753|NCT03232138|Protective Agents|protective agents|mesh-ancestor
139552754|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552755|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552756|NCT01814137|Insulin|insulin|mesh-list
139552757|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139552758|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
139552759|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
139552760|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139552761|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139552762|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552763|NCT01813435|Aspirin|aspirin|mesh-list
139552764|NCT01813435|Clopidogrel|clopidogrel|mesh-list
139552765|NCT01813435|Ticagrelor|ticagrelor|mesh-list
139552766|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139552767|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139552768|NCT01813435|Analgesics|analgesics|mesh-ancestor
139552769|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
139552770|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552771|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552772|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139552773|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552774|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139552775|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139552776|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552777|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139552778|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139552779|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552780|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
139552781|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139552782|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139552783|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139552784|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
139552785|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139552786|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
139552787|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139552788|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
139552789|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552790|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
139552791|NCT01798498|Protective Agents|protective agents|mesh-ancestor
139552792|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139552793|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139552794|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139552795|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
139552796|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552797|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139552798|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139552799|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552800|NCT02346526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139552801|NCT02346526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552802|NCT01811953|Metformin|metformin|mesh-list
139552803|NCT01811953|Empagliflozin|empagliflozin|mesh-list
139552804|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139552805|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552806|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139552807|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552808|NCT03895762|Fentanyl|fentanyl|mesh-list
139552809|NCT03895762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139552810|NCT03895762|Narcotics|narcotics|mesh-ancestor
139552811|NCT03895762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139552812|NCT03895762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552813|NCT03895762|Analgesics|analgesics|mesh-ancestor
139552814|NCT03895762|Sensory System Agents|sensory system agents|mesh-ancestor
139552815|NCT03895762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552816|NCT03895762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139552817|NCT03895762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139552818|NCT03895762|Anesthetics, General|anesthetics, general|mesh-ancestor
139552819|NCT03895762|Anesthetics|anesthetics|mesh-ancestor
139552820|NCT01033552|Cyclosporine|cyclosporine|mesh-list
139552821|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
139552822|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
139552823|NCT01033552|Fludarabine|fludarabine|mesh-list
139552824|NCT01033552|Cyclosporins|cyclosporins|mesh-list
139552825|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139552826|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139552827|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
139552828|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552829|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552830|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139552831|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
139552832|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552833|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552834|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139552835|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552836|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
139552837|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552838|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
139552839|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139552840|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139552841|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139552842|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
139552843|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139552844|NCT00997906|Paclitaxel|paclitaxel|mesh-list
139552845|NCT00997906|Carboplatin|carboplatin|mesh-list
139552846|NCT00997906|Gemcitabine|gemcitabine|mesh-list
139552847|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139552848|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552849|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
139552850|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
139552851|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
139552852|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552853|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139552854|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
139552855|NCT05246644|Acetaminophen|acetaminophen|mesh-list
139552856|NCT05246644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139552857|NCT05246644|Analgesics|analgesics|mesh-ancestor
139552858|NCT05246644|Sensory System Agents|sensory system agents|mesh-ancestor
139552859|NCT05246644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552860|NCT05246644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552861|NCT05246644|Antipyretics|antipyretics|mesh-ancestor
139552862|NCT01798576|Interferons|interferons|mesh-list
139552863|NCT01798576|Ribavirin|ribavirin|mesh-list
139552864|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
139552865|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
139552866|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139552867|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552868|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
139552869|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552870|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
139552871|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552872|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
139552873|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552874|NCT00565084|Ibuprofen|ibuprofen|mesh-list
139552875|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139552876|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139552877|NCT00565084|Analgesics|analgesics|mesh-ancestor
139552878|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
139552879|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552880|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552881|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139552882|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552883|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139552884|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552885|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552886|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
139552887|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
139552888|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139552889|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552890|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552891|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
139552892|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
139552893|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139552894|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139552895|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552896|NCT01613131|Estradiol|estradiol|mesh-list
139552897|NCT01613131|Estrogens|estrogens|mesh-ancestor
139552898|NCT01613131|Hormones|hormones|mesh-ancestor
139552899|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552900|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552901|NCT05362942|Cytarabine|cytarabine|mesh-list
139552902|NCT05362942|Azacitidine|azacitidine|mesh-list
139552903|NCT05362942|Decitabine|decitabine|mesh-list
139552904|NCT05362942|Venetoclax|venetoclax|mesh-list
139552905|NCT05362942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139552906|NCT05362942|Antimetabolites|antimetabolites|mesh-ancestor
139552907|NCT05362942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552908|NCT05362942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552909|NCT05362942|Antiviral Agents|antiviral agents|mesh-ancestor
139552910|NCT05362942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552911|NCT05362942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139552912|NCT05362942|Immunologic Factors|immunologic factors|mesh-ancestor
139552913|NCT05362942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552914|NCT05362942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552915|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
139552916|NCT01868893|Chlorambucil|chlorambucil|mesh-list
139552917|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139552918|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552919|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139552920|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
139552921|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552922|NCT01868503|Lapatinib|lapatinib|mesh-list
139552923|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552924|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139552925|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552926|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552927|NCT05204368|Meropenem|meropenem|mesh-list
139552928|NCT05204368|Imipenem|imipenem|mesh-list
139552929|NCT05204368|Cilastatin|cilastatin|mesh-list
139552930|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139552931|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552932|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
139552933|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552934|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552935|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
139552936|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552937|NCT04414969|Asparaginase|asparaginase|mesh-list
139552938|NCT04414969|Pegaspargase|pegaspargase|mesh-list
139552939|NCT04414969|Antibodies|antibodies|mesh-list
139552940|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
139552941|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
139552942|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552943|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552944|NCT01609933|Interferons|interferons|mesh-list
139552945|NCT01609933|Ritonavir|ritonavir|mesh-list
139552946|NCT01609933|Ribavirin|ribavirin|mesh-list
139552947|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
139552948|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
139552949|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139552950|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552951|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
139552952|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552953|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139552954|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139552955|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
139552956|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139552957|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552958|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139552959|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139552960|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139552961|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139552962|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
139552963|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
139023814|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
139552964|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552965|NCT05361772|Colchicine|colchicine|mesh-list
139552966|NCT05361772|Gout Suppressants|gout suppressants|mesh-ancestor
139552967|NCT05361772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139552968|NCT05361772|Tubulin Modulators|tubulin modulators|mesh-ancestor
139552969|NCT05361772|Antimitotic Agents|antimitotic agents|mesh-ancestor
139552970|NCT05361772|Mitosis Modulators|mitosis modulators|mesh-ancestor
139552971|NCT05361772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552972|NCT05361772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552973|NCT02958514|Tobramycin|tobramycin|mesh-list
139552974|NCT02958514|Dexamethasone|dexamethasone|mesh-list
139552975|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139552976|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
139552977|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
139552978|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139552979|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552980|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139552981|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
139552982|NCT02958514|Hormones|hormones|mesh-ancestor
139552983|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139552984|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139552985|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139552986|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139552987|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139552988|NCT01867021|Vaccines|vaccines|mesh-list
139552989|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
139552990|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139552991|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
139552992|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
139552993|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
139552994|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139552995|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
139552996|NCT01841593|Amlodipine|amlodipine|mesh-list
139552997|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139552998|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139552999|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139553000|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553001|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139553002|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553003|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
139553004|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139553005|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139553006|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
139553007|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139553008|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139553009|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139553010|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553011|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
139553012|NCT02454322|Analgesics|analgesics|mesh-ancestor
139553013|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
139553014|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553015|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553016|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
139553017|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139553018|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139553019|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
139553020|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139553021|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139553022|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553023|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139553024|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
139553025|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139553026|NCT04505566|Ketorolac|ketorolac|mesh-list
139553027|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139023893|NCT00926627|Bosentan|bosentan|mesh-list
139553028|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
139553029|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139553030|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139553031|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139553032|NCT04505566|Analgesics|analgesics|mesh-ancestor
139553033|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
139553034|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553035|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553036|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139553037|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139553038|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139553039|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553040|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334699|NCT03172052|Mesna|mesna|mesh-list
139553041|NCT04789330|Phenylephrine|phenylephrine|mesh-list
139553042|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
139553043|NCT04789330|Norepinephrine|norepinephrine|mesh-list
139553044|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139553045|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
139553046|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
139553047|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553048|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553049|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
139553050|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139553051|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
139553052|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
139553053|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139553054|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139553055|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139553056|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
139553057|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553058|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553059|NCT04789330|Protective Agents|protective agents|mesh-ancestor
139553061|NCT02339038|Ledipasvir|ledipasvir|mesh-list
139553062|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
139553063|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139553064|NCT04497298|Vaccines|vaccines|mesh-list
139553065|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
139553066|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553067|NCT04387786|Albuterol|albuterol|mesh-list
139553068|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139553069|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
139553070|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553071|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553072|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139553073|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
139553074|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
139553075|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139553076|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139553077|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139553078|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139553079|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
139553080|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553081|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553082|NCT00569530|Calfactant|calfactant|mesh-list
139553083|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139553084|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
139553085|NCT04509622|Cytarabine|cytarabine|mesh-list
139553086|NCT04509622|Venetoclax|venetoclax|mesh-list
139553087|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139553088|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
139553089|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553090|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553091|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
139553092|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139553093|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139553094|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
139553095|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553096|NCT00570700|Dasatinib|dasatinib|mesh-list
139553097|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553098|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139553099|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553100|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553101|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
139553102|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139553103|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139553104|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
139553105|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553106|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553107|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553108|NCT00573508|Urological Agents|urological agents|mesh-ancestor
139553109|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139553110|NCT00574834|Ramipril|ramipril|mesh-list
139553111|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139553112|NCT00574834|Diuretics|diuretics|mesh-ancestor
139553113|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
139553114|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553115|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139553116|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139553117|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553118|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139553119|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
139553120|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553121|NCT01592110|Risperidone|risperidone|mesh-list
139023958|NCT00934817|Metformin|metformin|mesh-list
139553122|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139553123|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
139553124|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553125|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553126|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553127|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139553128|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139553129|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139553130|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139553131|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139553132|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
139553133|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139553134|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
139553135|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
139553136|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139553137|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
139553138|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553139|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553140|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139553141|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
139553142|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
139553143|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139553144|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
139553145|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553146|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553147|NCT00579280|Valproic Acid|valproic acid|mesh-list
139553148|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139553149|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
139553150|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139553151|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139553152|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139553153|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139553154|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553155|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
139553156|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553157|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553158|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
139553159|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553160|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
139553161|NCT00580294|Oxymorphone|oxymorphone|mesh-list
139553162|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139553163|NCT00580294|Narcotics|narcotics|mesh-ancestor
139553164|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139553165|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553166|NCT00580294|Analgesics|analgesics|mesh-ancestor
139553167|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
139553168|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553169|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139553170|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
139553171|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139553172|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
139553173|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553174|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139553175|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139553176|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
139553177|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553178|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553179|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139553181|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139553182|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139553183|NCT02134210|Analgesics|analgesics|mesh-ancestor
139553184|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
139553185|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553186|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553187|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139553188|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139553189|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139553190|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139553191|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
139553192|NCT00607594|Saracatinib|saracatinib|mesh-list
139553193|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553194|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553195|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553196|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
139553197|NCT01866319|Ipilimumab|ipilimumab|mesh-list
139553198|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139553199|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553200|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139553201|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553202|NCT00607672|Candesartan|candesartan|mesh-list
139553203|NCT00607672|Candesartan cilexetil|candesartan cilexetil|mesh-list
139553204|NCT00607672|Ramipril|ramipril|mesh-list
139553205|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139553206|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139553207|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139553208|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553209|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139553210|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
139553211|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553212|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139553213|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139553214|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139553215|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139553216|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553217|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
139553218|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553219|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553220|NCT01802437|Fluoxetine|fluoxetine|mesh-list
139553221|NCT01802437|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139553222|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139553223|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139553224|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553225|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553226|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
139553227|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553228|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139553229|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
139553230|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139553231|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139553232|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139553233|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553234|NCT00608062|Estradiol|estradiol|mesh-list
139553235|NCT00608062|Ganirelix|ganirelix|mesh-list
139553236|NCT00608062|Estrogens|estrogens|mesh-ancestor
139553237|NCT00608062|Hormones|hormones|mesh-ancestor
139553238|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139553239|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553240|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
139553241|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
139553242|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139553243|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139553244|NCT02829268|Dantrolene|dantrolene|mesh-list
139553245|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139553246|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553247|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139553248|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553249|NCT02202772|Cisplatin|cisplatin|mesh-list
139553250|NCT02202772|Gemcitabine|gemcitabine|mesh-list
139553251|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553252|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139553253|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
139553254|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553255|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
139553256|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553257|NCT01801735|Meloxicam|meloxicam|mesh-list
139553258|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139553259|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139553260|NCT01801735|Analgesics|analgesics|mesh-ancestor
139553261|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
139553262|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553263|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553264|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139553265|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139553266|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139553267|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139553268|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553269|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553270|NCT00612430|Bevacizumab|bevacizumab|mesh-list
139553271|NCT00612430|Etoposide|etoposide|mesh-list
139553272|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
139553273|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139553274|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553275|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139553276|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139553277|NCT00612430|Growth Substances|growth substances|mesh-ancestor
139553278|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553279|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
139553280|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139553281|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139553282|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139553283|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553284|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553285|NCT01571128|Tenofovir|tenofovir|mesh-list
139553286|NCT01571128|Emtricitabine|emtricitabine|mesh-list
139553287|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
139553288|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139553289|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139553290|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139553291|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553292|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553293|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139553294|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139553295|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
139553296|NCT00614458|Valproic Acid|valproic acid|mesh-list
139553297|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139553298|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139553299|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
139553300|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139553301|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139553302|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139553303|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553304|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553305|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
139553306|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
139553307|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553308|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553309|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
139553310|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139553311|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139553312|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139553313|NCT01429168|Etoricoxib|etoricoxib|mesh-list
139553314|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139553315|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139553316|NCT01429168|Analgesics|analgesics|mesh-ancestor
139553317|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
139553318|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553319|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553320|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139553321|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139553322|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139553323|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139553324|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553325|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553326|NCT00771160|Montelukast|montelukast|mesh-list
139553327|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139553328|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
139553329|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139553330|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
139553331|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139553332|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553333|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139553334|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139553335|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553336|NCT00756418|Theophylline|theophylline|mesh-list
139553337|NCT00756418|Montelukast|montelukast|mesh-list
139553338|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139553339|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
139553340|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139553341|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
139553342|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139553343|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553344|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139553345|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139553346|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553347|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139553348|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
139553349|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553350|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139553351|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553352|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
139553353|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139553354|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139553355|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
139553356|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553357|NCT00615472|Remifentanil|remifentanil|mesh-list
139553358|NCT00615472|Propofol|propofol|mesh-list
139553359|NCT00615472|Isoflurane|isoflurane|mesh-list
139553360|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139553361|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139553362|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553363|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139553364|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
139553365|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
139553366|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139553367|NCT00615472|Narcotics|narcotics|mesh-ancestor
139553368|NCT00615472|Analgesics|analgesics|mesh-ancestor
139553369|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
139553370|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553371|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139553372|NCT00615784|Bexarotene|bexarotene|mesh-list
139553373|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553374|NCT00755794|Montelukast|montelukast|mesh-list
139553375|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139553376|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
139553377|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139553378|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
139553379|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139553380|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553381|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139553382|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139553383|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553384|NCT00652444|Simvastatin|simvastatin|mesh-list
139553385|NCT00652444|Ezetimibe|ezetimibe|mesh-list
139553386|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139553387|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139553388|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
139553389|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553390|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138547224|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139553391|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139553392|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553393|NCT00585910|Methylphenidate|methylphenidate|mesh-list
139553394|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139553395|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139553396|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553397|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139553398|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139553399|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139553400|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553401|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
139553402|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553403|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139553404|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
139553405|NCT00489346|Fluticasone|fluticasone|mesh-list
139553406|NCT00489346|Xhance|xhance|mesh-list
139553407|NCT00489346|Montelukast|montelukast|mesh-list
139553408|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139553409|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139553410|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
139553411|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553412|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553413|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139553414|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
139553415|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
139553416|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139553417|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553418|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139553419|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
139553420|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139553421|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139553422|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139553423|NCT00617188|Fulvestrant|fulvestrant|mesh-list
139553424|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139553425|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553426|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139553427|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139553428|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
139553429|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139553430|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553431|NCT00618436|Phenytoin|phenytoin|mesh-list
139553432|NCT00618436|Levetiracetam|levetiracetam|mesh-list
139553433|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
139553434|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
139553435|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139553436|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139553437|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139553438|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024172|NCT00936689|Estrogens|estrogens|mesh-ancestor
139553439|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139553440|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139553441|NCT00619060|Niacin|niacin|mesh-list
139553442|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
139553443|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139553444|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
139553445|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553446|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139553447|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
139553448|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
139553449|NCT00619060|Vitamins|vitamins|mesh-ancestor
139553450|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
139553451|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553452|NCT00092716|Atorvastatin|atorvastatin|mesh-list
139553453|NCT00092716|Ezetimibe|ezetimibe|mesh-list
139553454|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139553455|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139553456|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
139553457|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553458|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139553459|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139553460|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553461|NCT00619684|Lenalidomide|lenalidomide|mesh-list
139553462|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
139553463|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553464|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139553465|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139553466|NCT00619684|Growth Substances|growth substances|mesh-ancestor
139553467|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
139553468|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553469|NCT00588406|Prednisone|prednisone|mesh-list
139553470|NCT00588406|Budesonide|budesonide|mesh-list
139553471|NCT00588406|Bromides|bromides|mesh-list
139553472|NCT00588406|Albuterol|albuterol|mesh-list
139553473|NCT00588406|Ipratropium|ipratropium|mesh-list
139553474|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139553475|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
139553476|NCT00588406|Hormones|hormones|mesh-ancestor
139553477|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139553478|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553479|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139553480|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553481|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139553482|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
139553483|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553484|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139553485|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
139335085|NCT03133299|Hormones|hormones|mesh-ancestor
139553486|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
139553487|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
139553488|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139553489|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139553490|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139553491|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139553492|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
139553493|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553494|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553495|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139553496|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
139553497|NCT00668434|Prednisone|prednisone|mesh-list
139553498|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139553499|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
139553500|NCT00668434|Hormones|hormones|mesh-ancestor
139553501|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139553502|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553503|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139553504|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553505|NCT00668902|Pantoprazole|pantoprazole|mesh-list
139553506|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139553507|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139553508|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139553509|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553510|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553511|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139553512|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139553513|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139553514|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139553515|NCT00621946|Dexetimide|dexetimide|mesh-list
139553516|NCT00621946|Citalopram|citalopram|mesh-list
139553517|NCT00621946|Escitalopram|escitalopram|mesh-list
139553518|NCT00621946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139553519|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139553520|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139553521|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553522|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553523|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
139553524|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553525|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139553526|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139553527|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
139553528|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
139553529|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553530|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139553531|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139553532|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
139553533|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139553534|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
139553535|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139553536|NCT02139358|Gemcitabine|gemcitabine|mesh-list
139553537|NCT02139358|Trastuzumab|trastuzumab|mesh-list
139553538|NCT02139358|Pertuzumab|pertuzumab|mesh-list
139553539|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139553540|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
139553541|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553542|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553543|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139553544|NCT02140372|Colchicine|colchicine|mesh-list
139553545|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
139553546|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139553547|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
139553548|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
139553549|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
139553550|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553551|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553552|NCT00670774|Eculizumab|eculizumab|mesh-list
139553553|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139553554|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139553555|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
139553556|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553557|NCT00672100|Ropivacaine|ropivacaine|mesh-list
139553558|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
139553559|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
139024248|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553560|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139553561|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553562|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
139553563|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553564|NCT00593866|Gemcitabine|gemcitabine|mesh-list
139553565|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139553566|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
139553567|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553568|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553569|NCT00624910|Bupivacaine|bupivacaine|mesh-list
139553570|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
139553571|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
139553572|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139553573|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553574|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
139553575|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553576|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
139553577|NCT00626626|Clofarabine|clofarabine|mesh-list
139553578|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
139553579|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139553580|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553581|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139553582|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
139553583|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553584|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139553585|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
139553586|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553587|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139553588|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139553589|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
139553590|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139553591|NCT00626782|Ranibizumab|ranibizumab|mesh-list
139553592|NCT00626782|Mitomycins|mitomycins|mesh-list
139553593|NCT00626782|Mitomycin|mitomycin|mesh-list
139553594|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139553595|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139553596|NCT00626782|Growth Substances|growth substances|mesh-ancestor
139553597|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553598|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
139553599|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553600|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139553601|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
139553602|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553603|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139553604|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553605|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
139553606|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139553607|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139553608|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
139553609|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
139553610|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139553611|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553612|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139553613|NCT00627406|Buserelin|buserelin|mesh-list
139553614|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139553615|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553616|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139553617|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
139553618|NCT00673738|Docetaxel|docetaxel|mesh-list
139553619|NCT00673738|Cetuximab|cetuximab|mesh-list
139553620|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553621|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
139553622|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
139553623|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
139553624|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553625|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139553626|NCT00674206|Gemcitabine|gemcitabine|mesh-list
139553627|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
139553628|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139553629|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
139553630|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553631|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553632|NCT00595270|Vaccines|vaccines|mesh-list
139553633|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
139553634|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335239|NCT02401880|Incretins|incretins|mesh-ancestor
139553635|NCT00628498|Defibrotide|defibrotide|mesh-list
139553636|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139553637|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139553638|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553639|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139553640|NCT00629122|Clotrimazole|clotrimazole|mesh-list
139553641|NCT00629122|Miconazole|miconazole|mesh-list
139553642|NCT00629122|Nystatin|nystatin|mesh-list
139553643|NCT00629122|Tacrolimus|tacrolimus|mesh-list
139553644|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139553645|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
139553646|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553647|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139553648|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553649|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553650|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139553651|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139553652|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
139553653|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139553654|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139553655|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139553656|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
139553657|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139553658|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139553659|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139553660|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139553661|NCT00629122|Ionophores|ionophores|mesh-ancestor
139553662|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139553663|NCT00596440|Nicotine|nicotine|mesh-list
139553664|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139553665|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
139553666|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553667|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553668|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139553669|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139553670|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
139553671|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553672|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553673|NCT00632632|Cycloserine|cycloserine|mesh-list
139553674|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139553675|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139553676|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139553677|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
139553678|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139553679|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
139553680|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553681|NCT00633256|Isoniazid|isoniazid|mesh-list
139553682|NCT00633256|Cycloserine|cycloserine|mesh-list
139553683|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
139553684|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139553685|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024343|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
139553686|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139553687|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139553688|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
139553689|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553690|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139553691|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139553692|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139553693|NCT00634270|Sirolimus|sirolimus|mesh-list
139553694|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139553695|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139553696|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139553697|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553698|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
139553699|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139553700|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
139553701|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553702|NCT00678418|Naltrexone|naltrexone|mesh-list
139553703|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139553704|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139553705|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553706|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
139553707|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553708|NCT00600340|Paclitaxel|paclitaxel|mesh-list
139553709|NCT00600340|Bevacizumab|bevacizumab|mesh-list
139553710|NCT00600340|Capecitabine|capecitabine|mesh-list
139553711|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139553712|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553713|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
139553714|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
139553715|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
139553716|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553717|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139553718|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139553719|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139553720|NCT00600340|Growth Substances|growth substances|mesh-ancestor
139553721|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553722|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
139553723|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139553724|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
139553725|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139553726|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
139553727|NCT01799356|Metronidazole|metronidazole|mesh-list
139553728|NCT01799356|Ofloxacin|ofloxacin|mesh-list
139553729|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139553730|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139553731|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
139553732|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139553733|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139553734|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553735|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553736|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553737|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139553738|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139553739|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139553740|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139553741|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139553742|NCT00602290|Methylphenidate|methylphenidate|mesh-list
139553743|NCT00602290|Citalopram|citalopram|mesh-list
139553744|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139553745|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553746|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139553747|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139553748|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139553749|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553750|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
139553751|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553752|NCT00602290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139553753|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
139553754|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139553755|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
139553756|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139553757|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
139553758|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139553759|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139553760|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139553761|NCT00637780|Analgesics|analgesics|mesh-ancestor
139553762|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
139553763|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553764|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553765|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139553766|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139553767|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139553768|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
139553769|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139553770|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139553771|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
139553772|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024408|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139553773|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553774|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553775|NCT01799902|Urological Agents|urological agents|mesh-ancestor
139553776|NCT00602446|Deferasirox|deferasirox|mesh-list
139553777|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139553778|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
139553779|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
139553780|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553781|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
139553782|NCT00602836|Rituximab|rituximab|mesh-list
139553783|NCT00602836|Lenalidomide|lenalidomide|mesh-list
139553784|NCT00602836|Pentostatin|pentostatin|mesh-list
139553785|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139553786|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
139553787|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553788|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139553789|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139553790|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
139553791|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553792|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553793|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139553794|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139553795|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139553796|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139553797|NCT00602836|Growth Substances|growth substances|mesh-ancestor
139553798|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
139553799|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139553800|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553802|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139553803|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139553804|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139553805|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553806|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553807|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139553808|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
139553809|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553810|NCT00640822|Calcitriol|calcitriol|mesh-list
139553811|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
139553812|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139553813|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139553814|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139553815|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
139553816|NCT00640822|Calcipotriene|calcipotriene|mesh-list
139553817|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139553818|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
139553819|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139553820|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553821|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139553822|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139553823|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553824|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139553825|NCT00640822|Vitamins|vitamins|mesh-ancestor
139553826|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
139553827|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139553828|NCT00642694|Dexetimide|dexetimide|mesh-list
139553829|NCT00642694|Citalopram|citalopram|mesh-list
139553830|NCT00642694|Escitalopram|escitalopram|mesh-list
139553831|NCT00642694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139553832|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139553833|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139553834|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553835|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553836|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
139553837|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553838|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139553839|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139553840|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
139553841|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
139553842|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553843|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139553844|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139553845|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
139553846|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139553847|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
139553848|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139553849|NCT00705874|Leucovorin|leucovorin|mesh-list
139553850|NCT00705874|Bevacizumab|bevacizumab|mesh-list
139553851|NCT00705874|Sunitinib|sunitinib|mesh-list
139553852|NCT00705874|Gemcitabine|gemcitabine|mesh-list
139553853|NCT00705874|Docetaxel|docetaxel|mesh-list
139553854|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139553855|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139553856|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553857|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139335456|NCT03516903|Methotrexate|methotrexate|mesh-list
139553858|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139553859|NCT00705874|Growth Substances|growth substances|mesh-ancestor
139553860|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553861|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
139553862|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139024467|NCT00511004|Filaricides|filaricides|mesh-ancestor
139553863|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
139553864|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553865|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
139553866|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
139553867|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
139553868|NCT00705874|Antidotes|antidotes|mesh-ancestor
139553869|NCT00705874|Protective Agents|protective agents|mesh-ancestor
139553870|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
139553871|NCT00705874|Vitamins|vitamins|mesh-ancestor
139553872|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
139553873|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139553874|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553875|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
139553876|NCT00647998|Hematinics|hematinics|mesh-ancestor
139553877|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
139553878|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139553879|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139553880|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553881|NCT00687076|Aspirin|aspirin|mesh-list
139553883|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
139553884|NCT00687076|Clopidogrel|clopidogrel|mesh-list
139553885|NCT00687076|Ezetimibe|ezetimibe|mesh-list
139553886|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139553887|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139553888|NCT00687076|Analgesics|analgesics|mesh-ancestor
139553889|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
139553890|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553891|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553892|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139553893|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139553894|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139553895|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139553896|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553897|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139553898|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139553899|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553900|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
139553901|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139553902|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139553903|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139553904|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
139553905|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553906|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139553907|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139553908|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
139553909|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139553910|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
139553911|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
139553912|NCT00687076|Vitamins|vitamins|mesh-ancestor
139553913|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
139553914|NCT00687544|Ribavirin|ribavirin|mesh-list
139553915|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139553916|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
139553917|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553918|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
139553919|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139553920|NCT02143648|Nalbuphine|nalbuphine|mesh-list
139553921|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139553922|NCT02143648|Narcotics|narcotics|mesh-ancestor
139553923|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139553924|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553925|NCT02143648|Analgesics|analgesics|mesh-ancestor
139553926|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
139553927|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553928|NCT02997982|Valacyclovir|valacyclovir|mesh-list
139553929|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
139553930|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139553931|NCT00689572|Ondansetron|ondansetron|mesh-list
139553932|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
139335533|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
139553933|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
139553934|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139553935|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553936|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139553937|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
139553938|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
139553939|NCT00689572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139553940|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139553941|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
139553942|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139553943|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553944|NCT01840579|Paclitaxel|paclitaxel|mesh-list
139553945|NCT01840579|Etoposide|etoposide|mesh-list
139553946|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139553947|NCT01840579|Carboplatin|carboplatin|mesh-list
139553948|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
139553949|NCT01840579|Pemetrexed|pemetrexed|mesh-list
139553950|NCT01840579|Ipilimumab|ipilimumab|mesh-list
139553951|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139553952|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553953|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
139553954|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
139553955|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
139553956|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553957|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139553958|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139553959|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139553960|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139553961|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553962|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139553963|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139553964|NCT00651040|Prednisone|prednisone|mesh-list
139553965|NCT00651040|Prednisolone|prednisolone|mesh-list
139553966|NCT00651040|Methotrexate|methotrexate|mesh-list
139553967|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139553968|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
139553969|NCT00651040|Hormones|hormones|mesh-ancestor
139553970|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139553971|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553972|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139553973|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553974|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139553975|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
139553976|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139553977|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139553978|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
139553979|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553980|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
139553981|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553982|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139553983|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139553984|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
139553985|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139553986|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139553987|NCT00654784|Idebenone|idebenone|mesh-list
139553988|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
139553989|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553990|NCT00654784|Protective Agents|protective agents|mesh-ancestor
139553991|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139553992|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139553993|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139553994|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139553995|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139553996|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139553997|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139553998|NCT00691600|Trimethoprim|trimethoprim|mesh-list
139553999|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
139554000|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139554001|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554002|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
139554003|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139554004|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139554005|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139554006|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554007|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554008|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139554009|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139554010|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139554011|NCT00655642|Promethazine|promethazine|mesh-list
139554012|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
139554013|NCT00655642|Ondansetron|ondansetron|mesh-list
139554014|NCT00655642|Metoclopramide|metoclopramide|mesh-list
139554015|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
139554016|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
139554017|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554018|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554019|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139554020|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
139554021|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
139554022|NCT00655642|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139554023|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139554024|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
139554025|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554026|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554027|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139554028|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139554029|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
139554030|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139554031|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
139554032|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
139554033|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139554034|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139554035|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139554036|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139554037|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
139554038|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
139554039|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
139554040|NCT00656656|Dexamethasone|dexamethasone|mesh-list
139554041|NCT00656656|Rituximab|rituximab|mesh-list
139554042|NCT00656656|Azathioprine|azathioprine|mesh-list
139554043|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139554044|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
139554045|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
139554046|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554047|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554048|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139554049|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
139554050|NCT00656656|Hormones|hormones|mesh-ancestor
139554051|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139554052|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139554053|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554054|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139554055|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
139024596|NCT00522392|Dexamethasone|dexamethasone|mesh-list
139554056|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139554057|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
139554058|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554059|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139554060|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554061|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
139554062|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
139554063|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554064|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
139554065|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554066|NCT00656968|Esomeprazole|esomeprazole|mesh-list
139554067|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139554068|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139554069|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139554070|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554071|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554072|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139554073|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139554074|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554075|NCT00657280|Incretins|incretins|mesh-ancestor
139554076|NCT00657280|Hormones|hormones|mesh-ancestor
139554077|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139554078|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139554079|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
139554080|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554081|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554082|NCT00693160|Ketorolac|ketorolac|mesh-list
139554083|NCT00693160|Remifentanil|remifentanil|mesh-list
139554084|NCT00693160|Capsaicin|capsaicin|mesh-list
139554085|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139554086|NCT00693160|Narcotics|narcotics|mesh-ancestor
139554087|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139554088|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554089|NCT00693160|Analgesics|analgesics|mesh-ancestor
139554090|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
139554091|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554092|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139554093|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139554094|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139554095|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139554096|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139554097|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554098|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554099|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
139554100|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
139554101|NCT00695188|Methotrexate|methotrexate|mesh-list
139554102|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139554103|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
139554104|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139554105|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554106|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139554107|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
139554108|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024615|NCT01061320|Tocopherols|tocopherols|mesh-list
139554109|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554110|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
139554111|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554112|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139554113|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554114|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
139554115|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139554116|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139554118|NCT00706264|Trace Elements|trace elements|mesh-ancestor
139554119|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
139554120|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554121|NCT00695500|Varenicline|varenicline|mesh-list
139554122|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139554123|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139554124|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
139554125|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554126|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554127|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554128|NCT00695578|Bacitracin|bacitracin|mesh-list
139554129|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139554130|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554131|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139554132|NCT01792102|Dexamethasone|dexamethasone|mesh-list
139554133|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139554134|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
139554135|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
139554136|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554137|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554138|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139554139|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
139554140|NCT01792102|Hormones|hormones|mesh-ancestor
139554141|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139554142|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139554143|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554144|NCT02996734|Denosumab|denosumab|mesh-list
139554145|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139554146|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554147|NCT00699010|Oxycodone|oxycodone|mesh-list
139554148|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139554149|NCT00699010|Narcotics|narcotics|mesh-ancestor
139554150|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139554151|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554152|NCT00699010|Analgesics|analgesics|mesh-ancestor
139554153|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
139554154|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554155|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
139554156|NCT00706810|Verapamil|verapamil|mesh-list
139554157|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554158|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
139335770|NCT02303769|Tamsulosin|tamsulosin|mesh-list
139554159|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554160|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554161|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139554162|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139554163|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139554164|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139554165|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139554166|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554167|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
139554169|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
139554170|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139554171|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139554172|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554173|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554174|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
139554175|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554176|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139554177|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139554178|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139554179|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139554180|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139554181|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139554182|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139554183|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139554184|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139554185|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139554186|NCT00662818|Acetaminophen|acetaminophen|mesh-list
139554187|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139554188|NCT00662818|Analgesics|analgesics|mesh-ancestor
139554189|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
139554190|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554191|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554192|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
139554193|NCT00699556|Nicotine|nicotine|mesh-list
139554194|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139554195|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
139554196|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554197|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554198|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139554199|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139554200|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
139554201|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554202|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554203|NCT00700336|Cisplatin|cisplatin|mesh-list
139554204|NCT00700336|Pemetrexed|pemetrexed|mesh-list
139554205|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554206|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554207|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554208|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139554209|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139554210|NCT01795846|Immunomodulating Agents|immunomodulating agents|mesh-list
139554211|NCT01795846|Immunologic Factors|immunologic factors|mesh-ancestor
139554212|NCT01795846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554213|NCT00701896|Nicotine|nicotine|mesh-list
139554214|NCT00701896|Varenicline|varenicline|mesh-list
139554215|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139554216|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
139554217|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554218|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554219|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139554220|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139554221|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
139554222|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554223|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554224|NCT01839487|Dexamethasone|dexamethasone|mesh-list
139554225|NCT01839487|Paclitaxel|paclitaxel|mesh-list
139554226|NCT01839487|Gemcitabine|gemcitabine|mesh-list
139554227|NCT01839487|Enoxaparin|enoxaparin|mesh-list
139554228|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139554229|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554230|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
139554231|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
139554232|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
139554233|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335834|NCT02304237|Hormones|hormones|mesh-ancestor
139554234|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139554235|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
139554236|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
139554237|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554238|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554239|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139554240|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
139554241|NCT01839487|Hormones|hormones|mesh-ancestor
139554242|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139554243|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139554244|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139554245|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
139554246|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
139554247|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139554248|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139554249|NCT00665470|Aldesleukin|aldesleukin|mesh-list
139554250|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554251|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139554252|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139554253|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
139554254|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554255|NCT00666406|Factor VIII|factor viii|mesh-list
139554256|NCT00666406|Coagulants|coagulants|mesh-ancestor
139554257|NCT02995954|Amlodipine|amlodipine|mesh-list
139554258|NCT02995954|Perindopril|perindopril|mesh-list
139554259|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139554260|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139554261|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139554262|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554263|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139554264|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554265|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
139554266|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139554267|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
139554268|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554269|NCT01799941|Quinidine|quinidine|mesh-list
139554270|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
139554271|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
139554272|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
139554273|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139554274|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139554275|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554276|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554277|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554278|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139554279|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139554280|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
139554281|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139554282|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
139554283|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139554284|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139554285|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554286|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554287|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139554288|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139554289|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
139554290|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139554291|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139554292|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139554293|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139554294|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139554295|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139024699|NCT00482274|Docetaxel|docetaxel|mesh-list
139554296|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139554297|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139554298|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139554299|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554300|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
139554301|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554302|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554303|NCT00713284|Sirolimus|sirolimus|mesh-list
139554304|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139554305|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554306|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139554307|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554308|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
139554309|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554310|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
139554311|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554312|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
139554314|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139554315|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139554316|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139554317|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139554318|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554319|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
139554320|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554321|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554322|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139554323|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554324|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139554325|NCT02995720|Amlodipine|amlodipine|mesh-list
139554326|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139554327|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139554328|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139554329|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139024735|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
139554330|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554331|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139554332|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554333|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
139554334|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139554335|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139554336|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
139554337|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139554338|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139554339|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554340|NCT02990728|Metformin|metformin|mesh-list
139554341|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139554342|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554343|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
139554344|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
139554345|NCT02995330|Testosterone|testosterone|mesh-list
139554346|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
139554347|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
139554348|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139554349|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554350|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
139554351|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554352|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139554353|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139554354|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
139554355|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554356|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554357|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139554358|NCT02995330|Androgens|androgens|mesh-ancestor
139554359|NCT02995330|Hormones|hormones|mesh-ancestor
139554360|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139554361|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139554362|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
139554363|NCT02990884|Ketamine|ketamine|mesh-list
139554364|NCT02990884|Analgesics|analgesics|mesh-ancestor
139554365|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
139554366|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554367|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554368|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139554369|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139554370|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
139024777|NCT00322348|Goserelin|goserelin|mesh-list
139554371|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
139554372|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139554373|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139554374|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139554375|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554376|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554377|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
139554378|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139554379|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554380|NCT02990416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139554381|NCT02990416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554383|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139554384|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139554385|NCT02999776|Analgesics|analgesics|mesh-ancestor
139554386|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
139554387|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554388|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554389|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139554390|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139554391|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139554392|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554393|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
139554394|NCT02996656|Cefazolin|cefazolin|mesh-list
139554395|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
139554396|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139554397|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554398|NCT04387630|Metformin|metformin|mesh-list
139554399|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139554400|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554401|NCT04270318|Pemetrexed|pemetrexed|mesh-list
139554402|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554403|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554404|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554405|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139554406|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139554407|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
139554408|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554409|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
139554410|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554411|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139554412|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139554413|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
139554414|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554415|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554416|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139554417|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
139554418|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139554419|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139024815|NCT00308620|Filaricides|filaricides|mesh-ancestor
139554420|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554421|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139554422|NCT04270708|Analgesics|analgesics|mesh-ancestor
139554423|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
139554424|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554425|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139554426|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139554427|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139554428|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
139554429|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554430|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554431|NCT00704938|Aldesleukin|aldesleukin|mesh-list
139554432|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
139554433|NCT00704938|Fludarabine|fludarabine|mesh-list
139554434|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
139554435|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554436|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
139554437|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554438|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139554439|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139554440|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
139554441|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554442|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554443|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139554444|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139554445|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
139554446|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139554447|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139554448|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
139554449|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554450|NCT02994082|Bupropion|bupropion|mesh-list
139554451|NCT02994082|Nicotine|nicotine|mesh-list
139554452|NCT02994082|Varenicline|varenicline|mesh-list
139554453|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139554454|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
139336063|NCT02306733|Oxytocin|oxytocin|mesh-list
139554455|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554456|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554457|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139554458|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139554459|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
139554460|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024837|NCT00505778|Mesalamine|mesalamine|mesh-list
139554461|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554462|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139554463|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
139554464|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139554465|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139554466|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139554467|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139554468|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
139554469|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139554470|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139554471|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554472|NCT02995096|Sirolimus|sirolimus|mesh-list
139554473|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139554474|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554475|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139554476|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554477|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
139554478|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554479|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
139554480|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554481|NCT01275976|Complement C1s|complement c1s|mesh-list
139554482|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139554483|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
139554484|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
139554485|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554486|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139554487|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554488|NCT01270438|Leucovorin|leucovorin|mesh-list
139554489|NCT01270438|Bevacizumab|bevacizumab|mesh-list
139554490|NCT01270438|Fluorouracil|fluorouracil|mesh-list
139554491|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
139554492|NCT01270438|Calcium|calcium|mesh-list
139554493|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
139554494|NCT01270438|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139554495|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139554496|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554497|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139554498|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139554499|NCT01270438|Growth Substances|growth substances|mesh-ancestor
139554500|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554501|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
139554502|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139554503|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
139554504|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554505|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139554506|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554507|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
139554508|NCT01270438|Antidotes|antidotes|mesh-ancestor
139554509|NCT01270438|Protective Agents|protective agents|mesh-ancestor
139554510|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
139554511|NCT01270438|Vitamins|vitamins|mesh-ancestor
139554512|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
139554513|NCT01270438|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139554514|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554515|NCT01270672|Carvedilol|carvedilol|mesh-list
139554516|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139554517|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139554518|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139554519|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
139554520|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554521|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554522|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554523|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139554524|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
139554525|NCT01270672|Protective Agents|protective agents|mesh-ancestor
139554526|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139554527|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139554528|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139554529|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
139554530|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139554531|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139554532|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
139554533|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139554534|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
139554535|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139554536|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139554537|NCT01276210|Sorafenib|sorafenib|mesh-list
139554538|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554539|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139554540|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554541|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554542|NCT00727636|Vaccines|vaccines|mesh-list
139554543|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
139554544|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554545|NCT01270750|Bosentan|bosentan|mesh-list
139554546|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139554547|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139554548|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554549|NCT00709696|Varenicline|varenicline|mesh-list
139554550|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139554551|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139554552|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
139554553|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554554|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554555|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554556|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
139554557|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554558|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139554559|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554560|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554561|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
139554562|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139554563|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554564|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554565|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139554566|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139554567|NCT02992678|Protective Agents|protective agents|mesh-ancestor
139554568|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554569|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
139554570|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139554571|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
139554572|NCT02992912|Atezolizumab|atezolizumab|mesh-list
139554573|NCT02992912|Antibodies|antibodies|mesh-list
139554574|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
139554575|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554576|NCT02992912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139554577|NCT02992912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554578|NCT02992912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139554579|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554580|NCT01271140|Insulin|insulin|mesh-list
139554581|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139554582|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554583|NCT01271374|Losartan|losartan|mesh-list
139554584|NCT01271374|Amlodipine|amlodipine|mesh-list
139554585|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139554586|NCT01271374|Olmesartan|olmesartan|mesh-list
139554587|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
139554588|NCT01271374|Spironolactone|spironolactone|mesh-list
139554589|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139554590|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139554591|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139554592|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554593|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139024927|NCT01061788|Everolimus|everolimus|mesh-list
139554594|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554595|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
139554596|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139554597|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139554598|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139554599|NCT01271374|Diuretics|diuretics|mesh-ancestor
139554600|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
139554602|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139554603|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
139554604|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139554605|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139554606|NCT01276834|Everolimus|everolimus|mesh-list
139554607|NCT01276834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139554608|NCT01276834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139554609|NCT01276834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554610|NCT01276834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554611|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554612|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
139554613|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554614|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554615|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
139554616|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139554617|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554618|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
139554619|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139554620|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554621|NCT00717418|Cyclosporine|cyclosporine|mesh-list
139554622|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
139554623|NCT00717418|Cyclosporins|cyclosporins|mesh-list
139554624|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554625|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554626|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554627|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
139554628|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554629|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
139554630|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554631|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
139554632|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139554633|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139554634|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139554635|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139554636|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
139554637|NCT00717574|Propofol|propofol|mesh-list
139554638|NCT00717574|Sevoflurane|sevoflurane|mesh-list
139554639|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139024957|NCT03981094|Analgesics|analgesics|mesh-ancestor
139554640|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139554641|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554642|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139554643|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
139554644|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
139554645|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139554646|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139554647|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139554648|NCT00717574|Analgesics|analgesics|mesh-ancestor
139554649|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
139554650|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554651|NCT00719134|Rizatriptan|rizatriptan|mesh-list
139554652|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139554653|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
139554654|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554655|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554656|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554657|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
139554658|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139554659|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
139554660|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554661|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554662|NCT00721162|Ramucirumab|ramucirumab|mesh-list
139554663|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554664|NCT01838941|Betaine|betaine|mesh-list
139554665|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139554666|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
139554667|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139554668|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
139554669|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554670|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139554671|NCT01773109|Irinotecan|irinotecan|mesh-list
139554672|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
139554673|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
139554674|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139554675|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554676|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554677|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554678|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139554679|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
139554680|NCT01772719|Simvastatin|simvastatin|mesh-list
139554681|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139554682|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139554683|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
139554684|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554685|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139554686|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139554687|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554688|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139554689|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554690|NCT05582265|Paclitaxel|paclitaxel|mesh-list
139554691|NCT05582265|Cisplatin|cisplatin|mesh-list
139554692|NCT05582265|Tislelizumab|tislelizumab|mesh-list
139554693|NCT05582265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139554694|NCT05582265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554695|NCT05582265|Tubulin Modulators|tubulin modulators|mesh-ancestor
139554696|NCT05582265|Antimitotic Agents|antimitotic agents|mesh-ancestor
139554697|NCT05582265|Mitosis Modulators|mitosis modulators|mesh-ancestor
139554698|NCT05582265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554699|NCT05582265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139554700|NCT04144101|Etoricoxib|etoricoxib|mesh-list
139554701|NCT04144101|Aceclofenac|aceclofenac|mesh-list
139554702|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139554703|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139554704|NCT04144101|Analgesics|analgesics|mesh-ancestor
139554705|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
139554706|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554707|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554708|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139554709|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139554710|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139554711|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139554712|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554713|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554714|NCT01278004|Ethosuximide|ethosuximide|mesh-list
139554715|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
139554716|NCT01278238|Phenylephrine|phenylephrine|mesh-list
139554717|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
139554718|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139554719|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
139554720|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
139554721|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554722|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554723|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
139554724|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139554725|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
139554726|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
139554727|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139554728|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139554729|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139554730|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
139554731|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554732|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554733|NCT01278238|Protective Agents|protective agents|mesh-ancestor
139554734|NCT02706795|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139554735|NCT02706795|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139554736|NCT02706795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139554737|NCT02706795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554738|NCT02706795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554739|NCT02706795|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139554740|NCT02706795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139554741|NCT02706795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554742|NCT02706795|Cholinergic Agents|cholinergic agents|mesh-ancestor
139554743|NCT02706795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554744|NCT01272310|Interferons|interferons|mesh-list
139554745|NCT01272310|Ribavirin|ribavirin|mesh-list
139554746|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
139554747|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
139554748|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139554749|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
139554750|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554752|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554753|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
139554754|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554755|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
139554756|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554757|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
139554758|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139554759|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139554760|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554761|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139554762|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139554763|NCT04386850|Calcifediol|calcifediol|mesh-list
139554764|NCT04386850|Vitamins|vitamins|mesh-ancestor
139554765|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
139554766|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554767|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139554768|NCT01272778|Lorazepam|lorazepam|mesh-list
139554769|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
139554770|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
139554771|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
139554772|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554773|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554774|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139554775|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139554776|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139554777|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139554778|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139554779|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139554780|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
139554781|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
139554782|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554783|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554784|NCT01272856|Abatacept|abatacept|mesh-list
139554785|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139554786|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554787|NCT01272856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139554788|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554789|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554790|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
139554791|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554792|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139554793|NCT01273090|Imetelstat|imetelstat|mesh-list
139554794|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
139554795|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554796|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554797|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139554798|NCT01273246|Vaccines|vaccines|mesh-list
139554799|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
139554800|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554801|NCT00730522|Vigabatrin|vigabatrin|mesh-list
139554802|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
139554803|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554804|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554805|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
139554806|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554807|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554808|NCT04345276|Ritonavir|ritonavir|mesh-list
139554809|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139554810|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139554811|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
139554812|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554813|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554814|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139554815|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139554816|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
139554817|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554818|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139025082|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
139554819|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139554820|NCT01273558|Canagliflozin|canagliflozin|mesh-list
139554821|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139554822|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554823|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139554824|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554825|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
139554826|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139554827|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139554828|NCT00733096|Prednisolone|prednisolone|mesh-list
139554829|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
139554830|NCT00733096|Etanercept|etanercept|mesh-list
139554831|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139554832|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
139554833|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139554834|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
139554835|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
139554836|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554837|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554838|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139554839|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
139554840|NCT00733096|Hormones|hormones|mesh-ancestor
139554841|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139554842|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139554843|NCT00733096|Protective Agents|protective agents|mesh-ancestor
139554844|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139554845|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554846|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139554847|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139554848|NCT00733096|Analgesics|analgesics|mesh-ancestor
139554849|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
139554850|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139554851|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139554852|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
139554853|NCT02991196|Nivolumab|nivolumab|mesh-list
139554854|NCT02991196|DS-8273a|ds-8273a|mesh-list
139554855|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139554856|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554857|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139554858|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554859|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
139554860|NCT01278784|Chitosan|chitosan|mesh-list
139554861|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139554862|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139554863|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139554864|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
139554865|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554866|NCT01278784|Expectorants|expectorants|mesh-ancestor
139554867|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
139554868|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139554869|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
139554870|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554871|NCT01278784|Protective Agents|protective agents|mesh-ancestor
139554872|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554873|NCT01278784|Antidotes|antidotes|mesh-ancestor
139554874|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139554875|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139554876|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
139554877|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139554878|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
139554879|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
139554880|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
139554881|NCT01278784|Coagulants|coagulants|mesh-ancestor
139554882|NCT01276288|Empagliflozin|empagliflozin|mesh-list
139554883|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139554884|NCT01276288|Torsemide|torsemide|mesh-list
139554885|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139554886|NCT01276288|Diuretics|diuretics|mesh-ancestor
139554887|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
139554888|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554889|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139554890|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139554891|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554892|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139554893|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139554894|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139554895|NCT00722566|Bortezomib|bortezomib|mesh-list
139554896|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554897|NCT00722722|Bortezomib|bortezomib|mesh-list
139554898|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554899|NCT00723580|Risperidone|risperidone|mesh-list
139025153|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
139554900|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139336504|NCT03501615|Immunoconjugates|immunoconjugates|mesh-ancestor
139554901|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
139554902|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554903|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554904|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554905|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139554906|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139554907|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139554908|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139554909|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139554910|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
139554911|NCT01273948|Interferons|interferons|mesh-list
139554912|NCT01273948|Bavituximab|bavituximab|mesh-list
139554913|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554914|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
139554915|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554916|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139554917|NCT00734344|Tenofovir|tenofovir|mesh-list
139554918|NCT00734344|Efavirenz|efavirenz|mesh-list
139554919|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
139554920|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
139554921|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554922|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139554923|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139554924|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554925|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554926|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139554927|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139554928|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139554929|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139554930|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139554931|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139554932|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139554933|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139025188|NCT00414765|Aldesleukin|aldesleukin|mesh-list
139554934|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139554935|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139554936|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
139554937|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139554938|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554939|NCT04148937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139554940|NCT04148937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554941|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
139554942|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139554943|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554944|NCT03021057|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139554945|NCT03021057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554946|NCT00734500|Anidulafungin|anidulafungin|mesh-list
139554947|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
139554948|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554949|NCT04143321|Empagliflozin|empagliflozin|mesh-list
139554950|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139554951|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554952|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139554953|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554954|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
139554955|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139554956|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139554957|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139554958|NCT00735436|Bevacizumab|bevacizumab|mesh-list
139554959|NCT00735436|Irinotecan|irinotecan|mesh-list
139554960|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139554961|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554962|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139554963|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139554964|NCT00735436|Growth Substances|growth substances|mesh-ancestor
139554965|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554966|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
139554967|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139554968|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139554969|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554970|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554971|NCT04143165|Lidocaine|lidocaine|mesh-list
139554972|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
139554973|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
139554974|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139554975|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554976|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
139554977|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139554978|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139554979|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139554980|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139554981|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139554982|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554983|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139554984|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139554985|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139554986|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139554987|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554988|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139554989|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139554990|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139554991|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
139554992|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139554993|NCT00735826|Vorinostat|vorinostat|mesh-list
139554994|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139554995|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139554996|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139554997|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139554998|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139554999|NCT01276054|Methylene Blue|methylene blue|mesh-list
139025279|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
139555000|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
139555001|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555002|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555003|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139555004|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
139555005|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139555006|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
139555007|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555008|NCT00724594|Expectorants|expectorants|mesh-ancestor
139555009|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
139555010|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139555011|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
139555012|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555013|NCT00724594|Protective Agents|protective agents|mesh-ancestor
139555014|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555015|NCT00724594|Antidotes|antidotes|mesh-ancestor
139555016|NCT04142931|Nivolumab|nivolumab|mesh-list
139555017|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139555018|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555019|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139555020|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555021|NCT04143477|Peficitinib|peficitinib|mesh-list
139555022|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555023|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555024|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139555025|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
139555026|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555027|NCT05586009|Cisplatin|cisplatin|mesh-list
139555028|NCT05586009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555029|NCT03020979|Apatinib|apatinib|mesh-list
139555030|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555031|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139555032|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555033|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555034|NCT04142151|Aspirin|aspirin|mesh-list
139555035|NCT04142151|Clopidogrel|clopidogrel|mesh-list
139555036|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139555037|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139555038|NCT04142151|Analgesics|analgesics|mesh-ancestor
139555039|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
139555040|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555041|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555042|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139555043|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139555044|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139555045|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139555046|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555047|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139555048|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139555049|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555051|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139555052|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139555053|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139555054|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
139555055|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139555056|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139555057|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139555058|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139555059|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
139555060|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555061|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139555062|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139555063|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555064|NCT03904329|Anticoagulants|anticoagulants|mesh-list
139555065|NCT04149483|Atorvastatin|atorvastatin|mesh-list
139555066|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139555067|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139555068|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
139555069|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555070|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139555071|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139555072|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555073|NCT04149327|Amoxicillin|amoxicillin|mesh-list
139555074|NCT04149327|Metronidazole|metronidazole|mesh-list
139555075|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139555076|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555077|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139555078|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139555079|NCT05582577|Bevacizumab|bevacizumab|mesh-list
139555080|NCT05582577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139555081|NCT05582577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555082|NCT05582577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139555083|NCT05582577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139555084|NCT05582577|Growth Substances|growth substances|mesh-ancestor
139555085|NCT05582577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555086|NCT05582577|Growth Inhibitors|growth inhibitors|mesh-ancestor
139555087|NCT04149015|Paclitaxel|paclitaxel|mesh-list
139555088|NCT04149015|Fluorouracil|fluorouracil|mesh-list
139555089|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
139555090|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139555091|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555092|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
139555093|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
139555094|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
139555095|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555096|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
139555097|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139555098|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139555099|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
139555100|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555101|NCT04140591|Propranolol|propranolol|mesh-list
139555102|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139555103|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139555104|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139555105|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
139555106|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139555107|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555108|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555109|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139555110|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139555111|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
139555112|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555113|NCT05582109|Lenvatinib|lenvatinib|mesh-list
139555114|NCT05582109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555115|NCT05582109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139555116|NCT05582109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555117|NCT05582109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555118|NCT03020901|Teicoplanin|teicoplanin|mesh-list
139555119|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139555120|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555121|NCT04140201|Simvastatin|simvastatin|mesh-list
139555122|NCT04140201|Fenofibrate|fenofibrate|mesh-list
139555123|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139555124|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139555125|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
139555126|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555127|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139555128|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139555129|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555130|NCT05581875|Dexamethasone|dexamethasone|mesh-list
139555131|NCT05581875|Daratumumab|daratumumab|mesh-list
139555132|NCT05581875|Pomalidomide|pomalidomide|mesh-list
139555133|NCT05581875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139555134|NCT05581875|Antiemetics|antiemetics|mesh-ancestor
139555135|NCT05581875|Autonomic Agents|autonomic agents|mesh-ancestor
139555136|NCT05581875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555137|NCT05581875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555138|NCT05581875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139555139|NCT05581875|Glucocorticoids|glucocorticoids|mesh-ancestor
139555140|NCT05581875|Hormones|hormones|mesh-ancestor
139555141|NCT05581875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555142|NCT05581875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139555143|NCT05581875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555144|NCT05581875|Immunologic Factors|immunologic factors|mesh-ancestor
139555145|NCT05581875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139555146|NCT05581875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139555147|NCT05581875|Growth Substances|growth substances|mesh-ancestor
139555148|NCT05581875|Growth Inhibitors|growth inhibitors|mesh-ancestor
139555149|NCT04406025|Anesthetics|anesthetics|mesh-list
139555150|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139555151|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555152|NCT05587881|Vaccines|vaccines|mesh-list
139555153|NCT05587881|Immunologic Factors|immunologic factors|mesh-ancestor
139555154|NCT05587881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555155|NCT05582421|Diclofenac|diclofenac|mesh-list
139555156|NCT05582421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139555157|NCT05582421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139555158|NCT05582421|Analgesics|analgesics|mesh-ancestor
139555159|NCT05582421|Sensory System Agents|sensory system agents|mesh-ancestor
139555160|NCT05582421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555161|NCT05582421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555162|NCT05582421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139555163|NCT05582421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139555164|NCT05582421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139555165|NCT05582421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555166|NCT05582421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555167|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
139555168|NCT03580473|Dexamethasone|dexamethasone|mesh-list
139555169|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139555170|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139555171|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
139555172|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
139555173|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555174|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555175|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139555176|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
139555177|NCT03580473|Hormones|hormones|mesh-ancestor
139555178|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555179|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139555180|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555181|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555182|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555183|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139555184|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555185|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139555186|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139555187|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139555188|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
139555189|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139555190|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139555191|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139555192|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139555193|NCT03897309|Vaccines|vaccines|mesh-list
139555194|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
139555195|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555196|NCT03588429|Sevoflurane|sevoflurane|mesh-list
139555197|NCT03588429|Isoflurane|isoflurane|mesh-list
139555198|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139555199|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139555200|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
139555201|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
139555202|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139555203|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555204|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
139555205|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
139555206|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
139555207|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
139555208|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139555209|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555210|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
139555211|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139555212|NCT03588351|Chitosan|chitosan|mesh-list
139555213|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139555214|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555215|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
139555216|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
139555217|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139555218|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139555219|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
139555220|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555221|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139555222|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
139555223|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
139555224|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
139555225|NCT03588351|Coagulants|coagulants|mesh-ancestor
139555226|NCT03588273|Amoxicillin|amoxicillin|mesh-list
139555227|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139555228|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555229|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
139555230|NCT02984865|Sufentanil|sufentanil|mesh-list
139555231|NCT02984865|Nalbuphine|nalbuphine|mesh-list
139555232|NCT02984865|Dsuvia|dsuvia|mesh-list
139555233|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139555234|NCT02984865|Narcotics|narcotics|mesh-ancestor
139555235|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139555236|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555237|NCT02984865|Analgesics|analgesics|mesh-ancestor
139555238|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
139555239|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555240|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139555241|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139555242|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
139555243|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
139555244|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139555245|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139555246|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139555247|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139555248|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139555249|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555250|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555251|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139555252|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139555253|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139555254|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
139555255|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555256|NCT01611259|Rituximab|rituximab|mesh-list
139555257|NCT01611259|Lenalidomide|lenalidomide|mesh-list
139555258|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139555259|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555260|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
139555261|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555262|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139555263|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139555264|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139555265|NCT01611259|Growth Substances|growth substances|mesh-ancestor
139555266|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
139555267|NCT03586869|Leucovorin|leucovorin|mesh-list
139555268|NCT03586869|Paclitaxel|paclitaxel|mesh-list
139555269|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
139336906|NCT03904199|Insulin|insulin|mesh-list
139555270|NCT03586869|Bevacizumab|bevacizumab|mesh-list
139555271|NCT03586869|Capecitabine|capecitabine|mesh-list
139555272|NCT03586869|Fluorouracil|fluorouracil|mesh-list
139555273|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
139555275|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139555276|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555277|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
139555278|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
139555279|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
139555280|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555281|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139555282|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
139555283|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555284|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139555285|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139555286|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
139555287|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139555288|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139555289|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139555290|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139555291|NCT03586869|Growth Substances|growth substances|mesh-ancestor
139555292|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
139555293|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139555294|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
139555295|NCT03586869|Antidotes|antidotes|mesh-ancestor
139555296|NCT03586869|Protective Agents|protective agents|mesh-ancestor
139555297|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
139555298|NCT03586869|Vitamins|vitamins|mesh-ancestor
139555299|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
139555300|NCT03586791|Anesthetics|anesthetics|mesh-list
139555301|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139555302|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555303|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
139555304|NCT01795495|Remifentanil|remifentanil|mesh-list
139555305|NCT01795495|Methadone|methadone|mesh-list
139555306|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139555307|NCT01795495|Narcotics|narcotics|mesh-ancestor
139555308|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139555309|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555310|NCT01795495|Analgesics|analgesics|mesh-ancestor
139555311|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
139555312|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555313|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
139555314|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139555315|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
139555316|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139555317|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139555318|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555319|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139555320|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
139555321|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139555322|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
139555323|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
139555324|NCT04765527|Turmeric extract|turmeric extract|mesh-list
139555325|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
139555326|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555327|NCT04765527|Protective Agents|protective agents|mesh-ancestor
139555328|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555329|NCT02947503|Metformin|metformin|mesh-list
139555330|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139555331|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555332|NCT03586323|Lidocaine|lidocaine|mesh-list
139555333|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
139555334|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
139555335|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139555336|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555337|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
139555338|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555339|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139555340|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139555341|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139555342|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139555343|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555344|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
139555345|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139555346|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555347|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139555348|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555349|NCT03580395|Paclitaxel|paclitaxel|mesh-list
139555350|NCT03580395|Apatinib|apatinib|mesh-list
139555351|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139555352|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555353|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
139555354|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
139555355|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
139555356|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555357|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139555358|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555359|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139555360|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555361|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139555362|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555363|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555364|NCT03580239|Everolimus|everolimus|mesh-list
139555365|NCT03580239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139555366|NCT03580239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139555367|NCT03580239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555368|NCT03580239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555369|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139555370|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
139555371|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025522|NCT00510146|Olanzapine|olanzapine|mesh-list
139555372|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555373|NCT03156153|Bumetanide|bumetanide|mesh-list
139555374|NCT03156153|Diuretics|diuretics|mesh-ancestor
139555375|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
139555376|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555377|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139555378|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139555379|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555380|NCT03156231|Acetazolamide|acetazolamide|mesh-list
139555381|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
139555382|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139555383|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555384|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555385|NCT03156231|Diuretics|diuretics|mesh-ancestor
139555386|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
139555387|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555388|NCT05702151|Morphine|morphine|mesh-list
139555389|NCT05702151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139555390|NCT05702151|Narcotics|narcotics|mesh-ancestor
139555391|NCT05702151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139555392|NCT05702151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555393|NCT05702151|Analgesics|analgesics|mesh-ancestor
139555394|NCT05702151|Sensory System Agents|sensory system agents|mesh-ancestor
139555395|NCT05702151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555396|NCT01985321|Ethanol|ethanol|mesh-list
139555397|NCT01985321|Glycolic acid|glycolic acid|mesh-list
139555398|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139555399|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555400|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139555401|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555402|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
139555403|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
139555404|NCT03584919|Doxycycline|doxycycline|mesh-list
139555405|NCT03584919|Cefuroxime|cefuroxime|mesh-list
139555406|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
139555407|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139555408|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555409|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
139555410|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139555411|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139555412|NCT03584841|Pilocarpine|pilocarpine|mesh-list
139555413|NCT03584841|Miotics|miotics|mesh-ancestor
139555414|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
139555415|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555416|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555417|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139555418|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139555419|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
139555420|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139555421|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555422|NCT02000921|Nicotine|nicotine|mesh-list
139555423|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139555424|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
139555425|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555426|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555427|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139555428|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139555429|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
139555430|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139555431|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555433|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
139555434|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
139555435|NCT03586947|Vitamins|vitamins|mesh-list
139555436|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
139555437|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555438|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139555439|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139555440|NCT03584529|Vitamin D|vitamin d|mesh-list
139555441|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
139555442|NCT03584529|Vitamins|vitamins|mesh-ancestor
139555443|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
139555444|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555445|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139555446|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139555447|NCT00724984|Abexinostat|abexinostat|mesh-list
139555448|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139555449|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555450|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555451|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
139555452|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139555453|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139555454|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555455|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
139555456|NCT03113253|Coagulants|coagulants|mesh-ancestor
139555457|NCT01836523|Liraglutide|liraglutide|mesh-list
139555458|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139555459|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555460|NCT01836523|Incretins|incretins|mesh-ancestor
139555461|NCT01836523|Hormones|hormones|mesh-ancestor
139555462|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555463|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
139555464|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555465|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139555466|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555467|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555468|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139555469|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139555470|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555471|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
139555472|NCT02000531|Cisplatin|cisplatin|mesh-list
139555473|NCT02000531|Gemcitabine|gemcitabine|mesh-list
139555474|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139555475|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555476|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139555477|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
139555478|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555479|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139555480|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555481|NCT01609231|Irinotecan|irinotecan|mesh-list
139555482|NCT01609231|Cetuximab|cetuximab|mesh-list
139555483|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139555484|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139555485|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555486|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555487|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555488|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139555489|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
139555490|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139555491|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139555492|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139555493|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139555494|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555495|NCT04405011|Entecavir|entecavir|mesh-list
139555496|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
139555497|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555498|NCT01769443|Bortezomib|bortezomib|mesh-list
139555499|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555500|NCT03154827|Atezolizumab|atezolizumab|mesh-list
139555501|NCT03154827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139555502|NCT03154827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555503|NCT03154827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139555504|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555505|NCT01274182|Rituximab|rituximab|mesh-list
139555506|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139555507|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555508|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
139555509|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555510|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139555511|NCT01984229|Posaconazole|posaconazole|mesh-list
139555512|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
139555513|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555514|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139555515|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139555516|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139555517|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139555518|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139555519|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555520|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555521|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139555522|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
139555523|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555524|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555525|NCT01274104|Vitamin D|vitamin d|mesh-list
139555526|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
139555527|NCT01274104|Vitamins|vitamins|mesh-ancestor
139555528|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
139555529|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555530|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139555531|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139555532|NCT01279096|Dexamethasone|dexamethasone|mesh-list
139555533|NCT01279096|Etoposide|etoposide|mesh-list
139555534|NCT01279096|Asparaginase|asparaginase|mesh-list
139555535|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
139555536|NCT01279096|Clofarabine|clofarabine|mesh-list
139555537|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139555538|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
139555539|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
139555540|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555541|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555542|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139555543|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
139555544|NCT01279096|Hormones|hormones|mesh-ancestor
139555545|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555546|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139555547|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555548|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555549|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555550|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139555551|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139555552|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139555553|NCT01279096|Analgesics|analgesics|mesh-ancestor
139555554|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
139555555|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139555556|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
139555557|NCT01272934|Diclofenac|diclofenac|mesh-list
139555558|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139555559|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139555560|NCT01272934|Analgesics|analgesics|mesh-ancestor
139555561|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
139555562|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555563|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555564|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139555565|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139555566|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139555567|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555568|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555569|NCT01279252|Metronidazole|metronidazole|mesh-list
139555570|NCT01279252|Clarithromycin|clarithromycin|mesh-list
139555571|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
139555572|NCT01279252|Lansoprazole|lansoprazole|mesh-list
139555573|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
139555574|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555575|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139555576|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139555577|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139555578|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139555579|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555580|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555581|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139555582|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139555583|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139555584|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139555585|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555586|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139555587|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139555588|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139555589|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139555590|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139555591|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
139555592|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139555593|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139555594|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
139555595|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555596|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555597|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
139555598|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139555599|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139555600|NCT01274260|Prednisolone|prednisolone|mesh-list
139555601|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
139555602|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139555603|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
139555604|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139555605|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
139555606|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
139555607|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555608|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555609|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139555610|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
139555611|NCT01274260|Hormones|hormones|mesh-ancestor
139555612|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555613|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139555614|NCT01274260|Protective Agents|protective agents|mesh-ancestor
139555615|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139555616|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555617|NCT03154983|Docetaxel|docetaxel|mesh-list
139555618|NCT03154983|Apatinib|apatinib|mesh-list
139555619|NCT03154983|Tegafur|tegafur|mesh-list
139555620|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555621|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
139555622|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
139555623|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
139555624|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555625|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139555626|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555627|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139555628|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
139555629|NCT01983683|Vancomycin|vancomycin|mesh-list
139555630|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
139555631|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139555632|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555633|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139555634|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555635|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555636|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
139555637|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
139555638|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555639|NCT03158025|Zolpidem|zolpidem|mesh-list
139555640|NCT03158025|Suvorexant|suvorexant|mesh-list
139555641|NCT03158025|Lemborexant|lemborexant|mesh-list
139555642|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139555643|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139555644|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139555645|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555646|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139555647|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
139555648|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
139555649|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139555650|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555651|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139555653|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139555654|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555655|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
139555656|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555657|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139555658|NCT01791985|Letrozole|letrozole|mesh-list
139555659|NCT01791985|Anastrozole|anastrozole|mesh-list
139555660|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555661|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139555662|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139555663|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555664|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555665|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139555666|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
139555667|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555668|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555669|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139555670|NCT04176497|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139555671|NCT04176497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139555672|NCT04176497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555673|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139555674|NCT03154281|Everolimus|everolimus|mesh-list
139555675|NCT03154281|Niraparib|niraparib|mesh-list
139555676|NCT03154281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139555677|NCT03154281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139555678|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025785|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555679|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555680|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139555681|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
139555682|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555683|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555684|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139555685|NCT03157791|Simethicone|simethicone|mesh-list
139555686|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
139555687|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555688|NCT03157791|Emollients|emollients|mesh-ancestor
139555689|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
139555690|NCT03157479|Anesthetics|anesthetics|mesh-list
139555691|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
139555692|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139555693|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555694|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
139555695|NCT03013491|Ipilimumab|ipilimumab|mesh-list
139555696|NCT03013491|Vemurafenib|vemurafenib|mesh-list
139555697|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139555698|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555699|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139555700|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555701|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139555702|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555703|NCT01272232|Liraglutide|liraglutide|mesh-list
139555704|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139555705|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555706|NCT01272232|Incretins|incretins|mesh-ancestor
139555707|NCT01272232|Hormones|hormones|mesh-ancestor
139555708|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555709|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
139555710|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139555711|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139555712|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555713|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
139555714|NCT03157401|Coagulants|coagulants|mesh-ancestor
139555715|NCT03153813|Capsaicin|capsaicin|mesh-list
139555716|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
139555717|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
139555718|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
139555719|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555720|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555721|NCT03156855|Bismuth|bismuth|mesh-list
139555722|NCT03156855|Antacids|antacids|mesh-ancestor
139555723|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555724|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139555725|NCT00739960|Abatacept|abatacept|mesh-list
139555726|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139555727|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555728|NCT00739960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139555729|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555730|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139555731|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
139555732|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555733|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139555734|NCT03153657|Piroxicam|piroxicam|mesh-list
139555735|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
139555736|NCT03153657|Betadex|betadex|mesh-list
139555737|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139555738|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139555739|NCT03153657|Analgesics|analgesics|mesh-ancestor
139555740|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
139555741|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555742|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555743|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139555744|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139555745|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139555746|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555747|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555748|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
139555749|NCT01670955|Folic Acid|folic acid|mesh-list
139555750|NCT01670955|Hematinics|hematinics|mesh-ancestor
139555751|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
139555752|NCT01670955|Vitamins|vitamins|mesh-ancestor
139555753|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
139555754|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555755|NCT01275274|Tretinoin|tretinoin|mesh-list
139555756|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555757|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
139555758|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
139555759|NCT01997333|Capecitabine|capecitabine|mesh-list
139555760|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139555761|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
139555762|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555763|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555764|NCT01271920|Trastuzumab|trastuzumab|mesh-list
139555765|NCT01271920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139555766|NCT01271920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555767|NCT01275352|Eplerenone|eplerenone|mesh-list
139555768|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139555769|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
139555770|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555771|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555772|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139555773|NCT01275352|Diuretics|diuretics|mesh-ancestor
139555774|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
139555775|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139555776|NCT01676259|Paclitaxel|paclitaxel|mesh-list
139555777|NCT01676259|Gemcitabine|gemcitabine|mesh-list
139555778|NCT01676259|Folfirinox|folfirinox|mesh-list
139555779|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139555780|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555781|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
139555782|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
139555783|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
139555784|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555785|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139555786|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
139555787|NCT02662257|Propofol|propofol|mesh-list
139555788|NCT02662257|Sevoflurane|sevoflurane|mesh-list
139555789|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139555790|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139555791|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555792|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139555793|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
139555794|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
139555795|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139555796|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139555797|NCT03153267|Doxycycline|doxycycline|mesh-list
139555798|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139555799|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555800|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
139555801|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139555802|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139555803|NCT00746512|Prednisone|prednisone|mesh-list
139555804|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139555805|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
139555806|NCT00746512|Hormones|hormones|mesh-ancestor
139555807|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555808|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555809|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139555810|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555811|NCT05409027|Cortisone|cortisone|mesh-list
139555812|NCT05409027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139555813|NCT05409027|Glucocorticoids|glucocorticoids|mesh-list
139555814|NCT05409027|Hormones|hormones|mesh-ancestor
139555815|NCT05409027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555816|NCT05409027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555817|NCT01982435|Ranibizumab|ranibizumab|mesh-list
139555818|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139555819|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139555820|NCT01982435|Growth Substances|growth substances|mesh-ancestor
139555821|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555822|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
139555823|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555824|NCT00747214|Prednisolone|prednisolone|mesh-list
139555825|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
139555826|NCT00747214|Dipyridamole|dipyridamole|mesh-list
139555827|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139555828|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
139555829|NCT00747214|Hormones|hormones|mesh-ancestor
139555830|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555831|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555832|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139555833|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555834|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139025923|NCT01014104|Prednisolone|prednisolone|mesh-list
139555835|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555836|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555837|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139555838|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
139555839|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139555840|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139555841|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139555842|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139555843|NCT01279876|Melatonin|melatonin|mesh-list
139555844|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
139555845|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555846|NCT01279876|Protective Agents|protective agents|mesh-ancestor
139555847|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555848|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139555849|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139555850|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
139555851|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139555852|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139555853|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555854|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
139555855|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
139555856|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139555857|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
139555858|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555859|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139555860|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139555861|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
139555862|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555863|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555864|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139555865|NCT01279954|Abatacept|abatacept|mesh-list
139555866|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139555867|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555868|NCT01279954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139555869|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555870|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139555871|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
139555872|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555873|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139555874|NCT00763048|Triclosan|triclosan|mesh-list
139555875|NCT00763048|Fluorides|fluorides|mesh-list
139025969|NCT00501644|Interferons|interferons|mesh-list
139555876|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
139555877|NCT00763048|Protective Agents|protective agents|mesh-ancestor
139555878|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555879|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139555880|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555881|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139555882|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139555883|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
139555884|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555885|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139555886|NCT01278394|Tavaborole|tavaborole|mesh-list
139555887|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
139555888|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555889|NCT00240916|Vaccines|vaccines|mesh-list
139555890|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
139555891|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555892|NCT01278160|Insulin|insulin|mesh-list
139555893|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139555894|NCT01278160|Metformin|metformin|mesh-list
139555895|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
139555896|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
139555897|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139555898|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
139555899|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139555900|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
139555901|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139555902|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555903|NCT00748072|Vasopressins|vasopressins|mesh-list
139555904|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
139555905|NCT00748072|Coagulants|coagulants|mesh-ancestor
139555906|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139555907|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139555908|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
139555909|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555910|NCT01835587|Cc-486|cc-486|mesh-list
139555911|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555912|NCT01736917|Dexamethasone|dexamethasone|mesh-list
139555913|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
139555914|NCT01736917|Aprepitant|aprepitant|mesh-list
139555915|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139555916|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
139555917|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
139555918|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139555919|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555920|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139555921|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
139555922|NCT01736917|Hormones|hormones|mesh-ancestor
139555923|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555924|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139555925|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555926|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139555927|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139555928|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555929|NCT01277302|Ranibizumab|ranibizumab|mesh-list
139555930|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139555931|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139555932|NCT01277302|Growth Substances|growth substances|mesh-ancestor
139555933|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555934|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
139555935|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555936|NCT04414579|Insulin|insulin|mesh-list
139555937|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139555938|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
139555939|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
139026041|NCT01020708|Protective Agents|protective agents|mesh-ancestor
139555940|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139555941|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139555942|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555943|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
139555944|NCT01980875|Idelalisib|idelalisib|mesh-list
139555945|NCT01980875|Chlorambucil|chlorambucil|mesh-list
139555946|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139555947|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555948|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555949|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555950|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139555951|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
139555953|NCT01967225|Tedizolid|tedizolid|mesh-list
139555954|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
139555955|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139555956|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555957|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139555958|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555959|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555960|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139555961|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139555962|NCT01790503|Temozolomide|temozolomide|mesh-list
139555963|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139555964|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
139555965|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555966|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555967|NCT01765543|Rifampin|rifampin|mesh-list
139555968|NCT01765543|Vemurafenib|vemurafenib|mesh-list
139555969|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139555970|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
139555971|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139555972|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139555973|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
139555974|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139555975|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555976|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555977|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139555978|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139555979|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139555980|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139555981|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139026082|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
139555982|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139555983|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555984|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139555985|NCT00248170|Letrozole|letrozole|mesh-list
139555986|NCT00248170|Anastrozole|anastrozole|mesh-list
139555987|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139555988|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139555989|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139555990|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139555991|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139555992|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139555993|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
139555994|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139555995|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139555996|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139555997|NCT01764997|Adalimumab|adalimumab|mesh-list
139555998|NCT01764997|Etanercept|etanercept|mesh-list
139555999|NCT01764997|Methotrexate|methotrexate|mesh-list
139556000|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139556001|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
139556002|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139556003|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556004|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139556005|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
139556006|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556007|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556008|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
139556009|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556010|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139556011|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139556012|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
139556013|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139026113|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
139556014|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139556015|NCT01764997|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139556016|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556017|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139556018|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139556019|NCT01764997|Analgesics|analgesics|mesh-ancestor
139556020|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
139556021|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556022|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139337638|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
139556023|NCT01276756|Interferons|interferons|mesh-list
139556024|NCT01276756|Ribavirin|ribavirin|mesh-list
139556025|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
139556026|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
139556027|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139556028|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
139556029|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556030|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
139556031|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139556032|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
139556033|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556034|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
139556035|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556036|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139556038|NCT00246376|Fenofibrate|fenofibrate|mesh-list
139556039|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139556040|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
139556041|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556042|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139556043|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
139556044|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
139556045|NCT00246376|Vitamins|vitamins|mesh-ancestor
139556046|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
139556047|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556048|NCT03806062|Domperidone|domperidone|mesh-list
139556049|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
139556050|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
139556051|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556052|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556053|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139556054|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139556055|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
139556056|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556057|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556058|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
139556059|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139556060|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
139556061|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556062|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556063|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139556064|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
139556065|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139556066|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139556067|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139556068|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
139556069|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556070|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556071|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
139556072|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139556073|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139556074|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139556075|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139556076|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556077|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556078|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556079|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139556080|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139556081|NCT00245050|Pyridoxine|pyridoxine|mesh-list
139556082|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
139556083|NCT00245050|Doxorubicin|doxorubicin|mesh-list
139556084|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139556085|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139556086|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556087|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139556088|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139556089|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556090|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556091|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
139556092|NCT00245050|Vitamins|vitamins|mesh-ancestor
139556093|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
139556094|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337717|NCT03148899|Oxytocin|oxytocin|mesh-list
139556095|NCT04345588|Dexamethasone|dexamethasone|mesh-list
139556096|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
139556097|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556098|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
139556099|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
139556100|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556101|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556102|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139556103|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
139556104|NCT04345588|Hormones|hormones|mesh-ancestor
139556105|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556106|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139556107|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556108|NCT03806374|Lidocaine|lidocaine|mesh-list
139556109|NCT03806374|Fentanyl|fentanyl|mesh-list
139556110|NCT03806374|Ketamine|ketamine|mesh-list
139556111|NCT03806374|Propofol|propofol|mesh-list
139556112|NCT03806374|Cisatracurium|cisatracurium|mesh-list
139556113|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
139556114|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
139556115|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139556116|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556117|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
139556118|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556119|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139556120|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139556121|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139556122|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139556123|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556124|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139556125|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139556126|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
139556127|NCT03806374|Analgesics|analgesics|mesh-ancestor
139556128|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139556129|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139556130|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139556131|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556132|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139556133|NCT03806374|Narcotics|narcotics|mesh-ancestor
139556134|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139556135|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139556136|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139556137|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
139556138|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139556139|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
139556140|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556141|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
139556142|NCT00763360|Protective Agents|protective agents|mesh-ancestor
139556143|NCT00756106|Temozolomide|temozolomide|mesh-list
139556144|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139556145|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
139556146|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556147|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556148|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
139556149|NCT00243412|Rituximab|rituximab|mesh-list
139556150|NCT00243412|Methotrexate|methotrexate|mesh-list
139556151|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139556152|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556153|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
139556154|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556155|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139556156|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139556157|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
139556158|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139556159|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139556160|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
139556161|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556162|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
139556163|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556164|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139556165|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139556166|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139556167|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556168|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
139556169|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
139556170|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556171|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139556172|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
139556173|NCT00243412|Hormones|hormones|mesh-ancestor
139337786|NCT03667963|Lactulose|lactulose|mesh-list
139556174|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556175|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139556176|NCT00243412|Protective Agents|protective agents|mesh-ancestor
139556177|NCT00765232|Ketorolac|ketorolac|mesh-list
139556178|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139556179|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139556180|NCT00765232|Analgesics|analgesics|mesh-ancestor
139556181|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
139556182|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556183|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556184|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556185|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139556186|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139556187|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556188|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556189|NCT03805282|Lidocaine|lidocaine|mesh-list
139556190|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
139556191|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
139556192|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139556193|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556194|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
139556195|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556196|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139556197|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139556198|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139556199|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139556200|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556201|NCT03805750|Dronabinol|dronabinol|mesh-list
139556202|NCT03805750|Cannabidiol|cannabidiol|mesh-list
139556203|NCT03805750|Anticonvulsants|anticonvulsants|mesh-ancestor
139556204|NCT03805750|Hallucinogens|hallucinogens|mesh-ancestor
139556205|NCT03805750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556206|NCT03805750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139556207|NCT03805750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139556208|NCT03805750|Analgesics|analgesics|mesh-ancestor
139556209|NCT03805750|Sensory System Agents|sensory system agents|mesh-ancestor
139556210|NCT03805750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556211|NCT03805750|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139556212|NCT03805750|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139556213|NCT03805750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556214|NCT03805750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556215|NCT03805750|Hormones|hormones|mesh-ancestor
139556216|NCT03805750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556217|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139556218|NCT03804268|Pilocarpine|pilocarpine|mesh-list
139556219|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139556220|NCT03804268|Miotics|miotics|mesh-ancestor
139556221|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
139556222|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556223|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556224|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139556225|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139556226|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
139556227|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556228|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556229|NCT00765856|Oxymorphone|oxymorphone|mesh-list
139556230|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139556231|NCT00765856|Narcotics|narcotics|mesh-ancestor
139556232|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139556233|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556234|NCT00765856|Analgesics|analgesics|mesh-ancestor
139556235|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
139556236|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556237|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139556238|NCT00780208|Methylphenidate|methylphenidate|mesh-list
139556239|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139556240|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556241|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139556242|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139556243|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139556244|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556245|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
139556246|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556247|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
139556248|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
139556250|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
139556251|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556252|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
139556253|NCT00243022|Hematinics|hematinics|mesh-ancestor
139556254|NCT03805360|Ropivacaine|ropivacaine|mesh-list
139556255|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
139556256|NCT03805360|Anesthetics|anesthetics|mesh-list
139556257|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139556258|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556259|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
139556260|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556261|NCT00756964|Rasburicase|rasburicase|mesh-list
139556262|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
139556263|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139556264|NCT00780442|Cycloserine|cycloserine|mesh-list
139556265|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139556266|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139556267|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139556268|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
139556269|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139556270|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
139556271|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556272|NCT04384666|Rotigotine|rotigotine|mesh-list
139556273|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
139556274|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
139556275|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556276|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556277|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556278|NCT00767572|Atorvastatin|atorvastatin|mesh-list
139556279|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139556280|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139556281|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
139556282|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556283|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139026508|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556284|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139556285|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556286|NCT00780676|Dasatinib|dasatinib|mesh-list
139556287|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556288|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139556289|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556290|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556291|NCT00768118|Curcumin|curcumin|mesh-list
139556292|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139556293|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139556294|NCT00768118|Analgesics|analgesics|mesh-ancestor
139556295|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
139556296|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556297|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556298|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556299|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139556300|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556301|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556302|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556303|NCT04345432|Gabapentin|gabapentin|mesh-list
139556304|NCT04345432|Analgesics|analgesics|mesh-ancestor
139556305|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
139556306|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556307|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556308|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
139556309|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139556310|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139556311|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139556312|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139556313|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139556314|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139556315|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556316|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556317|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
139556318|NCT00757822|Dronabinol|dronabinol|mesh-list
139556319|NCT00757822|Ondansetron|ondansetron|mesh-list
139556320|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
139337955|NCT05436886|Gabapentin|gabapentin|mesh-list
139556321|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
139556322|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556323|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556325|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
139556326|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
139556327|NCT00757822|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139556328|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139556329|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
139556330|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556331|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556332|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
139556333|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139556334|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139556335|NCT00757822|Analgesics|analgesics|mesh-ancestor
139556336|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
139556337|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139556338|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139556339|NCT00757822|Hormones|hormones|mesh-ancestor
139556340|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556341|NCT00758836|Acetaminophen|acetaminophen|mesh-list
139556342|NCT00758836|Ibuprofen|ibuprofen|mesh-list
139556343|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139556344|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139556345|NCT00758836|Analgesics|analgesics|mesh-ancestor
139556346|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
139556347|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556348|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556349|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556350|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139556351|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139556352|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556353|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556354|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
139556355|NCT00769600|Itraconazole|itraconazole|mesh-list
139556356|NCT00769600|Pemetrexed|pemetrexed|mesh-list
139556357|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556358|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556359|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556360|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139556361|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139026605|NCT00331630|Paclitaxel|paclitaxel|mesh-list
139556362|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
139556363|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139556364|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139556365|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139556366|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139556367|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
139556368|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556369|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556370|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139556371|NCT03809650|Macitentan|macitentan|mesh-list
139556372|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139556373|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139556374|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556375|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139556376|NCT03809260|Metformin|metformin|mesh-list
139556377|NCT03809260|Vancomycin|vancomycin|mesh-list
139556378|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139556379|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556380|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139556381|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139556382|NCT01763905|Ezetimibe|ezetimibe|mesh-list
139556383|NCT01763905|Evolocumab|evolocumab|mesh-list
139556384|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139556385|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139556386|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139556387|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
139556388|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556389|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139556390|NCT01763905|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139556391|NCT01763905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139556392|NCT01763905|Protease Inhibitors|protease inhibitors|mesh-ancestor
139556393|NCT01763905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556394|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
139556395|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556397|NCT05743504|Cisplatin|cisplatin|mesh-list
139556398|NCT05743504|Atezolizumab|atezolizumab|mesh-list
139556399|NCT05743504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139556400|NCT05743504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556401|NCT05743504|Tubulin Modulators|tubulin modulators|mesh-ancestor
139556402|NCT05743504|Antimitotic Agents|antimitotic agents|mesh-ancestor
139556403|NCT05743504|Mitosis Modulators|mitosis modulators|mesh-ancestor
139556404|NCT05743504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556405|NCT05743504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139556406|NCT05743504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139556407|NCT03803254|Lenvatinib|lenvatinib|mesh-list
139556408|NCT03803254|Antibodies|antibodies|mesh-list
139556409|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
139556410|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556411|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556412|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139556413|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556414|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556415|NCT04730999|Bevacizumab|bevacizumab|mesh-list
139556416|NCT04730999|Atezolizumab|atezolizumab|mesh-list
139556417|NCT04730999|Carboplatin|carboplatin|mesh-list
139556418|NCT04730999|Etoposide|etoposide|mesh-list
139556419|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139556420|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556421|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139556422|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139556423|NCT04730999|Growth Substances|growth substances|mesh-ancestor
139556424|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556425|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
139556426|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139556427|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139556428|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139556429|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026663|NCT00301834|Cyclosporine|cyclosporine|mesh-list
139556430|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556431|NCT04730999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139556432|NCT00759772|Teriparatide|teriparatide|mesh-list
139556433|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139556434|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556435|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139556436|NCT01977677|Plerixafor|plerixafor|mesh-list
139556437|NCT01977677|Temozolomide|temozolomide|mesh-list
139556438|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139556439|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
139556440|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556441|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556442|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139556443|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139556444|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
139556445|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139556446|NCT04384744|Hormones|hormones|mesh-list
139556447|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556448|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556449|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
139556450|NCT01736215|Hematinics|hematinics|mesh-ancestor
139556451|NCT01786603|Rasagiline|rasagiline|mesh-list
139556452|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139556453|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556454|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556455|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139556456|NCT01786603|Protective Agents|protective agents|mesh-ancestor
139556457|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556458|NCT00786916|Lidocaine|lidocaine|mesh-list
139556459|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
139556460|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
139556461|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139556462|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556463|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
139556464|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556465|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139556466|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139556467|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139338092|NCT03131973|Leucovorin|leucovorin|mesh-list
139556468|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139556469|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556471|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
139556472|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
139556473|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556474|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139556475|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
139556476|NCT01619423|Edetic Acid|edetic acid|mesh-list
139556477|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
139556478|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139556479|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
139556480|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
139556481|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556482|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
139556483|NCT01619423|Vitamins|vitamins|mesh-ancestor
139556484|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
139556485|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556486|NCT03802552|Cephalexin|cephalexin|mesh-list
139556487|NCT03802552|Cefadroxil|cefadroxil|mesh-list
139556488|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139556489|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139556490|NCT01735279|Mineral Oil|mineral oil|mesh-list
139556491|NCT01735279|Emollients|emollients|mesh-ancestor
139556492|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
139556493|NCT03802318|Amoxicillin|amoxicillin|mesh-list
139556494|NCT03802318|Rabeprazole|rabeprazole|mesh-list
139556495|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139556496|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026739|NCT03926754|Mirabegron|mirabegron|mesh-list
139556497|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139556498|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139556499|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139556500|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556501|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556502|NCT01758523|Dutasteride|dutasteride|mesh-list
139556503|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139556504|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139556505|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556506|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556507|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
139556508|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556509|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556510|NCT00773422|Naltrexone|naltrexone|mesh-list
139556511|NCT00773422|Varenicline|varenicline|mesh-list
139556512|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139556513|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139556514|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556515|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
139556516|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556517|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139556518|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139556519|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
139556520|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556521|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556522|NCT00786994|Petrolatum|petrolatum|mesh-list
139556523|NCT00786994|Emollients|emollients|mesh-ancestor
139556524|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
139556525|NCT00774202|Prednisone|prednisone|mesh-list
139556526|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
139556527|NCT00774202|Rituximab|rituximab|mesh-list
139556528|NCT00774202|Vincristine|vincristine|mesh-list
139556529|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139556530|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
139026770|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139556531|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556532|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139556533|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139556534|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
139556535|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556536|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556537|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139556538|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139556539|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556540|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
139556541|NCT00774202|Hormones|hormones|mesh-ancestor
139556542|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556543|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139556544|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139556545|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
139556546|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
139556547|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
139556549|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139556550|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556551|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139556552|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556553|NCT03802162|Memantine|memantine|mesh-list
139556554|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139556555|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139556556|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
139556557|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556558|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556559|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556560|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139026808|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556561|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139556562|NCT01757275|Esomeprazole|esomeprazole|mesh-list
139556563|NCT01757275|Cimetidine|cimetidine|mesh-list
139556564|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139556565|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139556566|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139556567|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556568|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556569|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139556570|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
139556571|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
139556572|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556573|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556574|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139556575|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139556576|NCT00787852|Paclitaxel|paclitaxel|mesh-list
139556577|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139556578|NCT00787852|Dasatinib|dasatinib|mesh-list
139556579|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139556580|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556581|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
139556582|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
139556583|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
139556584|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556585|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139556586|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556587|NCT00788008|Propofol|propofol|mesh-list
139556588|NCT00788008|Isoflurane|isoflurane|mesh-list
139556589|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
139556590|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139556591|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556592|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139556593|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139556594|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
139556595|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139556596|NCT00760006|Ampicillin|ampicillin|mesh-list
139556597|NCT00760006|Sulbactam|sulbactam|mesh-list
139556598|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139556599|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139556600|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139556601|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139556602|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556603|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556604|NCT01784965|Liraglutide|liraglutide|mesh-list
139556605|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139556606|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556607|NCT01784965|Incretins|incretins|mesh-ancestor
139556608|NCT01784965|Hormones|hormones|mesh-ancestor
139556609|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556610|NCT05742724|Dronabinol|dronabinol|mesh-list
139556611|NCT05742724|Nabiximols|nabiximols|mesh-list
139556612|NCT05742724|Cannabidiol|cannabidiol|mesh-list
139556613|NCT05742724|Anticonvulsants|anticonvulsants|mesh-ancestor
139556614|NCT05742724|Hallucinogens|hallucinogens|mesh-ancestor
139556615|NCT05742724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556616|NCT05742724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139338238|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
139556617|NCT05742724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139556618|NCT05742724|Analgesics|analgesics|mesh-ancestor
139556619|NCT05742724|Sensory System Agents|sensory system agents|mesh-ancestor
139556620|NCT05742724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556621|NCT05742724|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139556622|NCT05742724|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139556623|NCT05742724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556624|NCT05742724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556625|NCT05742724|Hormones|hormones|mesh-ancestor
139556626|NCT05742724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556627|NCT01784419|Ivacaftor|ivacaftor|mesh-list
139556628|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139556629|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139556630|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556631|NCT01784029|Vitamin D|vitamin d|mesh-list
139556632|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
139556633|NCT01784029|Vitamins|vitamins|mesh-ancestor
139556634|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
139556635|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556636|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139556637|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139556638|NCT00789256|Bortezomib|bortezomib|mesh-list
139556639|NCT00789256|Melphalan|melphalan|mesh-list
139556640|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556641|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139556642|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
139556643|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556644|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139556645|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139556646|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
139556647|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556648|NCT01733329|Folic Acid|folic acid|mesh-list
139556649|NCT01733329|Misoprostol|misoprostol|mesh-list
139556650|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139556651|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
139556652|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139556653|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556654|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139556655|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139556656|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
139556657|NCT01733329|Hematinics|hematinics|mesh-ancestor
139556658|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
139556659|NCT01733329|Vitamins|vitamins|mesh-ancestor
139556660|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
139556661|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
139556662|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139556663|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139556664|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139556665|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139556666|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556667|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
139556668|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556669|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556670|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139556671|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556672|NCT01607593|Sertraline|sertraline|mesh-list
139556673|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
139556674|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139556675|NCT01607593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139556676|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139556677|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139556678|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556679|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556680|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
139556681|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556682|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139556683|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139556684|NCT01755637|Albendazole|albendazole|mesh-list
139556685|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
139556686|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139556687|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139556688|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
139556689|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139556690|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139556691|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
139556692|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
139556693|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
139556694|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556695|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556696|NCT03801226|Calcium|calcium|mesh-list
139556697|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139556698|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556699|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
139556700|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556701|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139556702|NCT02148874|Vaccines|vaccines|mesh-list
139556703|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
139556704|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556705|NCT01755091|Dronabinol|dronabinol|mesh-list
139556706|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
139556707|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556708|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139556709|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139556710|NCT01755091|Analgesics|analgesics|mesh-ancestor
139556711|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
139556712|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556713|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139556714|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139556715|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556716|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556717|NCT01755091|Hormones|hormones|mesh-ancestor
139556718|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556719|NCT00789802|Naproxen|naproxen|mesh-list
139556720|NCT00789802|Estradiol|estradiol|mesh-list
139556721|NCT00789802|Estrogens|estrogens|mesh-ancestor
139556722|NCT00789802|Hormones|hormones|mesh-ancestor
139556723|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556724|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556725|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139556726|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139556727|NCT00789802|Analgesics|analgesics|mesh-ancestor
139556728|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
139556729|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556730|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556731|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139556732|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
139556733|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139556734|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556735|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556736|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
139556737|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139556738|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556739|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139556740|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139556741|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139556742|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
139556743|NCT01783015|Etanercept|etanercept|mesh-list
139556744|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139556745|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139556746|NCT01783015|Analgesics|analgesics|mesh-ancestor
139556747|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
139556748|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556749|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556750|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556751|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139556752|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139556753|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139556754|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
139556755|NCT01782859|Prednisone|prednisone|mesh-list
139556756|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
139556757|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139556758|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139556759|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139556760|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556761|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
139556762|NCT01782859|Hormones|hormones|mesh-ancestor
139027035|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556763|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556764|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556765|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139556766|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556767|NCT01782313|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139556769|NCT01782313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139556770|NCT01782313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556771|NCT01782313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556772|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139556773|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139556774|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
139556775|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139556776|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139556777|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139027102|NCT00300274|Everolimus|everolimus|mesh-list
139556778|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139556779|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556780|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139556781|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139556782|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139556783|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
139556784|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556785|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556786|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139556787|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139556788|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
139556789|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139556790|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139556791|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
139556792|NCT01781611|Aspirin|aspirin|mesh-list
139556793|NCT01781611|Dipyridamole|dipyridamole|mesh-list
139556794|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139556795|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139556796|NCT01781611|Analgesics|analgesics|mesh-ancestor
139556797|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
139556798|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556799|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556800|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556801|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139556802|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139556803|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139027158|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
139556804|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556805|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139556806|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139556807|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556808|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
139556809|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139556810|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
139556811|NCT00790270|Ibuprofen|ibuprofen|mesh-list
139556812|NCT00790270|Amitriptyline|amitriptyline|mesh-list
139556813|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
139556814|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139556815|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139556816|NCT00790270|Analgesics|analgesics|mesh-ancestor
139556817|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
139556818|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556819|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556820|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556821|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139556822|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139556823|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556824|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556825|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139556826|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
139556827|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139556828|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139556829|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139556830|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139556831|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139556832|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139556833|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139556834|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139556835|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
139556836|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556837|NCT01780987|Heparin|heparin|mesh-list
139556838|NCT01780987|Calcium heparin|calcium heparin|mesh-list
139556839|NCT01780987|Warfarin|warfarin|mesh-list
139556840|NCT01780987|Apixaban|apixaban|mesh-list
139556841|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
139556842|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139556843|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139556844|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027255|NCT01011062|Losartan|losartan|mesh-list
139556845|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139556846|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
139556847|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139556848|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
139556849|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556850|NCT03800290|Clenbuterol|clenbuterol|mesh-list
139556851|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139556852|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139556853|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
139556854|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556855|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556856|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556857|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139556858|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
139556859|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556860|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139556861|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
139556862|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
139556863|NCT05709184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139556864|NCT05709184|Vancomycin|vancomycin|mesh-list
139556865|NCT05709184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139556866|NCT03831334|Minoxidil|minoxidil|mesh-list
139556867|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139556868|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
139556869|NCT00809848|Bimatoprost|bimatoprost|mesh-list
139556870|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139556871|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139556872|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139556873|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139556874|NCT01730053|Ezetimibe|ezetimibe|mesh-list
139556875|NCT01730053|Alirocumab|alirocumab|mesh-list
139556876|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139556877|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139556878|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
139556879|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556880|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139556881|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139556882|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556883|NCT01730053|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139556884|NCT01730053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139556885|NCT01730053|Protease Inhibitors|protease inhibitors|mesh-ancestor
139556886|NCT01751113|Fluticasone|fluticasone|mesh-list
139556887|NCT01751113|Xhance|xhance|mesh-list
139556888|NCT01751113|Bromides|bromides|mesh-list
139556889|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
139556890|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139556891|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139556892|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556893|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139556894|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
139556895|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556896|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556897|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139556898|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
139556899|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
139556900|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139556901|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
139556902|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139556903|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
139556904|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139556905|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556906|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139556907|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139556908|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139556909|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
139556910|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
139556911|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
139556912|NCT01751113|Hormones|hormones|mesh-ancestor
139556913|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556914|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
139556915|NCT01719380|Cetuximab|cetuximab|mesh-list
139556916|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139556917|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556919|NCT00792142|Dexamethasone|dexamethasone|mesh-list
139556920|NCT00792142|Bortezomib|bortezomib|mesh-list
139556921|NCT00792142|Melphalan|melphalan|mesh-list
139556922|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139556923|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
139556924|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
139556925|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139556926|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556927|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139556928|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
139556929|NCT00792142|Hormones|hormones|mesh-ancestor
139556930|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556931|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139556932|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556933|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139556934|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
139556935|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556936|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139556937|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139556938|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
139556939|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
139556940|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139556941|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139556942|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139556943|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139556944|NCT00792142|Growth Substances|growth substances|mesh-ancestor
139556945|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
139556946|NCT05640778|Cyclophosphamide|cyclophosphamide|mesh-list
139556947|NCT05640778|Taxane|taxane|mesh-list
139556948|NCT05640778|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139556949|NCT05640778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139027402|NCT00950261|Cisplatin|cisplatin|mesh-list
139556950|NCT05640778|Immunologic Factors|immunologic factors|mesh-ancestor
139556951|NCT05640778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556952|NCT05640778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139556953|NCT05640778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139556954|NCT05640778|Alkylating Agents|alkylating agents|mesh-ancestor
139556955|NCT05640778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556956|NCT05640778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556957|NCT05640778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139556958|NCT05640778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139556959|NCT05640778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556960|NCT05640778|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139556961|NCT05640778|Hormone Antagonists|hormone antagonists|mesh-ancestor
139556962|NCT05640778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556963|NCT01743560|Everolimus|everolimus|mesh-list
139556964|NCT01743560|Exemestane|exemestane|mesh-list
139556965|NCT01743560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139556966|NCT01743560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139556967|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556968|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556969|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139556970|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
139556971|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556972|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139556973|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139027433|NCT00494780|Prednisone|prednisone|mesh-list
139556974|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139556975|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139556976|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
139556977|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139556978|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
139556979|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139556980|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
139556981|NCT00792922|Azithromycin|azithromycin|mesh-list
139556982|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139556983|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139556984|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
139556985|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139556986|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139556987|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
139556988|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139556989|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139556990|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139556991|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139556992|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139556993|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
139556994|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139556995|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139556996|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139556997|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139556998|NCT04382170|Analgesics|analgesics|mesh-ancestor
139556999|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
139557000|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557001|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139557002|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139557003|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139557004|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
139557005|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557006|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557007|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139557008|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
139557009|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139557010|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
139557011|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139557012|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557013|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139557014|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139557015|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557016|NCT04718350|Simendan|simendan|mesh-list
139557017|NCT04718350|Milrinone|milrinone|mesh-list
139557018|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139557019|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
139557020|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139557021|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139557022|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557023|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557024|NCT04718350|Protective Agents|protective agents|mesh-ancestor
139557025|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557026|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139557027|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139557028|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139557029|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139557030|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139557031|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
139557032|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557033|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557034|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557035|NCT01729819|Urological Agents|urological agents|mesh-ancestor
139557036|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
139557037|NCT01729819|Coagulants|coagulants|mesh-ancestor
139557038|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139557039|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
139557040|NCT00811564|Timolol|timolol|mesh-list
139557041|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139557042|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139557043|NCT00811564|Latanoprost|latanoprost|mesh-list
139557044|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139557045|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557046|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139557047|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139557048|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
139557049|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557050|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557051|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139557052|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139557053|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139557054|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139557055|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139557056|NCT01709084|Tenofovir|tenofovir|mesh-list
139557057|NCT01709084|Emtricitabine|emtricitabine|mesh-list
139557058|NCT01709084|Efavirenz|efavirenz|mesh-list
139557059|NCT01709084|Rilpivirine|rilpivirine|mesh-list
139557060|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
139557061|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557062|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139557063|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139557064|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557065|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557066|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139338693|NCT03699839|Vaccines|vaccines|mesh-list
139557067|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139557068|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139557069|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139557070|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139557071|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139557072|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139557073|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139557074|NCT01741532|Deferiprone|deferiprone|mesh-list
139557075|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139557076|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
139557077|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
139557078|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557079|NCT01727713|Aripiprazole|aripiprazole|mesh-list
139557080|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
139557081|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139557082|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139557083|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139557084|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557085|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557086|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
139557087|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
139557088|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557089|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557090|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139557091|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139557092|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
139557093|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139557094|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139557095|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139557096|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139557097|NCT04658927|Dexamethasone|dexamethasone|mesh-list
139557098|NCT04658927|Prednisone|prednisone|mesh-list
139557099|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139557100|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
139557101|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
139557102|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557103|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557104|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139557105|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
139557106|NCT04658927|Hormones|hormones|mesh-ancestor
139557107|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139557108|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139557109|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557110|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
139557111|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139557112|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557113|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139557114|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139557115|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557116|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557117|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557118|NCT01976507|Dabigatran|dabigatran|mesh-list
139557119|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
139557120|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139557121|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
139557122|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557123|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557124|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
139557125|NCT01964963|Alogliptin|alogliptin|mesh-list
139557126|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139557127|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557128|NCT01964963|Incretins|incretins|mesh-ancestor
139557129|NCT01964963|Hormones|hormones|mesh-ancestor
139557130|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139557131|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139557132|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
139557133|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557134|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557135|NCT01974323|Dapsone|dapsone|mesh-list
139557136|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557137|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
139557138|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139557139|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139557140|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139557141|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557142|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557143|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
139557144|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139557145|NCT01973387|Rituximab|rituximab|mesh-list
139557146|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139557147|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557148|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
139557149|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557150|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139557151|NCT01973231|Liraglutide|liraglutide|mesh-list
139557152|NCT01973231|Lixisenatide|lixisenatide|mesh-list
139557153|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139557154|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557155|NCT01973231|Incretins|incretins|mesh-ancestor
139557156|NCT01973231|Hormones|hormones|mesh-ancestor
139557157|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139557158|NCT02151994|Zamicastat|zamicastat|mesh-list
139557159|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557160|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557161|NCT04382950|Tretinoin|tretinoin|mesh-list
139557162|NCT04382950|Isotretinoin|isotretinoin|mesh-list
139557163|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557164|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
139557165|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
139557166|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
139557167|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139557168|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557169|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557170|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139557171|NCT04383418|Analgesics|analgesics|mesh-ancestor
139557172|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
139557173|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557174|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139557175|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139557176|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139557177|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
139557178|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557179|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557180|NCT03414112|Oxytocin|oxytocin|mesh-list
139557181|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
139557182|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139557183|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557184|NCT03839134|Lidocaine|lidocaine|mesh-list
139557185|NCT03839134|Epinephrine|epinephrine|mesh-list
139557186|NCT03839134|Racepinephrine|racepinephrine|mesh-list
139557187|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
139557188|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
139557189|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
139027745|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557190|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557191|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557192|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
139557193|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557194|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139557195|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139557196|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139557197|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139557198|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557199|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139557200|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139557201|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
139557202|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557203|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139557204|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139557205|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
139557206|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139557207|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
139027800|NCT00299494|Rituximab|rituximab|mesh-list
139557208|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
139557209|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
139557210|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139557211|NCT03906526|Nivolumab|nivolumab|mesh-list
139557212|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139557213|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557214|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139557215|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557216|NCT03088930|Crizotinib|crizotinib|mesh-list
139557217|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557218|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139557219|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557220|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557221|NCT02152696|Methotrexate|methotrexate|mesh-list
139557222|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139557223|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
139557224|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139557225|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557226|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139557227|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
139557228|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557229|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557230|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
139557231|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557232|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139557233|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139557234|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
139557235|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139557236|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139557237|NCT01905436|Ivermectin|ivermectin|mesh-list
139557238|NCT01905436|Albendazole|albendazole|mesh-list
139557239|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139557240|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557241|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
139557242|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
139557243|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139557244|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139557245|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
139557246|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
139557247|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
139557248|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557249|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557250|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
139557251|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139557252|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
139557253|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557254|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557255|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139557256|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
139557257|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139557258|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139557259|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139557260|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
139557261|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557262|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557263|NCT01149850|Bevacizumab|bevacizumab|mesh-list
139557264|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139557265|NCT01149850|Temozolomide|temozolomide|mesh-list
139557266|NCT01149850|Antibodies|antibodies|mesh-list
139557267|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
139557268|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139557269|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557270|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139557271|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139557272|NCT01149850|Growth Substances|growth substances|mesh-ancestor
139557273|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557274|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
139557275|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
139557276|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139557277|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
139557278|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557279|NCT01972841|Mirabegron|mirabegron|mesh-list
139557280|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
139557281|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139557282|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139557283|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139557284|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
139557285|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557286|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557287|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557288|NCT01972841|Urological Agents|urological agents|mesh-ancestor
139557289|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139338915|NCT02681510|Nicotine|nicotine|mesh-list
139557290|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139557291|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
139557292|NCT01774903|Fentanyl|fentanyl|mesh-list
139557293|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139557294|NCT01774903|Narcotics|narcotics|mesh-ancestor
139027930|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557295|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557296|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557297|NCT01774903|Analgesics|analgesics|mesh-ancestor
139557298|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
139557299|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557300|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139557301|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139557302|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
139557303|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
139557304|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139557305|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139557306|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139557307|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557308|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
139557309|NCT01708915|Capsaicin|capsaicin|mesh-list
139557310|NCT01708915|Nonivamide|nonivamide|mesh-list
139557311|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
139557312|NCT01708915|Vitamins|vitamins|mesh-ancestor
139557313|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
139557314|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557315|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
139557316|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557317|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
139557318|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
139557319|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
139557320|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139557321|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
139557322|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557323|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557324|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139557325|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
139027978|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
139557326|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
139557327|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139557328|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
139557329|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557330|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557331|NCT01747915|Pregabalin|pregabalin|mesh-list
139557332|NCT01747915|Analgesics|analgesics|mesh-ancestor
139557333|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
139557334|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557335|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557336|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
139557337|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139557338|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139557339|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557340|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139557341|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139557342|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139557343|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557344|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139557345|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
139557346|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139557347|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139557348|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
139557349|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
139557350|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557351|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557352|NCT04656041|Paclitaxel|paclitaxel|mesh-list
139557353|NCT04656041|Carboplatin|carboplatin|mesh-list
139557354|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139557355|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557356|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
139557357|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
139557358|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
139557359|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557360|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139557361|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
139557362|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139557363|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139557364|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139557365|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557366|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557367|NCT01970501|Metoprolol|metoprolol|mesh-list
139557368|NCT01970501|Bucindolol|bucindolol|mesh-list
139557369|NCT01970501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139557370|NCT01970501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139557371|NCT01970501|Sympatholytics|sympatholytics|mesh-ancestor
139557372|NCT01970501|Autonomic Agents|autonomic agents|mesh-ancestor
139557373|NCT01970501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557374|NCT01970501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028065|NCT00551135|Pregabalin|pregabalin|mesh-list
139557375|NCT01970501|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139557376|NCT01970501|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139557377|NCT01970501|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139557378|NCT01970501|Adrenergic Agents|adrenergic agents|mesh-ancestor
139557379|NCT01970501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557380|NCT01970501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557381|NCT01970501|Sympathomimetics|sympathomimetics|mesh-ancestor
139557382|NCT01970501|Vasodilator Agents|vasodilator agents|mesh-ancestor
139557383|NCT01970501|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139557384|NCT01970501|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139557385|NCT01969799|Amikacin|amikacin|mesh-list
139557386|NCT01969799|Fosfomycin|fosfomycin|mesh-list
139557387|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139557388|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557389|NCT01969721|Fluticasone|fluticasone|mesh-list
139557390|NCT01969721|Xhance|xhance|mesh-list
139557391|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
139557392|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139557393|NCT01969721|Olodaterol|olodaterol|mesh-list
139557394|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139557395|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139557396|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
139557397|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557398|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557399|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139557400|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
139557401|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
139557402|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139557403|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
139557404|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139557405|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
139557406|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557407|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557408|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139557409|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139557410|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139557411|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
139557412|NCT01969565|Dexamethasone|dexamethasone|mesh-list
139557413|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139557414|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
139557415|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
139557416|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557417|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557418|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139557419|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
139557420|NCT01969565|Hormones|hormones|mesh-ancestor
139557421|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139557422|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139557423|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557424|NCT01968707|Ethanol|ethanol|mesh-list
139557425|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
139557426|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139557427|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139557428|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557429|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557430|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557431|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
139557432|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
139557433|NCT01746901|Naltrexone|naltrexone|mesh-list
139557434|NCT01746901|Oxycodone|oxycodone|mesh-list
139557435|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139557436|NCT01746901|Narcotics|narcotics|mesh-ancestor
139557437|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557438|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557439|NCT01746901|Analgesics|analgesics|mesh-ancestor
139339085|NCT03485625|Acetaminophen|acetaminophen|mesh-list
139557440|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
139557441|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557443|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139557444|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139557445|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139557446|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139557447|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
139557448|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557449|NCT01946165|Prednisone|prednisone|mesh-list
139557450|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
139557451|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139557452|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
139557453|NCT01946165|Hormones|hormones|mesh-ancestor
139557454|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139557455|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557456|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139557457|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557458|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139557459|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557460|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557461|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
139557462|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139557463|NCT01707667|Prucalopride|prucalopride|mesh-list
139557464|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139557465|NCT01707667|Laxatives|laxatives|mesh-ancestor
139557466|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139557467|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139557468|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139557469|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
139557470|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557471|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557472|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557473|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139557474|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
139557475|NCT01959503|Coagulants|coagulants|mesh-ancestor
139557476|NCT01706575|Interferons|interferons|mesh-list
139557477|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557478|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
139557479|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557480|NCT01725529|Ribavirin|ribavirin|mesh-list
139557481|NCT01725529|Simeprevir|simeprevir|mesh-list
139557482|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
139557483|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557484|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
139557485|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557486|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
139557487|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557488|NCT01744093|Doxycycline|doxycycline|mesh-list
139557489|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139557490|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557491|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
139557492|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139557493|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139557494|NCT01725451|Testosterone|testosterone|mesh-list
139557495|NCT01725451|Androgens|androgens|mesh-ancestor
139557496|NCT01725451|Hormones|hormones|mesh-ancestor
139557497|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139557498|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557499|NCT01707290|Ivacaftor|ivacaftor|mesh-list
139557500|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139557501|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139557502|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557503|NCT01717040|Pioglitazone|pioglitazone|mesh-list
139557504|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139557505|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557506|NCT00803062|Paclitaxel|paclitaxel|mesh-list
139557507|NCT00803062|Bevacizumab|bevacizumab|mesh-list
139557508|NCT00803062|Cisplatin|cisplatin|mesh-list
139557509|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139557510|NCT00803062|Topotecan|topotecan|mesh-list
139557511|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139557512|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
139557513|NCT00803062|Antibodies|antibodies|mesh-list
139557514|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
139557515|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139557516|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
139339142|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139557517|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139557518|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557519|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
139557520|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
139557521|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
139557522|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557523|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139557524|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139557525|NCT00803062|Growth Substances|growth substances|mesh-ancestor
139557526|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557527|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
139557528|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
139557529|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139557530|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139557531|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557532|NCT01743001|Macitentan|macitentan|mesh-list
139557533|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139557534|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139557535|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557536|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139557537|NCT01704079|Calcifediol|calcifediol|mesh-list
139557538|NCT01704079|Vitamins|vitamins|mesh-ancestor
139557539|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
139557540|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557541|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139557542|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
139557543|NCT01703845|Olodaterol|olodaterol|mesh-list
139557544|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139557545|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
139557546|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557547|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557548|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139557549|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
139557550|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
139557551|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139557552|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
139557553|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557554|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557555|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139557556|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139557557|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139557558|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557559|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557560|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139557561|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139557562|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139557563|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
139557564|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557565|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557566|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139557567|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139557568|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
139557569|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139557570|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139557571|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557572|NCT01703221|Incretins|incretins|mesh-ancestor
139557573|NCT01703221|Hormones|hormones|mesh-ancestor
139557574|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139557575|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139557576|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
139557577|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557578|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557579|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
139557580|NCT00803686|Calcitonin|calcitonin|mesh-list
139557581|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139557582|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557583|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139557584|NCT00823966|Delavirdine|delavirdine|mesh-list
139557585|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139557586|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139557587|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557588|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557589|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
139557590|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557591|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139557592|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139557593|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
139557594|NCT01702987|Atorvastatin|atorvastatin|mesh-list
139557595|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139557596|NCT01702987|Simvastatin|simvastatin|mesh-list
139557597|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139557598|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139557599|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
139557600|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557601|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139557602|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139557603|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557604|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
139557605|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557607|NCT00824044|Escitalopram|escitalopram|mesh-list
139557608|NCT00824044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139557609|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139557610|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139557611|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557612|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557613|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
139557614|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557615|NCT01702519|Nicotine|nicotine|mesh-list
139557616|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139557617|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
139557618|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557619|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557620|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139557621|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139557622|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
139557623|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557624|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557625|NCT01739335|Mifepristone|mifepristone|mesh-list
139557626|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139557627|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
139557628|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139557629|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557630|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139557631|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139557632|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139557633|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
139557634|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139557635|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139557636|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
139557637|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139557638|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
139557639|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139557640|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139557641|NCT00824746|Gefitinib|gefitinib|mesh-list
139557642|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557643|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139557644|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557645|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557646|NCT01722097|Rocuronium|rocuronium|mesh-list
139557647|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139557648|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139557649|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139557650|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557651|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557652|NCT00824824|Timolol|timolol|mesh-list
139557653|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139557654|NCT00824824|Dorzolamide|dorzolamide|mesh-list
139557655|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139557656|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139557657|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
139557658|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557659|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557660|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557661|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139339295|NCT04460547|Ivermectin|ivermectin|mesh-list
139557662|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139557663|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139557664|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139557665|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139557666|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139557667|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557668|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139557669|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139557670|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557672|NCT01701973|Hormones|hormones|mesh-ancestor
139557673|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139557674|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139557675|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
139557676|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557677|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557678|NCT00825370|Hydromorphone|hydromorphone|mesh-list
139557679|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139557680|NCT00825370|Narcotics|narcotics|mesh-ancestor
139557681|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557682|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557683|NCT00825370|Analgesics|analgesics|mesh-ancestor
139557684|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
139557685|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557686|NCT01721317|Ezogabine|ezogabine|mesh-list
139557687|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
139557688|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139557689|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557690|NCT00828412|Desonide|desonide|mesh-list
139557691|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139557692|NCT01959035|Aripiprazole|aripiprazole|mesh-list
139557693|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
139557694|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139557695|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139557696|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139557697|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557698|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557699|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
139557700|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
139557701|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557702|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557703|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139557704|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139557705|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
139557706|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139557707|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139557708|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139557709|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139557710|NCT01700959|Melatonin|melatonin|mesh-list
139557711|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
139557712|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557713|NCT01700959|Protective Agents|protective agents|mesh-ancestor
139557714|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557715|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557716|NCT00829738|Pantoprazole|pantoprazole|mesh-list
139557717|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139557718|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139557719|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139557720|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557721|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557722|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
139557723|NCT01737931|Promethazine|promethazine|mesh-list
139557724|NCT01737931|Dexamethasone|dexamethasone|mesh-list
139557725|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139557726|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
139557727|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139557728|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
139557729|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
139557730|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557731|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557732|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139557733|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
139557734|NCT01737931|Hormones|hormones|mesh-ancestor
139557735|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139557736|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139557737|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557738|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139557739|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139557740|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557741|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
139557742|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
139557743|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
139557744|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
139557745|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557746|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557747|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139557748|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
139557749|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
139557750|NCT01958489|Pravastatin|pravastatin|mesh-list
139557751|NCT01958489|Evacetrapib|evacetrapib|mesh-list
139557752|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139557753|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139557754|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
139557755|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557756|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139557757|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139557758|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557759|NCT00830362|Propranolol|propranolol|mesh-list
139557760|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139557761|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139557762|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
139557763|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557764|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557765|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557766|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139557767|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139557768|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
139557769|NCT01944839|Ranibizumab|ranibizumab|mesh-list
139557770|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139557771|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139557772|NCT01944839|Growth Substances|growth substances|mesh-ancestor
139557773|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557774|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
139557775|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557776|NCT01720225|Azacitidine|azacitidine|mesh-list
139557777|NCT01720225|Decitabine|decitabine|mesh-list
139557778|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139557779|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
139557780|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557781|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557782|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557783|NCT01943435|Acetaminophen|acetaminophen|mesh-list
139557784|NCT01943435|Ibuprofen|ibuprofen|mesh-list
139557785|NCT01943435|Celecoxib|celecoxib|mesh-list
139557786|NCT01943435|Diclofenac|diclofenac|mesh-list
139557787|NCT01943435|Gabapentin|gabapentin|mesh-list
139557788|NCT01943435|Tramadol|tramadol|mesh-list
139557789|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139557790|NCT01943435|Analgesics|analgesics|mesh-list
139557791|NCT01943435|Mirtazapine|mirtazapine|mesh-list
139557792|NCT01943435|Trazodone|trazodone|mesh-list
139557793|NCT01943435|Sertraline|sertraline|mesh-list
139557794|NCT01943435|Nortriptyline|nortriptyline|mesh-list
139557795|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
139557796|NCT01943435|Misoprostol|misoprostol|mesh-list
139557797|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139557798|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
139557799|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557800|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557801|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
139557802|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139557803|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139557804|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139557805|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139557806|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557807|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557808|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139557809|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139557810|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
139557811|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139557812|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139557813|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139557814|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
139557815|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
139557816|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139557817|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139557818|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557819|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139557820|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139557821|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139557822|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557823|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
139557824|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139557825|NCT01943435|Narcotics|narcotics|mesh-ancestor
139557826|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139557827|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139557828|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139557829|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
139557830|NCT01943435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139557831|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
139557832|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139557833|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
139557834|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
139557835|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139557836|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139557837|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139557838|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
139557839|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139557840|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139557841|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139557842|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139557843|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139557844|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139557845|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
139557846|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
139557847|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557848|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557849|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557850|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
139557851|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
139557852|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139557853|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139557854|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
139557855|NCT00807586|Prednisolone|prednisolone|mesh-list
139557856|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
139557857|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139557858|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
139557859|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139557860|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
139557861|NCT00807586|Hormones|hormones|mesh-ancestor
139557862|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139557863|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557864|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139557865|NCT00807586|Protective Agents|protective agents|mesh-ancestor
139557866|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139557867|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557868|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
139557869|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
139557870|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557871|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139557872|NCT01698775|Glipizide|glipizide|mesh-list
139557873|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139557874|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557875|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
139557876|NCT01941095|Chloroquine|chloroquine|mesh-list
139557877|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
139557878|NCT01941095|Methotrexate|methotrexate|mesh-list
139557879|NCT01941095|Azathioprine|azathioprine|mesh-list
139557880|NCT01941095|Leflunomide|leflunomide|mesh-list
139557881|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139557882|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
139557883|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139557884|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557885|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139557886|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
139557887|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557888|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557889|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
139557890|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557891|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139557892|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139557893|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
139557894|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139557895|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139557896|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
139557897|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139557898|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139557899|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557900|NCT01941095|Amebicides|amebicides|mesh-ancestor
139557901|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139557902|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139557903|NCT01941095|Analgesics|analgesics|mesh-ancestor
139557904|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
139557905|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557906|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139557907|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139557908|NCT00831766|Cytarabine|cytarabine|mesh-list
139557909|NCT00831766|Lenalidomide|lenalidomide|mesh-list
139557910|NCT00831766|Idarubicin|idarubicin|mesh-list
139557911|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
139557912|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139557913|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
139557914|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557915|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
139557916|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557917|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139557918|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
139557919|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557920|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139557921|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139557922|NCT00831766|Growth Substances|growth substances|mesh-ancestor
139557923|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
139557924|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139557925|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139557926|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139557927|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557928|NCT01957709|Interferons|interferons|mesh-list
139557929|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
139557930|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557931|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
139557932|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557933|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139557934|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139557935|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557936|NCT00832390|Incretins|incretins|mesh-ancestor
139557937|NCT00832390|Hormones|hormones|mesh-ancestor
139557938|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139557939|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139557940|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
139557941|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557942|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557943|NCT00844090|Methylphenidate|methylphenidate|mesh-list
139557944|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139557945|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557946|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139557947|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139557948|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139557949|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557950|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
139557951|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557952|NCT00844714|Rituximab|rituximab|mesh-list
139557953|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139557954|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557955|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
139557956|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557957|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139557958|NCT00834652|Metformin|metformin|mesh-list
139557959|NCT00834652|Sertraline|sertraline|mesh-list
139557960|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139557961|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557962|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
139557963|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139557964|NCT00834652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139557965|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139557966|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139557967|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557968|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139557969|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
139557970|NCT00834808|Tramadol|tramadol|mesh-list
139557971|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139557972|NCT00834808|Narcotics|narcotics|mesh-ancestor
139557973|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557974|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557975|NCT00834808|Analgesics|analgesics|mesh-ancestor
139557976|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
139557977|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139557978|NCT00850096|Insulin|insulin|mesh-list
139557979|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139557980|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557981|NCT00834886|Melatonin|melatonin|mesh-list
139557982|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
139557983|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557984|NCT00834886|Protective Agents|protective agents|mesh-ancestor
139557985|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139557986|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139557987|NCT00835198|Dapsone|dapsone|mesh-list
139557988|NCT00835198|Tretinoin|tretinoin|mesh-list
139557989|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139557990|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
139557991|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
139557992|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139557993|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
139557994|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139557995|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139557996|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139557997|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139557998|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139557999|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
139558000|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139558001|NCT00835510|Butenafine|butenafine|mesh-list
139558002|NCT00835510|Clotrimazole|clotrimazole|mesh-list
139558003|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
139558004|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558005|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139558006|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139558007|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139558008|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558009|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558010|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139558011|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
139558012|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139558013|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558014|NCT00835900|Varenicline|varenicline|mesh-list
139558015|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139558016|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139558017|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
139558018|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558019|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558020|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558021|NCT01954121|Carbamazepine|carbamazepine|mesh-list
139558022|NCT01954121|Levetiracetam|levetiracetam|mesh-list
139558023|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
139558024|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
139558025|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
139558026|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139558027|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139558028|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558029|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139558030|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139558031|NCT01954121|Analgesics|analgesics|mesh-ancestor
139558032|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
139558033|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558034|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139558035|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139558036|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558037|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139558038|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139558039|NCT00838162|Ritonavir|ritonavir|mesh-list
139558040|NCT00838162|TMC-310911|tmc-310911|mesh-list
139558041|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139558042|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139558043|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
139028923|NCT00954785|Diclofenac|diclofenac|mesh-list
139558044|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558045|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558046|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139558047|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139558048|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
139558049|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558050|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139558051|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139558052|NCT00841204|Sulindac|sulindac|mesh-list
139558053|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139558054|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139558055|NCT00841204|Analgesics|analgesics|mesh-ancestor
139558056|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
139558057|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558058|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558059|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558060|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139558061|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558062|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139558063|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558064|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558065|NCT00853840|Maraviroc|maraviroc|mesh-list
139558066|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139558067|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139558068|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139558069|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558070|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139558071|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139558072|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
139558073|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558074|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139558075|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
139558076|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139558077|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139558078|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558079|NCT00853840|Urological Agents|urological agents|mesh-ancestor
139558080|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
139558081|NCT00841828|Docetaxel|docetaxel|mesh-list
139558082|NCT00841828|Trastuzumab|trastuzumab|mesh-list
139558083|NCT00841828|Epirubicin|epirubicin|mesh-list
139558084|NCT00841828|Lapatinib|lapatinib|mesh-list
139558085|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139558086|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
139558087|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558088|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139558089|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139558090|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
139558091|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558092|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558093|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139558094|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
139558095|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
139558096|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
139558097|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139558098|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139558099|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139558100|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139558101|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558102|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139558103|NCT00855010|Pioglitazone|pioglitazone|mesh-list
139558104|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139558105|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558106|NCT00842608|Haloperidol|haloperidol|mesh-list
139558107|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
139558108|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139558109|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
139558110|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
139558111|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028991|NCT01028976|Protective Agents|protective agents|mesh-ancestor
139558112|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339748|NCT03475407|Hormones|hormones|mesh-ancestor
139558113|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139558114|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139558115|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139558116|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139558117|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139558118|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139558119|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
139558120|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558121|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558122|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139558123|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
139558124|NCT00856024|Ribavirin|ribavirin|mesh-list
139558125|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139558126|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
139558127|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558128|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
139558129|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558130|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
139558131|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139558132|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139558133|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139558134|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139558135|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558136|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
139558137|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558138|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558139|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139558140|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558141|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
139558142|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139558143|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558144|NCT00857272|Bisacodyl|bisacodyl|mesh-list
139558145|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139558146|NCT00857272|Cathartics|cathartics|mesh-ancestor
139558147|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139558148|NCT00857272|Laxatives|laxatives|mesh-ancestor
139558149|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
139558150|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139558151|NCT03696784|Fludarabine|fludarabine|mesh-list
139558152|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139558153|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
139558154|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558155|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139558156|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139558157|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
139558158|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558159|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558160|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139558161|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
139558162|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139558163|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139558164|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139558165|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
139558166|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558167|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558168|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558169|NCT04400890|Vitamin D|vitamin d|mesh-list
139558170|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
139558171|NCT04400890|Resveratrol|resveratrol|mesh-list
139558172|NCT04400890|Vitamins|vitamins|mesh-ancestor
139558173|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
139558174|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558175|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139558176|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139558177|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
139558178|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558179|NCT04400890|Protective Agents|protective agents|mesh-ancestor
139558180|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558181|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139558182|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139558183|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558184|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339823|NCT04672928|Paclitaxel|paclitaxel|mesh-list
139558185|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558186|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139558187|NCT04351438|Heparin|heparin|mesh-list
139558188|NCT04351438|Citric Acid|citric acid|mesh-list
139558189|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
139558190|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
139558191|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139558192|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
139558193|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
139558194|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558195|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139558196|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139558197|NCT00890656|Dexamethasone|dexamethasone|mesh-list
139558198|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
139558199|NCT00890656|Doxorubicin|doxorubicin|mesh-list
139558200|NCT00890656|Methotrexate|methotrexate|mesh-list
139558201|NCT00890656|Vincristine|vincristine|mesh-list
139558202|NCT00890656|Asparaginase|asparaginase|mesh-list
139558203|NCT00890656|Pegaspargase|pegaspargase|mesh-list
139558204|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139558205|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
139558206|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558207|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139558208|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139558209|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
139558210|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558211|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558212|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139558213|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558214|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
139558215|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
139558216|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558217|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139558218|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
139558219|NCT00890656|Hormones|hormones|mesh-ancestor
139558220|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139558221|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139558222|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558223|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139558224|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139558225|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139558226|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139558227|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
139558228|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139558229|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139558230|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
139558231|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
139558232|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139558233|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139558234|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139558235|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
139558236|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
139558237|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
139558238|NCT00814138|Methotrexate|methotrexate|mesh-list
139558239|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139558240|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
139558241|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139558242|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558243|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139558244|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
139558245|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558246|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558247|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
139558248|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558249|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139558250|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139558251|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
139558252|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139558253|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139558254|NCT00860938|Budesonide|budesonide|mesh-list
139558255|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558256|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139558257|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
139558258|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558259|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558260|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139558261|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
139558262|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
139558264|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139558265|NCT01719757|Oxycodone|oxycodone|mesh-list
139558266|NCT01719757|Naloxone|naloxone|mesh-list
139558267|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139558268|NCT01719757|Narcotics|narcotics|mesh-ancestor
139558269|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139558270|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558271|NCT01719757|Analgesics|analgesics|mesh-ancestor
139558272|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
139558273|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558274|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139558275|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139558276|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139558277|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558278|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139558279|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139029194|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139558280|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139558281|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558282|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
139558283|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558284|NCT00862810|Vaccines|vaccines|mesh-list
139558285|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
139558286|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558287|NCT00863122|Lapatinib|lapatinib|mesh-list
139558288|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558289|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139558290|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558291|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558292|NCT01604785|Dopamine|dopamine|mesh-list
139558293|NCT01604785|Propofol|propofol|mesh-list
139558294|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
139558295|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139558296|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139558297|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558298|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139558299|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
139558300|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
139558301|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139558302|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
139558303|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
139558304|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558305|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
139558306|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558307|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558308|NCT01604785|Protective Agents|protective agents|mesh-ancestor
139558309|NCT01681849|Paroxetine|paroxetine|mesh-list
139558310|NCT01681849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139558311|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139558312|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139558313|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558314|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558315|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
139558316|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558317|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139558318|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
139558319|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139558320|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139558321|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139558322|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558323|NCT00863356|Hemostatics|hemostatics|mesh-list
139558324|NCT00863356|Chitosan|chitosan|mesh-list
139558325|NCT00863356|Coagulants|coagulants|mesh-ancestor
139558326|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139558327|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139558328|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
139558329|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558330|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139558331|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
139558332|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
139558333|NCT00863434|Cytarabine|cytarabine|mesh-list
139558334|NCT00863434|Clofarabine|clofarabine|mesh-list
139558335|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139558336|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
139558337|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558338|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558339|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
139558340|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558341|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139558342|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
139558343|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558344|NCT04209790|Temozolomide|temozolomide|mesh-list
139558345|NCT04209790|Benzolamide|benzolamide|mesh-list
139558346|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139558347|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
139558348|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558349|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558350|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139558351|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558352|NCT01718353|Prednisone|prednisone|mesh-list
139558353|NCT01718353|Docetaxel|docetaxel|mesh-list
139558354|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558355|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
139558356|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
139558357|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
139558358|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558359|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558360|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
139558361|NCT01718353|Hormones|hormones|mesh-ancestor
139558362|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139558363|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558364|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139558365|NCT01716715|Paclitaxel|paclitaxel|mesh-list
139558366|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139558367|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139558368|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558369|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
139558370|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
139558371|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
139558372|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558373|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
139558374|NCT01696279|Calcium|calcium|mesh-list
139558375|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139558376|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558377|NCT01696279|Antacids|antacids|mesh-ancestor
139558378|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558379|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139558380|NCT01936181|Infliximab|infliximab|mesh-list
139558381|NCT01936181|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139558382|NCT01936181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558383|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
139558384|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139558385|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139558386|NCT01696045|Ipilimumab|ipilimumab|mesh-list
139558387|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139558388|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558389|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139558390|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558391|NCT01935947|Gemcitabine|gemcitabine|mesh-list
139558392|NCT01935947|Azacitidine|azacitidine|mesh-list
139558393|NCT01935947|Docetaxel|docetaxel|mesh-list
139558394|NCT01935947|Irinotecan|irinotecan|mesh-list
139558395|NCT01935947|Pemetrexed|pemetrexed|mesh-list
139558396|NCT01935947|Camptothecin|camptothecin|mesh-list
139558397|NCT01935947|Entinostat|entinostat|mesh-list
139558398|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139558399|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139558400|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
139558401|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558402|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558403|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
139558404|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
139558405|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
139558406|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139558407|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139558408|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558409|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138551645|NCT00263458|Buprenorphine|buprenorphine|mesh-list
139558410|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139558411|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139558413|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558414|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139558415|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
139558416|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558417|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558418|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139558419|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
139558420|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
139558421|NCT02986321|Hormones|hormones|mesh-ancestor
139558422|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139029400|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139558423|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139558424|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139558425|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558426|NCT01951157|Gemcitabine|gemcitabine|mesh-list
139558427|NCT01951157|Docetaxel|docetaxel|mesh-list
139558428|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139558429|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
139558430|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558431|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558432|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
139558433|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
139558434|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
139558435|NCT01363349|Risperidone|risperidone|mesh-list
139558436|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139558437|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
139558438|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558439|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558440|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558441|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139558442|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139558443|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139558444|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139558445|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139558446|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
139558447|NCT00818272|Infliximab|infliximab|mesh-list
139558448|NCT00818272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139558449|NCT00818272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558450|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
139558451|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139558452|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139558453|NCT00868348|Ketorolac|ketorolac|mesh-list
139558454|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139558455|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139558456|NCT00868348|Analgesics|analgesics|mesh-ancestor
139558457|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
139558458|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558459|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558460|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558461|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139558462|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139558463|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558464|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558465|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
139558466|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558467|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558468|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139558469|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139558470|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139558471|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558472|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139558473|NCT01933919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139558474|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139558475|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139558476|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558477|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
139558478|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139558479|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
139558480|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139558481|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139558482|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139558483|NCT05317468|Contraceptive Agents|contraceptive agents|mesh-list
139558484|NCT05317468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139558485|NCT05317468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558486|NCT01933217|Methylphenidate|methylphenidate|mesh-list
139558487|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139558488|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558489|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139558490|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139558491|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139558492|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558493|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
139558494|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558495|NCT01949051|Levocabastine|levocabastine|mesh-list
139558496|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139558497|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139558498|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
139558499|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
139558500|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558501|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558502|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558503|NCT01692301|Amlodipine|amlodipine|mesh-list
139558504|NCT01692301|Valsartan|valsartan|mesh-list
139558505|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139558506|NCT01692301|Olmesartan|olmesartan|mesh-list
139558507|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139558508|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139558509|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139558510|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139558511|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139558512|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558513|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139558514|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558515|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
139558516|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139558517|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139558518|NCT01692301|Diuretics|diuretics|mesh-ancestor
139558519|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
139558520|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139558521|NCT01592773|Memantine|memantine|mesh-list
139558522|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139558523|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139558524|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
139558525|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558526|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558527|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558528|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139558529|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139558530|NCT01592695|Ethanol|ethanol|mesh-list
139558531|NCT01592695|Bupropion|bupropion|mesh-list
139558532|NCT01592695|Nicotine|nicotine|mesh-list
139558533|NCT01592695|Varenicline|varenicline|mesh-list
139558534|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139558535|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
139558536|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558537|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558538|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139558539|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139558540|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
139558541|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558542|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558543|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139558544|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558545|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139558546|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139029815|NCT00366249|Ertapenem|ertapenem|mesh-list
139558547|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
139558548|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139558549|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139558550|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139558551|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139558552|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
139558553|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139558554|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139558555|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558556|NCT01929863|Metformin|metformin|mesh-list
139558557|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139558558|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558559|NCT01714609|Sorafenib|sorafenib|mesh-list
139558560|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558561|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139558562|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558563|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558564|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
139558565|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
139558566|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558567|NCT04768075|Paclitaxel|paclitaxel|mesh-list
139558568|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139558569|NCT04768075|Carboplatin|carboplatin|mesh-list
139558570|NCT04768075|Pemetrexed|pemetrexed|mesh-list
139558571|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139558572|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558573|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
139558574|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
139558575|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
139558576|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558577|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558578|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139558579|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139558580|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139558581|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558582|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139558583|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558584|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558585|NCT01929317|Ropinirole|ropinirole|mesh-list
139558586|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139558587|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139558588|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
139558589|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
139558590|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558591|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558592|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558593|NCT01711879|Aflibercept|aflibercept|mesh-list
139558594|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139558595|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139558596|NCT01711879|Growth Substances|growth substances|mesh-ancestor
139558597|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558598|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
139558599|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558600|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
139558601|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139558602|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558603|NCT01689649|Topiramate|topiramate|mesh-list
139558604|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
139558605|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139558606|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558607|NCT01929083|Ibutilide|ibutilide|mesh-list
139558608|NCT01929083|Progesterone|progesterone|mesh-list
139558609|NCT01929083|Progestins|progestins|mesh-ancestor
139558610|NCT01929083|Hormones|hormones|mesh-ancestor
139558611|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139558612|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558613|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139558614|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
139558615|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139558616|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558617|NCT00891436|Fluticasone|fluticasone|mesh-list
139558618|NCT00891436|Xhance|xhance|mesh-list
139558619|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558620|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139558621|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
139558622|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558623|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558624|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139029953|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
139558625|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
139558626|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
139558627|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139558628|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
139558629|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139558630|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
139340273|NCT03670043|Metformin|metformin|mesh-list
139558631|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558632|NCT01711645|Antacids|antacids|mesh-ancestor
139558633|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558634|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139558635|NCT00820534|Penciclovir|penciclovir|mesh-list
139558636|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
139558637|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558638|NCT01590433|Exenatide|exenatide|mesh-list
139558639|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139558640|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558641|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139558642|NCT01590433|Incretins|incretins|mesh-ancestor
139558643|NCT01590433|Hormones|hormones|mesh-ancestor
139558644|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139558645|NCT00820612|Indomethacin|indomethacin|mesh-list
139558646|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139558647|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139558648|NCT00820612|Analgesics|analgesics|mesh-ancestor
139558649|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
139558650|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558651|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558652|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558653|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139558654|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
139558655|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
139558656|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139558657|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139558658|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558659|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558660|NCT01928927|Telmisartan|telmisartan|mesh-list
139558661|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139558662|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139558663|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139558664|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558665|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
139558666|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139558667|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139558668|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558669|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139558670|NCT00871624|Analgesics|analgesics|mesh-ancestor
139558671|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
139558672|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558673|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139558674|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139558675|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139558676|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
139558677|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558678|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558679|NCT01710709|Aripiprazole|aripiprazole|mesh-list
139558680|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
139558681|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139558682|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139558683|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139558684|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139558685|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558686|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
139558687|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
139030048|NCT00975767|Docetaxel|docetaxel|mesh-list
139558688|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558689|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558690|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139558691|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139558692|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
139558693|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139558694|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139558695|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139558696|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139558697|NCT01709695|Guanfacine|guanfacine|mesh-list
139558698|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139558699|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139558700|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139558701|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139558702|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
139558703|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558704|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558705|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558706|NCT05236504|Melatonin|melatonin|mesh-list
139558707|NCT05236504|Antioxidants|antioxidants|mesh-ancestor
139558708|NCT05236504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558709|NCT05236504|Protective Agents|protective agents|mesh-ancestor
139558710|NCT05236504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558711|NCT05236504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139558712|NCT01685983|Prednisolone|prednisolone|mesh-list
139558713|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
139558714|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558715|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
139558716|NCT01685983|Hormones|hormones|mesh-ancestor
139558717|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139558718|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558719|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139558720|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558721|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139558722|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558723|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558724|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
139558725|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139558726|NCT02151448|Interferons|interferons|mesh-list
139558727|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
139558728|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
139558729|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
139558730|NCT02151448|Celecoxib|celecoxib|mesh-list
139558731|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558732|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
139558733|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558734|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
139558735|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558736|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139558737|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139558738|NCT02151448|Analgesics|analgesics|mesh-ancestor
139558739|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
139558740|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558741|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558742|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139558743|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139558744|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139558745|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030134|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558746|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558747|NCT00875212|Calcium|calcium|mesh-list
139558748|NCT00875212|Fluorides|fluorides|mesh-list
139558749|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
139558750|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139558751|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558752|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
139558753|NCT00875212|Protective Agents|protective agents|mesh-ancestor
139558754|NCT00875836|Buspirone|buspirone|mesh-list
139558755|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139558756|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139558757|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139558758|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558759|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139558760|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139558761|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
139558762|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558763|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558764|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
139558765|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
139558766|NCT01685203|Ribavirin|ribavirin|mesh-list
139558767|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
139558768|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558769|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
139558770|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558771|NCT01928771|Benralizumab|benralizumab|mesh-list
139558772|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139558773|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
139558774|NCT01589653|Insulin|insulin|mesh-list
139558775|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139558776|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
139558777|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
139558778|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139558779|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
139558780|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139558781|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
139558782|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139558783|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558784|NCT01928615|Trastuzumab|trastuzumab|mesh-list
139558785|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139558786|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139558787|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558788|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
139558789|NCT01589497|Rifampin|rifampin|mesh-list
139558790|NCT01589497|Isoniazid|isoniazid|mesh-list
139558791|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
139558792|NCT01589497|Ethambutol|ethambutol|mesh-list
139558793|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139558794|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030246|NCT02534961|Cefazolin|cefazolin|mesh-list
139558795|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139558796|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139558797|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558798|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558799|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558800|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139558801|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
139558802|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
139558803|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139558804|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139558805|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139558806|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139558807|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139558808|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139558809|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139558810|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139558811|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139558812|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
139558813|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139558814|NCT01928381|Pregabalin|pregabalin|mesh-list
139558815|NCT01928381|Analgesics|analgesics|mesh-ancestor
139558816|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
139558817|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558818|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558819|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
139558820|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139558821|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139558822|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558823|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139558824|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139558825|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139558826|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139558827|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139558828|NCT01928225|Vaccines|vaccines|mesh-list
139558829|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
139558830|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558831|NCT01927757|Etanercept|etanercept|mesh-list
139558832|NCT01927757|Methotrexate|methotrexate|mesh-list
139558833|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139558834|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
139558835|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139558836|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558837|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139558838|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
139558839|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558840|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558841|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
139558842|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558843|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139558844|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139558845|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
139558846|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139558847|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139558848|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139558849|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139558850|NCT01927757|Analgesics|analgesics|mesh-ancestor
139558851|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
139558852|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340502|NCT05170438|Paclitaxel|paclitaxel|mesh-list
139558854|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139558855|NCT01913639|Leucovorin|leucovorin|mesh-list
139558856|NCT01913639|Fluorouracil|fluorouracil|mesh-list
139558857|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
139558858|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
139558859|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558860|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139558861|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558862|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139558863|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
139558864|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558865|NCT01913639|Antidotes|antidotes|mesh-ancestor
139558866|NCT01913639|Protective Agents|protective agents|mesh-ancestor
139558867|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
139558868|NCT01913639|Vitamins|vitamins|mesh-ancestor
139558869|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
139558870|NCT01913483|Heparin|heparin|mesh-list
139558871|NCT01913483|Calcium heparin|calcium heparin|mesh-list
139558872|NCT01913483|Bivalirudin|bivalirudin|mesh-list
139558873|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
139558874|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139558875|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139558876|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030335|NCT00981773|Maraviroc|maraviroc|mesh-list
139558877|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
139558878|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139558879|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
139558880|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558881|NCT01913405|Factor VIII|factor viii|mesh-list
139558882|NCT01913405|BAX 855|bax 855|mesh-list
139558883|NCT01913405|Coagulants|coagulants|mesh-ancestor
139558884|NCT01927055|Mannitol|mannitol|mesh-list
139558885|NCT01927055|Droxidopa|droxidopa|mesh-list
139558886|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139558887|NCT01927055|Diuretics|diuretics|mesh-ancestor
139558888|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
139558889|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558890|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139558891|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139558892|NCT01913327|Risperidone|risperidone|mesh-list
139558893|NCT01913327|Aripiprazole|aripiprazole|mesh-list
139558894|NCT01913327|Modafinil|modafinil|mesh-list
139558895|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139558896|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
139558897|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558898|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558899|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558900|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139558901|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139558902|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139558903|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139558904|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139558905|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
139558906|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
139558907|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
139558908|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139558909|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139558910|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139558911|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139558912|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139558913|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139558914|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139558915|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139558916|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139558917|NCT01911845|Ribavirin|ribavirin|mesh-list
139558918|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
139558919|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558920|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
139558921|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558922|NCT01925183|Interferons|interferons|mesh-list
139558923|NCT01925183|Ribavirin|ribavirin|mesh-list
139558924|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
139558925|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
139558926|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139030400|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139558927|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340597|NCT02390258|S66913|s66913|mesh-list
139558928|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
139558929|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558930|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
139558931|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558932|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
139558933|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558935|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
139558936|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558937|NCT01910441|Metformin|metformin|mesh-list
139558938|NCT01910441|Glimepiride|glimepiride|mesh-list
139558939|NCT01910441|Vildagliptin|vildagliptin|mesh-list
139558940|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139558941|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558942|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139558943|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139558944|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
139558945|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139558946|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
139558947|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558948|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558949|NCT01923467|Nicotine|nicotine|mesh-list
139558950|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139558951|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
139558952|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558953|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558954|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139558955|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139558956|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
139558957|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139558958|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558959|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
139558960|NCT01908803|Dexamethasone|dexamethasone|mesh-list
139558961|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139558962|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
139558963|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
139558964|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139558965|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558966|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139558967|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
139558968|NCT01908803|Hormones|hormones|mesh-ancestor
139558969|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139558970|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139558971|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558972|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139558973|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558974|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139558975|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139558976|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139558977|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558978|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139558979|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139558980|NCT01908101|Halichondrin B|halichondrin b|mesh-list
139558981|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
139558982|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
139558983|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
139558984|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558985|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558986|NCT01588951|Cytarabine|cytarabine|mesh-list
139558987|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139558988|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
139558989|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139558990|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139558991|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
139558992|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139558993|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139558994|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
139030504|NCT00956267|Letrozole|letrozole|mesh-list
139558995|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139558996|NCT01588405|Treprostinil|treprostinil|mesh-list
139558997|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139558998|NCT01923311|Elvitegravir|elvitegravir|mesh-list
139558999|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139559000|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139559001|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
139559002|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559003|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139559004|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340650|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
139559005|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559006|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
139559007|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139559008|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139559009|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139559010|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139559011|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559012|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
139559013|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139559014|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559015|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139559016|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559017|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
139559018|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139559019|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139559020|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139559021|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139559022|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139030532|NCT01047423|Simvastatin|simvastatin|mesh-list
139559023|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559024|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
139559025|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139559026|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559027|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139559028|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559029|NCT01921829|Diuretics|diuretics|mesh-list
139559030|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
139559031|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559032|NCT01904903|Trastuzumab|trastuzumab|mesh-list
139559033|NCT01904903|Pertuzumab|pertuzumab|mesh-list
139559034|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139559035|NCT01904903|Maytansine|maytansine|mesh-list
139559036|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139559037|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559038|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139559039|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
139559040|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
139559041|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
139559042|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559043|NCT01904903|Immunotoxins|immunotoxins|mesh-ancestor
139559044|NCT01904903|Immunoconjugates|immunoconjugates|mesh-ancestor
139559045|NCT01904903|Immunologic Factors|immunologic factors|mesh-ancestor
139559046|NCT01904903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559047|NCT01921205|Lacosamide|lacosamide|mesh-list
139559048|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
139559049|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139559050|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139559051|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139559052|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559053|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
139559054|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139559055|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139559056|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
139559057|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139559058|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
139559059|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559060|NCT01709305|Metformin|metformin|mesh-list
139559061|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139559062|NCT01709305|Glimepiride|glimepiride|mesh-list
139559063|NCT01709305|Acarbose|acarbose|mesh-list
139559064|NCT01709305|Repaglinide|repaglinide|mesh-list
139559065|NCT01709305|Gliclazide|gliclazide|mesh-list
139559066|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139559067|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559068|NCT01709305|Incretins|incretins|mesh-ancestor
139559069|NCT01709305|Hormones|hormones|mesh-ancestor
139559070|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139559071|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139559072|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
139559073|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559074|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559075|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139559076|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139559077|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
139559078|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139559079|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
139559080|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139559081|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
139559082|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139559083|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
139559084|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559085|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559086|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
139559087|NCT01709227|Furosemide|furosemide|mesh-list
139559088|NCT01709227|Diuretics|diuretics|mesh-ancestor
139559089|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
139559090|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559091|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139559092|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139559093|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559094|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
139559095|NCT00879034|Pravastatin|pravastatin|mesh-list
139559096|NCT00879034|Lonafarnib|lonafarnib|mesh-list
139559097|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139559098|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559099|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139559100|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139559101|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
139559102|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559103|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139559104|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139559105|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559106|NCT00879190|Gentamicins|gentamicins|mesh-list
139559107|NCT00879190|Ampicillin|ampicillin|mesh-list
139559108|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139559109|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559110|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139559111|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559112|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559113|NCT01903811|Dexamethasone|dexamethasone|mesh-list
139559114|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
139559115|NCT01903811|Ichthammol|ichthammol|mesh-list
139559116|NCT01903811|BB 1101|bb 1101|mesh-list
139559117|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139559118|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
139559119|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
139559120|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559121|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559122|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139559123|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
139559124|NCT01903811|Hormones|hormones|mesh-ancestor
139559125|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139559126|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139559127|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559128|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
139559129|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559130|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559131|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
139559132|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
139559133|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559134|NCT01709149|Riluzole|riluzole|mesh-list
139559135|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
139559136|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139559137|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139559138|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139559139|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559140|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559141|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139559142|NCT01709149|Protective Agents|protective agents|mesh-ancestor
139559143|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
139559144|NCT05214196|Povidone|povidone|mesh-list
139559145|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
139559146|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
139559147|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139559148|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559149|NCT05311228|Azithromycin|azithromycin|mesh-list
139030697|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
139559150|NCT05311228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139559151|NCT05311228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559152|NCT04382014|Curcumin|curcumin|mesh-list
139559153|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139559154|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139559155|NCT04382014|Analgesics|analgesics|mesh-ancestor
139559156|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
139559157|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559158|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559159|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139559160|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139559161|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559162|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559163|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559164|NCT00892606|Morphine|morphine|mesh-list
139559165|NCT00892606|Methadone|methadone|mesh-list
139559166|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139559167|NCT00892606|Narcotics|narcotics|mesh-ancestor
139559168|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139559169|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559170|NCT00892606|Analgesics|analgesics|mesh-ancestor
139559171|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
139559172|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559173|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
139559174|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
139559175|NCT04416035|Paclitaxel|paclitaxel|mesh-list
139559176|NCT04416035|Bevacizumab|bevacizumab|mesh-list
139559177|NCT04416035|Carboplatin|carboplatin|mesh-list
139559178|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139559179|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559180|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
139559181|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
139559182|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
139559183|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559184|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139559185|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139559186|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139559187|NCT04416035|Growth Substances|growth substances|mesh-ancestor
139559188|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559189|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
139559190|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
139559191|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139559192|NCT04381858|Antibodies|antibodies|mesh-list
139559193|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
139559194|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559195|NCT01903031|Ritonavir|ritonavir|mesh-list
139559196|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139559197|NCT01903031|Tenofovir|tenofovir|mesh-list
139559198|NCT01903031|Efavirenz|efavirenz|mesh-list
139559199|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139559200|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139559201|NCT01903031|Etonogestrel|etonogestrel|mesh-list
139559202|NCT01903031|NuvaRing|nuvaring|mesh-list
139559203|NCT01903031|Estradiol|estradiol|mesh-list
139559204|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139559205|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139559206|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
139559207|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559208|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559209|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139559210|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139559211|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
139559212|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559213|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139559214|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139559215|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139559216|NCT01903031|Estrogens|estrogens|mesh-ancestor
139559217|NCT01903031|Hormones|hormones|mesh-ancestor
139559218|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139559219|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559220|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139559221|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
139559222|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139559223|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139559224|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139559225|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139559226|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139559227|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139559228|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139559229|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139559230|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139559231|NCT00883168|Fluticasone|fluticasone|mesh-list
139559233|NCT00883168|Azelastine|azelastine|mesh-list
139559234|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139559235|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139559236|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
139559237|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559238|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559239|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139559240|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
139559241|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
139559242|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139559243|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139559244|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559245|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559246|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139559247|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139559248|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
139559249|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
139559250|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139559251|NCT01616693|Zinc|zinc|mesh-list
139559252|NCT01616693|Vaccines|vaccines|mesh-list
139559253|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
139559254|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559255|NCT01616693|Trace Elements|trace elements|mesh-ancestor
139559256|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
139559257|NCT00893074|Dronabinol|dronabinol|mesh-list
139559258|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
139559259|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559260|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139559261|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139559262|NCT00893074|Analgesics|analgesics|mesh-ancestor
139559263|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
139559264|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559265|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139559266|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139559267|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139559268|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559269|NCT00893074|Hormones|hormones|mesh-ancestor
139559270|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139559271|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
139559272|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139559273|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139559274|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559275|NCT00887458|Itraconazole|itraconazole|mesh-list
139559276|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139559277|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
139559278|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559279|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139559280|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139559281|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559282|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559283|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139559284|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
139559285|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139559286|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031089|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
139559287|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139559288|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
139559289|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139559290|NCT03216304|Calcium|calcium|mesh-list
139559291|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139559292|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559293|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139559294|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139559295|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139559296|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
139559297|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559298|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139559299|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139559300|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559301|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
139559302|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139559303|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
139559304|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559305|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559306|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139559307|NCT03216538|Protective Agents|protective agents|mesh-ancestor
139559308|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139559309|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139559310|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559311|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559312|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
139559313|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559314|NCT03218722|Thrombin|thrombin|mesh-list
139559315|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
139559316|NCT03218722|Coagulants|coagulants|mesh-ancestor
139559317|NCT00888628|Etanercept|etanercept|mesh-list
139559318|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139559319|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139559320|NCT00888628|Analgesics|analgesics|mesh-ancestor
139559321|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
139559322|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559323|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559324|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139559325|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139559326|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139559327|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139559328|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
139559329|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
139559330|NCT03837886|Calcium|calcium|mesh-list
139559331|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139559332|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559333|NCT03837886|Antacids|antacids|mesh-ancestor
139559334|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559335|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139559336|NCT03219970|Osimertinib|osimertinib|mesh-list
139559337|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559338|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139559339|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559340|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559341|NCT00889330|Alcaftadine|alcaftadine|mesh-list
139559342|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139559343|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
139559344|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
139559345|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139559346|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559347|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559348|NCT03219580|Fluorouracil|fluorouracil|mesh-list
139559349|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
139559350|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559351|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139559352|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559353|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139559354|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
139559355|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559356|NCT03215446|Anesthetics|anesthetics|mesh-list
139559357|NCT03215446|Propofol|propofol|mesh-list
139559358|NCT03215446|Sevoflurane|sevoflurane|mesh-list
139559359|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139559360|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559361|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139559362|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139559363|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
139559364|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139559365|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139559366|NCT00896038|Aprepitant|aprepitant|mesh-list
139559367|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
139559368|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
139559369|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559370|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559371|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139559372|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139559373|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139559374|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559375|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
139559376|NCT04381234|Citric Acid|citric acid|mesh-list
139559377|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
139559378|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
139559379|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
139559380|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139559381|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
139559382|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
139559383|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559384|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139559386|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139559387|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
139559388|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559389|NCT03218254|Methylphenidate|methylphenidate|mesh-list
139559390|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139559391|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559392|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139559393|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139559394|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139559395|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559396|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
139559397|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139559398|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
139559399|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139031283|NCT01017380|Celecoxib|celecoxib|mesh-list
139559400|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
139559401|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
139559402|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139559403|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559404|NCT01919801|Icatibant|icatibant|mesh-list
139559405|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139559406|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139559407|NCT01919801|Analgesics|analgesics|mesh-ancestor
139559408|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
139559409|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559410|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559411|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139559412|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139559413|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
139559414|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
139559415|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031396|NCT00445770|Etanercept|etanercept|mesh-list
139559416|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139559417|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139559418|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
139559419|NCT01919723|Ticagrelor|ticagrelor|mesh-list
139559420|NCT01919723|Eptifibatide|eptifibatide|mesh-list
139559421|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139559422|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139559423|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139559424|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139559425|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
139559426|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139559427|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559428|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559429|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
139559430|NCT01919489|Liraglutide|liraglutide|mesh-list
139559431|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139559432|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559433|NCT01919489|Incretins|incretins|mesh-ancestor
139559434|NCT01919489|Hormones|hormones|mesh-ancestor
139559435|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139559436|NCT01919411|Amoxicillin|amoxicillin|mesh-list
139559437|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
139559438|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
139559439|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139559440|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139559441|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559442|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139559443|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559444|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559445|NCT01901393|Ibuprofen|ibuprofen|mesh-list
139559446|NCT01901393|Ketorolac|ketorolac|mesh-list
139559447|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139559448|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139559449|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139559450|NCT01901393|Analgesics|analgesics|mesh-ancestor
139559451|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
139559452|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559453|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559454|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139559455|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139559456|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139559457|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559458|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559459|NCT01890707|Anesthetics|anesthetics|mesh-list
139559460|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139559461|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559462|NCT01890473|Abatacept|abatacept|mesh-list
139559463|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139559464|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559465|NCT01890473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139559466|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559467|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139559468|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
139559469|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559470|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139559471|NCT01889069|Prednisone|prednisone|mesh-list
139559472|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
139559473|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139559474|NCT01889069|Rituximab|rituximab|mesh-list
139559475|NCT01889069|Doxorubicin|doxorubicin|mesh-list
139559476|NCT01889069|Vincristine|vincristine|mesh-list
139031495|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
139559477|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139559478|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
139559479|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559480|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139559481|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139559482|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
139559483|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559484|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559485|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139559486|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139559487|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139559488|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139559489|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139559490|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559491|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139559492|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
139559493|NCT01889069|Hormones|hormones|mesh-ancestor
139559494|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139559495|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139559496|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139559497|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
139559498|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
139559499|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
139559500|NCT00898222|Aspirin|aspirin|mesh-list
138304827|NCT01975272|Iron|iron|mesh-list
139559501|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139559502|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139559503|NCT00898222|Analgesics|analgesics|mesh-ancestor
139559504|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
139559505|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559506|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559507|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139559508|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139559509|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139559510|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139559511|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559512|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139559513|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139559514|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559515|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
139559516|NCT01830556|Cetuximab|cetuximab|mesh-list
139559517|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139559518|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559519|NCT03217942|Mitogens|mitogens|mesh-list
139559520|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
139559521|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559522|NCT00903448|Omeprazole|omeprazole|mesh-list
139559523|NCT00903448|Lansoprazole|lansoprazole|mesh-list
139559524|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139559525|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139559526|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139559527|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559528|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559529|NCT00895180|Ramucirumab|ramucirumab|mesh-list
139559530|NCT00895180|Olaratumab|olaratumab|mesh-list
139559531|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559532|NCT01830868|Zonisamide|zonisamide|mesh-list
139559533|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
139559534|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139559535|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139559536|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559537|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139559538|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559539|NCT03213964|Interleukin-2|interleukin-2|mesh-list
139559540|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559541|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139559542|NCT03213964|Analgesics|analgesics|mesh-ancestor
139559543|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
139559544|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559545|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559546|NCT03217474|Ganciclovir|ganciclovir|mesh-list
139559547|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139559548|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
139559549|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559550|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139559551|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559552|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559553|NCT01830946|Caseins|caseins|mesh-list
139559554|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
139559555|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
139559556|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559557|NCT03213886|Vitamin D|vitamin d|mesh-list
139559558|NCT03213886|Calcifediol|calcifediol|mesh-list
139559559|NCT03213886|Vitamins|vitamins|mesh-ancestor
139559560|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
139559561|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559562|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139559563|NCT03217084|Fluorides|fluorides|mesh-list
139559564|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
139559565|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
139559566|NCT03217084|Protective Agents|protective agents|mesh-ancestor
139559567|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559568|NCT00899470|Metformin|metformin|mesh-list
139559569|NCT00899470|Saxagliptin|saxagliptin|mesh-list
139559570|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139559571|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559572|NCT00899470|Incretins|incretins|mesh-ancestor
139559573|NCT00899470|Hormones|hormones|mesh-ancestor
139559574|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139559575|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139559576|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
139559577|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559578|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559579|NCT01738646|Bevacizumab|bevacizumab|mesh-list
139559580|NCT01738646|Vorinostat|vorinostat|mesh-list
139559581|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139559582|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559583|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139559584|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139559585|NCT01738646|Growth Substances|growth substances|mesh-ancestor
139559586|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559587|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
139559588|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139559589|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559590|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559591|NCT00904618|Lidocaine|lidocaine|mesh-list
139559592|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
139559593|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
139031695|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
139559594|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139559595|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559596|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
139559597|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559598|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139559599|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139559600|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139559601|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139559602|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559603|NCT01839370|Pramlintide|pramlintide|mesh-list
139559604|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139559605|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559606|NCT00907426|Bimatoprost|bimatoprost|mesh-list
139559607|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139559608|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139559609|NCT01832662|Caffeine|caffeine|mesh-list
139559610|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139559611|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559612|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139559613|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559614|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559615|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139559616|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139559617|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
139559618|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139559619|NCT00909064|PENTA|penta|mesh-list
139559620|NCT00909064|Fondaparinux|fondaparinux|mesh-list
139559621|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139559622|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
139559623|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139559624|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
139559625|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559626|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559627|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
139559628|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139559629|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139559630|NCT01832896|Ecallantide|ecallantide|mesh-list
139559631|NCT01832896|Analgesics|analgesics|mesh-ancestor
139559632|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
139559633|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559634|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559635|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139559636|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139559637|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139559638|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139559639|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139559640|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
139559641|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139559642|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139559643|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139559644|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559645|NCT01830478|Rituximab|rituximab|mesh-list
139559646|NCT01830478|Lenalidomide|lenalidomide|mesh-list
139559647|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139559648|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559649|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
139559650|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559651|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139559652|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139559653|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139559654|NCT01830478|Growth Substances|growth substances|mesh-ancestor
139559655|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
139559656|NCT04426695|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
139559657|NCT04426695|Antiviral Agents|antiviral agents|mesh-ancestor
139559658|NCT04426695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559659|NCT01838200|Isoniazid|isoniazid|mesh-list
139559660|NCT01838200|Ipilimumab|ipilimumab|mesh-list
139559661|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
139559662|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139559663|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559664|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139559665|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559666|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
139559667|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139559668|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559669|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139559670|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139559671|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
139559672|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139559673|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139559674|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
139341333|NCT04354025|Cytarabine|cytarabine|mesh-list
139559675|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559676|NCT01720030|Simendan|simendan|mesh-list
139559677|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139559678|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
139559679|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139559680|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139559681|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559682|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559683|NCT01720030|Protective Agents|protective agents|mesh-ancestor
139559684|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559685|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
139559686|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139559687|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
139559688|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139559689|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
139559690|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559691|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559692|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
139559693|NCT04380220|Protein C|protein c|mesh-list
139559694|NCT04380220|Antithrombins|antithrombins|mesh-list
139559695|NCT04380220|Protein S|protein s|mesh-list
139559696|NCT04380220|Factor VIII|factor viii|mesh-list
139559697|NCT04380220|Complement C3|complement c3|mesh-list
139559698|NCT04380220|Coagulants|coagulants|mesh-ancestor
139559699|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139559700|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559701|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139559702|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
139559703|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559704|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
139559705|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139559706|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
139559707|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559708|NCT01832974|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
139559709|NCT01832974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559710|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139559711|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
139559712|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139559713|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559714|NCT01671813|Immunotoxins|immunotoxins|mesh-ancestor
139559715|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
139559716|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559717|NCT03830398|Acetaminophen|acetaminophen|mesh-list
139559718|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139559719|NCT03830398|Analgesics|analgesics|mesh-ancestor
139559720|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
139559721|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559722|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559723|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
139559724|NCT04405323|Itraconazole|itraconazole|mesh-list
139559725|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
139559726|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559727|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139559728|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139559729|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559730|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559731|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139559732|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
139559733|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139559734|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559735|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139559736|NCT01720498|Remifentanil|remifentanil|mesh-list
139559737|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139559738|NCT01720498|Narcotics|narcotics|mesh-ancestor
139559739|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139559740|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559741|NCT01720498|Analgesics|analgesics|mesh-ancestor
139559742|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
139559743|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559744|NCT01672047|Vitamin D|vitamin d|mesh-list
139559745|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
139559746|NCT01672047|Vitamins|vitamins|mesh-ancestor
139559747|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
139559748|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554971|NCT00111891|Niacin|niacin|mesh-list
139559749|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139559750|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139559752|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
139559753|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
139559754|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
139559755|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
139559756|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
139559757|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
139559758|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559759|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139559760|NCT01833676|Sevoflurane|sevoflurane|mesh-list
139559761|NCT01833676|Desflurane|desflurane|mesh-list
139559762|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139559763|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139559764|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
139559765|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
139559766|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139559767|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559768|NCT04380376|Melphalan|melphalan|mesh-list
139559769|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139559770|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
139559771|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559772|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559773|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139559774|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139559775|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
139559776|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559777|NCT04380298|Ketorolac|ketorolac|mesh-list
139559778|NCT04380298|Epinephrine|epinephrine|mesh-list
139559779|NCT04380298|Ropivacaine|ropivacaine|mesh-list
139559780|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
139559781|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
139559782|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139559783|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559784|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
139559785|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559786|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139559787|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139559788|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
139559789|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139559790|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559791|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139559792|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139559793|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
139559794|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139559795|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
139559796|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
139559797|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
139559798|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139559799|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139559800|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139559801|NCT04380298|Analgesics|analgesics|mesh-ancestor
139559802|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139559803|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139559804|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139559805|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559806|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139559807|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139559808|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
139559809|NCT03210610|Colchicine|colchicine|mesh-list
139559810|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
139559811|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139559812|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
139559813|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
139559814|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
139559815|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559816|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559817|NCT03152955|Sufentanil|sufentanil|mesh-list
139559818|NCT03152955|Ketamine|ketamine|mesh-list
139559819|NCT03152955|Ondansetron|ondansetron|mesh-list
139559820|NCT03152955|Analgesics|analgesics|mesh-ancestor
139559821|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
139559822|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559823|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559824|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139559825|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139559826|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
139559827|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
139559828|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139559829|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139559830|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139559831|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139559832|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559834|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
139559835|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139559836|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
139559837|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
139559838|NCT03152955|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139559839|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139559840|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
139559841|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139559842|NCT03152955|Narcotics|narcotics|mesh-ancestor
139559843|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139559844|NCT01676493|Codeine|codeine|mesh-list
139559845|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139559846|NCT01676493|Narcotics|narcotics|mesh-ancestor
139559847|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139559848|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559849|NCT01676493|Analgesics|analgesics|mesh-ancestor
139559850|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
139559851|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559852|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
139559853|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
139559854|NCT01721434|Simendan|simendan|mesh-list
139559855|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139559856|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
139559857|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139559858|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139559859|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559860|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559861|NCT01721434|Protective Agents|protective agents|mesh-ancestor
139559862|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559863|NCT03210532|Amlodipine|amlodipine|mesh-list
139559864|NCT03210532|Telmisartan|telmisartan|mesh-list
139559865|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139559866|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139559867|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139559868|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139559869|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139559870|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559871|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139559872|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559873|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
139559874|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139559875|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139559876|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
139559877|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139559878|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139559879|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559880|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139559881|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139559882|NCT03152565|Avelumab|avelumab|mesh-list
139559883|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139559884|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559885|NCT03210064|Fluorouracil|fluorouracil|mesh-list
139559886|NCT03210064|Apatinib|apatinib|mesh-list
139559887|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
139559888|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559889|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139559890|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559891|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139559892|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
139559893|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559894|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139559895|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559896|NCT05372991|Atropine|atropine|mesh-list
139559897|NCT05372991|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139559898|NCT05372991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139559899|NCT05372991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139559900|NCT05372991|Autonomic Agents|autonomic agents|mesh-ancestor
139341560|NCT02178098|Antimetabolites|antimetabolites|mesh-ancestor
139559901|NCT05372991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559902|NCT05372991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559903|NCT05372991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139559904|NCT05372991|Respiratory System Agents|respiratory system agents|mesh-ancestor
139559905|NCT05372991|Mydriatics|mydriatics|mesh-ancestor
139559906|NCT05372991|Parasympatholytics|parasympatholytics|mesh-ancestor
139559907|NCT05372991|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139559908|NCT05372991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139559909|NCT05372991|Cholinergic Agents|cholinergic agents|mesh-ancestor
139559910|NCT05372991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139559911|NCT05372991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559912|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139559913|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559914|NCT01722448|Choline|choline|mesh-list
139559915|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
139559916|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139559917|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
139559918|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559919|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139559920|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139559921|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
139559922|NCT01834768|Eplerenone|eplerenone|mesh-list
139559923|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139559924|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
139559925|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139559926|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559927|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139559928|NCT01834768|Diuretics|diuretics|mesh-ancestor
139559929|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
139559930|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139559931|NCT01672671|Paclitaxel|paclitaxel|mesh-list
139559932|NCT01672671|Doxorubicin|doxorubicin|mesh-list
139559933|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139559934|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559935|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
139559936|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
139559937|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
139559938|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559939|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139559940|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139559941|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139559942|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559943|NCT02459457|Paclitaxel|paclitaxel|mesh-list
139559944|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139559945|NCT02459457|Carboplatin|carboplatin|mesh-list
139559946|NCT02459457|Fluorouracil|fluorouracil|mesh-list
139031996|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
139559947|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139559948|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559949|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
139559950|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
139559951|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
139559952|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559953|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
139559954|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139559955|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139559956|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
139559957|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559958|NCT01835236|Paclitaxel|paclitaxel|mesh-list
139559959|NCT01835236|Vinorelbine|vinorelbine|mesh-list
139559960|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139559961|NCT01835236|Trastuzumab|trastuzumab|mesh-list
139559962|NCT01835236|Pertuzumab|pertuzumab|mesh-list
139559963|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139559964|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559965|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
139559966|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
139559967|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
139559968|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559969|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139559970|NCT01835236|Immunotoxins|immunotoxins|mesh-ancestor
139559971|NCT01835236|Immunoconjugates|immunoconjugates|mesh-ancestor
139559972|NCT01835236|Immunologic Factors|immunologic factors|mesh-ancestor
139559973|NCT01835236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559974|NCT01671891|Capecitabine|capecitabine|mesh-list
139559975|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
139559976|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139559978|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559979|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139559980|NCT03152409|Aspirin|aspirin|mesh-list
139559981|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
139559982|NCT03152409|Salicylates|salicylates|mesh-list
139559983|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139559984|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139559985|NCT03152409|Analgesics|analgesics|mesh-ancestor
139559986|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
139559987|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139559988|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139559989|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139559990|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139559991|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139559992|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139559993|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139559994|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139559995|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139559996|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139559997|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
139559998|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139559999|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
139560000|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
139560001|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
139560002|NCT01830322|Gemcitabine|gemcitabine|mesh-list
139560003|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139560004|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
139560005|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560006|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560007|NCT01835314|Stiripentol|stiripentol|mesh-list
139560008|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
139560009|NCT01706198|Fluticasone|fluticasone|mesh-list
139560010|NCT01706198|Xhance|xhance|mesh-list
139560011|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139560012|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139560013|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
139560014|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560015|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560016|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139560017|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
139560018|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
139560019|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139560020|NCT04378972|Vitamin D|vitamin d|mesh-list
139560021|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
139560022|NCT04378972|Curcumin|curcumin|mesh-list
139560023|NCT04378972|Tramiprosate|tramiprosate|mesh-list
139560024|NCT04378972|Vitamins|vitamins|mesh-ancestor
139560025|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
139560026|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560027|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139560028|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139560029|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139560030|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139560031|NCT04378972|Analgesics|analgesics|mesh-ancestor
139560032|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
139560033|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560034|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139560035|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139560036|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560037|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560038|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560039|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
139560040|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
139560041|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
139560042|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560043|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
139560044|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
139560045|NCT01723150|Ertapenem|ertapenem|mesh-list
139560046|NCT01723150|Trimethoprim|trimethoprim|mesh-list
139560047|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
139560048|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139560049|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560050|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139560051|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139560052|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032120|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139560053|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560054|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560055|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139560056|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139560057|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139560058|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
139560059|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139560060|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139560061|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139560062|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139560063|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139560064|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139560065|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560066|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139560067|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560068|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560069|NCT01836016|Fluticasone|fluticasone|mesh-list
139560071|NCT01836016|Albuterol|albuterol|mesh-list
139560072|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
139560073|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139560074|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139560075|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139560076|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139560077|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
139560078|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032174|NCT04005365|Propranolol|propranolol|mesh-list
139560079|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560080|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139560081|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
139560082|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
139560083|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139560084|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139560085|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139560086|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139560087|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
139560088|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560089|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560090|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
139560091|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139560092|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
139560093|NCT01836016|Hormones|hormones|mesh-ancestor
139560094|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139560095|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
139560096|NCT01836094|Methylene Blue|methylene blue|mesh-list
139560097|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560098|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560099|NCT01726192|Ropivacaine|ropivacaine|mesh-list
139560100|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
139560101|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
139560102|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139560103|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560104|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
139560105|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560106|NCT01836328|Methadone|methadone|mesh-list
139560107|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139560108|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139560109|NCT01836328|Narcotics|narcotics|mesh-ancestor
139560110|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139560111|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560112|NCT01836328|Analgesics|analgesics|mesh-ancestor
139560113|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
139560114|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560115|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
139560116|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
139560117|NCT01836406|Ketorolac|ketorolac|mesh-list
139560118|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139560119|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139560120|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139560121|NCT01836406|Analgesics|analgesics|mesh-ancestor
139560122|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
139560123|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560124|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560125|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139560126|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139341789|NCT00121992|Docetaxel|docetaxel|mesh-list
139341810|NCT00070564|Paclitaxel|paclitaxel|mesh-list
139560127|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139560128|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560129|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560130|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139560131|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139560132|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560134|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139560135|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139560136|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
139560137|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560138|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139560139|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
139560140|NCT01726816|Protective Agents|protective agents|mesh-ancestor
139560141|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560142|NCT00915538|Budesonide|budesonide|mesh-list
139560143|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139560144|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139560145|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139560146|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
139560147|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560148|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560149|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139560150|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
139560151|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
139560152|NCT00915538|Hormones|hormones|mesh-ancestor
139032324|NCT00279916|Triamcinolone|triamcinolone|mesh-list
139560153|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139560154|NCT01724086|Interferons|interferons|mesh-list
139560155|NCT01724086|Ritonavir|ritonavir|mesh-list
139560156|NCT01724086|Ribavirin|ribavirin|mesh-list
139560157|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
139560158|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
139560159|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139560160|NCT01724086|Simeprevir|simeprevir|mesh-list
139560161|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560162|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
139560163|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560164|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139560165|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139560166|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
139560167|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560168|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560169|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139560170|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139560171|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139560172|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139560173|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
139560174|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
139560175|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560176|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139560177|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
139560178|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560179|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032366|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
139560180|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560181|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139560182|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
139560183|NCT01727050|Coagulants|coagulants|mesh-ancestor
139560184|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
139560185|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139560186|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139560187|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560188|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
139560189|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560190|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560191|NCT01837108|Eplerenone|eplerenone|mesh-list
139560192|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139560193|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
139560194|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139560195|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560196|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139560197|NCT01837108|Diuretics|diuretics|mesh-ancestor
139560198|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
139560199|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139560200|NCT01724554|Aflibercept|aflibercept|mesh-list
139560201|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139560202|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139560203|NCT01724554|Growth Substances|growth substances|mesh-ancestor
139560204|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560205|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
139560206|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560207|NCT01724788|Furosemide|furosemide|mesh-list
139560208|NCT01724788|Diuretics|diuretics|mesh-ancestor
139560209|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
139560210|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560211|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139560212|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139560213|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560214|NCT01837498|Neostigmine|neostigmine|mesh-list
139560215|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139560216|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560217|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560218|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
139560219|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560220|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560221|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139560222|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
139560223|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560224|NCT01705574|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139560225|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
139560226|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560227|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139560228|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139560229|NCT01837576|Calcipotriene|calcipotriene|mesh-list
139560230|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
139560231|NCT01728298|Immunomodulating Agents|immunomodulating agents|mesh-list
139560232|NCT01728298|Immunologic Factors|immunologic factors|mesh-ancestor
139560233|NCT01728298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560234|NCT01737710|Vaccines|vaccines|mesh-list
139560235|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
139560236|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560237|NCT01837810|Ibuprofen|ibuprofen|mesh-list
139560238|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139560239|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139560240|NCT01837810|Analgesics|analgesics|mesh-ancestor
139560241|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
139560242|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560243|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560244|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139560245|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139560246|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139560247|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032531|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
139560248|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560249|NCT01725100|Trametinib|trametinib|mesh-list
139560250|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139560251|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560252|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139560253|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560254|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560255|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139560256|NCT01725100|Protective Agents|protective agents|mesh-ancestor
139560257|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560258|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139560259|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
139560260|NCT01725412|Thiamine|thiamine|mesh-list
139560261|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
139560262|NCT01725412|Vitamins|vitamins|mesh-ancestor
139560263|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
139560264|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560265|NCT01725490|Metformin|metformin|mesh-list
139560266|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139560267|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560268|NCT01838434|Lenalidomide|lenalidomide|mesh-list
139560269|NCT01838434|Idelalisib|idelalisib|mesh-list
139560270|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
139560271|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560272|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139560273|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139560274|NCT01838434|Growth Substances|growth substances|mesh-ancestor
139341938|NCT03623087|Hormones|hormones|mesh-ancestor
139560275|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
139560276|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560277|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560278|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560279|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139560280|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
139560281|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139560282|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
139560283|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560284|NCT04377646|Zinc|zinc|mesh-list
139560285|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
139560286|NCT04377646|Trace Elements|trace elements|mesh-ancestor
139560287|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
139560288|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560289|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
139560290|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139560291|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139560292|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560293|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560294|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560295|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139560296|NCT01728922|Vitamin D|vitamin d|mesh-list
139560297|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
139560298|NCT01728922|Cholecalciferol|cholecalciferol|mesh-list
139560299|NCT01728922|Vitamins|vitamins|mesh-list
139560300|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
139560301|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560302|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139560303|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139560304|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
139560305|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
139560306|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560307|NCT01838902|Primaquine|primaquine|mesh-list
139560308|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
139560309|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139560310|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139560311|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560312|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
139560313|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
139560314|NCT01714544|Hormones|hormones|mesh-ancestor
139560315|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139560316|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560317|NCT01703858|Pantoprazole|pantoprazole|mesh-list
139560318|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139560319|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139560320|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139560321|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560322|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560323|NCT01729468|Aspirin|aspirin|mesh-list
139560324|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139560325|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139560326|NCT01729468|Analgesics|analgesics|mesh-ancestor
139560327|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
139560328|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560329|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560330|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139560331|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139560332|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139560333|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139560334|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560335|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139560336|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139560337|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560338|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
139560339|NCT04376788|Methylene Blue|methylene blue|mesh-list
139560340|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560341|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560342|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139560343|NCT01714310|Fluoxetine|fluoxetine|mesh-list
139560344|NCT01714310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139560345|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139560346|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139560347|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560348|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560349|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
139560350|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560351|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139560352|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
139560353|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139560354|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139560355|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139560356|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560357|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139032705|NCT00991133|Clofarabine|clofarabine|mesh-list
139560358|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139560359|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
139560360|NCT03401788|Belzutifan|belzutifan|mesh-list
139560361|NCT03401788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560362|NCT01728064|Ubiquinone|ubiquinone|mesh-list
139560363|NCT01728064|Micronutrients|micronutrients|mesh-ancestor
139560364|NCT01728064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560365|NCT03405142|Panitumumab|panitumumab|mesh-list
139560366|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
139560367|NCT03405142|Dextrans|dextrans|mesh-list
139560368|NCT03405142|Edetic Acid|edetic acid|mesh-list
139560369|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
139560370|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139560371|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560372|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
139560373|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
139560374|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
139560375|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139560376|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560377|NCT03405142|Antidotes|antidotes|mesh-ancestor
139560378|NCT03405142|Protective Agents|protective agents|mesh-ancestor
139560379|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560380|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
139560381|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
139560382|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139560383|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139560384|NCT03407872|Esketamine|esketamine|mesh-list
139560385|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
139560386|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139560387|NCT03834610|Tadalafil|tadalafil|mesh-list
139560388|NCT03834610|Testosterone|testosterone|mesh-list
139560389|NCT03834610|Androgens|androgens|mesh-ancestor
139560390|NCT03834610|Hormones|hormones|mesh-ancestor
139560391|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139560392|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560393|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
139560394|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139560395|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139560396|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560397|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560398|NCT03834610|Urological Agents|urological agents|mesh-ancestor
139560399|NCT01681472|Leucovorin|leucovorin|mesh-list
139560400|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
139560401|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
139560402|NCT01681472|Antidotes|antidotes|mesh-ancestor
139560403|NCT01681472|Protective Agents|protective agents|mesh-ancestor
139560404|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560405|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
139560406|NCT01681472|Vitamins|vitamins|mesh-ancestor
139560407|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
139560408|NCT00915928|Perindopril|perindopril|mesh-list
139560409|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139560410|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
139560411|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560412|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560413|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139560414|NCT03407404|Midazolam|midazolam|mesh-list
139560415|NCT03407404|Ketamine|ketamine|mesh-list
139560416|NCT03407404|Morphine|morphine|mesh-list
139560417|NCT03407404|Analgesics|analgesics|mesh-ancestor
139560418|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
139560419|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560420|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560421|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139560422|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139560423|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
139560424|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
139560425|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139560426|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139560427|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139560428|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560429|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560430|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139560431|NCT03407404|Narcotics|narcotics|mesh-ancestor
139560432|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139560433|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139560434|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139032866|NCT01564199|Fluticasone|fluticasone|mesh-list
139560435|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139560436|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139560437|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
139560438|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
139560439|NCT03830086|Midazolam|midazolam|mesh-list
139560440|NCT03830086|Sufentanil|sufentanil|mesh-list
139560441|NCT03830086|Bupivacaine|bupivacaine|mesh-list
139560442|NCT03830086|Propofol|propofol|mesh-list
139560443|NCT03830086|Sevoflurane|sevoflurane|mesh-list
139560444|NCT03830086|Rocuronium|rocuronium|mesh-list
139560445|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
139560446|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
139560447|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139560448|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560449|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
139560450|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560451|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139560452|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139560453|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
139560454|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139560455|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139560456|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139560457|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139560458|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
139560459|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
139560460|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560461|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560462|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139560463|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139560464|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139560465|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139560466|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139560467|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139560468|NCT03830086|Narcotics|narcotics|mesh-ancestor
139560469|NCT03830086|Analgesics|analgesics|mesh-ancestor
139560470|NCT02240212|Paclitaxel|paclitaxel|mesh-list
139560471|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139560472|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560473|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
139560474|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
139560475|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
139560476|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560477|NCT01047436|Artemether|artemether|mesh-list
139560478|NCT01047436|Quinine|quinine|mesh-list
139560479|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
139560480|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139560481|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139560482|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560483|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139560484|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560485|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139560486|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032974|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
139560487|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139560488|NCT01047436|Analgesics|analgesics|mesh-ancestor
139560489|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
139560490|NCT03406936|Midazolam|midazolam|mesh-list
139560491|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139560492|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139560493|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139560494|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560495|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139560496|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139560497|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139560498|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139560499|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
139560500|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
139560501|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
139560502|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
139560503|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560504|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560505|NCT02240602|Oxycodone|oxycodone|mesh-list
139560506|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139560507|NCT02240602|Narcotics|narcotics|mesh-ancestor
139560508|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139560509|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560510|NCT02240602|Analgesics|analgesics|mesh-ancestor
139560511|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
139560512|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560513|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
139560514|NCT03406546|Remifentanil|remifentanil|mesh-list
139560515|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139560516|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139560517|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560518|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139560519|NCT03406546|Analgesics|analgesics|mesh-ancestor
139560520|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
139560521|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560522|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139560523|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139560524|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139560525|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
139560526|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560527|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560528|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139560529|NCT03406546|Narcotics|narcotics|mesh-ancestor
139560530|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139560531|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139560532|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560533|NCT01046110|Incretins|incretins|mesh-ancestor
139560534|NCT01046110|Hormones|hormones|mesh-ancestor
139033030|NCT00347919|Lapatinib|lapatinib|mesh-list
139560535|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139560536|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139560537|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
139560538|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560539|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560540|NCT01713530|Insulin|insulin|mesh-list
139560541|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139560542|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
139560543|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
139560544|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139560545|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139560546|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560547|NCT01045798|Caspofungin|caspofungin|mesh-list
139560548|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
139560549|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560550|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560551|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560552|NCT02982694|Bevacizumab|bevacizumab|mesh-list
139560553|NCT02982694|Atezolizumab|atezolizumab|mesh-list
139560554|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139560555|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560556|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139560557|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139560558|NCT02982694|Growth Substances|growth substances|mesh-ancestor
139560559|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560560|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
139560561|NCT02982694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139560562|NCT02982694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560563|NCT01712984|Fluconazole|fluconazole|mesh-list
139560564|NCT01712984|Vaccines|vaccines|mesh-list
139560565|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
139560566|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560567|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
139560568|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560569|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139560570|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139560571|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560572|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560573|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139560574|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
139560575|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139560576|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139560577|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139560578|NCT00921310|Sirolimus|sirolimus|mesh-list
139560579|NCT00921310|Pemetrexed|pemetrexed|mesh-list
139342238|NCT02377076|Calcium|calcium|mesh-list
139560580|NCT00921310|Temsirolimus|temsirolimus|mesh-list
139560581|NCT00921310|MTOR Inhibitors|mtor inhibitors|mesh-list
139560582|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560583|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560584|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560585|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139560586|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139560587|NCT00921310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139560588|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139560589|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
139560590|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560591|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139033046|NCT00356421|Insulin|insulin|mesh-list
139560592|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560593|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139560594|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
139560595|NCT02241148|Acetaminophen|acetaminophen|mesh-list
139560596|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139560597|NCT02241148|Analgesics|analgesics|mesh-ancestor
139560598|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
139560599|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560600|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560601|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
139560602|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
139560603|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139560604|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139560605|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139560606|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
139560607|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560608|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560609|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560610|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
139560611|NCT01040728|Olodaterol|olodaterol|mesh-list
139560612|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139560613|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
139560614|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560615|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560616|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139560617|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
139560618|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
139560619|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139560620|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
139560621|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560622|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560623|NCT01593020|Paclitaxel|paclitaxel|mesh-list
139560624|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
139560625|NCT01593020|Doxorubicin|doxorubicin|mesh-list
139560626|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139560627|NCT01593020|Fluorouracil|fluorouracil|mesh-list
139560628|NCT01593020|Epirubicin|epirubicin|mesh-list
139560629|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139560630|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560631|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
139560632|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
139560633|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
139560634|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560635|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139560636|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
139560637|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560638|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139560639|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139560640|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
139560641|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139560642|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139560643|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139560644|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139560645|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560646|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
139560647|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139560648|NCT01040260|Nicotine|nicotine|mesh-list
139560649|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139560650|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
139560651|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560652|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560653|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139560654|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139560655|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
139560657|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560658|NCT01046422|Metformin|metformin|mesh-list
139560659|NCT01046422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139560660|NCT01046422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560661|NCT03405376|Aflibercept|aflibercept|mesh-list
139560662|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139560663|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139560664|NCT03405376|Growth Substances|growth substances|mesh-ancestor
139560665|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560666|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
139560667|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560668|NCT02241460|Lidocaine|lidocaine|mesh-list
139560669|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
139560670|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
139560671|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139560672|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560673|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
139560674|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560675|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139560676|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139560677|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139560678|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139560679|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560680|NCT01712204|Febuxostat|febuxostat|mesh-list
139560681|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
139560682|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139560683|NCT01592864|Fluorides|fluorides|mesh-list
139560684|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
139560685|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
139560686|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
139560687|NCT01592864|Protective Agents|protective agents|mesh-ancestor
139560688|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560689|NCT01592786|Memantine|memantine|mesh-list
139560690|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139560691|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139560692|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
139560693|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560694|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560695|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560696|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139560697|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139560698|NCT01592708|Erythromycin|erythromycin|mesh-list
139560699|NCT01592708|Ibuprofen|ibuprofen|mesh-list
139560700|NCT01592708|Ketorolac|ketorolac|mesh-list
139560701|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139560702|NCT01592708|Fentanyl|fentanyl|mesh-list
139560703|NCT01592708|Scopolamine|scopolamine|mesh-list
139560704|NCT01592708|Droperidol|droperidol|mesh-list
139560705|NCT01592708|Remifentanil|remifentanil|mesh-list
139560706|NCT01592708|Hydrocodone|hydrocodone|mesh-list
139560707|NCT01592708|Ondansetron|ondansetron|mesh-list
139560708|NCT01592708|Antiemetics|antiemetics|mesh-list
139560709|NCT01592708|Propofol|propofol|mesh-list
139560710|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
139560711|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139560712|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560713|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139560714|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139560715|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
139560716|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139560717|NCT01592708|Narcotics|narcotics|mesh-ancestor
139560718|NCT01592708|Analgesics|analgesics|mesh-ancestor
139560719|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
139560720|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560721|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139560722|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139560723|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139560724|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139560725|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139560726|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139560727|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560728|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560729|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
139560730|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139560731|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
139560732|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
139560733|NCT01592708|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139560734|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139560735|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
139560736|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560737|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
139560738|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
139560739|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139560740|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560741|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139560742|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
139560743|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139560744|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
139560745|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139560746|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
139560747|NCT01592708|Hormones|hormones|mesh-ancestor
139560748|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139560749|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139560750|NCT01592708|Protective Agents|protective agents|mesh-ancestor
139560751|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139560752|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560753|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139560754|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139560755|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139560756|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139560757|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139560758|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
139560759|NCT01042522|Paclitaxel|paclitaxel|mesh-list
139560760|NCT01042522|Etoposide|etoposide|mesh-list
139560761|NCT01042522|Cisplatin|cisplatin|mesh-list
139560762|NCT01042522|Carboplatin|carboplatin|mesh-list
139560763|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139560764|NCT01042522|Bleomycin|bleomycin|mesh-list
139560765|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
139560766|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139560767|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560768|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
139560769|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
139560770|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
139560771|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560772|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139560773|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139560774|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560775|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139560776|NCT01702844|Paclitaxel|paclitaxel|mesh-list
139560777|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139560778|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560779|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
139560780|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
139560781|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
139033350|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
139560782|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560783|NCT01702532|Nicotine|nicotine|mesh-list
139560784|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139560785|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
139560786|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560787|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560788|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139560789|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139560790|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
139560791|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560792|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560793|NCT02241616|Entecavir|entecavir|mesh-list
139560794|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
139560795|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560796|NCT03400306|Paclitaxel|paclitaxel|mesh-list
139560797|NCT03400306|Carboplatin|carboplatin|mesh-list
139560798|NCT03400306|Veliparib|veliparib|mesh-list
139560799|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139560800|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139560801|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
139560802|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
139560803|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
139560804|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560805|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139560806|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560807|NCT03405064|Linezolid|linezolid|mesh-list
139560808|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
139560809|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139560810|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560811|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139560812|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560813|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560814|NCT03405064|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139560815|NCT01702298|Metformin|metformin|mesh-list
139560816|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139560817|NCT01702298|Simvastatin|simvastatin|mesh-list
139560818|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139560819|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560820|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139560821|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139560822|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
139560823|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560824|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139560825|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139560826|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560827|NCT01702298|Incretins|incretins|mesh-ancestor
139560828|NCT01702298|Hormones|hormones|mesh-ancestor
139560829|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139560830|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139560831|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
139560832|NCT03404752|Lenograstim|lenograstim|mesh-list
139560833|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139560834|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
139560835|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560836|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
139560837|NCT03401710|Hematinics|hematinics|mesh-ancestor
139560838|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139560839|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139560840|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139560841|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560842|NCT01701362|Pregabalin|pregabalin|mesh-list
139560843|NCT01701362|Analgesics|analgesics|mesh-ancestor
139560844|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
139560845|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560846|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560847|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
139560848|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139560849|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139560850|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560851|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139560852|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139560853|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139033500|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560854|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139560855|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139560856|NCT00919126|Xenon|xenon|mesh-list
139560857|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139560858|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
139560859|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
139560860|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139560861|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560862|NCT01710800|Esomeprazole|esomeprazole|mesh-list
139560863|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139560864|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139560865|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139560866|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560867|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560868|NCT01710020|Tofacitinib|tofacitinib|mesh-list
139560869|NCT01710020|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139560870|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139560871|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560872|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560873|NCT02982850|Aspirin|aspirin|mesh-list
139560874|NCT02982850|Warfarin|warfarin|mesh-list
139560875|NCT02982850|Dabigatran|dabigatran|mesh-list
139560876|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139560877|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139560878|NCT02982850|Analgesics|analgesics|mesh-ancestor
139560879|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
139560880|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560881|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342541|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560882|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139560883|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139560884|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139560885|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139560886|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560887|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139560888|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139560889|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560890|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
139560891|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
139560892|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
139560893|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139560894|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
139560895|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
139560896|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
139560897|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139560898|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
139560899|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560900|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560901|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139560902|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
139560903|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139560904|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139560905|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139560906|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
139560907|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560908|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560909|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
139560910|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139560911|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
139560912|NCT03403972|Vancomycin|vancomycin|mesh-list
139560913|NCT03403972|Simvastatin|simvastatin|mesh-list
139560914|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139560915|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139560916|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
139560917|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560918|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139560919|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139560920|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139560921|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139560922|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139560923|NCT02242318|Valsartan|valsartan|mesh-list
139560924|NCT02242318|Telmisartan|telmisartan|mesh-list
139560925|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139033661|NCT00992537|Insulin|insulin|mesh-list
139560926|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139560927|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139560928|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560929|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
139560930|NCT01700192|Loratadine|loratadine|mesh-list
139560931|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139560932|NCT01700192|Epinephrine|epinephrine|mesh-list
139560933|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139560934|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139560935|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139560936|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
139560937|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139560938|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560939|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560940|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139560941|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139560942|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
139560943|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560944|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139560945|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
139560946|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
139560947|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
139560948|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139560949|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139560950|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
139560951|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139560952|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
139560953|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139560954|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139560955|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
139560956|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
139560957|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139560958|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139560959|NCT01700192|Analgesics|analgesics|mesh-ancestor
139560960|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
139560961|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139560962|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139560963|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139560964|NCT02242396|Telmisartan|telmisartan|mesh-list
139560965|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
139560966|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139560967|NCT02242396|Diuretics|diuretics|mesh-ancestor
139560968|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
139560969|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560970|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139560971|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139560972|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139560973|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139560974|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139560975|NCT02242474|Adalimumab|adalimumab|mesh-list
139560976|NCT02242474|Infliximab|infliximab|mesh-list
139560977|NCT02242474|Golimumab|golimumab|mesh-list
139560978|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
139560979|NCT02242474|Etanercept|etanercept|mesh-list
139560980|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139560981|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139560982|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139560983|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139560984|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
139560985|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139560986|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139560987|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139560988|NCT02242474|Analgesics|analgesics|mesh-ancestor
139560989|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
139560990|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139560991|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139560992|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139560993|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
139560994|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
139560995|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139560996|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139560997|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139560998|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
139560999|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139561000|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561001|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561002|NCT04878315|Captopril|captopril|mesh-list
139561003|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139561004|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
139561005|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561006|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561007|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139561008|NCT04374604|Mitogens|mitogens|mesh-list
139561009|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
139561010|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561011|NCT02242864|Telmisartan|telmisartan|mesh-list
139561012|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
139561013|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139033794|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561014|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139561015|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139561016|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561017|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139561018|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139561019|NCT02242864|Diuretics|diuretics|mesh-ancestor
139561020|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
139561021|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561022|NCT01709708|Bupivacaine|bupivacaine|mesh-list
139561023|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
139561024|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
139561025|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561026|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561027|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
139561028|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561029|NCT02243098|Digoxin|digoxin|mesh-list
139561030|NCT02243098|Atorvastatin|atorvastatin|mesh-list
139561031|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139342701|NCT02373722|Petrolatum|petrolatum|mesh-list
139561032|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139561033|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
139561034|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561035|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139561036|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139033844|NCT00338949|Ziprasidone|ziprasidone|mesh-list
139561037|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561038|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139561039|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139561040|NCT02243098|Protective Agents|protective agents|mesh-ancestor
139561041|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561042|NCT05289063|Atorvastatin|atorvastatin|mesh-list
139561043|NCT05289063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139561044|NCT05289063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139561045|NCT05289063|Antimetabolites|antimetabolites|mesh-ancestor
139561046|NCT05289063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561047|NCT05289063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139561048|NCT05289063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139561049|NCT05289063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561050|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139561051|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139561052|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139561053|NCT01709318|Etonogestrel|etonogestrel|mesh-list
139561054|NCT01709318|Estradiol|estradiol|mesh-list
139561055|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139561056|NCT01709318|Estrogens|estrogens|mesh-ancestor
139561057|NCT01709318|Hormones|hormones|mesh-ancestor
139561058|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139561059|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561060|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139561061|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
139561062|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139561063|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139561064|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139561065|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139561066|NCT02243254|Ibuprofen|ibuprofen|mesh-list
139561067|NCT02243254|Remifentanil|remifentanil|mesh-list
139561068|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139561069|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139561070|NCT02243254|Analgesics|analgesics|mesh-ancestor
139561071|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
139561072|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561073|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561074|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139561075|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561076|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139561077|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561078|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561079|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139561080|NCT02243254|Narcotics|narcotics|mesh-ancestor
139561081|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561082|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
139561083|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
139561084|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
139561085|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139561086|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561087|NCT03402880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139561088|NCT03402880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561089|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
139561090|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561091|NCT01673997|Metoprolol|metoprolol|mesh-list
139561092|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139561093|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139561094|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
139561095|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
139561096|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561097|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561098|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139561099|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139561100|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139561101|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
139561102|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139561103|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561104|NCT04373824|Ivermectin|ivermectin|mesh-list
139561105|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139561106|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561107|NCT01676571|Vortioxetine|vortioxetine|mesh-list
139034084|NCT01055301|Etoposide|etoposide|mesh-list
139561108|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
139561109|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139561110|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139561111|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139561112|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561113|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561114|NCT01676571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139561115|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139561116|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139561117|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561118|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139561119|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
139561120|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139561121|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139561122|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139561123|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139561124|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
139561125|NCT01699178|Testosterone|testosterone|mesh-list
139561126|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
139561127|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
139561128|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139561129|NCT01699178|Androgens|androgens|mesh-ancestor
139561131|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139561132|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561133|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139561134|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561135|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
139561136|NCT02077959|Lenalidomide|lenalidomide|mesh-list
139561137|NCT02077959|Pidilizumab|pidilizumab|mesh-list
139561138|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
139561139|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561140|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139561141|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139561142|NCT02077959|Growth Substances|growth substances|mesh-ancestor
139561143|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
139561144|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561145|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139561146|NCT04548518|Vaccines|vaccines|mesh-list
139561147|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
139561148|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561149|NCT01699022|CycloProvera|cycloprovera|mesh-list
139561150|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139561151|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139561152|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139561153|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
139561154|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139561155|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561156|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139561157|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139561158|NCT01670175|Sirolimus|sirolimus|mesh-list
139561159|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
139561160|NCT01670175|Topotecan|topotecan|mesh-list
139561161|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139561162|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
139561163|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561164|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561165|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139561166|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
139561167|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561168|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561169|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139561170|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139561171|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561172|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139561173|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
139561174|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561175|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139561176|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139561177|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139561178|NCT02243566|Telmisartan|telmisartan|mesh-list
139034223|NCT00322881|Paclitaxel|paclitaxel|mesh-list
139342837|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139561179|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
139561180|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139561181|NCT02243566|Diuretics|diuretics|mesh-ancestor
139561182|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
139561183|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561184|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139561185|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139561186|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561187|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139561188|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139561189|NCT02243644|Albendazole|albendazole|mesh-list
139561190|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
139561191|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139561192|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561193|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
139561194|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139561195|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139561196|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
139561197|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
139561198|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
139561199|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561200|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561201|NCT01988883|Propranolol|propranolol|mesh-list
139561202|NCT01988883|Modafinil|modafinil|mesh-list
139561203|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139561204|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139561205|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
139561206|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139561207|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561208|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561209|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139561210|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139561211|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
139561212|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139561213|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139561214|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139561215|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139561216|NCT04373356|Listerine|listerine|mesh-list
139561217|NCT04373356|Fluorides|fluorides|mesh-list
139561218|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
139561219|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
139561220|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
139561221|NCT04373356|Protective Agents|protective agents|mesh-ancestor
139561222|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561223|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139561224|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561225|NCT01745757|Paclitaxel|paclitaxel|mesh-list
139561226|NCT01745757|Bevacizumab|bevacizumab|mesh-list
139561227|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139561228|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561229|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
139561230|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
139561231|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
139561232|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561233|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139561234|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139561235|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139561236|NCT01745757|Growth Substances|growth substances|mesh-ancestor
139561237|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561238|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
139561239|NCT01709162|Ipilimumab|ipilimumab|mesh-list
139561240|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139561241|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561242|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139561243|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561244|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
139561245|NCT02243800|Vitamin D|vitamin d|mesh-list
139561246|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139561247|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561248|NCT02243800|Vitamins|vitamins|mesh-ancestor
139561249|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
139561250|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139561251|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139561252|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139561253|NCT04764045|Ropivacaine|ropivacaine|mesh-list
139561254|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
139561255|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
139561256|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561257|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561258|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
139561259|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561260|NCT01698554|Bimatoprost|bimatoprost|mesh-list
139561261|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139561262|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139561263|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139561264|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561265|NCT00895791|Umirolimus|umirolimus|mesh-list
139561266|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139561267|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139561268|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
139561269|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561270|NCT01698320|Albuterol|albuterol|mesh-list
139561271|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139561272|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
139561273|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561274|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561275|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139561276|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
139561277|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
139034418|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139561278|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139561279|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139561280|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139561281|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139561282|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
139561283|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139561284|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561285|NCT03401476|Morphine|morphine|mesh-list
139561286|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139561287|NCT03401476|Narcotics|narcotics|mesh-ancestor
139561288|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561289|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561290|NCT03401476|Analgesics|analgesics|mesh-ancestor
139561291|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
139561292|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561293|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
139561294|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139561295|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561296|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139561297|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561298|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139561299|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139561300|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139561301|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
139561302|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561303|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139561304|NCT01674855|Lenograstim|lenograstim|mesh-list
139561305|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139561306|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
139561307|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561308|NCT00924352|Dasatinib|dasatinib|mesh-list
139561309|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561310|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139561311|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561312|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561313|NCT01674933|Listerine|listerine|mesh-list
139561314|NCT01674933|Fluorides|fluorides|mesh-list
139561315|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
139561316|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
139561317|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
139561318|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
139561319|NCT01674933|Protective Agents|protective agents|mesh-ancestor
139561320|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561321|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139561322|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561323|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
139561324|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
139561325|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139561326|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139561327|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561328|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561329|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561330|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561331|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
139561332|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139561333|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561334|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
139561335|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139561336|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139561337|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139561338|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
139561339|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139561340|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561341|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561342|NCT01569152|Methotrexate|methotrexate|mesh-list
139561343|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139561344|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
139561345|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139561346|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561347|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139561348|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
139561349|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561350|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561351|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
139561352|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561353|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139561354|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139561355|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
139561356|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561357|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139561358|NCT01675557|Vitamin D|vitamin d|mesh-list
139561359|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
139561360|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
139561361|NCT01675557|Vitamins|vitamins|mesh-list
139561362|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
139561363|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561364|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139561365|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139561366|NCT01675947|Sirolimus|sirolimus|mesh-list
139561367|NCT01675947|Lidocaine|lidocaine|mesh-list
139561368|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
139561369|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
139561370|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561371|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561372|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
139561373|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561374|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139561375|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139561376|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139561377|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139561378|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561379|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139561380|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034510|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139561381|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139561382|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561383|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
139561384|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139561385|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
139561386|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139561387|NCT01567826|Atorvastatin|atorvastatin|mesh-list
139561388|NCT01567826|Simvastatin|simvastatin|mesh-list
139561389|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139561390|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139561391|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
139561392|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561393|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139561394|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139561395|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561396|NCT03743025|Dulaglutide|dulaglutide|mesh-list
139561397|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139561398|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561399|NCT02083107|Misoprostol|misoprostol|mesh-list
139561400|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139561401|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
139561402|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139561403|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561404|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139561405|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139561406|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
139561407|NCT02335905|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139561408|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139561409|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561410|NCT00925756|Maraviroc|maraviroc|mesh-list
139561411|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139561412|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139561413|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561414|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139561415|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139561416|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
139561417|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561418|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139561419|NCT04372732|Autoantibodies|autoantibodies|mesh-list
139561420|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
139561421|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561422|NCT02245126|Lidocaine|lidocaine|mesh-list
139561423|NCT02245126|Bupivacaine|bupivacaine|mesh-list
139561424|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
139561425|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
139561426|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561427|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561428|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
139561429|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561430|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139561431|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139561432|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139561433|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139561434|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561435|NCT04372342|Remifentanil|remifentanil|mesh-list
139561436|NCT04372342|Nalbuphine|nalbuphine|mesh-list
139561437|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139561438|NCT04372342|Narcotics|narcotics|mesh-ancestor
139561439|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561440|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561441|NCT04372342|Analgesics|analgesics|mesh-ancestor
139561442|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
139561443|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561444|NCT04372264|Acetaminophen|acetaminophen|mesh-list
139561445|NCT04372264|Ibuprofen|ibuprofen|mesh-list
139561446|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139561447|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139561448|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139561449|NCT04372264|Analgesics|analgesics|mesh-ancestor
139561450|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
139561451|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561452|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561453|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139561454|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561455|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139561456|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561457|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561458|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
139561459|NCT02083809|Oxytocin|oxytocin|mesh-list
139561460|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
139561461|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139561462|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561463|NCT02244112|Midazolam|midazolam|mesh-list
139561464|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139561465|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139561466|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561467|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561468|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139561469|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139561470|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139561471|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139561472|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
139561473|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
139561474|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
139561475|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
139561476|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139561477|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561478|NCT02244190|Ritonavir|ritonavir|mesh-list
139561479|NCT02244190|Tipranavir|tipranavir|mesh-list
139561480|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139561481|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139561482|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
139561483|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034739|NCT05637281|Indomethacin|indomethacin|mesh-list
139561484|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561485|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139561486|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139561487|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
139561488|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561489|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139561490|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139561491|NCT00926380|Denosumab|denosumab|mesh-list
139561492|NCT00926380|Teriparatide|teriparatide|mesh-list
139561493|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139561494|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561495|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139561496|NCT02244268|Tamsulosin|tamsulosin|mesh-list
139034796|NCT00463346|Acamprosate|acamprosate|mesh-list
139561497|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139561498|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139561499|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139561500|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
139561501|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139561502|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561503|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561504|NCT02244268|Urological Agents|urological agents|mesh-ancestor
139561505|NCT03630315|Bevacizumab|bevacizumab|mesh-list
139561506|NCT03630315|Ranibizumab|ranibizumab|mesh-list
139561507|NCT03630315|Aflibercept|aflibercept|mesh-list
139561508|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139561509|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561510|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139561511|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139561512|NCT03630315|Growth Substances|growth substances|mesh-ancestor
139561513|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561514|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
139561515|NCT00929344|Pregabalin|pregabalin|mesh-list
139034907|NCT00424008|Xhance|xhance|mesh-list
139561516|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139561517|NCT00929344|Analgesics|analgesics|mesh-ancestor
139561518|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
139561519|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561520|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561521|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
139561522|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139561523|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139561524|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561525|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139561526|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139561527|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139561528|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561529|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139561530|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139561531|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139561532|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139561533|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
139561534|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
139561535|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
139561536|NCT03630159|Tisagenlecleucel|tisagenlecleucel|mesh-list
139561537|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139561538|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561539|NCT03630159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139561540|NCT03630159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561541|NCT04371874|Aspirin|aspirin|mesh-list
139561542|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139561543|NCT04371874|Captopril|captopril|mesh-list
139561544|NCT04371874|Nitrendipine|nitrendipine|mesh-list
139561545|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139561546|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139561547|NCT04371874|Analgesics|analgesics|mesh-ancestor
139561548|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
139561549|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561550|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561551|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139561552|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561553|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139561554|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139561555|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561556|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139561557|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139561558|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561559|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
139561560|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139561561|NCT04371874|Diuretics|diuretics|mesh-ancestor
139561562|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
139561563|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139561564|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139561565|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139561566|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
139561567|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139561568|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139561569|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
139561570|NCT04376554|Amoxicillin|amoxicillin|mesh-list
139561571|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
139561572|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
139561573|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139561574|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139561575|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561576|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139561577|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561578|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561579|NCT03627741|Triamcinolone|triamcinolone|mesh-list
139561580|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139561581|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139561582|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139561583|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139561584|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
139561585|NCT03627741|Hormones|hormones|mesh-ancestor
139561586|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139561587|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561588|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139561589|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
139561590|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561591|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561592|NCT03626337|Thiamine|thiamine|mesh-list
139561593|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
139561594|NCT03626337|Vitamins|vitamins|mesh-ancestor
139561595|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
139561596|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561597|NCT00929578|Fluphenazine|fluphenazine|mesh-list
139561598|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
139561599|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
139561600|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139561601|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139561602|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561603|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561604|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139561605|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139561606|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
139561607|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139561608|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561609|NCT04371406|Azithromycin|azithromycin|mesh-list
139561610|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
139561611|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139561612|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561613|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
139561614|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139561615|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139561616|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561617|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561618|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561619|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
139561620|NCT03716739|Testosterone|testosterone|mesh-list
139561621|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
139561622|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
139561623|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139561624|NCT03716739|Androgens|androgens|mesh-ancestor
139561625|NCT03716739|Hormones|hormones|mesh-ancestor
139561626|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139561627|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561628|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139561629|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561630|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
139561631|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
139561632|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139561633|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139561634|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139561635|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139561636|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561637|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
139561638|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139561639|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561640|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139561641|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561642|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
139561643|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139561644|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561645|NCT03705429|Paclitaxel|paclitaxel|mesh-list
139561646|NCT03705429|Docetaxel|docetaxel|mesh-list
139561647|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139561648|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
139561649|NCT03705429|Trastuzumab|trastuzumab|mesh-list
139561650|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139561651|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561652|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
139561653|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
139561654|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
139561655|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561656|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139561657|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
139561658|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561659|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561660|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139561661|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
139561662|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139561663|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139561664|NCT04370782|Azithromycin|azithromycin|mesh-list
139561665|NCT04370782|Doxycycline|doxycycline|mesh-list
139561666|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
139561667|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
139561668|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139561669|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561670|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
139561671|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139561672|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139561673|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561674|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561675|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561676|NCT04370782|Astringents|astringents|mesh-ancestor
139561677|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561678|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
139561679|NCT03604653|Cisplatin|cisplatin|mesh-list
139035227|NCT01062087|Lidocaine|lidocaine|mesh-list
139561680|NCT03604653|Doxorubicin|doxorubicin|mesh-list
139561681|NCT03604653|Mitomycins|mitomycins|mesh-list
139561682|NCT03604653|Mitomycin|mitomycin|mesh-list
139561683|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561684|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139561685|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139561686|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139561687|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561688|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561689|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
139561690|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139561691|NCT04376086|Anesthetics|anesthetics|mesh-list
139561692|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561693|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561694|NCT04375852|Autoantibodies|autoantibodies|mesh-list
139561695|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
139561696|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561697|NCT04364464|Riociguat|riociguat|mesh-list
139561698|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
139561699|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561700|NCT01592240|Bococizumab|bococizumab|mesh-list
139561701|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139561702|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139561703|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
139561704|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561705|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139561706|NCT05620654|Paclitaxel|paclitaxel|mesh-list
139561707|NCT05620654|Cisplatin|cisplatin|mesh-list
139561708|NCT05620654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139561709|NCT05620654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561710|NCT05620654|Tubulin Modulators|tubulin modulators|mesh-ancestor
139561711|NCT05620654|Antimitotic Agents|antimitotic agents|mesh-ancestor
139561712|NCT05620654|Mitosis Modulators|mitosis modulators|mesh-ancestor
139561713|NCT05620654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561714|NCT04357522|Vaccines|vaccines|mesh-list
139561715|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139561716|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
139561717|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561718|NCT00005901|Pamidronate|pamidronate|mesh-list
139561719|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139561720|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561721|NCT04369534|Clopidogrel|clopidogrel|mesh-list
139561722|NCT04369534|Ticagrelor|ticagrelor|mesh-list
139561723|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139561724|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139561725|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139561726|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139561727|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
139561728|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035314|NCT00422058|Liraglutide|liraglutide|mesh-list
139561729|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561730|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561731|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
139561732|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561733|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
139561734|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
139561735|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
139561736|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
139561737|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
139561738|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139561739|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139561740|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561741|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561742|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561743|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561744|NCT03685149|Flecainide|flecainide|mesh-list
139561745|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139561746|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139561747|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139561748|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139561749|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561750|NCT04370080|Fluorides|fluorides|mesh-list
139561751|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
139561752|NCT04370080|Protective Agents|protective agents|mesh-ancestor
139561753|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561754|NCT01591616|Lidocaine|lidocaine|mesh-list
139561755|NCT01591616|Prilocaine|prilocaine|mesh-list
139561756|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
139561757|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
139561758|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561759|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561760|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
139561761|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561762|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139561763|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139561764|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139561765|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139561766|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561767|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
139561768|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139561769|NCT00938314|Hematinics|hematinics|mesh-ancestor
139561770|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139561771|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561772|NCT04370392|Anesthetics|anesthetics|mesh-list
139561773|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
139561774|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343436|NCT02989649|Hormones|hormones|mesh-ancestor
139561775|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561776|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
139561777|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561778|NCT04369222|Acetaminophen|acetaminophen|mesh-list
139561779|NCT04369222|Aspirin|aspirin|mesh-list
139561780|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
139561781|NCT04369222|Salicylates|salicylates|mesh-list
139561782|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139561783|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139561784|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139561785|NCT04369222|Analgesics|analgesics|mesh-ancestor
139561786|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
139561787|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561788|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561789|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
139561790|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561791|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
139561792|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
139561793|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
139561794|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561795|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139561796|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561797|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561798|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139561799|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139561800|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139561801|NCT01591460|Ribavirin|ribavirin|mesh-list
139561802|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139561803|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
139561804|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
139561805|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561806|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
139561807|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561808|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
139561809|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561810|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
139561811|NCT04363216|Vitamins|vitamins|mesh-ancestor
139561812|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
139561813|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561814|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
139561815|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561816|NCT04363216|Protective Agents|protective agents|mesh-ancestor
139561817|NCT03678675|Ketorolac|ketorolac|mesh-list
139561818|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139561819|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139561820|NCT03678675|Analgesics|analgesics|mesh-ancestor
139561821|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
139561822|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561823|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561824|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139561825|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561826|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139561827|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561828|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561829|NCT04363060|Amoxicillin|amoxicillin|mesh-list
139561830|NCT04363060|Azithromycin|azithromycin|mesh-list
139561831|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
139561832|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
139561833|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139561834|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139561835|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561836|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139561837|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561838|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561839|NCT01591382|Ketamine|ketamine|mesh-list
139561840|NCT01591382|Hydromorphone|hydromorphone|mesh-list
139561841|NCT01591382|Analgesics|analgesics|mesh-ancestor
139561842|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
139561843|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561844|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561845|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139561846|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139561847|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
139561848|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
139561849|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561850|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139561851|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139561852|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343508|NCT03653845|Epinephrine|epinephrine|mesh-list
139035501|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139561853|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561854|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139561855|NCT01591382|Narcotics|narcotics|mesh-ancestor
139561856|NCT03677817|Lidocaine|lidocaine|mesh-list
139561857|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
139561858|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
139561859|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561860|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561861|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
139561862|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561863|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139561864|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139561865|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139561866|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139561867|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561868|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
139561869|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139561870|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139561871|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561872|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139561873|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
139561874|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139561875|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139561876|NCT00928174|Fluorides|fluorides|mesh-list
139561877|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
139561878|NCT00928174|Protective Agents|protective agents|mesh-ancestor
139561879|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561880|NCT01696214|Fluticasone|fluticasone|mesh-list
139561881|NCT01696214|Xhance|xhance|mesh-list
139561882|NCT01696214|Theophylline|theophylline|mesh-list
139561883|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139561884|NCT01696214|Ipratropium|ipratropium|mesh-list
139561885|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139561886|NCT01696214|Montelukast|montelukast|mesh-list
139561887|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139561888|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139561889|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
139561890|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561891|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561892|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139561893|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
139561894|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
139561895|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139561896|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139561897|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139561898|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139561899|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
139561900|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139561901|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561902|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139561903|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
139561904|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139561905|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139561906|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139561907|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139561908|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
139561909|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139561910|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561911|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
139561912|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139561913|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139561914|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
139561915|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
139561916|NCT01696214|Hormones|hormones|mesh-ancestor
139561917|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
139561918|NCT03794037|Montelukast|montelukast|mesh-list
139561919|NCT03794037|Progesterone|progesterone|mesh-list
139561920|NCT03794037|Progestins|progestins|mesh-ancestor
139561921|NCT03794037|Hormones|hormones|mesh-ancestor
139561922|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139561923|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561924|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139561925|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
139561926|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139561927|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
139035647|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
139343581|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139561928|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139561929|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139561930|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561931|NCT04356508|Nivolumab|nivolumab|mesh-list
139561932|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139561933|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561934|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139561935|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561936|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
139561937|NCT04368598|Dexamethasone|dexamethasone|mesh-list
139561938|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
139561939|NCT04368598|BB 1101|bb 1101|mesh-list
139561940|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139561941|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139561942|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
139561943|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
139561944|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561945|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561946|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139561947|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
139561948|NCT04368598|Hormones|hormones|mesh-ancestor
139561949|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139561950|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139561951|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561952|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
139561953|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561954|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561955|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
139561956|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561957|NCT04368598|Expectorants|expectorants|mesh-ancestor
139561958|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
139561959|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139561960|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
139561961|NCT04368598|Protective Agents|protective agents|mesh-ancestor
139561962|NCT04368598|Antidotes|antidotes|mesh-ancestor
139561963|NCT05347641|Cytarabine|cytarabine|mesh-list
139561964|NCT05347641|Methotrexate|methotrexate|mesh-list
139561965|NCT05347641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139561966|NCT05347641|Immunologic Factors|immunologic factors|mesh-ancestor
139561967|NCT05347641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561968|NCT05347641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139561969|NCT05347641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139561970|NCT05347641|Abortifacient Agents|abortifacient agents|mesh-ancestor
139561971|NCT05347641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139561972|NCT05347641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139561973|NCT05347641|Antimetabolites|antimetabolites|mesh-ancestor
139561974|NCT05347641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561975|NCT05347641|Dermatologic Agents|dermatologic agents|mesh-ancestor
139561976|NCT05347641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139561977|NCT05347641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139561978|NCT05347641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139561979|NCT05347641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139561980|NCT05347641|Antiviral Agents|antiviral agents|mesh-ancestor
139561981|NCT05347641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139561982|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
139561983|NCT01696058|Olodaterol|olodaterol|mesh-list
139561984|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139561985|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
139561986|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139561987|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139561988|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139561989|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
139561990|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
139561991|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139561992|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
139561993|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035758|NCT00430638|Olmesartan|olmesartan|mesh-list
139561994|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139561995|NCT04368520|Vitamin D|vitamin d|mesh-list
139561996|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
139561997|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
139561998|NCT04368520|Vitamins|vitamins|mesh-list
139561999|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
139562000|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562001|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139562002|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139562003|NCT03790137|Fenfluramine|fenfluramine|mesh-list
139562004|NCT03790137|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139562005|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139562006|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139562007|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562009|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
139562010|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562011|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139562012|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139562013|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139562014|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
139562015|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562016|NCT03580317|Carbamazepine|carbamazepine|mesh-list
139562017|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
139562018|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
139562019|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139562020|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139562021|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562022|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139562023|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139562024|NCT03580317|Analgesics|analgesics|mesh-ancestor
139562025|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
139562026|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562027|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139562028|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139562029|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562030|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139562031|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139562032|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
139562033|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139562034|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
139562035|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562036|NCT04356118|Methotrexate|methotrexate|mesh-list
139562037|NCT04356118|Endostatins|endostatins|mesh-list
139562038|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139562039|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
139562040|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139562041|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562042|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139562043|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
139562044|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562045|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562046|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
139562047|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562048|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139562049|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139562050|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
139562051|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562052|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139562053|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139562054|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139562055|NCT04356118|Growth Substances|growth substances|mesh-ancestor
139562056|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
139562057|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
139562058|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
139562059|NCT04361812|Omalizumab|omalizumab|mesh-list
139562060|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139562061|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139562062|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139562063|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
139562064|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
139562065|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562066|NCT04355962|Sevoflurane|sevoflurane|mesh-list
139562067|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139562068|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139562069|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
139562070|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
139562071|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139562072|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562073|NCT00705081|Ezetimibe|ezetimibe|mesh-list
139562074|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139562075|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139562076|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
139562077|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562078|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139562080|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139562081|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
139562082|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562083|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562084|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562085|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139562086|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139562087|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
139562088|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
139562089|NCT00938548|Pregabalin|pregabalin|mesh-list
139562090|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562091|NCT00938548|Analgesics|analgesics|mesh-ancestor
139562092|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
139562093|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562094|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
139562095|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139562096|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139562097|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036075|NCT00307437|Ustekinumab|ustekinumab|mesh-list
139562098|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139562099|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139562100|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139562101|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139562102|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139562103|NCT00932620|Simvastatin|simvastatin|mesh-list
139562104|NCT00932620|Ezetimibe|ezetimibe|mesh-list
139562105|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139562106|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139562107|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
139562108|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562109|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139562110|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139562111|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562112|NCT04361188|Anesthetics|anesthetics|mesh-list
139562113|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139562114|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562115|NCT04367818|Anesthetics|anesthetics|mesh-list
139562116|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
139562117|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139562118|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562119|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
139562120|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562121|NCT01677273|Caseins|caseins|mesh-list
139562122|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
139562123|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
139562124|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562125|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139562126|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139562127|NCT04355806|Vaccines|vaccines|mesh-list
139562128|NCT04355806|Antibodies|antibodies|mesh-list
139562129|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
139562130|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139562131|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
139562132|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562133|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562134|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562135|NCT01677351|Clonidine|clonidine|mesh-list
139562136|NCT01677351|Analgesics|analgesics|mesh-ancestor
139562137|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
139562138|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562139|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562140|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139562141|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
139562142|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
139036165|NCT01565798|Copper|copper|mesh-list
139562143|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139562144|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139562145|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139562146|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
139562147|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562148|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562149|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139562150|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
139562151|NCT00938704|Glycerol|glycerol|mesh-list
139562152|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139562153|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
139562154|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562155|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
139562156|NCT00938704|Protective Agents|protective agents|mesh-ancestor
139562157|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139562158|NCT00938704|Laxatives|laxatives|mesh-ancestor
139562159|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139562160|NCT03666351|Losartan|losartan|mesh-list
139562161|NCT03666351|Amlodipine|amlodipine|mesh-list
139562162|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
139562163|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139562164|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139562165|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139562166|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562167|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139562168|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562169|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
139562170|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139562171|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139562172|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139562173|NCT03666351|Diuretics|diuretics|mesh-ancestor
139562174|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
139562175|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139562176|NCT00928642|Gemcitabine|gemcitabine|mesh-list
139562177|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
139562178|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139562179|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
139562180|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562181|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562182|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139562183|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562184|NCT04361422|Isotretinoin|isotretinoin|mesh-list
139562185|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
139562186|NCT03579615|Insulin|insulin|mesh-list
139562187|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
139562188|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139562189|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562190|NCT04355416|Curcumin|curcumin|mesh-list
139562191|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139562192|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139562193|NCT04355416|Analgesics|analgesics|mesh-ancestor
139562194|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
139562195|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562196|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562197|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139562198|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562199|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562200|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562201|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562202|NCT04355494|Eculizumab|eculizumab|mesh-list
139562203|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139562204|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139562205|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
139562206|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562207|NCT00934024|Varenicline|varenicline|mesh-list
139562208|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139562209|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139562210|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
139562211|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562212|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562213|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562214|NCT04361032|Deferoxamine|deferoxamine|mesh-list
139562215|NCT04361032|Siderophores|siderophores|mesh-ancestor
139562216|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139562217|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
139562218|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
139562219|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562220|NCT00928954|Gabapentin|gabapentin|mesh-list
139562221|NCT00928954|Memantine|memantine|mesh-list
139562222|NCT00928954|Analgesics|analgesics|mesh-ancestor
139562223|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
139562224|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562225|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562226|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
139562227|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139562228|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139562229|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139562230|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139562231|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139562232|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139562233|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562234|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562236|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139562237|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139562238|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
139562239|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
139562240|NCT04355026|Bromhexine|bromhexine|mesh-list
139562241|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
139562242|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139562243|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139562244|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562245|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562246|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564604|NCT00086255|Tiagabine|tiagabine|mesh-list
139562247|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562248|NCT04355026|Expectorants|expectorants|mesh-ancestor
139562249|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
139562250|NCT03548571|Temozolomide|temozolomide|mesh-list
139562251|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139562252|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
139562253|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562254|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562255|NCT00939562|Doxycycline|doxycycline|mesh-list
139562256|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139562257|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562258|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
139562259|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139562260|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139562261|NCT04359862|Propofol|propofol|mesh-list
139562262|NCT04359862|Sevoflurane|sevoflurane|mesh-list
139562263|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139562264|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139562265|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562266|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139562267|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
139562268|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
139562269|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139562270|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139562271|NCT04366960|Enoxaparin|enoxaparin|mesh-list
139562272|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
139562273|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139562274|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139562275|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562276|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
139562277|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139562278|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139562279|NCT03539445|Protective Agents|protective agents|mesh-ancestor
139562280|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562281|NCT04360876|Dexamethasone|dexamethasone|mesh-list
139562282|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
139562283|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139562284|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
139562285|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
139562286|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562287|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562288|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139562289|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
139562290|NCT04360876|Hormones|hormones|mesh-ancestor
139562291|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139562292|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139562293|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562294|NCT04359550|Antibodies|antibodies|mesh-list
139562295|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139562296|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
139562297|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562298|NCT02084511|Celecoxib|celecoxib|mesh-list
139562299|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139562300|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139562301|NCT02084511|Analgesics|analgesics|mesh-ancestor
139562302|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
139562303|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562304|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562305|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139562306|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562307|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139562308|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139562309|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562310|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562311|NCT00942448|Diclofenac|diclofenac|mesh-list
139562312|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139562313|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139562314|NCT00942448|Analgesics|analgesics|mesh-ancestor
139562315|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
139562316|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562317|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562318|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139562319|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562320|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139562321|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562322|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562323|NCT02982148|Methylene Blue|methylene blue|mesh-list
139562324|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562325|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562326|NCT04359316|Azithromycin|azithromycin|mesh-list
139562327|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
139562328|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139562329|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562330|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
139562331|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139562332|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139562333|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562334|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562335|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562336|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
139562337|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139562338|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139562339|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
139562340|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562341|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139562342|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139562343|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562344|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562345|NCT03557385|Adenosine|adenosine|mesh-list
139562346|NCT03557385|Analgesics|analgesics|mesh-ancestor
139562347|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
139562348|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562349|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562350|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139562351|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
139562352|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139562353|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
139562354|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
139562355|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562356|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562357|NCT05346861|Trastuzumab|trastuzumab|mesh-list
139562358|NCT05346861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139562359|NCT05346861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562360|NCT04358614|Ritonavir|ritonavir|mesh-list
139562361|NCT04358614|Lopinavir|lopinavir|mesh-list
139562362|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139562363|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139562364|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
139562365|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562366|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562367|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139562368|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139562369|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
139562370|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562371|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139562372|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139562373|NCT01670409|Cisplatin|cisplatin|mesh-list
139562374|NCT01670409|Fluorouracil|fluorouracil|mesh-list
139562375|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562376|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
139344045|NCT03650881|Adapalene|adapalene|mesh-list
139562377|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562378|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139562379|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139562380|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
139562381|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562382|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139562383|NCT04761705|Latanoprost|latanoprost|mesh-list
139562384|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139562385|NCT04358770|Clocortolone|clocortolone|mesh-list
139562386|NCT04358770|Fluocortolone|fluocortolone|mesh-list
139562387|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
139562388|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139562389|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
139562390|NCT04358770|Hormones|hormones|mesh-ancestor
139562391|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139562392|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562393|NCT05618470|Botulinum Toxins|botulinum toxins|mesh-list
139562394|NCT05618470|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139562395|NCT05618470|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139562396|NCT05618470|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139562397|NCT05618470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139562398|NCT05618470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562399|NCT05618470|Cholinergic Agents|cholinergic agents|mesh-ancestor
139562400|NCT05618470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139037042|NCT01041066|Labetalol|labetalol|mesh-list
139562401|NCT05618470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562402|NCT05618470|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139562403|NCT05618470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562404|NCT04358146|Locust bean gum|locust bean gum|mesh-list
139562405|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
139562406|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139562407|NCT05620498|Lenvatinib|lenvatinib|mesh-list
139562408|NCT05620498|Tislelizumab|tislelizumab|mesh-list
139562409|NCT05620498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562410|NCT05620498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139562411|NCT05620498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562412|NCT05620498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562413|NCT05620498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139562414|NCT01670565|Mycophenolic Acid|mycophenolic acid|mesh-list
139562415|NCT01670565|Belimumab|belimumab|mesh-list
139562416|NCT01670565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139562417|NCT01670565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562418|NCT01670565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139562419|NCT01670565|Antitubercular Agents|antitubercular agents|mesh-ancestor
139562420|NCT01670565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139562421|NCT01670565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562422|NCT01670565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562423|NCT01670565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562424|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139562425|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
139562426|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562427|NCT01670799|Ketorolac|ketorolac|mesh-list
139562428|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139562429|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139562430|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139562431|NCT01670799|Analgesics|analgesics|mesh-ancestor
139562432|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
139562433|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562434|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562435|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139562436|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562437|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139562438|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562439|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562440|NCT02404935|Cetuximab|cetuximab|mesh-list
139562441|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139562442|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562443|NCT04320940|Phenobarbital|phenobarbital|mesh-list
139562444|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
139562445|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139037213|NCT01037660|Metformin|metformin|mesh-list
139562446|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139562447|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562448|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139562449|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139562450|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562451|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562452|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
139562453|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
139562454|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139562455|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139562456|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139562458|NCT03422523|Atezolizumab|atezolizumab|mesh-list
139562459|NCT03422523|Gemcitabine|gemcitabine|mesh-list
139562460|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
139562461|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139562462|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562463|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
139562464|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562465|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562466|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139562467|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
139562468|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562469|NCT03422523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139562470|NCT03032536|Tenofovir|tenofovir|mesh-list
139562471|NCT03032536|Entecavir|entecavir|mesh-list
139562472|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
139562473|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562474|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139562475|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139562476|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562477|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562478|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139562479|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139562480|NCT03032614|Carboplatin|carboplatin|mesh-list
139562481|NCT03032614|Veliparib|veliparib|mesh-list
139562482|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562483|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139562484|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562485|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562486|NCT03032458|Ketorolac|ketorolac|mesh-list
139562487|NCT03032458|Lidocaine|lidocaine|mesh-list
139562488|NCT03032458|Meperidine|meperidine|mesh-list
139562489|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
139562490|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
139562491|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139562492|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562493|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
139562494|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562495|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139562496|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139562497|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139562498|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139562499|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562500|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139562501|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139562502|NCT03032458|Analgesics|analgesics|mesh-ancestor
139562503|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139562504|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562505|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139562506|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562507|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139562508|NCT03032458|Narcotics|narcotics|mesh-ancestor
139562509|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139562510|NCT02245438|Ritonavir|ritonavir|mesh-list
139562511|NCT02245438|Tipranavir|tipranavir|mesh-list
139562512|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139562513|NCT02245438|Norethindrone|norethindrone|mesh-list
139562514|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
139562515|NCT02245438|Norinyl|norinyl|mesh-list
139562516|NCT02245438|Estradiol|estradiol|mesh-list
139562517|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139562518|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139562519|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
139562520|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562521|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562522|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139562523|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139037394|NCT00403494|Verapamil|verapamil|mesh-list
139562524|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
139562525|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562526|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139562527|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139562528|NCT02245438|Estrogens|estrogens|mesh-ancestor
139562529|NCT02245438|Hormones|hormones|mesh-ancestor
139562530|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139562531|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562532|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139562533|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
139562534|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139562535|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139562536|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139562537|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139562538|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139562539|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139562540|NCT03087669|Norepinephrine|norepinephrine|mesh-list
139562541|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139562542|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139562543|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
139562544|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562545|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562546|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562547|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
139562548|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
139562549|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562550|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139562551|NCT00939952|Ertapenem|ertapenem|mesh-list
139562552|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139562553|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562554|NCT02401815|Sunitinib|sunitinib|mesh-list
139562555|NCT02401815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562556|NCT02401815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139562557|NCT02401815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139562558|NCT02401815|Growth Substances|growth substances|mesh-ancestor
139562559|NCT02401815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037421|NCT00406848|Analgesics|analgesics|mesh-ancestor
139562560|NCT02401815|Growth Inhibitors|growth inhibitors|mesh-ancestor
139562561|NCT02401815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139562562|NCT02401815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562563|NCT02401815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562564|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
139562565|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
139562566|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139562567|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
139562568|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562569|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139562570|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562571|NCT03456687|Exenatide|exenatide|mesh-list
139562572|NCT03456687|Glucagon|glucagon|mesh-list
139562573|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139562574|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139562575|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562576|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139562577|NCT03456687|Incretins|incretins|mesh-ancestor
139562578|NCT03456687|Hormones|hormones|mesh-ancestor
139562579|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139562580|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139562581|NCT00948298|Vitamin D|vitamin d|mesh-list
139562582|NCT00948298|Vitamins|vitamins|mesh-ancestor
139562583|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
139562584|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562585|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139562586|NCT00948610|Infliximab|infliximab|mesh-list
139562587|NCT00948610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139562588|NCT00948610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139562589|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
139562590|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139562591|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562592|NCT03031834|Quinapril|quinapril|mesh-list
139562593|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139562594|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
139562595|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562596|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562597|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139562598|NCT00944554|Varenicline|varenicline|mesh-list
139562599|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139562600|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139562601|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
139562602|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562603|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562605|NCT03031756|Glycine|glycine|mesh-list
139562606|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
139562607|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562608|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562609|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562610|NCT00944710|Atropine|atropine|mesh-list
139562611|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139562612|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139562613|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139562614|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
139562615|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562616|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562617|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139562618|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
139562619|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
139562620|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
139562621|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139562622|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139562623|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
139562624|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562625|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562626|NCT00949078|Omalizumab|omalizumab|mesh-list
139562627|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139562628|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139562629|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
139562630|NCT00945256|Nitroprusside|nitroprusside|mesh-list
139562631|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139562632|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
139562633|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139562634|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562635|NCT03854032|Nivolumab|nivolumab|mesh-list
139562636|NCT03854032|Linrodostat|linrodostat|mesh-list
139562637|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139562638|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562639|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139562640|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562641|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562642|NCT03031444|Leucovorin|leucovorin|mesh-list
139562643|NCT03031444|Cetuximab|cetuximab|mesh-list
139562644|NCT03031444|Fluorouracil|fluorouracil|mesh-list
139562645|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
139562646|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139562647|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562648|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
139562649|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562650|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139562651|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139562652|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
139562653|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562654|NCT03031444|Antidotes|antidotes|mesh-ancestor
139562655|NCT03031444|Protective Agents|protective agents|mesh-ancestor
139562656|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
139562657|NCT03031444|Vitamins|vitamins|mesh-ancestor
139562658|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
139562659|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
139562660|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139562661|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
139562662|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562663|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
139562664|NCT03031054|Protective Agents|protective agents|mesh-ancestor
139562665|NCT00945334|Rifaximin|rifaximin|mesh-list
139562666|NCT00945334|Neomycin|neomycin|mesh-list
139562667|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139562668|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562669|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139562670|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139562671|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562672|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562673|NCT03559114|Dalteparin|dalteparin|mesh-list
139562674|NCT03559114|Tinzaparin|tinzaparin|mesh-list
139562675|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139562676|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
139562677|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139562678|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139037658|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139562679|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562680|NCT05153590|Liraglutide|liraglutide|mesh-list
139562681|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139562682|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562683|NCT05153590|Incretins|incretins|mesh-ancestor
139562684|NCT05153590|Hormones|hormones|mesh-ancestor
139562685|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139562686|NCT03490864|Melatonin|melatonin|mesh-list
139562687|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
139562688|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562689|NCT03490864|Protective Agents|protective agents|mesh-ancestor
139562690|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562691|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139562692|NCT04402203|Favipiravir|favipiravir|mesh-list
139562693|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
139562694|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562695|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
139562696|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139562697|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
139562698|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562699|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562700|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139562701|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
139562702|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562703|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562704|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139562705|NCT00949234|Ritonavir|ritonavir|mesh-list
139562706|NCT00949234|Lopinavir|lopinavir|mesh-list
139562707|NCT00949234|Tenofovir|tenofovir|mesh-list
139562708|NCT00949234|Emtricitabine|emtricitabine|mesh-list
139562709|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139562710|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139562711|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
139562712|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562713|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562714|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139562715|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139562716|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
139562717|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562718|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139037756|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139562719|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139562720|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139562721|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139562722|NCT03090880|Tinzaparin|tinzaparin|mesh-list
139562723|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139562724|NCT03090880|Dalteparin|dalteparin|mesh-list
139562725|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
139562726|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139562727|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139562728|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562729|NCT03030430|Bevacizumab|bevacizumab|mesh-list
139562730|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139562731|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562732|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139562733|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139562734|NCT03030430|Growth Substances|growth substances|mesh-ancestor
139562735|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562736|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
139562737|NCT00089661|Denosumab|denosumab|mesh-list
139562738|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139562739|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562740|NCT00941668|Triclosan|triclosan|mesh-list
139562741|NCT00941668|Fluorides|fluorides|mesh-list
139562742|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
139562743|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
139562744|NCT00941668|Protective Agents|protective agents|mesh-ancestor
139562745|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562746|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139562747|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562748|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139562749|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139562750|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
139344413|NCT03934671|Protective Agents|protective agents|mesh-ancestor
139562751|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562752|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139562753|NCT01597414|Trastuzumab|trastuzumab|mesh-list
139562754|NCT01597414|Pertuzumab|pertuzumab|mesh-list
139562755|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139562756|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562757|NCT04984330|Dexamethasone|dexamethasone|mesh-list
139562758|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139562759|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
139562760|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
139562761|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562762|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562763|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139562764|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
139562765|NCT04984330|Hormones|hormones|mesh-ancestor
139562766|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139562767|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139562768|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562769|NCT03030196|Denosumab|denosumab|mesh-list
139562770|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139562771|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562772|NCT03035578|Morphine|morphine|mesh-list
139562773|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139562774|NCT03035578|Narcotics|narcotics|mesh-ancestor
139562775|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139562776|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562777|NCT03035578|Analgesics|analgesics|mesh-ancestor
139562778|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
139562779|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562780|NCT04933942|Lomustine|lomustine|mesh-list
139562781|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139562782|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
139562783|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562784|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562785|NCT00089583|Ritonavir|ritonavir|mesh-list
139562786|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
139562787|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139562788|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139562789|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
139562790|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562791|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562792|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139562793|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139562794|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
139562795|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562796|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139562797|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139562798|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
139562799|NCT03029494|Vitamins|vitamins|mesh-ancestor
139562800|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
139562801|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562802|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
139562803|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562804|NCT03029494|Protective Agents|protective agents|mesh-ancestor
139562805|NCT04402047|Diclofenac|diclofenac|mesh-list
139562806|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139562807|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139562808|NCT04402047|Analgesics|analgesics|mesh-ancestor
139562809|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
139562810|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562811|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562812|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139562813|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562814|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139562815|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562816|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562817|NCT03017248|Ketamine|ketamine|mesh-list
139562818|NCT03017248|Morphine|morphine|mesh-list
139562819|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139038109|NCT01045980|Vitamin D|vitamin d|mesh-list
139562820|NCT03017248|Analgesics|analgesics|mesh-ancestor
139562821|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
139562822|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562823|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562824|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139562825|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139562826|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
139562827|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
139562828|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139562829|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139562830|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139562831|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562832|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562833|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139562834|NCT03017248|Narcotics|narcotics|mesh-ancestor
139562835|NCT00088881|Prednisone|prednisone|mesh-list
139562836|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
139562837|NCT00088881|Rituximab|rituximab|mesh-list
139562838|NCT00088881|Doxorubicin|doxorubicin|mesh-list
139562839|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139562840|NCT00088881|Vincristine|vincristine|mesh-list
139562841|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139562842|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
139562843|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562844|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562845|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139562846|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
139562847|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562848|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562849|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139562850|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139562851|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139562852|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139562853|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139562854|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562855|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139562856|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
139562857|NCT00088881|Hormones|hormones|mesh-ancestor
139562858|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139562859|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139562860|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139562861|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
139562862|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
139562863|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
139562864|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
139562865|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139562866|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562867|NCT02981914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139562868|NCT02981914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562869|NCT03025750|Vaccines|vaccines|mesh-list
139562870|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
139562871|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562872|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
139562873|NCT03017404|Docetaxel|docetaxel|mesh-list
139562874|NCT03017404|Doxorubicin|doxorubicin|mesh-list
139562875|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139562876|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139038203|NCT00413660|Tofacitinib|tofacitinib|mesh-list
139562877|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
139562878|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562879|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562880|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139562881|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
139562882|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562883|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562884|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139562885|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
139562886|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
139562887|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
139562888|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139562889|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139562890|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139562891|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562892|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
139562893|NCT00953212|Amiodarone|amiodarone|mesh-list
139562894|NCT00953212|Metoprolol|metoprolol|mesh-list
139562895|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139562896|NCT00953212|Vitamins|vitamins|mesh-ancestor
139562897|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
139562898|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562899|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
139562900|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562901|NCT00953212|Protective Agents|protective agents|mesh-ancestor
139562902|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139562903|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
139562904|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562905|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139562906|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
139562907|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139562908|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139562909|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139562910|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139562911|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139562912|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562913|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139562914|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139562915|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139562916|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139562917|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
139562918|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
139562919|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562920|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139562921|NCT03034408|Mannitol|mannitol|mesh-list
139562922|NCT03034408|Baclofen|baclofen|mesh-list
139562923|NCT03034408|Nalmefene|nalmefene|mesh-list
139562924|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139562925|NCT03034408|Diuretics|diuretics|mesh-ancestor
139562926|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
139562927|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562928|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139562929|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139562930|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562931|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139562932|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
139562933|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
139562934|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562935|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562936|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139562937|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
139562938|NCT03023020|Aspirin|aspirin|mesh-list
139562939|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139562940|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139562941|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139562942|NCT03023020|Analgesics|analgesics|mesh-ancestor
139562943|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
139562944|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139562945|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562946|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139562947|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139562948|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139562949|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139562950|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562951|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139562952|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562953|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
139562954|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
139562955|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139562956|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139562957|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139562958|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
139562959|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
139562960|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139562961|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562962|NCT03022318|Levodopa|levodopa|mesh-list
139562963|NCT03022318|Carbidopa|carbidopa|mesh-list
139562964|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139562965|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139562966|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139562967|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
139562968|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139562969|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139562970|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562971|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139562972|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139562973|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139562974|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
139562975|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
139562976|NCT01677897|Metformin|metformin|mesh-list
139562977|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139562978|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344649|NCT04343651|Leronlimab|leronlimab|mesh-list
139562979|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139562981|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139562982|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562983|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
139562984|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139562985|NCT03086733|Metformin|metformin|mesh-list
139562986|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139562987|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562988|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
139562989|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139562990|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139562991|NCT00085917|Interferons|interferons|mesh-list
139562992|NCT00085917|Ribavirin|ribavirin|mesh-list
139562993|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
139562994|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139562995|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139562996|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
139562997|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139562998|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
139562999|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563000|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
139563001|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563002|NCT00084747|Bortezomib|bortezomib|mesh-list
139563003|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563004|NCT04402671|Glutaral|glutaral|mesh-list
139563005|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
139563006|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563007|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
139563008|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139563009|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563010|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139563011|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563012|NCT01678365|Metronidazole|metronidazole|mesh-list
139563013|NCT01678365|Gentamicins|gentamicins|mesh-list
139563014|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
139563015|NCT01678365|Ampicillin|ampicillin|mesh-list
139563016|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563017|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139563018|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139563019|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139563020|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139563021|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563022|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563023|NCT00946270|Thalidomide|thalidomide|mesh-list
139563024|NCT00946270|Prednisone|prednisone|mesh-list
139563025|NCT00946270|Pomalidomide|pomalidomide|mesh-list
139563026|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139563027|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
139563028|NCT00946270|Hormones|hormones|mesh-ancestor
139563029|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139563030|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563031|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139563032|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563033|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
139563034|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139563035|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139563036|NCT00946270|Growth Substances|growth substances|mesh-ancestor
139563037|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
139563038|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139563039|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
139563040|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139563041|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563042|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
139563043|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139563044|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563045|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139563046|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139563047|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038781|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139038791|NCT00232180|Diuretics|diuretics|mesh-ancestor
139563048|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563049|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563050|NCT03021694|Caseins|caseins|mesh-list
139563051|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
139563052|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
139563053|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563054|NCT00956254|Fentanyl|fentanyl|mesh-list
139563055|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139563056|NCT00956254|Narcotics|narcotics|mesh-ancestor
139563057|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563058|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563059|NCT00956254|Analgesics|analgesics|mesh-ancestor
139563060|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
139563061|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563062|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139563063|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139563064|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
139563065|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
139563066|NCT03020680|Ubiquinone|ubiquinone|mesh-list
139563067|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
139563068|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
139563069|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563070|NCT03020680|Vitamins|vitamins|mesh-ancestor
139563071|NCT01678599|Benzonidazole|benzonidazole|mesh-list
139563072|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139563073|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
139563074|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563075|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139563076|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139563077|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139563078|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563079|NCT03019822|Amphetamine|amphetamine|mesh-list
139563080|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
138696643|NCT01230307|Vitamin D|vitamin d|mesh-list
139563081|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139563082|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139563083|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139563084|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563085|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
139563086|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
139563087|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563088|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
139563089|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139563090|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563091|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
139563092|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139563093|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139563094|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139563095|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139563096|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
139563097|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139563098|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
139038948|NCT00404066|Docetaxel|docetaxel|mesh-list
139563099|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139563100|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139563101|NCT01678677|Vaccines|vaccines|mesh-list
139563102|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
139563103|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563104|NCT00946348|Dronabinol|dronabinol|mesh-list
139563105|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
139563106|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563107|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139563108|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139563109|NCT00946348|Analgesics|analgesics|mesh-ancestor
139563110|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
139563111|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563112|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139563113|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139563114|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039014|NCT00384930|Tadalafil|tadalafil|mesh-list
139563115|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563116|NCT00946348|Hormones|hormones|mesh-ancestor
139563117|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139563118|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
139563119|NCT00081159|Doxorubicin|doxorubicin|mesh-list
139563120|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139563121|NCT00081159|Leuprolide|leuprolide|mesh-list
139563122|NCT00081159|Goserelin|goserelin|mesh-list
139563123|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139563124|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563125|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139563126|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139563127|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563128|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563129|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139563130|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563131|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139563132|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
139563133|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139563134|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139563135|NCT03033472|Clindamycin|clindamycin|mesh-list
139563136|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
139563137|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
139563138|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139563139|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563140|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139563141|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563142|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563143|NCT02981836|Vaccines|vaccines|mesh-list
139563144|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
139563145|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563146|NCT03033160|Estradiol|estradiol|mesh-list
139563147|NCT03033160|Estrogens|estrogens|mesh-ancestor
139563148|NCT03033160|Hormones|hormones|mesh-ancestor
139563149|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139563150|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563151|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139563152|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139563153|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563154|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139563155|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139563156|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139563157|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563158|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
139563159|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139563160|NCT03033316|Dexamethasone|dexamethasone|mesh-list
139563161|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139563162|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
139563163|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
139563164|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563165|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563166|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139563167|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
139563168|NCT03033316|Hormones|hormones|mesh-ancestor
139563169|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139563170|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139039100|NCT01042782|Everolimus|everolimus|mesh-list
139563171|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563172|NCT03032848|Estrogens|estrogens|mesh-list
139563173|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139563174|NCT03032848|Hormones|hormones|mesh-ancestor
139563175|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139563176|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563177|NCT00080223|Pirfenidone|pirfenidone|mesh-list
139563178|NCT00080223|Analgesics|analgesics|mesh-ancestor
139563179|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
139563180|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563181|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563182|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139563183|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139563184|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139563185|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139563186|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563187|NCT04402359|Meropenem|meropenem|mesh-list
139563188|NCT04402359|Ceftazidime|ceftazidime|mesh-list
139563189|NCT04402359|Avibactam|avibactam|mesh-list
139563190|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139563191|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563192|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139563193|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563194|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563195|NCT00959764|Calcitonin|calcitonin|mesh-list
139563196|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
139563197|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139563198|NCT00959764|Katacalcin|katacalcin|mesh-list
139563199|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139563200|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563201|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139563202|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
139563203|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
139563204|NCT01005706|Sirolimus|sirolimus|mesh-list
139563205|NCT01005706|Temsirolimus|temsirolimus|mesh-list
139344863|NCT02980133|Fluticasone|fluticasone|mesh-list
139563206|NCT01005706|MTOR Inhibitors|mtor inhibitors|mesh-list
139563208|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139563209|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
139563210|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563211|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139563212|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563213|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563214|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139563215|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563216|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139563217|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
139563218|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139563219|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563220|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
139563221|NCT01005706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139563222|NCT01679691|Anesthetics|anesthetics|mesh-list
139563223|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563224|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563225|NCT03470805|Olaparib|olaparib|mesh-list
139563226|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139563227|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563228|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563229|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563230|NCT03084549|Ropivacaine|ropivacaine|mesh-list
139563231|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
139563232|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
139563233|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563234|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563235|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
139563236|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563237|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139563238|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563239|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
139563240|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563241|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139563242|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139563243|NCT01006252|Paclitaxel|paclitaxel|mesh-list
139563244|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139563245|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563246|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
139563247|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
139563248|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
139563249|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563250|NCT03080805|Capecitabine|capecitabine|mesh-list
139563251|NCT03080805|Lapatinib|lapatinib|mesh-list
139563252|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139563253|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
139563254|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563255|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563256|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139563257|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563258|NCT03019120|Vitamin D|vitamin d|mesh-list
139563259|NCT03019120|Vitamins|vitamins|mesh-ancestor
139563260|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
139563261|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563262|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139563263|NCT00960622|Tenofovir|tenofovir|mesh-list
139563264|NCT00960622|Lamivudine|lamivudine|mesh-list
139563265|NCT00960622|Emtricitabine|emtricitabine|mesh-list
139563266|NCT00960622|Zidovudine|zidovudine|mesh-list
139563267|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139563268|NCT00960622|Abacavir|abacavir|mesh-list
139563269|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
139563270|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139563271|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
139563272|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563273|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139563274|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139563275|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563276|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563277|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139563278|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139563279|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
139563280|NCT03430947|Vemurafenib|vemurafenib|mesh-list
139563281|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563282|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139563283|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563284|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563285|NCT00960778|Nicotine|nicotine|mesh-list
139563286|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139563287|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
139563288|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563289|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563290|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139563291|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139563292|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
139563293|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039418|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139563294|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563295|NCT03080181|Pasireotide|pasireotide|mesh-list
139563296|NCT03080181|Hormones|hormones|mesh-ancestor
139563297|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139563298|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563299|NCT03088293|Infliximab|infliximab|mesh-list
139563300|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
139563301|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139563302|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
139563303|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563304|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139039471|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139563305|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139563306|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
139563307|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563308|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563309|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139563310|NCT03088293|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139563311|NCT03088293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139563312|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
139563313|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139563314|NCT01008280|Baclofen|baclofen|mesh-list
139563315|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139563316|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563317|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139563318|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563319|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139563320|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
139563321|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
139563322|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139563323|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563324|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139563325|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
139563326|NCT03089073|Coagulants|coagulants|mesh-ancestor
139563327|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139563328|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
139563329|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563330|NCT05688813|Anesthetics|anesthetics|mesh-list
139563331|NCT05688813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563332|NCT05688813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563333|NCT01009918|Carvedilol|carvedilol|mesh-list
139563334|NCT01009918|Lisinopril|lisinopril|mesh-list
139563335|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139563336|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139563337|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
139563338|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139563339|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563340|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563341|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139563342|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
139563343|NCT01009918|Protective Agents|protective agents|mesh-ancestor
139563344|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138867823|NCT02849873|Tazarotene|tazarotene|mesh-list
139563345|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139563346|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139563347|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
139563348|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139563349|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139563350|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139563351|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
139563352|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563353|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139563354|NCT04401657|Adenosine|adenosine|mesh-list
139563355|NCT04401657|Analgesics|analgesics|mesh-ancestor
139563356|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
139563357|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563358|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563359|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139563360|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
139563361|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139563362|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
139563363|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
139563364|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139563365|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563366|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
139563367|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139563368|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139563369|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563370|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
139563371|NCT03019198|Coagulants|coagulants|mesh-ancestor
139563372|NCT03083613|Paclitaxel|paclitaxel|mesh-list
139563373|NCT03083613|Raltitrexed|raltitrexed|mesh-list
139563374|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139563375|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563376|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
139563377|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
139563378|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
138867862|NCT00617760|Vaccines|vaccines|mesh-list
139563379|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563380|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139563381|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
139563382|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139563383|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563384|NCT00963508|Permethrin|permethrin|mesh-list
139563385|NCT00963508|Malathion|malathion|mesh-list
139563386|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563387|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563388|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139563389|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
139563390|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139563391|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563392|NCT03088371|Lidocaine|lidocaine|mesh-list
139563393|NCT03088371|Bupivacaine|bupivacaine|mesh-list
139563394|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
139563395|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
139563396|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563397|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563398|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
139563399|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563400|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139563401|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139563402|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139563403|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139563404|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563405|NCT05685537|Simendan|simendan|mesh-list
139563406|NCT05685537|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139563407|NCT05685537|Vasodilator Agents|vasodilator agents|mesh-ancestor
139563408|NCT05685537|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139563409|NCT05685537|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139563410|NCT05685537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563411|NCT05685537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563412|NCT05685537|Protective Agents|protective agents|mesh-ancestor
139563413|NCT05685537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563414|NCT04400721|Ropivacaine|ropivacaine|mesh-list
139563415|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
139563416|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
139563417|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563418|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563419|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
139563420|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563421|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139563422|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
139563423|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
139563424|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563425|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
139563426|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139563427|NCT03018652|Antibodies|antibodies|mesh-list
139345090|NCT02417103|Liraglutide|liraglutide|mesh-list
139563428|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
139563429|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139563430|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
139563431|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563432|NCT01012336|Dexamethasone|dexamethasone|mesh-list
139563433|NCT01012336|Aprepitant|aprepitant|mesh-list
139563434|NCT01012336|Ramosetron|ramosetron|mesh-list
139563435|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139563436|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
139563437|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
139563438|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563439|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563440|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139563441|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
139563442|NCT01012336|Hormones|hormones|mesh-ancestor
139563443|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139563444|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139563445|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563446|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139563447|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139563448|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563449|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139563450|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
139563451|NCT03387501|Mitogens|mitogens|mesh-list
139563452|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
139563453|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563454|NCT01012492|Abatacept|abatacept|mesh-list
139563455|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139563456|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563457|NCT01012492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139563458|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563459|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139563460|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
139563461|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563462|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139563463|NCT05688345|Dexmedetomidine|dexmedetomidine|mesh-list
139563464|NCT05688345|Propofol|propofol|mesh-list
139563465|NCT05688345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139563466|NCT05688345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563467|NCT05688345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563468|NCT05688345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139563469|NCT05688345|Analgesics|analgesics|mesh-ancestor
139563470|NCT05688345|Sensory System Agents|sensory system agents|mesh-ancestor
139563471|NCT05688345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563472|NCT05688345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139563473|NCT05688345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139563474|NCT05688345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139563475|NCT05688345|Adrenergic Agents|adrenergic agents|mesh-ancestor
139563476|NCT05688345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139563477|NCT05688345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563478|NCT05688345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139563479|NCT05688345|Anesthetics, General|anesthetics, general|mesh-ancestor
139563480|NCT05688345|Anesthetics|anesthetics|mesh-ancestor
139563481|NCT03083457|Anesthetics|anesthetics|mesh-list
139563482|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
138868136|NCT01497509|Narcotics|narcotics|mesh-ancestor
139563483|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563484|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563485|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
139563486|NCT04401345|Bromides|bromides|mesh-list
139563487|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
139563488|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139563489|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139563490|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139563491|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
139563492|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139563493|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563494|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563495|NCT01015534|Temozolomide|temozolomide|mesh-list
139563496|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139563497|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
138868175|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
139563498|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563499|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563500|NCT00968890|Vaccines|vaccines|mesh-list
139563501|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
139563502|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563503|NCT00970216|Telbivudine|telbivudine|mesh-list
139563504|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
139563505|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563506|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139563507|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563508|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563509|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
139563510|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139563511|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139563512|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139563513|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139563514|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563515|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
139563516|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139563517|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563518|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139563519|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563520|NCT01884922|Vinblastine|vinblastine|mesh-list
139563521|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139563522|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563523|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
139563524|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
139563525|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
139563526|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563527|NCT05687409|Entecavir|entecavir|mesh-list
139563528|NCT05687409|Lactulose|lactulose|mesh-list
139563529|NCT05687409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139563530|NCT05687409|Antiviral Agents|antiviral agents|mesh-ancestor
139563531|NCT05687409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563532|NCT05687409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139563533|NCT02162680|Lidocaine|lidocaine|mesh-list
139563534|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
139563535|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
139563536|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563537|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563538|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
139563539|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563540|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139563541|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139563542|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139563543|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139563544|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563545|NCT01017250|Bevacizumab|bevacizumab|mesh-list
139563546|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139563547|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563548|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139563549|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139563550|NCT01017250|Growth Substances|growth substances|mesh-ancestor
139563551|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868340|NCT04315350|Analgesics|analgesics|mesh-ancestor
139563552|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
139563553|NCT00812032|Aspirin|aspirin|mesh-list
139563554|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139563555|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139563556|NCT00812032|Analgesics|analgesics|mesh-ancestor
139563557|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
139563558|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563559|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563560|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139563561|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139563562|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139563563|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139563564|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563565|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139563566|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139563567|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563568|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
139563569|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
139563570|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139563571|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563572|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139563573|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563574|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563575|NCT00417664|Midazolam|midazolam|mesh-list
139563576|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
139563578|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139563579|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563580|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868455|NCT02687256|Heparin|heparin|mesh-list
139563581|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139563582|NCT00417664|Analgesics|analgesics|mesh-ancestor
139563583|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
139563584|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563585|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139563586|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139563587|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139563588|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
139563589|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139563590|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563591|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139563592|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
139563593|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
139563594|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139563595|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139563596|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139563597|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139563598|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
139563599|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
139563600|NCT01021618|Dipyridamole|dipyridamole|mesh-list
139563601|NCT01021618|Regadenoson|regadenoson|mesh-list
139563602|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139563603|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139563604|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
139563605|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
139563606|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868575|NCT03711318|Naloxone|naloxone|mesh-list
139563607|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563608|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563609|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139563610|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563611|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139563612|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
139563613|NCT03082053|Capecitabine|capecitabine|mesh-list
139563614|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139563615|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
139563616|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563617|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563618|NCT03358563|Docetaxel|docetaxel|mesh-list
139563619|NCT03358563|Bicalutamide|bicalutamide|mesh-list
139563620|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139563621|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563622|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
139563623|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
139563624|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
139563625|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563626|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
139563627|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
139563628|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139563629|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563630|NCT03358563|Hematinics|hematinics|mesh-ancestor
139563631|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139563632|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139563633|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
139563634|NCT01018420|Colchicine|colchicine|mesh-list
139563635|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139563636|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563637|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139563638|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139563639|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563640|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563641|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563642|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
139563643|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139563644|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
138868733|NCT02574728|Sirolimus|sirolimus|mesh-list
139563645|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
139563646|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
139563647|NCT00974350|Bupivacaine|bupivacaine|mesh-list
139563648|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
139563649|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
139563650|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345312|NCT03443037|Analgesics|analgesics|mesh-ancestor
139563651|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563652|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
139563653|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563655|NCT05395702|Interferon-gamma|interferon-gamma|mesh-list
139563656|NCT05395702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563657|NCT05395702|Antiviral Agents|antiviral agents|mesh-ancestor
139563658|NCT05395702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563659|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139563660|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139563661|NCT01023178|Estradiol|estradiol|mesh-list
139563662|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139563663|NCT01023178|Estrogens|estrogens|mesh-list
139563664|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139563665|NCT01023178|Progesterone|progesterone|mesh-list
139563666|NCT01023178|Hormones|hormones|mesh-ancestor
139563667|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139563668|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563669|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139563670|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
139563671|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139563672|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139563673|NCT01023178|Progestins|progestins|mesh-ancestor
139563674|NCT03373851|Sufentanil|sufentanil|mesh-list
139563675|NCT03373851|Dsuvia|dsuvia|mesh-list
139563676|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139563677|NCT03373851|Narcotics|narcotics|mesh-ancestor
139563678|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563679|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563680|NCT03373851|Analgesics|analgesics|mesh-ancestor
139563681|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
139563682|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563683|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139563684|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139563685|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
139563686|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
139563687|NCT01023724|Ketorolac|ketorolac|mesh-list
139563688|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139563689|NCT01023724|Bromfenac|bromfenac|mesh-list
139563690|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139563691|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139563692|NCT01023724|Analgesics|analgesics|mesh-ancestor
139563693|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
139563694|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563695|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563696|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139563697|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139563698|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139563699|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563700|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563701|NCT00974818|Mitomycins|mitomycins|mesh-list
139563702|NCT00974818|Mitomycin|mitomycin|mesh-list
139563703|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
139563704|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139563705|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563706|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
138868943|NCT02680938|Oxytocin|oxytocin|mesh-list
139563707|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563708|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139563709|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563710|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139563711|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
139563712|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563713|NCT03371667|Methotrexate|methotrexate|mesh-list
139563714|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139563715|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
139563716|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139563717|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563718|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139563719|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
139563720|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563721|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563722|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
139563723|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563724|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139563725|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139563726|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
139563728|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139563729|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
139563730|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139563731|NCT01024738|Triclosan|triclosan|mesh-list
139563732|NCT01024738|Fluorides|fluorides|mesh-list
139563733|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
139563734|NCT01024738|Protective Agents|protective agents|mesh-ancestor
139563735|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563736|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139563737|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563738|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
139563739|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
139563740|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139563741|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139563742|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
139563743|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563744|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139563745|NCT05613153|Peppermint oil|peppermint oil|mesh-list
139563746|NCT05613153|Antiemetics|antiemetics|mesh-ancestor
139563747|NCT05613153|Autonomic Agents|autonomic agents|mesh-ancestor
139563748|NCT05613153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563749|NCT05613153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563750|NCT05613153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139563751|NCT05613153|Parasympatholytics|parasympatholytics|mesh-ancestor
139563752|NCT01024972|Mannitol|mannitol|mesh-list
139563753|NCT01024972|Dantrolene|dantrolene|mesh-list
139563754|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139563755|NCT01024972|Diuretics|diuretics|mesh-ancestor
139563756|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
139563757|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563758|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139563759|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138869116|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
139563760|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563761|NCT05686395|Bupivacaine|bupivacaine|mesh-list
139563762|NCT05686395|Anesthetics, Local|anesthetics, local|mesh-ancestor
139563763|NCT05686395|Anesthetics|anesthetics|mesh-ancestor
139563764|NCT05686395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563765|NCT05686395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563766|NCT05686395|Sensory System Agents|sensory system agents|mesh-ancestor
139563767|NCT05686395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563768|NCT01025830|Lamivudine|lamivudine|mesh-list
139563769|NCT01025830|Nevirapine|nevirapine|mesh-list
139563770|NCT01025830|Stavudine|stavudine|mesh-list
139563771|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
138869171|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
139563772|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139563773|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139563774|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563775|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563776|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
139563777|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563778|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139563779|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139563780|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139563781|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139563782|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
139563783|NCT03081039|Carboplatin|carboplatin|mesh-list
139563784|NCT03081039|Gemcitabine|gemcitabine|mesh-list
139563785|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563786|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139563787|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
139563788|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563789|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
139563790|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139563791|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563792|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139563793|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563794|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563795|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
139563796|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139563797|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139563798|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563799|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139563800|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
139563801|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139345463|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139563802|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563803|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
139563804|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563805|NCT00979732|Protective Agents|protective agents|mesh-ancestor
139563806|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563807|NCT03321981|Trastuzumab|trastuzumab|mesh-list
139563808|NCT03321981|Letrozole|letrozole|mesh-list
139563809|NCT03321981|Vinorelbine|vinorelbine|mesh-list
139563810|NCT03321981|Fulvestrant|fulvestrant|mesh-list
139563811|NCT03321981|Exemestane|exemestane|mesh-list
139563812|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139563813|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563814|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139563815|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139563816|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563817|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563818|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139563819|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
139563820|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139563821|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563822|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139563823|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
139563824|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
139563825|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
139563826|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139563827|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139563828|NCT01027468|Bevacizumab|bevacizumab|mesh-list
139563829|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139563830|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563831|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139563832|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139563833|NCT01027468|Growth Substances|growth substances|mesh-ancestor
139563834|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563835|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
139563836|NCT04278807|Anesthetics|anesthetics|mesh-list
139563837|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563838|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563839|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139563840|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563841|NCT03274401|Anticoagulants|anticoagulants|mesh-list
139563842|NCT05086107|Rifabutin|rifabutin|mesh-list
139563843|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139563844|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563845|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139563846|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
139563847|NCT01029730|Rituximab|rituximab|mesh-list
139563848|NCT01029730|Bortezomib|bortezomib|mesh-list
139563849|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139563850|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139563851|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563852|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
139563853|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563854|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139563855|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139563856|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
139563857|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563858|NCT05066997|Dexamethasone|dexamethasone|mesh-list
139563859|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
139563860|NCT05066997|BB 1101|bb 1101|mesh-list
139563861|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139563862|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
139563863|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
139563864|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563865|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563866|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139563867|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
139563868|NCT05066997|Hormones|hormones|mesh-ancestor
139563869|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139563870|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139563871|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563872|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
139563873|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002444|NCT00771641|Cobalt|cobalt|mesh-list
139563874|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563875|NCT05025033|Paclitaxel|paclitaxel|mesh-list
139563876|NCT05025033|Irinotecan|irinotecan|mesh-list
139563878|NCT05025033|Antibodies|antibodies|mesh-list
139563879|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
139563880|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139563881|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563882|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
139563883|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
139563884|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
139563885|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563886|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
139563887|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563888|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139563889|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139563890|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563891|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139563892|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139563893|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
139563894|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139563895|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139563896|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139563897|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563898|NCT00981214|Pancrelipase|pancrelipase|mesh-list
139563899|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139563900|NCT05415657|Denosumab|denosumab|mesh-list
139563901|NCT05415657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139563902|NCT05415657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563903|NCT03016234|Propofol|propofol|mesh-list
139563904|NCT03016234|Desflurane|desflurane|mesh-list
139563905|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139563906|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139563907|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563908|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139563909|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
139563910|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
139563911|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139563912|NCT02167204|Alovudine|alovudine|mesh-list
139563913|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
139563914|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563915|NCT00982072|Prednisolone|prednisolone|mesh-list
139563916|NCT00982072|Tacrolimus|tacrolimus|mesh-list
139563917|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139563918|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
139563919|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563920|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139563921|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563922|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563923|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139563924|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
139563925|NCT00982072|Hormones|hormones|mesh-ancestor
139563926|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139563927|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139563928|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563929|NCT01899053|Serabelisib|serabelisib|mesh-list
139563930|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563931|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563932|NCT01032694|Azithromycin|azithromycin|mesh-list
139563933|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139563934|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563935|NCT01032850|Capecitabine|capecitabine|mesh-list
139563936|NCT01032850|Sorafenib|sorafenib|mesh-list
139563937|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139563938|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
139563939|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563940|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563941|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139563942|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563943|NCT00983242|Colchicine|colchicine|mesh-list
139563944|NCT00983242|Verapamil|verapamil|mesh-list
139563945|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
139563946|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139563947|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
139563948|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
139563949|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
139563950|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345612|NCT03444519|Mannitol|mannitol|mesh-list
139563951|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563952|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139563953|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139563954|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139563955|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139563956|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563957|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
139563958|NCT00984334|Naloxone|naloxone|mesh-list
139563959|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139563960|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563961|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
139563962|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139563963|NCT02168062|Leuprolide|leuprolide|mesh-list
139563964|NCT02168062|Goserelin|goserelin|mesh-list
139563965|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139563966|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139563967|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
139563968|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139563969|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563970|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139563971|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563972|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
139563973|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139563974|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
139563975|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139563976|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139563977|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139563978|NCT05343117|Palbociclib|palbociclib|mesh-list
139563979|NCT05343117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139563980|NCT05343117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139563981|NCT05343117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139563982|NCT05343117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563983|NCT01898195|Varenicline|varenicline|mesh-list
139563984|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139563985|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139563986|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
139563987|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139563988|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139563989|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563990|NCT01897727|Spironolactone|spironolactone|mesh-list
139563991|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139563992|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
139563993|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139563994|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139563995|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139563996|NCT01897727|Diuretics|diuretics|mesh-ancestor
139563997|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
139563998|NCT01897493|Digoxin|digoxin|mesh-list
139563999|NCT01897493|Evacetrapib|evacetrapib|mesh-list
139564000|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139564001|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139564002|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564003|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564004|NCT01897493|Protective Agents|protective agents|mesh-ancestor
139564005|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564006|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139564007|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139564008|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
139564009|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139564010|NCT01887353|Ranolazine|ranolazine|mesh-list
139564011|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139564012|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139564013|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564014|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139564015|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
139564016|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139564017|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139564018|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139564019|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564020|NCT02160730|Roscovitine|roscovitine|mesh-list
139564021|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564022|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
139564023|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139564024|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139345683|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
139564025|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564026|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564027|NCT01896869|Ipilimumab|ipilimumab|mesh-list
139564028|NCT01896869|Folfirinox|folfirinox|mesh-list
139564029|NCT01896869|Vaccines|vaccines|mesh-list
139564030|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
139564031|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564032|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139564033|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564034|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139564035|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564036|NCT03329001|Niraparib|niraparib|mesh-list
139564037|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139564038|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564039|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564040|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564041|NCT01896557|Omeprazole|omeprazole|mesh-list
139564042|NCT01896557|Ranitidine|ranitidine|mesh-list
139564043|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139564044|NCT01896557|Clopidogrel|clopidogrel|mesh-list
139564045|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
139564046|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139564047|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139564048|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139564049|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
139564050|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564051|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564052|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564053|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139564054|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139564055|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139564056|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564057|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139564058|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
139564059|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
139564060|NCT02160808|Secretin|secretin|mesh-list
139564061|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139564062|NCT02160808|Hormones|hormones|mesh-ancestor
139564063|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139564064|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564065|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
139564066|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139564067|NCT01886105|Analgesics|analgesics|mesh-ancestor
139564068|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
139564069|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564070|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564071|NCT03262779|Nivolumab|nivolumab|mesh-list
139564072|NCT03262779|Ipilimumab|ipilimumab|mesh-list
139564073|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139564074|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564075|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139564076|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564077|NCT05022394|Nivolumab|nivolumab|mesh-list
139564078|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139564079|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564080|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139564081|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564082|NCT01895777|Dabigatran|dabigatran|mesh-list
139564083|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
138870059|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
139564084|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139564085|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
139564086|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564087|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564088|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
139564089|NCT00992602|Cytarabine|cytarabine|mesh-list
139564090|NCT00992602|Methotrexate|methotrexate|mesh-list
139564091|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139564092|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
139564093|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139564094|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564095|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139564096|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
139564097|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564098|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564099|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
139564100|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564101|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139564102|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139564103|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
139564104|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139564105|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139564106|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
139564107|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139564108|NCT00993226|Bupivacaine|bupivacaine|mesh-list
139564109|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
139564110|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
139564111|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139564112|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564113|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
139564114|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564115|NCT01885559|Telmisartan|telmisartan|mesh-list
139564116|NCT01885559|Lisinopril|lisinopril|mesh-list
139564117|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139564118|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139564119|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139564120|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139564121|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564122|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
139564123|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564124|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139564125|NCT01885559|Protective Agents|protective agents|mesh-ancestor
139564126|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564127|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
139564128|NCT00994318|Hematinics|hematinics|mesh-ancestor
139564129|NCT00995722|Prednisone|prednisone|mesh-list
139564130|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139564131|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
139564132|NCT00995722|Hormones|hormones|mesh-ancestor
139564133|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139564134|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564135|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139564136|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564137|NCT00996346|Sirolimus|sirolimus|mesh-list
139564138|NCT00996346|Irinotecan|irinotecan|mesh-list
139564139|NCT00996346|Temsirolimus|temsirolimus|mesh-list
139564140|NCT00996346|MTOR Inhibitors|mtor inhibitors|mesh-list
139564141|NCT00996346|Complement Factor H|complement factor h|mesh-list
139564142|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139564143|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139564144|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564145|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564146|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564147|NCT00996346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139564148|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139564149|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
139564150|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564151|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139564152|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139564153|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139564154|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
139564155|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139564156|NCT03016468|Treprostinil|treprostinil|mesh-list
139564157|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139564158|NCT00997204|Icatibant|icatibant|mesh-list
139564159|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139564160|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139564161|NCT00997204|Analgesics|analgesics|mesh-ancestor
139564162|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
139564163|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564164|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564165|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138870276|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
139564166|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139564167|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
139564168|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
139564169|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564170|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139564171|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139564172|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
139564173|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139564174|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
139564175|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139564176|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
139564177|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564178|NCT04225390|Dacarbazine|dacarbazine|mesh-list
139564179|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139564180|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
139564181|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564182|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564183|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
139564184|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
139564185|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139564186|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564187|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564188|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
139564189|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139564190|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139564191|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564192|NCT04606797|Nicotine|nicotine|mesh-list
139564193|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139564194|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
139564195|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564196|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564197|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139564198|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139564199|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
139564200|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564201|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564202|NCT02164240|Sunitinib|sunitinib|mesh-list
139564203|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564204|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139564205|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139564206|NCT02164240|Growth Substances|growth substances|mesh-ancestor
139564207|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564208|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
139564209|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139564210|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564211|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564212|NCT02169466|Opicapone|opicapone|mesh-list
139564213|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
139564214|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139564215|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564216|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564217|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139564218|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139564219|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
139564220|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870466|NCT02840279|BPN14770|bpn14770|mesh-list
139564221|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564222|NCT01001806|Ketorolac|ketorolac|mesh-list
139564223|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139564224|NCT01001806|Nepafenac|nepafenac|mesh-list
139564225|NCT01001806|Bromfenac|bromfenac|mesh-list
139564226|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139564227|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139564228|NCT01001806|Analgesics|analgesics|mesh-ancestor
139564229|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
139564230|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564231|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564232|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139564233|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139564234|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139564235|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564236|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564237|NCT04021264|Sufentanil|sufentanil|mesh-list
139564238|NCT04021264|Ropivacaine|ropivacaine|mesh-list
139564239|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
139564240|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
139564241|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139564242|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564243|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
139564244|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564245|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139564246|NCT04021264|Narcotics|narcotics|mesh-ancestor
139564247|NCT04021264|Analgesics|analgesics|mesh-ancestor
139564248|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139564249|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139564250|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
139564252|NCT04757571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139564253|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139564254|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139564255|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564256|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564257|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
139564258|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564259|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139564260|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
139564261|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139564262|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139564263|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139564264|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564265|NCT03232593|Atezolizumab|atezolizumab|mesh-list
139564266|NCT03232593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139564267|NCT03232593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564268|NCT03232593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139564269|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564270|NCT01895309|Etanercept|etanercept|mesh-list
139564271|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139564272|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139564273|NCT01895309|Analgesics|analgesics|mesh-ancestor
139564274|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
139564275|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564276|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564277|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139564278|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139564279|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139564280|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139564281|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
139564282|NCT04614311|Triamcinolone|triamcinolone|mesh-list
139564283|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139564284|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139564285|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139564286|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139564287|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
139564288|NCT04614311|Hormones|hormones|mesh-ancestor
139564289|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139564290|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564291|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139564292|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
139564293|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564294|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564295|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139564296|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139564297|NCT04323748|Rituximab|rituximab|mesh-list
139564298|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139564299|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564300|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
139564301|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564302|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139564303|NCT02808364|Vaccines|vaccines|mesh-list
139564304|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
139564305|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564306|NCT02709616|Vaccines|vaccines|mesh-list
139564307|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
139564308|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564309|NCT04817956|Trastuzumab|trastuzumab|mesh-list
139564310|NCT04817956|Atezolizumab|atezolizumab|mesh-list
139564311|NCT04817956|Pertuzumab|pertuzumab|mesh-list
139564312|NCT04817956|Vemurafenib|vemurafenib|mesh-list
139564313|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139564314|NCT04817956|Entrectinib|entrectinib|mesh-list
139564315|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139564316|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564317|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564318|NCT04817956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139564319|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564320|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
139564321|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139345991|NCT03650777|Warfarin|warfarin|mesh-list
139564322|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564323|NCT01894919|Vaccines|vaccines|mesh-list
139564324|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
139564325|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564326|NCT04130698|Nicotine|nicotine|mesh-list
139564327|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138870687|NCT04209920|Nickel|nickel|mesh-list
139564328|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
139564329|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564330|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564331|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139564332|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139564333|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
139564334|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564335|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564336|NCT05306223|Levofloxacin|levofloxacin|mesh-list
139564337|NCT05306223|Cycloserine|cycloserine|mesh-list
139564338|NCT05306223|Linezolid|linezolid|mesh-list
139564339|NCT05306223|Pyrazinamide|pyrazinamide|mesh-list
139564340|NCT05306223|Bedaquiline|bedaquiline|mesh-list
139564341|NCT05306223|Clofazimine|clofazimine|mesh-list
139564342|NCT05306223|Prothionamide|prothionamide|mesh-list
139564343|NCT05306223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139564344|NCT05306223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139564345|NCT05306223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139564346|NCT05306223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139564347|NCT05306223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139564348|NCT05306223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564349|NCT05306223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564350|NCT05306223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564351|NCT05306223|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139564352|NCT05306223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139564353|NCT05306223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138870703|NCT02660658|Analgesics|analgesics|mesh-ancestor
139564354|NCT05306223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139564355|NCT05306223|Antitubercular Agents|antitubercular agents|mesh-ancestor
139564356|NCT05306223|Antimetabolites|antimetabolites|mesh-ancestor
139564357|NCT05306223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139564358|NCT05306223|Leprostatic Agents|leprostatic agents|mesh-ancestor
139564359|NCT03016000|Thalidomide|thalidomide|mesh-list
139564360|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139564361|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
139564362|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564363|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
139564364|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139564365|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139564366|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139564367|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139564368|NCT03016000|Growth Substances|growth substances|mesh-ancestor
139564369|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
139564370|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564371|NCT04130152|Letrozole|letrozole|mesh-list
139564372|NCT04130152|Palbociclib|palbociclib|mesh-list
139564373|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564374|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139564375|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139564376|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564377|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564378|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139564379|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
139564380|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139564381|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564382|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139564383|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
139564384|NCT03254589|Methotrexate|methotrexate|mesh-list
139564385|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139564386|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
139564387|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139564388|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564389|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139564390|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
139564391|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564392|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564393|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
139564394|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564395|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139564396|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139346057|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
139564397|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
139564398|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139564399|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139564400|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139564401|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139564402|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139564403|NCT03254589|Analgesics|analgesics|mesh-ancestor
139564404|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
139564405|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564406|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139564407|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139564408|NCT04399395|Naltrexone|naltrexone|mesh-list
139564409|NCT04399395|Bupropion|bupropion|mesh-list
139564410|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139564411|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139564412|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564413|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
139564414|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564415|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139564416|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
139564417|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139564418|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139564419|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138870842|NCT00650442|Estradiol|estradiol|mesh-list
139564420|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139564421|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564422|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
139564423|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564424|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139564425|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139564426|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564427|NCT02000596|Trastuzumab|trastuzumab|mesh-list
139564428|NCT02000596|Pertuzumab|pertuzumab|mesh-list
139564429|NCT02000596|Fulvestrant|fulvestrant|mesh-list
139564430|NCT02000596|Anastrozole|anastrozole|mesh-list
139564431|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139564432|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564433|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139564434|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139564435|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139564436|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
139564437|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139564438|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564439|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139564440|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139564441|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564442|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564443|NCT03223779|Trifluridine|trifluridine|mesh-list
139564444|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
139564445|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564446|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
139564447|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139564448|NCT05168865|Letrozole|letrozole|mesh-list
139564449|NCT05168865|Estradiol|estradiol|mesh-list
139564450|NCT05168865|Progesterone|progesterone|mesh-list
139564451|NCT05168865|Estrogens|estrogens|mesh-ancestor
139564452|NCT05168865|Hormones|hormones|mesh-ancestor
139564453|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139564454|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564455|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564456|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139564457|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139564458|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564459|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564460|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139564461|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
139564462|NCT05168865|Progestins|progestins|mesh-ancestor
139564463|NCT01882985|Lycopene|lycopene|mesh-list
139564464|NCT01882985|Docetaxel|docetaxel|mesh-list
139564465|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564466|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
139564467|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
139564468|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
139564469|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564470|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139564471|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
139564472|NCT01882985|Protective Agents|protective agents|mesh-ancestor
139564473|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564474|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139564475|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139564476|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
139564477|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139564478|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139564479|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564480|NCT04460235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139564481|NCT04460235|Immunologic Factors|immunologic factors|mesh-ancestor
139564482|NCT04460235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564483|NCT03015922|Lenalidomide|lenalidomide|mesh-list
139564484|NCT03015922|Pomalidomide|pomalidomide|mesh-list
139564485|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
139564486|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564487|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139564488|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139564489|NCT03015922|Growth Substances|growth substances|mesh-ancestor
139564490|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
139564491|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564493|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139564494|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139564495|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564496|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
139564497|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564498|NCT01882907|Pioglitazone|pioglitazone|mesh-list
139564499|NCT01882907|Vildagliptin|vildagliptin|mesh-list
139564500|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139564501|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564502|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139564503|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
139564504|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564505|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564506|NCT01051570|Prednisone|prednisone|mesh-list
139564507|NCT01051570|Carboplatin|carboplatin|mesh-list
139564508|NCT01051570|Everolimus|everolimus|mesh-list
139564509|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564510|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139564511|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
139564512|NCT01051570|Hormones|hormones|mesh-ancestor
139564513|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139564514|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564515|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139564516|NCT01051570|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139564517|NCT01051570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139564518|NCT01051570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564519|NCT01051570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564520|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139564521|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
139564522|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
139564523|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139564524|NCT01893281|Testosterone|testosterone|mesh-list
139564525|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
138871040|NCT02828033|Rilonacept|rilonacept|mesh-list
139564526|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
139564527|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139564528|NCT01893281|Androgens|androgens|mesh-ancestor
139564529|NCT01893281|Hormones|hormones|mesh-ancestor
139564530|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139564531|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564532|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139564533|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564534|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
139564535|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139564536|NCT02981446|Latanoprost|latanoprost|mesh-list
139564537|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139564538|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139564539|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139564540|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
139564541|NCT05263947|Bevacizumab|bevacizumab|mesh-list
139564542|NCT05263947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139564543|NCT05263947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564544|NCT05263947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139564545|NCT05263947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139346207|NCT03416517|Irinotecan|irinotecan|mesh-list
139564546|NCT05263947|Growth Substances|growth substances|mesh-ancestor
139564547|NCT05263947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564548|NCT05263947|Growth Inhibitors|growth inhibitors|mesh-ancestor
139564549|NCT04415567|Lenvatinib|lenvatinib|mesh-list
139564550|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564551|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139564552|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564553|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564554|NCT03280251|Methylphenidate|methylphenidate|mesh-list
139564555|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139564556|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564557|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139564558|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139564559|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139564560|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564561|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
139564562|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564563|NCT01882829|Quinidine|quinidine|mesh-list
139564564|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
139564565|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
139564566|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
139564567|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139564568|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139564569|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564570|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871145|NCT00620204|Atorvastatin|atorvastatin|mesh-list
139564571|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564572|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139564573|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139564574|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
139564575|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139564576|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
139564577|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139564578|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139564579|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139564580|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564581|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139564582|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139564583|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
139564584|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139564585|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139564586|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139564587|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139564588|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139564589|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
139564590|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139564591|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138871190|NCT06096194|Micronutrients|micronutrients|mesh-ancestor
138871191|NCT06096194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871192|NCT06096194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138871193|NCT06096181|Dexmedetomidine|dexmedetomidine|mesh-list
138871194|NCT06096181|Remifentanil|remifentanil|mesh-list
138871195|NCT06096181|Propofol|propofol|mesh-list
138871196|NCT06096181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138871197|NCT06096181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139564592|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564593|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
139564594|NCT04760301|Coagulants|coagulants|mesh-ancestor
139564595|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
139564596|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
139564597|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
139564598|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564599|NCT01054768|Protective Agents|protective agents|mesh-ancestor
139564600|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564601|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
139564602|NCT01054768|Vitamins|vitamins|mesh-ancestor
139564603|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
139564604|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
139564605|NCT04387617|Cannabidiol|cannabidiol|mesh-list
139564606|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
139564607|NCT03014830|Alirocumab|alirocumab|mesh-list
139564608|NCT03014830|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139564609|NCT03014830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139564610|NCT03014830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139564611|NCT03014830|Antimetabolites|antimetabolites|mesh-ancestor
139564612|NCT03014830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564613|NCT03014830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139564614|NCT03014830|Protease Inhibitors|protease inhibitors|mesh-ancestor
139564615|NCT03014830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564616|NCT03014830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139564617|NCT01055704|Naltrexone|naltrexone|mesh-list
139564618|NCT01055704|Codeine|codeine|mesh-list
139564619|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
139564620|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139564621|NCT01055704|Narcotics|narcotics|mesh-ancestor
139564622|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139564623|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564625|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
139564626|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564627|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
139564628|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
139564629|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139564630|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139564631|NCT03280017|Ketamine|ketamine|mesh-list
139564632|NCT03280017|Analgesics|analgesics|mesh-ancestor
139564633|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
138871304|NCT06094868|Capecitabine|capecitabine|mesh-list
139564634|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564635|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564636|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139564637|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139564638|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
139564639|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
139564640|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139564641|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139564642|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139564643|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564644|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564645|NCT01882439|Tofacitinib|tofacitinib|mesh-list
139564646|NCT01882439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139564647|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139564648|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564649|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564650|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
139564651|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
139564652|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139564653|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139564654|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139564655|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564656|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564657|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139564658|NCT05225805|Lefamulin|lefamulin|mesh-list
139564659|NCT05225805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139564660|NCT05225805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139564661|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139564662|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
139564663|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564664|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564665|NCT01109056|Cyclosporine|cyclosporine|mesh-list
139564666|NCT01109056|Cyclosporins|cyclosporins|mesh-list
139564667|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564668|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564669|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139564670|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
139564671|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564672|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
139564673|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139564674|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
139564675|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139564676|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139564677|NCT03870399|Tamoxifen|tamoxifen|mesh-list
139564678|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139564679|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
139564680|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139564681|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564682|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139564683|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564684|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139564685|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139564686|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139564687|NCT04333407|Aspirin|aspirin|mesh-list
139564688|NCT04333407|Omeprazole|omeprazole|mesh-list
139564689|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
139564690|NCT04333407|Clopidogrel|clopidogrel|mesh-list
139564691|NCT04333407|Atorvastatin|atorvastatin|mesh-list
139564692|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139564693|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139564694|NCT04333407|Analgesics|analgesics|mesh-ancestor
139564695|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
139564696|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564697|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564698|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139564699|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139564700|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139564701|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139564702|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564703|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139564704|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139564705|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564706|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
139564707|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139564708|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139564709|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
139564710|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139564711|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139564712|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139564713|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139564714|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139564715|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
139564716|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564717|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139564718|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
139564719|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139564720|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
139564721|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
139564722|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139564723|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139564724|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139564725|NCT04398927|Folfirinox|folfirinox|mesh-list
139564726|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564727|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
139564728|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139564729|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139564730|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
139564731|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564732|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139564733|NCT04399083|Caffeine|caffeine|mesh-list
139564734|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139564735|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564736|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139564737|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564738|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564739|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139564740|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139564741|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
139564742|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564743|NCT01892345|Eculizumab|eculizumab|mesh-list
139564744|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139564745|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139564746|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
139564747|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564748|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
139564749|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
139564750|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139564751|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138871569|NCT05733403|Norepinephrine|norepinephrine|mesh-list
139564752|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564753|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564754|NCT01059994|Urological Agents|urological agents|mesh-ancestor
139564755|NCT01111318|Empagliflozin|empagliflozin|mesh-list
139564756|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139564757|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564758|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139564759|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564760|NCT01892189|Ketamine|ketamine|mesh-list
139564761|NCT01892189|Analgesics|analgesics|mesh-ancestor
139564762|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
139564763|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564764|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564765|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139564766|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139564767|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
139564768|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
139564769|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139564770|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139564771|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139564772|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564773|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564775|NCT01062568|Cosyntropin|cosyntropin|mesh-list
139564776|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139564777|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139564778|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
139564779|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139564780|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
139564781|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
139564782|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564783|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564784|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139564785|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
139564786|NCT01062568|Hormones|hormones|mesh-ancestor
139564787|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139564788|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139564789|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564790|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564791|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564792|NCT05155137|Amlodipine|amlodipine|mesh-list
139564793|NCT05155137|Valsartan|valsartan|mesh-list
139564794|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139564795|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139564796|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139564797|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139564798|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564799|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138871724|NCT05364762|Cyclophosphamide|cyclophosphamide|mesh-list
139564800|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564801|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
139564802|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139564803|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139564804|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
139564805|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139564806|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139564807|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564808|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139564809|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139564810|NCT01064284|Factor VIII|factor viii|mesh-list
139564811|NCT01064284|Coagulants|coagulants|mesh-ancestor
139564812|NCT01064362|Heparin|heparin|mesh-list
139564813|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139564814|NCT01064362|Tinzaparin|tinzaparin|mesh-list
139564815|NCT01064362|Dalteparin|dalteparin|mesh-list
139564816|NCT01064362|PENTA|penta|mesh-list
139564817|NCT01064362|Fondaparinux|fondaparinux|mesh-list
139564818|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
139564819|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139564820|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139564821|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564822|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139564823|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
139564824|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139564825|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
139564826|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564827|NCT03646461|Nivolumab|nivolumab|mesh-list
139564828|NCT03646461|Cetuximab|cetuximab|mesh-list
139564829|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139564830|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139564831|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139564832|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564833|NCT01880957|Lamotrigine|lamotrigine|mesh-list
139564834|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
139564835|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
139564836|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139564837|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564838|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564839|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
139564840|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139564841|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139564842|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564843|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
139346514|NCT03621527|Narcotics|narcotics|mesh-ancestor
139564844|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139564845|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139564846|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139564847|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139564848|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139564849|NCT01064830|Cyclosporine|cyclosporine|mesh-list
139564850|NCT01064830|Cyclosporins|cyclosporins|mesh-list
139564851|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564852|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871913|NCT04518046|Nivolumab|nivolumab|mesh-list
139564853|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139564854|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
139564855|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564856|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
139564857|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139564858|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
139564859|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139564860|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139564861|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139564862|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139564863|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564864|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139564865|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139564866|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139564867|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564868|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
139564869|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564870|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139564872|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139564873|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564874|NCT04398771|Valsartan|valsartan|mesh-list
139564875|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139564876|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139564877|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139564878|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
139564879|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564880|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139564881|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139564882|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139564883|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139564884|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139564885|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139564886|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139564887|NCT01863953|Bimatoprost|bimatoprost|mesh-list
139564888|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139564889|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139564890|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139564891|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139564892|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139564893|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139564894|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
139564895|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564896|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564897|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564898|NCT01068964|Timolol|timolol|mesh-list
139564899|NCT01068964|Bimatoprost|bimatoprost|mesh-list
139564900|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139564901|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139564902|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139564903|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139564904|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
139564905|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564906|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564907|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564908|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139564909|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139564910|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139564911|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
139564912|NCT02984475|Metformin|metformin|mesh-list
139564913|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139564914|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564915|NCT01069354|Lidocaine|lidocaine|mesh-list
139564916|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
139564918|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139564919|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871995|NCT04074564|Apatinib|apatinib|mesh-list
139564920|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
139564921|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564922|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139564923|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139564924|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139564925|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139564926|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564927|NCT01069510|Spironolactone|spironolactone|mesh-list
139564928|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139564929|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
139564930|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139564931|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564932|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139564933|NCT01069510|Diuretics|diuretics|mesh-ancestor
139564934|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
139564935|NCT04278495|Losartan|losartan|mesh-list
139564936|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139564937|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139564938|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139564939|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139564940|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564941|NCT04276545|Midazolam|midazolam|mesh-list
139564942|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139564943|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139564944|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139564945|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564946|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139564947|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139564948|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139564949|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139564950|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
139564951|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
139564952|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
139564953|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
138872172|NCT03465111|Hormones|hormones|mesh-list
139564954|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564955|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564956|NCT01117948|Lornoxicam|lornoxicam|mesh-list
139564957|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139564958|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139564959|NCT01117948|Analgesics|analgesics|mesh-ancestor
139564960|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
139564961|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564962|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564963|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139564964|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139564965|NCT03014440|Cannabidiol|cannabidiol|mesh-list
139564966|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
139564967|NCT03013036|Midazolam|midazolam|mesh-list
139564968|NCT03013036|Fentanyl|fentanyl|mesh-list
139564969|NCT03013036|Propofol|propofol|mesh-list
139564970|NCT03013036|Sevoflurane|sevoflurane|mesh-list
139564971|NCT03013036|Rocuronium|rocuronium|mesh-list
139564972|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139564973|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139564974|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139564975|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139564976|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
139564977|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
139564978|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139564979|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139564980|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139564981|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139564982|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
139564983|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
139564984|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139564985|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139564986|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139564987|NCT03013036|Narcotics|narcotics|mesh-ancestor
139564988|NCT03013036|Analgesics|analgesics|mesh-ancestor
139564989|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
139564990|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139564991|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139564992|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139564993|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139564994|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139564995|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139564997|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139564998|NCT01071538|Narcotics|narcotics|mesh-ancestor
139564999|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139565000|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565001|NCT01071538|Analgesics|analgesics|mesh-ancestor
139565002|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
139565003|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565004|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139565005|NCT04352686|Buspirone|buspirone|mesh-list
139565006|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139565007|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139565008|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139565009|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565010|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139565011|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139565012|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
139565013|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565014|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565015|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139565016|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565017|NCT02172742|Digoxin|digoxin|mesh-list
139565018|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139565019|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139565020|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139565021|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565022|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565023|NCT02172742|Protective Agents|protective agents|mesh-ancestor
139565024|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565025|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
139565026|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139565027|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139565028|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139565029|NCT01075204|Clarithromycin|clarithromycin|mesh-list
139565030|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139565031|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565032|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139565033|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565034|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565035|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139565036|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139565037|NCT01120834|Azacitidine|azacitidine|mesh-list
139565038|NCT01120834|Vorinostat|vorinostat|mesh-list
139565039|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139565040|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
139565041|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565042|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565043|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565044|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139565045|NCT01122160|Omeprazole|omeprazole|mesh-list
139565046|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139565047|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139565048|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139565049|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565050|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565051|NCT02623816|Omeprazole|omeprazole|mesh-list
139565052|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139565053|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139565054|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139565055|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565056|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565057|NCT01122238|Nicotine|nicotine|mesh-list
139565058|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139565059|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
139565060|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565061|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565062|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139565063|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139565064|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
139565065|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565066|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565067|NCT01122316|Metformin|metformin|mesh-list
139565068|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139565069|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565070|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
139565071|NCT03049449|Fludarabine|fludarabine|mesh-list
139565072|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139565073|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
139565074|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872460|NCT02650206|Hormones|hormones|mesh-ancestor
139565075|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565076|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139565077|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
139565078|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565079|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565080|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139565081|NCT02399943|Panitumumab|panitumumab|mesh-list
139565082|NCT02399943|Trametinib|trametinib|mesh-list
139565083|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139565084|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565085|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139565086|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565087|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565088|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
139565089|NCT03186027|Ubiquinone|ubiquinone|mesh-list
139565090|NCT03186027|Vitamins|vitamins|mesh-ancestor
139565091|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
139565092|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565093|NCT04397913|Acetaminophen|acetaminophen|mesh-list
139565094|NCT04397913|Ibuprofen|ibuprofen|mesh-list
139565095|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139565096|NCT04397913|Analgesics|analgesics|mesh-ancestor
139565097|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
139565098|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565099|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565100|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
139565101|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139565102|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565103|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565104|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139565105|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565106|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565107|NCT02176486|Ixazomib|ixazomib|mesh-list
139565108|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565109|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
139565110|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565111|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565112|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139565113|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139565114|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139565115|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139565116|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565117|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565118|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565119|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139565120|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
139565121|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139565122|NCT03013114|Bortezomib|bortezomib|mesh-list
139565123|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565124|NCT01077310|Naltrexone|naltrexone|mesh-list
139565125|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139565126|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138872710|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139565127|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565128|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
139565129|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565130|NCT02989857|Ivosidenib|ivosidenib|mesh-list
139565131|NCT02989857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565132|NCT02989857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565133|NCT02989857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565134|NCT02393937|Metronidazole|metronidazole|mesh-list
139565135|NCT02393937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565136|NCT02393937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139565137|NCT02393937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139565138|NCT02393937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139565139|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
139565140|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139565141|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
139565142|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139565143|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
139565144|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565145|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565146|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
139565147|NCT04397601|Bevacizumab|bevacizumab|mesh-list
139565148|NCT04397601|Aflibercept|aflibercept|mesh-list
139565149|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139565150|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565151|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139565152|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139565153|NCT04397601|Growth Substances|growth substances|mesh-ancestor
139565154|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565155|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
139565156|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
139565157|NCT02870829|Vitamin K|vitamin k|mesh-list
139565158|NCT02870829|Menaquinone 7|menaquinone 7|mesh-list
139565159|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139565160|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139565161|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565162|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
139565163|NCT02870829|Coagulants|coagulants|mesh-ancestor
139565164|NCT02870829|Vitamins|vitamins|mesh-ancestor
139565165|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
139565166|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565167|NCT01876823|Memantine|memantine|mesh-list
139565168|NCT01876823|Citalopram|citalopram|mesh-list
139565169|NCT01876823|Escitalopram|escitalopram|mesh-list
139565170|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139565171|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139565172|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
139565173|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565174|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565175|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565176|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139565177|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139565178|NCT01876823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139565179|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139565180|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139565181|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
139565182|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139565183|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
139565184|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139565185|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
139565186|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139565187|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565188|NCT01876511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139565189|NCT01876511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565190|NCT01993719|Vidarabine|vidarabine|mesh-list
139565191|NCT01993719|Aldesleukin|aldesleukin|mesh-list
139565192|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
139565193|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
139565194|NCT01993719|Fludarabine|fludarabine|mesh-list
139565195|NCT01993719|Fludarabine phosphate|fludarabine phosphate|mesh-list
139565196|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139565197|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
139565198|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565199|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565200|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139565201|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
139565202|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565203|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565204|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138873009|NCT00650286|Modafinil|modafinil|mesh-list
139565205|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139565206|NCT01993719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139565207|NCT01993719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139565208|NCT01993719|Antimetabolites|antimetabolites|mesh-ancestor
139565209|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
139565210|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565211|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139565212|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139565213|NCT02758665|Venetoclax|venetoclax|mesh-list
139565214|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
139565215|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346896|NCT05169801|Growth Substances|growth substances|mesh-ancestor
139565216|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139565217|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139565219|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565220|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565221|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565222|NCT00638157|Gentamicins|gentamicins|mesh-list
139565223|NCT00638157|Daptomycin|daptomycin|mesh-list
139565224|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139565225|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565226|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139565227|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565228|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565229|NCT00637377|Ranibizumab|ranibizumab|mesh-list
139565230|NCT00637377|Aflibercept|aflibercept|mesh-list
139565231|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139565232|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139565233|NCT00637377|Growth Substances|growth substances|mesh-ancestor
139565234|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565235|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
139565236|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565237|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
139565238|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565239|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139565240|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565241|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565242|NCT05307718|Anticoagulants|anticoagulants|mesh-list
139565243|NCT05307718|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
139565244|NCT05307718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139565245|NCT05307718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139565246|NCT05307718|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
139565247|NCT05307718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139565248|NCT05307718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139565249|NCT05307718|Antimetabolites|antimetabolites|mesh-ancestor
139565250|NCT05307718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565251|NCT05307718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565252|NCT05307718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139565253|NCT05307718|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138873212|NCT05660993|Nivolumab|nivolumab|mesh-list
139565254|NCT05307718|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139565255|NCT05307718|Purinergic Agents|purinergic agents|mesh-ancestor
139565256|NCT05307718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565257|NCT05307718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565258|NCT05307718|Antithrombins|antithrombins|mesh-ancestor
139565259|NCT05307718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139565260|NCT05307718|Protease Inhibitors|protease inhibitors|mesh-ancestor
139565261|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
139565262|NCT01033864|Prednisone|prednisone|mesh-list
139565263|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565264|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
139565265|NCT01033864|Hormones|hormones|mesh-ancestor
139565266|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565267|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565268|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138873242|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
139565269|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565270|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139565271|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139565272|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
139565273|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139565274|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873297|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
139565275|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565276|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565277|NCT01082380|Crizotinib|crizotinib|mesh-list
139565278|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565279|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139565280|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565281|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565282|NCT01083706|Azacitidine|azacitidine|mesh-list
139565283|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139565284|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
139565285|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565286|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565287|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565288|NCT01035346|Ibuprofen|ibuprofen|mesh-list
139565289|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139565290|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139565291|NCT01035346|Analgesics|analgesics|mesh-ancestor
139565292|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
139565293|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565294|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565295|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565296|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565297|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139565298|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565299|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565300|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
139565301|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139565302|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565303|NCT01085344|Factor VIII|factor viii|mesh-list
139565304|NCT01085344|Coagulants|coagulants|mesh-ancestor
139565305|NCT01035658|Doxorubicin|doxorubicin|mesh-list
139565306|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139565307|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139565308|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565309|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139565310|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139565311|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565312|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565313|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
139565314|NCT01037452|Lansoprazole|lansoprazole|mesh-list
139565315|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
139565316|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
139565317|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139565318|NCT01037452|Calcium|calcium|mesh-list
139565319|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139565320|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565321|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139565322|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139565323|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139565324|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139565325|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565326|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565327|NCT01037452|Antacids|antacids|mesh-ancestor
139565328|NCT03012646|Treprostinil|treprostinil|mesh-list
139565329|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139565330|NCT05289856|Avelumab|avelumab|mesh-list
139565331|NCT05289856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139565332|NCT05289856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565333|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
139565334|NCT00636441|Docetaxel|docetaxel|mesh-list
139565335|NCT00636441|Doxorubicin|doxorubicin|mesh-list
139565336|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139565337|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139565338|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
139565339|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565340|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565341|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139565342|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
139565343|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565344|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565345|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139565346|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
139565347|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
139565348|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
139565349|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139565350|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139565351|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139565352|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565353|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139565354|NCT02984397|Ketotifen|ketotifen|mesh-list
139565355|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
139565356|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
139565357|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139565358|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
139565359|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
139565360|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565361|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565362|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565363|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139565364|NCT01922427|RNS60|rns60|mesh-list
139565365|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139565366|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139565368|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
139565369|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565370|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565371|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565372|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565373|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139565374|NCT01088464|Necitumumab|necitumumab|mesh-list
139565375|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139565376|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139565377|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565378|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
139565379|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565380|NCT01090180|Dexamethasone|dexamethasone|mesh-list
139565381|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565382|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
139565383|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
139565384|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565385|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565386|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139565387|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
139565388|NCT01090180|Hormones|hormones|mesh-ancestor
139565389|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565390|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139565391|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565392|NCT00636207|Montelukast|montelukast|mesh-list
139565393|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139565394|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
139565395|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139565396|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
139565397|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565398|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565399|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139565400|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139565401|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565402|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
139565403|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
139565404|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
139565405|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565406|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139565407|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139565408|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
139565409|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565410|NCT01092676|Ibuprofen|ibuprofen|mesh-list
139565411|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139565412|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139565413|NCT01092676|Analgesics|analgesics|mesh-ancestor
139565414|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
138873529|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565415|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565416|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565417|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565418|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565419|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139565420|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565421|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565422|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
139565423|NCT01039792|Vitamins|vitamins|mesh-ancestor
139565424|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
139565425|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565426|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
139565427|NCT01041274|Citalopram|citalopram|mesh-list
138873592|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565428|NCT01041274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139565429|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139565430|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139565431|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565432|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565433|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
139565434|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565435|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139565436|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
139565437|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139565438|NCT00635349|Acetaminophen|acetaminophen|mesh-list
139565439|NCT00635349|Meloxicam|meloxicam|mesh-list
139565440|NCT00635349|Aceclofenac|aceclofenac|mesh-list
139565441|NCT00635349|Tramadol|tramadol|mesh-list
139565442|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139565443|NCT00635349|Analgesics|analgesics|mesh-ancestor
139565444|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
139565445|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993675|NCT00120289|Niacin|niacin|mesh-list
139565446|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565447|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
139565448|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139565449|NCT00635349|Narcotics|narcotics|mesh-ancestor
139565450|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139565451|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139565452|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565453|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565454|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139565455|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139565456|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565457|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565458|NCT00634803|Buprenorphine|buprenorphine|mesh-list
139565459|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139565460|NCT00634803|Narcotics|narcotics|mesh-ancestor
139565461|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139565462|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565463|NCT00634803|Analgesics|analgesics|mesh-ancestor
139565464|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
139565465|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565466|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139565467|NCT01042288|Carboplatin|carboplatin|mesh-list
139565468|NCT01042288|Pemetrexed|pemetrexed|mesh-list
139565469|NCT01042288|Panitumumab|panitumumab|mesh-list
139565470|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565471|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565472|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565473|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139565474|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139565475|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139565476|NCT01043926|Suvorexant|suvorexant|mesh-list
139565477|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139565478|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139565479|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139565480|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565481|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139565482|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565483|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565484|NCT01044706|Bicalutamide|bicalutamide|mesh-list
139565485|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
139565486|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
139565487|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565488|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565489|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565490|NCT04447534|Hydroxychloroquine|hydroxychloroquine|mesh-list
139565491|NCT04447534|Chloroquine|chloroquine|mesh-list
139565492|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139565493|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
139565494|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139565495|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139565496|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565497|NCT04447534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565498|NCT04447534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565499|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565500|NCT04447534|Amebicides|amebicides|mesh-ancestor
139565501|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139565502|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139565503|NCT04447534|Analgesics|analgesics|mesh-ancestor
139565504|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
139565505|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565506|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565507|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565508|NCT04447534|Filaricides|filaricides|mesh-ancestor
139565509|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
139565510|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
139565512|NCT01044862|Clomiphene|clomiphene|mesh-list
139565513|NCT01044862|Enclomiphene|enclomiphene|mesh-list
139565514|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
139565515|NCT01044862|Hormones|hormones|mesh-list
139565516|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139565517|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138873805|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139565518|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565519|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565520|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565521|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565522|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139565523|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565524|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139565525|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
139565526|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139565527|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
139565528|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139565529|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139565530|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139565531|NCT04361656|Lubiprostone|lubiprostone|mesh-list
139565532|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139565533|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139565534|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565535|NCT01047358|Exemestane|exemestane|mesh-list
139565536|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565537|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139565538|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139565539|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565540|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565541|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139565542|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
138801885|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
139565543|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565544|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565545|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
139565546|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139565547|NCT01048606|Estrogens|estrogens|mesh-ancestor
139565548|NCT01048606|Hormones|hormones|mesh-ancestor
139565549|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565550|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565551|NCT04224766|Bupivacaine|bupivacaine|mesh-list
139565552|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
139565553|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
139565554|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139565555|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565556|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
139565557|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565558|NCT01772004|Avelumab|avelumab|mesh-list
139565559|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138873983|NCT00875979|Trastuzumab|trastuzumab|mesh-list
139565560|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565561|NCT02930044|Insulin|insulin|mesh-list
139565562|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139565563|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
139565564|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139565565|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565566|NCT03683524|Dolutegravir|dolutegravir|mesh-list
139565567|NCT03683524|Darunavir|darunavir|mesh-list
139565568|NCT03683524|Cobicistat|cobicistat|mesh-list
139565569|NCT03683524|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139565570|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139565571|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139565572|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565573|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565574|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139565575|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139565576|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
139565577|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565578|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139565579|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139565580|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
139565581|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139565582|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139347276|NCT03393117|Narcotics|narcotics|mesh-list
139565584|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139565585|NCT02246842|Antibodies|antibodies|mesh-list
139565586|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139565587|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
139565588|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
139565589|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565590|NCT02182492|Clarithromycin|clarithromycin|mesh-list
139565591|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
139565592|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139565593|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565594|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139565595|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565596|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565597|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139565598|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139565599|NCT02182492|Hormones|hormones|mesh-ancestor
139565600|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565601|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565602|NCT01163656|Cobalt|cobalt|mesh-list
139565603|NCT01163656|Trace Elements|trace elements|mesh-ancestor
139565604|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
139565605|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565606|NCT01165840|Dapsone|dapsone|mesh-list
139565607|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565608|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
139565609|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139565610|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139565611|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139565612|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565613|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565614|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
139565615|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139565616|NCT00952692|Lapatinib|lapatinib|mesh-list
139565617|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565618|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139565619|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565620|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565621|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139565622|NCT01170754|Laxatives|laxatives|mesh-ancestor
139565623|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139565624|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139565625|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
139565626|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
139565627|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565628|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
139565629|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565630|NCT01131052|Insulin|insulin|mesh-list
139565631|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139565632|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
139565633|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
139565634|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139565635|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565636|NCT01379274|Lenalidomide|lenalidomide|mesh-list
139565637|NCT01379274|Azacitidine|azacitidine|mesh-list
139565638|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
139565639|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565640|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139565641|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139565642|NCT01379274|Growth Substances|growth substances|mesh-ancestor
139565643|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
139565644|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565645|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139565646|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
139565647|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565648|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565649|NCT01171690|Teriparatide|teriparatide|mesh-list
139565650|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139565651|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565652|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139565653|NCT05389176|Esmolol|esmolol|mesh-list
139565654|NCT05389176|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139565655|NCT05389176|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139565656|NCT05389176|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139347362|NCT03147092|Losartan|losartan|mesh-list
139565657|NCT05389176|Adrenergic Agents|adrenergic agents|mesh-ancestor
139565658|NCT05389176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565659|NCT05389176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565660|NCT05389176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565661|NCT01132846|Dopamine|dopamine|mesh-list
139565662|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139565663|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139565664|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
139565665|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
139565666|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565667|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565668|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
139565669|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565670|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565671|NCT01132846|Protective Agents|protective agents|mesh-ancestor
139565672|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
139565673|NCT01133158|Dexamethasone|dexamethasone|mesh-list
139565674|NCT01133158|Rituximab|rituximab|mesh-list
139565675|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139565676|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
139565677|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565678|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
139565679|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
139565680|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565681|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565682|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139565683|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
139565684|NCT01133158|Hormones|hormones|mesh-ancestor
139565685|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565686|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139565687|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565688|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139565689|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
139565690|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565691|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139565692|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
139565693|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565694|NCT01133158|Analgesics|analgesics|mesh-ancestor
139565695|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
139565696|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139565697|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139565698|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565699|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
139565700|NCT01134952|Sirolimus|sirolimus|mesh-list
139565701|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139565702|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565703|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139565704|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
139565705|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139565706|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565707|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565708|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565709|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
139565710|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139565711|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
139565712|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565713|NCT01175902|Timolol|timolol|mesh-list
139565714|NCT01175902|Dorzolamide|dorzolamide|mesh-list
139565715|NCT01175902|Latanoprost|latanoprost|mesh-list
139565716|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139565717|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139565718|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
139565719|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565720|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565721|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565722|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139565723|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139565724|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139565725|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139565726|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139565727|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565728|NCT01135186|Verapamil|verapamil|mesh-list
139565729|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139565730|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139565731|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139565732|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565733|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139565734|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565735|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
139565737|NCT05376228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139565738|NCT05376228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565739|NCT05164848|Afatinib|afatinib|mesh-list
139565740|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565741|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139565742|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565743|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565744|NCT05164770|Prednisone|prednisone|mesh-list
139565745|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
139565746|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
139565747|NCT05164770|Vincristine|vincristine|mesh-list
139565748|NCT05164770|Rituximab|rituximab|mesh-list
139565749|NCT05164770|Doxorubicin|doxorubicin|mesh-list
139565750|NCT05164770|Etoposide|etoposide|mesh-list
139565751|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565752|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139565753|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803139|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
139565754|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565755|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139565756|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
139565757|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565758|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565759|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139565760|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
139565761|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139565762|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565763|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
139565764|NCT05164770|Hormones|hormones|mesh-ancestor
139565765|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565766|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139565767|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139565768|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
139565769|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
139565770|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
139565771|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138874691|NCT02682758|Xenon|xenon|mesh-list
139565772|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139565773|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139565774|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139565775|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
139565776|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139565777|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139565778|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
139565779|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565780|NCT01175980|Vorinostat|vorinostat|mesh-list
139565781|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565782|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139565783|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565784|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565785|NCT04246554|Acetaminophen|acetaminophen|mesh-list
139565786|NCT04246554|Ketorolac|ketorolac|mesh-list
139565787|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139565788|NCT04246554|Oxycodone|oxycodone|mesh-list
139565789|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139565790|NCT04246554|Analgesics|analgesics|mesh-ancestor
139565791|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
139565792|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565793|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565794|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
139565795|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138803462|NCT02013141|Telavancin|telavancin|mesh-list
139565796|NCT04246554|Narcotics|narcotics|mesh-ancestor
139565797|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139565798|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139565799|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565800|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565801|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139565802|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565803|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565804|NCT01922817|Saxagliptin|saxagliptin|mesh-list
139565805|NCT01922817|Incretins|incretins|mesh-ancestor
139565806|NCT01922817|Hormones|hormones|mesh-ancestor
139565807|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565808|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565809|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139565810|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
139565811|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565812|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565813|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139565814|NCT04397289|Heparin|heparin|mesh-list
139565815|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
139565816|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
139565817|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139565818|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139565819|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565820|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139565821|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
139565822|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139565823|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
139565824|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565825|NCT00634179|Prednisone|prednisone|mesh-list
139565826|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
139565827|NCT00634179|Rituximab|rituximab|mesh-list
139565828|NCT00634179|Doxorubicin|doxorubicin|mesh-list
139565829|NCT00634179|Vincristine|vincristine|mesh-list
139565830|NCT00634179|Bortezomib|bortezomib|mesh-list
139565831|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139565832|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
139565833|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565834|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565835|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139565836|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
139565837|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565838|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565839|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139565840|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139565841|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139565842|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139565843|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139565844|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565845|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565846|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
139565847|NCT00634179|Hormones|hormones|mesh-ancestor
138874888|NCT05300347|Analgesics|analgesics|mesh-ancestor
139565848|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565849|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139565850|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139565851|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
139565852|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
139565853|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
139565854|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
139565855|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
139565856|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565857|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139565858|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565859|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565860|NCT01179490|Prednisolone|prednisolone|mesh-list
139565861|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565862|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
139565863|NCT01179490|Hormones|hormones|mesh-ancestor
139565864|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565865|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565866|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139565867|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565868|NCT01179568|Citalopram|citalopram|mesh-list
139565869|NCT01179568|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139565870|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139565871|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139565872|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565873|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565874|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
139565875|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565876|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139565877|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
139565878|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139565879|NCT01180036|Cyclosporine|cyclosporine|mesh-list
139565880|NCT01180036|Rituximab|rituximab|mesh-list
139565881|NCT01180036|Cyclosporins|cyclosporins|mesh-list
139347573|NCT02032927|Oxycodone|oxycodone|mesh-list
139565882|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139565884|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
139565885|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565886|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565887|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565888|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565889|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139565890|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
139565891|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565892|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
139565893|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139565894|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139565895|NCT01180894|Hematinics|hematinics|mesh-ancestor
139565896|NCT01181674|Insulin|insulin|mesh-list
139565897|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139565898|NCT01181674|Metformin|metformin|mesh-list
139565899|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
139565900|NCT01181674|Acarbose|acarbose|mesh-list
139565901|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139565902|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565903|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139565904|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565905|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875138|NCT05662904|Gemtuzumab|gemtuzumab|mesh-list
139565906|NCT01182376|Dronedarone|dronedarone|mesh-list
139565907|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139565908|NCT01183312|Flumazenil|flumazenil|mesh-list
139565909|NCT01183312|Antidotes|antidotes|mesh-ancestor
139565910|NCT01183312|Protective Agents|protective agents|mesh-ancestor
139565911|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565912|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
139565913|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
139565914|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565915|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565916|NCT03188172|Dexamethasone|dexamethasone|mesh-list
139565917|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
139565918|NCT03188172|Melphalan|melphalan|mesh-list
139565919|NCT03188172|Lenalidomide|lenalidomide|mesh-list
139565920|NCT03188172|Bortezomib|bortezomib|mesh-list
139565921|NCT03188172|Daratumumab|daratumumab|mesh-list
139565922|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139565923|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
139565924|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565925|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139565926|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139565927|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
139565928|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565929|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565930|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139565931|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565932|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
139565933|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
139565934|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565935|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139565936|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
139565937|NCT03188172|Hormones|hormones|mesh-ancestor
139565938|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565939|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139565940|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139565941|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139565942|NCT03188172|Growth Substances|growth substances|mesh-ancestor
139565943|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
139565944|NCT01184014|Insulin|insulin|mesh-list
139565945|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139565946|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
139565947|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
139565948|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
139565949|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
139565950|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
139565951|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139565952|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565953|NCT01185028|Interferons|interferons|mesh-list
139565954|NCT01185028|Ribavirin|ribavirin|mesh-list
139565955|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
139565956|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565957|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
139565958|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565959|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
139565960|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565961|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139565962|NCT02187016|Listerine|listerine|mesh-list
139565963|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139565964|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139565965|NCT05439798|Dexamethasone|dexamethasone|mesh-list
139565966|NCT05439798|Dexamethasone acetate|dexamethasone acetate|mesh-list
139565967|NCT05439798|Ondansetron|ondansetron|mesh-list
139565968|NCT05439798|Palonosetron|palonosetron|mesh-list
139565969|NCT05439798|BB 1101|bb 1101|mesh-list
139565970|NCT05439798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139565971|NCT05439798|Antiemetics|antiemetics|mesh-ancestor
139565972|NCT05439798|Autonomic Agents|autonomic agents|mesh-ancestor
139565973|NCT05439798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139565974|NCT05439798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139565975|NCT05439798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139565976|NCT05439798|Glucocorticoids|glucocorticoids|mesh-ancestor
139565977|NCT05439798|Hormones|hormones|mesh-ancestor
139565978|NCT05439798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139565979|NCT05439798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139565980|NCT05439798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139565981|NCT05439798|Protease Inhibitors|protease inhibitors|mesh-ancestor
139565982|NCT05439798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139565983|NCT05439798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565984|NCT05439798|Antipruritics|antipruritics|mesh-ancestor
139565985|NCT05439798|Dermatologic Agents|dermatologic agents|mesh-ancestor
139565986|NCT05439798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139565987|NCT05439798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139565988|NCT05439798|Serotonin Agents|serotonin agents|mesh-ancestor
139565989|NCT05439798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139565990|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
139565991|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139565992|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139565993|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139565994|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
139565995|NCT02188576|Coagulants|coagulants|mesh-ancestor
139565996|NCT02189122|Aspirin|aspirin|mesh-list
139565997|NCT02189122|Bradykinin|bradykinin|mesh-list
139565998|NCT02189122|Kininogens|kininogens|mesh-list
139565999|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139566000|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139566001|NCT02189122|Analgesics|analgesics|mesh-ancestor
139566002|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
139566003|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566004|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566005|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566006|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139566007|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139566008|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139566009|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566010|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139566011|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139566012|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566013|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
139566014|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
139566015|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139566016|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
139566017|NCT05309460|Labetalol|labetalol|mesh-list
139566018|NCT05309460|Nifedipine|nifedipine|mesh-list
139566019|NCT05309460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139566020|NCT05309460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139566021|NCT05309460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566022|NCT05309460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139566023|NCT05309460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566024|NCT05309460|Vasodilator Agents|vasodilator agents|mesh-ancestor
139566025|NCT05309460|Tocolytic Agents|tocolytic agents|mesh-ancestor
139566026|NCT05309460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139566027|NCT05309460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139566028|NCT05309460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139566029|NCT05309460|Adrenergic Agents|adrenergic agents|mesh-ancestor
139566030|NCT05309460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566031|NCT05309460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139566032|NCT05309460|Sympathomimetics|sympathomimetics|mesh-ancestor
139566033|NCT05309460|Autonomic Agents|autonomic agents|mesh-ancestor
139566034|NCT05309460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566035|NCT05309460|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139566037|NCT01093690|Metoclopramide|metoclopramide|mesh-list
139566038|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
139566039|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
139566040|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566041|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566042|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139566043|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139566044|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139566045|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
139566046|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566047|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566048|NCT01143688|Albuterol|albuterol|mesh-list
139566049|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139566050|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
139566051|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566052|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566053|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139566054|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
139566055|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
139566056|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139566057|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139566058|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139566059|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139566060|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
139566061|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566062|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566063|NCT04455594|Carboplatin|carboplatin|mesh-list
139566064|NCT04455594|Pemetrexed|pemetrexed|mesh-list
139566065|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139566066|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566067|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566068|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566069|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139566070|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139566071|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139566072|NCT05439408|Dasatinib|dasatinib|mesh-list
139566073|NCT05439408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566074|NCT05439408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139566075|NCT05439408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566076|NCT05439408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566077|NCT03011476|Donepezil|donepezil|mesh-list
139566078|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139566079|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566080|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566081|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
139566082|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566083|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566084|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
139566085|NCT02522754|Vaccines|vaccines|mesh-list
139566086|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
139566087|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566088|NCT01188694|Methylene Blue|methylene blue|mesh-list
139566089|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566090|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566091|NCT01188928|Betamethasone|betamethasone|mesh-list
139566092|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
139566093|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139566094|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
139566095|NCT01188928|Calcipotriene|calcipotriene|mesh-list
139566096|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139566097|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566098|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
139566099|NCT01188928|Hormones|hormones|mesh-ancestor
139566100|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566101|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566102|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139566103|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
139566104|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
139566105|NCT05438706|Carboplatin|carboplatin|mesh-list
139566106|NCT05438706|Capecitabine|capecitabine|mesh-list
139566107|NCT05438706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566108|NCT05438706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139566109|NCT05438706|Antimetabolites|antimetabolites|mesh-ancestor
139566110|NCT05438706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566111|NCT01189240|Bevacizumab|bevacizumab|mesh-list
139566112|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139566113|NCT01189240|Antibodies|antibodies|mesh-list
139566114|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
139566115|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139566116|NCT01189240|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139566117|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566118|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139566119|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139566120|NCT01189240|Growth Substances|growth substances|mesh-ancestor
139566121|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566122|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
139566123|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
139566124|NCT01189240|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139566125|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566126|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566127|NCT03467334|Simethicone|simethicone|mesh-list
139566128|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
139566129|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566130|NCT03467334|Emollients|emollients|mesh-ancestor
139566131|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
139566132|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
139566133|NCT02874144|Fluticasone|fluticasone|mesh-list
139566134|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566135|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
139566136|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139566137|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139566138|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
139566139|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566140|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566141|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139566142|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
139566143|NCT03467178|Paclitaxel|paclitaxel|mesh-list
139566144|NCT03467178|Carboplatin|carboplatin|mesh-list
139566145|NCT03467178|Gemcitabine|gemcitabine|mesh-list
139566146|NCT03467178|Doxorubicin|doxorubicin|mesh-list
139566147|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139566148|NCT03467178|Decitabine|decitabine|mesh-list
139566149|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139566150|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566151|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
139566152|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
139566153|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
139566154|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566155|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139566156|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
139566157|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139566158|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139566159|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139566160|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566161|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139566162|NCT02835534|Plasminogen|plasminogen|mesh-list
139566163|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139566164|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139566165|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566166|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
139566167|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566168|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
139566169|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139566170|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
139566171|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566172|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139566173|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139566174|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
139566175|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566176|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566177|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139566178|NCT02611830|Vedolizumab|vedolizumab|mesh-list
139566179|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139566180|NCT03461718|Midazolam|midazolam|mesh-list
139566181|NCT03461718|Fentanyl|fentanyl|mesh-list
139566182|NCT03461718|Ketamine|ketamine|mesh-list
139566183|NCT03461718|Analgesics|analgesics|mesh-ancestor
139566184|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
139566185|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566186|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566187|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139566188|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139566189|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
139566190|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
139566191|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139566192|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139566193|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139566194|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566195|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566196|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139566197|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139566198|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139566199|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139566200|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139566201|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
139566202|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
139566203|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139566204|NCT03461718|Narcotics|narcotics|mesh-ancestor
139566205|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
139566206|NCT03467022|Vitamins|vitamins|mesh-ancestor
139566207|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
139566208|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566209|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
139566210|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566211|NCT03467022|Protective Agents|protective agents|mesh-ancestor
139566212|NCT03129594|Glucagon|glucagon|mesh-list
139566213|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139566214|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139566215|NCT03129594|Hormones|hormones|mesh-ancestor
139566216|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566217|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566218|NCT03129594|Incretins|incretins|mesh-ancestor
139566219|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
139566220|NCT03466632|Propofol|propofol|mesh-list
139566221|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139566222|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139566223|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566224|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139566225|NCT03466632|Analgesics|analgesics|mesh-ancestor
139566226|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
139566227|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566228|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139566229|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139566230|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139566231|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
139566232|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566233|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566234|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139566235|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
139566236|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
139566237|NCT05339334|Ritonavir|ritonavir|mesh-list
139566238|NCT05339334|Nirmatrelvir|nirmatrelvir|mesh-list
139566239|NCT05339334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139566240|NCT05339334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139566241|NCT05339334|Protease Inhibitors|protease inhibitors|mesh-ancestor
139566242|NCT05339334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566243|NCT05339334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566244|NCT05339334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139566245|NCT05339334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139566246|NCT05339334|Antiviral Agents|antiviral agents|mesh-ancestor
139566247|NCT05339334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139566248|NCT05339334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139566249|NCT05339334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139566250|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
139566251|NCT03461328|Analgesics|analgesics|mesh-ancestor
139566252|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
139566253|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566254|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566255|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
139566256|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347945|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
139566257|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139566258|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
139566259|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139566260|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138876054|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
139566261|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566262|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139566263|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
139566264|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139566265|NCT01145638|Iron|iron|mesh-list
139566266|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139566267|NCT01145638|Trace Elements|trace elements|mesh-ancestor
139566268|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
139566269|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566270|NCT01145638|Hematinics|hematinics|mesh-ancestor
139566271|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
139566272|NCT03466320|Fludarabine|fludarabine|mesh-list
139566273|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139566274|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
139566275|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566276|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139566277|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139566278|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
139566279|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566280|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566281|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139566282|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
139566283|NCT03466242|Ketamine|ketamine|mesh-list
139566284|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139566285|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139566286|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566287|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139566288|NCT03466242|Analgesics|analgesics|mesh-ancestor
139566289|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
139566290|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566291|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139566292|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139566293|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139566294|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
139566295|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566296|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566297|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139566298|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139566299|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
139566300|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
139566301|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139566302|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139566303|NCT01190878|Bromfenac|bromfenac|mesh-list
139566304|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139566305|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139566306|NCT01190878|Analgesics|analgesics|mesh-ancestor
139566307|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
139566308|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566309|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566310|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566311|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139566312|NCT01146808|Adefovir|adefovir|mesh-list
139566313|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139566314|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
139566315|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139566316|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139566317|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139566318|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566319|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566320|NCT02522130|Naproxen|naproxen|mesh-list
139566321|NCT02522130|Lidocaine|lidocaine|mesh-list
139566322|NCT02522130|Misoprostol|misoprostol|mesh-list
139566323|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
139566324|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
139566325|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139566326|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566327|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
139566328|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566329|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139566330|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139566331|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139566332|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139566333|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566334|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139566336|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139566337|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139566338|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139566339|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
139566340|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139566341|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139566342|NCT02522130|Analgesics|analgesics|mesh-ancestor
139566343|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566344|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139566345|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
139566346|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139566347|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566348|NCT01148524|Vaccines|vaccines|mesh-list
139566349|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
139566350|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566351|NCT03460860|Tocopherols|tocopherols|mesh-list
139566352|NCT03460860|Vitamin E|vitamin e|mesh-list
139566353|NCT03460860|Tocotrienols|tocotrienols|mesh-list
139566354|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
139566355|NCT03460860|Lycopene|lycopene|mesh-list
139566356|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
139566357|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566358|NCT03460860|Protective Agents|protective agents|mesh-ancestor
139566359|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566360|NCT03460860|Vitamins|vitamins|mesh-ancestor
139566361|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
139566362|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566363|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139566364|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139566365|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566366|NCT03460782|Ipilimumab|ipilimumab|mesh-list
139566367|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139566368|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566369|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139566370|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566371|NCT01099618|Metformin|metformin|mesh-list
139566372|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139566373|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139566374|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566375|NCT01099618|Incretins|incretins|mesh-ancestor
139566376|NCT01099618|Hormones|hormones|mesh-ancestor
139566377|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566378|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139566379|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
139566380|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566381|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566382|NCT01099774|Bimatoprost|bimatoprost|mesh-list
139566383|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139566384|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139566385|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139566386|NCT01100242|Bortezomib|bortezomib|mesh-list
139566387|NCT01100242|Sorafenib|sorafenib|mesh-list
139566388|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566389|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139566390|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566391|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566392|NCT01148836|Ubiquinone|ubiquinone|mesh-list
139566393|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
139566394|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
139566395|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566396|NCT01148836|Vitamins|vitamins|mesh-ancestor
139566397|NCT01149616|Dexamethasone|dexamethasone|mesh-list
139566398|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566399|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
139566400|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
139566401|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566402|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566403|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139566404|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
139566405|NCT01149616|Hormones|hormones|mesh-ancestor
139566406|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566407|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139566408|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566409|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
139566410|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
139566411|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139566412|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139566413|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566414|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566415|NCT03460470|Urological Agents|urological agents|mesh-ancestor
139566416|NCT01101100|Brodalumab|brodalumab|mesh-list
139566417|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
139566418|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139566419|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139566420|NCT01101880|Cytarabine|cytarabine|mesh-list
139566421|NCT01101880|Clofarabine|clofarabine|mesh-list
139566422|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139566423|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
139566424|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566425|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566426|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
139566427|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139566428|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139566429|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
139566430|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876402|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
139566431|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139566432|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
139566433|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566434|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
139566435|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566436|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
139566437|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139566438|NCT01102270|Eszopiclone|eszopiclone|mesh-list
139566439|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139566440|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139566441|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566442|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
139566443|NCT01103440|Tirofiban|tirofiban|mesh-list
139566444|NCT01103440|Ticlopidine|ticlopidine|mesh-list
139566445|NCT01103440|Abciximab|abciximab|mesh-list
139566446|NCT01103440|Clopidogrel|clopidogrel|mesh-list
139566447|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139566448|NCT01103440|Cangrelor|cangrelor|mesh-list
139566449|NCT01103440|Eptifibatide|eptifibatide|mesh-list
139566450|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139566451|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139566452|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139566453|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139566454|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
139566455|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566456|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566457|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566458|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
139566459|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139566460|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139566461|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139566462|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
139566463|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139566464|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566465|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
139566466|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139566467|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
139566468|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139566469|NCT01103440|Protective Agents|protective agents|mesh-ancestor
139566470|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139566471|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139566472|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566473|NCT01105312|Letrozole|letrozole|mesh-list
139566474|NCT01105312|Panobinostat|panobinostat|mesh-list
139566475|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566476|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139566477|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139566478|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566479|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566480|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139566481|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
139566482|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566483|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566484|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139566485|NCT04488978|Amlodipine|amlodipine|mesh-list
139566486|NCT04488978|Irbesartan|irbesartan|mesh-list
139566487|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139566488|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139566489|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139566490|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566491|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139566492|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566493|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
139566494|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139566495|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139566496|NCT03460002|Vaccines|vaccines|mesh-list
139566497|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
139566498|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566499|NCT01105702|Bevacizumab|bevacizumab|mesh-list
139566500|NCT01105702|Temozolomide|temozolomide|mesh-list
139566501|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
139566502|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139566503|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566504|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139566505|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139566506|NCT01105702|Growth Substances|growth substances|mesh-ancestor
139566507|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566508|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
139566509|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139566510|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
139566511|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566512|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
139566513|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139566514|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566515|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
139566516|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139566517|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139566518|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139566519|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139566520|NCT04453332|Hormones|hormones|mesh-list
139566521|NCT04453332|Estradiol|estradiol|mesh-list
139566522|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139566523|NCT04453332|Progesterone|progesterone|mesh-list
139566524|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566525|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566526|NCT04453332|Estrogens|estrogens|mesh-ancestor
139566527|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139566528|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
139566529|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139566530|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139566531|NCT04453332|Progestins|progestins|mesh-ancestor
139566532|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
139566533|NCT03456570|Progestins|progestins|mesh-ancestor
139566534|NCT03456570|Hormones|hormones|mesh-ancestor
139566535|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566536|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566537|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139566538|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139566539|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139566540|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139566541|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566542|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566543|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566544|NCT03468348|Analgesics|analgesics|mesh-ancestor
139566545|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
139566546|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566547|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
139566548|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139566549|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
139566550|NCT03464682|Atorvastatin|atorvastatin|mesh-list
139566551|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139566552|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139566553|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
139566554|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876598|NCT00659412|Alefacept|alefacept|mesh-list
139566555|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139566556|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139566557|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566558|NCT03464058|Rabeprazole|rabeprazole|mesh-list
139566559|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139566560|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139566561|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139566562|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566563|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566565|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
139566566|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139566567|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566568|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139566569|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139566570|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139566571|NCT03130218|Peppermint oil|peppermint oil|mesh-list
139566572|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
139566573|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
139566574|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566575|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566576|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139566577|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
139566578|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
139566579|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566580|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139566581|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566582|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566583|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
139566584|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566585|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566586|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139566587|NCT01199926|Vitamin D|vitamin d|mesh-list
139566588|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
139566589|NCT01199926|Vitamins|vitamins|mesh-ancestor
139566590|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
139566591|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566592|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139566593|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139566594|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
139566595|NCT01106950|Fludarabine|fludarabine|mesh-list
139566596|NCT01106950|Interleukin-2|interleukin-2|mesh-list
139566597|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
139566598|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139566599|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
139566600|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566601|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139566602|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139566603|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
139566604|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566605|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566606|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139566607|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139566608|NCT01106950|Analgesics|analgesics|mesh-ancestor
139566609|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
139566610|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566611|NCT03463044|Nangibotide|nangibotide|mesh-list
139566612|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566613|NCT02522208|Hydralazine|hydralazine|mesh-list
139566614|NCT02522208|Isosorbide|isosorbide|mesh-list
139566615|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139566616|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139566617|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139566618|NCT02522208|Diuretics|diuretics|mesh-ancestor
139566619|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
139566620|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566621|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
139566622|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139566623|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566624|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139566625|NCT05684172|Tenecteplase|tenecteplase|mesh-list
139566626|NCT05684172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139566627|NCT05684172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139566628|NCT05684172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566629|NCT01200160|Niacin|niacin|mesh-list
139566630|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139566631|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
139566632|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566633|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139566634|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
139566635|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
139566636|NCT01200160|Vitamins|vitamins|mesh-ancestor
139566637|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
139566638|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566639|NCT01153672|Letrozole|letrozole|mesh-list
139566640|NCT01153672|Anastrozole|anastrozole|mesh-list
139566641|NCT01153672|Vorinostat|vorinostat|mesh-list
139566642|NCT01153672|Exemestane|exemestane|mesh-list
139566643|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566644|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139566645|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139566646|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566647|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566648|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139566649|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
139566650|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566651|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566652|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139566653|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139566654|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
139566655|NCT03010072|Hematinics|hematinics|mesh-ancestor
139566656|NCT03462810|Cabotegravir|cabotegravir|mesh-list
139566657|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139566658|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139566659|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566660|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566661|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139566662|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139566663|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
139566664|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139566665|NCT01219738|Budesonide|budesonide|mesh-list
139566666|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566667|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139566668|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
139566669|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566670|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566671|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139566672|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
139566673|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
139566674|NCT01219738|Hormones|hormones|mesh-ancestor
139566675|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566676|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
139566677|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139566678|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566679|NCT03848754|Immunotoxins|immunotoxins|mesh-ancestor
139566680|NCT03848754|Immunoconjugates|immunoconjugates|mesh-ancestor
139566681|NCT03848754|Immunologic Factors|immunologic factors|mesh-ancestor
139566682|NCT03848754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566683|NCT01155154|Clindamycin|clindamycin|mesh-list
139566684|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
139566685|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
139566686|NCT01155154|Cephalexin|cephalexin|mesh-list
139566687|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139566688|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139566689|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139566690|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566691|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566692|NCT04614714|Niacinamide|niacinamide|mesh-list
139566693|NCT04614714|Niacin|niacin|mesh-list
139566694|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
139566695|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
139566696|NCT04614714|Vitamins|vitamins|mesh-ancestor
139566697|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
139566698|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566699|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139566700|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
139566701|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566702|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139566703|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
139566704|NCT01221298|Ritonavir|ritonavir|mesh-list
139566705|NCT01221298|Ribavirin|ribavirin|mesh-list
139566706|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139566707|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139566708|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
139566709|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566710|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566711|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139566712|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139566713|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
139566714|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139566715|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139566716|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139566717|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
139566718|NCT01222234|Vitamin D|vitamin d|mesh-list
139566719|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
139566720|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
139566721|NCT01222234|Calcitriol|calcitriol|mesh-list
139566722|NCT01222234|Vitamins|vitamins|mesh-list
139566723|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
139566724|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566725|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139566726|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139566727|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139566728|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139566729|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566730|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139566731|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139566732|NCT01203046|Ertapenem|ertapenem|mesh-list
139566733|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139566734|NCT02460588|Prednisolone|prednisolone|mesh-list
139566735|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
139566736|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139566737|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
139566738|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566739|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139566740|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139566741|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
139566742|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566743|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566744|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139566745|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566746|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
139566747|NCT02460588|Hormones|hormones|mesh-ancestor
139566748|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566749|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139566750|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139566751|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
139566752|NCT03449082|Coagulants|coagulants|mesh-ancestor
139566753|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
139566754|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139566755|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139566756|NCT03413202|Protective Agents|protective agents|mesh-ancestor
139566757|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566758|NCT04169100|Prednisone|prednisone|mesh-list
139566759|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566760|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
139566761|NCT04169100|Hormones|hormones|mesh-ancestor
139566762|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566763|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566764|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139566765|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566766|NCT04155840|Rituximab|rituximab|mesh-list
139566767|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139566768|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139566769|NCT04155840|Antibodies|antibodies|mesh-list
139566770|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
139566771|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139566772|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
139566773|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566774|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566775|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139566776|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139566777|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
139566778|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566779|NCT03448770|Lactulose|lactulose|mesh-list
139566780|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139566781|NCT03443778|Dexamethasone|dexamethasone|mesh-list
139566782|NCT03443778|Bupivacaine|bupivacaine|mesh-list
139566783|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139566784|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
139566785|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
139566786|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566787|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566788|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139566789|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
139566790|NCT03443778|Hormones|hormones|mesh-ancestor
139566791|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566792|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139566793|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566794|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
139566795|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
139566796|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139566797|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
139566798|NCT03011008|Liraglutide|liraglutide|mesh-list
139566799|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139566800|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566801|NCT03011008|Incretins|incretins|mesh-ancestor
139566802|NCT03011008|Hormones|hormones|mesh-ancestor
139566803|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139566804|NCT01157416|Cycloserine|cycloserine|mesh-list
139566805|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139566806|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139566807|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139566808|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
139566809|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139566810|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
139566811|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566812|NCT01206478|Megestrol|megestrol|mesh-list
139566813|NCT01206478|Amitriptyline|amitriptyline|mesh-list
139566814|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139566815|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
139566816|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139566817|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139566818|NCT01206478|Analgesics|analgesics|mesh-ancestor
139566819|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
139566820|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566821|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876981|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
139566822|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139566823|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139566824|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139566825|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566826|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
139566827|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566828|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139566829|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139566830|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139566831|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
139566832|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139566833|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138877043|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
139566834|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139566835|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139566836|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566837|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
139566838|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
139566839|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139566840|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566841|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566842|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
139566843|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139566844|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139566845|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566846|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
139566847|NCT01158820|Midazolam|midazolam|mesh-list
139566848|NCT01158820|Fentanyl|fentanyl|mesh-list
139566849|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
139566850|NCT01158820|Ketamine|ketamine|mesh-list
139566851|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139566852|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139566853|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566854|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139566855|NCT01158820|Analgesics|analgesics|mesh-ancestor
139566856|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
139566857|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566858|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138877106|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
139566859|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139566860|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139566861|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
139566862|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566863|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566864|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139566865|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139566866|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
139566867|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
139566868|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139566869|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139566870|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139566871|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139566872|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139566873|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139566874|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
139566875|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
139566876|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139566877|NCT01158820|Narcotics|narcotics|mesh-ancestor
139566878|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139566879|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
139566880|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
139566881|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
139566882|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139566883|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139566884|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
138877153|NCT04157010|Methotrexate|methotrexate|mesh-list
139566885|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
139566886|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139566888|NCT03707028|Apatinib|apatinib|mesh-list
139566889|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139566890|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566891|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
139566892|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
139566893|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
139566894|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566895|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139566896|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566897|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
139566898|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139566899|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566900|NCT03447678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138877203|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
139566901|NCT03447678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566902|NCT01225354|Calcium|calcium|mesh-list
139566903|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139566904|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566905|NCT02521662|Nicotine|nicotine|mesh-list
139566906|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139566907|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
139566908|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139566909|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566910|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139566911|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139566912|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
139566913|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877266|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566914|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566915|NCT05183880|Vitamins|vitamins|mesh-list
139566916|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
139566917|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
139566918|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566919|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
139566920|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566921|NCT05183880|Protective Agents|protective agents|mesh-ancestor
139566922|NCT01159054|Niacin|niacin|mesh-list
139566923|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
139566924|NCT01159054|Niacinamide|niacinamide|mesh-list
139566925|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139566926|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
139566927|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566928|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139566929|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
139566930|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
139566931|NCT01159054|Vitamins|vitamins|mesh-ancestor
139566932|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
139566933|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566934|NCT01209442|Bevacizumab|bevacizumab|mesh-list
139566935|NCT01209442|Temozolomide|temozolomide|mesh-list
139566936|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139566937|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348625|NCT02334488|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139566938|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139566939|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139566940|NCT01209442|Growth Substances|growth substances|mesh-ancestor
139566941|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566942|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
139566943|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139566944|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
139566945|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566946|NCT01160380|Modafinil|modafinil|mesh-list
139566947|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139566948|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566949|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139566950|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139566951|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139566952|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566953|NCT04956042|Cytarabine|cytarabine|mesh-list
139566954|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139566955|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
139566956|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566957|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566958|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
139566959|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139566960|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139566961|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
139566962|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566963|NCT01228084|Sulforaphane|sulforaphane|mesh-list
139566964|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139566965|NCT01228084|Protective Agents|protective agents|mesh-ancestor
139566966|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566967|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139566968|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139566969|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139566970|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139566971|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139566972|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139566973|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
139566974|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566975|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566976|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566977|NCT01212484|Carbidopa|carbidopa|mesh-list
139566978|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139566979|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139566980|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
139566981|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566982|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566983|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566984|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139566985|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139566986|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139566987|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
139566988|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566989|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
139566990|NCT01212874|Esmolol|esmolol|mesh-list
139566991|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
139566992|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139566993|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139566994|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139566995|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
139566996|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139566997|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139566998|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139566999|NCT01859741|Carboplatin|carboplatin|mesh-list
139567000|NCT01859741|Etoposide|etoposide|mesh-list
139567001|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567002|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139567003|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139567004|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139567005|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567006|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567007|NCT01212952|Dexamethasone|dexamethasone|mesh-list
139567008|NCT01212952|Bortezomib|bortezomib|mesh-list
139567009|NCT01212952|Pomalidomide|pomalidomide|mesh-list
139567010|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567011|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
139567012|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
139567013|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567014|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567015|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139567016|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
139567017|NCT01212952|Hormones|hormones|mesh-ancestor
139567018|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139567019|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139567020|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567021|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
139567022|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139567023|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139567024|NCT01212952|Growth Substances|growth substances|mesh-ancestor
139567025|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
139567026|NCT04609865|Lidocaine|lidocaine|mesh-list
139567027|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
139567028|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
139567029|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567030|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567031|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
139567032|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567033|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139567034|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139567035|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139567036|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139567037|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567038|NCT01873859|Metformin|metformin|mesh-list
139567039|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139567040|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567041|NCT00493896|Enoxaparin|enoxaparin|mesh-list
139567042|NCT00493896|PENTA|penta|mesh-list
139567043|NCT00493896|Fondaparinux|fondaparinux|mesh-list
139567044|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
138809591|NCT01979211|Cetuximab|cetuximab|mesh-list
139567045|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139567046|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139567047|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567048|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139567049|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
139567050|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139567051|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
139567052|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567053|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139567054|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
139567055|NCT03449940|Diclofenac|diclofenac|mesh-list
139567056|NCT03449940|Lidocaine|lidocaine|mesh-list
139567057|NCT03449940|Analgesics|analgesics|mesh-list
139567058|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
139567059|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
139567060|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567061|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567062|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
139567063|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567064|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139567065|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139567066|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139567067|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139567068|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567069|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567070|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139567071|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139567072|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567073|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139567074|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139567075|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567076|NCT01230424|Triamcinolone|triamcinolone|mesh-list
139567077|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139567078|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139567079|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139567080|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567081|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
139567082|NCT01230424|Hormones|hormones|mesh-ancestor
139567083|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139567084|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567085|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139567086|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
139567087|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567088|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567089|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
139567090|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139567091|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567092|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139567093|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
139567094|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139567095|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567096|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567097|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567098|NCT03438240|Fentanyl|fentanyl|mesh-list
139567099|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
139567100|NCT03438240|Bupivacaine|bupivacaine|mesh-list
139567101|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
139567102|NCT03438240|Anesthetics|anesthetics|mesh-list
139567103|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
139567104|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567105|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567106|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
139567107|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567108|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139567109|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139567110|NCT03438240|Analgesics|analgesics|mesh-ancestor
139567111|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139567112|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139567113|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138877745|NCT02624505|Albuterol|albuterol|mesh-list
139567114|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
139567115|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567116|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567117|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139567118|NCT03438240|Narcotics|narcotics|mesh-ancestor
139567119|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139567120|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139567121|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
139567122|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
139567123|NCT01160848|Ethanol|ethanol|mesh-list
139567124|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139567125|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567126|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567127|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567128|NCT01213576|Ivermectin|ivermectin|mesh-list
139567129|NCT01213576|Albendazole|albendazole|mesh-list
139567130|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139567131|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567132|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
139567133|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
139567134|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139567135|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139567136|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
139567137|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
139567138|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
139567139|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567140|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567141|NCT04452318|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
139567142|NCT04452318|Antiviral Agents|antiviral agents|mesh-ancestor
139567143|NCT04452318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567144|NCT01161862|Glucagon|glucagon|mesh-list
139567145|NCT01161862|Pancrelipase|pancrelipase|mesh-list
139567146|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567147|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139567148|NCT01161862|Hormones|hormones|mesh-ancestor
139567149|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139567150|NCT01214356|Vitamin D|vitamin d|mesh-list
139567151|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
139567152|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
139567153|NCT01214356|Vitamins|vitamins|mesh-list
139567154|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
139567155|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567156|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139567157|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139567158|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
139567159|NCT01232920|Methotrexate|methotrexate|mesh-list
139567160|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139567161|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
139567162|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139567163|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567164|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139567165|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
139567166|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567167|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567168|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
139567169|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567170|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139567171|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139567172|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
139567173|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139567174|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139567175|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139567176|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139567177|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
139567178|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139567179|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567180|NCT03445182|Anesthetics|anesthetics|mesh-list
139567181|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567182|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567183|NCT03010540|Fentanyl|fentanyl|mesh-list
139567184|NCT03010540|Morphine|morphine|mesh-list
139567185|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139567186|NCT03010540|Narcotics|narcotics|mesh-ancestor
139567187|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567188|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567189|NCT03010540|Analgesics|analgesics|mesh-ancestor
139567190|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
139567191|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567192|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139567193|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139567194|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
139567195|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
139567196|NCT03445104|Huperzine A|huperzine a|mesh-list
139567197|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139567198|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567199|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567200|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
139567201|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567202|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567203|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139567204|NCT03445104|Protective Agents|protective agents|mesh-ancestor
139567205|NCT01234714|Liver Extracts|liver extracts|mesh-list
139567206|NCT01234714|Hematinics|hematinics|mesh-ancestor
139567207|NCT03440502|Anesthetics|anesthetics|mesh-list
139567208|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567209|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567210|NCT01234870|Adenosine|adenosine|mesh-list
139567211|NCT01234870|Analgesics|analgesics|mesh-ancestor
139567212|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
139567213|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567214|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567215|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139567216|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
139567217|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139567218|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
139567219|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
139567220|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567221|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567222|NCT03437460|Ibuprofen|ibuprofen|mesh-list
139567223|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567224|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139567225|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139567226|NCT03437460|Analgesics|analgesics|mesh-ancestor
139567227|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
139567228|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567229|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567230|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139567231|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139567232|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567233|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567234|NCT03444636|Fentanyl|fentanyl|mesh-list
139567235|NCT03444636|Bupivacaine|bupivacaine|mesh-list
139567236|NCT03444636|Ropivacaine|ropivacaine|mesh-list
139567237|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
139567238|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
139567239|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567240|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567241|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
139567242|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567243|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139567244|NCT03444636|Narcotics|narcotics|mesh-ancestor
139567245|NCT03444636|Analgesics|analgesics|mesh-ancestor
139567246|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139567247|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139567248|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
139567249|NCT01215292|Ketoconazole|ketoconazole|mesh-list
139567250|NCT01215292|Anastrozole|anastrozole|mesh-list
139567251|NCT01215292|Testosterone|testosterone|mesh-list
139567252|NCT01215292|Dutasteride|dutasteride|mesh-list
139567253|NCT01215292|Acyline|acyline|mesh-list
139567254|NCT01215292|Androgens|androgens|mesh-ancestor
139567255|NCT01215292|Hormones|hormones|mesh-ancestor
139567256|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139567257|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567258|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139567259|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567260|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139567261|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139567262|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567263|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567264|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139567265|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
139567266|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
139567267|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567268|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139567269|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139567270|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139567271|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139567272|NCT04796454|Gemcitabine|gemcitabine|mesh-list
139567273|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
139567274|NCT04796454|Temozolomide|temozolomide|mesh-list
139567275|NCT04796454|Pamiparib|pamiparib|mesh-list
139567276|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567277|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139567278|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
139567279|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567280|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139567281|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
139567282|NCT04796454|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139567283|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567284|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139567285|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139567286|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567287|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139567288|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567289|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567290|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
139567291|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138877980|NCT00648440|Midodrine|midodrine|mesh-list
139567292|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567293|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139567294|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
139567295|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139567296|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567297|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567298|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567299|NCT03437226|Simendan|simendan|mesh-list
139567300|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139567301|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
139567302|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139567303|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139567304|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567305|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567306|NCT03437226|Protective Agents|protective agents|mesh-ancestor
139567307|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567308|NCT04788420|Sorafenib|sorafenib|mesh-list
139567309|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567310|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139567311|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567312|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567313|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139567314|NCT01282138|Dextrans|dextrans|mesh-list
139567315|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139567316|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139567317|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
139567318|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
139567319|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
139567320|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139567321|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139567322|NCT01282138|Analgesics|analgesics|mesh-ancestor
139567323|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
139567324|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567325|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567326|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567327|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139567328|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139567329|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139567330|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139567331|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
139567332|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
139567333|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567334|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567335|NCT03444402|Esomeprazole|esomeprazole|mesh-list
139567336|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139567337|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139567338|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139567339|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567340|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567341|NCT01238536|Dexamethasone|dexamethasone|mesh-list
139567342|NCT01238536|Betamethasone|betamethasone|mesh-list
139567343|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139567344|NCT01238536|Lidocaine|lidocaine|mesh-list
139567345|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
139567346|NCT01238536|Anesthetics|anesthetics|mesh-list
139567347|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567348|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
139567349|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
139567350|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567351|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567352|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139567353|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
139567354|NCT01238536|Hormones|hormones|mesh-ancestor
139567355|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139567356|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139567357|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878027|NCT00648518|Metformin|metformin|mesh-list
139567358|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567359|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567360|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
139567361|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139567362|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139567363|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139567364|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139567365|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139567366|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
139567367|NCT03437070|Doxorubicin|doxorubicin|mesh-list
139567368|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139567369|NCT03437070|Trabectedin|trabectedin|mesh-list
139567370|NCT03437070|Olaratumab|olaratumab|mesh-list
139567371|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139567372|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567373|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139567374|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139567375|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567376|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567377|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139567378|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
139567379|NCT03128736|Esomeprazole|esomeprazole|mesh-list
139567380|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
139567381|NCT03128736|Lansoprazole|lansoprazole|mesh-list
139567382|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139567383|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139567384|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139567385|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567386|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349073|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
139567388|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139567389|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139567390|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567391|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
139567392|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567393|NCT03444246|Iodine|iodine|mesh-list
139567394|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
139567395|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139567396|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567397|NCT03444246|Trace Elements|trace elements|mesh-ancestor
139567398|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
139567399|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567400|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
139567401|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139567402|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
139567403|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567404|NCT03440268|Expectorants|expectorants|mesh-ancestor
139567405|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
139567406|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139567407|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
139567408|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567409|NCT03440268|Protective Agents|protective agents|mesh-ancestor
139567410|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567411|NCT03440268|Antidotes|antidotes|mesh-ancestor
139567412|NCT04369014|Anesthetics|anesthetics|mesh-list
139567413|NCT04369014|Propofol|propofol|mesh-list
139567414|NCT04369014|Etomidate|etomidate|mesh-list
139567415|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878131|NCT02781467|Analgesics|analgesics|mesh-ancestor
139567416|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567417|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139567418|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139567419|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
139567420|NCT03436836|Lidocaine|lidocaine|mesh-list
139567421|NCT03436836|Nalbuphine|nalbuphine|mesh-list
139567422|NCT03436836|Bupivacaine|bupivacaine|mesh-list
139567423|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
139567424|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
139567425|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567426|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878174|NCT00980551|Carboplatin|carboplatin|mesh-list
139567427|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
139567428|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567429|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139567430|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139567431|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139567432|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139567433|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567434|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139567435|NCT03436836|Narcotics|narcotics|mesh-ancestor
139567436|NCT03436836|Analgesics|analgesics|mesh-ancestor
139567437|NCT03444012|Ticagrelor|ticagrelor|mesh-list
139567438|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139567439|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139567440|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139567441|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139567442|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
139567443|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567444|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567445|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567446|NCT03440034|Pioglitazone|pioglitazone|mesh-list
139567447|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139567448|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567449|NCT03433326|Grazoprevir|grazoprevir|mesh-list
139567450|NCT03433326|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139567451|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
139567452|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567453|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139567454|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
139567455|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139567456|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139567457|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139567458|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567459|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349153|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
139567460|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139567461|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139567462|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567463|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
139567464|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567465|NCT04276389|Paclitaxel|paclitaxel|mesh-list
139567466|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139567467|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139567468|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567469|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
139567470|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
139567471|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
139567472|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567473|NCT03128619|Letrozole|letrozole|mesh-list
139567474|NCT03128619|Palbociclib|palbociclib|mesh-list
139567475|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567476|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139567477|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139567478|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567479|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567480|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139567481|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
139567482|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139567483|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567484|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139567485|NCT03433092|Carotenoids|carotenoids|mesh-list
139567486|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
139567487|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567488|NCT03433092|Protective Agents|protective agents|mesh-ancestor
139567489|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567490|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
139567491|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
139567492|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
139567493|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567494|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567495|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
139567496|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567497|NCT01872689|Pirfenidone|pirfenidone|mesh-list
139567498|NCT01872689|Analgesics|analgesics|mesh-ancestor
139567499|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
139567500|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567501|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567502|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139567503|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139567504|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567505|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139567506|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567507|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139567508|NCT03435900|Metronidazole|metronidazole|mesh-list
139567509|NCT03435900|Fosfomycin|fosfomycin|mesh-list
139567510|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139567511|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567512|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
139567513|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139567514|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139567515|NCT00632931|Vorinostat|vorinostat|mesh-list
139567516|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567517|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139567518|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567519|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567520|NCT01857323|Albuterol|albuterol|mesh-list
139567521|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139567522|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
139567523|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567524|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567525|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139567526|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
139567527|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
139567528|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139567529|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139567530|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139567531|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139567532|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
139567533|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567534|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567535|NCT03104439|Nivolumab|nivolumab|mesh-list
139567536|NCT03104439|Ipilimumab|ipilimumab|mesh-list
139567537|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139567538|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567539|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139567540|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567541|NCT03432780|Docetaxel|docetaxel|mesh-list
139567542|NCT03432780|Hormones|hormones|mesh-list
139567543|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567544|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
139567545|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
139567546|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
138878509|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
139567547|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567548|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139567549|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567550|NCT00055731|Aspirin|aspirin|mesh-list
139567551|NCT00055731|Docetaxel|docetaxel|mesh-list
139567552|NCT00055731|Goserelin|goserelin|mesh-list
139567553|NCT00055731|Bicalutamide|bicalutamide|mesh-list
139567554|NCT00055731|Estramustine|estramustine|mesh-list
139567555|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567556|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
139567557|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
139567558|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
139567559|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567560|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139567561|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139567562|NCT00055731|Analgesics|analgesics|mesh-ancestor
139567563|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
139567564|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567565|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567566|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567567|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139567568|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139567569|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139567570|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139567571|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139567572|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567573|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
139567574|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139567575|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
139567576|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
139567577|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139567578|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139567579|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
139567580|NCT03435744|Simvastatin|simvastatin|mesh-list
138878574|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
139567581|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139567582|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139567583|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
139567584|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567585|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139567586|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139567587|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567588|NCT03435666|Capecitabine|capecitabine|mesh-list
139567589|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139567590|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
139567591|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567592|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567593|NCT00632541|Bevacizumab|bevacizumab|mesh-list
139567594|NCT00632541|Sorafenib|sorafenib|mesh-list
139567595|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139567596|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567597|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139567598|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139567599|NCT00632541|Growth Substances|growth substances|mesh-ancestor
139567600|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567601|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
139567602|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139567603|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567604|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567605|NCT01872611|Prednisolone|prednisolone|mesh-list
139567606|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139567607|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
139567608|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139567609|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
139567610|NCT01872611|Nepafenac|nepafenac|mesh-list
139567611|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139567612|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
139567613|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567614|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
139567615|NCT01872611|Hormones|hormones|mesh-ancestor
139567616|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139567617|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567618|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139567619|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567620|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
139567621|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
139567622|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567623|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139567624|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139567625|NCT01872611|Protective Agents|protective agents|mesh-ancestor
139567626|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139567627|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139567628|NCT01872611|Analgesics|analgesics|mesh-ancestor
139567629|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
139567630|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139567631|NCT03432468|Valsartan|valsartan|mesh-list
139567632|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139567633|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139567634|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139567635|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567636|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
139567637|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567638|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
139567639|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139567640|NCT03432312|Nicotine|nicotine|mesh-list
139567641|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139567642|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
139567643|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567644|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567645|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139567646|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139567647|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
139567648|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567649|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567650|NCT03438942|Folic Acid|folic acid|mesh-list
139567651|NCT03438942|Hematinics|hematinics|mesh-ancestor
139567652|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
139567653|NCT03438942|Vitamins|vitamins|mesh-ancestor
139567654|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
139567655|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567656|NCT03432156|Immunomodulating Agents|immunomodulating agents|mesh-list
139567657|NCT03432156|Immunologic Factors|immunologic factors|mesh-ancestor
139567658|NCT03432156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567659|NCT04450680|Lactams|lactams|mesh-list
139567660|NCT04450680|beta-Lactams|beta-lactams|mesh-list
139567661|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139567662|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567663|NCT03438708|Axitinib|axitinib|mesh-list
139567664|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567665|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139567666|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567667|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567668|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139567669|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
139567670|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567671|NCT01923597|Protective Agents|protective agents|mesh-ancestor
139567672|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567673|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139567674|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139567675|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567676|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139567677|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139567678|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139567679|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139567680|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567681|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567682|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139567683|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139567684|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139567685|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
139567686|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567687|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567688|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139567689|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139567690|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
139567691|NCT00631137|Testosterone|testosterone|mesh-list
139567692|NCT00631137|Androgens|androgens|mesh-ancestor
139567693|NCT00631137|Hormones|hormones|mesh-ancestor
139567694|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139567695|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567696|NCT03428880|Morphine|morphine|mesh-list
139567697|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139567698|NCT03428880|Narcotics|narcotics|mesh-ancestor
139567699|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567700|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567701|NCT03428880|Analgesics|analgesics|mesh-ancestor
139567702|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
139567703|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567704|NCT01923831|Dexamethasone|dexamethasone|mesh-list
139567705|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
139567706|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567707|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
139567708|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
139567709|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567710|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567711|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139567712|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
139567713|NCT01923831|Hormones|hormones|mesh-ancestor
139567714|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139567715|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139567716|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567717|NCT01923831|Analgesics|analgesics|mesh-ancestor
139567718|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
139567719|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
139567720|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567721|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139567722|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
139567723|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139567724|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138878785|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567725|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567726|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139567727|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
139567728|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139567729|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139567730|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567731|NCT04892940|Analgesics|analgesics|mesh-list
139567732|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
139567733|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567734|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567735|NCT03085563|Midazolam|midazolam|mesh-list
139567736|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
139567737|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139567738|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139567739|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567740|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567741|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139567742|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139567743|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139567744|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139567745|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
139567746|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
139567747|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
139567748|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
139567749|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567750|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567751|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139567752|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139567753|NCT03085563|Analgesics|analgesics|mesh-ancestor
139567754|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
139567755|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567756|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
139567757|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139567758|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567759|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
139567760|NCT04450446|Heparin|heparin|mesh-list
139567761|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139567762|NCT04450446|Tinzaparin|tinzaparin|mesh-list
139567763|NCT04450446|Dalteparin|dalteparin|mesh-list
139567764|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
139567765|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139567766|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139567767|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567769|NCT03274752|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139567770|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139567771|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139567772|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567773|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567774|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
139567775|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567776|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139567777|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
139567778|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139567779|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139567780|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139567781|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567782|NCT03902418|Tenofovir|tenofovir|mesh-list
139567783|NCT03902418|Emtricitabine|emtricitabine|mesh-list
139567784|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
139567785|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567786|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139567787|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139567788|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567789|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567790|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139567791|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139567792|NCT03428568|Clarithromycin|clarithromycin|mesh-list
139567793|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139567794|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567795|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139567796|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879006|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567797|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567798|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139567799|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139567800|NCT00630825|Dulaglutide|dulaglutide|mesh-list
139567801|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139567802|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567803|NCT03434340|Dexamethasone|dexamethasone|mesh-list
139567804|NCT03434340|Granisetron|granisetron|mesh-list
139567805|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567806|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
139567807|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
139567808|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567809|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567810|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139567811|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
139567812|NCT03434340|Hormones|hormones|mesh-ancestor
139567813|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139567814|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139567815|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567816|NCT03434340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139567817|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139567818|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
139567819|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567820|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567821|NCT03088605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139567822|NCT03088605|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139567823|NCT01923987|Cetuximab|cetuximab|mesh-list
139567824|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139567825|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567826|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
139567827|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139567828|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
139567829|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567830|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
139567831|NCT03101163|Protective Agents|protective agents|mesh-ancestor
139567832|NCT01924065|Anticoagulants|anticoagulants|mesh-list
139567833|NCT03434106|Dextrans|dextrans|mesh-list
139567834|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
139567835|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
139567836|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
139567837|NCT01241344|Brincidofovir|brincidofovir|mesh-list
139567838|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
139567839|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139567840|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139567841|NCT03009682|Olaparib|olaparib|mesh-list
139567842|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139567843|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567844|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567845|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567846|NCT03431142|Aspirin|aspirin|mesh-list
139567847|NCT03431142|Clopidogrel|clopidogrel|mesh-list
139567848|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139567849|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139567850|NCT03431142|Analgesics|analgesics|mesh-ancestor
139567851|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
139567852|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567853|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567854|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567855|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139567856|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139567857|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138879121|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139567858|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567859|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139567860|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139567861|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567862|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
139567863|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139567864|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139567865|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139567866|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
139567867|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567868|NCT03831321|Diclofenac|diclofenac|mesh-list
139567869|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139567870|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139567871|NCT03831321|Analgesics|analgesics|mesh-ancestor
139567872|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
139567873|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567874|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567875|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567876|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139567877|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139567878|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567879|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567880|NCT04450134|Fexofenadine|fexofenadine|mesh-list
139567881|NCT04450134|Famotidine|famotidine|mesh-list
139567882|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139567883|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139567884|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139567885|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
139567886|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
139567887|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567888|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567889|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567890|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139567891|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139567892|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139567893|NCT01286818|Leucovorin|leucovorin|mesh-list
139567894|NCT01286818|Fluorouracil|fluorouracil|mesh-list
139567895|NCT01286818|Irinotecan|irinotecan|mesh-list
139567896|NCT01286818|Ramucirumab|ramucirumab|mesh-list
139567897|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139567898|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
139567899|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
139567900|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567901|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139567902|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567903|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139567904|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
139567905|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567906|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139567907|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139567908|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567909|NCT01286818|Antidotes|antidotes|mesh-ancestor
139567910|NCT01286818|Protective Agents|protective agents|mesh-ancestor
139567911|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
139567912|NCT01286818|Vitamins|vitamins|mesh-ancestor
139567913|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
139567914|NCT03428256|Anesthetics|anesthetics|mesh-list
139567915|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567916|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567917|NCT00635505|Albuterol|albuterol|mesh-list
139567918|NCT00635505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139567919|NCT00635505|Autonomic Agents|autonomic agents|mesh-ancestor
139567920|NCT00635505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567921|NCT00635505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567922|NCT00635505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139567923|NCT00635505|Respiratory System Agents|respiratory system agents|mesh-ancestor
139567924|NCT00635505|Tocolytic Agents|tocolytic agents|mesh-ancestor
139567925|NCT00635505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139567926|NCT00635505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139567927|NCT00635505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139567928|NCT00635505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139567929|NCT00635505|Adrenergic Agents|adrenergic agents|mesh-ancestor
139567930|NCT00635505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139567931|NCT00635505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567932|NCT01243450|Tretinoin|tretinoin|mesh-list
139567933|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567934|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
139567935|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
139567936|NCT05249751|Arginine Vasopressin|arginine vasopressin|mesh-list
139567937|NCT05249751|Hemostatics|hemostatics|mesh-ancestor
139567938|NCT05249751|Coagulants|coagulants|mesh-ancestor
139567939|NCT05249751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139567940|NCT05249751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139567941|NCT05249751|Natriuretic Agents|natriuretic agents|mesh-ancestor
139567942|NCT05249751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567943|NCT00635193|Doxorubicin|doxorubicin|mesh-list
139567944|NCT00635193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139567945|NCT00635193|Volociximab|volociximab|mesh-list
139567946|NCT00635193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139567947|NCT00635193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139567948|NCT00635193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567949|NCT00635193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139567950|NCT00635193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139567951|NCT00635193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879256|NCT02775773|Oxytocin|oxytocin|mesh-list
139567952|NCT00635193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567953|NCT00635193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139567954|NCT00635193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139567955|NCT00635193|Growth Substances|growth substances|mesh-ancestor
139567956|NCT00635193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567957|NCT00635193|Growth Inhibitors|growth inhibitors|mesh-ancestor
139567958|NCT00635193|Immunologic Factors|immunologic factors|mesh-ancestor
139567959|NCT00630201|Buprenorphine|buprenorphine|mesh-list
139567960|NCT00630201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139567961|NCT00630201|Narcotics|narcotics|mesh-ancestor
139567962|NCT00630201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567963|NCT00630201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567964|NCT00630201|Analgesics|analgesics|mesh-ancestor
139567965|NCT00630201|Sensory System Agents|sensory system agents|mesh-ancestor
139567966|NCT00630201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567967|NCT00630201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139567968|NCT01925547|Curcumin|curcumin|mesh-list
139567969|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139567970|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139567971|NCT01925547|Analgesics|analgesics|mesh-ancestor
139567972|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
139567973|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567974|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567975|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567976|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139567977|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139567978|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139567979|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139567980|NCT03122301|Bupivacaine|bupivacaine|mesh-list
139567981|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
139567982|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
139567983|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139567984|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567985|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
139567986|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567987|NCT01925859|Dexamethasone|dexamethasone|mesh-list
139567988|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
139567989|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139567990|NCT01925859|BB 1101|bb 1101|mesh-list
139567991|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139567992|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
139567993|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
139567994|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139567995|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139567996|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139567997|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
139567998|NCT01925859|Hormones|hormones|mesh-ancestor
139567999|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139568000|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139568001|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568002|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
139568003|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568004|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568005|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139568006|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139568007|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139568008|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568009|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568010|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139568011|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139568012|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568013|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
139568014|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568015|NCT01926639|Rituximab|rituximab|mesh-list
139568016|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139568017|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568018|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
139568019|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568020|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139568021|NCT02199496|Ustekinumab|ustekinumab|mesh-list
139568022|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
139568023|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
139568024|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139568025|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
139568026|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568027|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
139568028|NCT04395417|Protective Agents|protective agents|mesh-ancestor
139568029|NCT02199574|Bupivacaine|bupivacaine|mesh-list
139568030|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
139568031|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
139568032|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139568033|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568034|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
139568035|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568036|NCT02199652|Prazosin|prazosin|mesh-list
139568037|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139568038|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139568039|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139568040|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139568041|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
139568042|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568043|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568044|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568045|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139568046|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139568047|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139568048|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
139568049|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568050|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139568051|NCT01927029|Progesterone|progesterone|mesh-list
139568052|NCT01927029|Progestins|progestins|mesh-ancestor
139568053|NCT01927029|Hormones|hormones|mesh-ancestor
139568054|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139568055|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568056|NCT01921647|Amoxicillin|amoxicillin|mesh-list
139568057|NCT01921647|Clarithromycin|clarithromycin|mesh-list
138879522|NCT04666961|Anastrozole|anastrozole|mesh-list
139568058|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139568059|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568060|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139568061|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568062|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568063|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139568064|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139568065|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
139568066|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139568067|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
139568068|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568069|NCT01339858|Expectorants|expectorants|mesh-ancestor
139568070|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
139568071|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139568072|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
139568073|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568074|NCT01339858|Protective Agents|protective agents|mesh-ancestor
139568075|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568076|NCT01339858|Antidotes|antidotes|mesh-ancestor
139568077|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139568078|NCT01339936|Glycerol|glycerol|mesh-list
139568079|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139568080|NCT01339936|Protective Agents|protective agents|mesh-ancestor
139568081|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568082|NCT01339936|Laxatives|laxatives|mesh-ancestor
139568083|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139568084|NCT05246865|Androgens|androgens|mesh-list
139568085|NCT05246865|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139568086|NCT05246865|Hormones|hormones|mesh-ancestor
139568087|NCT05246865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139568088|NCT05246865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568089|NCT05246865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139568090|NCT05246865|Immunologic Factors|immunologic factors|mesh-ancestor
139568091|NCT03111537|Nicotine|nicotine|mesh-list
139568092|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139568093|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
139568094|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568095|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568096|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139568097|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139568098|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
139568099|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568100|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568101|NCT01927263|Infliximab|infliximab|mesh-list
139568102|NCT01927263|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139568103|NCT01927263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139568104|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
139568105|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139568106|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139568107|NCT01341730|Pioglitazone|pioglitazone|mesh-list
139568108|NCT01341730|Atorvastatin|atorvastatin|mesh-list
139568109|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139568110|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139568111|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
139568112|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568113|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139568114|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139568115|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568116|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139568117|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568118|NCT01247272|Fluoxetine|fluoxetine|mesh-list
139568119|NCT01247272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139568120|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139568121|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139568122|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568123|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568124|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
139568125|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568126|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139568127|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
139568128|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139568129|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139568130|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139568131|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568132|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
139568133|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
139568134|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139568135|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139568136|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568137|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568138|NCT01290484|Urological Agents|urological agents|mesh-ancestor
139568139|NCT04396743|Clotrimazole|clotrimazole|mesh-list
139568140|NCT04396743|Miconazole|miconazole|mesh-list
139568141|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139568142|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568143|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
139568144|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139568145|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139568146|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568147|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568148|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139568149|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
139568150|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139568151|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568152|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139568153|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139568154|NCT01928043|Curcumin|curcumin|mesh-list
139568155|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139568156|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139568157|NCT01928043|Analgesics|analgesics|mesh-ancestor
139568158|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
139568159|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568160|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568161|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139568162|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139568163|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568164|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568165|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568166|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139568167|NCT02979886|Menotropins|menotropins|mesh-list
139568168|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
138880049|NCT02651168|Aflibercept|aflibercept|mesh-list
139568169|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139568170|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
139568171|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139568172|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568173|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139568174|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139568175|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568176|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139568177|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
139568178|NCT01928511|Interferons|interferons|mesh-list
139568179|NCT01928511|Tenofovir|tenofovir|mesh-list
139568180|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
139568181|NCT01928511|Lamivudine|lamivudine|mesh-list
139568182|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
139568183|NCT01928511|Entecavir|entecavir|mesh-list
139568184|NCT01928511|Adefovir|adefovir|mesh-list
139568185|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139568186|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568187|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
139568188|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568189|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139568190|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139568191|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568192|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568193|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139568194|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138880120|NCT00581776|Dexamethasone|dexamethasone|mesh-list
139568195|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
139568196|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568197|NCT05241249|Paclitaxel|paclitaxel|mesh-list
139568198|NCT05241249|Gemcitabine|gemcitabine|mesh-list
139568199|NCT05241249|Bethanechol|bethanechol|mesh-list
139568200|NCT05241249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139568201|NCT05241249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568202|NCT05241249|Tubulin Modulators|tubulin modulators|mesh-ancestor
139568203|NCT05241249|Antimitotic Agents|antimitotic agents|mesh-ancestor
139568204|NCT05241249|Mitosis Modulators|mitosis modulators|mesh-ancestor
139568205|NCT05241249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568206|NCT05241249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139568207|NCT05241249|Antimetabolites|antimetabolites|mesh-ancestor
139568208|NCT05241249|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139568209|NCT05241249|Autonomic Agents|autonomic agents|mesh-ancestor
139568210|NCT05241249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568211|NCT05241249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568212|NCT05241249|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139568213|NCT05241249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139568214|NCT05241249|Cholinergic Agents|cholinergic agents|mesh-ancestor
139568215|NCT05241249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568216|NCT01928823|Cycloserine|cycloserine|mesh-list
139568217|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139568218|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568219|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139568220|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
139568221|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139568222|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
139568223|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568224|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
139568225|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
139568226|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139568227|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139568228|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
139568229|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568230|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568231|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139568232|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
138880219|NCT00649610|Analgesics|analgesics|mesh-ancestor
139568233|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139568234|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139568235|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139568236|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
139568237|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568238|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568239|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
139568240|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139568241|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
139568242|NCT02977494|Dexamethasone|dexamethasone|mesh-list
139568243|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
139568244|NCT02977494|Bortezomib|bortezomib|mesh-list
139568245|NCT02977494|Daratumumab|daratumumab|mesh-list
139568246|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139568247|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
139568248|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
139568249|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568250|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568251|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139568252|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
139568253|NCT02977494|Hormones|hormones|mesh-ancestor
139568254|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139568255|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139568256|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568257|NCT01929603|Rifampin|rifampin|mesh-list
139568258|NCT01929603|Olaparib|olaparib|mesh-list
139568259|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139568260|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568261|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568262|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568263|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139568264|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
139568265|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139568266|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568267|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
139568268|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139568269|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139568270|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139568271|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139568272|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139568273|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139568274|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139568275|NCT04178460|Niraparib|niraparib|mesh-list
139568276|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139568277|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568278|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568279|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568280|NCT01928901|Thymol|thymol|mesh-list
139568281|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568282|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139568283|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
139568284|NCT04395105|Dexamethasone|dexamethasone|mesh-list
139568285|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139568286|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
139349966|NCT03604471|Atorvastatin|atorvastatin|mesh-list
139568287|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
139568288|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568289|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568290|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139568291|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
139568293|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139568294|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139210406|NCT03384238|Antibodies|antibodies|mesh-list
139568295|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568296|NCT04072770|Caseins|caseins|mesh-list
139568297|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
139568298|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
139568299|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568300|NCT01291108|Bimatoprost|bimatoprost|mesh-list
139568301|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139568302|NCT01929213|Bosentan|bosentan|mesh-list
139568303|NCT01929213|Udenafil|udenafil|mesh-list
139568304|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139568305|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139568306|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568307|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139568308|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139568309|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568310|NCT03430518|Durvalumab|durvalumab|mesh-list
139568311|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139568312|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568313|NCT05240157|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139568314|NCT05240157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568315|NCT01925937|Ubiquinone|ubiquinone|mesh-list
139568316|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
139568317|NCT01925937|Atorvastatin|atorvastatin|mesh-list
139568318|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139568319|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139568320|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
139568321|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568322|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139568323|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139568324|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568325|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
139568326|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568327|NCT01925937|Vitamins|vitamins|mesh-ancestor
139568328|NCT03430362|Scopolamine|scopolamine|mesh-list
139568329|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139568330|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139568331|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
139568332|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
139568333|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568334|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568335|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139568336|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
139568337|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139568338|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
139568339|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568340|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880433|NCT04032210|Zinc|zinc|mesh-list
139568341|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139568342|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
139568343|NCT03428022|Apatinib|apatinib|mesh-list
139568344|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568345|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139568346|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568347|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568348|NCT00989781|Dexamethasone|dexamethasone|mesh-list
139568349|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139568350|NCT00989781|Hormones|hormones|mesh-list
139568351|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139568352|NCT00989781|Cosyntropin|cosyntropin|mesh-list
139568353|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139568354|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139568355|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
139568356|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139568357|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
139568358|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
139568359|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568360|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568361|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139350040|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
139568362|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
139568363|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139568364|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139568365|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568366|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139568367|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568368|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568369|NCT03430128|Immunomodulating Agents|immunomodulating agents|mesh-list
139568370|NCT03430128|Immunologic Factors|immunologic factors|mesh-ancestor
139568371|NCT03430128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568372|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
139568374|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139568375|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568376|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
139568377|NCT03427944|Coagulants|coagulants|mesh-ancestor
139568378|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139568379|NCT01922193|Hormones|hormones|mesh-ancestor
139568380|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139568381|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568382|NCT03429972|Paclitaxel|paclitaxel|mesh-list
139568383|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139568384|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568385|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
139568386|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
139568387|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
139568388|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568389|NCT05601999|Tenecteplase|tenecteplase|mesh-list
139568390|NCT05601999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139568391|NCT05601999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139568392|NCT05601999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568393|NCT01347034|Immunomodulating Agents|immunomodulating agents|mesh-list
139568394|NCT01347034|Immunologic Factors|immunologic factors|mesh-ancestor
139568395|NCT01347034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568396|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
139568397|NCT03079167|Hematinics|hematinics|mesh-ancestor
139568398|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
139568399|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
139568400|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139568401|NCT03427632|Protective Agents|protective agents|mesh-ancestor
139568402|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568403|NCT03427554|Tretinoin|tretinoin|mesh-list
139568404|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568405|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
139568406|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
139568407|NCT01349920|Infliximab|infliximab|mesh-list
139568408|NCT01349920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139568409|NCT01349920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139568410|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
139568411|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139568412|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139568413|NCT03128346|Aspirin|aspirin|mesh-list
139568414|NCT03128346|Acetaminophen|acetaminophen|mesh-list
139568415|NCT03128346|Fentanyl|fentanyl|mesh-list
139568416|NCT03128346|Hydromorphone|hydromorphone|mesh-list
139568417|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139568418|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139568419|NCT03128346|Analgesics|analgesics|mesh-ancestor
139568420|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
139568421|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568422|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568423|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139568424|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139568425|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139568426|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139568427|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568428|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139568429|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139568430|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568431|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
139568432|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139568433|NCT03128346|Narcotics|narcotics|mesh-ancestor
139568434|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139568435|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139568436|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139568437|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
139568438|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
139568439|NCT03423030|Macozinone|macozinone|mesh-list
139568440|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
139568441|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139568442|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568443|NCT03427242|Apatinib|apatinib|mesh-list
139568444|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568445|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139568446|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568447|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568448|NCT01252732|Vancomycin|vancomycin|mesh-list
139568449|NCT01252732|Oritavancin|oritavancin|mesh-list
139568450|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139568451|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568452|NCT00989235|Abatacept|abatacept|mesh-list
139568453|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139568454|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568455|NCT00989235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139568456|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568457|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139568458|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
139568459|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568460|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139568461|NCT06154096|Glucagon|glucagon|mesh-list
139568462|NCT06154096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139568463|NCT06154096|Hormones|hormones|mesh-ancestor
139568464|NCT06154096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138880824|NCT04073680|Canagliflozin|canagliflozin|mesh-list
139568465|NCT06154096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568466|NCT06154070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139568467|NCT06154070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139568468|NCT06154070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139568469|NCT06154070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568470|NCT06154070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568471|NCT06154070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139568472|NCT06154070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139568473|NCT06154070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568474|NCT06154070|Cholinergic Agents|cholinergic agents|mesh-ancestor
139568475|NCT06154070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568476|NCT06154018|Protamines|protamines|mesh-list
139568477|NCT06154018|Heparin Antagonists|heparin antagonists|mesh-ancestor
139568478|NCT06154018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568479|NCT06154018|Coagulants|coagulants|mesh-ancestor
139568480|NCT06153784|Thalidomide|thalidomide|mesh-list
139568481|NCT06153784|Hydroxyurea|hydroxyurea|mesh-list
139568482|NCT06153784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139568483|NCT06153784|Immunologic Factors|immunologic factors|mesh-ancestor
139568484|NCT06153784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568485|NCT06153784|Leprostatic Agents|leprostatic agents|mesh-ancestor
139568486|NCT06153784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139568487|NCT06153784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568488|NCT06153784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139568489|NCT06153784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139568490|NCT06153784|Growth Substances|growth substances|mesh-ancestor
139568491|NCT06153784|Growth Inhibitors|growth inhibitors|mesh-ancestor
139568492|NCT06153784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568493|NCT06153784|Antisickling Agents|antisickling agents|mesh-ancestor
139568494|NCT06153784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568495|NCT06153784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568496|NCT06153784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139568497|NCT06153706|Metronidazole|metronidazole|mesh-list
139568498|NCT06153706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568499|NCT06153706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139568500|NCT06153706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139568501|NCT06153706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139568502|NCT06153602|Nalbuphine|nalbuphine|mesh-list
139568503|NCT06153602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139568504|NCT06153602|Narcotics|narcotics|mesh-ancestor
139568505|NCT06153602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139568506|NCT06153602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568507|NCT06153602|Analgesics|analgesics|mesh-ancestor
139568508|NCT06153602|Sensory System Agents|sensory system agents|mesh-ancestor
139568509|NCT06153602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568510|NCT06153433|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139568511|NCT06153433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139568512|NCT06153433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139568514|NCT06153433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568515|NCT06153433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139568516|NCT06153433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139568517|NCT06153433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568518|NCT06153329|Insulin Lispro|insulin lispro|mesh-list
139568519|NCT06153329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139568520|NCT06153329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568521|NCT06153238|Pembrolizumab|pembrolizumab|mesh-list
139568522|NCT06153238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139568523|NCT06153238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568524|NCT06153238|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138818524|NCT06184698|Leucovorin|leucovorin|mesh-list
139568525|NCT06153238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568526|NCT06153186|Flunarizine|flunarizine|mesh-list
139568527|NCT06153186|Anticonvulsants|anticonvulsants|mesh-ancestor
139568528|NCT06153186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139568529|NCT06153186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139568530|NCT06153186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568531|NCT06153186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139568532|NCT06153186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568533|NCT06153186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139568534|NCT06153186|Histamine Antagonists|histamine antagonists|mesh-ancestor
139568535|NCT06153186|Histamine Agents|histamine agents|mesh-ancestor
139568536|NCT06153186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568537|NCT06153186|Vasodilator Agents|vasodilator agents|mesh-ancestor
139568538|NCT06153134|Kojic acid|kojic acid|mesh-list
139568539|NCT06153134|Antioxidants|antioxidants|mesh-ancestor
139568540|NCT06153134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568541|NCT06153134|Protective Agents|protective agents|mesh-ancestor
139568542|NCT06153134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568543|NCT06153043|Epinephrine|epinephrine|mesh-list
139568544|NCT06153043|Racepinephrine|racepinephrine|mesh-list
139568545|NCT06153043|Epinephryl borate|epinephryl borate|mesh-list
139568546|NCT06153043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139568547|NCT06153043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139568548|NCT06153043|Adrenergic Agents|adrenergic agents|mesh-ancestor
139568549|NCT06153043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568550|NCT06153043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568551|NCT06153043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568552|NCT06153043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139568553|NCT06153043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139568554|NCT06153043|Autonomic Agents|autonomic agents|mesh-ancestor
139568555|NCT06153043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568556|NCT06153043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139568557|NCT06153043|Respiratory System Agents|respiratory system agents|mesh-ancestor
139568558|NCT06153043|Mydriatics|mydriatics|mesh-ancestor
139568559|NCT06153043|Sympathomimetics|sympathomimetics|mesh-ancestor
139568560|NCT06153043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139568561|NCT06152939|Fibrinolytic Agents|fibrinolytic agents|mesh-list
139568562|NCT06152939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139568563|NCT06152939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568564|NCT06152926|Immunomodulating Agents|immunomodulating agents|mesh-list
139568565|NCT06152926|Immunologic Factors|immunologic factors|mesh-ancestor
139568566|NCT06152926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568567|NCT06152822|Bevacizumab|bevacizumab|mesh-list
139568568|NCT06152822|Capecitabine|capecitabine|mesh-list
139568569|NCT06152822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139568570|NCT06152822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568571|NCT06152822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139568572|NCT06152822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139568573|NCT06152822|Growth Substances|growth substances|mesh-ancestor
139568574|NCT06152822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568575|NCT06152822|Growth Inhibitors|growth inhibitors|mesh-ancestor
139568576|NCT06152822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139568577|NCT06152822|Antimetabolites|antimetabolites|mesh-ancestor
139568578|NCT06152822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568579|NCT06152796|Acetaminophen|acetaminophen|mesh-list
139568580|NCT06152796|Ibuprofen|ibuprofen|mesh-list
139568581|NCT06152796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139568582|NCT06152796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139568583|NCT06152796|Analgesics|analgesics|mesh-ancestor
139568584|NCT06152796|Sensory System Agents|sensory system agents|mesh-ancestor
139568585|NCT06152796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568586|NCT06152796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568587|NCT06152796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139568588|NCT06152796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139568589|NCT06152796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139568590|NCT06152796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568591|NCT06152796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568592|NCT06152796|Antipyretics|antipyretics|mesh-ancestor
139568593|NCT06152653|Acetylcysteine|acetylcysteine|mesh-list
139568594|NCT06152653|Albuterol|albuterol|mesh-list
139568595|NCT06152653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139568596|NCT06152653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139568597|NCT06152653|Autonomic Agents|autonomic agents|mesh-ancestor
139568598|NCT06152653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568599|NCT06152653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568600|NCT06152653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139568601|NCT06152653|Respiratory System Agents|respiratory system agents|mesh-ancestor
139568602|NCT06152653|Tocolytic Agents|tocolytic agents|mesh-ancestor
139568603|NCT06152653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139568604|NCT06152653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139568605|NCT06152653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139568606|NCT06152653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139568607|NCT06152653|Adrenergic Agents|adrenergic agents|mesh-ancestor
139568608|NCT06152653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568609|NCT06152653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568610|NCT06152653|Antiviral Agents|antiviral agents|mesh-ancestor
139568611|NCT06152653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568612|NCT06152653|Expectorants|expectorants|mesh-ancestor
139568613|NCT06152653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139568614|NCT06152653|Antioxidants|antioxidants|mesh-ancestor
139568615|NCT06152653|Protective Agents|protective agents|mesh-ancestor
139568616|NCT06152653|Antidotes|antidotes|mesh-ancestor
139568617|NCT06150794|Methotrexate|methotrexate|mesh-list
139568618|NCT06150794|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139568619|NCT06150794|Abortifacient Agents|abortifacient agents|mesh-ancestor
139568620|NCT06150794|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139568621|NCT06150794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568622|NCT06150794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139568623|NCT06150794|Antimetabolites|antimetabolites|mesh-ancestor
139568624|NCT06150794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568625|NCT06150794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568626|NCT06150794|Dermatologic Agents|dermatologic agents|mesh-ancestor
139568627|NCT06150794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568628|NCT06150794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139568629|NCT06150794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139568630|NCT06150794|Immunologic Factors|immunologic factors|mesh-ancestor
139568631|NCT06150794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139568632|NCT06150794|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139568633|NCT06150040|Azacitidine|azacitidine|mesh-list
139568634|NCT06150040|Venetoclax|venetoclax|mesh-list
139568635|NCT06150040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139568636|NCT06150040|Antimetabolites|antimetabolites|mesh-ancestor
139568637|NCT06150040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568638|NCT06150040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568639|NCT06150040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568640|NCT06144606|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
139568641|NCT06144606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139568642|NCT06144606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568643|NCT06122610|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139568644|NCT06122610|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139568645|NCT06122610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568646|NCT06080217|Ascorbic Acid|ascorbic acid|mesh-list
139568647|NCT06080217|Antioxidants|antioxidants|mesh-ancestor
139568648|NCT06080217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568649|NCT06080217|Protective Agents|protective agents|mesh-ancestor
139568650|NCT06080217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568651|NCT06080217|Vitamins|vitamins|mesh-ancestor
139568652|NCT06080217|Micronutrients|micronutrients|mesh-ancestor
139568653|NCT06045793|Cocaine|cocaine|mesh-list
139568654|NCT06045793|Anesthetics, Local|anesthetics, local|mesh-ancestor
139568655|NCT06045793|Anesthetics|anesthetics|mesh-ancestor
139568656|NCT06045793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139568657|NCT06045793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568658|NCT06045793|Sensory System Agents|sensory system agents|mesh-ancestor
139568659|NCT06045793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568660|NCT06045793|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139568661|NCT06045793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138881141|NCT02649530|LGK974|lgk974|mesh-list
139568662|NCT06045793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139568663|NCT06045793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139568664|NCT06045793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568666|NCT06045793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568667|NCT06036446|Progesterone|progesterone|mesh-list
139568668|NCT06036446|Progestins|progestins|mesh-ancestor
139568669|NCT06036446|Hormones|hormones|mesh-ancestor
139568670|NCT06036446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139568671|NCT06036446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568672|NCT06029049|Rocuronium|rocuronium|mesh-list
139568673|NCT06029049|Succinylcholine|succinylcholine|mesh-list
139568674|NCT06029049|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139568675|NCT06029049|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139568676|NCT06029049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139568677|NCT06029049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568678|NCT06029049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568679|NCT06029049|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139568680|NCT05999812|Bevacizumab|bevacizumab|mesh-list
139568681|NCT05999812|Atezolizumab|atezolizumab|mesh-list
139568682|NCT05999812|Tretinoin|tretinoin|mesh-list
139568683|NCT05999812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139568684|NCT05999812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568685|NCT05999812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139568686|NCT05999812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139568687|NCT05999812|Growth Substances|growth substances|mesh-ancestor
139568688|NCT05999812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568689|NCT05999812|Growth Inhibitors|growth inhibitors|mesh-ancestor
139568690|NCT05999812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139568691|NCT05999812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568692|NCT05999812|Keratolytic Agents|keratolytic agents|mesh-ancestor
139568693|NCT05999812|Dermatologic Agents|dermatologic agents|mesh-ancestor
139568694|NCT05998837|Dapagliflozin|dapagliflozin|mesh-list
139568695|NCT05998837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139568696|NCT05998837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568697|NCT05998837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139568698|NCT05998837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568699|NCT05918952|Antibodies|antibodies|mesh-list
139568700|NCT05918952|Immunologic Factors|immunologic factors|mesh-ancestor
139568701|NCT05918952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568702|NCT05909553|Venetoclax|venetoclax|mesh-list
139568703|NCT05909553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568704|NCT05872789|Diazepam|diazepam|mesh-list
139568705|NCT05872789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139568706|NCT05872789|Anticonvulsants|anticonvulsants|mesh-ancestor
139568707|NCT05872789|Antiemetics|antiemetics|mesh-ancestor
139568708|NCT05872789|Autonomic Agents|autonomic agents|mesh-ancestor
139568709|NCT05872789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568710|NCT05872789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568711|NCT05872789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139568712|NCT05872789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139568713|NCT05872789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139568714|NCT05872789|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139568715|NCT05872789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139568716|NCT05872789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139568717|NCT05872789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139568718|NCT05872789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139568719|NCT05872789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139568720|NCT05872789|Anesthetics, General|anesthetics, general|mesh-ancestor
139568721|NCT05872789|Anesthetics|anesthetics|mesh-ancestor
139568722|NCT05872789|GABA Modulators|gaba modulators|mesh-ancestor
139568723|NCT05872789|GABA Agents|gaba agents|mesh-ancestor
139568724|NCT05872789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568725|NCT05872789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568726|NCT05847322|Azithromycin|azithromycin|mesh-list
139568727|NCT05847322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139568728|NCT05847322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568729|NCT05807399|Moxifloxacin|moxifloxacin|mesh-list
139568730|NCT05807399|Rifampin|rifampin|mesh-list
139568731|NCT05807399|Isoniazid|isoniazid|mesh-list
139568732|NCT05807399|Pyrazinamide|pyrazinamide|mesh-list
139568733|NCT05807399|Bedaquiline|bedaquiline|mesh-list
139568734|NCT05807399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139568735|NCT05807399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139350413|NCT03604003|Losartan|losartan|mesh-list
139568736|NCT05807399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139568737|NCT05807399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139568738|NCT05807399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568739|NCT05807399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568740|NCT05807399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568741|NCT05807399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139568742|NCT05807399|Antitubercular Agents|antitubercular agents|mesh-ancestor
139568743|NCT05807399|Leprostatic Agents|leprostatic agents|mesh-ancestor
139568744|NCT05807399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139568745|NCT05807399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139568746|NCT05807399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139568747|NCT05807399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139568748|NCT05807399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139568749|NCT05807399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138881350|NCT02653898|Artesunate|artesunate|mesh-list
139568750|NCT05807399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139568751|NCT05807399|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139568752|NCT05807399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139568753|NCT05807399|Antimetabolites|antimetabolites|mesh-ancestor
139568754|NCT05807399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139568755|NCT05802056|Calcium, Dietary|calcium, dietary|mesh-list
139568756|NCT05802056|Leucovorin|leucovorin|mesh-list
139568757|NCT05802056|Folic Acid|folic acid|mesh-list
139568758|NCT05802056|Aldesleukin|aldesleukin|mesh-list
139568759|NCT05802056|Fluorouracil|fluorouracil|mesh-list
139568760|NCT05802056|Oxaliplatin|oxaliplatin|mesh-list
139568761|NCT05802056|Nivolumab|nivolumab|mesh-list
139568762|NCT05802056|Interleukin-2|interleukin-2|mesh-list
139568763|NCT05802056|Calcium|calcium|mesh-list
139568764|NCT05802056|Levoleucovorin|levoleucovorin|mesh-list
139568765|NCT05802056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139568766|NCT05802056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568767|NCT05802056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139568768|NCT05802056|Antimetabolites|antimetabolites|mesh-ancestor
139568769|NCT05802056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568770|NCT05802056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139568771|NCT05802056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568772|NCT05802056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139568773|NCT05802056|Immunologic Factors|immunologic factors|mesh-ancestor
139568774|NCT05802056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139568775|NCT05802056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139568776|NCT05802056|Antidotes|antidotes|mesh-ancestor
139568777|NCT05802056|Protective Agents|protective agents|mesh-ancestor
139568778|NCT05802056|Vitamin B Complex|vitamin b complex|mesh-ancestor
139568779|NCT05802056|Vitamins|vitamins|mesh-ancestor
139568780|NCT05802056|Micronutrients|micronutrients|mesh-ancestor
139568781|NCT05802056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139568782|NCT05802056|Analgesics|analgesics|mesh-ancestor
139568783|NCT05802056|Sensory System Agents|sensory system agents|mesh-ancestor
139568784|NCT05802056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568785|NCT05802056|Hematinics|hematinics|mesh-ancestor
139568786|NCT05802056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139568787|NCT05802056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139568788|NCT05802056|Antiviral Agents|antiviral agents|mesh-ancestor
139568789|NCT05802056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568790|NCT05792319|Copper|copper|mesh-list
139568791|NCT05792319|Trace Elements|trace elements|mesh-ancestor
139568792|NCT05792319|Micronutrients|micronutrients|mesh-ancestor
139568793|NCT05792319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568794|NCT05787743|Tocotrienols|tocotrienols|mesh-list
139568795|NCT05787743|Vitamin E|vitamin e|mesh-list
139568796|NCT05787743|Tocopherols|tocopherols|mesh-list
139568797|NCT05787743|Antioxidants|antioxidants|mesh-ancestor
139568798|NCT05787743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568799|NCT05787743|Protective Agents|protective agents|mesh-ancestor
139568800|NCT05787743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568801|NCT05787743|Vitamins|vitamins|mesh-ancestor
139568802|NCT05787743|Micronutrients|micronutrients|mesh-ancestor
139568803|NCT05782244|Sildenafil Citrate|sildenafil citrate|mesh-list
139568804|NCT05782244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568805|NCT05782244|Vasodilator Agents|vasodilator agents|mesh-ancestor
139568806|NCT05782244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139568807|NCT05782244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139568808|NCT05782244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568809|NCT05782244|Urological Agents|urological agents|mesh-ancestor
139568810|NCT05761860|Oxycodone|oxycodone|mesh-list
139568811|NCT05761860|Oxytocin|oxytocin|mesh-list
139568812|NCT05761860|Oxytocics|oxytocics|mesh-ancestor
139568813|NCT05761860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139568814|NCT05761860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568815|NCT05761860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139568817|NCT05761860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139568818|NCT05761860|Analgesics|analgesics|mesh-ancestor
139568819|NCT05761860|Sensory System Agents|sensory system agents|mesh-ancestor
139568820|NCT05761860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568821|NCT05693545|Penicillins|penicillins|mesh-list
139568822|NCT05693545|Penicillin G|penicillin g|mesh-list
139568823|NCT05693545|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139568824|NCT05693545|Penicillin G Procaine|penicillin g procaine|mesh-list
139568825|NCT05693545|Penicillin V|penicillin v|mesh-list
139568826|NCT05693545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139568827|NCT05693545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568828|NCT05682339|Quinine|quinine|mesh-list
139568829|NCT05682339|Antimalarials|antimalarials|mesh-ancestor
139568830|NCT05682339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139568831|NCT05682339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139568832|NCT05682339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568833|NCT05682339|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139568834|NCT05682339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568835|NCT05682339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139568836|NCT05682339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568837|NCT05682339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139568838|NCT05682339|Analgesics|analgesics|mesh-ancestor
139568839|NCT05682339|Sensory System Agents|sensory system agents|mesh-ancestor
139568840|NCT05676463|Ascorbic Acid|ascorbic acid|mesh-list
139568841|NCT05676463|Methyltestosterone|methyltestosterone|mesh-list
139568842|NCT05676463|Hormones|hormones|mesh-list
139568843|NCT05676463|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139568844|NCT05676463|Androgens|androgens|mesh-list
139568845|NCT05676463|Androgen Antagonists|androgen antagonists|mesh-list
139568846|NCT05676463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139568847|NCT05676463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568848|NCT05676463|Antioxidants|antioxidants|mesh-ancestor
139568849|NCT05676463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568850|NCT05676463|Protective Agents|protective agents|mesh-ancestor
139568851|NCT05676463|Vitamins|vitamins|mesh-ancestor
139568852|NCT05676463|Micronutrients|micronutrients|mesh-ancestor
139568853|NCT05676463|Estrogens|estrogens|mesh-ancestor
139568854|NCT05676463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139568855|NCT05676463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568856|NCT05676463|Anabolic Agents|anabolic agents|mesh-ancestor
139568857|NCT05676463|Hormone Antagonists|hormone antagonists|mesh-ancestor
139568858|NCT05635344|Pembrolizumab|pembrolizumab|mesh-list
138881635|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
139568859|NCT05635344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139568860|NCT05635344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568861|NCT05635344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139568862|NCT05635344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568863|NCT05630183|Paclitaxel|paclitaxel|mesh-list
139568864|NCT05630183|Gemcitabine|gemcitabine|mesh-list
139568865|NCT05630183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139568866|NCT05630183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568867|NCT05630183|Tubulin Modulators|tubulin modulators|mesh-ancestor
139568868|NCT05630183|Antimitotic Agents|antimitotic agents|mesh-ancestor
139568869|NCT05630183|Mitosis Modulators|mitosis modulators|mesh-ancestor
139568870|NCT05630183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568871|NCT05630183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139568872|NCT05630183|Antimetabolites|antimetabolites|mesh-ancestor
139568873|NCT05624918|Paclitaxel|paclitaxel|mesh-list
139568874|NCT05624918|Gemcitabine|gemcitabine|mesh-list
139568875|NCT05624918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139568876|NCT05624918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568877|NCT05624918|Tubulin Modulators|tubulin modulators|mesh-ancestor
139568878|NCT05624918|Antimitotic Agents|antimitotic agents|mesh-ancestor
139568879|NCT05624918|Mitosis Modulators|mitosis modulators|mesh-ancestor
139568880|NCT05624918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568881|NCT05624918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139568882|NCT05624918|Antimetabolites|antimetabolites|mesh-ancestor
139568883|NCT05587361|Propranolol|propranolol|mesh-list
139568884|NCT05587361|Nicotine|nicotine|mesh-list
139568885|NCT05587361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139568886|NCT05587361|Autonomic Agents|autonomic agents|mesh-ancestor
139568887|NCT05587361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568888|NCT05587361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568889|NCT05587361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139568890|NCT05587361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139568891|NCT05587361|Cholinergic Agents|cholinergic agents|mesh-ancestor
139568892|NCT05587361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568893|NCT05587361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568894|NCT05587361|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139568895|NCT05587361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138881736|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138881737|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138881738|NCT00652808|Analgesics|analgesics|mesh-ancestor
138881739|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
138881740|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881741|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881742|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138881743|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138881744|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
138881745|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138881746|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881747|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881748|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138881749|NCT00635531|Alprazolam|alprazolam|mesh-list
138881757|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
139568896|NCT05587361|Adrenergic Agents|adrenergic agents|mesh-ancestor
139568897|NCT05587361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139568898|NCT05587361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139568899|NCT05587361|Vasodilator Agents|vasodilator agents|mesh-ancestor
139568901|NCT05586360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139568902|NCT05586360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139568903|NCT05586360|Antimetabolites|antimetabolites|mesh-ancestor
139568904|NCT05586360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568905|NCT05586360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139568906|NCT05586360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139568907|NCT05586360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568908|NCT05570812|Neurosteroids|neurosteroids|mesh-list
139568909|NCT05570812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139568910|NCT05570812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568911|NCT05570812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568912|NCT05551936|Rituximab|rituximab|mesh-list
139568913|NCT05551936|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139568914|NCT05551936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139568915|NCT05551936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568916|NCT05551936|Immunologic Factors|immunologic factors|mesh-ancestor
139568917|NCT05551936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568918|NCT05551936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139568919|NCT05551936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139568920|NCT05551936|Alkylating Agents|alkylating agents|mesh-ancestor
139568921|NCT05551936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568922|NCT05535075|Vancomycin|vancomycin|mesh-list
139568923|NCT05535075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139568924|NCT05535075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568925|NCT05534984|Tecovirimat|tecovirimat|mesh-list
139568926|NCT05534984|Antiviral Agents|antiviral agents|mesh-ancestor
139568927|NCT05534984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139568928|NCT05523609|Vitamin D|vitamin d|mesh-list
139568929|NCT05523609|Cholecalciferol|cholecalciferol|mesh-list
139568930|NCT05523609|Letrozole|letrozole|mesh-list
139568931|NCT05523609|Calcium|calcium|mesh-list
139568932|NCT05523609|Vitamins|vitamins|mesh-ancestor
139568933|NCT05523609|Micronutrients|micronutrients|mesh-ancestor
139568934|NCT05523609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568935|NCT05523609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139568936|NCT05523609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139568937|NCT05523609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568938|NCT05523609|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139568939|NCT05523609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139568940|NCT05523609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139568941|NCT05523609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568942|NCT05523609|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139568943|NCT05523609|Hormone Antagonists|hormone antagonists|mesh-ancestor
139568944|NCT05523609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139568945|NCT05481437|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139568946|NCT05481437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139568947|NCT05481437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568948|NCT05481437|Immunotoxins|immunotoxins|mesh-ancestor
138881799|NCT01563835|Fentanyl|fentanyl|mesh-list
138881800|NCT01563835|Bupivacaine|bupivacaine|mesh-list
138881801|NCT01563835|Citric Acid|citric acid|mesh-list
138881802|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
138881803|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
138881804|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
138881810|NCT01563835|Narcotics|narcotics|mesh-ancestor
139568949|NCT05481437|Immunoconjugates|immunoconjugates|mesh-ancestor
139568950|NCT05481437|Immunologic Factors|immunologic factors|mesh-ancestor
139568951|NCT05481437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568952|NCT05475678|Carboplatin|carboplatin|mesh-list
139568953|NCT05475678|Docetaxel|docetaxel|mesh-list
139568954|NCT05475678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568955|NCT05475678|Tubulin Modulators|tubulin modulators|mesh-ancestor
139568956|NCT05475678|Antimitotic Agents|antimitotic agents|mesh-ancestor
139568957|NCT05475678|Mitosis Modulators|mitosis modulators|mesh-ancestor
139568958|NCT05475678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568959|NCT05468203|Dapagliflozin|dapagliflozin|mesh-list
139568960|NCT05468203|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139568961|NCT05468203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139568962|NCT05468203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139568963|NCT05468203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568964|NCT05429268|Lenalidomide|lenalidomide|mesh-list
139568965|NCT05429268|Immunologic Factors|immunologic factors|mesh-ancestor
139568966|NCT05429268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568967|NCT05429268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139568968|NCT05429268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139568969|NCT05429268|Growth Substances|growth substances|mesh-ancestor
139568970|NCT05429268|Growth Inhibitors|growth inhibitors|mesh-ancestor
139568971|NCT05429268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568972|NCT05405166|Dexamethasone|dexamethasone|mesh-list
139568973|NCT05405166|Pomalidomide|pomalidomide|mesh-list
138881829|NCT02653196|Melphalan|melphalan|mesh-list
139568974|NCT05405166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139568975|NCT05405166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139568976|NCT05405166|Antiemetics|antiemetics|mesh-ancestor
139568977|NCT05405166|Autonomic Agents|autonomic agents|mesh-ancestor
139568978|NCT05405166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139568979|NCT05405166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139568980|NCT05405166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139568981|NCT05405166|Glucocorticoids|glucocorticoids|mesh-ancestor
139568982|NCT05405166|Hormones|hormones|mesh-ancestor
139568983|NCT05405166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139568984|NCT05405166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139568985|NCT05405166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568986|NCT05405166|Immunologic Factors|immunologic factors|mesh-ancestor
139568987|NCT05405166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139568988|NCT05405166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139568989|NCT05405166|Growth Substances|growth substances|mesh-ancestor
139568990|NCT05405166|Growth Inhibitors|growth inhibitors|mesh-ancestor
139568991|NCT05397600|Bimatoprost|bimatoprost|mesh-list
139568992|NCT05397600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139568993|NCT05366166|Cisplatin|cisplatin|mesh-list
139568994|NCT05366166|Pembrolizumab|pembrolizumab|mesh-list
139568995|NCT05366166|Olaparib|olaparib|mesh-list
139568996|NCT05366166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139568997|NCT05366166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139568998|NCT05366166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139568999|NCT05366166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569000|NCT05366166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139569001|NCT05366166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569002|NCT05280275|Dexamethasone|dexamethasone|mesh-list
139569003|NCT05280275|Lenalidomide|lenalidomide|mesh-list
139569004|NCT05280275|Daratumumab|daratumumab|mesh-list
139569005|NCT05280275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139569006|NCT05280275|Antiemetics|antiemetics|mesh-ancestor
139569007|NCT05280275|Autonomic Agents|autonomic agents|mesh-ancestor
139569008|NCT05280275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569009|NCT05280275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569010|NCT05280275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139569011|NCT05280275|Glucocorticoids|glucocorticoids|mesh-ancestor
139569012|NCT05280275|Hormones|hormones|mesh-ancestor
139569013|NCT05280275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139569014|NCT05280275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139569015|NCT05280275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569016|NCT05280275|Immunologic Factors|immunologic factors|mesh-ancestor
139569017|NCT05280275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139569018|NCT05280275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139569019|NCT05280275|Growth Substances|growth substances|mesh-ancestor
139569020|NCT05280275|Growth Inhibitors|growth inhibitors|mesh-ancestor
139569021|NCT05278065|Nicotine|nicotine|mesh-list
139569022|NCT05278065|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139569023|NCT05278065|Autonomic Agents|autonomic agents|mesh-ancestor
139569024|NCT05278065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569025|NCT05278065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569026|NCT05278065|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139569027|NCT05278065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139569028|NCT05278065|Cholinergic Agents|cholinergic agents|mesh-ancestor
139569029|NCT05278065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569030|NCT05278065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569031|NCT05244226|Fentanyl|fentanyl|mesh-list
139569032|NCT05244226|Methadone|methadone|mesh-list
139569033|NCT05244226|Hydromorphone|hydromorphone|mesh-list
139569034|NCT05244226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139569035|NCT05244226|Narcotics|narcotics|mesh-ancestor
139569036|NCT05244226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139569037|NCT05244226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569038|NCT05244226|Analgesics|analgesics|mesh-ancestor
139569039|NCT05244226|Sensory System Agents|sensory system agents|mesh-ancestor
139569040|NCT05244226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350710|NCT06041529|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139569041|NCT05244226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139569042|NCT05244226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139569044|NCT05244226|Anesthetics|anesthetics|mesh-ancestor
139569045|NCT05244226|Antitussive Agents|antitussive agents|mesh-ancestor
139569046|NCT05244226|Respiratory System Agents|respiratory system agents|mesh-ancestor
139569047|NCT05242874|Dexamethasone|dexamethasone|mesh-list
139569048|NCT05242874|Dexamethasone acetate|dexamethasone acetate|mesh-list
139569049|NCT05242874|Olanzapine|olanzapine|mesh-list
139569050|NCT05242874|Fosaprepitant|fosaprepitant|mesh-list
139569051|NCT05242874|Aprepitant|aprepitant|mesh-list
139569052|NCT05242874|Antiemetics|antiemetics|mesh-list
139569053|NCT05242874|Tropisetron|tropisetron|mesh-list
139569054|NCT05242874|BB 1101|bb 1101|mesh-list
139569055|NCT05242874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139569056|NCT05242874|Autonomic Agents|autonomic agents|mesh-ancestor
139569057|NCT05242874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569058|NCT05242874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569059|NCT05242874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139569060|NCT05242874|Glucocorticoids|glucocorticoids|mesh-ancestor
139569061|NCT05242874|Hormones|hormones|mesh-ancestor
139569062|NCT05242874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139569063|NCT05242874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139569064|NCT05242874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569065|NCT05242874|Protease Inhibitors|protease inhibitors|mesh-ancestor
139569066|NCT05242874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569067|NCT05242874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569068|NCT05242874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139569069|NCT05242874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139569070|NCT05242874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139569071|NCT05242874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139569072|NCT05242874|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139569073|NCT05242874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139569074|NCT05242874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139569075|NCT05242874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569076|NCT05242874|Serotonin Agents|serotonin agents|mesh-ancestor
139569077|NCT05242874|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139569078|NCT05242874|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139569079|NCT05242874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139569080|NCT05194124|alpha-MSH|alpha-msh|mesh-list
139569081|NCT05194124|Hormones|hormones|mesh-ancestor
139569082|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139569083|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569084|NCT05157464|Losartan|losartan|mesh-list
139569085|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139569086|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139569087|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139569088|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139569089|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569090|NCT05116241|Vaccines|vaccines|mesh-list
139569091|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
139569092|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569093|NCT05079620|Amoxicillin|amoxicillin|mesh-list
139569094|NCT05079620|Vancomycin|vancomycin|mesh-list
139569095|NCT05079620|Levofloxacin|levofloxacin|mesh-list
139569096|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
139569097|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139569098|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
139569099|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
139569100|NCT05079620|Cefepime|cefepime|mesh-list
139569101|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139569102|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569103|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139569104|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139569105|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139569106|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569107|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569108|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569109|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139569110|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139569111|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139569112|NCT04969198|Nicotine|nicotine|mesh-list
139569113|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139569114|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
138881985|NCT03083041|Apatinib|apatinib|mesh-list
139569115|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569116|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569117|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139569118|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139569119|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
139569120|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569121|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569122|NCT04943900|Nivolumab|nivolumab|mesh-list
139569123|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569124|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569125|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139569126|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569127|NCT04935034|Vitamin D|vitamin d|mesh-list
139569128|NCT04935034|Vitamins|vitamins|mesh-ancestor
139569129|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
139569130|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569131|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139569132|NCT04928664|Bupivacaine|bupivacaine|mesh-list
139569133|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
139569134|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
139569135|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139569136|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569137|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
139569138|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569139|NCT04928261|Trastuzumab|trastuzumab|mesh-list
139569140|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569141|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569142|NCT04916392|Bupivacaine|bupivacaine|mesh-list
139569143|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
139569144|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
139569145|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139569146|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569147|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
139569148|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569149|NCT04854668|Bevacizumab|bevacizumab|mesh-list
139569150|NCT04854668|Capecitabine|capecitabine|mesh-list
139569151|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
139569152|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569153|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569154|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139569155|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139569156|NCT04854668|Growth Substances|growth substances|mesh-ancestor
139569157|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569158|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
139569159|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139569160|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
139569161|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569162|NCT04830410|Levan|levan|mesh-list
139569163|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569164|NCT04820933|Tenofovir|tenofovir|mesh-list
139569165|NCT04820933|Emtricitabine|emtricitabine|mesh-list
139569166|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
139569167|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569168|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139569169|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139569170|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569171|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569172|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139569173|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139569174|NCT04786093|Durvalumab|durvalumab|mesh-list
139569175|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569176|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569177|NCT04699838|Carboplatin|carboplatin|mesh-list
139569178|NCT04699838|Etoposide|etoposide|mesh-list
139569179|NCT04699838|Durvalumab|durvalumab|mesh-list
139569180|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569181|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139569182|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139569183|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139569184|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569185|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569186|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569187|NCT04621227|Midazolam|midazolam|mesh-list
139569188|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139569189|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139350862|NCT06000501|Dopamine Agents|dopamine agents|mesh-ancestor
139569190|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139569191|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139569192|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569193|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139569194|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139569195|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139569196|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139569197|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
139569198|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
139569199|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
139569200|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
139569201|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569202|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569203|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138882080|NCT02695745|Celecoxib|celecoxib|mesh-list
139569204|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139569205|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
139569206|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139569207|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139569208|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569209|NCT04597918|Faricimab|faricimab|mesh-list
139569210|NCT04597918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139569211|NCT04597918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139569212|NCT04597918|Growth Substances|growth substances|mesh-ancestor
139569213|NCT04597918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569214|NCT04597918|Growth Inhibitors|growth inhibitors|mesh-ancestor
139569215|NCT04597918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569216|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
139569217|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139569218|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139569219|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139569220|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139569221|NCT04586023|Teriflunomide|teriflunomide|mesh-list
139569222|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139569223|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139569224|NCT04586023|Analgesics|analgesics|mesh-ancestor
139569225|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
139569226|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569227|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569228|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139569229|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139569230|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139569231|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
139569232|NCT04546126|Dexamethasone|dexamethasone|mesh-list
139569233|NCT04546126|Cosyntropin|cosyntropin|mesh-list
139569234|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139569235|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
139569236|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
139569237|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569238|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569239|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139569240|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
139569241|NCT04546126|Hormones|hormones|mesh-ancestor
139569242|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139569243|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139569244|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569245|NCT04543617|Atezolizumab|atezolizumab|mesh-list
139569246|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139569247|NCT04543617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138882092|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569248|NCT04543617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569249|NCT04543617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569250|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569251|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
139569252|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569253|NCT04540211|Paclitaxel|paclitaxel|mesh-list
139569254|NCT04540211|Atezolizumab|atezolizumab|mesh-list
139569255|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139569256|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139569257|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569258|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
139569259|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
139569260|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
139569261|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569262|NCT04540211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139569263|NCT04540211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569264|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
139569265|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569266|NCT04513925|Atezolizumab|atezolizumab|mesh-list
139569267|NCT04513925|Durvalumab|durvalumab|mesh-list
139569268|NCT04513925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138882139|NCT04069858|Entecavir|entecavir|mesh-list
139569269|NCT04513925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569270|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569271|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569272|NCT04451863|Caryophyllene|caryophyllene|mesh-list
139569273|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569274|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139569275|NCT04451863|Analgesics|analgesics|mesh-ancestor
139569276|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
139569277|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569278|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139569279|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139569280|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139569281|NCT04398706|Vaccines|vaccines|mesh-list
139569282|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139569283|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
139569284|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569285|NCT04344717|Apixaban|apixaban|mesh-list
139569286|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139569287|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
139569288|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139569289|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
139569290|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569291|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569292|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
139569293|NCT04334759|Cisplatin|cisplatin|mesh-list
139569294|NCT04334759|Carboplatin|carboplatin|mesh-list
139569295|NCT04334759|Nivolumab|nivolumab|mesh-list
139569296|NCT04334759|Pemetrexed|pemetrexed|mesh-list
139569297|NCT04334759|Ipilimumab|ipilimumab|mesh-list
139569298|NCT04334759|Durvalumab|durvalumab|mesh-list
139569299|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569300|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569301|NCT04334759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139569302|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569303|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569304|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139569305|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139569306|NCT04210713|Minocycline|minocycline|mesh-list
139569307|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139569308|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569309|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
139569310|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139569311|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
139569312|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
139569313|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569314|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569315|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569316|NCT04133376|Nicotine|nicotine|mesh-list
139569317|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139569318|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
139569319|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569320|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569321|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139569322|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139569323|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
139569324|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569325|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569326|NCT04102098|Bevacizumab|bevacizumab|mesh-list
139569327|NCT04102098|Atezolizumab|atezolizumab|mesh-list
139569328|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569329|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569330|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139569331|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139569332|NCT04102098|Growth Substances|growth substances|mesh-ancestor
139569333|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569334|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
139569335|NCT04102098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139569336|NCT04102098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569337|NCT04083170|Vidarabine|vidarabine|mesh-list
139569338|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
139569339|NCT04083170|Thiotepa|thiotepa|mesh-list
139569340|NCT04083170|Fludarabine|fludarabine|mesh-list
139569341|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
139569342|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139569343|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
139569344|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569345|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139569346|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139569347|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
139569348|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569349|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569350|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139569351|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139569352|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
139569353|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
139569354|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569355|NCT04056910|Nivolumab|nivolumab|mesh-list
139569356|NCT04056910|Ivosidenib|ivosidenib|mesh-list
139569357|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569358|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569359|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139569360|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569361|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569362|NCT04048278|Lidocaine|lidocaine|mesh-list
139569363|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
139569364|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
139569365|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139569366|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569367|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
139569368|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569369|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139569370|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139569371|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139569372|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139569373|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569374|NCT04003506|Bupivacaine|bupivacaine|mesh-list
139569375|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
139569376|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
139569377|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139569378|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569379|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
139569380|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569381|NCT03964493|Vancomycin|vancomycin|mesh-list
139569382|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139569383|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569384|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
139569385|NCT03942653|Goserelin|goserelin|mesh-list
139569386|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569387|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569388|NCT03942653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139569389|NCT03942653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569390|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139569391|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
139569392|NCT03939026|Fludarabine|fludarabine|mesh-list
139569393|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139569394|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
139569395|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569396|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139569397|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139569398|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
139569399|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569400|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569401|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139569402|NCT03902912|Prednisolone|prednisolone|mesh-list
139569403|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139569404|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
139569405|NCT03902912|Hormones|hormones|mesh-ancestor
139570330|NCT05604261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569406|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139569407|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569408|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139569409|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569410|NCT03864406|Darunavir|darunavir|mesh-list
139569411|NCT03864406|Cobicistat|cobicistat|mesh-list
139569412|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139569413|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
139569414|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139569415|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
139569416|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139569417|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
139569418|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569419|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569420|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
139569421|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139569422|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139569423|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139569424|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139569425|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
139569426|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569427|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139569428|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139569430|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139569431|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139569432|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139569433|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139569434|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569435|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569436|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
139569437|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569438|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139569439|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139569440|NCT03823534|Acetaminophen|acetaminophen|mesh-list
139569441|NCT03823534|Ketorolac|ketorolac|mesh-list
139570331|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
139569442|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139569443|NCT03823534|Morphine|morphine|mesh-list
139569444|NCT03823534|Oxycodone|oxycodone|mesh-list
139569445|NCT03823534|Hydrocodone|hydrocodone|mesh-list
139569446|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139569447|NCT03823534|Narcotics|narcotics|mesh-ancestor
139569448|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139569449|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569450|NCT03823534|Analgesics|analgesics|mesh-ancestor
139569451|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
139569452|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569453|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139569454|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
139569455|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139569456|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139569457|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139569458|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139569459|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569460|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569461|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
139569462|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
139569463|NCT03807440|Empagliflozin|empagliflozin|mesh-list
139569464|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139569465|NCT03807440|Linagliptin|linagliptin|mesh-list
139569466|NCT03807440|Metformin|metformin|mesh-list
139569467|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139569468|NCT03807440|Glucagon|glucagon|mesh-list
139569469|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139569470|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569471|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139569472|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569473|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139569474|NCT03807440|Hormones|hormones|mesh-ancestor
139569475|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139569476|NCT03807440|Incretins|incretins|mesh-ancestor
139569477|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
139569478|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569479|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
139569480|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
139569481|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569482|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
139569483|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569484|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569485|NCT03796884|Linaclotide|linaclotide|mesh-list
139570332|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139569486|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139569487|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
139569488|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351188|NCT04892953|Paclitaxel|paclitaxel|mesh-list
139569489|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139569490|NCT03783403|Rituximab|rituximab|mesh-list
139569491|NCT03783403|Cetuximab|cetuximab|mesh-list
139569492|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569493|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569494|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
139569495|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569496|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139569497|NCT03770338|Teriparatide|teriparatide|mesh-list
139569498|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138882481|NCT02652728|Enalapril|enalapril|mesh-list
139569499|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569500|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139569501|NCT03710161|Vitamin D|vitamin d|mesh-list
139569502|NCT03710161|Vitamins|vitamins|mesh-ancestor
139569503|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
139569504|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569505|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139569506|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
139569507|NCT03682536|Luspatercept|luspatercept|mesh-list
139569508|NCT03682536|Hematinics|hematinics|mesh-ancestor
139569509|NCT03570892|Tisagenlecleucel|tisagenlecleucel|mesh-list
139569510|NCT03570892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569511|NCT03570892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569512|NCT03498378|Cetuximab|cetuximab|mesh-list
139569513|NCT03498378|Avelumab|avelumab|mesh-list
139569514|NCT03498378|Palbociclib|palbociclib|mesh-list
139569515|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569516|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569517|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139569518|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569519|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569520|NCT03493165|Everolimus|everolimus|mesh-list
139569521|NCT03493165|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139569522|NCT03493165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139569523|NCT03493165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569524|NCT03493165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569525|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139569526|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
139569527|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569528|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569529|NCT03478956|Etrolizumab|etrolizumab|mesh-list
139569530|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139569531|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
139569532|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569533|NCT03477110|Temozolomide|temozolomide|mesh-list
139569534|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139569535|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
139569536|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569537|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569538|NCT03467113|Cannabidiol|cannabidiol|mesh-list
139569539|NCT03467113|Anticonvulsants|anticonvulsants|mesh-ancestor
139569540|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139569541|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139569542|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569543|NCT03415828|Ethanol|ethanol|mesh-list
139569544|NCT03415828|Prednisolone|prednisolone|mesh-list
139569545|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139569546|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
139569547|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139569548|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
139569549|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139569550|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
139569551|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139569552|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
139569553|NCT03415828|Hormones|hormones|mesh-ancestor
139569554|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139569555|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569556|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139569557|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569558|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
139569559|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
139569560|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569561|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139570333|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
139569562|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139569563|NCT03415828|Protective Agents|protective agents|mesh-ancestor
139569564|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139569565|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569566|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139569568|NCT03347760|Edotreotide|edotreotide|mesh-list
139569569|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139569570|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569571|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139569572|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139569573|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569574|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
139569575|NCT03345576|Testosterone|testosterone|mesh-list
139569576|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
139569577|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
139569578|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139569579|NCT03345576|Androgens|androgens|mesh-ancestor
139569580|NCT03345576|Hormones|hormones|mesh-ancestor
139569581|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138882773|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139569582|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569583|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139569584|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569585|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
139569586|NCT03332303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139569587|NCT03332303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139569588|NCT03332303|Estradiol|estradiol|mesh-list
139569589|NCT03332303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139569590|NCT03332303|Estrogens|estrogens|mesh-ancestor
139569591|NCT03332303|Hormones|hormones|mesh-ancestor
139569592|NCT03332303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139569593|NCT03332303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569594|NCT03332303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139569595|NCT03332303|Contraceptive Agents|contraceptive agents|mesh-ancestor
139569596|NCT03332303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139569597|NCT03332303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139569598|NCT03283878|Cefazolin|cefazolin|mesh-list
139569599|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139569600|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569601|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
139569602|NCT03277729|Fludarabine|fludarabine|mesh-list
138882835|NCT00679224|Ambrisentan|ambrisentan|mesh-list
139569603|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
139569604|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139569605|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
139569606|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569607|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139569608|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139569609|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
139569610|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569611|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569612|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139569613|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139569614|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
139569615|NCT03093909|Gemcitabine|gemcitabine|mesh-list
138882884|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139569616|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139569617|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
139569618|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569619|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569620|NCT03083431|Propranolol|propranolol|mesh-list
139569621|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139569622|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139569623|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
139569624|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569625|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569626|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569627|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139569628|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139569629|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
139569630|NCT02951052|Rilpivirine|rilpivirine|mesh-list
139569631|NCT02951052|Cabotegravir|cabotegravir|mesh-list
139569632|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139569633|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139569634|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569635|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569636|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
139569637|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569638|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139351320|NCT04421820|Vitamin B Complex|vitamin b complex|mesh-ancestor
139569639|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139569640|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139569641|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139569642|NCT02927769|Nivolumab|nivolumab|mesh-list
139569643|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139569644|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139569645|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569646|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569647|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139569648|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569649|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139569650|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
139569651|NCT02927769|Immunotoxins|immunotoxins|mesh-ancestor
139569652|NCT02927769|Immunoconjugates|immunoconjugates|mesh-ancestor
139569653|NCT02927769|Immunologic Factors|immunologic factors|mesh-ancestor
139569654|NCT02927769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569655|NCT02827435|Bromides|bromides|mesh-list
139569656|NCT02827435|Rocuronium|rocuronium|mesh-list
139569657|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
139569658|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138882949|NCT00679458|Naloxone|naloxone|mesh-list
139569659|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139569660|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139569661|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569662|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569663|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
139569664|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139569665|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569666|NCT02794571|Paclitaxel|paclitaxel|mesh-list
139569667|NCT02794571|Etoposide|etoposide|mesh-list
139569668|NCT02794571|Bevacizumab|bevacizumab|mesh-list
139569669|NCT02794571|Carboplatin|carboplatin|mesh-list
139569670|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
139569671|NCT02794571|Capecitabine|capecitabine|mesh-list
139569672|NCT02794571|Pemetrexed|pemetrexed|mesh-list
139569673|NCT02794571|Atezolizumab|atezolizumab|mesh-list
139569674|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139569675|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569676|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
139569677|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
139569678|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
139569679|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569680|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569681|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139569682|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139569683|NCT02794571|Growth Substances|growth substances|mesh-ancestor
138883040|NCT00537979|Vitamins|vitamins|mesh-ancestor
139569684|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569685|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
139569686|NCT02794571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139569687|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139569688|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
139569689|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139569690|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139569691|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569692|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139569693|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139569694|NCT02788773|Durvalumab|durvalumab|mesh-list
139569695|NCT02788773|Tremelimumab|tremelimumab|mesh-list
139569696|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569697|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569698|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
139569699|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569700|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569701|NCT02768792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139569702|NCT02768792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569703|NCT02688400|Celecoxib|celecoxib|mesh-list
139569704|NCT02688400|Diacerein|diacerein|mesh-list
139569705|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139569706|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139569707|NCT02688400|Analgesics|analgesics|mesh-ancestor
139569708|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
139569709|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569710|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569711|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139569712|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139569713|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139569714|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139569715|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569716|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569717|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139569718|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
139569719|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569721|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
139569722|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139569723|NCT02626455|Rituximab|rituximab|mesh-list
139569724|NCT02626455|Doxorubicin|doxorubicin|mesh-list
139569725|NCT02626455|Vincristine|vincristine|mesh-list
139569726|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139569727|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
139569728|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569729|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139569730|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139569731|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
139569732|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569733|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569734|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139569735|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139569736|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139569737|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139569738|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139569739|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569740|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139569741|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
139569742|NCT02626455|Hormones|hormones|mesh-ancestor
139569743|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139569744|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139569745|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139569746|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
139569747|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
139569748|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
139569749|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
139569750|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139569751|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
138883285|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
139569752|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569753|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569754|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139569755|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
139569756|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
139569757|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139569758|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
139569759|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569760|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569761|NCT02193347|Temozolomide|temozolomide|mesh-list
139569762|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139569763|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
139569764|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569765|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569766|NCT02004275|Dexamethasone|dexamethasone|mesh-list
139569767|NCT02004275|Pomalidomide|pomalidomide|mesh-list
139569768|NCT02004275|Ixazomib|ixazomib|mesh-list
139569769|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139569770|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
139569771|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
139569772|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569773|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569774|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139569775|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
139569776|NCT02004275|Hormones|hormones|mesh-ancestor
139569777|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138883360|NCT03562871|Pemetrexed|pemetrexed|mesh-list
139569778|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139569779|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569780|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
139569781|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139569782|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139569783|NCT02004275|Growth Substances|growth substances|mesh-ancestor
139569784|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
139569785|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
139569786|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569787|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569788|NCT01935713|Nicotine|nicotine|mesh-list
139569789|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139569790|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
139569791|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569792|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569793|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139569794|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139569795|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
139569796|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569797|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569798|NCT01731444|Phenylephrine|phenylephrine|mesh-list
139569799|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
138658998|NCT00437229|Casopitant|casopitant|mesh-list
139569800|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139569801|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
139569802|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
139569803|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569804|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569805|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
139569806|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139569807|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
139569808|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
139569809|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139569810|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139569811|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139569812|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
139569813|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883541|NCT00685776|Anacetrapib|anacetrapib|mesh-list
139569814|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569815|NCT01731444|Protective Agents|protective agents|mesh-ancestor
139569816|NCT01559129|Pomalidomide|pomalidomide|mesh-list
139569817|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
139569818|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569819|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139569820|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139569821|NCT01559129|Growth Substances|growth substances|mesh-ancestor
139569822|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
139569823|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569824|NCT01005303|Vitamin D|vitamin d|mesh-list
139569825|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
139569826|NCT01005303|Vitamins|vitamins|mesh-ancestor
139569827|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
138883582|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
139569828|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569829|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139569830|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139569831|NCT01003028|Remifentanil|remifentanil|mesh-list
139569832|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139569833|NCT01003028|Narcotics|narcotics|mesh-ancestor
139569834|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139569835|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569836|NCT01003028|Analgesics|analgesics|mesh-ancestor
139569837|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
139569838|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569839|NCT00388882|Bromides|bromides|mesh-list
139569840|NCT00388882|Albuterol|albuterol|mesh-list
139569841|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
139569842|NCT00388882|Ipratropium|ipratropium|mesh-list
139569843|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139569844|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
139569845|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569846|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569847|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139569848|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
139569849|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
139569850|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139569851|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
139569852|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883703|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
139569853|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569854|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
139569855|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
139569856|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139569857|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139569858|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139569859|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139569860|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
139569861|NCT00275444|Tipranavir|tipranavir|mesh-list
139569862|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139569863|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139569864|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
139569865|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569866|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
139569867|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139569868|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139569869|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
139569870|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569871|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569872|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139569873|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
139569874|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
139569875|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139569876|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
139569877|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569878|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569879|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139569880|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139569881|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139569882|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
139569883|NCT00274508|Bromides|bromides|mesh-list
139569884|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
139569885|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138883832|NCT02737943|Analgesics|analgesics|mesh-list
139569886|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
139569887|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569888|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569889|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139569890|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
139569891|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
139569892|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139569893|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
139569894|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569895|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569896|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
139569897|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
139569898|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139569899|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
139569900|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569901|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569902|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139569903|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
139569904|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
139569905|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139569906|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
139569907|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569908|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569909|NCT00144248|Nevirapine|nevirapine|mesh-list
139569910|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139569911|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139569912|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569913|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569914|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
139569915|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569916|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139569917|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139569918|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139569919|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139569920|NCT00056641|Ritonavir|ritonavir|mesh-list
139569921|NCT00056641|Lopinavir|lopinavir|mesh-list
139569922|NCT00056641|Saquinavir|saquinavir|mesh-list
139569923|NCT00056641|Amprenavir|amprenavir|mesh-list
139569924|NCT00056641|Tipranavir|tipranavir|mesh-list
139569925|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139569926|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139569927|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
139569928|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569929|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569930|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139569931|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139569932|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
139569933|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569934|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139569935|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139569936|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139569937|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
139569938|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139569939|NCT03422874|Nelfinavir|nelfinavir|mesh-list
139569940|NCT03422874|Ixazomib|ixazomib|mesh-list
139569941|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139569942|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
139569943|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139569944|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569945|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139569946|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139569947|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139569948|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139569949|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
139569950|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139569951|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139569952|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138884008|NCT04067986|Apatinib|apatinib|mesh-list
139569953|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139569955|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
139569956|NCT01253824|Norinyl|norinyl|mesh-list
139569957|NCT01253824|Mestranol|mestranol|mesh-list
139569958|NCT01253824|Estradiol|estradiol|mesh-list
139569959|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139569960|NCT01253824|Estrogens|estrogens|mesh-ancestor
139569961|NCT01253824|Hormones|hormones|mesh-ancestor
139569962|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139569963|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569964|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139569965|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
139569966|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139569967|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139569968|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139569969|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139569970|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139569971|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139569972|NCT03422796|Cilostazol|cilostazol|mesh-list
139569973|NCT03422796|Sumatriptan|sumatriptan|mesh-list
139569974|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139569975|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
139569976|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139569977|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139569978|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139569979|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
139569980|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139569981|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139569982|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139569983|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139569984|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
139569985|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139569986|NCT03422796|Protective Agents|protective agents|mesh-ancestor
139569987|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139569988|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139569989|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884049|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139569990|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139569991|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139569992|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139569993|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
139569994|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569995|NCT04396977|Histamine|histamine|mesh-list
139569996|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
139569997|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
139569998|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139569999|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570000|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570001|NCT03429738|Ibuprofen|ibuprofen|mesh-list
139570002|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
139570003|NCT03429738|Ephedrine|ephedrine|mesh-list
139570004|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139570005|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139570006|NCT03429738|Analgesics|analgesics|mesh-ancestor
139570007|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
139570008|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570009|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570010|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139570011|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139570012|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139570013|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570014|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570015|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139570016|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
139570017|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139570018|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
139570020|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139570021|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139570022|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
139570023|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
139570024|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570025|NCT01253902|Bimatoprost|bimatoprost|mesh-list
139570026|NCT01253902|Travoprost|travoprost|mesh-list
139570027|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139570028|NCT01253902|Latanoprost|latanoprost|mesh-list
139570029|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139570030|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139570031|NCT01253980|Amoxicillin|amoxicillin|mesh-list
139570032|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139570033|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570034|NCT00988533|Ivermectin|ivermectin|mesh-list
139570035|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139570036|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570037|NCT01350388|Febuxostat|febuxostat|mesh-list
139570038|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
139570039|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139570040|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
139570041|NCT03154749|Carboplatin|carboplatin|mesh-list
139570042|NCT03154749|Docetaxel|docetaxel|mesh-list
139570043|NCT03154749|Epirubicin|epirubicin|mesh-list
139570044|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139570045|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
139570046|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570047|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139570048|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139570049|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
139570050|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570051|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570052|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139570053|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
139570054|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
139570055|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
139570056|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139570057|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139570058|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139570059|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570060|NCT03422640|Apremilast|apremilast|mesh-list
139570061|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139570062|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139570063|NCT03422640|Analgesics|analgesics|mesh-ancestor
139570064|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
139570065|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570066|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570067|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139570068|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139570069|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139570070|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139570071|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570072|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570073|NCT01351090|Ketorolac|ketorolac|mesh-list
139570074|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139570075|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139570076|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139570077|NCT01351090|Analgesics|analgesics|mesh-ancestor
139570078|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
139570079|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570080|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570081|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139570082|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139570083|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139570084|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570085|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570086|NCT01918644|Capecitabine|capecitabine|mesh-list
139570087|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139570088|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
139570089|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570090|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570091|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
139570092|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139570093|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139570095|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
139570096|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570097|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570098|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139570099|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
139570100|NCT00987831|Hormones|hormones|mesh-ancestor
139570101|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139570102|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139570103|NCT00987831|Protective Agents|protective agents|mesh-ancestor
139570104|NCT03608358|Metformin|metformin|mesh-list
139570105|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
139570106|NCT03608358|Saxagliptin|saxagliptin|mesh-list
139570107|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139570108|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570109|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139570110|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570111|NCT03608358|Incretins|incretins|mesh-ancestor
139570112|NCT03608358|Hormones|hormones|mesh-ancestor
139570113|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139570114|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139570115|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
139570116|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570117|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
139570118|NCT04274907|Venetoclax|venetoclax|mesh-list
139570119|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139570120|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570121|NCT04274907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139570122|NCT04274907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570123|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139570124|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139570125|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
139570126|NCT01256164|Coagulants|coagulants|mesh-ancestor
139570127|NCT03427086|Biotin|biotin|mesh-list
139570128|NCT03427086|Vitamins|vitamins|mesh-ancestor
139570129|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
139570130|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570131|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
139570132|NCT01887522|Vinblastine|vinblastine|mesh-list
139570133|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139570134|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570135|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
139570136|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
139570137|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
139570138|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570139|NCT03422406|Iodine|iodine|mesh-list
139570140|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139570141|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570142|NCT03422406|Trace Elements|trace elements|mesh-ancestor
139570143|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
139570144|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570145|NCT00986427|Cyclosporine|cyclosporine|mesh-list
139570146|NCT00986427|Cyclosporins|cyclosporins|mesh-list
139570147|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570148|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570149|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139570150|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
139570151|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570152|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
139570153|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570154|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
139570155|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139570156|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139570157|NCT03426462|Propofol|propofol|mesh-list
139570158|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139570159|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139570160|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570161|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139570162|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
139570163|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
139570164|NCT03421860|Phenylephrine|phenylephrine|mesh-list
139570165|NCT03421860|Epinephrine|epinephrine|mesh-list
139570166|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
139570167|NCT03421860|Ephedrine|ephedrine|mesh-list
139351857|NCT05849597|Propofol|propofol|mesh-list
139570168|NCT03421860|Norepinephrine|norepinephrine|mesh-list
139570169|NCT03421860|Ondansetron|ondansetron|mesh-list
139570170|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139570171|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139570172|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
139570173|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570174|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570175|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570176|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139570177|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139570178|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
139570179|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570180|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139570181|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
139570182|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
139570183|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
139570184|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139570185|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
139570186|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139570187|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
139570188|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
139570189|NCT03421860|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139570190|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139570191|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
139570192|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139570193|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
139570194|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139570195|NCT03421860|Protective Agents|protective agents|mesh-ancestor
139570196|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139570197|NCT03421314|Selenium|selenium|mesh-list
139570198|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
139570199|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570200|NCT03421314|Protective Agents|protective agents|mesh-ancestor
139570201|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570202|NCT03421314|Trace Elements|trace elements|mesh-ancestor
139570203|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
139570204|NCT03425994|Emtricitabine|emtricitabine|mesh-list
139570205|NCT03425994|Cobicistat|cobicistat|mesh-list
139570206|NCT03425994|Elvitegravir|elvitegravir|mesh-list
139570207|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
139570208|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570209|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139570210|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139570211|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570212|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570213|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139570214|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139570215|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139570216|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139570217|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139570218|NCT03421002|Micafungin|micafungin|mesh-list
139570219|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
139570220|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570221|NCT02521038|Ticagrelor|ticagrelor|mesh-list
139570222|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139570223|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139570224|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139570225|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139570226|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
139570227|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570228|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570229|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570230|NCT00985959|Prednisolone|prednisolone|mesh-list
139570231|NCT00985959|Bortezomib|bortezomib|mesh-list
139570232|NCT00985959|Melphalan|melphalan|mesh-list
139570233|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570234|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139570235|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
139570236|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570237|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139570238|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139570239|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
139570240|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570241|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139570242|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
139570243|NCT00985959|Hormones|hormones|mesh-ancestor
139570244|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139570245|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139570246|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139570247|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139570248|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570249|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139570250|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139570251|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139570252|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570253|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
139570254|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570255|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139570256|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570257|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139570258|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570259|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570260|NCT01351480|Abatacept|abatacept|mesh-list
139570261|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139570262|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570263|NCT01351480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139570264|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570265|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139570266|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
139570267|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570268|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139570269|NCT01352182|Pioglitazone|pioglitazone|mesh-list
139570270|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139570271|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570272|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
139570273|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139570274|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570275|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139570276|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570277|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139570278|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139570279|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139570280|NCT01294384|Laxatives|laxatives|mesh-ancestor
139570281|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139570282|NCT01257802|Leuprolide|leuprolide|mesh-list
139570283|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139570284|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
139570285|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139570286|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570287|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139570288|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570289|NCT05607303|Estrogens|estrogens|mesh-list
139570290|NCT05607303|Hormones|hormones|mesh-ancestor
139570291|NCT05607303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139570292|NCT05607303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472332|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472333|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139472334|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472335|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139472336|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
139472337|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139472338|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139472339|NCT02616640|Growth Substances|growth substances|mesh-ancestor
139472340|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
139472341|NCT02352883|Hormones|hormones|mesh-list
139472342|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472343|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472344|NCT02270632|Methotrexate|methotrexate|mesh-list
139472345|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139472346|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
139472347|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139472348|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472349|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139472350|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
139472351|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472352|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472353|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
139472354|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472355|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139472356|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139472357|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
139472358|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139472359|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139472360|NCT01891344|Rucaparib|rucaparib|mesh-list
139472361|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139472362|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472363|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472364|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472365|NCT01188096|Poly ICLC|poly iclc|mesh-list
139472366|NCT01188096|Interferon Inducers|interferon inducers|mesh-ancestor
139472367|NCT01188096|Immunologic Factors|immunologic factors|mesh-ancestor
139472368|NCT01188096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472369|NCT00632853|Carboplatin|carboplatin|mesh-list
139472370|NCT00632853|Etoposide|etoposide|mesh-list
139472371|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472372|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139472373|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139472374|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139472375|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472376|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472377|NCT00579826|Letrozole|letrozole|mesh-list
139472378|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472379|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139472380|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139472381|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472382|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472383|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139472384|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
139472385|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472386|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472387|NCT00106691|Toremifene|toremifene|mesh-list
139472388|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139472389|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472390|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139472391|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139472392|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
139472393|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472394|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472395|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139472396|NCT04576325|Voriconazole|voriconazole|mesh-list
139472397|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
139472398|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139472399|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139472400|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139472401|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139259156|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139570293|NCT00984009|Colchicine|colchicine|mesh-list
139472402|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472403|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139472404|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
139472405|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472406|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472407|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139472408|NCT03126617|Elotuzumab|elotuzumab|mesh-list
139472409|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472410|NCT04422743|Tramiprosate|tramiprosate|mesh-list
139472411|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139472412|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
139472413|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
139472414|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
139472415|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
139472416|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472417|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472418|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472419|NCT02535221|Epirubicin|epirubicin|mesh-list
139472420|NCT02535221|Goserelin|goserelin|mesh-list
139472421|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139472422|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472423|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139472424|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139472425|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472426|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472427|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139472428|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
139472429|NCT00000587|Hematinics|hematinics|mesh-ancestor
139472430|NCT04592159|Nabiximols|nabiximols|mesh-list
139472431|NCT04592159|Analgesics|analgesics|mesh-ancestor
139472432|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
139472433|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472434|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472435|NCT05137145|Linaclotide|linaclotide|mesh-list
139472436|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139472437|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
139472438|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472439|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139472440|NCT05304845|Aspirin|aspirin|mesh-list
139472441|NCT05304845|Fexuprazan|fexuprazan|mesh-list
139472442|NCT05304845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139472443|NCT05304845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139472444|NCT05304845|Analgesics|analgesics|mesh-ancestor
139472445|NCT05304845|Sensory System Agents|sensory system agents|mesh-ancestor
139472446|NCT05304845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472447|NCT05304845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472448|NCT05304845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139472449|NCT05304845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139472450|NCT05304845|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139472451|NCT05304845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139472452|NCT05304845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472453|NCT05304845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139472454|NCT05304845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139472455|NCT05304845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472456|NCT05304845|Antipyretics|antipyretics|mesh-ancestor
139472457|NCT05304845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139472458|NCT05303597|Lidocaine|lidocaine|mesh-list
139472459|NCT05303597|Anesthetics, Local|anesthetics, local|mesh-ancestor
139472460|NCT05303597|Anesthetics|anesthetics|mesh-ancestor
139472461|NCT05303597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139472462|NCT05303597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472463|NCT05303597|Sensory System Agents|sensory system agents|mesh-ancestor
139472464|NCT05303597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472465|NCT05303597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139472466|NCT05303597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139472467|NCT05303597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139472468|NCT05303597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139472469|NCT05303597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472470|NCT04892459|Vaccines|vaccines|mesh-list
139472471|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
139472472|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472473|NCT04881539|Cannabidiol|cannabidiol|mesh-list
139472474|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
139259235|NCT03701529|Propofol|propofol|mesh-list
139472475|NCT05303285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139472476|NCT05303285|Immunologic Factors|immunologic factors|mesh-ancestor
139472477|NCT05303285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472478|NCT04280939|Anesthetics|anesthetics|mesh-list
139472479|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139472480|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472481|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
139472482|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139472483|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
138884464|NCT00723658|Thalidomide|thalidomide|mesh-list
139472484|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472485|NCT04314713|Scopolamine|scopolamine|mesh-list
139472486|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139472487|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139472488|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
139472489|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
139472490|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472491|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472492|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139472493|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
139472494|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139472495|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
138884525|NCT03562195|Albuterol|albuterol|mesh-list
139472496|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472497|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472498|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139472499|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
139472500|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
139472501|NCT04121507|Thiotepa|thiotepa|mesh-list
139472502|NCT04121507|Fludarabine|fludarabine|mesh-list
139472503|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139472504|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
139472505|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472506|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139472507|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139472508|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
139472509|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472510|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472511|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139472512|NCT03790397|Osimertinib|osimertinib|mesh-list
139472513|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472514|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472515|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139472516|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472517|NCT01171937|Risperidone|risperidone|mesh-list
139472518|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139472519|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
139472520|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472521|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472522|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472523|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139472524|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139472525|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139472526|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139472527|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139472528|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
139472529|NCT00887783|Vinorelbine|vinorelbine|mesh-list
139472530|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139472531|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472532|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
139472533|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
139472534|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
139472535|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472536|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139472537|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
139472538|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139472539|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
139472540|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472541|NCT01125371|Ethanol|ethanol|mesh-list
139472542|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139472543|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139472544|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139472545|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472546|NCT03199547|Azithromycin|azithromycin|mesh-list
139472547|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139472548|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139472549|NCT00416351|Clofarabine|clofarabine|mesh-list
139472550|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139472551|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
139472552|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884687|NCT04001569|Paclitaxel|paclitaxel|mesh-list
139472553|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472554|NCT03938831|Fentanyl|fentanyl|mesh-list
139472555|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
139472556|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139472557|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139472558|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472559|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139472560|NCT03938831|Analgesics|analgesics|mesh-ancestor
139472561|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
139472562|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570294|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
139472563|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139472564|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139472565|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139472566|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
139472567|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472568|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472569|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139472570|NCT03938831|Narcotics|narcotics|mesh-ancestor
139472571|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139472572|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139472573|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
139472574|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
139472575|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
139472576|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139472577|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139472578|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
139472579|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139472580|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139472581|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472582|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139472583|NCT03102359|Analgesics|analgesics|mesh-ancestor
139472584|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
139472585|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472586|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139472587|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139472588|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139472589|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
139472590|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884820|NCT02725541|Trastuzumab|trastuzumab|mesh-list
139472591|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472592|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
139472593|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139472594|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
139472595|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139472596|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472597|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139472598|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139472599|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139472600|NCT03832049|Vaccines|vaccines|mesh-list
139472601|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
139472602|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472603|NCT02102477|Androgens|androgens|mesh-list
139472604|NCT02102477|Hormones|hormones|mesh-ancestor
139472605|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472606|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472607|NCT03103685|Clopidogrel|clopidogrel|mesh-list
139472608|NCT03103685|Ticagrelor|ticagrelor|mesh-list
139472609|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139472610|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139472611|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139472612|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139472613|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139472614|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
139472615|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570295|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139472616|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472617|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472618|NCT03748433|Insulin|insulin|mesh-list
139472619|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139472620|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472621|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139472622|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
139472623|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259390|NCT03540836|Cortisone|cortisone|mesh-list
139472625|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
139472626|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
139472627|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139472628|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472629|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
139472630|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472631|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139472632|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139472633|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138884916|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
139472634|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139472635|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472636|NCT05001815|Insulin|insulin|mesh-list
139472637|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139472638|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139472639|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472640|NCT02644967|Ipilimumab|ipilimumab|mesh-list
139472641|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139472642|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472643|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139472644|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472645|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
139472646|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139472647|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139472648|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472649|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139472650|NCT04771637|Analgesics|analgesics|mesh-ancestor
139472651|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
139472652|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472653|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139472654|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139472655|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139472656|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
139472657|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472658|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472659|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139472660|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
139472661|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139472662|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
139472663|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472664|NCT04701593|Triamcinolone|triamcinolone|mesh-list
139472665|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139472666|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139472667|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139472668|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139472669|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
139472670|NCT04701593|Hormones|hormones|mesh-ancestor
139472671|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472672|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472673|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139472674|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
139472675|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472676|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472677|NCT05243693|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139472678|NCT05243693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139472679|NCT05243693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472680|NCT05243693|Immunotoxins|immunotoxins|mesh-ancestor
139472681|NCT05243693|Immunoconjugates|immunoconjugates|mesh-ancestor
139472682|NCT05243693|Immunologic Factors|immunologic factors|mesh-ancestor
139472683|NCT05243693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472684|NCT04552847|Octreotide|octreotide|mesh-list
139472685|NCT04552847|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
139472686|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139472687|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139472688|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472689|NCT04552847|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139570296|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
139472690|NCT04552847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472691|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
139472692|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139472693|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
139472694|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
139472695|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139259458|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
139472696|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472697|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139472698|NCT05167331|Analgesics|analgesics|mesh-ancestor
139472699|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
139472700|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472701|NCT04509401|Vitamins|vitamins|mesh-list
139472702|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
139472703|NCT04509401|Pyridoxal|pyridoxal|mesh-list
139472704|NCT04509401|Pyridoxine|pyridoxine|mesh-list
139472705|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
139472706|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
139472707|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472708|NCT05155007|Cyclosporine|cyclosporine|mesh-list
139472709|NCT05155007|Cyclosporins|cyclosporins|mesh-list
139472710|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472711|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472712|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139472713|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
139472714|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472715|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
139472716|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139472717|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
139472718|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139472719|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139472720|NCT01641107|Ponatinib|ponatinib|mesh-list
139472721|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472722|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139472723|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472724|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472725|NCT03101423|Interleukin-2|interleukin-2|mesh-list
139472726|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472727|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139472728|NCT03101423|Analgesics|analgesics|mesh-ancestor
139472729|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
139472730|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472731|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472732|NCT05073029|Vitamin D|vitamin d|mesh-list
139472733|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
139472734|NCT05073029|Vitamins|vitamins|mesh-ancestor
139472735|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
139472736|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472737|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139472738|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139472739|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
139472740|NCT02642159|Niacin|niacin|mesh-list
139472741|NCT02642159|Niacinamide|niacinamide|mesh-list
139472742|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139472743|NCT02642159|Ezetimibe|ezetimibe|mesh-list
139472744|NCT02642159|Alirocumab|alirocumab|mesh-list
139472745|NCT02642159|Fenofibrate|fenofibrate|mesh-list
139472746|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139472747|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139472748|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
139472749|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472750|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139472751|NCT02642159|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139472752|NCT02642159|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139472753|NCT02642159|Protease Inhibitors|protease inhibitors|mesh-ancestor
139472754|NCT02642159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472755|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
139472756|NCT02642159|Vitamins|vitamins|mesh-ancestor
139472757|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
139472758|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472759|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
139472760|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
139472761|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139472762|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139472763|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472764|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
139472765|NCT05072873|Coagulants|coagulants|mesh-ancestor
139472766|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139472767|NCT05072405|Simvastatin|simvastatin|mesh-list
139472768|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139472769|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139472770|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
139472771|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139259534|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
139472772|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139472773|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139472774|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472775|NCT03101579|Folic Acid|folic acid|mesh-list
139472776|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
139472777|NCT03101579|Dexamethasone|dexamethasone|mesh-list
139472778|NCT03101579|Pemetrexed|pemetrexed|mesh-list
139472779|NCT03101579|Vitamins|vitamins|mesh-ancestor
139472780|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
139472781|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472782|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139472783|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
139472784|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
139472785|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472786|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139472787|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
139472788|NCT03101579|Hormones|hormones|mesh-ancestor
139570297|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
139472789|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472790|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139472791|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472792|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472793|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472794|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139472795|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139472796|NCT03101579|Hematinics|hematinics|mesh-ancestor
139472797|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
139472798|NCT05071781|Hormones|hormones|mesh-list
139472799|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139472800|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472801|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472802|NCT03882905|Ezetimibe|ezetimibe|mesh-list
139472803|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139472804|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139472805|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
139472806|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472807|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139472808|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139472809|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139472810|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472811|NCT04479865|Donepezil|donepezil|mesh-list
139472812|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139472813|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885343|NCT00885170|Vitamin D|vitamin d|mesh-list
139472814|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472815|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
139472816|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472817|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472818|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
139472819|NCT02668393|Docetaxel|docetaxel|mesh-list
139472820|NCT02668393|Nintedanib|nintedanib|mesh-list
139472821|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472822|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
139472823|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
139472824|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
139472825|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885418|NCT02724293|Pregabalin|pregabalin|mesh-list
139472826|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139472827|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472828|NCT01226563|Calcium|calcium|mesh-list
139472829|NCT01226563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139472830|NCT01226563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472831|NCT02382757|Insulin|insulin|mesh-list
139472832|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139472833|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139472834|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472835|NCT02382679|Vitamins|vitamins|mesh-list
139472836|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
139472837|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472838|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
139472839|NCT00916747|Pravastatin|pravastatin|mesh-list
139472840|NCT00916747|Lonafarnib|lonafarnib|mesh-list
139472841|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139472842|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472843|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139472844|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139472845|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
139472846|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472847|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139472848|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139472849|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472851|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139472852|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139472853|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139472854|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139472855|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
139472856|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472857|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472858|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472859|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139472860|NCT02382523|Hormones|hormones|mesh-ancestor
139472861|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472862|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472863|NCT02391805|Tenofovir|tenofovir|mesh-list
139472864|NCT02391805|Entecavir|entecavir|mesh-list
139472865|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
139472866|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139472867|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139472868|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139472869|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472870|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472871|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139472872|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139472873|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139472874|NCT02391181|Hematinics|hematinics|mesh-ancestor
139472875|NCT02381899|Rituximab|rituximab|mesh-list
139472876|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139472877|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139472878|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472879|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
139472880|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472881|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139472882|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139472883|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
139472884|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472885|NCT01998958|Esketamine|esketamine|mesh-list
139472886|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
139472887|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139472888|NCT02386111|Sunitinib|sunitinib|mesh-list
139472889|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472890|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139472891|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139472892|NCT02386111|Growth Substances|growth substances|mesh-ancestor
139472893|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472894|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
139472895|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139472896|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472897|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472898|NCT02386033|Atorvastatin|atorvastatin|mesh-list
139472899|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139472900|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139472901|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
139472902|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472903|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139472904|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139472905|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472906|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139472907|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139472908|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139472909|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472910|NCT02381275|Tenofovir|tenofovir|mesh-list
139472911|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
139472912|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139472913|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139472914|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139472915|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139472916|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472917|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139472918|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139472919|NCT04693507|Antarelix|antarelix|mesh-list
139472920|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
139472921|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139472922|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472923|NCT03105661|Atenolol|atenolol|mesh-list
139472924|NCT03105661|Labetalol|labetalol|mesh-list
139472925|NCT03105661|Nifedipine|nifedipine|mesh-list
139472926|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139472927|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139472928|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472929|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139472930|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472931|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
139472932|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
139472933|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139472934|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139472935|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139472936|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
139472937|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
139472938|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472939|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139472940|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139472941|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139472942|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
139472943|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139472944|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
139472945|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139472946|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139472947|NCT01998880|Rituximab|rituximab|mesh-list
139472948|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
139472949|NCT01998880|Chlorambucil|chlorambucil|mesh-list
139472950|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139472951|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139472952|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
139472953|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472954|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139472955|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139472956|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
139472957|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472958|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139472959|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139472960|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472961|NCT02385019|Immunomodulating Agents|immunomodulating agents|mesh-list
139472962|NCT02385019|Immunologic Factors|immunologic factors|mesh-ancestor
139472963|NCT02385019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472964|NCT02380417|Ropivacaine|ropivacaine|mesh-list
139472965|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
139472966|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
139472967|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139472968|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472969|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
139472970|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472971|NCT02390089|Capsaicin|capsaicin|mesh-list
139472972|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
139472973|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
139472974|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
139472975|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139472976|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472977|NCT02379793|Mineral Oil|mineral oil|mesh-list
139472978|NCT02379793|Emollients|emollients|mesh-ancestor
139472979|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
139472980|NCT01975246|Amlodipine|amlodipine|mesh-list
139472981|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139472982|NCT01975246|Telmisartan|telmisartan|mesh-list
139472983|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139472984|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139472985|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139472986|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139472987|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472988|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139472989|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139472990|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
139472991|NCT01975246|Diuretics|diuretics|mesh-ancestor
139472992|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
139472993|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139472994|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139472995|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139570298|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
139472996|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139472997|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139472998|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139472999|NCT02379715|Remifentanil|remifentanil|mesh-list
139473000|NCT02379715|Desflurane|desflurane|mesh-list
139473001|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139473002|NCT02379715|Narcotics|narcotics|mesh-ancestor
139473003|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139473004|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473005|NCT02379715|Analgesics|analgesics|mesh-ancestor
139473006|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
139473007|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473008|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139473009|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
139473010|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
139473011|NCT04439773|Lidocaine|lidocaine|mesh-list
139473012|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
139473013|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
139473014|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139473015|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473016|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
139473017|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885733|NCT00866619|Vaccines|vaccines|mesh-list
139473018|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139473019|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139473020|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139473021|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139473022|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473023|NCT02389231|Interleukin-2|interleukin-2|mesh-list
139473024|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473025|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139473026|NCT02389231|Analgesics|analgesics|mesh-ancestor
139473027|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
139473028|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473029|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473030|NCT02383927|Tipifarnib|tipifarnib|mesh-list
139473031|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473032|NCT02383771|Aspirin|aspirin|mesh-list
139473033|NCT02383771|Ticagrelor|ticagrelor|mesh-list
139473034|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139473035|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139473036|NCT02383771|Analgesics|analgesics|mesh-ancestor
139473037|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
139473038|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473039|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473040|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139473041|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139473042|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139473043|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139473044|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473045|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139473046|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139473047|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473048|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
139473049|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139473050|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139473051|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139473052|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
139473053|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473054|NCT02378623|Apixaban|apixaban|mesh-list
139473055|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139473056|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
139473057|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139473058|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
139473059|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473060|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473061|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
139473062|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
139473063|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139473064|NCT02372149|Antibodies|antibodies|mesh-list
139473065|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
139473066|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139473067|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
139473068|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473069|NCT02661061|Midazolam|midazolam|mesh-list
139473070|NCT02661061|Ketamine|ketamine|mesh-list
139473071|NCT02661061|Analgesics|analgesics|mesh-ancestor
139473073|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473074|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473075|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139473076|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139473077|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
139473078|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
139473079|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139473080|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139473081|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139473082|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473083|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473084|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139473085|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139473086|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139473087|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139473088|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139473089|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
139473090|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
139473091|NCT02376985|Everolimus|everolimus|mesh-list
139473092|NCT02376985|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139473093|NCT02376985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139473094|NCT02376985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473095|NCT02376985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473096|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139473097|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
139473098|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473099|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473100|NCT02371993|Choline|choline|mesh-list
139473101|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
139473102|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139473103|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
139473104|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473105|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139473106|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139473107|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
139473108|NCT02371603|Pioglitazone|pioglitazone|mesh-list
139473109|NCT02371603|Trimethoprim|trimethoprim|mesh-list
139473110|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139473111|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139473112|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139473113|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
139570334|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139473114|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473115|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139473116|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139473117|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473118|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139473119|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473120|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139473121|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139473122|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
139473123|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139473124|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139473125|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139473126|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139473127|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139473128|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139473129|NCT04149145|Niraparib|niraparib|mesh-list
139473130|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139473131|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473132|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473133|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473134|NCT02378389|Docetaxel|docetaxel|mesh-list
139473135|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473136|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
139473137|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
139473138|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
139473139|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473140|NCT02376595|Bromides|bromides|mesh-list
139473141|NCT02376595|Rocuronium|rocuronium|mesh-list
139473142|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
138886222|NCT00999349|Silymarin|silymarin|mesh-list
139473143|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139473144|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139473145|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139473146|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473147|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473148|NCT02370745|Insulin|insulin|mesh-list
139473149|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139473150|NCT02370745|Incretins|incretins|mesh-list
139473151|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139473152|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473153|NCT02370745|Hormones|hormones|mesh-ancestor
139570335|NCT03032601|Expectorants|expectorants|mesh-ancestor
138886308|NCT02716415|Menthol|menthol|mesh-list
139473154|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139473155|NCT02376049|Betamethasone|betamethasone|mesh-list
139473156|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
139473157|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139473158|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
139473159|NCT02376049|Clobetasol|clobetasol|mesh-list
139473160|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
139473161|NCT02376049|Emollients|emollients|mesh-list
139473162|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139473163|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139473164|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
139473165|NCT02376049|Hormones|hormones|mesh-ancestor
139473166|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139473167|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473168|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139473169|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
139473170|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139473171|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139473172|NCT02376049|Analgesics|analgesics|mesh-ancestor
139473173|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
139473174|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473175|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139473176|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
139473177|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139473178|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
139473179|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139473180|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473181|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473182|NCT02376205|Bupivacaine|bupivacaine|mesh-list
139473183|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139473184|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
139473185|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
139473186|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139473187|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473188|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
139473189|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473190|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
139473191|NCT02370433|Neostigmine|neostigmine|mesh-list
139473192|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139473193|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473194|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473195|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
139473196|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473197|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473198|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139473199|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
139473200|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473201|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139473202|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139473203|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139473204|NCT01957150|Fluticasone|fluticasone|mesh-list
139473206|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139473207|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139473208|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
139473209|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473210|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473211|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139473212|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
139473213|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
139473214|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139473215|NCT01995526|Insulin|insulin|mesh-list
139473216|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139473217|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473218|NCT01973218|Vaccines|vaccines|mesh-list
139473219|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
139473220|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139259986|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139473222|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
139473223|NCT01946152|Pomalidomide|pomalidomide|mesh-list
139473224|NCT01946152|Ichthammol|ichthammol|mesh-list
139473225|NCT01946152|Lenograstim|lenograstim|mesh-list
139473226|NCT01946152|BB 1101|bb 1101|mesh-list
139473227|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139473228|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
139473229|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
139473230|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473231|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473232|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139473233|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
139473234|NCT01946152|Hormones|hormones|mesh-ancestor
139473235|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139473236|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139473237|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473238|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139473239|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
139473240|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
139473241|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473242|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473243|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139473244|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139473245|NCT01946152|Growth Substances|growth substances|mesh-ancestor
139473246|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
139473247|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
139473248|NCT01971346|Etanercept|etanercept|mesh-list
139473249|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139473250|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139473251|NCT01971346|Analgesics|analgesics|mesh-ancestor
139473252|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
139473253|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473254|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473255|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886479|NCT02752763|Dextrans|dextrans|mesh-list
139473256|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139473257|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139473258|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139473259|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
139473260|NCT01945216|Alogliptin|alogliptin|mesh-list
139473261|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139473262|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473263|NCT01945216|Incretins|incretins|mesh-ancestor
139473264|NCT01945216|Hormones|hormones|mesh-ancestor
139473265|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139473266|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139473267|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
139473268|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473269|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473270|NCT02641379|Ribavirin|ribavirin|mesh-list
139473271|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139473272|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
139473273|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473274|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
139473275|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139473276|NCT02660983|Donepezil|donepezil|mesh-list
139473277|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139473278|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473279|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473280|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
139473281|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473282|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473283|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
139473284|NCT05070221|Axitinib|axitinib|mesh-list
139473285|NCT05070221|Antibodies|antibodies|mesh-list
139473286|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139473287|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
139473288|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473289|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473290|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139473291|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473292|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473293|NCT04404439|Topiramate|topiramate|mesh-list
139473294|NCT04404439|Verapamil|verapamil|mesh-list
139473295|NCT04404439|Paroxetine|paroxetine|mesh-list
139473296|NCT04404439|Nortriptyline|nortriptyline|mesh-list
139473297|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
139473298|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139473299|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473300|NCT04404439|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139473301|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139473302|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139473303|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473304|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473305|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
139473306|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139473307|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
139473308|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139473309|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139473310|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139473311|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886653|NCT00996697|Hormones|hormones|mesh-ancestor
139473312|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139473313|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139473314|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139473315|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
139473316|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139473317|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139473318|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
139473319|NCT01953328|Atorvastatin|atorvastatin|mesh-list
139473321|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139473322|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139473323|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139473324|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
139473325|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473326|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139473327|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139473328|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473329|NCT01953328|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139473330|NCT01953328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139473331|NCT01953328|Protease Inhibitors|protease inhibitors|mesh-ancestor
139473332|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
139473333|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473334|NCT03100955|Cisplatin|cisplatin|mesh-list
139473335|NCT03100955|Etoposide|etoposide|mesh-list
139473336|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
139473337|NCT03100955|Apatinib|apatinib|mesh-list
139473338|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473339|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139473340|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139473341|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139473342|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473343|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886790|NCT01000597|Xhance|xhance|mesh-list
139473344|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139473345|NCT02377609|Tacrolimus|tacrolimus|mesh-list
139473346|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139473347|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
139473348|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473349|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139473350|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473351|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473352|NCT02369965|Ritonavir|ritonavir|mesh-list
139473353|NCT02369965|Lopinavir|lopinavir|mesh-list
139473354|NCT02369965|Tenofovir|tenofovir|mesh-list
139473355|NCT02369965|Lamivudine|lamivudine|mesh-list
139473356|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139473357|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139473358|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
139473359|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570336|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
139473360|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473361|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139473362|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139473363|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
139473364|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139473365|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139473366|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139473367|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139473368|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139473369|NCT02640755|Paclitaxel|paclitaxel|mesh-list
139473370|NCT02640755|Fulvestrant|fulvestrant|mesh-list
139260137|NCT02172404|Ipratropium|ipratropium|mesh-list
139473371|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139473372|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473373|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
139473374|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
139473375|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
139473376|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473377|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139473378|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139473379|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139473380|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
139473381|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138886949|NCT02714543|Protective Agents|protective agents|mesh-ancestor
139473382|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473383|NCT04400539|Nivolumab|nivolumab|mesh-list
139473384|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139473385|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473386|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139473387|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473388|NCT03099785|Rifamycins|rifamycins|mesh-list
139473389|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
139473390|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139473391|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139473392|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139473393|NCT02375503|Vitamin D|vitamin d|mesh-list
139473394|NCT02375503|Calcium|calcium|mesh-list
139473395|NCT02375503|Vitamins|vitamins|mesh-ancestor
139473396|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
139473397|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473398|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139473399|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139473400|NCT00867191|Desloratadine|desloratadine|mesh-list
139473401|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139473402|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
139473403|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473404|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473405|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473406|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139473407|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138887077|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
139473408|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
139473409|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
139473410|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
139473411|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139473412|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
139473413|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139473414|NCT02643251|Clonidine|clonidine|mesh-list
139473415|NCT02643251|Analgesics|analgesics|mesh-ancestor
139473416|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
139473417|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473418|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473419|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139473420|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
139473421|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
139473422|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139473423|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139473424|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139473425|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
139473426|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473427|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473428|NCT02375191|Fentanyl|fentanyl|mesh-list
139473429|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
139473430|NCT02375191|Ropivacaine|ropivacaine|mesh-list
139473431|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139473432|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139473433|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473434|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139473435|NCT02375191|Analgesics|analgesics|mesh-ancestor
139473436|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
139473437|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473438|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139473439|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139473440|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139473441|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
139473442|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473443|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139260212|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
139473444|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
139473445|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
139473446|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139473447|NCT02375191|Narcotics|narcotics|mesh-ancestor
139473448|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139473449|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139473450|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
139473451|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
139473452|NCT03100877|Melphalan|melphalan|mesh-list
139473453|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
139473454|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139473455|NCT03100877|Lenalidomide|lenalidomide|mesh-list
139473456|NCT03100877|Lenograstim|lenograstim|mesh-list
139473457|NCT03100877|Mitogens|mitogens|mesh-list
139473458|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139473459|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
139473460|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473461|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139473462|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139473463|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
139473464|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473465|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473466|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139473467|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139473468|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139473469|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139473470|NCT03100877|Growth Substances|growth substances|mesh-ancestor
139473471|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
139473472|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
139473473|NCT00794495|Cetirizine|cetirizine|mesh-list
139473474|NCT00794495|Desloratadine|desloratadine|mesh-list
139473475|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139473476|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139473477|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139473478|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
139473479|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
139473480|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473481|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473482|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473483|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139473484|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
139473485|NCT04157075|Bupivacaine|bupivacaine|mesh-list
139473486|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
139473487|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
139473488|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139473489|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473490|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
139473491|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473492|NCT00763529|Fluticasone|fluticasone|mesh-list
139473493|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
139473494|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139473495|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139473496|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
139473497|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473498|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473499|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139473500|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
139473501|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
139473502|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139473503|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
139473504|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139473505|NCT03105505|Permethrin|permethrin|mesh-list
139473506|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139473507|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473508|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473509|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139473510|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139473511|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139473512|NCT03105193|Lidocaine|lidocaine|mesh-list
139473513|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
139473514|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
139473515|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139473516|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473517|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
139473518|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139260286|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139473519|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139473520|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139473522|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139473523|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473524|NCT05066633|Metoprolol|metoprolol|mesh-list
139473525|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139473526|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139473527|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
139473528|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
139473529|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473530|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473531|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139473532|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139473533|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139473534|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
139473535|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473536|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473537|NCT04439305|Dasatinib|dasatinib|mesh-list
139473538|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473539|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139473540|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473541|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473542|NCT02368951|Aprutumab ixadotin|aprutumab ixadotin|mesh-list
139473543|NCT02368951|Immunoconjugates|immunoconjugates|mesh-ancestor
139473544|NCT02368951|Immunologic Factors|immunologic factors|mesh-ancestor
139473545|NCT02368951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473546|NCT02368795|Indomethacin|indomethacin|mesh-list
139473547|NCT02368795|Isosorbide|isosorbide|mesh-list
139473548|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139473549|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139473550|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139473551|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139473552|NCT02368795|Analgesics|analgesics|mesh-ancestor
139473553|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
139473554|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473555|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473556|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139473557|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139473558|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
139473559|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
139210601|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473560|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139473561|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139473562|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473563|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473564|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139473565|NCT02368795|Diuretics|diuretics|mesh-ancestor
139473566|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
139473567|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
139473568|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139473569|NCT00650663|Simvastatin|simvastatin|mesh-list
139473570|NCT00650663|Ezetimibe|ezetimibe|mesh-list
139473571|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139473572|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139473573|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
139473574|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473575|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139570337|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139473576|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139473577|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473578|NCT02368717|Mesalamine|mesalamine|mesh-list
139473579|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139473580|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139473581|NCT02368717|Analgesics|analgesics|mesh-ancestor
139473582|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
139473583|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473584|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473585|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139473586|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139473587|NCT04231565|Tenofovir|tenofovir|mesh-list
139473588|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
139473589|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139473590|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139260362|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
139473591|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139473592|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473593|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473594|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139473595|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139473596|NCT03100565|Lidocaine|lidocaine|mesh-list
139473597|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
139473598|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
139473599|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139473600|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473601|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
139473602|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473603|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139473604|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139473605|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139473606|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139473607|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473608|NCT05035277|Aspirin|aspirin|mesh-list
139473609|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
139473610|NCT05035277|Apixaban|apixaban|mesh-list
139473611|NCT05035277|Edoxaban|edoxaban|mesh-list
139473612|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139473613|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
139473614|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139473615|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
139473616|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570338|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
139473617|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473618|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
139473619|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139473620|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139473621|NCT05035277|Analgesics|analgesics|mesh-ancestor
139473622|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
139473623|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473624|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473625|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139473626|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139473627|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139473628|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139473629|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139473630|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139473631|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
139473632|NCT02374645|Gefitinib|gefitinib|mesh-list
139473633|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473634|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139473635|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473636|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473637|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
139473638|NCT02368561|Hylan|hylan|mesh-list
139473639|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139473640|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
139473641|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473642|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
139473643|NCT02368561|Protective Agents|protective agents|mesh-ancestor
139473644|NCT04095845|Tacrine|tacrine|mesh-list
139473645|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139473646|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473647|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473648|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
139473649|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473650|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473651|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139473652|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
139473653|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473654|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
139473655|NCT02374489|Ceritinib|ceritinib|mesh-list
139473656|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473657|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139473658|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473659|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473660|NCT02374567|Topiramate|topiramate|mesh-list
139473661|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
139473662|NCT02374567|Promethazine|promethazine|mesh-list
139473663|NCT02374567|Pregabalin|pregabalin|mesh-list
139473664|NCT02374567|Lamotrigine|lamotrigine|mesh-list
139473665|NCT02374567|Lacosamide|lacosamide|mesh-list
139473666|NCT02374567|Carbamazepine|carbamazepine|mesh-list
139473667|NCT02374567|Phenytoin|phenytoin|mesh-list
139473668|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
139473669|NCT02374567|Nicergoline|nicergoline|mesh-list
139473670|NCT02374567|Midazolam|midazolam|mesh-list
139473671|NCT02374567|Diazepam|diazepam|mesh-list
139473672|NCT02374567|Triazolam|triazolam|mesh-list
139473673|NCT02374567|Acamprosate|acamprosate|mesh-list
139473674|NCT02374567|Gabapentin|gabapentin|mesh-list
139473675|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139473676|NCT02374567|Amitriptyline|amitriptyline|mesh-list
139473677|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
139473678|NCT02374567|Levetiracetam|levetiracetam|mesh-list
139473679|NCT02374567|Valproic Acid|valproic acid|mesh-list
139473680|NCT02374567|Lorazepam|lorazepam|mesh-list
139473681|NCT02374567|Clonazepam|clonazepam|mesh-list
139473682|NCT02374567|Phenobarbital|phenobarbital|mesh-list
139473683|NCT02374567|Clobazam|clobazam|mesh-list
139473684|NCT02374567|Zaleplon|zaleplon|mesh-list
139473685|NCT02374567|Nitrazepam|nitrazepam|mesh-list
139473686|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
139473687|NCT02374567|Memantine|memantine|mesh-list
139473688|NCT02374567|Biperiden|biperiden|mesh-list
139473689|NCT02374567|Haloperidol|haloperidol|mesh-list
139473690|NCT02374567|Pimozide|pimozide|mesh-list
139473691|NCT02374567|Olanzapine|olanzapine|mesh-list
139473692|NCT02374567|Zolpidem|zolpidem|mesh-list
139473693|NCT02374567|Alprazolam|alprazolam|mesh-list
139473694|NCT02374567|Zopiclone|zopiclone|mesh-list
139473695|NCT02374567|Agomelatine|agomelatine|mesh-list
139473696|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
139473697|NCT02374567|Doxepin|doxepin|mesh-list
139473698|NCT02374567|Oxazepam|oxazepam|mesh-list
139473699|NCT02374567|Temazepam|temazepam|mesh-list
139473700|NCT02374567|Brotizolam|brotizolam|mesh-list
139473701|NCT02374567|Lormetazepam|lormetazepam|mesh-list
139473702|NCT02374567|Flurazepam|flurazepam|mesh-list
139473703|NCT02374567|Mirtazapine|mirtazapine|mesh-list
139473704|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
139473705|NCT02374567|Buspirone|buspirone|mesh-list
139473706|NCT02374567|Trazodone|trazodone|mesh-list
139473707|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
139473708|NCT02374567|Bromazepam|bromazepam|mesh-list
139473709|NCT02374567|Risperidone|risperidone|mesh-list
139473710|NCT02374567|Melatonin|melatonin|mesh-list
139473711|NCT02374567|Aripiprazole|aripiprazole|mesh-list
139473712|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139473713|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139473714|NCT02374567|Ziprasidone|ziprasidone|mesh-list
139473715|NCT02374567|Clozapine|clozapine|mesh-list
139473716|NCT02374567|Amisulpride|amisulpride|mesh-list
139473717|NCT02374567|Flupenthixol|flupenthixol|mesh-list
139473718|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
139473719|NCT02374567|Perphenazine|perphenazine|mesh-list
139473720|NCT02374567|Sertindole|sertindole|mesh-list
139473721|NCT02374567|Sulpiride|sulpiride|mesh-list
139473722|NCT02374567|Fluphenazine|fluphenazine|mesh-list
139473723|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
139473724|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
139473725|NCT02374567|Thioridazine|thioridazine|mesh-list
139473726|NCT02374567|Pipamperone|pipamperone|mesh-list
139473727|NCT02374567|Clopenthixol|clopenthixol|mesh-list
139473728|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
139473729|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
139473730|NCT02374567|Fluspirilene|fluspirilene|mesh-list
139473731|NCT02374567|Perazine|perazine|mesh-list
139473732|NCT02374567|Bromperidol|bromperidol|mesh-list
139473733|NCT02374567|Benperidol|benperidol|mesh-list
139473734|NCT02374567|Rivastigmine|rivastigmine|mesh-list
139473735|NCT02374567|Piracetam|piracetam|mesh-list
139473736|NCT02374567|Donepezil|donepezil|mesh-list
139473737|NCT02374567|Galantamine|galantamine|mesh-list
139473738|NCT02374567|Citalopram|citalopram|mesh-list
139473739|NCT02374567|Bupropion|bupropion|mesh-list
139473740|NCT02374567|Sertraline|sertraline|mesh-list
139473741|NCT02374567|Fluoxetine|fluoxetine|mesh-list
139473742|NCT02374567|Paroxetine|paroxetine|mesh-list
139473743|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139260511|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
139473744|NCT02374567|Nortriptyline|nortriptyline|mesh-list
139473745|NCT02374567|Reboxetine|reboxetine|mesh-list
139473746|NCT02374567|Imipramine|imipramine|mesh-list
139473747|NCT02374567|Clomipramine|clomipramine|mesh-list
139473748|NCT02374567|Mianserin|mianserin|mesh-list
139473749|NCT02374567|Moclobemide|moclobemide|mesh-list
139473750|NCT02374567|Opipramol|opipramol|mesh-list
139473751|NCT02374567|Maprotiline|maprotiline|mesh-list
139473752|NCT02374567|Trimipramine|trimipramine|mesh-list
139473753|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
139473754|NCT02374567|Escitalopram|escitalopram|mesh-list
139473755|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139473756|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139473757|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139473758|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473759|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139473760|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139473761|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139473762|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139473763|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
139473764|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
139473765|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
139473766|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
139473767|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473768|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473769|NCT02374567|Analgesics|analgesics|mesh-ancestor
139473770|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
139473771|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473772|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
139473773|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139473774|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139473775|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139473776|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139473777|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139473778|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
139473779|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139473780|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
139473781|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139473782|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139473783|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
139473784|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
138961375|NCT00808314|Dipyridamole|dipyridamole|mesh-list
139473785|NCT02374567|Protective Agents|protective agents|mesh-ancestor
139473786|NCT02374567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139473787|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139473788|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139473789|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139473790|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
139473791|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
139473792|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139473793|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139473794|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
139473795|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139473796|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
139473797|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
139473798|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139473799|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139473800|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139473801|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139473802|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473803|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
139473804|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139473805|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139473806|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139473807|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139473808|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139473809|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139473810|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
139473811|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139473812|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139473813|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139473814|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
139473815|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139473816|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
139473817|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
139473818|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139473819|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
139473820|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
139473821|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139473822|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
139473823|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139473824|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139473825|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139473826|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139473827|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
139473828|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139473829|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139473830|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139473831|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139473832|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139473833|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139473834|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139473835|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139473836|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139473837|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139473838|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
139473839|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139473840|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139473841|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139473842|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139473843|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138961558|NCT00780104|Analgesics|analgesics|mesh-ancestor
139473844|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139473845|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
139473846|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
139473847|NCT03965741|Apixaban|apixaban|mesh-list
139473848|NCT03965741|Dabigatran|dabigatran|mesh-list
139473849|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139473850|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
139473851|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139473852|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
139473853|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473854|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473855|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
139473856|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
139473857|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
139473858|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139473859|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
139473860|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473861|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473862|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139473863|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
139473864|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139473865|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
139473866|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473867|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473868|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139473869|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
139473870|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
139473871|NCT02368171|Protective Agents|protective agents|mesh-ancestor
139473872|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
139473873|NCT02364583|Primaquine|primaquine|mesh-list
139473874|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
139473875|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139473876|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139473877|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139473878|NCT02368015|Cefazolin|cefazolin|mesh-list
139473879|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139473880|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139473881|NCT02373943|Carotenoids|carotenoids|mesh-list
139473882|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
139473883|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473884|NCT02373943|Protective Agents|protective agents|mesh-ancestor
139473885|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473886|NCT04632433|Cemiplimab|cemiplimab|mesh-list
139473887|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139473888|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139473889|NCT02368249|Terlipressin|terlipressin|mesh-list
139473890|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139473891|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139473892|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
139473893|NCT02367937|Midazolam|midazolam|mesh-list
139473894|NCT02367937|Omeprazole|omeprazole|mesh-list
139473895|NCT02367937|Simvastatin|simvastatin|mesh-list
139473896|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139473897|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139473898|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139473899|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473900|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139473901|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139473902|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139473903|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139473904|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
139473905|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
139473906|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
139473907|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
139473908|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473909|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473910|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139473911|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139473912|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
139473913|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139473914|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139473915|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473916|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139473917|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139473918|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139473919|NCT02367937|Analgesics|analgesics|mesh-ancestor
139473920|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
139473921|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473922|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139473923|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139473924|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139473925|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139473926|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139473927|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139473928|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139473929|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139473930|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
139473931|NCT05061641|Progesterone|progesterone|mesh-list
139473932|NCT05061641|Progestins|progestins|mesh-ancestor
139473933|NCT05061641|Hormones|hormones|mesh-ancestor
139473934|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139473935|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473936|NCT03100019|Resveratrol|resveratrol|mesh-list
139473937|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
139473938|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473939|NCT03100019|Protective Agents|protective agents|mesh-ancestor
139473940|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473941|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473942|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139473943|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139473944|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473945|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473946|NCT05046041|Misoprostol|misoprostol|mesh-list
139473947|NCT05046041|Mifepristone|mifepristone|mesh-list
139473948|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139473949|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
139473950|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139473951|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473952|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138961729|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
139473953|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139473954|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
139473955|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139473956|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139473957|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139473958|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139473959|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
139473960|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139473961|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139473962|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
139473963|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139473964|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
139473965|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139473966|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139473967|NCT01970878|Bromides|bromides|mesh-list
139473968|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
139473969|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139473970|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
139473971|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139473972|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473973|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139473974|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
139473975|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
139473976|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139473977|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
139473978|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139473979|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473980|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
139473981|NCT05045651|Cimetidine|cimetidine|mesh-list
139473982|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139473983|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139473984|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139473985|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
139473986|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
139473987|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961846|NCT00784940|Tamoxifen|tamoxifen|mesh-list
139473988|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139473989|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139473990|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139473992|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139473993|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
139473994|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139473995|NCT05059145|Fluconazole|fluconazole|mesh-list
139473996|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139473997|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139473998|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
139473999|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
139474000|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
139474001|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138961902|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
139474002|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139474003|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474004|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474005|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139474006|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
139474007|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474008|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474009|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139474010|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139474011|NCT01970488|Adalimumab|adalimumab|mesh-list
139474012|NCT01970488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139474013|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139474014|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139474015|NCT03097835|Anesthetics|anesthetics|mesh-list
139474016|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139474017|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474018|NCT03097601|Sunitinib|sunitinib|mesh-list
139474019|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474020|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139474021|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139474022|NCT03097601|Growth Substances|growth substances|mesh-ancestor
139474023|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474024|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
139474025|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139474026|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474027|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474028|NCT05058755|Etoposide|etoposide|mesh-list
139474029|NCT05058755|Lenalidomide|lenalidomide|mesh-list
139474030|NCT05058755|Azacitidine|azacitidine|mesh-list
139474031|NCT05058755|Tislelizumab|tislelizumab|mesh-list
139474032|NCT05058755|Pegaspargase|pegaspargase|mesh-list
139474033|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139474034|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474035|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139474036|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139474037|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474038|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474039|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
139474040|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474041|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139474042|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139474043|NCT05058755|Growth Substances|growth substances|mesh-ancestor
139474044|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
139474045|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139474046|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
139474047|NCT05058755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139474048|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
139474049|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139474050|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
139474051|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474052|NCT05058209|Triamcinolone|triamcinolone|mesh-list
139474053|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139474054|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139474055|NCT05058209|Betamethasone|betamethasone|mesh-list
139474056|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
139474057|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139474058|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
139474059|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
139474060|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139474061|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139474062|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139474063|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
139474064|NCT05058209|Hormones|hormones|mesh-ancestor
139474065|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474066|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474067|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139474068|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
139474069|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474070|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474071|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139474072|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
139474074|NCT05057663|Bleomycin|bleomycin|mesh-list
139474075|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
139474076|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474077|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139474078|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474079|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139474080|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
139474081|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474082|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139474083|NCT03097445|Nicotine|nicotine|mesh-list
139474084|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139474085|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
139474086|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474087|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474088|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139474089|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139474090|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
139474091|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474092|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474093|NCT05057351|Glycerol|glycerol|mesh-list
139474094|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139474095|NCT05057351|Protective Agents|protective agents|mesh-ancestor
139474096|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474097|NCT03097211|Levodopa|levodopa|mesh-list
139474098|NCT03097211|Benserazide|benserazide|mesh-list
139474099|NCT03097211|Resveratrol|resveratrol|mesh-list
139474100|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
139474101|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139474102|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139474103|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
139474104|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474105|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474106|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474107|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
139474108|NCT03097211|Protective Agents|protective agents|mesh-ancestor
139474109|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474110|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139474111|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
139474112|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139474113|NCT05056337|Lenvatinib|lenvatinib|mesh-list
139474114|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474115|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139474116|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962112|NCT02550912|Vitamin D|vitamin d|mesh-list
139474117|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474118|NCT05056025|Vitamins|vitamins|mesh-list
139474119|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
139474120|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474121|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139474122|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139474123|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474124|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139474125|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474126|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474127|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474128|NCT01952080|Teduglutide|teduglutide|mesh-list
139474129|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139474130|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139474131|NCT01952080|Protective Agents|protective agents|mesh-ancestor
139474132|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474133|NCT01951378|Albuterol|albuterol|mesh-list
139474134|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139474135|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
139260881|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
139474136|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474137|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474138|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139474139|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
139474140|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
139474141|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139474142|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139474143|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139474144|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139474145|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
139474146|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474147|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474148|NCT05043233|Methimazole|methimazole|mesh-list
139474149|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
139474150|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
139474151|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474152|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474153|NCT05054465|Venetoclax|venetoclax|mesh-list
139474154|NCT05054465|Navitoclax|navitoclax|mesh-list
139474155|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474156|NCT03860233|Oxytocin|oxytocin|mesh-list
139474157|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
139474158|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139474159|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962209|NCT00994006|Antacids|antacids|mesh-ancestor
139474160|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139474161|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
139474162|NCT01361009|Pramipexole|pramipexole|mesh-list
139474163|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
139474164|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474165|NCT01361009|Protective Agents|protective agents|mesh-ancestor
139474166|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474167|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139474168|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139474169|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
139474170|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
139474171|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474172|NCT02373163|Amlodipine|amlodipine|mesh-list
139474173|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139474174|NCT02373163|Telmisartan|telmisartan|mesh-list
139474175|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139474176|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139474177|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139474178|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474179|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139474180|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474181|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
139474182|NCT02373163|Diuretics|diuretics|mesh-ancestor
139474183|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
139474184|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139474185|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139474186|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139474187|NCT02366377|Metformin|metformin|mesh-list
139474188|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139474189|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474190|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
139474191|NCT02366299|Propofol|propofol|mesh-list
139474192|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139474193|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139474194|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474195|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139474196|NCT02366299|Analgesics|analgesics|mesh-ancestor
139474197|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
139474198|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474199|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139474200|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139474201|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139474202|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
139474203|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474204|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474205|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139474206|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
139474207|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
139474208|NCT05041985|Diazepam|diazepam|mesh-list
139474209|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139474210|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
139474211|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
139474212|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
139474213|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474214|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474215|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139474216|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139474217|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139474218|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139474219|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139474220|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139474221|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139474222|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139474223|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139474224|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
139474225|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
139474226|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
139474227|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
139474228|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474229|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474230|NCT05053841|Metformin|metformin|mesh-list
139474231|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139474232|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474233|NCT02372461|Amoxicillin|amoxicillin|mesh-list
139474234|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139474235|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139474236|NCT04499131|Progesterone|progesterone|mesh-list
139474237|NCT04499131|Progestins|progestins|mesh-ancestor
139474238|NCT04499131|Hormones|hormones|mesh-ancestor
139474239|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474240|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474241|NCT02366065|Acetaminophen|acetaminophen|mesh-list
139474242|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139474243|NCT02366065|Analgesics|analgesics|mesh-ancestor
139474244|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
139474245|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474246|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474247|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
139474248|NCT02362945|Oxytocin|oxytocin|mesh-list
139474249|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
139474250|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139474251|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474252|NCT02365909|Bupivacaine|bupivacaine|mesh-list
139474253|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
139474254|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
139474255|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139474256|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474257|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
139474258|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474259|NCT05052515|Choline|choline|mesh-list
139474260|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474261|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
139474262|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139474263|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
139474264|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139474265|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139474266|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
139474267|NCT02365675|Petrolatum|petrolatum|mesh-list
139474268|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139474269|NCT02365675|Laxatives|laxatives|mesh-ancestor
139474270|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139474271|NCT02365675|Emollients|emollients|mesh-ancestor
139474272|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
139474273|NCT05052437|Capecitabine|capecitabine|mesh-list
139474274|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139474275|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
139474276|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474277|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474278|NCT05052359|Lectins|lectins|mesh-list
139474279|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
139474280|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
139474281|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474282|NCT05052359|Coagulants|coagulants|mesh-ancestor
139474283|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
139474284|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139474285|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139474286|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
139474287|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139474288|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474289|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139474290|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139474291|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139474292|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139474293|NCT02362711|Estrogens|estrogens|mesh-ancestor
139474294|NCT02362711|Hormones|hormones|mesh-ancestor
139474295|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474296|NCT01944046|Oxytocin|oxytocin|mesh-list
139474297|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
139474298|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139474299|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474300|NCT00773695|Paclitaxel|paclitaxel|mesh-list
139474301|NCT00773695|Docetaxel|docetaxel|mesh-list
139474302|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
139474303|NCT00773695|Bevacizumab|bevacizumab|mesh-list
139474304|NCT00773695|Fluorouracil|fluorouracil|mesh-list
139474305|NCT00773695|Epirubicin|epirubicin|mesh-list
139474306|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139474307|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139474308|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474309|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
139474310|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
139474311|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
139474312|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474313|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139474314|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
139474315|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474316|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139474317|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139474318|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
139474319|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139474320|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139474321|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139474322|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139474323|NCT00773695|Growth Substances|growth substances|mesh-ancestor
139474324|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
139474325|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
139474326|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139474327|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139474328|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474329|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139474330|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
139474331|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474332|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139474333|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139474334|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139474335|NCT01969084|Linagliptin|linagliptin|mesh-list
139474336|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139474337|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474338|NCT01969084|Incretins|incretins|mesh-ancestor
139474339|NCT01969084|Hormones|hormones|mesh-ancestor
139474340|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474341|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139474342|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
139474343|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474344|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474345|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
139474346|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474347|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
139474348|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139474349|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139474350|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474351|NCT02362399|Urological Agents|urological agents|mesh-ancestor
139474352|NCT04410887|Olaparib|olaparib|mesh-list
139474353|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139474354|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474355|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474356|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474357|NCT02358499|Posaconazole|posaconazole|mesh-list
139474358|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
139474359|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139474360|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139474361|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139474362|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139474363|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139474364|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139474365|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474366|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474367|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139474368|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
138962662|NCT01007500|Hormones|hormones|mesh-ancestor
139474369|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474370|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474371|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
139474372|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
139474373|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
139474374|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139474375|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139474376|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
139474377|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
139474378|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474379|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474380|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474381|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139474382|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
139474383|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139474384|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
139474385|NCT01968694|Promethazine|promethazine|mesh-list
139474386|NCT01968694|Lidocaine|lidocaine|mesh-list
139474387|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
139474388|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
139474389|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139474390|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474391|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
139474392|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474393|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139474394|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139474395|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139474396|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139474397|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474398|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139474399|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139474400|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
139474401|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
139474402|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139474403|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139474404|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
139474405|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
139474406|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474407|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139474408|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
139474409|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
139474410|NCT05038007|Bupivacaine|bupivacaine|mesh-list
139474411|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
139474412|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
139474413|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139474414|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474415|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
139474416|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474417|NCT02362165|Dexamethasone|dexamethasone|mesh-list
139474418|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
139474419|NCT02362165|Doxorubicin|doxorubicin|mesh-list
139474420|NCT02362165|Bortezomib|bortezomib|mesh-list
139474421|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139474422|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
138962768|NCT00303667|Vidarabine|vidarabine|mesh-list
139474423|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474424|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139474425|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139474426|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
139474427|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474428|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474429|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139474430|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139474431|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
139474432|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
139474433|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474434|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139474435|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
139474436|NCT02362165|Hormones|hormones|mesh-ancestor
139474437|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474438|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139474439|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139474440|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139474441|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139474442|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474443|NCT05049473|Cytarabine|cytarabine|mesh-list
139474444|NCT05049473|Dexamethasone|dexamethasone|mesh-list
139474445|NCT05049473|Prednisone|prednisone|mesh-list
139474446|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
139474447|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
139474448|NCT05049473|Rituximab|rituximab|mesh-list
139474449|NCT05049473|Doxorubicin|doxorubicin|mesh-list
139474450|NCT05049473|Methotrexate|methotrexate|mesh-list
139474451|NCT05049473|Etoposide|etoposide|mesh-list
139474452|NCT05049473|Vincristine|vincristine|mesh-list
139474453|NCT05049473|Vindesine|vindesine|mesh-list
139474454|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139474455|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
139474456|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474457|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139474458|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139474459|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
139474460|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474461|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474462|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139474463|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139474464|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
139474465|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
139474466|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474467|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139474468|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
139474469|NCT05049473|Hormones|hormones|mesh-ancestor
139474470|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474471|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139474472|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139474473|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139474474|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139474475|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139474476|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963003|NCT05774028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474477|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139474478|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
139474479|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139474480|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139474481|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
139474482|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
139474483|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139474484|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139474485|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139474486|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
139474487|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139474488|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
138713927|NCT04590183|Tacrolimus|tacrolimus|mesh-list
139474489|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
139474490|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
139474491|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
139474492|NCT02361931|Hematinics|hematinics|mesh-ancestor
139474493|NCT05037695|Empagliflozin|empagliflozin|mesh-list
139474494|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139474495|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474496|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139474497|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474498|NCT02357563|Leuprolide|leuprolide|mesh-list
139474499|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
139474500|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139474501|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
139474502|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139474503|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474504|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139474505|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474506|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139474507|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
139474508|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139474509|NCT02640053|Paclitaxel|paclitaxel|mesh-list
139474510|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139474511|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139474512|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474513|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
139474514|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
139474515|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
139474516|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474517|NCT03160261|Exenatide|exenatide|mesh-list
139474518|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139474519|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474520|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139474521|NCT03160261|Incretins|incretins|mesh-ancestor
139474522|NCT03160261|Hormones|hormones|mesh-ancestor
139474523|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474524|NCT02361775|Ropivacaine|ropivacaine|mesh-list
139474525|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
139474526|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
139474527|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139474528|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474529|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
139474530|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474531|NCT02361619|Clarithromycin|clarithromycin|mesh-list
139474532|NCT02361619|Diclofenac|diclofenac|mesh-list
139474533|NCT02361619|Metoprolol|metoprolol|mesh-list
139474534|NCT02361619|Midazolam|midazolam|mesh-list
139474535|NCT02361619|Caffeine|caffeine|mesh-list
139474536|NCT02361619|Esomeprazole|esomeprazole|mesh-list
139474537|NCT02361619|Dabigatran|dabigatran|mesh-list
139474538|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139474539|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139474540|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139474541|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474542|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139474543|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139474544|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139474545|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139474546|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
139474547|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
139474548|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
139474549|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
139474550|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474551|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474552|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139474553|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139474554|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474555|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139474556|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139474557|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
139474558|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139474559|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139474560|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138963365|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139474561|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139474562|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139474563|NCT02361619|Analgesics|analgesics|mesh-ancestor
139474564|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
139474565|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474566|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139474567|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139474568|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139474569|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139474570|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139474571|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139474572|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139474573|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139474574|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
139474575|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139474576|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
139474577|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
139474578|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139474579|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139474580|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
139474581|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
139474582|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139474583|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139474584|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139474585|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
139474586|NCT02352025|Equol|equol|mesh-list
139474587|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
139474588|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139474589|NCT02352025|Estrogens|estrogens|mesh-ancestor
139474590|NCT02352025|Hormones|hormones|mesh-ancestor
139474591|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474592|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474593|NCT01950364|Rifampin|rifampin|mesh-list
139474594|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139474595|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139474596|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139474597|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
139474598|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139474599|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139474600|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
139474601|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139474602|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474603|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474604|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139474605|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139474606|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139474607|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139474608|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139474609|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139474610|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139474611|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474612|NCT01950364|Immunotoxins|immunotoxins|mesh-ancestor
139474613|NCT01950364|Immunoconjugates|immunoconjugates|mesh-ancestor
139474614|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
139474615|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474616|NCT05047991|Leucovorin|leucovorin|mesh-list
139474617|NCT05047991|Paclitaxel|paclitaxel|mesh-list
139474618|NCT05047991|Gemcitabine|gemcitabine|mesh-list
139474619|NCT05047991|Fluorouracil|fluorouracil|mesh-list
139474620|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
139474621|NCT05047991|Irinotecan|irinotecan|mesh-list
138963470|NCT03530371|Analgesics|analgesics|mesh-ancestor
139474622|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139474623|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474624|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
139474625|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
139474626|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
139474627|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474628|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139474629|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
139474630|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139474631|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
139474632|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474633|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139474634|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139474635|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474636|NCT05047991|Antidotes|antidotes|mesh-ancestor
139474637|NCT05047991|Protective Agents|protective agents|mesh-ancestor
139474638|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
139474639|NCT05047991|Vitamins|vitamins|mesh-ancestor
139474640|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
139474641|NCT00014443|Thalidomide|thalidomide|mesh-list
139474642|NCT00014443|Topotecan|topotecan|mesh-list
139474643|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139474644|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139474645|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474646|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474647|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474648|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139474649|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
139474650|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474651|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
139474652|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139474653|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139474654|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139474655|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139474656|NCT00014443|Growth Substances|growth substances|mesh-ancestor
139474657|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
139474658|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
139474659|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139474660|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139474661|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474662|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
139474663|NCT05047133|Coagulants|coagulants|mesh-ancestor
139474664|NCT04334863|Tyrphostins|tyrphostins|mesh-list
139474665|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474666|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474667|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474668|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
139474669|NCT02357407|Ofloxacin|ofloxacin|mesh-list
139474670|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139474671|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139474672|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139474673|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138963637|NCT01850355|Buspirone|buspirone|mesh-list
139474674|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474675|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474676|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474677|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139474678|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139474679|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139474680|NCT02038699|TIC10 compound|tic10 compound|mesh-list
139474681|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474682|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
139474683|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139474684|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139474685|NCT03160651|Prednisolone|prednisolone|mesh-list
139474686|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
139474687|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139474688|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
139474689|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139474690|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
139474691|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
139474692|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474693|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474694|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139474695|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
139474696|NCT03160651|Hormones|hormones|mesh-ancestor
139474697|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474698|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139474699|NCT03160651|Protective Agents|protective agents|mesh-ancestor
139474700|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139474701|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474702|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
139474703|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139474704|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
139474705|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474706|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
139474707|NCT05034965|Protective Agents|protective agents|mesh-ancestor
139474708|NCT03160339|Vaccines|vaccines|mesh-list
139474709|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
139474710|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474711|NCT05034887|Trastuzumab|trastuzumab|mesh-list
139474712|NCT05034887|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139474713|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139474714|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474715|NCT05034887|Immunoconjugates|immunoconjugates|mesh-ancestor
139474716|NCT05034887|Immunologic Factors|immunologic factors|mesh-ancestor
139474717|NCT05034887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474718|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
139474719|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139474720|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
139474721|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474722|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474723|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139474724|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
139474725|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
139474726|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139474727|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
139474728|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474729|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474730|NCT05024825|Acetaminophen|acetaminophen|mesh-list
139474731|NCT05024825|Ibuprofen|ibuprofen|mesh-list
139474732|NCT05024825|Gabapentin|gabapentin|mesh-list
139474733|NCT05024825|Hydrocodone|hydrocodone|mesh-list
139474734|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139474735|NCT05024825|Analgesics|analgesics|mesh-ancestor
139474736|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
139474737|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474738|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474739|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
139474740|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139474741|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139474742|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139474743|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139261478|NCT02191748|Hormones|hormones|mesh-ancestor
139474744|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474745|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474746|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
139474747|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139474748|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139474749|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139474750|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139474751|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139474752|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139474753|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474754|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
139474755|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139474756|NCT05024825|Narcotics|narcotics|mesh-ancestor
139474757|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
139474758|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
139474759|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139474760|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
139474761|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
139474762|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
139474763|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
139474764|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139474765|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139474766|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138963988|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
139474767|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474768|NCT03149653|SMOFlipid|smoflipid|mesh-list
139474769|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139474770|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139474771|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139474772|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
139474773|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139474774|NCT03093545|Antibodies|antibodies|mesh-list
139474775|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
139474776|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474777|NCT05024357|Dasatinib|dasatinib|mesh-list
139474778|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474779|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139474780|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474781|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474782|NCT03095105|Resveratrol|resveratrol|mesh-list
139474783|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
139474784|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474785|NCT03095105|Protective Agents|protective agents|mesh-ancestor
139474786|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474787|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474788|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139474789|NCT01968070|Celecoxib|celecoxib|mesh-list
139474790|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139474791|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139474792|NCT01968070|Analgesics|analgesics|mesh-ancestor
139474793|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
139474794|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474795|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474796|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139474797|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139474798|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139474799|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139474800|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474801|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474802|NCT03093389|Resveratrol|resveratrol|mesh-list
139474803|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
138964170|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139474804|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474805|NCT03093389|Protective Agents|protective agents|mesh-ancestor
139474806|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474807|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474808|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139474809|NCT01949116|Folic Acid|folic acid|mesh-list
139474810|NCT01949116|Methotrexate|methotrexate|mesh-list
139474811|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139474812|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
139474813|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139474814|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474815|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139474816|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
139474817|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139261544|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
139474818|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474819|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
139474820|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474821|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139474822|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139474823|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
139474824|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139474825|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139474826|NCT01949116|Hematinics|hematinics|mesh-ancestor
139474827|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
139474829|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
139474830|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
139474831|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474832|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139474833|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474834|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474835|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
139474836|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139474837|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139474838|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
139474839|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474840|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474841|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474842|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
139474843|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
139474844|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474845|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
139474846|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139474847|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
139474848|NCT02350543|Aspirin|aspirin|mesh-list
139474849|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139474850|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139474851|NCT02350543|Analgesics|analgesics|mesh-ancestor
139474852|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
139474853|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474854|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474855|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139474856|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139474857|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139474858|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139474859|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474860|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139474861|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139474862|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474863|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
139474864|NCT05023577|Metronidazole|metronidazole|mesh-list
139474865|NCT05023577|Clarithromycin|clarithromycin|mesh-list
139474866|NCT05023577|Levofloxacin|levofloxacin|mesh-list
139474867|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
139474868|NCT05023577|Rabeprazole|rabeprazole|mesh-list
139474869|NCT05023577|Bismuth|bismuth|mesh-list
138964344|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
139474870|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474871|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139474872|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139474873|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139474874|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139474875|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139474876|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474877|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139474878|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139474879|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139474880|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139474881|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139474882|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474883|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139474884|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139474885|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139474886|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139474887|NCT05023577|Antacids|antacids|mesh-ancestor
139474888|NCT05023577|Diuretics|diuretics|mesh-ancestor
139474889|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
139474890|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474891|NCT05023577|Expectorants|expectorants|mesh-ancestor
139474892|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
139474893|NCT03149419|Paroxetine|paroxetine|mesh-list
139474894|NCT03149419|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139261619|NCT02192450|Insulin|insulin|mesh-list
139474895|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139474896|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139474897|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474898|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474899|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
139474900|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474901|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139474902|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
139474903|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139474904|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139474905|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139474906|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474907|NCT03092765|Quetmolimab|quetmolimab|mesh-list
139474908|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139474909|NCT01939366|Pregabalin|pregabalin|mesh-list
139474910|NCT01939366|Analgesics|analgesics|mesh-ancestor
139474911|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
139474912|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474913|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474914|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
139474915|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139474916|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139474917|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474918|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138964505|NCT00525148|Afatinib|afatinib|mesh-list
139474919|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139474920|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139474921|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139474922|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139474923|NCT04434365|Aspirin|aspirin|mesh-list
139474924|NCT04434365|Clopidogrel|clopidogrel|mesh-list
139474925|NCT04434365|Atorvastatin|atorvastatin|mesh-list
139474926|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139474927|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139474928|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139474929|NCT04434365|Analgesics|analgesics|mesh-ancestor
139474930|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
139474931|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139474932|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474933|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139474934|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139474935|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139474936|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139474937|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474938|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139474939|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139474940|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474941|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
139474942|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139474943|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139474944|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
139474945|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139474946|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139474947|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139474948|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139474949|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139474950|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
139474951|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474952|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
139474953|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139474954|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139474955|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139474956|NCT05032001|Biguanides|biguanides|mesh-list
139474957|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474958|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139474959|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474960|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
139474961|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474962|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
139474963|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139474964|NCT05031689|Protective Agents|protective agents|mesh-ancestor
138964680|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
139474965|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474966|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
139474967|NCT02350231|Progesterone|progesterone|mesh-list
139474968|NCT02350231|Progestins|progestins|mesh-ancestor
139474970|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474971|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474972|NCT01918306|Cisplatin|cisplatin|mesh-list
139474973|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139474974|NCT05031143|Triamcinolone|triamcinolone|mesh-list
139474975|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139474976|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139474977|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139474978|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139474979|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
139474980|NCT05031143|Hormones|hormones|mesh-ancestor
139474981|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139474982|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474983|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139474984|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
139474985|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139474986|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474987|NCT01916980|Desloratadine|desloratadine|mesh-list
139474988|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139474989|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
139474990|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139474991|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139474992|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139474993|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139474994|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139474995|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
139474996|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
139474997|NCT02348281|Bicalutamide|bicalutamide|mesh-list
139474998|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
139474999|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
139475000|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139475001|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475002|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475003|NCT02349919|Procaterol|procaterol|mesh-list
139475004|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139475005|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
139475006|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475007|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475008|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138964779|NCT02548494|Insulin|insulin|mesh-list
139475009|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
139475010|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
139475011|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139475012|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139475013|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139475014|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
139475015|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475016|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475017|NCT02349763|Dexamethasone|dexamethasone|mesh-list
139475018|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
139475019|NCT02349763|BB 1101|bb 1101|mesh-list
139475020|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139475021|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
139475022|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
139475023|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475024|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475025|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139475026|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
139475027|NCT02349763|Hormones|hormones|mesh-ancestor
139475028|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139475029|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139475030|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964900|NCT00296491|Xhance|xhance|mesh-list
139475031|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
139475032|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475033|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475034|NCT02349841|Amoxicillin|amoxicillin|mesh-list
139475035|NCT02349841|Meropenem|meropenem|mesh-list
139475036|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
139475037|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
139475038|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139475039|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475040|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475041|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475042|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139475043|NCT02354053|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
139475044|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139475045|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139475046|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
139475047|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475048|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139475049|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475050|NCT03094481|Epinephrine|epinephrine|mesh-list
139475051|NCT03094481|Bupivacaine|bupivacaine|mesh-list
139475052|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
139475053|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
139475054|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139475055|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475056|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
139475057|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475058|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139475059|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139475060|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
139475061|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475062|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475063|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139475064|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139475065|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
139475066|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139475067|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
139475068|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
139475069|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
139475070|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139475071|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
139475072|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
139475073|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139475074|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139475075|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475076|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965075|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139475077|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475078|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139475079|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
139475080|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
139475081|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475082|NCT02348125|Protective Agents|protective agents|mesh-ancestor
139475083|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475084|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
139475085|NCT02348125|Vitamins|vitamins|mesh-ancestor
139475086|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
139475087|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
139475088|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139475089|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475090|NCT03094403|Azelaic acid|azelaic acid|mesh-list
139475091|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475092|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
139475093|NCT02347891|Belimumab|belimumab|mesh-list
139475094|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139475095|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
139475096|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475097|NCT03147157|Tacrolimus|tacrolimus|mesh-list
139475098|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139475099|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
139475100|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475101|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139475102|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475103|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475104|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139475105|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139475106|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475107|NCT02347501|Incretins|incretins|mesh-ancestor
139475108|NCT02347501|Hormones|hormones|mesh-ancestor
139475109|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139475110|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139475111|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
139475112|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475113|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475114|NCT03148717|Misoprostol|misoprostol|mesh-list
138965283|NCT02549742|Bleomycin|bleomycin|mesh-list
139475115|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139475116|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
139475117|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139475118|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475119|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139475120|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139475121|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
139475122|NCT02349607|Ibuprofen|ibuprofen|mesh-list
139475123|NCT02349607|Pregabalin|pregabalin|mesh-list
139475124|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139475125|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139475126|NCT02349607|Analgesics|analgesics|mesh-ancestor
139475127|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
139475128|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475129|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475130|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139475131|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139475132|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139475133|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475134|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475135|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
139475136|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139475137|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139475138|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139475139|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139475140|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139475141|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139475142|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139475143|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
139475144|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
139475145|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475146|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475147|NCT04478461|Antibodies|antibodies|mesh-list
139475148|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138965392|NCT00952575|Antibodies|antibodies|mesh-list
139475149|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
139475150|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475151|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139475152|NCT02353507|Laxatives|laxatives|mesh-ancestor
139475153|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139475154|NCT03148561|Misoprostol|misoprostol|mesh-list
139475155|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139475156|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
139475157|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139475158|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475159|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139475160|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139475161|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
139475162|NCT02353429|Toremifene|toremifene|mesh-list
139475163|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139475164|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475165|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139475166|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139475167|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
139475168|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139475169|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475170|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139475171|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139475172|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139475173|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475174|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475175|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139475176|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139475177|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475178|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
139475179|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475180|NCT03112135|Epinephrine|epinephrine|mesh-list
139475181|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
139475182|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139475183|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139475184|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475185|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
139475186|NCT03112135|Coagulants|coagulants|mesh-ancestor
139475187|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139475188|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139475189|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
139475190|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139261908|NCT02916927|Ketamine|ketamine|mesh-list
139475191|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475192|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139475193|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139475194|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
139475195|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475196|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139475197|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
139475198|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
139475199|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
139475200|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139475201|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139475202|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139475203|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475204|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475205|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
139475206|NCT03146533|Fludarabine|fludarabine|mesh-list
139475207|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139475208|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
139475209|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475210|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139475211|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139475212|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
139475213|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475214|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475215|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139475216|NCT03090971|Diclofenac|diclofenac|mesh-list
139475217|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139475218|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139475219|NCT03090971|Analgesics|analgesics|mesh-ancestor
139475220|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
139475221|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475222|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475223|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139475224|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139475225|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139475226|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475227|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475228|NCT03146689|Ibuprofen|ibuprofen|mesh-list
139475229|NCT03146689|Capsaicin|capsaicin|mesh-list
139475230|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139475231|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139475232|NCT03146689|Analgesics|analgesics|mesh-ancestor
139475233|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
139475234|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475235|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965781|NCT02547402|CXA-10|cxa-10|mesh-list
139475236|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139475237|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139475238|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139475239|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475240|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475241|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
139475242|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
139475243|NCT05255575|Ertapenem|ertapenem|mesh-list
139475244|NCT05255575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139475245|NCT05255575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475246|NCT05026229|Cytarabine|cytarabine|mesh-list
139475247|NCT05026229|Prednisone|prednisone|mesh-list
139475248|NCT05026229|Methotrexate|methotrexate|mesh-list
139475249|NCT05026229|Vincristine|vincristine|mesh-list
139475250|NCT05026229|Dasatinib|dasatinib|mesh-list
139475251|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139475252|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
139475253|NCT05026229|Hormones|hormones|mesh-ancestor
139475254|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139475255|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475256|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139475257|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475258|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139475259|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
139475260|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139475261|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139475262|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
138965859|NCT00838968|Interferons|interferons|mesh-list
139475263|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475264|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
139475265|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475266|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139475267|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139475268|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
139475269|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139475270|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139475271|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
139475272|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475273|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139475274|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
139475275|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
139475276|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
139475277|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139475278|NCT02343679|Ceritinib|ceritinib|mesh-list
139475279|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475280|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139475281|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475282|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475283|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139475284|NCT02348905|Hormones|hormones|mesh-ancestor
139475285|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139475286|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475287|NCT02347033|Sertraline|sertraline|mesh-list
139475288|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
139475289|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139475290|NCT02347033|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139475291|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138965983|NCT01069081|Cisplatin|cisplatin|mesh-list
139475292|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139475293|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475294|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475295|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
139475296|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475297|NCT04949633|Oxytocin|oxytocin|mesh-list
139475298|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
139475299|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139475300|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475301|NCT03146377|Capecitabine|capecitabine|mesh-list
139475302|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
139475303|NCT03146377|Irinotecan|irinotecan|mesh-list
139475304|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139475305|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
139475306|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475307|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475308|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139475309|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139475310|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475311|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
139475312|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139475313|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475314|NCT02346955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139475315|NCT02346955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475316|NCT03079505|Dasatinib|dasatinib|mesh-list
139475317|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475318|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139475319|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475320|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475321|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
139475322|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139475323|NCT02343211|Antibodies|antibodies|mesh-list
139475324|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
139475325|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475326|NCT03090503|Risperidone|risperidone|mesh-list
139475327|NCT03090503|Aripiprazole|aripiprazole|mesh-list
139475328|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139475329|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
139475330|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475331|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475332|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475333|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139475334|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139475335|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139475336|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139475337|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139475338|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
139475339|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
139475340|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
139475341|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139475342|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139475343|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139475344|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139475345|NCT02343289|Clarithromycin|clarithromycin|mesh-list
139475347|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139475348|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475349|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139475350|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475351|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475352|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139475353|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139475354|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
139475355|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139475356|NCT03090269|Methylphenidate|methylphenidate|mesh-list
139475357|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139475358|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475359|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139475360|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139475361|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139475362|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475363|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
139475364|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475365|NCT05008679|Oseltamivir|oseltamivir|mesh-list
138966143|NCT02547792|Vaccines|vaccines|mesh-list
139475366|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
139475367|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475368|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475369|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475370|NCT03090035|Interferons|interferons|mesh-list
139475371|NCT03090035|Ribavirin|ribavirin|mesh-list
139475372|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475373|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
139475374|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475375|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
139475376|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475377|NCT05008367|Dexamethasone|dexamethasone|mesh-list
139475378|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139475379|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
139475380|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
139475381|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475382|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475383|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139475384|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
139475385|NCT05008367|Hormones|hormones|mesh-ancestor
139475386|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966198|NCT00548145|Ezetimibe|ezetimibe|mesh-list
139475387|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139475388|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475389|NCT02342587|Lapatinib|lapatinib|mesh-list
139475390|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475391|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139475392|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475393|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475394|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139475395|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475396|NCT02342509|Sevoflurane|sevoflurane|mesh-list
139475397|NCT02342509|Desflurane|desflurane|mesh-list
139475398|NCT02342509|Isoflurane|isoflurane|mesh-list
139475399|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139475400|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139475401|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
139475402|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
139475403|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139475404|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475405|NCT03079271|Benzocaine|benzocaine|mesh-list
139475406|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
139475407|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
139475408|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139475409|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475410|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
139475411|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475412|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139475413|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475414|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139475415|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475416|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475417|NCT02337127|Lamivudine|lamivudine|mesh-list
139475418|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139475419|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139475420|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475421|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475422|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
139475423|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475424|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139475425|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139475426|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
139475427|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966371|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139475428|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475429|NCT05007587|Leucovorin|leucovorin|mesh-list
139475430|NCT05007587|Fluorouracil|fluorouracil|mesh-list
139475431|NCT05007587|Raltitrexed|raltitrexed|mesh-list
139475432|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
139475433|NCT05007587|Lenvatinib|lenvatinib|mesh-list
139475434|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
139475435|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475436|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139475437|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475438|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139475439|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
139475440|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475441|NCT05007587|Antidotes|antidotes|mesh-ancestor
139475442|NCT05007587|Protective Agents|protective agents|mesh-ancestor
139475443|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
139475444|NCT05007587|Vitamins|vitamins|mesh-ancestor
139475445|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
139475446|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139475447|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475448|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139475449|NCT02039323|Tenofovir|tenofovir|mesh-list
139475450|NCT02039323|Maraviroc|maraviroc|mesh-list
139475451|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
139475452|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475453|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139475454|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139475455|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475456|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475457|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139475458|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139475459|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139475460|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139475461|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139475462|NCT03079115|Atorvastatin|atorvastatin|mesh-list
139475463|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139475464|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138966501|NCT00574080|Hormones|hormones|mesh-ancestor
139475465|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
139475466|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475467|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139475468|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139475469|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475470|NCT05917431|Tislelizumab|tislelizumab|mesh-list
139475471|NCT05917431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139475472|NCT05917431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475473|NCT05917405|Fludarabine|fludarabine|mesh-list
139475474|NCT05917405|Busulfan|busulfan|mesh-list
139475475|NCT05917405|Clofarabine|clofarabine|mesh-list
139475476|NCT05917405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475477|NCT05917405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139475478|NCT05917405|Antimetabolites|antimetabolites|mesh-ancestor
139475479|NCT05917405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475480|NCT05917405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139475481|NCT05917405|Immunologic Factors|immunologic factors|mesh-ancestor
139475482|NCT05917405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475483|NCT05917405|Alkylating Agents|alkylating agents|mesh-ancestor
139475484|NCT05917405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139475485|NCT05917405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139475486|NCT05917288|Belimumab|belimumab|mesh-list
139475487|NCT05917288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139475488|NCT05917288|Immunologic Factors|immunologic factors|mesh-ancestor
139475489|NCT05917288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475491|NCT05991622|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
139475492|NCT05991622|Buprenorphine|buprenorphine|mesh-list
139475493|NCT05991622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139475494|NCT05991622|Narcotics|narcotics|mesh-ancestor
139475495|NCT05991622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139475496|NCT05991622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475497|NCT05991622|Analgesics|analgesics|mesh-ancestor
139475498|NCT05991622|Sensory System Agents|sensory system agents|mesh-ancestor
139475499|NCT05991622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475500|NCT05991622|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139475501|NCT05991622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139475502|NCT05991622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139475503|NCT05991622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475504|NCT05991622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475505|NCT05991622|Antiviral Agents|antiviral agents|mesh-ancestor
139475506|NCT05991622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475507|NCT05991622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139475508|NCT05991622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139475509|NCT05991518|Cisplatin|cisplatin|mesh-list
139475510|NCT05991518|Gemcitabine|gemcitabine|mesh-list
139475511|NCT05991518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475512|NCT05991518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139475513|NCT05991518|Antimetabolites|antimetabolites|mesh-ancestor
139475514|NCT05991518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475515|NCT05991466|Dexmedetomidine|dexmedetomidine|mesh-list
139475516|NCT05991466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139475517|NCT05991466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139475518|NCT05991466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475519|NCT05991466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139475520|NCT05991466|Analgesics|analgesics|mesh-ancestor
139475521|NCT05991466|Sensory System Agents|sensory system agents|mesh-ancestor
139475522|NCT05991466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580605|NCT01245166|Metformin|metformin|mesh-list
139475523|NCT05991466|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139475524|NCT05991466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139475525|NCT05991466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139475526|NCT05991466|Adrenergic Agents|adrenergic agents|mesh-ancestor
139475527|NCT05991466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475528|NCT05991466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475529|NCT05991388|Dexamethasone|dexamethasone|mesh-list
139475530|NCT05991388|Rituximab|rituximab|mesh-list
139475531|NCT05991388|Carboplatin|carboplatin|mesh-list
139475532|NCT05991388|Etoposide|etoposide|mesh-list
139475533|NCT05991388|Etoposide phosphate|etoposide phosphate|mesh-list
139475534|NCT05991388|Ifosfamide|ifosfamide|mesh-list
139475535|NCT05991388|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139475536|NCT05991388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139475537|NCT05991388|Antiemetics|antiemetics|mesh-ancestor
139475538|NCT05991388|Autonomic Agents|autonomic agents|mesh-ancestor
139475539|NCT05991388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475540|NCT05991388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475541|NCT05991388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139475542|NCT05991388|Glucocorticoids|glucocorticoids|mesh-ancestor
139475543|NCT05991388|Hormones|hormones|mesh-ancestor
138966867|NCT00853008|Daunorubicin|daunorubicin|mesh-list
139475544|NCT05991388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139475545|NCT05991388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139475546|NCT05991388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475547|NCT05991388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139475548|NCT05991388|Immunologic Factors|immunologic factors|mesh-ancestor
139475549|NCT05991388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139475550|NCT05991388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139475551|NCT05991388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139475552|NCT05991388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139475553|NCT05991388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475554|NCT05991388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966921|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139475555|NCT05991388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139475556|NCT05991388|Alkylating Agents|alkylating agents|mesh-ancestor
139475557|NCT05991375|Dexmedetomidine|dexmedetomidine|mesh-list
139475558|NCT05991375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139475559|NCT05991375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139475560|NCT05991375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475561|NCT05991375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139475562|NCT05991375|Analgesics|analgesics|mesh-ancestor
139475563|NCT05991375|Sensory System Agents|sensory system agents|mesh-ancestor
139475564|NCT05991375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475565|NCT05991375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139475566|NCT05991375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139475567|NCT05991375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139475568|NCT05991375|Adrenergic Agents|adrenergic agents|mesh-ancestor
139475569|NCT05991375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475570|NCT05991375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475571|NCT05991037|Psychotropic Drugs|psychotropic drugs|mesh-list
139475572|NCT05990933|Epinephrine|epinephrine|mesh-list
139475573|NCT05990933|Racepinephrine|racepinephrine|mesh-list
139475574|NCT05990933|Epinephryl borate|epinephryl borate|mesh-list
139475575|NCT05990933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139475576|NCT05990933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139475577|NCT05990933|Adrenergic Agents|adrenergic agents|mesh-ancestor
139475578|NCT05990933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475579|NCT05990933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475580|NCT05990933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475581|NCT05990933|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139475582|NCT05990933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139475583|NCT05990933|Autonomic Agents|autonomic agents|mesh-ancestor
139475584|NCT05990933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475585|NCT05990933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139475586|NCT05990933|Respiratory System Agents|respiratory system agents|mesh-ancestor
139475587|NCT05990933|Mydriatics|mydriatics|mesh-ancestor
139475588|NCT05990933|Sympathomimetics|sympathomimetics|mesh-ancestor
139475589|NCT05990933|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139475590|NCT05990881|Botulinum Toxins|botulinum toxins|mesh-list
139475591|NCT05990881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139475592|NCT05990881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139475593|NCT05990881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475594|NCT05990881|Cholinergic Agents|cholinergic agents|mesh-ancestor
139475595|NCT05990881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475596|NCT05990881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475597|NCT05990868|Acetaminophen|acetaminophen|mesh-list
139475598|NCT05990868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139475599|NCT05990868|Analgesics|analgesics|mesh-ancestor
139475600|NCT05990868|Sensory System Agents|sensory system agents|mesh-ancestor
139475601|NCT05990868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475602|NCT05990868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475603|NCT05990868|Antipyretics|antipyretics|mesh-ancestor
139475604|NCT05990842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139475605|NCT05990842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475606|NCT05990829|Aflibercept|aflibercept|mesh-list
139475607|NCT05990829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139475608|NCT05990829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139475609|NCT05990829|Growth Substances|growth substances|mesh-ancestor
139475610|NCT05990829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475611|NCT05990829|Growth Inhibitors|growth inhibitors|mesh-ancestor
139475612|NCT05990829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475613|NCT05990686|Fentanyl|fentanyl|mesh-list
139475614|NCT05990686|Tramadol|tramadol|mesh-list
139475615|NCT05990686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139475616|NCT05990686|Narcotics|narcotics|mesh-ancestor
139475617|NCT05990686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139475618|NCT05990686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475619|NCT05990686|Analgesics|analgesics|mesh-ancestor
139475620|NCT05990686|Sensory System Agents|sensory system agents|mesh-ancestor
139475621|NCT05990686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475622|NCT05990686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139475623|NCT05990686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139475624|NCT05990686|Anesthetics, General|anesthetics, general|mesh-ancestor
139475625|NCT05990686|Anesthetics|anesthetics|mesh-ancestor
139475626|NCT05990543|Capecitabine|capecitabine|mesh-list
139475627|NCT05990543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139475628|NCT05990543|Antimetabolites|antimetabolites|mesh-ancestor
139475629|NCT05990543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475630|NCT05990543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475631|NCT05990374|Tirzepatide|tirzepatide|mesh-list
139475632|NCT05990374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139475633|NCT05990374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475634|NCT05990374|Incretins|incretins|mesh-ancestor
139475635|NCT05990374|Hormones|hormones|mesh-ancestor
139475636|NCT05990374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139475637|NCT05990205|Metformin|metformin|mesh-list
139475638|NCT05990205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139475639|NCT05990205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475640|NCT05990127|Paclitaxel|paclitaxel|mesh-list
139475641|NCT05990127|Carboplatin|carboplatin|mesh-list
139475642|NCT05990127|Pemetrexed|pemetrexed|mesh-list
139475643|NCT05990127|Tislelizumab|tislelizumab|mesh-list
139475644|NCT05990127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139475645|NCT05990127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475646|NCT05990127|Tubulin Modulators|tubulin modulators|mesh-ancestor
139475647|NCT05990127|Antimitotic Agents|antimitotic agents|mesh-ancestor
139475648|NCT05990127|Mitosis Modulators|mitosis modulators|mesh-ancestor
139475649|NCT05990127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475650|NCT05990127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475651|NCT05990127|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139475652|NCT05990127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139475653|NCT05990127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139475654|NCT05989984|Iron|iron|mesh-list
139475655|NCT05989984|Trace Elements|trace elements|mesh-ancestor
139475656|NCT05989984|Micronutrients|micronutrients|mesh-ancestor
139475657|NCT05989984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475658|NCT05989633|Selenium|selenium|mesh-list
139475659|NCT05989633|Antioxidants|antioxidants|mesh-ancestor
139475660|NCT05989633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475661|NCT05989633|Protective Agents|protective agents|mesh-ancestor
139475662|NCT05989633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475663|NCT05989633|Trace Elements|trace elements|mesh-ancestor
139475664|NCT05989633|Micronutrients|micronutrients|mesh-ancestor
138967124|NCT02544906|Propofol|propofol|mesh-list
139475665|NCT05988879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139475666|NCT05988879|Antiviral Agents|antiviral agents|mesh-ancestor
139475667|NCT05988879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475668|NCT05987826|Aflutinib|aflutinib|mesh-list
139475669|NCT05987826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139475670|NCT05987826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475671|NCT05987826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475672|NCT05964647|Ketanserin|ketanserin|mesh-list
139475673|NCT05964647|Lorazepam|lorazepam|mesh-list
139475674|NCT05964647|Olanzapine|olanzapine|mesh-list
139475675|NCT05964647|Antiemetics|antiemetics|mesh-ancestor
139475676|NCT05964647|Autonomic Agents|autonomic agents|mesh-ancestor
139475677|NCT05964647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475678|NCT05964647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475679|NCT05964647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139475680|NCT05964647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139475681|NCT05964647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139475682|NCT05964647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139475683|NCT05964647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139475684|NCT05964647|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139475685|NCT05964647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138967171|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
139475686|NCT05964647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139475687|NCT05964647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475688|NCT05964647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475689|NCT05964647|Serotonin Agents|serotonin agents|mesh-ancestor
139475690|NCT05964647|Anticonvulsants|anticonvulsants|mesh-ancestor
139475691|NCT05964647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139475692|NCT05964647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139475693|NCT05964647|GABA Modulators|gaba modulators|mesh-ancestor
139475694|NCT05964647|GABA Agents|gaba agents|mesh-ancestor
139475695|NCT05964647|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139475696|NCT05964647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139475697|NCT05964647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139475698|NCT05949190|Azithromycin|azithromycin|mesh-list
139475699|NCT05949190|Pyrimethamine|pyrimethamine|mesh-list
139475700|NCT05949190|Sulfadoxine|sulfadoxine|mesh-list
139475701|NCT05949190|Albendazole|albendazole|mesh-list
139475702|NCT05949190|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139475703|NCT05949190|Choline|choline|mesh-list
139475704|NCT05949190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139475705|NCT05949190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475706|NCT05949190|Lipotropic Agents|lipotropic agents|mesh-ancestor
139475707|NCT05949190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139475708|NCT05949190|Antimetabolites|antimetabolites|mesh-ancestor
139475709|NCT05949190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475710|NCT05949190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139475711|NCT05949190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139475712|NCT05949190|Nootropic Agents|nootropic agents|mesh-ancestor
139475713|NCT05949190|Antimalarials|antimalarials|mesh-ancestor
139475714|NCT05949190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139262446|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
139475715|NCT05949190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139475716|NCT05949190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139475717|NCT05949190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475718|NCT05949190|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139475719|NCT05949190|Anthelmintics|anthelmintics|mesh-ancestor
139475720|NCT05949190|Anticestodal Agents|anticestodal agents|mesh-ancestor
139475721|NCT05949190|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139475722|NCT05949190|Tubulin Modulators|tubulin modulators|mesh-ancestor
139475723|NCT05949190|Antimitotic Agents|antimitotic agents|mesh-ancestor
139475724|NCT05949190|Mitosis Modulators|mitosis modulators|mesh-ancestor
139475725|NCT05949190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475726|NCT05915949|Dapagliflozin|dapagliflozin|mesh-list
139475727|NCT05915949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139475728|NCT05915949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475729|NCT05915949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139475730|NCT05915949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475731|NCT05874037|Fluvoxamine|fluvoxamine|mesh-list
139475732|NCT05874037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139475733|NCT05874037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139475734|NCT05874037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139475735|NCT05874037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475736|NCT05874037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139475737|NCT05874037|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139475738|NCT05874037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139475739|NCT05874037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139475740|NCT05874037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475741|NCT05874037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475742|NCT05874037|Serotonin Agents|serotonin agents|mesh-ancestor
139475743|NCT05874037|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139475744|NCT05874037|Antidepressive Agents|antidepressive agents|mesh-ancestor
139475745|NCT05874037|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139475746|NCT05874037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138967347|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
139475747|NCT05874037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475748|NCT05874037|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139475749|NCT05814939|Tofacitinib|tofacitinib|mesh-list
139475750|NCT05814939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475751|NCT05814939|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139475752|NCT05814939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139475753|NCT05814939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475754|NCT05732389|Nivolumab|nivolumab|mesh-list
139475755|NCT05732389|Ipilimumab|ipilimumab|mesh-list
139475756|NCT05732389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139475757|NCT05732389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475758|NCT05732389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139475759|NCT05732389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475760|NCT05698511|Psilocybin|psilocybin|mesh-list
139475761|NCT05698511|Hallucinogens|hallucinogens|mesh-ancestor
139475762|NCT05698511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475763|NCT05698511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139475764|NCT05671029|Moxifloxacin|moxifloxacin|mesh-list
139475765|NCT05671029|Pritelivir|pritelivir|mesh-list
139475766|NCT05671029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139475767|NCT05671029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139475768|NCT05671029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475769|NCT05671029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139475770|NCT05671029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139475771|NCT05671029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475772|NCT05671029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475773|NCT05671029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475774|NCT05671029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139475775|NCT05671029|Contraceptive Agents|contraceptive agents|mesh-ancestor
139475776|NCT05671029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139475777|NCT05671029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475778|NCT05671029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139475779|NCT05671029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139475780|NCT05671029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139475781|NCT05671029|Antiviral Agents|antiviral agents|mesh-ancestor
139475782|NCT05633615|Cyclophosphamide|cyclophosphamide|mesh-list
139475783|NCT05633615|Fludarabine|fludarabine|mesh-list
139475784|NCT05633615|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139475785|NCT05633615|Tisagenlecleucel|tisagenlecleucel|mesh-list
139475786|NCT05633615|Antibodies|antibodies|mesh-list
139475787|NCT05633615|Immunoglobulins|immunoglobulins|mesh-list
139475788|NCT05633615|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139475789|NCT05633615|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139262517|NCT02207426|Tobramycin|tobramycin|mesh-list
139475790|NCT05633615|Immunoconjugates|immunoconjugates|mesh-list
139475791|NCT05633615|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139475792|NCT05633615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139475793|NCT05633615|Immunologic Factors|immunologic factors|mesh-ancestor
139475794|NCT05633615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475795|NCT05633615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139475796|NCT05633615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139475797|NCT05633615|Alkylating Agents|alkylating agents|mesh-ancestor
139475798|NCT05633615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475799|NCT05633615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475800|NCT05633615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139475801|NCT05633615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139475802|NCT05608070|Oxytocin|oxytocin|mesh-list
139475803|NCT05608070|Oxytocics|oxytocics|mesh-ancestor
139475804|NCT05608070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139475805|NCT05608070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475806|NCT05553691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
139475807|NCT05553691|Hallucinogens|hallucinogens|mesh-ancestor
139475808|NCT05553691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475809|NCT05553691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139475810|NCT05553691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139475811|NCT05553691|Serotonin Agents|serotonin agents|mesh-ancestor
139475812|NCT05553691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475813|NCT05553691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475814|NCT05553691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139475815|NCT05530655|Lisinopril|lisinopril|mesh-list
139475816|NCT05530655|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139475817|NCT05530655|Protease Inhibitors|protease inhibitors|mesh-ancestor
139475818|NCT05530655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475819|NCT05530655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475820|NCT05530655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139475821|NCT05530655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139475822|NCT05530655|Protective Agents|protective agents|mesh-ancestor
139475823|NCT05530655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475824|NCT05374564|Flutemetamol|flutemetamol|mesh-list
139475825|NCT05374564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139475826|NCT05374564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475827|NCT05370599|Losartan|losartan|mesh-list
139475828|NCT05370599|Amlodipine|amlodipine|mesh-list
139475829|NCT05370599|Chlorthalidone|chlorthalidone|mesh-list
139475830|NCT05370599|Antihypertensive Agents|antihypertensive agents|mesh-list
139475831|NCT05370599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139475832|NCT05370599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139475833|NCT05370599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475834|NCT05370599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139475835|NCT05370599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475836|NCT05370599|Vasodilator Agents|vasodilator agents|mesh-ancestor
139475837|NCT05370599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139475838|NCT05370599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138582427|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
139475839|NCT05370599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139475840|NCT05370599|Diuretics|diuretics|mesh-ancestor
139475841|NCT05370599|Natriuretic Agents|natriuretic agents|mesh-ancestor
139475842|NCT05370599|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139475843|NCT05301712|Naloxone|naloxone|mesh-list
139475844|NCT05301712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139475845|NCT05301712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475846|NCT05301712|Sensory System Agents|sensory system agents|mesh-ancestor
139475847|NCT05301712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475848|NCT05266612|Nivolumab|nivolumab|mesh-list
139475849|NCT05266612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139475850|NCT05266612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475851|NCT05266612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139475852|NCT05266612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475853|NCT05222191|Chlorthalidone|chlorthalidone|mesh-list
139475854|NCT05222191|Spironolactone|spironolactone|mesh-list
139475855|NCT05222191|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139475856|NCT05222191|Hormone Antagonists|hormone antagonists|mesh-ancestor
139475857|NCT05222191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139475858|NCT05222191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475859|NCT05222191|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139475860|NCT05222191|Diuretics|diuretics|mesh-ancestor
139262590|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139475861|NCT05222191|Natriuretic Agents|natriuretic agents|mesh-ancestor
139475863|NCT05222191|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139475864|NCT05222191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139475865|NCT05222191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475866|NCT05189015|Olmesartan|olmesartan|mesh-list
139475867|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139475868|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139475869|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139475870|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139475871|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475872|NCT05153070|Cyclosporine|cyclosporine|mesh-list
139475873|NCT05153070|Cyclosporins|cyclosporins|mesh-list
139475874|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475875|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475876|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139475877|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
139475878|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475879|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
139475880|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475881|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
139475882|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139475883|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139475884|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139475885|NCT05065671|Tolcapone|tolcapone|mesh-list
139475886|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139475887|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139475888|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139475889|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475890|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475891|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475892|NCT05065671|Analgesics|analgesics|mesh-ancestor
139475893|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
139475894|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475895|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
139475896|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139475897|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
139475898|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139475899|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139475900|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139475901|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475902|NCT05045638|Sotorasib|sotorasib|mesh-list
139475903|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139475904|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139475905|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139475906|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
139475907|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475908|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139475909|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139475910|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475911|NCT05045638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139475912|NCT05045638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139475913|NCT05045638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475914|NCT05040360|Capecitabine|capecitabine|mesh-list
139475915|NCT05040360|Temozolomide|temozolomide|mesh-list
139475916|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139475917|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
139475918|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475919|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475920|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139475921|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
139475922|NCT05011513|Ritonavir|ritonavir|mesh-list
139475923|NCT05011513|Nirmatrelvir|nirmatrelvir|mesh-list
139475924|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139475925|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139475926|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
139475927|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475928|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475929|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139475930|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139475931|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
139475932|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139475933|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139475934|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139475935|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
139475936|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139475937|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475938|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139475939|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475940|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
139475941|NCT04812028|Analgesics|analgesics|mesh-ancestor
139475942|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
139475943|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475944|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475945|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
139475946|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139475947|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139475948|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
139475949|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139475950|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139475951|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475952|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139475953|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
139475954|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139475955|NCT04807972|Folfirinox|folfirinox|mesh-list
139475956|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475957|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
139475958|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139475959|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475960|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139475961|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475962|NCT04770012|Aspirin|aspirin|mesh-list
139475963|NCT04770012|Clopidogrel|clopidogrel|mesh-list
139475964|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139475965|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139475966|NCT04770012|Analgesics|analgesics|mesh-ancestor
139475967|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
138968244|NCT00975897|Vitamins|vitamins|mesh-ancestor
139475968|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139475969|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139475970|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139475971|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139475972|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139475973|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139475974|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475975|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139475976|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139475977|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475978|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
139475979|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139475980|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139475981|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139475982|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
139475983|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139475984|NCT04755244|Azacitidine|azacitidine|mesh-list
139475985|NCT04755244|Venetoclax|venetoclax|mesh-list
139475986|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139475987|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
139475988|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139475989|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139475990|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139475991|NCT04718740|Vitamin K|vitamin k|mesh-list
139475992|NCT04718740|Repaglinide|repaglinide|mesh-list
139475993|NCT04718740|Fluzoparib|fluzoparib|mesh-list
139475994|NCT04718740|Midazolam|midazolam|mesh-list
139475995|NCT04718740|Caffeine|caffeine|mesh-list
139475996|NCT04718740|Bupropion|bupropion|mesh-list
139475997|NCT04718740|Omeprazole|omeprazole|mesh-list
139475998|NCT04718740|Warfarin|warfarin|mesh-list
139475999|NCT04718740|Vitamins|vitamins|mesh-ancestor
139476000|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
139476001|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139476002|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139476003|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139476004|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139476005|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139476006|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139476007|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139476008|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139476009|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
139476010|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
139476011|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
139476012|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
139476013|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139476014|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139476015|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
139476016|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139476017|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139476018|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139476019|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139476020|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139476021|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
139476022|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139476023|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139476024|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138968471|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583777|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583778|NCT04669145|Ropivacaine|ropivacaine|mesh-list
139583779|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
139583780|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
139583781|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583782|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583783|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
139583784|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583786|NCT04650074|Ketamine|ketamine|mesh-list
139583787|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
139583788|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
139583789|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583790|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583791|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
139583792|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583793|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139583794|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139583795|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139583796|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139583797|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583798|NCT04650074|Analgesics|analgesics|mesh-ancestor
139583799|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139583800|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139583801|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
139583802|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139583803|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139583804|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583805|NCT04620304|UB-421|ub-421|mesh-list
139583806|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139583807|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
139583808|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139583809|NCT04578886|Guanfacine|guanfacine|mesh-list
139583810|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139583811|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139583812|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139583813|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139583814|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
139583815|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583816|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583817|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583818|NCT04550585|Insulin|insulin|mesh-list
139583819|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139583820|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139583821|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583822|NCT04545515|Ivacaftor|ivacaftor|mesh-list
139583823|NCT04545515|Elexacaftor|elexacaftor|mesh-list
139583824|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139583825|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139583826|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583827|NCT04512066|Risperidone|risperidone|mesh-list
139583828|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139583829|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
139583830|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583831|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583832|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583833|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139583834|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139583835|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583836|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139583837|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139583838|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
139583839|NCT04421092|Lidocaine|lidocaine|mesh-list
139583840|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
139583841|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
139583842|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583843|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583844|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
139583845|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583846|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139583847|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139583848|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139583849|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139583850|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583851|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139583852|NCT04406727|UB-421|ub-421|mesh-list
139365616|NCT04275232|Plasminogen|plasminogen|mesh-list
139583854|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139583855|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
139583856|NCT04364945|Remifentanil|remifentanil|mesh-list
139583857|NCT04364945|Sevoflurane|sevoflurane|mesh-list
139583858|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139583859|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583860|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583861|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139583862|NCT04364945|Analgesics|analgesics|mesh-ancestor
139583863|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
139583864|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583865|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139583866|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139583867|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139583868|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
139583869|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583870|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583871|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139583872|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139583873|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
139583874|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
139583875|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139583876|NCT04364945|Narcotics|narcotics|mesh-ancestor
139583877|NCT04235608|Propofol|propofol|mesh-list
139583878|NCT04235608|Sevoflurane|sevoflurane|mesh-list
139583879|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139583880|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583881|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583882|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139583883|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
139583884|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
139583885|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139583886|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139583887|NCT04161027|Pregabalin|pregabalin|mesh-list
139583888|NCT04161027|Analgesics|analgesics|mesh-ancestor
139583889|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
139583890|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583891|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583892|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
139583893|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139583894|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139583895|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583896|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139583897|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139583898|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139583899|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583900|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139583901|NCT04019964|Nivolumab|nivolumab|mesh-list
139583902|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139583903|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583904|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139583905|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583906|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139583907|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139583908|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583909|NCT03889756|Midazolam|midazolam|mesh-list
139583910|NCT03889756|Ketamine|ketamine|mesh-list
139583911|NCT03889756|Analgesics|analgesics|mesh-ancestor
139583912|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
139583913|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583914|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583915|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139583916|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139583917|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
139583918|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
139583919|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583920|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139583921|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139583922|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583923|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583924|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139583925|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139583926|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139583927|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139583928|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139583929|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
139583930|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
139583931|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
139583932|NCT03845114|Insulin|insulin|mesh-list
139583933|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139583934|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139583935|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583936|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
139583937|NCT03778502|Apixaban|apixaban|mesh-list
139583938|NCT03778502|Edoxaban|edoxaban|mesh-list
139583939|NCT03778502|Dabigatran|dabigatran|mesh-list
139583940|NCT03778502|Anticoagulants|anticoagulants|mesh-list
139583941|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139583942|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
139583943|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139583944|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
139583945|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583946|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583947|NCT03775200|Psilocybin|psilocybin|mesh-list
139583948|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
139583949|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583950|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139583951|NCT03689855|Atezolizumab|atezolizumab|mesh-list
139583952|NCT03689855|Ramucirumab|ramucirumab|mesh-list
139583953|NCT03689855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139583954|NCT03689855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583955|NCT03689855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138711900|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
139583956|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583957|NCT03635996|Etripamil|etripamil|mesh-list
139583958|NCT03635996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139583959|NCT03635996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139583960|NCT03635996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583961|NCT03635996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139583962|NCT03635996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583963|NCT03613181|Paclitaxel|paclitaxel|mesh-list
139583964|NCT03613181|Capecitabine|capecitabine|mesh-list
139583965|NCT03613181|Methotrexate|methotrexate|mesh-list
139583966|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139583967|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583968|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
139583969|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
139583970|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
139583971|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583972|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139583973|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
139583974|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139583975|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
139583976|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139583977|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583978|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
139583979|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583980|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139583981|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139583982|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
139583983|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139583984|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139583985|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
139583986|NCT03468478|Sirolimus|sirolimus|mesh-list
139583987|NCT03468478|Everolimus|everolimus|mesh-list
139583988|NCT03468478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139583989|NCT03468478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139583990|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583991|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583992|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139583993|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
139583994|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583995|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583996|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139583997|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139583998|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
139583999|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139584000|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584001|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
139584002|NCT03409367|Emollients|emollients|mesh-list
139584003|NCT03409367|Petrolatum|petrolatum|mesh-list
139584004|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
139584005|NCT03168464|Nivolumab|nivolumab|mesh-list
139584006|NCT03168464|Ipilimumab|ipilimumab|mesh-list
139584007|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139584008|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584009|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139584010|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584011|NCT03164447|UB-421|ub-421|mesh-list
139584012|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139584013|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
139584014|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584015|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
139584016|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139584017|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584018|NCT02875262|Deferoxamine|deferoxamine|mesh-list
139584019|NCT02875262|Siderophores|siderophores|mesh-ancestor
139584020|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139584021|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
139584022|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
139584023|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584024|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
139584025|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139584026|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584027|NCT02818920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139584028|NCT02818920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584029|NCT02811510|Dronabinol|dronabinol|mesh-list
139584030|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
139584031|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584032|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139584033|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139584034|NCT02811510|Analgesics|analgesics|mesh-ancestor
139584035|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
139584036|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584037|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139584038|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139584039|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584040|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584041|NCT02811510|Hormones|hormones|mesh-ancestor
139584042|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584043|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
139584044|NCT02786264|Propofol|propofol|mesh-list
139584045|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139584046|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139584047|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584048|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139584049|NCT02786264|Analgesics|analgesics|mesh-ancestor
139584050|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
139584051|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584052|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139584053|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139584054|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139584055|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
139584056|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584057|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584058|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139584059|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
139584060|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
139584061|NCT02778971|Flutemetamol|flutemetamol|mesh-list
139584062|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139584063|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584064|NCT02444546|Sargramostim|sargramostim|mesh-list
139584065|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
139584066|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584067|NCT01948505|Acetaminophen|acetaminophen|mesh-list
139584068|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139584069|NCT01948505|Analgesics|analgesics|mesh-ancestor
139584070|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
139584071|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584072|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584073|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
139584074|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139584075|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139584076|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584077|NCT01160926|Cediranib|cediranib|mesh-list
139584078|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365839|NCT03913559|Acetaminophen|acetaminophen|mesh-list
139584079|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139584080|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584081|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584082|NCT01126957|Fentanyl|fentanyl|mesh-list
139584083|NCT01126957|Ketamine|ketamine|mesh-list
139584084|NCT01126957|Propofol|propofol|mesh-list
139584085|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139584086|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139584087|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584088|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139584089|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
139584090|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
139584091|NCT01126957|Analgesics|analgesics|mesh-ancestor
139584092|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
139584093|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584094|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139584095|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139584096|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139584097|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584098|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584099|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139584100|NCT01126957|Narcotics|narcotics|mesh-ancestor
139584101|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139584102|NCT00811122|Corticosterone|corticosterone|mesh-list
139584103|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139584104|NCT00651885|Treprostinil|treprostinil|mesh-list
139584105|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139584106|NCT01457001|Vitamin D|vitamin d|mesh-list
139584107|NCT01457001|Vitamins|vitamins|mesh-ancestor
139584108|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
139584109|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584110|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139584111|NCT02846883|Plasma-lyte 148|plasma-lyte 148|mesh-list
139584112|NCT02846883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139584113|NCT02846883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139584114|NCT01457469|Nicotine|nicotine|mesh-list
139584115|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139584116|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
139584117|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584118|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584119|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139584120|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139584121|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
139584122|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584123|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584124|NCT01457547|Edetic Acid|edetic acid|mesh-list
139584125|NCT01457547|Vaccines|vaccines|mesh-list
139584126|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
139584127|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
139584128|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584129|NCT01457547|Antidotes|antidotes|mesh-ancestor
139584130|NCT01457547|Protective Agents|protective agents|mesh-ancestor
139584131|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
139584132|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
139584133|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584134|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139584135|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
139584136|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139584137|NCT01457859|Triclosan|triclosan|mesh-list
139584138|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139584139|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584140|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139584141|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139584142|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
139584143|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584144|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139584145|NCT01890993|Liraglutide|liraglutide|mesh-list
139584146|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139584147|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584148|NCT01890993|Incretins|incretins|mesh-ancestor
139584149|NCT01890993|Hormones|hormones|mesh-ancestor
139584150|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584151|NCT01457937|Interferons|interferons|mesh-list
139584152|NCT01457937|Ribavirin|ribavirin|mesh-list
139584153|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139584154|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584155|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
139584156|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584157|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
139584158|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584159|NCT04272255|Scopolamine|scopolamine|mesh-list
139584160|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139584161|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139584162|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
139584163|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
139584164|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584165|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584166|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139584167|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
139584168|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139584169|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
139584170|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584171|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584172|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139584173|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
139584174|NCT01458015|Oxycodone|oxycodone|mesh-list
139584175|NCT01458015|Tapentadol|tapentadol|mesh-list
139584176|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139584177|NCT01458015|Narcotics|narcotics|mesh-ancestor
139584178|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139584179|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584180|NCT01458015|Analgesics|analgesics|mesh-ancestor
139584181|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
139584182|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584183|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139584184|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139584185|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139584186|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584187|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
139584188|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584189|NCT01891227|Capecitabine|capecitabine|mesh-list
139584190|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139584191|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139584192|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
139584193|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584194|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584195|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139584196|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
139584197|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
139584198|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139584199|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139584200|NCT04391439|Prednisolone|prednisolone|mesh-list
139584201|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
139584202|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139584203|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
139584204|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139584205|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
139584206|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
139584207|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584208|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584209|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139584210|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
139584211|NCT04391439|Hormones|hormones|mesh-ancestor
139584212|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584213|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139584214|NCT04391439|Protective Agents|protective agents|mesh-ancestor
139584215|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139584216|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584217|NCT02884245|Estrogens|estrogens|mesh-list
139584218|NCT02884245|Hormones|hormones|mesh-ancestor
139584219|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138712140|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
139584220|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584221|NCT01891461|Hemostatics|hemostatics|mesh-list
139584222|NCT01891461|Coagulants|coagulants|mesh-ancestor
139584223|NCT04272567|Norepinephrine|norepinephrine|mesh-list
139584224|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139584225|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139584226|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
139584227|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584228|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584229|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584230|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
139584231|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
139584232|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584233|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139584234|NCT01891851|Ritonavir|ritonavir|mesh-list
139584235|NCT01891851|Simeprevir|simeprevir|mesh-list
139584236|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139584237|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139584238|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
139584239|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584240|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584241|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139584242|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139584243|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
139584244|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584245|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139584246|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139584247|NCT01459419|Antibodies|antibodies|mesh-list
139584248|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139584249|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
139584250|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584251|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139584252|NCT01892241|Entecavir|entecavir|mesh-list
139584253|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
139584254|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584255|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
139584256|NCT04391127|Ivermectin|ivermectin|mesh-list
139584257|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
139584258|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139584259|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139584260|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584261|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584262|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584263|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139584264|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
139584265|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139584266|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139584267|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584268|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
139584269|NCT05024253|Coagulants|coagulants|mesh-ancestor
139584270|NCT01459809|Metformin|metformin|mesh-list
139584271|NCT01459809|Glimepiride|glimepiride|mesh-list
139584272|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139584273|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584274|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139584275|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139584276|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
139584277|NCT01459887|Prednisone|prednisone|mesh-list
139584278|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
139584279|NCT01459887|Doxorubicin|doxorubicin|mesh-list
139584280|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139584281|NCT01459887|Vincristine|vincristine|mesh-list
139584282|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139584283|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
139584284|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584285|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139584286|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139584287|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
139584288|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584289|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584290|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139584291|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139584292|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139584293|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139584294|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584295|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139584296|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
139584297|NCT01459887|Hormones|hormones|mesh-ancestor
139584298|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584299|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139584300|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139584301|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
139584302|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
139584303|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
139584304|NCT02876211|Vitamin D|vitamin d|mesh-list
139584305|NCT02876211|Vitamins|vitamins|mesh-ancestor
139584306|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
139584307|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584308|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139584309|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
139584311|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139584312|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139584313|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584314|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584315|NCT02682147|Urological Agents|urological agents|mesh-ancestor
139584316|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
139584317|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139584318|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139584319|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
139584320|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584321|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584322|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139584323|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
139584324|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139584325|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139584326|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139584327|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
139584328|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584329|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584330|NCT01893723|Remifentanil|remifentanil|mesh-list
139584331|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139584332|NCT01893723|Narcotics|narcotics|mesh-ancestor
139584333|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139584334|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584335|NCT01893723|Analgesics|analgesics|mesh-ancestor
139584336|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
139584337|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584338|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
139584339|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139584340|NCT02669901|Naloxone|naloxone|mesh-list
139584341|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139584342|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584343|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
139584344|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584345|NCT01893099|Sorafenib|sorafenib|mesh-list
139584346|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584347|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139584348|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584349|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584350|NCT02327403|Abatacept|abatacept|mesh-list
139584351|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139584352|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584353|NCT02327403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139584354|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584355|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139584356|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
139584357|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584358|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139584359|NCT01893177|Vaccines|vaccines|mesh-list
139584360|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
139584361|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584362|NCT05740150|Taurolidine|taurolidine|mesh-list
139584363|NCT05740150|Heparin|heparin|mesh-list
139584364|NCT05740150|Calcium heparin|calcium heparin|mesh-list
139584365|NCT05740150|Anticoagulants|anticoagulants|mesh-ancestor
139584366|NCT05740150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584367|NCT05740150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139584368|NCT05740150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139584369|NCT05740150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584370|NCT05740150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139584371|NCT05740150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584372|NCT05734612|Colchicine|colchicine|mesh-list
139584373|NCT05734612|Gout Suppressants|gout suppressants|mesh-ancestor
139584374|NCT05734612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139584375|NCT05734612|Tubulin Modulators|tubulin modulators|mesh-ancestor
139584376|NCT05734612|Antimitotic Agents|antimitotic agents|mesh-ancestor
139584377|NCT05734612|Mitosis Modulators|mitosis modulators|mesh-ancestor
139584378|NCT05734612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584379|NCT05734612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584380|NCT02349867|Gemcitabine|gemcitabine|mesh-list
139584381|NCT02349867|Sorafenib|sorafenib|mesh-list
139584382|NCT02349867|Vorinostat|vorinostat|mesh-list
139584383|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139584384|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
139584385|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584386|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584387|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139584388|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584389|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139584390|NCT02629419|Amphotericin B|amphotericin b|mesh-list
139584391|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139584392|NCT02629419|Amebicides|amebicides|mesh-ancestor
139584393|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139584394|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139584395|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584396|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139584397|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
139584398|NCT02334735|Vaccines|vaccines|mesh-list
139584399|NCT02334735|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139584400|NCT02334735|Poly ICLC|poly iclc|mesh-list
139584401|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
139584402|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584403|NCT02334735|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139584404|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
139584405|NCT02329600|Triamcinolone|triamcinolone|mesh-list
139584406|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139584407|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139584408|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139584409|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139584410|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
139584411|NCT02329600|Hormones|hormones|mesh-ancestor
139584412|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584413|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584414|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139584415|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
139584416|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712378|NCT01870505|Letrozole|letrozole|mesh-list
139584417|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584418|NCT02620761|Fenoldopam|fenoldopam|mesh-list
139584419|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139584420|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
139584421|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
139584422|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
139584423|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584424|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584425|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584426|NCT04758273|Vaccines|vaccines|mesh-list
139584427|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
139584428|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584429|NCT01729871|Vitamin K|vitamin k|mesh-list
139584430|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
139584431|NCT01729871|Vitamins|vitamins|mesh-ancestor
139584432|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
139584433|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584434|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139584435|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
139584436|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139584437|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
139584438|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584439|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584440|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
139584441|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139584442|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139584443|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
139584444|NCT01729871|Coagulants|coagulants|mesh-ancestor
139584445|NCT02611323|Rituximab|rituximab|mesh-list
139584446|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
139584447|NCT02611323|Venetoclax|venetoclax|mesh-list
139584448|NCT02611323|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139584449|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139584450|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584451|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
139584452|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584453|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139584454|NCT02611323|Immunoconjugates|immunoconjugates|mesh-ancestor
139584455|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
139584456|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584457|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139584458|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584459|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584460|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
139584461|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584462|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584463|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139584464|NCT01729559|Heparin|heparin|mesh-list
139584465|NCT01729559|Enoxaparin|enoxaparin|mesh-list
139584466|NCT01729559|Calcium heparin|calcium heparin|mesh-list
139584467|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
139584468|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
139584469|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139584470|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139584471|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584472|NCT01926496|Imiquimod|imiquimod|mesh-list
139584473|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139584474|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
139584475|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584476|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584477|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
139584478|NCT01728779|Nelfinavir|nelfinavir|mesh-list
138712454|NCT01846481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712455|NCT01846481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138712456|NCT01846481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138712457|NCT01846481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138712458|NCT01846481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138712459|NCT01846481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712460|NCT01846481|Dopamine Agents|dopamine agents|mesh-ancestor
138712462|NCT04609293|Apatinib|apatinib|mesh-list
139584479|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139584480|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139584481|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
139584482|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584483|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584484|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139584485|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139584486|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
139584487|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584488|NCT01927120|Sirolimus|sirolimus|mesh-list
139584489|NCT01927120|Aldesleukin|aldesleukin|mesh-list
139584490|NCT01927120|Tacrolimus|tacrolimus|mesh-list
139584491|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139584492|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
139584493|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584494|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139584495|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584496|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584497|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139584498|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584499|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139584500|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584501|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
139584502|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139584503|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139584504|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
139584505|NCT01728623|Lenvatinib|lenvatinib|mesh-list
139584506|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584507|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139584508|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584509|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584510|NCT02573337|Lidocaine|lidocaine|mesh-list
139584511|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
139584512|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
139584513|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139584514|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584515|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
139584516|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584517|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139584518|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139584519|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139584520|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139584521|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584522|NCT01728077|Brivaracetam|brivaracetam|mesh-list
139584523|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
139584524|NCT01606007|Metformin|metformin|mesh-list
139584525|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
139584526|NCT01606007|Saxagliptin|saxagliptin|mesh-list
139584527|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139584528|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584529|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139584530|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584531|NCT01606007|Incretins|incretins|mesh-ancestor
139584532|NCT01606007|Hormones|hormones|mesh-ancestor
139584533|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584534|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139584535|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
139584536|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584537|NCT02304783|Acetaminophen|acetaminophen|mesh-list
139584538|NCT02304783|Piroxicam|piroxicam|mesh-list
139584539|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139584540|NCT02304783|Analgesics|analgesics|mesh-ancestor
139584541|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
139584542|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584543|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584544|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
139584545|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139584546|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139584547|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139584548|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139584549|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584550|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584551|NCT01928290|Leucovorin|leucovorin|mesh-list
139584552|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
139584553|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
139584554|NCT01928290|Fluorouracil|fluorouracil|mesh-list
139584555|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
139584556|NCT01928290|Trastuzumab|trastuzumab|mesh-list
139584557|NCT01928290|Irinotecan|irinotecan|mesh-list
139584558|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
139584559|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
139584560|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584561|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139584562|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584563|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139584564|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
139584565|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584566|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139584567|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139584568|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139584569|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584570|NCT01928290|Antidotes|antidotes|mesh-ancestor
139584571|NCT01928290|Protective Agents|protective agents|mesh-ancestor
139584572|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
139584573|NCT01928290|Vitamins|vitamins|mesh-ancestor
139584574|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
139584575|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
139584576|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
139584577|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139584578|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139584579|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584580|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139584581|NCT02282319|Analgesics|analgesics|mesh-ancestor
139584582|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
139584583|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584584|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139584585|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139584586|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139584587|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
139584588|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712539|NCT00564408|Analgesics|analgesics|mesh-ancestor
139584589|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584590|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
139584591|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
139584592|NCT02278965|Metformin|metformin|mesh-list
139584593|NCT02278965|Biguanides|biguanides|mesh-list
139584594|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139584595|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584596|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
139584597|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
139584598|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139584599|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584600|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584601|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
139584602|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139584603|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139584604|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584605|NCT02983383|Anesthetics|anesthetics|mesh-list
139584606|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139584607|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584608|NCT02748369|Glucagon|glucagon|mesh-list
139584609|NCT02748369|Hormones|hormones|mesh-list
139584610|NCT02748369|Somatostatin|somatostatin|mesh-list
139584611|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584612|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584613|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139584614|NCT01928680|Capecitabine|capecitabine|mesh-list
139584615|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584616|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139584617|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
139584618|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584619|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
139584620|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139584621|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584622|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139584623|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139584624|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584625|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584626|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584627|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139584628|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139584629|NCT02283814|Topiramate|topiramate|mesh-list
139584630|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139584631|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
139584632|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139584633|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584634|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139584635|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139584636|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139584637|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584638|NCT05739682|Anti-Infective Agents|anti-infective agents|mesh-list
139584639|NCT05739682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139584640|NCT05739682|Epinephrine|epinephrine|mesh-list
139584641|NCT05739682|Anesthetics|anesthetics|mesh-list
139584642|NCT05739682|Carticaine|carticaine|mesh-list
139584643|NCT05739682|Anesthetics, Local|anesthetics, local|mesh-list
139584644|NCT05739682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139584645|NCT05739682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584646|NCT05739682|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139584647|NCT05739682|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139584648|NCT05739682|Adrenergic Agents|adrenergic agents|mesh-ancestor
139584649|NCT05739682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584650|NCT05739682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584651|NCT05739682|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139584652|NCT05739682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139584653|NCT05739682|Autonomic Agents|autonomic agents|mesh-ancestor
139584654|NCT05739682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584655|NCT05739682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139584656|NCT05739682|Respiratory System Agents|respiratory system agents|mesh-ancestor
139584657|NCT05739682|Mydriatics|mydriatics|mesh-ancestor
139584658|NCT05739682|Sympathomimetics|sympathomimetics|mesh-ancestor
139584659|NCT05739682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139584660|NCT05739682|Sensory System Agents|sensory system agents|mesh-ancestor
139584661|NCT02462421|Canagliflozin|canagliflozin|mesh-list
139584662|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139584663|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584664|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139584665|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584666|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
139584667|NCT02727387|Temozolomide|temozolomide|mesh-list
139584668|NCT02727387|Melphalan|melphalan|mesh-list
139584669|NCT02727387|Busulfan|busulfan|mesh-list
139584670|NCT02727387|Ifosfamide|ifosfamide|mesh-list
139584671|NCT02727387|Irinotecan|irinotecan|mesh-list
139584672|NCT02727387|Etoposide|etoposide|mesh-list
139584673|NCT02727387|Vincristine|vincristine|mesh-list
139584674|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139584675|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
139584676|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584677|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139584678|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139584679|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
139584680|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584681|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584682|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139584683|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139584684|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139584685|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584686|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139584687|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139584688|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
139366442|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584689|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
139584690|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
139584691|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
139584692|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139584693|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584694|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139584695|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139584696|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584697|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584698|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584699|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139584700|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139584701|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
139584702|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139584703|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
139584704|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584705|NCT02445651|Expectorants|expectorants|mesh-ancestor
139584706|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
139584707|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139584708|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
139584709|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584710|NCT02445651|Protective Agents|protective agents|mesh-ancestor
139584711|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584712|NCT02445651|Antidotes|antidotes|mesh-ancestor
139584713|NCT02284516|Lifitegrast|lifitegrast|mesh-list
139584714|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139584715|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139584716|NCT02721537|Niacinamide|niacinamide|mesh-list
139584717|NCT02721537|Niacin|niacin|mesh-list
139584718|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
139584719|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
139584720|NCT02721537|Vitamins|vitamins|mesh-ancestor
139584721|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
139584722|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584723|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139584724|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
139584725|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584726|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139584727|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
139584728|NCT02185209|Amoxicillin|amoxicillin|mesh-list
139584729|NCT02185209|Metronidazole|metronidazole|mesh-list
139584730|NCT02185209|Penicillin V|penicillin v|mesh-list
139584731|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139584732|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584733|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139584734|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139584735|NCT01894035|Iloprost|iloprost|mesh-list
139584736|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139584737|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
139584738|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
139584739|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139584740|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139584741|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139584742|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
139584743|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584744|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584745|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584746|NCT02716311|Cetuximab|cetuximab|mesh-list
139584747|NCT02716311|Afatinib|afatinib|mesh-list
139584748|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139584749|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584750|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139584751|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584752|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584753|NCT05439694|Tranexamic Acid|tranexamic acid|mesh-list
139584754|NCT05439694|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139584755|NCT05439694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139584756|NCT05439694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584757|NCT05439694|Hemostatics|hemostatics|mesh-ancestor
139584758|NCT05439694|Coagulants|coagulants|mesh-ancestor
139584759|NCT02290444|Hormones|hormones|mesh-list
139584760|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139584761|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139584762|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
139584763|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584764|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366521|NCT01864109|Ifosfamide|ifosfamide|mesh-list
139584765|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584766|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584767|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139584768|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
139584769|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584770|NCT01752023|Itraconazole|itraconazole|mesh-list
139584771|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139584772|NCT01752023|Cisplatin|cisplatin|mesh-list
139584773|NCT01752023|Gemcitabine|gemcitabine|mesh-list
139584774|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584775|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139584776|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
139584777|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584778|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
139584779|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138712737|NCT00564525|Amitriptyline|amitriptyline|mesh-list
139584780|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139584781|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139584782|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584783|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139584784|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
139584785|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584786|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584787|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139584788|NCT02986906|Triamcinolone|triamcinolone|mesh-list
139584789|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139584790|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
139584791|NCT02986906|Hormones|hormones|mesh-ancestor
139584792|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584793|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584794|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
139584795|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
139584796|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139584797|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139584798|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584799|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584800|NCT01726049|Urological Agents|urological agents|mesh-ancestor
139584801|NCT02162667|Trastuzumab|trastuzumab|mesh-list
139584802|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139584803|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584804|NCT01605617|Fesoterodine|fesoterodine|mesh-list
139584805|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139584806|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139584807|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
139584808|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584809|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584810|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584811|NCT01605617|Urological Agents|urological agents|mesh-ancestor
139584812|NCT05402020|Tiotropium Bromide|tiotropium bromide|mesh-list
139584813|NCT05402020|Olodaterol|olodaterol|mesh-list
139584814|NCT05402020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139584815|NCT05402020|Autonomic Agents|autonomic agents|mesh-ancestor
139584816|NCT05402020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584817|NCT05402020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584818|NCT05402020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138712760|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139584819|NCT05402020|Respiratory System Agents|respiratory system agents|mesh-ancestor
139584820|NCT05402020|Parasympatholytics|parasympatholytics|mesh-ancestor
139584821|NCT05402020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139584822|NCT05402020|Cholinergic Agents|cholinergic agents|mesh-ancestor
139584823|NCT05402020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584824|NCT05402020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584825|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139584826|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
139584827|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139584828|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139584829|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139584830|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584831|NCT01751867|Decitabine|decitabine|mesh-list
139584832|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139584833|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
139584834|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584835|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584836|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584837|NCT02418195|Ketamine|ketamine|mesh-list
139584838|NCT02418195|Analgesics|analgesics|mesh-ancestor
139584839|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
139584840|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584841|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584842|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139584843|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139584844|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
139584845|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
139584846|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139584847|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139584848|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139584849|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139584850|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584851|NCT05633914|Paclitaxel|paclitaxel|mesh-list
139584852|NCT05633914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139584853|NCT05633914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584854|NCT05633914|Tubulin Modulators|tubulin modulators|mesh-ancestor
138712806|NCT01516346|Isosorbide|isosorbide|mesh-list
139584855|NCT05633914|Antimitotic Agents|antimitotic agents|mesh-ancestor
139584856|NCT05633914|Mitosis Modulators|mitosis modulators|mesh-ancestor
139584857|NCT05633914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584858|NCT05383612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139584859|NCT05383612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139584860|NCT05382364|Tucatinib|tucatinib|mesh-list
139584861|NCT05382364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584862|NCT05382364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139584863|NCT05382364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584864|NCT05382364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584865|NCT02712801|Ritonavir|ritonavir|mesh-list
139584866|NCT02712801|Lopinavir|lopinavir|mesh-list
139584867|NCT02712801|Lamivudine|lamivudine|mesh-list
139584868|NCT02712801|Zidovudine|zidovudine|mesh-list
139584869|NCT02712801|Nevirapine|nevirapine|mesh-list
139584870|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139584871|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139584872|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
139584873|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584874|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584875|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139584876|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139584877|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
139584878|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584879|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139584880|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139584881|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139584882|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139584883|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
139584884|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139584885|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139584886|NCT02712723|Letrozole|letrozole|mesh-list
139584887|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584888|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139584889|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139584890|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584891|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584892|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139584893|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
139584894|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584895|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584896|NCT01751087|Vitamins|vitamins|mesh-list
139584897|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
139584898|NCT01751087|Misoprostol|misoprostol|mesh-list
139584899|NCT01751087|Mifepristone|mifepristone|mesh-list
139584900|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
139584901|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584902|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139584903|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
139584904|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139584905|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139584906|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139584907|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
139584908|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
139584909|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139584910|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139584911|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139584912|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139584913|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
139584914|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139584915|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139584916|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
139584917|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584918|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
139584919|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139584920|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139584921|NCT02393157|Carboplatin|carboplatin|mesh-list
139584922|NCT02393157|Etoposide|etoposide|mesh-list
139584923|NCT02393157|Ifosfamide|ifosfamide|mesh-list
139584924|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
139584925|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584926|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139584927|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139584928|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139584929|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139584930|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584931|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139584932|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
139584933|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139584934|NCT01750697|Rituximab|rituximab|mesh-list
139584935|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139584936|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584937|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
139584938|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584939|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139584940|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
139584941|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139584942|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
139584943|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584944|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
139584945|NCT02127723|Protective Agents|protective agents|mesh-ancestor
139584946|NCT05586711|Estradiol|estradiol|mesh-list
139584947|NCT05586711|Estrogens|estrogens|mesh-ancestor
139584948|NCT05586711|Hormones|hormones|mesh-ancestor
139584949|NCT05586711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584950|NCT05586711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584951|NCT01724489|Hormones|hormones|mesh-list
139584952|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139584953|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584954|NCT01996293|Lamotrigine|lamotrigine|mesh-list
139584955|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
139584956|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139584957|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139584958|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584959|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139584960|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584961|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139584962|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139584963|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139584964|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139584965|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139584966|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139584967|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139584968|NCT05304364|Naltrexone|naltrexone|mesh-list
139584969|NCT05304364|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139584970|NCT05304364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139584971|NCT05304364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584972|NCT05304364|Sensory System Agents|sensory system agents|mesh-ancestor
139584973|NCT05304364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139584974|NCT01724177|Lenalidomide|lenalidomide|mesh-list
139584975|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
139584976|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584977|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139584978|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139584979|NCT01724177|Growth Substances|growth substances|mesh-ancestor
139584980|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
139584981|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584982|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139584983|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139584984|NCT05529784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139584985|NCT05529784|Immunologic Factors|immunologic factors|mesh-ancestor
139584986|NCT05529784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139584987|NCT01530009|Amoxicillin|amoxicillin|mesh-list
139584988|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139584989|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139584990|NCT04915144|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
139584991|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139584992|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139584993|NCT01724021|Prednisone|prednisone|mesh-list
139584994|NCT01724021|Prednisolone|prednisolone|mesh-list
139584995|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139584996|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
139584997|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139584998|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
139584999|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
139585000|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139585001|NCT01724021|Rituximab|rituximab|mesh-list
139585002|NCT01724021|Vincristine|vincristine|mesh-list
139585003|NCT01724021|Doxorubicin|doxorubicin|mesh-list
139585004|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138712950|NCT00555542|Rituximab|rituximab|mesh-list
139585005|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139585006|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
139585007|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139585008|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
139585009|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585010|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139585011|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139585012|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
139585013|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585014|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585015|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139585016|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139585017|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585018|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
139585019|NCT01724021|Hormones|hormones|mesh-ancestor
139585020|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139585021|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139585022|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139585023|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
139585024|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
139585025|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
139585026|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
139585027|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
139585028|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585029|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139585030|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139585031|NCT01724021|Protective Agents|protective agents|mesh-ancestor
139585032|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139585033|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139585034|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139585035|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585036|NCT05197504|Bevacizumab|bevacizumab|mesh-list
139585037|NCT05197504|Atezolizumab|atezolizumab|mesh-list
139585038|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139585039|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585040|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139585041|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139585042|NCT05197504|Growth Substances|growth substances|mesh-ancestor
139585043|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585044|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
139585045|NCT05197504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139585046|NCT05197504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585047|NCT02293096|Metoprolol|metoprolol|mesh-list
139585048|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
139585049|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139585050|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139585051|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
139585052|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
139585053|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585054|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585055|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139585056|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139585057|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139585058|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
139585059|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585060|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585061|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
139585062|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
139585063|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139585064|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139585065|NCT01722071|Oxytocin|oxytocin|mesh-list
139585066|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
139585067|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139585068|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585069|NCT04155580|Decitabine|decitabine|mesh-list
139585070|NCT04155580|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139585071|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139585072|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
139585073|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585074|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585075|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585076|NCT01721759|Nivolumab|nivolumab|mesh-list
139585077|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139585078|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585079|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139585080|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585081|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
139585082|NCT04776850|Dexamethasone|dexamethasone|mesh-list
139585083|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
139585084|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
139585085|NCT04776850|Busulfan|busulfan|mesh-list
139585086|NCT04776850|Rituximab|rituximab|mesh-list
139585087|NCT04776850|Fludarabine|fludarabine|mesh-list
139585088|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
139585089|NCT04776850|Bortezomib|bortezomib|mesh-list
139585090|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139585091|NCT04776850|Tacrolimus|tacrolimus|mesh-list
139585092|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
139585093|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139585094|NCT04776850|Antibodies|antibodies|mesh-list
139585095|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
139585096|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139585097|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
139585098|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139585099|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139585100|NCT04776850|BB 1101|bb 1101|mesh-list
139585101|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139585102|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
139585103|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585104|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139585105|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139585106|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
139585107|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585108|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585109|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139585110|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585111|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
139585112|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
139585113|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585114|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139585115|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
139585116|NCT04776850|Hormones|hormones|mesh-ancestor
139585117|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139585118|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139585119|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
139585120|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585121|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139585122|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
139585123|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139585124|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139585125|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139585126|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
139585127|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139585128|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585129|NCT04132648|Curcumin|curcumin|mesh-list
139585130|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139585131|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139585132|NCT04132648|Analgesics|analgesics|mesh-ancestor
139585133|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
139585134|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585135|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585136|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585137|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139585138|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585139|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585140|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585141|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
139585142|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139585143|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
139585144|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585145|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585146|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139585147|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
139585148|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
139585149|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139585150|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
139585151|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585152|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585153|NCT04095208|Nivolumab|nivolumab|mesh-list
139585154|NCT04095208|Relatlimab|relatlimab|mesh-list
139585155|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139585156|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585157|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139585158|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585159|NCT02292082|Cefazolin|cefazolin|mesh-list
139585160|NCT02292082|Dexamethasone|dexamethasone|mesh-list
139585161|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
139585162|NCT02292082|Midazolam|midazolam|mesh-list
139585163|NCT02292082|Morphine|morphine|mesh-list
139585164|NCT02292082|Bupivacaine|bupivacaine|mesh-list
139585165|NCT02292082|Propofol|propofol|mesh-list
139585166|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585167|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
139585168|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
139585169|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713132|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
139585170|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585171|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139585172|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
139585173|NCT02292082|Hormones|hormones|mesh-ancestor
139585174|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139585175|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139585176|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585177|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
139585178|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
139585179|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585180|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
139585181|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139585182|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139585183|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
139585184|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139585185|NCT02292082|Narcotics|narcotics|mesh-ancestor
139585186|NCT02292082|Analgesics|analgesics|mesh-ancestor
139585187|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139585188|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139585189|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139585190|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139585191|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
139585192|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
139585193|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585194|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585195|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139585196|NCT02292082|Protective Agents|protective agents|mesh-ancestor
139585197|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139585198|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585199|NCT05072704|Sufentanil|sufentanil|mesh-list
139585200|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
139585201|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139585202|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585203|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585204|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139585205|NCT05072704|Analgesics|analgesics|mesh-ancestor
139585206|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
139585207|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585208|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139585209|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139585210|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139585211|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
139585212|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713178|NCT00560924|Estradiol|estradiol|mesh-list
139585213|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585214|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139585215|NCT05072704|Narcotics|narcotics|mesh-ancestor
139585216|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139585217|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139585218|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
139585219|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
139585220|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
139585221|NCT04678336|Fludarabine|fludarabine|mesh-list
139585222|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139585223|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
139585224|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585225|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139585226|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139585227|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
139585228|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585229|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585230|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139585231|NCT04607122|Landiolol|landiolol|mesh-list
139585232|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139585233|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139585234|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
139585235|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585236|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585237|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585238|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139585239|NCT04590664|Verteporfin|verteporfin|mesh-list
139585240|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139585241|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
139585242|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
139585243|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139585244|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
139585245|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139585246|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
139585247|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585248|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585249|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
139585250|NCT02518594|Progesterone|progesterone|mesh-list
139585251|NCT02518594|Progestins|progestins|mesh-ancestor
139585252|NCT02518594|Hormones|hormones|mesh-ancestor
139585253|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139585254|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585255|NCT01516593|Cytarabine|cytarabine|mesh-list
139585256|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139585257|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
139585258|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585259|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585260|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
139585261|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585262|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139585263|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
139585264|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585265|NCT02042391|Cytarabine|cytarabine|mesh-list
139585266|NCT02042391|Prednisone|prednisone|mesh-list
139585267|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
139585268|NCT02042391|Rituximab|rituximab|mesh-list
139585269|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
139585270|NCT02042391|Doxorubicin|doxorubicin|mesh-list
139585271|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139585272|NCT02042391|Vincristine|vincristine|mesh-list
139585273|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139585274|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
139585275|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585276|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139585277|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139585278|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
139585279|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585280|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585281|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139585282|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139585283|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585284|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
139585285|NCT02042391|Hormones|hormones|mesh-ancestor
139585286|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139585287|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139585288|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139585289|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
139585290|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
139585291|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585292|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139585293|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139585294|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139585295|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585296|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139585297|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
139585298|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
139585299|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
139585300|NCT02461836|Gemcitabine|gemcitabine|mesh-list
139585301|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139585302|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
139585303|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585304|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585305|NCT01986946|Hydromorphone|hydromorphone|mesh-list
139585306|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139585307|NCT01986946|Narcotics|narcotics|mesh-ancestor
139585308|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585309|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585310|NCT01986946|Analgesics|analgesics|mesh-ancestor
139585311|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
139585312|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585313|NCT02427724|Lidocaine|lidocaine|mesh-list
139585314|NCT02427724|Tetracaine|tetracaine|mesh-list
139585315|NCT02427724|Prilocaine|prilocaine|mesh-list
139585316|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
139585317|NCT02427724|Anesthetics|anesthetics|mesh-list
139585318|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585319|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585320|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
139585321|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585322|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139585323|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139585324|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139585325|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139585326|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585327|NCT03437200|Nivolumab|nivolumab|mesh-list
139585328|NCT03437200|Ipilimumab|ipilimumab|mesh-list
139585329|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139585330|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585331|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139585332|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585333|NCT01903473|Sirolimus|sirolimus|mesh-list
139585334|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139585335|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585336|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139585337|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585338|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
139585339|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139585340|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
139585341|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585342|NCT02715726|Atorvastatin|atorvastatin|mesh-list
139585343|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139585344|NCT02715726|Simvastatin|simvastatin|mesh-list
139585345|NCT02715726|Ezetimibe|ezetimibe|mesh-list
139585346|NCT02715726|Alirocumab|alirocumab|mesh-list
139585347|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139585348|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139585349|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139585350|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
139585351|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585352|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139585353|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139585354|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585355|NCT02715726|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139585356|NCT02715726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139585357|NCT02715726|Protease Inhibitors|protease inhibitors|mesh-ancestor
139585358|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
139585359|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585360|NCT01893567|Clobetasol|clobetasol|mesh-list
139585361|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585362|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
139585363|NCT01893567|Hormones|hormones|mesh-ancestor
139585364|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367128|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
139585365|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585366|NCT04249596|Tianeptine|tianeptine|mesh-list
139585367|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139585368|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
139585369|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139585370|NCT01476501|Vitamin D|vitamin d|mesh-list
139585371|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
139585372|NCT01476501|Vitamins|vitamins|mesh-ancestor
139585373|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
139585374|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585375|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139585376|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139585377|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
139585378|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139585379|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585380|NCT02464020|Vancomycin|vancomycin|mesh-list
139585381|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139585382|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585383|NCT04756089|Oxytocin|oxytocin|mesh-list
139585384|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
139585385|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139585386|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585387|NCT03397888|Betrixaban|betrixaban|mesh-list
139585388|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139585389|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
139585390|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139585391|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
139585392|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585393|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585394|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
139585395|NCT01886859|Lenalidomide|lenalidomide|mesh-list
139585396|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
139585397|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585398|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139585399|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139585400|NCT01886859|Growth Substances|growth substances|mesh-ancestor
139585401|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
139585402|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585403|NCT01989910|Efavirenz|efavirenz|mesh-list
139585404|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
139585405|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139585406|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139585407|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585408|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585409|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
139585410|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585411|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139585412|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139585413|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139585414|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139585415|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139585416|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139585417|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139585418|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139585419|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139585420|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139585421|NCT02464722|Epinephrine|epinephrine|mesh-list
139585422|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
139585423|NCT02464722|Remifentanil|remifentanil|mesh-list
139585424|NCT02464722|Propofol|propofol|mesh-list
139585425|NCT02464722|Rocuronium|rocuronium|mesh-list
139585426|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139585427|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585428|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585429|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139585430|NCT02464722|Analgesics|analgesics|mesh-ancestor
139585431|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
139585432|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585433|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139585434|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139585435|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139585436|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
139585437|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585438|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585439|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138713405|NCT01156792|Montelukast|montelukast|mesh-list
139585440|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
139297192|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139585441|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
139585443|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139585444|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
139585445|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139585446|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
139585447|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
139585448|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
139585449|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139585450|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139585451|NCT02464722|Narcotics|narcotics|mesh-ancestor
139585452|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139585453|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139585454|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139585455|NCT01991548|Insulin|insulin|mesh-list
139585456|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139585457|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585458|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
139585459|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139585460|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585461|NCT02461914|Warfarin|warfarin|mesh-list
139585462|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
139585463|NCT01991860|Amisulpride|amisulpride|mesh-list
139585464|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139585465|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139585466|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585467|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585468|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139585469|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139585470|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
139585471|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585472|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585473|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139585474|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
139585475|NCT02463552|Naproxen|naproxen|mesh-list
139585476|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139585477|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139585478|NCT02463552|Analgesics|analgesics|mesh-ancestor
139585479|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
139585480|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585481|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585482|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585483|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139585484|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
139585485|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139585486|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585487|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585488|NCT01992016|Ranolazine|ranolazine|mesh-list
139585489|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139585490|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139585491|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585492|NCT01871571|Leucovorin|leucovorin|mesh-list
139585493|NCT01871571|Bevacizumab|bevacizumab|mesh-list
139585494|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139585495|NCT01871571|Fluorouracil|fluorouracil|mesh-list
139585496|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
139585497|NCT01871571|Antibodies|antibodies|mesh-list
139585498|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
139585499|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139585500|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
139585501|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585502|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139585503|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139585504|NCT01871571|Growth Substances|growth substances|mesh-ancestor
139585505|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585506|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
139585507|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
139585508|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
139585509|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585510|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139585511|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139585512|NCT01871571|Antidotes|antidotes|mesh-ancestor
139585513|NCT01871571|Protective Agents|protective agents|mesh-ancestor
139585514|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
139585515|NCT01871571|Vitamins|vitamins|mesh-ancestor
139585516|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
139585517|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
139585518|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139585519|NCT01992172|Protective Agents|protective agents|mesh-ancestor
139585520|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585521|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
139585522|NCT03296982|Enoxaparin|enoxaparin|mesh-list
139585523|NCT03296982|Edoxaban|edoxaban|mesh-list
139585524|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
139585525|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139585526|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139585527|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585528|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139585529|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
139585530|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139585531|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
139585532|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585533|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139585534|NCT01895829|Hematinics|hematinics|mesh-ancestor
139585535|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139585536|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139585537|NCT03298698|Prednisone|prednisone|mesh-list
139585538|NCT03298698|Prednisolone|prednisolone|mesh-list
139585539|NCT03298698|Rituximab|rituximab|mesh-list
139585540|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139585541|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585542|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
139585543|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585544|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139585545|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585546|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
139585547|NCT03298698|Hormones|hormones|mesh-ancestor
139585548|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139585549|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139585550|NCT02463942|Doxycycline|doxycycline|mesh-list
139585551|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139585552|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585553|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
139585554|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139585555|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139585556|NCT03298542|Golimumab|golimumab|mesh-list
139585557|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139585558|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585559|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139585560|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
139585561|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585562|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
139585563|NCT03296670|Alprostadil|alprostadil|mesh-list
139585564|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
139585565|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139585566|NCT03296670|Urological Agents|urological agents|mesh-ancestor
139585567|NCT03298464|Pioglitazone|pioglitazone|mesh-list
139585568|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139585569|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585570|NCT01852071|Busulfan|busulfan|mesh-list
139585571|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
139585572|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585573|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139585574|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
139585575|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585576|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139585577|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585578|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139585579|NCT04084548|Lidocaine|lidocaine|mesh-list
139585580|NCT04084548|Ketamine|ketamine|mesh-list
139585581|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
139585582|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
139585583|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585584|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585585|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
139585586|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585587|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139585588|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139585589|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139585590|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139585591|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585592|NCT04084548|Analgesics|analgesics|mesh-ancestor
139585593|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139585594|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139585595|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
139585596|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139585597|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139585598|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585599|NCT02059642|Metadoxine|metadoxine|mesh-list
139585600|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139585601|NCT03296358|Dexamethasone|dexamethasone|mesh-list
139585602|NCT03296358|Prednisolone|prednisolone|mesh-list
139585603|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585604|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
139585605|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
139585606|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585607|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585608|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139585609|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
139585610|NCT03296358|Hormones|hormones|mesh-ancestor
139585611|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139585612|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139585613|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585614|NCT04756323|Vaccines|vaccines|mesh-list
139585615|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
139585616|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585617|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
139585618|NCT00469755|Adapalene|adapalene|mesh-list
139585619|NCT00469755|Tazarotene|tazarotene|mesh-list
139585620|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139585621|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139585622|NCT00469755|Analgesics|analgesics|mesh-ancestor
139585623|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
139585624|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585625|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585626|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585627|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139585628|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
139585629|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
139585630|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
139585631|NCT00469755|Vitamins|vitamins|mesh-ancestor
139585632|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
139585633|NCT00453531|Acetylcholine|acetylcholine|mesh-list
139585634|NCT00453531|Vasodilator Agents|vasodilator agents|mesh-ancestor
139585635|NCT00453531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139585636|NCT00453531|Cholinergic Agents|cholinergic agents|mesh-ancestor
139585637|NCT00453531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585638|NCT00453531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585639|NCT00453531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585640|NCT03295968|Ibuprofen|ibuprofen|mesh-list
139585641|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139585642|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139585643|NCT03295968|Analgesics|analgesics|mesh-ancestor
139585644|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
139585645|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585646|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585647|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585648|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139585649|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139585650|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713610|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
139585651|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585652|NCT03298074|Etoposide|etoposide|mesh-list
139585653|NCT03298074|Apatinib|apatinib|mesh-list
139585654|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139585655|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585656|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139585657|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139585658|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585659|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585660|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139585661|NCT01992874|Niacinamide|niacinamide|mesh-list
139585662|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
139585663|NCT01992874|Vitamins|vitamins|mesh-ancestor
139585664|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
139585665|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585666|NCT04755543|Fluorouracil|fluorouracil|mesh-list
139585667|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367422|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
139585668|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
139585669|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585670|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139585671|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139585672|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
139585673|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585674|NCT01993108|Naltrexone|naltrexone|mesh-list
139585675|NCT01993108|Methylphenidate|methylphenidate|mesh-list
139585676|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139585677|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139585678|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585679|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
139585680|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585681|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139585682|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139585683|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139585684|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139585685|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585686|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
139585687|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585688|NCT02307526|Bromides|bromides|mesh-list
139585689|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139585690|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
139585691|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139585692|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585693|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585694|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
139585695|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585696|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585697|NCT01371201|Sunitinib|sunitinib|mesh-list
139585698|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585699|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139585700|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139585701|NCT01371201|Growth Substances|growth substances|mesh-ancestor
139585702|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585703|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
139585704|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139585705|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585706|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585707|NCT00436527|Metronidazole|metronidazole|mesh-list
139585708|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585709|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139585710|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139585711|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139585712|NCT02307916|Mitogens|mitogens|mesh-list
139585713|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
139585714|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585715|NCT00419367|Vorinostat|vorinostat|mesh-list
139585716|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585717|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139585718|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585719|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585720|NCT01994746|Glucagon|glucagon|mesh-list
139585721|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139585722|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139585723|NCT01994746|Hormones|hormones|mesh-ancestor
139585724|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139585725|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585726|NCT01994746|Incretins|incretins|mesh-ancestor
139585727|NCT00291525|Warfarin|warfarin|mesh-list
139585728|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
139585729|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
139585730|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139585731|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585732|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585733|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139585734|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139585735|NCT01337349|Protective Agents|protective agents|mesh-ancestor
139585736|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585737|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
139585738|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139585739|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
139585740|NCT01999348|Timolol|timolol|mesh-list
139585741|NCT01999348|Bimatoprost|bimatoprost|mesh-list
139585742|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139585743|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139585744|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
139585745|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585746|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585747|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585748|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139585749|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139585750|NCT00280761|Capecitabine|capecitabine|mesh-list
139585751|NCT00280761|Fluorouracil|fluorouracil|mesh-list
139585752|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139585753|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
139585754|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585755|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585756|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139585757|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
139585758|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585759|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139585760|NCT02463318|Melatonin|melatonin|mesh-list
139585761|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
139585762|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585763|NCT02463318|Protective Agents|protective agents|mesh-ancestor
139585764|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585765|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585766|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139585767|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585768|NCT01436968|Valacyclovir|valacyclovir|mesh-list
139585769|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
139585770|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585771|NCT02462772|Cabotegravir|cabotegravir|mesh-list
139585772|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139585773|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139585774|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139585775|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139585776|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139585777|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139585778|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585779|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585780|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139585781|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139585782|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
139585783|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585784|NCT02716194|Factor VIII|factor viii|mesh-list
139585785|NCT02716194|Coagulants|coagulants|mesh-ancestor
139585786|NCT02461056|Ibuprofen|ibuprofen|mesh-list
139585787|NCT02461056|Hydromorphone|hydromorphone|mesh-list
139585788|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139585789|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139585790|NCT02461056|Analgesics|analgesics|mesh-ancestor
139585791|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
139585792|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585793|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585794|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585795|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139585796|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139585797|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585798|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585799|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139585800|NCT02461056|Narcotics|narcotics|mesh-ancestor
139585801|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585802|NCT01173172|Boron|boron|mesh-list
139585803|NCT01173172|Trace Elements|trace elements|mesh-ancestor
139585804|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
139585805|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585806|NCT00003270|Cyclosporine|cyclosporine|mesh-list
139585807|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
139585808|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
139585809|NCT00003270|Busulfan|busulfan|mesh-list
139585810|NCT00003270|Cyclosporins|cyclosporins|mesh-list
139585811|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139585812|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139585813|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
139585814|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585815|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139585816|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139585817|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
139585818|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585819|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585820|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139367571|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
139585821|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585822|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
139585823|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585824|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
139585825|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139585826|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585827|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
139585828|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
139585829|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585830|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139585831|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
139585832|NCT00003270|Hormones|hormones|mesh-ancestor
139585833|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139585834|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139585835|NCT00003270|Protective Agents|protective agents|mesh-ancestor
139585836|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
139585837|NCT02005354|Anesthetics|anesthetics|mesh-list
139585838|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
139585839|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585840|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585841|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
139585842|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585843|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139585844|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
139585845|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139585846|NCT02005354|Analgesics|analgesics|mesh-ancestor
139585847|NCT03290820|Aspirin|aspirin|mesh-list
139585848|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139585849|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139585850|NCT03290820|Analgesics|analgesics|mesh-ancestor
139585851|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
139585852|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585853|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585854|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139585855|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139585856|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139585857|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139585858|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585859|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139585860|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139585861|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585862|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
139585863|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139585864|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
139585865|NCT03773484|Narcotics|narcotics|mesh-ancestor
139585866|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585867|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585868|NCT03773484|Analgesics|analgesics|mesh-ancestor
139585869|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
139585870|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585871|NCT03283410|Propofol|propofol|mesh-list
139585872|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139585873|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585874|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585875|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139585876|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
139585877|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
139585878|NCT04318704|Ifenprodil|ifenprodil|mesh-list
139585879|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139585880|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139585881|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
139585882|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585883|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585884|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585885|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
139585886|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139585887|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139585888|NCT03283176|Folic Acid|folic acid|mesh-list
139585889|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
139585890|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
139585891|NCT03283176|Vitamins|vitamins|mesh-ancestor
139585892|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
139585893|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585894|NCT03283176|Hematinics|hematinics|mesh-ancestor
139367645|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
139585895|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
139585896|NCT03290430|Nicotine|nicotine|mesh-list
139585897|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139585898|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
139585899|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585900|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585901|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139585902|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139585903|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
139585904|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585905|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585906|NCT03294798|Interferons|interferons|mesh-list
139585907|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
139585908|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
139585909|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139585910|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585911|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
139585912|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585913|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
139585914|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585915|NCT04488744|Nicotine|nicotine|mesh-list
139585916|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139585917|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
139585918|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585919|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585920|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139585921|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139585922|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
139585923|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585924|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585925|NCT02005666|Clindamycin|clindamycin|mesh-list
138713888|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
139585926|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
139585927|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
139585928|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139585929|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139585930|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585931|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139585932|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585933|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585934|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
139585935|NCT03283020|Naltrexone|naltrexone|mesh-list
139585936|NCT03283020|Remifentanil|remifentanil|mesh-list
139585937|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
139585938|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139585939|NCT03283020|Narcotics|narcotics|mesh-ancestor
139585940|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585941|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585942|NCT03283020|Analgesics|analgesics|mesh-ancestor
139585943|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
139585944|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585945|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139585946|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139585947|NCT00494182|Paclitaxel|paclitaxel|mesh-list
139585948|NCT00494182|Carboplatin|carboplatin|mesh-list
139585949|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139585950|NCT00494182|Sorafenib|sorafenib|mesh-list
139585951|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139585952|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585953|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
139585954|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
139585955|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
139585956|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585957|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139585958|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585959|NCT02006056|Ondansetron|ondansetron|mesh-list
139585960|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
139585961|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
139585962|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585963|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585964|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139585965|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
139585966|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
139585967|NCT02006056|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139585968|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139585969|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
139585970|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139585971|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585972|NCT03290196|Bupivacaine|bupivacaine|mesh-list
139585973|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
139585974|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
139585975|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139585976|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585977|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
139585978|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139585979|NCT02006836|Insulin|insulin|mesh-list
139585980|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139585981|NCT02006836|Metformin|metformin|mesh-list
139585982|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
139585983|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139585984|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139585985|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
139585986|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139585987|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585988|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139585989|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139585990|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139585991|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139585992|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139585993|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139585994|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139585995|NCT03294486|Flucytosine|flucytosine|mesh-list
139585996|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
139585997|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139585998|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
139585999|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586000|NCT03294252|Leucovorin|leucovorin|mesh-list
139586001|NCT03294252|Folic Acid|folic acid|mesh-list
139586002|NCT03294252|Fluorouracil|fluorouracil|mesh-list
139586003|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
139586004|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
139586005|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
139586006|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586007|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139586008|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586009|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139586010|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
139586011|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586012|NCT03294252|Antidotes|antidotes|mesh-ancestor
139586013|NCT03294252|Protective Agents|protective agents|mesh-ancestor
139586014|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
139586015|NCT03294252|Vitamins|vitamins|mesh-ancestor
139586016|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
139586017|NCT03294252|Hematinics|hematinics|mesh-ancestor
139586018|NCT03294174|Ropivacaine|ropivacaine|mesh-list
139586019|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
139586020|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
139586021|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139586022|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586023|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
139586024|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586025|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
139586026|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
139586027|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139586028|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139586029|NCT03289338|Prednisolone|prednisolone|mesh-list
139586030|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
139586031|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139586032|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
139586033|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139586034|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
139586035|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
139586036|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586037|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586038|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139586039|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
139586040|NCT03289338|Hormones|hormones|mesh-ancestor
139586041|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586042|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139586043|NCT03289338|Protective Agents|protective agents|mesh-ancestor
139586044|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139586045|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586046|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139586047|NCT02069704|Leucovorin|leucovorin|mesh-list
139586048|NCT02069704|Folic Acid|folic acid|mesh-list
139586049|NCT02069704|Bevacizumab|bevacizumab|mesh-list
139586050|NCT02069704|Fluorouracil|fluorouracil|mesh-list
139586051|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
139586052|NCT02069704|Irinotecan|irinotecan|mesh-list
139586053|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
139586054|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139586055|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586056|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139586057|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139586058|NCT02069704|Growth Substances|growth substances|mesh-ancestor
139586059|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586060|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
139586061|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
139586062|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586063|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139586064|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139586065|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
139586066|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139586067|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139586068|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586069|NCT02069704|Antidotes|antidotes|mesh-ancestor
139586070|NCT02069704|Protective Agents|protective agents|mesh-ancestor
139586071|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
139586072|NCT02069704|Vitamins|vitamins|mesh-ancestor
139586073|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
139586074|NCT02069704|Hematinics|hematinics|mesh-ancestor
139586075|NCT02314546|Lidocaine|lidocaine|mesh-list
139586076|NCT02314546|Midazolam|midazolam|mesh-list
139586077|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139586078|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139586079|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139586080|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586081|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139586082|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139586083|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139586084|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139586085|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
139586086|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
139586087|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
139586088|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
139586089|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586090|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586091|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
139586092|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
139586093|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586094|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139586095|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139586096|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139586097|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139586098|NCT03289260|Imiquimod|imiquimod|mesh-list
139586099|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139586100|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
139586101|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586102|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586103|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
139586104|NCT03289182|Rituximab|rituximab|mesh-list
139586105|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139586106|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586107|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
139586108|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586109|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139586110|NCT03289026|Aripiprazole|aripiprazole|mesh-list
139586111|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
139586112|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139586113|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139586114|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139586115|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139586116|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586117|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
139586118|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
139586119|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586120|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586121|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139586122|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139586123|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
139586124|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139586125|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139586126|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139586127|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139367885|NCT02105077|Xenon|xenon|mesh-list
139586128|NCT02460510|Mannitol|mannitol|mesh-list
139586129|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139586130|NCT02460510|Diuretics|diuretics|mesh-ancestor
139586131|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
139586132|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586133|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
139586134|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139586135|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139586136|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139586137|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139586138|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586139|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
139586140|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586141|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586142|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139586143|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586144|NCT03288870|Docetaxel|docetaxel|mesh-list
139586145|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586146|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
139586147|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
139586148|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
139586149|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586150|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
139586151|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
139586152|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139586153|NCT02460354|Metformin|metformin|mesh-list
139586154|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139586155|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586156|NCT02008942|Aspirin|aspirin|mesh-list
139586157|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139586158|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139586159|NCT02008942|Analgesics|analgesics|mesh-ancestor
139586160|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
139586161|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586162|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586163|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139586164|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139586165|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139586166|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139586167|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586168|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139586169|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139586170|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586171|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
139586172|NCT03288636|Ritonavir|ritonavir|mesh-list
139586173|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139586174|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139586175|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
139586176|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586177|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586178|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139586179|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139586180|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
139586181|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139586182|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139586183|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139586184|NCT03293472|Bupivacaine|bupivacaine|mesh-list
139586185|NCT03293472|Ropivacaine|ropivacaine|mesh-list
139586186|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
139586187|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
139586188|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139586189|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586190|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
139586191|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586192|NCT02071810|Opicapone|opicapone|mesh-list
139586193|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139586194|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586195|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586196|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139586197|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139586198|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
139586199|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139586200|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586201|NCT01959490|Paclitaxel|paclitaxel|mesh-list
139586202|NCT01959490|Docetaxel|docetaxel|mesh-list
139586203|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
139586204|NCT01959490|Bevacizumab|bevacizumab|mesh-list
139586205|NCT01959490|Carboplatin|carboplatin|mesh-list
139586206|NCT01959490|Doxorubicin|doxorubicin|mesh-list
139586207|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139586208|NCT01959490|Trastuzumab|trastuzumab|mesh-list
139586209|NCT01959490|Pertuzumab|pertuzumab|mesh-list
139586210|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139586211|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586212|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
139586213|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
139586214|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
139586215|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586216|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139586217|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
139586218|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586219|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139586220|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139586221|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
139586222|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139586223|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139586224|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138714194|NCT04581213|Anesthetics|anesthetics|mesh-list
139586225|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139586226|NCT01959490|Growth Substances|growth substances|mesh-ancestor
139586227|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
139586228|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139586229|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139586230|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139586231|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586232|NCT03288402|Caffeine|caffeine|mesh-list
139586233|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139586234|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586235|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139586236|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586237|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586238|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139586239|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139586240|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
139586241|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586242|NCT02011516|Baclofen|baclofen|mesh-list
139586243|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139586244|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586245|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139586246|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586247|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139586248|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
139586249|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
139586250|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586251|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586252|NCT04349410|Interferons|interferons|mesh-list
139586253|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
139586254|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
139586255|NCT04349410|Remdesivir|remdesivir|mesh-list
139586256|NCT04349410|Azithromycin|azithromycin|mesh-list
139586257|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
139586258|NCT04349410|Doxycycline|doxycycline|mesh-list
139586259|NCT04349410|Clindamycin|clindamycin|mesh-list
139586260|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
139586261|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
139586262|NCT04349410|Primaquine|primaquine|mesh-list
139586263|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
139586264|NCT04349410|Losartan|losartan|mesh-list
139586265|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586266|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
139586267|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139586268|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139586269|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
139586270|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
139586271|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586272|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586273|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139586274|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
139586275|NCT04349410|Hormones|hormones|mesh-ancestor
139586276|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586277|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139368013|NCT05039606|Nedaplatin|nedaplatin|mesh-list
139586278|NCT04349410|Protective Agents|protective agents|mesh-ancestor
139586279|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
139586280|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139586281|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
139586282|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139586283|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139586284|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586285|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586286|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139586287|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139586288|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139586289|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139586290|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139586291|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139586292|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
139586293|NCT03287388|Rocuronium|rocuronium|mesh-list
139586294|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139586295|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139586296|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139586297|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586298|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586299|NCT03293004|Vitamins|vitamins|mesh-list
139586300|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
139586301|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
139586302|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586303|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
139586304|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586305|NCT03293004|Protective Agents|protective agents|mesh-ancestor
139586306|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
139586307|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
138714271|NCT00562835|Protective Agents|protective agents|mesh-ancestor
139586308|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586309|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586310|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586311|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
139586312|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
139586313|NCT03282162|Oxytocin|oxytocin|mesh-list
139586314|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
139586315|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139586316|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586317|NCT03287076|Exenatide|exenatide|mesh-list
139586318|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139586319|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586320|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139586321|NCT03287076|Incretins|incretins|mesh-ancestor
139586322|NCT03287076|Hormones|hormones|mesh-ancestor
139586323|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586324|NCT02460276|Rituximab|rituximab|mesh-list
139586325|NCT02460276|Lenalidomide|lenalidomide|mesh-list
139586326|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139586327|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586328|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
139586329|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586330|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139586331|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139586332|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139586333|NCT02460276|Growth Substances|growth substances|mesh-ancestor
139586334|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
139586335|NCT02460432|Paclitaxel|paclitaxel|mesh-list
139586336|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139586337|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586338|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
139586339|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
139586340|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
139586341|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586342|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
139586343|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139586344|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139586345|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139586346|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
139586347|NCT03281928|Diuretics|diuretics|mesh-ancestor
139586348|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
139586349|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586350|NCT03281928|Expectorants|expectorants|mesh-ancestor
139586351|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
139586352|NCT03286764|Peppermint oil|peppermint oil|mesh-list
139586353|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
139586354|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
139586355|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586356|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586357|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139586358|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
139586359|NCT03281694|Nicotine|nicotine|mesh-list
139586360|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139586361|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
139586362|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586363|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586364|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139586365|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139586366|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
139586367|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586368|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586369|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
139586370|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139586371|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
139586372|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139586373|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586374|NCT03291054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139586375|NCT03291054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586376|NCT03286296|Antibodies|antibodies|mesh-list
139586377|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139586378|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
139586379|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586380|NCT03285906|Apatinib|apatinib|mesh-list
139586381|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586382|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139586383|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586384|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586385|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139586386|NCT01895205|Hematinics|hematinics|mesh-ancestor
139586387|NCT01748175|Triamcinolone|triamcinolone|mesh-list
139586388|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139586389|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139586390|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139586391|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139586392|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
139586393|NCT01748175|Hormones|hormones|mesh-ancestor
139586394|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586395|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586396|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139586397|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
139586398|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586399|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586400|NCT04755387|Ticagrelor|ticagrelor|mesh-list
139586401|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139586402|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139586403|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139586404|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139586405|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
139586406|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586407|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586408|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586409|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
139586410|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139586411|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139586412|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
139586413|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586414|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139586415|NCT03285360|Fluorides|fluorides|mesh-list
139586416|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
139586417|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
139586418|NCT03285360|Protective Agents|protective agents|mesh-ancestor
139586419|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586420|NCT00160173|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139586421|NCT00160173|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139586422|NCT00160173|Estradiol|estradiol|mesh-list
139586423|NCT00160173|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139586424|NCT00160173|Estrogens|estrogens|mesh-ancestor
139586425|NCT00160173|Hormones|hormones|mesh-ancestor
139586426|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586427|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586428|NCT00160173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139368171|NCT02110303|Ticagrelor|ticagrelor|mesh-list
139586429|NCT00160173|Contraceptive Agents|contraceptive agents|mesh-ancestor
139586430|NCT00160173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139586431|NCT00160173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139586432|NCT00136695|Anastrozole|anastrozole|mesh-list
139586433|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139586434|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586435|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139586436|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139586437|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586438|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586439|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139586440|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
139586441|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586442|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586443|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
139586444|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139586445|NCT02459574|Amiodarone|amiodarone|mesh-list
139586446|NCT02459574|Sotalol|sotalol|mesh-list
139586447|NCT02459574|Flecainide|flecainide|mesh-list
139586448|NCT02459574|Propafenone|propafenone|mesh-list
139586449|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139586450|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
139586451|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139586452|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586453|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139586454|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139586455|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
139586456|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586457|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586458|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
139586459|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139586460|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139586461|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139586462|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139586463|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139586464|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586465|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139586466|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139586467|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139586468|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
139586469|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
139586470|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586471|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139586472|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
139586473|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139586474|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139586475|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586476|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
139586477|NCT03280212|Coagulants|coagulants|mesh-ancestor
139586478|NCT03536520|Acetazolamide|acetazolamide|mesh-list
139586479|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
139586480|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139586481|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586482|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586483|NCT03536520|Diuretics|diuretics|mesh-ancestor
139586484|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
139586485|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586486|NCT01673217|Doxorubicin|doxorubicin|mesh-list
139586487|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139586488|NCT01673217|Decitabine|decitabine|mesh-list
139586489|NCT01673217|Azacitidine|azacitidine|mesh-list
139586490|NCT01673217|Vaccines|vaccines|mesh-list
139586491|NCT01673217|Sargramostim|sargramostim|mesh-list
139586492|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
139586493|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
139586494|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586495|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139586496|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586497|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139586498|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139586499|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586500|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586501|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139586502|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
139586503|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139586504|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
139586505|NCT03475134|Nivolumab|nivolumab|mesh-list
139586506|NCT03475134|Fludarabine|fludarabine|mesh-list
139586507|NCT03475134|Interleukin-2|interleukin-2|mesh-list
139586508|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139586509|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
139586510|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586511|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139586512|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139586513|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
139586514|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586515|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586516|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139586517|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138714490|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
139586518|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139586519|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139586520|NCT03475134|Analgesics|analgesics|mesh-ancestor
139586521|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
139586522|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586523|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139586524|NCT01668849|Fentanyl|fentanyl|mesh-list
139586525|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139586526|NCT01668849|Narcotics|narcotics|mesh-ancestor
139586527|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139586528|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586529|NCT01668849|Analgesics|analgesics|mesh-ancestor
139586530|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
139586531|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586532|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139586533|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139586534|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
139586535|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
139586536|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139586537|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139586538|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139586539|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139586540|NCT01252719|Vancomycin|vancomycin|mesh-list
139586541|NCT01252719|Oritavancin|oritavancin|mesh-list
139586542|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139586543|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139586544|NCT01230411|Ibuprofen|ibuprofen|mesh-list
139586545|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139586546|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139586547|NCT01230411|Analgesics|analgesics|mesh-ancestor
139586548|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
139586549|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586550|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586551|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139586552|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139586553|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139586554|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586555|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586556|NCT03283800|Copper|copper|mesh-list
139586557|NCT03283800|Trace Elements|trace elements|mesh-ancestor
139586558|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
139586559|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586560|NCT01962688|Diuretics|diuretics|mesh-list
139586561|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
139586562|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586563|NCT03274596|Vitamin E|vitamin e|mesh-list
139586564|NCT03274596|Vitamins|vitamins|mesh-ancestor
139586565|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
139586566|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586567|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
139586568|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586569|NCT03274596|Protective Agents|protective agents|mesh-ancestor
139586570|NCT01963078|Oxytocin|oxytocin|mesh-list
139586571|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
139586572|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139586573|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586574|NCT03269760|Zolpidem|zolpidem|mesh-list
139586575|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139586576|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139586577|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139586578|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586579|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139586580|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
139586581|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
139586582|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586583|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586584|NCT03269916|Hormones|hormones|mesh-list
139586585|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139586586|NCT03269916|Estrogens|estrogens|mesh-list
139586587|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586588|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586589|NCT02346916|Capsaicin|capsaicin|mesh-list
139586590|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
139586591|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
139586592|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
139586593|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586594|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586595|NCT02458482|Albuterol|albuterol|mesh-list
139586596|NCT02458482|Ipratropium|ipratropium|mesh-list
139586597|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139586598|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
139586599|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586600|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586601|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139586602|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
139586603|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
139586604|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139586605|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139586606|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139586607|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139586608|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
139586609|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586610|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586611|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139586612|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
139586613|NCT03273192|Adalimumab|adalimumab|mesh-list
139586614|NCT03273192|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139586615|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139586616|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139586617|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139586618|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139586619|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139586620|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
139586621|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
139586622|NCT02349178|Etoposide|etoposide|mesh-list
139586623|NCT02349178|Clofarabine|clofarabine|mesh-list
139586624|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139586625|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
139586626|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586627|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139586628|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139586629|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
139586630|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586631|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586632|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139586633|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139586634|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139586635|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139586636|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586637|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139586638|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
139586639|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139586640|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139586641|NCT05075460|Azacitidine|azacitidine|mesh-list
139586642|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138714618|NCT00563147|Sirolimus|sirolimus|mesh-list
139586643|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
139586644|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586645|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586646|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586647|NCT01966978|Insulin|insulin|mesh-list
139586648|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139586649|NCT01966978|Metformin|metformin|mesh-list
139586650|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
139586651|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
139586652|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139586653|NCT01966978|Liraglutide|liraglutide|mesh-list
139586654|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
139586655|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139586656|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586657|NCT01966978|Incretins|incretins|mesh-ancestor
139586658|NCT01966978|Hormones|hormones|mesh-ancestor
139586659|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586660|NCT03269214|Phenytoin|phenytoin|mesh-list
139586661|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
139586662|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139586663|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139586664|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139586665|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586666|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139586667|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139586668|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
139586669|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139586670|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586671|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139586672|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586673|NCT05074602|Fluconazole|fluconazole|mesh-list
139586674|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
139586675|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139586676|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139586677|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139586678|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586679|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586680|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139586681|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
139586682|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586683|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586684|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139586685|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139586686|NCT02457312|Letrozole|letrozole|mesh-list
139586687|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586688|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139586689|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139586690|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586691|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586692|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139586693|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
139586694|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586695|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586696|NCT03268902|Niacinamide|niacinamide|mesh-list
139586698|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
139586699|NCT03268902|Azithromycin|azithromycin|mesh-list
139586700|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
139586701|NCT03268902|Vitamins|vitamins|mesh-ancestor
139586702|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
139586703|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586704|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139586705|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139586706|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
139586707|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139586708|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
139586709|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586710|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139586711|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
139586712|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139586713|NCT02458716|Leuprolide|leuprolide|mesh-list
139586714|NCT02458716|Bicalutamide|bicalutamide|mesh-list
139586715|NCT02458716|Androgens|androgens|mesh-list
139586716|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
139586717|NCT02458716|Hormones|hormones|mesh-ancestor
139586718|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586719|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586720|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139586721|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
139586722|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139586723|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139586724|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586725|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
139586726|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
139586727|NCT03268278|Lidocaine|lidocaine|mesh-list
139586728|NCT03268278|Epinephrine|epinephrine|mesh-list
139586729|NCT03268278|Buprenorphine|buprenorphine|mesh-list
139586730|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
139586731|NCT03268278|Anesthetics|anesthetics|mesh-list
139368467|NCT02111317|Verapamil|verapamil|mesh-list
139586732|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139586733|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586734|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
139586735|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586736|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139586737|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139586738|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139586739|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139586740|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586741|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139586742|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139586743|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
139586744|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586745|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139586746|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139586747|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
139586748|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139586749|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
139586750|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
139586751|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
139586752|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139586753|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139586754|NCT03268278|Narcotics|narcotics|mesh-ancestor
139586755|NCT03268278|Analgesics|analgesics|mesh-ancestor
139586756|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139586757|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
139586758|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139586759|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
139586760|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586761|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
139586762|NCT05045586|Protective Agents|protective agents|mesh-ancestor
139586763|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
139586764|NCT03263520|Dexamethasone|dexamethasone|mesh-list
139586765|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
139586766|NCT03263520|Nandrolone|nandrolone|mesh-list
139586767|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
139586768|NCT03263520|BB 1101|bb 1101|mesh-list
139586769|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139586770|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
139586771|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
139586772|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586773|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586774|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139586775|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
139586776|NCT03263520|Hormones|hormones|mesh-ancestor
139586777|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586778|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139586779|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586780|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
139586781|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586782|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586783|NCT03263520|Androgens|androgens|mesh-ancestor
139586784|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
139586785|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139586786|NCT02456844|Leucovorin|leucovorin|mesh-list
139586787|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
139586788|NCT02456844|Methotrexate|methotrexate|mesh-list
139586789|NCT02456844|Digoxin|digoxin|mesh-list
139586790|NCT02456844|Midazolam|midazolam|mesh-list
139586791|NCT02456844|Pravastatin|pravastatin|mesh-list
139586792|NCT02456844|Montelukast|montelukast|mesh-list
139586793|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139586794|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
139586795|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139586796|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586797|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139586798|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
139586799|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586800|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586801|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
139586802|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586803|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139586804|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139586805|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
139586806|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138714797|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
139586807|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139586808|NCT02456844|Antidotes|antidotes|mesh-ancestor
139586809|NCT02456844|Protective Agents|protective agents|mesh-ancestor
139586810|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
139586811|NCT02456844|Vitamins|vitamins|mesh-ancestor
139586812|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
139586813|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139586814|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139586815|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139586816|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139586817|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139586818|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139586819|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139586820|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
139586821|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
139586822|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
139586823|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
139586824|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586825|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139586826|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
139586827|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139586828|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
139586829|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586830|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139586831|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139586832|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139586833|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139586834|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139586835|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139586836|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139586837|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139586838|NCT02456844|Analgesics|analgesics|mesh-ancestor
139586839|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
139586840|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586841|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139586842|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139586843|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139586844|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139586845|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
139586846|NCT03263208|Fludarabine|fludarabine|mesh-list
139586847|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139586848|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
139586849|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586850|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139586851|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139586852|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
139586853|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586854|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586855|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139586856|NCT03259542|Itraconazole|itraconazole|mesh-list
139586857|NCT03259542|Mifepristone|mifepristone|mesh-list
139586858|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
139586859|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139586860|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139586861|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139586862|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586863|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586864|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139586865|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
139586866|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586867|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586868|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139586869|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139586870|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
139586871|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139586872|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139586873|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139586874|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139586875|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
139586876|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139586877|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139586878|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
139586879|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139586880|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139586881|NCT03267654|Apatinib|apatinib|mesh-list
139586882|NCT03267654|Gefitinib|gefitinib|mesh-list
139586883|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586884|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139586885|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586886|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586887|NCT03263052|Tacrolimus|tacrolimus|mesh-list
139586888|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139586889|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
139586890|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586891|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139586892|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586893|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586894|NCT03267030|Eryaspase|eryaspase|mesh-list
139586895|NCT03267030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139586896|NCT03259152|Denosumab|denosumab|mesh-list
139586897|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139586898|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586899|NCT02456142|Morphine|morphine|mesh-list
139586900|NCT02456142|Bupivacaine|bupivacaine|mesh-list
139586901|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
139586902|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
139586903|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139586904|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586905|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
139586906|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139586907|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139586908|NCT02456142|Narcotics|narcotics|mesh-ancestor
139586909|NCT02456142|Analgesics|analgesics|mesh-ancestor
139586910|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139586911|NCT03262740|Norethindrone|norethindrone|mesh-list
139586912|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
139586913|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
139586914|NCT03262740|Estradiol|estradiol|mesh-list
139586915|NCT03262740|Branebrutinib|branebrutinib|mesh-list
139586916|NCT03262740|Estrogens|estrogens|mesh-ancestor
139586917|NCT03262740|Hormones|hormones|mesh-ancestor
139586918|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586919|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586920|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139586921|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
139586922|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139586923|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139586924|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139586925|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139586926|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139586927|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139586928|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
139586929|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139586930|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586931|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586932|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139586933|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139586934|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586935|NCT03258684|Thiamine|thiamine|mesh-list
139586936|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
139586937|NCT03258684|Vitamins|vitamins|mesh-ancestor
139586938|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
139586939|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586940|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139586941|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
139586942|NCT03266250|Anesthetics|anesthetics|mesh-list
139586943|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139586944|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586945|NCT03258372|Rifampin|rifampin|mesh-list
139586946|NCT03258372|Mifepristone|mifepristone|mesh-list
139586947|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139586948|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
139586949|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139586950|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139586951|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
139586952|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139586953|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586954|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586955|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139586956|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139586957|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139586958|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139586959|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139586960|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139586961|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139586962|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
139586963|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139586964|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586965|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139586966|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139586967|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139586968|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
139586969|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139586970|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139586971|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
139586972|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139586973|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
139586974|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139586975|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139586976|NCT02456454|Valproic Acid|valproic acid|mesh-list
139586977|NCT02456454|Risperidone|risperidone|mesh-list
139586978|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139586979|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
139586980|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139586981|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586982|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586983|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139586984|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139586985|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139586986|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139586987|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139586988|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
139586989|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
139586990|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139586991|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
139586992|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
139586993|NCT03258294|Melatonin|melatonin|mesh-list
139586994|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
139586995|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139586996|NCT03258294|Protective Agents|protective agents|mesh-ancestor
139586997|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139586998|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139586999|NCT03265782|Acetaminophen|acetaminophen|mesh-list
139587000|NCT03265782|Ibuprofen|ibuprofen|mesh-list
139587001|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139587002|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139587003|NCT03265782|Analgesics|analgesics|mesh-ancestor
139587004|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
139587005|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587006|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587007|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139587008|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139587009|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139587010|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587011|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587012|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
139587013|NCT03798054|Insulin|insulin|mesh-list
139587014|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139587015|NCT03798054|Metformin|metformin|mesh-list
139587016|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
139587017|NCT03798054|Lixisenatide|lixisenatide|mesh-list
139587018|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139587019|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139587020|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587021|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587022|NCT03265470|Fentanyl|fentanyl|mesh-list
139587023|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
139587024|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139587025|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587026|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587027|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139587028|NCT03265470|Analgesics|analgesics|mesh-ancestor
139587029|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
139587030|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587031|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139587032|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139587034|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
139587035|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587036|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587037|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139587038|NCT03265470|Narcotics|narcotics|mesh-ancestor
139587039|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139587040|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139587041|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
139587042|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
139587043|NCT02019940|Riluzole|riluzole|mesh-list
139587044|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
139587045|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139587046|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139587047|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587048|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587049|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715033|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
139587050|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139587051|NCT02019940|Protective Agents|protective agents|mesh-ancestor
139587052|NCT01229943|Bevacizumab|bevacizumab|mesh-list
139587053|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139587054|NCT01229943|Everolimus|everolimus|mesh-list
139587055|NCT01229943|Octreotide|octreotide|mesh-list
139587056|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
139587057|NCT01229943|Antibodies|antibodies|mesh-list
139587058|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
139587059|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139587060|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
139587061|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587062|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139587063|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139587064|NCT01229943|Growth Substances|growth substances|mesh-ancestor
139587065|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587066|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
139587067|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
139587068|NCT01229943|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139587069|NCT01229943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139587070|NCT01229943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587071|NCT01229943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587072|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139587073|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139587074|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139587075|NCT02020408|Raclopride|raclopride|mesh-list
139587076|NCT02020408|Amphetamine|amphetamine|mesh-list
139587077|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
138715084|NCT00575874|Pioglitazone|pioglitazone|mesh-list
139587078|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139587079|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587080|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
139587081|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
139587082|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587083|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
139587084|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587085|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587086|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
139587087|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139587088|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139587089|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139587090|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139587091|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139587092|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139587093|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587094|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139587095|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139587096|NCT01219257|Adalimumab|adalimumab|mesh-list
139587097|NCT01219257|Infliximab|infliximab|mesh-list
139587098|NCT01219257|Golimumab|golimumab|mesh-list
139587099|NCT01219257|Etanercept|etanercept|mesh-list
139587100|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139587101|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139587102|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139587103|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
139587104|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139587105|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139368909|NCT03552211|Biotin|biotin|mesh-list
139587106|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139587107|NCT01219257|Analgesics|analgesics|mesh-ancestor
139587108|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
139587109|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587110|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587111|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139587112|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
139587113|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139587114|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139587115|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587116|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139587117|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139587118|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139587119|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587120|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
138715112|NCT00565682|Etoricoxib|etoricoxib|mesh-list
139587121|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587122|NCT04389801|Deferoxamine|deferoxamine|mesh-list
139587123|NCT04389801|Siderophores|siderophores|mesh-ancestor
139587124|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139587125|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
139587126|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
139587127|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587128|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
139587129|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139587130|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
139587131|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139587132|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
139587133|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587134|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587135|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
139587137|NCT03548220|Enzyme Activators|enzyme activators|mesh-ancestor
139587138|NCT03548220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587139|NCT03257670|Lidocaine|lidocaine|mesh-list
139587140|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
139587141|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
139587142|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587143|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587144|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
139587145|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587146|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139587147|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139587148|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139587149|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139587150|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587151|NCT03265002|Psyllium|psyllium|mesh-list
139587152|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
139587153|NCT03265002|Cathartics|cathartics|mesh-ancestor
139587154|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139587155|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
139587156|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
139587157|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
139587158|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587159|NCT03257514|Protective Agents|protective agents|mesh-ancestor
139587160|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587161|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
139587162|NCT03257514|Vitamins|vitamins|mesh-ancestor
139587163|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
139587164|NCT04781751|Insulin|insulin|mesh-list
139587165|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139587166|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587167|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139587168|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139587169|NCT03261024|Nickel|nickel|mesh-list
139587170|NCT03261024|Trace Elements|trace elements|mesh-ancestor
139587171|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
139587172|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587173|NCT04777383|Atropine|atropine|mesh-list
139587174|NCT04777383|Phenylephrine|phenylephrine|mesh-list
139587175|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
139587176|NCT04777383|Norepinephrine|norepinephrine|mesh-list
139587177|NCT04777383|Acetylcholine|acetylcholine|mesh-list
139587178|NCT04777383|Neostigmine|neostigmine|mesh-list
139587179|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139587180|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
139587181|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
139587182|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587184|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
139587185|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139587186|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
139587187|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
139587188|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139587189|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139587190|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139587191|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
139587192|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587193|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587194|NCT04777383|Protective Agents|protective agents|mesh-ancestor
139587195|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139587196|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139587197|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139587198|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139587199|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
139587200|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139587201|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139587202|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
139587203|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139587204|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587205|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139587206|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
139587207|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139587208|NCT03257124|Osimertinib|osimertinib|mesh-list
139587209|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587210|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139587211|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587212|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587213|NCT02089113|Dexamethasone|dexamethasone|mesh-list
139587214|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139587215|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
139587216|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
139587217|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587218|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587219|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139587220|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
139587221|NCT02089113|Hormones|hormones|mesh-ancestor
139587222|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139587223|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139587224|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587225|NCT03260634|Voriconazole|voriconazole|mesh-list
139587226|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
139587227|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139587228|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139587229|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139587230|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587231|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587232|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139587233|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
139587234|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139587235|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587236|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139587237|NCT04777227|Lidocaine|lidocaine|mesh-list
139587238|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
139587239|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
139587240|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587241|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587242|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
139587243|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587244|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139587245|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139587246|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139587247|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139587248|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587249|NCT03260556|Pirfenidone|pirfenidone|mesh-list
139587250|NCT03260556|Analgesics|analgesics|mesh-ancestor
139587251|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
139587252|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587253|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368988|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
139587254|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139587255|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139587256|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139587257|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139587258|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587259|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139587260|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139587261|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587262|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139587263|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139587264|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139587265|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587266|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
139587267|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587268|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139587269|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
139587270|NCT03252366|Coagulants|coagulants|mesh-ancestor
139587271|NCT04346277|Antibodies|antibodies|mesh-list
139587272|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139587273|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
139587274|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587275|NCT04780347|Paclitaxel|paclitaxel|mesh-list
139587276|NCT04780347|Capecitabine|capecitabine|mesh-list
139587277|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139587278|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139587279|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587280|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
139587281|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
139587282|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
139587283|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587284|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139587285|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
139587286|NCT02455596|Interferons|interferons|mesh-list
139587287|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587288|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
139587289|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139587290|NCT02455440|Propofol|propofol|mesh-list
139587291|NCT02455440|Sevoflurane|sevoflurane|mesh-list
139587292|NCT02455440|Esmolol|esmolol|mesh-list
139587293|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139587294|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587295|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587296|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139587297|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
139587298|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
139587299|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139587300|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139587301|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139587302|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139587303|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139587304|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
139587305|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587306|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587307|NCT03260166|Niacinamide|niacinamide|mesh-list
139587308|NCT03260166|Niacin|niacin|mesh-list
139587309|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
139587310|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
139587311|NCT03260166|Vitamins|vitamins|mesh-ancestor
139587312|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
139587313|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587314|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139587315|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
139587316|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587317|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139587318|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
139587319|NCT03260010|Fosfomycin|fosfomycin|mesh-list
139587320|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139587321|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139587322|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
139587323|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139587324|NCT03260088|Antibodies|antibodies|mesh-list
139587325|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
139587326|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
139587327|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587328|NCT04776135|Edaravone|edaravone|mesh-list
139587329|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139587330|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
139587331|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587332|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139587333|NCT04776135|Protective Agents|protective agents|mesh-ancestor
139587334|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587335|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139587337|NCT03474276|Albendazole|albendazole|mesh-list
139587338|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
139587339|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139587340|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
139587341|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
139587342|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139587343|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139587344|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
139587345|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
139587346|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
139587347|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587348|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587349|NCT04779255|Acetaminophen|acetaminophen|mesh-list
139587350|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587351|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139587352|NCT04779255|Analgesics|analgesics|mesh-ancestor
139587353|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
139587354|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587355|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
139587356|NCT04779567|Acetaminophen|acetaminophen|mesh-list
139587357|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139587358|NCT04779567|Analgesics|analgesics|mesh-ancestor
139587359|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
139587360|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587361|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587362|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
139587363|NCT02352844|Everolimus|everolimus|mesh-list
139587364|NCT02352844|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139587365|NCT02352844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139587366|NCT02352844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587367|NCT02352844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587368|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139587369|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
139587370|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587371|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587372|NCT03255642|Clonazepam|clonazepam|mesh-list
139587373|NCT03255642|Melatonin|melatonin|mesh-list
139587374|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
139587375|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587376|NCT03255642|Protective Agents|protective agents|mesh-ancestor
139587377|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587378|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587379|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
139587380|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
139587381|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
139587382|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587383|NCT03562377|Vaccines|vaccines|mesh-list
139587384|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
139587385|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587386|NCT02352922|Bupivacaine|bupivacaine|mesh-list
139587387|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
139587388|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
139587389|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587390|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587391|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
139587392|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587393|NCT03255330|Dipyrone|dipyrone|mesh-list
139587394|NCT03255330|Gabapentin|gabapentin|mesh-list
139587395|NCT03255330|Tramadol|tramadol|mesh-list
139587396|NCT03255330|Analgesics|analgesics|mesh-ancestor
139587397|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
139587398|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587399|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587400|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
139587401|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139587402|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139587403|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587404|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139587405|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139587406|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139587407|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587408|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587409|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
139587410|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139587411|NCT03255330|Narcotics|narcotics|mesh-ancestor
139587412|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139587413|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139587414|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139587415|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139587416|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
139587417|NCT02353780|Etanercept|etanercept|mesh-list
139587418|NCT02353780|Infliximab|infliximab|mesh-list
139587419|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
139587420|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139587421|NCT02353780|Abatacept|abatacept|mesh-list
139587422|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139587423|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139587424|NCT02353780|Analgesics|analgesics|mesh-ancestor
139587425|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
139587426|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587427|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587428|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139587429|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139587430|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139587431|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139587432|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
139587433|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139587434|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587435|NCT02353780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139587436|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587437|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
139587438|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139587439|NCT03246360|Cloxacillin|cloxacillin|mesh-list
139587440|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139587441|NCT02354092|Anesthetics|anesthetics|mesh-list
139587442|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
139587443|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587444|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587445|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
139587446|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587447|NCT00907101|Adapalene|adapalene|mesh-list
139587448|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
139587449|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139587450|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
139587451|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139587452|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139587453|NCT00907101|Analgesics|analgesics|mesh-ancestor
139587454|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
139587455|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587456|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587457|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139587458|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139587459|NCT03245970|Atenolol|atenolol|mesh-list
139587460|NCT03245970|Labetalol|labetalol|mesh-list
139587461|NCT03245970|Nifedipine|nifedipine|mesh-list
139587462|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139587463|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139587464|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587465|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139587466|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587467|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
139587468|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
139587469|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139587470|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139587471|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139587472|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
139587473|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
139587474|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587475|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139587476|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139587477|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139587478|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
139587479|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587480|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
139587481|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139587482|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139587483|NCT02454348|Vasopressins|vasopressins|mesh-list
139587484|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
139587485|NCT02454348|Norepinephrine|norepinephrine|mesh-list
139587486|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139587487|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139587488|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
139587489|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587490|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587491|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587492|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
139587493|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
139587494|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587495|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139587496|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
139587497|NCT02454348|Coagulants|coagulants|mesh-ancestor
139587498|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139587499|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
139587500|NCT02455908|Aldesleukin|aldesleukin|mesh-list
139587501|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587502|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139587503|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139587504|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
139587505|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139587506|NCT06112665|Tofacitinib|tofacitinib|mesh-list
139587507|NCT06112665|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139587508|NCT06112665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139587509|NCT06112665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587510|NCT06112665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587511|NCT06112548|Acetaminophen|acetaminophen|mesh-list
139587512|NCT06112548|Ketorolac|ketorolac|mesh-list
139587513|NCT06112548|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139587514|NCT06112548|Epinephrine|epinephrine|mesh-list
139587515|NCT06112548|Tramadol|tramadol|mesh-list
139587516|NCT06112548|Bupivacaine|bupivacaine|mesh-list
139587517|NCT06112548|Anesthetics, Local|anesthetics, local|mesh-ancestor
139587518|NCT06112548|Anesthetics|anesthetics|mesh-ancestor
139587519|NCT06112548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587520|NCT06112548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587521|NCT06112548|Sensory System Agents|sensory system agents|mesh-ancestor
139587522|NCT06112548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587523|NCT06112548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139587524|NCT06112548|Analgesics|analgesics|mesh-ancestor
139587525|NCT06112548|Antipyretics|antipyretics|mesh-ancestor
139587526|NCT06112548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139587527|NCT06112548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139587528|NCT06112548|Adrenergic Agents|adrenergic agents|mesh-ancestor
139587529|NCT06112548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587530|NCT06112548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715513|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
139587531|NCT06112548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139587532|NCT06112548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139587533|NCT06112548|Autonomic Agents|autonomic agents|mesh-ancestor
139587534|NCT06112548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139587535|NCT06112548|Respiratory System Agents|respiratory system agents|mesh-ancestor
139587536|NCT06112548|Mydriatics|mydriatics|mesh-ancestor
139587537|NCT06112548|Sympathomimetics|sympathomimetics|mesh-ancestor
139587538|NCT06112548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139587539|NCT06112548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139587540|NCT06112548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139587541|NCT06112548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139587542|NCT06112548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139587543|NCT06112548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587544|NCT06112548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139587545|NCT06112548|Narcotics|narcotics|mesh-ancestor
139587546|NCT06112522|Tirbanibulin|tirbanibulin|mesh-list
139587547|NCT06112522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587548|NCT06112522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587549|NCT06112353|Glycopyrrolate|glycopyrrolate|mesh-list
139587550|NCT06112353|Neostigmine|neostigmine|mesh-list
139587551|NCT06112353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139587552|NCT06112353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587553|NCT06112353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587554|NCT06112353|Cholinergic Agents|cholinergic agents|mesh-ancestor
139587555|NCT06112353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369291|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139587556|NCT06112353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587557|NCT06112353|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139587558|NCT06112353|Autonomic Agents|autonomic agents|mesh-ancestor
139587559|NCT06112353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587560|NCT06112353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139587561|NCT06112353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139587562|NCT06112353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139587563|NCT06112314|Nivolumab|nivolumab|mesh-list
139587564|NCT06112314|Relatlimab|relatlimab|mesh-list
139587565|NCT06112314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139587566|NCT06112314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587567|NCT06112314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139587568|NCT06112314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587569|NCT06112223|Gabapentin|gabapentin|mesh-list
139587570|NCT06112223|Tramadol|tramadol|mesh-list
139587571|NCT06112223|Analgesics|analgesics|mesh-ancestor
139587572|NCT06112223|Sensory System Agents|sensory system agents|mesh-ancestor
139587573|NCT06112223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587574|NCT06112223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587575|NCT06112223|Anticonvulsants|anticonvulsants|mesh-ancestor
139587576|NCT06112223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139587577|NCT06112223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139587578|NCT06112223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587579|NCT06112223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139587580|NCT06112223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139587581|NCT06112223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139587582|NCT06112223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587583|NCT06112223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587584|NCT06112223|Antimanic Agents|antimanic agents|mesh-ancestor
139587585|NCT06112223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139587586|NCT06112223|Narcotics|narcotics|mesh-ancestor
139587587|NCT06112041|Thymopentin|thymopentin|mesh-list
139587588|NCT06112041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139587589|NCT06112041|Immunologic Factors|immunologic factors|mesh-ancestor
139587590|NCT06112041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587591|NCT06111885|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139587592|NCT06111885|Chlorthalidone|chlorthalidone|mesh-list
139587593|NCT06111885|Indapamide|indapamide|mesh-list
139587594|NCT06111885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139587595|NCT06111885|Diuretics|diuretics|mesh-ancestor
139587596|NCT06111885|Natriuretic Agents|natriuretic agents|mesh-ancestor
139587597|NCT06111885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587598|NCT06111885|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139587599|NCT06111885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139587600|NCT06111885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587601|NCT06111872|Midazolam|midazolam|mesh-list
139587602|NCT06111872|Meperidine|meperidine|mesh-list
139587603|NCT06111872|Ketamine|ketamine|mesh-list
139587604|NCT06111872|Analgesics|analgesics|mesh-ancestor
139587605|NCT06111872|Sensory System Agents|sensory system agents|mesh-ancestor
139587606|NCT06111872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587607|NCT06111872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587608|NCT06111872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139587609|NCT06111872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139587610|NCT06111872|Anesthetics, General|anesthetics, general|mesh-ancestor
139587611|NCT06111872|Anesthetics|anesthetics|mesh-ancestor
139587612|NCT06111872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587613|NCT06111872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139587614|NCT06111872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139587615|NCT06111872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587616|NCT06111872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587617|NCT06111872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139587618|NCT06111872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139587619|NCT06111872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139587620|NCT06111872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139587621|NCT06111872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139587622|NCT06111872|GABA Modulators|gaba modulators|mesh-ancestor
139587623|NCT06111872|GABA Agents|gaba agents|mesh-ancestor
139587624|NCT06111872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139587625|NCT06111872|Narcotics|narcotics|mesh-ancestor
139587626|NCT06111768|Dapagliflozin|dapagliflozin|mesh-list
139587627|NCT06111768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139587628|NCT06111768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587629|NCT06111768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139587630|NCT06111768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587631|NCT06111625|Blinatumomab|blinatumomab|mesh-list
139587632|NCT06111625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587633|NCT06111521|Digoxin|digoxin|mesh-list
139587634|NCT06111521|Midazolam|midazolam|mesh-list
139587635|NCT06111521|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139587636|NCT06111521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139587637|NCT06111521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139587638|NCT06111521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587639|NCT06111521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587640|NCT06111521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139587641|NCT06111521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139587642|NCT06111521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139587643|NCT06111521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139587644|NCT06111521|Anesthetics, General|anesthetics, general|mesh-ancestor
139587646|NCT06111521|GABA Modulators|gaba modulators|mesh-ancestor
139587647|NCT06111521|GABA Agents|gaba agents|mesh-ancestor
139587648|NCT06111521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587649|NCT06111521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587650|NCT06111521|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139587651|NCT06111521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139587652|NCT06111521|Antimetabolites|antimetabolites|mesh-ancestor
139587653|NCT06111521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139587654|NCT06111521|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139587655|NCT06111521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587656|NCT06111521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139587657|NCT06111521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139587658|NCT06111521|Protective Agents|protective agents|mesh-ancestor
139587659|NCT06111352|Atropine|atropine|mesh-list
139587660|NCT06111352|Pralidoxime|pralidoxime|mesh-list
139587661|NCT06111352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139587662|NCT06111352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139587663|NCT06111352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139587664|NCT06111352|Autonomic Agents|autonomic agents|mesh-ancestor
139587665|NCT06111352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587666|NCT06111352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587667|NCT06111352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139587668|NCT06111352|Respiratory System Agents|respiratory system agents|mesh-ancestor
139587669|NCT06111352|Mydriatics|mydriatics|mesh-ancestor
139587670|NCT06111352|Parasympatholytics|parasympatholytics|mesh-ancestor
139587671|NCT06111352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139587672|NCT06111352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139587673|NCT06111352|Cholinergic Agents|cholinergic agents|mesh-ancestor
139587674|NCT06111352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587675|NCT06111352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587676|NCT06111352|Antidotes|antidotes|mesh-ancestor
139587677|NCT06111352|Protective Agents|protective agents|mesh-ancestor
139587678|NCT06111352|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
139587679|NCT06111352|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
139587680|NCT06111326|Durvalumab|durvalumab|mesh-list
139587681|NCT06111326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139587682|NCT06111326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587683|NCT06111300|Dexmedetomidine|dexmedetomidine|mesh-list
139587684|NCT06111300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139587685|NCT06111300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587686|NCT06111300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587687|NCT06111300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139587688|NCT06111300|Analgesics|analgesics|mesh-ancestor
139587689|NCT06111300|Sensory System Agents|sensory system agents|mesh-ancestor
139587690|NCT06111300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587691|NCT06111300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139587692|NCT06111300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139587693|NCT06111300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139587694|NCT06111300|Adrenergic Agents|adrenergic agents|mesh-ancestor
139587695|NCT06111300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587696|NCT06111300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587697|NCT06111274|Gemcitabine|gemcitabine|mesh-list
139587698|NCT06111274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139587699|NCT06111274|Antimetabolites|antimetabolites|mesh-ancestor
139587700|NCT06111274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587701|NCT06111274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587702|NCT06111261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139587703|NCT06111209|Methyltestosterone|methyltestosterone|mesh-list
139587704|NCT06111209|Testosterone|testosterone|mesh-list
139587705|NCT06111209|Testosterone undecanoate|testosterone undecanoate|mesh-list
139587706|NCT06111209|Testosterone enanthate|testosterone enanthate|mesh-list
139587707|NCT06111209|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139587708|NCT06111209|Androgens|androgens|mesh-ancestor
139587709|NCT06111209|Hormones|hormones|mesh-ancestor
139587710|NCT06111209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369440|NCT04993040|Paclitaxel|paclitaxel|mesh-list
139587711|NCT06111209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587712|NCT06111209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139587713|NCT06111209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587714|NCT06111209|Anabolic Agents|anabolic agents|mesh-ancestor
139587715|NCT06111053|Nicotine|nicotine|mesh-list
139587716|NCT06111053|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139587717|NCT06111053|Autonomic Agents|autonomic agents|mesh-ancestor
139587718|NCT06111053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587719|NCT06111053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587720|NCT06111053|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139587721|NCT06111053|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139587722|NCT06111053|Cholinergic Agents|cholinergic agents|mesh-ancestor
139587723|NCT06111053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587724|NCT06111053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587725|NCT06110910|Hormones|hormones|mesh-list
139587726|NCT06110910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139587727|NCT06110910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587728|NCT06110663|Carboplatin|carboplatin|mesh-list
139587729|NCT06110663|Pemetrexed|pemetrexed|mesh-list
139587730|NCT06110663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587731|NCT06110663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587732|NCT06110663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587733|NCT06110663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139587734|NCT06110663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139587735|NCT06105554|Belumosudil|belumosudil|mesh-list
139587736|NCT06105554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139587737|NCT06105554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587738|NCT06105554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587739|NCT06101082|Cyclophosphamide|cyclophosphamide|mesh-list
139587740|NCT06101082|Fludarabine|fludarabine|mesh-list
139587741|NCT06101082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139587742|NCT06101082|Immunologic Factors|immunologic factors|mesh-ancestor
139587743|NCT06101082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587744|NCT06101082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139587745|NCT06101082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139587746|NCT06101082|Alkylating Agents|alkylating agents|mesh-ancestor
139587747|NCT06101082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587748|NCT06101082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587749|NCT06101082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139587750|NCT06100289|Vedolizumab|vedolizumab|mesh-list
139587751|NCT06100289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139587752|NCT06098846|Vitamin D|vitamin d|mesh-list
139587753|NCT06098846|Vitamins|vitamins|mesh-ancestor
139587754|NCT06098846|Micronutrients|micronutrients|mesh-ancestor
139587755|NCT06098846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587756|NCT06098846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139587757|NCT06069154|Anesthetics|anesthetics|mesh-list
139587758|NCT06069154|Anesthetics, Local|anesthetics, local|mesh-list
139587759|NCT06069154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587760|NCT06069154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587761|NCT06069154|Sensory System Agents|sensory system agents|mesh-ancestor
139587762|NCT06069154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587763|NCT06066710|Propranolol|propranolol|mesh-list
139587764|NCT06066710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139587765|NCT06066710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139587766|NCT06066710|Adrenergic Agents|adrenergic agents|mesh-ancestor
139587767|NCT06066710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587768|NCT06066710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587769|NCT06066710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587770|NCT06066710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139587771|NCT06066710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139587772|NCT06066710|Vasodilator Agents|vasodilator agents|mesh-ancestor
139587773|NCT06066450|Sirolimus|sirolimus|mesh-list
139587774|NCT06066450|Temsirolimus|temsirolimus|mesh-list
139587775|NCT06066450|MTOR Inhibitors|mtor inhibitors|mesh-list
139587776|NCT06066450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139587777|NCT06066450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139587778|NCT06066450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139587779|NCT06066450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587780|NCT06066450|Antifungal Agents|antifungal agents|mesh-ancestor
139587781|NCT06066450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139587782|NCT06066450|Immunologic Factors|immunologic factors|mesh-ancestor
139587783|NCT06066450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587784|NCT06066450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139587785|NCT06066450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587786|NCT06066450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587787|NCT06029530|Atropine|atropine|mesh-list
139587788|NCT06029530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139587789|NCT06029530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139587790|NCT06029530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139587791|NCT06029530|Autonomic Agents|autonomic agents|mesh-ancestor
139587792|NCT06029530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587793|NCT06029530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587794|NCT06029530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139587795|NCT06029530|Respiratory System Agents|respiratory system agents|mesh-ancestor
139587796|NCT06029530|Mydriatics|mydriatics|mesh-ancestor
139587797|NCT06029530|Parasympatholytics|parasympatholytics|mesh-ancestor
139587798|NCT06029530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139587799|NCT06029530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139587800|NCT06029530|Cholinergic Agents|cholinergic agents|mesh-ancestor
139587801|NCT06029530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139587802|NCT06029530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587803|NCT06024707|Omalizumab|omalizumab|mesh-list
139587804|NCT06024707|Benralizumab|benralizumab|mesh-list
139587805|NCT06024707|Reslizumab|reslizumab|mesh-list
139587806|NCT06024707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139587807|NCT06024707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139587808|NCT06024707|Respiratory System Agents|respiratory system agents|mesh-ancestor
139587809|NCT06023212|Tranexamic Acid|tranexamic acid|mesh-list
139587810|NCT06023212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139587811|NCT06023212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139587812|NCT06023212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587813|NCT06023212|Hemostatics|hemostatics|mesh-ancestor
139587814|NCT06023212|Coagulants|coagulants|mesh-ancestor
139587815|NCT05993039|Remifentanil|remifentanil|mesh-list
139587816|NCT05993039|Propofol|propofol|mesh-list
139587817|NCT05993039|Sevoflurane|sevoflurane|mesh-list
139587818|NCT05993039|Isoflurane|isoflurane|mesh-list
139587819|NCT05993039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139587820|NCT05993039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139587821|NCT05993039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587822|NCT05993039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139587823|NCT05993039|Anesthetics, General|anesthetics, general|mesh-ancestor
139587824|NCT05993039|Anesthetics|anesthetics|mesh-ancestor
139587825|NCT05993039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139587826|NCT05993039|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139587827|NCT05993039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139587828|NCT05993039|Narcotics|narcotics|mesh-ancestor
139587829|NCT05993039|Analgesics|analgesics|mesh-ancestor
139587830|NCT05993039|Sensory System Agents|sensory system agents|mesh-ancestor
139587831|NCT05993039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587832|NCT05988372|Paclitaxel|paclitaxel|mesh-list
139587833|NCT05988372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139587834|NCT05988372|Gemcitabine|gemcitabine|mesh-list
139587835|NCT05988372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139587836|NCT05988372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715831|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
139587837|NCT05988372|Tubulin Modulators|tubulin modulators|mesh-ancestor
139587838|NCT05988372|Antimitotic Agents|antimitotic agents|mesh-ancestor
139587839|NCT05988372|Mitosis Modulators|mitosis modulators|mesh-ancestor
139587840|NCT05988372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587841|NCT05988372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139587842|NCT05988372|Antimetabolites|antimetabolites|mesh-ancestor
139587843|NCT05980598|Pembrolizumab|pembrolizumab|mesh-list
139587844|NCT05980598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139587845|NCT05980598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587846|NCT05980598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139587847|NCT05980598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587848|NCT05972564|Empagliflozin|empagliflozin|mesh-list
139587849|NCT05972564|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139587850|NCT05972564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587851|NCT05972564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139587852|NCT05972564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587853|NCT05962034|Aspirin|aspirin|mesh-list
139587854|NCT05962034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139587855|NCT05962034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139587856|NCT05962034|Analgesics|analgesics|mesh-ancestor
139587857|NCT05962034|Sensory System Agents|sensory system agents|mesh-ancestor
139587858|NCT05962034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587859|NCT05962034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587860|NCT05962034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139587861|NCT05962034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139587862|NCT05962034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139587863|NCT05962034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139587864|NCT05962034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587865|NCT05962034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139587866|NCT05962034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139587867|NCT05962034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587868|NCT05962034|Antipyretics|antipyretics|mesh-ancestor
139587869|NCT05950334|Cyclophosphamide|cyclophosphamide|mesh-list
139587870|NCT05950334|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139587871|NCT05950334|Rituximab|rituximab|mesh-list
139587872|NCT05950334|Fludarabine|fludarabine|mesh-list
139587873|NCT05950334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139587874|NCT05950334|Immunologic Factors|immunologic factors|mesh-ancestor
139587875|NCT05950334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587876|NCT05950334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139587877|NCT05950334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139587878|NCT05950334|Alkylating Agents|alkylating agents|mesh-ancestor
139587879|NCT05950334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587880|NCT05950334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587881|NCT05950334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139587882|NCT05950334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139587883|NCT05920343|Rivaroxaban|rivaroxaban|mesh-list
139587884|NCT05920343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139587885|NCT05920343|Antithrombins|antithrombins|mesh-ancestor
139587886|NCT05920343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139587887|NCT05920343|Protease Inhibitors|protease inhibitors|mesh-ancestor
139587888|NCT05920343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587889|NCT05920343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587890|NCT05920343|Anticoagulants|anticoagulants|mesh-ancestor
139587891|NCT05883956|Azacitidine|azacitidine|mesh-list
139587892|NCT05883956|Decitabine|decitabine|mesh-list
139587893|NCT05883956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139587894|NCT05883956|Antimetabolites|antimetabolites|mesh-ancestor
139587895|NCT05883956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587896|NCT05883956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587897|NCT05883956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587898|NCT05861050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139587899|NCT05861050|Obinutuzumab|obinutuzumab|mesh-list
139587900|NCT05861050|Lenalidomide|lenalidomide|mesh-list
139587901|NCT05861050|Venetoclax|venetoclax|mesh-list
139587902|NCT05861050|Antibodies|antibodies|mesh-list
139587903|NCT05861050|Immunoglobulins|immunoglobulins|mesh-list
139587904|NCT05861050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139587905|NCT05861050|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139587906|NCT05861050|Immunologic Factors|immunologic factors|mesh-ancestor
139587907|NCT05861050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587908|NCT05861050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587909|NCT05861050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139587910|NCT05861050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139587911|NCT05861050|Growth Substances|growth substances|mesh-ancestor
139587912|NCT05861050|Growth Inhibitors|growth inhibitors|mesh-ancestor
139587913|NCT05849857|Dexamethasone|dexamethasone|mesh-list
139587914|NCT05849857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139587915|NCT05849857|Antiemetics|antiemetics|mesh-ancestor
139587916|NCT05849857|Autonomic Agents|autonomic agents|mesh-ancestor
139587917|NCT05849857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139587918|NCT05849857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587919|NCT05849857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139587920|NCT05849857|Glucocorticoids|glucocorticoids|mesh-ancestor
139587921|NCT05849857|Hormones|hormones|mesh-ancestor
139587922|NCT05849857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139587923|NCT05849857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139587924|NCT05849857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587925|NCT05812807|Pembrolizumab|pembrolizumab|mesh-list
139587926|NCT05812807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139587927|NCT05812807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587928|NCT05812807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139587929|NCT05812807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587930|NCT05773664|Dexamethasone|dexamethasone|mesh-list
139587931|NCT05773664|Dexamethasone acetate|dexamethasone acetate|mesh-list
139587932|NCT05773664|Ichthammol|ichthammol|mesh-list
139587933|NCT05773664|BB 1101|bb 1101|mesh-list
139587934|NCT05773664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139587935|NCT05773664|Antiemetics|antiemetics|mesh-ancestor
139587936|NCT05773664|Autonomic Agents|autonomic agents|mesh-ancestor
139369672|NCT03266445|Buprenorphine|buprenorphine|mesh-list
139587937|NCT05773664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715930|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139587938|NCT05773664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587939|NCT05773664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139587940|NCT05773664|Glucocorticoids|glucocorticoids|mesh-ancestor
139587941|NCT05773664|Hormones|hormones|mesh-ancestor
139587942|NCT05773664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139587943|NCT05773664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139587944|NCT05773664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587945|NCT05773664|Protease Inhibitors|protease inhibitors|mesh-ancestor
139587946|NCT05773664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587947|NCT05773664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587948|NCT05773664|Dermatologic Agents|dermatologic agents|mesh-ancestor
139587949|NCT05759949|Fulvestrant|fulvestrant|mesh-list
139587950|NCT05759949|Palbociclib|palbociclib|mesh-list
139587951|NCT05759949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139587952|NCT05759949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587953|NCT05759949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139587954|NCT05759949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139587955|NCT05759949|Hormone Antagonists|hormone antagonists|mesh-ancestor
139587956|NCT05759949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139587957|NCT05759949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587958|NCT05759949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139587959|NCT05759949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587960|NCT05759949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587961|NCT05710406|Cetuximab|cetuximab|mesh-list
139587962|NCT05710406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139587963|NCT05710406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587964|NCT05694871|Palbociclib|palbociclib|mesh-list
139587965|NCT05694871|Cemiplimab|cemiplimab|mesh-list
139587966|NCT05694871|Immunoglobulins|immunoglobulins|mesh-list
139587967|NCT05694871|Immunoglobulin G|immunoglobulin g|mesh-list
139587968|NCT05694871|Immunologic Factors|immunologic factors|mesh-ancestor
139587969|NCT05694871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587970|NCT05694871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587971|NCT05694871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139587972|NCT05694871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139587973|NCT05694871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587974|NCT05694871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139587975|NCT05647265|Nivolumab|nivolumab|mesh-list
139587976|NCT05647265|Ipilimumab|ipilimumab|mesh-list
139587977|NCT05647265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139587978|NCT05647265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587979|NCT05647265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139587980|NCT05647265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587981|NCT05611710|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139587982|NCT05611710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139587983|NCT05610163|Leucovorin|leucovorin|mesh-list
139587984|NCT05610163|Capecitabine|capecitabine|mesh-list
139587985|NCT05610163|Fluorouracil|fluorouracil|mesh-list
139587986|NCT05610163|Oxaliplatin|oxaliplatin|mesh-list
139587987|NCT05610163|Irinotecan|irinotecan|mesh-list
139587988|NCT05610163|Calcium|calcium|mesh-list
139587989|NCT05610163|Levoleucovorin|levoleucovorin|mesh-list
139587990|NCT05610163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139587991|NCT05610163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139587992|NCT05610163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139587993|NCT05610163|Antimetabolites|antimetabolites|mesh-ancestor
139587994|NCT05610163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139587995|NCT05610163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139587996|NCT05610163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139587997|NCT05610163|Immunologic Factors|immunologic factors|mesh-ancestor
139587998|NCT05610163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139587999|NCT05610163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139588000|NCT05610163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588001|NCT05610163|Antidotes|antidotes|mesh-ancestor
139588002|NCT05610163|Protective Agents|protective agents|mesh-ancestor
139588003|NCT05610163|Vitamin B Complex|vitamin b complex|mesh-ancestor
139588004|NCT05610163|Vitamins|vitamins|mesh-ancestor
139588005|NCT05610163|Micronutrients|micronutrients|mesh-ancestor
139588006|NCT05581589|Camptothecin|camptothecin|mesh-list
139588007|NCT05581589|Irinotecan|irinotecan|mesh-list
139588008|NCT05581589|Immunoconjugates|immunoconjugates|mesh-list
139588009|NCT05581589|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139588010|NCT05581589|Immunologic Factors|immunologic factors|mesh-ancestor
139588011|NCT05581589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588012|NCT05581589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139588013|NCT05581589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588014|NCT05581589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139588015|NCT05581589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139588016|NCT05581589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588017|NCT05581589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588018|NCT05571046|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
139588019|NCT05571046|Glucocorticoids|glucocorticoids|mesh-list
139588020|NCT05571046|Hormones|hormones|mesh-ancestor
139588021|NCT05571046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139588022|NCT05571046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588023|NCT05571046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139588024|NCT05546411|Leucovorin|leucovorin|mesh-list
139588025|NCT05546411|Fluorouracil|fluorouracil|mesh-list
139588026|NCT05546411|Oxaliplatin|oxaliplatin|mesh-list
139588027|NCT05546411|Irinotecan|irinotecan|mesh-list
139588028|NCT05546411|Camptothecin|camptothecin|mesh-list
138716021|NCT04583111|Sulpiride|sulpiride|mesh-list
139588029|NCT05546411|Levoleucovorin|levoleucovorin|mesh-list
139588030|NCT05546411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588031|NCT05546411|Antimetabolites|antimetabolites|mesh-ancestor
139588032|NCT05546411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588033|NCT05546411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139588034|NCT05546411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588035|NCT05546411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588036|NCT05546411|Immunologic Factors|immunologic factors|mesh-ancestor
139588037|NCT05546411|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139588038|NCT05546411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139588039|NCT05546411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588040|NCT05546411|Antidotes|antidotes|mesh-ancestor
139588041|NCT05546411|Protective Agents|protective agents|mesh-ancestor
139588042|NCT05546411|Vitamin B Complex|vitamin b complex|mesh-ancestor
139588043|NCT05546411|Vitamins|vitamins|mesh-ancestor
139588044|NCT05546411|Micronutrients|micronutrients|mesh-ancestor
139588045|NCT05546411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139588046|NCT05478954|Pyrimethamine|pyrimethamine|mesh-list
139588047|NCT05478954|Sulfadoxine|sulfadoxine|mesh-list
139588048|NCT05478954|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139588049|NCT05478954|Amodiaquine|amodiaquine|mesh-list
139588050|NCT05478954|Antimalarials|antimalarials|mesh-ancestor
139588051|NCT05478954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139588052|NCT05478954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139588053|NCT05478954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139588054|NCT05478954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139588055|NCT05478954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588056|NCT05478954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588057|NCT05478954|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139588058|NCT05471544|Pyrimethamine|pyrimethamine|mesh-list
139588059|NCT05471544|Sulfadoxine|sulfadoxine|mesh-list
139588060|NCT05471544|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139588061|NCT05471544|Amodiaquine|amodiaquine|mesh-list
139588062|NCT05471544|Antimalarials|antimalarials|mesh-ancestor
139588063|NCT05471544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139588064|NCT05471544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139588065|NCT05471544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139588066|NCT05471544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139588067|NCT05471544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716067|NCT00567060|Piracetam|piracetam|mesh-list
139588068|NCT05471544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588069|NCT05471544|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139588070|NCT05456113|Cannabidiol|cannabidiol|mesh-list
139588071|NCT05456113|Anticonvulsants|anticonvulsants|mesh-ancestor
139588072|NCT05331053|Atorvastatin|atorvastatin|mesh-list
139588073|NCT05331053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139588074|NCT05331053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139588075|NCT05331053|Antimetabolites|antimetabolites|mesh-ancestor
139588076|NCT05331053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588077|NCT05331053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139588078|NCT05331053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139588079|NCT05331053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588080|NCT05323721|Pyrimethamine|pyrimethamine|mesh-list
139588081|NCT05323721|Piperaquine|piperaquine|mesh-list
139588082|NCT05323721|Sulfadoxine|sulfadoxine|mesh-list
139588083|NCT05323721|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139588084|NCT05323721|Amodiaquine|amodiaquine|mesh-list
139588085|NCT05323721|Artenimol|artenimol|mesh-list
139588086|NCT05323721|Antimalarials|antimalarials|mesh-ancestor
139588087|NCT05323721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139588088|NCT05323721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139369815|NCT02132689|Heparin|heparin|mesh-list
139588089|NCT05323721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139588090|NCT05323721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139588091|NCT05323721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588092|NCT05323721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588093|NCT05323721|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139588094|NCT05306873|Mycophenolic Acid|mycophenolic acid|mesh-list
139588095|NCT05306873|Cyclosporine|cyclosporine|mesh-list
139588096|NCT05306873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139588097|NCT05306873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588098|NCT05306873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139588099|NCT05306873|Antitubercular Agents|antitubercular agents|mesh-ancestor
139588100|NCT05306873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139588101|NCT05306873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139588102|NCT05306873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588103|NCT05306873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588104|NCT05306873|Antifungal Agents|antifungal agents|mesh-ancestor
139588105|NCT05306873|Dermatologic Agents|dermatologic agents|mesh-ancestor
139588106|NCT05306873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588107|NCT05306873|Immunologic Factors|immunologic factors|mesh-ancestor
139588108|NCT05306873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588109|NCT05306873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139588110|NCT05306873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139588111|NCT05306587|Daratumumab|daratumumab|mesh-list
139588112|NCT05306587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588113|NCT05303987|Dexmedetomidine|dexmedetomidine|mesh-list
139588114|NCT05303987|Propofol|propofol|mesh-list
139588115|NCT05303987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139588116|NCT05303987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139588117|NCT05303987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588118|NCT05303987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139588119|NCT05303987|Analgesics|analgesics|mesh-ancestor
139588120|NCT05303987|Sensory System Agents|sensory system agents|mesh-ancestor
139588121|NCT05303987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588122|NCT05303987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139588123|NCT05303987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139588124|NCT05303987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139588125|NCT05303987|Adrenergic Agents|adrenergic agents|mesh-ancestor
139588126|NCT05303987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588127|NCT05303987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588128|NCT05303987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139588129|NCT05303987|Anesthetics, General|anesthetics, general|mesh-ancestor
139588130|NCT05303987|Anesthetics|anesthetics|mesh-ancestor
139588131|NCT05303792|Cytarabine|cytarabine|mesh-list
139588132|NCT05303792|Dexamethasone|dexamethasone|mesh-list
139588133|NCT05303792|Prednisone|prednisone|mesh-list
139588134|NCT05303792|Methylprednisolone|methylprednisolone|mesh-list
139588135|NCT05303792|Cyclophosphamide|cyclophosphamide|mesh-list
139588136|NCT05303792|Rituximab|rituximab|mesh-list
139588137|NCT05303792|Doxorubicin|doxorubicin|mesh-list
139588138|NCT05303792|Methotrexate|methotrexate|mesh-list
139588139|NCT05303792|Vincristine|vincristine|mesh-list
139588140|NCT05303792|Mercaptopurine|mercaptopurine|mesh-list
139588141|NCT05303792|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139588142|NCT05303792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588143|NCT05303792|Immunologic Factors|immunologic factors|mesh-ancestor
139588144|NCT05303792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588145|NCT05303792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139588146|NCT05303792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139588147|NCT05303792|Alkylating Agents|alkylating agents|mesh-ancestor
139588148|NCT05303792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588149|NCT05303792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588150|NCT05303792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139588151|NCT05303792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139588152|NCT05303792|Antiemetics|antiemetics|mesh-ancestor
139588153|NCT05303792|Autonomic Agents|autonomic agents|mesh-ancestor
139588154|NCT05303792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588155|NCT05303792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139588156|NCT05303792|Glucocorticoids|glucocorticoids|mesh-ancestor
139588157|NCT05303792|Hormones|hormones|mesh-ancestor
139588158|NCT05303792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139588159|NCT05303792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139588160|NCT05303792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139588161|NCT05303792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139588162|NCT05303792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139588163|NCT05303792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139588164|NCT05303792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588165|NCT05303792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139588166|NCT05303792|Abortifacient Agents|abortifacient agents|mesh-ancestor
139588167|NCT05303792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139588168|NCT05303792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139588169|NCT05303792|Antimetabolites|antimetabolites|mesh-ancestor
139588170|NCT05303792|Dermatologic Agents|dermatologic agents|mesh-ancestor
139588171|NCT05303792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139588172|NCT05303792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139588173|NCT05303792|Antiviral Agents|antiviral agents|mesh-ancestor
139588174|NCT05303792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139588175|NCT05303792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139588176|NCT05303792|Tubulin Modulators|tubulin modulators|mesh-ancestor
139588177|NCT05303792|Antimitotic Agents|antimitotic agents|mesh-ancestor
139588178|NCT05303792|Mitosis Modulators|mitosis modulators|mesh-ancestor
139588179|NCT05303792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139588180|NCT05303792|Protective Agents|protective agents|mesh-ancestor
139588181|NCT05303792|Immunotoxins|immunotoxins|mesh-ancestor
139588182|NCT05303792|Immunoconjugates|immunoconjugates|mesh-ancestor
139588183|NCT05263284|Venetoclax|venetoclax|mesh-list
139588184|NCT05263284|Adenosine|adenosine|mesh-list
139588185|NCT05263284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588186|NCT05263284|Analgesics|analgesics|mesh-ancestor
139588187|NCT05263284|Sensory System Agents|sensory system agents|mesh-ancestor
139588188|NCT05263284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588189|NCT05263284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588190|NCT05263284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139588191|NCT05263284|Vasodilator Agents|vasodilator agents|mesh-ancestor
139588192|NCT05263284|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139588193|NCT05263284|Purinergic Agonists|purinergic agonists|mesh-ancestor
139588194|NCT05263284|Purinergic Agents|purinergic agents|mesh-ancestor
139588195|NCT05263284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588196|NCT05263284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588197|NCT05255003|Enoxaparin|enoxaparin|mesh-list
139588198|NCT05255003|Dalteparin|dalteparin|mesh-list
139588199|NCT05255003|Tinzaparin|tinzaparin|mesh-list
139588200|NCT05255003|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139588201|NCT05255003|Anticoagulants|anticoagulants|mesh-ancestor
139588202|NCT05255003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139588203|NCT05255003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139588204|NCT05255003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588205|NCT05247905|Capecitabine|capecitabine|mesh-list
139588206|NCT05247905|Temozolomide|temozolomide|mesh-list
139588207|NCT05247905|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139588208|NCT05247905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139588209|NCT05247905|Antimetabolites|antimetabolites|mesh-ancestor
139588210|NCT05247905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588211|NCT05247905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588212|NCT05247905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139588213|NCT05247905|Alkylating Agents|alkylating agents|mesh-ancestor
139588214|NCT05247905|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139588215|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139588216|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139588217|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
139588218|NCT05217589|Hormones|hormones|mesh-ancestor
139588219|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139588220|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588221|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588222|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588223|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
139588224|NCT05170828|Sirolimus|sirolimus|mesh-list
139588225|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
139588226|NCT05170828|Busulfan|busulfan|mesh-list
139588227|NCT05170828|Fludarabine|fludarabine|mesh-list
139588228|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588229|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
139588230|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588231|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139588232|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139588233|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
139588234|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588235|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588236|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139588237|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139588238|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139588239|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
139588240|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139369967|NCT04991012|Triamcinolone|triamcinolone|mesh-list
139588241|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139588242|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588243|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
139588244|NCT05130788|Nicotine|nicotine|mesh-list
139588245|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139588246|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
139588247|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588248|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588249|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139588250|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139588251|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
139588252|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588253|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588254|NCT05055128|Lansoprazole|lansoprazole|mesh-list
139588255|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
139588256|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139588257|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139588258|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139588259|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588260|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588261|NCT05054439|Paclitaxel|paclitaxel|mesh-list
139588262|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139588263|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588264|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
139588265|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
139588266|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
139588267|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588268|NCT05022654|Irinotecan|irinotecan|mesh-list
139588269|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139588270|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139588271|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588272|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588273|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588274|NCT05020457|Paclitaxel|paclitaxel|mesh-list
139588275|NCT05020457|Docetaxel|docetaxel|mesh-list
139588276|NCT05020457|Cisplatin|cisplatin|mesh-list
139588277|NCT05020457|Pemetrexed|pemetrexed|mesh-list
139588278|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139588279|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588280|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
139588281|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
139588282|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
139588283|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588284|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588285|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139588286|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139588287|NCT05004987|Dexetimide|dexetimide|mesh-list
139588288|NCT05004987|Citalopram|citalopram|mesh-list
139588289|NCT05004987|Escitalopram|escitalopram|mesh-list
139588290|NCT05004987|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139588291|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139588292|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139588293|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588294|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588295|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
139588296|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588297|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139588298|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139588299|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
139588300|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
139588301|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588302|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139588303|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139588304|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
139588305|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139588306|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
139588307|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139588308|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
139588309|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139588310|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588311|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139588312|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588313|NCT04940286|Paclitaxel|paclitaxel|mesh-list
139588314|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139370042|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139588315|NCT04940286|Gemcitabine|gemcitabine|mesh-list
139588316|NCT04940286|Durvalumab|durvalumab|mesh-list
139588317|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
139588318|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139588319|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
139588320|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139588321|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588322|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
139588323|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
139588324|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
139588325|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588326|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139588327|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
139588328|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139588329|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
139588330|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588331|NCT04939090|Megestrol|megestrol|mesh-list
139588332|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
139588333|NCT04939090|Olanzapine|olanzapine|mesh-list
139588334|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
139588335|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
139588336|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588337|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588338|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139588339|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139588340|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139588341|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139588342|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139588343|NCT04939090|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139588344|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139588345|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139588346|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588347|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588348|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
139588349|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139588350|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139588351|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139588352|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
139588353|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139588354|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139588355|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139588356|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139588357|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588358|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
139588359|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139588360|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
139588361|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
139588362|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
139588363|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139588364|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588365|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
139588366|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588367|NCT04887857|Azacitidine|azacitidine|mesh-list
139588368|NCT04887857|Venetoclax|venetoclax|mesh-list
139588369|NCT04887857|Cc-486|cc-486|mesh-list
139588370|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139588371|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
139588372|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588373|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588374|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588375|NCT04878211|Interferons|interferons|mesh-list
139588376|NCT04878211|Ofatumumab|ofatumumab|mesh-list
139588377|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
139588378|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
139588379|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588380|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
139588381|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139588382|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139588383|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
139588384|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588385|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588386|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139588387|NCT04862650|Paclitaxel|paclitaxel|mesh-list
139588388|NCT04862650|Carboplatin|carboplatin|mesh-list
139588389|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139588390|NCT04862650|Cemiplimab|cemiplimab|mesh-list
139588391|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139588392|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588393|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
139588394|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
139588395|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
139588396|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716384|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588397|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139588398|NCT04841096|Metformin|metformin|mesh-list
139588399|NCT04841096|Glimepiride|glimepiride|mesh-list
139588400|NCT04841096|Vildagliptin|vildagliptin|mesh-list
139588401|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139588402|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588403|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139588404|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588405|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
139588406|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139588407|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
139588408|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588409|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588410|NCT04824612|Triamcinolone|triamcinolone|mesh-list
139588411|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139588412|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139588413|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139588414|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138716434|NCT03451500|Levodopa|levodopa|mesh-list
139588415|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
139588416|NCT04824612|Hormones|hormones|mesh-ancestor
139588417|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139588418|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588419|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588420|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
139588421|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588422|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588423|NCT04803201|Prednisone|prednisone|mesh-list
139588424|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
139588425|NCT04803201|Doxorubicin|doxorubicin|mesh-list
139588426|NCT04803201|Etoposide|etoposide|mesh-list
139588427|NCT04803201|Vincristine|vincristine|mesh-list
139588428|NCT04803201|Azacitidine|azacitidine|mesh-list
139588429|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588430|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
139588431|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588432|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139588433|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139588434|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
139588435|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588436|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588437|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139588438|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139588439|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139588440|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139588441|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588442|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139588443|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
139588444|NCT04803201|Hormones|hormones|mesh-ancestor
139588445|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139588446|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139588447|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139588448|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
139588449|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
139588450|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
139588451|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139588452|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
139588453|NCT04782258|Tolvaptan|tolvaptan|mesh-list
139588454|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139588455|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588456|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
139588457|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588458|NCT04779307|Vedolizumab|vedolizumab|mesh-list
139588459|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139588460|NCT04767191|Lumefantrine|lumefantrine|mesh-list
139588461|NCT04767191|Artemether|artemether|mesh-list
139588462|NCT04767191|Piperaquine|piperaquine|mesh-list
139588463|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139588464|NCT04767191|Artenimol|artenimol|mesh-list
139588465|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
139588466|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139588467|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139588468|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139588469|NCT04711109|Denosumab|denosumab|mesh-list
139588470|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139588471|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588472|NCT04668300|Durvalumab|durvalumab|mesh-list
139588473|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
139588474|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139588475|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
139588476|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139588477|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588478|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
139588479|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588480|NCT04666038|Rituximab|rituximab|mesh-list
139588481|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139588482|NCT04666038|Idelalisib|idelalisib|mesh-list
139588483|NCT04666038|Pirtobrutinib|pirtobrutinib|mesh-list
139588484|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139588485|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588486|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
139588487|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588488|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139588489|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139588490|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
139588491|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588492|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588493|NCT04666038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139588494|NCT04662125|Acetaminophen|acetaminophen|mesh-list
139588495|NCT04662125|Prednisolone|prednisolone|mesh-list
139588496|NCT04662125|Pregabalin|pregabalin|mesh-list
139588497|NCT04662125|Caffeine|caffeine|mesh-list
139588498|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139588499|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
139588500|NCT04662125|Hormones|hormones|mesh-ancestor
139588501|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139588502|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588503|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139588504|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716499|NCT04573803|Phenytoin|phenytoin|mesh-list
139588505|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588506|NCT04662125|Analgesics|analgesics|mesh-ancestor
139588507|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
139588508|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
139588509|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139588510|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139588511|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588512|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139588513|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139588514|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139588515|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139588516|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139588517|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139588518|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
139588519|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139588520|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139588521|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588522|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139588523|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139588524|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
139588525|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588526|NCT04654689|Curcumin|curcumin|mesh-list
139588527|NCT04654689|Resveratrol|resveratrol|mesh-list
139588528|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139588529|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139588530|NCT04654689|Analgesics|analgesics|mesh-ancestor
139588531|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
139588532|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588533|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588534|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139588535|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139588536|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588537|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588538|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588539|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
139588540|NCT04654689|Protective Agents|protective agents|mesh-ancestor
139588541|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139588542|NCT04600336|Oxybutynin|oxybutynin|mesh-list
139588543|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
139588544|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
139588545|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588546|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588547|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138716544|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139588548|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139588549|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
139588550|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588551|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588552|NCT04600336|Urological Agents|urological agents|mesh-ancestor
139588554|NCT04579848|Methotrexate|methotrexate|mesh-list
139588555|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139588556|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
139588557|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139588558|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588559|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139588560|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
139588561|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588562|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588563|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
139588564|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588565|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139588566|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588567|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
139588568|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139588569|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139588570|NCT04579848|Hematinics|hematinics|mesh-ancestor
139588571|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
139588572|NCT04579848|Vitamins|vitamins|mesh-ancestor
139588573|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
139588574|NCT04445662|Varenicline|varenicline|mesh-list
139588575|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139588576|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139588577|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
139588578|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588579|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588580|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588581|NCT04435834|Propofol|propofol|mesh-list
139588582|NCT04435834|Sevoflurane|sevoflurane|mesh-list
139588583|NCT04435834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139588584|NCT04435834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139588585|NCT04435834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588586|NCT04435834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138716589|NCT00572390|Hormones|hormones|mesh-ancestor
139588587|NCT04435834|Anesthetics, General|anesthetics, general|mesh-ancestor
139588588|NCT04435834|Anesthetics|anesthetics|mesh-ancestor
139588589|NCT04435834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139588590|NCT04435834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139588591|NCT04354012|Gentian Violet|gentian violet|mesh-list
139588592|NCT04354012|Methylene Blue|methylene blue|mesh-list
139588593|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588594|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588595|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139588596|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139588597|NCT04352400|Nafamostat|nafamostat|mesh-list
139588598|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139588599|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139588600|NCT04352400|Analgesics|analgesics|mesh-ancestor
139588601|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
139588602|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588603|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588604|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139588605|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139588606|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
139588607|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
139588608|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588609|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588610|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139588611|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139588612|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139588613|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588614|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
139588615|NCT04351698|Montelukast|montelukast|mesh-list
139588616|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139588617|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
139588618|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139588619|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
138716631|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
139588620|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139588621|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588622|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139588623|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139588624|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588625|NCT04340141|Leucovorin|leucovorin|mesh-list
139588626|NCT04340141|Fluorouracil|fluorouracil|mesh-list
139588627|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
139588628|NCT04340141|Irinotecan|irinotecan|mesh-list
139588629|NCT04340141|Calcium|calcium|mesh-list
139588630|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
139588631|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139588632|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588633|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
139588634|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588635|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139588636|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588637|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588638|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
139588639|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139588640|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139588641|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588642|NCT04340141|Antidotes|antidotes|mesh-ancestor
139588643|NCT04340141|Protective Agents|protective agents|mesh-ancestor
139588644|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
139588645|NCT04340141|Vitamins|vitamins|mesh-ancestor
139588646|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
139588647|NCT04300556|Dexamethasone|dexamethasone|mesh-list
139588648|NCT04300556|Prednisone|prednisone|mesh-list
139588649|NCT04300556|Prednisolone|prednisolone|mesh-list
139588650|NCT04300556|Farletuzumab|farletuzumab|mesh-list
139588651|NCT04300556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139588652|NCT04300556|Antiemetics|antiemetics|mesh-ancestor
139588653|NCT04300556|Autonomic Agents|autonomic agents|mesh-ancestor
139588654|NCT04300556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588655|NCT04300556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588656|NCT04300556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139588657|NCT04300556|Glucocorticoids|glucocorticoids|mesh-ancestor
139588658|NCT04300556|Hormones|hormones|mesh-ancestor
139588659|NCT04300556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139588660|NCT04300556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139588661|NCT04300556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588662|NCT04291105|Cemiplimab|cemiplimab|mesh-list
139588663|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139588664|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588665|NCT04245085|Paclitaxel|paclitaxel|mesh-list
139588666|NCT04245085|Bevacizumab|bevacizumab|mesh-list
139588667|NCT04245085|Carboplatin|carboplatin|mesh-list
139588668|NCT04245085|Pemetrexed|pemetrexed|mesh-list
139588669|NCT04245085|Atezolizumab|atezolizumab|mesh-list
139588670|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139588671|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588672|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
139588673|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
139588674|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
139588675|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588676|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139588677|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139588678|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139588679|NCT04245085|Growth Substances|growth substances|mesh-ancestor
139588680|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588681|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
139588682|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588683|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139588684|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139588685|NCT04245085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139588686|NCT04233346|Ponatinib|ponatinib|mesh-list
139588687|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588688|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139588689|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588690|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588691|NCT04229004|Paclitaxel|paclitaxel|mesh-list
139588692|NCT04229004|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139588693|NCT04229004|Gemcitabine|gemcitabine|mesh-list
139370430|NCT02134639|Edotreotide|edotreotide|mesh-list
139588694|NCT04229004|Spartalizumab|spartalizumab|mesh-list
139588695|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139588696|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588697|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
139588698|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
139588699|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
138716706|NCT00573404|Sunitinib|sunitinib|mesh-list
138716717|NCT01139125|Cysteamine|cysteamine|mesh-list
139588700|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588701|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139588702|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
139588703|NCT04229004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139588704|NCT04229004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139588705|NCT04207931|Fluocinonide|fluocinonide|mesh-list
139588706|NCT04207931|Triamcinolone|triamcinolone|mesh-list
139588707|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139588708|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139588709|NCT04207931|Betamethasone|betamethasone|mesh-list
139588710|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
139588711|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139588712|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
139588714|NCT04207931|Minoxidil|minoxidil|mesh-list
139588715|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139588716|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139588717|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139588718|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
139588719|NCT04207931|Hormones|hormones|mesh-ancestor
139588720|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139588721|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588722|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588723|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
139588724|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588725|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588726|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139588727|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
139588728|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139588729|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
139588730|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139588731|NCT04207723|Paroxetine|paroxetine|mesh-list
139588732|NCT04207723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139588733|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139588734|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139588735|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588736|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588737|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
139588738|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588739|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139588740|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
139588741|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139588742|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139588743|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139588744|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588745|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
139588746|NCT04207177|Tacrolimus|tacrolimus|mesh-list
139588747|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588748|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
139588749|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588750|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139588751|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588752|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588753|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139588754|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588755|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139588756|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
139588757|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139588758|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139588759|NCT04173494|Danazol|danazol|mesh-list
139588760|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
139588761|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139588762|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
139588763|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139588764|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588765|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139588766|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588767|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588768|NCT04150640|Pembrolizumab|pembrolizumab|mesh-list
139588769|NCT04150640|Nivolumab|nivolumab|mesh-list
139588770|NCT04150640|Trastuzumab|trastuzumab|mesh-list
139588771|NCT04150640|Fluorouracil|fluorouracil|mesh-list
139588772|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
139588773|NCT04150640|Irinotecan|irinotecan|mesh-list
139588774|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139588775|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588776|NCT04150640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139588777|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588778|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
139588779|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139588780|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588781|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
139588782|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588783|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139588784|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139588785|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588786|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
139588787|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139588788|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588789|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139588790|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139588791|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139588792|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588793|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588794|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588795|NCT04137107|Analgesics|analgesics|mesh-ancestor
139588796|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
139588797|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588798|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
139588799|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139588800|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
139588801|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
139588802|NCT04119024|Fludarabine|fludarabine|mesh-list
139588803|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
139588804|NCT04119024|Interleukin-2|interleukin-2|mesh-list
139588805|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588806|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
139588807|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588808|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139588809|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139588810|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
139588811|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588812|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588813|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139588814|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139588815|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
139588816|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139588817|NCT04119024|Analgesics|analgesics|mesh-ancestor
139588818|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
139588819|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588820|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139588821|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
139588822|NCT04038502|Carboplatin|carboplatin|mesh-list
139588823|NCT04038502|Olaparib|olaparib|mesh-list
139588824|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588825|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139588826|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588827|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588828|NCT03994796|Adagrasib|adagrasib|mesh-list
139588829|NCT03994796|Entrectinib|entrectinib|mesh-list
139588830|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139588831|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588832|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588833|NCT03994796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588834|NCT03951142|Losartan|losartan|mesh-list
139588835|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139588836|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139588837|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139588838|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139588839|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588840|NCT03937713|Eszopiclone|eszopiclone|mesh-list
139588841|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139588842|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139588843|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588845|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139588846|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139588847|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
139588848|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588849|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588850|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588851|NCT03874429|Hyaluronic Acid|hyaluronic acid|mesh-list
139588852|NCT03874429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139588853|NCT03874429|Immunologic Factors|immunologic factors|mesh-ancestor
139588854|NCT03874429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588855|NCT03874429|Viscosupplements|viscosupplements|mesh-ancestor
139588856|NCT03874429|Protective Agents|protective agents|mesh-ancestor
139588857|NCT03871153|Paclitaxel|paclitaxel|mesh-list
139588858|NCT03871153|Carboplatin|carboplatin|mesh-list
139588859|NCT03871153|Durvalumab|durvalumab|mesh-list
139588860|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139588861|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588862|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
139588863|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
139588864|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
139588865|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588866|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139588867|NCT03845517|PF-06700841|pf-06700841|mesh-list
139588868|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139588869|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588870|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588871|NCT03823768|Tacrolimus|tacrolimus|mesh-list
139588872|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588873|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
139588874|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588875|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139588876|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588877|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588878|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
139588879|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
139588880|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588881|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588882|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588883|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
139588884|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
139588885|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
139588886|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
139588887|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139588888|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588889|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588890|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
139588891|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
139588892|NCT03734211|Evolocumab|evolocumab|mesh-list
139588893|NCT03734211|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139588894|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139588895|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139588896|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
139588897|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588898|NCT03734211|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139588899|NCT03734211|Protease Inhibitors|protease inhibitors|mesh-ancestor
139588900|NCT03734211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588901|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139588902|NCT03673826|Dexamethasone|dexamethasone|mesh-list
139588903|NCT03673826|Lenalidomide|lenalidomide|mesh-list
139588904|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139588905|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
139588906|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
139588907|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139588908|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588909|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139588910|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
139588911|NCT03673826|Hormones|hormones|mesh-ancestor
139588912|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139588913|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139588914|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588915|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
139588916|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139588917|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139588918|NCT03673826|Growth Substances|growth substances|mesh-ancestor
139588919|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
139588920|NCT03609216|Gemcitabine|gemcitabine|mesh-list
139588921|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588922|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139588923|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
139588924|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588925|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
139588926|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
139588927|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588928|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139588929|NCT03559868|Digoxin|digoxin|mesh-list
139588930|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139588931|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139588932|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588933|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588934|NCT03559868|Protective Agents|protective agents|mesh-ancestor
139588935|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588936|NCT03534947|Imiquimod|imiquimod|mesh-list
139588937|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139588938|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
139588939|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588940|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588941|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
139588942|NCT03476330|Quercetin|quercetin|mesh-list
139588943|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
139588944|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588945|NCT03476330|Protective Agents|protective agents|mesh-ancestor
139588946|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588947|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
139588948|NCT03458455|Nivolumab|nivolumab|mesh-list
139588949|NCT03458455|Ipilimumab|ipilimumab|mesh-list
139588950|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139588951|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588952|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139588953|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588954|NCT03414034|Prednisone|prednisone|mesh-list
139588955|NCT03414034|Onvansertib|onvansertib|mesh-list
139588956|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139588957|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
139588958|NCT03414034|Hormones|hormones|mesh-ancestor
139588959|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139588960|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588961|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139588962|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588963|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139588964|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588965|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588966|NCT03391869|Nivolumab|nivolumab|mesh-list
139588967|NCT03391869|Ipilimumab|ipilimumab|mesh-list
139588968|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139588969|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588970|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139588971|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588972|NCT03340129|Nivolumab|nivolumab|mesh-list
139588973|NCT03340129|Ipilimumab|ipilimumab|mesh-list
139588974|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139588975|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588976|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139588977|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588978|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139588979|NCT03333408|Clindamycin|clindamycin|mesh-list
139588980|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
139588981|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
139588982|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139588983|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139588984|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139588985|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139588986|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588987|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139588988|NCT03240861|Aldesleukin|aldesleukin|mesh-list
139588989|NCT03240861|Plerixafor|plerixafor|mesh-list
139588990|NCT03240861|Fludarabine|fludarabine|mesh-list
139588992|NCT03240861|Interleukin-2|interleukin-2|mesh-list
139588993|NCT03240861|Lenograstim|lenograstim|mesh-list
139588994|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139588995|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139588996|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139588997|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
139588998|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139588999|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139589000|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
139589001|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139589002|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139589003|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139589004|NCT03240861|Analgesics|analgesics|mesh-ancestor
139589005|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
139589006|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589007|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139589008|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139589009|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
139589010|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139589011|NCT03237286|Ketamine|ketamine|mesh-list
139589012|NCT03237286|Analgesics|analgesics|mesh-ancestor
139589013|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
139589014|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589015|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589016|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139589017|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139589018|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
139589019|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
139589020|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589021|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139589022|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139589023|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589024|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589025|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139589026|NCT03179163|Enalapril|enalapril|mesh-list
139589027|NCT03179163|Captopril|captopril|mesh-list
139589028|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139589029|NCT03179163|Diuretics|diuretics|mesh-ancestor
139589030|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
139589031|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589032|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139589033|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139589034|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589035|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139589036|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
139589037|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589038|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
139589039|NCT03164993|Doxorubicin|doxorubicin|mesh-list
139589040|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139589041|NCT03164993|Atezolizumab|atezolizumab|mesh-list
139589042|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139589043|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
139589044|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589045|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139589046|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139589047|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
139589048|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589049|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589050|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139589051|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139589052|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139589053|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138717101|NCT00197106|Xhance|xhance|mesh-list
139589054|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589055|NCT03164993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139589056|NCT03164993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139589057|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
139589058|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139589059|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139589060|NCT03110822|Prednisolone|prednisolone|mesh-list
139589061|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
139589062|NCT03110822|Lenalidomide|lenalidomide|mesh-list
139589063|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139589064|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
139589065|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
139589066|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589067|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139589068|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139589069|NCT03110822|Growth Substances|growth substances|mesh-ancestor
139589070|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
139589071|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589072|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139589073|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
139589074|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
139589075|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589076|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139589077|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
139589078|NCT03110822|Hormones|hormones|mesh-ancestor
139589079|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139589080|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139589081|NCT03110822|Protective Agents|protective agents|mesh-ancestor
139589082|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139589083|NCT03077542|Sirolimus|sirolimus|mesh-list
139589084|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
139589085|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
139589086|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
139589087|NCT03077542|Pentostatin|pentostatin|mesh-list
139589088|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139589089|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
139589090|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589091|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139589092|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139589093|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
139589094|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589095|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589096|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139589097|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139589098|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139589099|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139589100|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
139589101|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589102|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139589103|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
139589104|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139589105|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139589106|NCT03051256|Methadone|methadone|mesh-list
139589107|NCT03051256|D-methadone|d-methadone|mesh-list
139589108|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139589109|NCT03051256|Narcotics|narcotics|mesh-ancestor
139589110|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589111|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589112|NCT03051256|Analgesics|analgesics|mesh-ancestor
139589113|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
139589114|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589115|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
139589116|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
139589117|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139589118|NCT02946996|Metformin|metformin|mesh-list
139589119|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139589120|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589121|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
139589122|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139589123|NCT02790853|Proflavine|proflavine|mesh-list
139589124|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139589125|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139589126|NCT02728531|Cytarabine|cytarabine|mesh-list
139589127|NCT02728531|Rituximab|rituximab|mesh-list
139589128|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139589129|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139589130|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589131|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
139589132|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589133|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139589134|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139589135|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
139589136|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589137|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
139589138|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139589139|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139589140|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139589141|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
139589142|NCT02710331|Ethanol|ethanol|mesh-list
139589143|NCT02710331|Dronabinol|dronabinol|mesh-list
139589144|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139589145|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139589146|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589147|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589148|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
139589149|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139589150|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139589151|NCT02710331|Analgesics|analgesics|mesh-ancestor
139589152|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
139589153|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589154|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139589155|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139589156|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589157|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589158|NCT02710331|Hormones|hormones|mesh-ancestor
139589159|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139589160|NCT02461927|Midazolam|midazolam|mesh-list
139589161|NCT02461927|Naltrexone|naltrexone|mesh-list
139589162|NCT02461927|Ketamine|ketamine|mesh-list
139589163|NCT02461927|Analgesics|analgesics|mesh-ancestor
139589164|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
139589165|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589166|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589167|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139589168|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139589169|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
139589170|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
139589171|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589172|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139589173|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139589174|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589175|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589176|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139589177|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139589178|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139589179|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139589180|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139589181|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
139589182|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
139589183|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139589184|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139589185|NCT02403323|Etrolizumab|etrolizumab|mesh-list
139589186|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139589187|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
139589188|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589189|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
139589190|NCT02394795|Leucovorin|leucovorin|mesh-list
139589191|NCT02394795|Bevacizumab|bevacizumab|mesh-list
139589192|NCT02394795|Panitumumab|panitumumab|mesh-list
139589193|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
139589194|NCT02394795|Fluorouracil|fluorouracil|mesh-list
139589195|NCT02394795|Calcium|calcium|mesh-list
139589196|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
139589197|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139589198|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589199|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139589200|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139589201|NCT02394795|Growth Substances|growth substances|mesh-ancestor
139589202|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589203|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
139589204|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139589205|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139589206|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
139589207|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589208|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139589209|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139589210|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
139589211|NCT02394795|Antidotes|antidotes|mesh-ancestor
139589212|NCT02394795|Protective Agents|protective agents|mesh-ancestor
139589213|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
139370955|NCT02135029|Atorvastatin|atorvastatin|mesh-list
139589214|NCT02394795|Vitamins|vitamins|mesh-ancestor
139589215|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
139589216|NCT02344498|Tenofovir|tenofovir|mesh-list
139589217|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
139589218|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139589219|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139589220|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139589221|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589222|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589223|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139589224|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139589225|NCT02294357|Dexamethasone|dexamethasone|mesh-list
139589226|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
139589227|NCT02294357|Prednisone|prednisone|mesh-list
139589228|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
139589229|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139589230|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139589231|NCT02294357|Prednisolone|prednisolone|mesh-list
139589232|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
139589233|NCT02294357|Lenalidomide|lenalidomide|mesh-list
139589234|NCT02294357|Pomalidomide|pomalidomide|mesh-list
139589235|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139589236|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
139589237|NCT02294357|BB 1101|bb 1101|mesh-list
139589238|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139589239|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
139589240|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
139589241|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589242|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589243|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139589244|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
139589245|NCT02294357|Hormones|hormones|mesh-ancestor
139589246|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139589247|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139589248|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589249|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
139589250|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589251|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589252|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
139589253|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139589254|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139589255|NCT02294357|Growth Substances|growth substances|mesh-ancestor
139589256|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
139589257|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139589258|NCT02294357|Protective Agents|protective agents|mesh-ancestor
139589259|NCT02128113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139589260|NCT02128113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139589261|NCT02013154|Paclitaxel|paclitaxel|mesh-list
139589262|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
139589263|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139589264|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589265|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
139589266|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
139589267|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
139589268|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589269|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139589270|NCT02013154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139589271|NCT01823848|Mineral Oil|mineral oil|mesh-list
139589272|NCT01823848|Emollients|emollients|mesh-ancestor
139589273|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
139589274|NCT01743950|Bevacizumab|bevacizumab|mesh-list
139589275|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139589276|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589277|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139589278|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139589279|NCT01743950|Growth Substances|growth substances|mesh-ancestor
139589280|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589281|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
139589282|NCT01522768|Paclitaxel|paclitaxel|mesh-list
139589283|NCT01522768|Afatinib|afatinib|mesh-list
139589284|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139589285|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589286|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
139589287|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
139589288|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
139589289|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589290|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139589291|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589292|NCT01484327|Carvedilol|carvedilol|mesh-list
139589293|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139589294|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139589295|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
139589296|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589297|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589298|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589299|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139589301|NCT01484327|Protective Agents|protective agents|mesh-ancestor
139589302|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139589303|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139589304|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139589305|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
139589306|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139589307|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139589308|NCT01327781|Tamoxifen|tamoxifen|mesh-list
139589309|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139589310|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
139589311|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139589312|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589313|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139589314|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589315|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139589316|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139589317|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139589318|NCT00887146|Vincristine|vincristine|mesh-list
139589319|NCT00887146|Temozolomide|temozolomide|mesh-list
139589320|NCT00887146|Procarbazine|procarbazine|mesh-list
139589321|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139589322|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589323|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
139589324|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
139589325|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
139589326|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589327|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139589328|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
139589329|NCT00836823|Alfuzosin|alfuzosin|mesh-list
139589330|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139589331|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139589332|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139589333|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
139589334|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589335|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589336|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589337|NCT00836823|Urological Agents|urological agents|mesh-ancestor
139589338|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
139589339|NCT00344058|Analgesics|analgesics|mesh-ancestor
139589340|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
139589341|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589342|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589343|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
139589344|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589345|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139589346|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
139589347|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139589348|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139589349|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589350|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139589351|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
139589352|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139589353|NCT00202007|Risperidone|risperidone|mesh-list
139589354|NCT00202007|Aripiprazole|aripiprazole|mesh-list
139589355|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139589356|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
139589357|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589358|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589359|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589360|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139589361|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139589362|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589363|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139589364|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139589365|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
139589366|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
139589367|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
139589368|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139589369|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139589370|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139589371|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139589372|NCT03245424|Ivosidenib|ivosidenib|mesh-list
139589373|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589374|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589375|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589376|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139589377|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
139589378|NCT03251040|Coagulants|coagulants|mesh-ancestor
139589379|NCT04754763|Propolis|propolis|mesh-list
139589380|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139589381|NCT02454894|Lidocaine|lidocaine|mesh-list
139589382|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
139589383|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
139589384|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589385|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589386|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
139589387|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589388|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139589389|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139589390|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139589391|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139589392|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589393|NCT03250962|Decitabine|decitabine|mesh-list
139589394|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139589395|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
139589396|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589397|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589398|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589399|NCT04774029|Lidocaine|lidocaine|mesh-list
139589400|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
139589401|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
139589402|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589403|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589404|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
139589405|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589406|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139589407|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139589408|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139589409|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139589410|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589411|NCT03245346|Anesthetics|anesthetics|mesh-list
139589412|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589413|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589414|NCT03244956|Trametinib|trametinib|mesh-list
139589415|NCT03244956|Dabrafenib|dabrafenib|mesh-list
139589416|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589417|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139589418|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717425|NCT00191646|Paclitaxel|paclitaxel|mesh-list
139589419|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589420|NCT03244488|Mecamylamine|mecamylamine|mesh-list
139589421|NCT03244488|Scopolamine|scopolamine|mesh-list
139589422|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139589423|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139589424|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
139589425|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
139589426|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589427|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589428|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139589429|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
139589430|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139589431|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
139589432|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589433|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589434|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139589435|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
139589436|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139589437|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
139589438|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139589439|NCT03254784|Deucravacitinib|deucravacitinib|mesh-list
139589440|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
139589441|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139589442|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589443|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589444|NCT03245190|Chiauranib|chiauranib|mesh-list
139589445|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589446|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139589447|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589448|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589449|NCT01969708|Bevacizumab|bevacizumab|mesh-list
139589450|NCT01969708|Aflibercept|aflibercept|mesh-list
139589451|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139589452|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589453|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139589454|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139589455|NCT01969708|Growth Substances|growth substances|mesh-ancestor
139589456|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589457|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
139589458|NCT03243864|Ceftazidime|ceftazidime|mesh-list
139589459|NCT03243864|Avibactam|avibactam|mesh-list
139589460|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
139589461|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139589462|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138717490|NCT00190749|Olanzapine|olanzapine|mesh-list
139589463|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139589464|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589465|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589466|NCT03250494|Dexamethasone|dexamethasone|mesh-list
139589467|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
139589468|NCT03250494|BB 1101|bb 1101|mesh-list
139589469|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139589470|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
139589471|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
139589472|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589473|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589474|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139589475|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
139589476|NCT03250494|Hormones|hormones|mesh-ancestor
139589477|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139589478|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139589479|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589480|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
139589481|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589482|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589483|NCT03254628|Misoprostol|misoprostol|mesh-list
139589484|NCT03254628|Oxytocin|oxytocin|mesh-list
139589485|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
139589486|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139589487|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589488|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139589489|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
139589490|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139589491|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139589492|NCT01970176|Tadalafil|tadalafil|mesh-list
139589493|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
139589494|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139589495|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139589496|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589497|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589498|NCT01970176|Urological Agents|urological agents|mesh-ancestor
139589499|NCT02024386|Riociguat|riociguat|mesh-list
139589500|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
139589501|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589502|NCT03250338|Cytarabine|cytarabine|mesh-list
139589503|NCT03250338|Fludarabine|fludarabine|mesh-list
139589504|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
139589505|NCT03250338|Idarubicin|idarubicin|mesh-list
139589506|NCT03250338|Crenolanib|crenolanib|mesh-list
139589507|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589508|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139589509|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
139589510|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589511|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139589512|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
139589513|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589514|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
139589515|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139589516|NCT03250338|Analgesics|analgesics|mesh-ancestor
139589517|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
139589518|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589519|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139589520|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139589521|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589522|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139589523|NCT01971580|Ambrisentan|ambrisentan|mesh-list
139589524|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139589525|NCT00354562|Docetaxel|docetaxel|mesh-list
139589526|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589527|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
139589528|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
139589529|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
139589530|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589531|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139589532|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139589533|NCT00838383|Sitaxsentan|sitaxsentan|mesh-list
139589534|NCT00838383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139589535|NCT00838383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589536|NCT02355886|Gabapentin|gabapentin|mesh-list
139589537|NCT02355886|Analgesics|analgesics|mesh-ancestor
139589538|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
139589539|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589540|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589541|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
139589542|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139589543|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139589544|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589545|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139589546|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139589547|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139589548|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589549|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589550|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
139589551|NCT02356198|Hydromorphone|hydromorphone|mesh-list
139589552|NCT02356198|Bupivacaine|bupivacaine|mesh-list
139589553|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
139589554|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
139589555|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589556|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589557|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
139589558|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589559|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139589560|NCT02356198|Narcotics|narcotics|mesh-ancestor
139589561|NCT02356198|Analgesics|analgesics|mesh-ancestor
139589562|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
139589563|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139589564|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589565|NCT03254004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139589566|NCT03254004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589567|NCT04778865|Vitamin D|vitamin d|mesh-list
139589568|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
139589569|NCT04778865|Cholecalciferol|cholecalciferol|mesh-list
139589570|NCT04778865|Vitamins|vitamins|mesh-list
139589571|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
139589572|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717588|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589573|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139589574|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139589575|NCT02025634|Acetaminophen|acetaminophen|mesh-list
139589576|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139589577|NCT02025634|Analgesics|analgesics|mesh-ancestor
139589578|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
139589579|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589580|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589581|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
139589582|NCT04773951|Antibodies|antibodies|mesh-list
139589583|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139589584|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
139589585|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589586|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
139589587|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
139589588|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589589|NCT04773717|Protective Agents|protective agents|mesh-ancestor
139589590|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589591|NCT04773717|Vitamins|vitamins|mesh-ancestor
139589592|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
139589593|NCT04444167|Lenvatinib|lenvatinib|mesh-list
139589594|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589595|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139589596|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589597|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589599|NCT03243006|Tramadol|tramadol|mesh-list
139589600|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139589601|NCT03243006|Analgesics|analgesics|mesh-ancestor
139589602|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
139589603|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589604|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589605|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
139589606|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139589607|NCT03243006|Narcotics|narcotics|mesh-ancestor
139589608|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589609|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
139589610|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139589611|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139589612|NCT03249402|Estradiol|estradiol|mesh-list
139589613|NCT03249402|Estrogens|estrogens|mesh-ancestor
139589614|NCT03249402|Hormones|hormones|mesh-ancestor
139589615|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139589616|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589617|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139589618|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
139589619|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139589620|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139589621|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139589622|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139589623|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139589624|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139589625|NCT03242460|Dexamethasone|dexamethasone|mesh-list
139589626|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
139589627|NCT03242460|Pomalidomide|pomalidomide|mesh-list
139589628|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139589629|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
139589630|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589631|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139589632|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139589633|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
139589634|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589635|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589636|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139589637|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139589638|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
139589639|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
139589640|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589641|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139589642|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
139589643|NCT03242460|Hormones|hormones|mesh-ancestor
139589644|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139589645|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139589646|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139589647|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139589648|NCT03242460|Growth Substances|growth substances|mesh-ancestor
139589649|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
139589650|NCT01972516|Tivozanib|tivozanib|mesh-list
139589651|NCT01972516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139589652|NCT01972516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589653|NCT01972516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589654|NCT03242616|Pemetrexed|pemetrexed|mesh-list
139589655|NCT03242616|Vinorelbine|vinorelbine|mesh-list
139589656|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589657|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589658|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589659|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139589660|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139589661|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139589662|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
139589663|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
139589664|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
139589665|NCT01748825|Adavosertib|adavosertib|mesh-list
139589666|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589667|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371407|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139589668|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
139589669|NCT03253224|Analgesics|analgesics|mesh-ancestor
139589670|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
139589671|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589672|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589673|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
139589674|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589675|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139589676|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
139589677|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139589678|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139589679|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589680|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139589681|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
139589682|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139589683|NCT00789399|PENTA|penta|mesh-list
139589684|NCT00789399|Fondaparinux|fondaparinux|mesh-list
139589685|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139589686|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
139589687|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139589688|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
139589689|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589690|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589691|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
139589692|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139589693|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139589694|NCT01720667|Levetiracetam|levetiracetam|mesh-list
139589695|NCT01720667|Phenobarbital|phenobarbital|mesh-list
139589696|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
139589697|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
139589698|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139589699|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589700|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589701|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139589702|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139589703|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589704|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589705|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
139589706|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
139589707|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139589708|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139589709|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139589710|NCT04773093|Lidocaine|lidocaine|mesh-list
139589711|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
139589712|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
139589713|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589714|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589715|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
139589716|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589717|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139589718|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139589719|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139589720|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139589721|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589722|NCT01720043|Bortezomib|bortezomib|mesh-list
139589723|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589724|NCT02455362|Morphine|morphine|mesh-list
139589725|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139589726|NCT02455362|Narcotics|narcotics|mesh-ancestor
139589727|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589728|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589729|NCT02455362|Analgesics|analgesics|mesh-ancestor
139589730|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
139589731|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589732|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
139589733|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139589734|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
139589735|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139589736|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589737|NCT03253068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139589738|NCT03253068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717764|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
139589739|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139371492|NCT05935293|Dexmedetomidine|dexmedetomidine|mesh-list
139589740|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139589742|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139589743|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139589744|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139589745|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589746|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
139589747|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589748|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139589749|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139589750|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139589751|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139589752|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589753|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589754|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589755|NCT03249168|Analgesics|analgesics|mesh-ancestor
139589756|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
139589757|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589758|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
139589759|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139589760|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
139589761|NCT03248856|Triamcinolone|triamcinolone|mesh-list
139589762|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139589763|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139589764|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139589765|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139589766|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
139589767|NCT03248856|Hormones|hormones|mesh-ancestor
139589768|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139589769|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589770|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139589771|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
139589772|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589773|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589774|NCT03241602|Lidocaine|lidocaine|mesh-list
139589775|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
139589776|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
139589777|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589778|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589779|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
139589780|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589781|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139589782|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139589783|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139589784|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139589785|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589786|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
139589787|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139589788|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
139589789|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139589790|NCT02357290|Expectorants|expectorants|mesh-ancestor
139589791|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
139589792|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139589793|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
139589794|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589795|NCT02357290|Protective Agents|protective agents|mesh-ancestor
139589796|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589797|NCT02357290|Antidotes|antidotes|mesh-ancestor
139589798|NCT00687765|Temozolomide|temozolomide|mesh-list
139589799|NCT00687765|Iniparib|iniparib|mesh-list
139589800|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139589801|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
139589802|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589803|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589804|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139589805|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589806|NCT03248544|Vitamin D|vitamin d|mesh-list
139589807|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
139589808|NCT03248544|Vitamins|vitamins|mesh-ancestor
139589809|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
139589810|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589811|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139371555|NCT05820594|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139589812|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139589814|NCT03248700|Vitamin A|vitamin a|mesh-list
139589815|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
139589816|NCT03248700|Retinol acetate|retinol acetate|mesh-list
139589817|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
139589818|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589819|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
139589820|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589821|NCT03248700|Protective Agents|protective agents|mesh-ancestor
139589822|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139589823|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589824|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139589825|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
139589826|NCT03238482|Fluticasone|fluticasone|mesh-list
139589827|NCT03238482|Xhance|xhance|mesh-list
139589828|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139589829|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139589830|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139589831|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139589832|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
139589833|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589834|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589835|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139589836|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
139589837|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
139589838|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139589839|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139589840|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139589841|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139589842|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
139589843|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589844|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589845|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
139589846|NCT03238482|Hormones|hormones|mesh-ancestor
139589847|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139589848|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
139589849|NCT02454504|Neostigmine|neostigmine|mesh-list
139589850|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139589851|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589852|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589853|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
139589854|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589855|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717881|NCT04602143|Testosterone|testosterone|mesh-list
139589856|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139589857|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
139589858|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589859|NCT03240822|Antibodies|antibodies|mesh-list
139589860|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139589861|NCT03240822|Tacrolimus|tacrolimus|mesh-list
139589862|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
139589863|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589864|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139589865|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139589866|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589867|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589868|NCT03238560|Montelukast|montelukast|mesh-list
139589869|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139589870|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
139589871|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139589872|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
139589873|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139589874|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589875|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139589876|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139589877|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589878|NCT04486092|Valproic Acid|valproic acid|mesh-list
139589879|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
139589880|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589881|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589882|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
139589883|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589884|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589885|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
139589887|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589888|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139589889|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
139589890|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139589891|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589892|NCT03238638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139589893|NCT03238638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589894|NCT00668655|Metronidazole|metronidazole|mesh-list
139589895|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139589896|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139589897|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139589898|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139589899|NCT02454426|Vortioxetine|vortioxetine|mesh-list
139589900|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
139589901|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139589902|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139589903|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139589904|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589905|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589906|NCT02454426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139589907|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139589908|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139589909|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589910|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139589911|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
139589912|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139589913|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139589914|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139589915|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139589916|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139589917|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139589918|NCT03238092|Estradiol|estradiol|mesh-list
139589919|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139589920|NCT03238092|Testosterone|testosterone|mesh-list
139589921|NCT03238092|Estrogens|estrogens|mesh-ancestor
139589922|NCT03238092|Hormones|hormones|mesh-ancestor
139589923|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139589924|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589925|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139589926|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
139589927|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139589928|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139589929|NCT03238092|Androgens|androgens|mesh-ancestor
139589930|NCT03247998|Remifentanil|remifentanil|mesh-list
139589931|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589932|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589933|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139589934|NCT03247998|Narcotics|narcotics|mesh-ancestor
139589935|NCT03247998|Analgesics|analgesics|mesh-ancestor
139589936|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
139589937|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589938|NCT03248076|Fentanyl|fentanyl|mesh-list
139589939|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139589940|NCT03248076|Narcotics|narcotics|mesh-ancestor
139589941|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139589942|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589943|NCT03248076|Analgesics|analgesics|mesh-ancestor
139589944|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
139589945|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589946|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139589947|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139589948|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
139589949|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
139589950|NCT03240120|Tinzaparin|tinzaparin|mesh-list
139589951|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139589952|NCT03240120|Dalteparin|dalteparin|mesh-list
139589953|NCT03240120|Dabigatran|dabigatran|mesh-list
139589954|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
139589955|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139589956|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
139589957|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589958|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589959|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
139589960|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139589961|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139589962|NCT03237936|Cyclosporine|cyclosporine|mesh-list
139589963|NCT03237936|Cyclosporins|cyclosporins|mesh-list
139589964|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589965|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589966|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139589967|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
139589968|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589969|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
139589970|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139589971|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
139589972|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139589973|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139589974|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139589975|NCT03247920|Amoxicillin|amoxicillin|mesh-list
139589976|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
139589977|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
139589978|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139589979|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139589980|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139589981|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589982|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139589983|NCT03239964|Dexamethasone|dexamethasone|mesh-list
139589984|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139589985|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
139589986|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
139589987|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139589988|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139589989|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139589990|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
139589991|NCT03239964|Hormones|hormones|mesh-ancestor
139589992|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139589993|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139589994|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589995|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
139589996|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139589997|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139589998|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139589999|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590000|NCT03102723|Cangrelor|cangrelor|mesh-list
139590001|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139590002|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139590003|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139590004|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139590005|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
139590006|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590007|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590008|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590009|NCT03237312|Hormones|hormones|mesh-list
139590010|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139590011|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590012|NCT03241914|Megestrol|megestrol|mesh-list
139590013|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
139590014|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
139590015|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139590016|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
139590017|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139590018|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590019|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139590020|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139590021|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139590022|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139590023|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139590024|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590025|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
139590026|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139590027|NCT00057681|Valproic Acid|valproic acid|mesh-list
139590028|NCT00057681|Risperidone|risperidone|mesh-list
139590029|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
139590030|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139590031|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
139590032|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590033|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590034|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590035|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139590036|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139590037|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139590038|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139590039|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139590040|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
139590041|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
139590042|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590043|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
139590044|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
139590045|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
139590046|NCT03234816|Norepinephrine|norepinephrine|mesh-list
139590047|NCT03234816|Bupivacaine|bupivacaine|mesh-list
139590048|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
139590049|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
139590050|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139590051|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590052|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
139590053|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590054|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139590055|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139590056|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
139590057|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590058|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590059|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
139590060|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
139590061|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139590062|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
139590063|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
139590064|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590065|NCT03247452|Protective Agents|protective agents|mesh-ancestor
139590066|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590067|NCT03247452|Vitamins|vitamins|mesh-ancestor
139590068|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
139590069|NCT03247140|Amlodipine|amlodipine|mesh-list
139590070|NCT03247140|Telmisartan|telmisartan|mesh-list
139590071|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139590072|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139590073|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139590074|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139590075|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139590076|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590077|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139590078|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590079|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
139590080|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139590081|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139590082|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
139590083|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139590084|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139590085|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590086|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139590087|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139590088|NCT03237546|Anesthetics|anesthetics|mesh-list
139590089|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139590090|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590091|NCT03247296|Ribavirin|ribavirin|mesh-list
139590092|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
139590093|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
139590094|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590095|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
139590096|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590097|NCT03247218|Memantine|memantine|mesh-list
139590098|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139590099|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139590100|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
139590101|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590102|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590103|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590104|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139590105|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139590106|NCT03237624|Chitosan|chitosan|mesh-list
139590107|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139371851|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590108|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139590109|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
139590110|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590111|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139590112|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
139590113|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
139590114|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
139590115|NCT03237624|Coagulants|coagulants|mesh-ancestor
139590116|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
139590117|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139590118|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139590119|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590120|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139590121|NCT03234660|Analgesics|analgesics|mesh-ancestor
139590122|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
139590123|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590124|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139590125|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139590126|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139590127|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
139590128|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590129|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590130|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
139590131|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139590132|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139590133|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139590134|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139590135|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590136|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
139590137|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590138|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590139|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139590140|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590141|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
139590142|NCT00059475|Interleukin-2|interleukin-2|mesh-list
139590143|NCT00059475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139590144|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590145|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139590146|NCT00059475|Analgesics|analgesics|mesh-ancestor
139590147|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
139590148|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590149|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590150|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139590151|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
139590152|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139590153|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
139590154|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590155|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
139590156|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139590157|NCT00059475|Protective Agents|protective agents|mesh-ancestor
139590158|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
139590159|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
139590160|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
139590161|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139590162|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139590163|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590164|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
139590165|NCT02453802|Coagulants|coagulants|mesh-ancestor
139590166|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139590167|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
139590168|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139590169|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
139590170|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590171|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
139590172|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
139590173|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139590174|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139590175|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139590176|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139590177|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139590178|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590179|NCT02028676|Lamivudine|lamivudine|mesh-list
139590180|NCT02028676|Zidovudine|zidovudine|mesh-list
139590181|NCT02028676|Efavirenz|efavirenz|mesh-list
139590182|NCT02028676|Nevirapine|nevirapine|mesh-list
139590183|NCT02028676|Abacavir|abacavir|mesh-list
139590184|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
139590185|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139371928|NCT03397004|Doxycycline|doxycycline|mesh-list
139590186|NCT02028676|Trimethoprim|trimethoprim|mesh-list
139590187|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
139590188|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139590189|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139590190|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139590191|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590192|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590193|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
139590194|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590195|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139590196|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139590197|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
139590198|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139590199|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139590200|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139590201|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139590202|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139590203|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139590204|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139590205|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
139590206|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139590207|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139590208|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139590209|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139590210|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139590211|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139590212|NCT03233880|Azithromycin|azithromycin|mesh-list
139590213|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139590214|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590215|NCT00061893|Celecoxib|celecoxib|mesh-list
139590216|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
139590217|NCT00061893|Ifosfamide|ifosfamide|mesh-list
139590218|NCT00061893|Doxorubicin|doxorubicin|mesh-list
139590219|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139590220|NCT00061893|Etoposide|etoposide|mesh-list
139590221|NCT00061893|Vincristine|vincristine|mesh-list
139590222|NCT00061893|Vinblastine|vinblastine|mesh-list
139590223|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139590224|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
139590225|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590226|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139590227|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139590228|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
139590229|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590230|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590231|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139590232|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139590233|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139590234|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139590235|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590236|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139590237|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
139590238|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
139590239|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
139590240|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139590241|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139590242|NCT00061893|Analgesics|analgesics|mesh-ancestor
139590243|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
139590244|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590245|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139590246|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139590247|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139590248|NCT02957019|Rituximab|rituximab|mesh-list
139590249|NCT02957019|Interleukin-2|interleukin-2|mesh-list
139590250|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139590251|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590252|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
139590253|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590254|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139590255|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139590256|NCT02957019|Analgesics|analgesics|mesh-ancestor
139590257|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
139590258|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590259|NCT02028754|Levofloxacin|levofloxacin|mesh-list
139372003|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
139590260|NCT02028754|Prednisolone|prednisolone|mesh-list
139590261|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
139590262|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139590263|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139590264|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
139590265|NCT02028754|Hormones|hormones|mesh-ancestor
139590266|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139590267|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590268|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139590269|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590270|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139590271|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139590272|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590273|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139590274|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139590275|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139590276|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590277|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590278|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139590279|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139590280|NCT02028754|Laxatives|laxatives|mesh-ancestor
139590281|NCT02453490|Fluorouracil|fluorouracil|mesh-list
139590282|NCT02453490|Raltitrexed|raltitrexed|mesh-list
139590283|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
139590284|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590285|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139590286|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590287|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139590288|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
139590289|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590290|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139590291|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590292|NCT01974700|Levetiracetam|levetiracetam|mesh-list
139590293|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
139590294|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
139590295|NCT03236610|Tenofovir|tenofovir|mesh-list
139590296|NCT03236610|Entecavir|entecavir|mesh-list
139590297|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
139590298|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590299|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139590300|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139590301|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590302|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590303|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139590304|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139590305|NCT05287893|Pyronaridine|pyronaridine|mesh-list
139590306|NCT05287893|Antimalarials|antimalarials|mesh-ancestor
139590307|NCT05287893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139590308|NCT05287893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139590309|NCT05287893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590310|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139590311|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590312|NCT02357836|Itraconazole|itraconazole|mesh-list
139590313|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
139590314|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590315|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139590316|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139590317|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590318|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590319|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139590320|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
139590321|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139590322|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590323|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139590324|NCT02359006|Minocycline|minocycline|mesh-list
139590325|NCT02359006|Tetracycline|tetracycline|mesh-list
139590326|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139590327|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590328|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139590329|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590330|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590331|NCT04485702|Midazolam|midazolam|mesh-list
139590332|NCT04485702|Ketamine|ketamine|mesh-list
139590333|NCT04485702|Analgesics|analgesics|mesh-ancestor
139590334|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
139590335|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590336|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590337|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139590338|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139590339|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
139590340|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
139590341|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139590342|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139590343|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139590344|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590345|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590346|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139590347|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139590348|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139590349|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139590350|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139590351|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
139590352|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
139590353|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139590354|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590355|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139590356|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590357|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590358|NCT03233412|Imiquimod|imiquimod|mesh-list
139590359|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139590360|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
139590361|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590362|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590363|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
139590364|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
139590365|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590366|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
139590367|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590368|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590369|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139590370|NCT01976572|Candesartan|candesartan|mesh-list
139590371|NCT01976572|Candesartan cilexetil|candesartan cilexetil|mesh-list
139590372|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139590373|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139590374|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139590375|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590376|NCT01976650|Dexamethasone|dexamethasone|mesh-list
139590377|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139590378|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
139590379|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
139590380|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590381|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590382|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139590383|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
139590384|NCT01976650|Hormones|hormones|mesh-ancestor
139590385|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139590386|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139590387|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590388|NCT01978600|Timolol|timolol|mesh-list
139590389|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139590390|NCT01978600|Brinzolamide|brinzolamide|mesh-list
139590391|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590392|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590393|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139590394|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139590395|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
139590396|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590397|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590398|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139590399|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139590400|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139590401|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139590402|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139590403|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139590404|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
139590405|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139590406|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
139590407|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590408|NCT03236220|Expectorants|expectorants|mesh-ancestor
139590409|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
139590410|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139590411|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
139590412|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590413|NCT03236220|Protective Agents|protective agents|mesh-ancestor
139590414|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590415|NCT03236220|Antidotes|antidotes|mesh-ancestor
139590416|NCT03232632|Flutemetamol|flutemetamol|mesh-list
139590417|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138718435|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139590418|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590419|NCT01747499|Azacitidine|azacitidine|mesh-list
139590420|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139590421|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
139590422|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590423|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590424|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590425|NCT00071721|Valproic Acid|valproic acid|mesh-list
139590426|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
139590427|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590428|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590429|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
139590430|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590431|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590432|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
139590433|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139590434|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139590435|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139590436|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
139590437|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139590438|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590439|NCT05606055|Tenofovir|tenofovir|mesh-list
139590440|NCT05606055|Emtricitabine|emtricitabine|mesh-list
139590441|NCT05606055|Antiviral Agents|antiviral agents|mesh-ancestor
139590442|NCT05606055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590443|NCT05606055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139590444|NCT05606055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139590445|NCT05606055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590446|NCT05606055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590447|NCT05606055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139590448|NCT05606055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139590449|NCT01896609|Interferons|interferons|mesh-list
139590450|NCT01896609|Ribavirin|ribavirin|mesh-list
139590451|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
139590452|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
139590453|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139590454|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
139590455|NCT01896609|Complement Factor H|complement factor h|mesh-list
139590456|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590457|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
139590458|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590459|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
139590460|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590461|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
139590462|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590463|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139590464|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139590465|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139590466|NCT03232554|Iron|iron|mesh-list
139590467|NCT03232554|Trace Elements|trace elements|mesh-ancestor
139590468|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
139590469|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590470|NCT03232398|Warfarin|warfarin|mesh-list
139590471|NCT03232398|Apixaban|apixaban|mesh-list
139590472|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
139590473|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139590474|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
139590475|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139590476|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
139590477|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590478|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590479|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
139590480|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
139590481|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139590482|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590483|NCT02362048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139590484|NCT02362048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372229|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
139590486|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139590487|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139590488|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139590489|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590490|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139590491|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139590492|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
139590493|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590494|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590495|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139590496|NCT03228576|Everolimus|everolimus|mesh-list
139590497|NCT03228576|Tacrolimus|tacrolimus|mesh-list
139590498|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139590499|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
139590500|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590501|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139590502|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590503|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590504|NCT03228576|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139590505|NCT03228576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139590506|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590507|NCT00158379|Paclitaxel|paclitaxel|mesh-list
139590508|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139590509|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590510|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
139590511|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
139590512|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
139590513|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590514|NCT03228498|Choline|choline|mesh-list
139590515|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
139590516|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139590517|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
139590518|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590519|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139590520|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139590521|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
139590522|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139590523|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139590524|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590525|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590526|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139590527|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139590528|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590529|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
139590530|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590531|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
139590532|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139590533|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590534|NCT02364076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139590535|NCT02364076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590536|NCT02453022|Omeprazole|omeprazole|mesh-list
139590537|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139590538|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139590539|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139590540|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590541|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590542|NCT00163293|Ciclesonide|ciclesonide|mesh-list
139590543|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
139590544|NCT00163293|Hormones|hormones|mesh-ancestor
139590545|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139590546|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590547|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139590548|NCT02365870|Rotigotine|rotigotine|mesh-list
139590549|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
139590550|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
139590551|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590552|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590553|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590554|NCT03228108|Amoxicillin|amoxicillin|mesh-list
139590555|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
139590556|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139590557|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
139372307|NCT03068234|Pirfenidone|pirfenidone|mesh-list
139590559|NCT03228108|Fosfomycin|fosfomycin|mesh-list
139590560|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139590561|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
139590562|NCT03228108|Trimethoprim|trimethoprim|mesh-list
139590563|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
139590564|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139590565|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590566|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139590567|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139590568|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590569|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590570|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590571|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139590572|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139590573|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139590574|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
139590575|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139590576|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139590577|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139590578|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139590579|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139590580|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139590581|NCT00078897|Selenium|selenium|mesh-list
139590582|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
138718609|NCT02210598|Oxytocin|oxytocin|mesh-list
139590583|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590584|NCT00078897|Protective Agents|protective agents|mesh-ancestor
139590585|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590586|NCT00078897|Trace Elements|trace elements|mesh-ancestor
139590587|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
139590588|NCT03228030|Thiamine|thiamine|mesh-list
139590589|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
139590590|NCT03228030|Vitamins|vitamins|mesh-ancestor
139590591|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
139590592|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590593|NCT01717313|Metformin|metformin|mesh-list
139590594|NCT01717313|Glimepiride|glimepiride|mesh-list
139590595|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139590596|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590597|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139590598|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139590599|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
139590600|NCT00081861|Bevacizumab|bevacizumab|mesh-list
139590601|NCT00081861|Rituximab|rituximab|mesh-list
139590602|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139590603|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590604|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139590605|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139590606|NCT00081861|Growth Substances|growth substances|mesh-ancestor
139590607|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590608|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
139590609|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
139590610|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139590611|NCT03120234|Fentanyl|fentanyl|mesh-list
139590612|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
139590613|NCT03120234|Ketamine|ketamine|mesh-list
139590614|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139590615|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139590616|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590617|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139590618|NCT03120234|Analgesics|analgesics|mesh-ancestor
139590619|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
139590620|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590621|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139590622|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139590623|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139590624|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
139590625|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590626|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590627|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139590628|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139590629|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
139590630|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
139372383|NCT05017610|Lomustine|lomustine|mesh-list
139590631|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139590632|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139590633|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139590634|NCT03120234|Narcotics|narcotics|mesh-ancestor
139590635|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139590636|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
139590637|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139590638|NCT03232710|Aripiprazole|aripiprazole|mesh-list
139590639|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
139590640|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139590641|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139590642|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139590643|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139590644|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590645|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
139590646|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
139590647|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590648|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590649|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139590650|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139590651|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
139590652|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139590653|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139590654|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139590655|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139590656|NCT03227484|Empagliflozin|empagliflozin|mesh-list
139590657|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139590658|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590659|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139590660|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590661|NCT02038894|Propofol|propofol|mesh-list
139590662|NCT02038894|Sevoflurane|sevoflurane|mesh-list
139590663|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139590664|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139590665|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590666|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139590667|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
139590668|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
139590669|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139590670|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139590671|NCT01375374|Lacosamide|lacosamide|mesh-list
139590672|NCT01375374|Levetiracetam|levetiracetam|mesh-list
139590673|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
139590674|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
139590675|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139590676|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139590677|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139590678|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590679|NCT04348786|Amoxicillin|amoxicillin|mesh-list
139590680|NCT04348786|Doxycycline|doxycycline|mesh-list
139590681|NCT04348786|Levofloxacin|levofloxacin|mesh-list
139590682|NCT04348786|Esomeprazole|esomeprazole|mesh-list
139590683|NCT04348786|Bismuth|bismuth|mesh-list
139590684|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
139590685|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139590686|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590687|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139590688|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139590689|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139590690|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590691|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590692|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
139590693|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139590694|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139590695|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139590696|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139590697|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139590698|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590699|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139590700|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139590701|NCT04348786|Antacids|antacids|mesh-ancestor
139590702|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
139590703|NCT02369068|Triamcinolone|triamcinolone|mesh-list
139590704|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139590705|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139590706|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139590707|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139590708|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
139590709|NCT02369068|Hormones|hormones|mesh-ancestor
139590710|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139590711|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590712|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139590713|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
139590714|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590715|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139590716|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590717|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139590718|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139590719|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
139590720|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590721|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
139590722|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139590723|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590724|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139590725|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590726|NCT02371252|Alendronate|alendronate|mesh-list
139590727|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139590728|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590729|NCT03221946|Diclofenac|diclofenac|mesh-list
139590730|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139590731|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139590732|NCT03221946|Analgesics|analgesics|mesh-ancestor
139590733|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
139590734|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590735|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590736|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139590737|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139590738|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139590739|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590740|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590741|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
139590742|NCT03229746|Vincristine|vincristine|mesh-list
139590743|NCT03229746|Azathioprine|azathioprine|mesh-list
139590744|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139590745|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590746|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
139590747|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
139590748|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
139590749|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590750|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
139590751|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139590752|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139590753|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590754|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590755|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139590756|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
139590757|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139590758|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139590759|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
139590760|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590761|NCT02040298|Clemastine|clemastine|mesh-list
139590762|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
139590763|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
139590764|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139590765|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
139590766|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
139590767|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590768|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590769|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590770|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139590771|NCT03229668|Pregabalin|pregabalin|mesh-list
139590772|NCT03229668|Analgesics|analgesics|mesh-ancestor
139590773|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
139590774|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590775|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590776|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
139590777|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139590778|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138718796|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
139590779|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590780|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139590781|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139590782|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139590783|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139590784|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139590785|NCT03230058|Voriconazole|voriconazole|mesh-list
139590786|NCT03230058|Natamycin|natamycin|mesh-list
139590787|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139590788|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139590789|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
139590790|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590791|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139590792|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139590793|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590794|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590795|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139590796|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
139590797|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139590798|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590799|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139590800|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139590801|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139590802|NCT01985542|Immunomodulating Agents|immunomodulating agents|mesh-list
139590803|NCT01985542|Immunologic Factors|immunologic factors|mesh-ancestor
139590804|NCT01985542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590805|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139590806|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590807|NCT00081939|Thalidomide|thalidomide|mesh-list
139590808|NCT00081939|Bortezomib|bortezomib|mesh-list
139590809|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590810|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139590811|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
139590812|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590813|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
139590814|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139590815|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590816|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139590817|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139590818|NCT00081939|Growth Substances|growth substances|mesh-ancestor
139590819|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
139590820|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
139590821|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
139590822|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139590823|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590824|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590825|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590826|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
139590827|NCT03221634|Daratumumab|daratumumab|mesh-list
139590828|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139590829|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590830|NCT03221634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139590831|NCT03221634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590832|NCT05003037|Carboplatin|carboplatin|mesh-list
139590833|NCT05003037|Pemetrexed|pemetrexed|mesh-list
139590834|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590835|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590836|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590837|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139590838|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139590839|NCT02374060|Dexamethasone|dexamethasone|mesh-list
139590840|NCT02374060|Triamcinolone|triamcinolone|mesh-list
139590841|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139590842|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139590843|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139590844|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139590845|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
139590846|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
139590847|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139590848|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590849|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139590850|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
139590851|NCT02374060|Hormones|hormones|mesh-ancestor
139590852|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139590853|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139590854|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590855|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139590856|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
139590857|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590858|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590859|NCT03221166|Thalidomide|thalidomide|mesh-list
139590861|NCT03221166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139590862|NCT03221166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139590863|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
139590864|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139590865|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139590866|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139590867|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
139590868|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590869|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
139590870|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139590871|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590872|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139590873|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139590874|NCT03221166|Growth Substances|growth substances|mesh-ancestor
139590875|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
139590876|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590877|NCT03220932|Bevacizumab|bevacizumab|mesh-list
139590878|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139590879|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590880|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139590881|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139590882|NCT03220932|Growth Substances|growth substances|mesh-ancestor
139590883|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590884|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
139590885|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
139590886|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139590887|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590888|NCT04484688|Bisoprolol|bisoprolol|mesh-list
139590889|NCT04484688|Perindopril|perindopril|mesh-list
139590890|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139590891|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
139590892|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
139590893|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718917|NCT01080222|Ribavirin|ribavirin|mesh-list
139590894|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590895|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139590896|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139590897|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139590898|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
139590899|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139590900|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590901|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139590902|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
139590903|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590904|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
139590905|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590906|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139590907|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590908|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590909|NCT00082329|Plerixafor|plerixafor|mesh-list
139590910|NCT00082329|Lenograstim|lenograstim|mesh-list
139590911|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139590912|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
139590913|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590914|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139590915|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139590916|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
139590917|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590918|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
139590919|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139590920|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590921|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139590922|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
139590923|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139590924|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590925|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139590926|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
139590927|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139590928|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139590929|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139590930|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139590931|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590932|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
139590933|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139590934|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590935|NCT03220542|Amoxicillin|amoxicillin|mesh-list
139590936|NCT03220542|Clarithromycin|clarithromycin|mesh-list
139590937|NCT03220542|Sulforaphane|sulforaphane|mesh-list
139590938|NCT03220542|Esomeprazole|esomeprazole|mesh-list
139590939|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139590940|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590941|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139590942|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139590943|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139590944|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590945|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590946|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139590947|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139590948|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139590949|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138718973|NCT04572542|Paclitaxel|paclitaxel|mesh-list
139590950|NCT03220542|Protective Agents|protective agents|mesh-ancestor
139590951|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590952|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590953|NCT03220152|Tenofovir|tenofovir|mesh-list
139590954|NCT03220152|Emtricitabine|emtricitabine|mesh-list
139590955|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
139590956|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590957|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139590958|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139590959|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139590960|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590961|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139590962|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139590963|NCT03220464|Interferons|interferons|mesh-list
139590964|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
139590965|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590966|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
139590967|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590968|NCT03206658|Spironolactone|spironolactone|mesh-list
139590969|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139590970|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
139590971|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139590972|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590973|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139590974|NCT03206658|Diuretics|diuretics|mesh-ancestor
139590975|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
139590976|NCT00170157|Ipilimumab|ipilimumab|mesh-list
139590977|NCT00170157|Leuprolide|leuprolide|mesh-list
139590978|NCT00170157|Goserelin|goserelin|mesh-list
139590979|NCT00170157|Bicalutamide|bicalutamide|mesh-list
139590980|NCT00170157|Flutamide|flutamide|mesh-list
139590981|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139590982|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139590983|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139590984|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139590985|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139590986|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
139590987|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139590988|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139590989|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139590990|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
139590991|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
139590992|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139590993|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
139590994|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
139590995|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139590996|NCT00170625|Topotecan|topotecan|mesh-list
139590997|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139590998|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139590999|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591000|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591001|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591002|NCT02043652|Chloroquine|chloroquine|mesh-list
139591003|NCT02043652|Primaquine|primaquine|mesh-list
139591004|NCT02043652|Amebicides|amebicides|mesh-ancestor
139591005|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139591006|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139591007|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591008|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
139591009|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591011|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139591012|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
139591013|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719029|NCT04565496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139591014|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591015|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139591016|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139591017|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
139591018|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591019|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591020|NCT03227016|Topotecan|topotecan|mesh-list
139591021|NCT03227016|Veliparib|veliparib|mesh-list
139591022|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139591023|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139591024|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139591025|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591026|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591027|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591028|NCT04748991|Amiodarone|amiodarone|mesh-list
139591029|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139591030|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
139591031|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139591032|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139591033|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591034|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139591035|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139591036|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139591037|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591038|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139591039|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139591040|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139591041|NCT03230136|Anesthetics|anesthetics|mesh-list
139591042|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139591043|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591044|NCT00176865|Cyclosporine|cyclosporine|mesh-list
139591045|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
139591046|NCT00176865|Fludarabine|fludarabine|mesh-list
139591047|NCT00176865|Melphalan|melphalan|mesh-list
139591048|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
139591049|NCT00176865|Cyclosporins|cyclosporins|mesh-list
139591050|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139591051|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
139591052|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139591053|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
139591054|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139591055|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591056|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591057|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139591058|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
139591059|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591060|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591061|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
139591062|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591063|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
139591064|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591065|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139591066|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139591067|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139591068|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
139591069|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139591070|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139591071|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
139591072|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139591073|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139591074|NCT02451072|Ketanserin|ketanserin|mesh-list
139591075|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139591076|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
139591077|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591078|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139591079|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139591080|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
139591081|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591082|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591083|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139591084|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139591085|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139591086|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139591087|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591088|NCT02450994|Dexamethasone|dexamethasone|mesh-list
139591089|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139591090|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
139591091|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
139591092|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591093|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591094|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139591095|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
139591096|NCT02450994|Hormones|hormones|mesh-ancestor
139591097|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139591098|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139591099|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591100|NCT00177255|Docetaxel|docetaxel|mesh-list
139591101|NCT00177255|Capecitabine|capecitabine|mesh-list
139591102|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591103|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
139591104|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
139591105|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
139591106|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591107|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139591108|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
139591109|NCT02401048|Durvalumab|durvalumab|mesh-list
139591110|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139591111|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591112|NCT02046382|Acetaminophen|acetaminophen|mesh-list
139591113|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139591114|NCT02046382|Analgesics|analgesics|mesh-ancestor
139591115|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
139591116|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591117|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591118|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
139591119|NCT03205176|Olaparib|olaparib|mesh-list
139591120|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139591121|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591122|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591123|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591124|NCT02046772|Morphine|morphine|mesh-list
139591125|NCT02046772|Bupivacaine|bupivacaine|mesh-list
139591126|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
139591127|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
139591128|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139591129|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591130|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
139591131|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591132|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139591133|NCT02046772|Narcotics|narcotics|mesh-ancestor
139591134|NCT02046772|Analgesics|analgesics|mesh-ancestor
139591135|NCT00178503|Methylphenidate|methylphenidate|mesh-list
139591136|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139591137|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591138|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139591139|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139591140|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139591141|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591142|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
139591143|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591144|NCT02376010|Warfarin|warfarin|mesh-list
139591145|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
139591146|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
139591147|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139591148|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
139591149|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139591150|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
139591151|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591152|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591153|NCT00085293|Decitabine|decitabine|mesh-list
139591154|NCT00085293|Azacitidine|azacitidine|mesh-list
139591155|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139591156|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139591157|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
139591158|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591159|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591160|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591161|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139591163|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591164|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139591165|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139591166|NCT02402062|Growth Substances|growth substances|mesh-ancestor
139591167|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591168|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
139591169|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139591170|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591171|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591172|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139591173|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139591174|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
139591175|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591176|NCT02450838|Antacids|antacids|mesh-ancestor
139591177|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591178|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139591179|NCT03214302|Tenofovir|tenofovir|mesh-list
139591180|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
139591181|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591182|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139591183|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139591184|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591185|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591186|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139591187|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139591188|NCT00085839|Paclitaxel|paclitaxel|mesh-list
139591189|NCT00085839|Carboplatin|carboplatin|mesh-list
139591190|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139591191|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139591192|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591193|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
139591194|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
139591195|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
139591196|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591197|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139591198|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591199|NCT03204474|Lacosamide|lacosamide|mesh-list
139591200|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
139591201|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139591202|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139591203|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139591204|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591205|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139591206|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139591207|NCT03204318|Norethindrone|norethindrone|mesh-list
139591208|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
139591209|NCT03204318|Estradiol|estradiol|mesh-list
139591210|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139591211|NCT03204318|Relugolix|relugolix|mesh-list
139591212|NCT03204318|Estrogens|estrogens|mesh-ancestor
139591213|NCT03204318|Hormones|hormones|mesh-ancestor
139591214|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139591215|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591216|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139591217|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
139591218|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139591219|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139591220|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139591221|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139591222|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139591223|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
139591224|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
139591225|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
139591226|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139591227|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139591228|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591229|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139591230|NCT03204006|Analgesics|analgesics|mesh-ancestor
139372981|NCT03063242|Sargramostim|sargramostim|mesh-list
139591231|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
139591232|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591233|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139591234|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139591235|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139591236|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
139591237|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591238|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591239|NCT03226080|Rocuronium|rocuronium|mesh-list
139591240|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139591241|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139591242|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139591243|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591244|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591245|NCT03225924|Prednisone|prednisone|mesh-list
139591246|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
139591247|NCT03225924|Rituximab|rituximab|mesh-list
139591248|NCT03225924|Doxorubicin|doxorubicin|mesh-list
139591249|NCT03225924|Vincristine|vincristine|mesh-list
139591250|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139591251|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
139591252|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591253|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591254|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139591255|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
139591256|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591257|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591258|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139591259|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139591260|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139591261|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139591262|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139591263|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591264|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139591265|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
139591266|NCT03225924|Hormones|hormones|mesh-ancestor
139591267|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139591268|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139591269|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139591270|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
139591271|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
139591272|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
139591273|NCT03119532|Metronidazole|metronidazole|mesh-list
139591274|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591275|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139591276|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139591277|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139591278|NCT02404168|Lamotrigine|lamotrigine|mesh-list
139591279|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
139591280|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139591281|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139591282|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591283|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139591284|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591285|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139591286|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139591287|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139591288|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139591289|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139591290|NCT04733937|Caseins|caseins|mesh-list
139591291|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
139591292|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
139591293|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591294|NCT02051452|Methylphenidate|methylphenidate|mesh-list
139591295|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139591296|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591297|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139591298|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139591299|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139591300|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591301|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
139591302|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373056|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
139591303|NCT00180687|Bupivacaine|bupivacaine|mesh-list
139591304|NCT00180687|Coal Tar|coal tar|mesh-list
139591305|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
139591306|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
139591307|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139591308|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591309|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
139591310|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591311|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
139591312|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
139591313|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139591314|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
139591315|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591316|NCT02384044|Listerine|listerine|mesh-list
139591317|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
139591318|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
139591319|NCT02384044|Protective Agents|protective agents|mesh-ancestor
139591320|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591321|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139591322|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591323|NCT02384200|Vancomycin|vancomycin|mesh-list
139591324|NCT02384200|Gentamicins|gentamicins|mesh-list
139591325|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
139591326|NCT02384200|Ampicillin|ampicillin|mesh-list
139591327|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
139591328|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139591329|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591330|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139591331|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591332|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591333|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139591334|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
139591335|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139591336|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139591337|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591338|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
139591339|NCT02051686|Coagulants|coagulants|mesh-ancestor
139591340|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
139591341|NCT00182793|Melphalan|melphalan|mesh-list
139591342|NCT00182793|Thiotepa|thiotepa|mesh-list
139591343|NCT00182793|Carboplatin|carboplatin|mesh-list
139591344|NCT00182793|Trastuzumab|trastuzumab|mesh-list
139591345|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139591346|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
139591347|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591348|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591349|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139591350|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
139591351|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591352|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591353|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139591354|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139591355|NCT00183339|Fluoxetine|fluoxetine|mesh-list
139591356|NCT00183339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139591357|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139591358|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139591359|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591360|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591361|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
139591362|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591363|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139591364|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
139591365|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139591366|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139591367|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139591368|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591369|NCT00183729|Memantine|memantine|mesh-list
139591370|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139591371|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139591372|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
139591373|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591374|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591375|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591376|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139591377|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139591378|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
139591380|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
139591381|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591382|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591383|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
139591384|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139591385|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139591386|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
139591387|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139591388|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139591389|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591390|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139591391|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
139591392|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139591393|NCT01742897|Fentanyl|fentanyl|mesh-list
139591394|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139591395|NCT01742897|Narcotics|narcotics|mesh-ancestor
139591396|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139591397|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591398|NCT01742897|Analgesics|analgesics|mesh-ancestor
139591399|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
139591400|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591401|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139591402|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139591403|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
139591404|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
139591405|NCT01741259|Meperidine|meperidine|mesh-list
139591406|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139591407|NCT01741259|Narcotics|narcotics|mesh-ancestor
139591408|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139591409|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591410|NCT01741259|Analgesics|analgesics|mesh-ancestor
139591411|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
139591412|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591413|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139591414|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139591415|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
139591416|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139591417|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
139591418|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139591419|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591420|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139591421|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139591422|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591423|NCT02387554|Losartan|losartan|mesh-list
139591424|NCT02387554|Amlodipine|amlodipine|mesh-list
139591425|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
139591426|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139591427|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139591428|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139591429|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591430|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139591431|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591432|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
139591433|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139591434|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139591435|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139591436|NCT02387554|Diuretics|diuretics|mesh-ancestor
139591437|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
139591438|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139591439|NCT02387710|Tiagabine|tiagabine|mesh-list
139591440|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
139591441|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
139591442|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139591443|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139591444|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591445|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
139591446|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591447|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591448|NCT01740791|Velpatasvir|velpatasvir|mesh-list
139591449|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
139591450|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591451|NCT01740323|Curcumin|curcumin|mesh-list
139591452|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139591453|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139591454|NCT01740323|Analgesics|analgesics|mesh-ancestor
139591455|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
139591456|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591457|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591458|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139591459|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591460|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591461|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591462|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591463|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
139591464|NCT00090051|Rituximab|rituximab|mesh-list
139591465|NCT00090051|Fludarabine|fludarabine|mesh-list
139591466|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
139591467|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139591468|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
139591469|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591470|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591471|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139591472|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
139591473|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591474|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591475|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139591476|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139591477|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139591478|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
139591479|NCT01740089|Ribavirin|ribavirin|mesh-list
139591480|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139591481|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
139591482|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591483|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
139591484|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591485|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
139591486|NCT01739933|Propofol|propofol|mesh-list
139591487|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139591488|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139591489|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591490|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139591491|NCT01739933|Analgesics|analgesics|mesh-ancestor
139591492|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
139591493|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591494|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139591495|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139591496|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139591497|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
139591498|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591499|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591500|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139591501|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
139591502|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
139591503|NCT00094497|Doxorubicin|doxorubicin|mesh-list
139591504|NCT00094497|Etoposide|etoposide|mesh-list
139591505|NCT00094497|Mitotane|mitotane|mesh-list
139591506|NCT00094497|Streptozocin|streptozocin|mesh-list
139591507|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591508|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139591509|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139591510|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139591511|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591512|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591513|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139591514|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139591515|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
139591516|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139591517|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
139591518|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591519|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591520|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139591521|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
139591522|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139591523|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
139591524|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591525|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591526|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139373277|NCT03819413|Antibodies|antibodies|mesh-list
139591527|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
139591528|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
139591529|NCT00094887|Protective Agents|protective agents|mesh-ancestor
139591530|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
139591531|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591532|NCT00097695|Icatibant|icatibant|mesh-list
139591533|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139591534|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139591535|NCT00097695|Analgesics|analgesics|mesh-ancestor
139591536|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
139591537|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591538|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591539|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139591540|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591541|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
139591542|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
139591543|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591544|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139591545|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139591546|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
139591547|NCT02096679|Osimertinib|osimertinib|mesh-list
139591548|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591549|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139591550|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591551|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591552|NCT00195039|Antibodies|antibodies|mesh-list
139591553|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139591554|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
139591555|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591556|NCT02054338|Paclitaxel|paclitaxel|mesh-list
139591557|NCT02054338|Gemcitabine|gemcitabine|mesh-list
139591558|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139591559|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591560|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
139591561|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
139591562|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
139591563|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591564|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139591565|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
139591566|NCT00198081|Celecoxib|celecoxib|mesh-list
139591567|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
139591568|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139591569|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139591570|NCT00198081|Analgesics|analgesics|mesh-ancestor
139591571|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
139591572|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591573|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591574|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139591575|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591576|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139591577|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591578|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591579|NCT00100659|Interferons|interferons|mesh-list
139591580|NCT00100659|Ribavirin|ribavirin|mesh-list
139591581|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591582|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
139591583|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591584|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
139591585|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591586|NCT00101361|Oxandrolone|oxandrolone|mesh-list
139591587|NCT00101361|Androgens|androgens|mesh-ancestor
139591588|NCT00101361|Hormones|hormones|mesh-ancestor
139591589|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139591590|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591591|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
139591592|NCT03225690|Morphine|morphine|mesh-list
139591593|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139591594|NCT03225690|Narcotics|narcotics|mesh-ancestor
139591595|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139591596|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591597|NCT03225690|Analgesics|analgesics|mesh-ancestor
139591598|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
139591599|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591600|NCT02389738|Temozolomide|temozolomide|mesh-list
139591601|NCT02389738|Regadenoson|regadenoson|mesh-list
139591602|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139591603|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
139591604|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591605|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591606|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139591607|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139591608|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
139591609|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
139591610|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591611|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591612|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139591613|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139591614|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139591615|NCT00201123|Interferons|interferons|mesh-list
139591616|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
139591617|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591618|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
139591619|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591620|NCT01712009|Loratadine|loratadine|mesh-list
139591621|NCT01712009|Naproxen|naproxen|mesh-list
139591622|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139591623|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139591624|NCT01712009|Analgesics|analgesics|mesh-ancestor
139591625|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
139591626|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591627|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591628|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139591629|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591630|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
139591631|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139591632|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591633|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591634|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
139591635|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
139591636|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139591637|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139591638|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139591639|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
139591640|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
139591641|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591642|NCT03212352|Misoprostol|misoprostol|mesh-list
139591643|NCT03212352|Mifepristone|mifepristone|mesh-list
139591644|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139591645|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
139591646|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139591647|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591648|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139591649|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139591650|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
139591651|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139591652|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139591653|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139591654|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139591655|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
139591656|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139591657|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139591658|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
139591659|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139591660|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
139591661|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139591662|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139591663|NCT00201825|Docetaxel|docetaxel|mesh-list
139591664|NCT00201825|Capecitabine|capecitabine|mesh-list
139591665|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591666|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
139591667|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
139591668|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
139591669|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591670|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139591671|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
139591672|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
139591673|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139591674|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591675|NCT01711853|Dabigatran|dabigatran|mesh-list
139591676|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
139591677|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139591678|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
139591679|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591680|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591681|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
139591682|NCT00202449|Prazosin|prazosin|mesh-list
139591683|NCT00202449|Paroxetine|paroxetine|mesh-list
139591684|NCT00202449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139591685|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139591686|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139591687|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591688|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591689|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
139591690|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591691|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139591692|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
139591693|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139591694|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139591695|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139591696|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591697|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139591698|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139591699|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139591700|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139591701|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
139591702|NCT03203304|Nivolumab|nivolumab|mesh-list
139591703|NCT03203304|Ipilimumab|ipilimumab|mesh-list
139591704|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139591705|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591706|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139591707|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591708|NCT03225456|Oxytocin|oxytocin|mesh-list
139591709|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
139591710|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139591711|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591712|NCT00203229|Lamotrigine|lamotrigine|mesh-list
139591713|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
139591714|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139591715|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139591716|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591717|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139591718|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591719|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139591720|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139591721|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139591722|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139591723|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139591724|NCT00203931|Pemetrexed|pemetrexed|mesh-list
139591725|NCT00203931|Cetuximab|cetuximab|mesh-list
139591726|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591727|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591728|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591729|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139591730|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139591731|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139591732|NCT02412982|Enoxaparin|enoxaparin|mesh-list
139591733|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
139591734|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
139591735|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139591736|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139591737|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591738|NCT03203616|Trastuzumab|trastuzumab|mesh-list
139591739|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139591740|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139591741|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591742|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
139591743|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
139591744|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
139591745|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591746|NCT03203616|Immunotoxins|immunotoxins|mesh-ancestor
139591747|NCT03203616|Immunoconjugates|immunoconjugates|mesh-ancestor
139591748|NCT03203616|Immunologic Factors|immunologic factors|mesh-ancestor
139591749|NCT03203616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591750|NCT02450214|Ketamine|ketamine|mesh-list
139591751|NCT02450214|Analgesics|analgesics|mesh-ancestor
139591752|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
139591753|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591754|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591755|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139591756|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139591757|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
139591758|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
139591759|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139591760|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139591761|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139591762|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591763|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591764|NCT02450682|Warfarin|warfarin|mesh-list
139591765|NCT02450682|Apixaban|apixaban|mesh-list
139591766|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
139591767|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139591768|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
139591769|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139591770|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
139591771|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591772|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591773|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
139591774|NCT01740401|Ipilimumab|ipilimumab|mesh-list
139591775|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139591776|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
139591777|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591778|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591779|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139591780|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
139591781|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591782|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591783|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139591784|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139591785|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139591786|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
139591787|NCT03202836|Progesterone|progesterone|mesh-list
139591788|NCT03202836|Progestins|progestins|mesh-ancestor
139591789|NCT03202836|Hormones|hormones|mesh-ancestor
139591790|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139591791|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591792|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139591793|NCT03203070|Dipyrone|dipyrone|mesh-list
139591794|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139591795|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139591796|NCT03203070|Analgesics|analgesics|mesh-ancestor
139591797|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
139591798|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591799|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591800|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139591801|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591802|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
139591803|NCT03209856|Vitamin D|vitamin d|mesh-list
139591804|NCT03209856|Calcitriol|calcitriol|mesh-list
139591805|NCT03209856|Vitamins|vitamins|mesh-ancestor
139591806|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
139591807|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591808|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139591809|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139591810|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139591811|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139591812|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591813|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139591814|NCT02413918|Iloperidone|iloperidone|mesh-list
139591815|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139591816|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139591817|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139591818|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591819|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139591820|NCT03209622|Nicotine|nicotine|mesh-list
139591821|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139591822|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
139591823|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591824|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591825|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139591826|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139591827|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
139591828|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591829|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591831|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139591832|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591833|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139591834|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139591835|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
139591836|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591837|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591838|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139591839|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
139591840|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139591841|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139591842|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139591843|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
139591844|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591845|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591846|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
139591847|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139591848|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139591849|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591850|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
139591851|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
139591852|NCT01710527|Metformin|metformin|mesh-list
139591853|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139591854|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591855|NCT00354952|Azithromycin|azithromycin|mesh-list
139591856|NCT00354952|Clarithromycin|clarithromycin|mesh-list
139591857|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139591858|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591859|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139591860|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591861|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591862|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139591863|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139591864|NCT01706939|Carboplatin|carboplatin|mesh-list
139591865|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591866|NCT03209232|Infliximab|infliximab|mesh-list
139591867|NCT03209232|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139591868|NCT03209232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139591869|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
139591870|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139591871|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591872|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
139591873|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139591874|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591875|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
139591876|NCT01709903|Fluticasone|fluticasone|mesh-list
139591877|NCT01709903|Xhance|xhance|mesh-list
139591878|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
139591879|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139591880|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139591881|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139591882|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139591883|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
139591884|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591885|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591886|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139591887|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
139591888|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
139591889|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139591890|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139591891|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139591892|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139591893|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
139591894|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591895|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591896|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
139591897|NCT01709903|Hormones|hormones|mesh-ancestor
139591898|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373646|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
139591899|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
139591900|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139591901|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139591902|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139591903|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
139591904|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
139591906|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139591907|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
139591908|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591909|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139591910|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139591911|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
139591912|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591913|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591914|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139591915|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139591916|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139591917|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
139591918|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139591919|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
139591920|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
139591921|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
139591922|NCT03202446|Coagulants|coagulants|mesh-ancestor
139591923|NCT05718934|Glycopyrrolate|glycopyrrolate|mesh-list
139591924|NCT05718934|Neostigmine|neostigmine|mesh-list
139591925|NCT05718934|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139591926|NCT05718934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591927|NCT05718934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591928|NCT05718934|Cholinergic Agents|cholinergic agents|mesh-ancestor
139591929|NCT05718934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591930|NCT05718934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591931|NCT05718934|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139591932|NCT05718934|Autonomic Agents|autonomic agents|mesh-ancestor
139591933|NCT05718934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591934|NCT05718934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139591935|NCT05718934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139591936|NCT05718934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139591937|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
139591938|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139591939|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
139591940|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139591941|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591942|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139591943|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
139591944|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139591945|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
139591946|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591947|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139591948|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139591949|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
139591950|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
139591951|NCT03208764|Protective Agents|protective agents|mesh-ancestor
139591952|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139591953|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
139591954|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139591955|NCT05718310|Nitroglycerin|nitroglycerin|mesh-list
139591956|NCT05718310|Vasodilator Agents|vasodilator agents|mesh-ancestor
139591957|NCT03224208|Vemurafenib|vemurafenib|mesh-list
139591958|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591959|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139591960|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591961|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591962|NCT05718232|Lenvatinib|lenvatinib|mesh-list
139591963|NCT05718232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591964|NCT05718232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139591965|NCT05718232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591966|NCT05718232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591967|NCT00355966|Misoprostol|misoprostol|mesh-list
139591968|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139591969|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
139591970|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139591971|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591972|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139591973|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139591974|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
139591975|NCT03208218|Lenalidomide|lenalidomide|mesh-list
139591976|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
139591977|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139591978|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139591979|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139591980|NCT03208218|Growth Substances|growth substances|mesh-ancestor
139591981|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
139591982|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139591984|NCT05372380|Ezetimibe|ezetimibe|mesh-list
139591985|NCT05372380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139591986|NCT05372380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139591987|NCT05372380|Antimetabolites|antimetabolites|mesh-ancestor
139591988|NCT05372380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591989|NCT05372380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139591990|NCT05372380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139591991|NCT05372380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591992|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
139591993|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139591994|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139591995|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139591996|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139591997|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139591998|NCT02451774|Protective Agents|protective agents|mesh-ancestor
139591999|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592000|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
139592001|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139592002|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
139592003|NCT00355576|Minocycline|minocycline|mesh-list
139592004|NCT00355576|Celecoxib|celecoxib|mesh-list
139592005|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139592006|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139592007|NCT00355576|Analgesics|analgesics|mesh-ancestor
139592008|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
139592009|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592010|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592011|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139592012|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139592013|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139592014|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139592015|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592016|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592017|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139592018|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592019|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
139592020|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139592021|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139592022|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592023|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
139592024|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
139592025|NCT02448264|Berotralstat|berotralstat|mesh-list
139592026|NCT02448264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139592027|NCT02448264|Protease Inhibitors|protease inhibitors|mesh-ancestor
139592028|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592029|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592030|NCT02451852|Osimertinib|osimertinib|mesh-list
139592031|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592032|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139592033|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592034|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592035|NCT00421642|Adalimumab|adalimumab|mesh-list
139592036|NCT00421642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139592037|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139592038|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139592039|NCT03200964|Anesthetics|anesthetics|mesh-list
139592040|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592041|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592042|NCT04484844|Listerine|listerine|mesh-list
139592043|NCT04484844|Fluorides|fluorides|mesh-list
139592044|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
139592045|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
139592046|NCT04484844|Protective Agents|protective agents|mesh-ancestor
139592047|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592048|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139592049|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592050|NCT03119454|Betamethasone|betamethasone|mesh-list
139373798|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139592051|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
139592052|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139592054|NCT03119454|Hormones|hormones|mesh-ancestor
139592055|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139592056|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592057|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139592058|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
139592059|NCT04485156|Rifampin|rifampin|mesh-list
139592060|NCT04485156|Isoniazid|isoniazid|mesh-list
139592061|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
139592062|NCT04485156|Ethambutol|ethambutol|mesh-list
139592063|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139592064|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
139592065|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139592066|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592067|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
139592068|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139592069|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592070|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592071|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139592072|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139592073|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139592074|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139592075|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139592076|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139592077|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139592078|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139592079|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
139592080|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139592081|NCT04637620|Sertraline|sertraline|mesh-list
139592082|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
139592083|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139592084|NCT04637620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139592085|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139592086|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139592087|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592088|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139592089|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
139592090|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592091|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
139592092|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139592093|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139592094|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592095|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
139592096|NCT00355108|Coagulants|coagulants|mesh-ancestor
139592097|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139592098|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139592099|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592100|NCT03200886|Triamcinolone|triamcinolone|mesh-list
139592101|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139592102|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139592103|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139592104|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139592105|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
139592106|NCT03200886|Hormones|hormones|mesh-ancestor
139592107|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139592108|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592109|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139592110|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
139592111|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592112|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592113|NCT05717764|Capecitabine|capecitabine|mesh-list
139592114|NCT05717764|Mitoxantrone|mitoxantrone|mesh-list
139592115|NCT05717764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139592116|NCT05717764|Antimetabolites|antimetabolites|mesh-ancestor
139592117|NCT05717764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592118|NCT05717764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592119|NCT05717764|Analgesics|analgesics|mesh-ancestor
139592120|NCT05717764|Sensory System Agents|sensory system agents|mesh-ancestor
139592121|NCT05717764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373872|NCT02426086|Vitamins|vitamins|mesh-ancestor
139592122|NCT05717764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592123|NCT05717764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139592124|NCT05717764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139592125|NCT05717764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592126|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139592127|NCT03118830|Cetrorelix|cetrorelix|mesh-list
139592128|NCT03118830|Hormones|hormones|mesh-list
139592129|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139592130|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139592131|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592132|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
139592133|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139592134|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
139592135|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139592136|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139592137|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139592138|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592139|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139592140|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
139592141|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
139592142|NCT03223506|Acetaminophen|acetaminophen|mesh-list
139592143|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139592144|NCT03223506|Analgesics|analgesics|mesh-ancestor
139592145|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
139592146|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592147|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592148|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
139592149|NCT03223896|Naloxone|naloxone|mesh-list
139592150|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139592151|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592152|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
139592153|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592154|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
139592155|NCT02447796|Propofol|propofol|mesh-list
139592156|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139592157|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592158|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592159|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139592160|NCT02447796|Analgesics|analgesics|mesh-ancestor
139592161|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
139592162|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592163|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139592164|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139592165|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139592166|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
139592167|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139592168|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592169|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139592170|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
139592171|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
139592172|NCT05225116|Lenvatinib|lenvatinib|mesh-list
139592173|NCT05225116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592174|NCT05225116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139592175|NCT05225116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592176|NCT05225116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592177|NCT03838042|Nivolumab|nivolumab|mesh-list
139592178|NCT03838042|Entinostat|entinostat|mesh-list
139592179|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139592180|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592181|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139592182|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592183|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139592184|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592185|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
139592186|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
139592187|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592188|NCT03222960|Propolis|propolis|mesh-list
139592189|NCT03222960|Fluorides|fluorides|mesh-list
139592190|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
139592191|NCT03222960|Protective Agents|protective agents|mesh-ancestor
139592192|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592193|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592194|NCT05681260|Cytarabine|cytarabine|mesh-list
139592195|NCT05681260|Dexamethasone|dexamethasone|mesh-list
139592196|NCT05681260|Dexamethasone acetate|dexamethasone acetate|mesh-list
139592197|NCT05681260|Prednisone|prednisone|mesh-list
139592198|NCT05681260|Cyclophosphamide|cyclophosphamide|mesh-list
139592199|NCT05681260|Ifosfamide|ifosfamide|mesh-list
139592200|NCT05681260|Doxorubicin|doxorubicin|mesh-list
139592201|NCT05681260|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139592202|NCT05681260|Methotrexate|methotrexate|mesh-list
139592203|NCT05681260|Etoposide|etoposide|mesh-list
139592204|NCT05681260|Vincristine|vincristine|mesh-list
139592205|NCT05681260|Bortezomib|bortezomib|mesh-list
139592206|NCT05681260|Daunorubicin|daunorubicin|mesh-list
139592207|NCT05681260|Asparaginase|asparaginase|mesh-list
139592208|NCT05681260|Mercaptopurine|mercaptopurine|mesh-list
139592209|NCT05681260|Vindesine|vindesine|mesh-list
139592210|NCT05681260|Pegaspargase|pegaspargase|mesh-list
139592211|NCT05681260|BB 1101|bb 1101|mesh-list
139592212|NCT05681260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139592213|NCT05681260|Immunologic Factors|immunologic factors|mesh-ancestor
139592214|NCT05681260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592215|NCT05681260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139592216|NCT05681260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139592217|NCT05681260|Alkylating Agents|alkylating agents|mesh-ancestor
139592218|NCT05681260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592219|NCT05681260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592220|NCT05681260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139592221|NCT05681260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139592222|NCT05681260|Antiemetics|antiemetics|mesh-ancestor
139592223|NCT05681260|Autonomic Agents|autonomic agents|mesh-ancestor
139592224|NCT05681260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592225|NCT05681260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139592226|NCT05681260|Glucocorticoids|glucocorticoids|mesh-ancestor
139592227|NCT05681260|Hormones|hormones|mesh-ancestor
139592228|NCT05681260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139592229|NCT05681260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139592230|NCT05681260|Protease Inhibitors|protease inhibitors|mesh-ancestor
139592231|NCT05681260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592232|NCT05681260|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139592233|NCT05681260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139592234|NCT05681260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139592235|NCT05681260|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139592236|NCT05681260|Abortifacient Agents|abortifacient agents|mesh-ancestor
139592237|NCT05681260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139592238|NCT05681260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139592239|NCT05681260|Antimetabolites|antimetabolites|mesh-ancestor
139592240|NCT05681260|Dermatologic Agents|dermatologic agents|mesh-ancestor
139592241|NCT05681260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139592242|NCT05681260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139592243|NCT05681260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139592244|NCT05681260|Antiviral Agents|antiviral agents|mesh-ancestor
139592245|NCT05681260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592246|NCT05681260|Tubulin Modulators|tubulin modulators|mesh-ancestor
139592247|NCT05681260|Antimitotic Agents|antimitotic agents|mesh-ancestor
139592248|NCT05681260|Mitosis Modulators|mitosis modulators|mesh-ancestor
139592249|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
139592250|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139592251|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592252|NCT03199950|Haloperidol|haloperidol|mesh-list
139592253|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
139592254|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
139592255|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
139592256|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592257|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592258|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139592259|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139592260|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139592261|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592262|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139592263|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139592264|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
139592265|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139592266|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592267|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139592268|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139592269|NCT05156632|Vaccines|vaccines|mesh-list
139592270|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
139592271|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592272|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139592273|NCT05156632|Antacids|antacids|mesh-ancestor
139592274|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592275|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139592276|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
139592277|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139592278|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139592279|NCT02447016|Tenofovir|tenofovir|mesh-list
139592280|NCT02447016|Emtricitabine|emtricitabine|mesh-list
139592281|NCT02447016|Efavirenz|efavirenz|mesh-list
139592282|NCT02447016|Rilpivirine|rilpivirine|mesh-list
139592283|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
139592284|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592285|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139592286|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139592287|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592288|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592289|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139592290|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139592291|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139592292|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139592293|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139592294|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139592295|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139592296|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139592297|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139592298|NCT02447094|Plasminogen|plasminogen|mesh-list
139592299|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139592300|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139592301|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592302|NCT02446860|Nivolumab|nivolumab|mesh-list
139592303|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139592304|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592305|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139592306|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592307|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
139592308|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139592309|NCT02449746|Antibodies|antibodies|mesh-list
139592310|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
139592311|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139592312|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
139592313|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592314|NCT02446782|Clindamycin|clindamycin|mesh-list
139592315|NCT02446782|Cefazolin|cefazolin|mesh-list
139592316|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139592317|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592318|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139592319|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592320|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592321|NCT06076434|Heparin|heparin|mesh-list
139592322|NCT06076434|Anticoagulants|anticoagulants|mesh-ancestor
139592323|NCT06076434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139592324|NCT06076434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139592325|NCT06076434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592326|NCT06076330|Plasma-lyte 148|plasma-lyte 148|mesh-list
139592327|NCT06076330|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139592328|NCT06076330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139592329|NCT06076200|Tazobactam|tazobactam|mesh-list
139592330|NCT06076200|Piperacillin|piperacillin|mesh-list
139592331|NCT06076200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139592332|NCT06076200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592333|NCT06076200|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139592334|NCT06076200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592335|NCT06076200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592336|NCT06075238|Blinatumomab|blinatumomab|mesh-list
139592337|NCT06075238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592338|NCT06075212|Blinatumomab|blinatumomab|mesh-list
139592339|NCT06075212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592340|NCT06075134|Zinc|zinc|mesh-list
139592341|NCT06075134|Botulinum Toxins|botulinum toxins|mesh-list
139592342|NCT06075134|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139592343|NCT06075134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139592344|NCT06075134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592345|NCT06075134|Cholinergic Agents|cholinergic agents|mesh-ancestor
139592346|NCT06075134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139592347|NCT06075134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592348|NCT06075134|Trace Elements|trace elements|mesh-ancestor
139592349|NCT06075134|Micronutrients|micronutrients|mesh-ancestor
139592350|NCT06074757|Fulvestrant|fulvestrant|mesh-list
139592351|NCT06074757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139592352|NCT06074757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592354|NCT06074757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139592355|NCT06074757|Hormone Antagonists|hormone antagonists|mesh-ancestor
139592356|NCT06074757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139592357|NCT06074757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592358|NCT06074484|Disitamab vedotin|disitamab vedotin|mesh-list
139592359|NCT06074484|Immunoconjugates|immunoconjugates|mesh-ancestor
139592360|NCT06074484|Immunologic Factors|immunologic factors|mesh-ancestor
139592361|NCT06074484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592362|NCT06074016|Oxazolidinones|oxazolidinones|mesh-list
139592363|NCT06074016|Zolmitriptan|zolmitriptan|mesh-list
139592364|NCT06074016|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139592365|NCT06074016|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139592366|NCT06074016|Serotonin Agents|serotonin agents|mesh-ancestor
139592367|NCT06074016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139592368|NCT06074016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592369|NCT06074016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592370|NCT06074016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592371|NCT06074016|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139592372|NCT06074016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592373|NCT06071455|Vitamin D|vitamin d|mesh-list
139592374|NCT06071455|Cholecalciferol|cholecalciferol|mesh-list
139592375|NCT06071455|Vitamins|vitamins|mesh-ancestor
139592376|NCT06071455|Micronutrients|micronutrients|mesh-ancestor
139592377|NCT06071455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592378|NCT06071455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139592379|NCT06071455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139592380|NCT06071429|Sirolimus|sirolimus|mesh-list
139592381|NCT06071429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139592382|NCT06071429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592383|NCT06071429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139592384|NCT06071429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592385|NCT06071429|Antifungal Agents|antifungal agents|mesh-ancestor
139592386|NCT06071429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139592387|NCT06071429|Immunologic Factors|immunologic factors|mesh-ancestor
139592388|NCT06071429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592389|NCT06071416|Calcium|calcium|mesh-list
139592390|NCT06071416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139592391|NCT06071416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592392|NCT06071156|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139592393|NCT06071156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139592394|NCT06054191|Trametinib|trametinib|mesh-list
139592395|NCT06054191|Dabrafenib|dabrafenib|mesh-list
139592396|NCT06054191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592397|NCT06054191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139592398|NCT06054191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592399|NCT06054191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592400|NCT06053489|Anesthetics|anesthetics|mesh-list
139592401|NCT06053489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592402|NCT06053489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592403|NCT06028672|Dactinomycin|dactinomycin|mesh-list
139592404|NCT06028672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139592405|NCT06028672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592406|NCT06028672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139592407|NCT06028672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592408|NCT06028672|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139592409|NCT06028672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592410|NCT06028672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592411|NCT06028672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139592412|NCT06028321|Pindolol|pindolol|mesh-list
139592413|NCT06028321|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139592414|NCT06028321|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139592415|NCT06028321|Adrenergic Agents|adrenergic agents|mesh-ancestor
139592416|NCT06028321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139592417|NCT06028321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592418|NCT06028321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592419|NCT06028321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139592420|NCT06028321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139592421|NCT06028321|Serotonin Agents|serotonin agents|mesh-ancestor
139592422|NCT06028321|Vasodilator Agents|vasodilator agents|mesh-ancestor
139592423|NCT06024733|Lidocaine|lidocaine|mesh-list
139592424|NCT06024733|Sevoflurane|sevoflurane|mesh-list
139592425|NCT06024733|Anesthetics, Local|anesthetics, local|mesh-ancestor
139592426|NCT06024733|Anesthetics|anesthetics|mesh-ancestor
139592427|NCT06024733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592428|NCT06024733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592429|NCT06024733|Sensory System Agents|sensory system agents|mesh-ancestor
139592430|NCT06024733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592431|NCT06024733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139592432|NCT06024733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139592433|NCT06024733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139592434|NCT06024733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139592435|NCT06024733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592436|NCT06024733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139592437|NCT06024733|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139592438|NCT06024733|Anesthetics, General|anesthetics, general|mesh-ancestor
139592439|NCT06000709|Phenol|phenol|mesh-list
139592440|NCT06000709|Methylprednisolone|methylprednisolone|mesh-list
139592441|NCT06000709|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139592442|NCT06000709|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139592443|NCT06000709|Prednisolone|prednisolone|mesh-list
139592444|NCT06000709|Prednisolone acetate|prednisolone acetate|mesh-list
139592445|NCT06000709|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139592446|NCT06000709|Prednisolone phosphate|prednisolone phosphate|mesh-list
139592447|NCT06000709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139592448|NCT06000709|Antiemetics|antiemetics|mesh-ancestor
139592449|NCT06000709|Autonomic Agents|autonomic agents|mesh-ancestor
139592450|NCT06000709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592451|NCT06000709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592452|NCT06000709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139592453|NCT06000709|Glucocorticoids|glucocorticoids|mesh-ancestor
139592454|NCT06000709|Hormones|hormones|mesh-ancestor
139592455|NCT06000709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139592456|NCT06000709|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139592457|NCT06000709|Protective Agents|protective agents|mesh-ancestor
139592458|NCT06000709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139592459|NCT06000709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592460|NCT06000709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139592461|NCT06000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592462|NCT06000709|Disinfectants|disinfectants|mesh-ancestor
139592463|NCT06000709|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139592464|NCT06000709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139592465|NCT05993949|Dasatinib|dasatinib|mesh-list
139592466|NCT05993949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592467|NCT05993949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139592468|NCT05993949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592469|NCT05993949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592470|NCT05957055|Methylphenidate|methylphenidate|mesh-list
138720497|NCT01087151|Navitoclax|navitoclax|mesh-list
139592471|NCT05957055|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139592472|NCT05957055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139592473|NCT05957055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592474|NCT05957055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139592475|NCT05957055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139592476|NCT05957055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139592477|NCT05957055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592478|NCT05957055|Dopamine Agents|dopamine agents|mesh-ancestor
139592479|NCT05957055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139592480|NCT05951465|Propofol|propofol|mesh-list
139592481|NCT05951465|Esketamine|esketamine|mesh-list
139592482|NCT05951465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139592483|NCT05951465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592484|NCT05951465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592485|NCT05951465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139592486|NCT05951465|Anesthetics, General|anesthetics, general|mesh-ancestor
139592487|NCT05951465|Anesthetics|anesthetics|mesh-ancestor
139592488|NCT05951465|Antidepressive Agents|antidepressive agents|mesh-ancestor
139592489|NCT05951465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139592490|NCT05940649|Norepinephrine|norepinephrine|mesh-list
139592491|NCT05940649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139592492|NCT05940649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139592493|NCT05940649|Adrenergic Agents|adrenergic agents|mesh-ancestor
139592494|NCT05940649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139592495|NCT05940649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592496|NCT05940649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592497|NCT05940649|Sympathomimetics|sympathomimetics|mesh-ancestor
139592498|NCT05940649|Autonomic Agents|autonomic agents|mesh-ancestor
139592499|NCT05940649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374244|NCT02794883|Durvalumab|durvalumab|mesh-list
139592500|NCT05940649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139592501|NCT05936203|Insulin|insulin|mesh-list
139592502|NCT05936203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139592503|NCT05936203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592504|NCT05911061|Vaccines|vaccines|mesh-list
139592505|NCT05911061|Immunologic Factors|immunologic factors|mesh-ancestor
139592506|NCT05911061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592507|NCT05911048|Vaccines|vaccines|mesh-list
139592508|NCT05911048|Immunologic Factors|immunologic factors|mesh-ancestor
139592509|NCT05911048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592510|NCT05896800|Nitric Oxide|nitric oxide|mesh-list
139592511|NCT05896800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139592512|NCT05896800|Autonomic Agents|autonomic agents|mesh-ancestor
139592513|NCT05896800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592514|NCT05896800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592515|NCT05896800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139592516|NCT05896800|Respiratory System Agents|respiratory system agents|mesh-ancestor
139592517|NCT05896800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139592518|NCT05896800|Antioxidants|antioxidants|mesh-ancestor
139592519|NCT05896800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592520|NCT05896800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139592521|NCT05896800|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139592522|NCT05896800|Vasodilator Agents|vasodilator agents|mesh-ancestor
139592523|NCT05896800|Gasotransmitters|gasotransmitters|mesh-ancestor
139592524|NCT05896800|Protective Agents|protective agents|mesh-ancestor
139592525|NCT05892887|Bupivacaine|bupivacaine|mesh-list
139592526|NCT05892887|Anesthetics, Local|anesthetics, local|mesh-ancestor
139592527|NCT05892887|Anesthetics|anesthetics|mesh-ancestor
139592528|NCT05892887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592529|NCT05892887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592530|NCT05892887|Sensory System Agents|sensory system agents|mesh-ancestor
139592531|NCT05892887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592532|NCT05834348|Docetaxel|docetaxel|mesh-list
139592533|NCT05834348|Bevacizumab|bevacizumab|mesh-list
139592534|NCT05834348|Carboplatin|carboplatin|mesh-list
139592535|NCT05834348|Pembrolizumab|pembrolizumab|mesh-list
139592536|NCT05834348|Nivolumab|nivolumab|mesh-list
139592537|NCT05834348|Atezolizumab|atezolizumab|mesh-list
139592538|NCT05834348|Gefitinib|gefitinib|mesh-list
139592539|NCT05834348|Osimertinib|osimertinib|mesh-list
139592540|NCT05834348|Afatinib|afatinib|mesh-list
139592541|NCT05834348|Crizotinib|crizotinib|mesh-list
139592542|NCT05834348|Ceritinib|ceritinib|mesh-list
139592543|NCT05834348|Entrectinib|entrectinib|mesh-list
139592544|NCT05834348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592545|NCT05834348|Tubulin Modulators|tubulin modulators|mesh-ancestor
139592546|NCT05834348|Antimitotic Agents|antimitotic agents|mesh-ancestor
139592547|NCT05834348|Mitosis Modulators|mitosis modulators|mesh-ancestor
139592548|NCT05834348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592549|NCT05834348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139592550|NCT05834348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139592551|NCT05834348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139592552|NCT05834348|Growth Substances|growth substances|mesh-ancestor
139592553|NCT05834348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592554|NCT05834348|Growth Inhibitors|growth inhibitors|mesh-ancestor
139592555|NCT05834348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139592556|NCT05834348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139592557|NCT05834348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592558|NCT05777278|Docetaxel|docetaxel|mesh-list
139592559|NCT05777278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592560|NCT05777278|Tubulin Modulators|tubulin modulators|mesh-ancestor
139592561|NCT05777278|Antimitotic Agents|antimitotic agents|mesh-ancestor
139592562|NCT05777278|Mitosis Modulators|mitosis modulators|mesh-ancestor
139592563|NCT05777278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592564|NCT05761431|Octreotide|octreotide|mesh-list
139592565|NCT05761431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139592566|NCT05761431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139592567|NCT05761431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592568|NCT05748236|Lamotrigine|lamotrigine|mesh-list
139592569|NCT05748236|Carbamazepine|carbamazepine|mesh-list
139592570|NCT05748236|Anticonvulsants|anticonvulsants|mesh-ancestor
139592571|NCT05748236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139592572|NCT05748236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139592573|NCT05748236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592574|NCT05748236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139592575|NCT05748236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592576|NCT05748236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139592577|NCT05748236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139592578|NCT05748236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592579|NCT05748236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139592580|NCT05748236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139592581|NCT05748236|Antimanic Agents|antimanic agents|mesh-ancestor
139592582|NCT05748236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139592583|NCT05748236|Analgesics|analgesics|mesh-ancestor
139592584|NCT05748236|Sensory System Agents|sensory system agents|mesh-ancestor
139592585|NCT05748236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592586|NCT05748236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139592587|NCT05748236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139592588|NCT05682547|Lubricant Eye Drops|lubricant eye drops|mesh-list
139592589|NCT05682547|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139592590|NCT05682547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139592592|NCT05608499|Halobetasol|halobetasol|mesh-list
139592593|NCT05608499|Tazarotene|tazarotene|mesh-list
139592594|NCT05608499|Dermatologic Agents|dermatologic agents|mesh-ancestor
139592595|NCT05608499|Keratolytic Agents|keratolytic agents|mesh-ancestor
138720626|NCT00479232|Decitabine|decitabine|mesh-list
139592596|NCT05608499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139592597|NCT05608499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139592598|NCT05608499|Glucocorticoids|glucocorticoids|mesh-ancestor
139592599|NCT05608499|Hormones|hormones|mesh-ancestor
139592600|NCT05608499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139592601|NCT05608499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592602|NCT05576662|Ritonavir|ritonavir|mesh-list
139592603|NCT05576662|Nirmatrelvir|nirmatrelvir|mesh-list
139592604|NCT05576662|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139592605|NCT05576662|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139592606|NCT05576662|Protease Inhibitors|protease inhibitors|mesh-ancestor
139592607|NCT05576662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592608|NCT05576662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592609|NCT05576662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139592610|NCT05576662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139592611|NCT05576662|Antiviral Agents|antiviral agents|mesh-ancestor
139592612|NCT05576662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592613|NCT05576662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139592614|NCT05576662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139592615|NCT05564650|Azacitidine|azacitidine|mesh-list
139592616|NCT05564650|Decitabine|decitabine|mesh-list
139592617|NCT05564650|Venetoclax|venetoclax|mesh-list
139592618|NCT05564650|Navitoclax|navitoclax|mesh-list
139592619|NCT05564650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139592620|NCT05564650|Antimetabolites|antimetabolites|mesh-ancestor
139592621|NCT05564650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592622|NCT05564650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592623|NCT05564650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592624|NCT05557721|Lidocaine|lidocaine|mesh-list
139592625|NCT05557721|Anesthetics, Local|anesthetics, local|mesh-ancestor
139592626|NCT05557721|Anesthetics|anesthetics|mesh-ancestor
139592627|NCT05557721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592628|NCT05557721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592629|NCT05557721|Sensory System Agents|sensory system agents|mesh-ancestor
139592630|NCT05557721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592631|NCT05557721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139592632|NCT05557721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139592633|NCT05557721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139592634|NCT05557721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139592635|NCT05557721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592636|NCT05557591|Cemiplimab|cemiplimab|mesh-list
139592637|NCT05557591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139592638|NCT05557591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592639|NCT05546788|Chlorhexidine|chlorhexidine|mesh-list
139592640|NCT05546788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139592641|NCT05546788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592642|NCT05546788|Disinfectants|disinfectants|mesh-ancestor
139592643|NCT05534802|Urinastatin|urinastatin|mesh-list
139592644|NCT05534802|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139592645|NCT05534802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139592646|NCT05534802|Protease Inhibitors|protease inhibitors|mesh-ancestor
139592647|NCT05534802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592648|NCT05534802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592649|NCT05510089|Cytarabine|cytarabine|mesh-list
139592650|NCT05510089|Etoposide|etoposide|mesh-list
139592651|NCT05510089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139592652|NCT05510089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592653|NCT05510089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139592654|NCT05510089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139592655|NCT05510089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592656|NCT05510089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592657|NCT05510089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139592658|NCT05510089|Antimetabolites|antimetabolites|mesh-ancestor
139592659|NCT05510089|Antiviral Agents|antiviral agents|mesh-ancestor
138720693|NCT00556205|Growth Substances|growth substances|mesh-ancestor
139592660|NCT05510089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592661|NCT05510089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139592662|NCT05510089|Immunologic Factors|immunologic factors|mesh-ancestor
139592663|NCT05510089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592664|NCT05497492|Lidocaine|lidocaine|mesh-list
139592665|NCT05497492|Sufentanil|sufentanil|mesh-list
139592666|NCT05497492|Propofol|propofol|mesh-list
139592667|NCT05497492|Esketamine|esketamine|mesh-list
139592668|NCT05497492|Anesthetics, Local|anesthetics, local|mesh-ancestor
139592669|NCT05497492|Anesthetics|anesthetics|mesh-ancestor
139592670|NCT05497492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592671|NCT05497492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592672|NCT05497492|Sensory System Agents|sensory system agents|mesh-ancestor
139592673|NCT05497492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592674|NCT05497492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139592675|NCT05497492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139592676|NCT05497492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139592677|NCT05497492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139592678|NCT05497492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592679|NCT05497492|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139592680|NCT05497492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139592681|NCT05497492|Anesthetics, General|anesthetics, general|mesh-ancestor
139592682|NCT05497492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139592683|NCT05497492|Narcotics|narcotics|mesh-ancestor
139592684|NCT05497492|Analgesics|analgesics|mesh-ancestor
139592685|NCT05497492|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139592686|NCT05497492|Antidepressive Agents|antidepressive agents|mesh-ancestor
139592687|NCT05497492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139592688|NCT05453500|Prednisone|prednisone|mesh-list
139592689|NCT05453500|Cortisone|cortisone|mesh-list
139592690|NCT05453500|Cyclophosphamide|cyclophosphamide|mesh-list
139592691|NCT05453500|Rituximab|rituximab|mesh-list
139592692|NCT05453500|Doxorubicin|doxorubicin|mesh-list
139592693|NCT05453500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139592694|NCT05453500|Etoposide|etoposide|mesh-list
139592695|NCT05453500|Vincristine|vincristine|mesh-list
139592696|NCT05453500|Etoposide phosphate|etoposide phosphate|mesh-list
139592697|NCT05453500|Daunorubicin|daunorubicin|mesh-list
139592698|NCT05453500|Podophyllotoxin|podophyllotoxin|mesh-list
139592699|NCT05453500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139592700|NCT05453500|Antibodies|antibodies|mesh-list
139592701|NCT05453500|Immunoglobulins|immunoglobulins|mesh-list
139592702|NCT05453500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139592703|NCT05453500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139592704|NCT05453500|Immunologic Factors|immunologic factors|mesh-ancestor
139592705|NCT05453500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592706|NCT05453500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139592707|NCT05453500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139592708|NCT05453500|Alkylating Agents|alkylating agents|mesh-ancestor
139592709|NCT05453500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592710|NCT05453500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592711|NCT05453500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139592712|NCT05453500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139592713|NCT05453500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139592714|NCT05453500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139592715|NCT05453500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592716|NCT05453500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139592717|NCT05453500|Glucocorticoids|glucocorticoids|mesh-ancestor
139592718|NCT05453500|Hormones|hormones|mesh-ancestor
139592719|NCT05453500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139592720|NCT05453500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139592721|NCT05453500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139592722|NCT05453500|Tubulin Modulators|tubulin modulators|mesh-ancestor
139592723|NCT05453500|Antimitotic Agents|antimitotic agents|mesh-ancestor
139592724|NCT05453500|Mitosis Modulators|mitosis modulators|mesh-ancestor
139592725|NCT05453500|Keratolytic Agents|keratolytic agents|mesh-ancestor
139592726|NCT05453500|Dermatologic Agents|dermatologic agents|mesh-ancestor
139592727|NCT05414136|Trastuzumab|trastuzumab|mesh-list
139592728|NCT05414136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139592729|NCT05414136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592730|NCT05410496|Tenofovir|tenofovir|mesh-list
139592731|NCT05410496|Antiviral Agents|antiviral agents|mesh-ancestor
139592732|NCT05410496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592733|NCT05410496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139592734|NCT05410496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139592735|NCT05410496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592736|NCT05410496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592737|NCT05410496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139592738|NCT05410496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139592739|NCT05391126|Irinotecan|irinotecan|mesh-list
139592740|NCT05391126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139592741|NCT05391126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139592742|NCT05391126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592743|NCT05391126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592744|NCT05391126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592745|NCT05384938|Benralizumab|benralizumab|mesh-list
139592746|NCT05384938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139592747|NCT05384938|Respiratory System Agents|respiratory system agents|mesh-ancestor
139592748|NCT05371132|Deferoxamine|deferoxamine|mesh-list
139592749|NCT05371132|Siderophores|siderophores|mesh-ancestor
139592750|NCT05371132|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139592751|NCT05371132|Chelating Agents|chelating agents|mesh-ancestor
139592752|NCT05371132|Sequestering Agents|sequestering agents|mesh-ancestor
139592753|NCT05371132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592754|NCT05359237|Vincristine|vincristine|mesh-list
139592755|NCT05359237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139592756|NCT05359237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592757|NCT05359237|Tubulin Modulators|tubulin modulators|mesh-ancestor
139592758|NCT05359237|Antimitotic Agents|antimitotic agents|mesh-ancestor
139592759|NCT05359237|Mitosis Modulators|mitosis modulators|mesh-ancestor
139592760|NCT05359237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592761|NCT05357898|Pembrolizumab|pembrolizumab|mesh-list
139592762|NCT05357898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139592763|NCT05357898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592764|NCT05357898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139592765|NCT05357898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592766|NCT05345990|Immunoglobulins|immunoglobulins|mesh-list
139592767|NCT05345990|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139592768|NCT05345990|Antibodies|antibodies|mesh-list
139592769|NCT05345990|Immunologic Factors|immunologic factors|mesh-ancestor
139592770|NCT05345990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592771|NCT05302011|Carboplatin|carboplatin|mesh-list
139592772|NCT05302011|Docetaxel|docetaxel|mesh-list
139592773|NCT05302011|Pembrolizumab|pembrolizumab|mesh-list
139592774|NCT05302011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592775|NCT05302011|Tubulin Modulators|tubulin modulators|mesh-ancestor
139592776|NCT05302011|Antimitotic Agents|antimitotic agents|mesh-ancestor
139592777|NCT05302011|Mitosis Modulators|mitosis modulators|mesh-ancestor
139592778|NCT05302011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592779|NCT05302011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139592780|NCT05302011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139592781|NCT05279872|Zanubrutinib|zanubrutinib|mesh-list
139592782|NCT05279872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592783|NCT05279872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139592784|NCT05279872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592785|NCT05279872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592786|NCT05245552|Vaccines|vaccines|mesh-list
139592787|NCT05245552|Immunologic Factors|immunologic factors|mesh-ancestor
139592788|NCT05245552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592789|NCT05206227|Histamine Antagonists|histamine antagonists|mesh-list
139592790|NCT05206227|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139592791|NCT05206227|Histamine Agents|histamine agents|mesh-ancestor
139592792|NCT05206227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139592793|NCT05206227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592794|NCT05206227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592795|NCT05118672|Acetaminophen|acetaminophen|mesh-list
139592796|NCT05118672|Fexofenadine|fexofenadine|mesh-list
139592797|NCT05118672|Phenylephrine|phenylephrine|mesh-list
139592798|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
139592799|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139592800|NCT05118672|Analgesics|analgesics|mesh-ancestor
139592801|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
139592802|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592803|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592804|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
139592805|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139592806|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
139592807|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
139592808|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
139592809|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139592810|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
139592811|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
139592812|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139592813|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139592814|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139592815|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
139592816|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139592817|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592818|NCT05118672|Protective Agents|protective agents|mesh-ancestor
139592819|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139592820|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139592821|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139592822|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
139592823|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
139592824|NCT05053633|Anesthetics|anesthetics|mesh-list
139592825|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592826|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592827|NCT05008484|Vitamin D|vitamin d|mesh-list
139592828|NCT05008484|Vitamins|vitamins|mesh-ancestor
139592829|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
139592830|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592831|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139592832|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139592833|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139592834|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139592835|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139592836|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592837|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592838|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
139592839|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592840|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139592841|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139592842|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139592843|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
139592844|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139592845|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
139592846|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592847|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
139592848|NCT04972383|Protective Agents|protective agents|mesh-ancestor
139592849|NCT04964414|Budesonide|budesonide|mesh-list
139592850|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
139592851|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139592852|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139592853|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
139592854|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592855|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592856|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139592857|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
139592858|NCT04964414|Hormones|hormones|mesh-ancestor
139592859|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139592860|NCT04953754|Melatonin|melatonin|mesh-list
139592861|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
139592862|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592863|NCT04953754|Protective Agents|protective agents|mesh-ancestor
139592864|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592865|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592866|NCT04892043|Nivolumab|nivolumab|mesh-list
139592867|NCT04892043|Ipilimumab|ipilimumab|mesh-list
139592868|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139592869|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592870|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139592871|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592872|NCT04867343|Fentanyl|fentanyl|mesh-list
139592873|NCT04867343|Remifentanil|remifentanil|mesh-list
139592874|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139592875|NCT04867343|Narcotics|narcotics|mesh-ancestor
139592876|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592877|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592878|NCT04867343|Analgesics|analgesics|mesh-ancestor
139592879|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
139592880|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592881|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139592882|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139592883|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
139592884|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
139592885|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139592886|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
139592887|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139592888|NCT04795869|Antibodies|antibodies|mesh-list
139592889|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
139592890|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139592891|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
139592892|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
139592893|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592894|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592895|NCT04795869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139592896|NCT04795869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592897|NCT04795869|Immunotoxins|immunotoxins|mesh-ancestor
139592898|NCT04677504|Bevacizumab|bevacizumab|mesh-list
139592899|NCT04677504|Atezolizumab|atezolizumab|mesh-list
139592900|NCT04677504|Gemcitabine|gemcitabine|mesh-list
139592901|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139592902|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592903|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139592904|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139592905|NCT04677504|Growth Substances|growth substances|mesh-ancestor
139592906|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592907|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
139592908|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139592909|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
139592910|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592911|NCT04677504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139592912|NCT04635631|Talazoparib|talazoparib|mesh-list
139592913|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139592914|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592915|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592916|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592917|NCT04502407|Cisplatin|cisplatin|mesh-list
139592918|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592919|NCT04483102|Liver Extracts|liver extracts|mesh-list
139592920|NCT04483102|Hematinics|hematinics|mesh-ancestor
139592921|NCT04477772|Antibodies|antibodies|mesh-list
139592922|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139592923|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
139592924|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592925|NCT04471597|Bupivacaine|bupivacaine|mesh-list
139592926|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
139592927|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
139592928|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592929|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592930|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
139592931|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592932|NCT04454411|Naltrexone|naltrexone|mesh-list
139592933|NCT04454411|Buprenorphine|buprenorphine|mesh-list
139592934|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139592935|NCT04454411|Narcotics|narcotics|mesh-ancestor
139592936|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592937|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592938|NCT04454411|Analgesics|analgesics|mesh-ancestor
139592939|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
139592940|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592941|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139592942|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139592943|NCT04387500|Axitinib|axitinib|mesh-list
139592944|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592945|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139592946|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592947|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592948|NCT04168879|Bupivacaine|bupivacaine|mesh-list
139592949|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
139592950|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
139592951|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139592952|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592953|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
139592954|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592955|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139374690|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139592956|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
139592957|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139592958|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139592959|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139592960|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139592961|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592962|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139592963|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139592964|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139592965|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139592966|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592967|NCT04046549|Methylprednisolone|methylprednisolone|mesh-list
139592968|NCT04046549|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139592969|NCT04046549|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139592970|NCT04046549|Prednisolone|prednisolone|mesh-list
139592971|NCT04046549|Prednisolone acetate|prednisolone acetate|mesh-list
139592972|NCT04046549|Abatacept|abatacept|mesh-list
139592973|NCT04046549|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139592974|NCT04046549|Prednisolone phosphate|prednisolone phosphate|mesh-list
139592975|NCT04046549|Thymoglobulin|thymoglobulin|mesh-list
139592976|NCT04046549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139592977|NCT04046549|Antiemetics|antiemetics|mesh-ancestor
139592978|NCT04046549|Autonomic Agents|autonomic agents|mesh-ancestor
139592979|NCT04046549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139592980|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139592981|NCT04046549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139592982|NCT04046549|Glucocorticoids|glucocorticoids|mesh-ancestor
139592983|NCT04046549|Hormones|hormones|mesh-ancestor
139592984|NCT04046549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139592985|NCT04046549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139592986|NCT04046549|Protective Agents|protective agents|mesh-ancestor
139592987|NCT04046549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139592988|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592989|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
139592990|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139592991|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139592992|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139592993|NCT04046549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139592994|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139592995|NCT03975231|Trametinib|trametinib|mesh-list
139592996|NCT03975231|Dabrafenib|dabrafenib|mesh-list
139592997|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139592998|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139592999|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593000|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593001|NCT03964753|Paclitaxel|paclitaxel|mesh-list
139593002|NCT03964753|Cisplatin|cisplatin|mesh-list
139593003|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139593004|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593005|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
139593006|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
139593007|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
139593008|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593009|NCT03933384|Tenofovir|tenofovir|mesh-list
139593010|NCT03933384|Entecavir|entecavir|mesh-list
139593011|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
139593012|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593013|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139593014|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139593015|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593016|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593017|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139593018|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139593019|NCT03821714|Vitamins|vitamins|mesh-list
139593020|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
139593021|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139593022|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139593023|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139593024|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
139593025|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
139593026|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593027|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139593028|NCT03821714|Hormones|hormones|mesh-ancestor
139593029|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139593030|NCT03783715|Ketoprofen|ketoprofen|mesh-list
139593031|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139374764|NCT04974944|Growth Substances|growth substances|mesh-ancestor
139593033|NCT03783715|Analgesics|analgesics|mesh-ancestor
139593034|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
139593035|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593036|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593037|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139593038|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139593039|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139593040|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593041|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593042|NCT03725436|Paclitaxel|paclitaxel|mesh-list
139593043|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139593044|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139593045|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593046|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
139593047|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
139593048|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
139593049|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593050|NCT03703050|Nivolumab|nivolumab|mesh-list
139593051|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139593052|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593053|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139593054|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593055|NCT03691350|Nicotine|nicotine|mesh-list
139593056|NCT03691350|Dimercaprol|dimercaprol|mesh-list
139593057|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139593058|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
139593059|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593060|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593061|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139593062|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139593063|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
139593064|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139593065|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593066|NCT03691350|Chelating Agents|chelating agents|mesh-ancestor
139593067|NCT03691350|Sequestering Agents|sequestering agents|mesh-ancestor
139593068|NCT03657342|Cyclosporine|cyclosporine|mesh-list
139593069|NCT03657342|Cyclosporins|cyclosporins|mesh-list
139593070|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593071|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593072|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139593073|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
139593074|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593075|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
139593076|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593077|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
139593078|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139593079|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139593080|NCT03656926|Cyclosporine|cyclosporine|mesh-list
139593081|NCT03656926|Cyclosporins|cyclosporins|mesh-list
139593082|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593083|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593084|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139593085|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
139593086|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593087|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
139593088|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593089|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
139593090|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139593091|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139593092|NCT03617458|Metformin|metformin|mesh-list
139593093|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139593094|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593095|NCT03607890|Nivolumab|nivolumab|mesh-list
139593096|NCT03607890|Relatlimab|relatlimab|mesh-list
139593097|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139593098|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593099|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139593100|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593101|NCT03580499|Vitamins|vitamins|mesh-list
139593102|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
139593103|NCT03580499|Pyridoxal|pyridoxal|mesh-list
139593104|NCT03580499|Pyridoxine|pyridoxine|mesh-list
139593105|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
139593106|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
139374847|NCT04424654|Testosterone|testosterone|mesh-list
139593107|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593108|NCT03466151|Sirolimus|sirolimus|mesh-list
139593109|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139593110|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593111|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139593112|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593113|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
139593114|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139593115|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
139593116|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593117|NCT03403205|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
139593118|NCT03403205|Choline|choline|mesh-list
139593119|NCT03403205|Lipotropic Agents|lipotropic agents|mesh-ancestor
139593120|NCT03403205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139593121|NCT03403205|Antimetabolites|antimetabolites|mesh-ancestor
139593122|NCT03403205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593123|NCT03403205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139593124|NCT03403205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139593125|NCT03403205|Nootropic Agents|nootropic agents|mesh-ancestor
139593126|NCT03403205|Chelating Agents|chelating agents|mesh-ancestor
139593127|NCT03403205|Sequestering Agents|sequestering agents|mesh-ancestor
139593128|NCT03403205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593129|NCT03403205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139593130|NCT03403205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139593131|NCT03403205|Growth Substances|growth substances|mesh-ancestor
139593132|NCT03403205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593133|NCT03403205|Growth Inhibitors|growth inhibitors|mesh-ancestor
139593134|NCT03403205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593135|NCT03375112|Bupivacaine|bupivacaine|mesh-list
139593136|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
139593137|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
139593138|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139593139|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593140|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
139593141|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593142|NCT03278509|Metoprolol|metoprolol|mesh-list
139593143|NCT03278509|Bisoprolol|bisoprolol|mesh-list
139593144|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139593145|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139593146|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
139593147|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
139593148|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593149|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593150|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139593151|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139593152|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139593153|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
139593154|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139593155|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593156|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
139593157|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139593158|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593159|NCT03162432|Vitamin D|vitamin d|mesh-list
139593160|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
139593161|NCT03162432|Vitamins|vitamins|mesh-ancestor
139593162|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
139593163|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593164|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139593165|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139593166|NCT03133923|Vaccines|vaccines|mesh-list
139593167|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
139593168|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593169|NCT03076203|Niraparib|niraparib|mesh-list
139593170|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139593171|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139593172|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593173|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593174|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593175|NCT03075423|Nivolumab|nivolumab|mesh-list
139593176|NCT03075423|Ipilimumab|ipilimumab|mesh-list
139593177|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139593178|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593179|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139593180|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593181|NCT03033914|Doxorubicin|doxorubicin|mesh-list
139593182|NCT03033914|Bleomycin|bleomycin|mesh-list
139593183|NCT03033914|Nivolumab|nivolumab|mesh-list
139593184|NCT03033914|Dacarbazine|dacarbazine|mesh-list
139593185|NCT03033914|Vinblastine|vinblastine|mesh-list
139593186|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139593187|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593188|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139593189|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139593190|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593191|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593192|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139593193|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139593194|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139593195|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
139593196|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139593197|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
139593198|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
139593199|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
139593200|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
139593201|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139593202|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593203|NCT03012230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139593204|NCT03012230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593205|NCT02957032|Cytarabine|cytarabine|mesh-list
139593206|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139593207|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
139593208|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593209|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593210|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
139593211|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593212|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139593213|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
139593214|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593215|NCT02923739|Paclitaxel|paclitaxel|mesh-list
139593216|NCT02923739|Bevacizumab|bevacizumab|mesh-list
139593217|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139593218|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139593219|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
139593220|NCT02923739|Antibodies|antibodies|mesh-list
139593221|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
139593222|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139593223|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
139593224|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139593225|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593226|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
139593227|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
139593228|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
139593229|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593230|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139593231|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139593232|NCT02923739|Growth Substances|growth substances|mesh-ancestor
139593233|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593234|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
139593235|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
139593236|NCT02897375|Carboplatin|carboplatin|mesh-list
139593237|NCT02897375|Palbociclib|palbociclib|mesh-list
139593238|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593239|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139593240|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593241|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593242|NCT02781792|Temozolomide|temozolomide|mesh-list
139593243|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139593244|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
139593245|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593246|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593247|NCT02753283|Vitamin D|vitamin d|mesh-list
139593248|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
139593249|NCT02753283|Denosumab|denosumab|mesh-list
139593250|NCT02753283|Calcium|calcium|mesh-list
139593251|NCT02753283|Vitamins|vitamins|mesh-ancestor
138721300|NCT04558268|Progestins|progestins|mesh-ancestor
139593252|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
139593253|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593254|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139593255|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139593256|NCT02660255|Cannabidiol|cannabidiol|mesh-list
139593257|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
139593258|NCT02596685|Nicotine|nicotine|mesh-list
139593259|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139593260|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
139593261|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593262|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593263|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139593264|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139593265|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
139593266|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139593267|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593268|NCT02509052|Leflunomide|leflunomide|mesh-list
139593269|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593270|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593271|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139593272|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
139593273|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593274|NCT02365597|Metformin|metformin|mesh-list
139593275|NCT02365597|Midazolam|midazolam|mesh-list
139593276|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139593277|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593278|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139593279|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139593280|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139593281|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139593282|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139593283|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139593284|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139593285|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
139593286|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
139593287|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
139593288|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
139593289|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139593290|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593291|NCT02231632|Vaccines|vaccines|mesh-list
139593292|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
139593293|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593294|NCT02220894|Paclitaxel|paclitaxel|mesh-list
139593295|NCT02220894|Carboplatin|carboplatin|mesh-list
139593296|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
139593297|NCT02220894|Pemetrexed|pemetrexed|mesh-list
139593298|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139593299|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593300|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
139593301|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
139593302|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
139593303|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593304|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139593305|NCT02220894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139593306|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593307|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139593308|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139593309|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139593310|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139593311|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
139593312|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
139593313|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593314|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
139593315|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593316|NCT02068092|Protective Agents|protective agents|mesh-ancestor
139593317|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593318|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139593319|NCT02023463|Leuprolide|leuprolide|mesh-list
139593320|NCT02023463|Goserelin|goserelin|mesh-list
139593321|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139593322|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
139593323|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139593324|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593325|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139593326|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593327|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
139593328|NCT01959672|Leucovorin|leucovorin|mesh-list
139593329|NCT01959672|Folic Acid|folic acid|mesh-list
139593330|NCT01959672|Nelfinavir|nelfinavir|mesh-list
139593331|NCT01959672|Gemcitabine|gemcitabine|mesh-list
139593332|NCT01959672|Fluorouracil|fluorouracil|mesh-list
139593333|NCT01959672|Oregovomab|oregovomab|mesh-list
139593334|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139593335|NCT01959672|Antibodies|antibodies|mesh-list
139593336|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
139593337|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139593338|NCT01959672|Calcium|calcium|mesh-list
139593339|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
139593340|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
139593341|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593342|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139593343|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
139593344|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593345|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593346|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139593347|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139593348|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139593349|NCT01959672|Antidotes|antidotes|mesh-ancestor
139593350|NCT01959672|Protective Agents|protective agents|mesh-ancestor
139593351|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
139593352|NCT01959672|Vitamins|vitamins|mesh-ancestor
139593353|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
139593354|NCT01959672|Hematinics|hematinics|mesh-ancestor
139593355|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139593356|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139593357|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
139593358|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593359|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139593360|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139593361|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
139593362|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593363|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139593364|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
139593365|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593366|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139593367|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
139593368|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139593369|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593370|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139593371|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139593372|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139593373|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
139593374|NCT01949857|Vaccines|vaccines|mesh-list
139593375|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
139593376|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593377|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139593378|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
139593379|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593380|NCT01420250|Bicalutamide|bicalutamide|mesh-list
139593381|NCT01420250|Hormones|hormones|mesh-list
139593382|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139593383|NCT01420250|Androgens|androgens|mesh-list
139593384|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
139593385|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139593386|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593387|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
139593388|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593389|NCT00617799|Aldesleukin|aldesleukin|mesh-list
139593390|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593391|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139593392|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139593393|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
139593394|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593395|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
139593396|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139593397|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593398|NCT00574509|Cytarabine|cytarabine|mesh-list
139593399|NCT00574509|Etoposide|etoposide|mesh-list
139593400|NCT00574509|Melphalan|melphalan|mesh-list
139593401|NCT00574509|Carmustine|carmustine|mesh-list
139593402|NCT00574509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139593403|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593404|NCT00574509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139593405|NCT00574509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139593406|NCT00574509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593407|NCT00574509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593408|NCT00574509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139593409|NCT00574509|Antimetabolites|antimetabolites|mesh-ancestor
139593410|NCT00574509|Antiviral Agents|antiviral agents|mesh-ancestor
139593411|NCT00574509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593412|NCT00574509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139593413|NCT00574509|Immunologic Factors|immunologic factors|mesh-ancestor
139593414|NCT00574509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593415|NCT00574509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139593416|NCT00574509|Alkylating Agents|alkylating agents|mesh-ancestor
139593417|NCT00574509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139593418|NCT00071760|Ritonavir|ritonavir|mesh-list
139593419|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
139593420|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139593421|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139593422|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
139593423|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593424|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593425|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139593426|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139593427|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
139593428|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593429|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139593430|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139593431|NCT04745260|Midazolam|midazolam|mesh-list
139593432|NCT04745260|Fentanyl|fentanyl|mesh-list
139593433|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139593434|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139593435|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139593436|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593437|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139593438|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139593439|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139593440|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139593441|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
139593442|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
139593443|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
139593444|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
139593445|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139593446|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593447|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139593448|NCT04745260|Narcotics|narcotics|mesh-ancestor
139593449|NCT04745260|Analgesics|analgesics|mesh-ancestor
139593450|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
139593451|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593452|NCT03199482|Dexamethasone|dexamethasone|mesh-list
139593453|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139593454|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
139593455|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
139593456|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593457|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593458|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139593459|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
139593460|NCT03199482|Hormones|hormones|mesh-ancestor
139593461|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139593462|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139593463|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593464|NCT02446704|Temozolomide|temozolomide|mesh-list
139593465|NCT02446704|Olaparib|olaparib|mesh-list
139593466|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139593467|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
139593468|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593469|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593470|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139593471|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593472|NCT01605227|Prednisone|prednisone|mesh-list
139593473|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139593474|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
139593475|NCT01605227|Hormones|hormones|mesh-ancestor
139593476|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139593477|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593478|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139593479|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593480|NCT02446548|Losartan|losartan|mesh-list
139593481|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139593482|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139593483|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139593484|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139593485|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593486|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139593487|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139593488|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593489|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
139593490|NCT03199170|Morphine|morphine|mesh-list
139593491|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139593492|NCT03199170|Narcotics|narcotics|mesh-ancestor
139593493|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139593494|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593495|NCT03199170|Analgesics|analgesics|mesh-ancestor
139593496|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
139593497|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593498|NCT03118128|Metformin|metformin|mesh-list
139593499|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139593500|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593501|NCT05087914|Naproxen|naproxen|mesh-list
139593502|NCT05087914|Levodopa|levodopa|mesh-list
139593503|NCT05087914|Carbidopa|carbidopa|mesh-list
139593504|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139593505|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139593506|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139593507|NCT05087914|Analgesics|analgesics|mesh-ancestor
139593508|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
139593509|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593510|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593511|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139593512|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139593513|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
139593514|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139593515|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593516|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593517|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139593518|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139593519|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
139593520|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139593521|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139593522|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139593523|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
139593524|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
139593525|NCT03194724|Vitamin A|vitamin a|mesh-list
139593526|NCT03194724|Vitamins|vitamins|mesh-ancestor
139593527|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
139593528|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593529|NCT01709513|Atorvastatin|atorvastatin|mesh-list
139593530|NCT01709513|Ezetimibe|ezetimibe|mesh-list
139593531|NCT01709513|Alirocumab|alirocumab|mesh-list
139593532|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139593533|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139593534|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
139593535|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593536|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139593537|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139593538|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593539|NCT01709513|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139593540|NCT01709513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139593541|NCT01709513|Protease Inhibitors|protease inhibitors|mesh-ancestor
139593542|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
139593543|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139593544|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139593545|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593546|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
139593547|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
139593548|NCT02446002|Lofexidine|lofexidine|mesh-list
139593549|NCT02446002|Clonidine|clonidine|mesh-list
139593550|NCT02446002|Naltrexone|naltrexone|mesh-list
139593551|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139593552|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139593553|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593554|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
139593555|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593556|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139593557|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139593558|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139593559|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139593560|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
139593561|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139593562|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593563|NCT02446002|Analgesics|analgesics|mesh-ancestor
139593564|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
139593565|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
139593566|NCT01605071|Estradiol|estradiol|mesh-list
139593568|NCT01605071|Hormones|hormones|mesh-ancestor
139593569|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139593570|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593571|NCT04345198|Epinephrine|epinephrine|mesh-list
139593572|NCT04345198|Racepinephrine|racepinephrine|mesh-list
139593573|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
139593574|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139593575|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139593576|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
139593577|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139593578|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593579|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593580|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139593581|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139593582|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
139593583|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593584|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139593585|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
139593586|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
139593587|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
139593588|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139593589|NCT03192618|Leucovorin|leucovorin|mesh-list
139593590|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
139593591|NCT03192618|Calcium|calcium|mesh-list
139593592|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
139593593|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139593594|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593595|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593596|NCT03192618|Antidotes|antidotes|mesh-ancestor
139593597|NCT03192618|Protective Agents|protective agents|mesh-ancestor
139593598|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
139593599|NCT03192618|Vitamins|vitamins|mesh-ancestor
139593600|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
139593601|NCT04113226|Rituximab|rituximab|mesh-list
139593602|NCT04113226|Lenalidomide|lenalidomide|mesh-list
139593603|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139593604|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593605|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
139593606|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593607|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139593608|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139593609|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139593610|NCT04113226|Growth Substances|growth substances|mesh-ancestor
138721644|NCT00578201|Cetuximab|cetuximab|mesh-list
139593611|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
139593612|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139593613|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139593614|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593615|NCT02444364|Incretins|incretins|mesh-ancestor
139593616|NCT02444364|Hormones|hormones|mesh-ancestor
139593617|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139593618|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139593619|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
139593620|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593621|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593622|NCT05039476|Vitamin A|vitamin a|mesh-list
139593623|NCT05039476|Vitamins|vitamins|mesh-ancestor
139593624|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
139593625|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593626|NCT00356356|Etanercept|etanercept|mesh-list
139593627|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139593628|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139593629|NCT00356356|Analgesics|analgesics|mesh-ancestor
139593630|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
139593631|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593632|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593633|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139593634|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139593635|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139593636|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139593637|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
139593638|NCT02443818|Sirolimus|sirolimus|mesh-list
139593639|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139593640|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593641|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139375365|NCT03240549|Growth Substances|growth substances|mesh-ancestor
139593642|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593643|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
139593644|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139593645|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
139593646|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593647|NCT01705691|Paclitaxel|paclitaxel|mesh-list
139593648|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
139593649|NCT01705691|Doxorubicin|doxorubicin|mesh-list
139593650|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139593651|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593652|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
139593653|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
139593654|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
139593655|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593656|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139593657|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
139593658|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593659|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139593660|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139593661|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
139593662|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138721705|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139593663|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139593664|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139593665|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139593666|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593667|NCT02450058|Paclitaxel|paclitaxel|mesh-list
139593668|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
139593669|NCT02450058|Fluorouracil|fluorouracil|mesh-list
139593670|NCT02450058|Epirubicin|epirubicin|mesh-list
139593671|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139593672|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593673|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
139593674|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
139593675|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
139593676|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593677|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139593678|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
139593679|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593680|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139593681|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139593682|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
139593683|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139593684|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
139593685|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139593686|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139593687|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139593688|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139593689|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593690|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139593691|NCT02445300|Laxatives|laxatives|mesh-ancestor
139593692|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139593693|NCT02445066|Vitamin D|vitamin d|mesh-list
139593694|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
139593695|NCT02445066|Vitamins|vitamins|mesh-ancestor
139593696|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
139593697|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593698|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139593699|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139593700|NCT03197298|Clopidogrel|clopidogrel|mesh-list
139593701|NCT03197298|Ticagrelor|ticagrelor|mesh-list
139593702|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139593703|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139593704|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139593705|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139593706|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
139593707|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139593708|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593709|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593710|NCT00357448|Interleukin-2|interleukin-2|mesh-list
139593711|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
139593712|NCT00357448|Immunotoxins|immunotoxins|mesh-list
139593713|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593714|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139593715|NCT00357448|Analgesics|analgesics|mesh-ancestor
139593716|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
139593717|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593718|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593719|NCT00357448|Immunoconjugates|immunoconjugates|mesh-ancestor
139593720|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
139593721|NCT05715658|Dabigatran|dabigatran|mesh-list
139593722|NCT05715658|Antithrombins|antithrombins|mesh-ancestor
139593723|NCT05715658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139593724|NCT05715658|Protease Inhibitors|protease inhibitors|mesh-ancestor
139593725|NCT05715658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593726|NCT05715658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593727|NCT05715658|Anticoagulants|anticoagulants|mesh-ancestor
139593728|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139593729|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139593730|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139593731|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139593732|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593733|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139593734|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593735|NCT02443194|Analgesics|analgesics|mesh-ancestor
139593736|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
139593737|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593738|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
139593739|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139593740|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
139593741|NCT03193944|Vitamin D|vitamin d|mesh-list
139593742|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
139593743|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
139593744|NCT03193944|Vitamins|vitamins|mesh-list
139593745|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
139593746|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593747|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139593748|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139593749|NCT00357604|Ritonavir|ritonavir|mesh-list
139593750|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139593751|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
139593752|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139593753|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139593754|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139593755|NCT00357604|Norgestimate|norgestimate|mesh-list
139593756|NCT00357604|Norgestrel|norgestrel|mesh-list
139593757|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139593758|NCT00357604|Estradiol|estradiol|mesh-list
139593759|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139593760|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139593761|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139593762|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
139593763|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593764|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593765|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139593766|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139593767|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
139593768|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593769|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139593770|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139593771|NCT00357604|Estrogens|estrogens|mesh-ancestor
139593772|NCT00357604|Hormones|hormones|mesh-ancestor
139593773|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139593774|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593775|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139593776|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
139593777|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139593778|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139593779|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139593780|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139593781|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139593782|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139593783|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139593784|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139593785|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139593786|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593787|NCT03193788|Folic Acid|folic acid|mesh-list
139593788|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
139593789|NCT03193788|Dexamethasone|dexamethasone|mesh-list
139593790|NCT03193788|Pemetrexed|pemetrexed|mesh-list
139593791|NCT03193788|Vitamins|vitamins|mesh-ancestor
139593792|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
139593793|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593794|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139593795|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
139593796|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
139593797|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593798|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139593799|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
139593800|NCT03193788|Hormones|hormones|mesh-ancestor
139593801|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139593802|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139593803|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593804|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593805|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593806|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139593807|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139593808|NCT03193788|Hematinics|hematinics|mesh-ancestor
139593809|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
139593810|NCT02442648|Rituximab|rituximab|mesh-list
139593811|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139593812|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593813|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
139593814|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593815|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139593816|NCT00356824|Artesunate|artesunate|mesh-list
139593817|NCT00356824|Amodiaquine|amodiaquine|mesh-list
139593818|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
139593819|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139593820|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139593821|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593822|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593823|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
139593824|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
139593825|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139593826|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
139593827|NCT01705145|Ivacaftor|ivacaftor|mesh-list
139593828|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139593829|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139593830|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593831|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139593832|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
139593833|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
139593834|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139593835|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
139593836|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593837|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139593838|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139593839|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139593840|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139593841|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593842|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
139593843|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
139593844|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139593845|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139593846|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593847|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593848|NCT02442492|Urological Agents|urological agents|mesh-ancestor
139593849|NCT01704755|Ribavirin|ribavirin|mesh-list
139593850|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
139593851|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593852|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
139593853|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593854|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
139593855|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139593856|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139593857|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
139593858|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593859|NCT04166669|Itraconazole|itraconazole|mesh-list
139593860|NCT04166669|Rifampin|rifampin|mesh-list
139593861|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
139593862|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139593863|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139593864|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139593865|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593866|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593867|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139593868|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
139593869|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139593870|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593871|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139593872|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139593873|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
139593874|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139593875|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
139593876|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139593877|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139593878|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139593879|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139593880|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139593881|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139593882|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139593884|NCT03193710|Propofol|propofol|mesh-list
139593885|NCT03193710|Sevoflurane|sevoflurane|mesh-list
139593886|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139593887|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139593888|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593889|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139593890|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
139593891|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
139593892|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139593893|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139593894|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139593895|NCT03193710|Narcotics|narcotics|mesh-ancestor
139593896|NCT03193710|Analgesics|analgesics|mesh-ancestor
139593897|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
139593898|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593899|NCT01704599|Vitamins|vitamins|mesh-list
139593900|NCT01704599|Folic Acid|folic acid|mesh-list
139593901|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
139593902|NCT01704599|Pyridoxine|pyridoxine|mesh-list
139593903|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
139593904|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
139593905|NCT01704599|Adalimumab|adalimumab|mesh-list
139593906|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
139593907|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593908|NCT01704599|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139593909|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139593910|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139593911|NCT01704599|Hematinics|hematinics|mesh-ancestor
139593912|NCT03196362|Metformin|metformin|mesh-list
139593913|NCT03196362|Pioglitazone|pioglitazone|mesh-list
139593914|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139593915|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593916|NCT02449278|Prednisone|prednisone|mesh-list
139593917|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
139593918|NCT02449278|Doxorubicin|doxorubicin|mesh-list
139593919|NCT02449278|Vincristine|vincristine|mesh-list
139593920|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139593921|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
139593922|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593923|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139593924|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139593925|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
139593926|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593927|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593928|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139593929|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139593930|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139593931|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139593932|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593933|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139593934|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
139593935|NCT02449278|Hormones|hormones|mesh-ancestor
139593936|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139593937|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139593938|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139593939|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
139593940|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
139593941|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
139593942|NCT03599518|Gefitinib|gefitinib|mesh-list
139593943|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139593944|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139375669|NCT04939766|Insulin|insulin|mesh-list
139593945|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139593946|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593947|NCT03099486|Leucovorin|leucovorin|mesh-list
139593948|NCT03099486|Antidotes|antidotes|mesh-ancestor
139593949|NCT03099486|Protective Agents|protective agents|mesh-ancestor
139593950|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593951|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
139593952|NCT03099486|Vitamins|vitamins|mesh-ancestor
139593953|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
139593954|NCT00358228|Rimonabant|rimonabant|mesh-list
139593955|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139593956|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
139593957|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139593958|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139593959|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593960|NCT00358228|Hormones|hormones|mesh-ancestor
139593961|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139593962|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593963|NCT05710198|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139593964|NCT05710198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139593965|NCT05710198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139593966|NCT05710198|Nootropic Agents|nootropic agents|mesh-ancestor
139593967|NCT01336530|Oxethazaine|oxethazaine|mesh-list
139593968|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139593969|NCT01336530|Antacids|antacids|mesh-list
139593970|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139593971|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139593972|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
139593973|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593974|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593975|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139593976|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
139593977|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
139593978|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139593979|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
139593980|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593981|NCT00777348|Reproterol|reproterol|mesh-list
139593982|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139593983|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139593984|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
139593985|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139593986|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139593987|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593988|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139593989|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
139593990|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593991|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139593992|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
139593993|NCT03836560|Nicotine|nicotine|mesh-list
139593994|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139593995|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
139593996|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139593997|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139593998|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139593999|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139594000|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
139594001|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594002|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594003|NCT04483596|Melatonin|melatonin|mesh-list
139594004|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
139594005|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594006|NCT04483596|Protective Agents|protective agents|mesh-ancestor
139594007|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594008|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139594009|NCT05721586|Listerine|listerine|mesh-list
139594010|NCT05721586|Fluorides|fluorides|mesh-list
139594011|NCT05721586|Fluorides, Topical|fluorides, topical|mesh-list
139594012|NCT05721586|Sodium Fluoride|sodium fluoride|mesh-list
139594013|NCT05721586|Cariostatic Agents|cariostatic agents|mesh-ancestor
139594014|NCT05721586|Protective Agents|protective agents|mesh-ancestor
139594015|NCT05721586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594016|NCT05721586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139594017|NCT05721586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594018|NCT02978482|Durvalumab|durvalumab|mesh-list
139594019|NCT02978482|Tremelimumab|tremelimumab|mesh-list
139594020|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139594021|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139594022|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594023|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
139594024|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594025|NCT00357682|Aspirin|aspirin|mesh-list
139594026|NCT00357682|Esomeprazole|esomeprazole|mesh-list
139594027|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139594028|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139594029|NCT00357682|Analgesics|analgesics|mesh-ancestor
139594030|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
139594031|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594032|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594033|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139594034|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139594035|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139594036|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139594037|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594038|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139594039|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139594040|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594041|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
139594042|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139594043|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139594044|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139594045|NCT00105027|Triamcinolone|triamcinolone|mesh-list
139594046|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139594047|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139594048|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139594049|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139594050|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
139594051|NCT00105027|Hormones|hormones|mesh-ancestor
139594052|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594053|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594054|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139594055|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
139594056|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594057|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594058|NCT03145012|Ranitidine|ranitidine|mesh-list
139594059|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139594060|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139594061|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139594062|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139594063|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
139594064|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
139594065|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594066|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594067|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594068|NCT03832660|Valsartan|valsartan|mesh-list
139594069|NCT03832660|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139594070|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139594071|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139594072|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139594073|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594074|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139594075|NCT00030147|Estradiol|estradiol|mesh-list
139594076|NCT00030147|Estrogens|estrogens|mesh-ancestor
139594077|NCT00030147|Hormones|hormones|mesh-ancestor
139594078|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594079|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594080|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139594081|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
139594082|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139594083|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139594084|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139594085|NCT02709486|Tanezumab|tanezumab|mesh-list
139594086|NCT02709486|Analgesics|analgesics|mesh-ancestor
139594087|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
139594088|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594089|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594090|NCT00106431|Romidepsin|romidepsin|mesh-list
139594091|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139594092|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594093|NCT00106431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139297193|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594094|NCT00106431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594095|NCT00106431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594096|NCT03107416|Bumetanide|bumetanide|mesh-list
139594097|NCT03107416|Diuretics|diuretics|mesh-ancestor
139594098|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
139594099|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594100|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139594101|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139594102|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594103|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139594104|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
139594105|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139594106|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
139594107|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594108|NCT03833596|Prednisone|prednisone|mesh-list
139594109|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139594110|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
139594111|NCT03833596|Hormones|hormones|mesh-ancestor
139594112|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594113|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594114|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139594115|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594116|NCT02831998|Ethanol|ethanol|mesh-list
139594117|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
139594118|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139594119|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139594120|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594121|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139594122|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594123|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
139594124|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
139594125|NCT02434614|Cisplatin|cisplatin|mesh-list
139594126|NCT02434614|Docetaxel|docetaxel|mesh-list
139594127|NCT02434614|Fluorouracil|fluorouracil|mesh-list
139594128|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594129|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
139594130|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
139594131|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
139594132|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594133|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
139594134|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139594135|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139594136|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
139594137|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594138|NCT05720260|Durvalumab|durvalumab|mesh-list
139594139|NCT05720260|Fulvestrant|fulvestrant|mesh-list
139594140|NCT05720260|Goserelin|goserelin|mesh-list
139594141|NCT05720260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139594142|NCT05720260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594143|NCT05720260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139594144|NCT05720260|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139594145|NCT05720260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139594146|NCT05720260|Hormone Antagonists|hormone antagonists|mesh-ancestor
139594147|NCT05720260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594148|NCT05720260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594149|NCT05720026|Docetaxel|docetaxel|mesh-list
139594150|NCT05720026|Trastuzumab|trastuzumab|mesh-list
139594151|NCT05720026|Pertuzumab|pertuzumab|mesh-list
139594152|NCT05720026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594153|NCT05720026|Tubulin Modulators|tubulin modulators|mesh-ancestor
139594154|NCT05720026|Antimitotic Agents|antimitotic agents|mesh-ancestor
139594155|NCT05720026|Mitosis Modulators|mitosis modulators|mesh-ancestor
139594156|NCT05720026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594157|NCT05720026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139594158|NCT04483674|Tenofovir|tenofovir|mesh-list
139594159|NCT04483674|Emtricitabine|emtricitabine|mesh-list
139594160|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
139594161|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594162|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139594163|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139594164|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594165|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594166|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139594167|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139594168|NCT02438982|Rituximab|rituximab|mesh-list
139594169|NCT02438982|Tacrolimus|tacrolimus|mesh-list
139594170|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139594171|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139594172|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594173|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
139594174|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594175|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139594176|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139594177|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594178|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594179|NCT02425774|Prucalopride|prucalopride|mesh-list
139594180|NCT02425774|Laxatives|laxatives|mesh-ancestor
139594181|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139594182|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139594183|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139594184|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
139594185|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594186|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594187|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594188|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
139594189|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139594190|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139594191|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139594192|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139594193|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594194|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
139594195|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594196|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594197|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139594198|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594199|NCT03117894|Acetaminophen|acetaminophen|mesh-list
139594201|NCT03117894|Morphine|morphine|mesh-list
139594202|NCT03117894|Remifentanil|remifentanil|mesh-list
139594203|NCT03117894|Ondansetron|ondansetron|mesh-list
139594204|NCT03117894|Propofol|propofol|mesh-list
139594205|NCT03117894|Ropivacaine|ropivacaine|mesh-list
139594206|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139594207|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139594208|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594209|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139594210|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
139594211|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
139594212|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139594213|NCT03117894|Narcotics|narcotics|mesh-ancestor
139594214|NCT03117894|Analgesics|analgesics|mesh-ancestor
139594215|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
139594216|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594217|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
139594218|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139594219|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
139594220|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
139594221|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
139594222|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139594223|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
139594224|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
139594225|NCT03117894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139594226|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139594227|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
139594228|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594229|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594230|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139594231|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139594232|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139594233|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139594234|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139594235|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594236|NCT00357292|Azithromycin|azithromycin|mesh-list
139594237|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139594238|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594239|NCT03187548|Calcium|calcium|mesh-list
139594240|NCT03187548|Caseins|caseins|mesh-list
139594241|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139594242|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594243|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
139594244|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
139594245|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594246|NCT02042326|Sirolimus|sirolimus|mesh-list
139594247|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139594248|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594249|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139594250|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594251|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
139594252|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139594253|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
139594254|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594255|NCT05718544|Sufentanil|sufentanil|mesh-list
139594256|NCT05718544|Dexmedetomidine|dexmedetomidine|mesh-list
139594257|NCT05718544|Esketamine|esketamine|mesh-list
139594258|NCT05718544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139594259|NCT05718544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139594260|NCT05718544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594261|NCT05718544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139594262|NCT05718544|Analgesics|analgesics|mesh-ancestor
139594263|NCT05718544|Sensory System Agents|sensory system agents|mesh-ancestor
139594264|NCT05718544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594265|NCT05718544|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139594266|NCT05718544|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139594267|NCT05718544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139594268|NCT05718544|Adrenergic Agents|adrenergic agents|mesh-ancestor
139594269|NCT05718544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594270|NCT05718544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594271|NCT05718544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139594272|NCT05718544|Narcotics|narcotics|mesh-ancestor
139594273|NCT05718544|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139594274|NCT05718544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139594275|NCT05718544|Anesthetics, General|anesthetics, general|mesh-ancestor
139594276|NCT05718544|Anesthetics|anesthetics|mesh-ancestor
139594277|NCT05718544|Antidepressive Agents|antidepressive agents|mesh-ancestor
139594278|NCT05718544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139594279|NCT05616598|Ribavirin|ribavirin|mesh-list
139594280|NCT05616598|Sofosbuvir|sofosbuvir|mesh-list
139594281|NCT05616598|Simeprevir|simeprevir|mesh-list
139594282|NCT05616598|Antimetabolites|antimetabolites|mesh-ancestor
139594283|NCT05616598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594284|NCT05616598|Antiviral Agents|antiviral agents|mesh-ancestor
139594285|NCT05616598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594286|NCT05616598|Protease Inhibitors|protease inhibitors|mesh-ancestor
139594287|NCT05616598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594288|NCT03187392|Lidocaine|lidocaine|mesh-list
139594289|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
139594290|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
139594291|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139594292|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722336|NCT01119898|Diclofenac|diclofenac|mesh-list
139594293|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
139594294|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594295|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139594296|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139594297|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139594298|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139594299|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594300|NCT01464268|Riboflavin|riboflavin|mesh-list
139594301|NCT01464268|Dextrans|dextrans|mesh-list
139594302|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
139594303|NCT01464268|Vitamins|vitamins|mesh-ancestor
139594304|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
139594305|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594306|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139594307|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
139594308|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
139594309|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
139594310|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
139594311|NCT00215787|Lansoprazole|lansoprazole|mesh-list
139594312|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
139594313|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139594314|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139594315|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139594316|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594317|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594318|NCT05716906|Melatonin|melatonin|mesh-list
139594319|NCT05716906|Antioxidants|antioxidants|mesh-ancestor
139594320|NCT05716906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594321|NCT05716906|Protective Agents|protective agents|mesh-ancestor
139594322|NCT05716906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594323|NCT05716906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139594324|NCT00216099|Folic Acid|folic acid|mesh-list
139594325|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
139594326|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
139594327|NCT00216099|Pemetrexed|pemetrexed|mesh-list
139594328|NCT00216099|Vitamins|vitamins|mesh-ancestor
139594329|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
139594330|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594331|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594332|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594333|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594334|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139594335|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139594336|NCT00216099|Hematinics|hematinics|mesh-ancestor
139594337|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
139594338|NCT00039195|Prednisone|prednisone|mesh-list
139594339|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
139594340|NCT00039195|Ifosfamide|ifosfamide|mesh-list
139594341|NCT00039195|Rituximab|rituximab|mesh-list
139594342|NCT00039195|Carboplatin|carboplatin|mesh-list
139594343|NCT00039195|Doxorubicin|doxorubicin|mesh-list
139594344|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139594345|NCT00039195|Etoposide|etoposide|mesh-list
139594346|NCT00039195|Vincristine|vincristine|mesh-list
139594347|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139594348|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
139594349|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594350|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139594351|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139594352|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
138722385|NCT04561947|Mitogens|mitogens|mesh-list
139594353|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594354|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594355|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139594356|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139594357|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139594358|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139594359|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139594360|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594361|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139594362|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
139594363|NCT00039195|Hormones|hormones|mesh-ancestor
139594364|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594365|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139594366|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139594367|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
139594368|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
139594369|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
139594370|NCT05591170|Cholecalciferol|cholecalciferol|mesh-list
139594371|NCT05591170|Vitamin D|vitamin d|mesh-list
139594372|NCT05591170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139594373|NCT05591170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594374|NCT05591170|Vitamins|vitamins|mesh-ancestor
139594375|NCT05591170|Micronutrients|micronutrients|mesh-ancestor
139594376|NCT05591170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139594377|NCT00218439|Paroxetine|paroxetine|mesh-list
139594378|NCT00218439|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139594379|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139594380|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139594381|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594382|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594383|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
139594384|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594385|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139594386|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
139594387|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139594388|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139594389|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139594390|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594391|NCT04344730|Dexamethasone|dexamethasone|mesh-list
139594392|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
139594393|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139594394|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
139594395|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
139594396|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594397|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594398|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139594399|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
139594400|NCT04344730|Hormones|hormones|mesh-ancestor
139594401|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594402|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139594403|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594405|NCT05716672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139594406|NCT05716672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594407|NCT05716672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594408|NCT00358384|Betamethasone|betamethasone|mesh-list
139594409|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
139594410|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139594411|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
139594412|NCT00358384|Calcipotriene|calcipotriene|mesh-list
139594413|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139594414|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139594415|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
139594416|NCT00358384|Hormones|hormones|mesh-ancestor
139594417|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594418|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594419|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139594420|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
139594421|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
139594422|NCT02959060|Rifampin|rifampin|mesh-list
139594423|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139594424|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
139594425|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139594426|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594427|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
139594428|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139594429|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594430|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594431|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139594432|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139594433|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139594434|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139594435|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139594436|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139594437|NCT00109005|Lenalidomide|lenalidomide|mesh-list
139594438|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
139594439|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594440|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139594441|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139594442|NCT00109005|Growth Substances|growth substances|mesh-ancestor
139594443|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
139594444|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594445|NCT05552950|Antiviral Agents|antiviral agents|mesh-list
139594446|NCT05552950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594447|NCT05547100|Olanzapine|olanzapine|mesh-list
139594448|NCT05547100|Antiemetics|antiemetics|mesh-ancestor
139594449|NCT05547100|Autonomic Agents|autonomic agents|mesh-ancestor
139594450|NCT05547100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594451|NCT05547100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594452|NCT05547100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139594453|NCT05547100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139594454|NCT05547100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139594455|NCT05547100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139594456|NCT05547100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139594457|NCT05547100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139594458|NCT05547100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139594459|NCT05547100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139594460|NCT05547100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594461|NCT05547100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594462|NCT05547100|Serotonin Agents|serotonin agents|mesh-ancestor
139594463|NCT00109473|Prednisone|prednisone|mesh-list
139594464|NCT00109473|Hormones|hormones|mesh-list
139594465|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139594466|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
139594467|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594468|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594469|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139594470|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594471|NCT00044655|Olanzapine|olanzapine|mesh-list
139594472|NCT00044655|Risperidone|risperidone|mesh-list
139594473|NCT00044655|Aripiprazole|aripiprazole|mesh-list
139594474|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139594475|NCT00044655|Ziprasidone|ziprasidone|mesh-list
139594476|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139594477|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
139594478|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594479|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594480|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594481|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139594482|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139594483|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139594484|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139594485|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139594486|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
139594487|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
139594488|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
139594489|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594490|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139594491|NCT00044655|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139594492|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139594493|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139594494|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
139594495|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
139594496|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139594497|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139594498|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139594499|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139594500|NCT05130892|Tranilast|tranilast|mesh-list
139594501|NCT05130892|Colchicine|colchicine|mesh-list
139594502|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
139594503|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139594504|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
139594505|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
139594506|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
139594507|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594508|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594509|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139594510|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139594511|NCT05130892|Analgesics|analgesics|mesh-ancestor
139594512|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
139594513|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594514|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594515|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139594516|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139594517|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139594518|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139594519|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139594520|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
139594521|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
139594522|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594523|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139594524|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139594525|NCT00223665|Leuprolide|leuprolide|mesh-list
139594526|NCT00223665|Flutamide|flutamide|mesh-list
139594527|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139594528|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
139594529|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139594530|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594531|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139594532|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594533|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
139594534|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
139594535|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594536|NCT05311540|Zinc Sulfate|zinc sulfate|mesh-list
139594537|NCT05311540|Astringents|astringents|mesh-ancestor
139594538|NCT05311540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594539|NCT05311540|Dermatologic Agents|dermatologic agents|mesh-ancestor
139594540|NCT00223821|Oxybutynin|oxybutynin|mesh-list
139594541|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
139594542|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
139594543|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594544|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594545|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139594546|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139594547|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
139594548|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594549|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594550|NCT00223821|Urological Agents|urological agents|mesh-ancestor
139594551|NCT00359164|Bevacizumab|bevacizumab|mesh-list
139594552|NCT00359164|Verteporfin|verteporfin|mesh-list
139594553|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139594554|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594555|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139594556|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139594557|NCT00359164|Growth Substances|growth substances|mesh-ancestor
139594558|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594559|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
139594560|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139594561|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
139594562|NCT00224289|Latanoprost|latanoprost|mesh-list
139594563|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139594564|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139594565|NCT00045435|Cyclosporine|cyclosporine|mesh-list
139594566|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
139594567|NCT00045435|Fludarabine|fludarabine|mesh-list
139594568|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
139594569|NCT00045435|Cyclosporins|cyclosporins|mesh-list
139594570|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594571|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139594572|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
139594573|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594574|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139594575|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
139594576|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594577|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594578|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
139594579|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594580|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
139594581|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139594582|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139594583|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139594584|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139594585|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
139594586|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139594587|NCT00111657|Rasburicase|rasburicase|mesh-list
139594588|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
139594589|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139594590|NCT05292586|Beclomethasone|beclomethasone|mesh-list
139594591|NCT05292586|Formoterol Fumarate|formoterol fumarate|mesh-list
139594592|NCT05292586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139594593|NCT05292586|Autonomic Agents|autonomic agents|mesh-ancestor
139594594|NCT05292586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594595|NCT05292586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594596|NCT05292586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139594597|NCT05292586|Respiratory System Agents|respiratory system agents|mesh-ancestor
139594598|NCT05292586|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139594599|NCT05292586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139594600|NCT05292586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139594601|NCT05292586|Adrenergic Agents|adrenergic agents|mesh-ancestor
139594602|NCT05292586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594603|NCT05292586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594604|NCT05292586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139594605|NCT05292586|Glucocorticoids|glucocorticoids|mesh-ancestor
139594606|NCT05292586|Hormones|hormones|mesh-ancestor
139594607|NCT05292586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594608|NCT02097303|Prednisone|prednisone|mesh-list
139594609|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
139594610|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139594611|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139594612|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
139594613|NCT02097303|Hormones|hormones|mesh-ancestor
139594614|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594615|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594616|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139594617|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594618|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139594619|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594620|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594621|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
139594622|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139297194|NCT04226963|Ketamine|ketamine|mesh-list
139594623|NCT00703326|Docetaxel|docetaxel|mesh-list
139594624|NCT00703326|Ramucirumab|ramucirumab|mesh-list
139594625|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594626|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
139594627|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
139594628|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
139594629|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594630|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
139594631|NCT02097537|Miotics|miotics|mesh-ancestor
139594632|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
139594633|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594634|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722664|NCT02211417|Antimetabolites|antimetabolites|mesh-ancestor
139594635|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139594636|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139594637|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
139594638|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139594639|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139594640|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
139594641|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594642|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594643|NCT02097849|Interferons|interferons|mesh-list
139594644|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139594645|NCT02097849|Vaccines|vaccines|mesh-list
139594646|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139594647|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
139594648|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594649|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594650|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
139594651|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594652|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
139594653|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139594654|NCT00047697|Donepezil|donepezil|mesh-list
139594655|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139594656|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594657|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594658|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
139594659|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594660|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594661|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
139594662|NCT02437812|Metformin|metformin|mesh-list
139594663|NCT02437812|Paclitaxel|paclitaxel|mesh-list
139594664|NCT02437812|Carboplatin|carboplatin|mesh-list
139594665|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139594666|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594667|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
139594668|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
139594669|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
139594670|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594671|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139594672|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594673|NCT00112593|Cyclosporine|cyclosporine|mesh-list
139594674|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
139594675|NCT00112593|Fludarabine|fludarabine|mesh-list
139594676|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
139594677|NCT00112593|Cyclosporins|cyclosporins|mesh-list
139594678|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594679|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139594680|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
139594681|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594682|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139594683|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
139594684|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594685|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594686|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
139594687|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594688|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
139594689|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139594690|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139594691|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139594692|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139594693|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
139594694|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139594695|NCT05280106|Citric Acid|citric acid|mesh-list
139594696|NCT05280106|Sodium Citrate|sodium citrate|mesh-list
139594697|NCT05280106|Dialysis Solutions|dialysis solutions|mesh-list
139594698|NCT05280106|Anticoagulants|anticoagulants|mesh-ancestor
139594699|NCT05280106|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139376412|NCT02148913|Melphalan|melphalan|mesh-list
139594700|NCT05280106|Chelating Agents|chelating agents|mesh-ancestor
139594701|NCT05280106|Sequestering Agents|sequestering agents|mesh-ancestor
139594702|NCT05280106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594703|NCT05280106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139594704|NCT00112671|Sorafenib|sorafenib|mesh-list
139594705|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594706|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139594707|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594708|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594709|NCT05279092|Dexamethasone|dexamethasone|mesh-list
139594710|NCT05279092|Methylprednisolone|methylprednisolone|mesh-list
139594711|NCT05279092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139594712|NCT05279092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139594713|NCT05279092|Prednisolone|prednisolone|mesh-list
139594714|NCT05279092|Prednisolone acetate|prednisolone acetate|mesh-list
139594715|NCT05279092|Dexamethasone acetate|dexamethasone acetate|mesh-list
139594716|NCT05279092|Bupivacaine|bupivacaine|mesh-list
139594717|NCT05279092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139594718|NCT05279092|Prednisolone phosphate|prednisolone phosphate|mesh-list
139594719|NCT05279092|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139594720|NCT05279092|BB 1101|bb 1101|mesh-list
139594721|NCT05279092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139594722|NCT05279092|Antiemetics|antiemetics|mesh-ancestor
139594723|NCT05279092|Autonomic Agents|autonomic agents|mesh-ancestor
139594724|NCT05279092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594725|NCT05279092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594726|NCT05279092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139594727|NCT05279092|Glucocorticoids|glucocorticoids|mesh-ancestor
139594728|NCT05279092|Hormones|hormones|mesh-ancestor
139594729|NCT05279092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594730|NCT05279092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139594731|NCT05279092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594732|NCT05279092|Anesthetics, Local|anesthetics, local|mesh-ancestor
139594733|NCT05279092|Anesthetics|anesthetics|mesh-ancestor
139594734|NCT05279092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139594735|NCT05279092|Sensory System Agents|sensory system agents|mesh-ancestor
139594736|NCT05279092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139594737|NCT05279092|Protective Agents|protective agents|mesh-ancestor
139594738|NCT05279092|Protease Inhibitors|protease inhibitors|mesh-ancestor
139594739|NCT05279092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594740|NCT05279092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594741|NCT02437656|Metformin|metformin|mesh-list
139594742|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139594743|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594744|NCT05273632|Tranexamic Acid|tranexamic acid|mesh-list
139594745|NCT05273632|Oxytocin|oxytocin|mesh-list
139594746|NCT05273632|Oxytocics|oxytocics|mesh-ancestor
139594747|NCT05273632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139594748|NCT05273632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594749|NCT05273632|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139594750|NCT05273632|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139594751|NCT05273632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594752|NCT05273632|Hemostatics|hemostatics|mesh-ancestor
139594753|NCT05273632|Coagulants|coagulants|mesh-ancestor
139594754|NCT02429622|Paclitaxel|paclitaxel|mesh-list
139594755|NCT02429622|Nedaplatin|nedaplatin|mesh-list
139594756|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139594757|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594758|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
139594759|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
139594760|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
139594761|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594762|NCT02429466|Guadecitabine|guadecitabine|mesh-list
139594763|NCT02429466|Azacitidine|azacitidine|mesh-list
139594764|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594765|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139594766|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
139594767|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594768|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594769|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
139594770|NCT02429388|Spironolactone|spironolactone|mesh-list
139594771|NCT02429388|Diuretics|diuretics|mesh-list
139594772|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
139594773|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139594774|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
139594775|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594776|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594777|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
139594778|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139594779|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594780|NCT02429232|Pioglitazone|pioglitazone|mesh-list
139594781|NCT02429232|Linagliptin|linagliptin|mesh-list
139594782|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139594783|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594784|NCT02429232|Incretins|incretins|mesh-ancestor
139594785|NCT02429232|Hormones|hormones|mesh-ancestor
139594786|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139594787|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139594788|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
139594789|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594790|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594791|NCT03189732|Metformin|metformin|mesh-list
139594792|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139594793|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594794|NCT02437032|Menotropins|menotropins|mesh-list
139594795|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139594796|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
139594797|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139594798|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594799|NCT05232994|Metformin|metformin|mesh-list
139594800|NCT05232994|Esomeprazole|esomeprazole|mesh-list
139594801|NCT05232994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139594802|NCT05232994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594803|NCT05232994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139594804|NCT05232994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139594805|NCT05232994|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139594806|NCT05232994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594807|NCT05232994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594808|NCT02436798|Ondansetron|ondansetron|mesh-list
139594809|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
139594810|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
139594811|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594812|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594813|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139594814|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
139594815|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
139594816|NCT02436798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139594817|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139594818|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
139594819|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594820|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594821|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
139594822|NCT03185130|Promethazine|promethazine|mesh-list
139594823|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
139594824|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139594825|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139594826|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139594827|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594828|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
139594829|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
139594830|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
139594831|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594832|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
139594833|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
139594834|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139594835|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139594836|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
139594837|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
139594838|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594839|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594840|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139594841|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
139594842|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
139594843|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139594844|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139594845|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139594846|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139594847|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
139594848|NCT00358618|Propofol|propofol|mesh-list
139594849|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139594850|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139594851|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594852|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139594853|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
139594854|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
139594855|NCT02428764|Carboplatin|carboplatin|mesh-list
139594856|NCT02428764|Gemcitabine|gemcitabine|mesh-list
139594857|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
139594858|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594859|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139594860|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
139594861|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594862|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139594863|NCT00358696|Tenofovir|tenofovir|mesh-list
139594864|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
139594865|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594866|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139594867|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139594868|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594869|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594870|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139594871|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139594872|NCT05429476|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139594873|NCT05429476|Plasminogen|plasminogen|mesh-list
139594874|NCT05429476|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139594875|NCT05429476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139594876|NCT05429476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594877|NCT00360178|Amlodipine|amlodipine|mesh-list
139594878|NCT00360178|Valsartan|valsartan|mesh-list
139594879|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139594880|NCT00360178|Candesartan|candesartan|mesh-list
139594881|NCT00360178|Candesartan cilexetil|candesartan cilexetil|mesh-list
139594882|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139594883|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139594884|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139594885|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594886|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139594887|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594888|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
139594889|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139594890|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139594891|NCT00360178|Diuretics|diuretics|mesh-ancestor
138722948|NCT04528797|Hormones|hormones|mesh-ancestor
139594892|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
139594893|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139594894|NCT00421720|Sufentanil|sufentanil|mesh-list
139594895|NCT00421720|Remifentanil|remifentanil|mesh-list
139594896|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139594897|NCT00421720|Narcotics|narcotics|mesh-ancestor
139594898|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139594899|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594900|NCT00421720|Analgesics|analgesics|mesh-ancestor
139594901|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
139594902|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139594903|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139594904|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139594905|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
139594906|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
139594907|NCT05008276|Dextrans|dextrans|mesh-list
139594908|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
139594909|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
139594910|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
139594911|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
139594912|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139594913|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139594914|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139594915|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594916|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594917|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
139594918|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139594919|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139594920|NCT04492306|Protective Agents|protective agents|mesh-ancestor
139594921|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594922|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139594923|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
139594924|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594925|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
139594926|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376667|NCT02142751|Meropenem|meropenem|mesh-list
139594927|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139594928|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594929|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594930|NCT04907110|Niacinamide|niacinamide|mesh-list
139594931|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
139594932|NCT04907110|Vitamins|vitamins|mesh-ancestor
139594933|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
139594934|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594935|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
139594936|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594937|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139594938|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139594939|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594940|NCT02977000|Propranolol|propranolol|mesh-list
139594941|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139594942|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139594943|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
139594944|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594945|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594946|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594947|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139594948|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139594949|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
139594950|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
139594951|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139594952|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594953|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
139594954|NCT00112827|Melphalan|melphalan|mesh-list
139594955|NCT00112827|Lenalidomide|lenalidomide|mesh-list
139594956|NCT00112827|Lenograstim|lenograstim|mesh-list
139594957|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138722991|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
139594958|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
139594959|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594960|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139594961|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139594962|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
139594963|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594964|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594965|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139594966|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139594967|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139594968|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139594969|NCT00112827|Growth Substances|growth substances|mesh-ancestor
139594970|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
139594971|NCT04752111|Esmolol|esmolol|mesh-list
139594972|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139594973|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139594974|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139594975|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
139594976|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139594977|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594978|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139594979|NCT00226239|Docetaxel|docetaxel|mesh-list
139594980|NCT00226239|Cetuximab|cetuximab|mesh-list
139594981|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594982|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
139594983|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
139594984|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
139594985|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139594986|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139594987|NCT00227019|Vitamins|vitamins|mesh-list
139594988|NCT00227019|Folic Acid|folic acid|mesh-list
139594989|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
139594990|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
139594991|NCT00227019|Dexamethasone|dexamethasone|mesh-list
139594992|NCT00227019|Bevacizumab|bevacizumab|mesh-list
139594993|NCT00227019|Pemetrexed|pemetrexed|mesh-list
139594994|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139594995|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139594996|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139594997|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139594998|NCT00227019|Growth Substances|growth substances|mesh-ancestor
139594999|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595000|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
139595001|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
139595002|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139595003|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
139595004|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
139595005|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595006|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139595007|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
139595008|NCT00227019|Hormones|hormones|mesh-ancestor
139595009|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595010|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139595011|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595012|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595013|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139595014|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139595015|NCT00227019|Hematinics|hematinics|mesh-ancestor
139595016|NCT00113217|Bevacizumab|bevacizumab|mesh-list
139595017|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139595018|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595019|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139595020|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139595021|NCT00113217|Growth Substances|growth substances|mesh-ancestor
139595022|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595023|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
139595024|NCT04718116|Tramadol|tramadol|mesh-list
139595025|NCT04718116|Tapentadol|tapentadol|mesh-list
139595026|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139595027|NCT04718116|Narcotics|narcotics|mesh-ancestor
139595028|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139595029|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595030|NCT04718116|Analgesics|analgesics|mesh-ancestor
139595031|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
139595032|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595033|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139595034|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139595035|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139595036|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595037|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
139595038|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595039|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
139595040|NCT04276792|Narcotics|narcotics|mesh-ancestor
139595041|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139595042|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595043|NCT04276792|Analgesics|analgesics|mesh-ancestor
139595044|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
139595045|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595046|NCT00053703|Olanzapine|olanzapine|mesh-list
139595047|NCT00053703|Risperidone|risperidone|mesh-list
139595048|NCT00053703|Molindone|molindone|mesh-list
139595049|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139595050|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
139595051|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595052|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595053|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595054|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139595055|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139595056|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139595057|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139595058|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139595059|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
139595060|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
139595061|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
139595062|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595063|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139595064|NCT00053703|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139595065|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139595066|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139595067|NCT02975440|Rifampin|rifampin|mesh-list
139595068|NCT02975440|Midazolam|midazolam|mesh-list
139595069|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139595070|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139595071|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139595072|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723123|NCT01203787|Sorafenib|sorafenib|mesh-list
139595073|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139595074|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139595075|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139595076|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139595077|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
139595078|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
139595079|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
139595080|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
139595081|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595082|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595083|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139595084|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
139595085|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139595086|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139595087|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
139595088|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139595089|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595090|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139595091|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139595092|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139595093|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139595094|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139595095|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139595096|NCT00231309|Lenograstim|lenograstim|mesh-list
139595097|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139595098|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
139595099|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595100|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
139595101|NCT04267120|Lenvatinib|lenvatinib|mesh-list
139595102|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139595103|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595104|NCT04267120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139595105|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595106|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139595107|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595108|NCT00232479|Carboplatin|carboplatin|mesh-list
139595109|NCT00232479|Docetaxel|docetaxel|mesh-list
139595110|NCT00232479|Trastuzumab|trastuzumab|mesh-list
139595111|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595112|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
139595113|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
139595114|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
139595115|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595116|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139595117|NCT00233103|Sertraline|sertraline|mesh-list
139595118|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
139595119|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139595120|NCT00233103|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139595121|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139595122|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139595123|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595124|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595125|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
139595126|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595127|NCT00703014|Progesterone|progesterone|mesh-list
139595128|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139595129|NCT00703014|Ganirelix|ganirelix|mesh-list
139595130|NCT00703014|Progestins|progestins|mesh-ancestor
139595131|NCT00703014|Hormones|hormones|mesh-ancestor
139595132|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595133|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723172|NCT01580033|Vaccines|vaccines|mesh-list
139595134|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
139595135|NCT02433522|Rituximab|rituximab|mesh-list
139595136|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139595137|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595138|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
139595139|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595140|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139595141|NCT02433912|Acetaminophen|acetaminophen|mesh-list
139595142|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
139595143|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139595144|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139595145|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139595146|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
139595147|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
139595148|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139595149|NCT02433912|Analgesics|analgesics|mesh-ancestor
139595150|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
139376877|NCT03118713|Metformin|metformin|mesh-list
139595151|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595152|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595154|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
139595155|NCT02436486|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
139595156|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139595157|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139595158|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139595159|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139595160|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595161|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595162|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595163|NCT02436486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595164|NCT02436486|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139595165|NCT02436486|Serotonin Agents|serotonin agents|mesh-ancestor
139595166|NCT02436486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595167|NCT04342858|Listerine|listerine|mesh-list
139595168|NCT04342858|Fluorides|fluorides|mesh-list
139595169|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
139595170|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
139595171|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595172|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
139595173|NCT04342858|Protective Agents|protective agents|mesh-ancestor
139595174|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139595175|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139595176|NCT02429076|Propofol|propofol|mesh-list
139595177|NCT02429076|Sevoflurane|sevoflurane|mesh-list
139595178|NCT02429076|Methylphenidate|methylphenidate|mesh-list
139595179|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139595180|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139595181|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595182|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139595183|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
139595184|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
139595185|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139595186|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139595187|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139595188|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139595189|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139595190|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139595191|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595192|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
139595193|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595194|NCT00255177|Mifepristone|mifepristone|mesh-list
139595195|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139595196|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
139595197|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139595198|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723233|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139595199|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139595200|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139595201|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139595202|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
139595203|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139595204|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139595205|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
139595206|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595207|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
139595208|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139595209|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139595210|NCT04670224|Anesthetics|anesthetics|mesh-list
139595211|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139595212|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595213|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
139595214|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
139595215|NCT00361114|Dapsone|dapsone|mesh-list
139595216|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139595217|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
139595218|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
139595219|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139595220|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139595221|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139595222|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139595223|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595224|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595225|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139595226|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
139595227|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139595228|NCT00702624|Hormones|hormones|mesh-list
139595229|NCT00702624|Progesterone|progesterone|mesh-list
139595230|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139595231|NCT00702624|Ganirelix|ganirelix|mesh-list
139595232|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595233|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595234|NCT00702624|Progestins|progestins|mesh-ancestor
139595235|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
139595236|NCT03915496|Abrocitinib|abrocitinib|mesh-list
139595237|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139595238|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595239|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595240|NCT00702546|Hormones|hormones|mesh-list
139595241|NCT00702546|Progesterone|progesterone|mesh-list
139595242|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139595243|NCT00702546|Ganirelix|ganirelix|mesh-list
139595244|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595245|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595246|NCT00702546|Progestins|progestins|mesh-ancestor
139595247|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
139595248|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
139595249|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139595250|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
139595251|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595252|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595253|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139595254|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
139595255|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
139595256|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139595257|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
139595258|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595259|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595260|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
139595261|NCT02428686|Hematinics|hematinics|mesh-ancestor
139595262|NCT02432976|Insulin|insulin|mesh-list
139595263|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139595264|NCT02432976|Exenatide|exenatide|mesh-list
139595265|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
139595266|NCT02432976|Incretins|incretins|mesh-list
139595267|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139595268|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595269|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139595270|NCT02432976|Hormones|hormones|mesh-ancestor
139595271|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595272|NCT02428374|Clopidogrel|clopidogrel|mesh-list
139595273|NCT02428374|Ticagrelor|ticagrelor|mesh-list
139595274|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139595275|NCT02428374|Simvastatin|simvastatin|mesh-list
139595276|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139595277|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139595278|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139595279|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139595280|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
139595281|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595282|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595283|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595284|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139595285|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139595286|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
139595287|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139595288|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139595289|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595290|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139595291|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
139595292|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139595293|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
139595294|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595295|NCT04606576|Insulin|insulin|mesh-list
139595296|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139595297|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139595298|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595299|NCT02428062|Phenylephrine|phenylephrine|mesh-list
139595300|NCT02428062|Dopamine|dopamine|mesh-list
139595301|NCT02428062|Epinephrine|epinephrine|mesh-list
139595302|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
139595303|NCT02428062|Norepinephrine|norepinephrine|mesh-list
139595304|NCT02428062|Ephedrine|ephedrine|mesh-list
139595305|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139595306|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595307|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139595308|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139595309|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
139595310|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595311|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595312|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139595313|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139595314|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
139595315|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595316|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139595317|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
139595318|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
139595319|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
139595320|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139595321|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
139595322|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139595323|NCT02428062|Protective Agents|protective agents|mesh-ancestor
139595324|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139595325|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
139595326|NCT04594798|Prednisone|prednisone|mesh-list
139595327|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
139595328|NCT04594798|Rituximab|rituximab|mesh-list
139595329|NCT04594798|Doxorubicin|doxorubicin|mesh-list
139595330|NCT04594798|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139595331|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139595332|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
139595333|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595334|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139595335|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139595336|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
139595337|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595338|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595339|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139595340|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139595341|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139595342|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139595343|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139595344|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595345|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139595346|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
139595347|NCT04594798|Hormones|hormones|mesh-ancestor
139595348|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595349|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139595350|NCT04594798|Immunoconjugates|immunoconjugates|mesh-ancestor
139595351|NCT02432664|Midazolam|midazolam|mesh-list
139595352|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139595353|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139595354|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139595355|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595356|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139595357|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139595358|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139595359|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139595360|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
139595361|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
139595362|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
139595363|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
139595364|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595365|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595366|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
139595367|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139595368|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595369|NCT03189186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139595370|NCT03189186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595371|NCT00361894|Enoxaparin|enoxaparin|mesh-list
139595372|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
139595373|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139595374|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
139595375|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139595376|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
139595377|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377097|NCT03202719|Vaccines|vaccines|mesh-list
138723416|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
139595378|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595379|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
139595380|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139595381|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139595382|NCT03185988|Trastuzumab|trastuzumab|mesh-list
139595383|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139595384|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595385|NCT00361348|Heparin|heparin|mesh-list
139595386|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
139595387|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139595388|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139595389|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595390|NCT02431728|Melatonin|melatonin|mesh-list
139595391|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
139595392|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595393|NCT02431728|Protective Agents|protective agents|mesh-ancestor
139595394|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595395|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139595396|NCT04343326|Menthol|menthol|mesh-list
139595397|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
139595398|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
139595399|NCT00362206|Simvastatin|simvastatin|mesh-list
139595400|NCT00362206|Pravastatin|pravastatin|mesh-list
139595401|NCT00362206|Fenofibrate|fenofibrate|mesh-list
139595402|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139595403|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139595404|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
139595405|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595406|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139595407|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139595408|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595409|NCT02314468|Glycerol|glycerol|mesh-list
139595410|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139595411|NCT02314468|Protective Agents|protective agents|mesh-ancestor
139595412|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595413|NCT01704287|Paclitaxel|paclitaxel|mesh-list
139595414|NCT01704287|Carboplatin|carboplatin|mesh-list
139595415|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
139595416|NCT01704287|Temozolomide|temozolomide|mesh-list
139595417|NCT01704287|Dacarbazine|dacarbazine|mesh-list
139595418|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139595419|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595420|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
139595421|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
139595422|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
139595423|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595424|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139595425|NCT01704287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139595426|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139595427|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
139595428|NCT00362752|Norfloxacin|norfloxacin|mesh-list
139595429|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139595430|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139595431|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139595432|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139595433|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595434|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595435|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595436|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139595437|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139595438|NCT00118209|Prednisone|prednisone|mesh-list
139595439|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
139595440|NCT00118209|Rituximab|rituximab|mesh-list
139595441|NCT00118209|Doxorubicin|doxorubicin|mesh-list
139595442|NCT00118209|Etoposide|etoposide|mesh-list
139595443|NCT00118209|Vincristine|vincristine|mesh-list
139595444|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139595445|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
139595446|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595447|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139595448|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139595449|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
139595450|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595451|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595452|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139595453|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139595454|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139595455|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139595456|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139595457|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595458|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139595459|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
139595460|NCT00118209|Hormones|hormones|mesh-ancestor
139595461|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595462|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139595463|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139595464|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
139595465|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
139595466|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
139595467|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
139595468|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595469|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595470|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139595471|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139595472|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
139595473|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
139595474|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139595475|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139595476|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139595477|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595478|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595479|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139595480|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
139595481|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
139595482|NCT01682837|Citric Acid|citric acid|mesh-list
139595483|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
139595484|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
139595485|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139595486|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
139595487|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
139595488|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595489|NCT01682837|Diuretics|diuretics|mesh-ancestor
139595490|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
139595491|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595492|NCT01682837|Expectorants|expectorants|mesh-ancestor
139595493|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
139595494|NCT01682837|Cathartics|cathartics|mesh-ancestor
139595495|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139595496|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
139595497|NCT02213068|Abatacept|abatacept|mesh-list
139595498|NCT02213068|Tacrolimus|tacrolimus|mesh-list
139595499|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139595500|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
139595501|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595502|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139595503|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595504|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595505|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139595506|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595507|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139595508|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
139595509|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139595510|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139595511|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139595512|NCT02213068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139595513|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139595514|NCT00702234|Progesterone|progesterone|mesh-list
139595515|NCT00702234|Progestins|progestins|mesh-ancestor
139595516|NCT00702234|Hormones|hormones|mesh-ancestor
139595517|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595518|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595519|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
139595520|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139595521|NCT04483284|Estrogens|estrogens|mesh-ancestor
139595522|NCT04483284|Hormones|hormones|mesh-ancestor
139595523|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595524|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595525|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139595526|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595527|NCT00235833|Adalimumab|adalimumab|mesh-list
139377253|NCT03196479|Ketamine|ketamine|mesh-list
139595528|NCT00235833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139595529|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139595530|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139595532|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139595533|NCT00255801|Bexarotene|bexarotene|mesh-list
139595534|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139595535|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595536|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139595537|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139595538|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595539|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595540|NCT02431416|Hormones|hormones|mesh-list
139595541|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595542|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595543|NCT01682759|Metformin|metformin|mesh-list
139595544|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
139595545|NCT01682759|Glimepiride|glimepiride|mesh-list
139595546|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139595547|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595548|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139595549|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139595550|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
139595551|NCT01682681|Topiramate|topiramate|mesh-list
139595552|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
139595553|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139595554|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595555|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
139595556|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139595557|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139595558|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139595559|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139595560|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595561|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
139595562|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595563|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595564|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139595565|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595566|NCT03183024|Benralizumab|benralizumab|mesh-list
139595567|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139595568|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
139595569|NCT00240981|Testosterone|testosterone|mesh-list
139595570|NCT00240981|Androgens|androgens|mesh-ancestor
139595571|NCT00240981|Hormones|hormones|mesh-ancestor
139595572|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595573|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595574|NCT01682213|Dabrafenib|dabrafenib|mesh-list
139595575|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595576|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139595577|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595578|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595579|NCT02126553|Lenalidomide|lenalidomide|mesh-list
139595580|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
139595581|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595582|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139595583|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139595584|NCT02126553|Growth Substances|growth substances|mesh-ancestor
139595585|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
139595586|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595587|NCT01703741|Testosterone|testosterone|mesh-list
139595588|NCT01703741|Androgens|androgens|mesh-ancestor
139595589|NCT01703741|Hormones|hormones|mesh-ancestor
139595590|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595591|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595592|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
139595593|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139595594|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139595595|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139595596|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139595597|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139595598|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595599|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
139595600|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595601|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595602|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139377323|NCT02444949|Cisplatin|cisplatin|mesh-list
139595603|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595604|NCT02430714|Lenvatinib|lenvatinib|mesh-list
139595605|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595606|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139595607|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595608|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595609|NCT02425254|Acetaminophen|acetaminophen|mesh-list
139595610|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139595611|NCT02425254|Analgesics|analgesics|mesh-ancestor
139595612|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
139595613|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595614|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595615|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
139595616|NCT02426736|Dexamethasone|dexamethasone|mesh-list
139595617|NCT02426736|Bupivacaine|bupivacaine|mesh-list
139595618|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139595619|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
139595620|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
139595621|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595622|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595623|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139595624|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
139595625|NCT02426736|Hormones|hormones|mesh-ancestor
139595626|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595627|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139595628|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595629|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
139595630|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
139595631|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139595632|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
139595633|NCT03182634|Fulvestrant|fulvestrant|mesh-list
139595634|NCT03182634|Olaparib|olaparib|mesh-list
139595635|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139595636|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595637|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139595638|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139595639|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
139595640|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595641|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595642|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139595643|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595644|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595645|NCT03182322|Insulin|insulin|mesh-list
139595646|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139595647|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595648|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
139595649|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595650|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
139595651|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139595652|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139595653|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595654|NCT03185364|Urological Agents|urological agents|mesh-ancestor
139595655|NCT02424552|Vitamin D|vitamin d|mesh-list
139595656|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
139595657|NCT02424552|Vitamins|vitamins|mesh-ancestor
139595658|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
139595659|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595660|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138723706|NCT01202227|Pregabalin|pregabalin|mesh-list
139595661|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139595662|NCT03182088|Norepinephrine|norepinephrine|mesh-list
139595663|NCT03182088|Bupivacaine|bupivacaine|mesh-list
139595664|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
139595665|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
139595666|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139595667|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595668|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
139595669|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595670|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139595671|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139595672|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
139595673|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595674|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595675|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
139595676|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
139595677|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139595678|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
139595679|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139595680|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
139595681|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139595682|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595683|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139595684|NCT02425722|Linaclotide|linaclotide|mesh-list
139595685|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139595686|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
139595687|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595688|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139595689|NCT02061514|Propofol|propofol|mesh-list
139595690|NCT02061514|Desflurane|desflurane|mesh-list
139595691|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139595692|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139595693|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595694|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139595695|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
139595696|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
139595697|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139595698|NCT03183492|Vaccines|vaccines|mesh-list
139595699|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
139595700|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595701|NCT02424318|Topiramate|topiramate|mesh-list
139595702|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
139595703|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139595704|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595705|NCT03179280|Insulin|insulin|mesh-list
139595706|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
139595707|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139595708|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595709|NCT01681433|Prednisone|prednisone|mesh-list
139595710|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
139595711|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139595712|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
139595713|NCT01681433|Hormones|hormones|mesh-ancestor
139595714|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595715|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595716|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139595717|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595718|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139595719|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595720|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595721|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
139595722|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139595723|NCT01703117|Riluzole|riluzole|mesh-list
139595724|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
139595725|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139595726|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139595727|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595728|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595729|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595730|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139595731|NCT01703117|Protective Agents|protective agents|mesh-ancestor
139595732|NCT01702961|Cytarabine|cytarabine|mesh-list
139595733|NCT01702961|Etoposide|etoposide|mesh-list
139595734|NCT01702961|Rituximab|rituximab|mesh-list
139595735|NCT01702961|Melphalan|melphalan|mesh-list
139595736|NCT01702961|Carmustine|carmustine|mesh-list
139595737|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139595738|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595739|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139595740|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139595741|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595742|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595743|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139595744|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
139595745|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
139595746|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139595747|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139595748|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
139595749|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595750|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139595751|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139595752|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139595753|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
139595754|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139595755|NCT01702025|Aminophylline|aminophylline|mesh-list
139595756|NCT01702025|Methazolamide|methazolamide|mesh-list
139595757|NCT01702025|Theophylline|theophylline|mesh-list
139595758|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139595759|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
139595760|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595761|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595762|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139595763|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
139595764|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139595765|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595766|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595767|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
139595768|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139595769|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139595770|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
139595771|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595772|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139595773|NCT01702025|Protective Agents|protective agents|mesh-ancestor
139595774|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139595775|NCT01702025|Diuretics|diuretics|mesh-ancestor
139595776|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
139595777|NCT01592747|Memantine|memantine|mesh-list
139595778|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139595779|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139595780|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
139595781|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595782|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595783|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595784|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139595785|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139595786|NCT02425488|Coal Tar|coal tar|mesh-list
139595787|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
139595788|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
139595789|NCT02426112|Azithromycin|azithromycin|mesh-list
139595790|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139595791|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139595792|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
139595793|NCT03117192|Astringents|astringents|mesh-ancestor
139595794|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595795|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
139595796|NCT04768439|Vitamin D|vitamin d|mesh-list
139595797|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
139595798|NCT04768439|Cholecalciferol|cholecalciferol|mesh-list
139595799|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
139595800|NCT04768439|Calcitriol|calcitriol|mesh-list
139595801|NCT04768439|Vitamins|vitamins|mesh-list
139595802|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
139595803|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595804|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139595805|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139595806|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139595807|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139595808|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595809|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139595810|NCT02421042|Lenvatinib|lenvatinib|mesh-list
139595811|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595812|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139595813|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595814|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595815|NCT03181464|Lidocaine|lidocaine|mesh-list
139595816|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
139595817|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
139595818|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139595819|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595820|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
139595821|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595822|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139595823|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139595824|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139595825|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139595826|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595827|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
139595828|NCT02423928|Ipilimumab|ipilimumab|mesh-list
139595829|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139595830|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
139595831|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595832|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139595833|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139595834|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
139595835|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595836|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595837|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139595838|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139595839|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139595840|NCT03106740|Minocycline|minocycline|mesh-list
139595841|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139595842|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139595843|NCT03106818|Ketorolac|ketorolac|mesh-list
139595844|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
139595845|NCT03106818|Bupivacaine|bupivacaine|mesh-list
139595846|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
139595847|NCT03106818|Anesthetics|anesthetics|mesh-list
139595848|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139595849|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595850|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
139595851|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595852|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139595853|NCT03106818|Analgesics|analgesics|mesh-ancestor
139595854|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139595855|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139595856|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139595857|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139595858|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595859|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595860|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139595861|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
139595862|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139595863|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139595864|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139595865|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
139595866|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139595867|NCT01592045|Aldesleukin|aldesleukin|mesh-list
139595868|NCT01592045|Molgramostim|molgramostim|mesh-list
139595869|NCT01592045|Dinutuximab|dinutuximab|mesh-list
139595870|NCT01592045|Isotretinoin|isotretinoin|mesh-list
139595871|NCT01592045|Sargramostim|sargramostim|mesh-list
139595872|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595873|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139595874|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139595875|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
139595876|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139595877|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
139595878|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
139595879|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595880|NCT03178656|Sorafenib|sorafenib|mesh-list
139595881|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139595882|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139595883|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595884|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595885|NCT01590797|Metformin|metformin|mesh-list
139595886|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139595887|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139595888|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595889|NCT01590797|Incretins|incretins|mesh-ancestor
139595890|NCT01590797|Hormones|hormones|mesh-ancestor
139595891|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139595892|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139595893|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
139595894|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595895|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595896|NCT02415192|Amlodipine|amlodipine|mesh-list
139595897|NCT02415192|Valsartan|valsartan|mesh-list
139595898|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139595899|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139595900|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139595901|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595902|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139595903|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595904|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
139595905|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139595906|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139595907|NCT02415270|Menthol|menthol|mesh-list
139595908|NCT02415270|Nicotine|nicotine|mesh-list
139595909|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139595910|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
139595911|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595912|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595913|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139595914|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139595915|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
139595916|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595917|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595918|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
139595919|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
139595920|NCT02415114|Resveratrol|resveratrol|mesh-list
139595921|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
139595922|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595923|NCT02415114|Protective Agents|protective agents|mesh-ancestor
139595924|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595925|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595926|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139595927|NCT03178422|Nicotine|nicotine|mesh-list
139595928|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139595929|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
139595930|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595931|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595932|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139595933|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139595934|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
139595935|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595936|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595937|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139595938|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139595939|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139595940|NCT02414880|Rocuronium|rocuronium|mesh-list
139595941|NCT02414880|Neostigmine|neostigmine|mesh-list
139595942|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139595943|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139595944|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139595945|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595946|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595947|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139595948|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139595949|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595950|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
139595951|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595952|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139595953|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
139595954|NCT02423694|Dexetimide|dexetimide|mesh-list
139595955|NCT02423694|Citalopram|citalopram|mesh-list
139595956|NCT02423694|Escitalopram|escitalopram|mesh-list
139595957|NCT02423694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139595958|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139595959|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139595960|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595961|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139595962|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
139595963|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595964|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139595965|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139595966|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
139595967|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
139595968|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139595969|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139595970|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139595971|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
139595972|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139595973|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
138724017|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
139595974|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139595975|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
139595976|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139595977|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
139595978|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297195|NCT04226963|Analgesics|analgesics|mesh-ancestor
139595979|NCT02420418|Expectorants|expectorants|mesh-ancestor
139595980|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
139595981|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139595982|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
139595983|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139595984|NCT02420418|Protective Agents|protective agents|mesh-ancestor
139595985|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595986|NCT02420418|Antidotes|antidotes|mesh-ancestor
139595987|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
139595988|NCT02414802|Heparin|heparin|mesh-list
139595989|NCT02414802|Calcium heparin|calcium heparin|mesh-list
139595990|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139595991|NCT02414802|Tinzaparin|tinzaparin|mesh-list
139595992|NCT02414802|Dalteparin|dalteparin|mesh-list
139595993|NCT02414802|Calcium|calcium|mesh-list
139595994|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139595995|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139595996|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139595997|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
139595998|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139595999|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139596000|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596001|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
139596002|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139596003|NCT01701401|Ledipasvir|ledipasvir|mesh-list
139596004|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
139596005|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139596006|NCT04482504|Vitamin D|vitamin d|mesh-list
139596007|NCT04482504|Vitamins|vitamins|mesh-ancestor
139596008|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
139596009|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596010|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139596011|NCT02414568|Prednisone|prednisone|mesh-list
139596012|NCT02414568|Doxorubicin|doxorubicin|mesh-list
139596013|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139596014|NCT02414568|Vinblastine|vinblastine|mesh-list
139596015|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139596016|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596017|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139596018|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139596019|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596020|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596021|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139596022|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
139596023|NCT02414568|Hormones|hormones|mesh-ancestor
139596024|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139596025|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596026|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139596027|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139596028|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
139596029|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139596030|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
139596031|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
139596032|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
139596033|NCT04348877|Antibodies|antibodies|mesh-list
139596034|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
139596035|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596036|NCT03176628|Niacinamide|niacinamide|mesh-list
139596037|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
139596038|NCT03176628|Vitamins|vitamins|mesh-ancestor
139596039|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
139596040|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596041|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
139596042|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139596043|NCT02414490|Antibodies|antibodies|mesh-list
139596044|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
139596045|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139596046|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
139596047|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596048|NCT01590017|Cisplatin|cisplatin|mesh-list
139596049|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596050|NCT01700621|Vaccines|vaccines|mesh-list
139596051|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
139596052|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596053|NCT03178500|Clomiphene|clomiphene|mesh-list
139596054|NCT03178500|Enclomiphene|enclomiphene|mesh-list
139596055|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
139596056|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139596057|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
139596058|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139596059|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596060|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139596061|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
139596062|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139596063|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139596064|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139596066|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
139596067|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139596068|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139596069|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139596070|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139596071|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596072|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
139596073|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596074|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596075|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139596076|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596077|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
139596078|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139596079|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
139596080|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139596081|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139596082|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139596083|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
139596084|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596085|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596086|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596087|NCT01587989|Methotrexate|methotrexate|mesh-list
139596088|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139596089|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
139596090|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139596091|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596092|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139596093|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
139596094|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596095|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596096|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
139596097|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596098|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139596099|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139596100|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
139596101|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139596102|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139596103|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139596104|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139596105|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139596106|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139596107|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139596108|NCT01697969|Analgesics|analgesics|mesh-ancestor
139596109|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
139596110|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596111|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596112|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139596113|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139596114|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139596115|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139596116|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139596117|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
139596118|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
139596119|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596120|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596121|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
139596122|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139596123|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139596124|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596125|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
139596126|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596127|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596128|NCT01697579|Ondansetron|ondansetron|mesh-list
139377851|NCT04908566|Folfirinox|folfirinox|mesh-list
139596130|NCT01697579|Aprepitant|aprepitant|mesh-list
139596131|NCT01697579|Serotonin|serotonin|mesh-list
139596132|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
139596133|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
139596134|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596135|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596136|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139596137|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
139596138|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
139596139|NCT01697579|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139596140|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139596141|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
139596142|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596143|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596144|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139596145|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139596146|NCT01586195|Vemurafenib|vemurafenib|mesh-list
139596147|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596148|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139596149|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596150|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596151|NCT01697345|Testosterone|testosterone|mesh-list
139596152|NCT01697345|Androgens|androgens|mesh-ancestor
139596153|NCT01697345|Hormones|hormones|mesh-ancestor
139596154|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139596155|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596156|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
139596157|NCT03467386|Tacrolimus|tacrolimus|mesh-list
139596158|NCT03467386|Lenograstim|lenograstim|mesh-list
139596159|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139596160|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
139596161|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596162|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139596163|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139596164|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
139596165|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596166|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596167|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139596168|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139596169|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139596170|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596171|NCT03465592|Nivolumab|nivolumab|mesh-list
139596172|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139596173|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596174|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139596175|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596176|NCT02441062|Edotreotide|edotreotide|mesh-list
139596177|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139596178|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596179|NCT02442700|Pitavastatin|pitavastatin|mesh-list
139596180|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139596181|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139596182|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139596183|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
139596184|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596185|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596186|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139596187|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
139596188|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139596189|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596190|NCT00568672|Olanzapine|olanzapine|mesh-list
139596191|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
139596192|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
139596193|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596194|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596195|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139596196|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139596197|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139596198|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596199|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139596200|NCT00568672|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139596201|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139377924|NCT04907474|Phenylephrine|phenylephrine|mesh-list
139596202|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139596203|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596204|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596205|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
139596206|NCT02448862|Fentanyl|fentanyl|mesh-list
139596207|NCT02448862|Analgesics|analgesics|mesh-list
139596208|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139596209|NCT02448862|Narcotics|narcotics|mesh-ancestor
139596210|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596211|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596212|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
139596213|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596214|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139596215|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139596216|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
139596217|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
139596218|NCT01697267|Rituximab|rituximab|mesh-list
139596219|NCT01697267|Azathioprine|azathioprine|mesh-list
139596220|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139596221|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596222|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
139596223|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596224|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139596225|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
139596226|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596227|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139596228|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139596229|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
139596230|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139596231|NCT00362986|Protective Agents|protective agents|mesh-ancestor
139596232|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596233|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
139596234|NCT00363376|Zonisamide|zonisamide|mesh-list
139596235|NCT00363376|Olanzapine|olanzapine|mesh-list
139596236|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
139596237|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
139596238|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596239|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596240|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139596241|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139596242|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139596243|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596244|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139596245|NCT00363376|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139596246|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139596247|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139596248|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596249|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596250|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
139596251|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
139596252|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139596253|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139596254|NCT02451202|Rocuronium|rocuronium|mesh-list
139596255|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139596256|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139596257|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139596258|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596259|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596260|NCT02452060|Ketamine|ketamine|mesh-list
139596261|NCT02452060|Analgesics|analgesics|mesh-ancestor
139596262|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
139596263|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596264|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596265|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139596266|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139596267|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
139596268|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
139596269|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596270|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139596271|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139596272|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596273|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596274|NCT01696955|Cetuximab|cetuximab|mesh-list
139596275|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139596276|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596277|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
139596278|NCT02452528|Promethazine|promethazine|mesh-list
139596279|NCT02452528|Tenofovir|tenofovir|mesh-list
139596280|NCT02452528|Entecavir|entecavir|mesh-list
139596281|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
139596282|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139596283|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139596284|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139596285|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724331|NCT01199731|Etravirine|etravirine|mesh-list
139596286|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596287|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139596288|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139596289|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139596290|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139596291|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596292|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596293|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
139596294|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
139596295|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
139596296|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596297|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
139596298|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
139596299|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139596300|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139596301|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
139596302|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
139596303|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596304|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139596305|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
139596306|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
139596307|NCT02702388|Lenvatinib|lenvatinib|mesh-list
139596308|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596309|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139596310|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596311|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596312|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
139596313|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
139596314|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139596315|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139596316|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139596317|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596318|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139596319|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139596320|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
139596321|NCT01696877|Molgramostim|molgramostim|mesh-list
139596322|NCT01696877|Sargramostim|sargramostim|mesh-list
139596323|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139596324|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
139596325|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596326|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139596327|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139596328|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
139596329|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596330|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596331|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139596332|NCT02416102|Losartan|losartan|mesh-list
139596333|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139596334|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139596335|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139596336|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139596337|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596338|NCT02414256|Anesthetics|anesthetics|mesh-list
139596339|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596340|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596341|NCT02458768|Menotropins|menotropins|mesh-list
139596342|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139596343|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
139596344|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139596345|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596346|NCT02418676|Insulin|insulin|mesh-list
139596347|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139596348|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596349|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139596350|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
139596351|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139596352|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
139596353|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596354|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
139596355|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139596356|NCT02422836|Protective Agents|protective agents|mesh-ancestor
139596357|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596358|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
139596360|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139596361|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
139596362|NCT00707304|Lactoferrin|lactoferrin|mesh-list
139596363|NCT00707304|Talactoferrin alfa|talactoferrin alfa|mesh-list
139596364|NCT00707304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139596365|NCT00707304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596366|NCT02423980|Glucagon|glucagon|mesh-list
139596367|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139596368|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139596369|NCT02423980|Hormones|hormones|mesh-ancestor
139596370|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139596371|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596372|NCT02423980|Incretins|incretins|mesh-ancestor
139596373|NCT03176316|Naloxone|naloxone|mesh-list
139596374|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139596375|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596376|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
139596377|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596378|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
139596379|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139596380|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
139596381|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596382|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139596383|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139596384|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
139596385|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596386|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596387|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139596388|NCT02974426|Cisplatin|cisplatin|mesh-list
139596389|NCT02974426|Carboplatin|carboplatin|mesh-list
139596390|NCT02974426|Pemetrexed|pemetrexed|mesh-list
139596391|NCT02974426|Vinorelbine|vinorelbine|mesh-list
139596392|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596393|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596394|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596395|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139596396|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139596397|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139596398|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
139596399|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
139596400|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
139596401|NCT02413554|Rivastigmine|rivastigmine|mesh-list
139596402|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139596403|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596404|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596405|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
139596406|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596407|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596408|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139596409|NCT02413554|Protective Agents|protective agents|mesh-ancestor
139596410|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
139596411|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139596412|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
139596413|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139596414|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
139596415|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596416|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596417|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
139596418|NCT02465632|Clindamycin|clindamycin|mesh-list
139596419|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
139596420|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
139596421|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139596422|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139596423|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139596424|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139596425|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378151|NCT02145091|Psilocybin|psilocybin|mesh-list
139596426|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596427|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
139596428|NCT02703636|Rivastigmine|rivastigmine|mesh-list
139596429|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139596430|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596431|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596432|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
139596433|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596434|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596435|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139596436|NCT02703636|Protective Agents|protective agents|mesh-ancestor
139596437|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
139596438|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139596439|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139596440|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596441|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
139596442|NCT02422056|Coagulants|coagulants|mesh-ancestor
139596443|NCT02466958|Milnacipran|milnacipran|mesh-list
139596444|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
139596445|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139596446|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139596447|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139596448|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596449|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596450|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596451|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
139596452|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139596453|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139596454|NCT02466958|Analgesics|analgesics|mesh-ancestor
139596455|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
139596456|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596457|NCT02467504|Folic Acid|folic acid|mesh-list
139596458|NCT02467504|Loxoprofen|loxoprofen|mesh-list
139596459|NCT02467504|Hematinics|hematinics|mesh-ancestor
139596460|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
139596461|NCT02467504|Vitamins|vitamins|mesh-ancestor
139596462|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
139596463|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596464|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139596465|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139596466|NCT02467504|Analgesics|analgesics|mesh-ancestor
139596467|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
139596468|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596469|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139596470|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139596471|NCT02413086|Chitosan|chitosan|mesh-list
139596472|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139596473|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139596474|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
139596475|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596476|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139596477|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
139596478|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
139596479|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
139596480|NCT02413086|Coagulants|coagulants|mesh-ancestor
139596481|NCT02468830|Mirabegron|mirabegron|mesh-list
139596482|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139596483|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139596484|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139596485|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
139596486|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596487|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596488|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596489|NCT02468830|Urological Agents|urological agents|mesh-ancestor
139596490|NCT02470234|Methylphenidate|methylphenidate|mesh-list
139596491|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139596492|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596493|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139596494|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139596495|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139596496|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596497|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
139596498|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596499|NCT02418702|Ketamine|ketamine|mesh-list
139378226|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
139596500|NCT02418702|Analgesics|analgesics|mesh-ancestor
139596501|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
139596502|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596503|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596504|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139596505|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139596506|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
139596507|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
139596508|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596509|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139596510|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139596511|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596512|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596513|NCT02412930|Tramadol|tramadol|mesh-list
139596514|NCT02412930|Bupivacaine|bupivacaine|mesh-list
139596515|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
139596516|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
139596517|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596518|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596519|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
139596520|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596521|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139596522|NCT02412930|Narcotics|narcotics|mesh-ancestor
139596523|NCT02412930|Analgesics|analgesics|mesh-ancestor
139596524|NCT02432716|Insulin|insulin|mesh-list
139596525|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139596526|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
139596527|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139596528|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596529|NCT02418624|Carboplatin|carboplatin|mesh-list
139596530|NCT02418624|Olaparib|olaparib|mesh-list
139596531|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596532|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139596533|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596534|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596535|NCT02440204|Remifentanil|remifentanil|mesh-list
139596536|NCT02440204|Sevoflurane|sevoflurane|mesh-list
139596537|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139596538|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139596539|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
139596540|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
139596541|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596542|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596543|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139596544|NCT02440204|Narcotics|narcotics|mesh-ancestor
139596545|NCT02440204|Analgesics|analgesics|mesh-ancestor
139596546|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
139596547|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596548|NCT02410590|Atropine|atropine|mesh-list
139596549|NCT02410590|Rocuronium|rocuronium|mesh-list
139596550|NCT02410590|Cisatracurium|cisatracurium|mesh-list
139596551|NCT02410590|Succinylcholine|succinylcholine|mesh-list
139596552|NCT02410590|Neostigmine|neostigmine|mesh-list
139596553|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139596554|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139596555|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139596556|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596557|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596558|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139596559|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139596560|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139596561|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
139596562|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139596563|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
139596564|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
139596565|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
139596566|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139596567|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139596568|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
139596569|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596570|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596571|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139596572|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596573|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139596574|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139378317|NCT02153125|Eplerenone|eplerenone|mesh-list
139596575|NCT02517580|Vitamin K|vitamin k|mesh-list
139596576|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
139596577|NCT02517580|Vitamins|vitamins|mesh-ancestor
139596578|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
139596579|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596580|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139596581|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139596582|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596583|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
139596584|NCT02517580|Coagulants|coagulants|mesh-ancestor
139596585|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
139596586|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596587|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
139596588|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596589|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596590|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139596591|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
139596592|NCT02412150|Remifentanil|remifentanil|mesh-list
139596593|NCT02412150|Desflurane|desflurane|mesh-list
139596594|NCT02412150|Anesthetics|anesthetics|mesh-list
139596595|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
139596596|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139596597|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596598|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596599|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139596600|NCT02412150|Analgesics|analgesics|mesh-ancestor
139596601|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
139596602|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596603|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139596604|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139596605|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139596606|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
139596607|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596608|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596609|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139596610|NCT02412150|Narcotics|narcotics|mesh-ancestor
139596611|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
139596612|NCT02523196|Cholic Acids|cholic acids|mesh-list
139596613|NCT02523196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139596614|NCT02418078|Anesthetics|anesthetics|mesh-list
139596615|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596616|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596617|NCT03175926|Budesonide|budesonide|mesh-list
139596618|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139596619|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139596620|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
139596621|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596622|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596623|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139596624|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
139596625|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
139596626|NCT03175926|Hormones|hormones|mesh-ancestor
139596627|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139596628|NCT02524054|Furosemide|furosemide|mesh-list
139596629|NCT02524054|Diuretics|diuretics|mesh-ancestor
139596630|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
139596631|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596632|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139596633|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139596634|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596635|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
139596636|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139596637|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
139596638|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596639|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139596640|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139596641|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
139596642|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596643|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596644|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139596645|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
139596646|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139596647|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
139596648|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596649|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
139596650|NCT02417610|Protective Agents|protective agents|mesh-ancestor
139596651|NCT03116490|Anesthetics|anesthetics|mesh-list
139596652|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596653|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596654|NCT02417298|Ketamine|ketamine|mesh-list
139596655|NCT02417298|Analgesics|analgesics|mesh-ancestor
139596656|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
139596657|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596658|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596659|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139596660|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139596661|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
139596662|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
139596663|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596664|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139596665|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139596666|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596667|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596668|NCT02525536|Trebananib|trebananib|mesh-list
139596669|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139596670|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139596671|NCT02525536|Growth Substances|growth substances|mesh-ancestor
139596672|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596673|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
139596674|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596675|NCT02411994|Artesunate|artesunate|mesh-list
139596676|NCT02411994|Lumefantrine|lumefantrine|mesh-list
139596677|NCT02411994|Artemether|artemether|mesh-list
139596678|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139596679|NCT02411994|Pyronaridine|pyronaridine|mesh-list
139596680|NCT02411994|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139596681|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
139596682|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139596683|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139596684|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139596685|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596686|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
139596687|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
139596688|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139596689|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
139596690|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
139596691|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139596692|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139596693|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139596694|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
139596695|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596696|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596697|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596698|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
139596699|NCT03177720|Imipenem|imipenem|mesh-list
139596700|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139596701|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139596702|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139596703|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139596704|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596705|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596706|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596707|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139596708|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139596709|NCT02411604|Tacrolimus|tacrolimus|mesh-list
139596710|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139596711|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
139596712|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596713|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139596714|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596715|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596716|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
139596717|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139596718|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
139596719|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596720|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
139596721|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139596722|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139596723|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139596724|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
139596725|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
139596726|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
139596727|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139596728|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139596729|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
139596730|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
139596731|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139596732|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596733|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596734|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139596735|NCT03174678|Analgesics|analgesics|mesh-ancestor
139596736|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
139596737|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596738|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139596739|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139596740|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139596741|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
139596742|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596743|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596744|NCT02409498|Bupivacaine|bupivacaine|mesh-list
139596745|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
139596746|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
139596747|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596748|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596749|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
139596750|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596751|NCT02409186|Paclitaxel|paclitaxel|mesh-list
139596752|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139596753|NCT02409186|Cisplatin|cisplatin|mesh-list
139596754|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
139596755|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139596756|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596757|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
139596758|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
139596759|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
139596760|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596761|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139596762|NCT02410746|Ibuprofen|ibuprofen|mesh-list
139596763|NCT02410746|Morphine|morphine|mesh-list
139596764|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
139596765|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139596766|NCT02410746|Narcotics|narcotics|mesh-ancestor
139596767|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596768|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596769|NCT02410746|Analgesics|analgesics|mesh-ancestor
139596770|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
139596771|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596772|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139596773|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139596774|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139596775|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139596776|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139596777|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596778|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596779|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
139596780|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
139596781|NCT03177174|Docetaxel|docetaxel|mesh-list
139596782|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596783|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
139596784|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
139596785|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
139596786|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596787|NCT03177252|Lidocaine|lidocaine|mesh-list
139596788|NCT03177252|Bupivacaine|bupivacaine|mesh-list
139596789|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
139596790|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
139596791|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596792|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596793|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
139596794|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596795|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139596796|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139596797|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139596798|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139596799|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596800|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
139596802|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596803|NCT02408562|Becaplermin|becaplermin|mesh-list
139596804|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
139596805|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
139596806|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139596807|NCT02408562|Growth Substances|growth substances|mesh-ancestor
139596808|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596809|NCT02701764|Pregabalin|pregabalin|mesh-list
139596810|NCT02701764|Analgesics|analgesics|mesh-ancestor
139596811|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
139596812|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596813|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596814|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
139596815|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139596816|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139596817|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596818|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139596819|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139596820|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139596821|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596822|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139596823|NCT03174288|Spironolactone|spironolactone|mesh-list
139596824|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139596825|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
139596826|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139596827|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596828|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139596829|NCT03174288|Diuretics|diuretics|mesh-ancestor
139596830|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
139596831|NCT02532010|Cytarabine|cytarabine|mesh-list
139596832|NCT02532010|Decitabine|decitabine|mesh-list
139596833|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139596834|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
139596835|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596836|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596837|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
139596838|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139596839|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139596840|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
139596841|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596842|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596843|NCT02406300|Bupivacaine|bupivacaine|mesh-list
139596844|NCT02406300|Ropivacaine|ropivacaine|mesh-list
139596845|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
139596846|NCT02406300|Sevoflurane|sevoflurane|mesh-list
139596847|NCT02406300|Desflurane|desflurane|mesh-list
139596848|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
139596849|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
139596850|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596851|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596852|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
139596853|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596854|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139596855|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139596856|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
139596857|NCT02538016|Tolvaptan|tolvaptan|mesh-list
139596858|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139596859|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596860|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
139596861|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596862|NCT02406144|Dexamethasone|dexamethasone|mesh-list
139596863|NCT02406144|Lenalidomide|lenalidomide|mesh-list
139596864|NCT02406144|Ixazomib|ixazomib|mesh-list
139596865|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139596866|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
139596867|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
139596868|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596869|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596870|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139596871|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
139596872|NCT02406144|Hormones|hormones|mesh-ancestor
139596873|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139596874|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139378643|NCT02086253|BQ 788|bq 788|mesh-list
139596875|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596876|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
139596877|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139596878|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139596879|NCT02406144|Growth Substances|growth substances|mesh-ancestor
139596880|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
139596881|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
139596882|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596883|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596884|NCT02416752|Remifentanil|remifentanil|mesh-list
139596885|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139596886|NCT02416752|Narcotics|narcotics|mesh-ancestor
139596887|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596888|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596889|NCT02416752|Analgesics|analgesics|mesh-ancestor
139596890|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
139596891|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596892|NCT02405910|Paclitaxel|paclitaxel|mesh-list
139596893|NCT02405910|Gemcitabine|gemcitabine|mesh-list
139596894|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139596895|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139596896|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
139596897|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
139596898|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
139596899|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596900|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139596901|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
139596902|NCT02539108|Vaccines|vaccines|mesh-list
139596903|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
139596904|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596905|NCT02406066|Oxazepam|oxazepam|mesh-list
139596906|NCT02406066|Metyrapone|metyrapone|mesh-list
139596907|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
139596908|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596909|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596910|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139596911|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596912|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596913|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139596914|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139596915|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139596916|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
139596917|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
139596918|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596919|NCT02408328|Caffeine|caffeine|mesh-list
139596920|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
139596921|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596922|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139596923|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596924|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139596925|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596926|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139596927|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139596928|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
139596929|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596930|NCT02539342|Calcium|calcium|mesh-list
139596931|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139596932|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596933|NCT02405988|Remifentanil|remifentanil|mesh-list
139596934|NCT02405988|Naloxone|naloxone|mesh-list
139596935|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139596936|NCT02405988|Narcotics|narcotics|mesh-ancestor
139596937|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596938|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596939|NCT02405988|Analgesics|analgesics|mesh-ancestor
139596940|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
139596941|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596942|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139596943|NCT02542150|Ethanol|ethanol|mesh-list
139596944|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139596945|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139596946|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596947|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596948|NCT02542462|Vaccines|vaccines|mesh-list
139596949|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
139596950|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596951|NCT03173898|Anesthetics|anesthetics|mesh-list
139596952|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139596953|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596954|NCT02408172|Metoprolol|metoprolol|mesh-list
139596955|NCT02408172|Amlodipine|amlodipine|mesh-list
139596956|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139596957|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139596958|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139596959|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596960|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139596961|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596962|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
139596963|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139596964|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
139596965|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
139596966|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596967|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139596968|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139596969|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139596970|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
139596971|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596972|NCT04481100|Itraconazole|itraconazole|mesh-list
139596973|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
139596974|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139596975|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139596976|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139596977|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139596978|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596979|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139596980|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
139596981|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139596982|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596983|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139596984|NCT02405598|Albuterol|albuterol|mesh-list
139596985|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139596986|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
139596987|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139596988|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139596989|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139596990|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
139596991|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
139596992|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139596993|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139596994|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139596995|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139596996|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
139596997|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139596998|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139596999|NCT03173508|Acetazolamide|acetazolamide|mesh-list
139597000|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
139597001|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139597002|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597003|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597004|NCT03173508|Diuretics|diuretics|mesh-ancestor
139597005|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
139597006|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597007|NCT03173430|Blinatumomab|blinatumomab|mesh-list
139597008|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597009|NCT02407782|Ivermectin|ivermectin|mesh-list
139597010|NCT02407782|Permethrin|permethrin|mesh-list
139597011|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139597012|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597013|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597014|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597015|NCT02405364|Dexamethasone|dexamethasone|mesh-list
139597016|NCT02405364|Lenalidomide|lenalidomide|mesh-list
139597017|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139597018|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
139597019|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
139597020|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597021|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597022|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139597023|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
139597024|NCT02405364|Hormones|hormones|mesh-ancestor
139597025|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139597026|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139597027|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597028|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
139597029|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139597030|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139597031|NCT02405364|Growth Substances|growth substances|mesh-ancestor
139597032|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
139597033|NCT02405130|Epinephrine|epinephrine|mesh-list
139597034|NCT02405130|Racepinephrine|racepinephrine|mesh-list
139597035|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
139597036|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139597037|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139597038|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
139597039|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597040|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597041|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597042|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139597043|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139597044|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
139597045|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597046|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139597047|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
139597048|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
139597049|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
139597050|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139597051|NCT03171090|Anesthetics|anesthetics|mesh-list
139597052|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
139597053|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139597054|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597055|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
139597056|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597057|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139597058|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
139597059|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597060|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139597062|NCT02407626|Sevoflurane|sevoflurane|mesh-list
139597063|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139597064|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139597065|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597066|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139597067|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
139597068|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
139597069|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139597070|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139597071|NCT02407392|Acetic Acid|acetic acid|mesh-list
139597072|NCT02407392|Retinol acetate|retinol acetate|mesh-list
139597073|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139597074|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597075|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139597076|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
139597077|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597078|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139597079|NCT02407392|Protective Agents|protective agents|mesh-ancestor
139597080|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597081|NCT02551432|Paclitaxel|paclitaxel|mesh-list
139597082|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
139597083|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139597084|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597085|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
138725141|NCT01643603|Dasatinib|dasatinib|mesh-list
139597086|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
139597087|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
139597088|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597089|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139597090|NCT02551432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139597091|NCT02407548|Vitamin E|vitamin e|mesh-list
139597092|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
139597093|NCT02407548|Ubiquinone|ubiquinone|mesh-list
139597094|NCT02407548|Vitamins|vitamins|mesh-ancestor
139597095|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
139597096|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597097|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
139597098|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597099|NCT02407548|Protective Agents|protective agents|mesh-ancestor
139597100|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
139597101|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
139597103|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
139597104|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597105|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
139597106|NCT02551744|Pantoprazole|pantoprazole|mesh-list
139597107|NCT02551744|Famotidine|famotidine|mesh-list
139597108|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139597109|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
139597110|NCT02551744|Histamine|histamine|mesh-list
139597111|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139597112|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139597113|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597114|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597115|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
139597116|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
139597117|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597118|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597119|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
139597120|NCT04743544|Voriconazole|voriconazole|mesh-list
139597121|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
139597122|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597123|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139597124|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139597125|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597126|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597127|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139597128|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
139597129|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139597130|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597131|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139597132|NCT04481802|Acemannan|acemannan|mesh-list
139597133|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139597134|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
139597135|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597136|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597137|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
139597138|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597139|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139597140|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
139597141|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597142|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597143|NCT02407314|Aspirin|aspirin|mesh-list
139597144|NCT02407314|Ticagrelor|ticagrelor|mesh-list
139597145|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139597146|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139597147|NCT02407314|Analgesics|analgesics|mesh-ancestor
139597148|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
139597149|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597150|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597151|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139597152|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139597153|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139597154|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139597155|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597156|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139597157|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139597158|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597159|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
139597160|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139597161|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139597162|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139597163|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
139597164|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597165|NCT02407080|Interferons|interferons|mesh-list
139597166|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
139597167|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
139597168|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139597169|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597170|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
138725257|NCT06047860|Growth Substances|growth substances|mesh-ancestor
139597171|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597172|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
139597173|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597174|NCT04743622|Latanoprost|latanoprost|mesh-list
139597175|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139597176|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139597177|NCT02701296|Epinephrine|epinephrine|mesh-list
139597178|NCT02701296|Ropivacaine|ropivacaine|mesh-list
139597179|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
139597180|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
139597181|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139597182|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597183|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
139597184|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597185|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139597186|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139597187|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
139597188|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597189|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597190|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139597191|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139597192|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
139597193|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139597194|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
139597195|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
139597196|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
139597197|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139597198|NCT02558374|Timolol|timolol|mesh-list
139597199|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139597200|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139597201|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597202|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139597203|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139597204|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
139597205|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597206|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597207|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139597208|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139597209|NCT01582451|Insulin|insulin|mesh-list
139597210|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139597211|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
139597212|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139597213|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597214|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139597215|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139597216|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597217|NCT03168828|Trospium chloride|trospium chloride|mesh-list
139597218|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
139597219|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
139597220|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597221|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597222|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139597223|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139597224|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
139597225|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597226|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597227|NCT03168828|Urological Agents|urological agents|mesh-ancestor
139597228|NCT02562898|Paclitaxel|paclitaxel|mesh-list
139597229|NCT02562898|Gemcitabine|gemcitabine|mesh-list
139597230|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139597231|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597232|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
139597233|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
139597234|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
139597235|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597236|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139597237|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
139597238|NCT03168594|Cisplatin|cisplatin|mesh-list
139597239|NCT03168594|Irinotecan|irinotecan|mesh-list
139597240|NCT03168594|Etoposide|etoposide|mesh-list
139597241|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597242|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139597243|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139597244|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597245|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597246|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139597247|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139597248|NCT02563834|Insulin|insulin|mesh-list
139597249|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139597250|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597251|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
139597252|NCT02564926|Glimepiride|glimepiride|mesh-list
139597253|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139597254|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597255|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139597256|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597257|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139597258|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139597259|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
139597260|NCT02567968|Caffeine|caffeine|mesh-list
139597261|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
139597262|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597263|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139597264|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597265|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139597266|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597267|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139597268|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139597269|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
139597270|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597271|NCT02571634|Fentanyl|fentanyl|mesh-list
139597272|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139597273|NCT02571634|Narcotics|narcotics|mesh-ancestor
139597274|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139597275|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597276|NCT02571634|Analgesics|analgesics|mesh-ancestor
139597277|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
139597278|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597279|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139597280|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139597281|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
139597282|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
139597283|NCT02404038|NuvaRing|nuvaring|mesh-list
139597284|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
139597285|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139597286|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
139597287|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139597288|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597289|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139597290|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139597291|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139597292|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139597293|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139597294|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
139597295|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139597296|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139597297|NCT02574598|Docetaxel|docetaxel|mesh-list
139597298|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
139597299|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597300|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
139597301|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
139597302|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
139597303|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597304|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139597305|NCT02574598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139597306|NCT02574832|Lidocaine|lidocaine|mesh-list
139597307|NCT02574832|Fentanyl|fentanyl|mesh-list
139597308|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
139597309|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
139597310|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139597311|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597312|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
139597313|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597314|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139597315|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139597316|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139597317|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139597318|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597319|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139597320|NCT02574832|Narcotics|narcotics|mesh-ancestor
139597321|NCT02574832|Analgesics|analgesics|mesh-ancestor
139597322|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139597323|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139597324|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
139597325|NCT02406690|Leuprolide|leuprolide|mesh-list
139597326|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139597328|NCT02406690|Estradiol|estradiol|mesh-list
139597329|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139597330|NCT02406690|Progesterone|progesterone|mesh-list
139597331|NCT02406690|Estrogens|estrogens|mesh-ancestor
139597332|NCT02406690|Hormones|hormones|mesh-ancestor
139597333|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139597334|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597335|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139597336|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
139597337|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139597338|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139597339|NCT02406690|Progestins|progestins|mesh-ancestor
139597340|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139597341|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
139597342|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139597343|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597344|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
139597345|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
139597346|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
139597347|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597348|NCT02974348|Acetaminophen|acetaminophen|mesh-list
139597349|NCT02974348|Amoxicillin|amoxicillin|mesh-list
139597350|NCT02974348|Artesunate|artesunate|mesh-list
139597351|NCT02974348|Lumefantrine|lumefantrine|mesh-list
139597352|NCT02974348|Piperaquine|piperaquine|mesh-list
139597353|NCT02974348|Artenimol|artenimol|mesh-list
139597354|NCT02974348|Mefloquine|mefloquine|mesh-list
139597355|NCT02974348|Quinine|quinine|mesh-list
139597356|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139597357|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597358|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139597359|NCT02974348|Analgesics|analgesics|mesh-ancestor
139597360|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
139597361|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597362|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597363|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
139597364|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
139597365|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139597366|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139597367|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597368|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
139597369|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
139597370|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139597371|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
139597372|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139597373|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139597374|NCT03170310|Apatinib|apatinib|mesh-list
139597375|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597376|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139597377|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597378|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597379|NCT00364000|Calcium|calcium|mesh-list
139597380|NCT00364000|Sevelamer|sevelamer|mesh-list
139597381|NCT00364000|Calcium acetate|calcium acetate|mesh-list
139597382|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139597383|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597384|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
139597385|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
139597386|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597387|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
139597388|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139597389|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139597390|NCT02403804|Betaine|betaine|mesh-list
139597391|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139597392|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
139597393|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139597394|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
139597395|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597396|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139597397|NCT03169764|Leucovorin|leucovorin|mesh-list
139597398|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
139597399|NCT03169764|Bevacizumab|bevacizumab|mesh-list
139597400|NCT03169764|Capecitabine|capecitabine|mesh-list
139597401|NCT03169764|Fluorouracil|fluorouracil|mesh-list
139597402|NCT03169764|Nivolumab|nivolumab|mesh-list
139597403|NCT03169764|Cetuximab|cetuximab|mesh-list
139597404|NCT03169764|Fulvestrant|fulvestrant|mesh-list
139597405|NCT03169764|Avelumab|avelumab|mesh-list
139597406|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597407|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597408|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139597409|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
139597410|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597411|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139597412|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139597413|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
139597414|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139597415|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139597416|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139597417|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139597418|NCT03169764|Growth Substances|growth substances|mesh-ancestor
139597419|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
139597420|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139597421|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
139597422|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139597423|NCT03169764|Antidotes|antidotes|mesh-ancestor
139597424|NCT03169764|Protective Agents|protective agents|mesh-ancestor
139597425|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
139597426|NCT03169764|Vitamins|vitamins|mesh-ancestor
139597427|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
139597428|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139597429|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139597430|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139597431|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
139597432|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139597433|NCT02399592|Bevacizumab|bevacizumab|mesh-list
139597434|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139597435|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597436|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139597437|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139597438|NCT02399592|Growth Substances|growth substances|mesh-ancestor
139597439|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597440|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
139597441|NCT03801304|Atezolizumab|atezolizumab|mesh-list
139597442|NCT03801304|Vinorelbine|vinorelbine|mesh-list
139597443|NCT03801304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139597444|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597445|NCT03801304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139597446|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597447|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139597448|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
139597449|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
138725499|NCT06044467|Antibodies|antibodies|mesh-list
139597450|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
139597451|NCT02696850|Budesonide|budesonide|mesh-list
139597452|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139597453|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139597454|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
139597455|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597456|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597457|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139597458|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
139597459|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
139597460|NCT02696850|Hormones|hormones|mesh-ancestor
139597461|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139597462|NCT00365170|Insulin|insulin|mesh-list
139597463|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139597464|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
139597465|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139597466|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597467|NCT02403648|Glucagon|glucagon|mesh-list
139597468|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139597469|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139597470|NCT02403648|Hormones|hormones|mesh-ancestor
139597471|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139597472|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597473|NCT02403648|Incretins|incretins|mesh-ancestor
139597474|NCT02396862|Factor VIII|factor viii|mesh-list
139597475|NCT02396862|Coagulants|coagulants|mesh-ancestor
139597476|NCT02377492|Vasopressins|vasopressins|mesh-list
139597477|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
139597478|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
139597479|NCT02377492|Coagulants|coagulants|mesh-ancestor
139597480|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139597481|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139597482|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
139597483|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597484|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139597485|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139597486|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
139597487|NCT02601976|Ribavirin|ribavirin|mesh-list
139597488|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139597489|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
139597490|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597491|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
139597492|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597493|NCT02603926|Pregnanolone|pregnanolone|mesh-list
139597494|NCT02603926|Brexanolone|brexanolone|mesh-list
139597495|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
139597496|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139597497|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597498|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
139597499|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597500|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597501|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
139597502|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
139597503|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
139597504|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139597505|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
139597506|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597507|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597508|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139597509|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
139597510|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
139597511|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139597512|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
139597513|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597514|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597515|NCT02395926|Choline|choline|mesh-list
139597516|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
139597517|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139597518|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
139597519|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597520|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139597521|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139597522|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
139597523|NCT02402868|Ketamine|ketamine|mesh-list
139597524|NCT02402868|Analgesics|analgesics|mesh-ancestor
139597525|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
139597526|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597527|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597528|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139597529|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139597530|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
139597531|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
139597532|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139597533|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139597534|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139597535|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597536|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597537|NCT02402712|Docetaxel|docetaxel|mesh-list
139597538|NCT02402712|Trastuzumab|trastuzumab|mesh-list
139597539|NCT02402712|Pertuzumab|pertuzumab|mesh-list
139597540|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597541|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
139597542|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
139597543|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
139597544|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597545|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139597546|NCT02395458|Amoxicillin|amoxicillin|mesh-list
139597547|NCT02395458|Metronidazole|metronidazole|mesh-list
139597548|NCT02395458|Clarithromycin|clarithromycin|mesh-list
139597549|NCT02395458|Omeprazole|omeprazole|mesh-list
139597550|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139597551|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597552|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139597553|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139597554|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139379254|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597555|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139597556|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139597557|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597558|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597559|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139597560|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139597561|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139597562|NCT02402400|Ticagrelor|ticagrelor|mesh-list
138725622|NCT06037993|Palmidrol|palmidrol|mesh-list
139597563|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139597564|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139597565|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139597566|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139597567|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
139597568|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597569|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597570|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597571|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
139597572|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
139597573|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139597574|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139597575|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597576|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
139597577|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597578|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597579|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139597580|NCT02395068|Irinotecan|irinotecan|mesh-list
139597581|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
139597582|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139597583|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139597584|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597585|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597586|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597587|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139597588|NCT02616250|Ivermectin|ivermectin|mesh-list
139597589|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139597590|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139597591|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597592|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139597593|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139597594|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139597595|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139597596|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
139597597|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597598|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597599|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597600|NCT02698410|Temozolomide|temozolomide|mesh-list
139597601|NCT02698410|Lanreotide|lanreotide|mesh-list
139597602|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139597603|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
139597604|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597605|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597606|NCT00365638|Simvastatin|simvastatin|mesh-list
139597607|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139597608|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139597609|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
139597610|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597611|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139597612|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139597613|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597614|NCT02699892|Rituximab|rituximab|mesh-list
139597615|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139597616|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597617|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
139597618|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597619|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139597620|NCT05731258|Doxorubicin|doxorubicin|mesh-list
139597621|NCT05731258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139597622|NCT05731258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139597623|NCT05731258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597624|NCT05731258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139597625|NCT05731258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139597626|NCT05731258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597627|NCT05731258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597628|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
139597629|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139597630|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597631|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139597632|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597633|NCT05730634|Atorvastatin|atorvastatin|mesh-list
139597634|NCT05730634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139597635|NCT05730634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139597636|NCT05730634|Antimetabolites|antimetabolites|mesh-ancestor
139597637|NCT05730634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597638|NCT05730634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139597639|NCT05730634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139597640|NCT05730634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597641|NCT05705830|Serotonin|serotonin|mesh-list
139597642|NCT05705830|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139597643|NCT05705830|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139597644|NCT05705830|Serotonin Agents|serotonin agents|mesh-ancestor
139597645|NCT05705830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597646|NCT05705830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597647|NCT05705830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597648|NCT05705830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139597649|NCT05705830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139597650|NCT05745714|Cytarabine|cytarabine|mesh-list
139597651|NCT05745714|Dexamethasone|dexamethasone|mesh-list
139597652|NCT05745714|Cyclophosphamide|cyclophosphamide|mesh-list
139597653|NCT05745714|Venetoclax|venetoclax|mesh-list
139597654|NCT05745714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139597655|NCT05745714|Immunologic Factors|immunologic factors|mesh-ancestor
139597656|NCT05745714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597657|NCT05745714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139597658|NCT05745714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139597659|NCT05745714|Alkylating Agents|alkylating agents|mesh-ancestor
139597660|NCT05745714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597661|NCT05745714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597662|NCT05745714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139597663|NCT05745714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139597664|NCT05745714|Antiemetics|antiemetics|mesh-ancestor
139597665|NCT05745714|Autonomic Agents|autonomic agents|mesh-ancestor
139597666|NCT05745714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597667|NCT05745714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139597668|NCT05745714|Glucocorticoids|glucocorticoids|mesh-ancestor
139597669|NCT05745714|Hormones|hormones|mesh-ancestor
139597670|NCT05745714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139597671|NCT05745714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139597672|NCT05745714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139597673|NCT05745714|Antimetabolites|antimetabolites|mesh-ancestor
139597674|NCT05745714|Antiviral Agents|antiviral agents|mesh-ancestor
139597675|NCT05745714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597676|NCT02974270|Leuprolide|leuprolide|mesh-list
139597677|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139597678|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
139597679|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139597680|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725730|NCT06009107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139597681|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139597682|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597683|NCT03167268|Lycopene|lycopene|mesh-list
139597684|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139597685|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
139597686|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597687|NCT03167268|Protective Agents|protective agents|mesh-ancestor
139597688|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597689|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139597690|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139597691|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597692|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139597693|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139597694|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597695|NCT02393898|Paclitaxel|paclitaxel|mesh-list
139597696|NCT02393898|Bevacizumab|bevacizumab|mesh-list
139597697|NCT02393898|Carboplatin|carboplatin|mesh-list
139597698|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139597699|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597700|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
139597701|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
139597702|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
139597703|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597704|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139597705|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139597706|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139597707|NCT02393898|Growth Substances|growth substances|mesh-ancestor
139597708|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597709|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
139597710|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
139597711|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139597712|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139597713|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597714|NCT04258852|Nicotine|nicotine|mesh-list
139597715|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139597716|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
139597717|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597718|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597719|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139597720|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139597721|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
139597722|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597723|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597724|NCT04145674|Methadone|methadone|mesh-list
139597725|NCT04145674|D-methadone|d-methadone|mesh-list
139597726|NCT04145674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139597727|NCT04145674|Narcotics|narcotics|mesh-ancestor
139597728|NCT04145674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139597729|NCT04145674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597730|NCT04145674|Analgesics|analgesics|mesh-ancestor
139597731|NCT04145674|Sensory System Agents|sensory system agents|mesh-ancestor
139597732|NCT04145674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597733|NCT04145674|Antitussive Agents|antitussive agents|mesh-ancestor
139597734|NCT04145674|Respiratory System Agents|respiratory system agents|mesh-ancestor
139597735|NCT04145674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139597736|NCT02394054|Vasopressins|vasopressins|mesh-list
139597737|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
139597738|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
139597739|NCT02394054|Coagulants|coagulants|mesh-ancestor
139597740|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139597741|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139597742|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
139597743|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597744|NCT02393664|Bupivacaine|bupivacaine|mesh-list
139597745|NCT02393664|Propofol|propofol|mesh-list
139597746|NCT02393664|Sevoflurane|sevoflurane|mesh-list
139597747|NCT02393664|Rocuronium|rocuronium|mesh-list
139597748|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
139597749|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
139597750|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139597751|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597752|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
139597753|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597754|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139597755|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139597756|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
139597757|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139597758|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139597759|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139597760|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139597761|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139597762|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139597763|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139597764|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597765|NCT02397486|Vitamin E|vitamin e|mesh-list
139597766|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
139597767|NCT02397486|Vitamins|vitamins|mesh-ancestor
139597768|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
139597769|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597770|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
139597771|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597772|NCT02397486|Protective Agents|protective agents|mesh-ancestor
139597773|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139597774|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597775|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139597776|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139597777|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
139597778|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139379475|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
139597779|NCT02393586|Amoxicillin|amoxicillin|mesh-list
139597780|NCT02393586|Rifampin|rifampin|mesh-list
139597781|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139597782|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
139597783|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
139597784|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139597785|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597786|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139597787|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
139597788|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
139597789|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139597790|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597791|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597792|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139597793|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139597794|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139597795|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139597796|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139597797|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139597798|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139597799|NCT02393430|Rebamipide|rebamipide|mesh-list
139597800|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139597801|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139597802|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
139597803|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597804|NCT02393430|Protective Agents|protective agents|mesh-ancestor
139597805|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597806|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597807|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
139597808|NCT03453892|Nivolumab|nivolumab|mesh-list
139597809|NCT03453892|Ipilimumab|ipilimumab|mesh-list
139597810|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139597811|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597812|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139597813|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597814|NCT00367120|Amoxicillin|amoxicillin|mesh-list
139597815|NCT00367120|Azithromycin|azithromycin|mesh-list
139597816|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
139597817|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
139597818|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139597819|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139597820|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597821|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139597822|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597823|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597824|NCT02397330|Morphine|morphine|mesh-list
139597825|NCT02397330|Bupivacaine|bupivacaine|mesh-list
139597826|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
139597827|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
139597828|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139597829|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597830|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
139597831|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597832|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139597833|NCT02397330|Narcotics|narcotics|mesh-ancestor
139597834|NCT02397330|Analgesics|analgesics|mesh-ancestor
139597835|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
139597836|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139597837|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
139597838|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597839|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597840|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139597841|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
139597842|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139597843|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
139597844|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597845|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597846|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139597847|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
139597848|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
139597849|NCT03081052|Protective Agents|protective agents|mesh-ancestor
139597850|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
139597851|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
139597852|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
139597853|NCT00422344|Sunitinib|sunitinib|mesh-list
139597854|NCT00422344|Everolimus|everolimus|mesh-list
139597855|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597856|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139597857|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139597858|NCT00422344|Growth Substances|growth substances|mesh-ancestor
139597859|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597860|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
139597861|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139597862|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597863|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597864|NCT00422344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139597865|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139597866|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
139597867|NCT00367276|Drospirenone|drospirenone|mesh-list
139597868|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139597869|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
139313225|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139597870|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139597871|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597872|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139597873|NCT00367276|Diuretics|diuretics|mesh-ancestor
139597874|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
139597875|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
139597876|NCT02546986|Azacitidine|azacitidine|mesh-list
139597877|NCT02546986|Cc-486|cc-486|mesh-list
139597878|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139597879|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597880|NCT02546986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139597881|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597882|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139597883|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
139597884|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597885|NCT02689206|Glycine|glycine|mesh-list
139597886|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
139597887|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597888|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597889|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597890|NCT01695239|Adalimumab|adalimumab|mesh-list
139597891|NCT01695239|Ixekizumab|ixekizumab|mesh-list
139597892|NCT01695239|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139597893|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139597894|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139597895|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
139597896|NCT02163694|Paclitaxel|paclitaxel|mesh-list
139597897|NCT02163694|Carboplatin|carboplatin|mesh-list
139597898|NCT02163694|Veliparib|veliparib|mesh-list
139597899|NCT02163694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139597900|NCT02163694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597901|NCT02163694|Tubulin Modulators|tubulin modulators|mesh-ancestor
139597902|NCT02163694|Antimitotic Agents|antimitotic agents|mesh-ancestor
139597903|NCT02163694|Mitosis Modulators|mitosis modulators|mesh-ancestor
139597904|NCT02163694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597905|NCT02163694|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139597906|NCT02163694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139597907|NCT00703222|Interleukin-2|interleukin-2|mesh-list
139597908|NCT00703222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139597909|NCT00703222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139597910|NCT00703222|Analgesics|analgesics|mesh-ancestor
139597911|NCT00703222|Sensory System Agents|sensory system agents|mesh-ancestor
139597912|NCT00703222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597913|NCT00703222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597914|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
139597915|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139597916|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597917|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139597918|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139597919|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139597920|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597921|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
139597922|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597923|NCT04317430|Niclosamide|niclosamide|mesh-list
139597924|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
139597925|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139597926|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
139597927|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139597928|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597929|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
139597930|NCT04277884|Firibastat|firibastat|mesh-list
139597931|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139597932|NCT00367822|Ropinirole|ropinirole|mesh-list
139597933|NCT00367822|Lisuride|lisuride|mesh-list
139597934|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139597935|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139597936|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
139597937|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
139597938|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597939|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597940|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597941|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139597942|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
139597943|NCT02643862|Omalizumab|omalizumab|mesh-list
139597944|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139597945|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139597946|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
139597947|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
139597948|NCT01694771|Olodaterol|olodaterol|mesh-list
139597949|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139597950|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
139597951|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597952|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597953|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139597954|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
139597955|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
139597956|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139597957|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
139597958|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597959|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597960|NCT02651272|Macitentan|macitentan|mesh-list
139597961|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139597962|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139597963|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597964|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139597965|NCT01582061|Pasireotide|pasireotide|mesh-list
139597966|NCT01582061|Hormones|hormones|mesh-ancestor
139597967|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139597968|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597969|NCT01693523|Minocycline|minocycline|mesh-list
139597970|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139597971|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139597972|NCT03924323|Escitalopram|escitalopram|mesh-list
139313226|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139597973|NCT03924323|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139597974|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139597975|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139597976|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597977|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597978|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
139597979|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597980|NCT01581281|Topiramate|topiramate|mesh-list
139597981|NCT01581281|Amitriptyline|amitriptyline|mesh-list
139597982|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
139597983|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139597984|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139597985|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139597986|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
139597987|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139597988|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139597989|NCT01581281|Analgesics|analgesics|mesh-ancestor
139597990|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
139597991|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139597992|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139597993|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139597994|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139597995|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139597996|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
139597997|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139597998|NCT01580969|Minocycline|minocycline|mesh-list
139597999|NCT01580969|Bevacizumab|bevacizumab|mesh-list
139598000|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139598001|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598002|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139598003|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139598004|NCT01580969|Growth Substances|growth substances|mesh-ancestor
139598005|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598006|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
139598007|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139598008|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598009|NCT02696226|Aspirin|aspirin|mesh-list
139598010|NCT02696226|Warfarin|warfarin|mesh-list
139598011|NCT02696226|Clopidogrel|clopidogrel|mesh-list
139598012|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139598013|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139598014|NCT02696226|Analgesics|analgesics|mesh-ancestor
139598015|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
139598016|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598017|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598018|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598019|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139598020|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139598021|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139598022|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598023|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139598024|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139598025|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598026|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
139598027|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139598028|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139598029|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139598030|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
139598031|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598032|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
139598033|NCT03167112|Leucovorin|leucovorin|mesh-list
139598034|NCT03167112|Fluorouracil|fluorouracil|mesh-list
139598035|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
139598036|NCT03167112|Irinotecan|irinotecan|mesh-list
139598037|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
139598038|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598039|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139598040|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598041|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139598042|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
139598043|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598044|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139598045|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139598046|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598047|NCT03167112|Antidotes|antidotes|mesh-ancestor
139598048|NCT03167112|Protective Agents|protective agents|mesh-ancestor
139598049|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
139598050|NCT03167112|Vitamins|vitamins|mesh-ancestor
139598051|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
139598052|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
139598053|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
139598054|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139598055|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
139598056|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598057|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139598058|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139598059|NCT03167034|Acetazolamide|acetazolamide|mesh-list
139598060|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
139598061|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139598062|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598063|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598064|NCT03167034|Diuretics|diuretics|mesh-ancestor
139598065|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
139598066|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598067|NCT01578551|Metformin|metformin|mesh-list
139598068|NCT01578551|Biguanides|biguanides|mesh-list
139598069|NCT01578551|Paclitaxel|paclitaxel|mesh-list
139598070|NCT01578551|Bevacizumab|bevacizumab|mesh-list
139598071|NCT01578551|Carboplatin|carboplatin|mesh-list
139598072|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139598073|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598074|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
139598075|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
139598076|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
139598077|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598078|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139379781|NCT02110745|Propofol|propofol|mesh-list
139598079|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139598080|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139598081|NCT01578551|Growth Substances|growth substances|mesh-ancestor
139598083|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
139598084|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139598085|NCT01692197|Cytarabine|cytarabine|mesh-list
139598086|NCT01692197|Dexamethasone|dexamethasone|mesh-list
139598087|NCT01692197|Idarubicin|idarubicin|mesh-list
139598088|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598089|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
139598090|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
139598091|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598092|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598093|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139598094|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
139598095|NCT01692197|Hormones|hormones|mesh-ancestor
139598096|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598097|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139598098|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598099|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139598100|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
139598101|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598102|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
139598103|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598104|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139598105|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
139598106|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139598107|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139598108|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139598109|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598110|NCT01691885|Fluticasone|fluticasone|mesh-list
139598111|NCT01691885|Xhance|xhance|mesh-list
139598112|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598113|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139598114|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
139598115|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598116|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598117|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139598118|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
139598119|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
139598120|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139598121|NCT03166800|Ubiquinone|ubiquinone|mesh-list
139598122|NCT03166800|Micronutrients|micronutrients|mesh-ancestor
139598123|NCT03166800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598124|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
139598125|NCT03166254|Vaccines|vaccines|mesh-list
139598126|NCT03166254|Poly ICLC|poly iclc|mesh-list
139598127|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
139598128|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598129|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139598130|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598131|NCT03166254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139598132|NCT03166254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598133|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
139598134|NCT02651428|Taurolidine|taurolidine|mesh-list
139598135|NCT02651428|Heparin|heparin|mesh-list
139598136|NCT02651428|Calcium heparin|calcium heparin|mesh-list
139598137|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
139598138|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598139|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139598140|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139598141|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598142|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139598143|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598144|NCT02686164|Lenvatinib|lenvatinib|mesh-list
139598145|NCT02686164|Midazolam|midazolam|mesh-list
139598146|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139598147|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139598148|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139598149|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598150|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139598151|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139598152|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139598153|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139598154|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
139598155|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
139598156|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
139598157|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
139598158|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598159|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598160|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598161|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139598162|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598163|NCT02651584|Buprenorphine|buprenorphine|mesh-list
139598164|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139598165|NCT02651584|Narcotics|narcotics|mesh-ancestor
139598166|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138726213|NCT05509569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598167|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598168|NCT02651584|Analgesics|analgesics|mesh-ancestor
139598169|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
139598170|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598171|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139598172|NCT02685072|Progesterone|progesterone|mesh-list
139598173|NCT02685072|Progestins|progestins|mesh-ancestor
139598174|NCT02685072|Hormones|hormones|mesh-ancestor
139598175|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598176|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598177|NCT02653144|Dexamethasone|dexamethasone|mesh-list
139598178|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
139598179|NCT02653144|Ropivacaine|ropivacaine|mesh-list
139598180|NCT02653144|Anesthetics|anesthetics|mesh-list
139598181|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598182|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
139598183|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
139598184|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598185|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598186|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139598187|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
139598188|NCT02653144|Hormones|hormones|mesh-ancestor
139598189|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598190|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139598191|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598192|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139598193|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139598194|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139598195|NCT02653144|Analgesics|analgesics|mesh-ancestor
139598196|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
139598197|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139598198|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139598199|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139598200|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
139598201|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598202|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598203|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
139598204|NCT00118365|Eflornithine|eflornithine|mesh-list
139598205|NCT00118365|Sulindac|sulindac|mesh-list
139598206|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598207|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139598208|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139598209|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139598210|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598211|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139598212|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598213|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598214|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139598215|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139598216|NCT00118365|Analgesics|analgesics|mesh-ancestor
139598217|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
139598218|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598219|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598220|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598221|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139598222|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139598223|NCT03165240|Eplerenone|eplerenone|mesh-list
139598224|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139598225|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
139598226|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598227|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598228|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139598229|NCT03165240|Diuretics|diuretics|mesh-ancestor
139598230|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
139598231|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139598232|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
139598233|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139598234|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
139598235|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598236|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598237|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139598238|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
139598239|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
139598240|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139598241|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
139598242|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598243|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598244|NCT03028909|Oseltamivir|oseltamivir|mesh-list
139598245|NCT03028909|MEDI8852|medi8852|mesh-list
139598246|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
139598247|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598248|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598249|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598250|NCT02654860|Acetaminophen|acetaminophen|mesh-list
139598251|NCT02654860|Bupivacaine|bupivacaine|mesh-list
139598252|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
139598253|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
139598254|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139598255|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598256|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
139598257|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598258|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139598259|NCT02654860|Analgesics|analgesics|mesh-ancestor
139598260|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
139598261|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
139598262|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139598263|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
139598264|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598265|NCT01587001|Expectorants|expectorants|mesh-ancestor
139598266|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
139598267|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139598268|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
139598269|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598270|NCT01587001|Protective Agents|protective agents|mesh-ancestor
139598271|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598272|NCT01587001|Antidotes|antidotes|mesh-ancestor
139598273|NCT01568047|Levodopa|levodopa|mesh-list
139598274|NCT01568047|Carbidopa|carbidopa|mesh-list
139598275|NCT01568047|Opicapone|opicapone|mesh-list
139598276|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139598277|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139598278|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
139598279|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598280|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598281|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598282|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139598283|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598284|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139598285|NCT01688921|Vaccines|vaccines|mesh-list
139598286|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
139598287|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598288|NCT00118755|Bevacizumab|bevacizumab|mesh-list
139598289|NCT00118755|Capecitabine|capecitabine|mesh-list
139598290|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
139598291|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139598292|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598293|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139598294|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139598295|NCT00118755|Growth Substances|growth substances|mesh-ancestor
139598296|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598297|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
139598298|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139598299|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
139598300|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598301|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139598302|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139598303|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139598304|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139598305|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598306|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139598307|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139598308|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139598309|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
139598310|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598311|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598312|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139598313|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139598314|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
139598315|NCT02662036|Bupivacaine|bupivacaine|mesh-list
139598316|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
139598317|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
139598318|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139598319|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598320|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
139598321|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598322|NCT01687673|Sirolimus|sirolimus|mesh-list
139598323|NCT01687673|Sorafenib|sorafenib|mesh-list
139598324|NCT01687673|Temsirolimus|temsirolimus|mesh-list
139598325|NCT01687673|MTOR Inhibitors|mtor inhibitors|mesh-list
139598326|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598327|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139598328|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598329|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598330|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139598331|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
139598332|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598333|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139598334|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598335|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139598336|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
139598337|NCT00121251|Gemcitabine|gemcitabine|mesh-list
139598338|NCT00121251|Capecitabine|capecitabine|mesh-list
139598339|NCT00121251|Sorafenib|sorafenib|mesh-list
139598340|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139598341|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
139598342|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598343|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598344|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139598345|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598346|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
139598347|NCT02664220|Povidone|povidone|mesh-list
139598348|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
139598349|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
139598350|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139598351|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598352|NCT04339348|Lidocaine|lidocaine|mesh-list
139598353|NCT04339348|Prilocaine|prilocaine|mesh-list
139598354|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139598355|NCT04339348|Misoprostol|misoprostol|mesh-list
139598356|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
139598357|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
139598358|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139598359|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598360|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
139598361|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598362|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139598363|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139598364|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139598365|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139598366|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598367|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139598368|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
139598369|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139598370|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139598371|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139598372|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
139598373|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139598374|NCT02664922|Ketamine|ketamine|mesh-list
139598375|NCT02664922|Remifentanil|remifentanil|mesh-list
139598376|NCT02664922|Propofol|propofol|mesh-list
139598377|NCT02664922|Sevoflurane|sevoflurane|mesh-list
139598378|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139598379|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139598380|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598381|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139598382|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
139598383|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
139598384|NCT02664922|Analgesics|analgesics|mesh-ancestor
139598385|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
139598386|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598388|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139598389|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139598390|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598391|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598392|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139598393|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139598394|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139598395|NCT02664922|Narcotics|narcotics|mesh-ancestor
139598396|NCT02666950|Cytarabine|cytarabine|mesh-list
139598397|NCT02666950|Adavosertib|adavosertib|mesh-list
139598398|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139598399|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
139598400|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598401|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598402|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
139598403|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598404|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139598405|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
139598406|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598407|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598408|NCT02668432|Amiodarone|amiodarone|mesh-list
139598409|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139598410|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
139598411|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139598412|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139598413|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598414|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139598415|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139598416|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139598417|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598418|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139598419|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139598420|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139598421|NCT01687283|Fluticasone|fluticasone|mesh-list
139598422|NCT01687283|Xhance|xhance|mesh-list
139598423|NCT01687283|Budesonide|budesonide|mesh-list
139598424|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598425|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139598426|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
139598427|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598428|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598429|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139598430|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
139598431|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
139598432|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139598433|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
139598434|NCT01687283|Hormones|hormones|mesh-ancestor
139598435|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598436|NCT02684370|Ustekinumab|ustekinumab|mesh-list
139598437|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139598438|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
139598439|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
139598440|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598441|NCT02669914|Durvalumab|durvalumab|mesh-list
139598442|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139598443|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598444|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
139598445|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139598446|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139598447|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139598448|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139598449|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598450|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
139598451|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598452|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598453|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139598454|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598455|NCT04739410|Ivermectin|ivermectin|mesh-list
139598456|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139598457|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598458|NCT02691936|Estrogens|estrogens|mesh-list
139598459|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139598460|NCT02691936|Hormones|hormones|mesh-ancestor
139598461|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598462|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598463|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
139598464|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139598465|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
139598467|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
139598468|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
139598469|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139598470|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598471|NCT02680054|Insulin|insulin|mesh-list
139598472|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
139598473|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139598474|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598475|NCT00367978|Amlodipine|amlodipine|mesh-list
139598476|NCT00367978|Benazepril|benazepril|mesh-list
139598477|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139598478|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139598479|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139598480|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598481|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139598482|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598483|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
139598484|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139598485|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
139598486|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598487|NCT00368056|Eszopiclone|eszopiclone|mesh-list
139598488|NCT00368056|Zopiclone|zopiclone|mesh-list
139598489|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139598490|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139598491|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598492|NCT01685801|Ivacaftor|ivacaftor|mesh-list
139598493|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139598494|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139598495|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598496|NCT01684943|Insulin|insulin|mesh-list
138726559|NCT05256472|Axitinib|axitinib|mesh-list
139598497|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139598498|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598499|NCT04739566|Trametinib|trametinib|mesh-list
139598500|NCT04739566|Dabrafenib|dabrafenib|mesh-list
139598501|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598502|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139598503|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598504|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598505|NCT05339542|Methylprednisolone|methylprednisolone|mesh-list
139598506|NCT05339542|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139598507|NCT05339542|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139598508|NCT05339542|Prednisolone|prednisolone|mesh-list
139598509|NCT05339542|Prednisolone acetate|prednisolone acetate|mesh-list
139598510|NCT05339542|Lidocaine|lidocaine|mesh-list
139598511|NCT05339542|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139598512|NCT05339542|Prednisolone phosphate|prednisolone phosphate|mesh-list
139598513|NCT05339542|Anesthetics, Local|anesthetics, local|mesh-ancestor
139598514|NCT05339542|Anesthetics|anesthetics|mesh-ancestor
139598515|NCT05339542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139598516|NCT05339542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598517|NCT05339542|Sensory System Agents|sensory system agents|mesh-ancestor
139598518|NCT05339542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598519|NCT05339542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139598520|NCT05339542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139598521|NCT05339542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139598522|NCT05339542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139598523|NCT05339542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598524|NCT05339542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598525|NCT05339542|Antiemetics|antiemetics|mesh-ancestor
139598526|NCT05339542|Autonomic Agents|autonomic agents|mesh-ancestor
139598527|NCT05339542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139598528|NCT05339542|Glucocorticoids|glucocorticoids|mesh-ancestor
139598529|NCT05339542|Hormones|hormones|mesh-ancestor
139598530|NCT05339542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598531|NCT05339542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139598532|NCT05339542|Protective Agents|protective agents|mesh-ancestor
139598533|NCT05339542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139598534|NCT05339542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380228|NCT05928741|Vitamin D|vitamin d|mesh-list
139598535|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
139598536|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139598537|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598538|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139598539|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139598540|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598541|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598542|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598543|NCT00368602|Timolol|timolol|mesh-list
139598544|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139598545|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
139598546|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
139598547|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598548|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598549|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598550|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139598551|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139598552|NCT01683071|Bupivacaine|bupivacaine|mesh-list
139598553|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
139598554|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
138726624|NCT05184348|Acitretin|acitretin|mesh-list
139598555|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139598556|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598557|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
139598558|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598559|NCT04707508|Metformin|metformin|mesh-list
139598560|NCT04707508|Valsartan|valsartan|mesh-list
139598561|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139598562|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598563|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139598564|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139598565|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139598566|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598567|NCT01567865|Vaccines|vaccines|mesh-list
139598568|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
139598569|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598570|NCT05049226|Vaccines|vaccines|mesh-list
139598571|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
139598572|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598573|NCT01567163|Docetaxel|docetaxel|mesh-list
139598574|NCT01567163|Ramucirumab|ramucirumab|mesh-list
139598575|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598576|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
139598577|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
139598578|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
139598579|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598580|NCT05002114|Cannabidiol|cannabidiol|mesh-list
139598581|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
139598582|NCT04338802|Nintedanib|nintedanib|mesh-list
139598583|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598584|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139598585|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598586|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598587|NCT04395508|Trastuzumab|trastuzumab|mesh-list
139598588|NCT04395508|Pertuzumab|pertuzumab|mesh-list
139598589|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139598590|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598591|NCT00368914|Sirolimus|sirolimus|mesh-list
139598592|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139598593|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598594|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139598595|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598596|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
139598597|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139598598|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
139598599|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598600|NCT01567085|Eculizumab|eculizumab|mesh-list
139598601|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139598602|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139598603|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
139598604|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598605|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
139598606|NCT04344184|Vitamins|vitamins|mesh-ancestor
139598607|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
139598608|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598609|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
139598610|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598611|NCT04344184|Protective Agents|protective agents|mesh-ancestor
139598612|NCT01566773|Bromides|bromides|mesh-list
139598613|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
139598614|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139598615|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
139598616|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598617|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598618|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139598619|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
139598620|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
139598621|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139598622|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
139598623|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138726670|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598624|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598625|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
139598626|NCT04134442|Bupivacaine|bupivacaine|mesh-list
139598627|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
139598628|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
139598629|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139598630|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598631|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
139598632|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598633|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
139598634|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
139598635|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
139598636|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139598637|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
139598638|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598639|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598640|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139598641|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
139598642|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139598643|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139598644|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139598645|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
139598646|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598647|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598648|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598649|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
139598650|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139598651|NCT03417388|Aspirin|aspirin|mesh-list
139598652|NCT03417388|Losartan|losartan|mesh-list
139598653|NCT03417388|Lisinopril|lisinopril|mesh-list
139598654|NCT03417388|Atorvastatin|atorvastatin|mesh-list
139598655|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139598656|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139598657|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139598658|NCT03417388|Analgesics|analgesics|mesh-ancestor
139598659|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
139598660|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598661|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598662|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598663|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139598664|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139598665|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139598666|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598667|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139598668|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139598669|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598670|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
139598671|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139598672|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139598673|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
139598674|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139598675|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139598676|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139598677|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139598678|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139598679|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139598680|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139598681|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
139598682|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139598683|NCT03417388|Protective Agents|protective agents|mesh-ancestor
139598684|NCT02691702|Melatonin|melatonin|mesh-list
139598685|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
139598686|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598688|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598689|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139598690|NCT01564277|Allopurinol|allopurinol|mesh-list
139598691|NCT01564277|Rasburicase|rasburicase|mesh-list
139598692|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
139598693|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598694|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598695|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
139598696|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139598697|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139598698|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
139598699|NCT01564277|Protective Agents|protective agents|mesh-ancestor
139598700|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598701|NCT01563185|Ibuprofen|ibuprofen|mesh-list
139598702|NCT01563185|Famotidine|famotidine|mesh-list
139598703|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139598704|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139598705|NCT01563185|Analgesics|analgesics|mesh-ancestor
139598706|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
139598707|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598708|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598709|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598710|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139598711|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139598712|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598713|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598714|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139598715|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139598716|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139598717|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
139598718|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
139598719|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598720|NCT02974660|Protamines|protamines|mesh-list
139598721|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
139598722|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598723|NCT02974660|Coagulants|coagulants|mesh-ancestor
139598724|NCT03305848|Nitroglycerin|nitroglycerin|mesh-list
139598725|NCT03305848|Vasodilator Agents|vasodilator agents|mesh-ancestor
139598726|NCT01563029|Fluticasone|fluticasone|mesh-list
139598727|NCT01563029|Xhance|xhance|mesh-list
139598728|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598729|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139598730|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
139598731|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598732|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598733|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139598734|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
139598735|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
139598736|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138726804|NCT05027386|Apatinib|apatinib|mesh-list
139598737|NCT03293368|Triamcinolone|triamcinolone|mesh-list
139598738|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139598739|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139598740|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139598741|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598742|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
139598743|NCT03293368|Hormones|hormones|mesh-ancestor
139598744|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598745|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598746|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139598747|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
139598748|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598749|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598750|NCT03273712|Octreotide|octreotide|mesh-list
139598751|NCT03273712|Edotreotide|edotreotide|mesh-list
139598752|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139598753|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139598754|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598755|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139598756|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598757|NCT04113317|Lenograstim|lenograstim|mesh-list
139598758|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139598759|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
139598760|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598761|NCT04341844|Methylene Blue|methylene blue|mesh-list
139598762|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598763|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598764|NCT01561313|Adalimumab|adalimumab|mesh-list
139598765|NCT01561313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139598766|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598767|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139598768|NCT01561079|Buprenorphine|buprenorphine|mesh-list
139598769|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139598770|NCT01561079|Narcotics|narcotics|mesh-ancestor
139598771|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139598772|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598773|NCT01561079|Analgesics|analgesics|mesh-ancestor
139598774|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
139598775|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598776|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139598777|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
139598778|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139598779|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139598780|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139598781|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139598782|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139598783|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
139598784|NCT01559675|Prednisolone|prednisolone|mesh-list
139598785|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
139598786|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139598787|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
139598788|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598789|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
139598790|NCT01559675|Hormones|hormones|mesh-ancestor
139598791|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598792|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598793|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139598794|NCT01559675|Protective Agents|protective agents|mesh-ancestor
139598795|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139598796|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598797|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
138726856|NCT04952792|Apixaban|apixaban|mesh-list
139598798|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
139598799|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598800|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139598801|NCT01374906|Pasireotide|pasireotide|mesh-list
139598802|NCT01374906|Hormones|hormones|mesh-ancestor
139598803|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598804|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598805|NCT00362596|Acyclovir|acyclovir|mesh-list
139598806|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
139598807|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598808|NCT02974504|Linagliptin|linagliptin|mesh-list
139598809|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139598810|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598811|NCT02974504|Incretins|incretins|mesh-ancestor
139598812|NCT02974504|Hormones|hormones|mesh-ancestor
139598813|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598814|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139598815|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
139598816|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598817|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598818|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
139598819|NCT03013504|Docetaxel|docetaxel|mesh-list
139598820|NCT03013504|Trastuzumab|trastuzumab|mesh-list
139598821|NCT03013504|Epirubicin|epirubicin|mesh-list
139598822|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139598823|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
139598824|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598825|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139598826|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139598827|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
139598828|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598829|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598830|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139598831|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
139598832|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
139598833|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
139598834|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139598835|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139598836|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139598837|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139598838|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598839|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
139598840|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139598841|NCT02683746|Incretins|incretins|mesh-ancestor
139598842|NCT02683746|Hormones|hormones|mesh-ancestor
139598843|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598844|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598845|NCT02691468|Silicon|silicon|mesh-list
139598846|NCT02691468|Trace Elements|trace elements|mesh-ancestor
139598847|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
139598848|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598849|NCT03162120|Metoprolol|metoprolol|mesh-list
139598850|NCT03162120|Flecainide|flecainide|mesh-list
139598851|NCT03162120|Ranolazine|ranolazine|mesh-list
139598852|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139598853|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139598854|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
139598855|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
139598856|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598857|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598858|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139598859|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139598860|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139598861|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
139598862|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598863|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598864|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139598865|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139598866|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139598867|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
139598868|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139598869|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
139598870|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598871|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598872|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139598873|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
139598874|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
139598875|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139598876|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
139598877|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598878|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598879|NCT03114228|Midostaurin|midostaurin|mesh-list
139598880|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598881|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139598882|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598883|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598884|NCT02678286|Meloxicam|meloxicam|mesh-list
139598885|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139598886|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139598887|NCT02678286|Analgesics|analgesics|mesh-ancestor
139598888|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
139598889|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139598890|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598891|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598892|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139598893|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139598894|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139598895|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598896|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598897|NCT03164694|Carboplatin|carboplatin|mesh-list
139598898|NCT03164694|Pemetrexed|pemetrexed|mesh-list
139598899|NCT03164694|Apatinib|apatinib|mesh-list
139598900|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598901|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598902|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598903|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139598904|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139598905|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139598906|NCT02930902|Paclitaxel|paclitaxel|mesh-list
139598907|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139598908|NCT02930902|Gemcitabine|gemcitabine|mesh-list
139598909|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
139598910|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139380622|NCT04469530|Analgesics|analgesics|mesh-ancestor
139598911|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598912|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
139598913|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
139598914|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
139598915|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598916|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139598918|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139598919|NCT02930902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139598920|NCT02767804|Crizotinib|crizotinib|mesh-list
139598921|NCT02767804|Ensartinib|ensartinib|mesh-list
139598922|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598923|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139598924|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598925|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598926|NCT02741128|Vaccines|vaccines|mesh-list
139598927|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
139598928|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598929|NCT01566721|Trastuzumab|trastuzumab|mesh-list
139598930|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139598931|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598932|NCT01541215|Metformin|metformin|mesh-list
139598933|NCT01541215|Liraglutide|liraglutide|mesh-list
139598934|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139598935|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598936|NCT01541215|Incretins|incretins|mesh-ancestor
139598937|NCT01541215|Hormones|hormones|mesh-ancestor
139598938|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598939|NCT01585987|Ipilimumab|ipilimumab|mesh-list
139598940|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139598941|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139598942|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139598943|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598944|NCT01585831|Testosterone|testosterone|mesh-list
139598945|NCT01585831|Androgens|androgens|mesh-ancestor
139598946|NCT01585831|Hormones|hormones|mesh-ancestor
139598947|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598948|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598949|NCT01565941|Insulin|insulin|mesh-list
139598950|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139598951|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139598952|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598953|NCT01558271|Liraglutide|liraglutide|mesh-list
139598954|NCT01558271|Dulaglutide|dulaglutide|mesh-list
139598955|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139598956|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598957|NCT01558271|Incretins|incretins|mesh-ancestor
139598958|NCT01558271|Hormones|hormones|mesh-ancestor
139598959|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139598960|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
139598961|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139598962|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139598963|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
139598964|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139598965|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598966|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598967|NCT01565707|Urological Agents|urological agents|mesh-ancestor
139598968|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139598969|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139598970|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139598971|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139598972|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598973|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
139598974|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727039|NCT04740697|Tamoxifen|tamoxifen|mesh-list
139598975|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598976|NCT04756271|Antibodies|antibodies|mesh-list
139598977|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
139598978|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
139598979|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139598980|NCT01538719|Rilonacept|rilonacept|mesh-list
139598981|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139598982|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
139598983|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139598984|NCT01537783|Mupirocin|mupirocin|mesh-list
139380686|NCT04102020|Azacitidine|azacitidine|mesh-list
139598985|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139598986|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139598987|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
139598988|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
139598989|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139598990|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139598991|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598992|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598994|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139598995|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139598996|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139598997|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139598998|NCT01556165|Protective Agents|protective agents|mesh-ancestor
139598999|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599000|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
139599001|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
139599002|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
139599003|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599004|NCT01537549|Protective Agents|protective agents|mesh-ancestor
139599005|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599006|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
139599007|NCT01537549|Vitamins|vitamins|mesh-ancestor
139599008|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
139599009|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
139599010|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
139599011|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139599012|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
139599013|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139599014|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599015|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139599016|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139599017|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139599018|NCT01583179|Buprenorphine|buprenorphine|mesh-list
139599019|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139599020|NCT01583179|Narcotics|narcotics|mesh-ancestor
139599021|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139599022|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599023|NCT01583179|Analgesics|analgesics|mesh-ancestor
139599024|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
139599025|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599026|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139599027|NCT01582945|Ketamine|ketamine|mesh-list
139599028|NCT01582945|Analgesics|analgesics|mesh-ancestor
139599029|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
139599030|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599031|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599032|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139599033|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139599034|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
139599035|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
139599036|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139599037|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139599038|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139599039|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599040|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599041|NCT01565083|Trastuzumab|trastuzumab|mesh-list
139599042|NCT01565083|Pertuzumab|pertuzumab|mesh-list
139599043|NCT01565083|Vinorelbine|vinorelbine|mesh-list
139599044|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139599045|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599046|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139599047|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
139599048|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
139599049|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
139599050|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599051|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
139599052|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139599053|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
139599054|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139599055|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
139599056|NCT01537081|Guaifenesin|guaifenesin|mesh-list
139599057|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139599058|NCT01537081|Expectorants|expectorants|mesh-ancestor
139599059|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
139599060|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139599061|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139599062|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
139599063|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599064|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599065|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599066|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
139599067|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139599068|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
139599069|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
139599070|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599071|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
139599072|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139599073|NCT01555073|Celecoxib|celecoxib|mesh-list
139599074|NCT01555073|Pregabalin|pregabalin|mesh-list
139599075|NCT01555073|Analgesics|analgesics|mesh-ancestor
139599076|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
139599077|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599078|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599079|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
139599080|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139599081|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139599082|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599083|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139599084|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139599085|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139599086|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139599087|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139599088|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139599089|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139599090|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139599091|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139599092|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139599093|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139599094|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599095|NCT01582243|Vildagliptin|vildagliptin|mesh-list
139599096|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138727161|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139599097|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599098|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139599099|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
139599100|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599101|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599102|NCT01536535|Prednisone|prednisone|mesh-list
139599103|NCT01536535|Mesalamine|mesalamine|mesh-list
139599104|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139599105|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
139599106|NCT01536535|Hormones|hormones|mesh-ancestor
139599107|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139599108|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599109|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139599110|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599111|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139599112|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139599113|NCT01536535|Analgesics|analgesics|mesh-ancestor
139599114|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
139599115|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599116|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139599117|NCT01553747|Eluxadoline|eluxadoline|mesh-list
139599118|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139599119|NCT01536379|Belimumab|belimumab|mesh-list
139599120|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139599121|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
139599122|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599123|NCT01536067|Bortezomib|bortezomib|mesh-list
139599124|NCT01536067|Ofatumumab|ofatumumab|mesh-list
139599125|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599126|NCT04410211|Midazolam|midazolam|mesh-list
139599127|NCT04410211|Sevoflurane|sevoflurane|mesh-list
139599128|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139599129|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139599130|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139599131|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599132|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139599133|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139599134|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139380890|NCT02848560|Xenon|xenon|mesh-list
139599135|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139599136|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
139599137|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
139599138|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
139599139|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
139599140|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599141|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599142|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139599143|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139599144|NCT01582009|Everolimus|everolimus|mesh-list
139599145|NCT01582009|Panobinostat|panobinostat|mesh-list
139599146|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139599147|NCT01582009|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139599148|NCT01582009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139599149|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599150|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599151|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139599152|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
138727223|NCT04502693|Vaccines|vaccines|mesh-list
139599153|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599154|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599155|NCT01553591|Eluxadoline|eluxadoline|mesh-list
139599156|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139599157|NCT01581931|Metformin|metformin|mesh-list
139599158|NCT01581931|Linagliptin|linagliptin|mesh-list
139599159|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139599160|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599161|NCT01581931|Incretins|incretins|mesh-ancestor
139599162|NCT01581931|Hormones|hormones|mesh-ancestor
139599163|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139599164|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139599165|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
139599166|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599167|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599168|NCT01581307|Leucovorin|leucovorin|mesh-list
139599169|NCT01581307|Folic Acid|folic acid|mesh-list
139599170|NCT01581307|Fluorouracil|fluorouracil|mesh-list
139599171|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
139599172|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
139599173|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
139599174|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599175|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139599176|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599177|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139599178|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
139599179|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599180|NCT01581307|Antidotes|antidotes|mesh-ancestor
139599181|NCT01581307|Protective Agents|protective agents|mesh-ancestor
139599182|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
139599183|NCT01581307|Vitamins|vitamins|mesh-ancestor
139599184|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
139599185|NCT01581307|Hematinics|hematinics|mesh-ancestor
139599186|NCT01580995|Valacyclovir|valacyclovir|mesh-list
139599187|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
139599188|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139599189|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139599190|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
139599191|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599192|NCT01562743|Rotigotine|rotigotine|mesh-list
139599193|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
139599194|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
139599195|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599196|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599197|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599198|NCT03028571|Trimethaphan|trimethaphan|mesh-list
139599199|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
139599200|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139599201|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139599202|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
139599203|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
139599204|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599205|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599206|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139599207|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139599208|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
139599209|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599210|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380911|NCT02792257|Analgesics|analgesics|mesh-ancestor
139599211|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
139599212|NCT01535443|Bromfenac|bromfenac|mesh-list
139599213|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139599214|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139599215|NCT01535443|Analgesics|analgesics|mesh-ancestor
139599216|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
139599217|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599218|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599219|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139599220|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139599221|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
139599222|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139599223|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139599224|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599225|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139599226|NCT01535287|Analgesics|analgesics|mesh-ancestor
139599227|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
139599228|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599229|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139599230|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139599231|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139599232|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
139599233|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599234|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599235|NCT01549613|Vancomycin|vancomycin|mesh-list
139599236|NCT01549613|Daptomycin|daptomycin|mesh-list
139599237|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139599238|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139599239|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
139599240|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599241|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599242|NCT01546883|Dabigatran|dabigatran|mesh-list
139599243|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
139599244|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139599245|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
139599246|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599247|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599248|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
139599249|NCT01546649|Leuprolide|leuprolide|mesh-list
139599250|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139599251|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
139599252|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139599253|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599254|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139599255|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599256|NCT02985983|Brodalumab|brodalumab|mesh-list
139599257|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
139599258|NCT01544309|Atorvastatin|atorvastatin|mesh-list
139599259|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139599260|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139599261|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139599262|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
139599263|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599264|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139599265|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139599266|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599267|NCT01544153|Nicotine|nicotine|mesh-list
139599268|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139599269|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
139599270|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599271|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599272|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139599273|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139599274|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
139599275|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599276|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599277|NCT01543685|Celecoxib|celecoxib|mesh-list
139599278|NCT01543685|Indomethacin|indomethacin|mesh-list
139599279|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139599280|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139599281|NCT01543685|Analgesics|analgesics|mesh-ancestor
139599282|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
139599283|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599284|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599285|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139599286|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139599287|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139599288|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139599289|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599290|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599291|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
139599292|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
139599293|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139599294|NCT01540565|Veliparib|veliparib|mesh-list
139599295|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139599296|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599297|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599298|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599299|NCT01540487|Metformin|metformin|mesh-list
139599300|NCT01540487|Linagliptin|linagliptin|mesh-list
139599301|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139599302|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599303|NCT01540487|Incretins|incretins|mesh-ancestor
139599304|NCT01540487|Hormones|hormones|mesh-ancestor
139599305|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139599306|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139599307|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
139599308|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599309|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599310|NCT01539317|Lidocaine|lidocaine|mesh-list
139599311|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
139599312|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
139599313|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139599314|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599315|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
139599316|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599317|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139599318|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139599319|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139599320|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139599321|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599322|NCT01539083|Thalidomide|thalidomide|mesh-list
139599323|NCT01539083|Dexamethasone|dexamethasone|mesh-list
139599324|NCT01539083|Prednisolone|prednisolone|mesh-list
139599325|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
139599326|NCT01539083|Bortezomib|bortezomib|mesh-list
139599327|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139599328|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
139599329|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599330|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139599331|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139599332|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
139599333|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599334|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599335|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139599336|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139599337|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
139599338|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
139599339|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599340|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139599341|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
139599342|NCT01539083|Hormones|hormones|mesh-ancestor
139599343|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139599344|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139599345|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
139599346|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139599347|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139599348|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139599349|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139599350|NCT01539083|Growth Substances|growth substances|mesh-ancestor
139599351|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
139599352|NCT01537133|Fluticasone|fluticasone|mesh-list
139599353|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139599354|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139599355|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
139599356|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599357|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599358|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139599359|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
139599360|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
139599361|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139599362|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139599363|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139599364|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
139599365|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599366|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599367|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139599368|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
139599369|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139599370|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139599371|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139599372|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
139599373|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599374|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599375|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
139599376|NCT02985905|Astringents|astringents|mesh-ancestor
139599377|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599378|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
139599379|NCT01535261|Ranibizumab|ranibizumab|mesh-list
139599380|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139599381|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139599382|NCT01535261|Growth Substances|growth substances|mesh-ancestor
139599383|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599384|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
139599385|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599386|NCT01534637|Gemcitabine|gemcitabine|mesh-list
139599387|NCT01534637|Capecitabine|capecitabine|mesh-list
139599388|NCT01534637|Fluorouracil|fluorouracil|mesh-list
139599389|NCT01534637|Aprepitant|aprepitant|mesh-list
139599390|NCT01534637|Antiemetics|antiemetics|mesh-list
139599391|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139599392|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
139599393|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599394|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599395|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139599396|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
139599397|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599398|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
139599399|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599400|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139599401|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139599402|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599403|NCT02655016|Niraparib|niraparib|mesh-list
139599404|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139599405|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599406|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599407|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599408|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
139599409|NCT01533935|Olodaterol|olodaterol|mesh-list
139599410|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139599411|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
139599412|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599413|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599414|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139599415|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
139599416|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
139599417|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139599418|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
139599419|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599420|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599421|NCT01532687|Gemcitabine|gemcitabine|mesh-list
139599422|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139599423|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
139599424|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599425|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599426|NCT02677116|Doxorubicin|doxorubicin|mesh-list
139599427|NCT02677116|Irinotecan|irinotecan|mesh-list
139599428|NCT02677116|Vincristine|vincristine|mesh-list
139599429|NCT02677116|Ifosfamide|ifosfamide|mesh-list
139599430|NCT02677116|Olaratumab|olaratumab|mesh-list
139599431|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139599432|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599433|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139599434|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139599435|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599436|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599437|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139599438|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139599439|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
139599440|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
139599441|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
139599442|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139599443|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
139599444|NCT02689518|Aflibercept|aflibercept|mesh-list
139599445|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139599446|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139599447|NCT02689518|Growth Substances|growth substances|mesh-ancestor
139599448|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599449|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
139599450|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599451|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
139599452|NCT02681094|Saxagliptin|saxagliptin|mesh-list
139599453|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139599454|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599455|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139599456|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599457|NCT02681094|Incretins|incretins|mesh-ancestor
139599458|NCT02681094|Hormones|hormones|mesh-ancestor
139599459|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139599460|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139599461|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
139599462|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599463|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
139599464|NCT03164304|Analgesics|analgesics|mesh-ancestor
139599465|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
139599466|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599467|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599468|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
139599469|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139599470|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139599471|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
139599472|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139599473|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139599474|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599475|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139599476|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
139599477|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139599478|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
139599479|NCT02689284|Margetuximab|margetuximab|mesh-list
139599480|NCT02689284|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139599481|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139599482|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727552|NCT03816176|Isavuconazole|isavuconazole|mesh-list
139599483|NCT02689284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139599484|NCT02689284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599485|NCT02689284|Immunologic Factors|immunologic factors|mesh-ancestor
139599486|NCT02689284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599487|NCT03165396|Propofol|propofol|mesh-list
139599488|NCT03165396|Sevoflurane|sevoflurane|mesh-list
139599489|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139599490|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139599491|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599492|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139599493|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
139599494|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
139599495|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139599496|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139599497|NCT03164382|Sorafenib|sorafenib|mesh-list
139599498|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599499|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139599500|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599501|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599502|NCT03161340|Sirolimus|sirolimus|mesh-list
139599503|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139599504|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139599505|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139599506|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599507|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
139599508|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139381223|NCT03040934|Sirolimus|sirolimus|mesh-list
139599509|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
139599510|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599511|NCT03161574|Fluorouracil|fluorouracil|mesh-list
139599512|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
139599514|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
139599515|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599516|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139599517|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599518|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139599519|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
139599520|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599521|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139599522|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139599523|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599524|NCT03163914|Phenylephrine|phenylephrine|mesh-list
139599525|NCT03163914|Epinephrine|epinephrine|mesh-list
139599526|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
139599527|NCT03163914|Norepinephrine|norepinephrine|mesh-list
139599528|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139599529|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139599530|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
139599531|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599532|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599533|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599534|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139599535|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139599536|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
139599537|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599538|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139599539|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
139599540|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
139599541|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
139599542|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139599543|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139599544|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
139599545|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139599546|NCT03163914|Protective Agents|protective agents|mesh-ancestor
139599547|NCT03160872|Hormones|hormones|mesh-list
139599548|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139599549|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599550|NCT03163680|Omeprazole|omeprazole|mesh-list
139599551|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139599552|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139599553|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139599554|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599555|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599556|NCT04574232|Triamcinolone|triamcinolone|mesh-list
139599557|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139599558|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139599559|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139599560|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139599561|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
139599562|NCT04574232|Hormones|hormones|mesh-ancestor
139599563|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139599564|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599565|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139599566|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
139599567|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599568|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599569|NCT05071716|Rifaximin|rifaximin|mesh-list
139599570|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139599571|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139599572|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139599573|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
139599574|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139599575|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
139599576|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599577|NCT04557384|Ramucirumab|ramucirumab|mesh-list
139599578|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599579|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
139599580|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139599581|NCT05231850|Tislelizumab|tislelizumab|mesh-list
139599582|NCT05231850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139381306|NCT03188835|Glycerol|glycerol|mesh-list
139599583|NCT05231850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599584|NCT03163212|Lactoferrin|lactoferrin|mesh-list
139599585|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139599586|NCT05007678|Leflunomide|leflunomide|mesh-list
139599587|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599588|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599589|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139599590|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
139599591|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599592|NCT03161106|Lactulose|lactulose|mesh-list
139599593|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139599594|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
139599595|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139599596|NCT02671500|Velpatasvir|velpatasvir|mesh-list
139599597|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
139599598|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139599599|NCT02671266|Oxytocin|oxytocin|mesh-list
139599600|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
139599601|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139599602|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599603|NCT03160404|Zolpidem|zolpidem|mesh-list
139599604|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139599605|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139599606|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139599607|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599608|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139599609|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
139599610|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
139599611|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599612|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599613|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
139599614|NCT03162588|Hematinics|hematinics|mesh-ancestor
139599615|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139599616|NCT03320070|Hormones|hormones|mesh-ancestor
139599617|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139599618|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599619|NCT04977336|Acetaminophen|acetaminophen|mesh-list
139599620|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139599621|NCT04977336|Analgesics|analgesics|mesh-ancestor
139599622|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
139599623|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599624|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599625|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
139599626|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
139599627|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139599628|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599629|NCT03284424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139599630|NCT03284424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599631|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139599632|NCT02674854|Latanoprost|latanoprost|mesh-list
139599633|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139599634|NCT04036188|Vitamin D|vitamin d|mesh-list
139599635|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
139599636|NCT04036188|Triamcinolone|triamcinolone|mesh-list
139599637|NCT04036188|Vitamins|vitamins|mesh-ancestor
139599638|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
139599639|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599640|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139599641|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139599642|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139599643|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
139599644|NCT04036188|Hormones|hormones|mesh-ancestor
139599645|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139599646|NCT02388516|Vitamin D|vitamin d|mesh-list
139599647|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
139599648|NCT02388516|Vitamins|vitamins|mesh-ancestor
139599649|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
139599650|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599651|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139599652|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139599653|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139599654|NCT01531673|Ivacaftor|ivacaftor|mesh-list
139599655|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139599656|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139599657|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599658|NCT01531205|Leuprolide|leuprolide|mesh-list
139599659|NCT01531205|Goserelin|goserelin|mesh-list
138727729|NCT03601897|Paclitaxel|paclitaxel|mesh-list
139599660|NCT01531205|Bicalutamide|bicalutamide|mesh-list
139599661|NCT01531205|Androgens|androgens|mesh-list
139599662|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139599663|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
139599664|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139599665|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599666|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139599667|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599668|NCT01531205|Hormones|hormones|mesh-ancestor
139599669|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139599670|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
139599671|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
139599672|NCT02985671|Acetaminophen|acetaminophen|mesh-list
139599673|NCT02985671|Diclofenac|diclofenac|mesh-list
139599674|NCT02985671|Orphenadrine|orphenadrine|mesh-list
139599675|NCT02985671|Caffeine|caffeine|mesh-list
139599676|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139599677|NCT02985671|Analgesics|analgesics|mesh-ancestor
139599678|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
139599679|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599680|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599681|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
139599682|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139599683|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139599684|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599685|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599686|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139599687|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139599688|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
139599689|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599690|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139599691|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139599692|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139599693|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139599694|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139599695|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139599696|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139599697|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139599698|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
139599699|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
139599700|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139599701|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139599702|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
139599703|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
139599704|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139599705|NCT01529645|Vaccines|vaccines|mesh-list
139599706|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
139599707|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599708|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139599709|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139599710|NCT01528709|Atorvastatin|atorvastatin|mesh-list
139599711|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139599712|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139599713|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
139599714|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599715|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139599716|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138727786|NCT03487809|Budesonide|budesonide|mesh-list
139599717|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599718|NCT01527383|Vaccines|vaccines|mesh-list
139599719|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
139599720|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599721|NCT01526057|Rituximab|rituximab|mesh-list
139599722|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139599723|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599724|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
139599725|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599726|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139599727|NCT01525901|Mitogens|mitogens|mesh-list
139599728|NCT01525901|Mecasermin|mecasermin|mesh-list
139599729|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599730|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
139599731|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599732|NCT01525901|Growth Substances|growth substances|mesh-ancestor
139599733|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
139599734|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139599735|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139599736|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139599737|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
139599738|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
139599739|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
139599740|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139599741|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599742|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599743|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139599744|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139599746|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139599747|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599748|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139599749|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139599750|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139599751|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
139599752|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599753|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139599754|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139599755|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599756|NCT00264381|Dalteparin|dalteparin|mesh-list
139599757|NCT00264381|Tinzaparin|tinzaparin|mesh-list
139599758|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139599759|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
139599760|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139599761|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139599762|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599763|NCT00246441|Paroxetine|paroxetine|mesh-list
139599764|NCT00246441|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139599765|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139599766|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139599767|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599768|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599769|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
139599770|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599771|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139599772|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
139599773|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139599774|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139599775|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139599776|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599777|NCT00246519|Atenolol|atenolol|mesh-list
139599778|NCT00246519|Metoprolol|metoprolol|mesh-list
139599779|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139599780|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
139599781|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139599782|NCT00246519|Diuretics|diuretics|mesh-ancestor
139599783|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
139599784|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599785|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139599786|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139599787|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599788|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139599789|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
139599790|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
139599791|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599792|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139599793|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139599794|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139599795|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
139599796|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599797|NCT00248547|Dexamethasone|dexamethasone|mesh-list
139599798|NCT00248547|Ondansetron|ondansetron|mesh-list
139599799|NCT00248547|Aprepitant|aprepitant|mesh-list
139599800|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139599801|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
139599802|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
139599803|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599804|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599805|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139599806|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
139599807|NCT00248547|Hormones|hormones|mesh-ancestor
139599808|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139599809|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139381526|NCT02429037|Cisplatin|cisplatin|mesh-list
139599810|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599811|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
139599812|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
139599813|NCT00248547|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139599814|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139599815|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
139599816|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599817|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599818|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139599819|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
139599821|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
139599822|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139599823|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139599824|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
139599825|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599826|NCT00266799|Doxorubicin|doxorubicin|mesh-list
139599827|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139599828|NCT00266799|Capecitabine|capecitabine|mesh-list
139599829|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139599830|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599831|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139599832|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139599833|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599834|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599835|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139599836|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
139599837|NCT00249249|Atorvastatin|atorvastatin|mesh-list
139599838|NCT00249249|Pitavastatin|pitavastatin|mesh-list
139599839|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139599840|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139599841|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
139599842|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599843|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139599844|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139599845|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599846|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139599847|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
139599848|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139599849|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
139599850|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599851|NCT00125931|Pentazocine|pentazocine|mesh-list
139599852|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139599853|NCT00125931|Narcotics|narcotics|mesh-ancestor
139599854|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139599855|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599856|NCT00125931|Analgesics|analgesics|mesh-ancestor
139599857|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
139599858|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599859|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139599860|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139599861|NCT00267111|Tetracaine|tetracaine|mesh-list
139599862|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
139599863|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
139599864|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139599865|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599866|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
139599867|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599868|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
139599869|NCT01521923|Methotrexate|methotrexate|mesh-list
139599870|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139599871|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
139599872|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139599873|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599874|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139599875|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
139599876|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599877|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599878|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
139599879|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599880|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139599881|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139599882|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
139599883|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139297196|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
139599884|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139599885|NCT01521923|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139599886|NCT01521923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139599888|NCT05240781|Temsirolimus|temsirolimus|mesh-list
139599889|NCT05240781|MTOR Inhibitors|mtor inhibitors|mesh-list
139599890|NCT05240781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139599891|NCT05240781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139599892|NCT05240781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139599893|NCT05240781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599894|NCT05240781|Antifungal Agents|antifungal agents|mesh-ancestor
139599895|NCT05240781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139599896|NCT05240781|Immunologic Factors|immunologic factors|mesh-ancestor
139599897|NCT05240781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727999|NCT03136146|Rituximab|rituximab|mesh-list
139599898|NCT05240781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139599899|NCT05240781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599900|NCT05240781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599901|NCT01520987|Opicapone|opicapone|mesh-list
139599902|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139599903|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599904|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599905|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139599906|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139599907|NCT00130923|Risperidone|risperidone|mesh-list
139599908|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139599909|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
139599910|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599911|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599912|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599913|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139599914|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139599915|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139599916|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139599917|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139599918|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
139599919|NCT04117581|Vitamin D|vitamin d|mesh-list
139599920|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
139599921|NCT04117581|Vitamins|vitamins|mesh-ancestor
139599922|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
139599923|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599924|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139599925|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139599926|NCT00272337|Aspirin|aspirin|mesh-list
139599927|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139599928|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139599929|NCT00272337|Analgesics|analgesics|mesh-ancestor
139599930|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
139599931|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139599932|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599933|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139599934|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139599935|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139599936|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139599937|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599938|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139599939|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139599940|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599941|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
139599942|NCT01562275|Ipatasertib|ipatasertib|mesh-list
139599943|NCT01562275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599944|NCT01562275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139599945|NCT01562275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599946|NCT01562275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599947|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
139599948|NCT01535053|Leucovorin|leucovorin|mesh-list
139599949|NCT01535053|Folic Acid|folic acid|mesh-list
139599950|NCT01535053|Dactinomycin|dactinomycin|mesh-list
139599951|NCT01535053|Methotrexate|methotrexate|mesh-list
139599952|NCT01535053|Calcium|calcium|mesh-list
139599953|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
139599954|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139599955|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599956|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139599957|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139599958|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
139599959|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139599960|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139599961|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
139599962|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599963|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599964|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
139599965|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599966|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139599967|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139599968|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
139599969|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139599970|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139599971|NCT01535053|Antidotes|antidotes|mesh-ancestor
139599972|NCT01535053|Protective Agents|protective agents|mesh-ancestor
139599973|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
139599974|NCT01535053|Vitamins|vitamins|mesh-ancestor
139599975|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
139599976|NCT01535053|Hematinics|hematinics|mesh-ancestor
139599977|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139599978|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139599979|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139599980|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139599981|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
139599982|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139599983|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139599984|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139599985|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139599986|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139599987|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599988|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139599989|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139599990|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139599991|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
139599992|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
139599993|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
139599994|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139599995|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139599996|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139599997|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139599998|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139599999|NCT01578499|Methotrexate|methotrexate|mesh-list
139600000|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139600001|NCT01578499|Bexarotene|bexarotene|mesh-list
139600002|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139600003|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
139600004|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139600005|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600006|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139600007|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
139600008|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600009|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600010|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
139600011|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600012|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139600013|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139600014|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
139600015|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139600016|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138728094|NCT06081101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600017|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139600018|NCT01578499|Immunotoxins|immunotoxins|mesh-ancestor
139600019|NCT01578499|Immunoconjugates|immunoconjugates|mesh-ancestor
139600020|NCT01561963|Rifampin|rifampin|mesh-list
139600021|NCT01561963|Apremilast|apremilast|mesh-list
139600022|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139600023|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
139600024|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139600025|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139600026|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
139600027|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139600028|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600029|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600030|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139600031|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139600032|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139600033|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139600034|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139600035|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139600036|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139600037|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139600038|NCT01561963|Analgesics|analgesics|mesh-ancestor
139600039|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
139600040|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600041|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600042|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139600043|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139600044|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139600045|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139600046|NCT04852003|Morphine|morphine|mesh-list
139600047|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139600048|NCT04852003|Narcotics|narcotics|mesh-ancestor
139600049|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600050|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600051|NCT04852003|Analgesics|analgesics|mesh-ancestor
139600052|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
139600053|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600054|NCT01534351|Tamsulosin|tamsulosin|mesh-list
139600055|NCT01534351|Finasteride|finasteride|mesh-list
139600056|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139600057|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139600058|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139600059|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
139600060|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600061|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600062|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600063|NCT01534351|Urological Agents|urological agents|mesh-ancestor
139600064|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139600065|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139600066|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600067|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
139600068|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139600069|NCT01534195|Prednisolone|prednisolone|mesh-list
139600070|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139600071|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
139600072|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139600073|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
139600074|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139600075|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139600076|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139600077|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
139600078|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139600079|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
139600080|NCT01534195|Hormones|hormones|mesh-ancestor
139600081|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139600082|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600083|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139600084|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600085|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
139600086|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
139600087|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600088|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139600089|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139600090|NCT01534195|Protective Agents|protective agents|mesh-ancestor
139600091|NCT01560949|Gemcitabine|gemcitabine|mesh-list
139600092|NCT01560949|Fluorouracil|fluorouracil|mesh-list
139600093|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
139600094|NCT01560949|Irinotecan|irinotecan|mesh-list
139600095|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139600096|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
139600097|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600098|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600099|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139600100|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
138728217|NCT06079918|Iron|iron|mesh-list
139600101|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600102|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139600103|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139600104|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600105|NCT03113448|Capsaicin|capsaicin|mesh-list
139600106|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
139600107|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
139600108|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
139600109|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600110|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600111|NCT01533493|Memantine|memantine|mesh-list
139600112|NCT01533493|Methylphenidate|methylphenidate|mesh-list
139600113|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139600114|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600115|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139600116|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139600117|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139600118|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600119|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
139600120|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600121|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139600122|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139600123|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139600124|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139600125|NCT02388048|Ofatumumab|ofatumumab|mesh-list
139600126|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600127|NCT02387892|Vitamin D|vitamin d|mesh-list
139600128|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
139600129|NCT02387892|Vitamins|vitamins|mesh-ancestor
139600130|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
139600131|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600132|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139600133|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139600134|NCT00133575|Vaccines|vaccines|mesh-list
139600135|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
139600136|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600137|NCT00134043|Vorinostat|vorinostat|mesh-list
139600138|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600139|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139600140|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600141|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600142|NCT03715998|Ramipril|ramipril|mesh-list
139600143|NCT03715998|Firibastat|firibastat|mesh-list
139600144|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139600145|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
139600146|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600147|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600148|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139600149|NCT01790529|Metronidazole|metronidazole|mesh-list
139600150|NCT01790529|Cefuroxime|cefuroxime|mesh-list
139600151|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
139600152|NCT01790529|Anesthetics|anesthetics|mesh-list
139600153|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600154|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600155|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139600156|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139600157|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139600158|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139600159|NCT01533181|Topotecan|topotecan|mesh-list
139600160|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139600161|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139600162|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600163|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600164|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600165|NCT04641507|Tadalafil|tadalafil|mesh-list
139600166|NCT04641507|Tamsulosin|tamsulosin|mesh-list
139600167|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
139600168|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139600169|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139600170|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600171|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600172|NCT04641507|Urological Agents|urological agents|mesh-ancestor
139600173|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139600174|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139600175|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139600176|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
139600177|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600178|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600179|NCT04489173|Trifluridine|trifluridine|mesh-list
139600180|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
139600181|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600182|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
139600183|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139600184|NCT00512070|Olanzapine|olanzapine|mesh-list
139600185|NCT00512070|Melatonin|melatonin|mesh-list
139600186|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
139600187|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600188|NCT00512070|Protective Agents|protective agents|mesh-ancestor
139600189|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600190|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600191|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
139600192|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
139600193|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600194|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139600195|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139600196|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139600197|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139600198|NCT00512070|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139600199|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139600200|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139600201|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600202|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
139600203|NCT05661552|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139600204|NCT05661552|Ezetimibe|ezetimibe|mesh-list
139600205|NCT05661552|Evolocumab|evolocumab|mesh-list
139600206|NCT05661552|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139600207|NCT05661552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139600208|NCT05661552|Antimetabolites|antimetabolites|mesh-ancestor
139600209|NCT05661552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600210|NCT05661552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139600211|NCT05661552|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139600212|NCT05661552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728300|NCT06078670|Paclitaxel|paclitaxel|mesh-list
139600213|NCT05661552|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139600214|NCT05661552|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139600215|NCT05661552|Protease Inhibitors|protease inhibitors|mesh-ancestor
139600216|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
139600217|NCT03534102|Narcotics|narcotics|mesh-ancestor
139600218|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600219|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600220|NCT03534102|Analgesics|analgesics|mesh-ancestor
139600221|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
139600222|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600223|NCT00144963|Dexamethasone|dexamethasone|mesh-list
139600224|NCT00144963|Vincristine|vincristine|mesh-list
139600225|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139600226|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
139600227|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
139600228|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600229|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600230|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139600231|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
139600232|NCT00144963|Hormones|hormones|mesh-ancestor
139600233|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139600234|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139600235|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600236|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139600237|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
139600238|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
139600239|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
139600240|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600241|NCT02662764|Sufentanil|sufentanil|mesh-list
139600242|NCT02662764|Dsuvia|dsuvia|mesh-list
139600243|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139600244|NCT02662764|Narcotics|narcotics|mesh-ancestor
139600245|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600246|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600247|NCT02662764|Analgesics|analgesics|mesh-ancestor
139600248|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
139600249|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600250|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139600251|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139600252|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
139600253|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
139600254|NCT01519817|Vaccines|vaccines|mesh-list
139600255|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
139600256|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600257|NCT05549154|Vitamin D|vitamin d|mesh-list
139381970|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600258|NCT05549154|Ergocalciferols|ergocalciferols|mesh-list
139600260|NCT05549154|Vitamins|vitamins|mesh-list
139600261|NCT05549154|Micronutrients|micronutrients|mesh-ancestor
139600262|NCT05549154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600263|NCT05549154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139600264|NCT05549154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139600265|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
139600266|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139600267|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139600268|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139600269|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139600270|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600271|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
139600272|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600273|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600274|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139600275|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600276|NCT02391636|Oxytocin|oxytocin|mesh-list
139600277|NCT02391636|Carbetocin|carbetocin|mesh-list
139600278|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
139600279|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139600280|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600281|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139600282|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
139600283|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600284|NCT02383212|Paclitaxel|paclitaxel|mesh-list
139600285|NCT02383212|Docetaxel|docetaxel|mesh-list
139600286|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
139600287|NCT02383212|Carboplatin|carboplatin|mesh-list
139600288|NCT02383212|Pemetrexed|pemetrexed|mesh-list
139600289|NCT02383212|Cemiplimab|cemiplimab|mesh-list
139600290|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139600291|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600292|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
139600293|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
139600294|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
139600295|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600296|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139600297|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
139600298|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600299|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139600300|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139600301|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
139600302|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139600303|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600304|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139600305|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139600306|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139600307|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
139600308|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600309|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
139600310|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600311|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600312|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139600313|NCT01531153|Galantamine|galantamine|mesh-list
139600314|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139600315|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600316|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600317|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
139600318|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600319|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600320|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139600321|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
139600322|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600323|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
139600324|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
139600325|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
139600326|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139600327|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139600328|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600329|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
139600330|NCT03027973|Coagulants|coagulants|mesh-ancestor
139600331|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139600332|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
139600333|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139600334|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600335|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139600336|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
139600337|NCT01529749|Losartan|losartan|mesh-list
139600338|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139600339|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139600340|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139600341|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139600342|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600343|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139600344|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139600345|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
139600346|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139600347|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139600348|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139600349|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600350|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139600351|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139600352|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139600353|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139600354|NCT01528969|Sorbitol|sorbitol|mesh-list
139600355|NCT01528969|Cathartics|cathartics|mesh-ancestor
139600356|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139600357|NCT01514201|Temozolomide|temozolomide|mesh-list
139600358|NCT01514201|Veliparib|veliparib|mesh-list
139600359|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139600360|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
139600361|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600362|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600363|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139600364|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600365|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139600366|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139600367|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
139600368|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600369|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139600370|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600371|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139600372|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600373|NCT01528735|Ribavirin|ribavirin|mesh-list
139600374|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
139600375|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600376|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
139600377|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139600378|NCT02386488|Vortioxetine|vortioxetine|mesh-list
139600379|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
139600380|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139600381|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139600382|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139600383|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600384|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600385|NCT02386488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139600386|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139600387|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139600388|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600389|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600390|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
139600391|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139600392|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139600393|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139600394|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139600395|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
139600396|NCT02661594|Amisulpride|amisulpride|mesh-list
139600397|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139600398|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139600399|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139600400|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139600401|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600402|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600403|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600404|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600405|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139600406|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139600407|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600408|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139600409|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139600410|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
139600411|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600412|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139600413|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
139600414|NCT02386566|Natalizumab|natalizumab|mesh-list
139600415|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
139600416|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600417|NCT01528345|Fulvestrant|fulvestrant|mesh-list
139600418|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139600419|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600420|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139600421|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139600422|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
139600423|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139600424|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600425|NCT01511939|Diclofenac|diclofenac|mesh-list
139600426|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139600427|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139600428|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139600429|NCT01511939|Analgesics|analgesics|mesh-ancestor
139600430|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
139600431|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600432|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600433|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139600434|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139600435|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600436|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600437|NCT02391480|Venetoclax|venetoclax|mesh-list
139600438|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600439|NCT01576705|Leucovorin|leucovorin|mesh-list
139600440|NCT01576705|Folic Acid|folic acid|mesh-list
139600441|NCT01576705|Hormones|hormones|mesh-list
139600442|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
139600443|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139600444|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600445|NCT01576705|Antidotes|antidotes|mesh-ancestor
139600446|NCT01576705|Protective Agents|protective agents|mesh-ancestor
139600447|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
139600448|NCT01576705|Vitamins|vitamins|mesh-ancestor
139600449|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
139600450|NCT01576705|Hematinics|hematinics|mesh-ancestor
139600451|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
139600452|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139600453|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600454|NCT02382666|Rolapitant|rolapitant|mesh-list
139600455|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139600456|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600457|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600458|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600459|NCT00145041|Vincristine|vincristine|mesh-list
139600460|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139600461|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600462|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
139600463|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
139600464|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
139600465|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600466|NCT04123561|Dexamethasone|dexamethasone|mesh-list
139600467|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
139600468|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139600469|NCT04123561|BB 1101|bb 1101|mesh-list
139600470|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139600471|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
139600472|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
139600473|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600474|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600475|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139600476|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
139600477|NCT04123561|Hormones|hormones|mesh-ancestor
139600478|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139600479|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139600480|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600481|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
139600482|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600483|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600484|NCT01510769|Febuxostat|febuxostat|mesh-list
139600485|NCT01510769|Lesinurad|lesinurad|mesh-list
139600486|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
139600487|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139600488|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
139600489|NCT02382354|Remifentanil|remifentanil|mesh-list
139600490|NCT02382354|Propofol|propofol|mesh-list
139600491|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139600492|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600493|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600494|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139600495|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
139600496|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
139600497|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139600498|NCT02382354|Narcotics|narcotics|mesh-ancestor
139600499|NCT02382354|Analgesics|analgesics|mesh-ancestor
139600500|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
139600501|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600502|NCT01510145|Travoprost|travoprost|mesh-list
139600503|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139600504|NCT03027167|Aspirin|aspirin|mesh-list
139600505|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139600506|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139600507|NCT03027167|Analgesics|analgesics|mesh-ancestor
139600508|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
139600509|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600510|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600511|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139600512|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139600513|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139600514|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139600515|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600516|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139600517|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139600518|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600519|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
139600520|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
139600521|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139600522|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139600523|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139600524|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
139600525|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600526|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600527|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600528|NCT02382432|Meperidine|meperidine|mesh-list
139600529|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
139600530|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139600531|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600532|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600533|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139600534|NCT02382432|Analgesics|analgesics|mesh-ancestor
139600535|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
139600536|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600537|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139600538|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139600539|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139600540|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
139600541|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600542|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600543|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139600544|NCT02382432|Narcotics|narcotics|mesh-ancestor
139600545|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139600546|NCT00145587|Antibodies|antibodies|mesh-list
139600547|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
139600548|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600549|NCT04298463|Vancomycin|vancomycin|mesh-list
139600550|NCT04298463|Daptomycin|daptomycin|mesh-list
139600551|NCT04298463|Teicoplanin|teicoplanin|mesh-list
139600552|NCT04298463|Dalbavancin|dalbavancin|mesh-list
139600553|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139382277|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
139600554|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139600555|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
139600556|NCT02381964|Vitamins|vitamins|mesh-ancestor
139600557|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
139600558|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600559|NCT01509053|Aripiprazole|aripiprazole|mesh-list
139600560|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
139600561|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139600562|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139600563|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139600564|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600565|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600566|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
139600567|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
139600568|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600569|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600570|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139600571|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139600572|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
139600573|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139600574|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139600575|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139600576|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139600577|NCT01560403|Teduglutide|teduglutide|mesh-list
139600578|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139600579|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139600580|NCT01560403|Protective Agents|protective agents|mesh-ancestor
139600581|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600582|NCT02100579|Bupivacaine|bupivacaine|mesh-list
139600583|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
139600584|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
139600585|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600586|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600587|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
139600588|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600589|NCT04251351|Acetaminophen|acetaminophen|mesh-list
139600590|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139600591|NCT04251351|Analgesics|analgesics|mesh-ancestor
139600592|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
139600593|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600594|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600595|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
139600596|NCT02390700|Golimumab|golimumab|mesh-list
139600597|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139600598|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139600599|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139600600|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
139600601|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600602|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139600603|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139600604|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139600605|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600606|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
139600607|NCT01527487|Docetaxel|docetaxel|mesh-list
139600608|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139600609|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
139600610|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600611|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139600612|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139600613|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
139600614|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600615|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600616|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139600617|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
139600618|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
139600619|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
139600620|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
139600621|NCT01506947|Hematinics|hematinics|mesh-ancestor
139600622|NCT00149643|Fluoxetine|fluoxetine|mesh-list
139600623|NCT00149643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139600624|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139600625|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139600626|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600627|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600628|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
139600629|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600630|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139600631|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
139600632|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139600633|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139600634|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139600635|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600637|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139600638|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139600639|NCT02381730|Growth Substances|growth substances|mesh-ancestor
139600640|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600641|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
139600642|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600643|NCT00149799|Escitalopram|escitalopram|mesh-list
139600644|NCT00149799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139600645|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139600646|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139600647|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600648|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600649|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
139600650|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600651|NCT02390544|Melphalan|melphalan|mesh-list
139600652|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139600653|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
139600654|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600655|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600656|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139600657|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139600658|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
139600659|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600660|NCT01790997|Aspirin|aspirin|mesh-list
139600661|NCT01790997|Clopidogrel|clopidogrel|mesh-list
139600662|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139600663|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139600664|NCT01790997|Analgesics|analgesics|mesh-ancestor
139600665|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
139600666|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600667|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600668|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139600669|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139600670|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139600671|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139600672|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600673|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139600674|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139600675|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600676|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
139600677|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139600678|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139600679|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139600680|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
139600681|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600682|NCT02385474|Fluorides|fluorides|mesh-list
139600683|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
139600684|NCT02385474|Protective Agents|protective agents|mesh-ancestor
139600685|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600686|NCT02390310|Lidocaine|lidocaine|mesh-list
139600687|NCT02390310|Prilocaine|prilocaine|mesh-list
139600688|NCT02390310|Anesthetics|anesthetics|mesh-list
139600689|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
138728771|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139600690|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600691|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600692|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
139600693|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600694|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139600695|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139600696|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139600697|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139600698|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600699|NCT02381184|Clomiphene|clomiphene|mesh-list
139600700|NCT02381184|Enclomiphene|enclomiphene|mesh-list
139600701|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
139600702|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139600703|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
139600704|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139600705|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600706|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139600707|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
139600708|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139600709|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139600710|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139600711|NCT02381028|Emollients|emollients|mesh-list
139600712|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
139600713|NCT00326781|Nicotine|nicotine|mesh-list
139600714|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139600715|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
139600716|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600717|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600718|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139600719|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139600720|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
139600721|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600722|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600723|NCT02385396|Folic Acid|folic acid|mesh-list
139600724|NCT02385396|Inositol|inositol|mesh-list
139600725|NCT02385396|Hematinics|hematinics|mesh-ancestor
139600726|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
139600727|NCT02385396|Vitamins|vitamins|mesh-ancestor
139600728|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
139600729|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600730|NCT02979405|Phenylephrine|phenylephrine|mesh-list
139600731|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
139600732|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139600733|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
139600734|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
139600735|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600736|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600737|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
139600738|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139600739|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
139600740|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
139600741|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139600742|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139600743|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139600744|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
139600745|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600746|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600747|NCT02979405|Protective Agents|protective agents|mesh-ancestor
139600748|NCT01791231|Canagliflozin|canagliflozin|mesh-list
139600749|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139600750|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600751|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139600752|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600753|NCT01791309|Panitumumab|panitumumab|mesh-list
139600754|NCT01791309|Vemurafenib|vemurafenib|mesh-list
139600755|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139600756|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600757|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139600758|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600759|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600760|NCT00329433|Heparin|heparin|mesh-list
139600761|NCT00329433|Desirudin|desirudin|mesh-list
139600762|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
139600763|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139600764|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139600765|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600766|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
139600767|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139600768|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139600769|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
139600770|NCT02389842|Palbociclib|palbociclib|mesh-list
139600771|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600772|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139600773|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600774|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600775|NCT00289653|Nicotine|nicotine|mesh-list
139600776|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139600777|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
139600778|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600779|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600780|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139600781|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139600782|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
139382496|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139600783|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600784|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600785|NCT00291135|Letrozole|letrozole|mesh-list
139600786|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600787|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139600788|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139600789|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600790|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600791|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139600792|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
139600793|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139600794|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600795|NCT02103855|Abatacept|abatacept|mesh-list
139600796|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139600797|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600798|NCT02103855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139600799|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600800|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139600801|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
139600802|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600803|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139600804|NCT03706053|Midodrine|midodrine|mesh-list
139600805|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
139600806|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
139600807|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600808|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600809|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139600810|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139600811|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139600812|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139600813|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
139600814|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600815|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600816|NCT01504841|Etravirine|etravirine|mesh-list
139600817|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139600818|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139600819|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600820|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600821|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
139600822|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139600823|NCT00330915|Pemetrexed|pemetrexed|mesh-list
139600824|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600825|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600826|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600827|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139600828|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139600829|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139600830|NCT03026933|Calcium|calcium|mesh-list
139600831|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139600832|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600833|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139600834|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139600835|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
139600836|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600837|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139600838|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139600839|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600840|NCT01502423|Adalimumab|adalimumab|mesh-list
139600841|NCT01502423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139600842|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139600843|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139600844|NCT04861584|Gemcitabine|gemcitabine|mesh-list
139600845|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600846|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139600847|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
139600848|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600849|NCT02388750|Palonosetron|palonosetron|mesh-list
139600850|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
139600851|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
139600852|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600853|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600854|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139382642|NCT04815200|Copper|copper|mesh-list
139600855|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139600856|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139600857|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
139600858|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600859|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600860|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
139600861|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139600862|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
139600863|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600864|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139600865|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139600866|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
139600867|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600868|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600869|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139600871|NCT01500317|Tapentadol|tapentadol|mesh-list
139600872|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139600873|NCT01500317|Narcotics|narcotics|mesh-ancestor
139600874|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600875|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600876|NCT01500317|Analgesics|analgesics|mesh-ancestor
139600877|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
139600878|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139600879|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139600880|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139600881|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139600882|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600883|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
139600884|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600885|NCT02379546|Desflurane|desflurane|mesh-list
139600886|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139600887|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
139600888|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
139600889|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600890|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600891|NCT00332163|Irinotecan|irinotecan|mesh-list
139600892|NCT00332163|Panitumumab|panitumumab|mesh-list
139600893|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139600894|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139600895|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600896|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600897|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600898|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139600899|NCT02379000|Triamcinolone|triamcinolone|mesh-list
139600900|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139600901|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139600902|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139600903|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139600904|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
139600905|NCT02379000|Hormones|hormones|mesh-ancestor
139600906|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139600907|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600908|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139600909|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
139600910|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600911|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600912|NCT00333177|Risperidone|risperidone|mesh-list
139600913|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139600914|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
139600915|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600916|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600917|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600918|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139600919|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139600920|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139600921|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139600922|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139600923|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
139600924|NCT02379156|Midodrine|midodrine|mesh-list
139600925|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
139600926|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
139600927|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382645|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
139600928|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600929|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139600930|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139600931|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139600932|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139600933|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
139600934|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139600935|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600936|NCT00335283|Lansoprazole|lansoprazole|mesh-list
139600937|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
139600938|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139600939|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139600940|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139600941|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600942|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600943|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139600944|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139600945|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
139600946|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600947|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600948|NCT02779257|Diazoxide|diazoxide|mesh-list
139600949|NCT02779257|Pasireotide|pasireotide|mesh-list
139600950|NCT02779257|Hormones|hormones|mesh-ancestor
139600951|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139600952|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600953|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139600954|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
139600955|NCT00295503|Bevacizumab|bevacizumab|mesh-list
139600956|NCT00295503|Pemetrexed|pemetrexed|mesh-list
139600957|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139600958|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600959|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139600960|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139600961|NCT00295503|Growth Substances|growth substances|mesh-ancestor
139600962|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600963|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
139600964|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600965|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600966|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139600967|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139600968|NCT02371590|Lenalidomide|lenalidomide|mesh-list
139600969|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
139600970|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
139600971|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600972|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139600973|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138729079|NCT03927690|Ranibizumab|ranibizumab|mesh-list
139600974|NCT02371590|Growth Substances|growth substances|mesh-ancestor
139600975|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
139600976|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600977|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139600978|NCT00298155|Ketoconazole|ketoconazole|mesh-list
139600979|NCT00298155|Goserelin|goserelin|mesh-list
139600980|NCT00298155|Bicalutamide|bicalutamide|mesh-list
139600981|NCT00298155|Dutasteride|dutasteride|mesh-list
139600982|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139600983|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139600984|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
139600985|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139600986|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139600987|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139600988|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139600989|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139600990|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139600991|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
139600992|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139600993|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139600994|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139600995|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
139600996|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139600997|NCT01499849|Dexamethasone|dexamethasone|mesh-list
139600998|NCT01499849|Granisetron|granisetron|mesh-list
139600999|NCT01499849|Rolapitant|rolapitant|mesh-list
139601000|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139601001|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
139601003|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601004|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601005|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139601006|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
139601007|NCT01499849|Hormones|hormones|mesh-ancestor
139601008|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139601009|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139601010|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601011|NCT01499849|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139601012|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139601013|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
139601014|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601015|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601016|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139601017|NCT00298233|Oseltamivir|oseltamivir|mesh-list
139601018|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
139601019|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139601020|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601021|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601022|NCT02376972|Rifaximin|rifaximin|mesh-list
139601023|NCT02376972|Metronidazole|metronidazole|mesh-list
139601024|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139601025|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139601026|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139601027|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139601028|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139601029|NCT02378532|Chloroquine|chloroquine|mesh-list
139601030|NCT02378532|Temozolomide|temozolomide|mesh-list
139601031|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139601032|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
139601033|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601034|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601035|NCT02378532|Amebicides|amebicides|mesh-ancestor
139601036|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139601037|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139601038|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138729144|NCT03721653|Antidotes|antidotes|mesh-ancestor
139601039|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
139601040|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139601041|NCT01498679|Fluticasone|fluticasone|mesh-list
139601042|NCT01498679|Xhance|xhance|mesh-list
139601043|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139601044|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139601045|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
139601046|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601047|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601048|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139601049|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
139601050|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
139601051|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139601052|NCT01000467|Probucol|probucol|mesh-list
139601053|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139601054|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139601055|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
139601056|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601057|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139601058|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
139601059|NCT01000467|Protective Agents|protective agents|mesh-ancestor
139601060|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601061|NCT00198315|Bleomycin|bleomycin|mesh-list
139601062|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139601063|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601064|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
139601065|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139601066|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139601067|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
139601068|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601069|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601070|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601071|NCT01559389|Urological Agents|urological agents|mesh-ancestor
139601072|NCT01526551|Vaccines|vaccines|mesh-list
139601073|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
139601074|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601075|NCT00343083|Paclitaxel|paclitaxel|mesh-list
139601076|NCT00343083|Carboplatin|carboplatin|mesh-list
139601077|NCT00343083|Cetuximab|cetuximab|mesh-list
139601078|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139601079|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601080|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
139601081|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
139601082|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
139601083|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601084|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139601085|NCT02376426|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139601086|NCT02376426|Antiviral Agents|antiviral agents|mesh-ancestor
139601087|NCT02376426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139601088|NCT00343785|Cyclosporine|cyclosporine|mesh-list
139601089|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
139601090|NCT00343785|Methotrexate|methotrexate|mesh-list
139601091|NCT00343785|Cyclosporins|cyclosporins|mesh-list
139601092|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
139601093|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139601094|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
139601095|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139601096|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
139601097|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601098|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139601099|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139601100|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
139601101|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601102|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601103|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139601104|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139601105|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
139601106|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139601107|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139601108|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
139601109|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
139601110|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601111|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139601112|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139601113|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
139601114|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139601115|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139601116|NCT00343863|Dexamethasone|dexamethasone|mesh-list
139601117|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
139601118|NCT00343863|Doxorubicin|doxorubicin|mesh-list
139601119|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139601120|NCT00343863|Ondansetron|ondansetron|mesh-list
139601121|NCT00343863|Palonosetron|palonosetron|mesh-list
139601122|NCT00343863|Antiemetics|antiemetics|mesh-list
139601123|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139601124|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
139601125|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601126|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139601127|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139601128|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
139601129|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601130|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601131|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139601132|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139601133|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
139601134|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601135|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139601136|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
139601137|NCT00343863|Hormones|hormones|mesh-ancestor
139601138|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139601139|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139601140|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139601141|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139601142|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139601143|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601144|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
139601145|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
139601146|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139601147|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139601148|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
139601149|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601150|NCT00344175|Simvastatin|simvastatin|mesh-list
139601151|NCT00344175|Pitavastatin|pitavastatin|mesh-list
139601152|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139601153|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139601154|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
139601155|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601156|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139601157|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139601158|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601159|NCT00345033|Aripiprazole|aripiprazole|mesh-list
139601160|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
139601161|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139601162|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139601163|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139601164|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139601165|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601166|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
139601167|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
139601168|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601169|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601170|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139601171|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139601172|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
139601173|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139601174|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139601175|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139601176|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139601177|NCT00345969|Testosterone|testosterone|mesh-list
139601178|NCT00345969|Androgens|androgens|mesh-ancestor
139601179|NCT00345969|Hormones|hormones|mesh-ancestor
139601180|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139601181|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601182|NCT01498445|Decitabine|decitabine|mesh-list
139601183|NCT01498445|Dasatinib|dasatinib|mesh-list
139601184|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139601185|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
139601186|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601187|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601188|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601189|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139601190|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
139601191|NCT01525615|Olodaterol|olodaterol|mesh-list
139601192|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139601193|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
139601194|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601195|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601196|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139601197|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
139601198|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
139601199|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139601200|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
139601201|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601202|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601203|NCT00309465|Insulin|insulin|mesh-list
139601204|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139601205|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
139601206|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139601207|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601208|NCT01791699|Moxonidine|moxonidine|mesh-list
139601209|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139601210|NCT00302133|Naltrexone|naltrexone|mesh-list
139601211|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139601212|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139601213|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601214|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
139601215|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601216|NCT01525225|Metformin|metformin|mesh-list
139601217|NCT01525225|Saxagliptin|saxagliptin|mesh-list
139601218|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139601219|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601220|NCT01525225|Incretins|incretins|mesh-ancestor
139601221|NCT01525225|Hormones|hormones|mesh-ancestor
139601222|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139601223|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139601224|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
139601225|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601226|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601227|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139601228|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139601229|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139601230|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139601231|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601232|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
139601233|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601234|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601235|NCT01524991|Gemcitabine|gemcitabine|mesh-list
139601236|NCT01524991|Ipilimumab|ipilimumab|mesh-list
139601237|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601238|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139601239|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
139601240|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601241|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139601242|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139601243|NCT04039230|Talazoparib|talazoparib|mesh-list
139601244|NCT04039230|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139601245|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139601246|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601247|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601248|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601249|NCT04039230|Immunoconjugates|immunoconjugates|mesh-ancestor
139601250|NCT04039230|Immunologic Factors|immunologic factors|mesh-ancestor
139601251|NCT04039230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601252|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
139601253|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139601254|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
139601255|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601256|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
139601257|NCT01524913|Protective Agents|protective agents|mesh-ancestor
139601258|NCT02376192|Phenylephrine|phenylephrine|mesh-list
139601259|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
139601260|NCT02376192|Ephedrine|ephedrine|mesh-list
139601261|NCT02376192|Bupivacaine|bupivacaine|mesh-list
139601262|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
139601263|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
139601264|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139601265|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601266|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
139601267|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601268|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139601269|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
139601270|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
139601271|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
139601272|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139601273|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
139601274|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
139601275|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139601276|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139601277|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139601278|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
139601279|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601280|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601281|NCT02376192|Protective Agents|protective agents|mesh-ancestor
139601282|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139601283|NCT02375880|Gemcitabine|gemcitabine|mesh-list
139601284|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601285|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139601286|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
139601287|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601288|NCT01524679|Interferons|interferons|mesh-list
139601289|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
139601290|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
139601291|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139601292|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601293|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
139601294|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139601295|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
139601296|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601297|NCT02365272|Amikacin|amikacin|mesh-list
139601298|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139601299|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139601300|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139601301|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139601302|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139601303|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
139601304|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601305|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139601306|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139601307|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601308|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
139601309|NCT04645602|Lenvatinib|lenvatinib|mesh-list
139601310|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139601311|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601312|NCT04645602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139601313|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601314|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139601315|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601316|NCT01880541|Anesthetics|anesthetics|mesh-list
139601317|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139601318|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601319|NCT02368860|Capecitabine|capecitabine|mesh-list
139601320|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
139601321|NCT02368860|Irinotecan|irinotecan|mesh-list
139601322|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139601323|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
139601324|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601325|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601326|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139601327|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139601328|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601329|NCT02375646|Heparin|heparin|mesh-list
139601330|NCT02375646|Enoxaparin|enoxaparin|mesh-list
139601331|NCT02375646|Warfarin|warfarin|mesh-list
139601332|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
139601333|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139601334|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139601335|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601336|NCT01524289|Anacetrapib|anacetrapib|mesh-list
139601337|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139601338|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139601339|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
139601340|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601341|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139601342|NCT01498289|Leucovorin|leucovorin|mesh-list
139601343|NCT01498289|Docetaxel|docetaxel|mesh-list
139601344|NCT01498289|Fluorouracil|fluorouracil|mesh-list
139601345|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
139601346|NCT01498289|Irinotecan|irinotecan|mesh-list
139601347|NCT01498289|Calcium|calcium|mesh-list
139601348|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
139601349|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601350|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
139601351|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
139601352|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
139601353|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601354|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139601355|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601356|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
139601357|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139601358|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139601359|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
139601360|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139601361|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139601362|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601363|NCT01498289|Antidotes|antidotes|mesh-ancestor
139601364|NCT01498289|Protective Agents|protective agents|mesh-ancestor
139601365|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
139601366|NCT01498289|Vitamins|vitamins|mesh-ancestor
139601367|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
139601368|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
139601369|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
139601370|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139601371|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139601372|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601373|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601374|NCT02364882|Urological Agents|urological agents|mesh-ancestor
139601375|NCT02364804|Aprepitant|aprepitant|mesh-list
139601376|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
139601377|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
139601378|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601379|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601380|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139601381|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139601382|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601383|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601384|NCT01524133|Sertraline|sertraline|mesh-list
139601385|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
139601386|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139601387|NCT01524133|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139601388|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139601389|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139601390|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601391|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601392|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
139601393|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601394|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
139601395|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139601396|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139601397|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601398|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729501|NCT02872259|Trametinib|trametinib|mesh-list
139601399|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139601400|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139601401|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601402|NCT05800587|Paclitaxel|paclitaxel|mesh-list
139601403|NCT05800587|Etoposide|etoposide|mesh-list
139601404|NCT05800587|Docetaxel|docetaxel|mesh-list
139601405|NCT05800587|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139601406|NCT05800587|Carboplatin|carboplatin|mesh-list
139601407|NCT05800587|Gemcitabine|gemcitabine|mesh-list
139601408|NCT05800587|Irinotecan|irinotecan|mesh-list
139601409|NCT05800587|Pemetrexed|pemetrexed|mesh-list
139601410|NCT05800587|Topotecan|topotecan|mesh-list
139601411|NCT05800587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139601412|NCT05800587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601413|NCT05800587|Tubulin Modulators|tubulin modulators|mesh-ancestor
139601414|NCT05800587|Antimitotic Agents|antimitotic agents|mesh-ancestor
139601415|NCT05800587|Mitosis Modulators|mitosis modulators|mesh-ancestor
139601416|NCT05800587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601417|NCT05800587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139601418|NCT05800587|Antimetabolites|antimetabolites|mesh-ancestor
139601419|NCT05800587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139601420|NCT05800587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139601421|NCT05800587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601422|NCT05800587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139601423|NCT05800587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139601424|NCT05800587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139601425|NCT05800418|Ramucirumab|ramucirumab|mesh-list
139601426|NCT05800418|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139601427|NCT05800418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601428|NCT05800418|Immunologic Factors|immunologic factors|mesh-ancestor
139601429|NCT05800418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601430|NCT05800340|Paclitaxel|paclitaxel|mesh-list
139601431|NCT05800340|Carboplatin|carboplatin|mesh-list
139601432|NCT05800340|Pemetrexed|pemetrexed|mesh-list
139601433|NCT05800340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139601434|NCT05800340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601435|NCT05800340|Tubulin Modulators|tubulin modulators|mesh-ancestor
139601436|NCT05800340|Antimitotic Agents|antimitotic agents|mesh-ancestor
139601437|NCT05800340|Mitosis Modulators|mitosis modulators|mesh-ancestor
139601438|NCT05800340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601439|NCT05800340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601440|NCT05800340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139601441|NCT05800340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139601442|NCT05800301|Neurotransmitter Agents|neurotransmitter agents|mesh-list
139601443|NCT05800301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601444|NCT05800301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601445|NCT05800106|Sunitinib|sunitinib|mesh-list
139601446|NCT05800106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601447|NCT05800106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139601448|NCT05800106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139601449|NCT05800106|Growth Substances|growth substances|mesh-ancestor
139601450|NCT05800106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601451|NCT05800106|Growth Inhibitors|growth inhibitors|mesh-ancestor
139601452|NCT05800106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139601453|NCT05800106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601454|NCT05800106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383180|NCT06171880|Tenofovir|tenofovir|mesh-list
139601455|NCT05800080|Oxaliplatin|oxaliplatin|mesh-list
139601456|NCT05800080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601457|NCT05800054|Docetaxel|docetaxel|mesh-list
139601458|NCT05800054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601459|NCT05800054|Tubulin Modulators|tubulin modulators|mesh-ancestor
139601460|NCT05800054|Antimitotic Agents|antimitotic agents|mesh-ancestor
139601461|NCT05800054|Mitosis Modulators|mitosis modulators|mesh-ancestor
139601462|NCT05800054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601463|NCT05800041|Cyclophosphamide|cyclophosphamide|mesh-list
139601464|NCT05800041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139601465|NCT05800041|Immunologic Factors|immunologic factors|mesh-ancestor
139601466|NCT05800041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601467|NCT05800041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139601468|NCT05800041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139601469|NCT05800041|Alkylating Agents|alkylating agents|mesh-ancestor
139601470|NCT05800041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601471|NCT05800041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601472|NCT05800041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139601473|NCT05799924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139601474|NCT05799924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139601475|NCT05799924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139601476|NCT05799924|Analgesics|analgesics|mesh-ancestor
139601477|NCT05799924|Sensory System Agents|sensory system agents|mesh-ancestor
139601478|NCT05799924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601479|NCT05799924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601480|NCT05799924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139601481|NCT05799469|Cisplatin|cisplatin|mesh-list
139601482|NCT05799469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601483|NCT05799443|Irinotecan|irinotecan|mesh-list
139601484|NCT05799443|Cetuximab|cetuximab|mesh-list
139601485|NCT05799443|Tislelizumab|tislelizumab|mesh-list
139601486|NCT05799443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139601487|NCT05799443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139601488|NCT05799443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601489|NCT05799443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601490|NCT05799443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601491|NCT05799443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139601492|NCT05799300|Anesthetics|anesthetics|mesh-list
139601493|NCT05799300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139601494|NCT05799300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601495|NCT05799053|Peppermint oil|peppermint oil|mesh-list
139601496|NCT05799053|Antiemetics|antiemetics|mesh-ancestor
139601497|NCT05799053|Autonomic Agents|autonomic agents|mesh-ancestor
139601498|NCT05799053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601499|NCT05799053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601500|NCT05799053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139601501|NCT05799053|Parasympatholytics|parasympatholytics|mesh-ancestor
139601502|NCT05798936|Ethanol|ethanol|mesh-list
139601503|NCT05798936|Polidocanol|polidocanol|mesh-list
139601504|NCT05798936|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139601505|NCT05798936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139601506|NCT05798936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139601507|NCT05798936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601508|NCT05798936|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139601509|NCT05798936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139601510|NCT05798871|Erythritol|erythritol|mesh-list
139601511|NCT05798871|Vasodilator Agents|vasodilator agents|mesh-ancestor
139601512|NCT05798819|Paclitaxel|paclitaxel|mesh-list
139601513|NCT05798819|Bevacizumab|bevacizumab|mesh-list
139601514|NCT05798819|Carboplatin|carboplatin|mesh-list
139601515|NCT05798819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139601516|NCT05798819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601517|NCT05798819|Tubulin Modulators|tubulin modulators|mesh-ancestor
139601518|NCT05798819|Antimitotic Agents|antimitotic agents|mesh-ancestor
139601519|NCT05798819|Mitosis Modulators|mitosis modulators|mesh-ancestor
139601520|NCT05798819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601521|NCT05798819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139601522|NCT05798819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139601523|NCT05798819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139601524|NCT05798819|Growth Substances|growth substances|mesh-ancestor
139601525|NCT05798819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601526|NCT05798819|Growth Inhibitors|growth inhibitors|mesh-ancestor
139601527|NCT05798728|Misoprostol|misoprostol|mesh-list
139601528|NCT05798728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139601529|NCT05798728|Abortifacient Agents|abortifacient agents|mesh-ancestor
139383255|NCT06162013|Niacinamide|niacinamide|mesh-list
139601530|NCT05798728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139601531|NCT05798728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601532|NCT05798728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139601533|NCT05798728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139601534|NCT05798728|Oxytocics|oxytocics|mesh-ancestor
139601535|NCT05798715|Metformin|metformin|mesh-list
139601536|NCT05798715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139601537|NCT05798715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139601538|NCT05798715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601539|NCT05798715|Incretins|incretins|mesh-ancestor
139601540|NCT05798715|Hormones|hormones|mesh-ancestor
139601541|NCT05798715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139601542|NCT05798715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139601543|NCT05798715|Protease Inhibitors|protease inhibitors|mesh-ancestor
139601544|NCT05798715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601545|NCT05798715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601546|NCT05795491|Fluconazole|fluconazole|mesh-list
139601547|NCT05795491|Antifungal Agents|antifungal agents|mesh-list
139601548|NCT05795491|Clotrimazole|clotrimazole|mesh-list
139601549|NCT05795491|Miconazole|miconazole|mesh-list
139601550|NCT05795491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139601551|NCT05795491|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139601552|NCT05795491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139601553|NCT05795491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601554|NCT05795491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601555|NCT05795491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139601556|NCT05795491|Hormone Antagonists|hormone antagonists|mesh-ancestor
139601557|NCT05795491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139601558|NCT05795491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601559|NCT05795491|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139601560|NCT05795491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139601561|NCT05795491|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139601562|NCT05795491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139601563|NCT05788627|Lactulose|lactulose|mesh-list
139601564|NCT05788627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139601565|NCT05777135|Propofol|propofol|mesh-list
139601566|NCT05777135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139601567|NCT05777135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139601568|NCT05777135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601569|NCT05777135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139601570|NCT05777135|Anesthetics, General|anesthetics, general|mesh-ancestor
139601571|NCT05777135|Anesthetics|anesthetics|mesh-ancestor
139601572|NCT05771883|Lenalidomide|lenalidomide|mesh-list
139601573|NCT05771883|Immunologic Factors|immunologic factors|mesh-ancestor
139601574|NCT05771883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601575|NCT05771883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139601576|NCT05771883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139601577|NCT05771883|Growth Substances|growth substances|mesh-ancestor
139601578|NCT05771883|Growth Inhibitors|growth inhibitors|mesh-ancestor
139601579|NCT05771883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601580|NCT05767892|Carboplatin|carboplatin|mesh-list
139601581|NCT05767892|Pemetrexed|pemetrexed|mesh-list
139601582|NCT05767892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601583|NCT05767892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601584|NCT05767892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601585|NCT05767892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139601586|NCT05767892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139601587|NCT05730816|Magnesium Sulfate|magnesium sulfate|mesh-list
139601588|NCT05730816|Analgesics|analgesics|mesh-ancestor
139601589|NCT05730816|Sensory System Agents|sensory system agents|mesh-ancestor
139601590|NCT05730816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601591|NCT05730816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601592|NCT05730816|Anesthetics|anesthetics|mesh-ancestor
139601593|NCT05730816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139601594|NCT05730816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139601595|NCT05730816|Anticonvulsants|anticonvulsants|mesh-ancestor
139601596|NCT05730816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139601597|NCT05730816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139601598|NCT05730816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601599|NCT05730816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139601600|NCT05730816|Tocolytic Agents|tocolytic agents|mesh-ancestor
139601601|NCT05730816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139601602|NCT05702333|Simendan|simendan|mesh-list
139383331|NCT06066216|Paclitaxel|paclitaxel|mesh-list
139601604|NCT05702333|Dopamine|dopamine|mesh-list
139601605|NCT05702333|Epinephrine|epinephrine|mesh-list
139601606|NCT05702333|Norepinephrine|norepinephrine|mesh-list
139601607|NCT05702333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139601608|NCT05702333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139601609|NCT05702333|Adrenergic Agents|adrenergic agents|mesh-ancestor
139601610|NCT05702333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601611|NCT05702333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601612|NCT05702333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601613|NCT05702333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139601614|NCT05702333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139601615|NCT05702333|Autonomic Agents|autonomic agents|mesh-ancestor
139601616|NCT05702333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601617|NCT05702333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139601618|NCT05702333|Respiratory System Agents|respiratory system agents|mesh-ancestor
139601619|NCT05702333|Mydriatics|mydriatics|mesh-ancestor
139601620|NCT05702333|Sympathomimetics|sympathomimetics|mesh-ancestor
139601621|NCT05702333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139601622|NCT05702333|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139601623|NCT05702333|Vasodilator Agents|vasodilator agents|mesh-ancestor
139601624|NCT05702333|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139601625|NCT05702333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139601626|NCT05702333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601627|NCT05702333|Protective Agents|protective agents|mesh-ancestor
139601628|NCT05702333|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139601629|NCT05702333|Dopamine Agents|dopamine agents|mesh-ancestor
139601630|NCT05671913|Ketamine|ketamine|mesh-list
139601631|NCT05671913|Analgesics|analgesics|mesh-ancestor
139601632|NCT05671913|Sensory System Agents|sensory system agents|mesh-ancestor
139601633|NCT05671913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601634|NCT05671913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601635|NCT05671913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139601636|NCT05671913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139601637|NCT05671913|Anesthetics, General|anesthetics, general|mesh-ancestor
139601638|NCT05671913|Anesthetics|anesthetics|mesh-ancestor
139601639|NCT05671913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139601640|NCT05671913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139601641|NCT05671913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139601642|NCT05671913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601643|NCT05671913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601644|NCT05668936|Moxifloxacin|moxifloxacin|mesh-list
139601645|NCT05668936|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139601646|NCT05668936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139601647|NCT05668936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139601648|NCT05668936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139601649|NCT05668936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139601650|NCT05668936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601651|NCT05668936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601652|NCT05668936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601653|NCT05668936|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139601654|NCT05668936|Contraceptive Agents|contraceptive agents|mesh-ancestor
139601655|NCT05668936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139601656|NCT05668936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601657|NCT05668936|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139601658|NCT05668936|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139601659|NCT05668936|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139601660|NCT05657990|Tamsulosin|tamsulosin|mesh-list
139601661|NCT05657990|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139601662|NCT05657990|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139601663|NCT05657990|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139601664|NCT05657990|Adrenergic Agents|adrenergic agents|mesh-ancestor
139601665|NCT05657990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601666|NCT05657990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601667|NCT05657990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601668|NCT05657990|Urological Agents|urological agents|mesh-ancestor
139601669|NCT05627752|Docetaxel|docetaxel|mesh-list
139601670|NCT05627752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601671|NCT05627752|Tubulin Modulators|tubulin modulators|mesh-ancestor
139601672|NCT05627752|Antimitotic Agents|antimitotic agents|mesh-ancestor
139601673|NCT05627752|Mitosis Modulators|mitosis modulators|mesh-ancestor
139601674|NCT05627752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601675|NCT05590676|Metformin|metformin|mesh-list
139601676|NCT05590676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139601677|NCT05590676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601678|NCT05559814|Peppermint oil|peppermint oil|mesh-list
139601679|NCT05559814|Antiemetics|antiemetics|mesh-ancestor
139601680|NCT05559814|Autonomic Agents|autonomic agents|mesh-ancestor
139601681|NCT05559814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601682|NCT05559814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601683|NCT05559814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139601684|NCT05559814|Parasympatholytics|parasympatholytics|mesh-ancestor
139601685|NCT05438420|Pembrolizumab|pembrolizumab|mesh-list
139601686|NCT05438420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139601687|NCT05438420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601688|NCT05438420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139601689|NCT05438420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601690|NCT05382481|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139601691|NCT05382481|Dalteparin|dalteparin|mesh-list
139601692|NCT05382481|Anticoagulants|anticoagulants|mesh-ancestor
139601693|NCT05382481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139601694|NCT05382481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139601695|NCT05382481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601696|NCT05323786|Anesthetics|anesthetics|mesh-list
139601697|NCT05323786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139601698|NCT05323786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601699|NCT05262387|Insulin Lispro|insulin lispro|mesh-list
139601700|NCT05262387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139601701|NCT05262387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601702|NCT05221554|Tacrine|tacrine|mesh-list
139601703|NCT05221554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139601704|NCT05221554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601705|NCT05221554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601706|NCT05221554|Cholinergic Agents|cholinergic agents|mesh-ancestor
139601707|NCT05221554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601708|NCT05221554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601709|NCT05221554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139601710|NCT05221554|Autonomic Agents|autonomic agents|mesh-ancestor
139601711|NCT05221554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601712|NCT05221554|Nootropic Agents|nootropic agents|mesh-ancestor
139601713|NCT05162937|Antibodies|antibodies|mesh-list
139601714|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
139601715|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601716|NCT04985500|Bupivacaine|bupivacaine|mesh-list
139601717|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
139601718|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
139601719|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139601720|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601721|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
139601722|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601723|NCT04973670|Sivelestat|sivelestat|mesh-list
139601724|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139601725|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
139601726|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601727|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601728|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
139601729|NCT04929626|Albuterol|albuterol|mesh-list
139601730|NCT04929626|Analgesics|analgesics|mesh-ancestor
139601731|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
139601732|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601733|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601734|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
139601735|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139601736|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138729861|NCT02049515|Ofatumumab|ofatumumab|mesh-list
139601737|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
139601738|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139601739|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139601740|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601741|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139601742|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
139601743|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139601744|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139601745|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
139601746|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139601747|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
139601748|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139601749|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139601750|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139601751|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
139601752|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601753|NCT04908202|Deucravacitinib|deucravacitinib|mesh-list
139601754|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
139601755|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139601756|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601757|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601758|NCT04826198|Olaparib|olaparib|mesh-list
139601759|NCT04826198|Niraparib|niraparib|mesh-list
139601760|NCT04826198|Rucaparib|rucaparib|mesh-list
139601761|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139601762|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601763|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601764|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601765|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
139601766|NCT04808934|Apixaban|apixaban|mesh-list
139601767|NCT04808934|Dabigatran|dabigatran|mesh-list
139601768|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139601769|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
139601770|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139601771|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
139601772|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601773|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601774|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
139601775|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
139601776|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139601777|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139601778|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601779|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
139601780|NCT04754230|Coagulants|coagulants|mesh-ancestor
139601781|NCT04733118|Trastuzumab|trastuzumab|mesh-list
139601782|NCT04733118|Pertuzumab|pertuzumab|mesh-list
139601783|NCT04733118|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139601784|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139601785|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601786|NCT04733118|Tubulin Modulators|tubulin modulators|mesh-ancestor
139601787|NCT04733118|Antimitotic Agents|antimitotic agents|mesh-ancestor
139601788|NCT04733118|Mitosis Modulators|mitosis modulators|mesh-ancestor
139601789|NCT04733118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601790|NCT04733118|Immunotoxins|immunotoxins|mesh-ancestor
139601791|NCT04733118|Immunoconjugates|immunoconjugates|mesh-ancestor
139601792|NCT04733118|Immunologic Factors|immunologic factors|mesh-ancestor
139601793|NCT04733118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601794|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139601795|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139601796|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139601797|NCT04653337|Norepinephrine|norepinephrine|mesh-list
139601798|NCT04653337|Serotonin|serotonin|mesh-list
139601799|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
139601800|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139601801|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139601802|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
139601803|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601804|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601805|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601806|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
139601807|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
139601808|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601809|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139601810|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139601811|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
139601812|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139601813|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139601814|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139601815|NCT04539626|Estradiol|estradiol|mesh-list
139601816|NCT04539626|Estrogens|estrogens|mesh-list
139601817|NCT04539626|Hormones|hormones|mesh-ancestor
139601818|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139601819|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601820|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139601821|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
139601822|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139601823|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139601824|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139601825|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139601826|NCT04512534|Antibodies|antibodies|mesh-list
139601827|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139601828|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
139601829|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601830|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601831|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601832|NCT04486118|Lisinopril|lisinopril|mesh-list
139601833|NCT04486118|Benazepril|benazepril|mesh-list
139601834|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139601835|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
139601836|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601837|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601838|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139601839|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139601840|NCT04486118|Protective Agents|protective agents|mesh-ancestor
139601841|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601842|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
139601843|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139601844|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601845|NCT04442581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139601846|NCT04442581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601847|NCT04436731|Phentolamine|phentolamine|mesh-list
139601848|NCT04436731|Phenylephrine|phenylephrine|mesh-list
139601849|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
139601850|NCT04436731|Norepinephrine|norepinephrine|mesh-list
139601851|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
139601852|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139601853|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139601854|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601855|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139601856|NCT04436731|Analgesics|analgesics|mesh-ancestor
139601857|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
139601858|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601859|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139601860|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139601861|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139601862|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
139601863|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601864|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601865|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139601866|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
139601867|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
139601868|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
139601869|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139601870|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
139601871|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
139601872|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139601873|NCT04436731|Protective Agents|protective agents|mesh-ancestor
139601874|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139601875|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139601876|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139601877|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
139601878|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139601879|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601880|NCT04268706|Fludarabine|fludarabine|mesh-list
139601881|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139601882|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601883|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601884|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139601885|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
139601886|NCT04223609|Oxycodone|oxycodone|mesh-list
139601887|NCT04223609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139601888|NCT04223609|Narcotics|narcotics|mesh-ancestor
139601889|NCT04223609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139601890|NCT04223609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601891|NCT04223609|Analgesics|analgesics|mesh-ancestor
139601892|NCT04223609|Sensory System Agents|sensory system agents|mesh-ancestor
139601893|NCT04223609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601894|NCT04118920|Insulin|insulin|mesh-list
139601895|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139601896|NCT04118920|Lubricant Eye Drops|lubricant eye drops|mesh-list
139601897|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139601898|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601899|NCT04118920|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139601900|NCT04118920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139601901|NCT04083144|Varenicline|varenicline|mesh-list
139297197|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139601902|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139601903|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139601904|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
139601905|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139601906|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601907|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601908|NCT04055818|Niacinamide|niacinamide|mesh-list
139601909|NCT04055818|Niacin|niacin|mesh-list
139601910|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
139601911|NCT04055818|Decitabine|decitabine|mesh-list
139601912|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
139601913|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139601914|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
139601915|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601916|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601917|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601918|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
139601919|NCT04055818|Vitamins|vitamins|mesh-ancestor
139601920|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
139601921|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601922|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139601923|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139601924|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
139601925|NCT04047953|Paclitaxel|paclitaxel|mesh-list
139601926|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139601927|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
139601928|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139601929|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601930|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
139601931|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
139601932|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
139601933|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601934|NCT03981900|Tofacitinib|tofacitinib|mesh-list
139601935|NCT03981900|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139601936|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139601937|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601938|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601939|NCT03941288|Cannabidiol|cannabidiol|mesh-list
139601940|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
139601941|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139601942|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139601943|NCT03856671|Metronidazole|metronidazole|mesh-list
139601944|NCT03856671|Neomycin|neomycin|mesh-list
139601945|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139601946|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139601947|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139601948|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139601949|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139601950|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601951|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601952|NCT03728361|Nivolumab|nivolumab|mesh-list
139601953|NCT03728361|Temozolomide|temozolomide|mesh-list
139601954|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139601955|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601956|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139601957|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601958|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139601959|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
139601960|NCT03662685|Coal Tar|coal tar|mesh-list
139601961|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
139601962|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
139601963|NCT03617328|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139601964|NCT03617328|Poly ICLC|poly iclc|mesh-list
139601965|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
139601966|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601967|NCT03617328|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139601968|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
139601969|NCT03391934|Leucovorin|leucovorin|mesh-list
139601970|NCT03391934|Fluorouracil|fluorouracil|mesh-list
139601971|NCT03391934|Irinotecan|irinotecan|mesh-list
139601972|NCT03391934|Cetuximab|cetuximab|mesh-list
139601973|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139601974|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
139601975|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601976|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139601977|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601978|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139601979|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
139601980|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139601981|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139601982|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601983|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139601984|NCT03391934|Antidotes|antidotes|mesh-ancestor
139601985|NCT03391934|Protective Agents|protective agents|mesh-ancestor
139601986|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
139601987|NCT03391934|Vitamins|vitamins|mesh-ancestor
139601988|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
139601989|NCT03333343|Gefitinib|gefitinib|mesh-list
139601990|NCT03333343|Trametinib|trametinib|mesh-list
139601991|NCT03333343|Nazartinib|nazartinib|mesh-list
139601992|NCT03333343|Naporafenib|naporafenib|mesh-list
139601993|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139601994|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139601995|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139601996|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139601997|NCT03326947|Docetaxel|docetaxel|mesh-list
139601998|NCT03326947|Fluorouracil|fluorouracil|mesh-list
139601999|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602000|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
139602001|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
139602002|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
139602003|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602004|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
139602005|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139602006|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139602007|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
139602008|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602009|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
139602010|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139602011|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602012|NCT03304639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139602013|NCT03304639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602014|NCT03289234|Edaravone|edaravone|mesh-list
139602015|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139602016|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
139602017|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602018|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139602019|NCT03289234|Protective Agents|protective agents|mesh-ancestor
139602020|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602021|NCT03289208|Edaravone|edaravone|mesh-list
139602022|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139602023|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
139602024|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602025|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139602026|NCT03289208|Protective Agents|protective agents|mesh-ancestor
139602027|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602028|NCT03244059|Belimumab|belimumab|mesh-list
139602029|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139602030|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
139602031|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602032|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
139602033|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
139602034|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139602035|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602036|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602037|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
139602038|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139602039|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139602040|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602041|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
139602042|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139602043|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
139602044|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602045|NCT02927249|Aspirin|aspirin|mesh-list
139602046|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139602047|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139602048|NCT02927249|Analgesics|analgesics|mesh-ancestor
139602049|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
139602050|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602051|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602052|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139602053|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139602054|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139602055|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139602056|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602057|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139602058|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139602059|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602060|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
139602061|NCT02890368|Interferons|interferons|mesh-list
139602062|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139602063|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139602064|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
139602065|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602066|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
139602067|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602068|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139602069|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
139602070|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602071|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602072|NCT02754141|Nivolumab|nivolumab|mesh-list
139602073|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139602074|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602075|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139602076|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602077|NCT02659059|Paclitaxel|paclitaxel|mesh-list
139602078|NCT02659059|Cisplatin|cisplatin|mesh-list
139602079|NCT02659059|Carboplatin|carboplatin|mesh-list
139602080|NCT02659059|Nivolumab|nivolumab|mesh-list
139602081|NCT02659059|Pemetrexed|pemetrexed|mesh-list
139602082|NCT02659059|Ipilimumab|ipilimumab|mesh-list
139602083|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139602084|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602085|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
139602086|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
139602087|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
139602088|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602089|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139602090|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139602091|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602092|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139602093|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139602094|NCT01505569|Etoposide|etoposide|mesh-list
139602095|NCT01505569|Carboplatin|carboplatin|mesh-list
139602096|NCT01505569|Melphalan|melphalan|mesh-list
139602097|NCT01505569|Busulfan|busulfan|mesh-list
139602098|NCT01505569|Ifosfamide|ifosfamide|mesh-list
139602099|NCT01505569|Thiotepa|thiotepa|mesh-list
139602100|NCT01505569|Lenograstim|lenograstim|mesh-list
139602101|NCT01505569|Mesna|mesna|mesh-list
139602102|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139602103|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602104|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602105|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139602106|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139602107|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602108|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139602109|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
139602110|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139602111|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139602112|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
138730244|NCT06031285|Growth Inhibitors|growth inhibitors|mesh-ancestor
139602113|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602114|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139602115|NCT01505569|Protective Agents|protective agents|mesh-ancestor
139602116|NCT02375178|Biguanides|biguanides|mesh-list
139602117|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
139602118|NCT02375178|Polihexanide|polihexanide|mesh-list
139602119|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139602120|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602121|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
139602122|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139602123|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602124|NCT02375100|Acetaminophen|acetaminophen|mesh-list
139602125|NCT02375100|Tramadol|tramadol|mesh-list
139602126|NCT02375100|Analgesics|analgesics|mesh-list
139602127|NCT02375100|Bupivacaine|bupivacaine|mesh-list
139602128|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
139602129|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
139602130|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139602131|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602132|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
139602133|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602134|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139602135|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
139602136|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139602137|NCT02375100|Narcotics|narcotics|mesh-ancestor
139602138|NCT02364258|Atorvastatin|atorvastatin|mesh-list
139602139|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139602140|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139602141|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139602142|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
139602143|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602144|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139602145|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139602146|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602147|NCT02375022|Endostar protein|endostar protein|mesh-list
139602148|NCT02375022|Endostatins|endostatins|mesh-list
139602149|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139602150|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139602151|NCT02375022|Growth Substances|growth substances|mesh-ancestor
139602152|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602153|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
139602154|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602155|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139602156|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139602157|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139602158|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
139602159|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602160|NCT01497275|Rituximab|rituximab|mesh-list
139602161|NCT01497275|Bortezomib|bortezomib|mesh-list
139602162|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139602163|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602164|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
139602165|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602166|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139602167|NCT01557517|Clobetasol|clobetasol|mesh-list
139602168|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139602169|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
139602170|NCT01557517|Hormones|hormones|mesh-ancestor
139602171|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139602172|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602173|NCT02363556|Misoprostol|misoprostol|mesh-list
139602174|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139602175|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
139602176|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139602177|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602178|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139602179|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139602180|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
139602181|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139602182|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139602183|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602184|NCT01557283|Etanercept|etanercept|mesh-list
139602185|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139602186|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139602187|NCT01557283|Analgesics|analgesics|mesh-ancestor
139602188|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
139602189|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602190|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602191|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139602192|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139602193|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139602194|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139602195|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
139602196|NCT02374632|Octreotide|octreotide|mesh-list
139602197|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139602198|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139602199|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602200|NCT02363400|Cisplatin|cisplatin|mesh-list
139602201|NCT02363400|Epirubicin|epirubicin|mesh-list
139602202|NCT02363400|Mitomycins|mitomycins|mesh-list
139602203|NCT02363400|Mitomycin|mitomycin|mesh-list
139602204|NCT02363400|Tegafur|tegafur|mesh-list
139602205|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602206|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139602207|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139383927|NCT04540133|Hormones|hormones|mesh-ancestor
139602208|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139602209|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602210|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602211|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
139602212|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139602213|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139602214|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
139602215|NCT00350025|Paclitaxel|paclitaxel|mesh-list
139602216|NCT00350025|Cetuximab|cetuximab|mesh-list
139602217|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139602218|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602219|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
139602220|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
139602221|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
139602222|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602223|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139602224|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139602225|NCT01496807|Ipilimumab|ipilimumab|mesh-list
139602226|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139602227|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602228|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139602229|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602230|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
139602231|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602232|NCT02374320|Bupivacaine|bupivacaine|mesh-list
139602233|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
139602234|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
139602235|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139602236|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602237|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
139602238|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602239|NCT01496183|Olanzapine|olanzapine|mesh-list
139602240|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
139602241|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
139602242|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602243|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602244|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139602245|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139602246|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139602247|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139602248|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139602249|NCT01496183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139602250|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139602251|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139602252|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602253|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139602254|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
139602255|NCT01495793|Rotigotine|rotigotine|mesh-list
139602256|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
139602257|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
139602258|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139602259|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602260|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602261|NCT02374008|Dexamethasone|dexamethasone|mesh-list
139602262|NCT02374008|Ketorolac|ketorolac|mesh-list
139602263|NCT02374008|Ropivacaine|ropivacaine|mesh-list
139602264|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139602265|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
139602266|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
139602267|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602268|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602269|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139602270|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
139602271|NCT02374008|Hormones|hormones|mesh-ancestor
139602272|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139602273|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139602274|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602275|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602276|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602277|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
139602278|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
139602279|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139602280|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
139602281|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139384002|NCT04393298|Antidotes|antidotes|mesh-ancestor
139602282|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139602284|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139602285|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139602286|NCT04505280|Lidocaine|lidocaine|mesh-list
139602287|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
139602288|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
139602289|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139602290|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602291|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
139602292|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602293|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139602294|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139602295|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139602296|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139602297|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602298|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
139602299|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139602300|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
139602301|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602302|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
139602303|NCT02366676|Protective Agents|protective agents|mesh-ancestor
139602304|NCT02373384|Allopurinol|allopurinol|mesh-list
139602305|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
139602306|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602307|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
139602308|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602309|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
139602310|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139602311|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139602312|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
139602313|NCT02373384|Protective Agents|protective agents|mesh-ancestor
139602314|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602315|NCT02373384|Diuretics|diuretics|mesh-ancestor
139602316|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
139602317|NCT02373384|Expectorants|expectorants|mesh-ancestor
139602318|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
139602319|NCT01494467|Azelaic acid|azelaic acid|mesh-list
139602320|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602321|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
139602322|NCT02881086|Cytarabine|cytarabine|mesh-list
139602323|NCT02881086|Dexamethasone|dexamethasone|mesh-list
139602324|NCT02881086|Prednisolone|prednisolone|mesh-list
139602325|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
139602326|NCT02881086|Rituximab|rituximab|mesh-list
139602327|NCT02881086|Methotrexate|methotrexate|mesh-list
139602328|NCT02881086|Fludarabine|fludarabine|mesh-list
139602329|NCT02881086|Vincristine|vincristine|mesh-list
139602330|NCT02881086|Doxorubicin|doxorubicin|mesh-list
139602331|NCT02881086|Daunorubicin|daunorubicin|mesh-list
139602332|NCT02881086|Asparaginase|asparaginase|mesh-list
139602333|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
139602334|NCT02881086|Idarubicin|idarubicin|mesh-list
139602335|NCT02881086|Pegaspargase|pegaspargase|mesh-list
139602336|NCT02881086|Vindesine|vindesine|mesh-list
139602337|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139602338|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
139602339|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602340|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139602341|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139602342|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
139602343|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602344|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602345|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139602346|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139602347|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
139602348|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
139602349|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602350|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139602351|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
139602352|NCT02881086|Hormones|hormones|mesh-ancestor
139602353|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139602354|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139602355|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139602356|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139384076|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602357|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
139602358|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139602359|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139602360|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
139602361|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
139602362|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602363|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139602364|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139602365|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
139602366|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602367|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139602368|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
139602369|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
139602370|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
139602371|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139602372|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139602373|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139602374|NCT03922542|Riboflavin|riboflavin|mesh-list
139602375|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
139602376|NCT03922542|Vitamins|vitamins|mesh-ancestor
139602377|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
139602378|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602379|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139602380|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
139602381|NCT01493687|Azelaic acid|azelaic acid|mesh-list
139602382|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602383|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
139602384|NCT02362308|Eplerenone|eplerenone|mesh-list
139602385|NCT02362308|Spironolactone|spironolactone|mesh-list
139602386|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139602387|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
139602388|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
139602389|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139602390|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602391|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139602392|NCT02362308|Diuretics|diuretics|mesh-ancestor
139602393|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
139602394|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139602395|NCT02362308|Hormones|hormones|mesh-ancestor
139602396|NCT02366208|Adefovir|adefovir|mesh-list
139602397|NCT02366208|Thymalfasin|thymalfasin|mesh-list
139602398|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
139602399|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602400|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139602401|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139602402|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602403|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602404|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139602405|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
139602406|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602407|NCT02373462|Olmesartan|olmesartan|mesh-list
139602408|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
139602409|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139602410|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139602411|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602412|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139602413|NCT01523587|Afatinib|afatinib|mesh-list
139602414|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602415|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139602416|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602417|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602418|NCT00310401|Albuterol|albuterol|mesh-list
139602419|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139602420|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
139602421|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602422|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602423|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139602424|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
139602425|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
139602426|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139602427|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139602428|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139602429|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139602430|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
139602431|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139602432|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602433|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
139602434|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139602435|NCT00310791|Hormones|hormones|mesh-list
139602436|NCT00310791|Estradiol|estradiol|mesh-list
139602437|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139602438|NCT00310791|Estrogens|estrogens|mesh-list
139602439|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139602440|NCT00310791|Progestins|progestins|mesh-list
139602441|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139602442|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602443|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139602444|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
139602445|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139602446|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139602447|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139602448|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139602449|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139602450|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139602451|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
139602452|NCT02362152|Diclofenac|diclofenac|mesh-list
139602453|NCT02362152|Fluorouracil|fluorouracil|mesh-list
139602454|NCT02362152|Imiquimod|imiquimod|mesh-list
139602455|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
139602456|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602457|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139602458|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602459|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139602460|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
139602461|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602462|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139602463|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139602464|NCT02362152|Analgesics|analgesics|mesh-ancestor
139602465|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
139602466|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602467|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139602468|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139602469|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139602470|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602471|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139602472|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
139602473|NCT01493531|Allopurinol|allopurinol|mesh-list
139602474|NCT01493531|Lesinurad|lesinurad|mesh-list
139602475|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
139602476|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602477|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602478|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
139602479|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139602480|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139602481|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
139602482|NCT01493531|Protective Agents|protective agents|mesh-ancestor
139602483|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602484|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
139602485|NCT02105415|Ketamine|ketamine|mesh-list
139602486|NCT02105415|Propofol|propofol|mesh-list
139602487|NCT02105415|Etomidate|etomidate|mesh-list
139602488|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139602489|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139602490|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602491|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139602492|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
139602493|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
139602494|NCT02105415|Analgesics|analgesics|mesh-ancestor
139602495|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
139602496|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602497|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139602498|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139602499|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139602500|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139602501|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602502|NCT01523275|Mitomycins|mitomycins|mesh-list
139602503|NCT01523275|Mitomycin|mitomycin|mesh-list
139602504|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139602505|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602506|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
139602507|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602508|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139602509|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602510|NCT00304707|Bupropion|bupropion|mesh-list
139602511|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139602512|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
139602513|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139602514|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139602515|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139602516|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139602517|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602518|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
139602519|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139602520|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602521|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139602522|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139602523|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602524|NCT04409483|Ritonavir|ritonavir|mesh-list
139602525|NCT04409483|Lopinavir|lopinavir|mesh-list
139602526|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139602527|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139602528|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
139602529|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602530|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602531|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139602532|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139602533|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
139602534|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602535|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139602536|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139602537|NCT02365740|Insulin|insulin|mesh-list
139602538|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139602539|NCT02365740|Hormones|hormones|mesh-list
139602540|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139602541|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602542|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139602543|NCT05267847|Anesthetics|anesthetics|mesh-list
139602544|NCT05267847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139602545|NCT05267847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602546|NCT05267457|Vanadium|vanadium|mesh-list
139602547|NCT05267457|Trace Elements|trace elements|mesh-ancestor
139602548|NCT05267457|Micronutrients|micronutrients|mesh-ancestor
139602549|NCT05267457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602550|NCT00351039|Bevacizumab|bevacizumab|mesh-list
139602551|NCT00351039|Pemetrexed|pemetrexed|mesh-list
139602552|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139602553|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139602554|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602555|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139602556|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139602557|NCT00351039|Growth Substances|growth substances|mesh-ancestor
139602558|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602559|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
139602560|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602561|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602562|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139602563|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139602564|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139602565|NCT02372916|Ranibizumab|ranibizumab|mesh-list
139602566|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139602567|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139602568|NCT02372916|Growth Substances|growth substances|mesh-ancestor
139602569|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602570|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
139602571|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602572|NCT02361528|Sargramostim|sargramostim|mesh-list
139602573|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
139602574|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602575|NCT01572727|Paclitaxel|paclitaxel|mesh-list
139602576|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139602577|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602578|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
139602579|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
139602580|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
139602581|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602582|NCT02359266|Vitamin D|vitamin d|mesh-list
139602583|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
139602584|NCT02359266|Vitamins|vitamins|mesh-ancestor
139602585|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
139384299|NCT03197922|Glycerol|glycerol|mesh-list
139602586|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602587|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139602588|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139602589|NCT02359500|Octreotide|octreotide|mesh-list
139602590|NCT02359500|Edotreotide|edotreotide|mesh-list
139602591|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139602592|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139602593|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602594|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139602595|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602596|NCT02372526|Orlistat|orlistat|mesh-list
139602597|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602598|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602599|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139602600|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139602601|NCT02985697|Midazolam|midazolam|mesh-list
139602602|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
139602603|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
138730751|NCT04781673|Analgesics|analgesics|mesh-ancestor
139602604|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139602605|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139602606|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602607|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139602608|NCT02985697|Analgesics|analgesics|mesh-ancestor
139602609|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
139602610|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602611|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139602612|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139602613|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139602614|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
139602615|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139602616|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602617|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139602618|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139602619|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139602620|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139602621|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139602622|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
139602623|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
139602624|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
139602625|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
139602626|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139602627|NCT02372760|Lidocaine|lidocaine|mesh-list
139602628|NCT02372760|Anesthetics|anesthetics|mesh-list
139602629|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
139602630|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139602631|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602632|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
139602633|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602634|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139602635|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139602636|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139602637|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139602638|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602639|NCT00352911|Mifepristone|mifepristone|mesh-list
139602640|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139602641|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
139602642|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139602643|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602644|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139602645|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139602646|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139602647|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
139602648|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139602649|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139602650|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
139602651|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139602652|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
139602653|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139602654|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139602655|NCT00353301|Sirolimus|sirolimus|mesh-list
139602656|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139602657|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602658|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139602659|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602660|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602661|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139602662|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602663|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139602664|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
139602665|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139602666|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
139602667|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602668|NCT02372604|Cetirizine|cetirizine|mesh-list
139602669|NCT02372604|Levocetirizine|levocetirizine|mesh-list
139602670|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139602671|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139602672|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
139602673|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
139602674|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139602675|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602676|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602677|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139602678|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
139602679|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139602680|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602681|NCT02358642|Lisinopril|lisinopril|mesh-list
139602682|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139602683|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139602684|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
139602685|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602686|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139602687|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139602688|NCT02358642|Protective Agents|protective agents|mesh-ancestor
139602689|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602690|NCT03160248|Apremilast|apremilast|mesh-list
139602691|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139602692|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139602693|NCT03160248|Analgesics|analgesics|mesh-ancestor
139602694|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
139602695|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602696|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602697|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139602698|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139602699|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139602700|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139602701|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602702|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602703|NCT01522651|Dronedarone|dronedarone|mesh-list
139602704|NCT01522651|Ranolazine|ranolazine|mesh-list
139602705|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139602706|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139602707|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602708|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139602709|NCT02372292|Furosemide|furosemide|mesh-list
139602710|NCT02372292|Diuretics|diuretics|mesh-ancestor
139602711|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
139602712|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602713|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139602714|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139602715|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602716|NCT01554241|Vitamin D|vitamin d|mesh-list
139602717|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
139602718|NCT01554241|Vitamins|vitamins|mesh-ancestor
139602719|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
139602720|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602721|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139602722|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139602723|NCT02353026|Artesunate|artesunate|mesh-list
139602724|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
139602725|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139602726|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139602727|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602728|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602729|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
139602730|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
139602731|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139602732|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
139602733|NCT01521559|Aflibercept|aflibercept|mesh-list
139602734|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139602735|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139602736|NCT01521559|Growth Substances|growth substances|mesh-ancestor
139602737|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602738|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
139602739|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602740|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
139602741|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139602742|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139602744|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
139602745|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139602746|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
139602747|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139602748|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
139602749|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
139602750|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602751|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602752|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139602753|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
139602754|NCT04438980|Hormones|hormones|mesh-ancestor
139602755|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139602756|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139602757|NCT04438980|Protective Agents|protective agents|mesh-ancestor
139602758|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139602759|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602760|NCT03824847|Clarithromycin|clarithromycin|mesh-list
139602761|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139602762|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602763|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139602764|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602765|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602766|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139602767|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139602768|NCT01554163|Celecoxib|celecoxib|mesh-list
139602769|NCT01554163|Etoricoxib|etoricoxib|mesh-list
139602770|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139602771|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139602772|NCT01554163|Analgesics|analgesics|mesh-ancestor
139602773|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
139602774|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602775|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602776|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139602777|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139602778|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139602779|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139602780|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602781|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602782|NCT02360826|Simvastatin|simvastatin|mesh-list
139602783|NCT02360826|Pravastatin|pravastatin|mesh-list
139602784|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139602785|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139602786|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
139602787|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602788|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139602789|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139602790|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602791|NCT02361060|Atropine|atropine|mesh-list
139602792|NCT02361060|Neostigmine|neostigmine|mesh-list
139602793|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139602794|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139602795|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139602796|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
139602797|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602798|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602799|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139602800|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
139602801|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
139602802|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
139602803|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139602804|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139602805|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
139602806|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139602807|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602808|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139602809|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602810|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139602811|NCT02360982|Fentanyl|fentanyl|mesh-list
139602812|NCT02360982|Propofol|propofol|mesh-list
139602813|NCT02360982|Bupivacaine|bupivacaine|mesh-list
139602814|NCT02360982|Rocuronium|rocuronium|mesh-list
139602815|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139602816|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139602817|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602818|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139602819|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
139602820|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
139602821|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139602822|NCT02360982|Narcotics|narcotics|mesh-ancestor
139602823|NCT02360982|Analgesics|analgesics|mesh-ancestor
139602824|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
139602825|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602826|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139602827|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
139602828|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139602829|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139602830|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139602831|NCT01553851|Trametinib|trametinib|mesh-list
139602832|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602833|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139602834|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313227|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139602835|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602836|NCT02358018|Edotreotide|edotreotide|mesh-list
139602837|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139602838|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602839|NCT01552915|Methylphenidate|methylphenidate|mesh-list
139602840|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139602841|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139602842|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602843|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139602844|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139602845|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139602846|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602847|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
139602848|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139602849|NCT02352714|Lidocaine|lidocaine|mesh-list
139602850|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
139602851|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
139602852|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139602853|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602854|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
139602855|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602856|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139602857|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139602858|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139602859|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139602860|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602861|NCT03911557|Durvalumab|durvalumab|mesh-list
139602862|NCT03911557|Tremelimumab|tremelimumab|mesh-list
139602863|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139602864|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602865|NCT00356031|Bevacizumab|bevacizumab|mesh-list
139602866|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139602867|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602868|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139602869|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139602870|NCT00356031|Growth Substances|growth substances|mesh-ancestor
139602871|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602872|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
139602873|NCT02038842|Vaccines|vaccines|mesh-list
139602874|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
139602875|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602876|NCT01790139|Simethicone|simethicone|mesh-list
139602877|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
139602878|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602879|NCT01790139|Emollients|emollients|mesh-ancestor
139602880|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
139602881|NCT02360592|Interferons|interferons|mesh-list
139602882|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
139602883|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
139602884|NCT02360592|Entecavir|entecavir|mesh-list
139602885|NCT02360592|Interleukin-2|interleukin-2|mesh-list
139602886|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602887|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
139602888|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602889|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
139602890|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602891|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139602892|NCT02360592|Analgesics|analgesics|mesh-ancestor
139602893|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
139602894|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602895|NCT02360202|Clobetasol|clobetasol|mesh-list
139602896|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139602897|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
139602898|NCT02360202|Hormones|hormones|mesh-ancestor
139602899|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139602900|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602901|NCT00322101|Cyclosporine|cyclosporine|mesh-list
139602902|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
139602903|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
139602904|NCT00322101|Busulfan|busulfan|mesh-list
139602905|NCT00322101|Methotrexate|methotrexate|mesh-list
139602906|NCT00322101|Fludarabine|fludarabine|mesh-list
139602907|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
139602908|NCT00322101|Tacrolimus|tacrolimus|mesh-list
139602909|NCT00322101|Cyclosporins|cyclosporins|mesh-list
139602910|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139602911|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
139602912|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602913|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139602914|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139602915|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
139602916|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602917|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602918|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139602919|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139602920|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
139602921|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139602922|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139602923|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
139602924|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
139602925|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139602926|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139602927|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139602928|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139602929|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
139602930|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602931|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139602932|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139602933|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
139602934|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139602935|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
139602936|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139602937|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
139602938|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
139602939|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602940|NCT02352402|Ticagrelor|ticagrelor|mesh-list
139602941|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139602942|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139602943|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139602944|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139602945|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
139602946|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139602947|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602948|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602949|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139602950|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139602951|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
139602952|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602953|NCT00322335|PENTA|penta|mesh-list
139602954|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
139602955|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139602956|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139602957|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602958|NCT03153852|Glycolic acid|glycolic acid|mesh-list
139602959|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
139602960|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
139384675|NCT05272865|Hormones|hormones|mesh-ancestor
139602962|NCT04751175|Ketamine|ketamine|mesh-list
139602963|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139602964|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
139602965|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
139602966|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602967|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139602968|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139602969|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
139602970|NCT04751175|Hormones|hormones|mesh-ancestor
139602971|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139602972|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139602973|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139602974|NCT04751175|Analgesics|analgesics|mesh-ancestor
139602975|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
139602976|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139602977|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139602978|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
139602979|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
139602980|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139602981|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139602982|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139602983|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139602984|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139602985|NCT01792557|Phenol|phenol|mesh-list
139602986|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139602987|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602988|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
139602989|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139602990|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139602991|NCT01792713|Sertaconazole|sertaconazole|mesh-list
139602992|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
139602993|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139602994|NCT02352168|Budesonide|budesonide|mesh-list
139602995|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139602996|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139602997|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
139602998|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139602999|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603000|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139603001|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
139603002|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
139603003|NCT02352168|Hormones|hormones|mesh-ancestor
139603004|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603005|NCT02357004|Carvedilol|carvedilol|mesh-list
139603006|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
139603007|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139603008|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139603009|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
139603010|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139603011|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603012|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603013|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139603014|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
139603015|NCT02357004|Protective Agents|protective agents|mesh-ancestor
139603016|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139603017|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139603018|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139603019|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
139603020|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139603021|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139603022|NCT02357004|Diuretics|diuretics|mesh-ancestor
139603023|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
139603024|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139603025|NCT01570387|Dexamethasone|dexamethasone|mesh-list
139603026|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
139603027|NCT01570387|Pomalidomide|pomalidomide|mesh-list
139603028|NCT01570387|BB 1101|bb 1101|mesh-list
139603029|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139603030|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
139603031|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
139603032|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603033|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603034|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603035|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
139603036|NCT01570387|Hormones|hormones|mesh-ancestor
139603037|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603038|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139603039|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603040|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
139603041|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603042|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603043|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
139603044|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139603045|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139603046|NCT01570387|Growth Substances|growth substances|mesh-ancestor
139603047|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
139603048|NCT02348424|Solithromycin|solithromycin|mesh-list
139603049|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139603050|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603051|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
139603052|NCT01570309|Vitamin D|vitamin d|mesh-list
139603053|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139603054|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603055|NCT01570309|Vitamins|vitamins|mesh-ancestor
139603056|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
139603057|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139603058|NCT02356146|Tacrolimus|tacrolimus|mesh-list
139603059|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139603060|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
139603061|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603062|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139603063|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603064|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603065|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139603066|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
139603067|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603068|NCT01519765|Misoprostol|misoprostol|mesh-list
139603069|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139603070|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
139603071|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139313228|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
139603072|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603073|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139603074|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603075|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
139603076|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
139603077|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
139603078|NCT03147066|Dezocine|dezocine|mesh-list
139603079|NCT03147066|Analgesics|analgesics|mesh-ancestor
139603080|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
139603081|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603082|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603083|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139603084|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139603085|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139603086|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139603087|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139603088|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603089|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603090|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139603091|NCT03147066|Narcotics|narcotics|mesh-ancestor
139603092|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603093|NCT02351622|Dexamethasone|dexamethasone|mesh-list
139603094|NCT02351622|Caffeic acid|caffeic acid|mesh-list
139603095|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139603096|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
139603097|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
139603098|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603099|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603100|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603101|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
139603102|NCT02351622|Hormones|hormones|mesh-ancestor
139603103|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603104|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139603105|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603106|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
139603107|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603108|NCT02351622|Protective Agents|protective agents|mesh-ancestor
139603109|NCT01552603|Pancrelipase|pancrelipase|mesh-list
139603110|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603111|NCT02348190|Heparin|heparin|mesh-list
139603112|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
139603113|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139603114|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139603115|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603116|NCT01552369|Valganciclovir|valganciclovir|mesh-list
139603117|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
139603118|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603119|NCT02351232|Liraglutide|liraglutide|mesh-list
139603120|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139603121|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603122|NCT02351232|Incretins|incretins|mesh-ancestor
139603123|NCT02351232|Hormones|hormones|mesh-ancestor
139603124|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603125|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
139603126|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
139603127|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139603128|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603129|NCT02355678|Acetaminophen|acetaminophen|mesh-list
139603130|NCT02355678|Dexamethasone|dexamethasone|mesh-list
139603131|NCT02355678|Propacetamol|propacetamol|mesh-list
139603132|NCT02355678|Tramadol|tramadol|mesh-list
138731274|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603133|NCT02355678|Anesthetics|anesthetics|mesh-list
139603134|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
139603135|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139603136|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
139603137|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
139603138|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603139|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603140|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603141|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
139603142|NCT02355678|Hormones|hormones|mesh-ancestor
139603143|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603144|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139603145|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603146|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603147|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139603148|NCT02355678|Analgesics|analgesics|mesh-ancestor
139603149|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
139603150|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
139603151|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139603152|NCT02355678|Narcotics|narcotics|mesh-ancestor
139603153|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139603154|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139603155|NCT02351310|Betamethasone|betamethasone|mesh-list
139603156|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139603157|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
139603158|NCT02351310|Hormones|hormones|mesh-ancestor
139603159|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603160|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603161|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139603162|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
139603163|NCT02347878|Aprepitant|aprepitant|mesh-list
139603164|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
139603165|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
139603166|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603167|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603168|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603169|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139603170|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139603171|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603172|NCT02355522|Lidocaine|lidocaine|mesh-list
139603173|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
139603174|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
139603175|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603176|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603177|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
139603178|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603179|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139603180|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139603181|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139603182|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139603183|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603184|NCT02355054|Choline|choline|mesh-list
139603185|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
139603186|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139603187|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
139603188|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603189|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603190|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139603191|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
139603192|NCT04478448|Favipiravir|favipiravir|mesh-list
139603193|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
139603194|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603195|NCT04478526|Norepinephrine|norepinephrine|mesh-list
139603196|NCT04478526|Serotonin|serotonin|mesh-list
139603197|NCT04478526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139603198|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
139603199|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139603200|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139603201|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
139603202|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139603203|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603204|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603205|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
139603206|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
139603207|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603208|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139603209|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139603210|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
139603211|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139603212|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139603213|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139603214|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139603215|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139603216|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139603217|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603218|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139603219|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603220|NCT01552057|Analgesics|analgesics|mesh-ancestor
139603221|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
139603222|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603223|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
139603224|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139603225|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
139603226|NCT02350686|Capecitabine|capecitabine|mesh-list
139603227|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
139603228|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139603229|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
139603230|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603231|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603232|NCT03159078|Imipenem|imipenem|mesh-list
139603233|NCT03159078|Polymyxins|polymyxins|mesh-list
139603234|NCT03159078|Polymyxin B|polymyxin b|mesh-list
139603235|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139603236|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603237|NCT01551745|Bevacizumab|bevacizumab|mesh-list
139603238|NCT01551745|Vaccines|vaccines|mesh-list
139603239|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
139603240|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603241|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139603242|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603243|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139603244|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139603245|NCT01551745|Growth Substances|growth substances|mesh-ancestor
139603246|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
139603247|NCT02350530|Bevacizumab|bevacizumab|mesh-list
139603248|NCT02350530|Fluorouracil|fluorouracil|mesh-list
139603249|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
139603250|NCT02350530|Irinotecan|irinotecan|mesh-list
139603251|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139603252|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603253|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139603254|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139603255|NCT02350530|Growth Substances|growth substances|mesh-ancestor
139603256|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603257|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
139603258|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
139603259|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603260|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139603261|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139603262|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
139603263|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139603264|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139603265|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603266|NCT01569841|Insulin|insulin|mesh-list
139603267|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139603268|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
139603269|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139603270|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603271|NCT01550965|Adalimumab|adalimumab|mesh-list
139603272|NCT01550965|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139603273|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139603274|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139603275|NCT05265819|Hormones|hormones|mesh-list
139603276|NCT05265819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603277|NCT05265819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603278|NCT02353494|Piperaquine|piperaquine|mesh-list
139603279|NCT02353494|Artenimol|artenimol|mesh-list
139603280|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
139603281|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139603282|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139603283|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603284|NCT02353260|Docetaxel|docetaxel|mesh-list
139603285|NCT02353260|Fluorouracil|fluorouracil|mesh-list
139603286|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603287|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
139603288|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
139603289|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
139603290|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603291|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
139603292|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139603293|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139603294|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
139603295|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603296|NCT03158610|Capecitabine|capecitabine|mesh-list
139603297|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139603298|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
139603299|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603300|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603301|NCT00323739|Bevacizumab|bevacizumab|mesh-list
139603302|NCT00323739|Everolimus|everolimus|mesh-list
139603303|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139603304|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603305|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139603306|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139603307|NCT00323739|Growth Substances|growth substances|mesh-ancestor
139603308|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603309|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
139603310|NCT00323739|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139603311|NCT00323739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139603312|NCT00323739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603313|NCT00323739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603314|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139603315|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
139603316|NCT02350218|Alprostadil|alprostadil|mesh-list
139603317|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139603318|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
139603319|NCT02350218|Urological Agents|urological agents|mesh-ancestor
139603320|NCT00390429|Docetaxel|docetaxel|mesh-list
139603321|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139603322|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603323|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
139603324|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
139603325|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
139603326|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603327|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139603328|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603329|NCT02349828|Acyclovir|acyclovir|mesh-list
139603330|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
139603331|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603332|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
139603333|NCT02353182|Remifentanil|remifentanil|mesh-list
139603334|NCT02353182|Bupivacaine|bupivacaine|mesh-list
139603335|NCT02353182|Ropivacaine|ropivacaine|mesh-list
139603336|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
139603337|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
139603338|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603339|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603340|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
139603341|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603342|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139603343|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139603345|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139603346|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139603347|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139603348|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
139603349|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139603350|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603351|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139603352|NCT02353182|Narcotics|narcotics|mesh-ancestor
139603353|NCT02349516|Squalamine|squalamine|mesh-list
139603354|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139603355|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139603356|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139603357|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603358|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139603359|NCT02349516|Protective Agents|protective agents|mesh-ancestor
139603360|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603361|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603362|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139603363|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139603364|NCT02349516|Growth Substances|growth substances|mesh-ancestor
139603365|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
139603366|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139603367|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139603368|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139603369|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139603370|NCT02346084|Maraviroc|maraviroc|mesh-list
139603371|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139603372|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139603373|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603374|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139603375|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139603376|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
139603377|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603378|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139603379|NCT03149250|Hemostatics|hemostatics|mesh-list
139603380|NCT03149250|Coagulants|coagulants|mesh-ancestor
139603381|NCT00391443|Bosentan|bosentan|mesh-list
139603382|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139603383|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139603384|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603385|NCT02343432|Triamcinolone|triamcinolone|mesh-list
139603386|NCT02343432|Bupivacaine|bupivacaine|mesh-list
139603387|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
139603388|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
139603389|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603390|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603391|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
139603392|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603393|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139603394|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
139603395|NCT02343432|Hormones|hormones|mesh-ancestor
139603396|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603397|NCT02349282|Vitamin D|vitamin d|mesh-list
139603398|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
139603399|NCT02349282|Calcifediol|calcifediol|mesh-list
139603400|NCT02349282|Vitamins|vitamins|mesh-ancestor
139603401|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
139603402|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603403|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139603404|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139603405|NCT02349204|Zaleplon|zaleplon|mesh-list
139603406|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
139603407|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139603408|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603409|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603410|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
139603411|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
139603412|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139603413|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603414|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
139603415|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139603416|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
139385122|NCT02130869|Cytarabine|cytarabine|mesh-list
139603417|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603418|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603419|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139603420|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
139603421|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139603422|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
139603423|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603424|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139603425|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139603426|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
139603427|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
139603428|NCT02345616|Protective Agents|protective agents|mesh-ancestor
139603429|NCT00391989|Dasatinib|dasatinib|mesh-list
139603430|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603431|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139603432|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603433|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603434|NCT03148704|Palonosetron|palonosetron|mesh-list
139603435|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
139603436|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
139603437|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603438|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603439|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603440|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139603441|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139603442|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
139603443|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139603444|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603445|NCT01795287|Anesthetics|anesthetics|mesh-list
139603446|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603447|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603448|NCT04976283|Pioglitazone|pioglitazone|mesh-list
139603449|NCT04976283|Empagliflozin|empagliflozin|mesh-list
139603450|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139603451|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603452|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139603453|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603454|NCT02345304|Digoxin|digoxin|mesh-list
139603455|NCT02345304|Midazolam|midazolam|mesh-list
139603456|NCT02345304|Omeprazole|omeprazole|mesh-list
139603457|NCT02345304|Warfarin|warfarin|mesh-list
139603458|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139603459|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139603460|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603461|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603462|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139603463|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139603464|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139603465|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139603466|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
139603467|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
139603468|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
139603469|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
139603470|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139603471|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603472|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
139603473|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139603474|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603475|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139603476|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603477|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139603478|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139603479|NCT02345304|Protective Agents|protective agents|mesh-ancestor
139603480|NCT01569295|Rituximab|rituximab|mesh-list
139603481|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139603482|NCT01569295|Idelalisib|idelalisib|mesh-list
139603483|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139603484|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603485|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
139603486|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603487|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139603488|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139603489|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
139603490|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385210|NCT03962114|Niacin|niacin|mesh-list
139603491|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603492|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
139603493|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603494|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
139603495|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
139603496|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
139603497|NCT02345148|Esketamine|esketamine|mesh-list
139603498|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
139603499|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139603500|NCT00394329|Beclomethasone|beclomethasone|mesh-list
139603501|NCT00394329|Albuterol|albuterol|mesh-list
139603502|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139603503|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
139603504|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603505|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603506|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139603507|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
139603508|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
139603509|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139603510|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139603511|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139603512|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139603513|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
139603514|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139603515|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603516|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139603517|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
139603518|NCT00394329|Hormones|hormones|mesh-ancestor
139603519|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603520|NCT03146052|Simethicone|simethicone|mesh-list
139603521|NCT03146052|Bisacodyl|bisacodyl|mesh-list
139603522|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603523|NCT03146052|Cathartics|cathartics|mesh-ancestor
138731681|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
139603524|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603525|NCT03146052|Laxatives|laxatives|mesh-ancestor
139603526|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
139603527|NCT03146052|Emollients|emollients|mesh-ancestor
139603528|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
139603529|NCT01549951|Prednisone|prednisone|mesh-list
139603530|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139603531|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
139603532|NCT01549951|Hormones|hormones|mesh-ancestor
139603533|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603534|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603535|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139603536|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603537|NCT03148314|Misoprostol|misoprostol|mesh-list
139603538|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139603539|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
139603540|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139603541|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603542|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139603543|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603544|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
139603545|NCT01517893|Simvastatin|simvastatin|mesh-list
139603546|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139603547|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139603548|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
139603549|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603550|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139603551|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139603552|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603553|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
139603554|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139603555|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603556|NCT01489891|Lidocaine|lidocaine|mesh-list
139603557|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
139603558|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
139603559|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603560|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603561|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
139603562|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603563|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139603564|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139603565|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139603566|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139603567|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603568|NCT02342574|Olorofim|olorofim|mesh-list
139603569|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
139603570|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603571|NCT03148002|Lactulose|lactulose|mesh-list
139603572|NCT03148002|Sennosides|sennosides|mesh-list
139603573|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603574|NCT03148002|Laxatives|laxatives|mesh-ancestor
139603575|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139603576|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
139603577|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603578|NCT00396201|Plerixafor|plerixafor|mesh-list
139603579|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139603580|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139603581|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
139603582|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603583|NCT03145896|Vitamin D|vitamin d|mesh-list
139603584|NCT03145896|Vitamins|vitamins|mesh-ancestor
139603585|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
138731721|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139603586|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603587|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139603588|NCT02341872|Calcium|calcium|mesh-list
139603589|NCT02341872|Fluorides|fluorides|mesh-list
139603590|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139603591|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603592|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
139603593|NCT02341872|Protective Agents|protective agents|mesh-ancestor
139603594|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139603595|NCT00360399|Escitalopram|escitalopram|mesh-list
139603596|NCT00360399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139603597|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139603598|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139603599|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603600|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139603601|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
139603602|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603603|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603604|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
139603605|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139603606|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139603607|NCT00360399|Analgesics|analgesics|mesh-ancestor
139603608|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
139603609|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
139603610|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139603611|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139603612|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139603613|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
139603614|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603615|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139603616|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139603617|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603618|NCT02344602|Febuxostat|febuxostat|mesh-list
139603619|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
139603620|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139603621|NCT02348268|Analgesics|analgesics|mesh-list
139603622|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
139603623|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603624|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603625|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
139603626|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
139603627|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139603628|NCT02348346|Protective Agents|protective agents|mesh-ancestor
139603629|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603630|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
139603631|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139603632|NCT00361257|Minocycline|minocycline|mesh-list
139603633|NCT00361257|Tetracycline|tetracycline|mesh-list
139603634|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139603635|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603636|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139603637|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603638|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603639|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
139603640|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
139385346|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139603641|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
139603642|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603643|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603644|NCT02341638|Aspirin|aspirin|mesh-list
139603645|NCT02341638|Itraconazole|itraconazole|mesh-list
139603646|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139603647|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139603648|NCT02341638|Analgesics|analgesics|mesh-ancestor
139603649|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
139603650|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603651|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603652|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139603653|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139603654|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139603655|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139603656|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603657|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139603658|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139603659|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603660|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
139603661|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
139603662|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603663|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139603664|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139603665|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139603666|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
139603667|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603668|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139603669|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
139603670|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139603671|NCT02337192|Curcumin|curcumin|mesh-list
139603672|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139603673|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139603674|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603675|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
139603676|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
139603677|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139603678|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139603679|NCT02337192|Analgesics|analgesics|mesh-ancestor
139603680|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
139603681|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603682|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603683|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139603684|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139603685|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603686|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603687|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603688|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
139603689|NCT03111966|Grazoprevir|grazoprevir|mesh-list
139603690|NCT03111966|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139603691|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
139603692|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603693|NCT02343666|Plerixafor|plerixafor|mesh-list
139603694|NCT02343666|Carmustine|carmustine|mesh-list
139603695|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
139603696|NCT02343666|Lenograstim|lenograstim|mesh-list
139603697|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139603698|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
139603699|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603700|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139603701|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
139603702|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603703|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603704|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139603705|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139603706|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
139603707|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603708|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603709|NCT02340936|Lenalidomide|lenalidomide|mesh-list
139603710|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
139603711|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603712|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139603713|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139603714|NCT02340936|Growth Substances|growth substances|mesh-ancestor
139603715|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
139603716|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297198|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603718|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139603719|NCT02337036|Tacrolimus|tacrolimus|mesh-list
139603720|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139603721|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
139603722|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603723|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139603724|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603725|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603726|NCT02336568|Oxytocin|oxytocin|mesh-list
139603727|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
139603728|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139603729|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603730|NCT05253768|Glycerol|glycerol|mesh-list
139603731|NCT05253768|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139603732|NCT05253768|Protective Agents|protective agents|mesh-ancestor
139603733|NCT05253768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603734|NCT04630938|Lidocaine|lidocaine|mesh-list
139603735|NCT04630938|Morphine|morphine|mesh-list
139603736|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
139603737|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
139603738|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603739|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603740|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
139603741|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603742|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139603743|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139603744|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139603745|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139603746|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603747|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139603748|NCT04630938|Narcotics|narcotics|mesh-ancestor
139603749|NCT04630938|Analgesics|analgesics|mesh-ancestor
139603750|NCT04594746|Amiodarone|amiodarone|mesh-list
139603751|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139603752|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
139603753|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139603754|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139603755|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603756|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139603757|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139603758|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139603759|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603760|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139603761|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139603762|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139603763|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
139603764|NCT02790138|Vedolizumab|vedolizumab|mesh-list
139603765|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139603766|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603767|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139603768|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139603769|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603770|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603771|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603772|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139603773|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139603774|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603775|NCT02339844|Aripiprazole|aripiprazole|mesh-list
139603776|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
139603777|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139603778|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139603779|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139603780|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603781|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603782|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
139603783|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
139603784|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139603785|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603786|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139603787|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139603788|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
139385495|NCT03548129|Fosfomycin|fosfomycin|mesh-list
139603789|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139603791|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139603792|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139603793|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
139603794|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139603795|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603796|NCT02331576|Fentanyl|fentanyl|mesh-list
139603797|NCT02331576|Ropivacaine|ropivacaine|mesh-list
139603798|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
139603799|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
139603800|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603801|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603802|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
139603803|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603804|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139603805|NCT02331576|Narcotics|narcotics|mesh-ancestor
139603806|NCT02331576|Analgesics|analgesics|mesh-ancestor
139603807|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139603808|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139603809|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
139603810|NCT00400803|Bevacizumab|bevacizumab|mesh-list
139603811|NCT00400803|Carboplatin|carboplatin|mesh-list
139603812|NCT00400803|Gemcitabine|gemcitabine|mesh-list
139603813|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139603814|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603815|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139603816|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139603817|NCT00400803|Growth Substances|growth substances|mesh-ancestor
139603818|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603819|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
139603820|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139603821|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
139603822|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603823|NCT04681443|Phenol|phenol|mesh-list
139603824|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139603825|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603826|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
139603827|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139603828|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139603829|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
139603830|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139603831|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139603832|NCT02339142|Prednisolone|prednisolone|mesh-list
139603833|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
139603834|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139603835|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
139603836|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139603837|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
139603838|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
139603839|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603840|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603841|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603842|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
139603843|NCT02339142|Hormones|hormones|mesh-ancestor
139603844|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603845|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139603846|NCT02339142|Protective Agents|protective agents|mesh-ancestor
139603847|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139603848|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603849|NCT00362817|Carboplatin|carboplatin|mesh-list
139603850|NCT00362817|Temozolomide|temozolomide|mesh-list
139603851|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603852|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139603853|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
139603854|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603855|NCT02338830|Progesterone|progesterone|mesh-list
139603856|NCT02338830|Progestins|progestins|mesh-ancestor
139603857|NCT02338830|Hormones|hormones|mesh-ancestor
139603858|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603859|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603860|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139603861|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139603862|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603863|NCT00364377|Incretins|incretins|mesh-ancestor
139603864|NCT00364377|Hormones|hormones|mesh-ancestor
139603865|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603866|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139603867|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
139603868|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603869|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603871|NCT02338674|Telbivudine|telbivudine|mesh-list
139603872|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
139603873|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139603874|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139603875|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139603876|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603877|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603878|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139603879|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139603880|NCT01826838|Dasatinib|dasatinib|mesh-list
139603881|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603882|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139603883|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732024|NCT01648127|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139603884|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603885|NCT00365391|Bevacizumab|bevacizumab|mesh-list
139603886|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139603887|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139603888|NCT00365391|Antibodies|antibodies|mesh-list
139603889|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
139603890|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139603891|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603892|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139603893|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139603894|NCT00365391|Growth Substances|growth substances|mesh-ancestor
139603895|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603896|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
139603897|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
139603898|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139603899|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603900|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603901|NCT03105180|Mannitol|mannitol|mesh-list
139603902|NCT03105180|Sorbitol|sorbitol|mesh-list
139603903|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139603904|NCT03105180|Diuretics|diuretics|mesh-ancestor
139603905|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
139603906|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603907|NCT03105180|Cathartics|cathartics|mesh-ancestor
139603908|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139603909|NCT02331030|Ropivacaine|ropivacaine|mesh-list
139603910|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
139603911|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
139603912|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603913|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603914|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
139603915|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603916|NCT04270929|Folfirinox|folfirinox|mesh-list
139603917|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603918|NCT00401817|Bevacizumab|bevacizumab|mesh-list
139603919|NCT00401817|Rituximab|rituximab|mesh-list
139603920|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139603921|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603922|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139603923|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139603924|NCT00401817|Growth Substances|growth substances|mesh-ancestor
139603925|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603926|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
139603927|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
139603928|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139603929|NCT04417179|Bupivacaine|bupivacaine|mesh-list
139603930|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
139603931|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
139603932|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603933|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603934|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
139603935|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603936|NCT02330796|Bucillamine|bucillamine|mesh-list
139603937|NCT02330796|Colchicine|colchicine|mesh-list
139603938|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
139603939|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139603940|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
139603942|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
139603943|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603944|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603945|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139603946|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139603947|NCT02330796|Analgesics|analgesics|mesh-ancestor
139603948|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
139603949|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603950|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603951|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139603952|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
139603953|NCT02330796|Protective Agents|protective agents|mesh-ancestor
139603954|NCT02330640|Clopidogrel|clopidogrel|mesh-list
139603955|NCT02330640|Ticagrelor|ticagrelor|mesh-list
139603956|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139603957|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139603958|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139603959|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139603960|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
139603961|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139603962|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603963|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603964|NCT02335398|Methadone|methadone|mesh-list
139603965|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139603966|NCT02335398|Narcotics|narcotics|mesh-ancestor
139603967|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139603968|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603969|NCT02335398|Analgesics|analgesics|mesh-ancestor
139603970|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
139603971|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139603972|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
139603973|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
139603974|NCT02338206|Hormones|hormones|mesh-list
139603975|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603976|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603977|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
139603978|NCT02338050|Immunotoxins|immunotoxins|mesh-ancestor
139603979|NCT02338050|Immunoconjugates|immunoconjugates|mesh-ancestor
139603980|NCT02338050|Immunologic Factors|immunologic factors|mesh-ancestor
139603981|NCT02338050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603982|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139603983|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139603984|NCT02330406|Anagliptin|anagliptin|mesh-list
139603985|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139603986|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139603987|NCT02330406|Incretins|incretins|mesh-ancestor
139603988|NCT02330406|Hormones|hormones|mesh-ancestor
139603989|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139603990|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139603991|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
139603992|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139603993|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139603994|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
139603995|NCT02337972|Povidone|povidone|mesh-list
139603996|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
139603997|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
139603998|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139603999|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604000|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
139604001|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
139604002|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
139604003|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604004|NCT02335164|Coagulants|coagulants|mesh-ancestor
139604005|NCT00365859|Aripiprazole|aripiprazole|mesh-list
139604006|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
139604007|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139604008|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139604009|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139604010|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139604011|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604012|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
139385725|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
139604013|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
139604014|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604015|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604016|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139604017|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139604018|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
139604019|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139604020|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139604021|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139604022|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139604023|NCT02337426|Temozolomide|temozolomide|mesh-list
139604024|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139604025|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139604026|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
139604027|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604028|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604029|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
139604030|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139604031|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
139604032|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604033|NCT03664830|Plerixafor|plerixafor|mesh-list
139604034|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139604035|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139604036|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
139604037|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604038|NCT00407355|Ranibizumab|ranibizumab|mesh-list
139604039|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139604040|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139604041|NCT00407355|Growth Substances|growth substances|mesh-ancestor
139604042|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604043|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
139604044|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604045|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139604046|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139604047|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
139604048|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604049|NCT02334462|Antacids|antacids|mesh-ancestor
139604050|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604051|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139604052|NCT03144882|Curcumin|curcumin|mesh-list
139604053|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139604054|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139604055|NCT03144882|Analgesics|analgesics|mesh-ancestor
139604056|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
139604057|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604058|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604059|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139604060|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139604061|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604062|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604063|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604064|NCT01793259|Methotrexate|methotrexate|mesh-list
139604065|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139604066|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
139604067|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139604068|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604069|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139604070|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
139604071|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604072|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604073|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
139604074|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604075|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139604076|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139604077|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
139604078|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139604079|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139604080|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139604081|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139604082|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604083|NCT03111810|Prednisolone|prednisolone|mesh-list
139604084|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139604085|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
139604086|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139604087|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
139604088|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139604089|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
139604090|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139604091|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
139604092|NCT03111810|Hormones|hormones|mesh-ancestor
139604093|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139604094|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604095|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139604096|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604097|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
139604098|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
139604099|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604100|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139604101|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139604102|NCT03111810|Protective Agents|protective agents|mesh-ancestor
139604103|NCT02334150|Sufentanil|sufentanil|mesh-list
139604104|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139604105|NCT02334150|Narcotics|narcotics|mesh-ancestor
139604106|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139604107|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604108|NCT02334150|Analgesics|analgesics|mesh-ancestor
139604109|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
139604110|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604111|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139604112|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139604113|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
139604114|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
139604115|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139604116|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139604117|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139604118|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604119|NCT04477590|Metformin|metformin|mesh-list
139604120|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139604121|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604122|NCT02333838|Fludarabine|fludarabine|mesh-list
139604123|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
139604124|NCT02333838|Busulfan|busulfan|mesh-list
139604125|NCT02333838|Thiotepa|thiotepa|mesh-list
139604126|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604127|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139604128|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
139604129|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604130|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139604131|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
139604132|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604133|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
139604134|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139604135|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139604136|NCT02326584|Cytarabine|cytarabine|mesh-list
139604137|NCT02326584|Daunorubicin|daunorubicin|mesh-list
139604138|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139604139|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
139604140|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604141|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604142|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
139604143|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604144|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139604145|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
139604146|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604147|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139604148|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139604149|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139604150|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604151|NCT03111342|Lidocaine|lidocaine|mesh-list
139604152|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
139604153|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
139604154|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139604155|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604156|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
139604157|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604158|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139604159|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139604160|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139604161|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139604162|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385870|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
139604163|NCT03111420|Clopidogrel|clopidogrel|mesh-list
139604164|NCT03111420|Ticagrelor|ticagrelor|mesh-list
139604165|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138732315|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
139604166|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139604167|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139604168|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139604169|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139604170|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
139604171|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604172|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604173|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604174|NCT02333682|Vitamin D|vitamin d|mesh-list
139604175|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
139604176|NCT02333682|Calcifediol|calcifediol|mesh-list
139604177|NCT02333682|Vitamins|vitamins|mesh-ancestor
139604178|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
139604179|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604180|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139604181|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139604182|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139604183|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139604184|NCT02326350|Aspirin|aspirin|mesh-list
139604185|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139604186|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139604187|NCT02326350|Analgesics|analgesics|mesh-ancestor
139604188|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
139604189|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604190|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604191|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139604192|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139604193|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139604194|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139604195|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604196|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139604197|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139604198|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604199|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
139604200|NCT02326194|Vaccines|vaccines|mesh-list
139604201|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
139604202|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604203|NCT02326038|Methylphenidate|methylphenidate|mesh-list
139604204|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139604205|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604206|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139604207|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139604208|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139604209|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604210|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
139604211|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604212|NCT00970866|Folic Acid|folic acid|mesh-list
139604213|NCT00970866|Micronutrients|micronutrients|mesh-list
139604214|NCT00970866|Trace Elements|trace elements|mesh-list
139604215|NCT00970866|Hematinics|hematinics|mesh-ancestor
139604216|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
139604217|NCT00970866|Vitamins|vitamins|mesh-ancestor
139604218|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604219|NCT03145584|Bupivacaine|bupivacaine|mesh-list
139604220|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
139604221|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
139604222|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139604223|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604224|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
139604225|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604226|NCT03145194|Ticagrelor|ticagrelor|mesh-list
139604227|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139604228|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139604229|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139604230|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139604231|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
139604232|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604233|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604234|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604235|NCT03143946|Vitamins|vitamins|mesh-list
139604236|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
139385950|NCT02158117|Naloxone|naloxone|mesh-list
139604237|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604238|NCT02039700|Lesinurad|lesinurad|mesh-list
139604239|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
139604240|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139604241|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
139604242|NCT05076474|Orlistat|orlistat|mesh-list
139604243|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604244|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604245|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139604246|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139604247|NCT02328144|Metronidazole|metronidazole|mesh-list
139604248|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604249|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139604250|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139604251|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139604252|NCT02327676|Emtricitabine|emtricitabine|mesh-list
139604253|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
139604254|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604255|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139604256|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139604257|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604258|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604259|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139604260|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139604261|NCT02333058|Treosulfan|treosulfan|mesh-list
139604262|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139604263|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
139604264|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604265|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604266|NCT03111186|Acetaminophen|acetaminophen|mesh-list
139604267|NCT03111186|Ibuprofen|ibuprofen|mesh-list
139604268|NCT03111186|Oxycodone|oxycodone|mesh-list
139604269|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139604270|NCT03111186|Analgesics|analgesics|mesh-ancestor
139604271|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
139604272|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604273|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604274|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
139604275|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139604276|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139604277|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139604278|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139604279|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604280|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604281|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139604282|NCT03111186|Narcotics|narcotics|mesh-ancestor
139604283|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139604284|NCT02332512|Apatinib|apatinib|mesh-list
139604285|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604286|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139604287|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604288|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604289|NCT02327754|FYX-051|fyx-051|mesh-list
139604290|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604291|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604292|NCT06103500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139604293|NCT06103500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604294|NCT06103292|Calcium|calcium|mesh-list
139604295|NCT06103292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139604296|NCT06103292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604297|NCT06103279|Empagliflozin|empagliflozin|mesh-list
139604298|NCT06103279|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139604299|NCT06103279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604300|NCT06103279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139604301|NCT06103279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604302|NCT06103266|Rivaroxaban|rivaroxaban|mesh-list
139604303|NCT06103266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139604304|NCT06103266|Antithrombins|antithrombins|mesh-ancestor
139604305|NCT06103266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139604306|NCT06103266|Protease Inhibitors|protease inhibitors|mesh-ancestor
139604307|NCT06103266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604308|NCT06103266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604309|NCT06103266|Anticoagulants|anticoagulants|mesh-ancestor
139604310|NCT06102863|Atorvastatin|atorvastatin|mesh-list
139604311|NCT06102863|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139604312|NCT06102863|Calcium|calcium|mesh-list
139604313|NCT06102863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139604314|NCT06102863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604315|NCT06102863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139604316|NCT06102863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139604317|NCT06102863|Antimetabolites|antimetabolites|mesh-ancestor
139604318|NCT06102863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604319|NCT06102863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139604320|NCT06102863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139604321|NCT06102863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604323|NCT06102707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604324|NCT06102707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139604325|NCT06102707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604326|NCT06102707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604327|NCT06102525|Valganciclovir|valganciclovir|mesh-list
139604328|NCT06102525|Antiviral Agents|antiviral agents|mesh-ancestor
139604329|NCT06102525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604330|NCT06102460|Caseins|caseins|mesh-list
139604331|NCT06102460|Chelating Agents|chelating agents|mesh-ancestor
139604332|NCT06102460|Sequestering Agents|sequestering agents|mesh-ancestor
139604333|NCT06102460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604334|NCT06102447|Dexamethasone|dexamethasone|mesh-list
139604335|NCT06102447|Palonosetron|palonosetron|mesh-list
139604336|NCT06102447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139604337|NCT06102447|Antiemetics|antiemetics|mesh-ancestor
139604338|NCT06102447|Autonomic Agents|autonomic agents|mesh-ancestor
139604339|NCT06102447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604340|NCT06102447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604341|NCT06102447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139604342|NCT06102447|Glucocorticoids|glucocorticoids|mesh-ancestor
139604343|NCT06102447|Hormones|hormones|mesh-ancestor
139604344|NCT06102447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139604345|NCT06102447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139604346|NCT06102447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604347|NCT06102447|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139604348|NCT06102447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139604349|NCT06102447|Serotonin Agents|serotonin agents|mesh-ancestor
139604350|NCT06102447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604351|NCT06102447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604352|NCT06102434|Psilocybin|psilocybin|mesh-list
139604353|NCT06102434|Hallucinogens|hallucinogens|mesh-ancestor
139604354|NCT06102434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604355|NCT06102434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139604356|NCT06102252|Paclitaxel|paclitaxel|mesh-list
139604357|NCT06102252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139604358|NCT06102252|Carboplatin|carboplatin|mesh-list
139604359|NCT06102252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139604360|NCT06102252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604361|NCT06102252|Tubulin Modulators|tubulin modulators|mesh-ancestor
139604362|NCT06102252|Antimitotic Agents|antimitotic agents|mesh-ancestor
139604363|NCT06102252|Mitosis Modulators|mitosis modulators|mesh-ancestor
139604364|NCT06102252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604365|NCT06102239|Bilirubin|bilirubin|mesh-list
139604366|NCT06102239|Antioxidants|antioxidants|mesh-ancestor
139604367|NCT06102239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604368|NCT06102239|Protective Agents|protective agents|mesh-ancestor
139604369|NCT06102239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604370|NCT06102200|Buprenorphine|buprenorphine|mesh-list
139604371|NCT06102200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139604372|NCT06102200|Narcotics|narcotics|mesh-ancestor
139604373|NCT06102200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139604374|NCT06102200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604375|NCT06102200|Analgesics|analgesics|mesh-ancestor
139604376|NCT06102200|Sensory System Agents|sensory system agents|mesh-ancestor
139604377|NCT06102200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604378|NCT06102200|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139604379|NCT06101420|Amoxicillin|amoxicillin|mesh-list
139604380|NCT06101420|Clarithromycin|clarithromycin|mesh-list
139604381|NCT06101420|Levofloxacin|levofloxacin|mesh-list
139604382|NCT06101420|Nitazoxanide|nitazoxanide|mesh-list
139604383|NCT06101420|Esomeprazole|esomeprazole|mesh-list
139604384|NCT06101420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139604385|NCT06101420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386097|NCT05610878|Curcumin|curcumin|mesh-list
139604386|NCT06101420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139604387|NCT06101420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139604388|NCT06101420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139604389|NCT06101420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604390|NCT06101420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604391|NCT06101420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139604392|NCT06101420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139604393|NCT06101420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139604394|NCT06101420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139604395|NCT06101420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139604396|NCT06101420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139604397|NCT06101420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604398|NCT06101420|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139604399|NCT06101420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139604400|NCT06099821|Apatinib|apatinib|mesh-list
139604401|NCT06099821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604402|NCT06099821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139604403|NCT06099821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604404|NCT06099821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604405|NCT06045299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139604406|NCT06045299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139604407|NCT06045299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139604408|NCT06045299|Aceclidine|aceclidine|mesh-list
139604409|NCT06045299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139604410|NCT06045299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139604411|NCT06045299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139604412|NCT06045299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139604413|NCT06045299|Adrenergic Agents|adrenergic agents|mesh-ancestor
139604414|NCT06045299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604415|NCT06045299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604416|NCT06045299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604417|NCT06045299|Miotics|miotics|mesh-ancestor
139604418|NCT06045299|Autonomic Agents|autonomic agents|mesh-ancestor
139604419|NCT06045299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604420|NCT06045299|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139604421|NCT06044493|Mycophenolic Acid|mycophenolic acid|mesh-list
139604422|NCT06044493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139604423|NCT06044493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604424|NCT06044493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139604425|NCT06044493|Antitubercular Agents|antitubercular agents|mesh-ancestor
139604426|NCT06044493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139604427|NCT06044493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604428|NCT06044493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604429|NCT06044493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604430|NCT06041789|Donepezil|donepezil|mesh-list
139604431|NCT06041789|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139604432|NCT06041789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604433|NCT06041789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604434|NCT06041789|Cholinergic Agents|cholinergic agents|mesh-ancestor
139604435|NCT06041789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604436|NCT06041789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604437|NCT06041789|Nootropic Agents|nootropic agents|mesh-ancestor
139604438|NCT05987293|Salicylic Acid|salicylic acid|mesh-list
139604439|NCT05987293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604440|NCT05987293|Antifungal Agents|antifungal agents|mesh-ancestor
139604441|NCT05987293|Keratolytic Agents|keratolytic agents|mesh-ancestor
139604442|NCT05987293|Dermatologic Agents|dermatologic agents|mesh-ancestor
139604443|NCT05941520|Tamoxifen|tamoxifen|mesh-list
139604444|NCT05941520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139604445|NCT05941520|Hormone Antagonists|hormone antagonists|mesh-ancestor
139604446|NCT05941520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139604447|NCT05941520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604448|NCT05941520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139604449|NCT05941520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604450|NCT05941520|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139604451|NCT05941520|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139604452|NCT05941520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139604453|NCT05933395|Everolimus|everolimus|mesh-list
139604454|NCT05933395|Fulvestrant|fulvestrant|mesh-list
139604455|NCT05933395|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139604456|NCT05933395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139604457|NCT05933395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604458|NCT05933395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604459|NCT05933395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139386179|NCT03107169|Vancomycin|vancomycin|mesh-list
139604460|NCT05933395|Immunologic Factors|immunologic factors|mesh-ancestor
139604461|NCT05933395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604462|NCT05933395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604463|NCT05933395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139604464|NCT05933395|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139604465|NCT05933395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139604466|NCT05933395|Hormone Antagonists|hormone antagonists|mesh-ancestor
139604467|NCT05933395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139604468|NCT05909800|Fenofibrate|fenofibrate|mesh-list
139604469|NCT05909800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139604470|NCT05909800|Antimetabolites|antimetabolites|mesh-ancestor
139604471|NCT05909800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604472|NCT05909800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139604473|NCT05905055|Cefepime|cefepime|mesh-list
139604474|NCT05905055|Aztreonam|aztreonam|mesh-list
139604475|NCT05905055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139604476|NCT05905055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604477|NCT05864209|Bisphenol A|bisphenol a|mesh-list
139604478|NCT05864209|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139604479|NCT05864209|Estrogens|estrogens|mesh-ancestor
139604480|NCT05864209|Hormones|hormones|mesh-ancestor
139604481|NCT05864209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139604482|NCT05864209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604483|NCT05864209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139604484|NCT05864209|Antioxidants|antioxidants|mesh-ancestor
139604485|NCT05864209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604486|NCT05864209|Protective Agents|protective agents|mesh-ancestor
139604487|NCT05782127|Venetoclax|venetoclax|mesh-list
139604488|NCT05782127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604489|NCT05778227|Etidronic Acid|etidronic acid|mesh-list
139604490|NCT05778227|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139604491|NCT05778227|Eusol|eusol|mesh-list
139604492|NCT05778227|Acetic Acid|acetic acid|mesh-list
139604493|NCT05778227|Retinol acetate|retinol acetate|mesh-list
139604494|NCT05778227|Ethylene|ethylene|mesh-list
139604495|NCT05778227|Maleic acid|maleic acid|mesh-list
139604496|NCT05778227|Disinfectants|disinfectants|mesh-ancestor
139604497|NCT05778227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604498|NCT05778227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139604499|NCT05778227|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139604500|NCT05778227|Immunologic Factors|immunologic factors|mesh-ancestor
139604501|NCT05778227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604502|NCT05778227|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139604503|NCT05778227|Protective Agents|protective agents|mesh-ancestor
139604504|NCT05778227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604505|NCT05778227|Plant Growth Regulators|plant growth regulators|mesh-ancestor
139604506|NCT05778227|Growth Substances|growth substances|mesh-ancestor
139604507|NCT05778227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604508|NCT05778227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604509|NCT05778227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139604510|NCT05753150|Primaquine|primaquine|mesh-list
139604511|NCT05753150|Tafenoquine|tafenoquine|mesh-list
139604512|NCT05753150|Antimalarials|antimalarials|mesh-ancestor
139604513|NCT05753150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139604514|NCT05753150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139604515|NCT05753150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604516|NCT05636904|Minoxidil|minoxidil|mesh-list
139604517|NCT05636904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139604518|NCT05636904|Dinoprost|dinoprost|mesh-list
139604519|NCT05636904|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
139604520|NCT05636904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139604521|NCT05636904|Vasodilator Agents|vasodilator agents|mesh-ancestor
139604522|NCT05636904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139604523|NCT05636904|Abortifacient Agents|abortifacient agents|mesh-ancestor
139604524|NCT05636904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139604525|NCT05636904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604526|NCT05636904|Oxytocics|oxytocics|mesh-ancestor
139604527|NCT05630794|TIC10 compound|tic10 compound|mesh-list
139604528|NCT05630794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604529|NCT05625555|Midazolam|midazolam|mesh-list
139604530|NCT05625555|Ketamine|ketamine|mesh-list
139604531|NCT05625555|Analgesics|analgesics|mesh-ancestor
139604532|NCT05625555|Sensory System Agents|sensory system agents|mesh-ancestor
139604533|NCT05625555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604534|NCT05625555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604535|NCT05625555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139604536|NCT05625555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139604537|NCT05625555|Anesthetics, General|anesthetics, general|mesh-ancestor
139604538|NCT05625555|Anesthetics|anesthetics|mesh-ancestor
139604539|NCT05625555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139604540|NCT05625555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139604541|NCT05625555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139604542|NCT05625555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604543|NCT05625555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604544|NCT05625555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139604545|NCT05625555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139604546|NCT05625555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139604547|NCT05625555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139604548|NCT05625555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139604549|NCT05625555|GABA Modulators|gaba modulators|mesh-ancestor
139604550|NCT05625555|GABA Agents|gaba agents|mesh-ancestor
139604551|NCT05590637|Pimavanserin|pimavanserin|mesh-list
138732716|NCT01687205|Tenofovir|tenofovir|mesh-list
139604552|NCT05590637|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139604553|NCT05590637|Antidepressive Agents|antidepressive agents|mesh-ancestor
139604554|NCT05590637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139604555|NCT05590637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139604556|NCT05590637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139604557|NCT05590637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139604558|NCT05590637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604559|NCT05590637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139604560|NCT05590637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139604561|NCT05590637|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139604562|NCT05590637|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139604563|NCT05590637|Serotonin Agents|serotonin agents|mesh-ancestor
139604564|NCT05590637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604565|NCT05590637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604566|NCT05583721|Regadenoson|regadenoson|mesh-list
139604567|NCT05583721|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139604568|NCT05583721|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139604569|NCT05583721|Purinergic Agonists|purinergic agonists|mesh-ancestor
139604570|NCT05583721|Purinergic Agents|purinergic agents|mesh-ancestor
139604571|NCT05583721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604572|NCT05583721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604573|NCT05583721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604574|NCT05559099|Tecovirimat|tecovirimat|mesh-list
139604575|NCT05559099|Antiviral Agents|antiviral agents|mesh-ancestor
139604576|NCT05559099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604577|NCT05457959|Poly I-C|poly i-c|mesh-list
139604578|NCT05457959|Nivolumab|nivolumab|mesh-list
139604579|NCT05457959|Ipilimumab|ipilimumab|mesh-list
139604580|NCT05457959|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139604581|NCT05457959|Vaccines|vaccines|mesh-list
139604582|NCT05457959|Poly ICLC|poly iclc|mesh-list
139604583|NCT05457959|Immunologic Factors|immunologic factors|mesh-ancestor
139604584|NCT05457959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604585|NCT05457959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139604586|NCT05457959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604587|NCT05457959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139604588|NCT05457959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604589|NCT05457959|Interferon Inducers|interferon inducers|mesh-ancestor
139604590|NCT05457959|Laxatives|laxatives|mesh-ancestor
139604591|NCT05457959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139604592|NCT05457959|Antiviral Agents|antiviral agents|mesh-ancestor
139604593|NCT05457959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604594|NCT05453396|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139604595|NCT05453396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139604596|NCT05453396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604597|NCT05415215|Trastuzumab|trastuzumab|mesh-list
139604598|NCT05415215|Pertuzumab|pertuzumab|mesh-list
139604599|NCT05415215|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139604600|NCT05415215|Maytansine|maytansine|mesh-list
139604601|NCT05415215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139604602|NCT05415215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604603|NCT05415215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139604604|NCT05415215|Tubulin Modulators|tubulin modulators|mesh-ancestor
139604605|NCT05415215|Antimitotic Agents|antimitotic agents|mesh-ancestor
139604606|NCT05415215|Mitosis Modulators|mitosis modulators|mesh-ancestor
139604607|NCT05415215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604608|NCT05415215|Immunotoxins|immunotoxins|mesh-ancestor
139604609|NCT05415215|Immunoconjugates|immunoconjugates|mesh-ancestor
139604610|NCT05415215|Immunologic Factors|immunologic factors|mesh-ancestor
139604611|NCT05415215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604612|NCT05375084|Nivolumab|nivolumab|mesh-list
139604613|NCT05375084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139604614|NCT05375084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604615|NCT05375084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139604616|NCT05375084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604617|NCT05363319|Cemiplimab|cemiplimab|mesh-list
139604618|NCT05363319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139604619|NCT05363319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604620|NCT05360966|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139604621|NCT05360966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139604622|NCT05339022|Coal Tar|coal tar|mesh-list
139604623|NCT05339022|Keratolytic Agents|keratolytic agents|mesh-ancestor
139604624|NCT05339022|Dermatologic Agents|dermatologic agents|mesh-ancestor
139604625|NCT05329545|Immunoconjugates|immunoconjugates|mesh-list
139604626|NCT05329545|Immunologic Factors|immunologic factors|mesh-ancestor
139604627|NCT05329545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604628|NCT05317858|Pembrolizumab|pembrolizumab|mesh-list
139604629|NCT05317858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139604630|NCT05317858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604631|NCT05317858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139604632|NCT05317858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604633|NCT05312762|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139604634|NCT05312762|Chitosan|chitosan|mesh-list
139604635|NCT05312762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139604636|NCT05312762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139604637|NCT05312762|Antimetabolites|antimetabolites|mesh-ancestor
139604638|NCT05312762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604639|NCT05312762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139604640|NCT05312762|Chelating Agents|chelating agents|mesh-ancestor
139604641|NCT05312762|Sequestering Agents|sequestering agents|mesh-ancestor
139604642|NCT05312762|Hemostatics|hemostatics|mesh-ancestor
139604643|NCT05312762|Coagulants|coagulants|mesh-ancestor
139604644|NCT05312762|Laxatives|laxatives|mesh-ancestor
139604645|NCT05312762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139604646|NCT05275205|Aflibercept|aflibercept|mesh-list
139604647|NCT05275205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139604648|NCT05275205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139604649|NCT05275205|Growth Substances|growth substances|mesh-ancestor
139604650|NCT05275205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604651|NCT05275205|Growth Inhibitors|growth inhibitors|mesh-ancestor
139604652|NCT05275205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604653|NCT05253495|Cytarabine|cytarabine|mesh-list
139604654|NCT05253495|Etoposide|etoposide|mesh-list
139604655|NCT05253495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139604656|NCT05253495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604657|NCT05253495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139604658|NCT05253495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139604659|NCT05253495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604660|NCT05253495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604661|NCT05253495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139604662|NCT05253495|Antimetabolites|antimetabolites|mesh-ancestor
139604663|NCT05253495|Antiviral Agents|antiviral agents|mesh-ancestor
139604664|NCT05253495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604665|NCT05253495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139604666|NCT05253495|Immunologic Factors|immunologic factors|mesh-ancestor
139604667|NCT05253495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604668|NCT05224050|Nicotine|nicotine|mesh-list
139604669|NCT05224050|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139604670|NCT05224050|Autonomic Agents|autonomic agents|mesh-ancestor
139604671|NCT05224050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604672|NCT05224050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604673|NCT05224050|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139604674|NCT05224050|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139604675|NCT05224050|Cholinergic Agents|cholinergic agents|mesh-ancestor
139604676|NCT05224050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604677|NCT05224050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604678|NCT05183646|Propagermanium|propagermanium|mesh-list
139604679|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604680|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
139604681|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
139604682|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604683|NCT05182658|Empagliflozin|empagliflozin|mesh-list
139604684|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139604685|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604686|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139604687|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604688|NCT05154669|Nicotine|nicotine|mesh-list
139604689|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139604690|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
139604691|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604692|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604693|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139604694|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139604695|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
139604696|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604697|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604698|NCT05148234|Decitabine|decitabine|mesh-list
139604699|NCT05148234|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139604700|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139604701|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
139604702|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604703|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604704|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604705|NCT05125016|Cemiplimab|cemiplimab|mesh-list
139604706|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139604707|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604708|NCT05109312|Acetaminophen|acetaminophen|mesh-list
139604709|NCT05109312|Ibuprofen|ibuprofen|mesh-list
139604710|NCT05109312|Bupivacaine|bupivacaine|mesh-list
139604711|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
139604712|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
139604713|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139604714|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604715|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
139604716|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604717|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139604718|NCT05109312|Analgesics|analgesics|mesh-ancestor
139604719|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
139604720|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139604721|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139604722|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139604723|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139604724|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604725|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604726|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
139604727|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139604728|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139604729|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604730|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
139604731|NCT05075200|Coagulants|coagulants|mesh-ancestor
139604732|NCT05053854|Talazoparib|talazoparib|mesh-list
139604733|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139604734|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604735|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604736|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604737|NCT05030194|Nicotine|nicotine|mesh-list
139604738|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139604739|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
139604740|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604741|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604742|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139604743|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139604744|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
139604745|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604746|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604747|NCT04937413|Evolocumab|evolocumab|mesh-list
139604748|NCT04937413|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139604749|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139604750|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139604751|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
139604752|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604753|NCT04937413|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139604754|NCT04937413|Protease Inhibitors|protease inhibitors|mesh-ancestor
139604755|NCT04937413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604756|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139604757|NCT04880655|Bacitracin|bacitracin|mesh-list
139604758|NCT04880655|Petrolatum|petrolatum|mesh-list
139604759|NCT04880655|Emollients|emollients|mesh-ancestor
139604760|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
139604761|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139604762|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604763|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139604764|NCT04861987|Capecitabine|capecitabine|mesh-list
139604765|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139604766|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
139604767|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604768|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604769|NCT04827056|Ethanol|ethanol|mesh-list
139604770|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
139604771|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139604772|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139604773|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604774|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139604775|NCT04827056|Analgesics|analgesics|mesh-ancestor
139604776|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
139604777|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604778|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139604779|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139604780|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139604781|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
139604782|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604783|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604784|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139604785|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604786|NCT04777422|Defibrotide|defibrotide|mesh-list
139604787|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139604788|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139604789|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604790|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139604791|NCT04691986|Niacinamide|niacinamide|mesh-list
139604792|NCT04691986|Niacin|niacin|mesh-list
139604793|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
139604794|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
139604795|NCT04691986|Vitamins|vitamins|mesh-ancestor
139604796|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
139604797|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604798|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139604799|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
139604800|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604801|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139604802|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
139604803|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139604804|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604805|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139604806|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
139604807|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139604808|NCT04656184|Antibodies|antibodies|mesh-list
139604809|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
139604810|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139604811|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
139604812|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604813|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139604814|NCT04641338|Dipyrone|dipyrone|mesh-list
139604815|NCT04641338|Codeine|codeine|mesh-list
139604816|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139604817|NCT04641338|Narcotics|narcotics|mesh-ancestor
139604818|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139604819|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604820|NCT04641338|Analgesics|analgesics|mesh-ancestor
139604821|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
139604822|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604823|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
139604824|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
139604825|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139604826|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139604827|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139604828|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139604829|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
139604830|NCT04587791|Cannabidiol|cannabidiol|mesh-list
139604831|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
139604832|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139604833|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139604834|NCT04549116|Progesterone|progesterone|mesh-list
139604835|NCT04549116|Progestins|progestins|mesh-ancestor
139604836|NCT04549116|Hormones|hormones|mesh-ancestor
139604837|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139604838|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604839|NCT04491370|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139604840|NCT04491370|Immunoconjugates|immunoconjugates|mesh-ancestor
139604841|NCT04491370|Immunologic Factors|immunologic factors|mesh-ancestor
139604842|NCT04491370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604843|NCT04478474|Ganciclovir|ganciclovir|mesh-list
139604844|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139604845|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
139604846|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139604847|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139604848|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604849|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604850|NCT04470817|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139604851|NCT04470817|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139604852|NCT04470817|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139604853|NCT04470817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604854|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
139604855|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139604856|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139604857|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604858|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139604859|NCT04470050|Analgesics|analgesics|mesh-ancestor
139604860|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
139604861|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604862|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139604863|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139604864|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139604865|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
139604866|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604867|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604868|NCT04457258|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139604869|NCT04457258|FAPI-46|fapi-46|mesh-list
139604870|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139604871|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604872|NCT04456660|Immunologic Factors|immunologic factors|mesh-list
139604873|NCT04456660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604874|NCT04430894|Dexamethasone|dexamethasone|mesh-list
139604875|NCT04430894|Lenalidomide|lenalidomide|mesh-list
139604876|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139604877|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
139604878|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
139604879|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139604880|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604881|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139604882|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
139604883|NCT04430894|Hormones|hormones|mesh-ancestor
139604884|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139604885|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139604886|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604887|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
139604888|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139604889|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139604890|NCT04430894|Growth Substances|growth substances|mesh-ancestor
139604891|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
139604892|NCT04375384|Cetuximab|cetuximab|mesh-list
139604893|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139604894|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604895|NCT04369664|Atorvastatin|atorvastatin|mesh-list
139604896|NCT04369664|Ezetimibe|ezetimibe|mesh-list
139604897|NCT04369664|Evolocumab|evolocumab|mesh-list
139604898|NCT04369664|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139604899|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139604900|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139604901|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
139604902|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604903|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139604904|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139604905|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604906|NCT04369664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139604907|NCT04369664|Protease Inhibitors|protease inhibitors|mesh-ancestor
139604908|NCT04338204|Tofacitinib|tofacitinib|mesh-list
139604909|NCT04338204|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139604910|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139604911|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604912|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604913|NCT04337580|Omeprazole|omeprazole|mesh-list
139604914|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139604915|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139604916|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139604917|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604918|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604920|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604921|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139604922|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604923|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604924|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
139604925|NCT04257578|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139604926|NCT04257578|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139604927|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604928|NCT04257578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139604929|NCT04257578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139604930|NCT04257578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604931|NCT04257578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139604932|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
139604933|NCT04245722|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139604934|NCT04245722|Rituximab|rituximab|mesh-list
139604935|NCT04245722|Fludarabine|fludarabine|mesh-list
139604936|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
139604937|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139604938|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
139604939|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604940|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139604941|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139604942|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
139604943|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604944|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604945|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139604946|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139604947|NCT04204772|Charcoal|charcoal|mesh-list
139604948|NCT04204772|Antidotes|antidotes|mesh-ancestor
139604949|NCT04204772|Protective Agents|protective agents|mesh-ancestor
139604950|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604951|NCT04188873|Varenicline|varenicline|mesh-list
139604952|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604953|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604954|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604955|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139604956|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139604957|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
139604958|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
139604959|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139604960|NCT04023071|Rituximab|rituximab|mesh-list
139604961|NCT04023071|Fludarabine|fludarabine|mesh-list
139604962|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
139604963|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139604964|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
139604965|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604966|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139604967|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139604968|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
139604969|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604970|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604971|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139604972|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139604973|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139604974|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139604975|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604976|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139604977|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139604978|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139604979|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139604980|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
139604981|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139604982|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
139604983|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139604984|NCT03910738|Testosterone|testosterone|mesh-list
139604985|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
139604986|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
139604987|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139604988|NCT03910738|Androgens|androgens|mesh-ancestor
139604989|NCT03910738|Hormones|hormones|mesh-ancestor
139604990|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139604991|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139604992|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139604993|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139604994|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
139604995|NCT03869996|Cytarabine|cytarabine|mesh-list
139604996|NCT03869996|Methotrexate|methotrexate|mesh-list
139604997|NCT03869996|Etoposide|etoposide|mesh-list
139604998|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139604999|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
139605000|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605001|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605002|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
139605003|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605004|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139605005|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
139605006|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605007|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139605008|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139605009|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139605010|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605011|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139605012|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
139605013|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138733179|NCT02270957|Abatacept|abatacept|mesh-list
139605014|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
139605015|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139605016|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139605017|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139605018|NCT03785223|Methylphenidate|methylphenidate|mesh-list
139605019|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139605020|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605021|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139605022|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139605023|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139605024|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605025|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
139605026|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605027|NCT03779087|Amoxicillin|amoxicillin|mesh-list
139605028|NCT03779087|Levofloxacin|levofloxacin|mesh-list
139605029|NCT03779087|Ofloxacin|ofloxacin|mesh-list
139605030|NCT03779087|Tetracycline|tetracycline|mesh-list
139605031|NCT03779087|Esomeprazole|esomeprazole|mesh-list
139605032|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139605033|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605034|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139605035|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139605036|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139605037|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605038|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605039|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139605040|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139605041|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139605042|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605043|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139605044|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139605045|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139605046|NCT03779074|Amoxicillin|amoxicillin|mesh-list
139605047|NCT03779074|Metronidazole|metronidazole|mesh-list
139605048|NCT03779074|Clarithromycin|clarithromycin|mesh-list
139605049|NCT03779074|Tetracycline|tetracycline|mesh-list
139605050|NCT03779074|Rabeprazole|rabeprazole|mesh-list
139605051|NCT03779074|Bismuth|bismuth|mesh-list
139605052|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139605053|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605054|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139605055|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139605056|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139605057|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605058|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605059|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139605060|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139605061|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139605062|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139605063|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139605064|NCT03779074|Antacids|antacids|mesh-ancestor
139386774|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
138733239|NCT04445415|Antibodies|antibodies|mesh-list
139605066|NCT03750786|Antidotes|antidotes|mesh-ancestor
139605067|NCT03750786|Protective Agents|protective agents|mesh-ancestor
139605068|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605069|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
139605070|NCT03750786|Vitamins|vitamins|mesh-ancestor
139605071|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
139605072|NCT03742414|Fluticasone|fluticasone|mesh-list
139605073|NCT03742414|Xhance|xhance|mesh-list
139605074|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139605075|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139605076|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
139605077|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605078|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605079|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139605080|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
139605081|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
139605082|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139605083|NCT03728933|Rotigotine|rotigotine|mesh-list
139605084|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
139605085|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
139605086|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605087|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605088|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605089|NCT03719105|Dexamethasone|dexamethasone|mesh-list
139605090|NCT03719105|Prednisone|prednisone|mesh-list
139605091|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
139605092|NCT03719105|Ifosfamide|ifosfamide|mesh-list
139605093|NCT03719105|Doxorubicin|doxorubicin|mesh-list
139605094|NCT03719105|Methotrexate|methotrexate|mesh-list
139605095|NCT03719105|Etoposide|etoposide|mesh-list
139605096|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139605097|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139605098|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
139605099|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605100|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139605101|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139605102|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
139605103|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605104|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605105|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139605106|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139605107|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
139605108|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
139605109|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605110|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139605111|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
139605112|NCT03719105|Hormones|hormones|mesh-ancestor
139605113|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139605114|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139605115|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139605116|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139605117|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139605118|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605119|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139605120|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
139605121|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139605122|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139605123|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
139605124|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
139605125|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139605126|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139605127|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139605128|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139605129|NCT03719105|Immunotoxins|immunotoxins|mesh-ancestor
139605130|NCT03719105|Immunoconjugates|immunoconjugates|mesh-ancestor
139605131|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
139605132|NCT03649841|Prednisone|prednisone|mesh-list
139605133|NCT03649841|Cortisone|cortisone|mesh-list
139605134|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
139605135|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
139605136|NCT03649841|Hormones|hormones|mesh-list
139605137|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139605138|NCT03649841|Androgens|androgens|mesh-list
139605139|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
139605140|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139605141|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
139605142|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139605143|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605144|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139605145|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605146|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139605147|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605148|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605149|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
139605150|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139605151|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
139605152|NCT03649841|Protective Agents|protective agents|mesh-ancestor
139605153|NCT03649841|Vitamins|vitamins|mesh-ancestor
139605154|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
139605155|NCT03649841|Estrogens|estrogens|mesh-ancestor
139605156|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
139605157|NCT03601923|Niraparib|niraparib|mesh-list
139605158|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139605159|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605160|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605161|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605162|NCT03557281|GSK656|gsk656|mesh-list
139605163|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139605164|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605165|NCT03537196|Ribavirin|ribavirin|mesh-list
139605166|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
139605167|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
139605168|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605169|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
139605170|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605171|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
139605172|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139605173|NCT03515304|Evolocumab|evolocumab|mesh-list
139605174|NCT03515304|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139605175|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139605176|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139605177|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
139605178|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605179|NCT03515304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139605180|NCT03515304|Protease Inhibitors|protease inhibitors|mesh-ancestor
139605181|NCT03515304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605182|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139605183|NCT03502746|Nivolumab|nivolumab|mesh-list
139605184|NCT03502746|Ramucirumab|ramucirumab|mesh-list
139605185|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139605186|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605187|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139605188|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605189|NCT03345797|Testosterone|testosterone|mesh-list
139605190|NCT03345797|Androgens|androgens|mesh-ancestor
139605191|NCT03345797|Hormones|hormones|mesh-ancestor
139313229|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605192|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139605193|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605194|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
139605195|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139605196|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139605197|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
139605198|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
139605199|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139605200|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605201|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
139605202|NCT03260894|Sunitinib|sunitinib|mesh-list
139605203|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139605204|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605205|NCT03260894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139605206|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605207|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139605208|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139605209|NCT03260894|Growth Substances|growth substances|mesh-ancestor
139605210|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605211|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
139605212|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139605213|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605214|NCT03197935|Paclitaxel|paclitaxel|mesh-list
139605215|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
139605216|NCT03197935|Doxorubicin|doxorubicin|mesh-list
139605217|NCT03197935|Atezolizumab|atezolizumab|mesh-list
139605218|NCT03197935|Antibodies|antibodies|mesh-list
139605219|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139605220|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605221|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
139605222|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
139605223|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
139605224|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605225|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139605226|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
139605227|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605228|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139605229|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139605230|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
139605231|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139605232|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139605233|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139605234|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139605235|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605236|NCT03197935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139605237|NCT03197935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139605238|NCT03115151|Fentanyl|fentanyl|mesh-list
139605239|NCT03115151|Hydromorphone|hydromorphone|mesh-list
139605240|NCT03115151|Bupivacaine|bupivacaine|mesh-list
139605241|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
139605242|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
139605243|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139605244|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605245|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
139605246|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605247|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139605248|NCT03115151|Narcotics|narcotics|mesh-ancestor
139605249|NCT03115151|Analgesics|analgesics|mesh-ancestor
139605250|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139605251|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139605252|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
139605253|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
139605254|NCT03105336|Fludarabine|fludarabine|mesh-list
139605255|NCT03105336|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139605256|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139605257|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
139605258|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605259|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139605260|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139605261|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
139605262|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605263|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605264|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139605265|NCT03105336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139605266|NCT02908685|Risdiplam|risdiplam|mesh-list
139605267|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139605268|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605269|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605270|NCT02845596|Cyclosporine|cyclosporine|mesh-list
139605271|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
139605272|NCT02845596|Methotrexate|methotrexate|mesh-list
139605273|NCT02845596|Fludarabine|fludarabine|mesh-list
139605274|NCT02845596|Cyclosporins|cyclosporins|mesh-list
139605275|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
139605276|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139605277|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139605278|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
139605279|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605280|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139605281|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139605282|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
139605283|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605284|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605285|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139605286|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139605287|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
139605288|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139605289|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139605290|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
139605291|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
139605292|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605293|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139605294|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139605295|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
139605297|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139605298|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
139605299|NCT02778685|Letrozole|letrozole|mesh-list
139605300|NCT02778685|Fulvestrant|fulvestrant|mesh-list
139605301|NCT02778685|Palbociclib|palbociclib|mesh-list
139605302|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139605303|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605304|NCT02778685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139605305|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605306|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139605307|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139605308|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605309|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139605310|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
139605311|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139605312|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605313|NCT02778685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139605314|NCT02778685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139605315|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139605316|NCT02676739|Adderall|adderall|mesh-list
139605317|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139605318|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605319|NCT02675959|Defibrotide|defibrotide|mesh-list
139605320|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139605321|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139605322|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605323|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139605324|NCT02668562|Ticagrelor|ticagrelor|mesh-list
139605325|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139605326|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139605327|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139605328|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139605329|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
139605330|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605331|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605332|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605333|NCT02646839|Biotin|biotin|mesh-list
139605334|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
139605335|NCT02646839|Vitamins|vitamins|mesh-ancestor
139605336|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
139605337|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605338|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
139605339|NCT02601313|Fludarabine|fludarabine|mesh-list
139605340|NCT02601313|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139605341|NCT02601313|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
139605342|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139605343|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
139605344|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605345|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139605346|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139605347|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
139605348|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605349|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605350|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139605351|NCT02601313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139605352|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
139605353|NCT02550652|Prednisone|prednisone|mesh-list
139605354|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
139605355|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
139605356|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139605357|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
139605358|NCT02550652|Hormones|hormones|mesh-ancestor
139605359|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139605360|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605361|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139605362|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605363|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139605364|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139605365|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
139605366|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139605367|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605368|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605369|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605370|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
139605371|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
139605372|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605373|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139605374|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139605375|NCT02550652|Protective Agents|protective agents|mesh-ancestor
139605376|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139605377|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139605378|NCT02547025|Amoxicillin|amoxicillin|mesh-list
139605379|NCT02547025|Clarithromycin|clarithromycin|mesh-list
139605380|NCT02547025|Levofloxacin|levofloxacin|mesh-list
139605381|NCT02547025|Ofloxacin|ofloxacin|mesh-list
139605382|NCT02547025|Tetracycline|tetracycline|mesh-list
139605383|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139605384|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
139605385|NCT02547025|Rabeprazole|rabeprazole|mesh-list
139605386|NCT02547025|Bismuth|bismuth|mesh-list
139605387|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605388|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
139605389|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139605390|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605391|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605392|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139605393|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139605394|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139605395|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139605396|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139605397|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605398|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139605399|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139605400|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139605401|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139605402|NCT02547025|Antacids|antacids|mesh-ancestor
139605403|NCT02491099|Afatinib|afatinib|mesh-list
139605404|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605405|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605406|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139605407|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605408|NCT02484443|Dinutuximab|dinutuximab|mesh-list
139605409|NCT02484443|Sargramostim|sargramostim|mesh-list
139605410|NCT02484443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139605411|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
139605412|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605413|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605414|NCT02422381|Gemcitabine|gemcitabine|mesh-list
139605415|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
139605416|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139605417|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
139605418|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605419|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605420|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139605421|NCT02422381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139605422|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
139605423|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
139605424|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
139605425|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605426|NCT02371941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139605427|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139605428|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139605429|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
139605430|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
139605431|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139605432|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605433|NCT02221310|Immunotoxins|immunotoxins|mesh-ancestor
139605434|NCT02221310|Immunoconjugates|immunoconjugates|mesh-ancestor
139605435|NCT02221310|Immunologic Factors|immunologic factors|mesh-ancestor
139605436|NCT02221310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605437|NCT02140788|Metformin|metformin|mesh-list
139605438|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139605439|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605440|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
139605441|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139605442|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605443|NCT02117297|Immunotoxins|immunotoxins|mesh-ancestor
139605444|NCT02117297|Immunoconjugates|immunoconjugates|mesh-ancestor
139605445|NCT02117297|Immunologic Factors|immunologic factors|mesh-ancestor
139605446|NCT02117297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605448|NCT01711554|Lenalidomide|lenalidomide|mesh-list
139605449|NCT01711554|Tretinoin|tretinoin|mesh-list
139605450|NCT01711554|Dinutuximab|dinutuximab|mesh-list
139605451|NCT01711554|Isotretinoin|isotretinoin|mesh-list
139605452|NCT01711554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139605453|NCT01711554|Vitamins|vitamins|mesh-ancestor
139605454|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
139605455|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605456|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
139605457|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139605458|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139605459|NCT01711554|Growth Substances|growth substances|mesh-ancestor
139605460|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
139605461|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605462|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
139605463|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
139605464|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139605465|NCT01703949|Nivolumab|nivolumab|mesh-list
139605466|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139605467|NCT01703949|Antibodies|antibodies|mesh-list
139605468|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
139605469|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139605470|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
139605471|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
139605472|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605473|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605474|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139605475|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605476|NCT01703949|Immunotoxins|immunotoxins|mesh-ancestor
139605477|NCT01695941|Rituximab|rituximab|mesh-list
139605478|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139605479|NCT01695941|Bortezomib|bortezomib|mesh-list
139605480|NCT01695941|Antibodies|antibodies|mesh-list
139605481|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
139605482|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139605483|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
139605484|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605485|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605486|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139605487|NCT01375829|Sirolimus|sirolimus|mesh-list
139605488|NCT01375829|Temsirolimus|temsirolimus|mesh-list
139605489|NCT01375829|Epothilone B|epothilone b|mesh-list
139605490|NCT01375829|MTOR Inhibitors|mtor inhibitors|mesh-list
139605491|NCT01375829|Epothilones|epothilones|mesh-list
139605492|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139605493|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605494|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139605495|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605496|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
139605497|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139605498|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
139605499|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605500|NCT01375829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139605501|NCT01375829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605502|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605503|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
139605504|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
139605505|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
139605506|NCT01364051|Cediranib|cediranib|mesh-list
139605507|NCT01364051|Maleic acid|maleic acid|mesh-list
139605508|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605509|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605510|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605511|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139605512|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
139605513|NCT01307956|Leucovorin|leucovorin|mesh-list
139605514|NCT01307956|Folic Acid|folic acid|mesh-list
139605515|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139605516|NCT01307956|Panitumumab|panitumumab|mesh-list
139605517|NCT01307956|Fluorouracil|fluorouracil|mesh-list
139605518|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
139605519|NCT01307956|Antibodies|antibodies|mesh-list
139605520|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
139605521|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139605522|NCT01307956|Calcium|calcium|mesh-list
139605523|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
139605524|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
139605525|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605526|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605527|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139605528|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139605529|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
139605530|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605531|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139605532|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139605533|NCT01307956|Antidotes|antidotes|mesh-ancestor
139605534|NCT01307956|Protective Agents|protective agents|mesh-ancestor
139605535|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
139605536|NCT01307956|Vitamins|vitamins|mesh-ancestor
139605537|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
139605538|NCT01307956|Hematinics|hematinics|mesh-ancestor
139605539|NCT01280669|Sirolimus|sirolimus|mesh-list
139605540|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139605541|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605542|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139605543|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605544|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
139605545|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139605546|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
139605547|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605548|NCT01225913|Fluticasone|fluticasone|mesh-list
139605550|NCT01225913|Budesonide|budesonide|mesh-list
139605551|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
139605552|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139605553|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139605554|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139605555|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139605556|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139605557|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
139605558|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605559|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605560|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139605561|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
139605562|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
139605563|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139605564|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
139605565|NCT01225913|Hormones|hormones|mesh-ancestor
139605566|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139605567|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139605568|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139605569|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139605570|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
139605571|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605572|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605573|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
139605574|NCT01041027|Paclitaxel|paclitaxel|mesh-list
139605575|NCT01041027|Carboplatin|carboplatin|mesh-list
139605576|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139605577|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605578|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
139605579|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
139605580|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
139605581|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605582|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
139605583|NCT00740805|Doxorubicin|doxorubicin|mesh-list
139605584|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139605585|NCT00740805|Veliparib|veliparib|mesh-list
139605586|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139605587|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
139605588|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605589|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139605590|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139605591|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
139605592|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605593|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605594|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139605595|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139605596|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139605597|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139605598|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605599|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139605600|NCT00669734|Metronidazole|metronidazole|mesh-list
139605601|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
139605602|NCT00669734|Vaccines|vaccines|mesh-list
139605603|NCT00669734|Sargramostim|sargramostim|mesh-list
139605604|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
139605605|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605606|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605607|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605608|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139605609|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139605610|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139605611|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
139605612|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605613|NCT00669734|Protective Agents|protective agents|mesh-ancestor
139605614|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
139605615|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
139605616|NCT00669734|Growth Substances|growth substances|mesh-ancestor
139605617|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139605618|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605619|NCT00576069|Fluticasone|fluticasone|mesh-list
139605620|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
139605621|NCT00576069|Prednisone|prednisone|mesh-list
139605622|NCT00576069|Budesonide|budesonide|mesh-list
139605623|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
139605624|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139605625|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139605626|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139605627|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139605628|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
139605629|NCT00576069|Hormones|hormones|mesh-ancestor
139605630|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139605631|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605632|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139605633|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605634|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139605635|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
139605636|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605637|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139605638|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
139605639|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
139605640|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139605641|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139605642|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139605643|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139605644|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
139605645|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605646|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605647|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
139605648|NCT00501150|Linezolid|linezolid|mesh-list
139605649|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139605650|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605651|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139605652|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605653|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605654|NCT00389610|Pancrelipase|pancrelipase|mesh-list
139605655|NCT00389610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139605656|NCT03142620|Vitamin D|vitamin d|mesh-list
139605657|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
139605658|NCT03142620|Amoxicillin|amoxicillin|mesh-list
139605659|NCT03142620|Clarithromycin|clarithromycin|mesh-list
139605660|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
139605661|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139605662|NCT03142620|Esomeprazole|esomeprazole|mesh-list
139605663|NCT03142620|Vitamins|vitamins|mesh-ancestor
139605664|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
139605665|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605666|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139605667|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139605668|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139605669|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605670|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139605671|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139605672|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139605673|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605674|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605675|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139387385|NCT06108453|Rifampin|rifampin|mesh-list
139605676|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139605678|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139605679|NCT03110952|alpha-Tocopherol|alpha-tocopherol|mesh-list
139605680|NCT03110952|Vaccines|vaccines|mesh-list
139605681|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
139605682|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605683|NCT03110952|Antioxidants|antioxidants|mesh-ancestor
139605684|NCT03110952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605685|NCT03110952|Protective Agents|protective agents|mesh-ancestor
139605686|NCT03110952|Vitamins|vitamins|mesh-ancestor
139605687|NCT03110952|Micronutrients|micronutrients|mesh-ancestor
139605688|NCT03143244|Ketorolac|ketorolac|mesh-list
139605689|NCT03143244|Midazolam|midazolam|mesh-list
139605690|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
139605691|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139605692|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139605693|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605694|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139605695|NCT03143244|Analgesics|analgesics|mesh-ancestor
139605696|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
139605697|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605698|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139605699|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139605700|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139605701|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
139605702|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733846|NCT01607918|Amoxicillin|amoxicillin|mesh-list
139605703|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605704|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139605705|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139605706|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139605707|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139605708|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139605709|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
139605710|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
139605711|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
139605712|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
139605713|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139605714|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139605715|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139605716|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139605717|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605718|NCT03838692|Ponatinib|ponatinib|mesh-list
139605719|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605720|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139605721|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605722|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605723|NCT03505944|Venetoclax|venetoclax|mesh-list
139605724|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605725|NCT01489189|Ranibizumab|ranibizumab|mesh-list
139605726|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139605727|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139605728|NCT01489189|Growth Substances|growth substances|mesh-ancestor
139605729|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605730|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
139605731|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605732|NCT01549873|Propofol|propofol|mesh-list
139605733|NCT01549873|Desflurane|desflurane|mesh-list
139605734|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139605735|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139605736|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605737|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139605738|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
139605739|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
139605740|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139605741|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
139605742|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
139605743|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605744|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
139605745|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605746|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605747|NCT01488487|Everolimus|everolimus|mesh-list
139605748|NCT01488487|Pasireotide|pasireotide|mesh-list
139605749|NCT01488487|Somatostatin|somatostatin|mesh-list
139605750|NCT01488487|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139605751|NCT01488487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139387478|NCT06104540|Petrolatum|petrolatum|mesh-list
139605752|NCT01488487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605753|NCT01488487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605754|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139605755|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
139605756|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605757|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605758|NCT01488487|Hormones|hormones|mesh-ancestor
139605759|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139605760|NCT03027115|Tamsulosin|tamsulosin|mesh-list
139605761|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139605762|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139605763|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139605764|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
139605765|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605766|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605767|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605768|NCT03027115|Urological Agents|urological agents|mesh-ancestor
139605769|NCT03026881|Paclitaxel|paclitaxel|mesh-list
139605770|NCT03026881|Apatinib|apatinib|mesh-list
139605771|NCT03026881|Fluzoparib|fluzoparib|mesh-list
139605772|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139605773|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605774|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
139605775|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
139605776|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
139605777|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605778|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139605779|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605780|NCT03026881|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139605781|NCT01516879|Atorvastatin|atorvastatin|mesh-list
139605782|NCT01516879|Ezetimibe|ezetimibe|mesh-list
139605783|NCT01516879|Evolocumab|evolocumab|mesh-list
139605784|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139605785|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139605786|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
139605787|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605788|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139605789|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139605790|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605791|NCT01516879|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139605792|NCT01516879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139605793|NCT01516879|Protease Inhibitors|protease inhibitors|mesh-ancestor
139605794|NCT01515865|Midodrine|midodrine|mesh-list
139605795|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
139605796|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
139605797|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605798|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605799|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139605800|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139605801|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139605802|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139605803|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
139605804|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605805|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605806|NCT01547299|Leuprolide|leuprolide|mesh-list
139605807|NCT01547299|Dutasteride|dutasteride|mesh-list
139605808|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139605809|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
139605810|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139605811|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605812|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139605813|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605814|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139605815|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139605816|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313230|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605817|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605818|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
139605819|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139605820|NCT04072107|Capecitabine|capecitabine|mesh-list
139605821|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139605822|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
139605823|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605824|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605825|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139605826|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139605827|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605828|NCT00411411|Incretins|incretins|mesh-ancestor
139605829|NCT00411411|Hormones|hormones|mesh-ancestor
139605830|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139605831|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139605832|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
139605833|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605834|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605835|NCT01794273|Phenylephrine|phenylephrine|mesh-list
139605836|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
139605837|NCT01794273|Ephedrine|ephedrine|mesh-list
139605838|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139605839|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
139605840|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
139605841|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605842|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605843|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
139605844|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139605845|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
139605846|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
139605847|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139605848|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139605849|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139605850|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
139605851|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605852|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605853|NCT01794273|Protective Agents|protective agents|mesh-ancestor
139605854|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139605855|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
139605856|NCT01795599|Mifepristone|mifepristone|mesh-list
139605857|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139605858|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
139605859|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139605860|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605861|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139605862|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139605863|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139605864|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
139605865|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139605866|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139605867|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
139605868|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139605869|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
139605870|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139605871|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139605872|NCT01794351|Resveratrol|resveratrol|mesh-list
139605873|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
139605874|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605875|NCT01794351|Protective Agents|protective agents|mesh-ancestor
139605876|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605877|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605878|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139605879|NCT04409431|Epinephrine|epinephrine|mesh-list
139605880|NCT04409431|Racepinephrine|racepinephrine|mesh-list
139605881|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
139605882|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139605883|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139605884|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
139605885|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605886|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605887|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605888|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139605889|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139605890|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
139605891|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605892|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139605893|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
139605894|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
139605895|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
139605896|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139605897|NCT01794507|Dexamethasone|dexamethasone|mesh-list
139605898|NCT01794507|Bortezomib|bortezomib|mesh-list
139605899|NCT01794507|Venetoclax|venetoclax|mesh-list
139605900|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139605901|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
139605902|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
139605903|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605904|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605905|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139605906|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
139605907|NCT01794507|Hormones|hormones|mesh-ancestor
139605908|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139605909|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139605910|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605911|NCT00412425|Palonosetron|palonosetron|mesh-list
139605912|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
139605913|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
139605914|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605915|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605916|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139605917|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139605918|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139605919|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
139605920|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605921|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605922|NCT01492361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139605923|NCT01492361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139605924|NCT01492361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139605925|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139605926|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
139605927|NCT00415857|Vaccines|vaccines|mesh-list
139605928|NCT00415857|Sargramostim|sargramostim|mesh-list
139605929|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
139605930|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605931|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605932|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139605933|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605934|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605935|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
139605936|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139605937|NCT03491631|Apatinib|apatinib|mesh-list
139605938|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605939|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139605940|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605941|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605942|NCT00416793|Carboplatin|carboplatin|mesh-list
139605943|NCT00416793|Bortezomib|bortezomib|mesh-list
139605944|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605945|NCT00417417|Rilonacept|rilonacept|mesh-list
139605946|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138734098|NCT01609205|Adalimumab|adalimumab|mesh-list
139605947|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
139605948|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139605949|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139605950|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
139605951|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605952|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605953|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605954|NCT00420459|Aripiprazole|aripiprazole|mesh-list
139605955|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
139605956|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139605957|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139605958|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139605959|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139605960|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605961|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
139605962|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
139605963|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605964|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605965|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139605966|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139605967|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
139605968|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139605969|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139605970|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139605971|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139605972|NCT00420771|Gabapentin|gabapentin|mesh-list
139605973|NCT00420771|Analgesics|analgesics|mesh-ancestor
139605974|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
139605975|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139605976|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139605977|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
139605978|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139605979|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139605980|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139605981|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139605982|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139605983|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139605984|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139605985|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605986|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
139605987|NCT00426153|Octreotide|octreotide|mesh-list
139605988|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139605989|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139605990|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139605991|NCT04750317|Tofacitinib|tofacitinib|mesh-list
139605992|NCT04750317|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139605993|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139605994|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139605995|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139605996|NCT01996449|Amlodipine|amlodipine|mesh-list
139605997|NCT01996449|Eplerenone|eplerenone|mesh-list
139605998|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139605999|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139606000|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139606001|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606002|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139606003|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606004|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
139606005|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139606006|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
139606007|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606008|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139606009|NCT01996449|Diuretics|diuretics|mesh-ancestor
139606010|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
139606011|NCT00426855|Bortezomib|bortezomib|mesh-list
139606012|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139606013|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606014|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139606015|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
138734160|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
139606016|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606017|NCT01491737|Trastuzumab|trastuzumab|mesh-list
139606018|NCT01491737|Pertuzumab|pertuzumab|mesh-list
139606019|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139606020|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139606021|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606022|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139606023|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606024|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606025|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139606026|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
139606027|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606028|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606029|NCT00427557|Rituximab|rituximab|mesh-list
139606030|NCT00427557|Fludarabine|fludarabine|mesh-list
139606031|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
139606032|NCT00427557|Melphalan|melphalan|mesh-list
139606033|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139606034|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606035|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
139606036|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606037|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139606038|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139606039|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
139606040|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606041|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139606042|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139606043|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
139606044|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139606045|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
139606046|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606047|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139606048|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606049|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606050|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
139606051|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606052|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606053|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139606054|NCT04088305|Vancomycin|vancomycin|mesh-list
139606055|NCT04088305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139606056|NCT04088305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139606057|NCT00427791|Rituximab|rituximab|mesh-list
139606058|NCT00427791|Etoposide|etoposide|mesh-list
139606059|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139606060|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606061|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
139606062|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606063|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139606064|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139606065|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139606066|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139606067|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606068|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606069|NCT01487161|Triamcinolone|triamcinolone|mesh-list
139606070|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139606071|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139606072|NCT01487161|FX006|fx006|mesh-list
139606073|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139606074|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139606075|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
139606076|NCT01487161|Hormones|hormones|mesh-ancestor
139606077|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606078|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606079|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139606080|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
139606081|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606082|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606083|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
139606084|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139606085|NCT00429507|Analgesics|analgesics|mesh-ancestor
139606086|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
139606087|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139606088|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606089|NCT01794897|Valacyclovir|valacyclovir|mesh-list
139606090|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
139606091|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139606092|NCT01794975|Ketamine|ketamine|mesh-list
139606093|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139606094|NCT01794975|Analgesics|analgesics|mesh-ancestor
139606095|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
139606096|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139606097|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606098|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139606099|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139606100|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
139606101|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
139606102|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139606103|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139606104|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139606105|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606106|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606107|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139606108|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139606109|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139606110|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
139606111|NCT05285787|Menaquinone 7|menaquinone 7|mesh-list
139606112|NCT05285787|Hemostatics|hemostatics|mesh-ancestor
139606113|NCT05285787|Coagulants|coagulants|mesh-ancestor
139606114|NCT01491035|Vortioxetine|vortioxetine|mesh-list
139606115|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
139606116|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139606117|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139606118|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139606119|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139606120|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606121|NCT01491035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139297199|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139606122|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139606123|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139606124|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606126|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
139606127|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139606128|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139606129|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139606130|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139606131|NCT00375999|Docetaxel|docetaxel|mesh-list
139606132|NCT00375999|Epirubicin|epirubicin|mesh-list
139606133|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606134|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
139606135|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
139606136|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
139606137|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606138|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139606139|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139606140|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139606141|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606142|NCT04409327|Dactolisib|dactolisib|mesh-list
139606143|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606144|NCT01488071|Vortioxetine|vortioxetine|mesh-list
139606145|NCT01488071|Agomelatine|agomelatine|mesh-list
139606146|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
139606147|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139606148|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139606149|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139606150|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139606151|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606152|NCT01488071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139606153|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139606154|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139606155|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606156|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606157|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
139606158|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139606159|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139606160|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139606161|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139606162|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139606163|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139606164|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139606165|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139606166|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139606167|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606168|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606169|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606170|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139606171|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
139606172|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139606173|NCT01484951|Timolol|timolol|mesh-list
139606174|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139606175|NCT01484951|Brinzolamide|brinzolamide|mesh-list
139606176|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139606177|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139606178|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139606179|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
139606180|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606181|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606182|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606183|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139606184|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139606185|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139606186|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606187|NCT01484873|Exenatide|exenatide|mesh-list
139606188|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139606189|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606190|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139606191|NCT01484873|Incretins|incretins|mesh-ancestor
139606192|NCT01484873|Hormones|hormones|mesh-ancestor
139387905|NCT05351502|Nitric Oxide|nitric oxide|mesh-list
139606193|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606194|NCT01486927|Factor VIII|factor viii|mesh-list
139606195|NCT01486927|Coagulants|coagulants|mesh-ancestor
139606196|NCT00379197|Naltrexone|naltrexone|mesh-list
139606197|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139606198|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139606199|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606200|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
139606201|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139606202|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139606203|NCT01513759|Plasminogen|plasminogen|mesh-list
139606204|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139606205|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139606206|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606207|NCT01484561|Tofacitinib|tofacitinib|mesh-list
139606208|NCT01484561|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139606209|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139606210|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606211|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606212|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
139606213|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139606214|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
139606215|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139606216|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606217|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139606218|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
139606219|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
139606220|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139606221|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
139606222|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606223|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606224|NCT01485991|Simeprevir|simeprevir|mesh-list
139606225|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
139606226|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139606227|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
139606228|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606229|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606230|NCT00379821|Azithromycin|azithromycin|mesh-list
139606231|NCT00379821|Artesunate|artesunate|mesh-list
139606232|NCT00379821|Chloroquine|chloroquine|mesh-list
139606233|NCT00379821|Atovaquone|atovaquone|mesh-list
139606234|NCT00379821|Proguanil|proguanil|mesh-list
139606235|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
139606236|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139606237|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139606238|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
139606239|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139606240|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139606241|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606242|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
139606243|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
139606244|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139606245|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
139606246|NCT00379821|Amebicides|amebicides|mesh-ancestor
139606247|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139606248|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606249|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606250|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
139606251|NCT01482767|Interferons|interferons|mesh-list
139606252|NCT01482767|Ribavirin|ribavirin|mesh-list
139606253|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
139606254|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
139606255|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139606256|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606257|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
139606258|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139606259|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
139606260|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606261|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
139606262|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606263|NCT00435591|Conivaptan|conivaptan|mesh-list
139606264|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139606265|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606266|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
139606267|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606268|NCT00439335|Vaccines|vaccines|mesh-list
139606269|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
139606270|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606272|NCT01545817|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139606273|NCT01545817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139606274|NCT01545817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606275|NCT01545817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606276|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139606277|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
139606278|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606279|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606280|NCT01512979|Metformin|metformin|mesh-list
139606281|NCT01512979|Linagliptin|linagliptin|mesh-list
139606282|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139606283|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606284|NCT01512979|Incretins|incretins|mesh-ancestor
139606285|NCT01512979|Hormones|hormones|mesh-ancestor
139606286|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606287|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139606288|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
139606289|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606290|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606291|NCT00383565|Romidepsin|romidepsin|mesh-list
139606292|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139606293|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606294|NCT00383565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139606295|NCT00383565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606296|NCT00383565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606297|NCT01512745|Apatinib|apatinib|mesh-list
139606298|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606299|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139606300|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606301|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606302|NCT01478321|Bevacizumab|bevacizumab|mesh-list
139606303|NCT01478321|Temozolomide|temozolomide|mesh-list
139606304|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139606305|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606306|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139606307|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139606308|NCT01478321|Growth Substances|growth substances|mesh-ancestor
139606309|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606310|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
139606311|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139606312|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
139606313|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606314|NCT01544491|Everolimus|everolimus|mesh-list
139606315|NCT01544491|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139606316|NCT01544491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139606317|NCT01544491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606318|NCT01544491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606319|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139606320|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
139606321|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606322|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606323|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
139606324|NCT00383643|Zolpidem|zolpidem|mesh-list
139606325|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139606326|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139606327|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139606328|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606329|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139606330|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
139606331|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
139606332|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606333|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606334|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139606335|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139606336|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
139606337|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
139606338|NCT00439413|Selegiline|selegiline|mesh-list
139606339|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
139606340|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139606341|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139606342|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139606343|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139606344|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606345|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606346|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139606347|NCT00439413|Protective Agents|protective agents|mesh-ancestor
139606348|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606349|NCT01477853|Metformin|metformin|mesh-list
139606350|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139606351|NCT01477853|Glimepiride|glimepiride|mesh-list
139606352|NCT01477853|Atorvastatin|atorvastatin|mesh-list
139606353|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139606354|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606355|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139606356|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139606357|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
139606358|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606359|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139606360|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139606361|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606362|NCT01477853|Incretins|incretins|mesh-ancestor
139606363|NCT01477853|Hormones|hormones|mesh-ancestor
139606364|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606365|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139606366|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
139606367|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139606368|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139606369|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
139606370|NCT00440505|Nicotine|nicotine|mesh-list
139606371|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139606372|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
139606373|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139606374|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606375|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139606376|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139606377|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
139606378|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606379|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606380|NCT00441285|Albendazole|albendazole|mesh-list
139606381|NCT00441285|Praziquantel|praziquantel|mesh-list
139606382|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
139606383|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139606384|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139606385|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
139606386|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139606387|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139606388|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
139606389|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
139606390|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
139606391|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606392|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606393|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139606394|NCT01796613|Desogestrel|desogestrel|mesh-list
139606395|NCT01796613|Etonogestrel|etonogestrel|mesh-list
139606396|NCT01796613|NuvaRing|nuvaring|mesh-list
139606397|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139606398|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139606399|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139606400|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
139606401|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139606402|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606403|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139606404|NCT01796613|Estrogens|estrogens|mesh-ancestor
139606405|NCT01796613|Hormones|hormones|mesh-ancestor
139606406|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606407|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139606408|NCT01796613|Progestins|progestins|mesh-ancestor
139606409|NCT00442611|Abatacept|abatacept|mesh-list
139606410|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139606411|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606412|NCT00442611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139606413|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606414|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139606415|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
139606416|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606417|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139606418|NCT01511107|Amoxicillin|amoxicillin|mesh-list
139606419|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
139606420|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
139606421|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139606422|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139606423|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139606424|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139606425|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606426|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606427|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139606428|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
139606429|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606430|NCT00442689|Flutamide|flutamide|mesh-list
139606431|NCT00442689|Drospirenone|drospirenone|mesh-list
139606432|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139606433|NCT00442689|Estradiol|estradiol|mesh-list
139606434|NCT00442689|Estrogens|estrogens|mesh-ancestor
139606435|NCT00442689|Hormones|hormones|mesh-ancestor
139606436|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606437|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606438|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139606439|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
139606440|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139606441|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139606442|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139606443|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139606444|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139606445|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
139606446|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139606447|NCT00442689|Diuretics|diuretics|mesh-ancestor
139606448|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
139606449|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
139606450|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139606451|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606452|NCT01484977|Lacosamide|lacosamide|mesh-list
139606453|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
139606454|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139606455|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139606456|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139606457|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606458|NCT00442767|Insulin|insulin|mesh-list
139606459|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139606460|NCT00442767|Pramlintide|pramlintide|mesh-list
139606461|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
139606462|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139606463|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606464|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
139606465|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139606466|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
139606467|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606468|NCT00445263|Tirofiban|tirofiban|mesh-list
139606469|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139606470|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139606471|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606472|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139606473|NCT00389493|Risperidone|risperidone|mesh-list
139606474|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139606475|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
139606476|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606477|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606478|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606479|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139606480|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139606481|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139606482|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139606483|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139606484|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
139606485|NCT04388709|Interferons|interferons|mesh-list
139606486|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606487|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
139606488|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139606489|NCT00389805|Pemetrexed|pemetrexed|mesh-list
139606490|NCT00389805|Bortezomib|bortezomib|mesh-list
139606491|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606492|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606493|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606494|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139606495|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139606496|NCT00456807|Vaccines|vaccines|mesh-list
139606497|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
139606498|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606499|NCT00456885|Exenatide|exenatide|mesh-list
139606500|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139606501|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606502|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139606503|NCT00456885|Incretins|incretins|mesh-ancestor
139606504|NCT00456885|Hormones|hormones|mesh-ancestor
139606505|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606506|NCT01475825|Mipomersen|mipomersen|mesh-list
139606507|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139606508|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139606509|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
139606510|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606511|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139606512|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139606513|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
139606514|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139606515|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139606516|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139606517|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139606518|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606519|NCT01484431|Tadalafil|tadalafil|mesh-list
139606520|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
139606521|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139606522|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139606523|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606524|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606525|NCT01484431|Urological Agents|urological agents|mesh-ancestor
139606526|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
139606527|NCT00445887|Norgestrel|norgestrel|mesh-list
139606528|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139606529|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
139606530|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139606531|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606532|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139606533|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139606534|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139606535|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139606536|NCT01473953|Liraglutide|liraglutide|mesh-list
139606537|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139606538|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606539|NCT01473953|Incretins|incretins|mesh-ancestor
139606540|NCT01473953|Hormones|hormones|mesh-ancestor
139606541|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606542|NCT00457977|Vaccines|vaccines|mesh-list
139606543|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139606544|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
139606545|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606546|NCT01473563|Pemetrexed|pemetrexed|mesh-list
139606547|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606548|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606549|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606550|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139606551|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139606552|NCT01795209|Ranibizumab|ranibizumab|mesh-list
139606553|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139606554|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139606555|NCT01795209|Growth Substances|growth substances|mesh-ancestor
139606556|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606557|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
139606558|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606559|NCT01484275|Siltuximab|siltuximab|mesh-list
139606560|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606561|NCT01484197|Maleic acid|maleic acid|mesh-list
139606562|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606563|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606564|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
139606565|NCT01473407|Hematinics|hematinics|mesh-ancestor
139606566|NCT04082897|Atezolizumab|atezolizumab|mesh-list
139606567|NCT04082897|Venetoclax|venetoclax|mesh-list
139606568|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
139606569|NCT04082897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139606570|NCT04082897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606571|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139606572|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606573|NCT01544179|Pemetrexed|pemetrexed|mesh-list
139606574|NCT01544179|Gefitinib|gefitinib|mesh-list
139606575|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606576|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606577|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606578|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139606579|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139606580|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139606581|NCT01483651|Insulin|insulin|mesh-list
139606582|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139606583|NCT01483651|Glucagon|glucagon|mesh-list
139606584|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138734755|NCT02272478|Immunoconjugates|immunoconjugates|mesh-ancestor
139606585|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606586|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139606587|NCT01483651|Hormones|hormones|mesh-ancestor
139606588|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606589|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139606590|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139606591|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139606592|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606593|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139606594|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139606595|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606596|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
139606597|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606598|NCT01482169|Adenosine|adenosine|mesh-list
139606599|NCT01482169|Regadenoson|regadenoson|mesh-list
139606600|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139606601|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139606602|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
139606603|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
139606604|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606605|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606606|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606607|NCT01482169|Analgesics|analgesics|mesh-ancestor
139606608|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
139606609|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139606610|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139606611|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
139606612|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
139606613|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139606614|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606615|NCT01509547|Varenicline|varenicline|mesh-list
139606616|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139606617|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139606618|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
139606619|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606620|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606621|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606622|NCT01509079|Vitamin D|vitamin d|mesh-list
139606623|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
139606624|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
139606625|NCT01509079|Vitamins|vitamins|mesh-list
139606626|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
139606627|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606628|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139606629|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139606630|NCT04650217|Levodopa|levodopa|mesh-list
139606631|NCT04650217|Carbidopa|carbidopa|mesh-list
139606632|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139606633|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139606634|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139606635|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
139606636|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606637|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606638|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606639|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139606640|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606641|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139606642|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
139606643|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
139606644|NCT01462435|Celecoxib|celecoxib|mesh-list
139297200|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139606645|NCT01462435|Diclofenac|diclofenac|mesh-list
139606646|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139606647|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139606648|NCT01462435|Analgesics|analgesics|mesh-ancestor
139606649|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
139606650|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139606651|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606652|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139606653|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139606654|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139606655|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139606656|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606657|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606658|NCT01472081|Nivolumab|nivolumab|mesh-list
139606659|NCT01472081|Ipilimumab|ipilimumab|mesh-list
139606660|NCT01472081|Sunitinib|sunitinib|mesh-list
139606661|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139606662|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606663|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139606664|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606665|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139606666|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139606667|NCT01472081|Growth Substances|growth substances|mesh-ancestor
139606668|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606669|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
139606670|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139606671|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606672|NCT01471691|Ranibizumab|ranibizumab|mesh-list
139606673|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139606674|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139606675|NCT01471691|Growth Substances|growth substances|mesh-ancestor
139606676|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606677|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
139606678|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606679|NCT01471379|Milnacipran|milnacipran|mesh-list
139606680|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
139606681|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139606682|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139606683|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139606684|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606685|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606686|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606687|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139606688|NCT01471379|Analgesics|analgesics|mesh-ancestor
139606689|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
139606690|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139606691|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
139606692|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139606693|NCT01470989|Triamcinolone|triamcinolone|mesh-list
139606694|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139606695|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139606696|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139606697|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139606698|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
139606699|NCT01470989|Hormones|hormones|mesh-ancestor
139606700|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606701|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606702|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139606703|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
139606704|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606705|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606706|NCT01470599|Tofacitinib|tofacitinib|mesh-list
139606707|NCT01470599|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139606708|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139606709|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606710|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606711|NCT01469819|Lubiprostone|lubiprostone|mesh-list
139606712|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139606713|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139606714|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606715|NCT04618523|Artesunate|artesunate|mesh-list
139606716|NCT04618523|Lumefantrine|lumefantrine|mesh-list
139606717|NCT04618523|Artemether|artemether|mesh-list
139388429|NCT03526874|Lidocaine|lidocaine|mesh-list
139606718|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139606720|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
139606721|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139606722|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139606723|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139606724|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606725|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
139606726|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
139606727|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139606728|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
139606729|NCT01507831|Alirocumab|alirocumab|mesh-list
139606730|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139606731|NCT01507831|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139606732|NCT01507831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139606733|NCT01507831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139606734|NCT01507831|Antimetabolites|antimetabolites|mesh-ancestor
139606735|NCT01507831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606736|NCT01507831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139606737|NCT01507831|Protease Inhibitors|protease inhibitors|mesh-ancestor
139606738|NCT01507831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606739|NCT01507831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139606740|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
139606741|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606742|NCT01479439|Losartan|losartan|mesh-list
139606743|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139606744|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139606745|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139606746|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139606747|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606748|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
139606749|NCT01478971|Hematinics|hematinics|mesh-ancestor
139606750|NCT01507051|Vitamin K|vitamin k|mesh-list
139606751|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
139606752|NCT01507051|Warfarin|warfarin|mesh-list
139606753|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
139606754|NCT01507051|Vitamins|vitamins|mesh-ancestor
139606755|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
139606756|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606757|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
139606758|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139606759|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
139606760|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139606761|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
139606762|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606763|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606764|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139606765|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139606766|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
139606767|NCT01507051|Coagulants|coagulants|mesh-ancestor
139606768|NCT04079257|Eculizumab|eculizumab|mesh-list
139606769|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139606770|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139606771|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
139606772|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606773|NCT01478113|Amphetamine|amphetamine|mesh-list
139606774|NCT01478113|Adderall|adderall|mesh-list
139606775|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
139606776|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139606777|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606778|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
139606779|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
139606780|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139606781|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
139606782|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606783|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606784|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
139606785|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139606786|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139606787|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139606788|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139606789|NCT01506271|Imipenem|imipenem|mesh-list
139606790|NCT01506271|Relebactam|relebactam|mesh-list
139606791|NCT01506271|Cilastatin|cilastatin|mesh-list
139606792|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139606793|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139606794|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
139606795|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606796|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606797|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139606799|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
139606800|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606801|NCT01505881|Warfarin|warfarin|mesh-list
139606802|NCT01505881|Dabigatran|dabigatran|mesh-list
139606803|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
139606804|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
139606805|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139606806|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
139606807|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606808|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606809|NCT01505647|Vaccines|vaccines|mesh-list
139606810|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
139606811|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606812|NCT01505491|Adalimumab|adalimumab|mesh-list
139606813|NCT01505491|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139606814|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139606815|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139606816|NCT01504867|Aspirin|aspirin|mesh-list
139606817|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139606818|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139606819|NCT01504867|Analgesics|analgesics|mesh-ancestor
139606820|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
139606821|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139606822|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606823|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139606824|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139606825|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139606826|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139606827|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606828|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139606829|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139606830|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606831|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
139606832|NCT01476475|Insulin|insulin|mesh-list
139606833|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139606834|NCT01476475|Metformin|metformin|mesh-list
139606835|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
139606836|NCT01476475|Lixisenatide|lixisenatide|mesh-list
139606837|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139606838|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606839|NCT01460719|Vaccines|vaccines|mesh-list
139606840|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
139606841|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606842|NCT00527943|Vorapaxar|vorapaxar|mesh-list
139606843|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139606844|NCT00448227|Famciclovir|famciclovir|mesh-list
139606845|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
139606846|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139606847|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139606848|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606849|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606850|NCT00529191|Atorvastatin|atorvastatin|mesh-list
139606851|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139606852|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139606853|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
139606854|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606855|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139606856|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139606857|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606858|NCT00449007|Bupropion|bupropion|mesh-list
139606859|NCT00449007|Fluoxetine|fluoxetine|mesh-list
139606860|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139606861|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
139606862|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139606863|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139606864|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139606865|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139606866|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606867|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
139606868|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606869|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606870|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139606871|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139606872|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606873|NCT00449007|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139606874|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
139606875|NCT00460551|Zalutumumab|zalutumumab|mesh-list
139606876|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139606877|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606878|NCT01468181|Dulaglutide|dulaglutide|mesh-list
139606879|NCT01468181|Biguanides|biguanides|mesh-list
139606880|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
139606881|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
139606882|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139606883|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606884|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606885|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606886|NCT01693562|Durvalumab|durvalumab|mesh-list
139606887|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139606888|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606889|NCT00461097|Immunomodulating Agents|immunomodulating agents|mesh-list
139606890|NCT00461097|Immunologic Factors|immunologic factors|mesh-ancestor
139606891|NCT00461097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606892|NCT00531453|Thalidomide|thalidomide|mesh-list
139606893|NCT00531453|Dexamethasone|dexamethasone|mesh-list
139606894|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
139606895|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
139606896|NCT00531453|Bortezomib|bortezomib|mesh-list
139606897|NCT00531453|BB 1101|bb 1101|mesh-list
139606898|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139606899|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
139606900|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606901|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139606902|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139606903|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
139606904|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606905|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606906|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139606907|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139606908|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
139606909|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
139606910|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139606911|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139606912|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
139606913|NCT00531453|Hormones|hormones|mesh-ancestor
139606914|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606915|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139606916|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
139606917|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606918|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
139606919|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139606920|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139606921|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139606922|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139606923|NCT00531453|Growth Substances|growth substances|mesh-ancestor
139606924|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
139606925|NCT00531843|PENTA|penta|mesh-list
139606926|NCT00531843|Fondaparinux|fondaparinux|mesh-list
139606927|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139606928|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
139606929|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139606930|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
139606931|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606932|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606933|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
139606934|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139606935|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139606936|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139606937|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
139606938|NCT01590758|Pexiganan|pexiganan|mesh-list
139606939|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139606940|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139606941|NCT00534417|Capecitabine|capecitabine|mesh-list
139606942|NCT00534417|Fulvestrant|fulvestrant|mesh-list
139606943|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139606944|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
139606945|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606946|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606947|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139606948|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139606949|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139606950|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
139606951|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606952|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606953|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
139606954|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139606955|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139606956|NCT01692626|Analgesics|analgesics|mesh-ancestor
139606957|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
139606958|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139606959|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606960|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139606961|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139606962|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
139606963|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139606964|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
139606965|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139606966|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606967|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606968|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139606969|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139606970|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606971|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606972|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
139606973|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139606974|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606975|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139606976|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139606977|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606978|NCT01475461|Incretins|incretins|mesh-ancestor
139606979|NCT01475461|Hormones|hormones|mesh-ancestor
139606980|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139606981|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139606982|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
139606983|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139606984|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139606985|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139606986|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
139606987|NCT01589822|Coagulants|coagulants|mesh-ancestor
139606988|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139606989|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139606990|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139606991|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
139606992|NCT01474993|Sulforaphane|sulforaphane|mesh-list
139606993|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139606994|NCT01474993|Protective Agents|protective agents|mesh-ancestor
139606995|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139606996|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139606997|NCT01691768|Tenofovir|tenofovir|mesh-list
139606998|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
139606999|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607000|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139607001|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139607002|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607003|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607004|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139607005|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139607006|NCT01503229|Prednisone|prednisone|mesh-list
139607007|NCT01503229|Cortisone|cortisone|mesh-list
139607008|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
139607009|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139607010|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
139607011|NCT01503229|Hormones|hormones|mesh-ancestor
139607012|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139607013|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607014|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139607015|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607016|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139607017|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607018|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607019|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
139607020|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139607021|NCT01460407|Clarithromycin|clarithromycin|mesh-list
139607022|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139607023|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607024|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139607025|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607026|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607027|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138735185|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139607028|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139607029|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
139607030|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139607031|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
139607032|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139607033|NCT01588496|Evolocumab|evolocumab|mesh-list
139607034|NCT01588496|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139607035|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139607036|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139607037|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
139607038|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607039|NCT01588496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139607040|NCT01588496|Protease Inhibitors|protease inhibitors|mesh-ancestor
139607041|NCT01588496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607042|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139607043|NCT01502293|Interleukin-12|interleukin-12|mesh-list
139607044|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139607045|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
139607046|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607047|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139607048|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139607049|NCT01502293|Growth Substances|growth substances|mesh-ancestor
139607050|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
139607051|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607052|NCT01588184|Bevacizumab|bevacizumab|mesh-list
139607053|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139607054|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607055|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139607056|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139607057|NCT01588184|Growth Substances|growth substances|mesh-ancestor
139607058|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607059|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
139607060|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139607061|NCT01564862|Vortioxetine|vortioxetine|mesh-list
139607062|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139607063|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139607064|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139607065|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607066|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607067|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607068|NCT01564862|Analgesics|analgesics|mesh-ancestor
139607069|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
139607070|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607071|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
139607072|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139607073|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
139607074|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139607075|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139607076|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139607077|NCT01564862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139607078|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
139607079|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139607080|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139607081|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139607082|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139607083|NCT01467479|Interferons|interferons|mesh-list
139607084|NCT01467479|Ribavirin|ribavirin|mesh-list
139607085|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
139607086|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
139607087|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139607088|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139607089|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607090|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
139607091|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607092|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
139607093|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607094|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
139607095|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607097|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
139607098|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607099|NCT00535743|Bromides|bromides|mesh-list
139607100|NCT00535743|Rocuronium|rocuronium|mesh-list
139607101|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
139607102|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139607103|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139607104|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139607105|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607106|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607107|NCT01564784|Cytarabine|cytarabine|mesh-list
139607108|NCT01564784|Fludarabine|fludarabine|mesh-list
139607109|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
139607110|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139607111|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607112|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139607113|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
139607114|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607115|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139607116|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
139607117|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607118|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
139607119|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607120|NCT01564784|Analgesics|analgesics|mesh-ancestor
139607121|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
139607122|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607123|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139607124|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139607125|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607126|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139607127|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139607128|NCT01564784|Immunotoxins|immunotoxins|mesh-ancestor
139607129|NCT01564784|Immunoconjugates|immunoconjugates|mesh-ancestor
139607130|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
139607131|NCT00536601|Melphalan|melphalan|mesh-list
139607132|NCT00536601|Busulfan|busulfan|mesh-list
139607133|NCT00536601|Thiotepa|thiotepa|mesh-list
139607134|NCT00536601|Carmustine|carmustine|mesh-list
139607135|NCT00536601|Carboplatin|carboplatin|mesh-list
139607136|NCT00536601|Etoposide|etoposide|mesh-list
139607137|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
139607138|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139607139|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
139607140|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607141|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139607142|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139607143|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
139607144|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607145|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607146|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139607147|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139607148|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139607149|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139607150|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607151|NCT00536913|Budesonide|budesonide|mesh-list
139607152|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
139607153|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139607154|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139607155|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139607156|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
139607157|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607158|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607159|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139607160|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
139607161|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
139607162|NCT00536913|Hormones|hormones|mesh-ancestor
139607163|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139607164|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139607165|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139607166|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139607167|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
139607168|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607169|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607170|NCT00462423|Bevacizumab|bevacizumab|mesh-list
139607171|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139607172|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139607173|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607174|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139607175|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139607176|NCT00462423|Growth Substances|growth substances|mesh-ancestor
139607177|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607178|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
139607180|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139607181|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
139607182|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
139607183|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139607184|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
139607185|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139607186|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607187|NCT00462735|Fluorouracil|fluorouracil|mesh-list
139607188|NCT00462735|Cetuximab|cetuximab|mesh-list
139607189|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
139607190|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
139607191|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607192|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139607193|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607194|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139607195|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
139607196|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607197|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139607198|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
139607199|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607200|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139607201|NCT01690988|Ketamine|ketamine|mesh-list
139607202|NCT01690988|Analgesics|analgesics|mesh-ancestor
139607203|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
139607204|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607205|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607206|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139607207|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139607208|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
139607209|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
139607210|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139607211|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139607212|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139607213|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607214|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607215|NCT00463437|Vaccines|vaccines|mesh-list
139607216|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139607217|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
139607218|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607219|NCT01466153|Rituximab|rituximab|mesh-list
139607220|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139607221|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139607222|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607223|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
139607224|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607225|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139607226|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139607227|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
139607228|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607229|NCT00464685|Dexamethasone|dexamethasone|mesh-list
139607230|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139607231|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
139607232|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
139607233|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607234|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607235|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139607236|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
139607237|NCT00464685|Hormones|hormones|mesh-ancestor
139607238|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139607239|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139607240|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607241|NCT01465997|Lacosamide|lacosamide|mesh-list
139607242|NCT01465997|Carbamazepine|carbamazepine|mesh-list
139607243|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
139607244|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139607245|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139607246|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139607247|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607248|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
139607249|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139607250|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139607251|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607252|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139607253|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139607254|NCT01465997|Analgesics|analgesics|mesh-ancestor
139607255|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
139607256|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607257|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139607258|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139607259|NCT00538863|Fentanyl|fentanyl|mesh-list
139607260|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139607261|NCT00538863|Narcotics|narcotics|mesh-ancestor
139607262|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139607263|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607264|NCT00538863|Analgesics|analgesics|mesh-ancestor
139607265|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
139607266|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607267|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139607268|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138735432|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
139607269|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
139607270|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
139607271|NCT01465763|Tofacitinib|tofacitinib|mesh-list
139607272|NCT01465763|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139607273|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139607274|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607275|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607276|NCT00540579|Gemcitabine|gemcitabine|mesh-list
139607277|NCT00540579|Pomalidomide|pomalidomide|mesh-list
139607278|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139607279|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
139607280|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607281|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607282|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
139607283|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607284|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139607285|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139607286|NCT00540579|Growth Substances|growth substances|mesh-ancestor
139607287|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
139607288|NCT01690520|Cyclosporine|cyclosporine|mesh-list
139607289|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
139607290|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
139607291|NCT01690520|Thiotepa|thiotepa|mesh-list
139607292|NCT01690520|Fludarabine|fludarabine|mesh-list
139607293|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
139607294|NCT01690520|Cyclosporins|cyclosporins|mesh-list
139607295|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139607296|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
139607297|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607298|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139607299|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139607300|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
139607301|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607302|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607303|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139607304|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139607305|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
139607306|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607307|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
139607308|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607309|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
139607310|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139607311|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139607312|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139607313|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
139607314|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139607315|NCT04081337|Tirzepatide|tirzepatide|mesh-list
139607316|NCT04081337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139607317|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607318|NCT04081337|Incretins|incretins|mesh-ancestor
139607319|NCT04081337|Hormones|hormones|mesh-ancestor
139607320|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139607321|NCT00541671|Promethazine|promethazine|mesh-list
139607322|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
139607323|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
139607324|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139607325|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
139607326|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
139607327|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607328|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607329|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607330|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139607331|NCT01563536|Ritonavir|ritonavir|mesh-list
139607332|NCT01563536|Ribavirin|ribavirin|mesh-list
138735490|NCT00601614|Temozolomide|temozolomide|mesh-list
139607333|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139607334|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139607335|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
139607336|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607337|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607338|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139607339|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139607340|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
139607341|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607342|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139607343|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139607344|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
139607345|NCT01690052|Pilocarpine|pilocarpine|mesh-list
139607346|NCT01690052|Cevimeline|cevimeline|mesh-list
139607347|NCT01690052|Miotics|miotics|mesh-ancestor
139607348|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
139607349|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607350|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607351|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139607352|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139607353|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
139607354|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607355|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607356|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139607357|NCT01689974|Ipilimumab|ipilimumab|mesh-list
139607358|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139607359|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607360|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139607361|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607362|NCT04750083|Carboplatin|carboplatin|mesh-list
139607363|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
139607364|NCT04750083|Pemetrexed|pemetrexed|mesh-list
139607365|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607366|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139607367|NCT04750083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139607368|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607369|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607370|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139607371|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139607372|NCT02954991|Nivolumab|nivolumab|mesh-list
139607373|NCT02954991|Mocetinostat|mocetinostat|mesh-list
139607374|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139607375|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607376|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139607377|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607378|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139607379|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607380|NCT02892591|Oxycodone|oxycodone|mesh-list
139607381|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139607382|NCT02892591|Narcotics|narcotics|mesh-ancestor
139607383|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139607384|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607385|NCT02892591|Analgesics|analgesics|mesh-ancestor
139607386|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
139607387|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607388|NCT00470301|Paclitaxel|paclitaxel|mesh-list
139607389|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
139607390|NCT00470301|Doxorubicin|doxorubicin|mesh-list
139607391|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139607392|NCT00470301|Tipifarnib|tipifarnib|mesh-list
139607393|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139607394|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607395|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
139607396|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
139607397|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
139607398|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607399|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139607400|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
139607401|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607402|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139607403|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139607404|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
139607405|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139607406|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139607407|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139607408|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139607409|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607410|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139607411|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
139607412|NCT00544713|Glycerol|glycerol|mesh-list
139607413|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139607414|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139607415|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139607416|NCT00544713|Protective Agents|protective agents|mesh-ancestor
139607417|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607418|NCT00544713|Laxatives|laxatives|mesh-ancestor
139607419|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139607420|NCT00545181|Metronidazole|metronidazole|mesh-list
139607421|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607422|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139607423|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139607424|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139607425|NCT01797315|Sirolimus|sirolimus|mesh-list
139607426|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139607427|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607428|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139607429|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607430|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
139607431|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139607432|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
139607433|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607434|NCT00471705|Miltefosine|miltefosine|mesh-list
139607435|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
139607436|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
139607437|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607438|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607439|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139607440|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139607441|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
139607442|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139607443|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
139607444|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607445|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607446|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
139607447|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607448|NCT01458535|Ritonavir|ritonavir|mesh-list
139607449|NCT01458535|Ribavirin|ribavirin|mesh-list
139607450|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139607451|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139607452|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
139607453|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607454|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607455|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139607456|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139607457|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
139607458|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607459|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139607460|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139607461|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
139607462|NCT01464827|Ritonavir|ritonavir|mesh-list
139607463|NCT01464827|Ribavirin|ribavirin|mesh-list
139607464|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139607465|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139607466|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
139607467|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607468|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607469|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139607470|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139607471|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
139607472|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607473|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139607474|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139607475|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
139607476|NCT01463111|Lamotrigine|lamotrigine|mesh-list
139607477|NCT01463111|Valproic Acid|valproic acid|mesh-list
139607478|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139607479|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607480|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607481|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
139607482|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139607483|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139607484|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607485|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
139607486|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139607487|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139607488|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139607489|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139607490|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139607491|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
139607492|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607493|NCT01463033|Levetiracetam|levetiracetam|mesh-list
139607494|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
139607495|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
139607496|NCT01461551|Propofol|propofol|mesh-list
139607497|NCT01461551|Sevoflurane|sevoflurane|mesh-list
139607498|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139607499|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139607500|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607501|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139607502|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
139607503|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
139607504|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139607505|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139607506|NCT01460381|Quinidine|quinidine|mesh-list
139607507|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
139607508|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139607509|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139607510|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
139607511|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607512|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607513|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735672|NCT02878837|Midazolam|midazolam|mesh-list
139607514|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139607515|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
139607516|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139607517|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139607518|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607519|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607520|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139607521|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139607522|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
139607523|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139607524|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139607525|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139607526|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139607527|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139607528|NCT00546897|Lenalidomide|lenalidomide|mesh-list
139607529|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
139607530|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607531|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139607532|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139607533|NCT00546897|Growth Substances|growth substances|mesh-ancestor
139607534|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
139607535|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607536|NCT00474123|Simvastatin|simvastatin|mesh-list
139607537|NCT00474123|Ezetimibe|ezetimibe|mesh-list
139607538|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139607539|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139607540|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
139607541|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607542|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139607543|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139607544|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607545|NCT00474201|Ritonavir|ritonavir|mesh-list
139607546|NCT00474201|Lopinavir|lopinavir|mesh-list
139607547|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
139607548|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139607549|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139607550|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
139389262|NCT02400645|Ketorolac|ketorolac|mesh-list
139607551|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607552|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607553|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139607554|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139607555|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
139607556|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607557|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139607558|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139607559|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139607560|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
139607561|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139607562|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139607563|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
139607564|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139607565|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139607566|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607567|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
139607568|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
139607569|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
139607570|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139607571|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139607572|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139607573|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139607574|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607575|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
139607576|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607577|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607578|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139607579|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607580|NCT00475215|Rocuronium|rocuronium|mesh-list
139607581|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139607582|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139607583|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139607584|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607585|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607586|NCT00477087|Molgramostim|molgramostim|mesh-list
139607587|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
139607588|NCT00477087|Sargramostim|sargramostim|mesh-list
139607589|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
139607590|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607591|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607592|NCT00477087|Analgesics|analgesics|mesh-ancestor
139607593|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
139607594|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607595|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139607596|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139607597|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607598|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607599|NCT04409912|Sirolimus|sirolimus|mesh-list
139607600|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139607601|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607602|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139607603|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607604|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
139607605|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139607606|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
139607607|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607608|NCT01473589|Vitamin D|vitamin d|mesh-list
139607609|NCT01473589|Teriparatide|teriparatide|mesh-list
139607610|NCT01473589|Calcium|calcium|mesh-list
139607611|NCT01473589|Vitamins|vitamins|mesh-ancestor
139607612|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
139607613|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607614|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139607615|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139607616|NCT00478335|Calcitonin|calcitonin|mesh-list
139607617|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
139607618|NCT00478335|Indomethacin|indomethacin|mesh-list
139607619|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139607620|NCT00478335|Amiloride|amiloride|mesh-list
139607621|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
139607622|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139607623|NCT00478335|Katacalcin|katacalcin|mesh-list
139389330|NCT02165449|Analgesics|analgesics|mesh-ancestor
139607624|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
139607625|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139607626|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139607627|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607628|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607629|NCT00478335|Urological Agents|urological agents|mesh-ancestor
139607630|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139607632|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
139607633|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607634|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139607635|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139607636|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139607637|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139607638|NCT00478335|Analgesics|analgesics|mesh-ancestor
139607639|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
139607640|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607641|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139607642|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139607643|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
139607644|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
139607645|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139607646|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139607647|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139607648|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139607649|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139607650|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139607651|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139607652|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139607653|NCT00478569|Hormones|hormones|mesh-list
139607654|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
139607655|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139607656|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607657|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139607658|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
139607659|NCT00479037|Hormones|hormones|mesh-list
139607660|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
139607661|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139607662|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607663|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139607664|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139607665|NCT02985229|Misoprostol|misoprostol|mesh-list
139607666|NCT02985229|Mifepristone|mifepristone|mesh-list
139607667|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139607668|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
139607669|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139607670|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607671|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139607672|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139607673|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
139607674|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139607675|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139607676|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139607677|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139607678|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
139607679|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139607680|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139607681|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
139607682|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139607683|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
139607684|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139607685|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139607686|NCT00479115|Plerixafor|plerixafor|mesh-list
139607687|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139607688|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139607689|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
139607690|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607691|NCT01472965|Ethanol|ethanol|mesh-list
139607692|NCT01472965|Heparin|heparin|mesh-list
139607693|NCT01472965|Calcium heparin|calcium heparin|mesh-list
139607694|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
139607695|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139607696|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139607697|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607698|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139607699|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607700|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139607701|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607702|NCT00480987|Cytarabine|cytarabine|mesh-list
139607703|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
139607704|NCT00480987|Fludarabine|fludarabine|mesh-list
139607705|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
139607706|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607707|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139607708|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
139607709|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607710|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139607711|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
139607712|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607713|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
139607714|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607715|NCT01457053|Torsemide|torsemide|mesh-list
139607716|NCT01457053|Furosemide|furosemide|mesh-list
139607717|NCT01457053|Bumetanide|bumetanide|mesh-list
139607718|NCT01457053|Diuretics|diuretics|mesh-list
139607719|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
139607720|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
139607721|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607722|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139607723|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607724|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139607725|NCT00481845|Anastrozole|anastrozole|mesh-list
139607726|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139607727|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607728|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139607729|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139607730|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607731|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607732|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139607733|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
139607734|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139607735|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607736|NCT01472185|Ranolazine|ranolazine|mesh-list
139607737|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139607738|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139607739|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607740|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139607741|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607742|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139607743|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607744|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607745|NCT00553839|Ketamine|ketamine|mesh-list
139607746|NCT00553839|Analgesics|analgesics|mesh-ancestor
139607747|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
139607748|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607749|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607750|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139607751|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139607752|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
139607753|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
139607754|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139607755|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139607756|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139607757|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607758|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607759|NCT00554463|Etoposide|etoposide|mesh-list
139607760|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607761|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139607762|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139607763|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139607764|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607765|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607766|NCT00554853|Pioglitazone|pioglitazone|mesh-list
139607767|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
139607768|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139607769|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607770|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
139607771|NCT00556491|Minocycline|minocycline|mesh-list
139607772|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139607773|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607774|NCT00485433|Epinephrine|epinephrine|mesh-list
139607775|NCT00485433|Bupivacaine|bupivacaine|mesh-list
139607776|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
139607777|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
139607778|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139607779|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607780|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
139607781|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607782|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139607783|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139607784|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
139607785|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607786|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607787|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139607788|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139607789|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
139607790|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139607791|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
139607792|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
139607793|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
139607794|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139607795|NCT02850081|Atorvastatin|atorvastatin|mesh-list
139607796|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139607797|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139607798|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139607799|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
139607800|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607801|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139607802|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607803|NCT01456039|Romidepsin|romidepsin|mesh-list
139607804|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139607805|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607806|NCT01456039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139607807|NCT01456039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607808|NCT01456039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607809|NCT01455415|Pregabalin|pregabalin|mesh-list
139607810|NCT01455415|Analgesics|analgesics|mesh-ancestor
139607811|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
139607812|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139607813|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607814|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
139607815|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139607816|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139607817|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607818|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139607819|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139607820|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139607821|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139607822|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139607823|NCT01471171|Bromides|bromides|mesh-list
139607824|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
139607825|NCT01471093|Rebamipide|rebamipide|mesh-list
139607826|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139607827|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139607828|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138735990|NCT00623168|Ribavirin|ribavirin|mesh-list
139607829|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139607830|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
139607831|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607832|NCT01471093|Protective Agents|protective agents|mesh-ancestor
139607833|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607834|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607835|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
139607836|NCT01471015|Hematinics|hematinics|mesh-ancestor
139607837|NCT01470469|Guanfacine|guanfacine|mesh-list
139607838|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139607839|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139607840|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139607841|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139607842|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
139607843|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607844|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607845|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607846|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
139607847|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139607848|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139607849|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
139607850|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607851|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607852|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607853|NCT01470001|Urological Agents|urological agents|mesh-ancestor
139607854|NCT01469377|Cariprazine|cariprazine|mesh-list
139607855|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139607856|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139607857|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139607858|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607859|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139607860|NCT01469221|Apaziquone|apaziquone|mesh-list
139607861|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607862|NCT01453855|Travoprost|travoprost|mesh-list
139607863|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139607864|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139607865|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139607866|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
139607867|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
139607868|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607869|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607870|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
139607871|NCT01469065|Vitamins|vitamins|mesh-ancestor
139607872|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
139607873|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607874|NCT01586156|Carvedilol|carvedilol|mesh-list
139607875|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139607876|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139607877|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
139607878|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607879|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607880|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607881|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139607882|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
139607883|NCT01586156|Protective Agents|protective agents|mesh-ancestor
139607884|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139607885|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139607886|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139607887|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
139607888|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139607889|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139607890|NCT01459913|Interferons|interferons|mesh-list
139607891|NCT01459913|Ribavirin|ribavirin|mesh-list
139607892|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
139607893|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
139607894|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139607895|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607896|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
139607897|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607898|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
139607899|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607900|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
139607901|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607902|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139607903|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139607904|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
139607905|NCT01458275|Ciclesonide|ciclesonide|mesh-list
139607906|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
139607907|NCT01458275|Hormones|hormones|mesh-ancestor
139607908|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139607909|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607910|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139607911|NCT02334527|Palbociclib|palbociclib|mesh-list
139607912|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607913|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139607914|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607915|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607916|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139607917|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139607918|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139607919|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139607920|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297201|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
139607921|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139607922|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139607923|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139607924|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607926|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139607927|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
139607928|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139607929|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139607930|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139607931|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607932|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139607933|NCT01456169|Diuretics|diuretics|mesh-ancestor
139607934|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
139607935|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607936|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139607937|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139607938|NCT01453595|Dactolisib|dactolisib|mesh-list
139607939|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607940|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139607941|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139607942|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607943|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139607944|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
139607945|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607946|NCT04124198|Nimorazole|nimorazole|mesh-list
139607947|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139607948|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139607949|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139607950|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139607951|NCT01453205|Rituximab|rituximab|mesh-list
139607952|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139607953|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607954|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
139607955|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607956|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139607957|NCT01453049|Glimepiride|glimepiride|mesh-list
139607958|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
139607959|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139607960|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139607961|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607962|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139607963|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
139607964|NCT01452347|Warfarin|warfarin|mesh-list
139607965|NCT01452347|Dabigatran|dabigatran|mesh-list
139607966|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
139607967|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
139607968|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139607969|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
139607970|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607971|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607972|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139607973|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
139607974|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607975|NCT01451723|Protective Agents|protective agents|mesh-ancestor
139607976|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607977|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139607978|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139607979|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607980|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139607981|NCT01451645|Colchicine|colchicine|mesh-list
139607982|NCT01451645|Allopurinol|allopurinol|mesh-list
139607983|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
139607984|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139607985|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
139607986|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
139607987|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
139607988|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139607989|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139607990|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
139607991|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139607992|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139607993|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
139607994|NCT01451645|Protective Agents|protective agents|mesh-ancestor
139389705|NCT02173639|Metformin|metformin|mesh-list
139607995|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139607996|NCT01450007|Dexamethasone|dexamethasone|mesh-list
139607997|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
139607998|NCT01450007|Ropivacaine|ropivacaine|mesh-list
139607999|NCT01450007|BB 1101|bb 1101|mesh-list
139608000|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139608001|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
139608002|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
139608003|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608004|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608005|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139608006|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
139608007|NCT01450007|Hormones|hormones|mesh-ancestor
139608008|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139608009|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139608010|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608011|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
139608012|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608013|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608014|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
139608015|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
139608016|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139608017|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
139608018|NCT01496365|Pregabalin|pregabalin|mesh-list
139608019|NCT01496365|Analgesics|analgesics|mesh-ancestor
139608020|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
139608021|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608022|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608023|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
139608024|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139608025|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139608026|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608027|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139608028|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139608029|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139608030|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139608031|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139608032|NCT01468987|Insulin|insulin|mesh-list
139608033|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139608034|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
139608035|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
139608036|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139608037|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608038|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139608039|NCT01687712|Hormones|hormones|mesh-ancestor
139608040|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139608041|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608042|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
139608043|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139608044|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139608045|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139608046|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139608047|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608048|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
139608049|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608050|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608051|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139608052|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608053|NCT01453153|Gemcitabine|gemcitabine|mesh-list
139608054|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139608055|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
139608056|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608057|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608058|NCT01584440|Quinidine|quinidine|mesh-list
139608059|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
139608060|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
139608061|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
139608062|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139608063|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139608064|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608065|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608066|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608067|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139608068|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139608069|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
139608070|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139608071|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
139608072|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139608073|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139608074|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139608075|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608076|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139608077|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139608078|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
139608079|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139608080|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139608081|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139608082|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139608083|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139608084|NCT01687478|Olanzapine|olanzapine|mesh-list
139608085|NCT01687478|Fluoxetine|fluoxetine|mesh-list
139608086|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
139608087|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
139608088|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608089|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608090|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139608091|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139608092|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139608093|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139608094|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139608095|NCT01687478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139608096|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139608097|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139608098|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608099|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608100|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
139608101|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139608102|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
139608103|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139608104|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139608105|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608106|NCT01468909|Paclitaxel|paclitaxel|mesh-list
139608107|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139608108|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139608109|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608110|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
139608111|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
139608112|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
139608113|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608114|NCT01687166|Acifluorfen|acifluorfen|mesh-list
139608115|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608116|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608117|NCT01561976|Metformin|metformin|mesh-list
139608118|NCT01561976|Glimepiride|glimepiride|mesh-list
139608119|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139608120|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608121|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139608122|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139608123|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
139608124|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139608125|NCT01686932|Vildagliptin|vildagliptin|mesh-list
139608126|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139608127|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608128|NCT01686932|Incretins|incretins|mesh-ancestor
139608129|NCT01686932|Hormones|hormones|mesh-ancestor
139608130|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139608131|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139608132|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
139608133|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608134|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608135|NCT01468207|Adalimumab|adalimumab|mesh-list
139608136|NCT01468207|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139608137|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139608138|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139608139|NCT03026725|Calcium|calcium|mesh-list
139608140|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139608141|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608142|NCT01686152|Imiquimod|imiquimod|mesh-list
139608143|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139608144|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
139608145|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608146|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608147|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
139608148|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139608149|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139608150|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139608151|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139608152|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608153|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139608154|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139608155|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139608156|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
139608157|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608158|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608159|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139608160|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139608161|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
139608162|NCT01452529|Hydrocodone|hydrocodone|mesh-list
139608163|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139608164|NCT01452529|Narcotics|narcotics|mesh-ancestor
139608165|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139608166|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608167|NCT01452529|Analgesics|analgesics|mesh-ancestor
139608168|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
139608169|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608170|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
139608171|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
139608172|NCT01685606|Immunomodulating Agents|immunomodulating agents|mesh-list
139608173|NCT01685606|Immunologic Factors|immunologic factors|mesh-ancestor
139608174|NCT01685606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608175|NCT01685372|Vaccines|vaccines|mesh-list
139608176|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
139608177|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608178|NCT01685138|Ceritinib|ceritinib|mesh-list
139608179|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608180|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139608181|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608182|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608183|NCT01685060|Ceritinib|ceritinib|mesh-list
139608184|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608185|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139608186|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608187|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608188|NCT01684202|Tolvaptan|tolvaptan|mesh-list
139608189|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139313231|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139608190|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608191|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
139608192|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608193|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139608194|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
139608195|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608196|NCT01683266|Insulin|insulin|mesh-list
139608197|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139608198|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
139608199|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139608200|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608201|NCT01467661|Anagrelide|anagrelide|mesh-list
139608202|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139608203|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139608204|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608205|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139608206|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139608207|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139608208|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139608209|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139608210|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608211|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139608212|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139608213|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139608214|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
139608215|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608216|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608217|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139608218|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139608219|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
139608220|NCT01559012|Clonidine|clonidine|mesh-list
139608221|NCT01559012|Analgesics|analgesics|mesh-ancestor
139608222|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
139608223|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608224|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608225|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139608226|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
139608227|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
139608228|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139608229|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139608230|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139608231|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
139608232|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608233|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608234|NCT01451827|Tolvaptan|tolvaptan|mesh-list
139608235|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139608236|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608237|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
139608238|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608239|NCT01557920|Propofol|propofol|mesh-list
139608240|NCT01557920|Sevoflurane|sevoflurane|mesh-list
139608241|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139608242|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139608243|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608244|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139608245|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
139608246|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
139608247|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139608248|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139608249|NCT01467583|PENTA|penta|mesh-list
139608250|NCT01467583|Fondaparinux|fondaparinux|mesh-list
139608251|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139608252|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
139608253|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139608254|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
139608255|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608256|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608257|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
139608258|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139608259|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139608260|NCT01576718|Fluticasone|fluticasone|mesh-list
139608261|NCT01576718|Xhance|xhance|mesh-list
139608262|NCT01576718|Albuterol|albuterol|mesh-list
139608263|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
139608264|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139608265|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139608266|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
139608267|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608268|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608269|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139608270|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
139608271|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
139608272|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139608273|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
139608274|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139608275|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139608276|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139608277|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
139608278|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608279|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608280|NCT01493557|Pantoprazole|pantoprazole|mesh-list
139608281|NCT01493557|Dabigatran|dabigatran|mesh-list
139608282|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
139608283|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139608284|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
139608285|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608286|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608287|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
139608288|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139608289|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139608290|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139608291|NCT01451749|Donepezil|donepezil|mesh-list
139608292|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139608293|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608294|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608295|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
139608296|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608297|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608298|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
139608299|NCT01576484|Alirocumab|alirocumab|mesh-list
139608300|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139608301|NCT01576484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139608302|NCT01576484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139608303|NCT01576484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139608304|NCT01576484|Antimetabolites|antimetabolites|mesh-ancestor
139608305|NCT01576484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608306|NCT01576484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139608307|NCT01576484|Protease Inhibitors|protease inhibitors|mesh-ancestor
139608308|NCT01576484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608309|NCT01576484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139608310|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
139608311|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608312|NCT01467505|Interferons|interferons|mesh-list
139608313|NCT01467505|Ribavirin|ribavirin|mesh-list
139608314|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
139608315|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
139608316|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139608317|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139608318|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608319|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
139608320|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139608321|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
139608322|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608323|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
139608324|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608325|NCT01449929|Ritonavir|ritonavir|mesh-list
139608326|NCT01449929|Darunavir|darunavir|mesh-list
139608327|NCT01449929|Dolutegravir|dolutegravir|mesh-list
139608328|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139608329|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139608330|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
139608331|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608332|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608333|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139608334|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139608335|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
139608336|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139608337|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139608338|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139608339|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139608340|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139608341|NCT01451515|Cytarabine|cytarabine|mesh-list
139608342|NCT01451515|Dexamethasone|dexamethasone|mesh-list
139608343|NCT01451515|Prednisone|prednisone|mesh-list
139608344|NCT01451515|Prednisolone|prednisolone|mesh-list
139608345|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
139608346|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
139608347|NCT01451515|Doxorubicin|doxorubicin|mesh-list
139608348|NCT01451515|Methotrexate|methotrexate|mesh-list
139608349|NCT01451515|Etoposide|etoposide|mesh-list
139608350|NCT01451515|Vincristine|vincristine|mesh-list
139608351|NCT01451515|Daunorubicin|daunorubicin|mesh-list
139608352|NCT01451515|Asparaginase|asparaginase|mesh-list
139608353|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
139608354|NCT01451515|Clofarabine|clofarabine|mesh-list
139608355|NCT01451515|Pegaspargase|pegaspargase|mesh-list
139608356|NCT01451515|Thioguanine|thioguanine|mesh-list
139608357|NCT01451515|Antimetabolites|antimetabolites|mesh-list
139608358|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139608359|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
139608360|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608361|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139608362|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139608363|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
139608364|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608365|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608366|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139608367|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139297202|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
139608368|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
139608369|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
139608370|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608371|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139608372|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
139608373|NCT01451515|Hormones|hormones|mesh-ancestor
139608374|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139608375|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139608376|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139608377|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139608378|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138736527|NCT01321710|Acetaminophen|acetaminophen|mesh-list
139608379|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608380|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139608381|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
139608382|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139608383|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139608384|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
139608385|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139608386|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139608387|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139608388|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
139608389|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139608390|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
139608391|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
139608392|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
139608393|NCT01576406|Crizotinib|crizotinib|mesh-list
139608394|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608395|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139608396|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608397|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608398|NCT01576172|Prednisone|prednisone|mesh-list
139608399|NCT01576172|Cortisone|cortisone|mesh-list
139608400|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
139608401|NCT01576172|Veliparib|veliparib|mesh-list
139608402|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139608403|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
139608404|NCT01576172|Hormones|hormones|mesh-ancestor
139608405|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139608406|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608407|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139608408|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608409|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139608410|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608411|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608412|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
139608413|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139608414|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139608415|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
139608416|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
139608417|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139608418|NCT01541930|Metronidazole|metronidazole|mesh-list
139608419|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139608420|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139608421|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139608422|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139608423|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
139608424|NCT03028298|Citric Acid|citric acid|mesh-list
139608425|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
139608426|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
139608427|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139608428|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
139608429|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
139608430|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608431|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
139608432|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139608433|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139608434|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608435|NCT03028298|Urological Agents|urological agents|mesh-ancestor
139608436|NCT01540838|Acetaminophen|acetaminophen|mesh-list
139608437|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139608438|NCT01540838|Analgesics|analgesics|mesh-ancestor
139608439|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
139608440|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608441|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608442|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
139608443|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
139608444|NCT01451203|Methotrexate|methotrexate|mesh-list
139608445|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139608446|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
139608447|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139390155|NCT02254577|Progesterone|progesterone|mesh-list
139608448|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608449|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139608450|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
139608451|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608452|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608453|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
139608454|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608455|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139608456|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139608457|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
139608458|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139608459|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139608460|NCT01451203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139608461|NCT01451203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139608462|NCT01556438|Dexamethasone|dexamethasone|mesh-list
139608463|NCT01556438|Bortezomib|bortezomib|mesh-list
139608464|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139608465|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
139608466|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
139608467|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608468|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608469|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139608470|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
139608471|NCT01556438|Hormones|hormones|mesh-ancestor
139608472|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139608473|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139608474|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608475|NCT02073487|Paclitaxel|paclitaxel|mesh-list
139608476|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139608477|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139608478|NCT02073487|Trastuzumab|trastuzumab|mesh-list
139608479|NCT02073487|Pertuzumab|pertuzumab|mesh-list
139608480|NCT02073487|Lapatinib|lapatinib|mesh-list
139608481|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139608482|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608483|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
139608484|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
139608485|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
139608486|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608487|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139608488|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139608489|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608490|NCT02073487|Immunotoxins|immunotoxins|mesh-ancestor
139608491|NCT02073487|Immunoconjugates|immunoconjugates|mesh-ancestor
139608492|NCT02073487|Immunologic Factors|immunologic factors|mesh-ancestor
139608493|NCT02073487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608494|NCT01466491|Lidocaine|lidocaine|mesh-list
139608495|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
139608496|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
139608497|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139608498|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608499|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
139608500|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608501|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139608502|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139608503|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139608504|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139608505|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608506|NCT01466179|Blinatumomab|blinatumomab|mesh-list
139608507|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608508|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
139608509|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139608510|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608511|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608512|NCT01450813|Bromides|bromides|mesh-list
139608513|NCT01450813|Rocuronium|rocuronium|mesh-list
139608514|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
139608515|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139608516|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139608517|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139608518|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608519|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608520|NCT01539512|Rituximab|rituximab|mesh-list
139608521|NCT01539512|Idelalisib|idelalisib|mesh-list
139608522|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139608523|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608525|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608526|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139608527|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608528|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608529|NCT01449955|Sirolimus|sirolimus|mesh-list
139608530|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139608531|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139608532|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139608533|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608534|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
139608535|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139608536|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
139608537|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608538|NCT01574612|Acyclovir|acyclovir|mesh-list
139608539|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
139608540|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139608541|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
139608542|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139608543|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
139608544|NCT01573910|Ofloxacin|ofloxacin|mesh-list
139608545|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139608546|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139608547|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139608548|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139608549|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139608550|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139608551|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608552|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608553|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608554|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139608555|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139608556|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139608557|NCT01491919|Lisinopril|lisinopril|mesh-list
139608558|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139608559|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
139608560|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608561|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608562|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139608563|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139608564|NCT01491919|Protective Agents|protective agents|mesh-ancestor
139608565|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608566|NCT01573442|Testosterone|testosterone|mesh-list
139608567|NCT01573442|Androgens|androgens|mesh-ancestor
139608568|NCT01573442|Hormones|hormones|mesh-ancestor
139608569|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139608570|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608571|NCT02319369|Azacitidine|azacitidine|mesh-list
139608572|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139608573|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
139608574|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608575|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608576|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608577|NCT01491841|Rituximab|rituximab|mesh-list
139608578|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139608579|NCT01491841|Pixantrone|pixantrone|mesh-list
139608580|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139608581|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608582|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
139608583|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608584|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139608585|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139608586|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
139608587|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608588|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139608589|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139608590|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608591|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
139608592|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139608593|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608594|NCT01553318|Ketotifen|ketotifen|mesh-list
139608595|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
139608596|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
139390306|NCT06008925|Nivolumab|nivolumab|mesh-list
139608597|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139608598|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
139608599|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
139608600|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608601|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608602|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608603|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139608604|NCT01572740|Liraglutide|liraglutide|mesh-list
139608605|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139608606|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608607|NCT01572740|Incretins|incretins|mesh-ancestor
139608608|NCT01572740|Hormones|hormones|mesh-ancestor
139608609|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139608610|NCT01491607|Vaccines|vaccines|mesh-list
139608611|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
139608612|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608613|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
139608614|NCT02338713|Antacids|antacids|mesh-ancestor
139608615|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608616|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139608617|NCT00557349|Omeprazole|omeprazole|mesh-list
139608618|NCT00557349|Famotidine|famotidine|mesh-list
139608619|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139608620|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139608621|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139608622|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608623|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608624|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139608625|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
139608626|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
139608627|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608628|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608629|NCT01553084|Nicotine|nicotine|mesh-list
139608630|NCT01553084|Varenicline|varenicline|mesh-list
139608631|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139608632|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
139608633|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608634|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608635|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139608636|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139608637|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
139608638|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608639|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608640|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
139608641|NCT01552928|Anagrelide|anagrelide|mesh-list
139608642|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139608643|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139608644|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139608645|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139608646|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608647|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608648|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608649|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139608650|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139608651|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139608652|NCT01448707|Ritonavir|ritonavir|mesh-list
139608653|NCT01448707|Darunavir|darunavir|mesh-list
139608654|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139608655|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139608656|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
139608657|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608658|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608659|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139608660|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139608661|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
139608662|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139608663|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139608664|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139608665|NCT01536704|Nicotine|nicotine|mesh-list
139608666|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139608667|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
139608668|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608669|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608670|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139608671|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139390376|NCT05920005|Diuretics|diuretics|mesh-ancestor
139608673|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608674|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608675|NCT04108676|Fluzoparib|fluzoparib|mesh-list
139608676|NCT04108676|Omeprazole|omeprazole|mesh-list
139608677|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139608678|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139608679|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139608680|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608681|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608682|NCT04108676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139608683|NCT04108676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608684|NCT01552772|Aripiprazole|aripiprazole|mesh-list
139608685|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
139608686|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139608687|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139608688|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139608689|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139608690|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736844|NCT00626665|Tadalafil|tadalafil|mesh-list
139608691|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
139608692|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
139608693|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608694|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608695|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139608696|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139608697|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
139608698|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139608699|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139608700|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139608701|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139608702|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139608703|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139608704|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608705|NCT01552694|Incretins|incretins|mesh-ancestor
139608706|NCT01552694|Hormones|hormones|mesh-ancestor
139608707|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139608708|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139608709|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
139608710|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608711|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608712|NCT01464931|Denosumab|denosumab|mesh-list
139608713|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139608714|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608715|NCT01536392|Ondansetron|ondansetron|mesh-list
139608716|NCT01536392|Granisetron|granisetron|mesh-list
139608717|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
139608718|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
139608719|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608720|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608721|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139608722|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
139608723|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
139608724|NCT01536392|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139608725|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139608726|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
139608727|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608728|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608729|NCT04767295|Paclitaxel|paclitaxel|mesh-list
139608730|NCT04767295|Carboplatin|carboplatin|mesh-list
139608731|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139608732|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608733|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
139608734|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
139608735|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
139608736|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608737|NCT02118831|Bevacizumab|bevacizumab|mesh-list
139608738|NCT02118831|Ranibizumab|ranibizumab|mesh-list
139608739|NCT02118831|Aflibercept|aflibercept|mesh-list
139608740|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139608741|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608742|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139608743|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139608744|NCT02118831|Growth Substances|growth substances|mesh-ancestor
139390466|NCT05677126|Copper|copper|mesh-list
139608745|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608746|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
139608747|NCT00490269|Dronabinol|dronabinol|mesh-list
139608748|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
139608749|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608750|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139608751|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139608752|NCT00490269|Analgesics|analgesics|mesh-ancestor
139608753|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
139608754|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608755|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139608756|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139608757|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608758|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608759|NCT00490269|Hormones|hormones|mesh-ancestor
139608760|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139608761|NCT05621499|Lenvatinib|lenvatinib|mesh-list
139608762|NCT05621499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608763|NCT05621499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139608764|NCT05621499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608765|NCT05621499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608766|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
139608767|NCT01490125|Albuterol|albuterol|mesh-list
139608768|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
139608769|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139608770|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
139608771|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608772|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608773|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139608774|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
139608775|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
139608776|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139608777|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
139608778|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608779|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608780|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
139608781|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139608782|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139608783|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139608784|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139608785|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
139608786|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139608787|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139608788|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
139608789|NCT00491751|Atorvastatin|atorvastatin|mesh-list
139608790|NCT00491751|Vitamins|vitamins|mesh-ancestor
139608791|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
139608792|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608793|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139608794|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139608795|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
139608796|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608797|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139608798|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139608799|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608800|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
139608801|NCT00491751|Protective Agents|protective agents|mesh-ancestor
139608802|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139608803|NCT01420549|Simvastatin|simvastatin|mesh-list
139608804|NCT01420549|Ezetimibe|ezetimibe|mesh-list
139608805|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139608806|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139608807|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
139608808|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608809|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139608810|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139608811|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608812|NCT01440595|Ribavirin|ribavirin|mesh-list
139608813|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139608814|NCT01440595|Grazoprevir|grazoprevir|mesh-list
139608815|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
139608816|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608817|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
139608818|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139608819|NCT05560035|Lidocaine|lidocaine|mesh-list
139608820|NCT05560035|Anesthetics, Local|anesthetics, local|mesh-ancestor
139608821|NCT05560035|Anesthetics|anesthetics|mesh-ancestor
139608822|NCT05560035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139608823|NCT05560035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608824|NCT05560035|Sensory System Agents|sensory system agents|mesh-ancestor
139608825|NCT05560035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608826|NCT05560035|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139608827|NCT05560035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139608828|NCT05560035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139608829|NCT05560035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139608830|NCT05560035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608831|NCT00497055|Aripiprazole|aripiprazole|mesh-list
139608832|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
139608833|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139608834|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139608835|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139608836|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139608837|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608838|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
139608839|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
139608840|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139608841|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608842|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139608843|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139608844|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
139608845|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139608846|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139608847|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139608848|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139608849|NCT00498615|Fasudil|fasudil|mesh-list
139608850|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139608851|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139608852|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608853|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139608854|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608855|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
139608856|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139608857|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608858|NCT00498927|Temozolomide|temozolomide|mesh-list
139608859|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139608860|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
139608861|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608862|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608863|NCT00499473|Sunitinib|sunitinib|mesh-list
139608864|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608865|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139608866|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139608867|NCT00499473|Growth Substances|growth substances|mesh-ancestor
139608868|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608869|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
139608870|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139608871|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608872|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608873|NCT00501891|Bevacizumab|bevacizumab|mesh-list
139608874|NCT00501891|Temozolomide|temozolomide|mesh-list
139608875|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139608876|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608877|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139608878|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139608879|NCT00501891|Growth Substances|growth substances|mesh-ancestor
139608880|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608881|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
139608882|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139608883|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
139608884|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608885|NCT01798017|Misoprostol|misoprostol|mesh-list
139608886|NCT01798017|Mifepristone|mifepristone|mesh-list
139608887|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139608888|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
139608889|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139608890|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608891|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139390617|NCT04902040|Nivolumab|nivolumab|mesh-list
139608892|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139608893|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
139608894|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139608895|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139608896|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139608897|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139608898|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
139608899|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139608900|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139608901|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
139608902|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139608903|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
139608904|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139608905|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139608906|NCT00502905|Fludarabine|fludarabine|mesh-list
139608907|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
139608908|NCT00502905|Busulfan|busulfan|mesh-list
139608909|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608910|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139608911|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
139608912|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608913|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139608914|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
139608915|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608916|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
139608917|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139608918|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139608919|NCT00505635|Interferons|interferons|mesh-list
139608920|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
139608921|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
139608922|NCT00505635|Thalidomide|thalidomide|mesh-list
139608923|NCT00505635|Cisplatin|cisplatin|mesh-list
139608924|NCT00505635|Temozolomide|temozolomide|mesh-list
139608925|NCT00505635|Interleukin-2|interleukin-2|mesh-list
139608926|NCT00505635|Vinblastine|vinblastine|mesh-list
139608927|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608928|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
139608929|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139608930|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139608931|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
139608932|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608933|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
139608934|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608935|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139608936|NCT00505635|Analgesics|analgesics|mesh-ancestor
139608937|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
139608938|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139608939|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139608940|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
139608941|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139608942|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139608943|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139608944|NCT00505635|Growth Substances|growth substances|mesh-ancestor
139608945|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
139608946|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139608947|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
139608948|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
139608949|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
139608950|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139608951|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139608952|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608953|NCT04479813|Moxonidine|moxonidine|mesh-list
139608954|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139608955|NCT04474899|Amlodipine|amlodipine|mesh-list
139608956|NCT04474899|Moxonidine|moxonidine|mesh-list
139608957|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139608958|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139608959|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139608960|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608961|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139608962|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608963|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
139608964|NCT00511173|Warfarin|warfarin|mesh-list
139608965|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
139608966|NCT01447927|Metformin|metformin|mesh-list
139608967|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139608968|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608969|NCT00513747|Rituximab|rituximab|mesh-list
139608970|NCT00513747|Fludarabine|fludarabine|mesh-list
139608971|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
139608972|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139608973|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608974|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
139608975|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608976|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139608977|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139608978|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
139608979|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608980|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139608981|NCT00514137|Sunitinib|sunitinib|mesh-list
139608982|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608983|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139608984|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139608985|NCT00514137|Growth Substances|growth substances|mesh-ancestor
139608986|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608987|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
139608988|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139608989|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139608990|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608991|NCT00514215|Molgramostim|molgramostim|mesh-list
139608992|NCT00514215|Sargramostim|sargramostim|mesh-list
139608993|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
139608994|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139608995|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139608996|NCT03912909|Empagliflozin|empagliflozin|mesh-list
139608997|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139608998|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139608999|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139609000|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609001|NCT02130063|Iron|iron|mesh-list
139609002|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139609003|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139609004|NCT02130063|Trace Elements|trace elements|mesh-ancestor
139609005|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
139609006|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609007|NCT02130063|Hematinics|hematinics|mesh-ancestor
139609008|NCT00515697|Ramucirumab|ramucirumab|mesh-list
139609009|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609010|NCT00516165|Everolimus|everolimus|mesh-list
139609011|NCT00516165|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139609012|NCT00516165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139609013|NCT00516165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609014|NCT00516165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609015|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139609016|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
139609017|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609018|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609019|NCT02132169|Cetirizine|cetirizine|mesh-list
139609020|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139609021|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139609022|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139609023|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
139609024|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
139609025|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609026|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609027|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609028|NCT03174405|Avelumab|avelumab|mesh-list
139609029|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139609030|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609031|NCT00522795|Paclitaxel|paclitaxel|mesh-list
139609032|NCT00522795|Cisplatin|cisplatin|mesh-list
139609033|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
139609034|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139609035|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609036|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
139609037|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
139609038|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
139609039|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609040|NCT02871687|Simvastatin|simvastatin|mesh-list
139609041|NCT02871687|Pravastatin|pravastatin|mesh-list
139390757|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
139609042|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139609043|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139609044|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
139609045|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609046|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139609047|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139609048|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609049|NCT00525057|Dalteparin|dalteparin|mesh-list
139609050|NCT00525057|Tinzaparin|tinzaparin|mesh-list
139609051|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139609052|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
139609053|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139609054|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139609055|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609056|NCT00525135|Valproic Acid|valproic acid|mesh-list
139609057|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
139609058|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609059|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609060|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
139609061|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609062|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609063|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
139609064|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139609065|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139609066|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139609067|NCT00525525|Bevacizumab|bevacizumab|mesh-list
139609068|NCT00525525|Temozolomide|temozolomide|mesh-list
139609069|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139609070|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139609071|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609072|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139609073|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139609074|NCT00525525|Growth Substances|growth substances|mesh-ancestor
139609075|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609076|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
139609077|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139609078|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
139609079|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609080|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139609081|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609082|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
139609083|NCT00525603|Rituximab|rituximab|mesh-list
139609084|NCT00525603|Fludarabine|fludarabine|mesh-list
139609085|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
139609086|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
139609087|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139609088|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
139609089|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609090|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139609091|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139609092|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
139609093|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609094|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609095|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139609096|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139609097|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139609098|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
139609099|NCT00398307|Cisplatin|cisplatin|mesh-list
139609100|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609101|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
139609102|NCT00564447|Azithromycin|azithromycin|mesh-list
139609103|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139609104|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139609105|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139609106|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139609107|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609108|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609109|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609110|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
139609111|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139609112|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139609113|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139609114|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139390830|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
139609115|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609116|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
139609117|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609118|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609120|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609121|NCT00525837|Varenicline|varenicline|mesh-list
139609122|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139609123|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139609124|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
139609125|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609126|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609127|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609128|NCT00527475|Ranibizumab|ranibizumab|mesh-list
139609129|NCT00527475|Verteporfin|verteporfin|mesh-list
139609130|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139609131|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139609132|NCT00527475|Growth Substances|growth substances|mesh-ancestor
139609133|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609134|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
139609135|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609136|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139609137|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
139609138|NCT01798251|Capecitabine|capecitabine|mesh-list
139609139|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
139609140|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139609141|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
139609142|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609143|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609144|NCT02121483|Empagliflozin|empagliflozin|mesh-list
139609145|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139609146|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609147|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139609148|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609149|NCT01572038|Paclitaxel|paclitaxel|mesh-list
139609150|NCT01572038|Docetaxel|docetaxel|mesh-list
139609151|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139609152|NCT01572038|Trastuzumab|trastuzumab|mesh-list
139609153|NCT01572038|Pertuzumab|pertuzumab|mesh-list
139609154|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139609155|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609156|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
139609157|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
139609158|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
139609159|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609160|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139609161|NCT01448213|Fluorometholone|fluorometholone|mesh-list
139609162|NCT01448213|Prednisolone|prednisolone|mesh-list
139609163|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139609164|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
139609165|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139609166|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
139609167|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139609168|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
139609169|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139609170|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
139609171|NCT01448213|Hormones|hormones|mesh-ancestor
139609172|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139609173|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609174|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139609175|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609176|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
139609177|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
139609178|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609179|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139609180|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139609181|NCT01448213|Protective Agents|protective agents|mesh-ancestor
139609182|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139609183|NCT01448057|Acetaminophen|acetaminophen|mesh-list
139609184|NCT01448057|Dimethindene|dimethindene|mesh-list
139609185|NCT01448057|Phenylephrine|phenylephrine|mesh-list
139609186|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
139609187|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139609188|NCT01448057|Analgesics|analgesics|mesh-ancestor
139609189|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
139609190|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609191|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609192|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
139609193|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609194|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139609195|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
139609196|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
139609197|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
139609198|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139609199|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
139609200|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
139609201|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139609202|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139609203|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139609204|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
139609205|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609206|NCT01448057|Protective Agents|protective agents|mesh-ancestor
139609207|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
139609208|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
139609209|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139609210|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
139609211|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
139609212|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139609213|NCT05246631|Dexamethasone|dexamethasone|mesh-list
139609214|NCT05246631|Dexamethasone acetate|dexamethasone acetate|mesh-list
139609215|NCT05246631|Haloperidol|haloperidol|mesh-list
139609216|NCT05246631|Haloperidol decanoate|haloperidol decanoate|mesh-list
139609217|NCT05246631|BB 1101|bb 1101|mesh-list
139609218|NCT05246631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139609219|NCT05246631|Antiemetics|antiemetics|mesh-ancestor
139609220|NCT05246631|Autonomic Agents|autonomic agents|mesh-ancestor
139609221|NCT05246631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609222|NCT05246631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609223|NCT05246631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139609224|NCT05246631|Glucocorticoids|glucocorticoids|mesh-ancestor
139609225|NCT05246631|Hormones|hormones|mesh-ancestor
139609226|NCT05246631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139609227|NCT05246631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139609228|NCT05246631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609229|NCT05246631|Protease Inhibitors|protease inhibitors|mesh-ancestor
139609230|NCT05246631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609231|NCT05246631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609232|NCT05246631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139609233|NCT05246631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139609234|NCT05246631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139609235|NCT05246631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139609236|NCT05246631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139609237|NCT05246631|Dopamine Agents|dopamine agents|mesh-ancestor
139609238|NCT05246631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609239|NCT05246631|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139609240|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
139609241|NCT01447433|Calcium|calcium|mesh-list
139609242|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139609243|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609244|NCT01447433|Antacids|antacids|mesh-ancestor
139609245|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609246|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139609247|NCT01798875|Metformin|metformin|mesh-list
139609248|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
139609249|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
139609250|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139609251|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609252|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139609253|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139609254|NCT05362851|Celecoxib|celecoxib|mesh-list
139609255|NCT05362851|Tramadol|tramadol|mesh-list
139609256|NCT05362851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138737428|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
139609257|NCT05362851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139609258|NCT05362851|Analgesics|analgesics|mesh-ancestor
139609259|NCT05362851|Sensory System Agents|sensory system agents|mesh-ancestor
139609260|NCT05362851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609261|NCT05362851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609262|NCT05362851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139609263|NCT05362851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139609264|NCT05362851|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139609265|NCT05362851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139609266|NCT05362851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609267|NCT05362851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609268|NCT05362851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139609270|NCT05362851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139609271|NCT04408235|Enoxaparin|enoxaparin|mesh-list
139609272|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
139609273|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139609274|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139609275|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609276|NCT01446809|Doxorubicin|doxorubicin|mesh-list
139609277|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139609278|NCT01446809|Ifosfamide|ifosfamide|mesh-list
139609279|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
139609280|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139609281|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609282|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139609283|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139609284|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609285|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609286|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139609287|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
139609288|NCT04387929|Antibodies|antibodies|mesh-list
139609289|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
139609290|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609291|NCT05361291|Dexamethasone|dexamethasone|mesh-list
139609292|NCT05361291|Lidocaine|lidocaine|mesh-list
139609293|NCT05361291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139609294|NCT05361291|Antiemetics|antiemetics|mesh-ancestor
139609295|NCT05361291|Autonomic Agents|autonomic agents|mesh-ancestor
139609296|NCT05361291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737482|NCT04326959|Triamcinolone|triamcinolone|mesh-list
139609297|NCT05361291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609298|NCT05361291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139609299|NCT05361291|Glucocorticoids|glucocorticoids|mesh-ancestor
139609300|NCT05361291|Hormones|hormones|mesh-ancestor
139609301|NCT05361291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139609302|NCT05361291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139609303|NCT05361291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609304|NCT05361291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609305|NCT05361291|Anesthetics, Local|anesthetics, local|mesh-ancestor
139609306|NCT05361291|Anesthetics|anesthetics|mesh-ancestor
139609307|NCT05361291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139609308|NCT05361291|Sensory System Agents|sensory system agents|mesh-ancestor
139609309|NCT05361291|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139609310|NCT05361291|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139609311|NCT05361291|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139609312|NCT05361291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139609313|NCT01445951|Insulin|insulin|mesh-list
139609314|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139609315|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
139609316|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139609317|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609318|NCT03169101|Nicotine|nicotine|mesh-list
139609319|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139609320|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
139609321|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609322|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609323|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139609324|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139609325|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
139609326|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609327|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609328|NCT00513435|Saracatinib|saracatinib|mesh-list
139609329|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609330|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609331|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609332|NCT05214339|Bevacizumab|bevacizumab|mesh-list
139609333|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139609334|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609335|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139609336|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139609337|NCT05214339|Growth Substances|growth substances|mesh-ancestor
139609338|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609339|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
139609340|NCT01444781|Vaccines|vaccines|mesh-list
139609341|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139609342|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
139391073|NCT02182765|Nevirapine|nevirapine|mesh-list
139609343|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609344|NCT02431845|Fluoxetine|fluoxetine|mesh-list
139609345|NCT02431845|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139609346|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139609347|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139609348|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609349|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609350|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
139609351|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609352|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139609353|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
139609354|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139609355|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139609356|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139609357|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609358|NCT01443923|Interferons|interferons|mesh-list
139609359|NCT01443923|Ribavirin|ribavirin|mesh-list
139609360|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
139609361|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
139609362|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139609363|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609364|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
139609365|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139609366|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
139609367|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609368|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
139609369|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609370|NCT00569673|Docetaxel|docetaxel|mesh-list
139609371|NCT00569673|Trabectedin|trabectedin|mesh-list
139609372|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609373|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
139609374|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
139609375|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
139609376|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609377|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139609378|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
139609379|NCT01551212|Everolimus|everolimus|mesh-list
139609380|NCT01551212|Tacrolimus|tacrolimus|mesh-list
139609381|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139609382|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
139609383|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609384|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139609385|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609386|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609387|NCT01551212|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139609388|NCT01551212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139609389|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609390|NCT00573261|Pregabalin|pregabalin|mesh-list
139609391|NCT00573261|Analgesics|analgesics|mesh-ancestor
139609392|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
139609393|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609394|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609395|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
139609396|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139609397|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139609398|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609399|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139609400|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139609401|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139609402|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139609403|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139609404|NCT04514211|Propofol|propofol|mesh-list
139609405|NCT04514211|Sevoflurane|sevoflurane|mesh-list
139609406|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139609407|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139609408|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609409|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139609410|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
139609411|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
139609412|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139609413|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139609414|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
139609415|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139391126|NCT02630459|Analgesics|analgesics|mesh-ancestor
139609416|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609417|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139609418|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
139609419|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139609420|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139609421|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609422|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609423|NCT00574587|Paclitaxel|paclitaxel|mesh-list
139609424|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
139609425|NCT00574587|Doxorubicin|doxorubicin|mesh-list
139609426|NCT00574587|Trastuzumab|trastuzumab|mesh-list
139609427|NCT00574587|Vorinostat|vorinostat|mesh-list
139609428|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139609429|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609430|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
139609431|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
139609432|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
139609433|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609434|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139609435|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
139609436|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609437|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139609438|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139609439|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
139609440|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139609441|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139609442|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139609443|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139609444|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609445|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139609446|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139609447|NCT00603993|Adalimumab|adalimumab|mesh-list
139609448|NCT00603993|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139609449|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139609450|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139609451|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
139609452|NCT00575367|Azithromycin|azithromycin|mesh-list
139609453|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139609454|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139609455|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139609456|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139609457|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139609458|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139609459|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139609460|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609461|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609462|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609463|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139609464|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
139609465|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139609466|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609467|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139609468|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139609469|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139609470|NCT00604461|Bevacizumab|bevacizumab|mesh-list
139609471|NCT00604461|Carboplatin|carboplatin|mesh-list
139609472|NCT00604461|Pemetrexed|pemetrexed|mesh-list
139609473|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139609474|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609475|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139609476|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139609477|NCT00604461|Growth Substances|growth substances|mesh-ancestor
139609478|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609479|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
139609480|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609481|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609482|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139609483|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139609484|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139609485|NCT04417569|Estradiol|estradiol|mesh-list
139609486|NCT04417569|Progesterone|progesterone|mesh-list
139609487|NCT04417569|Hormones|hormones|mesh-ancestor
139609488|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139609489|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609490|NCT04417569|Estrogens|estrogens|mesh-ancestor
139391198|NCT05518526|Annamycin|annamycin|mesh-list
139609491|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139609492|NCT04417569|Progestins|progestins|mesh-ancestor
139609493|NCT01550744|Ustekinumab|ustekinumab|mesh-list
139609494|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
139609496|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139609497|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139609498|NCT00606489|Analgesics|analgesics|mesh-ancestor
139609499|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
139609500|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609501|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609502|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139609503|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139609504|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139609505|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609506|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609507|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139609508|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139609509|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139609510|NCT00578331|Analgesics|analgesics|mesh-ancestor
139609511|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
139609512|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609513|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609514|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139609515|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139609516|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139609517|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139609518|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139609519|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
139609520|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
139609521|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609522|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609523|NCT00607113|Bevacizumab|bevacizumab|mesh-list
139609524|NCT00607113|Everolimus|everolimus|mesh-list
139609525|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139609526|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609527|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139609528|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139609529|NCT00607113|Growth Substances|growth substances|mesh-ancestor
139609530|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609531|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
139609532|NCT00607113|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139609533|NCT00607113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139609534|NCT00607113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609535|NCT00607113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609536|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139609537|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
139609538|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139609539|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139609540|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609541|NCT01549964|Incretins|incretins|mesh-ancestor
139609542|NCT01549964|Hormones|hormones|mesh-ancestor
139609543|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139609544|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139609545|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
139609546|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609547|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609548|NCT00579111|Fludarabine|fludarabine|mesh-list
139609549|NCT00579111|Busulfan|busulfan|mesh-list
139609550|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
139609551|NCT00579111|Tacrolimus|tacrolimus|mesh-list
139609552|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609553|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609554|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139609555|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
139609556|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609557|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139609558|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609559|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
139609560|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139609561|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139609562|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139609563|NCT04363437|Colchicine|colchicine|mesh-list
139609564|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
139609565|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139609566|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
139609567|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
139609568|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
139609569|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609570|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609571|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
139609572|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139609573|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139609574|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
139609575|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139609576|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609577|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139609578|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139609579|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139609580|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139609581|NCT01570244|Estrogens|estrogens|mesh-ancestor
139609582|NCT01570244|Hormones|hormones|mesh-ancestor
139609583|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139609584|NCT00579813|Pioglitazone|pioglitazone|mesh-list
139609585|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139609586|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609587|NCT01549886|Rituximab|rituximab|mesh-list
139609588|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139609589|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609590|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
139609591|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609592|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139609593|NCT00610311|Aldesleukin|aldesleukin|mesh-list
139609594|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
139609595|NCT00610311|Fludarabine|fludarabine|mesh-list
139609596|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
139609597|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139609598|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
139609599|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609600|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139609601|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139609602|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
139609603|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609604|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609605|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139609606|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139609607|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
139609608|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139609609|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139609610|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
139609611|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139609612|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
139609613|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139609614|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139609615|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
139609616|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609617|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609618|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609619|NCT00581061|Urological Agents|urological agents|mesh-ancestor
139609620|NCT01549652|Morphine|morphine|mesh-list
139609621|NCT01549652|Ondansetron|ondansetron|mesh-list
139609622|NCT01549652|Naloxone|naloxone|mesh-list
139609623|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139609624|NCT01549652|Narcotics|narcotics|mesh-ancestor
139609625|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139609626|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609627|NCT01549652|Analgesics|analgesics|mesh-ancestor
139609628|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
139609629|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609630|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
139609631|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
139609632|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139609633|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
139609634|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
139609635|NCT01549652|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139609636|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139609637|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
139609638|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609639|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609640|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139609642|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
139609643|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
139609644|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609645|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609646|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609647|NCT01534520|Lidocaine|lidocaine|mesh-list
139609648|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
139609649|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
139609650|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139609651|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609652|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
139609653|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609654|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139609655|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139609656|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139609657|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139609658|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609659|NCT00611325|Bevacizumab|bevacizumab|mesh-list
139609660|NCT00611325|Bortezomib|bortezomib|mesh-list
139609661|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139609662|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609663|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139609664|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139609665|NCT00611325|Growth Substances|growth substances|mesh-ancestor
139609666|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609667|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
139609668|NCT00611403|Cyclosporine|cyclosporine|mesh-list
139609669|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
139609670|NCT00611403|Cyclosporins|cyclosporins|mesh-list
139609671|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609672|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609673|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139609674|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
139609675|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609676|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
139609677|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139609678|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
139609679|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139609680|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139609681|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139609682|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139609683|NCT01534208|Enclomiphene|enclomiphene|mesh-list
139609684|NCT01534208|Clomiphene|clomiphene|mesh-list
139609685|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
139609686|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139609687|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
139609688|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139609689|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609690|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139609691|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
139609692|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139609693|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139609694|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139609695|NCT01548638|Galantamine|galantamine|mesh-list
139609696|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139609697|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609698|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609699|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
139609700|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609701|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609702|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139609703|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
139609704|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609705|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
139609706|NCT00612339|Bevacizumab|bevacizumab|mesh-list
139609707|NCT00612339|Temozolomide|temozolomide|mesh-list
139609708|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139609709|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609710|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139609711|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139609712|NCT00612339|Growth Substances|growth substances|mesh-ancestor
139609713|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609714|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
139609715|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139609716|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
139609717|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609718|NCT01533428|Capsaicin|capsaicin|mesh-list
139609719|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
139609720|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
139609721|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
139609722|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609723|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609724|NCT04066725|Aspirin|aspirin|mesh-list
139609725|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139609726|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139609727|NCT04066725|Analgesics|analgesics|mesh-ancestor
139609728|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
139609729|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609730|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609731|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139609732|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139609733|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139609734|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139609735|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609736|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139609737|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139609738|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609739|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
139609740|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
139609741|NCT01517984|Prednisone|prednisone|mesh-list
139609742|NCT01517984|Tacrolimus|tacrolimus|mesh-list
139609743|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
139609744|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139609745|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139609746|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139609747|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139609748|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
139609749|NCT01517984|Hormones|hormones|mesh-ancestor
139609750|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139609751|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609752|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139609753|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609754|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
139609755|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609756|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609757|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139609758|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139609759|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
139609760|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139609761|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139609762|NCT00612573|Doxycycline|doxycycline|mesh-list
139609763|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139609764|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139609765|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
139609766|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139609767|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139609768|NCT00614445|Pyridoxine|pyridoxine|mesh-list
139609769|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
139609770|NCT00614445|Doxylamine|doxylamine|mesh-list
139609771|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
139609772|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
139609773|NCT00614445|Vitamins|vitamins|mesh-ancestor
139609774|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
139609775|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609776|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
139609777|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
139609778|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609779|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139609780|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139609781|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
139609782|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
139609783|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609784|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609785|NCT00583011|Anesthetics|anesthetics|mesh-list
139609786|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139609787|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609788|NCT01547390|Aspirin|aspirin|mesh-list
139391519|NCT06218680|Propofol|propofol|mesh-list
139609789|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139609790|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139609792|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
139609793|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609794|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609795|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139609796|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139609797|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139609798|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139609799|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609800|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139609801|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139609802|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609803|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
139609804|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
139609805|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139609806|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
139609807|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
139609808|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609809|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139609810|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609811|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609812|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
139609813|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139609814|NCT01532648|Budesonide|budesonide|mesh-list
139609815|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139609816|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139609817|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
139609818|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609819|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609820|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139609821|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
139609822|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
139609823|NCT01532648|Hormones|hormones|mesh-ancestor
139609824|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139609825|NCT00617097|Ketorolac|ketorolac|mesh-list
139609826|NCT00617097|Lidocaine|lidocaine|mesh-list
139609827|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
139609828|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
139609829|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139609830|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609831|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
139609832|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609833|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139609834|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139609835|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139609836|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139609837|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609838|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139609839|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139609840|NCT00617097|Analgesics|analgesics|mesh-ancestor
139609841|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139609842|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139609843|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139609844|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609845|NCT01532414|Enclomiphene|enclomiphene|mesh-list
139609846|NCT01532414|Clomiphene|clomiphene|mesh-list
139609847|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
139609848|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139609849|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
139609850|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139609851|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609852|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139609853|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
139609854|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139609855|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139609856|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139609857|NCT01441973|Elotuzumab|elotuzumab|mesh-list
139609858|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139609859|NCT02074709|Bupivacaine|bupivacaine|mesh-list
139609860|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
139609861|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
139609862|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139609863|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609864|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
139609865|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609866|NCT03571191|Denosumab|denosumab|mesh-list
139609867|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139609868|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609869|NCT01575899|Amoxicillin|amoxicillin|mesh-list
139609870|NCT01575899|Clarithromycin|clarithromycin|mesh-list
139609871|NCT01575899|Levofloxacin|levofloxacin|mesh-list
139609872|NCT01575899|Ofloxacin|ofloxacin|mesh-list
139609873|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
139609874|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139609875|NCT01575899|Rabeprazole|rabeprazole|mesh-list
139609876|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139609877|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139609878|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139609879|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609880|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609881|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139609882|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139609883|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139609884|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139609885|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139609886|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738045|NCT01100944|Belinostat|belinostat|mesh-list
139609887|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139609888|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139609889|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139609890|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139609891|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139609892|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139609893|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
139609894|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609895|NCT00620061|Lubiprostone|lubiprostone|mesh-list
139609896|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139609897|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139609898|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609899|NCT04122443|Acetaminophen|acetaminophen|mesh-list
139609900|NCT04122443|Oxycodone|oxycodone|mesh-list
139609901|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139609902|NCT04122443|Analgesics|analgesics|mesh-ancestor
139609903|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
139609904|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609905|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609906|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
139609907|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139609908|NCT04122443|Narcotics|narcotics|mesh-ancestor
139609909|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139609910|NCT00587769|Bupropion|bupropion|mesh-list
139609911|NCT00587769|Varenicline|varenicline|mesh-list
139609912|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139609913|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
139609914|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139609915|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139609916|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139609917|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139609918|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609919|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
139609920|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609921|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609922|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139609923|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139609924|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609925|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139609926|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139609927|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
139609928|NCT00623181|Vaccines|vaccines|mesh-list
139609929|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
139609930|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609931|NCT03433833|Digoxin|digoxin|mesh-list
139609932|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139609933|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139609934|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609935|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609936|NCT03433833|Protective Agents|protective agents|mesh-ancestor
139609937|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609938|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
139609939|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
139609940|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
139609941|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139609942|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
139609943|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609944|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609945|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139609946|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
139609947|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139609948|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139609949|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139609950|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
139609951|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609952|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609953|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
139609954|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139609955|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
139609956|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139609957|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139609958|NCT01440803|Teriparatide|teriparatide|mesh-list
139609959|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139609960|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609961|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139609962|NCT05247177|Dexmedetomidine|dexmedetomidine|mesh-list
139609963|NCT05247177|Ketamine|ketamine|mesh-list
139609964|NCT05247177|Anesthetics|anesthetics|mesh-list
139609965|NCT05247177|Sevoflurane|sevoflurane|mesh-list
139609966|NCT05247177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139609967|NCT05247177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139609968|NCT05247177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139609969|NCT05247177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139609970|NCT05247177|Analgesics|analgesics|mesh-ancestor
139609971|NCT05247177|Sensory System Agents|sensory system agents|mesh-ancestor
139609972|NCT05247177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139609973|NCT05247177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139609974|NCT05247177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139609975|NCT05247177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139609976|NCT05247177|Adrenergic Agents|adrenergic agents|mesh-ancestor
139609977|NCT05247177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139609978|NCT05247177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609979|NCT05247177|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139609980|NCT05247177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139609981|NCT05247177|Anesthetics, General|anesthetics, general|mesh-ancestor
139609982|NCT05247177|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139609983|NCT05247177|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139609984|NCT05247177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139609985|NCT05247177|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139609986|NCT00624195|Etravirine|etravirine|mesh-list
139609987|NCT00624195|Maraviroc|maraviroc|mesh-list
139609988|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139609989|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139609990|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139609991|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139609992|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139609993|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
139609994|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139609995|NCT00624195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139609996|NCT00624195|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139609997|NCT00624195|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139609998|NCT00624195|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139609999|NCT01516970|Ritonavir|ritonavir|mesh-list
139610000|NCT01516970|Lopinavir|lopinavir|mesh-list
139610001|NCT01516970|Darunavir|darunavir|mesh-list
139610002|NCT01516970|Zidovudine|zidovudine|mesh-list
139610003|NCT01516970|Efavirenz|efavirenz|mesh-list
139610004|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139610005|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139610006|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
139610007|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610008|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610009|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139610010|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139610011|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
139610012|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610013|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139610014|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139610015|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
139610016|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139610017|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139610018|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139610019|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139610020|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138738180|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
139610021|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139610022|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139610023|NCT02140593|Rocuronium|rocuronium|mesh-list
139610024|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139610025|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139610026|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139610027|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610028|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610029|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
139610030|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139610031|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139610032|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139610033|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139610034|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610035|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
139610036|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610037|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610038|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139610039|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610040|NCT00668811|Sunitinib|sunitinib|mesh-list
139610041|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610042|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139610043|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139610044|NCT00668811|Growth Substances|growth substances|mesh-ancestor
139610045|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610046|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
139610047|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139610048|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610049|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610050|NCT02776605|Prednisone|prednisone|mesh-list
139610051|NCT02776605|Methotrexate|methotrexate|mesh-list
139610052|NCT02776605|Vincristine|vincristine|mesh-list
139610053|NCT02776605|Daunorubicin|daunorubicin|mesh-list
139610054|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
139610055|NCT02776605|Ponatinib|ponatinib|mesh-list
139610056|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139610057|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
139610058|NCT02776605|Hormones|hormones|mesh-ancestor
139610059|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139610060|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610061|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139610062|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610063|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139610064|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
139610065|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139610066|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139610067|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
139610068|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610069|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
139610070|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610071|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139610072|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139610073|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
139610074|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610075|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139610076|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139610077|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
139610078|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
139610079|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
139610080|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139610081|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139610082|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139610083|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139610084|NCT00627861|Metoprolol|metoprolol|mesh-list
139610085|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139610086|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139610087|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
139391868|NCT06097468|Nisin|nisin|mesh-list
139610088|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
139610089|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610090|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610091|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139610092|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139610093|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139610094|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
139610095|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610096|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610097|NCT00669279|Atenolol|atenolol|mesh-list
139610098|NCT00669279|Carvedilol|carvedilol|mesh-list
139610099|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139610100|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139610101|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
139610102|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610103|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610104|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610105|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139610106|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
139610107|NCT00669279|Protective Agents|protective agents|mesh-ancestor
139610108|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139610109|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139610110|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139610111|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
139610112|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139610113|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139610114|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139610115|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
139610116|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
139610117|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610118|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139610119|NCT01546688|Zonisamide|zonisamide|mesh-list
139610120|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
139610121|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139610122|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139610123|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610124|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139610125|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610126|NCT04409522|Melatonin|melatonin|mesh-list
139610127|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
139610128|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610129|NCT04409522|Protective Agents|protective agents|mesh-ancestor
139610130|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610131|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139610132|NCT00672243|Sirolimus|sirolimus|mesh-list
139610133|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139610134|NCT00672243|Temsirolimus|temsirolimus|mesh-list
139610135|NCT00672243|MTOR Inhibitors|mtor inhibitors|mesh-list
139610136|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610137|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139610138|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610139|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610140|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139610141|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610142|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139610143|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
139610144|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139610145|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
139610146|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610147|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
139610148|NCT04105946|Remifentanil|remifentanil|mesh-list
139610149|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139610150|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139610151|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610152|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139610153|NCT04105946|Analgesics|analgesics|mesh-ancestor
139610154|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
139610155|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610156|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139610157|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139610158|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139610159|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
139610160|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610161|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610162|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139610163|NCT04105946|Narcotics|narcotics|mesh-ancestor
139610164|NCT01440569|Darunavir|darunavir|mesh-list
139610165|NCT01440569|Cobicistat|cobicistat|mesh-list
139610166|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139610167|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139610168|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
139610169|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610170|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610171|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139610172|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139610173|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
139610174|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610175|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139610176|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139610177|NCT00629499|Paclitaxel|paclitaxel|mesh-list
139610178|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
139610179|NCT00629499|Trastuzumab|trastuzumab|mesh-list
139610180|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139610181|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610182|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
139610183|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
139610184|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
139610185|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610186|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139610187|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
139610188|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610189|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610190|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139610191|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
139610192|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139610193|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139610194|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
139610195|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139610196|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139610197|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
139610198|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610199|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139610200|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139610201|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610202|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610203|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
139610204|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139610205|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139610206|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
139610207|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610208|NCT01440101|Natalizumab|natalizumab|mesh-list
139610209|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
139610210|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610211|NCT01530464|Ambrisentan|ambrisentan|mesh-list
139610212|NCT01530464|Aminophylline|aminophylline|mesh-list
139610213|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139610214|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139610215|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
139610216|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610217|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610218|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139610219|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
139610220|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139610221|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139610222|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610223|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610224|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139610225|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139610226|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
139610227|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610228|NCT01530464|Protective Agents|protective agents|mesh-ancestor
139610229|NCT00633399|Ziprasidone|ziprasidone|mesh-list
139610230|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139610231|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
139610232|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610233|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610234|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610235|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139610236|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139610237|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139610238|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139610239|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139610240|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
139610241|NCT01077843|Etoricoxib|etoricoxib|mesh-list
139610242|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
139610243|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139610244|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139610245|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139610246|NCT01077843|Analgesics|analgesics|mesh-ancestor
139610247|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
139610248|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610249|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610250|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610251|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139610252|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610253|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610254|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139610255|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
139610256|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139610257|NCT00635817|Leuprolide|leuprolide|mesh-list
139610258|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139610259|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
139610260|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139610261|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610262|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139610263|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610264|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
139610265|NCT01439945|Antacids|antacids|mesh-ancestor
138738438|NCT01307579|Fluconazole|fluconazole|mesh-list
139610266|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610267|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139610268|NCT00651963|Ezetimibe|ezetimibe|mesh-list
139610269|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139610270|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139610271|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
139610272|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610273|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139610274|NCT00674115|Omeprazole|omeprazole|mesh-list
139610275|NCT00674115|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
139610276|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139610277|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139610278|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139610279|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610280|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610281|NCT02142153|Olorofim|olorofim|mesh-list
139610282|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
139610283|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610284|NCT00674583|Vaccines|vaccines|mesh-list
139610285|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
139610286|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610287|NCT01420081|Gedatolisib|gedatolisib|mesh-list
139610288|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139610289|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610290|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610291|NCT01439867|Cinacalcet|cinacalcet|mesh-list
139610292|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139610293|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610294|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139610295|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
139610296|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139610297|NCT00637923|Ribavirin|ribavirin|mesh-list
139610298|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139610299|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
139610300|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
139610301|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610302|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
139610303|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610304|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139610305|NCT01439711|Letrozole|letrozole|mesh-list
139610306|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610307|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139610308|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139610309|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610310|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610311|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139610312|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
139610313|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139610314|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610315|NCT01439555|Simvastatin|simvastatin|mesh-list
139610316|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139610317|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139610318|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
139610319|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610320|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139610321|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139610322|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610323|NCT00674739|Imiquimod|imiquimod|mesh-list
139610324|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139610325|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
139610326|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610327|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610328|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
139610329|NCT00675909|Midazolam|midazolam|mesh-list
139610330|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139610331|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139610332|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139610333|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610334|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139610335|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139610336|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139610337|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139610338|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
139610339|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
139610340|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
139610341|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
139610342|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610343|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610344|NCT03027908|Fluorides|fluorides|mesh-list
139610345|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
139610346|NCT03027908|Protective Agents|protective agents|mesh-ancestor
139610347|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610348|NCT00638937|Saracatinib|saracatinib|mesh-list
139610349|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610350|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610351|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610352|NCT01439009|Tolvaptan|tolvaptan|mesh-list
139610353|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139610354|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610355|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
139610356|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610357|NCT00675987|Losartan|losartan|mesh-list
139610358|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139610359|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139610360|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139610361|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139610362|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610363|NCT00639717|Etanercept|etanercept|mesh-list
139610364|NCT00639717|Methoxsalen|methoxsalen|mesh-list
139610365|NCT00639717|Tacrolimus|tacrolimus|mesh-list
139610366|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139610367|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
139610368|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610369|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139610370|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610371|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610372|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139610373|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139610374|NCT00639717|Analgesics|analgesics|mesh-ancestor
139610375|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
139610376|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610377|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139610378|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610379|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139610380|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139610381|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
139610382|NCT01571453|Vortioxetine|vortioxetine|mesh-list
139610383|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139610384|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139610385|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139610386|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139610387|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610388|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610389|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610390|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139610391|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
139610392|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139610393|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139610394|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139610395|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139610396|NCT01571453|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139610397|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
139610398|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139610399|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139610400|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139610401|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139610402|NCT04120961|Hirudins|hirudins|mesh-list
139610403|NCT04120961|Bivalirudin|bivalirudin|mesh-list
139610404|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
139610405|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139610406|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
139610407|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610408|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610409|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
139610410|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139610411|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139610412|NCT04410263|Dimercaprol|dimercaprol|mesh-list
139610413|NCT04410263|Chelating Agents|chelating agents|mesh-ancestor
139610414|NCT04410263|Sequestering Agents|sequestering agents|mesh-ancestor
139610415|NCT04410263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610416|NCT01444651|Tadalafil|tadalafil|mesh-list
139610417|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
139610418|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139610419|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139610420|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610421|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610422|NCT01444651|Urological Agents|urological agents|mesh-ancestor
139610423|NCT01570751|Insulin|insulin|mesh-list
139610424|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139610425|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
139610426|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139610427|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610428|NCT01419535|Mifepristone|mifepristone|mesh-list
139610429|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139610430|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
139610431|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139610432|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610433|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139610434|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139610435|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139610436|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
139610437|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139610438|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139610439|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
139610440|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139610441|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
139610442|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139610443|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139610444|NCT01438151|Infliximab|infliximab|mesh-list
139610445|NCT01438151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139610446|NCT01438151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139610447|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
139610448|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139610449|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610450|NCT02141451|Rituximab|rituximab|mesh-list
139610451|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139610452|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610453|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
139610454|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610455|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610456|NCT01418365|Metronidazole|metronidazole|mesh-list
139610457|NCT01418365|Mesalamine|mesalamine|mesh-list
139610458|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610459|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139610460|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139610461|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139610462|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139610463|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139610464|NCT01418365|Analgesics|analgesics|mesh-ancestor
139610465|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
139610466|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610467|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610468|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139610469|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610470|NCT02075125|Ticagrelor|ticagrelor|mesh-list
139610471|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139610472|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139610473|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139610474|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139610475|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139610476|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
139610477|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610478|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610479|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610480|NCT00678015|Masoprocol|masoprocol|mesh-list
139610481|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
139610482|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610483|NCT00678015|Protective Agents|protective agents|mesh-ancestor
139610484|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610485|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139610486|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610487|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138738668|NCT01294683|Vitamins|vitamins|mesh-ancestor
139610488|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139610489|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139610490|NCT00678015|Analgesics|analgesics|mesh-ancestor
139610491|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
139610492|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610493|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139610494|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610495|NCT01437995|Fluticasone|fluticasone|mesh-list
139610496|NCT01437995|Xhance|xhance|mesh-list
139610497|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139610498|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139610499|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139610500|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139610501|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
139610502|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610503|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610504|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139610505|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
139610506|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
139610507|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139610508|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139610509|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139610510|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139610511|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
139610512|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610513|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610514|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
139610515|NCT01437995|Hormones|hormones|mesh-ancestor
139610516|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139610517|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
139610518|NCT00641745|Risperidone|risperidone|mesh-list
139610519|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139610520|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139610521|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
139610522|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610523|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610524|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610525|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139610526|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139610527|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139610528|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139610529|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139610530|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
139610531|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139392251|NCT05840211|Paclitaxel|paclitaxel|mesh-list
139610532|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139610533|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139610534|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
139610535|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139610536|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139610537|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
139610538|NCT01799109|Albuterol|albuterol|mesh-list
139610539|NCT01799109|Analgesics|analgesics|mesh-ancestor
139610540|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
139610541|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610542|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610543|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
139610544|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139610545|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139610546|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
139610547|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139610548|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139610549|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610550|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139610551|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
139610552|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139610553|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139610554|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
139610555|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139610556|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
139610557|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139610558|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139610559|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139610560|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
139610561|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610562|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
139610563|NCT00588159|Promethazine|promethazine|mesh-list
139610564|NCT00588159|Gabapentin|gabapentin|mesh-list
139610565|NCT00588159|Analgesics|analgesics|mesh-ancestor
139610566|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
139610567|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610568|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610569|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
139610570|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139610571|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139610572|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139610573|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139610574|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139610575|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139610576|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610577|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610578|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
139610579|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139610580|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139610581|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
139610582|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
139610583|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
139610584|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
139610585|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139610586|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139610587|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
139610588|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
139610589|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139610590|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
139610591|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
139610592|NCT01439347|Vincristine|vincristine|mesh-list
139610593|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139610594|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610595|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
139610596|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
139610597|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
139610598|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610599|NCT00680823|Ropivacaine|ropivacaine|mesh-list
139610600|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
139610601|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
139610602|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139610603|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610604|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
139610605|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610606|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139610607|NCT00589329|Metronidazole|metronidazole|mesh-list
139610608|NCT00589329|Erythromycin|erythromycin|mesh-list
139610609|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
139610610|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139610611|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
139610612|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610613|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139610614|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139610615|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139610616|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139610617|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313232|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
139610618|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610619|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
139610620|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139610621|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139610622|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610623|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139610624|NCT01438957|Analgesics|analgesics|mesh-ancestor
139610625|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
139610626|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610627|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139610628|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139610629|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139610630|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
139610631|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610632|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610633|NCT00589563|Sirolimus|sirolimus|mesh-list
139610634|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
139610635|NCT00589563|Melphalan|melphalan|mesh-list
139610636|NCT00589563|Methotrexate|methotrexate|mesh-list
139610637|NCT00589563|Fludarabine|fludarabine|mesh-list
139610638|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
139610639|NCT00589563|Etoposide|etoposide|mesh-list
139610640|NCT00589563|Tacrolimus|tacrolimus|mesh-list
139610641|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139610642|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139610643|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
139610644|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610645|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610646|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139610647|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
139610648|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610649|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610650|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139610651|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139610652|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
139610653|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139610654|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138738870|NCT01013701|Xhance|xhance|mesh-list
139610655|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
139610656|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
139610657|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610658|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139610659|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139610660|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139610661|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139610662|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139610663|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139610664|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139610665|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610666|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139610667|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
139610668|NCT00645333|Docetaxel|docetaxel|mesh-list
139610669|NCT00645333|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
139610670|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610671|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
139610672|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
139610673|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
139610674|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610675|NCT00645333|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139610676|NCT00645333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610677|NCT00646581|Insulin|insulin|mesh-list
139610678|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139610679|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139610680|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610681|NCT00648375|Propranolol|propranolol|mesh-list
139392401|NCT05706506|Hormones|hormones|mesh-ancestor
139610682|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139610683|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139610684|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
139610685|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610686|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610687|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610688|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139610689|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139610690|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
139610691|NCT00654069|Niacin|niacin|mesh-list
139610692|NCT00654069|Niacinamide|niacinamide|mesh-list
139610693|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
139610694|NCT00654069|Oxycodone|oxycodone|mesh-list
139610695|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139610696|NCT00654069|Narcotics|narcotics|mesh-ancestor
139610697|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139610698|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610699|NCT00654069|Analgesics|analgesics|mesh-ancestor
139610700|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
139610701|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610702|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139610703|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
139610704|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610705|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139610706|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
139610707|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
139610708|NCT00654069|Vitamins|vitamins|mesh-ancestor
139610709|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
139610710|NCT00654147|Ritonavir|ritonavir|mesh-list
139610711|NCT00654147|Lopinavir|lopinavir|mesh-list
139610712|NCT00654147|Tenofovir|tenofovir|mesh-list
139610713|NCT00654147|Emtricitabine|emtricitabine|mesh-list
139610714|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
139610715|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139610716|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139610717|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
139610718|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610719|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610720|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139610721|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139610722|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
139610723|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610724|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139610725|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139610726|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139610727|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139610728|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139610729|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139610730|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139610731|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
139610732|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610733|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
139610734|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139610735|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139610736|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610737|NCT00655083|MEN 11420|men 11420|mesh-list
139610738|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139610739|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
139610740|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610741|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610742|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139610743|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
139610744|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139610745|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139610746|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139610747|NCT01418209|Estradiol|estradiol|mesh-list
139610748|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139610749|NCT01418209|Progesterone|progesterone|mesh-list
139610750|NCT01418209|Estrogens|estrogens|mesh-ancestor
139610751|NCT01418209|Hormones|hormones|mesh-ancestor
139610752|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139610753|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610754|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139610755|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
139610756|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139610757|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139610759|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139610760|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139610761|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139610762|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610763|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610764|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139610765|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
139610766|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139610767|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
139610768|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139610769|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139610770|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
139610771|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610772|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139610773|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139610774|NCT01417195|Menotropins|menotropins|mesh-list
139610775|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139610776|NCT01417195|Hormones|hormones|mesh-ancestor
139610777|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139610778|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610779|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139610780|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
139610781|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139610782|NCT00656487|Rimonabant|rimonabant|mesh-list
139610783|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139610784|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
139610785|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139610786|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610787|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610788|NCT00656487|Hormones|hormones|mesh-ancestor
139610789|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139610790|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610791|NCT01438177|Chloroquine|chloroquine|mesh-list
139610792|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
139610793|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139610794|NCT01438177|Bortezomib|bortezomib|mesh-list
139610795|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139610796|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
139610797|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610798|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610799|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139610800|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
139610801|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610802|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610803|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139610804|NCT01438177|Amebicides|amebicides|mesh-ancestor
139610805|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139610806|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139610807|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610808|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
139610809|NCT01442779|Interferons|interferons|mesh-list
139610810|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
139610811|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610812|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
139610813|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610814|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
139610815|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610816|NCT01436201|Dulaglutide|dulaglutide|mesh-list
139610817|NCT01436201|Digoxin|digoxin|mesh-list
139610818|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139610819|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139610820|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610821|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610822|NCT01436201|Protective Agents|protective agents|mesh-ancestor
139610823|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610824|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139610825|NCT01437397|Bromides|bromides|mesh-list
139610826|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
139610827|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139610828|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
139610829|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610830|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610831|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138739011|NCT01281813|Darunavir|darunavir|mesh-list
139610832|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
139610833|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139610834|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139610835|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139610836|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
139610837|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610838|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610839|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
139610840|NCT04070833|Vitamin D|vitamin d|mesh-list
139610841|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
139610842|NCT04070833|Cholecalciferol|cholecalciferol|mesh-list
139610843|NCT04070833|Vitamins|vitamins|mesh-list
139610844|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
139610845|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610846|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139610847|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139610848|NCT01442155|Capecitabine|capecitabine|mesh-list
139610849|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
139610850|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139610851|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
139610852|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610853|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610854|NCT01416181|Natalizumab|natalizumab|mesh-list
139610855|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
139610856|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610857|NCT03026023|Ribavirin|ribavirin|mesh-list
139610858|NCT03026023|Grazoprevir|grazoprevir|mesh-list
139610859|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
139610860|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610861|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
139610862|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610863|NCT01441765|Pidilizumab|pidilizumab|mesh-list
139610864|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139610865|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610866|NCT01419665|Rituximab|rituximab|mesh-list
139610867|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139610868|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610869|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
139610870|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610871|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610872|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
139610873|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
139610874|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
139610875|NCT01436305|Abatacept|abatacept|mesh-list
139610876|NCT01436305|Tacrolimus|tacrolimus|mesh-list
139610877|NCT01436305|Basiliximab|basiliximab|mesh-list
139610878|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139610879|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
139610880|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610881|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139610882|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610883|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610884|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139610885|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610886|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139610887|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
139610888|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139610889|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610890|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139610891|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
139610892|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
139610893|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610894|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139610895|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
139610896|NCT01436305|Hormones|hormones|mesh-ancestor
139610897|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139610898|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139610899|NCT01436305|Protective Agents|protective agents|mesh-ancestor
139610900|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139610901|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139610902|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610903|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139610904|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139610905|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610906|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139610907|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139610908|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139610909|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610911|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610912|NCT01415401|Timolol|timolol|mesh-list
139610913|NCT01415401|Brinzolamide|brinzolamide|mesh-list
139610914|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610915|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610916|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139610917|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139610918|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
139610919|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139610920|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610921|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139610922|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139610923|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139610924|NCT01414855|Prednisone|prednisone|mesh-list
139610925|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
139610926|NCT01414855|Doxorubicin|doxorubicin|mesh-list
139610927|NCT01414855|Vincristine|vincristine|mesh-list
139610928|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
139610929|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139610930|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
139610931|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610932|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610933|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139610934|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
139610935|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610936|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139610937|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139610938|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139610939|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139610940|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139610941|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610942|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139610943|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
139610944|NCT01414855|Hormones|hormones|mesh-ancestor
139610945|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139610946|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139313233|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
139610947|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139610948|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
139610949|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
139610950|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
139610951|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139610952|NCT02074735|Choline|choline|mesh-list
139610953|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139610954|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
139610955|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139610956|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
139610957|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610958|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139610959|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139610960|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
139610961|NCT01527110|Zanamivir|zanamivir|mesh-list
139610962|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
139610963|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610964|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610965|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610966|NCT01441063|Zidovudine|zidovudine|mesh-list
139610967|NCT01441063|Valganciclovir|valganciclovir|mesh-list
139610968|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
139610969|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139610970|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139610971|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139610972|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139610973|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
139610974|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139610975|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139610976|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139610977|NCT01436071|Fluticasone|fluticasone|mesh-list
139610978|NCT01436071|Xhance|xhance|mesh-list
139610979|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139610980|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139610981|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
139610982|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139610983|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610984|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139610985|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
139610986|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
139610987|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139610988|NCT01514240|Mesalamine|mesalamine|mesh-list
139610989|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139610990|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139610991|NCT01514240|Analgesics|analgesics|mesh-ancestor
139610992|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
139610993|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739195|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
139610994|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139610995|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139610996|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139610997|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139610998|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
139610999|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139611000|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139611001|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611002|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139611003|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139611004|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139611005|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611006|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
139611007|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611008|NCT01393405|Methotrexate|methotrexate|mesh-list
139611009|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139611010|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
139611011|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139611012|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611013|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139611014|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
139611015|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611016|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611017|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
139611018|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611019|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139611020|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139611021|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
139611022|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139611023|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139611024|NCT01419197|Trastuzumab|trastuzumab|mesh-list
139611025|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139611026|NCT01419197|Maytansine|maytansine|mesh-list
139611027|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139611028|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611029|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139611030|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
139611031|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
139611032|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
139611033|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611034|NCT01419197|Immunotoxins|immunotoxins|mesh-ancestor
139611035|NCT01419197|Immunoconjugates|immunoconjugates|mesh-ancestor
139611036|NCT01419197|Immunologic Factors|immunologic factors|mesh-ancestor
139611037|NCT01419197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611038|NCT01414075|Iron|iron|mesh-list
139611039|NCT01414075|Trace Elements|trace elements|mesh-ancestor
139611040|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
139611041|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611042|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
139611043|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
139611044|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139611045|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
139611046|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611047|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611048|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139611049|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
139611050|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
139611051|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139611052|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
139611053|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611054|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611055|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139611056|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139611057|NCT01418339|Aripiprazole|aripiprazole|mesh-list
139611058|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
139611059|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139611060|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139611061|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139611062|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611063|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611064|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
139611065|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
139611066|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611067|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611068|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139611069|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139611070|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
139611071|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139611072|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139611073|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139611074|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139611075|NCT01417481|Glycine|glycine|mesh-list
139611076|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
139611077|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611078|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611079|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611080|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
139611081|NCT01392469|Bosentan|bosentan|mesh-list
139611082|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
139611083|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611084|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139611085|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611086|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611087|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
139611088|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139611089|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139611090|NCT01392469|Urological Agents|urological agents|mesh-ancestor
139611091|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139611092|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139611093|NCT01435577|Tapentadol|tapentadol|mesh-list
139611094|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139611095|NCT01435577|Narcotics|narcotics|mesh-ancestor
139611096|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611097|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611098|NCT01435577|Analgesics|analgesics|mesh-ancestor
139611099|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
139611100|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611101|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139611102|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139611103|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139611104|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611105|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
139611106|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611107|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
139611108|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
139611109|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139611110|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139611111|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611112|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611113|NCT04039087|Urological Agents|urological agents|mesh-ancestor
139611114|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
139611115|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139611116|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611117|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
139611118|NCT01416389|Lenograstim|lenograstim|mesh-list
139611119|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139611120|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
139611121|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611122|NCT04497155|Norepinephrine|norepinephrine|mesh-list
139611123|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139611124|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139611125|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
139611126|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611127|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611128|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611129|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
139611130|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
139611131|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611132|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139611133|NCT01544348|Omalizumab|omalizumab|mesh-list
139611134|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139611135|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139611136|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
139611137|NCT01416155|Natalizumab|natalizumab|mesh-list
139611138|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
139611139|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611140|NCT01415921|Bromides|bromides|mesh-list
139611141|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139611142|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
139611143|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139611144|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611145|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611146|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
139611147|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611148|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611149|NCT01415531|Nebivolol|nebivolol|mesh-list
139611150|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139611151|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
139611152|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139611153|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139611154|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139611155|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
139611156|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611157|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611158|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611159|NCT01544114|Naproxen|naproxen|mesh-list
139611160|NCT01544114|Esomeprazole|esomeprazole|mesh-list
139611161|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139611162|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139611163|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139611164|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611165|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611166|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139611167|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139611168|NCT01544114|Analgesics|analgesics|mesh-ancestor
139611169|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
139611170|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611171|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611172|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139611173|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139611174|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
139611175|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139611176|NCT01410799|Hormones|hormones|mesh-list
139611177|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
139611178|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139611179|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611180|NCT01432171|Lacosamide|lacosamide|mesh-list
139611181|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
139611182|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139611183|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139611184|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139611185|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611186|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
139611187|NCT04046263|Hematinics|hematinics|mesh-ancestor
139611188|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
139611189|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139611190|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611191|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139611192|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611193|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611194|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611195|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139611196|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139611197|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
139611198|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611199|NCT01412957|Panitumumab|panitumumab|mesh-list
139611200|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139611201|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611202|NCT04973826|Aztreonam|aztreonam|mesh-list
139611203|NCT04973826|Avibactam|avibactam|mesh-list
139611204|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139611205|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611206|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139611207|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611208|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611209|NCT05387616|Obinutuzumab|obinutuzumab|mesh-list
139611210|NCT05387616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139611211|NCT05387616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611212|NCT03025841|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139611213|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139611214|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611215|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139611216|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139611217|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139611218|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139611219|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611220|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611221|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611222|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
139611223|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139611224|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
139611225|NCT05062278|Vinblastine|vinblastine|mesh-list
139611226|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611227|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
139611228|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611229|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611230|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139611231|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139611232|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
139611233|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
139611234|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
139611235|NCT02823990|Nivolumab|nivolumab|mesh-list
139611236|NCT02823990|Interleukin-2|interleukin-2|mesh-list
139611237|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611238|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139611239|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611240|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139611241|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611242|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139611243|NCT02823990|Analgesics|analgesics|mesh-ancestor
139611244|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
139611245|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611246|NCT02427126|Aspirin|aspirin|mesh-list
139611247|NCT02427126|Apixaban|apixaban|mesh-list
139611248|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139611249|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139611250|NCT02427126|Analgesics|analgesics|mesh-ancestor
139611251|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
139611252|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611253|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611254|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139611255|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139611256|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139611257|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139611258|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611259|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139611260|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139611261|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611262|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
139611263|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139611264|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
139611265|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139611266|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
139611267|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
139611268|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139611269|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139611270|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139611271|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611272|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611273|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139611274|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139611275|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611276|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
139611277|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611278|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
139611279|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139611280|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139611281|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
139611282|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611283|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139611285|NCT04797312|Remifentanil|remifentanil|mesh-list
139611286|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
139611287|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
139611288|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611289|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611290|NCT04797312|Narcotics|narcotics|mesh-ancestor
139611291|NCT04797312|Analgesics|analgesics|mesh-ancestor
139611292|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
139611293|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611294|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139611295|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139611296|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
139611297|NCT05080140|Ezetimibe|ezetimibe|mesh-list
139611298|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139611299|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139611300|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
139611301|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611302|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139611303|NCT01390441|Acetaminophen|acetaminophen|mesh-list
139611304|NCT01390441|Loratadine|loratadine|mesh-list
139611305|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
139611306|NCT01390441|Rituximab|rituximab|mesh-list
139611307|NCT01390441|Methotrexate|methotrexate|mesh-list
139313234|NCT02308098|Hormones|hormones|mesh-ancestor
139611308|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139611309|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611310|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
139611311|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611312|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139611313|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139611314|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
139611315|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139611316|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139611317|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
139611318|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611319|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
139611320|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611321|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139611322|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139611323|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139611324|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139611325|NCT01390441|Analgesics|analgesics|mesh-ancestor
139611326|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
139611327|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611328|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
139611329|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139611330|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
139611331|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
139611332|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139611333|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
139611334|NCT01390441|Hormones|hormones|mesh-ancestor
139611335|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139611336|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139611337|NCT01390441|Protective Agents|protective agents|mesh-ancestor
139611338|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
139611339|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139611340|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139611341|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139611342|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
139611343|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
139611344|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611345|NCT03142542|Udenafil|udenafil|mesh-list
139611346|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139611347|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139611348|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611349|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611350|NCT03025867|Niraparib|niraparib|mesh-list
139611351|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139611352|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393074|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
139611353|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611354|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611355|NCT01412879|Leucovorin|leucovorin|mesh-list
139611356|NCT01412879|Cytarabine|cytarabine|mesh-list
139611357|NCT01412879|Dexamethasone|dexamethasone|mesh-list
139611358|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
139611359|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139611360|NCT01412879|Rituximab|rituximab|mesh-list
139611361|NCT01412879|Doxorubicin|doxorubicin|mesh-list
139611362|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139611363|NCT01412879|Methotrexate|methotrexate|mesh-list
139611364|NCT01412879|Vincristine|vincristine|mesh-list
139611365|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
139611366|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139611367|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
139611368|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611369|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139611370|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139611371|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
139611372|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611373|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611374|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139611375|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139611376|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
139611377|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
139611378|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611379|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139611380|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
139611381|NCT01412879|Hormones|hormones|mesh-ancestor
139611382|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139611383|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139611384|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139611385|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139611386|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138739606|NCT01010971|Ciclesonide|ciclesonide|mesh-list
139611387|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139611388|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611389|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139611390|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
139611391|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139611392|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139611393|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
139611394|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
139611395|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139611396|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139611397|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
139611398|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611399|NCT01412879|Antidotes|antidotes|mesh-ancestor
139611400|NCT01412879|Protective Agents|protective agents|mesh-ancestor
139611401|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
139611402|NCT01412879|Vitamins|vitamins|mesh-ancestor
139611403|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
139611404|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139611405|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
139611406|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
139611407|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
139611408|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
139611409|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139611410|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611411|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611412|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139611413|NCT03143010|Analgesics|analgesics|mesh-ancestor
139611414|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
139611415|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611416|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139611417|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139611418|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139611419|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
139611420|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611421|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611422|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139611423|NCT03142776|Clarithromycin|clarithromycin|mesh-list
139611424|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611425|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139611426|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611427|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611428|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139611429|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139611431|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
139611432|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611433|NCT03140826|Meropenem|meropenem|mesh-list
139611434|NCT03140826|Tazobactam|tazobactam|mesh-list
139611435|NCT03140826|Piperacillin|piperacillin|mesh-list
139611436|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139611437|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139611438|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611439|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139611440|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611441|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611442|NCT01389973|Ustekinumab|ustekinumab|mesh-list
139611443|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
139611444|NCT04529460|Antibodies|antibodies|mesh-list
139611445|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
139611446|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611447|NCT04032067|Finasteride|finasteride|mesh-list
139611448|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139611449|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139611450|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611451|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611452|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
139611453|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139611454|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611455|NCT04032067|Urological Agents|urological agents|mesh-ancestor
139611456|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
139611457|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139611458|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611459|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
139611460|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
139611461|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139611462|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139611463|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611464|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611465|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139611466|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139611467|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611468|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611469|NCT04051957|Isosorbide|isosorbide|mesh-list
139611470|NCT04051957|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139611471|NCT04051957|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139611472|NCT04051957|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139611473|NCT04051957|Diuretics|diuretics|mesh-ancestor
139611474|NCT04051957|Natriuretic Agents|natriuretic agents|mesh-ancestor
139611475|NCT04051957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611476|NCT04051957|Vasodilator Agents|vasodilator agents|mesh-ancestor
139611477|NCT04051957|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139611478|NCT04051957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611479|NCT00591123|Leucovorin|leucovorin|mesh-list
139611480|NCT00591123|Fluorouracil|fluorouracil|mesh-list
139611481|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
139611482|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139611483|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
139611484|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611485|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
139611486|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611487|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139611488|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611489|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139611490|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
139611491|NCT00591123|Antidotes|antidotes|mesh-ancestor
139611492|NCT00591123|Protective Agents|protective agents|mesh-ancestor
139611493|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
139611494|NCT00591123|Vitamins|vitamins|mesh-ancestor
139611495|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
139611496|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139611497|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611498|NCT04149990|Valsartan|valsartan|mesh-list
139611499|NCT04149990|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139611500|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139611501|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139611502|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139611503|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611504|NCT00591825|Cycloserine|cycloserine|mesh-list
139611505|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139611506|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611507|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139611508|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
139611509|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139611510|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
139611511|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611513|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139611514|NCT01429285|Narcotics|narcotics|mesh-ancestor
139611515|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611516|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611517|NCT01429285|Analgesics|analgesics|mesh-ancestor
139611518|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
139611519|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611520|NCT00594945|Clonazepam|clonazepam|mesh-list
139611521|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
139611522|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
139611523|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
139611524|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611525|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611526|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611527|NCT00595101|Latanoprost|latanoprost|mesh-list
139611528|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139611529|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139611530|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139611531|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139611532|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611533|NCT00660075|Incretins|incretins|mesh-ancestor
139611534|NCT00660075|Hormones|hormones|mesh-ancestor
139611535|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139611536|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139611537|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
139611538|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611539|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611540|NCT01429051|Fentanyl|fentanyl|mesh-list
139611541|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139611542|NCT01429051|Narcotics|narcotics|mesh-ancestor
139611543|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611544|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611545|NCT01429051|Analgesics|analgesics|mesh-ancestor
139611546|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
139611547|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611548|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139611549|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139611550|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
139611551|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
139611552|NCT03968562|Doxycycline|doxycycline|mesh-list
139611553|NCT03968562|Petrolatum|petrolatum|mesh-list
139611554|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139611555|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611556|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
139611557|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139611558|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139611559|NCT03968562|Emollients|emollients|mesh-ancestor
139611560|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
139611561|NCT03425292|Bevacizumab|bevacizumab|mesh-list
139611562|NCT03425292|Nivolumab|nivolumab|mesh-list
139611563|NCT03425292|Ipilimumab|ipilimumab|mesh-list
139611564|NCT03425292|Temozolomide|temozolomide|mesh-list
139611565|NCT03425292|Lomustine|lomustine|mesh-list
139611566|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139611567|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611568|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139611569|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139611570|NCT03425292|Growth Substances|growth substances|mesh-ancestor
139611571|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611572|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
139611573|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139611574|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611575|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139611576|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
139611577|NCT00596271|Vaccines|vaccines|mesh-list
139611578|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
139393296|NCT04221477|Analgesics|analgesics|mesh-ancestor
139611579|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611580|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
139611581|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
139611582|NCT03139422|Calcium|calcium|mesh-list
139611583|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139611584|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611585|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139611586|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139611587|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611588|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
139611589|NCT03139422|Coagulants|coagulants|mesh-ancestor
139611590|NCT01428583|Naltrexone|naltrexone|mesh-list
139611591|NCT01428583|Oxycodone|oxycodone|mesh-list
139611592|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139611593|NCT01428583|Narcotics|narcotics|mesh-ancestor
139611594|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611595|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611596|NCT01428583|Analgesics|analgesics|mesh-ancestor
139611597|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
139611598|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611599|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139611600|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139611601|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139611602|NCT00660543|Hematinics|hematinics|mesh-ancestor
139611603|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139611604|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139611605|NCT01428193|Flutamide|flutamide|mesh-list
139611606|NCT01428193|Estradiol|estradiol|mesh-list
139611607|NCT01428193|Progesterone|progesterone|mesh-list
139611608|NCT01428193|Estrogens|estrogens|mesh-ancestor
139611609|NCT01428193|Hormones|hormones|mesh-ancestor
139611610|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139611611|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611612|NCT01428193|Progestins|progestins|mesh-ancestor
139611613|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
139611614|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
139611615|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139611616|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611617|NCT03864276|Propofol|propofol|mesh-list
139611618|NCT03864276|Desflurane|desflurane|mesh-list
139611619|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
139611620|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611621|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611622|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139611623|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139611624|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
139611625|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139611626|NCT03141918|Curcumin|curcumin|mesh-list
139611627|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139611628|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139611629|NCT03141918|Analgesics|analgesics|mesh-ancestor
139611630|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
139611631|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611632|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611633|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139611634|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139611635|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739853|NCT03764553|Leucovorin|leucovorin|mesh-list
139611636|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611637|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611638|NCT01427803|Naproxen|naproxen|mesh-list
139611639|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139611640|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139611641|NCT01427803|Analgesics|analgesics|mesh-ancestor
139611642|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
139611643|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611644|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611645|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139611646|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139611647|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
139611648|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139611649|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611650|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611651|NCT03139500|Midazolam|midazolam|mesh-list
139611652|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139611653|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139611654|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139393444|NCT03808961|Niacin|niacin|mesh-list
139611655|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611656|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139611657|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139611658|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139611659|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139611660|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
139611661|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
139611662|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
139611663|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
139611664|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611665|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611666|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139611667|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139611668|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139611669|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139611670|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139611671|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
139611672|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611673|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611674|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611675|NCT04476966|Mirabegron|mirabegron|mesh-list
139611676|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139611677|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139611678|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139611679|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
139611680|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611681|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611682|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611683|NCT04476966|Urological Agents|urological agents|mesh-ancestor
139611684|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
139611685|NCT03821610|Melphalan|melphalan|mesh-list
139611686|NCT03821610|Fludarabine|fludarabine|mesh-list
139611687|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
139611688|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139611689|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
139611690|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611691|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139611692|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139611693|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
139611694|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611695|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611696|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139611697|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139611698|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
139611699|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
139611700|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139611701|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611702|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139611703|NCT04044001|Isoniazid|isoniazid|mesh-list
139611704|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
139611705|NCT04044001|Ethambutol|ethambutol|mesh-list
139611706|NCT04044001|Dolutegravir|dolutegravir|mesh-list
139611707|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
139611708|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139611709|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611710|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611711|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611712|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139611713|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139611714|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
139611715|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139611716|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139611717|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139611718|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139611719|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139611720|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
139611721|NCT00684723|Lovastatin|lovastatin|mesh-list
139611722|NCT00684723|L 647318|l 647318|mesh-list
139611723|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
139611724|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139611725|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139611726|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
139611727|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611728|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139611729|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139611730|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611731|NCT01405027|Interferons|interferons|mesh-list
139393445|NCT03808961|Niacinamide|niacinamide|mesh-list
139611732|NCT01405027|Ribavirin|ribavirin|mesh-list
139611733|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
139611734|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
139611735|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139611736|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139611737|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611738|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
139611739|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611740|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
139611741|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611742|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
139611743|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611744|NCT00663039|Oxytocin|oxytocin|mesh-list
139611745|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
139611746|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139611747|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611748|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
139611749|NCT04387539|Simeprevir|simeprevir|mesh-list
139611750|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
139611751|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611752|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
139611753|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611754|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611755|NCT00664755|Nicotine|nicotine|mesh-list
139611756|NCT00664755|Varenicline|varenicline|mesh-list
139611757|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139611758|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
139611759|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611760|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611761|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139611762|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139611763|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
139611764|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611765|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611766|NCT01525628|Tolbutamide|tolbutamide|mesh-list
139611767|NCT01525628|Interferons|interferons|mesh-list
139611768|NCT01525628|Tenofovir|tenofovir|mesh-list
139611769|NCT01525628|Ribavirin|ribavirin|mesh-list
139611770|NCT01525628|Midazolam|midazolam|mesh-list
139611771|NCT01525628|Caffeine|caffeine|mesh-list
139611772|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611773|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
139611774|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611775|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139611776|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139611777|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611778|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611779|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139611780|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139611781|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139611782|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139611783|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
139611784|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
138740012|NCT01300260|Glucagon|glucagon|mesh-list
139611785|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
139611786|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
139611787|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611788|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611789|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139611790|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139611791|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611792|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139611793|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139611794|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
139611795|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139611796|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139611797|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139611798|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139611799|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
139611800|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139611801|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139611802|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
139611803|NCT02320695|Bacitracin|bacitracin|mesh-list
139611804|NCT02320695|Neomycin|neomycin|mesh-list
139611805|NCT02320695|Polymyxin B|polymyxin b|mesh-list
139611806|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139393524|NCT03592472|Abexinostat|abexinostat|mesh-list
139611807|NCT02320695|Ethanol|ethanol|mesh-list
139611808|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611809|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
139611810|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139611811|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611812|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611813|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139611814|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611815|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611816|NCT01426009|Bromides|bromides|mesh-list
139611817|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
139611818|NCT01426009|Ipratropium|ipratropium|mesh-list
139611819|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139611820|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
139611821|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139611822|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611823|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139611824|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
139611825|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
139611826|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139611827|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
139611828|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611829|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611830|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
139611831|NCT01543958|Sevelamer|sevelamer|mesh-list
139611832|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
139611833|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
139611834|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611835|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139611836|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139611837|NCT01411085|Risperidone|risperidone|mesh-list
139611838|NCT01411085|Desipramine|desipramine|mesh-list
139611839|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139611840|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
139611841|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740074|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611842|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611843|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611844|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139611845|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139611846|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611847|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139611848|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139611849|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
139611850|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139611851|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
139611852|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611853|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139611854|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139611855|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139611856|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
139611857|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
139611858|NCT01404949|Tretinoin|tretinoin|mesh-list
139611859|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611860|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
139611861|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
139611862|NCT01431521|Pioglitazone|pioglitazone|mesh-list
139611863|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139611864|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611865|NCT00601965|Escitalopram|escitalopram|mesh-list
139611866|NCT00601965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139611867|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139611868|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139611869|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611870|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611871|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
139611872|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611873|NCT04751994|Sorbitol|sorbitol|mesh-list
139611874|NCT04751994|Cathartics|cathartics|mesh-ancestor
139611875|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139611876|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139611877|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139611878|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611879|NCT02998437|Amoxicillin|amoxicillin|mesh-list
139611880|NCT02998437|Clarithromycin|clarithromycin|mesh-list
139611881|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139611882|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139611883|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139393598|NCT03478865|Vitamin A|vitamin a|mesh-list
139611885|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611886|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139611887|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139611888|NCT02618148|Estrogens|estrogens|mesh-list
139611889|NCT02618148|Hormones|hormones|mesh-ancestor
138740110|NCT01254669|Vaccines|vaccines|mesh-list
139611890|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139611891|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611892|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139611893|NCT01404325|Everolimus|everolimus|mesh-list
139611894|NCT01404325|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139611895|NCT01404325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139611896|NCT01404325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611897|NCT01404325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611898|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139611899|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
139611900|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611901|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611902|NCT00602355|Sertraline|sertraline|mesh-list
139611903|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
139611904|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139611905|NCT00602355|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139611906|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139611907|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139611908|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611909|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611910|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
139611911|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611912|NCT01425463|Glycine|glycine|mesh-list
139611913|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
139611914|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611915|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611916|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611917|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139611918|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
139611919|NCT02144259|Etonogestrel|etonogestrel|mesh-list
139611920|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139611921|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139611922|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139611923|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
139611924|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139611925|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611926|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139611927|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139611928|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139611929|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139611930|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611931|NCT04655586|Heparin|heparin|mesh-list
139611932|NCT04655586|Protein C|protein c|mesh-list
139611933|NCT04655586|Anticoagulants|anticoagulants|mesh-list
139611934|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138740155|NCT01295034|Vitamins|vitamins|mesh-list
139611935|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139611936|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611937|NCT01388647|Carboplatin|carboplatin|mesh-list
139611938|NCT01388647|Trastuzumab|trastuzumab|mesh-list
139611939|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611940|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139611941|NCT03140982|Propofol|propofol|mesh-list
139611942|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139611943|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611944|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611945|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139611946|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
139611947|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
139611948|NCT05392686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139611949|NCT05392686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139611950|NCT05392686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611951|NCT05392686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139611952|NCT05392686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611953|NCT05392686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139611954|NCT00705003|Melatonin|melatonin|mesh-list
139611955|NCT00705003|Buspirone|buspirone|mesh-list
139611956|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
139611957|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611958|NCT00705003|Protective Agents|protective agents|mesh-ancestor
139611959|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611960|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611961|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139611962|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139611963|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139611964|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139611965|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
139611966|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139611967|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
139611968|NCT03110640|Fludarabine|fludarabine|mesh-list
139611969|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139611970|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
139611971|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611972|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139611973|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139611974|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
139611975|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139611976|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139611977|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139611978|NCT00690495|Propofol|propofol|mesh-list
139611979|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139611980|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139611981|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611982|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139611983|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
139611984|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
139611985|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139611986|NCT00691197|Glycerol|glycerol|mesh-list
139611987|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139611988|NCT00691197|Protective Agents|protective agents|mesh-ancestor
139611989|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611990|NCT00691197|Laxatives|laxatives|mesh-ancestor
139611991|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139611992|NCT02997969|Vaccines|vaccines|mesh-list
139611993|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
139611994|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
138740242|NCT01075048|Irinotecan|irinotecan|mesh-list
139611995|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139611996|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139611997|NCT04351230|Trastuzumab|trastuzumab|mesh-list
139611998|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139611999|NCT04351230|Maytansine|maytansine|mesh-list
139612000|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
139612001|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139612002|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612003|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139612004|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
139612005|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
139612006|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
139612007|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612008|NCT04351230|Immunotoxins|immunotoxins|mesh-ancestor
139612009|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
139612010|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612011|NCT05392374|TIC10 compound|tic10 compound|mesh-list
139612012|NCT05392374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612013|NCT04028388|Docetaxel|docetaxel|mesh-list
139612014|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612015|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
139612016|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
139612017|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
139612018|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612019|NCT01402063|Temozolomide|temozolomide|mesh-list
139612020|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
139612021|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139612022|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
138740262|NCT02888301|Clofarabine|clofarabine|mesh-list
139612023|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612024|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612025|NCT01796301|Teriparatide|teriparatide|mesh-list
139612026|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139612027|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612028|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139612029|NCT00868179|Dabigatran|dabigatran|mesh-list
139612030|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
139612031|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139393748|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
139612032|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
139612033|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612034|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612035|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
139612036|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
139612037|NCT01204905|Maraviroc|maraviroc|mesh-list
139612038|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139612039|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139612040|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
139612041|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612042|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139612043|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139612044|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612045|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612046|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139612047|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139612048|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139612049|NCT00691665|Fluticasone|fluticasone|mesh-list
139612050|NCT00691665|Xhance|xhance|mesh-list
139612051|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139612052|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139612053|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139612054|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
139612055|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612056|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612057|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139612058|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
139612059|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
139612060|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139612061|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139612062|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139612063|NCT00691665|Analgesics|analgesics|mesh-ancestor
139612064|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
139612065|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139612066|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139612067|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139612068|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
139612069|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
139612070|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612071|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612072|NCT01388335|Warfarin|warfarin|mesh-list
139612073|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
139612074|NCT00713583|Levodopa|levodopa|mesh-list
139612075|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139612076|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139612077|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
139612078|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612079|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612080|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612081|NCT03359460|Lenalidomide|lenalidomide|mesh-list
139612082|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
139612083|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612084|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139612085|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139612086|NCT03359460|Growth Substances|growth substances|mesh-ancestor
139612087|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
139612088|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612089|NCT03025477|Paclitaxel|paclitaxel|mesh-list
139612090|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139612091|NCT03025477|Cisplatin|cisplatin|mesh-list
139612092|NCT03025477|Carboplatin|carboplatin|mesh-list
139612093|NCT03025477|Epirubicin|epirubicin|mesh-list
139612094|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139612095|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612096|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
139612097|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
139612098|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
139612099|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612100|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139612101|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139612102|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139612103|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612104|NCT03147378|Docetaxel|docetaxel|mesh-list
139612105|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612106|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
139612107|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
139612108|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
139612109|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612110|NCT00159744|Olanzapine|olanzapine|mesh-list
139612111|NCT00159744|Asenapine|asenapine|mesh-list
139612112|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
139612113|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
139612114|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612115|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612116|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139612117|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139612118|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139612119|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612120|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139612121|NCT00159744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139612122|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139612123|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139612124|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612125|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612126|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
139612127|NCT04041973|Lumefantrine|lumefantrine|mesh-list
139612128|NCT04041973|Artemether|artemether|mesh-list
139612129|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139612130|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
139612131|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139612132|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139612133|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612134|NCT02914470|Atezolizumab|atezolizumab|mesh-list
139612135|NCT02914470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139612136|NCT02914470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612137|NCT02914470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139612138|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740381|NCT04305028|Aspirin|aspirin|mesh-list
139612139|NCT05088330|Daratumumab|daratumumab|mesh-list
139612140|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612141|NCT00695097|Rituximab|rituximab|mesh-list
139612142|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139612143|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612144|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
139612145|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612146|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139612147|NCT01795911|Interferons|interferons|mesh-list
139612148|NCT01795911|Ribavirin|ribavirin|mesh-list
139612149|NCT01795911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612150|NCT01795911|Antiviral Agents|antiviral agents|mesh-ancestor
139612151|NCT01795911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612152|NCT01795911|Antimetabolites|antimetabolites|mesh-ancestor
139612153|NCT01795911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612154|NCT03137316|Hormones|hormones|mesh-list
139612155|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
139612156|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139612157|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612158|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139612159|NCT03137082|Guanfacine|guanfacine|mesh-list
139612160|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139612161|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139612162|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139612163|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139612164|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
139612165|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612166|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612167|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612168|NCT05088174|Cyclosporine|cyclosporine|mesh-list
139612169|NCT05088174|Cyclosporins|cyclosporins|mesh-list
139612170|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612171|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612172|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139612173|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
138740408|NCT02874664|Immunoconjugates|immunoconjugates|mesh-ancestor
139612174|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612175|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
139612176|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612177|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
139612178|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139612179|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139612180|NCT00695409|Cytarabine|cytarabine|mesh-list
139612181|NCT00695409|Rituximab|rituximab|mesh-list
139612182|NCT00695409|Etoposide|etoposide|mesh-list
139612183|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
139612185|NCT00695409|Carmustine|carmustine|mesh-list
139612186|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139612187|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139612188|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612189|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
139612190|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612191|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139612192|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139612193|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139612194|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139612195|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612196|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612197|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139612198|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
139612199|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
139612200|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612201|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139612202|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139612203|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
139612204|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139612205|NCT03469050|Rifaximin|rifaximin|mesh-list
139612206|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139612207|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612208|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139612209|NCT05087706|Bicalutamide|bicalutamide|mesh-list
139612210|NCT05087706|Leuprolide|leuprolide|mesh-list
139612211|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
139612212|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
139612213|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139612214|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612215|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612216|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139612217|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
139612218|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139612219|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139612220|NCT02990403|Aspirin|aspirin|mesh-list
139612221|NCT02990403|Prednisone|prednisone|mesh-list
139612222|NCT02990403|Heparin|heparin|mesh-list
139612223|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
139612224|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
139612225|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139612226|NCT02990403|Antibodies|antibodies|mesh-list
139612227|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139612228|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
139612229|NCT02990403|Hormones|hormones|mesh-ancestor
139612230|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139612231|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612232|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139612233|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612234|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139612235|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139612236|NCT02990403|Analgesics|analgesics|mesh-ancestor
139612237|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
139612238|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612239|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139612240|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139612241|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139612242|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612243|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139612244|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139612245|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612246|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
139612247|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
139612248|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
139612249|NCT02990403|Progestins|progestins|mesh-ancestor
139612250|NCT00697203|Pravastatin|pravastatin|mesh-list
139612251|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
139612252|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139612253|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139612254|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
139612255|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612256|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139612257|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139612258|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612259|NCT05086848|Leucovorin|leucovorin|mesh-list
139612260|NCT05086848|Fluorouracil|fluorouracil|mesh-list
139612261|NCT05086848|Irinotecan|irinotecan|mesh-list
139612262|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
139612263|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612264|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139612265|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612266|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139612267|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
139612268|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612269|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139612270|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139612271|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612272|NCT05086848|Antidotes|antidotes|mesh-ancestor
139612273|NCT05086848|Protective Agents|protective agents|mesh-ancestor
139612274|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
139612275|NCT05086848|Vitamins|vitamins|mesh-ancestor
139612276|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
139612277|NCT00830895|Everolimus|everolimus|mesh-list
139612278|NCT00830895|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139612279|NCT00830895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139612280|NCT00830895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612281|NCT00830895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612282|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139612283|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
139612284|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612285|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612286|NCT01158417|Resveratrol|resveratrol|mesh-list
139612287|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
139612288|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612289|NCT01158417|Protective Agents|protective agents|mesh-ancestor
139612290|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612291|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612292|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139612293|NCT05086614|Thymalfasin|thymalfasin|mesh-list
139612294|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139612295|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
139612296|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612297|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
139612298|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
139612299|NCT01795131|Vitamins|vitamins|mesh-ancestor
139612300|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
139612301|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612302|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
139612303|NCT01795131|Hematinics|hematinics|mesh-ancestor
139612304|NCT03137004|Docetaxel|docetaxel|mesh-list
139612305|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612306|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
139612307|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
139612308|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
139612309|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612310|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
139612311|NCT03113994|Vitamin D|vitamin d|mesh-list
139612312|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
139612313|NCT03113994|Ubiquinone|ubiquinone|mesh-list
139612314|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
139612315|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139612316|NCT03113994|Calcium|calcium|mesh-list
139612317|NCT03113994|Vitamins|vitamins|mesh-ancestor
139612318|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
139612319|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612320|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139612321|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139612322|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139612323|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139612324|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
139612325|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612326|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139612327|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139612328|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612329|NCT03113994|Antacids|antacids|mesh-ancestor
139612330|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139612331|NCT02003742|Tamsulosin|tamsulosin|mesh-list
139612332|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139612333|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139612334|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139612335|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
139394056|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139612336|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612337|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612338|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612339|NCT02003742|Urological Agents|urological agents|mesh-ancestor
139612340|NCT03134118|Nivolumab|nivolumab|mesh-list
139612341|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139612342|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612343|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139612344|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612345|NCT05085912|Ethanol|ethanol|mesh-list
139612346|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139612347|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612348|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612349|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612350|NCT02339415|Edoxaban|edoxaban|mesh-list
139612351|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139612352|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
139612353|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139612354|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
139612355|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612356|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612357|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
139612358|NCT02998047|Lintuzumab|lintuzumab|mesh-list
139612359|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139612360|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612361|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139612362|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139612363|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139612364|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139612365|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612366|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612367|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612368|NCT03110172|Analgesics|analgesics|mesh-ancestor
139612369|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
138740606|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
139612370|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612371|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
139612372|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139612373|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
139612374|NCT01400503|Siltuximab|siltuximab|mesh-list
139612375|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612376|NCT00706719|Enclomiphene|enclomiphene|mesh-list
139612377|NCT00706719|Clomiphene|clomiphene|mesh-list
139612378|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
139612379|NCT00706719|Testosterone|testosterone|mesh-list
139612380|NCT00706719|Androgens|androgens|mesh-ancestor
139612381|NCT00706719|Hormones|hormones|mesh-ancestor
139612382|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139612383|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612384|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139612385|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
139612386|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139612387|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
139612388|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139612389|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139612390|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139612391|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
139612392|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139612393|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612394|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612395|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139612396|NCT05079672|Analgesics|analgesics|mesh-ancestor
139612397|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
139612398|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612399|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139612400|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139612401|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139612402|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
139612403|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612404|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612405|NCT04766827|Paclitaxel|paclitaxel|mesh-list
139612406|NCT04766827|Docetaxel|docetaxel|mesh-list
139612407|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139612408|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139612409|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612410|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
139612411|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
139612412|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
139612413|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612414|NCT02960568|Primaquine|primaquine|mesh-list
139612415|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
139612416|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139612417|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139612418|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612419|NCT02996409|Lidocaine|lidocaine|mesh-list
139612420|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
139612421|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
139612422|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612423|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612424|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
139612425|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612426|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139612427|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139612428|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139612429|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139612430|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612431|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139612432|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139612433|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612434|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612435|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139612436|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139612437|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612438|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
139612439|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612440|NCT01421641|Lidocaine|lidocaine|mesh-list
139612441|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
139612442|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
139612443|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612444|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612445|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
139612446|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612447|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139612448|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139612449|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139612450|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139612451|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612452|NCT05068206|Bevacizumab|bevacizumab|mesh-list
139612453|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139612454|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612455|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139612456|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139612457|NCT05068206|Growth Substances|growth substances|mesh-ancestor
139612458|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612459|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
139612460|NCT05063370|Simendan|simendan|mesh-list
139612461|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139612462|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
139612463|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139612464|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139612465|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612466|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612467|NCT05063370|Protective Agents|protective agents|mesh-ancestor
139612468|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612469|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
139612470|NCT01421017|Imiquimod|imiquimod|mesh-list
139612471|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139612472|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
139612473|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612474|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139612475|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139612476|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
139612477|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612478|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612479|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139612480|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139612481|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
139612482|NCT05089344|Clomiphene|clomiphene|mesh-list
139612483|NCT05089344|Enclomiphene|enclomiphene|mesh-list
139612484|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
139612485|NCT05089344|Hormones|hormones|mesh-list
139612486|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139612487|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612488|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139612489|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
139612490|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139612491|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
139612492|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139612493|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139612494|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139612495|NCT01400113|Asenapine|asenapine|mesh-list
139612496|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139612497|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139612498|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612499|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612500|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139612501|NCT01399723|Amoxicillin|amoxicillin|mesh-list
139612502|NCT01399723|Penicillins|penicillins|mesh-list
139612503|NCT01399723|Penicillin G|penicillin g|mesh-list
139612504|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139612505|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
139612506|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139612507|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612508|NCT04726098|Dexamethasone|dexamethasone|mesh-list
139612509|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
139612510|NCT04726098|BB 1101|bb 1101|mesh-list
138740740|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
139612511|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139612512|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
139612513|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
139612514|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612515|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612516|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139612517|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
139612518|NCT04726098|Hormones|hormones|mesh-ancestor
139612519|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139612520|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139612521|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612522|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
139612523|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612524|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612525|NCT05088720|Misoprostol|misoprostol|mesh-list
139612526|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139612527|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
139612528|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139612529|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612530|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139612531|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139612532|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
139612533|NCT01383499|Bromides|bromides|mesh-list
139612534|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
139612535|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139612536|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
139612537|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612538|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612539|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139612540|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
139612541|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
139612542|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139612543|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
139612544|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612545|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612546|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
139612547|NCT05084118|Landiolol|landiolol|mesh-list
139612548|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139612549|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139612550|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
139612551|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612552|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612553|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612554|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139612555|NCT03025009|Insulin|insulin|mesh-list
139612556|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139612557|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
139612558|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139612559|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612560|NCT03135912|Terbinafine|terbinafine|mesh-list
139612561|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
139612562|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612563|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612564|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612565|NCT01397461|Retapamulin|retapamulin|mesh-list
139612566|NCT01397461|Ozenoxacin|ozenoxacin|mesh-list
139612567|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139612568|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612569|NCT01397461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139612570|NCT01397461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612571|NCT01397461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612572|NCT01397461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612573|NCT04335084|Vitamin D|vitamin d|mesh-list
139612574|NCT04335084|Vitamins|vitamins|mesh-list
139612575|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
139612576|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
139612577|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612578|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139612579|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
139612580|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139612581|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139612582|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612583|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612584|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612585|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139612586|NCT02996019|Etrolizumab|etrolizumab|mesh-list
139612587|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139612588|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
139612589|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612590|NCT02997501|Osimertinib|osimertinib|mesh-list
139612591|NCT02997501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612592|NCT02997501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139612593|NCT02997501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612594|NCT02997501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612595|NCT02998827|Thalidomide|thalidomide|mesh-list
139612596|NCT02998827|Infliximab|infliximab|mesh-list
139612597|NCT02998827|Azathioprine|azathioprine|mesh-list
139612598|NCT02998827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139612599|NCT02998827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139612600|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
139612601|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139612602|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139612603|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139612604|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
139612605|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612606|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
139612607|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139612608|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612609|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139612610|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139612611|NCT02998827|Growth Substances|growth substances|mesh-ancestor
139612612|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
139612613|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612614|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
139612615|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612616|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139612617|NCT02995707|Thalidomide|thalidomide|mesh-list
139612618|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139612619|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
139612620|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612621|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
139612622|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139612623|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612624|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139612625|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139612626|NCT02995707|Growth Substances|growth substances|mesh-ancestor
139612627|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
139612628|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612629|NCT01270035|Adalimumab|adalimumab|mesh-list
139612630|NCT01270035|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139612631|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139612632|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139612633|NCT01396447|Cariprazine|cariprazine|mesh-list
139612634|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139612635|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139612636|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612637|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612638|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139612639|NCT00704379|Sertraline|sertraline|mesh-list
139612640|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
139612641|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139612642|NCT00704379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139612643|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139612644|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139612645|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612646|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612647|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
139612648|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612649|NCT02991495|Vaccines|vaccines|mesh-list
139612650|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
139612651|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612652|NCT04449042|Anesthetics|anesthetics|mesh-list
139612653|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612654|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612655|NCT04341090|Apatinib|apatinib|mesh-list
139612656|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612657|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139612658|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612659|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612660|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139612661|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612662|NCT04089150|Leucovorin|leucovorin|mesh-list
139612663|NCT04089150|Paclitaxel|paclitaxel|mesh-list
139612664|NCT04089150|Gemcitabine|gemcitabine|mesh-list
139612665|NCT04089150|Capecitabine|capecitabine|mesh-list
139612666|NCT04089150|Fluorouracil|fluorouracil|mesh-list
139612667|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
139612668|NCT04089150|Irinotecan|irinotecan|mesh-list
139612669|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139612670|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612671|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
139612672|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
139612673|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
139612674|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612675|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139612676|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
139612677|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139612678|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
139612679|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612680|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139612681|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139612682|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612683|NCT04089150|Antidotes|antidotes|mesh-ancestor
139612684|NCT04089150|Protective Agents|protective agents|mesh-ancestor
139612685|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
139612686|NCT04089150|Vitamins|vitamins|mesh-ancestor
139612687|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
139612688|NCT02076919|Acrizanib|acrizanib|mesh-list
139612689|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139612690|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139612691|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139612692|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612693|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612694|NCT02076997|Methotrexate|methotrexate|mesh-list
139612695|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139612696|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
139612697|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139612698|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612699|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139612700|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
139612701|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612702|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612703|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
139612704|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612705|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139612706|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139612707|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
139612708|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139612709|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139612710|NCT05365165|Sevoflurane|sevoflurane|mesh-list
139612711|NCT05365165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139612712|NCT05365165|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139612713|NCT05365165|Anesthetics, General|anesthetics, general|mesh-ancestor
139612714|NCT05365165|Anesthetics|anesthetics|mesh-ancestor
139612715|NCT05365165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612716|NCT05365165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612717|NCT03925350|Niraparib|niraparib|mesh-list
139612718|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139612719|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612720|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612721|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612722|NCT00707967|Vaccines|vaccines|mesh-list
139612723|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
139612724|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612725|NCT02994381|Ozanimod|ozanimod|mesh-list
139612726|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139612727|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612728|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139612729|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
139612730|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612731|NCT00716079|Metoprolol|metoprolol|mesh-list
139612732|NCT00716079|Clonidine|clonidine|mesh-list
139612733|NCT00716079|Labetalol|labetalol|mesh-list
139612734|NCT00716079|Hydralazine|hydralazine|mesh-list
139612735|NCT00716079|Nicardipine|nicardipine|mesh-list
139612736|NCT00716079|Phentolamine|phentolamine|mesh-list
139612737|NCT00716079|Urapidil|urapidil|mesh-list
139612738|NCT00716079|Enalaprilat|enalaprilat|mesh-list
139612739|NCT00716079|Esmolol|esmolol|mesh-list
139612740|NCT00716079|Glycerol|glycerol|mesh-list
139612741|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139612742|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139612743|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
139612744|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
139612745|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612746|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612747|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139612748|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139612749|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139612750|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
139612751|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612752|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612753|NCT00716079|Analgesics|analgesics|mesh-ancestor
139612754|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
139612755|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139612756|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139612757|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139612758|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139612759|NCT00716079|Protective Agents|protective agents|mesh-ancestor
139612760|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
139612761|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139612762|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139612763|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
139612764|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139612765|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139612766|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139612767|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139612768|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
139612769|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139612770|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
139612771|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612772|NCT01270191|Exenatide|exenatide|mesh-list
139612773|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
139612774|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139612775|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612776|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139612777|NCT01270191|Incretins|incretins|mesh-ancestor
139612778|NCT01270191|Hormones|hormones|mesh-ancestor
139612779|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139612780|NCT02999919|Bupivacaine|bupivacaine|mesh-list
139612781|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
139612782|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
138741011|NCT06055244|Analgesics|analgesics|mesh-ancestor
139612783|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612784|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612785|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
139612786|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612787|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
139612788|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139612789|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612790|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612791|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139612792|NCT04526652|Analgesics|analgesics|mesh-ancestor
139612793|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
139612794|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612795|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139612796|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139612797|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139612798|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
139612799|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612800|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612801|NCT01381549|Imipenem|imipenem|mesh-list
139612802|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
139612803|NCT01381549|Cilastatin|cilastatin|mesh-list
139612804|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139612805|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612806|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
139612807|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612808|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612809|NCT00159432|Bevacizumab|bevacizumab|mesh-list
139612810|NCT00159432|Capecitabine|capecitabine|mesh-list
139612811|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
139612812|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139612813|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612814|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139612815|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139612816|NCT00159432|Growth Substances|growth substances|mesh-ancestor
139612817|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612818|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
139612819|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139612820|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
139612821|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612822|NCT02969850|Vitamin D|vitamin d|mesh-list
139612823|NCT02969850|Calcium|calcium|mesh-list
139612824|NCT02969850|Vitamins|vitamins|mesh-ancestor
139612825|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
139612826|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612827|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139612828|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139612829|NCT02339766|Morphine|morphine|mesh-list
139612830|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139612831|NCT02339766|Narcotics|narcotics|mesh-ancestor
139612832|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612833|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612834|NCT02339766|Analgesics|analgesics|mesh-ancestor
139612835|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
139612836|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612837|NCT04287660|Clarithromycin|clarithromycin|mesh-list
139612838|NCT04287660|Dexamethasone|dexamethasone|mesh-list
139612839|NCT04287660|Lenalidomide|lenalidomide|mesh-list
139612840|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139612841|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
139612842|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
139612843|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612844|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612845|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139612846|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
139612847|NCT04287660|Hormones|hormones|mesh-ancestor
139612848|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139612849|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139612850|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612851|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
139612852|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139612853|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139612854|NCT04287660|Growth Substances|growth substances|mesh-ancestor
139612855|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
139612856|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139612857|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612858|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139612859|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612860|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612861|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139612862|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139612863|NCT01396057|Dexamethasone|dexamethasone|mesh-list
139612864|NCT01396057|Ranibizumab|ranibizumab|mesh-list
139612865|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139612866|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
139612867|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
139612868|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612869|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612870|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139612871|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
139612872|NCT01396057|Hormones|hormones|mesh-ancestor
139612873|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139612874|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139612875|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612876|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139612877|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139612878|NCT01396057|Growth Substances|growth substances|mesh-ancestor
139612879|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
139612880|NCT02419560|Venetoclax|venetoclax|mesh-list
139612881|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612882|NCT00704847|Calcitonin|calcitonin|mesh-list
139612883|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
139612884|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139612885|NCT00704847|Katacalcin|katacalcin|mesh-list
139612886|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139612887|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612888|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139612889|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
139612890|NCT03393468|Dapivirine|dapivirine|mesh-list
139612891|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139612892|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139612893|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
139612894|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612895|NCT05091606|Anesthetics|anesthetics|mesh-list
139612896|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612897|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612898|NCT01395901|Ondansetron|ondansetron|mesh-list
139612899|NCT01395901|Palonosetron|palonosetron|mesh-list
139612900|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
139612901|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
139612902|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612903|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612904|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139612905|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
139612906|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
139612907|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139612908|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139612909|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
139612910|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139612911|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612912|NCT01395823|Vitamin D|vitamin d|mesh-list
139612913|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
139612914|NCT01395823|Vitamins|vitamins|mesh-ancestor
139612915|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
139612916|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741150|NCT05983354|Analgesics|analgesics|mesh-ancestor
139612917|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139612918|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139612919|NCT02993991|Durvalumab|durvalumab|mesh-list
139612920|NCT02993991|Mocetinostat|mocetinostat|mesh-list
139612921|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139612922|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612923|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139612924|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612925|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612926|NCT00158184|Oxycodone|oxycodone|mesh-list
139612927|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139612928|NCT00158184|Narcotics|narcotics|mesh-ancestor
139612929|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612930|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612931|NCT00158184|Analgesics|analgesics|mesh-ancestor
139612932|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
139612933|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612934|NCT02405520|Vaccines|vaccines|mesh-list
139612935|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
139612936|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612937|NCT02993835|Iron|iron|mesh-list
139612938|NCT02993835|Trace Elements|trace elements|mesh-ancestor
139612939|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
139612940|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612941|NCT05091138|Buprenorphine|buprenorphine|mesh-list
139612942|NCT05091138|Bupivacaine|bupivacaine|mesh-list
139612943|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
139612944|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
139612945|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139612946|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612947|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
139612948|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612949|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139612950|NCT05091138|Narcotics|narcotics|mesh-ancestor
139612951|NCT05091138|Analgesics|analgesics|mesh-ancestor
139612952|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139612953|NCT02999295|Nivolumab|nivolumab|mesh-list
139612954|NCT02999295|Ramucirumab|ramucirumab|mesh-list
139612955|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139612956|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612957|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139612958|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612959|NCT02998905|Aspirin|aspirin|mesh-list
139612960|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139612961|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139612962|NCT02998905|Analgesics|analgesics|mesh-ancestor
139612963|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
139612964|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139612965|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612966|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139612967|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139612968|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139612969|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139612970|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139612971|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139612972|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139612973|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139612974|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
139612975|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
139612976|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139612977|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139612978|NCT02993367|Protective Agents|protective agents|mesh-ancestor
139612979|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612980|NCT05094492|Fluorides|fluorides|mesh-list
139612981|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
139612982|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
139612983|NCT05094492|Protective Agents|protective agents|mesh-ancestor
139612984|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612985|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
139612986|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139612987|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612988|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
139612989|NCT05094414|Valacyclovir|valacyclovir|mesh-list
139612990|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
139612991|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139612992|NCT04386447|Oxytocin|oxytocin|mesh-list
139612993|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
139612994|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139612995|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139612996|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
139612997|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139612998|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139612999|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139613000|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
139613001|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139613002|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139613003|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613004|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613005|NCT01380535|Methoxsalen|methoxsalen|mesh-list
139613006|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139613007|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
139613008|NCT00725361|Ambrisentan|ambrisentan|mesh-list
139613009|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139613010|NCT02816424|TEMPO|tempo|mesh-list
139613011|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
139613012|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613013|NCT02816424|Protective Agents|protective agents|mesh-ancestor
139613014|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613015|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
139613016|NCT01275885|Vitamin D|vitamin d|mesh-list
139613017|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139394739|NCT02187133|Rituximab|rituximab|mesh-list
139613018|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613019|NCT01275885|Vitamins|vitamins|mesh-ancestor
139613020|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
139613021|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139613022|NCT02794896|Fentanyl|fentanyl|mesh-list
139613023|NCT02794896|Propofol|propofol|mesh-list
139613024|NCT02794896|Sevoflurane|sevoflurane|mesh-list
139613025|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139613026|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613027|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613028|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139613029|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
139613030|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
139613031|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139613032|NCT02794896|Narcotics|narcotics|mesh-ancestor
139613033|NCT02794896|Analgesics|analgesics|mesh-ancestor
139613034|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
139613035|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613036|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139613037|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139613038|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138741311|NCT05873881|Thiamine|thiamine|mesh-list
139613039|NCT01271283|Lenalidomide|lenalidomide|mesh-list
139613040|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
139613041|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613042|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139613043|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139613044|NCT01271283|Growth Substances|growth substances|mesh-ancestor
139613045|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
139613046|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613047|NCT01271439|Cetuximab|cetuximab|mesh-list
139613048|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139613049|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613050|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
139613051|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
139613052|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
139613053|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139613054|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613055|NCT05090592|Atropine|atropine|mesh-list
139613056|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139613057|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139613058|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139613059|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
139613060|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613061|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613062|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139613063|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
139613064|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
139613065|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
139613066|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139613067|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139613068|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
139613069|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613070|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613071|NCT02992665|Calcimycin|calcimycin|mesh-list
139613072|NCT02992665|Ionophores|ionophores|mesh-list
139613073|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139613074|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613075|NCT02992665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139613076|NCT02992665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139613077|NCT02992665|Calcium Ionophores|calcium ionophores|mesh-ancestor
139613078|NCT05093478|Lidocaine|lidocaine|mesh-list
139613079|NCT05093478|Capsaicin|capsaicin|mesh-list
139613080|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
139613081|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
139613082|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613083|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613084|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
138741321|NCT05873881|Vitamins|vitamins|mesh-ancestor
139613085|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613086|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139613087|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139613088|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139613089|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139613090|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394811|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
139613091|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
139613092|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
139613093|NCT00725751|Interferons|interferons|mesh-list
139613094|NCT00725751|Ribavirin|ribavirin|mesh-list
139613095|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
139613096|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
139613097|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139613098|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613099|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
139613100|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139613101|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
139613102|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613103|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
139613104|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613105|NCT05364385|Budesonide|budesonide|mesh-list
139613106|NCT05364385|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139613107|NCT05364385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139613108|NCT05364385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139613109|NCT05364385|Autonomic Agents|autonomic agents|mesh-ancestor
139613110|NCT05364385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613111|NCT05364385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613112|NCT05364385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139613113|NCT05364385|Respiratory System Agents|respiratory system agents|mesh-ancestor
139613114|NCT05364385|Glucocorticoids|glucocorticoids|mesh-ancestor
139613115|NCT05364385|Hormones|hormones|mesh-ancestor
139613116|NCT05364385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139613117|NCT00726375|Etanercept|etanercept|mesh-list
139613118|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139613119|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139613120|NCT00726375|Analgesics|analgesics|mesh-ancestor
139613121|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
139613122|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613123|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613124|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139613125|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139613126|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139613127|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139613128|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
139613129|NCT05363059|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139613130|NCT05363059|Antihypertensive Agents|antihypertensive agents|mesh-list
139613131|NCT05363059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613132|NCT01394185|Dronabinol|dronabinol|mesh-list
139613133|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
139613134|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613135|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139613136|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139613137|NCT01394185|Analgesics|analgesics|mesh-ancestor
139613138|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
139613139|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613140|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139613141|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139613142|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613143|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613144|NCT01394185|Hormones|hormones|mesh-ancestor
139613145|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139613146|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
139613147|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139613148|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613149|NCT04361851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139613150|NCT04361851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613151|NCT04407715|Anesthetics|anesthetics|mesh-list
139613152|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613153|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613154|NCT00727857|Metformin|metformin|mesh-list
139613155|NCT00727857|Pioglitazone|pioglitazone|mesh-list
139613156|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139613157|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613158|NCT05092152|Propofol|propofol|mesh-list
139613159|NCT05092152|Esketamine|esketamine|mesh-list
139613160|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139613161|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613162|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613163|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139613164|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
139613165|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
139613166|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
139613167|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139394887|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
139613168|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
139613170|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613171|NCT05001360|Nivolumab|nivolumab|mesh-list
139613172|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139613173|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139613174|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613175|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613176|NCT05022810|Acetaminophen|acetaminophen|mesh-list
139613177|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139613178|NCT05022810|Analgesics|analgesics|mesh-ancestor
139613179|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
139613180|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613181|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613182|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
139613183|NCT01525550|Sunitinib|sunitinib|mesh-list
139613184|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613185|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139613186|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139613187|NCT01525550|Growth Substances|growth substances|mesh-ancestor
139613188|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613189|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
139613190|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139613191|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613192|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613193|NCT04730232|Paclitaxel|paclitaxel|mesh-list
139613194|NCT04730232|Tislelizumab|tislelizumab|mesh-list
139613195|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139613196|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613197|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
139613198|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
139613199|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
139613200|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613201|NCT04730232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139613202|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
139613203|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139613204|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613205|NCT04701918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139613206|NCT04701918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613207|NCT04540848|Bupivacaine|bupivacaine|mesh-list
139613208|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
139613209|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
139613210|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613211|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613212|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
139613213|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613214|NCT04793100|Aflibercept|aflibercept|mesh-list
139613215|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139613216|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139613217|NCT04793100|Growth Substances|growth substances|mesh-ancestor
138741463|NCT05613842|Copper|copper|mesh-list
139613218|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613219|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
139613220|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613221|NCT04760028|Anesthetics|anesthetics|mesh-list
139613222|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613223|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613224|NCT05366101|Valsartan|valsartan|mesh-list
139613225|NCT05366101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139613226|NCT05366101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139613227|NCT05366101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139613228|NCT05366101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139613229|NCT05366101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613230|NCT04993560|Vaccines|vaccines|mesh-list
139613231|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
139613232|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613233|NCT05365555|Anesthetics|anesthetics|mesh-list
139613234|NCT05365555|Ropivacaine|ropivacaine|mesh-list
139613235|NCT05365555|Anesthetics, Local|anesthetics, local|mesh-list
139613236|NCT05365555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613237|NCT05365555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613238|NCT05365555|Sensory System Agents|sensory system agents|mesh-ancestor
139613239|NCT05365555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613240|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
139394961|NCT03536065|Analgesics|analgesics|mesh-ancestor
139613241|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139613242|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613243|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139613244|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613246|NCT05374356|Bupivacaine|bupivacaine|mesh-list
139613247|NCT05374356|Anesthetics, Local|anesthetics, local|mesh-ancestor
139613248|NCT05374356|Anesthetics|anesthetics|mesh-ancestor
139613249|NCT05374356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613250|NCT05374356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613251|NCT05374356|Sensory System Agents|sensory system agents|mesh-ancestor
139613252|NCT05374356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613253|NCT05374356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139613254|NCT05374356|Narcotics|narcotics|mesh-ancestor
139613255|NCT05374356|Analgesics|analgesics|mesh-ancestor
139613256|NCT00717405|Bevacizumab|bevacizumab|mesh-list
139613257|NCT00717405|Trastuzumab|trastuzumab|mesh-list
138741512|NCT05518929|Anesthetics|anesthetics|mesh-ancestor
139613258|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139613259|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613260|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139613261|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139613262|NCT00717405|Growth Substances|growth substances|mesh-ancestor
139613263|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613264|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
139613265|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
139613266|NCT01276977|Eletriptan|eletriptan|mesh-list
139613267|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139613268|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139613269|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
139613270|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613271|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613272|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613273|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
139613274|NCT03832699|Progesterone|progesterone|mesh-list
139613275|NCT03832699|Progestins|progestins|mesh-ancestor
139613276|NCT03832699|Hormones|hormones|mesh-ancestor
139613277|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139613278|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613279|NCT01277289|Dexamethasone|dexamethasone|mesh-list
139613280|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139613281|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
139613282|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
139613283|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613284|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613285|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139613286|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
139613287|NCT01277289|Hormones|hormones|mesh-ancestor
139613288|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139613289|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139613290|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613291|NCT01525082|Bevacizumab|bevacizumab|mesh-list
139613292|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139613293|NCT01525082|Capecitabine|capecitabine|mesh-list
139613294|NCT01525082|Temozolomide|temozolomide|mesh-list
139613295|NCT01525082|Antibodies|antibodies|mesh-list
139613296|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
139613297|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139613298|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613299|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139613300|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139613301|NCT01525082|Growth Substances|growth substances|mesh-ancestor
139613302|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613303|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
139613304|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
139613305|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139613306|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
139613307|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613308|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139613309|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
139613310|NCT03599791|Fluticasone|fluticasone|mesh-list
139613311|NCT03599791|Xhance|xhance|mesh-list
139613312|NCT03599791|Azelastine|azelastine|mesh-list
139613313|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139613314|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139613315|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
139613316|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613317|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613318|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139613319|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
139613320|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
139613321|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139613322|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139613323|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613324|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613325|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139613326|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139613327|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
139613328|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
139613329|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613330|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139613331|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139613332|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139613333|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
139613334|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613335|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613336|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613337|NCT01488578|Urological Agents|urological agents|mesh-ancestor
139613338|NCT00720369|Ubiquinone|ubiquinone|mesh-list
139613339|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
139613340|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
139613341|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613342|NCT00720369|Vitamins|vitamins|mesh-ancestor
139613343|NCT01524770|Dulaglutide|dulaglutide|mesh-list
139613344|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139613345|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613346|NCT02991339|Dexamethasone|dexamethasone|mesh-list
139613347|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
139613348|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139613349|NCT02991339|BB 1101|bb 1101|mesh-list
139613350|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139613351|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
139613352|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
139613353|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613354|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613355|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139613356|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
139613357|NCT02991339|Hormones|hormones|mesh-ancestor
139613358|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139613359|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139613360|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613361|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
139613362|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613363|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613364|NCT06123520|Paclitaxel|paclitaxel|mesh-list
139613365|NCT06123520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139613366|NCT06123520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139613367|NCT06123520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613368|NCT06123520|Tubulin Modulators|tubulin modulators|mesh-ancestor
139613369|NCT06123520|Antimitotic Agents|antimitotic agents|mesh-ancestor
139613370|NCT06123520|Mitosis Modulators|mitosis modulators|mesh-ancestor
139613371|NCT06123520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613372|NCT06123403|Methotrexate|methotrexate|mesh-list
139613373|NCT06123403|Cystatins|cystatins|mesh-list
139613374|NCT06123403|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139613375|NCT06123403|Abortifacient Agents|abortifacient agents|mesh-ancestor
139613376|NCT06123403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139613377|NCT06123403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613378|NCT06123403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139613379|NCT06123403|Antimetabolites|antimetabolites|mesh-ancestor
139613380|NCT06123403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613381|NCT06123403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613382|NCT06123403|Dermatologic Agents|dermatologic agents|mesh-ancestor
139613383|NCT06123403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613384|NCT06123403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139613385|NCT06123403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139613386|NCT06123403|Immunologic Factors|immunologic factors|mesh-ancestor
139613387|NCT06123403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139613388|NCT06123403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139613389|NCT06123403|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139613390|NCT06123403|Protease Inhibitors|protease inhibitors|mesh-ancestor
139613391|NCT06123377|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
139613392|NCT06123377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139613394|NCT06123377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613395|NCT06123169|Tazobactam|tazobactam|mesh-list
139613396|NCT06123169|Piperacillin|piperacillin|mesh-list
139613397|NCT06123169|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139613398|NCT06123169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139613399|NCT06123169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139613400|NCT06123169|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139613401|NCT06123169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613402|NCT06123169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613403|NCT06123156|Sildenafil Citrate|sildenafil citrate|mesh-list
139613404|NCT06123156|Vasodilator Agents|vasodilator agents|mesh-ancestor
139613405|NCT06123156|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139613406|NCT06123156|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139613407|NCT06123156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613408|NCT06123156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613409|NCT06123156|Urological Agents|urological agents|mesh-ancestor
139613410|NCT06123026|Cabergoline|cabergoline|mesh-list
139613411|NCT06123026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139613412|NCT06123026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139613413|NCT06123026|Dopamine Agonists|dopamine agonists|mesh-ancestor
139613414|NCT06123026|Dopamine Agents|dopamine agents|mesh-ancestor
139613415|NCT06123026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613416|NCT06123026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613417|NCT06123026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613418|NCT06122987|Hydrocortisone|hydrocortisone|mesh-list
139613419|NCT06122987|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139613420|NCT06122987|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139613421|NCT06122987|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139613422|NCT06122987|Angiotensin II|angiotensin ii|mesh-list
139613423|NCT06122987|Giapreza|giapreza|mesh-list
139613424|NCT06122987|Angiotensinogen|angiotensinogen|mesh-list
139613425|NCT06122987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139613426|NCT06122987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139613427|NCT06122987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139613428|NCT06122987|Protease Inhibitors|protease inhibitors|mesh-ancestor
139613429|NCT06122987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613430|NCT06122987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613431|NCT06122883|Anesthetics|anesthetics|mesh-list
139613432|NCT06122883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613433|NCT06122883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613434|NCT06122701|Thiamine|thiamine|mesh-list
139613435|NCT06122701|Vitamin B Complex|vitamin b complex|mesh-ancestor
139613436|NCT06122701|Vitamins|vitamins|mesh-ancestor
139613437|NCT06122701|Micronutrients|micronutrients|mesh-ancestor
139613438|NCT06122701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613439|NCT06122545|Bupivacaine|bupivacaine|mesh-list
139613440|NCT06122545|Anesthetics, Local|anesthetics, local|mesh-ancestor
139613441|NCT06122545|Anesthetics|anesthetics|mesh-ancestor
139613442|NCT06122545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613443|NCT06122545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613444|NCT06122545|Sensory System Agents|sensory system agents|mesh-ancestor
139613445|NCT06122545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613446|NCT06122493|Paclitaxel|paclitaxel|mesh-list
139613447|NCT06122493|Carboplatin|carboplatin|mesh-list
139613448|NCT06122493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139613449|NCT06122493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613450|NCT06122493|Tubulin Modulators|tubulin modulators|mesh-ancestor
139613451|NCT06122493|Antimitotic Agents|antimitotic agents|mesh-ancestor
139613452|NCT06122493|Mitosis Modulators|mitosis modulators|mesh-ancestor
139613453|NCT06122493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613454|NCT06122454|Tenofovir|tenofovir|mesh-list
139613455|NCT06122454|Antiviral Agents|antiviral agents|mesh-ancestor
139613456|NCT06122454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139613457|NCT06122454|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139613458|NCT06122454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139613459|NCT06122454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613460|NCT06122454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613461|NCT06122454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139613462|NCT06122454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139613463|NCT06122428|Riboflavin|riboflavin|mesh-list
139613464|NCT06122428|Hyaluronic Acid|hyaluronic acid|mesh-list
139613465|NCT06122428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139613466|NCT06122428|Immunologic Factors|immunologic factors|mesh-ancestor
139613467|NCT06122428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613468|NCT06122428|Viscosupplements|viscosupplements|mesh-ancestor
139613469|NCT06122428|Protective Agents|protective agents|mesh-ancestor
139613470|NCT06122428|Vitamin B Complex|vitamin b complex|mesh-ancestor
139613471|NCT06122428|Vitamins|vitamins|mesh-ancestor
139613472|NCT06122428|Micronutrients|micronutrients|mesh-ancestor
139613473|NCT06122428|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139613474|NCT06122428|Dermatologic Agents|dermatologic agents|mesh-ancestor
139613475|NCT06122324|Lidocaine|lidocaine|mesh-list
139613476|NCT06122324|Anesthetics, Local|anesthetics, local|mesh-ancestor
139613477|NCT06122324|Anesthetics|anesthetics|mesh-ancestor
139613478|NCT06122324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613479|NCT06122324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613480|NCT06122324|Sensory System Agents|sensory system agents|mesh-ancestor
139613481|NCT06122324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613482|NCT06122324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139613483|NCT06122324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139613484|NCT06122324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139613485|NCT06122324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139613486|NCT06122324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613487|NCT06122311|Acetylcysteine|acetylcysteine|mesh-list
139613488|NCT06122311|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139613489|NCT06122311|Antiviral Agents|antiviral agents|mesh-ancestor
139613490|NCT06122311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139613491|NCT06122311|Expectorants|expectorants|mesh-ancestor
139613492|NCT06122311|Respiratory System Agents|respiratory system agents|mesh-ancestor
139613493|NCT06122311|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139613494|NCT06122311|Antioxidants|antioxidants|mesh-ancestor
139613495|NCT06122311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613496|NCT06122311|Protective Agents|protective agents|mesh-ancestor
139613497|NCT06122311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613498|NCT06122311|Antidotes|antidotes|mesh-ancestor
139613499|NCT06122090|Bimatoprost|bimatoprost|mesh-list
139613500|NCT06122090|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139613501|NCT06121830|Fexuprazan|fexuprazan|mesh-list
139613502|NCT06121830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139613503|NCT06121804|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139613504|NCT06121804|Immunologic Factors|immunologic factors|mesh-ancestor
139613505|NCT06121804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613506|NCT06121765|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139613507|NCT06121765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139613508|NCT06121765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613509|NCT06121765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613510|NCT06121726|Anesthetics|anesthetics|mesh-list
139613511|NCT06121726|Anesthetics, Local|anesthetics, local|mesh-list
139613512|NCT06121726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613513|NCT06121726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613514|NCT06121726|Sensory System Agents|sensory system agents|mesh-ancestor
139613515|NCT06121726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613516|NCT06121700|Trastuzumab|trastuzumab|mesh-list
139613517|NCT06121700|Antibodies|antibodies|mesh-list
139613518|NCT06121700|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139613519|NCT06121700|Immunologic Factors|immunologic factors|mesh-ancestor
139613520|NCT06121700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613521|NCT06121700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139613522|NCT06121700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613523|NCT06121570|Paclitaxel|paclitaxel|mesh-list
139613524|NCT06121570|Cyclophosphamide|cyclophosphamide|mesh-list
139613525|NCT06121570|Doxorubicin|doxorubicin|mesh-list
139613526|NCT06121570|Fludarabine|fludarabine|mesh-list
139613527|NCT06121570|Interleukin-2|interleukin-2|mesh-list
139613528|NCT06121570|Epirubicin|epirubicin|mesh-list
139613529|NCT06121570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139613530|NCT06121570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613531|NCT06121570|Tubulin Modulators|tubulin modulators|mesh-ancestor
139613532|NCT06121570|Antimitotic Agents|antimitotic agents|mesh-ancestor
139613533|NCT06121570|Mitosis Modulators|mitosis modulators|mesh-ancestor
139613534|NCT06121570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613535|NCT06121570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139613536|NCT06121570|Immunologic Factors|immunologic factors|mesh-ancestor
139613537|NCT06121570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613538|NCT06121570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139613539|NCT06121570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139613540|NCT06121570|Alkylating Agents|alkylating agents|mesh-ancestor
139613541|NCT06121570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139297203|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613542|NCT06121570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139613543|NCT06121570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139613544|NCT06121570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139613545|NCT06121570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613546|NCT06121570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139613547|NCT06121570|Analgesics|analgesics|mesh-ancestor
139613548|NCT06121570|Sensory System Agents|sensory system agents|mesh-ancestor
139613549|NCT06121570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613550|NCT06121557|Cyclophosphamide|cyclophosphamide|mesh-list
139613551|NCT06121557|Fludarabine|fludarabine|mesh-list
139613552|NCT06121557|Interleukin-2|interleukin-2|mesh-list
139613553|NCT06121557|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139613554|NCT06121557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139613555|NCT06121557|Immunologic Factors|immunologic factors|mesh-ancestor
139613556|NCT06121557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613557|NCT06121557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139613558|NCT06121557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139613559|NCT06121557|Alkylating Agents|alkylating agents|mesh-ancestor
139613560|NCT06121557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613561|NCT06121557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613562|NCT06121557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139613563|NCT06121557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139613564|NCT06121557|Analgesics|analgesics|mesh-ancestor
139613565|NCT06121557|Sensory System Agents|sensory system agents|mesh-ancestor
139613566|NCT06121557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613567|NCT06121557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613568|NCT06121518|Verapamil|verapamil|mesh-list
139613569|NCT06121518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139613570|NCT06121518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139613571|NCT06121518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139613572|NCT06121518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613573|NCT06121518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139613574|NCT06121518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613575|NCT06121518|Vasodilator Agents|vasodilator agents|mesh-ancestor
139613576|NCT06120803|Esomeprazole|esomeprazole|mesh-list
139613577|NCT06120803|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139613578|NCT06120803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139613579|NCT06120803|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139613580|NCT06120803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613581|NCT06120803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613582|NCT06119373|Icodextrin|icodextrin|mesh-list
139613583|NCT06119373|Dialysis Solutions|dialysis solutions|mesh-ancestor
139613584|NCT06119373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139613585|NCT06119217|Paclitaxel|paclitaxel|mesh-list
139613586|NCT06119217|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139613587|NCT06119217|Gemcitabine|gemcitabine|mesh-list
139613588|NCT06119217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139613589|NCT06119217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613590|NCT06119217|Tubulin Modulators|tubulin modulators|mesh-ancestor
139613591|NCT06119217|Antimitotic Agents|antimitotic agents|mesh-ancestor
139613592|NCT06119217|Mitosis Modulators|mitosis modulators|mesh-ancestor
139613593|NCT06119217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613594|NCT06119217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139613595|NCT06119217|Antimetabolites|antimetabolites|mesh-ancestor
139613596|NCT06119139|Carticaine|carticaine|mesh-list
139613597|NCT06119139|Anesthetics, Local|anesthetics, local|mesh-ancestor
139613598|NCT06119139|Anesthetics|anesthetics|mesh-ancestor
139613599|NCT06119139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613600|NCT06119139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613601|NCT06119139|Sensory System Agents|sensory system agents|mesh-ancestor
139613602|NCT06119139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613603|NCT06119061|Telavancin|telavancin|mesh-list
139613604|NCT06119061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139613605|NCT06119061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139613606|NCT06118762|Raltitrexed|raltitrexed|mesh-list
139613607|NCT06118762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139613608|NCT06118762|Antimetabolites|antimetabolites|mesh-ancestor
139613609|NCT06118762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613610|NCT06118762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613611|NCT06118762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139613612|NCT06118762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613613|NCT06118710|Dexamethasone|dexamethasone|mesh-list
139613614|NCT06118710|Histamine Antagonists|histamine antagonists|mesh-list
139613615|NCT06118710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139613616|NCT06118710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139613617|NCT06118710|Antiemetics|antiemetics|mesh-ancestor
139613619|NCT06118710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613620|NCT06118710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613621|NCT06118710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139613622|NCT06118710|Glucocorticoids|glucocorticoids|mesh-ancestor
139613623|NCT06118710|Hormones|hormones|mesh-ancestor
139613624|NCT06118710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139613625|NCT06118710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139613626|NCT06118710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613627|NCT06118710|Histamine Agents|histamine agents|mesh-ancestor
138741885|NCT04191421|Spartalizumab|spartalizumab|mesh-list
139613628|NCT06118710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613629|NCT06118710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613630|NCT06118684|Digoxin|digoxin|mesh-list
139613631|NCT06118684|Verapamil|verapamil|mesh-list
139613632|NCT06118684|Midazolam|midazolam|mesh-list
139613633|NCT06118684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139613634|NCT06118684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139613635|NCT06118684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613636|NCT06118684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613637|NCT06118684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139613638|NCT06118684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139613639|NCT06118684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139613640|NCT06118684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139613641|NCT06118684|Anesthetics, General|anesthetics, general|mesh-ancestor
139613642|NCT06118684|Anesthetics|anesthetics|mesh-ancestor
139613643|NCT06118684|GABA Modulators|gaba modulators|mesh-ancestor
139613644|NCT06118684|GABA Agents|gaba agents|mesh-ancestor
139613645|NCT06118684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613646|NCT06118684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613647|NCT06118684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139613648|NCT06118684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139613649|NCT06118684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613650|NCT06118684|Protective Agents|protective agents|mesh-ancestor
139613651|NCT06118684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139613652|NCT06118684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139613653|NCT06118684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139613654|NCT06118684|Vasodilator Agents|vasodilator agents|mesh-ancestor
139613655|NCT06118658|Tislelizumab|tislelizumab|mesh-list
139613656|NCT06118658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139613657|NCT06118658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613658|NCT06118645|Paclitaxel|paclitaxel|mesh-list
139613659|NCT06118645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139613660|NCT06118645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613661|NCT06118645|Tubulin Modulators|tubulin modulators|mesh-ancestor
139613662|NCT06118645|Antimitotic Agents|antimitotic agents|mesh-ancestor
139613663|NCT06118645|Mitosis Modulators|mitosis modulators|mesh-ancestor
139613664|NCT06118645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613665|NCT06118580|Ethanol|ethanol|mesh-list
139613666|NCT06118580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139613667|NCT06118580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139613668|NCT06118580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613669|NCT06118580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613670|NCT06118567|Nitrous Oxide|nitrous oxide|mesh-list
139613671|NCT06118567|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139613672|NCT06118567|Anesthetics, General|anesthetics, general|mesh-ancestor
139613673|NCT06118567|Anesthetics|anesthetics|mesh-ancestor
139613674|NCT06118567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613675|NCT06118567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613676|NCT06118567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139613677|NCT06118567|Analgesics|analgesics|mesh-ancestor
139613678|NCT06118567|Sensory System Agents|sensory system agents|mesh-ancestor
139613679|NCT06118567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613680|NCT06118515|Letermovir|letermovir|mesh-list
139613681|NCT06118515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139613682|NCT06118515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613683|NCT06118515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613684|NCT06118515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613685|NCT06118515|Antiviral Agents|antiviral agents|mesh-ancestor
139613686|NCT06118515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139613687|NCT06118398|Methylprednisolone|methylprednisolone|mesh-list
139613688|NCT06118398|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139613689|NCT06118398|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139613690|NCT06118398|Prednisolone|prednisolone|mesh-list
139613691|NCT06118398|Prednisolone acetate|prednisolone acetate|mesh-list
139395411|NCT05261971|Etodolac|etodolac|mesh-list
139613693|NCT06118398|Prednisolone phosphate|prednisolone phosphate|mesh-list
139613694|NCT06118398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139613695|NCT06118398|Antiemetics|antiemetics|mesh-ancestor
139613696|NCT06118398|Autonomic Agents|autonomic agents|mesh-ancestor
139613697|NCT06118398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613698|NCT06118398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613699|NCT06118398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139613700|NCT06118398|Glucocorticoids|glucocorticoids|mesh-ancestor
139613701|NCT06118398|Hormones|hormones|mesh-ancestor
139613702|NCT06118398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139613703|NCT06118398|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139613704|NCT06118398|Protective Agents|protective agents|mesh-ancestor
139613705|NCT06118398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139613706|NCT06118398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613707|NCT06118216|Anesthetics|anesthetics|mesh-list
139613708|NCT06118216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613709|NCT06118216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613710|NCT06118190|Lidocaine|lidocaine|mesh-list
139613711|NCT06118190|Anesthetics, Local|anesthetics, local|mesh-ancestor
139613712|NCT06118190|Anesthetics|anesthetics|mesh-ancestor
139613713|NCT06118190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613714|NCT06118190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613715|NCT06118190|Sensory System Agents|sensory system agents|mesh-ancestor
139613716|NCT06118190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613717|NCT06118190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139613718|NCT06118190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139613719|NCT06118190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139613720|NCT06118190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139613721|NCT06118190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613722|NCT06118151|Hemagglutinins|hemagglutinins|mesh-list
139613723|NCT06118151|Vaccines|vaccines|mesh-list
139613724|NCT06118151|Immunologic Factors|immunologic factors|mesh-ancestor
139613725|NCT06118151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613726|NCT06118151|Agglutinins|agglutinins|mesh-ancestor
139613727|NCT06118151|Coagulants|coagulants|mesh-ancestor
139613728|NCT06118047|Cetuximab|cetuximab|mesh-list
139613729|NCT06118047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139613730|NCT06118047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613731|NCT06118034|Colchicine|colchicine|mesh-list
139613732|NCT06118034|Gout Suppressants|gout suppressants|mesh-ancestor
139613733|NCT06118034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139613734|NCT06118034|Tubulin Modulators|tubulin modulators|mesh-ancestor
139613735|NCT06118034|Antimitotic Agents|antimitotic agents|mesh-ancestor
139613736|NCT06118034|Mitosis Modulators|mitosis modulators|mesh-ancestor
139613737|NCT06118034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613738|NCT06118034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613739|NCT06117917|Pregabalin|pregabalin|mesh-list
139613740|NCT06117917|Ketamine|ketamine|mesh-list
139613741|NCT06117917|Esketamine|esketamine|mesh-list
139613742|NCT06117917|Analgesics|analgesics|mesh-ancestor
139613743|NCT06117917|Sensory System Agents|sensory system agents|mesh-ancestor
139613744|NCT06117917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613745|NCT06117917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613746|NCT06117917|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139613747|NCT06117917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139613748|NCT06117917|Anesthetics, General|anesthetics, general|mesh-ancestor
139613749|NCT06117917|Anesthetics|anesthetics|mesh-ancestor
139613750|NCT06117917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613751|NCT06117917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139613752|NCT06117917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139613753|NCT06117917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613754|NCT06117917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613755|NCT06117917|Anticonvulsants|anticonvulsants|mesh-ancestor
139613756|NCT06117917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139613757|NCT06117917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139613758|NCT06117917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139613759|NCT06117917|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139613760|NCT06117917|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139613761|NCT06117917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139613762|NCT06117917|Antidepressive Agents|antidepressive agents|mesh-ancestor
139613763|NCT06117722|Eplerenone|eplerenone|mesh-list
139613764|NCT06117722|Torsemide|torsemide|mesh-list
139613765|NCT06117722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139613766|NCT06117722|Hormone Antagonists|hormone antagonists|mesh-ancestor
138742028|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
139613767|NCT06117722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139613768|NCT06117722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613769|NCT06117722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139613770|NCT06117722|Diuretics|diuretics|mesh-ancestor
139613771|NCT06117722|Natriuretic Agents|natriuretic agents|mesh-ancestor
139613772|NCT06117722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139613773|NCT06117722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139613774|NCT06117722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139613775|NCT06117722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613777|NCT06117644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139613778|NCT06117644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613779|NCT06117644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613780|NCT06117436|Selenium|selenium|mesh-list
139613781|NCT06117436|Cilostazol|cilostazol|mesh-list
139613782|NCT06117436|Antioxidants|antioxidants|mesh-ancestor
139613783|NCT06117436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613784|NCT06117436|Protective Agents|protective agents|mesh-ancestor
139613785|NCT06117436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613786|NCT06117436|Trace Elements|trace elements|mesh-ancestor
139613787|NCT06117436|Micronutrients|micronutrients|mesh-ancestor
139613788|NCT06117436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139613789|NCT06117436|Autonomic Agents|autonomic agents|mesh-ancestor
139613790|NCT06117436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613791|NCT06117436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139613792|NCT06117436|Respiratory System Agents|respiratory system agents|mesh-ancestor
139613793|NCT06117436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139613794|NCT06117436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139613795|NCT06117436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139613796|NCT06117436|Vasodilator Agents|vasodilator agents|mesh-ancestor
139613797|NCT06117436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139613798|NCT06117436|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139613799|NCT06117436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139613800|NCT06117436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613801|NCT06117423|Adalimumab|adalimumab|mesh-list
139613802|NCT06117423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139613803|NCT06117423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139613804|NCT06117423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139613805|NCT06117306|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139613806|NCT06117306|Hallucinogens|hallucinogens|mesh-ancestor
139613807|NCT06117306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613808|NCT06117306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139613809|NCT06117306|Serotonin Agents|serotonin agents|mesh-ancestor
139613810|NCT06117306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613811|NCT06117306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613812|NCT06117306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139613813|NCT06117306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139613814|NCT06117306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139613815|NCT06117306|Adrenergic Agents|adrenergic agents|mesh-ancestor
139613816|NCT06117280|Theophylline|theophylline|mesh-list
139613817|NCT06117280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139613818|NCT06117280|Autonomic Agents|autonomic agents|mesh-ancestor
139613819|NCT06117280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613820|NCT06117280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613821|NCT06117280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139613822|NCT06117280|Respiratory System Agents|respiratory system agents|mesh-ancestor
139613823|NCT06117280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139613824|NCT06117280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613825|NCT06117280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613826|NCT06117280|Vasodilator Agents|vasodilator agents|mesh-ancestor
139613827|NCT06117280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139613828|NCT06117280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139613829|NCT06117280|Purinergic Agents|purinergic agents|mesh-ancestor
139613830|NCT06117280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613831|NCT06117267|Titanium dioxide|titanium dioxide|mesh-list
139613832|NCT06117267|Sunscreening Agents|sunscreening agents|mesh-ancestor
139613833|NCT06117267|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139613834|NCT06117267|Protective Agents|protective agents|mesh-ancestor
139613835|NCT06117267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613836|NCT06117267|Dermatologic Agents|dermatologic agents|mesh-ancestor
139613837|NCT06117267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139613838|NCT06115473|Epinephrine|epinephrine|mesh-list
139395555|NCT05977647|Silodosin|silodosin|mesh-list
139613839|NCT06115473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139613840|NCT06115473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139613841|NCT06115473|Adrenergic Agents|adrenergic agents|mesh-ancestor
139613842|NCT06115473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613843|NCT06115473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613844|NCT06115473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613845|NCT06115473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139613846|NCT06115473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139613848|NCT06115473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613849|NCT06115473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139613850|NCT06115473|Respiratory System Agents|respiratory system agents|mesh-ancestor
139613851|NCT06115473|Mydriatics|mydriatics|mesh-ancestor
139613852|NCT06115473|Sympathomimetics|sympathomimetics|mesh-ancestor
139613853|NCT06115473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139613854|NCT06115460|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139613855|NCT06115460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139613856|NCT06115460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613857|NCT06115460|Incretins|incretins|mesh-ancestor
139613858|NCT06115460|Hormones|hormones|mesh-ancestor
139613859|NCT06115460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139613860|NCT06115460|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139613861|NCT06115460|Protease Inhibitors|protease inhibitors|mesh-ancestor
139613862|NCT06115460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613863|NCT06115460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613864|NCT06114836|Omeprazole|omeprazole|mesh-list
139613865|NCT06114836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139613866|NCT06114836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139613867|NCT06114836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139613868|NCT06114836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613869|NCT06114836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613870|NCT06113744|Vaccines|vaccines|mesh-list
139613871|NCT06113744|Immunologic Factors|immunologic factors|mesh-ancestor
139613872|NCT06113744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613873|NCT06113731|Vaccines|vaccines|mesh-list
139613874|NCT06113731|Immunologic Factors|immunologic factors|mesh-ancestor
139613875|NCT06113731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613876|NCT06102720|Colchicine|colchicine|mesh-list
139613877|NCT06102720|Clopidogrel|clopidogrel|mesh-list
139613878|NCT06102720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139613879|NCT06102720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139613880|NCT06102720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139613881|NCT06102720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139613882|NCT06102720|Purinergic Agents|purinergic agents|mesh-ancestor
139613883|NCT06102720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613884|NCT06102720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613885|NCT06102720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613886|NCT06102720|Gout Suppressants|gout suppressants|mesh-ancestor
139613887|NCT06102720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139613888|NCT06102720|Tubulin Modulators|tubulin modulators|mesh-ancestor
139613889|NCT06102720|Antimitotic Agents|antimitotic agents|mesh-ancestor
139613890|NCT06102720|Mitosis Modulators|mitosis modulators|mesh-ancestor
139613891|NCT06102720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613892|NCT06100692|Vitamin D|vitamin d|mesh-list
139613893|NCT06100692|Vitamins|vitamins|mesh-ancestor
139613894|NCT06100692|Micronutrients|micronutrients|mesh-ancestor
139613895|NCT06100692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613896|NCT06100692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139613897|NCT06098872|Trametinib|trametinib|mesh-list
139613898|NCT06098872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613899|NCT06098872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139613900|NCT06098872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139613901|NCT06098872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613902|NCT06095908|Bupivacaine|bupivacaine|mesh-list
139613903|NCT06095908|Anesthetics, Local|anesthetics, local|mesh-ancestor
139613904|NCT06095908|Anesthetics|anesthetics|mesh-ancestor
139613905|NCT06095908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613906|NCT06095908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613907|NCT06095908|Sensory System Agents|sensory system agents|mesh-ancestor
139613908|NCT06095908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613909|NCT06083857|Tepotinib|tepotinib|mesh-list
139613910|NCT06083857|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
139613911|NCT06083857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613912|NCT06083857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139613913|NCT06028347|Vaccines|vaccines|mesh-list
139613914|NCT06028347|Immunologic Factors|immunologic factors|mesh-ancestor
139613915|NCT06028347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613916|NCT06003075|Nivolumab|nivolumab|mesh-list
139613917|NCT06003075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139613918|NCT06003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613919|NCT06003075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139613920|NCT06003075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613921|NCT05999240|Pimavanserin|pimavanserin|mesh-list
139613922|NCT05999240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139613923|NCT05999240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139613924|NCT05999240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139613925|NCT05999240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139613926|NCT05999240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613927|NCT05999240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613928|NCT05999240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139613929|NCT05999240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139613930|NCT05999240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139613931|NCT05999240|Serotonin Agents|serotonin agents|mesh-ancestor
139613932|NCT05999240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613933|NCT05999240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613934|NCT05994534|Acetylcysteine|acetylcysteine|mesh-list
139613935|NCT05994534|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139613936|NCT05994534|Cysteamine|cysteamine|mesh-list
139613937|NCT05994534|Antiviral Agents|antiviral agents|mesh-ancestor
139613938|NCT05994534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139613939|NCT05994534|Expectorants|expectorants|mesh-ancestor
139613940|NCT05994534|Respiratory System Agents|respiratory system agents|mesh-ancestor
139613941|NCT05994534|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139613942|NCT05994534|Antioxidants|antioxidants|mesh-ancestor
139613943|NCT05994534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613944|NCT05994534|Protective Agents|protective agents|mesh-ancestor
139613945|NCT05994534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613946|NCT05994534|Antidotes|antidotes|mesh-ancestor
139613947|NCT05994534|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
139613948|NCT05989828|Aldesleukin|aldesleukin|mesh-list
139613949|NCT05989828|Cyclophosphamide|cyclophosphamide|mesh-list
139613950|NCT05989828|Fludarabine|fludarabine|mesh-list
139613951|NCT05989828|Interleukin-2|interleukin-2|mesh-list
139613952|NCT05989828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139613953|NCT05989828|Immunologic Factors|immunologic factors|mesh-ancestor
139613954|NCT05989828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613955|NCT05989828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139613956|NCT05989828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139613957|NCT05989828|Alkylating Agents|alkylating agents|mesh-ancestor
139613958|NCT05989828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613959|NCT05989828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613960|NCT05989828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139613961|NCT05989828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139613962|NCT05989828|Analgesics|analgesics|mesh-ancestor
139613963|NCT05989828|Sensory System Agents|sensory system agents|mesh-ancestor
139613964|NCT05989828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613965|NCT05989828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139613966|NCT05989828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139613967|NCT05989828|Antiviral Agents|antiviral agents|mesh-ancestor
139613968|NCT05989828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139613969|NCT05986942|Fentanyl|fentanyl|mesh-list
139613970|NCT05986942|Dexmedetomidine|dexmedetomidine|mesh-list
139613971|NCT05986942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139613972|NCT05986942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139613973|NCT05986942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613974|NCT05986942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139613975|NCT05986942|Analgesics|analgesics|mesh-ancestor
139613976|NCT05986942|Sensory System Agents|sensory system agents|mesh-ancestor
139613977|NCT05986942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139613978|NCT05986942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139613979|NCT05986942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139613980|NCT05986942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139613981|NCT05986942|Adrenergic Agents|adrenergic agents|mesh-ancestor
139613982|NCT05986942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139613983|NCT05986942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139613984|NCT05986942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139613985|NCT05986942|Narcotics|narcotics|mesh-ancestor
139613986|NCT05986942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139613987|NCT05986942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139613988|NCT05986942|Anesthetics, General|anesthetics, general|mesh-ancestor
139613989|NCT05986942|Anesthetics|anesthetics|mesh-ancestor
139613990|NCT05970289|Interferons|interferons|mesh-list
139613991|NCT05970289|Interferon-alpha|interferon-alpha|mesh-list
139613992|NCT05970289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139613993|NCT05970289|Antiviral Agents|antiviral agents|mesh-ancestor
139613994|NCT05970289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139613995|NCT05970289|Immunologic Factors|immunologic factors|mesh-ancestor
139613996|NCT05970289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139613997|NCT05945797|Dexamethasone|dexamethasone|mesh-list
139613998|NCT05945797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139613999|NCT05945797|Antiemetics|antiemetics|mesh-ancestor
139614000|NCT05945797|Autonomic Agents|autonomic agents|mesh-ancestor
139614001|NCT05945797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614002|NCT05945797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614003|NCT05945797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139614004|NCT05945797|Glucocorticoids|glucocorticoids|mesh-ancestor
139614005|NCT05945797|Hormones|hormones|mesh-ancestor
139614006|NCT05945797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139614007|NCT05945797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139614008|NCT05945797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614009|NCT05940285|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
139614010|NCT05940285|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139614011|NCT05940285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614012|NCT05909059|Cyclophosphamide|cyclophosphamide|mesh-list
139614013|NCT05909059|Fludarabine|fludarabine|mesh-list
139614014|NCT05909059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139614015|NCT05909059|Immunologic Factors|immunologic factors|mesh-ancestor
139614016|NCT05909059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614017|NCT05909059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139614018|NCT05909059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139614019|NCT05909059|Alkylating Agents|alkylating agents|mesh-ancestor
139614020|NCT05909059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614021|NCT05909059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614022|NCT05909059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139614023|NCT05905341|Fulvestrant|fulvestrant|mesh-list
139614024|NCT05905341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139614025|NCT05905341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614026|NCT05905341|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139614027|NCT05905341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139614028|NCT05905341|Hormone Antagonists|hormone antagonists|mesh-ancestor
139614029|NCT05905341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139614030|NCT05905341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614031|NCT05882734|Cemiplimab|cemiplimab|mesh-list
139614032|NCT05882734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614033|NCT05882734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614034|NCT05874401|Topotecan|topotecan|mesh-list
139614035|NCT05874401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139614036|NCT05874401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139614037|NCT05874401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614038|NCT05874401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614039|NCT05874401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614040|NCT05867472|Sevoflurane|sevoflurane|mesh-list
139614041|NCT05867472|Isoflurane|isoflurane|mesh-list
139614042|NCT05867472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139614043|NCT05867472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139614044|NCT05867472|Anesthetics, General|anesthetics, general|mesh-ancestor
139614045|NCT05867472|Anesthetics|anesthetics|mesh-ancestor
139614046|NCT05867472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139614047|NCT05867472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614048|NCT05863325|Docetaxel|docetaxel|mesh-list
139614049|NCT05863325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614050|NCT05863325|Tubulin Modulators|tubulin modulators|mesh-ancestor
139614051|NCT05863325|Antimitotic Agents|antimitotic agents|mesh-ancestor
139614052|NCT05863325|Mitosis Modulators|mitosis modulators|mesh-ancestor
139614053|NCT05863325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614054|NCT05848713|Heparin|heparin|mesh-list
139614055|NCT05848713|Anticoagulants|anticoagulants|mesh-ancestor
139614056|NCT05848713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139614057|NCT05848713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138742332|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
139614058|NCT05848713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614059|NCT05815199|Nicotine|nicotine|mesh-list
139614060|NCT05815199|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139614061|NCT05815199|Autonomic Agents|autonomic agents|mesh-ancestor
139614062|NCT05815199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614063|NCT05815199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614064|NCT05815199|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139614065|NCT05815199|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139614066|NCT05815199|Cholinergic Agents|cholinergic agents|mesh-ancestor
139614067|NCT05815199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614068|NCT05815199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614069|NCT05809986|Ofatumumab|ofatumumab|mesh-list
139614070|NCT05809986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614071|NCT05809921|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139614072|NCT05809921|Tenecteplase|tenecteplase|mesh-list
139614073|NCT05809921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139614074|NCT05809921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139614075|NCT05809921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614076|NCT05805826|Vaccines|vaccines|mesh-list
139614077|NCT05805826|Immunologic Factors|immunologic factors|mesh-ancestor
139614078|NCT05805826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614079|NCT05805800|Dexamethasone|dexamethasone|mesh-list
139614080|NCT05805800|Olanzapine|olanzapine|mesh-list
139614081|NCT05805800|Serotonin|serotonin|mesh-list
139614082|NCT05805800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139614083|NCT05805800|Antiemetics|antiemetics|mesh-ancestor
139614084|NCT05805800|Autonomic Agents|autonomic agents|mesh-ancestor
139614085|NCT05805800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614086|NCT05805800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614087|NCT05805800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139614088|NCT05805800|Glucocorticoids|glucocorticoids|mesh-ancestor
139614089|NCT05805800|Hormones|hormones|mesh-ancestor
139614090|NCT05805800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139614091|NCT05805800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139614092|NCT05805800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614093|NCT05805800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139614094|NCT05805800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138742379|NCT00550615|Dasatinib|dasatinib|mesh-list
139614095|NCT05805800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139614096|NCT05805800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139614097|NCT05805800|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139614098|NCT05805800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139614099|NCT05805800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139614100|NCT05805800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614101|NCT05805800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614102|NCT05805800|Serotonin Agents|serotonin agents|mesh-ancestor
139614103|NCT05805800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139614104|NCT05794503|Neostigmine|neostigmine|mesh-list
139614105|NCT05794503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139614106|NCT05794503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614107|NCT05794503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614108|NCT05794503|Cholinergic Agents|cholinergic agents|mesh-ancestor
139614109|NCT05794503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614110|NCT05794503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614111|NCT05794503|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139614112|NCT05794503|Autonomic Agents|autonomic agents|mesh-ancestor
139614113|NCT05794503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614114|NCT05763550|Pregabalin|pregabalin|mesh-list
139614115|NCT05763550|Analgesics|analgesics|mesh-ancestor
139614116|NCT05763550|Sensory System Agents|sensory system agents|mesh-ancestor
139614117|NCT05763550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614118|NCT05763550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614119|NCT05763550|Anticonvulsants|anticonvulsants|mesh-ancestor
139614120|NCT05763550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139614121|NCT05763550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139614122|NCT05763550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614123|NCT05763550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139614124|NCT05763550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139614125|NCT05763550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139614126|NCT05763550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139614127|NCT05763550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139614128|NCT05756777|Ivosidenib|ivosidenib|mesh-list
139614129|NCT05756777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614130|NCT05756777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614131|NCT05756777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614132|NCT05755204|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139614133|NCT05755204|Cabotegravir|cabotegravir|mesh-list
139614134|NCT05755204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139614135|NCT05755204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139614136|NCT05755204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614137|NCT05755204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614138|NCT05755204|Antiviral Agents|antiviral agents|mesh-ancestor
139614139|NCT05755204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139614140|NCT05755204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139614141|NCT05755204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139614142|NCT05755204|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139614143|NCT05755204|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139614144|NCT05750758|Rivaroxaban|rivaroxaban|mesh-list
139614145|NCT05750758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139614146|NCT05750758|Antithrombins|antithrombins|mesh-ancestor
139614147|NCT05750758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139614148|NCT05750758|Protease Inhibitors|protease inhibitors|mesh-ancestor
139614149|NCT05750758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614150|NCT05750758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614151|NCT05750758|Anticoagulants|anticoagulants|mesh-ancestor
139614152|NCT05747352|Insulin|insulin|mesh-list
139614153|NCT05747352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139614154|NCT05747352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614155|NCT05746819|Antipyretics|antipyretics|mesh-list
139614156|NCT05746819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614157|NCT05733507|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139614158|NCT05733507|Tenecteplase|tenecteplase|mesh-list
139614159|NCT05733507|Tirofiban|tirofiban|mesh-list
139614160|NCT05733507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139614161|NCT05733507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139614162|NCT05733507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614163|NCT05733507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139614164|NCT05728736|Lemborexant|lemborexant|mesh-list
139614165|NCT05728736|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139614166|NCT05728736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614167|NCT05728736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614168|NCT05728736|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139614169|NCT05728736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139614170|NCT05728736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139614171|NCT05728736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614172|NCT05706701|Nicotine|nicotine|mesh-list
139614173|NCT05706701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139614174|NCT05706701|Autonomic Agents|autonomic agents|mesh-ancestor
139614175|NCT05706701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614176|NCT05706701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742466|NCT01022398|Vitamin D|vitamin d|mesh-list
139614177|NCT05706701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139614178|NCT05706701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139614179|NCT05706701|Cholinergic Agents|cholinergic agents|mesh-ancestor
139614180|NCT05706701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614181|NCT05706701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614182|NCT05689424|Insulin Lispro|insulin lispro|mesh-list
139614183|NCT05689424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139614184|NCT05689424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614185|NCT05689359|Hydroxychloroquine|hydroxychloroquine|mesh-list
139614186|NCT05689359|Antimalarials|antimalarials|mesh-ancestor
139614187|NCT05689359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139614188|NCT05689359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139614189|NCT05689359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139614190|NCT05689359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614191|NCT05689359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614192|NCT05689359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139614193|NCT05689021|Prednisone|prednisone|mesh-list
139614194|NCT05689021|Cortisone|cortisone|mesh-list
139614195|NCT05689021|Abiraterone Acetate|abiraterone acetate|mesh-list
139614196|NCT05689021|Niraparib|niraparib|mesh-list
139614197|NCT05689021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139614198|NCT05689021|Glucocorticoids|glucocorticoids|mesh-ancestor
139614199|NCT05689021|Hormones|hormones|mesh-ancestor
139614200|NCT05689021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139614201|NCT05689021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614202|NCT05689021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139614203|NCT05689021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614204|NCT05689021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139614205|NCT05689021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614206|NCT05689021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614207|NCT05689021|Hormone Antagonists|hormone antagonists|mesh-ancestor
139614208|NCT05689021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139614209|NCT05689021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139614210|NCT05673629|Docetaxel|docetaxel|mesh-list
139614211|NCT05673629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614212|NCT05673629|Tubulin Modulators|tubulin modulators|mesh-ancestor
139614213|NCT05673629|Antimitotic Agents|antimitotic agents|mesh-ancestor
139614214|NCT05673629|Mitosis Modulators|mitosis modulators|mesh-ancestor
139614215|NCT05673629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614216|NCT05673590|Docetaxel|docetaxel|mesh-list
139614217|NCT05673590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614218|NCT05673590|Tubulin Modulators|tubulin modulators|mesh-ancestor
139614219|NCT05673590|Antimitotic Agents|antimitotic agents|mesh-ancestor
139614220|NCT05673590|Mitosis Modulators|mitosis modulators|mesh-ancestor
139614221|NCT05673590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614222|NCT05669924|Methylphenidate|methylphenidate|mesh-list
139614223|NCT05669924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139614224|NCT05669924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614225|NCT05669924|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139614226|NCT05669924|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139614227|NCT05669924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139614228|NCT05669924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614229|NCT05669924|Dopamine Agents|dopamine agents|mesh-ancestor
139614230|NCT05669924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614231|NCT05650736|Abrocitinib|abrocitinib|mesh-list
139614232|NCT05650736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139614233|NCT05650736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614234|NCT05650736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614235|NCT05629234|Osimertinib|osimertinib|mesh-list
139614236|NCT05629234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614237|NCT05629234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139614238|NCT05629234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614239|NCT05629234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614240|NCT05605756|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139614241|NCT05605756|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139614242|NCT05605756|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139614243|NCT05605756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614244|NCT05605756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614245|NCT05605756|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139614246|NCT05605756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139614247|NCT05605756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614248|NCT05605756|Cholinergic Agents|cholinergic agents|mesh-ancestor
139614249|NCT05605756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614250|NCT05593497|Abiraterone Acetate|abiraterone acetate|mesh-list
139614251|NCT05593497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614252|NCT05593497|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139614253|NCT05593497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614254|NCT05593497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614255|NCT05593497|Hormone Antagonists|hormone antagonists|mesh-ancestor
139614256|NCT05593497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139614257|NCT05593497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614258|NCT05593497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139614259|NCT05582083|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
139614260|NCT05582083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139614261|NCT05582083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614262|NCT05582083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614263|NCT05580523|Aspirin|aspirin|mesh-list
139614264|NCT05580523|Metformin|metformin|mesh-list
139614265|NCT05580523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139614266|NCT05580523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614267|NCT05580523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139614268|NCT05580523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139614269|NCT05580523|Analgesics|analgesics|mesh-ancestor
139614270|NCT05580523|Sensory System Agents|sensory system agents|mesh-ancestor
139614271|NCT05580523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614272|NCT05580523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139614273|NCT05580523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139614274|NCT05580523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139614275|NCT05580523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139614276|NCT05580523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614277|NCT05580523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139614278|NCT05580523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139614279|NCT05580523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614280|NCT05580523|Antipyretics|antipyretics|mesh-ancestor
139614281|NCT05571059|Ifetroban|ifetroban|mesh-list
139614282|NCT05571059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139614283|NCT05564390|Cytarabine|cytarabine|mesh-list
139614284|NCT05564390|Azacitidine|azacitidine|mesh-list
139614285|NCT05564390|Daunorubicin|daunorubicin|mesh-list
139614286|NCT05564390|Venetoclax|venetoclax|mesh-list
139614287|NCT05564390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139614288|NCT05564390|Antimetabolites|antimetabolites|mesh-ancestor
139614289|NCT05564390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614290|NCT05564390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614291|NCT05564390|Antiviral Agents|antiviral agents|mesh-ancestor
139614292|NCT05564390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139614293|NCT05564390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139614294|NCT05564390|Immunologic Factors|immunologic factors|mesh-ancestor
139614295|NCT05564390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614296|NCT05564390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614297|NCT05564390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139614298|NCT05564390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139614299|NCT05564390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139614300|NCT05558137|Mivacurium|mivacurium|mesh-list
139614301|NCT05558137|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139614302|NCT05558137|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139614303|NCT05558137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139614304|NCT05558137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614305|NCT05558137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614306|NCT05554406|Cytarabine|cytarabine|mesh-list
139614307|NCT05554406|Azacitidine|azacitidine|mesh-list
139614308|NCT05554406|Daunorubicin|daunorubicin|mesh-list
139614309|NCT05554406|Venetoclax|venetoclax|mesh-list
139614310|NCT05554406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139614311|NCT05554406|Antimetabolites|antimetabolites|mesh-ancestor
139614312|NCT05554406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614313|NCT05554406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614314|NCT05554406|Antiviral Agents|antiviral agents|mesh-ancestor
139614315|NCT05554406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139614316|NCT05554406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139614317|NCT05554406|Immunologic Factors|immunologic factors|mesh-ancestor
139614318|NCT05554406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614319|NCT05554406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614320|NCT05554406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139614321|NCT05554406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139614322|NCT05554406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139614323|NCT05554393|Cytarabine|cytarabine|mesh-list
139614324|NCT05554393|Azacitidine|azacitidine|mesh-list
139614325|NCT05554393|Daunorubicin|daunorubicin|mesh-list
139614326|NCT05554393|Venetoclax|venetoclax|mesh-list
139614327|NCT05554393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139614328|NCT05554393|Antimetabolites|antimetabolites|mesh-ancestor
139614329|NCT05554393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614330|NCT05554393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614331|NCT05554393|Antiviral Agents|antiviral agents|mesh-ancestor
139614332|NCT05554393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139614333|NCT05554393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139614334|NCT05554393|Immunologic Factors|immunologic factors|mesh-ancestor
139614335|NCT05554393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614336|NCT05554393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614337|NCT05554393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139614338|NCT05554393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139614339|NCT05554393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139614340|NCT05553743|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139614341|NCT05553743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139614342|NCT05553314|Carvedilol|carvedilol|mesh-list
139614343|NCT05553314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139614344|NCT05553314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139614345|NCT05553314|Adrenergic Agents|adrenergic agents|mesh-ancestor
139614346|NCT05553314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614347|NCT05553314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614348|NCT05553314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614349|NCT05553314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139614350|NCT05553314|Antioxidants|antioxidants|mesh-ancestor
139614351|NCT05553314|Protective Agents|protective agents|mesh-ancestor
139614352|NCT05553314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139614353|NCT05553314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139614354|NCT05553314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139614355|NCT05553314|Vasodilator Agents|vasodilator agents|mesh-ancestor
139614356|NCT05553314|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139614357|NCT05553314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139614358|NCT05544071|Sertraline|sertraline|mesh-list
139396081|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
139614359|NCT05544071|Antidepressive Agents|antidepressive agents|mesh-ancestor
139614360|NCT05544071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139614361|NCT05544071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139614362|NCT05544071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139614363|NCT05544071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139614364|NCT05544071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614365|NCT05544071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614366|NCT05544071|Serotonin Agents|serotonin agents|mesh-ancestor
139614367|NCT05544071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614368|NCT05544045|Calcium Carbonate|calcium carbonate|mesh-list
139614369|NCT05544045|Antacids|antacids|mesh-ancestor
139614370|NCT05544045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614371|NCT05544045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139614372|NCT05535166|Cyclophosphamide|cyclophosphamide|mesh-list
139614373|NCT05535166|Carboplatin|carboplatin|mesh-list
139614374|NCT05535166|Methotrexate|methotrexate|mesh-list
139614375|NCT05535166|Etoposide|etoposide|mesh-list
139614376|NCT05535166|Vincristine|vincristine|mesh-list
139614377|NCT05535166|Topotecan|topotecan|mesh-list
139614378|NCT05535166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139614379|NCT05535166|Immunologic Factors|immunologic factors|mesh-ancestor
139614380|NCT05535166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614381|NCT05535166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139614382|NCT05535166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139614383|NCT05535166|Alkylating Agents|alkylating agents|mesh-ancestor
139614384|NCT05535166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614385|NCT05535166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614386|NCT05535166|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139614387|NCT05535166|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139614388|NCT05535166|Abortifacient Agents|abortifacient agents|mesh-ancestor
139614389|NCT05535166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139614390|NCT05535166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139614391|NCT05535166|Antimetabolites|antimetabolites|mesh-ancestor
139614392|NCT05535166|Dermatologic Agents|dermatologic agents|mesh-ancestor
139614393|NCT05535166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614394|NCT05535166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139614395|NCT05535166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139614396|NCT05535166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139614397|NCT05535166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139614398|NCT05535166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139614399|NCT05535166|Tubulin Modulators|tubulin modulators|mesh-ancestor
139614400|NCT05535166|Antimitotic Agents|antimitotic agents|mesh-ancestor
139614401|NCT05535166|Mitosis Modulators|mitosis modulators|mesh-ancestor
139614402|NCT05535166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139614403|NCT05523323|Pembrolizumab|pembrolizumab|mesh-list
139614404|NCT05523323|Lenvatinib|lenvatinib|mesh-list
139614405|NCT05523323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614406|NCT05523323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614407|NCT05523323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139614408|NCT05523323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614409|NCT05523323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139614410|NCT05523323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614411|NCT05518812|Carboprost|carboprost|mesh-list
139614412|NCT05518812|Carboprost tromethamine|carboprost tromethamine|mesh-list
139614413|NCT05518812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139614414|NCT05518812|Abortifacient Agents|abortifacient agents|mesh-ancestor
139614415|NCT05518812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139614416|NCT05518812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614417|NCT05518812|Oxytocics|oxytocics|mesh-ancestor
139614418|NCT05512364|Tamoxifen|tamoxifen|mesh-list
139614419|NCT05512364|Letrozole|letrozole|mesh-list
139614420|NCT05512364|Anastrozole|anastrozole|mesh-list
139614421|NCT05512364|Exemestane|exemestane|mesh-list
139614422|NCT05512364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614423|NCT05512364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139614424|NCT05512364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139614425|NCT05512364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614426|NCT05512364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614427|NCT05512364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139614428|NCT05512364|Hormone Antagonists|hormone antagonists|mesh-ancestor
139614429|NCT05512364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138742740|NCT01259466|Nicotine|nicotine|mesh-list
139614430|NCT05512364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614431|NCT05512364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139614432|NCT05512364|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139614433|NCT05512364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139614434|NCT05512364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139614435|NCT05491720|Risperidone|risperidone|mesh-list
139614436|NCT05491720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139614437|NCT05491720|Serotonin Agents|serotonin agents|mesh-ancestor
139614438|NCT05491720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614439|NCT05491720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614440|NCT05491720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614441|NCT05491720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139614442|NCT05491720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139614443|NCT05491720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139614444|NCT05491720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139614445|NCT05491720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139614446|NCT05491720|Dopamine Agents|dopamine agents|mesh-ancestor
139614447|NCT05491226|Pembrolizumab|pembrolizumab|mesh-list
139614448|NCT05491226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614449|NCT05491226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614450|NCT05491226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139614451|NCT05491226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614452|NCT05490485|Cisplatin|cisplatin|mesh-list
139614453|NCT05490485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614454|NCT05482334|Molgramostim|molgramostim|mesh-list
138742773|NCT00624078|Antivenins|antivenins|mesh-list
139614455|NCT05482334|Sargramostim|sargramostim|mesh-list
139614456|NCT05482334|Immunologic Factors|immunologic factors|mesh-ancestor
139614457|NCT05482334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614458|NCT05482334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614459|NCT05479812|Pembrolizumab|pembrolizumab|mesh-list
139614460|NCT05479812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614461|NCT05479812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614462|NCT05479812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139614463|NCT05479812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614464|NCT05478863|Caffeine|caffeine|mesh-list
139614465|NCT05478863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139614466|NCT05478863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614467|NCT05478863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139614468|NCT05478863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614469|NCT05478863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614470|NCT05478863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139614471|NCT05478863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139614472|NCT05478863|Purinergic Agents|purinergic agents|mesh-ancestor
139614473|NCT05478863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614474|NCT05478499|Deucravacitinib|deucravacitinib|mesh-list
139614475|NCT05478499|Dermatologic Agents|dermatologic agents|mesh-ancestor
139614476|NCT05478499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139614477|NCT05478499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614478|NCT05478499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614479|NCT05466539|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139614480|NCT05466539|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139614481|NCT05466539|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139614482|NCT05466539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139614483|NCT05466539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614484|NCT05466539|Cholinergic Agents|cholinergic agents|mesh-ancestor
139614485|NCT05466539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614486|NCT05466539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614487|NCT05466539|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139614488|NCT05466539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614489|NCT05456685|Carboplatin|carboplatin|mesh-list
139614490|NCT05456685|Maytansine|maytansine|mesh-list
139614491|NCT05456685|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139614492|NCT05456685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614493|NCT05456685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139614494|NCT05456685|Tubulin Modulators|tubulin modulators|mesh-ancestor
139614495|NCT05456685|Antimitotic Agents|antimitotic agents|mesh-ancestor
139614496|NCT05456685|Mitosis Modulators|mitosis modulators|mesh-ancestor
139614497|NCT05456685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614498|NCT05456685|Immunoconjugates|immunoconjugates|mesh-ancestor
139614499|NCT05456685|Immunologic Factors|immunologic factors|mesh-ancestor
139614500|NCT05456685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614501|NCT05419193|Propranolol|propranolol|mesh-list
139614502|NCT05419193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139614503|NCT05419193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139614504|NCT05419193|Adrenergic Agents|adrenergic agents|mesh-ancestor
139614505|NCT05419193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614506|NCT05419193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614507|NCT05419193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614508|NCT05419193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139614509|NCT05419193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139614510|NCT05419193|Vasodilator Agents|vasodilator agents|mesh-ancestor
139614512|NCT05417971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614513|NCT05403307|Vaccines|vaccines|mesh-list
139614514|NCT05403307|Immunologic Factors|immunologic factors|mesh-ancestor
139614515|NCT05403307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614516|NCT05375760|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139614517|NCT05375760|Antiviral Agents|antiviral agents|mesh-ancestor
139614518|NCT05375760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139614519|NCT05372614|Trastuzumab|trastuzumab|mesh-list
139614520|NCT05372614|Camptothecin|camptothecin|mesh-list
139614521|NCT05372614|Maleic acid|maleic acid|mesh-list
139614522|NCT05372614|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139614523|NCT05372614|Immunoconjugates|immunoconjugates|mesh-list
139614524|NCT05372614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614525|NCT05372614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614526|NCT05372614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614527|NCT05372614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614528|NCT05372614|Immunologic Factors|immunologic factors|mesh-ancestor
139614529|NCT05372614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614530|NCT05372614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139614531|NCT05372614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139614532|NCT05372614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139614533|NCT05366933|Folic Acid|folic acid|mesh-list
139614534|NCT05366933|Vitamin B Complex|vitamin b complex|mesh-list
139614535|NCT05366933|Vitamins|vitamins|mesh-ancestor
139614536|NCT05366933|Micronutrients|micronutrients|mesh-ancestor
139614537|NCT05366933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614538|NCT05366933|Hematinics|hematinics|mesh-ancestor
139614539|NCT05360784|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139614540|NCT05360784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139614541|NCT05360784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139614542|NCT05360784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139614543|NCT05360784|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139614544|NCT05360784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139614545|NCT05360784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139614546|NCT05360784|Adrenergic Agents|adrenergic agents|mesh-ancestor
139614547|NCT05360784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614548|NCT05360784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614549|NCT05360784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614550|NCT05355701|Cetuximab|cetuximab|mesh-list
139614551|NCT05355701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614552|NCT05355701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614553|NCT05342974|Misoprostol|misoprostol|mesh-list
139614554|NCT05342974|Atorvastatin|atorvastatin|mesh-list
139614555|NCT05342974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139614556|NCT05342974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139614557|NCT05342974|Antimetabolites|antimetabolites|mesh-ancestor
139614558|NCT05342974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614559|NCT05342974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139614560|NCT05342974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139614561|NCT05342974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614562|NCT05342974|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139614563|NCT05342974|Abortifacient Agents|abortifacient agents|mesh-ancestor
139614564|NCT05342974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139614565|NCT05342974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614566|NCT05342974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139614567|NCT05342974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139614568|NCT05342974|Oxytocics|oxytocics|mesh-ancestor
139614569|NCT05339256|Buprenorphine|buprenorphine|mesh-list
139614570|NCT05339256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139614571|NCT05339256|Narcotics|narcotics|mesh-ancestor
139614572|NCT05339256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139614573|NCT05339256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614574|NCT05339256|Analgesics|analgesics|mesh-ancestor
139614575|NCT05339256|Sensory System Agents|sensory system agents|mesh-ancestor
139614576|NCT05339256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614577|NCT05339256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139614578|NCT05336812|Venetoclax|venetoclax|mesh-list
139614579|NCT05336812|Obinutuzumab|obinutuzumab|mesh-list
139614580|NCT05336812|Acalabrutinib|acalabrutinib|mesh-list
139614581|NCT05336812|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139614582|NCT05336812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614583|NCT05336812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614584|NCT05336812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139614585|NCT05336812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614586|NCT05336812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614588|NCT05333250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139614589|NCT05333250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614590|NCT05333250|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139614591|NCT05333250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139614592|NCT05333250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139614593|NCT05333250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614594|NCT05321706|Dapagliflozin|dapagliflozin|mesh-list
139614595|NCT05321706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139614596|NCT05321706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614597|NCT05321706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139614598|NCT05321706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614599|NCT05276973|Paclitaxel|paclitaxel|mesh-list
139614600|NCT05276973|Carboplatin|carboplatin|mesh-list
139614601|NCT05276973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139614602|NCT05276973|Ipatasertib|ipatasertib|mesh-list
139614603|NCT05276973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139614604|NCT05276973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614605|NCT05276973|Tubulin Modulators|tubulin modulators|mesh-ancestor
139614606|NCT05276973|Antimitotic Agents|antimitotic agents|mesh-ancestor
139614607|NCT05276973|Mitosis Modulators|mitosis modulators|mesh-ancestor
139614608|NCT05276973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614609|NCT05276973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139614610|NCT05276973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614611|NCT05272826|Dexamethasone|dexamethasone|mesh-list
139614612|NCT05272826|Bortezomib|bortezomib|mesh-list
139614613|NCT05272826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139614614|NCT05272826|Antiemetics|antiemetics|mesh-ancestor
139614615|NCT05272826|Autonomic Agents|autonomic agents|mesh-ancestor
139614616|NCT05272826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614617|NCT05272826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614618|NCT05272826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139614619|NCT05272826|Glucocorticoids|glucocorticoids|mesh-ancestor
139614620|NCT05272826|Hormones|hormones|mesh-ancestor
139614621|NCT05272826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139614622|NCT05272826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139614623|NCT05272826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614624|NCT05246514|Trastuzumab|trastuzumab|mesh-list
139614625|NCT05246514|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139614626|NCT05246514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614627|NCT05246514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614628|NCT05246514|Immunoconjugates|immunoconjugates|mesh-ancestor
139614629|NCT05246514|Immunologic Factors|immunologic factors|mesh-ancestor
139614630|NCT05246514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614631|NCT05232071|Empagliflozin|empagliflozin|mesh-list
139614632|NCT05232071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139614633|NCT05232071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614634|NCT05232071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139614635|NCT05232071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614636|NCT05206877|Insulin|insulin|mesh-list
139614637|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139614638|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139614639|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614640|NCT05189483|Paclitaxel|paclitaxel|mesh-list
139614641|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139614642|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139614643|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614644|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
139614645|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
139614646|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
139614647|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614648|NCT05166876|Brequinar|brequinar|mesh-list
139614649|NCT05166876|Dipyridamole|dipyridamole|mesh-list
139614650|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139614651|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614652|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614653|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139614654|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
139614655|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614656|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139614657|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
139614658|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614659|NCT05142241|Temozolomide|temozolomide|mesh-list
139614660|NCT05142241|Talazoparib|talazoparib|mesh-list
139614661|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139614662|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
139614663|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614664|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614665|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139614666|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614667|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
139614668|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
139614669|NCT05115630|Melphalan|melphalan|mesh-list
139614670|NCT05115630|Fludarabine|fludarabine|mesh-list
139614671|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
139614672|NCT05115630|Tacrolimus|tacrolimus|mesh-list
139614673|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139614674|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
139614675|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614676|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139614677|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139614678|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
139614679|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614680|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614681|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139614682|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139614683|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
139614684|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139614685|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614686|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139614687|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139614688|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
139614689|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139614690|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139614691|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139614692|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139614693|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139614694|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614695|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614696|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139614697|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139614698|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614699|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
139614700|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614701|NCT05080218|Adalimumab|adalimumab|mesh-list
139614702|NCT05080218|Golimumab|golimumab|mesh-list
139614703|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139614704|NCT05080218|Etanercept|etanercept|mesh-list
139614705|NCT05080218|Abatacept|abatacept|mesh-list
139614706|NCT05080218|Upadacitinib|upadacitinib|mesh-list
139614707|NCT05080218|Ixekizumab|ixekizumab|mesh-list
139614708|NCT05080218|Tofacitinib|tofacitinib|mesh-list
139614709|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139614710|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139614711|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139614712|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139614713|NCT05080218|Analgesics|analgesics|mesh-ancestor
139614714|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
139614715|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614716|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614717|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139614718|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139614719|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
139614720|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139614721|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614722|NCT05080218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138743014|NCT01257204|Ribavirin|ribavirin|mesh-list
139614723|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614724|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139614725|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139614726|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614727|NCT05080218|Dermatologic Agents|dermatologic agents|mesh-ancestor
139614728|NCT05042102|Donepezil|donepezil|mesh-list
139614729|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139614730|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396463|NCT01897571|Prednisolone|prednisolone|mesh-list
139614731|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614732|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
139614733|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614734|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614735|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
139614736|NCT05041101|Halichondrin B|halichondrin b|mesh-list
139614737|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
139614738|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
139614739|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
139614740|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614741|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614742|NCT05005689|Fluorides|fluorides|mesh-list
139614743|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
139614744|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614745|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
139614746|NCT05005689|Protective Agents|protective agents|mesh-ancestor
139614747|NCT04999969|Paclitaxel|paclitaxel|mesh-list
139614748|NCT04999969|Gemcitabine|gemcitabine|mesh-list
139614749|NCT04999969|Durvalumab|durvalumab|mesh-list
139614750|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139614751|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614752|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
139614753|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
139614754|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
139614755|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614756|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139614757|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
139614758|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614759|NCT04998604|Omalizumab|omalizumab|mesh-list
139614760|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139614761|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139614762|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
139614763|NCT04998344|Vaccines|vaccines|mesh-list
139614764|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
139614765|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614766|NCT04996498|Oxytocin|oxytocin|mesh-list
139614767|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
139614768|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139614769|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614770|NCT04987372|Lidocaine|lidocaine|mesh-list
139614771|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
139614772|NCT04987372|Pregabalin|pregabalin|mesh-list
139614773|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
139614774|NCT04987372|Ketamine|ketamine|mesh-list
139614775|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
139614776|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
139614777|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139614778|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614779|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
139614780|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614781|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139614782|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139614783|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139614784|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139614785|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614786|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139614787|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139614788|NCT04987372|Analgesics|analgesics|mesh-ancestor
139614789|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139614790|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139614791|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139614792|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
139614793|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614794|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139614795|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139614796|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
139614797|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139614798|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139614799|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
139614800|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139614801|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139614802|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139614803|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139614804|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139614805|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
139614806|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139614807|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
139614808|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614809|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614810|NCT04977375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139614811|NCT04977375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614812|NCT04977024|Vaccines|vaccines|mesh-list
139614813|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
139614814|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614815|NCT04957615|Nivolumab|nivolumab|mesh-list
139614816|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614817|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614818|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139614819|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614820|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
139614821|NCT04955743|Lenvatinib|lenvatinib|mesh-list
139614822|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614823|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614824|NCT04955743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139614825|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614826|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139614827|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614828|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
139614829|NCT04947254|Prednisone|prednisone|mesh-list
139614830|NCT04947254|Cortisone|cortisone|mesh-list
139614831|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
139614832|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
139614833|NCT04947254|Niraparib|niraparib|mesh-list
139614834|NCT04947254|Hormones|hormones|mesh-list
139614835|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139614836|NCT04947254|Androgens|androgens|mesh-list
139614837|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
139614838|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138743144|NCT01296698|Nicotine|nicotine|mesh-list
139614839|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
139614840|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139614841|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614842|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139614843|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614844|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139614845|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614846|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614847|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
139614848|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139614849|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139614850|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
139614851|NCT04947254|Protective Agents|protective agents|mesh-ancestor
139614852|NCT04947254|Vitamins|vitamins|mesh-ancestor
139614853|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
139614854|NCT04947254|Estrogens|estrogens|mesh-ancestor
139614855|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
139614856|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
139614857|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614858|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614859|NCT04939701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139614860|NCT04939701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614861|NCT04917055|Dexamethasone|dexamethasone|mesh-list
139614862|NCT04917055|Epinephrine|epinephrine|mesh-list
139614863|NCT04917055|Ropivacaine|ropivacaine|mesh-list
139614864|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139614865|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
139614866|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
139614867|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614868|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614869|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139614870|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
139614871|NCT04917055|Hormones|hormones|mesh-ancestor
139614872|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139614873|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139614874|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614875|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
139614876|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
139614877|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139614878|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
139614879|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139614880|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139614881|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
139614882|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614883|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614884|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139614885|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139614886|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139614887|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
139614888|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
139614889|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
139614890|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139614891|NCT04909801|Adalimumab|adalimumab|mesh-list
139614892|NCT04909801|Methotrexate|methotrexate|mesh-list
139614893|NCT04909801|Abatacept|abatacept|mesh-list
139614894|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139614895|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
139614896|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139614897|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614898|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139614899|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
139614900|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614901|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614902|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
139614903|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614904|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139614905|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139614906|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
139614907|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139614908|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139614909|NCT04909801|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139614910|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139614911|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139614912|NCT04909801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614913|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
139614914|NCT04892277|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139614915|NCT04892277|Fludarabine|fludarabine|mesh-list
139614916|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139614917|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
139614918|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614919|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139614920|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139614921|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
139614922|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614923|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614924|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139614925|NCT04877821|Paclitaxel|paclitaxel|mesh-list
139614926|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
139614927|NCT04877821|Carboplatin|carboplatin|mesh-list
139614928|NCT04877821|Epirubicin|epirubicin|mesh-list
139614929|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139614930|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614931|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
139614932|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
139614933|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
139614934|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614935|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139614936|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
139614937|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614938|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139614939|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139614940|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
139614941|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139614942|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139614943|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139614944|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139614945|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614946|NCT04877288|Cyclosporine|cyclosporine|mesh-list
139614947|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
139614948|NCT04877288|Abatacept|abatacept|mesh-list
139614949|NCT04877288|Tacrolimus|tacrolimus|mesh-list
139614950|NCT04877288|Cyclosporins|cyclosporins|mesh-list
139614951|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139614952|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
139614953|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614954|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139614955|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614956|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614957|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
139614958|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139614959|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
139614960|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139614961|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139614962|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614963|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139614964|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
139614965|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139614966|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139614967|NCT04877288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614969|NCT04858529|Trastuzumab|trastuzumab|mesh-list
139614970|NCT04858529|Pertuzumab|pertuzumab|mesh-list
139614971|NCT04858529|Taxane|taxane|mesh-list
139614972|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614973|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614974|NCT04855136|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
139614975|NCT04855136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139614976|NCT04855136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139614977|NCT04821830|Levodopa|levodopa|mesh-list
139614978|NCT04821830|Carbidopa|carbidopa|mesh-list
139614979|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139614980|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139614981|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139614982|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
139614983|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139614984|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139614985|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614986|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139614987|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139614988|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139614989|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
139614990|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
139614991|NCT04787848|Bromides|bromides|mesh-list
139614992|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
139614993|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
139614994|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139614995|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139614996|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
139614997|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139614998|NCT04787731|Lidocaine|lidocaine|mesh-list
139614999|NCT04787731|Bupivacaine|bupivacaine|mesh-list
139615000|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
139615001|NCT04787731|Anesthetics|anesthetics|mesh-list
139615002|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139615003|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615004|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
139615005|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615006|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139615007|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139615008|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139615009|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139615010|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615011|NCT04745910|Rasburicase|rasburicase|mesh-list
139615012|NCT04745910|Uric Acid|uric acid|mesh-list
139615013|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
139615014|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139615015|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
139615016|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615017|NCT04745910|Protective Agents|protective agents|mesh-ancestor
139615018|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615019|NCT04729114|Dexamethasone|dexamethasone|mesh-list
139615020|NCT04729114|Prednisone|prednisone|mesh-list
139615021|NCT04729114|Docetaxel|docetaxel|mesh-list
139615022|NCT04729114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139615023|NCT04729114|Antiemetics|antiemetics|mesh-ancestor
139615024|NCT04729114|Autonomic Agents|autonomic agents|mesh-ancestor
139615025|NCT04729114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615026|NCT04729114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615027|NCT04729114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139615028|NCT04729114|Glucocorticoids|glucocorticoids|mesh-ancestor
139615029|NCT04729114|Hormones|hormones|mesh-ancestor
139615030|NCT04729114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139615031|NCT04729114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139615032|NCT04729114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615033|NCT04729114|Tubulin Modulators|tubulin modulators|mesh-ancestor
139615034|NCT04729114|Antimitotic Agents|antimitotic agents|mesh-ancestor
139615035|NCT04729114|Mitosis Modulators|mitosis modulators|mesh-ancestor
139615036|NCT04729114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615037|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139615038|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
139615039|NCT04728087|Coagulants|coagulants|mesh-ancestor
139615040|NCT04663750|Aflibercept|aflibercept|mesh-list
139615041|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139615042|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139615043|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139615044|NCT04663750|Growth Substances|growth substances|mesh-ancestor
139615045|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615046|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
139615047|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615048|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139615049|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139615050|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615051|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139615052|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
139615053|NCT04639466|Vaccines|vaccines|mesh-list
139615054|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
139615055|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615056|NCT04634604|Bevacizumab|bevacizumab|mesh-list
139615057|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615058|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615059|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139615060|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139615061|NCT04634604|Growth Substances|growth substances|mesh-ancestor
139615062|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615063|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
139615064|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139615065|NCT04631601|Androgens|androgens|mesh-list
139615066|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
139615067|NCT04631601|Hormones|hormones|mesh-ancestor
139615068|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139615069|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615070|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615071|NCT04631601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615072|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615073|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
139615074|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
139615075|NCT04628429|Erenumab|erenumab|mesh-list
139615076|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139615077|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615078|NCT04628429|Analgesics|analgesics|mesh-ancestor
139615079|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
139615080|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615081|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615082|NCT04616560|Trastuzumab|trastuzumab|mesh-list
139615083|NCT04616560|Camptothecin|camptothecin|mesh-list
139615084|NCT04616560|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139615085|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
139615086|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615087|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615088|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
139615089|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615090|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139615091|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139615092|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139615093|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615094|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615095|NCT04603066|Ondansetron|ondansetron|mesh-list
139615096|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
139615097|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
139615098|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615099|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615100|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139615101|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
139615102|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
139615103|NCT04603066|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139615104|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139615105|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
139615106|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139615107|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615108|NCT04602026|Coal Tar|coal tar|mesh-list
139615109|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
139615110|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
139615111|NCT04576455|Fulvestrant|fulvestrant|mesh-list
139615112|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139615113|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139615114|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615115|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139615116|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139615117|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
139615118|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138743441|NCT02869165|Estrogens|estrogens|mesh-list
139615119|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615120|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139615121|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615122|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615123|NCT04553770|Trastuzumab|trastuzumab|mesh-list
139615124|NCT04553770|Anastrozole|anastrozole|mesh-list
139615125|NCT04553770|Camptothecin|camptothecin|mesh-list
139615126|NCT04553770|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139615127|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
139615128|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615129|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615130|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139615131|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139615132|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139615133|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615134|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615135|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139615136|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
139615137|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139615138|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615139|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
139615140|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139615141|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139615142|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139615143|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
139615144|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
139615145|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139615146|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139615147|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139615148|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615149|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615150|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139615151|NCT04514029|Dexamethasone|dexamethasone|mesh-list
139615152|NCT04514029|Simvastatin|simvastatin|mesh-list
139615153|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139615154|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
139615155|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
139615156|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615157|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615158|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139615159|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
139615160|NCT04514029|Hormones|hormones|mesh-ancestor
139615161|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139615162|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139615163|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615164|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139615165|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139615166|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
139615167|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615168|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139615169|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139615170|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615171|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
139615172|NCT04503616|Abatacept|abatacept|mesh-list
139615173|NCT04503616|Tacrolimus|tacrolimus|mesh-list
139615174|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139615175|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
139615176|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615177|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139615178|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139615179|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
138743495|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139615180|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615181|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615182|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139615183|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139615184|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615185|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139615186|NCT04503616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615187|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139615188|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
139615189|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615191|NCT04473820|Prilocaine|prilocaine|mesh-list
139615192|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139615193|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
139615194|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
139615195|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139615196|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615197|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
139615198|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615199|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139615200|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139615201|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139615202|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139615203|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615204|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139615205|NCT04468230|Nicotine|nicotine|mesh-list
139615206|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139615207|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
139615208|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615209|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615210|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139615211|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139615212|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
139615213|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139615214|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615215|NCT04467801|Ipatasertib|ipatasertib|mesh-list
139615216|NCT04467801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615217|NCT04467801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139615218|NCT04467801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615219|NCT04467801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615220|NCT04460937|Adavosertib|adavosertib|mesh-list
139615221|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615222|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615223|NCT04456517|Ranolazine|ranolazine|mesh-list
139615224|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139615225|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139615226|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615227|NCT04439227|Adavosertib|adavosertib|mesh-list
139615228|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615229|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615230|NCT04439136|Afatinib|afatinib|mesh-list
139615231|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615232|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139615233|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615234|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615235|NCT04416334|Acetaminophen|acetaminophen|mesh-list
139615236|NCT04416334|Colchicine|colchicine|mesh-list
139615237|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139615238|NCT04416334|Analgesics|analgesics|mesh-ancestor
139615239|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
139615240|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615241|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615242|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
139615243|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
139615244|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139615245|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
139615246|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
139615247|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
139615248|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615249|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615250|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
139615251|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
139615252|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139615253|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139297204|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139615254|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139615255|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615256|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615257|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139615258|NCT04383639|Locust bean gum|locust bean gum|mesh-list
139615259|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
139615260|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139615261|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139615262|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139615264|NCT04305691|Glycine|glycine|mesh-list
139615265|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615266|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615267|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
139615268|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615269|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
139615270|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139615271|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615272|NCT04299880|Leucovorin|leucovorin|mesh-list
139615273|NCT04299880|Paclitaxel|paclitaxel|mesh-list
139615274|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139615275|NCT04299880|Bevacizumab|bevacizumab|mesh-list
139615276|NCT04299880|Gemcitabine|gemcitabine|mesh-list
139615277|NCT04299880|Fluorouracil|fluorouracil|mesh-list
139615278|NCT04299880|Nivolumab|nivolumab|mesh-list
139615279|NCT04299880|Irinotecan|irinotecan|mesh-list
139615280|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139615281|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615282|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
139615283|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
139615284|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
139615285|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615286|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615287|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139615288|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139615289|NCT04299880|Growth Substances|growth substances|mesh-ancestor
139615290|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615291|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
139615292|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139615293|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
139615294|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139615295|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
139615296|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139615297|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139615298|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139615299|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615300|NCT04299880|Antidotes|antidotes|mesh-ancestor
139615301|NCT04299880|Protective Agents|protective agents|mesh-ancestor
139615302|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
139615303|NCT04299880|Vitamins|vitamins|mesh-ancestor
139615304|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
139615305|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
139615306|NCT04284787|Azacitidine|azacitidine|mesh-list
139615307|NCT04284787|Venetoclax|venetoclax|mesh-list
139615308|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138743612|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
139615309|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615310|NCT04284787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139615311|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615312|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139615313|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
139615314|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615315|NCT04280848|Temozolomide|temozolomide|mesh-list
139615316|NCT04280848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139615317|NCT04280848|Alkylating Agents|alkylating agents|mesh-ancestor
139615318|NCT04280848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615319|NCT04280848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615320|NCT04277442|Nivolumab|nivolumab|mesh-list
139615321|NCT04277442|Decitabine|decitabine|mesh-list
139615322|NCT04277442|Venetoclax|venetoclax|mesh-list
139615323|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615324|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615325|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139615326|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615327|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139615328|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
139397066|NCT05500742|Protective Agents|protective agents|mesh-ancestor
139615329|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615331|NCT04256421|Etoposide|etoposide|mesh-list
139615332|NCT04256421|Atezolizumab|atezolizumab|mesh-list
139615333|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615334|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139615335|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139615336|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139615337|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615338|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615339|NCT04256421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139615340|NCT04256421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615341|NCT04252742|Erenumab|erenumab|mesh-list
139615342|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139615343|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615344|NCT04252742|Analgesics|analgesics|mesh-ancestor
139615345|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
139615346|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615347|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615348|NCT04237623|Sargramostim|sargramostim|mesh-list
139615349|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
139615350|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615351|NCT04204902|Tepotinib|tepotinib|mesh-list
139615352|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615353|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
139615354|NCT04198428|Narcotics|narcotics|mesh-ancestor
139615355|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139615356|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615357|NCT04198428|Analgesics|analgesics|mesh-ancestor
139615358|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
139615359|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615360|NCT04197713|Olaparib|olaparib|mesh-list
139615361|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139615362|NCT04197713|Adavosertib|adavosertib|mesh-list
139615363|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615364|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615365|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615366|NCT04191616|Dexamethasone|dexamethasone|mesh-list
139615367|NCT04191616|Pomalidomide|pomalidomide|mesh-list
139615368|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139615369|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
139615370|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
139615371|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615372|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615373|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139615374|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
139615375|NCT04191616|Hormones|hormones|mesh-ancestor
139615376|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139615377|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139615378|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615379|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
139615380|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139615381|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139615382|NCT04191616|Growth Substances|growth substances|mesh-ancestor
139615383|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
139615384|NCT04191187|Fludarabine|fludarabine|mesh-list
139615385|NCT04191187|Melphalan|melphalan|mesh-list
139615386|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615387|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615388|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139615389|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
139615390|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615391|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139615392|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
139615393|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139615394|NCT04176705|Triamcinolone|triamcinolone|mesh-list
139615395|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139615396|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139615397|NCT04176705|Lidocaine|lidocaine|mesh-list
139615398|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139615399|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
139615400|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
139615401|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139615402|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615403|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
139397142|NCT02209909|Analgesics|analgesics|mesh-ancestor
139615404|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615405|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139615406|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139615407|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139615408|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139615409|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615410|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139615411|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
139615412|NCT04176705|Hormones|hormones|mesh-ancestor
139615413|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139615414|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139615415|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
139615416|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615417|NCT04166383|Nivolumab|nivolumab|mesh-list
139615418|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615419|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615420|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139615421|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615422|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139615423|NCT04163458|Menotropins|menotropins|mesh-list
139615424|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139615425|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
139615426|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139615427|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615428|NCT04130464|Ketorolac|ketorolac|mesh-list
139615429|NCT04130464|Ropivacaine|ropivacaine|mesh-list
139615430|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
139615431|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
139615432|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139615433|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615434|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
139615435|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615436|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139615437|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139615438|NCT04130464|Analgesics|analgesics|mesh-ancestor
139615439|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139615440|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139615441|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139615442|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615443|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615444|NCT04126200|Dexamethasone|dexamethasone|mesh-list
139615445|NCT04126200|Lenalidomide|lenalidomide|mesh-list
139615446|NCT04126200|Pomalidomide|pomalidomide|mesh-list
139615447|NCT04126200|Dostarlimab|dostarlimab|mesh-list
139615448|NCT04126200|Nirogacestat|nirogacestat|mesh-list
139615449|NCT04126200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139615450|NCT04126200|Antiemetics|antiemetics|mesh-ancestor
139615451|NCT04126200|Autonomic Agents|autonomic agents|mesh-ancestor
139615452|NCT04126200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615453|NCT04126200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615454|NCT04126200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139615455|NCT04126200|Glucocorticoids|glucocorticoids|mesh-ancestor
139615456|NCT04126200|Hormones|hormones|mesh-ancestor
139615457|NCT04126200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139615458|NCT04126200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139615459|NCT04126200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615460|NCT04126200|Immunologic Factors|immunologic factors|mesh-ancestor
139615461|NCT04126200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139615462|NCT04126200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139615463|NCT04126200|Growth Substances|growth substances|mesh-ancestor
139615464|NCT04126200|Growth Inhibitors|growth inhibitors|mesh-ancestor
139615465|NCT04126200|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139615466|NCT04126200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615467|NCT04126200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615468|NCT04108858|Trastuzumab|trastuzumab|mesh-list
139615469|NCT04108858|Pertuzumab|pertuzumab|mesh-list
139615470|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139615471|NCT04108858|Antibodies|antibodies|mesh-list
139615472|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
139615473|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139615474|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
139615475|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615476|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615477|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397239|NCT02220829|Silodosin|silodosin|mesh-list
139615478|NCT04098237|Pancrelipase|pancrelipase|mesh-list
139615479|NCT04098237|Pancreatin|pancreatin|mesh-list
139615480|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139615481|NCT04084860|Ketamine|ketamine|mesh-list
139615482|NCT04084860|Analgesics|analgesics|mesh-ancestor
139615483|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
139615484|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615485|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615486|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139615487|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139615488|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
139615489|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
139615490|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139615491|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139615492|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139615493|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139615494|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615495|NCT04075526|Vancomycin|vancomycin|mesh-list
139615496|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
139615497|NCT04075526|Povidone|povidone|mesh-list
139615498|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139615499|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139615500|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
139615501|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
139615502|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139615503|NCT04060628|Docetaxel|docetaxel|mesh-list
139615504|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615505|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
139615506|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
139615507|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
138743837|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
139615508|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615509|NCT04037605|Ketoconazole|ketoconazole|mesh-list
139615510|NCT04037605|Dexamethasone|dexamethasone|mesh-list
139615511|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
139615512|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
139615513|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139615514|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139615515|NCT04037605|Hormones|hormones|mesh-list
139615516|NCT04037605|Cosyntropin|cosyntropin|mesh-list
139615517|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139615518|NCT04037605|BB 1101|bb 1101|mesh-list
139615519|NCT04037605|Ganirelix|ganirelix|mesh-list
139615520|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139615521|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
139615522|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
139615523|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615524|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615525|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139615526|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
139615527|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139615528|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139615529|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615530|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
139615531|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615532|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615533|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
139615534|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139615535|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139615536|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139615537|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139615538|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
139615539|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139615540|NCT04018937|Fludarabine|fludarabine|mesh-list
139615541|NCT04018937|Melphalan|melphalan|mesh-list
139615542|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
139615543|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615544|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615545|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139615546|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
139615547|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615548|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139615549|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
139615550|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139615551|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615552|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139615553|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139615554|NCT04016389|Paclitaxel|paclitaxel|mesh-list
139615555|NCT04016389|Carboplatin|carboplatin|mesh-list
139615556|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139615557|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615558|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
139615559|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
139615560|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
139615561|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615562|NCT04009681|Antibodies|antibodies|mesh-list
139615563|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
139615564|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615565|NCT04009668|Adalimumab|adalimumab|mesh-list
139615566|NCT04009668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139615567|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139615568|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139615569|NCT03943667|Paclitaxel|paclitaxel|mesh-list
139615570|NCT03943667|Gemcitabine|gemcitabine|mesh-list
139615571|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139615572|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615573|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
139615574|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
139615575|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
139615576|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615577|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139615578|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
139615579|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139615580|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
139615581|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615582|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
139615583|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139615584|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139615585|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615586|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
139615587|NCT03923959|Coagulants|coagulants|mesh-ancestor
139615588|NCT03923374|Buprenorphine|buprenorphine|mesh-list
139615589|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139615590|NCT03923374|Narcotics|narcotics|mesh-ancestor
139615591|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139615592|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615593|NCT03923374|Analgesics|analgesics|mesh-ancestor
139615594|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
139615595|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615596|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139615597|NCT03923270|Durvalumab|durvalumab|mesh-list
139615598|NCT03923270|Olaparib|olaparib|mesh-list
139615599|NCT03923270|Tremelimumab|tremelimumab|mesh-list
139615600|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139615601|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615602|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615603|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139615604|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615605|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615606|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
139615607|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615608|NCT03911466|Buprenorphine|buprenorphine|mesh-list
139615609|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139615610|NCT03911466|Narcotics|narcotics|mesh-ancestor
139615611|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139615612|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615613|NCT03911466|Analgesics|analgesics|mesh-ancestor
139615614|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
139615615|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615616|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139615617|NCT03910244|Pomalidomide|pomalidomide|mesh-list
139615618|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
139615619|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615620|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139615621|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139615622|NCT03910244|Growth Substances|growth substances|mesh-ancestor
139615623|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
139615624|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615625|NCT03907475|Paclitaxel|paclitaxel|mesh-list
139615626|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139397368|NCT05503706|Selenium|selenium|mesh-list
139615627|NCT03907475|Carboplatin|carboplatin|mesh-list
139615628|NCT03907475|Gemcitabine|gemcitabine|mesh-list
139615629|NCT03907475|Doxorubicin|doxorubicin|mesh-list
139615630|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139615632|NCT03907475|Durvalumab|durvalumab|mesh-list
139615633|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
139615634|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139615635|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
139615636|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139615637|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615638|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
139615639|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
139615640|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
139615641|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615642|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139615643|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
139615644|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139615645|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139615646|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139615647|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615648|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615649|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
139615650|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615651|NCT03904550|Rocuronium|rocuronium|mesh-list
139615652|NCT03904550|Cisatracurium|cisatracurium|mesh-list
139615653|NCT03904550|Neostigmine|neostigmine|mesh-list
139615654|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139615655|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139615656|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139615657|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615658|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615659|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139615660|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615661|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615662|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
139615663|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139615664|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139615665|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
139615666|NCT03895099|Desogestrel|desogestrel|mesh-list
139615667|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139615668|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139615669|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139615670|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
139615671|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139615672|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615673|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139615674|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139615675|NCT03895099|Progestins|progestins|mesh-ancestor
139615676|NCT03895099|Hormones|hormones|mesh-ancestor
139615677|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139615678|NCT03845166|Atezolizumab|atezolizumab|mesh-list
139615679|NCT03845166|Avelumab|avelumab|mesh-list
139615680|NCT03845166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139615681|NCT03845166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615682|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615683|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615684|NCT03834519|Prednisone|prednisone|mesh-list
139615685|NCT03834519|Prednisolone|prednisolone|mesh-list
139615686|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
139615687|NCT03834519|Olaparib|olaparib|mesh-list
139615688|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
139615689|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615690|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615691|NCT03834519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139615692|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615693|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139615694|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
139615695|NCT03834519|Hormones|hormones|mesh-ancestor
139615696|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139615697|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615698|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139615699|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139615700|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615701|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139615702|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
139615703|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139615704|NCT03808610|Cytarabine|cytarabine|mesh-list
139615705|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
139615706|NCT03808610|Dexamethasone|dexamethasone|mesh-list
139615707|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
139615708|NCT03808610|Prednisone|prednisone|mesh-list
139615709|NCT03808610|Cortisone|cortisone|mesh-list
139615710|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
139615711|NCT03808610|Rituximab|rituximab|mesh-list
139615712|NCT03808610|Methotrexate|methotrexate|mesh-list
139615713|NCT03808610|Vincristine|vincristine|mesh-list
139615714|NCT03808610|Venetoclax|venetoclax|mesh-list
139615715|NCT03808610|Asparaginase|asparaginase|mesh-list
139615716|NCT03808610|Pegaspargase|pegaspargase|mesh-list
139615717|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139615718|NCT03808610|Antibodies|antibodies|mesh-list
139615719|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
139615720|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139615721|NCT03808610|BB 1101|bb 1101|mesh-list
139615722|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139615723|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
139615724|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615725|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139615726|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139615727|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
139615728|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615729|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615730|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139615731|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139615732|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
139615733|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
139615734|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615735|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139615736|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
139615737|NCT03808610|Hormones|hormones|mesh-ancestor
139615738|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139615739|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139615740|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
139615741|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615742|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139615743|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
139615744|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139615745|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139615746|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
139615747|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
139615748|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139615749|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139615750|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
139615751|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139615752|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139615753|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
139615754|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
139615755|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
139615756|NCT03798678|Dexamethasone|dexamethasone|mesh-list
139615757|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
139615758|NCT03798678|Ichthammol|ichthammol|mesh-list
139615759|NCT03798678|BB 1101|bb 1101|mesh-list
139615760|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139615761|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
139615762|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
139615763|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615764|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615765|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139615766|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
139615767|NCT03798678|Hormones|hormones|mesh-ancestor
139615768|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139615769|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139615770|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615771|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
139615772|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615773|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615774|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
139615775|NCT03792516|Artesunate|artesunate|mesh-list
139615776|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
139615777|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139615778|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139397518|NCT02231203|Vitamins|vitamins|mesh-ancestor
139615779|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139615780|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615781|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
139615782|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
139615783|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139615784|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
139615785|NCT03783442|Paclitaxel|paclitaxel|mesh-list
139615786|NCT03783442|Capecitabine|capecitabine|mesh-list
139615787|NCT03783442|Fluorouracil|fluorouracil|mesh-list
139615788|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
139615789|NCT03783442|Tislelizumab|tislelizumab|mesh-list
139615790|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139615791|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615792|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
139615793|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
138744156|NCT00977665|Rasagiline|rasagiline|mesh-list
139615794|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
139615795|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615796|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139615797|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
139615798|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139615799|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
139615800|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615801|NCT03783442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615802|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
139615803|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139615804|NCT03772925|Belinostat|belinostat|mesh-list
139615805|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139615806|NCT03772925|Pevonedistat|pevonedistat|mesh-list
139615807|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615808|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615809|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139615810|NCT03756311|Paclitaxel|paclitaxel|mesh-list
139615811|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139615812|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139615813|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615814|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
139615815|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
139615816|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
139615817|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615818|NCT03745950|Olaparib|olaparib|mesh-list
139615819|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139615820|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615821|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615822|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615823|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
139615824|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615825|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139615826|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615827|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615828|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
139615829|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615830|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615831|NCT03728972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139615832|NCT03728972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615833|NCT03722680|Riluzole|riluzole|mesh-list
139615834|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
139615835|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139615836|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139615837|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139615838|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615839|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615840|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139615841|NCT03722680|Protective Agents|protective agents|mesh-ancestor
139615842|NCT03693300|Durvalumab|durvalumab|mesh-list
139615843|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139615844|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615845|NCT03632720|Vaccines|vaccines|mesh-list
139615846|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
139615847|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615848|NCT03624062|Insulin|insulin|mesh-list
139615849|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139615850|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615851|NCT03587311|Paclitaxel|paclitaxel|mesh-list
139615852|NCT03587311|Maytansine|maytansine|mesh-list
139615853|NCT03587311|Bevacizumab|bevacizumab|mesh-list
139615854|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139615855|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139615856|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
139615857|NCT03587311|Antibodies|antibodies|mesh-list
139615858|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
139615859|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139615860|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
139615861|NCT03587311|Anetumab ravtansine|anetumab ravtansine|mesh-list
139615862|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139615863|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615864|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
139615865|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
139615866|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
139615867|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615868|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139615869|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139615870|NCT03587311|Growth Substances|growth substances|mesh-ancestor
138744218|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
139615871|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615872|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
139615873|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
139615874|NCT03587311|Immunoconjugates|immunoconjugates|mesh-ancestor
139615875|NCT03579316|Olaparib|olaparib|mesh-list
139615876|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139615877|NCT03579316|Adavosertib|adavosertib|mesh-list
139615878|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615879|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615880|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615881|NCT03539302|Flecainide|flecainide|mesh-list
139615882|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139615883|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139615884|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139615885|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139615886|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615887|NCT03513562|Venetoclax|venetoclax|mesh-list
139615888|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615889|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139615890|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139615891|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615892|NCT03490344|Lenalidomide|lenalidomide|mesh-list
139615893|NCT03490344|Daratumumab|daratumumab|mesh-list
139615894|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
139615895|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615896|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139615897|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139615898|NCT03490344|Growth Substances|growth substances|mesh-ancestor
139615899|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
139615900|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615901|NCT03489018|Vaccines|vaccines|mesh-list
139615902|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139615903|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
139615904|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615905|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
139615906|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139615907|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
139615908|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139615909|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
139615910|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615911|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615912|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
139615913|NCT03450018|Gemcitabine|gemcitabine|mesh-list
139615914|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139615915|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
139615916|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615917|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615918|NCT03435718|Albendazole|albendazole|mesh-list
139615919|NCT03435718|Oxfendazole|oxfendazole|mesh-list
139615920|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
139615921|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139615922|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139615923|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
139615924|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139615925|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139615926|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
139615927|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
139615928|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
139615929|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615930|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615931|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
139615932|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
139615933|NCT03338621|Rifampin|rifampin|mesh-list
139615934|NCT03338621|Isoniazid|isoniazid|mesh-list
139615935|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
139615936|NCT03338621|Ethambutol|ethambutol|mesh-list
139615937|NCT03338621|Bedaquiline|bedaquiline|mesh-list
139615938|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139615939|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139615940|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139615941|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139615942|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615943|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615944|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615945|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139615946|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
139615947|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
139615948|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139615949|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139615950|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139615951|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139615952|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139615953|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139615954|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139615955|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139615956|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139080497|NCT00003656|Tretinoin|tretinoin|mesh-list
139615957|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
139615958|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139615959|NCT03323034|Irinotecan|irinotecan|mesh-list
139615960|NCT03323034|Temozolomide|temozolomide|mesh-list
139615961|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139615962|NCT03323034|Pevonedistat|pevonedistat|mesh-list
139615963|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139615964|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139615965|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615966|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139615967|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139615968|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
139615969|NCT03315910|Nicotine|nicotine|mesh-list
139615970|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139615971|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
139615972|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139615973|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615974|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139615975|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139615976|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
139615977|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139615978|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615979|NCT03307252|Metformin|metformin|mesh-list
139615980|NCT03307252|Rifampin|rifampin|mesh-list
139615981|NCT03307252|Probenecid|probenecid|mesh-list
139615982|NCT03307252|Digoxin|digoxin|mesh-list
139615983|NCT03307252|Verapamil|verapamil|mesh-list
139615984|NCT03307252|Furosemide|furosemide|mesh-list
139615985|NCT03307252|Cimetidine|cimetidine|mesh-list
139615986|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139615987|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139615988|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139615989|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139615990|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139615991|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
139615992|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139615993|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139615994|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139615995|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139615996|NCT03307252|Diuretics|diuretics|mesh-ancestor
139615997|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
139615998|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139615999|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139616000|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139616001|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
139616002|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139616003|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744371|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616004|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
139616005|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139616006|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139616007|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139616008|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139616009|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139616010|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139616011|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139616012|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139616013|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139616014|NCT03307252|Protective Agents|protective agents|mesh-ancestor
139616015|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139616016|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139616017|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
139616018|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
139616019|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
139616020|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139616021|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139616022|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139616023|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139616024|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
139616025|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
139616026|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139616027|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139616028|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139616029|NCT03284385|Adavosertib|adavosertib|mesh-list
139616030|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616031|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616032|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
139616033|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
139616034|NCT03247088|Busulfan|busulfan|mesh-list
139616035|NCT03247088|Fludarabine|fludarabine|mesh-list
139616036|NCT03247088|Sorafenib|sorafenib|mesh-list
139616037|NCT03247088|Tacrolimus|tacrolimus|mesh-list
139616038|NCT03247088|Lenograstim|lenograstim|mesh-list
139616039|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139616040|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
139616041|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616042|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139616043|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139616044|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
139616045|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616046|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616047|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139616048|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139616049|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139616050|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616051|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139616052|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139616053|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
139616054|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139616055|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139616056|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139616057|NCT03233139|Paclitaxel|paclitaxel|mesh-list
139616058|NCT03233139|Gemcitabine|gemcitabine|mesh-list
139616059|NCT03233139|Pemetrexed|pemetrexed|mesh-list
139616060|NCT03233139|Ipilimumab|ipilimumab|mesh-list
139616061|NCT03233139|Cemiplimab|cemiplimab|mesh-list
139616062|NCT03233139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139616063|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616064|NCT03233139|Tubulin Modulators|tubulin modulators|mesh-ancestor
139616065|NCT03233139|Antimitotic Agents|antimitotic agents|mesh-ancestor
139616066|NCT03233139|Mitosis Modulators|mitosis modulators|mesh-ancestor
139616067|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616068|NCT03233139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139616069|NCT03233139|Antimetabolites|antimetabolites|mesh-ancestor
139616070|NCT03233139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616071|NCT03233139|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139616072|NCT03233139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139616073|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616074|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616075|NCT03213002|Capecitabine|capecitabine|mesh-list
139616076|NCT03213002|Temozolomide|temozolomide|mesh-list
139616077|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139616078|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
139616079|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616080|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616081|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139616082|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
139616083|NCT03206047|Poly I-C|poly i-c|mesh-list
139616084|NCT03206047|Atezolizumab|atezolizumab|mesh-list
139616085|NCT03206047|Guadecitabine|guadecitabine|mesh-list
139616086|NCT03206047|Azacitidine|azacitidine|mesh-list
139616087|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139616088|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139616089|NCT03206047|Poly ICLC|poly iclc|mesh-list
139616090|NCT03206047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616091|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616092|NCT03206047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616093|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616094|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
139616095|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616096|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
139616097|NCT03206047|Laxatives|laxatives|mesh-ancestor
139616098|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139616099|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
139616100|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139616101|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139616102|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
139616103|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616104|NCT03191786|Gemcitabine|gemcitabine|mesh-list
139616105|NCT03191786|Atezolizumab|atezolizumab|mesh-list
139616106|NCT03191786|Vinorelbine|vinorelbine|mesh-list
139616107|NCT03191786|Antibodies|antibodies|mesh-list
139616108|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139616109|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
139616110|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616111|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139616112|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
139616113|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616114|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616115|NCT03191786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616116|NCT03191786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616117|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139616118|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
139616119|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
139616120|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
139616121|NCT03174938|Flutemetamol|flutemetamol|mesh-list
139616122|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139616123|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616124|NCT03170518|Canagliflozin|canagliflozin|mesh-list
139616125|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139616126|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616127|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139616128|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616129|NCT03153462|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139616130|NCT03153462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616131|NCT03153462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616132|NCT03138733|Daptomycin|daptomycin|mesh-list
139616133|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
139616134|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
139616135|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139616136|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139616137|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
139616138|NCT03121001|Sirolimus|sirolimus|mesh-list
139616139|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
139616140|NCT03121001|Fludarabine|fludarabine|mesh-list
139616141|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
139616142|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139616143|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
139616144|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616145|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139616146|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139616147|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
139616148|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616149|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616150|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139616151|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139616152|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139616153|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
139616154|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139616155|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139616156|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616157|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
139616158|NCT03077685|Paclitaxel|paclitaxel|mesh-list
139616159|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139616160|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397888|NCT02396979|Methadone|methadone|mesh-list
139616161|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
139616162|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
139616163|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
139616164|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616165|NCT03038672|Nivolumab|nivolumab|mesh-list
138744489|NCT04288219|Nifedipine|nifedipine|mesh-list
139616166|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
139616167|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
139616168|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139616169|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616170|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616171|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616172|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616173|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
139616174|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616175|NCT03026062|Durvalumab|durvalumab|mesh-list
139616176|NCT03026062|Ipilimumab|ipilimumab|mesh-list
139616177|NCT03026062|Tremelimumab|tremelimumab|mesh-list
139616178|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
139616179|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139616180|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
139616181|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616182|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616183|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
139616184|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616185|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616186|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616187|NCT03020030|Leucovorin|leucovorin|mesh-list
139616188|NCT03020030|Cytarabine|cytarabine|mesh-list
139616189|NCT03020030|Dexamethasone|dexamethasone|mesh-list
139616190|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
139616191|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
139616192|NCT03020030|Doxorubicin|doxorubicin|mesh-list
139616193|NCT03020030|Methotrexate|methotrexate|mesh-list
139616194|NCT03020030|Etoposide|etoposide|mesh-list
139616195|NCT03020030|Vincristine|vincristine|mesh-list
139616196|NCT03020030|Asparaginase|asparaginase|mesh-list
139616197|NCT03020030|Dasatinib|dasatinib|mesh-list
139616198|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
139616199|NCT03020030|Pegaspargase|pegaspargase|mesh-list
139616200|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
139616201|NCT03020030|Razoxane|razoxane|mesh-list
139616202|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
139616203|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139616204|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
139616205|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616206|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139616207|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139616208|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
139616209|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616210|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616211|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139616212|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139616213|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
139616214|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
139616215|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139616216|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139616217|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
139616218|NCT03020030|Hormones|hormones|mesh-ancestor
139616219|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139616220|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139616221|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139616222|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139616223|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139616224|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616225|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139616226|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
139616227|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139616228|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139616229|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
139616230|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
139616231|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139616232|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139616233|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139616234|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
139616235|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139616236|NCT03020030|Antidotes|antidotes|mesh-ancestor
139616237|NCT03020030|Protective Agents|protective agents|mesh-ancestor
139616238|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
139616239|NCT03020030|Vitamins|vitamins|mesh-ancestor
139616240|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
139616241|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
139616242|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
139616243|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
139616244|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139616245|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139616246|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139616248|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139616249|NCT03008278|Ramucirumab|ramucirumab|mesh-list
139616250|NCT03008278|Antibodies|antibodies|mesh-list
139616251|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
139616252|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139616253|NCT03008278|Lexatumumab|lexatumumab|mesh-list
139616254|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
139616255|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616256|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616257|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616258|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616259|NCT02989636|Nivolumab|nivolumab|mesh-list
139616260|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616261|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616262|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616263|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616264|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
139616265|NCT02955290|Nivolumab|nivolumab|mesh-list
139616266|NCT02955290|Vaccines|vaccines|mesh-list
139616267|NCT02955290|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139616268|NCT02955290|Mitogens|mitogens|mesh-list
139616269|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
139616270|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616271|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616272|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616273|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616274|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616275|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
139616276|NCT02955290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139616277|NCT02924311|Aflibercept|aflibercept|mesh-list
139616278|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616279|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616280|NCT02924311|Growth Substances|growth substances|mesh-ancestor
139616281|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616282|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
139616283|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616284|NCT02921893|Dexamethasone|dexamethasone|mesh-list
139616285|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
139616286|NCT02921893|Lenalidomide|lenalidomide|mesh-list
139616287|NCT02921893|Ixazomib|ixazomib|mesh-list
139616288|NCT02921893|Ichthammol|ichthammol|mesh-list
139616289|NCT02921893|BB 1101|bb 1101|mesh-list
139616290|NCT02921893|Glycine|glycine|mesh-list
139616291|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139616292|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
139616293|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
139616294|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139616295|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616296|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139616297|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
139616298|NCT02921893|Hormones|hormones|mesh-ancestor
139616299|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139616300|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139616301|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616302|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
139616303|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616304|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616305|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
139616306|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616307|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616308|NCT02921893|Growth Substances|growth substances|mesh-ancestor
139616309|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
139616310|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
139616311|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
139616312|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139616313|NCT02893917|Olaparib|olaparib|mesh-list
139616314|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139616315|NCT02893917|Cediranib|cediranib|mesh-list
139616316|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616317|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616318|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616319|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139616320|NCT02890329|Ipilimumab|ipilimumab|mesh-list
139616321|NCT02890329|Decitabine|decitabine|mesh-list
139616322|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616323|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616324|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616325|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616326|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139616327|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
139616328|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616329|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139616330|NCT02879695|Nivolumab|nivolumab|mesh-list
139616331|NCT02879695|Ipilimumab|ipilimumab|mesh-list
139616332|NCT02879695|Blinatumomab|blinatumomab|mesh-list
139616333|NCT02879695|Antibodies|antibodies|mesh-list
139616334|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
139616335|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139616336|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
139616337|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139616338|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
139616339|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616340|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616341|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616342|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616343|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139616344|NCT02854527|Metformin|metformin|mesh-list
139616345|NCT02854527|Digoxin|digoxin|mesh-list
139616346|NCT02854527|Furosemide|furosemide|mesh-list
139616347|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139616348|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139616349|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616350|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139616351|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139616352|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
139616353|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616354|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139616355|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139616356|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616357|NCT02854527|Diuretics|diuretics|mesh-ancestor
139616358|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
139616359|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139616360|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139616361|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139616362|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139616363|NCT02854527|Protective Agents|protective agents|mesh-ancestor
139616364|NCT02839707|Bevacizumab|bevacizumab|mesh-list
139616365|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139616366|NCT02839707|Atezolizumab|atezolizumab|mesh-list
139616367|NCT02839707|Doxorubicin|doxorubicin|mesh-list
139616368|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139616369|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
139616370|NCT02839707|Antibodies|antibodies|mesh-list
139616371|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
139616372|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139616373|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
139616374|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616375|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616376|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616377|NCT02839707|Growth Substances|growth substances|mesh-ancestor
139616378|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616379|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
139616380|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
139616381|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139616382|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139616383|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139616384|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744709|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
139616385|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616386|NCT02839707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616387|NCT02830477|Factor VIII|factor viii|mesh-list
139616388|NCT02830477|Coagulants|coagulants|mesh-ancestor
139616389|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
139616390|NCT02828592|Fludarabine|fludarabine|mesh-list
139616391|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
139616392|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139616393|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
139616394|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616395|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139616396|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139616397|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
139616398|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616399|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616400|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139616401|NCT02800486|Cetuximab|cetuximab|mesh-list
139616402|NCT02800486|Mannitol|mannitol|mesh-list
139616403|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616404|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616405|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139616406|NCT02800486|Diuretics|diuretics|mesh-ancestor
139616407|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
139616408|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616409|NCT02772081|Poractant alfa|poractant alfa|mesh-list
139616410|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139616411|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
139616412|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
139616413|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139616414|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
139616415|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139616416|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
139616417|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616418|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616419|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
139616420|NCT02705859|Trastuzumab|trastuzumab|mesh-list
139616421|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616422|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616423|NCT02633137|Cytarabine|cytarabine|mesh-list
139616424|NCT02633137|Lenalidomide|lenalidomide|mesh-list
139616425|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139616426|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
139616427|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616428|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616429|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
139616430|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139616431|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139616432|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
139616433|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616434|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616435|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616436|NCT02633137|Growth Substances|growth substances|mesh-ancestor
139616437|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
139616438|NCT02584478|Paclitaxel|paclitaxel|mesh-list
139616439|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139616440|NCT02584478|Carboplatin|carboplatin|mesh-list
139616441|NCT02584478|Doxorubicin|doxorubicin|mesh-list
139616442|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139616443|NCT02584478|Topotecan|topotecan|mesh-list
139616444|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139616445|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616446|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
139616447|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
139616448|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
139616449|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616450|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139616451|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139616452|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139616453|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616454|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139616455|NCT02581891|Aflibercept|aflibercept|mesh-list
139616456|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616457|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616458|NCT02581891|Growth Substances|growth substances|mesh-ancestor
139616459|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616460|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
139616461|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616462|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
139616463|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616464|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139616465|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616466|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616467|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
139616468|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139616469|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616470|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139616471|NCT02574845|Metformin|metformin|mesh-list
139616472|NCT02574845|Furosemide|furosemide|mesh-list
139616473|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139616474|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139616475|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616476|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139616477|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139616478|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
139616479|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616480|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139616481|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139616482|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616483|NCT02574845|Diuretics|diuretics|mesh-ancestor
139616484|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
139616485|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139616486|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139616487|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
139616488|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616489|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616490|NCT02521844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616491|NCT02521844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616492|NCT02520778|Osimertinib|osimertinib|mesh-list
139616493|NCT02520778|Navitoclax|navitoclax|mesh-list
139616494|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616495|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139616496|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616497|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616498|NCT02500407|Atezolizumab|atezolizumab|mesh-list
139616499|NCT02500407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616500|NCT02500407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616501|NCT02500407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616502|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616503|NCT02498613|Misonidazole|misonidazole|mesh-list
139616504|NCT02498613|Olaparib|olaparib|mesh-list
139616505|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139616506|NCT02498613|Cediranib|cediranib|mesh-list
139616507|NCT02498613|Maleic acid|maleic acid|mesh-list
139616508|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616509|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616510|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616511|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139616512|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139616513|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139616514|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139616515|NCT02496663|Osimertinib|osimertinib|mesh-list
139616516|NCT02496663|Necitumumab|necitumumab|mesh-list
139616517|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139616518|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616519|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616520|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139616521|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616522|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616523|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
139616524|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616525|NCT02453620|Nivolumab|nivolumab|mesh-list
139616526|NCT02453620|Ipilimumab|ipilimumab|mesh-list
139616527|NCT02453620|Entinostat|entinostat|mesh-list
139616528|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139616529|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616530|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616531|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616532|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616533|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616534|NCT02408861|Nivolumab|nivolumab|mesh-list
139616535|NCT02408861|Ipilimumab|ipilimumab|mesh-list
139616536|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616537|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616538|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139616539|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616540|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
139616541|NCT02344355|Temozolomide|temozolomide|mesh-list
139616542|NCT02344355|Vitamins|vitamins|mesh-ancestor
139616543|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
139616544|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616545|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139616546|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
139616547|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616548|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616549|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
139616550|NCT02344355|Protective Agents|protective agents|mesh-ancestor
139616551|NCT02289924|Aflibercept|aflibercept|mesh-list
139616552|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616553|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616554|NCT02289924|Growth Substances|growth substances|mesh-ancestor
139616555|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616556|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
139616557|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616558|NCT02279537|Aflibercept|aflibercept|mesh-list
139616559|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616560|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616561|NCT02279537|Growth Substances|growth substances|mesh-ancestor
139616562|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616563|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
139616564|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616565|NCT02256865|Ketoconazole|ketoconazole|mesh-list
139616566|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
139616567|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139616568|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139616569|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139616570|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
139616571|NCT02256865|Testosterone|testosterone|mesh-list
139616572|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
139616573|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
139616574|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139616575|NCT02256865|Androgens|androgens|mesh-ancestor
139616576|NCT02256865|Hormones|hormones|mesh-ancestor
139616577|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139616578|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616579|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139616580|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616581|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
139616582|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139616583|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
139616584|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139616585|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139616586|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139616587|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616588|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616589|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139616590|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
139616591|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139616592|NCT02193191|Plerixafor|plerixafor|mesh-list
139616593|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139616594|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139616595|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
139616596|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139616597|NCT02188264|Cyclosporine|cyclosporine|mesh-list
139616598|NCT02188264|Cyclosporins|cyclosporins|mesh-list
139616599|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616600|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616601|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139616602|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
139616603|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616604|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
139616605|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139616606|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
139616607|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139616608|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139616609|NCT02162849|Nicotine|nicotine|mesh-list
139616610|NCT02162849|Varenicline|varenicline|mesh-list
139616611|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139616612|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
139616613|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139616614|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616615|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139616616|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139616617|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
139616618|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139616619|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616620|NCT02159989|Aflibercept|aflibercept|mesh-list
139616621|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
139616622|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616623|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616624|NCT02159989|Growth Substances|growth substances|mesh-ancestor
139616625|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616626|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
139616627|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616628|NCT02159755|Palbociclib|palbociclib|mesh-list
139616629|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616630|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139616631|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616632|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616633|NCT02101905|Lapatinib|lapatinib|mesh-list
139616634|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616635|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139616636|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616637|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616638|NCT02070549|Trametinib|trametinib|mesh-list
139616639|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616640|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139616641|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616642|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616643|NCT02015117|Trametinib|trametinib|mesh-list
139616644|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616645|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139616646|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616647|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616648|NCT01957436|Docetaxel|docetaxel|mesh-list
139616649|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
139616650|NCT01957436|Androgens|androgens|mesh-list
139616651|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616652|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
139616653|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
139616654|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
139616655|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616656|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139616657|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616658|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
139616659|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139616660|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616661|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139616662|NCT01957436|Hormones|hormones|mesh-ancestor
139616663|NCT01955499|Lenalidomide|lenalidomide|mesh-list
139616664|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
139616665|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616666|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616667|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616668|NCT01955499|Growth Substances|growth substances|mesh-ancestor
139616669|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
138745029|NCT05736341|GABA Agents|gaba agents|mesh-ancestor
138745043|NCT05690984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138745044|NCT05690984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745045|NCT05690984|Immunologic Factors|immunologic factors|mesh-ancestor
138745046|NCT05690984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138745047|NCT05690984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616670|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616671|NCT01849146|Temozolomide|temozolomide|mesh-list
139616672|NCT01849146|Adavosertib|adavosertib|mesh-list
139616673|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139616674|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
139616675|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616676|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616677|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616678|NCT01829568|Rituximab|rituximab|mesh-list
139616679|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139616680|NCT01829568|Lenalidomide|lenalidomide|mesh-list
139616681|NCT01829568|Antibodies|antibodies|mesh-list
139616682|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
139616683|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139616684|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
139616685|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616686|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616687|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139616688|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616689|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616690|NCT01829568|Growth Substances|growth substances|mesh-ancestor
139616691|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
139616692|NCT01783925|Aflibercept|aflibercept|mesh-list
139616693|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616694|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616695|NCT01783925|Growth Substances|growth substances|mesh-ancestor
139616696|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616697|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
139616698|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616699|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139616700|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139616701|NCT01638533|Romidepsin|romidepsin|mesh-list
139616702|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139616703|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139616704|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616705|NCT01638533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139616706|NCT01638533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616707|NCT01638533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616708|NCT01624805|Cyclosporine|cyclosporine|mesh-list
139616709|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
138745083|NCT05354453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745084|NCT05354453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745085|NCT05354453|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138745093|NCT05053087|Ropivacaine|ropivacaine|mesh-list
139616710|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139616711|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139616712|NCT01624805|Prednisolone|prednisolone|mesh-list
139616713|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
139616714|NCT01624805|Lenograstim|lenograstim|mesh-list
139616715|NCT01624805|Cyclosporins|cyclosporins|mesh-list
139616716|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
139616717|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139616718|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139616719|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
139616720|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139616721|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
139616722|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616723|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616724|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616725|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139616726|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
139616727|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139616728|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
139616729|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139616730|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139616731|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139616732|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
139616733|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
139616734|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139616735|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139616736|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
139616737|NCT01624805|Hormones|hormones|mesh-ancestor
139616738|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139616739|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139616740|NCT01624805|Protective Agents|protective agents|mesh-ancestor
139616741|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139616742|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616743|NCT01623167|Cyclosporine|cyclosporine|mesh-list
139616744|NCT01623167|Cyclosporins|cyclosporins|mesh-list
139616745|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139616746|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616747|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616748|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139616749|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
139616750|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616751|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
139616752|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139616753|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
139616754|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139616755|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139616756|NCT01587352|Vorinostat|vorinostat|mesh-list
139616757|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616758|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139616759|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616760|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616761|NCT01453660|Cisplatin|cisplatin|mesh-list
139616762|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616763|NCT01434316|Veliparib|veliparib|mesh-list
139616764|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139616765|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616766|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616767|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616768|NCT01366144|Paclitaxel|paclitaxel|mesh-list
139616769|NCT01366144|Carboplatin|carboplatin|mesh-list
139616770|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139616771|NCT01366144|Veliparib|veliparib|mesh-list
139616772|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139616773|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616774|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
139616775|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
139616776|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
139616777|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616778|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139616779|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616780|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
139616781|NCT01351909|Veliparib|veliparib|mesh-list
139616782|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139616783|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
139616784|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616785|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139616786|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139616787|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
139616788|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616789|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616790|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139616791|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139616792|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616793|NCT01351896|Lenalidomide|lenalidomide|mesh-list
139616794|NCT01351896|Vaccines|vaccines|mesh-list
139616795|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139616796|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
139616797|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616798|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616799|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616800|NCT01351896|Growth Substances|growth substances|mesh-ancestor
139616801|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
139616802|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616803|NCT01347294|Bleomycin|bleomycin|mesh-list
139616804|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139616805|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616806|NCT01281176|Paclitaxel|paclitaxel|mesh-list
139616807|NCT01281176|Carboplatin|carboplatin|mesh-list
139616808|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139616809|NCT01281176|Vorinostat|vorinostat|mesh-list
139616810|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139616811|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616812|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
139616813|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
139616814|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
139616815|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616816|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139616817|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616818|NCT01139970|Temozolomide|temozolomide|mesh-list
139616819|NCT01139970|Veliparib|veliparib|mesh-list
139616820|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139616821|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
139616822|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616823|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616824|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139616825|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616826|NCT01133990|Leucovorin|leucovorin|mesh-list
139616827|NCT01133990|Bevacizumab|bevacizumab|mesh-list
139616828|NCT01133990|Fluorouracil|fluorouracil|mesh-list
139616829|NCT01133990|Irinotecan|irinotecan|mesh-list
139616830|NCT01133990|Calcium|calcium|mesh-list
139616831|NCT01133990|Levoleucovorin|levoleucovorin|mesh-list
139616832|NCT01133990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139616833|NCT01133990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616834|NCT01133990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616835|NCT01133990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139616836|NCT01133990|Growth Substances|growth substances|mesh-ancestor
139616837|NCT01133990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616838|NCT01133990|Growth Inhibitors|growth inhibitors|mesh-ancestor
139616839|NCT01133990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139616840|NCT01133990|Antimetabolites|antimetabolites|mesh-ancestor
139616841|NCT01133990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616842|NCT01133990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139616843|NCT01133990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139616844|NCT01133990|Immunologic Factors|immunologic factors|mesh-ancestor
138745173|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139616845|NCT01133990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139616846|NCT01133990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139616847|NCT01133990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616848|NCT01133990|Antidotes|antidotes|mesh-ancestor
139616849|NCT01133990|Protective Agents|protective agents|mesh-ancestor
139616851|NCT01133990|Vitamins|vitamins|mesh-ancestor
139616852|NCT01133990|Micronutrients|micronutrients|mesh-ancestor
139616853|NCT00910429|Riociguat|riociguat|mesh-list
139616854|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
139616855|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616856|NCT00878163|Gemcitabine|gemcitabine|mesh-list
139616857|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139616858|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139616859|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
139616860|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616861|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616862|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139616863|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616864|NCT00863681|Riociguat|riociguat|mesh-list
139616865|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
139616866|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616867|NCT00802230|Terbutaline|terbutaline|mesh-list
139616868|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139616869|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
139616870|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139616871|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616872|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139616873|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
139616874|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
139616875|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
138745222|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616876|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139616877|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139616878|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139616879|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139616880|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
139616881|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139616882|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616883|NCT00734149|Prednisone|prednisone|mesh-list
139616884|NCT00734149|Bortezomib|bortezomib|mesh-list
139616885|NCT00734149|Melphalan|melphalan|mesh-list
139616886|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139616887|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
139616888|NCT00734149|Hormones|hormones|mesh-ancestor
139616889|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139616890|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616891|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139616892|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616893|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139616894|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
139616895|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616896|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139616897|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139616898|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
139616899|NCT00588991|Carboplatin|carboplatin|mesh-list
139616900|NCT00588991|Topotecan|topotecan|mesh-list
139616901|NCT00588991|Veliparib|veliparib|mesh-list
139616902|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616903|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139616904|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139616905|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616906|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616907|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139616908|NCT00587431|Docetaxel|docetaxel|mesh-list
139616909|NCT00587431|Leuprolide|leuprolide|mesh-list
139616910|NCT00587431|Testosterone|testosterone|mesh-list
139616911|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616912|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
139616913|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
139616914|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
139616915|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616916|NCT00587431|Androgens|androgens|mesh-ancestor
139616917|NCT00587431|Hormones|hormones|mesh-ancestor
139616918|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139616919|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616920|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139616921|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139616922|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
139616923|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139616924|NCT00514618|Misoprostol|misoprostol|mesh-list
139616925|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139616926|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
139616927|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139616928|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616929|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139616930|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139616931|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
139616932|NCT00392353|Azacitidine|azacitidine|mesh-list
139616933|NCT00392353|Vorinostat|vorinostat|mesh-list
139616934|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139616935|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
139616936|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616937|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616938|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616939|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139616940|NCT00336063|Azacitidine|azacitidine|mesh-list
139616941|NCT00336063|Vorinostat|vorinostat|mesh-list
139616942|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139616943|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
139616944|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616945|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616946|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616947|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139616948|NCT00268385|Temozolomide|temozolomide|mesh-list
139616949|NCT00268385|Vorinostat|vorinostat|mesh-list
139616950|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139616951|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
139616952|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616953|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139616954|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139616955|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139616956|NCT00227253|Hormones|hormones|mesh-list
139616957|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139616958|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616959|NCT00097786|Nateglinide|nateglinide|mesh-list
139616960|NCT00097786|Valsartan|valsartan|mesh-list
139616961|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139616962|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139616963|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139616964|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139616965|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139616966|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616967|NCT04018105|Metformin|metformin|mesh-list
139616968|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139616969|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616970|NCT05632549|Biotin|biotin|mesh-list
139616971|NCT05632549|Vitamin B Complex|vitamin b complex|mesh-ancestor
139616972|NCT05632549|Vitamins|vitamins|mesh-ancestor
139616973|NCT05632549|Micronutrients|micronutrients|mesh-ancestor
139616974|NCT05632549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616975|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139616976|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139616977|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139616978|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139616979|NCT03597997|Propofol|propofol|mesh-list
139616980|NCT03597997|Sevoflurane|sevoflurane|mesh-list
139616981|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139616982|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139616983|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616984|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139616985|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
139616986|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
139616987|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139616988|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139616989|NCT01277835|Lidocaine|lidocaine|mesh-list
139616990|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
139616991|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
139616992|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138745327|NCT03207945|Protease Inhibitors|protease inhibitors|mesh-ancestor
139616993|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139616994|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
139616995|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139616996|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139616997|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139398712|NCT04480359|Meloxicam|meloxicam|mesh-list
139616998|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139616999|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139617000|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617001|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
139617002|NCT01431287|Olodaterol|olodaterol|mesh-list
139617003|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139617004|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
139617005|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617006|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617007|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139617008|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
139617009|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
139617010|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139617011|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
139617012|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617013|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617014|NCT05632159|Anesthetics|anesthetics|mesh-list
139617015|NCT05632159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617016|NCT05632159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617017|NCT04017013|Lidocaine|lidocaine|mesh-list
139617018|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
139617019|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
139617020|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617021|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617022|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
139617023|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617024|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139617025|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139617026|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139617027|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139617028|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617029|NCT01277913|Vitamin D|vitamin d|mesh-list
139617030|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
139617031|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
139617032|NCT01277913|Vitamins|vitamins|mesh-list
139617033|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
139617034|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617035|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139617036|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139617037|NCT05631847|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139617038|NCT05631847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139617039|NCT05631847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139617040|NCT05631847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617041|NCT00729807|Pentamidine|pentamidine|mesh-list
139617042|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
139617043|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617044|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139617045|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139617046|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139617047|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139617048|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139617049|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617050|NCT03592693|Vitamins|vitamins|mesh-list
139617051|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
139617052|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
139617053|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617054|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139617055|NCT00730353|Paclitaxel|paclitaxel|mesh-list
139617056|NCT00730353|Sunitinib|sunitinib|mesh-list
139617057|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139617058|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617059|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
139617060|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
139617061|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
139617062|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617063|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139617064|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139617065|NCT00730353|Growth Substances|growth substances|mesh-ancestor
139617066|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617067|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
139617068|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139617069|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617070|NCT01272531|Valproic Acid|valproic acid|mesh-list
139617071|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
139617072|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
139617073|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617074|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617075|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
139617076|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617077|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617078|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
139617079|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139617080|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617081|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139617082|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
139617083|NCT01272609|Timolol|timolol|mesh-list
139617084|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139617085|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139617086|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
139617087|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617088|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745458|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
139617089|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617090|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139617091|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139617092|NCT03595189|Cilastatin|cilastatin|mesh-list
139617093|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
139617094|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617095|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617096|NCT01410227|Factor VIII|factor viii|mesh-list
139617097|NCT01410227|Coagulants|coagulants|mesh-ancestor
139617098|NCT01274559|Niacin|niacin|mesh-list
139617099|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139617100|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
139617101|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617102|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139617103|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
139617104|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
139617105|NCT01274559|Vitamins|vitamins|mesh-ancestor
139617106|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
139617107|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617108|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
139617109|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
139617110|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139617111|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139617112|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617113|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617114|NCT01409993|Urological Agents|urological agents|mesh-ancestor
139617115|NCT01409915|Molgramostim|molgramostim|mesh-list
139617116|NCT01409915|Sargramostim|sargramostim|mesh-list
139617117|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
139617118|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617119|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617120|NCT01272921|Bupivacaine|bupivacaine|mesh-list
139617121|NCT01272921|Ropivacaine|ropivacaine|mesh-list
139617122|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
139617123|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
139617124|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617125|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617126|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
139617127|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617128|NCT01409837|Lisinopril|lisinopril|mesh-list
139617129|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139617130|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
139617131|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617132|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617133|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139617134|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139617135|NCT01409837|Protective Agents|protective agents|mesh-ancestor
139617136|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617137|NCT01278459|Atorvastatin|atorvastatin|mesh-list
139617138|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139617139|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139617140|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
139617141|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617142|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139617143|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139617144|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617145|NCT00731055|Varenicline|varenicline|mesh-list
139617146|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139617147|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139617148|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
139617149|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617150|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617151|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617152|NCT03594565|Fluticasone|fluticasone|mesh-list
139617154|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139617155|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139617156|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
139617157|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617158|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617159|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139617160|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
139617161|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
139617162|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139617163|NCT01430585|Letrozole|letrozole|mesh-list
139617164|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617165|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139617166|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139617167|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617168|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617169|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139617170|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
139617171|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139617172|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617173|NCT04005859|Lidocaine|lidocaine|mesh-list
139617174|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
139617175|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
139617176|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617177|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617178|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
139617179|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617180|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139617181|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139617182|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139617183|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139617184|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617185|NCT05633719|Carboplatin|carboplatin|mesh-list
139617186|NCT05633719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617187|NCT01408901|Molgramostim|molgramostim|mesh-list
139617188|NCT01408901|Sargramostim|sargramostim|mesh-list
139617189|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
139617190|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617191|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617192|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
139617193|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
139617194|NCT02080195|Fludarabine|fludarabine|mesh-list
139617195|NCT02080195|Tacrolimus|tacrolimus|mesh-list
139617196|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
139617197|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139617198|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139617199|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
139617200|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617201|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139617202|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139617203|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
139617204|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617205|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617206|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139617207|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139617208|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617209|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139617210|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139617211|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
139617212|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139617213|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617214|NCT04044131|Sorbitol|sorbitol|mesh-list
139617215|NCT04044131|Cathartics|cathartics|mesh-ancestor
139617216|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139617217|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
139617218|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
139617219|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
139617220|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139617221|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139617222|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139617223|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398934|NCT05496764|Hormones|hormones|mesh-ancestor
139617225|NCT01428713|Coagulants|coagulants|mesh-ancestor
139617226|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139617227|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617228|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139617229|NCT01408043|Plerixafor|plerixafor|mesh-list
139617230|NCT01408043|Etoposide|etoposide|mesh-list
139617231|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
138745590|NCT01873326|Paclitaxel|paclitaxel|mesh-list
139617232|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139617233|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617234|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139617235|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139617236|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617237|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617238|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139617239|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139617240|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
139617241|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617242|NCT00219349|Escitalopram|escitalopram|mesh-list
139617243|NCT00219349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139617244|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139617245|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139617246|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617247|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617248|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
139617249|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617250|NCT00218257|Progesterone|progesterone|mesh-list
139617251|NCT00218257|Progestins|progestins|mesh-ancestor
139617252|NCT00218257|Hormones|hormones|mesh-ancestor
139617253|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139617254|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617255|NCT01523366|Clopidogrel|clopidogrel|mesh-list
139617256|NCT01523366|Ticagrelor|ticagrelor|mesh-list
139617257|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139617258|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139617259|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138745624|NCT01745588|Clarithromycin|clarithromycin|mesh-list
139617260|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139617261|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
139617262|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617263|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617264|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617265|NCT03024697|Anesthetics|anesthetics|mesh-list
139617266|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
139617267|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617268|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617269|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
139617270|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617271|NCT01427933|Ramucirumab|ramucirumab|mesh-list
139617272|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617273|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
139617274|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617275|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
139617276|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139617277|NCT01406873|Mexiletine|mexiletine|mesh-list
139617278|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139617279|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139617280|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139617281|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139617282|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617283|NCT01406795|Heparin|heparin|mesh-list
139617284|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
139617285|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139617286|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139617287|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617288|NCT01406015|Spironolactone|spironolactone|mesh-list
139617289|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139617290|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
139617291|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139617292|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617293|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139617294|NCT01406015|Diuretics|diuretics|mesh-ancestor
139617295|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
139617296|NCT00215137|Escitalopram|escitalopram|mesh-list
139617297|NCT00215137|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139617298|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139617299|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139617300|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617301|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617302|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
139617303|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617304|NCT04406779|Hormones|hormones|mesh-list
139617305|NCT04406779|Autoantibodies|autoantibodies|mesh-list
139617306|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139617307|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617308|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
139617309|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139617310|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617311|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617312|NCT03598075|Pramlintide|pramlintide|mesh-list
139617313|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139617314|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617315|NCT03597919|Vaccines|vaccines|mesh-list
139617316|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
139617317|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617318|NCT04001413|Durvalumab|durvalumab|mesh-list
139617319|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139617320|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617321|NCT01677858|Dexamethasone|dexamethasone|mesh-list
139617322|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139617323|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
139617324|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
139617325|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617326|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617327|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139617328|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
139617329|NCT01677858|Hormones|hormones|mesh-ancestor
139617330|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139617331|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139617332|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617333|NCT03027284|Gemcitabine|gemcitabine|mesh-list
139617334|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617335|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139617336|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
139617337|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617338|NCT03592069|Amoxicillin|amoxicillin|mesh-list
139617339|NCT03592069|Metronidazole|metronidazole|mesh-list
139617340|NCT03592069|Clarithromycin|clarithromycin|mesh-list
139617341|NCT03592069|Esomeprazole|esomeprazole|mesh-list
139617342|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139617343|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617344|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139617345|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139617346|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139617347|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139617348|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139617349|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617350|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617351|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139617352|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139617353|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139617354|NCT03591991|Empagliflozin|empagliflozin|mesh-list
139617355|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139617356|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617357|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139617358|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617359|NCT03591913|Misoprostol|misoprostol|mesh-list
139617360|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139617361|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
139617362|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139617363|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617364|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139617365|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139617366|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
139617367|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139617368|NCT04198129|Amoxicillin|amoxicillin|mesh-list
139617369|NCT04198129|Clindamycin|clindamycin|mesh-list
139617370|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
139617371|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
139617372|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139617373|NCT04198129|Ampicillin|ampicillin|mesh-list
139617374|NCT04198129|Sultamicillin|sultamicillin|mesh-list
139617375|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139617376|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617377|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
139617378|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139617379|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617380|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617381|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139617382|NCT03591757|Tolcapone|tolcapone|mesh-list
139617383|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139617384|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139617385|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139617386|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617387|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617388|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
139617389|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139617390|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139617391|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
139617392|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139617393|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617394|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
139617395|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
139617396|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139617397|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
139617398|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617399|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
139617400|NCT04438434|Protective Agents|protective agents|mesh-ancestor
139617401|NCT03591679|Oxytocin|oxytocin|mesh-list
139617402|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
139617403|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139617404|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617405|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139617406|NCT04197817|Antibodies|antibodies|mesh-list
139617407|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
139617408|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139617409|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
139617410|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617411|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617412|NCT04585854|Caffeine|caffeine|mesh-list
139617413|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139617414|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617415|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139617416|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617417|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617418|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139617419|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139617420|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
139617421|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617422|NCT03481842|Axitinib|axitinib|mesh-list
139617423|NCT03481842|Afatinib|afatinib|mesh-list
139617424|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617425|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139617426|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617427|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617428|NCT04197739|Amikacin|amikacin|mesh-list
139617429|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139617430|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617431|NCT04197349|Sumatriptan|sumatriptan|mesh-list
139617432|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139617433|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139617434|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139617435|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
139617436|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617437|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617438|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617439|NCT03422094|Nivolumab|nivolumab|mesh-list
139617440|NCT03422094|Ipilimumab|ipilimumab|mesh-list
139617441|NCT03422094|Poly ICLC|poly iclc|mesh-list
139617442|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139617443|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617444|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139399164|NCT03995017|Nivolumab|nivolumab|mesh-list
139617445|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617446|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
139617447|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
139617448|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617450|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
139617451|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617452|NCT03591289|Bromides|bromides|mesh-list
139617453|NCT03591289|Rocuronium|rocuronium|mesh-list
139617454|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
139617455|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139617456|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139617457|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139617458|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617459|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617460|NCT02471118|Adalimumab|adalimumab|mesh-list
139617461|NCT02471118|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139617462|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139617463|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139617464|NCT04197115|Vitamins|vitamins|mesh-list
139617465|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
139617466|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
139617467|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
139617468|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139617469|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139617470|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139617471|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
139617472|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617473|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139617474|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
139617475|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617476|NCT04197115|Protective Agents|protective agents|mesh-ancestor
139617477|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
139617478|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139617479|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
139617480|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617481|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617482|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139617483|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
139617484|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
139617485|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139617486|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
139617487|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617488|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617489|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139617490|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139617491|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
139617492|NCT03590587|Hormones|hormones|mesh-ancestor
139617493|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139617494|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617495|NCT03590431|Iodine|iodine|mesh-list
139617496|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
139617497|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139617498|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617499|NCT03590431|Trace Elements|trace elements|mesh-ancestor
139617500|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
139617501|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617502|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
139617503|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617504|NCT05102448|Methotrexate|methotrexate|mesh-list
139617505|NCT05102448|Tofacitinib|tofacitinib|mesh-list
139617506|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139617507|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
139617508|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139617509|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617510|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139617511|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
139617512|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617513|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617514|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
139617515|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617516|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139617517|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139617518|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
139399251|NCT02235961|Hormones|hormones|mesh-ancestor
139617519|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139617520|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139617521|NCT05102448|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139617522|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139617523|NCT03599323|Clotrimazole|clotrimazole|mesh-list
139617524|NCT03599323|Miconazole|miconazole|mesh-list
139617525|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139617526|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617527|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
139617528|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139617529|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139617530|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617531|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617532|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139617533|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
139617534|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139617535|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617536|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139617537|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139617538|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139617539|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139617540|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
139617541|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617542|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617543|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139617544|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
139617545|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139617546|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139617547|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139617548|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
139617549|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617550|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617551|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
139617552|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139617553|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617554|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617555|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139617556|NCT05102058|Analgesics|analgesics|mesh-ancestor
139617557|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
139617558|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617559|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139617560|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139617561|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139617562|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
139617563|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138745935|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139617564|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617565|NCT03956797|Anesthetics|anesthetics|mesh-list
139617566|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617567|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617568|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
139617569|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139617570|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139617571|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139617572|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139617573|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617574|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
139617575|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617576|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617577|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139617578|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617579|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
139617580|NCT04195243|Empagliflozin|empagliflozin|mesh-list
139617581|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139617582|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617583|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138745972|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139617584|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617585|NCT04195321|Phenylephrine|phenylephrine|mesh-list
139617586|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
139617587|NCT04195321|Norepinephrine|norepinephrine|mesh-list
139617588|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139617589|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
139617590|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
139617591|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617592|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617593|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
139617594|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139617595|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
139617596|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
139617597|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139617598|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139617599|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139617600|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
139617601|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617602|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617603|NCT04195321|Protective Agents|protective agents|mesh-ancestor
139617604|NCT06012760|Epoetin Alfa|epoetin alfa|mesh-list
139617605|NCT06012760|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139617606|NCT06012760|Hematinics|hematinics|mesh-ancestor
139617607|NCT06012695|Temozolomide|temozolomide|mesh-list
139617608|NCT06012695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139617609|NCT06012695|Alkylating Agents|alkylating agents|mesh-ancestor
139617610|NCT06012695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617611|NCT06012695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617612|NCT06012682|Metformin|metformin|mesh-list
139617613|NCT06012682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139617614|NCT06012682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617615|NCT06012552|Tianeptine|tianeptine|mesh-list
139617616|NCT06012552|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139617617|NCT06012552|Antidepressive Agents|antidepressive agents|mesh-ancestor
139617618|NCT06012552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139617619|NCT06012500|Xenon|xenon|mesh-list
139617620|NCT06012500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139617621|NCT06012500|Anesthetics, General|anesthetics, general|mesh-ancestor
139617622|NCT06012500|Anesthetics|anesthetics|mesh-ancestor
139617623|NCT06012500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617624|NCT06012500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617625|NCT06012435|Docetaxel|docetaxel|mesh-list
139617626|NCT06012435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617627|NCT06012435|Tubulin Modulators|tubulin modulators|mesh-ancestor
139617628|NCT06012435|Antimitotic Agents|antimitotic agents|mesh-ancestor
139617629|NCT06012435|Mitosis Modulators|mitosis modulators|mesh-ancestor
139617630|NCT06012435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617631|NCT06012383|Bortezomib|bortezomib|mesh-list
139617632|NCT06012383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617633|NCT06012266|Dapagliflozin|dapagliflozin|mesh-list
139617634|NCT06012266|Empagliflozin|empagliflozin|mesh-list
139617635|NCT06012266|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139617636|NCT06012266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617637|NCT06012266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139617638|NCT06012266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617639|NCT06012097|Diclofenac|diclofenac|mesh-list
139617640|NCT06012097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139617641|NCT06012097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139617642|NCT06012097|Analgesics|analgesics|mesh-ancestor
139617643|NCT06012097|Sensory System Agents|sensory system agents|mesh-ancestor
139617644|NCT06012097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617645|NCT06012097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617646|NCT06012097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139617647|NCT06012097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138746036|NCT01178853|Warfarin|warfarin|mesh-list
139617648|NCT06012097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139617649|NCT06012097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617650|NCT06012097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617651|NCT06011980|Growth Inhibitors|growth inhibitors|mesh-list
139617652|NCT06011980|Growth Substances|growth substances|mesh-ancestor
139617653|NCT06011980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617654|NCT06011460|Clozapine|clozapine|mesh-list
139617655|NCT06011460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139617656|NCT06011460|Serotonin Agents|serotonin agents|mesh-ancestor
139617657|NCT06011460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617658|NCT06011460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617659|NCT06011460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617660|NCT06011460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139617661|NCT06011460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139617662|NCT06011460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617663|NCT06011460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139617664|NCT06011460|GABA Antagonists|gaba antagonists|mesh-ancestor
139617665|NCT06011460|GABA Agents|gaba agents|mesh-ancestor
139617666|NCT06011421|Anesthetics|anesthetics|mesh-list
139617667|NCT06011421|Anesthetics, Local|anesthetics, local|mesh-list
139617668|NCT06011421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617669|NCT06011421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617670|NCT06011421|Sensory System Agents|sensory system agents|mesh-ancestor
139617671|NCT06011421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617672|NCT06011343|Meglumine Antimoniate|meglumine antimoniate|mesh-list
139617673|NCT06011343|Tofacitinib|tofacitinib|mesh-list
139617674|NCT06011343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139617675|NCT06011343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139617676|NCT06011343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617677|NCT06011343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617678|NCT06011343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139617679|NCT06011343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139617680|NCT06011343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617681|NCT06011265|Mirabegron|mirabegron|mesh-list
139617682|NCT06011265|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138746062|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
139617683|NCT06011265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139617684|NCT06011265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139617685|NCT06011265|Adrenergic Agents|adrenergic agents|mesh-ancestor
139617686|NCT06011265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617687|NCT06011265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617688|NCT06011265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617689|NCT06011265|Urological Agents|urological agents|mesh-ancestor
139617690|NCT06011083|Betamethasone|betamethasone|mesh-list
139617691|NCT06011083|Betamethasone Valerate|betamethasone valerate|mesh-list
139617692|NCT06011083|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139617693|NCT06011083|Betamethasone benzoate|betamethasone benzoate|mesh-list
139617694|NCT06011083|Calcipotriene|calcipotriene|mesh-list
139617695|NCT06011083|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139617696|NCT06011083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139617697|NCT06011083|Glucocorticoids|glucocorticoids|mesh-ancestor
139617698|NCT06011083|Hormones|hormones|mesh-ancestor
139617699|NCT06011083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139617700|NCT06011083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617701|NCT06011083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139617702|NCT06011083|Respiratory System Agents|respiratory system agents|mesh-ancestor
139617703|NCT06011083|Dermatologic Agents|dermatologic agents|mesh-ancestor
139617704|NCT06011005|Benzocaine|benzocaine|mesh-list
139617705|NCT06011005|Ethyl Chloride|ethyl chloride|mesh-list
139617706|NCT06011005|Anesthetics, Local|anesthetics, local|mesh-ancestor
139617707|NCT06011005|Anesthetics|anesthetics|mesh-ancestor
139617708|NCT06011005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617709|NCT06011005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617710|NCT06011005|Sensory System Agents|sensory system agents|mesh-ancestor
139617711|NCT06011005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617712|NCT06010992|Nitazoxanide|nitazoxanide|mesh-list
139617713|NCT06010992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139617714|NCT06010992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617715|NCT06010745|Biotin|biotin|mesh-list
139617716|NCT06010745|Silicon|silicon|mesh-list
139617717|NCT06010745|Vitamin B Complex|vitamin b complex|mesh-ancestor
139617718|NCT06010745|Vitamins|vitamins|mesh-ancestor
139617719|NCT06010745|Micronutrients|micronutrients|mesh-ancestor
139617720|NCT06010745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617721|NCT06010745|Trace Elements|trace elements|mesh-ancestor
139617722|NCT06010368|Tranexamic Acid|tranexamic acid|mesh-list
139617723|NCT06010368|Oxytocin|oxytocin|mesh-list
139617724|NCT06010368|Oxytocics|oxytocics|mesh-ancestor
139617725|NCT06010368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139617726|NCT06010368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617727|NCT06010368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139617728|NCT06010368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139617729|NCT06010368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617730|NCT06010368|Hemostatics|hemostatics|mesh-ancestor
139617731|NCT06010368|Coagulants|coagulants|mesh-ancestor
139617732|NCT06010121|Vitamin D|vitamin d|mesh-list
139617733|NCT06010121|Ergocalciferols|ergocalciferols|mesh-list
139617734|NCT06010121|Cholecalciferol|cholecalciferol|mesh-list
139617735|NCT06010121|Vitamins|vitamins|mesh-list
139617736|NCT06010121|Micronutrients|micronutrients|mesh-ancestor
139617737|NCT06010121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617738|NCT06010121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139617739|NCT06010121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139617740|NCT06008990|Buprenorphine|buprenorphine|mesh-list
139617741|NCT06008990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139617742|NCT06008990|Narcotics|narcotics|mesh-ancestor
139617743|NCT06008990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139297205|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139617744|NCT06008990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617745|NCT06008990|Analgesics|analgesics|mesh-ancestor
139617746|NCT06008990|Sensory System Agents|sensory system agents|mesh-ancestor
139617747|NCT06008990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617748|NCT06008990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139617749|NCT06008002|Tramadol|tramadol|mesh-list
139617750|NCT06008002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139617751|NCT06008002|Narcotics|narcotics|mesh-ancestor
139617752|NCT06008002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617753|NCT06008002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617754|NCT06008002|Analgesics|analgesics|mesh-ancestor
139617755|NCT06008002|Sensory System Agents|sensory system agents|mesh-ancestor
139617756|NCT06008002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617757|NCT05967286|Olaparib|olaparib|mesh-list
139617758|NCT05967286|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139617759|NCT05967286|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
139617760|NCT05967286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617761|NCT05967286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617762|NCT05967286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746175|NCT01178073|Ambrisentan|ambrisentan|mesh-list
139617763|NCT05935774|Atezolizumab|atezolizumab|mesh-list
139617764|NCT05935774|Trabedersen|trabedersen|mesh-list
139617765|NCT05935774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139617766|NCT05935774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617767|NCT05935774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139617768|NCT05935774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617769|NCT05926440|Vaccines|vaccines|mesh-list
139617770|NCT05926440|Somatomedin B|somatomedin b|mesh-list
139617771|NCT05926440|Immunologic Factors|immunologic factors|mesh-ancestor
139617772|NCT05926440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617773|NCT05926440|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139617774|NCT05926440|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139617775|NCT05926440|Protease Inhibitors|protease inhibitors|mesh-ancestor
139617776|NCT05926440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617777|NCT05926440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617778|NCT05802693|Mitogens|mitogens|mesh-list
139617779|NCT05802693|Mitosis Modulators|mitosis modulators|mesh-ancestor
139617780|NCT05802693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617781|NCT05799521|Glycine|glycine|mesh-list
139617782|NCT05799521|Glycine Agents|glycine agents|mesh-ancestor
139617783|NCT05799521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617784|NCT05799521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617785|NCT05799521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617786|NCT05784870|Ferrous succinate|ferrous succinate|mesh-list
139617787|NCT05784870|Hematinics|hematinics|mesh-ancestor
139617788|NCT05767684|Nivolumab|nivolumab|mesh-list
139617789|NCT05767684|Lenvatinib|lenvatinib|mesh-list
139617790|NCT05767684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139617791|NCT05767684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617792|NCT05767684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139617793|NCT05767684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617794|NCT05767684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139617795|NCT05767684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617796|NCT05734794|Rituximab|rituximab|mesh-list
139617797|NCT05734794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139617798|NCT05734794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617799|NCT05734794|Immunologic Factors|immunologic factors|mesh-ancestor
139617800|NCT05734794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617801|NCT05734794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139617802|NCT05705128|Dexmedetomidine|dexmedetomidine|mesh-list
139617803|NCT05705128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139617804|NCT05705128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617805|NCT05705128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617806|NCT05705128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139617807|NCT05705128|Analgesics|analgesics|mesh-ancestor
139617808|NCT05705128|Sensory System Agents|sensory system agents|mesh-ancestor
139617809|NCT05705128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617810|NCT05705128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139617811|NCT05705128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139617812|NCT05705128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139617813|NCT05705128|Adrenergic Agents|adrenergic agents|mesh-ancestor
139617814|NCT05705128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617815|NCT05705128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617816|NCT05630859|Vaccines|vaccines|mesh-list
139617817|NCT05630859|Immunologic Factors|immunologic factors|mesh-ancestor
139617818|NCT05630859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617819|NCT05575518|Rifamycins|rifamycins|mesh-list
139617820|NCT05575518|Fluoroquinolones|fluoroquinolones|mesh-list
139617821|NCT05575518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139617822|NCT05575518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617823|NCT05575518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139617825|NCT05575518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617826|NCT05458765|Tenofovir|tenofovir|mesh-list
139617827|NCT05458765|Emtricitabine|emtricitabine|mesh-list
139617828|NCT05458765|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139617829|NCT05458765|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139617830|NCT05458765|Antiviral Agents|antiviral agents|mesh-ancestor
139617831|NCT05458765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617832|NCT05458765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139617833|NCT05458765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139617834|NCT05458765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617835|NCT05458765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617836|NCT05458765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139617837|NCT05458765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139617838|NCT05442983|Probenecid|probenecid|mesh-list
139617839|NCT05442983|Uricosuric Agents|uricosuric agents|mesh-ancestor
139617840|NCT05442983|Gout Suppressants|gout suppressants|mesh-ancestor
139617841|NCT05442983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139617842|NCT05404945|Doxorubicin|doxorubicin|mesh-list
139617843|NCT05404945|Pembrolizumab|pembrolizumab|mesh-list
139617844|NCT05404945|Dacarbazine|dacarbazine|mesh-list
139617845|NCT05404945|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139617846|NCT05404945|Vinblastine|vinblastine|mesh-list
139617847|NCT05404945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139617848|NCT05404945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617849|NCT05404945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139617850|NCT05404945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139617851|NCT05404945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617852|NCT05404945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617853|NCT05404945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138746231|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
139617854|NCT05404945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139617855|NCT05404945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139617856|NCT05404945|Alkylating Agents|alkylating agents|mesh-ancestor
139617857|NCT05404945|Immunotoxins|immunotoxins|mesh-ancestor
139617858|NCT05404945|Immunoconjugates|immunoconjugates|mesh-ancestor
139617859|NCT05404945|Immunologic Factors|immunologic factors|mesh-ancestor
139617860|NCT05404945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617861|NCT05404945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139617862|NCT05404945|Tubulin Modulators|tubulin modulators|mesh-ancestor
139617863|NCT05404945|Antimitotic Agents|antimitotic agents|mesh-ancestor
139617864|NCT05404945|Mitosis Modulators|mitosis modulators|mesh-ancestor
139617865|NCT05305989|Belumosudil|belumosudil|mesh-list
139617866|NCT05305989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139617867|NCT05305989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617868|NCT05305989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617869|NCT05279456|Myeloma Proteins|myeloma proteins|mesh-list
139617870|NCT05279456|Paraproteins|paraproteins|mesh-list
139617871|NCT05279456|Immunologic Factors|immunologic factors|mesh-ancestor
139617872|NCT05279456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617873|NCT05276830|Dexmedetomidine|dexmedetomidine|mesh-list
139617874|NCT05276830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139617875|NCT05276830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617876|NCT05276830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617877|NCT05276830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139617878|NCT05276830|Analgesics|analgesics|mesh-ancestor
139617879|NCT05276830|Sensory System Agents|sensory system agents|mesh-ancestor
139617880|NCT05276830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617881|NCT05276830|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139617882|NCT05276830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139617883|NCT05276830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139617884|NCT05276830|Adrenergic Agents|adrenergic agents|mesh-ancestor
139617885|NCT05276830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617886|NCT05276830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617887|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139617888|NCT05194735|Aldesleukin|aldesleukin|mesh-list
139617889|NCT05194735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617890|NCT05194735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139617891|NCT05194735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139617892|NCT05194735|Antiviral Agents|antiviral agents|mesh-ancestor
139617893|NCT05194735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617894|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139617896|NCT05070364|Interferons|interferons|mesh-list
139617897|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617898|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
139617899|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139617900|NCT05060068|Ketamine|ketamine|mesh-list
139617901|NCT05060068|Esketamine|esketamine|mesh-list
139617902|NCT05060068|Analgesics|analgesics|mesh-ancestor
139617903|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
139617904|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617905|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617906|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139617907|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139617908|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
139617909|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
139617910|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139617911|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139617912|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139617913|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617914|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617915|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
138746329|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139617916|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139617917|NCT05043350|Loratadine|loratadine|mesh-list
139617918|NCT05043350|Famotidine|famotidine|mesh-list
139617919|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139617920|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139617921|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139617922|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
139617923|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
139617924|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139617925|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617926|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617927|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
139617928|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
139617929|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139617930|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139617931|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139617932|NCT04985266|Tamoxifen|tamoxifen|mesh-list
139617933|NCT04985266|Letrozole|letrozole|mesh-list
139617934|NCT04985266|Fulvestrant|fulvestrant|mesh-list
139617935|NCT04985266|Palbociclib|palbociclib|mesh-list
139617936|NCT04985266|Anastrozole|anastrozole|mesh-list
139617937|NCT04985266|Exemestane|exemestane|mesh-list
139617938|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617939|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139617940|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139617941|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139617942|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617943|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139617944|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
139617945|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139617946|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617947|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139617948|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139617949|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139617950|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139617951|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139617952|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139617953|NCT04947020|Metformin|metformin|mesh-list
139617954|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139617955|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617956|NCT04896697|Atezolizumab|atezolizumab|mesh-list
139617957|NCT04896697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139617958|NCT04896697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139617959|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139617960|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617961|NCT04862468|Dexamethasone|dexamethasone|mesh-list
139617962|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139617963|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
139617964|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
139617965|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139617966|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617967|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139617968|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
139617969|NCT04862468|Hormones|hormones|mesh-ancestor
139617970|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139617971|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139617972|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617973|NCT04814927|Copper|copper|mesh-list
138746360|NCT02886195|Pemetrexed|pemetrexed|mesh-list
139617974|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139617975|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
139617976|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
139617977|NCT04814927|Etonogestrel|etonogestrel|mesh-list
139617978|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139617979|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
139617980|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139617981|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139617982|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139617983|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139617984|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139617985|NCT04814927|Trace Elements|trace elements|mesh-ancestor
139617986|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
139617987|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139617988|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139617989|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139617990|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139617991|NCT04747912|Dexamethasone|dexamethasone|mesh-list
139617992|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
139617993|NCT04747912|Methotrexate|methotrexate|mesh-list
139617994|NCT04747912|Vincristine|vincristine|mesh-list
139617995|NCT04747912|Dasatinib|dasatinib|mesh-list
139617996|NCT04747912|Ponatinib|ponatinib|mesh-list
139617997|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139617998|NCT04747912|BB 1101|bb 1101|mesh-list
139617999|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139618000|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
139618001|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
139618002|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618003|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618004|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139618005|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
139618006|NCT04747912|Hormones|hormones|mesh-ancestor
139618007|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618008|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139618009|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618010|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
139618011|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618012|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618013|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139618014|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
139618015|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139618016|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139618017|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
139618018|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
139618019|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139618020|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139618021|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
139618022|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139618023|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139618024|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139618025|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
139618026|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
139618027|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
139618028|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139618029|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618030|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139618031|NCT04747912|Immunotoxins|immunotoxins|mesh-ancestor
139618032|NCT04747912|Immunoconjugates|immunoconjugates|mesh-ancestor
139618033|NCT04603911|Dexamethasone|dexamethasone|mesh-list
139618034|NCT04603911|Clonidine|clonidine|mesh-list
139618035|NCT04603911|Epinephrine|epinephrine|mesh-list
139618036|NCT04603911|Bupivacaine|bupivacaine|mesh-list
139618037|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139618038|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
139618039|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
139618040|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618041|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618042|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139618043|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
139618044|NCT04603911|Hormones|hormones|mesh-ancestor
139399758|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139618045|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138746417|NCT01174173|Ranolazine|ranolazine|mesh-list
139618046|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139618047|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618048|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
139618049|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
139618050|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139618051|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
139618052|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139618053|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139618054|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
139618055|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139618056|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618057|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139618058|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139618059|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139618060|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
139618061|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
139618062|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
139618063|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139618064|NCT04603911|Analgesics|analgesics|mesh-ancestor
139618065|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139618066|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
139618067|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139618068|NCT04597424|Doxycycline|doxycycline|mesh-list
139618069|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139618070|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618071|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
139618072|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139618073|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139618074|NCT04501978|Remdesivir|remdesivir|mesh-list
139618075|NCT04501978|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139618076|NCT04501978|Bamlanivimab|bamlanivimab|mesh-list
139618077|NCT04501978|Sotrovimab|sotrovimab|mesh-list
139618078|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
139618079|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618080|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
139618081|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618082|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
139618083|NCT04348747|Vaccines|vaccines|mesh-list
139618084|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
139618085|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618086|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618087|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618088|NCT04348747|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139618089|NCT04348747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618090|NCT04342819|Empagliflozin|empagliflozin|mesh-list
139618091|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139618092|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618093|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139618094|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618095|NCT04187248|Asparaginase|asparaginase|mesh-list
139618096|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618097|NCT04156087|Gemcitabine|gemcitabine|mesh-list
139618098|NCT04156087|Durvalumab|durvalumab|mesh-list
139618099|NCT04156087|Tremelimumab|tremelimumab|mesh-list
139618100|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139618101|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
139618102|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618103|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618104|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618105|NCT04112212|Vedolizumab|vedolizumab|mesh-list
139618106|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139618107|NCT04107077|Mitomycins|mitomycins|mesh-list
139618108|NCT04107077|Mitomycin|mitomycin|mesh-list
139618109|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618110|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139618111|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
139618112|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618113|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139618114|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618115|NCT04051320|Leuprolide|leuprolide|mesh-list
139618116|NCT04051320|Estradiol|estradiol|mesh-list
139618117|NCT04051320|Progesterone|progesterone|mesh-list
139618118|NCT04051320|Estrogens|estrogens|mesh-ancestor
139618119|NCT04051320|Hormones|hormones|mesh-ancestor
139618120|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618121|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618122|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139618123|NCT04051320|Progestins|progestins|mesh-ancestor
139618124|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139618125|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
139618126|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139618127|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618128|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
139618129|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618130|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618131|NCT03990961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139618132|NCT03990961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618134|NCT03841526|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139618135|NCT03841526|Glucagon|glucagon|mesh-list
139618136|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139618137|NCT03841526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139618138|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618139|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139618140|NCT03841526|Hormones|hormones|mesh-ancestor
139618141|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618142|NCT03841526|Incretins|incretins|mesh-ancestor
139618143|NCT03834506|Dexamethasone|dexamethasone|mesh-list
139618144|NCT03834506|Prednisone|prednisone|mesh-list
139618145|NCT03834506|Docetaxel|docetaxel|mesh-list
139618146|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
139618147|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139618148|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
139618149|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
139618150|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618151|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618152|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139618153|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
139618154|NCT03834506|Hormones|hormones|mesh-ancestor
139618155|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618156|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139618157|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618158|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
139618159|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
139618160|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
139618161|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618162|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618163|NCT03834506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139618164|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
139618165|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139618166|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139618167|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
139618168|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618169|NCT03474744|Rituximab|rituximab|mesh-list
139618170|NCT03474744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618171|NCT03474744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618172|NCT03474744|Immunologic Factors|immunologic factors|mesh-ancestor
139618173|NCT03474744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618174|NCT03474744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139618175|NCT03367871|Paclitaxel|paclitaxel|mesh-list
139618176|NCT03367871|Bevacizumab|bevacizumab|mesh-list
139618177|NCT03367871|Carboplatin|carboplatin|mesh-list
139618178|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
139618179|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139618180|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618181|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
139618182|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
139618183|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
139618184|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618185|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618186|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139618187|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139618188|NCT03367871|Growth Substances|growth substances|mesh-ancestor
139618189|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618190|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
139618191|NCT03367871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139618192|NCT03340064|Levetiracetam|levetiracetam|mesh-list
139618193|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
139618194|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
139618195|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
139618196|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618197|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618198|NCT03277638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139618199|NCT03277638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618200|NCT03180684|Imiquimod|imiquimod|mesh-list
139618201|NCT03180684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139618202|NCT03180684|Immunologic Factors|immunologic factors|mesh-ancestor
139618203|NCT03180684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618204|NCT03180684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618205|NCT03180684|Interferon Inducers|interferon inducers|mesh-ancestor
139618206|NCT03161652|Ranibizumab|ranibizumab|mesh-list
139618207|NCT03161652|Dopamine|dopamine|mesh-list
139618208|NCT03161652|Sulpiride|sulpiride|mesh-list
139618209|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139618210|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139618211|NCT03161652|Growth Substances|growth substances|mesh-ancestor
139618212|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618213|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
139618214|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618215|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139618216|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
139618217|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
139618218|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618219|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
139618220|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139618221|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618222|NCT03161652|Protective Agents|protective agents|mesh-ancestor
139618223|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139618224|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139618225|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139618226|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139618227|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139618228|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139618229|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
139618230|NCT03131037|Valacyclovir|valacyclovir|mesh-list
139618231|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
139618232|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618233|NCT02992457|Interferons|interferons|mesh-list
139618234|NCT02992457|Ribavirin|ribavirin|mesh-list
139618235|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
139618236|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
139618237|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139618238|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
139618239|NCT02992457|Ledipasvir|ledipasvir|mesh-list
139618240|NCT02992457|Simeprevir|simeprevir|mesh-list
139618241|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139618242|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618243|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
139618244|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618245|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
139618246|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618247|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
139618248|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618249|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
139618250|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618251|NCT02829424|Methotrexate|methotrexate|mesh-list
139618252|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139618253|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
139618254|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139618255|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618256|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139618257|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
139618258|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618259|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618260|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
139618261|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618262|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139618263|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139618264|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
139618265|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139618266|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139618267|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
139618268|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618269|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618270|NCT02740920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139618271|NCT02740920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618272|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
139618273|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618274|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618275|NCT02515227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139618276|NCT02515227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618277|NCT02369458|Mitomycins|mitomycins|mesh-list
139618278|NCT02369458|Mitomycin|mitomycin|mesh-list
139618279|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139618280|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618281|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
139618282|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618283|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139618284|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618285|NCT02122172|Afatinib|afatinib|mesh-list
139618286|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618287|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139618288|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618289|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618290|NCT02052609|Brodalumab|brodalumab|mesh-list
139618291|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
139618292|NCT02031939|Capecitabine|capecitabine|mesh-list
139618293|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
139618294|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139618295|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
139618296|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618297|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618298|NCT01997190|Valacyclovir|valacyclovir|mesh-list
139618299|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
139618300|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618301|NCT01154920|Paclitaxel|paclitaxel|mesh-list
139618302|NCT01154920|Docetaxel|docetaxel|mesh-list
139618303|NCT01154920|Cisplatin|cisplatin|mesh-list
139618304|NCT01154920|Carboplatin|carboplatin|mesh-list
139618305|NCT01154920|Fluorouracil|fluorouracil|mesh-list
139618306|NCT01154920|Cetuximab|cetuximab|mesh-list
139618307|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139618308|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618309|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
139618310|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
139618311|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
139618312|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618313|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
139618314|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139618315|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139618316|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
139618317|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618318|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618319|NCT01028963|Pioglitazone|pioglitazone|mesh-list
139618320|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139618321|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618322|NCT00754845|Letrozole|letrozole|mesh-list
139618323|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618324|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139618325|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139618326|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618327|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618328|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139618329|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
139618330|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618331|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618332|NCT00751270|Valacyclovir|valacyclovir|mesh-list
139618333|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
139618334|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618335|NCT00638612|Valacyclovir|valacyclovir|mesh-list
139618336|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
139618337|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618338|NCT00634231|Valacyclovir|valacyclovir|mesh-list
139618339|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
139618340|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618341|NCT00555555|Factor VIII|factor viii|mesh-list
139618342|NCT00555555|Coagulants|coagulants|mesh-ancestor
139618343|NCT00312039|Lamivudine|lamivudine|mesh-list
139618344|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
139618345|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139400056|NCT01345045|Analgesics|analgesics|mesh-ancestor
139618346|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139618347|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618348|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618349|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
139618350|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618352|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139618353|NCT00095784|Decitabine|decitabine|mesh-list
139618354|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139618355|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
139618356|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618357|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618358|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618359|NCT00083174|Exemestane|exemestane|mesh-list
139618360|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618361|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139618362|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139618363|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618364|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618365|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139618366|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
139618367|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618368|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618369|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
139618370|NCT00070499|Dasatinib|dasatinib|mesh-list
139618371|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618372|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139618373|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618374|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618375|NCT00066573|Anastrozole|anastrozole|mesh-list
139618376|NCT00066573|Exemestane|exemestane|mesh-list
139618377|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139618378|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618379|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139618380|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139618381|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618382|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618383|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139618384|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
139618385|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618386|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618387|NCT03965845|Palbociclib|palbociclib|mesh-list
139618388|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618389|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139618390|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618391|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618392|NCT04766359|Paclitaxel|paclitaxel|mesh-list
139618393|NCT04766359|Cisplatin|cisplatin|mesh-list
139618394|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139618395|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139618396|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618397|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
139618398|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
139618399|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
138703123|NCT01699464|Timolol|timolol|mesh-list
139618400|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618401|NCT04020601|Ropivacaine|ropivacaine|mesh-list
139618402|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
139618403|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
139618404|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139618405|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618406|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
139618407|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618408|NCT04193137|Captopril|captopril|mesh-list
139618409|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139618410|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
139618411|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618412|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618413|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139618414|NCT05060484|Vaccines|vaccines|mesh-list
139618415|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
139618416|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618417|NCT04193059|Paclitaxel|paclitaxel|mesh-list
139618418|NCT04193059|Docetaxel|docetaxel|mesh-list
139618419|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
139618420|NCT04193059|Carboplatin|carboplatin|mesh-list
139618421|NCT04193059|Trastuzumab|trastuzumab|mesh-list
139618422|NCT04193059|Epirubicin|epirubicin|mesh-list
139618423|NCT04193059|Pertuzumab|pertuzumab|mesh-list
139618424|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139618425|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618426|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
139618427|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
139618428|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
139618429|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618430|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139618431|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
139618432|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618433|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139618434|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139618435|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
139618436|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139618437|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618438|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139618439|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139618440|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139618441|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618442|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
139618443|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139618444|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
139618445|NCT05092074|Velpatasvir|velpatasvir|mesh-list
139618446|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
139618447|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618448|NCT02080273|Listerine|listerine|mesh-list
139618449|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
139618450|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
139618451|NCT02080273|Protective Agents|protective agents|mesh-ancestor
139618452|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618453|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139618454|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618455|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
139618456|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139618457|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
139618458|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
139618459|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139618460|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618461|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139618462|NCT04199143|Analgesics|analgesics|mesh-ancestor
139618463|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
139618464|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618465|NCT04616274|Venetoclax|venetoclax|mesh-list
139618466|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618467|NCT04613622|Venetoclax|venetoclax|mesh-list
139618468|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618469|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139618470|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139618471|NCT05096676|Oxytocin|oxytocin|mesh-list
139618472|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
139618473|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139618474|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618475|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
139618476|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618477|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618478|NCT03948763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139618479|NCT03948763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618480|NCT05096520|Lidocaine|lidocaine|mesh-list
139618481|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
139618482|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
139618483|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139618484|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618485|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
139618486|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618487|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139618488|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139618489|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139618490|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139618491|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618492|NCT03832465|Levofloxacin|levofloxacin|mesh-list
139618493|NCT03832465|Ofloxacin|ofloxacin|mesh-list
139618494|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139618495|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139618496|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618497|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139618498|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139618499|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139400207|NCT02152475|Curcumin|curcumin|mesh-list
139618500|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618501|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618502|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618503|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139618504|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139618505|NCT04190173|Prucalopride|prucalopride|mesh-list
139618506|NCT04190173|Laxatives|laxatives|mesh-ancestor
139618507|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139618508|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139618509|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139618510|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
139618511|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139618512|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618513|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618514|NCT01272219|Liraglutide|liraglutide|mesh-list
139618515|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139618516|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618517|NCT01272219|Incretins|incretins|mesh-ancestor
139618518|NCT01272219|Hormones|hormones|mesh-ancestor
139618519|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618520|NCT04020133|Epinephrine|epinephrine|mesh-list
139618521|NCT04020133|Bupivacaine|bupivacaine|mesh-list
138746915|NCT01166763|Vitamin D|vitamin d|mesh-list
139618522|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
139618523|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
139618524|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139618525|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618526|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
139618527|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618528|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139618529|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139618530|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
139618531|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139618532|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618533|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139618534|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139618535|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
139618536|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139618537|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
139618538|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
139618539|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
139618540|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139618541|NCT04565574|Rifampin|rifampin|mesh-list
139618542|NCT04565574|Rabeprazole|rabeprazole|mesh-list
139618543|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139618544|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139618545|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139618546|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618547|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618548|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139618549|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
139618550|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139618551|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618552|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
139618553|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139618554|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139618555|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139618556|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139618557|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139618558|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139618559|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139618560|NCT01270971|Tavaborole|tavaborole|mesh-list
139618561|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139618562|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
139618563|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618564|NCT04026841|Antibodies|antibodies|mesh-list
139618565|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
139618566|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618567|NCT04128774|Dexamethasone|dexamethasone|mesh-list
139618568|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
139618569|NCT04128774|BB 1101|bb 1101|mesh-list
139618570|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139618571|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
139618572|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
139618573|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618574|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618575|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139618576|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
139618577|NCT04128774|Hormones|hormones|mesh-ancestor
139618578|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618579|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139618580|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618581|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
139618582|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618583|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618584|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
139618585|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139618586|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
139618587|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618588|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
139618589|NCT00732225|Protective Agents|protective agents|mesh-ancestor
139618590|NCT04026685|Phenylephrine|phenylephrine|mesh-list
139618591|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
139618592|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139618593|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
139618594|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
139618595|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618596|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618597|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
139618598|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139618599|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
139618600|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
139618601|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139618602|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139618603|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139618604|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
139618605|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139618606|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618607|NCT04026685|Protective Agents|protective agents|mesh-ancestor
139618608|NCT00751179|Bromides|bromides|mesh-list
139618609|NCT00751179|Rocuronium|rocuronium|mesh-list
139618610|NCT00751179|Succinylcholine|succinylcholine|mesh-list
139618611|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
139618612|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139618613|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139618614|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139618615|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618616|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618617|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139618618|NCT01273233|Vaccines|vaccines|mesh-list
139618619|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
139618620|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618621|NCT01277211|NuvaRing|nuvaring|mesh-list
139618622|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139618623|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
139618624|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139618625|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618626|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
139618627|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139618628|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
139618629|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618630|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618631|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139618632|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
139618633|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139618634|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
139618635|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618636|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139618637|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139618638|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
139618639|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
139618640|NCT04022161|Protective Agents|protective agents|mesh-ancestor
139618641|NCT01676220|Insulin|insulin|mesh-list
139618642|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139618643|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
139618644|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139618645|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618646|NCT01275105|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139618647|NCT01275105|Phenylephrine|phenylephrine|mesh-list
139618648|NCT01275105|Oxymetazoline|oxymetazoline|mesh-list
139618649|NCT01275105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138747056|NCT00956293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139618650|NCT01275105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139618651|NCT01275105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139618652|NCT01275105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139618653|NCT01275105|Adrenergic Agents|adrenergic agents|mesh-ancestor
139618654|NCT01275105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139618655|NCT01275105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618656|NCT01275105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618657|NCT01275105|Sympathomimetics|sympathomimetics|mesh-ancestor
139618658|NCT01275105|Autonomic Agents|autonomic agents|mesh-ancestor
139618659|NCT01275105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618660|NCT01275105|Nasal Decongestants|nasal decongestants|mesh-ancestor
139618661|NCT01275105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139618662|NCT01275105|Respiratory System Agents|respiratory system agents|mesh-ancestor
139618663|NCT01275105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139618664|NCT01275105|Mydriatics|mydriatics|mesh-ancestor
139618665|NCT01275105|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139618666|NCT01275105|Protective Agents|protective agents|mesh-ancestor
139618667|NCT01270347|Levofloxacin|levofloxacin|mesh-list
139618668|NCT01270347|Ofloxacin|ofloxacin|mesh-list
139618669|NCT01270347|Tobramycin|tobramycin|mesh-list
139618670|NCT01270347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139618671|NCT01270347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139618672|NCT01270347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618673|NCT01270347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139618674|NCT01270347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139618675|NCT01270347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139618676|NCT01270347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618677|NCT01270347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618678|NCT01270347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618679|NCT01270347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139618680|NCT01270347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139618681|NCT03608436|Bromides|bromides|mesh-list
139618682|NCT03608436|Rocuronium|rocuronium|mesh-list
139618683|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
139618684|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139618685|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139618686|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139618687|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618688|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618689|NCT04025671|Naloxone|naloxone|mesh-list
139618690|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139618691|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618692|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
139618693|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618694|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139618695|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
139618696|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618697|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
139618698|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618699|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139618700|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
139618701|NCT03412188|Hormones|hormones|mesh-ancestor
139618702|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618703|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139618704|NCT03412188|Protective Agents|protective agents|mesh-ancestor
139618705|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139618706|NCT01278849|Vadimezan|vadimezan|mesh-list
139618707|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618708|NCT04949412|Vitamin D|vitamin d|mesh-list
139618709|NCT04949412|Vitamins|vitamins|mesh-ancestor
139618710|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
139618711|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618712|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139618713|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139618714|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
139618715|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139618716|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
139618717|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618718|NCT01485614|Metformin|metformin|mesh-list
139618719|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139618720|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139618721|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618722|NCT01485614|Incretins|incretins|mesh-ancestor
139618723|NCT01485614|Hormones|hormones|mesh-ancestor
139618724|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618725|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139400429|NCT02774681|Trastuzumab|trastuzumab|mesh-list
139618726|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
139618727|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618728|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618730|NCT00722553|Folic Acid|folic acid|mesh-list
139618731|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
139618732|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
139618733|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
139618734|NCT00722553|Aminopterin|aminopterin|mesh-list
139618735|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
139618736|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618737|NCT00722553|Hematinics|hematinics|mesh-ancestor
139618738|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139618739|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618740|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618741|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618742|NCT03022747|Allopurinol|allopurinol|mesh-list
139618743|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
139618744|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618745|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618746|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
139618747|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139618748|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139618749|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
139618750|NCT03022747|Protective Agents|protective agents|mesh-ancestor
139618751|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618752|NCT03928015|Analgesics|analgesics|mesh-list
139618753|NCT03928015|Dronabinol|dronabinol|mesh-list
139618754|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
139618755|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618756|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618757|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
139618758|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139618759|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139618760|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139618761|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139618762|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139618763|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618764|NCT03928015|Hormones|hormones|mesh-ancestor
139618765|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618766|NCT00735969|Ribavirin|ribavirin|mesh-list
139618767|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
139618768|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618769|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
139618770|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618771|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
139618772|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618773|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
139618774|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139618775|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139618776|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618777|NCT03229512|Urological Agents|urological agents|mesh-ancestor
139618778|NCT01279083|Timolol|timolol|mesh-list
139618779|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139618780|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618781|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139618782|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139618783|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
139618784|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139618785|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618786|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139618787|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139618788|NCT03022201|Domperidone|domperidone|mesh-list
139618789|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
139618790|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
139618791|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618792|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618793|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139618794|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139618795|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
139618796|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139618797|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618798|NCT04716114|Cytarabine|cytarabine|mesh-list
139618799|NCT04716114|Fludarabine|fludarabine|mesh-list
139400505|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
139618800|NCT04716114|Azacitidine|azacitidine|mesh-list
139618801|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
139618802|NCT04716114|Aclarubicin|aclarubicin|mesh-list
139618803|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618804|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139618805|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
139618806|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618807|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139618808|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
139618809|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618810|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
139618811|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618812|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618813|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139618814|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139618815|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139618816|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139618817|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139618818|NCT00752973|Malathion|malathion|mesh-list
139618819|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139618820|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618821|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618822|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
139618823|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139618824|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618825|NCT04025593|Prednisone|prednisone|mesh-list
139618826|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
139618827|NCT04025593|Rituximab|rituximab|mesh-list
139618828|NCT04025593|Doxorubicin|doxorubicin|mesh-list
139618829|NCT04025593|Vincristine|vincristine|mesh-list
139618830|NCT04025593|Lenalidomide|lenalidomide|mesh-list
139618831|NCT04025593|Decitabine|decitabine|mesh-list
139618832|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139618833|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
139618834|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618835|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139618836|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139618837|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
139618838|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618839|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618840|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139618841|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618842|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139618843|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139618844|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139618845|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618846|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139618847|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
139618848|NCT04025593|Hormones|hormones|mesh-ancestor
139618849|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618850|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139618851|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139618852|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
139618853|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
139618854|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
139618855|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139618856|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139618857|NCT04025593|Growth Substances|growth substances|mesh-ancestor
139618858|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
139618859|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139618860|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
139618861|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139618862|NCT01279707|Epratuzumab|epratuzumab|mesh-list
139618863|NCT01279707|Veltuzumab|veltuzumab|mesh-list
139618864|NCT01279707|Antibodies|antibodies|mesh-list
139618865|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
139618866|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139618867|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
139618868|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618869|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618870|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
139618871|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139618872|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
139618873|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139618874|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618875|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139618876|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139618878|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
139618879|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618880|NCT03022123|Prednisone|prednisone|mesh-list
139618881|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
139618882|NCT03022123|Doxorubicin|doxorubicin|mesh-list
139618883|NCT03022123|Vincristine|vincristine|mesh-list
139618884|NCT03022123|Epirubicin|epirubicin|mesh-list
139618885|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139618886|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
139618887|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618888|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139618889|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139618890|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
139618891|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618892|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618893|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139618894|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139618895|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139618896|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139618897|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618898|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139618899|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
139618900|NCT03022123|Hormones|hormones|mesh-ancestor
139618901|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618902|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139618903|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139618904|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
139618905|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
139618906|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor
139618907|NCT00722865|Bevacizumab|bevacizumab|mesh-list
139618908|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139618909|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618910|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139618911|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139618912|NCT00722865|Growth Substances|growth substances|mesh-ancestor
139618913|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618914|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
139618915|NCT02700529|Ubenimex|ubenimex|mesh-list
139618916|NCT02700529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139618917|NCT02700529|Immunologic Factors|immunologic factors|mesh-ancestor
139618918|NCT02700529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618919|NCT02700529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139618920|NCT02700529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618921|NCT02700529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139618922|NCT02700529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618923|NCT02700529|Protease Inhibitors|protease inhibitors|mesh-ancestor
139618924|NCT02700529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618925|NCT02700529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618926|NCT02700529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139618927|NCT02700529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139618928|NCT02700529|Antiviral Agents|antiviral agents|mesh-ancestor
139618929|NCT00723099|Cyclosporine|cyclosporine|mesh-list
139618930|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
139618931|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
139618932|NCT00723099|Fludarabine|fludarabine|mesh-list
139618933|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
139618934|NCT00723099|Cyclosporins|cyclosporins|mesh-list
139618935|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139618936|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
139618937|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618938|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139618939|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139618940|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
139618941|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618942|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618943|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139618944|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139618945|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
139618946|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139618947|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
139618948|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139618949|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
139618950|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139618951|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139400708|NCT02266927|Xhance|xhance|mesh-list
139618952|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139618953|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
139618954|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139618955|NCT01508936|Reslizumab|reslizumab|mesh-list
139618956|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139618957|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
139618958|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
139618959|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139618960|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
139618961|NCT04146259|Calcium|calcium|mesh-list
139618962|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139618963|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618964|NCT04146259|Antacids|antacids|mesh-ancestor
139618965|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618966|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139618967|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139618968|NCT04146259|Vitamins|vitamins|mesh-ancestor
139618969|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
139618970|NCT05100186|Dexamethasone|dexamethasone|mesh-list
138747398|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747399|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138747400|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138747401|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138747402|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747403|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
138747404|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
139618971|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139618972|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
139618973|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
139618974|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618975|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618976|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139618977|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
139618978|NCT05100186|Hormones|hormones|mesh-ancestor
139618979|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139618980|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139618981|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139618982|NCT04323462|Insulin|insulin|mesh-list
139618983|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139618984|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
139618985|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139618986|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618987|NCT00723177|Ibudilast|ibudilast|mesh-list
139618988|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139618989|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
139618990|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139618991|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618992|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139618993|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
139618994|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139618995|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550805|NCT00257257|Hormones|hormones|mesh-ancestor
138747431|NCT01162473|Caseins|caseins|mesh-list
138747432|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
138747433|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
138666893|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139081965|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081966|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081967|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139618996|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139618997|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139618998|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
139618999|NCT04318392|Dimercaprol|dimercaprol|mesh-list
139619000|NCT04318392|Chelating Agents|chelating agents|mesh-ancestor
139619001|NCT04318392|Sequestering Agents|sequestering agents|mesh-ancestor
139619002|NCT04318392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619003|NCT04698434|Esketamine|esketamine|mesh-list
139619004|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
139619005|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139619006|NCT04142749|Oltipraz|oltipraz|mesh-list
139619007|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
139081968|NCT01052051|Vitamin D|vitamin d|mesh-list
138747435|NCT01162239|Varenicline|varenicline|mesh-list
139619008|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619009|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
139619010|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139619011|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
139619012|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139619013|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139619014|NCT04142749|Protective Agents|protective agents|mesh-ancestor
139619015|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619016|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619017|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139619018|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139619019|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619020|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619021|NCT01508702|Lesinurad|lesinurad|mesh-list
139619022|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
139619023|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139619024|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
139619025|NCT04024813|Seladelpar|seladelpar|mesh-list
139619026|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139619027|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
139619028|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619029|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139619030|NCT01276041|Paclitaxel|paclitaxel|mesh-list
139619031|NCT01276041|Trastuzumab|trastuzumab|mesh-list
139619032|NCT01276041|Pertuzumab|pertuzumab|mesh-list
139619033|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139619034|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619035|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
139619036|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
139619037|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
139619038|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619039|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139619040|NCT04150770|Infliximab|infliximab|mesh-list
139619041|NCT04150770|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139619042|NCT04150770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139619043|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
139619044|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139619045|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139619046|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
139619047|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
139619048|NCT04026438|Protective Agents|protective agents|mesh-ancestor
139619049|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619050|NCT01275339|Tadalafil|tadalafil|mesh-list
139619051|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
139619052|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139619053|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139619054|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619055|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619056|NCT01275339|Urological Agents|urological agents|mesh-ancestor
139619057|NCT01520402|Warfarin|warfarin|mesh-list
139619058|NCT01520402|Anticoagulants|anticoagulants|mesh-list
139619059|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
139619060|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139619061|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619062|NCT05108220|Cannabidiol|cannabidiol|mesh-list
139619063|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
139619064|NCT03027674|Nifedipine|nifedipine|mesh-list
139619065|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
139619066|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
139619067|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139619068|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138747471|NCT01232556|Gemcitabine|gemcitabine|mesh-list
139619069|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619070|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619071|NCT03027674|Urological Agents|urological agents|mesh-ancestor
139619072|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139619073|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139619074|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139619075|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619076|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
139619077|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139619078|NCT04094948|Clenbuterol|clenbuterol|mesh-list
139619079|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139619080|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139619081|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
139619082|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619083|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619084|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619085|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139619086|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
139619087|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619088|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139619089|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
139619090|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
139619091|NCT04023565|Perindopril|perindopril|mesh-list
139619092|NCT04023565|Moxonidine|moxonidine|mesh-list
139619093|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139619094|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
139619095|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619096|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619097|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139619098|NCT01506908|Nicotine|nicotine|mesh-list
139619099|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139619100|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
139619101|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619102|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619103|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139619104|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139619106|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619107|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619108|NCT01519778|Tedizolid|tedizolid|mesh-list
139619109|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139619110|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619111|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
139619112|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139619113|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139619114|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619115|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139619116|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619117|NCT04149067|Incretins|incretins|mesh-ancestor
139619118|NCT04149067|Hormones|hormones|mesh-ancestor
139619119|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139619120|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139619121|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
139619122|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619123|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
139619124|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
139619125|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619126|NCT05087862|Anesthetics|anesthetics|mesh-list
139619127|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
139619128|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619129|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619130|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
139619131|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619132|NCT01519700|Lenograstim|lenograstim|mesh-list
139619133|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139619134|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
139619135|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619136|NCT04143685|Misoprostol|misoprostol|mesh-list
139619137|NCT04143685|Oxytocin|oxytocin|mesh-list
139619138|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
139619139|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139619140|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619141|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139619142|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
139619143|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139619144|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139619145|NCT04148599|Lidocaine|lidocaine|mesh-list
139619146|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
139619147|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
139619148|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
139619149|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619150|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619151|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
139619152|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619153|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139619154|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139619155|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139619156|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139619157|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619158|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139619159|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139619160|NCT04148599|Analgesics|analgesics|mesh-ancestor
139619161|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139619162|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139619163|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139619164|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
139619165|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619166|NCT04930458|Listerine|listerine|mesh-list
139619167|NCT04930458|Calcium|calcium|mesh-list
139619168|NCT04930458|Fluorides|fluorides|mesh-list
139619169|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
139619170|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
139619171|NCT04930458|Caseins|caseins|mesh-list
139619172|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139619173|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619174|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
139619175|NCT04930458|Protective Agents|protective agents|mesh-ancestor
139619176|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139619177|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619178|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
139619179|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
139619180|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619182|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
139619183|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
139619184|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619185|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619186|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
139619187|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619188|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139619189|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139619190|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139619191|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139619192|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619193|NCT04022317|Insulin|insulin|mesh-list
139619194|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139619195|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619196|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
139619197|NCT05099250|Bupivacaine|bupivacaine|mesh-list
139619198|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
139619199|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
139619200|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619201|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619202|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
139619203|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619204|NCT05099250|Analgesics|analgesics|mesh-ancestor
139619205|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139619206|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
139619207|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139619208|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139619209|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619210|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139619211|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
139619212|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139619213|NCT04143451|Imiquimod|imiquimod|mesh-list
139619214|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139619215|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
139619216|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619217|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619218|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
139619219|NCT05105412|Gemcitabine|gemcitabine|mesh-list
139619220|NCT05105412|Lenalidomide|lenalidomide|mesh-list
139619221|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139619222|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
139619223|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619224|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619225|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
139619226|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619227|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139619228|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139619229|NCT05105412|Growth Substances|growth substances|mesh-ancestor
139619230|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
139619231|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
139619232|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139619233|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619234|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619235|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139619236|NCT04766047|Analgesics|analgesics|mesh-ancestor
139619237|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
139619238|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619239|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139619240|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139619241|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139619242|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
139619243|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619244|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619245|NCT02080819|Levodopa|levodopa|mesh-list
139619246|NCT02080819|Carbidopa|carbidopa|mesh-list
139619247|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139619248|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139619249|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
139619250|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619251|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619252|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619253|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139619254|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619255|NCT05104788|Carboplatin|carboplatin|mesh-list
139619256|NCT05104788|Pemetrexed|pemetrexed|mesh-list
139619257|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619258|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619259|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619260|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139619261|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139619262|NCT04405843|Ivermectin|ivermectin|mesh-list
139619263|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139619264|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619265|NCT04316364|Paclitaxel|paclitaxel|mesh-list
139619266|NCT04316364|Carboplatin|carboplatin|mesh-list
139619267|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139619268|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619269|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
139619270|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
139619271|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
139619272|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619273|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
139619274|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139619275|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619276|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
139619277|NCT04018872|Itraconazole|itraconazole|mesh-list
139619278|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
139619279|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747690|NCT01153269|Ritonavir|ritonavir|mesh-list
139619280|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139619281|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139619282|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619283|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619284|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139619285|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
139619286|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139619287|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619288|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139619289|NCT05076786|Carboplatin|carboplatin|mesh-list
139619290|NCT05076786|Etoposide|etoposide|mesh-list
139619291|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619292|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139619293|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139619294|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139619295|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619296|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619297|NCT03476317|Vancomycin|vancomycin|mesh-list
139619298|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
139619299|NCT03476317|Neomycin|neomycin|mesh-list
139619300|NCT03476317|Fluconazole|fluconazole|mesh-list
139619301|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139619302|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139619303|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619304|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139619305|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139619306|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619307|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619308|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619309|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139619310|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139619311|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
139619312|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139619313|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139619314|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
139619315|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139619316|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619317|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139619318|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139619319|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139619320|NCT03476317|Laxatives|laxatives|mesh-ancestor
139619321|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139619322|NCT02658084|Trastuzumab|trastuzumab|mesh-list
139619323|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139619324|NCT02658084|Vinorelbine|vinorelbine|mesh-list
139619325|NCT02658084|Maytansine|maytansine|mesh-list
139619326|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139619327|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619328|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139619329|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
139619330|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
139619331|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
139619332|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619333|NCT02658084|Immunotoxins|immunotoxins|mesh-ancestor
139619334|NCT02658084|Immunoconjugates|immunoconjugates|mesh-ancestor
139619335|NCT02658084|Immunologic Factors|immunologic factors|mesh-ancestor
139619336|NCT02658084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619337|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139619338|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139619339|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619340|NCT03588715|Interferons|interferons|mesh-list
139619341|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
139619342|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
139619343|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138747755|NCT01149369|Aprepitant|aprepitant|mesh-list
139619344|NCT03588715|Antibodies, Blocking|antibodies, blocking|mesh-list
139619345|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619346|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
139619347|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619348|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
139619349|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619350|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
139619351|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619352|NCT04140409|Octreotide|octreotide|mesh-list
139619353|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139619354|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139619355|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619356|NCT03912805|Botulinum Toxins|botulinum toxins|mesh-list
139619357|NCT03912805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139619358|NCT03912805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139619359|NCT03912805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139619360|NCT03912805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139619361|NCT03912805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619362|NCT03912805|Cholinergic Agents|cholinergic agents|mesh-ancestor
139619363|NCT03912805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619364|NCT03912805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619365|NCT03912805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139619366|NCT03912805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619367|NCT04642950|Sargramostim|sargramostim|mesh-list
139619368|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
139619369|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619370|NCT04374240|Tretazicar|tretazicar|mesh-list
139619371|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619372|NCT05109390|Cyclosporine|cyclosporine|mesh-list
139619373|NCT05109390|Simethicone|simethicone|mesh-list
139619374|NCT05109390|Omeprazole|omeprazole|mesh-list
139619375|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
139619376|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
139619377|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139619378|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
139619379|NCT05109390|Antacids|antacids|mesh-list
139619380|NCT05109390|Tacrolimus|tacrolimus|mesh-list
139619381|NCT05109390|Cyclosporins|cyclosporins|mesh-list
139619382|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619383|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139619384|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
139619385|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139619386|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619387|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619388|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
139619389|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619390|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
139619391|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139619392|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139619393|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139619394|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
139619395|NCT05109390|Emollients|emollients|mesh-ancestor
139619396|NCT04030182|Vitamin D|vitamin d|mesh-list
139619397|NCT04030182|Vitamins|vitamins|mesh-ancestor
139619398|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
139619399|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619400|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139619401|NCT03661632|Nivolumab|nivolumab|mesh-list
139619402|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139619403|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619404|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139619405|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619406|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
139619407|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139619408|NCT04748250|Estrogens|estrogens|mesh-ancestor
139619409|NCT04748250|Hormones|hormones|mesh-ancestor
139619410|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139619411|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619412|NCT04726878|Acetaminophen|acetaminophen|mesh-list
139619413|NCT04726878|Oxycodone|oxycodone|mesh-list
139619414|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619415|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619416|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139619417|NCT04726878|Analgesics|analgesics|mesh-ancestor
139619418|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
139619419|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619420|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
139619421|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139619422|NCT04726878|Narcotics|narcotics|mesh-ancestor
139619423|NCT04525638|Nivolumab|nivolumab|mesh-list
139619424|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139619425|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139619426|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619427|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139619428|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619429|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139619430|NCT01482962|Gemcitabine|gemcitabine|mesh-list
139619431|NCT01482962|Romidepsin|romidepsin|mesh-list
139619432|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139619433|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
139619434|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619435|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619436|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139619437|NCT01482962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139619438|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619439|NCT04701060|Apatinib|apatinib|mesh-list
139619440|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619441|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139619442|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619443|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619444|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139619445|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
139619446|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619447|NCT05116098|Protective Agents|protective agents|mesh-ancestor
139619448|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619449|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139619450|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139619451|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619452|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139619453|NCT04464408|Favipiravir|favipiravir|mesh-list
139619454|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
139619455|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619456|NCT04339218|Carboplatin|carboplatin|mesh-list
139619457|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
139619458|NCT04339218|Pemetrexed|pemetrexed|mesh-list
139619459|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619460|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139619461|NCT04339218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139619462|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619463|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619464|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139619465|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139619466|NCT03895801|Prednisone|prednisone|mesh-list
139619467|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
139619468|NCT03895801|Vilobelimab|vilobelimab|mesh-list
139619469|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139619470|NCT03895801|Hormones|hormones|mesh-ancestor
139619471|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139619472|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619473|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139619474|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619475|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139619476|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139619477|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
139619478|NCT03021421|Bupivacaine|bupivacaine|mesh-list
139619479|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
139619481|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619482|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619483|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
139619484|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619485|NCT04521582|Amlodipine|amlodipine|mesh-list
139619486|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139619487|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139619488|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139619489|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619490|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139619491|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619492|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
139619493|NCT03588091|Docetaxel|docetaxel|mesh-list
139619494|NCT03588091|Trastuzumab|trastuzumab|mesh-list
139619495|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619496|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
139619497|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
139619498|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
139619499|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619500|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139619501|NCT04436172|Anesthetics|anesthetics|mesh-list
139619502|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619503|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619504|NCT03587779|Sevoflurane|sevoflurane|mesh-list
139619505|NCT03587779|Desflurane|desflurane|mesh-list
138747928|NCT00943111|Eliglustat|eliglustat|mesh-list
139619506|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139619507|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139619508|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
139619509|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
139619510|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619511|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619512|NCT04405921|Azithromycin|azithromycin|mesh-list
139619513|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
139619514|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139619515|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619516|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
139619517|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139619518|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139619519|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619520|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619521|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139619522|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139619523|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139619524|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
139619525|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619526|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139619527|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
139619528|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619529|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619530|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139619531|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139619532|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139619533|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
139619534|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139619535|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139619536|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
139619537|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
139619538|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
139619539|NCT03581149|Laxatives|laxatives|mesh-list
139619540|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619541|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
139619542|NCT03581149|Protective Agents|protective agents|mesh-ancestor
139619543|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619544|NCT03581149|Vitamins|vitamins|mesh-ancestor
139619545|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
139619546|NCT03581149|Cathartics|cathartics|mesh-ancestor
139619547|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139619548|NCT05583409|Osimertinib|osimertinib|mesh-list
139619549|NCT05583409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619550|NCT05583409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139619551|NCT05583409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619552|NCT05583409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619553|NCT03020953|Estrogens|estrogens|mesh-list
139619554|NCT03020953|Hormones|hormones|mesh-ancestor
139619555|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139619556|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619558|NCT03580681|Vitamins|vitamins|mesh-ancestor
139619559|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
139619560|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619561|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
139619562|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619563|NCT03580681|Protective Agents|protective agents|mesh-ancestor
139619564|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
139619565|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139619566|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
139619567|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619568|NCT03069300|Expectorants|expectorants|mesh-ancestor
139619569|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
139619570|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139619571|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
139619572|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619573|NCT03069300|Protective Agents|protective agents|mesh-ancestor
139619574|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619575|NCT03069300|Antidotes|antidotes|mesh-ancestor
139619576|NCT05582317|Simvastatin|simvastatin|mesh-list
139619577|NCT05582317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139619578|NCT05582317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139619579|NCT05582317|Antimetabolites|antimetabolites|mesh-ancestor
139619580|NCT05582317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619581|NCT05582317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139619582|NCT05582317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139619583|NCT05582317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619584|NCT03891355|Dexamethasone|dexamethasone|mesh-list
139619585|NCT03891355|Lenalidomide|lenalidomide|mesh-list
139619586|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139619587|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
139619588|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
139619589|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619590|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619591|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139619592|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
139619593|NCT03891355|Hormones|hormones|mesh-ancestor
139619594|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139619595|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139619596|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619597|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
139619598|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139619599|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139619600|NCT03891355|Growth Substances|growth substances|mesh-ancestor
139619601|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
139619602|NCT03954132|Cholinergic Agents|cholinergic agents|mesh-list
139619603|NCT03954132|Muscarinic Antagonists|muscarinic antagonists|mesh-list
139619604|NCT03954132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619605|NCT03954132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619606|NCT03954132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619607|NCT03954132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139619608|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
139619609|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139619610|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619611|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139619612|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
139619613|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139619614|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619615|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619616|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619617|NCT02936388|Cisplatin|cisplatin|mesh-list
139619618|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619619|NCT03586141|Chrysarobin|chrysarobin|mesh-list
139619620|NCT03586141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139619621|NCT03586141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139619622|NCT03586141|Analgesics|analgesics|mesh-ancestor
139619623|NCT03586141|Sensory System Agents|sensory system agents|mesh-ancestor
139619624|NCT03586141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619625|NCT03586141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619626|NCT03586141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138748036|NCT01145625|Minoxidil|minoxidil|mesh-list
139619627|NCT03586141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139619628|NCT03020563|Bupivacaine|bupivacaine|mesh-list
139401335|NCT00782431|Vaccines|vaccines|mesh-list
139619629|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
139619630|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
139619631|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619632|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619633|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
139619634|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619635|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
139619636|NCT04591626|Dulaglutide|dulaglutide|mesh-list
139619637|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139619638|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619639|NCT03580135|Propolis|propolis|mesh-list
139619640|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619641|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139619642|NCT03901573|Atezolizumab|atezolizumab|mesh-list
139619643|NCT03901573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139619644|NCT03901573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619645|NCT03901573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139619646|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619647|NCT03585829|Prednisolone|prednisolone|mesh-list
139619648|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
139619649|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139619650|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
139619651|NCT03585829|Hormones|hormones|mesh-ancestor
139619652|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139619653|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619654|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139619655|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619656|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139619657|NCT03585751|Simvastatin|simvastatin|mesh-list
139619658|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619659|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139619660|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139619661|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
139619662|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619663|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139619664|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139619665|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619666|NCT03583333|Linezolid|linezolid|mesh-list
139619667|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139619668|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619669|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139619670|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619671|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619672|NCT03585673|Docetaxel|docetaxel|mesh-list
139619673|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
139619674|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619675|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
139619676|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
139619677|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
139619678|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619679|NCT01602510|Lamotrigine|lamotrigine|mesh-list
139619680|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
139619681|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139619682|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139619683|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619684|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139619685|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619686|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139619687|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139619688|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619689|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139619690|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139619691|NCT05701813|Inositol|inositol|mesh-list
139619692|NCT05701813|Vitamin B Complex|vitamin b complex|mesh-ancestor
139619693|NCT05701813|Vitamins|vitamins|mesh-ancestor
139619694|NCT05701813|Micronutrients|micronutrients|mesh-ancestor
139619695|NCT05701813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619696|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
139619697|NCT03586219|Narcotics|narcotics|mesh-ancestor
139619698|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619699|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619700|NCT03586219|Analgesics|analgesics|mesh-ancestor
139619701|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
139619702|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619703|NCT05118984|Azithromycin|azithromycin|mesh-list
139619704|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139619705|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619706|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139619707|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139619708|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619709|NCT02802852|Lenograstim|lenograstim|mesh-list
139619710|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139619711|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
139619712|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619713|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
139619714|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139619715|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
139619716|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619717|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139619718|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139619719|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
139619720|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619721|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619722|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139619723|NCT05118048|Chrysarobin|chrysarobin|mesh-list
139619724|NCT05118048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139619725|NCT05118048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139619726|NCT05118048|Analgesics|analgesics|mesh-ancestor
139619727|NCT05118048|Sensory System Agents|sensory system agents|mesh-ancestor
139619728|NCT05118048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619729|NCT05118048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619730|NCT05118048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139619731|NCT05118048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139619732|NCT04405375|Dexamethasone|dexamethasone|mesh-list
139619733|NCT04405375|Etoposide|etoposide|mesh-list
139619734|NCT04405375|Pegaspargase|pegaspargase|mesh-list
139619735|NCT04405375|Gemcitabine|gemcitabine|mesh-list
139619736|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139619737|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
139619738|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
139619739|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619740|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619741|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139619742|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
139619743|NCT04405375|Hormones|hormones|mesh-ancestor
139619744|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139619745|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139619746|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619747|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139619748|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139619749|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139619750|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619751|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619752|NCT04405375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139619753|NCT04405375|Antimetabolites|antimetabolites|mesh-ancestor
139619754|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
139619755|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
139619756|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619757|NCT03029611|Paclitaxel|paclitaxel|mesh-list
139619758|NCT03029611|Carboplatin|carboplatin|mesh-list
139619759|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139619760|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139619761|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619762|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
139619763|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
139619764|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
139619765|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619766|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
139619767|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139619768|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
139619769|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619770|NCT03589495|Expectorants|expectorants|mesh-ancestor
139619771|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
139619772|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139619773|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
139619774|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619775|NCT03589495|Protective Agents|protective agents|mesh-ancestor
139619776|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619777|NCT03589495|Antidotes|antidotes|mesh-ancestor
139619778|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139619779|NCT03159559|Alprostadil|alprostadil|mesh-list
139619781|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619782|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619783|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139619784|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139619785|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139619786|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139619787|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
139619788|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619789|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
139619790|NCT03159559|Urological Agents|urological agents|mesh-ancestor
139619791|NCT03159403|Oritavancin|oritavancin|mesh-list
139619792|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139619793|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619794|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
139619795|NCT03583567|Ranitidine|ranitidine|mesh-list
139619796|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139619797|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139619798|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138748208|NCT00604357|Sirolimus|sirolimus|mesh-list
139619799|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139619800|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
139619801|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
139619802|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619803|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619804|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619805|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
139619806|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
139619807|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139619808|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139619809|NCT03583489|Ondansetron|ondansetron|mesh-list
139619810|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
139619811|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
139619812|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619813|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619814|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139619815|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
139619816|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
139619817|NCT03583489|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139619818|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139619819|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
139619820|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619821|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619822|NCT03158935|Aldesleukin|aldesleukin|mesh-list
139619823|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
139619824|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
139619825|NCT03158935|Fludarabine|fludarabine|mesh-list
139619826|NCT03158935|Interleukin-2|interleukin-2|mesh-list
139619827|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139619828|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
139619829|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619830|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139619831|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139619832|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
139619833|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619834|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619835|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139619836|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139619837|NCT03158935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139619838|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139619839|NCT03158935|Analgesics|analgesics|mesh-ancestor
139619840|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
139619841|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619842|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139619843|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139619844|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
139619845|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619846|NCT04818372|Dexamethasone|dexamethasone|mesh-list
139619847|NCT04818372|Lenalidomide|lenalidomide|mesh-list
139619848|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139619849|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
139619850|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
139619851|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619852|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619853|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139619854|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
139619855|NCT04818372|Hormones|hormones|mesh-ancestor
139619856|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139619857|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139619858|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619859|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
139619860|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139619861|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139619862|NCT04818372|Growth Substances|growth substances|mesh-ancestor
139619863|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
139619865|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139619866|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
139619867|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619868|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619869|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619870|NCT03059173|Inositol|inositol|mesh-list
139619871|NCT03059173|Clomiphene|clomiphene|mesh-list
139619872|NCT03059173|Enclomiphene|enclomiphene|mesh-list
139619873|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
139619874|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139619875|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
139619876|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139619877|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748290|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
139619878|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139619879|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
139619880|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139619881|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139619882|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139619883|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
139619884|NCT03059173|Vitamins|vitamins|mesh-ancestor
139619885|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
139619886|NCT05122338|Lidocaine|lidocaine|mesh-list
139619887|NCT05122338|Ropivacaine|ropivacaine|mesh-list
139619888|NCT05122338|Esketamine|esketamine|mesh-list
139619889|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
139619890|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
139619891|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619892|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619893|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
139619894|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619895|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139619896|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139619897|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139619898|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139619899|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619900|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
139619901|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139619902|NCT03157843|Heparin|heparin|mesh-list
139619903|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139619904|NCT03157843|Tinzaparin|tinzaparin|mesh-list
139619905|NCT03157843|Dalteparin|dalteparin|mesh-list
139619906|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
139619907|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139619908|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139619909|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619910|NCT03589027|Ritonavir|ritonavir|mesh-list
139619911|NCT03589027|Darunavir|darunavir|mesh-list
139619912|NCT03589027|Rilpivirine|rilpivirine|mesh-list
139619913|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
139619914|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139619915|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139619916|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
139619917|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619918|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619919|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139619920|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139619921|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
139619922|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139619923|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139619924|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139619925|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139619926|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
139619927|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139619928|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619929|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139619930|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139619931|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139619932|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139619933|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139619934|NCT03874494|Aripiprazole|aripiprazole|mesh-list
139619935|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
139619936|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
139619937|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139619938|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139619939|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139619940|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139619941|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619942|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
139619943|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
139619944|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619945|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619946|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139619947|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139619948|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
139619949|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139619950|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139619951|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139619952|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139619953|NCT03156439|Huperzine A|huperzine a|mesh-list
139619954|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139619955|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619956|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619957|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
139619958|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619959|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619960|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139619961|NCT03156439|Protective Agents|protective agents|mesh-ancestor
139619962|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
139619963|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139619964|NCT03156361|Insulin|insulin|mesh-list
139619965|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139619966|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
139619967|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139619968|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619969|NCT05690035|Tislelizumab|tislelizumab|mesh-list
139619970|NCT05690035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139619971|NCT05690035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619972|NCT05002530|Vitamin D|vitamin d|mesh-list
139619973|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
139619974|NCT05002530|Cholecalciferol|cholecalciferol|mesh-list
139619975|NCT05002530|Vitamins|vitamins|mesh-list
139619976|NCT05002530|Tretinoin|tretinoin|mesh-list
139619977|NCT05002530|Isotretinoin|isotretinoin|mesh-list
139619978|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
139619979|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619980|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139619981|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139619982|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619983|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
139619984|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
139619985|NCT03583021|Neostigmine|neostigmine|mesh-list
139619986|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139619987|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139619988|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139619989|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
139619990|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139619991|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139619992|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139619993|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
139619994|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139619995|NCT03155971|Paclitaxel|paclitaxel|mesh-list
139619996|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139619997|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139619998|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
139619999|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
139620000|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
139620001|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620002|NCT03582319|Formaldehyde|formaldehyde|mesh-list
139620003|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
139620004|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139620005|NCT00307242|Adefovir|adefovir|mesh-list
139620006|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139620007|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
139620008|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139620009|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139620010|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139620011|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620012|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620013|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139620014|NCT03582007|Murepavadin|murepavadin|mesh-list
139620015|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139620016|NCT02895373|Alprostadil|alprostadil|mesh-list
139620017|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139620018|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
139620019|NCT02895373|Urological Agents|urological agents|mesh-ancestor
139620020|NCT05698771|Niacinamide|niacinamide|mesh-list
139620021|NCT05698771|Niacin|niacin|mesh-list
139620022|NCT05698771|Nicotinic Acids|nicotinic acids|mesh-list
139620023|NCT05698771|Vitamin B Complex|vitamin b complex|mesh-ancestor
139620024|NCT05698771|Vitamins|vitamins|mesh-ancestor
139620025|NCT05698771|Micronutrients|micronutrients|mesh-ancestor
139620026|NCT05698771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620027|NCT05698771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139620028|NCT05698771|Antimetabolites|antimetabolites|mesh-ancestor
139620029|NCT05698771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620030|NCT05698771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139620031|NCT05698771|Vasodilator Agents|vasodilator agents|mesh-ancestor
139620032|NCT03156907|Buprenorphine|buprenorphine|mesh-list
139620033|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139620034|NCT03156907|Narcotics|narcotics|mesh-ancestor
139620035|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139620036|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620037|NCT03156907|Analgesics|analgesics|mesh-ancestor
139620038|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
139620039|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620040|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139620041|NCT03156829|Betamethasone|betamethasone|mesh-list
139620042|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620043|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
139620044|NCT03156829|Hormones|hormones|mesh-ancestor
138748456|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139620045|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139620046|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620047|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139620048|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
139620049|NCT05229276|Bone wax|bone wax|mesh-list
139620050|NCT05229276|Hemostatics|hemostatics|mesh-ancestor
139620051|NCT05229276|Coagulants|coagulants|mesh-ancestor
139620052|NCT03581773|Folic Acid|folic acid|mesh-list
139620053|NCT03581773|Hematinics|hematinics|mesh-ancestor
139620054|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
139620055|NCT03581773|Vitamins|vitamins|mesh-ancestor
139620056|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
139620057|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620058|NCT04425174|Anesthetics|anesthetics|mesh-list
139620059|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139620060|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620061|NCT05119452|Adalimumab|adalimumab|mesh-list
139620062|NCT05119452|Infliximab|infliximab|mesh-list
139620063|NCT05119452|Golimumab|golimumab|mesh-list
139620064|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
139620065|NCT05119452|Etanercept|etanercept|mesh-list
139620066|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
139620067|NCT05119452|Tofacitinib|tofacitinib|mesh-list
139620068|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139620069|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620070|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
139620071|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138748482|NCT00934843|Protective Agents|protective agents|mesh-ancestor
139620072|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139620073|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139620074|NCT05119452|Analgesics|analgesics|mesh-ancestor
139620075|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
139620076|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620077|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620078|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139620079|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
139620080|NCT05119452|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139297206|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620081|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139620082|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620083|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620084|NCT02788591|Esomeprazole|esomeprazole|mesh-list
139620085|NCT02788591|Omeprazole|omeprazole|mesh-list
139620086|NCT02788591|Pantoprazole|pantoprazole|mesh-list
139620087|NCT02788591|Lansoprazole|lansoprazole|mesh-list
139620088|NCT02788591|Sucralfate|sucralfate|mesh-list
139620089|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139620090|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139620091|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139620092|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620093|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620094|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
139620095|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
139620096|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139620097|NCT03076164|Trametinib|trametinib|mesh-list
139620098|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620099|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139620100|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620101|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620102|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
139620103|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
139620104|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139620105|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139620106|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139620107|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139620108|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139620109|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620110|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620111|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620112|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139620113|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
139620114|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139620115|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620116|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139620117|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139620118|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139620119|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
139620120|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139620121|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139620122|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139620123|NCT01670773|Analgesics|analgesics|mesh-ancestor
139620124|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
139620125|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620126|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620127|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620128|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139620129|NCT05228418|Naltrexone|naltrexone|mesh-list
139620130|NCT05228418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139620131|NCT05228418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139620132|NCT05228418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620133|NCT05228418|Sensory System Agents|sensory system agents|mesh-ancestor
139620134|NCT05228418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620135|NCT01676233|Insulin|insulin|mesh-list
139620136|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139620137|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
139620138|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139620139|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620140|NCT01670929|Progesterone|progesterone|mesh-list
139620141|NCT01670929|Progestins|progestins|mesh-ancestor
139620142|NCT01670929|Hormones|hormones|mesh-ancestor
138748551|NCT01266590|Digoxin|digoxin|mesh-list
139620143|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139620144|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620145|NCT02673996|Phenylephrine|phenylephrine|mesh-list
139620146|NCT02673996|Isoproterenol|isoproterenol|mesh-list
139620147|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
139620148|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139620149|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
139620150|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
139620151|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620152|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620153|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
139620154|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139620155|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
139620156|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
139620157|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139620158|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139620159|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139620160|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
139620161|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620162|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620163|NCT02673996|Protective Agents|protective agents|mesh-ancestor
139620164|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139620165|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138748582|NCT01263704|Rituximab|rituximab|mesh-list
139620166|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139620167|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
139620168|NCT04746937|Norfloxacin|norfloxacin|mesh-list
139620169|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139620170|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139620171|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139620172|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139620173|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139620174|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620175|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620176|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620177|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139620178|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139620179|NCT05220319|Methylprednisolone|methylprednisolone|mesh-list
139620180|NCT05220319|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139620181|NCT05220319|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139620182|NCT05220319|Prednisolone|prednisolone|mesh-list
139620183|NCT05220319|Prednisolone acetate|prednisolone acetate|mesh-list
139620184|NCT05220319|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139620185|NCT05220319|Prednisolone phosphate|prednisolone phosphate|mesh-list
139620186|NCT05220319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620187|NCT05220319|Antiemetics|antiemetics|mesh-ancestor
139620188|NCT05220319|Autonomic Agents|autonomic agents|mesh-ancestor
139620189|NCT05220319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620190|NCT05220319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620191|NCT05220319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139620192|NCT05220319|Glucocorticoids|glucocorticoids|mesh-ancestor
139620193|NCT05220319|Hormones|hormones|mesh-ancestor
138748607|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
139620194|NCT05220319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139620195|NCT05220319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139620196|NCT05220319|Protective Agents|protective agents|mesh-ancestor
139620197|NCT05220319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139620198|NCT05220319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620199|NCT03155035|Vitamin D|vitamin d|mesh-list
139620200|NCT03155035|Albendazole|albendazole|mesh-list
139620201|NCT03155035|Calcium|calcium|mesh-list
139620202|NCT03155035|Vitamins|vitamins|mesh-ancestor
139620203|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
139620204|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620205|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139620206|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139620207|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
139620208|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139620209|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139620210|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
139620211|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139620212|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139620213|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
139620214|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
139620215|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
139620216|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620217|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620218|NCT03154723|Vitamin A|vitamin a|mesh-list
139620219|NCT03154723|Vitamins|vitamins|mesh-ancestor
139620220|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
139620221|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620222|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139620223|NCT04080908|Hematinics|hematinics|mesh-ancestor
139620224|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139620225|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139620226|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
139620227|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139620228|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620229|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139620230|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620231|NCT03154567|Yohimbine|yohimbine|mesh-list
139620232|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
139620233|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
139620234|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620235|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401941|NCT00833521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139620236|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139620237|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139620238|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139620239|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
139620240|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748656|NCT04321070|Clindamycin|clindamycin|mesh-list
139620241|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620242|NCT03154567|Urological Agents|urological agents|mesh-ancestor
139620243|NCT04310748|Anesthetics|anesthetics|mesh-list
139620244|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139620245|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620246|NCT03154645|Ibuprofen|ibuprofen|mesh-list
139620247|NCT03154645|Acetazolamide|acetazolamide|mesh-list
139620248|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139620249|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139620250|NCT03154645|Analgesics|analgesics|mesh-ancestor
139620251|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
139620252|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620253|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620254|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620255|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139620256|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139620257|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620258|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620259|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
139620260|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139620261|NCT03154645|Diuretics|diuretics|mesh-ancestor
139620262|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
139620263|NCT01671709|Montelukast|montelukast|mesh-list
139620264|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139620265|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
139620266|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139620267|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
139620268|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139620269|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620270|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139620271|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139620272|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620273|NCT05222256|Simendan|simendan|mesh-list
139620274|NCT05222256|Epinephrine|epinephrine|mesh-list
139620275|NCT05222256|Racepinephrine|racepinephrine|mesh-list
139620276|NCT05222256|Epinephryl borate|epinephryl borate|mesh-list
139620277|NCT05222256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139620278|NCT05222256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139620279|NCT05222256|Adrenergic Agents|adrenergic agents|mesh-ancestor
139620280|NCT05222256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620281|NCT05222256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620282|NCT05222256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620283|NCT05222256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139620284|NCT05222256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139620285|NCT05222256|Autonomic Agents|autonomic agents|mesh-ancestor
139620286|NCT05222256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620287|NCT05222256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139620288|NCT05222256|Respiratory System Agents|respiratory system agents|mesh-ancestor
139620289|NCT05222256|Mydriatics|mydriatics|mesh-ancestor
139620290|NCT05222256|Sympathomimetics|sympathomimetics|mesh-ancestor
139620291|NCT05222256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139620292|NCT05222256|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138748724|NCT00608179|Glyburide|glyburide|mesh-list
139620293|NCT05222256|Vasodilator Agents|vasodilator agents|mesh-ancestor
139620294|NCT05222256|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139620295|NCT05222256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139620296|NCT05222256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620297|NCT05222256|Protective Agents|protective agents|mesh-ancestor
139620298|NCT01671787|Tenofovir|tenofovir|mesh-list
139620299|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
139620300|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139620301|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139620302|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139620303|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620304|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620305|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139620306|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139620307|NCT05229510|Ribavirin|ribavirin|mesh-list
139620308|NCT05229510|Antimetabolites|antimetabolites|mesh-ancestor
139620309|NCT05229510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620310|NCT05229510|Antiviral Agents|antiviral agents|mesh-ancestor
139620311|NCT05229510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139620312|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139620313|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139620314|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
139620315|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
139620316|NCT00698022|Risperidone|risperidone|mesh-list
139620317|NCT00698022|Mifepristone|mifepristone|mesh-list
139620318|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139620319|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
139620320|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620321|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620322|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620323|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139620324|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139620325|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139620326|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139620327|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139620328|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
139620329|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139620330|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
139620331|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139620332|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139620333|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139620334|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139620335|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
139620336|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139620337|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139620338|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
139620339|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139620340|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
138748761|NCT05937880|Leflunomide|leflunomide|mesh-list
139620341|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139620342|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139620343|NCT02570503|Ketorolac|ketorolac|mesh-list
139620344|NCT02570503|Clonidine|clonidine|mesh-list
139620345|NCT02570503|Epinephrine|epinephrine|mesh-list
139620346|NCT02570503|Ropivacaine|ropivacaine|mesh-list
139620347|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
139620348|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
139620349|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139620350|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620351|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
139620352|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620353|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139620354|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139620355|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
139620356|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620357|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620358|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139620359|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139620360|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
138748786|NCT05937711|Dopamine Agents|dopamine agents|mesh-ancestor
139620361|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139620362|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
139620363|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
139620364|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
139620365|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139620366|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139620367|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139620368|NCT02570503|Analgesics|analgesics|mesh-ancestor
139620369|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620370|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139620371|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139620372|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620373|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139620374|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
139620375|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139620376|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
139620377|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139620378|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139620379|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620380|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139620381|NCT02492269|Analgesics|analgesics|mesh-ancestor
139620382|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
139620383|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620384|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139620385|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139620386|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139620387|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
139620388|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620389|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620390|NCT05561179|Hyaluronic Acid|hyaluronic acid|mesh-list
139620391|NCT05561179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139620392|NCT05561179|Immunologic Factors|immunologic factors|mesh-ancestor
139620393|NCT05561179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620394|NCT05561179|Viscosupplements|viscosupplements|mesh-ancestor
139620395|NCT05561179|Protective Agents|protective agents|mesh-ancestor
139620396|NCT02467153|Vitamin D|vitamin d|mesh-list
139620397|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
139620398|NCT02467153|Vitamins|vitamins|mesh-ancestor
139620399|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
139620400|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620401|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139620402|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139620403|NCT04933903|Nivolumab|nivolumab|mesh-list
139620404|NCT04933903|Ipilimumab|ipilimumab|mesh-list
139620405|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139620406|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620407|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139620408|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620409|NCT03153163|Trastuzumab|trastuzumab|mesh-list
139620410|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139620411|NCT03153163|Maytansine|maytansine|mesh-list
139620412|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139620413|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620414|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139620415|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
139620416|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
139620417|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
139620418|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620419|NCT03153163|Immunotoxins|immunotoxins|mesh-ancestor
139620420|NCT03153163|Immunoconjugates|immunoconjugates|mesh-ancestor
139620421|NCT03153163|Immunologic Factors|immunologic factors|mesh-ancestor
139620422|NCT03153163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620423|NCT03153085|Ipilimumab|ipilimumab|mesh-list
139620424|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139620425|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620426|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139620427|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620428|NCT03463525|Osimertinib|osimertinib|mesh-list
139620429|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620430|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139620431|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620432|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620433|NCT01675128|Irinotecan|irinotecan|mesh-list
139620434|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139620435|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139620436|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620437|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620438|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620439|NCT02626507|Fulvestrant|fulvestrant|mesh-list
139620440|NCT02626507|Goserelin|goserelin|mesh-list
139620441|NCT02626507|Palbociclib|palbociclib|mesh-list
139620442|NCT02626507|Gedatolisib|gedatolisib|mesh-list
139620443|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139620444|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620445|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139620446|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139620447|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
139620448|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139620449|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620450|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139620451|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620452|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620453|NCT03413995|Rucaparib|rucaparib|mesh-list
139620454|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139620455|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620456|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620457|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620458|NCT03243175|Apixaban|apixaban|mesh-list
139402168|NCT02283775|Hormones|hormones|mesh-ancestor
139620459|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139620460|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
139620461|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139620462|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
139620463|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620464|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620465|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
139620466|NCT04764955|Vitamin D|vitamin d|mesh-list
139620467|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
139620468|NCT04764955|Vitamins|vitamins|mesh-ancestor
139620469|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
139620470|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620471|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139620472|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139620473|NCT01674127|Methyldopa|methyldopa|mesh-list
139620474|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139620475|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
139620476|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
139620477|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620478|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620479|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139620480|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139620481|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139620482|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
139620483|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620484|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620485|NCT02081443|Ticagrelor|ticagrelor|mesh-list
139620486|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139620487|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139620488|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139620489|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139620490|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
139620491|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620492|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620493|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620494|NCT01674205|Vaccines|vaccines|mesh-list
139620495|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
139620496|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620497|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
139620498|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
139620499|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
139620500|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139620501|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
139620502|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139620503|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139620504|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
139620505|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620506|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620507|NCT03151057|Idelalisib|idelalisib|mesh-list
139620508|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620509|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620510|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620511|NCT01674283|Glucagon|glucagon|mesh-list
139620512|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139620513|NCT01674283|Hormones|hormones|mesh-ancestor
139620514|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139620515|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620516|NCT04404517|Adalimumab|adalimumab|mesh-list
139620517|NCT04404517|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139620518|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620519|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139620520|NCT01674517|Montelukast|montelukast|mesh-list
139620521|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139620522|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
139620523|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139620524|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
139620525|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139620526|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620527|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139620528|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139620529|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620530|NCT01923649|Lanreotide|lanreotide|mesh-list
139620531|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620532|NCT01670071|Risperidone|risperidone|mesh-list
139402243|NCT02273635|Analgesics|analgesics|mesh-ancestor
139620533|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139620534|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139620535|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
139620536|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620537|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620538|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620539|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139620540|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139620541|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139620542|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139620543|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139620544|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
139620545|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139620546|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139620548|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
139620549|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620550|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
139620551|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139620552|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139620553|NCT03852901|Empagliflozin|empagliflozin|mesh-list
139620554|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139620555|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620556|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139620557|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620558|NCT01675999|Leucovorin|leucovorin|mesh-list
139620559|NCT01675999|Cetuximab|cetuximab|mesh-list
139620560|NCT01675999|Fluorouracil|fluorouracil|mesh-list
139620561|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
139620562|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139620563|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620564|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
139620565|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620566|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139620567|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139620568|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
139620569|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620570|NCT01675999|Antidotes|antidotes|mesh-ancestor
139620571|NCT01675999|Protective Agents|protective agents|mesh-ancestor
138748988|NCT05408065|Hormones|hormones|mesh-ancestor
139620572|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
139620573|NCT01675999|Vitamins|vitamins|mesh-ancestor
139620574|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
139620575|NCT01425359|Ranolazine|ranolazine|mesh-list
139620576|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139620577|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139620578|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620579|NCT04404751|Folic Acid|folic acid|mesh-list
139620580|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
139620581|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
139620582|NCT04404751|Iron|iron|mesh-list
139620583|NCT04404751|Vitamins|vitamins|mesh-ancestor
139620584|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
139620585|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620586|NCT04404751|Trace Elements|trace elements|mesh-ancestor
139620587|NCT04404751|Hematinics|hematinics|mesh-ancestor
139620588|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
139620589|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
139620590|NCT01403051|Vitamin D|vitamin d|mesh-list
139620591|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
139620592|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
139620593|NCT01403051|Vitamins|vitamins|mesh-list
139620594|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
139620595|NCT01403051|Calcium|calcium|mesh-list
139620596|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
139620597|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620598|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139620599|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139620600|NCT01403051|Antacids|antacids|mesh-ancestor
139620601|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620602|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139620603|NCT03873337|Nicotine|nicotine|mesh-list
139620604|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139620605|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
139620606|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620607|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620608|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139620609|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139402316|NCT04481841|Vitamins|vitamins|mesh-list
139620611|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620612|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620613|NCT04115748|Adalimumab|adalimumab|mesh-list
139620614|NCT04115748|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139620615|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620616|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139620617|NCT04747015|Oxytocin|oxytocin|mesh-list
139620618|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
139620619|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139620620|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620621|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
139620622|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138749052|NCT04793867|Xenon|xenon|mesh-list
139620623|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139620624|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620625|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139620626|NCT04747171|Analgesics|analgesics|mesh-ancestor
139620627|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
139620628|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620629|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139620630|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139620631|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139620632|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
139620633|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620634|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620635|NCT02082769|Allopurinol|allopurinol|mesh-list
139620636|NCT02082769|Febuxostat|febuxostat|mesh-list
139620637|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
139620638|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620639|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620640|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
139620641|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139620642|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139620643|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
139620644|NCT02082769|Protective Agents|protective agents|mesh-ancestor
139620645|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620646|NCT03751423|Fentanyl|fentanyl|mesh-list
139620647|NCT03751423|Ketamine|ketamine|mesh-list
139620648|NCT03751423|Morphine|morphine|mesh-list
139620649|NCT03751423|Analgesics|analgesics|mesh-ancestor
139620650|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
139620651|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620652|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620653|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139620654|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139620655|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
139620656|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
139620657|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139620658|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139620659|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139620660|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620661|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620662|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139620663|NCT03751423|Narcotics|narcotics|mesh-ancestor
139620664|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139620665|NCT03745729|Allopurinol|allopurinol|mesh-list
139620666|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
139620667|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620668|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620669|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
139620670|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139620671|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139620672|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
139620673|NCT03745729|Protective Agents|protective agents|mesh-ancestor
139620674|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620675|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
139620676|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139620677|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
139620678|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139620679|NCT04904952|Expectorants|expectorants|mesh-ancestor
139620680|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
139620681|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139620682|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
139620683|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402393|NCT02404077|Clonidine|clonidine|mesh-list
139620684|NCT04904952|Protective Agents|protective agents|mesh-ancestor
139620685|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620686|NCT04904952|Antidotes|antidotes|mesh-ancestor
139620687|NCT03661411|Aspirin|aspirin|mesh-list
139620688|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139620689|NCT03661411|Clopidogrel|clopidogrel|mesh-list
139620690|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139620691|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139620692|NCT03661411|Analgesics|analgesics|mesh-ancestor
139620693|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
139620694|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620695|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620696|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620697|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139620698|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139620699|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139620700|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620701|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139620702|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139620703|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620704|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
139620705|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139620706|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139620707|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139620708|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
139620709|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620710|NCT03742297|Dexamethasone|dexamethasone|mesh-list
139620711|NCT03742297|Prednisone|prednisone|mesh-list
139620712|NCT03742297|Lenalidomide|lenalidomide|mesh-list
139620713|NCT03742297|Bortezomib|bortezomib|mesh-list
139620714|NCT03742297|Melphalan|melphalan|mesh-list
139620715|NCT03742297|Daratumumab|daratumumab|mesh-list
139620716|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620717|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
139620718|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
139620719|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620720|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620721|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139620722|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
139620723|NCT03742297|Hormones|hormones|mesh-ancestor
139620724|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139620725|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139620726|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620727|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
139620728|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138749161|NCT03920007|Polymyxins|polymyxins|mesh-list
139620729|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139620730|NCT03742297|Growth Substances|growth substances|mesh-ancestor
139620731|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
139620732|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139620733|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
139620734|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620735|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139620736|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139620737|NCT01677403|Tobramycin|tobramycin|mesh-list
139620738|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139620739|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139620740|NCT03441750|Metformin|metformin|mesh-list
139620741|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139620742|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620743|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139620744|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139620745|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139620746|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620747|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749193|NCT03695744|Dexamethasone|dexamethasone|mesh-list
139620748|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139620749|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139620750|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620751|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
139620752|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620753|NCT03825757|Aspirin|aspirin|mesh-list
139620754|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
139620755|NCT03825757|Salicylates|salicylates|mesh-list
139620756|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139620757|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
139620758|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
139620759|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
139620760|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139620761|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139620763|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
139620764|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620765|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620766|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620767|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139620768|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139620769|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620770|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620771|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139620772|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139620773|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139620774|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
139620775|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139620776|NCT03657433|Hematinics|hematinics|mesh-ancestor
139620777|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139620778|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139620779|NCT03651895|Metformin|metformin|mesh-list
139620780|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139620781|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620782|NCT02398656|Tenecteplase|tenecteplase|mesh-list
139620783|NCT02398656|Clopidogrel|clopidogrel|mesh-list
139620784|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139620785|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139620786|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139620787|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139620788|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
139620789|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620790|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620791|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620792|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139620793|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139620794|NCT03807037|Tocotrienols|tocotrienols|mesh-list
139620795|NCT03807037|Vitamin E|vitamin e|mesh-list
139620796|NCT03807037|Tocopherols|tocopherols|mesh-list
139620797|NCT03807037|Tocovid|tocovid|mesh-list
139620798|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
138749230|NCT03222076|Nivolumab|nivolumab|mesh-list
139620799|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620800|NCT03807037|Protective Agents|protective agents|mesh-ancestor
139620801|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620802|NCT03807037|Vitamins|vitamins|mesh-ancestor
139620803|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
139620804|NCT03805399|Sirolimus|sirolimus|mesh-list
139620805|NCT03805399|Paclitaxel|paclitaxel|mesh-list
139620806|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139620807|NCT03805399|Capecitabine|capecitabine|mesh-list
139620808|NCT03805399|Everolimus|everolimus|mesh-list
139620809|NCT03805399|Apatinib|apatinib|mesh-list
139620810|NCT03805399|Temsirolimus|temsirolimus|mesh-list
139620811|NCT03805399|MTOR Inhibitors|mtor inhibitors|mesh-list
139620812|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139620813|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139620814|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620815|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
139620816|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
139620817|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
139620818|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620819|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139620820|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
139620821|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139620822|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620823|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139620824|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
139620825|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620826|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139620827|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139620828|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139620829|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
139620830|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139620831|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
139620832|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139620833|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139620834|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139620835|NCT03637075|Insulin|insulin|mesh-list
139620836|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139620837|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620838|NCT04403503|Thrombin|thrombin|mesh-list
139620839|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139620840|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
139620841|NCT04403503|Coagulants|coagulants|mesh-ancestor
139620842|NCT00249795|Irbesartan|irbesartan|mesh-list
139620843|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139620844|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139620845|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139620846|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620847|NCT04404127|Basiliximab|basiliximab|mesh-list
138749273|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139620848|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139620849|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
139620850|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620851|NCT02651220|Adapalene|adapalene|mesh-list
139620852|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
139620853|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139620854|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
139620855|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139620856|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139620857|NCT02651220|Analgesics|analgesics|mesh-ancestor
139620858|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
139620859|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620860|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620861|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620862|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139620863|NCT01279551|Lidocaine|lidocaine|mesh-list
139620864|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
139620865|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
139620866|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
139620867|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139620868|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620869|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
139620870|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620871|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139620872|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139620873|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139620874|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139620875|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620876|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
139620877|NCT00780403|Cetirizine|cetirizine|mesh-list
139620878|NCT00780403|Desloratadine|desloratadine|mesh-list
139620879|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139620880|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139620881|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139620882|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
139620883|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
139620884|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620885|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620886|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620887|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139620888|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
139620889|NCT03704610|Infliximab|infliximab|mesh-list
139620890|NCT03704610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139620891|NCT03704610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620892|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
139620893|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139620894|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139620895|NCT01979796|Nicotine|nicotine|mesh-list
139620896|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139620897|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
139620898|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620899|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620900|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139620901|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139620902|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
139620903|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620904|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620905|NCT03628339|Tepotinib|tepotinib|mesh-list
139620906|NCT03628339|Midazolam|midazolam|mesh-list
139620907|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139620908|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139620909|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139620910|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620911|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139620912|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139620913|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139620914|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139620915|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
139620916|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
139620917|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
139620918|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
139620919|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620920|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620921|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620922|NCT04412694|Dexamethasone|dexamethasone|mesh-list
139620923|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
139620924|NCT04412694|BB 1101|bb 1101|mesh-list
139620925|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620926|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
139620927|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
139620928|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620929|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620930|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139620931|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
139620932|NCT04412694|Hormones|hormones|mesh-ancestor
138749360|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
139620933|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139620934|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139620935|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620936|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
139620937|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620938|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620939|NCT03627715|Propagermanium|propagermanium|mesh-list
139620940|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620941|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
139620942|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
139620943|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620944|NCT00246753|Lapatinib|lapatinib|mesh-list
139620945|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620946|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139620947|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139620948|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620949|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
139620950|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139620951|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139620952|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
139620953|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139620954|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139620955|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620956|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
139620957|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
139620958|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620959|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
139620960|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139620961|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
139620962|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
139620963|NCT00246129|Daclizumab|daclizumab|mesh-list
139620964|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139620965|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620966|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139620967|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
139620968|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620969|NCT01274247|Benzocaine|benzocaine|mesh-list
139620970|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
139620971|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
139620972|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139620973|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620974|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
139620975|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620976|NCT01279629|Tazarotene|tazarotene|mesh-list
139620977|NCT01279629|Calcipotriene|calcipotriene|mesh-list
139620978|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
139620979|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
139620980|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139620981|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139620982|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
139620983|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139620984|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139620985|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139620986|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
139620987|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
139620988|NCT01274325|Hormones|hormones|mesh-ancestor
139620989|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139620990|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
139620991|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
139620992|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139620993|NCT01274403|Thalidomide|thalidomide|mesh-list
139620994|NCT01274403|Prednisone|prednisone|mesh-list
139620995|NCT01274403|Melphalan|melphalan|mesh-list
139620996|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139620997|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
139620998|NCT01274403|Hormones|hormones|mesh-ancestor
139620999|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139621000|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621001|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139621002|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621003|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139621004|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
138749438|NCT01666080|Fludarabine|fludarabine|mesh-list
139621005|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621006|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139621007|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139621008|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
139621009|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
139621010|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139621011|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621012|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139621013|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139621014|NCT01274403|Growth Substances|growth substances|mesh-ancestor
139621015|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
139621016|NCT03700099|Docetaxel|docetaxel|mesh-list
139621017|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621018|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
139621019|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
139621020|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
139621021|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621022|NCT01274481|Iloprost|iloprost|mesh-list
139621023|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139621024|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
139621025|NCT00245583|Topiramate|topiramate|mesh-list
139621026|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
139621027|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139621028|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621029|NCT01379989|Carboplatin|carboplatin|mesh-list
139621030|NCT01379989|Doxorubicin|doxorubicin|mesh-list
139621031|NCT01379989|Trabectedin|trabectedin|mesh-list
139621032|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621033|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139621034|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139621035|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139621036|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621037|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621038|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139621039|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
139621040|NCT02652156|Bupivacaine|bupivacaine|mesh-list
139621041|NCT02652156|Ropivacaine|ropivacaine|mesh-list
139621042|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
139621043|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
139621044|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621045|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621046|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
139621047|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621048|NCT03699865|Nicotine|nicotine|mesh-list
139621049|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139621050|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
139621051|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621052|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621053|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139621054|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139621055|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
139621056|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621057|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621058|NCT00754923|Sorafenib|sorafenib|mesh-list
139621059|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621060|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139621061|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402765|NCT03537443|Vitamin D|vitamin d|mesh-list
139621062|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621063|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139621064|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
139621065|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139621066|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139621067|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139621068|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621069|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621070|NCT02117076|Gabapentin|gabapentin|mesh-list
139621071|NCT02117076|Analgesics|analgesics|mesh-ancestor
139621072|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
139621073|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621074|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621075|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
139621076|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139621077|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139621078|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621079|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139621080|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139621081|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139621082|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621083|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621084|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
139621085|NCT01274793|Mosapride|mosapride|mesh-list
139621086|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621087|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139621088|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139621089|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
139621090|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621091|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621092|NCT00746889|Triamcinolone|triamcinolone|mesh-list
139621093|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139621094|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139621095|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139621096|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139621097|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
139621098|NCT00746889|Hormones|hormones|mesh-ancestor
139621099|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139621100|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621101|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139621102|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
139621103|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621104|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621105|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
139621106|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
139621107|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
139621108|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139621109|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139621110|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
139621111|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
139621112|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621113|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621114|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621115|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139621116|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
139621117|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139621118|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139621119|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
139621120|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139621121|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139621122|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139621123|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621124|NCT00244881|Cediranib|cediranib|mesh-list
139621125|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621126|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621127|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621128|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139621129|NCT00530517|Sumatriptan|sumatriptan|mesh-list
139621130|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139621131|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139621132|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139621133|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
139621134|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621135|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621136|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621138|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
139621139|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
139621140|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621141|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621142|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139621143|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139621144|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139621145|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621146|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139621147|NCT05123976|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139621148|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139621149|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139621150|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621151|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621152|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
139621153|NCT00005803|Cytarabine|cytarabine|mesh-list
139621154|NCT00005803|Cyclosporine|cyclosporine|mesh-list
139621155|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
139621156|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
139621157|NCT00005803|Melphalan|melphalan|mesh-list
139621158|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
139621159|NCT00005803|Carmustine|carmustine|mesh-list
139621160|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139621161|NCT00005803|Fludarabine|fludarabine|mesh-list
139621162|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
139621163|NCT00005803|Etoposide|etoposide|mesh-list
139621164|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
139621165|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
139621166|NCT00005803|Cyclosporins|cyclosporins|mesh-list
139621167|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139621168|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
139621169|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621170|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139621171|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139621172|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
139621173|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621174|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621175|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139621176|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139621177|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
139621178|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138749614|NCT05937282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139621179|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139621180|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139621181|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621182|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
139621183|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621184|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
139621185|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
139621186|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139621187|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139621188|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139621189|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
139621190|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139621191|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
139621192|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
139621193|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
139621194|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
139621195|NCT00244725|Warfarin|warfarin|mesh-list
139621196|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
139621197|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
139621198|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139621199|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621200|NCT04185012|Benralizumab|benralizumab|mesh-list
139621201|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139621202|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
139621203|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
139621204|NCT01275183|Cisplatin|cisplatin|mesh-list
139621205|NCT01275183|Docetaxel|docetaxel|mesh-list
139621206|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621207|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
139621208|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
139621209|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
139621210|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749652|NCT05933642|Aminophylline|aminophylline|mesh-list
139621211|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139621212|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139621213|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
139621214|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621215|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139621216|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139621217|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621218|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
139621219|NCT05126004|Azacitidine|azacitidine|mesh-list
139621220|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139621221|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139621222|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
139621223|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621224|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621225|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621226|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
139621227|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621228|NCT05126004|Expectorants|expectorants|mesh-ancestor
139621229|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
139621230|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139621231|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
139621232|NCT05126004|Protective Agents|protective agents|mesh-ancestor
139621233|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621234|NCT05126004|Antidotes|antidotes|mesh-ancestor
139621235|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
139621236|NCT00350701|Testosterone|testosterone|mesh-list
139621237|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
139621238|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
139621239|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139621240|NCT00350701|Androgens|androgens|mesh-ancestor
139621241|NCT00350701|Hormones|hormones|mesh-ancestor
139621242|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139621243|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621244|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139621245|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621246|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
139621247|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
139621248|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139621249|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139621250|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139621251|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139621252|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621253|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
139621254|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621255|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621256|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139621257|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621258|NCT01505114|Tenofovir|tenofovir|mesh-list
139621259|NCT01505114|Emtricitabine|emtricitabine|mesh-list
139621260|NCT01505114|Maraviroc|maraviroc|mesh-list
139621261|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
139621262|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621263|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139621264|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139621265|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621266|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621267|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139621268|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139621269|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139621270|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139621271|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139621272|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
139621273|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139621274|NCT00243867|Paclitaxel|paclitaxel|mesh-list
139621275|NCT00243867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139621276|NCT00243867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621277|NCT00243867|Tubulin Modulators|tubulin modulators|mesh-ancestor
139621278|NCT00243867|Antimitotic Agents|antimitotic agents|mesh-ancestor
139621279|NCT00243867|Mitosis Modulators|mitosis modulators|mesh-ancestor
139621280|NCT00243867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621281|NCT01679899|Vildagliptin|vildagliptin|mesh-list
139621282|NCT01679899|Gliclazide|gliclazide|mesh-list
139621283|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139621284|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621285|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139621286|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
139621287|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402993|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139621288|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621289|NCT01276821|Epinephrine|epinephrine|mesh-list
139621290|NCT01276821|Racepinephrine|racepinephrine|mesh-list
139621291|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
139621292|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139621293|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139621294|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
139621295|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621296|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621297|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621298|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138749731|NCT05911776|Adrenergic Agents|adrenergic agents|mesh-ancestor
139621299|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139621300|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
139621301|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621302|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139621303|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
139621304|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
139621305|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
139621306|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139621307|NCT00245037|Cyclosporine|cyclosporine|mesh-list
139621308|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
139621309|NCT00245037|Methotrexate|methotrexate|mesh-list
139621310|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
139621311|NCT00245037|Fludarabine|fludarabine|mesh-list
139621312|NCT00245037|Busulfan|busulfan|mesh-list
139621313|NCT00245037|Phenytoin|phenytoin|mesh-list
139621314|NCT00245037|Cyclosporins|cyclosporins|mesh-list
139621315|NCT00245037|Lenograstim|lenograstim|mesh-list
139621316|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139621317|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
139621318|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139621319|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621320|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139621321|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
139621322|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621323|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621324|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
139621325|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621326|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139621327|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139621328|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
139621329|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139621330|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139621331|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
139621332|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621333|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139621334|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139621335|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139621336|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
139621337|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139621338|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
139621339|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139621340|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139621341|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139621342|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
138749780|NCT05881083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139621343|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139621344|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139621345|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139621346|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139621347|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139621348|NCT00241839|Allopurinol|allopurinol|mesh-list
139621349|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
139621350|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
139621351|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621352|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621353|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
139621354|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139621355|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139621356|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
139621357|NCT00241839|Protective Agents|protective agents|mesh-ancestor
139621358|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621359|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139621360|NCT00241839|Diuretics|diuretics|mesh-ancestor
139621361|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
139621362|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139621363|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139621364|NCT05347381|Dexamethasone|dexamethasone|mesh-list
139621365|NCT05347381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139621366|NCT05347381|Antiemetics|antiemetics|mesh-ancestor
139621367|NCT05347381|Autonomic Agents|autonomic agents|mesh-ancestor
139621368|NCT05347381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621369|NCT05347381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621370|NCT05347381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139621371|NCT05347381|Glucocorticoids|glucocorticoids|mesh-ancestor
139621372|NCT05347381|Hormones|hormones|mesh-ancestor
139621373|NCT05347381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139621374|NCT05347381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139621375|NCT05347381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621376|NCT02651688|Enclomiphene|enclomiphene|mesh-list
139621377|NCT02651688|Clomiphene|clomiphene|mesh-list
139621378|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
139621379|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139621380|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
139621381|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139621382|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621383|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139621384|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
139621385|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139621386|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139621387|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139621388|NCT01276353|Donepezil|donepezil|mesh-list
139621389|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139621390|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621391|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621392|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
139621393|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621394|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621395|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
139621396|NCT03807921|Aspirin|aspirin|mesh-list
139621397|NCT03807921|Warfarin|warfarin|mesh-list
139621398|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139621399|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139621400|NCT03807921|Analgesics|analgesics|mesh-ancestor
139621401|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
139621402|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621403|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621404|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139621405|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139621406|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139621407|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139621408|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621409|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139621410|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139621411|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621412|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
139621413|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
139621414|NCT01675609|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139621415|NCT01675609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139621416|NCT01675609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139621417|NCT01675609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139621418|NCT01675609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139621419|NCT01675609|Adrenergic Agents|adrenergic agents|mesh-ancestor
139621420|NCT01675609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621421|NCT01675609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621422|NCT01675609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621423|NCT01673659|Mometasone Furoate|mometasone furoate|mesh-list
139621424|NCT01673659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139621425|NCT01673659|Dermatologic Agents|dermatologic agents|mesh-ancestor
139621426|NCT01673659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139621427|NCT00762177|Triclosan|triclosan|mesh-list
139621428|NCT00762177|Fluorides|fluorides|mesh-list
139621429|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
139621430|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
139621431|NCT00762177|Protective Agents|protective agents|mesh-ancestor
139621432|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621433|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139621434|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621435|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139621436|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139621437|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
139621438|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621439|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139621440|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139621441|NCT02536794|Durvalumab|durvalumab|mesh-list
139621443|NCT02536794|Tremelimumab|tremelimumab|mesh-list
139621444|NCT02536794|Antibodies|antibodies|mesh-list
139621445|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
139621446|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139621447|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
139621448|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621449|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621450|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139621451|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621452|NCT00777855|Rifampin|rifampin|mesh-list
139621453|NCT00777855|Warfarin|warfarin|mesh-list
139621454|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
139621455|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139621456|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
139621457|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138749895|NCT05444777|Ketamine|ketamine|mesh-list
138749923|NCT05355168|Nimotuzumab|nimotuzumab|mesh-list
139621458|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621459|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
139621460|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139621461|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621462|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621463|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139621464|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139621465|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139621466|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139621467|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139621468|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139621469|NCT03523429|Blinatumomab|blinatumomab|mesh-list
139621470|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621471|NCT02403193|Spartalizumab|spartalizumab|mesh-list
139621472|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139621473|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749927|NCT05330130|Hormones|hormones|mesh-ancestor
139621474|NCT02403193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139621475|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621476|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
139621477|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
139621478|NCT03807297|Propofol|propofol|mesh-list
139621479|NCT03807297|Sevoflurane|sevoflurane|mesh-list
139621480|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139621481|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621482|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621483|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139621484|NCT03807297|Analgesics|analgesics|mesh-ancestor
139621485|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
139621486|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621487|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139621488|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139621489|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139621490|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
139621491|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621492|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621493|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139621494|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
139621495|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
139621496|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138749964|NCT05289492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138749965|NCT05289492|Antiemetics|antiemetics|mesh-ancestor
138749966|NCT05289492|Autonomic Agents|autonomic agents|mesh-ancestor
138749967|NCT05289492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749968|NCT05289492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749969|NCT05289492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138749970|NCT05289492|Glucocorticoids|glucocorticoids|mesh-ancestor
138749971|NCT05289492|Hormones|hormones|mesh-ancestor
138749972|NCT05289492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749973|NCT05289492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138749974|NCT05289492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083809|NCT01125254|Amlodipine|amlodipine|mesh-list
139621497|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139621498|NCT05387148|Cannabidiol|cannabidiol|mesh-list
139621499|NCT05387148|Anticonvulsants|anticonvulsants|mesh-ancestor
139621500|NCT03809637|Pemetrexed|pemetrexed|mesh-list
139621501|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621502|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621503|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621504|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139621505|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139621506|NCT03513445|Epinephrine|epinephrine|mesh-list
139621507|NCT03513445|Morphine|morphine|mesh-list
139621508|NCT03513445|Ropivacaine|ropivacaine|mesh-list
139621509|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139621510|NCT03513445|Narcotics|narcotics|mesh-ancestor
139621511|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621512|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621513|NCT03513445|Analgesics|analgesics|mesh-ancestor
139621514|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
139621515|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621516|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139621517|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139621518|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
139621519|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749990|NCT05255666|Pembrolizumab|pembrolizumab|mesh-list
138749991|NCT05255666|Irinotecan|irinotecan|mesh-list
138749992|NCT05255666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139621520|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621521|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139621522|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139621523|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
139621524|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139621525|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
139621526|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
139621527|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
139621528|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139621529|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
139621530|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
139621531|NCT03802071|Doxorubicin|doxorubicin|mesh-list
139621532|NCT03802071|Durvalumab|durvalumab|mesh-list
139621533|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139621534|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621535|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139621536|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139621537|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621538|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621539|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139621540|NCT00758667|Mesna|mesna|mesh-list
139621541|NCT00758667|Protective Agents|protective agents|mesh-ancestor
139621542|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621543|NCT05041920|Omeprazole|omeprazole|mesh-list
139621544|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139621545|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138749993|NCT05255666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621546|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139621547|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621548|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621549|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139621550|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139621551|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621552|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
139621553|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
139621554|NCT04412850|Analgesics|analgesics|mesh-ancestor
139621555|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
139621556|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621557|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621558|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
139621559|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621560|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139621561|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
139621562|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139621563|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139621564|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621565|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139621566|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
139621567|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139621568|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139621569|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139621570|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621571|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139621572|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621573|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621574|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
139621575|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621576|NCT00778869|Infliximab|infliximab|mesh-list
139621577|NCT00778869|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139621578|NCT00778869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139621579|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
139621580|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139621581|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139621582|NCT05008536|Fludarabine|fludarabine|mesh-list
139621583|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
139621584|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750038|NCT05023980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139621585|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403286|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621586|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139621587|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
139621588|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621589|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139621590|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139621592|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139621593|NCT04345419|Remdesivir|remdesivir|mesh-list
139621594|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
139621595|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621596|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
139621597|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621598|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
139621599|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139621600|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139621601|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621602|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
139621603|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139621604|NCT00759603|Rituximab|rituximab|mesh-list
139621605|NCT00759603|Lenalidomide|lenalidomide|mesh-list
139621606|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139621607|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621608|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
139621609|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621610|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139621611|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139621612|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139621613|NCT00759603|Growth Substances|growth substances|mesh-ancestor
139621614|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
139621615|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139621616|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139621617|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139621618|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621619|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621620|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139621621|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139621622|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139621623|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
139621624|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621625|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621626|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139621627|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139621628|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
139621629|NCT03510390|Metformin|metformin|mesh-list
139621630|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139621631|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621632|NCT03806673|Bupivacaine|bupivacaine|mesh-list
139621633|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
139621634|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
139621635|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621636|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621637|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
139621638|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621639|NCT03291990|Temozolomide|temozolomide|mesh-list
139621640|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139621641|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
139621642|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621643|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621644|NCT03806595|Lidocaine|lidocaine|mesh-list
139621645|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139621646|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
139621647|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
139621648|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621649|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621650|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
139621651|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621652|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139621653|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139621654|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139621655|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139621656|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621657|NCT03807999|Paclitaxel|paclitaxel|mesh-list
139621658|NCT03807999|Gemcitabine|gemcitabine|mesh-list
139621659|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139621660|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621661|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
139621662|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
139621663|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
139403358|NCT00547651|Topotecan|topotecan|mesh-list
139621664|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621665|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139621666|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
139621667|NCT04762147|Acetaminophen|acetaminophen|mesh-list
139621668|NCT04762147|Fentanyl|fentanyl|mesh-list
139621669|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139621670|NCT04762147|Narcotics|narcotics|mesh-ancestor
139621671|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621672|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621673|NCT04762147|Analgesics|analgesics|mesh-ancestor
139621674|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
139621675|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621676|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139621677|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139621678|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
139621679|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
139621680|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139621681|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
139621682|NCT04273737|Amantadine|amantadine|mesh-list
139621683|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139621684|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139621685|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
139621686|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621687|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
139621688|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621689|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621690|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621691|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139621692|NCT04273737|Analgesics|analgesics|mesh-ancestor
139621693|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
139621694|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621695|NCT02963064|Antibodies|antibodies|mesh-list
139621696|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139621697|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
139621698|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621699|NCT04183062|Gemcitabine|gemcitabine|mesh-list
139621700|NCT04183062|Docetaxel|docetaxel|mesh-list
139621701|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139621702|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
139621703|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621704|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621705|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
139621706|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
139621707|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
139621708|NCT04325880|Tamsulosin|tamsulosin|mesh-list
139621709|NCT04325880|Mirabegron|mirabegron|mesh-list
139621710|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
139621711|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139621712|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139621713|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139621714|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
139621715|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621716|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621717|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621718|NCT04325880|Urological Agents|urological agents|mesh-ancestor
139621719|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139621720|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139621721|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139621722|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139621723|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139621724|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
139621725|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139621726|NCT04846218|Progesterone|progesterone|mesh-list
139621727|NCT04846218|Progestins|progestins|mesh-ancestor
139621728|NCT04846218|Hormones|hormones|mesh-ancestor
138750174|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139621729|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139621730|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621731|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
139621732|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139621733|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
139621734|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139621735|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139621736|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139621737|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621738|NCT04152486|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139621739|NCT04152486|Antiviral Agents|antiviral agents|mesh-ancestor
139621740|NCT04152486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621741|NCT02512692|Gemcitabine|gemcitabine|mesh-list
139621742|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621743|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139621744|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
139621745|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621746|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139621747|NCT01594398|Exemestane|exemestane|mesh-list
139621748|NCT01594398|Entinostat|entinostat|mesh-list
139621749|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621750|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139621751|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621752|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621753|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139621754|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139621755|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139621756|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
139621757|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139621758|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621759|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139621760|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
139621761|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
139621762|NCT00782379|Busulfan|busulfan|mesh-list
139621763|NCT00782379|Fludarabine|fludarabine|mesh-list
139621764|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
139621765|NCT00782379|Tacrolimus|tacrolimus|mesh-list
139621766|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139621767|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
139621768|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621769|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139621770|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139621771|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
139621772|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621773|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621774|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139621775|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139621776|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
139621777|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139621778|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621779|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139621780|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139621781|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
139621782|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139621783|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621784|NCT04572828|Naproxen|naproxen|mesh-list
139621785|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139621786|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139621787|NCT04572828|Analgesics|analgesics|mesh-ancestor
139621788|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
139621789|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621790|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621791|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139621792|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139621793|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
139621794|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139621795|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621796|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621797|NCT05134350|Omeprazole|omeprazole|mesh-list
139621798|NCT05134350|Pirtobrutinib|pirtobrutinib|mesh-list
139621799|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139621800|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139621801|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139621802|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621803|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621804|NCT05134350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139621805|NCT05134194|Gemcitabine|gemcitabine|mesh-list
139621806|NCT05134194|Capecitabine|capecitabine|mesh-list
139621807|NCT05134194|Vinorelbine|vinorelbine|mesh-list
139621808|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139621809|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
139621810|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621811|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621812|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139403504|NCT00375193|Amrubicin|amrubicin|mesh-list
139621813|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
139621814|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
139621815|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
139621816|NCT00761085|Morphine|morphine|mesh-list
139621817|NCT00761085|Methadone|methadone|mesh-list
139621818|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139621819|NCT00761085|Narcotics|narcotics|mesh-ancestor
139621820|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621821|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621822|NCT00761085|Analgesics|analgesics|mesh-ancestor
139621823|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
139621824|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621825|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
139621826|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
139621827|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
139621828|NCT02145039|Fludarabine|fludarabine|mesh-list
139621829|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139621830|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
139621831|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621832|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139621833|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139621834|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
139621835|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621836|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621837|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139621838|NCT03806049|Paclitaxel|paclitaxel|mesh-list
139621839|NCT03806049|Bevacizumab|bevacizumab|mesh-list
139621840|NCT03806049|Carboplatin|carboplatin|mesh-list
139621841|NCT03806049|Niraparib|niraparib|mesh-list
139621842|NCT03806049|Dostarlimab|dostarlimab|mesh-list
139621843|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139621844|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621845|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
139621846|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
139621847|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
139621848|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621849|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139621850|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139621851|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139621852|NCT03806049|Growth Substances|growth substances|mesh-ancestor
139621853|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621854|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
139621855|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139621856|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621857|NCT00089479|Capecitabine|capecitabine|mesh-list
139621858|NCT00089479|Docetaxel|docetaxel|mesh-list
139621859|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139621860|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
139621861|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621862|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621863|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
139621864|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
139621865|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
139621866|NCT01463306|Pregabalin|pregabalin|mesh-list
139621867|NCT01463306|Analgesics|analgesics|mesh-ancestor
139621868|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
139621869|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621870|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621871|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
139621872|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139621873|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139621874|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621875|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139621876|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139621877|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139621878|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621879|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139621880|NCT05055726|Benzydamine|benzydamine|mesh-list
139621881|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139621882|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
139621883|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139621884|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139621885|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138750348|NCT03333616|Ipilimumab|ipilimumab|mesh-list
139621886|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139403582|NCT02185547|Sertraline|sertraline|mesh-list
139621887|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621888|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
139621889|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621890|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621891|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139621892|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621893|NCT03451591|Cilostazol|cilostazol|mesh-list
139621894|NCT03451591|Isosorbide|isosorbide|mesh-list
139621895|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139621896|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139621897|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139621898|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
139621899|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750369|NCT03162653|Mannitol|mannitol|mesh-list
139621900|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621901|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139621902|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
139621903|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139621904|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139621905|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621906|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139621907|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
139621908|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139621909|NCT03451591|Protective Agents|protective agents|mesh-ancestor
139621910|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139621911|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139621912|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621913|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139621914|NCT03451591|Diuretics|diuretics|mesh-ancestor
139621915|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
139621916|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139621917|NCT05744115|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139621918|NCT05744115|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139621919|NCT05744115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621920|NCT01677559|Paclitaxel|paclitaxel|mesh-list
139621921|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139621922|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621923|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
139621924|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
139621925|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
139621926|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621927|NCT05132712|Losartan|losartan|mesh-list
139621928|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139621929|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139621930|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139621931|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139621932|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621933|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
139621934|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139621935|NCT02149173|Fluorides|fluorides|mesh-list
139621936|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139621937|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621938|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
139621939|NCT02149173|Protective Agents|protective agents|mesh-ancestor
139621940|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621941|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
139621942|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
139621943|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621944|NCT04789434|Tislelizumab|tislelizumab|mesh-list
139621945|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139621946|NCT04789434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139621947|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139621948|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621949|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
139621950|NCT03805503|Procaine|procaine|mesh-list
139621951|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
139621952|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
139621953|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621954|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621955|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
139621956|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621957|NCT01504412|Pregabalin|pregabalin|mesh-list
139621958|NCT01504412|Analgesics|analgesics|mesh-ancestor
139621959|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
139621960|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621961|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621962|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
139621963|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139621964|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139621965|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621966|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139621967|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139621968|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139621969|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621970|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139621971|NCT04702464|Fluconazole|fluconazole|mesh-list
139621972|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
139621973|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139621974|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139621975|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139621976|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139621977|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621978|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139621979|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
139621980|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139621981|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621982|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139621983|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139621985|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
139621986|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
139621987|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139621988|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139621989|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139621990|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139621991|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139621992|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139621993|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139621994|NCT00088465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139621995|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139621996|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139621997|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139621998|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139621999|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
139622000|NCT04405674|Paclitaxel|paclitaxel|mesh-list
139622001|NCT04405674|Bevacizumab|bevacizumab|mesh-list
139622002|NCT04405674|Carboplatin|carboplatin|mesh-list
139622003|NCT04405674|Pemetrexed|pemetrexed|mesh-list
139622004|NCT04405674|Tislelizumab|tislelizumab|mesh-list
139622005|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139622006|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622007|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
139622008|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
139622009|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
139622010|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622011|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139622012|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139622013|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139622014|NCT04405674|Growth Substances|growth substances|mesh-ancestor
139622015|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622016|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
139622017|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622018|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139622019|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139622020|NCT00088153|Progesterone|progesterone|mesh-list
139622021|NCT00088153|Estrogens|estrogens|mesh-list
139622022|NCT00088153|Progestins|progestins|mesh-ancestor
139622023|NCT00088153|Hormones|hormones|mesh-ancestor
138750482|NCT01622335|Analgesics|analgesics|mesh-ancestor
139622024|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139622025|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622026|NCT02074358|Apixaban|apixaban|mesh-list
139622027|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139622028|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
139622029|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139622030|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
139622031|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622032|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622033|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
139622034|NCT05743725|Magnesium Sulfate|magnesium sulfate|mesh-list
139622035|NCT05743725|Dexmedetomidine|dexmedetomidine|mesh-list
139622036|NCT05743725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139622037|NCT05743725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139622038|NCT05743725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622039|NCT05743725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139622040|NCT05743725|Analgesics|analgesics|mesh-ancestor
139622041|NCT05743725|Sensory System Agents|sensory system agents|mesh-ancestor
139622042|NCT05743725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622043|NCT05743725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139622044|NCT05743725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139622045|NCT05743725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139622046|NCT05743725|Adrenergic Agents|adrenergic agents|mesh-ancestor
139622047|NCT05743725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622048|NCT05743725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622049|NCT05743725|Anesthetics|anesthetics|mesh-ancestor
139622050|NCT05743725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139622051|NCT05743725|Anticonvulsants|anticonvulsants|mesh-ancestor
139622052|NCT05743725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139622053|NCT05743725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139622054|NCT05743725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139622055|NCT05743725|Tocolytic Agents|tocolytic agents|mesh-ancestor
139622056|NCT05743725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139622057|NCT05547321|Pembrolizumab|pembrolizumab|mesh-list
139622058|NCT05547321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139622059|NCT05547321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622060|NCT05547321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139622061|NCT05547321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622062|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
139622063|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139622064|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139622065|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622066|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139622067|NCT04912518|Analgesics|analgesics|mesh-ancestor
139622068|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
139622069|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622070|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139622071|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139622072|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139622073|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
139622074|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622075|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622076|NCT04094558|Lactulose|lactulose|mesh-list
139622077|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139622078|NCT01502228|Sunitinib|sunitinib|mesh-list
139622079|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622080|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139622081|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139622082|NCT01502228|Growth Substances|growth substances|mesh-ancestor
139622083|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622084|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
139622085|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139622086|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622087|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622088|NCT05011812|Ritonavir|ritonavir|mesh-list
139622089|NCT05011812|Midazolam|midazolam|mesh-list
139622090|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139622091|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139622092|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138750587|NCT00537680|Ubiquinone|ubiquinone|mesh-list
139622093|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622094|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139622095|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139622096|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139622097|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139622098|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
139622099|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
139622100|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
139622101|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
139622102|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622103|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622104|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139622105|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139622106|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
139622107|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622108|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139403806|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139622109|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139622110|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
139622111|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139622112|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139622113|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139622114|NCT05535231|Curcumin|curcumin|mesh-list
139622115|NCT05535231|Turmeric extract|turmeric extract|mesh-list
139622116|NCT05535231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139622117|NCT05535231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139622118|NCT05535231|Analgesics|analgesics|mesh-ancestor
139622119|NCT05535231|Sensory System Agents|sensory system agents|mesh-ancestor
139622120|NCT05535231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622121|NCT05535231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622122|NCT05535231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139622123|NCT05535231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139622124|NCT05535231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622125|NCT05535231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622126|NCT05535231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622127|NCT05535231|Antioxidants|antioxidants|mesh-ancestor
139622128|NCT05535231|Protective Agents|protective agents|mesh-ancestor
139622129|NCT01502072|Ribavirin|ribavirin|mesh-list
139622130|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
139622131|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622132|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
139622133|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139622134|NCT01462370|Acetaminophen|acetaminophen|mesh-list
139622135|NCT01462370|Ibuprofen|ibuprofen|mesh-list
139622136|NCT01462370|Etoricoxib|etoricoxib|mesh-list
139622137|NCT01462370|Caffeine|caffeine|mesh-list
139622138|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139622139|NCT01462370|Analgesics|analgesics|mesh-ancestor
139622140|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
139622141|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622142|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622143|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
138750647|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139622144|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139622145|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139622146|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139622147|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139622148|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622149|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622150|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139622151|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139622152|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139622153|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139622154|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
139622155|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622156|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139622157|NCT05743179|Zoledronic Acid|zoledronic acid|mesh-list
139622158|NCT05743179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139622159|NCT05743179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622160|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
139622161|NCT01479764|Neostigmine|neostigmine|mesh-list
139622162|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139622163|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622164|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622165|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
139622166|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622167|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622168|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139622169|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
139622170|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622171|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139622172|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139622173|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139622174|NCT01479530|Rasagiline|rasagiline|mesh-list
139622175|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139622176|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622177|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622178|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139622179|NCT01479530|Protective Agents|protective agents|mesh-ancestor
139622180|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622181|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139622182|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139622183|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139622184|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139622185|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139622186|NCT01479374|Analgesics|analgesics|mesh-ancestor
139622187|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
139622188|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622189|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622190|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139622191|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139622192|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139622193|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139622194|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139622195|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
139622196|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
139622197|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622198|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622199|NCT00087529|Rituximab|rituximab|mesh-list
139622200|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139622201|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622202|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
139622203|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622204|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139622205|NCT00794313|Topiramate|topiramate|mesh-list
139622206|NCT00794313|Amantadine|amantadine|mesh-list
139622207|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
139622208|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139622209|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622210|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139622211|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139622212|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
139622213|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139622214|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
139622215|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622216|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622217|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139622218|NCT00794313|Analgesics|analgesics|mesh-ancestor
139622219|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
139622220|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622221|NCT05743101|Levofloxacin|levofloxacin|mesh-list
139622222|NCT05743101|Ofloxacin|ofloxacin|mesh-list
139622223|NCT05743101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139622224|NCT05743101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139622225|NCT05743101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139622226|NCT05743101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139622227|NCT05743101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139622228|NCT05743101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622229|NCT05743101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622230|NCT05743101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622231|NCT05743101|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139622232|NCT05743101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139622233|NCT01500434|Aspirin|aspirin|mesh-list
139622234|NCT01500434|Ticlopidine|ticlopidine|mesh-list
139622235|NCT01500434|Clopidogrel|clopidogrel|mesh-list
139622236|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139622237|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139622238|NCT01500434|Analgesics|analgesics|mesh-ancestor
139622239|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
139622240|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622241|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622242|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139622243|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139622244|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139622245|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139622246|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622247|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139622248|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139622249|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622250|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
139622251|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139622252|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139622253|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139622254|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
139622255|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622256|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139622257|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139622258|NCT00087139|Epothilones|epothilones|mesh-list
139622259|NCT00087139|Epothilone B|epothilone b|mesh-list
139622260|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
139622261|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
139622262|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
139622263|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622264|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622265|NCT00794547|Calcitriol|calcitriol|mesh-list
139622266|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139622267|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622268|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139622269|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139622270|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622271|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139622272|NCT00794547|Vitamins|vitamins|mesh-ancestor
139622273|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
139622274|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139622275|NCT00786825|Somatostatin|somatostatin|mesh-list
139622276|NCT00786825|Hormones|hormones|mesh-ancestor
139622277|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139622278|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622279|NCT00768261|Memantine|memantine|mesh-list
139622280|NCT00768261|Donepezil|donepezil|mesh-list
139622281|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139622282|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622283|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622284|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
139622285|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622286|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622287|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
139622288|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139622289|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139622290|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
139622291|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139622292|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139622293|NCT03804723|Prednisone|prednisone|mesh-list
139622294|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139622295|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
139622296|NCT03804723|Hormones|hormones|mesh-ancestor
139622297|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139622298|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622299|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139622300|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622301|NCT00797277|Lorazepam|lorazepam|mesh-list
139622302|NCT00797277|Haloperidol|haloperidol|mesh-list
139622303|NCT00797277|Olanzapine|olanzapine|mesh-list
139622304|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
139622305|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
139622306|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
139622307|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622308|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622309|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139622310|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139622311|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139622312|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139622313|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139622314|NCT00797277|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139622315|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139622316|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139622317|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622318|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622319|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
139622320|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139622321|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
139622322|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139622323|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
139622324|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139622325|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139622326|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
139622327|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
139622328|NCT03837015|Estradiol|estradiol|mesh-list
139622329|NCT03837015|Estrogens|estrogens|mesh-ancestor
138425046|NCT02175030|Copper|copper|mesh-list
139622330|NCT03837015|Hormones|hormones|mesh-ancestor
139622331|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139622332|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622333|NCT01500278|Adalimumab|adalimumab|mesh-list
139622334|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
139622335|NCT01500278|Methotrexate|methotrexate|mesh-list
139622336|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139622337|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
139622338|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139622339|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622340|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139622341|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
139622342|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622343|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622344|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
139622345|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622346|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139622347|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139622348|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
139622349|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139622350|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139622351|NCT01500278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138750838|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
139622352|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139622353|NCT00086281|Zolpidem|zolpidem|mesh-list
139622354|NCT00086281|Modafinil|modafinil|mesh-list
139622355|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139622356|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622357|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139622358|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139622359|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139622360|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622361|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139622362|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139622363|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139622364|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139622365|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
139622366|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
139622367|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622368|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
139622369|NCT00787761|Busulfan|busulfan|mesh-list
139622370|NCT00787761|Methotrexate|methotrexate|mesh-list
139622371|NCT00787761|Fludarabine|fludarabine|mesh-list
139622372|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
139622373|NCT00787761|Tacrolimus|tacrolimus|mesh-list
139622374|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
139622375|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139622376|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139622377|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
139622378|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622379|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139622380|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139622381|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
139622382|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622383|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622384|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139622385|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139622386|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
139622387|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139622388|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139622389|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
139622390|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
139622391|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622392|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139622393|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139622394|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139622395|NCT01478828|Lovastatin|lovastatin|mesh-list
139622396|NCT01478828|L 647318|l 647318|mesh-list
139622397|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
139622398|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139622399|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139622400|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
138750895|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
139622401|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622402|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139622403|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139622404|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622405|NCT00085423|Aldesleukin|aldesleukin|mesh-list
139622406|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
139622407|NCT00085423|Fludarabine|fludarabine|mesh-list
139622408|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
139622409|NCT00085423|Interleukin-2|interleukin-2|mesh-list
139622410|NCT00085423|Molgramostim|molgramostim|mesh-list
139622411|NCT00085423|Sargramostim|sargramostim|mesh-list
139622412|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139622413|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
139622414|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622415|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139622416|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138750910|NCT01217190|Ondansetron|ondansetron|mesh-list
139622417|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
139622418|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622419|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622420|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139622421|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139622422|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
139622423|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139622424|NCT00085423|Analgesics|analgesics|mesh-ancestor
139622425|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
139622426|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622427|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139622428|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139622429|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
139622430|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139622431|NCT04079192|Umirolimus|umirolimus|mesh-list
139622432|NCT04079192|Paclitaxel|paclitaxel|mesh-list
139622433|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139622434|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622435|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
139622436|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
139622437|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
139622438|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622439|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139622440|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139622441|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
139622442|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622443|NCT03087877|Acetaminophen|acetaminophen|mesh-list
139622444|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139622445|NCT03087877|Analgesics|analgesics|mesh-ancestor
139622446|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
139622447|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622448|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622449|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
139622450|NCT05742477|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139622451|NCT05742477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139622452|NCT03447379|Aspirin|aspirin|mesh-list
139622453|NCT03447379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139622454|NCT03447379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139622455|NCT03447379|Analgesics|analgesics|mesh-ancestor
139622456|NCT03447379|Sensory System Agents|sensory system agents|mesh-ancestor
139622457|NCT03447379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622458|NCT03447379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622459|NCT03447379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139622460|NCT03447379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139622461|NCT03447379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139622462|NCT03447379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139622463|NCT03447379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622464|NCT03447379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139622465|NCT03447379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139622466|NCT03447379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622467|NCT03447379|Antipyretics|antipyretics|mesh-ancestor
139622468|NCT03803553|Fluorouracil|fluorouracil|mesh-list
139622469|NCT03803553|Nivolumab|nivolumab|mesh-list
139622470|NCT03803553|Irinotecan|irinotecan|mesh-list
139622471|NCT03803553|Cetuximab|cetuximab|mesh-list
139622472|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
139622473|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622474|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139622475|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622476|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139622477|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
139622478|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622479|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139622480|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139622481|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139622482|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139622483|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622484|NCT05740449|Decitabine|decitabine|mesh-list
139622485|NCT05740449|Venetoclax|venetoclax|mesh-list
139622486|NCT05740449|Navitoclax|navitoclax|mesh-list
139622487|NCT05740449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139622488|NCT05740449|Antimetabolites|antimetabolites|mesh-ancestor
139622489|NCT05740449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622490|NCT05740449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622491|NCT05740449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622492|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
139622493|NCT01677949|Etoposide|etoposide|mesh-list
139622494|NCT01677949|Clofarabine|clofarabine|mesh-list
139622495|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139622496|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
139622497|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622498|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139622499|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139622500|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
139622501|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622502|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622503|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139622504|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139622505|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139622506|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139622507|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622508|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139622509|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
139622510|NCT03483883|Gemcitabine|gemcitabine|mesh-list
139622511|NCT03483883|Avelumab|avelumab|mesh-list
139622512|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139622513|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
139622514|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622515|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622516|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139622517|NCT00799227|Dexamethasone|dexamethasone|mesh-list
139622518|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139622519|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
139622520|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
139622521|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622522|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622523|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139622524|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
139622525|NCT00799227|Hormones|hormones|mesh-ancestor
139622526|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139622527|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139622528|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622529|NCT03439267|Calcium|calcium|mesh-list
138751013|NCT01134315|Vitamins|vitamins|mesh-ancestor
139622530|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139622531|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622532|NCT00770133|Ketotifen|ketotifen|mesh-list
139622533|NCT00770133|Naphazoline|naphazoline|mesh-list
139622534|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
139622535|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
139622536|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139622537|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
139622538|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
139622539|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622540|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622541|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622542|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139622543|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139622544|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139622545|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
139622546|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
139622547|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139622548|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
139622549|NCT00770757|Pomalidomide|pomalidomide|mesh-list
139622550|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
139622551|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622552|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139622553|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139622554|NCT00770757|Growth Substances|growth substances|mesh-ancestor
139622555|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
139622556|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622557|NCT01425281|Everolimus|everolimus|mesh-list
139622558|NCT01425281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139622559|NCT01425281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139622560|NCT01425281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622561|NCT01425281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751043|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
139622562|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139622563|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
139622564|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622565|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622566|NCT04384653|Furosemide|furosemide|mesh-list
139622567|NCT04384653|Diuretics|diuretics|mesh-ancestor
139622568|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
139622569|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622570|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139622571|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139622572|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622573|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
139622574|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
139622575|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139622576|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139622577|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622578|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139622579|NCT04113720|Analgesics|analgesics|mesh-ancestor
139622580|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
139622581|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622582|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138751081|NCT00919633|Ribavirin|ribavirin|mesh-list
139622583|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139622584|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139622585|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
139622586|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622587|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622588|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
139622589|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
139622590|NCT01402817|Sunitinib|sunitinib|mesh-list
139622591|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622592|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139622593|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139622594|NCT01402817|Growth Substances|growth substances|mesh-ancestor
139622595|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622596|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
139622597|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139622598|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622599|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622600|NCT01425203|Ribavirin|ribavirin|mesh-list
139622601|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139622602|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
139622603|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622604|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
139622605|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139622606|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
139622607|NCT04215120|Hematinics|hematinics|mesh-ancestor
139622608|NCT00081289|Leucovorin|leucovorin|mesh-list
139622609|NCT00081289|Folic Acid|folic acid|mesh-list
139622610|NCT00081289|Capecitabine|capecitabine|mesh-list
139622611|NCT00081289|Fluorouracil|fluorouracil|mesh-list
139622612|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
139622613|NCT00081289|Irinotecan|irinotecan|mesh-list
139622614|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
139622615|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139622616|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
139622617|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622618|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622619|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139622620|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
139622621|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622622|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139622623|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139622624|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622625|NCT00081289|Antidotes|antidotes|mesh-ancestor
139622626|NCT00081289|Protective Agents|protective agents|mesh-ancestor
139622627|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
139622628|NCT00081289|Vitamins|vitamins|mesh-ancestor
139622629|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
139622630|NCT00081289|Hematinics|hematinics|mesh-ancestor
139622631|NCT01478594|Bevacizumab|bevacizumab|mesh-list
139622632|NCT01478594|Tivozanib|tivozanib|mesh-list
139622633|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139622634|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622635|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139622636|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139622637|NCT01478594|Growth Substances|growth substances|mesh-ancestor
139622638|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622639|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
139622640|NCT01478594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139622641|NCT01478594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622642|NCT01478594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622643|NCT01424813|Albuterol|albuterol|mesh-list
139622644|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139622645|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
139622646|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622647|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622648|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139622649|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
139622650|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
139622651|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139622652|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139622653|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139622654|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139622655|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
139622656|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622657|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622658|NCT03389022|Ketamine|ketamine|mesh-list
139622659|NCT03389022|Analgesics|analgesics|mesh-ancestor
139622660|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
139622661|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622662|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622663|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139622664|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139622665|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
139622666|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
139622667|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139622668|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139622669|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139622670|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622671|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622672|NCT00080899|Fenretinide|fenretinide|mesh-list
139622673|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622674|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139622675|NCT00080899|Protective Agents|protective agents|mesh-ancestor
139622676|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622677|NCT03627858|Beclomethasone|beclomethasone|mesh-list
139622678|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
139622679|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
139622680|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139622681|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
139622682|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622683|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622684|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139622685|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
139622686|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139622687|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139622688|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139622689|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
139622690|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622691|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622692|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139622693|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
139622694|NCT03627858|Hormones|hormones|mesh-ancestor
139622695|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139622696|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139622697|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139622698|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139622699|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
139622700|NCT03086785|Apatinib|apatinib|mesh-list
139622701|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622702|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139622703|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622704|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622705|NCT03259698|Tenofovir|tenofovir|mesh-list
139622706|NCT03259698|Emtricitabine|emtricitabine|mesh-list
139622707|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139622708|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
139622709|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139622710|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139622711|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138751175|NCT04254523|Narcotics|narcotics|mesh-ancestor
139622712|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622713|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622714|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139622715|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139622717|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139622718|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622719|NCT03445728|Nicorandil|nicorandil|mesh-list
139622720|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139622721|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139622722|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
139622723|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
139622724|NCT03445728|Vitamins|vitamins|mesh-ancestor
139622725|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
139622726|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622727|NCT02795520|OTS167|ots167|mesh-list
139622728|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139622729|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622730|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622731|NCT03159000|Lidocaine|lidocaine|mesh-list
139622732|NCT03159000|Bupivacaine|bupivacaine|mesh-list
139622733|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
139622734|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
139622735|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139622736|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622737|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
139622738|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622739|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139622740|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139622741|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139622742|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139622743|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622744|NCT00086671|Antibodies|antibodies|mesh-list
139622745|NCT00086671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139622746|NCT00086671|Immunologic Factors|immunologic factors|mesh-ancestor
139622747|NCT00086671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622748|NCT02010606|Bevacizumab|bevacizumab|mesh-list
139622749|NCT02010606|Temozolomide|temozolomide|mesh-list
139622750|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139622751|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622752|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139622753|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139622754|NCT02010606|Growth Substances|growth substances|mesh-ancestor
139622755|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622756|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
139622757|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139622758|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
139622759|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622760|NCT00084253|Ritonavir|ritonavir|mesh-list
139622761|NCT00084253|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139622762|NCT00084253|Lamivudine|lamivudine|mesh-list
139622763|NCT00084253|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139622764|NCT00084253|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139622765|NCT00084253|Protease Inhibitors|protease inhibitors|mesh-ancestor
139622766|NCT00084253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622767|NCT00084253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622768|NCT00084253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139622769|NCT00084253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139622770|NCT00084253|Antiviral Agents|antiviral agents|mesh-ancestor
139622771|NCT00084253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139622772|NCT00084253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139622773|NCT00084253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139622774|NCT00084253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139622775|NCT00084253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139622776|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
139622777|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139622778|NCT02951364|Ledipasvir|ledipasvir|mesh-list
139622779|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
139622780|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139622781|NCT01678417|Rituximab|rituximab|mesh-list
139622782|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139622783|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622784|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
139622785|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622786|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139622787|NCT00083941|Interleukin-2|interleukin-2|mesh-list
139622788|NCT00083941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622789|NCT00083941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139622790|NCT00083941|Analgesics|analgesics|mesh-ancestor
139622791|NCT00083941|Sensory System Agents|sensory system agents|mesh-ancestor
139622792|NCT00083941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622793|NCT00083941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622794|NCT01678495|Plasminogen|plasminogen|mesh-list
139622795|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139622796|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139622797|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139622798|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622799|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
139622800|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622801|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139622802|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622803|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622804|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
139622805|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139622806|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622807|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139622808|NCT01678651|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139622809|NCT01678651|Hormones|hormones|mesh-ancestor
139622810|NCT01678651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139622811|NCT01678651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622812|NCT04094090|Riboflavin|riboflavin|mesh-list
139622813|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
139622814|NCT04094090|Vitamins|vitamins|mesh-ancestor
139622815|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
139622816|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622817|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139622818|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
139622819|NCT04670796|Trastuzumab|trastuzumab|mesh-list
139622820|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139622821|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622822|NCT01019616|Paclitaxel|paclitaxel|mesh-list
139622823|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139622824|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622825|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
139622826|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
139622827|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
139622828|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622829|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
138751285|NCT04252261|Sulforaphane|sulforaphane|mesh-list
139622830|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139622831|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622832|NCT03083197|Azithromycin|azithromycin|mesh-list
139622833|NCT03083197|Doxycycline|doxycycline|mesh-list
139622834|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139622835|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139622836|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
139622837|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139622838|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139622839|NCT03086239|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
139622840|NCT03086239|Immunoconjugates|immunoconjugates|mesh-ancestor
139622841|NCT03086239|Immunologic Factors|immunologic factors|mesh-ancestor
139622842|NCT03086239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622843|NCT01678963|Squalamine|squalamine|mesh-list
139622844|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139622845|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139622846|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139622847|NCT01678963|Protective Agents|protective agents|mesh-ancestor
139622848|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622849|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622850|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139622851|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139622852|NCT01678963|Growth Substances|growth substances|mesh-ancestor
139622853|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
139622854|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139622855|NCT00790335|Plasminogen|plasminogen|mesh-list
139622856|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139622857|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139622858|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622859|NCT05136534|Anesthetics|anesthetics|mesh-list
139622860|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139622861|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622862|NCT05135442|Bortezomib|bortezomib|mesh-list
139622863|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622864|NCT05130684|Paclitaxel|paclitaxel|mesh-list
139622865|NCT05130684|Cisplatin|cisplatin|mesh-list
139622866|NCT05130684|Nivolumab|nivolumab|mesh-list
139622867|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139622868|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622869|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
139622870|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
139622871|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
139622872|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622873|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139622874|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139622875|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
139622876|NCT04402411|Narcotics|narcotics|mesh-ancestor
139622877|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139622878|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622879|NCT04402411|Analgesics|analgesics|mesh-ancestor
139622880|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
139622881|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622882|NCT05265507|Glycopyrrolate|glycopyrrolate|mesh-list
139622883|NCT05265507|Ondansetron|ondansetron|mesh-list
139622884|NCT05265507|Antiemetics|antiemetics|mesh-ancestor
139622885|NCT05265507|Autonomic Agents|autonomic agents|mesh-ancestor
139622886|NCT05265507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622887|NCT05265507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622888|NCT05265507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139622889|NCT05265507|Antipruritics|antipruritics|mesh-ancestor
139622890|NCT05265507|Dermatologic Agents|dermatologic agents|mesh-ancestor
139622891|NCT05265507|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139622892|NCT05265507|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139622893|NCT05265507|Serotonin Agents|serotonin agents|mesh-ancestor
139622894|NCT05265507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622895|NCT05265507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622896|NCT05265507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139622897|NCT05265507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139622898|NCT05265507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139622899|NCT05265507|Cholinergic Agents|cholinergic agents|mesh-ancestor
139622900|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139622901|NCT05135286|Carbachol|carbachol|mesh-list
139622902|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139622903|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139622904|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139622905|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139622906|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
139622907|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622908|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622909|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622910|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139622911|NCT05135286|Miotics|miotics|mesh-ancestor
139622912|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
139622913|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622914|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139622915|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
139622916|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139622917|NCT05135286|Analgesics|analgesics|mesh-ancestor
139622918|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
139622919|NCT05135286|Protective Agents|protective agents|mesh-ancestor
139622920|NCT03089671|Vitamins|vitamins|mesh-list
139622921|NCT03089671|Riboflavin|riboflavin|mesh-list
139622922|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
139622923|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
139622924|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622925|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139622926|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
139622927|NCT05136924|Varenicline|varenicline|mesh-list
139622928|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139622929|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139622930|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
139622931|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622932|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622933|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622934|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
139622935|NCT00791037|Sargramostim|sargramostim|mesh-list
139622936|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139622937|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
139622938|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622939|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139622940|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139622941|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
139622942|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622943|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622944|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139622946|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
139622947|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
139622948|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622949|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622950|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139622951|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
139622952|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
139622953|NCT04403191|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139622954|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139622955|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
139622956|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622957|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622958|NCT04383093|Tadalafil|tadalafil|mesh-list
139622959|NCT04383093|Tamsulosin|tamsulosin|mesh-list
139622960|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
139622961|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139622962|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139622963|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139622964|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622965|NCT04383093|Urological Agents|urological agents|mesh-ancestor
139622966|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139622967|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139622968|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139622969|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
139622970|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622971|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622972|NCT05301660|Nicotine|nicotine|mesh-list
139622973|NCT05301660|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139622974|NCT05301660|Autonomic Agents|autonomic agents|mesh-ancestor
139622975|NCT05301660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622976|NCT05301660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622977|NCT05301660|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139622978|NCT05301660|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139622979|NCT05301660|Cholinergic Agents|cholinergic agents|mesh-ancestor
139622980|NCT05301660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622981|NCT05301660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139622982|NCT01401959|Trastuzumab|trastuzumab|mesh-list
139622983|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139622984|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139622985|NCT04767035|Midazolam|midazolam|mesh-list
139622986|NCT04767035|Ketamine|ketamine|mesh-list
139622987|NCT04767035|Analgesics|analgesics|mesh-ancestor
139622988|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
139622989|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139622990|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139622991|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139622992|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139622993|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
139622994|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
139622995|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139622996|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139622997|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139622998|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139622999|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623000|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139623001|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139623002|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139623003|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139623004|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139623005|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
139623006|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
139623007|NCT03081169|Heparin|heparin|mesh-list
139623008|NCT03081169|Enoxaparin|enoxaparin|mesh-list
139623009|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
139623010|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
139623011|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139623012|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139623013|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623014|NCT03803163|Treprostinil|treprostinil|mesh-list
139623015|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139623016|NCT05287308|Paclitaxel|paclitaxel|mesh-list
139623017|NCT05287308|Docetaxel|docetaxel|mesh-list
139623018|NCT05287308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139623019|NCT05287308|Cyclophosphamide|cyclophosphamide|mesh-list
139623020|NCT05287308|Doxorubicin|doxorubicin|mesh-list
139623021|NCT05287308|Epirubicin|epirubicin|mesh-list
139623022|NCT05287308|Pirarubicin|pirarubicin|mesh-list
139623023|NCT05287308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139623024|NCT05287308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623025|NCT05287308|Tubulin Modulators|tubulin modulators|mesh-ancestor
139623026|NCT05287308|Antimitotic Agents|antimitotic agents|mesh-ancestor
139623027|NCT05287308|Mitosis Modulators|mitosis modulators|mesh-ancestor
139623028|NCT05287308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623029|NCT05287308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139623030|NCT05287308|Immunologic Factors|immunologic factors|mesh-ancestor
139623031|NCT05287308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623032|NCT05287308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139623033|NCT05287308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139623034|NCT05287308|Alkylating Agents|alkylating agents|mesh-ancestor
139623035|NCT05287308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139623036|NCT05287308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139623037|NCT05287308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139623038|NCT05287308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139623039|NCT05287308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623040|NCT00801723|Budesonide|budesonide|mesh-list
139623041|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623042|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139623043|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
139623044|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623045|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623046|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139623047|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
139623048|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
139623049|NCT00801723|Hormones|hormones|mesh-ancestor
139623050|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139623051|NCT05346211|Curcumin|curcumin|mesh-list
139623052|NCT05346211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139623053|NCT05346211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139623054|NCT05346211|Analgesics|analgesics|mesh-ancestor
139623055|NCT05346211|Sensory System Agents|sensory system agents|mesh-ancestor
139623056|NCT05346211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623057|NCT05346211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623058|NCT05346211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623059|NCT05346211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139623060|NCT05346211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623061|NCT05346211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623062|NCT05346211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623063|NCT05694897|Magnesium Sulfate|magnesium sulfate|mesh-list
139623064|NCT05694897|Bupivacaine|bupivacaine|mesh-list
139623065|NCT05694897|Anesthetics, Local|anesthetics, local|mesh-ancestor
139623066|NCT05694897|Anesthetics|anesthetics|mesh-ancestor
139623067|NCT05694897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139623068|NCT05694897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623069|NCT05694897|Sensory System Agents|sensory system agents|mesh-ancestor
139623070|NCT05694897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623071|NCT05694897|Analgesics|analgesics|mesh-ancestor
139623072|NCT05694897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139623073|NCT05694897|Anticonvulsants|anticonvulsants|mesh-ancestor
139623074|NCT05694897|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139623075|NCT05694897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139623076|NCT05694897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623077|NCT05694897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139623078|NCT05694897|Tocolytic Agents|tocolytic agents|mesh-ancestor
139623079|NCT05694897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139623080|NCT01478048|Dexamethasone|dexamethasone|mesh-list
139623081|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
139623082|NCT01478048|Bortezomib|bortezomib|mesh-list
139623083|NCT01478048|Elotuzumab|elotuzumab|mesh-list
139623084|NCT01478048|BB 1101|bb 1101|mesh-list
139623085|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623086|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
139623087|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
139623088|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623089|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623090|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139623091|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
139623092|NCT01478048|Hormones|hormones|mesh-ancestor
139623093|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139623094|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139623095|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623096|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
139623097|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623098|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623099|NCT04585776|Insulin|insulin|mesh-list
139623100|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139623101|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623102|NCT01401647|Lidocaine|lidocaine|mesh-list
139623103|NCT01401647|Amiodarone|amiodarone|mesh-list
139623104|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
139623105|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
139623106|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139623107|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623108|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
139623109|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623110|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139623111|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139623112|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139623113|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139623114|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623115|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
139623116|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139623117|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139623118|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139623119|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623120|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139623121|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139623122|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139623123|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139623124|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139623125|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139623126|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139623127|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623128|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139623129|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139623130|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139623131|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139623132|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
139623133|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139623134|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623135|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139623136|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139623137|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
139623138|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139623139|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139623140|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
139623141|NCT03088891|Antioxidants|antioxidants|mesh-list
139623142|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623143|NCT03088891|Protective Agents|protective agents|mesh-ancestor
139623144|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623145|NCT01477892|Remifentanil|remifentanil|mesh-list
139623146|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139623147|NCT01477892|Narcotics|narcotics|mesh-ancestor
139623148|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139623149|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623150|NCT01477892|Analgesics|analgesics|mesh-ancestor
139623151|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
139623152|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623153|NCT00801801|Docetaxel|docetaxel|mesh-list
139623154|NCT00801801|Sorafenib|sorafenib|mesh-list
139623155|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623156|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
139623157|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
139623158|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
139623159|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623160|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139623161|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623162|NCT01499576|Acetic Acid|acetic acid|mesh-list
139623163|NCT01499576|Retinol acetate|retinol acetate|mesh-list
139623164|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139623165|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623166|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139623167|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
139623168|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623169|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139623170|NCT01499576|Protective Agents|protective agents|mesh-ancestor
139623171|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623172|NCT00802113|Fludarabine|fludarabine|mesh-list
139623173|NCT00802113|Busulfan|busulfan|mesh-list
139623174|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139623175|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623176|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623177|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139623178|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
139623179|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623180|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
139623181|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139623182|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139623183|NCT03084601|Calcium|calcium|mesh-list
139623184|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139623185|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623186|NCT00791973|Fluticasone|fluticasone|mesh-list
139623187|NCT00791973|Xhance|xhance|mesh-list
139623188|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623189|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139623190|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
139623191|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623192|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623193|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139623194|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
139623195|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
139623196|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139623197|NCT00773955|Acetic Acid|acetic acid|mesh-list
139623198|NCT00773955|Retinol acetate|retinol acetate|mesh-list
139623199|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
139623200|NCT00773955|Gossypol|gossypol|mesh-list
139623201|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139623202|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623203|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139623204|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
139623205|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623206|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139623207|NCT00773955|Protective Agents|protective agents|mesh-ancestor
139623208|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623209|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139623210|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
139623211|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139623212|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139623213|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139623214|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
139623215|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
139623216|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
139623217|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139623218|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623219|NCT01498952|Sorafenib|sorafenib|mesh-list
139623220|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623221|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139623222|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623223|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623224|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
139623225|NCT04499196|Hormones|hormones|mesh-ancestor
139623226|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139623227|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623228|NCT04608266|Camostat|camostat|mesh-list
139623229|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
139623230|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623231|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623232|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139623233|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139623234|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139623235|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139623236|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
139623237|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139623238|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623239|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139623240|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139623241|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139623242|NCT01421303|Etanercept|etanercept|mesh-list
139623243|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139623244|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139623245|NCT01421303|Analgesics|analgesics|mesh-ancestor
139623246|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
139623247|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623248|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623249|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623250|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139623251|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139623252|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139623253|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
139623254|NCT03703375|Gemcitabine|gemcitabine|mesh-list
139623255|NCT03703375|Azacitidine|azacitidine|mesh-list
139623256|NCT03703375|Romidepsin|romidepsin|mesh-list
139623257|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139623258|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
139623259|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623260|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623261|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623262|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139623263|NCT03703375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139623264|NCT05303688|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139623265|NCT05303688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139623266|NCT05303688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139623267|NCT05303688|Analgesics|analgesics|mesh-ancestor
139623268|NCT05303688|Sensory System Agents|sensory system agents|mesh-ancestor
139623269|NCT05303688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623270|NCT05303688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623271|NCT05303688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623272|NCT05303688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139623273|NCT04383717|Azithromycin|azithromycin|mesh-list
139623274|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
139623275|NCT04383717|Levamisole|levamisole|mesh-list
139623276|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
139623277|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139623278|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623279|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
139623280|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139623281|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139623282|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623283|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623284|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139623285|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139623286|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
139623287|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623288|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
139623289|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
139623290|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
139623291|NCT01400243|Nicotine|nicotine|mesh-list
139623292|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139623293|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
139623294|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623295|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623296|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139623297|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139623298|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
139623299|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139623300|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623301|NCT00809055|Caffeine|caffeine|mesh-list
139623302|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
139623303|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623304|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139623305|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623306|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139623307|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623308|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139623309|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139623310|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
139405022|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
139623311|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139623312|NCT01421225|Insulin|insulin|mesh-list
139623313|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139623314|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139623315|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623316|NCT03082885|Thymalfasin|thymalfasin|mesh-list
139623317|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139623318|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
139623319|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623320|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139623321|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
139623322|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623323|NCT05688631|Antioxidants|antioxidants|mesh-list
139623324|NCT05688631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623325|NCT05688631|Protective Agents|protective agents|mesh-ancestor
139623326|NCT05688631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623327|NCT04348032|Apatinib|apatinib|mesh-list
139623328|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623329|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139623330|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623331|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623332|NCT01474772|Pregabalin|pregabalin|mesh-list
139623333|NCT01474772|Analgesics|analgesics|mesh-ancestor
139623334|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
139623335|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623336|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623337|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
139623338|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139623339|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139623340|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623341|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139623342|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139623343|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139623344|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139623345|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139623346|NCT03082339|Cortisone|cortisone|mesh-list
139623347|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623348|NCT03801759|Adefovir|adefovir|mesh-list
139623349|NCT03801759|Digoxin|digoxin|mesh-list
139623350|NCT03801759|Furosemide|furosemide|mesh-list
139623351|NCT03801759|Diuretics|diuretics|mesh-ancestor
139623352|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
138751810|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139623353|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623354|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139623355|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139623356|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623357|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139623358|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139623359|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623360|NCT03801759|Protective Agents|protective agents|mesh-ancestor
139623361|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
139623362|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623363|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139623364|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139623365|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
139623366|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139623367|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623368|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139623369|NCT03082573|Hormones|hormones|mesh-ancestor
139623370|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139623371|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623372|NCT01497938|Insulin|insulin|mesh-list
139623373|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139623374|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623375|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
139623376|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
139623377|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623378|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139623379|NCT04301310|Rifampin|rifampin|mesh-list
139623380|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139623381|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
139623382|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139623383|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623384|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
139623385|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139623386|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623387|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623388|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139623389|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139623390|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139623391|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139623392|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139623393|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139623394|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
139623395|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623396|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
139623397|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
139623398|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
139623399|NCT00804609|Lidocaine|lidocaine|mesh-list
139623400|NCT00804609|Morphine|morphine|mesh-list
139623401|NCT00804609|Anesthetics|anesthetics|mesh-list
139623402|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
139623403|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139623404|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623405|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
139623406|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623407|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139623408|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139623409|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139623410|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139623411|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623412|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139623413|NCT00804609|Narcotics|narcotics|mesh-ancestor
139623414|NCT00804609|Analgesics|analgesics|mesh-ancestor
139623415|NCT03082183|Rifampin|rifampin|mesh-list
139623416|NCT03082183|BI 425809|bi 425809|mesh-list
139623417|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139623418|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
139623419|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139623420|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623421|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
139623422|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139623423|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623424|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623425|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139623426|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139623427|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139623428|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139623429|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139623430|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139623431|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
139623432|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139623433|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139623434|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623435|NCT00810303|Efavirenz|efavirenz|mesh-list
139623436|NCT00810303|Ezetimibe|ezetimibe|mesh-list
139623437|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139623438|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139623439|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
139623440|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623441|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139623442|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139623443|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139623444|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623445|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
139623446|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623447|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139623448|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139623449|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139623450|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139623451|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139623452|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139623453|NCT04401085|Antibodies|antibodies|mesh-list
139623454|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
139623455|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623456|NCT05645107|Immunoglobulins|immunoglobulins|mesh-list
139623457|NCT05645107|gamma-Globulins|gamma-globulins|mesh-list
139623458|NCT05645107|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139623459|NCT05645107|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139623460|NCT05645107|Immunologic Factors|immunologic factors|mesh-ancestor
139623461|NCT05645107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405158|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
139623462|NCT04227756|Psilocybin|psilocybin|mesh-list
139623463|NCT04227756|Mescaline|mescaline|mesh-list
139623464|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
139623465|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623466|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139623467|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139623468|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
139623469|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139623470|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623471|NCT01460342|Tadalafil|tadalafil|mesh-list
139623472|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
139623473|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139623474|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139623475|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623476|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623477|NCT01460342|Urological Agents|urological agents|mesh-ancestor
139623478|NCT00775671|Metoprolol|metoprolol|mesh-list
139623479|NCT00775671|Nebivolol|nebivolol|mesh-list
139623480|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139623481|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139623482|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
139623483|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
139623484|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623485|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623486|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139623487|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139623488|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139623489|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
139623490|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139623491|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623492|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
139623493|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139623494|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139623495|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139623496|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139623497|NCT03800745|Laxatives|laxatives|mesh-ancestor
139623498|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139623499|NCT01459796|Rilonacept|rilonacept|mesh-list
139623500|NCT01459796|Allopurinol|allopurinol|mesh-list
139623501|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
139623502|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623503|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623504|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
139623505|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139623506|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139623507|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
139623508|NCT01459796|Protective Agents|protective agents|mesh-ancestor
139623509|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623510|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623511|NCT04721691|Cannabidiol|cannabidiol|mesh-list
139623512|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
139623513|NCT04760821|Trimetazidine|trimetazidine|mesh-list
139623514|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
139623515|NCT04382079|Propolis|propolis|mesh-list
139623516|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623517|NCT05688007|Hormones|hormones|mesh-list
139623518|NCT05688007|Parathyroid Hormone|parathyroid hormone|mesh-list
139623519|NCT05688007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139623520|NCT05688007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623521|NCT05688007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139623522|NCT01459718|Deferasirox|deferasirox|mesh-list
139623523|NCT01459718|Deferoxamine|deferoxamine|mesh-list
139623524|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139623525|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
139623526|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
139623527|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623528|NCT01459718|Siderophores|siderophores|mesh-ancestor
139623529|NCT04918407|Empagliflozin|empagliflozin|mesh-list
139623530|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139623531|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623532|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139623533|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623534|NCT04989660|Phenol|phenol|mesh-list
139623535|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139623536|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623537|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
139623538|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139623540|NCT03081325|Immunomodulating Agents|immunomodulating agents|mesh-list
139623541|NCT03081325|Immunologic Factors|immunologic factors|mesh-ancestor
139623542|NCT03081325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623543|NCT04384731|Poractant alfa|poractant alfa|mesh-list
139623544|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139623545|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
139623546|NCT05042466|Psilocybin|psilocybin|mesh-list
139623547|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
139623548|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623549|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139623550|NCT05615467|Metformin|metformin|mesh-list
139623551|NCT05615467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139623552|NCT05615467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623553|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
139623554|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139623555|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623556|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623557|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139623558|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139623559|NCT03800433|Protective Agents|protective agents|mesh-ancestor
139623560|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623561|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
139623562|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139623563|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
139623564|NCT03395899|Bevacizumab|bevacizumab|mesh-list
139623565|NCT03395899|Atezolizumab|atezolizumab|mesh-list
139623566|NCT03395899|Ipatasertib|ipatasertib|mesh-list
139623567|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139623568|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623569|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139623570|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139623571|NCT03395899|Growth Substances|growth substances|mesh-ancestor
139623572|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623573|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
139623574|NCT03395899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139623575|NCT03395899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623576|NCT03395899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139623577|NCT03395899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623578|NCT05602597|Itraconazole|itraconazole|mesh-list
139623579|NCT05602597|Fluconazole|fluconazole|mesh-list
139623580|NCT05602597|Rifampin|rifampin|mesh-list
139623581|NCT05602597|Rabeprazole|rabeprazole|mesh-list
139623582|NCT05602597|Antifungal Agents|antifungal agents|mesh-ancestor
139623583|NCT05602597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623584|NCT05602597|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139623585|NCT05602597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139623586|NCT05602597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623587|NCT05602597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623588|NCT05602597|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139623589|NCT05602597|Hormone Antagonists|hormone antagonists|mesh-ancestor
139623590|NCT05602597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139623591|NCT05602597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623592|NCT05602597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139623593|NCT05602597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139623594|NCT05602597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139623595|NCT05602597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139623596|NCT05602597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139623597|NCT05602597|Antitubercular Agents|antitubercular agents|mesh-ancestor
139623598|NCT05602597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139623599|NCT05602597|Leprostatic Agents|leprostatic agents|mesh-ancestor
139623600|NCT05602597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139623601|NCT05602597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139623602|NCT05602597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139623603|NCT05602597|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139623604|NCT05602597|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139623605|NCT05602597|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139623606|NCT05602597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139623607|NCT05602597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139623608|NCT05602597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139623609|NCT04608201|Nicotine|nicotine|mesh-list
139623610|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139623611|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
139623612|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623613|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623615|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139623616|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
139623617|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139623618|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623619|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
139623620|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
139623621|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139623622|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139623623|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623624|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623625|NCT04110444|Urological Agents|urological agents|mesh-ancestor
139623626|NCT04951986|Levofloxacin|levofloxacin|mesh-list
139623627|NCT04951986|Rifampin|rifampin|mesh-list
139623628|NCT04951986|Isoniazid|isoniazid|mesh-list
139623629|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
139623630|NCT04951986|Ethambutol|ethambutol|mesh-list
139623631|NCT04951986|Prednisone|prednisone|mesh-list
139623632|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623633|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
139623634|NCT04951986|Hormones|hormones|mesh-ancestor
139623635|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139623636|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623637|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139623638|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623639|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139623640|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623641|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139623642|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139623643|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139623644|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623645|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623646|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139623647|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139623648|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139623649|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
139623650|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
139623651|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139623652|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139623653|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139623654|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139623655|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139623656|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139623657|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139623658|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139623659|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139623660|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
139623661|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139623662|NCT04278859|Antibodies|antibodies|mesh-list
139623663|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139623664|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
139623665|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623666|NCT01474538|Insulin|insulin|mesh-list
139623667|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139623668|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
139623669|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
139623670|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139623671|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623672|NCT04278703|Oxycodone|oxycodone|mesh-list
139623673|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139623674|NCT04278703|Narcotics|narcotics|mesh-ancestor
139623675|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139623676|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623677|NCT04278703|Analgesics|analgesics|mesh-ancestor
139623678|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
139623679|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623680|NCT02647788|Acetaminophen|acetaminophen|mesh-list
139623681|NCT02647788|Ibuprofen|ibuprofen|mesh-list
139623682|NCT02647788|Codeine|codeine|mesh-list
139623683|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139623684|NCT02647788|Analgesics|analgesics|mesh-ancestor
139623685|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
139623686|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623687|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623688|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
139623689|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139623690|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623691|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139623692|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139623693|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623694|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623695|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139623696|NCT02647788|Narcotics|narcotics|mesh-ancestor
139623697|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139623698|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
139623699|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
139623700|NCT04382859|Bupivacaine|bupivacaine|mesh-list
139623701|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
139623702|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
139623703|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139623704|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623705|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
139623706|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623707|NCT03318133|Anesthetics|anesthetics|mesh-list
139623708|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139623709|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623710|NCT04520217|Imipramine|imipramine|mesh-list
139623711|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139623712|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
139623713|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139623714|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139623715|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139623716|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139623717|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623718|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
139623719|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139623720|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623721|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139623722|NCT04134663|Oxytocin|oxytocin|mesh-list
139623723|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
139623724|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139623725|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623726|NCT05431764|Gemcitabine|gemcitabine|mesh-list
139623727|NCT05431764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139623728|NCT05431764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623729|NCT05431764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623730|NCT05431764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139623731|NCT05431764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139623732|NCT05431764|Antimetabolites|antimetabolites|mesh-ancestor
139623733|NCT04311411|Liraglutide|liraglutide|mesh-list
139623734|NCT04311411|Tirzepatide|tirzepatide|mesh-list
139623735|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139623736|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623737|NCT04311411|Incretins|incretins|mesh-ancestor
139623738|NCT04311411|Hormones|hormones|mesh-ancestor
139623739|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139623740|NCT00843531|Everolimus|everolimus|mesh-list
139623741|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139623742|NCT00843531|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139623743|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139623744|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623745|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623746|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139623747|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
139623748|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623749|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623750|NCT00812877|Calcium|calcium|mesh-list
139623751|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139623752|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623753|NCT00813111|Epinephrine|epinephrine|mesh-list
139623754|NCT00813111|Bupivacaine|bupivacaine|mesh-list
139623755|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
139623756|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
139623757|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139623758|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623759|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
139623760|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623761|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139623762|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139623763|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
139623764|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139623765|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623766|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139623767|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139623768|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
139623769|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139623770|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
139623771|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
139623772|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
139623773|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139623774|NCT00845481|Calcitriol|calcitriol|mesh-list
139623775|NCT00845481|Betamethasone|betamethasone|mesh-list
139623776|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623777|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
139623778|NCT00845481|Hormones|hormones|mesh-ancestor
139623779|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139623780|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623781|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139623782|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
139623783|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139623784|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139623785|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139623786|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623787|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139623788|NCT00845481|Vitamins|vitamins|mesh-ancestor
139623789|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
139623790|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139623791|NCT03641001|Micronutrients|micronutrients|mesh-list
139623792|NCT03641001|Trace Elements|trace elements|mesh-list
139623793|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623794|NCT01421069|Etanercept|etanercept|mesh-list
139623795|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139623796|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139623797|NCT01421069|Analgesics|analgesics|mesh-ancestor
139623798|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
139623799|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623800|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623801|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623802|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139623803|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139623804|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139623805|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
139623806|NCT04276233|Albuterol|albuterol|mesh-list
139623807|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139623808|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
139623809|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623810|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623811|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139623812|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
139623813|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
139623814|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139623815|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139623816|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139623817|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139623818|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
139623819|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139623820|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623821|NCT04681430|Gabexate|gabexate|mesh-list
139623822|NCT04681430|Camostat|camostat|mesh-list
139623823|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
139623824|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623825|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623826|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139623827|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139623828|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
139623829|NCT00814671|Rifampin|rifampin|mesh-list
139623830|NCT00814671|Rifapentine|rifapentine|mesh-list
139623831|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139623832|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
139623833|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139623834|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405536|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
139623835|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
139623836|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139623837|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623838|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623839|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139623840|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139623841|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139623842|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139623843|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139623844|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139623845|NCT03379051|Lenalidomide|lenalidomide|mesh-list
139623846|NCT03379051|Venetoclax|venetoclax|mesh-list
139623847|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
139623848|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623849|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139623850|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139623851|NCT03379051|Growth Substances|growth substances|mesh-ancestor
139623852|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
139623853|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623854|NCT01473836|Metronidazole|metronidazole|mesh-list
139623855|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
139623856|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623857|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139623858|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139623859|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139623860|NCT03340909|Prednisolone|prednisolone|mesh-list
139623861|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623862|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
139623863|NCT03340909|Hormones|hormones|mesh-ancestor
139623864|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139623865|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623866|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139623867|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623868|NCT05686915|Cobalt|cobalt|mesh-list
139623869|NCT05686915|Chromium|chromium|mesh-list
139623870|NCT05686915|Trace Elements|trace elements|mesh-ancestor
139623871|NCT05686915|Micronutrients|micronutrients|mesh-ancestor
139623872|NCT05686915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623873|NCT03674151|Povidone|povidone|mesh-list
139623874|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
139623875|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
139623876|NCT03643965|Budesonide|budesonide|mesh-list
139623877|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623878|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139623879|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
139623880|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623881|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623882|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139623883|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
139623884|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
139623885|NCT03643965|Hormones|hormones|mesh-ancestor
139623886|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139623887|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
139623888|NCT01420679|Aminopterin|aminopterin|mesh-list
139623889|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139623890|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623891|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623892|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623893|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139623894|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139623895|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139623896|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
139623897|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623898|NCT04401007|Lidocaine|lidocaine|mesh-list
139623899|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
139623900|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
139623901|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139623902|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623903|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
139623904|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623905|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139623906|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139623907|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139623908|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139623909|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623910|NCT01496846|Lidocaine|lidocaine|mesh-list
139623912|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
139623913|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
139623914|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139623915|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623916|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
139623917|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623918|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139623919|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139623920|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139623921|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139623922|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623923|NCT00964002|Efavirenz|efavirenz|mesh-list
139623924|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139623925|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139623926|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623927|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623928|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
139623929|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623930|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139623931|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139623932|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139623933|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139623934|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139623935|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139623936|NCT00818337|Aspirin|aspirin|mesh-list
139623937|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139623938|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139623939|NCT00818337|Analgesics|analgesics|mesh-ancestor
139623940|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
139623941|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623942|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623943|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623944|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139623945|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139623946|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139623947|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623948|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139623949|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139623950|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623951|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
139623952|NCT02577120|Decanoic acid|decanoic acid|mesh-list
139623953|NCT02577120|Petrolatum|petrolatum|mesh-list
139623954|NCT02577120|Emollients|emollients|mesh-ancestor
139623955|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
139623956|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
139623957|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139623958|NCT01399697|Methotrexate|methotrexate|mesh-list
139623959|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139623960|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
139623961|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139623962|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623963|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139623964|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
139623965|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623966|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139623967|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
139623968|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139623969|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139623970|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139623971|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
139623972|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139623973|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139623974|NCT00853671|Adenosine|adenosine|mesh-list
139623975|NCT00853671|Analgesics|analgesics|mesh-ancestor
139623976|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
139623977|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623978|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623979|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139623980|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
139623981|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139623982|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
139623983|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
139623984|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139623985|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139623986|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139623987|NCT00818805|Tranilast|tranilast|mesh-list
139623988|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139623989|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139623990|NCT00818805|Analgesics|analgesics|mesh-ancestor
139623991|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
139623992|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139623993|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139623994|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139623995|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139623996|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139623997|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139623998|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139623999|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
139624000|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
139624001|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624002|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624003|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139624004|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139624005|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139624006|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139624007|NCT00854061|Prednisone|prednisone|mesh-list
139624008|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
139624009|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139624010|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
139624011|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139624012|NCT00854061|Prednisolone|prednisolone|mesh-list
139624013|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139624014|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
139624015|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139624016|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
139624017|NCT00854061|Hormones|hormones|mesh-ancestor
139624018|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624019|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624020|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139624021|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624022|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
139624023|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
139624024|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624025|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139624026|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139624027|NCT00854061|Protective Agents|protective agents|mesh-ancestor
139624028|NCT01473602|Vitamin D|vitamin d|mesh-list
139624029|NCT01473602|Teriparatide|teriparatide|mesh-list
139624030|NCT01473602|Calcium|calcium|mesh-list
139624031|NCT01473602|Vitamins|vitamins|mesh-ancestor
139624032|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
139624033|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624034|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139624035|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139624036|NCT03336073|Dexamethasone|dexamethasone|mesh-list
139624037|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
139624038|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139624039|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
139624040|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624041|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139624042|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139624043|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
139624044|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624045|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624046|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139624047|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139624048|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
139624049|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
139624050|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624051|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139624052|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
139624053|NCT03336073|Hormones|hormones|mesh-ancestor
139624054|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624055|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139624056|NCT01496612|Buspirone|buspirone|mesh-list
139624057|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139624058|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139624059|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139624060|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624061|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139624062|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139624063|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
139624064|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624065|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624066|NCT00790218|Adenosine|adenosine|mesh-list
139624067|NCT00790218|Analgesics|analgesics|mesh-ancestor
139624068|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
139624069|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624070|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624071|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139624072|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
139624073|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139624074|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
139624075|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
139624076|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624077|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624078|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
139624079|NCT00818961|Busulfan|busulfan|mesh-list
139624080|NCT00818961|Rituximab|rituximab|mesh-list
139624081|NCT00818961|Methotrexate|methotrexate|mesh-list
139624082|NCT00818961|Fludarabine|fludarabine|mesh-list
139624083|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
139624084|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
139624085|NCT00818961|Tacrolimus|tacrolimus|mesh-list
139624086|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139624087|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
139624088|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624089|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139624090|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139624091|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
138752549|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
139624092|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624093|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624094|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139624095|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139624096|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139624097|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
139624098|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139624099|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139624100|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
139624101|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
139624102|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624103|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139624104|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139624105|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139624106|NCT05431218|Cholecalciferol|cholecalciferol|mesh-list
139624107|NCT05431218|Vitamin D|vitamin d|mesh-list
139624108|NCT05431218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139624109|NCT05431218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624110|NCT05431218|Vitamins|vitamins|mesh-ancestor
139624111|NCT05431218|Micronutrients|micronutrients|mesh-ancestor
139624112|NCT05431218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139624113|NCT05431062|Bupivacaine|bupivacaine|mesh-list
139624114|NCT05431062|Anesthetics, Local|anesthetics, local|mesh-ancestor
139624115|NCT05431062|Anesthetics|anesthetics|mesh-ancestor
139624116|NCT05431062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139624117|NCT05431062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624118|NCT05431062|Sensory System Agents|sensory system agents|mesh-ancestor
139624119|NCT05431062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624120|NCT00819507|Fluocinonide|fluocinonide|mesh-list
139624121|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139624122|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
139624123|NCT00819507|Hormones|hormones|mesh-ancestor
139624124|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624125|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624126|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139624127|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139624128|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
139624129|NCT03696121|Coagulants|coagulants|mesh-ancestor
139624130|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139624131|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
139624132|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624133|NCT01457924|Ofatumumab|ofatumumab|mesh-list
139624134|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139624135|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624136|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
139624137|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624138|NCT05237115|Amoxicillin|amoxicillin|mesh-list
139624139|NCT05237115|Clarithromycin|clarithromycin|mesh-list
139624140|NCT05237115|Esomeprazole|esomeprazole|mesh-list
139624141|NCT05237115|Bismuth|bismuth|mesh-list
139624142|NCT05237115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139624143|NCT05237115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624144|NCT05237115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139624145|NCT05237115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139624146|NCT05237115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139624147|NCT05237115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624148|NCT05237115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624149|NCT05237115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139624150|NCT05237115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139624151|NCT05237115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139624152|NCT05237115|Antacids|antacids|mesh-ancestor
139624153|NCT04040621|Ceftazidime|ceftazidime|mesh-list
139624154|NCT04040621|Avibactam|avibactam|mesh-list
139624155|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
139624156|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139624157|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624158|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139624159|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624160|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624161|NCT00856791|ON 01910|on 01910|mesh-list
139624162|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624163|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139624164|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624165|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624166|NCT00857493|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139624167|NCT00857493|Antiviral Agents|antiviral agents|mesh-ancestor
139624168|NCT00857493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624169|NCT05236569|Tranexamic Acid|tranexamic acid|mesh-list
139624170|NCT05236569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139624171|NCT05236569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139624172|NCT05236569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624173|NCT05236569|Hemostatics|hemostatics|mesh-ancestor
139624174|NCT05236569|Coagulants|coagulants|mesh-ancestor
139624175|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
139624176|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139624177|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139624178|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624179|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139624180|NCT00857727|Analgesics|analgesics|mesh-ancestor
139624181|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
139624182|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624183|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139624184|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139624185|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139624186|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
139624187|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624188|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624189|NCT00857961|Testosterone|testosterone|mesh-list
139624190|NCT00857961|Androgens|androgens|mesh-ancestor
139624191|NCT00857961|Hormones|hormones|mesh-ancestor
139624192|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624193|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624194|NCT03839433|Ciclesonide|ciclesonide|mesh-list
139624195|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
139624196|NCT03839433|Hormones|hormones|mesh-ancestor
139624197|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624198|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624199|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139624200|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139624201|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139624202|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
139624203|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624204|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624205|NCT00824733|Trastuzumab|trastuzumab|mesh-list
139624206|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139624207|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624208|NCT02150499|Albuterol|albuterol|mesh-list
139624209|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139624211|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624212|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624213|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139624214|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
139624215|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
139624216|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139624217|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139624218|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139624219|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139624220|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
139624221|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624222|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624223|NCT03287947|Nintedanib|nintedanib|mesh-list
139624224|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624225|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139624226|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624227|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624228|NCT05685667|Hyaluronic Acid|hyaluronic acid|mesh-list
139624229|NCT05685667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139624230|NCT05685667|Immunologic Factors|immunologic factors|mesh-ancestor
139624231|NCT05685667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624232|NCT05685667|Viscosupplements|viscosupplements|mesh-ancestor
139624233|NCT05685667|Protective Agents|protective agents|mesh-ancestor
139624234|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
139624235|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139624236|NCT00859131|Daclizumab|daclizumab|mesh-list
139624237|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
139624238|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624239|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139624240|NCT00859833|Adenosine|adenosine|mesh-list
139624241|NCT00859833|Regadenoson|regadenoson|mesh-list
139624242|NCT00859833|Analgesics|analgesics|mesh-ancestor
139624243|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
139624244|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624245|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624246|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139624247|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
139624248|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139624249|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
139624250|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
139624251|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624252|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624253|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139624254|NCT02154477|Insulin|insulin|mesh-list
139624255|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139624256|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624257|NCT00860379|Selenium|selenium|mesh-list
139624258|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
139624259|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624260|NCT00860379|Protective Agents|protective agents|mesh-ancestor
139624261|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624262|NCT00860379|Trace Elements|trace elements|mesh-ancestor
139624263|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
139624264|NCT00860457|Rituximab|rituximab|mesh-list
139624265|NCT00860457|Fludarabine|fludarabine|mesh-list
139624266|NCT00860457|Lenalidomide|lenalidomide|mesh-list
139624267|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139624268|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624269|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
139624270|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624271|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139624272|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139624273|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139624274|NCT00860457|Growth Substances|growth substances|mesh-ancestor
139624275|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
139624276|NCT00827073|Lidocaine|lidocaine|mesh-list
139624277|NCT00827073|Tetracaine|tetracaine|mesh-list
139624278|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
139624279|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
139624280|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139624281|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624282|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
139624283|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624284|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139624285|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139624286|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139624287|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139624288|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624289|NCT00860847|Ubiquinone|ubiquinone|mesh-list
139624290|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
139624291|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
139624292|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624293|NCT00860847|Vitamins|vitamins|mesh-ancestor
139624294|NCT04347733|Triamcinolone|triamcinolone|mesh-list
139624295|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139624296|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139624297|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139624298|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139624299|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
139624300|NCT04347733|Hormones|hormones|mesh-ancestor
139624301|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624302|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624303|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139624304|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
139624305|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624306|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624307|NCT02155101|Ritonavir|ritonavir|mesh-list
139624308|NCT02155101|Lopinavir|lopinavir|mesh-list
139624309|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139624310|NCT02155101|Darunavir|darunavir|mesh-list
139624311|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139624312|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139624313|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
139624314|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624315|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624316|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139624317|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139624318|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
139624319|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624320|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139624321|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139624322|NCT02155257|Gabapentin|gabapentin|mesh-list
139624323|NCT02155257|Modafinil|modafinil|mesh-list
139624324|NCT02155257|Analgesics|analgesics|mesh-ancestor
139624325|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
139624326|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624327|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624328|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
139624329|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139624330|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139624331|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139624332|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139624333|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139624334|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139624335|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624336|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624337|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
139624338|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139624339|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139624340|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138752805|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139624341|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139624342|NCT03243019|Sirolimus|sirolimus|mesh-list
139624343|NCT03243019|Temsirolimus|temsirolimus|mesh-list
139624344|NCT03243019|MTOR Inhibitors|mtor inhibitors|mesh-list
139624345|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139624346|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624347|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139624348|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624349|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
139624350|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139624351|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
139624352|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624353|NCT03243019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139624354|NCT03243019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624355|NCT03243019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624356|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
139624357|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
139624358|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139406062|NCT01306942|Paclitaxel|paclitaxel|mesh-list
139624359|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139624360|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624361|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624362|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624363|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139624364|NCT01673646|Pasireotide|pasireotide|mesh-list
139624366|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624367|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624368|NCT00862563|Topiramate|topiramate|mesh-list
139624369|NCT00862563|Zonisamide|zonisamide|mesh-list
139624370|NCT00862563|Levetiracetam|levetiracetam|mesh-list
139624371|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
139624372|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139624373|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624374|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
139624375|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139624376|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139624377|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624378|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139624379|NCT04278937|Azithromycin|azithromycin|mesh-list
139624380|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139624381|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624382|NCT02647944|Liraglutide|liraglutide|mesh-list
139624383|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139624384|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624385|NCT02647944|Incretins|incretins|mesh-ancestor
139624386|NCT02647944|Hormones|hormones|mesh-ancestor
139624387|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624388|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
139624389|NCT04278547|Valganciclovir|valganciclovir|mesh-list
139624390|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
139624391|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624392|NCT00863109|Ribavirin|ribavirin|mesh-list
139624393|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139624394|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
139624395|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624396|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
139624397|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624398|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139624399|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139624400|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624401|NCT05246371|Dexmedetomidine|dexmedetomidine|mesh-list
139624402|NCT05246371|Propofol|propofol|mesh-list
139624403|NCT05246371|Desflurane|desflurane|mesh-list
139624404|NCT05246371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139624405|NCT05246371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139624406|NCT05246371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624407|NCT05246371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139624408|NCT05246371|Analgesics|analgesics|mesh-ancestor
139624409|NCT05246371|Sensory System Agents|sensory system agents|mesh-ancestor
139624410|NCT05246371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624411|NCT05246371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139624412|NCT05246371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139624413|NCT05246371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139624414|NCT05246371|Adrenergic Agents|adrenergic agents|mesh-ancestor
139624415|NCT05246371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624416|NCT05246371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624417|NCT05246371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139624418|NCT05246371|Anesthetics, General|anesthetics, general|mesh-ancestor
139624419|NCT05246371|Anesthetics|anesthetics|mesh-ancestor
139624420|NCT05246371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139624421|NCT00863265|Ezetimibe|ezetimibe|mesh-list
139624422|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139624423|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139624424|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
139624425|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624426|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139624427|NCT00831675|Vaccines|vaccines|mesh-list
139624428|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
139624429|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624430|NCT01397825|Rituximab|rituximab|mesh-list
139624431|NCT01397825|Vincristine|vincristine|mesh-list
139624432|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139624433|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624434|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
139624435|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624436|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139624437|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139624438|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
139624439|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
139624440|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
139624441|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624442|NCT05353764|Ropivacaine|ropivacaine|mesh-list
139624443|NCT05353764|Anesthetics, Local|anesthetics, local|mesh-ancestor
139624444|NCT05353764|Anesthetics|anesthetics|mesh-ancestor
139624445|NCT05353764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139624446|NCT05353764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624447|NCT05353764|Sensory System Agents|sensory system agents|mesh-ancestor
139624448|NCT05353764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624449|NCT00831987|Vaccines|vaccines|mesh-list
139624450|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
139624451|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624452|NCT05239884|Nicotine|nicotine|mesh-list
139624453|NCT05239884|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139624454|NCT05239884|Autonomic Agents|autonomic agents|mesh-ancestor
139624455|NCT05239884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624456|NCT05239884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624457|NCT05239884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139624458|NCT05239884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139624459|NCT05239884|Cholinergic Agents|cholinergic agents|mesh-ancestor
139624460|NCT05239884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624461|NCT05239884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624462|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
139624463|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
139624464|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139624465|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
139624466|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624467|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139624468|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139624469|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
139624470|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624471|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624472|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139624473|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139624474|NCT03836352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139624475|NCT01397201|Fluticasone|fluticasone|mesh-list
139624476|NCT01397201|Xhance|xhance|mesh-list
139624477|NCT01397201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139624478|NCT01397201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139624479|NCT01397201|Autonomic Agents|autonomic agents|mesh-ancestor
139624480|NCT01397201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624481|NCT01397201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624482|NCT01397201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139624483|NCT01397201|Respiratory System Agents|respiratory system agents|mesh-ancestor
139624484|NCT01397201|Dermatologic Agents|dermatologic agents|mesh-ancestor
139624485|NCT01397201|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139624486|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139624487|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139624488|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
139624489|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139624490|NCT00834171|Tobramycin|tobramycin|mesh-list
139624491|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139624492|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624493|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139624494|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139624495|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
139624496|NCT05205577|Iodine|iodine|mesh-list
139624497|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139624498|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624499|NCT05205577|Trace Elements|trace elements|mesh-ancestor
139624500|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
139624501|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624502|NCT00835185|Leucovorin|leucovorin|mesh-list
139624503|NCT00835185|Folic Acid|folic acid|mesh-list
139624504|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
139624505|NCT00835185|Necitumumab|necitumumab|mesh-list
139624506|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
139624507|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139624508|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624509|NCT00835185|Antidotes|antidotes|mesh-ancestor
139406208|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
139624510|NCT00835185|Protective Agents|protective agents|mesh-ancestor
139624511|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624512|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
139624514|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
139624515|NCT00835185|Hematinics|hematinics|mesh-ancestor
139624516|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139624517|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
139624518|NCT04399525|Cetirizine|cetirizine|mesh-list
139624519|NCT04399525|Loratadine|loratadine|mesh-list
139624520|NCT04399525|Levocetirizine|levocetirizine|mesh-list
139624521|NCT04399525|Desloratadine|desloratadine|mesh-list
139624522|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139624523|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139624524|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
139624525|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
139624526|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624527|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624528|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624529|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139624530|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139624531|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
139624532|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
139624533|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
139624534|NCT00864123|Cycloserine|cycloserine|mesh-list
139624535|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139624536|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624537|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139624538|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
139624539|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139624540|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
139624541|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624542|NCT03858465|Phenylephrine|phenylephrine|mesh-list
139624543|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
139624544|NCT03858465|Ephedrine|ephedrine|mesh-list
139624545|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139624546|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
139624547|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
139624548|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624549|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624550|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
139624551|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139624552|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
139624553|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
139624554|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139624555|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139624556|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139624557|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
139624558|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624559|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624560|NCT03858465|Protective Agents|protective agents|mesh-ancestor
139624561|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139624562|NCT00867789|Trimethoprim|trimethoprim|mesh-list
139624563|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139624564|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
139624565|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139624566|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624567|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
139624568|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139624569|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139624570|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139624571|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624572|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624573|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139624574|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139624575|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139624576|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139624577|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
139624578|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
139624579|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624580|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624581|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624582|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
139624583|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
139624584|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139624585|NCT04797013|Plasminogen|plasminogen|mesh-list
139624586|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139624587|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139624588|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624589|NCT00838695|Phenylephrine|phenylephrine|mesh-list
139624590|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
139624591|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139624592|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
139624593|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
139624594|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624595|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624596|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
139624597|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139624598|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
139624599|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
139624600|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139624601|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139624602|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139624603|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
139624604|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624605|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624606|NCT00838695|Protective Agents|protective agents|mesh-ancestor
139624607|NCT01396265|Rifampin|rifampin|mesh-list
139624608|NCT01396265|Afatinib|afatinib|mesh-list
139624609|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139624610|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
139624611|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139624612|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624613|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
139624614|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139624615|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624616|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624617|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139624618|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139624619|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139624620|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139624621|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139624622|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139624623|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624624|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139624625|NCT04760431|Paclitaxel|paclitaxel|mesh-list
139624626|NCT04760431|Docetaxel|docetaxel|mesh-list
139624627|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139624628|NCT04760431|Trastuzumab|trastuzumab|mesh-list
139624629|NCT04760431|Pertuzumab|pertuzumab|mesh-list
139624630|NCT04760431|Taxane|taxane|mesh-list
139624631|NCT04760431|Tucatinib|tucatinib|mesh-list
139624632|NCT04760431|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139624633|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139624634|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624635|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
139624636|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
139624637|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
139624638|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624639|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139624640|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139624641|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624642|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139624643|NCT00839319|Testosterone|testosterone|mesh-list
139624644|NCT00839319|Acyline|acyline|mesh-list
139624645|NCT00839319|Androgens|androgens|mesh-ancestor
139624646|NCT00839319|Hormones|hormones|mesh-ancestor
139624647|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624648|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624649|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139624650|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
139624651|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139624652|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139624653|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139624654|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139624655|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624656|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139624657|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139624658|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139624659|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139624660|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
138753141|NCT01259024|Hormones|hormones|mesh-ancestor
139624661|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406366|NCT04467931|Bisoprolol|bisoprolol|mesh-list
139624662|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624663|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139624664|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139624665|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
139624666|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139624667|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139624668|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
139624669|NCT02647866|KHK4083|khk4083|mesh-list
139624670|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
139624671|NCT02246127|Everolimus|everolimus|mesh-list
139624672|NCT02246127|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139624673|NCT02246127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139624674|NCT02246127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624675|NCT02246127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624676|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139624677|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
139624678|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624679|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624680|NCT04277923|SMOFlipid|smoflipid|mesh-list
139624681|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139624682|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139624683|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139624684|NCT00870363|Efavirenz|efavirenz|mesh-list
139624685|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139624686|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
139624687|NCT00870363|Maraviroc|maraviroc|mesh-list
139624688|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139624689|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624690|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624691|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
139624692|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624693|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139624694|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139624695|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139624696|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139624697|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139624698|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139624699|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139624700|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139624701|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139624702|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139624703|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139624704|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139624705|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139624706|NCT03104634|Bromides|bromides|mesh-list
139624707|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
139624708|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139624709|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
139624710|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624711|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624712|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139624713|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
139624714|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139624715|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139624716|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139624717|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
139624718|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624719|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624720|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
139624721|NCT00871689|Aldesleukin|aldesleukin|mesh-list
139624722|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
139624723|NCT00871689|Fludarabine|fludarabine|mesh-list
139624724|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
139624725|NCT00871689|Interleukin-2|interleukin-2|mesh-list
139624726|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139624727|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
139624728|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624729|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139624730|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139624731|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
139624732|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624733|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624734|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139406451|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
139624736|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
139624737|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
139624738|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624739|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139624740|NCT00871689|Analgesics|analgesics|mesh-ancestor
139624741|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
139624742|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624743|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139624744|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139624745|NCT02084797|Vasopressins|vasopressins|mesh-list
139624746|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
139624747|NCT02084797|Tolvaptan|tolvaptan|mesh-list
139624748|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
139624749|NCT02084797|Coagulants|coagulants|mesh-ancestor
139624750|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139624751|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139624752|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
139624753|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624754|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139624755|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624756|NCT00873327|Tazobactam|tazobactam|mesh-list
139624757|NCT00873327|Piperacillin|piperacillin|mesh-list
139624758|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139624759|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139624760|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624761|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139624762|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624763|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624764|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
139624765|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139624766|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624767|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
139624768|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139624769|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624770|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139624771|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624772|NCT00841971|Fluconazole|fluconazole|mesh-list
139624773|NCT00841971|Anidulafungin|anidulafungin|mesh-list
139624774|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
139624775|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624776|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139624777|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139624778|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624779|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624780|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139624781|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
139624782|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624783|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624784|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139624785|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139624786|NCT00842751|Finasteride|finasteride|mesh-list
139624787|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139624788|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139624789|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624790|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624791|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
139624792|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624793|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624794|NCT00842751|Urological Agents|urological agents|mesh-ancestor
139624795|NCT03104010|Hormones|hormones|mesh-list
139624796|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624797|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624798|NCT03907969|AZD7648|azd7648|mesh-list
139624799|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139624800|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624801|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624802|NCT04399213|Histamine|histamine|mesh-list
139624803|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
139624804|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
139624805|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
139624806|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624807|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624808|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624809|NCT02154243|Midodrine|midodrine|mesh-list
139624810|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
139624811|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
139624812|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624813|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624814|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139624815|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139624816|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139624817|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139624818|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
139624819|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624820|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624821|NCT03995004|Dexamethasone|dexamethasone|mesh-list
139624822|NCT03995004|Melatonin|melatonin|mesh-list
139624823|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
139624824|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139624825|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
139624826|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
139624827|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624828|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624829|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139624830|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
139624831|NCT03995004|Hormones|hormones|mesh-ancestor
139624832|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138753307|NCT01203852|Metoprolol|metoprolol|mesh-list
139624833|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139624834|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624835|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
139624836|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624837|NCT03995004|Protective Agents|protective agents|mesh-ancestor
139624838|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139624839|NCT03995004|Cathartics|cathartics|mesh-ancestor
139624840|NCT03216447|Tacrolimus|tacrolimus|mesh-list
139624841|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139624842|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
139624843|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624844|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139624845|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624846|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624847|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
139624848|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624849|NCT03957876|Cytarabine|cytarabine|mesh-list
139624850|NCT03957876|Daunorubicin|daunorubicin|mesh-list
139624851|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139624852|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
139624853|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624854|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624855|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
139624856|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624857|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139624858|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
139624859|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624860|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139624861|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139624862|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139624863|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624864|NCT03837925|Atorvastatin|atorvastatin|mesh-list
139624865|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139624866|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139624867|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
139624868|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624869|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139624870|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139624871|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624872|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
139624873|NCT04398589|Ropivacaine|ropivacaine|mesh-list
139624874|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139624875|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139624876|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624877|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139624878|NCT04398589|Analgesics|analgesics|mesh-ancestor
139624879|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
139624880|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139624881|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139624882|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139624883|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139624884|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
139624885|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624886|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624887|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
139624889|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
139624890|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
139624891|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139624892|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139624893|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139624894|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139624895|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139624896|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139624897|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624898|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624899|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624900|NCT00875277|Betamethasone|betamethasone|mesh-list
139624901|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
139624902|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139624903|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
139624904|NCT00875277|Calcipotriene|calcipotriene|mesh-list
139624905|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139624906|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139624907|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
139624908|NCT00875277|Hormones|hormones|mesh-ancestor
139624909|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624910|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624911|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139624912|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
139624913|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
139624914|NCT04457245|Fluorides|fluorides|mesh-list
139624915|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
139624916|NCT04457245|Protective Agents|protective agents|mesh-ancestor
139624917|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624918|NCT01395017|Dasatinib|dasatinib|mesh-list
139624919|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624920|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139624921|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624922|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624923|NCT03235986|Poractant alfa|poractant alfa|mesh-list
139624924|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139624925|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
139624926|NCT03600090|Paclitaxel|paclitaxel|mesh-list
139624927|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139624928|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624929|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
139624930|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
139624931|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
139624932|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624933|NCT02912988|Letrozole|letrozole|mesh-list
139624934|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624935|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139624936|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139624937|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624938|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624939|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139624940|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
139624941|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624942|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624943|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
139624944|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139624945|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139624946|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139624947|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624948|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
139624949|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139624950|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624951|NCT00876915|Dalteparin|dalteparin|mesh-list
139624952|NCT00876915|Tinzaparin|tinzaparin|mesh-list
139624953|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139624954|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
139624955|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139624956|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139624957|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624958|NCT02854488|Ipilimumab|ipilimumab|mesh-list
139624959|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139624960|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624961|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139624962|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624963|NCT00896181|Carboplatin|carboplatin|mesh-list
139624964|NCT00896181|Docetaxel|docetaxel|mesh-list
139624965|NCT00896181|Fluorouracil|fluorouracil|mesh-list
139624966|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624967|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
139624968|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
139624969|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
139624970|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624971|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
139624972|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139624973|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139624974|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
139624975|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624976|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139624977|NCT02647320|Firuglipel|firuglipel|mesh-list
139624978|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139624979|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139624980|NCT02647320|Incretins|incretins|mesh-ancestor
139624981|NCT02647320|Hormones|hormones|mesh-ancestor
139624982|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139624983|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139624984|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
139624985|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139624986|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139624987|NCT03457896|Trastuzumab|trastuzumab|mesh-list
139624988|NCT03457896|Cetuximab|cetuximab|mesh-list
139624989|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139624990|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139624991|NCT04380597|Betamethasone|betamethasone|mesh-list
139624992|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
139624993|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139624994|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
139624995|NCT04380597|Calcipotriene|calcipotriene|mesh-list
139624996|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139624997|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139624998|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
139624999|NCT04380597|Hormones|hormones|mesh-ancestor
139625000|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139625001|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625002|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139625003|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
139625004|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
139625005|NCT03214731|Artesunate|artesunate|mesh-list
139625006|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
139625007|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139625008|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139625009|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625010|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625011|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
139625012|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
139625013|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139625014|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
139625015|NCT04424862|Cyclosporine|cyclosporine|mesh-list
139625016|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
139625017|NCT04424862|Prednisone|prednisone|mesh-list
139625018|NCT04424862|Cyclosporins|cyclosporins|mesh-list
139625019|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139625020|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
139625021|NCT04424862|Hormones|hormones|mesh-ancestor
139625022|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139625023|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625024|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139625025|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625026|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625027|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625028|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139625029|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
139625030|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
139625031|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625032|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
139625033|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139625034|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139625035|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139625036|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139625037|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
139625038|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139625039|NCT00882687|Lifitegrast|lifitegrast|mesh-list
139625040|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139625041|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139625042|NCT04313166|Copper|copper|mesh-list
139625043|NCT04313166|Trace Elements|trace elements|mesh-ancestor
139625044|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
139625045|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625046|NCT00883233|Adapalene|adapalene|mesh-list
139625047|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139625048|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139625049|NCT00883233|Analgesics|analgesics|mesh-ancestor
139625050|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
139625051|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625052|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625053|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139625054|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139625055|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
139625056|NCT01394939|Irinotecan|irinotecan|mesh-list
139625057|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139625058|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139625059|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625060|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625061|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625062|NCT01394627|Eplerenone|eplerenone|mesh-list
139625063|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139625064|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
139625065|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139625066|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625067|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139625068|NCT01394627|Diuretics|diuretics|mesh-ancestor
139625069|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
139625070|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139625071|NCT02288377|Lanreotide|lanreotide|mesh-list
139625072|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625073|NCT04133532|Metoprolol|metoprolol|mesh-list
139625074|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139625075|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139625076|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
139625077|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
139625078|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625079|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625080|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139625081|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139625082|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139625083|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
139625084|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139625085|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625086|NCT01391663|Alogliptin|alogliptin|mesh-list
139625087|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139625088|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625089|NCT01391663|Incretins|incretins|mesh-ancestor
139625090|NCT01391663|Hormones|hormones|mesh-ancestor
139625091|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139625092|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139625093|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
139625094|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625095|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625096|NCT05072106|Bosentan|bosentan|mesh-list
139625097|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139625098|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139625099|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625100|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139625101|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
139625102|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625103|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
139625104|NCT05071482|Flumatinib|flumatinib|mesh-list
139625105|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625106|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139625107|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625108|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625109|NCT03213249|Gentamicins|gentamicins|mesh-list
139625110|NCT03213249|Cefazolin|cefazolin|mesh-list
139625111|NCT03213249|Bacitracin|bacitracin|mesh-list
139625112|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139625113|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625114|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139625115|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625116|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625117|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139625118|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
139625119|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139625120|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139625121|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625122|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139625123|NCT03317067|Analgesics|analgesics|mesh-ancestor
139625124|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
139625125|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625126|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139625127|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139625128|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139625129|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
139625130|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139625131|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625132|NCT04440007|Abivertinib|abivertinib|mesh-list
139625133|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625134|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625135|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139625136|NCT05312541|Bupivacaine|bupivacaine|mesh-list
139625137|NCT05312541|Anesthetics, Local|anesthetics, local|mesh-list
139625138|NCT05312541|Anesthetics|anesthetics|mesh-list
139625139|NCT05312541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139625140|NCT05312541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625141|NCT05312541|Sensory System Agents|sensory system agents|mesh-ancestor
139625142|NCT05312541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625143|NCT04398823|Polidocanol|polidocanol|mesh-list
139625144|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139625145|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139625146|NCT04410913|Psilocybin|psilocybin|mesh-list
139625147|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
139625148|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625149|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139625150|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
139625151|NCT02013336|Irinotecan|irinotecan|mesh-list
139625152|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138753615|NCT01101165|Oxycodone|oxycodone|mesh-list
139625153|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
139625154|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625155|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139625156|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139625157|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
139625158|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625159|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625160|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139625161|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139625162|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139625163|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625164|NCT04397653|Ezetimibe|ezetimibe|mesh-list
139625165|NCT04397653|Evolocumab|evolocumab|mesh-list
139625166|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139625167|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139625168|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
139625169|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625170|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139625171|NCT04397653|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139625172|NCT04397653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139625173|NCT04397653|Protease Inhibitors|protease inhibitors|mesh-ancestor
139625174|NCT04397653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625175|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
139625176|NCT03212781|Dextrans|dextrans|mesh-list
139625177|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
139625178|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
139406920|NCT02290717|Xhance|xhance|mesh-list
139625179|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
139625180|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
139625181|NCT03212781|Trace Elements|trace elements|mesh-ancestor
139625182|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
139625183|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625184|NCT03212781|Hematinics|hematinics|mesh-ancestor
139625185|NCT03212937|Carboplatin|carboplatin|mesh-list
139625186|NCT03212937|Etoposide|etoposide|mesh-list
139625187|NCT03212937|Ifosfamide|ifosfamide|mesh-list
139625188|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625189|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139625190|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139625191|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139625192|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625193|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625194|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139625195|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
139625196|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
139625197|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139625198|NCT04397341|Docetaxel|docetaxel|mesh-list
139625199|NCT04397341|Fluorouracil|fluorouracil|mesh-list
139625200|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625201|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
139625202|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
139625203|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
139625204|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625205|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
139625206|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139625207|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139625208|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
139625209|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625210|NCT03940326|Levetiracetam|levetiracetam|mesh-list
139625211|NCT03940326|Valproic Acid|valproic acid|mesh-list
139625212|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
139625213|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
139625214|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625215|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625216|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
139625217|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753677|NCT01097577|Pregabalin|pregabalin|mesh-list
139625218|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625219|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
139625220|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139625221|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139625222|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139625223|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
139625224|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
139625225|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139625226|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139625227|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625228|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625229|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625230|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139625231|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139625232|NCT01473524|Cathartics|cathartics|mesh-ancestor
139625233|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139625234|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139625235|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
139625236|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625237|NCT03696355|GDC-0084|gdc-0084|mesh-list
139625238|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625239|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625240|NCT03882996|Atorvastatin|atorvastatin|mesh-list
139625241|NCT03882996|Ezetimibe|ezetimibe|mesh-list
139625242|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139625243|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139625244|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
139625245|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625246|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139625247|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139625248|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625249|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139625250|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139625251|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139625252|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139625253|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625254|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139625255|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139625256|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139625257|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139625258|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
139625259|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139625260|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625261|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139625262|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139625263|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
139625264|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139625265|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139625266|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
139625267|NCT05070468|Dexamethasone|dexamethasone|mesh-list
139625268|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139625269|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
139625270|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
139625271|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625272|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625273|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139625274|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
139625275|NCT05070468|Hormones|hormones|mesh-ancestor
139625276|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139625277|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139625278|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625279|NCT01390181|Losartan|losartan|mesh-list
139625280|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139625281|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139625282|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139625283|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139625284|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625285|NCT02641080|Aspirin|aspirin|mesh-list
139625286|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139625287|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139625288|NCT02641080|Analgesics|analgesics|mesh-ancestor
139625289|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
139625290|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625291|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625292|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139625293|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139625294|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139625295|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139625296|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625297|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139625298|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139625299|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625300|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
139625301|NCT03101280|Atezolizumab|atezolizumab|mesh-list
139625302|NCT03101280|Rucaparib|rucaparib|mesh-list
139625303|NCT03101280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139625304|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625305|NCT03101280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139625306|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625307|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139625308|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625309|NCT04015739|Bevacizumab|bevacizumab|mesh-list
139625310|NCT04015739|Durvalumab|durvalumab|mesh-list
139625311|NCT04015739|Olaparib|olaparib|mesh-list
139625312|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139625313|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625314|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139625315|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139625316|NCT04015739|Growth Substances|growth substances|mesh-ancestor
139625317|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625318|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
139625319|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139625320|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625321|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625322|NCT03867318|Atorvastatin|atorvastatin|mesh-list
139625323|NCT03867318|Ezetimibe|ezetimibe|mesh-list
139625324|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139625325|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139625326|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
139625327|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625328|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139625329|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139625330|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625331|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139625332|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625333|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139625334|NCT05360615|Empagliflozin|empagliflozin|mesh-list
139625335|NCT05360615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139625336|NCT05360615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625337|NCT05360615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139625338|NCT05360615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625339|NCT04381377|Bromides|bromides|mesh-list
139625340|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
139625341|NCT01457846|Paclitaxel|paclitaxel|mesh-list
139625342|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139625343|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625344|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
139625345|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
139625346|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
139625347|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625348|NCT04032119|Epinephrine|epinephrine|mesh-list
139625349|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139625350|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139625351|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
139625352|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139625353|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625354|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625355|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139625356|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139625357|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
139625358|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625359|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139625360|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
139625361|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
139625362|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
139625363|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139625364|NCT03211455|Lidocaine|lidocaine|mesh-list
139625365|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
139625366|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
139625367|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139625368|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625369|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
139625370|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625371|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139625372|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139625373|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139625374|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139625375|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625376|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
139625377|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139625378|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625379|NCT03172819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139625380|NCT03172819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625381|NCT01389323|Interferons|interferons|mesh-list
139625382|NCT01389323|Ribavirin|ribavirin|mesh-list
139625383|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
139625384|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
139625385|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139625386|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625387|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
139625388|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625389|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
139625390|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625391|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
139625392|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625393|NCT05310591|Nivolumab|nivolumab|mesh-list
139625394|NCT05310591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139625395|NCT05310591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625396|NCT05310591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139625397|NCT05310591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625398|NCT05314569|Midazolam|midazolam|mesh-list
139625399|NCT05314569|Fentanyl|fentanyl|mesh-list
139625400|NCT05314569|Dexmedetomidine|dexmedetomidine|mesh-list
139625401|NCT05314569|Ketamine|ketamine|mesh-list
139625402|NCT05314569|Isoflurane|isoflurane|mesh-list
139625403|NCT05314569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139625404|NCT05314569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407126|NCT02352597|Clomiphene|clomiphene|mesh-list
139625405|NCT05314569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625406|NCT05314569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139625407|NCT05314569|Analgesics|analgesics|mesh-ancestor
139625408|NCT05314569|Sensory System Agents|sensory system agents|mesh-ancestor
139625409|NCT05314569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625410|NCT05314569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139625411|NCT05314569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139625412|NCT05314569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139625413|NCT05314569|Adrenergic Agents|adrenergic agents|mesh-ancestor
139625414|NCT05314569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139625415|NCT05314569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625416|NCT05314569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139625417|NCT05314569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139625418|NCT05314569|Anesthetics, General|anesthetics, general|mesh-ancestor
139625419|NCT05314569|Anesthetics|anesthetics|mesh-ancestor
139625420|NCT05314569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139625421|NCT05314569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139625422|NCT05314569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139625423|NCT05314569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139625424|NCT05314569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139625425|NCT05314569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139625426|NCT05314569|GABA Modulators|gaba modulators|mesh-ancestor
139625427|NCT05314569|GABA Agents|gaba agents|mesh-ancestor
139625428|NCT05314569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139625429|NCT05314569|Narcotics|narcotics|mesh-ancestor
139625430|NCT05314569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139625431|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139625432|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
139625433|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139625434|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139625435|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625436|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
139625437|NCT02638389|Sirolimus|sirolimus|mesh-list
139625438|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139625439|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625440|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139625441|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625442|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
139625443|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139625444|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
139625445|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625446|NCT01494584|Ezogabine|ezogabine|mesh-list
139625447|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
139625448|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139625449|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625450|NCT03211143|Esomeprazole|esomeprazole|mesh-list
139625451|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139625452|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139625453|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139625454|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625455|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625456|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139625457|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139625458|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139625459|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
139625460|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625461|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625462|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139625463|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139625464|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
139625465|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625466|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139625467|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
139625468|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
139625469|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139625470|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139625471|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139625472|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625473|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139625474|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139625475|NCT00893997|Vaccines|vaccines|mesh-list
139625476|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
139625477|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625478|NCT00512317|Ganaxolone|ganaxolone|mesh-list
139625479|NCT00512317|Neurosteroids|neurosteroids|mesh-ancestor
139625480|NCT00512317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139625481|NCT00512317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625482|NCT00512317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625483|NCT00512317|GABA Modulators|gaba modulators|mesh-ancestor
139625484|NCT00512317|GABA Agents|gaba agents|mesh-ancestor
139625485|NCT01494506|Leucovorin|leucovorin|mesh-list
139625486|NCT01494506|Fluorouracil|fluorouracil|mesh-list
139625487|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
139625488|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625489|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139625490|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625491|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139625492|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
139625493|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625494|NCT01494506|Antidotes|antidotes|mesh-ancestor
139625495|NCT01494506|Protective Agents|protective agents|mesh-ancestor
139625496|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
139625497|NCT01494506|Vitamins|vitamins|mesh-ancestor
139625498|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
139625499|NCT03024905|Misoprostol|misoprostol|mesh-list
139625500|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139625501|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
139625502|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139625503|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625504|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139625505|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139625506|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
139625507|NCT02643420|Cyclophosphamide|cyclophosphamide|mesh-list
139625508|NCT02643420|Docetaxel|docetaxel|mesh-list
139625509|NCT02643420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139625510|NCT02643420|Immunologic Factors|immunologic factors|mesh-ancestor
139625511|NCT02643420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625512|NCT02643420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139625513|NCT02643420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139625514|NCT02643420|Alkylating Agents|alkylating agents|mesh-ancestor
139625515|NCT02643420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625516|NCT02643420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625517|NCT02643420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139625518|NCT02643420|Tubulin Modulators|tubulin modulators|mesh-ancestor
139625519|NCT02643420|Antimitotic Agents|antimitotic agents|mesh-ancestor
139625520|NCT02643420|Mitosis Modulators|mitosis modulators|mesh-ancestor
139625521|NCT01830465|Rituximab|rituximab|mesh-list
139625522|NCT01830465|Bortezomib|bortezomib|mesh-list
139625523|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139625524|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625525|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
139625526|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625527|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139625528|NCT00894465|Midazolam|midazolam|mesh-list
139625529|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139625530|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139625531|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139625532|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625533|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139625534|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139625535|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139625536|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139625537|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
139625538|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
139625539|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
139625540|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
139625541|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139625542|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625543|NCT01456130|Alogliptin|alogliptin|mesh-list
139625544|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
139625545|NCT01456130|Secretagogues|secretagogues|mesh-list
139625546|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139625547|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625548|NCT01456130|Incretins|incretins|mesh-ancestor
139625549|NCT01456130|Hormones|hormones|mesh-ancestor
139625550|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139625551|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139625552|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
139625553|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625554|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625555|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139407265|NCT02231255|Pramipexole|pramipexole|mesh-list
139625556|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139625557|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139625558|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139625559|NCT03219645|Aspirin|aspirin|mesh-list
139625560|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139625561|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139625562|NCT03219645|Analgesics|analgesics|mesh-ancestor
139625563|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
139625564|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625565|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625566|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139625567|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139625568|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139625569|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139625570|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625571|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139625572|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139625573|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625574|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
139625575|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
139625576|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139625577|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625578|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
139625579|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139625580|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625581|NCT01387607|Pregabalin|pregabalin|mesh-list
139625582|NCT01387607|Analgesics|analgesics|mesh-ancestor
139625583|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
139625584|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625585|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625586|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
139625587|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139625588|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139625589|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625590|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139625591|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139625592|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139625593|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139625594|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139625595|NCT05069454|Vaccines|vaccines|mesh-list
139625596|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
139625597|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625598|NCT05069688|Rifampin|rifampin|mesh-list
139625599|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139625600|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
139625601|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139625602|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625603|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
139625604|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139625605|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625606|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625607|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139625608|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139625609|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139625610|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139625611|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139625612|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139625613|NCT01830777|Cytarabine|cytarabine|mesh-list
139625614|NCT01830777|Etoposide|etoposide|mesh-list
139625615|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
139625616|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139625617|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139625618|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625619|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139625620|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139625621|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625622|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625623|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139625624|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
139625625|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
139625626|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625627|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139625628|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
139625629|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407339|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139625630|NCT01830777|Analgesics|analgesics|mesh-ancestor
139625631|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
139625632|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625633|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139625634|NCT01830777|Immunotoxins|immunotoxins|mesh-ancestor
139625635|NCT01830777|Immunoconjugates|immunoconjugates|mesh-ancestor
139625636|NCT03218631|Oxandrolone|oxandrolone|mesh-list
139625637|NCT03218631|Androgens|androgens|mesh-ancestor
139625638|NCT03218631|Hormones|hormones|mesh-ancestor
139625639|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139625640|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625641|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
139625642|NCT03451045|Dronabinol|dronabinol|mesh-list
139625643|NCT03451045|Lenabasum|lenabasum|mesh-list
139625644|NCT03451045|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139625645|NCT03451045|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139625646|NCT03451045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139625647|NCT03451045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625648|NCT03451045|Hormones|hormones|mesh-ancestor
139625649|NCT03451045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139625650|NCT03451045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625651|NCT03451045|Hallucinogens|hallucinogens|mesh-ancestor
139625652|NCT03451045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139625653|NCT03451045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139625654|NCT03451045|Analgesics|analgesics|mesh-ancestor
139625655|NCT03451045|Sensory System Agents|sensory system agents|mesh-ancestor
139625656|NCT03451045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625657|NCT01831011|Aspirin|aspirin|mesh-list
139625658|NCT01831011|Cinepazide|cinepazide|mesh-list
139625659|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
139625660|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139625661|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139625662|NCT01831011|Analgesics|analgesics|mesh-ancestor
139625663|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
139625664|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625665|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625666|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139625667|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139625668|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139625669|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139625670|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625671|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139625672|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139625673|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625674|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
139625675|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
139625676|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139625677|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
139625678|NCT03218709|Vitamins|vitamins|mesh-list
139625679|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
139625680|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625681|NCT03218553|Dexamethasone|dexamethasone|mesh-list
139625682|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139625683|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
139625684|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
139625685|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625686|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625687|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139625688|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
139625689|NCT03218553|Hormones|hormones|mesh-ancestor
139625690|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139625691|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139625692|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625693|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
139625694|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139625695|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
139625696|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139625697|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139625698|NCT01831323|Rifaximin|rifaximin|mesh-list
139625699|NCT01831323|Mesalamine|mesalamine|mesh-list
139625700|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139625701|NCT01831323|Psyllium|psyllium|mesh-list
139625702|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625703|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139625704|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139625705|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139625706|NCT01831323|Analgesics|analgesics|mesh-ancestor
139625707|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
139625708|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625709|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625710|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139625711|NCT01831323|Cathartics|cathartics|mesh-ancestor
139625713|NCT03221400|Folic Acid|folic acid|mesh-list
139625714|NCT03221400|Fluorouracil|fluorouracil|mesh-list
139625715|NCT03221400|Niraparib|niraparib|mesh-list
139625716|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
139625717|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
139625718|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625719|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139625720|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625721|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139625722|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
139625723|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625724|NCT03221400|Antidotes|antidotes|mesh-ancestor
139625725|NCT03221400|Protective Agents|protective agents|mesh-ancestor
139625726|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
139625727|NCT03221400|Vitamins|vitamins|mesh-ancestor
139625728|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
139625729|NCT03221400|Hematinics|hematinics|mesh-ancestor
139625730|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139625731|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625732|NCT01384877|Lidocaine|lidocaine|mesh-list
139625733|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
139625734|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
139625735|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139625736|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625737|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
138754201|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139625738|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625739|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139625740|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139625741|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139625742|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139625743|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625744|NCT00114517|Hormones|hormones|mesh-list
139625745|NCT00114517|Estradiol|estradiol|mesh-list
139625746|NCT00114517|Estrogens|estrogens|mesh-list
139625747|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139625748|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625749|NCT01831479|Olmesartan|olmesartan|mesh-list
139625750|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139625751|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139625752|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139625753|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139625754|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
139625755|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625756|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139625757|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139625758|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625759|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139625760|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139625761|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139625762|NCT03099720|Ropivacaine|ropivacaine|mesh-list
139625763|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
139625764|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
139625765|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139625766|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625767|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
139625768|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625769|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
139625770|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139625771|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139625772|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625773|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139625774|NCT03025295|Analgesics|analgesics|mesh-ancestor
139625775|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
139625776|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625777|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139625778|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139625779|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139625780|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
139625781|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139625782|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625784|NCT01471574|Ribavirin|ribavirin|mesh-list
139625785|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
139625786|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
139625787|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139625788|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625789|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
139625790|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625791|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
139625792|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625793|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
139625794|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625795|NCT01383707|Leucovorin|leucovorin|mesh-list
139625796|NCT01383707|Bevacizumab|bevacizumab|mesh-list
139625797|NCT01383707|Fluorouracil|fluorouracil|mesh-list
139625798|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
139625799|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
139625800|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139625801|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625802|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139625803|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139625804|NCT01383707|Growth Substances|growth substances|mesh-ancestor
139625805|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625806|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
139625807|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
139625808|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625809|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139625810|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139625811|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
139625812|NCT01383707|Antidotes|antidotes|mesh-ancestor
139625813|NCT01383707|Protective Agents|protective agents|mesh-ancestor
139625814|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
139625815|NCT01383707|Vitamins|vitamins|mesh-ancestor
139625816|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
139625817|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
139625818|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139625819|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
139625820|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139625821|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
139625822|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625823|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625824|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
139625825|NCT03306901|Fluorouracil|fluorouracil|mesh-list
139625826|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625827|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
139625828|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625829|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139625830|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139625831|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
139625832|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625833|NCT01455428|Pregabalin|pregabalin|mesh-list
139625834|NCT01455428|Analgesics|analgesics|mesh-ancestor
139625835|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
139625836|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625837|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625838|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
139625839|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139625840|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139625841|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625842|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139625843|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139625844|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139625845|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139625846|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139625847|NCT01831947|Ranibizumab|ranibizumab|mesh-list
139625848|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139625849|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139625850|NCT01831947|Growth Substances|growth substances|mesh-ancestor
139625851|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625852|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
139625853|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625854|NCT01383161|Curcumin|curcumin|mesh-list
139625855|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139625856|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139625857|NCT01383161|Analgesics|analgesics|mesh-ancestor
139625858|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
139625859|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625860|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625861|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139625862|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139625863|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625864|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625865|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625866|NCT00894699|Sufentanil|sufentanil|mesh-list
139625867|NCT00894699|Triazolam|triazolam|mesh-list
139625868|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139625869|NCT00894699|Narcotics|narcotics|mesh-ancestor
139625870|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139625871|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625872|NCT00894699|Analgesics|analgesics|mesh-ancestor
139625873|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
139625874|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625875|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139625876|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139625877|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
139625878|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
139625879|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139625880|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139625881|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139625882|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
139625883|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
139625884|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139625885|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625886|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
139625887|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139625888|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625889|NCT03087019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139625890|NCT03087019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625891|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139625892|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
139625893|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139625894|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139625895|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
139625896|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625897|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
139625898|NCT01382225|Protective Agents|protective agents|mesh-ancestor
139625899|NCT01381679|Ezetimibe|ezetimibe|mesh-list
139625900|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139625901|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139625902|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
139625903|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625904|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139625905|NCT01832415|Bevacizumab|bevacizumab|mesh-list
139625906|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139625907|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625908|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139625909|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139625910|NCT01832415|Growth Substances|growth substances|mesh-ancestor
139625911|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625912|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
139625913|NCT01455194|Ciclesonide|ciclesonide|mesh-list
139625914|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
139625915|NCT01455194|Hormones|hormones|mesh-ancestor
139625916|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139625917|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625918|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139625919|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
139625920|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139625921|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139625922|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625923|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139625924|NCT03216759|Analgesics|analgesics|mesh-ancestor
139625925|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
139625926|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625927|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139625928|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139625929|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139625930|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
139625931|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139625932|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625933|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139625934|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139625935|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139625936|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625937|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625938|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
139625939|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625940|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139625941|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139625942|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139625943|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139625944|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625945|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139625946|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
139625947|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625948|NCT05368805|Dabigatran|dabigatran|mesh-list
139625949|NCT05368805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139625950|NCT05368805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139625951|NCT05368805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139625952|NCT05368805|Antimetabolites|antimetabolites|mesh-ancestor
139625953|NCT05368805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625954|NCT05368805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139625955|NCT05368805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139625956|NCT05368805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625957|NCT05368805|Antithrombins|antithrombins|mesh-ancestor
139625958|NCT05368805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139625959|NCT05368805|Protease Inhibitors|protease inhibitors|mesh-ancestor
139625960|NCT05368805|Anticoagulants|anticoagulants|mesh-ancestor
139625961|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
139625962|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
139625963|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625964|NCT01839981|Protective Agents|protective agents|mesh-ancestor
139625965|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625966|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
139625967|NCT01839981|Vitamins|vitamins|mesh-ancestor
139625968|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
139625969|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
139625970|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
139625971|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139625972|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
139625973|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139625974|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139625975|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139625976|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
139625977|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139625978|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139625979|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139625980|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
139625981|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139625982|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625983|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139625984|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139625985|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138754449|NCT02850211|Analgesics|analgesics|mesh-ancestor
139625986|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
139625987|NCT01494350|Gentamicins|gentamicins|mesh-list
139625988|NCT01494350|Paromomycin|paromomycin|mesh-list
139625989|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139625990|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139625991|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139625992|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139625993|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139625994|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139625995|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139625996|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139625997|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139625998|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
139625999|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
139626000|NCT03258385|Vitamins|vitamins|mesh-ancestor
139626001|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
139626002|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626003|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
139626004|NCT03258385|Hematinics|hematinics|mesh-ancestor
139626005|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
139626006|NCT03024515|Narcotics|narcotics|mesh-ancestor
139626007|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139626008|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626009|NCT03024515|Analgesics|analgesics|mesh-ancestor
139626010|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
139626011|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626012|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
139626013|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139626014|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139626015|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139626016|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626017|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
139626018|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626019|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626020|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
139626021|NCT04287829|Lenvatinib|lenvatinib|mesh-list
139626022|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139626023|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626024|NCT04287829|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139626025|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626026|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139626027|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626028|NCT05367869|Methylene Blue|methylene blue|mesh-list
139626029|NCT05367869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626030|NCT05367869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626031|NCT01720095|Niacin|niacin|mesh-list
139626032|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
139626033|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139626034|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
138754514|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139626035|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626036|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139626037|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
139626038|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
139626039|NCT01720095|Vitamins|vitamins|mesh-ancestor
139626040|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
139626041|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626042|NCT03836157|Bevacizumab|bevacizumab|mesh-list
139626043|NCT03836157|Maytansine|maytansine|mesh-list
139626044|NCT03836157|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139626045|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139626046|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626047|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139626048|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139626049|NCT03836157|Growth Substances|growth substances|mesh-ancestor
139626050|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626051|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
139626052|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139626053|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
139626054|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
139626055|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
139626056|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626057|NCT03836157|Immunoconjugates|immunoconjugates|mesh-ancestor
139626058|NCT03836157|Immunologic Factors|immunologic factors|mesh-ancestor
139626059|NCT03080545|Calcitriol|calcitriol|mesh-list
139626060|NCT03080545|Betamethasone|betamethasone|mesh-list
139626061|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139626062|NCT03080545|Calcipotriene|calcipotriene|mesh-list
139626063|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139626064|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
139626065|NCT03080545|Hormones|hormones|mesh-ancestor
139626066|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139626067|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626068|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139626069|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
139626070|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139626071|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139626072|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139626073|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626074|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139626075|NCT03080545|Vitamins|vitamins|mesh-ancestor
139626076|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
139626077|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139626078|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
139626079|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
139626080|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139626081|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139407789|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
139626082|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626083|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
139626084|NCT03101124|Coagulants|coagulants|mesh-ancestor
139626085|NCT02985203|Vinorelbine|vinorelbine|mesh-list
139626086|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139626087|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626088|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
139626089|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
139626090|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
139626091|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626092|NCT04283617|Insulin|insulin|mesh-list
139626093|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139626094|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626095|NCT05247619|Paclitaxel|paclitaxel|mesh-list
139626096|NCT05247619|Bevacizumab|bevacizumab|mesh-list
139626097|NCT05247619|Carboplatin|carboplatin|mesh-list
139626098|NCT05247619|Tislelizumab|tislelizumab|mesh-list
139626099|NCT05247619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139626100|NCT05247619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626101|NCT05247619|Tubulin Modulators|tubulin modulators|mesh-ancestor
139626102|NCT05247619|Antimitotic Agents|antimitotic agents|mesh-ancestor
139626103|NCT05247619|Mitosis Modulators|mitosis modulators|mesh-ancestor
139626104|NCT05247619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626105|NCT05247619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139626106|NCT05247619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139626107|NCT05247619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139626108|NCT05247619|Growth Substances|growth substances|mesh-ancestor
139626109|NCT05247619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626110|NCT05247619|Growth Inhibitors|growth inhibitors|mesh-ancestor
139626111|NCT00805584|Desloratadine|desloratadine|mesh-list
139626112|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139626113|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
139626114|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626115|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626116|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626117|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139626118|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139626119|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
139626120|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
139626121|NCT01833351|Vitamins|vitamins|mesh-list
139626122|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
139626123|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
139626124|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626125|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
139626126|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626127|NCT01833351|Protective Agents|protective agents|mesh-ancestor
139626128|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139626129|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139626130|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139626131|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626132|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
139626133|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626134|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139626135|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139626136|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139626137|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139626138|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626139|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
139626140|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626141|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626142|NCT00795522|Desloratadine|desloratadine|mesh-list
139626143|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139626144|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
139626145|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626146|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626147|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626148|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139626149|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139626150|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
139626151|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
139626152|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
139626153|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139626154|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139407880|NCT02298205|Hormones|hormones|mesh-ancestor
139626155|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139626156|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139626157|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626158|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
139626159|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626160|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626161|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139626162|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626163|NCT05243251|Olanzapine|olanzapine|mesh-list
139626164|NCT05243251|Antiemetics|antiemetics|mesh-ancestor
139626165|NCT05243251|Autonomic Agents|autonomic agents|mesh-ancestor
139626166|NCT05243251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626167|NCT05243251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626168|NCT05243251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139626169|NCT05243251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139626170|NCT05243251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139626171|NCT05243251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139626172|NCT05243251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139626173|NCT05243251|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139626174|NCT05243251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139626175|NCT05243251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139626176|NCT05243251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626177|NCT05243251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626178|NCT05243251|Serotonin Agents|serotonin agents|mesh-ancestor
139626179|NCT05242705|Cystatins|cystatins|mesh-list
139626180|NCT05242705|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139626181|NCT05242705|Protease Inhibitors|protease inhibitors|mesh-ancestor
139626182|NCT05242705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626183|NCT05242705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626184|NCT00216671|Risperidone|risperidone|mesh-list
139626185|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139626186|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
139626187|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626188|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626189|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626190|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139626191|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139626192|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139626193|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139626194|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139626195|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
139626196|NCT00783354|Loratadine|loratadine|mesh-list
139626197|NCT00783354|Desloratadine|desloratadine|mesh-list
139626198|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139626199|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
139626200|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626201|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626202|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626203|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139626204|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139626205|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
139626206|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
139626207|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
139626208|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
139626209|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139626210|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
139626211|NCT01833663|Estrogens|estrogens|mesh-list
139626212|NCT01833663|Hormones|hormones|mesh-ancestor
139626213|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139626214|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626215|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139626216|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139626217|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
139626218|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626219|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626220|NCT01833663|Urological Agents|urological agents|mesh-ancestor
139626221|NCT01720875|Dexamethasone|dexamethasone|mesh-list
139626222|NCT01720875|Bortezomib|bortezomib|mesh-list
139626223|NCT01720875|Vorinostat|vorinostat|mesh-list
139626224|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139626225|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
139626226|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
139626227|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626228|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626229|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139626230|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
139626231|NCT01720875|Hormones|hormones|mesh-ancestor
139626232|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139626233|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139626234|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626235|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139626236|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626237|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626238|NCT04277143|Daptomycin|daptomycin|mesh-list
139626239|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139626240|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626241|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
139626242|NCT00750750|Amoxicillin|amoxicillin|mesh-list
139626243|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139626244|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626245|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139626246|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
139626247|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139626248|NCT05066802|Folfirinox|folfirinox|mesh-list
139626249|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626250|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139626251|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139626252|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626253|NCT05248633|Dexamethasone|dexamethasone|mesh-list
139626254|NCT05248633|Lenalidomide|lenalidomide|mesh-list
139626255|NCT05248633|Bortezomib|bortezomib|mesh-list
139626256|NCT05248633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139626257|NCT05248633|Antiemetics|antiemetics|mesh-ancestor
139626258|NCT05248633|Autonomic Agents|autonomic agents|mesh-ancestor
138754736|NCT04778787|Diuretics|diuretics|mesh-list
139626259|NCT05248633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626260|NCT05248633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626261|NCT05248633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139626262|NCT05248633|Glucocorticoids|glucocorticoids|mesh-ancestor
139626263|NCT05248633|Hormones|hormones|mesh-ancestor
139626264|NCT05248633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139626265|NCT05248633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139626266|NCT05248633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626267|NCT05248633|Immunologic Factors|immunologic factors|mesh-ancestor
139626268|NCT05248633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139626269|NCT05248633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139626270|NCT05248633|Growth Substances|growth substances|mesh-ancestor
139626271|NCT05248633|Growth Inhibitors|growth inhibitors|mesh-ancestor
139626272|NCT00216203|Pemetrexed|pemetrexed|mesh-list
139626273|NCT00216203|Cetuximab|cetuximab|mesh-list
139626274|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626275|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626276|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626277|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139626278|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139626279|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139626280|NCT01727271|Interferons|interferons|mesh-list
139626281|NCT01727271|Tenofovir|tenofovir|mesh-list
139626282|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
139626283|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
139626284|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139626285|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626286|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
139626287|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626288|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139626289|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139626290|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626291|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626292|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139626293|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139626294|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
139626295|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626296|NCT00653796|Atorvastatin|atorvastatin|mesh-list
139626297|NCT00653796|Ezetimibe|ezetimibe|mesh-list
139626298|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139626299|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139626300|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
139626301|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626302|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139626303|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139626304|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626305|NCT01833819|Lidocaine|lidocaine|mesh-list
139626306|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
139626307|NCT01833819|Remifentanil|remifentanil|mesh-list
139626308|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
139626309|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
139626310|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139626311|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626312|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
139626313|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626314|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139626315|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139626316|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139626317|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138754793|NCT02848963|Ketamine|ketamine|mesh-list
139626318|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626319|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139626320|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139626321|NCT01833819|Analgesics|analgesics|mesh-ancestor
139626322|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139626323|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139626324|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139626325|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
139626326|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626327|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139626328|NCT01833819|Narcotics|narcotics|mesh-ancestor
139626329|NCT05244109|Antibodies|antibodies|mesh-list
139626330|NCT05244109|Immunoglobulins|immunoglobulins|mesh-list
139626331|NCT05244109|Immunologic Factors|immunologic factors|mesh-ancestor
139626332|NCT05244109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626333|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139626334|NCT00651144|Ezetimibe|ezetimibe|mesh-list
139626335|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139626336|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139626337|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
139626338|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626339|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139626340|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139626341|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626342|NCT01721031|Tramadol|tramadol|mesh-list
139626343|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139626344|NCT01721031|Narcotics|narcotics|mesh-ancestor
139626345|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139626346|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626347|NCT01721031|Analgesics|analgesics|mesh-ancestor
139626348|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
139626349|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626350|NCT03218683|Venetoclax|venetoclax|mesh-list
139626351|NCT03218683|AZD5991|azd5991|mesh-list
139626352|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626353|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
139626354|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
139626355|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626356|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139626357|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139626358|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139626359|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626360|NCT04378647|Immunotoxins|immunotoxins|mesh-ancestor
139626361|NCT04378647|Immunoconjugates|immunoconjugates|mesh-ancestor
139626362|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
139626363|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626364|NCT00370890|Gemcitabine|gemcitabine|mesh-list
139626365|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626366|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139626367|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
139626368|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626369|NCT02669953|Aflibercept|aflibercept|mesh-list
139626370|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139626371|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139626372|NCT02669953|Growth Substances|growth substances|mesh-ancestor
139626373|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626374|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
139626375|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626376|NCT01721655|Spironolactone|spironolactone|mesh-list
139626377|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139626378|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
139626379|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139626380|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626381|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139626382|NCT01721655|Diuretics|diuretics|mesh-ancestor
139626383|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
139626384|NCT00904995|Voriconazole|voriconazole|mesh-list
139626385|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
139626386|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754850|NCT04697485|Eplerenone|eplerenone|mesh-list
139626387|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139626388|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139626389|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626390|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626391|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139626392|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
139626393|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139626394|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626395|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139626396|NCT05249725|Irsogladine|irsogladine|mesh-list
139626397|NCT05249725|Hydrotalcite|hydrotalcite|mesh-list
139626398|NCT05249725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626399|NCT05249725|Antacids|antacids|mesh-ancestor
139626400|NCT05249725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139626401|NCT05249725|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139626402|NCT05249725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626403|NCT05249725|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139626404|NCT05249725|Protective Agents|protective agents|mesh-ancestor
139626405|NCT05249725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626406|NCT05249725|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139626407|NCT01834209|Prednisone|prednisone|mesh-list
139626408|NCT01834209|Prednisolone|prednisolone|mesh-list
139626409|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
139626410|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139626411|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
139626412|NCT01834209|Hormones|hormones|mesh-ancestor
139626413|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139626414|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626415|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139626416|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626417|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139626418|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626419|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626420|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
139626421|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139626422|NCT05241535|Moxifloxacin|moxifloxacin|mesh-list
139626423|NCT05241535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139626424|NCT05241535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626425|NCT05241535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139626426|NCT05241535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139626427|NCT05241535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626428|NCT05241535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626429|NCT05241535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626430|NCT02488135|Hemostatics|hemostatics|mesh-list
139626431|NCT02488135|Coagulants|coagulants|mesh-ancestor
139626432|NCT01727973|Doxycycline|doxycycline|mesh-list
139626433|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139626434|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626435|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
139626436|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139626437|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139626438|NCT03100734|Etanercept|etanercept|mesh-list
139626439|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139626440|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139626441|NCT03100734|Analgesics|analgesics|mesh-ancestor
139626442|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
139626443|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626444|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626445|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139626446|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139626447|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139626448|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139626449|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
139626450|NCT05243706|Loratadine|loratadine|mesh-list
139626451|NCT05243706|Antipruritics|antipruritics|mesh-ancestor
139626452|NCT05243706|Dermatologic Agents|dermatologic agents|mesh-ancestor
139626453|NCT05243706|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139626454|NCT05243706|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139626455|NCT05243706|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139626456|NCT05243706|Histamine Antagonists|histamine antagonists|mesh-ancestor
139626458|NCT05243706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626459|NCT05243706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626460|NCT05243706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626461|NCT01728051|Melphalan|melphalan|mesh-list
139626462|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139626463|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
139626464|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626465|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626466|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139626467|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139626468|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
139626469|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626470|NCT01722201|Risperidone|risperidone|mesh-list
139626471|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139626472|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
139626473|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626474|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626475|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626476|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139626477|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139626478|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139626479|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139626480|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139626481|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
139626482|NCT01722513|Alprostadil|alprostadil|mesh-list
139626483|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139626484|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
139626485|NCT01722513|Urological Agents|urological agents|mesh-ancestor
139626486|NCT03179995|Octreotide|octreotide|mesh-list
139626487|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139626488|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139626489|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626490|NCT01728441|Paclitaxel|paclitaxel|mesh-list
139626491|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139626492|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139626493|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626494|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
139626495|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
139626496|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
139626497|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626498|NCT03099408|Metronidazole|metronidazole|mesh-list
139626499|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626500|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139626501|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139626502|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139626503|NCT04984200|Mydriatics|mydriatics|mesh-list
139626504|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
139626505|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626506|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626507|NCT00912873|Ropivacaine|ropivacaine|mesh-list
139626508|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
139626509|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
139626510|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139626511|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626512|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
139626513|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626514|NCT01494038|Isoniazid|isoniazid|mesh-list
139626515|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
139626516|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139626517|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626518|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139626519|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139626520|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
138754977|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139626521|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626522|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139626523|NCT05059782|Coal Tar|coal tar|mesh-list
139626524|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
139626525|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
139626526|NCT05242081|Sufentanil|sufentanil|mesh-list
139626527|NCT05242081|Ketamine|ketamine|mesh-list
139626528|NCT05242081|Esketamine|esketamine|mesh-list
139626529|NCT05242081|Analgesics|analgesics|mesh-ancestor
139626530|NCT05242081|Sensory System Agents|sensory system agents|mesh-ancestor
139626531|NCT05242081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626533|NCT05242081|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139626534|NCT05242081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139626535|NCT05242081|Anesthetics, General|anesthetics, general|mesh-ancestor
139626536|NCT05242081|Anesthetics|anesthetics|mesh-ancestor
139626537|NCT05242081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139626538|NCT05242081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139626539|NCT05242081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139626540|NCT05242081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626541|NCT05242081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626542|NCT05242081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139626543|NCT05242081|Narcotics|narcotics|mesh-ancestor
139626544|NCT05242081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139626545|NCT05242081|Antidepressive Agents|antidepressive agents|mesh-ancestor
139626546|NCT05242081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139626547|NCT04412304|Dalteparin|dalteparin|mesh-list
139626548|NCT04412304|Tinzaparin|tinzaparin|mesh-list
139626549|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139626550|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
139626551|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139626552|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139626553|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626554|NCT00915603|Paclitaxel|paclitaxel|mesh-list
139626555|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139626556|NCT00915603|Bevacizumab|bevacizumab|mesh-list
139626557|NCT00915603|Everolimus|everolimus|mesh-list
139626558|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139626559|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626560|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
139626561|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
139626562|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
139626563|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626564|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139626565|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139626566|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139626567|NCT00915603|Growth Substances|growth substances|mesh-ancestor
139626568|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626569|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
139626570|NCT00915603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139626571|NCT00915603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139626572|NCT00915603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626573|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139626574|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
139626575|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139626576|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139626577|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
139626578|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626579|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626580|NCT01929421|Gemcitabine|gemcitabine|mesh-list
139626581|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139626582|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
139626583|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626584|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626585|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
139626586|NCT04474002|Cathartics|cathartics|mesh-ancestor
139626587|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139626588|NCT01929577|Peficitinib|peficitinib|mesh-list
139626589|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626590|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626591|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139626592|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
139626593|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626594|NCT03142321|Vedolizumab|vedolizumab|mesh-list
139626595|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139626596|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139626597|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626598|NCT03836703|Iron|iron|mesh-list
139626599|NCT03836703|Trace Elements|trace elements|mesh-ancestor
139626600|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
139626601|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626602|NCT02398825|Ponatinib|ponatinib|mesh-list
139626603|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626604|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139626605|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408317|NCT00157339|Insulin|insulin|mesh-list
139626606|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626608|NCT01723059|Metronidazole|metronidazole|mesh-list
139626609|NCT01723059|Clarithromycin|clarithromycin|mesh-list
139626610|NCT01723059|Omeprazole|omeprazole|mesh-list
139626611|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139626612|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626613|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139626614|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139626615|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139626616|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139626617|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139626618|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626619|NCT01723059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626620|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139626621|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139626622|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139626623|NCT04379271|Calcium|calcium|mesh-list
139626624|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139626625|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626626|NCT01728909|Oxytocin|oxytocin|mesh-list
139626627|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
139626628|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139626629|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626630|NCT01922713|Vitamin A|vitamin a|mesh-list
139626631|NCT01922713|Beta Carotene|beta carotene|mesh-list
139626632|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
139626633|NCT01922713|Vitamins|vitamins|mesh-ancestor
139626634|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
139626635|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626636|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
139626637|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626638|NCT01922713|Protective Agents|protective agents|mesh-ancestor
139626639|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139626640|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626641|NCT01922713|Provitamins|provitamins|mesh-ancestor
139626642|NCT05061732|Amoxicillin|amoxicillin|mesh-list
139626643|NCT05061732|Metronidazole|metronidazole|mesh-list
139626644|NCT05061732|Clarithromycin|clarithromycin|mesh-list
139626645|NCT05061732|Doxycycline|doxycycline|mesh-list
139626646|NCT05061732|Levofloxacin|levofloxacin|mesh-list
139626647|NCT05061732|Tetracycline|tetracycline|mesh-list
139626648|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
139626649|NCT05061732|Rabeprazole|rabeprazole|mesh-list
139626650|NCT05061732|Bismuth|bismuth|mesh-list
139626651|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626652|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139626653|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626654|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139626655|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139626656|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139626657|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626658|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139626659|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139626660|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
139626661|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139626662|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139626663|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139626664|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626665|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139626666|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139626667|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139626668|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139626669|NCT05061732|Antacids|antacids|mesh-ancestor
139626670|NCT05061732|Diuretics|diuretics|mesh-ancestor
139626671|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
139626672|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626673|NCT05061732|Expectorants|expectorants|mesh-ancestor
139626674|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
139626675|NCT02391571|Naltrexone|naltrexone|mesh-list
139626676|NCT02391571|Oxycodone|oxycodone|mesh-list
139626677|NCT02391571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139626678|NCT02391571|Narcotics|narcotics|mesh-ancestor
139626679|NCT02391571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139626680|NCT02391571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626681|NCT02391571|Analgesics|analgesics|mesh-ancestor
139626682|NCT02391571|Sensory System Agents|sensory system agents|mesh-ancestor
139626683|NCT02391571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626684|NCT02391571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139626685|NCT02391571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139626686|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
139626687|NCT01728987|Vitamin D|vitamin d|mesh-list
139626688|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139626689|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626690|NCT01728987|Vitamins|vitamins|mesh-ancestor
139626691|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
139626692|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139626693|NCT01834989|Mitogens|mitogens|mesh-list
139626694|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
139626695|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626696|NCT01835067|Ranibizumab|ranibizumab|mesh-list
139626697|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139626698|NCT01835067|Plasminogen|plasminogen|mesh-list
139626699|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139626700|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139626701|NCT01835067|Growth Substances|growth substances|mesh-ancestor
139626702|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626703|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
139626704|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626705|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139626706|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139626707|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626708|NCT03100422|Armin|armin|mesh-list
139626709|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139626710|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626711|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626712|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
139626713|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626714|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626715|NCT00639769|Cisplatin|cisplatin|mesh-list
139626716|NCT00639769|Irinotecan|irinotecan|mesh-list
139626717|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626718|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139626719|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139626720|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626721|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626722|NCT01723371|Carvedilol|carvedilol|mesh-list
139626723|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139626724|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139626725|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
139626726|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626727|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626728|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626729|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139626730|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
139626731|NCT01723371|Protective Agents|protective agents|mesh-ancestor
139626732|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139626733|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139626734|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139626735|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
139626736|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139626737|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139626738|NCT00639457|Pioglitazone|pioglitazone|mesh-list
139626739|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139626740|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626741|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
139626742|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139626743|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139626744|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139626745|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626746|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
139626747|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626748|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626749|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139626750|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626751|NCT01723527|Buprenorphine|buprenorphine|mesh-list
139626752|NCT01723527|Methadone|methadone|mesh-list
139626753|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139626754|NCT01723527|Narcotics|narcotics|mesh-ancestor
139626755|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139626756|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626757|NCT01723527|Analgesics|analgesics|mesh-ancestor
139408476|NCT05254899|Antibodies|antibodies|mesh-list
139626758|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
139626759|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626760|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139626761|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
139626762|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
139626763|NCT00639223|Pravastatin|pravastatin|mesh-list
139626764|NCT00639223|Red yeast rice|red yeast rice|mesh-list
139626765|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139626766|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139626767|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
139626768|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755231|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626769|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139626770|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139626771|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626772|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139626773|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
139626774|NCT03519984|Cytarabine|cytarabine|mesh-list
139626775|NCT03519984|Vincristine|vincristine|mesh-list
139626776|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139626777|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
139626778|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626779|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626780|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
139626781|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626782|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139626783|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
139626784|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626785|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139626786|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
139626787|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
139626788|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
139626789|NCT05056896|Aspirin|aspirin|mesh-list
139626790|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
139626791|NCT05056896|Salicylates|salicylates|mesh-list
139626792|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139626793|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139626794|NCT05056896|Analgesics|analgesics|mesh-ancestor
139626795|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
139626796|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626797|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626798|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139626799|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139626800|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139626801|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139626802|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626803|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139626804|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139626805|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626806|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
139626807|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626808|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
139626809|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
139626810|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
139626811|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139626812|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
139626813|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626814|NCT01835691|Vitamin D|vitamin d|mesh-list
139626815|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
139626816|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
139626817|NCT01835691|Vitamins|vitamins|mesh-list
139626818|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
139626819|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626820|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139626821|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139626822|NCT01729767|Acyclovir|acyclovir|mesh-list
139626823|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
139626824|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626825|NCT00913263|Flutamide|flutamide|mesh-list
139626826|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
139626827|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
139626828|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
139626829|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139626830|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408546|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139626831|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139626832|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626834|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139626835|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626836|NCT04377867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139626837|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626838|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139626839|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
139626840|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626841|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139626842|NCT00637273|Pioglitazone|pioglitazone|mesh-list
139626843|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139626844|NCT00637273|Exenatide|exenatide|mesh-list
139626845|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139626846|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626847|NCT00637273|Incretins|incretins|mesh-ancestor
139626848|NCT00637273|Hormones|hormones|mesh-ancestor
139626849|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139626850|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139626851|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
139626852|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626853|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626854|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139626855|NCT01923259|Donepezil|donepezil|mesh-list
139626856|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139626857|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626858|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626859|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
139626860|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626861|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626862|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
139626863|NCT01923337|Irinotecan|irinotecan|mesh-list
139626864|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139626865|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139626866|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626867|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626868|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626869|NCT03098160|Ipilimumab|ipilimumab|mesh-list
139626870|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139626871|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626872|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139626873|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626874|NCT01724385|Bevacizumab|bevacizumab|mesh-list
139626875|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139626876|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626877|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139626878|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139626879|NCT01724385|Growth Substances|growth substances|mesh-ancestor
139626880|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626881|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
139626882|NCT04377789|Quercetin|quercetin|mesh-list
139626883|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
139626884|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626885|NCT04377789|Protective Agents|protective agents|mesh-ancestor
139626886|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626887|NCT00988117|Rivastigmine|rivastigmine|mesh-list
139626888|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139626889|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139626890|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626891|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
138755372|NCT05337085|Midazolam|midazolam|mesh-list
139626892|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626893|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626894|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139626895|NCT00988117|Protective Agents|protective agents|mesh-ancestor
139626896|NCT01728753|Favipiravir|favipiravir|mesh-list
139626897|NCT01728753|Antiviral Agents|antiviral agents|mesh-ancestor
139626898|NCT01728753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139626899|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
139626900|NCT01724619|Androgens|androgens|mesh-ancestor
139626901|NCT01724619|Hormones|hormones|mesh-ancestor
139626902|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139626903|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626904|NCT05045508|Varenicline|varenicline|mesh-list
139626905|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139408621|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
139626906|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139626907|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
139626908|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626909|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626910|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626911|NCT00637195|Vaccines|vaccines|mesh-list
139626912|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
139626913|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626914|NCT05045274|Aspirin|aspirin|mesh-list
139626915|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
139626916|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
139626917|NCT05045274|Giapreza|giapreza|mesh-list
139626918|NCT05045274|Clopidogrel|clopidogrel|mesh-list
139626919|NCT05045274|Ticagrelor|ticagrelor|mesh-list
139626920|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139626921|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139626922|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
139626923|NCT05045274|Diuretics|diuretics|mesh-list
139626924|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139626925|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139626926|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139626927|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
139626928|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139626929|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139626930|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139626931|NCT05045274|Analgesics|analgesics|mesh-ancestor
139626932|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
139626933|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139626934|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626935|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139626936|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139626937|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139626938|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139626939|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626940|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139626941|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139626942|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
139626943|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139626944|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139626945|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139626946|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
139626947|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626948|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139626949|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139626950|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139626951|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139626952|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
139626953|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139626954|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
139626955|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139626956|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
139626957|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139626958|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139626959|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
139626960|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
139626961|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139626962|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139626963|NCT05045274|Hormones|hormones|mesh-ancestor
139626964|NCT01721733|Ubiquinone|ubiquinone|mesh-list
139626965|NCT01721733|Micronutrients|micronutrients|mesh-ancestor
139626966|NCT01721733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626967|NCT01720485|Prednisolone|prednisolone|mesh-list
139626968|NCT01720485|Betamethasone|betamethasone|mesh-list
139626969|NCT01720485|Desloratadine|desloratadine|mesh-list
139626970|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
139626971|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139626972|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
139626973|NCT01720485|Hormones|hormones|mesh-ancestor
139626974|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139626975|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626976|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139626977|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626978|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139626979|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
139626980|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139408699|NCT02300701|Omalizumab|omalizumab|mesh-list
139626981|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
139626982|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139626983|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139626984|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139626985|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139626986|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
139626987|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
139626988|NCT01726725|Desflurane|desflurane|mesh-list
139626989|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139626990|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
139626991|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
139626992|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139626993|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139626994|NCT05044728|Paclitaxel|paclitaxel|mesh-list
139626995|NCT05044728|Carboplatin|carboplatin|mesh-list
139626996|NCT05044728|Antibodies|antibodies|mesh-list
139626997|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139626998|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139626999|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
139627000|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
139627001|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
139627002|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627003|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
139627004|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627005|NCT05054478|Daratumumab|daratumumab|mesh-list
139627006|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627007|NCT01041807|Losartan|losartan|mesh-list
139627008|NCT01041807|Amlodipine|amlodipine|mesh-list
139627009|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139627010|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139627011|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139627012|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627013|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139627014|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627015|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
139627016|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139627017|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138755479|NCT02842567|Vitamin E|vitamin e|mesh-list
139627018|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139627019|NCT01724931|Aminopterin|aminopterin|mesh-list
139627020|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139627021|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627022|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627023|NCT00635089|Reslizumab|reslizumab|mesh-list
139627024|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139627025|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
139627026|NCT01725009|Levetiracetam|levetiracetam|mesh-list
139627027|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
139627028|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
139627029|NCT01725087|Tapentadol|tapentadol|mesh-list
139627030|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139627031|NCT01725087|Narcotics|narcotics|mesh-ancestor
139627032|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627033|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627034|NCT01725087|Analgesics|analgesics|mesh-ancestor
139627035|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
139627036|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627037|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139627038|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139627039|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139627040|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627041|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
139627042|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627043|NCT00634543|Acetaminophen|acetaminophen|mesh-list
139627044|NCT00634543|Gabapentin|gabapentin|mesh-list
139627045|NCT00634543|Tramadol|tramadol|mesh-list
139627046|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139627047|NCT00634543|Analgesics|analgesics|mesh-ancestor
139627048|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
139627049|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627050|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627051|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
139627052|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
139627053|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139627054|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139627055|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627056|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139627057|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139627058|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139627059|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627060|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627061|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
139627062|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139627063|NCT00634543|Narcotics|narcotics|mesh-ancestor
139627064|NCT05054322|Fluticasone|fluticasone|mesh-list
139627065|NCT05054322|Xhance|xhance|mesh-list
139627066|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139627067|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139627068|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
139627069|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627070|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627071|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139627072|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
139627073|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
139627074|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139627075|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139627076|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
139627077|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627078|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
139627079|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139627080|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
139627081|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627082|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627083|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139627084|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
139627085|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
139627086|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139627087|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
139627088|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627089|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627090|NCT04759729|Vitamin D|vitamin d|mesh-list
139627091|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
139627092|NCT04759729|Cholecalciferol|cholecalciferol|mesh-list
139627093|NCT04759729|Vitamins|vitamins|mesh-list
139627094|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
139627095|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627096|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139627097|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139627098|NCT05053386|Epirubicin|epirubicin|mesh-list
139627099|NCT05053386|Idarubicin|idarubicin|mesh-list
139627100|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139627101|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627102|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139627103|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139627104|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627105|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627106|NCT01725243|Carbetocin|carbetocin|mesh-list
139627107|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
139627108|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139627109|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627110|NCT01725477|Methylene Blue|methylene blue|mesh-list
139627111|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627112|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627113|NCT03096990|Apremilast|apremilast|mesh-list
139627114|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139627115|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139627116|NCT03096990|Analgesics|analgesics|mesh-ancestor
139627117|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
139627118|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627119|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627120|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139627121|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627122|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139627123|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139627124|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627125|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627126|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
139627127|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139627128|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627129|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
139408845|NCT03509545|Torsemide|torsemide|mesh-list
139627130|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
139627132|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
139627133|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
139627134|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627135|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
139627136|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139627137|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139627138|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
139627139|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627140|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139627141|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139627142|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627143|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627144|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
139627145|NCT03836781|Ketorolac|ketorolac|mesh-list
139627146|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139627147|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627148|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
139627149|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139627150|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139627151|NCT03836781|Analgesics|analgesics|mesh-ancestor
139627152|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
139627153|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627154|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627155|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139627156|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627157|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139627158|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627159|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627160|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139627161|NCT01360866|Fluoxetine|fluoxetine|mesh-list
139627162|NCT01360866|Paroxetine|paroxetine|mesh-list
139627163|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139627164|NCT01360866|Sertraline|sertraline|mesh-list
139627165|NCT01360866|Escitalopram|escitalopram|mesh-list
139627166|NCT01360866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139627167|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139627168|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139627169|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627170|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627171|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
139627172|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627173|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627174|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139627175|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
139627176|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139627177|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139627178|NCT01360866|Analgesics|analgesics|mesh-ancestor
139627179|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
139627180|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
139627181|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139627182|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139627183|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627184|NCT00984061|Clarithromycin|clarithromycin|mesh-list
139627185|NCT00984061|Colchicine|colchicine|mesh-list
139627186|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139627187|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627188|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139627189|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627190|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627191|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139627192|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139627193|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
139627194|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627195|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
139627196|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
139627197|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
139627198|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627199|NCT01046643|Estradiol|estradiol|mesh-list
139627200|NCT01046643|Progesterone|progesterone|mesh-list
139627201|NCT01046643|Estrogens|estrogens|mesh-ancestor
139627202|NCT01046643|Hormones|hormones|mesh-ancestor
139627203|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139408921|NCT02304055|Oxytocin|oxytocin|mesh-list
139627204|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627206|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
139627207|NCT03096756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139627208|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
139627209|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627210|NCT03096756|Protective Agents|protective agents|mesh-ancestor
139627211|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627212|NCT00983905|Colchicine|colchicine|mesh-list
139627213|NCT00983905|Theophylline|theophylline|mesh-list
139627214|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
139627215|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627216|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
139627217|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
139627218|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
139627219|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627220|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627221|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139627222|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
139627223|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627224|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627225|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139627226|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
139627227|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139627228|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627229|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
139627230|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139627231|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139627232|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
139627233|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627234|NCT01046565|Adapalene|adapalene|mesh-list
139627235|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139627236|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139627237|NCT01046565|Analgesics|analgesics|mesh-ancestor
139627238|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
139627239|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627240|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627241|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139627242|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627243|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
139627244|NCT01046253|Lansoprazole|lansoprazole|mesh-list
139627245|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
139627246|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139627247|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139627248|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139627249|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627250|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627251|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139627252|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139627253|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139627254|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139627255|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627256|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627257|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627258|NCT05050656|Analgesics|analgesics|mesh-ancestor
139627259|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
139627260|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627261|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
139627262|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139627263|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
139627264|NCT00983515|Ritonavir|ritonavir|mesh-list
139627265|NCT00983515|Colchicine|colchicine|mesh-list
139627266|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139627267|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139627268|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
139627269|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627270|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627271|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139627272|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139627273|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
139627274|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627275|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139627276|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139627277|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
139627278|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627279|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
139627280|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
139627281|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
139627282|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627283|NCT05033574|Hormones|hormones|mesh-list
139627284|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139627285|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627286|NCT04434378|Tamsulosin|tamsulosin|mesh-list
139627287|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139627288|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139627289|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139627290|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
139627291|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627292|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627293|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627294|NCT04434378|Urological Agents|urological agents|mesh-ancestor
139627295|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
139627296|NCT00981799|Methotrexate|methotrexate|mesh-list
139627297|NCT00981799|Etoposide|etoposide|mesh-list
139627298|NCT00981799|Lenograstim|lenograstim|mesh-list
139627299|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139627300|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
139627301|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627302|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627303|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139627304|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
139627305|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627306|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627307|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139627308|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139627309|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
139627310|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139627311|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139627312|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
139627313|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
139627314|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627315|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139627316|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139627317|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139627318|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139627319|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139627320|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139627321|NCT05033106|Bevacizumab|bevacizumab|mesh-list
139627322|NCT05033106|Ranibizumab|ranibizumab|mesh-list
139627323|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139627324|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627325|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139627326|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139627327|NCT05033106|Growth Substances|growth substances|mesh-ancestor
139627328|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627329|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
139627330|NCT03095040|Everolimus|everolimus|mesh-list
139627331|NCT03095040|Vorolanib|vorolanib|mesh-list
139627332|NCT03095040|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139627333|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139627334|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627335|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627336|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139627337|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
139627338|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627339|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627340|NCT03096522|Phenytoin|phenytoin|mesh-list
139627341|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
139627342|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139627343|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139627344|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139627345|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627346|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139627347|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139627348|NCT01045161|Bromides|bromides|mesh-list
139627349|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
139627350|NCT05032248|Tacrolimus|tacrolimus|mesh-list
139627351|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139627352|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
139627353|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627354|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139627355|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627356|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627357|NCT00633217|Fluticasone|fluticasone|mesh-list
139627358|NCT00633217|Xhance|xhance|mesh-list
139627359|NCT00633217|Norflurane|norflurane|mesh-list
139627360|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139627361|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139627362|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139627363|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139627364|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
139627365|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627366|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627367|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139627368|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
139627369|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
139627370|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139627371|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139627372|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139627373|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139627374|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
139627375|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627376|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627377|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
139627378|NCT00633217|Hormones|hormones|mesh-ancestor
139627379|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139627380|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
139627381|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
139627382|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627383|NCT01673490|Tamsulosin|tamsulosin|mesh-list
139627384|NCT01673490|Dutasteride|dutasteride|mesh-list
139627385|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139627386|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139627387|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139627388|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
139627389|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627390|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627391|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627392|NCT01673490|Urological Agents|urological agents|mesh-ancestor
139627393|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139627394|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139627395|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627396|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
139627397|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139627398|NCT00633061|Enoxaparin|enoxaparin|mesh-list
139627399|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
139627400|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139627401|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139627402|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627403|NCT00632827|Leucovorin|leucovorin|mesh-list
139627404|NCT00632827|Cytarabine|cytarabine|mesh-list
139627405|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
139627406|NCT00632827|Carmustine|carmustine|mesh-list
139627407|NCT00632827|Gemcitabine|gemcitabine|mesh-list
139627408|NCT00632827|Doxorubicin|doxorubicin|mesh-list
139627409|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139627410|NCT00632827|Methotrexate|methotrexate|mesh-list
139627411|NCT00632827|Etoposide|etoposide|mesh-list
139627412|NCT00632827|Vincristine|vincristine|mesh-list
139627413|NCT00632827|Vinorelbine|vinorelbine|mesh-list
139627414|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
139627415|NCT00632827|Lenograstim|lenograstim|mesh-list
139627416|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139627417|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
139627418|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627419|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627420|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139627421|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
139627422|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627423|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627424|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139627425|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139627426|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
139627427|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139627428|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139627429|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139627430|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627431|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139627432|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
139627433|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139627434|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
139627435|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139627436|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139627437|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139627438|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
139627439|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627440|NCT00632827|Antidotes|antidotes|mesh-ancestor
139627441|NCT00632827|Protective Agents|protective agents|mesh-ancestor
139627442|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
139627443|NCT00632827|Vitamins|vitamins|mesh-ancestor
139627444|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
139627445|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
139627446|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
139627447|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
139627448|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139627449|NCT00214019|Fluticasone|fluticasone|mesh-list
139627450|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139627451|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139627452|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139627453|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139627454|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
139627455|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627456|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627457|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139627458|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
139627459|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
139627460|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139627461|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139627462|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139627463|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139627464|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
139627465|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627466|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627467|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
139627468|NCT00214019|Hormones|hormones|mesh-ancestor
139627469|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139627470|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
139627471|NCT03097848|Sorafenib|sorafenib|mesh-list
139627472|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627473|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139627474|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627475|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627476|NCT05047848|Fulvestrant|fulvestrant|mesh-list
139627477|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139627478|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627479|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139627480|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139627481|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
139627482|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139627483|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627484|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
139627485|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627486|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139627487|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627488|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627489|NCT01044459|Bromides|bromides|mesh-list
139627490|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
139627491|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
139627492|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
139627493|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
139627494|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627495|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627496|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139627497|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139627498|NCT01837329|Growth Substances|growth substances|mesh-ancestor
139627499|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627500|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
139627501|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409218|NCT02326779|Analgesics|analgesics|mesh-ancestor
139627502|NCT05040906|Rituximab|rituximab|mesh-list
139627503|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139627504|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627505|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
139627506|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627507|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627508|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
139627509|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138755991|NCT04249531|Amikacin|amikacin|mesh-list
139627510|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627511|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139627512|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
139627513|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139627514|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627515|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627516|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627517|NCT05040828|Montelukast|montelukast|mesh-list
139627518|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139627519|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
139627520|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139627521|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
139627522|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139627523|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627524|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139627525|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139627526|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627527|NCT00983437|Modafinil|modafinil|mesh-list
139627528|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139627529|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627530|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139627531|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139627532|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139627533|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627534|NCT03599609|Simvastatin|simvastatin|mesh-list
139627535|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139627536|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139627537|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
139627538|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627539|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139627540|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139627541|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627542|NCT05040594|Lidocaine|lidocaine|mesh-list
139627543|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
139627544|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
139627545|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627546|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627547|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
139627548|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627549|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139627550|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139627551|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139627552|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139627553|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627554|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
139627555|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139627556|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627557|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139627558|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627559|NCT03598673|Nebivolol|nebivolol|mesh-list
139627560|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139627561|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
139627562|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139627563|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139627564|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139627565|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
139627566|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627567|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627568|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627569|NCT05039580|Dexamethasone|dexamethasone|mesh-list
139627570|NCT05039580|Antibodies|antibodies|mesh-list
139627571|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139627572|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
139409301|NCT02305069|Octreotide|octreotide|mesh-list
139627573|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756046|NCT00971932|Fluorouracil|fluorouracil|mesh-list
139627574|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139627575|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
139627576|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
139627577|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627578|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139627579|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
139627580|NCT05039580|Hormones|hormones|mesh-ancestor
139627581|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139627582|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139627583|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627584|NCT05025228|Acetaminophen|acetaminophen|mesh-list
139627585|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139627586|NCT05025228|Analgesics|analgesics|mesh-ancestor
139627587|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
139627588|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627589|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627590|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
139627591|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
139627592|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627593|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
139627594|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627595|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627596|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139627597|NCT05024604|Progesterone|progesterone|mesh-list
139627598|NCT05024604|Progestins|progestins|mesh-ancestor
139627599|NCT05024604|Hormones|hormones|mesh-ancestor
139627600|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139627601|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627602|NCT03597893|Oxytocin|oxytocin|mesh-list
139627603|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
139627604|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139627605|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627606|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139627607|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
139627608|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627609|NCT05024448|Prednisone|prednisone|mesh-list
139627610|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139627611|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
139627612|NCT05024448|Hormones|hormones|mesh-ancestor
139627613|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139627614|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627615|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139627616|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627617|NCT03596957|Tolvaptan|tolvaptan|mesh-list
139627618|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139627619|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627620|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
139627621|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627622|NCT03408015|Lifitegrast|lifitegrast|mesh-list
139627623|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138756114|NCT04286152|Urological Agents|urological agents|mesh-ancestor
139627624|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139627625|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
139627626|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139627627|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
139627628|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139627629|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139627630|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627631|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139627632|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627633|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139627634|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627635|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139627636|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627637|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627638|NCT03596099|Acetic Acid|acetic acid|mesh-list
139627639|NCT03596099|Retinol acetate|retinol acetate|mesh-list
139627640|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139627641|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627642|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139627643|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
139627644|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627645|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139627646|NCT03596099|Protective Agents|protective agents|mesh-ancestor
139627647|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627648|NCT01041417|Molgramostim|molgramostim|mesh-list
139627649|NCT01041417|Sargramostim|sargramostim|mesh-list
139627650|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
139627651|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627652|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627653|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
139627654|NCT03595397|Fentanyl|fentanyl|mesh-list
139627655|NCT03595397|Bupivacaine|bupivacaine|mesh-list
139627656|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
139627657|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
139627658|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627659|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627660|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
139627661|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627662|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139627663|NCT03595397|Narcotics|narcotics|mesh-ancestor
139627664|NCT03595397|Analgesics|analgesics|mesh-ancestor
139627665|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139627666|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139627667|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
139627668|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139627669|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
139627670|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139627671|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139627672|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627673|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139627674|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
139627675|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139627676|NCT03595319|Sevoflurane|sevoflurane|mesh-list
139627677|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139627678|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139627679|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
139627680|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
139627681|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627682|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627683|NCT01040871|Prednisone|prednisone|mesh-list
139627684|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
139627685|NCT01040871|Rituximab|rituximab|mesh-list
139627686|NCT01040871|Doxorubicin|doxorubicin|mesh-list
139627687|NCT01040871|Vincristine|vincristine|mesh-list
139627688|NCT01040871|Bortezomib|bortezomib|mesh-list
139627689|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139627690|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
139627691|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627692|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627693|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139627694|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
139627695|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627696|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627697|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139627698|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139627699|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139627700|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139627701|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139627702|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627703|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139627704|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
139627705|NCT01040871|Hormones|hormones|mesh-ancestor
139627706|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139627707|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139627708|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139627709|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
139627710|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
139627711|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
139627712|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
139627713|NCT01040169|Calcium|calcium|mesh-list
139627714|NCT01040169|Fluorides|fluorides|mesh-list
139627715|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139627716|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627717|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
139627718|NCT01040169|Protective Agents|protective agents|mesh-ancestor
139627719|NCT01040169|Antacids|antacids|mesh-ancestor
139627720|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627721|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139627722|NCT01044381|Luliconazole|luliconazole|mesh-list
139627723|NCT01044381|Antifungal Agents|antifungal agents|mesh-ancestor
139627724|NCT01044381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627725|NCT03594461|Aflibercept|aflibercept|mesh-list
139627726|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139627727|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139627728|NCT03594461|Growth Substances|growth substances|mesh-ancestor
139627729|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627730|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
139627731|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627732|NCT03407703|Grazoprevir|grazoprevir|mesh-list
139627733|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139627734|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
139627735|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627736|NCT03594149|Levofloxacin|levofloxacin|mesh-list
139627737|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139627738|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627739|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139627740|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139627741|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139627742|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627743|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627744|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627745|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139627746|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139627747|NCT00916539|Calpastatin|calpastatin|mesh-list
139627748|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139627749|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
139627750|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627751|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627752|NCT03593447|Ribavirin|ribavirin|mesh-list
139627753|NCT03593447|Yimitasvir|yimitasvir|mesh-list
139627754|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
139627755|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627756|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
139627757|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627758|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139627759|NCT03593291|Dalteparin|dalteparin|mesh-list
139627760|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
139627761|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139627762|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139627763|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627764|NCT03593135|Metformin|metformin|mesh-list
139627765|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139627766|NCT03593135|Acetic Acid|acetic acid|mesh-list
139627767|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139627768|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627769|NCT03593135|Incretins|incretins|mesh-ancestor
139627770|NCT03593135|Hormones|hormones|mesh-ancestor
139627771|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139627772|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139627773|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
139627774|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627775|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627776|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139627777|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627778|NCT03592901|Anesthetics|anesthetics|mesh-list
139627779|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627780|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627781|NCT03830385|Carboplatin|carboplatin|mesh-list
139627782|NCT03830385|Bleomycin|bleomycin|mesh-list
139627783|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627784|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139627785|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
139627786|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
139627787|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139627788|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139627789|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627790|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627791|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627792|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627793|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
139627794|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139627795|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627796|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139627797|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627798|NCT03406689|Nepafenac|nepafenac|mesh-list
139627800|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139627801|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139627802|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139627803|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139627804|NCT03406689|Analgesics|analgesics|mesh-ancestor
139627805|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
139627806|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627807|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627808|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139627809|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627810|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139627811|NCT03591575|Deferiprone|deferiprone|mesh-list
139627812|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139627813|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
139627814|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
139627815|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627816|NCT03406533|Midazolam|midazolam|mesh-list
139627817|NCT03406533|Fentanyl|fentanyl|mesh-list
139627818|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
139627819|NCT03406533|Remifentanil|remifentanil|mesh-list
139627820|NCT03406533|Propofol|propofol|mesh-list
139627821|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139627822|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627823|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627824|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139627825|NCT03406533|Analgesics|analgesics|mesh-ancestor
139627826|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
139627827|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627828|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139627829|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139627830|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139627831|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
139627832|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627833|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627834|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139627835|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
139627836|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
139627837|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139627838|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139627839|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139627840|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139627841|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
139627842|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
139627843|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139627844|NCT03406533|Narcotics|narcotics|mesh-ancestor
139627845|NCT03591341|Melatonin|melatonin|mesh-list
139627846|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
139627847|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627848|NCT03591341|Protective Agents|protective agents|mesh-ancestor
139627849|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627850|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627851|NCT04377399|Vitamin D|vitamin d|mesh-list
139627852|NCT04377399|Vitamins|vitamins|mesh-ancestor
139627853|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
139627854|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627855|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139627856|NCT03400995|Ziresovir|ziresovir|mesh-list
139627857|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
139627858|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627859|NCT03590873|Vasopressins|vasopressins|mesh-list
139627860|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
139627861|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627862|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
139627863|NCT03590873|Coagulants|coagulants|mesh-ancestor
139627864|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139627865|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139627866|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
139627867|NCT02155335|Golimumab|golimumab|mesh-list
139627868|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139627869|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139627870|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139627871|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139627872|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
139627873|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627874|NCT05024526|Edaravone|edaravone|mesh-list
139627875|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139627876|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
139627877|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627878|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139627879|NCT05024526|Protective Agents|protective agents|mesh-ancestor
139627880|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627881|NCT03597035|Spironolactone|spironolactone|mesh-list
139627882|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139627883|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
139627884|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139627885|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627886|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139627887|NCT03597035|Diuretics|diuretics|mesh-ancestor
139627888|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
139627889|NCT03400683|Letrozole|letrozole|mesh-list
139627890|NCT03400683|Misoprostol|misoprostol|mesh-list
139627891|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627892|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139627893|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139627894|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627895|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627896|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139627897|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
139627898|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139627899|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627900|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139627901|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
139627902|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139627903|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139627904|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139627905|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
139627906|NCT05037240|Quercetin|quercetin|mesh-list
139627907|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
139627908|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627909|NCT05037240|Protective Agents|protective agents|mesh-ancestor
139627910|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627911|NCT05037006|Anesthetics|anesthetics|mesh-list
139627912|NCT05037006|Sevoflurane|sevoflurane|mesh-list
139627913|NCT05037006|Neostigmine|neostigmine|mesh-list
139627914|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627915|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627916|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139627917|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139627918|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
139627919|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139627920|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139627921|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627922|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
139627923|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627924|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139627925|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
139627926|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139627927|NCT03093090|Furosemide|furosemide|mesh-list
139627928|NCT03093090|Diuretics|diuretics|mesh-ancestor
139627929|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
139627930|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627931|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139627932|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139627933|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627934|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
139627935|NCT03093168|Fludarabine|fludarabine|mesh-list
139627936|NCT03093168|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
139627937|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139627938|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
139627939|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627940|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627941|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139627942|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
139627943|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627944|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627945|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139627946|NCT03093168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139627947|NCT04377321|Colchicine|colchicine|mesh-list
139627948|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
139627949|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627950|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
139627951|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
139627952|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
139627953|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627954|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139627955|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
139627956|NCT05018364|Hematinics|hematinics|mesh-ancestor
139627957|NCT03593213|Cariprazine|cariprazine|mesh-list
139627958|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139627959|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139627960|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627961|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627962|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139627963|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
139627964|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139627965|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
139627966|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139627967|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139627968|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627969|NCT03595163|Folic Acid|folic acid|mesh-list
139627970|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
139627971|NCT03595163|Propofol|propofol|mesh-list
139627972|NCT03595163|Sevoflurane|sevoflurane|mesh-list
139627973|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139627974|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139627975|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627976|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139627977|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
139627978|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
139627979|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139627980|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139627981|NCT03595163|Hematinics|hematinics|mesh-ancestor
139627982|NCT03595163|Vitamins|vitamins|mesh-ancestor
139627983|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
139627984|NCT03404115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139627985|NCT03404115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139627986|NCT04199819|Entecavir|entecavir|mesh-list
139627987|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
139627988|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139627989|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
139627990|NCT00918723|Rituximab|rituximab|mesh-list
139627991|NCT00918723|Fludarabine|fludarabine|mesh-list
139627992|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
139627993|NCT00918723|Vorinostat|vorinostat|mesh-list
139627994|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139627995|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
139627996|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139627997|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139627998|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139627999|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
139628000|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628001|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628002|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139628003|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139628004|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139628005|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
139628006|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139628007|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628008|NCT04192331|Paclitaxel|paclitaxel|mesh-list
139628009|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139628010|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139628011|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628012|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
139628013|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
139628014|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
139628015|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628016|NCT00919035|Temsirolimus|temsirolimus|mesh-list
139628017|NCT00919035|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139628018|NCT00919035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139628019|NCT00919035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628020|NCT00919035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628021|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139628022|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
139628023|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628024|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628025|NCT04374981|Celecoxib|celecoxib|mesh-list
139409746|NCT02320357|Clopidogrel|clopidogrel|mesh-list
139628026|NCT04374981|Montelukast|montelukast|mesh-list
139628027|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139628028|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139628029|NCT04374981|Analgesics|analgesics|mesh-ancestor
139628030|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
139628031|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628032|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628033|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139628034|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139628035|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139628036|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139628037|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628038|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628039|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139628040|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
139628041|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139628042|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
139628043|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139628044|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139628045|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139628046|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139628047|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
139628048|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139628049|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
139628050|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628051|NCT03090516|Donepezil|donepezil|mesh-list
139628052|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139628053|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628054|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628055|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
139628056|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628057|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628058|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
139628059|NCT04198571|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139628060|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139628061|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628062|NCT03092310|Pancrelipase|pancrelipase|mesh-list
139628063|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139628064|NCT03405207|Vitamin D|vitamin d|mesh-list
139628065|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
139628066|NCT03405207|Vitamins|vitamins|mesh-ancestor
139628067|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
139628068|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628069|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139628070|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139628071|NCT04197323|Alprostadil|alprostadil|mesh-list
139628072|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139628073|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
139628074|NCT04197323|Urological Agents|urological agents|mesh-ancestor
139628075|NCT04196855|Teriparatide|teriparatide|mesh-list
139628076|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139628077|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628078|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139628079|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
139628080|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139628081|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139628082|NCT04196309|Heparin|heparin|mesh-list
139628083|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139628084|NCT04196309|Tinzaparin|tinzaparin|mesh-list
139628085|NCT04196309|Dalteparin|dalteparin|mesh-list
139628086|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
139628087|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139628088|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139628089|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628090|NCT03090048|Vitamin A|vitamin a|mesh-list
139628091|NCT03090048|Azithromycin|azithromycin|mesh-list
139628092|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
139628093|NCT03090048|Vitamins|vitamins|mesh-ancestor
139628094|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
139628095|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628096|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139628097|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628098|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
138756603|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139628099|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409822|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628100|NCT03090048|Protective Agents|protective agents|mesh-ancestor
139628101|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139628102|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628103|NCT04195997|Heparin|heparin|mesh-list
139628104|NCT04195997|Bivalirudin|bivalirudin|mesh-list
139628105|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
139628106|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139628107|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139628108|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628109|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
139628110|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139628111|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
139628112|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628113|NCT05023122|Vitamin D|vitamin d|mesh-list
139628114|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
139628115|NCT05023122|Calcium|calcium|mesh-list
139628116|NCT05023122|Vitamins|vitamins|mesh-ancestor
139628117|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
139628118|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628119|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139628120|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139628121|NCT04195373|Flucytosine|flucytosine|mesh-list
139628122|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
139628123|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628124|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
139628125|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628126|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139628127|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139628128|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
139628129|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139628130|NCT04194905|Estradiol|estradiol|mesh-list
139628131|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139628132|NCT04194905|Estrogens|estrogens|mesh-ancestor
139628133|NCT04194905|Hormones|hormones|mesh-ancestor
139628134|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139628135|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628136|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139628137|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
139628138|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139628139|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139628140|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139628141|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139628142|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139628143|NCT05017428|Niacinamide|niacinamide|mesh-list
139628144|NCT05017428|Niacin|niacin|mesh-list
139628145|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
139628146|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
139628147|NCT05017428|Vitamins|vitamins|mesh-ancestor
139628148|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
139628149|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628150|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139628151|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
139628152|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628153|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139628154|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
139628155|NCT04196231|Insulin|insulin|mesh-list
139628156|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139628157|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139628158|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628159|NCT00013611|Aldesleukin|aldesleukin|mesh-list
139628160|NCT00013611|Interleukin-2|interleukin-2|mesh-list
139628161|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628162|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139628163|NCT00013611|Analgesics|analgesics|mesh-ancestor
139628164|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
139628165|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628166|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628167|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139628168|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139628169|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
139628170|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628171|NCT04194515|Metformin|metformin|mesh-list
139628172|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139628173|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628174|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139628175|NCT03094182|Hematinics|hematinics|mesh-ancestor
139628176|NCT05022030|Cetuximab|cetuximab|mesh-list
139628177|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139628178|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628179|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
139628180|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139628181|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139628182|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628184|NCT04192643|Coagulants|coagulants|mesh-ancestor
139628185|NCT00010257|Paclitaxel|paclitaxel|mesh-list
139628186|NCT00010257|Carboplatin|carboplatin|mesh-list
139628187|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139628188|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628189|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
139628190|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
139628191|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
139628192|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628193|NCT05022186|Cannabidiol|cannabidiol|mesh-list
139628194|NCT05022186|Tramiprosate|tramiprosate|mesh-list
139628195|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
139628196|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
139628197|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
139628198|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628199|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628200|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628201|NCT02240043|Hormones|hormones|mesh-list
139628202|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139628203|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628204|NCT03404037|Endostatins|endostatins|mesh-list
139628205|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628206|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139628207|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139628208|NCT03404037|Growth Substances|growth substances|mesh-ancestor
138756709|NCT02830243|Desflurane|desflurane|mesh-list
139628209|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628210|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
139628211|NCT02240199|Lidocaine|lidocaine|mesh-list
139628212|NCT02240199|Pregabalin|pregabalin|mesh-list
139628213|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
139628214|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
139628215|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139628216|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628217|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
139628218|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628219|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139628220|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139628221|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139628222|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139628223|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628224|NCT02240199|Analgesics|analgesics|mesh-ancestor
139628225|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
139628226|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139628227|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139628228|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139628229|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139628230|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139628231|NCT04190927|Estradiol|estradiol|mesh-list
139628232|NCT04190927|Progesterone|progesterone|mesh-list
139628233|NCT04190927|Estrogens|estrogens|mesh-ancestor
139628234|NCT04190927|Hormones|hormones|mesh-ancestor
139628235|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139628236|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628237|NCT04190927|Progestins|progestins|mesh-ancestor
139628238|NCT00919191|Adapalene|adapalene|mesh-list
139628239|NCT00919191|Tretinoin|tretinoin|mesh-list
139628240|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139628241|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
139628242|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139628243|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139628244|NCT00919191|Analgesics|analgesics|mesh-ancestor
139628245|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
139628246|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628247|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628248|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139628249|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139628250|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628251|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
139628252|NCT05021406|Carvedilol|carvedilol|mesh-list
139628253|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139628254|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139628255|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
139628256|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628257|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628258|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628259|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139628260|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
139628261|NCT05021406|Protective Agents|protective agents|mesh-ancestor
139628262|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139628263|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139628264|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139628265|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
139628266|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139628267|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139628268|NCT04766177|Bumetanide|bumetanide|mesh-list
139628269|NCT04766177|Diuretics|diuretics|mesh-ancestor
139628270|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
139628271|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628272|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139628273|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139628274|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628275|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
139628276|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
139628277|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139628278|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139628279|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628280|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628281|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628282|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139628283|NCT05016180|Ropivacaine|ropivacaine|mesh-list
139628284|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
139628285|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
139628286|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139628287|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628288|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
139628289|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628290|NCT03023501|Gabapentin|gabapentin|mesh-list
139628291|NCT03023501|Analgesics|analgesics|mesh-ancestor
139628292|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
139628293|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628294|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628295|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
139628296|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139628297|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139628298|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139628299|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139628300|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139628301|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139628302|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628303|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628304|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
139628305|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
139628306|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139628307|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139628308|NCT05015322|Prednisolone|prednisolone|mesh-list
139628309|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
139628310|NCT05015322|Bupivacaine|bupivacaine|mesh-list
139628311|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139628312|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
139628313|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
139628314|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
139628315|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139628316|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628317|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
139628318|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628319|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139628320|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
139628321|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
139628322|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139628323|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
139628324|NCT05015322|Hormones|hormones|mesh-ancestor
139628325|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139628326|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139628327|NCT05015322|Protective Agents|protective agents|mesh-ancestor
139628328|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139628329|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628330|NCT00919503|Cyclosporine|cyclosporine|mesh-list
139628331|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
139628332|NCT00919503|Methotrexate|methotrexate|mesh-list
139628333|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
139628334|NCT00919503|Fludarabine|fludarabine|mesh-list
139628335|NCT00919503|Treosulfan|treosulfan|mesh-list
139628336|NCT00919503|Busulfan|busulfan|mesh-list
139628337|NCT00919503|Tacrolimus|tacrolimus|mesh-list
139628338|NCT00919503|Cyclosporins|cyclosporins|mesh-list
139628339|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
139628340|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139628341|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139628342|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
139628343|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139628344|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628345|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139628346|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
139628347|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628348|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628349|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
139628350|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628351|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139628352|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139628353|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
139628354|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139628355|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139628356|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139628357|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
139628358|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628359|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139628360|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139628361|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
139628362|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139628363|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139628364|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
139628365|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139628366|NCT05020704|Empagliflozin|empagliflozin|mesh-list
139628367|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139628368|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628369|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139628370|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628371|NCT02979665|Ranibizumab|ranibizumab|mesh-list
139628372|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139628373|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139628374|NCT02979665|Growth Substances|growth substances|mesh-ancestor
139628375|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628376|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
139628377|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628378|NCT03092076|Ticagrelor|ticagrelor|mesh-list
139628379|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139628380|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139628381|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139628382|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139628383|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
139628384|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628385|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628386|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628387|NCT04193501|Melatonin|melatonin|mesh-list
139628388|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
139628389|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628390|NCT04193501|Protective Agents|protective agents|mesh-ancestor
139628391|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628392|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139628393|NCT04374279|Bicalutamide|bicalutamide|mesh-list
139628394|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
139628395|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
139628396|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139628397|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628398|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628399|NCT02240433|Sorafenib|sorafenib|mesh-list
139628400|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628401|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139628402|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628403|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628404|NCT03403647|Vitamin D|vitamin d|mesh-list
139628405|NCT03403647|Vitamins|vitamins|mesh-ancestor
139628406|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
139628407|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628408|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139628409|NCT05014464|Crizotinib|crizotinib|mesh-list
139628410|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628411|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139628412|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628413|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628414|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
139628415|NCT03403101|Irinotecan|irinotecan|mesh-list
139628416|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628417|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139628418|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139628419|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628420|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628421|NCT00211757|Valproic Acid|valproic acid|mesh-list
139628422|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
139628423|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628424|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628425|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
139628426|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628427|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628428|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
139628429|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139628430|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139628431|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139628432|NCT04373967|Metformin|metformin|mesh-list
139628433|NCT04373967|Liraglutide|liraglutide|mesh-list
139628434|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139628435|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628436|NCT04373967|Incretins|incretins|mesh-ancestor
139628437|NCT04373967|Hormones|hormones|mesh-ancestor
139628438|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139628439|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
139628440|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139628441|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
139628442|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628443|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
139628444|NCT04026191|Protective Agents|protective agents|mesh-ancestor
139628445|NCT04022057|Ropivacaine|ropivacaine|mesh-list
139628446|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
139628447|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
139628448|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139628449|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628450|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
139628451|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628452|NCT00921843|Methadone|methadone|mesh-list
139628453|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139628454|NCT00921843|Narcotics|narcotics|mesh-ancestor
139628455|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139628456|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628457|NCT00921843|Analgesics|analgesics|mesh-ancestor
139628458|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
139628459|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628460|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
139628461|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
139628462|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
139628463|NCT04020653|Lumefantrine|lumefantrine|mesh-list
139628464|NCT04020653|Artemether|artemether|mesh-list
139628465|NCT04020653|Artemisinins|artemisinins|mesh-list
139628466|NCT04020653|Artemisinin|artemisinin|mesh-list
139628467|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139628468|NCT04020653|Citric Acid|citric acid|mesh-list
139628469|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
139628470|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
139628471|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139628472|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
139628473|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
139628474|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628475|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
139628476|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139628477|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139628478|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628479|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139410192|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
139628480|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
139628481|NCT04020653|Trace Elements|trace elements|mesh-ancestor
139628482|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
139628483|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628485|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
139628486|NCT05008458|Coagulants|coagulants|mesh-ancestor
139628487|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139628488|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139628489|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
139628490|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628491|NCT02080637|Ambrisentan|ambrisentan|mesh-list
139628492|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139628493|NCT05019690|Paclitaxel|paclitaxel|mesh-list
139628494|NCT05019690|Apatinib|apatinib|mesh-list
139628495|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139628496|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139628497|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628498|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
139628499|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
139628500|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
139628501|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628502|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139628503|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628504|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
139628505|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139628506|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139628507|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628508|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139628509|NCT04029467|Analgesics|analgesics|mesh-ancestor
139628510|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
139628511|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756998|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
139628512|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139628513|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139628514|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139628515|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
139628516|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628517|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628518|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139628519|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
139628520|NCT03402321|Coagulants|coagulants|mesh-ancestor
139628521|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
139628522|NCT03402165|Ledipasvir|ledipasvir|mesh-list
139628523|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139628524|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
139628525|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628526|NCT03402087|Leucovorin|leucovorin|mesh-list
139628527|NCT03402087|Methotrexate|methotrexate|mesh-list
139628528|NCT03402087|Deucravacitinib|deucravacitinib|mesh-list
139628529|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139628530|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
139628531|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139628532|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628533|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139628534|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
139628535|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628536|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628537|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
139628538|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628539|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139628540|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139628541|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
139628542|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139628543|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139628544|NCT03402087|Antidotes|antidotes|mesh-ancestor
139628545|NCT03402087|Protective Agents|protective agents|mesh-ancestor
139628546|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
139628547|NCT03402087|Vitamins|vitamins|mesh-ancestor
139628548|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
139628549|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139628550|NCT04020263|Simendan|simendan|mesh-list
139628551|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139628552|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
139628553|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139628554|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139628555|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410268|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139628556|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628557|NCT04020263|Protective Agents|protective agents|mesh-ancestor
139628558|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628560|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
139628561|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
139628562|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628563|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628564|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628565|NCT05008068|Simvastatin|simvastatin|mesh-list
139628566|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139628567|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139628568|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
139628569|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628570|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139628571|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139628572|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628573|NCT00925119|Atenolol|atenolol|mesh-list
139628574|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139628575|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139628576|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
139628577|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
139628578|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628579|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628580|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139628581|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139628582|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139628583|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
139628584|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628585|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628586|NCT04020809|Atezolizumab|atezolizumab|mesh-list
139628587|NCT04020809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139628588|NCT04020809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628589|NCT04020809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139628590|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628591|NCT04027751|Tropisetron|tropisetron|mesh-list
139628592|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
139628593|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
139628594|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628595|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628596|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139628597|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139628598|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139628599|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
139628600|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628601|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628602|NCT05018988|Vitamin D|vitamin d|mesh-list
139628603|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
139628604|NCT05018988|Cholecalciferol|cholecalciferol|mesh-list
139628605|NCT05018988|Vitamins|vitamins|mesh-list
139628606|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
139628607|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628608|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139628609|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139628610|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
139628611|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139628612|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628613|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139628614|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139628615|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628616|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628617|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628618|NCT04434144|Azithromycin|azithromycin|mesh-list
139628619|NCT04434144|Doxycycline|doxycycline|mesh-list
139628620|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
139628621|NCT04434144|Ivermectin|ivermectin|mesh-list
139628622|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139628623|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628624|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
139628625|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139628626|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139628627|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628628|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628629|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139628630|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
139628631|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139628632|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628633|NCT04027283|Erythritol|erythritol|mesh-list
139628634|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
139628635|NCT04028141|Ketamine|ketamine|mesh-list
139628636|NCT04028141|Propofol|propofol|mesh-list
139628637|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139628638|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139628639|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628640|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139628641|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
139628642|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
139628643|NCT04028141|Analgesics|analgesics|mesh-ancestor
139628644|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
139628645|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628646|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139628647|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139628648|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139628649|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628650|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628651|NCT03401541|Vitamin D|vitamin d|mesh-list
139628652|NCT03401541|Calcifediol|calcifediol|mesh-list
139628653|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
139628654|NCT03401541|Vitamins|vitamins|mesh-ancestor
139628655|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
139628656|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628657|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139628658|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139628659|NCT03953261|Curcumin|curcumin|mesh-list
139628660|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139628661|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139628662|NCT03953261|Analgesics|analgesics|mesh-ancestor
139628663|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
139628664|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628665|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628666|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139628667|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139628668|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628669|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628670|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628671|NCT02242149|Diacerein|diacerein|mesh-list
139628672|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139628673|NCT03022565|Vorinostat|vorinostat|mesh-list
139628674|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628675|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139628676|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628677|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628678|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
139628679|NCT03079050|Lansoprazole|lansoprazole|mesh-list
139628680|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139628681|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139628682|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139628683|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628684|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628685|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
139628686|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139628687|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139628688|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628689|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139628690|NCT03834129|Analgesics|analgesics|mesh-ancestor
139628691|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
139628692|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628693|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139628694|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139628695|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139628696|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
139628697|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628698|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628699|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
139628700|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139628701|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628702|NCT03022409|Olaparib|olaparib|mesh-list
139628703|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139628704|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628705|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628706|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628707|NCT03833895|Phenylephrine|phenylephrine|mesh-list
139628708|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
139628709|NCT03833895|Norepinephrine|norepinephrine|mesh-list
139628710|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139628711|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
139628712|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
139628713|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628714|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628715|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
139628716|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139628717|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
139628718|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
139628719|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139628720|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139628721|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139628722|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
139628723|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628724|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628725|NCT03833895|Protective Agents|protective agents|mesh-ancestor
139628726|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139628727|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139628728|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
139628729|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628730|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628731|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139628732|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
139628733|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139628734|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139628735|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139628736|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
139628737|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628738|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628739|NCT05000892|Paclitaxel|paclitaxel|mesh-list
139628740|NCT05000892|Carboplatin|carboplatin|mesh-list
139628741|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139628742|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628743|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
139628744|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
139628745|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
139628746|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628747|NCT04372407|Itraconazole|itraconazole|mesh-list
139628748|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
139628749|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628750|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139628751|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139628752|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628753|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628754|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139628755|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
139628756|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139628757|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628758|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139628759|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139628760|NCT02242383|Telmisartan|telmisartan|mesh-list
139628761|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139628762|NCT02242383|Diuretics|diuretics|mesh-ancestor
139628763|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
139628764|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628765|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139628766|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139628767|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628768|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139628769|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139628770|NCT04366089|Azithromycin|azithromycin|mesh-list
139628771|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
139628772|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139628773|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628774|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
139628775|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139628776|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139628777|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628778|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628780|NCT03079830|Pirinitramide|pirinitramide|mesh-list
139628781|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139628782|NCT03079830|Narcotics|narcotics|mesh-ancestor
139628783|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139628784|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628785|NCT03079830|Analgesics|analgesics|mesh-ancestor
139628786|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
139628787|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628788|NCT02242695|Clotrimazole|clotrimazole|mesh-list
139628789|NCT02242695|Dequalinium|dequalinium|mesh-list
139628790|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139628791|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628792|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
139628793|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139628794|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139628795|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628796|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628797|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139628798|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
139628799|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139628800|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628801|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
139628802|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139628803|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628804|NCT04999800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139628805|NCT04999800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628806|NCT02242851|Telmisartan|telmisartan|mesh-list
139628807|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139628808|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139628809|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139628810|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628811|NCT04999878|Dexamethasone|dexamethasone|mesh-list
139628812|NCT04999878|Gemcitabine|gemcitabine|mesh-list
139628813|NCT04999878|Etoposide|etoposide|mesh-list
139628814|NCT04999878|Cisplatin|cisplatin|mesh-list
139628815|NCT04999878|Pegaspargase|pegaspargase|mesh-list
139628816|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139628817|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
139628818|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
139628819|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628820|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628821|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139628822|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
139628823|NCT04999878|Hormones|hormones|mesh-ancestor
139628824|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139628825|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139628826|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628827|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139628828|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
139628829|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628830|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139628831|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139628832|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139628833|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628834|NCT02242929|Imiquimod|imiquimod|mesh-list
139628835|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139628836|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
139628837|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628838|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628839|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
139628840|NCT04457856|Plonmarlimab|plonmarlimab|mesh-list
139628841|NCT04457856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139628842|NCT04457856|Antiviral Agents|antiviral agents|mesh-ancestor
139628843|NCT04457856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628844|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139628845|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
139628846|NCT05006898|Pilocarpine|pilocarpine|mesh-list
139628847|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139628848|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139628849|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139628850|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139628851|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
139628852|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628853|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628854|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628855|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
139628856|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
139628857|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628858|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
139628859|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139628860|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
139628862|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139628863|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139628864|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
139628865|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
139628866|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139628867|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139628868|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628869|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139628870|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139628871|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628872|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628873|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628874|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139628875|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
139628876|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139628877|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628878|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139628879|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139628880|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139628881|NCT04365309|Aspirin|aspirin|mesh-list
139628882|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139628883|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139628884|NCT04365309|Analgesics|analgesics|mesh-ancestor
139628885|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
139628886|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139628887|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628888|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139628889|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139628890|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139628891|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139628892|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628893|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139628894|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139628895|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628896|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
139628897|NCT02243553|Vitamin K|vitamin k|mesh-list
139628898|NCT02243553|Ritonavir|ritonavir|mesh-list
139628899|NCT02243553|Tipranavir|tipranavir|mesh-list
139628900|NCT02243553|Digoxin|digoxin|mesh-list
139628901|NCT02243553|Midazolam|midazolam|mesh-list
139628902|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
139628903|NCT02243553|Caffeine|caffeine|mesh-list
139628904|NCT02243553|Omeprazole|omeprazole|mesh-list
139628905|NCT02243553|Warfarin|warfarin|mesh-list
139628906|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139628907|NCT02243553|Vitamins|vitamins|mesh-ancestor
139628908|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
139628909|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628910|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139628911|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139628912|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139628913|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139628914|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139628915|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139628916|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139628917|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
139628918|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
139628919|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
139628920|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
139628921|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139628922|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628923|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139628924|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139628925|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
139628926|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628927|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139628928|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139628929|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
139628930|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139628931|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139628932|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139628933|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
139628934|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139628935|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139628936|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139628937|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139628938|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
139628939|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139628940|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139628941|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139628942|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139628943|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139628944|NCT02243553|Protective Agents|protective agents|mesh-ancestor
139628945|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139628946|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139628947|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
139628948|NCT02243553|Coagulants|coagulants|mesh-ancestor
139628949|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
139628950|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
139628951|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139628952|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139628953|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
139628954|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139628955|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
139628956|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139628957|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628958|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139628959|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139628960|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139628961|NCT05006664|Prednisone|prednisone|mesh-list
139628962|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
139628963|NCT05006664|Doxorubicin|doxorubicin|mesh-list
139628964|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139628965|NCT05006664|Etoposide|etoposide|mesh-list
139628966|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
139628967|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139628968|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139628969|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
139628970|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628971|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139628972|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139628973|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
139628974|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139628975|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628976|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139628977|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139628978|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139628979|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139628980|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139628981|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139628982|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
139628983|NCT05006664|Hormones|hormones|mesh-ancestor
139628984|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138757456|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
139628985|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139628986|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139628987|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139628988|NCT05006664|Immunotoxins|immunotoxins|mesh-ancestor
139628989|NCT05006664|Immunoconjugates|immunoconjugates|mesh-ancestor
139628990|NCT04346901|Methimazole|methimazole|mesh-list
139628991|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
139628992|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
139628993|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139628994|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139628995|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139628996|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139628997|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139628998|NCT02244021|Immunotoxins|immunotoxins|mesh-ancestor
139628999|NCT02244021|Immunoconjugates|immunoconjugates|mesh-ancestor
139629000|NCT02244021|Immunologic Factors|immunologic factors|mesh-ancestor
139629001|NCT02244021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629002|NCT04364451|Asparaginase|asparaginase|mesh-list
139629003|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410732|NCT01183949|Bortezomib|bortezomib|mesh-list
139629005|NCT02245269|Tipranavir|tipranavir|mesh-list
139629006|NCT02245269|Atorvastatin|atorvastatin|mesh-list
139629007|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139629008|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139629009|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
139629010|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629011|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139629012|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139629013|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629014|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139629015|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139629016|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
139629017|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139629018|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139629019|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
139629020|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629021|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139629022|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139629023|NCT04364139|Metoprolol|metoprolol|mesh-list
139629024|NCT04364139|Amlodipine|amlodipine|mesh-list
139629025|NCT04364139|Ramipril|ramipril|mesh-list
139629026|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139629027|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139629028|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139629029|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629030|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139629031|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629032|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
139629033|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139629034|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
139629035|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
139629036|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629037|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139629038|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139629039|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139629040|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
139629041|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629042|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139629043|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
139629044|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629045|NCT02244255|Tamsulosin|tamsulosin|mesh-list
139629046|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139629047|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139629048|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139629049|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
139629050|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629051|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629052|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629053|NCT02244255|Urological Agents|urological agents|mesh-ancestor
139629054|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
139629055|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
139629056|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139629057|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139629058|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629059|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629060|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629061|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139629062|NCT00923949|Pioglitazone|pioglitazone|mesh-list
139629063|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139629064|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629065|NCT04376541|Fentanyl|fentanyl|mesh-list
139629066|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139629067|NCT04376541|Narcotics|narcotics|mesh-ancestor
139629068|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629069|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629070|NCT04376541|Analgesics|analgesics|mesh-ancestor
139629071|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
139629072|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629073|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139629074|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139629075|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
139629076|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
139629077|NCT04376307|Anesthetics|anesthetics|mesh-list
139629078|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629079|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629080|NCT02244489|Capecitabine|capecitabine|mesh-list
139629081|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
139629082|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
139629083|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139629084|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
139629085|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629086|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629087|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139629088|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629089|NCT02244567|Metformin|metformin|mesh-list
139629090|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629091|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139629092|NCT04376073|Niraparib|niraparib|mesh-list
139629093|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139629094|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629095|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629096|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629097|NCT04999176|Enoxaparin|enoxaparin|mesh-list
139629098|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
139629099|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139629100|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
139629101|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139629102|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
139629103|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629104|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629105|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
139629106|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139629107|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139629108|NCT04363203|Azithromycin|azithromycin|mesh-list
139629109|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
139629110|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139629111|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629112|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
139629113|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139629114|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139629115|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629116|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629117|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139629118|NCT02244879|Resveratrol|resveratrol|mesh-list
139629119|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
139629120|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629121|NCT02244879|Protective Agents|protective agents|mesh-ancestor
139629122|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629123|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629124|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139629125|NCT04362735|Vedolizumab|vedolizumab|mesh-list
139629126|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139629127|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
139629128|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139629129|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
139629130|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629131|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629132|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139629133|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
139629134|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139629135|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
139629136|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629137|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629138|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139629139|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
139629140|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
139629141|NCT04375995|Protective Agents|protective agents|mesh-ancestor
139629142|NCT04365231|Azithromycin|azithromycin|mesh-list
139629143|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
139629144|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139629145|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629146|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
139629147|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139629148|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139629149|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629150|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629151|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139410873|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629152|NCT04993014|Trastuzumab|trastuzumab|mesh-list
139629153|NCT04993014|Pertuzumab|pertuzumab|mesh-list
139629154|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139629155|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629156|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
139629157|NCT05005494|Analgesics|analgesics|mesh-ancestor
139629158|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
139629159|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629160|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629161|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
139629162|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629163|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139629164|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
139629165|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139629166|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139629167|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629168|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139629169|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
139629170|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139629171|NCT04025567|Vancomycin|vancomycin|mesh-list
139629172|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139629173|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629174|NCT03074994|Anesthetics|anesthetics|mesh-list
139629175|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
139629176|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629177|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629178|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
139629179|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629180|NCT04025177|Indomethacin|indomethacin|mesh-list
139629181|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139629182|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139629183|NCT04025177|Analgesics|analgesics|mesh-ancestor
139629184|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
139629185|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629186|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629187|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139629188|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139629189|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
139629190|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
139629191|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139629192|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139629193|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629194|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629195|NCT02985281|Ribavirin|ribavirin|mesh-list
139629196|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
139629197|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
139629198|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629199|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
139629200|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629201|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
139629202|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
139629203|NCT00927849|Glycerol|glycerol|mesh-list
139629204|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139629205|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139629206|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629207|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
139629208|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629209|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629210|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139629211|NCT00927849|Protective Agents|protective agents|mesh-ancestor
139629212|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
139629213|NCT04149587|Brodalumab|brodalumab|mesh-list
139629214|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
139629215|NCT02985125|Everolimus|everolimus|mesh-list
139629216|NCT02985125|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139629217|NCT02985125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139629218|NCT02985125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629219|NCT02985125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629220|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139629221|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
139629222|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629223|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629224|NCT04912596|Albuterol|albuterol|mesh-list
139629225|NCT04912596|Procaterol|procaterol|mesh-list
139629226|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
139629227|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139629228|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
139629229|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629230|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629231|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139629232|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
139629233|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
139629234|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139629235|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139629236|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139629237|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139629238|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
139629239|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629240|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629242|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139629243|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139629244|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139629245|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139629246|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
139629247|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
139629248|NCT00936741|Mifepristone|mifepristone|mesh-list
139629249|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139629250|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
139629251|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139629252|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629253|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139629254|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139629255|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139629256|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
139629257|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139629258|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139629259|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
139629260|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139629261|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
139629262|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139629263|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139629264|NCT04024865|Domperidone|domperidone|mesh-list
139629265|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
139629266|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
139629267|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629268|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629269|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139629270|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139629271|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
139629272|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629273|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629274|NCT04024241|Cytarabine|cytarabine|mesh-list
139629275|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
139629276|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139629277|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
139629278|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629279|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629280|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
139629281|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629282|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139629283|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
139629284|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629285|NCT04024241|Analgesics|analgesics|mesh-ancestor
139629286|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
139629287|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629288|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139629289|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139629290|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629291|NCT04996290|Ropivacaine|ropivacaine|mesh-list
139629292|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
139629293|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
139629294|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629295|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629296|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
139629297|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629298|NCT04023617|Docetaxel|docetaxel|mesh-list
139629299|NCT04023617|Nivolumab|nivolumab|mesh-list
139629300|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629301|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
139411041|NCT05414084|Phenol|phenol|mesh-list
139629302|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
139629303|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
139629304|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629305|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139629306|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139629307|NCT04023149|Aldesleukin|aldesleukin|mesh-list
139629308|NCT04023149|Interleukin-2|interleukin-2|mesh-list
139629309|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629310|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139629311|NCT04023149|Analgesics|analgesics|mesh-ancestor
139629312|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
139629313|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629314|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629315|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139629316|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139629317|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
139629318|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629319|NCT04149275|Nivolumab|nivolumab|mesh-list
139629320|NCT04149275|Ipilimumab|ipilimumab|mesh-list
139629321|NCT04149275|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139629322|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139629323|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629324|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139629325|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629326|NCT04149275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139629327|NCT04149275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629328|NCT04148963|Loxapine|loxapine|mesh-list
139629329|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139629330|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139629331|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629332|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629333|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139629334|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139629335|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
139629336|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629337|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629338|NCT04022837|Pantoprazole|pantoprazole|mesh-list
139629339|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139629340|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139629341|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139629342|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629343|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629344|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
139629345|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139629346|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139629347|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629348|NCT04148885|Paclitaxel|paclitaxel|mesh-list
139629349|NCT04148885|Carboplatin|carboplatin|mesh-list
139629350|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139629351|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629352|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
139629353|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
139629354|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
139629355|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629356|NCT04022525|Leflunomide|leflunomide|mesh-list
139629357|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629358|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629359|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139629360|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
139629361|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629362|NCT04022291|Insulin|insulin|mesh-list
139629363|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139629364|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139629365|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629366|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
139629367|NCT03074448|Cathartics|cathartics|mesh-ancestor
139629368|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139629369|NCT04021433|Ketamine|ketamine|mesh-list
139629370|NCT04021433|Analgesics|analgesics|mesh-ancestor
139629371|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
139629372|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629373|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629374|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139629375|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139629376|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
139629377|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
139629378|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629379|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139629380|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139629381|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629382|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629383|NCT04147481|Anesthetics|anesthetics|mesh-list
139629384|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
139629385|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629386|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629387|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
139629388|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629389|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
139629390|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139629391|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139629392|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139629393|NCT04148261|Epinephrine|epinephrine|mesh-list
139629394|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139629395|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139629396|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
139629397|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629398|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629399|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629400|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139629401|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139629402|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
139629403|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629404|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139629405|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
139629406|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
139629407|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
139629408|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139629409|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139629410|NCT03072264|Fluoxetine|fluoxetine|mesh-list
139629411|NCT03072264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139629412|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139629413|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139629414|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629415|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629416|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
139629417|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629418|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139629419|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
139629420|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139629421|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139629422|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139629423|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629424|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
139629425|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
139629426|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139629427|NCT04991064|Protective Agents|protective agents|mesh-ancestor
139629428|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629429|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
139629430|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139629431|NCT00928083|Artefenomel|artefenomel|mesh-list
139629432|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
139629433|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139629434|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139629435|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629436|NCT04996446|Tislelizumab|tislelizumab|mesh-list
139629437|NCT04996446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139629438|NCT04996446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629439|NCT04361721|Erenumab|erenumab|mesh-list
139629440|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139629441|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629442|NCT04361721|Analgesics|analgesics|mesh-ancestor
139629443|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
139629444|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629445|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629446|NCT04361643|Lenalidomide|lenalidomide|mesh-list
139629447|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
139629448|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629449|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139629450|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139629451|NCT04361643|Growth Substances|growth substances|mesh-ancestor
139629452|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
139629453|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629455|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139629456|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139629457|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
139629458|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629459|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629460|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629461|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
139629462|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
139629463|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629464|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139629465|NCT04991298|Midazolam|midazolam|mesh-list
139629466|NCT04991298|Fentanyl|fentanyl|mesh-list
139629467|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139629468|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139629469|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629470|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629471|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139629472|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139629473|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139629474|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139629475|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
139629476|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
139629477|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
139629478|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
139629479|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629480|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629481|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139629482|NCT04991298|Narcotics|narcotics|mesh-ancestor
139629483|NCT04991298|Analgesics|analgesics|mesh-ancestor
139629484|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
139629485|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629486|NCT04361175|Letrozole|letrozole|mesh-list
139629487|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629488|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629489|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139629490|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139629491|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629492|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139629493|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
139629494|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139629495|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629496|NCT04368819|Allopurinol|allopurinol|mesh-list
139629497|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
139629498|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629499|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629500|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
139629501|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139629502|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139629503|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
139629504|NCT04368819|Protective Agents|protective agents|mesh-ancestor
139629505|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629506|NCT04368585|Simethicone|simethicone|mesh-list
139629507|NCT04368585|Omeprazole|omeprazole|mesh-list
139629508|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139629509|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139629510|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
139629511|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
139629512|NCT04368585|TEMPO|tempo|mesh-list
139629513|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139629514|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139629515|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139629516|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629517|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629518|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
139629519|NCT04368585|Emollients|emollients|mesh-ancestor
139629520|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
139629521|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139629522|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
139629523|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629524|NCT04368585|Antacids|antacids|mesh-ancestor
139629525|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
139629526|NCT04368585|Protective Agents|protective agents|mesh-ancestor
139629527|NCT04361331|Lenvatinib|lenvatinib|mesh-list
139629528|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629529|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139629530|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629531|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629532|NCT04990830|Heparin|heparin|mesh-list
139629533|NCT04990830|Enoxaparin|enoxaparin|mesh-list
139629534|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139629535|NCT04990830|Tinzaparin|tinzaparin|mesh-list
139629536|NCT04990830|Dalteparin|dalteparin|mesh-list
139629537|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
139629538|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
139629539|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139629540|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139629541|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629542|NCT04361409|Rituximab|rituximab|mesh-list
139629543|NCT04361409|Gemcitabine|gemcitabine|mesh-list
139629544|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139629545|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629546|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
139629547|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629548|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139629549|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139629550|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
139629551|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629552|NCT04368273|Antibodies|antibodies|mesh-list
139629553|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
139629554|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629555|NCT04995354|Mitogens|mitogens|mesh-list
139629556|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
139629557|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629558|NCT04368351|Azithromycin|azithromycin|mesh-list
139629559|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
139629560|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139629561|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629562|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
139629563|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139629564|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139629565|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629566|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629567|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139629568|NCT04360317|Docetaxel|docetaxel|mesh-list
139629569|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629570|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
139629571|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
139629572|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
139629573|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629574|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139629575|NCT03074136|Eusol|eusol|mesh-list
139629576|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
139629577|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629578|NCT04146155|Liraglutide|liraglutide|mesh-list
139629579|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139629580|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629581|NCT04146155|Incretins|incretins|mesh-ancestor
139629582|NCT04146155|Hormones|hormones|mesh-ancestor
139629583|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139629584|NCT04990752|Urinastatin|urinastatin|mesh-list
139629585|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139629586|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139629587|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
139629588|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629589|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629590|NCT02245191|Phenylephrine|phenylephrine|mesh-list
139629591|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
139629592|NCT02245191|Ephedrine|ephedrine|mesh-list
139629593|NCT02245191|Metaraminol|metaraminol|mesh-list
139629594|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139629595|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
139629596|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
139629597|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629598|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629599|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
139629600|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139629601|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
139629602|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
139629603|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139629604|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139629605|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139629606|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
139629607|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629608|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629609|NCT02245191|Protective Agents|protective agents|mesh-ancestor
139629610|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139629612|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139629613|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629614|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629615|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
139629616|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629617|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629618|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139629619|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
139629620|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629621|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
139629622|NCT04145687|Metformin|metformin|mesh-list
139629623|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139629624|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629625|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
139629626|NCT04359615|Favipiravir|favipiravir|mesh-list
139629627|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
139629628|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139629629|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139629630|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629631|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758120|NCT02805049|Micafungin|micafungin|mesh-list
139629632|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629633|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139629634|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
139629635|NCT02635386|Metformin|metformin|mesh-list
139629636|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
139629637|NCT02635386|Exenatide|exenatide|mesh-list
139629638|NCT02635386|Topiramate|topiramate|mesh-list
139629639|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139629640|NCT02635386|Phentermine|phentermine|mesh-list
139629641|NCT02635386|Glucagon|glucagon|mesh-list
139629642|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139629643|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139629644|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629645|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629646|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139629647|NCT02635386|Incretins|incretins|mesh-ancestor
139629648|NCT02635386|Hormones|hormones|mesh-ancestor
139629649|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139629650|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
139629651|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139629652|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139629653|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
139629654|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
139629655|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
139629656|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629657|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
139629658|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629659|NCT00934635|Risperidone|risperidone|mesh-list
139629660|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139629661|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139629662|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
139629663|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629664|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629665|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629666|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139629667|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139629668|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629669|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139629670|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139629671|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
139629672|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139629673|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139629674|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
139629675|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
139629676|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139629677|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139629678|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629679|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629680|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629681|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139629682|NCT03922997|Atezolizumab|atezolizumab|mesh-list
139629683|NCT03922997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139629684|NCT03922997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629685|NCT03922997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139629686|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629687|NCT04356417|Antimalarials|antimalarials|mesh-list
139629688|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139629689|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139629690|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629691|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139629692|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139629693|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629694|NCT04355949|Vitamin D|vitamin d|mesh-list
139629695|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
139629696|NCT04355949|Cholecalciferol|cholecalciferol|mesh-list
139629697|NCT04355949|Vitamins|vitamins|mesh-list
139629698|NCT04355949|Folic Acid|folic acid|mesh-list
139629699|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
139629700|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
139629701|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
139629702|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
139629703|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629704|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139629705|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139629706|NCT04355949|Hematinics|hematinics|mesh-ancestor
139629707|NCT05580887|Paclitaxel|paclitaxel|mesh-list
139629708|NCT05580887|Cyclophosphamide|cyclophosphamide|mesh-list
139629709|NCT05580887|Carboplatin|carboplatin|mesh-list
139629710|NCT05580887|Doxorubicin|doxorubicin|mesh-list
139629711|NCT05580887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139629712|NCT05580887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629713|NCT05580887|Tubulin Modulators|tubulin modulators|mesh-ancestor
139629714|NCT05580887|Antimitotic Agents|antimitotic agents|mesh-ancestor
139629715|NCT05580887|Mitosis Modulators|mitosis modulators|mesh-ancestor
139629716|NCT05580887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629717|NCT05580887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139629718|NCT05580887|Immunologic Factors|immunologic factors|mesh-ancestor
139629719|NCT05580887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629720|NCT05580887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139629721|NCT05580887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139629722|NCT05580887|Alkylating Agents|alkylating agents|mesh-ancestor
139629723|NCT05580887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139629724|NCT05580887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139629725|NCT05580887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139629726|NCT05580887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139629727|NCT05580887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629728|NCT04994262|Menthol|menthol|mesh-list
139629729|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
139629730|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
139629731|NCT00939159|Panobinostat|panobinostat|mesh-list
139629732|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629733|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139629734|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629735|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629736|NCT04144439|Butyric Acid|butyric acid|mesh-list
139629737|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
139629738|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
139629739|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629740|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629741|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629742|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
139629743|NCT04994574|Olodaterol|olodaterol|mesh-list
139629744|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139629745|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
139629746|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629747|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629748|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139629749|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
139629750|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
139629751|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139629752|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
139629753|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629754|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629755|NCT04355637|Budesonide|budesonide|mesh-list
139629756|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139629757|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139629758|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
139629759|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629760|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629761|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139629762|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
139629763|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
139629764|NCT04355637|Hormones|hormones|mesh-ancestor
139629765|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139629766|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
139629767|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629768|NCT03076710|Bupivacaine|bupivacaine|mesh-list
139629769|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
139629770|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
139629771|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629772|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629773|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
139629774|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629775|NCT04143581|Empagliflozin|empagliflozin|mesh-list
139629776|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139629777|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629778|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139629779|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629780|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139629781|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139629782|NCT03071172|Progesterone|progesterone|mesh-list
139629783|NCT03071172|Hormones|hormones|mesh-ancestor
139629784|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139629785|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629786|NCT03071172|Progestins|progestins|mesh-ancestor
139629787|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
139629788|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139629789|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
139629790|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139629791|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139629792|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139629793|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629794|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
139629795|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139629796|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
139629797|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139629798|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139629799|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139629800|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139629801|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629802|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
139629803|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629804|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629805|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139629806|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629807|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
139629808|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139629809|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139629810|NCT04355247|Prednisolone|prednisolone|mesh-list
139629811|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
139629812|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139629813|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
139629814|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139629815|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
139629816|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
139629817|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629818|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629819|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139629820|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
139629821|NCT04355247|Hormones|hormones|mesh-ancestor
139629822|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139629823|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139629824|NCT04355247|Protective Agents|protective agents|mesh-ancestor
139629825|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139629826|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629827|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
139629828|NCT03903809|Hematinics|hematinics|mesh-ancestor
139629829|NCT04987554|Immunoferon|immunoferon|mesh-list
139629830|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139629831|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
139629832|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629833|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
139629834|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139629835|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629836|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629837|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139629839|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
139629840|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629841|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139629842|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139629843|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139629844|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
139629845|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629846|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629847|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
139629848|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
139629849|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629850|NCT03917303|Adalimumab|adalimumab|mesh-list
139629851|NCT03917303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139629852|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139629853|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139629854|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139629855|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139629856|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629857|NCT05583149|Cyclophosphamide|cyclophosphamide|mesh-list
139629858|NCT05583149|Fludarabine|fludarabine|mesh-list
139629859|NCT05583149|Acalabrutinib|acalabrutinib|mesh-list
139629860|NCT05583149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139629861|NCT05583149|Immunologic Factors|immunologic factors|mesh-ancestor
139629862|NCT05583149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629863|NCT05583149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139629864|NCT05583149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139629865|NCT05583149|Alkylating Agents|alkylating agents|mesh-ancestor
139629866|NCT05583149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629867|NCT05583149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629868|NCT05583149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139629869|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
139629870|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629871|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
139629872|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
139629873|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
139629874|NCT04989270|Anesthetics|anesthetics|mesh-list
139629875|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629876|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629877|NCT04346823|Sevoflurane|sevoflurane|mesh-list
139629878|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139629879|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139629880|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
139629881|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
139629882|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629883|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629884|NCT05582837|Topiramate|topiramate|mesh-list
139629885|NCT05582837|Nortriptyline|nortriptyline|mesh-list
139629886|NCT05582837|Anticonvulsants|anticonvulsants|mesh-ancestor
139629887|NCT05582837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139629888|NCT05582837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629889|NCT05582837|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139629890|NCT05582837|Antidepressive Agents|antidepressive agents|mesh-ancestor
139629891|NCT05582837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139629892|NCT05582837|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138758380|NCT02792335|Dabigatran|dabigatran|mesh-list
139629893|NCT05582837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139629894|NCT05582837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139629895|NCT05582837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629896|NCT05582837|Adrenergic Agents|adrenergic agents|mesh-ancestor
139629897|NCT05582837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629898|NCT05003700|Lenvatinib|lenvatinib|mesh-list
139629899|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629900|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139629901|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629902|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629903|NCT04143191|Sorafenib|sorafenib|mesh-list
139629904|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629905|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139629906|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629907|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629908|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139629909|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139629910|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629912|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139629913|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
139629914|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629915|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629916|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139629917|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139629918|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
139629919|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629920|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629921|NCT05582135|Morphine|morphine|mesh-list
139629922|NCT05582135|Esketamine|esketamine|mesh-list
139629923|NCT05582135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139629924|NCT05582135|Narcotics|narcotics|mesh-ancestor
139629925|NCT05582135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139629926|NCT05582135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629927|NCT05582135|Analgesics|analgesics|mesh-ancestor
139629928|NCT05582135|Sensory System Agents|sensory system agents|mesh-ancestor
139629929|NCT05582135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139629930|NCT05582135|Antidepressive Agents|antidepressive agents|mesh-ancestor
139629931|NCT05582135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139629932|NCT03070704|Liraglutide|liraglutide|mesh-list
139629933|NCT03070704|Xultophy|xultophy|mesh-list
139629934|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139629935|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629936|NCT03070704|Incretins|incretins|mesh-ancestor
139629937|NCT03070704|Hormones|hormones|mesh-ancestor
139629938|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139629939|NCT03069768|Varenicline|varenicline|mesh-list
139629940|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139629941|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139629942|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
139629943|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139629944|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629945|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629946|NCT04141553|Diltiazem|diltiazem|mesh-list
139629947|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139629948|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139629949|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139629950|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629951|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139629952|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629953|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
139629954|NCT04141163|Metformin|metformin|mesh-list
139629955|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139629956|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629957|NCT00942825|Cisplatin|cisplatin|mesh-list
139629958|NCT00942825|Pemetrexed|pemetrexed|mesh-list
139629959|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629960|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629961|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629962|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139629963|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139629964|NCT04544943|Gentamicins|gentamicins|mesh-list
139629965|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139629966|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629967|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139629968|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629969|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629970|NCT04140461|Amphotericin B|amphotericin b|mesh-list
139629971|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139629972|NCT04140461|Flucytosine|flucytosine|mesh-list
139629973|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139629974|NCT04140461|Amebicides|amebicides|mesh-ancestor
139629975|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139629976|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139629977|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139629978|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
139629979|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
139629980|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629981|NCT03021629|Vitamin D|vitamin d|mesh-list
139411712|NCT00905567|Topiramate|topiramate|mesh-list
139629982|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
139629983|NCT03021629|Vitamins|vitamins|mesh-ancestor
139629984|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
139629985|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629986|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139629987|NCT03021395|Decitabine|decitabine|mesh-list
139629988|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139629989|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
139629990|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139629991|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629992|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139629993|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139629994|NCT03021317|Hormones|hormones|mesh-ancestor
139629995|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139629996|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139629997|NCT04987632|Letrozole|letrozole|mesh-list
139629998|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139629999|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139630000|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139630001|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630002|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630003|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139630004|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
139630005|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139630006|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630007|NCT03032367|Bedaquiline|bedaquiline|mesh-list
139630008|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
139630009|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139630010|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630011|NCT02634606|Tocotrienols|tocotrienols|mesh-list
139630012|NCT02634606|Vitamin E|vitamin e|mesh-list
139630013|NCT02634606|Tocopherols|tocopherols|mesh-list
139630014|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
139630015|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630016|NCT02634606|Protective Agents|protective agents|mesh-ancestor
139630017|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630018|NCT02634606|Vitamins|vitamins|mesh-ancestor
139630019|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
139630020|NCT05002686|Paclitaxel|paclitaxel|mesh-list
139630021|NCT05002686|Capecitabine|capecitabine|mesh-list
139630022|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
139630023|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139630024|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630025|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
139630026|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
139630027|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
139630028|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630029|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139630030|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
139630031|NCT03588689|Ropivacaine|ropivacaine|mesh-list
139630032|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
139630033|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
139630034|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139630035|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630036|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
139630037|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630038|NCT04985526|Octenidine|octenidine|mesh-list
139630039|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630040|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139630041|NCT03588611|Hirudins|hirudins|mesh-list
139630042|NCT03588611|Bivalirudin|bivalirudin|mesh-list
139630043|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
139630044|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139630045|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
139630046|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630047|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630048|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
139630049|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139630050|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139630051|NCT03588533|Capecitabine|capecitabine|mesh-list
139630052|NCT03588533|Trastuzumab|trastuzumab|mesh-list
139630053|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630054|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139630055|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
139630056|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630057|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139630058|NCT00939705|Topiramate|topiramate|mesh-list
139630059|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
139630060|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139630061|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630062|NCT05001672|Tenofovir|tenofovir|mesh-list
139630063|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
139630064|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630065|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139630066|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139630067|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630068|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630069|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139630070|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139630071|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139630072|NCT04354545|Lifitegrast|lifitegrast|mesh-list
139630073|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139630074|NCT03587285|Goserelin|goserelin|mesh-list
139630075|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
139630076|NCT03587285|Bicalutamide|bicalutamide|mesh-list
139630077|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139630078|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630079|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139630080|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630081|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630082|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
138758572|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139630083|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139630084|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630085|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139630086|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
139630087|NCT03587129|Apatinib|apatinib|mesh-list
139630088|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630089|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139630090|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630091|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630092|NCT02245503|Tamsulosin|tamsulosin|mesh-list
139630093|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139630094|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139630095|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139630096|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
139630097|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630098|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630099|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630100|NCT02245503|Urological Agents|urological agents|mesh-ancestor
139630101|NCT03586817|Palonosetron|palonosetron|mesh-list
139630102|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
139630103|NCT03586817|Aprepitant|aprepitant|mesh-list
139630104|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
139630105|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
139630106|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630107|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630108|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139630109|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139630110|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139630111|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
139630112|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630113|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630114|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139630115|NCT03891173|Vinorelbine|vinorelbine|mesh-list
139630116|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630117|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139630118|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
139630119|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
139630120|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
139630121|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630122|NCT03585725|Ribavirin|ribavirin|mesh-list
139630123|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
139630124|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630125|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
139630126|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630127|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139630128|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139630129|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139630130|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139630131|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630133|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630134|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630135|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139630136|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630137|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
139630138|NCT03585179|Hydroquinone|hydroquinone|mesh-list
139630139|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139630140|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139630141|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630142|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
139630143|NCT03585179|Coagulants|coagulants|mesh-ancestor
139630144|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
139630145|NCT03585179|Protective Agents|protective agents|mesh-ancestor
139630146|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630147|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139630148|NCT03585101|Grazoprevir|grazoprevir|mesh-list
139630149|NCT03585101|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139630150|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
139630151|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630152|NCT03584087|Terlipressin|terlipressin|mesh-list
139630153|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139630154|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139630155|NCT03031353|Misoprostol|misoprostol|mesh-list
139630156|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139630157|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
139630158|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139630159|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630160|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139630161|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139630162|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
139630163|NCT05702957|Letrozole|letrozole|mesh-list
139630164|NCT05702957|Clomiphene|clomiphene|mesh-list
139630165|NCT05702957|Enclomiphene|enclomiphene|mesh-list
139630166|NCT05702957|Zuclomiphene|zuclomiphene|mesh-list
139630167|NCT05702957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630168|NCT05702957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630169|NCT05702957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139630170|NCT05702957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139630171|NCT05702957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630172|NCT05702957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139630173|NCT05702957|Hormone Antagonists|hormone antagonists|mesh-ancestor
139630174|NCT05702957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139630175|NCT05702957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630176|NCT05702957|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139630177|NCT05702957|Fertility Agents|fertility agents|mesh-ancestor
139630178|NCT05702957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139630179|NCT05702957|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139630180|NCT05702957|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139630181|NCT04405505|Paclitaxel|paclitaxel|mesh-list
139630182|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139630183|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630184|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
139630185|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
139630186|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
139630187|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630188|NCT03580733|Caspofungin|caspofungin|mesh-list
139630189|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
139630190|NCT03580733|Clotrimazole|clotrimazole|mesh-list
139630191|NCT03580733|Miconazole|miconazole|mesh-list
139630192|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630193|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630194|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630195|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139630196|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139630197|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139630198|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139630199|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
139630200|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139630201|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630202|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139630203|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139630204|NCT05581979|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139630205|NCT05581979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139630206|NCT05581979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630208|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139630209|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139630210|NCT00951561|Analgesics|analgesics|mesh-ancestor
139630211|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
139630212|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630213|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630214|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139630215|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139630216|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139630217|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630218|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630219|NCT03031119|Atorvastatin|atorvastatin|mesh-list
139630220|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139630221|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139630222|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
139630223|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630224|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139630225|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139630226|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630227|NCT03581903|Vaccines|vaccines|mesh-list
139630228|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
139630229|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630230|NCT02783547|Azacitidine|azacitidine|mesh-list
139630231|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139630232|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
139630233|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630234|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630235|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630236|NCT02555007|Vinorelbine|vinorelbine|mesh-list
139630237|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139630238|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630239|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
139630240|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
139630241|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
139630242|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630243|NCT03898037|Metformin|metformin|mesh-list
139630244|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139630245|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630246|NCT03068208|Methylene Blue|methylene blue|mesh-list
139630247|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630248|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630249|NCT03067974|Ketamine|ketamine|mesh-list
139630250|NCT03067974|Analgesics|analgesics|mesh-ancestor
139630251|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
139630252|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630253|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630254|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139630255|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139630256|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
139630257|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
139630258|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139630259|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139630260|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139630261|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630262|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630263|NCT03582137|Cannabidiol|cannabidiol|mesh-list
139630264|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
139630265|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
139630266|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139630267|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
139630268|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630269|NCT04405193|Expectorants|expectorants|mesh-ancestor
139630270|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
139630271|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139630272|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
139630273|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630274|NCT04405193|Protective Agents|protective agents|mesh-ancestor
139630275|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630276|NCT04405193|Antidotes|antidotes|mesh-ancestor
139630277|NCT05227833|Pantoprazole|pantoprazole|mesh-list
139630278|NCT05227833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139630279|NCT05227833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139630280|NCT05227833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139630281|NCT05227833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630282|NCT05227833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630283|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
139630284|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139630285|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139630286|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630287|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139630288|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139630289|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
139630290|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630291|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630292|NCT05701475|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139630293|NCT05701475|Dermatologic Agents|dermatologic agents|mesh-ancestor
139630294|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139630295|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
139630296|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630297|NCT04405271|Tenofovir|tenofovir|mesh-list
139630298|NCT04405271|Emtricitabine|emtricitabine|mesh-list
139630299|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139630300|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
139630301|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630302|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139630303|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139630304|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630305|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630306|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139630307|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139630308|NCT03034941|Metformin|metformin|mesh-list
139630309|NCT03034941|Liraglutide|liraglutide|mesh-list
139630310|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139630311|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630312|NCT03034941|Incretins|incretins|mesh-ancestor
139630313|NCT03034941|Hormones|hormones|mesh-ancestor
138758801|NCT05340985|Vitamin D|vitamin d|mesh-list
139630314|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139630315|NCT03030105|Scopolamine|scopolamine|mesh-list
139630316|NCT03030105|Donepezil|donepezil|mesh-list
139630317|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139630318|NCT03030105|BPN14770|bpn14770|mesh-list
139630319|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139630320|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630321|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630322|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
139630323|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630324|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630325|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
139630326|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139630327|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
139630328|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
139630329|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630330|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139630331|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
139630332|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139630333|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139630334|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
139630335|NCT03030105|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139630336|NCT03030105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139630337|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
139630338|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
139630339|NCT03067896|Bupivacaine|bupivacaine|mesh-list
139630340|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
139630341|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
139630342|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139630343|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630344|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
139630345|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630346|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139630347|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139630348|NCT03067896|Analgesics|analgesics|mesh-ancestor
139630349|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139630350|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139630351|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139630352|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
139630353|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630354|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630355|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139630356|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
139630357|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139630358|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139630359|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139630360|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
139630361|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139630362|NCT03034707|Biotin|biotin|mesh-list
139630363|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
139630364|NCT03034707|Vitamins|vitamins|mesh-ancestor
139630365|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
139630366|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630367|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
139630368|NCT03067740|Bupivacaine|bupivacaine|mesh-list
139630369|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
139630370|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
139630371|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139630372|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630373|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
139630374|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630375|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139630376|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139630377|NCT03067740|Analgesics|analgesics|mesh-ancestor
139630378|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139630379|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139630380|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139630381|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
139630382|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630383|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630384|NCT05730114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139630385|NCT03027843|Hormones|hormones|mesh-list
139630386|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139630387|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630388|NCT03068832|Poly I-C|poly i-c|mesh-list
139630389|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139630390|NCT03068832|Poly ICLC|poly iclc|mesh-list
139630391|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
139630392|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
139630393|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630394|NCT03068832|Laxatives|laxatives|mesh-ancestor
139630395|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139630396|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
139630397|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630398|NCT04801797|Cytarabine|cytarabine|mesh-list
139630399|NCT04801797|Azacitidine|azacitidine|mesh-list
139630400|NCT04801797|Daunorubicin|daunorubicin|mesh-list
139630401|NCT04801797|Venetoclax|venetoclax|mesh-list
139630402|NCT04801797|Idarubicin|idarubicin|mesh-list
139630403|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139630404|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
139630405|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630406|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630407|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
139630408|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630409|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139630410|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
139630411|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630412|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630413|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139630414|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139630415|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139630416|NCT03033537|Verapamil|verapamil|mesh-list
139630417|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
139630418|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139630419|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630420|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139630421|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139630422|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630423|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
138758934|NCT02779387|Goserelin|goserelin|mesh-list
139630424|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
139630425|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139630426|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630427|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139630428|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139630429|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630430|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412144|NCT00857285|Losartan|losartan|mesh-list
139630431|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630432|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139630433|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139630434|NCT03069144|Calcitriol|calcitriol|mesh-list
139630435|NCT03069144|Calcipotriene|calcipotriene|mesh-list
139630436|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
139630437|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139630438|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630439|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139630440|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139630441|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630442|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139630443|NCT03069144|Vitamins|vitamins|mesh-ancestor
139630444|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
139630445|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139630446|NCT03017703|Eplerenone|eplerenone|mesh-list
139630447|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139630448|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
139630449|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139630450|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630451|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139630452|NCT03017703|Diuretics|diuretics|mesh-ancestor
139630453|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
139630454|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139630455|NCT01670669|Prucalopride|prucalopride|mesh-list
139630456|NCT01670669|Laxatives|laxatives|mesh-ancestor
139630457|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139630458|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139630459|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139630460|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
139630461|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630462|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630463|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630464|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
139630465|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
139630466|NCT00946023|Rituximab|rituximab|mesh-list
139630467|NCT00946023|Fludarabine|fludarabine|mesh-list
139630468|NCT00946023|Tacrolimus|tacrolimus|mesh-list
139630469|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139630470|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
139630471|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630472|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139630473|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139630474|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
139630475|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630476|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630477|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139630478|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139630479|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139630480|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630481|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139630482|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139630483|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
139630484|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139630485|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630486|NCT01672151|Sirolimus|sirolimus|mesh-list
139630487|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139630488|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630489|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139630490|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630491|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
139630492|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139630493|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
139630494|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630495|NCT01672229|Bortezomib|bortezomib|mesh-list
139630496|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630497|NCT01672307|Minoxidil|minoxidil|mesh-list
139630498|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139630499|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
139630500|NCT03067194|Celecoxib|celecoxib|mesh-list
139630501|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139630502|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139630503|NCT03067194|Analgesics|analgesics|mesh-ancestor
139630504|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
139630505|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630506|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630507|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139630509|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139630510|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139630511|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630512|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630513|NCT05629494|Ibuprofen|ibuprofen|mesh-list
139630514|NCT05629494|Naproxen|naproxen|mesh-list
139630515|NCT05629494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139630516|NCT05629494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139630517|NCT05629494|Analgesics|analgesics|mesh-ancestor
139630518|NCT05629494|Sensory System Agents|sensory system agents|mesh-ancestor
139630519|NCT05629494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630520|NCT05629494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630521|NCT05629494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139630522|NCT05629494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139630523|NCT05629494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139630524|NCT05629494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630525|NCT05629494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630526|NCT05629494|Gout Suppressants|gout suppressants|mesh-ancestor
139630527|NCT00952653|Midazolam|midazolam|mesh-list
139630528|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139630529|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139630530|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138759032|NCT04883437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630531|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139630532|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630533|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139630534|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139630535|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139630536|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139630537|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
139630538|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
139630539|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
139630540|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
139630541|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630542|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630543|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139630544|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139630545|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139630546|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
139630547|NCT01673087|Dexamethasone|dexamethasone|mesh-list
139630548|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139630549|NCT01673087|Cosyntropin|cosyntropin|mesh-list
139630550|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
139630551|NCT01673087|Metyrapone|metyrapone|mesh-list
139630552|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139630553|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
139630554|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
139630555|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630556|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630557|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139630558|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
139630559|NCT01673087|Hormones|hormones|mesh-ancestor
139630560|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139630561|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139630562|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630563|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
139630564|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630565|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630566|NCT02299505|Ceritinib|ceritinib|mesh-list
139630567|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630568|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139630569|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630570|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630571|NCT01673399|Atosiban|atosiban|mesh-list
139630572|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
139630573|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139630574|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630575|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
139630576|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139630577|NCT02235701|Ifosfamide|ifosfamide|mesh-list
139630578|NCT02235701|Doxorubicin|doxorubicin|mesh-list
139412304|NCT00840281|Cefprozil|cefprozil|mesh-list
139630579|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139630580|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
139630581|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630582|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630583|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139630584|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139630585|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139630586|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630587|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139630589|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
139630590|NCT01674257|Protective Agents|protective agents|mesh-ancestor
139630591|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630592|NCT01674257|Hematinics|hematinics|mesh-ancestor
139630593|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139630594|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139630595|NCT01674413|Adalimumab|adalimumab|mesh-list
139630596|NCT01674413|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139630597|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139630598|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139630599|NCT00953121|Bevacizumab|bevacizumab|mesh-list
139630600|NCT00953121|Carboplatin|carboplatin|mesh-list
139630601|NCT00953121|Irinotecan|irinotecan|mesh-list
139630602|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139630603|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630604|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139630605|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139630606|NCT00953121|Growth Substances|growth substances|mesh-ancestor
139630607|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630608|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
139630609|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139630610|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139630611|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630612|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630613|NCT03017391|Dexamethasone|dexamethasone|mesh-list
139630614|NCT03017391|Metoclopramide|metoclopramide|mesh-list
139630615|NCT03017391|Granisetron|granisetron|mesh-list
139630616|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139630617|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
139630618|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
139630619|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630620|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630621|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139630622|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
139630623|NCT03017391|Hormones|hormones|mesh-ancestor
139630624|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139630625|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139630626|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630627|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139630628|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139630629|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
139630630|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630631|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630632|NCT03017391|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138759150|NCT04771741|Analgesics|analgesics|mesh-ancestor
139630633|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139630634|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
139630635|NCT00953199|Lidocaine|lidocaine|mesh-list
139630636|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
139630637|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
139630638|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139630639|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630640|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
139630641|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630642|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139630643|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139630644|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139630645|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139630646|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630647|NCT03033147|Amoxicillin|amoxicillin|mesh-list
139630648|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
139630649|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
139630650|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139630651|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139630652|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630653|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139630654|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630655|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630656|NCT01675895|Lidocaine|lidocaine|mesh-list
139630657|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
139630658|NCT01675895|Anesthetics|anesthetics|mesh-list
139630659|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
139630660|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139630661|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630662|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
139630663|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630664|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139630665|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139630666|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139630667|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139630668|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630669|NCT01675973|Ranolazine|ranolazine|mesh-list
139630670|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139630671|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139630672|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630673|NCT04764851|Ecopipam|ecopipam|mesh-list
139630674|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139630675|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139630676|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139630677|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630678|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139630679|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139630680|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
139630681|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630682|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630683|NCT00956085|Memantine|memantine|mesh-list
139630684|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139630685|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139630686|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
139630687|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630688|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630689|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630690|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139630691|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139630692|NCT01005459|Bupivacaine|bupivacaine|mesh-list
139630693|NCT01005459|Tetracaine|tetracaine|mesh-list
139630694|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
139630695|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
139630696|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139630697|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630698|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
139630699|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630700|NCT01676285|Metoprolol|metoprolol|mesh-list
139630701|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139630702|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139630703|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
139630704|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
139630705|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630706|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630707|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139630708|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139630709|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139630710|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
139630711|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630712|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630713|NCT01676363|Diflunisal|diflunisal|mesh-list
139630714|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139630715|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139630716|NCT01676363|Analgesics|analgesics|mesh-ancestor
139630717|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
139630718|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630719|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630720|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139630721|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139630722|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139630723|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630724|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630725|NCT00956709|Ropivacaine|ropivacaine|mesh-list
139630726|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
139630727|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
139630728|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
139630729|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139630730|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630731|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
139630732|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630733|NCT00957333|Ketamine|ketamine|mesh-list
139630734|NCT00957333|Analgesics|analgesics|mesh-ancestor
139630735|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
139630736|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630737|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630738|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139630739|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139630740|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
139630741|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
139630742|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139630743|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139630744|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139630745|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630746|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630747|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138759259|NCT02767375|Fluorouracil|fluorouracil|mesh-list
139630748|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139630749|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139630750|NCT02159547|Analgesics|analgesics|mesh-ancestor
139630751|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
139630752|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630753|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630754|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139630755|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139630756|NCT00958035|Bimatoprost|bimatoprost|mesh-list
139630757|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139630758|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139630759|NCT01011075|Paclitaxel|paclitaxel|mesh-list
139630760|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
139630761|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139630762|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630763|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
139630764|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
139630765|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
139630766|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630767|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139630768|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630769|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
139630770|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
139630771|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139630772|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139630773|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630774|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
139630775|NCT00958581|Coagulants|coagulants|mesh-ancestor
139630776|NCT01012089|Daptomycin|daptomycin|mesh-list
139630777|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139630778|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630779|NCT04265651|Infigratinib|infigratinib|mesh-list
139630780|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630781|NCT04055753|Doxorubicin|doxorubicin|mesh-list
139630782|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139630783|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630784|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139630785|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139630786|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630787|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630788|NCT03589547|Durvalumab|durvalumab|mesh-list
139630789|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139630790|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630791|NCT04764383|Histamine|histamine|mesh-list
139630792|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
139630793|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
139630794|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630795|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630796|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630797|NCT03016611|Ticagrelor|ticagrelor|mesh-list
139630798|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139630799|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139630800|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139630801|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139630802|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139630803|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
139630804|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630805|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630806|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630807|NCT00961233|Budesonide|budesonide|mesh-list
139630808|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139630809|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139630810|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
139630811|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139630812|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630813|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139630814|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
139630815|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
139630816|NCT00961233|Hormones|hormones|mesh-ancestor
139630817|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139630818|NCT00962871|Tenofovir|tenofovir|mesh-list
139630819|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139630820|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
139630821|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630822|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139630823|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139630824|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630825|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630826|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139630827|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139630828|NCT01014351|Paclitaxel|paclitaxel|mesh-list
139630829|NCT01014351|Carboplatin|carboplatin|mesh-list
139630830|NCT01014351|Everolimus|everolimus|mesh-list
139630831|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139630832|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630833|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
139630834|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
139630835|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
139630836|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630837|NCT01014351|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139630838|NCT01014351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139630839|NCT01014351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630840|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139630841|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
139630842|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630843|NCT01014741|Ibutilide|ibutilide|mesh-list
139630844|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139630845|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
139630846|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139630847|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
139630848|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630849|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139630850|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139630851|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
139630852|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630853|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630854|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139630855|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
139630856|NCT00962949|Giapreza|giapreza|mesh-list
139630857|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
139630858|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139630859|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139630860|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
139630861|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630862|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630863|NCT01244789|Paclitaxel|paclitaxel|mesh-list
139630864|NCT01244789|Carboplatin|carboplatin|mesh-list
139630865|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139630866|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630867|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
139630868|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
139630869|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
139630870|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630871|NCT02631876|Paclitaxel|paclitaxel|mesh-list
139630872|NCT02631876|Maytansine|maytansine|mesh-list
139630873|NCT02631876|Doxorubicin|doxorubicin|mesh-list
139630874|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139630875|NCT02631876|Topotecan|topotecan|mesh-list
139630876|NCT02631876|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139630877|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139630878|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630879|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
139630880|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
139630881|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
139630882|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630883|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139630884|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139630885|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139630886|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630887|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139630888|NCT02631876|Immunoconjugates|immunoconjugates|mesh-ancestor
139630889|NCT02631876|Immunologic Factors|immunologic factors|mesh-ancestor
139630890|NCT02631876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630891|NCT03156179|Calcium|calcium|mesh-list
139630892|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139630893|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630894|NCT04436796|Pancrelipase|pancrelipase|mesh-list
139630895|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139630896|NCT02081963|Amikacin|amikacin|mesh-list
139630897|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139630898|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630899|NCT04765085|Aripiprazole|aripiprazole|mesh-list
139630900|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
139630901|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139630902|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139630903|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139630904|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139630905|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630906|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
139630907|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
139630908|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630909|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630910|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139630911|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139630912|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
139630913|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139630914|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139630915|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139630916|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139630917|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139630918|NCT02633046|Hormones|hormones|mesh-ancestor
139630919|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139630920|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630921|NCT03881345|Anticoagulants|anticoagulants|mesh-list
139630922|NCT01676597|Rifaximin|rifaximin|mesh-list
139630923|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
139630924|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139630925|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630926|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139630927|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139630928|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630929|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630930|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139630931|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139630932|NCT01676597|Protective Agents|protective agents|mesh-ancestor
139630933|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630934|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
139630935|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139630936|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
139630937|NCT05540964|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139630938|NCT05540964|Antiviral Agents|antiviral agents|mesh-ancestor
139630939|NCT05540964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630940|NCT04364802|Iodine|iodine|mesh-list
139630941|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
139630942|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
139630943|NCT04364802|Povidone|povidone|mesh-list
139630944|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139630945|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630946|NCT04364802|Trace Elements|trace elements|mesh-ancestor
139630947|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
139630948|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630949|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
139630950|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
139630951|NCT03155087|Metformin|metformin|mesh-list
139630952|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139630953|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630954|NCT00963105|Lenalidomide|lenalidomide|mesh-list
139630955|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
139630956|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630957|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139630958|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139630959|NCT00963105|Growth Substances|growth substances|mesh-ancestor
139630960|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
139630961|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139630962|NCT04879992|Amoxicillin|amoxicillin|mesh-list
139630963|NCT04879992|Metronidazole|metronidazole|mesh-list
139630964|NCT04879992|Tetracycline|tetracycline|mesh-list
139630965|NCT04879992|Rifabutin|rifabutin|mesh-list
139630966|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
139630967|NCT04879992|Esomeprazole|esomeprazole|mesh-list
139630968|NCT04879992|Bismuth|bismuth|mesh-list
139630969|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630970|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139630971|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139630972|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139630973|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139630974|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139630975|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138759482|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
139630976|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139630977|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139630978|NCT04879992|Antacids|antacids|mesh-ancestor
139630979|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139630980|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139630981|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
139630982|NCT04879992|Diuretics|diuretics|mesh-ancestor
139630983|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
139630984|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630985|NCT04879992|Expectorants|expectorants|mesh-ancestor
139630986|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
139630987|NCT01016691|Bimatoprost|bimatoprost|mesh-list
139630988|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139630989|NCT04181736|Guanfacine|guanfacine|mesh-list
139630990|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139630991|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139630992|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139630993|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139630994|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
139630995|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139630996|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139630997|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139630998|NCT04404491|Capecitabine|capecitabine|mesh-list
139630999|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139631000|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
139631001|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631002|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631003|NCT05573568|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
139631004|NCT05573568|Hallucinogens|hallucinogens|mesh-ancestor
139631005|NCT05573568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631006|NCT05573568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139631007|NCT05573568|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139631008|NCT05573568|Serotonin Agents|serotonin agents|mesh-ancestor
139631009|NCT05573568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139631010|NCT05573568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631011|NCT05573568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139631012|NCT03858491|Cobicistat|cobicistat|mesh-list
139631013|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139631014|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139631015|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
139631016|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631017|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139631018|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139631019|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631020|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631021|NCT01672788|Metformin|metformin|mesh-list
139631022|NCT01672788|Empagliflozin|empagliflozin|mesh-list
139631023|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139631024|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631025|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139631026|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631027|NCT02705963|Trametinib|trametinib|mesh-list
139631028|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139631029|NCT02705963|Norethindrone|norethindrone|mesh-list
139631030|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
139631031|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
139631032|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
139631033|NCT02705963|Estradiol|estradiol|mesh-list
139631034|NCT02705963|Estrogens|estrogens|mesh-ancestor
139631035|NCT02705963|Hormones|hormones|mesh-ancestor
139631036|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139631037|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631038|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139631039|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139631040|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139631041|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631042|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138759546|NCT00951496|Paclitaxel|paclitaxel|mesh-list
139631043|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631044|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631045|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139631046|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139631047|NCT03065868|Clarithromycin|clarithromycin|mesh-list
139631048|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139631049|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631050|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139631051|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631052|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631053|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139631054|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139631055|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139631056|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139631057|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
139631058|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139631059|NCT03830723|Hormones|hormones|mesh-ancestor
139631060|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139631061|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631063|NCT03814109|Indapamide|indapamide|mesh-list
139631064|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139631065|NCT03814109|Diuretics|diuretics|mesh-ancestor
139631066|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
139631067|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631068|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139631069|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139631070|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631071|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139631072|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
139631073|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139631074|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
139631075|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
139631076|NCT03814109|Vitamins|vitamins|mesh-ancestor
139631077|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
139631078|NCT01016769|Sirolimus|sirolimus|mesh-list
139631079|NCT01016769|Paclitaxel|paclitaxel|mesh-list
139631080|NCT01016769|Carboplatin|carboplatin|mesh-list
139631081|NCT01016769|Temsirolimus|temsirolimus|mesh-list
139631082|NCT01016769|MTOR Inhibitors|mtor inhibitors|mesh-list
139631083|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139631084|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631085|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
139631086|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
139631087|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
139631088|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631089|NCT01016769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139631090|NCT01016769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631091|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139631092|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
139631093|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631094|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139631095|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631096|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139631097|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
139631098|NCT03019809|Plerixafor|plerixafor|mesh-list
139631099|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139631100|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139631101|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
139631102|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631103|NCT00964353|Warfarin|warfarin|mesh-list
139631104|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
139631105|NCT00964431|Celecoxib|celecoxib|mesh-list
139631106|NCT00964431|Indomethacin|indomethacin|mesh-list
139631107|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139631108|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139631109|NCT00964431|Analgesics|analgesics|mesh-ancestor
139631110|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
139631111|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631112|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631113|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139631114|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139631115|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139631116|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139631117|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631118|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631119|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
139631120|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
139631121|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139631122|NCT05475054|Liver Extracts|liver extracts|mesh-list
139631123|NCT05475054|Hematinics|hematinics|mesh-ancestor
139631124|NCT01017003|Colchicine|colchicine|mesh-list
139631125|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
139631126|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139631127|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
139631128|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
139631129|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
139631130|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631131|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631132|NCT01017237|Midazolam|midazolam|mesh-list
139631133|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
139631134|NCT01017237|Ketamine|ketamine|mesh-list
139631135|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139631136|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139631137|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631138|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139631139|NCT01017237|Analgesics|analgesics|mesh-ancestor
139631140|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
139631141|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631142|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139631143|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139631144|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139631145|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
139631146|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139631147|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631148|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139631149|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139631150|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
139631151|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
139631152|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139631153|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139631154|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139631155|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139631156|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139631157|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139631158|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
139631159|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
139631160|NCT04442412|Vitamin D|vitamin d|mesh-list
139631161|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
139631162|NCT04442412|Vitamins|vitamins|mesh-ancestor
139631163|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
139631164|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631165|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139631166|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139631167|NCT01018095|Metronidazole|metronidazole|mesh-list
139631168|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631169|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139631170|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139631171|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139631172|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
139631173|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
139631174|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631175|NCT03788759|Protective Agents|protective agents|mesh-ancestor
139631176|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631177|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
139631178|NCT03788759|Vitamins|vitamins|mesh-ancestor
139631179|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
139631180|NCT00967551|Zinc|zinc|mesh-list
139412889|NCT05003570|Narcotics|narcotics|mesh-ancestor
139631181|NCT00967551|Trace Elements|trace elements|mesh-list
139631182|NCT00967551|Micronutrients|micronutrients|mesh-list
139631183|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631184|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139631186|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139631187|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
139631188|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631189|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631190|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
139631191|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631192|NCT00970203|Vaccines|vaccines|mesh-list
139631193|NCT00970203|Androgens|androgens|mesh-list
139631194|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
139631195|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631196|NCT00970203|Hormones|hormones|mesh-ancestor
139631197|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139631198|NCT00971295|Metformin|metformin|mesh-list
139631199|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139631200|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139631201|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631202|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
139631203|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139631204|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139631205|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139631206|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631207|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139631208|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
139631209|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139631210|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139631211|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139631212|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139631213|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631214|NCT00971841|Paclitaxel|paclitaxel|mesh-list
139631215|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139631216|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631217|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
139631218|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
139631219|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
139631220|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631221|NCT02246049|Leucovorin|leucovorin|mesh-list
139631222|NCT02246049|Bevacizumab|bevacizumab|mesh-list
139631223|NCT02246049|Fluorouracil|fluorouracil|mesh-list
139631224|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
139631225|NCT02246049|Irinotecan|irinotecan|mesh-list
139631226|NCT02246049|Calcium|calcium|mesh-list
139631227|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
139631228|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139631229|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631230|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139631231|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139631232|NCT02246049|Growth Substances|growth substances|mesh-ancestor
139631233|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631234|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
139631235|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139631236|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
139631237|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631238|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139631239|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139631240|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
139631241|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139631242|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139631243|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631244|NCT02246049|Antidotes|antidotes|mesh-ancestor
139631245|NCT02246049|Protective Agents|protective agents|mesh-ancestor
139631246|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
139631247|NCT02246049|Vitamins|vitamins|mesh-ancestor
139631248|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
139631249|NCT05395143|Zinc Sulfate|zinc sulfate|mesh-list
139631250|NCT05395143|Astringents|astringents|mesh-ancestor
139631251|NCT05395143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631252|NCT05395143|Dermatologic Agents|dermatologic agents|mesh-ancestor
139631253|NCT05394909|Methylprednisolone|methylprednisolone|mesh-list
139631254|NCT05394909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139631255|NCT05394909|Antiemetics|antiemetics|mesh-ancestor
139631256|NCT05394909|Autonomic Agents|autonomic agents|mesh-ancestor
139413000|NCT02322853|Tamoxifen|tamoxifen|mesh-list
139631257|NCT05394909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631258|NCT05394909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631259|NCT05394909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139631260|NCT05394909|Glucocorticoids|glucocorticoids|mesh-ancestor
139631262|NCT05394909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139631263|NCT05394909|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139631264|NCT05394909|Protective Agents|protective agents|mesh-ancestor
139631265|NCT02159859|Ertapenem|ertapenem|mesh-list
139631266|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139631267|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631268|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139631269|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139631270|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631271|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
139631272|NCT02083679|Paclitaxel|paclitaxel|mesh-list
139631273|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139631274|NCT02083679|Cisplatin|cisplatin|mesh-list
139631275|NCT02083679|Carboplatin|carboplatin|mesh-list
139631276|NCT02083679|Gemcitabine|gemcitabine|mesh-list
139631277|NCT02083679|Pemetrexed|pemetrexed|mesh-list
139631278|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139631279|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139631280|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631281|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
139631282|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
139631283|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
139631284|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631285|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139631286|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
139631287|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631288|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139631289|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139631290|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
139631291|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631292|NCT01672710|Niacin|niacin|mesh-list
139631293|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139631294|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
139631295|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631296|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139631297|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
139631298|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
139631299|NCT01672710|Vitamins|vitamins|mesh-ancestor
139631300|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
139631301|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631302|NCT03766763|Venetoclax|venetoclax|mesh-list
139631303|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631304|NCT04790448|Irinotecan|irinotecan|mesh-list
139631305|NCT04790448|Camptothecin|camptothecin|mesh-list
139631306|NCT04790448|Cetuximab|cetuximab|mesh-list
139631307|NCT04790448|Vemurafenib|vemurafenib|mesh-list
139631308|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139631309|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139631310|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631311|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631312|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631313|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139631314|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139631315|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139631316|NCT00976521|Abciximab|abciximab|mesh-list
139631317|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
139631318|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139631319|NCT04410588|Fentanyl|fentanyl|mesh-list
139631320|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
139631321|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139631322|NCT04410588|Narcotics|narcotics|mesh-ancestor
139631323|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139631324|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631325|NCT04410588|Analgesics|analgesics|mesh-ancestor
139631326|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
139631327|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631328|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139631329|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139631330|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
139631331|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
139631332|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
139631333|NCT05303220|Branebrutinib|branebrutinib|mesh-list
139631334|NCT05303220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139631335|NCT05303220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631336|NCT05303220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631337|NCT04444830|Ketorolac|ketorolac|mesh-list
139631338|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139631339|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139631340|NCT04444830|Analgesics|analgesics|mesh-ancestor
139631341|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
139631342|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631343|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631344|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139631345|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139631346|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139631347|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631348|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631349|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139631350|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139631351|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
139631352|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631353|NCT03738917|Bromides|bromides|mesh-list
139631354|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
139631355|NCT03738917|Ipratropium|ipratropium|mesh-list
139631356|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139631357|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
139631358|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
139631359|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
139631360|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139631361|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139631362|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139631363|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631364|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631365|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139631366|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
139631367|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631368|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139631369|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
139631370|NCT00976599|Methotrexate|methotrexate|mesh-list
139631371|NCT00976599|Tofacitinib|tofacitinib|mesh-list
139631372|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139631373|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
139631374|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139631375|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631376|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139631377|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
139631378|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631379|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631380|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
139631381|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631382|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139631383|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139631384|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
139631385|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139631386|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139631387|NCT00976599|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139631388|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139631389|NCT02630472|Quinine|quinine|mesh-list
139631390|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
139631391|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139631392|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139631393|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631394|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139631395|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631396|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139631397|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631398|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139631399|NCT02630472|Analgesics|analgesics|mesh-ancestor
139631400|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
139631401|NCT05264922|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139631402|NCT05264922|Hemostatics|hemostatics|mesh-ancestor
139631403|NCT05264922|Coagulants|coagulants|mesh-ancestor
139631404|NCT00977769|Oxytocin|oxytocin|mesh-list
139631405|NCT00977769|Carbetocin|carbetocin|mesh-list
139631406|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
139631407|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139631408|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631409|NCT03725501|Ranibizumab|ranibizumab|mesh-list
139631410|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139631411|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139631412|NCT03725501|Growth Substances|growth substances|mesh-ancestor
139631413|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631414|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
139631415|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631416|NCT00979017|Bevacizumab|bevacizumab|mesh-list
139631417|NCT00979017|Irinotecan|irinotecan|mesh-list
139631418|NCT00979017|Temozolomide|temozolomide|mesh-list
139631419|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139631420|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631421|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139631422|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139631423|NCT00979017|Growth Substances|growth substances|mesh-ancestor
139631424|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631425|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
139631426|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139631427|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139631428|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631429|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631430|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139631431|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
139631432|NCT01670526|Rivastigmine|rivastigmine|mesh-list
139631433|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
139631434|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631435|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631436|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
139631437|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139631438|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631439|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139631440|NCT01670526|Protective Agents|protective agents|mesh-ancestor
139631441|NCT00945035|Etoricoxib|etoricoxib|mesh-list
139631442|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139631443|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139631444|NCT00945035|Analgesics|analgesics|mesh-ancestor
139631445|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
139631446|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631447|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631448|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139631449|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139631450|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139631451|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139631452|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631453|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631454|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
139631455|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139631456|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631457|NCT03720431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139631458|NCT03720431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631459|NCT05386953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139631460|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139631461|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
139631462|NCT05176548|Paraproteins|paraproteins|mesh-list
139631463|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
139631464|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631465|NCT00979875|Insulin|insulin|mesh-list
139631466|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139631467|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
139631468|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
139631469|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
139631470|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139631471|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631472|NCT03710603|Dexamethasone|dexamethasone|mesh-list
139631473|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
139631474|NCT03710603|Lenalidomide|lenalidomide|mesh-list
139631475|NCT03710603|Bortezomib|bortezomib|mesh-list
139631476|NCT03710603|Daratumumab|daratumumab|mesh-list
139631477|NCT03710603|BB 1101|bb 1101|mesh-list
139631478|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139631479|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
139631480|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
139631481|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631482|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631483|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139631484|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
139413189|NCT00796289|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139631485|NCT03710603|Hormones|hormones|mesh-ancestor
139631486|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139631487|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139631488|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631489|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
139631490|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631491|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631492|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
139631493|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139631494|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139631495|NCT03710603|Growth Substances|growth substances|mesh-ancestor
139631496|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
139631497|NCT02630706|Metformin|metformin|mesh-list
139631498|NCT02630706|Glimepiride|glimepiride|mesh-list
139631499|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
139631500|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139631501|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631502|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139631503|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139631504|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
139631505|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139631506|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631507|NCT04763057|Calcium|calcium|mesh-list
139631508|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139631509|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631510|NCT03702179|Durvalumab|durvalumab|mesh-list
139631511|NCT03702179|Tremelimumab|tremelimumab|mesh-list
139631512|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139631513|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631514|NCT01677143|Bupivacaine|bupivacaine|mesh-list
139631515|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
139631516|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
139631517|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139631518|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631519|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
139631520|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631521|NCT03692663|Cyclophosphamide|cyclophosphamide|mesh-list
139631522|NCT03692663|Fludarabine|fludarabine|mesh-list
139631523|NCT03692663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139631524|NCT03692663|Immunologic Factors|immunologic factors|mesh-ancestor
139631525|NCT03692663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631526|NCT03692663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139631527|NCT03692663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139631528|NCT03692663|Alkylating Agents|alkylating agents|mesh-ancestor
139631529|NCT03692663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631530|NCT03692663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631531|NCT03692663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139631532|NCT02084069|Atorvastatin|atorvastatin|mesh-list
139631533|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139631534|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139631535|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
139631536|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631537|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139631538|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139631539|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631540|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139631541|NCT00981045|Hematinics|hematinics|mesh-ancestor
139631542|NCT00981435|Prednisolone|prednisolone|mesh-list
139631543|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
139631544|NCT00981435|Ketorolac|ketorolac|mesh-list
139631545|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
139631546|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139631547|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
139631548|NCT00981435|Hormones|hormones|mesh-ancestor
139631549|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139631550|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631551|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139631552|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631553|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631554|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139631555|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139631556|NCT00981435|Analgesics|analgesics|mesh-ancestor
139631557|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
139631558|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139631559|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139631560|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413264|NCT02812667|Nivolumab|nivolumab|mesh-list
139631561|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631562|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139631563|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139631564|NCT00981669|Vaccines|vaccines|mesh-list
139631565|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
139631566|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631567|NCT00981825|Listerine|listerine|mesh-list
139631568|NCT00981825|Triclosan|triclosan|mesh-list
139631569|NCT00981825|Fluorides|fluorides|mesh-list
139631570|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
139631571|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
139631572|NCT00981825|Protective Agents|protective agents|mesh-ancestor
138760128|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760129|NCT02852122|Choline|choline|mesh-list
138434448|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138434449|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
138434450|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
138434451|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760137|NCT01035255|Enalapril|enalapril|mesh-list
139631573|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631574|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139631575|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631576|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139631577|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139631578|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
139631579|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631580|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139631581|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139631582|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631583|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139631584|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631585|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631586|NCT04762745|Thalidomide|thalidomide|mesh-list
139631587|NCT04762745|Dexamethasone|dexamethasone|mesh-list
139631588|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
139631589|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139631590|NCT04762745|Pomalidomide|pomalidomide|mesh-list
139631591|NCT04762745|BB 1101|bb 1101|mesh-list
139631592|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139631593|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
139631594|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
139631595|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631596|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631597|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139631598|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
139631599|NCT04762745|Hormones|hormones|mesh-ancestor
139631600|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139631601|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139631602|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631603|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
139631604|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631605|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631606|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139631607|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
139631608|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
139631609|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139631610|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139631611|NCT04762745|Growth Substances|growth substances|mesh-ancestor
139631612|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
139631613|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139631614|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
139631615|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139631616|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631617|NCT00983541|Gemcitabine|gemcitabine|mesh-list
139631618|NCT00983541|Fluorouracil|fluorouracil|mesh-list
139631619|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139631620|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
139631621|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631622|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631623|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139631624|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
139631625|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631626|NCT03667703|Famotidine|famotidine|mesh-list
139631627|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139631628|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139631629|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139631630|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
139631631|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
139631632|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138289395|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139631633|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631634|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631635|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
139413339|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
139631636|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
139631637|NCT03062904|Miotics|miotics|mesh-ancestor
139631638|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
139631639|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631640|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631641|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139631642|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139631643|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
139631644|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139631645|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139631646|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
139631647|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139631648|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631649|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139631650|NCT00986583|Succinylcholine|succinylcholine|mesh-list
139631651|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139631652|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139631653|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139631654|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631655|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631656|NCT05056974|UB-421|ub-421|mesh-list
139631657|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139631658|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
139631659|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631660|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
139631661|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139631662|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631663|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631664|NCT04762511|Vaccines|vaccines|mesh-list
139631665|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
139631666|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631667|NCT04762901|Paclitaxel|paclitaxel|mesh-list
139631668|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
139631669|NCT04762901|Carboplatin|carboplatin|mesh-list
139631670|NCT04762901|Doxorubicin|doxorubicin|mesh-list
139631671|NCT04762901|Niraparib|niraparib|mesh-list
139631672|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139631673|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631674|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
139631675|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
139631676|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
139631677|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631678|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139631679|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
139631680|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631681|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139631682|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139631683|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
139631684|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139631685|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139631686|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139631687|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139631688|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631689|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139631690|NCT00988143|Vaccines|vaccines|mesh-list
139631691|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
139631692|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631693|NCT03018171|Clonidine|clonidine|mesh-list
139631694|NCT03018171|Sufentanil|sufentanil|mesh-list
139631695|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139631696|NCT03018171|Narcotics|narcotics|mesh-ancestor
139631697|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139631698|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631699|NCT03018171|Analgesics|analgesics|mesh-ancestor
139631700|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
139631701|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631702|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139631703|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139631704|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
139631705|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
139631706|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139631707|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
139631708|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
139631709|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139631710|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139413422|NCT00774761|Xhance|xhance|mesh-list
139631711|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139631712|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
139631713|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139631714|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631715|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139631716|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139631717|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139631718|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138760220|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
139631719|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631720|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139631721|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631722|NCT00989157|Analgesics|analgesics|mesh-ancestor
139631723|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
139631724|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631725|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
139631726|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139631727|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
139631728|NCT00990561|Clobetasol|clobetasol|mesh-list
139631729|NCT00990561|Halobetasol|halobetasol|mesh-list
139631730|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139631731|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139631732|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
139631733|NCT00990561|Hormones|hormones|mesh-ancestor
139631734|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139631735|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631736|NCT03018015|Ibuprofen|ibuprofen|mesh-list
139631737|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139631738|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139631739|NCT03018015|Analgesics|analgesics|mesh-ancestor
139631740|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
139631741|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631742|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631743|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139631744|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139631745|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139631746|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631747|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631748|NCT03609593|Rituximab|rituximab|mesh-list
139631749|NCT03609593|Venetoclax|venetoclax|mesh-list
139631750|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139631751|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139631752|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631753|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
139631754|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631755|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139631756|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139631757|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
139631758|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631759|NCT00004547|Paclitaxel|paclitaxel|mesh-list
139631760|NCT00004547|Cisplatin|cisplatin|mesh-list
139631761|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139631762|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631763|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
139631764|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
139631765|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
139631766|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631767|NCT00005669|Metformin|metformin|mesh-list
139631768|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139631769|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631770|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
139631771|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139631772|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139631773|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631774|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139631775|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631776|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139631777|NCT01363661|Molsidomine|molsidomine|mesh-list
139631778|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
139631779|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139631780|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631781|NCT02628600|Amikacin|amikacin|mesh-list
139631782|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139631783|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631784|NCT00006101|Eflornithine|eflornithine|mesh-list
139631785|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631786|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139631787|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139631788|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139631789|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631790|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139631791|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631792|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631793|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
139631794|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139631795|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631796|NCT00991029|Clopidogrel|clopidogrel|mesh-list
139631797|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139631798|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139631799|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139631800|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139631801|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
139631802|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139631803|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631804|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631805|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
139631806|NCT00991809|Promethazine|promethazine|mesh-list
139631807|NCT00991809|Alfentanil|alfentanil|mesh-list
139631808|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139631809|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139631810|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139631811|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631812|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
139631813|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
139631814|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
139631815|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631816|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
139631817|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
139631818|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139631819|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139631820|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
139631821|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
139631822|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139631823|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631824|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139631825|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
139631826|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
139631827|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139631828|NCT00991809|Narcotics|narcotics|mesh-ancestor
139631829|NCT00991809|Analgesics|analgesics|mesh-ancestor
139631830|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139631831|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
139631832|NCT02627274|Trastuzumab|trastuzumab|mesh-list
139631833|NCT02627274|Cetuximab|cetuximab|mesh-list
139631834|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139631835|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631836|NCT04982016|Methamphetamine|methamphetamine|mesh-list
139631837|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139631838|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631839|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
139631840|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
139631841|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631842|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
139631843|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139631844|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631845|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
139631846|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139631847|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139631848|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139631849|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139631850|NCT00994929|Oprelvekin|oprelvekin|mesh-list
139631851|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631852|NCT00929253|Buprenorphine|buprenorphine|mesh-list
139631853|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139631854|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139631855|NCT00929253|Narcotics|narcotics|mesh-ancestor
139631856|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139631857|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631858|NCT00929253|Analgesics|analgesics|mesh-ancestor
139413590|NCT00656357|Cocaine|cocaine|mesh-list
139631859|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
139631860|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631861|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139631862|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
139631863|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
139631864|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139631865|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139631866|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631867|NCT04374903|Sirolimus|sirolimus|mesh-list
139631868|NCT04374903|Azithromycin|azithromycin|mesh-list
139631869|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
139631870|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139631871|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631872|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139631873|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631874|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
139631875|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139631876|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
139631877|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631878|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631879|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631880|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
139631881|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139631882|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139631883|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139631884|NCT03062982|Fluzoparib|fluzoparib|mesh-list
139631885|NCT03062982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139631886|NCT03062982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631887|NCT03062982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631888|NCT03062982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631889|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
139631890|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
139631891|NCT03062436|Protective Agents|protective agents|mesh-ancestor
139631892|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631893|NCT00997113|Alfentanil|alfentanil|mesh-list
139631894|NCT00997113|Propofol|propofol|mesh-list
139631895|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139631896|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139631897|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631898|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139631899|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
139631900|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
139631901|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139631902|NCT00997113|Narcotics|narcotics|mesh-ancestor
139631903|NCT00997113|Analgesics|analgesics|mesh-ancestor
139631904|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
139631905|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631906|NCT04981704|Itraconazole|itraconazole|mesh-list
139631907|NCT04981704|Phenytoin|phenytoin|mesh-list
139631908|NCT04981704|Paroxetine|paroxetine|mesh-list
139631909|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
139631910|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631911|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139631912|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139631913|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631914|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631915|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139631916|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
139631917|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139631918|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631919|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139631920|NCT04981704|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139631921|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139631922|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139631923|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139631924|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
139631925|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139631926|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
139631927|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139631928|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139631929|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
139631930|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139631931|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139631932|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139631933|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139631934|NCT02163837|Rifaximin|rifaximin|mesh-list
139631935|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139631936|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631937|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139631938|NCT04974060|Remifentanil|remifentanil|mesh-list
139631939|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139631940|NCT04974060|Narcotics|narcotics|mesh-ancestor
139631941|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139631942|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631943|NCT04974060|Analgesics|analgesics|mesh-ancestor
139631944|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
139631945|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631946|NCT01021761|Ketorolac|ketorolac|mesh-list
139631947|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139631948|NCT01021761|Nepafenac|nepafenac|mesh-list
139631949|NCT01021761|Bromfenac|bromfenac|mesh-list
139631950|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139631951|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139631952|NCT01021761|Analgesics|analgesics|mesh-ancestor
139631953|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
139631954|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631955|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631956|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139631957|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139631958|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139631959|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139631960|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631961|NCT04973904|Paclitaxel|paclitaxel|mesh-list
139631962|NCT04973904|Bevacizumab|bevacizumab|mesh-list
139631963|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139631964|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139631965|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
139631966|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
139631967|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
139631968|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139631969|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139631970|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139631971|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139631972|NCT04973904|Growth Substances|growth substances|mesh-ancestor
139631973|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631974|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
139631975|NCT00998049|Plerixafor|plerixafor|mesh-list
139631976|NCT00998049|Lenograstim|lenograstim|mesh-list
139631977|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139631978|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
139631979|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631980|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139631981|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139631982|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
139631983|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139631984|NCT00998205|Atropine|atropine|mesh-list
139631985|NCT00998205|Dobutamine|dobutamine|mesh-list
139631986|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139631987|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139631988|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139631989|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
139631990|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139631991|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139631992|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139631993|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
139631994|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
139631995|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
139631996|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139631997|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139631998|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
139631999|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632000|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632001|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139632002|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
139632003|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139632004|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139632005|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139632006|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
139632007|NCT00998205|Protective Agents|protective agents|mesh-ancestor
139632008|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
139632009|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
139632010|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139632011|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139632012|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632013|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632014|NCT02626182|Urological Agents|urological agents|mesh-ancestor
139632015|NCT01023477|Chloroquine|chloroquine|mesh-list
139632016|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139632017|NCT01023477|Amebicides|amebicides|mesh-ancestor
139632018|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139632019|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139632020|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632021|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
139632022|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139632023|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139632024|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632025|NCT01023477|Analgesics|analgesics|mesh-ancestor
139632026|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
139632027|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632028|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632029|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139632030|NCT01023477|Filaricides|filaricides|mesh-ancestor
139632031|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
139632032|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
139632033|NCT01023711|Vaccines|vaccines|mesh-list
139632034|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
139632035|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632036|NCT01001403|Nafamostat|nafamostat|mesh-list
139632037|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139632038|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632039|NCT01001403|Analgesics|analgesics|mesh-ancestor
139632040|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
139632041|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632042|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632043|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139632044|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139632045|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
139632046|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
139632047|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632048|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632049|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139632050|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139632051|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139632052|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139632053|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
139632054|NCT01024335|Naltrexone|naltrexone|mesh-list
139632055|NCT01024335|Dronabinol|dronabinol|mesh-list
139632056|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139632057|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139632058|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632059|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
139632060|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632061|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
139632062|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139632063|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632064|NCT01024335|Analgesics|analgesics|mesh-ancestor
139632065|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139632066|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139632067|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632068|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632069|NCT01024335|Hormones|hormones|mesh-ancestor
139632070|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139632071|NCT01001559|Norepinephrine|norepinephrine|mesh-list
139632072|NCT01001559|Serotonin|serotonin|mesh-list
139632073|NCT01001559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139632074|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
139632075|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139632076|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139632077|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
139632078|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632079|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632080|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632081|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
139632082|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
139632083|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632084|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139413788|NCT05647408|Dexamethasone|dexamethasone|mesh-list
139632085|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139632086|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
139632087|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139632088|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139632090|NCT01025427|Emtricitabine|emtricitabine|mesh-list
139632091|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
139632092|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
139632093|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632094|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139632095|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139632096|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632097|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632098|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139632099|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139632100|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139632101|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139632102|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
139632103|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139632104|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632105|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632106|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632107|NCT02162433|Analgesics|analgesics|mesh-ancestor
139632108|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
139632109|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632110|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139632111|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139632112|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139632113|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
139632114|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632115|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632116|NCT01004991|Prednisone|prednisone|mesh-list
139632117|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
139632118|NCT01004991|Rituximab|rituximab|mesh-list
139632119|NCT01004991|Doxorubicin|doxorubicin|mesh-list
139632120|NCT01004991|Vincristine|vincristine|mesh-list
139632121|NCT01004991|Azacitidine|azacitidine|mesh-list
139632122|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139632123|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
139632124|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632125|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139632126|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139632127|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
139632128|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632129|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632130|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139632131|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139632132|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139632133|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139632134|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139632135|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632136|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139632137|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
139632138|NCT01004991|Hormones|hormones|mesh-ancestor
139632139|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139632140|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139632141|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139632142|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
139632143|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
139632144|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
139632145|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139632146|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
139632147|NCT03063060|Vitamin D|vitamin d|mesh-list
139632148|NCT03063060|Calcium|calcium|mesh-list
139632149|NCT03063060|Vitamins|vitamins|mesh-ancestor
139632150|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
139632151|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632152|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139632153|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139632154|NCT03115047|Meperidine|meperidine|mesh-list
139632155|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
139632156|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139632157|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139413864|NCT05984212|Dexmedetomidine|dexmedetomidine|mesh-list
139632158|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632159|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632160|NCT03115047|Analgesics|analgesics|mesh-ancestor
139632161|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
139632162|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632163|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139632164|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139632165|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139632166|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
139632167|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632168|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632169|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139632170|NCT03115047|Narcotics|narcotics|mesh-ancestor
139632171|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139632172|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139632173|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139632174|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
139632175|NCT03015519|Incretins|incretins|mesh-ancestor
139632176|NCT03015519|Hormones|hormones|mesh-ancestor
139632177|NCT03015519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139632178|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632179|NCT01030653|Voriconazole|voriconazole|mesh-list
139632180|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
139632181|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632182|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139632183|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139632184|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632185|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632186|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139632187|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
139632188|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139632189|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632190|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139632191|NCT01031043|Bethanechol|bethanechol|mesh-list
139632192|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139632193|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
139632194|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632195|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632196|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139632197|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139632198|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
139632199|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632200|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632201|NCT01050153|Aspirin|aspirin|mesh-list
139632202|NCT01050153|Dalteparin|dalteparin|mesh-list
139632203|NCT01050153|Tinzaparin|tinzaparin|mesh-list
139632204|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139632205|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139632206|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632207|NCT01050153|Analgesics|analgesics|mesh-ancestor
139632208|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
139632209|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632210|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632211|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139632212|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139632213|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139632214|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139632215|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632216|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139632217|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139632218|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632219|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
139632220|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
139632221|NCT04358133|Morphine|morphine|mesh-list
139632222|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139632223|NCT04358133|Narcotics|narcotics|mesh-ancestor
139632224|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632225|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632226|NCT04358133|Analgesics|analgesics|mesh-ancestor
139632227|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
139632228|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632229|NCT01032759|Memantine|memantine|mesh-list
139632230|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139632231|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139632232|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
139632233|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632234|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632235|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632236|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139632237|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139632238|NCT01032993|Ubiquinone|ubiquinone|mesh-list
139632239|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
139632240|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
139632241|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632242|NCT01032993|Vitamins|vitamins|mesh-ancestor
139632243|NCT01033773|Metformin|metformin|mesh-list
139632244|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139632245|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632246|NCT01053507|Naproxen|naproxen|mesh-list
139632247|NCT01053507|Sumatriptan|sumatriptan|mesh-list
139632248|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139632249|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632250|NCT01053507|Analgesics|analgesics|mesh-ancestor
139632251|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
139632252|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632253|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632254|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139632255|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139632256|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
139632257|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139632258|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632259|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632260|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139632261|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139632262|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139632263|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
139632264|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632265|NCT01053819|Etanercept|etanercept|mesh-list
139632266|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139632267|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632268|NCT01053819|Analgesics|analgesics|mesh-ancestor
139632269|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
139632270|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632271|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632272|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139632273|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139632274|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139632275|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139632276|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
139632277|NCT01054911|Sunitinib|sunitinib|mesh-list
139632278|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632279|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139632280|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139632281|NCT01054911|Growth Substances|growth substances|mesh-ancestor
139632282|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632283|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
139632284|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139632285|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632286|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632287|NCT01055223|Troglitazone|troglitazone|mesh-list
139632288|NCT01055223|Amiloride|amiloride|mesh-list
139632289|NCT01055223|Spironolactone|spironolactone|mesh-list
139632290|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139632291|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
139632292|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139632293|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632294|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139632295|NCT01055223|Diuretics|diuretics|mesh-ancestor
139632296|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
139632297|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139632298|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139632299|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139632300|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632301|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139632302|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139632303|NCT02168361|Interferons|interferons|mesh-list
139632304|NCT02168361|Ribavirin|ribavirin|mesh-list
139632305|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
139632306|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
139632307|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
139632308|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139632309|NCT02168361|Simeprevir|simeprevir|mesh-list
139632310|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632311|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
139632312|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632313|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
139632314|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632315|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
139632316|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632317|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
139632318|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632319|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139632320|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632321|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139632322|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632323|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632324|NCT01055769|Linezolid|linezolid|mesh-list
139632325|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139632326|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632327|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139632328|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632329|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632330|NCT01057017|Panitumumab|panitumumab|mesh-list
139632331|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139632332|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632333|NCT04972032|Estrogens|estrogens|mesh-list
139632334|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
139632335|NCT04972032|Hormones|hormones|mesh-ancestor
139632336|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139632337|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632338|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139632339|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
139632340|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
139632341|NCT04972032|Protective Agents|protective agents|mesh-ancestor
139632342|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
139632343|NCT04432662|Hematinics|hematinics|mesh-ancestor
139632344|NCT04152564|Bupivacaine|bupivacaine|mesh-list
139632345|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
139632346|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
139632347|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
139632348|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632349|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632350|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
139632351|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632352|NCT04977960|Canrenone|canrenone|mesh-list
139632353|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
139632354|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139632355|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
139632356|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139632357|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632358|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139632359|NCT04977960|Diuretics|diuretics|mesh-ancestor
139632360|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
139632361|NCT05593809|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
139632362|NCT05593809|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139632363|NCT05593809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632364|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
139632365|NCT01062009|Astringents|astringents|mesh-ancestor
139632366|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632367|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
139632368|NCT01062165|Caspofungin|caspofungin|mesh-list
139632369|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
139632370|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632371|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632372|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632373|NCT04041843|Apixaban|apixaban|mesh-list
139632374|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139632375|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
139632376|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139632377|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
139632378|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632379|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632380|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
139632381|NCT01068873|Ritonavir|ritonavir|mesh-list
139632382|NCT01068873|Lopinavir|lopinavir|mesh-list
139632383|NCT01068873|Maraviroc|maraviroc|mesh-list
139632384|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139632385|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139632387|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632388|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632389|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139632390|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139632391|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
139632392|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632393|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139632394|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139632395|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139632396|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139632397|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139632398|NCT01072773|Dexamethasone|dexamethasone|mesh-list
139632399|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
139632400|NCT01072773|Bortezomib|bortezomib|mesh-list
139632401|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139632402|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
139632403|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632404|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139632405|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139632406|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
139632407|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632408|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632409|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139632410|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139632411|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
139632412|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
139632413|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632414|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139632415|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
139632416|NCT01072773|Hormones|hormones|mesh-ancestor
139632417|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139632418|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139632419|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139632420|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139632421|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139632422|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
139632423|NCT01074177|Afatinib|afatinib|mesh-list
139632424|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632425|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139632426|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632427|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632428|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
139632429|NCT01076283|Baclofen|baclofen|mesh-list
139632430|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139632431|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632432|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139632433|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632434|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139632435|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
139632436|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
139632437|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632438|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632439|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
139632440|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
139632441|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139632442|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139632443|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
139632444|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
139632445|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139632446|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
139632447|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139632448|NCT01076985|Ritonavir|ritonavir|mesh-list
139632449|NCT01076985|Lopinavir|lopinavir|mesh-list
139632450|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139632451|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139632452|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
139632453|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632454|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632455|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139632456|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139632457|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
139632458|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632459|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139632460|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139632461|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
139632462|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139632463|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632464|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139632465|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139632466|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632467|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632468|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632469|NCT05539911|Fentanyl|fentanyl|mesh-list
139632470|NCT05539911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139632471|NCT05539911|Narcotics|narcotics|mesh-ancestor
139632472|NCT05539911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632473|NCT05539911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632474|NCT05539911|Analgesics|analgesics|mesh-ancestor
139632475|NCT05539911|Sensory System Agents|sensory system agents|mesh-ancestor
139632476|NCT05539911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632477|NCT05539911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139632478|NCT05539911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139632479|NCT05539911|Anesthetics, General|anesthetics, general|mesh-ancestor
139632480|NCT05539911|Anesthetics|anesthetics|mesh-ancestor
139632481|NCT03589833|Methotrexate|methotrexate|mesh-list
139632482|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139632483|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
139632484|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139632485|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632486|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139632487|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
139632488|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632489|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632490|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
139632491|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632492|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139632493|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139632494|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
139632495|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139632496|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139632497|NCT01077921|Propranolol|propranolol|mesh-list
139632498|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139632499|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139632500|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
139632501|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632502|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632503|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632504|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139632505|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139632506|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
139632507|NCT05498181|Valsartan|valsartan|mesh-list
139632508|NCT05498181|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139632509|NCT05498181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139632510|NCT05498181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139632511|NCT05498181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139632512|NCT05498181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632513|NCT04970238|Simendan|simendan|mesh-list
139632514|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139632515|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
139632516|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138760980|NCT02758873|Montelukast|montelukast|mesh-list
139632517|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139632518|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632519|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632520|NCT04970238|Protective Agents|protective agents|mesh-ancestor
139632521|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632522|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139632523|NCT02169453|Opicapone|opicapone|mesh-list
139632524|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139632525|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
139632526|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632527|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139632528|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139632529|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
139632530|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
139632531|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632532|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632533|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139632535|NCT01765296|Celecoxib|celecoxib|mesh-list
139632536|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139632537|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632538|NCT01765296|Analgesics|analgesics|mesh-ancestor
139632539|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
139632540|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632541|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632542|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139632543|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139632544|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139632545|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139632546|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632547|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632548|NCT01081041|Carboplatin|carboplatin|mesh-list
139632549|NCT01081041|Fluorouracil|fluorouracil|mesh-list
139632550|NCT01081041|Cetuximab|cetuximab|mesh-list
139632551|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632552|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
139632553|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632554|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139632555|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139632556|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
139632557|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632558|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139632559|NCT03022617|Apremilast|apremilast|mesh-list
139632560|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139632561|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632562|NCT03022617|Analgesics|analgesics|mesh-ancestor
139632563|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
139632564|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632565|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632566|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139632567|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139632568|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139632569|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139632570|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632571|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632572|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
139632573|NCT02089685|Ipilimumab|ipilimumab|mesh-list
139632574|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139632575|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632576|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139632577|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632578|NCT01088295|Telmisartan|telmisartan|mesh-list
139632579|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139632580|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139632581|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138761044|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632582|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632583|NCT03013335|Nivolumab|nivolumab|mesh-list
139632584|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139632585|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632586|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139632587|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632588|NCT04730531|Epinephrine|epinephrine|mesh-list
139632589|NCT04730531|Bupivacaine|bupivacaine|mesh-list
139632590|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
139632591|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
139632592|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632593|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632594|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
139632595|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632596|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139632597|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139632598|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
139632599|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632600|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632601|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139632602|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139632603|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
139632604|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139632605|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
139632606|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
139632607|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
139632608|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139632609|NCT05569733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139632610|NCT05569733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139632611|NCT05569733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632612|NCT05853224|Lidocaine|lidocaine|mesh-list
139632613|NCT05853224|Hyaluronic Acid|hyaluronic acid|mesh-list
139632614|NCT05853224|Anesthetics, Local|anesthetics, local|mesh-ancestor
139632615|NCT05853224|Anesthetics|anesthetics|mesh-ancestor
139632616|NCT05853224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632617|NCT05853224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632618|NCT05853224|Sensory System Agents|sensory system agents|mesh-ancestor
139632619|NCT05853224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632620|NCT05853224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139632621|NCT05853224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139632622|NCT05853224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139632623|NCT05853224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139632624|NCT05853224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632625|NCT05853224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139632626|NCT05853224|Immunologic Factors|immunologic factors|mesh-ancestor
139632627|NCT05853224|Viscosupplements|viscosupplements|mesh-ancestor
139632628|NCT05853224|Protective Agents|protective agents|mesh-ancestor
139632629|NCT05853172|Paclitaxel|paclitaxel|mesh-list
139632630|NCT05853172|Apatinib|apatinib|mesh-list
139632631|NCT05853172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139632632|NCT05853172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632633|NCT05853172|Tubulin Modulators|tubulin modulators|mesh-ancestor
139632634|NCT05853172|Antimitotic Agents|antimitotic agents|mesh-ancestor
139632635|NCT05853172|Mitosis Modulators|mitosis modulators|mesh-ancestor
139632636|NCT05853172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632637|NCT05853172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139632638|NCT05853172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632639|NCT05853263|Acetaminophen|acetaminophen|mesh-list
139632640|NCT05853263|Morphine|morphine|mesh-list
139632641|NCT05853263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139632642|NCT05853263|Narcotics|narcotics|mesh-ancestor
139632643|NCT05853263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632644|NCT05853263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632645|NCT05853263|Analgesics|analgesics|mesh-ancestor
139632646|NCT05853263|Sensory System Agents|sensory system agents|mesh-ancestor
139632647|NCT05853263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632648|NCT05853263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632649|NCT05853263|Antipyretics|antipyretics|mesh-ancestor
139632650|NCT05852847|Danazol|danazol|mesh-list
139632651|NCT05852847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139632652|NCT05852847|Hormone Antagonists|hormone antagonists|mesh-ancestor
139632653|NCT05852847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139632654|NCT05852847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632655|NCT05852704|Dapagliflozin|dapagliflozin|mesh-list
139632656|NCT05852704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139632657|NCT05852704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632658|NCT05852704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139632659|NCT05852704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632660|NCT05852496|Vitamin D|vitamin d|mesh-list
139632661|NCT05852496|Vitamins|vitamins|mesh-ancestor
139632662|NCT05852496|Micronutrients|micronutrients|mesh-ancestor
139632663|NCT05852496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632664|NCT05852496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139632665|NCT05852223|Pembrolizumab|pembrolizumab|mesh-list
139632666|NCT05852223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139632667|NCT05852223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632668|NCT05852223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139632669|NCT05852223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632670|NCT05852197|Anticoagulants|anticoagulants|mesh-list
139632671|NCT05852197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139632672|NCT05852119|Anticoagulants|anticoagulants|mesh-list
139632673|NCT05852093|Celecoxib|celecoxib|mesh-list
139632674|NCT05852093|Buprenorphine|buprenorphine|mesh-list
139632675|NCT05852093|Tizanidine|tizanidine|mesh-list
139632676|NCT05852093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139632677|NCT05852093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632678|NCT05852093|Analgesics|analgesics|mesh-ancestor
139632679|NCT05852093|Sensory System Agents|sensory system agents|mesh-ancestor
139632680|NCT05852093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632681|NCT05852093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632682|NCT05852093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139632683|NCT05852093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139632684|NCT05852093|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139632685|NCT05852093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139632686|NCT05852093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632687|NCT05852093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632688|NCT05852093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139632689|NCT05852093|Narcotics|narcotics|mesh-ancestor
139632690|NCT05852093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632691|NCT05852093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139632692|NCT05852093|Anticonvulsants|anticonvulsants|mesh-ancestor
139632693|NCT05852093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139632694|NCT05852093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139632695|NCT05852093|Parasympatholytics|parasympatholytics|mesh-ancestor
139632696|NCT05852093|Autonomic Agents|autonomic agents|mesh-ancestor
139632697|NCT05852093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139632698|NCT05852093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139632699|NCT05852093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139632700|NCT05852093|Adrenergic Agents|adrenergic agents|mesh-ancestor
139632701|NCT05852093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632702|NCT05845762|Obinutuzumab|obinutuzumab|mesh-list
139632703|NCT05845762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139632704|NCT05845762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632705|NCT05830396|Ambroxol|ambroxol|mesh-list
139632706|NCT05830396|Expectorants|expectorants|mesh-ancestor
139632707|NCT05830396|Respiratory System Agents|respiratory system agents|mesh-ancestor
139632708|NCT05810311|Darbepoetin alfa|darbepoetin alfa|mesh-list
139632709|NCT05810311|Hematinics|hematinics|mesh-ancestor
139632710|NCT05809297|Ciclopirox|ciclopirox|mesh-list
139632711|NCT05809297|Chitosan|chitosan|mesh-list
139632712|NCT05809297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139632713|NCT05809297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139632714|NCT05809297|Antimetabolites|antimetabolites|mesh-ancestor
139632715|NCT05809297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632716|NCT05809297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139632717|NCT05809297|Chelating Agents|chelating agents|mesh-ancestor
139632718|NCT05809297|Sequestering Agents|sequestering agents|mesh-ancestor
139632719|NCT05809297|Hemostatics|hemostatics|mesh-ancestor
139632720|NCT05809297|Coagulants|coagulants|mesh-ancestor
139632721|NCT05809297|Antifungal Agents|antifungal agents|mesh-ancestor
139632722|NCT05809297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632723|NCT05770375|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139632724|NCT05770375|Hallucinogens|hallucinogens|mesh-ancestor
139632725|NCT05770375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632726|NCT05770375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139632727|NCT05770375|Serotonin Agents|serotonin agents|mesh-ancestor
139632728|NCT05770375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632729|NCT05770375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632730|NCT05770375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139632731|NCT05770375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139632732|NCT05770375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139632733|NCT05770375|Adrenergic Agents|adrenergic agents|mesh-ancestor
139632734|NCT05745987|Vaccines|vaccines|mesh-list
139632735|NCT05745987|Immunologic Factors|immunologic factors|mesh-ancestor
139632736|NCT05745987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632737|NCT05736198|Dexmedetomidine|dexmedetomidine|mesh-list
139632738|NCT05736198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139632739|NCT05736198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632740|NCT05736198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632741|NCT05736198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632742|NCT05736198|Analgesics|analgesics|mesh-ancestor
139632743|NCT05736198|Sensory System Agents|sensory system agents|mesh-ancestor
139632744|NCT05736198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632745|NCT05736198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139632746|NCT05736198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139632747|NCT05736198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139632748|NCT05736198|Adrenergic Agents|adrenergic agents|mesh-ancestor
139632749|NCT05736198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632750|NCT05736198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632751|NCT05729503|Lidocaine|lidocaine|mesh-list
139632752|NCT05729503|Anesthetics, Local|anesthetics, local|mesh-ancestor
139632753|NCT05729503|Anesthetics|anesthetics|mesh-ancestor
139632754|NCT05729503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632755|NCT05729503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632756|NCT05729503|Sensory System Agents|sensory system agents|mesh-ancestor
139632757|NCT05729503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632758|NCT05729503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139632759|NCT05729503|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139632760|NCT05729503|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139632761|NCT05729503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139632762|NCT05729503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632763|NCT05725876|Ustekinumab|ustekinumab|mesh-list
139632764|NCT05725876|Dermatologic Agents|dermatologic agents|mesh-ancestor
139632765|NCT05720390|Quinine|quinine|mesh-list
139632766|NCT05720390|Antimalarials|antimalarials|mesh-ancestor
139632767|NCT05720390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139632768|NCT05720390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139632769|NCT05720390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632770|NCT05720390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139632771|NCT05720390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632772|NCT05720390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139632773|NCT05720390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632774|NCT05720390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139632775|NCT05720390|Analgesics|analgesics|mesh-ancestor
139632776|NCT05720390|Sensory System Agents|sensory system agents|mesh-ancestor
139632777|NCT05711641|Lidocaine|lidocaine|mesh-list
139632778|NCT05711641|Anesthetics, Local|anesthetics, local|mesh-ancestor
139632779|NCT05711641|Anesthetics|anesthetics|mesh-ancestor
139632780|NCT05711641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632781|NCT05711641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632782|NCT05711641|Sensory System Agents|sensory system agents|mesh-ancestor
139632783|NCT05711641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632784|NCT05711641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139632785|NCT05711641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139632786|NCT05711641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139632787|NCT05711641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139632788|NCT05711641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632789|NCT05693467|Dexamethasone|dexamethasone|mesh-list
139632790|NCT05693467|Ropivacaine|ropivacaine|mesh-list
139632791|NCT05693467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139632792|NCT05693467|Antiemetics|antiemetics|mesh-ancestor
139632793|NCT05693467|Autonomic Agents|autonomic agents|mesh-ancestor
139632794|NCT05693467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632795|NCT05693467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632796|NCT05693467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139632797|NCT05693467|Glucocorticoids|glucocorticoids|mesh-ancestor
139632798|NCT05693467|Hormones|hormones|mesh-ancestor
139632799|NCT05693467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139632800|NCT05693467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139632801|NCT05693467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632802|NCT05693467|Anesthetics, Local|anesthetics, local|mesh-ancestor
139632803|NCT05693467|Anesthetics|anesthetics|mesh-ancestor
139632804|NCT05693467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632805|NCT05693467|Sensory System Agents|sensory system agents|mesh-ancestor
139632806|NCT05658887|Gabapentin|gabapentin|mesh-list
139632807|NCT05658887|Analgesics|analgesics|mesh-ancestor
139632808|NCT05658887|Sensory System Agents|sensory system agents|mesh-ancestor
139632809|NCT05658887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632810|NCT05658887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632811|NCT05658887|Anticonvulsants|anticonvulsants|mesh-ancestor
139632812|NCT05658887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139632813|NCT05658887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139632814|NCT05658887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632815|NCT05658887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139632816|NCT05658887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139632817|NCT05658887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139632818|NCT05658887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632819|NCT05658887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632820|NCT05658887|Antimanic Agents|antimanic agents|mesh-ancestor
139632821|NCT05652283|Pamiparib|pamiparib|mesh-list
139632822|NCT05652283|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139632823|NCT05652283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632824|NCT05652283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632825|NCT05652283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632826|NCT05572255|Cenobamate|cenobamate|mesh-list
139632827|NCT05572255|Anticonvulsants|anticonvulsants|mesh-ancestor
139632828|NCT05531123|Gemcitabine|gemcitabine|mesh-list
139632829|NCT05531123|Tislelizumab|tislelizumab|mesh-list
139632830|NCT05531123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414552|NCT02804022|Morphine|morphine|mesh-list
139632831|NCT05531123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139632832|NCT05531123|Antimetabolites|antimetabolites|mesh-ancestor
139632833|NCT05531123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632834|NCT05531123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139632835|NCT05483465|Niacinamide|niacinamide|mesh-list
139632836|NCT05483465|Niacin|niacin|mesh-list
139632837|NCT05483465|Nicotinic Acids|nicotinic acids|mesh-list
139632838|NCT05483465|Vitamin B Complex|vitamin b complex|mesh-ancestor
139632839|NCT05483465|Vitamins|vitamins|mesh-ancestor
139632840|NCT05483465|Micronutrients|micronutrients|mesh-ancestor
139632841|NCT05483465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632842|NCT05483465|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139632843|NCT05483465|Antimetabolites|antimetabolites|mesh-ancestor
139632844|NCT05483465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632845|NCT05483465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139632846|NCT05483465|Vasodilator Agents|vasodilator agents|mesh-ancestor
139632847|NCT05477108|Budesonide|budesonide|mesh-list
139632848|NCT05477108|Formoterol Fumarate|formoterol fumarate|mesh-list
139632849|NCT05477108|Charcoal|charcoal|mesh-list
139632850|NCT05477108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139632851|NCT05477108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139632852|NCT05477108|Autonomic Agents|autonomic agents|mesh-ancestor
139632853|NCT05477108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632854|NCT05477108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632855|NCT05477108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139632856|NCT05477108|Respiratory System Agents|respiratory system agents|mesh-ancestor
139632857|NCT05477108|Glucocorticoids|glucocorticoids|mesh-ancestor
139632858|NCT05477108|Hormones|hormones|mesh-ancestor
139632859|NCT05477108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139632860|NCT05477108|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139632861|NCT05477108|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139632862|NCT05477108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139632863|NCT05477108|Adrenergic Agents|adrenergic agents|mesh-ancestor
139632864|NCT05477108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632865|NCT05477108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632866|NCT05477108|Antidotes|antidotes|mesh-ancestor
139632867|NCT05477108|Protective Agents|protective agents|mesh-ancestor
139632868|NCT05464979|Midazolam|midazolam|mesh-list
139632869|NCT05464979|Fentanyl|fentanyl|mesh-list
139632870|NCT05464979|Ketamine|ketamine|mesh-list
139632871|NCT05464979|Esketamine|esketamine|mesh-list
139632872|NCT05464979|Analgesics|analgesics|mesh-ancestor
139632873|NCT05464979|Sensory System Agents|sensory system agents|mesh-ancestor
139632874|NCT05464979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632875|NCT05464979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632876|NCT05464979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139632877|NCT05464979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139632878|NCT05464979|Anesthetics, General|anesthetics, general|mesh-ancestor
139632879|NCT05464979|Anesthetics|anesthetics|mesh-ancestor
139632880|NCT05464979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632881|NCT05464979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139632882|NCT05464979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139632883|NCT05464979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632884|NCT05464979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632885|NCT05464979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139632886|NCT05464979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139632887|NCT05464979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139632888|NCT05464979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139632889|NCT05464979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139632890|NCT05464979|GABA Modulators|gaba modulators|mesh-ancestor
139632891|NCT05464979|GABA Agents|gaba agents|mesh-ancestor
139632892|NCT05464979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139632893|NCT05464979|Narcotics|narcotics|mesh-ancestor
139632894|NCT05464979|Antidepressive Agents|antidepressive agents|mesh-ancestor
139632895|NCT05442463|Captopril|captopril|mesh-list
139632896|NCT05442463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139632897|NCT05442463|Protease Inhibitors|protease inhibitors|mesh-ancestor
139632898|NCT05442463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632899|NCT05442463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632900|NCT05442463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139632901|NCT05435222|Psychotropic Drugs|psychotropic drugs|mesh-list
139632902|NCT05402319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139632903|NCT05402319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139632904|NCT05402319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632905|NCT05402319|Antitubercular Agents|antitubercular agents|mesh-ancestor
139632906|NCT05398289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139632907|NCT05398289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139632908|NCT05398289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632909|NCT05398289|Antitubercular Agents|antitubercular agents|mesh-ancestor
139632910|NCT05373108|Macitentan|macitentan|mesh-list
139632911|NCT05373108|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139632912|NCT05373108|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139632913|NCT05373108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632914|NCT05373108|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139632915|NCT05368753|Lidocaine|lidocaine|mesh-list
139632916|NCT05368753|Ropivacaine|ropivacaine|mesh-list
139632917|NCT05368753|Anesthetics, Local|anesthetics, local|mesh-ancestor
139632918|NCT05368753|Anesthetics|anesthetics|mesh-ancestor
139632919|NCT05368753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139632920|NCT05368753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632921|NCT05368753|Sensory System Agents|sensory system agents|mesh-ancestor
139632922|NCT05368753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632923|NCT05368753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139632924|NCT05368753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139632925|NCT05368753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139632926|NCT05368753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139632927|NCT05368753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632928|NCT05345691|Denosumab|denosumab|mesh-list
139632929|NCT05345691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139632930|NCT05345691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632931|NCT05325073|Epoetin Alfa|epoetin alfa|mesh-list
139632932|NCT05325073|Hematinics|hematinics|mesh-ancestor
139632933|NCT05314998|Leucovorin|leucovorin|mesh-list
139632934|NCT05314998|Folic Acid|folic acid|mesh-list
139632935|NCT05314998|Gemcitabine|gemcitabine|mesh-list
139632936|NCT05314998|Capecitabine|capecitabine|mesh-list
139632937|NCT05314998|Fluorouracil|fluorouracil|mesh-list
139632938|NCT05314998|Oxaliplatin|oxaliplatin|mesh-list
139632939|NCT05314998|Irinotecan|irinotecan|mesh-list
139632940|NCT05314998|Levoleucovorin|levoleucovorin|mesh-list
139632941|NCT05314998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139632942|NCT05314998|Antimetabolites|antimetabolites|mesh-ancestor
139632943|NCT05314998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632944|NCT05314998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632945|NCT05314998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139632946|NCT05314998|Immunologic Factors|immunologic factors|mesh-ancestor
139632947|NCT05314998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632948|NCT05314998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139632949|NCT05314998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139632950|NCT05314998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632951|NCT05314998|Antidotes|antidotes|mesh-ancestor
139632952|NCT05314998|Protective Agents|protective agents|mesh-ancestor
139632953|NCT05314998|Vitamin B Complex|vitamin b complex|mesh-ancestor
139632954|NCT05314998|Vitamins|vitamins|mesh-ancestor
139632955|NCT05314998|Micronutrients|micronutrients|mesh-ancestor
139632956|NCT05314998|Hematinics|hematinics|mesh-ancestor
139632957|NCT05284344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139632958|NCT05284344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632959|NCT05250895|Misonidazole|misonidazole|mesh-list
139632960|NCT05250895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139632961|NCT05250895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139632962|NCT05250895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139632963|NCT05250895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139632964|NCT05219409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139632965|NCT05219409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139632966|NCT05219409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632967|NCT05219409|Incretins|incretins|mesh-ancestor
139632968|NCT05219409|Hormones|hormones|mesh-ancestor
139632969|NCT05219409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139632970|NCT05219409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139632971|NCT05219409|Protease Inhibitors|protease inhibitors|mesh-ancestor
139632972|NCT05219409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139632973|NCT05219409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632974|NCT05196932|Antibodies|antibodies|mesh-list
139632975|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
139632976|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632977|NCT05194111|Valsartan|valsartan|mesh-list
139632978|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139632979|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139632980|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139632981|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139632982|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632983|NCT05189756|Aprepitant|aprepitant|mesh-list
139632984|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
139632985|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
139632986|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
139632987|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139632988|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632989|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139632990|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139632991|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139632992|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139632994|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139632995|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139632996|NCT05181150|Hormones|hormones|mesh-ancestor
139632997|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139632998|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139632999|NCT05181150|Incretins|incretins|mesh-ancestor
139633000|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
139633001|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
139633002|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633003|NCT05151159|Antibodies|antibodies|mesh-list
139633004|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
139633005|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633006|NCT05144529|Nivolumab|nivolumab|mesh-list
139633007|NCT05144529|Ipilimumab|ipilimumab|mesh-list
139633008|NCT05144529|Evolocumab|evolocumab|mesh-list
139633009|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633010|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633011|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139633012|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633013|NCT05144529|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139633014|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139633015|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139633016|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
139633017|NCT05144529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139633018|NCT05144529|Protease Inhibitors|protease inhibitors|mesh-ancestor
139633019|NCT05144529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633020|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139633021|NCT05132920|Dexamethasone|dexamethasone|mesh-list
139633022|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139633023|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
139633024|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
139633025|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633026|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633027|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139633028|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
139633029|NCT05132920|Hormones|hormones|mesh-ancestor
139633030|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139633031|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139633032|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633033|NCT05129085|Dexamethasone|dexamethasone|mesh-list
139633034|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139633035|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
139633036|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
139633037|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633038|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633039|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139633040|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
139633041|NCT05129085|Hormones|hormones|mesh-ancestor
139633042|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139633043|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139633044|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633045|NCT05099471|Dexamethasone|dexamethasone|mesh-list
139633046|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
139633047|NCT05099471|Rituximab|rituximab|mesh-list
139633048|NCT05099471|Venetoclax|venetoclax|mesh-list
139633049|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633050|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
139633051|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633052|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139633053|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139633054|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
139633055|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633056|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633057|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139633058|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139414776|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
139633059|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
139633060|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
139633061|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633062|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139633063|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
139633064|NCT05099471|Hormones|hormones|mesh-ancestor
139633065|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139633066|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139633067|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633068|NCT05087693|Albuterol|albuterol|mesh-list
139633069|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139633070|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
139633071|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633072|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633073|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139633074|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
139633075|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
139633076|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139633077|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139633078|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139633079|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139633080|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
139633081|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633082|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633083|NCT05081583|Midazolam|midazolam|mesh-list
139633084|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139633085|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139633086|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633087|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633088|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139633089|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139633090|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139633091|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139633092|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
139633093|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
139633094|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
139633095|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
139633096|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633097|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633098|NCT05070754|Cantharidin|cantharidin|mesh-list
139633099|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633100|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633101|NCT05052099|Bevacizumab|bevacizumab|mesh-list
139633102|NCT05052099|Atezolizumab|atezolizumab|mesh-list
139633103|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633104|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633105|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139633106|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139633107|NCT05052099|Growth Substances|growth substances|mesh-ancestor
139633108|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633109|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
139633110|NCT05052099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139633111|NCT05052099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633112|NCT05037487|Dronabinol|dronabinol|mesh-list
139633113|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
139633114|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633115|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139633116|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139633117|NCT05037487|Analgesics|analgesics|mesh-ancestor
139633118|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
139633119|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633120|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139633121|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139633122|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633123|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633124|NCT05037487|Hormones|hormones|mesh-ancestor
139633125|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139633126|NCT05001074|Tacrolimus|tacrolimus|mesh-list
139633127|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633128|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
139633129|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633130|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139633131|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633132|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633133|NCT04985890|UB-421|ub-421|mesh-list
139633134|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139633135|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
139633136|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139633137|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139633138|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
139633139|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139633140|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633141|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139633142|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139633143|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139633144|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633145|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
139633146|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633147|NCT04899115|Vancomycin|vancomycin|mesh-list
139633148|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139633149|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139633150|NCT04868903|Vitamin D|vitamin d|mesh-list
139633151|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
139633152|NCT04868903|Vitamins|vitamins|mesh-ancestor
139633153|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
139633154|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633155|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139633156|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139633157|NCT04859530|Lugol's solution|lugol's solution|mesh-list
139633158|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
139633159|NCT04859530|Coagulants|coagulants|mesh-ancestor
139633160|NCT04851301|Naloxone|naloxone|mesh-list
139633161|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139633162|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633163|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
139633164|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633165|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
139633166|NCT04801966|Nivolumab|nivolumab|mesh-list
139633167|NCT04801966|Atezolizumab|atezolizumab|mesh-list
139633168|NCT04801966|Olaparib|olaparib|mesh-list
139633169|NCT04801966|Palbociclib|palbociclib|mesh-list
139633170|NCT04801966|Trametinib|trametinib|mesh-list
139633171|NCT04801966|Vemurafenib|vemurafenib|mesh-list
139633172|NCT04801966|Dabrafenib|dabrafenib|mesh-list
139633173|NCT04801966|Talazoparib|talazoparib|mesh-list
139633174|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633175|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633176|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139633177|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633178|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139633179|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633180|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139633181|NCT04789915|Memantine|memantine|mesh-list
139633182|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139633183|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139633184|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
139633185|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633186|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633187|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633188|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139633189|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139633190|NCT04771299|Cariprazine|cariprazine|mesh-list
139633191|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139633192|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139633193|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633194|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633195|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139633196|NCT04704063|Vitamin E|vitamin e|mesh-list
139633197|NCT04704063|Tocopherols|tocopherols|mesh-list
139633198|NCT04704063|Tocotrienols|tocotrienols|mesh-list
139633199|NCT04704063|Tocovid|tocovid|mesh-list
139633200|NCT04704063|Vitamins|vitamins|mesh-ancestor
138761670|NCT02726503|Lenvatinib|lenvatinib|mesh-list
139633201|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
139633202|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633203|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
139633204|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633205|NCT04704063|Protective Agents|protective agents|mesh-ancestor
139633206|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
139633207|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139633208|NCT04703036|Glycine|glycine|mesh-list
139633209|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
139633210|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139633211|NCT04703036|Expectorants|expectorants|mesh-ancestor
139633212|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
139633213|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139633214|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
139633215|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633216|NCT04703036|Protective Agents|protective agents|mesh-ancestor
139633217|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633218|NCT04703036|Antidotes|antidotes|mesh-ancestor
139633219|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
139633220|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633221|NCT04636255|Calcium|calcium|mesh-list
139633222|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139633223|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633224|NCT04635176|Dexamethasone|dexamethasone|mesh-list
139633225|NCT04635176|Epinephrine|epinephrine|mesh-list
139633226|NCT04635176|Bupivacaine|bupivacaine|mesh-list
139633227|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139633228|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
139633229|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
139633230|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633231|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633232|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139633233|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
139633234|NCT04635176|Hormones|hormones|mesh-ancestor
139633235|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139633236|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139633237|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633238|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
139633239|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
139633240|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633241|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
139633242|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139633243|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139633244|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
139633245|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633246|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633247|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139633248|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139633249|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139633250|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
139633251|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
139633252|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
139633253|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139633254|NCT04625907|Dactinomycin|dactinomycin|mesh-list
139633255|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
139633256|NCT04625907|Temozolomide|temozolomide|mesh-list
139633257|NCT04625907|Ifosfamide|ifosfamide|mesh-list
139633258|NCT04625907|Doxorubicin|doxorubicin|mesh-list
139633259|NCT04625907|Irinotecan|irinotecan|mesh-list
139633260|NCT04625907|Vincristine|vincristine|mesh-list
139633261|NCT04625907|Vinorelbine|vinorelbine|mesh-list
138761734|NCT02694289|Metformin|metformin|mesh-list
139633262|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633263|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
139633264|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633265|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139633266|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139633267|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
139633268|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633269|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633270|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139633271|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139633272|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139633273|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139633274|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633275|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139633276|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139633277|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
139633278|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
139633279|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
139633280|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139633281|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139633282|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139633283|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139633284|NCT04623086|Insulin|insulin|mesh-list
139633285|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139633286|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
139633287|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139633288|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633289|NCT04574713|Candesartan|candesartan|mesh-list
139633290|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
139633291|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139633292|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139633293|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139633294|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633295|NCT04569877|Molgramostim|molgramostim|mesh-list
139633296|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139633297|NCT04569877|Sargramostim|sargramostim|mesh-list
139633298|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633299|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
139633300|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633301|NCT04550234|Allopurinol|allopurinol|mesh-list
139633302|NCT04550234|Verinurad|verinurad|mesh-list
139633303|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
139633304|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633305|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633306|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
139633307|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139633308|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139633309|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
139633310|NCT04550234|Protective Agents|protective agents|mesh-ancestor
139633311|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633312|NCT04541797|Empagliflozin|empagliflozin|mesh-list
139633313|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139633314|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633315|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139633316|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633317|NCT04540666|Propofol|propofol|mesh-list
139633318|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139633319|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633320|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633321|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139633322|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
139633323|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
139633324|NCT04530383|Metformin|metformin|mesh-list
139633325|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139633326|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633327|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
139633328|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139633329|NCT04431245|Entecavir|entecavir|mesh-list
139633330|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
139633331|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139633332|NCT04421248|Methylphenidate|methylphenidate|mesh-list
139633333|NCT04421248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139633334|NCT04421248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633335|NCT04421248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139633336|NCT04421248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139633337|NCT04421248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139633338|NCT04421248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633339|NCT04421248|Dopamine Agents|dopamine agents|mesh-ancestor
139633340|NCT04421248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633341|NCT04303689|Colchicine|colchicine|mesh-list
139633342|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
139633343|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139633344|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
139633345|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
139633346|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
139633347|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633348|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633349|NCT04217278|Cytarabine|cytarabine|mesh-list
139633350|NCT04217278|Fludarabine|fludarabine|mesh-list
139633351|NCT04217278|Busulfan|busulfan|mesh-list
139633352|NCT04217278|Thiotepa|thiotepa|mesh-list
139633353|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633354|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139633355|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
139633356|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633357|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633358|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
139633359|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633360|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
139633361|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139633362|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
139633363|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139633364|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139633366|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633367|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633368|NCT04177953|Carboplatin|carboplatin|mesh-list
139633369|NCT04177953|Nivolumab|nivolumab|mesh-list
139633370|NCT04177953|Pemetrexed|pemetrexed|mesh-list
139633371|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633372|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633373|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139633374|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633375|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633376|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138761858|NCT02716129|Morphine|morphine|mesh-list
139633377|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139633378|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139633379|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
139633380|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633381|NCT04061512|Dexamethasone|dexamethasone|mesh-list
139633382|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
139633383|NCT04061512|Rituximab|rituximab|mesh-list
139633384|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633385|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
139633386|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633387|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139633388|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139633389|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
139633390|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633391|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633392|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139633393|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139633394|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
139633395|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
139633396|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633397|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139633398|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
139633399|NCT04061512|Hormones|hormones|mesh-ancestor
139633400|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139633401|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139633402|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633403|NCT04019548|Cisplatin|cisplatin|mesh-list
139633404|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633405|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
139633406|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139633407|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139633408|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
139633409|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
139633410|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633411|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633412|NCT04002271|Propofol|propofol|mesh-list
139633413|NCT04002271|Sevoflurane|sevoflurane|mesh-list
139633414|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
139633415|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633416|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633417|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139633418|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139633419|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
139633420|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139633421|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139633422|NCT03972592|Sirolimus|sirolimus|mesh-list
139633423|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139633424|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139633425|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139633426|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633427|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
139633428|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633429|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
139633430|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633431|NCT03889743|Dexamethasone|dexamethasone|mesh-list
139633432|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139633433|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
139633434|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
139633435|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633436|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633437|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139633438|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
139415150|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139633439|NCT03889743|Hormones|hormones|mesh-ancestor
139633440|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139633441|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139633442|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633444|NCT03875872|Anesthetics|anesthetics|mesh-list
139633445|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
139633446|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139633447|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633448|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633449|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139633450|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
139633451|NCT03859908|Ethanol|ethanol|mesh-list
139633452|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
139633453|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139633454|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139633455|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139633456|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633457|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633458|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
139633459|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
139633460|NCT03825536|Methamphetamine|methamphetamine|mesh-list
139633461|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139633462|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633463|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
139633464|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
139633465|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633466|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
139633467|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633468|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633469|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
139633470|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139633471|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139633472|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139633473|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139633474|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
139633475|NCT03797196|Everolimus|everolimus|mesh-list
139633476|NCT03797196|Tacrolimus|tacrolimus|mesh-list
139633477|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633478|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
139633479|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633480|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139633481|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633482|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633483|NCT03797196|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139633484|NCT03797196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139633485|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633486|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139633487|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139633488|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
139633489|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139633490|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139633491|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
139633492|NCT03775382|Vitamins|vitamins|mesh-ancestor
139633493|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
139633494|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633495|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
139633496|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633497|NCT03775382|Protective Agents|protective agents|mesh-ancestor
139633498|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
139633499|NCT03747432|Propofol|propofol|mesh-list
139633500|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139633501|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633502|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633503|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139633504|NCT03747432|Analgesics|analgesics|mesh-ancestor
139633505|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
139633506|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633507|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139633508|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139633509|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139633510|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
139633511|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633512|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415232|NCT05944341|Mydriatics|mydriatics|mesh-ancestor
139633513|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139633515|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
139633516|NCT03724019|Ketamine|ketamine|mesh-list
139633517|NCT03724019|Analgesics|analgesics|mesh-ancestor
139633518|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
139633519|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633520|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633521|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139633522|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139633523|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
139633524|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
139633525|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633526|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139633527|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139633528|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633529|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633530|NCT03697512|Rituximab|rituximab|mesh-list
139633531|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633532|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633533|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
139633534|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633535|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139633536|NCT03667651|Decanoic acid|decanoic acid|mesh-list
139633537|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
139633538|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139633539|NCT03649633|Vitamins|vitamins|mesh-list
139633540|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
139633541|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
139633542|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633543|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139633544|NCT03620903|Rituximab|rituximab|mesh-list
139633545|NCT03620903|Bortezomib|bortezomib|mesh-list
139633546|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633547|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633548|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
139633549|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633550|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139633551|NCT03497156|Lercanidipine|lercanidipine|mesh-list
139633552|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139633553|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139633554|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139633555|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633556|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139633557|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633558|NCT03471117|Pioglitazone|pioglitazone|mesh-list
139633559|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139633560|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633561|NCT03435939|Losartan|losartan|mesh-list
139633562|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139633563|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139633564|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139633565|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139633566|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633567|NCT03422393|Venetoclax|venetoclax|mesh-list
139633568|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633569|NCT03377543|Aspirin|aspirin|mesh-list
139633570|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139633571|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139633572|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139633573|NCT03377543|Analgesics|analgesics|mesh-ancestor
139633574|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
139633575|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633576|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633577|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139633578|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139633579|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139633580|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633581|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139633582|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139633583|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633584|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
139633585|NCT03365908|Ropivacaine|ropivacaine|mesh-list
139633586|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
139633587|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
139633588|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633589|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633590|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
139633591|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633592|NCT03362047|Macitentan|macitentan|mesh-list
139633593|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139633594|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139633595|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633596|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139633597|NCT03337919|Nivolumab|nivolumab|mesh-list
139633598|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633599|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633600|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139633601|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633602|NCT03236324|Epinephrine|epinephrine|mesh-list
139633603|NCT03236324|Bupivacaine|bupivacaine|mesh-list
139633604|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
139633605|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
139633606|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633607|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633608|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
139633609|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633610|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139633611|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139633612|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
139633613|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633614|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633615|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139633616|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139633617|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
139633618|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139633619|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
139633620|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
139633621|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
139633622|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139633623|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
139633624|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139633625|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633626|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
139633627|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139633628|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139633629|NCT03229538|Prednisolone|prednisolone|mesh-list
139633630|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
139633631|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139633632|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
139633633|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139633634|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
139633635|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
139633636|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633637|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633638|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139633639|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
139633640|NCT03229538|Hormones|hormones|mesh-ancestor
139633641|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139633642|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139633643|NCT03229538|Protective Agents|protective agents|mesh-ancestor
139633644|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139633645|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633646|NCT03148795|Talazoparib|talazoparib|mesh-list
139633647|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139633648|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633649|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633650|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633651|NCT03070054|Epinephrine|epinephrine|mesh-list
139633652|NCT03070054|Bupivacaine|bupivacaine|mesh-list
139633653|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
139633654|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
139633655|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633656|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633657|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
139633658|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633659|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139633660|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139633661|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
139633662|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633663|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633664|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139633665|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139633666|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
139633667|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139633668|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
139633669|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
139633670|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
139633671|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139633672|NCT03040778|Vitamin E|vitamin e|mesh-list
139633673|NCT03040778|Tocopherols|tocopherols|mesh-list
139633674|NCT03040778|Tocotrienols|tocotrienols|mesh-list
139633675|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
139633676|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
139633677|NCT03040778|Vitamins|vitamins|mesh-ancestor
139633678|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
139633679|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633680|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
139633681|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633682|NCT03040778|Protective Agents|protective agents|mesh-ancestor
139633683|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139633684|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633685|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139633686|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139633687|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
139633688|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139633689|NCT02962414|Everolimus|everolimus|mesh-list
139633690|NCT02962414|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139633691|NCT02962414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139633692|NCT02962414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633693|NCT02962414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633694|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633695|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
139633696|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633697|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633698|NCT02959047|Alirocumab|alirocumab|mesh-list
139633699|NCT02959047|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139633700|NCT02959047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139633701|NCT02959047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139633702|NCT02959047|Antimetabolites|antimetabolites|mesh-ancestor
139633703|NCT02959047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633704|NCT02959047|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139633705|NCT02959047|Protease Inhibitors|protease inhibitors|mesh-ancestor
139633706|NCT02959047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633707|NCT02959047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139633708|NCT02895750|Metformin|metformin|mesh-list
139633709|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139633710|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633711|NCT02895360|Lisavanbulin|lisavanbulin|mesh-list
139633712|NCT02895360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139633713|NCT02895360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633714|NCT02895360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633715|NCT02895360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633716|NCT02890784|Dasatinib|dasatinib|mesh-list
139633717|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633718|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139633719|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633720|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633721|NCT02863809|Riboflavin|riboflavin|mesh-list
139633722|NCT02863809|Dextrans|dextrans|mesh-list
139633723|NCT02863809|Vitamins|vitamins|mesh-ancestor
139633724|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
139633725|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633726|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
139633727|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139633728|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
139633729|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
139633730|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
139633731|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
139633732|NCT02823028|Nicotine|nicotine|mesh-list
139633733|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139633734|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
139633735|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633736|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633737|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139633738|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139633739|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
139633740|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633741|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633742|NCT02768363|Valacyclovir|valacyclovir|mesh-list
139633743|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
139633744|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139633745|NCT02729805|Ketamine|ketamine|mesh-list
139633746|NCT02729805|Analgesics|analgesics|mesh-ancestor
139633747|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
139633748|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633749|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633750|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139633751|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139633752|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
139633753|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
139633754|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633755|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139633756|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139633757|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633758|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633759|NCT02521311|Clemastine|clemastine|mesh-list
139633760|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
139633761|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
139633762|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139633763|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
139633764|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
139633765|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139633766|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633767|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633768|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139633769|NCT02437045|Meropenem|meropenem|mesh-list
139633770|NCT02437045|Tazobactam|tazobactam|mesh-list
139633771|NCT02437045|Piperacillin|piperacillin|mesh-list
139633772|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139633773|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139633774|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139633775|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139633776|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633777|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633778|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
139633779|NCT02308527|Temozolomide|temozolomide|mesh-list
139633780|NCT02308527|Bevacizumab|bevacizumab|mesh-list
139633781|NCT02308527|Irinotecan|irinotecan|mesh-list
139633782|NCT02308527|Topotecan|topotecan|mesh-list
139633783|NCT02308527|Dinutuximab|dinutuximab|mesh-list
139633784|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633785|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
139633786|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633787|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139633788|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139633789|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
139633790|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633791|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633792|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139633793|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633794|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139633795|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139633796|NCT02308527|Growth Substances|growth substances|mesh-ancestor
139633797|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
139633798|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139633799|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139633800|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633801|NCT02289079|Bupivacaine|bupivacaine|mesh-list
139633802|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
139633803|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
139633804|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633805|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633806|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
139633807|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633808|NCT02131753|Cladribine|cladribine|mesh-list
139633809|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633810|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633811|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
139633812|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633813|NCT02058706|Leuprolide|leuprolide|mesh-list
139633814|NCT02058706|Goserelin|goserelin|mesh-list
139633815|NCT02058706|Bicalutamide|bicalutamide|mesh-list
139633816|NCT02058706|Androgens|androgens|mesh-list
139633817|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139633818|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
139633819|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139633820|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633821|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139633822|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633823|NCT02058706|Hormones|hormones|mesh-ancestor
139633824|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139633825|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
139633826|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
139633827|NCT01644110|Pomalidomide|pomalidomide|mesh-list
139633828|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
139633829|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633830|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139633831|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139633832|NCT01644110|Growth Substances|growth substances|mesh-ancestor
139633833|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
139633834|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633835|NCT01478542|Rituximab|rituximab|mesh-list
139633836|NCT01478542|Vincristine|vincristine|mesh-list
139633837|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633838|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633839|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
139633840|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633841|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139633842|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139633843|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
139633844|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
139633845|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
139633846|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633847|NCT01406678|Sufentanil|sufentanil|mesh-list
139633848|NCT01406678|Dsuvia|dsuvia|mesh-list
139633849|NCT01406678|Isoflurane|isoflurane|mesh-list
139633850|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
139633851|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633852|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633853|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139633854|NCT01406678|Narcotics|narcotics|mesh-ancestor
139633855|NCT01406678|Analgesics|analgesics|mesh-ancestor
139633856|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
139633857|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633858|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139633859|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139633860|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
139633861|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139633862|NCT01397929|Lisavanbulin|lisavanbulin|mesh-list
139633863|NCT01397929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139633864|NCT01397929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633865|NCT01397929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139633866|NCT01397929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633867|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139633868|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633869|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633870|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633871|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139633872|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139633873|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139633874|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
139633875|NCT00695214|Propofol|propofol|mesh-list
139633876|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139633877|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139633878|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633879|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139633880|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
139633881|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
139633882|NCT00678327|Prednisolone|prednisolone|mesh-list
139633883|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
139633884|NCT00678327|Dacarbazine|dacarbazine|mesh-list
139633885|NCT00678327|Doxorubicin|doxorubicin|mesh-list
139633886|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139633887|NCT00678327|Etoposide|etoposide|mesh-list
139633888|NCT00678327|Vincristine|vincristine|mesh-list
139633889|NCT00678327|Bleomycin|bleomycin|mesh-list
139633890|NCT00678327|Vinblastine|vinblastine|mesh-list
139633891|NCT00678327|Procarbazine|procarbazine|mesh-list
139633892|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633893|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
139633894|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633895|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139633896|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139633897|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
139633898|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633899|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633900|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139633901|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139633902|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139633903|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139633904|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633905|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139633906|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
139633907|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
139633908|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
139633909|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139633910|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
139633911|NCT00678327|Hormones|hormones|mesh-ancestor
139633912|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139633913|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139633914|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
139633915|NCT00602667|Cisplatin|cisplatin|mesh-list
139633916|NCT00602667|Carboplatin|carboplatin|mesh-list
139633917|NCT00602667|Methotrexate|methotrexate|mesh-list
139633918|NCT00602667|Etoposide|etoposide|mesh-list
139633919|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
139633920|NCT00602667|Vincristine|vincristine|mesh-list
139633921|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139633922|NCT00602667|Topotecan|topotecan|mesh-list
139633923|NCT00602667|Vinblastine|vinblastine|mesh-list
139633924|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633925|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
139633926|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633927|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139633928|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139633929|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
139633930|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633931|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633932|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139633933|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139633934|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
139633935|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139633936|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139633937|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
139633938|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
139633939|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633940|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139633941|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139633942|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139633943|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139633944|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139633945|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
139633946|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
139633947|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
139633948|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139633949|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139633950|NCT00544466|Fludarabine|fludarabine|mesh-list
139633951|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
139633952|NCT00544466|Melphalan|melphalan|mesh-list
139633953|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633954|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139633955|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
139633956|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633957|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633958|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
139633959|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633960|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139633961|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
139633962|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139633963|NCT00519675|Alitretinoin|alitretinoin|mesh-list
139633964|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633965|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
139633966|NCT00492999|Leucovorin|leucovorin|mesh-list
139633967|NCT00492999|Dexamethasone|dexamethasone|mesh-list
139633968|NCT00492999|Fluorouracil|fluorouracil|mesh-list
139633969|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
139633970|NCT00492999|Irinotecan|irinotecan|mesh-list
139633971|NCT00492999|Floxuridine|floxuridine|mesh-list
139633972|NCT00492999|Calcium|calcium|mesh-list
139633973|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
139633974|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139633975|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
139633976|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
139633977|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139633978|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139633979|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139633980|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
139633981|NCT00492999|Hormones|hormones|mesh-ancestor
139633982|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139633983|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139633984|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139633985|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139633986|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
139633987|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139633988|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139633989|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139633990|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
139633991|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139633992|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139633993|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139633994|NCT00492999|Antidotes|antidotes|mesh-ancestor
139633995|NCT00492999|Protective Agents|protective agents|mesh-ancestor
139633996|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
139633997|NCT00492999|Vitamins|vitamins|mesh-ancestor
139633998|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
139633999|NCT00413439|Isavuconazole|isavuconazole|mesh-list
139634000|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
139634001|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634002|NCT00374075|Valproic Acid|valproic acid|mesh-list
139634003|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
139634004|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634005|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634006|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
139634007|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634008|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634009|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
139634010|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139634011|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139634012|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139634013|NCT00309621|Alitretinoin|alitretinoin|mesh-list
139634014|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634015|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
139634016|NCT00124475|Alitretinoin|alitretinoin|mesh-list
139634017|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634018|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
139634019|NCT00124436|Alitretinoin|alitretinoin|mesh-list
139634020|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634021|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
139634022|NCT00112931|Rituximab|rituximab|mesh-list
139634023|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139634024|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634025|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
139634026|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634027|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634028|NCT00110110|Cyclosporine|cyclosporine|mesh-list
139634029|NCT00110110|Carboplatin|carboplatin|mesh-list
139634030|NCT00110110|Etoposide|etoposide|mesh-list
139634031|NCT00110110|Vincristine|vincristine|mesh-list
139634032|NCT00110110|Cyclosporins|cyclosporins|mesh-list
139634033|NCT00110110|Lenograstim|lenograstim|mesh-list
139634034|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634035|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139634036|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139634037|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139634038|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634039|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634040|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139634041|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
139634042|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634043|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
139634044|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
139634045|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
139415756|NCT03699319|Antidotes|antidotes|mesh-ancestor
139634046|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139634047|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
139634048|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634049|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
139634050|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634051|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139634052|NCT05307003|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139634053|NCT05307003|Trazodone|trazodone|mesh-list
139634054|NCT05307003|Antidepressive Agents|antidepressive agents|mesh-ancestor
139634055|NCT05307003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139634056|NCT05307003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139634057|NCT05307003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139634058|NCT05307003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139634059|NCT05307003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634060|NCT05307003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139634061|NCT05307003|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139634062|NCT05307003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139634063|NCT05307003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139634064|NCT05307003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634065|NCT05307003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634066|NCT05307003|Serotonin Agents|serotonin agents|mesh-ancestor
139634067|NCT05307003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139634068|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
139634069|NCT03153917|Melatonin|melatonin|mesh-list
139634070|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
139634071|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634072|NCT03153917|Protective Agents|protective agents|mesh-ancestor
139634073|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634074|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139634075|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139634076|NCT01096875|Atorvastatin|atorvastatin|mesh-list
139634077|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139634078|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139634079|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
139634080|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634081|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139634082|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139634083|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634084|NCT01097343|Clopidogrel|clopidogrel|mesh-list
139634085|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139634086|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139634087|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139634088|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139634089|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
139634090|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634091|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634092|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634093|NCT03580187|Morphine|morphine|mesh-list
139634094|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139634095|NCT03580187|Narcotics|narcotics|mesh-ancestor
139634096|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139634097|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634098|NCT03580187|Analgesics|analgesics|mesh-ancestor
139634099|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
139634100|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634101|NCT01098747|Ibuprofen|ibuprofen|mesh-list
139634102|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139634103|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139634104|NCT01098747|Analgesics|analgesics|mesh-ancestor
139634105|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
139634106|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634107|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634108|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139634109|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634110|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139634111|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634112|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634113|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
139634114|NCT02085161|Olodaterol|olodaterol|mesh-list
139634115|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139634116|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
139634117|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634118|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634119|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139634120|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
139415825|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
139634121|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
139634122|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139634123|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
139634124|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634125|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634127|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634128|NCT01035333|Orlistat|orlistat|mesh-list
139634129|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634130|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634131|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139634132|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139634133|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
139634134|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139634135|NCT03152981|Remifentanil|remifentanil|mesh-list
139634136|NCT03152981|Propofol|propofol|mesh-list
139634137|NCT03152981|Desflurane|desflurane|mesh-list
139634138|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139634139|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139634140|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634141|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139634142|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
139634143|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
139634144|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139634145|NCT03152981|Narcotics|narcotics|mesh-ancestor
139634146|NCT03152981|Analgesics|analgesics|mesh-ancestor
139634147|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
139634148|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634149|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139634150|NCT05384015|Carboplatin|carboplatin|mesh-list
139634151|NCT05384015|Pembrolizumab|pembrolizumab|mesh-list
139634152|NCT05384015|Etoposide|etoposide|mesh-list
139634153|NCT05384015|Etoposide phosphate|etoposide phosphate|mesh-list
139634154|NCT05384015|Lenvatinib|lenvatinib|mesh-list
139634155|NCT05384015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634156|NCT05384015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139634157|NCT05384015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139634158|NCT05384015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634159|NCT05384015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139634160|NCT05384015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139634161|NCT05384015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139634162|NCT05384015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634163|NCT05384015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139634164|NCT03572387|Azacitidine|azacitidine|mesh-list
139634165|NCT03572387|Tretinoin|tretinoin|mesh-list
139634166|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139634167|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
139634168|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634169|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634170|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634171|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
139634172|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
139634173|NCT04728971|Caspofungin|caspofungin|mesh-list
139634174|NCT04728971|Micafungin|micafungin|mesh-list
139634175|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
139634176|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634177|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634178|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634179|NCT03568643|Amoxicillin|amoxicillin|mesh-list
139634180|NCT03568643|Azithromycin|azithromycin|mesh-list
139634181|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139634182|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634183|NCT01100931|Paclitaxel|paclitaxel|mesh-list
139634184|NCT01100931|Carboplatin|carboplatin|mesh-list
139634185|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139634186|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634187|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
139634188|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
139634189|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
139634190|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634191|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
139634192|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
139634193|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139634194|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139634195|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634196|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
139634197|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139634198|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139634200|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
139634201|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634202|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634203|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139634204|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634205|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
139634206|NCT02246595|Vilobelimab|vilobelimab|mesh-list
139634207|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139634208|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139634209|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
139634210|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634211|NCT01106859|Zolpidem|zolpidem|mesh-list
139634212|NCT01106859|Zopiclone|zopiclone|mesh-list
139634213|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139634214|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139634215|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139634216|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634217|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139634218|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
139634219|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
139634220|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634221|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634222|NCT01042509|Rituximab|rituximab|mesh-list
139634223|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
139634224|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139634225|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634226|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
139634227|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634228|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634229|NCT02179671|Docetaxel|docetaxel|mesh-list
139634230|NCT02179671|Gefitinib|gefitinib|mesh-list
139634231|NCT02179671|Tremelimumab|tremelimumab|mesh-list
139634232|NCT02179671|Osimertinib|osimertinib|mesh-list
139634233|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634234|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
139634235|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
139634236|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
139634237|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634238|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139634239|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634240|NCT01110135|Dexamethasone|dexamethasone|mesh-list
139634241|NCT01110135|Etoposide|etoposide|mesh-list
139634242|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
139634243|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139634244|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139634245|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
139634246|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
139634247|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634248|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634249|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139634250|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
139634251|NCT01110135|Hormones|hormones|mesh-ancestor
139634252|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139634253|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139634254|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634255|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139634256|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139634257|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139634258|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634259|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634260|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139634261|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
139634262|NCT01112241|Albuterol|albuterol|mesh-list
139634263|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
139634264|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139634265|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
139634266|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634267|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634268|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139634269|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
139634270|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
139634271|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139634272|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
139634273|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634274|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634275|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
139634276|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139634277|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139634278|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139634279|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139634280|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
139634281|NCT03013881|Trastuzumab|trastuzumab|mesh-list
139634282|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139634283|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634284|NCT02174913|Fentanyl|fentanyl|mesh-list
139634285|NCT02174913|Propofol|propofol|mesh-list
139634286|NCT02174913|Atracurium|atracurium|mesh-list
139634287|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139634288|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139634289|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634290|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139634291|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
139634292|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
139634293|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139634294|NCT02174913|Narcotics|narcotics|mesh-ancestor
139634295|NCT02174913|Analgesics|analgesics|mesh-ancestor
139634296|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
139634297|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634298|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139634299|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139634300|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139634301|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139634302|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139634303|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139634304|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
139634305|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634306|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634307|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
139634308|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139634309|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139634310|NCT01114503|Prednisolone|prednisolone|mesh-list
139634311|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
139634312|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139634313|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
139634314|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139634315|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
139634316|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
139634317|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634318|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634319|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139634320|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
139634321|NCT01114503|Hormones|hormones|mesh-ancestor
139634322|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139634323|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139634324|NCT01114503|Protective Agents|protective agents|mesh-ancestor
139634325|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139634326|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634327|NCT03015831|Colchicine|colchicine|mesh-list
139634328|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
139634329|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634330|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
139634331|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
139634332|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
139634333|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634334|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634335|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
139634336|NCT01114581|Guaifenesin|guaifenesin|mesh-list
139634337|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139634338|NCT01114581|Expectorants|expectorants|mesh-ancestor
139634339|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
139634340|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139634341|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139634342|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
139634343|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138986512|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139634344|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634345|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634346|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
139634347|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139634348|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
139634349|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
139634350|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634351|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
139634352|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139634353|NCT01114893|Travoprost|travoprost|mesh-list
139634354|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139634355|NCT01114971|Labetalol|labetalol|mesh-list
139634356|NCT01114971|Fentanyl|fentanyl|mesh-list
139634357|NCT01114971|Esmolol|esmolol|mesh-list
139634358|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139634359|NCT01114971|Narcotics|narcotics|mesh-ancestor
139634360|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139634361|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634362|NCT01114971|Analgesics|analgesics|mesh-ancestor
139634363|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
139634364|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634365|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139634366|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139634367|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
139634368|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
139634369|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139634370|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139634371|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139634372|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
139634373|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634374|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634375|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139634376|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
139634377|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
139634378|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139634379|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139634380|NCT01044693|Metoprolol|metoprolol|mesh-list
139634381|NCT01044693|Nebivolol|nebivolol|mesh-list
139634382|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
139634383|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
139634384|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139634385|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139634386|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634387|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634388|NCT01044693|Urological Agents|urological agents|mesh-ancestor
139634389|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139634390|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139634391|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
139634392|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
139634393|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634394|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634395|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139634396|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139634397|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139634398|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
139634399|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634400|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139634401|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139634402|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139634403|NCT01115517|Bevacizumab|bevacizumab|mesh-list
139634404|NCT01115517|Mitomycins|mitomycins|mesh-list
139634405|NCT01115517|Mitomycin|mitomycin|mesh-list
139634406|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139634407|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634408|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139634409|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139634410|NCT01115517|Growth Substances|growth substances|mesh-ancestor
139634411|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634412|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
139634413|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139634414|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
139634415|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634416|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139634417|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634418|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
139634419|NCT03015675|Vitamins|vitamins|mesh-ancestor
139634420|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
139634421|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634422|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
139634423|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634424|NCT03015675|Protective Agents|protective agents|mesh-ancestor
139634425|NCT01044771|Tenofovir|tenofovir|mesh-list
139634426|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
139634427|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
139634428|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634429|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139634430|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139634431|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634432|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634433|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139634434|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139634435|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139634436|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139634437|NCT01115673|Acetaminophen|acetaminophen|mesh-list
139634438|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139634439|NCT01115673|Analgesics|analgesics|mesh-ancestor
139634440|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
139634441|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634442|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634443|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
139634444|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139634445|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
139634446|NCT01118091|Aldesleukin|aldesleukin|mesh-list
139634447|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634448|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139634449|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139634450|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
139634451|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634452|NCT01045551|Apremilast|apremilast|mesh-list
139634453|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139634454|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139634455|NCT01045551|Analgesics|analgesics|mesh-ancestor
139634456|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
139634457|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634458|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634459|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139634460|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634461|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139634462|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139634463|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634464|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634465|NCT01047189|Clindamycin|clindamycin|mesh-list
139634466|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
139634467|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
139634468|NCT01047189|Tretinoin|tretinoin|mesh-list
139634469|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139634470|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634471|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139634472|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634473|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634474|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634475|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
139634476|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
139634477|NCT03012945|Anesthetics|anesthetics|mesh-list
139634478|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139634479|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634480|NCT01121211|Testosterone|testosterone|mesh-list
139634481|NCT01121211|Androgens|androgens|mesh-ancestor
139634482|NCT01121211|Hormones|hormones|mesh-ancestor
139634483|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139634484|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634485|NCT01162551|Sirolimus|sirolimus|mesh-list
139634486|NCT01162551|Methotrexate|methotrexate|mesh-list
139634487|NCT01162551|Temsirolimus|temsirolimus|mesh-list
139634488|NCT01162551|MTOR Inhibitors|mtor inhibitors|mesh-list
139634489|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139634490|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
139634491|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139634492|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634493|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139634494|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
139634495|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634496|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634497|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
139634498|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634499|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139634500|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139634501|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
139634502|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634503|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139634504|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139634505|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634506|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139634507|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
139634508|NCT01162551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139634509|NCT01163097|Heparin|heparin|mesh-list
139634510|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
139634511|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139634512|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139634513|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634514|NCT03013101|Antibodies|antibodies|mesh-list
139634515|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139634516|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
139634517|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634518|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139634519|NCT03088137|Hormones|hormones|mesh-ancestor
139634520|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139634521|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634522|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
139634523|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139634524|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
138986556|NCT03537586|Analgesics|analgesics|mesh-ancestor
139634525|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634526|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634527|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139634528|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
139634529|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139634530|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
139634531|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634532|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634533|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139634534|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
139634535|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
139634536|NCT01165047|Protective Agents|protective agents|mesh-ancestor
139634537|NCT01166997|Heparin|heparin|mesh-list
139634538|NCT01166997|Calcium heparin|calcium heparin|mesh-list
139634539|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
139634540|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139634541|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139634542|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634543|NCT01170117|Olanzapine|olanzapine|mesh-list
139634544|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
139634545|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
139634546|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634547|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634548|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139634549|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139634550|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139634551|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139634552|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139634553|NCT01170117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139634554|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139634555|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139634556|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634557|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634558|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
139634559|NCT01172145|Modafinil|modafinil|mesh-list
139634560|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139634561|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634562|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139634563|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139634564|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139634565|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634566|NCT01175343|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139634567|NCT01175343|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139634568|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634569|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634570|NCT01176435|Levodopa|levodopa|mesh-list
139634571|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139634572|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139416276|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
139634573|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
139634574|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634575|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634576|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634577|NCT01176591|Aprepitant|aprepitant|mesh-list
139634578|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
139634579|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
139634580|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
139634581|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634582|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634583|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139634584|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139634585|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634586|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634587|NCT01176981|Methotrexate|methotrexate|mesh-list
139634588|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139634589|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
139634590|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139634591|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634592|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139634593|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
139634594|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634595|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634596|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
139634597|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634598|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139634599|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139634600|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
139634601|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634602|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139634603|NCT01126593|Bupivacaine|bupivacaine|mesh-list
139634604|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
139634605|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
139634606|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139634607|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634608|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
139634609|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634610|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
139634611|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139634612|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634613|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634614|NCT01126671|Vitamin D|vitamin d|mesh-list
139634615|NCT01126671|Vitamins|vitamins|mesh-ancestor
139634616|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
139634617|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634618|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139634619|NCT01182675|Plerixafor|plerixafor|mesh-list
139634620|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
139634621|NCT01182675|Lenograstim|lenograstim|mesh-list
139634622|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139634623|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
139634624|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634625|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139634626|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634627|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139634628|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139634629|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
139634630|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634631|NCT01129245|Celecoxib|celecoxib|mesh-list
139634632|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139634633|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139634634|NCT01129245|Analgesics|analgesics|mesh-ancestor
139634635|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
139634636|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634637|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634638|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139634639|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634640|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139634641|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139634642|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634643|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634644|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139634645|NCT01183533|Plasminogen|plasminogen|mesh-list
139634646|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139634647|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139634648|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634649|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139634650|NCT01188369|Simendan|simendan|mesh-list
139634651|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139634652|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
139634653|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139634654|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139634655|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634656|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634657|NCT01188369|Protective Agents|protective agents|mesh-ancestor
139634658|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634659|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
139634660|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
139634661|NCT01135329|Busulfan|busulfan|mesh-list
139634662|NCT01135329|Fludarabine|fludarabine|mesh-list
139634663|NCT01135329|Tacrolimus|tacrolimus|mesh-list
139634664|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139634665|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
139634666|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634667|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634668|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139634669|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
139634670|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634671|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634672|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139634673|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139634674|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634675|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139634676|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139634677|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
139634678|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139634679|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634680|NCT03012009|Lidocaine|lidocaine|mesh-list
139634681|NCT03012009|Epinephrine|epinephrine|mesh-list
139634682|NCT03012009|Racepinephrine|racepinephrine|mesh-list
139634683|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
139634684|NCT03012009|Anesthetics|anesthetics|mesh-list
139634685|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139634686|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
139634687|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139634688|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634689|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
139634690|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634691|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139634692|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139634693|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139634694|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139634695|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634696|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139634697|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139634698|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
139634699|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634700|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139634701|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139634702|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
139634703|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139634704|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
139634705|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
139634706|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
139634707|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139634708|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139634709|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
139634710|NCT04403555|Ivermectin|ivermectin|mesh-list
139634711|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139634712|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634713|NCT03565835|Prednisone|prednisone|mesh-list
139634714|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
139634715|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139634716|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
139634717|NCT03565835|Hormones|hormones|mesh-ancestor
139634718|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139634719|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634720|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139634721|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416438|NCT00429923|Hormones|hormones|mesh-ancestor
139634722|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139634723|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634724|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634725|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
139634726|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139634727|NCT01624259|Metformin|metformin|mesh-list
139634728|NCT01624259|Liraglutide|liraglutide|mesh-list
139634729|NCT01624259|Dulaglutide|dulaglutide|mesh-list
139634730|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139634731|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634732|NCT01624259|Incretins|incretins|mesh-ancestor
139634733|NCT01624259|Hormones|hormones|mesh-ancestor
139634734|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139634735|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
139634736|NCT02081183|Prednisone|prednisone|mesh-list
139634737|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
139634738|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139634739|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
139634740|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634741|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634742|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139634743|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
139634744|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634745|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634746|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139634747|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139634748|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
139634749|NCT02081183|Hormones|hormones|mesh-ancestor
139634750|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139634751|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139634752|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139634753|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139634754|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
139634755|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139634756|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634757|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634758|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
139634759|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139634760|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139634761|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634762|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
139634763|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
139634764|NCT02079077|Aspirin|aspirin|mesh-list
139634765|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
139634766|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
139634767|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139634768|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139634769|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634770|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634771|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634772|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634773|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139634774|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139634775|NCT02079077|Analgesics|analgesics|mesh-ancestor
139634776|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
139634777|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634778|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634779|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139634780|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139634781|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139634782|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139634783|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139634784|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
139634785|NCT03547271|Vaccines|vaccines|mesh-list
139634786|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139634787|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
139634788|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634789|NCT01191255|Sevelamer|sevelamer|mesh-list
139634790|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
139634791|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
139634792|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634793|NCT02078219|Allopurinol|allopurinol|mesh-list
139634794|NCT02078219|Verinurad|verinurad|mesh-list
139634795|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
139634796|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634797|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416495|NCT00356681|Niacinamide|niacinamide|mesh-list
139634798|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
139634799|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634800|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139634801|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
139634802|NCT02078219|Protective Agents|protective agents|mesh-ancestor
139634803|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634804|NCT03536039|Prednisone|prednisone|mesh-list
139634805|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
139634806|NCT03536039|Rituximab|rituximab|mesh-list
139634807|NCT03536039|Doxorubicin|doxorubicin|mesh-list
139634808|NCT03536039|Vincristine|vincristine|mesh-list
139634809|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139634810|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
139634811|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634812|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634813|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139634814|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
139634815|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634816|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986627|NCT02573051|Isosorbide|isosorbide|mesh-list
139634817|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139634818|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139634819|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139634820|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139634821|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139634822|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634823|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139634824|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
139634825|NCT03536039|Hormones|hormones|mesh-ancestor
139634826|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139634827|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139634828|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139634829|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
139634830|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
139634831|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
139634832|NCT02075255|Benralizumab|benralizumab|mesh-list
139634833|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139634834|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
139634835|NCT03532217|Nivolumab|nivolumab|mesh-list
139634836|NCT03532217|Ipilimumab|ipilimumab|mesh-list
139634837|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139634838|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634839|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139634840|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634841|NCT03529487|Phenylephrine|phenylephrine|mesh-list
139634842|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
139634843|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139634844|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139634845|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
139634846|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139634847|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634848|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634849|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
139634850|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
139634851|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634852|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
139634853|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139634854|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
139634855|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139634856|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
139634857|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139634858|NCT03529487|Protective Agents|protective agents|mesh-ancestor
139634859|NCT03527147|Rituximab|rituximab|mesh-list
139634860|NCT03527147|Magrolimab|magrolimab|mesh-list
139634861|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
139634862|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139634863|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634864|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
139634865|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634866|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634867|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139634868|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139634869|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139634870|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
139634871|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634872|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139634873|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139634874|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634875|NCT01677611|Resveratrol|resveratrol|mesh-list
139634876|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
139634877|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634878|NCT01677611|Protective Agents|protective agents|mesh-ancestor
139634879|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634880|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634881|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139634882|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
139634883|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139634884|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139634885|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139634886|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139634887|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634888|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634889|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634890|NCT01193049|Prednisone|prednisone|mesh-list
139634891|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139634892|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
139634893|NCT01193049|Hormones|hormones|mesh-ancestor
139634894|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139634895|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634896|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139634897|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634898|NCT01679951|Methotrexate|methotrexate|mesh-list
139634899|NCT01679951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139634900|NCT01679951|Abortifacient Agents|abortifacient agents|mesh-ancestor
139634901|NCT01679951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139634902|NCT01679951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634903|NCT01679951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139634904|NCT01679951|Antimetabolites|antimetabolites|mesh-ancestor
139634905|NCT01679951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634906|NCT01679951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634907|NCT01679951|Dermatologic Agents|dermatologic agents|mesh-ancestor
139634908|NCT01679951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634909|NCT01679951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139634910|NCT01679951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139634911|NCT01679951|Immunologic Factors|immunologic factors|mesh-ancestor
139634912|NCT01679951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139634913|NCT01679951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139634914|NCT01194297|Vaccines|vaccines|mesh-list
139634915|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
139634916|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634917|NCT01194453|Folic Acid|folic acid|mesh-list
139634918|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
139634919|NCT01194453|Dexamethasone|dexamethasone|mesh-list
139634920|NCT01194453|Cisplatin|cisplatin|mesh-list
139634921|NCT01194453|Gemcitabine|gemcitabine|mesh-list
139634922|NCT01194453|Vitamins|vitamins|mesh-ancestor
139634923|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
139634924|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634925|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139634926|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
139634927|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
139634928|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139634929|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139634930|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
139634931|NCT01194453|Hormones|hormones|mesh-ancestor
139634932|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139634933|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139634934|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634935|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139634936|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
139634937|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634938|NCT01194453|Hematinics|hematinics|mesh-ancestor
139634939|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
139634940|NCT03507413|Metformin|metformin|mesh-list
139634941|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139634942|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634943|NCT01195467|Tenofovir|tenofovir|mesh-list
139634944|NCT01195467|Emtricitabine|emtricitabine|mesh-list
139634945|NCT01195467|Efavirenz|efavirenz|mesh-list
139634946|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
139634947|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139634948|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
139634949|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416656|NCT02480114|Ibuprofen|ibuprofen|mesh-list
139634950|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139634951|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139634952|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634953|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634954|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139634955|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139634956|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139634957|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139634958|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139634959|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139634960|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139634961|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139634962|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139634963|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139634964|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139634965|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
139634966|NCT01195779|Vaccines|vaccines|mesh-list
139634967|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
139634968|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634969|NCT02405585|Leucovorin|leucovorin|mesh-list
139634970|NCT02405585|Gemcitabine|gemcitabine|mesh-list
139634971|NCT02405585|Fluorouracil|fluorouracil|mesh-list
139634972|NCT02405585|Oxaliplatin|oxaliplatin|mesh-list
139634973|NCT02405585|Irinotecan|irinotecan|mesh-list
139634974|NCT02405585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139634975|NCT02405585|Antimetabolites|antimetabolites|mesh-ancestor
139634976|NCT02405585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634977|NCT02405585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634978|NCT02405585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139634979|NCT02405585|Immunologic Factors|immunologic factors|mesh-ancestor
139634980|NCT02405585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139634981|NCT02405585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139634982|NCT02405585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139634983|NCT02405585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634984|NCT02405585|Antidotes|antidotes|mesh-ancestor
139634985|NCT02405585|Protective Agents|protective agents|mesh-ancestor
139634986|NCT02405585|Vitamin B Complex|vitamin b complex|mesh-ancestor
139634987|NCT02405585|Vitamins|vitamins|mesh-ancestor
139634988|NCT02405585|Micronutrients|micronutrients|mesh-ancestor
139634989|NCT03491345|Avelumab|avelumab|mesh-list
139634990|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139634991|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634992|NCT00089999|Lapatinib|lapatinib|mesh-list
139634993|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139634994|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139634995|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139634996|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139634997|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
139634998|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
139634999|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
139635000|NCT00089843|Testosterone|testosterone|mesh-list
139635001|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
139635002|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
139635003|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139635004|NCT00089843|Androgens|androgens|mesh-ancestor
139635005|NCT00089843|Hormones|hormones|mesh-ancestor
139635006|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635007|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635008|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139635009|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635010|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
139635011|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139635012|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139635013|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635014|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139635015|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139635016|NCT01677923|Metformin|metformin|mesh-list
139635017|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139635018|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635019|NCT00089297|Paclitaxel|paclitaxel|mesh-list
139635020|NCT00089297|Carboplatin|carboplatin|mesh-list
139635021|NCT00089297|Cetuximab|cetuximab|mesh-list
139635022|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139635023|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635024|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
139635025|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
139635027|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635028|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139635029|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139635030|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139635031|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635032|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635033|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139635034|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139635035|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635036|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
139635037|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139635038|NCT03482297|Midodrine|midodrine|mesh-list
139635039|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
139635040|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
139635041|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635042|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635043|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139635044|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139635045|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138986994|NCT01010451|Calcium|calcium|mesh-list
139635046|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139635047|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
139635048|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139635049|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635050|NCT00088907|Docetaxel|docetaxel|mesh-list
139635051|NCT00088907|Gefitinib|gefitinib|mesh-list
139635052|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635053|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
139635054|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
139635055|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
139635056|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635057|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139635058|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635059|NCT00088829|Paclitaxel|paclitaxel|mesh-list
139635060|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139635061|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139635062|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635063|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
139635064|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
139635065|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
139635066|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635067|NCT00088595|Pasireotide|pasireotide|mesh-list
139635068|NCT00088595|Hormones|hormones|mesh-ancestor
139635069|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635070|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635071|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
139635072|NCT01678079|Calcium|calcium|mesh-list
139635073|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139635074|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635075|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139635076|NCT01678235|Insulin|insulin|mesh-list
139635077|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139635078|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
139635079|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
139635080|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139635081|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635082|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
139635083|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139635084|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
139635085|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635086|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
139635087|NCT01197495|Protective Agents|protective agents|mesh-ancestor
139635088|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139635089|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139635090|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138987076|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139635091|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635092|NCT03011931|Simvastatin|simvastatin|mesh-list
139635093|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139635094|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139635095|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
139635096|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635097|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139416797|NCT00252005|Antithrombins|antithrombins|mesh-ancestor
139635098|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139635099|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635101|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
139635102|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139635103|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139635104|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
139635105|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
139635106|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139635107|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635108|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635109|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139635110|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139635111|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139635112|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139635113|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139635114|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139635115|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
139635116|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139635117|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139635118|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
139635119|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139635120|NCT00085709|Cytarabine|cytarabine|mesh-list
139635121|NCT00085709|Daunorubicin|daunorubicin|mesh-list
139635122|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
139635123|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139635124|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
139635125|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635126|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635127|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
139635128|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139635129|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139635130|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
138987175|NCT00902954|Letrozole|letrozole|mesh-list
139635131|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635132|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139635133|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139635134|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139635135|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635136|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139635137|NCT00085709|Immunotoxins|immunotoxins|mesh-ancestor
139635138|NCT00085709|Immunoconjugates|immunoconjugates|mesh-ancestor
139635139|NCT01201863|Testosterone|testosterone|mesh-list
139635140|NCT01201863|Androgens|androgens|mesh-ancestor
139635141|NCT01201863|Hormones|hormones|mesh-ancestor
139635142|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635143|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635144|NCT01202253|Anidulafungin|anidulafungin|mesh-list
139635145|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
139635146|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139635147|NCT01678703|Misoprostol|misoprostol|mesh-list
139635148|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139635149|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
139635150|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139635151|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635152|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139635153|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139635154|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
139635155|NCT00085631|Cisplatin|cisplatin|mesh-list
139635156|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635157|NCT01141491|Vaccines|vaccines|mesh-list
139635158|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
139635159|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
139635160|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635161|NCT01141569|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139635162|NCT01141569|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139635163|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635164|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635165|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139635166|NCT01141725|Idarubicin|idarubicin|mesh-list
139635167|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139635168|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
139635169|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416883|NCT02478398|Loratadine|loratadine|mesh-list
139635170|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635171|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139635172|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139635173|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139635175|NCT01202721|Atenolol|atenolol|mesh-list
139635176|NCT01202721|Telmisartan|telmisartan|mesh-list
139635177|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139635178|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139635179|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139635180|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635181|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139635182|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
139635183|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
139635184|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635185|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635186|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139635187|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139635188|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139635189|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
139635190|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139635191|NCT00084617|Capecitabine|capecitabine|mesh-list
139635192|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
139635193|NCT00084617|Irinotecan|irinotecan|mesh-list
139635194|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139635195|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
139635196|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635197|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635198|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139635199|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139635200|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635201|NCT01203189|Ketoconazole|ketoconazole|mesh-list
139635202|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
139635203|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139635204|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139635205|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139635206|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635207|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635208|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139635209|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
139635210|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635211|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635212|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139635213|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
139635214|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139635215|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635216|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
139635217|NCT01679327|Leucovorin|leucovorin|mesh-list
139635218|NCT01679327|Bevacizumab|bevacizumab|mesh-list
139635219|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
139635220|NCT01679327|Calcium|calcium|mesh-list
139635221|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
139635222|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139635223|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635224|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139635225|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139635226|NCT01679327|Growth Substances|growth substances|mesh-ancestor
139635227|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635228|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
139635229|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139635230|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139635231|NCT01679327|Antidotes|antidotes|mesh-ancestor
139635232|NCT01679327|Protective Agents|protective agents|mesh-ancestor
139635233|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
139635234|NCT01679327|Vitamins|vitamins|mesh-ancestor
139635235|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
139635236|NCT01206387|Desoximetasone|desoximetasone|mesh-list
139635237|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139635238|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
139635239|NCT01206387|Hormones|hormones|mesh-ancestor
139635240|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635241|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635242|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139416948|NCT00380653|Sapacitabine|sapacitabine|mesh-list
139635243|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139635244|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139635245|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139635246|NCT01679639|Rifampin|rifampin|mesh-list
139635247|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139635248|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
139635249|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139635250|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139635251|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
139635252|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139635253|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635254|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635255|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139635256|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139635257|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139635258|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139635259|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139635260|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139635261|NCT01679795|Tibolone|tibolone|mesh-list
139635262|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
139635263|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
139635264|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635265|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635266|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139635267|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139635268|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635269|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139635270|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
139635271|NCT01679795|Hormones|hormones|mesh-ancestor
139635272|NCT01207401|Lidocaine|lidocaine|mesh-list
139635273|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
138987409|NCT00903656|Lapatinib|lapatinib|mesh-list
139635274|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
139635275|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139635276|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635277|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
139635278|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635279|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139635280|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139635281|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139635282|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139635283|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635284|NCT04761731|Tacrolimus|tacrolimus|mesh-list
139635285|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139635286|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
139635287|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635288|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139635289|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635290|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635291|NCT03087539|Abciximab|abciximab|mesh-list
139635292|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
139635293|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139635294|NCT03087149|Vitamin D|vitamin d|mesh-list
139635295|NCT03087149|Vitamins|vitamins|mesh-ancestor
139635296|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
139635297|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635298|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139635299|NCT03086681|Cisplatin|cisplatin|mesh-list
139635300|NCT03086681|Endostar protein|endostar protein|mesh-list
139635301|NCT03086681|Endostatins|endostatins|mesh-list
139635302|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635303|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139635304|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139635305|NCT03086681|Growth Substances|growth substances|mesh-ancestor
139635306|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635307|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
139635308|NCT03086759|Triamcinolone|triamcinolone|mesh-list
139635309|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139635310|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139635311|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139635312|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139635313|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
139635314|NCT03086759|Hormones|hormones|mesh-ancestor
139635315|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635316|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635317|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139635318|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
139635319|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635320|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635321|NCT03086291|Simvastatin|simvastatin|mesh-list
139635322|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139635323|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139635324|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
139635325|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635326|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139635327|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139635328|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635329|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
139635330|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139635331|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635332|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635333|NCT01209195|Paclitaxel|paclitaxel|mesh-list
139635334|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139635335|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635336|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
139635337|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
139635338|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
139635339|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635340|NCT03084809|Leucovorin|leucovorin|mesh-list
139635341|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
139635342|NCT03084809|Fluorouracil|fluorouracil|mesh-list
139635343|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
139635344|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635345|NCT03084809|Antidotes|antidotes|mesh-ancestor
139635346|NCT03084809|Protective Agents|protective agents|mesh-ancestor
139635347|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635348|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
139635349|NCT03084809|Vitamins|vitamins|mesh-ancestor
139635350|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
139635351|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
139635352|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635353|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139635354|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139635355|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
139635356|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
139635357|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139635358|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139635359|NCT01144143|Prednisolone|prednisolone|mesh-list
139635360|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
139635361|NCT01144143|Infliximab|infliximab|mesh-list
139635362|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139635363|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
139635364|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139635365|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
139635366|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
139635367|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635368|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635369|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139635370|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
139635371|NCT01144143|Hormones|hormones|mesh-ancestor
139635372|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635373|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139635374|NCT01144143|Protective Agents|protective agents|mesh-ancestor
139635375|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139635376|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635377|NCT01144143|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139635378|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
139635379|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139635380|NCT03084575|Glycerol|glycerol|mesh-list
139635381|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139635382|NCT03084575|Protective Agents|protective agents|mesh-ancestor
139635383|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635384|NCT01212471|Bromfenac|bromfenac|mesh-list
139635385|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139635386|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139635387|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139635388|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139635389|NCT01212471|Analgesics|analgesics|mesh-ancestor
139635390|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
139635391|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635392|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635393|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139635394|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139635395|NCT03084419|Abatacept|abatacept|mesh-list
139635396|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139635397|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635398|NCT03084419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139635399|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635400|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139635401|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
139635402|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635403|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139635404|NCT03084029|Oxytocin|oxytocin|mesh-list
139635405|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
139635406|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139635407|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635408|NCT04278053|Inositol|inositol|mesh-list
139635409|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
139635410|NCT04278053|Vitamins|vitamins|mesh-ancestor
139635411|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
139635412|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635413|NCT05346107|Paclitaxel|paclitaxel|mesh-list
139635414|NCT05346107|Cyclophosphamide|cyclophosphamide|mesh-list
139635415|NCT05346107|Doxorubicin|doxorubicin|mesh-list
139635416|NCT05346107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139635417|NCT05346107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139635418|NCT05346107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635419|NCT05346107|Tubulin Modulators|tubulin modulators|mesh-ancestor
139635420|NCT05346107|Antimitotic Agents|antimitotic agents|mesh-ancestor
139635421|NCT05346107|Mitosis Modulators|mitosis modulators|mesh-ancestor
139635422|NCT05346107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635423|NCT05346107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139635424|NCT05346107|Immunologic Factors|immunologic factors|mesh-ancestor
139635425|NCT05346107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635426|NCT05346107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139635427|NCT05346107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139635428|NCT05346107|Alkylating Agents|alkylating agents|mesh-ancestor
139635429|NCT05346107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139635430|NCT05346107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139635431|NCT05346107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139635432|NCT05346107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139635433|NCT05346107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635434|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139635435|NCT00083915|Thalidomide|thalidomide|mesh-list
139635436|NCT00083915|Dexamethasone|dexamethasone|mesh-list
139635437|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
139635438|NCT00083915|Melphalan|melphalan|mesh-list
139635439|NCT00083915|Cisplatin|cisplatin|mesh-list
139635440|NCT00083915|Doxorubicin|doxorubicin|mesh-list
139635441|NCT00083915|Etoposide|etoposide|mesh-list
139635442|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139635443|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139635444|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
139635445|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635446|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139635447|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139635448|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
139635449|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635450|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635451|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139635452|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139635453|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
139635454|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
139635455|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635456|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139635457|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
139635458|NCT00083915|Hormones|hormones|mesh-ancestor
139635459|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635460|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139635461|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139635462|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139635463|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139635464|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635465|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139417177|NCT02446418|Xhance|xhance|mesh-list
139635466|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
139635467|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139635468|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139635469|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139635470|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139635471|NCT00083915|Growth Substances|growth substances|mesh-ancestor
139635472|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
139635473|NCT04401839|Oxytocin|oxytocin|mesh-list
139635474|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
139635475|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139635476|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635477|NCT04761185|Raltitrexed|raltitrexed|mesh-list
139635478|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139635479|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
139635480|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635481|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635482|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139635483|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635484|NCT01144455|Gemcitabine|gemcitabine|mesh-list
139635485|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
139635486|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139635487|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
139635488|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635489|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635490|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139635491|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
139635492|NCT03080675|Vitamins|vitamins|mesh-list
139635493|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
139635494|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635495|NCT03080363|Lidocaine|lidocaine|mesh-list
139635496|NCT03080363|Bupivacaine|bupivacaine|mesh-list
139635497|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
139635498|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
139635499|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139635500|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635501|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
139635502|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635503|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139635504|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139635505|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139635506|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139635507|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635508|NCT01145001|Nicotine|nicotine|mesh-list
139635509|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139635510|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
139635511|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635512|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635513|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139635514|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139635515|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
139635516|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139635517|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635518|NCT03011463|Clarithromycin|clarithromycin|mesh-list
139635519|NCT03011463|Ranitidine|ranitidine|mesh-list
139635520|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139635521|NCT03011463|Trospium chloride|trospium chloride|mesh-list
139635522|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139635523|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139635524|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139635525|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635526|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635527|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139635528|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139635529|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139635530|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139635531|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139635532|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
138987845|NCT00567476|Omalizumab|omalizumab|mesh-list
139635533|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
139635534|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139635535|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635536|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
139635537|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
139635538|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635539|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139635540|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139635541|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
139635542|NCT03011463|Urological Agents|urological agents|mesh-ancestor
139635543|NCT01214109|Pramipexole|pramipexole|mesh-list
139635544|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
139635545|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635546|NCT01214109|Protective Agents|protective agents|mesh-ancestor
139635547|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635548|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139635549|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139635550|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
139635551|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
139635552|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139635553|NCT05688761|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139635554|NCT05688761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635555|NCT05688761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635556|NCT01215123|Bevacizumab|bevacizumab|mesh-list
139635557|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139635558|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635559|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139635560|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139635561|NCT01215123|Growth Substances|growth substances|mesh-ancestor
139635562|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635563|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
139635564|NCT05688449|Fentanyl|fentanyl|mesh-list
139635565|NCT05688449|Bupivacaine|bupivacaine|mesh-list
139635566|NCT05688449|Anesthetics, Local|anesthetics, local|mesh-ancestor
139635567|NCT05688449|Anesthetics|anesthetics|mesh-ancestor
139635568|NCT05688449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139635569|NCT05688449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635570|NCT05688449|Sensory System Agents|sensory system agents|mesh-ancestor
139635571|NCT05688449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635572|NCT05688449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139635573|NCT05688449|Narcotics|narcotics|mesh-ancestor
139635574|NCT05688449|Analgesics|analgesics|mesh-ancestor
139635575|NCT05688449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139635576|NCT05688449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139635577|NCT05688449|Anesthetics, General|anesthetics, general|mesh-ancestor
139635578|NCT04401137|Topiramate|topiramate|mesh-list
139635579|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
139635580|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139635581|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635582|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139635583|NCT02189889|Hematinics|hematinics|mesh-ancestor
139635584|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139635585|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139635586|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139635587|NCT01148745|Hematinics|hematinics|mesh-ancestor
139635588|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139635589|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139635590|NCT04761029|Tramadol|tramadol|mesh-list
139635591|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139635592|NCT04761029|Narcotics|narcotics|mesh-ancestor
139635593|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139635594|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635595|NCT04761029|Analgesics|analgesics|mesh-ancestor
139635596|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
139635597|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635598|NCT05687981|Dexamethasone|dexamethasone|mesh-list
139635599|NCT05687981|Bupivacaine|bupivacaine|mesh-list
139635600|NCT05687981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139635601|NCT05687981|Antiemetics|antiemetics|mesh-ancestor
139635602|NCT05687981|Autonomic Agents|autonomic agents|mesh-ancestor
139635603|NCT05687981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635604|NCT05687981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635605|NCT05687981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139635606|NCT05687981|Glucocorticoids|glucocorticoids|mesh-ancestor
139635607|NCT05687981|Hormones|hormones|mesh-ancestor
139635608|NCT05687981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635609|NCT05687981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139635610|NCT05687981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635611|NCT05687981|Anesthetics, Local|anesthetics, local|mesh-ancestor
139635612|NCT05687981|Anesthetics|anesthetics|mesh-ancestor
139635613|NCT05687981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139635614|NCT05687981|Sensory System Agents|sensory system agents|mesh-ancestor
139635615|NCT05687747|FAPI-46|fapi-46|mesh-list
139635616|NCT05687747|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139635617|NCT05687747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635618|NCT05687669|Phentolamine|phentolamine|mesh-list
139635619|NCT05687669|Nitroglycerin|nitroglycerin|mesh-list
139635620|NCT05687669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139635621|NCT05687669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139635622|NCT05687669|Adrenergic Agents|adrenergic agents|mesh-ancestor
139635623|NCT05687669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139635624|NCT05687669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635625|NCT05687669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635626|NCT05687669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139635627|NCT05687669|Vasodilator Agents|vasodilator agents|mesh-ancestor
139635628|NCT04400747|Vitamin D|vitamin d|mesh-list
139635629|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
139635630|NCT04400747|Vitamins|vitamins|mesh-ancestor
139635631|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
139635632|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635633|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139635634|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139635635|NCT02190903|Anesthetics|anesthetics|mesh-list
139635636|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139635637|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635638|NCT03369041|Irinotecan|irinotecan|mesh-list
139635639|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139635640|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139635641|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635642|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635643|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635644|NCT01149759|Cyclosporine|cyclosporine|mesh-list
139635645|NCT01149759|Cyclosporins|cyclosporins|mesh-list
139635646|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635647|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635648|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139635649|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
139635650|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635651|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
139635652|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139635653|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
139635654|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139635655|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139635656|NCT01216761|Iodine|iodine|mesh-list
139635657|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
139635658|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139635659|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
139635660|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
139635661|NCT01216761|Povidone|povidone|mesh-list
139635662|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139635663|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139635664|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
139635665|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
139635666|NCT01216761|Trace Elements|trace elements|mesh-ancestor
139635667|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
139635668|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635669|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
139635670|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
139635671|NCT04279379|Decitabine|decitabine|mesh-list
139635672|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139635673|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
139635674|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635675|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635676|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635677|NCT01150461|Losartan|losartan|mesh-list
139635678|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
139635679|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139635680|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139635681|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139635682|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139635683|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635684|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139635685|NCT01218399|Budesonide|budesonide|mesh-list
139635686|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139635687|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139635688|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139635689|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
139635690|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635691|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635692|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139635693|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
139635694|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
139635695|NCT01218399|Hormones|hormones|mesh-ancestor
139635696|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635698|NCT01219881|Desflurane|desflurane|mesh-list
139635699|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139635700|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139635701|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
139635702|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
139635703|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139635704|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635705|NCT01220973|Celecoxib|celecoxib|mesh-list
139635706|NCT01220973|Atorvastatin|atorvastatin|mesh-list
139635707|NCT01220973|Calcium|calcium|mesh-list
139635708|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139635709|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635710|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139635711|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139635712|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
139635713|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635714|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139635715|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139635716|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635717|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139635718|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139635719|NCT01220973|Analgesics|analgesics|mesh-ancestor
139635720|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
139635721|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635722|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139635723|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139635724|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139635725|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139635726|NCT05375747|Propofol|propofol|mesh-list
139635727|NCT05375747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139635728|NCT05375747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139635729|NCT05375747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635730|NCT05375747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139635731|NCT05375747|Anesthetics, General|anesthetics, general|mesh-ancestor
139635732|NCT05375747|Anesthetics|anesthetics|mesh-ancestor
139635733|NCT01221207|Calpastatin|calpastatin|mesh-list
139635734|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139635735|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
139635736|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635737|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635738|NCT03296813|Torsemide|torsemide|mesh-list
139635739|NCT03296813|Furosemide|furosemide|mesh-list
139635740|NCT03296813|Diuretics|diuretics|mesh-ancestor
139635741|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
139635742|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635743|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139635744|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139635745|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635746|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139635747|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
139635748|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139635749|NCT04400045|Treosulfan|treosulfan|mesh-list
139635750|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139635751|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
139635752|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635753|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635754|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139635755|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635756|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139635757|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635758|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635759|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139635760|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139635761|NCT01153581|Estradiol|estradiol|mesh-list
139635762|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139635763|NCT01153581|Progesterone|progesterone|mesh-list
139635764|NCT01153581|Ganirelix|ganirelix|mesh-list
139635765|NCT01153581|Estrogens|estrogens|mesh-ancestor
139635766|NCT01153581|Hormones|hormones|mesh-ancestor
139635767|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635768|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635769|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139635770|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
139635771|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139635772|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139635773|NCT01153581|Progestins|progestins|mesh-ancestor
138615179|NCT00412698|Rimonabant|rimonabant|mesh-list
139635774|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
139635775|NCT04278599|Zinc|zinc|mesh-list
139635776|NCT04278599|Trace Elements|trace elements|mesh-ancestor
139635777|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
139635778|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635779|NCT05277623|Mannitol|mannitol|mesh-list
139635780|NCT05277623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139635781|NCT05277623|Diuretics|diuretics|mesh-ancestor
139635782|NCT05277623|Natriuretic Agents|natriuretic agents|mesh-ancestor
139635783|NCT05277623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635784|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139635785|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139635786|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139635787|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635788|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988317|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
139635789|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139635790|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139635791|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635792|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
139635793|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139635794|NCT04760327|Cisplatin|cisplatin|mesh-list
139635795|NCT04760327|Bleomycin|bleomycin|mesh-list
139635796|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635797|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139635798|NCT01225263|Vitamin D|vitamin d|mesh-list
139635799|NCT01225263|Simvastatin|simvastatin|mesh-list
139635800|NCT01225263|Vitamins|vitamins|mesh-ancestor
139635801|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
139635802|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635803|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139635804|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139635805|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139635806|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
139635807|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635808|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139635809|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139635810|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635811|NCT04278287|Paclitaxel|paclitaxel|mesh-list
139635812|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139635813|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139635814|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635815|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
139635816|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
139635817|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
139635818|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635819|NCT05162027|Erenumab|erenumab|mesh-list
139635820|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139635821|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635822|NCT05162027|Analgesics|analgesics|mesh-ancestor
139635823|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
139635824|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635825|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635826|NCT03278717|Olaparib|olaparib|mesh-list
139635827|NCT03278717|Cediranib|cediranib|mesh-list
139635828|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139635829|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635830|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635831|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635832|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139635833|NCT01227993|Finasteride|finasteride|mesh-list
139635834|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139635835|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139635836|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635837|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635838|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
139635839|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635840|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635841|NCT01227993|Urological Agents|urological agents|mesh-ancestor
139635842|NCT01155999|Tobramycin|tobramycin|mesh-list
139635843|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139417549|NCT00002411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635844|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139635845|NCT03275597|Durvalumab|durvalumab|mesh-list
139635846|NCT03275597|Tremelimumab|tremelimumab|mesh-list
138988486|NCT00711191|Antibodies|antibodies|mesh-list
139635847|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139635848|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635849|NCT01228149|Acetazolamide|acetazolamide|mesh-list
139635850|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
139635851|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139635852|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635853|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635854|NCT01228149|Diuretics|diuretics|mesh-ancestor
139635855|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
139635856|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635857|NCT04989413|Dronabinol|dronabinol|mesh-list
139635858|NCT04989413|Cannabidiol|cannabidiol|mesh-list
139635859|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
139635860|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
139635861|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635862|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139635863|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139635864|NCT04989413|Analgesics|analgesics|mesh-ancestor
139635865|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
139635866|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635867|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139635868|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139635869|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139635870|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635871|NCT04989413|Hormones|hormones|mesh-ancestor
139635872|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635873|NCT02192541|Aflibercept|aflibercept|mesh-list
139635874|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139635875|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139635876|NCT02192541|Growth Substances|growth substances|mesh-ancestor
139635877|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635878|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
139635879|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635880|NCT01156701|Zanamivir|zanamivir|mesh-list
139635881|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
139635882|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139635883|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635884|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635885|NCT06222593|Sunitinib|sunitinib|mesh-list
139635886|NCT06222593|Bicalutamide|bicalutamide|mesh-list
139635887|NCT06222593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635888|NCT06222593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139635889|NCT06222593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139635890|NCT06222593|Growth Substances|growth substances|mesh-ancestor
139635891|NCT06222593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635892|NCT06222593|Growth Inhibitors|growth inhibitors|mesh-ancestor
139635893|NCT06222593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139635894|NCT06222593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635895|NCT06222593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635896|NCT06222593|Androgen Antagonists|androgen antagonists|mesh-ancestor
139635897|NCT06222593|Hormone Antagonists|hormone antagonists|mesh-ancestor
139635898|NCT06222593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635899|NCT06222567|Benzocaine|benzocaine|mesh-list
139635900|NCT06222567|Anesthetics, Local|anesthetics, local|mesh-ancestor
139635901|NCT06222567|Anesthetics|anesthetics|mesh-ancestor
139635902|NCT06222567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139635903|NCT06222567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635904|NCT06222567|Sensory System Agents|sensory system agents|mesh-ancestor
139635905|NCT06222567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635906|NCT06222489|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
139635907|NCT06222489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139635908|NCT06222489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635909|NCT06222476|Gliclazide|gliclazide|mesh-list
139635910|NCT06222476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139635911|NCT06222476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635912|NCT06222372|Rifampin|rifampin|mesh-list
139635913|NCT06222372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139635914|NCT06222372|Antitubercular Agents|antitubercular agents|mesh-ancestor
139635915|NCT06222372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139635916|NCT06222372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139635917|NCT06222372|Leprostatic Agents|leprostatic agents|mesh-ancestor
139635918|NCT06222372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139635919|NCT06222372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139635920|NCT06222372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635921|NCT06222372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139635922|NCT06222372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139635923|NCT06222372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139635924|NCT06222372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139635925|NCT06222372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139635926|NCT06222372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139635927|NCT06222320|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139635928|NCT06222320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139635929|NCT06222320|Analgesics|analgesics|mesh-ancestor
139635930|NCT06222320|Sensory System Agents|sensory system agents|mesh-ancestor
139635931|NCT06222320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635932|NCT06222320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635933|NCT06222320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139635934|NCT06222320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139635935|NCT06222320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139635936|NCT06222294|Propofol|propofol|mesh-list
139635937|NCT06222294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139635938|NCT06222294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139635939|NCT06222294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635940|NCT06222294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139635941|NCT06222294|Anesthetics, General|anesthetics, general|mesh-ancestor
139635942|NCT06222294|Anesthetics|anesthetics|mesh-ancestor
139635943|NCT06222268|Dronabinol|dronabinol|mesh-list
139635944|NCT06222268|Cannabidiol|cannabidiol|mesh-list
139635945|NCT06222268|Anticonvulsants|anticonvulsants|mesh-ancestor
139635946|NCT06222268|Hallucinogens|hallucinogens|mesh-ancestor
139635947|NCT06222268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635948|NCT06222268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139635949|NCT06222268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139635950|NCT06222268|Analgesics|analgesics|mesh-ancestor
139635951|NCT06222268|Sensory System Agents|sensory system agents|mesh-ancestor
139635952|NCT06222268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139635953|NCT06222268|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139635954|NCT06222268|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139635955|NCT06222268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139635956|NCT06222268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635957|NCT06222268|Hormones|hormones|mesh-ancestor
139635958|NCT06222268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635959|NCT06221969|Tirzepatide|tirzepatide|mesh-list
139635960|NCT06221969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139635961|NCT06221969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635962|NCT06221969|Incretins|incretins|mesh-ancestor
139635963|NCT06221969|Hormones|hormones|mesh-ancestor
139635964|NCT06221969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139635965|NCT06221826|Emoxypine succinate|emoxypine succinate|mesh-list
139635966|NCT06221826|Antioxidants|antioxidants|mesh-ancestor
139635967|NCT06221826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635968|NCT06221826|Protective Agents|protective agents|mesh-ancestor
139635969|NCT06221826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635970|NCT06221826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139635971|NCT06221826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139635972|NCT06221761|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139635973|NCT06221761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139635974|NCT06221761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139635975|NCT06221761|Antitubercular Agents|antitubercular agents|mesh-ancestor
139635976|NCT06221748|Paclitaxel|paclitaxel|mesh-list
139635977|NCT06221748|Disitamab vedotin|disitamab vedotin|mesh-list
139635978|NCT06221748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139635979|NCT06221748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635980|NCT06221748|Tubulin Modulators|tubulin modulators|mesh-ancestor
139635981|NCT06221748|Antimitotic Agents|antimitotic agents|mesh-ancestor
139635982|NCT06221748|Mitosis Modulators|mitosis modulators|mesh-ancestor
139635983|NCT06221748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635984|NCT06221748|Immunoconjugates|immunoconjugates|mesh-ancestor
139635985|NCT06221748|Immunologic Factors|immunologic factors|mesh-ancestor
139635986|NCT06221748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635987|NCT06221735|Interferon-beta|interferon-beta|mesh-list
139635988|NCT06221735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139635989|NCT06221735|Antiviral Agents|antiviral agents|mesh-ancestor
139635990|NCT06221735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139635991|NCT06221735|Immunologic Factors|immunologic factors|mesh-ancestor
139635992|NCT06221735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139635993|NCT06221722|Fluoxetine|fluoxetine|mesh-list
139635994|NCT06221722|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139635995|NCT06221722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139635996|NCT06221722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139635997|NCT06221722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139635998|NCT06221722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139635999|NCT06221722|Serotonin Agents|serotonin agents|mesh-ancestor
139636000|NCT06221722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636001|NCT06221722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139636002|NCT06221722|Antidepressive Agents|antidepressive agents|mesh-ancestor
139636003|NCT06221722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139636004|NCT06221722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139636005|NCT06221722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139636006|NCT06221722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636007|NCT06221527|Hyaluronic Acid|hyaluronic acid|mesh-list
139636008|NCT06221527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139636009|NCT06221527|Immunologic Factors|immunologic factors|mesh-ancestor
139636010|NCT06221527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636011|NCT06221527|Viscosupplements|viscosupplements|mesh-ancestor
139636012|NCT06221527|Protective Agents|protective agents|mesh-ancestor
139636013|NCT06221475|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139636014|NCT06221371|Tenecteplase|tenecteplase|mesh-list
139636015|NCT06221371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139636016|NCT06221371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139636017|NCT06221371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636018|NCT06221345|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139636019|NCT06221345|Lubricant Eye Drops|lubricant eye drops|mesh-list
139636020|NCT06221345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139636021|NCT06221241|Pregabalin|pregabalin|mesh-list
139636022|NCT06221241|Analgesics|analgesics|mesh-ancestor
139636023|NCT06221241|Sensory System Agents|sensory system agents|mesh-ancestor
139636024|NCT06221241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636025|NCT06221241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636026|NCT06221241|Anticonvulsants|anticonvulsants|mesh-ancestor
139636027|NCT06221241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139636028|NCT06221241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139636029|NCT06221241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636030|NCT06221241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139636031|NCT06221241|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139636032|NCT06221241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139636033|NCT06221241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636034|NCT06221241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139636035|NCT06221072|Zoledronic Acid|zoledronic acid|mesh-list
139636036|NCT06221072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139636037|NCT06221072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636038|NCT06220942|Phenylephrine|phenylephrine|mesh-list
139636039|NCT06220942|Oxymetazoline|oxymetazoline|mesh-list
139636040|NCT06220942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139636041|NCT06220942|Mydriatics|mydriatics|mesh-ancestor
139636042|NCT06220942|Autonomic Agents|autonomic agents|mesh-ancestor
139636043|NCT06220942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636044|NCT06220942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636045|NCT06220942|Sympathomimetics|sympathomimetics|mesh-ancestor
139636046|NCT06220942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139636047|NCT06220942|Nasal Decongestants|nasal decongestants|mesh-ancestor
139636048|NCT06220942|Respiratory System Agents|respiratory system agents|mesh-ancestor
139636049|NCT06220942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139636050|NCT06220942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139636051|NCT06220942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139636052|NCT06220942|Adrenergic Agents|adrenergic agents|mesh-ancestor
139636053|NCT06220942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636054|NCT06220942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636055|NCT06220942|Protective Agents|protective agents|mesh-ancestor
139636056|NCT06220929|Ceftriaxone|ceftriaxone|mesh-list
139636057|NCT06220929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139636058|NCT06220929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636059|NCT06220877|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139636060|NCT06220877|Cellulose, Oxidized|cellulose, oxidized|mesh-list
139636061|NCT06220877|Hemostatics|hemostatics|mesh-ancestor
139636062|NCT06220877|Coagulants|coagulants|mesh-ancestor
139636063|NCT06220721|Nifedipine|nifedipine|mesh-list
139636064|NCT06220721|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139636065|NCT06220721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139636066|NCT06220721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636067|NCT06220721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139636068|NCT06220721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636069|NCT06220721|Vasodilator Agents|vasodilator agents|mesh-ancestor
139636070|NCT06220721|Tocolytic Agents|tocolytic agents|mesh-ancestor
139636071|NCT06220721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139636072|NCT06220643|Triamcinolone|triamcinolone|mesh-list
139636073|NCT06220643|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139636074|NCT06220643|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139636076|NCT06220643|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139636077|NCT06220643|Anesthetics, Local|anesthetics, local|mesh-ancestor
139636078|NCT06220643|Anesthetics|anesthetics|mesh-ancestor
139636079|NCT06220643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636080|NCT06220643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636081|NCT06220643|Sensory System Agents|sensory system agents|mesh-ancestor
139636082|NCT06220643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636083|NCT06220643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139636084|NCT06220643|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139636085|NCT06220643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139636086|NCT06220643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139636087|NCT06220643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636088|NCT06220643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139636089|NCT06220643|Glucocorticoids|glucocorticoids|mesh-ancestor
139636090|NCT06220643|Hormones|hormones|mesh-ancestor
139636091|NCT06220643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139636092|NCT06220643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139636093|NCT06220643|Immunologic Factors|immunologic factors|mesh-ancestor
139636094|NCT06220643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636095|NCT06220604|Deucravacitinib|deucravacitinib|mesh-list
139636096|NCT06220604|Dermatologic Agents|dermatologic agents|mesh-ancestor
139636097|NCT06220604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139636098|NCT06220604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636099|NCT06220604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636100|NCT06220487|Prednisone|prednisone|mesh-list
139636101|NCT06220487|Blinatumomab|blinatumomab|mesh-list
139636102|NCT06220487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139636103|NCT06220487|Glucocorticoids|glucocorticoids|mesh-ancestor
139636104|NCT06220487|Hormones|hormones|mesh-ancestor
139636105|NCT06220487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139636106|NCT06220487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636107|NCT06220487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139636108|NCT06220487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636109|NCT06220461|Folic Acid|folic acid|mesh-list
139636110|NCT06220461|Hematinics|hematinics|mesh-ancestor
139636111|NCT06220461|Vitamin B Complex|vitamin b complex|mesh-ancestor
139636112|NCT06220461|Vitamins|vitamins|mesh-ancestor
139636113|NCT06220461|Micronutrients|micronutrients|mesh-ancestor
139636114|NCT06220461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636115|NCT06219174|Eflornithine|eflornithine|mesh-list
139636116|NCT06219174|Pembrolizumab|pembrolizumab|mesh-list
139636117|NCT06219174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636118|NCT06219174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636119|NCT06219174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139636120|NCT06219174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636121|NCT06219174|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139636122|NCT06219174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139636123|NCT06219174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139636124|NCT06219174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636125|NCT06219174|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139636126|NCT06219174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636127|NCT06218628|Talazoparib|talazoparib|mesh-list
139636128|NCT06218628|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139636129|NCT06218628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636130|NCT06218628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636131|NCT06218628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636132|NCT06217731|Clonazepam|clonazepam|mesh-list
139636133|NCT06217731|Anticonvulsants|anticonvulsants|mesh-ancestor
139636134|NCT06217731|GABA Modulators|gaba modulators|mesh-ancestor
139636135|NCT06217731|GABA Agents|gaba agents|mesh-ancestor
139636136|NCT06217731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636137|NCT06217731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636138|NCT06217731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636139|NCT06216769|Rivaroxaban|rivaroxaban|mesh-list
139636140|NCT06216769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139636141|NCT06216769|Antithrombins|antithrombins|mesh-ancestor
139636142|NCT06216769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139636143|NCT06216769|Protease Inhibitors|protease inhibitors|mesh-ancestor
139636144|NCT06216769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636145|NCT06216769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636146|NCT06216769|Anticoagulants|anticoagulants|mesh-ancestor
139636147|NCT06214910|Isoniazid|isoniazid|mesh-list
139636148|NCT06214910|Rifapentine|rifapentine|mesh-list
139636149|NCT06214910|Antitubercular Agents|antitubercular agents|mesh-ancestor
139636150|NCT06214910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139636151|NCT06214910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636152|NCT06214910|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139636153|NCT06214910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139636154|NCT06214910|Antimetabolites|antimetabolites|mesh-ancestor
139636155|NCT06214910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636156|NCT06214910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139636157|NCT06214910|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139636158|NCT06214910|Leprostatic Agents|leprostatic agents|mesh-ancestor
139636159|NCT06214897|Choline|choline|mesh-list
139636160|NCT06214897|Lipotropic Agents|lipotropic agents|mesh-ancestor
139636161|NCT06214897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139636162|NCT06214897|Antimetabolites|antimetabolites|mesh-ancestor
139636163|NCT06214897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636164|NCT06214897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139636165|NCT06214897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139636166|NCT06214897|Nootropic Agents|nootropic agents|mesh-ancestor
139636167|NCT06209619|Rituximab|rituximab|mesh-list
139636168|NCT06209619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139636169|NCT06209619|Antibodies|antibodies|mesh-list
139636170|NCT06209619|Immunoglobulins|immunoglobulins|mesh-list
139636171|NCT06209619|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139636172|NCT06209619|Immunologic Factors|immunologic factors|mesh-ancestor
139636173|NCT06209619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636174|NCT06209619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636175|NCT06209619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139636176|NCT06209112|Sevoflurane|sevoflurane|mesh-list
139636177|NCT06209112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139636178|NCT06209112|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139636179|NCT06209112|Anesthetics, General|anesthetics, general|mesh-ancestor
139636180|NCT06209112|Anesthetics|anesthetics|mesh-ancestor
139636181|NCT06209112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636182|NCT06209112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636183|NCT06205199|Hydromorphone|hydromorphone|mesh-list
139636184|NCT06205199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139636185|NCT06205199|Narcotics|narcotics|mesh-ancestor
139636186|NCT06205199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636187|NCT06205199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636188|NCT06205199|Analgesics|analgesics|mesh-ancestor
139636189|NCT06205199|Sensory System Agents|sensory system agents|mesh-ancestor
139636190|NCT06205199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636191|NCT06193863|Rivaroxaban|rivaroxaban|mesh-list
139636192|NCT06193863|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139636193|NCT06193863|Antithrombins|antithrombins|mesh-ancestor
139636194|NCT06193863|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139636195|NCT06193863|Protease Inhibitors|protease inhibitors|mesh-ancestor
139636196|NCT06193863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636197|NCT06193863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636198|NCT06193863|Anticoagulants|anticoagulants|mesh-ancestor
139636199|NCT06188715|Albendazole|albendazole|mesh-list
139636200|NCT06188715|Moxidectin|moxidectin|mesh-list
139636201|NCT06188715|Anthelmintics|anthelmintics|mesh-ancestor
139636202|NCT06188715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139636203|NCT06188715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636204|NCT06188715|Anticestodal Agents|anticestodal agents|mesh-ancestor
139636205|NCT06188715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139636206|NCT06188715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139636207|NCT06188715|Tubulin Modulators|tubulin modulators|mesh-ancestor
139636208|NCT06188715|Antimitotic Agents|antimitotic agents|mesh-ancestor
139636209|NCT06188715|Mitosis Modulators|mitosis modulators|mesh-ancestor
139636210|NCT06188715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636211|NCT06188715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636212|NCT06188715|Antinematodal Agents|antinematodal agents|mesh-ancestor
139636213|NCT06170489|Gemcitabine|gemcitabine|mesh-list
138989110|NCT06069180|Alkylating Agents|alkylating agents|mesh-ancestor
139636214|NCT06170489|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139636215|NCT06170489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139636216|NCT06170489|Antimetabolites|antimetabolites|mesh-ancestor
139636217|NCT06170489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636218|NCT06170489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636219|NCT06170489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139636221|NCT06151574|Carboplatin|carboplatin|mesh-list
139636222|NCT06151574|Pembrolizumab|pembrolizumab|mesh-list
139636223|NCT06151574|Pemetrexed|pemetrexed|mesh-list
139636224|NCT06151574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636225|NCT06151574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636226|NCT06151574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139636227|NCT06151574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636228|NCT06151574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636229|NCT06151574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139636230|NCT06151574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139636231|NCT06144177|Midazolam|midazolam|mesh-list
139636232|NCT06144177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139636233|NCT06144177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139636234|NCT06144177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636235|NCT06144177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636236|NCT06144177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139636237|NCT06144177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139636238|NCT06144177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139636239|NCT06144177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139636240|NCT06144177|Anesthetics, General|anesthetics, general|mesh-ancestor
139636241|NCT06144177|Anesthetics|anesthetics|mesh-ancestor
139636242|NCT06144177|GABA Modulators|gaba modulators|mesh-ancestor
139636243|NCT06144177|GABA Agents|gaba agents|mesh-ancestor
139636244|NCT06144177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636245|NCT06144177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636246|NCT06139692|Midazolam|midazolam|mesh-list
139636247|NCT06139692|Dexmedetomidine|dexmedetomidine|mesh-list
138989154|NCT06042647|Glucocorticoids|glucocorticoids|mesh-ancestor
139636248|NCT06139692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139636249|NCT06139692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636250|NCT06139692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636251|NCT06139692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139636252|NCT06139692|Analgesics|analgesics|mesh-ancestor
139636253|NCT06139692|Sensory System Agents|sensory system agents|mesh-ancestor
139636254|NCT06139692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636255|NCT06139692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139636256|NCT06139692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139636257|NCT06139692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139636258|NCT06139692|Adrenergic Agents|adrenergic agents|mesh-ancestor
139636259|NCT06139692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636260|NCT06139692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636261|NCT06139692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139636262|NCT06139692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139636263|NCT06139692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139636264|NCT06139692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139636265|NCT06139692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139636266|NCT06139692|Anesthetics, General|anesthetics, general|mesh-ancestor
139636267|NCT06139692|Anesthetics|anesthetics|mesh-ancestor
139636268|NCT06139692|GABA Modulators|gaba modulators|mesh-ancestor
139636269|NCT06139692|GABA Agents|gaba agents|mesh-ancestor
139636270|NCT06127316|Carbon Fiber|carbon fiber|mesh-list
139636271|NCT06127316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139636272|NCT06127316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636273|NCT06124898|Ethanol|ethanol|mesh-list
139636274|NCT06124898|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139636275|NCT06124898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636276|NCT06124898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636277|NCT06124898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636278|NCT06122480|Folfirinox|folfirinox|mesh-list
139636279|NCT06122480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636280|NCT06116669|Vaccines|vaccines|mesh-list
139636281|NCT06116669|Immunologic Factors|immunologic factors|mesh-ancestor
139636282|NCT06116669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636283|NCT06115135|Venetoclax|venetoclax|mesh-list
139636284|NCT06115135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636285|NCT06103864|Paclitaxel|paclitaxel|mesh-list
139636286|NCT06103864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139636287|NCT06103864|Carboplatin|carboplatin|mesh-list
139636288|NCT06103864|Gemcitabine|gemcitabine|mesh-list
139636289|NCT06103864|Pembrolizumab|pembrolizumab|mesh-list
139636290|NCT06103864|Durvalumab|durvalumab|mesh-list
139636291|NCT06103864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139636292|NCT06103864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636293|NCT06103864|Tubulin Modulators|tubulin modulators|mesh-ancestor
139636294|NCT06103864|Antimitotic Agents|antimitotic agents|mesh-ancestor
139636295|NCT06103864|Mitosis Modulators|mitosis modulators|mesh-ancestor
139636296|NCT06103864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636297|NCT06103864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139636298|NCT06103864|Antimetabolites|antimetabolites|mesh-ancestor
139636299|NCT06103864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636300|NCT06103864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139636301|NCT06100952|Riboflavin|riboflavin|mesh-list
139636302|NCT06100952|Vitamin B Complex|vitamin b complex|mesh-ancestor
139636303|NCT06100952|Vitamins|vitamins|mesh-ancestor
139636304|NCT06100952|Micronutrients|micronutrients|mesh-ancestor
139636305|NCT06100952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636306|NCT06100952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139636307|NCT06100952|Dermatologic Agents|dermatologic agents|mesh-ancestor
139636308|NCT06100939|Riboflavin|riboflavin|mesh-list
139636309|NCT06100939|Vitamin B Complex|vitamin b complex|mesh-ancestor
139636310|NCT06100939|Vitamins|vitamins|mesh-ancestor
139636311|NCT06100939|Micronutrients|micronutrients|mesh-ancestor
139636312|NCT06100939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636313|NCT06100939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139636314|NCT06100939|Dermatologic Agents|dermatologic agents|mesh-ancestor
139636315|NCT06098677|Carotenoids|carotenoids|mesh-list
139636316|NCT06098677|Antioxidants|antioxidants|mesh-ancestor
139636317|NCT06098677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636318|NCT06098677|Protective Agents|protective agents|mesh-ancestor
139636319|NCT06098677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636320|NCT06094816|Furosemide|furosemide|mesh-list
139636321|NCT06094816|Diuretics|diuretics|mesh-list
139636322|NCT06094816|Natriuretic Agents|natriuretic agents|mesh-ancestor
139636323|NCT06094816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636324|NCT06094816|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139636325|NCT06094816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139636326|NCT06094816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636327|NCT06091865|Prednisone|prednisone|mesh-list
139636328|NCT06091865|Prednisolone|prednisolone|mesh-list
139636329|NCT06091865|Cyclophosphamide|cyclophosphamide|mesh-list
139636330|NCT06091865|Rituximab|rituximab|mesh-list
139636331|NCT06091865|Doxorubicin|doxorubicin|mesh-list
139636332|NCT06091865|Vincristine|vincristine|mesh-list
139636333|NCT06091865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139636334|NCT06091865|Immunologic Factors|immunologic factors|mesh-ancestor
139636335|NCT06091865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636336|NCT06091865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139636337|NCT06091865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139636338|NCT06091865|Alkylating Agents|alkylating agents|mesh-ancestor
139636339|NCT06091865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636340|NCT06091865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617003|NCT00225615|Verapamil|verapamil|mesh-list
139636341|NCT06091865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139636342|NCT06091865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636343|NCT06091865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139636344|NCT06091865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139636345|NCT06091865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139636346|NCT06091865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636347|NCT06091865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139636348|NCT06091865|Glucocorticoids|glucocorticoids|mesh-ancestor
139636349|NCT06091865|Hormones|hormones|mesh-ancestor
139636350|NCT06091865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139636351|NCT06091865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139636352|NCT06091865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139636353|NCT06091865|Tubulin Modulators|tubulin modulators|mesh-ancestor
139636354|NCT06091865|Antimitotic Agents|antimitotic agents|mesh-ancestor
139636355|NCT06091865|Mitosis Modulators|mitosis modulators|mesh-ancestor
139636356|NCT06091020|Botulinum Toxins|botulinum toxins|mesh-list
139636357|NCT06091020|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139636358|NCT06091020|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139636359|NCT06091020|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139636360|NCT06091020|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139636361|NCT06091020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139636362|NCT06091020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636363|NCT06091020|Cholinergic Agents|cholinergic agents|mesh-ancestor
139636364|NCT06091020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636365|NCT06091020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636366|NCT06091020|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139636367|NCT06091020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636368|NCT06088290|Doxorubicin|doxorubicin|mesh-list
139636369|NCT06088290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139636370|NCT06088290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636371|NCT06088290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139418103|NCT02987686|Infliximab|infliximab|mesh-list
139636373|NCT06088290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636374|NCT06088290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636375|NCT06078709|Calcium, Dietary|calcium, dietary|mesh-list
139636376|NCT06078709|Leucovorin|leucovorin|mesh-list
139636377|NCT06078709|Folic Acid|folic acid|mesh-list
139636378|NCT06078709|Fluorouracil|fluorouracil|mesh-list
139636379|NCT06078709|Oxaliplatin|oxaliplatin|mesh-list
139636380|NCT06078709|Calcium|calcium|mesh-list
139636381|NCT06078709|Levoleucovorin|levoleucovorin|mesh-list
139636382|NCT06078709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139636383|NCT06078709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636384|NCT06078709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139636385|NCT06078709|Antimetabolites|antimetabolites|mesh-ancestor
139636386|NCT06078709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636387|NCT06078709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139636388|NCT06078709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636389|NCT06078709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139636390|NCT06078709|Immunologic Factors|immunologic factors|mesh-ancestor
139636391|NCT06078709|Antidotes|antidotes|mesh-ancestor
139636392|NCT06078709|Protective Agents|protective agents|mesh-ancestor
139636393|NCT06078709|Vitamin B Complex|vitamin b complex|mesh-ancestor
139636394|NCT06078709|Vitamins|vitamins|mesh-ancestor
139636395|NCT06078709|Micronutrients|micronutrients|mesh-ancestor
139636396|NCT06078709|Hematinics|hematinics|mesh-ancestor
139636397|NCT06075667|Tirzepatide|tirzepatide|mesh-list
139636398|NCT06075667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139636399|NCT06075667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636400|NCT06075667|Incretins|incretins|mesh-ancestor
139636401|NCT06075667|Hormones|hormones|mesh-ancestor
139636402|NCT06075667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139636403|NCT06066957|Letermovir|letermovir|mesh-list
139636404|NCT06066957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139636405|NCT06066957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636406|NCT06066957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636407|NCT06066957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636408|NCT06066957|Antiviral Agents|antiviral agents|mesh-ancestor
139636409|NCT06066957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636410|NCT06065657|Ethanol|ethanol|mesh-list
139636411|NCT06065657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139636412|NCT06065657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636413|NCT06065657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636414|NCT06065657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636415|NCT06062628|Ketamine|ketamine|mesh-list
139636416|NCT06062628|Analgesics|analgesics|mesh-ancestor
139636417|NCT06062628|Sensory System Agents|sensory system agents|mesh-ancestor
139636418|NCT06062628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636419|NCT06062628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636420|NCT06062628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139636421|NCT06062628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139636422|NCT06062628|Anesthetics, General|anesthetics, general|mesh-ancestor
139636423|NCT06062628|Anesthetics|anesthetics|mesh-ancestor
139636424|NCT06062628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636425|NCT06062628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139636426|NCT06062628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139636427|NCT06062628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138989364|NCT05926466|Antitubercular Agents|antitubercular agents|mesh-ancestor
139636428|NCT06062628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636429|NCT06039995|Chlorhexidine|chlorhexidine|mesh-list
139636430|NCT06039995|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139636431|NCT06039995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139636432|NCT06039995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636433|NCT06039995|Disinfectants|disinfectants|mesh-ancestor
139636434|NCT06039995|Dermatologic Agents|dermatologic agents|mesh-ancestor
139636435|NCT06027268|Carboplatin|carboplatin|mesh-list
139636436|NCT06027268|Gemcitabine|gemcitabine|mesh-list
139636437|NCT06027268|Pembrolizumab|pembrolizumab|mesh-list
139636438|NCT06027268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636439|NCT06027268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139636440|NCT06027268|Antimetabolites|antimetabolites|mesh-ancestor
139636441|NCT06027268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636442|NCT06027268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636443|NCT06027268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139636444|NCT06021925|Antibodies|antibodies|mesh-list
139636445|NCT06021925|Immunologic Factors|immunologic factors|mesh-ancestor
139636446|NCT06021925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636447|NCT05990738|Topotecan|topotecan|mesh-list
139636448|NCT05990738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139636449|NCT05990738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139636450|NCT05990738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636451|NCT05990738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636452|NCT05990738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636453|NCT05989347|Dapagliflozin|dapagliflozin|mesh-list
139636454|NCT05989347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139636455|NCT05989347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636456|NCT05989347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139636457|NCT05989347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636458|NCT05985343|Glycopyrrolate|glycopyrrolate|mesh-list
139636459|NCT05985343|Neostigmine|neostigmine|mesh-list
139636460|NCT05985343|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139636461|NCT05985343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636462|NCT05985343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636463|NCT05985343|Cholinergic Agents|cholinergic agents|mesh-ancestor
139636464|NCT05985343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636465|NCT05985343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636466|NCT05985343|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139636467|NCT05985343|Autonomic Agents|autonomic agents|mesh-ancestor
139636468|NCT05985343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636469|NCT05985343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139636470|NCT05985343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138989524|NCT05766514|Immunologic Factors|immunologic factors|mesh-ancestor
139636471|NCT05985343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139636472|NCT05983770|Tacrolimus|tacrolimus|mesh-list
139636473|NCT05983770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139636474|NCT05983770|Immunologic Factors|immunologic factors|mesh-ancestor
139636475|NCT05983770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636476|NCT05983770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139636477|NCT05983770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636478|NCT05983770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636479|NCT05976217|Venetoclax|venetoclax|mesh-list
139636480|NCT05976217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636481|NCT05972551|Diphosphonates|diphosphonates|mesh-list
139636482|NCT05972551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139636483|NCT05972551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636484|NCT05965492|Acetaminophen|acetaminophen|mesh-list
139636485|NCT05965492|Celecoxib|celecoxib|mesh-list
139636486|NCT05965492|Oxycodone|oxycodone|mesh-list
139636487|NCT05965492|Gabapentin|gabapentin|mesh-list
139636488|NCT05965492|Famotidine|famotidine|mesh-list
139636489|NCT05965492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139636490|NCT05965492|Analgesics|analgesics|mesh-ancestor
139636491|NCT05965492|Sensory System Agents|sensory system agents|mesh-ancestor
139636492|NCT05965492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636493|NCT05965492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636494|NCT05965492|Antipyretics|antipyretics|mesh-ancestor
139636495|NCT05965492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139636496|NCT05965492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139636497|NCT05965492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636498|NCT05965492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636499|NCT05965492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139636500|NCT05965492|Narcotics|narcotics|mesh-ancestor
139636501|NCT05965492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636502|NCT05965492|Anticonvulsants|anticonvulsants|mesh-ancestor
139636503|NCT05965492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139636504|NCT05965492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139636505|NCT05965492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139636506|NCT05965492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139636507|NCT05965492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139636508|NCT05965492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636509|NCT05965492|Antimanic Agents|antimanic agents|mesh-ancestor
139636510|NCT05965492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139636511|NCT05965492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139636512|NCT05965492|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139636513|NCT05965492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139636514|NCT05965492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139636515|NCT05965492|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139636516|NCT05965492|Histamine Antagonists|histamine antagonists|mesh-ancestor
139636517|NCT05965492|Histamine Agents|histamine agents|mesh-ancestor
139636518|NCT05955261|Cytarabine|cytarabine|mesh-list
139636519|NCT05955261|Fludarabine|fludarabine|mesh-list
139636520|NCT05955261|Fludarabine phosphate|fludarabine phosphate|mesh-list
139636521|NCT05955261|Etoposide|etoposide|mesh-list
139636522|NCT05955261|Azacitidine|azacitidine|mesh-list
139636523|NCT05955261|Daunorubicin|daunorubicin|mesh-list
139636524|NCT05955261|Venetoclax|venetoclax|mesh-list
139636525|NCT05955261|Mitoxantrone|mitoxantrone|mesh-list
139636526|NCT05955261|Idarubicin|idarubicin|mesh-list
139636527|NCT05955261|Gemtuzumab|gemtuzumab|mesh-list
139636528|NCT05955261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636529|NCT05955261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139636530|NCT05955261|Antimetabolites|antimetabolites|mesh-ancestor
139636531|NCT05955261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636532|NCT05955261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139636533|NCT05955261|Immunologic Factors|immunologic factors|mesh-ancestor
139636534|NCT05955261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636535|NCT05955261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139636536|NCT05955261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139636537|NCT05955261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139636538|NCT05955261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636539|NCT05955261|Antiviral Agents|antiviral agents|mesh-ancestor
139636540|NCT05955261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636541|NCT05955261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139636542|NCT05955261|Analgesics|analgesics|mesh-ancestor
138989687|NCT05640245|Adalimumab|adalimumab|mesh-list
139636543|NCT05955261|Sensory System Agents|sensory system agents|mesh-ancestor
139636544|NCT05955261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636545|NCT05955261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636546|NCT05955261|Immunotoxins|immunotoxins|mesh-ancestor
139636547|NCT05955261|Immunoconjugates|immunoconjugates|mesh-ancestor
139636548|NCT05949658|Sirolimus|sirolimus|mesh-list
139636549|NCT05949658|Everolimus|everolimus|mesh-list
139636550|NCT05949658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139636551|NCT05949658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139636552|NCT05949658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636553|NCT05949658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636554|NCT05949658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139636555|NCT05949658|Immunologic Factors|immunologic factors|mesh-ancestor
139636556|NCT05949658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636557|NCT05949658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636558|NCT05949658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139636559|NCT05949658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636560|NCT05949658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139636561|NCT05949658|Antifungal Agents|antifungal agents|mesh-ancestor
139636562|NCT05945823|Calcium, Dietary|calcium, dietary|mesh-list
139636563|NCT05945823|Leucovorin|leucovorin|mesh-list
139636564|NCT05945823|Pembrolizumab|pembrolizumab|mesh-list
139636565|NCT05945823|Oxaliplatin|oxaliplatin|mesh-list
139636566|NCT05945823|Irinotecan|irinotecan|mesh-list
139636567|NCT05945823|Futibatinib|futibatinib|mesh-list
139636568|NCT05945823|Calcium|calcium|mesh-list
139636569|NCT05945823|Levoleucovorin|levoleucovorin|mesh-list
139636570|NCT05945823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636571|NCT05945823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636572|NCT05945823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139636573|NCT05945823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636574|NCT05945823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139636575|NCT05945823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636576|NCT05945823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139636577|NCT05945823|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139636578|NCT05945823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139636579|NCT05945823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636580|NCT05945823|Antidotes|antidotes|mesh-ancestor
139636581|NCT05945823|Protective Agents|protective agents|mesh-ancestor
139636582|NCT05945823|Vitamin B Complex|vitamin b complex|mesh-ancestor
139636583|NCT05945823|Vitamins|vitamins|mesh-ancestor
139636584|NCT05945823|Micronutrients|micronutrients|mesh-ancestor
139636585|NCT05934942|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139636586|NCT05934942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139636587|NCT05934942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636588|NCT05926570|Cinacalcet|cinacalcet|mesh-list
139636589|NCT05926570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139636590|NCT05926570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636591|NCT05926570|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139636592|NCT05926570|Hormone Antagonists|hormone antagonists|mesh-ancestor
139636593|NCT05926570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139636594|NCT05919537|Paclitaxel|paclitaxel|mesh-list
139636595|NCT05919537|Docetaxel|docetaxel|mesh-list
139636596|NCT05919537|Gemcitabine|gemcitabine|mesh-list
139636597|NCT05919537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139636598|NCT05919537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636599|NCT05919537|Tubulin Modulators|tubulin modulators|mesh-ancestor
139636600|NCT05919537|Antimitotic Agents|antimitotic agents|mesh-ancestor
139636601|NCT05919537|Mitosis Modulators|mitosis modulators|mesh-ancestor
139636602|NCT05919537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636603|NCT05919537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139636604|NCT05919537|Antimetabolites|antimetabolites|mesh-ancestor
139636605|NCT05915702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139636606|NCT05915702|Chelating Agents|chelating agents|mesh-ancestor
139636607|NCT05915702|Sequestering Agents|sequestering agents|mesh-ancestor
139636608|NCT05915702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636609|NCT05910827|Docetaxel|docetaxel|mesh-list
139636610|NCT05910827|Cetuximab|cetuximab|mesh-list
139636611|NCT05910827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636612|NCT05910827|Tubulin Modulators|tubulin modulators|mesh-ancestor
139636613|NCT05910827|Antimitotic Agents|antimitotic agents|mesh-ancestor
139636614|NCT05910827|Mitosis Modulators|mitosis modulators|mesh-ancestor
139636615|NCT05910827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636616|NCT05910827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636617|NCT05890027|Phenylephrine|phenylephrine|mesh-list
139636618|NCT05890027|Oxymetazoline|oxymetazoline|mesh-list
139636619|NCT05890027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139636620|NCT05890027|Mydriatics|mydriatics|mesh-ancestor
139636621|NCT05890027|Autonomic Agents|autonomic agents|mesh-ancestor
139636622|NCT05890027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636623|NCT05890027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636624|NCT05890027|Sympathomimetics|sympathomimetics|mesh-ancestor
139636625|NCT05890027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139636626|NCT05890027|Nasal Decongestants|nasal decongestants|mesh-ancestor
139636627|NCT05890027|Respiratory System Agents|respiratory system agents|mesh-ancestor
139636628|NCT05890027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139636629|NCT05890027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139636630|NCT05890027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139636631|NCT05890027|Adrenergic Agents|adrenergic agents|mesh-ancestor
139636632|NCT05890027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636633|NCT05890027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636634|NCT05890027|Protective Agents|protective agents|mesh-ancestor
139636635|NCT05886049|Cytarabine|cytarabine|mesh-list
139636636|NCT05886049|Daunorubicin|daunorubicin|mesh-list
139636637|NCT05886049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139636638|NCT05886049|Antimetabolites|antimetabolites|mesh-ancestor
139636639|NCT05886049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636640|NCT05886049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636641|NCT05886049|Antiviral Agents|antiviral agents|mesh-ancestor
139636642|NCT05886049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636643|NCT05886049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139636644|NCT05886049|Immunologic Factors|immunologic factors|mesh-ancestor
139636645|NCT05886049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636646|NCT05886049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139636647|NCT05886049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139636648|NCT05886049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139636649|NCT05886049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636650|NCT05860933|Itraconazole|itraconazole|mesh-list
139636651|NCT05860933|Carbamazepine|carbamazepine|mesh-list
139636652|NCT05860933|Antifungal Agents|antifungal agents|mesh-ancestor
139636653|NCT05860933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636654|NCT05860933|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139636655|NCT05860933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139636656|NCT05860933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636657|NCT05860933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636658|NCT05860933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139636659|NCT05860933|Hormone Antagonists|hormone antagonists|mesh-ancestor
139636660|NCT05860933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139636661|NCT05860933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636662|NCT05860933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139636663|NCT05860933|Anticonvulsants|anticonvulsants|mesh-ancestor
139636664|NCT05860933|Antimanic Agents|antimanic agents|mesh-ancestor
139636665|NCT05860933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139636666|NCT05860933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636667|NCT05860933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139636668|NCT05860933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139636669|NCT05860933|Analgesics|analgesics|mesh-ancestor
139636670|NCT05860933|Sensory System Agents|sensory system agents|mesh-ancestor
139636671|NCT05860933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636672|NCT05860933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139636673|NCT05860933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139636674|NCT05860933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139636675|NCT05860933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139636676|NCT05848011|Prednisone|prednisone|mesh-list
139636677|NCT05848011|Docetaxel|docetaxel|mesh-list
139636678|NCT05848011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636679|NCT05848011|Tubulin Modulators|tubulin modulators|mesh-ancestor
139636680|NCT05848011|Antimitotic Agents|antimitotic agents|mesh-ancestor
139636681|NCT05848011|Mitosis Modulators|mitosis modulators|mesh-ancestor
139636682|NCT05848011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636683|NCT05848011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139636684|NCT05848011|Glucocorticoids|glucocorticoids|mesh-ancestor
139636685|NCT05848011|Hormones|hormones|mesh-ancestor
139636686|NCT05848011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139636687|NCT05848011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636688|NCT05848011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139636689|NCT05846620|Dimercaprol|dimercaprol|mesh-list
139636690|NCT05846620|Chelating Agents|chelating agents|mesh-ancestor
139636691|NCT05846620|Sequestering Agents|sequestering agents|mesh-ancestor
139636692|NCT05846620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636693|NCT05800015|Paclitaxel|paclitaxel|mesh-list
139636694|NCT05800015|Carboplatin|carboplatin|mesh-list
139636695|NCT05800015|Pemetrexed|pemetrexed|mesh-list
139636696|NCT05800015|Cemiplimab|cemiplimab|mesh-list
139636697|NCT05800015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139636698|NCT05800015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636699|NCT05800015|Tubulin Modulators|tubulin modulators|mesh-ancestor
139636700|NCT05800015|Antimitotic Agents|antimitotic agents|mesh-ancestor
139636701|NCT05800015|Mitosis Modulators|mitosis modulators|mesh-ancestor
139636702|NCT05800015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636703|NCT05800015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636704|NCT05800015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139636705|NCT05800015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139636706|NCT05800015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636707|NCT05785767|Cemiplimab|cemiplimab|mesh-list
139636708|NCT05785767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636709|NCT05785767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636710|NCT05784363|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139636711|NCT05784363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139636712|NCT05784363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636713|NCT05784363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636714|NCT05784363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139636715|NCT05784363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139636716|NCT05784363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636717|NCT05784363|Cholinergic Agents|cholinergic agents|mesh-ancestor
139636718|NCT05784363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636719|NCT05774626|Contraceptive Agents|contraceptive agents|mesh-list
139636720|NCT05774626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139636721|NCT05774626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636722|NCT05773053|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139636723|NCT05773053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139636724|NCT05773053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139636725|NCT05773053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636726|NCT05773053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636727|NCT05773053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139636728|NCT05773053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139636729|NCT05773053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636730|NCT05773053|Cholinergic Agents|cholinergic agents|mesh-ancestor
139636731|NCT05773053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636732|NCT05757167|Lumefantrine|lumefantrine|mesh-list
139636733|NCT05757167|Artemether|artemether|mesh-list
139636734|NCT05757167|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139636735|NCT05757167|Antimalarials|antimalarials|mesh-ancestor
139636736|NCT05757167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139636737|NCT05757167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139636738|NCT05757167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636739|NCT05748834|Doxorubicin|doxorubicin|mesh-list
139636740|NCT05748834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139636741|NCT05748834|Tucatinib|tucatinib|mesh-list
139636742|NCT05748834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139636743|NCT05748834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636744|NCT05748834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139418454|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636745|NCT05748834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139636746|NCT05748834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636747|NCT05748834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636748|NCT05748834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139636749|NCT05748665|Etomidate|etomidate|mesh-list
139636750|NCT05748665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139636751|NCT05748665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636752|NCT05748665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636753|NCT05748665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139636754|NCT05748665|Anesthetics, General|anesthetics, general|mesh-ancestor
139636755|NCT05748665|Anesthetics|anesthetics|mesh-ancestor
139636756|NCT05730036|Dexamethasone|dexamethasone|mesh-list
139636757|NCT05730036|Pomalidomide|pomalidomide|mesh-list
139636758|NCT05730036|Elotuzumab|elotuzumab|mesh-list
139636759|NCT05730036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139636760|NCT05730036|Antiemetics|antiemetics|mesh-ancestor
139636761|NCT05730036|Autonomic Agents|autonomic agents|mesh-ancestor
139636762|NCT05730036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636763|NCT05730036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636764|NCT05730036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139636765|NCT05730036|Glucocorticoids|glucocorticoids|mesh-ancestor
139636766|NCT05730036|Hormones|hormones|mesh-ancestor
139636767|NCT05730036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139636768|NCT05730036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139636769|NCT05730036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636770|NCT05730036|Immunologic Factors|immunologic factors|mesh-ancestor
139636771|NCT05730036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139636772|NCT05730036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139636773|NCT05730036|Growth Substances|growth substances|mesh-ancestor
139636774|NCT05730036|Growth Inhibitors|growth inhibitors|mesh-ancestor
139636775|NCT05727904|Pembrolizumab|pembrolizumab|mesh-list
139636776|NCT05727904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636777|NCT05727904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636778|NCT05727904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139636779|NCT05727904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636780|NCT05712356|Paclitaxel|paclitaxel|mesh-list
139636781|NCT05712356|Gemcitabine|gemcitabine|mesh-list
139636782|NCT05712356|Durvalumab|durvalumab|mesh-list
139636783|NCT05712356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139636784|NCT05712356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636785|NCT05712356|Tubulin Modulators|tubulin modulators|mesh-ancestor
139636786|NCT05712356|Antimitotic Agents|antimitotic agents|mesh-ancestor
139636787|NCT05712356|Mitosis Modulators|mitosis modulators|mesh-ancestor
139636788|NCT05712356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636789|NCT05712356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139636790|NCT05712356|Antimetabolites|antimetabolites|mesh-ancestor
139636791|NCT05712356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636792|NCT05693246|Glycopyrrolate|glycopyrrolate|mesh-list
139636793|NCT05693246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139636794|NCT05693246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139636795|NCT05693246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139636796|NCT05693246|Cholinergic Agents|cholinergic agents|mesh-ancestor
139636797|NCT05693246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636798|NCT05693246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636799|NCT05693246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636800|NCT05692180|Benralizumab|benralizumab|mesh-list
139636801|NCT05692180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139636802|NCT05692180|Respiratory System Agents|respiratory system agents|mesh-ancestor
139636803|NCT05651607|Cannabidiol|cannabidiol|mesh-list
139636804|NCT05651607|Anticonvulsants|anticonvulsants|mesh-ancestor
139636805|NCT05645536|Tamoxifen|tamoxifen|mesh-list
139636806|NCT05645536|Letrozole|letrozole|mesh-list
139636807|NCT05645536|Anastrozole|anastrozole|mesh-list
139636808|NCT05645536|Exemestane|exemestane|mesh-list
139636809|NCT05645536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636810|NCT05645536|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139636811|NCT05645536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139636812|NCT05645536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636813|NCT05645536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636814|NCT05645536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139636815|NCT05645536|Hormone Antagonists|hormone antagonists|mesh-ancestor
139636816|NCT05645536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139636817|NCT05645536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636818|NCT05645536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139636819|NCT05645536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139636820|NCT05645536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139636821|NCT05645536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139636822|NCT05639322|Ketamine|ketamine|mesh-list
139636823|NCT05639322|Analgesics|analgesics|mesh-ancestor
139636824|NCT05639322|Sensory System Agents|sensory system agents|mesh-ancestor
139636825|NCT05639322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636826|NCT05639322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636827|NCT05639322|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139636828|NCT05639322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139636829|NCT05639322|Anesthetics, General|anesthetics, general|mesh-ancestor
139636830|NCT05639322|Anesthetics|anesthetics|mesh-ancestor
139636831|NCT05639322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636832|NCT05639322|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139636833|NCT05639322|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139636834|NCT05639322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636835|NCT05639322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636837|NCT05617820|Estrogens|estrogens|mesh-ancestor
139636838|NCT05617820|Hormones|hormones|mesh-ancestor
139636839|NCT05617820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139636840|NCT05617820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636841|NCT05617313|Pembrolizumab|pembrolizumab|mesh-list
139636842|NCT05617313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636843|NCT05617313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636844|NCT05617313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139636845|NCT05617313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636846|NCT05609578|Carboplatin|carboplatin|mesh-list
139636847|NCT05609578|Pembrolizumab|pembrolizumab|mesh-list
139636848|NCT05609578|Pemetrexed|pemetrexed|mesh-list
139636849|NCT05609578|Adagrasib|adagrasib|mesh-list
139636850|NCT05609578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636851|NCT05609578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636852|NCT05609578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139636853|NCT05609578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636854|NCT05609578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636855|NCT05609578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139636856|NCT05609578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139636857|NCT05590585|Emollients|emollients|mesh-list
139636858|NCT05590585|Dermatologic Agents|dermatologic agents|mesh-ancestor
139636859|NCT05576077|Pembrolizumab|pembrolizumab|mesh-list
139636860|NCT05576077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636861|NCT05576077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636862|NCT05576077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139636863|NCT05576077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636864|NCT05516914|Cisplatin|cisplatin|mesh-list
139636865|NCT05516914|Gemcitabine|gemcitabine|mesh-list
139636866|NCT05516914|Docetaxel|docetaxel|mesh-list
139636867|NCT05516914|Tislelizumab|tislelizumab|mesh-list
139636868|NCT05516914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636869|NCT05516914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139636870|NCT05516914|Antimetabolites|antimetabolites|mesh-ancestor
139636871|NCT05516914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636872|NCT05516914|Tubulin Modulators|tubulin modulators|mesh-ancestor
139636873|NCT05516914|Antimitotic Agents|antimitotic agents|mesh-ancestor
139636874|NCT05516914|Mitosis Modulators|mitosis modulators|mesh-ancestor
139636875|NCT05516914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139636876|NCT05436418|Sirolimus|sirolimus|mesh-list
139636877|NCT05436418|Cyclophosphamide|cyclophosphamide|mesh-list
139636878|NCT05436418|Melphalan|melphalan|mesh-list
139636879|NCT05436418|Fludarabine|fludarabine|mesh-list
139636880|NCT05436418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139636881|NCT05436418|Immunologic Factors|immunologic factors|mesh-ancestor
139636882|NCT05436418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636883|NCT05436418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139636884|NCT05436418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139636885|NCT05436418|Alkylating Agents|alkylating agents|mesh-ancestor
139636886|NCT05436418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636887|NCT05436418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636888|NCT05436418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139636889|NCT05436418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139636890|NCT05436418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139636891|NCT05436418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636892|NCT05436418|Antifungal Agents|antifungal agents|mesh-ancestor
139636893|NCT05432804|Temozolomide|temozolomide|mesh-list
139636894|NCT05432804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139636895|NCT05432804|Alkylating Agents|alkylating agents|mesh-ancestor
139636896|NCT05432804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636897|NCT05432804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636898|NCT05400109|Cyclophosphamide|cyclophosphamide|mesh-list
139636899|NCT05400109|Fludarabine|fludarabine|mesh-list
139636900|NCT05400109|Fludarabine phosphate|fludarabine phosphate|mesh-list
139636901|NCT05400109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139636902|NCT05400109|Immunologic Factors|immunologic factors|mesh-ancestor
139636903|NCT05400109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636904|NCT05400109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139636905|NCT05400109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139636906|NCT05400109|Alkylating Agents|alkylating agents|mesh-ancestor
139636907|NCT05400109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636908|NCT05400109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139636909|NCT05400109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139636910|NCT05400109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139636911|NCT05400109|Antimetabolites|antimetabolites|mesh-ancestor
139636912|NCT05383742|Rifampin|rifampin|mesh-list
139636913|NCT05383742|Isoniazid|isoniazid|mesh-list
139636914|NCT05383742|Linezolid|linezolid|mesh-list
139636915|NCT05383742|Pyrazinamide|pyrazinamide|mesh-list
139636916|NCT05383742|Ethambutol|ethambutol|mesh-list
139636917|NCT05383742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139636918|NCT05383742|Antitubercular Agents|antitubercular agents|mesh-ancestor
139636919|NCT05383742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139636920|NCT05383742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139636921|NCT05383742|Leprostatic Agents|leprostatic agents|mesh-ancestor
139636922|NCT05383742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139636923|NCT05383742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636924|NCT05383742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636925|NCT05383742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139636926|NCT05383742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139636927|NCT05383742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138990426|NCT04912115|Midazolam|midazolam|mesh-list
139636928|NCT05383742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139636929|NCT05383742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139636930|NCT05383742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139636931|NCT05383742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139636932|NCT05383742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139636933|NCT05383742|Antimetabolites|antimetabolites|mesh-ancestor
139636934|NCT05383742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139636935|NCT05383742|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139636936|NCT05381974|Psilocybin|psilocybin|mesh-list
139636937|NCT05381974|Hallucinogens|hallucinogens|mesh-ancestor
139636938|NCT05381974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636939|NCT05381974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139636940|NCT05379959|Methamphetamine|methamphetamine|mesh-list
139636941|NCT05379959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139636942|NCT05379959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636943|NCT05379959|Sympathomimetics|sympathomimetics|mesh-ancestor
139636944|NCT05379959|Autonomic Agents|autonomic agents|mesh-ancestor
139636945|NCT05379959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636946|NCT05379959|Dopamine Agents|dopamine agents|mesh-ancestor
139636947|NCT05379959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636948|NCT05379959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636949|NCT05379959|Adrenergic Agents|adrenergic agents|mesh-ancestor
139636950|NCT05379959|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139636951|NCT05379959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139636952|NCT05379959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139636953|NCT05379959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139636954|NCT05344625|Ketamine|ketamine|mesh-list
139636955|NCT05344625|Analgesics|analgesics|mesh-ancestor
139636956|NCT05344625|Sensory System Agents|sensory system agents|mesh-ancestor
139636957|NCT05344625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636958|NCT05344625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636959|NCT05344625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139636960|NCT05344625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139636961|NCT05344625|Anesthetics, General|anesthetics, general|mesh-ancestor
139636962|NCT05344625|Anesthetics|anesthetics|mesh-ancestor
139636963|NCT05344625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636964|NCT05344625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139636965|NCT05344625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139636966|NCT05344625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139636967|NCT05344625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636968|NCT05331144|Losartan|losartan|mesh-list
139636969|NCT05331144|Amlodipine|amlodipine|mesh-list
139636970|NCT05331144|Calcium Channel Blockers|calcium channel blockers|mesh-list
139636971|NCT05331144|Angiotensin II|angiotensin ii|mesh-list
139636972|NCT05331144|Giapreza|giapreza|mesh-list
139636973|NCT05331144|Calcium|calcium|mesh-list
139636974|NCT05331144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139636975|NCT05331144|Angiotensinogen|angiotensinogen|mesh-list
139636976|NCT05331144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139636977|NCT05331144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636978|NCT05331144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139636979|NCT05331144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139636980|NCT05331144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139636981|NCT05331144|Vasodilator Agents|vasodilator agents|mesh-ancestor
139636982|NCT05331144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139636983|NCT05331144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139636984|NCT05331144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139636985|NCT05331144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139636986|NCT05331144|Protease Inhibitors|protease inhibitors|mesh-ancestor
139636987|NCT05331144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139636988|NCT05331131|Ketamine|ketamine|mesh-list
139636989|NCT05331131|Analgesics|analgesics|mesh-ancestor
139636990|NCT05331131|Sensory System Agents|sensory system agents|mesh-ancestor
139636991|NCT05331131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139636992|NCT05331131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139636993|NCT05331131|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139636994|NCT05331131|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139636995|NCT05331131|Anesthetics, General|anesthetics, general|mesh-ancestor
139636996|NCT05331131|Anesthetics|anesthetics|mesh-ancestor
139636997|NCT05331131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139636998|NCT05331131|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139636999|NCT05331131|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139637000|NCT05331131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637001|NCT05331131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637002|NCT05324384|Sirolimus|sirolimus|mesh-list
139637003|NCT05324384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139637004|NCT05324384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139637005|NCT05324384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139637006|NCT05324384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637007|NCT05324384|Antifungal Agents|antifungal agents|mesh-ancestor
139637008|NCT05324384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139637009|NCT05324384|Immunologic Factors|immunologic factors|mesh-ancestor
139637010|NCT05324384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637011|NCT05307705|Paclitaxel|paclitaxel|mesh-list
139637012|NCT05307705|Letrozole|letrozole|mesh-list
139637013|NCT05307705|Fulvestrant|fulvestrant|mesh-list
139637014|NCT05307705|Anastrozole|anastrozole|mesh-list
139637015|NCT05307705|Exemestane|exemestane|mesh-list
139637016|NCT05307705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139637017|NCT05307705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637018|NCT05307705|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637019|NCT05307705|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637020|NCT05307705|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637021|NCT05307705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637022|NCT05307705|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139637023|NCT05307705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139637024|NCT05307705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637025|NCT05307705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139637026|NCT05307705|Hormone Antagonists|hormone antagonists|mesh-ancestor
139637027|NCT05307705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138990554|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
139637028|NCT05307705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637029|NCT05307705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139637030|NCT05307705|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139637031|NCT05279898|Dexmedetomidine|dexmedetomidine|mesh-list
139637032|NCT05279898|Ketamine|ketamine|mesh-list
139637033|NCT05279898|Remifentanil|remifentanil|mesh-list
139637034|NCT05279898|Propofol|propofol|mesh-list
139637035|NCT05279898|Ropivacaine|ropivacaine|mesh-list
139637036|NCT05279898|Rocuronium|rocuronium|mesh-list
139637037|NCT05279898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139637038|NCT05279898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139637039|NCT05279898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637040|NCT05279898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139637041|NCT05279898|Analgesics|analgesics|mesh-ancestor
139637042|NCT05279898|Sensory System Agents|sensory system agents|mesh-ancestor
139637043|NCT05279898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139637044|NCT05279898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139637045|NCT05279898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139637046|NCT05279898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139637047|NCT05279898|Adrenergic Agents|adrenergic agents|mesh-ancestor
139637048|NCT05279898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637049|NCT05279898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637050|NCT05279898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139637051|NCT05279898|Anesthetics, General|anesthetics, general|mesh-ancestor
139637052|NCT05279898|Anesthetics|anesthetics|mesh-ancestor
139637053|NCT05279898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139637054|NCT05279898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139637055|NCT05279898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139637056|NCT05279898|Anesthetics, Local|anesthetics, local|mesh-ancestor
139637057|NCT05279898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139637058|NCT05279898|Narcotics|narcotics|mesh-ancestor
139637059|NCT05279898|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139637060|NCT05279898|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139637061|NCT05279898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139637062|NCT05255991|Treprostinil|treprostinil|mesh-list
139637063|NCT05255991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139637064|NCT05254184|Nivolumab|nivolumab|mesh-list
139637065|NCT05254184|Ipilimumab|ipilimumab|mesh-list
139637066|NCT05254184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637067|NCT05254184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637068|NCT05254184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637069|NCT05254184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637070|NCT05239624|Pembrolizumab|pembrolizumab|mesh-list
139637071|NCT05239624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637072|NCT05239624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637073|NCT05239624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637074|NCT05239624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637075|NCT05238142|Insulin|insulin|mesh-list
139637076|NCT05238142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139637077|NCT05238142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637078|NCT05223231|Antibodies|antibodies|mesh-list
139637079|NCT05223231|Immunoglobulins|immunoglobulins|mesh-list
139637080|NCT05223231|Immunologic Factors|immunologic factors|mesh-ancestor
139637081|NCT05223231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637082|NCT05209412|Aspirin|aspirin|mesh-list
139637083|NCT05209412|Paclitaxel|paclitaxel|mesh-list
139637084|NCT05209412|Clopidogrel|clopidogrel|mesh-list
139637085|NCT05209412|Ticagrelor|ticagrelor|mesh-list
139637086|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139637087|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637088|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637089|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637090|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637091|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637092|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139637093|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139637094|NCT05209412|Analgesics|analgesics|mesh-ancestor
139637095|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
139637096|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139637097|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637098|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139637099|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139637100|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139637101|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139637102|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139637103|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139637104|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637105|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
139637106|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139637107|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139637108|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139637109|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
139637110|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637111|NCT05183126|Paclitaxel|paclitaxel|mesh-list
139637112|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139637113|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139637114|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637115|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637116|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637117|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637118|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637119|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139637120|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
139637121|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637122|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139637123|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
139637124|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637125|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637126|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139637127|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139637128|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139637129|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
139637130|NCT05160597|Edetic Acid|edetic acid|mesh-list
139637131|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139637132|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
139637133|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
139637134|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637135|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
139637136|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139637137|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139637138|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139637139|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
139637140|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637141|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139637142|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
139637143|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637144|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637145|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139637146|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139637147|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139637148|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
139637149|NCT05137054|Lenalidomide|lenalidomide|mesh-list
139637150|NCT05137054|Pomalidomide|pomalidomide|mesh-list
139637151|NCT05137054|Bortezomib|bortezomib|mesh-list
139637152|NCT05137054|Daratumumab|daratumumab|mesh-list
139637153|NCT05137054|Cemiplimab|cemiplimab|mesh-list
139637154|NCT05137054|Nirogacestat|nirogacestat|mesh-list
139637155|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
139637156|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637157|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139637158|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139637159|NCT05137054|Growth Substances|growth substances|mesh-ancestor
139637160|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
139637161|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637162|NCT05137054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637163|NCT05137054|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139637164|NCT05137054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637165|NCT05137054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637166|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
139637167|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637168|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637169|NCT05128487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637170|NCT05128487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637171|NCT05063552|Bevacizumab|bevacizumab|mesh-list
139637172|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139637173|NCT05063552|Cetuximab|cetuximab|mesh-list
139637174|NCT05063552|Atezolizumab|atezolizumab|mesh-list
139637175|NCT05063552|Cisplatin|cisplatin|mesh-list
138990661|NCT04581382|Nivolumab|nivolumab|mesh-list
139637176|NCT05063552|Carboplatin|carboplatin|mesh-list
139637177|NCT05063552|Docetaxel|docetaxel|mesh-list
139637178|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
139637179|NCT05063552|Antibodies|antibodies|mesh-list
139637180|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
139637181|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139637182|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
139637183|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637184|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139637185|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139637186|NCT05063552|Growth Substances|growth substances|mesh-ancestor
139637187|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637188|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
139637189|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
139637190|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637191|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637192|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637193|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637194|NCT05063552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637195|NCT05058924|Aspirin|aspirin|mesh-list
139418902|NCT03109977|Pertuzumab|pertuzumab|mesh-list
139637196|NCT05058924|Heparin|heparin|mesh-list
139637197|NCT05058924|Calcium heparin|calcium heparin|mesh-list
139637198|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139637199|NCT05058924|Tinzaparin|tinzaparin|mesh-list
139637200|NCT05058924|Dalteparin|dalteparin|mesh-list
139637201|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139637202|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139637203|NCT05058924|Analgesics|analgesics|mesh-ancestor
139637204|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
139637205|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139637206|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637207|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139637208|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139637209|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139637210|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139637211|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637212|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139637213|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139637214|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637215|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
139637216|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
139637217|NCT05058651|Cisplatin|cisplatin|mesh-list
139637218|NCT05058651|Carboplatin|carboplatin|mesh-list
139637219|NCT05058651|Etoposide|etoposide|mesh-list
139637220|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
139637221|NCT05058651|Atezolizumab|atezolizumab|mesh-list
139637222|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
139637223|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139637224|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637225|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139637226|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139637227|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139637228|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637229|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637230|NCT05058651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637231|NCT05058651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637232|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
139637233|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637234|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
139637235|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
139637236|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637237|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637238|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637239|NCT05041335|Heparin|heparin|mesh-list
139637240|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
139637241|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139637242|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139637243|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637244|NCT05029726|Clonidine|clonidine|mesh-list
139637245|NCT05029726|Epinephrine|epinephrine|mesh-list
139637246|NCT05029726|Bupivacaine|bupivacaine|mesh-list
139637247|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
139637248|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
139637249|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139637250|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637251|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
139637252|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139637253|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139637254|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139637255|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
139637256|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637257|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637258|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139637259|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139637260|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
139637261|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139637262|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
139637263|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
139637264|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
139637265|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139637266|NCT05029726|Analgesics|analgesics|mesh-ancestor
139637267|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139637268|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
139637269|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139637270|NCT05016895|Azithromycin|azithromycin|mesh-list
139637271|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139637272|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139637273|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139637274|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139637275|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637276|NCT05006573|Benralizumab|benralizumab|mesh-list
139637277|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139637278|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
139637279|NCT05003076|Methamphetamine|methamphetamine|mesh-list
139637280|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139637281|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637282|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
139637283|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
139637284|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139637285|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
139637286|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637287|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637288|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
139637289|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139637290|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139637291|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139637292|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139637293|NCT05001880|Bevacizumab|bevacizumab|mesh-list
139637294|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139637295|NCT05001880|Atezolizumab|atezolizumab|mesh-list
139637296|NCT05001880|Carboplatin|carboplatin|mesh-list
139637297|NCT05001880|Pemetrexed|pemetrexed|mesh-list
139637298|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
139637299|NCT05001880|Antibodies|antibodies|mesh-list
139637300|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
139637301|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139637302|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
139637303|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637304|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139637305|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139637306|NCT05001880|Growth Substances|growth substances|mesh-ancestor
139637307|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637308|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
139637309|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
139637310|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637311|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637312|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139637313|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139637314|NCT05001880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637315|NCT04995653|Vancomycin|vancomycin|mesh-list
139637316|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139637317|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139637318|NCT04990258|Infliximab|infliximab|mesh-list
139637319|NCT04990258|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139637320|NCT04990258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139637321|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
139637322|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139637323|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139637324|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139637325|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
139637326|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637327|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139637328|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
139637329|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637330|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637331|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139637332|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139637333|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139637334|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
139637335|NCT04964934|Letrozole|letrozole|mesh-list
139637336|NCT04964934|Palbociclib|palbociclib|mesh-list
139637337|NCT04964934|Anastrozole|anastrozole|mesh-list
139637338|NCT04964934|Hormones|hormones|mesh-list
139637339|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139637340|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139637341|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637342|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637343|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139637344|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139637345|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637346|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637347|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139637348|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
139637349|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139637350|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139637351|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139637352|NCT04964544|Calcium|calcium|mesh-list
139637353|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139637354|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637355|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139637356|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139637357|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
139637358|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637359|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139637360|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139637361|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637362|NCT04957368|Midazolam|midazolam|mesh-list
139637363|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
139637364|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139637365|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139637366|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139637367|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637368|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139637369|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139637370|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139637371|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139637372|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
139637373|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
139637374|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
139637375|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
139637376|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637377|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637378|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139637379|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139637380|NCT04957368|Analgesics|analgesics|mesh-ancestor
139637381|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
139637382|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139637383|NCT04929041|Paclitaxel|paclitaxel|mesh-list
139637384|NCT04929041|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139637385|NCT04929041|Carboplatin|carboplatin|mesh-list
139637386|NCT04929041|Pembrolizumab|pembrolizumab|mesh-list
139637387|NCT04929041|Nivolumab|nivolumab|mesh-list
139637388|NCT04929041|Pemetrexed|pemetrexed|mesh-list
139637389|NCT04929041|Ipilimumab|ipilimumab|mesh-list
139637390|NCT04929041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139637391|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637392|NCT04929041|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637393|NCT04929041|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637394|NCT04929041|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637395|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637396|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637397|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637398|NCT04929041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637399|NCT04929041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139637400|NCT04929041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139637401|NCT04906395|Tamoxifen|tamoxifen|mesh-list
139637402|NCT04906395|Letrozole|letrozole|mesh-list
139637403|NCT04906395|Anastrozole|anastrozole|mesh-list
139637404|NCT04906395|Exemestane|exemestane|mesh-list
139637405|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637406|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138990944|NCT04028596|Vasodilator Agents|vasodilator agents|mesh-ancestor
139637407|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139637408|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637409|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637410|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139637411|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
139637412|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139637413|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637414|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139637415|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139637416|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139637417|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139637418|NCT04905693|Treprostinil|treprostinil|mesh-list
139637419|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139637420|NCT04884763|Erenumab|erenumab|mesh-list
139637421|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139637422|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637423|NCT04884763|Analgesics|analgesics|mesh-ancestor
139637424|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
139637425|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139637426|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637427|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
139637428|NCT04881240|Fludarabine|fludarabine|mesh-list
139637429|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139637430|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
139637431|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637432|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139637433|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139637434|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
139637435|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637436|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637437|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139637438|NCT04799275|Prednisone|prednisone|mesh-list
139637439|NCT04799275|Cortisone|cortisone|mesh-list
139637440|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
139637441|NCT04799275|Rituximab|rituximab|mesh-list
139637442|NCT04799275|Doxorubicin|doxorubicin|mesh-list
139637443|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139637444|NCT04799275|Vincristine|vincristine|mesh-list
139637445|NCT04799275|Azacitidine|azacitidine|mesh-list
139637446|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139637447|NCT04799275|Antibodies|antibodies|mesh-list
139637448|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
139637449|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139637450|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139637451|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
139637452|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637453|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139637454|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139637455|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
139637456|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637457|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637458|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139637459|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139637460|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139637461|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139637462|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637463|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139637464|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
139637465|NCT04799275|Hormones|hormones|mesh-ancestor
139637466|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139637467|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139637468|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139637469|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637470|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637471|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637472|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139637473|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
139637474|NCT04787744|Prednisone|prednisone|mesh-list
139637475|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
139637476|NCT04787744|Docetaxel|docetaxel|mesh-list
139637477|NCT04787744|Leuprolide|leuprolide|mesh-list
139637478|NCT04787744|Goserelin|goserelin|mesh-list
139637479|NCT04787744|Bicalutamide|bicalutamide|mesh-list
139637480|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139637481|NCT04787744|Flutamide|flutamide|mesh-list
139637482|NCT04787744|Nilutamide|nilutamide|mesh-list
139637483|NCT04787744|Relugolix|relugolix|mesh-list
139637484|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637485|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637486|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637487|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637488|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637489|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139637490|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
139637491|NCT04787744|Hormones|hormones|mesh-ancestor
139637492|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139637493|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637494|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139637495|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
139637496|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
139637497|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139637498|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139637499|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139637500|NCT04787744|Protective Agents|protective agents|mesh-ancestor
139637501|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139637502|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
139637503|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139637504|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
139637505|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
139637506|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
139637507|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139637508|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
139637509|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139637510|NCT04784143|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139637511|NCT04784143|Hallucinogens|hallucinogens|mesh-ancestor
139637512|NCT04784143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637513|NCT04784143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139637514|NCT04784143|Serotonin Agents|serotonin agents|mesh-ancestor
139637515|NCT04784143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637516|NCT04784143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637517|NCT04784143|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139637518|NCT04784143|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139637519|NCT04784143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139637520|NCT04784143|Adrenergic Agents|adrenergic agents|mesh-ancestor
139637521|NCT04781387|REP 3123|rep 3123|mesh-list
139637522|NCT04781387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139637523|NCT04781387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139637524|NCT04775173|Sirolimus|sirolimus|mesh-list
139637525|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139637526|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139637527|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139637528|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637529|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
139637530|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139637531|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
139637532|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637533|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
139637534|NCT04767984|Atorvastatin|atorvastatin|mesh-list
139637535|NCT04767984|Calcium|calcium|mesh-list
139637536|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139637537|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637538|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139637539|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139637540|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139637541|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
139637542|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637543|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139637544|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139637545|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637546|NCT04751370|Nivolumab|nivolumab|mesh-list
139637547|NCT04751370|Ipilimumab|ipilimumab|mesh-list
139637548|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637549|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637550|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637551|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637552|NCT04726969|Ivermectin|ivermectin|mesh-list
139637553|NCT04726969|Albendazole|albendazole|mesh-list
139637554|NCT04726969|Moxidectin|moxidectin|mesh-list
139637555|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139637556|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139637557|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
139637558|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
139637559|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139637560|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139637561|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637562|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637563|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637564|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637565|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637566|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
139637567|NCT04714359|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139637568|NCT04714359|Hallucinogens|hallucinogens|mesh-ancestor
139637569|NCT04714359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637570|NCT04714359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139637571|NCT04714359|Serotonin Agents|serotonin agents|mesh-ancestor
139637572|NCT04714359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637573|NCT04714359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637574|NCT04714359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139637575|NCT04714359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139637576|NCT04714359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139637577|NCT04714359|Adrenergic Agents|adrenergic agents|mesh-ancestor
139637578|NCT04708782|Treprostinil|treprostinil|mesh-list
139637579|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139637580|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
139637581|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637582|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637583|NCT04708418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637584|NCT04708418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637585|NCT04707391|Vaccines|vaccines|mesh-list
139637586|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
139637587|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637588|NCT04703868|Rabeprazole|rabeprazole|mesh-list
139637589|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139637590|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139637591|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139637592|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637593|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637594|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
139637595|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637596|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637597|NCT04665739|Everolimus|everolimus|mesh-list
139637598|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139637599|NCT04665739|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139637600|NCT04665739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139637601|NCT04665739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637602|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637603|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139637604|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
139637605|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637606|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637607|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139637608|NCT04639414|Empagliflozin|empagliflozin|mesh-list
139637609|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139637610|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637611|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139637612|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637613|NCT04632927|Ustekinumab|ustekinumab|mesh-list
139637614|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
139637615|NCT04628767|Cisplatin|cisplatin|mesh-list
139637616|NCT04628767|Gemcitabine|gemcitabine|mesh-list
139637617|NCT04628767|Doxorubicin|doxorubicin|mesh-list
139637618|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139637619|NCT04628767|Methotrexate|methotrexate|mesh-list
139637620|NCT04628767|Durvalumab|durvalumab|mesh-list
139637621|NCT04628767|Vinblastine|vinblastine|mesh-list
139637622|NCT04628767|Lenograstim|lenograstim|mesh-list
139637623|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
139637624|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139637625|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
139637626|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637627|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139637628|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
139637629|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637630|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139637631|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139637632|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139637633|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637634|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139637635|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
139637636|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139637637|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637638|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
139637639|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139637640|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139637641|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
139637642|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139637643|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139637644|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139637645|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637646|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139637647|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637648|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637649|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637650|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
139637651|NCT04613596|Adagrasib|adagrasib|mesh-list
139637652|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139419356|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139637653|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637654|NCT04613596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637655|NCT04613596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637656|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
139637657|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637658|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637659|NCT04592653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637660|NCT04592653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637661|NCT04530565|Cytarabine|cytarabine|mesh-list
139637662|NCT04530565|Dexamethasone|dexamethasone|mesh-list
139637663|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
139637664|NCT04530565|Prednisone|prednisone|mesh-list
139637665|NCT04530565|Cortisone|cortisone|mesh-list
139637666|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
139637667|NCT04530565|Doxorubicin|doxorubicin|mesh-list
139637668|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139637669|NCT04530565|Methotrexate|methotrexate|mesh-list
139637670|NCT04530565|Vincristine|vincristine|mesh-list
139637671|NCT04530565|Dasatinib|dasatinib|mesh-list
139637672|NCT04530565|Blinatumomab|blinatumomab|mesh-list
139637673|NCT04530565|Ponatinib|ponatinib|mesh-list
139637674|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139637675|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
139637676|NCT04530565|Antibodies|antibodies|mesh-list
139637677|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
139637678|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139637679|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139637680|NCT04530565|BB 1101|bb 1101|mesh-list
139637681|NCT04530565|Mesna|mesna|mesh-list
139637682|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139637683|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
139637684|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637685|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139637686|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139637687|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
139637688|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637689|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637690|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139637691|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139637692|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
139637693|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
139637694|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139637695|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139637696|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
139637697|NCT04530565|Hormones|hormones|mesh-ancestor
139637698|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139637699|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139637700|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
139637701|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637702|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138991172|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
138991173|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991174|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991175|NCT03753659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991176|NCT03753659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991177|NCT03679676|Omalizumab|omalizumab|mesh-list
139637703|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139637704|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139637705|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139637706|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
139637707|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139637708|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139637709|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
139637710|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
139637711|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139637712|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139637713|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
139637714|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139637715|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139637716|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637717|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637718|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637719|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139637720|NCT04530565|Protective Agents|protective agents|mesh-ancestor
139637721|NCT04526691|Carboplatin|carboplatin|mesh-list
139637722|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
139637723|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637724|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637725|NCT04526691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637726|NCT04526691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419438|NCT03509831|Nizatidine|nizatidine|mesh-list
139637727|NCT04491942|Cisplatin|cisplatin|mesh-list
139637728|NCT04491942|Gemcitabine|gemcitabine|mesh-list
139637729|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637730|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139637732|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637733|NCT04488601|Sirolimus|sirolimus|mesh-list
139637734|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139637735|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139637736|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139637737|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637738|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
139637739|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139637740|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
139637741|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637742|NCT04465760|Antibodies|antibodies|mesh-list
139637743|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
139637744|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
139637745|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637746|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139637747|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
139637748|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637749|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139637750|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
139637751|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637752|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637753|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139637754|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139637755|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139637756|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
139637757|NCT04444921|Paclitaxel|paclitaxel|mesh-list
139637758|NCT04444921|Carboplatin|carboplatin|mesh-list
139637759|NCT04444921|Nivolumab|nivolumab|mesh-list
139637760|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139637761|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139637762|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637763|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637764|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637765|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637766|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637767|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637768|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637769|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139637770|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
139637771|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637772|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139637773|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
139637774|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637775|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637776|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139637777|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139637778|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139637779|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
139637780|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
139637781|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637782|NCT04400695|Paclitaxel|paclitaxel|mesh-list
139637783|NCT04400695|Vinorelbine|vinorelbine|mesh-list
139637784|NCT04400695|Docetaxel|docetaxel|mesh-list
139637785|NCT04400695|Capecitabine|capecitabine|mesh-list
139637786|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139637787|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637788|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637789|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637790|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637791|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637792|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139637793|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
139637794|NCT04384484|Rituximab|rituximab|mesh-list
139637795|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139637796|NCT04384484|Gemcitabine|gemcitabine|mesh-list
139637797|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
139637798|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637799|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637800|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
139637801|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637802|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139637803|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139419504|NCT02303951|Vemurafenib|vemurafenib|mesh-list
139637804|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
139637805|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637806|NCT04307576|Dexamethasone|dexamethasone|mesh-list
139637807|NCT04307576|Doxorubicin|doxorubicin|mesh-list
139637808|NCT04307576|Vincristine|vincristine|mesh-list
139637809|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
139637810|NCT04307576|Blinatumomab|blinatumomab|mesh-list
139637811|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139637812|NCT04307576|Thioguanine|thioguanine|mesh-list
139637813|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139637814|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
139637815|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
139637816|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139637817|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637818|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139637819|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
139637820|NCT04307576|Hormones|hormones|mesh-ancestor
139637821|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139637822|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139637823|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637824|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139637825|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139637826|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139637827|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637828|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637829|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139637830|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637831|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637832|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637833|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139637834|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637835|NCT04307576|Immunotoxins|immunotoxins|mesh-ancestor
139637836|NCT04307576|Immunoconjugates|immunoconjugates|mesh-ancestor
139637837|NCT04307576|Immunologic Factors|immunologic factors|mesh-ancestor
139637838|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139637839|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
139637840|NCT04300790|Tamoxifen|tamoxifen|mesh-list
139637841|NCT04300790|Metformin|metformin|mesh-list
139637842|NCT04300790|Vildagliptin|vildagliptin|mesh-list
139637843|NCT04300790|Letrozole|letrozole|mesh-list
139637844|NCT04300790|Fulvestrant|fulvestrant|mesh-list
139637845|NCT04300790|Exemestane|exemestane|mesh-list
139637846|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139637847|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637848|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637849|NCT04300790|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139637850|NCT04300790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139637851|NCT04300790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991322|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637852|NCT04300790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637853|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139637854|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
139637855|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139637856|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139637857|NCT04300790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139637858|NCT04300790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139637859|NCT04300790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139637860|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139637861|NCT04300790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139637862|NCT04300790|Protease Inhibitors|protease inhibitors|mesh-ancestor
139637863|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139637864|NCT04257500|Etonogestrel|etonogestrel|mesh-list
139637865|NCT04257500|NuvaRing|nuvaring|mesh-list
139637866|NCT04257500|Estradiol|estradiol|mesh-list
139637867|NCT04257500|Estrogens|estrogens|mesh-ancestor
139637868|NCT04257500|Hormones|hormones|mesh-ancestor
139637869|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139637870|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637871|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139637872|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
139637873|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139637874|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139637875|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139637876|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139637877|NCT04254913|Edaravone|edaravone|mesh-list
139637878|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139637879|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
139637880|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637881|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139637882|NCT04254913|Protective Agents|protective agents|mesh-ancestor
139637883|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637884|NCT04247646|Melatonin|melatonin|mesh-list
139637885|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
139637886|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637887|NCT04247646|Protective Agents|protective agents|mesh-ancestor
139637888|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637889|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139637890|NCT04223752|Tazobactam|tazobactam|mesh-list
139637891|NCT04223752|Ceftolozane|ceftolozane|mesh-list
139637892|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
139637893|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139637894|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139637895|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139637896|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637897|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637898|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139637899|NCT04176224|Edaravone|edaravone|mesh-list
139637900|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139637901|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
139637902|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637903|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139637904|NCT04176224|Protective Agents|protective agents|mesh-ancestor
139637905|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637906|NCT04166487|Paclitaxel|paclitaxel|mesh-list
139637907|NCT04166487|Carboplatin|carboplatin|mesh-list
139637908|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
139637909|NCT04166487|Pemetrexed|pemetrexed|mesh-list
139637910|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139637911|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637912|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637913|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637914|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
138991417|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
139637915|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637916|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637917|NCT04166487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637918|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139637919|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139637920|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139637921|NCT04164082|Gemcitabine|gemcitabine|mesh-list
139637922|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
139637923|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139637924|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
139637925|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637926|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637927|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637928|NCT04164082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637929|NCT04160091|FX006|fx006|mesh-list
139637930|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139637931|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
139637932|NCT04160091|Hormones|hormones|mesh-ancestor
139637933|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139637934|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637935|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139637936|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
139637937|NCT04113018|Dexamethasone|dexamethasone|mesh-list
139637938|NCT04113018|Lenalidomide|lenalidomide|mesh-list
139637939|NCT04113018|Daratumumab|daratumumab|mesh-list
139637940|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139637941|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
139637942|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
139637943|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139637944|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637945|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139637946|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
139637947|NCT04113018|Hormones|hormones|mesh-ancestor
139637948|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139637949|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139637950|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637951|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
139637952|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139637953|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139637954|NCT04113018|Growth Substances|growth substances|mesh-ancestor
139637955|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
139637956|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
139637957|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139637958|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637959|NCT04093167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139637960|NCT04093167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637961|NCT04092179|Venetoclax|venetoclax|mesh-list
139637962|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637963|NCT04085445|Paclitaxel|paclitaxel|mesh-list
139637964|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139637965|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139637966|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
139637967|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
139637968|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
139637969|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637970|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139637971|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
139637972|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637973|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139637974|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
139637975|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637976|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637977|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139637978|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139637979|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139637980|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
139637981|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139637982|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
139637983|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637984|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139637985|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
139637986|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139637987|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139637988|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139637989|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139637990|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139637991|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
139637992|NCT04068948|Midazolam|midazolam|mesh-list
139637993|NCT04068948|Meperidine|meperidine|mesh-list
139637994|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
139637995|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139637996|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139637997|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139637998|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139637999|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139638000|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139638001|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638002|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139638003|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
139638004|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
139638005|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
139638006|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
139638007|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638008|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638009|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139638010|NCT04068948|Narcotics|narcotics|mesh-ancestor
139638011|NCT04068948|Analgesics|analgesics|mesh-ancestor
139638012|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
139638013|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139638014|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
139638015|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
139638016|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139638017|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
139638018|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
139638020|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638021|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
139638022|NCT04065074|Hormones|hormones|mesh-ancestor
139638023|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139638024|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638025|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638026|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
139638027|NCT04056962|Tacrolimus|tacrolimus|mesh-list
139638028|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638029|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
139638030|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638031|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139638032|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638033|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638034|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
139638035|NCT04025216|Fludarabine|fludarabine|mesh-list
139638036|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638037|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
139638038|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991538|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
139638039|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139638040|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139638041|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
139638042|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638043|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638044|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139638045|NCT04021121|Linezolid|linezolid|mesh-list
139638046|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139638047|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139638048|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139638049|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638050|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638051|NCT03950739|Treprostinil|treprostinil|mesh-list
139638052|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139638053|NCT03874338|Colchicine|colchicine|mesh-list
139638054|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
139638055|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139638056|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
139638057|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
139638058|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
139638059|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638060|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638061|NCT03793010|FX006|fx006|mesh-list
139638062|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638063|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
139638064|NCT03793010|Hormones|hormones|mesh-ancestor
139638065|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139638066|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638067|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638068|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
139638069|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139638070|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
139638071|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638072|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638073|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139638074|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
139638075|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138991565|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
139638076|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638077|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139638078|NCT03761511|Niacinamide|niacinamide|mesh-list
139638079|NCT03761511|Niacin|niacin|mesh-list
139638080|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
139638081|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
139638082|NCT03761511|Vitamins|vitamins|mesh-ancestor
139638083|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
139638084|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638085|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139638086|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
139638087|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638088|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139638089|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
139638090|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
139638091|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638092|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638093|NCT03727880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139638094|NCT03727880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638095|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
139638096|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638097|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638098|NCT03712605|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139638099|NCT03712605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638100|NCT03701308|Cytarabine|cytarabine|mesh-list
139638101|NCT03701308|Daunorubicin|daunorubicin|mesh-list
139638102|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139638103|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
139638104|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638105|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638106|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
139638107|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139638108|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638109|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
139638110|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638111|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139638112|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139638113|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139638114|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638115|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139638116|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
139638117|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638118|NCT03620578|Nivolumab|nivolumab|mesh-list
139638119|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638120|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638121|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139638122|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638123|NCT03615534|Niacin|niacin|mesh-list
139638124|NCT03615534|Fenofibrate|fenofibrate|mesh-list
139638125|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139638126|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
139638127|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638128|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139638129|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
139638130|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
139638131|NCT03615534|Vitamins|vitamins|mesh-ancestor
139638132|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
139638133|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638134|NCT03609047|Paclitaxel|paclitaxel|mesh-list
139638135|NCT03609047|Docetaxel|docetaxel|mesh-list
139638136|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
139638137|NCT03609047|Doxorubicin|doxorubicin|mesh-list
139638138|NCT03609047|Epirubicin|epirubicin|mesh-list
139638139|NCT03609047|Palbociclib|palbociclib|mesh-list
139638140|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139638141|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638142|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
139638143|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
139638144|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
139638145|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638146|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638147|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
139638148|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638149|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139638150|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139638151|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
139638152|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139638153|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139638154|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139638155|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139638156|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638157|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139638158|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638159|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
139638160|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638161|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638162|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
139638163|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638164|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638165|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638166|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638167|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638168|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638169|NCT03599622|Deucravacitinib|deucravacitinib|mesh-list
139638170|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
139638171|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139638172|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638173|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638174|NCT03584516|Prednisone|prednisone|mesh-list
139638175|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
139638176|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139419905|NCT04539327|Rucaparib|rucaparib|mesh-list
139638177|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139638178|NCT03584516|Prednisolone|prednisolone|mesh-list
139638179|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
139638180|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139638182|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638183|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
139638184|NCT03584516|Hormones|hormones|mesh-ancestor
139638185|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139638186|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638187|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139638188|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638189|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
139638190|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
139638191|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139638192|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139638193|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139638194|NCT03584516|Protective Agents|protective agents|mesh-ancestor
139638195|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638196|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
139638197|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638198|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638199|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
139638200|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638201|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638202|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638203|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638204|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138991739|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
139638205|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638206|NCT03529942|FX006|fx006|mesh-list
139638207|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638208|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
139638209|NCT03529942|Hormones|hormones|mesh-ancestor
139638210|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139638211|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638212|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638213|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
139638214|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638215|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
139638216|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638217|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638218|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
139638219|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638220|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638221|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638222|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638223|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638224|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638225|NCT03484819|Nivolumab|nivolumab|mesh-list
139638226|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638227|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991776|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638228|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139638229|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638230|NCT03476369|Fentanyl|fentanyl|mesh-list
139638231|NCT03476369|Ticagrelor|ticagrelor|mesh-list
139638232|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139638233|NCT03476369|Narcotics|narcotics|mesh-ancestor
139638234|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139638235|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638236|NCT03476369|Analgesics|analgesics|mesh-ancestor
139638237|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
139638238|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139638239|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139638240|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139638241|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
139638242|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
139638243|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139638244|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139638245|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139638246|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139638247|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
139638248|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638249|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638250|NCT03442413|Nicotine|nicotine|mesh-list
139638251|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139638252|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
139419956|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
139638253|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139638254|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638255|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139638256|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139638257|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
139638258|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638259|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638260|NCT03432949|Dexamethasone|dexamethasone|mesh-list
139638261|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
139638262|NCT03432949|BB 1101|bb 1101|mesh-list
139638263|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638264|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
139638265|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
139638266|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139638267|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638268|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139638269|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
139638270|NCT03432949|Hormones|hormones|mesh-ancestor
139638271|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139638272|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139638273|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638274|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
139638275|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638276|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638277|NCT03388632|Nivolumab|nivolumab|mesh-list
139638278|NCT03388632|Ipilimumab|ipilimumab|mesh-list
139638279|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638280|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638281|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139638282|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638283|NCT03382262|Triamcinolone|triamcinolone|mesh-list
139638284|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139638285|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139638286|NCT03382262|FX006|fx006|mesh-list
139638287|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139638288|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638289|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
139638290|NCT03382262|Hormones|hormones|mesh-ancestor
138991875|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
139638291|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139638292|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638293|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638294|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
139638295|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638296|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638297|NCT03381274|Osimertinib|osimertinib|mesh-list
139638298|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638299|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139638300|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638301|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638302|NCT03378076|Triamcinolone|triamcinolone|mesh-list
139638303|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139638304|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139638305|NCT03378076|FX006|fx006|mesh-list
139638306|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139638307|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638308|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
139638309|NCT03378076|Hormones|hormones|mesh-ancestor
139638310|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139638311|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638312|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638313|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
139638314|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638315|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638316|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638317|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
139638318|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638319|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638320|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
139638321|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638322|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638323|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638324|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138991914|NCT00741910|Semapimod|semapimod|mesh-list
139638325|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638326|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638328|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139638329|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139638330|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139638331|NCT03197194|Analgesics|analgesics|mesh-ancestor
139638332|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
139638333|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139638334|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638335|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638336|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139638337|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139638338|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139638339|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638340|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139638341|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139638342|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638343|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
139638344|NCT03182244|Cytarabine|cytarabine|mesh-list
139638345|NCT03182244|Fludarabine|fludarabine|mesh-list
139638346|NCT03182244|Etoposide|etoposide|mesh-list
139638347|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
139638348|NCT03182244|Lenograstim|lenograstim|mesh-list
139638349|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638350|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139638351|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
139638352|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638353|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638354|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
139638355|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638356|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139638357|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139638358|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139638359|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638360|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
139638361|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139638362|NCT03182244|Analgesics|analgesics|mesh-ancestor
139638363|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
139638364|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139638365|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139638366|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638367|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
139638368|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638369|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638370|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
139638371|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638372|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638373|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638374|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638375|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638376|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638377|NCT03155620|Olaparib|olaparib|mesh-list
139638378|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139638379|NCT03155620|Palbociclib|palbociclib|mesh-list
139638380|NCT03155620|Vemurafenib|vemurafenib|mesh-list
139638381|NCT03155620|Tipifarnib|tipifarnib|mesh-list
139638382|NCT03155620|Ensartinib|ensartinib|mesh-list
139638383|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638384|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638385|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638386|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139638387|NCT03099356|Sirolimus|sirolimus|mesh-list
139638388|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
139638389|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638390|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
139638391|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638392|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139638393|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139638394|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
139638395|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638396|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638397|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139638398|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139638399|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139638400|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139638401|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
139638403|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139638404|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139638405|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
139638406|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638407|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638408|NCT03046446|FX006|fx006|mesh-list
139638409|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638410|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
139638411|NCT03046446|Hormones|hormones|mesh-ancestor
139638412|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139638413|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638414|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638415|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
139638416|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
139638417|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
139638418|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638419|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
139638420|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638421|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139638422|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139638423|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
139638424|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638425|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638426|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139638427|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638428|NCT03029403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139638429|NCT03017820|Iodine|iodine|mesh-list
139638430|NCT03017820|Interferons|interferons|mesh-list
139638431|NCT03017820|Interferon-beta|interferon-beta|mesh-list
139638432|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
139638433|NCT03017820|Nivolumab|nivolumab|mesh-list
139638434|NCT03017820|Ipilimumab|ipilimumab|mesh-list
139638435|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638436|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
138992034|NCT00737555|Tosedostat|tosedostat|mesh-list
139638437|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638438|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139638439|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139638440|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
139638441|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638442|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638443|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139638444|NCT03017820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638445|NCT03017820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139638446|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
139638447|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139638448|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139638449|NCT03017820|Trace Elements|trace elements|mesh-ancestor
139638450|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
139638451|NCT02925234|Bevacizumab|bevacizumab|mesh-list
139638452|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
139638453|NCT02925234|Nivolumab|nivolumab|mesh-list
139638454|NCT02925234|Trastuzumab|trastuzumab|mesh-list
139638455|NCT02925234|Ipilimumab|ipilimumab|mesh-list
139638456|NCT02925234|Atezolizumab|atezolizumab|mesh-list
139638457|NCT02925234|Durvalumab|durvalumab|mesh-list
139638458|NCT02925234|Pertuzumab|pertuzumab|mesh-list
139638459|NCT02925234|Panitumumab|panitumumab|mesh-list
139638460|NCT02925234|Sunitinib|sunitinib|mesh-list
139638461|NCT02925234|Lenvatinib|lenvatinib|mesh-list
139638462|NCT02925234|Olaparib|olaparib|mesh-list
139638463|NCT02925234|Palbociclib|palbociclib|mesh-list
139638464|NCT02925234|Trametinib|trametinib|mesh-list
139638465|NCT02925234|Niraparib|niraparib|mesh-list
139638466|NCT02925234|Axitinib|axitinib|mesh-list
139638467|NCT02925234|Afatinib|afatinib|mesh-list
139638468|NCT02925234|Vemurafenib|vemurafenib|mesh-list
139638469|NCT02925234|Dabrafenib|dabrafenib|mesh-list
139638470|NCT02925234|Crizotinib|crizotinib|mesh-list
139638471|NCT02925234|Talazoparib|talazoparib|mesh-list
139638472|NCT02925234|Rucaparib|rucaparib|mesh-list
139638473|NCT02925234|Tepotinib|tepotinib|mesh-list
139638474|NCT02925234|Entrectinib|entrectinib|mesh-list
139638475|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638476|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638477|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139638478|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139638479|NCT02925234|Growth Substances|growth substances|mesh-ancestor
139638480|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638481|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
139638482|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139638483|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638484|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139638485|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638486|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139638487|NCT02917993|Osimertinib|osimertinib|mesh-list
139638488|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638489|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139638490|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638491|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638492|NCT02876172|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638493|NCT02876172|Hallucinogens|hallucinogens|mesh-ancestor
139638494|NCT02876172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638495|NCT02876172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638496|NCT02876172|Serotonin Agents|serotonin agents|mesh-ancestor
139638497|NCT02876172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638498|NCT02876172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638499|NCT02876172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638500|NCT02876172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638501|NCT02876172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638502|NCT02876172|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638503|NCT02861898|Cetuximab|cetuximab|mesh-list
139638504|NCT02861898|Mannitol|mannitol|mesh-list
139638505|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638506|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638507|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139638508|NCT02861898|Diuretics|diuretics|mesh-ancestor
139638509|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
139638510|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638511|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
139638512|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638513|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638514|NCT02799095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139638515|NCT02799095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638516|NCT02762370|Triamcinolone|triamcinolone|mesh-list
139638517|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139638518|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139638519|NCT02762370|FX006|fx006|mesh-list
139638520|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139638521|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638522|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
139638523|NCT02762370|Hormones|hormones|mesh-ancestor
138992095|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139638524|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139638525|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638526|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638527|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
139638528|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638529|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638530|NCT02734069|Carboplatin|carboplatin|mesh-list
139638531|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638532|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
139638533|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638534|NCT02648997|Nivolumab|nivolumab|mesh-list
139638535|NCT02648997|Ipilimumab|ipilimumab|mesh-list
139638536|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638537|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638538|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139638539|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638540|NCT02543983|Ketamine|ketamine|mesh-list
139638541|NCT02543983|Analgesics|analgesics|mesh-ancestor
139638542|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
139638543|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139638544|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638545|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139638546|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139638547|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
139638548|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
139638549|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139638550|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139638551|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139638552|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638553|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638554|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
139638555|NCT02518945|Liraglutide|liraglutide|mesh-list
139638556|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139638557|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638558|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139638559|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638560|NCT02518945|Incretins|incretins|mesh-ancestor
139638561|NCT02518945|Hormones|hormones|mesh-ancestor
139638562|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139638563|NCT02513394|Palbociclib|palbociclib|mesh-list
139638564|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638565|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139638566|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638567|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638568|NCT02492074|Dronabinol|dronabinol|mesh-list
139638569|NCT02492074|Cannabidiol|cannabidiol|mesh-list
139638570|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
139638571|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
139638572|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638573|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638574|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139638575|NCT02492074|Analgesics|analgesics|mesh-ancestor
139638576|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
139638577|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139638578|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139638579|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139638580|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638581|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638582|NCT02492074|Hormones|hormones|mesh-ancestor
139638583|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139638584|NCT02468583|Triamcinolone|triamcinolone|mesh-list
139638585|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139638586|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139638588|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139638589|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638590|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
139638591|NCT02468583|Hormones|hormones|mesh-ancestor
139638592|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139638593|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638594|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638595|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
139638596|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638597|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638598|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638599|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
139638600|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638601|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638602|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
139638603|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638604|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638605|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638606|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638607|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638608|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638609|NCT02392429|Cytarabine|cytarabine|mesh-list
139638610|NCT02392429|Alovudine|alovudine|mesh-list
139638611|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139638612|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
139638613|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638614|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638615|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
139638616|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139638617|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638618|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
139638619|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638620|NCT02151084|Gemcitabine|gemcitabine|mesh-list
139638621|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638622|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139638623|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
139638624|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638625|NCT02116972|FX006|fx006|mesh-list
139638626|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638627|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
139638628|NCT02116972|Hormones|hormones|mesh-ancestor
138992206|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
139638629|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139638630|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638631|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638632|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
139638633|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638634|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
139638635|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638636|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638637|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
139638638|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638639|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638640|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638641|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638642|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638643|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638644|NCT02091960|Trastuzumab|trastuzumab|mesh-list
139638645|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638646|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638647|NCT02009449|Leucovorin|leucovorin|mesh-list
139638648|NCT02009449|Paclitaxel|paclitaxel|mesh-list
139638649|NCT02009449|Docetaxel|docetaxel|mesh-list
139638650|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139638651|NCT02009449|Carboplatin|carboplatin|mesh-list
139638652|NCT02009449|Gemcitabine|gemcitabine|mesh-list
139638653|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
139638654|NCT02009449|Capecitabine|capecitabine|mesh-list
139638655|NCT02009449|Fluorouracil|fluorouracil|mesh-list
139638656|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
139638657|NCT02009449|Nivolumab|nivolumab|mesh-list
139638658|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
139638659|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139638660|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638661|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
139638662|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
139638663|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
139638664|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638665|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139638666|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
139638667|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638668|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139638669|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638670|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
139638671|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638672|NCT02009449|Antidotes|antidotes|mesh-ancestor
139638673|NCT02009449|Protective Agents|protective agents|mesh-ancestor
139638674|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
139638675|NCT02009449|Vitamins|vitamins|mesh-ancestor
139638676|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
139638677|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638678|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
139638679|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638680|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638681|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
139638682|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638683|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638684|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638685|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638686|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638687|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638688|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
139638689|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
139638690|NCT01904136|Melphalan|melphalan|mesh-list
139638691|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
139638692|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139638693|NCT01904136|Fludarabine|fludarabine|mesh-list
139638694|NCT01904136|Tacrolimus|tacrolimus|mesh-list
139638695|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638696|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
139638697|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638698|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139638699|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139638700|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
139638701|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638702|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638703|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139638704|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139638705|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638706|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139638707|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139638708|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
139638709|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139638710|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139638711|NCT01894633|Chloroquine|chloroquine|mesh-list
139638712|NCT01894633|Amebicides|amebicides|mesh-ancestor
139638713|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139638714|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139638715|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139638716|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
139638717|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139638718|NCT01864096|Metformin|metformin|mesh-list
139638719|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139638720|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638721|NCT01853826|Afatinib|afatinib|mesh-list
139638722|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638723|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139638724|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638725|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638726|NCT01828099|Carboplatin|carboplatin|mesh-list
139638727|NCT01828099|Pemetrexed|pemetrexed|mesh-list
139638728|NCT01828099|Ceritinib|ceritinib|mesh-list
139638729|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638730|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638731|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638732|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139638733|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139638734|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139638735|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638736|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
139638737|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992333|NCT00933452|Analgesics|analgesics|mesh-ancestor
139638738|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638739|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
139638740|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638741|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638742|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638743|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638744|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638745|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638746|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139638747|NCT01769222|Ipilimumab|ipilimumab|mesh-list
139638748|NCT01769222|Antibodies|antibodies|mesh-list
139638749|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
139638750|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139638751|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
139638752|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638753|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638754|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139638755|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638756|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638757|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
139638758|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638759|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638760|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
139638761|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638762|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638763|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638764|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638765|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638766|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638767|NCT01605318|Irinotecan|irinotecan|mesh-list
139638768|NCT01605318|Labetuzumab|labetuzumab|mesh-list
139638769|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
139638770|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
139638771|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638772|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139638773|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139638774|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638775|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638776|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638777|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638778|NCT01458327|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638779|NCT01458327|Hallucinogens|hallucinogens|mesh-ancestor
139638780|NCT01458327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638781|NCT01458327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638782|NCT01458327|Serotonin Agents|serotonin agents|mesh-ancestor
139638783|NCT01458327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638784|NCT01458327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638785|NCT01458327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638786|NCT01458327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638787|NCT01458327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638788|NCT01458327|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638789|NCT01419561|Zidovudine|zidovudine|mesh-list
139638790|NCT01419561|Rituximab|rituximab|mesh-list
139638791|NCT01419561|Doxorubicin|doxorubicin|mesh-list
139638792|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139638793|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638794|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638795|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
139638796|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638797|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139638798|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139638799|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139638800|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139638801|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638802|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638803|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
139638804|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139638805|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139638806|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
139638807|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139638808|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138992402|NCT00577031|Bevacizumab|bevacizumab|mesh-list
139638809|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139638810|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638811|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
139638812|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638813|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638814|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
139638815|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638816|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638817|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638818|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638819|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638820|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638821|NCT01386710|Bevacizumab|bevacizumab|mesh-list
139638822|NCT01386710|Carboplatin|carboplatin|mesh-list
139638823|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638824|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638825|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139638826|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139638827|NCT01386710|Growth Substances|growth substances|mesh-ancestor
139638828|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638829|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
139638830|NCT01269853|Bevacizumab|bevacizumab|mesh-list
139638831|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638832|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638833|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139638834|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139638835|NCT01269853|Growth Substances|growth substances|mesh-ancestor
139638836|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638837|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
139638838|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638839|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
139638840|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638841|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638842|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
139638843|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638844|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638845|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638846|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638847|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638848|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638849|NCT01083966|Bevacizumab|bevacizumab|mesh-list
138992446|NCT00934154|Hormones|hormones|mesh-ancestor
139638850|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638851|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638852|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139638853|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139638854|NCT01083966|Growth Substances|growth substances|mesh-ancestor
139638855|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638856|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
139638857|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638858|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
139638859|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638860|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638861|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
139638862|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638863|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638864|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638865|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638866|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638867|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638868|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139638869|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
139638870|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638871|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139638872|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
139638873|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638874|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638875|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139638876|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139638877|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638878|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638879|NCT00001337|Rituximab|rituximab|mesh-list
139638880|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139638881|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638882|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
139638883|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638884|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139638885|NCT03266081|Bupivacaine|bupivacaine|mesh-list
139638886|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
139638887|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
139638888|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139638889|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638890|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
139638891|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139638892|NCT03010995|Prazosin|prazosin|mesh-list
139638893|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139638894|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139638895|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139638896|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139638897|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638898|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638899|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638900|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638901|NCT01230177|Etanercept|etanercept|mesh-list
139638902|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139638903|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139638904|NCT01230177|Analgesics|analgesics|mesh-ancestor
139638905|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
139638906|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139638907|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638908|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139638909|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139638910|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139638911|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638912|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
139638913|NCT02984657|Anesthetics|anesthetics|mesh-list
139638914|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139638915|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638916|NCT01158651|Everolimus|everolimus|mesh-list
139638917|NCT01158651|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139638918|NCT01158651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139638919|NCT01158651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638920|NCT01158651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638921|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139638922|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
139638923|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638924|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638925|NCT04852679|Lanreotide|lanreotide|mesh-list
139638926|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638927|NCT03262103|Poly I-C|poly i-c|mesh-list
139638928|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139638929|NCT03262103|Poly ICLC|poly iclc|mesh-list
139638930|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
139638931|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
139638932|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638933|NCT03262103|Laxatives|laxatives|mesh-ancestor
139638934|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139638935|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
139638936|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139638937|NCT04775225|Lidocaine|lidocaine|mesh-list
139638938|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
139638939|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
139638940|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139638941|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638942|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
139638943|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139638944|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139638945|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139638946|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139638947|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139638948|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638949|NCT04685915|Acalabrutinib|acalabrutinib|mesh-list
139638950|NCT04685915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139638951|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139638952|NCT04399187|Eusol|eusol|mesh-list
139638953|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
139638954|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139638955|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
139638956|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139638957|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638958|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
139638959|NCT04746365|Ivermectin|ivermectin|mesh-list
139638960|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
139638961|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139638962|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139638963|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139638964|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139638965|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638966|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139638967|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
139638968|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139638969|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139638970|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638971|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139638972|NCT04399343|Analgesics|analgesics|mesh-ancestor
139638973|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
139638974|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139638975|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139638976|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139638977|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139638978|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
139638979|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139638980|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638981|NCT03676049|Cannabidiol|cannabidiol|mesh-list
139638982|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
139638983|NCT03233633|Cannabidiol|cannabidiol|mesh-list
139638984|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
139638985|NCT02984345|Caseins|caseins|mesh-list
139638986|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
139638987|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
139638988|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638989|NCT01232205|Micronutrients|micronutrients|mesh-list
139638990|NCT01232205|Trace Elements|trace elements|mesh-list
139638991|NCT01232205|Antioxidants|antioxidants|mesh-list
139638992|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139638993|NCT01232205|Protective Agents|protective agents|mesh-ancestor
139638994|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139638995|NCT04584125|Riboflavin|riboflavin|mesh-list
139638996|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
139638997|NCT04584125|Dextrans|dextrans|mesh-list
139638998|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139638999|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139639000|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
139420706|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
139639001|NCT04584125|Vitamins|vitamins|mesh-ancestor
139639002|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
139639003|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639004|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139639005|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
139639006|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
139639007|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
139639008|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
139639009|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
139639010|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139639011|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639013|NCT01158885|Methotrexate|methotrexate|mesh-list
139639014|NCT01158885|Clofarabine|clofarabine|mesh-list
139639015|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139639016|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
139639017|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139639018|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639019|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139639020|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
139639021|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639022|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639023|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
139639024|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639025|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138992581|NCT04948463|Vancomycin|vancomycin|mesh-list
139639026|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139639027|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
139639028|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139639029|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139639030|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
139639031|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639032|NCT01232829|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139639033|NCT01232829|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139639034|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639035|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639036|NCT01233921|Mitogens|mitogens|mesh-list
139639037|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
139639038|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639039|NCT03226301|Venetoclax|venetoclax|mesh-list
139639040|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639041|NCT01236105|Charcoal|charcoal|mesh-list
139639042|NCT01236105|Antidotes|antidotes|mesh-ancestor
139639043|NCT01236105|Protective Agents|protective agents|mesh-ancestor
139639044|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639045|NCT04533347|Tafenoquine|tafenoquine|mesh-list
139639046|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
139639047|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139639048|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139639049|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639050|NCT01160445|Aldesleukin|aldesleukin|mesh-list
139639051|NCT01160445|Zanolimumab|zanolimumab|mesh-list
139639052|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639053|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139639054|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139639055|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
139639056|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639057|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139639058|NCT01237041|Niacin|niacin|mesh-list
139639059|NCT01237041|Niacinamide|niacinamide|mesh-list
139639060|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
139639061|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139639062|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
139639063|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639064|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139639065|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
139639066|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
139639067|NCT01237041|Vitamins|vitamins|mesh-ancestor
139639068|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
139639069|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639070|NCT01237197|Exenatide|exenatide|mesh-list
139639071|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138992604|NCT00111241|Letrozole|letrozole|mesh-list
139639072|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639073|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139639074|NCT01237197|Incretins|incretins|mesh-ancestor
139639075|NCT01237197|Hormones|hormones|mesh-ancestor
139639076|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139639077|NCT01237353|Rabeprazole|rabeprazole|mesh-list
139639078|NCT01237353|Betaine|betaine|mesh-list
139639079|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139639080|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139639081|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139639082|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639083|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639084|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
139639085|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139639086|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
139639087|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139639088|NCT04410341|Vildagliptin|vildagliptin|mesh-list
139639089|NCT04410341|Escitalopram|escitalopram|mesh-list
139639090|NCT04410341|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139639091|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139639092|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139639093|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639094|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639095|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
139639096|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639097|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139639098|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139639099|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
139639100|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639101|NCT03010761|Moclobemide|moclobemide|mesh-list
139639102|NCT03010761|Escitalopram|escitalopram|mesh-list
139639103|NCT03010761|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139639104|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139639105|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139639106|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639107|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639108|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
139639109|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639110|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
139639111|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139639112|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139639113|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639114|NCT01243593|Anesthetics|anesthetics|mesh-list
139639115|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639116|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639117|NCT04362761|Ivacaftor|ivacaftor|mesh-list
139639118|NCT04362761|Elexacaftor|elexacaftor|mesh-list
139639119|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139639120|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139639121|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639122|NCT01162005|Tacrolimus|tacrolimus|mesh-list
139639123|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139639124|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
139639125|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639126|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139639127|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639128|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639129|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139639130|NCT01244451|Ofatumumab|ofatumumab|mesh-list
139639131|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139639132|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
139639133|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639134|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639135|NCT01246401|Naltrexone|naltrexone|mesh-list
139639136|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139639137|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139639138|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639139|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
139639140|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639141|NCT01281501|Scopolamine|scopolamine|mesh-list
139639142|NCT01281501|Pantoprazole|pantoprazole|mesh-list
139639143|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
139639144|NCT01281501|Antacids|antacids|mesh-list
139639145|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139639146|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139639147|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139639148|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639149|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639150|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139639151|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
139639152|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
139639153|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639154|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639155|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
139639156|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139639157|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
139639158|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639159|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139639160|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
139639161|NCT03353831|Bevacizumab|bevacizumab|mesh-list
139639162|NCT03353831|Atezolizumab|atezolizumab|mesh-list
139639163|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139639164|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639165|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139639166|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139639167|NCT03353831|Growth Substances|growth substances|mesh-ancestor
139639168|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639169|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
139639170|NCT03353831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139639171|NCT03353831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639172|NCT01246713|Acetaminophen|acetaminophen|mesh-list
139639173|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139639174|NCT01246713|Analgesics|analgesics|mesh-ancestor
139639175|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
139639176|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639177|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639178|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
139639179|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139639180|NCT01246791|Norethindrone|norethindrone|mesh-list
139639181|NCT01246791|Norinyl|norinyl|mesh-list
139639182|NCT01246791|Estradiol|estradiol|mesh-list
139639183|NCT01246791|Estrogens|estrogens|mesh-ancestor
139639184|NCT01246791|Hormones|hormones|mesh-ancestor
139639185|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139639186|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639187|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139639188|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
139639189|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139639190|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139639191|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139639192|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139639193|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139639194|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139639195|NCT04319081|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139639196|NCT04319081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139639197|NCT04319081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139639198|NCT04319081|Antimetabolites|antimetabolites|mesh-ancestor
139639199|NCT04319081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639200|NCT04319081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139639201|NCT04319081|Protease Inhibitors|protease inhibitors|mesh-ancestor
139639202|NCT04319081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639203|NCT04319081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139639204|NCT05345639|Ropivacaine|ropivacaine|mesh-list
139639205|NCT05345639|Anesthetics|anesthetics|mesh-ancestor
139639206|NCT05345639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639207|NCT05345639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639208|NCT05345639|Anesthetics, Local|anesthetics, local|mesh-ancestor
139639209|NCT05345639|Sensory System Agents|sensory system agents|mesh-ancestor
139639210|NCT05345639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639211|NCT04303325|Esketamine|esketamine|mesh-list
139639212|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
139639213|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139639214|NCT04248335|Midazolam|midazolam|mesh-list
139639215|NCT04248335|Pantoprazole|pantoprazole|mesh-list
139639216|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139639217|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139639218|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639219|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639220|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139639221|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139639222|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139639223|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139639224|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
139639225|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
139639226|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
139639227|NCT04248335|GABA Agents|gaba agents|mesh-ancestor
138992766|NCT00939848|Cisplatin|cisplatin|mesh-list
139639228|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639229|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420932|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139639230|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139639231|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139639232|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139639233|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639234|NCT04746209|Blinatumomab|blinatumomab|mesh-list
139639235|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639236|NCT04168931|Trastuzumab|trastuzumab|mesh-list
139639237|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139639238|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639239|NCT03211949|Mepivacaine|mepivacaine|mesh-list
139639240|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
139639241|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
139639242|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639243|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639244|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
139639245|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639246|NCT01285635|Docetaxel|docetaxel|mesh-list
139639247|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639248|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
139639249|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
139639250|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
139639251|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639252|NCT01286259|Disulfiram|disulfiram|mesh-list
139639253|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139639254|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139639255|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639256|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639257|NCT01286805|Bupivacaine|bupivacaine|mesh-list
139639258|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
139639259|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
139639260|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639261|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639262|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
139639263|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639264|NCT01288521|Ketoconazole|ketoconazole|mesh-list
139639265|NCT01288521|Tacrolimus|tacrolimus|mesh-list
139639266|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139639267|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
139639268|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639269|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139639270|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639271|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639272|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
139639273|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639274|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139639275|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139639276|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139639277|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
139639278|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139639279|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139639280|NCT00632749|Cytarabine|cytarabine|mesh-list
139639281|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139639282|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
139639283|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639284|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639285|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
139639286|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639287|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139639288|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
139639289|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639290|NCT01289067|Satraplatin|satraplatin|mesh-list
139639291|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639292|NCT00632359|Lenalidomide|lenalidomide|mesh-list
139639293|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
139639294|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639295|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139639296|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139639297|NCT00632359|Growth Substances|growth substances|mesh-ancestor
139639298|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
139639299|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639300|NCT03954899|Melatonin|melatonin|mesh-list
139639301|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
139639302|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992824|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
139639303|NCT03954899|Protective Agents|protective agents|mesh-ancestor
139639304|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421019|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
139639306|NCT03934307|Irbesartan|irbesartan|mesh-list
139639307|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139639308|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139639309|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139639310|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639311|NCT03924635|Budesonide|budesonide|mesh-list
139639312|NCT03924635|Albuterol|albuterol|mesh-list
139639313|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
139639314|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139639315|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139639316|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139639317|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
139639318|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639319|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639320|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139639321|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
139639322|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
139639323|NCT03924635|Hormones|hormones|mesh-ancestor
139639324|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139639325|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139639326|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139639327|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139639328|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
139639329|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639330|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639331|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
139639332|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139639333|NCT04398251|Febuxostat|febuxostat|mesh-list
139639334|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
139639335|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139639336|NCT00632203|Temozolomide|temozolomide|mesh-list
139639337|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139639338|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
139639339|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639340|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639341|NCT01289457|Cytarabine|cytarabine|mesh-list
139639342|NCT01289457|Fludarabine|fludarabine|mesh-list
139639343|NCT01289457|Idarubicin|idarubicin|mesh-list
139639344|NCT01289457|Clofarabine|clofarabine|mesh-list
139639345|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639346|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139639347|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
139639348|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639349|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139639350|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
139639351|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639352|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
139639353|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639354|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139639355|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139639356|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139639357|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639358|NCT03830333|Metronidazole|metronidazole|mesh-list
139639359|NCT03830333|Meropenem|meropenem|mesh-list
139639360|NCT03830333|Tazobactam|tazobactam|mesh-list
139639361|NCT03830333|Ceftolozane|ceftolozane|mesh-list
139639362|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
139639363|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639364|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139639365|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139639366|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139639367|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139639368|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639369|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639370|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139639371|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
139639372|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139639373|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
139639374|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639375|NCT01251315|Expectorants|expectorants|mesh-ancestor
139639376|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
139639377|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139639378|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
139421085|NCT06229977|Palmidrol|palmidrol|mesh-list
139639379|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639380|NCT01251315|Protective Agents|protective agents|mesh-ancestor
139639381|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639382|NCT01251315|Antidotes|antidotes|mesh-ancestor
139639383|NCT03810287|Domperidone|domperidone|mesh-list
139639384|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
139639385|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
139639386|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639387|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639388|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139639389|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139639390|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
139639391|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639392|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639393|NCT01290237|Vancomycin|vancomycin|mesh-list
139639394|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139639395|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639396|NCT01251393|Biperiden|biperiden|mesh-list
139639397|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139639398|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139639399|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
139639400|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
139639401|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639402|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639403|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139639404|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139639405|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
139639406|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639407|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639408|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139639409|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
139639410|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139639411|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139639412|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639413|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639414|NCT00631969|Urological Agents|urological agents|mesh-ancestor
139639415|NCT01255137|Axitinib|axitinib|mesh-list
139639416|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639417|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139639418|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639419|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639420|NCT01255449|Albuterol|albuterol|mesh-list
139639421|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139639422|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
139639423|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639424|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639425|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139639426|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
139639427|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
139639428|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139639429|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139639430|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139639431|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139639432|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
139639433|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639434|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639435|NCT00631657|Mirtazapine|mirtazapine|mesh-list
139639436|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
139639437|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139639438|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139639439|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
139639440|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
139639441|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639442|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639443|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639444|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139639445|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139639446|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639447|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139639448|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139639449|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139639450|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
139639451|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139421162|NCT06229145|Methotrexate|methotrexate|mesh-list
139639452|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139639453|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
139639454|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139639455|NCT01257087|Insulin|insulin|mesh-list
139639456|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139639457|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
139639458|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139639459|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639460|NCT00631189|Atorvastatin|atorvastatin|mesh-list
139639461|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139639462|NCT00631189|Pravastatin|pravastatin|mesh-list
139639463|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139639464|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139639465|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
139639466|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639467|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139639468|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139639469|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639470|NCT00630877|Aspirin|aspirin|mesh-list
139639471|NCT00630877|Niacin|niacin|mesh-list
139639472|NCT00630877|Niacinamide|niacinamide|mesh-list
139639473|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
139639474|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139639475|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139639476|NCT00630877|Analgesics|analgesics|mesh-ancestor
139639477|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
139639478|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639479|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639480|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139639481|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139639482|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139639483|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139639484|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639485|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139639486|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139639487|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639488|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
139639489|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139639490|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
139639491|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139639492|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
139639493|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
139639494|NCT00630877|Vitamins|vitamins|mesh-ancestor
139639495|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
139639496|NCT04557163|Itraconazole|itraconazole|mesh-list
139639497|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
139639498|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639499|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139639500|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139639501|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639502|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639503|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139639504|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
139639505|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139639506|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639507|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139639508|NCT02915783|Everolimus|everolimus|mesh-list
139639509|NCT02915783|Lenvatinib|lenvatinib|mesh-list
139639510|NCT02915783|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139639511|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139639512|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639513|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639514|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139639515|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
139639516|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639517|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639518|NCT02736149|Ubenimex|ubenimex|mesh-list
139639519|NCT02736149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139639520|NCT02736149|Immunologic Factors|immunologic factors|mesh-ancestor
139639521|NCT02736149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639522|NCT02736149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139639523|NCT02736149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639524|NCT02736149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139639525|NCT02736149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421237|NCT06228820|Antipyretics|antipyretics|mesh-ancestor
139639526|NCT02736149|Protease Inhibitors|protease inhibitors|mesh-ancestor
139639527|NCT02736149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639528|NCT02736149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993099|NCT00444106|Artesunate|artesunate|mesh-list
139639529|NCT02736149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139639530|NCT02736149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139639531|NCT02736149|Antiviral Agents|antiviral agents|mesh-ancestor
139639532|NCT02307149|Ipilimumab|ipilimumab|mesh-list
139639533|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139639534|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639535|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139639536|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639537|NCT04397393|Midazolam|midazolam|mesh-list
139639538|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139639539|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139639540|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639541|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639542|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139639543|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139639544|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139639545|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139639546|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
139639547|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
139639548|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
139639549|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
139639550|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639551|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639552|NCT01176461|Nivolumab|nivolumab|mesh-list
139639553|NCT01176461|Vaccines|vaccines|mesh-list
139639554|NCT01176461|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139639555|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
139639556|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639557|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139639558|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639559|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139639560|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639561|NCT01176461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139639562|NCT00630331|Vaccines|vaccines|mesh-list
139639563|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
139639564|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639565|NCT04555291|Ropivacaine|ropivacaine|mesh-list
139639566|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
139639567|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
139639568|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639569|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639570|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
139639571|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639572|NCT04275115|Midazolam|midazolam|mesh-list
139639573|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139639574|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139639575|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639576|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639577|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139639578|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139639579|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138993265|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
139639580|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139639581|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
139639582|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
139639583|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
139639584|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
139639585|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639586|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639587|NCT00633997|Vildagliptin|vildagliptin|mesh-list
139639588|NCT00633997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139639589|NCT00633997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639590|NCT00633997|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139639591|NCT00633997|Protease Inhibitors|protease inhibitors|mesh-ancestor
139639592|NCT00633997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639593|NCT00633997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639594|NCT04559347|Bupivacaine|bupivacaine|mesh-list
139639595|NCT04559347|Ropivacaine|ropivacaine|mesh-list
139639596|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
139639597|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
139639598|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639599|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639600|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
139639601|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639602|NCT00631111|Aspirin|aspirin|mesh-list
139639603|NCT00631111|Ibuprofen|ibuprofen|mesh-list
139639604|NCT00631111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639605|NCT00631111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139639606|NCT00631111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139639607|NCT00631111|Analgesics|analgesics|mesh-ancestor
139639608|NCT00631111|Sensory System Agents|sensory system agents|mesh-ancestor
139639609|NCT00631111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639610|NCT00631111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993325|NCT03995134|Narcotics|narcotics|mesh-ancestor
139639611|NCT00631111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139639612|NCT00631111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139639613|NCT00631111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139639614|NCT00631111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639615|NCT00631111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139639616|NCT00631111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139639617|NCT00631111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639618|NCT00631111|Antipyretics|antipyretics|mesh-ancestor
139639619|NCT00630799|Leuprolide|leuprolide|mesh-list
139639620|NCT00630799|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139639621|NCT00630799|Fertility Agents|fertility agents|mesh-ancestor
139639622|NCT00630799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139639623|NCT00630799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639624|NCT00630799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139639625|NCT00630799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639626|NCT01925287|Curcumin|curcumin|mesh-list
139639627|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139639628|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139639629|NCT01925287|Analgesics|analgesics|mesh-ancestor
139639630|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
139639631|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639632|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639633|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993373|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
139639634|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139639635|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639636|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639637|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639638|NCT01924273|Talaporfin|talaporfin|mesh-list
139639639|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639640|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139639641|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
139639642|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
139639643|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139639644|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
139639645|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639646|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
139639647|NCT04276649|Antacids|antacids|mesh-ancestor
139639648|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639649|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139639650|NCT04553419|Cephalexin|cephalexin|mesh-list
139639651|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139639652|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639653|NCT04346407|Dronabinol|dronabinol|mesh-list
139639654|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
139639655|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639656|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139639657|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139639658|NCT04346407|Analgesics|analgesics|mesh-ancestor
139639659|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
139639660|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639661|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139639662|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139639663|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639664|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639665|NCT04346407|Hormones|hormones|mesh-ancestor
139639666|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139639667|NCT04397549|Morphine|morphine|mesh-list
139639668|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139639669|NCT04397549|Narcotics|narcotics|mesh-ancestor
139639670|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639671|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639672|NCT04397549|Analgesics|analgesics|mesh-ancestor
139639673|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
139639674|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421380|NCT06227533|Mitogens|mitogens|mesh-list
139639675|NCT03080441|Midodrine|midodrine|mesh-list
139639676|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
139639677|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
138993481|NCT01030042|Leucovorin|leucovorin|mesh-list
139639678|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639679|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639680|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139639681|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139639682|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139639683|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139639684|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
139639685|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639686|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639687|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
139639688|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139639689|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
139639690|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139639691|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
139639692|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639693|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639694|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
139639695|NCT01920919|Dexamethasone|dexamethasone|mesh-list
139639696|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139639697|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
139639698|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
139639699|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639700|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639701|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139639702|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
139639703|NCT01920919|Hormones|hormones|mesh-ancestor
139639704|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139639705|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139639706|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639707|NCT01925911|Midazolam|midazolam|mesh-list
139639708|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139639709|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139639710|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639711|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639712|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139639713|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139639714|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139639715|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139639716|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
139639717|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
139639718|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
139639719|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
139639720|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639721|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639722|NCT05241431|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138993596|NCT00952094|Cinacalcet|cinacalcet|mesh-list
139639723|NCT05241431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639724|NCT05241431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139639725|NCT05241431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639726|NCT01921231|Bupivacaine|bupivacaine|mesh-list
139639727|NCT01921231|Prilocaine|prilocaine|mesh-list
139639728|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
139639729|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
139639730|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639731|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639732|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
139639733|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639734|NCT03056833|Paclitaxel|paclitaxel|mesh-list
139639735|NCT03056833|Carboplatin|carboplatin|mesh-list
139639736|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139639737|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639738|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
139639739|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
139639740|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
139639741|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639742|NCT05240261|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139639743|NCT05240261|Antidepressive Agents|antidepressive agents|mesh-ancestor
139639744|NCT05240261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139639745|NCT05240261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139639746|NCT05240261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139639747|NCT05240261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639748|NCT05240261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639749|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
139639750|NCT03148457|Apixaban|apixaban|mesh-list
139639751|NCT03148457|Edoxaban|edoxaban|mesh-list
139639752|NCT03148457|Dabigatran|dabigatran|mesh-list
139639753|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139639755|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139639756|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
139639757|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639758|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639759|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
139639760|NCT01926379|Isoniazid|isoniazid|mesh-list
139639761|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
139639762|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139639763|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639764|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139639765|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139639766|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
139639767|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639768|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139639769|NCT03351647|Ustekinumab|ustekinumab|mesh-list
139639770|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
139639771|NCT02392637|Paclitaxel|paclitaxel|mesh-list
139639772|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139639773|NCT02392637|Cisplatin|cisplatin|mesh-list
139639774|NCT02392637|Gemcitabine|gemcitabine|mesh-list
139639775|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139639776|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639777|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
139639778|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
139639779|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
139639780|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993686|NCT00120289|Vitamins|vitamins|mesh-ancestor
139639781|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139639782|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
139639783|NCT05600881|Methylphenidate|methylphenidate|mesh-list
139639784|NCT05600881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139639785|NCT05600881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639786|NCT05600881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139639787|NCT05600881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139639788|NCT05600881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139639789|NCT05600881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639790|NCT05600881|Dopamine Agents|dopamine agents|mesh-ancestor
139639791|NCT05600881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639792|NCT01926769|Metformin|metformin|mesh-list
139639793|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139639794|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639795|NCT04394143|Mannitol|mannitol|mesh-list
139639796|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139639797|NCT04394143|Diuretics|diuretics|mesh-ancestor
139639798|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
139639799|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639800|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139639801|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
139639802|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639803|NCT01926847|Riociguat|riociguat|mesh-list
139639804|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
139639805|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639806|NCT05586815|Minocycline|minocycline|mesh-list
139639807|NCT05586815|Colistin|colistin|mesh-list
139639808|NCT05586815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139639809|NCT05586815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639810|NCT05607901|Hydrocortisone|hydrocortisone|mesh-list
139639811|NCT05607901|Tacrolimus|tacrolimus|mesh-list
139639812|NCT05607901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139639813|NCT05607901|Immunologic Factors|immunologic factors|mesh-ancestor
139639814|NCT05607901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639815|NCT05607901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139639816|NCT05607901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639817|NCT05607901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639818|NCT05607901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139639819|NCT03133325|Lidocaine|lidocaine|mesh-list
139639820|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
139639821|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
139639822|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639823|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639824|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
139639825|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639826|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139639827|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139639828|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139639829|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139639830|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639831|NCT00638963|Temozolomide|temozolomide|mesh-list
139639832|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139639833|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
139639834|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639835|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639837|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
139639838|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639839|NCT04278677|Protective Agents|protective agents|mesh-ancestor
139639840|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639841|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639842|NCT00638027|Memantine|memantine|mesh-list
139639843|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139639844|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139639845|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
139639846|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139639847|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639848|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639849|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139639850|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139639851|NCT03342911|Paclitaxel|paclitaxel|mesh-list
139639852|NCT03342911|Carboplatin|carboplatin|mesh-list
139639853|NCT03342911|Nivolumab|nivolumab|mesh-list
139639854|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139639855|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639856|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
139639857|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
139639858|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
139639859|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639860|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139639861|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139639862|NCT05607199|Calcium|calcium|mesh-list
139639863|NCT05607199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139639864|NCT05607199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639865|NCT01927315|Fenofibrate|fenofibrate|mesh-list
139639866|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139639867|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
139639868|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639869|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139639870|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
139639871|NCT00636155|Rituximab|rituximab|mesh-list
139639872|NCT00636155|Fludarabine|fludarabine|mesh-list
139639873|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139639874|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
139639875|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639876|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139639877|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139639878|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
139639879|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639880|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639881|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139639882|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139639883|NCT00634907|Warfarin|warfarin|mesh-list
139639884|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
139639885|NCT04124497|Dexamethasone|dexamethasone|mesh-list
139639886|NCT04124497|Daratumumab|daratumumab|mesh-list
139639887|NCT04124497|Pomalidomide|pomalidomide|mesh-list
139639888|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139639889|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
139639890|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
139639891|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639892|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639893|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139639894|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
139639895|NCT04124497|Hormones|hormones|mesh-ancestor
139639896|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139639897|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139639898|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639899|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
139639900|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139639901|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139639902|NCT04124497|Growth Substances|growth substances|mesh-ancestor
139639903|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
139639904|NCT04127851|Cyclosporine|cyclosporine|mesh-list
139639905|NCT04127851|Cyclosporins|cyclosporins|mesh-list
139639906|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639907|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639908|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139639909|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
139639910|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639911|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
139639912|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639913|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
139639914|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139639915|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139639916|NCT04394533|Bupivacaine|bupivacaine|mesh-list
139639917|NCT04394533|Prilocaine|prilocaine|mesh-list
139639918|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
139639919|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
139639920|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139639921|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639922|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
139639923|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139639924|NCT05602129|Heparin|heparin|mesh-list
139639925|NCT05602129|Calcium heparin|calcium heparin|mesh-list
139639926|NCT05602129|Anticoagulants|anticoagulants|mesh-ancestor
139639927|NCT05602129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139639928|NCT05602129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139639929|NCT05602129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639930|NCT01928563|Udenafil|udenafil|mesh-list
139639931|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139639932|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139639933|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639934|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639935|NCT04129255|Octreotide|octreotide|mesh-list
139639936|NCT04129255|Somatostatin|somatostatin|mesh-list
139639937|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139639938|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139639939|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639940|NCT04129255|Hormones|hormones|mesh-ancestor
139639941|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139639942|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639943|NCT04129489|Cannabidiol|cannabidiol|mesh-list
139639944|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
139639945|NCT04128787|Omeprazole|omeprazole|mesh-list
139639946|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139639947|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139639948|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139639949|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639950|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639951|NCT04394377|Heparin|heparin|mesh-list
139639952|NCT04394377|Enoxaparin|enoxaparin|mesh-list
139639953|NCT04394377|Calcium heparin|calcium heparin|mesh-list
139639954|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
139639955|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
139639956|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
139639957|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139639958|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139639959|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639960|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139639961|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
139639962|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139639963|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
139639964|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639965|NCT02984293|Atorvastatin|atorvastatin|mesh-list
139639966|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139639967|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139639968|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
139639969|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639970|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139639971|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139639972|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639973|NCT01929187|Amorolfine|amorolfine|mesh-list
139639974|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
139639975|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139639976|NCT00634751|Capecitabine|capecitabine|mesh-list
139639977|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
139639978|NCT00634751|Sorafenib|sorafenib|mesh-list
139639979|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139639980|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
139639981|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639982|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639983|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139639984|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639985|NCT04396223|Methotrexate|methotrexate|mesh-list
139639986|NCT04396223|Avelumab|avelumab|mesh-list
139639987|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139639988|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
139639989|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139639990|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139639991|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139639992|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
139639993|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139639994|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139639995|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
139639996|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139639997|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139639998|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139639999|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
139640000|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139640001|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139640002|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139640003|NCT04396067|Tretinoin|tretinoin|mesh-list
139640004|NCT04396067|Isotretinoin|isotretinoin|mesh-list
139640005|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640006|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
139640007|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
139640008|NCT05608213|Lenvatinib|lenvatinib|mesh-list
139640009|NCT05608213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640010|NCT05608213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139640011|NCT05608213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640012|NCT05608213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640013|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138994188|NCT02565173|Timolol|timolol|mesh-list
139640014|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139640015|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640016|NCT03015259|Budesonide|budesonide|mesh-list
139640017|NCT03015259|Formoterol Fumarate|formoterol fumarate|mesh-list
139640018|NCT03015259|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139640019|NCT03015259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139640020|NCT03015259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139640021|NCT03015259|Autonomic Agents|autonomic agents|mesh-ancestor
139640022|NCT03015259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640023|NCT03015259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640024|NCT03015259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139640025|NCT03015259|Respiratory System Agents|respiratory system agents|mesh-ancestor
138994252|NCT03954834|Tirzepatide|tirzepatide|mesh-list
139640026|NCT03015259|Glucocorticoids|glucocorticoids|mesh-ancestor
139640027|NCT03015259|Hormones|hormones|mesh-ancestor
139640028|NCT03015259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139640029|NCT03015259|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139640030|NCT03015259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139640031|NCT03015259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139640032|NCT03015259|Adrenergic Agents|adrenergic agents|mesh-ancestor
139640033|NCT03015259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640034|NCT03015259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640035|NCT03236545|Estradiol|estradiol|mesh-list
139640036|NCT03236545|Estrogens|estrogens|mesh-list
139640037|NCT03236545|Hormones|hormones|mesh-ancestor
139640038|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139640039|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640040|NCT04126993|Apatinib|apatinib|mesh-list
139640041|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640042|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139640043|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640044|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640045|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139640046|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139640047|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139640048|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139640049|NCT03828175|Anesthetics|anesthetics|mesh-list
139640050|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139640051|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640052|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
139640053|NCT04392973|Favipiravir|favipiravir|mesh-list
139640054|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
139640056|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139640057|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139640058|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640059|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640060|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139640061|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
139640062|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
139640063|NCT03267277|Antidotes|antidotes|mesh-ancestor
139640064|NCT03267277|Protective Agents|protective agents|mesh-ancestor
139640065|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640066|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
139640067|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640068|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
139640069|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139640070|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139640071|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
139640072|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
139640073|NCT00634049|Isavuconazole|isavuconazole|mesh-list
139640074|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
139640075|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139640076|NCT04123249|Propofol|propofol|mesh-list
139640077|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
139640078|NCT04123249|Anesthetics|anesthetics|mesh-list
139640079|NCT04123249|Sevoflurane|sevoflurane|mesh-list
139640080|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139640081|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139640082|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640083|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
139640084|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139640085|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139640086|NCT03336203|Allopurinol|allopurinol|mesh-list
139640087|NCT03336203|Febuxostat|febuxostat|mesh-list
139640088|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
139640089|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640090|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640091|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
139640092|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139640093|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139640094|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
139640095|NCT03336203|Protective Agents|protective agents|mesh-ancestor
139640096|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640097|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
139640098|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640099|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640100|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640101|NCT04274257|Rituximab|rituximab|mesh-list
139640102|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139640103|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640104|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
139640105|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640106|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139640107|NCT03831815|Rocuronium|rocuronium|mesh-list
139640108|NCT03831815|Cisatracurium|cisatracurium|mesh-list
138994482|NCT00956462|Analgesics|analgesics|mesh-ancestor
139640109|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139640110|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139640111|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139640112|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640113|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640114|NCT00632099|Progesterone|progesterone|mesh-list
139640115|NCT00632099|Progestins|progestins|mesh-ancestor
139640116|NCT00632099|Hormones|hormones|mesh-ancestor
139640117|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139640118|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640119|NCT03827629|Naloxone|naloxone|mesh-list
139640120|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139640121|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640122|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
139640123|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640124|NCT00631475|Bosentan|bosentan|mesh-list
139640125|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139640126|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139640127|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640128|NCT03826615|Gabapentin|gabapentin|mesh-list
139640129|NCT03826615|Analgesics|analgesics|mesh-ancestor
139640130|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
139640131|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640132|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640133|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
139640134|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139640135|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139640136|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139640137|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139640138|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139640139|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139640140|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640141|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640142|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
139640143|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
139640144|NCT04124887|Listerine|listerine|mesh-list
139640145|NCT04124887|Calcium|calcium|mesh-list
139640146|NCT04124887|Fluorides|fluorides|mesh-list
139640147|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
139640148|NCT04124887|Caseins|caseins|mesh-list
139640149|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139640150|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640151|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139640152|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
139640153|NCT04124887|Protective Agents|protective agents|mesh-ancestor
139640154|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139640155|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139640156|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
139640157|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
139640158|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640159|NCT04121767|Warfarin|warfarin|mesh-list
139640160|NCT04121767|Edoxaban|edoxaban|mesh-list
139640161|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
139640162|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139640163|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
139640164|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139640165|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
139640166|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640167|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640168|NCT04121689|Caseins|caseins|mesh-list
139640169|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
139640170|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
139640171|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640172|NCT03830827|Vortioxetine|vortioxetine|mesh-list
139640173|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
139640174|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139640175|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139640176|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139640177|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139640178|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640179|NCT03830827|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139640180|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139640181|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139640182|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640183|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640184|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
139640185|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139640186|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139640187|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139640188|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139640189|NCT03098485|Azithromycin|azithromycin|mesh-list
139640190|NCT03098485|Levofloxacin|levofloxacin|mesh-list
139640191|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
139640192|NCT03098485|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
139640193|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139640194|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139640195|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139640196|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139640197|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139640198|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640199|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640200|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640201|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139640202|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139640203|NCT04121533|Vitamin D|vitamin d|mesh-list
139640204|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
139640205|NCT04121533|Vitamins|vitamins|mesh-ancestor
139640206|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
139640207|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640208|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139640209|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139640210|NCT03822169|Choline|choline|mesh-list
139640211|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
139640212|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139640213|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
139640214|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640215|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139640216|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139640217|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
139640218|NCT03825601|Flumazenil|flumazenil|mesh-list
139640219|NCT03825601|Antidotes|antidotes|mesh-ancestor
139640220|NCT03825601|Protective Agents|protective agents|mesh-ancestor
139640221|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640222|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
139640223|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
139640224|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640225|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640226|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139640227|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139640228|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640229|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139640230|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139640231|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640232|NCT03064867|Rituximab|rituximab|mesh-list
139640233|NCT03064867|Carboplatin|carboplatin|mesh-list
139640234|NCT03064867|Etoposide|etoposide|mesh-list
139640235|NCT03064867|Venetoclax|venetoclax|mesh-list
139640236|NCT03064867|Ifosfamide|ifosfamide|mesh-list
139640237|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139640238|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640239|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
139640240|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640241|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139640242|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139640243|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139640244|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139640245|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640246|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640247|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139640248|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
139640249|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
139640250|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139640251|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139640252|NCT03824665|Fentanyl|fentanyl|mesh-list
139640253|NCT03824665|Nalbuphine|nalbuphine|mesh-list
139640254|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139640255|NCT03824665|Narcotics|narcotics|mesh-ancestor
139640256|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139640257|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640258|NCT03824665|Analgesics|analgesics|mesh-ancestor
139640259|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
139640260|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640261|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139640262|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139640263|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
139640264|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
139640265|NCT04120831|Abatacept|abatacept|mesh-list
139640266|NCT04120831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139640267|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640268|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
139640269|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640270|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139640271|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138994765|NCT00549302|Tadalafil|tadalafil|mesh-list
139640272|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640273|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139640274|NCT00631163|Deferasirox|deferasirox|mesh-list
139640275|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139640276|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
139640277|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
139640278|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640279|NCT04120519|Thalidomide|thalidomide|mesh-list
139640280|NCT04120519|Dexamethasone|dexamethasone|mesh-list
139640281|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
139640282|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139640283|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
139640284|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640285|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139640286|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139640287|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
139640288|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640289|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640290|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139640291|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139640292|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
139640293|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
139640294|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640295|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139640296|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
139640297|NCT04120519|Hormones|hormones|mesh-ancestor
139640298|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139640299|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139640300|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
139640301|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139640302|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139640303|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139640304|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139640305|NCT04120519|Growth Substances|growth substances|mesh-ancestor
139640306|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
139640307|NCT00631007|Pioglitazone|pioglitazone|mesh-list
139640308|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139640309|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640310|NCT00630539|Tamoxifen|tamoxifen|mesh-list
139640311|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139640312|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
139640313|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139640314|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640315|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139640316|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640317|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139640318|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139640319|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139640320|NCT00634829|Albuterol|albuterol|mesh-list
139640321|NCT00634829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139640322|NCT00634829|Autonomic Agents|autonomic agents|mesh-ancestor
139640323|NCT00634829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640324|NCT00634829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640325|NCT00634829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139640326|NCT00634829|Respiratory System Agents|respiratory system agents|mesh-ancestor
139640327|NCT00634829|Tocolytic Agents|tocolytic agents|mesh-ancestor
139640328|NCT00634829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139640329|NCT00634829|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139640330|NCT00634829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139640331|NCT00634829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139640332|NCT00634829|Adrenergic Agents|adrenergic agents|mesh-ancestor
139640333|NCT00634829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640334|NCT00634829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640335|NCT00634517|Albuterol|albuterol|mesh-list
139640336|NCT00634517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139640337|NCT00634517|Autonomic Agents|autonomic agents|mesh-ancestor
139640338|NCT00634517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640339|NCT00634517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640340|NCT00634517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139640341|NCT00634517|Respiratory System Agents|respiratory system agents|mesh-ancestor
139640342|NCT00634517|Tocolytic Agents|tocolytic agents|mesh-ancestor
139640343|NCT00634517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139640344|NCT00634517|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139640345|NCT00634517|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139640346|NCT00634517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139640347|NCT00634517|Adrenergic Agents|adrenergic agents|mesh-ancestor
139640348|NCT00634517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640349|NCT00634517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640350|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
139640351|NCT01920113|Remifentanil|remifentanil|mesh-list
139640352|NCT01920113|Propofol|propofol|mesh-list
139640353|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139640354|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139422047|NCT05675410|Antibodies|antibodies|mesh-list
139640355|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640356|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139640358|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
139640359|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640360|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139640361|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139640362|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139640363|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
139640364|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640365|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640366|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139640367|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
139640368|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
139640369|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139640370|NCT01920113|Narcotics|narcotics|mesh-ancestor
139640371|NCT01920191|Poly ICLC|poly iclc|mesh-list
139640372|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
139640373|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
139640374|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640375|NCT01920269|Mitomycins|mitomycins|mesh-list
139640376|NCT01920269|Mitomycin|mitomycin|mesh-list
139640377|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139640378|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640379|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
139640380|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640381|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139640382|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640383|NCT01920503|Doxorubicin|doxorubicin|mesh-list
139640384|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139640385|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640386|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139640387|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138995095|NCT02563847|Erythritol|erythritol|mesh-list
139640388|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640389|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640390|NCT01293825|Ziprasidone|ziprasidone|mesh-list
139640391|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139640392|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
139640393|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640394|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640395|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640396|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139640397|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139640398|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139640399|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139640400|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139640401|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
139640402|NCT03009513|Glimepiride|glimepiride|mesh-list
139640403|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139640404|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138995149|NCT00964626|Paclitaxel|paclitaxel|mesh-list
139640405|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640406|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139640407|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
139640408|NCT02983591|Misoprostol|misoprostol|mesh-list
139640409|NCT02983591|Oxytocin|oxytocin|mesh-list
139640410|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
139640411|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139640412|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640413|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139640414|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
139640415|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139640416|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139640417|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
139640418|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139640419|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640420|NCT01263717|Hormones|hormones|mesh-list
139640421|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
139640422|NCT01263717|Tesamorelin|tesamorelin|mesh-list
139640423|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139640424|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640425|NCT01263717|Growth Substances|growth substances|mesh-ancestor
139640426|NCT04120753|Amlodipine|amlodipine|mesh-list
139640427|NCT04120753|Olmesartan|olmesartan|mesh-list
139640428|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139640429|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139422126|NCT05607004|Exemestane|exemestane|mesh-list
139640430|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139640431|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640432|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138995265|NCT04010942|Metformin|metformin|mesh-list
139640433|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640434|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
139640435|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139640436|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139640437|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
139640438|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
139640439|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139640440|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139640441|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640442|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139640443|NCT01921361|Analgesics|analgesics|mesh-ancestor
139640444|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
139640445|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640446|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139640447|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139640448|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139640449|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
139640450|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640451|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640452|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
139640453|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
139640454|NCT01921673|Docetaxel|docetaxel|mesh-list
139640455|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640456|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
139640457|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
139640458|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
139640459|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640460|NCT01921985|Terlipressin|terlipressin|mesh-list
139640461|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139640462|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139640463|NCT02943733|Temozolomide|temozolomide|mesh-list
139640464|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139640465|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
139640466|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640467|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640468|NCT01922141|Amlodipine|amlodipine|mesh-list
139640469|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139640470|NCT01922141|Ramipril|ramipril|mesh-list
138995385|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
139640471|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139640472|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139640473|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139640474|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640475|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139640476|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640477|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
139640478|NCT01922141|Diuretics|diuretics|mesh-ancestor
139640479|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
139640480|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139640481|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139640482|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
139640483|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640484|NCT03111485|Levodopa|levodopa|mesh-list
139640485|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139640486|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139640487|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139640488|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
139640489|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640490|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640491|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640492|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139640493|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
139640494|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
139640495|NCT02856295|Enoxaparin|enoxaparin|mesh-list
139640496|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
139640497|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139640498|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139640499|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640500|NCT01266447|Topotecan|topotecan|mesh-list
139640501|NCT01266447|Veliparib|veliparib|mesh-list
139640502|NCT01266447|Lenograstim|lenograstim|mesh-list
139422198|NCT05564403|Vitamins|vitamins|mesh-ancestor
139640503|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139640504|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
139640505|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640506|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139640507|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139640508|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640509|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640510|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640511|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139640513|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139640514|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139640515|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
139640516|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640517|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640518|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640519|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139640520|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139640521|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139640522|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139640523|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139640524|NCT03823339|Liraglutide|liraglutide|mesh-list
139640525|NCT03823339|Xultophy|xultophy|mesh-list
139640526|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139640527|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640528|NCT03823339|Incretins|incretins|mesh-ancestor
139640529|NCT03823339|Hormones|hormones|mesh-ancestor
139640530|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139640531|NCT01922687|Amlodipine|amlodipine|mesh-list
139640532|NCT01922687|Atorvastatin|atorvastatin|mesh-list
139640533|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139640534|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139640535|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
139640536|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640537|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139640538|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139640539|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640540|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139640541|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139640542|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139640543|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139640544|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640545|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
139640546|NCT01268553|Treprostinil|treprostinil|mesh-list
139640547|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139640548|NCT01922999|Melatonin|melatonin|mesh-list
139640549|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
139640550|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995553|NCT00105469|Tobramycin|tobramycin|mesh-list
139640551|NCT01922999|Protective Agents|protective agents|mesh-ancestor
139640552|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640553|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139640554|NCT01268943|Capecitabine|capecitabine|mesh-list
139640555|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139640556|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
139640557|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640558|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640559|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139640560|NCT01923077|Simvastatin|simvastatin|mesh-list
139640561|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139640562|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139640563|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
139640564|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640565|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139640566|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139640567|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640568|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
138995591|NCT00962624|Vaccines|vaccines|mesh-list
139640569|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139640570|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139640571|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139640572|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139640573|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640574|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
139640575|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640576|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640577|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139640578|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640579|NCT01297335|Clonidine|clonidine|mesh-list
139640580|NCT01297335|Analgesics|analgesics|mesh-ancestor
139640581|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
139640582|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640583|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640584|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139640585|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
139640586|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
139640587|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139640588|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138995657|NCT00750113|Nifedipine|nifedipine|mesh-list
139640589|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139640590|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
139640591|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640592|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640593|NCT05498129|Micronutrients|micronutrients|mesh-list
139640594|NCT05498129|Trace Elements|trace elements|mesh-list
139640595|NCT05498129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640596|NCT01270659|Acetaminophen|acetaminophen|mesh-list
139640597|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139640598|NCT01270659|Fentanyl|fentanyl|mesh-list
139640599|NCT01270659|Oxycodone|oxycodone|mesh-list
139640600|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139640601|NCT01270659|Narcotics|narcotics|mesh-ancestor
139640602|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139640603|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640604|NCT01270659|Analgesics|analgesics|mesh-ancestor
139640605|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
139640606|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640607|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139640608|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139640609|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
139640610|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
139640611|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139640612|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
139640613|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139640614|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138995694|NCT00546078|Vaccines|vaccines|mesh-list
139640615|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139640616|NCT01271907|Aldesleukin|aldesleukin|mesh-list
139640617|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
139640618|NCT01271907|Fludarabine|fludarabine|mesh-list
139640619|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139640620|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
139640621|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640622|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139640623|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139640624|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
139640625|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640626|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640627|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139640628|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139640629|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139640630|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
139640631|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139640632|NCT01929941|Paclitaxel|paclitaxel|mesh-list
139640633|NCT01929941|Gemcitabine|gemcitabine|mesh-list
139640634|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139640635|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640636|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
139640637|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
139640638|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
139640639|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640640|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139640641|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
139640642|NCT01922843|Calcitriol|calcitriol|mesh-list
139640643|NCT01922843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139640644|NCT01922843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640645|NCT01922843|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139640646|NCT01922843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139640647|NCT01922843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640648|NCT01922843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139640649|NCT01922843|Vitamins|vitamins|mesh-ancestor
139640650|NCT01922843|Micronutrients|micronutrients|mesh-ancestor
139640651|NCT01922843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139640652|NCT01302483|Lidocaine|lidocaine|mesh-list
139640653|NCT01302483|Phenylephrine|phenylephrine|mesh-list
139640654|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
139640655|NCT01302483|Tetracaine|tetracaine|mesh-list
139640656|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
139640657|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
139640658|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139640659|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640660|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
139640661|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640662|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139640663|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139640664|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139640665|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139640666|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640667|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139640668|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139640669|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
139640670|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640671|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
139640672|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
139640673|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
139640674|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139640675|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
139640676|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139640677|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
139640678|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139640679|NCT01302483|Protective Agents|protective agents|mesh-ancestor
139640680|NCT04769583|Metronidazole|metronidazole|mesh-list
139640681|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139640682|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139640683|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139640684|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139640685|NCT01279317|Acetic Acid|acetic acid|mesh-list
139640686|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139640687|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139640688|NCT01304589|Milnacipran|milnacipran|mesh-list
139640689|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
139640690|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139640691|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139640692|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139640693|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640694|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640695|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640696|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139640697|NCT01304589|Analgesics|analgesics|mesh-ancestor
139640698|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
139640699|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640700|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
139640701|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139640702|NCT01280409|Metformin|metformin|mesh-list
139640703|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139640704|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640705|NCT01926197|Leucovorin|leucovorin|mesh-list
139640706|NCT01926197|Fluorouracil|fluorouracil|mesh-list
139640707|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
139640708|NCT01926197|Irinotecan|irinotecan|mesh-list
139640709|NCT01926197|Camptothecin|camptothecin|mesh-list
139640710|NCT01926197|Antimetabolites|antimetabolites|mesh-ancestor
139640711|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640712|NCT01926197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139640713|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640714|NCT01926197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139640715|NCT01926197|Immunologic Factors|immunologic factors|mesh-ancestor
139640716|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640717|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139640718|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139640719|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640720|NCT01926197|Antidotes|antidotes|mesh-ancestor
139640721|NCT01926197|Protective Agents|protective agents|mesh-ancestor
139640722|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
139640723|NCT01926197|Vitamins|vitamins|mesh-ancestor
139640724|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
139640725|NCT01926197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139640726|NCT01923545|Lenograstim|lenograstim|mesh-list
139640727|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139640728|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
139640729|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640730|NCT01925027|Sirolimus|sirolimus|mesh-list
139640731|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139640732|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139640733|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139640734|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640735|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
139640736|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139640737|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
139640738|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640739|NCT01305213|Bevacizumab|bevacizumab|mesh-list
139640740|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139640741|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
139640742|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
139640743|NCT01305213|Antibodies|antibodies|mesh-list
139640744|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
139640745|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139640746|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
139640747|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640748|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139640749|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139640750|NCT01305213|Growth Substances|growth substances|mesh-ancestor
139640751|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640752|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
139640753|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
139640754|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139640755|NCT00989963|Beraprost|beraprost|mesh-list
139640756|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139640757|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
139640758|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139640759|NCT01339299|Hormones|hormones|mesh-list
139640760|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139640761|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640762|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139640763|NCT01307007|Dextrans|dextrans|mesh-list
139640764|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
139640765|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
139640766|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
139640767|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
139640768|NCT01307007|Hematinics|hematinics|mesh-ancestor
139640769|NCT02197455|Tofacitinib|tofacitinib|mesh-list
139640770|NCT02197455|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139640771|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139640772|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640773|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640774|NCT03101501|Mitomycins|mitomycins|mesh-list
139640775|NCT03101501|Mitomycin|mitomycin|mesh-list
139640776|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139640777|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640778|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
139640779|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640780|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139640781|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640782|NCT01923623|Ropivacaine|ropivacaine|mesh-list
139640783|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
139640784|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
139640785|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139640786|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640787|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
139640788|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640789|NCT01923857|Enclomiphene|enclomiphene|mesh-list
139640790|NCT01923857|Clomiphene|clomiphene|mesh-list
139640791|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
139640792|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139640793|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
139640794|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139640795|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640796|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139640797|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
139640798|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139640799|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139640800|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139640801|NCT03100253|Adalimumab|adalimumab|mesh-list
139640802|NCT03100253|Infliximab|infliximab|mesh-list
139640803|NCT03100253|Golimumab|golimumab|mesh-list
139640804|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
139640805|NCT03100253|Etanercept|etanercept|mesh-list
139640806|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139640807|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139640808|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139640809|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
139640810|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139640811|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139640812|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139640814|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
139640815|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640816|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640817|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139640818|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
139640819|NCT01924091|Dapivirine|dapivirine|mesh-list
139640820|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139640821|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139640822|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
139640823|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139640824|NCT03485729|TIC10 compound|tic10 compound|mesh-list
139640825|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640826|NCT01924325|Aspirin|aspirin|mesh-list
139640827|NCT01924325|Apixaban|apixaban|mesh-list
139640828|NCT01924325|Clopidogrel|clopidogrel|mesh-list
139640829|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139640830|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139640831|NCT01924325|Analgesics|analgesics|mesh-ancestor
139640832|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
139640833|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640834|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640835|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139640836|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139640837|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139640838|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139640839|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640840|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139640841|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139640842|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640843|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
139640844|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139640845|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139640846|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139640847|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
139640848|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640849|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139640850|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
139640851|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139640852|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
139640853|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
139640854|NCT01924481|Theobromine|theobromine|mesh-list
139640855|NCT01924481|Caffeine|caffeine|mesh-list
139640856|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139640857|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640858|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139640859|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640860|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640861|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139640862|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139640863|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
139640864|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640865|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139640866|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
139640867|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640868|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139640869|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
139640870|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
139640871|NCT01924637|Insulin|insulin|mesh-list
139640872|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139640873|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
139640874|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
139640875|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139640876|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139640877|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640878|NCT01925729|Phenylephrine|phenylephrine|mesh-list
139640879|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
139640880|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
139640881|NCT01925729|Ephedrine|ephedrine|mesh-list
139640883|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139640884|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
139640885|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640886|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640887|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139640888|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
139640889|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
139640890|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139640891|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139640892|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
139640893|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
139640894|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640895|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640896|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139640897|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139640898|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139640899|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
139640900|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139640901|NCT01925729|Protective Agents|protective agents|mesh-ancestor
139640902|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
139640903|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
139640904|NCT01926587|Azacitidine|azacitidine|mesh-list
139640905|NCT01926587|ON 01910|on 01910|mesh-list
139640906|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139640907|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
139640908|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640909|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640910|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640911|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139640912|NCT01922765|Amoxicillin|amoxicillin|mesh-list
139640913|NCT01922765|Metronidazole|metronidazole|mesh-list
139640914|NCT01922765|Clarithromycin|clarithromycin|mesh-list
139640915|NCT01922765|Rabeprazole|rabeprazole|mesh-list
139640916|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139640917|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139640918|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139640919|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139640920|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139640921|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640922|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640923|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139640924|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139640925|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139640926|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139640927|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138996292|NCT00974532|Calcium|calcium|mesh-list
139640928|NCT01926665|Dexamethasone|dexamethasone|mesh-list
139640929|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139640930|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
139640931|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
139640932|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139640933|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640934|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139640935|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
139640936|NCT01926665|Hormones|hormones|mesh-ancestor
139640937|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139640938|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139640939|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640940|NCT01926821|Sizofiran|sizofiran|mesh-list
139640941|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139640942|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
139640943|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640944|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139640945|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640946|NCT01926899|Bortezomib|bortezomib|mesh-list
139640947|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640948|NCT03430661|Clopidogrel|clopidogrel|mesh-list
139640949|NCT03430661|Ticagrelor|ticagrelor|mesh-list
139640950|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139640951|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139640952|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139640953|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139640954|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139640955|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
138996334|NCT00415168|Pemetrexed|pemetrexed|mesh-list
139640956|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139640957|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640958|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640959|NCT01927835|Vaccines|vaccines|mesh-list
139640960|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
139640961|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640962|NCT01927913|Deferasirox|deferasirox|mesh-list
139640963|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139640964|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
139640965|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
139640966|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640967|NCT01928069|Montelukast|montelukast|mesh-list
139640968|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139640969|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
139640970|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139640971|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
139640972|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139640973|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640974|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139640975|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139640976|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640977|NCT01928459|Infigratinib|infigratinib|mesh-list
139640978|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640979|NCT01928537|ON 01910|on 01910|mesh-list
139640980|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640981|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139640982|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640983|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640984|NCT01307397|Vemurafenib|vemurafenib|mesh-list
139640985|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640986|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139640987|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640988|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139640989|NCT01929161|Oxytocin|oxytocin|mesh-list
139640990|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
139640991|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139640992|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139640993|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
139640994|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640995|NCT04552535|Afatinib|afatinib|mesh-list
139640996|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139640997|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139640998|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139640999|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641000|NCT02197767|Rituximab|rituximab|mesh-list
139641001|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641002|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641003|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
139641004|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641005|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139641006|NCT01342029|Ranolazine|ranolazine|mesh-list
139641007|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139641008|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139641009|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641010|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139641011|NCT05601479|Acetylcarnitine|acetylcarnitine|mesh-list
139641012|NCT05601479|Vitamin B Complex|vitamin b complex|mesh-ancestor
139641013|NCT05601479|Vitamins|vitamins|mesh-ancestor
139641014|NCT05601479|Micronutrients|micronutrients|mesh-ancestor
139641015|NCT05601479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641016|NCT05601479|Nootropic Agents|nootropic agents|mesh-ancestor
139641017|NCT04275245|Meplazumab|meplazumab|mesh-list
139641018|NCT04275245|Antiviral Agents|antiviral agents|mesh-ancestor
139641019|NCT04275245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641020|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
139641021|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
139641022|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641023|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139641024|NCT04394897|Remifentanil|remifentanil|mesh-list
139641025|NCT04394897|Propofol|propofol|mesh-list
139641026|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139641027|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641028|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641029|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139422722|NCT04759586|Antibodies|antibodies|mesh-list
139641030|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
139641031|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
139641032|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139641033|NCT04394897|Narcotics|narcotics|mesh-ancestor
139641034|NCT04394897|Analgesics|analgesics|mesh-ancestor
139641035|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
139641036|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641037|NCT05607641|Ketorolac|ketorolac|mesh-list
139641038|NCT05607641|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139641039|NCT05607641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139641040|NCT05607641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139641041|NCT05607641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139641042|NCT05607641|Analgesics|analgesics|mesh-ancestor
139641043|NCT05607641|Sensory System Agents|sensory system agents|mesh-ancestor
139641044|NCT05607641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641045|NCT05607641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641046|NCT05607641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139641047|NCT05607641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139641048|NCT05607641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139641049|NCT05607641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641050|NCT05607641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641051|NCT05603039|Bevacizumab|bevacizumab|mesh-list
139641052|NCT05603039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641053|NCT05603039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641054|NCT05603039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138996476|NCT04974996|Prednisone|prednisone|mesh-list
139641055|NCT05603039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139641056|NCT05603039|Growth Substances|growth substances|mesh-ancestor
139641057|NCT05603039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641058|NCT05603039|Growth Inhibitors|growth inhibitors|mesh-ancestor
139641059|NCT05609903|Paclitaxel|paclitaxel|mesh-list
139641060|NCT05609903|Atezolizumab|atezolizumab|mesh-list
139641061|NCT05609903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139641062|NCT05609903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641063|NCT05609903|Tubulin Modulators|tubulin modulators|mesh-ancestor
139641064|NCT05609903|Antimitotic Agents|antimitotic agents|mesh-ancestor
139641065|NCT05609903|Mitosis Modulators|mitosis modulators|mesh-ancestor
139641066|NCT05609903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641067|NCT05609903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139641068|NCT05609903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641069|NCT04161599|Metronidazole|metronidazole|mesh-list
139641070|NCT04161599|Cefuroxime|cefuroxime|mesh-list
139641071|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
139641072|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
139641073|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
139641074|NCT04161599|Citric Acid|citric acid|mesh-list
139641075|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
139641076|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641077|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139641078|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139641079|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139641080|NCT04161599|Antacids|antacids|mesh-ancestor
139641081|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641082|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139641083|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
139641084|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139641085|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
139641086|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
139641087|NCT04161599|Cathartics|cathartics|mesh-ancestor
139641088|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139641089|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139641090|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641091|NCT05601167|Ritonavir|ritonavir|mesh-list
139641092|NCT05601167|Nirmatrelvir|nirmatrelvir|mesh-list
139641093|NCT05601167|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139641094|NCT05601167|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139641095|NCT05601167|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139641096|NCT05601167|Protease Inhibitors|protease inhibitors|mesh-ancestor
139641097|NCT05601167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641098|NCT05601167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641099|NCT05601167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139641100|NCT05601167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139641101|NCT05601167|Antiviral Agents|antiviral agents|mesh-ancestor
139641102|NCT05601167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641103|NCT05601167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139641104|NCT05601167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139422806|NCT04548752|Olaparib|olaparib|mesh-list
139641105|NCT05605613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139641106|NCT05605613|Antibodies|antibodies|mesh-list
139641107|NCT05605613|Immunologic Factors|immunologic factors|mesh-ancestor
139641108|NCT05605613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641109|NCT05605613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641110|NCT05605613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641111|NCT05605613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641112|NCT05602259|Dimercaprol|dimercaprol|mesh-list
139641113|NCT05602259|Chelating Agents|chelating agents|mesh-ancestor
139641114|NCT05602259|Sequestering Agents|sequestering agents|mesh-ancestor
139641115|NCT05602259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641116|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
139641117|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641118|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641119|NCT04393883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139641120|NCT04393883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641121|NCT05603975|Esketamine|esketamine|mesh-list
139641122|NCT05603975|Antidepressive Agents|antidepressive agents|mesh-ancestor
139641123|NCT05603975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139641124|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
139641125|NCT04120363|Testosterone|testosterone|mesh-list
139641126|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
139641127|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
139641128|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139641129|NCT04120363|Androgens|androgens|mesh-ancestor
139641130|NCT04120363|Hormones|hormones|mesh-ancestor
139641131|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139641132|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641133|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139641134|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641135|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
139641136|NCT04125745|CXA-10|cxa-10|mesh-list
139641137|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139641138|NCT04393805|Heparin|heparin|mesh-list
139641139|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139641140|NCT04393805|Tinzaparin|tinzaparin|mesh-list
139641141|NCT04393805|Dalteparin|dalteparin|mesh-list
139641142|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
139641143|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139641144|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139641145|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641146|NCT04122755|Buprenorphine|buprenorphine|mesh-list
139641147|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139641148|NCT04122755|Narcotics|narcotics|mesh-ancestor
139641149|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641150|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641151|NCT04122755|Analgesics|analgesics|mesh-ancestor
139641152|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
139641153|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641154|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139641155|NCT04129697|Dexamethasone|dexamethasone|mesh-list
139641156|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
139641157|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139641158|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139641159|NCT04129697|Prednisolone|prednisolone|mesh-list
139641160|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
139641161|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139641162|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
139641163|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139641164|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
139641165|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
139641166|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641167|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641168|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139641169|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
139641170|NCT04129697|Hormones|hormones|mesh-ancestor
139641171|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139641172|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139641173|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641174|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139641175|NCT04129697|Protective Agents|protective agents|mesh-ancestor
139641176|NCT05793892|Lidocaine|lidocaine|mesh-list
139641177|NCT05793892|Tetracaine|tetracaine|mesh-list
139641178|NCT05793892|Anesthetics, Local|anesthetics, local|mesh-ancestor
139641179|NCT05793892|Anesthetics|anesthetics|mesh-ancestor
139641180|NCT05793892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641181|NCT05793892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641182|NCT05793892|Sensory System Agents|sensory system agents|mesh-ancestor
139641183|NCT05793892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641184|NCT05793892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139641185|NCT05793892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139641186|NCT05793892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139641187|NCT05793892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139641188|NCT05793892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641189|NCT05793359|Methylprednisolone|methylprednisolone|mesh-list
139641190|NCT05793359|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139641191|NCT05793359|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139641193|NCT05793359|Prednisolone acetate|prednisolone acetate|mesh-list
139641194|NCT05793359|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139641195|NCT05793359|Prednisolone phosphate|prednisolone phosphate|mesh-list
139641196|NCT05793359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139641197|NCT05793359|Antiemetics|antiemetics|mesh-ancestor
139641198|NCT05793359|Autonomic Agents|autonomic agents|mesh-ancestor
139641199|NCT05793359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641200|NCT05793359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641201|NCT05793359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139641202|NCT05793359|Glucocorticoids|glucocorticoids|mesh-ancestor
139641203|NCT05793359|Hormones|hormones|mesh-ancestor
139641204|NCT05793359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139641205|NCT05793359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139641206|NCT05793359|Protective Agents|protective agents|mesh-ancestor
139641207|NCT05793359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139641208|NCT05793359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641209|NCT05793268|Tenofovir|tenofovir|mesh-list
139641210|NCT05793268|Entecavir|entecavir|mesh-list
139641211|NCT05793268|Antiviral Agents|antiviral agents|mesh-ancestor
139641212|NCT05793268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641213|NCT05793268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139641214|NCT05793268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139641215|NCT05793268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641216|NCT05793268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635630|NCT00264654|Paroxetine|paroxetine|mesh-list
139641217|NCT05793268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139641218|NCT05793268|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139641219|NCT05792995|Pembrolizumab|pembrolizumab|mesh-list
139641220|NCT05792995|Nivolumab|nivolumab|mesh-list
139641221|NCT05792995|Durvalumab|durvalumab|mesh-list
139641222|NCT05792995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641223|NCT05792995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641224|NCT05792995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139641225|NCT05792995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641226|NCT05792878|Interferons|interferons|mesh-list
139641227|NCT05792878|Interferon-alpha|interferon-alpha|mesh-list
139641228|NCT05792878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641229|NCT05792878|Antiviral Agents|antiviral agents|mesh-ancestor
139641230|NCT05792878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641231|NCT05792878|Immunologic Factors|immunologic factors|mesh-ancestor
139641232|NCT05792878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641233|NCT05792865|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139641234|NCT05792865|Antiviral Agents|antiviral agents|mesh-ancestor
139641235|NCT05792865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641236|NCT05792761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139641237|NCT05792761|Antiviral Agents|antiviral agents|mesh-ancestor
139641238|NCT05792761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641239|NCT05792748|Hemostatics|hemostatics|mesh-list
139641240|NCT05792748|Coagulants|coagulants|mesh-ancestor
139641241|NCT05792644|Crizotinib|crizotinib|mesh-list
139641242|NCT05792644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641243|NCT05792644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138996713|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
139641244|NCT05792644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641245|NCT05792644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641246|NCT05792410|Bevacizumab|bevacizumab|mesh-list
139641247|NCT05792410|Fulvestrant|fulvestrant|mesh-list
139641248|NCT05792410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641249|NCT05792410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641250|NCT05792410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139641251|NCT05792410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139641252|NCT05792410|Growth Substances|growth substances|mesh-ancestor
139641253|NCT05792410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641254|NCT05792410|Growth Inhibitors|growth inhibitors|mesh-ancestor
139641255|NCT05792410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139641256|NCT05792410|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139422969|NCT04269902|Venetoclax|venetoclax|mesh-list
139641257|NCT05792410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139641258|NCT05792410|Hormone Antagonists|hormone antagonists|mesh-ancestor
139641259|NCT05792410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139641260|NCT05792111|Triamcinolone|triamcinolone|mesh-list
139641261|NCT05792111|Lidocaine|lidocaine|mesh-list
139641262|NCT05792111|Bupivacaine|bupivacaine|mesh-list
139641263|NCT05792111|Anesthetics, Local|anesthetics, local|mesh-ancestor
139641264|NCT05792111|Anesthetics|anesthetics|mesh-ancestor
139641265|NCT05792111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641266|NCT05792111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641267|NCT05792111|Sensory System Agents|sensory system agents|mesh-ancestor
139641268|NCT05792111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641269|NCT05792111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139641270|NCT05792111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139641271|NCT05792111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139641272|NCT05792111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139641273|NCT05792111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641274|NCT05792111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139641275|NCT05792111|Glucocorticoids|glucocorticoids|mesh-ancestor
139641276|NCT05792111|Hormones|hormones|mesh-ancestor
139641277|NCT05792111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139641278|NCT05789732|Tadalafil|tadalafil|mesh-list
139641279|NCT05789732|Silodosin|silodosin|mesh-list
139641280|NCT05789732|Vasodilator Agents|vasodilator agents|mesh-ancestor
139641281|NCT05789732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139641282|NCT05789732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139641283|NCT05789732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641284|NCT05789732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641285|NCT05789732|Urological Agents|urological agents|mesh-ancestor
139641286|NCT05789732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139641287|NCT05789732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139641288|NCT05789732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139641289|NCT05789732|Adrenergic Agents|adrenergic agents|mesh-ancestor
139641290|NCT05789732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139641291|NCT05789732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641292|NCT05789615|Letermovir|letermovir|mesh-list
139641293|NCT05789615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139641294|NCT05789615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641295|NCT05789615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641296|NCT05789615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641297|NCT05789615|Antiviral Agents|antiviral agents|mesh-ancestor
139641298|NCT05789615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641299|NCT05783817|Methamphetamine|methamphetamine|mesh-list
139641300|NCT05783817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139641301|NCT05783817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641302|NCT05783817|Sympathomimetics|sympathomimetics|mesh-ancestor
139641303|NCT05783817|Autonomic Agents|autonomic agents|mesh-ancestor
139641304|NCT05783817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641305|NCT05783817|Dopamine Agents|dopamine agents|mesh-ancestor
139641306|NCT05783817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139641307|NCT05783817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641308|NCT05783817|Adrenergic Agents|adrenergic agents|mesh-ancestor
139641309|NCT05783817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139641310|NCT05783817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139641311|NCT05783817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139641312|NCT05783817|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139641313|NCT05761080|Amoxicillin|amoxicillin|mesh-list
139641314|NCT05761080|Clavulanic Acids|clavulanic acids|mesh-list
139641315|NCT05761080|Clavulanic Acid|clavulanic acid|mesh-list
139641316|NCT05761080|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139641317|NCT05761080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139641318|NCT05761080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641319|NCT05761080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641320|NCT05761080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641321|NCT05761080|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139641322|NCT05743764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139641323|NCT05743764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139641324|NCT05737186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139641325|NCT05737186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641326|NCT05737186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139641327|NCT05737186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641328|NCT05700669|Olaparib|olaparib|mesh-list
139641329|NCT05700669|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139641330|NCT05700669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641331|NCT05700669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641332|NCT05700669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641333|NCT05652660|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139641334|NCT05652660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139641335|NCT05652660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139641336|NCT05652660|Antimetabolites|antimetabolites|mesh-ancestor
139641337|NCT05652660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641338|NCT05652660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139641339|NCT05652660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139641340|NCT05652660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641342|NCT05456932|Ferrous fumarate|ferrous fumarate|mesh-list
139641343|NCT05456932|Ferric maltol|ferric maltol|mesh-list
139641344|NCT05456932|Trace Elements|trace elements|mesh-ancestor
139641345|NCT05456932|Micronutrients|micronutrients|mesh-ancestor
139641346|NCT05456932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641347|NCT05456932|Hematinics|hematinics|mesh-ancestor
139641348|NCT05447780|Anesthetics|anesthetics|mesh-list
139641349|NCT05447780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641350|NCT05447780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641351|NCT05437289|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139641352|NCT05437289|Antiviral Agents|antiviral agents|mesh-ancestor
139641353|NCT05437289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641354|NCT05389930|Ethanol|ethanol|mesh-list
139641355|NCT05389930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139641356|NCT05389930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641357|NCT05389930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641358|NCT05389930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641359|NCT05382546|Ketorolac|ketorolac|mesh-list
139641360|NCT05382546|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139641361|NCT05382546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139641362|NCT05382546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139641363|NCT05382546|Analgesics|analgesics|mesh-ancestor
139641364|NCT05382546|Sensory System Agents|sensory system agents|mesh-ancestor
139641365|NCT05382546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641366|NCT05382546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641367|NCT05382546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139641368|NCT05382546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139641369|NCT05382546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139641370|NCT05382546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641371|NCT05382546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641372|NCT05278351|Irinotecan|irinotecan|mesh-list
139641373|NCT05278351|Cetuximab|cetuximab|mesh-list
139641374|NCT05278351|Tislelizumab|tislelizumab|mesh-list
139641375|NCT05278351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139641376|NCT05278351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139641377|NCT05278351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641378|NCT05278351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641379|NCT05278351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641380|NCT05278351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641381|NCT05263700|FAPI-46|fapi-46|mesh-list
139641382|NCT05263700|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139641383|NCT05263700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641384|NCT05257447|Baclofen|baclofen|mesh-list
139641385|NCT05257447|Chlorzoxazone|chlorzoxazone|mesh-list
139641386|NCT05257447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139641387|NCT05257447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641388|NCT05257447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139641389|NCT05257447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641390|NCT05257447|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139641391|NCT05257447|GABA Agonists|gaba agonists|mesh-ancestor
139641392|NCT05257447|GABA Agents|gaba agents|mesh-ancestor
139641393|NCT05257447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139641394|NCT05257447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641395|NCT05211154|Diclofenac|diclofenac|mesh-list
139641396|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139641397|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139641398|NCT05211154|Analgesics|analgesics|mesh-ancestor
139641399|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
139641400|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641401|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641402|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139641403|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139641404|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139641405|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641406|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641408|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
139641409|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641410|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641411|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
139641412|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139641413|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641414|NCT05093296|Naltrexone|naltrexone|mesh-list
139641415|NCT05093296|Oxytocin|oxytocin|mesh-list
139641416|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
139641417|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139641418|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641419|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139641420|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139641421|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
139641422|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641423|NCT05071833|Peppermint oil|peppermint oil|mesh-list
139641424|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
139641425|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
139641426|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641427|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641428|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139641429|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
139641430|NCT04729101|Lansoprazole|lansoprazole|mesh-list
139641431|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
139641432|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139641433|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139641434|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139641435|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641436|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641437|NCT04670081|Niacinamide|niacinamide|mesh-list
139641438|NCT04670081|Niacin|niacin|mesh-list
139641439|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
139641440|NCT04670081|Psilocybin|psilocybin|mesh-list
139641441|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
139641442|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641443|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139641444|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
139641445|NCT04670081|Vitamins|vitamins|mesh-ancestor
139641446|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
139641447|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139641448|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
139641449|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641450|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139641451|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
139641452|NCT04648280|Fostemsavir|fostemsavir|mesh-list
139641453|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139641454|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139641455|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
139641456|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641457|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139641458|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139641459|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641460|NCT04601961|Propofol|propofol|mesh-list
139641461|NCT04601961|Sevoflurane|sevoflurane|mesh-list
139641462|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139641463|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641464|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641465|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139641466|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
139641467|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
139641468|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139641469|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139641470|NCT04513314|Valproic Acid|valproic acid|mesh-list
139641471|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139641472|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
139641473|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139641474|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139641475|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139641476|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641477|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641478|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
139641479|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423179|NCT03936933|Goserelin|goserelin|mesh-list
139641480|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641481|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
139641482|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139641483|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
139641484|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
139641485|NCT04469868|Narcotics|narcotics|mesh-ancestor
139641486|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641487|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641488|NCT04469868|Analgesics|analgesics|mesh-ancestor
139641489|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
139641490|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641491|NCT04451187|Zopiclone|zopiclone|mesh-list
139641492|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139641493|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641494|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641495|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
139641496|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139641497|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641498|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139641499|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641500|NCT04282629|Milrinone|milrinone|mesh-list
139641501|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139641502|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139641503|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
139641504|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139641505|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139641506|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641507|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641508|NCT04282629|Protective Agents|protective agents|mesh-ancestor
139641509|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641510|NCT04275492|Pramipexole|pramipexole|mesh-list
139641511|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
139641512|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641513|NCT04275492|Protective Agents|protective agents|mesh-ancestor
139641514|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997191|NCT00987870|Betamethasone|betamethasone|mesh-list
139641515|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139641516|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139641517|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
139641518|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
139641519|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139641520|NCT04265105|Fluticasone|fluticasone|mesh-list
139641521|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139641522|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139641523|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
139641524|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641525|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641526|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139641527|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
139641528|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
139641529|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139641530|NCT04246229|Bilirubin|bilirubin|mesh-list
139641531|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
138997234|NCT04005612|Vitamin D|vitamin d|mesh-list
139641532|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641533|NCT04246229|Protective Agents|protective agents|mesh-ancestor
139641534|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641535|NCT04031833|Amphotericin B|amphotericin b|mesh-list
139641536|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139641537|NCT04031833|Amebicides|amebicides|mesh-ancestor
139641538|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139641539|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139641540|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641541|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139641542|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
139641543|NCT03943875|Vaccines|vaccines|mesh-list
139641544|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
139641545|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641546|NCT03908307|Dexamethasone|dexamethasone|mesh-list
139641547|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
139641548|NCT03908307|BB 1101|bb 1101|mesh-list
139641549|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139641550|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
139641551|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
139641552|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641553|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641554|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139641555|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
139641557|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139641558|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139641559|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641560|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
139641561|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641562|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641563|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139641564|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
139641565|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139641566|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
139641567|NCT03684590|Narcotics|narcotics|mesh-ancestor
139641568|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641569|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641570|NCT03684590|Analgesics|analgesics|mesh-ancestor
138997352|NCT05919121|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139641571|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
139641572|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641573|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139641574|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
139641575|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139641576|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
139641577|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641578|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641579|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641580|NCT03385304|Iodine|iodine|mesh-list
139641581|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
139641582|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139641583|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
139641584|NCT03385304|Povidone|povidone|mesh-list
139641585|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139641586|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641587|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
139641588|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
139641589|NCT03385304|Trace Elements|trace elements|mesh-ancestor
139641590|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
139641591|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641592|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
139641593|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
139641594|NCT03285568|Palbociclib|palbociclib|mesh-list
139641595|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641596|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139641597|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641598|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641599|NCT03117816|Interferons|interferons|mesh-list
139641600|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
138997409|NCT05917691|Anesthetics|anesthetics|mesh-list
139641601|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
139641602|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641603|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
139641604|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641605|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
139641606|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641607|NCT03038802|Vaccines|vaccines|mesh-list
139641608|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
139641609|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641610|NCT02938793|Durvalumab|durvalumab|mesh-list
139641611|NCT02938793|Tremelimumab|tremelimumab|mesh-list
139641612|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641613|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641614|NCT02837094|Insulin|insulin|mesh-list
139641615|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139641616|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641617|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
139641618|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139641619|NCT02836925|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139641620|NCT02836925|Ledipasvir|ledipasvir|mesh-list
139641621|NCT02836925|Velpatasvir|velpatasvir|mesh-list
139641622|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
139641623|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641624|NCT02728037|Lidocaine|lidocaine|mesh-list
139641625|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
139641626|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
139641627|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
139641628|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641629|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423326|NCT03872947|Protective Agents|protective agents|mesh-ancestor
139641630|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
139641631|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641632|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139641633|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139641634|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139641635|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139641636|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641638|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
139641639|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139641640|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139641641|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
139641642|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139641643|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139641644|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
139641645|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139641646|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
139641647|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641648|NCT02275780|Ritonavir|ritonavir|mesh-list
139641649|NCT02275780|Darunavir|darunavir|mesh-list
139641650|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139641651|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139641652|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139641653|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
139641654|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641655|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641656|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139641657|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139641658|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
139641659|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641660|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139641661|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139641662|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139641663|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139641664|NCT00545077|Bevacizumab|bevacizumab|mesh-list
139641665|NCT00545077|Letrozole|letrozole|mesh-list
139641666|NCT00545077|Fulvestrant|fulvestrant|mesh-list
139641667|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641668|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641669|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139641670|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139641671|NCT00545077|Growth Substances|growth substances|mesh-ancestor
139641672|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641673|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
139641674|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139641675|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139641676|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641677|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641678|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139641679|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
139641680|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139641681|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139641682|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139641683|NCT00251433|Docetaxel|docetaxel|mesh-list
139641684|NCT00251433|Trastuzumab|trastuzumab|mesh-list
139641685|NCT00251433|Lapatinib|lapatinib|mesh-list
139641686|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641687|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
139641688|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
139641689|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
139641690|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641691|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138997608|NCT05254574|Diclofenac|diclofenac|mesh-list
139641692|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139641693|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641694|NCT00130533|Capecitabine|capecitabine|mesh-list
139641695|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139641696|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
139641697|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641698|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641699|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
139641700|NCT00129935|Docetaxel|docetaxel|mesh-list
139641701|NCT00129935|Capecitabine|capecitabine|mesh-list
139641702|NCT00129935|Epirubicin|epirubicin|mesh-list
139641703|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139641704|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
139423407|NCT03436485|Midazolam|midazolam|mesh-list
139641705|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641706|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139641707|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139641708|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
139641709|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641710|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641711|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139641712|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
139641713|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
139641714|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
139641715|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139641716|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
139641717|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139641718|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139641719|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139641720|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641722|NCT02760667|Carboplatin|carboplatin|mesh-list
139641723|NCT02760667|Docetaxel|docetaxel|mesh-list
139641724|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641725|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
139641726|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
139641727|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
139641728|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641729|NCT04127357|Fluorides|fluorides|mesh-list
139641730|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
139641731|NCT04127357|Protective Agents|protective agents|mesh-ancestor
139641732|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641733|NCT01450111|Lacosamide|lacosamide|mesh-list
139641734|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
139641735|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139641736|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139641737|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139641738|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641739|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139641740|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139641741|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641742|NCT02697253|Incretins|incretins|mesh-ancestor
139641743|NCT02697253|Hormones|hormones|mesh-ancestor
139641744|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139641745|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139641746|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
139641747|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641748|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641749|NCT02660905|Tenofovir|tenofovir|mesh-list
139641750|NCT02660905|Emtricitabine|emtricitabine|mesh-list
139641751|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
139641752|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139641753|NCT02660905|Rilpivirine|rilpivirine|mesh-list
139641754|NCT02660905|Ledipasvir|ledipasvir|mesh-list
139641755|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
139641756|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641757|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139641758|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139641759|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641760|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641761|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139641762|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139641763|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139641764|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139641765|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641766|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641767|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139641768|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
139641769|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139641770|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641771|NCT01450345|Pregabalin|pregabalin|mesh-list
139641772|NCT01450345|Analgesics|analgesics|mesh-ancestor
139641773|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
139641774|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641775|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641776|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
139641777|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139641778|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139641779|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641780|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139641781|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139641782|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139641783|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641784|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139641785|NCT03822559|Timolol|timolol|mesh-list
139641786|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139641787|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138997807|NCT04250636|Antibodies|antibodies|mesh-list
139641788|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139641789|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139641790|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
139641791|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139641792|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641793|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641794|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139641795|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139641796|NCT01647828|Paclitaxel|paclitaxel|mesh-list
139641797|NCT01647828|Gemcitabine|gemcitabine|mesh-list
139641798|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139641799|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641800|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
139641801|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
139641802|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
139641803|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641804|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139641805|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
139641806|NCT03825367|Nivolumab|nivolumab|mesh-list
139641807|NCT03825367|Azacitidine|azacitidine|mesh-list
138997862|NCT04061421|Decitabine|decitabine|mesh-list
139641808|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641809|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641810|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139641811|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641812|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139641813|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
139641814|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641815|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
139641816|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139641817|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139641818|NCT04273321|Prednisolone|prednisolone|mesh-list
139641819|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
139641820|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139641821|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
139641822|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139641823|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
138997920|NCT03787680|Olaparib|olaparib|mesh-list
139641824|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
139641825|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641826|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641827|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139641828|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
139641829|NCT04273321|Hormones|hormones|mesh-ancestor
139641830|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139641831|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139641832|NCT04273321|Protective Agents|protective agents|mesh-ancestor
139641833|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139641834|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641835|NCT01243476|Lenalidomide|lenalidomide|mesh-list
139641836|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
139641837|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641838|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139641839|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139641840|NCT01243476|Growth Substances|growth substances|mesh-ancestor
139641841|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
139641842|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641843|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
139641844|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139641845|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139641846|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
139641847|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641848|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139641849|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139641850|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641851|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641852|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
139423557|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
138997979|NCT03533946|Rucaparib|rucaparib|mesh-list
139641853|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641854|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641855|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
139641856|NCT01454011|Testosterone|testosterone|mesh-list
139641857|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
139641858|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
139641859|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139641860|NCT01454011|Androgens|androgens|mesh-ancestor
139641861|NCT01454011|Hormones|hormones|mesh-ancestor
139641862|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139641863|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641864|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139641865|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641866|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
139641867|NCT03060018|Oxitropium|oxitropium|mesh-list
139641868|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
139641869|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
139641870|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641871|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641872|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
139641873|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139641874|NCT04975932|Estrogens|estrogens|mesh-ancestor
139641875|NCT04975932|Hormones|hormones|mesh-ancestor
138998023|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
139641876|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139641877|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641878|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139641879|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641880|NCT01454479|Lapatinib|lapatinib|mesh-list
139641881|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641882|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139641883|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641884|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641885|NCT03061032|Ribavirin|ribavirin|mesh-list
139641886|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
139641887|NCT03061032|Ledipasvir|ledipasvir|mesh-list
139641888|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
139641889|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641890|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
139641891|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641892|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
139641893|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139641894|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138998070|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641895|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641896|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
139641897|NCT02911831|Coagulants|coagulants|mesh-ancestor
139641898|NCT03061734|Acetaminophen|acetaminophen|mesh-list
139641899|NCT03061734|Naltrexone|naltrexone|mesh-list
139641900|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139641901|NCT03061734|Analgesics|analgesics|mesh-ancestor
139641902|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
139641903|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641904|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641905|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
139641906|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139641907|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139641908|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
139641909|NCT03061656|Melphalan|melphalan|mesh-list
139641910|NCT03061656|Thiotepa|thiotepa|mesh-list
139641911|NCT03061656|Carboplatin|carboplatin|mesh-list
139641912|NCT03061656|Etoposide|etoposide|mesh-list
139641913|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139641914|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
139641915|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641916|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139641917|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139641918|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
139641919|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641920|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641921|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139641922|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139641923|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139641924|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139641925|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641926|NCT02906761|Aspirin|aspirin|mesh-list
138998126|NCT02237079|Hormones|hormones|mesh-ancestor
139641927|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139641928|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139423629|NCT02194738|Paclitaxel|paclitaxel|mesh-list
139641929|NCT02906761|Analgesics|analgesics|mesh-ancestor
139641930|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
139641931|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139641932|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641933|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139641934|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139641935|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139641936|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139641937|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641938|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139641939|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139641940|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641941|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
139641942|NCT01455025|Plerixafor|plerixafor|mesh-list
139641943|NCT01455025|Lenograstim|lenograstim|mesh-list
139641944|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139641945|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
139641946|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641947|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139641948|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139641949|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
139641950|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641951|NCT03060798|Desflurane|desflurane|mesh-list
139641952|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139641953|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
139641954|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
139641955|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139641956|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641957|NCT01451593|Phenytoin|phenytoin|mesh-list
139641958|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
139641959|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139641960|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139641961|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139641962|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641963|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139641964|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139641965|NCT01455103|BMS-936559|bms-936559|mesh-list
139641966|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139641967|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139641968|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139641969|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
139641970|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641971|NCT04975074|Iron|iron|mesh-list
139641972|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
139641973|NCT04975074|Trace Elements|trace elements|mesh-ancestor
139641974|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
139641975|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641976|NCT04975074|Hematinics|hematinics|mesh-ancestor
139641977|NCT04963998|Copper|copper|mesh-list
139641978|NCT04963998|Trace Elements|trace elements|mesh-ancestor
139641979|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
139641980|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641981|NCT01451905|Liraglutide|liraglutide|mesh-list
139641982|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139641983|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641984|NCT01451905|Incretins|incretins|mesh-ancestor
139641985|NCT01451905|Hormones|hormones|mesh-ancestor
139641986|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139641987|NCT01455649|Cyclosporine|cyclosporine|mesh-list
139641988|NCT01455649|Everolimus|everolimus|mesh-list
139641989|NCT01455649|Tacrolimus|tacrolimus|mesh-list
139641990|NCT01455649|Cyclosporins|cyclosporins|mesh-list
139641991|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138998316|NCT00750347|Rimonabant|rimonabant|mesh-list
139641992|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139641993|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
139641994|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139641995|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139641996|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139641997|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
139641998|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139641999|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
139642000|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139642001|NCT01455649|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139642002|NCT01455649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139642003|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642004|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139642005|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
139642006|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642007|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139642008|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139642009|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
139642010|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139642011|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139642012|NCT01455883|Glimepiride|glimepiride|mesh-list
139642013|NCT01455883|Exenatide|exenatide|mesh-list
139642014|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139642015|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139642016|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642017|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139642018|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
139642019|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139642020|NCT01455883|Incretins|incretins|mesh-ancestor
139642021|NCT01455883|Hormones|hormones|mesh-ancestor
139642022|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139642023|NCT01452217|Secretin|secretin|mesh-list
139642024|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139642025|NCT01452217|Hormones|hormones|mesh-ancestor
138998393|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642026|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139642027|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642028|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139642029|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139642030|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642031|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642032|NCT04954560|Losartan|losartan|mesh-list
139642033|NCT04954560|Eprosartan|eprosartan|mesh-list
139642034|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139642035|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139642036|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139642037|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139642038|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642039|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
139642040|NCT01456117|Pioglitazone|pioglitazone|mesh-list
139642041|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139642042|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642043|NCT03829345|Olaparib|olaparib|mesh-list
139642044|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139642045|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642046|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642047|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642048|NCT01456351|Rituximab|rituximab|mesh-list
139642049|NCT01456351|Fludarabine|fludarabine|mesh-list
139642050|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139642051|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139642052|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642053|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
139642054|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642055|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139642056|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642057|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139642058|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
139642059|NCT01452685|Leuprolide|leuprolide|mesh-list
139642060|NCT01452685|Relugolix|relugolix|mesh-list
139642061|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139642062|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
139642063|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139642064|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642065|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139642066|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642067|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
139642068|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
139642069|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139642070|NCT01452763|Lansoprazole|lansoprazole|mesh-list
139642071|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
139642072|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139642073|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139642074|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139642075|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642076|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642077|NCT04954014|Bevacizumab|bevacizumab|mesh-list
139642078|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139642079|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423788|NCT00861042|Lacosamide|lacosamide|mesh-list
139642080|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139642081|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139642082|NCT04954014|Growth Substances|growth substances|mesh-ancestor
139642083|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642084|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
139642085|NCT00988559|Imiquimod|imiquimod|mesh-list
139642086|NCT00988559|Vaccines|vaccines|mesh-list
139642087|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
139642088|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642089|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139642090|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642091|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
139642092|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139642093|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642094|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139642095|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642096|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642097|NCT02967133|Paclitaxel|paclitaxel|mesh-list
139642098|NCT02967133|Nivolumab|nivolumab|mesh-list
139642099|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139642100|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642101|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
139642102|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
139642103|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
139642104|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642105|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139642106|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139642107|NCT04961970|Leucovorin|leucovorin|mesh-list
139642108|NCT04961970|Gemcitabine|gemcitabine|mesh-list
139642109|NCT04961970|Fluorouracil|fluorouracil|mesh-list
139642110|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
139297207|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297208|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139297209|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139297210|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139297211|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139297212|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297213|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297214|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297215|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139297216|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
139297217|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139297218|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
139297219|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
139297220|NCT04205240|Melphalan|melphalan|mesh-list
139297221|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
139297222|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139297223|NCT04205240|Fludarabine|fludarabine|mesh-list
139297224|NCT04205240|Daratumumab|daratumumab|mesh-list
139297225|NCT04205240|Tacrolimus|tacrolimus|mesh-list
139297226|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139297227|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
139297228|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297229|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139297230|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139297231|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
139297232|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297233|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297234|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139297235|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139297236|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297237|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139297238|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139297239|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
139297240|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139297241|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297242|NCT04153383|Milrinone|milrinone|mesh-list
139297243|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138880687|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
139297244|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139297245|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
139297246|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139297247|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139297248|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642111|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091616|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
139091617|NCT04381936|BB 1101|bb 1101|mesh-list
139091618|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
139091620|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139091621|NCT04381936|Antiemetics|antiemetics|mesh-ancestor
139210642|NCT03044613|Carboplatin|carboplatin|mesh-list
139210643|NCT03044613|Nivolumab|nivolumab|mesh-list
139210644|NCT03044613|Relatlimab|relatlimab|mesh-list
139210645|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139210646|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210647|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
139210648|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210649|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
139210650|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210651|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210652|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210653|NCT03041688|Decitabine|decitabine|mesh-list
139210654|NCT03041688|Venetoclax|venetoclax|mesh-list
139210655|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139210656|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
139210657|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210658|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210659|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210660|NCT02944071|Paclitaxel|paclitaxel|mesh-list
139210661|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139210662|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210663|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
139210664|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210665|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
139210666|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210667|NCT02942355|Palbociclib|palbociclib|mesh-list
139210668|NCT02942355|Anastrozole|anastrozole|mesh-list
139210669|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210670|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139210671|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210672|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210673|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139210674|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139210675|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139210676|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139210677|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
139210678|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139210679|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210680|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
139210681|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139210682|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210683|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210684|NCT02889809|Fluticasone|fluticasone|mesh-list
139210685|NCT02889809|Xhance|xhance|mesh-list
139210686|NCT02889809|Montelukast|montelukast|mesh-list
139210687|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139210688|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139210689|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
139210690|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210691|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210692|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139210693|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
139210694|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
139210695|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139210696|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139210697|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
139210698|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139210699|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139210700|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139210701|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210702|NCT02884648|Bevacizumab|bevacizumab|mesh-list
139210703|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210704|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210705|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139210706|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139210707|NCT02884648|Growth Substances|growth substances|mesh-ancestor
139210708|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210709|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
139210710|NCT02815592|Carboplatin|carboplatin|mesh-list
139210711|NCT02815592|Etoposide|etoposide|mesh-list
139210712|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210713|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139167350|NCT06140953|Niacin|niacin|mesh-list
139210714|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139210715|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139210716|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210717|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210719|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139210720|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210721|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139210722|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139210723|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
138998915|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
139210724|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139210725|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210726|NCT02785224|Vasopressins|vasopressins|mesh-list
139210727|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
139210728|NCT02785224|Epinephrine|epinephrine|mesh-list
139210729|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139210730|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139210731|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
139210732|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139210733|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210734|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210735|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139210736|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139210737|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
139210738|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210739|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139210740|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
139210741|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
139210742|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
139210743|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139210744|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
139210745|NCT02785224|Coagulants|coagulants|mesh-ancestor
139210746|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139210747|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
139210748|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
139210749|NCT02784171|Pemetrexed|pemetrexed|mesh-list
139210750|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210751|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210752|NCT02784171|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138998968|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139210753|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210754|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210755|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139210756|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139210757|NCT02759107|Dulaglutide|dulaglutide|mesh-list
139210758|NCT02759107|Tirzepatide|tirzepatide|mesh-list
139210759|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139210760|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210761|NCT02759107|Incretins|incretins|mesh-ancestor
139210762|NCT02759107|Hormones|hormones|mesh-ancestor
139210763|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139210764|NCT02733133|Testosterone|testosterone|mesh-list
139210765|NCT02733133|Androgens|androgens|mesh-ancestor
139210766|NCT02733133|Hormones|hormones|mesh-ancestor
139210767|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139210768|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210769|NCT02697227|Nicotine|nicotine|mesh-list
139210770|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139210771|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
139210772|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210773|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210774|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139210775|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139210776|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
139210777|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139210778|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210779|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
139210780|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139210781|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139210782|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210783|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139210784|NCT02604940|Analgesics|analgesics|mesh-ancestor
139210785|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
139210786|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210787|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139210788|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139210789|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139210790|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
139210791|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139210792|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210793|NCT02581137|Metformin|metformin|mesh-list
139210794|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139210795|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210796|NCT02530697|Miltefosine|miltefosine|mesh-list
139210797|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
139210798|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
139210799|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139210800|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210801|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999076|NCT00682643|Xhance|xhance|mesh-list
139210802|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139210803|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139210804|NCT02530697|Protective Agents|protective agents|mesh-ancestor
139210805|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210806|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
139210807|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139210808|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
139210809|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
139210810|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139210811|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210812|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139210813|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139210814|NCT02489006|Olaparib|olaparib|mesh-list
139210815|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139210816|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210817|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210818|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210819|NCT02467582|Aspirin|aspirin|mesh-list
139210820|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139210821|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139210822|NCT02467582|Analgesics|analgesics|mesh-ancestor
139210823|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
139210824|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210825|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210826|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139210827|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139210828|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139210829|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139210830|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210831|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139210832|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139210833|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210834|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
139210835|NCT02465736|Cisplatin|cisplatin|mesh-list
139210836|NCT02465736|Docetaxel|docetaxel|mesh-list
139210837|NCT02465736|Vinorelbine|vinorelbine|mesh-list
139210838|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210839|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
139210840|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210841|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
139210842|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210843|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139210844|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
139210845|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210846|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210847|NCT02453594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210848|NCT02453594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210849|NCT02441803|Cytarabine|cytarabine|mesh-list
139210850|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
139210851|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
139210852|NCT02441803|Busulfan|busulfan|mesh-list
139210853|NCT02441803|Fludarabine|fludarabine|mesh-list
139210854|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
139210855|NCT02441803|Decitabine|decitabine|mesh-list
139210856|NCT02441803|Idarubicin|idarubicin|mesh-list
139210857|NCT02441803|Clofarabine|clofarabine|mesh-list
139210858|NCT02441803|Tacrolimus|tacrolimus|mesh-list
139210859|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
139210860|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139210861|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139210862|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
139081004|NCT05249569|Avelumab|avelumab|mesh-list
139210865|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139210866|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
139210867|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210868|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210869|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139210870|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139210871|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
139210872|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
139210873|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139210874|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139210875|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210876|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139210877|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139210878|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
139210879|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139210880|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139210881|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139210882|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
139210883|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139210884|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139210885|NCT02385110|Dexamethasone|dexamethasone|mesh-list
139210886|NCT02385110|Methotrexate|methotrexate|mesh-list
139210887|NCT02385110|Etoposide|etoposide|mesh-list
139210888|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
139210889|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139210890|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
139210891|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
139210892|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210893|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210894|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139210895|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
139210896|NCT02385110|Hormones|hormones|mesh-ancestor
139210897|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139210898|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139210899|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210900|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139210901|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
139210902|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139210903|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139210904|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
139210905|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210906|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
139210907|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210908|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139210909|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139210910|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
139210911|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139210912|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139210913|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139210914|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139210915|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139210916|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210917|NCT02379416|Paclitaxel|paclitaxel|mesh-list
139210918|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139210919|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210920|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
139210921|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210922|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
139210923|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210924|NCT02264678|Carboplatin|carboplatin|mesh-list
139210925|NCT02264678|Durvalumab|durvalumab|mesh-list
139210926|NCT02264678|Olaparib|olaparib|mesh-list
139210927|NCT02264678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139210928|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210929|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210930|NCT02264678|Immunologic Factors|immunologic factors|mesh-ancestor
139210931|NCT02264678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999258|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139210932|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139210933|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210934|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210945|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210946|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210947|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
139210948|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210949|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139210950|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139210951|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
139210952|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139210953|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139210954|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
139210955|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210956|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
139210957|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210958|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139210959|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139210960|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139210961|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
139210962|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139210963|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
139210964|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
139210965|NCT02143830|Busulfan|busulfan|mesh-list
139210966|NCT02143830|Fludarabine|fludarabine|mesh-list
139210967|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
139210968|NCT02143830|Lenograstim|lenograstim|mesh-list
139210969|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139210970|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
139210971|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210972|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139210973|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139210974|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
139210975|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210976|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210977|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139210978|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139210979|NCT02105766|Sirolimus|sirolimus|mesh-list
139210980|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
139210981|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
139210982|NCT02105766|Pentostatin|pentostatin|mesh-list
139210983|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139210984|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
139210985|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210986|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139210987|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139210988|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
139210989|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210990|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210991|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139210992|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139210993|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139210994|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139210995|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
139210996|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210997|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210998|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139210999|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
139211000|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139211001|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139211002|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
139211003|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211004|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211005|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211006|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
139211007|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
139211008|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211009|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
139211010|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139211011|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
139211012|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
139211013|NCT01949129|Busulfan|busulfan|mesh-list
139211014|NCT01949129|Thiotepa|thiotepa|mesh-list
139211015|NCT01949129|Treosulfan|treosulfan|mesh-list
139211016|NCT01949129|Fludarabine|fludarabine|mesh-list
139211018|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
139211019|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139211020|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
139211021|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139211022|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
139211023|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211024|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211025|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139211026|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
139211027|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211028|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211029|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139211030|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139211031|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139211032|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139211033|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211034|NCT01898793|Aldesleukin|aldesleukin|mesh-list
139211035|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
139211036|NCT01898793|Fludarabine|fludarabine|mesh-list
139211037|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
139211038|NCT01898793|Interleukin-2|interleukin-2|mesh-list
139211039|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139211040|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
139211041|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211042|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211043|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139211044|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
139211045|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211046|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211047|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139211048|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139211049|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
139211050|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
139211051|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139211052|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139211053|NCT01898793|Analgesics|analgesics|mesh-ancestor
139211054|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
139211055|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211056|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139211057|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139211058|NCT01857934|Aldesleukin|aldesleukin|mesh-list
139211059|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
139211060|NCT01857934|Melphalan|melphalan|mesh-list
139211061|NCT01857934|Busulfan|busulfan|mesh-list
139211062|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
139211063|NCT01857934|Doxorubicin|doxorubicin|mesh-list
139211064|NCT01857934|Etoposide|etoposide|mesh-list
139211065|NCT01857934|Vincristine|vincristine|mesh-list
139211066|NCT01857934|Topotecan|topotecan|mesh-list
139211067|NCT01857934|Interleukin-2|interleukin-2|mesh-list
139211068|NCT01857934|Molgramostim|molgramostim|mesh-list
139211069|NCT01857934|Dinutuximab|dinutuximab|mesh-list
139211070|NCT01857934|Levetiracetam|levetiracetam|mesh-list
139211071|NCT01857934|Isotretinoin|isotretinoin|mesh-list
139211072|NCT01857934|Antibodies|antibodies|mesh-list
139211073|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
139211074|NCT01857934|Sargramostim|sargramostim|mesh-list
139211075|NCT01857934|Lenograstim|lenograstim|mesh-list
139211076|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139211077|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
139211078|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211079|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211080|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139211081|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
139211082|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211083|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211084|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139211085|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139211086|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139211087|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139211088|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211089|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139211090|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
139211091|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
139211092|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
139211093|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139211094|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139211095|NCT01857934|Analgesics|analgesics|mesh-ancestor
139211096|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
139211097|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211098|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139211099|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139211100|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
139211101|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139211102|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139211103|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
139211104|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
139211105|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
139211107|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139211108|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211109|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
139211110|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211111|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211113|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139211114|NCT01748149|Vemurafenib|vemurafenib|mesh-list
139211115|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211116|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139211117|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211118|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211119|NCT01589081|Nicotine|nicotine|mesh-list
139211120|NCT01589081|Progesterone|progesterone|mesh-list
139211121|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139211122|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
139211123|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211124|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211125|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139211126|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139211127|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
139211128|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211129|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211130|NCT01589081|Progestins|progestins|mesh-ancestor
139211131|NCT01589081|Hormones|hormones|mesh-ancestor
139211132|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139211133|NCT01589068|Nicotine|nicotine|mesh-list
139211134|NCT01589068|Progesterone|progesterone|mesh-list
139211135|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139211136|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
139211137|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211138|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211139|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139211140|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139211141|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
139211142|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211143|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211144|NCT01589068|Progestins|progestins|mesh-ancestor
139211145|NCT01589068|Hormones|hormones|mesh-ancestor
139211146|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139211147|NCT01589055|Nicotine|nicotine|mesh-list
139211148|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139211149|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
139211150|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211151|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211152|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139211153|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139211154|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
139211155|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211156|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211157|NCT01543763|Abexinostat|abexinostat|mesh-list
139211158|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139211159|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211160|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211161|NCT01515527|Cytarabine|cytarabine|mesh-list
139211162|NCT01515527|Decitabine|decitabine|mesh-list
139211163|NCT01515527|Cladribine|cladribine|mesh-list
139211164|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139211165|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
139211166|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211167|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211168|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
139211169|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139211170|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139211171|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
139211172|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211173|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211174|NCT01501513|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139211175|NCT01501513|Laxatives|laxatives|mesh-ancestor
139211176|NCT01501513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139211177|NCT01500551|Tofacitinib|tofacitinib|mesh-list
139211178|NCT01500551|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139211179|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139211180|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211181|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211182|NCT01410942|Methylphenidate|methylphenidate|mesh-list
139211183|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139211184|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211185|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139211186|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139211187|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139211188|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211189|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
139211190|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211192|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139211193|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
139211194|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
139211195|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211196|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211197|NCT01275677|Paclitaxel|paclitaxel|mesh-list
139211198|NCT01275677|Docetaxel|docetaxel|mesh-list
139211199|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
139211200|NCT01275677|Doxorubicin|doxorubicin|mesh-list
139211201|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139211202|NCT01275677|Trastuzumab|trastuzumab|mesh-list
139211203|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139211204|NCT01275677|Daunorubicin|daunorubicin|mesh-list
139211205|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139211206|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139211207|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211208|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
139211209|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
139211210|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
139211211|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211212|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139211213|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
139211214|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211215|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211216|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139211217|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
139211218|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139211219|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139211220|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139211221|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139211222|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211223|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139211224|NCT01217931|Bevacizumab|bevacizumab|mesh-list
139211225|NCT01217931|Everolimus|everolimus|mesh-list
139211226|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139211227|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211228|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139211229|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139211230|NCT01217931|Growth Substances|growth substances|mesh-ancestor
139211231|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211232|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
139211233|NCT01217931|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139211234|NCT01217931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139211235|NCT01217931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211236|NCT01217931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211237|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139211238|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
139211239|NCT01192568|Oxybutynin|oxybutynin|mesh-list
139211240|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
139211241|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
139211242|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211243|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211244|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139211245|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139211246|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
139211247|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211248|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211250|NCT01174121|Aldesleukin|aldesleukin|mesh-list
139211251|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
139211252|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
139211253|NCT01174121|Fludarabine|fludarabine|mesh-list
139211254|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139211255|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
139211256|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211257|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211258|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139211259|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
139211260|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211261|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211262|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139211263|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139211264|NCT01174121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139211265|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139211266|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139211267|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
139211268|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139211269|NCT00936936|Carboplatin|carboplatin|mesh-list
139211270|NCT00936936|Gemcitabine|gemcitabine|mesh-list
139211271|NCT00936936|Docetaxel|docetaxel|mesh-list
139211272|NCT00936936|Etoposide|etoposide|mesh-list
139211273|NCT00936936|Melphalan|melphalan|mesh-list
139211274|NCT00936936|Ifosfamide|ifosfamide|mesh-list
139211275|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211276|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139211277|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
139211278|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211279|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
139211280|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
139211281|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
139211282|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139211283|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139211284|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139211285|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211286|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139211287|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
139211288|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139211289|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139211290|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
139211291|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211292|NCT00680901|Capecitabine|capecitabine|mesh-list
139211293|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
139211294|NCT00680901|Lapatinib|lapatinib|mesh-list
139211295|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139211296|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
139211297|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211298|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211299|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139211300|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211301|NCT00601900|Tamoxifen|tamoxifen|mesh-list
139211302|NCT00601900|Bevacizumab|bevacizumab|mesh-list
139211303|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139211304|NCT00601900|Letrozole|letrozole|mesh-list
139211305|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
139211306|NCT00601900|Antibodies|antibodies|mesh-list
139211307|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
139211308|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139211309|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
139211310|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211311|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139211312|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139211313|NCT00601900|Growth Substances|growth substances|mesh-ancestor
139211314|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211315|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
139211316|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
139211317|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211318|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139211319|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139211320|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211321|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139211322|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
139211323|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139642112|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138999783|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
139211324|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139211325|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139211326|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139211327|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139211328|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
139211329|NCT00557193|Leucovorin|leucovorin|mesh-list
139211330|NCT00557193|Folic Acid|folic acid|mesh-list
139211331|NCT00557193|Cytarabine|cytarabine|mesh-list
139211332|NCT00557193|Dexamethasone|dexamethasone|mesh-list
139211333|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
139211334|NCT00557193|Prednisone|prednisone|mesh-list
139211335|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
139211336|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139211337|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139211338|NCT00557193|Prednisolone|prednisolone|mesh-list
139211339|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
139211340|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
139211341|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139211342|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139211343|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139211344|NCT00557193|Cortisone|cortisone|mesh-list
139211345|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
139211346|NCT00557193|Methotrexate|methotrexate|mesh-list
139211347|NCT00557193|Etoposide|etoposide|mesh-list
139211348|NCT00557193|Vincristine|vincristine|mesh-list
139211349|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
139211350|NCT00557193|Daunorubicin|daunorubicin|mesh-list
139211351|NCT00557193|Asparaginase|asparaginase|mesh-list
139211352|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
139211353|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
139211354|NCT00557193|Pegaspargase|pegaspargase|mesh-list
139211355|NCT00557193|Lenograstim|lenograstim|mesh-list
139211356|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139211357|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
139211358|NCT00557193|BB 1101|bb 1101|mesh-list
139211359|NCT00557193|Calcium|calcium|mesh-list
139211360|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
139211361|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139211362|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
139211363|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211364|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211365|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139211366|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
139211367|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211368|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211369|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139211370|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139211371|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
139211372|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
139211373|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211374|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139211375|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
139211376|NCT00557193|Hormones|hormones|mesh-ancestor
139211377|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139211378|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139211379|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
139211380|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211381|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139211382|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139211383|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139211384|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
139211385|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139211386|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139211387|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
139211388|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
139211389|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139211390|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139211391|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139211392|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139211393|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139211394|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
139211395|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139211396|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139211397|NCT00557193|Antidotes|antidotes|mesh-ancestor
139211398|NCT00557193|Protective Agents|protective agents|mesh-ancestor
139211399|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
139211400|NCT00557193|Vitamins|vitamins|mesh-ancestor
139211401|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
139211402|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
139211403|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
139211404|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
139211405|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139211406|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139211407|NCT00557193|Hematinics|hematinics|mesh-ancestor
139211408|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
139211409|NCT00516724|Paclitaxel|paclitaxel|mesh-list
139211410|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139211411|NCT00516724|Carboplatin|carboplatin|mesh-list
139211412|NCT00516724|Olaparib|olaparib|mesh-list
139211413|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139211414|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139211415|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211416|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
139211417|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
139211418|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
139211419|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211420|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211421|NCT00390793|Cytarabine|cytarabine|mesh-list
139211422|NCT00390793|Dexamethasone|dexamethasone|mesh-list
139211423|NCT00390793|Prednisone|prednisone|mesh-list
139211424|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
139211425|NCT00390793|Cortisone|cortisone|mesh-list
139211426|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
139211427|NCT00390793|Doxorubicin|doxorubicin|mesh-list
139211428|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139211429|NCT00390793|Methotrexate|methotrexate|mesh-list
139211430|NCT00390793|Vincristine|vincristine|mesh-list
139211431|NCT00390793|Daunorubicin|daunorubicin|mesh-list
139211432|NCT00390793|Dasatinib|dasatinib|mesh-list
139211433|NCT00390793|BB 1101|bb 1101|mesh-list
139211434|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139211435|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
139211436|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211437|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211438|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139211439|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
139211440|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211441|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211442|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139211443|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139211444|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
139211445|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
139211446|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211447|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139211448|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
139211449|NCT00390793|Hormones|hormones|mesh-ancestor
139211450|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139211451|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139211452|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139211453|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139211454|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139211455|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211456|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139211457|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
139211458|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139211459|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139211460|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
139211461|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
139211462|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139211463|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139211464|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
139211465|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139211466|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139211467|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
139211468|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
139211469|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
139211470|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139211471|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
139211472|NCT00364637|Anesthetics|anesthetics|mesh-list
139211473|NCT00364637|Sevoflurane|sevoflurane|mesh-list
139211474|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211475|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168100|NCT04625972|Antiviral Agents|antiviral agents|mesh-ancestor
139211476|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139211477|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139211478|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
139211514|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139211515|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211516|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139211517|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
139211518|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
139211519|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
139211520|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139211521|NCT03078192|Xenon|xenon|mesh-list
139211522|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139211523|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
139211524|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
139211525|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211526|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211527|NCT00703846|Ketoconazole|ketoconazole|mesh-list
139211528|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
139211529|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139211530|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139211531|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139211532|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211533|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211534|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139211535|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
139211536|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139211537|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211538|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139211539|NCT03309436|Clomiphene|clomiphene|mesh-list
139211540|NCT03309436|Enclomiphene|enclomiphene|mesh-list
139211541|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
139211542|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139211543|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
139211544|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139211545|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211546|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139211547|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
139211548|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139211549|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139211550|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139211551|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
139642113|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
139168168|NCT04478279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211553|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
139211554|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139211555|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139211556|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211557|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211558|NCT05183334|Urological Agents|urological agents|mesh-ancestor
139211559|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139211561|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211562|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211563|NCT05183334|Analgesics|analgesics|mesh-ancestor
139211564|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
139211565|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211566|NCT06065371|Capecitabine|capecitabine|mesh-list
139211567|NCT06065371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139211568|NCT06065371|Antimetabolites|antimetabolites|mesh-ancestor
139211569|NCT06065371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211570|NCT06065371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211571|NCT06065267|Amoxicillin|amoxicillin|mesh-list
139211572|NCT06065267|Metronidazole|metronidazole|mesh-list
139211573|NCT06065267|Levofloxacin|levofloxacin|mesh-list
139211574|NCT06065267|Esomeprazole|esomeprazole|mesh-list
139211575|NCT06065267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139211576|NCT06065267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139211577|NCT06065267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139211578|NCT06065267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139211579|NCT06065267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139211580|NCT06065267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139211581|NCT06065267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139211582|NCT06065267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211583|NCT06065267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211584|NCT06065267|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139211585|NCT06065267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139211586|NCT06065267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139211587|NCT06065267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211588|NCT06065267|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139211589|NCT06065267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139211590|NCT06065137|Midazolam|midazolam|mesh-list
139211591|NCT06065137|Fentanyl|fentanyl|mesh-list
139211592|NCT06065137|Sufentanil|sufentanil|mesh-list
139211593|NCT06065137|Ketamine|ketamine|mesh-list
139211594|NCT06065137|Remifentanil|remifentanil|mesh-list
139211595|NCT06065137|Alfentanil|alfentanil|mesh-list
139211596|NCT06065137|Propofol|propofol|mesh-list
139211597|NCT06065137|Etomidate|etomidate|mesh-list
139211598|NCT06065137|Atracurium|atracurium|mesh-list
139211599|NCT06065137|Rocuronium|rocuronium|mesh-list
139211600|NCT06065137|Cisatracurium|cisatracurium|mesh-list
139211601|NCT06065137|Succinylcholine|succinylcholine|mesh-list
139211602|NCT06065137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139211603|NCT06065137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211604|NCT06065137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211605|NCT06065137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139211606|NCT06065137|Anesthetics, General|anesthetics, general|mesh-ancestor
139211607|NCT06065137|Anesthetics|anesthetics|mesh-ancestor
139211608|NCT06065137|Analgesics|analgesics|mesh-ancestor
139211609|NCT06065137|Sensory System Agents|sensory system agents|mesh-ancestor
139211610|NCT06065137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211611|NCT06065137|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139211612|NCT06065137|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139211613|NCT06065137|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139211614|NCT06065137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211615|NCT06065137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211616|NCT06065137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139211617|NCT06065137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139211618|NCT06065137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139211619|NCT06065137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139211620|NCT06065137|GABA Modulators|gaba modulators|mesh-ancestor
139211621|NCT06065137|GABA Agents|gaba agents|mesh-ancestor
139211622|NCT06065137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139211623|NCT06065137|Narcotics|narcotics|mesh-ancestor
139211624|NCT06065137|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139211625|NCT06065137|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139211626|NCT06065137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139211627|NCT06065137|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139211628|NCT06065137|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139211629|NCT06065137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139211630|NCT06065137|Cholinergic Agents|cholinergic agents|mesh-ancestor
139211631|NCT06064669|Metformin|metformin|mesh-list
139211632|NCT06064669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139211633|NCT06064669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211634|NCT06064539|Rifampin|rifampin|mesh-list
139211635|NCT06064539|Gemfibrozil|gemfibrozil|mesh-list
139211636|NCT06064539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139211637|NCT06064539|Antitubercular Agents|antitubercular agents|mesh-ancestor
139211638|NCT06064539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139211639|NCT06064539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139211640|NCT06064539|Leprostatic Agents|leprostatic agents|mesh-ancestor
139211641|NCT06064539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139211642|NCT06064539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211643|NCT06064539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211644|NCT06064539|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139211645|NCT06064539|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139211646|NCT06064539|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139211647|NCT06064539|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139211648|NCT06064539|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139211649|NCT06064539|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139211650|NCT06064539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139211651|NCT06064539|Antimetabolites|antimetabolites|mesh-ancestor
139211652|NCT06064539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139211653|NCT06064539|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139211654|NCT06064539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139211655|NCT06064344|Rituximab|rituximab|mesh-list
139211656|NCT06064344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139211657|NCT06064344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211658|NCT06064344|Immunologic Factors|immunologic factors|mesh-ancestor
139211659|NCT06064344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211660|NCT06064344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211661|NCT06064331|Lidocaine|lidocaine|mesh-list
139211662|NCT06064331|Anesthetics, Local|anesthetics, local|mesh-ancestor
139211663|NCT06064331|Anesthetics|anesthetics|mesh-ancestor
139211664|NCT06064331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211665|NCT06064331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211666|NCT06064331|Sensory System Agents|sensory system agents|mesh-ancestor
139211667|NCT06064331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211668|NCT06064331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139211669|NCT06064331|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139211670|NCT06064331|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139211671|NCT06064331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139211672|NCT06064331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211673|NCT06064279|Poly ICLC|poly iclc|mesh-list
139211674|NCT06064279|Interferon Inducers|interferon inducers|mesh-ancestor
139211675|NCT06064279|Immunologic Factors|immunologic factors|mesh-ancestor
139211676|NCT06064279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211677|NCT06064175|Ibuprofen|ibuprofen|mesh-list
139211678|NCT06064175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139211679|NCT06064175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139211680|NCT06064175|Analgesics|analgesics|mesh-ancestor
139211681|NCT06064175|Sensory System Agents|sensory system agents|mesh-ancestor
139211682|NCT06064175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211683|NCT06064175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211684|NCT06064175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139211685|NCT06064175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211686|NCT06064175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139211687|NCT06064175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211688|NCT06064175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211689|NCT06064162|Ketamine|ketamine|mesh-list
139211690|NCT06064162|Analgesics|analgesics|mesh-ancestor
139211691|NCT06064162|Sensory System Agents|sensory system agents|mesh-ancestor
139211692|NCT06064162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211693|NCT06064162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211694|NCT06064162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139211695|NCT06064162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139211696|NCT06064162|Anesthetics, General|anesthetics, general|mesh-ancestor
139211697|NCT06064162|Anesthetics|anesthetics|mesh-ancestor
139211698|NCT06064162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211699|NCT06064162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139211700|NCT06064162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139642114|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211701|NCT06064162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139168316|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139211702|NCT06064162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211703|NCT06063798|Anesthetics|anesthetics|mesh-list
139211704|NCT06063798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211705|NCT06063798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211706|NCT06063772|Clevidipine|clevidipine|mesh-list
139211707|NCT06063772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139211708|NCT06063772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139211709|NCT06063772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211710|NCT06063772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139211711|NCT06063772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211712|NCT06062134|Ropivacaine|ropivacaine|mesh-list
139211713|NCT06062134|Anesthetics, Local|anesthetics, local|mesh-ancestor
139211714|NCT06062134|Anesthetics|anesthetics|mesh-ancestor
139211715|NCT06062134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211716|NCT06062134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211717|NCT06062134|Sensory System Agents|sensory system agents|mesh-ancestor
139211718|NCT06062134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211719|NCT06059911|Caffeine|caffeine|mesh-list
139211720|NCT06059911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139211721|NCT06059911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211722|NCT06059911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139211723|NCT06059911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211724|NCT06059911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211725|NCT06059911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139211726|NCT06059911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139211727|NCT06059911|Purinergic Agents|purinergic agents|mesh-ancestor
139211728|NCT06059911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211729|NCT06059339|Analgesics, Opioid|analgesics, opioid|mesh-list
139211730|NCT06059339|Narcotics|narcotics|mesh-ancestor
139211731|NCT06059339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211732|NCT06059339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211733|NCT06059339|Analgesics|analgesics|mesh-ancestor
139211734|NCT06059339|Sensory System Agents|sensory system agents|mesh-ancestor
139211735|NCT06059339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211736|NCT06055894|Curcumin|curcumin|mesh-list
139211737|NCT06055894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139211738|NCT06055894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139211739|NCT06055894|Analgesics|analgesics|mesh-ancestor
139211740|NCT06055894|Sensory System Agents|sensory system agents|mesh-ancestor
139211741|NCT06055894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211742|NCT06055894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211743|NCT06055894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139211744|NCT06055894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211745|NCT06055894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211746|NCT06055894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211747|NCT06055894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211748|NCT06041932|Carvedilol|carvedilol|mesh-list
139211749|NCT06041932|Pentoxifylline|pentoxifylline|mesh-list
139211750|NCT06041932|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139211751|NCT06041932|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139211752|NCT06041932|Adrenergic Agents|adrenergic agents|mesh-ancestor
139211753|NCT06041932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211754|NCT06041932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211755|NCT06041932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211756|NCT06041932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139211757|NCT06041932|Antioxidants|antioxidants|mesh-ancestor
139211758|NCT06041932|Protective Agents|protective agents|mesh-ancestor
139211759|NCT06041932|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139211760|NCT06041932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139211761|NCT06041932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139211762|NCT06041932|Vasodilator Agents|vasodilator agents|mesh-ancestor
139211763|NCT06041932|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139211764|NCT06041932|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139211765|NCT06041932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139211766|NCT06041932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211767|NCT06041932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139211768|NCT06041932|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139211769|NCT06041932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139211770|NCT06040424|Albuterol|albuterol|mesh-list
139211771|NCT06040424|Ipratropium|ipratropium|mesh-list
139211772|NCT06040424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139211773|NCT06040424|Autonomic Agents|autonomic agents|mesh-ancestor
139211774|NCT06040424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211775|NCT06040424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211776|NCT06040424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139211777|NCT06040424|Respiratory System Agents|respiratory system agents|mesh-ancestor
139211778|NCT06040424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139211779|NCT06040424|Cholinergic Agents|cholinergic agents|mesh-ancestor
139211780|NCT06040424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211781|NCT06040424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211782|NCT06040424|Tocolytic Agents|tocolytic agents|mesh-ancestor
139211783|NCT06040424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139211784|NCT06040424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139211785|NCT06040424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139211786|NCT06040424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139211787|NCT06040424|Adrenergic Agents|adrenergic agents|mesh-ancestor
139211788|NCT06036823|Insulin|insulin|mesh-list
139211789|NCT06036823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139211790|NCT06036823|Albuterol|albuterol|mesh-list
139211791|NCT06036823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139211792|NCT06036823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211793|NCT06036823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139211794|NCT06036823|Autonomic Agents|autonomic agents|mesh-ancestor
139211795|NCT06036823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211796|NCT06036823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139211797|NCT06036823|Respiratory System Agents|respiratory system agents|mesh-ancestor
139211798|NCT06036823|Tocolytic Agents|tocolytic agents|mesh-ancestor
139211799|NCT06036823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139211800|NCT06036823|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139211801|NCT06036823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139211802|NCT06036823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139211803|NCT06036823|Adrenergic Agents|adrenergic agents|mesh-ancestor
139211804|NCT06036823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211805|NCT06036823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211806|NCT06021990|Clopidogrel|clopidogrel|mesh-list
139211807|NCT06021990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139211808|NCT06021990|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139211809|NCT06021990|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139211810|NCT06021990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139211811|NCT06021990|Purinergic Agents|purinergic agents|mesh-ancestor
139211812|NCT06021990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211813|NCT06021990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211814|NCT06021990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211815|NCT06007378|Fentanyl|fentanyl|mesh-list
139211816|NCT06007378|Ketamine|ketamine|mesh-list
139211817|NCT06007378|Bupivacaine|bupivacaine|mesh-list
139211818|NCT06007378|Anesthetics, Local|anesthetics, local|mesh-ancestor
139211819|NCT06007378|Anesthetics|anesthetics|mesh-ancestor
139211820|NCT06007378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211821|NCT06007378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211822|NCT06007378|Sensory System Agents|sensory system agents|mesh-ancestor
139211823|NCT06007378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211824|NCT06007378|Analgesics|analgesics|mesh-ancestor
139211825|NCT06007378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139211826|NCT06007378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139211827|NCT06007378|Anesthetics, General|anesthetics, general|mesh-ancestor
139211828|NCT06007378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139211829|NCT06007378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139211830|NCT06007378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211831|NCT06007378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211832|NCT06007378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139211833|NCT06007378|Narcotics|narcotics|mesh-ancestor
139211834|NCT06007378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139211835|NCT05937776|Deoxyglucose|deoxyglucose|mesh-list
139211836|NCT05937776|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139211837|NCT05937776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139211838|NCT05937776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139211839|NCT05937776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211840|NCT05937776|Antimetabolites|antimetabolites|mesh-ancestor
139211841|NCT05937776|Antiviral Agents|antiviral agents|mesh-ancestor
139211842|NCT05937776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139211843|NCT05937776|Chelating Agents|chelating agents|mesh-ancestor
139211844|NCT05937776|Sequestering Agents|sequestering agents|mesh-ancestor
139211845|NCT05907993|Ibuprofen|ibuprofen|mesh-list
139211846|NCT05907993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139211847|NCT05907993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139211849|NCT05907993|Sensory System Agents|sensory system agents|mesh-ancestor
139211850|NCT05907993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211851|NCT05907993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211852|NCT05907993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139211853|NCT05907993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211854|NCT05907993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139211855|NCT05907993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211856|NCT05907993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211857|NCT05902754|Sulforaphane|sulforaphane|mesh-list
139211858|NCT05902754|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139211859|NCT05902754|Protective Agents|protective agents|mesh-ancestor
139211860|NCT05902754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211861|NCT05902754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211862|NCT05890898|Nitrous Oxide|nitrous oxide|mesh-list
139211863|NCT05890898|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139211864|NCT05890898|Anesthetics, General|anesthetics, general|mesh-ancestor
139211865|NCT05890898|Anesthetics|anesthetics|mesh-ancestor
139211866|NCT05890898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211867|NCT05890898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211868|NCT05890898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139211869|NCT05890898|Analgesics|analgesics|mesh-ancestor
139211870|NCT05890898|Sensory System Agents|sensory system agents|mesh-ancestor
139211871|NCT05890898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211872|NCT05875948|Terlipressin|terlipressin|mesh-list
139211873|NCT05875948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139211874|NCT05875948|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139211875|NCT05855967|Ixekizumab|ixekizumab|mesh-list
139211876|NCT05855967|Dermatologic Agents|dermatologic agents|mesh-ancestor
139211877|NCT05854966|Metformin|metformin|mesh-list
139211878|NCT05854966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139211879|NCT05854966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211880|NCT05852041|Fluorides|fluorides|mesh-list
139211881|NCT05852041|Cariostatic Agents|cariostatic agents|mesh-ancestor
139211882|NCT05852041|Protective Agents|protective agents|mesh-ancestor
139211883|NCT05852041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211884|NCT05735717|Rituximab|rituximab|mesh-list
139211885|NCT05735717|Fludarabine|fludarabine|mesh-list
139211886|NCT05735717|Melphalan|melphalan|mesh-list
139211887|NCT05735717|Busulfan|busulfan|mesh-list
139211888|NCT05735717|Levetiracetam|levetiracetam|mesh-list
139211889|NCT05735717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139211890|NCT05735717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211891|NCT05735717|Immunologic Factors|immunologic factors|mesh-ancestor
139211892|NCT05735717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211893|NCT05735717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139211894|NCT05735717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211895|NCT05735717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139211896|NCT05735717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139211897|NCT05735717|Alkylating Agents|alkylating agents|mesh-ancestor
139211898|NCT05735717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139211899|NCT05735717|Anticonvulsants|anticonvulsants|mesh-ancestor
139211900|NCT05735717|Nootropic Agents|nootropic agents|mesh-ancestor
139211901|NCT05723276|Psilocybin|psilocybin|mesh-list
139211902|NCT05723276|Hallucinogens|hallucinogens|mesh-ancestor
139211903|NCT05723276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211904|NCT05723276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139211905|NCT05681195|Pemetrexed|pemetrexed|mesh-list
139211906|NCT05681195|Zanubrutinib|zanubrutinib|mesh-list
139211907|NCT05681195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211908|NCT05681195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139211909|NCT05681195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211910|NCT05681195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139211911|NCT05681195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139211912|NCT05681195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139211913|NCT05671081|Magnesium Sulfate|magnesium sulfate|mesh-list
139211914|NCT05671081|Dexmedetomidine|dexmedetomidine|mesh-list
139211915|NCT05671081|Analgesics|analgesics|mesh-list
139211916|NCT05671081|Narcotics|narcotics|mesh-list
139211917|NCT05671081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139211918|NCT05671081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211919|NCT05671081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642115|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139211920|NCT05671081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139211921|NCT05671081|Sensory System Agents|sensory system agents|mesh-ancestor
139211922|NCT05671081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211923|NCT05671081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139211924|NCT05671081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139211925|NCT05671081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139211926|NCT05671081|Adrenergic Agents|adrenergic agents|mesh-ancestor
139211927|NCT05671081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211928|NCT05671081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211929|NCT05671081|Anesthetics|anesthetics|mesh-ancestor
139211930|NCT05671081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139211931|NCT05671081|Anticonvulsants|anticonvulsants|mesh-ancestor
139211932|NCT05671081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139211933|NCT05671081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139211934|NCT05671081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139211935|NCT05671081|Tocolytic Agents|tocolytic agents|mesh-ancestor
139211936|NCT05671081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139211937|NCT05641623|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|mesh-list
139211938|NCT05641623|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139211939|NCT05641623|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139211940|NCT05641623|Dopamine Agents|dopamine agents|mesh-ancestor
139211941|NCT05641623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139211942|NCT05641623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211943|NCT05641623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211944|NCT05635201|Anesthetics|anesthetics|mesh-list
139211945|NCT05635201|Propofol|propofol|mesh-list
139211946|NCT05635201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139211947|NCT05635201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211948|NCT05635201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139211949|NCT05635201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139211950|NCT05635201|Anesthetics, General|anesthetics, general|mesh-ancestor
139211951|NCT05613777|BI 425809|bi 425809|mesh-list
139211952|NCT05613777|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139211953|NCT05613777|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
139211954|NCT05613777|Nootropic Agents|nootropic agents|mesh-ancestor
139211955|NCT05613777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139211956|NCT05613777|Contraceptive Agents|contraceptive agents|mesh-ancestor
139211957|NCT05613777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139211958|NCT05613777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211959|NCT05613777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139211960|NCT05613777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139211961|NCT05613777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139211962|NCT05613777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139211963|NCT05613777|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139211964|NCT05613777|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
139211965|NCT05613777|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139000241|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211966|NCT05613777|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139211967|NCT05561725|Dexamethasone|dexamethasone|mesh-list
139211968|NCT05561725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139211969|NCT05561725|Antiemetics|antiemetics|mesh-ancestor
139211970|NCT05561725|Autonomic Agents|autonomic agents|mesh-ancestor
139211971|NCT05561725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139211972|NCT05561725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211973|NCT05561725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139211974|NCT05561725|Glucocorticoids|glucocorticoids|mesh-ancestor
139211975|NCT05561725|Hormones|hormones|mesh-ancestor
139211976|NCT05561725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139211977|NCT05561725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139211978|NCT05561725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139211979|NCT05506969|Vaccines|vaccines|mesh-list
139211980|NCT05506969|1018 oligonucleotide|1018 oligonucleotide|mesh-list
139211981|NCT05506969|Immunologic Factors|immunologic factors|mesh-ancestor
139211982|NCT05506969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211983|NCT05506969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139211984|NCT05501483|Pioglitazone|pioglitazone|mesh-list
139211985|NCT05501483|Empagliflozin|empagliflozin|mesh-list
139211986|NCT05501483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139211987|NCT05501483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211988|NCT05501483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139211989|NCT05501483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139211990|NCT05500599|Midazolam|midazolam|mesh-list
139211991|NCT05500599|Fentanyl|fentanyl|mesh-list
139211992|NCT05500599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139211993|NCT05500599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139211994|NCT05500599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642116|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
139211995|NCT05500599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139211996|NCT05500599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139211997|NCT05500599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139212004|NCT05500599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139212005|NCT05500599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212006|NCT05500599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139212008|NCT05500599|Analgesics|analgesics|mesh-ancestor
139212009|NCT05500599|Sensory System Agents|sensory system agents|mesh-ancestor
139212010|NCT05500599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212011|NCT05475431|Bismuth|bismuth|mesh-list
139212012|NCT05475431|Antacids|antacids|mesh-ancestor
139212013|NCT05475431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212014|NCT05475431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139212015|NCT05456269|Cytarabine|cytarabine|mesh-list
139212016|NCT05456269|Decitabine|decitabine|mesh-list
139212017|NCT05456269|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139212018|NCT05456269|Bisantrene|bisantrene|mesh-list
139212019|NCT05456269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139212020|NCT05456269|Antimetabolites|antimetabolites|mesh-ancestor
139212021|NCT05456269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212022|NCT05456269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212023|NCT05456269|Antiviral Agents|antiviral agents|mesh-ancestor
139212024|NCT05456269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139212025|NCT05456269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212026|NCT05456269|Immunologic Factors|immunologic factors|mesh-ancestor
139212027|NCT05456269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212028|NCT05456269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212029|NCT05456269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139212030|NCT05451173|Durvalumab|durvalumab|mesh-list
139212031|NCT05451173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212032|NCT05451173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212033|NCT05449392|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
139212034|NCT05449392|Petrolatum|petrolatum|mesh-list
139212035|NCT05449392|Emollients|emollients|mesh-ancestor
139212036|NCT05449392|Dermatologic Agents|dermatologic agents|mesh-ancestor
139212037|NCT05449392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139212038|NCT05449392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139212039|NCT05449392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139212040|NCT05449327|Rivaroxaban|rivaroxaban|mesh-list
139212041|NCT05449327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139212042|NCT05449327|Antithrombins|antithrombins|mesh-ancestor
139212043|NCT05449327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139212044|NCT05449327|Protease Inhibitors|protease inhibitors|mesh-ancestor
139212045|NCT05449327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212046|NCT05449327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212047|NCT05449327|Anticoagulants|anticoagulants|mesh-ancestor
139212048|NCT05411237|Paclitaxel|paclitaxel|mesh-list
139212049|NCT05411237|Doxorubicin|doxorubicin|mesh-list
139212050|NCT05411237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139212051|NCT05411237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139212052|NCT05411237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212053|NCT05411237|Tubulin Modulators|tubulin modulators|mesh-ancestor
139212054|NCT05411237|Antimitotic Agents|antimitotic agents|mesh-ancestor
139212055|NCT05411237|Mitosis Modulators|mitosis modulators|mesh-ancestor
139000275|NCT05360394|Paclitaxel|paclitaxel|mesh-list
139212056|NCT05411237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212057|NCT05411237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139212058|NCT05411237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139212059|NCT05411237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139212060|NCT05411237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212066|NCT05374291|Dapagliflozin|dapagliflozin|mesh-list
139212067|NCT05374291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139212068|NCT05374291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212069|NCT05374291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139212070|NCT05374291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212071|NCT05360732|Folfirinox|folfirinox|mesh-list
139212072|NCT05360732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212073|NCT05320757|Olaparib|olaparib|mesh-list
139212074|NCT05320757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139212075|NCT05320757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212076|NCT05320757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212077|NCT05320757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212078|NCT05267470|Paclitaxel|paclitaxel|mesh-list
139212079|NCT05267470|Docetaxel|docetaxel|mesh-list
139212080|NCT05267470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139212085|NCT05267470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212086|NCT05267470|Tubulin Modulators|tubulin modulators|mesh-ancestor
139212087|NCT05267470|Antimitotic Agents|antimitotic agents|mesh-ancestor
139212088|NCT05267470|Mitosis Modulators|mitosis modulators|mesh-ancestor
139212089|NCT05267470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212090|NCT05267470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212091|NCT05267470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139212093|NCT05257655|Narcotics|narcotics|mesh-ancestor
139212094|NCT05257655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139212095|NCT05257655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212096|NCT05257655|Analgesics|analgesics|mesh-ancestor
139212097|NCT05257655|Sensory System Agents|sensory system agents|mesh-ancestor
139212098|NCT05257655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212103|NCT05218733|Fentanyl|fentanyl|mesh-list
139212104|NCT05218733|Morphine|morphine|mesh-list
139212105|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
139212106|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139212107|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212108|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139212109|NCT05218733|Narcotics|narcotics|mesh-ancestor
139212110|NCT05218733|Analgesics|analgesics|mesh-ancestor
139212111|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
139212112|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212113|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139212114|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139212115|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
139212116|NCT05197192|Venetoclax|venetoclax|mesh-list
139212117|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
139212118|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
139212119|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212120|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212121|NCT05190094|Letrozole|letrozole|mesh-list
139212122|NCT05190094|Palbociclib|palbociclib|mesh-list
139212123|NCT05190094|Anastrozole|anastrozole|mesh-list
139212124|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139212125|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212126|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139212127|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212128|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212129|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139212130|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
139212131|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139212132|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212133|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139212134|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139212135|NCT05147220|Teriflunomide|teriflunomide|mesh-list
139212136|NCT05147220|Remibrutinib|remibrutinib|mesh-list
139212137|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139212138|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139212139|NCT05147220|Analgesics|analgesics|mesh-ancestor
139212140|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
139212141|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212142|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212143|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139212144|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139212145|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212146|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
139212147|NCT05147220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139212148|NCT05147220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212149|NCT05147220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212150|NCT05064449|Itraconazole|itraconazole|mesh-list
139212151|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
139212152|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
139212153|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139212154|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139212155|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139212156|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212157|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212158|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139212159|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
139212160|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139212161|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212162|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139212163|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139212164|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139212165|NCT05064449|Analgesics|analgesics|mesh-ancestor
139212166|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
139212167|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212168|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139212169|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139212170|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139212171|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
139212172|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212173|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212174|NCT05059470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139212175|NCT05059470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212176|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
139212177|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139212178|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
139212179|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139212180|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
139212181|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212182|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212183|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
139212184|NCT05020522|Phenobarbital|phenobarbital|mesh-list
139212185|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
139212186|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139212187|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139212188|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212189|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139212190|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139212191|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139212192|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212193|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
139212194|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
139212195|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139212196|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139212197|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139212198|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139212199|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139212200|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139212201|NCT04997811|Valproic Acid|valproic acid|mesh-list
139212202|NCT04997811|Bezafibrate|bezafibrate|mesh-list
139212203|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
139212204|NCT04997811|Danazol|danazol|mesh-list
139212205|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
139212206|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212207|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212208|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
139212209|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139212210|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212211|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
139212212|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139212213|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139212214|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139212215|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139212216|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139212217|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139212218|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
139212219|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139212220|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139212221|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139212222|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139212223|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139212224|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212225|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139212226|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
139212227|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139212228|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139212229|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
139212230|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139212231|NCT04970069|Analgesics|analgesics|mesh-list
139212232|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
139212233|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212234|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212235|NCT04969276|Vaccines|vaccines|mesh-list
139212236|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
139212237|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212238|NCT04969224|Ivacaftor|ivacaftor|mesh-list
139212239|NCT04969224|Elexacaftor|elexacaftor|mesh-list
139212240|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139212241|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139212242|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212243|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
139212244|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139212245|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139212246|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
139212247|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
139212248|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212249|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212250|NCT04881799|Topiramate|topiramate|mesh-list
139212251|NCT04881799|Phentermine|phentermine|mesh-list
139212252|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
139212253|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139212254|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212255|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139212256|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
139212257|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139212258|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
139212259|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
139212260|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212261|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
139212262|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139212263|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212264|NCT04856215|Antibodies|antibodies|mesh-list
139212265|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139212266|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
139212267|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212268|NCT04821284|Leucovorin|leucovorin|mesh-list
139212269|NCT04821284|Paclitaxel|paclitaxel|mesh-list
139212270|NCT04821284|Gemcitabine|gemcitabine|mesh-list
139212271|NCT04821284|Fluorouracil|fluorouracil|mesh-list
139212272|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
139212273|NCT04821284|Irinotecan|irinotecan|mesh-list
139212274|NCT04821284|Calcium|calcium|mesh-list
139212275|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
139212276|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139212277|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212278|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
139212279|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
139212280|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
139212281|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212282|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139212283|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
139212284|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139212285|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212286|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212287|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
139212288|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139212289|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139212290|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212291|NCT04821284|Antidotes|antidotes|mesh-ancestor
139212292|NCT04821284|Protective Agents|protective agents|mesh-ancestor
139212293|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
139212294|NCT04821284|Vitamins|vitamins|mesh-ancestor
139212295|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
139212296|NCT04818632|Everolimus|everolimus|mesh-list
139212297|NCT04818632|Palbociclib|palbociclib|mesh-list
139168934|NCT00098475|Thalidomide|thalidomide|mesh-list
139212298|NCT04818632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139212299|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139212300|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212301|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642117|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212303|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
139212304|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212305|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212306|NCT04790045|Venetoclax|venetoclax|mesh-list
139212307|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212308|NCT04779216|Alendronate|alendronate|mesh-list
138495032|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
139212309|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139212310|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212311|NCT04754035|Venetoclax|venetoclax|mesh-list
139212312|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212313|NCT04748419|Durvalumab|durvalumab|mesh-list
139212314|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212315|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212316|NCT04728633|Carmustine|carmustine|mesh-list
139212317|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
139212318|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139212319|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
139212320|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212321|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212322|NCT04680923|Bupivacaine|bupivacaine|mesh-list
139212323|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
139212324|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
139212325|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139212326|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212327|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
139212328|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212329|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139212330|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139212331|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212332|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212333|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
139212334|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212335|NCT04646005|Cemiplimab|cemiplimab|mesh-list
139212336|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212337|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212338|NCT04617535|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
139212339|NCT04617535|Antiviral Agents|antiviral agents|mesh-ancestor
139212340|NCT04617535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139212341|NCT04591431|Nivolumab|nivolumab|mesh-list
139212342|NCT04591431|Trastuzumab|trastuzumab|mesh-list
139212343|NCT04591431|Ipilimumab|ipilimumab|mesh-list
139212344|NCT04591431|Atezolizumab|atezolizumab|mesh-list
139212345|NCT04591431|Pertuzumab|pertuzumab|mesh-list
139212346|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139212347|NCT04591431|Everolimus|everolimus|mesh-list
139212348|NCT04591431|Palbociclib|palbociclib|mesh-list
139212349|NCT04591431|Lapatinib|lapatinib|mesh-list
139212350|NCT04591431|Vemurafenib|vemurafenib|mesh-list
139212351|NCT04591431|Maytansine|maytansine|mesh-list
139212352|NCT04591431|Talazoparib|talazoparib|mesh-list
139212353|NCT04591431|Ponatinib|ponatinib|mesh-list
139212354|NCT04591431|Ipatasertib|ipatasertib|mesh-list
139212355|NCT04591431|Tepotinib|tepotinib|mesh-list
139212356|NCT04591431|Pralsetinib|pralsetinib|mesh-list
139212357|NCT04591431|Entrectinib|entrectinib|mesh-list
139212358|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212359|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212360|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139212361|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212362|NCT04591431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139212363|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139212364|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212365|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212366|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
139212367|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212368|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139212369|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
139212370|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
139212371|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
139212372|NCT04591431|Immunotoxins|immunotoxins|mesh-ancestor
139212373|NCT04591431|Immunoconjugates|immunoconjugates|mesh-ancestor
139212374|NCT04591431|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139212375|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
139212376|NCT04588311|Hematinics|hematinics|mesh-ancestor
139212377|NCT04551677|Vaccines|vaccines|mesh-list
139212378|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
139212379|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212380|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
139212381|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
139642118|NCT04961970|Antidotes|antidotes|mesh-ancestor
139212382|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212383|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212384|NCT04546074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139212385|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212386|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139212387|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212389|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139212390|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
139212391|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
139212392|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212393|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139212394|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
139212395|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212396|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212397|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139212398|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212399|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
139212400|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139212401|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
139212402|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212403|NCT04498832|Vaccines|vaccines|mesh-list
139212404|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
139212405|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212406|NCT04490018|Vaccines|vaccines|mesh-list
139212407|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
139212408|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212409|NCT04481204|Leucovorin|leucovorin|mesh-list
139212410|NCT04481204|Paclitaxel|paclitaxel|mesh-list
139212411|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139212412|NCT04481204|Cisplatin|cisplatin|mesh-list
139212413|NCT04481204|Gemcitabine|gemcitabine|mesh-list
139212414|NCT04481204|Fluorouracil|fluorouracil|mesh-list
139212415|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
139212416|NCT04481204|Irinotecan|irinotecan|mesh-list
139212417|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139212418|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212419|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
139212420|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
139212421|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
139212422|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212423|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139212424|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
139212425|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212426|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
139212427|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212428|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139212429|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139212430|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212431|NCT04481204|Antidotes|antidotes|mesh-ancestor
139212432|NCT04481204|Protective Agents|protective agents|mesh-ancestor
139212433|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
139212434|NCT04481204|Vitamins|vitamins|mesh-ancestor
139212435|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
139212436|NCT04455139|Melphalan|melphalan|mesh-list
139212437|NCT04455139|Topotecan|topotecan|mesh-list
139212438|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139212439|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
139212440|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212441|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212442|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139212443|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212444|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
139212445|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212446|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139212447|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139212448|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212449|NCT04389632|Carboplatin|carboplatin|mesh-list
139212450|NCT04389632|Pembrolizumab|pembrolizumab|mesh-list
139212451|NCT04389632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212452|NCT04389632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139169088|NCT01132027|Tacrolimus|tacrolimus|mesh-list
139212453|NCT04389632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139212454|NCT04389632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212456|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
139212457|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
139000448|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212458|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139212459|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212460|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
139642119|NCT04961970|Protective Agents|protective agents|mesh-ancestor
139212461|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212462|NCT04296396|Oxycodone|oxycodone|mesh-list
139212463|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139212464|NCT04296396|Narcotics|narcotics|mesh-ancestor
139212465|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139212466|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212467|NCT04296396|Analgesics|analgesics|mesh-ancestor
139212468|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
139212469|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212470|NCT04259658|Calcium|calcium|mesh-list
139212471|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139212472|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212473|NCT04251715|Leucovorin|leucovorin|mesh-list
139212474|NCT04251715|Dexamethasone|dexamethasone|mesh-list
139212475|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
139212476|NCT04251715|Fluorouracil|fluorouracil|mesh-list
139212477|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
139212478|NCT04251715|Irinotecan|irinotecan|mesh-list
139212479|NCT04251715|Floxuridine|floxuridine|mesh-list
139212480|NCT04251715|BB 1101|bb 1101|mesh-list
139212481|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
139212482|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139212483|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
139212484|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
139212485|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212486|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212487|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139212488|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
139212489|NCT04251715|Hormones|hormones|mesh-ancestor
139212490|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139212491|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139212492|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212493|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
139212494|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212495|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212496|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
139212497|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139212498|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212499|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
139212500|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139212501|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139212502|NCT04251715|Antidotes|antidotes|mesh-ancestor
139212503|NCT04251715|Protective Agents|protective agents|mesh-ancestor
139212504|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
139212505|NCT04251715|Vitamins|vitamins|mesh-ancestor
139212506|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
139212507|NCT04220021|Metformin|metformin|mesh-list
139212508|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139212509|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212510|NCT04193306|Alirocumab|alirocumab|mesh-list
139212511|NCT04193306|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139212512|NCT04193306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139212513|NCT04193306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139212514|NCT04193306|Antimetabolites|antimetabolites|mesh-ancestor
139212515|NCT04193306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212516|NCT04193306|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139000463|NCT00966602|Ivacaftor|ivacaftor|mesh-list
139212517|NCT04193306|Protease Inhibitors|protease inhibitors|mesh-ancestor
139212518|NCT04193306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212519|NCT04193306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139212520|NCT04141995|Leucovorin|leucovorin|mesh-list
139212521|NCT04141995|Fluorouracil|fluorouracil|mesh-list
139212522|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
139212523|NCT04141995|Irinotecan|irinotecan|mesh-list
139212524|NCT04141995|Camptothecin|camptothecin|mesh-list
139212525|NCT04141995|Digoxin|digoxin|mesh-list
139212526|NCT04141995|Calcium|calcium|mesh-list
139212527|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
139212528|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139212529|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212530|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
139212531|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212532|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139212533|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212534|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212535|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
139212536|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139212537|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139212538|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212539|NCT04141995|Antidotes|antidotes|mesh-ancestor
139212540|NCT04141995|Protective Agents|protective agents|mesh-ancestor
139212541|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
139212542|NCT04141995|Vitamins|vitamins|mesh-ancestor
139212543|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
139212544|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139212545|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139212546|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139212547|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
139212548|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212549|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212550|NCT04134559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139212551|NCT04134559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212552|NCT04107675|Cyclosporine|cyclosporine|mesh-list
139212553|NCT04107675|Cyclosporins|cyclosporins|mesh-list
139212554|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212555|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212556|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212557|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
139212558|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212559|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
139212560|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139212561|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
139212562|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139212563|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139212564|NCT03982082|Coal Tar|coal tar|mesh-list
139212565|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
139212566|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
139212567|NCT03915405|Avelumab|avelumab|mesh-list
139212568|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212569|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212570|NCT03829254|Pembrolizumab|pembrolizumab|mesh-list
139212571|NCT03829254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212572|NCT03829254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212573|NCT03829254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139212574|NCT03829254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212575|NCT03826589|Avelumab|avelumab|mesh-list
139212576|NCT03826589|Axitinib|axitinib|mesh-list
139212577|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212578|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212579|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139212580|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212581|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212582|NCT03781414|Tacrolimus|tacrolimus|mesh-list
139212583|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212584|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
139212585|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212586|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139212587|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212588|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212589|NCT03704363|Infliximab|infliximab|mesh-list
139212590|NCT03704363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139212591|NCT03704363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139212592|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
139212593|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139212594|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139212595|NCT03650114|Ofatumumab|ofatumumab|mesh-list
139212596|NCT03650114|Vaccines|vaccines|mesh-list
139212597|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139212598|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
139212599|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
139212600|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212601|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212602|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139212603|NCT03611556|Leucovorin|leucovorin|mesh-list
139212604|NCT03611556|Folic Acid|folic acid|mesh-list
139212605|NCT03611556|Gemcitabine|gemcitabine|mesh-list
139212606|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
139212607|NCT03611556|Fluorouracil|fluorouracil|mesh-list
139169225|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139212608|NCT03611556|Durvalumab|durvalumab|mesh-list
139212609|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
139212610|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212611|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212612|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139212613|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
139212614|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212615|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
139041910|NCT03974685|Niacin|niacin|mesh-list
139212616|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642120|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
139212617|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212619|NCT03611556|Protective Agents|protective agents|mesh-ancestor
139212620|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
139212621|NCT03611556|Vitamins|vitamins|mesh-ancestor
139212622|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
139212623|NCT03611556|Hematinics|hematinics|mesh-ancestor
139212624|NCT03608657|Apremilast|apremilast|mesh-list
139212625|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139212626|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139212627|NCT03608657|Analgesics|analgesics|mesh-ancestor
139212628|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
139212629|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212630|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212631|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139212632|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139212633|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139212634|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139212635|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212636|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212637|NCT03601078|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
139212638|NCT03601078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212639|NCT03601078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212640|NCT03600857|Misoprostol|misoprostol|mesh-list
139212641|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139212642|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
139212643|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139212644|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212645|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139212646|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139212647|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
139212648|NCT03580525|Nicotine|nicotine|mesh-list
139212649|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139212650|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
139212651|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212652|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212653|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139212654|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139212655|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
139212656|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139212657|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212658|NCT03568630|Chrysarobin|chrysarobin|mesh-list
139212659|NCT03568630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139212660|NCT03568630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139212661|NCT03568630|Analgesics|analgesics|mesh-ancestor
139212662|NCT03568630|Sensory System Agents|sensory system agents|mesh-ancestor
139212663|NCT03568630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212664|NCT03568630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212665|NCT03568630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139212666|NCT03568630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139212667|NCT03477162|Metformin|metformin|mesh-list
139212668|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139212669|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212670|NCT03426761|Vancomycin|vancomycin|mesh-list
139212671|NCT03426761|Cefazolin|cefazolin|mesh-list
139212672|NCT03426761|Daptomycin|daptomycin|mesh-list
139212673|NCT03426761|Dalbavancin|dalbavancin|mesh-list
139212674|NCT03426761|Nafcillin|nafcillin|mesh-list
139212675|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139212676|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139212677|NCT03332667|Vorinostat|vorinostat|mesh-list
139212678|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139212679|NCT03332667|Dinutuximab|dinutuximab|mesh-list
139212680|NCT03332667|Sargramostim|sargramostim|mesh-list
139212681|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
139212682|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212683|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212684|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139212685|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212686|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212687|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139212688|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
139212689|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212690|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212691|NCT03248479|Azacitidine|azacitidine|mesh-list
139212692|NCT03248479|Magrolimab|magrolimab|mesh-list
139212693|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139212694|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
139212695|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212696|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212697|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212698|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212699|NCT03194126|Misoprostol|misoprostol|mesh-list
139212700|NCT03194126|Mifepristone|mifepristone|mesh-list
139212701|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139212702|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
139212703|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139212704|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212705|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139212706|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139212707|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
139212708|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139212709|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139212710|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139212711|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139212712|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
139212713|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139212714|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139212715|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
139212716|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139212717|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
139212718|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139212719|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139212720|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
139212721|NCT03107988|Topotecan|topotecan|mesh-list
139212722|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212723|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
139212724|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212725|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139212726|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139212727|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
139212728|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212729|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212730|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139212731|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139212732|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139212733|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212734|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
139212735|NCT03061565|Hematinics|hematinics|mesh-ancestor
139212736|NCT02910414|Ethanol|ethanol|mesh-list
139212737|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139212738|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139212739|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139212740|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212741|NCT02909036|Melphalan|melphalan|mesh-list
139212742|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139212743|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
139212744|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212745|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212746|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139212747|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212748|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
139212749|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212750|NCT02744092|Enoxaparin|enoxaparin|mesh-list
139212751|NCT02744092|Dalteparin|dalteparin|mesh-list
139212752|NCT02744092|PENTA|penta|mesh-list
139212753|NCT02744092|Warfarin|warfarin|mesh-list
139212754|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
139212755|NCT02744092|Dabigatran|dabigatran|mesh-list
139212756|NCT02744092|Apixaban|apixaban|mesh-list
139212757|NCT02744092|Edoxaban|edoxaban|mesh-list
139212758|NCT02744092|Fondaparinux|fondaparinux|mesh-list
139212759|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
139212760|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139212761|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
139212762|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139212763|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
139212764|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212765|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212766|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139212767|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139212768|NCT02647827|Metformin|metformin|mesh-list
139642121|NCT04961970|Vitamins|vitamins|mesh-ancestor
139212769|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139212770|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212771|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
139212772|NCT02605421|Melphalan|melphalan|mesh-list
139212773|NCT02605421|Thiotepa|thiotepa|mesh-list
139212774|NCT02605421|Carboplatin|carboplatin|mesh-list
139212775|NCT02605421|Etoposide|etoposide|mesh-list
139212776|NCT02605421|Lenograstim|lenograstim|mesh-list
139212777|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212778|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
139212779|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212780|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139212781|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139212782|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
139212783|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212784|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212785|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139212786|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139212787|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139212788|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139212789|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212790|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139212791|NCT02582905|Choline|choline|mesh-list
139212792|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139212793|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
139212794|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139212795|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
139212796|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212797|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139212798|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139212799|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
139212800|NCT02548364|Vitamin D|vitamin d|mesh-list
139212801|NCT02548364|Calcifediol|calcifediol|mesh-list
139212802|NCT02548364|Vitamins|vitamins|mesh-ancestor
139212803|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
139212804|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212805|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139212806|NCT02504333|Paclitaxel|paclitaxel|mesh-list
139212807|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139212808|NCT02504333|Gemcitabine|gemcitabine|mesh-list
139212809|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139212810|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212811|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
139212812|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
139212813|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
139212814|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212815|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139212816|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
139212817|NCT02473042|Promethazine|promethazine|mesh-list
139212818|NCT02473042|Dexamethasone|dexamethasone|mesh-list
139212819|NCT02473042|Ondansetron|ondansetron|mesh-list
139212820|NCT02473042|Famotidine|famotidine|mesh-list
139212821|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139212822|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
139212823|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
139212824|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212825|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212826|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139212827|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
139212828|NCT02473042|Hormones|hormones|mesh-ancestor
139000604|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
139212829|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139212830|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139212831|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212832|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
139212833|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
139212834|NCT02473042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139212835|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139212836|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
139212837|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139212838|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212839|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139212840|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139212841|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
139212842|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
139212843|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139212844|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139212845|NCT02305173|Dexamethasone|dexamethasone|mesh-list
139212846|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139212847|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
139212848|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
139212849|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212850|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212851|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139212852|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
139212853|NCT02305173|Hormones|hormones|mesh-ancestor
139212854|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139212855|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139212856|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212857|NCT02272790|Paclitaxel|paclitaxel|mesh-list
139212858|NCT02272790|Carboplatin|carboplatin|mesh-list
139212859|NCT02272790|Gemcitabine|gemcitabine|mesh-list
139212860|NCT02272790|Adavosertib|adavosertib|mesh-list
139212861|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139212862|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212863|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
139212864|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
139212865|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
139212866|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212867|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139212868|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
139212869|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212870|NCT02100956|Oxytocin|oxytocin|mesh-list
139212871|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
139212872|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139212873|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212874|NCT02081885|Chitosan|chitosan|mesh-list
139212875|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139212876|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139212877|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
139212878|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212879|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139212880|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
139212881|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
139212882|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
139212883|NCT02081885|Coagulants|coagulants|mesh-ancestor
139212884|NCT02068586|Sunitinib|sunitinib|mesh-list
139212885|NCT02068586|Valproic Acid|valproic acid|mesh-list
139212886|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212887|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139212888|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139212889|NCT02068586|Growth Substances|growth substances|mesh-ancestor
139212890|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212891|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
139212892|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139212893|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212894|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212895|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
139212896|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
139212897|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139212898|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
139212899|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139212900|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139212901|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139212902|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
139212903|NCT01757418|Antibodies|antibodies|mesh-list
139212904|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
139212905|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139212906|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139212907|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
139212908|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212909|NCT01438411|Cholic Acids|cholic acids|mesh-list
139212910|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139212911|NCT01302834|Cetuximab|cetuximab|mesh-list
139212912|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212913|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212914|NCT01153698|Dabigatran|dabigatran|mesh-list
139212915|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
139212916|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139212917|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
139212918|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212919|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169524|NCT02300740|Niacin|niacin|mesh-list
139212920|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
139212921|NCT01115582|Cholic Acids|cholic acids|mesh-list
139212922|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139212923|NCT00804856|Cytarabine|cytarabine|mesh-list
139212924|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139642122|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
139212925|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
139212926|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212927|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212928|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
139212929|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139212930|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139212931|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
139212932|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212933|NCT00294580|Maloprim|maloprim|mesh-list
139212934|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
139212935|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139212936|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139212937|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139212938|NCT03304444|Bupivacaine|bupivacaine|mesh-list
139212939|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
139212940|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
139212941|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139212942|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212943|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
139212944|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212945|NCT03304288|Rituximab|rituximab|mesh-list
139212946|NCT03304288|Tretinoin|tretinoin|mesh-list
139212947|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139212948|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212949|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
139212950|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212951|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139212952|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
139212953|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
139212954|NCT03313960|Insulin|insulin|mesh-list
139212955|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139212956|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212957|NCT03308890|Entecavir|entecavir|mesh-list
139212958|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
139212959|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139212960|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139212961|NCT03313726|Hormones|hormones|mesh-ancestor
139212962|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139212963|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212964|NCT03303976|Vaccines|vaccines|mesh-list
139000630|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139212965|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139212966|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
139212967|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212968|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
139212969|NCT03313414|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139212970|NCT03313414|Velpatasvir|velpatasvir|mesh-list
139212971|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
139212972|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139212973|NCT02468518|Vitamin E|vitamin e|mesh-list
139212974|NCT02468518|Vitamins|vitamins|mesh-ancestor
139212975|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
139212976|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212977|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
139212978|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212979|NCT02468518|Protective Agents|protective agents|mesh-ancestor
139212980|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139212981|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
139212982|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
139212983|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139212984|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139212985|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
139212986|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139212987|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139212988|NCT05262322|Rivaroxaban|rivaroxaban|mesh-list
139212989|NCT05262322|Apixaban|apixaban|mesh-list
139212990|NCT05262322|Edoxaban|edoxaban|mesh-list
139212991|NCT05262322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139212992|NCT05262322|Antithrombins|antithrombins|mesh-ancestor
139212993|NCT05262322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139212994|NCT05262322|Protease Inhibitors|protease inhibitors|mesh-ancestor
139212995|NCT05262322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139212996|NCT05262322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139212997|NCT05262322|Anticoagulants|anticoagulants|mesh-ancestor
139212999|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139213000|NCT04490980|Narcotics|narcotics|mesh-ancestor
139213001|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139083089|NCT00353873|Xhance|xhance|mesh-list
139642123|NCT01311687|Dexamethasone|dexamethasone|mesh-list
139213002|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213003|NCT04490980|Analgesics|analgesics|mesh-ancestor
139213004|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
139213005|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213006|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
139213007|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
139213008|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139213009|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139213010|NCT03307720|Hormones|hormones|mesh-list
139213011|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139213012|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213013|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139213014|NCT04608786|Capecitabine|capecitabine|mesh-list
139213015|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139213016|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
139213017|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213018|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213019|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139213020|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139213021|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139213022|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
139213023|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213024|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213025|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213026|NCT01314872|Urological Agents|urological agents|mesh-ancestor
139213027|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139213028|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139213029|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139213030|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139213031|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213032|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
139213033|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213034|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213035|NCT00703924|Paromomycin|paromomycin|mesh-list
139213036|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139213037|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139213038|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139213039|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139213040|NCT03302650|Norepinephrine|norepinephrine|mesh-list
139213041|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
139213042|NCT03302650|Giapreza|giapreza|mesh-list
139213043|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
139213044|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139213045|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139213046|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
139213047|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213048|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213049|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213050|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
139213051|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
139213052|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213053|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139213054|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139213055|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
139213056|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213057|NCT01343706|BI 409306|bi 409306|mesh-list
139213058|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139213059|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213060|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213061|NCT03312478|Antibodies|antibodies|mesh-list
139213062|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213063|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
139213064|NCT03312244|Bromides|bromides|mesh-list
139213065|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139213066|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
139213067|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139213068|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213069|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213070|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
139213071|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213072|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213073|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
139213074|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139213075|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139642124|NCT01311687|Pomalidomide|pomalidomide|mesh-list
139213084|NCT00739050|Simvastatin|simvastatin|mesh-list
139213085|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139213086|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139213087|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
139213088|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213089|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139213090|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139213091|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213092|NCT03302182|Ritonavir|ritonavir|mesh-list
139213093|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139213094|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139213095|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
139213096|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213097|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213098|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139213099|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139213100|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
139213101|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139213102|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139213103|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139213104|NCT01343862|Cycloserine|cycloserine|mesh-list
139213105|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139213106|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139213107|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139213108|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
139213109|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139213110|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
139213111|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213112|NCT03311932|Hydrocortisone|hydrocortisone|mesh-list
139213113|NCT03311932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213114|NCT00604812|Rizatriptan|rizatriptan|mesh-list
139213115|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139213116|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
139213117|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213118|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213119|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213120|NCT04347408|Antibodies|antibodies|mesh-list
139213121|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
139213122|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213123|NCT03306550|Aspirin|aspirin|mesh-list
139213124|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139213125|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139213126|NCT03306550|Analgesics|analgesics|mesh-ancestor
139213127|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
139213128|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213129|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213130|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213131|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139213132|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139213133|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139213134|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213135|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139213136|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139213137|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213138|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
139642125|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213174|NCT02468206|Polidocanol|polidocanol|mesh-list
139213175|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139213176|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139213177|NCT01344174|Lamivudine|lamivudine|mesh-list
139213178|NCT01344174|Dexamethasone|dexamethasone|mesh-list
139213179|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213180|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
139213181|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
139213182|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213183|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213184|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139213185|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
139213186|NCT01344174|Hormones|hormones|mesh-ancestor
139213187|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139213188|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139213189|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213190|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139213191|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139213192|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213193|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213194|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
139213195|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139213196|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139213197|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139213198|NCT05162274|Lazertinib|lazertinib|mesh-list
139213199|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139213200|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213201|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213202|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139213203|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
139213204|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
139213205|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213206|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139213207|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139213208|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139213209|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213210|NCT02468908|Molgramostim|molgramostim|mesh-list
139213211|NCT02468908|Sargramostim|sargramostim|mesh-list
139213212|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
139213213|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213214|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213215|NCT02468128|Nalbuphine|nalbuphine|mesh-list
139213216|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139213217|NCT02468128|Narcotics|narcotics|mesh-ancestor
139169822|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213218|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139213219|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642126|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
139213220|NCT02468128|Analgesics|analgesics|mesh-ancestor
139213221|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
139213222|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213224|NCT03305536|Vitamins|vitamins|mesh-list
139213225|NCT03305536|Vitamin K|vitamin k|mesh-list
139213226|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
139213227|NCT03305536|Menaquinone 7|menaquinone 7|mesh-list
139213228|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
139213229|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213230|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139213231|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139213232|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139213233|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213234|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
139213235|NCT03305536|Coagulants|coagulants|mesh-ancestor
139213236|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
139213237|NCT02467426|Analgesics|analgesics|mesh-ancestor
139213238|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
139213239|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213240|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213241|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213242|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139213243|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139213244|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213245|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213246|NCT04296942|Trastuzumab|trastuzumab|mesh-list
139213247|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139213248|NCT04296942|Maytansine|maytansine|mesh-list
139213249|NCT04296942|Entinostat|entinostat|mesh-list
139213250|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139213251|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000673|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
139213252|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139213253|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
139213254|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
139213255|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
139213256|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213257|NCT04296942|Immunotoxins|immunotoxins|mesh-ancestor
139213258|NCT04296942|Immunoconjugates|immunoconjugates|mesh-ancestor
139213259|NCT04296942|Immunologic Factors|immunologic factors|mesh-ancestor
139213260|NCT04296942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213261|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139213262|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213263|NCT01344564|Leuprolide|leuprolide|mesh-list
139213264|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139213265|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
139213266|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139213267|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213268|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139213269|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213270|NCT01344720|Etoricoxib|etoricoxib|mesh-list
139213271|NCT01344720|Oxycodone|oxycodone|mesh-list
139213272|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139213273|NCT01344720|Narcotics|narcotics|mesh-ancestor
139213274|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139213275|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213276|NCT01344720|Analgesics|analgesics|mesh-ancestor
139213277|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
139213278|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213279|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139213280|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139213281|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213282|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139213283|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139213284|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139213285|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213286|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213287|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139213288|NCT03220854|Antibodies|antibodies|mesh-list
139213289|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
139213290|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139169894|NCT01358396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213291|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
139213292|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213293|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213295|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139213296|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139213297|NCT03305068|Analgesics|analgesics|mesh-ancestor
139213298|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
139213299|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213300|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213301|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213302|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139213303|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139213304|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139213305|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213306|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213307|NCT04490590|Etoposide|etoposide|mesh-list
139213308|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139213309|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213310|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139213311|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139213312|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213313|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213314|NCT03299998|Anesthetics|anesthetics|mesh-list
139213315|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139213316|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213317|NCT02720536|Deferasirox|deferasirox|mesh-list
139213318|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139213319|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
139000685|NCT00985322|Ramipril|ramipril|mesh-list
139213320|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
139213321|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213322|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
139213323|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
139213324|NCT03168438|Fludarabine|fludarabine|mesh-list
139213325|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139213326|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
139213327|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213328|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139213329|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139213330|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
139213331|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213332|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213333|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139213334|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139213335|NCT03168438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139213336|NCT03299296|Enoxaparin|enoxaparin|mesh-list
139213337|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
139213338|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139213339|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
139213340|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139213341|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
139213342|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213343|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213344|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
139213345|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139213346|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139213347|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
139213348|NCT03137784|Bromides|bromides|mesh-list
139213349|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
139213350|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139213351|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139213352|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139213353|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
139213354|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213355|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213356|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213357|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
139213358|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139213359|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139213360|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
139213361|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139213362|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
139213363|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213364|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213365|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
139213366|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
139169970|NCT03514810|Ketoprofen|ketoprofen|mesh-list
139213367|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213369|NCT01347996|Histamine|histamine|mesh-list
139213370|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
139213371|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642127|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
139213372|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139213374|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
139213375|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213376|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213377|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
139213378|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
139213379|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213380|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213381|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139213382|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
139213383|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139213384|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
139213385|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213386|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
139213387|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213388|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
139213389|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139213390|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139213391|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213392|NCT02466802|Urological Agents|urological agents|mesh-ancestor
139213393|NCT01348308|Maraviroc|maraviroc|mesh-list
139213394|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139213395|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139213396|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213397|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139213398|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139213399|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
139213400|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139213401|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139213402|NCT04074174|Acetaminophen|acetaminophen|mesh-list
139213403|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
139213404|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
139213405|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139213406|NCT04074174|Analgesics|analgesics|mesh-ancestor
139213407|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
139213408|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213409|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213410|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
139213411|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139213412|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139213413|NCT03620292|Bevacizumab|bevacizumab|mesh-list
139213414|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139213415|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213416|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139213417|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139213418|NCT03620292|Growth Substances|growth substances|mesh-ancestor
139213419|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213420|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
139213421|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
139213422|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139213423|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139213424|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213425|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139213426|NCT01353378|Analgesics|analgesics|mesh-ancestor
139213427|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
139213428|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213429|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139213430|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139213431|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139213432|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
139213433|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213434|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213435|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
139213436|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139213437|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139213438|NCT01465334|Prednisolone|prednisolone|mesh-list
139213439|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
139213440|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
139213441|NCT01465334|Ofatumumab|ofatumumab|mesh-list
139213442|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139213443|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
139213444|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213445|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
139213446|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
139213448|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213449|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139213450|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
139213451|NCT01465334|Hormones|hormones|mesh-ancestor
139213452|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139213453|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139213454|NCT01465334|Protective Agents|protective agents|mesh-ancestor
139213455|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139213456|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213457|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139213458|NCT04019262|Temozolomide|temozolomide|mesh-list
139213459|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139213460|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
139213461|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213462|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213463|NCT05549726|Cabotegravir|cabotegravir|mesh-list
139213464|NCT05549726|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139213465|NCT05549726|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139213466|NCT05549726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213467|NCT05549726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213468|NCT05549726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139213469|NCT05549726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139213470|NCT05549726|Antiviral Agents|antiviral agents|mesh-ancestor
139213471|NCT05549726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139213472|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
139213473|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139213474|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139213475|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213476|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139213477|NCT01353456|Analgesics|analgesics|mesh-ancestor
139213478|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
139213479|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213480|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139213481|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139213482|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139213483|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
139213484|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213485|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213486|NCT04948814|Vancomycin|vancomycin|mesh-list
139213487|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139213488|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139213489|NCT02718898|Ixekizumab|ixekizumab|mesh-list
139213490|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
139213491|NCT05726734|Amoxicillin|amoxicillin|mesh-list
139213492|NCT05726734|Metronidazole|metronidazole|mesh-list
139213493|NCT05726734|Potassium Citrate|potassium citrate|mesh-list
139213494|NCT05726734|Esomeprazole|esomeprazole|mesh-list
139213495|NCT05726734|Bismuth|bismuth|mesh-list
139213496|NCT05726734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213497|NCT05726734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139213498|NCT05726734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139213499|NCT05726734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139213500|NCT05726734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139213501|NCT05726734|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139213502|NCT05726734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139213503|NCT05726734|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139213504|NCT05726734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213505|NCT05726734|Antacids|antacids|mesh-ancestor
139213506|NCT05726734|Diuretics|diuretics|mesh-ancestor
139213507|NCT05726734|Natriuretic Agents|natriuretic agents|mesh-ancestor
139213508|NCT05726734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213509|NCT05726734|Expectorants|expectorants|mesh-ancestor
139213510|NCT05726734|Respiratory System Agents|respiratory system agents|mesh-ancestor
139213511|NCT01317966|Rituximab|rituximab|mesh-list
139213512|NCT01317966|Oprelvekin|oprelvekin|mesh-list
139213513|NCT01317966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139213514|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213515|NCT01317966|Immunologic Factors|immunologic factors|mesh-ancestor
139213516|NCT01317966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213517|NCT01317966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139213518|NCT01345734|Liraglutide|liraglutide|mesh-list
139213520|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213521|NCT01345734|Incretins|incretins|mesh-ancestor
139213522|NCT01345734|Hormones|hormones|mesh-ancestor
139083566|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139213523|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139213524|NCT01318044|Thiopental|thiopental|mesh-list
139213525|NCT01318044|Propofol|propofol|mesh-list
139213526|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139213527|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139213528|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213529|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139213530|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
139213531|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
139213532|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
139213533|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
139213534|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
139213535|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213536|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213537|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139213538|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139213539|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139213540|NCT01353846|Estradiol|estradiol|mesh-list
139213541|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139213542|NCT01353846|Progesterone|progesterone|mesh-list
139213543|NCT01353846|Estrogens|estrogens|mesh-ancestor
139213544|NCT01353846|Hormones|hormones|mesh-ancestor
139213545|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139213546|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213547|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139213548|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
139213549|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139213550|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139213551|NCT01353846|Progestins|progestins|mesh-ancestor
139213552|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
139213553|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139213554|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213555|NCT01349010|Probucol|probucol|mesh-list
139213556|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139213557|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139213558|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
139213559|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213560|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139213561|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
139213562|NCT01349010|Protective Agents|protective agents|mesh-ancestor
139213563|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213564|NCT05232370|Losartan|losartan|mesh-list
139213565|NCT05232370|Enalapril|enalapril|mesh-list
139213566|NCT05232370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139213567|NCT05232370|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139213568|NCT05232370|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139213569|NCT05232370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139213570|NCT05232370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139213571|NCT05232370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139213572|NCT05232370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213573|NCT05232370|Protease Inhibitors|protease inhibitors|mesh-ancestor
139213574|NCT01349088|Niacinamide|niacinamide|mesh-list
139213575|NCT01349088|Capecitabine|capecitabine|mesh-list
139213576|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
139213577|NCT01349088|Imetelstat|imetelstat|mesh-list
139213578|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139213579|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
139213580|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213581|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213582|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139213583|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213584|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
139213585|NCT01349088|Vitamins|vitamins|mesh-ancestor
139213586|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
139213587|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213588|NCT04490434|Celecoxib|celecoxib|mesh-list
139213589|NCT04490434|Naproxen|naproxen|mesh-list
139213590|NCT04490434|Meloxicam|meloxicam|mesh-list
139213591|NCT04490434|Fexuprazan|fexuprazan|mesh-list
139213592|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139213593|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139213594|NCT04490434|Analgesics|analgesics|mesh-ancestor
139213595|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
139642128|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213596|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213597|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213598|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213599|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139213600|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139213601|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139213602|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213603|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213604|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
139213605|NCT04490434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139213606|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
139213607|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139213608|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
139213609|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213610|NCT03143166|Telmisartan|telmisartan|mesh-list
139213611|NCT03143166|Dabigatran|dabigatran|mesh-list
139213612|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139213613|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139213614|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139213615|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213616|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
139213617|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139213618|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
139213619|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213620|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
139213621|NCT02466568|Nivolumab|nivolumab|mesh-list
139213622|NCT02466568|Vaccines|vaccines|mesh-list
139213623|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
139213624|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213625|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139213626|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213627|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139213628|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213629|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
139213630|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139213631|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213632|NCT02879994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139213633|NCT02879994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213634|NCT02466022|Midazolam|midazolam|mesh-list
139213635|NCT02466022|Fentanyl|fentanyl|mesh-list
139213636|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
139213637|NCT02466022|Bupivacaine|bupivacaine|mesh-list
139213638|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
139213639|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
139213640|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139213641|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213642|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
139213643|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213644|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139213645|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139213646|NCT02466022|Analgesics|analgesics|mesh-ancestor
139213647|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139213648|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139213649|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139213650|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
139213651|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213652|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213653|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139213654|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139213655|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139213656|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139213657|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139213658|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
139213659|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
139213660|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
139213661|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139213662|NCT02466022|Narcotics|narcotics|mesh-ancestor
139213663|NCT03937596|Cycloserine|cycloserine|mesh-list
139213664|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139213665|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139213666|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139213667|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
139213668|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139213669|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
139213670|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213671|NCT03578172|Menotropins|menotropins|mesh-list
139213672|NCT03578172|Hormones|hormones|mesh-list
139083715|NCT01124630|Leucovorin|leucovorin|mesh-list
139642129|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213673|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139213674|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213675|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139213677|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139213678|NCT03928158|Valsartan|valsartan|mesh-list
139213679|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139213680|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139213681|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139213682|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139213683|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213684|NCT05174884|Etonogestrel|etonogestrel|mesh-list
139213685|NCT05174884|Desogestrel|desogestrel|mesh-list
139213686|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139213687|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
139213688|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139213689|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213690|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139213691|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139213692|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139213693|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139213694|NCT05174884|Progestins|progestins|mesh-ancestor
139213695|NCT05174884|Hormones|hormones|mesh-ancestor
139213696|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139213697|NCT01354158|Droxidopa|droxidopa|mesh-list
139213698|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139213699|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139213700|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139213701|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139213702|NCT02466490|Diuretics|diuretics|mesh-ancestor
139213703|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
139213704|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213705|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139213706|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139000745|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139213707|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213708|NCT04547842|Dexamethasone|dexamethasone|mesh-list
139213709|NCT04547842|Mirtazapine|mirtazapine|mesh-list
139213710|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213711|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
139213712|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
139213713|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213714|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213715|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139213716|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
139213717|NCT04547842|Hormones|hormones|mesh-ancestor
139213718|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139213719|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139213720|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213721|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
139213722|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139213723|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139213724|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
139213725|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
139213726|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213727|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213728|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139213729|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139213730|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139213731|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139213732|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139213733|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139213734|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
139213735|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139213736|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139213737|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
139213738|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139213739|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
139213740|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
139213741|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213742|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
139170344|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
139083791|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139213743|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213744|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213745|NCT00702052|Everolimus|everolimus|mesh-list
139213746|NCT00702052|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139213747|NCT00702052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139213748|NCT00702052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213749|NCT00702052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213750|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139213751|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
139213752|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213753|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213754|NCT01354470|Modafinil|modafinil|mesh-list
139213755|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139213756|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213757|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139213758|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139213759|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139213760|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213761|NCT01349556|Tretinoin|tretinoin|mesh-list
139213762|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213763|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
139213764|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
139213765|NCT01354704|Enoxaparin|enoxaparin|mesh-list
139213766|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
139213767|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139213768|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139213769|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213770|NCT01346670|Lovastatin|lovastatin|mesh-list
139213771|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139213772|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139213773|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
139213774|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213775|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139213776|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139213777|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213778|NCT03136068|Digoxin|digoxin|mesh-list
139213779|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139213780|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139213781|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213782|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213783|NCT03136068|Protective Agents|protective agents|mesh-ancestor
139213784|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213785|NCT01350024|Lidocaine|lidocaine|mesh-list
139213786|NCT01350024|Epinephrine|epinephrine|mesh-list
139213787|NCT01350024|Racepinephrine|racepinephrine|mesh-list
139213788|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
139213789|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
139213790|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
139213791|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139213792|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213793|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
139213794|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213795|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139213796|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139213797|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139213798|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139213799|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213800|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139213801|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139213802|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
139213803|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213804|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139213805|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139213806|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
139213807|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139213808|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
139213809|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
139213810|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
139213811|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139213812|NCT01318590|Triamcinolone|triamcinolone|mesh-list
139213813|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139213814|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139213815|NCT01318590|Bupivacaine|bupivacaine|mesh-list
139213816|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139642130|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139213817|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
139213818|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
139213819|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139213820|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213821|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
139213822|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213823|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213824|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
139213825|NCT01318590|Hormones|hormones|mesh-ancestor
139213826|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139213827|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139213828|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
139213829|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213830|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213831|NCT01346826|Infliximab|infliximab|mesh-list
139213832|NCT01346826|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139213833|NCT01346826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213834|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
139213835|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139213836|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139213837|NCT01354860|Lobeline|lobeline|mesh-list
139213838|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139213839|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
139213840|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213841|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213842|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139213843|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139213844|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
139213845|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213846|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213847|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
139213848|NCT02556606|Midazolam|midazolam|mesh-list
139213849|NCT02556606|Ketamine|ketamine|mesh-list
139213850|NCT02556606|Analgesics|analgesics|mesh-ancestor
139213851|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
139213852|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213853|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213854|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139213855|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139213856|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
139213857|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
139213858|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139213859|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139213860|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139213861|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213862|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213863|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139213864|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139213865|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139213866|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139213867|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139213868|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
139213869|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
139213870|NCT01355562|Interleukin-2|interleukin-2|mesh-list
139213871|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213872|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139213873|NCT01355562|Analgesics|analgesics|mesh-ancestor
139213874|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
139000792|NCT05450900|Biotin|biotin|mesh-list
139213875|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213876|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213877|NCT01350570|Loperamide|loperamide|mesh-list
139213878|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
139213879|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139213880|NCT01355718|Repaglinide|repaglinide|mesh-list
139213881|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139213882|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213883|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139213884|NCT03377790|Cantharidin|cantharidin|mesh-list
139213885|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213886|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213887|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
139213888|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139213889|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139213890|NCT02422368|Prednisolone|prednisolone|mesh-list
139213891|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
139213892|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139213893|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
139213894|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139213895|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
139213896|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
139213897|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139213898|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213899|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139213900|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
139213901|NCT02422368|Hormones|hormones|mesh-ancestor
139213902|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139213903|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139213904|NCT02422368|Protective Agents|protective agents|mesh-ancestor
139213905|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139213906|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213907|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
139213908|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
139213909|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213910|NCT01355952|Protective Agents|protective agents|mesh-ancestor
139213911|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213912|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
139213913|NCT01355952|Vitamins|vitamins|mesh-ancestor
139213914|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
139213915|NCT05720572|Antazoline|antazoline|mesh-list
139213916|NCT05720572|Propafenone|propafenone|mesh-list
139213917|NCT05720572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139213918|NCT05720572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139213919|NCT05720572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139213920|NCT05720572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139213921|NCT05720572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213922|NCT05720572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139213923|NCT05720572|Histamine Antagonists|histamine antagonists|mesh-ancestor
139213924|NCT05720572|Histamine Agents|histamine agents|mesh-ancestor
139213925|NCT05720572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213926|NCT05720572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213927|NCT05720572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139213928|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
139213929|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
139213930|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139213931|NCT05716750|Vitamin D|vitamin d|mesh-list
139213932|NCT05716750|Vitamins|vitamins|mesh-ancestor
139213933|NCT05716750|Micronutrients|micronutrients|mesh-ancestor
139213934|NCT05716750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213935|NCT05716750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139213936|NCT01350882|Rituximab|rituximab|mesh-list
139213937|NCT01350882|Citric Acid|citric acid|mesh-list
139213938|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
139213939|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139213940|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213941|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
139213942|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213943|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139213944|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
139213945|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139213946|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
139213947|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
139213948|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213949|NCT01844856|Ertapenem|ertapenem|mesh-list
139213950|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139213951|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139213952|NCT00618098|Thrombin|thrombin|mesh-list
139213953|NCT00618098|Hemostatics|hemostatics|mesh-ancestor
139213954|NCT00618098|Coagulants|coagulants|mesh-ancestor
139213955|NCT02464228|Tipifarnib|tipifarnib|mesh-list
139213956|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213957|NCT01351038|Capecitabine|capecitabine|mesh-list
139213958|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
139213959|NCT01351038|Panitumumab|panitumumab|mesh-list
139213960|NCT01351038|Epirubicin|epirubicin|mesh-list
139213961|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139213962|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
139213963|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213964|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213965|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139213966|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139213967|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139213968|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139213969|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139213970|NCT02464462|Vitamin D|vitamin d|mesh-list
139213971|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
139213972|NCT02464462|Calcium|calcium|mesh-list
139213973|NCT02464462|Vitamins|vitamins|mesh-ancestor
139213974|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
139213975|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213976|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139213977|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139213978|NCT04270864|Nivolumab|nivolumab|mesh-list
139213979|NCT04270864|Ipilimumab|ipilimumab|mesh-list
139213980|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139213981|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139213982|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139213983|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213984|NCT01318668|Vaccines|vaccines|mesh-list
139213985|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
139213986|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213987|NCT01351272|Methylphenidate|methylphenidate|mesh-list
139213988|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139213989|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139213990|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139213991|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139213992|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139213993|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139213994|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
139213995|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139213996|NCT01351428|Nifedipine|nifedipine|mesh-list
139213997|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139213998|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139213999|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214000|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139214001|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214002|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
139214003|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
139214004|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139214005|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139214006|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139214007|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214008|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
139214009|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
139214010|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214011|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
139214012|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139214013|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214014|NCT01351818|Hormones|hormones|mesh-list
139214015|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214016|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214017|NCT02463994|Atezolizumab|atezolizumab|mesh-list
139214018|NCT02463994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139214019|NCT02463994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214020|NCT02463994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139214021|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214022|NCT04235686|Amphetamine|amphetamine|mesh-list
139214023|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
139214024|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139214025|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214026|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
139214027|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
139214028|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214029|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
139214030|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214031|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214032|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
139214033|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139214034|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139214035|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139214036|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139214037|NCT02079948|Folic Acid|folic acid|mesh-list
139214038|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
139214039|NCT02079948|Methotrexate|methotrexate|mesh-list
139214040|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139214041|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
139214042|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139642131|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
139214043|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170645|NCT02313220|Incretins|incretins|mesh-ancestor
139214044|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139214045|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
139214046|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214047|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214048|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
139214049|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214050|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139214051|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139214052|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
139214053|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139214054|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139214055|NCT02079948|Hematinics|hematinics|mesh-ancestor
139214056|NCT02079948|Vitamins|vitamins|mesh-ancestor
139214057|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
139214058|NCT01357902|Lamotrigine|lamotrigine|mesh-list
139214059|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
139214060|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139214061|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139214062|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214063|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139214064|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214065|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139214066|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139000828|NCT01563614|Lomustine|lomustine|mesh-list
139214067|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139214068|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139214069|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139214070|NCT04634409|Bamlanivimab|bamlanivimab|mesh-list
139214071|NCT04634409|Sotrovimab|sotrovimab|mesh-list
139214072|NCT04634409|Antiviral Agents|antiviral agents|mesh-ancestor
139214073|NCT04634409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214074|NCT01352130|Ondansetron|ondansetron|mesh-list
139214075|NCT01352130|Granisetron|granisetron|mesh-list
139214076|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
139214077|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
139214078|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
139214079|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214080|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214081|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139214082|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
139214083|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
139214084|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139214085|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
139214086|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214087|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214088|NCT05605834|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139214089|NCT05605834|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139214090|NCT05605834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214091|NCT00005780|Prednisone|prednisone|mesh-list
139214092|NCT00005780|Cyclophosphamide|cyclophosphamide|mesh-list
139214093|NCT00005780|Doxorubicin|doxorubicin|mesh-list
139214094|NCT00005780|Etoposide|etoposide|mesh-list
139214095|NCT00005780|Vincristine|vincristine|mesh-list
139214096|NCT00005780|Sargramostim|sargramostim|mesh-list
139214097|NCT00005780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139214098|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
139214099|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214100|NCT00005780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139214101|NCT00005780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139214102|NCT00005780|Alkylating Agents|alkylating agents|mesh-ancestor
139214103|NCT00005780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214104|NCT00005780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214105|NCT00005780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139214106|NCT00005780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139214107|NCT00005780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139214108|NCT00005780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139214109|NCT00005780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214110|NCT00005780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139214111|NCT00005780|Glucocorticoids|glucocorticoids|mesh-ancestor
139214112|NCT00005780|Hormones|hormones|mesh-ancestor
139214113|NCT00005780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214114|NCT00005780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139214115|NCT00005780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139214116|NCT00005780|Tubulin Modulators|tubulin modulators|mesh-ancestor
139214117|NCT00005780|Antimitotic Agents|antimitotic agents|mesh-ancestor
139214118|NCT00005780|Mitosis Modulators|mitosis modulators|mesh-ancestor
139214119|NCT01356732|Sufentanil|sufentanil|mesh-list
139214120|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139214121|NCT01356732|Narcotics|narcotics|mesh-ancestor
139214122|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139214123|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214124|NCT01356732|Analgesics|analgesics|mesh-ancestor
139214125|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
139214126|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214127|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139214128|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139214129|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
139214130|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
139214131|NCT02463682|Insulin|insulin|mesh-list
139214132|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139214133|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214134|NCT01978938|Levofloxacin|levofloxacin|mesh-list
139214135|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139214136|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214137|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139214138|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139214139|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139214140|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214141|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214142|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214143|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139214144|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139214145|NCT02465320|Lidocaine|lidocaine|mesh-list
139214146|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
139214147|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
139214148|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139214149|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214150|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
139214151|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214152|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139214153|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139214154|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139214155|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139214156|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214157|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
139214158|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
139214159|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
139214160|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139214161|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214162|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
139214163|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214164|NCT04105114|Buspirone|buspirone|mesh-list
139214165|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139214166|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139214167|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139214168|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214169|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139214170|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139214171|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
139214172|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214173|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214174|NCT05573230|Cyclosporine|cyclosporine|mesh-list
139214175|NCT05573230|Midazolam|midazolam|mesh-list
139214176|NCT05573230|Cyclosporins|cyclosporins|mesh-list
139214177|NCT05573230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139214178|NCT05573230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139214179|NCT05573230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139214180|NCT05573230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214181|NCT05573230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139214182|NCT05573230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139214183|NCT05573230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139214184|NCT05573230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139214185|NCT05573230|Anesthetics, General|anesthetics, general|mesh-ancestor
139214186|NCT05573230|Anesthetics|anesthetics|mesh-ancestor
139214187|NCT05573230|GABA Modulators|gaba modulators|mesh-ancestor
139214188|NCT05573230|GABA Agents|gaba agents|mesh-ancestor
139214189|NCT05573230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214190|NCT05573230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214191|NCT05573230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214192|NCT05573230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139214193|NCT05573230|Immunologic Factors|immunologic factors|mesh-ancestor
139214194|NCT05573230|Antifungal Agents|antifungal agents|mesh-ancestor
139214195|NCT05573230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214196|NCT05573230|Dermatologic Agents|dermatologic agents|mesh-ancestor
139214197|NCT05573230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139214198|NCT05573230|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139214199|NCT05550142|Vaccines|vaccines|mesh-list
139214200|NCT05550142|Immunologic Factors|immunologic factors|mesh-ancestor
139214201|NCT05550142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214202|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
139214203|NCT00116142|Docetaxel|docetaxel|mesh-list
139214204|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
139214205|NCT00116142|Androgens|androgens|mesh-list
139214206|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139214207|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214208|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
139214209|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
139214210|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
139214211|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214212|NCT00116142|Hormones|hormones|mesh-ancestor
139214213|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214214|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214215|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
139214216|NCT00116142|Protective Agents|protective agents|mesh-ancestor
139214217|NCT00116142|Vitamins|vitamins|mesh-ancestor
139214218|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
139214219|NCT00116142|Estrogens|estrogens|mesh-ancestor
139214220|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139214221|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
139214222|NCT05547256|Vaccines|vaccines|mesh-list
139214223|NCT05547256|Immunologic Factors|immunologic factors|mesh-ancestor
139214224|NCT05547256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214225|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
139214226|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
139214227|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139214228|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139214229|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214230|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214231|NCT01757782|Urological Agents|urological agents|mesh-ancestor
139214232|NCT02023905|Everolimus|everolimus|mesh-list
139214233|NCT02023905|Temozolomide|temozolomide|mesh-list
139214234|NCT02023905|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139214235|NCT02023905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139214236|NCT02023905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214237|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214238|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139214239|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
139214240|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214241|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214242|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139214243|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
139214244|NCT01330563|Ketoconazole|ketoconazole|mesh-list
139214245|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
139214246|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214247|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139214248|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139214249|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214250|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214251|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139214252|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
139214253|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214254|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214255|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139214256|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
139214257|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
139214258|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214259|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214260|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214261|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
139214262|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
139214263|NCT04897503|Riboflavin|riboflavin|mesh-list
139214264|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
139214265|NCT04897503|Vitamins|vitamins|mesh-ancestor
139214266|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
139642446|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214267|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214268|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139214269|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
139170892|NCT01235143|Desflurane|desflurane|mesh-list
139214270|NCT01333917|Curcumin|curcumin|mesh-list
139214271|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139214272|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139214273|NCT01333917|Analgesics|analgesics|mesh-ancestor
139214274|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
139214275|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214276|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214277|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139214278|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139214279|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214280|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214281|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214282|NCT03129360|Levetiracetam|levetiracetam|mesh-list
139214283|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
139214284|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
139214285|NCT01315275|Ranibizumab|ranibizumab|mesh-list
139214286|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139214287|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139214288|NCT01315275|Growth Substances|growth substances|mesh-ancestor
139214289|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214290|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
139214291|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214292|NCT01319448|Artesunate|artesunate|mesh-list
139214293|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
139214294|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
139214295|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139214296|NCT01319448|Amodiaquine|amodiaquine|mesh-list
139214297|NCT01319448|Mefloquine|mefloquine|mesh-list
139214298|NCT01319448|Proguanil|proguanil|mesh-list
139214299|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
139214300|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139214301|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139214302|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214303|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214304|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
139214305|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
139214306|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139214307|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
139214308|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139214309|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214310|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214311|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139214312|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
139214313|NCT01334073|Everolimus|everolimus|mesh-list
139214314|NCT01334073|Axitinib|axitinib|mesh-list
139214315|NCT01334073|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139214316|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139214317|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214318|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214319|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139214320|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
139214321|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214322|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214323|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139214324|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139214325|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214326|NCT01928199|Incretins|incretins|mesh-ancestor
139214327|NCT01928199|Hormones|hormones|mesh-ancestor
139214328|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214329|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139214330|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
139214331|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214332|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214333|NCT01845441|Midazolam|midazolam|mesh-list
139214334|NCT01845441|Fentanyl|fentanyl|mesh-list
139214335|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
139214336|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139214337|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139214338|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214339|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139214340|NCT01845441|Analgesics|analgesics|mesh-ancestor
139214341|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
139214342|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214343|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139214344|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139214345|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139170949|NCT04462822|Fluticasone|fluticasone|mesh-list
139214346|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
139214347|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214348|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214349|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139214350|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139214351|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139214352|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139214353|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139214354|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
139214355|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
139214356|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
139214357|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
139214358|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139214359|NCT01845441|Narcotics|narcotics|mesh-ancestor
139214360|NCT03296488|Fentanyl|fentanyl|mesh-list
139214361|NCT03296488|Nalbuphine|nalbuphine|mesh-list
139214362|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139214363|NCT03296488|Narcotics|narcotics|mesh-ancestor
139214364|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139214365|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214366|NCT03296488|Analgesics|analgesics|mesh-ancestor
139214367|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
139214368|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214369|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139214370|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139214371|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
139214372|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
139214373|NCT01365936|Menotropins|menotropins|mesh-list
139214374|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139214375|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
139214376|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139214377|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214378|NCT01334151|Insulin|insulin|mesh-list
139214379|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139214380|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
139214381|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139214382|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214383|NCT03296410|Vaccines|vaccines|mesh-list
139214384|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
139000883|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139214385|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214386|NCT05189184|Paclitaxel|paclitaxel|mesh-list
139214387|NCT05189184|Apatinib|apatinib|mesh-list
139214388|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139214389|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139214390|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214391|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
139214392|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
139214393|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
139214394|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214395|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139214396|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214397|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
139214398|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139214399|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
139214400|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139214401|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214402|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
139214403|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139214404|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214405|NCT03735290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139214406|NCT03735290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214407|NCT03619538|Nefopam|nefopam|mesh-list
139214408|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139214409|NCT03619538|Analgesics|analgesics|mesh-ancestor
139214410|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
139214411|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214412|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214413|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
139214414|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139214415|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
139214416|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139214417|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642447|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139214418|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139214419|NCT01366326|Bromides|bromides|mesh-list
139214420|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
139214421|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
139214422|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139214423|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214424|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
139214425|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214427|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139214428|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
139214429|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214430|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214431|NCT01331421|Exemestane|exemestane|mesh-list
139214432|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214433|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139214434|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139214435|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214436|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214437|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139214438|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
139214439|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214440|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214441|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
139214442|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139214443|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139214444|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139214445|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139214446|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
139214447|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139214448|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214449|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139214450|NCT01656434|Estrogens|estrogens|mesh-ancestor
139214451|NCT01656434|Hormones|hormones|mesh-ancestor
139214452|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214453|NCT01656434|Trace Elements|trace elements|mesh-ancestor
139214454|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
139214455|NCT01319214|Propranolol|propranolol|mesh-list
139214456|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139214457|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139214458|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
139214459|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214460|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214461|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214462|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139214463|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139214464|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
139214465|NCT01359228|Rifaximin|rifaximin|mesh-list
139214466|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139214467|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214468|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139214469|NCT02461030|Listerine|listerine|mesh-list
139214470|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
139214471|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
139214472|NCT02461030|Protective Agents|protective agents|mesh-ancestor
139214473|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214474|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139214475|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214476|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139214477|NCT01599494|Progesterone|progesterone|mesh-list
139214478|NCT01599494|Ganirelix|ganirelix|mesh-list
139214479|NCT01599494|Progestins|progestins|mesh-ancestor
139214480|NCT01599494|Hormones|hormones|mesh-ancestor
139214481|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214482|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214483|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139214484|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
139214485|NCT03295786|Dopamine|dopamine|mesh-list
139214486|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139214487|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
139214488|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
139214489|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214490|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214491|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
139642448|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139214492|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084524|NCT01221116|Simendan|simendan|mesh-list
139214493|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214495|NCT03194932|Cytarabine|cytarabine|mesh-list
139214496|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
139214497|NCT03194932|Methotrexate|methotrexate|mesh-list
139214498|NCT03194932|Azacitidine|azacitidine|mesh-list
139214499|NCT03194932|Venetoclax|venetoclax|mesh-list
139214500|NCT03194932|Idarubicin|idarubicin|mesh-list
139214501|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139214503|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139214504|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214505|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139214506|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
139214507|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000917|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
139214508|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214509|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
139214510|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214511|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139214512|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139214513|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
139214514|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139214515|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139214516|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
139214517|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214518|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139214519|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139214520|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139214521|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139214522|NCT03037580|Treprostinil|treprostinil|mesh-list
139214523|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139214524|NCT05154734|Belimumab|belimumab|mesh-list
139214525|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139214526|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
139214527|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214528|NCT02978404|Nivolumab|nivolumab|mesh-list
139214529|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139214530|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214531|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139214532|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214533|NCT04441918|Antibodies|antibodies|mesh-list
139214534|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139214535|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
139214536|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214537|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
139214538|NCT01331655|Drospirenone|drospirenone|mesh-list
139214539|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139214540|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
139214541|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214542|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214543|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139214544|NCT01331655|Diuretics|diuretics|mesh-ancestor
139214545|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
139214546|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
139214547|NCT01331655|Vitamins|vitamins|mesh-ancestor
139214548|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
139214549|NCT03289390|Acetaminophen|acetaminophen|mesh-list
139214550|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139214551|NCT03289390|Analgesics|analgesics|mesh-ancestor
139214552|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
139214553|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214554|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214555|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
139214556|NCT00897104|Sumatriptan|sumatriptan|mesh-list
139214557|NCT00897104|Rizatriptan|rizatriptan|mesh-list
139214558|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139214559|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139214560|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139214561|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
139214562|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214563|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214564|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214565|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
139214566|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139214567|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214568|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214570|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
139214571|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214572|NCT03295162|Protective Agents|protective agents|mesh-ancestor
139171170|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
139214573|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214574|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139214575|NCT03295084|Capecitabine|capecitabine|mesh-list
139214576|NCT03295084|Irinotecan|irinotecan|mesh-list
139214577|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139214578|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
139214579|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214580|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214581|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139214582|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139214583|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214584|NCT01339689|Ganaxolone|ganaxolone|mesh-list
139214585|NCT01339689|Neurosteroids|neurosteroids|mesh-ancestor
139214586|NCT01339689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214587|NCT01339689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214588|NCT01339689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214589|NCT01339689|GABA Modulators|gaba modulators|mesh-ancestor
139214590|NCT01339689|GABA Agents|gaba agents|mesh-ancestor
139214591|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139214592|NCT00702806|Ganirelix|ganirelix|mesh-list
139214593|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
139214594|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214595|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214596|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139214597|NCT03635931|Mitogens|mitogens|mesh-list
139214598|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
139214599|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214600|NCT01331967|Pioglitazone|pioglitazone|mesh-list
139214601|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139214602|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214603|NCT00696878|Progesterone|progesterone|mesh-list
139214604|NCT00696878|Progestins|progestins|mesh-ancestor
139214605|NCT00696878|Hormones|hormones|mesh-ancestor
139214606|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214607|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214608|NCT00731757|Adalimumab|adalimumab|mesh-list
139214609|NCT00731757|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139214610|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139214611|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139214612|NCT03108274|Fexofenadine|fexofenadine|mesh-list
139214613|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
139214614|NCT03108274|Midazolam|midazolam|mesh-list
139214615|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139214616|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139214617|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139214618|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214619|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139214620|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139214621|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139214622|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139214623|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
139214624|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
139214625|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
139214626|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
139214627|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214628|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214629|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139214630|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214631|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139214632|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
139214633|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139214634|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214635|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214636|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139214637|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139214638|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139214639|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
139214640|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
139214641|NCT02278588|Rasagiline|rasagiline|mesh-list
139214642|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139214643|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214644|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214645|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139214646|NCT02278588|Protective Agents|protective agents|mesh-ancestor
139214647|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214648|NCT03288610|Vasopressins|vasopressins|mesh-list
139214649|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
139214650|NCT03288610|Coagulants|coagulants|mesh-ancestor
139214651|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139214652|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139214653|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
139214654|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214655|NCT00696800|Progesterone|progesterone|mesh-list
139214656|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139214657|NCT00696800|Ganirelix|ganirelix|mesh-list
139214658|NCT00696800|Progestins|progestins|mesh-ancestor
139214659|NCT00696800|Hormones|hormones|mesh-ancestor
139214660|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214661|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214662|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
139214663|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
139214664|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139214665|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214666|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
139214667|NCT03288532|Durvalumab|durvalumab|mesh-list
139214668|NCT03288532|Tremelimumab|tremelimumab|mesh-list
139214669|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139214670|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214671|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139214672|NCT00598208|Hormones|hormones|mesh-ancestor
139214673|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214674|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214675|NCT00480662|Alendronate|alendronate|mesh-list
139214676|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139214677|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214678|NCT00398606|Alendronate|alendronate|mesh-list
139214679|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
139214680|NCT00398606|Calcium|calcium|mesh-list
139214681|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139214682|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214683|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214684|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139214685|NCT00398606|Antacids|antacids|mesh-ancestor
139214686|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139214687|NCT00395408|Beclomethasone|beclomethasone|mesh-list
139214688|NCT00395408|Montelukast|montelukast|mesh-list
139214689|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214690|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214691|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
139214692|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139214693|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139214694|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
139214695|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214696|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139214697|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139214698|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139214699|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
139214700|NCT00395408|Hormones|hormones|mesh-ancestor
139214701|NCT02462044|Iodine|iodine|mesh-list
139214702|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
139214703|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139214704|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214705|NCT02462044|Trace Elements|trace elements|mesh-ancestor
139214706|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
139214707|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214708|NCT00289874|Montelukast|montelukast|mesh-list
139214709|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139214710|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
139214711|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139214712|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
139214713|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214714|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214715|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139214716|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139084752|NCT01228292|Heparin|heparin|mesh-list
139642449|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139214717|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214718|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139214719|NCT00245570|Montelukast|montelukast|mesh-list
139214720|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139214721|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
139214722|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171318|NCT01363778|Tivozanib|tivozanib|mesh-list
139214723|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214724|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139214725|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
139214726|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139214727|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139214728|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139214729|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
139214730|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214731|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214732|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139214733|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
139214734|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214735|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139214736|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139214737|NCT02461888|Dexamethasone|dexamethasone|mesh-list
139214738|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
139214739|NCT02461888|Ixazomib|ixazomib|mesh-list
139214740|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139214741|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
139214742|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214743|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139214744|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139214745|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
139214746|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214747|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214748|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139214749|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139214750|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
139214751|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
139214752|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214753|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139214754|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
139214755|NCT02461888|Hormones|hormones|mesh-ancestor
139214756|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214757|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139214758|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
139214759|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214760|NCT00229970|Montelukast|montelukast|mesh-list
139214761|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139000963|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
139214762|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
139214763|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139214764|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
139214765|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214766|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214767|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139214768|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139214769|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214770|NCT00111722|Rizatriptan|rizatriptan|mesh-list
139214771|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214772|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214773|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214774|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139214775|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
139214776|NCT04626596|Etonogestrel|etonogestrel|mesh-list
139214777|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139214778|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
139214779|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139214780|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214781|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139214782|NCT05235100|Apatinib|apatinib|mesh-list
139214783|NCT05235100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214784|NCT05235100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139214785|NCT05235100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214786|NCT05235100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214787|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
139214788|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139214789|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139214790|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139214791|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139214792|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214793|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
139214794|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214795|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214796|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139214797|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214798|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
139214799|NCT00092066|Vitamin D|vitamin d|mesh-list
139214800|NCT00092066|Alendronate|alendronate|mesh-list
139214801|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139214802|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214803|NCT00092066|Vitamins|vitamins|mesh-ancestor
139214804|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
139214805|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139214806|NCT01334619|Ropivacaine|ropivacaine|mesh-list
139214807|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
139214808|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
139214809|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139214810|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214811|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
139214812|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214813|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
139214814|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139214815|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214816|NCT03287128|Immunotoxins|immunotoxins|mesh-ancestor
139214817|NCT03287128|Immunoconjugates|immunoconjugates|mesh-ancestor
139214818|NCT03287128|Immunologic Factors|immunologic factors|mesh-ancestor
139214819|NCT03287128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214820|NCT00457275|Ezetimibe|ezetimibe|mesh-list
139214821|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139214822|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139214823|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
139214824|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214825|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139214826|NCT03294070|Amlodipine|amlodipine|mesh-list
139000971|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
139214827|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139214828|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139214829|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139214830|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214831|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139214832|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214833|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
139214834|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
139214835|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
139214836|NCT04479566|Calcium|calcium|mesh-list
139214837|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139214838|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214839|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
139214840|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139214841|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214842|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214843|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
139214844|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139214845|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139214846|NCT04479566|Antacids|antacids|mesh-ancestor
139214847|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139214848|NCT06030219|Moxifloxacin|moxifloxacin|mesh-list
139214849|NCT06030219|Vancomycin|vancomycin|mesh-list
139214850|NCT06030219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139214851|NCT06030219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214852|NCT06030219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139214853|NCT06030219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139214854|NCT06030219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214855|NCT06030219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214856|NCT06030219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214857|NCT06030089|Azacitidine|azacitidine|mesh-list
139214858|NCT06030089|Venetoclax|venetoclax|mesh-list
139214859|NCT06030089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139214860|NCT06030089|Antimetabolites|antimetabolites|mesh-ancestor
139214861|NCT06030089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214862|NCT06030089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214863|NCT06030089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214864|NCT06029933|Vaccines|vaccines|mesh-list
139214865|NCT06029933|Immunologic Factors|immunologic factors|mesh-ancestor
139214866|NCT06029933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214867|NCT06029803|Epinephrine|epinephrine|mesh-list
139214868|NCT06029803|Racepinephrine|racepinephrine|mesh-list
139214869|NCT06029803|Epinephryl borate|epinephryl borate|mesh-list
139214870|NCT06029803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139214871|NCT06029803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139214872|NCT06029803|Adrenergic Agents|adrenergic agents|mesh-ancestor
139214873|NCT06029803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214874|NCT06029803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214875|NCT06029803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214876|NCT06029803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139214877|NCT06029803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139214878|NCT06029803|Autonomic Agents|autonomic agents|mesh-ancestor
139214879|NCT06029803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214880|NCT06029803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139214881|NCT06029803|Respiratory System Agents|respiratory system agents|mesh-ancestor
139214882|NCT06029803|Mydriatics|mydriatics|mesh-ancestor
139214883|NCT06029803|Sympathomimetics|sympathomimetics|mesh-ancestor
139214884|NCT06029803|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139214885|NCT06029569|Sirolimus|sirolimus|mesh-list
139214886|NCT06029569|Paclitaxel|paclitaxel|mesh-list
139214887|NCT06029569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139214888|NCT06029569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214889|NCT06029569|Tubulin Modulators|tubulin modulators|mesh-ancestor
139214890|NCT06029569|Antimitotic Agents|antimitotic agents|mesh-ancestor
139214891|NCT06029569|Mitosis Modulators|mitosis modulators|mesh-ancestor
139214892|NCT06029569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214893|NCT06029569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139000982|NCT00538902|Adalimumab|adalimumab|mesh-list
139214894|NCT06029569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214895|NCT06029569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139214896|NCT06029569|Antifungal Agents|antifungal agents|mesh-ancestor
139214897|NCT06029569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139214898|NCT06029569|Immunologic Factors|immunologic factors|mesh-ancestor
139214899|NCT06029569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214900|NCT06029296|Diclofenac|diclofenac|mesh-list
139214901|NCT06029296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139214902|NCT06029296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139214903|NCT06029296|Analgesics|analgesics|mesh-ancestor
139214904|NCT06029296|Sensory System Agents|sensory system agents|mesh-ancestor
139214905|NCT06029296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214906|NCT06029296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214907|NCT06029296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139214908|NCT06029296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139214909|NCT06029296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139214910|NCT06029296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214911|NCT06029296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214912|NCT06029023|Propolis|propolis|mesh-list
139214913|NCT06029023|Curcumin|curcumin|mesh-list
139214914|NCT06029023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139214915|NCT06029023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139214916|NCT06029023|Analgesics|analgesics|mesh-ancestor
139214917|NCT06029023|Sensory System Agents|sensory system agents|mesh-ancestor
139214918|NCT06029023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214919|NCT06029023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214920|NCT06029023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139214921|NCT06029023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139214922|NCT06029023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214923|NCT06029023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214924|NCT06029023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214925|NCT06029023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139214926|NCT06028828|Fludarabine|fludarabine|mesh-list
139214927|NCT06028828|Melphalan|melphalan|mesh-list
139214928|NCT06028828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214929|NCT06028828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214930|NCT06028828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139214931|NCT06028828|Immunologic Factors|immunologic factors|mesh-ancestor
139214932|NCT06028828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214933|NCT06028828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139214934|NCT06028828|Alkylating Agents|alkylating agents|mesh-ancestor
139214935|NCT06028828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139214936|NCT06028737|Leucovorin|leucovorin|mesh-list
139214937|NCT06028737|Docetaxel|docetaxel|mesh-list
139214938|NCT06028737|Fluorouracil|fluorouracil|mesh-list
139214939|NCT06028737|Oxaliplatin|oxaliplatin|mesh-list
139214940|NCT06028737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214941|NCT06028737|Tubulin Modulators|tubulin modulators|mesh-ancestor
139214942|NCT06028737|Antimitotic Agents|antimitotic agents|mesh-ancestor
139214943|NCT06028737|Mitosis Modulators|mitosis modulators|mesh-ancestor
139214944|NCT06028737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214945|NCT06028737|Antimetabolites|antimetabolites|mesh-ancestor
139214946|NCT06028737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139171540|NCT02939209|Hydromorphone|hydromorphone|mesh-list
139214947|NCT06028737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139214948|NCT06028737|Immunologic Factors|immunologic factors|mesh-ancestor
139214949|NCT06028737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214951|NCT06028737|Protective Agents|protective agents|mesh-ancestor
139214952|NCT06028737|Vitamin B Complex|vitamin b complex|mesh-ancestor
139214953|NCT06028737|Vitamins|vitamins|mesh-ancestor
139214954|NCT06028737|Micronutrients|micronutrients|mesh-ancestor
139214955|NCT06028633|Paclitaxel|paclitaxel|mesh-list
139214956|NCT06028633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139214957|NCT06028633|Pembrolizumab|pembrolizumab|mesh-list
139214958|NCT06028633|Lenvatinib|lenvatinib|mesh-list
139214959|NCT06028633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139214960|NCT06028633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214961|NCT06028633|Tubulin Modulators|tubulin modulators|mesh-ancestor
139214962|NCT06028633|Antimitotic Agents|antimitotic agents|mesh-ancestor
139000989|NCT00687323|Temozolomide|temozolomide|mesh-list
139214963|NCT06028633|Mitosis Modulators|mitosis modulators|mesh-ancestor
139214964|NCT06028633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214965|NCT06028633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139214966|NCT06028633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139214967|NCT06028633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139214968|NCT06028633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139214969|NCT06028256|Norepinephrine|norepinephrine|mesh-list
139214970|NCT06028256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139214971|NCT06028256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139214972|NCT06028256|Adrenergic Agents|adrenergic agents|mesh-ancestor
139214973|NCT06028256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139214974|NCT06028256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214975|NCT06028256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214976|NCT06028256|Sympathomimetics|sympathomimetics|mesh-ancestor
139214977|NCT06028256|Autonomic Agents|autonomic agents|mesh-ancestor
139214978|NCT06028256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139214979|NCT06028256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139214980|NCT06018116|Avelumab|avelumab|mesh-list
139214981|NCT06018116|Bicalutamide|bicalutamide|mesh-list
139214982|NCT06018116|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139214983|NCT06018116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139214984|NCT06018116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139214985|NCT06018116|Immunologic Factors|immunologic factors|mesh-ancestor
139214986|NCT06018116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214987|NCT06018116|Androgen Antagonists|androgen antagonists|mesh-ancestor
139214988|NCT06018116|Hormone Antagonists|hormone antagonists|mesh-ancestor
139214989|NCT06018116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139214990|NCT06012331|Mitogens|mitogens|mesh-list
139214991|NCT06012331|Mitosis Modulators|mitosis modulators|mesh-ancestor
139214992|NCT06012331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139214993|NCT05964335|Nalbuphine|nalbuphine|mesh-list
139214994|NCT05964335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139214995|NCT05964335|Narcotics|narcotics|mesh-ancestor
139214996|NCT05964335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139214997|NCT05964335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139214998|NCT05964335|Analgesics|analgesics|mesh-ancestor
139214999|NCT05964335|Sensory System Agents|sensory system agents|mesh-ancestor
139215000|NCT05964335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215001|NCT05959720|Cytarabine|cytarabine|mesh-list
139215002|NCT05959720|Prednisone|prednisone|mesh-list
139215003|NCT05959720|Cyclophosphamide|cyclophosphamide|mesh-list
139215004|NCT05959720|Doxorubicin|doxorubicin|mesh-list
139215005|NCT05959720|Methotrexate|methotrexate|mesh-list
139215006|NCT05959720|Daunorubicin|daunorubicin|mesh-list
139215007|NCT05959720|Asparaginase|asparaginase|mesh-list
139215008|NCT05959720|Mercaptopurine|mercaptopurine|mesh-list
139215009|NCT05959720|Pegaspargase|pegaspargase|mesh-list
139215010|NCT05959720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139215011|NCT05959720|Immunologic Factors|immunologic factors|mesh-ancestor
139215012|NCT05959720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215013|NCT05959720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139215014|NCT05959720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139215015|NCT05959720|Alkylating Agents|alkylating agents|mesh-ancestor
139642450|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
139215016|NCT05959720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215017|NCT05959720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215018|NCT05959720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139215019|NCT05959720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139215020|NCT05959720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139215021|NCT05959720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139215022|NCT05959720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215023|NCT05959720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139215024|NCT05959720|Glucocorticoids|glucocorticoids|mesh-ancestor
139215026|NCT05959720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139215027|NCT05959720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139215028|NCT05959720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139215029|NCT05959720|Abortifacient Agents|abortifacient agents|mesh-ancestor
139215030|NCT05959720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139215031|NCT05959720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139215032|NCT05959720|Antimetabolites|antimetabolites|mesh-ancestor
139215033|NCT05959720|Dermatologic Agents|dermatologic agents|mesh-ancestor
139215034|NCT05959720|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139215035|NCT05959720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139215036|NCT05959720|Antiviral Agents|antiviral agents|mesh-ancestor
139215037|NCT05959720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215038|NCT05926180|Digoxin|digoxin|mesh-list
139215039|NCT05926180|Midazolam|midazolam|mesh-list
139215040|NCT05926180|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139215041|NCT05926180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139215042|NCT05926180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139215043|NCT05926180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215044|NCT05926180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215045|NCT05926180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139215046|NCT05926180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139215047|NCT05926180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139215048|NCT05926180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139215049|NCT05926180|Anesthetics, General|anesthetics, general|mesh-ancestor
139215050|NCT05926180|Anesthetics|anesthetics|mesh-ancestor
139215051|NCT05926180|GABA Modulators|gaba modulators|mesh-ancestor
139215052|NCT05926180|GABA Agents|gaba agents|mesh-ancestor
139215053|NCT05926180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215054|NCT05926180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215055|NCT05926180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139215056|NCT05926180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139215057|NCT05926180|Antimetabolites|antimetabolites|mesh-ancestor
139215058|NCT05926180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139215059|NCT05926180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139215060|NCT05926180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215061|NCT05926180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139215062|NCT05926180|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139215063|NCT05926180|Protective Agents|protective agents|mesh-ancestor
139215064|NCT05925140|Ritonavir|ritonavir|mesh-list
139215065|NCT05925140|Lopinavir|lopinavir|mesh-list
139215066|NCT05925140|Remdesivir|remdesivir|mesh-list
139215067|NCT05925140|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139215068|NCT05925140|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139215069|NCT05925140|Protease Inhibitors|protease inhibitors|mesh-ancestor
139215070|NCT05925140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215071|NCT05925140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215072|NCT05925140|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139215073|NCT05925140|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139215074|NCT05925140|Antiviral Agents|antiviral agents|mesh-ancestor
139215075|NCT05925140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215076|NCT05925140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139215077|NCT05925140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139215078|NCT05925140|Antimetabolites|antimetabolites|mesh-ancestor
139215079|NCT05917067|Parathyroid Hormone|parathyroid hormone|mesh-list
139215080|NCT05917067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139215081|NCT05917067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215082|NCT05875272|Hemostatics|hemostatics|mesh-list
139215083|NCT05875272|Coagulants|coagulants|mesh-ancestor
139215084|NCT05859074|Pembrolizumab|pembrolizumab|mesh-list
139215085|NCT05859074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215086|NCT05859074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215087|NCT05859074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215088|NCT05859074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215089|NCT05821517|Methoxyflurane|methoxyflurane|mesh-list
139215090|NCT05821517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139215091|NCT05821517|Anesthetics, General|anesthetics, general|mesh-ancestor
139215093|NCT05821517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215094|NCT05821517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215095|NCT05803811|Riboflavin|riboflavin|mesh-list
139215096|NCT05803811|Vitamin B Complex|vitamin b complex|mesh-ancestor
139215097|NCT05803811|Vitamins|vitamins|mesh-ancestor
139215098|NCT05803811|Micronutrients|micronutrients|mesh-ancestor
139215099|NCT05803811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215100|NCT05803811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139215101|NCT05803811|Dermatologic Agents|dermatologic agents|mesh-ancestor
139215102|NCT05764057|Dapagliflozin|dapagliflozin|mesh-list
139215103|NCT05764057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139215104|NCT05764057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215105|NCT05764057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139215106|NCT05764057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215107|NCT05758597|Midazolam|midazolam|mesh-list
139215108|NCT05758597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139215109|NCT05758597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139215110|NCT05758597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215111|NCT05758597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215112|NCT05758597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139215113|NCT05758597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139215114|NCT05758597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139215115|NCT05758597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139215116|NCT05758597|Anesthetics, General|anesthetics, general|mesh-ancestor
139215117|NCT05758597|Anesthetics|anesthetics|mesh-ancestor
139215118|NCT05758597|GABA Modulators|gaba modulators|mesh-ancestor
139215119|NCT05758597|GABA Agents|gaba agents|mesh-ancestor
139215120|NCT05758597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215121|NCT05758597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215122|NCT05745038|Zaleplon|zaleplon|mesh-list
139215123|NCT05745038|Anticonvulsants|anticonvulsants|mesh-ancestor
139215124|NCT05745038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139215125|NCT05745038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215126|NCT05745038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215127|NCT05745038|GABA Modulators|gaba modulators|mesh-ancestor
139215128|NCT05745038|GABA Agents|gaba agents|mesh-ancestor
139215129|NCT05745038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215130|NCT05745038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215131|NCT05652673|Nivolumab|nivolumab|mesh-list
139215132|NCT05652673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215133|NCT05652673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215134|NCT05652673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215135|NCT05652673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215136|NCT05641194|Caffeine|caffeine|mesh-list
139215137|NCT05641194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139215138|NCT05641194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215139|NCT05641194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139215140|NCT05641194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215141|NCT05641194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215142|NCT05641194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139215143|NCT05641194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139215144|NCT05641194|Purinergic Agents|purinergic agents|mesh-ancestor
139215145|NCT05641194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215146|NCT05638932|Tofacitinib|tofacitinib|mesh-list
139215147|NCT05638932|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139215148|NCT05638932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139215149|NCT05638932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215150|NCT05638932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215151|NCT05600127|Avelumab|avelumab|mesh-list
139215152|NCT05600127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215153|NCT05600127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215154|NCT05568160|Vasopressins|vasopressins|mesh-list
139215155|NCT05568160|Arginine Vasopressin|arginine vasopressin|mesh-list
139215156|NCT05568160|Norepinephrine|norepinephrine|mesh-list
139215157|NCT05568160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139215158|NCT05568160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139215159|NCT05568160|Adrenergic Agents|adrenergic agents|mesh-ancestor
139215160|NCT05568160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215161|NCT05568160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215162|NCT05568160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215163|NCT05568160|Sympathomimetics|sympathomimetics|mesh-ancestor
139215164|NCT05568160|Autonomic Agents|autonomic agents|mesh-ancestor
139215165|NCT05568160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215166|NCT05568160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139215167|NCT05568160|Hemostatics|hemostatics|mesh-ancestor
139215168|NCT05568160|Coagulants|coagulants|mesh-ancestor
139215169|NCT05568160|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139215170|NCT05568160|Natriuretic Agents|natriuretic agents|mesh-ancestor
139215171|NCT05555862|Artesunate|artesunate|mesh-list
139215172|NCT05555862|Artenimol|artenimol|mesh-list
139215173|NCT05555862|Artemisinins|artemisinins|mesh-list
139215174|NCT05555862|Artemisinin|artemisinin|mesh-list
139171770|NCT01142557|Interferons|interferons|mesh-list
139215175|NCT05555862|Antimalarials|antimalarials|mesh-ancestor
139215176|NCT05555862|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139215177|NCT05555862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139215178|NCT05555862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215179|NCT05555862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215180|NCT05555862|Antiviral Agents|antiviral agents|mesh-ancestor
139215181|NCT05555862|Schistosomicides|schistosomicides|mesh-ancestor
139215182|NCT05555862|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139215183|NCT05555862|Anthelmintics|anthelmintics|mesh-ancestor
139215185|NCT05552287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139215186|NCT05552287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139215187|NCT05552287|Dermatologic Agents|dermatologic agents|mesh-ancestor
139215188|NCT05552287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139215189|NCT05552287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139215190|NCT05542407|Atezolizumab|atezolizumab|mesh-list
139215191|NCT05542407|TIC10 compound|tic10 compound|mesh-list
139215192|NCT05542407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215193|NCT05542407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215194|NCT05542407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215195|NCT05542407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215196|NCT05517642|Vaccines|vaccines|mesh-list
139215197|NCT05517642|Immunologic Factors|immunologic factors|mesh-ancestor
139215198|NCT05517642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215199|NCT05513586|Immunoglobulins|immunoglobulins|mesh-list
139215200|NCT05513586|Immunologic Factors|immunologic factors|mesh-ancestor
139215201|NCT05513586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215202|NCT05438498|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139215203|NCT05438498|Antiviral Agents|antiviral agents|mesh-ancestor
139215204|NCT05438498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215205|NCT05436964|Dexmedetomidine|dexmedetomidine|mesh-list
139215206|NCT05436964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139215207|NCT05436964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215208|NCT05436964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215209|NCT05436964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139215210|NCT05436964|Analgesics|analgesics|mesh-ancestor
139215211|NCT05436964|Sensory System Agents|sensory system agents|mesh-ancestor
139215212|NCT05436964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215213|NCT05436964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139215214|NCT05436964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139215215|NCT05436964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139215216|NCT05436964|Adrenergic Agents|adrenergic agents|mesh-ancestor
139215217|NCT05436964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215218|NCT05436964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215219|NCT05412706|Niraparib|niraparib|mesh-list
139215220|NCT05412706|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139215221|NCT05412706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215222|NCT05412706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215223|NCT05412706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215224|NCT05338671|Anesthetics|anesthetics|mesh-list
139215225|NCT05338671|Anesthetics, Local|anesthetics, local|mesh-list
139215226|NCT05338671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215227|NCT05338671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215228|NCT05338671|Sensory System Agents|sensory system agents|mesh-ancestor
139215229|NCT05338671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215230|NCT05338398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139215231|NCT05338398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139215232|NCT05338398|Benzydamine|benzydamine|mesh-list
139215233|NCT05338398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215234|NCT05306548|Triamcinolone|triamcinolone|mesh-list
139215235|NCT05306548|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139215236|NCT05306548|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139215237|NCT05306548|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139215238|NCT05306548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139215239|NCT05306548|Glucocorticoids|glucocorticoids|mesh-ancestor
139642451|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215240|NCT05306548|Hormones|hormones|mesh-ancestor
139215241|NCT05306548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139215242|NCT05306548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215243|NCT05306548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139215244|NCT05306548|Immunologic Factors|immunologic factors|mesh-ancestor
139215245|NCT05306548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215246|NCT05306548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215247|NCT05283109|Vaccines|vaccines|mesh-list
139215248|NCT05283109|Poly ICLC|poly iclc|mesh-list
139001076|NCT00759005|Propranolol|propranolol|mesh-list
139215249|NCT05283109|Immunologic Factors|immunologic factors|mesh-ancestor
139215250|NCT05283109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215251|NCT05283109|Interferon Inducers|interferon inducers|mesh-ancestor
139215252|NCT05237687|Sirolimus|sirolimus|mesh-list
139215253|NCT05237687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139215254|NCT05237687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215255|NCT05237687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139215256|NCT05237687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215257|NCT05237687|Antifungal Agents|antifungal agents|mesh-ancestor
139215258|NCT05237687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139215259|NCT05237687|Immunologic Factors|immunologic factors|mesh-ancestor
139215260|NCT05237687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215261|NCT05205109|Pembrolizumab|pembrolizumab|mesh-list
139215262|NCT05205109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215263|NCT05205109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215264|NCT05205109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215265|NCT05205109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215266|NCT05200143|Nivolumab|nivolumab|mesh-list
139215267|NCT05200143|Ipilimumab|ipilimumab|mesh-list
139215268|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215269|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215270|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215271|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215272|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
139215273|NCT05142254|Tadalafil|tadalafil|mesh-list
139215274|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
139215275|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139215276|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139215277|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215278|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215279|NCT05142254|Urological Agents|urological agents|mesh-ancestor
139215280|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215281|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
139215282|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139215283|NCT05125978|Dipyrone|dipyrone|mesh-list
139215284|NCT05125978|Tramadol|tramadol|mesh-list
139215285|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139215286|NCT05125978|Narcotics|narcotics|mesh-ancestor
139215287|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215288|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215289|NCT05125978|Analgesics|analgesics|mesh-ancestor
139215290|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
139215291|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215292|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139215293|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139215294|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139215295|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139215296|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
139215297|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139215298|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
139215299|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215300|NCT05098574|Drospirenone|drospirenone|mesh-list
139215301|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139215302|NCT05098574|Estradiol|estradiol|mesh-list
139215303|NCT05098574|Estrogens|estrogens|mesh-ancestor
139215304|NCT05098574|Hormones|hormones|mesh-ancestor
139215305|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139215306|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215307|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139215308|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
139215309|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139215310|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139215311|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139215312|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139215313|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139215314|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
139001085|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
139215315|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139215316|NCT05098574|Diuretics|diuretics|mesh-ancestor
139215317|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
139215319|NCT04970108|Telmisartan|telmisartan|mesh-list
139215320|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139215321|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215322|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139215323|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171932|NCT01146145|Ketamine|ketamine|mesh-list
139215324|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139215325|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139215326|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139215327|NCT04968015|Cytarabine|cytarabine|mesh-list
139215328|NCT04968015|Venetoclax|venetoclax|mesh-list
139215329|NCT04968015|Idarubicin|idarubicin|mesh-list
139215330|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139215331|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
139215332|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215333|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215334|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
139215335|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215336|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139215337|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
139215338|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215339|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139215340|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139215341|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139215342|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215343|NCT04955366|Abatacept|abatacept|mesh-list
139215344|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215345|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215346|NCT04955366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215347|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215348|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139215349|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
139215350|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215351|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139215352|NCT04864743|Factor VIII|factor viii|mesh-list
139215353|NCT04864743|Coagulants|coagulants|mesh-ancestor
139215354|NCT04783935|Cladribine|cladribine|mesh-list
139215355|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215356|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139215357|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
139215358|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215359|NCT04767061|Propranolol|propranolol|mesh-list
139215360|NCT04767061|Metoprolol|metoprolol|mesh-list
139215361|NCT04767061|Atenolol|atenolol|mesh-list
139215362|NCT04767061|Sotalol|sotalol|mesh-list
139215363|NCT04767061|Nadolol|nadolol|mesh-list
139215364|NCT04767061|Acebutolol|acebutolol|mesh-list
139215365|NCT04767061|Carvedilol|carvedilol|mesh-list
139215366|NCT04767061|Nebivolol|nebivolol|mesh-list
139215367|NCT04767061|Bisoprolol|bisoprolol|mesh-list
139215368|NCT04767061|Labetalol|labetalol|mesh-list
139215369|NCT04767061|Pindolol|pindolol|mesh-list
139215370|NCT04767061|Betaxolol|betaxolol|mesh-list
139215371|NCT04767061|Penbutolol|penbutolol|mesh-list
139215372|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139215373|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139215374|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
139215375|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215376|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215377|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215378|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139215379|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139215380|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
139215381|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
139215382|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
139215383|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215384|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139215385|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
139215386|NCT04767061|Protective Agents|protective agents|mesh-ancestor
139215387|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139215388|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139215389|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139215390|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139215391|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139215392|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139215393|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139215394|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139215395|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
139215396|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139215397|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
139215399|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139215400|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
139215401|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
139215402|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
139215403|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215404|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215405|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139215406|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139215407|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215408|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139215409|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139215410|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139215411|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139215412|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139215413|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139215414|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
139215415|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
139215416|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
139215417|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
139215418|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215419|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215420|NCT04750967|Lidocaine|lidocaine|mesh-list
139215421|NCT04750967|Amitriptyline|amitriptyline|mesh-list
139215422|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
139215423|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
139215424|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215425|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215426|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
139215427|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215428|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139215429|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139215430|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139215431|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139215432|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215433|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139215434|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
139215435|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139215436|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139215437|NCT04750967|Analgesics|analgesics|mesh-ancestor
139215438|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139215439|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139215440|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
139215441|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215442|NCT04742075|Durvalumab|durvalumab|mesh-list
139215443|NCT04742075|Olaparib|olaparib|mesh-list
139215444|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139215445|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215446|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215447|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
139215448|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215449|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139215450|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215451|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215452|NCT04729517|Azelastine|azelastine|mesh-list
139215453|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139215454|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
139215455|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215456|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215457|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139215458|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
139215459|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139215460|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215461|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215462|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139215463|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139215464|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139215465|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
139215466|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
139215467|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215468|NCT04726332|Prednisone|prednisone|mesh-list
139215469|NCT04726332|Fulvestrant|fulvestrant|mesh-list
139215470|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139215471|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
139215472|NCT04726332|Hormones|hormones|mesh-ancestor
139215473|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139215474|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215475|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139215476|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215477|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139215478|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139215479|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
139215480|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
139215481|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139215482|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215483|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215484|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139215485|NCT04720963|Analgesics|analgesics|mesh-ancestor
139215486|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
139215487|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215488|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139215489|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139215490|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139215491|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
139215492|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215493|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215494|NCT04666701|Ketorolac|ketorolac|mesh-list
139215495|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139215496|NCT04666701|Scopolamine|scopolamine|mesh-list
139215497|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139215498|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139215499|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139215500|NCT04666701|Analgesics|analgesics|mesh-ancestor
139215501|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
139215502|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215503|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215504|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139215505|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139215506|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139215507|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215508|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215509|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139215510|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
139215511|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
139215512|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139215513|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
139215514|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139215515|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
139215516|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215517|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139215518|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
139215519|NCT04643405|Paclitaxel|paclitaxel|mesh-list
139215520|NCT04643405|Gemcitabine|gemcitabine|mesh-list
139215521|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139215522|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215523|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
139215524|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
139215525|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
139215526|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215527|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139215528|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
139215529|NCT04638660|Phentolamine|phentolamine|mesh-list
139215530|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139215531|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139215532|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139215533|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139215534|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
139215535|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215536|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215537|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215538|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139215539|NCT04593329|Dipyrone|dipyrone|mesh-list
139215540|NCT04593329|Tramadol|tramadol|mesh-list
139215541|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139215542|NCT04593329|Narcotics|narcotics|mesh-ancestor
139215543|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215544|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215545|NCT04593329|Analgesics|analgesics|mesh-ancestor
139215546|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
139215547|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215548|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139215549|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139215550|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139215551|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139215552|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
139215553|NCT04448392|Valacyclovir|valacyclovir|mesh-list
139215554|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
139215555|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215556|NCT04388904|Tenofovir|tenofovir|mesh-list
139215557|NCT04388904|Emtricitabine|emtricitabine|mesh-list
139215558|NCT04388904|Darunavir|darunavir|mesh-list
139215559|NCT04388904|Cobicistat|cobicistat|mesh-list
139215560|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139215561|NCT04388904|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139215562|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
139215563|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215564|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139215565|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139215566|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215567|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215568|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139215569|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139215570|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139215571|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139215572|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
139215573|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139215574|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139215575|NCT04373941|Lenograstim|lenograstim|mesh-list
139215576|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139215577|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
139215578|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215579|NCT04281706|Propofol|propofol|mesh-list
139215580|NCT04281706|Etomidate|etomidate|mesh-list
139215581|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139215582|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215583|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215584|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139215585|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
139215586|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
139215587|NCT04246437|Carbidopa|carbidopa|mesh-list
139215588|NCT04246437|Entacapone|entacapone|mesh-list
139215589|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139215590|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139215591|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
139215592|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215593|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215594|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215595|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139215596|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215597|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139215598|NCT04111458|Trametinib|trametinib|mesh-list
139215599|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215600|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139215601|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215602|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215603|NCT04098744|Artesunate|artesunate|mesh-list
139215604|NCT04098744|Artemisinins|artemisinins|mesh-list
139215605|NCT04098744|Artemisinin|artemisinin|mesh-list
139215606|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
139215607|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139215608|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139215609|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215610|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215611|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
139215612|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
139215613|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139215614|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
139215615|NCT04049539|Cytarabine|cytarabine|mesh-list
139215616|NCT04049539|Daunorubicin|daunorubicin|mesh-list
139215617|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139215618|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
139215619|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215620|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215628|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139215630|NCT03976323|Cisplatin|cisplatin|mesh-list
139215631|NCT03976323|Carboplatin|carboplatin|mesh-list
139215632|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
139215633|NCT03976323|Pemetrexed|pemetrexed|mesh-list
139215634|NCT03976323|Olaparib|olaparib|mesh-list
139215635|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215636|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215637|NCT03976323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215638|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215639|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215640|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139215641|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139215642|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139215643|NCT03974152|Nicotine|nicotine|mesh-list
139215644|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139215645|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
139215646|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215647|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215648|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139215649|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139215650|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
139215651|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215652|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215660|NCT03826628|Sirolimus|sirolimus|mesh-list
139215661|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139215662|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215663|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139215664|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215665|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
139215666|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139215667|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
139215668|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215669|NCT03772028|Cisplatin|cisplatin|mesh-list
139215670|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215671|NCT03740165|Paclitaxel|paclitaxel|mesh-list
139215672|NCT03740165|Docetaxel|docetaxel|mesh-list
139215673|NCT03740165|Bevacizumab|bevacizumab|mesh-list
139215674|NCT03740165|Carboplatin|carboplatin|mesh-list
139215675|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
139215676|NCT03740165|Olaparib|olaparib|mesh-list
139215677|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139215678|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215679|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
139215680|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
139215681|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
139215682|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215683|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215684|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139215685|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139215686|NCT03740165|Growth Substances|growth substances|mesh-ancestor
139215687|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215688|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
139215689|NCT03740165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215690|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139215691|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215692|NCT03737240|Insulin|insulin|mesh-list
139215693|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139215694|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
139215695|NCT03737240|Liraglutide|liraglutide|mesh-list
139215696|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
139215697|NCT03737240|Xultophy|xultophy|mesh-list
139215698|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139215699|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215701|NCT03737240|Hormones|hormones|mesh-ancestor
139215702|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139215703|NCT03632044|Ropivacaine|ropivacaine|mesh-list
139215704|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
139215705|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
139215706|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215707|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215708|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
139215709|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215710|NCT03582722|Orlistat|orlistat|mesh-list
139215711|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215712|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215713|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139215714|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139215715|NCT03553875|Memantine|memantine|mesh-list
139215716|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139215717|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139215718|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
139215719|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215720|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215721|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215722|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139215723|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139215724|NCT03532178|Rocuronium|rocuronium|mesh-list
139215725|NCT03532178|Succinylcholine|succinylcholine|mesh-list
139215726|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139215727|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139215728|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139215729|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215730|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215731|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139215732|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
139215733|NCT03519997|Bavituximab|bavituximab|mesh-list
139215734|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215735|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215736|NCT03519997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215737|NCT03519997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215738|NCT03511976|Methylphenidate|methylphenidate|mesh-list
139215739|NCT03511976|Amphetamine|amphetamine|mesh-list
139215740|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139215741|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215742|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139215743|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139215744|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139215745|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215746|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
139215747|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215748|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
139215749|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
139215750|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215751|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
139215752|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139215753|NCT03452111|ST 1435|st 1435|mesh-list
139215754|NCT03452111|Testosterone|testosterone|mesh-list
139215755|NCT03452111|Androgens|androgens|mesh-ancestor
139215756|NCT03452111|Hormones|hormones|mesh-ancestor
139215757|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139215758|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215759|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139215760|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
139215761|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139215762|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139215763|NCT03449901|Gemcitabine|gemcitabine|mesh-list
139215764|NCT03449901|Docetaxel|docetaxel|mesh-list
139215765|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139215766|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
139215767|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215768|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215769|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
139215770|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
139215771|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
139215773|NCT03363659|Temozolomide|temozolomide|mesh-list
139215774|NCT03363659|Disulfiram|disulfiram|mesh-list
139215775|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139215776|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
139215777|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215778|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215779|NCT03363659|Trace Elements|trace elements|mesh-ancestor
139215789|NCT03295227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215791|NCT03225664|Trametinib|trametinib|mesh-list
139215792|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215793|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215794|NCT03225664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215795|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215796|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139215797|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215798|NCT03217747|Avelumab|avelumab|mesh-list
139215799|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139215800|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
139215801|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215802|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215803|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
139215804|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215805|NCT03204812|Durvalumab|durvalumab|mesh-list
139215806|NCT03204812|Ipilimumab|ipilimumab|mesh-list
139215807|NCT03204812|Tremelimumab|tremelimumab|mesh-list
139215808|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
139215809|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139215810|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
139215811|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215812|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215813|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
139215814|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215815|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215816|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215817|NCT03201250|Dexamethasone|dexamethasone|mesh-list
139215818|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139215819|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
139215820|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
139215821|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215822|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215823|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139215824|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
139215825|NCT03201250|Hormones|hormones|mesh-ancestor
139215826|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139215827|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139215828|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215829|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
139215830|NCT03149029|Trametinib|trametinib|mesh-list
139215831|NCT03149029|Dabrafenib|dabrafenib|mesh-list
139215832|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215833|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215834|NCT03149029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215835|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215836|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139215837|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215848|NCT02853305|Carboplatin|carboplatin|mesh-list
139215849|NCT02853305|Gemcitabine|gemcitabine|mesh-list
139215850|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
139215851|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215852|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139215853|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
139215854|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215855|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215856|NCT02853305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139215857|NCT02815995|Durvalumab|durvalumab|mesh-list
139215858|NCT02815995|Tremelimumab|tremelimumab|mesh-list
139215859|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215860|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215861|NCT02735902|Aspirin|aspirin|mesh-list
139215862|NCT02735902|Vitamin K|vitamin k|mesh-list
139215863|NCT02735902|Anticoagulants|anticoagulants|mesh-list
139215864|NCT02735902|Vitamins|vitamins|mesh-ancestor
139215865|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
139215866|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215867|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139215868|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139215869|NCT02735902|Analgesics|analgesics|mesh-ancestor
139215870|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
139215871|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215872|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139215873|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139215874|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139215875|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139215876|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215877|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139215878|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139215879|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215880|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
139215881|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139215882|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
139215883|NCT02735902|Coagulants|coagulants|mesh-ancestor
139215884|NCT02524275|Docetaxel|docetaxel|mesh-list
139215885|NCT02524275|Capecitabine|capecitabine|mesh-list
139215886|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215887|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
139215888|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
139215889|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
139215890|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215891|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139215892|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
139215893|NCT02499120|Cetuximab|cetuximab|mesh-list
139215894|NCT02499120|Palbociclib|palbociclib|mesh-list
139215895|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215896|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215897|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139215898|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215899|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215900|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139215901|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
139215902|NCT02227992|Coagulants|coagulants|mesh-ancestor
139215903|NCT01906853|Vaccines|vaccines|mesh-list
139215904|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
139215905|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
139215906|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215907|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139215908|NCT01871766|Dactinomycin|dactinomycin|mesh-list
139215909|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
139215910|NCT01871766|Ifosfamide|ifosfamide|mesh-list
139215911|NCT01871766|Bevacizumab|bevacizumab|mesh-list
139215912|NCT01871766|Doxorubicin|doxorubicin|mesh-list
139215913|NCT01871766|Irinotecan|irinotecan|mesh-list
139215914|NCT01871766|Etoposide|etoposide|mesh-list
139215915|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
139215916|NCT01871766|Vincristine|vincristine|mesh-list
139215917|NCT01871766|Sorafenib|sorafenib|mesh-list
139215918|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
139215919|NCT01871766|Razoxane|razoxane|mesh-list
139215920|NCT01871766|Mitogens|mitogens|mesh-list
139215921|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139215922|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
139215923|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215924|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139215925|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139215926|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
139215927|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215928|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215929|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139215930|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139215931|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139215932|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139215933|NCT01871766|Growth Substances|growth substances|mesh-ancestor
139215934|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
139215935|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139215936|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139215937|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139215938|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139215939|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139642133|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139215940|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139215941|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
139215942|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
139215943|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
139215944|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139215945|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139215946|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139215947|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139215948|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139215949|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139215950|NCT01871766|Protective Agents|protective agents|mesh-ancestor
139215951|NCT01628029|Melatonin|melatonin|mesh-list
139215952|NCT01628029|Methylphenidate|methylphenidate|mesh-list
139215953|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
139215954|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215955|NCT01628029|Protective Agents|protective agents|mesh-ancestor
139215956|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215957|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215958|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139215959|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139215960|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139215961|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139215962|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
139215963|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139215964|NCT01346787|Dexamethasone|dexamethasone|mesh-list
139215965|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
139215966|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139215967|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
139215968|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215969|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139215970|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139215971|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
139215972|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215973|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215974|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139215975|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139215976|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
139215977|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
139215978|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139215979|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139215980|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
139215981|NCT01346787|Hormones|hormones|mesh-ancestor
139215982|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139215983|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139215984|NCT01033565|Melatonin|melatonin|mesh-list
139215985|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
139215986|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215987|NCT01033565|Protective Agents|protective agents|mesh-ancestor
139215988|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139215989|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139215990|NCT00981656|Fluorouracil|fluorouracil|mesh-list
139215991|NCT00981656|Mitomycins|mitomycins|mesh-list
139215992|NCT00981656|Mitomycin|mitomycin|mesh-list
139215993|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139215994|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
139215995|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139215996|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139215997|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139215998|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
139215999|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216000|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139216001|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
139216002|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139216003|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216004|NCT00742157|Hormones|hormones|mesh-list
139216005|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139216006|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216007|NCT00539591|Interferons|interferons|mesh-list
139216008|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
139216009|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
139216010|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139216011|NCT00539591|Temozolomide|temozolomide|mesh-list
139216012|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216013|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
139216014|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216015|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139216016|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
139216017|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216018|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
139216019|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216020|NCT03293992|Latanoprost|latanoprost|mesh-list
139216021|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139216022|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139216023|NCT01332201|Tacrolimus|tacrolimus|mesh-list
139216024|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139216025|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
139216026|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216027|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139216028|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216029|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216030|NCT01332279|Everolimus|everolimus|mesh-list
139216031|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139216032|NCT01332279|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139216033|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139216034|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216035|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216036|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139216037|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
139216038|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216039|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216040|NCT03298906|Ticlopidine|ticlopidine|mesh-list
139216041|NCT03298906|Esketamine|esketamine|mesh-list
139216042|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
139216043|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139216044|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139216045|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139216046|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216047|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139216048|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139216049|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139216050|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139216051|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
139216052|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216053|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216054|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139216055|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139216056|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216057|NCT03697629|Daratumumab|daratumumab|mesh-list
139216058|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216059|NCT00398541|Losartan|losartan|mesh-list
139001216|NCT05232630|Fenfluramine|fenfluramine|mesh-list
139216060|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139216061|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139216062|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139216063|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139216064|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139216065|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216066|NCT00398541|Diuretics|diuretics|mesh-ancestor
139216067|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
139216068|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216069|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139216070|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139216071|NCT03286582|Clobetasol|clobetasol|mesh-list
139216072|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216073|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
139216074|NCT03286582|Hormones|hormones|mesh-ancestor
139216075|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139216076|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216077|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139216078|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139216079|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
139216080|NCT05202002|Hormones|hormones|mesh-ancestor
139216081|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172680|NCT01319942|Sorafenib|sorafenib|mesh-list
139216082|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216083|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216084|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216085|NCT02460640|Morphine|morphine|mesh-list
139216086|NCT02460640|Ropivacaine|ropivacaine|mesh-list
139216087|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139216088|NCT02460640|Narcotics|narcotics|mesh-ancestor
139216089|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216090|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216091|NCT02460640|Analgesics|analgesics|mesh-ancestor
139216092|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
139216093|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216094|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
139216095|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
139216096|NCT03298516|Azacitidine|azacitidine|mesh-list
139216097|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139216098|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
139216099|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216100|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216101|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216102|NCT03285802|Everolimus|everolimus|mesh-list
139216103|NCT03285802|Letrozole|letrozole|mesh-list
139216104|NCT03285802|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139216105|NCT03285802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139216106|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216107|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216108|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139216109|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
139216110|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216111|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216112|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139216113|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139216114|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139216115|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
139216116|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139216117|NCT05130086|Islatravir|islatravir|mesh-list
139216118|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
139216119|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216120|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216121|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216122|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139216123|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139216124|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139216125|NCT02461186|Piperaquine|piperaquine|mesh-list
139216126|NCT02461186|Artenimol|artenimol|mesh-list
139216127|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
139216128|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139216129|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139216130|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216131|NCT04921670|Infliximab|infliximab|mesh-list
139216132|NCT04921670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139216133|NCT04921670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216134|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
139216135|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139216136|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139216137|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
139216138|NCT03512210|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139216139|NCT03512210|Velpatasvir|velpatasvir|mesh-list
139216140|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
139216141|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216142|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
139216143|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
139216144|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139216145|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
139216146|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216147|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216148|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139216149|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
139216150|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139216151|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139216152|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139216153|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
139216154|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216155|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216156|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216157|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
139216158|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139216160|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139216161|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216162|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
139216163|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
139216164|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
139216165|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216166|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
139216167|NCT03297502|Tacrolimus|tacrolimus|mesh-list
139642134|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139216168|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139216169|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139216170|NCT03297502|Analgesics|analgesics|mesh-ancestor
139216171|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
139216172|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216173|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216174|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216175|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139216176|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
139216177|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139216178|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
139216179|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139216180|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216181|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216182|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
139216183|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
139216184|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139216185|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139216186|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216187|NCT03292744|Vitamins|vitamins|mesh-ancestor
139216188|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
139216189|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139216190|NCT03035942|Dexamethasone|dexamethasone|mesh-list
139216191|NCT03035942|Ondansetron|ondansetron|mesh-list
139216192|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216193|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
139216194|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
139216195|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216196|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216197|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139216198|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
139216199|NCT03035942|Hormones|hormones|mesh-ancestor
139216200|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139216201|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139216202|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216203|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
139216204|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
139216205|NCT03035942|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139216206|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139216207|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
139216208|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216209|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216210|NCT02820519|Loxapine|loxapine|mesh-list
139216211|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139216212|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139216213|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216214|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216215|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139216216|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139216217|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
139216218|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139216219|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216220|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139216221|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139216222|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
139216223|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139216224|NCT02616146|Etonogestrel|etonogestrel|mesh-list
139216225|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139216226|NCT02616146|Estradiol|estradiol|mesh-list
139216227|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139216228|NCT02616146|Estrogens|estrogens|mesh-ancestor
139216229|NCT02616146|Hormones|hormones|mesh-ancestor
139216230|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139216231|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216232|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139216233|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
139216234|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139216235|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139216236|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139216237|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139216238|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139216239|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139216240|NCT01332747|Atorvastatin|atorvastatin|mesh-list
139216241|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139216242|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139216243|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
139216244|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216245|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139216246|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139216247|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216248|NCT01337427|Interferons|interferons|mesh-list
139216249|NCT01337427|Interferon-beta|interferon-beta|mesh-list
139216250|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
139216251|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216252|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
139216253|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216254|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
139216255|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216256|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139216257|NCT02459938|Glucagon|glucagon|mesh-list
139216258|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139216259|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139216260|NCT02459938|Hormones|hormones|mesh-ancestor
139216261|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139216262|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216263|NCT02459938|Incretins|incretins|mesh-ancestor
139216264|NCT03284164|Tenofovir|tenofovir|mesh-list
139216265|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
139216266|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216267|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139216268|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139216269|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216270|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216271|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139216272|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139216273|NCT01337583|Dapivirine|dapivirine|mesh-list
139216274|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139216275|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139216276|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
139216277|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216278|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
139216279|NCT03107962|Antibodies|antibodies|mesh-list
139216280|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
139216281|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
139216282|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216283|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139216284|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216285|NCT03107962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139216286|NCT03107962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216287|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
139216288|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139216289|NCT04891172|Antibodies|antibodies|mesh-list
139216290|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
139216291|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139216292|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
139216293|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216294|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
139216295|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139216296|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216297|NCT01335321|Triamcinolone|triamcinolone|mesh-list
139216298|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
139216300|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216301|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
139216302|NCT01335321|Hormones|hormones|mesh-ancestor
139216303|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139216304|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216305|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
139172892|NCT01373528|Hormones|hormones|mesh-ancestor
139216306|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
139216307|NCT01335321|Protective Agents|protective agents|mesh-ancestor
139216308|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139216309|NCT01333137|Carboplatin|carboplatin|mesh-list
139216310|NCT01333137|Gemcitabine|gemcitabine|mesh-list
139216311|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216312|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139216313|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
139216314|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216315|NCT03282838|Celecoxib|celecoxib|mesh-list
139216316|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139216317|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139086325|NCT01240850|Hormones|hormones|mesh-ancestor
139642135|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216319|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
139216320|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216321|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216322|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216323|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139216324|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139216325|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139216326|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216327|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216328|NCT04431466|Ivermectin|ivermectin|mesh-list
139216329|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139216330|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139216331|NCT03291418|Naproxen|naproxen|mesh-list
139216332|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139216333|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139216334|NCT03291418|Analgesics|analgesics|mesh-ancestor
139216335|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
139216336|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139216337|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216338|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139216339|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139216340|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
139216341|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139216342|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216343|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216344|NCT02885181|Methotrexate|methotrexate|mesh-list
139216345|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139216346|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
139216347|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139216348|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216349|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139216350|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
139216351|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216352|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216353|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
139216354|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216355|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139216356|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139216357|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
139216358|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139216359|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139216360|NCT02459782|Anesthetics|anesthetics|mesh-list
139216361|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139216362|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216363|NCT02884089|Metformin|metformin|mesh-list
139216364|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139216365|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216366|NCT01315431|Capecitabine|capecitabine|mesh-list
139216367|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139216368|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
139216369|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216370|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216371|NCT00092625|Ezetimibe|ezetimibe|mesh-list
139216372|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139216373|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139216374|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
139216375|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216376|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139216377|NCT01333449|Decitabine|decitabine|mesh-list
139216378|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139216379|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
139216380|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139216381|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139216382|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139216383|NCT01341717|Metformin|metformin|mesh-list
139216384|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139216385|NCT01341717|Glimepiride|glimepiride|mesh-list
139216386|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139216387|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139216388|NCT01341717|Incretins|incretins|mesh-ancestor
139216389|NCT01341717|Hormones|hormones|mesh-ancestor
139216390|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139196907|NCT01187849|Metformin|metformin|mesh-list
139381609|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381611|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139381612|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139381613|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139381614|NCT04839536|Sevoflurane|sevoflurane|mesh-list
139381615|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139381616|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139381617|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
139381618|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
139197113|NCT01186445|Analgesics|analgesics|mesh-ancestor
139381619|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381620|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381622|NCT02428257|Bupivacaine|bupivacaine|mesh-list
139381623|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
139381624|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
139381625|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381626|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381627|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
139197406|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
139381628|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197631|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139381629|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139381630|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
139381631|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
139197798|NCT01187303|Ofatumumab|ofatumumab|mesh-list
139197934|NCT05375097|Erenumab|erenumab|mesh-list
139381632|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139381633|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
139381634|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198301|NCT03575065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381635|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381636|NCT04839224|Phenylephrine|phenylephrine|mesh-list
139381637|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
139381638|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139198595|NCT03055988|Xhance|xhance|mesh-list
139381639|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
139381641|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381642|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381643|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
139381644|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139381645|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
139199035|NCT01567904|Semuloparin|semuloparin|mesh-list
139381646|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
139381647|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139001280|NCT04731974|Melatonin|melatonin|mesh-list
139381648|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139381649|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139381650|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
139199637|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
139381651|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139381652|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381653|NCT04839224|Protective Agents|protective agents|mesh-ancestor
139199935|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
139381654|NCT03036644|Nicotine|nicotine|mesh-list
139381655|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139381656|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
139200002|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139381657|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381658|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381659|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139381661|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
139381662|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200825|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
139381663|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381664|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
139381665|NCT02424201|Misoprostol|misoprostol|mesh-list
139381666|NCT02424201|Vitamins|vitamins|mesh-ancestor
139381667|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
139381668|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201347|NCT04737889|Temozolomide|temozolomide|mesh-list
139201495|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
139381669|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139381670|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
139381671|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139201719|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
139381673|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139381674|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
139381675|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
139381676|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381677|NCT02424201|Protective Agents|protective agents|mesh-ancestor
139381678|NCT02432781|Insulin|insulin|mesh-list
139381679|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139381680|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381681|NCT01667900|Dulaglutide|dulaglutide|mesh-list
139381682|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139381683|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381685|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
139202690|NCT03328312|Atropine|atropine|mesh-list
139381686|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
139381687|NCT04833296|Ropivacaine|ropivacaine|mesh-list
139381688|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
139381689|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
139203139|NCT03499873|Analgesics|analgesics|mesh-ancestor
139203217|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139381690|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203368|NCT04493554|Vasopressins|vasopressins|mesh-list
139381691|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203740|NCT02486926|Remifentanil|remifentanil|mesh-list
139381692|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
139381693|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204112|NCT03777761|Tucatinib|tucatinib|mesh-list
139204187|NCT03781505|Acetaminophen|acetaminophen|mesh-list
139381695|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139381696|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
139381697|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139204336|NCT01313819|Analgesics|analgesics|mesh-ancestor
139381698|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381699|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139381700|NCT00702273|Progesterone|progesterone|mesh-list
139381701|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139381702|NCT00702273|Ganirelix|ganirelix|mesh-list
139381703|NCT00702273|Progestins|progestins|mesh-ancestor
139381704|NCT00702273|Hormones|hormones|mesh-ancestor
139381705|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139381706|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381707|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
139381708|NCT02433795|Rituximab|rituximab|mesh-list
139381709|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139204620|NCT02482636|Vaccines|vaccines|mesh-list
139381710|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139381711|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381712|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
139381713|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381714|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139381715|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139381716|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
139381717|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381718|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
139381719|NCT03038516|Vitamin D|vitamin d|mesh-list
139381720|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139381721|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381722|NCT03038516|Vitamins|vitamins|mesh-ancestor
139381723|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
139381724|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139381725|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
139381726|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139381727|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139381729|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
139381730|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139381731|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
139381732|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139381733|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
139381734|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
139381735|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038575|NCT00283803|Analgesics|analgesics|mesh-ancestor
139381736|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381737|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139381738|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
139381739|NCT02424435|Hormones|hormones|mesh-ancestor
139381740|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139381741|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139381742|NCT02424435|Protective Agents|protective agents|mesh-ancestor
139381743|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139381744|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381745|NCT04842968|Methylene Blue|methylene blue|mesh-list
139381746|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205272|NCT03758339|Tucatinib|tucatinib|mesh-list
139381747|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381748|NCT04832204|Apatinib|apatinib|mesh-list
139381749|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381750|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139381751|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205404|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
139381752|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381753|NCT03038282|Chromium|chromium|mesh-list
139205555|NCT02477488|Allopurinol|allopurinol|mesh-list
139381754|NCT03038282|Chromous chloride|chromous chloride|mesh-list
139205625|NCT02470780|Rifaximin|rifaximin|mesh-list
139205771|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
139381755|NCT03038282|Trace Elements|trace elements|mesh-ancestor
139381756|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
139001309|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381757|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381758|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
139206077|NCT06208410|Paclitaxel|paclitaxel|mesh-list
139206147|NCT06208072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381759|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381760|NCT03038282|Protective Agents|protective agents|mesh-ancestor
139381761|NCT02424045|Dexamethasone|dexamethasone|mesh-list
139381762|NCT02424045|Carboplatin|carboplatin|mesh-list
139206448|NCT06205875|Analgesics|analgesics|mesh-ancestor
139381763|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139381764|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139381765|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
139381766|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
139381767|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381768|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381769|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139381770|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
139381771|NCT02424045|Hormones|hormones|mesh-ancestor
139206748|NCT06123494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206821|NCT06106880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139206896|NCT06068530|Piperaquine|piperaquine|mesh-list
139207043|NCT06049797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139381772|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139381773|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139381774|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381775|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139381776|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
139381777|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207239|NCT05954442|Everolimus|everolimus|mesh-list
139381778|NCT03037970|Becaplermin|becaplermin|mesh-list
139207411|NCT05852002|Protective Agents|protective agents|mesh-ancestor
139207412|NCT05845099|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
139207413|NCT05845099|Vasodilator Agents|vasodilator agents|mesh-ancestor
139207414|NCT05845099|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139207415|NCT05845099|Protective Agents|protective agents|mesh-ancestor
139207416|NCT05845099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207417|NCT05843188|Leucovorin|leucovorin|mesh-list
139207418|NCT05843188|Hydroxychloroquine|hydroxychloroquine|mesh-list
139207419|NCT05843188|Bevacizumab|bevacizumab|mesh-list
139207574|NCT05771480|Paclitaxel|paclitaxel|mesh-list
139381780|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
139381781|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139381782|NCT03037970|Growth Substances|growth substances|mesh-ancestor
139381783|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381784|NCT04841720|Metformin|metformin|mesh-list
139381785|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139381786|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381787|NCT03039842|Valproic Acid|valproic acid|mesh-list
139381788|NCT03039842|Memantine|memantine|mesh-list
139381789|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
139381790|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139381791|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139381792|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
139381793|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139381794|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381795|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208606|NCT05101551|Gemcitabine|gemcitabine|mesh-list
139381796|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139381797|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139381798|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
139381799|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381800|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
139381801|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
139381802|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139381803|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381804|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139381805|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
139381806|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
139381808|NCT03181815|Cladribine|cladribine|mesh-list
139381809|NCT03181815|Aclarubicin|aclarubicin|mesh-list
139381810|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
139381811|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139381812|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
139381813|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209048|NCT04826341|Immunoconjugates|immunoconjugates|mesh-ancestor
139381814|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381815|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
139209201|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
139381816|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381817|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139381818|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
139209498|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139209573|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139209649|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139381819|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381820|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139381821|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139381822|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139381823|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381824|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139381825|NCT03038048|Ranibizumab|ranibizumab|mesh-list
139381826|NCT03038048|Aflibercept|aflibercept|mesh-list
139381827|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139381828|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139209944|NCT03953300|Benralizumab|benralizumab|mesh-list
139209945|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139209946|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
139209947|NCT03946878|Venetoclax|venetoclax|mesh-list
139209948|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
139209949|NCT03946878|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139209950|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209951|NCT03946878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139209952|NCT03946878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209953|NCT03946878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209954|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139209955|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139209956|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139209957|NCT03937830|Bevacizumab|bevacizumab|mesh-list
139209958|NCT03937830|Durvalumab|durvalumab|mesh-list
139209959|NCT03937830|Doxorubicin|doxorubicin|mesh-list
139209960|NCT03937830|Tremelimumab|tremelimumab|mesh-list
139209961|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210019|NCT03875144|Pemetrexed|pemetrexed|mesh-list
139381829|NCT03038048|Growth Substances|growth substances|mesh-ancestor
139210248|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
139381830|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381831|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
139381832|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837281|NCT04252274|Darunavir|darunavir|mesh-list
139381833|NCT03185871|Celecoxib|celecoxib|mesh-list
139381834|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139381835|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139381836|NCT03185871|Analgesics|analgesics|mesh-ancestor
139381837|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
139381838|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001328|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381839|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381840|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139381841|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139381842|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139381843|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139381844|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837651|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381845|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381846|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139381847|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139381848|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
138838026|NCT00652327|Ezetimibe|ezetimibe|mesh-list
138838099|NCT00808171|Anesthetics|anesthetics|mesh-list
138838190|NCT02863913|Analgesics|analgesics|mesh-ancestor
139381849|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381851|NCT03180957|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139381852|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139381853|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139381854|NCT02427165|Albuterol|albuterol|mesh-list
139381855|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138838630|NCT00811915|Sirolimus|sirolimus|mesh-list
138838689|NCT04203368|Adenosine|adenosine|mesh-list
139381856|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
138838769|NCT04273880|Vitamins|vitamins|mesh-ancestor
138838835|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490935|NCT03959332|Baloxavir|baloxavir|mesh-list
139381857|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381858|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839060|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
139381859|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138839132|NCT02863679|Tetracaine|tetracaine|mesh-list
139381860|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
139381861|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
139381862|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139381863|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138839430|NCT00826891|Topotecan|topotecan|mesh-list
138839502|NCT04400383|Antibodies|antibodies|mesh-list
139381864|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139381865|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138839731|NCT02862509|Budesonide|budesonide|mesh-list
139381866|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
138839877|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
138839956|NCT02847884|Infliximab|infliximab|mesh-list
139381867|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840246|NCT05241938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138840406|NCT00829231|Sorafenib|sorafenib|mesh-list
139381868|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381869|NCT03037736|Bevacizumab|bevacizumab|mesh-list
139381870|NCT03037736|Fluorouracil|fluorouracil|mesh-list
139381871|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138840622|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
139381872|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381873|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138840703|NCT02834286|Dexamethasone|dexamethasone|mesh-list
138840769|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840843|NCT05878158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138840995|NCT05411887|Olmesartan|olmesartan|mesh-list
139381874|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139381875|NCT03037736|Growth Substances|growth substances|mesh-ancestor
138841213|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841289|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841377|NCT00566098|Melphalan|melphalan|mesh-list
139381876|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381877|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
139381878|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
139381879|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381880|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138841891|NCT00844207|Azithromycin|azithromycin|mesh-list
139381881|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139381882|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
139381883|NCT04838132|Ropivacaine|ropivacaine|mesh-list
138842037|NCT02841176|Golimumab|golimumab|mesh-list
139381884|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
138842177|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138842328|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139381886|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381887|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381888|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
138842697|NCT05660694|Vasodilator Agents|vasodilator agents|mesh-ancestor
139381889|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381890|NCT03037892|Midazolam|midazolam|mesh-list
139381892|NCT03037892|Remifentanil|remifentanil|mesh-list
138843150|NCT00961571|Capecitabine|capecitabine|mesh-list
139381893|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139381894|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138843370|NCT02814630|Omalizumab|omalizumab|mesh-list
138843441|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381895|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381896|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381897|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139381898|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138843667|NCT03312257|Atropine|atropine|mesh-list
139381899|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139381900|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139381901|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
138843962|NCT00961961|Fluoxetine|fluoxetine|mesh-list
139381903|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
139381904|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
139381905|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844265|NCT02799888|Maraviroc|maraviroc|mesh-list
139381906|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844337|NCT05980156|Amebicides|amebicides|mesh-ancestor
139381907|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139381908|NCT03037892|Narcotics|narcotics|mesh-ancestor
139381909|NCT03037892|Analgesics|analgesics|mesh-ancestor
139381910|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
139381911|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381912|NCT03183843|Warfarin|warfarin|mesh-list
139381913|NCT03183843|Dabigatran|dabigatran|mesh-list
139381914|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
139381915|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
139381916|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139381917|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
139381918|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381919|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381920|NCT03180879|Ibuprofen|ibuprofen|mesh-list
139381921|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139381922|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139381923|NCT03180879|Analgesics|analgesics|mesh-ancestor
138844560|NCT05969587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844561|NCT05969587|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138844574|NCT05929898|Dopamine|dopamine|mesh-list
138844575|NCT05929898|Dopamine Agonists|dopamine agonists|mesh-list
138844604|NCT05602519|Fentanyl|fentanyl|mesh-list
139381924|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
139381925|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381926|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381927|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139381929|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139381931|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381932|NCT03180723|Cyclosporine|cyclosporine|mesh-list
139381933|NCT03180723|Rituximab|rituximab|mesh-list
139381934|NCT03180723|Cyclosporins|cyclosporins|mesh-list
138845530|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138845602|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845681|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
139381935|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138845770|NCT00866515|Ketoconazole|ketoconazole|mesh-list
139381937|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
138845894|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
139381938|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381939|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138845974|NCT00867061|ON 01910|on 01910|mesh-list
139381940|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846043|NCT04040491|Growth Substances|growth substances|mesh-ancestor
138846208|NCT02789202|Fluorides|fluorides|mesh-list
139381941|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846352|NCT00876889|Riluzole|riluzole|mesh-list
138846491|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139381942|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139381943|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
138846641|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
139381944|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381945|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
138846716|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
139381946|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139381947|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139381948|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
139381949|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381950|NCT02426697|Fentanyl|fentanyl|mesh-list
139381951|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139381952|NCT02426697|Narcotics|narcotics|mesh-ancestor
139381953|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381954|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381956|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
139381957|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381958|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139381959|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139381960|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
139381961|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
139381962|NCT03039608|Prednisone|prednisone|mesh-list
139381963|NCT03039608|Triamcinolone|triamcinolone|mesh-list
139381964|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139381965|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
139381966|NCT03039608|Hormones|hormones|mesh-ancestor
139381967|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139381968|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381969|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139381971|NCT02423811|Fursultiamin|fursultiamin|mesh-list
139381972|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
139381974|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
139381975|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381976|NCT04837664|Nystatin|nystatin|mesh-list
139381977|NCT04837664|Curcumin|curcumin|mesh-list
139381978|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139381979|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139381980|NCT04837664|Analgesics|analgesics|mesh-ancestor
139381981|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
139381982|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381983|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381984|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139381985|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139381986|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847157|NCT05903131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139381988|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381989|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139381990|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381991|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
139381992|NCT04837664|Ionophores|ionophores|mesh-ancestor
139381993|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139381994|NCT01331837|Etanercept|etanercept|mesh-list
139381995|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139381996|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139381997|NCT01331837|Analgesics|analgesics|mesh-ancestor
139381998|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
139381999|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382000|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382001|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382002|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139382003|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139382004|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139382005|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
139382006|NCT02706483|Plecanatide|plecanatide|mesh-list
138847384|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
139382007|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139382008|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
138847752|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
139382009|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382010|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139382011|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
139382013|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
139382014|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848204|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139382015|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848351|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382016|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139382017|NCT03183297|Fexofenadine|fexofenadine|mesh-list
139382019|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139382020|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139382021|NCT03183297|Analgesics|analgesics|mesh-ancestor
139382022|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
139382023|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382024|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382025|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382026|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139382027|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
139382028|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139382029|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382030|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382031|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139382032|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139382033|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138849089|NCT03894345|Prazosin|prazosin|mesh-list
139382036|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849383|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
139382037|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139382038|NCT02426619|Fluorides|fluorides|mesh-list
139382039|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
139382040|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
139382041|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
139382042|NCT02426619|Protective Agents|protective agents|mesh-ancestor
138849829|NCT02767674|Rituximab|rituximab|mesh-list
139382043|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382045|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850059|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
139382047|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139382048|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138850276|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139382049|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139382050|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850422|NCT00887029|Latanoprost|latanoprost|mesh-list
138850569|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382051|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382052|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
139382053|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138850791|NCT02768220|Hormones|hormones|mesh-ancestor
138850952|NCT02758470|Acetazolamide|acetazolamide|mesh-list
138851018|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
139382055|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139382056|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
139382057|NCT01648348|Antibodies|antibodies|mesh-list
139382059|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139382060|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
139382061|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382062|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139382063|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139382064|NCT01648348|Growth Substances|growth substances|mesh-ancestor
139382065|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382066|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
139382067|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
139382068|NCT03180255|Dexamethasone|dexamethasone|mesh-list
139382069|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
139382070|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139382071|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382072|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
139382073|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
139382074|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382075|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382076|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139382077|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
139382078|NCT03180255|Hormones|hormones|mesh-ancestor
139382079|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139382080|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139382081|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382082|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
139382083|NCT02431221|Perhexiline|perhexiline|mesh-list
139382084|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139382085|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139382086|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382087|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139382088|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382089|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
139382090|NCT02108639|Asunaprevir|asunaprevir|mesh-list
139382091|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
139382092|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382093|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382094|NCT03180099|Bupivacaine|bupivacaine|mesh-list
139382095|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
139382096|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
139382097|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382098|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382099|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
139382100|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382101|NCT02251145|Ritonavir|ritonavir|mesh-list
139382102|NCT02251145|Tenofovir|tenofovir|mesh-list
139382103|NCT02251145|Tipranavir|tipranavir|mesh-list
139382104|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139382105|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139382106|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
139382107|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382108|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382109|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139382110|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139382111|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
139382112|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138851361|NCT00792909|Vaccines|vaccines|mesh-list
139382113|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138851486|NCT02756598|Narcotics|narcotics|mesh-ancestor
139382114|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138851564|NCT02751528|Vaccines|vaccines|mesh-list
139382115|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139382116|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139382117|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139382119|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382120|NCT00709371|Zonisamide|zonisamide|mesh-list
139382121|NCT00709371|Bupropion|bupropion|mesh-list
139382122|NCT00709371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139382123|NCT00709371|Antidepressive Agents|antidepressive agents|mesh-ancestor
139382124|NCT00709371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139382125|NCT00709371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138852372|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382126|NCT00709371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139001375|NCT04334174|Immunotoxins|immunotoxins|mesh-ancestor
138852518|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138852588|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852738|NCT00915915|Gestodene|gestodene|mesh-list
138852964|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
139382127|NCT00709371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138853115|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382128|NCT00709371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382129|NCT00709371|Dopamine Agents|dopamine agents|mesh-ancestor
139382130|NCT00709371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139382131|NCT00709371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853495|NCT05658692|GABA Agents|gaba agents|mesh-ancestor
139382132|NCT00709371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139382133|NCT00709371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139382134|NCT00709371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853717|NCT05382923|Melatonin|melatonin|mesh-list
139382135|NCT00709371|Anticonvulsants|anticonvulsants|mesh-ancestor
139382136|NCT00709371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139382137|NCT00709371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139382139|NCT02426463|Propofol|propofol|mesh-list
139382140|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139382141|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382142|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382143|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139382144|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
138853866|NCT00775203|Trazodone|trazodone|mesh-list
139382146|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138854080|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
139382148|NCT02426463|Analgesics|analgesics|mesh-ancestor
139382149|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
138854376|NCT05382143|Tocolytic Agents|tocolytic agents|mesh-ancestor
139382150|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382151|NCT02426229|Dabigatran|dabigatran|mesh-list
139382152|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
139382153|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139382154|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
139382155|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854899|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139382156|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855213|NCT02808104|Mazindol|mazindol|mesh-list
139382157|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
139382159|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139382160|NCT01648270|Narcotics|narcotics|mesh-ancestor
139382161|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382162|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382163|NCT01648270|Analgesics|analgesics|mesh-ancestor
139382164|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
139382165|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382166|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139382167|NCT02108795|Remifentanil|remifentanil|mesh-list
139382168|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139382170|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382171|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382172|NCT02108795|Analgesics|analgesics|mesh-ancestor
138855851|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
139382173|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
138856088|NCT05331027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139382174|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382175|NCT02431143|Miltefosine|miltefosine|mesh-list
139382176|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
139382177|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382178|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382179|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139382180|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139382181|NCT02302846|Ixazomib|ixazomib|mesh-list
139382182|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382183|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
139382184|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382185|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382186|NCT02431065|Ropivacaine|ropivacaine|mesh-list
139382187|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
139382188|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
139382189|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382190|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382191|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
139382192|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382193|NCT04836806|Cetirizine|cetirizine|mesh-list
139382194|NCT04836806|Famotidine|famotidine|mesh-list
139382195|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139382196|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138857128|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
138857270|NCT02811692|Growth Substances|growth substances|mesh-ancestor
139382197|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139382198|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
139382199|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
139382200|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857496|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139382201|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857646|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382202|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857796|NCT03983018|Rituximab|rituximab|mesh-list
139382204|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139382205|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139382206|NCT04836728|Paclitaxel|paclitaxel|mesh-list
138858165|NCT02715024|Urological Agents|urological agents|mesh-ancestor
139382207|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139382208|NCT04836728|Carboplatin|carboplatin|mesh-list
139382209|NCT04836728|Pemetrexed|pemetrexed|mesh-list
139382210|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139382211|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139382212|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382214|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
139382215|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
138858833|NCT06004765|Growth Substances|growth substances|mesh-ancestor
138858913|NCT05949099|Nirogacestat|nirogacestat|mesh-list
139382216|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382217|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382218|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138859142|NCT05345509|Donepezil|donepezil|mesh-list
139382219|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138859283|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138859359|NCT04300296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382220|NCT04836728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139382221|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
139382223|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
139382224|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139382225|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
139382226|NCT02430909|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139382227|NCT02430909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382228|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139382229|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
139382230|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382231|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139382232|NCT02105675|Docetaxel|docetaxel|mesh-list
139382233|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382234|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
139382235|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
139382236|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
139382237|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382238|NCT02336230|Remestemcel-l|remestemcel-l|mesh-list
139382239|NCT02336230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382240|NCT02336230|Antiviral Agents|antiviral agents|mesh-ancestor
139001401|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139382241|NCT02336230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138860630|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
139382242|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139382243|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
139382244|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382245|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139382246|NCT04824404|Buprenorphine|buprenorphine|mesh-list
139382247|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139382248|NCT04824404|Narcotics|narcotics|mesh-ancestor
139382249|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382250|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382251|NCT04824404|Analgesics|analgesics|mesh-ancestor
139382252|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
139382253|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382254|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139382255|NCT02109341|Paclitaxel|paclitaxel|mesh-list
139382256|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139382257|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139382258|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382259|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
139382260|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
139382262|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382263|NCT04367168|Colchicine|colchicine|mesh-list
139382264|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
139382265|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139382266|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
139382267|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
139382268|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
139382269|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382270|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382271|NCT02113943|Citalopram|citalopram|mesh-list
139382272|NCT02113943|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139382273|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139382274|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139382275|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382276|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861044|NCT04229264|Apixaban|apixaban|mesh-list
139382278|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382279|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139382280|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
139382281|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139382283|NCT02114021|Lidocaine|lidocaine|mesh-list
139382284|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
139382285|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
139382286|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382287|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861112|NCT04962152|Analgesics|analgesics|mesh-ancestor
139382288|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
139382289|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382290|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139382291|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139382292|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139382293|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139382294|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382295|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382297|NCT02114021|Hormones|hormones|mesh-ancestor
139382298|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139382299|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139382300|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
139382301|NCT04826822|Dexamethasone|dexamethasone|mesh-list
138861555|NCT04179266|Ketamine|ketamine|mesh-list
139382302|NCT04826822|Spironolactone|spironolactone|mesh-list
139382303|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382304|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
139382305|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
138861910|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
138861983|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138862056|NCT02766764|Hormones|hormones|mesh-list
139382306|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382307|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382308|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139382309|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
139382310|NCT04826822|Hormones|hormones|mesh-ancestor
139382311|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138862348|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139382312|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138862424|NCT02769884|Pancrelipase|pancrelipase|mesh-list
138862571|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
138862643|NCT00647049|Cytarabine|cytarabine|mesh-list
138862792|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382313|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862935|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382314|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139382315|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
139382316|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139382319|NCT02251457|Ranolazine|ranolazine|mesh-list
139382321|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139382322|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382323|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
139382324|NCT02112305|Analgesics|analgesics|mesh-ancestor
139382325|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
139382326|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382327|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382328|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
139382329|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382330|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139382331|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
139382332|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139382333|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139382334|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863512|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139382335|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139382336|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
139382337|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138863882|NCT00913835|Olaratumab|olaratumab|mesh-list
139382340|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139382341|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
138864027|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139001424|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
138864100|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138864172|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382342|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039174|NCT01039142|Acitretin|acitretin|mesh-list
138864550|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138864633|NCT02695004|Donepezil|donepezil|mesh-list
138864700|NCT02730026|Analgesics|analgesics|mesh-ancestor
138864774|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
138864848|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138864998|NCT02737124|Acetaminophen|acetaminophen|mesh-list
139382343|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138865094|NCT02726126|Fentanyl|fentanyl|mesh-list
138865149|NCT02718950|Liraglutide|liraglutide|mesh-list
138865150|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138865151|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865152|NCT02718950|Incretins|incretins|mesh-ancestor
138865299|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138865373|NCT02712476|Diuretics|diuretics|mesh-ancestor
138865595|NCT02644629|Ketamine|ketamine|mesh-list
138865596|NCT02644629|Analgesics|analgesics|mesh-ancestor
138865821|NCT02641899|Atorvastatin|atorvastatin|mesh-list
139382344|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138788159|NCT02679820|Copper|copper|mesh-list
139382345|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382346|NCT02251223|Ritonavir|ritonavir|mesh-list
139382347|NCT02251223|Tipranavir|tipranavir|mesh-list
138865973|NCT02709200|Analgesics|analgesics|mesh-ancestor
139382349|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138866192|NCT02706236|Pancrelipase|pancrelipase|mesh-list
139382350|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
139382351|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866480|NCT00880191|Gabapentin|gabapentin|mesh-list
138866557|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866641|NCT02632071|Paclitaxel|paclitaxel|mesh-list
138866706|NCT00666393|Narcotics|narcotics|mesh-ancestor
139382352|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382353|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139382354|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139382355|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
138867229|NCT02703272|Hormones|hormones|mesh-ancestor
139382356|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382357|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138867376|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139382358|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138867526|NCT02705534|Ledipasvir|ledipasvir|mesh-list
139382360|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
139382361|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382362|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
138867680|NCT03170882|Dexamethasone|dexamethasone|mesh-list
139382363|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139091736|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
139091810|NCT03910972|Antacids|antacids|mesh-ancestor
139382364|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382366|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139382367|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139382368|NCT02114645|Estradiol|estradiol|mesh-list
139382369|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139382370|NCT02114645|Progesterone|progesterone|mesh-list
139382371|NCT02114645|Estrogens|estrogens|mesh-ancestor
139382372|NCT02114645|Hormones|hormones|mesh-ancestor
139092101|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139092102|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092103|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092104|NCT02627092|Copper|copper|mesh-list
138848373|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848374|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848375|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848377|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
138848378|NCT02436707|Rituximab|rituximab|mesh-list
138848379|NCT02436707|Gemcitabine|gemcitabine|mesh-list
139092249|NCT00953771|Danazol|danazol|mesh-list
139092250|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138848380|NCT02436707|Etoposide|etoposide|mesh-list
139092400|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139382373|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139382374|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382375|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139382376|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
139092852|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
139382377|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139382378|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139382379|NCT02114645|Progestins|progestins|mesh-ancestor
139093001|NCT00366899|Vaccines|vaccines|mesh-list
139382381|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
139382382|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139382383|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382385|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139382386|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093447|NCT01195766|Ofatumumab|ofatumumab|mesh-list
139093527|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139382387|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
139093603|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139093675|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139382388|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382390|NCT04361162|Ipilimumab|ipilimumab|mesh-list
139094116|NCT05669768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139382391|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139382392|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382393|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139094416|NCT04568200|Paclitaxel|paclitaxel|mesh-list
139382394|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382396|NCT04823390|Fentanyl|fentanyl|mesh-list
139382397|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139382398|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139382399|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382400|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094858|NCT02532569|Vaccines|vaccines|mesh-list
139382401|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139382402|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139095083|NCT03952572|Prednisone|prednisone|mesh-list
139382403|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139095156|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
139095235|NCT03216226|Glucagon|glucagon|mesh-list
139382404|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139382405|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
139382406|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
139382407|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
139382408|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
139382409|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848381|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139382410|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382411|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139382412|NCT04823390|Narcotics|narcotics|mesh-ancestor
139382413|NCT04823390|Analgesics|analgesics|mesh-ancestor
139382414|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
139382415|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382416|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
139382417|NCT04826510|Perospirone|perospirone|mesh-list
139096132|NCT01342744|Metformin|metformin|mesh-list
139382418|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
139096194|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
139382419|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139382420|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382421|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382422|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
139382423|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139382424|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382425|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382426|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139382427|NCT03036800|Liraglutide|liraglutide|mesh-list
139382428|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139382429|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382430|NCT03036800|Incretins|incretins|mesh-ancestor
139382431|NCT03036800|Hormones|hormones|mesh-ancestor
139382432|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139382433|NCT02301988|Paclitaxel|paclitaxel|mesh-list
139382434|NCT02301988|Ipatasertib|ipatasertib|mesh-list
139382435|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139382436|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382437|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
139382438|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
139382439|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
139382440|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848382|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
139382441|NCT02301988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139382442|NCT02301988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382443|NCT04326920|Sargramostim|sargramostim|mesh-list
139382444|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
139382445|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382446|NCT02112929|Xenon|xenon|mesh-list
139382447|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139382448|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
139382449|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
139382450|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382451|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382452|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
139382453|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139382454|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382455|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139382456|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139382457|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096468|NCT00262847|Paclitaxel|paclitaxel|mesh-list
138848383|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848384|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139096675|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
139382458|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096830|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
139382459|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382460|NCT02115035|Vemurafenib|vemurafenib|mesh-list
139382461|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382462|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139382463|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382464|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382465|NCT02113319|Dasatinib|dasatinib|mesh-list
139382466|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382467|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139097045|NCT01306760|Analgesics|analgesics|mesh-ancestor
139097135|NCT05694728|Vaccines|vaccines|mesh-list
139382468|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001497|NCT03335072|Azithromycin|azithromycin|mesh-list
139382469|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382471|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139097270|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
139382472|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382473|NCT03553433|Apremilast|apremilast|mesh-list
139097359|NCT00379288|Xhance|xhance|mesh-list
139097413|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
139382474|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139382475|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139097566|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
139097668|NCT01321034|Niacin|niacin|mesh-list
139382476|NCT03553433|Analgesics|analgesics|mesh-ancestor
139382477|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
139382478|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098011|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
139098156|NCT03762824|Vaccines|vaccines|mesh-list
139382479|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098303|NCT01352650|Plerixafor|plerixafor|mesh-list
139098378|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098454|NCT04848662|Budesonide|budesonide|mesh-list
139382480|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382481|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139382482|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139382483|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139382484|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098902|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
139098971|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139099045|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
139099120|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382485|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382486|NCT02604212|Tenofovir|tenofovir|mesh-list
139382487|NCT02604212|Entecavir|entecavir|mesh-list
139382488|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
139382489|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139382490|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
139382491|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382492|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139382493|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139382495|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382497|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139382498|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
139382499|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139382500|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382501|NCT02115659|Triptolide|triptolide|mesh-list
139382502|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
139382503|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382504|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139382505|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
139382506|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139382507|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139382508|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
139382509|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139382510|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
139382511|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382512|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382513|NCT02113631|Interferons|interferons|mesh-list
139382514|NCT02113631|Ribavirin|ribavirin|mesh-list
139382515|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
139382516|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
139382517|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139382518|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382519|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
139382520|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382521|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
138848385|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138848386|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
139100249|NCT05577702|Paclitaxel|paclitaxel|mesh-list
139382522|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382523|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
139382524|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382525|NCT02123069|Nitroprusside|nitroprusside|mesh-list
139382526|NCT02123069|Phenylephrine|phenylephrine|mesh-list
139382527|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
139382528|NCT02123069|Norepinephrine|norepinephrine|mesh-list
139100761|NCT04324229|Hormones|hormones|mesh-ancestor
139382529|NCT02123069|Acetylcholine|acetylcholine|mesh-list
139382530|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139382531|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
139382532|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
139101052|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382533|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101124|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
139101203|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
139382534|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382535|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
139101646|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382536|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139382537|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
139382538|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
139101870|NCT05460416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101943|NCT03763760|Dexamethasone|dexamethasone|mesh-list
139382539|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139102088|NCT03135028|Daunorubicin|daunorubicin|mesh-list
139382540|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139382541|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139382542|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
139382543|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139382544|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382545|NCT02123069|Protective Agents|protective agents|mesh-ancestor
139102532|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
139382547|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
139102629|NCT03796728|Lidocaine|lidocaine|mesh-list
139382548|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139102757|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
139382549|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139382550|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
139382551|NCT04428632|Berotralstat|berotralstat|mesh-list
139103211|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
139103273|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
139103349|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
139382552|NCT04428632|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139103651|NCT03783702|Narcotics|narcotics|mesh-ancestor
139382554|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103733|NCT03936426|Copper|copper|mesh-list
139382555|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382556|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139382557|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
139382558|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139104098|NCT01221402|Niacin|niacin|mesh-list
139104235|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139382561|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139382562|NCT04807166|Paclitaxel|paclitaxel|mesh-list
139382563|NCT04807166|Carboplatin|carboplatin|mesh-list
139104382|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
139382564|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139382565|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382566|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
139382567|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
139382568|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
139382569|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039406|NCT00401960|Daptomycin|daptomycin|mesh-list
139382570|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139382571|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139382573|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139382574|NCT02251925|Estrogens|estrogens|mesh-ancestor
139382575|NCT02251925|Hormones|hormones|mesh-ancestor
139382576|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105040|NCT05401032|Adrenergic Agents|adrenergic agents|mesh-ancestor
139382577|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382578|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139105263|NCT01234506|Vitamin D|vitamin d|mesh-list
139382580|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139382581|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139382583|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
139382584|NCT03552653|Cholecalciferol|cholecalciferol|mesh-list
139382585|NCT03552653|Vitamins|vitamins|mesh-list
139382586|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
139382587|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382588|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139382589|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139382590|NCT01359644|Ribavirin|ribavirin|mesh-list
139382591|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
139382592|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
139382593|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382594|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
139382595|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382596|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
139382597|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139382598|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139382599|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382600|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382601|NCT04806230|Mirtazapine|mirtazapine|mesh-list
139382602|NCT04806230|Citalopram|citalopram|mesh-list
139382603|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139382604|NCT04806230|Sertraline|sertraline|mesh-list
139382605|NCT04806230|Escitalopram|escitalopram|mesh-list
139382606|NCT04806230|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139382607|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139382608|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139382609|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382610|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139382611|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
139382612|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105961|NCT05805072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105962|NCT05805072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105963|NCT05805072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139105964|NCT05805072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139105965|NCT05805072|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139105966|NCT05805072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139105967|NCT05797090|Cardioplegic Solutions|cardioplegic solutions|mesh-list
139105968|NCT05797090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139105969|NCT05772364|Calcium|calcium|mesh-list
139105970|NCT05772364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139105971|NCT05772364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105972|NCT05770180|Vaccines|vaccines|mesh-list
139105973|NCT05770180|Immunologic Factors|immunologic factors|mesh-ancestor
138856562|NCT02675829|Trastuzumab|trastuzumab|mesh-list
139105974|NCT05770180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105975|NCT05765682|Bupivacaine|bupivacaine|mesh-list
139105976|NCT05765682|Mepivacaine|mepivacaine|mesh-list
139105977|NCT05765682|Anesthetics, Local|anesthetics, local|mesh-ancestor
139105978|NCT05765682|Anesthetics|anesthetics|mesh-ancestor
139105979|NCT05765682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105980|NCT05765682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105981|NCT05765682|Sensory System Agents|sensory system agents|mesh-ancestor
139001529|NCT04003844|Aspirin|aspirin|mesh-list
139105982|NCT05765682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105984|NCT05765604|Immunologic Factors|immunologic factors|mesh-ancestor
139105985|NCT05765604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105986|NCT05753592|Remibrutinib|remibrutinib|mesh-list
139105988|NCT05753592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106038|NCT05678205|Alkylating Agents|alkylating agents|mesh-ancestor
139106188|NCT05248321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106189|NCT05248321|Hemostatics|hemostatics|mesh-ancestor
139106190|NCT05248321|Coagulants|coagulants|mesh-ancestor
139106191|NCT05241093|Cytarabine|cytarabine|mesh-list
139106192|NCT05241093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139106193|NCT05241093|Antimetabolites|antimetabolites|mesh-ancestor
139106194|NCT05241093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106195|NCT05241093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106264|NCT05159531|Tenofovir|tenofovir|mesh-list
139106412|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139382613|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139382614|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
139382615|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139382616|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139382617|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139382618|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
139382619|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
139382620|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139382621|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139382622|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382623|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139382624|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139382625|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139382626|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
139106492|NCT04852484|Ketamine|ketamine|mesh-list
139382627|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139106698|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
139382628|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139106775|NCT04445714|Hormones|hormones|mesh-ancestor
139382629|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139382630|NCT02603120|Tenofovir|tenofovir|mesh-list
139382631|NCT02603120|Emtricitabine|emtricitabine|mesh-list
139382632|NCT02603120|Lamivudine|lamivudine|mesh-list
139382633|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139107068|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139107069|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
139107070|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139382634|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
139382635|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382636|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139382637|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139382638|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107365|NCT03250117|Ropinirole|ropinirole|mesh-list
139382639|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382640|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139382641|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139382643|NCT04815200|Nickel|nickel|mesh-list
139382644|NCT04815200|Trace Elements|trace elements|mesh-ancestor
139382646|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107811|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
139382648|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108116|NCT05389852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139108213|NCT05054725|Sotorasib|sotorasib|mesh-list
139382649|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108336|NCT04316676|Regadenoson|regadenoson|mesh-list
139382650|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139108484|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108709|NCT01236144|Plerixafor|plerixafor|mesh-list
139108714|NCT02528526|Inositol|inositol|mesh-list
139108788|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108859|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382651|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001537|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139109006|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139109082|NCT01375348|Analgesics|analgesics|mesh-ancestor
139382652|NCT04814030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139382653|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109312|NCT01243086|Hormones|hormones|mesh-ancestor
139382654|NCT04412252|Tofacitinib|tofacitinib|mesh-list
139382655|NCT04412252|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139382656|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139382657|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382658|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382659|NCT04813952|Sevoflurane|sevoflurane|mesh-list
139382660|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139382661|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139382662|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
139382663|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
139382664|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382665|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382666|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
139382667|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139382668|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
139382669|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
139382670|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382671|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382672|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139382673|NCT04813874|Analgesics|analgesics|mesh-ancestor
139382674|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
139382675|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382676|NCT04803500|Simvastatin|simvastatin|mesh-list
139382677|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139382678|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139382679|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
139109457|NCT01148004|Ritonavir|ritonavir|mesh-list
139382680|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382681|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139382682|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139382683|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382685|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139382686|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139382687|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
138860173|NCT00634556|Levodopa|levodopa|mesh-list
139109649|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
139382688|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139382689|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382690|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109870|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139382691|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139382692|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
139382693|NCT02120339|Protective Agents|protective agents|mesh-ancestor
139382694|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139382695|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139382696|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139382697|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
139110688|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
139382698|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139110918|NCT00679783|Olaparib|olaparib|mesh-list
139382699|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139382700|NCT02123381|Cetuximab|cetuximab|mesh-list
139110992|NCT01255410|Vaccines|vaccines|mesh-list
139382701|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139111290|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
139382702|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382703|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
139382704|NCT02123615|Antibodies|antibodies|mesh-list
139111445|NCT01157052|Calcium|calcium|mesh-list
139001549|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
139382705|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
139382706|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139382707|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139382708|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
139382709|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
139382710|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382711|NCT02120651|Hemostatics|hemostatics|mesh-list
139382712|NCT02120651|Coagulants|coagulants|mesh-ancestor
139382713|NCT02117219|Azacitidine|azacitidine|mesh-list
139382714|NCT02117219|Durvalumab|durvalumab|mesh-list
139382715|NCT02117219|Tremelimumab|tremelimumab|mesh-list
139382716|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139382717|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
139382718|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382719|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382721|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139382722|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139112025|NCT01159236|Paclitaxel|paclitaxel|mesh-list
139382723|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139382724|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139382725|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
139382726|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382727|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139112235|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382728|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139382729|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382730|NCT02124005|Bupivacaine|bupivacaine|mesh-list
139382731|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
139382732|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
139112682|NCT05594680|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139112758|NCT04872608|Letrozole|letrozole|mesh-list
139112907|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112908|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112909|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112910|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139112917|NCT03565445|Nivolumab|nivolumab|mesh-list
139112918|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112919|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112920|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139112921|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112922|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
139112923|NCT03516812|Olaparib|olaparib|mesh-list
139112924|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139112925|NCT03516812|Testosterone|testosterone|mesh-list
139112926|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
139112927|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
139112928|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139112929|NCT03516812|Androgens|androgens|mesh-ancestor
139112930|NCT03516812|Hormones|hormones|mesh-ancestor
139382733|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382734|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382735|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
139113055|NCT02659293|Dexamethasone|dexamethasone|mesh-list
139382736|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382737|NCT03551873|Plecanatide|plecanatide|mesh-list
139382738|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139382739|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
139001554|NCT05589584|Expectorants|expectorants|mesh-ancestor
139382740|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382741|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139382742|NCT02117765|Ustekinumab|ustekinumab|mesh-list
139382743|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
139382744|NCT02121119|Lidocaine|lidocaine|mesh-list
139382745|NCT02121119|Bupivacaine|bupivacaine|mesh-list
139382746|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
139382747|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
139382748|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382749|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382750|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
139382751|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001578|NCT00764855|Propofol|propofol|mesh-list
139382752|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139382753|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139382754|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139382755|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139382756|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113205|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113206|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113207|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
139113208|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
139113209|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113210|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139113211|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139113212|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
139113213|NCT02213913|Prednisone|prednisone|mesh-list
139113214|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
139113215|NCT02213913|Rituximab|rituximab|mesh-list
139113216|NCT02213913|Doxorubicin|doxorubicin|mesh-list
139113218|NCT02213913|Etoposide|etoposide|mesh-list
139113219|NCT02213913|Vincristine|vincristine|mesh-list
139113220|NCT02213913|Lenalidomide|lenalidomide|mesh-list
139113221|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
139113222|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139113223|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
139113224|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113225|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139382758|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382759|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
139382760|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
139382761|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382762|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382763|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139382764|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
139382765|NCT02121197|Hormones|hormones|mesh-ancestor
139382766|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139382767|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139382768|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382769|NCT02124317|Paclitaxel|paclitaxel|mesh-list
139382770|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139382771|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139382772|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382773|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
139382774|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
139382775|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
139382776|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382777|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
139382778|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382779|NCT02121353|Ranibizumab|ranibizumab|mesh-list
139382780|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139382781|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139382782|NCT02121353|Growth Substances|growth substances|mesh-ancestor
139382783|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382784|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
139382785|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382787|NCT05617430|Bevacizumab|bevacizumab|mesh-list
139382788|NCT05617430|Fluorouracil|fluorouracil|mesh-list
139382789|NCT05617430|Oxaliplatin|oxaliplatin|mesh-list
139382790|NCT05617430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139382791|NCT05617430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382792|NCT05617430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139382793|NCT05617430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139382794|NCT05617430|Growth Substances|growth substances|mesh-ancestor
139382795|NCT05617430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382796|NCT05617430|Growth Inhibitors|growth inhibitors|mesh-ancestor
139382797|NCT05617430|Antimetabolites|antimetabolites|mesh-ancestor
139382798|NCT05617430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382799|NCT05617430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139382800|NCT05617430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139382801|NCT05617430|Immunologic Factors|immunologic factors|mesh-ancestor
139382802|NCT05617430|Antidotes|antidotes|mesh-ancestor
139382803|NCT05617430|Protective Agents|protective agents|mesh-ancestor
139382804|NCT05617430|Vitamin B Complex|vitamin b complex|mesh-ancestor
139382805|NCT05617430|Vitamins|vitamins|mesh-ancestor
139382806|NCT05617430|Micronutrients|micronutrients|mesh-ancestor
139382807|NCT02251691|Tacrolimus|tacrolimus|mesh-list
139382808|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139382809|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
139382810|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382811|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139382812|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114146|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139382813|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382814|NCT02595398|Triamcinolone|triamcinolone|mesh-list
139382815|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139382816|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139382817|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139382818|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382819|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
139382820|NCT02595398|Hormones|hormones|mesh-ancestor
139382821|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139382822|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382823|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139114244|NCT01177176|Bupropion|bupropion|mesh-list
139382824|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
139382825|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382826|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382827|NCT02251769|Ritonavir|ritonavir|mesh-list
139382828|NCT02251769|Tipranavir|tipranavir|mesh-list
139382829|NCT02251769|Clarithromycin|clarithromycin|mesh-list
139382830|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139382831|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139382832|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
139382833|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382834|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382835|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139382836|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139382837|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
139382838|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382839|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139382840|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139382841|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139382842|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139382843|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
139382844|NCT02118311|Fludarabine|fludarabine|mesh-list
139382845|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139382846|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
139382847|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382848|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139382849|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139114340|NCT01289496|Interferons|interferons|mesh-list
139382850|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
139382851|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382852|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001643|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
139382853|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139382854|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139382855|NCT01368497|Entecavir|entecavir|mesh-list
139382856|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
139382857|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382858|NCT04812860|Tramadol|tramadol|mesh-list
139382859|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139382860|NCT04812860|Narcotics|narcotics|mesh-ancestor
139382861|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382862|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382863|NCT04812860|Analgesics|analgesics|mesh-ancestor
139382864|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
139382865|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382866|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
139382867|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139382868|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139114409|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
139382869|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382870|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
139382871|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
139382873|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
139382874|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139382875|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382876|NCT04801940|Apixaban|apixaban|mesh-list
139382877|NCT04801940|Atorvastatin|atorvastatin|mesh-list
139382878|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139382879|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139382880|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
139382881|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382882|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139114465|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
139382883|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139382884|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382885|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139382886|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
139382887|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139382888|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
139382889|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
139382890|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139382891|NCT02251847|Ezetimibe|ezetimibe|mesh-list
139382892|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139382893|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139382894|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
139382895|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382896|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139382897|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139382898|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139382899|NCT06173596|Itraconazole|itraconazole|mesh-list
139382900|NCT06173596|Fluconazole|fluconazole|mesh-list
139382901|NCT06173596|Carbamazepine|carbamazepine|mesh-list
139382902|NCT06173596|Antifungal Agents|antifungal agents|mesh-ancestor
139114805|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139382903|NCT06173596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382904|NCT06173596|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139382905|NCT06173596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139382906|NCT06173596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115262|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001665|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382907|NCT06173596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382908|NCT06173596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139382909|NCT06173596|Hormone Antagonists|hormone antagonists|mesh-ancestor
139382910|NCT06173596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139382911|NCT06173596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382912|NCT06173596|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139115778|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
139115853|NCT01204164|Hormones|hormones|mesh-ancestor
139115926|NCT01298466|Pregabalin|pregabalin|mesh-list
139382913|NCT06173596|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139116151|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
139382914|NCT06173596|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139116314|NCT01297686|Hormones|hormones|mesh-ancestor
139382915|NCT06173596|Anticonvulsants|anticonvulsants|mesh-ancestor
139382916|NCT06173596|Antimanic Agents|antimanic agents|mesh-ancestor
139382917|NCT06173596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139116594|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
139382918|NCT06173596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116741|NCT01303926|Paclitaxel|paclitaxel|mesh-list
139382919|NCT06173596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139382920|NCT06173596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139382921|NCT06173596|Analgesics|analgesics|mesh-ancestor
139382923|NCT06173596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382924|NCT06173596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139117186|NCT01307202|Analgesics|analgesics|mesh-ancestor
139382925|NCT06173596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139382926|NCT06173596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139382927|NCT06173596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139382928|NCT06173362|Prednisone|prednisone|mesh-list
139382930|NCT06173362|Androgen Antagonists|androgen antagonists|mesh-list
139382931|NCT06173362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382932|NCT06173362|Glucocorticoids|glucocorticoids|mesh-ancestor
139382933|NCT06173362|Hormones|hormones|mesh-ancestor
139117864|NCT02575144|Hormones|hormones|mesh-ancestor
139117936|NCT03771768|Hormones|hormones|mesh-ancestor
139117944|NCT03768258|Anastrozole|anastrozole|mesh-list
139118010|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
138848387|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118160|NCT05223244|Bupivacaine|bupivacaine|mesh-list
139118240|NCT04920838|Acetaminophen|acetaminophen|mesh-list
139118313|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138848388|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118461|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
139118613|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118687|NCT03757650|Clarithromycin|clarithromycin|mesh-list
139382934|NCT06173362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139382935|NCT06173362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382936|NCT06173362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139382937|NCT06173362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382938|NCT06173362|Hormone Antagonists|hormone antagonists|mesh-ancestor
139382939|NCT06173349|Paclitaxel|paclitaxel|mesh-list
139382940|NCT06173349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139382941|NCT06173349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139382942|NCT06173349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382943|NCT06173349|Tubulin Modulators|tubulin modulators|mesh-ancestor
139382944|NCT06173349|Antimitotic Agents|antimitotic agents|mesh-ancestor
139382945|NCT06173349|Mitosis Modulators|mitosis modulators|mesh-ancestor
139382946|NCT06173349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382947|NCT06173245|Ranibizumab|ranibizumab|mesh-list
139382948|NCT06173245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139382949|NCT06173245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139382950|NCT06173245|Growth Substances|growth substances|mesh-ancestor
139382951|NCT06173245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382952|NCT06173245|Growth Inhibitors|growth inhibitors|mesh-ancestor
139382953|NCT06173245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382954|NCT06173011|Pembrolizumab|pembrolizumab|mesh-list
139382955|NCT06173011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139382956|NCT06173011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382957|NCT06173011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139382958|NCT06173011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382959|NCT06172998|Phentolamine|phentolamine|mesh-list
139382960|NCT06172998|Nitroglycerin|nitroglycerin|mesh-list
139382961|NCT06172998|Vasodilator Agents|vasodilator agents|mesh-ancestor
139382962|NCT06172998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139382963|NCT06172998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139382964|NCT06172998|Adrenergic Agents|adrenergic agents|mesh-ancestor
139382965|NCT06172998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139382966|NCT06172998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382967|NCT06172998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382968|NCT06172998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139382969|NCT06172920|Morphine|morphine|mesh-list
139382970|NCT06172920|Tramadol|tramadol|mesh-list
139382971|NCT06172920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139382972|NCT06172920|Narcotics|narcotics|mesh-ancestor
139382973|NCT06172920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139382974|NCT06172920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382975|NCT06172920|Analgesics|analgesics|mesh-ancestor
139382976|NCT06172920|Sensory System Agents|sensory system agents|mesh-ancestor
139382977|NCT06172920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139382978|NCT06172829|Imidacloprid|imidacloprid|mesh-list
139382979|NCT06172829|Cholinergic Agents|cholinergic agents|mesh-ancestor
139382980|NCT06172829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139382981|NCT06172829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139382982|NCT06172829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382983|NCT06172686|Doxycycline|doxycycline|mesh-list
139382984|NCT06172686|Piperaquine|piperaquine|mesh-list
139382985|NCT06172686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139382986|NCT06172686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139382987|NCT06172686|Antimalarials|antimalarials|mesh-ancestor
139382988|NCT06172686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139382989|NCT06172686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139382990|NCT06172660|Vaccines|vaccines|mesh-list
139382991|NCT06172660|Immunologic Factors|immunologic factors|mesh-ancestor
139382992|NCT06172660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139382993|NCT06172478|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
139382994|NCT06172478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139382995|NCT06172478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139382996|NCT06172361|Prednisone|prednisone|mesh-list
139382997|NCT06172361|Tofacitinib|tofacitinib|mesh-list
139382998|NCT06172361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139382999|NCT06172361|Glucocorticoids|glucocorticoids|mesh-ancestor
139383000|NCT06172361|Hormones|hormones|mesh-ancestor
139383001|NCT06172361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139383002|NCT06172361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383003|NCT06172361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139383004|NCT06172361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383005|NCT06172361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139383006|NCT06172361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139383007|NCT06172361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383008|NCT06172361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383009|NCT06172322|Fulvestrant|fulvestrant|mesh-list
139383010|NCT06172322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139383011|NCT06172322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383012|NCT06172322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139383013|NCT06172322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139383014|NCT06172322|Hormone Antagonists|hormone antagonists|mesh-ancestor
139383015|NCT06172322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139383016|NCT06172322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383017|NCT06172296|Vitamin A|vitamin a|mesh-list
139383018|NCT06172296|Cyclophosphamide|cyclophosphamide|mesh-list
139383019|NCT06172296|Temozolomide|temozolomide|mesh-list
139383020|NCT06172296|Melphalan|melphalan|mesh-list
139383021|NCT06172296|Mechlorethamine|mechlorethamine|mesh-list
139383022|NCT06172296|Thiotepa|thiotepa|mesh-list
139383023|NCT06172296|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139383024|NCT06172296|Cisplatin|cisplatin|mesh-list
139383025|NCT06172296|Carboplatin|carboplatin|mesh-list
139383026|NCT06172296|Doxorubicin|doxorubicin|mesh-list
139383027|NCT06172296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139383028|NCT06172296|Irinotecan|irinotecan|mesh-list
139383029|NCT06172296|Etoposide|etoposide|mesh-list
139383030|NCT06172296|Vincristine|vincristine|mesh-list
139383031|NCT06172296|Etoposide phosphate|etoposide phosphate|mesh-list
139383032|NCT06172296|Daunorubicin|daunorubicin|mesh-list
139383033|NCT06172296|Topotecan|topotecan|mesh-list
139383034|NCT06172296|Tretinoin|tretinoin|mesh-list
139383035|NCT06172296|Podophyllotoxin|podophyllotoxin|mesh-list
139383036|NCT06172296|Dinutuximab|dinutuximab|mesh-list
139383037|NCT06172296|Dexrazoxane|dexrazoxane|mesh-list
139383038|NCT06172296|Razoxane|razoxane|mesh-list
139383039|NCT06172296|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
139383040|NCT06172296|Isotretinoin|isotretinoin|mesh-list
139383041|NCT06172296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139383042|NCT06172296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139383043|NCT06172296|Immunologic Factors|immunologic factors|mesh-ancestor
139383044|NCT06172296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383045|NCT06172296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139383046|NCT06172296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139383047|NCT06172296|Alkylating Agents|alkylating agents|mesh-ancestor
139383048|NCT06172296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383049|NCT06172296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383050|NCT06172296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139383051|NCT06172296|Vitamins|vitamins|mesh-ancestor
139383052|NCT06172296|Micronutrients|micronutrients|mesh-ancestor
139383053|NCT06172296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139383054|NCT06172296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139383055|NCT06172296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139383056|NCT06172296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383057|NCT06172296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139383058|NCT06172296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139383059|NCT06172296|Tubulin Modulators|tubulin modulators|mesh-ancestor
139383060|NCT06172296|Antimitotic Agents|antimitotic agents|mesh-ancestor
139383061|NCT06172296|Mitosis Modulators|mitosis modulators|mesh-ancestor
139383062|NCT06172296|Keratolytic Agents|keratolytic agents|mesh-ancestor
139383063|NCT06172296|Dermatologic Agents|dermatologic agents|mesh-ancestor
139383064|NCT06172296|Protective Agents|protective agents|mesh-ancestor
139383065|NCT06172296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139383066|NCT06172257|Dexamethasone|dexamethasone|mesh-list
139383067|NCT06172257|Dexamethasone acetate|dexamethasone acetate|mesh-list
139383068|NCT06172257|BB 1101|bb 1101|mesh-list
139383069|NCT06172257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139383070|NCT06172257|Antiemetics|antiemetics|mesh-ancestor
139383071|NCT06172257|Autonomic Agents|autonomic agents|mesh-ancestor
139383072|NCT06172257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383073|NCT06172257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383074|NCT06172257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139383075|NCT06172257|Glucocorticoids|glucocorticoids|mesh-ancestor
139383076|NCT06172257|Hormones|hormones|mesh-ancestor
139383077|NCT06172257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139383078|NCT06172257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139383079|NCT06172257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383080|NCT06172257|Protease Inhibitors|protease inhibitors|mesh-ancestor
139383081|NCT06172257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383082|NCT06172257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383083|NCT06172205|Leucovorin|leucovorin|mesh-list
139383084|NCT06172205|Apatinib|apatinib|mesh-list
139383085|NCT06172205|Fluorouracil|fluorouracil|mesh-list
139383086|NCT06172205|Oxaliplatin|oxaliplatin|mesh-list
139383087|NCT06172205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383088|NCT06172205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139383089|NCT06172205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383090|NCT06172205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383091|NCT06172205|Antimetabolites|antimetabolites|mesh-ancestor
139383092|NCT06172205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139383093|NCT06172205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139383094|NCT06172205|Immunologic Factors|immunologic factors|mesh-ancestor
139383095|NCT06172205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383096|NCT06172205|Antidotes|antidotes|mesh-ancestor
139383097|NCT06172205|Protective Agents|protective agents|mesh-ancestor
139383098|NCT06172205|Vitamin B Complex|vitamin b complex|mesh-ancestor
139383099|NCT06172205|Vitamins|vitamins|mesh-ancestor
139383100|NCT06172205|Micronutrients|micronutrients|mesh-ancestor
139383101|NCT06172140|Propofol|propofol|mesh-list
139383102|NCT06172140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139383103|NCT06172140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139383104|NCT06172140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383105|NCT06172140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139383106|NCT06172140|Anesthetics, General|anesthetics, general|mesh-ancestor
139383107|NCT06172140|Anesthetics|anesthetics|mesh-ancestor
139383108|NCT06172127|Trastuzumab|trastuzumab|mesh-list
139383109|NCT06172127|Pertuzumab|pertuzumab|mesh-list
139383110|NCT06172127|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139383111|NCT06172127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383112|NCT06172127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383113|NCT06172127|Immunoconjugates|immunoconjugates|mesh-ancestor
139383114|NCT06172127|Immunologic Factors|immunologic factors|mesh-ancestor
139383115|NCT06172127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383116|NCT06172036|Oxaliplatin|oxaliplatin|mesh-list
139383117|NCT06172036|Irinotecan|irinotecan|mesh-list
139383118|NCT06172036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383119|NCT06172036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139383120|NCT06172036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139383121|NCT06172036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383122|NCT06172036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383123|NCT06172023|Chitosan|chitosan|mesh-list
139383124|NCT06172023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139383125|NCT06172023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139383126|NCT06172023|Antimetabolites|antimetabolites|mesh-ancestor
139383127|NCT06172023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383128|NCT06172023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139383129|NCT06172023|Chelating Agents|chelating agents|mesh-ancestor
139383130|NCT06172023|Sequestering Agents|sequestering agents|mesh-ancestor
139383131|NCT06172023|Hemostatics|hemostatics|mesh-ancestor
139383132|NCT06172023|Coagulants|coagulants|mesh-ancestor
139383133|NCT06172010|Levofloxacin|levofloxacin|mesh-list
139383134|NCT06172010|Rifampin|rifampin|mesh-list
139383135|NCT06172010|Clindamycin|clindamycin|mesh-list
139383136|NCT06172010|Clindamycin palmitate|clindamycin palmitate|mesh-list
139383137|NCT06172010|Clindamycin phosphate|clindamycin phosphate|mesh-list
139383138|NCT06172010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139383139|NCT06172010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139383140|NCT06172010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139383141|NCT06172010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139383142|NCT06172010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139383143|NCT06172010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383144|NCT06172010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383145|NCT06172010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383146|NCT06172010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139383147|NCT06172010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139383148|NCT06172010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139383149|NCT06172010|Antitubercular Agents|antitubercular agents|mesh-ancestor
139383150|NCT06172010|Leprostatic Agents|leprostatic agents|mesh-ancestor
139383151|NCT06172010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139383152|NCT06172010|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139383153|NCT06172010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139383154|NCT06172010|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139383155|NCT06172010|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139383156|NCT06172010|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139383157|NCT06172010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139383158|NCT06172010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139383159|NCT06171932|Methylprednisolone|methylprednisolone|mesh-list
139383160|NCT06171932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139383161|NCT06171932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139383163|NCT06171932|Prednisolone acetate|prednisolone acetate|mesh-list
139383164|NCT06171932|Hydrocortisone|hydrocortisone|mesh-list
139383165|NCT06171932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139383166|NCT06171932|Prednisolone phosphate|prednisolone phosphate|mesh-list
139383167|NCT06171932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139383168|NCT06171932|Antiemetics|antiemetics|mesh-ancestor
139383169|NCT06171932|Autonomic Agents|autonomic agents|mesh-ancestor
139001733|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
139383170|NCT06171932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383171|NCT06171932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383172|NCT06171932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139383173|NCT06171932|Glucocorticoids|glucocorticoids|mesh-ancestor
139383174|NCT06171932|Hormones|hormones|mesh-ancestor
139383175|NCT06171932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139383176|NCT06171932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139383177|NCT06171932|Protective Agents|protective agents|mesh-ancestor
139383178|NCT06171932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139383179|NCT06171932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383181|NCT06171880|Antiviral Agents|antiviral agents|mesh-ancestor
139383182|NCT06171880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139383183|NCT06171880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139383184|NCT06171880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139383185|NCT06171880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383186|NCT06171880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383187|NCT06171880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139383188|NCT06171880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139383189|NCT06171776|Calcium|calcium|mesh-list
139383190|NCT06171776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139383191|NCT06171776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383192|NCT06167681|Dopamine|dopamine|mesh-list
139383193|NCT06167681|Dopamine Agonists|dopamine agonists|mesh-list
139383194|NCT06167681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139383195|NCT06167681|Sympathomimetics|sympathomimetics|mesh-ancestor
139383196|NCT06167681|Autonomic Agents|autonomic agents|mesh-ancestor
139383197|NCT06167681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383198|NCT06167681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383199|NCT06167681|Dopamine Agents|dopamine agents|mesh-ancestor
139383200|NCT06167681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383201|NCT06167681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383202|NCT06167681|Protective Agents|protective agents|mesh-ancestor
139383203|NCT06166602|Bupivacaine|bupivacaine|mesh-list
139383204|NCT06166602|Anesthetics, Local|anesthetics, local|mesh-ancestor
139383205|NCT06166602|Anesthetics|anesthetics|mesh-ancestor
139383206|NCT06166602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139383207|NCT06166602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383208|NCT06166602|Sensory System Agents|sensory system agents|mesh-ancestor
139383209|NCT06166602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383210|NCT06165458|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139383211|NCT06165458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139383212|NCT06165458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139383213|NCT06165068|Aspirin|aspirin|mesh-list
139383214|NCT06165068|Acetylcysteine|acetylcysteine|mesh-list
139383215|NCT06165068|Clopidogrel|clopidogrel|mesh-list
139383216|NCT06165068|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139383217|NCT06165068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139383218|NCT06165068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139383219|NCT06165068|Analgesics|analgesics|mesh-ancestor
139383220|NCT06165068|Sensory System Agents|sensory system agents|mesh-ancestor
139383221|NCT06165068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383222|NCT06165068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383223|NCT06165068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139383224|NCT06165068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139383225|NCT06165068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139383226|NCT06165068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139383227|NCT06165068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383228|NCT06165068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139383229|NCT06165068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139383230|NCT06165068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383231|NCT06165068|Antipyretics|antipyretics|mesh-ancestor
139383232|NCT06165068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139383233|NCT06165068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139383234|NCT06165068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139383235|NCT06165068|Purinergic Agents|purinergic agents|mesh-ancestor
139383236|NCT06165068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383237|NCT06165068|Antiviral Agents|antiviral agents|mesh-ancestor
139383238|NCT06165068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139383239|NCT06165068|Expectorants|expectorants|mesh-ancestor
139383240|NCT06165068|Respiratory System Agents|respiratory system agents|mesh-ancestor
139383241|NCT06165068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139383242|NCT06165068|Antioxidants|antioxidants|mesh-ancestor
139383243|NCT06165068|Protective Agents|protective agents|mesh-ancestor
139383244|NCT06165068|Antidotes|antidotes|mesh-ancestor
139383245|NCT06164795|Zoledronic Acid|zoledronic acid|mesh-list
139383246|NCT06164795|Denosumab|denosumab|mesh-list
139383247|NCT06164795|Teriparatide|teriparatide|mesh-list
139383248|NCT06164795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139383249|NCT06164795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001846|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139383250|NCT06164795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139383251|NCT06163443|Vitamins|vitamins|mesh-list
139383252|NCT06163443|Vitamin B Complex|vitamin b complex|mesh-list
139383253|NCT06163443|Micronutrients|micronutrients|mesh-ancestor
139383254|NCT06163443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383256|NCT06162013|Niacin|niacin|mesh-list
139383257|NCT06162013|Nicotinic Acids|nicotinic acids|mesh-list
139383258|NCT06162013|Vitamin B Complex|vitamin b complex|mesh-ancestor
139383259|NCT06162013|Vitamins|vitamins|mesh-ancestor
139383260|NCT06162013|Micronutrients|micronutrients|mesh-ancestor
139383261|NCT06162013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383262|NCT06162013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139383263|NCT06162013|Antimetabolites|antimetabolites|mesh-ancestor
139383264|NCT06162013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383265|NCT06162013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139383266|NCT06162013|Vasodilator Agents|vasodilator agents|mesh-ancestor
139383267|NCT06161675|Nicotine|nicotine|mesh-list
139383268|NCT06161675|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139383269|NCT06161675|Autonomic Agents|autonomic agents|mesh-ancestor
139383270|NCT06161675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383271|NCT06161675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383272|NCT06161675|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139383273|NCT06161675|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139383274|NCT06161675|Cholinergic Agents|cholinergic agents|mesh-ancestor
139383275|NCT06161675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383276|NCT06161675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383277|NCT06151431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139383278|NCT06151431|Adrenergic Agents|adrenergic agents|mesh-list
139383279|NCT06151431|Adrenergic Agonists|adrenergic agonists|mesh-list
139383280|NCT06151431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383281|NCT06151431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383282|NCT06151431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383283|NCT06145893|Hemay005|hemay005|mesh-list
139383284|NCT06145893|Dermatologic Agents|dermatologic agents|mesh-ancestor
139383285|NCT06145893|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139383286|NCT06145893|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139383287|NCT06145893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383288|NCT06145893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383289|NCT06135298|Zoledronic Acid|zoledronic acid|mesh-list
139383290|NCT06135298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139383291|NCT06135298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383292|NCT06103721|Dexmedetomidine|dexmedetomidine|mesh-list
139383293|NCT06103721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139383294|NCT06103721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139383295|NCT06103721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383296|NCT06103721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139383297|NCT06103721|Analgesics|analgesics|mesh-ancestor
139383298|NCT06103721|Sensory System Agents|sensory system agents|mesh-ancestor
139383299|NCT06103721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383300|NCT06103721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139383301|NCT06103721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139383302|NCT06103721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139383303|NCT06103721|Adrenergic Agents|adrenergic agents|mesh-ancestor
139383304|NCT06103721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383305|NCT06103721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383306|NCT06096337|Flecainide|flecainide|mesh-list
139383307|NCT06096337|Sotalol|sotalol|mesh-list
139383308|NCT06096337|Propafenone|propafenone|mesh-list
139383309|NCT06096337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139383310|NCT06096337|Dofetilide|dofetilide|mesh-list
139383311|NCT06096337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139383312|NCT06096337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139383313|NCT06096337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139383314|NCT06096337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383315|NCT06096337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139383316|NCT06096337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139383317|NCT06096337|Adrenergic Agents|adrenergic agents|mesh-ancestor
139383318|NCT06096337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383319|NCT06096337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383320|NCT06096337|Sympatholytics|sympatholytics|mesh-ancestor
139383321|NCT06096337|Autonomic Agents|autonomic agents|mesh-ancestor
139383322|NCT06096337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383323|NCT06096337|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139383324|NCT06092957|Cisplatin|cisplatin|mesh-list
139383325|NCT06092957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383326|NCT06069726|Atezolizumab|atezolizumab|mesh-list
139383327|NCT06069726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139383328|NCT06069726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383329|NCT06069726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383330|NCT06069726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383332|NCT06066216|Carboplatin|carboplatin|mesh-list
139383333|NCT06066216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139383334|NCT06066216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383335|NCT06066216|Tubulin Modulators|tubulin modulators|mesh-ancestor
139383336|NCT06066216|Antimitotic Agents|antimitotic agents|mesh-ancestor
139383337|NCT06066216|Mitosis Modulators|mitosis modulators|mesh-ancestor
139383338|NCT06066216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383339|NCT06065059|Olaparib|olaparib|mesh-list
139383340|NCT06065059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139383341|NCT06065059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383342|NCT06065059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383343|NCT06065059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383344|NCT06047977|Cyclophosphamide|cyclophosphamide|mesh-list
139383345|NCT06047977|Fludarabine|fludarabine|mesh-list
139383346|NCT06047977|Interleukin-2|interleukin-2|mesh-list
139383347|NCT06047977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139383348|NCT06047977|Immunologic Factors|immunologic factors|mesh-ancestor
139383349|NCT06047977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383350|NCT06047977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139383351|NCT06047977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139383352|NCT06047977|Alkylating Agents|alkylating agents|mesh-ancestor
139383353|NCT06047977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383354|NCT06047977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383355|NCT06047977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139383356|NCT06047977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139383357|NCT06047977|Analgesics|analgesics|mesh-ancestor
139383358|NCT06047977|Sensory System Agents|sensory system agents|mesh-ancestor
139383359|NCT06047977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383360|NCT06026319|Cyclophosphamide|cyclophosphamide|mesh-list
139383361|NCT06026319|Fludarabine|fludarabine|mesh-list
139383362|NCT06026319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139383363|NCT06026319|Immunologic Factors|immunologic factors|mesh-ancestor
139383364|NCT06026319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383365|NCT06026319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139383366|NCT06026319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139383367|NCT06026319|Alkylating Agents|alkylating agents|mesh-ancestor
139383368|NCT06026319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383369|NCT06026319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383370|NCT06026319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139383371|NCT06001047|Betahistine|betahistine|mesh-list
139383372|NCT06001047|Vasodilator Agents|vasodilator agents|mesh-ancestor
139383373|NCT06001047|Histamine Agonists|histamine agonists|mesh-ancestor
139383374|NCT06001047|Histamine Agents|histamine agents|mesh-ancestor
139383375|NCT06001047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383376|NCT06001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383377|NCT06001047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383378|NCT05999708|Indomethacin|indomethacin|mesh-list
139383379|NCT05999708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139383380|NCT05999708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139383381|NCT05999708|Analgesics|analgesics|mesh-ancestor
139383382|NCT05999708|Sensory System Agents|sensory system agents|mesh-ancestor
139383383|NCT05999708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383384|NCT05999708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383385|NCT05999708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139383386|NCT05999708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139383387|NCT05999708|Gout Suppressants|gout suppressants|mesh-ancestor
139383388|NCT05999708|Tocolytic Agents|tocolytic agents|mesh-ancestor
139383389|NCT05999708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139383390|NCT05999708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139383391|NCT05999708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383392|NCT05999708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383393|NCT05990387|Mirabegron|mirabegron|mesh-list
139383394|NCT05990387|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139383395|NCT05990387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139383396|NCT05990387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139383397|NCT05990387|Adrenergic Agents|adrenergic agents|mesh-ancestor
139383398|NCT05990387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383399|NCT05990387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383400|NCT05990387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383401|NCT05990387|Urological Agents|urological agents|mesh-ancestor
139383402|NCT05970263|Budesonide|budesonide|mesh-list
139383403|NCT05970263|Glycopyrrolate|glycopyrrolate|mesh-list
139383404|NCT05970263|Formoterol Fumarate|formoterol fumarate|mesh-list
139383405|NCT05970263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139383406|NCT05970263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139383407|NCT05970263|Autonomic Agents|autonomic agents|mesh-ancestor
139383408|NCT05970263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383409|NCT05970263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383410|NCT05970263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139383411|NCT05970263|Respiratory System Agents|respiratory system agents|mesh-ancestor
139383412|NCT05970263|Glucocorticoids|glucocorticoids|mesh-ancestor
139383413|NCT05970263|Hormones|hormones|mesh-ancestor
139383414|NCT05970263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139383415|NCT05970263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139383416|NCT05970263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139383417|NCT05970263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139383418|NCT05970263|Adrenergic Agents|adrenergic agents|mesh-ancestor
139383419|NCT05970263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383420|NCT05970263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383421|NCT05970263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139383422|NCT05970263|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139383423|NCT05970263|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139383424|NCT05970263|Cholinergic Agents|cholinergic agents|mesh-ancestor
139383425|NCT05967403|Propofol|propofol|mesh-list
139383426|NCT05967403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139383427|NCT05967403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139383428|NCT05967403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383429|NCT05967403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139383430|NCT05967403|Anesthetics, General|anesthetics, general|mesh-ancestor
139383431|NCT05967403|Anesthetics|anesthetics|mesh-ancestor
139383432|NCT05833126|Bevacizumab|bevacizumab|mesh-list
139383433|NCT05833126|Atezolizumab|atezolizumab|mesh-list
139383434|NCT05833126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383435|NCT05833126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383436|NCT05833126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139383437|NCT05833126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139383438|NCT05833126|Growth Substances|growth substances|mesh-ancestor
139383439|NCT05833126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383440|NCT05833126|Growth Inhibitors|growth inhibitors|mesh-ancestor
139383441|NCT05833126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139383442|NCT05833126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383443|NCT05818735|Escitalopram|escitalopram|mesh-list
139383444|NCT05818735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139383445|NCT05818735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139383446|NCT05818735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139383447|NCT05818735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383448|NCT05818735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383449|NCT05818735|Serotonin Agents|serotonin agents|mesh-ancestor
139383450|NCT05818735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383451|NCT05817240|Nintedanib|nintedanib|mesh-list
139383452|NCT05817240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383453|NCT05817240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139383454|NCT05817240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383455|NCT05817240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383456|NCT05801237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139383457|NCT05801237|Antibodies|antibodies|mesh-list
139383458|NCT05801237|Immunoglobulins|immunoglobulins|mesh-list
139383459|NCT05801237|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139383460|NCT05801237|Immunologic Factors|immunologic factors|mesh-ancestor
139383461|NCT05801237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383462|NCT05801237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383464|NCT05796661|Sodium Citrate|sodium citrate|mesh-list
139383465|NCT05796661|Anticoagulants|anticoagulants|mesh-ancestor
139383466|NCT05796661|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139383467|NCT05796661|Chelating Agents|chelating agents|mesh-ancestor
139383468|NCT05796661|Sequestering Agents|sequestering agents|mesh-ancestor
139383469|NCT05796661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383470|NCT05782881|Glucagon|glucagon|mesh-list
139383471|NCT05782881|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139383472|NCT05782881|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139383473|NCT05782881|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139383474|NCT05782881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139383475|NCT05782881|Hormones|hormones|mesh-ancestor
139383476|NCT05782881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139383477|NCT05782881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383478|NCT05782881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383479|NCT05782881|Incretins|incretins|mesh-ancestor
139383480|NCT05782881|Protease Inhibitors|protease inhibitors|mesh-ancestor
139383481|NCT05780073|Dasatinib|dasatinib|mesh-list
139383482|NCT05780073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383483|NCT05780073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139383484|NCT05780073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383485|NCT05780073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383486|NCT05755789|Cefoxitin|cefoxitin|mesh-list
139383487|NCT05755789|Cefotaxime|cefotaxime|mesh-list
139383488|NCT05755789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139383489|NCT05755789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139383490|NCT05702970|Vitamin D|vitamin d|mesh-list
139383491|NCT05702970|Vitamins|vitamins|mesh-ancestor
139383492|NCT05702970|Micronutrients|micronutrients|mesh-ancestor
139383493|NCT05702970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383494|NCT05702970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139383495|NCT05691517|Exatecan|exatecan|mesh-list
139383496|NCT05691517|Camptothecin|camptothecin|mesh-list
139383497|NCT05691517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139383498|NCT05691517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139383499|NCT05691517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383500|NCT05691517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383501|NCT05691517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383502|NCT05691517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139383503|NCT05689619|Silybin|silybin|mesh-list
139383504|NCT05689619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139383505|NCT05689619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383506|NCT05689619|Protective Agents|protective agents|mesh-ancestor
139383507|NCT05689619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383508|NCT05674994|Prednisone|prednisone|mesh-list
139383509|NCT05674994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139383510|NCT05674994|Glucocorticoids|glucocorticoids|mesh-ancestor
139383511|NCT05674994|Hormones|hormones|mesh-ancestor
139383512|NCT05674994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139383513|NCT05674994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383514|NCT05674994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139383515|NCT05674994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383516|NCT05665530|Zanubrutinib|zanubrutinib|mesh-list
139383517|NCT05665530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383518|NCT05665530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139383519|NCT05665530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383520|NCT05665530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383521|NCT05653271|Cyclophosphamide|cyclophosphamide|mesh-list
139383522|NCT05653271|Fludarabine|fludarabine|mesh-list
139383523|NCT05653271|Obinutuzumab|obinutuzumab|mesh-list
139383524|NCT05653271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139383525|NCT05653271|Immunologic Factors|immunologic factors|mesh-ancestor
139383526|NCT05653271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383527|NCT05653271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139383528|NCT05653271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139383529|NCT05653271|Alkylating Agents|alkylating agents|mesh-ancestor
139383530|NCT05653271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383531|NCT05653271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383532|NCT05653271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139383533|NCT05653271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383534|NCT05611268|Pentoxifylline|pentoxifylline|mesh-list
139383535|NCT05611268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139383537|NCT05611268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383538|NCT05611268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139383539|NCT05611268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139383540|NCT05611268|Protective Agents|protective agents|mesh-ancestor
139383541|NCT05611268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383542|NCT05611268|Vasodilator Agents|vasodilator agents|mesh-ancestor
139383543|NCT05611268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139383544|NCT05611268|Antioxidants|antioxidants|mesh-ancestor
139383545|NCT05593458|Oxaliplatin|oxaliplatin|mesh-list
139383546|NCT05593458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383547|NCT05567562|Clopidogrel|clopidogrel|mesh-list
139383548|NCT05567562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383549|NCT05567562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383550|NCT05567562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139383551|NCT05567562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139383552|NCT05567562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139383553|NCT05567562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139383554|NCT05567562|Purinergic Agents|purinergic agents|mesh-ancestor
139383555|NCT05567562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383556|NCT05560516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139383557|NCT05560516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139383558|NCT05560516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139383559|NCT05560516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139383560|NCT05560516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383561|NCT05560516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383562|NCT05560516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383563|NCT05560516|Analgesics|analgesics|mesh-ancestor
139383564|NCT05560516|Sensory System Agents|sensory system agents|mesh-ancestor
139383565|NCT05560516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383566|NCT05560516|Antidepressive Agents|antidepressive agents|mesh-ancestor
139383567|NCT05560516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139383568|NCT05560516|Dopamine Agents|dopamine agents|mesh-ancestor
139383569|NCT05554419|Cytarabine|cytarabine|mesh-list
139383570|NCT05554419|Azacitidine|azacitidine|mesh-list
139383571|NCT05554419|Daunorubicin|daunorubicin|mesh-list
139383572|NCT05554419|Venetoclax|venetoclax|mesh-list
139383573|NCT05554419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139383574|NCT05554419|Antimetabolites|antimetabolites|mesh-ancestor
139383575|NCT05554419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383576|NCT05554419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383577|NCT05554419|Antiviral Agents|antiviral agents|mesh-ancestor
139383578|NCT05554419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139383579|NCT05554419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139383580|NCT05554419|Immunologic Factors|immunologic factors|mesh-ancestor
139383581|NCT05554419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383582|NCT05554419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383583|NCT05554419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139383584|NCT05554419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139383585|NCT05554419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139383586|NCT05553834|Cemiplimab|cemiplimab|mesh-list
139383587|NCT05553834|Alirocumab|alirocumab|mesh-list
139383588|NCT05553834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383589|NCT05553834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383590|NCT05553834|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139383591|NCT05553834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139383592|NCT05553834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139383593|NCT05553834|Antimetabolites|antimetabolites|mesh-ancestor
139383594|NCT05553834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383595|NCT05553834|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139383596|NCT05553834|Protease Inhibitors|protease inhibitors|mesh-ancestor
139383597|NCT05553834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383598|NCT05553834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139383599|NCT05542264|Olanzapine|olanzapine|mesh-list
139383600|NCT05542264|Risperidone|risperidone|mesh-list
139383601|NCT05542264|Aripiprazole|aripiprazole|mesh-list
139383602|NCT05542264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139383603|NCT05542264|Antipsychotic Agents|antipsychotic agents|mesh-list
139383604|NCT05542264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139383605|NCT05542264|Serotonin Agents|serotonin agents|mesh-ancestor
139383606|NCT05542264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383607|NCT05542264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118766|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139383608|NCT05542264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383609|NCT05542264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139383610|NCT05542264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139383611|NCT05542264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139383612|NCT05542264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139383613|NCT05542264|Dopamine Agents|dopamine agents|mesh-ancestor
139383614|NCT05542264|Antiemetics|antiemetics|mesh-ancestor
139383615|NCT05542264|Autonomic Agents|autonomic agents|mesh-ancestor
139383616|NCT05542264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383617|NCT05542264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139383618|NCT05542264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139383619|NCT05542264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139383620|NCT05542264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139383621|NCT05542264|Antidepressive Agents|antidepressive agents|mesh-ancestor
139383622|NCT05542264|Dopamine Agonists|dopamine agonists|mesh-ancestor
139383623|NCT05542264|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139040443|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
139383624|NCT05542264|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139383625|NCT05542264|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139383626|NCT05542264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139383627|NCT05533242|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
139383628|NCT05533242|Immunologic Factors|immunologic factors|mesh-ancestor
139383629|NCT05533242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383630|NCT05492578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139383631|NCT05492578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383632|NCT05492578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383633|NCT05464615|Amoxicillin|amoxicillin|mesh-list
139383634|NCT05464615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139383635|NCT05464615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139383636|NCT05458401|Trastuzumab|trastuzumab|mesh-list
139383637|NCT05458401|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139383638|NCT05458401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383639|NCT05458401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383640|NCT05458401|Immunoconjugates|immunoconjugates|mesh-ancestor
139383641|NCT05458401|Immunologic Factors|immunologic factors|mesh-ancestor
139001907|NCT00762983|Loratadine|loratadine|mesh-list
139383642|NCT05458401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383643|NCT05360537|Insulin|insulin|mesh-list
139383644|NCT05360537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139383645|NCT05360537|Insulin Glargine|insulin glargine|mesh-list
139383646|NCT05360537|Liraglutide|liraglutide|mesh-list
139383647|NCT05360537|Insulin, Long-Acting|insulin, long-acting|mesh-list
139383648|NCT05360537|Xultophy|xultophy|mesh-list
139383649|NCT05360537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139383650|NCT05360537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383651|NCT05360537|Incretins|incretins|mesh-ancestor
139383652|NCT05360537|Hormones|hormones|mesh-ancestor
139383653|NCT05360537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139383654|NCT05327530|Avelumab|avelumab|mesh-list
139383655|NCT05327530|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139383656|NCT05327530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383657|NCT05327530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383658|NCT05327530|Immunoconjugates|immunoconjugates|mesh-ancestor
139383659|NCT05327530|Immunologic Factors|immunologic factors|mesh-ancestor
139383660|NCT05327530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383661|NCT05306028|Metformin|metformin|mesh-list
139383662|NCT05306028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139383663|NCT05306028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383664|NCT05297565|Nivolumab|nivolumab|mesh-list
139383665|NCT05297565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383666|NCT05297565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383667|NCT05297565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139383668|NCT05297565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383669|NCT05268744|Micronutrients|micronutrients|mesh-list
139383670|NCT05268744|Trace Elements|trace elements|mesh-list
139383671|NCT05268744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383672|NCT05261139|Ritonavir|ritonavir|mesh-list
139383673|NCT05261139|Nirmatrelvir|nirmatrelvir|mesh-list
139383674|NCT05261139|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139383675|NCT05261139|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139383676|NCT05261139|Protease Inhibitors|protease inhibitors|mesh-ancestor
139383677|NCT05261139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383678|NCT05261139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383679|NCT05261139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139383680|NCT05261139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139383681|NCT05261139|Antiviral Agents|antiviral agents|mesh-ancestor
139383682|NCT05261139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139383683|NCT05261139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139383684|NCT05261139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139383685|NCT05251129|Atorvastatin|atorvastatin|mesh-list
139383686|NCT05251129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139383687|NCT05251129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139383688|NCT05251129|Antimetabolites|antimetabolites|mesh-ancestor
139383689|NCT05251129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383690|NCT05251129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139383691|NCT05251129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139383692|NCT05251129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383693|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139383694|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139383695|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
139383696|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
139383697|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139383698|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383699|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139383700|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383701|NCT05156710|Rituximab|rituximab|mesh-list
139383702|NCT05156710|Tacrolimus|tacrolimus|mesh-list
139383703|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
139383704|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139383705|NCT05156710|Antibodies|antibodies|mesh-list
139383706|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139383707|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
139383708|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139383709|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383710|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383711|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
139383712|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383713|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139383714|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139383715|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139383716|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383717|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383718|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
139383719|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139383720|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
139383721|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383722|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139383723|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139383724|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
139383725|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383726|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383727|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139383728|NCT05150236|Nivolumab|nivolumab|mesh-list
139383729|NCT05150236|Ipilimumab|ipilimumab|mesh-list
139383730|NCT05150236|177Lu-PSMA-617|177lu-psma-617|mesh-list
139383731|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383732|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383733|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139383734|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383735|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139383736|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
139383737|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383738|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139383739|NCT05083481|Pembrolizumab|pembrolizumab|mesh-list
139383740|NCT05083481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383741|NCT05083481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383742|NCT05083481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139383743|NCT05083481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383744|NCT05070156|Vaccines|vaccines|mesh-list
139383745|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
139383746|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383747|NCT05050188|Lansoprazole|lansoprazole|mesh-list
139383748|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
139383749|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139383750|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139383751|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139383752|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383753|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383754|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139383756|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
139383757|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139383758|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
139383759|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383760|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383761|NCT04951063|Immunomodulating Agents|immunomodulating agents|mesh-list
139383762|NCT04951063|Immunologic Factors|immunologic factors|mesh-ancestor
139383763|NCT04951063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383764|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
139383765|NCT04947501|Ifosfamide|ifosfamide|mesh-list
139383766|NCT04947501|Carboplatin|carboplatin|mesh-list
139383767|NCT04947501|Doxorubicin|doxorubicin|mesh-list
139383768|NCT04947501|Etoposide|etoposide|mesh-list
139383769|NCT04947501|Vincristine|vincristine|mesh-list
139383770|NCT04947501|Topotecan|topotecan|mesh-list
139383771|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139383772|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
139383773|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383774|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139383775|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139383776|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
139383777|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383778|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383779|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139383780|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139001923|NCT00403234|Analgesics|analgesics|mesh-ancestor
139383781|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139383782|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139383783|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383784|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139383785|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
139383786|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
139383787|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
139383788|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139383789|NCT04939272|Venetoclax|venetoclax|mesh-list
139383790|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383791|NCT04882085|Ceftazidime|ceftazidime|mesh-list
139383792|NCT04882085|Avibactam|avibactam|mesh-list
139383793|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
139383794|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139383795|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139383796|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139383797|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383798|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383799|NCT04870112|Carboplatin|carboplatin|mesh-list
139383800|NCT04870112|Etoposide|etoposide|mesh-list
139383801|NCT04870112|Durvalumab|durvalumab|mesh-list
139383802|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383803|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139383804|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139383805|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139383806|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383807|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383808|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383809|NCT04840589|Nivolumab|nivolumab|mesh-list
139383810|NCT04840589|Ipilimumab|ipilimumab|mesh-list
139383811|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383812|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383813|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139383814|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383815|NCT04838288|Tacrolimus|tacrolimus|mesh-list
139383816|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139383817|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
139383818|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383819|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139383820|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383821|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383822|NCT04827745|Blinatumomab|blinatumomab|mesh-list
139383823|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383824|NCT04798027|Vaccines|vaccines|mesh-list
139383825|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
139383826|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383827|NCT04788667|Erenumab|erenumab|mesh-list
139383828|NCT04788667|Botulinum Toxins|botulinum toxins|mesh-list
139383829|NCT04788667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139383830|NCT04788667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139383831|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383833|NCT04788667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383834|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383835|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139383836|NCT04788667|Analgesics|analgesics|mesh-ancestor
139383837|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
139383838|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383839|NCT04778397|Cytarabine|cytarabine|mesh-list
139383840|NCT04778397|Azacitidine|azacitidine|mesh-list
139383841|NCT04778397|Daunorubicin|daunorubicin|mesh-list
139383842|NCT04778397|Venetoclax|venetoclax|mesh-list
139383843|NCT04778397|Idarubicin|idarubicin|mesh-list
139383844|NCT04778397|Magrolimab|magrolimab|mesh-list
139383845|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139383846|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139383847|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
139383848|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383849|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383850|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
139383851|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139383852|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139383853|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
139383854|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383855|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383856|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139383857|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139383858|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139383859|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139383860|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383861|NCT04775953|Vancomycin|vancomycin|mesh-list
139383862|NCT04775953|Cefazolin|cefazolin|mesh-list
139383863|NCT04775953|Daptomycin|daptomycin|mesh-list
139383864|NCT04775953|Dalbavancin|dalbavancin|mesh-list
139383865|NCT04775953|Oxacillin|oxacillin|mesh-list
139383866|NCT04775953|Nafcillin|nafcillin|mesh-list
139383867|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139383868|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139383869|NCT04711824|Paclitaxel|paclitaxel|mesh-list
139383870|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139383871|NCT04711824|Cisplatin|cisplatin|mesh-list
139383872|NCT04711824|Carboplatin|carboplatin|mesh-list
139383873|NCT04711824|Gemcitabine|gemcitabine|mesh-list
139383874|NCT04711824|Capecitabine|capecitabine|mesh-list
139383875|NCT04711824|Durvalumab|durvalumab|mesh-list
139383876|NCT04711824|Olaparib|olaparib|mesh-list
139383877|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139383878|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383879|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
139383880|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
139383881|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
139383882|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383883|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139383884|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
139383885|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383886|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139383887|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383888|NCT04707625|Aflibercept|aflibercept|mesh-list
139383889|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139383890|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139383891|NCT04707625|Growth Substances|growth substances|mesh-ancestor
139383892|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383893|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
139383894|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383895|NCT04702893|Nintedanib|nintedanib|mesh-list
139383896|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383897|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139383898|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383899|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383900|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
139383901|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139383902|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383903|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139383904|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383905|NCT04682405|Melphalan|melphalan|mesh-list
138888653|NCT00695994|Gemcitabine|gemcitabine|mesh-list
139383906|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139383907|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
139383908|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383909|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383910|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139383911|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139383912|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
139383913|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383914|NCT04607980|Ustekinumab|ustekinumab|mesh-list
139383915|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
139383916|NCT04540133|Dexamethasone|dexamethasone|mesh-list
139383917|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
139383918|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139383919|NCT04540133|BB 1101|bb 1101|mesh-list
139383920|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139383921|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
139383922|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
139383923|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383924|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383925|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139383926|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
139383928|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139383929|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139383930|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383931|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
139383932|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383933|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383934|NCT04521647|Nicotine|nicotine|mesh-list
139383935|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139383936|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
139383937|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383938|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383939|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139383940|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139383941|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
139383942|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139383943|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383944|NCT04494880|Bupivacaine|bupivacaine|mesh-list
139383945|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
139383946|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
139383947|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139383948|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383949|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
139383950|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383951|NCT04456608|Aspirin|aspirin|mesh-list
139383952|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139383953|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139383954|NCT04456608|Analgesics|analgesics|mesh-ancestor
139383955|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
139383956|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139383957|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383958|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139383959|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139383960|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139383961|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139383962|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383963|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139383964|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139383965|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139383966|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
139383967|NCT04405349|Atezolizumab|atezolizumab|mesh-list
139383968|NCT04405349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139383969|NCT04405349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383970|NCT04405349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383971|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383972|NCT04404283|Rituximab|rituximab|mesh-list
139383973|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139383974|NCT04404283|Lenalidomide|lenalidomide|mesh-list
139383975|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139383976|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383977|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
139383978|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383979|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139383980|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139383981|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139383983|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
139383984|NCT04404283|Immunotoxins|immunotoxins|mesh-ancestor
139383985|NCT04404283|Immunoconjugates|immunoconjugates|mesh-ancestor
139383986|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139383987|NCT04401553|Vancomycin|vancomycin|mesh-list
139383988|NCT04401553|Cephalosporins|cephalosporins|mesh-list
139383989|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139383990|NCT04393298|Leucovorin|leucovorin|mesh-list
139383991|NCT04393298|Trifluridine|trifluridine|mesh-list
139383992|NCT04393298|Fluorouracil|fluorouracil|mesh-list
139383993|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139383994|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
139383995|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139383996|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139383997|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139383998|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139383999|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
139384000|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
139384001|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384003|NCT04393298|Protective Agents|protective agents|mesh-ancestor
139384004|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
139384005|NCT04393298|Vitamins|vitamins|mesh-ancestor
139384006|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
139384007|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
139384008|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139384009|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
139384010|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384011|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139384012|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
139384013|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139384014|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139384015|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384016|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139384017|NCT04289142|Analgesics|analgesics|mesh-ancestor
139384018|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
139384019|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384020|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139384021|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139384022|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139384023|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
139384024|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139384025|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384026|NCT04284852|Niraparib|niraparib|mesh-list
139384027|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139384028|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384029|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384030|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384031|NCT04233801|Empagliflozin|empagliflozin|mesh-list
139384032|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139384033|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384034|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139384035|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384036|NCT04225039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139384037|NCT04225039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384038|NCT04225039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139384039|NCT04225039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384040|NCT04181333|Trastuzumab|trastuzumab|mesh-list
139384041|NCT04181333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139384042|NCT04181333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384043|NCT04130659|Omeprazole|omeprazole|mesh-list
139384044|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139384045|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139384046|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139384047|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384048|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384049|NCT04109066|Paclitaxel|paclitaxel|mesh-list
139384050|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
139384051|NCT04109066|Nivolumab|nivolumab|mesh-list
139384052|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139384053|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384054|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
139384055|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
139384057|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384058|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139384059|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
139384060|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384061|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139384062|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139384063|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
139384064|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139384065|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139384066|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139384067|NCT04097730|Riboflavin|riboflavin|mesh-list
139384068|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
139384069|NCT04097730|Difluprednate|difluprednate|mesh-list
139384070|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139384071|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384072|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139384073|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139384074|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040894|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
139384075|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384077|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384078|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
139384079|NCT04097730|Vitamins|vitamins|mesh-ancestor
139384080|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
139384081|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139384082|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
139384083|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
139384084|NCT04097730|Hormones|hormones|mesh-ancestor
139384085|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384086|NCT04075136|Triamcinolone|triamcinolone|mesh-list
139384087|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139384088|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139384089|NCT04075136|Ranibizumab|ranibizumab|mesh-list
139384090|NCT04075136|Verteporfin|verteporfin|mesh-list
139384091|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139384092|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139384093|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139384094|NCT04075136|Growth Substances|growth substances|mesh-ancestor
139384095|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384096|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
139384097|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384098|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139384099|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
139384100|NCT04075136|Hormones|hormones|mesh-ancestor
139384101|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384102|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139384103|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
139384104|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384105|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384106|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139384107|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
139384108|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
139384109|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139384110|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139384111|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139384112|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139001971|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139384113|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384114|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
139384115|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139384116|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384117|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139384118|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384119|NCT04069156|Aspirin|aspirin|mesh-list
139384120|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139384121|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139384122|NCT04069156|Analgesics|analgesics|mesh-ancestor
139384123|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
139384124|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384125|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384126|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139384127|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139384128|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139384129|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139384130|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384131|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139384132|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139384133|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384134|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
139384136|NCT04059484|Letrozole|letrozole|mesh-list
139384137|NCT04059484|Fulvestrant|fulvestrant|mesh-list
139384138|NCT04059484|Anastrozole|anastrozole|mesh-list
139384139|NCT04059484|Exemestane|exemestane|mesh-list
139384140|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384141|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139384142|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139384143|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384144|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384145|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139384146|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
139384147|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384148|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384149|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139384150|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139384151|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139384152|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139384153|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139384154|NCT04019015|Thrombin|thrombin|mesh-list
139384155|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
139384156|NCT04019015|Coagulants|coagulants|mesh-ancestor
139384157|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
139384158|NCT04013555|Tryptophan|tryptophan|mesh-list
139384159|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139384160|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
139384161|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384162|NCT04013555|Expectorants|expectorants|mesh-ancestor
139384163|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
139384164|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139384165|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
139384166|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384167|NCT04013555|Protective Agents|protective agents|mesh-ancestor
139384168|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384169|NCT04013555|Antidotes|antidotes|mesh-ancestor
139384170|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139384171|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
139384172|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139384173|NCT03980314|Nivolumab|nivolumab|mesh-list
139384174|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139384175|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384176|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139384177|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384178|NCT03956680|Nivolumab|nivolumab|mesh-list
139384179|NCT03956680|Ipilimumab|ipilimumab|mesh-list
139384180|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139384181|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384182|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139384183|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384184|NCT03928314|Paclitaxel|paclitaxel|mesh-list
139384185|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139384186|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384187|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
139384188|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
139384189|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
139384190|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384191|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
139384192|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139384193|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384194|NCT03924869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139384195|NCT03924869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384196|NCT03916185|Vaccines|vaccines|mesh-list
139384197|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
139384198|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384199|NCT03909334|Osimertinib|osimertinib|mesh-list
139384200|NCT03909334|Ramucirumab|ramucirumab|mesh-list
139384201|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384202|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139384203|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888959|NCT00656864|Pioglitazone|pioglitazone|mesh-list
139384204|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384205|NCT03719924|Paclitaxel|paclitaxel|mesh-list
139384206|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139384207|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384208|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
139384209|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
139384210|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
139384211|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384212|NCT03713879|Indomethacin|indomethacin|mesh-list
139384213|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139384214|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139384215|NCT03713879|Analgesics|analgesics|mesh-ancestor
139384216|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
139384217|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384218|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384219|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139384220|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139384221|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
139384222|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
139041041|NCT00184600|Insulin|insulin|mesh-list
139384223|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139384224|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139384225|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384226|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384227|NCT03635788|Rilpivirine|rilpivirine|mesh-list
139384228|NCT03635788|Cabotegravir|cabotegravir|mesh-list
139384229|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139384230|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139384231|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384232|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384233|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
139384234|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384235|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139384236|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139384237|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139384238|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139384239|NCT03478878|Vitamin A|vitamin a|mesh-list
139384240|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
139384241|NCT03478878|Vitamins|vitamins|mesh-ancestor
139384242|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
139384243|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384244|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
139384245|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384246|NCT03478878|Protective Agents|protective agents|mesh-ancestor
139384247|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139384248|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384249|NCT03415854|Paclitaxel|paclitaxel|mesh-list
139384250|NCT03415854|Cisplatin|cisplatin|mesh-list
139384251|NCT03415854|Gemcitabine|gemcitabine|mesh-list
139384252|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139384253|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139384254|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384255|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
139384256|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
139384257|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
139384258|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384259|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139384260|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
139384261|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139384262|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
139384263|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384264|NCT03260920|Oxytocin|oxytocin|mesh-list
139384265|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
139384266|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139384267|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384268|NCT03248063|Cefazolin|cefazolin|mesh-list
139384269|NCT03248063|Cloxacillin|cloxacillin|mesh-list
139384270|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139384271|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384272|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
139384273|NCT03221257|Pirfenidone|pirfenidone|mesh-list
139384274|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139384275|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384276|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139384277|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
139384278|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139384279|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384280|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384281|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384282|NCT03221257|Analgesics|analgesics|mesh-ancestor
139384283|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
139384284|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384285|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384286|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139384287|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139384288|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139384289|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139384290|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
139384291|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139384292|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
139384293|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
139384294|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139384295|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139384296|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384297|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384298|NCT03199612|Urological Agents|urological agents|mesh-ancestor
139384300|NCT03197922|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139384301|NCT03197922|Protective Agents|protective agents|mesh-ancestor
139384302|NCT03197922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384303|NCT02981173|Psilocybin|psilocybin|mesh-list
139384304|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
139384305|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384306|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139384307|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
139384308|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139384309|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384310|NCT02967172|Epinephrine|epinephrine|mesh-list
139384311|NCT02967172|Morphine|morphine|mesh-list
139384312|NCT02967172|Ropivacaine|ropivacaine|mesh-list
139384313|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139384314|NCT02967172|Narcotics|narcotics|mesh-ancestor
139048583|NCT00314262|Analgesics|analgesics|mesh-ancestor
139384315|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139384316|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384317|NCT02967172|Analgesics|analgesics|mesh-ancestor
139384318|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
139384319|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384320|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
139384321|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
139384322|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139384323|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139384324|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
139384325|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139384326|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384327|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139384328|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139384329|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
139384330|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139384331|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
139384332|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
139384333|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
139384334|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139384335|NCT02916316|Doxorubicin|doxorubicin|mesh-list
139384336|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139384337|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139384338|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384339|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139384340|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139384341|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384342|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384343|NCT02834403|Aspirin|aspirin|mesh-list
139384344|NCT02834403|Docetaxel|docetaxel|mesh-list
139384345|NCT02834403|Amlodipine|amlodipine|mesh-list
139384346|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
139384347|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384348|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
139384349|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
139384350|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
139384351|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384352|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139384353|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139384354|NCT02834403|Analgesics|analgesics|mesh-ancestor
139384355|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
139384356|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384357|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384358|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139384359|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139384360|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139384361|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139384362|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139384363|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139384364|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384366|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139384367|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139384368|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139384369|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139384370|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
139384371|NCT02682511|Ifetroban|ifetroban|mesh-list
139384372|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139384373|NCT02675452|Itraconazole|itraconazole|mesh-list
139041192|NCT03989310|Antibodies|antibodies|mesh-list
139384374|NCT02675452|Azacitidine|azacitidine|mesh-list
139384375|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139384376|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
139384377|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384378|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384379|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384380|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
139384381|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384382|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139384383|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139384384|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139384385|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
139384386|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384387|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384388|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139384389|NCT02456974|Amoxicillin|amoxicillin|mesh-list
139384390|NCT02456974|Vancomycin|vancomycin|mesh-list
139384391|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
139384392|NCT02456974|Meropenem|meropenem|mesh-list
139384393|NCT02456974|Tazobactam|tazobactam|mesh-list
139384394|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
139384395|NCT02456974|Amikacin|amikacin|mesh-list
139384396|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139384397|NCT02456974|Teicoplanin|teicoplanin|mesh-list
139384398|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139384399|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384400|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139384401|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139384402|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384403|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384404|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384405|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139384406|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139384407|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139384408|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
139384409|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139384410|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384411|NCT02411656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139384412|NCT02411656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384421|NCT02060188|Nivolumab|nivolumab|mesh-list
139384422|NCT02060188|Ipilimumab|ipilimumab|mesh-list
139384423|NCT02060188|Relatlimab|relatlimab|mesh-list
139384424|NCT02060188|Daratumumab|daratumumab|mesh-list
139384425|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139384426|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384427|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139384428|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384429|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
139384430|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384431|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
139384432|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384433|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384434|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139384435|NCT01946074|Paclitaxel|paclitaxel|mesh-list
139384436|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139384437|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384438|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
139384439|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
139384440|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
139384441|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384442|NCT01856478|Methotrexate|methotrexate|mesh-list
139384443|NCT01856478|Afatinib|afatinib|mesh-list
139384444|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139384445|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
139384446|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139384447|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384448|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139384449|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
139384450|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384451|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384452|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
139384453|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384454|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139384455|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139384456|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
139384457|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139384458|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139384459|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139384460|NCT01254864|Prednisone|prednisone|mesh-list
139384461|NCT01254864|Sunitinib|sunitinib|mesh-list
139384462|NCT01254864|Dasatinib|dasatinib|mesh-list
139384463|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
139384464|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139384465|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
139384466|NCT01254864|Hormones|hormones|mesh-ancestor
139384467|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384468|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384469|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139384470|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384471|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139384472|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139384473|NCT01254864|Growth Substances|growth substances|mesh-ancestor
139384474|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
139384475|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139384476|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384477|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384478|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139384479|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
139384480|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139384481|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
139384482|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139384483|NCT00868283|Protective Agents|protective agents|mesh-ancestor
139384484|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384485|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
139384486|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139384487|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139384488|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384489|NCT02127047|Incretins|incretins|mesh-ancestor
139384490|NCT02127047|Hormones|hormones|mesh-ancestor
139384491|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384492|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139384493|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
139384494|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384495|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384496|NCT02122055|Midazolam|midazolam|mesh-list
139384497|NCT02122055|Fentanyl|fentanyl|mesh-list
139384498|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
139384499|NCT02122055|Propofol|propofol|mesh-list
139384500|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139384501|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139384502|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384503|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139384504|NCT02122055|Analgesics|analgesics|mesh-ancestor
139384505|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
139384506|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384507|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139384508|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139384509|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139384510|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
139384511|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139384512|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384513|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139384514|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
139384515|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
139384516|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139384517|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139384518|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139384519|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139384520|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
139384521|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
139384522|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139384523|NCT02122055|Narcotics|narcotics|mesh-ancestor
139384524|NCT02125409|Aspirin|aspirin|mesh-list
139384525|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139384526|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139384527|NCT02125409|Analgesics|analgesics|mesh-ancestor
139384528|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
139384529|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384530|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384531|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139384532|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139384533|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139384534|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139384535|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384536|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139384537|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139384538|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384539|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
139384540|NCT04816838|Osimertinib|osimertinib|mesh-list
139384541|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384542|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139384543|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384544|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384545|NCT02788175|Vedolizumab|vedolizumab|mesh-list
139384546|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139384547|NCT03551171|Niraparib|niraparib|mesh-list
139384548|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139384549|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384550|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384551|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384552|NCT02787083|Mirabegron|mirabegron|mesh-list
139384553|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139384554|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139384555|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139384556|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
139384557|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139384558|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384559|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384560|NCT02787083|Urological Agents|urological agents|mesh-ancestor
139384561|NCT02122211|Betaine|betaine|mesh-list
139384562|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139384563|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
139384564|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139384565|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
139384566|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384567|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139384568|NCT02125565|Lidocaine|lidocaine|mesh-list
139384569|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
139384570|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
139384571|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139384572|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384573|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
139384574|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384575|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139384576|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139384577|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139384578|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139384579|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384580|NCT02125643|Caffeine|caffeine|mesh-list
139384581|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139384582|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384583|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139384584|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384585|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384586|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139384587|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139384588|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
139384589|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139384590|NCT02127437|Lanreotide|lanreotide|mesh-list
139384591|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384592|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
139384593|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139384594|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
139384595|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384596|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
139384597|NCT02122601|Protective Agents|protective agents|mesh-ancestor
139384598|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
139384599|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139384600|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139384601|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139384602|NCT02127593|Norgestimate|norgestimate|mesh-list
139384603|NCT02127593|Norgestrel|norgestrel|mesh-list
139384604|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139384605|NCT02127593|Estradiol|estradiol|mesh-list
139384606|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139384607|NCT02127593|Estrogens|estrogens|mesh-ancestor
139384608|NCT02127593|Hormones|hormones|mesh-ancestor
139384609|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384610|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384611|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139384612|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
139384613|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139384614|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139384615|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139384616|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139384617|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139384618|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139384619|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384620|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139384621|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139384622|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384623|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384624|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384625|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139384626|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
139384627|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139384628|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139384629|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384630|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
139384631|NCT02122679|Coagulants|coagulants|mesh-ancestor
139384632|NCT04810754|Daratumumab|daratumumab|mesh-list
139384633|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384634|NCT02127749|Metronidazole|metronidazole|mesh-list
139384635|NCT02127749|Vancomycin|vancomycin|mesh-list
139384636|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
139384637|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384638|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139384639|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139384640|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139384641|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139384642|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139384643|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384644|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384645|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384646|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139384647|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139384648|NCT04797338|Nafarelin|nafarelin|mesh-list
139384649|NCT04797338|Progesterone|progesterone|mesh-list
139384650|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
139384651|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
139384652|NCT04797338|Estradiol|estradiol|mesh-list
139384653|NCT04797338|Progestins|progestins|mesh-ancestor
139384654|NCT04797338|Hormones|hormones|mesh-ancestor
139384655|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384656|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384657|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139384658|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
139384659|NCT04797338|Estrogens|estrogens|mesh-ancestor
139384660|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139384661|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139384662|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
139384663|NCT05272865|Dronabinol|dronabinol|mesh-list
139384664|NCT05272865|Hallucinogens|hallucinogens|mesh-ancestor
139384665|NCT05272865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384666|NCT05272865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139384667|NCT05272865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139384668|NCT05272865|Analgesics|analgesics|mesh-ancestor
139384669|NCT05272865|Sensory System Agents|sensory system agents|mesh-ancestor
139384670|NCT05272865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384671|NCT05272865|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139384672|NCT05272865|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139384673|NCT05272865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139384674|NCT05272865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384676|NCT05272865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384677|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139384678|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
139384679|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384680|NCT04809818|Aspirin|aspirin|mesh-list
139384681|NCT04809818|Dabigatran|dabigatran|mesh-list
139384682|NCT04809818|Apixaban|apixaban|mesh-list
139384683|NCT04809818|Clopidogrel|clopidogrel|mesh-list
139384684|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139384685|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139384686|NCT04809818|Analgesics|analgesics|mesh-ancestor
139384687|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
139384688|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384689|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384690|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139384691|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139384692|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139384693|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139384694|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384695|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139384696|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139384697|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384698|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
139384699|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139384700|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139384701|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139384702|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
139384703|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139384704|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
139384705|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139384706|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
139384707|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
139384708|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139384709|NCT04796402|Bamlanivimab|bamlanivimab|mesh-list
139384710|NCT04796402|Antiviral Agents|antiviral agents|mesh-ancestor
139384711|NCT04796402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384712|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
139384713|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384714|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139384715|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
139384716|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
139384717|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139384718|NCT02126267|Azithromycin|azithromycin|mesh-list
139384719|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139384720|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384721|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
139384722|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
139384723|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139384724|NCT02128061|Rituximab|rituximab|mesh-list
139384725|NCT02128061|Lenalidomide|lenalidomide|mesh-list
139384726|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139384727|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384728|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
139384729|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384730|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139384731|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139384732|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139384733|NCT02128061|Growth Substances|growth substances|mesh-ancestor
139384734|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
139384735|NCT02596958|Bevacizumab|bevacizumab|mesh-list
139384736|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139384737|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384738|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139384739|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139384740|NCT02596958|Growth Substances|growth substances|mesh-ancestor
139384741|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384742|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
139384743|NCT04808648|Itraconazole|itraconazole|mesh-list
139384744|NCT04808648|Rifampin|rifampin|mesh-list
139384745|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
139384746|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384747|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139041567|NCT00249873|Clopidogrel|clopidogrel|mesh-list
139384748|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139384749|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384750|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384751|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139384752|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
139384753|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384754|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384755|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139384756|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139384757|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
139384758|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139384759|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
139384760|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139384761|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139384762|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139384763|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139384764|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139384765|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139384766|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139384767|NCT02126657|Glycolic acid|glycolic acid|mesh-list
139384768|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
139384769|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
139384770|NCT02128451|Fentanyl|fentanyl|mesh-list
139384771|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139384772|NCT02128451|Narcotics|narcotics|mesh-ancestor
139384773|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139384774|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384775|NCT02128451|Analgesics|analgesics|mesh-ancestor
139384776|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
139384777|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384778|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139384779|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139384780|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
139384781|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
139384782|NCT04785716|Niraparib|niraparib|mesh-list
139384783|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139384784|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384785|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384786|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384787|NCT01367249|Bromfenac|bromfenac|mesh-list
139384788|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139384789|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139384790|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139384791|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139384792|NCT01367249|Analgesics|analgesics|mesh-ancestor
139384793|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
139384794|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384795|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384796|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139384797|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139384798|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
139384799|NCT02128685|Progestins|progestins|mesh-ancestor
139384800|NCT02128685|Hormones|hormones|mesh-ancestor
139384801|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384802|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384803|NCT02252627|Phenylephrine|phenylephrine|mesh-list
139384804|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
139384805|NCT02252627|Ephedrine|ephedrine|mesh-list
139384806|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139384807|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
139384808|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
139384809|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384810|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384811|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
139384812|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139384813|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
139384814|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
139384815|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139384816|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139384817|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139384818|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
139384819|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139384820|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384821|NCT02252627|Protective Agents|protective agents|mesh-ancestor
139384822|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139384823|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
139384824|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139384825|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
139384826|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139384827|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
139384828|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384829|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384830|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
139384831|NCT03550859|Telmisartan|telmisartan|mesh-list
139384832|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139384833|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139384834|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139384835|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
139384836|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384837|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139384838|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139384839|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384840|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139384841|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139384842|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139384843|NCT03550781|Prednisone|prednisone|mesh-list
139384844|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
139384845|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139384846|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
139384847|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384848|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139384849|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139384850|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
139384851|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384852|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384853|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139384854|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139384855|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
139384856|NCT03550781|Hormones|hormones|mesh-ancestor
139384857|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384858|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139384859|NCT02260661|Fulvestrant|fulvestrant|mesh-list
139384860|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139384861|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384862|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139384863|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139384864|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
139384865|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384866|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384867|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
139384868|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
139384869|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139384870|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139384871|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384872|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384873|NCT02136329|Urological Agents|urological agents|mesh-ancestor
139384874|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
139384875|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139384877|NCT02129231|Ezetimibe|ezetimibe|mesh-list
139384878|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
139384879|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139384880|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139384881|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
139384882|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384883|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139384884|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139384885|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384886|NCT02129231|Antacids|antacids|mesh-ancestor
139384887|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139384888|NCT02136641|Midazolam|midazolam|mesh-list
139384889|NCT02136641|Fentanyl|fentanyl|mesh-list
139384890|NCT02136641|Ketamine|ketamine|mesh-list
139384891|NCT02136641|Analgesics|analgesics|mesh-ancestor
139384892|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
139384893|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002091|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
139384894|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384895|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139384896|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139384897|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
139384898|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
139384899|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139384900|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139384901|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139384902|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139384903|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384904|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139384905|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139384906|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139384907|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139384908|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139384909|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
139384910|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
139384911|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139384912|NCT02136641|Narcotics|narcotics|mesh-ancestor
139384913|NCT03549689|Tenofovir|tenofovir|mesh-list
139384914|NCT03549689|Lamivudine|lamivudine|mesh-list
139384915|NCT03549689|Dolutegravir|dolutegravir|mesh-list
139384916|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
139384917|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139384918|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139384919|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139384920|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139384921|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384922|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139384923|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139384924|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139384925|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139384926|NCT02129621|Spironolactone|spironolactone|mesh-list
139384927|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139384928|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
139384929|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384930|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384931|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139384932|NCT02129621|Diuretics|diuretics|mesh-ancestor
139384933|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
139384934|NCT02129699|Denosumab|denosumab|mesh-list
139384935|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139384936|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384937|NCT03549923|Esmolol|esmolol|mesh-list
139384938|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139384939|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139384940|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139384941|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
139384942|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139384943|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384944|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384945|NCT02136875|Fluticasone|fluticasone|mesh-list
139384946|NCT02136875|Xhance|xhance|mesh-list
139384947|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139384948|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139384949|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139384950|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
139384951|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384952|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384953|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139384954|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
139384955|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
139384956|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139384957|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139002098|NCT00991796|Carboplatin|carboplatin|mesh-list
139384958|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139384959|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139384960|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
139384961|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139384962|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384963|NCT02129933|Bevacizumab|bevacizumab|mesh-list
139384964|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139384965|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139384966|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139384967|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139384968|NCT02129933|Growth Substances|growth substances|mesh-ancestor
139384969|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384970|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
139384971|NCT02132897|Carbamazepine|carbamazepine|mesh-list
139384972|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
139384973|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
139384974|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139384975|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139384976|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384977|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139384978|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139384979|NCT02132897|Analgesics|analgesics|mesh-ancestor
139384980|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
139384981|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139384982|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139384983|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139384984|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139384985|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139384986|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139384987|NCT02133053|Beclomethasone|beclomethasone|mesh-list
139384988|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139384989|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
139384991|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139384992|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384993|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139384994|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
139384995|NCT02137109|Natalizumab|natalizumab|mesh-list
139384996|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
139384997|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139384998|NCT02130167|Atropine|atropine|mesh-list
139384999|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139385000|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139385001|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139385002|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
139385003|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385004|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385005|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139385006|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
139385007|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
139385008|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
139385009|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139385010|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139385011|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
139385012|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385013|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385014|NCT02130323|Imiquimod|imiquimod|mesh-list
139385015|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139385016|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
139385017|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385018|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385019|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
139385020|NCT03549611|Acetaminophen|acetaminophen|mesh-list
139385021|NCT03549611|Celecoxib|celecoxib|mesh-list
139385022|NCT03549611|Oxycodone|oxycodone|mesh-list
139385023|NCT03549611|Gabapentin|gabapentin|mesh-list
139385024|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139385025|NCT03549611|Analgesics|analgesics|mesh-ancestor
139385026|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
139385027|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385028|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385029|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
139385030|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139385031|NCT03549611|Narcotics|narcotics|mesh-ancestor
139385032|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139385033|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139385034|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139385035|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139385036|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139385037|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139385038|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385039|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385040|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
139385041|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139385042|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139385043|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139385044|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139385045|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139385046|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385047|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
139385048|NCT02133287|Sirolimus|sirolimus|mesh-list
139385049|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
139385050|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139385051|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139385052|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139385053|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385054|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
139385055|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139385056|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
139385057|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385058|NCT02137265|Clomiphene|clomiphene|mesh-list
139385059|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139385060|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
139385061|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385062|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385063|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139385064|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
139385065|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139385066|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139385067|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139385068|NCT02592434|Tofacitinib|tofacitinib|mesh-list
139385069|NCT02592434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139385070|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139385071|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385072|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385073|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
139385074|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139385075|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139385076|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139385077|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385078|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385079|NCT02137421|Resveratrol|resveratrol|mesh-list
139385080|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
139385081|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385082|NCT02137421|Protective Agents|protective agents|mesh-ancestor
139385083|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385084|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385085|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139385086|NCT02133677|Temozolomide|temozolomide|mesh-list
139385087|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139385088|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
139385089|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385090|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385091|NCT02137733|Carvedilol|carvedilol|mesh-list
139385092|NCT02137733|Bisoprolol|bisoprolol|mesh-list
139385093|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139385094|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139385095|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
139385096|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385098|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385099|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139385100|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
139385101|NCT02137733|Protective Agents|protective agents|mesh-ancestor
139385102|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139385103|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139385104|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139385105|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
139385106|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139385107|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139385108|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
139385109|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
139385110|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385111|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139385112|NCT02133755|Bromocriptine|bromocriptine|mesh-list
139385113|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139385114|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139385115|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
139385116|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385117|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385118|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
139385119|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
139385120|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385121|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385123|NCT02130869|Aldesleukin|aldesleukin|mesh-list
139385124|NCT02130869|Carboplatin|carboplatin|mesh-list
139385125|NCT02130869|Etoposide|etoposide|mesh-list
139385126|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
139385127|NCT02130869|Melphalan|melphalan|mesh-list
139385128|NCT02130869|Busulfan|busulfan|mesh-list
139385129|NCT02130869|Interleukin-2|interleukin-2|mesh-list
139385130|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139385131|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
139385132|NCT02130869|Sargramostim|sargramostim|mesh-list
139385133|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385134|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139385135|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139385136|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139385137|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385138|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385139|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139385140|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
139385141|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
139385142|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139385143|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139385144|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
139385145|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385146|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139385147|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
139385148|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139385149|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139385150|NCT02130869|Analgesics|analgesics|mesh-ancestor
139385151|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
139385152|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385153|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139385154|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139385155|NCT02133911|Ranolazine|ranolazine|mesh-list
139385156|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139385157|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139002121|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139385158|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385159|NCT02133989|Ticlopidine|ticlopidine|mesh-list
139385160|NCT02133989|Clopidogrel|clopidogrel|mesh-list
139385161|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139385162|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139385163|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139385164|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139385165|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
139385166|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385167|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385168|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385169|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139385170|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139385171|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139385172|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139385173|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385175|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139385176|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385177|NCT02138045|Incretins|incretins|mesh-ancestor
139385178|NCT02138045|Hormones|hormones|mesh-ancestor
139385179|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385180|NCT02134067|Paclitaxel|paclitaxel|mesh-list
139385181|NCT02134067|TAS-119|tas-119|mesh-list
139385182|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139385183|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385184|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
139385185|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
139385186|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
139385187|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385188|NCT02134067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139385189|NCT02134067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385190|NCT04091126|Dexamethasone|dexamethasone|mesh-list
139385191|NCT04091126|Lenalidomide|lenalidomide|mesh-list
139385192|NCT04091126|Bortezomib|bortezomib|mesh-list
139385193|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139385194|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
139385195|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
139385196|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385197|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385198|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139385199|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
139385200|NCT04091126|Hormones|hormones|mesh-ancestor
139385201|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385202|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139385203|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385204|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
139385205|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139385206|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139385207|NCT04091126|Growth Substances|growth substances|mesh-ancestor
139385208|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
139385209|NCT03962114|Niacinamide|niacinamide|mesh-list
139385211|NCT03962114|Nicotinic Acids|nicotinic acids|mesh-list
139385212|NCT03962114|Vitamins|vitamins|mesh-ancestor
139385213|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
139385214|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385215|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
139385216|NCT03962114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139385217|NCT03962114|Antimetabolites|antimetabolites|mesh-ancestor
139385218|NCT03962114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385219|NCT03962114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139002142|NCT00768677|Topiramate|topiramate|mesh-list
139385220|NCT03962114|Vasodilator Agents|vasodilator agents|mesh-ancestor
139385221|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
139385222|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
139385223|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
139385224|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385225|NCT05472896|Epirubicin|epirubicin|mesh-list
139385226|NCT05472896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139385227|NCT05472896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385228|NCT05472896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139385229|NCT05472896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139385230|NCT05472896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385231|NCT05472896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385232|NCT03596918|Vincristine|vincristine|mesh-list
139385233|NCT03596918|Bleomycin|bleomycin|mesh-list
139385234|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139385235|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385236|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
139385237|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
139385238|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
139385239|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385240|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139385241|NCT02134379|Clotrimazole|clotrimazole|mesh-list
139385242|NCT02134379|Miconazole|miconazole|mesh-list
139385243|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139385244|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139385245|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
139385246|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139385247|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139385249|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385250|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139385251|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
139385252|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385253|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385254|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139385255|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139385256|NCT02134457|Ranibizumab|ranibizumab|mesh-list
139385257|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139385258|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139385259|NCT02134457|Growth Substances|growth substances|mesh-ancestor
139385260|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385261|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
139385262|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385263|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
139385264|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139385265|NCT04090190|Fesoterodine|fesoterodine|mesh-list
139385266|NCT04090190|Oxybutynin|oxybutynin|mesh-list
139385267|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139385268|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139385269|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
139385270|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139042094|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
139385271|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385272|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385273|NCT04090190|Urological Agents|urological agents|mesh-ancestor
139385274|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
139385275|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
139385276|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385277|NCT04792034|Cocaine|cocaine|mesh-list
139385278|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
139385279|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
139385280|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139385281|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385282|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
139385283|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002148|NCT02557451|Growth Substances|growth substances|mesh-ancestor
139385284|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139385285|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139385286|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139385287|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139385288|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385289|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
139385290|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385291|NCT02253095|Micronutrients|micronutrients|mesh-list
139385292|NCT02253095|Trace Elements|trace elements|mesh-list
139385293|NCT02253095|Albendazole|albendazole|mesh-list
139385294|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
139385295|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139385296|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139385297|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
139385298|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139385299|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139385300|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
139385301|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
139385302|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
139385303|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385304|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385305|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385306|NCT04791332|Aticaprant|aticaprant|mesh-list
139385307|NCT04791332|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139385308|NCT04791332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385309|NCT04791332|Sensory System Agents|sensory system agents|mesh-ancestor
139385310|NCT04791332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385311|NCT04791020|Lidocaine|lidocaine|mesh-list
139385312|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
139385313|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
139385314|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139385315|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385316|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
139385317|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385318|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139385319|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139385321|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139385322|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385323|NCT02531906|Oxycodone|oxycodone|mesh-list
139385324|NCT02531906|Methadone|methadone|mesh-list
139385325|NCT02531906|Gabapentin|gabapentin|mesh-list
139385326|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139385327|NCT02531906|Narcotics|narcotics|mesh-ancestor
139385328|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139385329|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385330|NCT02531906|Analgesics|analgesics|mesh-ancestor
139385331|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
139385332|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385333|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
139385334|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139385335|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139385336|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139385337|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139385338|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139385339|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385340|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385341|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
139385342|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
139385343|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
139385344|NCT02783729|Zolpidem|zolpidem|mesh-list
139385345|NCT02783729|Lemborexant|lemborexant|mesh-list
139385347|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139385348|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139385349|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385350|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139385351|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
139385352|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
139385353|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385354|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385355|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139385356|NCT02227940|Paclitaxel|paclitaxel|mesh-list
139385357|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139385358|NCT02227940|Cisplatin|cisplatin|mesh-list
139385359|NCT02227940|Gemcitabine|gemcitabine|mesh-list
139385360|NCT02227940|Ceritinib|ceritinib|mesh-list
139385361|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139385362|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385363|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
139385364|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
139385365|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
139385366|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385367|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139385368|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
139385369|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139385370|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385371|NCT02072486|Sorafenib|sorafenib|mesh-list
139385372|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385373|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139385374|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385375|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385376|NCT00988364|Simvastatin|simvastatin|mesh-list
139385377|NCT00988364|Ezetimibe|ezetimibe|mesh-list
139385378|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
139385379|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139385380|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139385381|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
139385382|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385383|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139385384|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139385385|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385386|NCT05578001|Pilocarpine|pilocarpine|mesh-list
139385387|NCT05578001|Miotics|miotics|mesh-ancestor
139385388|NCT05578001|Autonomic Agents|autonomic agents|mesh-ancestor
139385389|NCT05578001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385390|NCT05578001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385391|NCT05578001|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139385392|NCT05578001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139385394|NCT05578001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385395|NCT05578001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385396|NCT05577923|Trastuzumab|trastuzumab|mesh-list
139385397|NCT05577923|Fulvestrant|fulvestrant|mesh-list
139119835|NCT02717416|Coagulants|coagulants|mesh-ancestor
139119911|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139385398|NCT05577923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139385399|NCT05577923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385400|NCT05577923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139385401|NCT05577923|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139385402|NCT05577923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139385403|NCT05577923|Hormone Antagonists|hormone antagonists|mesh-ancestor
139385404|NCT05577923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385405|NCT05577923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385406|NCT04790708|Octreotide|octreotide|mesh-list
139385407|NCT04790708|Edotreotide|edotreotide|mesh-list
139385408|NCT04790708|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
139385409|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139120127|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
138848389|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139385410|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385411|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139385412|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139385413|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385414|NCT05614934|Clarithromycin|clarithromycin|mesh-list
139385415|NCT05614934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139120497|NCT03050398|Letrozole|letrozole|mesh-list
139120567|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139385416|NCT05614934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120642|NCT03629054|Incretins|incretins|mesh-ancestor
139385417|NCT05614934|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139385419|NCT05614934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385420|NCT05614934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139385421|NCT05614934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139385422|NCT02135393|Folic Acid|folic acid|mesh-list
139385423|NCT02135393|Hematinics|hematinics|mesh-ancestor
139121160|NCT03735134|Colchicine|colchicine|mesh-list
139121241|NCT03729284|Analgesics|analgesics|mesh-ancestor
139385424|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
139385426|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
139385427|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121526|NCT05041426|Valganciclovir|valganciclovir|mesh-list
139385428|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
139385429|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139385430|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139385431|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139385432|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139121894|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139122071|NCT03726788|Hormones|hormones|mesh-ancestor
139385433|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848392|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
139122352|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
139385434|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139385435|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385436|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139122638|NCT03699904|Valacyclovir|valacyclovir|mesh-list
139385437|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139122785|NCT02530359|Pirfenidone|pirfenidone|mesh-list
139122930|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
139123081|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
139385438|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139385439|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139123381|NCT03725904|Hormones|hormones|mesh-ancestor
139385440|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139385441|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
139385442|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385443|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
139385444|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139385445|NCT02139761|Analgesics|analgesics|mesh-ancestor
139385446|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
139123900|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139385447|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385448|NCT05614778|Zoledronic Acid|zoledronic acid|mesh-list
139385449|NCT05614778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139385450|NCT05614778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385451|NCT05474924|Prednisolone|prednisolone|mesh-list
139385453|NCT05474924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139385454|NCT05474924|Glucocorticoids|glucocorticoids|mesh-ancestor
139385455|NCT05474924|Hormones|hormones|mesh-ancestor
139124572|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139124646|NCT03951285|Niacinamide|niacinamide|mesh-list
138848393|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125025|NCT01069900|Amoxicillin|amoxicillin|mesh-list
139385456|NCT05474924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385457|NCT05474924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125322|NCT05974423|Acetaminophen|acetaminophen|mesh-list
139385458|NCT05474924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139385459|NCT05474924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385460|NCT05474924|Autonomic Agents|autonomic agents|mesh-ancestor
139125693|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139125769|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
139385461|NCT05474924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385462|NCT05474924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139385463|NCT05474924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139385464|NCT05474924|Respiratory System Agents|respiratory system agents|mesh-ancestor
139126276|NCT04438330|Nickel|nickel|mesh-list
139385465|NCT02135627|Epinephrine|epinephrine|mesh-list
139385466|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139385468|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
139385469|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385470|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126887|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139126964|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
139385471|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385472|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139127114|NCT01109121|Allopurinol|allopurinol|mesh-list
139127262|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
139127337|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
139385473|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139385474|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
139385475|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385476|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139385477|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
139385478|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
139385479|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
139127859|NCT01119885|Narcotics|narcotics|mesh-ancestor
139127932|NCT01217697|Prednisone|prednisone|mesh-list
139385480|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139128009|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
139128094|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
139385481|NCT05614622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139385482|NCT05614622|Cyclopentolate|cyclopentolate|mesh-list
139128302|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
139385483|NCT05614622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139385484|NCT05614622|Mydriatics|mydriatics|mesh-ancestor
139385486|NCT05614622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128522|NCT01130025|Tinzaparin|tinzaparin|mesh-list
139385487|NCT05614622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385488|NCT05614622|Parasympatholytics|parasympatholytics|mesh-ancestor
139385489|NCT05614622|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139385490|NCT05614622|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139385491|NCT05614622|Cholinergic Agents|cholinergic agents|mesh-ancestor
139385492|NCT05614622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128818|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139385493|NCT05614622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129113|NCT01224951|Hormones|hormones|mesh-ancestor
139385494|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139385496|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
139385497|NCT02140073|Domperidone|domperidone|mesh-list
139385498|NCT02140073|Omeprazole|omeprazole|mesh-list
139385499|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139385500|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139385501|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139385502|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385503|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385504|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
139385505|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
139385506|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385507|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385508|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139385509|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
139385510|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385511|NCT05474690|Cyclophosphamide|cyclophosphamide|mesh-list
139385512|NCT05474690|Carboplatin|carboplatin|mesh-list
139385513|NCT05474690|Docetaxel|docetaxel|mesh-list
139385514|NCT05474690|Trastuzumab|trastuzumab|mesh-list
139385515|NCT05474690|Epirubicin|epirubicin|mesh-list
139385516|NCT05474690|Pertuzumab|pertuzumab|mesh-list
139385517|NCT05474690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139385518|NCT05474690|Immunologic Factors|immunologic factors|mesh-ancestor
139385519|NCT05474690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385520|NCT05474690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139385521|NCT05474690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139385522|NCT05474690|Alkylating Agents|alkylating agents|mesh-ancestor
139385523|NCT05474690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385524|NCT05474690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385525|NCT05474690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139385526|NCT05474690|Tubulin Modulators|tubulin modulators|mesh-ancestor
139385527|NCT05474690|Antimitotic Agents|antimitotic agents|mesh-ancestor
139385528|NCT05474690|Mitosis Modulators|mitosis modulators|mesh-ancestor
139385529|NCT05474690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139129839|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
139129915|NCT03674541|Bromides|bromides|mesh-list
138848395|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
139385530|NCT05474690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139385531|NCT05474690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139385532|NCT05474690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139385533|NCT05474690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385534|NCT05575973|Rituximab|rituximab|mesh-list
139385535|NCT05575973|Lenalidomide|lenalidomide|mesh-list
139385536|NCT05575973|Mitoxantrone|mitoxantrone|mesh-list
139385537|NCT05575973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848396|NCT02436707|Hormones|hormones|mesh-ancestor
139642475|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139642476|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642477|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
139642478|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642479|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139642480|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
139642481|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642482|NCT04843423|Cariprazine|cariprazine|mesh-list
139642483|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139642484|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139642485|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642486|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642487|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139642488|NCT01459081|Zanamivir|zanamivir|mesh-list
139642489|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
139642490|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139642491|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642492|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642493|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
139642494|NCT04421196|Analgesics|analgesics|mesh-list
139642495|NCT04421196|Narcotics|narcotics|mesh-ancestor
139642496|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642497|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642498|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
139642499|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642500|NCT01459315|Dolutegravir|dolutegravir|mesh-list
139642501|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139642502|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139642503|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642504|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642505|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139642506|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139642507|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
139642508|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139642509|NCT04948788|Gemcitabine|gemcitabine|mesh-list
139642510|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
139642511|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139642512|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
139642513|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642514|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642515|NCT02865811|Doxorubicin|doxorubicin|mesh-list
139642516|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139642517|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
139642518|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139642519|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642520|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139642521|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139642522|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642523|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642524|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139642525|NCT02865811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139642526|NCT03058224|Acetaminophen|acetaminophen|mesh-list
139642527|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139642528|NCT03058224|Analgesics|analgesics|mesh-ancestor
139642529|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
139642530|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642531|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642532|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
139642533|NCT04957212|Carboplatin|carboplatin|mesh-list
139642534|NCT04957212|Docetaxel|docetaxel|mesh-list
139642535|NCT04957212|Trastuzumab|trastuzumab|mesh-list
139642536|NCT04957212|Pertuzumab|pertuzumab|mesh-list
139642537|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642538|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
139642539|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
139642540|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
139642541|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642542|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139642543|NCT04390789|Calcium|calcium|mesh-list
139642544|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139642545|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642546|NCT04947774|Immunomodulating Agents|immunomodulating agents|mesh-list
139642547|NCT04947774|Immunologic Factors|immunologic factors|mesh-ancestor
139642548|NCT04947774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642549|NCT04948164|Naproxen|naproxen|mesh-list
139642550|NCT04948164|Sumatriptan|sumatriptan|mesh-list
139642551|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139642552|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139642553|NCT04948164|Analgesics|analgesics|mesh-ancestor
139642554|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
139642555|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642556|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642557|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139642558|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139642559|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
139642560|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139642561|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642562|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642563|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139642564|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139642565|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139642566|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
139642567|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642568|NCT02808871|Pirfenidone|pirfenidone|mesh-list
139642569|NCT02808871|Analgesics|analgesics|mesh-ancestor
139642570|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
139642571|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642572|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642573|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138712155|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642574|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139642575|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139642576|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139642577|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642578|NCT01892683|Propofol|propofol|mesh-list
139642579|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
139642580|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642581|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642582|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139642583|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139642584|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
139642585|NCT01459627|Ticagrelor|ticagrelor|mesh-list
139642586|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139642587|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139642588|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139642589|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139642590|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139642591|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
139642592|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642593|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642594|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642595|NCT02467621|Pantoprazole|pantoprazole|mesh-list
139642596|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139642597|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139642598|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139642599|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642600|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642601|NCT04937946|Fentanyl|fentanyl|mesh-list
139642602|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139642603|NCT04937946|Narcotics|narcotics|mesh-ancestor
139642604|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642605|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642606|NCT04937946|Analgesics|analgesics|mesh-ancestor
139642607|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
139642608|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642609|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139642610|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139642611|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
139642612|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
139642613|NCT05160987|Midazolam|midazolam|mesh-list
139642614|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139642615|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139642616|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642617|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642618|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139642619|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139642620|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139642621|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139642622|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
139642623|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
139642624|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
139642625|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
139642626|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642627|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642629|NCT01892995|Analgesics|analgesics|mesh-ancestor
139642630|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
139642631|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642632|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642633|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139642634|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139642635|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
139642636|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
139642637|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642638|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139642639|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139642640|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642641|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642642|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
139642643|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139642644|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139642645|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139642646|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139642647|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642648|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
139642649|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642650|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642651|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139642652|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642653|NCT02181075|Doxorubicin|doxorubicin|mesh-list
139642654|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139642655|NCT02181075|Liver Extracts|liver extracts|mesh-list
139642656|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139642657|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642658|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139642659|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139642660|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642661|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642662|NCT02181075|Hematinics|hematinics|mesh-ancestor
139642663|NCT01359735|Bacitracin|bacitracin|mesh-list
139642664|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139642665|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139642666|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139642667|NCT01361217|Midazolam|midazolam|mesh-list
139642668|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
139642669|NCT01361217|Caffeine|caffeine|mesh-list
139642670|NCT01361217|Fluoxetine|fluoxetine|mesh-list
139642671|NCT01361217|Omeprazole|omeprazole|mesh-list
139642672|NCT01361217|Lovastatin|lovastatin|mesh-list
139642673|NCT01361217|L 647318|l 647318|mesh-list
139642674|NCT01361217|Dihydromevinolin|dihydromevinolin|mesh-list
139642675|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139642676|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139642677|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642678|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642679|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139642680|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139642681|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139642682|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139642683|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
139642684|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
139642685|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
139642686|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
139642687|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642688|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642689|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139642690|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139642691|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642692|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139642693|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139642694|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
139642695|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139642696|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139642697|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139642698|NCT01361217|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139642699|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139642700|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139642701|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
139642702|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139642703|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
139642704|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138712175|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
139642705|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139642706|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
139642707|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
139642708|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139642709|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139642710|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139642711|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139642712|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
139642713|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139642714|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139642715|NCT04271839|Fluticasone|fluticasone|mesh-list
139642716|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
139642717|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139642718|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139642719|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
139642720|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642721|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642722|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139642723|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
139642724|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
139642725|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139642726|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139642727|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139642728|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139642729|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
139642730|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642731|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642732|NCT04945434|Methamphetamine|methamphetamine|mesh-list
139642733|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139642734|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642735|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
139642736|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
139642737|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642738|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
139642739|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642740|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642741|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
139642742|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139642743|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139642744|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139642745|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139642746|NCT04408560|Acetaminophen|acetaminophen|mesh-list
139642747|NCT04408560|Analgesics|analgesics|mesh-list
139642748|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139642749|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
139642750|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642751|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642752|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
139642753|NCT04844905|Ivermectin|ivermectin|mesh-list
139642754|NCT04844905|Piperaquine|piperaquine|mesh-list
139642755|NCT04844905|Artenimol|artenimol|mesh-list
139642756|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139642757|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139642758|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
139642759|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139642760|NCT04418856|Methamphetamine|methamphetamine|mesh-list
139642761|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139642762|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642763|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
139642764|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
139642765|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642766|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
139642767|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642768|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712191|NCT00561132|Antacids|antacids|mesh-ancestor
139642769|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
139642770|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139642771|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139642772|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139642773|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139642774|NCT01454635|Sertraline|sertraline|mesh-list
139642775|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
139642776|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139642777|NCT01454635|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139642778|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139642779|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139642780|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642781|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642782|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
139642783|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642784|NCT02196831|Tesamorelin|tesamorelin|mesh-list
139642785|NCT02196831|Growth Substances|growth substances|mesh-ancestor
139642786|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642787|NCT04944966|Lumefantrine|lumefantrine|mesh-list
139642788|NCT04944966|Artemether|artemether|mesh-list
139642789|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139642790|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
139642791|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139642792|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139642793|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139642794|NCT04955262|Nivolumab|nivolumab|mesh-list
139642795|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139642796|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642797|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139642798|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642799|NCT01363479|Dexamethasone|dexamethasone|mesh-list
139642800|NCT01363479|Palonosetron|palonosetron|mesh-list
139642801|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139642802|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
139642803|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
139642804|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642805|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642806|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139642807|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
139642808|NCT01363479|Hormones|hormones|mesh-ancestor
139642809|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139642810|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139642811|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642812|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139642813|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139642814|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
139642815|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642816|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642817|NCT01893385|Vitamin D|vitamin d|mesh-list
139642818|NCT01893385|Vitamins|vitamins|mesh-ancestor
139642819|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
139642820|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642821|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139642822|NCT04935450|Dimercaprol|dimercaprol|mesh-list
139642823|NCT04935450|Chelating Agents|chelating agents|mesh-ancestor
139642824|NCT04935450|Sequestering Agents|sequestering agents|mesh-ancestor
139642825|NCT04935450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642826|NCT02181231|Buprenorphine|buprenorphine|mesh-list
139642827|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139642828|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139642829|NCT02181231|Narcotics|narcotics|mesh-ancestor
139642830|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642831|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642832|NCT02181231|Analgesics|analgesics|mesh-ancestor
139642833|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
139642834|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642835|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139642836|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139642837|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139642838|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139642839|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642840|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642841|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139642842|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
139642843|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139642844|NCT01364259|Amifostine|amifostine|mesh-list
139642845|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139642846|NCT01364259|Protective Agents|protective agents|mesh-ancestor
139642847|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881629|NCT00676416|Propofol|propofol|mesh-list
139131177|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
139642848|NCT01321437|Axitinib|axitinib|mesh-list
139642849|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642850|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139642851|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642852|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642853|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
139642854|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642855|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
139642856|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139642857|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139642858|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642859|NCT01365585|Urological Agents|urological agents|mesh-ancestor
139642860|NCT04407390|Niacinamide|niacinamide|mesh-list
139642861|NCT04407390|Niacin|niacin|mesh-list
139642862|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
139642863|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
139642864|NCT04407390|Vitamins|vitamins|mesh-ancestor
139642865|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
139642866|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642867|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139642868|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
139642869|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642870|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139642871|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
139642872|NCT02181387|Acetaminophen|acetaminophen|mesh-list
139642873|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139642874|NCT02181387|Analgesics|analgesics|mesh-ancestor
139642875|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
139642876|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642877|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642878|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
139642879|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
139642880|NCT04921878|Analgesics|analgesics|mesh-ancestor
139642881|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
139642882|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642883|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642884|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642885|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139642886|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139642887|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642888|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642889|NCT04351347|Ivermectin|ivermectin|mesh-list
139642890|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139642891|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139642892|NCT04932564|Leflunomide|leflunomide|mesh-list
139642893|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642894|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642895|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139642896|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
139642897|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642898|NCT04921566|Torsemide|torsemide|mesh-list
139642899|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139642900|NCT04921566|Diuretics|diuretics|mesh-ancestor
139642901|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
139642902|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642903|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139642904|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139642905|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642906|NCT02655601|Manganese|manganese|mesh-list
139642907|NCT02655601|Temozolomide|temozolomide|mesh-list
139642908|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139642909|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
139642910|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642911|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642912|NCT02655601|Trace Elements|trace elements|mesh-ancestor
139642913|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
139642914|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642915|NCT02652247|Dimercaprol|dimercaprol|mesh-list
139642916|NCT02652247|Chelating Agents|chelating agents|mesh-ancestor
139642917|NCT02652247|Sequestering Agents|sequestering agents|mesh-ancestor
139642918|NCT02652247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642919|NCT01365819|Varenicline|varenicline|mesh-list
139642920|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139642921|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139642922|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
139642923|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642924|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642925|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642926|NCT02635555|Phenylephrine|phenylephrine|mesh-list
139642927|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
139642928|NCT02635555|Ephedrine|ephedrine|mesh-list
139642929|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139642930|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
139642931|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
139642932|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642933|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642934|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
139642935|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139642936|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
139642937|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
139642938|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139642939|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139642940|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139642941|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
139642942|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642943|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642944|NCT02635555|Protective Agents|protective agents|mesh-ancestor
139642945|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139642946|NCT01893541|Propranolol|propranolol|mesh-list
139642947|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139642948|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139642949|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
139642950|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139642951|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642952|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642953|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139642954|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139642955|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
139642956|NCT02849899|Vildagliptin|vildagliptin|mesh-list
139642957|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139642958|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642959|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139642960|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
139642961|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642962|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642963|NCT01369875|Aldesleukin|aldesleukin|mesh-list
139642964|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
139642965|NCT01369875|Fludarabine|fludarabine|mesh-list
139642966|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139642967|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
139642968|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642969|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139642970|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139642971|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
139642972|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642973|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642974|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139642975|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139642976|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139642977|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
139642978|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139642979|NCT02620189|Adalimumab|adalimumab|mesh-list
139642980|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
139642981|NCT02620189|Etanercept|etanercept|mesh-list
139642982|NCT02620189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139642983|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139642984|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139642985|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139642986|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139642987|NCT02620189|Analgesics|analgesics|mesh-ancestor
139642988|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
139642989|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642990|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642991|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139642992|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139642993|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
139642994|NCT02763319|Rituximab|rituximab|mesh-list
139642995|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139642996|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139642997|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642998|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
139642999|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643000|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139643001|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139643002|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
139643003|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643004|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
139643005|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139643006|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139643007|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
139643008|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643009|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139643010|NCT02594371|Paclitaxel|paclitaxel|mesh-list
139643011|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139643012|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139643013|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643014|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
139643015|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
139643016|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
139643017|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643018|NCT02197065|Atorvastatin|atorvastatin|mesh-list
139643019|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139643020|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139643021|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
139643022|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643023|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139643024|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139643025|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643026|NCT01375491|Doxycycline|doxycycline|mesh-list
139643027|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139643028|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643029|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
139643030|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139643031|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139643032|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
139643033|NCT02591251|Povidone|povidone|mesh-list
139643034|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139643035|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
139643036|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
139643037|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139643038|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643039|NCT01325181|Ranibizumab|ranibizumab|mesh-list
139643040|NCT01325181|Verteporfin|verteporfin|mesh-list
139643041|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139643042|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139643043|NCT01325181|Growth Substances|growth substances|mesh-ancestor
139643044|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643045|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
139643046|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643047|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139643048|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
139643049|NCT02588443|Paclitaxel|paclitaxel|mesh-list
139643050|NCT02588443|Gemcitabine|gemcitabine|mesh-list
139643051|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139643052|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643053|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
139643054|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
139643055|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
139643056|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643057|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139643058|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
139643059|NCT02582359|Cytarabine|cytarabine|mesh-list
139643060|NCT02582359|Daunorubicin|daunorubicin|mesh-list
139643061|NCT02582359|Ixazomib|ixazomib|mesh-list
139643062|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139643063|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
139643064|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643065|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643066|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
139643067|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643068|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139643069|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
139643070|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643071|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139643072|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139385538|NCT05575973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643073|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139385539|NCT05575973|Immunologic Factors|immunologic factors|mesh-ancestor
139643074|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643075|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
139643077|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139643078|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643079|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
139643080|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139643081|NCT02730715|Basiliximab|basiliximab|mesh-list
139643082|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
139643083|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643084|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139643085|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
139643086|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
139643087|NCT04919460|Coagulants|coagulants|mesh-ancestor
139643088|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
139643089|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643090|NCT04037241|Leucovorin|leucovorin|mesh-list
139643091|NCT04037241|Paclitaxel|paclitaxel|mesh-list
139643092|NCT04037241|Gemcitabine|gemcitabine|mesh-list
139643093|NCT04037241|Capecitabine|capecitabine|mesh-list
139643094|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139643095|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643096|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
139643097|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
139643098|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
139643099|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643100|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139643101|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
139643102|NCT04037241|Antidotes|antidotes|mesh-ancestor
139643103|NCT04037241|Protective Agents|protective agents|mesh-ancestor
139643104|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643105|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
139643106|NCT04037241|Vitamins|vitamins|mesh-ancestor
139643107|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
139643108|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
139643109|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139643110|NCT04912128|Growth Substances|growth substances|mesh-ancestor
139643111|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643112|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
139643113|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643114|NCT01327677|Fentanyl|fentanyl|mesh-list
139643115|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139643116|NCT01327677|Narcotics|narcotics|mesh-ancestor
139643117|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139643118|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643119|NCT01327677|Analgesics|analgesics|mesh-ancestor
139643120|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
139643121|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643122|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139643123|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139643124|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
139643125|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
139643126|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
139643127|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139643128|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139643129|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139643130|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139643131|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643132|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
139643133|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139643134|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643135|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139643136|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643137|NCT04918914|Dapsone|dapsone|mesh-list
139643138|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643139|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
139643140|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139643141|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139643142|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139643143|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643144|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385540|NCT05575973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643145|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
139643146|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139643147|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
139385541|NCT05575973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139643148|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139643149|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139643150|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643151|NCT05586763|Promethazine|promethazine|mesh-list
139643152|NCT05586763|Diphenhydramine|diphenhydramine|mesh-list
139643153|NCT05586763|Metoclopramide|metoclopramide|mesh-list
139643154|NCT05586763|Antiemetics|antiemetics|mesh-ancestor
139643155|NCT05586763|Autonomic Agents|autonomic agents|mesh-ancestor
139643156|NCT05586763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643157|NCT05586763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643158|NCT05586763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139643159|NCT05586763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139643160|NCT05586763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139643161|NCT05586763|Dopamine Agents|dopamine agents|mesh-ancestor
139643162|NCT05586763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139643163|NCT05586763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643164|NCT05586763|Antipruritics|antipruritics|mesh-ancestor
139643165|NCT05586763|Dermatologic Agents|dermatologic agents|mesh-ancestor
139643166|NCT05586763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139643167|NCT05586763|Histamine Antagonists|histamine antagonists|mesh-ancestor
139643168|NCT05586763|Histamine Agents|histamine agents|mesh-ancestor
139643169|NCT05586763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139643170|NCT05586763|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139643171|NCT05586763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139643172|NCT05586763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139643173|NCT05586763|Anesthetics, Local|anesthetics, local|mesh-ancestor
139643174|NCT05586763|Anesthetics|anesthetics|mesh-ancestor
139643175|NCT05586763|Sensory System Agents|sensory system agents|mesh-ancestor
139643176|NCT01328769|Febuxostat|febuxostat|mesh-list
139643177|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
139643178|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139643179|NCT02552641|Amoxicillin|amoxicillin|mesh-list
139643180|NCT02552641|Clarithromycin|clarithromycin|mesh-list
139643181|NCT02552641|Esomeprazole|esomeprazole|mesh-list
139643182|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139643183|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643184|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139643185|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139643186|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139643187|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643188|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643189|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139643190|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139643191|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139643192|NCT02620020|Fasinumab|fasinumab|mesh-list
139643193|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139643194|NCT02620020|Analgesics|analgesics|mesh-ancestor
139643195|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
139643196|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643197|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643198|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
139643199|NCT01378299|Testosterone|testosterone|mesh-list
139643200|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
139643201|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
139643202|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139643203|NCT01378299|Androgens|androgens|mesh-ancestor
139643204|NCT01378299|Hormones|hormones|mesh-ancestor
139643205|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139643206|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643207|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139643208|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643209|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
139643210|NCT04929522|Anesthetics|anesthetics|mesh-list
139643211|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139643212|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643213|NCT02549833|Poly I-C|poly i-c|mesh-list
139643214|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139643215|NCT02549833|Poly ICLC|poly iclc|mesh-list
139643216|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
139643217|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
139643218|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385542|NCT05575973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139643219|NCT02549833|Laxatives|laxatives|mesh-ancestor
139643220|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139385543|NCT05575973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139643221|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
139643222|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643223|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139643224|NCT02542969|Simvastatin|simvastatin|mesh-list
139643225|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139643226|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139643227|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
139643228|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643229|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139643230|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139643231|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643232|NCT03054168|Goserelin|goserelin|mesh-list
139643233|NCT03054168|Testosterone|testosterone|mesh-list
139643234|NCT03054168|Hormones|hormones|mesh-ancestor
139643235|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139643236|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643237|NCT03054168|Androgens|androgens|mesh-ancestor
139643238|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139643239|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643240|NCT04757779|Docetaxel|docetaxel|mesh-list
139643241|NCT04757779|Irinotecan|irinotecan|mesh-list
139643242|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643243|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
139643244|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
139643245|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
139643246|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643247|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139643248|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139643249|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643250|NCT03053856|Paclitaxel|paclitaxel|mesh-list
139643251|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
139643252|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139643253|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643254|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
139643255|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
139643256|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
139643257|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643258|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139643259|NCT03053856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139643260|NCT02489695|Axitinib|axitinib|mesh-list
139643261|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643262|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139643263|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643264|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643265|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
139643266|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139643267|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
139643268|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643269|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643270|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139643271|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
139643272|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139643273|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
139643274|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643275|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139643276|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139643277|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
139643278|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
139643279|NCT03053388|Protective Agents|protective agents|mesh-ancestor
139643280|NCT03053544|Metformin|metformin|mesh-list
139643281|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139643282|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643283|NCT02384083|Dexamethasone|dexamethasone|mesh-list
139643284|NCT02384083|Pomalidomide|pomalidomide|mesh-list
139643285|NCT02384083|Filanesib|filanesib|mesh-list
139643286|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139643287|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
139643288|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
139643289|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643290|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643291|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139643292|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
139643293|NCT02384083|Hormones|hormones|mesh-ancestor
139643294|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385544|NCT05575973|Growth Substances|growth substances|mesh-ancestor
139643295|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139643296|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643297|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
139643298|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139643299|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139643300|NCT02384083|Growth Substances|growth substances|mesh-ancestor
139643301|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
139643302|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
139643303|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
139643304|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643306|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139643307|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643308|NCT03053622|Mirikizumab|mirikizumab|mesh-list
139643309|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139643310|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139643311|NCT03053622|Analgesics|analgesics|mesh-ancestor
139643312|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
139643313|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643314|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643315|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139643316|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139643317|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139643318|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139643319|NCT02380573|Methylene Blue|methylene blue|mesh-list
139643320|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643321|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643322|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
139643323|NCT02461537|Analgesics|analgesics|mesh-ancestor
139643324|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
139643325|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643326|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643327|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643328|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139643329|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139643330|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643331|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643332|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139643333|NCT05028673|Antacids|antacids|mesh-list
139643334|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139643335|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139643336|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
139643337|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643338|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643339|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139643340|NCT04916574|Antibodies|antibodies|mesh-list
139643341|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
139643342|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643343|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
139643344|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139643345|NCT02460445|Cyproterone|cyproterone|mesh-list
138712647|NCT01698281|Glucocorticoids|glucocorticoids|mesh-ancestor
139643346|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139643347|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139643348|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139643349|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
139643350|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139643351|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643352|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139643353|NCT02460445|Estrogens|estrogens|mesh-ancestor
139643354|NCT02460445|Hormones|hormones|mesh-ancestor
139643355|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139643356|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
139643357|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
139643358|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643359|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139643360|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
139643361|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139643362|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643363|NCT05023837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139643364|NCT05023837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643365|NCT02358967|Vitamin E|vitamin e|mesh-list
139643366|NCT02358967|Tocopherols|tocopherols|mesh-list
139643367|NCT02358967|Tocotrienols|tocotrienols|mesh-list
139643368|NCT02358967|Vitamins|vitamins|mesh-ancestor
139643369|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
139643370|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643371|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
139643372|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643373|NCT02358967|Protective Agents|protective agents|mesh-ancestor
139643374|NCT03052998|Ivermectin|ivermectin|mesh-list
139643375|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
139643376|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139643377|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643378|NCT05586061|Tislelizumab|tislelizumab|mesh-list
139643379|NCT05586061|Disitamab vedotin|disitamab vedotin|mesh-list
139643380|NCT05586061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139643381|NCT05586061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643382|NCT05586061|Immunoconjugates|immunoconjugates|mesh-ancestor
139643383|NCT05586061|Immunologic Factors|immunologic factors|mesh-ancestor
139643384|NCT05586061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643385|NCT02354131|Bevacizumab|bevacizumab|mesh-list
139643386|NCT02354131|Niraparib|niraparib|mesh-list
139643387|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139643388|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643389|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139643390|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139643391|NCT02354131|Growth Substances|growth substances|mesh-ancestor
139643392|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643393|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
139643394|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139643395|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643396|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643397|NCT02352337|Gemcitabine|gemcitabine|mesh-list
139643398|NCT02352337|Folfirinox|folfirinox|mesh-list
139643399|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139643400|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
139643401|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643402|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643403|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
139643404|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139643405|NCT02827201|Paclitaxel|paclitaxel|mesh-list
139643406|NCT02827201|Gemcitabine|gemcitabine|mesh-list
139643407|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139643408|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643409|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
139643410|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
139643411|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
139643412|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643413|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139643414|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
139643415|NCT01378377|Niacinamide|niacinamide|mesh-list
139643416|NCT01378377|Sirolimus|sirolimus|mesh-list
139643417|NCT01378377|Temsirolimus|temsirolimus|mesh-list
139643418|NCT01378377|MTOR Inhibitors|mtor inhibitors|mesh-list
139643419|NCT01378377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139643420|NCT01378377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643421|NCT01378377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643422|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139643423|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
139643424|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643425|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643426|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139643427|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643428|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139643429|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
139643430|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
139643431|NCT01378377|Vitamins|vitamins|mesh-ancestor
139643432|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
139643433|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
139643434|NCT04907838|BQ 788|bq 788|mesh-list
139643435|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139643436|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139643437|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643438|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139643439|NCT03056274|Metformin|metformin|mesh-list
139643440|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139643441|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139643442|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643443|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139643444|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139643445|NCT03056118|Aspirin|aspirin|mesh-list
139385545|NCT05575973|Growth Inhibitors|growth inhibitors|mesh-ancestor
139643446|NCT03056118|Clopidogrel|clopidogrel|mesh-list
139643447|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139643448|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139643449|NCT03056118|Analgesics|analgesics|mesh-ancestor
139643450|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
139643451|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643452|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643453|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139643454|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139643455|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139643456|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139643457|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643458|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139643459|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139643460|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643461|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
139643462|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139643463|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139643464|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139643465|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
139643466|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139643467|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139643468|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139643469|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
139643470|NCT00987935|Sorafenib|sorafenib|mesh-list
139643471|NCT00987935|Nintedanib|nintedanib|mesh-list
139643472|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643473|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138712983|NCT01162486|Rifampin|rifampin|mesh-list
139643474|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643475|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643476|NCT00987467|Cyclosporine|cyclosporine|mesh-list
139643477|NCT00987467|Cyclosporins|cyclosporins|mesh-list
139643478|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643479|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643480|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139643481|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
139643482|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643483|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
139643484|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643485|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
139643486|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139643487|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139643488|NCT05874440|Tenofovir|tenofovir|mesh-list
139643489|NCT05874440|Antiviral Agents|antiviral agents|mesh-ancestor
139643490|NCT05874440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643491|NCT05874440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139643492|NCT05874440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139643493|NCT05874440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643494|NCT05874440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643495|NCT05874440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139643496|NCT05874440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139643497|NCT05874180|Metformin|metformin|mesh-list
139643498|NCT05874180|Linagliptin|linagliptin|mesh-list
139643499|NCT05874180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139643500|NCT05874180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643501|NCT05874180|Incretins|incretins|mesh-ancestor
139643502|NCT05874180|Hormones|hormones|mesh-ancestor
139643503|NCT05874180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139643504|NCT05874180|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139643505|NCT05874180|Protease Inhibitors|protease inhibitors|mesh-ancestor
139643506|NCT05874180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643507|NCT05874180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643508|NCT05874167|Metformin|metformin|mesh-list
139643509|NCT05874167|Linagliptin|linagliptin|mesh-list
139643510|NCT05874167|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139643511|NCT05874167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643512|NCT05874167|Incretins|incretins|mesh-ancestor
139643513|NCT05874167|Hormones|hormones|mesh-ancestor
139643514|NCT05874167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139643515|NCT05874167|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139643516|NCT05874167|Protease Inhibitors|protease inhibitors|mesh-ancestor
139643517|NCT05874167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643518|NCT05874167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643519|NCT05873972|Cetuximab|cetuximab|mesh-list
139131778|NCT03710252|Ritonavir|ritonavir|mesh-list
139643520|NCT05873972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139385546|NCT05575973|Analgesics|analgesics|mesh-ancestor
139643521|NCT05873972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643522|NCT05873751|Vaccines|vaccines|mesh-list
139643523|NCT05873751|Immunologic Factors|immunologic factors|mesh-ancestor
139643524|NCT05873751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643525|NCT05873738|Nicotine|nicotine|mesh-list
139643526|NCT05873738|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139643527|NCT05873738|Autonomic Agents|autonomic agents|mesh-ancestor
139643528|NCT05873738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643529|NCT05873738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643530|NCT05873738|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139643531|NCT05873738|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139643532|NCT05873738|Cholinergic Agents|cholinergic agents|mesh-ancestor
139643533|NCT05873738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139643534|NCT05873738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643535|NCT05873673|Ubiquinone|ubiquinone|mesh-list
139643536|NCT05873673|Coenzyme Q10|coenzyme q10|mesh-list
139643537|NCT05873673|Micronutrients|micronutrients|mesh-ancestor
139643538|NCT05873673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643539|NCT05873673|Vitamins|vitamins|mesh-ancestor
139643540|NCT05873465|Midazolam|midazolam|mesh-list
139643541|NCT05873465|Fentanyl|fentanyl|mesh-list
139643542|NCT05873465|Propofol|propofol|mesh-list
139643543|NCT05873465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139643544|NCT05873465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139643545|NCT05873465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643546|NCT05873465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139643547|NCT05873465|Anesthetics, General|anesthetics, general|mesh-ancestor
139643548|NCT05873465|Anesthetics|anesthetics|mesh-ancestor
139643549|NCT05873465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139643550|NCT05873465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139643551|NCT05873465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139643552|NCT05873465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139643553|NCT05873465|GABA Modulators|gaba modulators|mesh-ancestor
139643554|NCT05873465|GABA Agents|gaba agents|mesh-ancestor
139643555|NCT05873465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139643556|NCT05873465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643557|NCT05873465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139643558|NCT05873465|Narcotics|narcotics|mesh-ancestor
139643559|NCT05873465|Analgesics|analgesics|mesh-ancestor
139643560|NCT05873465|Sensory System Agents|sensory system agents|mesh-ancestor
139643561|NCT05873465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643562|NCT05873192|Talazoparib|talazoparib|mesh-list
139643563|NCT05873192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139643564|NCT05873192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643565|NCT05873192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643566|NCT05873192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643567|NCT05872698|Carvedilol|carvedilol|mesh-list
139643568|NCT05872698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139643569|NCT05872698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139643570|NCT05872698|Adrenergic Agents|adrenergic agents|mesh-ancestor
139643571|NCT05872698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139643572|NCT05872698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643573|NCT05872698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643574|NCT05872698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139643575|NCT05872698|Antioxidants|antioxidants|mesh-ancestor
139643576|NCT05872698|Protective Agents|protective agents|mesh-ancestor
139643577|NCT05872698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139643578|NCT05872698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139643579|NCT05872698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139643580|NCT05872698|Vasodilator Agents|vasodilator agents|mesh-ancestor
139643581|NCT05872698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139643582|NCT05872698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139643583|NCT05872568|Mycophenolic Acid|mycophenolic acid|mesh-list
139643584|NCT05872568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139643585|NCT05872568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643586|NCT05872568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139643587|NCT05872568|Antitubercular Agents|antitubercular agents|mesh-ancestor
139643588|NCT05872568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139643589|NCT05872568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643590|NCT05872568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643591|NCT05872568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643592|NCT05872555|Antipsychotic Agents|antipsychotic agents|mesh-list
139643593|NCT05872555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139643594|NCT05872555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139643595|NCT05872555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643596|NCT05872555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139385547|NCT05575973|Sensory System Agents|sensory system agents|mesh-ancestor
139385548|NCT05575973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643598|NCT05872386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139643599|NCT05872386|Narcotics|narcotics|mesh-ancestor
139643600|NCT05872386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139643601|NCT05872386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643602|NCT05872386|Analgesics|analgesics|mesh-ancestor
139643603|NCT05872386|Sensory System Agents|sensory system agents|mesh-ancestor
138713061|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139643604|NCT05872386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643605|NCT05872386|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139643606|NCT05872087|Midazolam|midazolam|mesh-list
139643607|NCT05872087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139643608|NCT05872087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139643609|NCT05872087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139643610|NCT05872087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643611|NCT05872087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139643612|NCT05872087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139643613|NCT05872087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139643614|NCT05872087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139643615|NCT05872087|Anesthetics, General|anesthetics, general|mesh-ancestor
139643616|NCT05872087|Anesthetics|anesthetics|mesh-ancestor
139643617|NCT05872087|GABA Modulators|gaba modulators|mesh-ancestor
139643618|NCT05872087|GABA Agents|gaba agents|mesh-ancestor
139643619|NCT05872087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139643620|NCT05872087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643621|NCT05871619|Fluorides|fluorides|mesh-list
139643622|NCT05871619|Fluorides, Topical|fluorides, topical|mesh-list
139643623|NCT05871619|Cariostatic Agents|cariostatic agents|mesh-ancestor
139643624|NCT05871619|Protective Agents|protective agents|mesh-ancestor
139643625|NCT05871619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643626|NCT05869357|Turmeric extract|turmeric extract|mesh-list
139643627|NCT05869357|Antioxidants|antioxidants|mesh-ancestor
139643628|NCT05869357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643629|NCT05869357|Protective Agents|protective agents|mesh-ancestor
139643630|NCT05869357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643631|NCT05869188|Isotretinoin|isotretinoin|mesh-list
139643632|NCT05869188|Dermatologic Agents|dermatologic agents|mesh-ancestor
139643633|NCT05868889|Trabectedin|trabectedin|mesh-list
139643634|NCT05868889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139643635|NCT05868889|Alkylating Agents|alkylating agents|mesh-ancestor
139643636|NCT05868889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643637|NCT05868889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643638|NCT05868174|Peposertib|peposertib|mesh-list
139643639|NCT05868174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139643640|NCT05868174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643641|NCT05868174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643642|NCT05849740|Daratumumab|daratumumab|mesh-list
139643643|NCT05849740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643644|NCT05797467|Bevacizumab|bevacizumab|mesh-list
139643645|NCT05797467|Cetuximab|cetuximab|mesh-list
139643646|NCT05797467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139643647|NCT05797467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643648|NCT05797467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139643649|NCT05797467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139643650|NCT05797467|Growth Substances|growth substances|mesh-ancestor
139643651|NCT05797467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643652|NCT05797467|Growth Inhibitors|growth inhibitors|mesh-ancestor
139643653|NCT05796973|Atorvastatin|atorvastatin|mesh-list
139643654|NCT05796973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139643655|NCT05796973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139643656|NCT05796973|Antimetabolites|antimetabolites|mesh-ancestor
139643657|NCT05796973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643658|NCT05796973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139643659|NCT05796973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139643660|NCT05796973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643661|NCT05733741|Benoxinate|benoxinate|mesh-list
139643662|NCT05733741|Hyaluronic Acid|hyaluronic acid|mesh-list
139643663|NCT05733741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139643664|NCT05733741|Immunologic Factors|immunologic factors|mesh-ancestor
139643665|NCT05733741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643666|NCT05733741|Viscosupplements|viscosupplements|mesh-ancestor
139643667|NCT05733741|Protective Agents|protective agents|mesh-ancestor
139385549|NCT05575973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138713069|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
139385550|NCT05575973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139643668|NCT05733741|Anesthetics, Local|anesthetics, local|mesh-ancestor
139643669|NCT05733741|Anesthetics|anesthetics|mesh-ancestor
139643670|NCT05733741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139643671|NCT05733741|Sensory System Agents|sensory system agents|mesh-ancestor
139643672|NCT05733741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643674|NCT05711082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139643675|NCT05711082|Sympathomimetics|sympathomimetics|mesh-ancestor
139643676|NCT05711082|Autonomic Agents|autonomic agents|mesh-ancestor
139643677|NCT05711082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643678|NCT05711082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643679|NCT05711082|Dopamine Agents|dopamine agents|mesh-ancestor
139643680|NCT05711082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139643681|NCT05711082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643682|NCT05711082|Protective Agents|protective agents|mesh-ancestor
139643683|NCT05689463|Immunoglobulins|immunoglobulins|mesh-list
139643684|NCT05689463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139643685|NCT05689463|Antibodies|antibodies|mesh-list
139643686|NCT05689463|Immunologic Factors|immunologic factors|mesh-ancestor
139643687|NCT05689463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643688|NCT05686993|Nifedipine|nifedipine|mesh-list
139643689|NCT05686993|Cinnarizine|cinnarizine|mesh-list
139643690|NCT05686993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139385551|NCT05575973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385552|NCT05575973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385553|NCT03547895|Vitamin K|vitamin k|mesh-list
139385554|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
139385555|NCT03547895|Ribavirin|ribavirin|mesh-list
139385556|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
139385557|NCT03547895|Furosemide|furosemide|mesh-list
139385558|NCT03547895|Spironolactone|spironolactone|mesh-list
139385559|NCT03547895|Silymarin|silymarin|mesh-list
139385560|NCT03547895|Vitamins|vitamins|mesh-ancestor
139385561|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
139385562|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385563|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
139385564|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385565|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
139385566|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139385567|NCT03547895|Diuretics|diuretics|mesh-ancestor
139385568|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
139385569|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139385570|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139385571|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139385572|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
139643691|NCT05686993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139643692|NCT05686993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643693|NCT05686993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139643694|NCT05686993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643695|NCT05686993|Vasodilator Agents|vasodilator agents|mesh-ancestor
139643696|NCT05686993|Tocolytic Agents|tocolytic agents|mesh-ancestor
139643697|NCT05686993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139643698|NCT05686993|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139643699|NCT05686993|Histamine Antagonists|histamine antagonists|mesh-ancestor
139643700|NCT05686993|Histamine Agents|histamine agents|mesh-ancestor
139643701|NCT05686993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139643702|NCT05673577|Cetuximab|cetuximab|mesh-list
139643703|NCT05673577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139643704|NCT05673577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643705|NCT05533164|Rituximab|rituximab|mesh-list
139643706|NCT05533164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138648833|NCT00324831|Doxorubicin|doxorubicin|mesh-list
139643707|NCT05533164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643708|NCT05533164|Immunologic Factors|immunologic factors|mesh-ancestor
139643709|NCT05533164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643710|NCT05533164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139643711|NCT05533125|Rituximab|rituximab|mesh-list
139643712|NCT05533125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139643713|NCT05533125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643714|NCT05533125|Immunologic Factors|immunologic factors|mesh-ancestor
139643715|NCT05533125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643716|NCT05533125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139643717|NCT05407584|Paclitaxel|paclitaxel|mesh-list
139643718|NCT05407584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139643719|NCT05407584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643720|NCT05407584|Tubulin Modulators|tubulin modulators|mesh-ancestor
139385573|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139643721|NCT05407584|Antimitotic Agents|antimitotic agents|mesh-ancestor
139643722|NCT05407584|Mitosis Modulators|mitosis modulators|mesh-ancestor
139643723|NCT05407584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643724|NCT05321251|Insulin|insulin|mesh-list
139643725|NCT05321251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139643726|NCT05321251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643727|NCT05294588|Ciprofloxacin|ciprofloxacin|mesh-list
139643728|NCT05294588|Ceftriaxone|ceftriaxone|mesh-list
139643729|NCT05294588|Cefixime|cefixime|mesh-list
139643730|NCT05294588|Vaccines|vaccines|mesh-list
139643731|NCT05294588|Immunologic Factors|immunologic factors|mesh-ancestor
139643732|NCT05294588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643733|NCT05294588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139643734|NCT05294588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643735|NCT05294588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139643736|NCT05294588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139643737|NCT05294588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643738|NCT05294588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643739|NCT05294588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643740|NCT05294588|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139643741|NCT05294588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139643742|NCT05170139|Caffeine|caffeine|mesh-list
139643743|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139643744|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643745|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139643746|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643747|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643748|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139643749|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139643750|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
139643751|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139643752|NCT05140811|Azacitidine|azacitidine|mesh-list
139643753|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139643754|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
139643755|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643756|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643757|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643758|NCT05046184|Midazolam|midazolam|mesh-list
139643759|NCT05046184|Ketamine|ketamine|mesh-list
139643760|NCT05046184|Analgesics|analgesics|mesh-ancestor
139643761|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
139643762|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643763|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643764|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139643765|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139643766|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
139643767|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
139643768|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139643769|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139643770|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139643771|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713123|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643772|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643773|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139643774|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139643775|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139643776|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139643777|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139643778|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
139643779|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
139643780|NCT05033522|Sorafenib|sorafenib|mesh-list
139643781|NCT05033522|Lenvatinib|lenvatinib|mesh-list
139643782|NCT05033522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643783|NCT05033522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139643784|NCT05033522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643785|NCT05033522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643786|NCT05020028|Cannabidiol|cannabidiol|mesh-list
139643787|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
139643788|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
139643789|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139643790|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139643791|NCT04976868|Analgesics|analgesics|mesh-ancestor
139643792|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
139643793|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385574|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139643794|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643795|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139643796|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139643797|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
139643798|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139643799|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
139643800|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139643801|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643802|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643803|NCT04944654|Emtricitabine|emtricitabine|mesh-list
139643804|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
139643805|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643806|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139643807|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139643808|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643809|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643810|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139643811|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139643812|NCT04886232|Lidocaine|lidocaine|mesh-list
139643813|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
139643814|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
139643815|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139643816|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643817|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
139643818|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643819|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139643820|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139643821|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139643822|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139643823|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643824|NCT04885712|Metformin|metformin|mesh-list
139643825|NCT04885712|Pioglitazone|pioglitazone|mesh-list
139643826|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
139643827|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139643828|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643829|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139643830|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643831|NCT04843046|Pioglitazone|pioglitazone|mesh-list
139643832|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139643833|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643834|NCT04789499|Theophylline|theophylline|mesh-list
139643835|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139643836|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
139643837|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139643838|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643839|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139643840|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
139643841|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139643842|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643843|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643844|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
139643845|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139643846|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139643847|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
139643848|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139643849|NCT04706130|Artesunate|artesunate|mesh-list
139643850|NCT04706130|Primaquine|primaquine|mesh-list
139643851|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
139643852|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139643853|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139643854|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643855|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643856|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
139643857|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
139643858|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139643859|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
139643860|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
139643861|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139643862|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
139643863|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643864|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
139643865|NCT04697823|Protective Agents|protective agents|mesh-ancestor
139643866|NCT04674462|Vaccines|vaccines|mesh-list
139643867|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
139643868|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385575|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139643869|NCT04657016|Tirzepatide|tirzepatide|mesh-list
139643870|NCT04657016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139643871|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643872|NCT04657016|Incretins|incretins|mesh-ancestor
139643873|NCT04657016|Hormones|hormones|mesh-ancestor
139643874|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139643875|NCT04638036|Cetuximab|cetuximab|mesh-list
139643876|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139643877|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643878|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
139643879|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
139643880|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139643881|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139643882|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643883|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643884|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643885|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139643886|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
139643887|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139643888|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139643889|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643890|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
139643891|NCT04560010|Coagulants|coagulants|mesh-ancestor
139643892|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
139643893|NCT04558866|Testosterone|testosterone|mesh-list
139643894|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
139643895|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
139643896|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139643897|NCT04558866|Androgens|androgens|mesh-ancestor
139643898|NCT04558866|Hormones|hormones|mesh-ancestor
139643899|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139643900|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643901|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139643902|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643903|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
139643904|NCT04397679|Chloroquine|chloroquine|mesh-list
139643905|NCT04397679|Temozolomide|temozolomide|mesh-list
139643906|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139643907|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
139643908|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643909|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643910|NCT04397679|Amebicides|amebicides|mesh-ancestor
139643911|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139643912|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139643913|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643914|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
139643915|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139643916|NCT04258423|Everolimus|everolimus|mesh-list
139643917|NCT04258423|Tacrolimus|tacrolimus|mesh-list
139643918|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139643919|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
139643920|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643921|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139643922|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643923|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643924|NCT04258423|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139643925|NCT04258423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139643926|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643927|NCT04211987|Cytarabine|cytarabine|mesh-list
139643928|NCT04211987|Methotrexate|methotrexate|mesh-list
139643929|NCT04211987|Etoposide|etoposide|mesh-list
139643930|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139643931|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
139643932|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643933|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643934|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
139643935|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643936|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139643937|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
139643938|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643939|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139643940|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139643941|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139643942|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643943|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139643944|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
139643945|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139643946|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
139643947|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139643948|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139643949|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139643951|NCT04190433|Lisinopril|lisinopril|mesh-list
139643952|NCT04190433|Spironolactone|spironolactone|mesh-list
139643953|NCT04190433|Pravastatin|pravastatin|mesh-list
139643954|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139643955|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
139643956|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139643957|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643958|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139643959|NCT04190433|Diuretics|diuretics|mesh-ancestor
139643960|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
139643961|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139643962|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139643963|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
139643964|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139643965|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643966|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139643967|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
139643968|NCT04190433|Protective Agents|protective agents|mesh-ancestor
139643969|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139643970|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139643971|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139643972|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
139643973|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139643974|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139643975|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139643976|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139643977|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
139643978|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139643979|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139643980|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139643981|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139643982|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
139643983|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139643984|NCT04177810|Plerixafor|plerixafor|mesh-list
139643985|NCT04177810|Cemiplimab|cemiplimab|mesh-list
139643986|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139643987|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139643988|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
139643989|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139643990|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139643991|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643992|NCT04163900|Gemcitabine|gemcitabine|mesh-list
139643993|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139643994|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139643995|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
138713642|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139643996|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139643997|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139643998|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
139643999|NCT04146038|Azacitidine|azacitidine|mesh-list
139644000|NCT04146038|Decitabine|decitabine|mesh-list
139644001|NCT04146038|Venetoclax|venetoclax|mesh-list
139644002|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139644003|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
139644004|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644005|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644006|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644007|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139644008|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139644009|NCT04146038|Analgesics|analgesics|mesh-ancestor
139644010|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
139644011|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644012|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644013|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139644014|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139644015|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139644016|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
139644017|NCT04109885|Promethazine|promethazine|mesh-list
139644018|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
139644019|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139132271|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139385576|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139385577|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
139644020|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139644021|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644022|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644023|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
139644024|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
139644025|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
139644026|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644027|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
139644028|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
139644029|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139644030|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139644031|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
139644032|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
139644033|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644034|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644035|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139644036|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
139644037|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
139644038|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139644039|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139644040|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139644041|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139644042|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
139644043|NCT04087668|Anesthetics|anesthetics|mesh-list
139644044|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644045|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644046|NCT04006873|Ivacaftor|ivacaftor|mesh-list
139644047|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139644048|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139644049|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644050|NCT03942419|Atropine|atropine|mesh-list
139644051|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139644052|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139644053|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139644054|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139644055|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139644056|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
139644057|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644058|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644059|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139644060|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
139644061|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
139644062|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
139644063|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139644064|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139644065|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
139644066|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644067|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644068|NCT03820310|Immunomodulating Agents|immunomodulating agents|mesh-list
139644069|NCT03820310|Immunologic Factors|immunologic factors|mesh-ancestor
139644070|NCT03820310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644071|NCT03780673|Rifaximin|rifaximin|mesh-list
139644072|NCT03780673|Simvastatin|simvastatin|mesh-list
139644073|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139644074|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139644075|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
139644076|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644077|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139644078|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139644079|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644080|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139644081|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139644082|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139644083|NCT03769311|Cetuximab|cetuximab|mesh-list
139644084|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139644085|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644086|NCT03767335|Trastuzumab|trastuzumab|mesh-list
139644087|NCT03767335|Fulvestrant|fulvestrant|mesh-list
139644088|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139644089|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644090|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139644091|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139644092|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139644093|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
139385578|NCT03547895|Coagulants|coagulants|mesh-ancestor
139385579|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
139644094|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139644095|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644096|NCT03745430|Ramucirumab|ramucirumab|mesh-list
139644097|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644098|NCT03651882|Oxytocin|oxytocin|mesh-list
139644099|NCT03651882|Carbetocin|carbetocin|mesh-list
139644100|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
139644101|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139644102|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644103|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
139644104|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139644105|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
139644106|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139644107|NCT03636932|Expectorants|expectorants|mesh-ancestor
139644108|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
139644109|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139644110|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
139644111|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644112|NCT03636932|Protective Agents|protective agents|mesh-ancestor
139644113|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644114|NCT03636932|Antidotes|antidotes|mesh-ancestor
139644115|NCT05910554|Metformin|metformin|mesh-list
139644116|NCT05910554|Glyburide|glyburide|mesh-list
139644117|NCT05910554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139644118|NCT05910554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644119|NCT05910476|Ezetimibe|ezetimibe|mesh-list
139644120|NCT05910476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139644121|NCT05910476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139644122|NCT05910476|Antimetabolites|antimetabolites|mesh-ancestor
139644123|NCT05910476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644124|NCT05910476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139644125|NCT05910450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139644126|NCT05910177|Etoposide|etoposide|mesh-list
139644127|NCT05910177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644128|NCT05910177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139644129|NCT05910177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139644130|NCT05910177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139644131|NCT05910177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644132|NCT05910177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644133|NCT05910125|Aspirin|aspirin|mesh-list
139644134|NCT05910125|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139644135|NCT05910125|Clopidogrel|clopidogrel|mesh-list
139644136|NCT05910125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139644137|NCT05910125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139644138|NCT05910125|Analgesics|analgesics|mesh-ancestor
139644139|NCT05910125|Sensory System Agents|sensory system agents|mesh-ancestor
139644140|NCT05910125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644141|NCT05910125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644142|NCT05910125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139644143|NCT05910125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139644144|NCT05910125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139644145|NCT05910125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139644146|NCT05910125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644147|NCT05910125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139644148|NCT05910125|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139644149|NCT05910125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644150|NCT05910125|Antipyretics|antipyretics|mesh-ancestor
139644151|NCT05910125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139644152|NCT05910125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139644153|NCT05910125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139644154|NCT05910125|Purinergic Agents|purinergic agents|mesh-ancestor
139644155|NCT05910125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644156|NCT05910034|Docetaxel|docetaxel|mesh-list
139644157|NCT05910034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644158|NCT05910034|Tubulin Modulators|tubulin modulators|mesh-ancestor
139644159|NCT05910034|Antimitotic Agents|antimitotic agents|mesh-ancestor
139644160|NCT05910034|Mitosis Modulators|mitosis modulators|mesh-ancestor
139644161|NCT05910034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644162|NCT05909852|Adalimumab|adalimumab|mesh-list
139644163|NCT05909852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139644164|NCT05909852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139644165|NCT05909852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139644166|NCT05909826|Dexamethasone|dexamethasone|mesh-list
139644167|NCT05909826|Cyclophosphamide|cyclophosphamide|mesh-list
139644168|NCT05909826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139385580|NCT03547895|Protective Agents|protective agents|mesh-ancestor
139644169|NCT05909826|Immunologic Factors|immunologic factors|mesh-ancestor
139644170|NCT05909826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644171|NCT05909826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139644172|NCT05909826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139644173|NCT05909826|Alkylating Agents|alkylating agents|mesh-ancestor
139644174|NCT05909826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644175|NCT05909826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644176|NCT05909826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139644177|NCT05909826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139644178|NCT05909826|Antiemetics|antiemetics|mesh-ancestor
139644179|NCT05909826|Autonomic Agents|autonomic agents|mesh-ancestor
139644180|NCT05909826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644181|NCT05909826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139644182|NCT05909826|Glucocorticoids|glucocorticoids|mesh-ancestor
139644183|NCT05909826|Hormones|hormones|mesh-ancestor
139644184|NCT05909826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139644185|NCT05909826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139644186|NCT05909462|Triamcinolone|triamcinolone|mesh-list
139644187|NCT05909462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139644188|NCT05909462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139644189|NCT05909462|Lidocaine|lidocaine|mesh-list
139644190|NCT05909462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139644191|NCT05909462|Anesthetics, Local|anesthetics, local|mesh-ancestor
139644192|NCT05909462|Anesthetics|anesthetics|mesh-ancestor
139644193|NCT05909462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644194|NCT05909462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644195|NCT05909462|Sensory System Agents|sensory system agents|mesh-ancestor
139644196|NCT05909462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644197|NCT05909462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139644198|NCT05909462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139644199|NCT05909462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139644200|NCT05909462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139644201|NCT05909462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644202|NCT05909462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139644203|NCT05909462|Glucocorticoids|glucocorticoids|mesh-ancestor
139644204|NCT05909462|Hormones|hormones|mesh-ancestor
139644205|NCT05909462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139644206|NCT05909462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139644207|NCT05909462|Immunologic Factors|immunologic factors|mesh-ancestor
139644208|NCT05909462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644209|NCT05909423|Pembrolizumab|pembrolizumab|mesh-list
139644210|NCT05909423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139644211|NCT05909423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644212|NCT05909423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139644213|NCT05909423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644214|NCT05909293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139644215|NCT05909293|Venetoclax|venetoclax|mesh-list
139644216|NCT05909293|Antiemetics|antiemetics|mesh-list
139644217|NCT05909293|Lenograstim|lenograstim|mesh-list
139644218|NCT05909293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139644219|NCT05909293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139644220|NCT05909293|Immunologic Factors|immunologic factors|mesh-ancestor
139644221|NCT05909293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644222|NCT05909293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644223|NCT05909293|Autonomic Agents|autonomic agents|mesh-ancestor
139644224|NCT05909293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644225|NCT05909293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139644226|NCT05909215|Dexmedetomidine|dexmedetomidine|mesh-list
139644227|NCT05909215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139644228|NCT05909215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644229|NCT05909215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644230|NCT05909215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139644231|NCT05909215|Analgesics|analgesics|mesh-ancestor
139644232|NCT05909215|Sensory System Agents|sensory system agents|mesh-ancestor
139644233|NCT05909215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644234|NCT05909215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139644235|NCT05909215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139644236|NCT05909215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139644237|NCT05909215|Adrenergic Agents|adrenergic agents|mesh-ancestor
139644238|NCT05909215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644239|NCT05909215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644240|NCT05909137|Immunomodulating Agents|immunomodulating agents|mesh-list
139644241|NCT05909137|Immunologic Factors|immunologic factors|mesh-ancestor
139644242|NCT05909137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644243|NCT05909072|Tranexamic Acid|tranexamic acid|mesh-list
139644244|NCT05909072|Hyaluronic Acid|hyaluronic acid|mesh-list
139644245|NCT05909072|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139644246|NCT05909072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139644247|NCT05909072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644248|NCT05909072|Hemostatics|hemostatics|mesh-ancestor
139644249|NCT05909072|Coagulants|coagulants|mesh-ancestor
139644250|NCT05909072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139644251|NCT05909072|Immunologic Factors|immunologic factors|mesh-ancestor
139644252|NCT05909072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644253|NCT05909072|Viscosupplements|viscosupplements|mesh-ancestor
139644254|NCT05909072|Protective Agents|protective agents|mesh-ancestor
139644255|NCT05908864|Magnesium Sulfate|magnesium sulfate|mesh-list
139644256|NCT05908864|Analgesics|analgesics|mesh-ancestor
139644257|NCT05908864|Sensory System Agents|sensory system agents|mesh-ancestor
139644258|NCT05908864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644259|NCT05908864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644260|NCT05908864|Anesthetics|anesthetics|mesh-ancestor
139644261|NCT05908864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644262|NCT05908864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139644263|NCT05908864|Anticonvulsants|anticonvulsants|mesh-ancestor
139644264|NCT05908864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139644265|NCT05908864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139644266|NCT05908864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644267|NCT05908864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139644268|NCT05908864|Tocolytic Agents|tocolytic agents|mesh-ancestor
139644269|NCT05908864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139644270|NCT05908851|Ketorolac|ketorolac|mesh-list
139644271|NCT05908851|Epinephrine|epinephrine|mesh-list
139644272|NCT05908851|Morphine|morphine|mesh-list
139644273|NCT05908851|Ropivacaine|ropivacaine|mesh-list
139644274|NCT05908851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139644275|NCT05908851|Narcotics|narcotics|mesh-ancestor
139644276|NCT05908851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644277|NCT05908851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644278|NCT05908851|Analgesics|analgesics|mesh-ancestor
139644279|NCT05908851|Sensory System Agents|sensory system agents|mesh-ancestor
139644280|NCT05908851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644281|NCT05908851|Anesthetics, Local|anesthetics, local|mesh-ancestor
139644282|NCT05908851|Anesthetics|anesthetics|mesh-ancestor
139644283|NCT05908851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139644284|NCT05908851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139644285|NCT05908851|Adrenergic Agents|adrenergic agents|mesh-ancestor
139644286|NCT05908851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644287|NCT05908851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644288|NCT05908851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139644289|NCT05908851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139644290|NCT05908851|Autonomic Agents|autonomic agents|mesh-ancestor
139644291|NCT05908851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139644292|NCT05908851|Respiratory System Agents|respiratory system agents|mesh-ancestor
139644293|NCT05908851|Mydriatics|mydriatics|mesh-ancestor
139644294|NCT05908851|Sympathomimetics|sympathomimetics|mesh-ancestor
139644295|NCT05908851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139644296|NCT05908851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139644297|NCT05908851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139644298|NCT05908851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139644299|NCT05908851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139644300|NCT05908851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139644301|NCT05908851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644302|NCT05906121|Lidocaine|lidocaine|mesh-list
139644303|NCT05906121|Ketamine|ketamine|mesh-list
139644304|NCT05906121|Anesthetics, Local|anesthetics, local|mesh-ancestor
139644305|NCT05906121|Anesthetics|anesthetics|mesh-ancestor
139644306|NCT05906121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644307|NCT05906121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644308|NCT05906121|Sensory System Agents|sensory system agents|mesh-ancestor
139644309|NCT05906121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644310|NCT05906121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139644311|NCT05906121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139644312|NCT05906121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139644313|NCT05906121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139644314|NCT05906121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644315|NCT05906121|Analgesics|analgesics|mesh-ancestor
139644316|NCT05906121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139385581|NCT01359254|Fludarabine|fludarabine|mesh-list
139385582|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
139644317|NCT05906121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139644318|NCT05906121|Anesthetics, General|anesthetics, general|mesh-ancestor
139644319|NCT05906121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139644320|NCT05906121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139644321|NCT05906121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644322|NCT05904587|Imidacloprid|imidacloprid|mesh-list
139644323|NCT05904587|Cholinergic Agents|cholinergic agents|mesh-ancestor
139644324|NCT05904587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644325|NCT05904587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644326|NCT05904587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644327|NCT05904457|Bevacizumab|bevacizumab|mesh-list
139644328|NCT05904457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139644329|NCT05904457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139644330|NCT05904457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644331|NCT05904457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139644332|NCT05904457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139644333|NCT05904457|Growth Substances|growth substances|mesh-ancestor
139644334|NCT05904457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644335|NCT05904457|Growth Inhibitors|growth inhibitors|mesh-ancestor
139644336|NCT05904457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139644337|NCT05904457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644338|NCT05904457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644339|NCT05904275|Dexamethasone|dexamethasone|mesh-list
139644340|NCT05904275|Ropivacaine|ropivacaine|mesh-list
139644341|NCT05904275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139644342|NCT05904275|Antiemetics|antiemetics|mesh-ancestor
139644343|NCT05904275|Autonomic Agents|autonomic agents|mesh-ancestor
139644344|NCT05904275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644345|NCT05904275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644346|NCT05904275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139644347|NCT05904275|Glucocorticoids|glucocorticoids|mesh-ancestor
139644348|NCT05904275|Hormones|hormones|mesh-ancestor
139644349|NCT05904275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139644350|NCT05904275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139644351|NCT05904275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644352|NCT05904275|Anesthetics, Local|anesthetics, local|mesh-ancestor
139644353|NCT05904275|Anesthetics|anesthetics|mesh-ancestor
139644354|NCT05904275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644355|NCT05904275|Sensory System Agents|sensory system agents|mesh-ancestor
139644356|NCT05904184|Calcium, Dietary|calcium, dietary|mesh-list
139644357|NCT05904184|Calcium|calcium|mesh-list
139644358|NCT05904184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139644359|NCT05904184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644360|NCT05904184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139644361|NCT05904119|Lomustine|lomustine|mesh-list
139644362|NCT05904119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139644363|NCT05904119|Alkylating Agents|alkylating agents|mesh-ancestor
139644364|NCT05904119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644365|NCT05904119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644366|NCT05904002|Budesonide|budesonide|mesh-list
139644367|NCT05904002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139644368|NCT05904002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139644369|NCT05904002|Autonomic Agents|autonomic agents|mesh-ancestor
139644370|NCT05904002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644371|NCT05904002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644372|NCT05904002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139644373|NCT05904002|Respiratory System Agents|respiratory system agents|mesh-ancestor
139644374|NCT05904002|Glucocorticoids|glucocorticoids|mesh-ancestor
139644375|NCT05904002|Hormones|hormones|mesh-ancestor
139644376|NCT05904002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139644377|NCT05903963|Midazolam|midazolam|mesh-list
139644378|NCT05903963|Dexmedetomidine|dexmedetomidine|mesh-list
139644379|NCT05903963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139644380|NCT05903963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644381|NCT05903963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644382|NCT05903963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139644383|NCT05903963|Analgesics|analgesics|mesh-ancestor
139644384|NCT05903963|Sensory System Agents|sensory system agents|mesh-ancestor
139644385|NCT05903963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644386|NCT05903963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139644387|NCT05903963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139644388|NCT05903963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139644389|NCT05903963|Adrenergic Agents|adrenergic agents|mesh-ancestor
139644390|NCT05903963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644391|NCT05903963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644392|NCT05903963|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139644393|NCT05903963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139644394|NCT05903963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139644395|NCT05903963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139644396|NCT05903963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139644397|NCT05903963|Anesthetics, General|anesthetics, general|mesh-ancestor
139644398|NCT05903963|Anesthetics|anesthetics|mesh-ancestor
139644399|NCT05903963|GABA Modulators|gaba modulators|mesh-ancestor
139644400|NCT05903963|GABA Agents|gaba agents|mesh-ancestor
139644401|NCT05903937|Melphalan|melphalan|mesh-list
139644402|NCT05903937|Interleukin-2|interleukin-2|mesh-list
139644403|NCT05903937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139644404|NCT05903937|Alkylating Agents|alkylating agents|mesh-ancestor
139644405|NCT05903937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644406|NCT05903937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644407|NCT05903937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139644408|NCT05903937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139644409|NCT05903937|Immunologic Factors|immunologic factors|mesh-ancestor
139644410|NCT05903937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644411|NCT05903937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139644412|NCT05903937|Analgesics|analgesics|mesh-ancestor
139644413|NCT05903937|Sensory System Agents|sensory system agents|mesh-ancestor
139644414|NCT05903937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644415|NCT05903833|Pembrolizumab|pembrolizumab|mesh-list
139644416|NCT05903833|Lenvatinib|lenvatinib|mesh-list
139644417|NCT05903833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139644418|NCT05903833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644419|NCT05903833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139644420|NCT05903833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644421|NCT05903833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139644422|NCT05903833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644423|NCT05903755|Methamphetamine|methamphetamine|mesh-list
139644424|NCT05903755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139644425|NCT05903755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644426|NCT05903755|Sympathomimetics|sympathomimetics|mesh-ancestor
139644427|NCT05903755|Autonomic Agents|autonomic agents|mesh-ancestor
139644428|NCT05903755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644429|NCT05903755|Dopamine Agents|dopamine agents|mesh-ancestor
139644430|NCT05903755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644431|NCT05903755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644432|NCT05903755|Adrenergic Agents|adrenergic agents|mesh-ancestor
139644433|NCT05903755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139644434|NCT05903755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139644435|NCT05903755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139644436|NCT05903755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139644437|NCT05903716|Isotretinoin|isotretinoin|mesh-list
139644438|NCT05903716|Hormones|hormones|mesh-list
139644439|NCT05903716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139644440|NCT05903716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644441|NCT05903716|Dermatologic Agents|dermatologic agents|mesh-ancestor
139644442|NCT05903703|Canagliflozin|canagliflozin|mesh-list
139644443|NCT05903703|Gemcitabine|gemcitabine|mesh-list
139644444|NCT05903703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139644445|NCT05903703|Antimetabolites|antimetabolites|mesh-ancestor
139644446|NCT05903703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644447|NCT05903703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644448|NCT05903703|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139644449|NCT05903703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139644450|NCT05903703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644451|NCT05903456|Lenvatinib|lenvatinib|mesh-list
139644452|NCT05903456|Immunologic Factors|immunologic factors|mesh-list
139644453|NCT05903456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644454|NCT05903456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139644455|NCT05903456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644456|NCT05903456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644457|NCT05903456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644458|NCT05903326|Dexmedetomidine|dexmedetomidine|mesh-list
139644459|NCT05903326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139644460|NCT05903326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644461|NCT05903326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644462|NCT05903326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139644463|NCT05903326|Analgesics|analgesics|mesh-ancestor
139385584|NCT01359254|Busulfan|busulfan|mesh-list
139132788|NCT01260519|Heparin|heparin|mesh-list
139644464|NCT05903326|Sensory System Agents|sensory system agents|mesh-ancestor
139644465|NCT05903326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644466|NCT05903326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139644467|NCT05903326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139644468|NCT05903326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139644469|NCT05903326|Adrenergic Agents|adrenergic agents|mesh-ancestor
139644470|NCT05903326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644471|NCT05903326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644472|NCT05902728|Itraconazole|itraconazole|mesh-list
139644473|NCT05902728|Rifampin|rifampin|mesh-list
139644474|NCT05902728|Antifungal Agents|antifungal agents|mesh-ancestor
139644475|NCT05902728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139644476|NCT05902728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139644477|NCT05902728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139644478|NCT05902728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644479|NCT05902728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644480|NCT05902728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139644481|NCT05902728|Hormone Antagonists|hormone antagonists|mesh-ancestor
139644482|NCT05902728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139644483|NCT05902728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644484|NCT05902728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139644485|NCT05902728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139644486|NCT05902728|Antitubercular Agents|antitubercular agents|mesh-ancestor
139644487|NCT05902728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139644488|NCT05902728|Leprostatic Agents|leprostatic agents|mesh-ancestor
139644489|NCT05902728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139644490|NCT05902728|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139644491|NCT05902728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139644492|NCT05902728|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139644493|NCT05902728|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139644494|NCT05902728|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139644495|NCT05902728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139644496|NCT05902468|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139644497|NCT05902468|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139644498|NCT05902468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139644499|NCT05902429|Cladribine|cladribine|mesh-list
139644500|NCT05902429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644501|NCT05902429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139644502|NCT05902429|Immunologic Factors|immunologic factors|mesh-ancestor
139644503|NCT05902429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644504|NCT05901428|Cyclophosphamide|cyclophosphamide|mesh-list
139644505|NCT05901428|Carboplatin|carboplatin|mesh-list
139644506|NCT05901428|Docetaxel|docetaxel|mesh-list
139644507|NCT05901428|Epirubicin|epirubicin|mesh-list
139644508|NCT05901428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139644509|NCT05901428|Immunologic Factors|immunologic factors|mesh-ancestor
139644510|NCT05901428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644511|NCT05901428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139644512|NCT05901428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139644513|NCT05901428|Alkylating Agents|alkylating agents|mesh-ancestor
139644514|NCT05901428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644515|NCT05901428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644516|NCT05901428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139644517|NCT05901428|Tubulin Modulators|tubulin modulators|mesh-ancestor
139644518|NCT05901428|Antimitotic Agents|antimitotic agents|mesh-ancestor
139644519|NCT05901428|Mitosis Modulators|mitosis modulators|mesh-ancestor
139644520|NCT05901428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139644521|NCT05901428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139644522|NCT05901428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139644523|NCT05901428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644524|NCT05895383|Nitrous Oxide|nitrous oxide|mesh-list
139644525|NCT05895383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139644526|NCT05895383|Anesthetics, General|anesthetics, general|mesh-ancestor
139644527|NCT05895383|Anesthetics|anesthetics|mesh-ancestor
139644528|NCT05895383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644529|NCT05895383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644530|NCT05895383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139644531|NCT05895383|Analgesics|analgesics|mesh-ancestor
139644532|NCT05895383|Sensory System Agents|sensory system agents|mesh-ancestor
139644533|NCT05895383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644534|NCT05885685|Nabilone|nabilone|mesh-list
139385585|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139644535|NCT05885685|Antiemetics|antiemetics|mesh-ancestor
139644536|NCT05885685|Autonomic Agents|autonomic agents|mesh-ancestor
139644537|NCT05885685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644538|NCT05885685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644539|NCT05885685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139644540|NCT05885685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139644541|NCT05885685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139644542|NCT05885685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644543|NCT05885685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139644544|NCT05861570|Triamcinolone|triamcinolone|mesh-list
139644545|NCT05861570|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139644546|NCT05861570|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139644547|NCT05861570|Lidocaine|lidocaine|mesh-list
139644548|NCT05861570|Hyaluronic Acid|hyaluronic acid|mesh-list
139644549|NCT05861570|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139644550|NCT05861570|Anesthetics, Local|anesthetics, local|mesh-ancestor
139644551|NCT05861570|Anesthetics|anesthetics|mesh-ancestor
139644552|NCT05861570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644553|NCT05861570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644554|NCT05861570|Sensory System Agents|sensory system agents|mesh-ancestor
139644555|NCT05861570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644556|NCT05861570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139644557|NCT05861570|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139644558|NCT05861570|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139644559|NCT05861570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139644560|NCT05861570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644561|NCT05861570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139644562|NCT05861570|Glucocorticoids|glucocorticoids|mesh-ancestor
139644563|NCT05861570|Hormones|hormones|mesh-ancestor
139644564|NCT05861570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139644565|NCT05861570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139644566|NCT05861570|Immunologic Factors|immunologic factors|mesh-ancestor
139644567|NCT05861570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644568|NCT05861570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139644569|NCT05861570|Viscosupplements|viscosupplements|mesh-ancestor
139644570|NCT05861570|Protective Agents|protective agents|mesh-ancestor
139644571|NCT05857163|Amoxicillin|amoxicillin|mesh-list
139644572|NCT05857163|Clarithromycin|clarithromycin|mesh-list
139644573|NCT05857163|Potassium Citrate|potassium citrate|mesh-list
139644574|NCT05857163|Rabeprazole|rabeprazole|mesh-list
139644575|NCT05857163|Bismuth|bismuth|mesh-list
139644576|NCT05857163|Citric Acid|citric acid|mesh-list
139644577|NCT05857163|Sodium Citrate|sodium citrate|mesh-list
139644578|NCT05857163|Anticoagulants|anticoagulants|mesh-ancestor
139644579|NCT05857163|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139644580|NCT05857163|Chelating Agents|chelating agents|mesh-ancestor
139644581|NCT05857163|Sequestering Agents|sequestering agents|mesh-ancestor
139644582|NCT05857163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644583|NCT05857163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139644584|NCT05857163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139644585|NCT05857163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139644586|NCT05857163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644587|NCT05857163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139644588|NCT05857163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139644589|NCT05857163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139644590|NCT05857163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139644591|NCT05857163|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139644592|NCT05857163|Antacids|antacids|mesh-ancestor
139644593|NCT05857163|Diuretics|diuretics|mesh-ancestor
139644594|NCT05857163|Natriuretic Agents|natriuretic agents|mesh-ancestor
139644595|NCT05857163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644596|NCT05857163|Expectorants|expectorants|mesh-ancestor
139644597|NCT05857163|Respiratory System Agents|respiratory system agents|mesh-ancestor
139644598|NCT05839301|Vaccines|vaccines|mesh-list
139644599|NCT05839301|Immunologic Factors|immunologic factors|mesh-ancestor
139644600|NCT05839301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644601|NCT05821556|Paclitaxel|paclitaxel|mesh-list
139644602|NCT05821556|Gemcitabine|gemcitabine|mesh-list
139644603|NCT05821556|Capecitabine|capecitabine|mesh-list
139644604|NCT05821556|Valproic Acid|valproic acid|mesh-list
139644605|NCT05821556|Simvastatin|simvastatin|mesh-list
139644606|NCT05821556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139644607|NCT05821556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644608|NCT05821556|Tubulin Modulators|tubulin modulators|mesh-ancestor
139644609|NCT05821556|Antimitotic Agents|antimitotic agents|mesh-ancestor
139644610|NCT05821556|Mitosis Modulators|mitosis modulators|mesh-ancestor
139644611|NCT05821556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385586|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644612|NCT05821556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139644613|NCT05821556|Antimetabolites|antimetabolites|mesh-ancestor
139644614|NCT05821556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139644615|NCT05821556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139644616|NCT05821556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139644617|NCT05821556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139644618|NCT05821556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644619|NCT05821556|Anticonvulsants|anticonvulsants|mesh-ancestor
139644620|NCT05821556|GABA Agents|gaba agents|mesh-ancestor
139644621|NCT05821556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644622|NCT05821556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644623|NCT05821556|Antimanic Agents|antimanic agents|mesh-ancestor
139644624|NCT05821556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139644625|NCT05821556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644626|NCT05821556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139644627|NCT05774717|Tranexamic Acid|tranexamic acid|mesh-list
139644628|NCT05774717|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139644629|NCT05774717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139644630|NCT05774717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644631|NCT05774717|Hemostatics|hemostatics|mesh-ancestor
139644632|NCT05774717|Coagulants|coagulants|mesh-ancestor
139644633|NCT05767359|Cyclophosphamide|cyclophosphamide|mesh-list
139644634|NCT05767359|Fludarabine|fludarabine|mesh-list
139644635|NCT05767359|Fludarabine phosphate|fludarabine phosphate|mesh-list
139644636|NCT05767359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139644637|NCT05767359|Immunologic Factors|immunologic factors|mesh-ancestor
139644638|NCT05767359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644639|NCT05767359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139644640|NCT05767359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139644641|NCT05767359|Alkylating Agents|alkylating agents|mesh-ancestor
139644642|NCT05767359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644643|NCT05767359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644644|NCT05767359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139644645|NCT05767359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139644646|NCT05767359|Antimetabolites|antimetabolites|mesh-ancestor
139644647|NCT05733286|Suvorexant|suvorexant|mesh-list
139644648|NCT05733286|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139644649|NCT05733286|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139644650|NCT05733286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644651|NCT05733286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644652|NCT05733286|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139644653|NCT05733286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644654|NCT05733286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644655|NCT05669625|Vaccines|vaccines|mesh-list
139644656|NCT05669625|Immunologic Factors|immunologic factors|mesh-ancestor
139644657|NCT05669625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644658|NCT05663411|Cinacalcet|cinacalcet|mesh-list
139644659|NCT05663411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139644660|NCT05663411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644661|NCT05663411|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139644662|NCT05663411|Hormone Antagonists|hormone antagonists|mesh-ancestor
139644663|NCT05663411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139644664|NCT05634785|Cyclophosphamide|cyclophosphamide|mesh-list
139644665|NCT05634785|Fludarabine|fludarabine|mesh-list
139644666|NCT05634785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139644667|NCT05634785|Immunologic Factors|immunologic factors|mesh-ancestor
139644668|NCT05634785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644669|NCT05634785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139644670|NCT05634785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139644671|NCT05634785|Alkylating Agents|alkylating agents|mesh-ancestor
139644672|NCT05634785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644673|NCT05634785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644674|NCT05634785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139644675|NCT05600231|Listerine|listerine|mesh-list
139644676|NCT05600231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139644677|NCT05600231|Sodium Fluoride|sodium fluoride|mesh-list
139644678|NCT05600231|Cariostatic Agents|cariostatic agents|mesh-ancestor
139644679|NCT05600231|Protective Agents|protective agents|mesh-ancestor
139644680|NCT05600231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644681|NCT05600231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139644682|NCT05510895|Cetuximab|cetuximab|mesh-list
139644683|NCT05510895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139385587|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139644684|NCT05510895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644685|NCT05489731|Osimertinib|osimertinib|mesh-list
139644686|NCT05489731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644687|NCT05489731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139644688|NCT05489731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644689|NCT05489731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644690|NCT05478291|Vitamin D|vitamin d|mesh-list
139644691|NCT05478291|Vitamins|vitamins|mesh-ancestor
139644692|NCT05478291|Micronutrients|micronutrients|mesh-ancestor
139644693|NCT05478291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644694|NCT05478291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139644695|NCT05467293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139644696|NCT05467293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139644697|NCT05463367|Acetaminophen|acetaminophen|mesh-list
139644698|NCT05463367|Naproxen|naproxen|mesh-list
139644699|NCT05463367|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139644700|NCT05463367|Oxymorphone|oxymorphone|mesh-list
139644701|NCT05463367|Morphine|morphine|mesh-list
139644702|NCT05463367|Oxycodone|oxycodone|mesh-list
139644703|NCT05463367|Tramadol|tramadol|mesh-list
139644704|NCT05463367|Hydrocodone|hydrocodone|mesh-list
139644705|NCT05463367|Codeine|codeine|mesh-list
139644706|NCT05463367|Levodopa|levodopa|mesh-list
139644707|NCT05463367|Carbidopa|carbidopa|mesh-list
139644708|NCT05463367|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139644709|NCT05463367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139644710|NCT05463367|Narcotics|narcotics|mesh-ancestor
139644711|NCT05463367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644712|NCT05463367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644713|NCT05463367|Analgesics|analgesics|mesh-ancestor
139644714|NCT05463367|Sensory System Agents|sensory system agents|mesh-ancestor
139644715|NCT05463367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644716|NCT05463367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139644717|NCT05463367|Antipyretics|antipyretics|mesh-ancestor
139644718|NCT05463367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139644719|NCT05463367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139644720|NCT05463367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139644721|NCT05463367|Gout Suppressants|gout suppressants|mesh-ancestor
139644722|NCT05463367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139644723|NCT05463367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644724|NCT05463367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644725|NCT05463367|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139644726|NCT05463367|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139644727|NCT05463367|Dopamine Agents|dopamine agents|mesh-ancestor
139644728|NCT05463367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644729|NCT05463367|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139644730|NCT05463367|Antitussive Agents|antitussive agents|mesh-ancestor
139644731|NCT05463367|Respiratory System Agents|respiratory system agents|mesh-ancestor
139644732|NCT05463367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139644733|NCT05463367|Immunologic Factors|immunologic factors|mesh-ancestor
139644734|NCT05463367|Dopamine Agonists|dopamine agonists|mesh-ancestor
139644735|NCT05463367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139644736|NCT05436535|Triamcinolone|triamcinolone|mesh-list
139644737|NCT05436535|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139644738|NCT05436535|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139644739|NCT05436535|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139644740|NCT05436535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139644741|NCT05436535|Glucocorticoids|glucocorticoids|mesh-ancestor
139644742|NCT05436535|Hormones|hormones|mesh-ancestor
139644743|NCT05436535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139644744|NCT05436535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644745|NCT05436535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139644746|NCT05436535|Immunologic Factors|immunologic factors|mesh-ancestor
139644747|NCT05436535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644748|NCT05436535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644749|NCT05401097|Azacitidine|azacitidine|mesh-list
139644750|NCT05401097|Venetoclax|venetoclax|mesh-list
139644751|NCT05401097|Ivosidenib|ivosidenib|mesh-list
139644752|NCT05401097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139644753|NCT05401097|Antimetabolites|antimetabolites|mesh-ancestor
139644754|NCT05401097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644755|NCT05401097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644756|NCT05401097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644757|NCT05382871|Vaccines|vaccines|mesh-list
139644758|NCT05382871|Immunologic Factors|immunologic factors|mesh-ancestor
139644759|NCT05382871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644760|NCT05374954|Vaccines|vaccines|mesh-list
139385588|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
139644761|NCT05374954|Immunologic Factors|immunologic factors|mesh-ancestor
139644762|NCT05374954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644763|NCT05363007|Leucovorin|leucovorin|mesh-list
139644764|NCT05363007|Irinotecan|irinotecan|mesh-list
139644765|NCT05363007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139644766|NCT05363007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139644767|NCT05363007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644768|NCT05363007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644769|NCT05363007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644770|NCT05363007|Antidotes|antidotes|mesh-ancestor
139644771|NCT05363007|Protective Agents|protective agents|mesh-ancestor
139644772|NCT05363007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644773|NCT05363007|Vitamin B Complex|vitamin b complex|mesh-ancestor
139644774|NCT05363007|Vitamins|vitamins|mesh-ancestor
139644775|NCT05363007|Micronutrients|micronutrients|mesh-ancestor
139644776|NCT05351606|Bupropion|bupropion|mesh-list
139644777|NCT05351606|Nicotine|nicotine|mesh-list
139644778|NCT05351606|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139644779|NCT05351606|Autonomic Agents|autonomic agents|mesh-ancestor
139644780|NCT05351606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644781|NCT05351606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649813|NCT00297674|Clarithromycin|clarithromycin|mesh-list
139644782|NCT05351606|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139644783|NCT05351606|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139644784|NCT05351606|Cholinergic Agents|cholinergic agents|mesh-ancestor
139644785|NCT05351606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644786|NCT05351606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644787|NCT05351606|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139644788|NCT05351606|Antidepressive Agents|antidepressive agents|mesh-ancestor
139644789|NCT05351606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139644790|NCT05351606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139644791|NCT05351606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139644792|NCT05351606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139644793|NCT05351606|Dopamine Agents|dopamine agents|mesh-ancestor
139644794|NCT05351606|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139644795|NCT05351606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139644796|NCT05351606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644797|NCT05346159|Androgens|androgens|mesh-list
139644798|NCT05346159|Hormones|hormones|mesh-ancestor
139644799|NCT05346159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139644800|NCT05346159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644801|NCT05338723|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139644802|NCT05338723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139644803|NCT05338723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139644804|NCT05338723|Antimetabolites|antimetabolites|mesh-ancestor
139644805|NCT05338723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644806|NCT05338723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139644807|NCT05338723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139644808|NCT05338723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644809|NCT05329090|Rituximab|rituximab|mesh-list
139644810|NCT05329090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139644811|NCT05329090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644812|NCT05329090|Immunologic Factors|immunologic factors|mesh-ancestor
139644813|NCT05329090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644814|NCT05329090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139644815|NCT05328154|Diphosphonates|diphosphonates|mesh-list
139644816|NCT05328154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139644817|NCT05328154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644818|NCT05324059|Pregabalin|pregabalin|mesh-list
139644819|NCT05324059|Tramadol|tramadol|mesh-list
139644820|NCT05324059|Analgesics|analgesics|mesh-ancestor
139644821|NCT05324059|Sensory System Agents|sensory system agents|mesh-ancestor
139644822|NCT05324059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644823|NCT05324059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644824|NCT05324059|Anticonvulsants|anticonvulsants|mesh-ancestor
139644825|NCT05324059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139644826|NCT05324059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139644827|NCT05324059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644828|NCT05324059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139644829|NCT05324059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139644830|NCT05324059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139644831|NCT05324059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644832|NCT05324059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139644833|NCT05324059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139644834|NCT05324059|Narcotics|narcotics|mesh-ancestor
139133087|NCT03894189|Theophylline|theophylline|mesh-list
139644835|NCT05303636|Drospirenone|drospirenone|mesh-list
139644836|NCT05303636|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139644837|NCT05303636|Hormone Antagonists|hormone antagonists|mesh-ancestor
139644838|NCT05303636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139644839|NCT05303636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644840|NCT05303636|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139644841|NCT05303636|Diuretics|diuretics|mesh-ancestor
139644842|NCT05303636|Natriuretic Agents|natriuretic agents|mesh-ancestor
139644843|NCT05226429|Vaccines|vaccines|mesh-list
139644844|NCT05226429|Immunologic Factors|immunologic factors|mesh-ancestor
139644845|NCT05226429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644846|NCT05212012|Methadone|methadone|mesh-list
139644847|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139644848|NCT05212012|Narcotics|narcotics|mesh-ancestor
139644849|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644850|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644851|NCT05212012|Analgesics|analgesics|mesh-ancestor
139644852|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
139644853|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644854|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
139644855|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
139644856|NCT05198804|Niraparib|niraparib|mesh-list
139644857|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139644858|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644859|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644860|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644861|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
139644862|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139644863|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644864|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644865|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139644866|NCT05197439|Analgesics|analgesics|mesh-ancestor
139644867|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
139644868|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644869|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139644870|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139644871|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139644872|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
139644873|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644874|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644875|NCT05169372|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139644876|NCT05169372|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139644877|NCT05169372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644878|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139644879|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139644880|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139644881|NCT05169060|Analgesics|analgesics|mesh-ancestor
139644882|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
139644883|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644884|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644885|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139644886|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139644887|NCT05153408|Carboplatin|carboplatin|mesh-list
139644888|NCT05153408|Pemetrexed|pemetrexed|mesh-list
139644889|NCT05153408|Osimertinib|osimertinib|mesh-list
139644890|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644891|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644892|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644893|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139644894|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139644895|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139644896|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
139644897|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138714437|NCT02940002|Betamethasone|betamethasone|mesh-list
139644898|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644899|NCT05100628|Doxorubicin|doxorubicin|mesh-list
139644900|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139644901|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644902|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139644903|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139644904|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644905|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644906|NCT05091619|Vaccines|vaccines|mesh-list
139644907|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
139133163|NCT01159587|Factor VIII|factor viii|mesh-list
139385589|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644908|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644909|NCT05089370|Nivolumab|nivolumab|mesh-list
139644910|NCT05089370|Decitabine|decitabine|mesh-list
139644911|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139644912|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644913|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139644914|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644915|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139644916|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
139644917|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644918|NCT05084911|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139644919|NCT05084911|Antiviral Agents|antiviral agents|mesh-ancestor
139644920|NCT05084911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139644921|NCT05081388|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
139644922|NCT05081388|Antiviral Agents|antiviral agents|mesh-ancestor
139644923|NCT05081388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139644924|NCT05039177|Cetuximab|cetuximab|mesh-list
139644925|NCT05039177|Palbociclib|palbociclib|mesh-list
139644926|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139644927|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644928|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139644929|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139644930|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644931|NCT05025800|Rituximab|rituximab|mesh-list
139644932|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139644933|NCT05025800|Lenalidomide|lenalidomide|mesh-list
139644934|NCT05025800|Antibodies|antibodies|mesh-list
139644935|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
139644936|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139644937|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
139644938|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644939|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644940|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139644941|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139644942|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139644943|NCT05025800|Growth Substances|growth substances|mesh-ancestor
139644944|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
139644945|NCT05017246|Lidocaine|lidocaine|mesh-list
139644946|NCT05017246|Morphine|morphine|mesh-list
139644947|NCT05017246|Bupivacaine|bupivacaine|mesh-list
139644948|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
139644949|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
139644950|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139644951|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644952|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
139644953|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644954|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139644955|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139644956|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139644957|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139644958|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644959|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139644960|NCT05017246|Narcotics|narcotics|mesh-ancestor
139644961|NCT05017246|Analgesics|analgesics|mesh-ancestor
139644962|NCT05007041|Vaccines|vaccines|mesh-list
139644963|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
139644964|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644965|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
139644966|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139644967|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644968|NCT04883255|Dronabinol|dronabinol|mesh-list
139644969|NCT04883255|Cannabidiol|cannabidiol|mesh-list
139644970|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
139644971|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
139644972|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644973|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139644974|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139644975|NCT04883255|Analgesics|analgesics|mesh-ancestor
139644976|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
139644977|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139644978|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139644979|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139644980|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139644981|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139644982|NCT04883255|Hormones|hormones|mesh-ancestor
139644983|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139644984|NCT04880850|Insulin|insulin|mesh-list
139644985|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139644986|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
139644987|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
139644988|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139644989|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644990|NCT04868838|Daratumumab|daratumumab|mesh-list
139644991|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139644992|NCT04863638|Vaccines|vaccines|mesh-list
139644993|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
139644994|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644995|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
139644996|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
139644997|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139644998|NCT04790786|Sotrovimab|sotrovimab|mesh-list
139644999|NCT04790786|Bamlanivimab|bamlanivimab|mesh-list
139645000|NCT04790786|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
139645001|NCT04790786|Antiviral Agents|antiviral agents|mesh-ancestor
139645002|NCT04790786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645003|NCT04786210|Triamcinolone|triamcinolone|mesh-list
139645004|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139645005|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139645006|NCT04786210|Fluorouracil|fluorouracil|mesh-list
139645007|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139645008|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
139645009|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645010|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139645011|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645012|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139645013|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
139645014|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645015|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139645016|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
139645017|NCT04786210|Hormones|hormones|mesh-ancestor
139645018|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139645019|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645020|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
139645021|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139645022|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
139645023|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139645024|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714480|NCT04585230|Mineral Oil|mineral oil|mesh-list
139645025|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139645026|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139645027|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139645028|NCT04724252|Gabapentin|gabapentin|mesh-list
139645029|NCT04724252|Analgesics|analgesics|mesh-ancestor
139645030|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
139645031|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645032|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645033|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
139645034|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139645035|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139645036|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139645037|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139645038|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139645039|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139645040|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139645041|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645042|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
139645043|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
139645044|NCT04670068|Fludarabine|fludarabine|mesh-list
139645045|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139645046|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
139645047|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645048|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139645049|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139645050|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
139645051|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645052|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645053|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139645054|NCT04618289|Vitamin D|vitamin d|mesh-list
139645055|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
139645056|NCT04618289|Vitamins|vitamins|mesh-ancestor
139645057|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
139645058|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645059|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139645060|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139645061|NCT04617795|Insulin|insulin|mesh-list
139645062|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139645063|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645064|NCT04588441|Adenosine|adenosine|mesh-list
139645065|NCT04588441|Analgesics|analgesics|mesh-ancestor
139645066|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
139645067|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645068|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645069|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139645070|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
139645071|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139645072|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
139645073|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
139645074|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139645075|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645076|NCT04578015|Metronidazole|metronidazole|mesh-list
139645077|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645078|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139645079|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139645080|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139645081|NCT04510207|Vaccines|vaccines|mesh-list
139645082|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
139645083|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645084|NCT04445519|Latanoprost|latanoprost|mesh-list
139645085|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139645086|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139645087|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139645088|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
139645089|NCT04420585|Coagulants|coagulants|mesh-ancestor
139645090|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139645091|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
139645092|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645093|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
139645094|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139645095|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139645096|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645097|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139645098|NCT04268303|Analgesics|analgesics|mesh-ancestor
139645099|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
139645100|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645101|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139645102|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139645103|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139645104|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
139645105|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139645106|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645107|NCT04267497|Amphotericin B|amphotericin b|mesh-list
139645108|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139645109|NCT04267497|Amebicides|amebicides|mesh-ancestor
139645110|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139645111|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139645112|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645113|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139645114|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
139645115|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
139645116|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645117|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645118|NCT04266730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139645119|NCT04266730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645120|NCT04263831|Aldesleukin|aldesleukin|mesh-list
139645121|NCT04263831|Interleukin-2|interleukin-2|mesh-list
139645122|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645123|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139645124|NCT04263831|Analgesics|analgesics|mesh-ancestor
139645125|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
139645126|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645127|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645128|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139645129|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139645130|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
139645131|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645132|NCT04249687|Botulinum Toxins|botulinum toxins|mesh-list
139645133|NCT04249687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139645134|NCT04249687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139645135|NCT04249687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645136|NCT04249687|Cholinergic Agents|cholinergic agents|mesh-ancestor
139645137|NCT04249687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139645138|NCT04249687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645139|NCT04249583|Botulinum Toxins|botulinum toxins|mesh-list
139645140|NCT04249583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139645141|NCT04249583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139645142|NCT04249583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645143|NCT04249583|Cholinergic Agents|cholinergic agents|mesh-ancestor
139645144|NCT04249583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139645145|NCT04249583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645146|NCT04225260|Botulinum Toxins|botulinum toxins|mesh-list
139645147|NCT04225260|Neurotransmitter Agents|neurotransmitter agents|mesh-list
139645148|NCT04225260|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139645149|NCT04225260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139645150|NCT04225260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645151|NCT04225260|Cholinergic Agents|cholinergic agents|mesh-ancestor
139645152|NCT04225260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645154|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645155|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645156|NCT04205227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139645157|NCT04205227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645158|NCT04159155|Paclitaxel|paclitaxel|mesh-list
139645159|NCT04159155|Carboplatin|carboplatin|mesh-list
139645160|NCT04159155|Niraparib|niraparib|mesh-list
139645161|NCT04159155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139645162|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645163|NCT04159155|Tubulin Modulators|tubulin modulators|mesh-ancestor
139645164|NCT04159155|Antimitotic Agents|antimitotic agents|mesh-ancestor
139645165|NCT04159155|Mitosis Modulators|mitosis modulators|mesh-ancestor
139645166|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645167|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139645168|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645169|NCT04117074|Bupivacaine|bupivacaine|mesh-list
139645170|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
139645171|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
139645172|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139645173|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645174|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
139645175|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645176|NCT04094675|Sirolimus|sirolimus|mesh-list
139645177|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139645178|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645179|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139645180|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645181|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
139645182|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139645183|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
139645184|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645185|NCT04092452|PF-06700841|pf-06700841|mesh-list
139645186|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139645187|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645188|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645189|NCT04046614|Nivolumab|nivolumab|mesh-list
139645190|NCT04046614|Nintedanib|nintedanib|mesh-list
139645191|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645192|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645193|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139645194|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645195|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139645196|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645197|NCT04029116|Fluconazole|fluconazole|mesh-list
139645198|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
139645199|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
139645200|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645201|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139645202|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139645203|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645204|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645205|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139645206|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
139645207|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139645208|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645209|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139645210|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139645211|NCT04025489|Vitamin D|vitamin d|mesh-list
139645212|NCT04025489|Vitamins|vitamins|mesh-ancestor
139645213|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
139645214|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645215|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139645216|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
139645217|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
139645218|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139645219|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
139645220|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139645221|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139645222|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645223|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139645224|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645225|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645226|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139645227|NCT03926026|Fluticasone|fluticasone|mesh-list
139645228|NCT03926026|Xhance|xhance|mesh-list
139645229|NCT03926026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714792|NCT00568347|Xhance|xhance|mesh-list
139645230|NCT03926026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139645231|NCT03926026|Autonomic Agents|autonomic agents|mesh-ancestor
139645232|NCT03926026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645233|NCT03926026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645234|NCT03926026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139645235|NCT03926026|Respiratory System Agents|respiratory system agents|mesh-ancestor
139645236|NCT03926026|Dermatologic Agents|dermatologic agents|mesh-ancestor
139645237|NCT03926026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139645238|NCT03917082|Tamoxifen|tamoxifen|mesh-list
139645239|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139645240|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645241|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139645242|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
139645243|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139645244|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645245|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139645246|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645247|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139645248|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139645249|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139645250|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139645251|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645252|NCT03739996|Cabotegravir|cabotegravir|mesh-list
139645253|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139645254|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139645255|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139645256|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645257|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645258|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139645259|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139645260|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
139645261|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645262|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139645263|NCT03734029|Paclitaxel|paclitaxel|mesh-list
139645264|NCT03734029|Camptothecin|camptothecin|mesh-list
139645265|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139645266|NCT03734029|Gemcitabine|gemcitabine|mesh-list
139645267|NCT03734029|Capecitabine|capecitabine|mesh-list
139645268|NCT03734029|Trastuzumab|trastuzumab|mesh-list
139645269|NCT03734029|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139645270|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
139645271|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139645272|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645273|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
139645274|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
139645275|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
139645276|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645277|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139385590|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139645278|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
139133536|NCT01265199|Cytarabine|cytarabine|mesh-list
139385591|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
139645279|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645280|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
139645281|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645282|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139645283|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139645284|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645285|NCT03705962|Tobramycin|tobramycin|mesh-list
139645286|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139645287|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645288|NCT03693183|Ketorolac|ketorolac|mesh-list
139645289|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139645290|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139645291|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139645292|NCT03693183|Analgesics|analgesics|mesh-ancestor
139645293|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
139645294|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645295|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645296|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139645297|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139645298|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139645299|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645300|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645301|NCT03657797|Latanoprost|latanoprost|mesh-list
139645302|NCT03657797|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139645303|NCT03657797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139645304|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
139645305|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645306|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645307|NCT03546361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139645308|NCT03546361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645309|NCT03473574|Gemcitabine|gemcitabine|mesh-list
139645310|NCT03473574|Durvalumab|durvalumab|mesh-list
139645311|NCT03473574|Tremelimumab|tremelimumab|mesh-list
139645312|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645313|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139645314|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
139645315|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645316|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645317|NCT03472040|Berotralstat|berotralstat|mesh-list
139645318|NCT03472040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139645319|NCT03472040|Protease Inhibitors|protease inhibitors|mesh-ancestor
139645320|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645321|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645322|NCT03428126|Durvalumab|durvalumab|mesh-list
139645323|NCT03428126|Trametinib|trametinib|mesh-list
139645324|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645325|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645326|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139645327|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645328|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645329|NCT03416530|TIC10 compound|tic10 compound|mesh-list
139645330|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645331|NCT03345810|Paclitaxel|paclitaxel|mesh-list
139645332|NCT03345810|Vinorelbine|vinorelbine|mesh-list
139645333|NCT03345810|Carboplatin|carboplatin|mesh-list
139645334|NCT03345810|Gemcitabine|gemcitabine|mesh-list
139645335|NCT03345810|Durvalumab|durvalumab|mesh-list
138715065|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139645336|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139645337|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645338|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
139645339|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
139645340|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
139645341|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645342|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139645343|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
139645344|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645345|NCT03344965|Olaparib|olaparib|mesh-list
139645346|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139645347|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645348|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645349|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645350|NCT03323385|Meloxicam|meloxicam|mesh-list
139645351|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139645352|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139645353|NCT03323385|Analgesics|analgesics|mesh-ancestor
139645354|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
139645355|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645356|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645357|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139645358|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139645359|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139645360|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139645361|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645362|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645363|NCT03295396|TIC10 compound|tic10 compound|mesh-list
139645364|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645365|NCT03215719|Cisplatin|cisplatin|mesh-list
139645366|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645367|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
139645368|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645369|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645370|NCT03197467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139645371|NCT03197467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645372|NCT03132636|Cemiplimab|cemiplimab|mesh-list
139645373|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645374|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645375|NCT03047993|Azacitidine|azacitidine|mesh-list
139645376|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139645377|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
139645378|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645379|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645380|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645381|NCT03044587|Leucovorin|leucovorin|mesh-list
139645382|NCT03044587|Gemcitabine|gemcitabine|mesh-list
139645383|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645384|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139645385|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
139645386|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645387|NCT03044587|Antidotes|antidotes|mesh-ancestor
139645388|NCT03044587|Protective Agents|protective agents|mesh-ancestor
139645389|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645390|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
139645391|NCT03044587|Vitamins|vitamins|mesh-ancestor
139645392|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
139645393|NCT02947620|Metformin|metformin|mesh-list
139645394|NCT02947620|Atorvastatin|atorvastatin|mesh-list
139645395|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139645396|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645397|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139645398|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139645399|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
138715139|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139645400|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645401|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139645402|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139645403|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645404|NCT02869789|Nivolumab|nivolumab|mesh-list
139645405|NCT02869789|Ipilimumab|ipilimumab|mesh-list
139645406|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645407|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645408|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139645409|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645410|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
139645411|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139645412|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
139645413|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139645414|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645415|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139645416|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139645417|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139645418|NCT02671890|Gemcitabine|gemcitabine|mesh-list
139645419|NCT02671890|Disulfiram|disulfiram|mesh-list
139645420|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139645421|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
139645422|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645423|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645424|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139645425|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139645426|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133682|NCT03110432|Niacin|niacin|mesh-list
139645427|NCT02661282|Temozolomide|temozolomide|mesh-list
139645428|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139645429|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
139645430|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645431|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645432|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139645433|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139645434|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645435|NCT02634333|Aflibercept|aflibercept|mesh-list
139645436|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
139645437|NCT02634333|Mitogens|mitogens|mesh-list
139645438|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139645439|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139645440|NCT02634333|Growth Substances|growth substances|mesh-ancestor
139645441|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645442|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
139645443|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645444|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
139645445|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645446|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
139645447|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139645448|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645449|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645450|NCT02450331|Atezolizumab|atezolizumab|mesh-list
139645451|NCT02450331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139645452|NCT02450331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645453|NCT02450331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645454|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645455|NCT02391025|Citric Acid|citric acid|mesh-list
139645456|NCT02391025|Sodium Citrate|sodium citrate|mesh-list
139645457|NCT02391025|Anticoagulants|anticoagulants|mesh-ancestor
139645458|NCT02391025|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139645459|NCT02391025|Chelating Agents|chelating agents|mesh-ancestor
139645460|NCT02391025|Sequestering Agents|sequestering agents|mesh-ancestor
139645461|NCT02391025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645462|NCT02335944|Nazartinib|nazartinib|mesh-list
139645463|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645464|NCT02326974|Pertuzumab|pertuzumab|mesh-list
139645465|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645466|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645467|NCT02299518|Cytarabine|cytarabine|mesh-list
139645468|NCT02299518|Etoposide|etoposide|mesh-list
139645469|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
139645470|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
139645471|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139645472|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645473|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139645474|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139645475|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645476|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645477|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139645478|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
139645479|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
139645480|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645481|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139645482|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
139645483|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645484|NCT02299518|Analgesics|analgesics|mesh-ancestor
139645485|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
139645486|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645487|NCT02214550|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
139645488|NCT02214550|Norinyl|norinyl|mesh-list
139645489|NCT02214550|Mestranol|mestranol|mesh-list
139645490|NCT02214550|Norethindrone|norethindrone|mesh-list
139645491|NCT02214550|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139645492|NCT02214550|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139645493|NCT02214550|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139645494|NCT02214550|Contraceptive Agents|contraceptive agents|mesh-ancestor
139645495|NCT02214550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139645496|NCT02214550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645497|NCT02214550|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139645498|NCT02214550|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139385592|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385593|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139645499|NCT02214550|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
139645500|NCT02214550|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139645501|NCT02214550|Estrogens|estrogens|mesh-ancestor
139645502|NCT02214550|Hormones|hormones|mesh-ancestor
139645503|NCT02214550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139645504|NCT02200445|Aldesleukin|aldesleukin|mesh-list
139645505|NCT02200445|Interleukin-2|interleukin-2|mesh-list
139645506|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645507|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139645508|NCT02200445|Analgesics|analgesics|mesh-ancestor
139645509|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
138715186|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139645510|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645511|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645512|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139645513|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139645514|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
139645515|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645516|NCT02120352|Rilpivirine|rilpivirine|mesh-list
139645517|NCT02120352|Cabotegravir|cabotegravir|mesh-list
139645518|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139645519|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139645520|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645521|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645522|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
139645523|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645524|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139645525|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139645526|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139645527|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139645528|NCT02058693|Amphetamine|amphetamine|mesh-list
139645529|NCT02058693|Adderall|adderall|mesh-list
139645530|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139645531|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645532|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
139645533|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
139645534|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645535|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
139645536|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139645537|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645538|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
139645539|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139645540|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139645541|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139645542|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139645543|NCT02047513|Paclitaxel|paclitaxel|mesh-list
139645544|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139645545|NCT02047513|Gemcitabine|gemcitabine|mesh-list
139645546|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139645547|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645548|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
139645549|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
139645550|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
139645551|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645552|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139645553|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
139645554|NCT01991873|Leucovorin|leucovorin|mesh-list
139645555|NCT01991873|Folic Acid|folic acid|mesh-list
139645556|NCT01991873|Fluorouracil|fluorouracil|mesh-list
139645557|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
139645558|NCT01991873|Panitumumab|panitumumab|mesh-list
139645559|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
139645560|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
139645561|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645562|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139645563|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645564|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139645565|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
139645566|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645567|NCT01991873|Antidotes|antidotes|mesh-ancestor
139645568|NCT01991873|Protective Agents|protective agents|mesh-ancestor
139645569|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
139645570|NCT01991873|Vitamins|vitamins|mesh-ancestor
139645571|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
139645572|NCT01991873|Hematinics|hematinics|mesh-ancestor
139645573|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645574|NCT01843556|Donepezil|donepezil|mesh-list
139385594|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
139645575|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139645576|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645577|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645578|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
139645579|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139645580|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645581|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
139645582|NCT01618136|Paclitaxel|paclitaxel|mesh-list
139645583|NCT01618136|Carboplatin|carboplatin|mesh-list
139645584|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139645585|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645586|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
139645587|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
139645588|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
139645589|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645590|NCT01539031|Donepezil|donepezil|mesh-list
139645591|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139645592|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645593|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645594|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
139645595|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139645596|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645597|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
139645598|NCT01328171|Folic Acid|folic acid|mesh-list
139645599|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
139645600|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
139645601|NCT01328171|Irinotecan|irinotecan|mesh-list
139645602|NCT01328171|Panitumumab|panitumumab|mesh-list
139645603|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645604|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139645605|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139645606|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645607|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645608|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645609|NCT01328171|Hematinics|hematinics|mesh-ancestor
139645610|NCT01328171|Vitamins|vitamins|mesh-ancestor
139645611|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
139645612|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645613|NCT01288963|Aldesleukin|aldesleukin|mesh-list
139645614|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645615|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139645616|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139645617|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
139645618|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645619|NCT01269190|Proflavine|proflavine|mesh-list
139645620|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139645621|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645622|NCT01248715|Oseltamivir|oseltamivir|mesh-list
139645623|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
139645624|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645625|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645626|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645627|NCT00963040|Oxytocin|oxytocin|mesh-list
139645628|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
139645629|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139645630|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645631|NCT00941109|Decitabine|decitabine|mesh-list
139645632|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139645633|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
139645634|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645635|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645636|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645637|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
139645638|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139645639|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139645640|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139645641|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139645642|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645643|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
139645644|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715262|NCT04596839|Remdesivir|remdesivir|mesh-list
139645645|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645646|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139645647|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645648|NCT00812214|Eszopiclone|eszopiclone|mesh-list
139645649|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139645650|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139645651|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645652|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
139645653|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
139645654|NCT00444613|Vitamins|vitamins|mesh-ancestor
139645655|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
139645656|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645657|NCT00217425|Prednisone|prednisone|mesh-list
139645658|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
139645659|NCT00217425|Bevacizumab|bevacizumab|mesh-list
139645660|NCT00217425|Doxorubicin|doxorubicin|mesh-list
139645661|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139645662|NCT00217425|Vincristine|vincristine|mesh-list
139645663|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139645664|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
139645665|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645666|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139645667|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139645668|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
139645669|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645670|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645671|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139645672|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645673|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139645674|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139645675|NCT00217425|Growth Substances|growth substances|mesh-ancestor
139645676|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
139645677|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139645678|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139645679|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139645680|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645681|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139645682|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
139645683|NCT00217425|Hormones|hormones|mesh-ancestor
139645684|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139645685|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139645686|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139645687|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
139645688|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
139645689|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
139645690|NCT00209599|Fospropofol|fospropofol|mesh-list
139645691|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139645692|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139645693|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645694|NCT00060567|Irinotecan|irinotecan|mesh-list
139645695|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
139645696|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139645697|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139645698|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645699|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645700|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645701|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139645702|NCT00049348|Gemcitabine|gemcitabine|mesh-list
139645703|NCT00049348|Fluorouracil|fluorouracil|mesh-list
139645704|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
139645705|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645706|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139645707|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
139645708|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645709|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139645710|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
139645711|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645712|NCT00049348|Hematinics|hematinics|mesh-ancestor
139645713|NCT00004125|Tamoxifen|tamoxifen|mesh-list
139645714|NCT00004125|Paclitaxel|paclitaxel|mesh-list
139645715|NCT00004125|Docetaxel|docetaxel|mesh-list
139645716|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
139645717|NCT00004125|Doxorubicin|doxorubicin|mesh-list
139645718|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139645719|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139645720|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645721|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
139645722|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
139645723|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
139645724|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133979|NCT05363384|Protease Inhibitors|protease inhibitors|mesh-ancestor
139385595|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139645725|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139645726|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
139645727|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645728|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139645729|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139645730|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
139645731|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139645732|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139645733|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139645734|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139645735|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645736|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139645737|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
139645738|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139645739|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139645740|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139645741|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139645742|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139645743|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139645744|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139645745|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645746|NCT03452865|Esomeprazole|esomeprazole|mesh-list
139645747|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139645748|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139645749|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139645750|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645751|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645752|NCT03446001|Methylene Blue|methylene blue|mesh-list
139645753|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645754|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645755|NCT03345095|Temozolomide|temozolomide|mesh-list
139645756|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139645757|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
139645758|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645759|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645760|NCT03208231|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139645761|NCT03208231|Antiviral Agents|antiviral agents|mesh-ancestor
139645762|NCT03208231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645763|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139645764|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139645765|NCT03102242|Atezolizumab|atezolizumab|mesh-list
139645766|NCT03102242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139645767|NCT03102242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645768|NCT03102242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645769|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645770|NCT03090776|Ketamine|ketamine|mesh-list
139645771|NCT03090776|Analgesics|analgesics|mesh-ancestor
139645772|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
139645773|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645774|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645775|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139645776|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139645777|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
139645778|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
139645779|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139645780|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139645781|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139645782|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139645783|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645784|NCT02994784|Melphalan|melphalan|mesh-list
139645785|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139645786|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
139645787|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645788|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645789|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139645790|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139645791|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
139645792|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645793|NCT02966847|Anesthetics|anesthetics|mesh-list
139645794|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134057|NCT01583283|Hormones|hormones|mesh-ancestor
139385596|NCT05575739|Antioxidants|antioxidants|mesh-list
139645795|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645796|NCT02884440|Ropivacaine|ropivacaine|mesh-list
139645797|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
139645798|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139645799|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645800|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
139645801|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
139645802|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645803|NCT02851303|Morphine|morphine|mesh-list
139645804|NCT02851303|Methadone|methadone|mesh-list
139645805|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139645806|NCT02851303|Narcotics|narcotics|mesh-ancestor
139645807|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139645808|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645809|NCT02851303|Analgesics|analgesics|mesh-ancestor
139645810|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
139645811|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645812|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
139645813|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
139645814|NCT02775500|Apremilast|apremilast|mesh-list
139645815|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139645816|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139645817|NCT02775500|Analgesics|analgesics|mesh-ancestor
139645818|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
139645819|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645820|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645821|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139645822|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139645823|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139645824|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139645825|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645826|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645827|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
139645828|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139645829|NCT02549170|Antibodies|antibodies|mesh-list
139645830|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
139645831|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
139645832|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139645833|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
139645834|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645835|NCT02384122|Octreotide|octreotide|mesh-list
139645836|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139645837|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139645838|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645839|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139645840|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139645841|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645842|NCT02363335|Incretins|incretins|mesh-ancestor
139645843|NCT02363335|Hormones|hormones|mesh-ancestor
139645844|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139645845|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139645846|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
139645847|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645848|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645849|NCT02103361|Ustekinumab|ustekinumab|mesh-list
139645850|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
139645851|NCT01918397|Levofloxacin|levofloxacin|mesh-list
139645852|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139645853|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645854|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139645855|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139645856|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139645857|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645858|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645859|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645860|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139645861|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139645862|NCT01883024|Insulin|insulin|mesh-list
139645863|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139645864|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645865|NCT01611116|Sirolimus|sirolimus|mesh-list
139645866|NCT01611116|Temsirolimus|temsirolimus|mesh-list
139645867|NCT01611116|MTOR Inhibitors|mtor inhibitors|mesh-list
139645868|NCT01611116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139645869|NCT01611116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385597|NCT05575739|Superoxide Dismutase|superoxide dismutase|mesh-list
139645870|NCT01611116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645871|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139645872|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
139645873|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645874|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645875|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139645876|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645877|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139645878|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
139645879|NCT01576315|Itraconazole|itraconazole|mesh-list
139645880|NCT01576315|Voriconazole|voriconazole|mesh-list
139645881|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
139645882|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645883|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139645884|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139645885|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645886|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645887|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139645888|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
139645889|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139645890|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645891|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139645892|NCT01388387|Tacrolimus|tacrolimus|mesh-list
139645893|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139645894|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
139645895|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645896|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139645897|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645898|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645899|NCT01039090|Dopamine|dopamine|mesh-list
139645900|NCT01039090|Apomorphine|apomorphine|mesh-list
139645901|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
139645902|NCT01039090|Emetics|emetics|mesh-ancestor
139645903|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645904|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
139645905|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645906|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139645907|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
139645908|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139645909|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645910|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139645911|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
139645912|NCT01039090|Protective Agents|protective agents|mesh-ancestor
139645913|NCT00819637|Albuterol|albuterol|mesh-list
139645914|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
139645915|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139645916|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
139645917|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645918|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645919|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139645920|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
139645921|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139645922|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139645923|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139645924|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
139645925|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139645926|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645927|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
139645928|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139645929|NCT00593060|Sirolimus|sirolimus|mesh-list
139645930|NCT00593060|Cetuximab|cetuximab|mesh-list
139645931|NCT00593060|Temsirolimus|temsirolimus|mesh-list
139645932|NCT00593060|MTOR Inhibitors|mtor inhibitors|mesh-list
139645933|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139645934|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645935|NCT00593060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139645936|NCT00593060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645937|NCT00593060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645938|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139645939|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
139645940|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645941|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139645942|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715381|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
139385598|NCT05575739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645943|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139645944|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
139645945|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
139645946|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645947|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139645948|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645949|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645950|NCT01332357|Fluticasone|fluticasone|mesh-list
139645951|NCT01332357|Xhance|xhance|mesh-list
139645952|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139645953|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139645954|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139645955|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139645956|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
139645957|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139645958|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645959|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139645960|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
139645961|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
139645962|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139645963|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139645964|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139645965|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139645966|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
139645967|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139645968|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645969|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
139645970|NCT01332357|Hormones|hormones|mesh-ancestor
139645971|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139645972|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
139645973|NCT04914936|Rifampin|rifampin|mesh-list
139645974|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
139645975|NCT04914936|Omeprazole|omeprazole|mesh-list
139645976|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
139645977|NCT04914936|Calcium|calcium|mesh-list
139645978|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139645979|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139645980|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139645981|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139645982|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139645983|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139645984|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139645985|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139645986|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
139645987|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139645988|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139645989|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
139645990|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139645991|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139645992|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139645993|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139645994|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139645995|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139645996|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139645997|NCT04914936|Antacids|antacids|mesh-ancestor
139645998|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139645999|NCT03054948|SMOFlipid|smoflipid|mesh-list
139646000|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139646001|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139646002|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139646003|NCT00986921|Mifepristone|mifepristone|mesh-list
139646004|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139646005|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
139646006|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139646007|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646008|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139646009|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139646010|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139646011|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
139646012|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139646013|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139646014|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
139646015|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139646016|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
139646017|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139646018|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139646019|NCT01383759|Dexamethasone|dexamethasone|mesh-list
139646020|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
139646021|NCT01383759|Bortezomib|bortezomib|mesh-list
139646022|NCT01383759|BB 1101|bb 1101|mesh-list
139646023|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139646024|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
139646025|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
139646026|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646027|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646028|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139646029|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
139646030|NCT01383759|Hormones|hormones|mesh-ancestor
139646031|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139646032|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139646033|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646034|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
139646035|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646036|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646037|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
139646038|NCT01384539|Vitamin D|vitamin d|mesh-list
139646039|NCT01384539|Calcitriol|calcitriol|mesh-list
139646040|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139646041|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646042|NCT01384539|Vitamins|vitamins|mesh-ancestor
139646043|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
139646044|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139646045|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139646046|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139646047|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646048|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139646049|NCT04902222|Morphine|morphine|mesh-list
139646050|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139646051|NCT04902222|Narcotics|narcotics|mesh-ancestor
139646052|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139646053|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646054|NCT04902222|Analgesics|analgesics|mesh-ancestor
139646055|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
139646056|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646057|NCT04904406|Lamivudine|lamivudine|mesh-list
139646058|NCT04904406|Abacavir|abacavir|mesh-list
139646059|NCT04904406|Dolutegravir|dolutegravir|mesh-list
139646060|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139646061|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139646062|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646063|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646064|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
139646065|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139646066|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139646067|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139646068|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139646069|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139646070|NCT00985751|Vaccines|vaccines|mesh-list
139646071|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139646072|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
139646073|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646074|NCT02429557|Midodrine|midodrine|mesh-list
139646075|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
139646076|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
139646077|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646078|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646079|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139646080|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139646081|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139646082|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139646083|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
139646084|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646085|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646086|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139646087|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139646088|NCT04884516|Vitamin A|vitamin a|mesh-list
139646089|NCT04884516|Vitamins|vitamins|mesh-ancestor
139646090|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
139646091|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646092|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
139646093|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
139646094|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139646095|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139646096|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139646097|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646098|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646099|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139646100|NCT04883736|Tretinoin|tretinoin|mesh-list
139646101|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646102|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
139646103|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
139646104|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
139646105|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646106|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646107|NCT02312557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139646108|NCT02312557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646109|NCT01387815|Adalimumab|adalimumab|mesh-list
139646110|NCT01387815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139646111|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139646112|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139646113|NCT04883034|Analgesics|analgesics|mesh-list
139646114|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
139646115|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646116|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646117|NCT01596504|Metformin|metformin|mesh-list
139646118|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
139646119|NCT01596504|Liraglutide|liraglutide|mesh-list
139646120|NCT01596504|Lixisenatide|lixisenatide|mesh-list
139646121|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139646122|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646123|NCT01596504|Incretins|incretins|mesh-ancestor
139646124|NCT01596504|Hormones|hormones|mesh-ancestor
139646125|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139646126|NCT02394769|Aspirin|aspirin|mesh-list
139646127|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139646128|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139646129|NCT02394769|Analgesics|analgesics|mesh-ancestor
139646130|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
139646131|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646132|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646133|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139646134|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139646135|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139646136|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139646137|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646138|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139646139|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139646140|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646141|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
139646142|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139646143|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139646144|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646145|NCT01334229|Incretins|incretins|mesh-ancestor
139646146|NCT01334229|Hormones|hormones|mesh-ancestor
139646147|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139646148|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139646149|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
139646150|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646151|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646152|NCT01390077|Nitisinone|nitisinone|mesh-list
139646153|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646154|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646155|NCT02292979|Doxorubicin|doxorubicin|mesh-list
139646156|NCT02292979|Bleomycin|bleomycin|mesh-list
139646157|NCT02292979|Dacarbazine|dacarbazine|mesh-list
139646158|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139646159|NCT02292979|Vinblastine|vinblastine|mesh-list
139646160|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139646161|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646162|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139646163|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139385599|NCT05575739|Protective Agents|protective agents|mesh-ancestor
139385600|NCT05575739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385601|NCT05575739|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139646164|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646165|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646166|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139646167|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
139646168|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646169|NCT02292979|Immunotoxins|immunotoxins|mesh-ancestor
139646170|NCT02292979|Immunoconjugates|immunoconjugates|mesh-ancestor
139646171|NCT02292979|Immunologic Factors|immunologic factors|mesh-ancestor
139646172|NCT02292979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646173|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139646174|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
139646175|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
139646176|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
139646177|NCT02394535|Paclitaxel|paclitaxel|mesh-list
139646178|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139646179|NCT02394535|Capecitabine|capecitabine|mesh-list
138715553|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
139646180|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139646181|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646182|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
139646183|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
139646184|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
139646185|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646186|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139646187|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
139646188|NCT02285959|Bevacizumab|bevacizumab|mesh-list
139646189|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646190|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646191|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139646192|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139646193|NCT02285959|Growth Substances|growth substances|mesh-ancestor
139646194|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646195|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
139646196|NCT01404429|Methotrexate|methotrexate|mesh-list
139646197|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139646198|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
139646199|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139646200|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646201|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139646202|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
139646203|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646204|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646205|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
139646206|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646207|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139646208|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139646209|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
139646210|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139646211|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139646212|NCT03051906|Cetuximab|cetuximab|mesh-list
139646213|NCT03051906|Durvalumab|durvalumab|mesh-list
139646214|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646215|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646216|NCT01390233|Dinoprostone|dinoprostone|mesh-list
139646217|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
139646218|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139646219|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646220|NCT03051360|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139646221|NCT03051360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139646222|NCT03051360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139646223|NCT03051360|Antimetabolites|antimetabolites|mesh-ancestor
139646224|NCT03051360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646225|NCT03051360|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139646226|NCT03051360|Protease Inhibitors|protease inhibitors|mesh-ancestor
139646227|NCT03051360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646228|NCT03051360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139646229|NCT05026567|Midazolam|midazolam|mesh-list
139646230|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139646231|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139646232|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139646233|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646234|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139646235|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139646236|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139646237|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139646238|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
139646239|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
139646240|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
139646241|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
139646242|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646243|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646244|NCT01391013|Ritonavir|ritonavir|mesh-list
139646245|NCT01391013|Darunavir|darunavir|mesh-list
139646246|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139646247|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139646248|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139646249|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
139646250|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646251|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646252|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139646253|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139646254|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
139646255|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139646256|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139646257|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139646258|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139646259|NCT01891747|Bevacizumab|bevacizumab|mesh-list
139646260|NCT01891747|Temozolomide|temozolomide|mesh-list
139646261|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646262|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646263|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139646264|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139646265|NCT01891747|Growth Substances|growth substances|mesh-ancestor
139646266|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646267|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
139646268|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139646269|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
139646270|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646271|NCT04899570|Prednisone|prednisone|mesh-list
139646272|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
139646273|NCT04899570|Rituximab|rituximab|mesh-list
139646274|NCT04899570|Epirubicin|epirubicin|mesh-list
139646275|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
139646276|NCT04899570|Vindesine|vindesine|mesh-list
139646277|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139646278|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
139646279|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646280|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139646281|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139646282|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
139646283|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646284|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646285|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139646286|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646287|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139646288|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
139646289|NCT04899570|Hormones|hormones|mesh-ancestor
139646290|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139646291|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139646292|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139646293|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139646294|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139646295|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646296|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139646297|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139646298|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
139646299|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
139646300|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
139646301|NCT02274415|Vaccines|vaccines|mesh-list
139646302|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139646303|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
139646304|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646305|NCT03049878|Acetaminophen|acetaminophen|mesh-list
139646306|NCT03049878|Codeine|codeine|mesh-list
139646307|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139646308|NCT03049878|Analgesics|analgesics|mesh-ancestor
139646309|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
139646310|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646311|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646312|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
139385602|NCT05035862|Interferons|interferons|mesh-list
139385603|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
139646313|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139646314|NCT03049878|Narcotics|narcotics|mesh-ancestor
139646315|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139646316|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
139646317|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
139646318|NCT01391325|Allopurinol|allopurinol|mesh-list
139646319|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
139646320|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646321|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646322|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
139646323|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139646324|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139646325|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
139646326|NCT01391325|Protective Agents|protective agents|mesh-ancestor
139646327|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646328|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
139646329|NCT04891458|Anesthetics|anesthetics|mesh-list
139646330|NCT04891458|Propofol|propofol|mesh-list
139646331|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139646332|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646333|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139646334|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139646335|NCT04891458|Analgesics|analgesics|mesh-ancestor
139646336|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
139646337|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646338|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139646339|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139646340|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139646341|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
139646342|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715688|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139646343|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646344|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139646345|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
139646346|NCT04899414|Dexamethasone|dexamethasone|mesh-list
139646347|NCT04899414|Azacitidine|azacitidine|mesh-list
139646348|NCT04899414|Tislelizumab|tislelizumab|mesh-list
139646349|NCT04899414|Pegaspargase|pegaspargase|mesh-list
139646350|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139646351|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
139646352|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
139646353|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646354|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646355|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139646356|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
139646357|NCT04899414|Hormones|hormones|mesh-ancestor
139646358|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139646359|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139646360|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646361|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139646362|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
139646363|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646364|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646365|NCT04899414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646366|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
139646367|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139646368|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139646369|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646370|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
139646371|NCT03008655|Coagulants|coagulants|mesh-ancestor
139646372|NCT05585671|Belimumab|belimumab|mesh-list
139646373|NCT05585671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139646374|NCT05585671|Immunologic Factors|immunologic factors|mesh-ancestor
139646375|NCT05585671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646376|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139646377|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
139646378|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139646379|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
139646380|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646381|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646382|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139646383|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
139646384|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139646385|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139646386|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139646387|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
139646388|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646389|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646390|NCT01335789|Oxytocin|oxytocin|mesh-list
139646391|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
139646392|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139646393|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646394|NCT02202135|Vancomycin|vancomycin|mesh-list
139646395|NCT02202135|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139646396|NCT02202135|Aztreonam|aztreonam|mesh-list
139646397|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139646398|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139646399|NCT05585281|Fluzoparib|fluzoparib|mesh-list
139646400|NCT05585281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139646401|NCT05585281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646402|NCT05585281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646403|NCT05585281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646404|NCT01335867|Vigabatrin|vigabatrin|mesh-list
139646405|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
139646406|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646407|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646408|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
139646409|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646410|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646411|NCT01894711|Trastuzumab|trastuzumab|mesh-list
139646412|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646413|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646414|NCT00985439|Celecoxib|celecoxib|mesh-list
139646415|NCT00985439|Diclofenac|diclofenac|mesh-list
139646416|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139646417|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139646418|NCT00985439|Analgesics|analgesics|mesh-ancestor
139646419|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
139646420|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646421|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646422|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139646423|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139646424|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139646425|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139646426|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646427|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646428|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
139646429|NCT02984111|Hematinics|hematinics|mesh-ancestor
139646430|NCT04412148|Triamcinolone|triamcinolone|mesh-list
139646431|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139646432|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139646433|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139646434|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139646435|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
139646436|NCT04412148|Hormones|hormones|mesh-ancestor
139646437|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139646438|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646439|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139646440|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
139646441|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646442|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646443|NCT04890522|Gemcitabine|gemcitabine|mesh-list
139646444|NCT04890522|Fluorouracil|fluorouracil|mesh-list
139646445|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646446|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139646447|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
139646448|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646449|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139646450|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
139646451|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646452|NCT01525069|Dexamethasone|dexamethasone|mesh-list
139646453|NCT01525069|Gemcitabine|gemcitabine|mesh-list
139646454|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
139646455|NCT01525069|Floxuridine|floxuridine|mesh-list
139646456|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139646457|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
139646458|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
139646459|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646460|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646461|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139646462|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
139646463|NCT01525069|Hormones|hormones|mesh-ancestor
139646464|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139646465|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139646466|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646467|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139646468|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
139646469|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646470|NCT04898946|Vaccines|vaccines|mesh-list
139646471|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
139646472|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646473|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139646474|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139646475|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139646476|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139646477|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139646478|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
139646479|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646480|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646481|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646482|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
139646483|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139646484|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139646485|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
139646486|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139646487|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646488|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139646489|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139646490|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139646491|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139646492|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139646493|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139646494|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139646495|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646496|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646497|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646498|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
139646499|NCT01894867|Antacids|antacids|mesh-ancestor
139646500|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646501|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139646502|NCT01521403|Metronidazole|metronidazole|mesh-list
139646503|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139646504|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139646505|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139646506|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139646507|NCT04881942|Menthol|menthol|mesh-list
139646508|NCT04881942|Nicotine|nicotine|mesh-list
139646509|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139646510|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
139646511|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646512|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646513|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139646514|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139646515|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
139646516|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646517|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646518|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
139646519|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
139646520|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
139646521|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139646522|NCT04126811|Apatinib|apatinib|mesh-list
139646523|NCT04126811|Ifosfamide|ifosfamide|mesh-list
139646524|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
139646525|NCT04126811|Pirarubicin|pirarubicin|mesh-list
139646526|NCT04126811|Doxorubicin|doxorubicin|mesh-list
139646527|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646528|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139646529|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646530|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646531|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139646532|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
139646533|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139646534|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139646535|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139646536|NCT01406223|Bupropion|bupropion|mesh-list
139646537|NCT01406223|Nicotine|nicotine|mesh-list
139646538|NCT01406223|Varenicline|varenicline|mesh-list
139646539|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139646540|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
138715774|NCT00581607|Bosentan|bosentan|mesh-list
139646541|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646542|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646543|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139646544|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139646545|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
139646546|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646547|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646548|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139646549|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
139646550|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139646551|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139646552|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139646553|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139646554|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
139646555|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139646556|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139646557|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646558|NCT02230969|Interferons|interferons|mesh-list
139646559|NCT02230969|Interferon-beta|interferon-beta|mesh-list
139646560|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
139646561|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646562|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
139646563|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139646564|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
139646565|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646566|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139646567|NCT04881474|Ibuprofen|ibuprofen|mesh-list
139646568|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139646569|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139646570|NCT04881474|Analgesics|analgesics|mesh-ancestor
139646571|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
139646572|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646573|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646574|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139646575|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139646576|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139646577|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646578|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646579|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139646580|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139646581|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139646582|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139646583|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646584|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646585|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646586|NCT00981149|Analgesics|analgesics|mesh-ancestor
139646587|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
139646588|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646589|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
139646590|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139646591|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
139646592|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
139646593|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139646594|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646595|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139646596|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646597|NCT01595646|Insulin|insulin|mesh-list
139646598|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139646599|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
139646600|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139646601|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646602|NCT01907191|Bupivacaine|bupivacaine|mesh-list
139646603|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
139646604|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
139646605|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139646606|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646607|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
139646608|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646609|NCT01395537|Paclitaxel|paclitaxel|mesh-list
139646610|NCT01395537|Carboplatin|carboplatin|mesh-list
139646611|NCT01395537|Lapatinib|lapatinib|mesh-list
139385604|NCT05035862|Prednisone|prednisone|mesh-list
139646612|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139646613|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646614|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
139646615|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
139646616|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
139646617|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646618|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139646619|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646620|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
139646621|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139646622|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139646623|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646624|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
139646625|NCT04898712|Coagulants|coagulants|mesh-ancestor
139646626|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139646627|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139646628|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
139646629|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646630|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
139646631|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139646632|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139646633|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646634|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
139646635|NCT02317549|Coagulants|coagulants|mesh-ancestor
139646636|NCT05583643|Calcium, Dietary|calcium, dietary|mesh-list
139646637|NCT05583643|Atorvastatin|atorvastatin|mesh-list
139646638|NCT05583643|Calcium|calcium|mesh-list
139646639|NCT05583643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139646640|NCT05583643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646641|NCT05583643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139646642|NCT05583643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139646643|NCT05583643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139646644|NCT05583643|Antimetabolites|antimetabolites|mesh-ancestor
139646645|NCT05583643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646646|NCT05583643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139646647|NCT05583643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139646648|NCT05583643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646649|NCT02225275|Lenalidomide|lenalidomide|mesh-list
139646650|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
139646651|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
139646652|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646653|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139646654|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139646655|NCT02225275|Growth Substances|growth substances|mesh-ancestor
139646656|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
139646657|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646658|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646659|NCT01897441|Paclitaxel|paclitaxel|mesh-list
139646660|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
139646661|NCT01897441|Doxorubicin|doxorubicin|mesh-list
139646662|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139646663|NCT01897441|Trastuzumab|trastuzumab|mesh-list
139646664|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139646665|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139646666|NCT01897441|Antibodies|antibodies|mesh-list
139646667|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
139646668|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139646669|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139646670|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646671|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
139646672|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
139646673|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
139646674|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646675|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139646676|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
139646677|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646678|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139646679|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139646680|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
139646681|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139646682|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139646683|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139646684|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139385605|NCT05035862|Albuterol|albuterol|mesh-list
139134961|NCT02822794|Ribavirin|ribavirin|mesh-list
139646685|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646686|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139646687|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139646688|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
139646689|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646690|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139646691|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139646692|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
139646693|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
139646694|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646695|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646696|NCT04430556|Sertraline|sertraline|mesh-list
139646697|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
139646698|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139646699|NCT04430556|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139646700|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139646701|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139646702|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646703|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646704|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
139646705|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646706|NCT04897854|Folfirinox|folfirinox|mesh-list
139646707|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646708|NCT01892527|Cetuximab|cetuximab|mesh-list
139646709|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646710|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646711|NCT01399827|Methylphenidate|methylphenidate|mesh-list
139646712|NCT01399827|Amphetamine|amphetamine|mesh-list
139646713|NCT01399827|Adderall|adderall|mesh-list
139646714|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
139646715|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
139646716|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139646717|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139646718|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646719|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139646720|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139646721|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139646722|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646723|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
139646724|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646725|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139646726|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
139646727|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
139646728|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
139646729|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646730|NCT04897386|Pemetrexed|pemetrexed|mesh-list
139646731|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646732|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646733|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646734|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139646735|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139646736|NCT04879446|Mitogens|mitogens|mesh-list
139646737|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
139646738|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646739|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
139646740|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139646741|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139646742|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646743|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
139646744|NCT02618382|Coagulants|coagulants|mesh-ancestor
139646745|NCT02177071|Infliximab|infliximab|mesh-list
139646746|NCT02177071|Methotrexate|methotrexate|mesh-list
139646747|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
139646748|NCT02177071|Azathioprine|azathioprine|mesh-list
139646749|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139646750|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
139646751|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139646752|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646753|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139646754|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
139646755|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646756|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646757|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
139385606|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139646758|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385607|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
139646759|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139646760|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139646761|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
139646762|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139646763|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139646764|NCT02177071|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139646765|NCT02177071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139646766|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139646767|NCT04889196|Fluorides|fluorides|mesh-list
139646768|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
139646769|NCT04889196|Protective Agents|protective agents|mesh-ancestor
139646770|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646771|NCT03049176|Tenofovir|tenofovir|mesh-list
139646772|NCT03049176|Emtricitabine|emtricitabine|mesh-list
139646773|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139646774|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139646775|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
139646776|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139646777|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139646778|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139646779|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646780|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646781|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139646782|NCT01895023|Midazolam|midazolam|mesh-list
139646783|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
139646784|NCT01895023|GABA Modulators|gaba modulators|mesh-list
139646785|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139646786|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139646787|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646788|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139646789|NCT01895023|Analgesics|analgesics|mesh-ancestor
139646790|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
139646791|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646792|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139646793|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139646794|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139646795|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
139646796|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646797|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646798|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139646799|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139646800|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139646801|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139646802|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139646803|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
139646804|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
139646805|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
139646806|NCT04888728|Nebivolol|nebivolol|mesh-list
139646807|NCT04888728|Paroxetine|paroxetine|mesh-list
139646808|NCT04888728|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139646809|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139646810|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139646811|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646812|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646813|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
139646814|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646815|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139646816|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
139646817|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139646818|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139646819|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139646820|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646821|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139646822|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
139646823|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139646824|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139646825|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139646826|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
139646827|NCT04125719|Nivolumab|nivolumab|mesh-list
139646828|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646829|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646830|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139646831|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646832|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
139646833|NCT01428973|Sirolimus|sirolimus|mesh-list
139646834|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139646835|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646836|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139646837|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
139646838|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139646839|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139646840|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646841|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646842|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
139646843|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139646844|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
139646845|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646846|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139646847|NCT01475643|Prednisolone|prednisolone|mesh-list
139646848|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139646849|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
139646850|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139646851|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
139646852|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139646853|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
139646854|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139646855|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
139646856|NCT01475643|Hormones|hormones|mesh-ancestor
139646857|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139646858|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646859|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139646860|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646861|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
139646862|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
139646863|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646864|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139646865|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139646866|NCT01475643|Protective Agents|protective agents|mesh-ancestor
139646867|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139646868|NCT03004001|Atorvastatin|atorvastatin|mesh-list
139646869|NCT03004001|Alirocumab|alirocumab|mesh-list
139646870|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139646871|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139646872|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139646873|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
139646874|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646875|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139646876|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139646877|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646878|NCT03004001|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139646879|NCT03004001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139646880|NCT03004001|Protease Inhibitors|protease inhibitors|mesh-ancestor
139646881|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
139646882|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646883|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139646884|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139646885|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139646886|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
139646887|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646888|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139646889|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139646890|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646891|NCT03237377|Durvalumab|durvalumab|mesh-list
139646892|NCT03237377|Tremelimumab|tremelimumab|mesh-list
139646893|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646894|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646895|NCT04124081|Entecavir|entecavir|mesh-list
139646896|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
139646897|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139646898|NCT04123925|Nivolumab|nivolumab|mesh-list
139646899|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646900|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646901|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139646902|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646903|NCT04759079|Antiemetics|antiemetics|mesh-list
139385608|NCT05035862|Hormones|hormones|mesh-ancestor
139646904|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
139646905|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646906|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646908|NCT03048942|Paclitaxel|paclitaxel|mesh-list
139646909|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139646910|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646911|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
139646912|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
139646913|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
139646914|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646915|NCT04393025|Clopidogrel|clopidogrel|mesh-list
139646916|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646917|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646918|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139646919|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139646920|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139646921|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139646922|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
139646923|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646924|NCT05257902|Choline|choline|mesh-list
139646925|NCT05257902|Lipotropic Agents|lipotropic agents|mesh-ancestor
139646926|NCT05257902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139646927|NCT05257902|Antimetabolites|antimetabolites|mesh-ancestor
139646928|NCT05257902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646929|NCT05257902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139646930|NCT05257902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139646931|NCT05257902|Nootropic Agents|nootropic agents|mesh-ancestor
139646932|NCT02143219|Leucovorin|leucovorin|mesh-list
139646933|NCT02143219|Folic Acid|folic acid|mesh-list
139646934|NCT02143219|Irinotecan|irinotecan|mesh-list
139646935|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
139646936|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
139646937|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139646938|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139646939|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139646940|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646941|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646942|NCT02143219|Antidotes|antidotes|mesh-ancestor
139646943|NCT02143219|Protective Agents|protective agents|mesh-ancestor
139646944|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646945|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
139646946|NCT02143219|Vitamins|vitamins|mesh-ancestor
139646947|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
139646948|NCT02143219|Hematinics|hematinics|mesh-ancestor
139646949|NCT04122911|Temozolomide|temozolomide|mesh-list
139646950|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139646951|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
139646952|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646953|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646954|NCT04122599|Melatonin|melatonin|mesh-list
139646955|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
139646956|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646957|NCT04122599|Protective Agents|protective agents|mesh-ancestor
139646958|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646959|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139646960|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139646961|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139646962|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
139646963|NCT03048474|Nivolumab|nivolumab|mesh-list
139646964|NCT03048474|Ipilimumab|ipilimumab|mesh-list
139646965|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139646966|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646967|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139646968|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646969|NCT04121975|Endostar protein|endostar protein|mesh-list
139646970|NCT04121975|Endostatins|endostatins|mesh-list
139646971|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139646972|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139646973|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139646974|NCT04121975|Growth Substances|growth substances|mesh-ancestor
139646975|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646976|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
139646977|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
139646978|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139646979|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139135235|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139646980|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646981|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
139646982|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646983|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139646984|NCT03830957|Metoprolol|metoprolol|mesh-list
139646985|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139646986|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139646987|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
139646988|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
139646989|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139646990|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716191|NCT04575675|Diuretics|diuretics|mesh-ancestor
139646991|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139646992|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139646993|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139646994|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
139646995|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139646996|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139646997|NCT04121819|Cytarabine|cytarabine|mesh-list
139646998|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139646999|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
139647000|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647001|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647002|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
139647003|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647004|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139647005|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
139647006|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647007|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
139647008|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139647009|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139647010|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
139647011|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647012|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139647013|NCT05189730|Paclitaxel|paclitaxel|mesh-list
139647014|NCT05189730|Carboplatin|carboplatin|mesh-list
139647015|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139647016|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647017|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
139647018|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
139647019|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
139647020|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647021|NCT04121273|Immunomodulating Agents|immunomodulating agents|mesh-list
139647022|NCT04121273|Immunologic Factors|immunologic factors|mesh-ancestor
139647023|NCT04121273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647024|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
139647025|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139647026|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647027|NCT04121039|Apatinib|apatinib|mesh-list
139647028|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647029|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139647030|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647031|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647032|NCT01401543|Tadalafil|tadalafil|mesh-list
139647033|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
139647034|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139647035|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139647036|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647037|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647038|NCT01401543|Urological Agents|urological agents|mesh-ancestor
139647039|NCT04120259|Metformin|metformin|mesh-list
139647040|NCT04120259|Acetic Acid|acetic acid|mesh-list
139647041|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139647042|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647043|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139647044|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647045|NCT04392102|Niraparib|niraparib|mesh-list
139647046|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139647047|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647048|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647049|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647050|NCT05256342|Etoricoxib|etoricoxib|mesh-list
139647051|NCT05256342|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139647052|NCT05256342|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139647053|NCT05256342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139647054|NCT05256342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139647055|NCT05256342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647056|NCT05256342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139647057|NCT05256342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647058|NCT05256342|Analgesics|analgesics|mesh-ancestor
139647059|NCT05256342|Sensory System Agents|sensory system agents|mesh-ancestor
139647060|NCT05256342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647061|NCT05256342|Antidepressive Agents|antidepressive agents|mesh-ancestor
139385609|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385610|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385611|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139385612|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385613|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
139385614|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139385615|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139385616|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
139385617|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385618|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139385619|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
139385620|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
139385621|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139385622|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139385623|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139385624|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139385625|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
139385626|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385627|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385628|NCT03549221|Ketorolac|ketorolac|mesh-list
139385629|NCT03549221|Epinephrine|epinephrine|mesh-list
139385630|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
139385631|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139385632|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139385633|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
139385634|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385635|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385636|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385637|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139385638|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139385639|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
139385640|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385641|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139385642|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
139385643|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
139042467|NCT03966118|Avelumab|avelumab|mesh-list
139385644|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
139385645|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139385646|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139385647|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139385648|NCT03549221|Analgesics|analgesics|mesh-ancestor
139385649|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
139385650|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139385651|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139385652|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139385653|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385654|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
139385655|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
139385656|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139385657|NCT05185505|Bevacizumab|bevacizumab|mesh-list
139385658|NCT05185505|Atezolizumab|atezolizumab|mesh-list
139385659|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139385660|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385661|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139385662|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138716286|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
139385663|NCT05185505|Growth Substances|growth substances|mesh-ancestor
139385664|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385665|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
139385666|NCT05185505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139385667|NCT05185505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385668|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139647062|NCT05256342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139647063|NCT05256342|Dopamine Agents|dopamine agents|mesh-ancestor
139647064|NCT05256342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139385669|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
139385670|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139385671|NCT05575271|Norepinephrine|norepinephrine|mesh-list
139385672|NCT05575271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139385673|NCT05575271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139385674|NCT05575271|Adrenergic Agents|adrenergic agents|mesh-ancestor
139385675|NCT05575271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385676|NCT05575271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385677|NCT05575271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385678|NCT05575271|Sympathomimetics|sympathomimetics|mesh-ancestor
139385679|NCT05575271|Autonomic Agents|autonomic agents|mesh-ancestor
139385680|NCT05575271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385681|NCT05575271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139385682|NCT04750460|Teriparatide|teriparatide|mesh-list
139385683|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139385684|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385685|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139385686|NCT05575037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139385687|NCT05575037|Immunologic Factors|immunologic factors|mesh-ancestor
139385688|NCT05575037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385689|NCT05574881|Trastuzumab|trastuzumab|mesh-list
139385690|NCT05574881|Pertuzumab|pertuzumab|mesh-list
139385691|NCT05574881|Fulvestrant|fulvestrant|mesh-list
139385692|NCT05574881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139385693|NCT05574881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385694|NCT05574881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139385695|NCT05574881|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139385696|NCT05574881|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139385697|NCT05574881|Hormone Antagonists|hormone antagonists|mesh-ancestor
139385698|NCT05574881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385699|NCT05574881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385700|NCT04787510|Heparin|heparin|mesh-list
139385701|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139385702|NCT04787510|Tinzaparin|tinzaparin|mesh-list
139385703|NCT04787510|Dalteparin|dalteparin|mesh-list
139385704|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
139385705|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139385706|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139385707|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385708|NCT05424263|Calcium, Dietary|calcium, dietary|mesh-list
139385709|NCT05424263|Calcium Carbonate|calcium carbonate|mesh-list
139385710|NCT05424263|Calcium|calcium|mesh-list
139385711|NCT05424263|Calcium acetate|calcium acetate|mesh-list
139385712|NCT05424263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139385713|NCT05424263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385714|NCT05424263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139385715|NCT05424263|Antacids|antacids|mesh-ancestor
139385716|NCT05424263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385717|NCT05424263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139385718|NCT05424263|Chelating Agents|chelating agents|mesh-ancestor
139385719|NCT05424263|Sequestering Agents|sequestering agents|mesh-ancestor
139385720|NCT04787276|Rifaximin|rifaximin|mesh-list
139385721|NCT04787276|Lactulose|lactulose|mesh-list
139385722|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139385723|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139385724|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139385726|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139385727|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139385728|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139385729|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139385730|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385731|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
139385732|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385733|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385734|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139385735|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385736|NCT05613140|Valsartan|valsartan|mesh-list
139385737|NCT05613140|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139385738|NCT05613140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139385739|NCT05613140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139647065|NCT05256342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139647066|NCT05256342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139647067|NCT05256342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139647068|NCT05256342|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139647069|NCT05256342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139647070|NCT05256342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647071|NCT01895881|Estradiol|estradiol|mesh-list
139647072|NCT01895881|Estrogens|estrogens|mesh-ancestor
139385740|NCT05613140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139385741|NCT05613140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385742|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
139385743|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
139385744|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139385745|NCT03547505|Protective Agents|protective agents|mesh-ancestor
139385746|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385747|NCT05279183|Erythritol|erythritol|mesh-list
139385748|NCT05279183|Vasodilator Agents|vasodilator agents|mesh-ancestor
139385749|NCT04462952|Adavosertib|adavosertib|mesh-list
139385750|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385751|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385752|NCT02253485|Telbivudine|telbivudine|mesh-list
139385753|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
139385754|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139385755|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139385756|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385757|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385758|NCT05612516|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139385759|NCT05612516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139385760|NCT05612516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139385761|NCT02589626|Empagliflozin|empagliflozin|mesh-list
139385762|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139385763|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385764|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139385765|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385766|NCT04976036|Nintedanib|nintedanib|mesh-list
139385767|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385768|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139385769|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385770|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385771|NCT05557604|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139385772|NCT05557604|Luteolytic Agents|luteolytic agents|mesh-ancestor
139385773|NCT05557604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139385774|NCT05557604|Contraceptive Agents|contraceptive agents|mesh-ancestor
139385775|NCT05557604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139385776|NCT05557604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385777|NCT05557604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139385778|NCT05557604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139385779|NCT05557604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385780|NCT05556122|Betamethasone|betamethasone|mesh-list
139385781|NCT05556122|Ropivacaine|ropivacaine|mesh-list
139385782|NCT05556122|Anesthetics, Local|anesthetics, local|mesh-ancestor
139385783|NCT05556122|Anesthetics|anesthetics|mesh-ancestor
139385784|NCT05556122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139385785|NCT05556122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385786|NCT05556122|Sensory System Agents|sensory system agents|mesh-ancestor
139385787|NCT05556122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385788|NCT05556122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139385789|NCT05556122|Glucocorticoids|glucocorticoids|mesh-ancestor
139385790|NCT05556122|Hormones|hormones|mesh-ancestor
139385791|NCT05556122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385792|NCT05556122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139042615|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139385793|NCT05556122|Respiratory System Agents|respiratory system agents|mesh-ancestor
139385794|NCT05549570|Metformin|metformin|mesh-list
139385795|NCT05549570|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139385796|NCT05549570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139385797|NCT05549570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385798|NCT05549570|Incretins|incretins|mesh-ancestor
139385799|NCT05549570|Hormones|hormones|mesh-ancestor
139385800|NCT05549570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385801|NCT05549570|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139385802|NCT05549570|Protease Inhibitors|protease inhibitors|mesh-ancestor
139385803|NCT05549570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385804|NCT05549570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385805|NCT05549492|Buprenorphine|buprenorphine|mesh-list
139385806|NCT05549492|Ropivacaine|ropivacaine|mesh-list
139647073|NCT01895881|Hormones|hormones|mesh-ancestor
139647074|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139647075|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647076|NCT04537962|Listerine|listerine|mesh-list
139385807|NCT05549492|Anesthetics, Local|anesthetics, local|mesh-ancestor
139385808|NCT05549492|Anesthetics|anesthetics|mesh-ancestor
139385809|NCT05549492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139385810|NCT05549492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385811|NCT05549492|Sensory System Agents|sensory system agents|mesh-ancestor
139385812|NCT05549492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385813|NCT05549492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139385814|NCT05549492|Narcotics|narcotics|mesh-ancestor
139385815|NCT05549492|Analgesics|analgesics|mesh-ancestor
139054793|NCT01517100|Hormones|hormones|mesh-ancestor
139385816|NCT05549492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139385817|NCT04331132|Tolvaptan|tolvaptan|mesh-list
139385818|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139385819|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385820|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
139385821|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385822|NCT05549336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139385823|NCT05549336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385824|NCT05549336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139385825|NCT05549336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385826|NCT05549024|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139385827|NCT05549024|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139385828|NCT05549024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385829|NCT01666730|Leucovorin|leucovorin|mesh-list
139385830|NCT01666730|Metformin|metformin|mesh-list
139385831|NCT01666730|Fluorouracil|fluorouracil|mesh-list
139385832|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
139385833|NCT01666730|Calcium|calcium|mesh-list
139385834|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
139385835|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139385836|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385837|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139385838|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
139385839|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385840|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139385841|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385842|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139385843|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
139385844|NCT01666730|Antidotes|antidotes|mesh-ancestor
139385845|NCT01666730|Protective Agents|protective agents|mesh-ancestor
139385846|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
139385847|NCT01666730|Vitamins|vitamins|mesh-ancestor
139385848|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
139385849|NCT05554094|Psilocybin|psilocybin|mesh-list
139385850|NCT05554094|Hallucinogens|hallucinogens|mesh-ancestor
139385851|NCT05554094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385852|NCT05554094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139385853|NCT04434560|Nivolumab|nivolumab|mesh-list
139385854|NCT04434560|Ipilimumab|ipilimumab|mesh-list
139385855|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139647077|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
139647078|NCT04537962|Fluorides|fluorides|mesh-list
139647079|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
139647080|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
139647081|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
139647082|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
139647083|NCT04537962|Protective Agents|protective agents|mesh-ancestor
139647084|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647085|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139647086|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647087|NCT04126733|Nivolumab|nivolumab|mesh-list
139647088|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139647089|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647090|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139647091|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647092|NCT04885764|Vaccines|vaccines|mesh-list
139647093|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
139647094|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647095|NCT04311606|Aflibercept|aflibercept|mesh-list
139647096|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139647097|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139054870|NCT03955354|Apatinib|apatinib|mesh-list
139647098|NCT04311606|Growth Substances|growth substances|mesh-ancestor
139647099|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647100|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
139385856|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385857|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139385858|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647101|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647102|NCT02980835|Dexamethasone|dexamethasone|mesh-list
139647103|NCT02980835|Epinephrine|epinephrine|mesh-list
139647104|NCT02980835|Ropivacaine|ropivacaine|mesh-list
139385859|NCT05700656|Capecitabine|capecitabine|mesh-list
139385860|NCT05700656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139385861|NCT05700656|Antimetabolites|antimetabolites|mesh-ancestor
139385862|NCT05700656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385863|NCT05700656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385864|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
139385865|NCT00103285|Leucovorin|leucovorin|mesh-list
139385866|NCT00103285|Folic Acid|folic acid|mesh-list
139385867|NCT00103285|Cytarabine|cytarabine|mesh-list
139385868|NCT00103285|Dexamethasone|dexamethasone|mesh-list
139385869|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
139385871|NCT00103285|Doxorubicin|doxorubicin|mesh-list
139385872|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139385873|NCT00103285|Methotrexate|methotrexate|mesh-list
139385874|NCT00103285|Vincristine|vincristine|mesh-list
139385875|NCT00103285|Asparaginase|asparaginase|mesh-list
139385876|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
139385877|NCT00103285|Pegaspargase|pegaspargase|mesh-list
139385878|NCT00103285|Thioguanine|thioguanine|mesh-list
139385879|NCT00103285|BB 1101|bb 1101|mesh-list
139385880|NCT00103285|Calcium|calcium|mesh-list
139385881|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
139385882|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
139385883|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139385884|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
139385885|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385886|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139385887|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139385888|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
139385889|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385890|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385891|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139385892|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139385893|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
139385894|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
139385895|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385896|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139385897|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
139385898|NCT00103285|Hormones|hormones|mesh-ancestor
139385899|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385900|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139385901|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
139385902|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385903|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139385904|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139385905|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139385906|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139385907|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139385908|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139385909|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
139385910|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139385911|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139385912|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
139385913|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
139385914|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139385915|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139385916|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
139385917|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139385918|NCT00103285|Antidotes|antidotes|mesh-ancestor
139385919|NCT00103285|Protective Agents|protective agents|mesh-ancestor
139385920|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
139385921|NCT00103285|Vitamins|vitamins|mesh-ancestor
139385922|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
139385923|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139385924|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
139385925|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
139385926|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
139647105|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139647106|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
139385927|NCT00103285|Hematinics|hematinics|mesh-ancestor
139385928|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
139385929|NCT03541915|Analgesics|analgesics|mesh-ancestor
139385930|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
139385931|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385932|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385933|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
139135434|NCT01177371|Protective Agents|protective agents|mesh-ancestor
139647107|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
139385934|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139385935|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139385936|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
139385937|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139385938|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139385939|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385940|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139385941|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
139385942|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139385943|NCT03541837|Ropivacaine|ropivacaine|mesh-list
139385944|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
139385945|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
139385946|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139385947|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385948|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
139385949|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385951|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139385952|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385953|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
139385954|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385955|NCT03541603|Simendan|simendan|mesh-list
139385956|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139385957|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
139385958|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139385959|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139385960|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385961|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385962|NCT03541603|Protective Agents|protective agents|mesh-ancestor
139385963|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385964|NCT02160223|Neostigmine|neostigmine|mesh-list
139385965|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139385966|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139385967|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139385968|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
139385969|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139385970|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385971|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139385972|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
139385973|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385974|NCT02160301|Acetaminophen|acetaminophen|mesh-list
139385975|NCT02160301|Dexamethasone|dexamethasone|mesh-list
139385976|NCT02160301|Celecoxib|celecoxib|mesh-list
139385977|NCT02160301|Oxycodone|oxycodone|mesh-list
139385978|NCT02160301|Gabapentin|gabapentin|mesh-list
139385979|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139385980|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
139385981|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
139385982|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139385983|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139385984|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139385985|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
139385986|NCT02160301|Hormones|hormones|mesh-ancestor
139385987|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139385988|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139385989|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139385990|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139385991|NCT02160301|Analgesics|analgesics|mesh-ancestor
139385992|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
139385993|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
139385994|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139385995|NCT02160301|Narcotics|narcotics|mesh-ancestor
139385996|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139385997|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139385998|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139385999|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139386000|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139386001|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386002|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386003|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
139647108|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647109|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647110|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139647111|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
139135439|NCT01178931|Hormones|hormones|mesh-ancestor
139647112|NCT02980835|Hormones|hormones|mesh-ancestor
139386004|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139386005|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139386006|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139386007|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139386008|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139386009|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386010|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
139386012|NCT03541759|Pirinitramide|pirinitramide|mesh-list
139386013|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139386014|NCT03541759|Narcotics|narcotics|mesh-ancestor
139386015|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139386016|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386017|NCT03541759|Analgesics|analgesics|mesh-ancestor
139386018|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
139386019|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386020|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139386021|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
139042839|NCT01058850|Rindopepimut|rindopepimut|mesh-list
139386022|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139386023|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
139386024|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386025|NCT01666652|Antacids|antacids|mesh-ancestor
138716587|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139386026|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386027|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139386028|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139386029|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
139386030|NCT05174585|Antibodies|antibodies|mesh-list
139386031|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
139386032|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139386033|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
139386034|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386035|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386036|NCT05174585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139386037|NCT05174585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386038|NCT04428086|Metformin|metformin|mesh-list
139386039|NCT04428086|Apatinib|apatinib|mesh-list
139386040|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139386041|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139386042|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386043|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139386044|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139386045|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
139386046|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386047|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139386048|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139386049|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386050|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386051|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139386052|NCT04355858|Paclitaxel|paclitaxel|mesh-list
139386053|NCT04355858|Capecitabine|capecitabine|mesh-list
139386054|NCT04355858|Everolimus|everolimus|mesh-list
139386055|NCT04355858|Fluzoparib|fluzoparib|mesh-list
139386056|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139386057|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386058|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
139386059|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
139386060|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
139386061|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386062|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139386063|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
139386064|NCT04355858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139386065|NCT04355858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139386066|NCT04355858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386067|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139386068|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
139386069|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386070|NCT04355858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139386071|NCT05610956|Empagliflozin|empagliflozin|mesh-list
139386072|NCT05610956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139386073|NCT05610956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386074|NCT05610956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139386075|NCT05610956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647113|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139386076|NCT00109733|Hormones|hormones|mesh-list
139647114|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139647115|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647116|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
139647117|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
139647118|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139386077|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139386078|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386079|NCT05699876|Gabapentin|gabapentin|mesh-list
139386080|NCT05699876|Melatonin|melatonin|mesh-list
139386081|NCT05699876|Analgesics|analgesics|mesh-ancestor
139386082|NCT05699876|Sensory System Agents|sensory system agents|mesh-ancestor
139386083|NCT05699876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386084|NCT05699876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386085|NCT05699876|Anticonvulsants|anticonvulsants|mesh-ancestor
139386086|NCT05699876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139386087|NCT05699876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139386088|NCT05699876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139386089|NCT05699876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139386090|NCT05699876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139386091|NCT05699876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139386092|NCT05699876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386093|NCT05699876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386094|NCT05699876|Antimanic Agents|antimanic agents|mesh-ancestor
139386095|NCT05699876|Antioxidants|antioxidants|mesh-ancestor
139042917|NCT00337194|Vinorelbine|vinorelbine|mesh-list
139386096|NCT05699876|Protective Agents|protective agents|mesh-ancestor
139386098|NCT05610878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139386099|NCT05610878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139386100|NCT05610878|Analgesics|analgesics|mesh-ancestor
139386101|NCT05610878|Sensory System Agents|sensory system agents|mesh-ancestor
139386102|NCT05610878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386103|NCT05610878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386104|NCT05610878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139386105|NCT05610878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386106|NCT05610878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386107|NCT05610878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386108|NCT05610878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386109|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
139386110|NCT02706405|Fludarabine|fludarabine|mesh-list
139386111|NCT02706405|Durvalumab|durvalumab|mesh-list
139386112|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
139386113|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139386114|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
139386115|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139386116|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
139386117|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386118|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386119|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139386120|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
139386121|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386122|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386123|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139386124|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139647119|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
139647120|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139647121|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139647122|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
139647123|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139647124|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647125|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139647126|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139647127|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139647128|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
139647129|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
139647130|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
139647131|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139647132|NCT04871724|Fluconazole|fluconazole|mesh-list
139647133|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
139647134|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647135|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139647136|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139647137|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647138|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647139|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139647140|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
139386126|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139386127|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139386128|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386129|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386130|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386131|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
139386132|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139386133|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139386134|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386135|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
139386136|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386137|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386138|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139386139|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139386140|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139386141|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139386142|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386143|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139386144|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139386145|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139386146|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139386147|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
139386148|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386149|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386150|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139386151|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139386152|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
139386153|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139386154|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139386155|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
139386156|NCT02253953|Ritonavir|ritonavir|mesh-list
139386157|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139386158|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139386159|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
139386160|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386161|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386162|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139386163|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139386164|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
139386165|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386166|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139386167|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139386168|NCT03546803|Protective Agents|protective agents|mesh-list
139386169|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386170|NCT02422953|Micronutrients|micronutrients|mesh-list
139386171|NCT02422953|Trace Elements|trace elements|mesh-list
139386172|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386173|NCT04053140|Penicillins|penicillins|mesh-list
139386174|NCT04053140|Penicillin G|penicillin g|mesh-list
139386175|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139386176|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
139386177|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139386178|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386180|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139386181|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386182|NCT05552300|Antihypertensive Agents|antihypertensive agents|mesh-list
139386183|NCT02425605|Sorafenib|sorafenib|mesh-list
139647141|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139647142|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647143|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139647144|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139647145|NCT04871802|Taxifolin|taxifolin|mesh-list
139647146|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139647147|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139647148|NCT04871802|Analgesics|analgesics|mesh-ancestor
139647149|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
138716783|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139647150|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386184|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386185|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139386186|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135472|NCT03855579|Protective Agents|protective agents|mesh-ancestor
139647151|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647152|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139647153|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139647154|NCT04871646|Nafamostat|nafamostat|mesh-list
139647155|NCT04871646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139386187|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386188|NCT02422563|Paclitaxel|paclitaxel|mesh-list
139386189|NCT02422563|Carboplatin|carboplatin|mesh-list
139386190|NCT02422563|Ifosfamide|ifosfamide|mesh-list
139386191|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139386192|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386193|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
139386194|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
139386195|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
139386196|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386197|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139386198|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
139386199|NCT03185403|Sufentanil|sufentanil|mesh-list
139386200|NCT03185403|Ropivacaine|ropivacaine|mesh-list
139386201|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
139386202|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
139386203|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139386204|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386205|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
139386206|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386207|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139386208|NCT03185403|Narcotics|narcotics|mesh-ancestor
139386209|NCT03185403|Analgesics|analgesics|mesh-ancestor
139386210|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139386211|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139386212|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
139386213|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139386214|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139386215|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139386216|NCT02422485|Analgesics|analgesics|mesh-ancestor
139386217|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
139386218|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386219|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386220|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139386221|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386222|NCT05551910|Remifentanil|remifentanil|mesh-list
139386223|NCT05551910|Propofol|propofol|mesh-list
139386224|NCT05551910|Esketamine|esketamine|mesh-list
139386225|NCT05551910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139386226|NCT05551910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139386227|NCT05551910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386228|NCT05551910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139386229|NCT05551910|Anesthetics, General|anesthetics, general|mesh-ancestor
139386230|NCT05551910|Anesthetics|anesthetics|mesh-ancestor
139386231|NCT05551910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139386232|NCT05551910|Narcotics|narcotics|mesh-ancestor
139386233|NCT05551910|Analgesics|analgesics|mesh-ancestor
139386234|NCT05551910|Sensory System Agents|sensory system agents|mesh-ancestor
139386235|NCT05551910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386236|NCT05551910|Antidepressive Agents|antidepressive agents|mesh-ancestor
139386237|NCT05551910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139386238|NCT05699720|Magnesium Sulfate|magnesium sulfate|mesh-list
139386239|NCT05699720|Analgesics|analgesics|mesh-ancestor
139386240|NCT05699720|Sensory System Agents|sensory system agents|mesh-ancestor
139386241|NCT05699720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386242|NCT05699720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386243|NCT05699720|Anesthetics|anesthetics|mesh-ancestor
139386244|NCT05699720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139386245|NCT05699720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139386246|NCT05699720|Anticonvulsants|anticonvulsants|mesh-ancestor
139386247|NCT05699720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139386248|NCT05699720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139386249|NCT05699720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386250|NCT05699720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139647156|NCT04871646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139386251|NCT05699720|Tocolytic Agents|tocolytic agents|mesh-ancestor
139386252|NCT05699720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139386253|NCT05546762|Povidone-Iodine|povidone-iodine|mesh-list
139386254|NCT05546762|Povidone|povidone|mesh-list
139386255|NCT05546762|Plasma Substitutes|plasma substitutes|mesh-ancestor
139386256|NCT05546762|Blood Substitutes|blood substitutes|mesh-ancestor
139135484|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
139647157|NCT04871646|Analgesics|analgesics|mesh-ancestor
139647158|NCT04871646|Sensory System Agents|sensory system agents|mesh-ancestor
139647159|NCT04871646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386257|NCT05546762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139386258|NCT05546762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386259|NCT05551598|Mitoxantrone|mitoxantrone|mesh-list
139386260|NCT05551598|Analgesics|analgesics|mesh-ancestor
139386261|NCT05551598|Sensory System Agents|sensory system agents|mesh-ancestor
139386262|NCT05551598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386263|NCT05551598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386264|NCT05551598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386265|NCT05551598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139386266|NCT05551598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139386267|NCT05551598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386268|NCT05551598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386269|NCT03185793|Benzbromarone|benzbromarone|mesh-list
139386270|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
139386271|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
139386272|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386273|NCT03660488|Penicillins|penicillins|mesh-list
139386274|NCT03660488|Cefixime|cefixime|mesh-list
139386275|NCT03660488|Penicillin G|penicillin g|mesh-list
139386276|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139386277|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
139386278|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139386279|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386280|NCT02422017|Timolol|timolol|mesh-list
139386281|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139386282|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139386283|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
139386284|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386285|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386286|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386287|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139386288|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139386289|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
139386290|NCT02761915|Fludarabine|fludarabine|mesh-list
139386291|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139386292|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
139386293|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386294|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386295|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139386296|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
139386297|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386298|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386299|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139386300|NCT03464084|Melatonin|melatonin|mesh-list
139386301|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
139386302|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386303|NCT03464084|Protective Agents|protective agents|mesh-ancestor
139386304|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716856|NCT00574652|Aldesleukin|aldesleukin|mesh-list
139386305|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139386306|NCT05551208|Bevacizumab|bevacizumab|mesh-list
139386307|NCT05551208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139386308|NCT05551208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386309|NCT05551208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139386310|NCT05551208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139386311|NCT05551208|Growth Substances|growth substances|mesh-ancestor
139386312|NCT05551208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386313|NCT05551208|Growth Inhibitors|growth inhibitors|mesh-ancestor
139386314|NCT02764333|Durvalumab|durvalumab|mesh-list
139386315|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139386316|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386317|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
139386318|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139386319|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139386320|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139386321|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139647160|NCT04871646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647161|NCT04871646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139647162|NCT04871646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386322|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386323|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
139386324|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139135492|NCT01181505|Urological Agents|urological agents|mesh-ancestor
139386325|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386326|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139386327|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386328|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
139386329|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139386330|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386331|NCT02161237|Tacrolimus|tacrolimus|mesh-list
139386332|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139386333|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
139386334|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386335|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139386336|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386337|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386338|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139386339|NCT03173066|Hematinics|hematinics|mesh-ancestor
139386340|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139386341|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139386342|NCT05546060|Dexamethasone|dexamethasone|mesh-list
139386343|NCT05546060|Etoposide|etoposide|mesh-list
139386344|NCT05546060|Venetoclax|venetoclax|mesh-list
139386345|NCT05546060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139386346|NCT05546060|Antiemetics|antiemetics|mesh-ancestor
139386347|NCT05546060|Autonomic Agents|autonomic agents|mesh-ancestor
139386348|NCT05546060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386349|NCT05546060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386350|NCT05546060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139386351|NCT05546060|Glucocorticoids|glucocorticoids|mesh-ancestor
139386352|NCT05546060|Hormones|hormones|mesh-ancestor
139386353|NCT05546060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139386354|NCT05546060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139386355|NCT05546060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386356|NCT05546060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139386357|NCT05546060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139386358|NCT05546060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139386359|NCT05546060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386360|NCT05546060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386361|NCT02416869|Dexamethasone|dexamethasone|mesh-list
139386362|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
139386363|NCT02416869|BB 1101|bb 1101|mesh-list
139386364|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139386365|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
139386366|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
139386367|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386368|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386369|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139386370|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
139386371|NCT02416869|Hormones|hormones|mesh-ancestor
139386372|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139386373|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139386374|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386375|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
139386376|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386377|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386378|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
139386379|NCT02588612|Fludarabine|fludarabine|mesh-list
139386380|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139386381|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
139386382|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386383|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386384|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139386385|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
139386386|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386387|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386388|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139386389|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
139386390|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
139386391|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386392|NCT03540979|Letrozole|letrozole|mesh-list
139647163|NCT04871646|Anticoagulants|anticoagulants|mesh-ancestor
139647164|NCT04871646|Protease Inhibitors|protease inhibitors|mesh-ancestor
139386393|NCT03540979|Progesterone|progesterone|mesh-list
139386394|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386395|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139647165|NCT04871646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647166|NCT04871646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647167|NCT04871646|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139647168|NCT04871646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139386396|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139386397|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386398|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386399|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139386400|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
139386401|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139386402|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386403|NCT03540979|Progestins|progestins|mesh-ancestor
139386404|NCT03540979|Hormones|hormones|mesh-ancestor
139386405|NCT02946788|Minocycline|minocycline|mesh-list
139386406|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139386407|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386408|NCT02159131|Cabotegravir|cabotegravir|mesh-list
139386409|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
139386410|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139386411|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
139386412|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139386413|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386414|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139386415|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139386416|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139386417|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139386418|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139386419|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386420|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386421|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139386422|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139386423|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
139386424|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386425|NCT05550506|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139386426|NCT05550506|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138716876|NCT00574769|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139386427|NCT05550506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139386428|NCT05550506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139386429|NCT05550506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386430|NCT05550506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386431|NCT05550506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386432|NCT05550506|Analgesics|analgesics|mesh-ancestor
139386433|NCT05550506|Sensory System Agents|sensory system agents|mesh-ancestor
139386434|NCT05550506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386435|NCT05550506|Antidepressive Agents|antidepressive agents|mesh-ancestor
139386436|NCT05550506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139386437|NCT05550506|Dopamine Agents|dopamine agents|mesh-ancestor
139386438|NCT03174795|Meropenem|meropenem|mesh-list
139386439|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139386440|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386441|NCT02163655|Furosemide|furosemide|mesh-list
139386442|NCT02163655|Diuretics|diuretics|mesh-ancestor
139386443|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
139386444|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386445|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139386446|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139386447|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386448|NCT02410083|Aspirin|aspirin|mesh-list
139386449|NCT02410083|Clopidogrel|clopidogrel|mesh-list
139386450|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139386451|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139386452|NCT02410083|Analgesics|analgesics|mesh-ancestor
139386453|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
139386454|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386455|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386456|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139386457|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386458|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139386459|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139386460|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386461|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139386462|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139386463|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647169|NCT04871646|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139647170|NCT04871646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139386464|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
139386465|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139386466|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139386467|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139386468|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
139386469|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386470|NCT02416245|Micronutrients|micronutrients|mesh-list
139386471|NCT02416245|Trace Elements|trace elements|mesh-list
139386472|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386473|NCT02416167|Dotinurad|dotinurad|mesh-list
139386474|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
139386475|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
139386476|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386477|NCT02166853|Midazolam|midazolam|mesh-list
139386478|NCT02166853|Sevoflurane|sevoflurane|mesh-list
139386479|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139386480|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139386481|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139386482|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386483|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139386484|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139386485|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139386486|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139386487|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
139386488|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
139386489|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
139386490|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
139386491|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386492|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386493|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139386494|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139386495|NCT02162251|Donepezil|donepezil|mesh-list
139386496|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139386497|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386498|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386499|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
139386500|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386501|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386502|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
139386503|NCT02164045|Fostemsavir|fostemsavir|mesh-list
139386504|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139386505|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139386506|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
139386507|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386508|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139386509|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139386510|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386511|NCT02410005|Calcitriol|calcitriol|mesh-list
139386512|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
139386513|NCT02410005|Losartan|losartan|mesh-list
139386514|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139386515|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139386516|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139386517|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139386518|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386519|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139386520|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386521|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139386522|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139386523|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139386524|NCT02410005|Vitamins|vitamins|mesh-ancestor
139386525|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
139386526|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139386527|NCT05543330|Cisplatin|cisplatin|mesh-list
139386528|NCT05543330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386529|NCT03174561|Choline|choline|mesh-list
139386530|NCT03174561|Silymarin|silymarin|mesh-list
139386531|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
139386532|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139386533|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
139647171|NCT04871646|Immunologic Factors|immunologic factors|mesh-ancestor
139647172|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
139647173|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647174|NCT03589014|Propranolol|propranolol|mesh-list
139647175|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139386534|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647176|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139647177|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
139386535|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139386536|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139386537|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
139386538|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
139386539|NCT03174561|Protective Agents|protective agents|mesh-ancestor
139386540|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386541|NCT05545592|Estrogens|estrogens|mesh-list
139386542|NCT05545592|Hormones|hormones|mesh-ancestor
139386543|NCT05545592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139386544|NCT05545592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386545|NCT05545436|Capecitabine|capecitabine|mesh-list
139386546|NCT05545436|Oxaliplatin|oxaliplatin|mesh-list
139386547|NCT05545436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139386548|NCT05545436|Antimetabolites|antimetabolites|mesh-ancestor
139386549|NCT05545436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386550|NCT05545436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386551|NCT02167165|Digoxin|digoxin|mesh-list
139386552|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139386553|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139386554|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386555|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386556|NCT02167165|Protective Agents|protective agents|mesh-ancestor
139386557|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386558|NCT05545124|Tislelizumab|tislelizumab|mesh-list
139386559|NCT05545124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139386560|NCT05545124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386561|NCT02409849|Octreotide|octreotide|mesh-list
139386562|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139386563|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139386564|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386565|NCT00664040|Aspirin|aspirin|mesh-list
139386566|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139386567|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139386568|NCT00664040|Analgesics|analgesics|mesh-ancestor
139386569|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
139386570|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386571|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386572|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139386573|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386574|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139386575|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139386576|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386577|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139386578|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139386579|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386580|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
139386581|NCT02162407|Insulin|insulin|mesh-list
139386582|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139386583|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
139386584|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139386585|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386586|NCT02162485|Fluticasone|fluticasone|mesh-list
139386587|NCT02162485|Xhance|xhance|mesh-list
139386588|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139386589|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139386590|NCT02162485|Charcoal|charcoal|mesh-list
139386591|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139386592|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139386593|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
139386594|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386595|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386596|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139386597|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
139386598|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
139386599|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139386600|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139386601|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139386602|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139386603|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
139386604|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386605|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386606|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
139386607|NCT02162485|Hormones|hormones|mesh-ancestor
139135510|NCT06008522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139647178|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386608|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139386609|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
139386610|NCT02162485|Antidotes|antidotes|mesh-ancestor
139386611|NCT02162485|Protective Agents|protective agents|mesh-ancestor
139386613|NCT02415777|Thiamine|thiamine|mesh-list
139386614|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139386615|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
139386616|NCT02415777|Vitamins|vitamins|mesh-ancestor
139386617|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
139043480|NCT00517829|Docetaxel|docetaxel|mesh-list
139386618|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386619|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139386620|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
139386621|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139386622|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139386623|NCT03178539|Diclofenac|diclofenac|mesh-list
139386624|NCT03178539|Ketorolac|ketorolac|mesh-list
139386625|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139386626|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139386627|NCT03178539|Analgesics|analgesics|mesh-ancestor
139386628|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
139386629|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386630|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386631|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139386632|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386633|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139386634|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386635|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386636|NCT03174483|Fluticasone|fluticasone|mesh-list
139386637|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139386638|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139386639|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
139386640|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386641|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386642|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139386643|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
139386644|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
139386645|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139386646|NCT05699174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139386647|NCT05699174|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139386648|NCT05699174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386649|NCT05699174|Antitubercular Agents|antitubercular agents|mesh-ancestor
139386650|NCT04320914|Ibuprofen|ibuprofen|mesh-list
139386651|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139386652|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139386653|NCT04320914|Analgesics|analgesics|mesh-ancestor
139386654|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
139386655|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386656|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386657|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139386658|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386659|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139386660|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386661|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386662|NCT05544812|Cetuximab|cetuximab|mesh-list
139386663|NCT05544812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139386664|NCT05544812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386665|NCT02415699|Leucovorin|leucovorin|mesh-list
139386666|NCT02415699|Fluorouracil|fluorouracil|mesh-list
139386667|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
139386668|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
139647179|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647180|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647181|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139647182|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139647183|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
139647184|NCT04884906|Paclitaxel|paclitaxel|mesh-list
139647185|NCT04884906|Cisplatin|cisplatin|mesh-list
139647186|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139647187|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647188|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
139647189|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
139386669|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386670|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139386671|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647190|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
139647191|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386672|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139386673|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
139386674|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386675|NCT02415699|Antidotes|antidotes|mesh-ancestor
139386676|NCT02415699|Protective Agents|protective agents|mesh-ancestor
139386677|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
139386678|NCT02415699|Vitamins|vitamins|mesh-ancestor
139386679|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
139386680|NCT05544656|Tolperisone|tolperisone|mesh-list
139386681|NCT05544656|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139386682|NCT05544656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386683|NCT05544656|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139386684|NCT05544656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386685|NCT02409537|Resveratrol|resveratrol|mesh-list
139386686|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
139386687|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386688|NCT02409537|Protective Agents|protective agents|mesh-ancestor
139386689|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386690|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386691|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139386692|NCT03177993|Ivermectin|ivermectin|mesh-list
139386693|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139386694|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386695|NCT04425590|Aspirin|aspirin|mesh-list
139386696|NCT04425590|Atorvastatin|atorvastatin|mesh-list
139386697|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139386698|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139386699|NCT04425590|Analgesics|analgesics|mesh-ancestor
139386700|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
139386701|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386702|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386703|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139386704|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386705|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139386706|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139386707|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386708|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139386709|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139386710|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386711|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
139386712|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139386713|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139386714|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
139386715|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138716943|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
139386716|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139386717|NCT00707889|Leucovorin|leucovorin|mesh-list
139386718|NCT00707889|Folic Acid|folic acid|mesh-list
139386719|NCT00707889|Bevacizumab|bevacizumab|mesh-list
139386720|NCT00707889|Fluorouracil|fluorouracil|mesh-list
139386721|NCT00707889|Oxaliplatin|oxaliplatin|mesh-list
139386722|NCT00707889|Levoleucovorin|levoleucovorin|mesh-list
139386723|NCT00707889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139386724|NCT00707889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386725|NCT00707889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139386726|NCT00707889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139386727|NCT00707889|Growth Substances|growth substances|mesh-ancestor
139386728|NCT00707889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386729|NCT00707889|Growth Inhibitors|growth inhibitors|mesh-ancestor
139386730|NCT00707889|Antimetabolites|antimetabolites|mesh-ancestor
139386731|NCT00707889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386732|NCT00707889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139386733|NCT00707889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139386734|NCT00707889|Immunologic Factors|immunologic factors|mesh-ancestor
139386735|NCT00707889|Antidotes|antidotes|mesh-ancestor
139386736|NCT00707889|Protective Agents|protective agents|mesh-ancestor
139386737|NCT00707889|Vitamin B Complex|vitamin b complex|mesh-ancestor
139386738|NCT00707889|Vitamins|vitamins|mesh-ancestor
139386739|NCT00707889|Micronutrients|micronutrients|mesh-ancestor
139647192|NCT03046758|Metronidazole|metronidazole|mesh-list
139647193|NCT03046758|Fosfomycin|fosfomycin|mesh-list
139386740|NCT00707889|Hematinics|hematinics|mesh-ancestor
139386741|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
139386742|NCT00109031|Etoposide|etoposide|mesh-list
139386743|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139386744|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
139386745|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386746|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139647194|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647195|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139386747|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139386748|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
139386749|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386750|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386751|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139386752|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139386753|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139386754|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139386755|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386756|NCT02419443|Gabapentin|gabapentin|mesh-list
139386757|NCT02419443|Analgesics|analgesics|mesh-ancestor
139386758|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
139386759|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386760|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386761|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
139386762|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139386763|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139386764|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139386765|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139386766|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139386767|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139386768|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386769|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386770|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
139386771|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
139386772|NCT02414919|Etonogestrel|etonogestrel|mesh-list
139386773|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139386775|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139386776|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386777|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139386778|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139386779|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139386780|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
139386781|NCT05005559|Paraproteins|paraproteins|mesh-list
139386782|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
139386783|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386784|NCT05543954|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139386785|NCT05543954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139386786|NCT05543954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386787|NCT02408679|Vitamin D|vitamin d|mesh-list
139386788|NCT02408679|Vitamins|vitamins|mesh-ancestor
139386789|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
139386790|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386791|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139386792|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
139386793|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139386794|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386795|NCT04486781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139386796|NCT04486781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386797|NCT05089565|Interferons|interferons|mesh-list
139386798|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
139386799|NCT05089565|Antibodies|antibodies|mesh-list
139386800|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
139386801|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
139386802|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386803|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386804|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
139386805|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386806|NCT03174171|Everolimus|everolimus|mesh-list
139386807|NCT03174171|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139386808|NCT03174171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139386809|NCT03174171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647196|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139647197|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139647198|NCT03825887|Morphine|morphine|mesh-list
139647199|NCT03825887|Nalbuphine|nalbuphine|mesh-list
139386810|NCT03174171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386811|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139386812|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
138886067|NCT02722343|Tenofovir|tenofovir|mesh-list
139647200|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139647201|NCT03825887|Narcotics|narcotics|mesh-ancestor
139647202|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139386813|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386815|NCT02414529|Vitamin D|vitamin d|mesh-list
139386816|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
139386817|NCT02414529|Cholecalciferol|cholecalciferol|mesh-list
139386818|NCT02414529|Vitamins|vitamins|mesh-list
139386819|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
139386820|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386821|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139386822|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139386823|NCT02418273|Denosumab|denosumab|mesh-list
139386824|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139386825|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386826|NCT02414685|Paclitaxel|paclitaxel|mesh-list
139386827|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139386828|NCT02414685|Cisplatin|cisplatin|mesh-list
139386829|NCT02414685|Ifosfamide|ifosfamide|mesh-list
139386830|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
139386831|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139386832|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386833|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
139386834|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
139386835|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
139386836|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386837|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139386838|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
139386839|NCT04425824|Rituximab|rituximab|mesh-list
139386840|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139386841|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386842|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
139386843|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386844|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139386845|NCT02414451|Propranolol|propranolol|mesh-list
139386846|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139386847|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139386848|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
139386849|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386850|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386851|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386852|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139386853|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139386854|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
139386855|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
139386856|NCT02408289|Procyanidin|procyanidin|mesh-list
139386857|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
139386858|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386859|NCT02408289|Protective Agents|protective agents|mesh-ancestor
139386860|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386861|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139386862|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139386863|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386864|NCT02417883|Furosemide|furosemide|mesh-list
139386865|NCT02417883|Diuretics|diuretics|mesh-ancestor
139386866|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
139386867|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386868|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139386869|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139386870|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386871|NCT01664624|Exenatide|exenatide|mesh-list
139386872|NCT01664624|Alogliptin|alogliptin|mesh-list
139386873|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139386874|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386875|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139386876|NCT01664624|Incretins|incretins|mesh-ancestor
139386877|NCT01664624|Hormones|hormones|mesh-ancestor
139386878|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139386879|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139386880|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
139386881|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386882|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647203|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647204|NCT03825887|Analgesics|analgesics|mesh-ancestor
139647205|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
139386883|NCT03173781|Droxidopa|droxidopa|mesh-list
139386884|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139647206|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386886|NCT05540834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139386887|NCT05540834|Plasminogen|plasminogen|mesh-list
139386888|NCT05540834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139386889|NCT05540834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139386890|NCT05540834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386891|NCT05696132|Povidone-Iodine|povidone-iodine|mesh-list
139386892|NCT05696132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139386893|NCT05696132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386894|NCT02407899|Vitamin D|vitamin d|mesh-list
139386895|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
139386896|NCT02407899|Insulin|insulin|mesh-list
139386897|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139386898|NCT02407899|Metformin|metformin|mesh-list
139386899|NCT02407899|Saxagliptin|saxagliptin|mesh-list
139386900|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139386901|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139386902|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386903|NCT02407899|Vitamins|vitamins|mesh-ancestor
139386904|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
139386905|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139386906|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139386907|NCT02407899|Incretins|incretins|mesh-ancestor
139386908|NCT02407899|Hormones|hormones|mesh-ancestor
139386909|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139386910|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
139386911|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386912|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386913|NCT02417493|Epinephrine|epinephrine|mesh-list
139386914|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139386915|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139386916|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
139386917|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386918|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386919|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386920|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139386921|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139386922|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
139386923|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386924|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139386925|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
139386926|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
139386927|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
139386928|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139386929|NCT05540600|Digoxin|digoxin|mesh-list
139386930|NCT05540600|Bisoprolol|bisoprolol|mesh-list
139386931|NCT05540600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139386932|NCT05540600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139386933|NCT05540600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386934|NCT05540600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386935|NCT05540600|Protective Agents|protective agents|mesh-ancestor
139386936|NCT05540600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386937|NCT05540600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139386938|NCT05540600|Sympatholytics|sympatholytics|mesh-ancestor
139386939|NCT05540600|Autonomic Agents|autonomic agents|mesh-ancestor
139386940|NCT05540600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386941|NCT05540600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139386942|NCT05540600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139386943|NCT05540600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139386944|NCT05540600|Adrenergic Agents|adrenergic agents|mesh-ancestor
139386945|NCT05540600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139386946|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
139386947|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139386948|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
139647207|NCT03825809|Acetaminophen|acetaminophen|mesh-list
139647208|NCT03825809|Celecoxib|celecoxib|mesh-list
139647209|NCT03825809|Ketorolac|ketorolac|mesh-list
139647210|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139647211|NCT03825809|Diazepam|diazepam|mesh-list
139647212|NCT03825809|Gabapentin|gabapentin|mesh-list
139647213|NCT03825809|Hydrocodone|hydrocodone|mesh-list
139647214|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139647215|NCT03825809|Analgesics|analgesics|mesh-ancestor
139386949|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386950|NCT03265574|Enalapril|enalapril|mesh-list
139647216|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
139386951|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139386953|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386954|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386955|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139386956|NCT03177837|Acetazolamide|acetazolamide|mesh-list
139386957|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
139386958|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139386959|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386960|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386961|NCT03177837|Diuretics|diuretics|mesh-ancestor
139386962|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
139386963|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386964|NCT02414373|Bupivacaine|bupivacaine|mesh-list
139386965|NCT02414373|Ropivacaine|ropivacaine|mesh-list
139386966|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
139386967|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
139386968|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139386969|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386970|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
139386971|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139386972|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
139386973|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139386974|NCT03173235|Vitamin D|vitamin d|mesh-list
139386975|NCT03173235|Vitamins|vitamins|mesh-ancestor
139386976|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
139386977|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386978|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139386979|NCT05697692|Heparin|heparin|mesh-list
139386980|NCT05697692|Calcium heparin|calcium heparin|mesh-list
139386981|NCT05697692|Anticoagulants|anticoagulants|mesh-ancestor
139386982|NCT05697692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139386983|NCT05697692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139386984|NCT05697692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386985|NCT02761057|Sunitinib|sunitinib|mesh-list
139386986|NCT02761057|Crizotinib|crizotinib|mesh-list
139386987|NCT02761057|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139386988|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139386989|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139386990|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139386991|NCT02761057|Growth Substances|growth substances|mesh-ancestor
139386992|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139386993|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
139386994|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139386995|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139386996|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139386997|NCT02407821|Escitalopram|escitalopram|mesh-list
139386998|NCT02407821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139386999|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139387000|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139387001|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387002|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139387003|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
139387004|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387005|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
139387006|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139387007|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387008|NCT02417337|Acetaminophen|acetaminophen|mesh-list
139387009|NCT02417337|Ibuprofen|ibuprofen|mesh-list
139387010|NCT02417337|Diclofenac|diclofenac|mesh-list
139387011|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
139387012|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139387013|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139387014|NCT02417337|Analgesics|analgesics|mesh-ancestor
139387015|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
139387016|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387017|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387018|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139387019|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139647217|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647218|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647219|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
139647220|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139387020|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139647221|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139387021|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387022|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387023|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
139387024|NCT02167321|Leucovorin|leucovorin|mesh-list
139387025|NCT02167321|Fluorouracil|fluorouracil|mesh-list
139387026|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
139387027|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
139387028|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387029|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139387030|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387031|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139387032|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
139387033|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387034|NCT02167321|Antidotes|antidotes|mesh-ancestor
139387035|NCT02167321|Protective Agents|protective agents|mesh-ancestor
139387036|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
139387037|NCT02167321|Vitamins|vitamins|mesh-ancestor
139387038|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
139387039|NCT02162797|Zinc|zinc|mesh-list
139387040|NCT02162797|Trace Elements|trace elements|mesh-ancestor
139387041|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
139387042|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387043|NCT02162875|Praziquantel|praziquantel|mesh-list
139387044|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
139387045|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139387046|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387047|NCT02167633|Pantoprazole|pantoprazole|mesh-list
139387048|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139387049|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
139387050|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139387051|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139387052|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387053|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387054|NCT02167633|Hormones|hormones|mesh-ancestor
139387055|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139387056|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387057|NCT02413281|Buprenorphine|buprenorphine|mesh-list
139387058|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139387059|NCT02413281|Narcotics|narcotics|mesh-ancestor
139387060|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387061|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387062|NCT02413281|Analgesics|analgesics|mesh-ancestor
139387063|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
139387064|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387065|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139387066|NCT02170909|Dabigatran|dabigatran|mesh-list
139387067|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
139387068|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139387069|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
139387070|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387071|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387072|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
139387073|NCT02164825|Morphine|morphine|mesh-list
139387074|NCT02164825|Ropivacaine|ropivacaine|mesh-list
139387075|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139387076|NCT02164825|Narcotics|narcotics|mesh-ancestor
139387077|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387078|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387079|NCT02164825|Analgesics|analgesics|mesh-ancestor
139387080|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
139387081|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387082|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
139387083|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
139387084|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
139387085|NCT02170987|Dabigatran|dabigatran|mesh-list
139387086|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139387087|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387088|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139387089|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139647222|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387090|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387091|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387092|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387093|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
139647223|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139387094|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139387095|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
138891797|NCT02628392|Firuglipel|firuglipel|mesh-list
139387096|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
139387097|NCT03176121|Oxycodone|oxycodone|mesh-list
139387098|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139387099|NCT03176121|Narcotics|narcotics|mesh-ancestor
139387100|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387101|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387102|NCT03176121|Analgesics|analgesics|mesh-ancestor
139387103|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
139387104|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387105|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139387106|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387107|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387108|NCT02171143|ASP2409|asp2409|mesh-list
139387109|NCT02171143|Immunoconjugates|immunoconjugates|mesh-ancestor
139387110|NCT02171143|Immunologic Factors|immunologic factors|mesh-ancestor
139387111|NCT02171143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387112|NCT03176199|Oxycodone|oxycodone|mesh-list
139387113|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139387114|NCT03176199|Narcotics|narcotics|mesh-ancestor
139387115|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387116|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387117|NCT03176199|Analgesics|analgesics|mesh-ancestor
139387118|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
139387119|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387120|NCT05697614|Lamotrigine|lamotrigine|mesh-list
139387121|NCT05697614|Carbamazepine|carbamazepine|mesh-list
139387122|NCT05697614|Phenytoin|phenytoin|mesh-list
139387123|NCT05697614|Oxcarbazepine|oxcarbazepine|mesh-list
139387124|NCT05697614|Valproic Acid|valproic acid|mesh-list
139387125|NCT05697614|Clobazam|clobazam|mesh-list
139387126|NCT05697614|Anticonvulsants|anticonvulsants|mesh-ancestor
139387127|NCT05697614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139387128|NCT05697614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139387129|NCT05697614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387130|NCT05697614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139387131|NCT05697614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387132|NCT05697614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139387133|NCT05697614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139387134|NCT05697614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387135|NCT05697614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139387136|NCT05697614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139387137|NCT05697614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387138|NCT05697614|GABA Agents|gaba agents|mesh-ancestor
139387139|NCT05697614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139387140|NCT05697614|Antimanic Agents|antimanic agents|mesh-ancestor
139387141|NCT05697614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139387142|NCT05697614|Analgesics|analgesics|mesh-ancestor
139387143|NCT05697614|Sensory System Agents|sensory system agents|mesh-ancestor
138717059|NCT05181436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387144|NCT05697614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387145|NCT05697614|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139387146|NCT05697614|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139387147|NCT05697614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139387148|NCT05697614|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139387149|NCT05697614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139387150|NCT05697614|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139387151|NCT05697614|GABA Agonists|gaba agonists|mesh-ancestor
139387152|NCT02171221|DFP-11207|dfp-11207|mesh-list
139387153|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139387154|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
139387155|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387156|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387157|NCT02413515|Nifedipine|nifedipine|mesh-list
139387158|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139387159|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139387160|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387161|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139387162|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647224|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139647225|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647226|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647227|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
139647228|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139387163|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
139387164|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
139135557|NCT06008106|Tubulin Modulators|tubulin modulators|mesh-ancestor
139647229|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139647230|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139647231|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139387165|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139387166|NCT03194906|Memantine|memantine|mesh-list
139387167|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139387168|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139387169|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
139387170|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139387171|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387172|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387173|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139387174|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139387175|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
139387176|NCT03171987|Lidocaine|lidocaine|mesh-list
139387177|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
139387178|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
139387179|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387180|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387181|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
139387182|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387183|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139387184|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139387185|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139387186|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139387187|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387188|NCT03171987|Analgesics|analgesics|mesh-ancestor
139387189|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139387190|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139387191|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139387192|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387193|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139387194|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387195|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
139387196|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139387197|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138717100|NCT00197106|Fluticasone|fluticasone|mesh-list
139387198|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387199|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139387200|NCT03172065|Analgesics|analgesics|mesh-ancestor
139387201|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
139387202|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387203|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139387204|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139387205|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139387206|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
139387207|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139387208|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387209|NCT06110598|Capecitabine|capecitabine|mesh-list
139387210|NCT06110598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139387211|NCT06110598|Antimetabolites|antimetabolites|mesh-ancestor
139387212|NCT06110598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387213|NCT06110598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387214|NCT06110546|Methadone|methadone|mesh-list
139387215|NCT06110546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139387216|NCT06110546|Narcotics|narcotics|mesh-ancestor
139387217|NCT06110546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387218|NCT06110546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387219|NCT06110546|Analgesics|analgesics|mesh-ancestor
139387220|NCT06110546|Sensory System Agents|sensory system agents|mesh-ancestor
139387221|NCT06110546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387222|NCT06110546|Antitussive Agents|antitussive agents|mesh-ancestor
139387223|NCT06110546|Respiratory System Agents|respiratory system agents|mesh-ancestor
139387224|NCT06110494|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139387226|NCT06110494|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139387227|NCT06110494|Hematinics|hematinics|mesh-ancestor
139387228|NCT06110494|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139387229|NCT06110494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139647232|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139647233|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139647234|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139387230|NCT06110494|Disinfectants|disinfectants|mesh-ancestor
139387231|NCT06110494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647235|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
139387232|NCT06110195|Paclitaxel|paclitaxel|mesh-list
139647236|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139647237|NCT03825809|Narcotics|narcotics|mesh-ancestor
139387233|NCT06110195|Carboplatin|carboplatin|mesh-list
139387234|NCT06110195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139387235|NCT06110195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387236|NCT06110195|Tubulin Modulators|tubulin modulators|mesh-ancestor
139387237|NCT06110195|Antimitotic Agents|antimitotic agents|mesh-ancestor
139387238|NCT06110195|Mitosis Modulators|mitosis modulators|mesh-ancestor
139387239|NCT06110195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387240|NCT06110078|Acetazolamide|acetazolamide|mesh-list
139387241|NCT06110078|Anticonvulsants|anticonvulsants|mesh-ancestor
139387242|NCT06110078|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139387243|NCT06110078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387244|NCT06110078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387245|NCT06110078|Diuretics|diuretics|mesh-ancestor
139387246|NCT06110078|Natriuretic Agents|natriuretic agents|mesh-ancestor
139387247|NCT06110078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387248|NCT06109701|Erythritol|erythritol|mesh-list
139387249|NCT06109701|Vasodilator Agents|vasodilator agents|mesh-ancestor
139387250|NCT06109688|Lactoferrin|lactoferrin|mesh-list
139387251|NCT06109688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387252|NCT06109649|Afamelanotide|afamelanotide|mesh-list
139387253|NCT06109649|Dermatologic Agents|dermatologic agents|mesh-ancestor
139387254|NCT06109623|Hormones|hormones|mesh-list
138717107|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387255|NCT06109623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139387256|NCT06109623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387257|NCT06109467|Leucovorin|leucovorin|mesh-list
139387258|NCT06109467|Pembrolizumab|pembrolizumab|mesh-list
139387259|NCT06109467|Trastuzumab|trastuzumab|mesh-list
139387260|NCT06109467|Fluorouracil|fluorouracil|mesh-list
139387261|NCT06109467|Oxaliplatin|oxaliplatin|mesh-list
139387262|NCT06109467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139387263|NCT06109467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387264|NCT06109467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139387265|NCT06109467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387266|NCT06109467|Antimetabolites|antimetabolites|mesh-ancestor
139387267|NCT06109467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139387268|NCT06109467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139387269|NCT06109467|Immunologic Factors|immunologic factors|mesh-ancestor
139387270|NCT06109467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387271|NCT06109467|Antidotes|antidotes|mesh-ancestor
139387272|NCT06109467|Protective Agents|protective agents|mesh-ancestor
139387273|NCT06109467|Vitamin B Complex|vitamin b complex|mesh-ancestor
139387274|NCT06109467|Vitamins|vitamins|mesh-ancestor
139387275|NCT06109467|Micronutrients|micronutrients|mesh-ancestor
139387276|NCT06109428|Acetaminophen|acetaminophen|mesh-list
139387277|NCT06109428|Ibuprofen|ibuprofen|mesh-list
139387278|NCT06109428|Bupivacaine|bupivacaine|mesh-list
139387279|NCT06109428|Anesthetics, Local|anesthetics, local|mesh-ancestor
139387280|NCT06109428|Anesthetics|anesthetics|mesh-ancestor
139387281|NCT06109428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387282|NCT06109428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387283|NCT06109428|Sensory System Agents|sensory system agents|mesh-ancestor
139387284|NCT06109428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387285|NCT06109428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139387286|NCT06109428|Analgesics|analgesics|mesh-ancestor
139387287|NCT06109428|Antipyretics|antipyretics|mesh-ancestor
139387288|NCT06109428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139387289|NCT06109428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139387290|NCT06109428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387291|NCT06109428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139387292|NCT06109428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387293|NCT06109428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387294|NCT06109415|Acetaminophen|acetaminophen|mesh-list
139387295|NCT06109415|Ibuprofen|ibuprofen|mesh-list
139387296|NCT06109415|Bupivacaine|bupivacaine|mesh-list
139387297|NCT06109415|Anesthetics, Local|anesthetics, local|mesh-ancestor
139387298|NCT06109415|Anesthetics|anesthetics|mesh-ancestor
139387299|NCT06109415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387300|NCT06109415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387301|NCT06109415|Sensory System Agents|sensory system agents|mesh-ancestor
139387302|NCT06109415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387303|NCT06109415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139387304|NCT06109415|Analgesics|analgesics|mesh-ancestor
139387305|NCT06109415|Antipyretics|antipyretics|mesh-ancestor
139387306|NCT06109415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139387307|NCT06109415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139647238|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
139387308|NCT06109415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387309|NCT06109415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139387310|NCT06109415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387311|NCT06109415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387313|NCT06109389|Anesthetics, Local|anesthetics, local|mesh-ancestor
139387314|NCT06109389|Anesthetics|anesthetics|mesh-ancestor
139387315|NCT06109389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387316|NCT06109389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387317|NCT06109389|Sensory System Agents|sensory system agents|mesh-ancestor
139387318|NCT06109389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387319|NCT06109389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139387320|NCT06109389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139387321|NCT06109389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139387322|NCT06109389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139387323|NCT06109389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387324|NCT06109155|Tranexamic Acid|tranexamic acid|mesh-list
139387325|NCT06109155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139387326|NCT06109155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139387327|NCT06109155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387328|NCT06109155|Hemostatics|hemostatics|mesh-ancestor
139387329|NCT06109155|Coagulants|coagulants|mesh-ancestor
139387330|NCT06109064|Azacitidine|azacitidine|mesh-list
139387331|NCT06109064|Venetoclax|venetoclax|mesh-list
139387332|NCT06109064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139387333|NCT06109064|Antimetabolites|antimetabolites|mesh-ancestor
139387334|NCT06109064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387335|NCT06109064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387336|NCT06109064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387337|NCT06108947|Aspirin|aspirin|mesh-list
139387338|NCT06108947|Salicylic Acid|salicylic acid|mesh-list
139387339|NCT06108947|Salicylates|salicylates|mesh-list
139387340|NCT06108947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139387341|NCT06108947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139387342|NCT06108947|Analgesics|analgesics|mesh-ancestor
139387343|NCT06108947|Sensory System Agents|sensory system agents|mesh-ancestor
139387344|NCT06108947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387345|NCT06108947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387346|NCT06108947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139387347|NCT06108947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387348|NCT06108947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139387349|NCT06108947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139387350|NCT06108947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387351|NCT06108947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139387352|NCT06108947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139387353|NCT06108947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387354|NCT06108947|Antipyretics|antipyretics|mesh-ancestor
139387355|NCT06108947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387356|NCT06108947|Antifungal Agents|antifungal agents|mesh-ancestor
139387357|NCT06108947|Keratolytic Agents|keratolytic agents|mesh-ancestor
139387358|NCT06108947|Dermatologic Agents|dermatologic agents|mesh-ancestor
139387359|NCT06108739|Cyclophosphamide|cyclophosphamide|mesh-list
139387360|NCT06108739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139387361|NCT06108739|Immunologic Factors|immunologic factors|mesh-ancestor
139387362|NCT06108739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387363|NCT06108739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387364|NCT06108739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139387365|NCT06108739|Alkylating Agents|alkylating agents|mesh-ancestor
139387366|NCT06108739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387367|NCT06108739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387368|NCT06108739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139387369|NCT06108518|Carvedilol|carvedilol|mesh-list
139387370|NCT06108518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139387371|NCT06108518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139387372|NCT06108518|Adrenergic Agents|adrenergic agents|mesh-ancestor
139387373|NCT06108518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139387374|NCT06108518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387375|NCT06108518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387376|NCT06108518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139387377|NCT06108518|Antioxidants|antioxidants|mesh-ancestor
139647239|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
139647240|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139647241|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
139647242|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
139647243|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139647244|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139647245|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139647246|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139647247|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139387378|NCT06108518|Protective Agents|protective agents|mesh-ancestor
139387379|NCT06108518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139387380|NCT06108518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139387381|NCT06108518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139387382|NCT06108518|Vasodilator Agents|vasodilator agents|mesh-ancestor
139387383|NCT06108518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139387384|NCT06108518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139387386|NCT06108453|Methotrexate|methotrexate|mesh-list
139387387|NCT06108453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139387388|NCT06108453|Abortifacient Agents|abortifacient agents|mesh-ancestor
139387389|NCT06108453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139387390|NCT06108453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387391|NCT06108453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139387392|NCT06108453|Antimetabolites|antimetabolites|mesh-ancestor
139387393|NCT06108453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387394|NCT06108453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387395|NCT06108453|Dermatologic Agents|dermatologic agents|mesh-ancestor
139387396|NCT06108453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387397|NCT06108453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139387398|NCT06108453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139387399|NCT06108453|Immunologic Factors|immunologic factors|mesh-ancestor
139387400|NCT06108453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387401|NCT06108453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139387402|NCT06108453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139387403|NCT06108453|Antitubercular Agents|antitubercular agents|mesh-ancestor
139387404|NCT06108453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139387405|NCT06108453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387406|NCT06108453|Leprostatic Agents|leprostatic agents|mesh-ancestor
139387407|NCT06108453|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139387408|NCT06108453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139387409|NCT06108453|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139387410|NCT06108453|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139387411|NCT06108453|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139387412|NCT06108453|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139387413|NCT06108414|Rivaroxaban|rivaroxaban|mesh-list
139387414|NCT06108414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139387415|NCT06108414|Antithrombins|antithrombins|mesh-ancestor
139387416|NCT06108414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139387417|NCT06108414|Protease Inhibitors|protease inhibitors|mesh-ancestor
139387418|NCT06108414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387419|NCT06108414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387420|NCT06108414|Anticoagulants|anticoagulants|mesh-ancestor
139387421|NCT06108362|Terlipressin|terlipressin|mesh-list
139387422|NCT06108362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139387423|NCT06108362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139387424|NCT06108349|Cannabidiol|cannabidiol|mesh-list
139387425|NCT06108349|Anticonvulsants|anticonvulsants|mesh-ancestor
139387426|NCT06108297|Lithium Carbonate|lithium carbonate|mesh-list
139387427|NCT06108297|Antidepressive Agents|antidepressive agents|mesh-ancestor
139387428|NCT06108297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139387429|NCT06108297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387430|NCT06108297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387431|NCT06108297|Antimanic Agents|antimanic agents|mesh-ancestor
139387432|NCT06108297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139387433|NCT06108297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387434|NCT06108297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387435|NCT06108232|Obinutuzumab|obinutuzumab|mesh-list
139387436|NCT06108232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139387437|NCT06108232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717163|NCT00587496|Aspirin|aspirin|mesh-list
139387438|NCT06107569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139387439|NCT06107569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387440|NCT06107504|Sucralfate|sucralfate|mesh-list
139387441|NCT06107504|Tranexamic Acid|tranexamic acid|mesh-list
139647248|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
139387442|NCT06107504|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139387443|NCT06107504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139387444|NCT06107504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387445|NCT06107504|Hemostatics|hemostatics|mesh-ancestor
139647249|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
139647250|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
139387446|NCT06107504|Coagulants|coagulants|mesh-ancestor
139387447|NCT06107504|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139387448|NCT06107504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139387449|NCT06105619|Etoposide|etoposide|mesh-list
139387450|NCT06105619|Temozolomide|temozolomide|mesh-list
139387451|NCT06105619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387452|NCT06105619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139387453|NCT06105619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139387454|NCT06105619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139387455|NCT06105619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044272|NCT05776108|Cabotegravir|cabotegravir|mesh-list
139387456|NCT06105619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387457|NCT06105619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139387458|NCT06105619|Alkylating Agents|alkylating agents|mesh-ancestor
139387459|NCT06105060|Acetylcysteine|acetylcysteine|mesh-list
139387460|NCT06105060|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139387461|NCT06105060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139387462|NCT06105060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139387463|NCT06105060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139387464|NCT06105060|Antimetabolites|antimetabolites|mesh-ancestor
139387465|NCT06105060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387466|NCT06105060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139387467|NCT06105060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139387468|NCT06105060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387469|NCT06105060|Antiviral Agents|antiviral agents|mesh-ancestor
139387470|NCT06105060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387471|NCT06105060|Expectorants|expectorants|mesh-ancestor
139387472|NCT06105060|Respiratory System Agents|respiratory system agents|mesh-ancestor
139387473|NCT06105060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139387474|NCT06105060|Antioxidants|antioxidants|mesh-ancestor
139387475|NCT06105060|Protective Agents|protective agents|mesh-ancestor
139387476|NCT06105060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387477|NCT06105060|Antidotes|antidotes|mesh-ancestor
139387479|NCT06104540|Emollients|emollients|mesh-ancestor
139387480|NCT06104540|Dermatologic Agents|dermatologic agents|mesh-ancestor
139387481|NCT06101147|Vitamin D|vitamin d|mesh-list
139387482|NCT06101147|Cholecalciferol|cholecalciferol|mesh-list
139387483|NCT06101147|Vitamins|vitamins|mesh-ancestor
139387484|NCT06101147|Micronutrients|micronutrients|mesh-ancestor
139387485|NCT06101147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387486|NCT06101147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139387487|NCT06101147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139387488|NCT06095128|Vedolizumab|vedolizumab|mesh-list
139387489|NCT06095128|Tofacitinib|tofacitinib|mesh-list
139387490|NCT06095128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139387491|NCT06095128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139387492|NCT06095128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387493|NCT06095128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387494|NCT06095128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139387495|NCT06094998|Insulin|insulin|mesh-list
139387496|NCT06094998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139387497|NCT06094998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387498|NCT06074692|Fluzoparib|fluzoparib|mesh-list
139387499|NCT06074692|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139387500|NCT06074692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387501|NCT06074692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387502|NCT06074692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387503|NCT06073470|Methylphenidate|methylphenidate|mesh-list
139387504|NCT06073470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139387505|NCT06073470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647251|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
139647252|NCT03824717|Ropivacaine|ropivacaine|mesh-list
139647253|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
139647254|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
139647255|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139647256|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647257|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
139647258|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647259|NCT04392557|Metformin|metformin|mesh-list
139387506|NCT06073470|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139387507|NCT06073470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139387508|NCT06073470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139135581|NCT06007222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139647260|NCT04392557|Pioglitazone|pioglitazone|mesh-list
139647261|NCT04392557|Alogliptin|alogliptin|mesh-list
139647262|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139387509|NCT06073470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387510|NCT06073470|Dopamine Agents|dopamine agents|mesh-ancestor
139387511|NCT06073470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139387512|NCT06072612|Interferons|interferons|mesh-list
139387513|NCT06072612|Cyclophosphamide|cyclophosphamide|mesh-list
139387514|NCT06072612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139387515|NCT06072612|Immunologic Factors|immunologic factors|mesh-ancestor
139387516|NCT06072612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387517|NCT06072612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387518|NCT06072612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139387519|NCT06072612|Alkylating Agents|alkylating agents|mesh-ancestor
139387520|NCT06072612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387521|NCT06072612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387522|NCT06072612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139387523|NCT06072612|Antiviral Agents|antiviral agents|mesh-ancestor
139387524|NCT06072612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387525|NCT06063486|Curcumin|curcumin|mesh-list
139387526|NCT06063486|Piperine|piperine|mesh-list
139387527|NCT06063486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139387528|NCT06063486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139387529|NCT06063486|Analgesics|analgesics|mesh-ancestor
139387530|NCT06063486|Sensory System Agents|sensory system agents|mesh-ancestor
139387531|NCT06063486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387532|NCT06063486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387533|NCT06063486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139387534|NCT06063486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387535|NCT06063486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387536|NCT06063486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387537|NCT06063486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387538|NCT06063486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139387539|NCT06043830|Acetazolamide|acetazolamide|mesh-list
139387540|NCT06043830|Anticonvulsants|anticonvulsants|mesh-ancestor
139387541|NCT06043830|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139387542|NCT06043830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387543|NCT06043830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387544|NCT06043830|Diuretics|diuretics|mesh-ancestor
139387545|NCT06043830|Natriuretic Agents|natriuretic agents|mesh-ancestor
139387546|NCT06043830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387547|NCT06026657|Gemcitabine|gemcitabine|mesh-list
139387548|NCT06026657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139387549|NCT06026657|Antibodies|antibodies|mesh-list
139387550|NCT06026657|Immunoglobulins|immunoglobulins|mesh-list
139387551|NCT06026657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139387552|NCT06026657|Immunologic Factors|immunologic factors|mesh-ancestor
139387553|NCT06026657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387554|NCT06026657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139387555|NCT06026657|Antimetabolites|antimetabolites|mesh-ancestor
139387556|NCT06026657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387557|NCT06026657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387558|NCT06003829|Denatonium|denatonium|mesh-list
139387559|NCT06003829|Aversive Agents|aversive agents|mesh-ancestor
139387560|NCT06003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387561|NCT06003829|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
139387562|NCT06003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387563|NCT06003829|Sensory System Agents|sensory system agents|mesh-ancestor
139387564|NCT06003829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387565|NCT05993975|Dexmedetomidine|dexmedetomidine|mesh-list
139387566|NCT05993975|Bupivacaine|bupivacaine|mesh-list
139387567|NCT05993975|Anesthetics, Local|anesthetics, local|mesh-ancestor
139387568|NCT05993975|Anesthetics|anesthetics|mesh-ancestor
139387569|NCT05993975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387570|NCT05993975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387571|NCT05993975|Sensory System Agents|sensory system agents|mesh-ancestor
139387572|NCT05993975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387573|NCT05993975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139387574|NCT05993975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139387575|NCT05993975|Analgesics|analgesics|mesh-ancestor
139647263|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647264|NCT04392557|Incretins|incretins|mesh-ancestor
139647265|NCT04392557|Hormones|hormones|mesh-ancestor
139647266|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139647267|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139135593|NCT06006923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647268|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
139387579|NCT05993975|Adrenergic Agents|adrenergic agents|mesh-ancestor
139387580|NCT05993975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139387581|NCT05993975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387588|NCT05970666|Bevacizumab|bevacizumab|mesh-list
139387589|NCT05970666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139387590|NCT05970666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387591|NCT05970666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139387592|NCT05970666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139387593|NCT05970666|Growth Substances|growth substances|mesh-ancestor
139387594|NCT05970666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387595|NCT05970666|Growth Inhibitors|growth inhibitors|mesh-ancestor
139387596|NCT05966025|Antihypertensive Agents|antihypertensive agents|mesh-list
139387597|NCT05966025|Hypolipidemic Agents|hypolipidemic agents|mesh-list
139387598|NCT05966025|Antimetabolites|antimetabolites|mesh-ancestor
139387599|NCT05966025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387600|NCT05966025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139387601|NCT05965531|Trifluridine|trifluridine|mesh-list
139387602|NCT05965531|Antimetabolites|antimetabolites|mesh-ancestor
139387603|NCT05965531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387604|NCT05965531|Antiviral Agents|antiviral agents|mesh-ancestor
138717223|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
139387605|NCT05965531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387606|NCT05960942|Sufentanil|sufentanil|mesh-list
139387607|NCT05960942|Propofol|propofol|mesh-list
139387608|NCT05960942|Esketamine|esketamine|mesh-list
139387609|NCT05960942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139387610|NCT05960942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387611|NCT05960942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387612|NCT05960942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139387613|NCT05960942|Anesthetics, General|anesthetics, general|mesh-ancestor
139387614|NCT05960942|Anesthetics|anesthetics|mesh-ancestor
139387615|NCT05960942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139387616|NCT05960942|Narcotics|narcotics|mesh-ancestor
139387617|NCT05960942|Analgesics|analgesics|mesh-ancestor
139387618|NCT05960942|Sensory System Agents|sensory system agents|mesh-ancestor
139387619|NCT05960942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387620|NCT05960942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139387621|NCT05960942|Antidepressive Agents|antidepressive agents|mesh-ancestor
139387622|NCT05960942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139387623|NCT05953610|Acetazolamide|acetazolamide|mesh-list
139387624|NCT05953610|Eszopiclone|eszopiclone|mesh-list
139387625|NCT05953610|Anticonvulsants|anticonvulsants|mesh-ancestor
139387626|NCT05953610|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139387627|NCT05953610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387628|NCT05953610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387629|NCT05953610|Diuretics|diuretics|mesh-ancestor
139387630|NCT05953610|Natriuretic Agents|natriuretic agents|mesh-ancestor
139387631|NCT05953610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387632|NCT05953610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139387633|NCT05953610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387634|NCT05877313|Nitric Oxide|nitric oxide|mesh-list
139387635|NCT05877313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139387636|NCT05877313|Autonomic Agents|autonomic agents|mesh-ancestor
139387637|NCT05877313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387638|NCT05877313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387639|NCT05877313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139387640|NCT05877313|Respiratory System Agents|respiratory system agents|mesh-ancestor
139387641|NCT05877313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139647272|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387642|NCT05877313|Antioxidants|antioxidants|mesh-ancestor
139387643|NCT05877313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387644|NCT05877313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139647273|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
139387645|NCT05877313|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139647275|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139387646|NCT05877313|Vasodilator Agents|vasodilator agents|mesh-ancestor
139387647|NCT05877313|Gasotransmitters|gasotransmitters|mesh-ancestor
139387648|NCT05877313|Protective Agents|protective agents|mesh-ancestor
139387649|NCT05833958|Metformin|metformin|mesh-list
139387650|NCT05833958|Dapagliflozin|dapagliflozin|mesh-list
139387651|NCT05833958|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139387652|NCT05833958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139387653|NCT05833958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387654|NCT05833958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139387655|NCT05833958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387656|NCT05833958|Incretins|incretins|mesh-ancestor
139387657|NCT05833958|Hormones|hormones|mesh-ancestor
139387658|NCT05833958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139387659|NCT05833958|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139387660|NCT05833958|Protease Inhibitors|protease inhibitors|mesh-ancestor
139387661|NCT05833958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387662|NCT05830071|Moxifloxacin|moxifloxacin|mesh-list
139387663|NCT05830071|Beclomethasone|beclomethasone|mesh-list
139387664|NCT05830071|Glycopyrrolate|glycopyrrolate|mesh-list
139387665|NCT05830071|Bromides|bromides|mesh-list
139387666|NCT05830071|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139387667|NCT05830071|Formoterol Fumarate|formoterol fumarate|mesh-list
139387668|NCT05830071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139387669|NCT05830071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387670|NCT05830071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139387671|NCT05830071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139387672|NCT05830071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717227|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387673|NCT05830071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387674|NCT05830071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387675|NCT05830071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139387676|NCT05830071|Contraceptive Agents|contraceptive agents|mesh-ancestor
139044495|NCT05226598|Tubulin Modulators|tubulin modulators|mesh-ancestor
139387677|NCT05830071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139387678|NCT05830071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387679|NCT05830071|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139387680|NCT05830071|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139387681|NCT05830071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139387682|NCT05830071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139387683|NCT05830071|Autonomic Agents|autonomic agents|mesh-ancestor
139387684|NCT05830071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387685|NCT05830071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139387686|NCT05830071|Respiratory System Agents|respiratory system agents|mesh-ancestor
139387687|NCT05830071|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139387688|NCT05830071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139387689|NCT05830071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139387690|NCT05830071|Adrenergic Agents|adrenergic agents|mesh-ancestor
139387691|NCT05830071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139387692|NCT05830071|Anticonvulsants|anticonvulsants|mesh-ancestor
139387693|NCT05830071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139387694|NCT05830071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139387695|NCT05830071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139387696|NCT05830071|Cholinergic Agents|cholinergic agents|mesh-ancestor
139387697|NCT05830071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139387698|NCT05830071|Glucocorticoids|glucocorticoids|mesh-ancestor
139387699|NCT05830071|Hormones|hormones|mesh-ancestor
139387700|NCT05830071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139387701|NCT05828836|Allopurinol|allopurinol|mesh-list
139387702|NCT05828836|Antimetabolites|antimetabolites|mesh-ancestor
139387703|NCT05828836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387704|NCT05828836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387705|NCT05828836|Gout Suppressants|gout suppressants|mesh-ancestor
139387706|NCT05828836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387707|NCT05828836|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139387708|NCT05828836|Antioxidants|antioxidants|mesh-ancestor
139387709|NCT05828836|Protective Agents|protective agents|mesh-ancestor
139647276|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139647277|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647278|NCT03824171|Vitamins|vitamins|mesh-ancestor
139647279|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
139647280|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139647281|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139647282|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
139387710|NCT05828836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647283|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139647284|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139387711|NCT05821075|Prednisolone|prednisolone|mesh-list
139387712|NCT05821075|Cerebrolysin|cerebrolysin|mesh-list
139387713|NCT05821075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139387714|NCT05821075|Glucocorticoids|glucocorticoids|mesh-ancestor
139387716|NCT05821075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139387717|NCT05821075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387718|NCT05821075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139387719|NCT05821075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387720|NCT05821075|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139387721|NCT05821075|Protective Agents|protective agents|mesh-ancestor
139387722|NCT05821075|Nootropic Agents|nootropic agents|mesh-ancestor
139387723|NCT05797233|Cyclophosphamide|cyclophosphamide|mesh-list
139387724|NCT05797233|Fludarabine|fludarabine|mesh-list
139387725|NCT05797233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139387726|NCT05797233|Immunologic Factors|immunologic factors|mesh-ancestor
139387727|NCT05797233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387728|NCT05797233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387729|NCT05797233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139387730|NCT05797233|Alkylating Agents|alkylating agents|mesh-ancestor
139387731|NCT05797233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387732|NCT05797233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387733|NCT05797233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139387734|NCT05785325|Bevacizumab|bevacizumab|mesh-list
139387735|NCT05785325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139387736|NCT05785325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387737|NCT05785325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139387738|NCT05785325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139387739|NCT05785325|Growth Substances|growth substances|mesh-ancestor
139387740|NCT05785325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387741|NCT05785325|Growth Inhibitors|growth inhibitors|mesh-ancestor
139387742|NCT05765513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139387743|NCT05756166|Interferons|interferons|mesh-list
139387744|NCT05756166|Interferon-alpha|interferon-alpha|mesh-list
139387745|NCT05756166|Interferon alpha-2|interferon alpha-2|mesh-list
139387746|NCT05756166|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
139387747|NCT05756166|Celecoxib|celecoxib|mesh-list
139387748|NCT05756166|Pembrolizumab|pembrolizumab|mesh-list
139387749|NCT05756166|Benzenesulfonamide|benzenesulfonamide|mesh-list
139387750|NCT05756166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139387751|NCT05756166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387752|NCT05756166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139387753|NCT05756166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387754|NCT05756166|Antiviral Agents|antiviral agents|mesh-ancestor
139387755|NCT05756166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387756|NCT05756166|Immunologic Factors|immunologic factors|mesh-ancestor
139387757|NCT05756166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387758|NCT05756166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139387759|NCT05756166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139387760|NCT05756166|Analgesics|analgesics|mesh-ancestor
139387761|NCT05756166|Sensory System Agents|sensory system agents|mesh-ancestor
139387762|NCT05756166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387763|NCT05756166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139387764|NCT05756166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387765|NCT05756166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139387766|NCT05756166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139387767|NCT05756166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387768|NCT05756166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139387769|NCT05719831|Amoxicillin|amoxicillin|mesh-list
139387770|NCT05719831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139387771|NCT05719831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387772|NCT05704400|Rituximab|rituximab|mesh-list
139387773|NCT05704400|Daratumumab|daratumumab|mesh-list
139387774|NCT05704400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139387775|NCT05704400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387776|NCT05704400|Immunologic Factors|immunologic factors|mesh-ancestor
139387777|NCT05704400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387778|NCT05704400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387779|NCT05660941|Insulin Lispro|insulin lispro|mesh-list
139387780|NCT05660941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139387781|NCT05660941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387782|NCT05629546|Nivolumab|nivolumab|mesh-list
139135614|NCT06006663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139387783|NCT05629546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139647285|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139387784|NCT05629546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387785|NCT05629546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139387786|NCT05629546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387788|NCT05624866|Dexmedetomidine|dexmedetomidine|mesh-list
139387789|NCT05624866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139387790|NCT05624866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387791|NCT05624866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387792|NCT05624866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139387793|NCT05624866|Analgesics|analgesics|mesh-ancestor
139387794|NCT05624866|Sensory System Agents|sensory system agents|mesh-ancestor
139387795|NCT05624866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387796|NCT05624866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139387797|NCT05624866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139387798|NCT05624866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139387799|NCT05624866|Adrenergic Agents|adrenergic agents|mesh-ancestor
139387800|NCT05624866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139387801|NCT05624866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387802|NCT05624866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139387803|NCT05624866|Glucocorticoids|glucocorticoids|mesh-ancestor
139387804|NCT05624866|Hormones|hormones|mesh-ancestor
139387805|NCT05624866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139387806|NCT05613361|Colistin|colistin|mesh-list
139387807|NCT05613361|Curcumin|curcumin|mesh-list
139387808|NCT05613361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139387809|NCT05613361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139387810|NCT05613361|Analgesics|analgesics|mesh-ancestor
139387811|NCT05613361|Sensory System Agents|sensory system agents|mesh-ancestor
139387812|NCT05613361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387813|NCT05613361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387814|NCT05613361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139387815|NCT05613361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387816|NCT05613361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387817|NCT05613361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387818|NCT05613361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387819|NCT05613361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139387820|NCT05613361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387821|NCT05591092|Iodine|iodine|mesh-list
139387822|NCT05591092|Cadexomer iodine|cadexomer iodine|mesh-list
139387823|NCT05591092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139387824|NCT05591092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139387825|NCT05591092|Trace Elements|trace elements|mesh-ancestor
139387826|NCT05591092|Micronutrients|micronutrients|mesh-ancestor
139387827|NCT05591092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387828|NCT05579665|Hyaluronic Acid|hyaluronic acid|mesh-list
139387829|NCT05579665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139387830|NCT05579665|Immunologic Factors|immunologic factors|mesh-ancestor
139387831|NCT05579665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387832|NCT05579665|Viscosupplements|viscosupplements|mesh-ancestor
139387833|NCT05579665|Protective Agents|protective agents|mesh-ancestor
139387834|NCT05565378|Pembrolizumab|pembrolizumab|mesh-list
139387835|NCT05565378|Dostarlimab|dostarlimab|mesh-list
139387836|NCT05565378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139387837|NCT05565378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387838|NCT05565378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139387839|NCT05565378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387840|NCT05558098|Dapagliflozin|dapagliflozin|mesh-list
139387841|NCT05558098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138717273|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387842|NCT05558098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387843|NCT05558098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139387844|NCT05558098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387845|NCT05510115|Empagliflozin|empagliflozin|mesh-list
139387846|NCT05510115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139387847|NCT05510115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387848|NCT05510115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139387849|NCT05510115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387850|NCT05501548|Ascorbic Acid|ascorbic acid|mesh-list
139387851|NCT05501548|Olaparib|olaparib|mesh-list
139647286|NCT02946125|Phenylephrine|phenylephrine|mesh-list
139647287|NCT02946125|Oxymetazoline|oxymetazoline|mesh-list
139387852|NCT05501548|Vitamins|vitamins|mesh-ancestor
139387853|NCT05501548|Micronutrients|micronutrients|mesh-ancestor
139387854|NCT05501548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387855|NCT05501548|Antioxidants|antioxidants|mesh-ancestor
139387856|NCT05501548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387857|NCT05501548|Protective Agents|protective agents|mesh-ancestor
139387858|NCT05501548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139387859|NCT05501548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387860|NCT05501548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387861|NCT05422885|Dasatinib|dasatinib|mesh-list
139387862|NCT05422885|Quercetin|quercetin|mesh-list
139387863|NCT05422885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387864|NCT05422885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139387865|NCT05422885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387866|NCT05422885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387867|NCT05422885|Antioxidants|antioxidants|mesh-ancestor
139387868|NCT05422885|Protective Agents|protective agents|mesh-ancestor
139387869|NCT05422885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387870|NCT05407233|Insulin|insulin|mesh-list
139387871|NCT05407233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139387872|NCT05407233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139387873|NCT05407233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387874|NCT05391893|Diltiazem|diltiazem|mesh-list
139387875|NCT05391893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139387876|NCT05391893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139387877|NCT05391893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139387878|NCT05391893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387879|NCT05391893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139387880|NCT05391893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387881|NCT05391893|Vasodilator Agents|vasodilator agents|mesh-ancestor
139387882|NCT05367336|Fentanyl|fentanyl|mesh-list
139387883|NCT05367336|Morphine|morphine|mesh-list
139387884|NCT05367336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139387885|NCT05367336|Narcotics|narcotics|mesh-ancestor
139387886|NCT05367336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387887|NCT05367336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387888|NCT05367336|Analgesics|analgesics|mesh-ancestor
139387889|NCT05367336|Sensory System Agents|sensory system agents|mesh-ancestor
139387890|NCT05367336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387891|NCT05367336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139387892|NCT05367336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139387893|NCT05367336|Anesthetics, General|anesthetics, general|mesh-ancestor
139387894|NCT05367336|Anesthetics|anesthetics|mesh-ancestor
139387895|NCT05359133|Tetrodotoxin|tetrodotoxin|mesh-list
139387896|NCT05359133|Anesthetics, Local|anesthetics, local|mesh-ancestor
139387897|NCT05359133|Anesthetics|anesthetics|mesh-ancestor
139387898|NCT05359133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387899|NCT05359133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387900|NCT05359133|Sensory System Agents|sensory system agents|mesh-ancestor
139387901|NCT05359133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387902|NCT05359133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139387903|NCT05359133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139387904|NCT05359133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387906|NCT05351502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139387907|NCT05351502|Autonomic Agents|autonomic agents|mesh-ancestor
139387908|NCT05351502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387909|NCT05351502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387910|NCT05351502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139387911|NCT05351502|Respiratory System Agents|respiratory system agents|mesh-ancestor
139387912|NCT05351502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139387913|NCT05351502|Antioxidants|antioxidants|mesh-ancestor
139387914|NCT05351502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387915|NCT05351502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139387916|NCT05351502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139387917|NCT05351502|Vasodilator Agents|vasodilator agents|mesh-ancestor
139387918|NCT05351502|Gasotransmitters|gasotransmitters|mesh-ancestor
139387919|NCT05351502|Protective Agents|protective agents|mesh-ancestor
139387920|NCT05280223|Dexmedetomidine|dexmedetomidine|mesh-list
139387921|NCT05280223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139387922|NCT05280223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135622|NCT06006650|Paclitaxel|paclitaxel|mesh-list
139647288|NCT02946125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139647289|NCT02946125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139647290|NCT02946125|Mydriatics|mydriatics|mesh-ancestor
139647291|NCT02946125|Autonomic Agents|autonomic agents|mesh-ancestor
139647292|NCT02946125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647293|NCT02946125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387923|NCT05280223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387924|NCT05280223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139387925|NCT05280223|Analgesics|analgesics|mesh-ancestor
139387926|NCT05280223|Sensory System Agents|sensory system agents|mesh-ancestor
139387927|NCT05280223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387928|NCT05280223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139387929|NCT05280223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139387930|NCT05280223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139387931|NCT05280223|Adrenergic Agents|adrenergic agents|mesh-ancestor
139387932|NCT05280223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139387933|NCT05280223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387934|NCT05238506|Lidocaine|lidocaine|mesh-list
139387935|NCT05238506|Anesthetics, Local|anesthetics, local|mesh-ancestor
139387936|NCT05238506|Anesthetics|anesthetics|mesh-ancestor
139387937|NCT05238506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387938|NCT05238506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387939|NCT05238506|Sensory System Agents|sensory system agents|mesh-ancestor
139387940|NCT05238506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387941|NCT05238506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139387942|NCT05238506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139387943|NCT05238506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139387944|NCT05238506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139387945|NCT05238506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387946|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139387947|NCT05216328|Antacids|antacids|mesh-ancestor
139387948|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387949|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139387950|NCT05177991|Bupivacaine|bupivacaine|mesh-list
139387951|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
139387952|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
139387953|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138717300|NCT00564200|Dexamethasone|dexamethasone|mesh-list
139387954|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387955|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
139387956|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387957|NCT05141877|Anesthetics|anesthetics|mesh-list
139387958|NCT05141877|Propofol|propofol|mesh-list
139387959|NCT05141877|Sevoflurane|sevoflurane|mesh-list
139387960|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139387961|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387962|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139387963|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139387964|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
139387965|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139387966|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139387967|NCT05120622|Tremelimumab|tremelimumab|mesh-list
139387968|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387969|NCT05099666|Doxorubicin|doxorubicin|mesh-list
139387970|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139387971|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139387972|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139387973|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139387974|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139387975|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139387976|NCT05090124|Adalimumab|adalimumab|mesh-list
139387977|NCT05090124|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139387978|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139387979|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387980|NCT05036577|Dexamethasone|dexamethasone|mesh-list
139387981|NCT05036577|Rituximab|rituximab|mesh-list
139387982|NCT05036577|Methotrexate|methotrexate|mesh-list
139387983|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139387984|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
139387985|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
139387986|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139387987|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139387988|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139387989|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
139387990|NCT05036577|Hormones|hormones|mesh-ancestor
139387991|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139387992|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139387993|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647294|NCT02946125|Sympathomimetics|sympathomimetics|mesh-ancestor
139647295|NCT02946125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139135626|NCT06006650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647296|NCT02946125|Nasal Decongestants|nasal decongestants|mesh-ancestor
139647297|NCT02946125|Respiratory System Agents|respiratory system agents|mesh-ancestor
139387994|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139387995|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
139387996|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139387997|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139387998|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
139387999|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139388000|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139388001|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
139388002|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388003|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
139388004|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388005|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139388006|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388007|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139388008|NCT05017116|Entecavir|entecavir|mesh-list
139388009|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
139388010|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138717337|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
139388011|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139388012|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139388013|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
139388014|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139388015|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139388016|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388017|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139388018|NCT04946396|Analgesics|analgesics|mesh-ancestor
139388019|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
139388020|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388021|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139388022|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139388023|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139388024|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
139388025|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139388026|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388027|NCT04932135|Hormones|hormones|mesh-list
139388028|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139388029|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388030|NCT04903314|Cenobamate|cenobamate|mesh-list
139388031|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
139388032|NCT04892875|Cisplatin|cisplatin|mesh-list
139388033|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388034|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
139388035|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139388036|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139388037|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388038|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
139388039|NCT04818866|Coagulants|coagulants|mesh-ancestor
139388040|NCT04817826|Durvalumab|durvalumab|mesh-list
139388041|NCT04817826|Tremelimumab|tremelimumab|mesh-list
139388042|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139388043|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388044|NCT04794842|Phenol|phenol|mesh-list
139388045|NCT04794842|Tetracaine|tetracaine|mesh-list
139388046|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
139388047|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
139388048|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139388049|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388050|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
139388051|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044882|NCT04240002|Cytarabine|cytarabine|mesh-list
139388052|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139388053|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139388054|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
139388055|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139388056|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139388057|NCT04770155|Bosentan|bosentan|mesh-list
139388058|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
139647298|NCT02946125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139647299|NCT02946125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139647300|NCT02946125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139388059|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
139388060|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139388061|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139388062|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135629|NCT06006650|Mitosis Modulators|mitosis modulators|mesh-ancestor
139647301|NCT02946125|Adrenergic Agents|adrenergic agents|mesh-ancestor
139388063|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388064|NCT04770155|Urological Agents|urological agents|mesh-ancestor
139388065|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139388066|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139388067|NCT04753203|Capecitabine|capecitabine|mesh-list
139388068|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139388069|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
139388070|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388071|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388072|NCT04751955|Capecitabine|capecitabine|mesh-list
139388073|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139388074|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
139388075|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388076|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388077|NCT04734080|Dronabinol|dronabinol|mesh-list
139388078|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
139388079|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388080|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139388081|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139388082|NCT04734080|Analgesics|analgesics|mesh-ancestor
139388083|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
139388084|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388085|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139388086|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139388087|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139388088|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388089|NCT04734080|Hormones|hormones|mesh-ancestor
139388090|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139388091|NCT04709276|Carboplatin|carboplatin|mesh-list
139388092|NCT04709276|Nivolumab|nivolumab|mesh-list
139388093|NCT04709276|Ipilimumab|ipilimumab|mesh-list
139388094|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388095|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139388096|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139388097|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388098|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
139388099|NCT04696731|Fludarabine|fludarabine|mesh-list
139388100|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388101|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
139388102|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388103|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139388104|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139388105|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
139388106|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388107|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388108|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139388109|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139388110|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139388111|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139388112|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
139388113|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
139388114|NCT04645719|Analgesics|analgesics|mesh-ancestor
139388115|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
139388116|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388117|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388118|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
138717377|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139388119|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139388120|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139388121|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
139388122|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139388123|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139044962|NCT03962647|Letrozole|letrozole|mesh-list
139388124|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388125|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139388126|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
139388127|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139388128|NCT04601324|Fluticasone|fluticasone|mesh-list
139388129|NCT04601324|Xhance|xhance|mesh-list
139388130|NCT04601324|Azelastine|azelastine|mesh-list
139647302|NCT02946125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139647303|NCT02946125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647304|NCT02946125|Protective Agents|protective agents|mesh-ancestor
139647305|NCT02946125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139388131|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139388132|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139388133|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
139388134|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388135|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388136|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139388137|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
139388138|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
139388139|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139388140|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139388141|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388142|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388143|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139388144|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139388145|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
139388146|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
139388147|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139388148|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139388149|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139388150|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388151|NCT04561739|Sirolimus|sirolimus|mesh-list
139388152|NCT04561739|Paclitaxel|paclitaxel|mesh-list
139388153|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139388154|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388155|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
139388156|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
139388157|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
139388158|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388159|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139388160|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139388161|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139388162|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
139388163|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388164|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
139388165|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388166|NCT04547439|Melatonin|melatonin|mesh-list
139388167|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
139388168|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388169|NCT04547439|Protective Agents|protective agents|mesh-ancestor
139388170|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388171|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139388172|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
139388173|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139388174|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139388175|NCT04519476|Prednisolone|prednisolone|mesh-list
139388176|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
139388177|NCT04519476|Lenalidomide|lenalidomide|mesh-list
139388178|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139388179|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
139388180|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
139388181|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388182|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139388183|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139388184|NCT04519476|Growth Substances|growth substances|mesh-ancestor
139388185|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
139388186|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388187|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139388188|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
139388189|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
139388190|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388191|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139388192|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
139388193|NCT04519476|Hormones|hormones|mesh-ancestor
139388194|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139388195|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139388196|NCT04519476|Protective Agents|protective agents|mesh-ancestor
139388197|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139388198|NCT04498234|Bupivacaine|bupivacaine|mesh-list
139388199|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
139388200|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
139388201|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139647306|NCT01895257|Leucovorin|leucovorin|mesh-list
139647307|NCT01895257|Fluorouracil|fluorouracil|mesh-list
139647308|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
139388202|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647309|NCT01895257|Antidotes|antidotes|mesh-ancestor
139388203|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
139388204|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647310|NCT01895257|Protective Agents|protective agents|mesh-ancestor
139388205|NCT04446351|Dostarlimab|dostarlimab|mesh-list
139388206|NCT04446351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388207|NCT04367233|Anesthetics|anesthetics|mesh-list
138717411|NCT00192075|Hematinics|hematinics|mesh-ancestor
139388208|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139388209|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388210|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
139388211|NCT04363164|Testosterone|testosterone|mesh-list
139388212|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
139388213|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
139388214|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139388215|NCT04363164|Androgens|androgens|mesh-ancestor
139388216|NCT04363164|Hormones|hormones|mesh-ancestor
139388217|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139388218|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388219|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139388220|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388221|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
139388222|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
139388223|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139388224|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388225|NCT04199728|Liraglutide|liraglutide|mesh-list
139388226|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139388227|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388228|NCT04199728|Incretins|incretins|mesh-ancestor
139388229|NCT04199728|Hormones|hormones|mesh-ancestor
139388230|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139388231|NCT04156347|Topotecan|topotecan|mesh-list
139388232|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139388233|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139388234|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388235|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388236|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388237|NCT04044534|Insulin|insulin|mesh-list
139388238|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139388239|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388240|NCT04039464|Bosentan|bosentan|mesh-list
139388241|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
139388242|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
139388243|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139388244|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139388245|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388246|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388247|NCT04039464|Urological Agents|urological agents|mesh-ancestor
139388248|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139388249|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139388250|NCT03974139|Metformin|metformin|mesh-list
139388251|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139388252|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388253|NCT03968822|Lidocaine|lidocaine|mesh-list
139388254|NCT03968822|Bupivacaine|bupivacaine|mesh-list
139388255|NCT03968822|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139388256|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
139388257|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
139388258|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139388259|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388260|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
139388261|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388262|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139388263|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139388264|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139388265|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139388266|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388267|NCT03968822|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139388268|NCT03968822|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139388269|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139388270|NCT03960008|Doxorubicin|doxorubicin|mesh-list
139647311|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647312|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
139647313|NCT01895257|Vitamins|vitamins|mesh-ancestor
139647314|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
139647315|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
139647316|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135647|NCT06006624|Hormones|hormones|mesh-ancestor
139388271|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139388272|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139388273|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388274|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139388275|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139388276|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388277|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388278|NCT03946800|Durvalumab|durvalumab|mesh-list
139388279|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139388280|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388281|NCT03932136|Sulforaphane|sulforaphane|mesh-list
139388282|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139388283|NCT03932136|Protective Agents|protective agents|mesh-ancestor
139388284|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388285|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388286|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
139388287|NCT03898180|Lenvatinib|lenvatinib|mesh-list
139388288|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139388289|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388290|NCT03898180|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139388291|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388292|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139388293|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388294|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
139388295|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139388296|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139388297|NCT03804229|Protective Agents|protective agents|mesh-ancestor
139388298|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388299|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
139388300|NCT03797326|Lenvatinib|lenvatinib|mesh-list
139388301|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139388302|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388303|NCT03797326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139388304|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388305|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139388306|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388307|NCT03781700|Prednisolone|prednisolone|mesh-list
139388308|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139388309|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
139388310|NCT03781700|Hormones|hormones|mesh-ancestor
139388311|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139388312|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388313|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139388314|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388315|NCT03749018|Prednisone|prednisone|mesh-list
139388316|NCT03749018|Cortisone|cortisone|mesh-list
139388317|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
139388318|NCT03749018|Rituximab|rituximab|mesh-list
139388319|NCT03749018|Doxorubicin|doxorubicin|mesh-list
139388320|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139388321|NCT03749018|Nivolumab|nivolumab|mesh-list
139388322|NCT03749018|Etoposide|etoposide|mesh-list
139388323|NCT03749018|Vincristine|vincristine|mesh-list
139388324|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
139388325|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
139388326|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139388327|NCT03749018|Antibodies|antibodies|mesh-list
139388328|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
139388329|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139388330|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388331|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
139388332|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388333|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139388334|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139388335|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
139388336|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388337|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388338|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139388339|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139388340|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139388341|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139647317|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139647318|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388342|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647319|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388343|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139647321|NCT04392713|Ivermectin|ivermectin|mesh-list
139647322|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139388344|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
139388345|NCT03749018|Hormones|hormones|mesh-ancestor
139388346|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139388347|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139388348|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139388349|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139388350|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
139388351|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
139388352|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
139388353|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
139388354|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
139388355|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139388356|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139388357|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139388358|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388359|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388360|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139388361|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139388362|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388363|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
139388364|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139388365|NCT03691376|Aldesleukin|aldesleukin|mesh-list
139388366|NCT03691376|Melphalan|melphalan|mesh-list
139388367|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
139388368|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139388369|NCT03691376|Interleukin-2|interleukin-2|mesh-list
139388370|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139388371|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
139388372|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388373|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388374|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139388375|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388376|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
139388377|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388378|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139388379|NCT03691376|Analgesics|analgesics|mesh-ancestor
139388380|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
139388381|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388382|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139388383|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139388384|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
139388385|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139388386|NCT03637400|Doxycycline|doxycycline|mesh-list
139388387|NCT03637400|Trimethoprim|trimethoprim|mesh-list
139388388|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
139388389|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139388390|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139388391|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
139388392|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139388393|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139388394|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139388395|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139388396|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388397|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388398|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139388399|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139388400|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139388401|NCT03586453|Osimertinib|osimertinib|mesh-list
139388402|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388403|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139388404|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388405|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388406|NCT03583255|Dexamethasone|dexamethasone|mesh-list
139388407|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
139388408|NCT03583255|Ichthammol|ichthammol|mesh-list
139388409|NCT03583255|BB 1101|bb 1101|mesh-list
139388410|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139647323|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647324|NCT03823625|Nivolumab|nivolumab|mesh-list
139647325|NCT03823625|Ipilimumab|ipilimumab|mesh-list
139388411|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
139388412|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
139388413|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647326|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139647327|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647328|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139647329|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388414|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388415|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139388416|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
139388417|NCT03583255|Hormones|hormones|mesh-ancestor
139388418|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139388419|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139388420|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388421|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
139388422|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388423|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388424|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
139388425|NCT03530124|Vaccines|vaccines|mesh-list
139388426|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139388427|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
139388428|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388430|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
139388431|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
139388432|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139388433|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388434|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
139388435|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388436|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139388437|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139388438|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139388439|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139388440|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388441|NCT03471143|Betadex|betadex|mesh-list
139388442|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
139388443|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388444|NCT03412591|Suvorexant|suvorexant|mesh-list
139388445|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139388446|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139388447|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139388448|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388449|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139388450|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139388451|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388452|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139388453|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139388454|NCT03409432|Lenalidomide|lenalidomide|mesh-list
139388455|NCT03409432|Antibodies|antibodies|mesh-list
139388456|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
139388457|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139388458|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
139388459|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
138717560|NCT00198276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388460|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388461|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388462|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139388463|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139388464|NCT03409432|Growth Substances|growth substances|mesh-ancestor
139388465|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
139388466|NCT03409432|Immunotoxins|immunotoxins|mesh-ancestor
139388467|NCT03326245|Methylphenidate|methylphenidate|mesh-list
139388468|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139388469|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388470|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139388471|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139388472|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139388473|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388474|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
139388475|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139388476|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
139388477|NCT03323476|Prednisone|prednisone|mesh-list
139647330|NCT02053909|Aspirin|aspirin|mesh-list
139647331|NCT02053909|Ticagrelor|ticagrelor|mesh-list
139647332|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139388478|NCT03323476|Rituximab|rituximab|mesh-list
139388479|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139135662|NCT06006091|Letrozole|letrozole|mesh-list
139647333|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139388480|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139388481|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388482|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
139388483|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388484|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139388485|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139388486|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139388487|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
139388488|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139388489|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139388490|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388491|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388492|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139388493|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
139388494|NCT03323476|Hormones|hormones|mesh-ancestor
139388495|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139388496|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139388497|NCT03315312|Fluorides|fluorides|mesh-list
139388498|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
139388499|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
139388500|NCT03315312|Protective Agents|protective agents|mesh-ancestor
139388501|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388502|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
139388503|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139388504|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139388505|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388506|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139388507|NCT03289325|Analgesics|analgesics|mesh-ancestor
139388508|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
139388509|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388510|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139388511|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139388512|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139388513|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
139388514|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139388515|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388516|NCT03190954|Raclopride|raclopride|mesh-list
139388517|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139388518|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139388519|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139388520|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388521|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139388522|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139388523|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
139388524|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139388525|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388526|NCT03122717|Gefitinib|gefitinib|mesh-list
139388527|NCT03122717|Osimertinib|osimertinib|mesh-list
139388528|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388529|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139388530|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388531|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388532|NCT03006068|Upadacitinib|upadacitinib|mesh-list
139388533|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139388534|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139388535|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388536|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388537|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139388538|NCT02965703|Aspirin|aspirin|mesh-list
139388539|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139388540|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139388541|NCT02965703|Analgesics|analgesics|mesh-ancestor
139388542|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
139388543|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388544|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388545|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139388546|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139388547|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139647334|NCT02053909|Analgesics|analgesics|mesh-ancestor
139647335|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
139647336|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647337|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647338|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139647339|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139647340|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139647341|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139647342|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388548|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139388549|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388550|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139388551|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139388552|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388553|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
139388554|NCT02926196|Avelumab|avelumab|mesh-list
139388555|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139388556|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388557|NCT02772003|Interleukin-12|interleukin-12|mesh-list
139388558|NCT02772003|Vaccines|vaccines|mesh-list
139388559|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
139388560|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388561|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139388562|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139388563|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139388564|NCT02772003|Growth Substances|growth substances|mesh-ancestor
139388565|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
139388566|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388567|NCT02708394|Olanzapine|olanzapine|mesh-list
139388568|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
139388569|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
139388570|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388571|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388572|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139388573|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139388574|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139388575|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139388576|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139388577|NCT02708394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139388578|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139388579|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139388580|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388581|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139388582|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
139388583|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
139388584|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388585|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139388586|NCT02662062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139388587|NCT02662062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388588|NCT02649855|Docetaxel|docetaxel|mesh-list
139388589|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388590|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
139388591|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
139388592|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
139388593|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388594|NCT02619682|Lenalidomide|lenalidomide|mesh-list
139388595|NCT02619682|Ixazomib|ixazomib|mesh-list
139388596|NCT02619682|Glycine|glycine|mesh-list
139388597|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
139388598|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388599|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139388600|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139388601|NCT02619682|Growth Substances|growth substances|mesh-ancestor
139388602|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
139388603|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388604|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388605|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
139388606|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388607|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
139388608|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139388609|NCT02613507|Docetaxel|docetaxel|mesh-list
139388610|NCT02613507|Nivolumab|nivolumab|mesh-list
139388611|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388612|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
139388613|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
139388614|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
139388615|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647343|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139388616|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139135672|NCT06005870|Zanubrutinib|zanubrutinib|mesh-list
139647344|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139647345|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388617|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139388619|NCT02538510|Vorinostat|vorinostat|mesh-list
139388620|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139388621|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388622|NCT02538510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139388623|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388624|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139388625|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388626|NCT02521285|Aspirin|aspirin|mesh-list
139388627|NCT02521285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139388628|NCT02521285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139388629|NCT02521285|Analgesics|analgesics|mesh-ancestor
139388630|NCT02521285|Sensory System Agents|sensory system agents|mesh-ancestor
139388631|NCT02521285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388632|NCT02521285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388633|NCT02521285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139388634|NCT02521285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139388635|NCT02521285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139388636|NCT02521285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139388637|NCT02521285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388638|NCT02521285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139388639|NCT02521285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139388640|NCT02521285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388641|NCT02521285|Antipyretics|antipyretics|mesh-ancestor
139388642|NCT02436226|Citric Acid|citric acid|mesh-list
139388643|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
139388644|NCT02436226|Clomiphene|clomiphene|mesh-list
139388645|NCT02436226|Enclomiphene|enclomiphene|mesh-list
139388646|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
139388647|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139045474|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139388648|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
139388649|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139388650|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
139388651|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
139388652|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388653|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139388654|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
139388655|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139388656|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388657|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139388658|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
139388659|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139388660|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139388661|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139388662|NCT02419040|Lidocaine|lidocaine|mesh-list
139388663|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
139388664|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
139388665|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139388666|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388667|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
139388668|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388669|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139388670|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139388671|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139388672|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139388673|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388674|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
139388675|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139388676|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388677|NCT02407171|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139388678|NCT02407171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388679|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
139388680|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388681|NCT02381535|Cisplatin|cisplatin|mesh-list
139647346|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
139647347|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139647348|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139388682|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388683|NCT02331134|Lenograstim|lenograstim|mesh-list
139135678|NCT06002789|Antibodies|antibodies|mesh-list
139647349|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139647350|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
139647351|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139647352|NCT02863991|TIC10 compound|tic10 compound|mesh-list
139388684|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139388685|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
139388686|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388687|NCT02303171|Enoxaparin|enoxaparin|mesh-list
139388688|NCT02303171|Warfarin|warfarin|mesh-list
139388689|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
139388690|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138717633|NCT00564824|Caffeine|caffeine|mesh-list
139388691|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139388692|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388693|NCT02233829|Dopamine|dopamine|mesh-list
139388694|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139388695|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
139388696|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
139388697|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388698|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388699|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
139388700|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139388701|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388702|NCT02233829|Protective Agents|protective agents|mesh-ancestor
139388703|NCT02135042|Paclitaxel|paclitaxel|mesh-list
139388704|NCT02135042|Cisplatin|cisplatin|mesh-list
139388705|NCT02135042|Gemcitabine|gemcitabine|mesh-list
139388706|NCT02135042|Fluorouracil|fluorouracil|mesh-list
139388707|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139388708|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139388709|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388710|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
139388711|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
139388712|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
139388713|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388714|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139388715|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
139388716|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388717|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
139388718|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388719|NCT01693601|Panobinostat|panobinostat|mesh-list
139388720|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388721|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139388722|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388723|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388724|NCT01671982|Tenofovir|tenofovir|mesh-list
139388725|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
139388726|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139388727|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139388728|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139388729|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388730|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388731|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139388732|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139388733|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139388734|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139388735|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139388736|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388737|NCT01508312|Immunotoxins|immunotoxins|mesh-ancestor
139388738|NCT01508312|Immunoconjugates|immunoconjugates|mesh-ancestor
139388739|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
139388740|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388741|NCT00082706|Leucovorin|leucovorin|mesh-list
139388742|NCT00082706|Cisplatin|cisplatin|mesh-list
139388743|NCT00082706|Gemcitabine|gemcitabine|mesh-list
139388744|NCT00082706|Fluorouracil|fluorouracil|mesh-list
139388745|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388746|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139388747|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
139388748|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388749|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388750|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
139388751|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647353|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647354|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
139388752|NCT00082706|Antidotes|antidotes|mesh-ancestor
139388753|NCT00082706|Protective Agents|protective agents|mesh-ancestor
139647355|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139388754|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
139388755|NCT00082706|Vitamins|vitamins|mesh-ancestor
139388756|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
139388757|NCT00020345|Gemcitabine|gemcitabine|mesh-list
139388758|NCT00020345|Fluorouracil|fluorouracil|mesh-list
139388759|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139388760|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
139388761|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388762|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388763|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388764|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
139388765|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388766|NCT00020046|Thalidomide|thalidomide|mesh-list
139388767|NCT00020046|Docetaxel|docetaxel|mesh-list
139388768|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388769|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
139388770|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
139388771|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
139388772|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388773|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388774|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
139388775|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388776|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
139388777|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139388778|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139388779|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139388780|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139388781|NCT00020046|Growth Substances|growth substances|mesh-ancestor
139388782|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
139388783|NCT00019968|Melphalan|melphalan|mesh-list
139388784|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139388785|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
139388786|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388787|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388788|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139388789|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388790|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
139388791|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388792|NCT00019760|Leucovorin|leucovorin|mesh-list
139388793|NCT00019760|Melphalan|melphalan|mesh-list
139388794|NCT00019760|Floxuridine|floxuridine|mesh-list
139388795|NCT00019760|Calcium|calcium|mesh-list
139045622|NCT00110890|Cinacalcet|cinacalcet|mesh-list
139388796|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
139388797|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139388798|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388799|NCT00019760|Antidotes|antidotes|mesh-ancestor
139388800|NCT00019760|Protective Agents|protective agents|mesh-ancestor
139388801|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
139388802|NCT00019760|Vitamins|vitamins|mesh-ancestor
139388803|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
139388804|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139388805|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
139388806|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388807|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388808|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139388809|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388810|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
139388811|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139388812|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
139388813|NCT02171299|Ropivacaine|ropivacaine|mesh-list
139388814|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
139388815|NCT02171299|Anesthetics|anesthetics|mesh-list
139388816|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139388817|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388818|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
139388819|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388820|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
139647356|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139647357|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139647358|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139647359|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647360|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
139388821|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
139388822|NCT03171831|Busulfan|busulfan|mesh-list
139388823|NCT03171831|Methotrexate|methotrexate|mesh-list
139388824|NCT03171831|Fludarabine|fludarabine|mesh-list
139388825|NCT03171831|Tacrolimus|tacrolimus|mesh-list
139388826|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
139388827|NCT03171831|Basiliximab|basiliximab|mesh-list
139388828|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388829|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
139388830|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388831|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139388832|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139388833|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
139388834|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388835|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388836|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139388837|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139388838|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
139388839|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139388840|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139388841|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
139388842|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
139388843|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388844|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139388845|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139388846|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139388847|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139388848|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139388849|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
139388850|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139388851|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139388852|NCT02171455|Dabigatran|dabigatran|mesh-list
139388853|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
139388854|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139388855|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
139388856|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388857|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388858|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
139388859|NCT02171533|Verapamil|verapamil|mesh-list
139388860|NCT02171533|Dabigatran|dabigatran|mesh-list
139388861|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
139388862|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139388863|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
139388864|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388865|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388866|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
139388867|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139388868|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139388869|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139388870|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139388871|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388872|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
139388873|NCT04482543|Methotrexate|methotrexate|mesh-list
139388874|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139388875|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
139388876|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139388877|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388878|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139388879|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
139388880|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388881|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388882|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
139388883|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388884|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139388885|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388886|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
139388887|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139388888|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139388889|NCT02406183|Ipilimumab|ipilimumab|mesh-list
139388890|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139388891|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388892|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893616|NCT03667482|Cetuximab|cetuximab|mesh-list
139647361|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139647362|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647363|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139647364|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647365|NCT03823781|Milrinone|milrinone|mesh-list
139647366|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139647367|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139647368|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
139388893|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388894|NCT04723472|Cefuroxime|cefuroxime|mesh-list
139388895|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
139388896|NCT04723472|Bismuth|bismuth|mesh-list
139388897|NCT04723472|Antacids|antacids|mesh-ancestor
139388898|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388899|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139388900|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139388901|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139388902|NCT02412813|Cobalt|cobalt|mesh-list
139388903|NCT02412813|Trace Elements|trace elements|mesh-ancestor
139388904|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
139388905|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388906|NCT03116295|Opicapone|opicapone|mesh-list
139388907|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139388908|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388909|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388910|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139388911|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139388912|NCT02405715|Oxytocin|oxytocin|mesh-list
139388913|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
139388914|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139388915|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388916|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
139388917|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139388918|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
139388919|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388920|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139388921|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139388922|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
139388923|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388924|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388925|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139388926|NCT02412345|Alprostadil|alprostadil|mesh-list
139388927|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139388928|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
139388929|NCT02412345|Urological Agents|urological agents|mesh-ancestor
139388930|NCT05679050|Folfirinox|folfirinox|mesh-list
139388931|NCT05679050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388932|NCT02412267|Carboplatin|carboplatin|mesh-list
139388933|NCT02412267|Etoposide|etoposide|mesh-list
139388934|NCT02412267|Ifosfamide|ifosfamide|mesh-list
139388935|NCT02412267|Ofatumumab|ofatumumab|mesh-list
139388936|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139388937|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139388938|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139388939|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139388940|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388941|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388942|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139388943|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
139388944|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139388945|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139388946|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139388947|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
139388948|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388949|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388950|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
139045772|NCT00132028|Vorinostat|vorinostat|mesh-list
139388951|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139388952|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
139388953|NCT05698394|Esketamine|esketamine|mesh-list
139388954|NCT05698394|Antidepressive Agents|antidepressive agents|mesh-ancestor
139388955|NCT05698394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139388956|NCT05539118|Interferons|interferons|mesh-list
139388957|NCT05539118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647369|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139647370|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139647371|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647372|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388958|NCT05539118|Antiviral Agents|antiviral agents|mesh-ancestor
139388959|NCT05539118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139388960|NCT02405793|Meloxicam|meloxicam|mesh-list
139388961|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139388962|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139388963|NCT02405793|Analgesics|analgesics|mesh-ancestor
139388964|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
139388965|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388966|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388967|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139388969|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139388970|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139388971|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388972|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388973|NCT05695664|Ibuprofen|ibuprofen|mesh-list
139388974|NCT05695664|Ketorolac|ketorolac|mesh-list
139388975|NCT05695664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139388976|NCT05695664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139388977|NCT05695664|Analgesics|analgesics|mesh-ancestor
139388978|NCT05695664|Sensory System Agents|sensory system agents|mesh-ancestor
139388979|NCT05695664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388980|NCT05695664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388981|NCT05695664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139388982|NCT05695664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139388983|NCT05695664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139388984|NCT05695664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139388985|NCT05695664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388986|NCT02412189|Norepinephrine|norepinephrine|mesh-list
139388987|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139388988|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139388989|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
139388990|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139388991|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139388992|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139388993|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
139388994|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
139388995|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139388996|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139388997|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
139388998|NCT02411955|Tazarotene|tazarotene|mesh-list
139388999|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
139389000|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
139389001|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
139389002|NCT02411955|Vitamins|vitamins|mesh-ancestor
139389003|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
139389004|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389005|NCT03172533|Dienogest|dienogest|mesh-list
139389006|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139389007|NCT03172533|Estradiol|estradiol|mesh-list
139389008|NCT03172533|Estrogens|estrogens|mesh-ancestor
139389009|NCT03172533|Hormones|hormones|mesh-ancestor
139389010|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389011|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389012|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139389013|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
139389014|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139389015|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139389016|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139389017|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139389018|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139389019|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
139389020|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139389021|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389022|NCT02412033|Misoprostol|misoprostol|mesh-list
139389023|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139389024|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
139389025|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139389026|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389027|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139389028|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139389029|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
139647373|NCT03823781|Protective Agents|protective agents|mesh-ancestor
139647374|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647375|NCT03823079|Irinotecan|irinotecan|mesh-list
139647376|NCT03823079|Raltitrexed|raltitrexed|mesh-list
139647377|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139389030|NCT02401971|Thalidomide|thalidomide|mesh-list
139647378|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139647379|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389031|NCT02401971|Irinotecan|irinotecan|mesh-list
139135704|NCT05988528|Nifuroxazide|nifuroxazide|mesh-list
139647380|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647381|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389032|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139389033|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139389034|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389035|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389036|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389037|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139389038|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
139389039|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389040|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
139389041|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139389042|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389043|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139389044|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139389045|NCT02401971|Growth Substances|growth substances|mesh-ancestor
139389046|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
139389047|NCT00701883|Atorvastatin|atorvastatin|mesh-list
139389048|NCT00701883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139389049|NCT00701883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139389050|NCT00701883|Antimetabolites|antimetabolites|mesh-ancestor
139389051|NCT00701883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389052|NCT00701883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139389053|NCT00701883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139389054|NCT00701883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389055|NCT05678738|Antioxidants|antioxidants|mesh-list
139389056|NCT05678738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389057|NCT05678738|Protective Agents|protective agents|mesh-ancestor
139389058|NCT05678738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389059|NCT03175653|Oxycodone|oxycodone|mesh-list
139389060|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139389061|NCT03175653|Narcotics|narcotics|mesh-ancestor
139389062|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389063|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389064|NCT03175653|Analgesics|analgesics|mesh-ancestor
139389065|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
139389066|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389067|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139389068|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
139389069|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389070|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
139389071|NCT03175341|Vitamins|vitamins|mesh-ancestor
139389072|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
139389073|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389074|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
139389075|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389076|NCT03175341|Protective Agents|protective agents|mesh-ancestor
139389077|NCT05538026|Mesalamine|mesalamine|mesh-list
139389078|NCT05538026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139389079|NCT05538026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139389080|NCT05538026|Analgesics|analgesics|mesh-ancestor
139389081|NCT05538026|Sensory System Agents|sensory system agents|mesh-ancestor
139389082|NCT05538026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389083|NCT05538026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389084|NCT05538026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139389085|NCT05538026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139389086|NCT02401425|Letrozole|letrozole|mesh-list
139389087|NCT02401425|Misoprostol|misoprostol|mesh-list
139389088|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389089|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139389090|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139389091|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389092|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389093|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139389094|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
139389095|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389096|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389097|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139389098|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
139647382|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139647383|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
139389099|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139389100|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139389101|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139647384|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139389102|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
139389103|NCT02401269|Aspirin|aspirin|mesh-list
139389104|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139389105|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139389106|NCT02401269|Analgesics|analgesics|mesh-ancestor
139389107|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
139389108|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389109|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389110|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139389111|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139389112|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139389113|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139389114|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389115|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139389116|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139389117|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389118|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
139389119|NCT04480827|Cholic Acids|cholic acids|mesh-list
139389120|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139389121|NCT02582684|Lamivudine|lamivudine|mesh-list
139389122|NCT02582684|Dolutegravir|dolutegravir|mesh-list
139389123|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139389124|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139389125|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389126|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389127|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
139389128|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389129|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139389130|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139389131|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139389132|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139389133|NCT02411877|Clotrimazole|clotrimazole|mesh-list
139389134|NCT02411877|Miconazole|miconazole|mesh-list
139389135|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139389136|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389137|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
139389138|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139389139|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139389140|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389141|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389142|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139389143|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
139389144|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389145|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389146|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139389147|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139389148|NCT03169569|Hemostatics|hemostatics|mesh-list
139389149|NCT03169569|Coagulants|coagulants|mesh-ancestor
139389150|NCT02585960|Factor VIII|factor viii|mesh-list
139389151|NCT02585960|BAX 855|bax 855|mesh-list
139389152|NCT02585960|Coagulants|coagulants|mesh-ancestor
139389153|NCT03169413|Adenosine|adenosine|mesh-list
139389154|NCT03169413|Analgesics|analgesics|mesh-ancestor
139389155|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
139389156|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389157|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389158|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139389159|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
139389160|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139389161|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
139389162|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
139389163|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389164|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389165|NCT03169335|Paclitaxel|paclitaxel|mesh-list
139389166|NCT03169335|Bevacizumab|bevacizumab|mesh-list
139389167|NCT03169335|Carboplatin|carboplatin|mesh-list
139389168|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139389169|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389170|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
139647385|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
139647386|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139389171|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
139389172|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
139647387|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
139647388|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647389|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139647390|NCT02839265|Protective Agents|protective agents|mesh-ancestor
139647391|NCT00988247|Beclomethasone|beclomethasone|mesh-list
139647392|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139389173|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389174|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139389175|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139389176|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139389177|NCT03169335|Growth Substances|growth substances|mesh-ancestor
139389178|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389179|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
139389180|NCT03106623|Mirabegron|mirabegron|mesh-list
139389181|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
139389182|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139389183|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139389184|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139389185|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
139389186|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389187|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389188|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389189|NCT03106623|Urological Agents|urological agents|mesh-ancestor
139389190|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139389191|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139389192|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
139389193|NCT02411175|Ethanol|ethanol|mesh-list
139389194|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139389195|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389196|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389197|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389198|NCT05537558|Antidepressive Agents|antidepressive agents|mesh-list
139389199|NCT05537558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139389200|NCT02411331|Ethanol|ethanol|mesh-list
139389201|NCT02411331|Enoxaparin|enoxaparin|mesh-list
139389202|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
139389203|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139389204|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139389205|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389206|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139389207|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389208|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389209|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389210|NCT00100789|Paclitaxel|paclitaxel|mesh-list
139389211|NCT00100789|Gemcitabine|gemcitabine|mesh-list
139389212|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139389213|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389214|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
139389215|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
139389216|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
139389217|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389218|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139389219|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
139389220|NCT02410863|Trametinib|trametinib|mesh-list
139389221|NCT02410863|Dabrafenib|dabrafenib|mesh-list
139389222|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389223|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139389224|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389225|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389226|NCT05678192|Hormones|hormones|mesh-list
139389227|NCT05678192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389228|NCT05678192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389229|NCT00708123|Listerine|listerine|mesh-list
139389230|NCT00708123|Fluorides|fluorides|mesh-list
139389231|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
139389232|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
139389233|NCT00708123|Protective Agents|protective agents|mesh-ancestor
139389234|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389235|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139389236|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389237|NCT05678036|Analgesics, Opioid|analgesics, opioid|mesh-list
139389238|NCT05678036|Narcotics|narcotics|mesh-ancestor
139389239|NCT05678036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389240|NCT05678036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389241|NCT05678036|Analgesics|analgesics|mesh-ancestor
139389242|NCT05678036|Sensory System Agents|sensory system agents|mesh-ancestor
139389243|NCT05678036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647393|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
139647394|NCT00988247|Hormones|hormones|mesh-ancestor
139647395|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139647396|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647397|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139389244|NCT02400879|Sufentanil|sufentanil|mesh-list
139389245|NCT02400879|Remifentanil|remifentanil|mesh-list
139389246|NCT02400879|Sevoflurane|sevoflurane|mesh-list
139389247|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139389248|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139389249|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
139389250|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
139389251|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389252|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389253|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139389254|NCT02400879|Narcotics|narcotics|mesh-ancestor
139389255|NCT02400879|Analgesics|analgesics|mesh-ancestor
139389256|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
139389257|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389258|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139389259|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139389260|NCT04133480|Cannabidiol|cannabidiol|mesh-list
139389261|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
139389263|NCT02400645|Bupivacaine|bupivacaine|mesh-list
139389264|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
139389265|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
139389266|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389267|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389268|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
139389269|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389270|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139389271|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139389272|NCT02400645|Analgesics|analgesics|mesh-ancestor
139389273|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139389274|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139389275|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139389276|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389277|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389278|NCT02165215|Etrolizumab|etrolizumab|mesh-list
139389279|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139389280|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
139389281|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389282|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139389283|NCT02400801|Dienogest|dienogest|mesh-list
139389284|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139389285|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
139389286|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139389287|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
139389288|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139389289|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389290|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139389291|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139389292|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389293|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139389294|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139389295|NCT02400801|Estrogens|estrogens|mesh-ancestor
139389296|NCT02400801|Hormones|hormones|mesh-ancestor
139647398|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
139647399|NCT02832401|Caffeine|caffeine|mesh-list
139647400|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139647401|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647402|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139647403|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647404|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647405|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139647406|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139647407|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
139389297|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718003|NCT01133977|Lenvatinib|lenvatinib|mesh-list
139389298|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139389299|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
139389300|NCT02168569|Artesunate|artesunate|mesh-list
139389301|NCT02168569|Lumefantrine|lumefantrine|mesh-list
139389302|NCT02168569|Artemether|artemether|mesh-list
139389303|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139389304|NCT02168569|Amodiaquine|amodiaquine|mesh-list
139389305|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
139389306|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139389307|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139389308|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389309|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389310|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
139389311|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
139389312|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139389313|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
139389314|NCT02171689|Afatinib|afatinib|mesh-list
139389315|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389316|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139389317|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389318|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389319|NCT02171767|Afatinib|afatinib|mesh-list
139389320|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389321|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139389322|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389323|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389324|NCT02400021|Progesterone|progesterone|mesh-list
139389325|NCT02400021|Progestins|progestins|mesh-ancestor
139389326|NCT02400021|Hormones|hormones|mesh-ancestor
139389327|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389328|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389329|NCT02165449|Ketamine|ketamine|mesh-list
139389331|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
139389332|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389333|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389334|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139389335|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139389336|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
139389337|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
139389338|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389339|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139389340|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139389341|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389342|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389343|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139389344|NCT02172001|Hematinics|hematinics|mesh-ancestor
139389345|NCT05535998|Chlorotrianisene|chlorotrianisene|mesh-list
139389346|NCT05535998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139389347|NCT05535998|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139389348|NCT05535998|Estrogens|estrogens|mesh-ancestor
139389349|NCT05535998|Hormones|hormones|mesh-ancestor
139389350|NCT05535998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389351|NCT05535998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389352|NCT05535998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139389353|NCT05535998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389354|NCT05535998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389355|NCT05535998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139389356|NCT03540199|Antibodies|antibodies|mesh-list
139389357|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139389358|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
139389359|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389360|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
139389361|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139389362|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
139389363|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389364|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
139389365|NCT02165917|Protective Agents|protective agents|mesh-ancestor
139389366|NCT02168881|Misoprostol|misoprostol|mesh-list
139389367|NCT02168881|Dinoprostone|dinoprostone|mesh-list
139389368|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139389369|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
139389370|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139389371|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389372|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139389373|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139389374|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
139389375|NCT02168959|Bupivacaine|bupivacaine|mesh-list
139389376|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
139389377|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
139647408|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139647409|NCT03044808|Lidocaine|lidocaine|mesh-list
139389378|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135738|NCT05986318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139647410|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
139647411|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
139389379|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389380|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
139389381|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389382|NCT05696678|Morphine|morphine|mesh-list
139389383|NCT05696678|Ropivacaine|ropivacaine|mesh-list
139389384|NCT05696678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139389385|NCT05696678|Narcotics|narcotics|mesh-ancestor
139389386|NCT05696678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389387|NCT05696678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389388|NCT05696678|Analgesics|analgesics|mesh-ancestor
139389389|NCT05696678|Sensory System Agents|sensory system agents|mesh-ancestor
139389390|NCT05696678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389391|NCT05696678|Anesthetics, Local|anesthetics, local|mesh-ancestor
139389392|NCT05696678|Anesthetics|anesthetics|mesh-ancestor
139389393|NCT05450822|Lamotrigine|lamotrigine|mesh-list
139389394|NCT05450822|Levetiracetam|levetiracetam|mesh-list
139389395|NCT05450822|Anticonvulsants|anticonvulsants|mesh-list
139389396|NCT05450822|Nootropic Agents|nootropic agents|mesh-ancestor
139389397|NCT05450822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139389398|NCT05450822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139389399|NCT05450822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389400|NCT05450822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139389401|NCT05450822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389402|NCT05450822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139389403|NCT05450822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139046216|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389404|NCT05450822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389405|NCT05450822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139389406|NCT05450822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139389407|NCT02172157|Olodaterol|olodaterol|mesh-list
139389408|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139389409|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
139389410|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389411|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389412|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139389413|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
139389414|NCT02172235|Pioglitazone|pioglitazone|mesh-list
139389415|NCT02172235|Empagliflozin|empagliflozin|mesh-list
139389416|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139389417|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389418|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139389419|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389420|NCT02166229|Valproic Acid|valproic acid|mesh-list
139389421|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
139389422|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389423|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389424|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
139389425|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389426|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389427|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
139389428|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139389429|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389430|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139389431|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
139389432|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139389433|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389434|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389435|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139389436|NCT02757625|Analgesics|analgesics|mesh-ancestor
139389437|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
139389438|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389439|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139389440|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139389441|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139389442|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
139647412|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139647413|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647414|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
139647415|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647416|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139647417|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139647418|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139389443|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139135741|NCT05986318|Antidotes|antidotes|mesh-ancestor
139647419|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139647420|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389444|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389445|NCT05691920|Fentanyl|fentanyl|mesh-list
139389446|NCT05691920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139389447|NCT05691920|Narcotics|narcotics|mesh-ancestor
139389448|NCT05691920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389449|NCT05691920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389450|NCT05691920|Analgesics|analgesics|mesh-ancestor
139389451|NCT05691920|Sensory System Agents|sensory system agents|mesh-ancestor
139389452|NCT05691920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389453|NCT05691920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139389454|NCT05691920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139389455|NCT05691920|Anesthetics, General|anesthetics, general|mesh-ancestor
139389456|NCT05691920|Anesthetics|anesthetics|mesh-ancestor
139389457|NCT05696366|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139389458|NCT05696366|Volagidemab|volagidemab|mesh-list
139389459|NCT05696366|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139389460|NCT05696366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389461|NCT05696366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139389462|NCT05696366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389463|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139389464|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
139389465|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139389466|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
139389467|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389468|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389469|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139389470|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
139389471|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
139389472|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139389473|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
139389474|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389475|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389476|NCT00109681|Iloprost|iloprost|mesh-list
139389477|NCT00109681|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139389478|NCT00109681|Vasodilator Agents|vasodilator agents|mesh-ancestor
139389479|NCT02172469|Bromides|bromides|mesh-list
139389480|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
139389481|NCT02172469|Ipratropium|ipratropium|mesh-list
139389482|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139389483|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
139389484|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389485|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389486|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139389487|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
139389488|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
139389489|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139389490|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
139389491|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389492|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389493|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
139389494|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
139389495|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139389496|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
139389497|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389498|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389499|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139389500|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
139389501|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
139389502|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139389503|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
139389504|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389505|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389506|NCT02174887|Paclitaxel|paclitaxel|mesh-list
139389507|NCT02174887|Gemcitabine|gemcitabine|mesh-list
139389508|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139389509|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389510|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
139647421|NCT04430166|Antibodies|antibodies|mesh-list
139647422|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139647423|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
139647424|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389511|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
139389512|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
139389513|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389514|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139389515|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
139389516|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139389517|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
139389518|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
139389519|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389521|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
139389522|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389523|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
139389524|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389525|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389526|NCT04298528|Dronabinol|dronabinol|mesh-list
139389527|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
139389528|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389529|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139389530|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139389531|NCT04298528|Analgesics|analgesics|mesh-ancestor
139389532|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
139389533|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389534|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139389535|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139389536|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389537|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389538|NCT04298528|Hormones|hormones|mesh-ancestor
139389539|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389540|NCT00100711|Motexafin gadolinium|motexafin gadolinium|mesh-list
139389541|NCT00100711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389542|NCT00100711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139389543|NCT00100711|Dermatologic Agents|dermatologic agents|mesh-ancestor
139389544|NCT02581202|Ritonavir|ritonavir|mesh-list
139389545|NCT02581202|Lopinavir|lopinavir|mesh-list
139389546|NCT02581202|Lamivudine|lamivudine|mesh-list
139389547|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139389548|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139389549|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
139389550|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046367|NCT00383786|Vofopitant|vofopitant|mesh-list
139389551|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389552|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139389553|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139389554|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
139389555|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389556|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139389557|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139389558|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139389559|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139389560|NCT02758171|Empagliflozin|empagliflozin|mesh-list
139389561|NCT02758171|Linagliptin|linagliptin|mesh-list
139389562|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139389563|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389564|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139389565|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389566|NCT02758171|Incretins|incretins|mesh-ancestor
139389567|NCT02758171|Hormones|hormones|mesh-ancestor
139389568|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389569|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139389570|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
139389571|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389572|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
139389573|NCT02172781|Ipratropium|ipratropium|mesh-list
139389574|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139389575|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
139389576|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389577|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647425|NCT04877106|Metformin|metformin|mesh-list
139647426|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139647427|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139647428|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718145|NCT00470847|Lapatinib|lapatinib|mesh-list
139647429|NCT04877106|Incretins|incretins|mesh-ancestor
139647430|NCT04877106|Hormones|hormones|mesh-ancestor
139389578|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139389579|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
139389580|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
139389581|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139389582|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
139389583|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389584|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389585|NCT02173093|Aldesleukin|aldesleukin|mesh-list
139389586|NCT02173093|Interleukin-2|interleukin-2|mesh-list
139389587|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389588|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139389589|NCT02173093|Analgesics|analgesics|mesh-ancestor
139389590|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
139389591|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389592|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389593|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139389594|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139389595|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
139389596|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389597|NCT05142085|Mineral Oil|mineral oil|mesh-list
139389598|NCT05142085|Emollients|emollients|mesh-ancestor
139389599|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
139389600|NCT00103831|Taxane|taxane|mesh-list
139389601|NCT00103831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389602|NCT03538483|Bupivacaine|bupivacaine|mesh-list
139389603|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
139389604|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
139389605|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389606|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389607|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
139389608|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389609|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139389610|NCT02175355|Telmisartan|telmisartan|mesh-list
139389611|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139389612|NCT02175355|Diuretics|diuretics|mesh-ancestor
139389613|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
139389614|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389615|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139389616|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139389617|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389618|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139389619|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139389620|NCT03538327|Silybin|silybin|mesh-list
139389621|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139389622|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389623|NCT03538327|Protective Agents|protective agents|mesh-ancestor
139389624|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389625|NCT02170597|Dabigatran|dabigatran|mesh-list
139389626|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
138718159|NCT00584168|Dexamethasone|dexamethasone|mesh-list
139389627|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139389628|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
139389629|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389630|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389631|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
139389632|NCT02170675|Ketoconazole|ketoconazole|mesh-list
139389633|NCT02170675|Dabigatran|dabigatran|mesh-list
139389634|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
139389635|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139389636|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
139389637|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389638|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389639|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
139389640|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
139389641|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389642|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139389643|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139389644|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139389645|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
139647431|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139647432|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139389646|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389647|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389648|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139389649|NCT02175433|AGS67E|ags67e|mesh-list
139389650|NCT02175433|Immunoconjugates|immunoconjugates|mesh-ancestor
139389651|NCT02175433|Immunologic Factors|immunologic factors|mesh-ancestor
139389652|NCT02175433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389654|NCT04154150|Analgesics|analgesics|mesh-ancestor
139389655|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
139389656|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389657|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389658|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139389659|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139389660|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
139389661|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
139389662|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389663|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139389664|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139389665|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389666|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389667|NCT00521846|Cimetidine|cimetidine|mesh-list
139389668|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139389669|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139389670|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139389671|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
139389672|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
139389673|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389674|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389675|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389676|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139389677|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139389678|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389679|NCT02170831|Dabigatran|dabigatran|mesh-list
139389680|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
139389681|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139389682|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
139389683|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389684|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389685|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
139389686|NCT02175589|Colchicine|colchicine|mesh-list
138718180|NCT01133275|Hormones|hormones|mesh-ancestor
139389687|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
139389688|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139389689|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
139389690|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
139389691|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
139389692|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389693|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389694|NCT05438186|Liraglutide|liraglutide|mesh-list
139389695|NCT05438186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139389696|NCT05438186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389697|NCT05438186|Incretins|incretins|mesh-ancestor
139389698|NCT05438186|Hormones|hormones|mesh-ancestor
139046518|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
139389699|NCT05438186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389700|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139389701|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389702|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139389703|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389704|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389706|NCT02173639|Linagliptin|linagliptin|mesh-list
139389707|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139389708|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389709|NCT02173639|Incretins|incretins|mesh-ancestor
139389710|NCT02173639|Hormones|hormones|mesh-ancestor
139389711|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389712|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139389713|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
139389714|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389715|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389716|NCT02173717|Rifampin|rifampin|mesh-list
139647433|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
139389717|NCT02173717|Dabigatran|dabigatran|mesh-list
139647434|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647435|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647436|NCT00981617|ALKS-33|alks-33|mesh-list
139647437|NCT00981617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139647438|NCT00981617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647439|NCT00981617|Sensory System Agents|sensory system agents|mesh-ancestor
139647440|NCT00981617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389718|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
139389719|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139389720|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
139389721|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389722|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389723|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
139389724|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139389725|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
139389726|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139389727|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389728|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
139389729|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139389730|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139389731|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139389732|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139389733|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139389734|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139389735|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139389736|NCT04067648|Sufentanil|sufentanil|mesh-list
139389737|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139389738|NCT04067648|Narcotics|narcotics|mesh-ancestor
139389739|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389740|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389741|NCT04067648|Analgesics|analgesics|mesh-ancestor
139389742|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
139389743|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389744|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138718228|NCT00584636|Budesonide|budesonide|mesh-list
139389745|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139389746|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
139389747|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
139389748|NCT02173795|Fenoterol|fenoterol|mesh-list
139389749|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139389750|NCT02173795|Ipratropium|ipratropium|mesh-list
139389751|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139389752|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
139389753|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389754|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389755|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139389756|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
139389757|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
139389758|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
139389759|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139389760|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139389761|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139389762|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139389763|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
139389764|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389765|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389766|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139389767|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
139389768|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139389769|NCT02175901|Amoxicillin|amoxicillin|mesh-list
139389770|NCT02175901|Metronidazole|metronidazole|mesh-list
139389771|NCT02175901|Clarithromycin|clarithromycin|mesh-list
139389772|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139389773|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
139389774|NCT02175901|Lansoprazole|lansoprazole|mesh-list
139389775|NCT02175901|Bismuth|bismuth|mesh-list
139389776|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139389777|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389778|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389779|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
139389780|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139647441|NCT04876716|Voriconazole|voriconazole|mesh-list
139647442|NCT04876716|Posaconazole|posaconazole|mesh-list
139647443|NCT04876716|Isavuconazole|isavuconazole|mesh-list
139647444|NCT04876716|Anidulafungin|anidulafungin|mesh-list
139647445|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
139647446|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389781|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139389782|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139389783|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389784|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139647447|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139389785|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139647448|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139647449|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389786|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139389787|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139389788|NCT02175901|Antacids|antacids|mesh-ancestor
139389789|NCT02175901|Diuretics|diuretics|mesh-ancestor
139389790|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
139389791|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389792|NCT02175901|Expectorants|expectorants|mesh-ancestor
139389793|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
139389794|NCT02173873|Aflibercept|aflibercept|mesh-list
139389795|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139389796|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139389797|NCT02173873|Growth Substances|growth substances|mesh-ancestor
139389798|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389799|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
139389800|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389801|NCT02176057|Azithromycin|azithromycin|mesh-list
139389802|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139389803|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389804|NCT02173951|Deferiprone|deferiprone|mesh-list
139389805|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139389806|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
139389807|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
139389808|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389809|NCT02176135|Auranofin|auranofin|mesh-list
139389810|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139389811|NCT02176213|Dexamethasone|dexamethasone|mesh-list
139389812|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
139389813|NCT02176213|Pomalidomide|pomalidomide|mesh-list
139389814|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139389815|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
139389816|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389817|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139389818|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139389819|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
139389820|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389821|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389822|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139389823|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139389824|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
139389825|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
139389826|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389827|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139389828|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
139389829|NCT02176213|Hormones|hormones|mesh-ancestor
139389830|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389831|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139389832|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139389833|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139389834|NCT02176213|Growth Substances|growth substances|mesh-ancestor
139389835|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
139389836|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
139389837|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
139389838|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
139389839|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139389840|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389841|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389842|NCT04305002|Exenatide|exenatide|mesh-list
139389843|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139389844|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389845|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139389846|NCT04305002|Incretins|incretins|mesh-ancestor
139389847|NCT04305002|Hormones|hormones|mesh-ancestor
139389848|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389849|NCT02253797|Ritonavir|ritonavir|mesh-list
139389850|NCT02253797|Tipranavir|tipranavir|mesh-list
139647450|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647451|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139647452|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
139647453|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139389851|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139389852|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139389853|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
139389854|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389855|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389856|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139647454|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647455|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139389857|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139389858|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
139389859|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389860|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139389861|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139389862|NCT02253875|Ritonavir|ritonavir|mesh-list
139389863|NCT02253875|Tipranavir|tipranavir|mesh-list
139389864|NCT02253875|Omeprazole|omeprazole|mesh-list
139389865|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139389866|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139389867|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
139389868|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389869|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389870|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139389871|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139389872|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
139389873|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389874|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139389875|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139389876|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139389877|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139389878|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139389879|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139389880|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139389881|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389882|NCT04597268|Midazolam|midazolam|mesh-list
139389883|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
139389884|NCT04597268|Ketamine|ketamine|mesh-list
139389885|NCT04597268|Propofol|propofol|mesh-list
139389886|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139389887|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389888|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389889|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139389890|NCT04597268|Analgesics|analgesics|mesh-ancestor
139389891|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
139389892|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389893|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139389894|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139389895|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139389896|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
139389897|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389898|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389899|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139389900|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
139389901|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
139389902|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139389903|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139389904|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139389905|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139389906|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139389907|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139389908|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139389909|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
139389910|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
139389911|NCT04976543|Nadroparin|nadroparin|mesh-list
139389912|NCT04976543|Warfarin|warfarin|mesh-list
139389913|NCT04976543|Calcium|calcium|mesh-list
139389914|NCT04976543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139389915|NCT04976543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389916|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
139389917|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139389918|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139389919|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389920|NCT02924441|Lidocaine|lidocaine|mesh-list
139647456|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139647457|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139647458|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139389921|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
139389922|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
139647459|NCT04865250|Paclitaxel|paclitaxel|mesh-list
139647460|NCT04865250|Carboplatin|carboplatin|mesh-list
139389923|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389924|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647461|NCT04865250|Atezolizumab|atezolizumab|mesh-list
139647462|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139389926|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389927|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139389928|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139389929|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139389930|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139389931|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389932|NCT00109967|Sirolimus|sirolimus|mesh-list
139389933|NCT00109967|Rituximab|rituximab|mesh-list
139389934|NCT00109967|Temsirolimus|temsirolimus|mesh-list
139389935|NCT00109967|MTOR Inhibitors|mtor inhibitors|mesh-list
139389936|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139389937|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139389938|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
139389939|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389940|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139389941|NCT00109967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139389942|NCT00109967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389943|NCT00109967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389944|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139389945|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139389946|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139389947|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139389948|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
139389949|NCT02579096|Allopurinol|allopurinol|mesh-list
139389950|NCT02579096|Febuxostat|febuxostat|mesh-list
139389951|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
139389952|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389953|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389954|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
139389955|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139389956|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139389957|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
139389958|NCT02579096|Protective Agents|protective agents|mesh-ancestor
139389959|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389960|NCT02578862|Propofol|propofol|mesh-list
139389961|NCT02578862|Sevoflurane|sevoflurane|mesh-list
139389962|NCT02578862|Isoflurane|isoflurane|mesh-list
139389963|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139389964|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139389965|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389966|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139389967|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
139389968|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
139389969|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139389970|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139389971|NCT02578706|Aspirin|aspirin|mesh-list
139389972|NCT02578706|Clopidogrel|clopidogrel|mesh-list
139389973|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139389974|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139389975|NCT02578706|Analgesics|analgesics|mesh-ancestor
139389976|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
139389977|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139389978|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139389979|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139389980|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139389981|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139389982|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139389983|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139389984|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139389985|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139389986|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139389987|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
139389988|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139389989|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139389990|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139647463|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647464|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
139647465|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
139647466|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
139389991|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
139389992|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139389993|NCT03455504|Venetoclax|venetoclax|mesh-list
139135790|NCT05928871|Oxytocics|oxytocics|mesh-ancestor
139389994|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647467|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647468|NCT04865250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139647469|NCT04865250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139389996|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139389997|NCT00108953|Sorafenib|sorafenib|mesh-list
139389998|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139389999|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390000|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139390001|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139390002|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390003|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390004|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139390005|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139390006|NCT02578316|Lenvatinib|lenvatinib|mesh-list
139390007|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390008|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139390009|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390010|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390011|NCT05532878|Apixaban|apixaban|mesh-list
139390012|NCT05532878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139390013|NCT05532878|Antithrombins|antithrombins|mesh-ancestor
139390014|NCT05532878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139390015|NCT05532878|Protease Inhibitors|protease inhibitors|mesh-ancestor
139390016|NCT05532878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390017|NCT05532878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390018|NCT05532878|Anticoagulants|anticoagulants|mesh-ancestor
139390019|NCT02576678|Apremilast|apremilast|mesh-list
139390020|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139390021|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139390022|NCT02576678|Analgesics|analgesics|mesh-ancestor
139390023|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
139390024|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390025|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390026|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139390027|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138718337|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
139390028|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139390029|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139390030|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390031|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390032|NCT05532332|Fluoxetine|fluoxetine|mesh-list
139390033|NCT05532332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139390034|NCT05532332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139390035|NCT05532332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139390036|NCT05532332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390037|NCT05532332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390038|NCT05532332|Serotonin Agents|serotonin agents|mesh-ancestor
139390039|NCT05532332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390040|NCT05532332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139390041|NCT05532332|Antidepressive Agents|antidepressive agents|mesh-ancestor
139390042|NCT05532332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139390043|NCT05532332|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139390044|NCT05532332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139390045|NCT05532332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390046|NCT05532254|Aripiprazole|aripiprazole|mesh-list
139390047|NCT05532254|Antidepressive Agents|antidepressive agents|mesh-ancestor
139390048|NCT05532254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139390049|NCT05532254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139390050|NCT05532254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139390051|NCT05532254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139390052|NCT05532254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390053|NCT05532254|Dopamine Agonists|dopamine agonists|mesh-ancestor
139390054|NCT05532254|Dopamine Agents|dopamine agents|mesh-ancestor
139390055|NCT05532254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390056|NCT05532254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390057|NCT05532254|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139390058|NCT05532254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139390059|NCT05532254|Serotonin Agents|serotonin agents|mesh-ancestor
139390060|NCT05532254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139647470|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
139647471|NCT04865562|Testosterone|testosterone|mesh-list
139390061|NCT05532254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139390062|NCT05532254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139390063|NCT05532254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139390064|NCT05471648|Pertuzumab|pertuzumab|mesh-list
139390065|NCT05471648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390066|NCT05471648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390067|NCT00108745|Paclitaxel|paclitaxel|mesh-list
139390068|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139390069|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
139390070|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139390071|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390072|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
139390073|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
139390074|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
139390075|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390076|NCT05532020|Diazoxide|diazoxide|mesh-list
139390077|NCT05532020|Choline|choline|mesh-list
139390078|NCT05532020|Lipotropic Agents|lipotropic agents|mesh-ancestor
139390079|NCT05532020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139390080|NCT05532020|Antimetabolites|antimetabolites|mesh-ancestor
139390081|NCT05532020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390082|NCT05532020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139390083|NCT05532020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139390084|NCT05532020|Nootropic Agents|nootropic agents|mesh-ancestor
139390085|NCT05532020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139390086|NCT05532020|Vasodilator Agents|vasodilator agents|mesh-ancestor
139390087|NCT02098343|Carboplatin|carboplatin|mesh-list
139390088|NCT02098343|Doxorubicin|doxorubicin|mesh-list
139390089|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139390090|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390091|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139390092|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139390093|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139390094|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390095|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390096|NCT02176369|Vinorelbine|vinorelbine|mesh-list
139390097|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139390098|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390099|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
139390100|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
139390101|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
139390102|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390103|NCT02716805|Melphalan|melphalan|mesh-list
139390104|NCT02716805|Durvalumab|durvalumab|mesh-list
139390105|NCT02716805|Tremelimumab|tremelimumab|mesh-list
139390106|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139390107|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
139390108|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390109|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390110|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139390111|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139390112|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
139390113|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390114|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390115|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
139390116|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
139390117|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
139390118|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390119|NCT04152473|Proglumide|proglumide|mesh-list
139390120|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139390121|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139390122|NCT02581982|Paclitaxel|paclitaxel|mesh-list
139390123|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
139390124|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139390125|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139647472|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
139647473|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
139647474|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139647475|NCT04865562|Androgens|androgens|mesh-ancestor
139647476|NCT04865562|Hormones|hormones|mesh-ancestor
139647477|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139647478|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647479|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139390126|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390127|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
139390128|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
139390129|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
139647480|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647481|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
139390130|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390131|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390132|NCT02581982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390133|NCT03751397|Cystatins|cystatins|mesh-list
139390134|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139390135|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
139390136|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390137|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390138|NCT02176681|Vildagliptin|vildagliptin|mesh-list
139390139|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139390140|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390141|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139390142|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
139390143|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390144|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390145|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
139390146|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138718358|NCT01089543|Rabeprazole|rabeprazole|mesh-list
139390147|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139390148|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139390149|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390150|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
139390151|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390152|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390153|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139390154|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390156|NCT02254577|Progestins|progestins|mesh-ancestor
139390157|NCT02254577|Hormones|hormones|mesh-ancestor
139390158|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139390159|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390160|NCT02176759|Citric Acid|citric acid|mesh-list
139390161|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
139390162|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
139390163|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139390164|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
139390165|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
139390166|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390167|NCT06010602|Analgesics|analgesics|mesh-list
139390168|NCT06010602|Sensory System Agents|sensory system agents|mesh-ancestor
139390169|NCT06010602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390170|NCT06010602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390171|NCT06010290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139390172|NCT06010290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139390173|NCT06010290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390174|NCT06010277|Leucovorin|leucovorin|mesh-list
139390175|NCT06010277|Folic Acid|folic acid|mesh-list
139390176|NCT06010277|Levoleucovorin|levoleucovorin|mesh-list
139390177|NCT06010277|Antidotes|antidotes|mesh-ancestor
139390178|NCT06010277|Protective Agents|protective agents|mesh-ancestor
139390179|NCT06010277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390180|NCT06010277|Vitamin B Complex|vitamin b complex|mesh-ancestor
139390181|NCT06010277|Vitamins|vitamins|mesh-ancestor
139390182|NCT06010277|Micronutrients|micronutrients|mesh-ancestor
139390183|NCT06010277|Hematinics|hematinics|mesh-ancestor
139390184|NCT06010212|Paclitaxel|paclitaxel|mesh-list
139390185|NCT06010212|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139390186|NCT06010212|Nedaplatin|nedaplatin|mesh-list
139390187|NCT06010212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139390188|NCT06010212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390189|NCT06010212|Tubulin Modulators|tubulin modulators|mesh-ancestor
139390190|NCT06010212|Antimitotic Agents|antimitotic agents|mesh-ancestor
139390191|NCT06010212|Mitosis Modulators|mitosis modulators|mesh-ancestor
139390192|NCT06010212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390193|NCT06010095|Nivolumab|nivolumab|mesh-list
139647482|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139647483|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
139647484|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647485|NCT00984659|Fluticasone|fluticasone|mesh-list
139647486|NCT00984659|Xhance|xhance|mesh-list
139647487|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139390194|NCT06010095|Ipilimumab|ipilimumab|mesh-list
139390195|NCT06010095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390196|NCT06010095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647488|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139390197|NCT06010095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390198|NCT06010095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390199|NCT06010056|Ketamine|ketamine|mesh-list
139390200|NCT06010056|Morphine|morphine|mesh-list
139390201|NCT06010056|Analgesics|analgesics|mesh-ancestor
139390202|NCT06010056|Sensory System Agents|sensory system agents|mesh-ancestor
139390203|NCT06010056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390204|NCT06010056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390205|NCT06010056|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139390206|NCT06010056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139390207|NCT06010056|Anesthetics, General|anesthetics, general|mesh-ancestor
139390208|NCT06010056|Anesthetics|anesthetics|mesh-ancestor
139390209|NCT06010056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139390210|NCT06010056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139390211|NCT06010056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139390212|NCT06010056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390213|NCT06010056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390214|NCT06010056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139390215|NCT06010056|Narcotics|narcotics|mesh-ancestor
139390216|NCT06009900|Celecoxib|celecoxib|mesh-list
139390217|NCT06009900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139390218|NCT06009900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139390219|NCT06009900|Analgesics|analgesics|mesh-ancestor
139390220|NCT06009900|Sensory System Agents|sensory system agents|mesh-ancestor
139390221|NCT06009900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390222|NCT06009900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390223|NCT06009900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139390224|NCT06009900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139390225|NCT06009900|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139390226|NCT06009900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139390227|NCT06009900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390228|NCT06009900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390229|NCT06009874|Dapagliflozin|dapagliflozin|mesh-list
139390230|NCT06009874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139390231|NCT06009874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390232|NCT06009874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139390233|NCT06009874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390234|NCT06009861|Paclitaxel|paclitaxel|mesh-list
139390235|NCT06009861|Tislelizumab|tislelizumab|mesh-list
139390236|NCT06009861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139390237|NCT06009861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139390238|NCT06009861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390239|NCT06009861|Tubulin Modulators|tubulin modulators|mesh-ancestor
139390240|NCT06009861|Antimitotic Agents|antimitotic agents|mesh-ancestor
139390241|NCT06009861|Mitosis Modulators|mitosis modulators|mesh-ancestor
139390242|NCT06009861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390243|NCT06009861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390244|NCT06009744|Vitamins|vitamins|mesh-list
139390245|NCT06009744|Ascorbic Acid|ascorbic acid|mesh-list
139390246|NCT06009744|Zinc|zinc|mesh-list
139390247|NCT06009744|Micronutrients|micronutrients|mesh-ancestor
139390248|NCT06009744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390249|NCT06009744|Trace Elements|trace elements|mesh-ancestor
139390250|NCT06009744|Antioxidants|antioxidants|mesh-ancestor
139390251|NCT06009744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390252|NCT06009744|Protective Agents|protective agents|mesh-ancestor
139390253|NCT06009679|Misoprostol|misoprostol|mesh-list
139390254|NCT06009679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139390255|NCT06009679|Abortifacient Agents|abortifacient agents|mesh-ancestor
139390256|NCT06009679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139390257|NCT06009679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390258|NCT06009679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139390259|NCT06009679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139390260|NCT06009679|Oxytocics|oxytocics|mesh-ancestor
139390261|NCT06009627|Cyclophosphamide|cyclophosphamide|mesh-list
139390262|NCT06009627|Docetaxel|docetaxel|mesh-list
139390263|NCT06009627|Epirubicin|epirubicin|mesh-list
139390264|NCT06009627|Exemestane|exemestane|mesh-list
139390265|NCT06009627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139390266|NCT06009627|Immunologic Factors|immunologic factors|mesh-ancestor
139390267|NCT06009627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390268|NCT06009627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139647489|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139647490|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
139135818|NCT05892237|Immunologic Factors|immunologic factors|mesh-ancestor
139647491|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390269|NCT06009627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139390270|NCT06009627|Alkylating Agents|alkylating agents|mesh-ancestor
139390271|NCT06009627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390272|NCT06009627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390273|NCT06009627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139390274|NCT06009627|Tubulin Modulators|tubulin modulators|mesh-ancestor
139390275|NCT06009627|Antimitotic Agents|antimitotic agents|mesh-ancestor
139390276|NCT06009627|Mitosis Modulators|mitosis modulators|mesh-ancestor
139390277|NCT06009627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139390278|NCT06009627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139390279|NCT06009627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139390280|NCT06009627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390281|NCT06009627|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139390282|NCT06009627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139390283|NCT06009627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139390284|NCT06009627|Hormone Antagonists|hormone antagonists|mesh-ancestor
139390285|NCT06009627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139390287|NCT06009497|Cyclosporins|cyclosporins|mesh-list
139390288|NCT06009497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390289|NCT06009497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390290|NCT06009497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139390291|NCT06009497|Immunologic Factors|immunologic factors|mesh-ancestor
139390292|NCT06009497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390293|NCT06009497|Antifungal Agents|antifungal agents|mesh-ancestor
139390294|NCT06009497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139390295|NCT06009497|Dermatologic Agents|dermatologic agents|mesh-ancestor
139390296|NCT06009497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139390297|NCT06009497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139390298|NCT06009042|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139390299|NCT06009042|gamma-Globulins|gamma-globulins|mesh-list
139047132|NCT01015547|Analgesics|analgesics|mesh-ancestor
139390300|NCT06009042|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139390301|NCT06009042|Immunologic Factors|immunologic factors|mesh-ancestor
139390302|NCT06009042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390303|NCT06009029|Immunomodulating Agents|immunomodulating agents|mesh-list
139390304|NCT06009029|Immunologic Factors|immunologic factors|mesh-ancestor
139390305|NCT06009029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390307|NCT06008925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390308|NCT06008925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390309|NCT06008925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390310|NCT06008925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390311|NCT06006273|Irinotecan|irinotecan|mesh-list
139390312|NCT06006273|Temozolomide|temozolomide|mesh-list
139390313|NCT06006273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139390314|NCT06006273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139390315|NCT06006273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390316|NCT06006273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390317|NCT06006273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390318|NCT06006273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139390319|NCT06006273|Alkylating Agents|alkylating agents|mesh-ancestor
139390320|NCT06005597|Ezetimibe|ezetimibe|mesh-list
139390321|NCT06005597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139390322|NCT06005597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139390323|NCT06005597|Antimetabolites|antimetabolites|mesh-ancestor
139390324|NCT06005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390325|NCT06005597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139390326|NCT05981352|Hyaluronic Acid|hyaluronic acid|mesh-list
139390327|NCT05981352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139390328|NCT05981352|Immunologic Factors|immunologic factors|mesh-ancestor
139390329|NCT05981352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390330|NCT05981352|Viscosupplements|viscosupplements|mesh-ancestor
139390331|NCT05981352|Protective Agents|protective agents|mesh-ancestor
139390332|NCT05969327|Vitamin D|vitamin d|mesh-list
139390333|NCT05969327|Vitamins|vitamins|mesh-ancestor
139390334|NCT05969327|Micronutrients|micronutrients|mesh-ancestor
139390335|NCT05969327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390336|NCT05969327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139390337|NCT05945901|Bevacizumab|bevacizumab|mesh-list
139390338|NCT05945901|Oxaliplatin|oxaliplatin|mesh-list
139647492|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647493|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139647494|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
139390339|NCT05945901|Fluorouracil|fluorouracil|mesh-list
139135821|NCT05840016|Tislelizumab|tislelizumab|mesh-list
139647495|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
139390340|NCT05945901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390341|NCT05945901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390342|NCT05945901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139390343|NCT05945901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139390344|NCT05945901|Growth Substances|growth substances|mesh-ancestor
139390345|NCT05945901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390346|NCT05945901|Growth Inhibitors|growth inhibitors|mesh-ancestor
139390347|NCT05945901|Antimetabolites|antimetabolites|mesh-ancestor
139390348|NCT05945901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390349|NCT05945901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139390350|NCT05945901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139390351|NCT05945901|Immunologic Factors|immunologic factors|mesh-ancestor
139390352|NCT05920642|Morphine|morphine|mesh-list
139390353|NCT05920642|Analgesics|analgesics|mesh-list
139390354|NCT05920642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139390355|NCT05920642|Narcotics|narcotics|mesh-ancestor
139390356|NCT05920642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139390357|NCT05920642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390358|NCT05920642|Sensory System Agents|sensory system agents|mesh-ancestor
139390359|NCT05920642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390360|NCT05920005|Amlodipine|amlodipine|mesh-list
139390361|NCT05920005|Valsartan|valsartan|mesh-list
139390362|NCT05920005|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139390363|NCT05920005|Candesartan|candesartan|mesh-list
139390364|NCT05920005|Candesartan cilexetil|candesartan cilexetil|mesh-list
139390365|NCT05920005|Chlorthalidone|chlorthalidone|mesh-list
139390366|NCT05920005|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
139390367|NCT05920005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139390368|NCT05920005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139390369|NCT05920005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139390370|NCT05920005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390371|NCT05920005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139390372|NCT05920005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390373|NCT05920005|Vasodilator Agents|vasodilator agents|mesh-ancestor
139390374|NCT05920005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138718422|NCT00586274|Fludarabine|fludarabine|mesh-list
139390375|NCT05920005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139390377|NCT05920005|Natriuretic Agents|natriuretic agents|mesh-ancestor
139390378|NCT05920005|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139390379|NCT05918796|Dexamethasone|dexamethasone|mesh-list
139390380|NCT05918796|Bupivacaine|bupivacaine|mesh-list
139390381|NCT05918796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139390382|NCT05918796|Antiemetics|antiemetics|mesh-ancestor
139390383|NCT05918796|Autonomic Agents|autonomic agents|mesh-ancestor
139390384|NCT05918796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390385|NCT05918796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390386|NCT05918796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139390387|NCT05918796|Glucocorticoids|glucocorticoids|mesh-ancestor
139390388|NCT05918796|Hormones|hormones|mesh-ancestor
139390389|NCT05918796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139390390|NCT05918796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139390391|NCT05918796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390392|NCT05918796|Anesthetics, Local|anesthetics, local|mesh-ancestor
139390393|NCT05918796|Anesthetics|anesthetics|mesh-ancestor
139390394|NCT05918796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139390395|NCT05918796|Sensory System Agents|sensory system agents|mesh-ancestor
139390396|NCT05846698|Tibolone|tibolone|mesh-list
139390397|NCT05846698|Androgen Antagonists|androgen antagonists|mesh-ancestor
139390398|NCT05846698|Hormone Antagonists|hormone antagonists|mesh-ancestor
139390399|NCT05846698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139390400|NCT05846698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390401|NCT05846698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139390402|NCT05846698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139390403|NCT05846698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390404|NCT05846698|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139390405|NCT05846698|Anabolic Agents|anabolic agents|mesh-ancestor
139390406|NCT05846698|Hormones|hormones|mesh-ancestor
139390407|NCT05800600|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139390408|NCT05800600|Hematinics|hematinics|mesh-ancestor
139647496|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139647497|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139390409|NCT05774704|Curcumin|curcumin|mesh-list
139390410|NCT05774704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139647498|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139647499|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139647500|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
139647501|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390411|NCT05774704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139390412|NCT05774704|Analgesics|analgesics|mesh-ancestor
139390413|NCT05774704|Sensory System Agents|sensory system agents|mesh-ancestor
139390414|NCT05774704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390415|NCT05774704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390416|NCT05774704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139390417|NCT05774704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139390418|NCT05774704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390419|NCT05774704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390420|NCT05774704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390421|NCT05745233|Pembrolizumab|pembrolizumab|mesh-list
139390422|NCT05745233|Nivolumab|nivolumab|mesh-list
139390423|NCT05745233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390424|NCT05745233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390425|NCT05745233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390426|NCT05745233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390427|NCT05725382|Remifentanil|remifentanil|mesh-list
139390428|NCT05725382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139390429|NCT05725382|Narcotics|narcotics|mesh-ancestor
139390430|NCT05725382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139390431|NCT05725382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390432|NCT05725382|Analgesics|analgesics|mesh-ancestor
139390433|NCT05725382|Sensory System Agents|sensory system agents|mesh-ancestor
139390434|NCT05725382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390435|NCT05721404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139390436|NCT05721404|Icodextrin|icodextrin|mesh-list
139390437|NCT05721404|Dialysis Solutions|dialysis solutions|mesh-list
139390438|NCT05710874|Fluorides|fluorides|mesh-list
139390439|NCT05710874|Cariostatic Agents|cariostatic agents|mesh-ancestor
139390440|NCT05710874|Protective Agents|protective agents|mesh-ancestor
139390441|NCT05710874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390442|NCT05710237|Risperidone|risperidone|mesh-list
139390443|NCT05710237|Psilocybin|psilocybin|mesh-list
139390444|NCT05710237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139390445|NCT05710237|Serotonin Agents|serotonin agents|mesh-ancestor
139390446|NCT05710237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390447|NCT05710237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390448|NCT05710237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390449|NCT05710237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139047276|NCT00485303|Prednisone|prednisone|mesh-list
139390450|NCT05710237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139390451|NCT05710237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139390452|NCT05710237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139390453|NCT05710237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139390454|NCT05710237|Dopamine Agents|dopamine agents|mesh-ancestor
139390455|NCT05710237|Hallucinogens|hallucinogens|mesh-ancestor
139390456|NCT05696080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139390457|NCT05696080|Immunologic Factors|immunologic factors|mesh-ancestor
139390458|NCT05696080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390459|NCT05684289|Sildenafil Citrate|sildenafil citrate|mesh-list
139390460|NCT05684289|Vasodilator Agents|vasodilator agents|mesh-ancestor
139390461|NCT05684289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139390462|NCT05684289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139390463|NCT05684289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390464|NCT05684289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390465|NCT05684289|Urological Agents|urological agents|mesh-ancestor
139390467|NCT05677126|Trace Elements|trace elements|mesh-list
139390468|NCT05677126|Selenious Acid|selenious acid|mesh-list
139390469|NCT05677126|Micronutrients|micronutrients|mesh-list
139390470|NCT05677126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390471|NCT05661682|Zinc|zinc|mesh-list
139390472|NCT05661682|Copper|copper|mesh-list
139390473|NCT05661682|Manganese|manganese|mesh-list
139390474|NCT05661682|Trace Elements|trace elements|mesh-list
139390475|NCT05661682|Selenious Acid|selenious acid|mesh-list
139390476|NCT05661682|Micronutrients|micronutrients|mesh-list
139390477|NCT05661682|Copper Sulfate|copper sulfate|mesh-list
139647502|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647503|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
139647504|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139647505|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
139647506|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390478|NCT05661682|Zinc Sulfate|zinc sulfate|mesh-list
139390479|NCT05661682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390480|NCT05661682|Astringents|astringents|mesh-ancestor
139390481|NCT05661682|Dermatologic Agents|dermatologic agents|mesh-ancestor
139647507|NCT04864314|Protective Agents|protective agents|mesh-ancestor
139390482|NCT05661682|Antidotes|antidotes|mesh-ancestor
139390483|NCT05661682|Protective Agents|protective agents|mesh-ancestor
139390484|NCT05661682|Emetics|emetics|mesh-ancestor
139390485|NCT05661682|Autonomic Agents|autonomic agents|mesh-ancestor
139390486|NCT05661682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390487|NCT05661682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139390488|NCT05607147|Antibodies|antibodies|mesh-list
139390489|NCT05607147|Immunologic Factors|immunologic factors|mesh-ancestor
139390490|NCT05607147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390491|NCT05579964|Dexmedetomidine|dexmedetomidine|mesh-list
139390492|NCT05579964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139390493|NCT05579964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139390494|NCT05579964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390495|NCT05579964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139390496|NCT05579964|Analgesics|analgesics|mesh-ancestor
139390497|NCT05579964|Sensory System Agents|sensory system agents|mesh-ancestor
139390498|NCT05579964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390499|NCT05579964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139390500|NCT05579964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139390501|NCT05579964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139390502|NCT05579964|Adrenergic Agents|adrenergic agents|mesh-ancestor
139390503|NCT05579964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390504|NCT05579964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390505|NCT05567770|Androgens|androgens|mesh-list
139390506|NCT05567770|Hormones|hormones|mesh-ancestor
139390507|NCT05567770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139390508|NCT05567770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390509|NCT05550337|Trifarotene|trifarotene|mesh-list
139390510|NCT05550337|Dermatologic Agents|dermatologic agents|mesh-ancestor
139390511|NCT05549180|Emtricitabine|emtricitabine|mesh-list
139390512|NCT05549180|Antiviral Agents|antiviral agents|mesh-ancestor
139390513|NCT05549180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139390514|NCT05549180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139390515|NCT05549180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139390516|NCT05549180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390517|NCT05549180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390518|NCT05549180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139390519|NCT05549180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139390520|NCT05514119|Fenofibrate|fenofibrate|mesh-list
139390521|NCT05514119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139390522|NCT05514119|Antimetabolites|antimetabolites|mesh-ancestor
139390523|NCT05514119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390524|NCT05514119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139390525|NCT05416229|Psilocybin|psilocybin|mesh-list
139390526|NCT05416229|Hallucinogens|hallucinogens|mesh-ancestor
139390527|NCT05416229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390528|NCT05416229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139390529|NCT05414877|Phenylephrine|phenylephrine|mesh-list
139390530|NCT05414877|Oxymetazoline|oxymetazoline|mesh-list
139390531|NCT05414877|Norepinephrine|norepinephrine|mesh-list
139390532|NCT05414877|Ephedrine|ephedrine|mesh-list
139390533|NCT05414877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139390534|NCT05414877|Mydriatics|mydriatics|mesh-ancestor
139390535|NCT05414877|Autonomic Agents|autonomic agents|mesh-ancestor
139390536|NCT05414877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390537|NCT05414877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390538|NCT05414877|Sympathomimetics|sympathomimetics|mesh-ancestor
139390539|NCT05414877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139390540|NCT05414877|Nasal Decongestants|nasal decongestants|mesh-ancestor
139390541|NCT05414877|Respiratory System Agents|respiratory system agents|mesh-ancestor
139390542|NCT05414877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139390543|NCT05414877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139390544|NCT05414877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139390545|NCT05414877|Adrenergic Agents|adrenergic agents|mesh-ancestor
139390546|NCT05414877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390547|NCT05414877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390548|NCT05414877|Protective Agents|protective agents|mesh-ancestor
139647508|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647509|NCT04874844|Antibodies|antibodies|mesh-list
139647510|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139647511|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
139647512|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647513|NCT03046290|Lidocaine|lidocaine|mesh-list
139390549|NCT05414877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139390550|NCT05345327|Metformin|metformin|mesh-list
139647514|NCT03046290|Ropivacaine|ropivacaine|mesh-list
139647515|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
139390551|NCT05345327|Dapagliflozin|dapagliflozin|mesh-list
139390552|NCT05345327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139390553|NCT05345327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390554|NCT05345327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139390555|NCT05345327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390556|NCT05305287|Pioglitazone|pioglitazone|mesh-list
139390557|NCT05305287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139390558|NCT05305287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390559|NCT05188677|Vaccines|vaccines|mesh-list
139390560|NCT05188677|Immunologic Factors|immunologic factors|mesh-ancestor
139390561|NCT05188677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390562|NCT05177055|Methamphetamine|methamphetamine|mesh-list
139390563|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139390564|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390565|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
139390566|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
139390567|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390568|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
139390569|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390570|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390571|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
139390572|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139390573|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139390574|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139390575|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139390576|NCT05170009|Oseltamivir|oseltamivir|mesh-list
139390577|NCT05170009|Baloxavir|baloxavir|mesh-list
139390578|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
139390579|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139390580|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390581|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390582|NCT05159427|Glipizide|glipizide|mesh-list
139390583|NCT05159427|Rifaximin|rifaximin|mesh-list
139390584|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139390585|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139390586|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139390587|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139390588|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390589|NCT05132699|Cannabidiol|cannabidiol|mesh-list
139390590|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139390591|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
139390592|NCT05033665|Benzocaine|benzocaine|mesh-list
139390593|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
139390594|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
139390595|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139390596|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390597|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
139390598|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390599|NCT04919629|Bevacizumab|bevacizumab|mesh-list
139047415|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390600|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139390601|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
139390602|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
139390603|NCT04919629|Antibodies|antibodies|mesh-list
139390604|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
139390605|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139390606|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
139390607|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390608|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139390609|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139390610|NCT04919629|Growth Substances|growth substances|mesh-ancestor
139390611|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390612|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
139390613|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
139390614|NCT04919629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390615|NCT04919629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647516|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
139647517|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139647518|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647519|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
139647520|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647521|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139390616|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
139390618|NCT04902040|Atezolizumab|atezolizumab|mesh-list
139390619|NCT04902040|Durvalumab|durvalumab|mesh-list
139647522|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139647523|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139647524|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139647525|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390620|NCT04902040|Avelumab|avelumab|mesh-list
139390621|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
139390622|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139390623|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
139390624|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390625|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390626|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390627|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390628|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
139390629|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390630|NCT04901208|Nicotine|nicotine|mesh-list
139390631|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139390632|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
139390633|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390634|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390635|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139390636|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139390637|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
139390638|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390639|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390640|NCT04701307|Niraparib|niraparib|mesh-list
139390641|NCT04701307|Dostarlimab|dostarlimab|mesh-list
139390642|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
139390643|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
139390644|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
139390645|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390646|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139390647|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390648|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390649|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390650|NCT04673461|Xylometazoline|xylometazoline|mesh-list
139390651|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
139390652|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139390653|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
139390654|NCT04673175|Tazobactam|tazobactam|mesh-list
139390655|NCT04673175|Ceftolozane|ceftolozane|mesh-list
139390656|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
139390657|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139390658|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139390659|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139390660|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390661|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390662|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139390663|NCT04666649|Venetoclax|venetoclax|mesh-list
139390664|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390665|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
139390666|NCT04606901|Neostigmine|neostigmine|mesh-list
139390667|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139390668|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390669|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390670|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
139390671|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390672|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390673|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139390674|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
139390675|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390676|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139390677|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139390678|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139390679|NCT04545736|Metformin|metformin|mesh-list
139390680|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139647526|NCT04874688|Provitamins|provitamins|mesh-list
139647527|NCT04874688|Beta Carotene|beta carotene|mesh-list
139647528|NCT04874688|Vitamins|vitamins|mesh-ancestor
139647529|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
139390681|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390682|NCT04534725|Interferons|interferons|mesh-list
139390683|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
139390684|NCT04534725|Lenzilumab|lenzilumab|mesh-list
139390685|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390686|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
139390687|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647530|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647531|NCT02612064|Fluorides|fluorides|mesh-list
139390688|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
139390689|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390690|NCT04534725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139390691|NCT04463498|Methamphetamine|methamphetamine|mesh-list
139390692|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139390693|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390694|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
139390695|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
139390696|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390697|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
139390698|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390699|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390700|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
139390701|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139390702|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139390703|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139390704|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139390705|NCT04385433|Pravastatin|pravastatin|mesh-list
139390706|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139390707|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139390708|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
139390709|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390710|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139390711|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139390712|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390713|NCT04362839|Nivolumab|nivolumab|mesh-list
139390714|NCT04362839|Ipilimumab|ipilimumab|mesh-list
139390715|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390716|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390717|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390718|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390719|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139390720|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139390721|NCT04284761|Bicalutamide|bicalutamide|mesh-list
139390722|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
139390723|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
139390724|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139390725|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390726|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390727|NCT04275024|Calcipotriene|calcipotriene|mesh-list
139390728|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
139390729|NCT04259255|Edaravone|edaravone|mesh-list
139390730|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139390731|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
139390732|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390733|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139390734|NCT04259255|Protective Agents|protective agents|mesh-ancestor
139390735|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390736|NCT04169763|Nelfinavir|nelfinavir|mesh-list
139390737|NCT04169763|Cisplatin|cisplatin|mesh-list
139390738|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390739|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139390740|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139390741|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
139390742|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390743|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390744|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139390745|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139390746|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
139390747|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139390748|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139390749|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
139390750|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390751|NCT04011345|Folic Acid|folic acid|mesh-list
139390752|NCT04011345|Hematinics|hematinics|mesh-ancestor
139390753|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
139390754|NCT04011345|Vitamins|vitamins|mesh-ancestor
139390755|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
139390756|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647532|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
139647533|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
139390758|NCT03993353|Tadalafil|tadalafil|mesh-list
139135857|NCT05773365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647534|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
139390759|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390760|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390761|NCT03993353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390762|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390763|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
139390764|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139390765|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139390766|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390767|NCT03993353|Urological Agents|urological agents|mesh-ancestor
139390768|NCT03970837|Tofacitinib|tofacitinib|mesh-list
139390769|NCT03970837|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139390770|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139390771|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390772|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390773|NCT03945357|Clindamycin|clindamycin|mesh-list
139390774|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
139390775|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
139390776|NCT03945357|Gemcitabine|gemcitabine|mesh-list
139390777|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139390778|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
139390779|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390780|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390781|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139390782|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139390783|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139390784|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390786|NCT03896009|Rizatriptan|rizatriptan|mesh-list
138718521|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
139390787|NCT03896009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139390788|NCT03896009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139390789|NCT03896009|Analgesics|analgesics|mesh-ancestor
139390790|NCT03896009|Sensory System Agents|sensory system agents|mesh-ancestor
139390791|NCT03896009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390792|NCT03896009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390793|NCT03896009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139390794|NCT03896009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139390795|NCT03896009|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139390796|NCT03896009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139390797|NCT03896009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390798|NCT03896009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390799|NCT03896009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139390800|NCT03896009|Serotonin Agents|serotonin agents|mesh-ancestor
139390801|NCT03896009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390802|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139390803|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139390804|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390805|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
139390806|NCT03606174|Nivolumab|nivolumab|mesh-list
139390807|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390808|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390809|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390810|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390811|NCT03450707|Thiamine|thiamine|mesh-list
139390812|NCT03450707|Vitamins|vitamins|mesh-ancestor
139390813|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
139390814|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390815|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
139390816|NCT03392311|Calcipotriene|calcipotriene|mesh-list
139390817|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
139390818|NCT03337009|Naloxone|naloxone|mesh-list
139390819|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139390820|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390821|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
139390822|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390823|NCT03324373|Everolimus|everolimus|mesh-list
139390824|NCT03324373|Lenvatinib|lenvatinib|mesh-list
139390825|NCT03324373|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139390826|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139390827|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390828|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390829|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139647535|NCT02612064|Protective Agents|protective agents|mesh-ancestor
139647536|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647537|NCT04553003|Prednisone|prednisone|mesh-list
139647538|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
139647539|NCT04553003|Choline|choline|mesh-list
139647540|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
139647541|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
139390831|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390832|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390833|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
139390834|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390835|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390836|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139390837|NCT03296527|Hormones|hormones|mesh-ancestor
139390838|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139390839|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390840|NCT03267498|Nivolumab|nivolumab|mesh-list
139390841|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390842|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390843|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390844|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390845|NCT03241771|Naloxone|naloxone|mesh-list
139390846|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139390847|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390848|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
139390849|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390850|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139390851|NCT03228680|Hormones|hormones|mesh-ancestor
139390852|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139390853|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390854|NCT03194542|Luspatercept|luspatercept|mesh-list
139390855|NCT03194542|Hematinics|hematinics|mesh-ancestor
139390856|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
139390857|NCT03160079|Blinatumomab|blinatumomab|mesh-list
139390858|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390859|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390860|NCT03160079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390861|NCT03160079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390862|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
139390863|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390864|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390865|NCT03083808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390866|NCT03083808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390867|NCT03047330|Leuprolide|leuprolide|mesh-list
139390868|NCT03047330|Estradiol|estradiol|mesh-list
139390869|NCT03047330|Estrogens|estrogens|mesh-ancestor
139390870|NCT03047330|Hormones|hormones|mesh-ancestor
139390871|NCT03047330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139390872|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390873|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139390874|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139390875|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
139390876|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139390877|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390878|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
139390879|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390880|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
139390881|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139390882|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
139390883|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139390884|NCT02608216|Paclitaxel|paclitaxel|mesh-list
139390885|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139390886|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390887|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
139390888|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
139390889|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
139390890|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390891|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
139390892|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
139390893|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390894|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390895|NCT02362035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390896|NCT02362035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647542|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139390897|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
138895613|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
139647543|NCT04553003|Hormones|hormones|mesh-ancestor
139390901|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139390902|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139390903|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390904|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
139390905|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139390906|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
139390907|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390908|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139390909|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139390910|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
139390911|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390912|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390913|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139390918|NCT00390325|Sorafenib|sorafenib|mesh-list
139390919|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390920|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139390921|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390922|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390923|NCT00265798|Sorafenib|sorafenib|mesh-list
139390924|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390925|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139390926|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390927|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390928|NCT03538171|Exemestane|exemestane|mesh-list
139390929|NCT03538171|Entinostat|entinostat|mesh-list
139390930|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390931|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139390932|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139390933|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390934|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390935|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139390936|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
139390937|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139390938|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390939|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139390940|NCT05312216|Durvalumab|durvalumab|mesh-list
139390941|NCT05312216|Lenvatinib|lenvatinib|mesh-list
139390942|NCT05312216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390943|NCT05312216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390944|NCT05312216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139390945|NCT05312216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390946|NCT05312216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390947|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
139390948|NCT02256319|Propofol|propofol|mesh-list
139390949|NCT02256319|Imidazole|imidazole|mesh-list
139390950|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139390951|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139390952|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390953|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139390954|NCT02256319|Analgesics|analgesics|mesh-ancestor
139390955|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
139390956|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390957|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139390958|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139390959|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139647545|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647546|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139647547|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647548|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
139647549|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
139647550|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647551|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139647552|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139390960|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
139647553|NCT04553003|Protective Agents|protective agents|mesh-ancestor
139390961|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390962|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390963|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139390964|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
139390965|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
139390966|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390967|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
139390968|NCT04510285|Trastuzumab|trastuzumab|mesh-list
139390969|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139390970|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390971|NCT04510285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139390972|NCT04510285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390973|NCT05450432|Ketamine|ketamine|mesh-list
139390974|NCT05450432|Esketamine|esketamine|mesh-list
139390975|NCT05450432|Analgesics|analgesics|mesh-ancestor
139390976|NCT05450432|Sensory System Agents|sensory system agents|mesh-ancestor
139390977|NCT05450432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139390978|NCT05450432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390979|NCT05450432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139390980|NCT05450432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139390981|NCT05450432|Anesthetics, General|anesthetics, general|mesh-ancestor
139390982|NCT05450432|Anesthetics|anesthetics|mesh-ancestor
139390983|NCT05450432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139390984|NCT05450432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139390985|NCT05450432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139390986|NCT05450432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139390987|NCT05450432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390988|NCT05450432|Antidepressive Agents|antidepressive agents|mesh-ancestor
139390989|NCT05450432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139390990|NCT02179255|Hormones|hormones|mesh-list
139390991|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139390992|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139390993|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139390994|NCT02182063|Nintedanib|nintedanib|mesh-list
139390995|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139390996|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139390997|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139390998|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139390999|NCT02182141|Nintedanib|nintedanib|mesh-list
139391000|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391001|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139391002|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391003|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391004|NCT02182219|Nintedanib|nintedanib|mesh-list
139391005|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391006|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139391007|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391008|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391009|NCT05303480|Mechlorethamine|mechlorethamine|mesh-list
139391010|NCT05303480|Alkylating Agents|alkylating agents|mesh-ancestor
139391011|NCT05303480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391012|NCT05303480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139391013|NCT05303480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391014|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
139391015|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139391016|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139391017|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
139391018|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139391019|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139391020|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139391021|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391022|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391023|NCT02179567|Bevacizumab|bevacizumab|mesh-list
139391024|NCT02179567|Docetaxel|docetaxel|mesh-list
139391025|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139391026|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391027|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139391028|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139647554|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
139647555|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139647556|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
139391029|NCT02179567|Growth Substances|growth substances|mesh-ancestor
139135878|NCT05471609|Dopamine Agents|dopamine agents|mesh-ancestor
139391030|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391031|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
139391032|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
139391033|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
139391034|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
139391035|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391036|NCT02182453|Empagliflozin|empagliflozin|mesh-list
139391037|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139391038|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391039|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139391040|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391041|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
139391042|NCT02182531|Ephedrine|ephedrine|mesh-list
139391043|NCT02182531|Epinastine|epinastine|mesh-list
139391044|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139391045|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
139391046|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391047|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391048|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139047863|NCT00359762|Exenatide|exenatide|mesh-list
139391049|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
139391050|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
139391051|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139391052|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139391053|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
139391054|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
139391055|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391056|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391057|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139391058|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
139391059|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
138718655|NCT00588926|Remifentanil|remifentanil|mesh-list
139391060|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139391061|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
139391062|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139391063|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
139391064|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391065|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391066|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139391067|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
139391068|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
139391069|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139391070|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
139391071|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391072|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391074|NCT02182765|Abacavir|abacavir|mesh-list
139391075|NCT02182765|Amprenavir|amprenavir|mesh-list
139391076|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139391077|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139391078|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391079|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391080|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
139391081|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139391082|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139391083|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139391084|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139391085|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139391086|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139391087|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
139391088|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139391089|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139391090|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139391091|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
139391092|NCT02179645|Celecoxib|celecoxib|mesh-list
139391093|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139647557|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647558|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139647559|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
139647560|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
139647561|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
139647562|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139647563|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139647564|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647565|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
139135883|NCT05471609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647566|NCT03044184|Coagulants|coagulants|mesh-ancestor
139647567|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
139647568|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139647569|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139391094|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139391095|NCT02179645|Analgesics|analgesics|mesh-ancestor
139391096|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
139391097|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391098|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391099|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139391100|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139391101|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139391102|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139391103|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391104|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391105|NCT03537157|Rifaximin|rifaximin|mesh-list
139391106|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139391107|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139391108|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139391109|NCT01606202|Nabiximols|nabiximols|mesh-list
139391110|NCT01606202|Analgesics|analgesics|mesh-ancestor
139391111|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
139391112|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391113|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391114|NCT03536611|Warfarin|warfarin|mesh-list
139391115|NCT03536611|Dabigatran|dabigatran|mesh-list
139391116|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
139391117|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
139391118|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139391119|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
139047936|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139391120|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391121|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391122|NCT02630459|Erenumab|erenumab|mesh-list
139391123|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139391124|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139391125|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391127|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
139391128|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391129|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391130|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
139391131|NCT02183077|Meloxicam|meloxicam|mesh-list
139391132|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139391133|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139391134|NCT02183077|Analgesics|analgesics|mesh-ancestor
139391135|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
139391136|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391137|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391138|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139391139|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139391140|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139391141|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139391142|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391143|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391144|NCT02183155|Indomethacin|indomethacin|mesh-list
139391145|NCT02183155|Meloxicam|meloxicam|mesh-list
139391146|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139391147|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139391148|NCT02183155|Analgesics|analgesics|mesh-ancestor
139391149|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
139391150|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391151|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391152|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139391153|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139391154|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
139391155|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
139391156|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139391157|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139391158|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391159|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391160|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139391161|NCT02177461|Telmisartan|telmisartan|mesh-list
139391162|NCT02177461|Clonidine|clonidine|mesh-list
139391163|NCT02177461|Enalapril|enalapril|mesh-list
139391164|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139647570|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391165|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139391166|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139391167|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391168|NCT02177461|Analgesics|analgesics|mesh-ancestor
139391169|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
139391170|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391171|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391172|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
139391173|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
139391174|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139391175|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139391176|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139391177|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
139391178|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718715|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139391179|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139391180|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
139391181|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391182|NCT03545243|Pantoprazole|pantoprazole|mesh-list
139391183|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139391184|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139391185|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139391186|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391187|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391188|NCT02183311|Linagliptin|linagliptin|mesh-list
139391189|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139391190|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391191|NCT02183311|Incretins|incretins|mesh-ancestor
139391192|NCT02183311|Hormones|hormones|mesh-ancestor
139391193|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139391194|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139391195|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
139391196|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391197|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391199|NCT05518526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139391200|NCT05518526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391201|NCT01464593|Doxorubicin|doxorubicin|mesh-list
139391202|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139391203|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139391204|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391205|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139391206|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139391207|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391208|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391209|NCT02183389|Linagliptin|linagliptin|mesh-list
139391210|NCT02183389|Warfarin|warfarin|mesh-list
139391211|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
139391212|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139391213|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391214|NCT02183389|Incretins|incretins|mesh-ancestor
139391215|NCT02183389|Hormones|hormones|mesh-ancestor
139391216|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139391217|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139391218|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
139391219|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391220|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391221|NCT02177539|Phenylephrine|phenylephrine|mesh-list
139391222|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
139391223|NCT02177539|Tropicamide|tropicamide|mesh-list
139391224|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
139391225|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139391226|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
139391227|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
139391228|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391229|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391230|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
139647571|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139647572|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139647573|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139647574|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647575|NCT03047772|Atorvastatin|atorvastatin|mesh-list
139647576|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139647577|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139647578|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
139391231|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139391232|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
139391233|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
139391234|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139391235|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139391236|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139391237|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
139391238|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391239|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391240|NCT02177539|Protective Agents|protective agents|mesh-ancestor
139391241|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139391242|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139391243|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
139391244|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
139391245|NCT06220279|Diclofenac|diclofenac|mesh-list
139391246|NCT06220279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139391247|NCT06220279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139391248|NCT06220279|Analgesics|analgesics|mesh-ancestor
139391249|NCT06220279|Sensory System Agents|sensory system agents|mesh-ancestor
139391250|NCT06220279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391251|NCT06220279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391252|NCT06220279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139391253|NCT06220279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139391254|NCT06220279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139391255|NCT06220279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391256|NCT06220279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391263|NCT06220201|Cyclophosphamide|cyclophosphamide|mesh-list
139391264|NCT06220201|Fludarabine|fludarabine|mesh-list
139391265|NCT06220201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139391266|NCT06220201|Immunologic Factors|immunologic factors|mesh-ancestor
139391267|NCT06220201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391268|NCT06220201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139391269|NCT06220201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139391270|NCT06220201|Alkylating Agents|alkylating agents|mesh-ancestor
139391271|NCT06220201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391272|NCT06220201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391273|NCT06220201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139391274|NCT06220175|Lidocaine|lidocaine|mesh-list
139391275|NCT06220175|Anesthetics, Local|anesthetics, local|mesh-ancestor
139391276|NCT06220175|Anesthetics|anesthetics|mesh-ancestor
139391277|NCT06220175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391278|NCT06220175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391279|NCT06220175|Sensory System Agents|sensory system agents|mesh-ancestor
139391280|NCT06220175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391281|NCT06220175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139391282|NCT06220175|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139391283|NCT06220175|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139391284|NCT06220175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139391285|NCT06220175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391286|NCT06220162|Azacitidine|azacitidine|mesh-list
139391287|NCT06220162|Venetoclax|venetoclax|mesh-list
139391288|NCT06220162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139391289|NCT06220162|Antimetabolites|antimetabolites|mesh-ancestor
139391290|NCT06220162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391291|NCT06220162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391292|NCT06220162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391293|NCT06220123|Enoxaparin|enoxaparin|mesh-list
139391294|NCT06220123|Rivaroxaban|rivaroxaban|mesh-list
139391295|NCT06220123|Enoxaparin sodium|enoxaparin sodium|mesh-list
139391296|NCT06220123|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139391297|NCT06220123|Antithrombins|antithrombins|mesh-ancestor
138718771|NCT00590447|Rituximab|rituximab|mesh-list
139391298|NCT06220123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139391299|NCT06220123|Protease Inhibitors|protease inhibitors|mesh-ancestor
139647584|NCT03047538|Perindopril|perindopril|mesh-list
139391300|NCT06220123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391301|NCT06220123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391302|NCT06220123|Anticoagulants|anticoagulants|mesh-ancestor
139391303|NCT06220123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139391304|NCT06220123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139391305|NCT06220097|Fludarabine|fludarabine|mesh-list
139391306|NCT06220097|Mitoxantrone|mitoxantrone|mesh-list
139391307|NCT06220097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391308|NCT06220097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391309|NCT06220097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391310|NCT06220097|Analgesics|analgesics|mesh-ancestor
139391311|NCT06220097|Sensory System Agents|sensory system agents|mesh-ancestor
139391312|NCT06220097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391313|NCT06220097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139391314|NCT06220097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139391315|NCT06220097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391316|NCT06220045|Fluorides|fluorides|mesh-list
139391317|NCT06220045|Cariostatic Agents|cariostatic agents|mesh-ancestor
139391318|NCT06220045|Protective Agents|protective agents|mesh-ancestor
139391319|NCT06220045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391320|NCT06220032|Prednisolone|prednisolone|mesh-list
139391321|NCT06220032|Cyclophosphamide|cyclophosphamide|mesh-list
139391322|NCT06220032|Rituximab|rituximab|mesh-list
139391323|NCT06220032|Doxorubicin|doxorubicin|mesh-list
139391324|NCT06220032|Vincristine|vincristine|mesh-list
139391325|NCT06220032|Lenalidomide|lenalidomide|mesh-list
139391326|NCT06220032|Dexrazoxane|dexrazoxane|mesh-list
139391327|NCT06220032|Razoxane|razoxane|mesh-list
139391328|NCT06220032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139391329|NCT06220032|Immunologic Factors|immunologic factors|mesh-ancestor
139391330|NCT06220032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391331|NCT06220032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139391332|NCT06220032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139391333|NCT06220032|Alkylating Agents|alkylating agents|mesh-ancestor
139391334|NCT06220032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391335|NCT06220032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391336|NCT06220032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139391337|NCT06220032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139391338|NCT06220032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139391339|NCT06220032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139391340|NCT06220032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139391341|NCT06220032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391342|NCT06220032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139391343|NCT06220032|Tubulin Modulators|tubulin modulators|mesh-ancestor
139391344|NCT06220032|Antimitotic Agents|antimitotic agents|mesh-ancestor
139391345|NCT06220032|Mitosis Modulators|mitosis modulators|mesh-ancestor
139048158|NCT00316602|Antiviral Agents|antiviral agents|mesh-ancestor
139391346|NCT06220032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139391347|NCT06220032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139391348|NCT06220032|Growth Substances|growth substances|mesh-ancestor
139391349|NCT06220032|Growth Inhibitors|growth inhibitors|mesh-ancestor
139391350|NCT06220032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139391351|NCT06220032|Glucocorticoids|glucocorticoids|mesh-ancestor
139391352|NCT06220032|Hormones|hormones|mesh-ancestor
139391353|NCT06220032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139391354|NCT06220032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139391355|NCT06220032|Protective Agents|protective agents|mesh-ancestor
139391356|NCT06220032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139391357|NCT06219967|Charcoal|charcoal|mesh-list
139391358|NCT06219967|Antidotes|antidotes|mesh-ancestor
139391359|NCT06219967|Protective Agents|protective agents|mesh-ancestor
139391360|NCT06219967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391361|NCT06219941|Leucovorin|leucovorin|mesh-list
139391362|NCT06219941|Gemcitabine|gemcitabine|mesh-list
139391363|NCT06219941|Fluorouracil|fluorouracil|mesh-list
139391364|NCT06219941|Irinotecan|irinotecan|mesh-list
139391365|NCT06219941|Levoleucovorin|levoleucovorin|mesh-list
139647585|NCT03047538|Atorvastatin|atorvastatin|mesh-list
139647586|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139647587|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139647588|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
139391366|NCT06219941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139647589|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391367|NCT06219941|Antimetabolites|antimetabolites|mesh-ancestor
139391368|NCT06219941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391369|NCT06219941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135909|NCT05372315|Protease Inhibitors|protease inhibitors|mesh-ancestor
139391370|NCT06219941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139647590|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139647591|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139391371|NCT06219941|Immunologic Factors|immunologic factors|mesh-ancestor
139391372|NCT06219941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391373|NCT06219941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139391374|NCT06219941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139391375|NCT06219941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391376|NCT06219941|Antidotes|antidotes|mesh-ancestor
139391377|NCT06219941|Protective Agents|protective agents|mesh-ancestor
139391378|NCT06219941|Vitamin B Complex|vitamin b complex|mesh-ancestor
139391379|NCT06219941|Vitamins|vitamins|mesh-ancestor
139391380|NCT06219941|Micronutrients|micronutrients|mesh-ancestor
139391381|NCT06219928|Dexmedetomidine|dexmedetomidine|mesh-list
139391382|NCT06219928|Ketamine|ketamine|mesh-list
139391383|NCT06219928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139391384|NCT06219928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391385|NCT06219928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391386|NCT06219928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139391387|NCT06219928|Analgesics|analgesics|mesh-ancestor
139391388|NCT06219928|Sensory System Agents|sensory system agents|mesh-ancestor
139391389|NCT06219928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391390|NCT06219928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139391391|NCT06219928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139391392|NCT06219928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139391393|NCT06219928|Adrenergic Agents|adrenergic agents|mesh-ancestor
139391394|NCT06219928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391395|NCT06219928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391396|NCT06219928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139391397|NCT06219928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139391398|NCT06219928|Anesthetics, General|anesthetics, general|mesh-ancestor
139391399|NCT06219928|Anesthetics|anesthetics|mesh-ancestor
139391400|NCT06219928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139391401|NCT06219928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139391402|NCT06219915|Levodopa|levodopa|mesh-list
139391403|NCT06219915|Carbidopa|carbidopa|mesh-list
139391404|NCT06219915|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139391405|NCT06219915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139391406|NCT06219915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139391407|NCT06219915|Dopamine Agents|dopamine agents|mesh-ancestor
139391408|NCT06219915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391409|NCT06219915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718815|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
139391410|NCT06219915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391411|NCT06219915|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139391412|NCT06219915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391413|NCT06219915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139391414|NCT06219915|Immunologic Factors|immunologic factors|mesh-ancestor
139391415|NCT06219915|Dopamine Agonists|dopamine agonists|mesh-ancestor
139391416|NCT06219902|Zopiclone|zopiclone|mesh-list
139391417|NCT06219902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139391418|NCT06219902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391419|NCT06219902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048267|NCT00335738|Etoposide|etoposide|mesh-list
139391420|NCT06219837|Bupivacaine|bupivacaine|mesh-list
139391421|NCT06219837|Anesthetics, Local|anesthetics, local|mesh-ancestor
139391422|NCT06219837|Anesthetics|anesthetics|mesh-ancestor
139391423|NCT06219837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391424|NCT06219837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391425|NCT06219837|Sensory System Agents|sensory system agents|mesh-ancestor
139391426|NCT06219837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391427|NCT06219824|Pemetrexed|pemetrexed|mesh-list
139391428|NCT06219824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391429|NCT06219824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391430|NCT06219824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391431|NCT06219824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139391432|NCT06219824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139391433|NCT06219733|Imatinib Mesylate|imatinib mesylate|mesh-list
139391434|NCT06219733|Vactosertib|vactosertib|mesh-list
139647592|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647593|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139647594|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139391435|NCT06219733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391436|NCT06219733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139391437|NCT06219733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391438|NCT06219733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391451|NCT06219486|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139391452|NCT06219486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139391453|NCT06219486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391454|NCT06219486|Hemostatics|hemostatics|mesh-ancestor
139391455|NCT06219486|Coagulants|coagulants|mesh-ancestor
139391456|NCT06219317|Cemiplimab|cemiplimab|mesh-list
139391457|NCT06219317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139391458|NCT06219317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391459|NCT06219096|Liver Extracts|liver extracts|mesh-list
139391460|NCT06219096|Hematinics|hematinics|mesh-ancestor
139391461|NCT06218979|Risperidone|risperidone|mesh-list
139391462|NCT06218979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139391463|NCT06218979|Serotonin Agents|serotonin agents|mesh-ancestor
139391464|NCT06218979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391465|NCT06218979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391466|NCT06218979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391467|NCT06218979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139391468|NCT06218979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139391469|NCT06218979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391470|NCT06218979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139391471|NCT06218979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139391472|NCT06218979|Dopamine Agents|dopamine agents|mesh-ancestor
139391473|NCT06218901|Immunomodulating Agents|immunomodulating agents|mesh-list
139391474|NCT06218901|Immunologic Factors|immunologic factors|mesh-ancestor
139391475|NCT06218901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391476|NCT06218888|Tislelizumab|tislelizumab|mesh-list
139391477|NCT06218888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139391478|NCT06218888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391479|NCT06218862|Antiviral Agents|antiviral agents|mesh-list
139391480|NCT06218862|Sivelestat|sivelestat|mesh-list
139391481|NCT06218862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139391482|NCT06218862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139391483|NCT06218862|Protease Inhibitors|protease inhibitors|mesh-ancestor
139391484|NCT06218862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391485|NCT06218862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391497|NCT06218810|Bevacizumab|bevacizumab|mesh-list
139391498|NCT06218810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139391499|NCT06218810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391500|NCT06218810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139391501|NCT06218810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139391502|NCT06218810|Growth Substances|growth substances|mesh-ancestor
139391503|NCT06218810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391504|NCT06218810|Growth Inhibitors|growth inhibitors|mesh-ancestor
139391505|NCT06218797|Dexmedetomidine|dexmedetomidine|mesh-list
139391506|NCT06218797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139391507|NCT06218797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139647595|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139647596|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139391508|NCT06218797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647597|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647598|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
139135919|NCT05190770|Triamcinolone|triamcinolone|mesh-list
139391509|NCT06218797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139647599|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139647600|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
139391510|NCT06218797|Analgesics|analgesics|mesh-ancestor
139391511|NCT06218797|Sensory System Agents|sensory system agents|mesh-ancestor
139391512|NCT06218797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391513|NCT06218797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139391514|NCT06218797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139391515|NCT06218797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139391516|NCT06218797|Adrenergic Agents|adrenergic agents|mesh-ancestor
139391517|NCT06218797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391518|NCT06218797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391520|NCT06218680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139391521|NCT06218680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391522|NCT06218680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391523|NCT06218680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139391524|NCT06218680|Anesthetics, General|anesthetics, general|mesh-ancestor
139391525|NCT06218680|Anesthetics|anesthetics|mesh-ancestor
139391526|NCT06218550|Dronabinol|dronabinol|mesh-list
139391527|NCT06218550|Hallucinogens|hallucinogens|mesh-ancestor
139391528|NCT06218550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391529|NCT06218550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139391530|NCT06218550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139391531|NCT06218550|Analgesics|analgesics|mesh-ancestor
139391532|NCT06218550|Sensory System Agents|sensory system agents|mesh-ancestor
139391533|NCT06218550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391534|NCT06218550|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139391535|NCT06218550|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139391536|NCT06218550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391537|NCT06218550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391538|NCT06218550|Hormones|hormones|mesh-ancestor
139391539|NCT06218550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139391540|NCT06218524|Temozolomide|temozolomide|mesh-list
139391541|NCT06218524|Haloperidol|haloperidol|mesh-list
139391542|NCT06218524|Haloperidol decanoate|haloperidol decanoate|mesh-list
139391543|NCT06218524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139391544|NCT06218524|Alkylating Agents|alkylating agents|mesh-ancestor
139391545|NCT06218524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391546|NCT06218524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391547|NCT06218524|Antiemetics|antiemetics|mesh-ancestor
139391548|NCT06218524|Autonomic Agents|autonomic agents|mesh-ancestor
139391549|NCT06218524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391550|NCT06218524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391551|NCT06218524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139391552|NCT06218524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139391553|NCT06218524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139391554|NCT06218524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391555|NCT06218524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139391556|NCT06218524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139391557|NCT06218524|Dopamine Agents|dopamine agents|mesh-ancestor
139391558|NCT06218524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391559|NCT06218524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139391560|NCT06218511|Durvalumab|durvalumab|mesh-list
139391561|NCT06218511|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139391562|NCT06218511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139391563|NCT06218511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391564|NCT06218511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139391565|NCT06218511|Immunologic Factors|immunologic factors|mesh-ancestor
139391566|NCT06218511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391567|NCT06218498|Minoxidil|minoxidil|mesh-list
139391568|NCT06218498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139391569|NCT06218498|Vasodilator Agents|vasodilator agents|mesh-ancestor
139391570|NCT06218407|Caryophyllene|caryophyllene|mesh-list
139391571|NCT06218407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139391572|NCT06218407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139391573|NCT06218407|Analgesics|analgesics|mesh-ancestor
139391574|NCT06218407|Sensory System Agents|sensory system agents|mesh-ancestor
139391575|NCT06218407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647601|NCT01728805|Vorinostat|vorinostat|mesh-list
139647602|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
139391576|NCT06218407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391577|NCT06218407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139391578|NCT06218407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139391579|NCT06218394|Minoxidil|minoxidil|mesh-list
139647603|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647604|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139647605|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647606|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391580|NCT06218394|Mitogens|mitogens|mesh-list
139391581|NCT06218394|Mitosis Modulators|mitosis modulators|mesh-ancestor
139391582|NCT06218394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391583|NCT06218394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139391584|NCT06218394|Vasodilator Agents|vasodilator agents|mesh-ancestor
139391585|NCT06218316|Botulinum Toxins|botulinum toxins|mesh-list
139391586|NCT06218316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139391587|NCT06218316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139391588|NCT06218316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139391589|NCT06218316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139391590|NCT06218316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391591|NCT06218316|Cholinergic Agents|cholinergic agents|mesh-ancestor
139391592|NCT06218316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391593|NCT06218316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391594|NCT06218316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139391595|NCT06218316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391596|NCT06218303|Letrozole|letrozole|mesh-list
139391597|NCT06218303|Anastrozole|anastrozole|mesh-list
139391598|NCT06218303|Exemestane|exemestane|mesh-list
139391599|NCT06218303|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139391600|NCT06218303|Poly ICLC|poly iclc|mesh-list
139391601|NCT06218303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391602|NCT06218303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139391603|NCT06218303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391604|NCT06218303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391605|NCT06218303|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139391606|NCT06218303|Hormone Antagonists|hormone antagonists|mesh-ancestor
139391607|NCT06218303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139391608|NCT06218303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391609|NCT06218303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139391610|NCT06218303|Interferon Inducers|interferon inducers|mesh-ancestor
139391611|NCT06218303|Immunologic Factors|immunologic factors|mesh-ancestor
139391612|NCT06218251|Botulinum Toxins|botulinum toxins|mesh-list
139391613|NCT06218251|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139391614|NCT06218251|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139391615|NCT06218251|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139391616|NCT06218251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139391617|NCT06218251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391618|NCT06218251|Cholinergic Agents|cholinergic agents|mesh-ancestor
139391619|NCT06218251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391620|NCT06218251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391621|NCT06218251|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139391622|NCT06218251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391623|NCT06218212|Calcium Carbonate|calcium carbonate|mesh-list
139391624|NCT06218212|Calcium|calcium|mesh-list
139391625|NCT06218212|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
139391626|NCT06218212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139391627|NCT06218212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391628|NCT06218212|Antacids|antacids|mesh-ancestor
139391629|NCT06218212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391630|NCT06218212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139391631|NCT06218212|Chelating Agents|chelating agents|mesh-ancestor
139391632|NCT06218212|Sequestering Agents|sequestering agents|mesh-ancestor
139391633|NCT06218199|Valsartan|valsartan|mesh-list
139391634|NCT06218199|Hydralazine|hydralazine|mesh-list
139391635|NCT06218199|Torsemide|torsemide|mesh-list
139391636|NCT06218199|Furosemide|furosemide|mesh-list
139391637|NCT06218199|Isosorbide|isosorbide|mesh-list
139391638|NCT06218199|Bumetanide|bumetanide|mesh-list
139391639|NCT06218199|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139391640|NCT06218199|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139391641|NCT06218199|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139391642|NCT06218199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139391643|NCT06218199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139391644|NCT06218199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139391645|NCT06218199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391646|NCT06218199|Diuretics|diuretics|mesh-ancestor
139391647|NCT06218199|Natriuretic Agents|natriuretic agents|mesh-ancestor
139391648|NCT06218199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391649|NCT06218199|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139647607|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139391650|NCT06218199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139391651|NCT06218199|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139391652|NCT06218199|Vasodilator Agents|vasodilator agents|mesh-ancestor
139391653|NCT06218199|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139391654|NCT06218160|Hydromorphone|hydromorphone|mesh-list
139391655|NCT06218160|Ropivacaine|ropivacaine|mesh-list
139391656|NCT06218160|Anesthetics, Local|anesthetics, local|mesh-ancestor
139391657|NCT06218160|Anesthetics|anesthetics|mesh-ancestor
139391658|NCT06218160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391659|NCT06218160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391660|NCT06218160|Sensory System Agents|sensory system agents|mesh-ancestor
139391661|NCT06218160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391662|NCT06218160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139391663|NCT06218160|Narcotics|narcotics|mesh-ancestor
139391664|NCT06218160|Analgesics|analgesics|mesh-ancestor
139391665|NCT06218056|Cannabidiol|cannabidiol|mesh-list
139391666|NCT06218056|Anticonvulsants|anticonvulsants|mesh-ancestor
139391667|NCT06217939|Hydrocortisone|hydrocortisone|mesh-list
139391668|NCT06217939|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139391669|NCT06217939|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139391670|NCT06217939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139391671|NCT06217939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139391672|NCT06217887|Metformin|metformin|mesh-list
139391673|NCT06217887|Gliclazide|gliclazide|mesh-list
139391674|NCT06217887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139391675|NCT06217887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391676|NCT06217848|Liraglutide|liraglutide|mesh-list
139391677|NCT06217848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139391678|NCT06217848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391679|NCT06217848|Incretins|incretins|mesh-ancestor
139391680|NCT06217848|Hormones|hormones|mesh-ancestor
139391681|NCT06217848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139391682|NCT06214273|Miconazole|miconazole|mesh-list
139391683|NCT06214273|Clotrimazole|clotrimazole|mesh-list
139391684|NCT06214273|Antifungal Agents|antifungal agents|mesh-list
139391685|NCT06214273|Ibuprofen|ibuprofen|mesh-list
139391686|NCT06214273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139391687|NCT06214273|Analgesics|analgesics|mesh-list
139391688|NCT06214273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139391689|NCT06214273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139391690|NCT06214273|Sensory System Agents|sensory system agents|mesh-ancestor
139391691|NCT06214273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391692|NCT06214273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391693|NCT06214273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139391694|NCT06214273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139391695|NCT06214273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391696|NCT06214273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391697|NCT06214273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139391698|NCT06214273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139391699|NCT06214273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139391700|NCT06214273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139391701|NCT06214273|Hormone Antagonists|hormone antagonists|mesh-ancestor
139391702|NCT06214273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139391703|NCT06214273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139391704|NCT06214273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139391705|NCT06214273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139391706|NCT06214130|Valproic Acid|valproic acid|mesh-list
139391707|NCT06214130|Anticonvulsants|anticonvulsants|mesh-ancestor
139391708|NCT06214130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391709|NCT06214130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391710|NCT06214130|GABA Agents|gaba agents|mesh-ancestor
139391711|NCT06214130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391712|NCT06214130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391713|NCT06214130|Antimanic Agents|antimanic agents|mesh-ancestor
139391714|NCT06214130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139391715|NCT06214130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391716|NCT06214130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139391717|NCT06213233|Cannabidiol|cannabidiol|mesh-list
139391718|NCT06213233|Anticonvulsants|anticonvulsants|mesh-ancestor
139391719|NCT06212102|Progestins|progestins|mesh-list
139048534|NCT00314340|Phenobarbital|phenobarbital|mesh-list
139647608|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139391720|NCT06212102|Hormones|hormones|mesh-ancestor
139391721|NCT06212102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139647609|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139135932|NCT05121883|Edaravone|edaravone|mesh-list
139647612|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139647613|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391722|NCT06212102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391723|NCT06209879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139391724|NCT06209879|Lubricant Eye Drops|lubricant eye drops|mesh-list
139391725|NCT06209879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139391726|NCT06209554|Erythritol|erythritol|mesh-list
139391727|NCT06209554|Vasodilator Agents|vasodilator agents|mesh-ancestor
139391728|NCT06207981|Mitomycins|mitomycins|mesh-list
139391729|NCT06207981|Mitomycin|mitomycin|mesh-list
139391730|NCT06207981|Capecitabine|capecitabine|mesh-list
139391731|NCT06207981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139391732|NCT06207981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391733|NCT06207981|Alkylating Agents|alkylating agents|mesh-ancestor
139391734|NCT06207981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391735|NCT06207981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139391736|NCT06207981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391737|NCT06207981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139391738|NCT06207981|Antimetabolites|antimetabolites|mesh-ancestor
139391739|NCT06207175|Vaccines|vaccines|mesh-list
139391740|NCT06207175|Immunologic Factors|immunologic factors|mesh-ancestor
139391741|NCT06207175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391742|NCT06206850|Osimertinib|osimertinib|mesh-list
139391743|NCT06206850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391744|NCT06206850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139391745|NCT06206850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391746|NCT06206850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391747|NCT06206525|Insulin|insulin|mesh-list
139391748|NCT06206525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139391749|NCT06206525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391750|NCT06205316|Ascorbic Acid|ascorbic acid|mesh-list
139391751|NCT06205316|Methyltestosterone|methyltestosterone|mesh-list
139391752|NCT06205316|Hormones|hormones|mesh-list
139391753|NCT06205316|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139391754|NCT06205316|Androgens|androgens|mesh-list
139391755|NCT06205316|Androgen Antagonists|androgen antagonists|mesh-list
139391756|NCT06205316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139391757|NCT06205316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391758|NCT06205316|Antioxidants|antioxidants|mesh-ancestor
139391759|NCT06205316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391760|NCT06205316|Protective Agents|protective agents|mesh-ancestor
139391761|NCT06205316|Vitamins|vitamins|mesh-ancestor
139391762|NCT06205316|Micronutrients|micronutrients|mesh-ancestor
139391763|NCT06205316|Estrogens|estrogens|mesh-ancestor
139391764|NCT06205316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139391765|NCT06205316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391766|NCT06205316|Anabolic Agents|anabolic agents|mesh-ancestor
139391767|NCT06205316|Hormone Antagonists|hormone antagonists|mesh-ancestor
139391768|NCT06200467|Moxifloxacin|moxifloxacin|mesh-list
139391769|NCT06200467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139391770|NCT06200467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139391771|NCT06200467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139391772|NCT06200467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139391773|NCT06200467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139391774|NCT06200467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391775|NCT06200467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391776|NCT06200467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391777|NCT06200467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139391778|NCT06200467|Contraceptive Agents|contraceptive agents|mesh-ancestor
139391779|NCT06200467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139391780|NCT06200467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391781|NCT06200467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139391782|NCT06200467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139391783|NCT06200467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139391787|NCT06197269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139391788|NCT06197269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139391789|NCT06197269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139391790|NCT06197269|Antitubercular Agents|antitubercular agents|mesh-ancestor
139391791|NCT06192108|Dapagliflozin|dapagliflozin|mesh-list
139391792|NCT06192108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139391793|NCT06192108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391794|NCT06192108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139391795|NCT06192108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391796|NCT06186401|Cyclophosphamide|cyclophosphamide|mesh-list
139391797|NCT06186401|Fludarabine|fludarabine|mesh-list
139391798|NCT06186401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139391799|NCT06186401|Immunologic Factors|immunologic factors|mesh-ancestor
139391800|NCT06186401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391801|NCT06186401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139391802|NCT06186401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139391803|NCT06186401|Alkylating Agents|alkylating agents|mesh-ancestor
139391804|NCT06186401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391805|NCT06186401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391806|NCT06186401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139391807|NCT06178991|Vaccines|vaccines|mesh-list
139391808|NCT06178991|Immunologic Factors|immunologic factors|mesh-ancestor
139391809|NCT06178991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391810|NCT06178289|Protective Agents|protective agents|mesh-list
139391811|NCT06178289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391812|NCT06175923|Edetic Acid|edetic acid|mesh-list
139391813|NCT06175923|Pentetic Acid|pentetic acid|mesh-list
139391814|NCT06175923|Anticoagulants|anticoagulants|mesh-ancestor
139391815|NCT06175923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139391816|NCT06175923|Chelating Agents|chelating agents|mesh-ancestor
139391817|NCT06175923|Sequestering Agents|sequestering agents|mesh-ancestor
139391818|NCT06175923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391819|NCT06175923|Antidotes|antidotes|mesh-ancestor
139391820|NCT06175923|Protective Agents|protective agents|mesh-ancestor
139391821|NCT06175923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391822|NCT06175923|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139391823|NCT06169410|Paclitaxel|paclitaxel|mesh-list
139391824|NCT06169410|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139391825|NCT06169410|Ramucirumab|ramucirumab|mesh-list
139391826|NCT06169410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139391827|NCT06169410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391828|NCT06169410|Tubulin Modulators|tubulin modulators|mesh-ancestor
139391829|NCT06169410|Antimitotic Agents|antimitotic agents|mesh-ancestor
139391830|NCT06169410|Mitosis Modulators|mitosis modulators|mesh-ancestor
139391831|NCT06169410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647614|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
139647615|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139647616|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
139647617|NCT03821987|Busulfan|busulfan|mesh-list
139647618|NCT03821987|Fludarabine|fludarabine|mesh-list
139647619|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
139647620|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139647621|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
139647622|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647623|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139647624|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139647625|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
139647626|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647627|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647628|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139647629|NCT04273763|Interferons|interferons|mesh-list
139647630|NCT04273763|Bromhexine|bromhexine|mesh-list
139647631|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647632|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
139647633|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647634|NCT04273763|Expectorants|expectorants|mesh-ancestor
139647635|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
139647636|NCT03820037|Opicapone|opicapone|mesh-list
139647637|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139647638|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647639|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647640|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139647641|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139647642|NCT03829007|Durvalumab|durvalumab|mesh-list
139647643|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139647644|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139647645|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647646|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
139647647|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391832|NCT06155435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139391833|NCT06136585|Neostigmine|neostigmine|mesh-list
139647648|NCT02614560|Fludarabine|fludarabine|mesh-list
139647649|NCT02614560|Melphalan|melphalan|mesh-list
139391834|NCT06136585|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139647650|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391835|NCT06136585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391836|NCT06136585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391837|NCT06136585|Cholinergic Agents|cholinergic agents|mesh-ancestor
139391838|NCT06136585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391839|NCT06136585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391840|NCT06136585|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139391842|NCT06136585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391843|NCT06123117|Ropivacaine|ropivacaine|mesh-list
139391844|NCT06123117|Anesthetics, Local|anesthetics, local|mesh-ancestor
139391845|NCT06123117|Anesthetics|anesthetics|mesh-ancestor
139391846|NCT06123117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391847|NCT06123117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391848|NCT06123117|Sensory System Agents|sensory system agents|mesh-ancestor
139391849|NCT06123117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391850|NCT06120881|Metformin|metformin|mesh-list
139391851|NCT06120881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139391852|NCT06120881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391853|NCT06120816|Nitric Oxide|nitric oxide|mesh-list
139391854|NCT06120816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139391855|NCT06120816|Autonomic Agents|autonomic agents|mesh-ancestor
139391856|NCT06120816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391857|NCT06120816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391858|NCT06120816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139391859|NCT06120816|Respiratory System Agents|respiratory system agents|mesh-ancestor
139391860|NCT06120816|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139391861|NCT06120816|Antioxidants|antioxidants|mesh-ancestor
139391862|NCT06120816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391863|NCT06120816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391864|NCT06120816|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139391865|NCT06120816|Vasodilator Agents|vasodilator agents|mesh-ancestor
139391866|NCT06120816|Gasotransmitters|gasotransmitters|mesh-ancestor
139391867|NCT06120816|Protective Agents|protective agents|mesh-ancestor
139391869|NCT06097468|Nisin Z|nisin z|mesh-list
139391870|NCT06097468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139391871|NCT06097468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139391872|NCT06096038|Cyclophosphamide|cyclophosphamide|mesh-list
139391873|NCT06096038|Fludarabine|fludarabine|mesh-list
139391874|NCT06096038|Fludarabine phosphate|fludarabine phosphate|mesh-list
139391875|NCT06096038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139391876|NCT06096038|Immunologic Factors|immunologic factors|mesh-ancestor
139391877|NCT06096038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391878|NCT06096038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139391879|NCT06096038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139391880|NCT06096038|Alkylating Agents|alkylating agents|mesh-ancestor
139391881|NCT06096038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391882|NCT06096038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391883|NCT06096038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139391884|NCT06096038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139391885|NCT06096038|Antimetabolites|antimetabolites|mesh-ancestor
139391886|NCT06090227|Metformin|metformin|mesh-list
139391887|NCT06090227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139391888|NCT06090227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391889|NCT06087601|Ethanol|ethanol|mesh-list
139391890|NCT06087601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139391891|NCT06087601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139391892|NCT06087601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391893|NCT06087601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391894|NCT06087549|Ropivacaine|ropivacaine|mesh-list
139391895|NCT06087549|Anesthetics, Local|anesthetics, local|mesh-ancestor
139391896|NCT06087549|Anesthetics|anesthetics|mesh-ancestor
139391897|NCT06087549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391898|NCT06087549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391899|NCT06087549|Sensory System Agents|sensory system agents|mesh-ancestor
139391900|NCT06087549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391901|NCT06086444|Tranexamic Acid|tranexamic acid|mesh-list
139391902|NCT06086444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139391903|NCT06086444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139647651|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647652|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139391904|NCT06086444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391905|NCT06086444|Hemostatics|hemostatics|mesh-ancestor
139647653|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
139391906|NCT06086444|Coagulants|coagulants|mesh-ancestor
139391907|NCT06086431|Dexamethasone|dexamethasone|mesh-list
139391908|NCT06086431|Dexmedetomidine|dexmedetomidine|mesh-list
139391909|NCT06086431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139391910|NCT06086431|Antiemetics|antiemetics|mesh-ancestor
139391911|NCT06086431|Autonomic Agents|autonomic agents|mesh-ancestor
139391912|NCT06086431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391913|NCT06086431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391914|NCT06086431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139391915|NCT06086431|Glucocorticoids|glucocorticoids|mesh-ancestor
139391916|NCT06086431|Hormones|hormones|mesh-ancestor
139391917|NCT06086431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139391918|NCT06086431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139391919|NCT06086431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391920|NCT06086431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139391921|NCT06086431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391922|NCT06086431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139391923|NCT06086431|Analgesics|analgesics|mesh-ancestor
139391924|NCT06086431|Sensory System Agents|sensory system agents|mesh-ancestor
139391925|NCT06086431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139391926|NCT06086431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139391927|NCT06086431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139391928|NCT06086431|Adrenergic Agents|adrenergic agents|mesh-ancestor
139391929|NCT06086431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139391930|NCT06086431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391931|NCT06086418|Dexamethasone|dexamethasone|mesh-list
139391932|NCT06086418|Dexamethasone acetate|dexamethasone acetate|mesh-list
139391933|NCT06086418|BB 1101|bb 1101|mesh-list
139391934|NCT06086418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139391935|NCT06086418|Antiemetics|antiemetics|mesh-ancestor
139391936|NCT06086418|Autonomic Agents|autonomic agents|mesh-ancestor
139391937|NCT06086418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391938|NCT06086418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391939|NCT06086418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139391940|NCT06086418|Glucocorticoids|glucocorticoids|mesh-ancestor
139391941|NCT06086418|Hormones|hormones|mesh-ancestor
139391942|NCT06086418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139391943|NCT06086418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139391944|NCT06086418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391945|NCT06086418|Protease Inhibitors|protease inhibitors|mesh-ancestor
139391946|NCT06086418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391947|NCT06086418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391948|NCT06086392|Dexamethasone|dexamethasone|mesh-list
139391949|NCT06086392|Dexamethasone acetate|dexamethasone acetate|mesh-list
139391950|NCT06086392|BB 1101|bb 1101|mesh-list
139391951|NCT06086392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139391952|NCT06086392|Antiemetics|antiemetics|mesh-ancestor
139391953|NCT06086392|Autonomic Agents|autonomic agents|mesh-ancestor
139391954|NCT06086392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391955|NCT06086392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391956|NCT06086392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139391957|NCT06086392|Glucocorticoids|glucocorticoids|mesh-ancestor
139391958|NCT06086392|Hormones|hormones|mesh-ancestor
139391959|NCT06086392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139391960|NCT06086392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139391961|NCT06086392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391962|NCT06086392|Protease Inhibitors|protease inhibitors|mesh-ancestor
139391963|NCT06086392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391964|NCT06086392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391965|NCT06083428|Ropivacaine|ropivacaine|mesh-list
139391966|NCT06083428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139391967|NCT06083428|Anesthetics, Local|anesthetics, local|mesh-ancestor
139391968|NCT06083428|Anesthetics|anesthetics|mesh-ancestor
139391969|NCT06083428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139391970|NCT06083428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391971|NCT06083428|Sensory System Agents|sensory system agents|mesh-ancestor
139391972|NCT06083428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139391973|NCT06077500|Carboplatin|carboplatin|mesh-list
139391974|NCT06077500|Etoposide|etoposide|mesh-list
139647654|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647655|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139647656|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
139391975|NCT06077500|Atezolizumab|atezolizumab|mesh-list
139391976|NCT06077500|Durvalumab|durvalumab|mesh-list
139391977|NCT06077500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391978|NCT06077500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139391979|NCT06077500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139391980|NCT06077500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139391981|NCT06077500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391982|NCT06077500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391983|NCT06077500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139391984|NCT06077500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139391985|NCT06075953|Tamoxifen|tamoxifen|mesh-list
139391986|NCT06075953|Letrozole|letrozole|mesh-list
139391987|NCT06075953|Exemestane|exemestane|mesh-list
139391988|NCT06075953|Anastrozole|anastrozole|mesh-list
139391989|NCT06075953|Testosterone|testosterone|mesh-list
139391990|NCT06075953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139391991|NCT06075953|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139391992|NCT06075953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139391993|NCT06075953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139391994|NCT06075953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139391995|NCT06075953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138719058|NCT03452579|Bevacizumab|bevacizumab|mesh-list
139391996|NCT06075953|Hormone Antagonists|hormone antagonists|mesh-ancestor
139391997|NCT06075953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139391998|NCT06075953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139391999|NCT06075953|Androgens|androgens|mesh-ancestor
139392000|NCT06075953|Hormones|hormones|mesh-ancestor
139392001|NCT06075953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139392002|NCT06075953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139392003|NCT06075953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139392004|NCT06075953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139392005|NCT06070597|Moxifloxacin|moxifloxacin|mesh-list
139392006|NCT06070597|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139392007|NCT06070597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139392008|NCT06070597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392009|NCT06070597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139392010|NCT06070597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139392011|NCT06070597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392012|NCT06070597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392013|NCT06070597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392014|NCT06070597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139392015|NCT06070597|Contraceptive Agents|contraceptive agents|mesh-ancestor
139392016|NCT06070597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139392017|NCT06070597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392018|NCT06070597|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139392019|NCT06070597|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139392020|NCT06070597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139392021|NCT06063967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139392022|NCT06063967|Immunologic Factors|immunologic factors|mesh-ancestor
139392023|NCT06063967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392024|NCT06051409|Imatinib Mesylate|imatinib mesylate|mesh-list
139392025|NCT06051409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392026|NCT06051409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139392027|NCT06051409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392028|NCT06051409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392029|NCT06033131|Metformin|metformin|mesh-list
139392030|NCT06033131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139392031|NCT06033131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392032|NCT06013839|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
139392033|NCT06013839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139392034|NCT06013839|Vasodilator Agents|vasodilator agents|mesh-ancestor
139392035|NCT06004674|Enoxaparin|enoxaparin|mesh-list
139392036|NCT06004674|Anticoagulants|anticoagulants|mesh-ancestor
139392037|NCT06004674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139392038|NCT06004674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139392039|NCT06004674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392040|NCT06003231|Disitamab vedotin|disitamab vedotin|mesh-list
139392041|NCT06003231|Immunoconjugates|immunoconjugates|mesh-ancestor
139392042|NCT06003231|Immunologic Factors|immunologic factors|mesh-ancestor
139392043|NCT06003231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392044|NCT05999435|Fenretinide|fenretinide|mesh-list
139392045|NCT05999435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392046|NCT05999435|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139647657|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139647658|NCT03828929|Thiamine|thiamine|mesh-list
139392047|NCT05999435|Protective Agents|protective agents|mesh-ancestor
139135981|NCT04862260|Atorvastatin|atorvastatin|mesh-list
139647659|NCT03828929|Vitamins|vitamins|mesh-ancestor
139647660|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
139647661|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647662|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
139647663|NCT04873440|Manganese|manganese|mesh-list
139392048|NCT05999435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392049|NCT05997979|Capsaicin|capsaicin|mesh-list
139392050|NCT05997979|Antipruritics|antipruritics|mesh-ancestor
139392051|NCT05997979|Dermatologic Agents|dermatologic agents|mesh-ancestor
139392052|NCT05997979|Sensory System Agents|sensory system agents|mesh-ancestor
139392053|NCT05997979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392054|NCT05997979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392055|NCT05997017|Sirolimus|sirolimus|mesh-list
139392056|NCT05997017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139392057|NCT05997017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392058|NCT05997017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139392059|NCT05997017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392060|NCT05997017|Antifungal Agents|antifungal agents|mesh-ancestor
139392061|NCT05997017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139392062|NCT05997017|Immunologic Factors|immunologic factors|mesh-ancestor
139392063|NCT05997017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392064|NCT05979389|Bicalutamide|bicalutamide|mesh-list
139392065|NCT05979389|Androgen Antagonists|androgen antagonists|mesh-ancestor
139392066|NCT05979389|Hormone Antagonists|hormone antagonists|mesh-ancestor
139392067|NCT05979389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392068|NCT05979389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392069|NCT05979389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392070|NCT05977920|Caffeine|caffeine|mesh-list
139392071|NCT05977920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139392072|NCT05977920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392073|NCT05977920|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139392074|NCT05977920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392075|NCT05977920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392076|NCT05977920|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139392077|NCT05977920|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139392078|NCT05977920|Purinergic Agents|purinergic agents|mesh-ancestor
139392079|NCT05977920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139392080|NCT05963139|Morphine|morphine|mesh-list
139392081|NCT05963139|Bupivacaine|bupivacaine|mesh-list
139392082|NCT05963139|Anesthetics, Local|anesthetics, local|mesh-ancestor
139392083|NCT05963139|Anesthetics|anesthetics|mesh-ancestor
139392084|NCT05963139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139392085|NCT05963139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392086|NCT05963139|Sensory System Agents|sensory system agents|mesh-ancestor
139392087|NCT05963139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392088|NCT05963139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139392089|NCT05963139|Narcotics|narcotics|mesh-ancestor
139392090|NCT05963139|Analgesics|analgesics|mesh-ancestor
139392091|NCT05951452|Oxytocin|oxytocin|mesh-list
139392092|NCT05951452|Testosterone|testosterone|mesh-list
139392093|NCT05951452|Oxytocics|oxytocics|mesh-ancestor
139392094|NCT05951452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139392095|NCT05951452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392096|NCT05951452|Androgens|androgens|mesh-ancestor
139392097|NCT05951452|Hormones|hormones|mesh-ancestor
139392098|NCT05951452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392099|NCT05949632|Axitinib|axitinib|mesh-list
139392100|NCT05949632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392101|NCT05949632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139392102|NCT05949632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392103|NCT05949632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392104|NCT05938387|Vaccines|vaccines|mesh-list
139392105|NCT05938387|Immunologic Factors|immunologic factors|mesh-ancestor
139392106|NCT05938387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392107|NCT05925478|Bupivacaine|bupivacaine|mesh-list
139392108|NCT05925478|Anesthetics, Local|anesthetics, local|mesh-ancestor
139392109|NCT05925478|Anesthetics|anesthetics|mesh-ancestor
139392110|NCT05925478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139392111|NCT05925478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392112|NCT05925478|Sensory System Agents|sensory system agents|mesh-ancestor
139392113|NCT05925478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392114|NCT05924594|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
139392115|NCT05924594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139647664|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392116|NCT05924594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135986|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139647665|NCT04873440|Trace Elements|trace elements|mesh-ancestor
139647666|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
139647667|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
139647668|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
139647669|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139647670|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392117|NCT05924594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139392118|NCT05924594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139392119|NCT05924594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139392120|NCT05924594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392121|NCT05924594|Dopamine Agents|dopamine agents|mesh-ancestor
139392122|NCT05924594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139392123|NCT05916586|Prednisone|prednisone|mesh-list
139392124|NCT05916586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139392125|NCT05916586|Glucocorticoids|glucocorticoids|mesh-ancestor
139392126|NCT05916586|Hormones|hormones|mesh-ancestor
139392127|NCT05916586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392128|NCT05916586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392129|NCT05916586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139392130|NCT05916586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392131|NCT05911295|Carboplatin|carboplatin|mesh-list
139392132|NCT05911295|Gemcitabine|gemcitabine|mesh-list
139392133|NCT05911295|Pembrolizumab|pembrolizumab|mesh-list
139392134|NCT05911295|Disitamab vedotin|disitamab vedotin|mesh-list
139392135|NCT05911295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392136|NCT05911295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139392137|NCT05911295|Antimetabolites|antimetabolites|mesh-ancestor
139392138|NCT05911295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392139|NCT05911295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139392140|NCT05911295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139392141|NCT05911295|Immunoconjugates|immunoconjugates|mesh-ancestor
139392142|NCT05911295|Immunologic Factors|immunologic factors|mesh-ancestor
139392143|NCT05911295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392144|NCT05910970|Lenvatinib|lenvatinib|mesh-list
139392145|NCT05910970|Tislelizumab|tislelizumab|mesh-list
139392146|NCT05910970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392147|NCT05910970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139392148|NCT05910970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392149|NCT05910970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392150|NCT05910970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139392151|NCT05906732|Dofetilide|dofetilide|mesh-list
139392152|NCT05906732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139392153|NCT05906732|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139392154|NCT05906732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139392155|NCT05906732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392156|NCT05906511|Dronabinol|dronabinol|mesh-list
139392157|NCT05906511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139392158|NCT05906511|Hallucinogens|hallucinogens|mesh-ancestor
139392159|NCT05906511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392160|NCT05906511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139392161|NCT05906511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139392162|NCT05906511|Analgesics|analgesics|mesh-ancestor
139392163|NCT05906511|Sensory System Agents|sensory system agents|mesh-ancestor
139392164|NCT05906511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392165|NCT05906511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139392166|NCT05906511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139392167|NCT05906511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139392168|NCT05906511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392169|NCT05906511|Hormones|hormones|mesh-ancestor
139392170|NCT05906511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139048981|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
139392171|NCT05898841|Tenofovir|tenofovir|mesh-list
139392172|NCT05898841|Emtricitabine|emtricitabine|mesh-list
139392173|NCT05898841|Dolutegravir|dolutegravir|mesh-list
139392174|NCT05898841|Rilpivirine|rilpivirine|mesh-list
139392175|NCT05898841|Antiviral Agents|antiviral agents|mesh-ancestor
139392176|NCT05898841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392177|NCT05898841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139392178|NCT05898841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139392179|NCT05898841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392180|NCT05898841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392181|NCT05898841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139392182|NCT05898841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139392183|NCT05898841|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139392184|NCT05898841|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139392185|NCT05893147|Lactams|lactams|mesh-list
139647671|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139647672|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139647673|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647674|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392186|NCT05893147|Cephalosporins|cephalosporins|mesh-list
139392187|NCT05893147|beta-Lactams|beta-lactams|mesh-list
139392188|NCT05893147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139392189|NCT05893147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392190|NCT05887765|Dexamethasone|dexamethasone|mesh-list
139392191|NCT05887765|Dexamethasone acetate|dexamethasone acetate|mesh-list
139392192|NCT05887765|BB 1101|bb 1101|mesh-list
139392193|NCT05887765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139392194|NCT05887765|Antiemetics|antiemetics|mesh-ancestor
139392195|NCT05887765|Autonomic Agents|autonomic agents|mesh-ancestor
139392196|NCT05887765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392197|NCT05887765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392198|NCT05887765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139392199|NCT05887765|Glucocorticoids|glucocorticoids|mesh-ancestor
139392200|NCT05887765|Hormones|hormones|mesh-ancestor
139392201|NCT05887765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392202|NCT05887765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139392203|NCT05887765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392204|NCT05887765|Protease Inhibitors|protease inhibitors|mesh-ancestor
139392205|NCT05887765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392206|NCT05887765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392207|NCT05879029|Rabeprazole|rabeprazole|mesh-list
139392208|NCT05879029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139392209|NCT05879029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139392210|NCT05879029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139392211|NCT05879029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392212|NCT05879029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392213|NCT05878353|Doxycycline|doxycycline|mesh-list
139392214|NCT05878353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139392215|NCT05878353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392216|NCT05878353|Antimalarials|antimalarials|mesh-ancestor
139392217|NCT05878353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139392218|NCT05878353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139392219|NCT05863104|Glycopyrrolate|glycopyrrolate|mesh-list
139392220|NCT05863104|Bromides|bromides|mesh-list
139392221|NCT05863104|Anticonvulsants|anticonvulsants|mesh-ancestor
139392222|NCT05863104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139392223|NCT05863104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139392224|NCT05863104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139392225|NCT05863104|Cholinergic Agents|cholinergic agents|mesh-ancestor
139392226|NCT05863104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139392227|NCT05863104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392228|NCT05863104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392229|NCT05862272|Relugolix|relugolix|mesh-list
139392230|NCT05862272|Androgen Antagonists|androgen antagonists|mesh-ancestor
139392231|NCT05862272|Hormone Antagonists|hormone antagonists|mesh-ancestor
139392232|NCT05862272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392233|NCT05862272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392234|NCT05848843|Durvalumab|durvalumab|mesh-list
139392235|NCT05848843|Adagrasib|adagrasib|mesh-list
139392236|NCT05848843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139392237|NCT05848843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392238|NCT05841056|Amiodarone|amiodarone|mesh-list
139392239|NCT05841056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139392240|NCT05841056|Vasodilator Agents|vasodilator agents|mesh-ancestor
139392241|NCT05841056|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139392242|NCT05841056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139392243|NCT05841056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392244|NCT05841056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139392245|NCT05841056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139647675|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647676|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139647677|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647678|NCT04391621|Triamcinolone|triamcinolone|mesh-list
139647679|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139647680|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139647681|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139392246|NCT05841056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139392247|NCT05841056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392248|NCT05841056|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139392249|NCT05841056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139392250|NCT05841056|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139392252|NCT05840211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139392254|NCT05840211|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139392255|NCT05840211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139392256|NCT05840211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392257|NCT05840211|Tubulin Modulators|tubulin modulators|mesh-ancestor
139392258|NCT05840211|Antimitotic Agents|antimitotic agents|mesh-ancestor
139392259|NCT05840211|Mitosis Modulators|mitosis modulators|mesh-ancestor
139392260|NCT05840211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392261|NCT05840211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139392262|NCT05840211|Antimetabolites|antimetabolites|mesh-ancestor
139392263|NCT05840211|Immunoconjugates|immunoconjugates|mesh-ancestor
139392264|NCT05840211|Immunologic Factors|immunologic factors|mesh-ancestor
139392265|NCT05840211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392266|NCT05828810|Chlorhexidine|chlorhexidine|mesh-list
139392267|NCT05828810|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139392268|NCT05828810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392269|NCT05828810|Disinfectants|disinfectants|mesh-ancestor
139392270|NCT05811676|Tranexamic Acid|tranexamic acid|mesh-list
139392271|NCT05811676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139392272|NCT05811676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139392273|NCT05811676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392274|NCT05811676|Hemostatics|hemostatics|mesh-ancestor
139392275|NCT05811676|Coagulants|coagulants|mesh-ancestor
139392276|NCT05806749|Belumosudil|belumosudil|mesh-list
139392277|NCT05806749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139392278|NCT05806749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392279|NCT05806749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392280|NCT05798663|Atezolizumab|atezolizumab|mesh-list
139392281|NCT05798663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139392282|NCT05798663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392283|NCT05798663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139392284|NCT05798663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392285|NCT05795244|Nivolumab|nivolumab|mesh-list
139392286|NCT05795244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139392287|NCT05795244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392288|NCT05795244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139392289|NCT05795244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392290|NCT05761756|Caffeine|caffeine|mesh-list
139392291|NCT05761756|Methylphenidate|methylphenidate|mesh-list
139392292|NCT05761756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139392293|NCT05761756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392294|NCT05761756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139392295|NCT05761756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392296|NCT05761756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392297|NCT05761756|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139392298|NCT05761756|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139392299|NCT05761756|Purinergic Agents|purinergic agents|mesh-ancestor
139392300|NCT05761756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139392301|NCT05761756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139392302|NCT05761756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139392303|NCT05761756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139392304|NCT05761756|Dopamine Agents|dopamine agents|mesh-ancestor
139392305|NCT05758389|Paclitaxel|paclitaxel|mesh-list
139392306|NCT05758389|Tislelizumab|tislelizumab|mesh-list
139392307|NCT05758389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139392308|NCT05758389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392309|NCT05758389|Tubulin Modulators|tubulin modulators|mesh-ancestor
139392310|NCT05758389|Antimitotic Agents|antimitotic agents|mesh-ancestor
139392311|NCT05758389|Mitosis Modulators|mitosis modulators|mesh-ancestor
139392312|NCT05758389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647682|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139647683|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
139647684|NCT04391621|Hormones|hormones|mesh-ancestor
139647685|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139647686|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647687|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139647688|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
139647689|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647690|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647691|NCT01669122|Nicotine|nicotine|mesh-list
139392313|NCT05758389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139392314|NCT05741385|Metoprolol|metoprolol|mesh-list
139392315|NCT05741385|Midazolam|midazolam|mesh-list
139647692|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139647693|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
139647694|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647695|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392316|NCT05741385|Caffeine|caffeine|mesh-list
139392317|NCT05741385|Omeprazole|omeprazole|mesh-list
139392318|NCT05741385|Warfarin|warfarin|mesh-list
139392319|NCT05741385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139392320|NCT05741385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139392321|NCT05741385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139392322|NCT05741385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392323|NCT05741385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139392324|NCT05741385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139392325|NCT05741385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139392326|NCT05741385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139392327|NCT05741385|Anesthetics, General|anesthetics, general|mesh-ancestor
139392328|NCT05741385|Anesthetics|anesthetics|mesh-ancestor
139392329|NCT05741385|GABA Modulators|gaba modulators|mesh-ancestor
139392330|NCT05741385|GABA Agents|gaba agents|mesh-ancestor
139392331|NCT05741385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139392332|NCT05741385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392333|NCT05741385|Anticoagulants|anticoagulants|mesh-ancestor
139392334|NCT05741385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139392335|NCT05741385|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139392336|NCT05741385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392337|NCT05741385|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139392338|NCT05741385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139392339|NCT05741385|Purinergic Agents|purinergic agents|mesh-ancestor
139392340|NCT05741385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139392341|NCT05741385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139392342|NCT05741385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139392343|NCT05741385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139392344|NCT05741385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139392345|NCT05741385|Sympatholytics|sympatholytics|mesh-ancestor
139392346|NCT05741385|Autonomic Agents|autonomic agents|mesh-ancestor
139392347|NCT05741385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392348|NCT05741385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139392349|NCT05741385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139392350|NCT05741385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139392351|NCT05741385|Adrenergic Agents|adrenergic agents|mesh-ancestor
139392352|NCT05737563|Capecitabine|capecitabine|mesh-list
139392353|NCT05737563|Irinotecan|irinotecan|mesh-list
139392354|NCT05737563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139392355|NCT05737563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139392356|NCT05737563|Antimetabolites|antimetabolites|mesh-ancestor
139392357|NCT05737563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392358|NCT05737563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392359|NCT05737563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139392360|NCT05737563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139392361|NCT05737563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392362|NCT05737563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139392363|NCT05734105|Sunitinib|sunitinib|mesh-list
139392364|NCT05734105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392365|NCT05734105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139392366|NCT05734105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139392367|NCT05734105|Growth Substances|growth substances|mesh-ancestor
139392368|NCT05734105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647696|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139647697|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139647698|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
139647699|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139647700|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647701|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
139647702|NCT03629483|Ropivacaine|ropivacaine|mesh-list
139647703|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139647704|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139647705|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647706|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139647707|NCT03629483|Analgesics|analgesics|mesh-ancestor
139647708|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
139647709|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647710|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139392369|NCT05734105|Growth Inhibitors|growth inhibitors|mesh-ancestor
139647711|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139136019|NCT04788615|Analgesics|analgesics|mesh-ancestor
139392370|NCT05734105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139392371|NCT05734105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392372|NCT05734105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392374|NCT05711823|Dexamethasone acetate|dexamethasone acetate|mesh-list
139392375|NCT05711823|Aprepitant|aprepitant|mesh-list
139392376|NCT05711823|Granisetron|granisetron|mesh-list
139392377|NCT05711823|BB 1101|bb 1101|mesh-list
139392378|NCT05711823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139392379|NCT05711823|Antiemetics|antiemetics|mesh-ancestor
139392380|NCT05711823|Autonomic Agents|autonomic agents|mesh-ancestor
139392381|NCT05711823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392382|NCT05711823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392383|NCT05711823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139392384|NCT05711823|Glucocorticoids|glucocorticoids|mesh-ancestor
139392385|NCT05711823|Hormones|hormones|mesh-ancestor
139392386|NCT05711823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392387|NCT05711823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139392388|NCT05711823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392389|NCT05711823|Protease Inhibitors|protease inhibitors|mesh-ancestor
139392390|NCT05711823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392391|NCT05711823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392392|NCT05711823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139392393|NCT05711823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139392394|NCT05711823|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139392395|NCT05711823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139091578|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139392396|NCT05711823|Serotonin Agents|serotonin agents|mesh-ancestor
139392397|NCT05706506|Tirzepatide|tirzepatide|mesh-list
139392398|NCT05706506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139392399|NCT05706506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392400|NCT05706506|Incretins|incretins|mesh-ancestor
139392402|NCT05706506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392403|NCT05673200|Paclitaxel|paclitaxel|mesh-list
139392404|NCT05673200|Pembrolizumab|pembrolizumab|mesh-list
139392405|NCT05673200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139392406|NCT05673200|Decitabine|decitabine|mesh-list
139392407|NCT05673200|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139392408|NCT05673200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139392409|NCT05673200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392410|NCT05673200|Tubulin Modulators|tubulin modulators|mesh-ancestor
139392411|NCT05673200|Antimitotic Agents|antimitotic agents|mesh-ancestor
139392412|NCT05673200|Mitosis Modulators|mitosis modulators|mesh-ancestor
139392413|NCT05673200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392414|NCT05673200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139392415|NCT05673200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139392416|NCT05673200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139392417|NCT05673200|Antimetabolites|antimetabolites|mesh-ancestor
139392418|NCT05673200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392419|NCT05664958|Bupivacaine|bupivacaine|mesh-list
139392420|NCT05664958|Anesthetics, Local|anesthetics, local|mesh-ancestor
139392421|NCT05664958|Anesthetics|anesthetics|mesh-ancestor
139392422|NCT05664958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139392423|NCT05664958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392424|NCT05664958|Sensory System Agents|sensory system agents|mesh-ancestor
139392425|NCT05664958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392426|NCT05660785|Cyclosporine|cyclosporine|mesh-list
139392427|NCT05660785|Cyclosporins|cyclosporins|mesh-list
139392428|NCT05660785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392429|NCT05660785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392430|NCT05660785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139392431|NCT05660785|Immunologic Factors|immunologic factors|mesh-ancestor
139392432|NCT05660785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392433|NCT05660785|Antifungal Agents|antifungal agents|mesh-ancestor
139392434|NCT05660785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392435|NCT05660785|Dermatologic Agents|dermatologic agents|mesh-ancestor
139392436|NCT05660785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139392437|NCT05660785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139392438|NCT05655130|Dexamethasone|dexamethasone|mesh-list
139647712|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139647713|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
139392439|NCT05655130|Methylprednisolone|methylprednisolone|mesh-list
139392440|NCT05655130|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139392441|NCT05655130|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139392442|NCT05655130|Prednisolone|prednisolone|mesh-list
139392443|NCT05655130|Prednisolone acetate|prednisolone acetate|mesh-list
139392444|NCT05655130|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139647714|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139647715|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647716|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
139647718|NCT04873284|Dexamethasone|dexamethasone|mesh-list
139647719|NCT04873284|Aprepitant|aprepitant|mesh-list
139647720|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
139647721|NCT04873284|Granisetron|granisetron|mesh-list
139647722|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139647723|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
139647724|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
139647725|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647726|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647727|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139392445|NCT05655130|Prednisolone phosphate|prednisolone phosphate|mesh-list
139392446|NCT05655130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139392447|NCT05655130|Antiemetics|antiemetics|mesh-ancestor
139392448|NCT05655130|Autonomic Agents|autonomic agents|mesh-ancestor
139392449|NCT05655130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392450|NCT05655130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392451|NCT05655130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139392452|NCT05655130|Glucocorticoids|glucocorticoids|mesh-ancestor
139392453|NCT05655130|Hormones|hormones|mesh-ancestor
139392454|NCT05655130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392455|NCT05655130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139392456|NCT05655130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392457|NCT05655130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139392458|NCT05655130|Protective Agents|protective agents|mesh-ancestor
139392459|NCT05635929|Betaine|betaine|mesh-list
139392460|NCT05635929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139392461|NCT05635929|Lipotropic Agents|lipotropic agents|mesh-ancestor
139392462|NCT05635929|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139392463|NCT05635929|Antimetabolites|antimetabolites|mesh-ancestor
139392464|NCT05635929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392465|NCT05635929|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139392466|NCT05616910|Nitric Oxide|nitric oxide|mesh-list
139392467|NCT05616910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139392468|NCT05616910|Autonomic Agents|autonomic agents|mesh-ancestor
139392469|NCT05616910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392470|NCT05616910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049284|NCT03981770|Anesthetics|anesthetics|mesh-list
139392471|NCT05616910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139392472|NCT05616910|Respiratory System Agents|respiratory system agents|mesh-ancestor
139392473|NCT05616910|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139392474|NCT05616910|Antioxidants|antioxidants|mesh-ancestor
139392475|NCT05616910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392476|NCT05616910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139392477|NCT05616910|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139392478|NCT05616910|Vasodilator Agents|vasodilator agents|mesh-ancestor
139392479|NCT05616910|Gasotransmitters|gasotransmitters|mesh-ancestor
139392480|NCT05616910|Protective Agents|protective agents|mesh-ancestor
139392481|NCT05605093|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139392482|NCT05605093|Protease Inhibitors|protease inhibitors|mesh-list
139392483|NCT05605093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392484|NCT05605093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392485|NCT05605093|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139392486|NCT05605093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139392487|NCT05605093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139392488|NCT05605093|Antiviral Agents|antiviral agents|mesh-ancestor
139392489|NCT05605093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392490|NCT05592379|Psilocybin|psilocybin|mesh-list
139647728|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
139647729|NCT04873284|Hormones|hormones|mesh-ancestor
139647730|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139647731|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139647732|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647733|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139647734|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139647735|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392491|NCT05592379|Hallucinogens|hallucinogens|mesh-ancestor
139392492|NCT05592379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392493|NCT05592379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139647736|NCT04873284|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139392494|NCT05571072|Analgesics, Opioid|analgesics, opioid|mesh-list
139392495|NCT05571072|Narcotics|narcotics|mesh-ancestor
139392496|NCT05571072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139392497|NCT05571072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392498|NCT05571072|Analgesics|analgesics|mesh-ancestor
139392499|NCT05571072|Sensory System Agents|sensory system agents|mesh-ancestor
139392500|NCT05571072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392502|NCT05562466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139392503|NCT05562466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139392504|NCT05562466|Autonomic Agents|autonomic agents|mesh-ancestor
139392505|NCT05562466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392506|NCT05562466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392507|NCT05562466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139392508|NCT05562466|Respiratory System Agents|respiratory system agents|mesh-ancestor
139392509|NCT05562466|Glucocorticoids|glucocorticoids|mesh-ancestor
139392510|NCT05562466|Hormones|hormones|mesh-ancestor
139392511|NCT05562466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392512|NCT05554354|Fulvestrant|fulvestrant|mesh-list
139392513|NCT05554354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139392514|NCT05554354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392515|NCT05554354|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139392516|NCT05554354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139392517|NCT05554354|Hormone Antagonists|hormone antagonists|mesh-ancestor
139392518|NCT05554354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392519|NCT05554354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392520|NCT05554328|Olaparib|olaparib|mesh-list
139392521|NCT05554328|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139392522|NCT05554328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392523|NCT05554328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392524|NCT05554328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392525|NCT05543278|Amiodarone|amiodarone|mesh-list
139392526|NCT05543278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139392527|NCT05543278|Vasodilator Agents|vasodilator agents|mesh-ancestor
139392528|NCT05543278|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139392529|NCT05543278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139392530|NCT05543278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392531|NCT05543278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139392532|NCT05543278|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139392533|NCT05543278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139392534|NCT05543278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392535|NCT05543278|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139392536|NCT05543278|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139392537|NCT05543278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139392538|NCT05532319|Lenvatinib|lenvatinib|mesh-list
139392539|NCT05532319|Tislelizumab|tislelizumab|mesh-list
139392540|NCT05532319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392541|NCT05532319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139392542|NCT05532319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392543|NCT05532319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392544|NCT05532319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139392545|NCT05516862|Camphor|camphor|mesh-list
139392546|NCT05516862|Salicylates|salicylates|mesh-list
139392547|NCT05516862|Methyl salicylate|methyl salicylate|mesh-list
139392548|NCT05516862|Menthol|menthol|mesh-list
139392549|NCT05516862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139392550|NCT05516862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392551|NCT05516862|Antipruritics|antipruritics|mesh-ancestor
139392552|NCT05516862|Dermatologic Agents|dermatologic agents|mesh-ancestor
139647737|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139647738|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
139647739|NCT01450865|Flupirtine|flupirtine|mesh-list
139647740|NCT01450865|Analgesics|analgesics|mesh-ancestor
139647741|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
139647742|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647743|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647744|NCT01308619|Doxycycline|doxycycline|mesh-list
139647745|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139647746|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647747|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
139647748|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139647749|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139647750|NCT02611752|Buprenorphine|buprenorphine|mesh-list
139647751|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139647752|NCT02611752|Narcotics|narcotics|mesh-ancestor
139392553|NCT05516862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139392554|NCT05516862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139392556|NCT05516862|Sensory System Agents|sensory system agents|mesh-ancestor
139392557|NCT05516862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392558|NCT05516862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392559|NCT05516862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139392560|NCT05516862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139392561|NCT05516862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139392562|NCT05516862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392563|NCT05516862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392564|NCT05495464|Cyclophosphamide|cyclophosphamide|mesh-list
139392565|NCT05495464|Rituximab|rituximab|mesh-list
139392566|NCT05495464|Fludarabine|fludarabine|mesh-list
139392567|NCT05495464|Fludarabine phosphate|fludarabine phosphate|mesh-list
139392568|NCT05495464|Acalabrutinib|acalabrutinib|mesh-list
139392569|NCT05495464|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
139392570|NCT05495464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139392571|NCT05495464|Immunologic Factors|immunologic factors|mesh-ancestor
139392572|NCT05495464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392573|NCT05495464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139392574|NCT05495464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139392575|NCT05495464|Alkylating Agents|alkylating agents|mesh-ancestor
139392576|NCT05495464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392577|NCT05495464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392578|NCT05495464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139392579|NCT05495464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139392580|NCT05495464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139392581|NCT05495464|Antimetabolites|antimetabolites|mesh-ancestor
139392582|NCT05489211|Leucovorin|leucovorin|mesh-list
139392583|NCT05489211|Prednisone|prednisone|mesh-list
139392584|NCT05489211|Prednisolone|prednisolone|mesh-list
139392585|NCT05489211|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139392586|NCT05489211|Methylprednisolone|methylprednisolone|mesh-list
139392587|NCT05489211|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139392588|NCT05489211|Prednisolone acetate|prednisolone acetate|mesh-list
139392589|NCT05489211|Bevacizumab|bevacizumab|mesh-list
139392590|NCT05489211|Durvalumab|durvalumab|mesh-list
139392591|NCT05489211|Carboplatin|carboplatin|mesh-list
139392592|NCT05489211|Capecitabine|capecitabine|mesh-list
139392593|NCT05489211|Fluorouracil|fluorouracil|mesh-list
139392594|NCT05489211|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139392595|NCT05489211|Prednisolone phosphate|prednisolone phosphate|mesh-list
139392596|NCT05489211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139392597|NCT05489211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392598|NCT05489211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139392599|NCT05489211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139392600|NCT05489211|Growth Substances|growth substances|mesh-ancestor
139392601|NCT05489211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392602|NCT05489211|Growth Inhibitors|growth inhibitors|mesh-ancestor
139392603|NCT05489211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139392604|NCT05489211|Antimetabolites|antimetabolites|mesh-ancestor
139392605|NCT05489211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392606|NCT05489211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139392607|NCT05489211|Immunologic Factors|immunologic factors|mesh-ancestor
139392608|NCT05489211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139392609|NCT05489211|Glucocorticoids|glucocorticoids|mesh-ancestor
139392610|NCT05489211|Hormones|hormones|mesh-ancestor
139392611|NCT05489211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392612|NCT05489211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139392613|NCT05489211|Antidotes|antidotes|mesh-ancestor
139392614|NCT05489211|Protective Agents|protective agents|mesh-ancestor
139392615|NCT05489211|Vitamin B Complex|vitamin b complex|mesh-ancestor
139647753|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139647754|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647755|NCT02611752|Analgesics|analgesics|mesh-ancestor
139647756|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
139647757|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647758|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139647759|NCT01307605|Rituximab|rituximab|mesh-list
139647760|NCT01307605|Lenalidomide|lenalidomide|mesh-list
139647761|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139647762|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647763|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
139392616|NCT05489211|Vitamins|vitamins|mesh-ancestor
139647764|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392617|NCT05489211|Micronutrients|micronutrients|mesh-ancestor
139392618|NCT05489211|Antiemetics|antiemetics|mesh-ancestor
139392619|NCT05489211|Autonomic Agents|autonomic agents|mesh-ancestor
139392620|NCT05489211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392621|NCT05489211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139392622|NCT05489211|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139392623|NCT05445804|Cannabidiol|cannabidiol|mesh-list
139392624|NCT05445804|Anticonvulsants|anticonvulsants|mesh-ancestor
139392625|NCT05432388|Remibrutinib|remibrutinib|mesh-list
139392626|NCT05432388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139392627|NCT05432388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392628|NCT05432388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392629|NCT05429489|Morphine|morphine|mesh-list
139392630|NCT05429489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139392631|NCT05429489|Narcotics|narcotics|mesh-ancestor
139392632|NCT05429489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139392633|NCT05429489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392634|NCT05429489|Analgesics|analgesics|mesh-ancestor
139392635|NCT05429489|Sensory System Agents|sensory system agents|mesh-ancestor
139392636|NCT05429489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392637|NCT05419011|Vaccines|vaccines|mesh-list
139392638|NCT05419011|Immunologic Factors|immunologic factors|mesh-ancestor
139392639|NCT05419011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392640|NCT05413369|Metformin|metformin|mesh-list
139392641|NCT05413369|Insulin Glargine|insulin glargine|mesh-list
139392642|NCT05413369|Lixisenatide|lixisenatide|mesh-list
139392643|NCT05413369|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139392644|NCT05413369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139392645|NCT05413369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392646|NCT05413369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392647|NCT05411107|Iloprost|iloprost|mesh-list
139392648|NCT05411107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139392649|NCT05411107|Vasodilator Agents|vasodilator agents|mesh-ancestor
139392650|NCT05370885|Vancomycin|vancomycin|mesh-list
139392651|NCT05370885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139392652|NCT05370885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392653|NCT05369351|Mirabegron|mirabegron|mesh-list
139392654|NCT05369351|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139392655|NCT05369351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139392656|NCT05369351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139392657|NCT05369351|Adrenergic Agents|adrenergic agents|mesh-ancestor
139392658|NCT05369351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139392659|NCT05369351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392660|NCT05369351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392661|NCT05369351|Urological Agents|urological agents|mesh-ancestor
139392662|NCT05362994|Sirolimus|sirolimus|mesh-list
139392663|NCT05362994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139392664|NCT05362994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392665|NCT05362994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139392666|NCT05362994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392667|NCT05362994|Antifungal Agents|antifungal agents|mesh-ancestor
139392668|NCT05362994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139647765|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139647766|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139647767|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139647768|NCT01307605|Growth Substances|growth substances|mesh-ancestor
139647769|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
139647770|NCT04758689|Methotrexate|methotrexate|mesh-list
139647771|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139647772|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
139647773|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139647774|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647775|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139647776|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
139647777|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647778|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647779|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
139647780|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647781|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139647782|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139647783|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
139392669|NCT05362994|Immunologic Factors|immunologic factors|mesh-ancestor
139392670|NCT05362994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392671|NCT05342467|Dinoprostone|dinoprostone|mesh-list
139392672|NCT05342467|Gemeprost|gemeprost|mesh-list
139392673|NCT05342467|Oxytocics|oxytocics|mesh-ancestor
139136097|NCT04442022|Dexamethasone|dexamethasone|mesh-list
139392674|NCT05342467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139647784|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139392675|NCT05342467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392676|NCT05342467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139392677|NCT05342467|Abortifacient Agents|abortifacient agents|mesh-ancestor
139392678|NCT05329155|Heparin|heparin|mesh-list
139392679|NCT05329155|Calcium heparin|calcium heparin|mesh-list
139392680|NCT05329155|Anticoagulants|anticoagulants|mesh-ancestor
139392681|NCT05329155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139392682|NCT05329155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139392683|NCT05329155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392684|NCT05286762|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
139392685|NCT05286762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139392686|NCT05286762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392687|NCT05286762|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139392688|NCT05286762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139392689|NCT05286762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139392690|NCT05286762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392691|NCT05286762|Dopamine Agents|dopamine agents|mesh-ancestor
139392692|NCT05286762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139392693|NCT05280704|Lidocaine|lidocaine|mesh-list
139392694|NCT05280704|Anesthetics, Local|anesthetics, local|mesh-ancestor
139392695|NCT05280704|Anesthetics|anesthetics|mesh-ancestor
139392696|NCT05280704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139049510|NCT03981068|Nimorazole|nimorazole|mesh-list
138812929|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
139392697|NCT05280704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392698|NCT05280704|Sensory System Agents|sensory system agents|mesh-ancestor
139392699|NCT05280704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392700|NCT05280704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139392701|NCT05280704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139392702|NCT05280704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139392703|NCT05280704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139392704|NCT05280704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392705|NCT05279131|Tirbanibulin|tirbanibulin|mesh-list
139392706|NCT05279131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392707|NCT05279131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392708|NCT05275374|Trametinib|trametinib|mesh-list
139392709|NCT05275374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392710|NCT05275374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139392711|NCT05275374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392712|NCT05275374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392713|NCT05269706|Cannabidiol|cannabidiol|mesh-list
139392714|NCT05269706|Anticonvulsants|anticonvulsants|mesh-ancestor
139392715|NCT05267613|Esomeprazole|esomeprazole|mesh-list
139392716|NCT05267613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139392717|NCT05267613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139392718|NCT05267613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139392719|NCT05267613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392720|NCT05267613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392721|NCT05253651|Leucovorin|leucovorin|mesh-list
139392722|NCT05253651|Bevacizumab|bevacizumab|mesh-list
139392723|NCT05253651|Trastuzumab|trastuzumab|mesh-list
139392724|NCT05253651|Cetuximab|cetuximab|mesh-list
139647785|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139647786|NCT01451333|Efavirenz|efavirenz|mesh-list
139647787|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139647788|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139647789|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647790|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647791|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
139647792|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647793|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139647794|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139647795|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139647796|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139647797|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139647798|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139647799|NCT01702831|Lenalidomide|lenalidomide|mesh-list
139647800|NCT01702831|Melphalan|melphalan|mesh-list
139647801|NCT01702831|Busulfan|busulfan|mesh-list
139647802|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
139392725|NCT05253651|Fluorouracil|fluorouracil|mesh-list
139647803|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647804|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139647805|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139647806|NCT01702831|Growth Substances|growth substances|mesh-ancestor
139392726|NCT05253651|Oxaliplatin|oxaliplatin|mesh-list
139392727|NCT05253651|Tucatinib|tucatinib|mesh-list
139392728|NCT05253651|Levoleucovorin|levoleucovorin|mesh-list
139392729|NCT05253651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139392730|NCT05253651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392731|NCT05253651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139392732|NCT05253651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139392733|NCT05253651|Growth Substances|growth substances|mesh-ancestor
139392734|NCT05253651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392735|NCT05253651|Growth Inhibitors|growth inhibitors|mesh-ancestor
139392736|NCT05253651|Antimetabolites|antimetabolites|mesh-ancestor
139392737|NCT05253651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392738|NCT05253651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139392739|NCT05253651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139392740|NCT05253651|Immunologic Factors|immunologic factors|mesh-ancestor
139392741|NCT05253651|Antidotes|antidotes|mesh-ancestor
139392742|NCT05253651|Protective Agents|protective agents|mesh-ancestor
139392743|NCT05253651|Vitamin B Complex|vitamin b complex|mesh-ancestor
139392744|NCT05253651|Vitamins|vitamins|mesh-ancestor
139392745|NCT05253651|Micronutrients|micronutrients|mesh-ancestor
139392746|NCT05253651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139392747|NCT05253651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392748|NCT05252416|Carboplatin|carboplatin|mesh-list
139392749|NCT05252416|Fulvestrant|fulvestrant|mesh-list
139392750|NCT05252416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392751|NCT05252416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139392752|NCT05252416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139392753|NCT05252416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139392754|NCT05252416|Hormone Antagonists|hormone antagonists|mesh-ancestor
139392755|NCT05252416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392756|NCT05252416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392757|NCT05251233|Pantoprazole|pantoprazole|mesh-list
139392758|NCT05251233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139392759|NCT05251233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139392760|NCT05251233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139392761|NCT05251233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392762|NCT05251233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392763|NCT05250011|Dapagliflozin|dapagliflozin|mesh-list
139392764|NCT05250011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139392765|NCT05250011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392766|NCT05250011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139392767|NCT05250011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392768|NCT05242965|Vaccines|vaccines|mesh-list
139392769|NCT05242965|Sargramostim|sargramostim|mesh-list
139392770|NCT05242965|Immunologic Factors|immunologic factors|mesh-ancestor
139392771|NCT05242965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392772|NCT05241288|Albuterol|albuterol|mesh-list
139392773|NCT05241288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139392774|NCT05241288|Autonomic Agents|autonomic agents|mesh-ancestor
139392775|NCT05241288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392776|NCT05241288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392777|NCT05241288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139392778|NCT05241288|Respiratory System Agents|respiratory system agents|mesh-ancestor
139392779|NCT05241288|Tocolytic Agents|tocolytic agents|mesh-ancestor
139392780|NCT05241288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139392781|NCT05241288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139392782|NCT05241288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139392783|NCT05241288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139392784|NCT05241288|Adrenergic Agents|adrenergic agents|mesh-ancestor
139392785|NCT05241288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139392786|NCT05241288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392787|NCT05239169|Capecitabine|capecitabine|mesh-list
139392788|NCT05239169|Durvalumab|durvalumab|mesh-list
139647807|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
139647808|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647809|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139647810|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
139647811|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647812|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139647813|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139392789|NCT05239169|Tremelimumab|tremelimumab|mesh-list
139392790|NCT05239169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139392791|NCT05239169|Antimetabolites|antimetabolites|mesh-ancestor
139392792|NCT05239169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392793|NCT05239169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647814|NCT03045510|Decitabine|decitabine|mesh-list
139647815|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139647816|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
139647817|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647818|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392794|NCT05239169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139392795|NCT05238831|Paclitaxel|paclitaxel|mesh-list
139392796|NCT05238831|Vinorelbine|vinorelbine|mesh-list
139392797|NCT05238831|Maytansine|maytansine|mesh-list
139392798|NCT05238831|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139392799|NCT05238831|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139392800|NCT05238831|Bevacizumab|bevacizumab|mesh-list
139392801|NCT05238831|Carboplatin|carboplatin|mesh-list
139392802|NCT05238831|Capecitabine|capecitabine|mesh-list
139392803|NCT05238831|Trastuzumab|trastuzumab|mesh-list
139392804|NCT05238831|Irinotecan|irinotecan|mesh-list
139392805|NCT05238831|Atezolizumab|atezolizumab|mesh-list
139392806|NCT05238831|Letrozole|letrozole|mesh-list
139392807|NCT05238831|Fulvestrant|fulvestrant|mesh-list
139392808|NCT05238831|Olaparib|olaparib|mesh-list
139392809|NCT05238831|Palbociclib|palbociclib|mesh-list
139392810|NCT05238831|Pertuzumab|pertuzumab|mesh-list
139392811|NCT05238831|Anastrozole|anastrozole|mesh-list
139392812|NCT05238831|Niraparib|niraparib|mesh-list
139392813|NCT05238831|Vemurafenib|vemurafenib|mesh-list
139392814|NCT05238831|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139392815|NCT05238831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139392816|NCT05238831|Endothelial Growth Factors|endothelial growth factors|mesh-list
139392817|NCT05238831|Antibodies|antibodies|mesh-list
139392818|NCT05238831|Immunoglobulins|immunoglobulins|mesh-list
139392819|NCT05238831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139392820|NCT05238831|Immunoglobulin G|immunoglobulin g|mesh-list
139392821|NCT05238831|Entrectinib|entrectinib|mesh-list
139392822|NCT05238831|Immunoconjugates|immunoconjugates|mesh-list
139392823|NCT05238831|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
139392824|NCT05238831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139392825|NCT05238831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392826|NCT05238831|Tubulin Modulators|tubulin modulators|mesh-ancestor
139392827|NCT05238831|Antimitotic Agents|antimitotic agents|mesh-ancestor
139392828|NCT05238831|Mitosis Modulators|mitosis modulators|mesh-ancestor
139392829|NCT05238831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392830|NCT05238831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139392831|NCT05238831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139392832|NCT05238831|Growth Substances|growth substances|mesh-ancestor
139392833|NCT05238831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392834|NCT05238831|Growth Inhibitors|growth inhibitors|mesh-ancestor
139392835|NCT05238831|Immunologic Factors|immunologic factors|mesh-ancestor
139392836|NCT05238831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139392837|NCT05238831|Antimetabolites|antimetabolites|mesh-ancestor
139392838|NCT05238831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139392839|NCT05238831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139647819|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647820|NCT01451879|Miglustat|miglustat|mesh-list
139647821|NCT01451879|Rituximab|rituximab|mesh-list
139647822|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139647823|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647824|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
139647825|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647826|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139647827|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647828|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647829|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139647830|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139647831|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
139647832|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647833|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139647834|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139647835|NCT03045198|Azithromycin|azithromycin|mesh-list
139647836|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139392840|NCT05238831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392841|NCT05238831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139392842|NCT05238831|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139647837|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392843|NCT05238831|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139392844|NCT05238831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139392845|NCT05238831|Hormone Antagonists|hormone antagonists|mesh-ancestor
139647838|NCT01452113|Vildagliptin|vildagliptin|mesh-list
139647839|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139049656|NCT01066494|Cytarabine|cytarabine|mesh-list
139392846|NCT05238831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392847|NCT05238831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139392848|NCT05238831|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139392849|NCT05238831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139392850|NCT05238831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139392851|NCT05238831|Immunotoxins|immunotoxins|mesh-ancestor
139392852|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
139392853|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
139392854|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392855|NCT05189977|Propranolol|propranolol|mesh-list
139392856|NCT05189977|Prazosin|prazosin|mesh-list
139392857|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139392858|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139392859|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
139392860|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139392861|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392862|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392863|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139392864|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139392865|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
139392866|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139392867|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139392868|NCT05189535|Paclitaxel|paclitaxel|mesh-list
139392869|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
139392870|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139392871|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392872|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
139392873|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
139392874|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
139392875|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392876|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139392877|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392878|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139392879|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139392880|NCT05189535|Protective Agents|protective agents|mesh-ancestor
139392881|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392882|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
139392883|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139392884|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
139392885|NCT05183828|Letrozole|letrozole|mesh-list
139392886|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392887|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139392888|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139392889|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392890|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392891|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139392892|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
139392893|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392894|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392895|NCT05178407|Micronutrients|micronutrients|mesh-list
139392896|NCT05178407|Trace Elements|trace elements|mesh-list
139392897|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392898|NCT05153915|Tacrolimus|tacrolimus|mesh-list
139392899|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139392900|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
139392901|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392902|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139392903|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392904|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392905|NCT05152628|Tacrolimus|tacrolimus|mesh-list
139392906|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139647840|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647841|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139647842|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
139647843|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647844|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647845|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
139647846|NCT02022709|Sertraline|sertraline|mesh-list
139647847|NCT02022709|Fluoxetine|fluoxetine|mesh-list
139647848|NCT02022709|Paroxetine|paroxetine|mesh-list
139647849|NCT02022709|Citalopram|citalopram|mesh-list
139647850|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
139647851|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139647852|NCT02022709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139392907|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
139647853|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139647854|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139647855|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647856|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139647857|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
139647858|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647859|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139647860|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139647861|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139647862|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647863|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139647864|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139647865|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139392908|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392909|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139392910|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392911|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392913|NCT05132582|Pertuzumab|pertuzumab|mesh-list
139392914|NCT05132582|Tucatinib|tucatinib|mesh-list
139392915|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139647866|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139392916|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392917|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139392918|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392919|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392920|NCT05101096|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139392921|NCT05101096|Immunoconjugates|immunoconjugates|mesh-ancestor
139392922|NCT05101096|Immunologic Factors|immunologic factors|mesh-ancestor
139392923|NCT05101096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392924|NCT05100472|Androgens|androgens|mesh-list
139392925|NCT05100472|Hormones|hormones|mesh-ancestor
139392926|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139392927|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392928|NCT05062837|Apatinib|apatinib|mesh-list
139392929|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392930|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139392931|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392932|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392933|NCT05048238|Tofacitinib|tofacitinib|mesh-list
139392934|NCT05048238|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139392935|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139392936|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392937|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392938|NCT05047978|Caseins|caseins|mesh-list
139392939|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
139392940|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
139392941|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392942|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
139392943|NCT05005182|Luspatercept|luspatercept|mesh-list
139392944|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
139392945|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392946|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
139392947|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139392948|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392949|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139392950|NCT05005182|Hematinics|hematinics|mesh-ancestor
139392951|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
139392952|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392953|NCT04998006|Ethanol|ethanol|mesh-list
139392954|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139392955|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139392956|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139392957|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392958|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
139392959|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392960|NCT04970355|Erenumab|erenumab|mesh-list
139392961|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139392962|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392963|NCT04970355|Analgesics|analgesics|mesh-ancestor
139392964|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
139392980|NCT04936230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139392982|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392983|NCT04936230|Immunologic Factors|immunologic factors|mesh-ancestor
139392984|NCT04936230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392985|NCT04928339|Bupivacaine|bupivacaine|mesh-list
139392986|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
139392987|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
139392988|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139392989|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139392990|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
139392991|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139392992|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
139392993|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139392994|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
139392995|NCT04912765|Nivolumab|nivolumab|mesh-list
139392996|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139049818|NCT01067118|Insulin|insulin|mesh-list
139392997|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139392998|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139392999|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393000|NCT04854499|Carboplatin|carboplatin|mesh-list
139393001|NCT04854499|Docetaxel|docetaxel|mesh-list
139393002|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
139393003|NCT04854499|Magrolimab|magrolimab|mesh-list
139393004|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393005|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
139393006|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
139393007|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
139393008|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393009|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393010|NCT04854499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139647868|NCT02635841|Deferiprone|deferiprone|mesh-list
139647869|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139647870|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
139647871|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
139647872|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647873|NCT01452659|Relugolix|relugolix|mesh-list
139647874|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
139647875|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
139393041|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
139393042|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139393043|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139393044|NCT04808843|Dienogest|dienogest|mesh-list
139393045|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139393046|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
139393047|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139393048|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393049|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139393050|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139393051|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139393052|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139393053|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
139393054|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393055|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139393056|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393057|NCT04779645|Volagidemab|volagidemab|mesh-list
139393058|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139393059|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393060|NCT04760717|Spironolactone|spironolactone|mesh-list
139393061|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139393062|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
139393063|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393064|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393065|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139393066|NCT04760717|Diuretics|diuretics|mesh-ancestor
139393067|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
139393068|NCT04731480|Propofol|propofol|mesh-list
139393069|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139393070|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139393071|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393072|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139393073|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
139393075|NCT04711161|Paclitaxel|paclitaxel|mesh-list
139393076|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139393077|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393078|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
139393079|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
139393080|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
139393081|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393082|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
139393083|NCT04700696|Narcotics|narcotics|mesh-ancestor
139393084|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139393085|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647879|NCT01896349|Amitriptyline|amitriptyline|mesh-list
139647880|NCT01896349|Risperidone|risperidone|mesh-list
139647881|NCT01896349|Sulpiride|sulpiride|mesh-list
139647882|NCT01896349|Mirtazapine|mirtazapine|mesh-list
139647883|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
139647884|NCT01896349|Trazodone|trazodone|mesh-list
139647885|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
139647886|NCT01896349|Citalopram|citalopram|mesh-list
139647887|NCT01896349|Bupropion|bupropion|mesh-list
139647888|NCT01896349|Sertraline|sertraline|mesh-list
139647889|NCT01896349|Fluoxetine|fluoxetine|mesh-list
139647890|NCT01896349|Paroxetine|paroxetine|mesh-list
139647891|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139647892|NCT01896349|Nortriptyline|nortriptyline|mesh-list
139647893|NCT01896349|Imipramine|imipramine|mesh-list
139393086|NCT04700696|Analgesics|analgesics|mesh-ancestor
139647894|NCT01896349|Clomipramine|clomipramine|mesh-list
139647895|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
139647896|NCT01896349|Escitalopram|escitalopram|mesh-list
139647897|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139647898|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
139647899|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139647900|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647901|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393087|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
139393088|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139393089|NCT04698746|Anesthetics|anesthetics|mesh-list
139393090|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
139393091|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139393092|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393093|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
139393094|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139393095|NCT04685876|Bupivacaine|bupivacaine|mesh-list
139393096|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
139393097|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
139393098|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139393099|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393100|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
139393101|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139393102|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139393103|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
139393104|NCT04669678|Etonogestrel|etonogestrel|mesh-list
139393105|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139393106|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139393107|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139393108|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
139393109|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139393110|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393111|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139393112|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139393113|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139393114|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139393115|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393116|NCT04638517|Danazol|danazol|mesh-list
139393117|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139393118|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
139393119|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393120|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393121|NCT04638400|Simvastatin|simvastatin|mesh-list
139393122|NCT04638400|Ezetimibe|ezetimibe|mesh-list
139393123|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139393124|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139393125|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
139393126|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393127|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139393128|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139393129|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393130|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
139647902|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139647903|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139647904|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139647905|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139647906|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139647907|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
139647908|NCT01896349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139647909|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139647910|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139647911|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719375|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
139647912|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139647913|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139647914|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139647915|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139647916|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647917|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139647918|NCT01896349|Analgesics|analgesics|mesh-ancestor
139647919|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
139647920|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139647921|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
139647922|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
139647923|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139393131|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139393132|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393133|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139647924|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139393134|NCT04609566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139393135|NCT04609566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393136|NCT04609566|Immunotoxins|immunotoxins|mesh-ancestor
139393137|NCT04609566|Immunoconjugates|immunoconjugates|mesh-ancestor
139393138|NCT04609566|Immunologic Factors|immunologic factors|mesh-ancestor
139393139|NCT04609566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393140|NCT04595994|Gemcitabine|gemcitabine|mesh-list
139393141|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139393142|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
139393143|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393144|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393145|NCT04585035|Pembrolizumab|pembrolizumab|mesh-list
139393146|NCT04585035|Cetuximab|cetuximab|mesh-list
139393147|NCT04585035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393148|NCT04585035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393149|NCT04585035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139393150|NCT04585035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393151|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139393152|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139393153|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139393154|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
139393155|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393156|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139393157|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139393158|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393159|NCT04527393|Morphine|morphine|mesh-list
139393160|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139393161|NCT04527393|Narcotics|narcotics|mesh-ancestor
139393162|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139393163|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393164|NCT04527393|Analgesics|analgesics|mesh-ancestor
139393165|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
139393166|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139393167|NCT04465487|Cemiplimab|cemiplimab|mesh-list
139393168|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393169|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393170|NCT04434040|Atezolizumab|atezolizumab|mesh-list
139393171|NCT04434040|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139393172|NCT04434040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139393173|NCT04434040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393174|NCT04434040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393175|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393176|NCT04434040|Immunoconjugates|immunoconjugates|mesh-ancestor
139393177|NCT04434040|Immunologic Factors|immunologic factors|mesh-ancestor
139393178|NCT04434040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393179|NCT04423367|Dexamethasone|dexamethasone|mesh-list
139393180|NCT04423367|Bortezomib|bortezomib|mesh-list
139393181|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139393182|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
139393183|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
139393184|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139393185|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393186|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139393187|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
139393188|NCT04423367|Hormones|hormones|mesh-ancestor
139393189|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393190|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139393191|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393192|NCT04401748|Azacitidine|azacitidine|mesh-list
139393193|NCT04401748|Venetoclax|venetoclax|mesh-list
139393194|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139393195|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
139393196|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393197|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393198|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393199|NCT04385940|Vitamin D|vitamin d|mesh-list
139393200|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
139647925|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139647926|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139647927|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
139647928|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139393201|NCT04385940|Vitamins|vitamins|mesh-ancestor
139393202|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
139647929|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139647930|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139647931|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139393203|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393204|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139393205|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139393207|NCT04379635|Carboplatin|carboplatin|mesh-list
139393208|NCT04379635|Pemetrexed|pemetrexed|mesh-list
139393209|NCT04379635|Tislelizumab|tislelizumab|mesh-list
139393210|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139393211|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393212|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
139393213|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
139393214|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
139393215|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393216|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393217|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139393218|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139393219|NCT04379635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393220|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139393221|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139393222|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139393223|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139393224|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393225|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
139393226|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139393227|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393228|NCT04342585|Progesterone|progesterone|mesh-list
139393229|NCT04342585|Progestins|progestins|mesh-ancestor
139393230|NCT04342585|Hormones|hormones|mesh-ancestor
139393231|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393232|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393233|NCT04341311|Panobinostat|panobinostat|mesh-list
139393234|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393235|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139393236|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393237|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393238|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
139393239|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
139393240|NCT04339777|Busulfan|busulfan|mesh-list
139393241|NCT04339777|Fludarabine|fludarabine|mesh-list
139393242|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
139393243|NCT04339777|Tacrolimus|tacrolimus|mesh-list
139393244|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139393245|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
139393246|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393247|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139393248|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139393249|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
139393250|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393251|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393252|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139393253|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139393254|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393255|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139393256|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139393257|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
139393258|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139393259|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139393260|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393261|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
139393262|NCT04245423|Narcotics|narcotics|mesh-ancestor
139393263|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139393264|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393265|NCT04245423|Analgesics|analgesics|mesh-ancestor
139393266|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
139393267|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139393268|NCT04226690|Dronabinol|dronabinol|mesh-list
139393269|NCT04226690|Hallucinogens|hallucinogens|mesh-ancestor
139647932|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139393270|NCT04226690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393271|NCT04226690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139393272|NCT04226690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139393273|NCT04226690|Analgesics|analgesics|mesh-ancestor
139393274|NCT04226690|Sensory System Agents|sensory system agents|mesh-ancestor
139647933|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139647934|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139647935|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139647936|NCT01452737|Bisacodyl|bisacodyl|mesh-list
139647937|NCT01452737|Cathartics|cathartics|mesh-ancestor
139647938|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139647939|NCT01452737|Laxatives|laxatives|mesh-ancestor
139393275|NCT04226690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139393276|NCT04226690|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139393277|NCT04226690|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139393278|NCT04226690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139393279|NCT04226690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393280|NCT04226690|Hormones|hormones|mesh-ancestor
139393281|NCT04226690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393282|NCT04221477|Acetaminophen|acetaminophen|mesh-list
139393283|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
139393284|NCT04221477|Promethazine|promethazine|mesh-list
139393285|NCT04221477|Prednisone|prednisone|mesh-list
139647940|NCT00595933|Muramidase|muramidase|mesh-list
139647941|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139647942|NCT00580489|Fentanyl|fentanyl|mesh-list
139393286|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
139393287|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
139393288|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139393289|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
139647943|NCT00580489|Morphine|morphine|mesh-list
139647944|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139647945|NCT00580489|Narcotics|narcotics|mesh-ancestor
139393290|NCT04221477|Hormones|hormones|mesh-ancestor
139393291|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393292|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393293|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139393294|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393295|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139050107|NCT00298272|Adalimumab|adalimumab|mesh-list
139393297|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
139393298|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139393299|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
139393300|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
139393301|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
139393302|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139393303|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139393304|NCT04221477|Protective Agents|protective agents|mesh-ancestor
139393305|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393306|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139393307|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139393308|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139393309|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
139393310|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
139393311|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139393312|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
139393313|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
139393314|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139393315|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393316|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139393317|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
139393318|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
139393319|NCT04183205|Sertraline|sertraline|mesh-list
139393320|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
139393321|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139647946|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139647947|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647948|NCT00580489|Analgesics|analgesics|mesh-ancestor
139647949|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
139647950|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647951|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139647952|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139647953|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
139647954|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
139647955|NCT01659307|Aspirin|aspirin|mesh-list
139647956|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139393322|NCT04183205|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139393323|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139647957|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139647958|NCT01659307|Analgesics|analgesics|mesh-ancestor
139647959|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
139647960|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139647961|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647962|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139393324|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139393325|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393326|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139393327|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
139393328|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393329|NCT04141696|Midazolam|midazolam|mesh-list
139393330|NCT04141696|Ketamine|ketamine|mesh-list
139393331|NCT04141696|Analgesics|analgesics|mesh-ancestor
139393332|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
139393333|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139393334|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393335|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139393336|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139393337|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
139393338|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
139393339|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139393340|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139393341|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139393342|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139393343|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393344|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139393345|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139393346|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139393347|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139393348|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139393349|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
139393350|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
139393351|NCT04138706|Vancomycin|vancomycin|mesh-list
139393352|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139393353|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139393354|NCT04098718|Prednisolone|prednisolone|mesh-list
139393355|NCT04098718|Benralizumab|benralizumab|mesh-list
139393356|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139393357|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
139393358|NCT04098718|Hormones|hormones|mesh-ancestor
139393359|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393360|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393361|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139393362|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393363|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139393364|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
139393365|NCT04024696|Abexinostat|abexinostat|mesh-list
139393366|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139393367|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393368|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393369|NCT03975647|Tucatinib|tucatinib|mesh-list
139393370|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393371|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393372|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139393373|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393374|NCT03940352|Venetoclax|venetoclax|mesh-list
139393375|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393376|NCT03936153|Abexinostat|abexinostat|mesh-list
139393377|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139647963|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139647964|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139647965|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139647966|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647967|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139647968|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139647969|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647970|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
139647971|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
139393378|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393379|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393380|NCT03934567|Abexinostat|abexinostat|mesh-list
139393381|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139393382|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393383|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393384|NCT03930953|Rituximab|rituximab|mesh-list
138898112|NCT02688023|Irinotecan|irinotecan|mesh-list
139647972|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139647974|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139393385|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
139393386|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393387|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393388|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
139393389|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393390|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139393391|NCT03877809|Sirolimus|sirolimus|mesh-list
139393392|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139393393|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139393394|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139393395|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393396|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
139393397|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139393398|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
139393399|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393400|NCT03867201|Erenumab|erenumab|mesh-list
139393401|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139393402|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393403|NCT03867201|Analgesics|analgesics|mesh-ancestor
139393404|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
139393405|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139393406|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393407|NCT03866382|Nivolumab|nivolumab|mesh-list
139393408|NCT03866382|Ipilimumab|ipilimumab|mesh-list
139393409|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393410|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393411|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139393412|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393413|NCT03834688|Rituximab|rituximab|mesh-list
139393414|NCT03834688|Venetoclax|venetoclax|mesh-list
139393415|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139393416|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393417|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393418|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
139393419|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393420|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139393421|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139393422|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
139393423|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393424|NCT03816332|Prednisone|prednisone|mesh-list
139393425|NCT03816332|Cortisone|cortisone|mesh-list
139393426|NCT03816332|Nivolumab|nivolumab|mesh-list
139393427|NCT03816332|Ipilimumab|ipilimumab|mesh-list
139393428|NCT03816332|Tacrolimus|tacrolimus|mesh-list
139393429|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139393430|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
139393431|NCT03816332|Hormones|hormones|mesh-ancestor
139393432|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393433|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393434|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139393435|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393436|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393437|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139393438|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393439|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139393440|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
139393441|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139393442|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393443|NCT03808961|Vitamins|vitamins|mesh-list
139091579|NCT04428866|Hormones|hormones|mesh-ancestor
139393446|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
139393447|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
139393448|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
139393449|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647975|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647976|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139647977|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139647978|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139647979|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
139647980|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139647981|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393450|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139393451|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
139393452|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393453|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139393454|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
139393455|NCT03794349|Eflornithine|eflornithine|mesh-list
139393456|NCT03794349|Irinotecan|irinotecan|mesh-list
139393457|NCT03794349|Camptothecin|camptothecin|mesh-list
139393458|NCT03794349|Temozolomide|temozolomide|mesh-list
139393459|NCT03794349|Dinutuximab|dinutuximab|mesh-list
139393460|NCT03794349|Sargramostim|sargramostim|mesh-list
139393461|NCT03794349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139393462|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139393463|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139393464|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393465|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393466|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393467|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139393468|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
139393469|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
139393470|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393471|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139393472|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139393473|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139393474|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139393475|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139393476|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139393477|NCT03738852|Insulin|insulin|mesh-list
139393478|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139393479|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393480|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
139393481|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139393482|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393483|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139393484|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393485|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
139393486|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
139393487|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139393488|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139393489|NCT03703778|Androgens|androgens|mesh-list
139393490|NCT03703778|Hormones|hormones|mesh-ancestor
139393491|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393492|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393493|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
139393494|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393495|NCT03703778|Protective Agents|protective agents|mesh-ancestor
139393496|NCT03703778|Vitamins|vitamins|mesh-ancestor
139393497|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
139393498|NCT03703778|Estrogens|estrogens|mesh-ancestor
139393499|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139393500|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393501|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
139393502|NCT03637543|Nivolumab|nivolumab|mesh-list
139393503|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393504|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393505|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139393506|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393507|NCT03604991|Paclitaxel|paclitaxel|mesh-list
139393508|NCT03604991|Carboplatin|carboplatin|mesh-list
139393509|NCT03604991|Nivolumab|nivolumab|mesh-list
139393510|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139393511|NCT03604991|Ipilimumab|ipilimumab|mesh-list
139393512|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139393513|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393514|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
139393515|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
139647982|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647983|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139647984|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139647985|NCT04391231|Protective Agents|protective agents|mesh-ancestor
139647986|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647987|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
139647988|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139393516|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
139393517|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136305|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139647989|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
139393519|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139393521|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139393522|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393523|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393525|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139393526|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393527|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393528|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139393529|NCT03583528|Edotreotide|edotreotide|mesh-list
139393530|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139393531|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393532|NCT03551964|Ticagrelor|ticagrelor|mesh-list
139393533|NCT03551964|Cangrelor|cangrelor|mesh-list
139393534|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139393535|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139393536|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139393537|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139393538|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
139393539|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139393540|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393541|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393542|NCT03547973|Carboplatin|carboplatin|mesh-list
139393543|NCT03547973|Gemcitabine|gemcitabine|mesh-list
139393544|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
139393545|NCT03547973|Avelumab|avelumab|mesh-list
139393546|NCT03547973|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139393547|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393548|NCT03547973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139393549|NCT03547973|Antimetabolites|antimetabolites|mesh-ancestor
139393550|NCT03547973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393551|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393552|NCT03547973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139393553|NCT03547973|Immunoconjugates|immunoconjugates|mesh-ancestor
139393554|NCT03547973|Immunologic Factors|immunologic factors|mesh-ancestor
139393555|NCT03547973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393556|NCT03543813|CX-2029|cx-2029|mesh-list
139393557|NCT03543813|Immunoconjugates|immunoconjugates|mesh-ancestor
139393558|NCT03543813|Immunologic Factors|immunologic factors|mesh-ancestor
139393559|NCT03543813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393560|NCT03527537|Insulin|insulin|mesh-list
139393561|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139393562|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393563|NCT03520790|Paclitaxel|paclitaxel|mesh-list
139393564|NCT03520790|Gemcitabine|gemcitabine|mesh-list
139393565|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139393566|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393567|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
139393568|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
139393569|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
139393570|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393571|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139393572|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
139393576|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
139393577|NCT03511391|Nivolumab|nivolumab|mesh-list
139647992|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139647993|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139647994|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139647995|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139647996|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139647997|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139647998|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
139647999|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648000|NCT04872192|Anesthetics|anesthetics|mesh-list
139648001|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139393578|NCT03511391|Atezolizumab|atezolizumab|mesh-list
139393579|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139136316|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
139648003|NCT01454609|Clonidine|clonidine|mesh-list
139393580|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393581|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393582|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393583|NCT03486834|Vaccines|vaccines|mesh-list
139393584|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
139393585|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393586|NCT03485209|Carboplatin|carboplatin|mesh-list
139393587|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
139393588|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
139393589|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393590|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393591|NCT03485209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139393592|NCT03485209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393593|NCT03482167|Niacinamide|niacinamide|mesh-list
139393594|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
139393595|NCT03482167|Vitamins|vitamins|mesh-ancestor
139393596|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
139393597|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393599|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
139393600|NCT03478865|Vitamins|vitamins|mesh-ancestor
138719583|NCT00171314|Letrozole|letrozole|mesh-list
139393601|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
139393602|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393603|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
139393604|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393605|NCT03478865|Protective Agents|protective agents|mesh-ancestor
139393606|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139393607|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393608|NCT03412877|Aldesleukin|aldesleukin|mesh-list
139393609|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
139393610|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
139393611|NCT03412877|Fludarabine|fludarabine|mesh-list
139393612|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139393613|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
139393614|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393615|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139393616|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139393617|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
139393618|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393619|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393620|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139393621|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393622|NCT03412877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139393623|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139393624|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139393625|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
139393626|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139393627|NCT03312738|Everolimus|everolimus|mesh-list
139393628|NCT03312738|Exemestane|exemestane|mesh-list
139393629|NCT03312738|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139393630|NCT03312738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139393631|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393632|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393633|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139393634|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
139393635|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393636|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393637|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139393638|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139393639|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139648004|NCT01454609|Bupivacaine|bupivacaine|mesh-list
139648005|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
139648006|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
139648007|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139648008|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648009|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
139648010|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648011|NCT01454609|Analgesics|analgesics|mesh-ancestor
139648012|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139648013|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
139648014|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
139393640|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
139393641|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393642|NCT03297359|Dalteparin|dalteparin|mesh-list
139393643|NCT03297359|Tinzaparin|tinzaparin|mesh-list
139393644|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139393645|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
139393646|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139393647|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139393648|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393649|NCT03284866|Vaccines|vaccines|mesh-list
139393650|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
139393651|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393652|NCT03269669|Prednisone|prednisone|mesh-list
139393653|NCT03269669|Cortisone|cortisone|mesh-list
139393654|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
139393655|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139393656|NCT03269669|Doxorubicin|doxorubicin|mesh-list
139393657|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139393658|NCT03269669|Vincristine|vincristine|mesh-list
139393659|NCT03269669|Lenalidomide|lenalidomide|mesh-list
139393660|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
139393661|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139393662|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
139393663|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393664|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139393665|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139393666|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
139393667|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393668|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393669|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139393670|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139393671|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139393672|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139393673|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393674|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139393675|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
139393676|NCT03269669|Hormones|hormones|mesh-ancestor
139393677|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393678|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139393679|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139393680|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
139393681|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
139393682|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
139393683|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139393684|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139393685|NCT03269669|Growth Substances|growth substances|mesh-ancestor
139393686|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
139393687|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393688|NCT03268954|Azacitidine|azacitidine|mesh-list
139393689|NCT03268954|Pevonedistat|pevonedistat|mesh-list
139393690|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139393691|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
139393692|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393693|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393694|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393695|NCT03242382|Palbociclib|palbociclib|mesh-list
139393696|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393697|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139393698|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393699|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393700|NCT03223610|Prednisone|prednisone|mesh-list
139393701|NCT03223610|Lenalidomide|lenalidomide|mesh-list
139393702|NCT03223610|Venetoclax|venetoclax|mesh-list
139393703|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
139393704|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139393705|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
139393706|NCT03223610|Hormones|hormones|mesh-ancestor
139393707|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393708|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393709|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139393710|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393711|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
139393712|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139648015|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139648016|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139648017|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139648018|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
139648019|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139393713|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139393714|NCT03223610|Growth Substances|growth substances|mesh-ancestor
139648020|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648021|NCT03042234|Insulin|insulin|mesh-list
139648022|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139393715|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
139393716|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393717|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
139393718|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393719|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393720|NCT03196232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139393721|NCT03196232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393722|NCT03191149|Osimertinib|osimertinib|mesh-list
139393723|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393724|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139393725|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393726|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393727|NCT03120624|Iodine|iodine|mesh-list
139393728|NCT03120624|Interferons|interferons|mesh-list
139393729|NCT03120624|Interferon-beta|interferon-beta|mesh-list
139393730|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
139393731|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393732|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
139393733|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139393734|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
139393735|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393736|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139393737|NCT03120624|Trace Elements|trace elements|mesh-ancestor
139393738|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
139393739|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139393740|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393741|NCT03117933|Paclitaxel|paclitaxel|mesh-list
139393742|NCT03117933|Olaparib|olaparib|mesh-list
139393743|NCT03117933|Cediranib|cediranib|mesh-list
139393744|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139393745|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050559|NCT00295022|Montelukast|montelukast|mesh-list
139393746|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
139393747|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
139393749|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393750|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139393751|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393752|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139393753|NCT03114527|Everolimus|everolimus|mesh-list
139393754|NCT03114527|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139393755|NCT03114527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139393756|NCT03114527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393757|NCT03114527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393758|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139393759|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
139393760|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393761|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393762|NCT03094663|Cefazolin|cefazolin|mesh-list
139393763|NCT03094663|Cephalosporins|cephalosporins|mesh-list
139393764|NCT03094663|Dexamethasone|dexamethasone|mesh-list
139393765|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
139393766|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
139393767|NCT03094663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139393768|NCT03094663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139393769|NCT03094663|Epinephrine|epinephrine|mesh-list
139393770|NCT03094663|Racepinephrine|racepinephrine|mesh-list
139393771|NCT03094663|Bupivacaine|bupivacaine|mesh-list
139393772|NCT03094663|Epinephryl borate|epinephryl borate|mesh-list
139393773|NCT03094663|BB 1101|bb 1101|mesh-list
139393774|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139393775|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
139393776|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
139393777|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139393778|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393779|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139393780|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
139393781|NCT03094663|Hormones|hormones|mesh-ancestor
139648023|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139648024|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648025|NCT02905799|Resveratrol|resveratrol|mesh-list
139648026|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
139393782|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139393783|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139393784|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393785|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
139393786|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393787|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393788|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
139393790|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139393791|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
139393792|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139393793|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139393794|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139393795|NCT03094663|Protective Agents|protective agents|mesh-ancestor
139393796|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139393797|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139393798|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
139393799|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139393800|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139393801|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139393802|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139393803|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
139393804|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
139393805|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
139393806|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139393807|NCT03076554|Avelumab|avelumab|mesh-list
139393808|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393809|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393810|NCT03065335|Ketamine|ketamine|mesh-list
139393811|NCT03065335|Analgesics|analgesics|mesh-ancestor
139393812|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
139393813|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139393814|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393815|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139393816|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139393817|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
139393818|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
139393819|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139393820|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139393821|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139050653|NCT00294554|Memantine|memantine|mesh-list
139393822|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139393823|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393824|NCT02979522|Doxorubicin|doxorubicin|mesh-list
139393825|NCT02979522|Dacarbazine|dacarbazine|mesh-list
139393826|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139393827|NCT02979522|Vinblastine|vinblastine|mesh-list
139393828|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139393829|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719648|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
139648027|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648028|NCT02905799|Protective Agents|protective agents|mesh-ancestor
139648029|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648030|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648031|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139648032|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139648033|NCT00469183|Tretinoin|tretinoin|mesh-list
139648034|NCT00469183|Hydroquinone|hydroquinone|mesh-list
139648035|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648036|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
139648037|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
139648038|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139648039|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
139648040|NCT00469183|Hormones|hormones|mesh-ancestor
139648041|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139648042|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648043|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
139648044|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648045|NCT00469183|Protective Agents|protective agents|mesh-ancestor
139648046|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139648047|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139648048|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139648049|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139648050|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648051|NCT00468715|Bicalutamide|bicalutamide|mesh-list
139393830|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139648052|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
139648053|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
139393831|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139393832|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393833|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393834|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139393835|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
139393836|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393838|NCT02979522|Immunoconjugates|immunoconjugates|mesh-ancestor
139393839|NCT02979522|Immunologic Factors|immunologic factors|mesh-ancestor
139393840|NCT02979522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393841|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139393842|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
139393843|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
139393844|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
139393845|NCT02945800|Paclitaxel|paclitaxel|mesh-list
139393846|NCT02945800|Gemcitabine|gemcitabine|mesh-list
139393847|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139393848|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393849|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
139393850|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
139393851|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
139393852|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393853|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139393854|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
139393855|NCT02663622|Methotrexate|methotrexate|mesh-list
139393856|NCT02663622|Tacrolimus|tacrolimus|mesh-list
139393857|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139393858|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
139393859|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139393860|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393861|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139393862|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
139393863|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393864|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393865|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
139393866|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393867|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139393868|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139393869|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
139393870|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139393871|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139393872|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139393873|NCT02650271|Tenofovir|tenofovir|mesh-list
139393874|NCT02650271|Entecavir|entecavir|mesh-list
139393875|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
139393876|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139393877|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139393878|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139393879|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393880|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393881|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139393882|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139393883|NCT02553473|Doxycycline|doxycycline|mesh-list
139393884|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139393885|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139393886|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
139393887|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139393888|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139393889|NCT02465060|Nivolumab|nivolumab|mesh-list
139393890|NCT02465060|Trastuzumab|trastuzumab|mesh-list
139648054|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139648055|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648056|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648057|NCT01456247|Lansoprazole|lansoprazole|mesh-list
139648058|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
139648059|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139648060|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139648061|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139648062|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648063|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648064|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139648065|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648066|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139648067|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393891|NCT02465060|Pertuzumab|pertuzumab|mesh-list
139393892|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139648068|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648069|NCT04866498|Analgesics|analgesics|mesh-list
139648070|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
139393893|NCT02465060|Relatlimab|relatlimab|mesh-list
139393894|NCT02465060|Sunitinib|sunitinib|mesh-list
139393895|NCT02465060|Dasatinib|dasatinib|mesh-list
139393896|NCT02465060|Palbociclib|palbociclib|mesh-list
139393897|NCT02465060|Trametinib|trametinib|mesh-list
139393898|NCT02465060|Osimertinib|osimertinib|mesh-list
139393899|NCT02465060|Afatinib|afatinib|mesh-list
139393900|NCT02465060|Dabrafenib|dabrafenib|mesh-list
139393901|NCT02465060|Crizotinib|crizotinib|mesh-list
139393902|NCT02465060|Maytansine|maytansine|mesh-list
139393903|NCT02465060|Ipatasertib|ipatasertib|mesh-list
139393904|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139393905|NCT02465060|GSK2636771|gsk2636771|mesh-list
139393906|NCT02465060|Antibodies|antibodies|mesh-list
139393907|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
139393908|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
139393909|NCT02465060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139393910|NCT02465060|Adavosertib|adavosertib|mesh-list
139393911|NCT02465060|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139393912|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
139393913|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
139393914|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393915|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393916|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393917|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139393918|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393919|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139393920|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139393921|NCT02465060|Growth Substances|growth substances|mesh-ancestor
139393922|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
139393923|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139393924|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393925|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139393926|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
139393927|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
139393928|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
139393929|NCT02465060|Immunotoxins|immunotoxins|mesh-ancestor
139393930|NCT02421939|Cytarabine|cytarabine|mesh-list
139393931|NCT02421939|Fludarabine|fludarabine|mesh-list
139393932|NCT02421939|Etoposide|etoposide|mesh-list
139393933|NCT02421939|Azacitidine|azacitidine|mesh-list
139393934|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
139393935|NCT02421939|Idarubicin|idarubicin|mesh-list
139393936|NCT02421939|Lenograstim|lenograstim|mesh-list
139393937|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393938|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139393939|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
139393940|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393941|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139393942|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
139393943|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393944|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139393945|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139393946|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139393947|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139393948|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
139393949|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139393950|NCT02421939|Analgesics|analgesics|mesh-ancestor
139393951|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
139393952|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139393953|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139393954|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139393955|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138719693|NCT00478244|Busulfan|busulfan|mesh-list
139393956|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139393957|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393958|NCT02169310|Raclopride|raclopride|mesh-list
139648071|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648072|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393959|NCT02169310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139393960|NCT02169310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139648073|NCT04866654|Nivolumab|nivolumab|mesh-list
139393961|NCT02169310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139393962|NCT02169310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393963|NCT02169310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139393964|NCT02169310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139393965|NCT02169310|Dopamine Agents|dopamine agents|mesh-ancestor
139648074|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139393991|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
139393992|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
139393993|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139393994|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139393995|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139393996|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139393997|NCT01896999|Immunotoxins|immunotoxins|mesh-ancestor
139393998|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
139393999|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
139394000|NCT01861106|Busulfan|busulfan|mesh-list
139394001|NCT01861106|Fludarabine|fludarabine|mesh-list
139394002|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
139394003|NCT01861106|Tacrolimus|tacrolimus|mesh-list
139394004|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139394005|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139394006|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
139394007|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394008|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139394009|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139394010|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
139394011|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394012|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394013|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139394014|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139394015|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
139394016|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139394017|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394018|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139394019|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139394020|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
139394021|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139394022|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138719734|NCT00477464|Capecitabine|capecitabine|mesh-list
139648075|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648076|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139648077|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394038|NCT01722240|Liraglutide|liraglutide|mesh-list
139648082|NCT01895569|Pioglitazone|pioglitazone|mesh-list
139648083|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139648084|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139648085|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648086|NCT01895569|Incretins|incretins|mesh-ancestor
139394044|NCT01319565|Aldesleukin|aldesleukin|mesh-list
139394045|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
139394046|NCT01319565|Fludarabine|fludarabine|mesh-list
139394047|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139394048|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
139394049|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394050|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139394051|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139394052|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
139394053|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394054|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394055|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139394057|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139394058|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
139394059|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394069|NCT01190787|Prednisone|prednisone|mesh-list
139394070|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
139394071|NCT01190787|Melphalan|melphalan|mesh-list
139394072|NCT01190787|Bortezomib|bortezomib|mesh-list
139394073|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139394074|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
139394075|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394076|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139394077|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139394078|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
139394079|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394080|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394081|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139394082|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394083|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
139394084|NCT01190787|Hormones|hormones|mesh-ancestor
139394085|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394086|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139394087|NCT01107717|Metformin|metformin|mesh-list
139394088|NCT01107717|Pioglitazone|pioglitazone|mesh-list
139394089|NCT01107717|Exenatide|exenatide|mesh-list
139394090|NCT01107717|Glyburide|glyburide|mesh-list
139394091|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139394092|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394093|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139394094|NCT01107717|Incretins|incretins|mesh-ancestor
139394095|NCT01107717|Hormones|hormones|mesh-ancestor
139394096|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394097|NCT00978458|Temozolomide|temozolomide|mesh-list
139648087|NCT01895569|Hormones|hormones|mesh-ancestor
139648088|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139648089|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139648090|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
139648091|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394098|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139394099|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
139394100|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719776|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
139648092|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394102|NCT00967785|Plerixafor|plerixafor|mesh-list
139394103|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139394104|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139394105|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
139394106|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394107|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
139394108|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
139394109|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139394110|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139394111|NCT00882895|Prednisolone|prednisolone|mesh-list
139394112|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
139394113|NCT00882895|Tacrolimus|tacrolimus|mesh-list
139394114|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
139394115|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139394116|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139394117|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
139394118|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139394119|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
139394120|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394121|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139394122|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394123|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394124|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139394125|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394126|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139394127|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
139394128|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139394129|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394130|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394131|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
139394132|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
139394133|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394134|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139394135|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
139394136|NCT00882895|Hormones|hormones|mesh-ancestor
139394137|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394138|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139394139|NCT00882895|Protective Agents|protective agents|mesh-ancestor
139394140|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139394141|NCT00819546|Everolimus|everolimus|mesh-list
139394142|NCT00819546|Midostaurin|midostaurin|mesh-list
139394143|NCT00819546|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139394144|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139394145|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394146|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394147|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139394148|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
139394149|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394150|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648093|NCT01457261|Albuterol|albuterol|mesh-list
139648094|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139648095|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
139648096|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648097|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648098|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139648099|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
139648100|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
139648101|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139648102|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139648103|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139648104|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139648105|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
139648106|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648107|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648108|NCT01457495|Edetic Acid|edetic acid|mesh-list
139648109|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
139648110|NCT01457495|Antidotes|antidotes|mesh-ancestor
139648111|NCT01457495|Protective Agents|protective agents|mesh-ancestor
139648112|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394151|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
139648113|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
139394152|NCT00097474|Melatonin|melatonin|mesh-list
139394153|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394154|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
139136416|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648114|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
139648115|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648116|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139394155|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394156|NCT00097474|Protective Agents|protective agents|mesh-ancestor
139394157|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394158|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139394159|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
139394160|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394161|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139394162|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394163|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394164|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
139394165|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
139394166|NCT00001521|Letrozole|letrozole|mesh-list
139394167|NCT00001521|Flutamide|flutamide|mesh-list
139394168|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394169|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139394170|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139394171|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394172|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394173|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139394174|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
139394175|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394176|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394177|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394178|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
139394179|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139394180|NCT00001481|Estradiol|estradiol|mesh-list
139394181|NCT00001481|Progesterone|progesterone|mesh-list
139394182|NCT00001481|Estrogens|estrogens|mesh-ancestor
139394183|NCT00001481|Hormones|hormones|mesh-ancestor
139394184|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394185|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394186|NCT00001481|Progestins|progestins|mesh-ancestor
139394187|NCT00001230|Diethylcarbamazine|diethylcarbamazine|mesh-list
139394188|NCT00001230|Filaricides|filaricides|mesh-ancestor
139394189|NCT00001230|Antinematodal Agents|antinematodal agents|mesh-ancestor
139394190|NCT00001230|Anthelmintics|anthelmintics|mesh-ancestor
139394191|NCT00001230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139394192|NCT00001230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394193|NCT00001230|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139394194|NCT00001230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394195|NCT00001230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394196|NCT04141904|Tofacitinib|tofacitinib|mesh-list
139394197|NCT04141904|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139394198|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139394199|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394200|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394201|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139394202|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
139394203|NCT01361711|Ofatumumab|ofatumumab|mesh-list
139394204|NCT01361711|Antibodies|antibodies|mesh-list
139394205|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
139394206|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139394207|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
139394208|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394209|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394210|NCT05517746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139394211|NCT05527340|Dexamethasone|dexamethasone|mesh-list
139394212|NCT05527340|Daratumumab|daratumumab|mesh-list
139394213|NCT05527340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394214|NCT05527340|Antiemetics|antiemetics|mesh-ancestor
139394215|NCT05527340|Autonomic Agents|autonomic agents|mesh-ancestor
139394216|NCT05527340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394217|NCT05527340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394218|NCT05527340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139394219|NCT05527340|Glucocorticoids|glucocorticoids|mesh-ancestor
139394220|NCT05527340|Hormones|hormones|mesh-ancestor
139648117|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
139648118|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139648119|NCT04778137|Omalizumab|omalizumab|mesh-list
139648120|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139648121|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139394221|NCT05527340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394222|NCT05527340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139394223|NCT05527340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648122|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
139648123|NCT01458041|Iloprost|iloprost|mesh-list
139394224|NCT05527106|Ascorbic Acid|ascorbic acid|mesh-list
139394225|NCT05527106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139394226|NCT05527106|Vitamins|vitamins|mesh-ancestor
139394227|NCT05527106|Micronutrients|micronutrients|mesh-ancestor
139394228|NCT05527106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394229|NCT05527106|Antioxidants|antioxidants|mesh-ancestor
139394230|NCT05527106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394231|NCT05527106|Protective Agents|protective agents|mesh-ancestor
139394232|NCT05527106|Nootropic Agents|nootropic agents|mesh-ancestor
139394233|NCT05526794|Analgesics|analgesics|mesh-list
139394234|NCT05526794|Sensory System Agents|sensory system agents|mesh-ancestor
139394235|NCT05526794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394236|NCT05526794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394237|NCT05522894|Paclitaxel|paclitaxel|mesh-list
139394238|NCT05522894|Cisplatin|cisplatin|mesh-list
139394239|NCT05522894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139394240|NCT05522894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394241|NCT05522894|Tubulin Modulators|tubulin modulators|mesh-ancestor
139394242|NCT05522894|Antimitotic Agents|antimitotic agents|mesh-ancestor
139394243|NCT05522894|Mitosis Modulators|mitosis modulators|mesh-ancestor
139394244|NCT05522894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394245|NCT05522816|Tirbanibulin|tirbanibulin|mesh-list
139394246|NCT05522816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394247|NCT05522816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394248|NCT02573870|Fluticasone|fluticasone|mesh-list
139394249|NCT02573870|Xhance|xhance|mesh-list
139394250|NCT02573870|Albuterol|albuterol|mesh-list
139394251|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394252|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139394253|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
139394254|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394255|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394256|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139394257|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
139394258|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
139394259|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139394260|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
139394261|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139394262|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139394263|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139394264|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139394265|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
139394266|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139394267|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394268|NCT05148026|Heparin|heparin|mesh-list
139394269|NCT05148026|Calcium heparin|calcium heparin|mesh-list
139394270|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
139394271|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
139394272|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139394273|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139394274|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394275|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139394276|NCT05522270|Mitogens|mitogens|mesh-list
139394277|NCT05522270|Mitosis Modulators|mitosis modulators|mesh-ancestor
139394278|NCT05522270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394279|NCT05522192|Venetoclax|venetoclax|mesh-list
139394280|NCT05522192|Mitoxantrone|mitoxantrone|mesh-list
139394281|NCT05522192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394282|NCT05522192|Analgesics|analgesics|mesh-ancestor
139394283|NCT05522192|Sensory System Agents|sensory system agents|mesh-ancestor
139394284|NCT05522192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394285|NCT05522192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394286|NCT05522192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139394287|NCT05522192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139394288|NCT05522192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394289|NCT05522192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394290|NCT05525234|Thalidomide|thalidomide|mesh-list
139394291|NCT05525234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139648124|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139648125|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
139648126|NCT02610816|Fluticasone|fluticasone|mesh-list
139394292|NCT05525234|Immunologic Factors|immunologic factors|mesh-ancestor
139394293|NCT05525234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394294|NCT05525234|Leprostatic Agents|leprostatic agents|mesh-ancestor
139394295|NCT05525234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139394296|NCT05525234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394297|NCT05525234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139648127|NCT02610816|Xhance|xhance|mesh-list
139648128|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394298|NCT05525234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139394299|NCT05525234|Growth Substances|growth substances|mesh-ancestor
139394300|NCT05525234|Growth Inhibitors|growth inhibitors|mesh-ancestor
139394301|NCT05525234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394302|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139394303|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139394304|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394305|NCT04295330|Lidocaine|lidocaine|mesh-list
139394306|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
139394307|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
139394308|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139394309|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394310|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
139394311|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394312|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139394313|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139394314|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139394315|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139394316|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394317|NCT05525156|Aspirin|aspirin|mesh-list
139394318|NCT05525156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139394319|NCT05525156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139394320|NCT05525156|Analgesics|analgesics|mesh-ancestor
139394321|NCT05525156|Sensory System Agents|sensory system agents|mesh-ancestor
139394322|NCT05525156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394323|NCT05525156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394324|NCT05525156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394325|NCT05525156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139394326|NCT05525156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139394327|NCT05525156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139394328|NCT05525156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394329|NCT05525156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139394330|NCT05525156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139394331|NCT05525156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394332|NCT05525156|Antipyretics|antipyretics|mesh-ancestor
139394333|NCT05512130|Empagliflozin|empagliflozin|mesh-list
139394334|NCT05512130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139394335|NCT05512130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394336|NCT05512130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139394337|NCT05512130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394338|NCT02180425|Adapalene|adapalene|mesh-list
139394339|NCT02180425|Tretinoin|tretinoin|mesh-list
139394340|NCT02180425|Isotretinoin|isotretinoin|mesh-list
139394341|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
139394342|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394343|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
139394344|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139394345|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139394346|NCT02180425|Analgesics|analgesics|mesh-ancestor
139394347|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
139394348|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394349|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648129|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139648130|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
139648131|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648132|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648133|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139648134|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
139648135|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
139648136|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139648137|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
139648138|NCT00332605|Naltrexone|naltrexone|mesh-list
139648139|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139648140|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139648141|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139394350|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394351|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139648142|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648143|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
139648144|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648145|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
139648146|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394353|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
139394354|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139394355|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394356|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139394357|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139394358|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394359|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394360|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394361|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394362|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139394363|NCT02183467|Incretins|incretins|mesh-ancestor
139394364|NCT02183467|Hormones|hormones|mesh-ancestor
139394365|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394366|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139394367|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
139394368|NCT02180503|Linagliptin|linagliptin|mesh-list
139394369|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139394370|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394371|NCT02180503|Incretins|incretins|mesh-ancestor
139394372|NCT02180503|Hormones|hormones|mesh-ancestor
139394373|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394374|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139394375|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
139394376|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394377|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394378|NCT02177851|Iron|iron|mesh-list
139394379|NCT02177851|Trace Elements|trace elements|mesh-ancestor
139394380|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
139394381|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394382|NCT05075876|Granisetron|granisetron|mesh-list
139394383|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
139394384|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
138720355|NCT00556088|Growth Substances|growth substances|mesh-ancestor
139394385|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394386|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394387|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139394388|NCT05075876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139394389|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139394390|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
139394391|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139394392|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394393|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
139394394|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139394395|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139394396|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394397|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139394398|NCT02180737|Analgesics|analgesics|mesh-ancestor
139394399|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
139394400|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394401|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139394402|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139394403|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139394404|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
139394405|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139394406|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394407|NCT05520944|Chlorpheniramine|chlorpheniramine|mesh-list
139394408|NCT05520944|Antipruritics|antipruritics|mesh-ancestor
139394409|NCT05520944|Dermatologic Agents|dermatologic agents|mesh-ancestor
139394410|NCT05520944|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139394411|NCT05520944|Histamine Antagonists|histamine antagonists|mesh-ancestor
139394412|NCT05520944|Histamine Agents|histamine agents|mesh-ancestor
139394413|NCT05520944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139394414|NCT05520944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394415|NCT05520944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394416|NCT05520944|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139394417|NCT02183623|Linagliptin|linagliptin|mesh-list
139394418|NCT02183623|Simvastatin|simvastatin|mesh-list
139648147|NCT00332605|Expectorants|expectorants|mesh-ancestor
139648148|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
139394419|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139394420|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139394421|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
139394422|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648149|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139648151|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648152|NCT00332605|Protective Agents|protective agents|mesh-ancestor
139394423|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139394424|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139394425|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394426|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139394427|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394428|NCT02183623|Incretins|incretins|mesh-ancestor
139394429|NCT02183623|Hormones|hormones|mesh-ancestor
139394430|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394431|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139394432|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
139394433|NCT02183701|Losartan|losartan|mesh-list
139394434|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139394435|NCT02183701|Telmisartan|telmisartan|mesh-list
139394436|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139394437|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139394438|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139394439|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139394440|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394441|NCT02183701|Diuretics|diuretics|mesh-ancestor
139394442|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
139394443|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394444|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139394445|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139394446|NCT02183779|Fluconazole|fluconazole|mesh-list
139394447|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
139394448|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394449|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139394450|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139394451|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394452|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394453|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139394454|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
139394455|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394456|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394457|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139394458|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139394459|NCT02184091|Nevirapine|nevirapine|mesh-list
139394460|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139394461|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139394462|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394463|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394464|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
139394465|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394466|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139394467|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139394468|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139394469|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139394470|NCT02184247|Theophylline|theophylline|mesh-list
139394471|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139394472|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
139394473|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394474|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394475|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139394476|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
139394477|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139394478|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394479|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394480|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
139648153|NCT00332605|Antidotes|antidotes|mesh-ancestor
139648154|NCT01458743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139648155|NCT01458743|Cephalosporins|cephalosporins|mesh-list
139648156|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139648157|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648158|NCT01415583|Dexamethasone|dexamethasone|mesh-list
139648159|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139648160|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
139648161|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
139648162|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648163|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648164|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139394481|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139394482|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139394483|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
139394484|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139394486|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139394487|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139394488|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139394489|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394490|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
139394491|NCT04292756|Hormones|hormones|mesh-ancestor
139394492|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394493|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394494|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139394495|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
139394496|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394497|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394498|NCT05074706|Antibodies|antibodies|mesh-list
139394499|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
139394500|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
139394501|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720641|NCT00556127|Cytarabine|cytarabine|mesh-list
139394502|NCT02181205|Bupivacaine|bupivacaine|mesh-list
139394503|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
139394504|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
139394505|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139394506|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394507|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
139394508|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394509|NCT02184559|Ropivacaine|ropivacaine|mesh-list
139394510|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
139394511|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
139394512|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139394513|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394514|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
139394515|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394516|NCT02185651|Miglustat|miglustat|mesh-list
139394517|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394518|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394519|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139394520|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139394521|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
139394522|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394523|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139394524|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139394525|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394526|NCT02181361|Aspirin|aspirin|mesh-list
139394527|NCT02181361|Hirudins|hirudins|mesh-list
139394528|NCT02181361|Warfarin|warfarin|mesh-list
139394529|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138720687|NCT00556205|Bevacizumab|bevacizumab|mesh-list
139394530|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139394531|NCT02181361|Analgesics|analgesics|mesh-ancestor
139394532|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
139394533|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394534|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394535|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394536|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139394537|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139394538|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139394539|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394540|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139394541|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139394542|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394543|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
139394544|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
139394545|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
139394546|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139394547|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
139648165|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
139648166|NCT01415583|Hormones|hormones|mesh-ancestor
139648167|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394548|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
139394549|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
139394550|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394551|NCT02184637|Lumefantrine|lumefantrine|mesh-list
139394552|NCT02184637|Artemether|artemether|mesh-list
139394553|NCT02184637|Piperaquine|piperaquine|mesh-list
139648168|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139648169|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394554|NCT02184637|Artenimol|artenimol|mesh-list
139394555|NCT02184637|Tafenoquine|tafenoquine|mesh-list
139394556|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139394557|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
139394558|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139394559|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139394560|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394561|NCT04870424|Colchicine|colchicine|mesh-list
139394562|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
139394563|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139394564|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
139394565|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
139394566|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
139394567|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394568|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394569|NCT03536845|Vitamin D|vitamin d|mesh-list
139394570|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
139394571|NCT03536845|Vitamins|vitamins|mesh-ancestor
139394572|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
139394573|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394574|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139394575|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139394576|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139394577|NCT02181985|Heparin|heparin|mesh-list
139394578|NCT02181985|Enoxaparin|enoxaparin|mesh-list
139051383|NCT00467831|Zileuton|zileuton|mesh-list
139394579|NCT02181985|Tenecteplase|tenecteplase|mesh-list
139394580|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139394581|NCT02181985|Abciximab|abciximab|mesh-list
139394582|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
139394583|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139394584|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139394585|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394586|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139394587|NCT05514080|Insulin|insulin|mesh-list
139394588|NCT05514080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139394589|NCT05514080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394590|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139394591|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139394592|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139394593|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
139394594|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394595|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139394596|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139394597|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394598|NCT02186119|Ranibizumab|ranibizumab|mesh-list
139394599|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139394600|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139394601|NCT02186119|Growth Substances|growth substances|mesh-ancestor
139394602|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394603|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
139394604|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394605|NCT02185261|Interferons|interferons|mesh-list
139394606|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
139394607|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
139394608|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394609|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
139394610|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394611|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
139394612|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394613|NCT02573012|Prednisone|prednisone|mesh-list
139394614|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139648170|NCT01458977|Tenofovir|tenofovir|mesh-list
139648171|NCT01458977|Emtricitabine|emtricitabine|mesh-list
139648172|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139648173|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
139394615|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
139648174|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648175|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139648176|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139394616|NCT02573012|Hormones|hormones|mesh-ancestor
139394617|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394618|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394619|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139394620|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394621|NCT04128176|Omalizumab|omalizumab|mesh-list
139394622|NCT04128176|Rituximab|rituximab|mesh-list
139394623|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139394624|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394625|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
139394626|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394627|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139394628|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139394629|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139394630|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
139394631|NCT02186275|Vitamin D|vitamin d|mesh-list
139394632|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
139394633|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
139394634|NCT02186275|Vitamins|vitamins|mesh-list
139394635|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
139394636|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394637|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139394638|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139394639|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
139394640|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
139394641|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
139394642|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139394643|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394644|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
139394645|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394646|NCT05519072|Ciprofloxacin|ciprofloxacin|mesh-list
138720906|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
139394647|NCT05519072|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139394648|NCT05519072|Cephalexin|cephalexin|mesh-list
139394649|NCT05519072|Fosfomycin|fosfomycin|mesh-list
139394650|NCT05519072|Nitrofurantoin|nitrofurantoin|mesh-list
139394651|NCT05519072|Trimethoprim|trimethoprim|mesh-list
139394652|NCT05519072|Sulfamethoxazole|sulfamethoxazole|mesh-list
139394653|NCT05519072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139394654|NCT05519072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394655|NCT05519072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139394656|NCT05519072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139394657|NCT05519072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394658|NCT05519072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394659|NCT05519072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394660|NCT05519072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139394661|NCT05519072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139394662|NCT05519072|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139648177|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648178|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648179|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139648180|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139648181|NCT02508311|Albuterol|albuterol|mesh-list
139648182|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139648183|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
139648184|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648185|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648186|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139648187|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
139648188|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
139648189|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139648190|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139648191|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139648192|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139648193|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
139648194|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648195|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648196|NCT00256399|Alfuzosin|alfuzosin|mesh-list
139648197|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139648198|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139648199|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139648200|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
139648201|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648202|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648203|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648204|NCT00256399|Urological Agents|urological agents|mesh-ancestor
139394663|NCT05519072|Antimalarials|antimalarials|mesh-ancestor
139394664|NCT05519072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139648205|NCT01459133|Insulin|insulin|mesh-list
139394665|NCT05519072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139648206|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139648207|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648208|NCT01459211|Dexamethasone|dexamethasone|mesh-list
139648209|NCT01459211|Lenalidomide|lenalidomide|mesh-list
139648210|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139648211|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
139648212|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
139648213|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648214|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648215|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139648216|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
139648217|NCT01459211|Hormones|hormones|mesh-ancestor
139648218|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139648219|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139394666|NCT05519072|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139394667|NCT05519072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139394668|NCT05519072|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139394669|NCT05519072|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139394670|NCT04411706|Capecitabine|capecitabine|mesh-list
139394671|NCT04411706|Apatinib|apatinib|mesh-list
139394672|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139394673|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
139394674|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394675|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394676|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139394677|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394678|NCT05518994|Bevacizumab|bevacizumab|mesh-list
139394679|NCT05518994|Tislelizumab|tislelizumab|mesh-list
139394680|NCT05518994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139394681|NCT05518994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394682|NCT05518994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139394683|NCT05518994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139394684|NCT05518994|Growth Substances|growth substances|mesh-ancestor
139394685|NCT05518994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394686|NCT05518994|Growth Inhibitors|growth inhibitors|mesh-ancestor
139394687|NCT02256943|Amitriptyline|amitriptyline|mesh-list
139394688|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139394689|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139394690|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
139394691|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139394692|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139394693|NCT02256943|Analgesics|analgesics|mesh-ancestor
139394694|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
139394695|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394696|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394697|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139394698|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139394699|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139394700|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394701|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
139394702|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139394703|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139394704|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139394705|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
139394706|NCT02256943|Urological Agents|urological agents|mesh-ancestor
139648220|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648221|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
139648222|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139648223|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139648224|NCT01459211|Growth Substances|growth substances|mesh-ancestor
139648225|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
139648226|NCT00198991|Cytarabine|cytarabine|mesh-list
139648227|NCT00198991|Dexamethasone|dexamethasone|mesh-list
139648228|NCT00198991|Prednisolone|prednisolone|mesh-list
139648229|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
139648230|NCT00198991|Methotrexate|methotrexate|mesh-list
139648231|NCT00198991|Fludarabine|fludarabine|mesh-list
139648232|NCT00198991|Etoposide|etoposide|mesh-list
139648233|NCT00198991|Etoposide phosphate|etoposide phosphate|mesh-list
139648234|NCT00198991|Vincristine|vincristine|mesh-list
139648235|NCT00198991|Doxorubicin|doxorubicin|mesh-list
139648236|NCT00198991|Daunorubicin|daunorubicin|mesh-list
139394707|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139136530|NCT03855267|Propofol|propofol|mesh-list
139648237|NCT00198991|Asparaginase|asparaginase|mesh-list
139648238|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
139648239|NCT00198991|Idarubicin|idarubicin|mesh-list
139394708|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648240|NCT00198991|Thioguanine|thioguanine|mesh-list
139648242|NCT00198991|Vindesine|vindesine|mesh-list
139648243|NCT00198991|Teniposide|teniposide|mesh-list
139394709|NCT05059951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139394710|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394711|NCT02186899|Anesthetics|anesthetics|mesh-list
139394712|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139394713|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394714|NCT05510024|Immunomodulating Agents|immunomodulating agents|mesh-list
139394715|NCT05510024|Immunologic Factors|immunologic factors|mesh-ancestor
139394716|NCT05510024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394717|NCT02752633|Allopurinol|allopurinol|mesh-list
139394718|NCT02752633|Febuxostat|febuxostat|mesh-list
139394719|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
139394720|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394721|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394722|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
139394723|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139394724|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139394725|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
139394726|NCT02752633|Protective Agents|protective agents|mesh-ancestor
139394727|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394728|NCT02191189|Nevirapine|nevirapine|mesh-list
139394729|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139394730|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139394731|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394732|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394733|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
139394734|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394735|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139394736|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139394737|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139394738|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139394740|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139394741|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139394742|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394743|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
139394744|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394745|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139394746|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139394747|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
139394748|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394749|NCT04411862|Choline|choline|mesh-list
139394750|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
139394751|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139394752|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
139394753|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394754|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139394755|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139394756|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
138721340|NCT04545801|Ketamine|ketamine|mesh-list
139394757|NCT02187211|Minocycline|minocycline|mesh-list
139394758|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139394759|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394760|NCT04766996|Aspirin|aspirin|mesh-list
139394761|NCT04766996|Acetaminophen|acetaminophen|mesh-list
139394762|NCT04766996|Prednisone|prednisone|mesh-list
139394763|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139394764|NCT04766996|Meloxicam|meloxicam|mesh-list
139394765|NCT04766996|Diclofenac|diclofenac|mesh-list
139394766|NCT04766996|Lidocaine|lidocaine|mesh-list
139394767|NCT04766996|Pregabalin|pregabalin|mesh-list
139394768|NCT04766996|Tramadol|tramadol|mesh-list
139394769|NCT04766996|Bupivacaine|bupivacaine|mesh-list
139394770|NCT04766996|Propofol|propofol|mesh-list
139394771|NCT04766996|Omeprazole|omeprazole|mesh-list
139394772|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
139394773|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
139394774|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
139394775|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139394776|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648244|NCT00198991|Pegaspargase|pegaspargase|mesh-list
139648245|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139394777|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
139394778|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394779|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139394780|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139394781|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139394782|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139394783|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394784|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394785|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
139394786|NCT04766996|Hormones|hormones|mesh-ancestor
139394787|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394788|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139394789|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394790|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139394791|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139394792|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
139394793|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139394794|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139394795|NCT04766996|Analgesics|analgesics|mesh-ancestor
139394796|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139394797|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139394798|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139394799|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139394800|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139394801|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394802|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
139394803|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139394804|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
139394805|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139394806|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139394807|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139394808|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139394809|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139394810|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139394812|NCT04766996|Coagulants|coagulants|mesh-ancestor
139394813|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139394814|NCT04766996|Narcotics|narcotics|mesh-ancestor
139394815|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139394816|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139394817|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139394818|NCT02191423|Oxytocin|oxytocin|mesh-list
139394819|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
139394820|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139394821|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394822|NCT05509946|Celecoxib|celecoxib|mesh-list
139394823|NCT05509946|Pregabalin|pregabalin|mesh-list
139394824|NCT05509946|Analgesics|analgesics|mesh-ancestor
139394825|NCT05509946|Sensory System Agents|sensory system agents|mesh-ancestor
139394826|NCT05509946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394827|NCT05509946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394828|NCT05509946|Anticonvulsants|anticonvulsants|mesh-ancestor
139394829|NCT05509946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139394830|NCT05509946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139394831|NCT05509946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394832|NCT05509946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139394833|NCT05509946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139394834|NCT05509946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139394835|NCT05509946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139394836|NCT05509946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139394837|NCT05509946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139394838|NCT05509946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139394839|NCT05509946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394840|NCT05509946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139394841|NCT05509946|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139394842|NCT05509946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139394843|NCT05509946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394844|NCT04304209|Capecitabine|capecitabine|mesh-list
139394845|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
139394846|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139394847|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
139394848|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394849|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394850|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
139136567|NCT01180179|Lansoprazole|lansoprazole|mesh-list
139648246|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
139648247|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648248|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139648249|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139648250|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
139394851|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139394852|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
138721456|NCT01124617|Tapentadol|tapentadol|mesh-list
139394853|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394854|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139394855|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139394856|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
139394857|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394858|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394859|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139394861|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394862|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139394863|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
139394864|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394865|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394866|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139394867|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
139394868|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
139394869|NCT02187445|Hormones|hormones|mesh-ancestor
139394870|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394871|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139394872|NCT02187523|Telmisartan|telmisartan|mesh-list
139394873|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139394874|NCT02187523|Diuretics|diuretics|mesh-ancestor
139394875|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
139394876|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394877|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139394878|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139394879|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394880|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139394881|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139394882|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139394883|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139394884|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139394885|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139394886|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394888|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139394889|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394890|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139394891|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394892|NCT05507606|Bevacizumab|bevacizumab|mesh-list
139394893|NCT05507606|Carboplatin|carboplatin|mesh-list
139394894|NCT05507606|Pemetrexed|pemetrexed|mesh-list
139394895|NCT05507606|Osimertinib|osimertinib|mesh-list
139394896|NCT05507606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139394897|NCT05507606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394898|NCT05507606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139394899|NCT05507606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139394900|NCT05507606|Growth Substances|growth substances|mesh-ancestor
139394901|NCT05507606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394902|NCT05507606|Growth Inhibitors|growth inhibitors|mesh-ancestor
139394903|NCT05507606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394904|NCT05507606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394905|NCT05507606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139394906|NCT05507606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139394907|NCT05507606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139394908|NCT02191657|Deferiprone|deferiprone|mesh-list
139394909|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139394910|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
139648251|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648252|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648253|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139648254|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139648255|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
139648256|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
139648257|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648258|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139648259|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
139648260|NCT00198991|Hormones|hormones|mesh-ancestor
139648261|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139648262|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139648263|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139648264|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
139648265|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139648266|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139648267|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
139648268|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
139648269|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648270|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139648271|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139648272|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139648273|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139648274|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139648275|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
139648276|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648277|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
139648278|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
139648279|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
139648280|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139648281|NCT01459367|Lansoprazole|lansoprazole|mesh-list
139648282|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
139648283|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139648284|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139648285|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139648286|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648287|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648288|NCT04777591|Bupivacaine|bupivacaine|mesh-list
139648289|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
139648290|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
139648291|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139648292|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648293|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
139648294|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648295|NCT01459601|Cabergoline|cabergoline|mesh-list
139648296|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139648297|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139648298|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
139394911|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
139394912|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394913|NCT02191891|Afatinib|afatinib|mesh-list
139394914|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721751|NCT04557137|Somatostatin|somatostatin|mesh-list
139394915|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139394916|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394917|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394918|NCT05507372|Pimozide|pimozide|mesh-list
139394919|NCT05507372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139394920|NCT05507372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139394921|NCT05507372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139394922|NCT05507372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394923|NCT05507372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139394924|NCT05507372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139394925|NCT05507372|Dopamine Agents|dopamine agents|mesh-ancestor
139394926|NCT05507372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139394927|NCT05507372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394928|NCT05507372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139394929|NCT02192203|Diclofenac|diclofenac|mesh-list
139394930|NCT02192203|Menthol|menthol|mesh-list
139394931|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139394932|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139394933|NCT02192203|Analgesics|analgesics|mesh-ancestor
139394934|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
139394935|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394936|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648299|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
139648300|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648301|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648302|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648303|NCT01418001|Gemcitabine|gemcitabine|mesh-list
139648304|NCT01418001|Docetaxel|docetaxel|mesh-list
139648305|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139648306|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
139648307|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648308|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139394937|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139648309|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
139394938|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139648310|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
139394939|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139394940|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394941|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394942|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
139394943|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
139394944|NCT02257021|Ritonavir|ritonavir|mesh-list
139394945|NCT02257021|Tipranavir|tipranavir|mesh-list
139648311|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
139394946|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139394947|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139394948|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
139394949|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394950|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394951|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139394952|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139394953|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
139394954|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139394955|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139394956|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139394957|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
139394958|NCT03536065|Narcotics|narcotics|mesh-ancestor
139394959|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139394960|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394962|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
139394963|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394964|NCT02192827|Dexamethasone|dexamethasone|mesh-list
139394965|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
139394966|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139394967|NCT02192827|BB 1101|bb 1101|mesh-list
139394968|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139394969|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
139394970|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
139394971|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139394972|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394973|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139394974|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
139394975|NCT02192827|Hormones|hormones|mesh-ancestor
139394976|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139394977|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139394978|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721857|NCT04542213|Hormones|hormones|mesh-ancestor
139394979|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
139394980|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394981|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394982|NCT02188225|Fluoxetine|fluoxetine|mesh-list
139394983|NCT02188225|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139394984|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139394985|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139394986|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139394987|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139394988|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
139394989|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139394990|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139394991|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
139394992|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139394993|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139394994|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139394995|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139394996|NCT04535089|Lidocaine|lidocaine|mesh-list
139394997|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
139394998|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
139394999|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
139395000|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139395001|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648312|NCT00394147|Gemcitabine|gemcitabine|mesh-list
139648313|NCT00394147|Pemetrexed|pemetrexed|mesh-list
139648314|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139648315|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
139648316|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648317|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648318|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648319|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139648320|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139648321|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139648322|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139395002|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
139648323|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139395003|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395004|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139395005|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139395006|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139395007|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139395008|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395009|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139395010|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139395011|NCT04535089|Analgesics|analgesics|mesh-ancestor
139395012|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139395013|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139395014|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139395015|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
139395016|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139395017|NCT02188537|Nelfinavir|nelfinavir|mesh-list
139395018|NCT02188537|Dexamethasone|dexamethasone|mesh-list
139395019|NCT02188537|Bortezomib|bortezomib|mesh-list
139395020|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139395021|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
139395022|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
139395023|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395024|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395025|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139395026|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
139395027|NCT02188537|Hormones|hormones|mesh-ancestor
139395028|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139395029|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139395030|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395031|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139395032|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139395033|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
139395034|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395035|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395036|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139395037|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139395038|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
139395039|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395040|NCT03535051|Tacrolimus|tacrolimus|mesh-list
139395041|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139395042|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
139395043|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395044|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139395045|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395046|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395047|NCT02188615|Vinorelbine|vinorelbine|mesh-list
139395048|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395049|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139395050|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
139395051|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
139395052|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
139395053|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395054|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
139395055|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139395056|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
139395057|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395058|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
139395059|NCT02188771|Protective Agents|protective agents|mesh-ancestor
139395060|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
139395061|NCT02194075|Methylphenidate|methylphenidate|mesh-list
139395062|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139395063|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395064|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139395065|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139648324|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
139648325|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648326|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139648327|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139648328|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648329|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
139395066|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139648330|NCT01542255|Dacarbazine|dacarbazine|mesh-list
139648331|NCT01542255|Vinblastine|vinblastine|mesh-list
139395067|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648333|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
139648334|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395068|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
139395069|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139395070|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139395071|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139395072|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139395073|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139395074|NCT02194075|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139395075|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
139395076|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139395077|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
139395078|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139395079|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139395080|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395081|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139395082|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139395083|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139395084|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395085|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139395086|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
139395087|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395088|NCT03534973|Caffeine|caffeine|mesh-list
139395089|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139395090|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395091|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139395092|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395093|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395094|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139395095|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139395096|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
139395097|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139395098|NCT03534895|Midazolam|midazolam|mesh-list
139395099|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
139395100|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139395101|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395102|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139051911|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
139395103|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139395104|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139395105|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139395106|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139395107|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139395108|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
139395109|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
139395110|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
139395111|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139395112|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395113|NCT03535753|Decitabine|decitabine|mesh-list
139395114|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139395115|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
139395116|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395117|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395118|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395119|NCT02189395|Insulin|insulin|mesh-list
139395120|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
139395121|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139395122|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139395123|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395124|NCT03535519|Methotrexate|methotrexate|mesh-list
139395125|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139395126|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
139395127|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139395128|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395129|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139395130|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
139395131|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395132|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395133|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
139648335|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139648336|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139395134|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395135|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139395136|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139395137|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
139395138|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139395139|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139395140|NCT02194153|Tenecteplase|tenecteplase|mesh-list
139395141|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139395142|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139395143|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395144|NCT02194231|Trabectedin|trabectedin|mesh-list
139395145|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139395146|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
139395147|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395148|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395149|NCT02933671|Ropivacaine|ropivacaine|mesh-list
139395150|NCT02933671|Anesthetics, Local|anesthetics, local|mesh-ancestor
139395151|NCT02933671|Anesthetics|anesthetics|mesh-ancestor
139395152|NCT02933671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139395153|NCT02933671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722220|NCT01120600|Vitamin D|vitamin d|mesh-list
139395154|NCT02933671|Sensory System Agents|sensory system agents|mesh-ancestor
139395155|NCT02933671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395156|NCT05509478|Lenvatinib|lenvatinib|mesh-list
139395157|NCT05509478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139395158|NCT05509478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395159|NCT05509478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139395160|NCT05509478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395161|NCT05509478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395162|NCT05509478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139395163|NCT02194309|Amlodipine|amlodipine|mesh-list
139395164|NCT02194309|Telmisartan|telmisartan|mesh-list
139395165|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139395166|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139395167|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139395168|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395169|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139395170|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395171|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
139395172|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139395173|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139395174|NCT04392505|Durvalumab|durvalumab|mesh-list
139395175|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052010|NCT00290498|Cytarabine|cytarabine|mesh-list
139395176|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395177|NCT05502458|Propofol|propofol|mesh-list
139395178|NCT05502458|Desflurane|desflurane|mesh-list
139395179|NCT05502458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139395180|NCT05502458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139395181|NCT05502458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395182|NCT05502458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139395183|NCT05502458|Anesthetics, General|anesthetics, general|mesh-ancestor
139395184|NCT05502458|Anesthetics|anesthetics|mesh-ancestor
139395185|NCT05502458|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139395186|NCT03534037|Febuxostat|febuxostat|mesh-list
139395187|NCT03534037|Benzbromarone|benzbromarone|mesh-list
139395188|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
139395189|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139395190|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
139395191|NCT03533959|Alirocumab|alirocumab|mesh-list
139395192|NCT03533959|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139648337|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
139648338|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648339|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648340|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138722351|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139648341|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139648342|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
139648343|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
139648344|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
139648345|NCT01456481|Midodrine|midodrine|mesh-list
139648346|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
139395193|NCT03533959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139395194|NCT03533959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139395195|NCT03533959|Antimetabolites|antimetabolites|mesh-ancestor
139136655|NCT01180413|Lercanidipine|lercanidipine|mesh-list
139648347|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
139648348|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648349|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648350|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139395196|NCT03533959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395197|NCT03533959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139395198|NCT03533959|Protease Inhibitors|protease inhibitors|mesh-ancestor
139395199|NCT03533959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395200|NCT03533959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139395201|NCT05502380|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139395202|NCT05502380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395203|NCT02567708|Nemiralisib|nemiralisib|mesh-list
139395204|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139395205|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395206|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395207|NCT05509244|Acetaminophen|acetaminophen|mesh-list
139395208|NCT05509244|Ibuprofen|ibuprofen|mesh-list
139395209|NCT05509244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139395210|NCT05509244|Analgesics|analgesics|mesh-ancestor
139395211|NCT05509244|Sensory System Agents|sensory system agents|mesh-ancestor
139395212|NCT05509244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395213|NCT05509244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395214|NCT05509244|Antipyretics|antipyretics|mesh-ancestor
139395215|NCT05509244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139395216|NCT05509244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139395217|NCT05509244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139395218|NCT05509244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139395219|NCT05509244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395220|NCT05509244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395221|NCT05502068|Vitamin D|vitamin d|mesh-list
139395222|NCT05502068|Vitamins|vitamins|mesh-ancestor
139395223|NCT05502068|Micronutrients|micronutrients|mesh-ancestor
139395224|NCT05502068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395225|NCT05502068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139395226|NCT02194777|Olcegepant|olcegepant|mesh-list
139395227|NCT02194777|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139395228|NCT02194777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395229|NCT02194777|Analgesics|analgesics|mesh-ancestor
139395230|NCT02194777|Sensory System Agents|sensory system agents|mesh-ancestor
139395231|NCT02194777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395232|NCT02194777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395233|NCT02030977|Resveratrol|resveratrol|mesh-list
139395234|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
139395235|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395236|NCT02030977|Protective Agents|protective agents|mesh-ancestor
139395237|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395238|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395239|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139395240|NCT02194855|Rocuronium|rocuronium|mesh-list
139395241|NCT02194855|Cisatracurium|cisatracurium|mesh-list
138722484|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139395242|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139395243|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139395244|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139395245|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395246|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395247|NCT03534661|Teduglutide|teduglutide|mesh-list
139395248|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
139395249|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395250|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052054|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
139395251|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139395252|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139395253|NCT03534661|Protective Agents|protective agents|mesh-ancestor
139395254|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648351|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139648352|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139648353|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139648354|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
139648355|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648356|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648357|NCT04776655|Leucovorin|leucovorin|mesh-list
139648358|NCT04776655|Bevacizumab|bevacizumab|mesh-list
139395255|NCT02562716|Paclitaxel|paclitaxel|mesh-list
139395256|NCT02562716|Camptothecin|camptothecin|mesh-list
139395257|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139395258|NCT02562716|Gemcitabine|gemcitabine|mesh-list
139395259|NCT02562716|Fluorouracil|fluorouracil|mesh-list
139395260|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
139395261|NCT02562716|Irinotecan|irinotecan|mesh-list
139395262|NCT02562716|Pancrelipase|pancrelipase|mesh-list
139395263|NCT02562716|Pancreatin|pancreatin|mesh-list
139395264|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139395265|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395266|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
139395267|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
139395268|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
139395269|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395270|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139395271|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
139395272|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139395273|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
139395274|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395275|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139395276|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139395277|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395278|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139395279|NCT02031211|Etanercept|etanercept|mesh-list
139395280|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139395281|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139395282|NCT02031211|Analgesics|analgesics|mesh-ancestor
139395283|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
139395284|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395285|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395286|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139395287|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139395288|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139395289|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139395290|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
139395291|NCT02195089|Vaccines|vaccines|mesh-list
139395292|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
139395293|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395294|NCT02031289|Folic Acid|folic acid|mesh-list
139395295|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
139395296|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
139395297|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
139395298|NCT02031289|Vitamins|vitamins|mesh-ancestor
139395299|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
139395300|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395301|NCT02031289|Hematinics|hematinics|mesh-ancestor
139395302|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
139395303|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
139395304|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139395305|NCT02197741|Narcotics|narcotics|mesh-ancestor
139395306|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139395307|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395308|NCT02197741|Analgesics|analgesics|mesh-ancestor
139395309|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
139395310|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395311|NCT02196493|Azithromycin|azithromycin|mesh-list
139395312|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139395313|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722689|NCT04552067|Enoxaparin|enoxaparin|mesh-list
139395314|NCT05506592|Dermatologic Agents|dermatologic agents|mesh-list
139395315|NCT03533803|Indomethacin|indomethacin|mesh-list
139395316|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139395317|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139395318|NCT03533803|Analgesics|analgesics|mesh-ancestor
139395319|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
139395320|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395321|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395322|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139395323|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139395324|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
139395325|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
139395326|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139395327|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139395328|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395329|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648360|NCT04776655|Fluorouracil|fluorouracil|mesh-list
139648361|NCT04776655|Irinotecan|irinotecan|mesh-list
139648362|NCT04776655|Calcium|calcium|mesh-list
139395330|NCT02198209|Liraglutide|liraglutide|mesh-list
139395331|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139395332|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648363|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
139648364|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139395333|NCT02198209|Incretins|incretins|mesh-ancestor
139395334|NCT02198209|Hormones|hormones|mesh-ancestor
139395335|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139395336|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139395337|NCT02195557|Hylan|hylan|mesh-list
139395338|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
139395339|NCT02195557|Protective Agents|protective agents|mesh-ancestor
139395340|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395341|NCT02195635|Octreotide|octreotide|mesh-list
139395342|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139395343|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139395344|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395345|NCT03534505|Ketorolac|ketorolac|mesh-list
139395346|NCT03534505|Bupivacaine|bupivacaine|mesh-list
139395347|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
139395348|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
139395349|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139395350|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395351|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
139395352|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395353|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139395354|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139395355|NCT03534505|Analgesics|analgesics|mesh-ancestor
139395356|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139395357|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139395358|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139395359|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395360|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395361|NCT02195791|Pioglitazone|pioglitazone|mesh-list
139395362|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139395363|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395364|NCT02196805|Probucol|probucol|mesh-list
139395365|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139395366|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139395367|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
139395368|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395369|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139395370|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
139395371|NCT02196805|Protective Agents|protective agents|mesh-ancestor
139395372|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395373|NCT02198443|Ritonavir|ritonavir|mesh-list
139395374|NCT02198443|Lopinavir|lopinavir|mesh-list
139395375|NCT02198443|Tenofovir|tenofovir|mesh-list
139395376|NCT02198443|Emtricitabine|emtricitabine|mesh-list
139395377|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139395378|NCT02198443|Cobicistat|cobicistat|mesh-list
139395379|NCT02198443|Elvitegravir|elvitegravir|mesh-list
139395380|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139395381|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139395382|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
139395383|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395384|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395385|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139395386|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139395387|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
139395388|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395389|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139395390|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139395391|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139395392|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139395393|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139395394|NCT03533179|Glucagon|glucagon|mesh-list
139395395|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139395396|NCT03533179|Esmolol|esmolol|mesh-list
139395397|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139395398|NCT03533179|Hormones|hormones|mesh-ancestor
139395399|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139395400|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395401|NCT03533179|Incretins|incretins|mesh-ancestor
139395402|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139395403|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139648365|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395404|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139395405|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
139395406|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139395407|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395408|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139395409|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
139395410|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395412|NCT05261971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139395413|NCT05261971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139395414|NCT05261971|Analgesics|analgesics|mesh-ancestor
139395415|NCT05261971|Sensory System Agents|sensory system agents|mesh-ancestor
139395416|NCT05261971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395417|NCT05261971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395418|NCT05261971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139395419|NCT05261971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139395420|NCT05261971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139395421|NCT05261971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139395422|NCT05261971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395423|NCT05261971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395424|NCT02201563|Minocycline|minocycline|mesh-list
139395425|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139395426|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395427|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139395428|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138723014|NCT01181986|Exenatide|exenatide|mesh-list
139395429|NCT02206477|Protective Agents|protective agents|mesh-ancestor
139395430|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395431|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139395432|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
139395433|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395434|NCT02201641|Calcium|calcium|mesh-list
139395435|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139395436|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395437|NCT02206555|Tenofovir|tenofovir|mesh-list
139395438|NCT02206555|Emtricitabine|emtricitabine|mesh-list
139395439|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138723045|NCT04548557|Antibodies|antibodies|mesh-list
139395440|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
139395441|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395442|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139395443|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139395444|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395445|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395446|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139395447|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139395448|NCT02206711|BMS-955176|bms-955176|mesh-list
139395449|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139395450|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139395451|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
139395452|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395453|NCT02202187|Gepotidacin|gepotidacin|mesh-list
139395454|NCT02202187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139395455|NCT02202187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395456|NCT02202187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395457|NCT02202187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395458|NCT02206789|Cyclosporine|cyclosporine|mesh-list
139395459|NCT02206789|Prednisolone|prednisolone|mesh-list
139395460|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139395461|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
139648366|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139648367|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139648368|NCT04776655|Growth Substances|growth substances|mesh-ancestor
139648369|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648370|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
139648371|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139648372|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
139648373|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648374|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139648375|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139648376|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
139648377|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139648378|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139648379|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648380|NCT04776655|Antidotes|antidotes|mesh-ancestor
139648381|NCT04776655|Protective Agents|protective agents|mesh-ancestor
139648382|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
139395462|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139136698|NCT02524899|Guanfacine|guanfacine|mesh-list
139395463|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
139395464|NCT02206789|Cyclosporins|cyclosporins|mesh-list
139395465|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139395466|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
139395467|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395468|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395469|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139395470|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
139395471|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395472|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
139395473|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395474|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
139395475|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139395476|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139395477|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139395478|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
139395479|NCT02206789|Hormones|hormones|mesh-ancestor
139395480|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139395481|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139395482|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395483|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
139395484|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
139395485|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395486|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139395487|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139395488|NCT02206789|Protective Agents|protective agents|mesh-ancestor
139395489|NCT03892369|Ethanol|ethanol|mesh-list
139395490|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139395491|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395492|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139395493|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395494|NCT02206867|Adalimumab|adalimumab|mesh-list
139395495|NCT02206867|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139395496|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139395497|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139395498|NCT02751931|Mirabegron|mirabegron|mesh-list
139395499|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138723207|NCT04546256|Xhance|xhance|mesh-list
139395500|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139395501|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139395502|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
139395503|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139395504|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395505|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395506|NCT02751931|Urological Agents|urological agents|mesh-ancestor
139395507|NCT05261581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139395508|NCT05261581|Analgesics|analgesics|mesh-list
139395509|NCT05261581|Sensory System Agents|sensory system agents|mesh-ancestor
139395510|NCT05261581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395511|NCT05261581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395512|NCT02199223|Panitumumab|panitumumab|mesh-list
139395513|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139395514|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395515|NCT02207335|Carboplatin|carboplatin|mesh-list
139395516|NCT02207335|Gemcitabine|gemcitabine|mesh-list
139395517|NCT02207335|Capecitabine|capecitabine|mesh-list
139395518|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395519|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139395520|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
139395521|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395522|NCT02561078|Insulin|insulin|mesh-list
139395523|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139395524|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139395525|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395526|NCT02202889|Calcium|calcium|mesh-list
139395527|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139395528|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648384|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
139648385|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
139648386|NCT01455233|Besifloxacin|besifloxacin|mesh-list
139648387|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139648388|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139395529|NCT04058197|Deferoxamine|deferoxamine|mesh-list
139648389|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139395530|NCT04058197|Siderophores|siderophores|mesh-ancestor
139395531|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139395541|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139395542|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
139395554|NCT05977647|Tamsulosin|tamsulosin|mesh-list
139395556|NCT05977647|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139395557|NCT05977647|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139395558|NCT05977647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139395559|NCT05977647|Adrenergic Agents|adrenergic agents|mesh-ancestor
139395560|NCT05977647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139395561|NCT05977647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395562|NCT05977647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395563|NCT05977647|Urological Agents|urological agents|mesh-ancestor
139395564|NCT05977400|Gentamicins|gentamicins|mesh-list
139395565|NCT05977400|Ampicillin|ampicillin|mesh-list
139395566|NCT05977400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139395567|NCT05977400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395568|NCT05977400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139395569|NCT05977400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395570|NCT05977400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395571|NCT05977101|Antibodies|antibodies|mesh-list
139395572|NCT05977101|Immunoglobulins|immunoglobulins|mesh-list
139395573|NCT05977101|Antibodies, Blocking|antibodies, blocking|mesh-list
139395574|NCT05977101|Immunologic Factors|immunologic factors|mesh-ancestor
139395575|NCT05977101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395576|NCT05976932|Doxorubicin|doxorubicin|mesh-list
139395577|NCT05976932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139395578|NCT05976932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139395579|NCT05976932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395580|NCT05976932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139395581|NCT05976932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139395582|NCT05976932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395583|NCT05976932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395584|NCT05976893|Evolocumab|evolocumab|mesh-list
139395585|NCT05976893|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139395586|NCT05976893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139395587|NCT05976893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139395588|NCT05976893|Antimetabolites|antimetabolites|mesh-ancestor
139395589|NCT05976893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395590|NCT05976893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139395591|NCT05976893|Protease Inhibitors|protease inhibitors|mesh-ancestor
139395592|NCT05976893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395593|NCT05976893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139395594|NCT05976802|Budesonide|budesonide|mesh-list
139395595|NCT05976802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139395596|NCT05976802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139648392|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139648393|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139648394|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395597|NCT05976802|Autonomic Agents|autonomic agents|mesh-ancestor
139648395|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395598|NCT05976802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395599|NCT05976802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395600|NCT05976802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139395601|NCT05976802|Respiratory System Agents|respiratory system agents|mesh-ancestor
139395602|NCT05976802|Glucocorticoids|glucocorticoids|mesh-ancestor
139395603|NCT05976802|Hormones|hormones|mesh-ancestor
139395604|NCT05976802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139395605|NCT05976737|Levodopa|levodopa|mesh-list
139395606|NCT05976737|Carbidopa|carbidopa|mesh-list
139395607|NCT05976737|Entacapone|entacapone|mesh-list
139395608|NCT05976737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139395609|NCT05976737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139395610|NCT05976737|Dopamine Agents|dopamine agents|mesh-ancestor
139395611|NCT05976737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139395612|NCT05976737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395613|NCT05976737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395614|NCT05976737|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139395615|NCT05976737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395616|NCT05976737|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139395617|NCT05976698|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139395618|NCT05976698|Hallucinogens|hallucinogens|mesh-ancestor
139395619|NCT05976698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395620|NCT05976698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139395621|NCT05976698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139395622|NCT05976698|Serotonin Agents|serotonin agents|mesh-ancestor
139395623|NCT05976698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139395624|NCT05976698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395625|NCT05976698|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139395626|NCT05976568|Bevacizumab|bevacizumab|mesh-list
139395627|NCT05976568|Capecitabine|capecitabine|mesh-list
139395628|NCT05976568|Oxaliplatin|oxaliplatin|mesh-list
139395629|NCT05976568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138723499|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
139395630|NCT05976568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395631|NCT05976568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139395632|NCT05976568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139395633|NCT05976568|Growth Substances|growth substances|mesh-ancestor
139395634|NCT05976568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395635|NCT05976568|Growth Inhibitors|growth inhibitors|mesh-ancestor
139395636|NCT05976568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139395637|NCT05976568|Antimetabolites|antimetabolites|mesh-ancestor
139395638|NCT05976568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395639|NCT05976438|Amlodipine|amlodipine|mesh-list
139395640|NCT05976438|Chlorthalidone|chlorthalidone|mesh-list
139395641|NCT05976438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139395642|NCT05976438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139395643|NCT05976438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139395644|NCT05976438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395645|NCT05976438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139395646|NCT05976438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395647|NCT05976438|Vasodilator Agents|vasodilator agents|mesh-ancestor
139395648|NCT05976438|Diuretics|diuretics|mesh-ancestor
139395649|NCT05976438|Natriuretic Agents|natriuretic agents|mesh-ancestor
139395650|NCT05976438|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139395651|NCT05976360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139395652|NCT05976360|Immunologic Factors|immunologic factors|mesh-ancestor
139395653|NCT05976360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395654|NCT05976152|3-n-butylphthalide|3-n-butylphthalide|mesh-list
139395655|NCT05976152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139395656|NCT05976152|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139395657|NCT05976152|Protective Agents|protective agents|mesh-ancestor
139395658|NCT05976152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395659|NCT05976126|Trace Elements|trace elements|mesh-list
139395660|NCT05976126|Micronutrients|micronutrients|mesh-list
139395661|NCT05976126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395662|NCT05975996|Cyclophosphamide|cyclophosphamide|mesh-list
139395663|NCT05975996|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139395664|NCT05975996|Immunologic Factors|immunologic factors|mesh-ancestor
139395665|NCT05975996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395666|NCT05975996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139395667|NCT05975996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139395668|NCT05975996|Alkylating Agents|alkylating agents|mesh-ancestor
139648396|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648397|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139648398|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
139648399|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139648400|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648401|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139648402|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139395669|NCT05975996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395670|NCT05975996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395671|NCT05975996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139395672|NCT05975944|Olaparib|olaparib|mesh-list
139395673|NCT05975944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139395674|NCT05975944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395675|NCT05975944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395676|NCT05975944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395677|NCT05975879|Vitamin D|vitamin d|mesh-list
139395678|NCT05975879|Cholecalciferol|cholecalciferol|mesh-list
139395679|NCT05975879|Vitamins|vitamins|mesh-list
139395680|NCT05975879|Dimethyl sulfone|dimethyl sulfone|mesh-list
139395681|NCT05975879|Micronutrients|micronutrients|mesh-ancestor
139395682|NCT05975879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395683|NCT05975879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139395684|NCT05975879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139395685|NCT05975879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139395686|NCT05975866|Curcumin|curcumin|mesh-list
139395687|NCT05975866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139395688|NCT05975866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139395689|NCT05975866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139395690|NCT05975866|Analgesics|analgesics|mesh-ancestor
139395691|NCT05975866|Sensory System Agents|sensory system agents|mesh-ancestor
139395692|NCT05975866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395693|NCT05975866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395694|NCT05975866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139395695|NCT05975866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395696|NCT05975866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395697|NCT05975866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395698|NCT05975528|Glimepiride|glimepiride|mesh-list
139395699|NCT05975528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139395700|NCT05975528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138723727|NCT01682772|Olaparib|olaparib|mesh-list
139395701|NCT05975528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139395702|NCT05975528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395703|NCT05975528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139395704|NCT05975528|Immunologic Factors|immunologic factors|mesh-ancestor
139395705|NCT05975528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395706|NCT05974124|Chlorhexidine|chlorhexidine|mesh-list
139395707|NCT05974124|Povidone-Iodine|povidone-iodine|mesh-list
139395708|NCT05974124|Povidone|povidone|mesh-list
139395709|NCT05974124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139395710|NCT05974124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395711|NCT05974124|Disinfectants|disinfectants|mesh-ancestor
139395712|NCT05974124|Plasma Substitutes|plasma substitutes|mesh-ancestor
139395713|NCT05974124|Blood Substitutes|blood substitutes|mesh-ancestor
139395714|NCT05969054|Lacosamide|lacosamide|mesh-list
139395715|NCT05969054|Levetiracetam|levetiracetam|mesh-list
139395716|NCT05969054|Anticonvulsants|anticonvulsants|mesh-ancestor
139395717|NCT05969054|Nootropic Agents|nootropic agents|mesh-ancestor
139395718|NCT05969054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139395719|NCT05969054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138723781|NCT02279628|Analgesics|analgesics|mesh-ancestor
139395720|NCT05969054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139395721|NCT05969054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395722|NCT05957107|Antibodies|antibodies|mesh-list
139395723|NCT05957107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139395724|NCT05957107|Immunologic Factors|immunologic factors|mesh-ancestor
139395725|NCT05957107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395726|NCT05866536|BCG Vaccine|bcg vaccine|mesh-list
139395727|NCT05866536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139395728|NCT05866536|Immunologic Factors|immunologic factors|mesh-ancestor
139395729|NCT05866536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395730|NCT05790525|Bismuth|bismuth|mesh-list
139395731|NCT05790525|Antacids|antacids|mesh-ancestor
139395732|NCT05790525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395733|NCT05790525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139395734|NCT05751668|Paclitaxel|paclitaxel|mesh-list
139395735|NCT05751668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139395736|NCT05751668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395737|NCT05751668|Tubulin Modulators|tubulin modulators|mesh-ancestor
139395738|NCT05751668|Antimitotic Agents|antimitotic agents|mesh-ancestor
139648403|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139648404|NCT01459679|Riboflavin|riboflavin|mesh-list
139648405|NCT01459679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139395739|NCT05751668|Mitosis Modulators|mitosis modulators|mesh-ancestor
139136722|NCT03854175|Estrogens|estrogens|mesh-ancestor
139395740|NCT05751668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648406|NCT01459679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139648407|NCT01459679|Vitamin B Complex|vitamin b complex|mesh-ancestor
139395741|NCT05667285|Sirolimus|sirolimus|mesh-list
139395742|NCT05667285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139395743|NCT05667285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395744|NCT05667285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139395745|NCT05667285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395746|NCT05667285|Antifungal Agents|antifungal agents|mesh-ancestor
139395747|NCT05667285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139395748|NCT05667285|Immunologic Factors|immunologic factors|mesh-ancestor
139395749|NCT05667285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395750|NCT05642780|Pembrolizumab|pembrolizumab|mesh-list
139395751|NCT05642780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139395752|NCT05642780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395753|NCT05642780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139395754|NCT05642780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395755|NCT05627635|Calcium, Dietary|calcium, dietary|mesh-list
139395756|NCT05627635|Leucovorin|leucovorin|mesh-list
139395757|NCT05627635|Folic Acid|folic acid|mesh-list
139395758|NCT05627635|Bevacizumab|bevacizumab|mesh-list
139395759|NCT05627635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139395760|NCT05627635|Fluorouracil|fluorouracil|mesh-list
139395761|NCT05627635|Oxaliplatin|oxaliplatin|mesh-list
139395762|NCT05627635|Endothelial Growth Factors|endothelial growth factors|mesh-list
139395763|NCT05627635|Antibodies|antibodies|mesh-list
139395764|NCT05627635|Immunoglobulins|immunoglobulins|mesh-list
139395765|NCT05627635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139395766|NCT05627635|Immunoglobulin G|immunoglobulin g|mesh-list
139395767|NCT05627635|Calcium|calcium|mesh-list
139395768|NCT05627635|Levoleucovorin|levoleucovorin|mesh-list
139395769|NCT05627635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395770|NCT05627635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139395771|NCT05627635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139395772|NCT05627635|Growth Substances|growth substances|mesh-ancestor
139395773|NCT05627635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395774|NCT05627635|Growth Inhibitors|growth inhibitors|mesh-ancestor
139395775|NCT05627635|Immunologic Factors|immunologic factors|mesh-ancestor
139395776|NCT05627635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139395777|NCT05627635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139395778|NCT05627635|Antimetabolites|antimetabolites|mesh-ancestor
139395779|NCT05627635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395780|NCT05627635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139395781|NCT05627635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139395782|NCT05627635|Antidotes|antidotes|mesh-ancestor
139395783|NCT05627635|Protective Agents|protective agents|mesh-ancestor
139395784|NCT05627635|Vitamin B Complex|vitamin b complex|mesh-ancestor
139395785|NCT05627635|Vitamins|vitamins|mesh-ancestor
139395786|NCT05627635|Micronutrients|micronutrients|mesh-ancestor
139395787|NCT05627635|Hematinics|hematinics|mesh-ancestor
139395788|NCT05590598|Azelastine|azelastine|mesh-list
139395789|NCT05590598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139395790|NCT05590598|Autonomic Agents|autonomic agents|mesh-ancestor
139395791|NCT05590598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395792|NCT05590598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395793|NCT05590598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139395794|NCT05590598|Respiratory System Agents|respiratory system agents|mesh-ancestor
139395795|NCT05590598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139395796|NCT05590598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395797|NCT05590598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395798|NCT05590598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139395799|NCT05590598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139395800|NCT05590598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139395801|NCT05590598|Histamine Antagonists|histamine antagonists|mesh-ancestor
139395802|NCT05590598|Histamine Agents|histamine agents|mesh-ancestor
139395803|NCT05590598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139395804|NCT05507775|Digoxin|digoxin|mesh-list
139395805|NCT05507775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139395806|NCT05507775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139395807|NCT05507775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648408|NCT01459679|Vitamins|vitamins|mesh-ancestor
139648409|NCT01459679|Micronutrients|micronutrients|mesh-ancestor
139395808|NCT05507775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395809|NCT05507775|Protective Agents|protective agents|mesh-ancestor
139395810|NCT05507775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395811|NCT05503797|Cobicistat|cobicistat|mesh-list
139648410|NCT01459679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395812|NCT05503797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139648411|NCT01459679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139395813|NCT05503797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139395814|NCT05503797|Antiviral Agents|antiviral agents|mesh-ancestor
139395815|NCT05503797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723937|NCT04528290|Ozanimod|ozanimod|mesh-list
139395816|NCT05503797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139395817|NCT05503797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139395818|NCT05503797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395819|NCT05503797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395820|NCT05495945|Propofol|propofol|mesh-list
139395821|NCT05495945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139395822|NCT05495945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139395823|NCT05495945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395824|NCT05495945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139395825|NCT05495945|Anesthetics, General|anesthetics, general|mesh-ancestor
139395826|NCT05495945|Anesthetics|anesthetics|mesh-ancestor
139395827|NCT05441592|Tranexamic Acid|tranexamic acid|mesh-list
139395828|NCT05441592|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139395829|NCT05441592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139395830|NCT05441592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395831|NCT05441592|Hemostatics|hemostatics|mesh-ancestor
139395832|NCT05441592|Coagulants|coagulants|mesh-ancestor
139395833|NCT05406505|Dapagliflozin|dapagliflozin|mesh-list
139395834|NCT05406505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139395835|NCT05406505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395836|NCT05406505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139395837|NCT05406505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395838|NCT05398094|Sotorasib|sotorasib|mesh-list
139395839|NCT05398094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139395840|NCT05398094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395841|NCT05398094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139395842|NCT05398094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395843|NCT05331183|Ivacaftor|ivacaftor|mesh-list
139395844|NCT05331183|Elexacaftor|elexacaftor|mesh-list
139395845|NCT05331183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139395846|NCT05331183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139395847|NCT05331183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395848|NCT05259800|Peppermint oil|peppermint oil|mesh-list
139395849|NCT05259800|Mineral Oil|mineral oil|mesh-list
139395850|NCT05259800|Antiemetics|antiemetics|mesh-ancestor
139395851|NCT05259800|Autonomic Agents|autonomic agents|mesh-ancestor
139395852|NCT05259800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395853|NCT05259800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395854|NCT05259800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139395855|NCT05259800|Parasympatholytics|parasympatholytics|mesh-ancestor
139052665|NCT01095172|Rituximab|rituximab|mesh-list
139395856|NCT05259800|Emollients|emollients|mesh-ancestor
139395857|NCT05259800|Dermatologic Agents|dermatologic agents|mesh-ancestor
139395858|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
139395859|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139395860|NCT05215236|Narcotics|narcotics|mesh-ancestor
139395861|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139395862|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395863|NCT05215236|Analgesics|analgesics|mesh-ancestor
139395864|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
139395865|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395866|NCT05157971|Cytarabine|cytarabine|mesh-list
139395867|NCT05157971|Prednisone|prednisone|mesh-list
139395868|NCT05157971|Cortisone|cortisone|mesh-list
139395869|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
139395870|NCT05157971|Methotrexate|methotrexate|mesh-list
139395871|NCT05157971|Vincristine|vincristine|mesh-list
139395872|NCT05157971|Daunorubicin|daunorubicin|mesh-list
139395873|NCT05157971|Venetoclax|venetoclax|mesh-list
139395874|NCT05157971|Asparaginase|asparaginase|mesh-list
139395875|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
139395876|NCT05157971|Pegaspargase|pegaspargase|mesh-list
139395877|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139395878|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
139395879|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395880|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139648412|NCT01459679|Dermatologic Agents|dermatologic agents|mesh-ancestor
139395881|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139395882|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
139395883|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395884|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648413|NCT00048295|Alicaforsen|alicaforsen|mesh-list
139648414|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139648415|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139395885|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139395886|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139395887|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
139395888|NCT05157971|Hormones|hormones|mesh-ancestor
139395889|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139395890|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139395891|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139395892|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
139395893|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139395894|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139395895|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
139395896|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
139395897|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139395898|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139395899|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139395900|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
139395901|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139395902|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139395903|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
139395904|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
139395905|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
139395906|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139395907|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139395908|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139395909|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
139395910|NCT04972968|Hormones|hormones|mesh-ancestor
139395911|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139395912|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395913|NCT04928651|Clonidine|clonidine|mesh-list
139395914|NCT04928651|Analgesics|analgesics|mesh-ancestor
139395915|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
139395916|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395917|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395918|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139395919|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
139395920|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
139395921|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139395922|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139395923|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139395924|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
139395925|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139395926|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395927|NCT04916327|Antioxidants|antioxidants|mesh-list
139395928|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395929|NCT04916327|Protective Agents|protective agents|mesh-ancestor
139395930|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395931|NCT04907227|Dexamethasone|dexamethasone|mesh-list
139395932|NCT04907227|Prednisone|prednisone|mesh-list
139395933|NCT04907227|Docetaxel|docetaxel|mesh-list
139395934|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
139395935|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139395936|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
139395937|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
139395938|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395939|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648416|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
139648417|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648418|NCT01455857|Exenatide|exenatide|mesh-list
139648419|NCT01455857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139648420|NCT01455857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648421|NCT01455857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139648422|NCT01455857|Incretins|incretins|mesh-ancestor
139648423|NCT01455857|Hormones|hormones|mesh-ancestor
139648424|NCT01455857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139648425|NCT03043248|Digoxin|digoxin|mesh-list
139648426|NCT03043248|Midazolam|midazolam|mesh-list
139648427|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139648428|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139648429|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139648430|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648431|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139648432|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138724149|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
139395940|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139648433|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139395941|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
139648434|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139395943|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139395944|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139395945|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395946|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
139395947|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
139395948|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
139395949|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395950|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139395951|NCT04907227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139395952|NCT04875364|Eszopiclone|eszopiclone|mesh-list
139395953|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139395954|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139395955|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395956|NCT04848116|Nivolumab|nivolumab|mesh-list
139395957|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139395958|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395959|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139395960|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395961|NCT04846829|Citalopram|citalopram|mesh-list
139395962|NCT04846829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139395963|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139395964|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139395965|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139395966|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139395967|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
138724180|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
139395968|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395969|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139395970|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
139395971|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139395972|NCT04825704|Bupivacaine|bupivacaine|mesh-list
139395973|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
139395974|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
139395975|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139395976|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395977|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
139395978|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139395979|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139395980|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139395981|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
139395982|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
139395983|NCT04798469|Testosterone|testosterone|mesh-list
139395984|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
139395985|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
139395986|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139395987|NCT04798469|Androgens|androgens|mesh-ancestor
139395988|NCT04798469|Hormones|hormones|mesh-ancestor
139395989|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139395990|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395991|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139395992|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139395993|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
139395994|NCT04758000|Metformin|metformin|mesh-list
139395995|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139395996|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139395997|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139395998|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139395999|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139396000|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396001|NCT04659616|Cytarabine|cytarabine|mesh-list
139396002|NCT04659616|Daunorubicin|daunorubicin|mesh-list
139396003|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139396004|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
139396005|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052806|NCT06202755|Cilostazol|cilostazol|mesh-list
139396006|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648435|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
139648436|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
139648437|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
139648438|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
139648439|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648440|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648441|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139648442|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139648443|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396007|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
139396008|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139396009|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139396010|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
139396011|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396012|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139396013|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139396014|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139396015|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396017|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139396018|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396019|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396020|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396021|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396022|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396023|NCT04610671|Nivolumab|nivolumab|mesh-list
139396024|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396025|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396026|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139396027|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396028|NCT04595617|Antibodies|antibodies|mesh-list
139396029|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
139396030|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396031|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
139396032|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139396033|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396034|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139396035|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396036|NCT04508790|Dexamethasone|dexamethasone|mesh-list
139396037|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
139396038|NCT04508790|Pomalidomide|pomalidomide|mesh-list
139396039|NCT04508790|Ichthammol|ichthammol|mesh-list
139396040|NCT04508790|BB 1101|bb 1101|mesh-list
139396041|NCT04508790|Leflunomide|leflunomide|mesh-list
139396042|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396043|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
139396044|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
139396045|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396046|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396047|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139396048|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
139396049|NCT04508790|Hormones|hormones|mesh-ancestor
139396050|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396051|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139396052|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396053|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
139396054|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396055|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396056|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
139396057|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139396058|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139396059|NCT04508790|Growth Substances|growth substances|mesh-ancestor
139396060|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
139396061|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
139396062|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139396063|NCT04492566|Pancrelipase|pancrelipase|mesh-list
139396064|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139396065|NCT04393389|Paclitaxel|paclitaxel|mesh-list
139396066|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139396067|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396068|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396069|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
139648444|NCT03043248|Protective Agents|protective agents|mesh-ancestor
139648445|NCT04843631|Ustekinumab|ustekinumab|mesh-list
139648446|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
139648447|NCT03043326|Tenofovir|tenofovir|mesh-list
139648448|NCT03043326|Emtricitabine|emtricitabine|mesh-list
139648449|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
139648450|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648451|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139396070|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396071|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648452|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139648453|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396072|NCT04273061|Atezolizumab|atezolizumab|mesh-list
139396073|NCT04273061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139396074|NCT04273061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396075|NCT04273061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396076|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396077|NCT04140266|Tenofovir|tenofovir|mesh-list
139396078|NCT04140266|Emtricitabine|emtricitabine|mesh-list
139396079|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139396080|NCT04140266|Dapivirine|dapivirine|mesh-list
139396082|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139396083|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139396084|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139396085|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396086|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396087|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139396088|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139396089|NCT04120415|Vedolizumab|vedolizumab|mesh-list
139396090|NCT04120415|Vaccines|vaccines|mesh-list
139396091|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
139396092|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396093|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139396094|NCT04093570|Decitabine|decitabine|mesh-list
138724381|NCT02217956|Bevacizumab|bevacizumab|mesh-list
139396095|NCT04093570|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139396096|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139396097|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
139396098|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396099|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396100|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396101|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139396102|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139396103|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396104|NCT03939520|Pirfenidone|pirfenidone|mesh-list
139396105|NCT03939520|Nintedanib|nintedanib|mesh-list
139396106|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396107|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396108|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396109|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396110|NCT03939520|Analgesics|analgesics|mesh-ancestor
139396111|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
139396112|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396113|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396114|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139396115|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139396116|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396117|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139396118|NCT03926143|Maytansine|maytansine|mesh-list
139396119|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
139396120|NCT03926143|Anetumab ravtansine|anetumab ravtansine|mesh-list
139396121|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139396122|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396123|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396124|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396125|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396126|NCT03926143|Immunoconjugates|immunoconjugates|mesh-ancestor
139396127|NCT03926143|Immunologic Factors|immunologic factors|mesh-ancestor
139396128|NCT03926143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396129|NCT03878459|Pioglitazone|pioglitazone|mesh-list
139396130|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139396131|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396132|NCT03876262|Ivermectin|ivermectin|mesh-list
139396133|NCT03876262|Moxidectin|moxidectin|mesh-list
139396134|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139396135|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139396136|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
139396137|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
139396138|NCT03867682|Venetoclax|venetoclax|mesh-list
139396139|NCT03867682|Lintuzumab|lintuzumab|mesh-list
139396140|NCT03867682|Spironolactone|spironolactone|mesh-list
139648454|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396141|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648455|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139396142|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139396143|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
139396144|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396145|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396146|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139396147|NCT03867682|Diuretics|diuretics|mesh-ancestor
139396148|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
139396149|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396150|NCT03846505|Oxytocin|oxytocin|mesh-list
139396151|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
139396152|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139396153|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396154|NCT03815643|Avelumab|avelumab|mesh-list
139396155|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396156|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396157|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
139396158|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396159|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396160|NCT03799003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139396161|NCT03799003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396162|NCT03768570|Durvalumab|durvalumab|mesh-list
139396163|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396164|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396165|NCT03617445|Vancomycin|vancomycin|mesh-list
139396166|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139396167|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139396168|NCT03550391|Memantine|memantine|mesh-list
139396169|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139396170|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139396171|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
139396172|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139396173|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396174|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396175|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139396176|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139396177|NCT03480776|Aspirin|aspirin|mesh-list
139396178|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139396179|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139396180|NCT03480776|Analgesics|analgesics|mesh-ancestor
139396181|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
139396182|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396183|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396184|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396185|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139396186|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139396187|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139396188|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396189|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139396190|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139396191|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396192|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
139396193|NCT03421652|Nivolumab|nivolumab|mesh-list
139396194|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396195|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396196|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139396197|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396198|NCT03215524|Thalidomide|thalidomide|mesh-list
139396199|NCT03215524|Dexamethasone|dexamethasone|mesh-list
139396200|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
139396201|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
139396202|NCT03215524|Daratumumab|daratumumab|mesh-list
139396203|NCT03215524|Pomalidomide|pomalidomide|mesh-list
139396204|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139396205|NCT03215524|BB 1101|bb 1101|mesh-list
139396206|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139396207|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
139396208|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396209|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139396210|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139396211|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
139136768|NCT01290471|U3-1565|u3-1565|mesh-list
139648456|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139648457|NCT04845737|Vitamin D|vitamin d|mesh-list
139648458|NCT04845737|Vitamins|vitamins|mesh-ancestor
139648459|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
139648460|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648461|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139648462|NCT04849715|Rituximab|rituximab|mesh-list
139396212|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648463|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139648464|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139648465|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396213|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396214|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139396215|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396216|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
139396217|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
139396218|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396219|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139396220|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
139396221|NCT03215524|Hormones|hormones|mesh-ancestor
139396222|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396223|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139396224|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
139396225|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396226|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139396227|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139396228|NCT03215524|Growth Substances|growth substances|mesh-ancestor
139396229|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
139396230|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
139396231|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139396232|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139396233|NCT03045029|Treprostinil|treprostinil|mesh-list
139396234|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139396235|NCT03018080|Paclitaxel|paclitaxel|mesh-list
139396236|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
139396237|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139396238|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396239|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396240|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396241|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396242|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396243|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396244|NCT03018080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139396245|NCT02905318|Palbociclib|palbociclib|mesh-list
139396246|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396247|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396248|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396249|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396250|NCT02799641|Lidocaine|lidocaine|mesh-list
139396251|NCT02799641|Diazepam|diazepam|mesh-list
139396252|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
139396253|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
139396254|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139396255|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396256|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
139396257|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396258|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139396259|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139396260|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139396261|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139396262|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396263|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139396264|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
139396265|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
139396266|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
139396267|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139396268|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139396269|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139396270|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139396271|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139396272|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139396273|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139396274|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139396275|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
139396276|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
139396277|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
139648466|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
139648467|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648468|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139396278|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648469|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139396279|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
139396280|NCT02782546|Tacrolimus|tacrolimus|mesh-list
139396281|NCT02782546|Lenograstim|lenograstim|mesh-list
139396282|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139396283|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
139396284|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396285|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139396286|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396287|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396288|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139396289|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396290|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139396291|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
139396292|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139396293|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139396294|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139396295|NCT02781090|Nicotine|nicotine|mesh-list
139396296|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139396297|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
139396298|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396299|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396300|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139396301|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139396302|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
139396303|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139396304|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396305|NCT02774291|Aldesleukin|aldesleukin|mesh-list
139396306|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
139396307|NCT02774291|Fludarabine|fludarabine|mesh-list
139396308|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
139396309|NCT02774291|Interleukin-2|interleukin-2|mesh-list
139396310|NCT02774291|Lenograstim|lenograstim|mesh-list
139396311|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139396312|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
139396313|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396314|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139396315|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139396316|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
139396317|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396318|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396319|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139396320|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139396321|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
139396322|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139396323|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139396324|NCT02774291|Analgesics|analgesics|mesh-ancestor
139396325|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
139396326|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396327|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139396328|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139396329|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
139396330|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139396331|NCT02734771|Prednisone|prednisone|mesh-list
139396332|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
139396333|NCT02734771|Rituximab|rituximab|mesh-list
139396334|NCT02734771|Doxorubicin|doxorubicin|mesh-list
139396335|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139396336|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139396337|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
139396338|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396339|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139396340|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139396341|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
139396342|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396343|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648470|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
139648471|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648472|NCT03044964|Ranolazine|ranolazine|mesh-list
139648473|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139648474|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139648475|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648476|NCT01419639|Everolimus|everolimus|mesh-list
139648477|NCT01419639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139648478|NCT01419639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396344|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139396345|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139648479|NCT01419639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396371|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
139396372|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396373|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139396374|NCT02689024|Narcotics|narcotics|mesh-ancestor
139396375|NCT02689024|Analgesics|analgesics|mesh-ancestor
139396376|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139396377|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139396378|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
139396379|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139396380|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
139396381|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139396382|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396383|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139396384|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139396385|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396386|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396387|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
139396388|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
139396389|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396390|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396391|NCT02658279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139396392|NCT02658279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396393|NCT02649686|Trastuzumab|trastuzumab|mesh-list
139396394|NCT02649686|Durvalumab|durvalumab|mesh-list
139396395|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396396|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648480|NCT01419639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648481|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139136789|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
139396484|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396486|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396487|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139396488|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
139396489|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396490|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139648484|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648485|NCT02856893|Gefitinib|gefitinib|mesh-list
139648486|NCT02856893|Osimertinib|osimertinib|mesh-list
139648487|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396491|NCT01846390|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139396492|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396493|NCT01783197|Paclitaxel|paclitaxel|mesh-list
139396494|NCT01783197|Carboplatin|carboplatin|mesh-list
139396495|NCT01783197|Pemetrexed|pemetrexed|mesh-list
139396496|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139396497|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396498|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396499|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396500|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396501|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396502|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396503|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139396504|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139396505|NCT01765855|Betrixaban|betrixaban|mesh-list
139396506|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139396507|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
139396508|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139396509|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
139396510|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396511|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396512|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
139396513|NCT01708993|Docetaxel|docetaxel|mesh-list
139396514|NCT01708993|Pemetrexed|pemetrexed|mesh-list
139396515|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396516|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396517|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396518|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396519|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396520|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396521|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139396522|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139396523|NCT01656538|Paclitaxel|paclitaxel|mesh-list
139396524|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139396525|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396526|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396527|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396528|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396529|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396530|NCT01619813|Prednisone|prednisone|mesh-list
139396531|NCT01619813|Docetaxel|docetaxel|mesh-list
139396532|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396533|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396534|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396535|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
139053346|NCT05997433|Bismuth|bismuth|mesh-list
139396536|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396537|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396538|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
139396539|NCT01619813|Hormones|hormones|mesh-ancestor
139396540|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396541|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396542|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139396543|NCT01591421|Panitumumab|panitumumab|mesh-list
139396544|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396545|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396546|NCT01419834|Antibodies|antibodies|mesh-list
139396547|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139396548|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
139396549|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396550|NCT01138384|Lapatinib|lapatinib|mesh-list
139396551|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396552|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396553|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396554|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396555|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139396556|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396557|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648488|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396558|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139648489|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648490|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648491|NCT01419795|Rituximab|rituximab|mesh-list
139396559|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136797|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
139396560|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396561|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396562|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396563|NCT00930332|Methadone|methadone|mesh-list
139396564|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139396565|NCT00930332|Narcotics|narcotics|mesh-ancestor
139396566|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139396567|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396568|NCT00930332|Analgesics|analgesics|mesh-ancestor
139396569|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
139396570|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396571|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
139396572|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
139396573|NCT00869752|Etoposide|etoposide|mesh-list
139396574|NCT00869752|Antibodies|antibodies|mesh-list
139396575|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139396576|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
139396577|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396578|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396579|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139396580|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139396581|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139396582|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396583|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396584|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139396585|NCT00836485|Ketotifen|ketotifen|mesh-list
139396586|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
139396587|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139396588|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139396589|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139396590|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139396591|NCT00836485|Analgesics|analgesics|mesh-ancestor
139396592|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
138725058|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
139396593|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396594|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396595|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396596|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139396597|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139396598|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139396599|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139396600|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
139396601|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
139396602|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139396603|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396604|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
139396605|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
139396606|NCT00658593|Gemcitabine|gemcitabine|mesh-list
139396607|NCT00658593|Capecitabine|capecitabine|mesh-list
139396608|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139396609|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
139396610|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396611|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396612|NCT00651326|Docetaxel|docetaxel|mesh-list
139396613|NCT00651326|Leuprolide|leuprolide|mesh-list
139396614|NCT00651326|Goserelin|goserelin|mesh-list
139396615|NCT00651326|Bicalutamide|bicalutamide|mesh-list
138725125|NCT01641536|Entecavir|entecavir|mesh-list
139648493|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139648494|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648495|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
139648496|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648497|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139648498|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139648499|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139648500|NCT01419795|Growth Substances|growth substances|mesh-ancestor
139648501|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
139648502|NCT04783753|Itraconazole|itraconazole|mesh-list
139648503|NCT04783753|Quinidine|quinidine|mesh-list
139648504|NCT04783753|Carbamazepine|carbamazepine|mesh-list
139648505|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
139648506|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139396616|NCT00651326|Flutamide|flutamide|mesh-list
139396617|NCT00651326|Buserelin|buserelin|mesh-list
139648507|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139648508|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139648509|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136805|NCT01290549|Rituximab|rituximab|mesh-list
139396618|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396619|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396620|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396621|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396622|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396623|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139396624|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
139396625|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139396626|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396627|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139396628|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
139396629|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
139396630|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396631|NCT00640471|Cetuximab|cetuximab|mesh-list
139396632|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396633|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396634|NCT00535353|Irinotecan|irinotecan|mesh-list
139396635|NCT00535353|Olaparib|olaparib|mesh-list
139396636|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139396637|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139396638|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396639|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396640|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396641|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139396642|NCT00516828|Cytarabine|cytarabine|mesh-list
139396643|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139396644|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
139396645|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396646|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396647|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
139396648|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139396649|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139396650|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
139396651|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396652|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139396653|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725300|NCT06046859|Fluoxetine|fluoxetine|mesh-list
139396654|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396655|NCT00482755|Sunitinib|sunitinib|mesh-list
139396656|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396657|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139396658|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139396659|NCT00482755|Growth Substances|growth substances|mesh-ancestor
139396660|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396661|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
139396662|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396663|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396664|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396665|NCT00471432|Docetaxel|docetaxel|mesh-list
139396666|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396667|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396668|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396669|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396670|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396671|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
139396672|NCT00470353|Vitamin D|vitamin d|mesh-list
139396673|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
139396674|NCT00470353|Calcium|calcium|mesh-list
139396675|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139396676|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396677|NCT00470353|Vitamins|vitamins|mesh-ancestor
139396678|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
139396679|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139396680|NCT00470353|Antacids|antacids|mesh-ancestor
139396681|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396682|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139396683|NCT00428142|Prednisone|prednisone|mesh-list
139396684|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
138725369|NCT06045975|Tremelimumab|tremelimumab|mesh-list
139648510|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648511|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139648512|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
139648513|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396685|NCT00428142|Rituximab|rituximab|mesh-list
139396686|NCT00428142|Vincristine|vincristine|mesh-list
139396687|NCT00428142|Bortezomib|bortezomib|mesh-list
139396688|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139396689|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
139396690|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396691|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139396692|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139396693|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
139396694|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396695|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396696|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139396697|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396698|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396699|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
139396701|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396702|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139396703|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139396704|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396705|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396706|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396707|NCT00387400|Everolimus|everolimus|mesh-list
139396708|NCT00387400|Temozolomide|temozolomide|mesh-list
139396709|NCT00387400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139396710|NCT00387400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396711|NCT00387400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396712|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396713|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139396714|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
139396715|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396716|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396717|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139396718|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
139396719|NCT00377052|Gemcitabine|gemcitabine|mesh-list
139396720|NCT00377052|Bortezomib|bortezomib|mesh-list
139396721|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139396722|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
139396723|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396724|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396725|NCT00372736|Docetaxel|docetaxel|mesh-list
139396726|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396727|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396728|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396729|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396730|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396731|NCT00357747|Docetaxel|docetaxel|mesh-list
139396732|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396733|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396734|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396735|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396736|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396737|NCT00352079|Gefitinib|gefitinib|mesh-list
139396738|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
139396739|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396740|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396741|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396742|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396743|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139396744|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
139396745|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396746|NCT00343408|Leucovorin|leucovorin|mesh-list
139396747|NCT00343408|Gemcitabine|gemcitabine|mesh-list
139396748|NCT00343408|Fluorouracil|fluorouracil|mesh-list
139396749|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
139396750|NCT00343408|Cediranib|cediranib|mesh-list
139396751|NCT00343408|Calcium|calcium|mesh-list
139396752|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
139396753|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396754|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139648514|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648515|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139648516|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
139648517|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
139648518|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139648519|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139396755|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
139396756|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648520|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139648521|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139396757|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139396758|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053570|NCT05669001|Abatacept|abatacept|mesh-list
139396759|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139396760|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
139396761|NCT00343408|Antidotes|antidotes|mesh-ancestor
139396762|NCT00343408|Protective Agents|protective agents|mesh-ancestor
139396763|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
139396764|NCT00343408|Vitamins|vitamins|mesh-ancestor
139396765|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
139396766|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396767|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396768|NCT00305812|Dexamethasone|dexamethasone|mesh-list
139396769|NCT00305812|Lenalidomide|lenalidomide|mesh-list
139396770|NCT00305812|Melphalan|melphalan|mesh-list
139396771|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396772|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
139396773|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
139396774|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396775|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396776|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139396777|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
139396778|NCT00305812|Hormones|hormones|mesh-ancestor
139396779|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396780|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139396781|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396782|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
139396783|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139396784|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139396785|NCT00305812|Growth Substances|growth substances|mesh-ancestor
139396786|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
139396787|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139396788|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
139396789|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396790|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139396791|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139396792|NCT00265876|Gemcitabine|gemcitabine|mesh-list
139396793|NCT00265876|Saracatinib|saracatinib|mesh-list
139396794|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139396795|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
139396796|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396797|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396798|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396799|NCT00258388|Prednisone|prednisone|mesh-list
139396800|NCT00258388|Docetaxel|docetaxel|mesh-list
139396801|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396802|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396803|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
138725611|NCT06038682|Heparin|heparin|mesh-list
139396804|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396805|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396806|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396807|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
139396808|NCT00258388|Hormones|hormones|mesh-ancestor
139396809|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396810|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396811|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139396812|NCT00258375|Docetaxel|docetaxel|mesh-list
139396813|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396814|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396815|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396816|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396817|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396818|NCT00255788|Everolimus|everolimus|mesh-list
139396819|NCT00255788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139396820|NCT00255788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396821|NCT00255788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396822|NCT00255788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396823|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139396824|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
139648522|NCT04783753|Analgesics|analgesics|mesh-ancestor
139648523|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
139648524|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396825|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396826|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396843|NCT00084734|Docetaxel|docetaxel|mesh-list
139396844|NCT00084734|Capecitabine|capecitabine|mesh-list
139396845|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396846|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396847|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396848|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396849|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396850|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139396851|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
139396869|NCT00079079|Carboplatin|carboplatin|mesh-list
139396870|NCT00079079|Gemcitabine|gemcitabine|mesh-list
139396871|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396872|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139396873|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
139396874|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396875|NCT00079066|Cetuximab|cetuximab|mesh-list
139396876|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139396877|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396878|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139396879|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396880|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396881|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725768|NCT05975684|GABA Agonists|gaba agonists|mesh-ancestor
139396882|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396883|NCT00066443|Docetaxel|docetaxel|mesh-list
139396884|NCT00066443|Epirubicin|epirubicin|mesh-list
139396885|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648525|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139648526|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139648527|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139648528|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139648529|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139648530|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139648531|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
139648532|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648533|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139648534|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
139648535|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139648536|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139648537|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139396886|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
139648538|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139396887|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
139648539|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
139648540|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139396888|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396889|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396890|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139396891|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139396892|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139396893|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396895|NCT00054106|Buserelin|buserelin|mesh-list
139396896|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
139396897|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
139396898|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396899|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396900|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139396901|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396902|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139396903|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
139396904|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139396905|NCT00030875|Bortezomib|bortezomib|mesh-list
139396906|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396907|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
139396908|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
139396909|NCT03532867|Protective Agents|protective agents|mesh-ancestor
139396910|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396911|NCT02207959|Proflavine|proflavine|mesh-list
139396912|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139396913|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139396914|NCT02567552|Progesterone|progesterone|mesh-list
139396915|NCT02567552|Progestins|progestins|mesh-ancestor
139396916|NCT02567552|Hormones|hormones|mesh-ancestor
139396917|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396918|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396919|NCT02208427|Isoniazid|isoniazid|mesh-list
139396920|NCT02208427|Rifapentine|rifapentine|mesh-list
139396921|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
139396922|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139396923|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139396924|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139396925|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139396926|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
139396927|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396928|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139396929|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139396930|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
139396931|NCT05508620|Sirolimus|sirolimus|mesh-list
139396932|NCT05508620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139396933|NCT05508620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139396934|NCT05508620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139396935|NCT05508620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396936|NCT05508620|Antifungal Agents|antifungal agents|mesh-ancestor
139396937|NCT05508620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139396938|NCT05508620|Immunologic Factors|immunologic factors|mesh-ancestor
139396939|NCT05508620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396940|NCT03803605|Vorinostat|vorinostat|mesh-list
139396941|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396942|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139396943|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396944|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396945|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
139396946|NCT02208505|Remifentanil|remifentanil|mesh-list
139396947|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139396948|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139396949|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396950|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139396951|NCT02208505|Analgesics|analgesics|mesh-ancestor
139648541|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139648542|NCT02856581|Varenicline|varenicline|mesh-list
139648543|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139648544|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139648545|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
139396952|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
139396953|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139396954|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139396955|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139396956|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139648546|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139396957|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
139396958|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139396959|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396960|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139396962|NCT02208583|Prednisone|prednisone|mesh-list
139396963|NCT02208583|Cisplatin|cisplatin|mesh-list
139396964|NCT02208583|Docetaxel|docetaxel|mesh-list
139396965|NCT02208583|Etoposide|etoposide|mesh-list
139396966|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
139396967|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396968|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
139396969|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
139396970|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
139396971|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396972|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139396973|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
139396974|NCT02208583|Hormones|hormones|mesh-ancestor
139396975|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139396976|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396977|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139396978|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139396979|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139396980|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139396981|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396982|NCT05501288|Pholcodine|pholcodine|mesh-list
139396983|NCT05501288|Analgesics|analgesics|mesh-ancestor
139396984|NCT05501288|Sensory System Agents|sensory system agents|mesh-ancestor
139396985|NCT05501288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053788|NCT05321810|Protease Inhibitors|protease inhibitors|mesh-ancestor
139396986|NCT05501288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139396987|NCT05501288|Antitussive Agents|antitussive agents|mesh-ancestor
139396988|NCT05501288|Respiratory System Agents|respiratory system agents|mesh-ancestor
139396989|NCT02199379|Lenvatinib|lenvatinib|mesh-list
139396990|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139396991|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139396992|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139396993|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139396994|NCT03532711|Leucovorin|leucovorin|mesh-list
139396995|NCT03532711|Capecitabine|capecitabine|mesh-list
139396996|NCT03532711|Fluorouracil|fluorouracil|mesh-list
139396997|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
139396998|NCT03532711|Irinotecan|irinotecan|mesh-list
139396999|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
139397000|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397001|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139397002|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
139397003|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397004|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397005|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139397006|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
139397007|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139397008|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139397009|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397010|NCT03532711|Antidotes|antidotes|mesh-ancestor
139397011|NCT03532711|Protective Agents|protective agents|mesh-ancestor
139397012|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
139397013|NCT03532711|Vitamins|vitamins|mesh-ancestor
139397014|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
139397015|NCT04714112|Dexamethasone|dexamethasone|mesh-list
139397016|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
139397017|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139397018|NCT04714112|BB 1101|bb 1101|mesh-list
139397019|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139397020|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
139397021|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
139397022|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397023|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397024|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139397025|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
139397026|NCT04714112|Hormones|hormones|mesh-ancestor
139397027|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139648547|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397028|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139397029|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648548|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648549|NCT03042000|Capecitabine|capecitabine|mesh-list
139648550|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
139397030|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
139397031|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397032|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397033|NCT02199613|Darunavir|darunavir|mesh-list
139397034|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139397035|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139397036|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
139397037|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397038|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397039|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139397040|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139397041|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
139397042|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397043|NCT02209441|Sorafenib|sorafenib|mesh-list
139397044|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397045|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139397046|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397047|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397048|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
139397049|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139397050|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139397051|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
139397052|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397053|NCT03338647|Doxorubicin|doxorubicin|mesh-list
139397054|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139397055|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397056|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139397057|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138726184|NCT05520814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726191|NCT05515796|Trastuzumab|trastuzumab|mesh-list
138726192|NCT05515796|Tislelizumab|tislelizumab|mesh-list
138726193|NCT05515796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726194|NCT05515796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726195|NCT05513209|Anesthetics|anesthetics|mesh-list
139397058|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397059|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397060|NCT05500742|Selenium|selenium|mesh-list
139397061|NCT05500742|Ubiquinone|ubiquinone|mesh-list
139397062|NCT05500742|Coenzyme Q10|coenzyme q10|mesh-list
139397063|NCT05500742|Resveratrol|resveratrol|mesh-list
139397064|NCT05500742|Antioxidants|antioxidants|mesh-ancestor
139397065|NCT05500742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397067|NCT05500742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397068|NCT05500742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397069|NCT05500742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139397070|NCT05500742|Trace Elements|trace elements|mesh-ancestor
139397071|NCT05500742|Micronutrients|micronutrients|mesh-ancestor
139397072|NCT05500742|Vitamins|vitamins|mesh-ancestor
139397073|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
139397074|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
139397075|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139397076|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397077|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
139397078|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
139397079|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
139397080|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139397081|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397082|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397083|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139397084|NCT02200159|Analgesics|analgesics|mesh-ancestor
139397085|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
138726243|NCT05499390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397086|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397087|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139397088|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139397089|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139397090|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
139397091|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397092|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397093|NCT02204527|Vitamin D|vitamin d|mesh-list
139648551|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139648552|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
139648553|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648554|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648555|NCT01039285|Poractant alfa|poractant alfa|mesh-list
139648556|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139648557|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
139648558|NCT03043482|Calcitriol|calcitriol|mesh-list
139648559|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139648560|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397094|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
139648561|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139648562|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139648563|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648564|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139648565|NCT03043482|Vitamins|vitamins|mesh-ancestor
139648566|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
139648567|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139648568|NCT04775563|Vaccines|vaccines|mesh-list
139648569|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
139648570|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648571|NCT01480089|Ropivacaine|ropivacaine|mesh-list
139648572|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
139648573|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
139648574|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139648575|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648576|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
139648577|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648578|NCT03523975|Rituximab|rituximab|mesh-list
139648579|NCT03523975|Lenalidomide|lenalidomide|mesh-list
139648580|NCT03523975|Venetoclax|venetoclax|mesh-list
139648581|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139648582|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648583|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
139648584|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726388|NCT05389423|Cyclophosphamide|cyclophosphamide|mesh-list
139648585|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139648586|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139648587|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139648588|NCT03523975|Growth Substances|growth substances|mesh-ancestor
139648589|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
139648590|NCT01542645|Fentanyl|fentanyl|mesh-list
139648591|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
139648592|NCT01542645|Methadone|methadone|mesh-list
139648593|NCT01542645|Narcotics|narcotics|mesh-ancestor
139648594|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139648595|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648596|NCT01542645|Analgesics|analgesics|mesh-ancestor
139648597|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
139648598|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648599|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139648600|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139648601|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
139648602|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
139648603|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
139648604|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
139648605|NCT04857450|Ketamine|ketamine|mesh-list
139648606|NCT04857450|Etomidate|etomidate|mesh-list
139648607|NCT04857450|Analgesics|analgesics|mesh-ancestor
139648608|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
139648609|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648610|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648611|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139648612|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139648613|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
139648614|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
139648615|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139648616|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139648617|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139648618|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648619|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648620|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139648621|NCT01420653|Acetaminophen|acetaminophen|mesh-list
139648622|NCT01420653|Ibuprofen|ibuprofen|mesh-list
139648623|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139648624|NCT01420653|Analgesics|analgesics|mesh-ancestor
139648625|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
139648626|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648627|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648628|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
139648629|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139648630|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139648631|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139648632|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139648633|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648634|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648635|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139648636|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139648637|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139648638|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
139648639|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648640|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648641|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139648642|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139648643|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
139648644|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648645|NCT04844957|Vitamin D|vitamin d|mesh-list
139648646|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
139648647|NCT04844957|Cholecalciferol|cholecalciferol|mesh-list
139648648|NCT04844957|Vitamins|vitamins|mesh-list
139648649|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
139648650|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648651|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139648652|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139648653|NCT01421589|Hormones|hormones|mesh-list
139648654|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139648655|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726547|NCT05263206|Loratadine|loratadine|mesh-list
139648656|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
139648657|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139648658|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648659|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
139648660|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
139648661|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139648662|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139648663|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648664|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648665|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648666|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139648667|NCT04390685|Tacrolimus|tacrolimus|mesh-list
139648668|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139648669|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
139648670|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648671|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139648672|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648673|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648674|NCT04848246|Bupropion|bupropion|mesh-list
139648675|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139648676|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
139648677|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139648678|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139648679|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139648680|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139648681|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648682|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
139648683|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648684|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648685|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139648686|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139648687|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648688|NCT04842071|Listerine|listerine|mesh-list
139648689|NCT04842071|Fluorides|fluorides|mesh-list
138726604|NCT05195918|Pirfenidone|pirfenidone|mesh-list
139648690|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
139648691|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
139648692|NCT04842071|Protective Agents|protective agents|mesh-ancestor
139648693|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648694|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139648695|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648696|NCT04774627|Olaparib|olaparib|mesh-list
139648697|NCT04774627|Niraparib|niraparib|mesh-list
139648698|NCT04774627|Talazoparib|talazoparib|mesh-list
139648699|NCT04774627|Veliparib|veliparib|mesh-list
139648700|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139648701|NCT04774627|Rucaparib|rucaparib|mesh-list
139648702|NCT04774627|Pamiparib|pamiparib|mesh-list
139648703|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648704|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648705|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648706|NCT04855968|Analgesics|analgesics|mesh-list
139648707|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
139397096|NCT02204527|Vitamins|vitamins|mesh-list
139397097|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
139136954|NCT03852303|Ivermectin|ivermectin|mesh-list
139648708|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648709|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648710|NCT01545765|Lidocaine|lidocaine|mesh-list
139648711|NCT01545765|Tetracaine|tetracaine|mesh-list
139648712|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
139648713|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
139648714|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139648715|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648716|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
139648717|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648718|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139648719|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139648720|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139648721|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139648722|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648723|NCT04856124|Ketamine|ketamine|mesh-list
139648724|NCT04856124|Esketamine|esketamine|mesh-list
139648725|NCT04856124|Analgesics|analgesics|mesh-ancestor
139648726|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
139648727|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648728|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648729|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139648730|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139648731|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
139648732|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
139648733|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139648734|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139648735|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139648736|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648737|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648738|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
139648739|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139648740|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139648741|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139648742|NCT04847622|Remdesivir|remdesivir|mesh-list
139648743|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
139648744|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648745|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
139648746|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648747|NCT04781803|Cyclosporine|cyclosporine|mesh-list
139648748|NCT04781803|Cyclosporins|cyclosporins|mesh-list
139648749|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648750|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648751|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139648752|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
139648753|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648754|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
139648755|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648756|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
139648757|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139648758|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139648759|NCT01422369|Ritonavir|ritonavir|mesh-list
139648760|NCT01422369|Darunavir|darunavir|mesh-list
139648761|NCT01422369|Pitavastatin|pitavastatin|mesh-list
139648762|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139648763|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139648764|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
139648765|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648766|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648767|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139648768|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139648769|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
139648770|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648771|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138726773|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139648772|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139648773|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139648774|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139648775|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139648776|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
139648777|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139648778|NCT05023343|Ropivacaine|ropivacaine|mesh-list
139648779|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
139648780|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
139397098|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648781|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139648782|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648783|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
139648784|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648786|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139648787|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
139648788|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648789|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648790|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648791|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139648792|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139648793|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648794|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139648795|NCT04773301|Ropivacaine|ropivacaine|mesh-list
139648796|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
139648797|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
139648798|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
139648799|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139648800|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648801|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
139648802|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648803|NCT04780945|Olaparib|olaparib|mesh-list
139648804|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139648805|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648806|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648807|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648808|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
139648809|NCT05021315|Povidone|povidone|mesh-list
139648810|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
139648811|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
139648812|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139648813|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648814|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
139648815|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139648816|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
139648817|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648818|NCT01427517|Expectorants|expectorants|mesh-ancestor
139648819|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
139648820|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139648821|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
139648822|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648823|NCT01427517|Protective Agents|protective agents|mesh-ancestor
139648824|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648825|NCT01427517|Antidotes|antidotes|mesh-ancestor
139648826|NCT02835131|Pasireotide|pasireotide|mesh-list
139648827|NCT02835131|Hormones|hormones|mesh-ancestor
139648828|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139648829|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648830|NCT04846452|Paclitaxel|paclitaxel|mesh-list
139648831|NCT04846452|Carboplatin|carboplatin|mesh-list
139648832|NCT04846452|Pemetrexed|pemetrexed|mesh-list
139648833|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139648834|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648835|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
139648836|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
139648837|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
139648838|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648839|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648840|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138726893|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139648841|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139648842|NCT04859244|Remdesivir|remdesivir|mesh-list
139648843|NCT04859244|GS-441524|gs-441524|mesh-list
139648844|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
139648845|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648846|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
139648847|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648848|NCT04779853|Antibodies|antibodies|mesh-list
139648849|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
139648850|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648851|NCT04855110|Warfarin|warfarin|mesh-list
139397099|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139397100|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139648852|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
139648853|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
139397101|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
139648854|NCT01485393|Zolpidem|zolpidem|mesh-list
139648855|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139137092|NCT01297023|Vitamin D|vitamin d|mesh-list
139648856|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397102|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139648857|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648858|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139648859|NCT01485393|Analgesics|analgesics|mesh-ancestor
139648860|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
139648861|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726949|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139648862|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139648863|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139648864|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139648865|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
139648866|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648867|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648868|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139648869|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139648870|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
139648871|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
139648872|NCT04772287|Paclitaxel|paclitaxel|mesh-list
139648873|NCT04772287|Vinorelbine|vinorelbine|mesh-list
139648874|NCT04772287|Docetaxel|docetaxel|mesh-list
139648875|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139648876|NCT04772287|Cisplatin|cisplatin|mesh-list
139648877|NCT04772287|Carboplatin|carboplatin|mesh-list
139648878|NCT04772287|Gemcitabine|gemcitabine|mesh-list
139648879|NCT04772287|Pemetrexed|pemetrexed|mesh-list
139648880|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139648881|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648882|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
139648883|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
139648884|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
139648885|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648886|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139648887|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
139648888|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648889|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139648890|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139648891|NCT01890005|Aspirin|aspirin|mesh-list
139648892|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139648893|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139648894|NCT01890005|Analgesics|analgesics|mesh-ancestor
139648895|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
139648896|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648897|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648898|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139648899|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139648900|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139648901|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139648902|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648903|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139648904|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139648905|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648906|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
139648907|NCT04854252|Fentanyl|fentanyl|mesh-list
139648908|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139648909|NCT04854252|Narcotics|narcotics|mesh-ancestor
139648910|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139648911|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648912|NCT04854252|Analgesics|analgesics|mesh-ancestor
139648913|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
139648914|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648915|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139648916|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139648917|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
139648918|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
139648919|NCT03040830|Progesterone|progesterone|mesh-list
139648920|NCT03040830|Progestins|progestins|mesh-ancestor
139648921|NCT03040830|Hormones|hormones|mesh-ancestor
139648922|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139648923|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648924|NCT04390295|Metformin|metformin|mesh-list
138727077|NCT04620746|Penicillin G|penicillin g|mesh-list
139648925|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139648926|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648927|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
139648928|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139397103|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
139648929|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648930|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139648931|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397104|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648932|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
139648933|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139648934|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139648935|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648936|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
139648937|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
139648938|NCT01890629|Metformin|metformin|mesh-list
139648939|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139648940|NCT01890629|Glimepiride|glimepiride|mesh-list
139648941|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139648942|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648943|NCT01890629|Incretins|incretins|mesh-ancestor
139648944|NCT01890629|Hormones|hormones|mesh-ancestor
139648945|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139648946|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139648947|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
139648948|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139648949|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648950|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139648951|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139648952|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
139648953|NCT01890863|Fluticasone|fluticasone|mesh-list
139648954|NCT01890863|Xhance|xhance|mesh-list
139648955|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139648956|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139648957|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139648958|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139648959|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
139648960|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648961|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648962|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139648963|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
139648964|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
139648965|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139648966|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139648967|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139648968|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139648969|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
139648970|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139648971|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139648972|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
139648973|NCT01890863|Hormones|hormones|mesh-ancestor
139648974|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139648975|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
139648976|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
139648977|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
139648978|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
139648979|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139648980|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139648981|NCT01891019|Thalidomide|thalidomide|mesh-list
139648982|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139648983|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
139648984|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648985|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
139648986|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139648987|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139648988|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139648989|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139648990|NCT01891019|Growth Substances|growth substances|mesh-ancestor
139648991|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
139648992|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139648993|NCT04374474|Budesonide|budesonide|mesh-list
139648994|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139648995|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139648996|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
139648997|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139648998|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139648999|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139649000|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
139649001|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
139397105|NCT02200237|Antacids|antacids|mesh-ancestor
139649002|NCT04374474|Hormones|hormones|mesh-ancestor
139649003|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649005|NCT02983097|Dexamethasone|dexamethasone|mesh-list
139649006|NCT02983097|Rituximab|rituximab|mesh-list
139649007|NCT02983097|Carboplatin|carboplatin|mesh-list
139649008|NCT02983097|Lenalidomide|lenalidomide|mesh-list
139649009|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139649010|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
139649011|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
139649012|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649013|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649014|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139649015|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
139649016|NCT02983097|Hormones|hormones|mesh-ancestor
139649017|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649018|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139649019|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649020|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139649021|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
139649022|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139649023|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139649024|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
139649025|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649026|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
139649027|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139649028|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139649029|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139649030|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139649031|NCT02983097|Growth Substances|growth substances|mesh-ancestor
139649032|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
139649033|NCT01891175|Anesthetics|anesthetics|mesh-list
139649034|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139649035|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649036|NCT02347865|Denosumab|denosumab|mesh-list
139649037|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139649038|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649039|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
139649040|NCT01550367|Aldesleukin|aldesleukin|mesh-list
139649041|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
139649042|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139649043|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139649044|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139649045|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649046|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649047|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139649048|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649049|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139649050|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139649051|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
139649052|NCT01427595|Metformin|metformin|mesh-list
139649053|NCT01427595|Progesterone|progesterone|mesh-list
139649054|NCT01427595|Estradiol|estradiol|mesh-list
139649055|NCT01427595|Estrogens|estrogens|mesh-list
139649056|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139649057|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649058|NCT01427595|Progestins|progestins|mesh-ancestor
139649059|NCT01427595|Hormones|hormones|mesh-ancestor
139649060|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649061|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
139649062|NCT04390061|Tofacitinib|tofacitinib|mesh-list
139649063|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
139649064|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139649065|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139649066|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139649067|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649068|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649069|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139649070|NCT04390061|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139649071|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139649072|NCT01892813|Bupropion|bupropion|mesh-list
139649073|NCT01892813|Nicotine|nicotine|mesh-list
139397106|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397107|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139397108|NCT02209831|Pantoprazole|pantoprazole|mesh-list
139397109|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139649074|NCT01892813|Varenicline|varenicline|mesh-list
139649075|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139649076|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
139649077|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649078|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397110|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139649079|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139649080|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139649081|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
139649082|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649083|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727377|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
139649084|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139649085|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
139649086|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139649087|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139649088|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139649089|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139649090|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
139649091|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139649092|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139649093|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649094|NCT00716443|Lidocaine|lidocaine|mesh-list
139649095|NCT00716443|Tetracaine|tetracaine|mesh-list
139649096|NCT00716443|Benzocaine|benzocaine|mesh-list
139649097|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
139649098|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
139649099|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139649100|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649101|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
139649102|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649103|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139649104|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139649105|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139649106|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139649107|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397111|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139397112|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137459|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649108|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139649109|NCT00650143|Lenograstim|lenograstim|mesh-list
139649110|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139649111|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649112|NCT00650143|Incretins|incretins|mesh-ancestor
139649113|NCT00650143|Hormones|hormones|mesh-ancestor
139649114|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649115|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139649116|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
139649117|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649118|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649119|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139649120|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
139649121|NCT04770961|Ropivacaine|ropivacaine|mesh-list
139649122|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
139649123|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
139649124|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139649125|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649126|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
139649127|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649128|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
139649129|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139649130|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
139649131|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139649132|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
139649133|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649134|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649135|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
139649136|NCT04769557|Acetaminophen|acetaminophen|mesh-list
139649137|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139649138|NCT04769557|Analgesics|analgesics|mesh-ancestor
139649139|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
139649140|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649141|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649142|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
139649143|NCT05606497|Dexamethasone|dexamethasone|mesh-list
139649144|NCT05606497|Betamethasone|betamethasone|mesh-list
139649145|NCT05606497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139649146|NCT05606497|Antiemetics|antiemetics|mesh-ancestor
139649147|NCT05606497|Autonomic Agents|autonomic agents|mesh-ancestor
139649148|NCT05606497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649149|NCT05606497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649150|NCT05606497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139649151|NCT05606497|Glucocorticoids|glucocorticoids|mesh-ancestor
139649152|NCT05606497|Hormones|hormones|mesh-ancestor
139649153|NCT05606497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649154|NCT05606497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139649155|NCT05606497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649156|NCT05606497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139649157|NCT05606497|Respiratory System Agents|respiratory system agents|mesh-ancestor
139649158|NCT04778917|Heparin|heparin|mesh-list
139649159|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139649160|NCT04778917|Tinzaparin|tinzaparin|mesh-list
139649161|NCT04778917|Dalteparin|dalteparin|mesh-list
139649162|NCT04778917|Calcium heparin|calcium heparin|mesh-list
139649163|NCT04778917|Calcium|calcium|mesh-list
139649164|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139649165|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649166|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
139649167|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139649168|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139649169|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649170|NCT02213289|Nivolumab|nivolumab|mesh-list
139649171|NCT02213289|Trastuzumab|trastuzumab|mesh-list
139649172|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
139649173|NCT02213289|Ramucirumab|ramucirumab|mesh-list
139649174|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139649175|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649176|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139649177|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649178|NCT05606107|Tofacitinib|tofacitinib|mesh-list
139649179|NCT05606107|Glucocorticoids|glucocorticoids|mesh-list
139649180|NCT05606107|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139649181|NCT05606107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139649182|NCT05606107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649183|NCT05606107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649184|NCT05606107|Hormones|hormones|mesh-ancestor
139649185|NCT05606107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649186|NCT05606107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649187|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
139649188|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
139649189|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
139649190|NCT00053989|Fludarabine|fludarabine|mesh-list
139649191|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
139649192|NCT00053989|Tacrolimus|tacrolimus|mesh-list
139649193|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139649194|NCT00053989|Sargramostim|sargramostim|mesh-list
139649195|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139649196|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
139649197|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649198|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139649199|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139649200|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
139649201|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649202|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649203|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139649204|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139649205|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
139649206|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139649207|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649208|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139649209|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139649210|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
139649211|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139649212|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139649213|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139649214|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
139649215|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
139649216|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649217|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139649218|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
139649219|NCT00053989|Hormones|hormones|mesh-ancestor
139649220|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649221|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139649222|NCT00053989|Protective Agents|protective agents|mesh-ancestor
139649223|NCT02740595|Nicotine|nicotine|mesh-list
139649224|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139649225|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
139649226|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649227|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649228|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139649229|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139649230|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
139649231|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649232|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649233|NCT02214615|Carbamazepine|carbamazepine|mesh-list
139649234|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
139649235|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
139649236|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139649237|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139649238|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649239|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139649240|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139649241|NCT02214615|Analgesics|analgesics|mesh-ancestor
139649242|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
139649243|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649244|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139649245|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139649246|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649247|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139649248|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139649249|NCT02661503|Dexamethasone|dexamethasone|mesh-list
139649250|NCT02661503|Prednisone|prednisone|mesh-list
139649251|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
139649252|NCT02661503|Dacarbazine|dacarbazine|mesh-list
139649253|NCT02661503|Doxorubicin|doxorubicin|mesh-list
139649254|NCT02661503|Etoposide|etoposide|mesh-list
139397113|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397114|NCT01663532|Aripiprazole|aripiprazole|mesh-list
139137537|NCT01200537|Norinyl|norinyl|mesh-list
139649255|NCT02661503|Vincristine|vincristine|mesh-list
139397115|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
139649256|NCT02661503|Bleomycin|bleomycin|mesh-list
139649257|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139649258|NCT02661503|Procarbazine|procarbazine|mesh-list
139649259|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139649260|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
139649261|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649262|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139649263|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139649264|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
139649265|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649266|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649267|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139649268|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139649269|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
139649270|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
139649271|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649272|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139649273|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
139649274|NCT02661503|Hormones|hormones|mesh-ancestor
139649275|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649276|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139649277|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139649278|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139649279|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139649280|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649281|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139649282|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
139649283|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
139649284|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
139649285|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139649286|NCT02661503|Immunotoxins|immunotoxins|mesh-ancestor
139649287|NCT02661503|Immunoconjugates|immunoconjugates|mesh-ancestor
139649288|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139649289|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139649290|NCT03040752|Nifedipine|nifedipine|mesh-list
139649291|NCT03040752|Ritodrine|ritodrine|mesh-list
139649292|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139649293|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139649294|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649295|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139649296|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649297|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
139649298|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
139649299|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139649300|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
139649301|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
139649302|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649303|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139649304|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139649305|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139649306|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
139649307|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649308|NCT01668654|Ezogabine|ezogabine|mesh-list
139649309|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
139649310|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139649311|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649312|NCT01431105|Atorvastatin|atorvastatin|mesh-list
139649313|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139649314|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139649315|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
139649316|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649317|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139649318|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139649319|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649320|NCT03038958|Prilocaine|prilocaine|mesh-list
139649321|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
139649322|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
139649323|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
139649324|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397116|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139397117|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139397118|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139397119|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137606|NCT01202097|Hormones|hormones|mesh-ancestor
139397120|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397121|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
139397122|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
139397123|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649325|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649326|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
139649327|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649328|NCT04840290|Paclitaxel|paclitaxel|mesh-list
139649329|NCT04840290|Carboplatin|carboplatin|mesh-list
139649330|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139649331|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649332|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
139649333|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
139649334|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
139649335|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649336|NCT02630069|Choline|choline|mesh-list
139649337|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139649338|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
139649339|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139649340|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
139649341|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649342|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139649343|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139649344|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
139649345|NCT01431339|Vancomycin|vancomycin|mesh-list
139649346|NCT01431339|Linezolid|linezolid|mesh-list
139649347|NCT01431339|Dalbavancin|dalbavancin|mesh-list
139649348|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139649349|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139649350|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139649351|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727865|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649352|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649353|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
139649354|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
139649355|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139649356|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649357|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649358|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
139649359|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139649360|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139649361|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649362|NCT04843644|Propolis|propolis|mesh-list
139649363|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139649364|NCT02588105|Leucovorin|leucovorin|mesh-list
139649365|NCT02588105|Folic Acid|folic acid|mesh-list
139649366|NCT02588105|Fluorouracil|fluorouracil|mesh-list
139649367|NCT02588105|Irinotecan|irinotecan|mesh-list
139649368|NCT02588105|Olaparib|olaparib|mesh-list
139649369|NCT02588105|AZD0156|azd0156|mesh-list
139649370|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
139649371|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
138727887|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
139649372|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649373|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139649374|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649375|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139649376|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
139649377|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649378|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139649379|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139649380|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649381|NCT02588105|Antidotes|antidotes|mesh-ancestor
139649382|NCT02588105|Protective Agents|protective agents|mesh-ancestor
139649383|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
139649384|NCT02588105|Vitamins|vitamins|mesh-ancestor
139649385|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
139649386|NCT02588105|Hematinics|hematinics|mesh-ancestor
139649387|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139649388|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139649389|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139649390|NCT01488279|Dexamethasone|dexamethasone|mesh-list
139649391|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
139397124|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397125|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139649392|NCT01488279|BB 1101|bb 1101|mesh-list
139649393|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139649394|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
139649395|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
139649396|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397126|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139649397|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649398|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139649399|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
139649400|NCT01488279|Hormones|hormones|mesh-ancestor
139649401|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649402|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139649403|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649404|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
139649405|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649406|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649407|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139649408|NCT01488279|Incretins|incretins|mesh-ancestor
139649409|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139649410|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
139649411|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
139649412|NCT03008109|Endostatins|endostatins|mesh-list
139649413|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649414|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139649415|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139649416|NCT03008109|Growth Substances|growth substances|mesh-ancestor
139649417|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649418|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
139649419|NCT02562443|ON 01910|on 01910|mesh-list
139649420|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649421|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139649422|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649423|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649424|NCT04843098|Paclitaxel|paclitaxel|mesh-list
139649425|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139649426|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649427|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
139649428|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
139649429|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
139649430|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649431|NCT01490931|Ketorolac|ketorolac|mesh-list
139649432|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139649433|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139649434|NCT01490931|Analgesics|analgesics|mesh-ancestor
139649435|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
139649436|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649437|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649438|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139649439|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139649440|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139649441|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649442|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649443|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
139649444|NCT02562365|Carboplatin|carboplatin|mesh-list
139649445|NCT02562365|Etoposide|etoposide|mesh-list
139649446|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139649447|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
139649448|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649449|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139649450|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139649451|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
139649452|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649453|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649454|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139649455|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139649456|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139649457|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139649458|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649459|NCT01491633|Dasatinib|dasatinib|mesh-list
139649460|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649461|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139649462|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649463|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649464|NCT01433913|Metformin|metformin|mesh-list
139649465|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139649466|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649467|NCT04839198|Nicotine|nicotine|mesh-list
139397127|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
139397128|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139649468|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139649469|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
139649470|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649471|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649472|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139649473|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139649474|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
139649475|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649476|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649477|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
139649478|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139649479|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139649480|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139649481|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649482|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
139649483|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649484|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649485|NCT02508467|Fisogatinib|fisogatinib|mesh-list
139649486|NCT02508467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649487|NCT05586347|Nicardipine|nicardipine|mesh-list
139649488|NCT05586347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139649489|NCT05586347|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139649490|NCT05586347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139649491|NCT05586347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649492|NCT05586347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139649493|NCT05586347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649494|NCT05586347|Vasodilator Agents|vasodilator agents|mesh-ancestor
139649495|NCT01436799|Alfentanil|alfentanil|mesh-list
139649496|NCT01436799|Propofol|propofol|mesh-list
139649497|NCT01436799|Desflurane|desflurane|mesh-list
139649498|NCT01436799|Rocuronium|rocuronium|mesh-list
139649499|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139649500|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139649501|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649502|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139649503|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
139649504|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
139649505|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139649506|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139649507|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139649508|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649509|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139649510|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139649511|NCT01436799|Narcotics|narcotics|mesh-ancestor
139649512|NCT01436799|Analgesics|analgesics|mesh-ancestor
139649513|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
139649514|NCT04851132|Durvalumab|durvalumab|mesh-list
139649515|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139649516|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649517|NCT02504489|Docetaxel|docetaxel|mesh-list
139649518|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649519|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
139649520|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
139649521|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
139649522|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649523|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139649524|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649525|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139649526|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649527|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649528|NCT02415413|Dexamethasone|dexamethasone|mesh-list
139649529|NCT02415413|Lenalidomide|lenalidomide|mesh-list
139649530|NCT02415413|Melphalan|melphalan|mesh-list
139649531|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139649532|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
139649533|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
139649534|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649535|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649536|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139649537|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
139397129|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139397130|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139397131|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139649538|NCT02415413|Hormones|hormones|mesh-ancestor
139649539|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649541|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649542|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
139649543|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139649544|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139649545|NCT02415413|Growth Substances|growth substances|mesh-ancestor
139649546|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
139649547|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139649548|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
139649549|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649550|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139649551|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139649552|NCT01894061|Bevacizumab|bevacizumab|mesh-list
139649553|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139649554|NCT01894061|Antibodies|antibodies|mesh-list
139649555|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
139649556|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139649557|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649558|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139649559|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139649560|NCT01894061|Growth Substances|growth substances|mesh-ancestor
139649561|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649562|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
139649563|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
139649564|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
139649565|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139649566|NCT01561053|Antibodies|antibodies|mesh-list
139649567|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
139649568|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649569|NCT01561833|Sorafenib|sorafenib|mesh-list
139649570|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649571|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139649572|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649573|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649574|NCT02607306|Insulin|insulin|mesh-list
139649575|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139649576|NCT02607306|Liraglutide|liraglutide|mesh-list
139649577|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
139649578|NCT02607306|Xultophy|xultophy|mesh-list
139649579|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139649580|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649581|NCT02607306|Incretins|incretins|mesh-ancestor
139649582|NCT02607306|Hormones|hormones|mesh-ancestor
139649583|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649584|NCT03040128|Minocycline|minocycline|mesh-list
139649585|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139649586|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139649587|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
139649588|NCT04850040|Apatinib|apatinib|mesh-list
139649589|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649590|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139649591|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649592|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649593|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
139649594|NCT03038334|Analgesics|analgesics|mesh-ancestor
139649595|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
139649596|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649597|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649598|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
139649599|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139649600|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139649601|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
139649602|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138728638|NCT05180032|Denosumab|denosumab|mesh-list
139649603|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139649604|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649605|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139649606|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
139649607|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139649608|NCT01441245|Furosemide|furosemide|mesh-list
139649609|NCT01441245|Diuretics|diuretics|mesh-ancestor
139649610|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
139649611|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649612|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139649613|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139137887|NCT01202487|Lidocaine|lidocaine|mesh-list
139649614|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649615|NCT01563081|Cetirizine|cetirizine|mesh-list
139649616|NCT01563081|Levocetirizine|levocetirizine|mesh-list
139649617|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139649618|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138728709|NCT05101018|Denosumab|denosumab|mesh-list
139649619|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
139649620|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
139649621|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649622|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649623|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649624|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139649625|NCT04833738|Triamcinolone|triamcinolone|mesh-list
139649626|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139649627|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139649628|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
139649629|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139649630|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139649631|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
139649632|NCT04833738|Hormones|hormones|mesh-ancestor
139649633|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649634|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649635|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139649636|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
139649637|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649638|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649639|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139649640|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
139649641|NCT04833738|Protective Agents|protective agents|mesh-ancestor
139649642|NCT01441401|Gabapentin|gabapentin|mesh-list
139649643|NCT01441401|Analgesics|analgesics|mesh-ancestor
139649644|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
139649645|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649646|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649647|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
139649648|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139649649|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139649650|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139649651|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139649652|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139649653|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139649654|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649655|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649656|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
139649657|NCT02268695|Docetaxel|docetaxel|mesh-list
139649658|NCT02268695|Cetuximab|cetuximab|mesh-list
139649659|NCT02268695|Lenograstim|lenograstim|mesh-list
139649660|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649661|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
139649662|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
139649663|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
139649664|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649665|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139649666|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139649667|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
139649668|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649669|NCT01495923|Gabapentin|gabapentin|mesh-list
139649670|NCT01495923|Analgesics|analgesics|mesh-ancestor
139649671|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
139649672|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649673|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649674|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
139649675|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139649676|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139649677|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139649678|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139649679|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139649680|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139649681|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649682|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649683|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
139397132|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
139649684|NCT03037944|Drospirenone|drospirenone|mesh-list
139649685|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
139397133|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139397134|NCT02204839|Insulin|insulin|mesh-list
139397135|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
139397136|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
139649686|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139649687|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139649688|NCT03037944|Estradiol|estradiol|mesh-list
139649689|NCT03037944|Estrogens|estrogens|mesh-ancestor
139649690|NCT03037944|Hormones|hormones|mesh-ancestor
139649691|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649692|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649693|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139649694|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
139649695|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139649696|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139649697|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139649698|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139649699|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139649700|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139649701|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
139649702|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139649703|NCT03037944|Diuretics|diuretics|mesh-ancestor
139649704|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
139649705|NCT03039426|Diclofenac|diclofenac|mesh-list
139649706|NCT03039426|Bupivacaine|bupivacaine|mesh-list
139649707|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
139649708|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
139649709|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139649710|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649711|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
139649712|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649713|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139649714|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139649715|NCT03039426|Analgesics|analgesics|mesh-ancestor
139649716|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139649717|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139649718|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139649719|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649720|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649721|NCT02205515|Everolimus|everolimus|mesh-list
139649722|NCT02205515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139649723|NCT02205515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139649724|NCT02205515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649725|NCT02205515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649726|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139649727|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
139649728|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649729|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649730|NCT04833036|Irinotecan|irinotecan|mesh-list
139649731|NCT04833036|Cetuximab|cetuximab|mesh-list
139649732|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139649733|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139649734|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649735|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649736|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649737|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139649738|NCT04832880|Remdesivir|remdesivir|mesh-list
139649739|NCT04832880|Dexamethasone|dexamethasone|mesh-list
139649740|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139649741|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
139649742|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
139649743|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649744|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728992|NCT04355572|Vitamin D|vitamin d|mesh-list
139649745|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139649746|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
139649747|NCT04832880|Hormones|hormones|mesh-ancestor
139649748|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649749|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139649750|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649751|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
139649752|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649753|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
139649754|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397137|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139397138|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649755|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
139649756|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139397139|NCT02209909|Aspirin|aspirin|mesh-list
139649757|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139649758|NCT01894295|Vitamin D|vitamin d|mesh-list
139649759|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139649760|NCT01894295|Vitamins|vitamins|mesh-ancestor
139649761|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
139649762|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649763|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139649764|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139649765|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139649766|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
139649767|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649768|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649769|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649770|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
139649771|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
139649772|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139649773|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139649774|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139649775|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139649776|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649777|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649778|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649779|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
139649780|NCT04824924|Venetoclax|venetoclax|mesh-list
139649781|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649782|NCT04553705|Quinine|quinine|mesh-list
139649783|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
139649784|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139649785|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139649786|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139649787|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139649788|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649789|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139649790|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649791|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139649792|NCT04553705|Analgesics|analgesics|mesh-ancestor
139649793|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
139649794|NCT02140151|Ranibizumab|ranibizumab|mesh-list
139649795|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139649796|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139649797|NCT02140151|Growth Substances|growth substances|mesh-ancestor
139649798|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649799|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
139649800|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649801|NCT02135315|Isosorbide|isosorbide|mesh-list
139649802|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139649803|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139649804|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139649805|NCT02135315|Diuretics|diuretics|mesh-ancestor
139649806|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
139649807|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649808|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
139649809|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139649810|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649811|NCT01894373|Immunomodulating Agents|immunomodulating agents|mesh-list
139649812|NCT01894373|Immunologic Factors|immunologic factors|mesh-ancestor
138729161|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
139649813|NCT01894373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649814|NCT04837170|Ketamine|ketamine|mesh-list
139649815|NCT04837170|Esketamine|esketamine|mesh-list
139649816|NCT04837170|Analgesics|analgesics|mesh-ancestor
139649817|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
139649818|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649819|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649820|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139649821|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139649822|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
139649823|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
139649824|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139649825|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139649826|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139649827|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649828|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649829|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
139397140|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139649830|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139649831|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139649832|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
139649833|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139649834|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
139649835|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139649836|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649837|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139649838|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139649839|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649840|NCT02099591|Naloxegol|naloxegol|mesh-list
139649841|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139649842|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649843|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
139649844|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649845|NCT01568073|Levodopa|levodopa|mesh-list
139649846|NCT01568073|Carbidopa|carbidopa|mesh-list
139649847|NCT01568073|Opicapone|opicapone|mesh-list
139649848|NCT01568073|Entacapone|entacapone|mesh-list
139649849|NCT01568073|Benserazide|benserazide|mesh-list
139649850|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139649851|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139649852|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
139649853|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649854|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649855|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649856|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139649857|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649858|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139649859|NCT04274933|Capecitabine|capecitabine|mesh-list
139649860|NCT04274933|Venetoclax|venetoclax|mesh-list
139649861|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139649862|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
139649863|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649864|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649865|NCT02603952|Oseltamivir|oseltamivir|mesh-list
139649866|NCT02603952|MEDI8852|medi8852|mesh-list
139649867|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
139649868|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139649869|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649870|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649871|NCT02062463|Budesonide|budesonide|mesh-list
139649872|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
139649873|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139649874|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139649875|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139649876|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
139649877|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649878|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649879|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139649880|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
139649881|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
139649882|NCT02062463|Hormones|hormones|mesh-ancestor
139649883|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649884|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139649885|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139649886|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139649887|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
139649888|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649889|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649890|NCT01501929|Metoprolol|metoprolol|mesh-list
139649891|NCT01501929|Nebivolol|nebivolol|mesh-list
139649892|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139649893|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139649894|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
139649895|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
139649896|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649897|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649898|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139649899|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139649900|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139649901|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
139649902|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397141|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139397143|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
139138180|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397144|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729548|NCT02741570|Cisplatin|cisplatin|mesh-list
139649903|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649904|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
139649905|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139649906|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139649907|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139649908|NCT05618496|Hyaluronic Acid|hyaluronic acid|mesh-list
139649909|NCT05618496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139649910|NCT05618496|Immunologic Factors|immunologic factors|mesh-ancestor
139649911|NCT05618496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649912|NCT05618496|Viscosupplements|viscosupplements|mesh-ancestor
139649913|NCT05618496|Protective Agents|protective agents|mesh-ancestor
139649914|NCT02049593|Irinotecan|irinotecan|mesh-list
139649915|NCT02049593|Temozolomide|temozolomide|mesh-list
139649916|NCT02049593|Talazoparib|talazoparib|mesh-list
139649917|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139649918|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139649919|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139649920|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649921|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649922|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649923|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139649924|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
139649925|NCT02049047|Everolimus|everolimus|mesh-list
139649926|NCT02049047|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139649927|NCT02049047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139649928|NCT02049047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649929|NCT02049047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649930|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139649931|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
139649932|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649933|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649934|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139649935|NCT04778358|Hormones|hormones|mesh-ancestor
139649936|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649937|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649938|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139649939|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139649940|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649941|NCT01449747|Incretins|incretins|mesh-ancestor
139649942|NCT01449747|Hormones|hormones|mesh-ancestor
139649943|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139649944|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139649945|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
139649946|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649947|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649948|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
139649949|NCT03035838|Aprepitant|aprepitant|mesh-list
139649950|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
139649951|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
139649952|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649953|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649954|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139649955|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139649956|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139649957|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649958|NCT01569087|Lenograstim|lenograstim|mesh-list
139649959|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139649960|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
139649961|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649962|NCT02024087|Sorafenib|sorafenib|mesh-list
139649963|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649964|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139649965|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139649966|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649967|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
139649968|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
139649969|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649970|NCT01895621|Protective Agents|protective agents|mesh-ancestor
139649971|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649972|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
139649973|NCT01895621|Vitamins|vitamins|mesh-ancestor
139649974|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
139649975|NCT01517711|Tramadol|tramadol|mesh-list
139649976|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139397145|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649978|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139649979|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139649980|NCT01517711|Analgesics|analgesics|mesh-ancestor
139649981|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
139649982|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139649983|NCT04836078|Chitosan|chitosan|mesh-list
139649984|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139649985|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139649986|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
139649987|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139649988|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139649989|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
139649990|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
139649991|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
139649992|NCT04836078|Coagulants|coagulants|mesh-ancestor
139649993|NCT00055237|Bevacizumab|bevacizumab|mesh-list
139649994|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139649995|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139649996|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139649997|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139649998|NCT00055237|Growth Substances|growth substances|mesh-ancestor
139649999|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650000|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
139650001|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
139650002|NCT04836156|Carboplatin|carboplatin|mesh-list
139650003|NCT04836156|Docetaxel|docetaxel|mesh-list
139650004|NCT04836156|Epirubicin|epirubicin|mesh-list
139650005|NCT04836156|Phenobarbital|phenobarbital|mesh-list
139650006|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139650007|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
139650008|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650009|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139650010|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139650011|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
139650012|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650013|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650014|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139650015|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
139650016|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
139650017|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
139650018|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139650019|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139650020|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139650021|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650022|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
139650023|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139650024|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650025|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139650026|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139650027|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650028|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
139650029|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
139650030|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139650031|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139650032|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139650033|NCT01502787|Metoprolol|metoprolol|mesh-list
139650034|NCT01502787|Nebivolol|nebivolol|mesh-list
139650035|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
139650036|NCT01502787|Giapreza|giapreza|mesh-list
139650037|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
139650038|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139650039|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139650040|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
139650041|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
139650042|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650043|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650044|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139650045|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139650046|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139650047|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
139397146|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139650048|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650049|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397147|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139650050|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
139650051|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139650052|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139650053|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138729786|NCT02199184|Cortisone|cortisone|mesh-list
139650054|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139650055|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139650056|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
139650057|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650059|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650060|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650061|NCT00153985|Fludarabine|fludarabine|mesh-list
139650062|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
139650063|NCT00153985|Busulfan|busulfan|mesh-list
139650064|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650065|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650066|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139650067|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
139650068|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650069|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139650070|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
139650071|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139650072|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139650073|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
139650074|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139650075|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139650076|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
139650077|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139650078|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139650079|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139650080|NCT02318303|Analgesics|analgesics|mesh-ancestor
139650081|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
139650082|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650083|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650084|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139650085|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139650086|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139650087|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
139650088|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
139650089|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650090|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650091|NCT01451775|Empagliflozin|empagliflozin|mesh-list
139650092|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138729915|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
139650093|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650094|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139650095|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650096|NCT04304040|Antibodies|antibodies|mesh-list
139650097|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139650098|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
139650099|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650100|NCT00156013|Clofarabine|clofarabine|mesh-list
139650101|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139650102|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
139650103|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650104|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650105|NCT01358669|Denosumab|denosumab|mesh-list
139650106|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139650107|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650108|NCT00156247|Acitretin|acitretin|mesh-list
139650109|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
139650110|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
139650111|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139650112|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
139650113|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139650114|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139650115|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139650116|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650117|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650118|NCT01573533|Rituximab|rituximab|mesh-list
139397148|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139397149|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139650119|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139650120|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397150|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650121|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
139650122|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650123|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139650124|NCT01455519|Hydromorphone|hydromorphone|mesh-list
139650125|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139650126|NCT01455519|Narcotics|narcotics|mesh-ancestor
139650127|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138730171|NCT00546351|Lacosamide|lacosamide|mesh-list
139650128|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650129|NCT01455519|Analgesics|analgesics|mesh-ancestor
139650130|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
139650131|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650132|NCT00157573|Sargramostim|sargramostim|mesh-list
139650133|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
139650134|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650135|NCT04822038|Vitamin D|vitamin d|mesh-list
139650136|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
139650137|NCT04822038|Vitamins|vitamins|mesh-ancestor
139650138|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
139650139|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650140|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138730225|NCT06031363|Analgesics|analgesics|mesh-ancestor
139650141|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139650142|NCT01576809|Acetaminophen|acetaminophen|mesh-list
139650143|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
139650144|NCT01576809|Phenylephrine|phenylephrine|mesh-list
139650145|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
139650146|NCT01576809|Guaifenesin|guaifenesin|mesh-list
139650147|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139650148|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139650149|NCT01576809|Analgesics|analgesics|mesh-ancestor
139650150|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
139650151|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650152|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650153|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
139650154|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139650155|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
139650156|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
139650157|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
139650158|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139650159|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
139650160|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
139650161|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139650162|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139650163|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139650164|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
139650165|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650166|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650167|NCT01576809|Protective Agents|protective agents|mesh-ancestor
139650168|NCT01576809|Expectorants|expectorants|mesh-ancestor
139650169|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
139650170|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139650171|NCT01456143|Proflavine|proflavine|mesh-list
139650172|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139650173|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139650174|NCT01456299|Remifentanil|remifentanil|mesh-list
139650175|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139650176|NCT01456299|Narcotics|narcotics|mesh-ancestor
139650177|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650178|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650179|NCT01456299|Analgesics|analgesics|mesh-ancestor
139650180|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
139650181|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650182|NCT00158743|Digoxin|digoxin|mesh-list
139650183|NCT00158743|Antibodies|antibodies|mesh-list
139650184|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
139650185|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
139650186|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650187|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139650188|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139650189|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650190|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650191|NCT00158743|Protective Agents|protective agents|mesh-ancestor
139650192|NCT00161473|Prazosin|prazosin|mesh-list
139650193|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139650194|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139650195|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139650196|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139397151|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139650198|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650199|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650200|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650201|NCT01319981|Cytarabine|cytarabine|mesh-list
139650202|NCT01319981|Dexamethasone|dexamethasone|mesh-list
139650203|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
139650204|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139650205|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139650206|NCT01319981|Prednisolone|prednisolone|mesh-list
139650207|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
139650208|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
139650209|NCT01319981|Rituximab|rituximab|mesh-list
139650210|NCT01319981|Doxorubicin|doxorubicin|mesh-list
139650211|NCT01319981|Methotrexate|methotrexate|mesh-list
139650212|NCT01319981|Vincristine|vincristine|mesh-list
139650213|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
139650214|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139650215|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
139650216|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139650217|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
139650218|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730523|NCT05615012|Leucovorin|leucovorin|mesh-list
139650219|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139650220|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139650221|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
139650222|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650223|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650224|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139650225|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139650226|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
139650227|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
139650228|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650229|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139650230|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
139650231|NCT01319981|Hormones|hormones|mesh-ancestor
139650232|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139650233|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139650234|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139650235|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139650236|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139650237|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139650238|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650239|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139650240|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
139650241|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139650242|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139650243|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
139650244|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
139650245|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139650246|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139650247|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
139650248|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139650249|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139650250|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
139650251|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
139650252|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
139650253|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139650254|NCT01319981|Protective Agents|protective agents|mesh-ancestor
139650255|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139650256|NCT01458561|Thrombin|thrombin|mesh-list
139650257|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139650258|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
139650259|NCT01458561|Coagulants|coagulants|mesh-ancestor
139650260|NCT00065611|Dexamethasone|dexamethasone|mesh-list
139650261|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139650262|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
139650263|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
139650264|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650265|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650266|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139397152|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139650267|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
139650268|NCT00065611|Hormones|hormones|mesh-ancestor
139138547|NCT03813303|Narcotics|narcotics|mesh-ancestor
139650269|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139650270|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139650271|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650272|NCT00066781|Gemcitabine|gemcitabine|mesh-list
139650273|NCT00066781|Irinotecan|irinotecan|mesh-list
139650274|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139650275|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
139650276|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650277|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650278|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139650279|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139650280|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650281|NCT01431755|Lidocaine|lidocaine|mesh-list
139650282|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
139650283|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
139650284|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
139650285|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650286|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650287|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
139650288|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650289|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139650290|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139650291|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139650292|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139650293|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650294|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139650295|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
139650296|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
139650297|NCT01431755|Protective Agents|protective agents|mesh-ancestor
139650298|NCT00066937|Benztropine|benztropine|mesh-list
139650299|NCT00066937|Nortriptyline|nortriptyline|mesh-list
139650300|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139650301|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
139650302|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139650303|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139650304|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139650305|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139650306|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650307|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
139650308|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650309|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650310|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139650311|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139650312|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
139650313|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
139650314|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650315|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139650316|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139650317|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
139650318|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139650319|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
139650320|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
139650321|NCT01064375|Molgramostim|molgramostim|mesh-list
139650322|NCT01064375|Sargramostim|sargramostim|mesh-list
139650323|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139650324|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
139650325|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650326|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139650327|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139650328|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
139650329|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650330|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650331|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139650332|NCT01061411|Sunitinib|sunitinib|mesh-list
139650333|NCT01061411|Dalteparin|dalteparin|mesh-list
139650334|NCT01061411|Tinzaparin|tinzaparin|mesh-list
139650335|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139650336|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650337|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139650338|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139650339|NCT01061411|Growth Substances|growth substances|mesh-ancestor
139397154|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
139650340|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650341|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
139138632|NCT02047552|Iron|iron|mesh-list
139650342|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139650343|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650344|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650345|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
139650346|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139650347|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139650348|NCT01505673|Liraglutide|liraglutide|mesh-list
139650349|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139650350|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650351|NCT01505673|Incretins|incretins|mesh-ancestor
139650352|NCT01505673|Hormones|hormones|mesh-ancestor
139650353|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139650354|NCT04834986|Lenvatinib|lenvatinib|mesh-list
139650355|NCT04834986|Tislelizumab|tislelizumab|mesh-list
139650356|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650357|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139650358|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650359|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650360|NCT04834986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139650361|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
139650362|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139650363|NCT02247141|Antibodies|antibodies|mesh-list
139650364|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
139650365|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650366|NCT01896245|Sevoflurane|sevoflurane|mesh-list
139650367|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139650368|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139650369|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
139650370|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
139650371|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650372|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650373|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
139650374|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139650375|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
139650376|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650377|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
139650378|NCT04821804|Protective Agents|protective agents|mesh-ancestor
139650379|NCT04835064|Paclitaxel|paclitaxel|mesh-list
139650380|NCT04835064|Gemcitabine|gemcitabine|mesh-list
139650381|NCT04835064|Folfirinox|folfirinox|mesh-list
139650382|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139650383|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650384|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
139650385|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
139650386|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
139650387|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650388|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139650389|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
139650390|NCT00819221|Doxorubicin|doxorubicin|mesh-list
139650391|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139650392|NCT00819221|Olaparib|olaparib|mesh-list
139650393|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139650394|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650395|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139650396|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139650397|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650398|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650399|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139650400|NCT01507779|Vaccines|vaccines|mesh-list
139650401|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
139650402|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731121|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
138731122|NCT03781934|Lenvatinib|lenvatinib|mesh-list
138731123|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138731124|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731125|NCT03781934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138731126|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731127|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138731128|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731129|NCT03779854|Vidarabine|vidarabine|mesh-list
138731130|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
138731131|NCT03779854|Busulfan|busulfan|mesh-list
138731132|NCT03779854|Thiotepa|thiotepa|mesh-list
139650403|NCT01896323|Ketoconazole|ketoconazole|mesh-list
139650404|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
139650405|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139650406|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139650407|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139650408|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650409|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650410|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139397155|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139397156|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
139397157|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397158|NCT02205151|Amlodipine|amlodipine|mesh-list
139650411|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
138731168|NCT03725202|Upadacitinib|upadacitinib|mesh-list
139650412|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139397159|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139397160|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139650413|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650414|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139650415|NCT00068341|Carboplatin|carboplatin|mesh-list
139650417|NCT00068341|Trastuzumab|trastuzumab|mesh-list
139650418|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650419|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
139650420|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
139650421|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
139650422|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650423|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139650424|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
139650425|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139650426|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
139650427|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139650428|NCT02605824|Expectorants|expectorants|mesh-ancestor
139650429|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
139650430|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139650431|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
139650432|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650433|NCT02605824|Protective Agents|protective agents|mesh-ancestor
139650434|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650435|NCT02605824|Antidotes|antidotes|mesh-ancestor
138731243|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731244|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138731245|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731246|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138731247|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
138731248|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731249|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731250|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138731251|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138731252|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138731253|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138731254|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
138731255|NCT03150329|Vorinostat|vorinostat|mesh-list
139650436|NCT01896661|Amlodipine|amlodipine|mesh-list
139650437|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
139650438|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
139650439|NCT01896661|Amiloride|amiloride|mesh-list
139650440|NCT01896661|Calcium|calcium|mesh-list
139650441|NCT01896661|Diuretics|diuretics|mesh-list
139650442|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139650443|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650444|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139650445|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139650446|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650447|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
139650448|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
139650449|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139650450|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139650451|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139650452|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139650453|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139650454|NCT01462773|Interferons|interferons|mesh-list
139650455|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
139650456|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
139650457|NCT01462773|Bortezomib|bortezomib|mesh-list
139650458|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650459|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
139650460|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139650461|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
139650462|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650463|NCT02096029|Nicotine|nicotine|mesh-list
139650464|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139650465|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
139650466|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650467|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650468|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139650469|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139650470|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
139650471|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731435|NCT00626990|Temozolomide|temozolomide|mesh-list
139650472|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650473|NCT02205801|Bupivacaine|bupivacaine|mesh-list
139650474|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
139650475|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
139650476|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650477|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650478|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
139650479|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650480|NCT02096107|Everolimus|everolimus|mesh-list
139650481|NCT02096107|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139650482|NCT02096107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139650483|NCT02096107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650484|NCT02096107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650485|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139138764|NCT02050360|Urological Agents|urological agents|mesh-ancestor
139650486|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
139650487|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650488|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650489|NCT04834440|Ropivacaine|ropivacaine|mesh-list
139650490|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
139650491|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
139650492|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650493|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650494|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
139650495|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650496|NCT00068575|Interferons|interferons|mesh-list
139650497|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
139650498|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
139650499|NCT00068575|Cisplatin|cisplatin|mesh-list
139650500|NCT00068575|Fluorouracil|fluorouracil|mesh-list
139650501|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650502|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
139650503|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650504|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139650505|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139650506|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
139650507|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650508|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
139650509|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139650510|NCT00784823|Bortezomib|bortezomib|mesh-list
139650511|NCT00784823|Melphalan|melphalan|mesh-list
139650512|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650513|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139650514|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
139650515|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650516|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139650517|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139650518|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
139650519|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650520|NCT04428684|Goserelin|goserelin|mesh-list
139650521|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139650522|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650523|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139650524|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
139650525|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650526|NCT00773357|Guanfacine|guanfacine|mesh-list
139650527|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139650528|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139650529|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139650530|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139650531|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
139650532|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650533|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650534|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650535|NCT05617950|Salicylic Acid|salicylic acid|mesh-list
139650536|NCT05617950|Salicylates|salicylates|mesh-list
139650537|NCT05617950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139650538|NCT05617950|Antifungal Agents|antifungal agents|mesh-ancestor
139650539|NCT05617950|Keratolytic Agents|keratolytic agents|mesh-ancestor
139650540|NCT05617950|Dermatologic Agents|dermatologic agents|mesh-ancestor
139650541|NCT05617950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139650542|NCT05617950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139650543|NCT05617950|Analgesics|analgesics|mesh-ancestor
139650544|NCT05617950|Sensory System Agents|sensory system agents|mesh-ancestor
139650545|NCT05617950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650546|NCT05617950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650547|NCT05617950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139650548|NCT05617950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139650549|NCT05617950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139650550|NCT05617950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650551|NCT05617950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650552|NCT04834752|Esomeprazole|esomeprazole|mesh-list
139650553|NCT04834752|Omeprazole|omeprazole|mesh-list
139650554|NCT04834752|Rabeprazole|rabeprazole|mesh-list
139397161|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139397162|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650555|NCT04834752|Pantoprazole|pantoprazole|mesh-list
139650556|NCT04834752|Lansoprazole|lansoprazole|mesh-list
139138837|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
139650557|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
139650558|NCT04834752|Famotidine|famotidine|mesh-list
139650559|NCT04834752|Ranitidine|ranitidine|mesh-list
139650560|NCT04834752|Cimetidine|cimetidine|mesh-list
139650561|NCT04834752|Nizatidine|nizatidine|mesh-list
139650562|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139650563|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139650564|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139650565|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650566|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650567|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139650568|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
139650569|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
139650570|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650571|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650572|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139650573|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139650574|NCT04834674|Apatinib|apatinib|mesh-list
139650575|NCT04834674|Antibodies|antibodies|mesh-list
139650576|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
139650577|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650578|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650579|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139650580|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650581|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650582|NCT04826406|Apatinib|apatinib|mesh-list
139650583|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650584|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139650585|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650586|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650587|NCT05617872|Acetic Acid|acetic acid|mesh-list
139650588|NCT05617872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139650589|NCT05617872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139650590|NCT00437255|Betamethasone|betamethasone|mesh-list
139650591|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
139650592|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139650593|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
139650594|NCT00437255|Clobetasol|clobetasol|mesh-list
139650595|NCT00437255|Calcipotriene|calcipotriene|mesh-list
139650596|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139650597|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139650598|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
139650599|NCT00437255|Hormones|hormones|mesh-ancestor
139650600|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139650601|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650602|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139650603|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
139650604|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
139650605|NCT02324673|Cannabidiol|cannabidiol|mesh-list
139650606|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
139650607|NCT00373217|Paclitaxel|paclitaxel|mesh-list
139650608|NCT00373217|Carboplatin|carboplatin|mesh-list
139650609|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139650610|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731939|NCT01608360|Lidocaine|lidocaine|mesh-list
139650611|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
139650612|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
139650613|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
139650614|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650615|NCT02605122|Amoxicillin|amoxicillin|mesh-list
139650616|NCT02605122|Azithromycin|azithromycin|mesh-list
139650617|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
139650618|NCT02605122|Erythromycin|erythromycin|mesh-list
139650619|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
139650620|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139650621|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
139650622|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
139650623|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
139650624|NCT02605122|Ampicillin|ampicillin|mesh-list
139650625|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139650626|NCT02605122|Solithromycin|solithromycin|mesh-list
139650627|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
139650628|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139650629|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139650630|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139650631|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139397163|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139650632|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650633|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650634|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139650635|NCT01579305|Lidocaine|lidocaine|mesh-list
139397164|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650636|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
139650637|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
139650638|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650639|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650640|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
139650641|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650642|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139650643|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139650644|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139650645|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139650646|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650647|NCT00212147|Nitrous Oxide|nitrous oxide|mesh-list
139650648|NCT00212147|Anesthetics|anesthetics|mesh-list
139650649|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650650|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650651|NCT00212147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139650652|NCT00212147|Anesthetics, General|anesthetics, general|mesh-ancestor
139650653|NCT00212147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139650654|NCT00212147|Analgesics|analgesics|mesh-ancestor
139650655|NCT00212147|Sensory System Agents|sensory system agents|mesh-ancestor
139650656|NCT00212147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650657|NCT04820010|Insulin|insulin|mesh-list
139650658|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139650659|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650660|NCT04819776|Iloperidone|iloperidone|mesh-list
139650661|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139650662|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139650663|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650664|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732147|NCT01688583|Fentanyl|fentanyl|mesh-list
139650665|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139650666|NCT01454102|Paclitaxel|paclitaxel|mesh-list
139650667|NCT01454102|Bevacizumab|bevacizumab|mesh-list
139650668|NCT01454102|Carboplatin|carboplatin|mesh-list
139650669|NCT01454102|Gemcitabine|gemcitabine|mesh-list
139650670|NCT01454102|Nivolumab|nivolumab|mesh-list
139650671|NCT01454102|Pemetrexed|pemetrexed|mesh-list
139650672|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139650673|NCT01454102|Ipilimumab|ipilimumab|mesh-list
139650674|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139650675|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650676|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
139650677|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
139650678|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
139650679|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650680|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139650681|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139650682|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139650683|NCT01454102|Growth Substances|growth substances|mesh-ancestor
139650684|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650685|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
139650686|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139650687|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
139650688|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139650689|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650690|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139650691|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139650692|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139650693|NCT04192253|Paclitaxel|paclitaxel|mesh-list
139650694|NCT04192253|Carboplatin|carboplatin|mesh-list
139650695|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139650696|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650697|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
139650698|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
138732338|NCT01609491|Phenylephrine|phenylephrine|mesh-list
139650699|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
139650700|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650701|NCT04825938|Paclitaxel|paclitaxel|mesh-list
139650702|NCT04825938|Carboplatin|carboplatin|mesh-list
139650703|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139650704|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650705|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
139650706|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
139397165|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
139650707|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
139650708|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650710|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139650711|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650712|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
139650713|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
139650714|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
139650715|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650716|NCT01509807|Morphine|morphine|mesh-list
139650717|NCT01509807|Bupivacaine|bupivacaine|mesh-list
139650718|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
139650719|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
139650720|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650721|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650722|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
139650723|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650724|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139650725|NCT01509807|Narcotics|narcotics|mesh-ancestor
139650726|NCT01509807|Analgesics|analgesics|mesh-ancestor
139650727|NCT00070135|Methotrexate|methotrexate|mesh-list
139650728|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
139650729|NCT00070135|Fludarabine|fludarabine|mesh-list
139650730|NCT00070135|Busulfan|busulfan|mesh-list
139650731|NCT00070135|Tacrolimus|tacrolimus|mesh-list
139650732|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139650733|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139650734|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
139650735|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139650736|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650737|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139650738|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
139650739|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650740|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650741|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
139650742|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650743|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139650744|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139650745|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
139650746|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139650747|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139650748|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139650749|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
139650750|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139650751|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139650752|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
139650753|NCT01583985|Narcotics|narcotics|mesh-ancestor
139650754|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650755|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650756|NCT01583985|Analgesics|analgesics|mesh-ancestor
139650757|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
139650758|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650759|NCT04816344|Anesthetics|anesthetics|mesh-list
139650760|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650761|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650762|NCT01467999|Guanfacine|guanfacine|mesh-list
139650763|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139650764|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139650765|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139650766|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139650767|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
139650768|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650769|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650770|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650771|NCT05617482|Anesthetics|anesthetics|mesh-list
139650772|NCT05617482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650773|NCT05617482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650774|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
139650775|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139650776|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
139650777|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139650778|NCT01470027|Expectorants|expectorants|mesh-ancestor
139650779|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
139397166|NCT05262985|Durvalumab|durvalumab|mesh-list
139397167|NCT05262985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139650780|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139650781|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
139397168|NCT05262985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397169|NCT05504720|Pembrolizumab|pembrolizumab|mesh-list
139397170|NCT05504720|Trastuzumab|trastuzumab|mesh-list
139650782|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650783|NCT01470027|Protective Agents|protective agents|mesh-ancestor
139650784|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650785|NCT01470027|Antidotes|antidotes|mesh-ancestor
139650786|NCT01470651|Modafinil|modafinil|mesh-list
139650787|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139650788|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650789|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139650790|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139650791|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139650792|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650793|NCT01512225|Domperidone|domperidone|mesh-list
139650794|NCT01512225|Maleic acid|maleic acid|mesh-list
139650795|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650796|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650797|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
139650798|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
139650799|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650800|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650801|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139650802|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139650803|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
139650804|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650805|NCT01472445|Vitamin D|vitamin d|mesh-list
139650806|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
139650807|NCT01472445|Vitamins|vitamins|mesh-ancestor
139650808|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
139650809|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650810|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139650811|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139650812|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139650813|NCT04782089|Fluzoparib|fluzoparib|mesh-list
139650814|NCT04782089|Antibodies|antibodies|mesh-list
139650815|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
139650816|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650817|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650818|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650819|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650820|NCT02604342|Docetaxel|docetaxel|mesh-list
139650821|NCT02604342|Pemetrexed|pemetrexed|mesh-list
139650822|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650823|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
139650824|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
139650825|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
139650826|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650827|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650828|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139650829|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139650830|NCT04781777|Insulin|insulin|mesh-list
139650831|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139650832|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650833|NCT04781075|Bupivacaine|bupivacaine|mesh-list
139650834|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
139650835|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
139650836|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139650837|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650838|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
139650839|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650840|NCT01586091|Fexofenadine|fexofenadine|mesh-list
139650841|NCT01586091|Levocetirizine|levocetirizine|mesh-list
139650842|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139650843|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139650844|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
139650845|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
139650846|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650847|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650848|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650849|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139650850|NCT05565573|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139650851|NCT05565573|Levonorgestrel|levonorgestrel|mesh-list
139650852|NCT05565573|Medroxyprogesterone|medroxyprogesterone|mesh-list
139650853|NCT05565573|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139397171|NCT05504720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139650854|NCT05565573|Contraceptive Agents|contraceptive agents|mesh-ancestor
139397172|NCT05504720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650855|NCT05565573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139650856|NCT05565573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650857|NCT05565573|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139650858|NCT05565573|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139650859|NCT05565573|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139650860|NCT05565573|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139650861|NCT05565573|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139650862|NCT05565573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139650863|NCT05565573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650864|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
139650865|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
139650866|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139650867|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139650868|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139650869|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650870|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650871|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139650872|NCT01587027|Aminophylline|aminophylline|mesh-list
139650873|NCT01587027|Methazolamide|methazolamide|mesh-list
139650874|NCT01587027|Theophylline|theophylline|mesh-list
139650875|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139650876|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
139650877|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650878|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650879|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139650880|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
139650881|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139650882|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650883|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650884|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
139650885|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139650886|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138733027|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
139650887|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
139650888|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650889|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139650890|NCT01587027|Protective Agents|protective agents|mesh-ancestor
139650891|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139650892|NCT01587027|Diuretics|diuretics|mesh-ancestor
139650893|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
139650894|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
139650895|NCT01471340|Prednisone|prednisone|mesh-list
139650896|NCT01471340|Prednisolone|prednisolone|mesh-list
139650897|NCT01471340|Albuterol|albuterol|mesh-list
139650898|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
139650899|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
139650900|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139650901|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
139650902|NCT01471340|Hormones|hormones|mesh-ancestor
139650903|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139650904|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650905|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139650906|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650907|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
139650908|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650909|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139650910|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139650911|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
139650912|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139650913|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139650914|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139650915|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
139650916|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650917|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650918|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
139650919|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139650920|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
139650921|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139650922|NCT04754789|Aspirin|aspirin|mesh-list
139650923|NCT04754789|Ticagrelor|ticagrelor|mesh-list
139650924|NCT04754789|Atorvastatin|atorvastatin|mesh-list
139397173|NCT05504720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139397174|NCT05504720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650925|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139397175|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
139650926|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139650927|NCT04754789|Analgesics|analgesics|mesh-ancestor
139650928|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
139650929|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650930|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650931|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139650932|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139650933|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139650934|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139650935|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650936|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139650937|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139650938|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650939|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
139650940|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139650941|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139650942|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
139650943|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138733200|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139650944|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139650945|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139650946|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139650947|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139650948|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
139650949|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139650950|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139650951|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139650952|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139650953|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
139650954|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139650955|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139650956|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139650957|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139650958|NCT04815408|Paclitaxel|paclitaxel|mesh-list
139650959|NCT04815408|Carboplatin|carboplatin|mesh-list
139650960|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139650961|NCT04815408|Tislelizumab|tislelizumab|mesh-list
139650962|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139650963|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650964|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
139650965|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
139650966|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
139650967|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733254|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139650968|NCT04815408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139650969|NCT04778813|Artesunate|artesunate|mesh-list
139650970|NCT04778813|Lumefantrine|lumefantrine|mesh-list
139650971|NCT04778813|Artemether|artemether|mesh-list
139650972|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139650973|NCT04778813|Artenimol|artenimol|mesh-list
139650974|NCT04778813|Pyronaridine|pyronaridine|mesh-list
139650975|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
139650976|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139650977|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139650978|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139650979|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650980|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
139650981|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
139650982|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139650983|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
139650984|NCT04817982|Dexamethasone|dexamethasone|mesh-list
139650985|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
139650986|NCT04817982|Lidocaine|lidocaine|mesh-list
139650987|NCT04817982|BB 1101|bb 1101|mesh-list
139650988|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139650989|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
139650990|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
139650991|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650992|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139650993|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139397176|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139397177|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
139397178|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139650994|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
139650995|NCT04817982|Hormones|hormones|mesh-ancestor
139139274|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
139397179|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733321|NCT01193257|Prednisone|prednisone|mesh-list
139650996|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139650997|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139650998|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139650999|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
139651000|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651001|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651002|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
139651003|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
139651004|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139651005|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
139651006|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139651007|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139651008|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139651009|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139651011|NCT04779047|Lopinavir|lopinavir|mesh-list
139651012|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
139651013|NCT04779047|Ivermectin|ivermectin|mesh-list
139651014|NCT04779047|Remdesivir|remdesivir|mesh-list
139651015|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139651016|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139651017|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
139651018|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651019|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651020|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139651021|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139651022|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
139651023|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651024|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139651025|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139651026|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
139651027|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139651028|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139651029|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139651030|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
139651031|NCT01515345|Clopidogrel|clopidogrel|mesh-list
139651032|NCT01515345|Ticagrelor|ticagrelor|mesh-list
139651033|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139651034|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139651035|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139651036|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139651037|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139651038|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
139651039|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651040|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651041|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651042|NCT01492400|Dexamethasone|dexamethasone|mesh-list
139651043|NCT01492400|Ranibizumab|ranibizumab|mesh-list
139651044|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139651045|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
139651046|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
139651047|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651048|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651049|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139651050|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
139651051|NCT01492400|Hormones|hormones|mesh-ancestor
139651052|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139651053|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139651054|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651055|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139651056|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139651057|NCT01492400|Growth Substances|growth substances|mesh-ancestor
138733502|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
139651058|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
139651059|NCT00168337|Dexamethasone|dexamethasone|mesh-list
139651060|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139651061|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
139651062|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
139651063|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651064|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651065|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139397180|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139651066|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
139651067|NCT00168337|Hormones|hormones|mesh-ancestor
139397181|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
139397182|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139651068|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139651069|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139651070|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651071|NCT01515657|Aspirin|aspirin|mesh-list
139651072|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139651073|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139651074|NCT01515657|Analgesics|analgesics|mesh-ancestor
139651075|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
139651076|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651077|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651078|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139651079|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139651080|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139651081|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139651082|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651083|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138733569|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
139651084|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139651085|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651086|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
139651087|NCT01515891|Opicapone|opicapone|mesh-list
139651088|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139651089|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651090|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651091|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139651092|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139651093|NCT00073957|Cytarabine|cytarabine|mesh-list
139651094|NCT00073957|Rituximab|rituximab|mesh-list
139651095|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139651096|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651097|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
139651098|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651099|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139651100|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139651101|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
139651102|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651103|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
139651104|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651105|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139651106|NCT04354428|Folic Acid|folic acid|mesh-list
139651107|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
139651108|NCT04354428|Ritonavir|ritonavir|mesh-list
139651109|NCT04354428|Lopinavir|lopinavir|mesh-list
139651110|NCT04354428|Azithromycin|azithromycin|mesh-list
139651111|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
139651112|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139651113|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139651114|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
139651115|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651116|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651117|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139651118|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139651119|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
139651120|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651121|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139651122|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139651123|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139651124|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
139651125|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139651126|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139651127|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139651128|NCT04354428|Hematinics|hematinics|mesh-ancestor
139651129|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
139651130|NCT04354428|Vitamins|vitamins|mesh-ancestor
139651131|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
139651132|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651133|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
139651134|NCT04354428|Protective Agents|protective agents|mesh-ancestor
139651135|NCT02090075|Warfarin|warfarin|mesh-list
139651136|NCT02090075|Apixaban|apixaban|mesh-list
139651137|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
139651138|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139651139|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
139651140|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139651141|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
139651142|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651143|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651144|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139651145|NCT04817202|Antibodies|antibodies|mesh-list
139651146|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
139651147|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139651148|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
139651149|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651150|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651151|NCT04775303|Cyclosporine|cyclosporine|mesh-list
139651152|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139651153|NCT04775303|Cyclosporins|cyclosporins|mesh-list
139651154|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651155|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651156|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139651157|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
139651158|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651159|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
139651160|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651161|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
139651162|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139651163|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139651164|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139651165|NCT04816968|Vancomycin|vancomycin|mesh-list
139651166|NCT04816968|Meropenem|meropenem|mesh-list
139651167|NCT04816968|Tazobactam|tazobactam|mesh-list
139651168|NCT04816968|Piperacillin|piperacillin|mesh-list
139651169|NCT04816968|Cefepime|cefepime|mesh-list
139651170|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139651171|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139651172|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651173|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139651174|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651175|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651176|NCT02210247|Bupivacaine|bupivacaine|mesh-list
139651177|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
139651178|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
139651179|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139651180|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651181|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
139651182|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651183|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139651184|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
139651185|NCT04806438|Lidocaine|lidocaine|mesh-list
139651186|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
139651187|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
139651188|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139651189|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651190|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
139651191|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651192|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139651193|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139651194|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139651195|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139651196|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651197|NCT00074035|Pentostatin|pentostatin|mesh-list
139651198|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651199|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139651200|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651201|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651202|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139651203|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139651204|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
139651205|NCT00074815|Citalopram|citalopram|mesh-list
139651206|NCT00074815|Fluoxetine|fluoxetine|mesh-list
139651207|NCT00074815|Paroxetine|paroxetine|mesh-list
139651208|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139651209|NCT00074815|Sertraline|sertraline|mesh-list
139651210|NCT00074815|Clomipramine|clomipramine|mesh-list
139651211|NCT00074815|Escitalopram|escitalopram|mesh-list
139651212|NCT00074815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139651213|NCT00074815|Serotonin|serotonin|mesh-list
139651214|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139651215|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139397183|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
139651216|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651217|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651218|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
139139552|NCT01308177|Ecabet|ecabet|mesh-list
139397184|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651219|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651220|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139651221|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
139651222|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139651223|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138733781|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
139651224|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139651225|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651226|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139651227|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139651228|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139651229|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139651230|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139651231|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139651232|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139651233|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139651234|NCT04772729|Insulin|insulin|mesh-list
139651235|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139651236|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
139651237|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139651238|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651239|NCT05562375|Tolonium Chloride|tolonium chloride|mesh-list
139651240|NCT05562375|Hemostatics|hemostatics|mesh-ancestor
139651241|NCT05562375|Coagulants|coagulants|mesh-ancestor
139651242|NCT05562375|Heparin Antagonists|heparin antagonists|mesh-ancestor
139651243|NCT05562375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651244|NCT00075829|Thalidomide|thalidomide|mesh-list
139651245|NCT00075829|Dexamethasone|dexamethasone|mesh-list
139651246|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139651247|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
139651248|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
139651249|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651250|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651251|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139651252|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
139651253|NCT00075829|Hormones|hormones|mesh-ancestor
139651254|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139651255|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139651256|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651257|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139651258|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
139651259|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
139651260|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139651261|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651262|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139651263|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139651264|NCT00075829|Growth Substances|growth substances|mesh-ancestor
139651265|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
139651266|NCT02218203|Lidocaine|lidocaine|mesh-list
139651267|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
139651268|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
139651269|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
139651270|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139651271|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651272|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
139651273|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651274|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139651275|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139651276|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139651277|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139651278|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651279|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
139651280|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
139651281|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139651282|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139651283|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651284|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
139651285|NCT04771715|Nivolumab|nivolumab|mesh-list
139651286|NCT04771715|Tislelizumab|tislelizumab|mesh-list
139651287|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139651288|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651289|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139651290|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651291|NCT04771559|Antibodies|antibodies|mesh-list
139651292|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
139651293|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651294|NCT02592876|Rituximab|rituximab|mesh-list
139651295|NCT02592876|Carboplatin|carboplatin|mesh-list
139651296|NCT02592876|Etoposide|etoposide|mesh-list
139651297|NCT02592876|Ifosfamide|ifosfamide|mesh-list
139651298|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139651299|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651300|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
139651301|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651302|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139651303|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139651304|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139651305|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139651306|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651307|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651308|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139651309|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
139651310|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139651311|NCT02763137|Carbidopa|carbidopa|mesh-list
139651312|NCT02763137|Levodopa|levodopa|mesh-list
139651313|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139651314|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
139651315|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651316|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139651317|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139651318|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
139651319|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
139651320|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651321|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651322|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139651323|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651324|NCT01896739|Vaccines|vaccines|mesh-list
139651325|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
139651326|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651327|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
139651328|NCT00176839|Melphalan|melphalan|mesh-list
139651329|NCT00176839|Busulfan|busulfan|mesh-list
139651330|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139651331|NCT00176839|Lenograstim|lenograstim|mesh-list
139651332|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139651333|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
139651334|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651335|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139651336|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139651337|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
139651338|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651339|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651340|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139651341|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139651342|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
139651343|NCT00176917|Busulfan|busulfan|mesh-list
139651344|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
139651345|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139651346|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
139651347|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651348|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139651349|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139651350|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
139651351|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651352|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651353|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139651354|NCT02664155|Vitamin K|vitamin k|mesh-list
139651355|NCT02664155|Heparin|heparin|mesh-list
139651356|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
139651357|NCT02664155|Apixaban|apixaban|mesh-list
139651358|NCT02664155|Vitamins|vitamins|mesh-ancestor
139651359|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
139651360|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651361|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
139651362|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139651363|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139651364|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139644|NCT03785613|Analgesics|analgesics|mesh-ancestor
139651365|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139651366|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
139651367|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139651368|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
139651369|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651370|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139651372|NCT02664155|Coagulants|coagulants|mesh-ancestor
139651373|NCT04770389|Ezetimibe|ezetimibe|mesh-list
139651374|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
139651375|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139651376|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
139651377|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651378|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139651379|NCT04753619|Niclosamide|niclosamide|mesh-list
139651380|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
139651381|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139651382|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
139651383|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139651384|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651385|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
139651386|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139651387|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139651388|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651389|NCT01492088|Immunotoxins|immunotoxins|mesh-ancestor
139651390|NCT01492088|Immunoconjugates|immunoconjugates|mesh-ancestor
139651391|NCT01492088|Immunologic Factors|immunologic factors|mesh-ancestor
139651392|NCT01492088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651393|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
139651394|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139651395|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139651396|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651397|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
139651398|NCT04753151|Coagulants|coagulants|mesh-ancestor
139651399|NCT05605925|Ivermectin|ivermectin|mesh-list
139651400|NCT05605925|Lumefantrine|lumefantrine|mesh-list
139651401|NCT05605925|Artemether|artemether|mesh-list
139651402|NCT05605925|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139651403|NCT05605925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139651404|NCT05605925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651405|NCT05605925|Antimalarials|antimalarials|mesh-ancestor
139651406|NCT05605925|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139651407|NCT01520727|Opicapone|opicapone|mesh-list
139651408|NCT01520727|Entacapone|entacapone|mesh-list
139651409|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139651410|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651411|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651412|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139651413|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139651414|NCT01855607|Menthol|menthol|mesh-list
139651415|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
139651416|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
139651417|NCT01596699|Fludarabine|fludarabine|mesh-list
139651418|NCT01596699|Busulfan|busulfan|mesh-list
139651419|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
139651420|NCT01596699|Clofarabine|clofarabine|mesh-list
139651421|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651422|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139651423|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
139651424|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651425|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139651426|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
139651427|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651428|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
139651429|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139651430|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139651431|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139651432|NCT01148849|Margetuximab|margetuximab|mesh-list
139651433|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651434|NCT05605301|Deoxyglucose|deoxyglucose|mesh-list
139651435|NCT05605301|Antimetabolites|antimetabolites|mesh-ancestor
139651436|NCT05605301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651437|NCT05605301|Antiviral Agents|antiviral agents|mesh-ancestor
139651438|NCT05605301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651439|NCT05566743|Capecitabine|capecitabine|mesh-list
139651440|NCT05566743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139651441|NCT05566743|Antimetabolites|antimetabolites|mesh-ancestor
139139719|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
139651442|NCT05566743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651443|NCT05566743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651444|NCT05596721|Azithromycin|azithromycin|mesh-list
139139788|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139651445|NCT05596721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139651446|NCT05596721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651447|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
139651448|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139651449|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139651450|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139651451|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139651452|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651453|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
139651454|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651455|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651456|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139651457|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651458|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139651459|NCT01525173|Bimatoprost|bimatoprost|mesh-list
139651460|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139651461|NCT01525173|Latanoprost|latanoprost|mesh-list
139651462|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139651463|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
139651464|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139651465|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139651466|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139651467|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139651468|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
139651469|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651470|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651471|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651472|NCT03007563|Bilirubin|bilirubin|mesh-list
139651473|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
139651474|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651475|NCT03007563|Protective Agents|protective agents|mesh-ancestor
139651476|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651477|NCT01526577|Ticagrelor|ticagrelor|mesh-list
139651478|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139651479|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139651480|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139651481|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139651482|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
139651483|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651484|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651485|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651486|NCT01894451|Bevacizumab|bevacizumab|mesh-list
139651487|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
139651488|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139651489|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651490|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139651491|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139651492|NCT01894451|Growth Substances|growth substances|mesh-ancestor
139651493|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651494|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
139651495|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139651496|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651497|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
139651498|NCT01527045|Cyclosporine|cyclosporine|mesh-list
139651499|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
139651500|NCT01527045|Fludarabine|fludarabine|mesh-list
139651501|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
139651502|NCT01527045|Atorvastatin|atorvastatin|mesh-list
139651503|NCT01527045|Calcium|calcium|mesh-list
139651504|NCT01527045|Cyclosporins|cyclosporins|mesh-list
139651505|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139651506|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651507|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139651508|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651509|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139651510|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
139651511|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651512|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139651513|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
139651514|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651515|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
139651516|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651517|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
139397185|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139862|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139651518|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139651519|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139651520|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139651521|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139651522|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139651523|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139651524|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139651525|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139651526|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
139651527|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139651528|NCT00078403|Ribavirin|ribavirin|mesh-list
139651529|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139651530|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
139651531|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651532|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
139651533|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651534|NCT01976585|Poly ICLC|poly iclc|mesh-list
139651535|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
139651536|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
139651537|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651538|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139651539|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
139651540|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139651541|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139651542|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139651543|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651544|NCT03001635|Oxytocin|oxytocin|mesh-list
139651545|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
139651546|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139651547|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651548|NCT02592798|Abatacept|abatacept|mesh-list
139651549|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139651550|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651551|NCT02592798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139651552|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651553|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139651554|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
139651555|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651556|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139651557|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139651558|NCT01530243|Terazosin|terazosin|mesh-list
139651559|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139651560|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139651561|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
139651562|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651563|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651564|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651565|NCT01530243|Urological Agents|urological agents|mesh-ancestor
139651566|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139651567|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139651568|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139651569|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
139651570|NCT04797546|Morphine|morphine|mesh-list
139651571|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139651572|NCT04797546|Narcotics|narcotics|mesh-ancestor
139651573|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139651574|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651575|NCT04797546|Analgesics|analgesics|mesh-ancestor
139651576|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
139651577|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651578|NCT02980809|Apatinib|apatinib|mesh-list
139651579|NCT02980809|Topotecan|topotecan|mesh-list
139651580|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651581|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139651582|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651583|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651584|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139651585|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139651586|NCT00078559|Acetaminophen|acetaminophen|mesh-list
139651587|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
139651588|NCT00078559|Promethazine|promethazine|mesh-list
139651589|NCT00078559|Sirolimus|sirolimus|mesh-list
139651590|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139651591|NCT00078559|Nystatin|nystatin|mesh-list
139139937|NCT02055586|Alovudine|alovudine|mesh-list
139651592|NCT00078559|Clotrimazole|clotrimazole|mesh-list
139651593|NCT00078559|Miconazole|miconazole|mesh-list
139651594|NCT00078559|Pentamidine|pentamidine|mesh-list
139651595|NCT00078559|Trimethoprim|trimethoprim|mesh-list
139651596|NCT00078559|Acyclovir|acyclovir|mesh-list
139651597|NCT00078559|Valganciclovir|valganciclovir|mesh-list
139651598|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
139651599|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
139651600|NCT00078559|Tacrolimus|tacrolimus|mesh-list
139651601|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139651602|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
139651603|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651604|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139651605|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651606|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651607|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139651608|NCT00078559|Analgesics|analgesics|mesh-ancestor
139651609|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
139651610|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651611|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
139651612|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139651613|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651614|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139651615|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651616|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
139651617|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139651618|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
139651619|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
139651620|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139651621|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
139651622|NCT00078559|Hormones|hormones|mesh-ancestor
139651623|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139651624|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139651625|NCT00078559|Protective Agents|protective agents|mesh-ancestor
139651626|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139651627|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139651628|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139651629|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139651630|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
139651631|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
139651632|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139651633|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
139651634|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
139651635|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651636|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139651637|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
139651638|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
139651639|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139651640|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
139651641|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139651642|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139651643|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139651644|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139651645|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139651646|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139651647|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
139651648|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139651649|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139651650|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139651651|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
139651652|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139651653|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139651654|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139651655|NCT00078559|Ionophores|ionophores|mesh-ancestor
139651656|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139651657|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
139651658|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139651659|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651660|NCT00078715|Yohimbine|yohimbine|mesh-list
139651661|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
139651662|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
139651663|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651664|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651665|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139651666|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139397186|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139397187|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
139397188|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
139397189|NCT04476992|Protective Agents|protective agents|mesh-ancestor
139397190|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
139397191|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
139397192|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397193|NCT02220673|Protective Agents|protective agents|mesh-ancestor
139397194|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397195|NCT02220751|Doxycycline|doxycycline|mesh-list
139397196|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139397197|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397198|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
139397199|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139397200|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139397201|NCT02205541|Eculizumab|eculizumab|mesh-list
139397202|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139397203|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139397204|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
139397205|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397206|NCT02205619|Glycine|glycine|mesh-list
139397207|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
139397208|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397209|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397210|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397211|NCT05504330|Aspirin|aspirin|mesh-list
139397212|NCT05504330|Clopidogrel|clopidogrel|mesh-list
139397213|NCT05504330|Atorvastatin|atorvastatin|mesh-list
139397214|NCT05504330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139397215|NCT05504330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139397216|NCT05504330|Analgesics|analgesics|mesh-ancestor
139397217|NCT05504330|Sensory System Agents|sensory system agents|mesh-ancestor
139397218|NCT05504330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397219|NCT05504330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397220|NCT05504330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139397221|NCT05504330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139397222|NCT05504330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139397223|NCT05504330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138734288|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139397224|NCT05504330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397225|NCT05504330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139397226|NCT05504330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139397227|NCT05504330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397228|NCT05504330|Antipyretics|antipyretics|mesh-ancestor
139397229|NCT05504330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139397230|NCT05504330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139397231|NCT05504330|Antimetabolites|antimetabolites|mesh-ancestor
139397232|NCT05504330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139397233|NCT05504330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139397234|NCT05504330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139397235|NCT05504330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139397236|NCT05504330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139397237|NCT05504330|Purinergic Agents|purinergic agents|mesh-ancestor
139397238|NCT05504330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397240|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139397241|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139397242|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139397243|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
139397244|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397245|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397246|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397247|NCT02220829|Urological Agents|urological agents|mesh-ancestor
139397248|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
139397249|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139397250|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139397251|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
139397252|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397253|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139397254|NCT02215213|Vitamin D|vitamin d|mesh-list
139397255|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
139397256|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
139397257|NCT02215213|Vitamins|vitamins|mesh-list
139397258|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
138734341|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139397259|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397260|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139651667|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139397261|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139397262|NCT02205775|Atorvastatin|atorvastatin|mesh-list
139397263|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139397264|NCT02205775|Ezetimibe|ezetimibe|mesh-list
139397265|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139397266|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139397267|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
139397268|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397269|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139397270|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139397271|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397272|NCT02217787|PF-06372865|pf-06372865|mesh-list
139397273|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
139397274|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
139397275|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397276|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397277|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397278|NCT02205931|Topiramate|topiramate|mesh-list
139397279|NCT02205931|Lamotrigine|lamotrigine|mesh-list
139397280|NCT02205931|Zonisamide|zonisamide|mesh-list
139397281|NCT02205931|Carbamazepine|carbamazepine|mesh-list
139397282|NCT02205931|Phenytoin|phenytoin|mesh-list
139397283|NCT02205931|Rufinamide|rufinamide|mesh-list
139397284|NCT02205931|Levetiracetam|levetiracetam|mesh-list
139397285|NCT02205931|Valproic Acid|valproic acid|mesh-list
139397286|NCT02205931|Clonazepam|clonazepam|mesh-list
139397287|NCT02205931|Vigabatrin|vigabatrin|mesh-list
139397288|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
139397289|NCT02205931|Clobazam|clobazam|mesh-list
139397290|NCT02205931|Ethosuximide|ethosuximide|mesh-list
139397291|NCT02205931|Stiripentol|stiripentol|mesh-list
139397292|NCT02205931|Nitrazepam|nitrazepam|mesh-list
139397293|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139397294|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397295|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
139397296|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139397297|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139397298|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397299|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139397300|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139397301|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139397302|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397303|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139397304|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139397305|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397306|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
139397307|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397308|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
139397309|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139397310|NCT02205931|Analgesics|analgesics|mesh-ancestor
139397311|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
139397312|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397313|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139397314|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139397315|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139397316|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139397317|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
139397318|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139397319|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139397320|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
139397321|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139397322|NCT02221063|Thiamine|thiamine|mesh-list
139397323|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
139397324|NCT02221063|Vitamins|vitamins|mesh-ancestor
139397325|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
139397326|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397327|NCT02220049|Bortezomib|bortezomib|mesh-list
139397328|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397329|NCT01351805|Vitamin D|vitamin d|mesh-list
139397330|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
139397331|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
139397332|NCT01351805|Vitamins|vitamins|mesh-list
139397333|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
139651668|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
139397334|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397335|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139397336|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139397337|NCT02206165|Amlodipine|amlodipine|mesh-list
139397338|NCT02206165|Candesartan|candesartan|mesh-list
139397339|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
139651669|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397340|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139397341|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139397342|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139397343|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397344|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139397345|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397346|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
139397347|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139397348|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139397349|NCT04356950|Thrombin|thrombin|mesh-list
139397350|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
139397351|NCT04356950|Coagulants|coagulants|mesh-ancestor
139397352|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139397353|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139397354|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
139397355|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397356|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397357|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139397358|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
139397359|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139397360|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139397361|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139397362|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
139397363|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397364|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397365|NCT05563610|Amoxicillin|amoxicillin|mesh-list
139397366|NCT05563610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139397367|NCT05563610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397369|NCT05503706|Salicylic Acid|salicylic acid|mesh-list
139397370|NCT05503706|Salicylates|salicylates|mesh-list
139397371|NCT05503706|Selenium disulfide|selenium disulfide|mesh-list
139397372|NCT05503706|Antioxidants|antioxidants|mesh-ancestor
139397373|NCT05503706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397374|NCT05503706|Protective Agents|protective agents|mesh-ancestor
139397375|NCT05503706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397376|NCT05503706|Trace Elements|trace elements|mesh-ancestor
139397377|NCT05503706|Micronutrients|micronutrients|mesh-ancestor
139397378|NCT05503706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397379|NCT05503706|Antifungal Agents|antifungal agents|mesh-ancestor
139397380|NCT05503706|Keratolytic Agents|keratolytic agents|mesh-ancestor
139397381|NCT05503706|Dermatologic Agents|dermatologic agents|mesh-ancestor
139397382|NCT05503706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139397383|NCT05503706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139397384|NCT05503706|Analgesics|analgesics|mesh-ancestor
139397385|NCT05503706|Sensory System Agents|sensory system agents|mesh-ancestor
139397386|NCT05503706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397387|NCT05503706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139397388|NCT05503706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139397389|NCT05503706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139397390|NCT05503706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397391|NCT02174861|Erenumab|erenumab|mesh-list
139397392|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139397393|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397394|NCT02174861|Analgesics|analgesics|mesh-ancestor
139397395|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
138734487|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
139397396|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397397|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397398|NCT02221375|Ciclesonide|ciclesonide|mesh-list
139397399|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
139397400|NCT02221375|Hormones|hormones|mesh-ancestor
139397401|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139397402|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397403|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139397404|NCT02399709|Simvastatin|simvastatin|mesh-list
139397405|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139397406|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139397407|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
139397408|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397409|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139397410|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139397411|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397412|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
139397414|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397415|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397416|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139397417|NCT02220361|Analgesics|analgesics|mesh-ancestor
139397418|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
139397419|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397420|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139397421|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139397422|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139397423|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
139397424|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397425|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397426|NCT05175001|Betamethasone|betamethasone|mesh-list
139397427|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
139397428|NCT05175001|Ropivacaine|ropivacaine|mesh-list
139397429|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
139397430|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
139397431|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397432|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397433|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
139397434|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397435|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139397436|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
139397437|NCT05175001|Hormones|hormones|mesh-ancestor
139397438|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139397439|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139397440|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
139397441|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139397442|NCT00140855|Ipilimumab|ipilimumab|mesh-list
139397443|NCT00140855|Antibodies|antibodies|mesh-list
139397444|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
139397445|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139397446|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
139397447|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397448|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397449|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139397450|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397451|NCT02399397|Midazolam|midazolam|mesh-list
139397452|NCT02399397|Fentanyl|fentanyl|mesh-list
139397453|NCT02399397|Anesthetics|anesthetics|mesh-list
139397454|NCT02399397|Propofol|propofol|mesh-list
139397455|NCT02399397|Rocuronium|rocuronium|mesh-list
139397456|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397457|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397458|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139397459|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139397460|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
139397461|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139397462|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139397463|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139397464|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139397465|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
139397466|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
139397467|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397468|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397469|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139397470|NCT02399397|Narcotics|narcotics|mesh-ancestor
139397471|NCT02399397|Analgesics|analgesics|mesh-ancestor
139397472|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
139397473|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397474|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138734556|NCT02271035|Protective Agents|protective agents|mesh-ancestor
139397475|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139397476|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139397477|NCT02221453|Triamcinolone|triamcinolone|mesh-list
139397478|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139397479|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139397480|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139397481|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139397482|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
139397483|NCT02221453|Hormones|hormones|mesh-ancestor
139397484|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139397485|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397486|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139397487|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
139397488|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397489|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397490|NCT03106545|Bupivacaine|bupivacaine|mesh-list
139397491|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
139397492|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
139397493|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397494|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397495|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
139397496|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397497|NCT02221531|Carbetocin|carbetocin|mesh-list
139397498|NCT02221531|Oxytocin|oxytocin|mesh-list
139397499|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
139397500|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139397501|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397502|NCT02231125|Losartan|losartan|mesh-list
139397503|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139397504|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139397505|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139397506|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139397507|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397508|NCT02396433|Carboplatin|carboplatin|mesh-list
139397509|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139397510|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397511|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397512|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397513|NCT02231203|Tocopherols|tocopherols|mesh-list
139397514|NCT02231203|Antioxidants|antioxidants|mesh-list
138734586|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
139397515|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397516|NCT02231203|Protective Agents|protective agents|mesh-ancestor
139397517|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397519|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
139397520|NCT02231281|Ritonavir|ritonavir|mesh-list
139397521|NCT02231281|Lopinavir|lopinavir|mesh-list
139397522|NCT02231281|Tenofovir|tenofovir|mesh-list
139397523|NCT02231281|Lamivudine|lamivudine|mesh-list
139397524|NCT02231281|Zidovudine|zidovudine|mesh-list
139397525|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139397526|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139397527|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
139397528|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397529|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397530|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139397531|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139397532|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
139397533|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397534|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139397535|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139397536|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139397537|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139397538|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
139397539|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139397540|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139397541|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
139397542|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397543|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397544|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139397545|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
139397546|NCT02780687|Afatinib|afatinib|mesh-list
139397547|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397548|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139397549|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397550|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397551|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139397552|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139397553|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
139397554|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397555|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397556|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139397557|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
139397558|NCT02147873|Azacitidine|azacitidine|mesh-list
139397559|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139397560|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
139651670|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651671|NCT00078715|Urological Agents|urological agents|mesh-ancestor
139397561|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397562|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397563|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397564|NCT02398929|Bisoprolol|bisoprolol|mesh-list
139397565|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139397566|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
139397567|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
139397568|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397569|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397570|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139397571|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139397572|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139397573|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
139397574|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397575|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397576|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
139397577|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139397578|NCT02221765|Hormones|hormones|mesh-ancestor
139397579|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139397580|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397581|NCT05069129|Vaccines|vaccines|mesh-list
139397582|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
139397583|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397584|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139397585|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139397586|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397587|NCT03544073|Leuprolide|leuprolide|mesh-list
139397588|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139054390|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
139397589|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
139397590|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139397591|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397592|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139397593|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397594|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139397595|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397596|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
139397597|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139397598|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139397599|NCT02781311|Finasteride|finasteride|mesh-list
139397600|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139397601|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139397602|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397603|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397604|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
139397605|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139397606|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397607|NCT02781311|Urological Agents|urological agents|mesh-ancestor
139397608|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
139397609|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139397610|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397611|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139397612|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139397613|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397614|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139397615|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
139397616|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397617|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139397618|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
139397619|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397620|NCT02564198|Ramucirumab|ramucirumab|mesh-list
139397621|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397622|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
139397623|NCT02398539|Triamcinolone|triamcinolone|mesh-list
139397624|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139397625|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
139397626|NCT02398539|Hormones|hormones|mesh-ancestor
139397627|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139397628|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397629|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139397630|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397631|NCT02144753|Psyllium|psyllium|mesh-list
139651672|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
139397632|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
139397633|NCT02144753|Cathartics|cathartics|mesh-ancestor
139397634|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139397635|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
139397636|NCT02231905|Pramipexole|pramipexole|mesh-list
139397637|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
139397638|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397639|NCT02231905|Protective Agents|protective agents|mesh-ancestor
139397640|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397641|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139397642|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139397643|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
139397644|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
139397645|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397646|NCT02141087|Pirfenidone|pirfenidone|mesh-list
139397647|NCT02141087|Analgesics|analgesics|mesh-ancestor
139397648|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
139397649|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397650|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397651|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139397652|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139397653|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139397654|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139397655|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397656|NCT02698293|Vitamin D|vitamin d|mesh-list
139397657|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
139397658|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
139397659|NCT02698293|Vitamins|vitamins|mesh-list
139397660|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
139397661|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734746|NCT02272478|Decitabine|decitabine|mesh-list
139397662|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139397663|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139397664|NCT02226289|Bevacizumab|bevacizumab|mesh-list
139397665|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139397666|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397667|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139397668|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139397669|NCT02226289|Growth Substances|growth substances|mesh-ancestor
139397670|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397671|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
139397672|NCT04480593|Propolis|propolis|mesh-list
139397673|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397674|NCT05079217|Vaccines|vaccines|mesh-list
139397675|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
139397676|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397677|NCT02141321|Alprostadil|alprostadil|mesh-list
139397678|NCT02141321|Misoprostol|misoprostol|mesh-list
139397679|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139397680|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
139397681|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139397682|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397683|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139397684|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139397685|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
139397686|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139397687|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
139397688|NCT02141321|Urological Agents|urological agents|mesh-ancestor
139397689|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139397690|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139397691|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139397692|NCT02141477|Decitabine|decitabine|mesh-list
139397693|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
139397694|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139397695|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
139397696|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397697|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397698|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397699|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139397700|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139397701|NCT02232139|Midazolam|midazolam|mesh-list
139397702|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139397703|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139397704|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397705|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397706|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139397707|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139397708|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139397709|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139397710|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
139397712|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
139397713|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
139397714|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397715|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397716|NCT02226601|Aprepitant|aprepitant|mesh-list
139397717|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
139397718|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
139397719|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397720|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397721|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139397722|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139397723|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397724|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397725|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
139397726|NCT02397603|Bupivacaine|bupivacaine|mesh-list
139397727|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
139397728|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
139397729|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397730|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397731|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
139397732|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397733|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139397734|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139397735|NCT02397603|Analgesics|analgesics|mesh-ancestor
139397736|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139397737|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139397738|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139397739|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
139397740|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397741|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397742|NCT02145065|Paclitaxel|paclitaxel|mesh-list
139397743|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139397744|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397745|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
139397746|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
139397747|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
139397748|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397749|NCT02226757|Paclitaxel|paclitaxel|mesh-list
139397750|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139397751|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397752|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
139397753|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
139397754|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
139397755|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397756|NCT04616924|Clarithromycin|clarithromycin|mesh-list
139397757|NCT04616924|Rifabutin|rifabutin|mesh-list
139397758|NCT04616924|Clofazimine|clofazimine|mesh-list
139397759|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139397760|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397761|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139397762|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397763|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397764|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139397765|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139397766|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139397767|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
139397768|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139397769|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
139397770|NCT02226913|Lidocaine|lidocaine|mesh-list
139397771|NCT02226913|Epinephrine|epinephrine|mesh-list
139397772|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
139397773|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
138734890|NCT01588847|Propofol|propofol|mesh-list
139397774|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397775|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397776|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
139397777|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397778|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139397779|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139397780|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139397781|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139651673|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397782|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397783|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139397784|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139397785|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
139397786|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397787|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139397788|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139397789|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
139397790|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139397791|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
139397792|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
139397793|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
139397794|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139397795|NCT05491616|Nivolumab|nivolumab|mesh-list
138734930|NCT01335971|Sulforaphane|sulforaphane|mesh-list
139397796|NCT05491616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139397797|NCT05491616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397798|NCT05491616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139397799|NCT05491616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397800|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
139397801|NCT02254655|Puerarin|puerarin|mesh-list
139397802|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
139397803|NCT02226991|Ritonavir|ritonavir|mesh-list
139397804|NCT02226991|Tipranavir|tipranavir|mesh-list
139397805|NCT02226991|Efavirenz|efavirenz|mesh-list
139397806|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139397807|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139397808|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
139397809|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397810|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397811|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139397812|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139397813|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
139397814|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397815|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139397816|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139397817|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139397818|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139397819|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139397820|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139397821|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139397822|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139397823|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139397824|NCT05042791|Capecitabine|capecitabine|mesh-list
139397825|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139397826|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
139397827|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397828|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397829|NCT00705783|Aripiprazole|aripiprazole|mesh-list
139397830|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
139397831|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139397832|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139397833|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139397834|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397835|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397836|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
139397837|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
139397838|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397839|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397840|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139397841|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139397842|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
139397843|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139397844|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139397845|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139397846|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139397847|NCT02145611|Vildagliptin|vildagliptin|mesh-list
139397848|NCT02145611|Glyburide|glyburide|mesh-list
139397849|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139397850|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397851|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139397852|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
139397853|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902548|NCT00878969|Valsartan|valsartan|mesh-list
139397854|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397855|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
139397856|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139397857|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397858|NCT03543683|Aspirin|aspirin|mesh-list
139397859|NCT03543683|Osimertinib|osimertinib|mesh-list
139397860|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139397861|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139397862|NCT03543683|Analgesics|analgesics|mesh-ancestor
139397863|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
139397864|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397865|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397866|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139397867|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139397868|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139397869|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139397870|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397871|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139397872|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139397873|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397874|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
139397875|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397876|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139397877|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
139397878|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139397879|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139397880|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139397881|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139397882|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397883|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
139397884|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397885|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054694|NCT02470299|Ketorolac|ketorolac|mesh-list
139397886|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139397887|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397889|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139397890|NCT02396979|Narcotics|narcotics|mesh-ancestor
139397891|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397892|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397893|NCT02396979|Analgesics|analgesics|mesh-ancestor
139397894|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
139397895|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397896|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
139397897|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
139397898|NCT02145767|Progesterone|progesterone|mesh-list
139397899|NCT02145767|Progestins|progestins|mesh-ancestor
139397900|NCT02145767|Hormones|hormones|mesh-ancestor
139397901|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139397902|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397903|NCT02031523|Analgesics|analgesics|mesh-list
139397904|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
139397905|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397906|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397907|NCT02397213|Cyclosporine|cyclosporine|mesh-list
139397908|NCT02397213|Cyclosporins|cyclosporins|mesh-list
139397909|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139397910|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397911|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139397912|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
139397913|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397914|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
139397915|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397916|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
139397917|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139397918|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139397919|NCT04480281|Lidocaine|lidocaine|mesh-list
139397920|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
139397921|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
139397922|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397923|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397924|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
139397925|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397926|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139140017|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
139651674|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
139397927|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139397928|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139397929|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139397930|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397931|NCT03544775|Anesthetics|anesthetics|mesh-list
139397932|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397933|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397934|NCT02258815|Dinutuximab|dinutuximab|mesh-list
139397935|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397936|NCT02149433|Prednisone|prednisone|mesh-list
139397937|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139397938|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
139397939|NCT02149433|Hormones|hormones|mesh-ancestor
138735149|NCT05649878|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139397940|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139397941|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397942|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139397943|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397944|NCT02228005|Sertraline|sertraline|mesh-list
139397945|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
139397946|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139397947|NCT02228005|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139397948|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139397949|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139397950|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397951|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397952|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
139397953|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397954|NCT02228083|Lidocaine|lidocaine|mesh-list
139397955|NCT02228083|Epinephrine|epinephrine|mesh-list
139397956|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
139397957|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
139397958|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139397959|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397960|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
139397961|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139397962|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139397963|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139397964|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139397965|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139397966|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397967|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139397968|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139397969|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
139397970|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397971|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139397972|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139397973|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
139397974|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139397975|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
139397976|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
139397977|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
139397978|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139397979|NCT02394483|Olorofim|olorofim|mesh-list
139397980|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
139397981|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139397982|NCT02142335|Rituximab|rituximab|mesh-list
139397983|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139397984|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139397985|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
139397986|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397987|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139397988|NCT02228239|Mirtazapine|mirtazapine|mesh-list
139397989|NCT02228239|Esketamine|esketamine|mesh-list
139397990|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
139397991|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139397992|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139397993|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
139397994|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
139397995|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139397996|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139397997|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139397998|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139397999|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139398000|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139398001|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139398002|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139398003|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139398004|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
139398005|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139398006|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139398007|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
139398008|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139398009|NCT03167385|Apatinib|apatinib|mesh-list
139398010|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398011|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139398012|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398013|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398014|NCT02142569|Tocotrienols|tocotrienols|mesh-list
139398015|NCT02142569|Vitamin E|vitamin e|mesh-list
139398016|NCT02142569|Tocopherols|tocopherols|mesh-list
139398017|NCT02142569|Red yeast rice|red yeast rice|mesh-list
139398018|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
139398019|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398020|NCT02142569|Protective Agents|protective agents|mesh-ancestor
139398021|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398022|NCT02142569|Vitamins|vitamins|mesh-ancestor
139398023|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
139398024|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139398025|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139398026|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139398027|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
139398028|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398029|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139398030|NCT02228473|Atropine|atropine|mesh-list
139398031|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
139398032|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139398033|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139398034|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139398035|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
139398036|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398037|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398038|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139398039|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
139398040|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
139398041|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
139398042|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139398043|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139398044|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
139398045|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398046|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398047|NCT02394093|Aspirin|aspirin|mesh-list
139398048|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139398049|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139398050|NCT02394093|Analgesics|analgesics|mesh-ancestor
139398051|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
139398052|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735404|NCT00599898|Nifedipine|nifedipine|mesh-list
139398053|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398054|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398055|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139398056|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139398057|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139398058|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398059|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139398060|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139398061|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398062|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
139398063|NCT02146391|Enclomiphene|enclomiphene|mesh-list
139398064|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139398065|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
139398066|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398067|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398068|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139398069|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
139398070|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139398071|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139398072|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139398073|NCT04225273|Lidocaine|lidocaine|mesh-list
139398074|NCT04225273|Anesthetics, Local|anesthetics, local|mesh-ancestor
139651675|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139651676|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139398075|NCT04225273|Anesthetics|anesthetics|mesh-ancestor
139398076|NCT04225273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139398077|NCT04225273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398078|NCT04225273|Sensory System Agents|sensory system agents|mesh-ancestor
139398079|NCT04225273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398080|NCT04225273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139398081|NCT04225273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138735417|NCT00600054|Antibodies|antibodies|mesh-list
139398082|NCT04225273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139398083|NCT04225273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139398084|NCT04225273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398085|NCT02146547|Aripiprazole|aripiprazole|mesh-list
139398086|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139398087|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
139398088|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139398089|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139398090|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139398091|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139398092|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398093|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
139398094|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
139398095|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398096|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398097|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139398098|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139398099|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
139398100|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139398101|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139398102|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139398103|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139398104|NCT02394015|Doxorubicin|doxorubicin|mesh-list
139398105|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139398106|NCT02394015|Trabectedin|trabectedin|mesh-list
139398107|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139054906|NCT03670355|Tenofovir|tenofovir|mesh-list
139398108|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398109|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139398110|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139398111|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398112|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398113|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139398114|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
139398115|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
139398116|NCT02146703|Gemcitabine|gemcitabine|mesh-list
139398117|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139398118|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
139398119|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398120|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398121|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139398122|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139398123|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139398124|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398125|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398126|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139398127|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139398128|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398129|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
139398130|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398131|NCT02782169|Pregabalin|pregabalin|mesh-list
139398132|NCT02782169|Analgesics|analgesics|mesh-ancestor
139398133|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
139398134|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398135|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398136|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
139398137|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139398138|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139398139|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398140|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139398141|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139398142|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139398143|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139398144|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139651677|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398145|NCT04163185|Meloxicam|meloxicam|mesh-list
139398146|NCT04163185|Rizatriptan|rizatriptan|mesh-list
139398147|NCT04163185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139398148|NCT04163185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139398149|NCT04163185|Analgesics|analgesics|mesh-ancestor
139398150|NCT04163185|Sensory System Agents|sensory system agents|mesh-ancestor
139398151|NCT04163185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398152|NCT04163185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398153|NCT04163185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398154|NCT04163185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139398155|NCT04163185|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139398156|NCT04163185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139398157|NCT04163185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398158|NCT04163185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398159|NCT04163185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139398160|NCT04163185|Serotonin Agents|serotonin agents|mesh-ancestor
139398161|NCT04163185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398162|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
139398163|NCT02149901|Ephedrine|ephedrine|mesh-list
139398164|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139398165|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
139398166|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398167|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398168|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139398169|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
139398170|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
139398171|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139398172|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139398173|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
139398174|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
139398175|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398176|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398177|NCT04440267|Dexamethasone|dexamethasone|mesh-list
139398178|NCT04440267|Prednisone|prednisone|mesh-list
139398179|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
139398180|NCT04440267|Methotrexate|methotrexate|mesh-list
139398181|NCT04440267|Vincristine|vincristine|mesh-list
139398182|NCT04440267|Daunorubicin|daunorubicin|mesh-list
139398183|NCT04440267|Asparaginase|asparaginase|mesh-list
139398184|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
139398185|NCT04440267|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139398186|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139398187|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
139398188|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398189|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139398190|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139398191|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
139398192|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398193|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398194|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139398195|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398196|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
139398197|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
138735584|NCT02881177|Oxytocin|oxytocin|mesh-list
139398198|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398199|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139398200|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
139398201|NCT04440267|Hormones|hormones|mesh-ancestor
139398202|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398203|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139398204|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139398205|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
139398206|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139398207|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139398208|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
139398209|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
139398210|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398211|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139398212|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139398213|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139398214|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
139398215|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
139398216|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
139398217|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139398218|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139398219|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139398220|NCT04440267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139398221|NCT02043847|Melphalan|melphalan|mesh-list
139398222|NCT02043847|Lenograstim|lenograstim|mesh-list
139398223|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139398224|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
139398225|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398226|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139398227|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
139398228|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398229|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398230|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139398231|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139398232|NCT02146937|Bicalutamide|bicalutamide|mesh-list
139398233|NCT02146937|Finasteride|finasteride|mesh-list
139398234|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
139398235|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
139398236|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398237|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735612|NCT04308343|Methotrexate|methotrexate|mesh-list
139398238|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398239|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139398240|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139398241|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398242|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398243|NCT02146937|Urological Agents|urological agents|mesh-ancestor
139398244|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139398245|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
139398246|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
139398247|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
139398248|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
139398249|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398250|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398251|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
139398252|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
139398253|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398254|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398255|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139398256|NCT02147015|Hormones|hormones|mesh-ancestor
139398257|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398258|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139398259|NCT02147015|Protective Agents|protective agents|mesh-ancestor
139398260|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398261|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398262|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139398263|NCT02229175|Bevacizumab|bevacizumab|mesh-list
139398264|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139398265|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398266|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139398267|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139398268|NCT02229175|Growth Substances|growth substances|mesh-ancestor
139398269|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398270|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
139398271|NCT04947007|Bupivacaine|bupivacaine|mesh-list
139398272|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
139398273|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
139398274|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139398275|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398276|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
139398277|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398278|NCT04104685|Minocycline|minocycline|mesh-list
139398279|NCT04104685|Adapalene|adapalene|mesh-list
139398280|NCT04104685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139398281|NCT04104685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398282|NCT04104685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139398283|NCT04104685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139398284|NCT04104685|Analgesics|analgesics|mesh-ancestor
139398285|NCT04104685|Sensory System Agents|sensory system agents|mesh-ancestor
139398286|NCT04104685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398287|NCT04104685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398288|NCT04104685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398289|NCT04104685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139398290|NCT04104685|Dermatologic Agents|dermatologic agents|mesh-ancestor
139398291|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139398292|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651678|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
139651679|NCT01530399|Coagulants|coagulants|mesh-ancestor
139651680|NCT02596620|Amoxicillin|amoxicillin|mesh-list
139398294|NCT02392845|Epirubicin|epirubicin|mesh-list
139398295|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398296|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
139398297|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
139398298|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
139398299|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398300|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139398301|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139398302|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139398303|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398304|NCT04093765|Antimalarials|antimalarials|mesh-list
139398305|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139398306|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139398307|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398308|NCT03166605|Simethicone|simethicone|mesh-list
139398309|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
139398310|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398311|NCT03166605|Emollients|emollients|mesh-ancestor
139398312|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
139398313|NCT03699956|Carboplatin|carboplatin|mesh-list
139398314|NCT03699956|Etoposide|etoposide|mesh-list
139398315|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398316|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139398317|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139398318|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139398319|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735771|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
139398320|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398321|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
139398322|NCT03166527|Antibodies|antibodies|mesh-list
139398323|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
139398324|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139398325|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139398326|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
139398327|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398328|NCT02695719|Lubiprostone|lubiprostone|mesh-list
139398329|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139398330|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139398331|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398332|NCT05498012|Cannabidiol|cannabidiol|mesh-list
139398333|NCT05498012|Anticonvulsants|anticonvulsants|mesh-ancestor
139398334|NCT02150291|Folic Acid|folic acid|mesh-list
139398335|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
139398336|NCT02150291|Hematinics|hematinics|mesh-ancestor
139398337|NCT02150291|Vitamins|vitamins|mesh-ancestor
139398338|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
139398339|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398340|NCT04907071|Coal Tar|coal tar|mesh-list
139398341|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
139398342|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
139398343|NCT02155517|Propofol|propofol|mesh-list
139398344|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139398345|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139398346|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398347|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139398348|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
139398349|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
139398350|NCT05497934|Glycerol|glycerol|mesh-list
139398351|NCT05497934|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139398352|NCT05497934|Protective Agents|protective agents|mesh-ancestor
139398353|NCT05497934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398354|NCT02229721|Oxytocin|oxytocin|mesh-list
139398355|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
139398356|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139398357|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398358|NCT05497700|Norepinephrine|norepinephrine|mesh-list
139398359|NCT05497700|Ephedrine|ephedrine|mesh-list
139398360|NCT05497700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139398361|NCT05497700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139398362|NCT05497700|Adrenergic Agents|adrenergic agents|mesh-ancestor
139398363|NCT05497700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398364|NCT05497700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398365|NCT05497700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398366|NCT05497700|Sympathomimetics|sympathomimetics|mesh-ancestor
139398367|NCT05497700|Autonomic Agents|autonomic agents|mesh-ancestor
139398368|NCT05497700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555064|NCT00078260|Pemetrexed|pemetrexed|mesh-list
139398369|NCT05497700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139398370|NCT05497700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139398371|NCT03106389|Misoprostol|misoprostol|mesh-list
139398372|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139398373|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
139398374|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139398375|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398376|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139398377|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139398378|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
139398379|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139398380|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139398381|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398382|NCT02255045|Diclofenac|diclofenac|mesh-list
139398383|NCT02255045|Meloxicam|meloxicam|mesh-list
139398384|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139398385|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139398386|NCT02255045|Analgesics|analgesics|mesh-ancestor
139398387|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
139398388|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398389|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398390|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398391|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139398392|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139398393|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398394|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398395|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139398396|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139398397|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139398398|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139398399|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398400|NCT02150447|Lansoprazole|lansoprazole|mesh-list
139398401|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139398402|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139398403|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139398404|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398405|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398406|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139398407|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398408|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398409|NCT02229955|Cyclosporine|cyclosporine|mesh-list
139398410|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139398411|NCT02229955|Cyclosporins|cyclosporins|mesh-list
139398412|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398413|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398414|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139398415|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
139398416|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398417|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
139398418|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398419|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
139398420|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139398421|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139398422|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139398423|NCT02230033|Itraconazole|itraconazole|mesh-list
139398424|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
139398425|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
139398426|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398427|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139398428|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139398429|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398430|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398431|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139398432|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
139398433|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398434|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398435|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139398436|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139398437|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
139398438|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139398439|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139651681|NCT02596620|Metronidazole|metronidazole|mesh-list
139651682|NCT02596620|Levofloxacin|levofloxacin|mesh-list
139651683|NCT02596620|Esomeprazole|esomeprazole|mesh-list
139398441|NCT05740371|Antithrombins|antithrombins|mesh-ancestor
139398442|NCT05740371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139398443|NCT05740371|Protease Inhibitors|protease inhibitors|mesh-ancestor
139398444|NCT05740371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398445|NCT05740371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398446|NCT05740371|Anticoagulants|anticoagulants|mesh-ancestor
139398447|NCT05740371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139398448|NCT02223949|Alprostadil|alprostadil|mesh-list
139398449|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139398450|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
139398451|NCT02223949|Urological Agents|urological agents|mesh-ancestor
139398452|NCT02691507|Decanoic acid|decanoic acid|mesh-list
139398453|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
139398454|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398455|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
139398456|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139398457|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139398458|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398459|NCT02151695|Aflibercept|aflibercept|mesh-list
139398460|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139398461|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139398462|NCT02151695|Growth Substances|growth substances|mesh-ancestor
139398463|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398464|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
139398465|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398466|NCT02151929|Everolimus|everolimus|mesh-list
139398467|NCT02151929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139398468|NCT02151929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139398469|NCT02151929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398470|NCT02151929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398471|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139398472|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
139398473|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398474|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398475|NCT03542357|Calcitonin|calcitonin|mesh-list
139398476|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
139398477|NCT03542357|Sumatriptan|sumatriptan|mesh-list
139398478|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139398479|NCT03542357|Katacalcin|katacalcin|mesh-list
139398480|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139398481|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139398482|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139055279|NCT03954964|Narcotics|narcotics|mesh-ancestor
139398483|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
139398484|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398485|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398486|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398487|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139398488|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139398489|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
139398490|NCT04811001|Osimertinib|osimertinib|mesh-list
139398491|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398492|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139398493|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398494|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398495|NCT02150993|Ritonavir|ritonavir|mesh-list
139398496|NCT02150993|Lopinavir|lopinavir|mesh-list
139398497|NCT02150993|Tenofovir|tenofovir|mesh-list
139398498|NCT02150993|Lamivudine|lamivudine|mesh-list
139398499|NCT02150993|Emtricitabine|emtricitabine|mesh-list
139398500|NCT02150993|Zidovudine|zidovudine|mesh-list
139398501|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
139398502|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139398503|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139398504|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139398505|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
139398506|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398507|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398508|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139398509|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139398510|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
139398511|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398512|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139651684|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139140022|NCT03777423|Chromium|chromium|mesh-list
139398513|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139398514|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139398515|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139398517|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139398518|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139398519|NCT02690727|Tenalisib|tenalisib|mesh-list
139398520|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139398521|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398522|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398523|NCT02224105|Prednisolone|prednisolone|mesh-list
139398524|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139398525|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
139398526|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139398527|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
139398528|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139398529|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
139398530|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398531|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
139398532|NCT02224105|Hormones|hormones|mesh-ancestor
139398533|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398534|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398535|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139398536|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398537|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
139398538|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
139398539|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398540|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139398541|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139398542|NCT02224105|Protective Agents|protective agents|mesh-ancestor
139398543|NCT02156375|Ustekinumab|ustekinumab|mesh-list
139398544|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
139398545|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
139398546|NCT03542279|Hormones|hormones|mesh-ancestor
139398547|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398548|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398549|NCT02230735|Epinephrine|epinephrine|mesh-list
139398550|NCT02230735|Racepinephrine|racepinephrine|mesh-list
139398551|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
139398552|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139398553|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139398554|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
139398555|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398556|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398557|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398558|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139398559|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139398560|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
139398561|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398562|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139398563|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
139398564|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
139398565|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
138736125|NCT04908865|Belimumab|belimumab|mesh-list
139398566|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139398567|NCT02258581|Tenofovir|tenofovir|mesh-list
139398568|NCT02258581|Vesatolimod|vesatolimod|mesh-list
139398569|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
139398570|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398571|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139398572|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139398573|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398574|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398575|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139398576|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139398577|NCT03165825|Dexamethasone|dexamethasone|mesh-list
139398578|NCT03165825|Betamethasone|betamethasone|mesh-list
139398579|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398580|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
139398581|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
139398582|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398583|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398584|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139398585|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
139398586|NCT03165825|Hormones|hormones|mesh-ancestor
139398587|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398588|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139398589|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398590|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139398591|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
139398593|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139398594|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
139398595|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398596|NCT05746143|Zolpidem|zolpidem|mesh-list
139398597|NCT05746143|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139398598|NCT05746143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139398599|NCT05746143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139398600|NCT05746143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398601|NCT05746143|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139398602|NCT05746143|GABA Agonists|gaba agonists|mesh-ancestor
139398603|NCT05746143|GABA Agents|gaba agents|mesh-ancestor
139398604|NCT05746143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398605|NCT05746143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398606|NCT03165591|Vaccines|vaccines|mesh-list
139398607|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
139398608|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398609|NCT03114813|Carvedilol|carvedilol|mesh-list
139398610|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139398611|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139398612|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
139398613|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398614|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398615|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398616|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139398617|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
139398618|NCT03114813|Protective Agents|protective agents|mesh-ancestor
139398619|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139398620|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139398621|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139398622|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
139398623|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139398624|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139398625|NCT01358864|Interferons|interferons|mesh-list
139398626|NCT01358864|Ribavirin|ribavirin|mesh-list
139398627|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
139398628|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398629|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
139398630|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398631|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
139398632|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398633|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
139398634|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398635|NCT02750761|Tedizolid|tedizolid|mesh-list
139398636|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
139398637|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
139398638|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139398639|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398640|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139398641|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736206|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139398642|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398643|NCT02814019|Idebenone|idebenone|mesh-list
139398644|NCT02814019|Antioxidants|antioxidants|mesh-ancestor
139398645|NCT02814019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398646|NCT02814019|Protective Agents|protective agents|mesh-ancestor
139398647|NCT02814019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398648|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
139398649|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
139398650|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139398651|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139398652|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398653|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398654|NCT03364244|Urological Agents|urological agents|mesh-ancestor
139398655|NCT03165123|Azithromycin|azithromycin|mesh-list
139398656|NCT03165123|Dexamethasone|dexamethasone|mesh-list
139398657|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398658|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
139398659|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
139398660|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398661|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398662|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139651685|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651686|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139398663|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
139398664|NCT03165123|Hormones|hormones|mesh-ancestor
139398665|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398666|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139398667|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398668|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139398669|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398670|NCT01131169|Vidarabine|vidarabine|mesh-list
139398671|NCT01131169|Fludarabine|fludarabine|mesh-list
139398672|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
139398673|NCT01131169|Melphalan|melphalan|mesh-list
139398674|NCT01131169|Busulfan|busulfan|mesh-list
139398675|NCT01131169|Lenograstim|lenograstim|mesh-list
139398676|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398677|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139398678|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
139398679|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398680|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139398681|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
139398682|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398683|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
139398684|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398685|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139398686|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139398687|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
139398688|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139398689|NCT02688933|Insulin|insulin|mesh-list
139398690|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139398691|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
139398692|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139398693|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398694|NCT04372628|Ritonavir|ritonavir|mesh-list
139398695|NCT04372628|Lopinavir|lopinavir|mesh-list
139398696|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139398697|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139398698|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
139398699|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398700|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398701|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139398702|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139398703|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
139398704|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398705|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139398706|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139398707|NCT00882505|Vitamin D|vitamin d|mesh-list
139398708|NCT00882505|Vitamins|vitamins|mesh-ancestor
139398709|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
139398710|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398711|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139398713|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139398714|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139398715|NCT04480359|Analgesics|analgesics|mesh-ancestor
139398716|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
139398717|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398718|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398719|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398720|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139398721|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139398722|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139398723|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398724|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398725|NCT03724825|Testosterone|testosterone|mesh-list
139398726|NCT03724825|Androgens|androgens|mesh-ancestor
139398727|NCT03724825|Hormones|hormones|mesh-ancestor
139398728|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398729|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398730|NCT04227704|Ketamine|ketamine|mesh-list
139398731|NCT04227704|Analgesics|analgesics|mesh-ancestor
139398732|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
139398733|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398734|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398735|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139398736|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139398737|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
139398738|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
139398739|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139398740|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139398741|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139398742|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398743|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398744|NCT03720613|Naloxegol|naloxegol|mesh-list
139398745|NCT03720613|Lubiprostone|lubiprostone|mesh-list
139398746|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138736381|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398747|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139398748|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398749|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139398750|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398751|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
139398752|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398753|NCT02709512|Cisplatin|cisplatin|mesh-list
139398754|NCT02709512|Carboplatin|carboplatin|mesh-list
139398755|NCT02709512|Pemetrexed|pemetrexed|mesh-list
139398756|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398757|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398758|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398759|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139398760|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139398761|NCT03659929|Amphetamine|amphetamine|mesh-list
139398762|NCT03659929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139398763|NCT03659929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398764|NCT03659929|Sympathomimetics|sympathomimetics|mesh-ancestor
139398765|NCT03659929|Autonomic Agents|autonomic agents|mesh-ancestor
139398766|NCT03659929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398767|NCT03659929|Dopamine Agents|dopamine agents|mesh-ancestor
139398768|NCT03659929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398769|NCT03659929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398770|NCT03659929|Adrenergic Agents|adrenergic agents|mesh-ancestor
139398771|NCT03659929|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139398772|NCT03659929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139398773|NCT03659929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139398774|NCT03659929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139398775|NCT02811679|Blinatumomab|blinatumomab|mesh-list
139398776|NCT02811679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398777|NCT03448081|Calcipotriene|calcipotriene|mesh-list
139398778|NCT03448081|Dermatologic Agents|dermatologic agents|mesh-ancestor
139398779|NCT02232607|Lacidipine|lacidipine|mesh-list
139398780|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139398781|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139398782|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139398783|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398784|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139398785|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398786|NCT02232685|Choline|choline|mesh-list
139398787|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
139398788|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139398789|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
139398790|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398791|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139398792|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139398793|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
139398794|NCT02232763|Losartan|losartan|mesh-list
139398795|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139398796|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139398797|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138736494|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139398798|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139398799|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398800|NCT04294784|Paclitaxel|paclitaxel|mesh-list
139398801|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139398802|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139398803|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139398804|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398805|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
139398806|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
139398807|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
139398808|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398809|NCT04294784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139651687|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139398810|NCT02262559|Telmisartan|telmisartan|mesh-list
139398811|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139398812|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139398813|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139398814|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398815|NCT05491460|Rivaroxaban|rivaroxaban|mesh-list
139398817|NCT05491460|Edoxaban|edoxaban|mesh-list
139398818|NCT05491460|Dabigatran|dabigatran|mesh-list
139398819|NCT05491460|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139398820|NCT05491460|Antithrombins|antithrombins|mesh-ancestor
139398821|NCT05491460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139398822|NCT05491460|Protease Inhibitors|protease inhibitors|mesh-ancestor
139398823|NCT05491460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398824|NCT05491460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398825|NCT05491460|Anticoagulants|anticoagulants|mesh-ancestor
139398826|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
139398827|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139398828|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139398829|NCT02762929|Bupivacaine|bupivacaine|mesh-list
139398830|NCT02762929|Anesthetics, Local|anesthetics, local|mesh-ancestor
139398831|NCT02762929|Anesthetics|anesthetics|mesh-ancestor
139398832|NCT02762929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139398833|NCT02762929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398834|NCT02762929|Sensory System Agents|sensory system agents|mesh-ancestor
139398835|NCT02762929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398836|NCT02262637|Telmisartan|telmisartan|mesh-list
139398837|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
139398838|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139398839|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139398840|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139398841|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398842|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139398843|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139398844|NCT02262637|Diuretics|diuretics|mesh-ancestor
139398845|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
139398846|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398847|NCT02606305|Bevacizumab|bevacizumab|mesh-list
139398848|NCT02606305|Pembrolizumab|pembrolizumab|mesh-list
139398849|NCT02606305|Carboplatin|carboplatin|mesh-list
139398850|NCT02606305|Doxorubicin|doxorubicin|mesh-list
139398851|NCT02606305|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139398852|NCT02606305|Maytansine|maytansine|mesh-list
139398853|NCT02606305|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139398854|NCT02606305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139398855|NCT02606305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398856|NCT02606305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139398857|NCT02606305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139398858|NCT02606305|Growth Substances|growth substances|mesh-ancestor
139398859|NCT02606305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398860|NCT02606305|Growth Inhibitors|growth inhibitors|mesh-ancestor
139398861|NCT02606305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139398862|NCT02606305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139398863|NCT02606305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139398864|NCT02606305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398865|NCT02606305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398866|NCT02606305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139398867|NCT02606305|Immunoconjugates|immunoconjugates|mesh-ancestor
139398868|NCT02606305|Immunologic Factors|immunologic factors|mesh-ancestor
139398869|NCT02606305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139398870|NCT02606305|Tubulin Modulators|tubulin modulators|mesh-ancestor
139398871|NCT02606305|Antimitotic Agents|antimitotic agents|mesh-ancestor
139398872|NCT02606305|Mitosis Modulators|mitosis modulators|mesh-ancestor
139398873|NCT01662986|Bromides|bromides|mesh-list
139398874|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
139398875|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139398876|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
139398877|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398878|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398879|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139398880|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
139398881|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
138736583|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
139398882|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139398883|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
139398884|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139398885|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398886|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
139398888|NCT05497232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139398889|NCT00054158|Thalidomide|thalidomide|mesh-list
139398890|NCT00054158|Dexamethasone|dexamethasone|mesh-list
139398891|NCT00054158|Doxorubicin|doxorubicin|mesh-list
139398892|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139398893|NCT00054158|Vincristine|vincristine|mesh-list
139398894|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398895|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
139398896|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
139398897|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398898|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398899|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139398900|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
139398901|NCT00054158|Hormones|hormones|mesh-ancestor
139398902|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398903|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139398904|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398905|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139398906|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139398907|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139398908|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398909|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398910|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139398911|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
139398912|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
139398913|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
139398914|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139398915|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
139398916|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
139398917|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139398918|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398919|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139398920|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139398921|NCT00054158|Growth Substances|growth substances|mesh-ancestor
139398922|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
139398923|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139398924|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
139398925|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398926|NCT05496764|Dexamethasone|dexamethasone|mesh-list
139398927|NCT05496764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398928|NCT05496764|Antiemetics|antiemetics|mesh-ancestor
139398929|NCT05496764|Autonomic Agents|autonomic agents|mesh-ancestor
139398930|NCT05496764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139398931|NCT05496764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398932|NCT05496764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139398933|NCT05496764|Glucocorticoids|glucocorticoids|mesh-ancestor
139398935|NCT05496764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398936|NCT05496764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139398937|NCT05496764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398938|NCT05496530|Triamcinolone|triamcinolone|mesh-list
139398939|NCT05496530|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138736671|NCT01170364|Sibutramine|sibutramine|mesh-list
139398940|NCT05496530|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139398941|NCT05496530|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139398942|NCT05496530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398943|NCT05496530|Glucocorticoids|glucocorticoids|mesh-ancestor
139398944|NCT05496530|Hormones|hormones|mesh-ancestor
139398945|NCT05496530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398946|NCT05496530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398947|NCT05496530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139398948|NCT05496530|Immunologic Factors|immunologic factors|mesh-ancestor
139398949|NCT05496530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398950|NCT05496530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398951|NCT02744833|Enoxaparin|enoxaparin|mesh-list
139398952|NCT02744833|Enoxaparin sodium|enoxaparin sodium|mesh-list
139398953|NCT02744833|Anticoagulants|anticoagulants|mesh-ancestor
139398954|NCT02744833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139398955|NCT02744833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139398956|NCT02744833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398957|NCT02234869|Interferons|interferons|mesh-list
139398958|NCT02234869|Interferon-beta|interferon-beta|mesh-list
139398959|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
139398960|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
139398961|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398963|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398964|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
139398965|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398966|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139398967|NCT05499026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139398968|NCT05499026|Cathartics|cathartics|mesh-ancestor
139398969|NCT05499026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139398970|NCT05498714|Lactulose|lactulose|mesh-list
139398971|NCT05498714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139398972|NCT05490836|Interferon-alpha|interferon-alpha|mesh-list
139398973|NCT05490836|Interferon alpha-2|interferon alpha-2|mesh-list
139398974|NCT05490836|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139398975|NCT05490836|Antiviral Agents|antiviral agents|mesh-ancestor
139398976|NCT05490836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398977|NCT05490836|Immunologic Factors|immunologic factors|mesh-ancestor
139398978|NCT05490836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398979|NCT05490836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139398980|NCT01338025|Lamivudine|lamivudine|mesh-list
139398981|NCT01338025|Emtricitabine|emtricitabine|mesh-list
139398982|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139398983|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139398984|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139398985|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139398986|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
139398987|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139398988|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139398989|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139398990|NCT05498636|Prednisone|prednisone|mesh-list
139398991|NCT05498636|Etoposide|etoposide|mesh-list
139398992|NCT05498636|Lenalidomide|lenalidomide|mesh-list
139398993|NCT05498636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398994|NCT05498636|Glucocorticoids|glucocorticoids|mesh-ancestor
139398995|NCT05498636|Hormones|hormones|mesh-ancestor
138736771|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139398996|NCT05498636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139398997|NCT05498636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139398998|NCT05498636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139398999|NCT05498636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399000|NCT05498636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139399001|NCT05498636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139399002|NCT05498636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139399003|NCT05498636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399004|NCT05498636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399005|NCT05498636|Immunologic Factors|immunologic factors|mesh-ancestor
139399006|NCT05498636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139399007|NCT05498636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139399008|NCT05498636|Growth Substances|growth substances|mesh-ancestor
139399009|NCT05498636|Growth Inhibitors|growth inhibitors|mesh-ancestor
139399010|NCT02262715|Oseltamivir|oseltamivir|mesh-list
139399011|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
139399012|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399013|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399014|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399015|NCT04424420|Acetaminophen|acetaminophen|mesh-list
139399016|NCT04424420|Ibuprofen|ibuprofen|mesh-list
139399017|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139399018|NCT04424420|Analgesics|analgesics|mesh-ancestor
139399019|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
139399020|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399021|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399022|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
139399023|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139399024|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139399025|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139399026|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139399027|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399028|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399029|NCT05495750|Bupivacaine|bupivacaine|mesh-list
139399030|NCT05495750|Anesthetics, Local|anesthetics, local|mesh-ancestor
139399031|NCT05495750|Anesthetics|anesthetics|mesh-ancestor
139399032|NCT05495750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139399033|NCT05495750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399034|NCT05495750|Sensory System Agents|sensory system agents|mesh-ancestor
139399035|NCT05495750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399036|NCT02233075|Interferons|interferons|mesh-list
139399037|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
139399038|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
139399039|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139399040|NCT02233075|REP 2139|rep 2139|mesh-list
139399041|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399042|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
139399043|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399044|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
139399045|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399046|NCT04300244|Nivolumab|nivolumab|mesh-list
139399047|NCT04300244|Ipilimumab|ipilimumab|mesh-list
139399048|NCT04300244|Sargramostim|sargramostim|mesh-list
139399049|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139399050|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399051|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139399052|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399053|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
139399054|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399055|NCT02578771|Methylene Blue|methylene blue|mesh-list
139399056|NCT02578771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399057|NCT02578771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399058|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
139399059|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139399060|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
139399061|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
139399062|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399063|NCT02259595|Expectorants|expectorants|mesh-ancestor
139399064|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
139399065|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139399066|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
139399067|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399068|NCT02259595|Protective Agents|protective agents|mesh-ancestor
139399069|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399070|NCT02259595|Antidotes|antidotes|mesh-ancestor
139399071|NCT02804035|Furosemide|furosemide|mesh-list
139399072|NCT02804035|Diuretics|diuretics|mesh-ancestor
139399073|NCT02804035|Natriuretic Agents|natriuretic agents|mesh-ancestor
139399074|NCT02804035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399075|NCT02804035|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139399076|NCT02804035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139399077|NCT02804035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399078|NCT02262793|Telmisartan|telmisartan|mesh-list
139399079|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139399080|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139399081|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139055882|NCT06086275|Analgesics|analgesics|mesh-ancestor
139399082|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399083|NCT02559206|Linaclotide|linaclotide|mesh-list
139399084|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139399085|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
139399086|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399087|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139399088|NCT05485766|Paclitaxel|paclitaxel|mesh-list
139399089|NCT05485766|Carboplatin|carboplatin|mesh-list
139399090|NCT05485766|Pembrolizumab|pembrolizumab|mesh-list
139399091|NCT05485766|Olaparib|olaparib|mesh-list
139399092|NCT05485766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139399093|NCT05485766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399094|NCT05485766|Tubulin Modulators|tubulin modulators|mesh-ancestor
139399095|NCT05485766|Antimitotic Agents|antimitotic agents|mesh-ancestor
139399096|NCT05485766|Mitosis Modulators|mitosis modulators|mesh-ancestor
139399097|NCT05485766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399098|NCT05485766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139399099|NCT05485766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139399100|NCT05485766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139399101|NCT05485766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399102|NCT04402723|Cytarabine|cytarabine|mesh-list
139399103|NCT04402723|Daunorubicin|daunorubicin|mesh-list
139399104|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139399105|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
139399106|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651688|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139399107|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399108|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
139399109|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651689|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139651690|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139399110|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139399111|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
139399112|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399113|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139399114|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139399115|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139399116|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399118|NCT02235337|Vitamins|vitamins|mesh-ancestor
139399119|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
139399120|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399121|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
139399122|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139399123|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
139399124|NCT02233231|Varenicline|varenicline|mesh-list
139399125|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139399126|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139399127|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
139399128|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399129|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399130|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399131|NCT02263027|Vaccines|vaccines|mesh-list
139399132|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
139399133|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399134|NCT02263105|Temozolomide|temozolomide|mesh-list
139399135|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139399136|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
139399137|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399138|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399139|NCT05485064|Fentanyl|fentanyl|mesh-list
139399140|NCT05485064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139399141|NCT05485064|Narcotics|narcotics|mesh-ancestor
139399142|NCT05485064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139399143|NCT05485064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399144|NCT05485064|Analgesics|analgesics|mesh-ancestor
139399145|NCT05485064|Sensory System Agents|sensory system agents|mesh-ancestor
139399146|NCT05485064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399147|NCT05485064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139399148|NCT05485064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139399149|NCT05485064|Anesthetics, General|anesthetics, general|mesh-ancestor
139399150|NCT05485064|Anesthetics|anesthetics|mesh-ancestor
139399151|NCT05626153|Anesthetics|anesthetics|mesh-list
139399152|NCT05626153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139399153|NCT05626153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399154|NCT02553343|Vaccines|vaccines|mesh-list
139399155|NCT02553343|Immunologic Factors|immunologic factors|mesh-ancestor
139399156|NCT02553343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399157|NCT02235415|Lacidipine|lacidipine|mesh-list
139399158|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139399159|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139399160|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139399161|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399162|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139399163|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399165|NCT03995017|Ramucirumab|ramucirumab|mesh-list
139399166|NCT03995017|Rucaparib|rucaparib|mesh-list
138693390|NCT05056584|Glucagon|glucagon|mesh-list
139399167|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139399168|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399169|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139399170|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399171|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139399172|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399173|NCT02558894|Durvalumab|durvalumab|mesh-list
139399174|NCT02558894|Tremelimumab|tremelimumab|mesh-list
139399175|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139399176|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139399177|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399178|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
139399179|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399180|NCT02233387|Imidazole|imidazole|mesh-list
139399181|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399182|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399183|NCT02510599|Solithromycin|solithromycin|mesh-list
139399184|NCT02510599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139651691|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399185|NCT02510599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399186|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
139399187|NCT02235805|Cathartics|cathartics|mesh-ancestor
139399188|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139399189|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139399190|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139399191|NCT02688387|Ambrisentan|ambrisentan|mesh-list
139399192|NCT02688387|Tadalafil|tadalafil|mesh-list
139399193|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
139399194|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139399195|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139399196|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399197|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399198|NCT02688387|Urological Agents|urological agents|mesh-ancestor
139399199|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139399200|NCT05489900|Dexmedetomidine|dexmedetomidine|mesh-list
139399201|NCT05489900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139399202|NCT05489900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139399203|NCT05489900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399204|NCT05489900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139399205|NCT05489900|Analgesics|analgesics|mesh-ancestor
139399206|NCT05489900|Sensory System Agents|sensory system agents|mesh-ancestor
139399207|NCT05489900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399208|NCT05489900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139399209|NCT05489900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139399210|NCT05489900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139399211|NCT05489900|Adrenergic Agents|adrenergic agents|mesh-ancestor
139399212|NCT05489900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399213|NCT05489900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399214|NCT05489666|Vitamin D|vitamin d|mesh-list
139399215|NCT05489666|Cholecalciferol|cholecalciferol|mesh-list
139399216|NCT05489666|Vitamins|vitamins|mesh-ancestor
139399217|NCT05489666|Micronutrients|micronutrients|mesh-ancestor
139399218|NCT05489666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399219|NCT05489666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139399220|NCT05489666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139399221|NCT05484284|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139399222|NCT05484284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399223|NCT05483894|Atorvastatin|atorvastatin|mesh-list
139399224|NCT05483894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139399225|NCT05483894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139399226|NCT05483894|Antimetabolites|antimetabolites|mesh-ancestor
139399227|NCT05483894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399228|NCT05483894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139399229|NCT05483894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139399230|NCT05483894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399231|NCT01621243|Paclitaxel|paclitaxel|mesh-list
139399232|NCT01621243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139399233|NCT01621243|Gemcitabine|gemcitabine|mesh-list
139399234|NCT01621243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139399235|NCT01621243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399236|NCT01621243|Tubulin Modulators|tubulin modulators|mesh-ancestor
139399237|NCT01621243|Antimitotic Agents|antimitotic agents|mesh-ancestor
139399238|NCT01621243|Mitosis Modulators|mitosis modulators|mesh-ancestor
139399239|NCT01621243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399240|NCT01621243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139399241|NCT01621243|Antimetabolites|antimetabolites|mesh-ancestor
139399242|NCT04076761|Trifluridine|trifluridine|mesh-list
139399243|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
139399244|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399245|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
139399246|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399247|NCT02235961|Liraglutide|liraglutide|mesh-list
139399248|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139399249|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399250|NCT02235961|Incretins|incretins|mesh-ancestor
139399252|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139399253|NCT01610245|Oseltamivir|oseltamivir|mesh-list
139399254|NCT01610245|Nitazoxanide|nitazoxanide|mesh-list
139399255|NCT01610245|Antiviral Agents|antiviral agents|mesh-ancestor
139399256|NCT01610245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399257|NCT01610245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399258|NCT01610245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399259|NCT01610245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139399260|NCT04138628|Atezolizumab|atezolizumab|mesh-list
139399261|NCT04138628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139399262|NCT04138628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399263|NCT04138628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139399264|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399265|NCT02741791|Bupropion|bupropion|mesh-list
139399266|NCT02741791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139399267|NCT02741791|Antidepressive Agents|antidepressive agents|mesh-ancestor
139399268|NCT02741791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139399269|NCT02741791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139399270|NCT02741791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139399271|NCT02741791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139399272|NCT02741791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399273|NCT02741791|Dopamine Agents|dopamine agents|mesh-ancestor
139399274|NCT02741791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399275|NCT02741791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399276|NCT02741791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139399277|NCT02741791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139399278|NCT02741791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399279|NCT04275518|Cytarabine|cytarabine|mesh-list
139399280|NCT04275518|Azacitidine|azacitidine|mesh-list
139399281|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139399282|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
139399283|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399284|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399285|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
139399286|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399287|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138737316|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
139399288|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
139399289|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399290|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399291|NCT02263495|Paclitaxel|paclitaxel|mesh-list
139399292|NCT02263495|Gemcitabine|gemcitabine|mesh-list
139399293|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139399294|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399295|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
139399296|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
139399297|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
139399298|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399299|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139399300|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
139399301|NCT02687451|Oxymorphone|oxymorphone|mesh-list
139399302|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139399303|NCT02687451|Narcotics|narcotics|mesh-ancestor
139399304|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139399305|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399306|NCT02687451|Analgesics|analgesics|mesh-ancestor
139399307|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
139056103|NCT05294640|Autonomic Agents|autonomic agents|mesh-ancestor
139399308|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399309|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139399310|NCT02557646|Ribavirin|ribavirin|mesh-list
139399311|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139399312|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
139399313|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399314|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
139399315|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399316|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
139399317|NCT02679573|Linezolid|linezolid|mesh-list
139399318|NCT02679573|Delafloxacin|delafloxacin|mesh-list
139399319|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139399320|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399321|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139399322|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139399323|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399324|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399325|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399326|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139399327|NCT05493332|Leucovorin|leucovorin|mesh-list
139399328|NCT05493332|Fluorouracil|fluorouracil|mesh-list
139399329|NCT05493332|Oxaliplatin|oxaliplatin|mesh-list
139399330|NCT05493332|Antimetabolites|antimetabolites|mesh-ancestor
139399331|NCT05493332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399332|NCT05493332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139399333|NCT05493332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399334|NCT05493332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139399335|NCT05493332|Immunologic Factors|immunologic factors|mesh-ancestor
139399336|NCT05493332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399338|NCT05493332|Protective Agents|protective agents|mesh-ancestor
139399339|NCT05493332|Vitamin B Complex|vitamin b complex|mesh-ancestor
139399340|NCT05493332|Vitamins|vitamins|mesh-ancestor
139399341|NCT05493332|Micronutrients|micronutrients|mesh-ancestor
139399342|NCT01591447|Solithromycin|solithromycin|mesh-list
139399343|NCT01591447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139399344|NCT01591447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399345|NCT01578655|Prednisone|prednisone|mesh-list
139399346|NCT01578655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139399347|NCT01578655|Glucocorticoids|glucocorticoids|mesh-ancestor
139399348|NCT01578655|Hormones|hormones|mesh-ancestor
139399349|NCT01578655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139399350|NCT01578655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399351|NCT01578655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139399352|NCT01578655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399353|NCT05361447|Diazepam|diazepam|mesh-list
139399354|NCT05361447|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139399355|NCT05361447|Anticonvulsants|anticonvulsants|mesh-ancestor
139399356|NCT05361447|Antiemetics|antiemetics|mesh-ancestor
139399357|NCT05361447|Autonomic Agents|autonomic agents|mesh-ancestor
139399358|NCT05361447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399359|NCT05361447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399360|NCT05361447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139399361|NCT05361447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139399362|NCT05361447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139399363|NCT05361447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139399364|NCT05361447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139399365|NCT05361447|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139399366|NCT05361447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139399367|NCT05361447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139399368|NCT05361447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139399369|NCT05361447|Anesthetics, General|anesthetics, general|mesh-ancestor
139399370|NCT05361447|Anesthetics|anesthetics|mesh-ancestor
139399371|NCT05361447|GABA Modulators|gaba modulators|mesh-ancestor
139399372|NCT05361447|GABA Agents|gaba agents|mesh-ancestor
139399373|NCT05361447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399374|NCT05361447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399375|NCT01577173|Cetuximab|cetuximab|mesh-list
139399376|NCT01577173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139399377|NCT01577173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399378|NCT01573351|Interferons|interferons|mesh-list
139399379|NCT01573351|Ribavirin|ribavirin|mesh-list
139399380|NCT01573351|Interferon-alpha|interferon-alpha|mesh-list
139399381|NCT01573351|Interferon alpha-2|interferon alpha-2|mesh-list
139399382|NCT01573351|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139399383|NCT01573351|Asunaprevir|asunaprevir|mesh-list
139399384|NCT01573351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399385|NCT01573351|Antiviral Agents|antiviral agents|mesh-ancestor
139399386|NCT01573351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399387|NCT01573351|Antimetabolites|antimetabolites|mesh-ancestor
139399388|NCT01573351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399389|NCT01573351|Immunologic Factors|immunologic factors|mesh-ancestor
139399390|NCT01573351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399391|NCT01573351|Protease Inhibitors|protease inhibitors|mesh-ancestor
139399392|NCT01573351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399393|NCT02685033|Dalbavancin|dalbavancin|mesh-list
139399394|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139399395|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399396|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
139399397|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
139399398|NCT00258427|Busulfan|busulfan|mesh-list
139399399|NCT00258427|Fludarabine|fludarabine|mesh-list
139399400|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
139399401|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139399402|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139399403|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
139399404|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399405|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139399406|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139399407|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
139399408|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399409|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399410|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139399411|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139399412|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
139399413|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139399414|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
139399415|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
139399416|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399417|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139399418|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
139399419|NCT00258427|Hormones|hormones|mesh-ancestor
139399420|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139399421|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139399422|NCT00258427|Protective Agents|protective agents|mesh-ancestor
139399423|NCT01531699|Povidone-Iodine|povidone-iodine|mesh-list
139399424|NCT01531699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139399425|NCT01531699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139399426|NCT01531699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399427|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139399428|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139399429|NCT02233621|Estradiol|estradiol|mesh-list
139399430|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139399431|NCT02233621|Estrogens|estrogens|mesh-ancestor
139399432|NCT02233621|Hormones|hormones|mesh-ancestor
139399433|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139399434|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399435|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139399436|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
139399437|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139399438|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139399439|NCT02557100|Adalimumab|adalimumab|mesh-list
139399440|NCT02557100|Methotrexate|methotrexate|mesh-list
139399441|NCT02557100|Abatacept|abatacept|mesh-list
139399442|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139399443|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
139399444|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139399445|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399446|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139399447|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
139399448|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399449|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399450|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
139399451|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399452|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139399453|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139399454|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
139399455|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139399456|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139399457|NCT02557100|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139399458|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139399459|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139399460|NCT02557100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139399461|NCT02233777|Pregabalin|pregabalin|mesh-list
139399462|NCT02233777|Analgesics|analgesics|mesh-ancestor
139399463|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
139399464|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399465|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399466|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
139399467|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139399468|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139399469|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399470|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139399471|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139399472|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139399473|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139399474|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139399475|NCT02634853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139399476|NCT02634853|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139399477|NCT01520545|Baclofen|baclofen|mesh-list
139399478|NCT01520545|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139399479|NCT01520545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399480|NCT01520545|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139399481|NCT01520545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399482|NCT01520545|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139399483|NCT01520545|GABA Agonists|gaba agonists|mesh-ancestor
139399484|NCT01520545|GABA Agents|gaba agents|mesh-ancestor
139651692|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399485|NCT01520545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399486|NCT01520545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399487|NCT05488106|Riboflavin|riboflavin|mesh-list
139399488|NCT05488106|Vitamin B Complex|vitamin b complex|mesh-ancestor
139399489|NCT05488106|Vitamins|vitamins|mesh-ancestor
139399490|NCT05488106|Micronutrients|micronutrients|mesh-ancestor
139399491|NCT05488106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399492|NCT05488106|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139399493|NCT05488106|Dermatologic Agents|dermatologic agents|mesh-ancestor
139399494|NCT05492318|Clarithromycin|clarithromycin|mesh-list
139399495|NCT05492318|Midazolam|midazolam|mesh-list
139399496|NCT05492318|Dabigatran|dabigatran|mesh-list
139399497|NCT05492318|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
139399498|NCT05492318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139399499|NCT05492318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139399500|NCT05492318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139399501|NCT05492318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399502|NCT05492318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139399503|NCT05492318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139399504|NCT05492318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139399505|NCT05492318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139399506|NCT05492318|Anesthetics, General|anesthetics, general|mesh-ancestor
139399507|NCT05492318|Anesthetics|anesthetics|mesh-ancestor
139399508|NCT05492318|GABA Modulators|gaba modulators|mesh-ancestor
139399509|NCT05492318|GABA Agents|gaba agents|mesh-ancestor
139399510|NCT05492318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399511|NCT05492318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399512|NCT05492318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139399513|NCT05492318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399514|NCT05492318|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139399515|NCT05492318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399516|NCT05492318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139399517|NCT05492318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139399518|NCT05492318|Antithrombins|antithrombins|mesh-ancestor
139399519|NCT05492318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139399520|NCT05492318|Protease Inhibitors|protease inhibitors|mesh-ancestor
139399521|NCT05492318|Anticoagulants|anticoagulants|mesh-ancestor
139399522|NCT05492318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139399523|NCT01337635|Vitamin D|vitamin d|mesh-list
139399524|NCT01337635|Vitamins|vitamins|mesh-ancestor
139399525|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
139399526|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737654|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
139399527|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139399528|NCT02264041|Itraconazole|itraconazole|mesh-list
139399529|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
139399530|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399531|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139399532|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139399533|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399534|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399535|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139399536|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
139056344|NCT04317872|BB 1101|bb 1101|mesh-list
139399537|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139399538|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399539|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139399540|NCT02261779|Tretinoin|tretinoin|mesh-list
139399541|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
139399542|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399543|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
139399544|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
139399545|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
139399546|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139399547|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139399548|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399549|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399550|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139399551|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139399552|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139399553|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399554|NCT05157685|Azithromycin|azithromycin|mesh-list
139399555|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139399556|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399557|NCT02556632|Curcumin|curcumin|mesh-list
139399558|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139399559|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139399560|NCT02556632|Analgesics|analgesics|mesh-ancestor
139399561|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
139399562|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399563|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399564|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139399565|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139399566|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399567|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399568|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399569|NCT05491928|Tempol|tempol|mesh-list
139399570|NCT05491928|Antioxidants|antioxidants|mesh-ancestor
139399571|NCT05491928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399572|NCT05491928|Protective Agents|protective agents|mesh-ancestor
139399573|NCT05491928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737689|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399574|NCT05491928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139399575|NCT05491928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399576|NCT05491928|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139399577|NCT05491928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139399578|NCT01515007|Ciprofloxacin|ciprofloxacin|mesh-list
139399579|NCT01515007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139399580|NCT01515007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399581|NCT01515007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139399582|NCT01515007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139399583|NCT01515007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399584|NCT01515007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399585|NCT01515007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399586|NCT01515007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139399587|NCT01515007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139399588|NCT02262169|Omeprazole|omeprazole|mesh-list
139399589|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139399590|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139399591|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139399592|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399593|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399594|NCT05491694|Paclitaxel|paclitaxel|mesh-list
139399595|NCT05491694|Cyclophosphamide|cyclophosphamide|mesh-list
139399596|NCT05491694|Carboplatin|carboplatin|mesh-list
139399597|NCT05491694|Epirubicin|epirubicin|mesh-list
139399598|NCT05491694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139399599|NCT05491694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399600|NCT05491694|Tubulin Modulators|tubulin modulators|mesh-ancestor
139399601|NCT05491694|Antimitotic Agents|antimitotic agents|mesh-ancestor
139399602|NCT05491694|Mitosis Modulators|mitosis modulators|mesh-ancestor
139399603|NCT05491694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399604|NCT05491694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139399605|NCT05491694|Immunologic Factors|immunologic factors|mesh-ancestor
139399606|NCT05491694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399607|NCT05491694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139399608|NCT05491694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139399609|NCT05491694|Alkylating Agents|alkylating agents|mesh-ancestor
139056403|NCT04170556|Nivolumab|nivolumab|mesh-list
139399610|NCT05491694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139399611|NCT05491694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139399612|NCT05491694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138737732|NCT01062763|Spironolactone|spironolactone|mesh-list
139399613|NCT05491694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139399614|NCT05491694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399615|NCT05480072|Palmidrol|palmidrol|mesh-list
139399616|NCT05480072|Analgesics|analgesics|mesh-ancestor
139399617|NCT05480072|Sensory System Agents|sensory system agents|mesh-ancestor
139399618|NCT05480072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399619|NCT05480072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399620|NCT05480072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139399621|NCT05480072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139399622|NCT05480072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139399623|NCT05480072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139399624|NCT05480072|Antiviral Agents|antiviral agents|mesh-ancestor
139399625|NCT05480072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399626|NCT05480072|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139399627|NCT05480072|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139399628|NCT05480072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399629|NCT05480072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651693|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139399630|NCT05480072|Hormones|hormones|mesh-ancestor
139399631|NCT05480072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139399632|NCT01499563|Risperidone|risperidone|mesh-list
139399633|NCT01499563|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139399634|NCT01499563|Serotonin Agents|serotonin agents|mesh-ancestor
139399635|NCT01499563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399636|NCT01499563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399637|NCT01499563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399638|NCT01499563|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139399639|NCT01499563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139399640|NCT01499563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139399641|NCT01499563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139399642|NCT01499563|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139399643|NCT01499563|Dopamine Agents|dopamine agents|mesh-ancestor
139399644|NCT03922880|Nivolumab|nivolumab|mesh-list
139399645|NCT03922880|Ipilimumab|ipilimumab|mesh-list
139399646|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139399647|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399648|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139399649|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399650|NCT02264119|Pantoprazole|pantoprazole|mesh-list
139399651|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139399652|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139399653|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139399654|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399655|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399656|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
139399657|NCT02262481|Progestins|progestins|mesh-ancestor
139399658|NCT02262481|Hormones|hormones|mesh-ancestor
139399659|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139399660|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399661|NCT01435369|Pidilizumab|pidilizumab|mesh-list
139399662|NCT01435369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139399663|NCT01435369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399664|NCT01257607|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139399665|NCT01257607|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139399666|NCT01252693|Goserelin|goserelin|mesh-list
139399667|NCT01252693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139399668|NCT01252693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399669|NCT01486849|Riluzole|riluzole|mesh-list
139399670|NCT01486849|Anticonvulsants|anticonvulsants|mesh-ancestor
139399671|NCT01486849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139399672|NCT01486849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139399673|NCT01486849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399674|NCT01486849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399675|NCT01486849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399676|NCT01486849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139399677|NCT01486849|Protective Agents|protective agents|mesh-ancestor
139399678|NCT01484119|Cetirizine|cetirizine|mesh-list
139399679|NCT01484119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139399680|NCT01484119|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139399681|NCT01484119|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139399682|NCT01484119|Histamine Antagonists|histamine antagonists|mesh-ancestor
139399683|NCT01484119|Histamine Agents|histamine agents|mesh-ancestor
139399684|NCT01484119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399685|NCT01484119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399686|NCT01484119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399687|NCT01482403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139399688|NCT01482403|Interferon-alpha|interferon-alpha|mesh-list
139399689|NCT01482403|Ribavirin|ribavirin|mesh-list
139399690|NCT01482403|Antiviral Agents|antiviral agents|mesh-ancestor
139399691|NCT01482403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399692|NCT01482403|Immunologic Factors|immunologic factors|mesh-ancestor
139399693|NCT01482403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399694|NCT01482403|Antimetabolites|antimetabolites|mesh-ancestor
139399695|NCT01482403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399696|NCT01481077|Latanoprost|latanoprost|mesh-list
139399697|NCT01481077|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139399698|NCT01481077|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139399699|NCT02268409|Luspatercept|luspatercept|mesh-list
139399700|NCT02268409|Hematinics|hematinics|mesh-ancestor
139399701|NCT02268487|Sertraline|sertraline|mesh-list
139399702|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
139399703|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139651694|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139399704|NCT02268487|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139399705|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139399706|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139399707|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399709|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
139399710|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399711|NCT02265289|Clopidogrel|clopidogrel|mesh-list
139399712|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139399713|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139399714|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139399715|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139399716|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
139399717|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399718|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399719|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399720|NCT02265445|beta-Lactams|beta-lactams|mesh-list
139399721|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139399722|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399723|NCT04476121|Aspirin|aspirin|mesh-list
139399724|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139399725|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139399726|NCT04476121|Analgesics|analgesics|mesh-ancestor
139399727|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
139399728|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399729|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399730|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139399731|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139399732|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139399733|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139399734|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399735|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139399736|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139399737|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399738|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
139399739|NCT01234519|Doxorubicin|doxorubicin|mesh-list
139399740|NCT01234519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139399741|NCT01234519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399742|NCT01234519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139399743|NCT01234519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139399744|NCT01234519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399745|NCT01234519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399746|NCT01474135|Travoprost|travoprost|mesh-list
139399747|NCT01474135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139399748|NCT02268565|Aspirin|aspirin|mesh-list
139399749|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139399750|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139399751|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139399752|NCT02268565|Analgesics|analgesics|mesh-ancestor
139399753|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
139399754|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399755|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399756|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139399757|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139399759|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399760|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139399761|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139399762|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399763|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
139399764|NCT05479448|Prednisone|prednisone|mesh-list
139399765|NCT05479448|Hormones|hormones|mesh-list
139399766|NCT05479448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139399767|NCT05479448|Glucocorticoids|glucocorticoids|mesh-ancestor
139399768|NCT05479448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139399769|NCT05479448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399770|NCT05479448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139399771|NCT05479448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399772|NCT02264587|Domperidone|domperidone|mesh-list
139399773|NCT02264587|Mosapride|mosapride|mesh-list
139399774|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
139399775|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
139651695|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139651696|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738033|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
139651697|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139399776|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399777|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399778|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139399779|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139399780|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
139399781|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399782|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399783|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139399784|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
139399785|NCT05475080|Anticoagulants|anticoagulants|mesh-list
139399786|NCT05475080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139399787|NCT02683941|Lanreotide|lanreotide|mesh-list
139399788|NCT02683941|Somatostatin|somatostatin|mesh-list
139399789|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399790|NCT02683941|Hormones|hormones|mesh-ancestor
139399791|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139399792|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399793|NCT01225393|Adalimumab|adalimumab|mesh-list
139399794|NCT01225393|Methotrexate|methotrexate|mesh-list
139399795|NCT01225393|Leflunomide|leflunomide|mesh-list
139399796|NCT01225393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139399797|NCT01225393|Abortifacient Agents|abortifacient agents|mesh-ancestor
139399798|NCT01225393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139399799|NCT01225393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399800|NCT01225393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139399801|NCT01225393|Antimetabolites|antimetabolites|mesh-ancestor
139399802|NCT01225393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399803|NCT01225393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399804|NCT01225393|Dermatologic Agents|dermatologic agents|mesh-ancestor
139399805|NCT01225393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399806|NCT01225393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139399807|NCT01225393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139399808|NCT01225393|Immunologic Factors|immunologic factors|mesh-ancestor
139399809|NCT01225393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139399810|NCT01225393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139399811|NCT01225393|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139399812|NCT01225393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139399813|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139399814|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139399815|NCT02264743|Estradiol|estradiol|mesh-list
139399816|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139399817|NCT02264743|Estrogens|estrogens|mesh-ancestor
139399818|NCT02264743|Hormones|hormones|mesh-ancestor
139399819|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139399820|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399821|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139399822|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
139399823|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139399824|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139399825|NCT01220947|Ritonavir|ritonavir|mesh-list
139399826|NCT01220947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139399827|NCT01220947|Lactams|lactams|mesh-list
139399828|NCT01220947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139399829|NCT01220947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139399830|NCT01220947|Protease Inhibitors|protease inhibitors|mesh-ancestor
139056627|NCT00222729|Growth Substances|growth substances|mesh-ancestor
139399831|NCT01220947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399832|NCT01220947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399833|NCT01220947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139399834|NCT01220947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139399835|NCT01220947|Antiviral Agents|antiviral agents|mesh-ancestor
139399836|NCT01220947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399837|NCT01220947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139399838|NCT01220947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139399839|NCT01220947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139399840|NCT01393639|Prednisone|prednisone|mesh-list
139399841|NCT01393639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139399842|NCT01393639|Glucocorticoids|glucocorticoids|mesh-ancestor
139399843|NCT01393639|Hormones|hormones|mesh-ancestor
139399844|NCT01393639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139399845|NCT01393639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399846|NCT01393639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139651698|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139399847|NCT01393639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399848|NCT01379209|Mycophenolic Acid|mycophenolic acid|mesh-list
139399850|NCT01379209|Methotrexate|methotrexate|mesh-list
139399851|NCT01379209|KRN 7000|krn 7000|mesh-list
139399852|NCT01379209|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139399853|NCT01379209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139399854|NCT01379209|Abortifacient Agents|abortifacient agents|mesh-ancestor
139399855|NCT01379209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139399856|NCT01379209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399857|NCT01379209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139399858|NCT01379209|Antimetabolites|antimetabolites|mesh-ancestor
139399859|NCT01379209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399860|NCT01379209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399861|NCT01379209|Dermatologic Agents|dermatologic agents|mesh-ancestor
139399862|NCT01379209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399863|NCT01379209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139399864|NCT01379209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139399865|NCT01379209|Immunologic Factors|immunologic factors|mesh-ancestor
139399866|NCT01379209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139399867|NCT01379209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139399868|NCT01379209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139399869|NCT01379209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139399870|NCT01379209|Antitubercular Agents|antitubercular agents|mesh-ancestor
139399871|NCT01379209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139399872|NCT01379209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399873|NCT01379209|Antifungal Agents|antifungal agents|mesh-ancestor
139399874|NCT01379209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139399875|NCT01204099|Docetaxel|docetaxel|mesh-list
139399876|NCT01204099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399877|NCT01204099|Tubulin Modulators|tubulin modulators|mesh-ancestor
139399878|NCT01204099|Antimitotic Agents|antimitotic agents|mesh-ancestor
139399879|NCT01204099|Mitosis Modulators|mitosis modulators|mesh-ancestor
139399880|NCT01204099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399881|NCT02853500|Doxorubicin|doxorubicin|mesh-list
139399882|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139399883|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399884|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139399885|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139399886|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399887|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399888|NCT01188187|Dexamethasone|dexamethasone|mesh-list
139399889|NCT01188187|Prednisone|prednisone|mesh-list
139399890|NCT01188187|Docetaxel|docetaxel|mesh-list
139399891|NCT01188187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139399892|NCT01188187|Antiemetics|antiemetics|mesh-ancestor
139399893|NCT01188187|Autonomic Agents|autonomic agents|mesh-ancestor
139399894|NCT01188187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399895|NCT01188187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399896|NCT01188187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139399897|NCT01188187|Glucocorticoids|glucocorticoids|mesh-ancestor
139399898|NCT01188187|Hormones|hormones|mesh-ancestor
139399899|NCT01188187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139399900|NCT01188187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139399901|NCT01188187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399902|NCT01188187|Tubulin Modulators|tubulin modulators|mesh-ancestor
139399903|NCT01188187|Antimitotic Agents|antimitotic agents|mesh-ancestor
139399904|NCT01188187|Mitosis Modulators|mitosis modulators|mesh-ancestor
139399905|NCT01188187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399906|NCT05478356|Atropine|atropine|mesh-list
139399907|NCT05478356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139399908|NCT05478356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139399909|NCT05478356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139399910|NCT05478356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139399911|NCT05478356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139399912|NCT05478356|Autonomic Agents|autonomic agents|mesh-ancestor
139399913|NCT05478356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399914|NCT05478356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399915|NCT05478356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139399916|NCT05478356|Respiratory System Agents|respiratory system agents|mesh-ancestor
139399917|NCT05478356|Mydriatics|mydriatics|mesh-ancestor
139399918|NCT05478356|Parasympatholytics|parasympatholytics|mesh-ancestor
139399919|NCT05478356|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139399920|NCT05478356|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139651699|NCT01531959|Midodrine|midodrine|mesh-list
139399921|NCT05478356|Cholinergic Agents|cholinergic agents|mesh-ancestor
139399922|NCT05478356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399923|NCT05478356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399924|NCT01186861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139399925|NCT01186861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399926|NCT01186861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139399927|NCT01186861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399928|NCT01186861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399929|NCT01175785|Cyclosporine|cyclosporine|mesh-list
139399930|NCT01175785|Mycophenolic Acid|mycophenolic acid|mesh-list
139399931|NCT01175785|Cyclophosphamide|cyclophosphamide|mesh-list
139399932|NCT01175785|Fludarabine|fludarabine|mesh-list
139399933|NCT01175785|Fludarabine phosphate|fludarabine phosphate|mesh-list
139399934|NCT01175785|Cyclosporins|cyclosporins|mesh-list
139399935|NCT01175785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139399936|NCT01175785|Immunologic Factors|immunologic factors|mesh-ancestor
139399937|NCT01175785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399938|NCT01175785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139399939|NCT01175785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139399940|NCT01175785|Alkylating Agents|alkylating agents|mesh-ancestor
139399941|NCT01175785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399942|NCT01175785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399943|NCT01175785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139399944|NCT01175785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139399945|NCT01175785|Antimetabolites|antimetabolites|mesh-ancestor
139399946|NCT01175785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139399947|NCT01175785|Antifungal Agents|antifungal agents|mesh-ancestor
139399948|NCT01175785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139399949|NCT01175785|Dermatologic Agents|dermatologic agents|mesh-ancestor
139399950|NCT01175785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139399951|NCT01175785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139399952|NCT01175785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138738161|NCT00623285|Pregabalin|pregabalin|mesh-list
139399953|NCT01175785|Antitubercular Agents|antitubercular agents|mesh-ancestor
139399954|NCT01175785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139399955|NCT05478044|Ascorbic Acid|ascorbic acid|mesh-list
139399956|NCT05478044|Vitamins|vitamins|mesh-ancestor
139399957|NCT05478044|Micronutrients|micronutrients|mesh-ancestor
139399958|NCT05478044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399959|NCT05478044|Antioxidants|antioxidants|mesh-ancestor
139399960|NCT05478044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399961|NCT05478044|Protective Agents|protective agents|mesh-ancestor
139399962|NCT05472506|Nivolumab|nivolumab|mesh-list
139399963|NCT05472506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139399964|NCT05472506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399965|NCT05472506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139399966|NCT05472506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399967|NCT01445899|Ranibizumab|ranibizumab|mesh-list
139399968|NCT01445899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139399969|NCT01445899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139399970|NCT01445899|Growth Substances|growth substances|mesh-ancestor
139399971|NCT01445899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399972|NCT01445899|Growth Inhibitors|growth inhibitors|mesh-ancestor
139399973|NCT01445899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139399974|NCT03649724|Leuprolide|leuprolide|mesh-list
139399975|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139399976|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
139399977|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139399978|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399979|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139399980|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056776|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
139399981|NCT01358695|Botulinum Toxins|botulinum toxins|mesh-list
139399982|NCT01358695|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139399983|NCT01358695|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139399984|NCT01358695|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139399985|NCT01358695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139399986|NCT01358695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139399987|NCT01358695|Cholinergic Agents|cholinergic agents|mesh-ancestor
139399988|NCT01358695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139399989|NCT01358695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399990|NCT01358695|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139399991|NCT01358695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139399992|NCT02266303|Insulin|insulin|mesh-list
139399993|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139399994|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139399995|NCT02551874|Metformin|metformin|mesh-list
139651700|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
139399996|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
139399997|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
139399998|NCT02551874|Saxagliptin|saxagliptin|mesh-list
139399999|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139400000|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400001|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139400002|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400003|NCT02551874|Incretins|incretins|mesh-ancestor
139400004|NCT02551874|Hormones|hormones|mesh-ancestor
139400005|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139400006|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139400007|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
139400008|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400009|NCT03646604|Upadacitinib|upadacitinib|mesh-list
139400010|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139400011|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139400012|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400013|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400014|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139400015|NCT01354717|Fluorouracil|fluorouracil|mesh-list
139400016|NCT01354717|Antimetabolites|antimetabolites|mesh-ancestor
139400017|NCT01354717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400018|NCT01354717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139400019|NCT01354717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400020|NCT01354717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139400021|NCT01354717|Immunologic Factors|immunologic factors|mesh-ancestor
139400022|NCT01354717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400023|NCT01072981|Gemcitabine|gemcitabine|mesh-list
139400024|NCT01072981|Fluorouracil|fluorouracil|mesh-list
139400025|NCT01072981|Pancrelipase|pancrelipase|mesh-list
139400026|NCT01072981|Immunologic Factors|immunologic factors|mesh-list
139400027|NCT01072981|Immunomodulating Agents|immunomodulating agents|mesh-list
139400028|NCT01072981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139400029|NCT01072981|Antimetabolites|antimetabolites|mesh-ancestor
139400030|NCT01072981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400031|NCT01072981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400032|NCT01072981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139400033|NCT01072981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400034|NCT01072981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139400035|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139400036|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
139400037|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139400038|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
139400039|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400040|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
139400041|NCT03347708|Protective Agents|protective agents|mesh-ancestor
139400042|NCT01159249|Vildagliptin|vildagliptin|mesh-list
139400043|NCT01159249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139400044|NCT01159249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400045|NCT01159249|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139400046|NCT01159249|Protease Inhibitors|protease inhibitors|mesh-ancestor
139400047|NCT01159249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400048|NCT01159249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400049|NCT01156753|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
139400050|NCT01156753|Immunoconjugates|immunoconjugates|mesh-ancestor
139400051|NCT01156753|Immunologic Factors|immunologic factors|mesh-ancestor
139400052|NCT01156753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400053|NCT01156753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139400054|NCT01156753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400055|NCT01345045|Pregabalin|pregabalin|mesh-list
139400057|NCT01345045|Sensory System Agents|sensory system agents|mesh-ancestor
139400058|NCT01345045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738294|NCT02878564|Praziquantel|praziquantel|mesh-list
139400059|NCT01345045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400060|NCT01345045|Anticonvulsants|anticonvulsants|mesh-ancestor
139400061|NCT01345045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139400062|NCT01345045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139400063|NCT01345045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400064|NCT01345045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139400065|NCT01345045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139400066|NCT01345045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139400067|NCT01345045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139400068|NCT01345045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139400069|NCT01344187|Riboflavin|riboflavin|mesh-list
139400070|NCT01344187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139400071|NCT01344187|Vitamin B Complex|vitamin b complex|mesh-ancestor
139400073|NCT01344187|Micronutrients|micronutrients|mesh-ancestor
139400074|NCT01344187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400075|NCT01344187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139400076|NCT01344187|Dermatologic Agents|dermatologic agents|mesh-ancestor
139400077|NCT01338883|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139400078|NCT01338883|Efavirenz|efavirenz|mesh-list
139400079|NCT01338883|Cenicriviroc|cenicriviroc|mesh-list
139400080|NCT01338883|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139400081|NCT01338883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139400082|NCT01338883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400083|NCT01338883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400084|NCT01338883|Antiviral Agents|antiviral agents|mesh-ancestor
139400085|NCT01338883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400086|NCT01338883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139400087|NCT01338883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139400088|NCT01338883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139400089|NCT01338883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139400090|NCT01338883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139400091|NCT01338883|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139400092|NCT01338883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139400093|NCT01338883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139400094|NCT01338883|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139400095|NCT05625919|Sirolimus|sirolimus|mesh-list
139400096|NCT05625919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139400097|NCT05625919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400098|NCT05625919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139400099|NCT05625919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400100|NCT05625919|Antifungal Agents|antifungal agents|mesh-ancestor
139400101|NCT05625919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139400102|NCT05625919|Immunologic Factors|immunologic factors|mesh-ancestor
139400103|NCT05625919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400104|NCT02266537|Doxazosin|doxazosin|mesh-list
139400105|NCT02266537|Tamsulosin|tamsulosin|mesh-list
139400106|NCT02266537|Alfuzosin|alfuzosin|mesh-list
139400107|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139400108|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139400109|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139400110|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
139400111|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139400112|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400113|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400114|NCT02266537|Urological Agents|urological agents|mesh-ancestor
139400115|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139400116|NCT02269735|Insulin|insulin|mesh-list
139400117|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139400118|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
139400119|NCT02269735|MK-2640|mk-2640|mesh-list
139400120|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139400121|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400122|NCT01038739|Mesalamine|mesalamine|mesh-list
139400123|NCT01038739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139400124|NCT01038739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139400125|NCT01038739|Analgesics|analgesics|mesh-ancestor
139400126|NCT01038739|Sensory System Agents|sensory system agents|mesh-ancestor
139400127|NCT01038739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400128|NCT01038739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056931|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
139400129|NCT01038739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139400130|NCT01038739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139400131|NCT01336465|Etrolizumab|etrolizumab|mesh-list
139400132|NCT01336465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139400133|NCT01336465|Immunologic Factors|immunologic factors|mesh-ancestor
139400134|NCT01336465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400135|NCT02769065|Donepezil|donepezil|mesh-list
139400136|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139400137|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400138|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400139|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
139400140|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139400141|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400142|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
139400143|NCT02540954|Aflibercept|aflibercept|mesh-list
139400144|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139400145|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139400146|NCT02540954|Growth Substances|growth substances|mesh-ancestor
139400147|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400148|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
139400149|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400150|NCT05265975|Rituximab|rituximab|mesh-list
139400151|NCT05265975|Lenalidomide|lenalidomide|mesh-list
139400152|NCT05265975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139400153|NCT05265975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400154|NCT05265975|Immunologic Factors|immunologic factors|mesh-ancestor
139400155|NCT05265975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400156|NCT05265975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139400157|NCT05265975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139400158|NCT05265975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139400159|NCT05265975|Growth Substances|growth substances|mesh-ancestor
139400160|NCT05265975|Growth Inhibitors|growth inhibitors|mesh-ancestor
139400161|NCT02151305|Remifentanil|remifentanil|mesh-list
139400162|NCT02151305|Propofol|propofol|mesh-list
139400163|NCT02151305|Sevoflurane|sevoflurane|mesh-list
139400164|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139400165|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139400166|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400167|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139400168|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
139400169|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
139400170|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139400171|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139400172|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139400173|NCT02151305|Narcotics|narcotics|mesh-ancestor
139400174|NCT02151305|Analgesics|analgesics|mesh-ancestor
139400175|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
139400176|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400177|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
139400178|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139400179|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
139400180|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400181|NCT03164421|Expectorants|expectorants|mesh-ancestor
139400182|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
139400183|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139400184|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
139400185|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400186|NCT03164421|Protective Agents|protective agents|mesh-ancestor
138738410|NCT01307891|Paclitaxel|paclitaxel|mesh-list
139400187|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400188|NCT03164421|Antidotes|antidotes|mesh-ancestor
139400189|NCT05228613|Vaccines|vaccines|mesh-list
139400190|NCT05228613|Immunologic Factors|immunologic factors|mesh-ancestor
139400191|NCT05228613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400192|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139400193|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139400194|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400195|NCT02628704|Dexamethasone|dexamethasone|mesh-list
139400196|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139400197|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
139400198|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
139400199|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400200|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400201|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139400202|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
139400203|NCT02628704|Hormones|hormones|mesh-ancestor
139400204|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139400205|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139400206|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400208|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139400209|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139400210|NCT02152475|Analgesics|analgesics|mesh-ancestor
139400211|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
139400212|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400213|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400214|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139400215|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139400216|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400217|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400218|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400219|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
139400220|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139651701|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
139400221|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139400222|NCT03161457|Rituximab|rituximab|mesh-list
139400223|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139400224|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400225|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
139400226|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400227|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139400228|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139400229|NCT02159573|Natalizumab|natalizumab|mesh-list
139400230|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
139400231|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400232|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
139400233|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139400234|NCT02152709|Vaccines|vaccines|mesh-list
139400235|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
139400236|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400237|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
139400238|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
139400239|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139400240|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400241|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139400242|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139400243|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400244|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400245|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400246|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400247|NCT03164109|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139400248|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
139400249|NCT03164109|Protective Agents|protective agents|mesh-ancestor
139400250|NCT02152787|Propofol|propofol|mesh-list
139400251|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139400252|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139400253|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400254|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139400255|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
139400256|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
139400257|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
139400258|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
139400259|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400260|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139400261|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400262|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400263|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
139400264|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139400265|NCT02765399|Liraglutide|liraglutide|mesh-list
139400266|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139400267|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400268|NCT02765399|Incretins|incretins|mesh-ancestor
139400269|NCT02765399|Hormones|hormones|mesh-ancestor
139400270|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139400271|NCT01037179|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139400272|NCT01037179|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139400273|NCT01037179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139400274|NCT01037179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139400275|NCT01037179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139400276|NCT01037179|Analgesics|analgesics|mesh-ancestor
139400277|NCT01037179|Sensory System Agents|sensory system agents|mesh-ancestor
139400278|NCT01037179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400279|NCT01037179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057077|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400280|NCT01037179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139400281|NCT01037179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139400282|NCT01037179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139400283|NCT01037179|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139400284|NCT01037179|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139400285|NCT01037179|Histamine Antagonists|histamine antagonists|mesh-ancestor
139400286|NCT01037179|Histamine Agents|histamine agents|mesh-ancestor
139400287|NCT01037179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139400288|NCT01037179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400289|NCT02269969|Tobramycin|tobramycin|mesh-list
139400290|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139400291|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651702|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400292|NCT03555578|Leuprolide|leuprolide|mesh-list
139651703|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400293|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139400294|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
139400295|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139400296|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400297|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139400298|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400299|NCT03232424|Temozolomide|temozolomide|mesh-list
139400300|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139400301|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
139400302|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400303|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400304|NCT03163407|Norepinephrine|norepinephrine|mesh-list
139400305|NCT03163407|Ephedrine|ephedrine|mesh-list
139400306|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139400307|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139400308|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
139400309|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139400310|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400311|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400312|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
139400313|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
139400314|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400315|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139400316|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139400317|NCT02547974|Vaccines|vaccines|mesh-list
139400318|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
139400319|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400320|NCT00154297|Everolimus|everolimus|mesh-list
139400321|NCT00154297|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139400322|NCT00154297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139400323|NCT00154297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400324|NCT00154297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400325|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139400326|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
139400327|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400328|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400329|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
139400330|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139400331|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139400332|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400333|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139400334|NCT02270281|Analgesics|analgesics|mesh-ancestor
139400335|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
139400336|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400337|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139400338|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139400339|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139400340|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
139400341|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139400342|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400343|NCT01033123|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139400344|NCT01033123|Iniparib|iniparib|mesh-list
139400345|NCT01033123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400346|NCT01033123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400347|NCT01033123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400348|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
139400349|NCT03163173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139400350|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
139400351|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400352|NCT03163173|Protective Agents|protective agents|mesh-ancestor
139057157|NCT01097278|Vitamin D|vitamin d|mesh-list
139400353|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400354|NCT01323205|Antipsychotic Agents|antipsychotic agents|mesh-list
139400355|NCT01323205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139400356|NCT01323205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139400357|NCT01323205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400358|NCT01323205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139400359|NCT03162861|Anesthetics|anesthetics|mesh-list
139400360|NCT03162861|Propofol|propofol|mesh-list
139400361|NCT03162861|Sevoflurane|sevoflurane|mesh-list
139400362|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139400363|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400364|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139400365|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139400367|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139400368|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139400369|NCT02765165|Lomustine|lomustine|mesh-list
139400370|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139400371|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
138738555|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
139400372|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400373|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400374|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
139400375|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
139400376|NCT02156843|Vitamins|vitamins|mesh-ancestor
139400377|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
139400378|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400379|NCT02675907|Meloxicam|meloxicam|mesh-list
139400380|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139400381|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139400382|NCT02675907|Analgesics|analgesics|mesh-ancestor
139400383|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
139400384|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400385|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400386|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139400387|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139400388|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139400389|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139400390|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400391|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400392|NCT02152865|Lupeol|lupeol|mesh-list
139400393|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139400394|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139400395|NCT02152943|Trastuzumab|trastuzumab|mesh-list
139400396|NCT02152943|Everolimus|everolimus|mesh-list
139400397|NCT02152943|Letrozole|letrozole|mesh-list
139400398|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139400399|NCT02152943|Antibodies|antibodies|mesh-list
139400400|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
139400401|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139400402|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
139400403|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400404|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400405|NCT02152943|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139400406|NCT02152943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139400407|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400408|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400409|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139400410|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139400411|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139400412|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139400413|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
139400414|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139400415|NCT02156999|Vitamin D|vitamin d|mesh-list
139400416|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
139400417|NCT02156999|Vitamins|vitamins|mesh-ancestor
139400418|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
139400419|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400420|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139400421|NCT02159651|Tacrolimus|tacrolimus|mesh-list
139400422|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139400423|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
139400424|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400425|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139400426|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400427|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400428|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139400430|NCT02774681|Palbociclib|palbociclib|mesh-list
139400431|NCT02774681|Antibodies|antibodies|mesh-list
139400432|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
139400433|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139400434|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
139400435|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400436|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400437|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139400438|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651704|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139400439|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400440|NCT02157311|Tenofovir|tenofovir|mesh-list
139400441|NCT02157311|Lamivudine|lamivudine|mesh-list
139400442|NCT02157311|Emtricitabine|emtricitabine|mesh-list
139651705|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139400443|NCT02157311|Efavirenz|efavirenz|mesh-list
139400444|NCT02157311|Lopinavir|lopinavir|mesh-list
139400445|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139400446|NCT02157311|Darunavir|darunavir|mesh-list
139400447|NCT02157311|Abacavir|abacavir|mesh-list
139400448|NCT02157311|Rilpivirine|rilpivirine|mesh-list
139400449|NCT02157311|Etravirine|etravirine|mesh-list
139400450|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
139400451|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400452|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139400453|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139400454|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400455|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400456|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139400457|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139400458|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139400459|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139400460|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139400461|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139400462|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139400463|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139400464|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139400465|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139400466|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
139400467|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139400468|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
139400469|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139400470|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139400471|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400472|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
139400473|NCT04784039|Coagulants|coagulants|mesh-ancestor
139400474|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
139400475|NCT02157467|BMS-955176|bms-955176|mesh-list
139400476|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139400477|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139400478|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400479|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139400480|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139400481|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400482|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400483|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400484|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139400485|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
139400486|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139400487|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400488|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139400489|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139400490|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139400491|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139400492|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139400493|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
139400494|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139400495|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
139400496|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139400497|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
139400498|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139400499|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400500|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139400501|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139400502|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400503|NCT00152971|Enoxaparin|enoxaparin|mesh-list
139400504|NCT00152971|Dabigatran|dabigatran|mesh-list
139400506|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139400507|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139400508|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400509|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
139400510|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139400511|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
139400512|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400513|NCT02538614|Idelalisib|idelalisib|mesh-list
139400514|NCT02538614|BI 836826|bi 836826|mesh-list
139651706|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139400515|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140040|NCT03783273|Vitamin D|vitamin d|mesh-list
139651707|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139400516|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400517|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400518|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139400519|NCT03504644|Vincristine|vincristine|mesh-list
139400520|NCT03504644|Venetoclax|venetoclax|mesh-list
139400521|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139400522|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400523|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
139400524|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
139400525|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
139400526|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400527|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139400528|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139400529|NCT02160275|Insulin|insulin|mesh-list
139400530|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139400531|NCT02160275|Pancrelipase|pancrelipase|mesh-list
139400532|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139400533|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400534|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139400535|NCT03126968|Epinephrine|epinephrine|mesh-list
139400536|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139400537|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139400538|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
139400539|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139400540|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400541|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400542|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139400543|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139400544|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
139400545|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400546|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139400547|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
139400548|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
139400549|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
139400550|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139400551|NCT02266849|Loperamide|loperamide|mesh-list
139400552|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
139400553|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139400554|NCT01309945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139400555|NCT01309945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139400556|NCT01309945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139400557|NCT01309945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139400558|NCT01309945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400559|NCT01309945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139400560|NCT01309945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400561|NCT01309945|Analgesics|analgesics|mesh-ancestor
139400562|NCT01309945|Sensory System Agents|sensory system agents|mesh-ancestor
139400563|NCT01309945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400564|NCT01309945|Antidepressive Agents|antidepressive agents|mesh-ancestor
139400565|NCT01309945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139400566|NCT01309945|Dopamine Agents|dopamine agents|mesh-ancestor
139400567|NCT02153567|Escitalopram|escitalopram|mesh-list
139400568|NCT02153567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139400569|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139400570|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139400571|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400572|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139400573|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
139400574|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400575|NCT02441660|Capsaicin|capsaicin|mesh-list
139400576|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
139400577|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
139400578|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
139400579|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400580|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400581|NCT01303783|Candesartan|candesartan|mesh-list
139400582|NCT01303783|Candesartan cilexetil|candesartan cilexetil|mesh-list
139400583|NCT01303783|Nifedipine|nifedipine|mesh-list
139400584|NCT01303783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139400585|NCT01303783|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139400586|NCT01303783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139400587|NCT01303783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651708|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
139400588|NCT01303783|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139400589|NCT01303783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139400590|NCT01303783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139400591|NCT01303783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400592|NCT01303783|Vasodilator Agents|vasodilator agents|mesh-ancestor
139400594|NCT01303783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139400595|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
139400596|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139400597|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139400598|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400599|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
139400600|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
139400601|NCT02153879|Niacin|niacin|mesh-list
139400602|NCT02153879|Fenofibrate|fenofibrate|mesh-list
139400603|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139400604|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
139400605|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400606|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139400607|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
139400608|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
139400609|NCT02153879|Vitamins|vitamins|mesh-ancestor
139400610|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
139400611|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400612|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
139400613|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139400614|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139400615|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400616|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139400617|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139400618|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400619|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400620|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400621|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139400622|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
139400623|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139400624|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400625|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139400626|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139400627|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139400628|NCT02160743|Metformin|metformin|mesh-list
139400629|NCT02160743|Atorvastatin|atorvastatin|mesh-list
139400630|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139400631|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400632|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139400633|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139400634|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
139400635|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400636|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139400637|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139400638|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400639|NCT02158013|Diltiazem|diltiazem|mesh-list
139400640|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139400641|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139400642|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139400643|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400644|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139400645|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400646|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
139400647|NCT01023295|Fosbretabulin|fosbretabulin|mesh-list
139400648|NCT01023295|Combretastatin|combretastatin|mesh-list
139400649|NCT01023295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139400650|NCT01023295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400651|NCT01023295|Tubulin Modulators|tubulin modulators|mesh-ancestor
139400652|NCT01023295|Antimitotic Agents|antimitotic agents|mesh-ancestor
139400653|NCT01023295|Mitosis Modulators|mitosis modulators|mesh-ancestor
139400654|NCT01023295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400655|NCT05468138|Antibodies|antibodies|mesh-list
139400656|NCT05468138|Immunologic Factors|immunologic factors|mesh-ancestor
139400657|NCT05468138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400658|NCT01140217|Norethindrone|norethindrone|mesh-list
139400659|NCT01140217|Norethindrone Acetate|norethindrone acetate|mesh-list
139400660|NCT01140217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139400661|NCT01140217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139651709|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651710|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400662|NCT01140217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139400663|NCT01140217|Contraceptive Agents|contraceptive agents|mesh-ancestor
139400664|NCT01140217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139400665|NCT01140217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400666|NCT01140217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139400667|NCT01140217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139400668|NCT01297543|Lenograstim|lenograstim|mesh-list
139400669|NCT01297543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139400670|NCT01297543|Immunologic Factors|immunologic factors|mesh-ancestor
139400671|NCT01297543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400672|NCT03541265|Bupivacaine|bupivacaine|mesh-list
139400673|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
139400674|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
139400675|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139400676|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400677|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
139400678|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400679|NCT02547038|Amoxicillin|amoxicillin|mesh-list
139400680|NCT02547038|Metronidazole|metronidazole|mesh-list
139400681|NCT02547038|Clarithromycin|clarithromycin|mesh-list
139400682|NCT02547038|Tetracycline|tetracycline|mesh-list
139400683|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
139400684|NCT02547038|Pantoprazole|pantoprazole|mesh-list
139400685|NCT02547038|Bismuth|bismuth|mesh-list
139400686|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139400687|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400688|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139400689|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139400690|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139400691|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400692|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400693|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139400694|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139400695|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139400696|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139400697|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139400698|NCT02547038|Antacids|antacids|mesh-ancestor
139400699|NCT02161055|Insulin|insulin|mesh-list
139400700|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139400701|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139400702|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400703|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139400704|NCT02764697|Hormones|hormones|mesh-ancestor
139400705|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139400706|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400707|NCT02266927|Fluticasone|fluticasone|mesh-list
139400709|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139400710|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139400711|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
139400712|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400713|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400714|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139400715|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
139400716|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
139400717|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139400718|NCT02158481|Carotenoids|carotenoids|mesh-list
139400719|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
139400720|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400721|NCT02158481|Protective Agents|protective agents|mesh-ancestor
139400722|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400723|NCT05445362|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139400724|NCT05445362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400725|NCT01020565|Entecavir|entecavir|mesh-list
139400726|NCT01020565|Antiviral Agents|antiviral agents|mesh-ancestor
139400727|NCT01020565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057529|NCT01097980|Trazodone|trazodone|mesh-list
139400728|NCT01020097|Fluorides|fluorides|mesh-list
139400729|NCT01020097|Cariostatic Agents|cariostatic agents|mesh-ancestor
139400730|NCT01020097|Protective Agents|protective agents|mesh-ancestor
139400731|NCT01020097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400732|NCT02154269|Lenograstim|lenograstim|mesh-list
139400733|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139400734|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
139400735|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400736|NCT03738683|Tazobactam|tazobactam|mesh-list
139400737|NCT03738683|Piperacillin|piperacillin|mesh-list
139400738|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139400739|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139400740|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400741|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139400742|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400743|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400744|NCT04475887|Iron|iron|mesh-list
139400745|NCT04475887|Trace Elements|trace elements|mesh-ancestor
139400746|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
139400747|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400748|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
139400749|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139400750|NCT02267239|Listerine|listerine|mesh-list
139400751|NCT02267239|Hexetidine|hexetidine|mesh-list
139400752|NCT02267239|Menthol|menthol|mesh-list
139400753|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
139400754|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139400755|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400756|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
139400757|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
139400758|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
139400759|NCT02267239|Protective Agents|protective agents|mesh-ancestor
139400760|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400761|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
139400762|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
139400763|NCT02766023|Metronidazole|metronidazole|mesh-list
139400764|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400765|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139400766|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139400767|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139400768|NCT05466500|Dexamethasone|dexamethasone|mesh-list
139400769|NCT05466500|Dexamethasone acetate|dexamethasone acetate|mesh-list
139400770|NCT05466500|Bupivacaine|bupivacaine|mesh-list
139400771|NCT05466500|BB 1101|bb 1101|mesh-list
139400772|NCT05466500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139400773|NCT05466500|Antiemetics|antiemetics|mesh-ancestor
139400774|NCT05466500|Autonomic Agents|autonomic agents|mesh-ancestor
139400775|NCT05466500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400776|NCT05466500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400777|NCT05466500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139400778|NCT05466500|Glucocorticoids|glucocorticoids|mesh-ancestor
139400779|NCT05466500|Hormones|hormones|mesh-ancestor
139400780|NCT05466500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139400781|NCT05466500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139400782|NCT05466500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400783|NCT05466500|Protease Inhibitors|protease inhibitors|mesh-ancestor
139400784|NCT05466500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400785|NCT05466500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400786|NCT05466500|Anesthetics, Local|anesthetics, local|mesh-ancestor
139400787|NCT05466500|Anesthetics|anesthetics|mesh-ancestor
139400788|NCT05466500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139400789|NCT05466500|Sensory System Agents|sensory system agents|mesh-ancestor
139400790|NCT04475107|Artesunate|artesunate|mesh-list
139400791|NCT04475107|Pyronaridine|pyronaridine|mesh-list
139400792|NCT04475107|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139400793|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
139400794|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139400795|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139400796|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400797|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400798|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
139400799|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
139400800|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139400801|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
139400802|NCT02254967|Vancomycin|vancomycin|mesh-list
139400803|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
139400804|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139400805|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400806|NCT05444036|Ketamine|ketamine|mesh-list
139400807|NCT05444036|Analgesics|analgesics|mesh-ancestor
139400808|NCT05444036|Sensory System Agents|sensory system agents|mesh-ancestor
139651711|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
139400809|NCT05444036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400810|NCT05444036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400811|NCT05444036|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139400812|NCT05444036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139400813|NCT05444036|Anesthetics, General|anesthetics, general|mesh-ancestor
139400814|NCT05444036|Anesthetics|anesthetics|mesh-ancestor
139651712|NCT01532349|Vitamin D|vitamin d|mesh-list
139400815|NCT05444036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139400816|NCT05444036|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139400817|NCT05444036|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139400818|NCT05444036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139400819|NCT05444036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400820|NCT02161367|Simethicone|simethicone|mesh-list
139400821|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
139400822|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400823|NCT02161367|Emollients|emollients|mesh-ancestor
139400824|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
139400825|NCT03542825|Iron|iron|mesh-list
139400826|NCT03542825|Lactoferrin|lactoferrin|mesh-list
139400827|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
139400828|NCT03542825|Trace Elements|trace elements|mesh-ancestor
139400829|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
139400830|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400831|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400832|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
139400833|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
139400834|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400835|NCT01001923|Fasinumab|fasinumab|mesh-list
139400836|NCT01001923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139400837|NCT01001923|Analgesics|analgesics|mesh-ancestor
139400838|NCT01001923|Sensory System Agents|sensory system agents|mesh-ancestor
139400839|NCT01001923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400840|NCT01001923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400841|NCT02154503|Minoxidil|minoxidil|mesh-list
139400842|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139400843|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
139400844|NCT02536976|Mirabegron|mirabegron|mesh-list
139400845|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139400846|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139400847|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139400848|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
139400849|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139400850|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400851|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400852|NCT02536976|Urological Agents|urological agents|mesh-ancestor
139400853|NCT05526703|Antihypertensive Agents|antihypertensive agents|mesh-list
139400854|NCT00992563|Ranibizumab|ranibizumab|mesh-list
139400855|NCT00992563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139400856|NCT00992563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139400857|NCT00992563|Growth Substances|growth substances|mesh-ancestor
139400858|NCT00992563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400859|NCT00992563|Growth Inhibitors|growth inhibitors|mesh-ancestor
139400860|NCT00992563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400861|NCT02267707|Paclitaxel|paclitaxel|mesh-list
139400862|NCT02267707|Gemcitabine|gemcitabine|mesh-list
139400863|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139400864|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400865|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
139400866|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
139400867|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
139400868|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400869|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139400870|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
139400871|NCT01373229|Plerixafor|plerixafor|mesh-list
139400872|NCT01373229|Rituximab|rituximab|mesh-list
139400873|NCT01373229|Lenalidomide|lenalidomide|mesh-list
139400874|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139400875|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400876|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
139400877|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400878|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139400879|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139400880|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139400881|NCT01373229|Growth Substances|growth substances|mesh-ancestor
139400882|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
139400883|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139400884|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139400885|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
139400886|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400887|NCT02671461|Aspirin|aspirin|mesh-list
139400888|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139651713|NCT01532349|Vitamins|vitamins|mesh-ancestor
139400889|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139400890|NCT02671461|Analgesics|analgesics|mesh-ancestor
139400891|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
139400892|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400893|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400894|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139400895|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139400896|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139400897|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139400898|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400899|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139400900|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139400901|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139400902|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
139400903|NCT05467033|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139400904|NCT05467033|Hemostatics|hemostatics|mesh-ancestor
139400905|NCT05467033|Coagulants|coagulants|mesh-ancestor
139400906|NCT05467033|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139400907|NCT05467033|Natriuretic Agents|natriuretic agents|mesh-ancestor
139400908|NCT05467033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400909|NCT04196283|Paclitaxel|paclitaxel|mesh-list
139400910|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139400911|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400912|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
139400913|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
139400914|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
139400915|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400916|NCT02268019|Epinephrine|epinephrine|mesh-list
139400917|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139400918|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139400919|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
139400920|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139400921|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400922|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400923|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139400924|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139400925|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
139400926|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400927|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139400928|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
139400929|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
139400930|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
139400931|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139400932|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139400933|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139400934|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
139400935|NCT01110889|Agomelatine|agomelatine|mesh-list
139400936|NCT01110889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139400937|NCT01110889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139400938|NCT01110889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400939|NCT01106989|Lidocaine|lidocaine|mesh-list
139400940|NCT01106989|Tetracaine|tetracaine|mesh-list
139400941|NCT01106989|Anesthetics, Local|anesthetics, local|mesh-ancestor
139400942|NCT01106989|Anesthetics|anesthetics|mesh-ancestor
139400943|NCT01106989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139400944|NCT01106989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400945|NCT01106989|Sensory System Agents|sensory system agents|mesh-ancestor
139400946|NCT01106989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400947|NCT01106989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139400948|NCT01106989|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139400949|NCT01106989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139400950|NCT01106989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139400951|NCT01106989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400952|NCT00975091|Entecavir|entecavir|mesh-list
139400953|NCT00975091|Antiviral Agents|antiviral agents|mesh-ancestor
139400954|NCT00975091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400955|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
139400956|NCT02535416|Promethazine|promethazine|mesh-list
139400957|NCT02535416|Cetirizine|cetirizine|mesh-list
139400958|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139400959|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139400960|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139400961|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400962|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
139400963|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
139400964|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
138905657|NCT00770536|Topotecan|topotecan|mesh-list
139651714|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
139651715|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400965|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400966|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
139400967|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
139400968|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139400969|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139400970|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
139400971|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
139400972|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139400973|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400974|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139400975|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
139400976|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
139400977|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139400978|NCT00911443|Interferons|interferons|mesh-list
139400979|NCT00911443|Interferon-alpha|interferon-alpha|mesh-list
139400980|NCT00911443|Interferon alpha-2|interferon alpha-2|mesh-list
139400981|NCT00911443|Dacarbazine|dacarbazine|mesh-list
139400982|NCT00911443|Thymalfasin|thymalfasin|mesh-list
139400983|NCT00911443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139400984|NCT00911443|Antiviral Agents|antiviral agents|mesh-ancestor
139400985|NCT00911443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139400986|NCT00911443|Immunologic Factors|immunologic factors|mesh-ancestor
139400987|NCT00911443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139400988|NCT00911443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139400989|NCT00911443|Alkylating Agents|alkylating agents|mesh-ancestor
139400990|NCT00911443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139400991|NCT00911443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139400992|NCT03949478|Ibuprofen|ibuprofen|mesh-list
139400993|NCT03949478|Nifedipine|nifedipine|mesh-list
139400994|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139400995|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139400996|NCT03949478|Analgesics|analgesics|mesh-ancestor
139400997|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
139400998|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139400999|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401000|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401001|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139401002|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139401003|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401004|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401005|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139401006|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139401007|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139401008|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
139401009|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
139401010|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138739319|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
139401011|NCT00909649|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139401012|NCT00909649|Hemostatics|hemostatics|mesh-ancestor
139401013|NCT00909649|Coagulants|coagulants|mesh-ancestor
139401014|NCT00971035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139401015|NCT00971035|Immunologic Factors|immunologic factors|mesh-ancestor
139401016|NCT00971035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401017|NCT04787965|Opicapone|opicapone|mesh-list
139401018|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139401019|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401020|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401021|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139401022|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139401023|NCT02670915|Insulin|insulin|mesh-list
139401024|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139401025|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
139401026|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
139401027|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139401028|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139401029|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401030|NCT02545868|Vaccines|vaccines|mesh-list
139401031|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
139401032|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401033|NCT00821977|Vildagliptin|vildagliptin|mesh-list
139057832|NCT00429299|Fluorouracil|fluorouracil|mesh-list
139401034|NCT00821977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139401035|NCT00821977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401036|NCT00821977|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139401037|NCT00821977|Protease Inhibitors|protease inhibitors|mesh-ancestor
139401038|NCT00821977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401039|NCT00821977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401040|NCT04474327|Montelukast|montelukast|mesh-list
139401041|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139401042|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
139401043|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139401044|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
139401045|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139401046|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401047|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139401048|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139401049|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401050|NCT00961675|Ciprofloxacin|ciprofloxacin|mesh-list
139401051|NCT00961675|Povidone-Iodine|povidone-iodine|mesh-list
139401052|NCT00961675|Dexamethasone|dexamethasone|mesh-list
139401053|NCT00961675|Dexamethasone acetate|dexamethasone acetate|mesh-list
139401054|NCT00961675|Povidone|povidone|mesh-list
139401055|NCT00961675|BB 1101|bb 1101|mesh-list
139401056|NCT00961675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401057|NCT00961675|Antiemetics|antiemetics|mesh-ancestor
139401058|NCT00961675|Autonomic Agents|autonomic agents|mesh-ancestor
138739500|NCT04295551|Ritonavir|ritonavir|mesh-list
139401059|NCT00961675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401060|NCT00961675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401061|NCT00961675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139401062|NCT00961675|Glucocorticoids|glucocorticoids|mesh-ancestor
139401063|NCT00961675|Hormones|hormones|mesh-ancestor
139401064|NCT00961675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139401065|NCT00961675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139401066|NCT00961675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401067|NCT00961675|Protease Inhibitors|protease inhibitors|mesh-ancestor
139401068|NCT00961675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401069|NCT00961675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401070|NCT00961675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139401071|NCT00961675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401072|NCT00961675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139401073|NCT00961675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139401074|NCT00961675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139401075|NCT00961675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139401076|NCT00961675|Plasma Substitutes|plasma substitutes|mesh-ancestor
139401077|NCT00961675|Blood Substitutes|blood substitutes|mesh-ancestor
139401078|NCT00961675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139401079|NCT00819169|Conatumumab|conatumumab|mesh-list
139401080|NCT00819169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139401081|NCT00819169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401082|NCT02161679|Carboplatin|carboplatin|mesh-list
139401083|NCT02161679|Camptothecin|camptothecin|mesh-list
139401084|NCT02161679|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139401085|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
139401086|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401087|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
139401088|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401089|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139401090|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139401091|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139401092|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401093|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401094|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
139401095|NCT04262492|Apixaban|apixaban|mesh-list
139401096|NCT04262492|Edoxaban|edoxaban|mesh-list
139401097|NCT04262492|Dabigatran|dabigatran|mesh-list
139401098|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139401099|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
139401100|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139401101|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
139401102|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401103|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401104|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
139401105|NCT00955981|Lesinurad|lesinurad|mesh-list
139401106|NCT00955981|Gout Suppressants|gout suppressants|mesh-ancestor
139401107|NCT00955981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139401108|NCT00955981|Uricosuric Agents|uricosuric agents|mesh-ancestor
139401109|NCT03541031|Micronutrients|micronutrients|mesh-list
139401110|NCT03541031|Trace Elements|trace elements|mesh-list
139401111|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401112|NCT02154737|Gemcitabine|gemcitabine|mesh-list
139401113|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139401114|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139401115|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
139401116|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401117|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401118|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139401119|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401120|NCT00813163|Irinotecan|irinotecan|mesh-list
139401121|NCT00813163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139401122|NCT00813163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139401123|NCT00813163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401124|NCT00813163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401125|NCT00813163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401126|NCT00901693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139401127|NCT00901693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139401128|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
139401129|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
139401130|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139401131|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401132|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401133|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
139401134|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139401135|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139401136|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401137|NCT02159027|Maraviroc|maraviroc|mesh-list
139401138|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139401139|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139401140|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401141|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139401142|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139401143|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
139401144|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401145|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139401146|NCT02161991|Aprepitant|aprepitant|mesh-list
139401147|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
139401148|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
139401149|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401150|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401151|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139401152|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139401153|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139401154|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401155|NCT00948961|Poly I-C|poly i-c|mesh-list
139401156|NCT00948961|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139401157|NCT00948961|Poly ICLC|poly iclc|mesh-list
139401158|NCT00948961|Interferon Inducers|interferon inducers|mesh-ancestor
139401159|NCT00948961|Immunologic Factors|immunologic factors|mesh-ancestor
139401160|NCT00948961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401161|NCT00948961|Laxatives|laxatives|mesh-ancestor
139401162|NCT00948961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139401163|NCT00948961|Antiviral Agents|antiviral agents|mesh-ancestor
139401164|NCT00948961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401165|NCT02159105|Chrysarobin|chrysarobin|mesh-list
139401166|NCT02159105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139401167|NCT02159105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139401168|NCT02159105|Analgesics|analgesics|mesh-ancestor
139401169|NCT02159105|Sensory System Agents|sensory system agents|mesh-ancestor
139401170|NCT02159105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401171|NCT02159105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401172|NCT02159105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401173|NCT02159105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139401174|NCT00890305|Pidilizumab|pidilizumab|mesh-list
139401175|NCT00890305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139401176|NCT00890305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401177|NCT01661972|Capecitabine|capecitabine|mesh-list
139401178|NCT01661972|Aflibercept|aflibercept|mesh-list
139401179|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139401180|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
139401181|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401182|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401183|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139401184|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139401185|NCT01661972|Growth Substances|growth substances|mesh-ancestor
139057992|NCT00127101|Vorinostat|vorinostat|mesh-list
139401186|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401188|NCT02155049|Bimatoprost|bimatoprost|mesh-list
139401189|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139401190|NCT03540953|Mitomycins|mitomycins|mesh-list
139401191|NCT03540953|Mitomycin|mitomycin|mesh-list
139401192|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139401193|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739843|NCT04021017|Estradiol|estradiol|mesh-list
139401194|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
139401195|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401196|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139401197|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401198|NCT00888355|Losartan|losartan|mesh-list
139401199|NCT00888355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139401200|NCT00888355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139401201|NCT00888355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139401202|NCT00888355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139401203|NCT00888355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401204|NCT00794677|Ezetimibe|ezetimibe|mesh-list
139401205|NCT00794677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139401206|NCT00794677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139401207|NCT00794677|Antimetabolites|antimetabolites|mesh-ancestor
139401208|NCT00794677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401209|NCT00794677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139401210|NCT00792727|Ketoprofen|ketoprofen|mesh-list
139401211|NCT00792727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139401212|NCT00792727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139401213|NCT00792727|Analgesics|analgesics|mesh-ancestor
139401214|NCT00792727|Sensory System Agents|sensory system agents|mesh-ancestor
139401215|NCT00792727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401216|NCT00792727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401217|NCT00792727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401218|NCT00792727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139401219|NCT00792727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139401220|NCT00792727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401221|NCT00792727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401222|NCT00945763|Ibuprofen|ibuprofen|mesh-list
139401223|NCT00945763|Meloxicam|meloxicam|mesh-list
139401224|NCT00945763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139401225|NCT00945763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139401226|NCT00945763|Analgesics|analgesics|mesh-ancestor
139401227|NCT00945763|Sensory System Agents|sensory system agents|mesh-ancestor
139401228|NCT00945763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401229|NCT00945763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401230|NCT00945763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401231|NCT00945763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139401232|NCT00945763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139401233|NCT00945763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401234|NCT00945763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401235|NCT00945763|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139401236|NCT02770391|Leuprolide|leuprolide|mesh-list
139401237|NCT02770391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139401238|NCT02770391|Fertility Agents|fertility agents|mesh-ancestor
138740001|NCT05640804|Dasatinib|dasatinib|mesh-list
139401239|NCT02770391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139401240|NCT02770391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401241|NCT02770391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139401242|NCT02770391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401243|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
139401244|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139401245|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401246|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139401247|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139401248|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401249|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401250|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401251|NCT02162303|Colchicine|colchicine|mesh-list
139401252|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
139401253|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139401254|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
139401255|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
139401256|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
139401257|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401258|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401259|NCT05430308|Chlorhexidine|chlorhexidine|mesh-list
139401260|NCT05430308|Povidone-Iodine|povidone-iodine|mesh-list
139401261|NCT05430308|Povidone|povidone|mesh-list
139401262|NCT05430308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139401263|NCT05430308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401264|NCT05430308|Disinfectants|disinfectants|mesh-ancestor
139401265|NCT05430308|Plasma Substitutes|plasma substitutes|mesh-ancestor
139401266|NCT05430308|Blood Substitutes|blood substitutes|mesh-ancestor
139401267|NCT00877903|Remestemcel-l|remestemcel-l|mesh-list
139401268|NCT00877903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401269|NCT00877903|Antiviral Agents|antiviral agents|mesh-ancestor
139401270|NCT00877903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401271|NCT04707703|Isavuconazole|isavuconazole|mesh-list
139401272|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
139401273|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401274|NCT00936871|Moxifloxacin|moxifloxacin|mesh-list
139401275|NCT00936871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139401276|NCT00936871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401277|NCT00936871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139401278|NCT00936871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139401279|NCT00936871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401280|NCT00936871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401281|NCT00936871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401282|NCT00934921|Ondansetron|ondansetron|mesh-list
139401283|NCT00934921|Antiemetics|antiemetics|mesh-ancestor
139401284|NCT00934921|Autonomic Agents|autonomic agents|mesh-ancestor
139401285|NCT00934921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401286|NCT00934921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401287|NCT00934921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139401288|NCT00934921|Antipruritics|antipruritics|mesh-ancestor
139401289|NCT00934921|Dermatologic Agents|dermatologic agents|mesh-ancestor
139401290|NCT00934921|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139401291|NCT00934921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139401292|NCT00934921|Serotonin Agents|serotonin agents|mesh-ancestor
139401293|NCT00934921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139401294|NCT00934921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401295|NCT05429450|Triamcinolone|triamcinolone|mesh-list
139401296|NCT05429450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139401297|NCT05429450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139401298|NCT05429450|Methotrexate|methotrexate|mesh-list
139401299|NCT05429450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139401300|NCT05429450|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139401301|NCT05429450|Abortifacient Agents|abortifacient agents|mesh-ancestor
139401302|NCT05429450|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139401303|NCT05429450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401304|NCT05429450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139401305|NCT05429450|Antimetabolites|antimetabolites|mesh-ancestor
139401306|NCT05429450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401307|NCT05429450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401308|NCT05429450|Dermatologic Agents|dermatologic agents|mesh-ancestor
139401309|NCT05429450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401310|NCT05429450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139401311|NCT05429450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139401312|NCT05429450|Immunologic Factors|immunologic factors|mesh-ancestor
139401313|NCT05429450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139401314|NCT05429450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139401315|NCT05429450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401316|NCT05429450|Glucocorticoids|glucocorticoids|mesh-ancestor
139401317|NCT05429450|Hormones|hormones|mesh-ancestor
138740360|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139401318|NCT05429450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139401319|NCT00103259|Irinotecan|irinotecan|mesh-list
139401320|NCT00103259|Bortezomib|bortezomib|mesh-list
139401321|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139401322|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139401323|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401324|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401325|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401326|NCT02162381|Methylphenidate|methylphenidate|mesh-list
139401327|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139401328|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401329|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139401330|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139401331|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139401332|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401333|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
139401334|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139058148|NCT01099462|Ibuprofen|ibuprofen|mesh-list
139651716|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139401336|NCT00782431|Immunologic Factors|immunologic factors|mesh-ancestor
139401337|NCT00782431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401338|NCT02155439|Triamcinolone|triamcinolone|mesh-list
139401339|NCT02155439|Fluorouracil|fluorouracil|mesh-list
139401340|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
139401341|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401342|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139401343|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401344|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139401345|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
139401346|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401347|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401348|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
139401349|NCT02155439|Hormones|hormones|mesh-ancestor
139401350|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139401351|NCT02544152|Lubiprostone|lubiprostone|mesh-list
139401352|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139401353|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139401354|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401355|NCT02162537|Bevacizumab|bevacizumab|mesh-list
139401356|NCT02162537|Pemetrexed|pemetrexed|mesh-list
139401357|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139401358|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401359|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139401360|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139401361|NCT02162537|Growth Substances|growth substances|mesh-ancestor
139401362|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401363|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
139401364|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401365|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401366|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139401367|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139401368|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
139401369|NCT00864175|Docetaxel|docetaxel|mesh-list
139401370|NCT00864175|Trastuzumab|trastuzumab|mesh-list
139401371|NCT00864175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401372|NCT00864175|Tubulin Modulators|tubulin modulators|mesh-ancestor
139401373|NCT00864175|Antimitotic Agents|antimitotic agents|mesh-ancestor
139401374|NCT00864175|Mitosis Modulators|mitosis modulators|mesh-ancestor
139401375|NCT00864175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401376|NCT00864175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139401377|NCT02166593|Atorvastatin|atorvastatin|mesh-list
139401378|NCT02166593|Pravastatin|pravastatin|mesh-list
139401379|NCT02166593|Fenofibrate|fenofibrate|mesh-list
139401380|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139401381|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139401382|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
139401383|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401384|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139401385|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139401386|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401387|NCT00858871|Sorafenib|sorafenib|mesh-list
139401388|NCT00858871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401389|NCT00858871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139401390|NCT00858871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401391|NCT00858871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401392|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
139401393|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139401394|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
139401395|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401396|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
139401397|NCT02162693|Protective Agents|protective agents|mesh-ancestor
139401398|NCT02163161|Abrocitinib|abrocitinib|mesh-list
139401399|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139401400|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401401|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401402|NCT00917293|Pyridoxal|pyridoxal|mesh-list
139401403|NCT00917293|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
139401404|NCT00917293|Vitamin B Complex|vitamin b complex|mesh-ancestor
139401405|NCT00917293|Vitamins|vitamins|mesh-ancestor
139401406|NCT00917293|Micronutrients|micronutrients|mesh-ancestor
139401407|NCT00917293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401408|NCT00845299|Benzalkonium Compounds|benzalkonium compounds|mesh-list
139401409|NCT00845299|Latanoprost|latanoprost|mesh-list
139401411|NCT00845299|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139401412|NCT00845299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139401413|NCT00845299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139401414|NCT00845299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401415|NCT02255591|Lidocaine|lidocaine|mesh-list
139401416|NCT02255591|Epinephrine|epinephrine|mesh-list
139401417|NCT02255591|Racepinephrine|racepinephrine|mesh-list
139401418|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
139401419|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
139401420|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
139401421|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139401422|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401423|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
139401424|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401425|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139401426|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139401427|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139401428|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139401429|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401430|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139401431|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139401432|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
139401433|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139401434|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139401435|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139401436|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
139401437|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139401438|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
139401439|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
139401440|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
139401441|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139401442|NCT00913393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138740947|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
139401443|NCT00913393|Immunologic Factors|immunologic factors|mesh-ancestor
139401444|NCT00913393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401445|NCT02167061|Metformin|metformin|mesh-list
139401446|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139401447|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401448|NCT03715465|Melatonin|melatonin|mesh-list
139401449|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
139401450|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401451|NCT03715465|Protective Agents|protective agents|mesh-ancestor
139401452|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401453|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139401454|NCT02171039|Dabigatran|dabigatran|mesh-list
139401455|NCT02171039|Atorvastatin|atorvastatin|mesh-list
139401456|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139401457|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139401458|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
139401459|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401460|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139401461|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139401462|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401463|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
139401464|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139401465|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
139401466|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
139401467|NCT00840073|Trandolapril|trandolapril|mesh-list
139401468|NCT00840073|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139401469|NCT00840073|Protease Inhibitors|protease inhibitors|mesh-ancestor
139401470|NCT00840073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401471|NCT00840073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401472|NCT00840073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139401473|NCT02261207|Axitinib|axitinib|mesh-list
139401474|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401475|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139401476|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401477|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401478|NCT00838279|Lamotrigine|lamotrigine|mesh-list
139401479|NCT00838279|Anticonvulsants|anticonvulsants|mesh-ancestor
139401480|NCT00838279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139401481|NCT00838279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139401482|NCT00838279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401483|NCT00838279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139401484|NCT00838279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401485|NCT00838279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139401486|NCT00838279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139401487|NCT00838279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139401488|NCT00838279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139401489|NCT00838279|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139401490|NCT02163707|Psilocybin|psilocybin|mesh-list
139401491|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
139401492|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401493|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139401494|NCT00769795|Goserelin|goserelin|mesh-list
139401495|NCT00769795|Bicalutamide|bicalutamide|mesh-list
139401496|NCT00769795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139401497|NCT00769795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401498|NCT00769795|Androgen Antagonists|androgen antagonists|mesh-ancestor
139401499|NCT00769795|Hormone Antagonists|hormone antagonists|mesh-ancestor
139401500|NCT00769795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139401501|NCT00769795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401502|NCT03134677|Bupivacaine|bupivacaine|mesh-list
139401503|NCT03134677|Sevoflurane|sevoflurane|mesh-list
139401504|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
139401505|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
139401506|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139401507|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401508|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
139401509|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401510|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139401511|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139401512|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
139401513|NCT00722917|Pioglitazone|pioglitazone|mesh-list
139401514|NCT00722917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139401515|NCT00722917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401516|NCT02164097|Heparin|heparin|mesh-list
139401517|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
139401518|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139401519|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139401520|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401521|NCT00717457|Exenatide|exenatide|mesh-list
139401522|NCT00717457|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139401523|NCT00717457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139401524|NCT00717457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401525|NCT00717457|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139401526|NCT00717457|Incretins|incretins|mesh-ancestor
139401527|NCT00717457|Hormones|hormones|mesh-ancestor
139401528|NCT00717457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139401529|NCT02171507|Diclofenac|diclofenac|mesh-list
139401530|NCT02171507|Dabigatran|dabigatran|mesh-list
139401531|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139401532|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139401533|NCT02171507|Analgesics|analgesics|mesh-ancestor
139401534|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
139401535|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401536|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401537|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401538|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139401539|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139401540|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401541|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401542|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
139401543|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139401544|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
139401545|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
139401546|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139401547|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139401548|NCT00758953|Danazol|danazol|mesh-list
139401549|NCT00758953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139401550|NCT00758953|Hormone Antagonists|hormone antagonists|mesh-ancestor
139401551|NCT00758953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139401552|NCT00758953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401553|NCT02167685|Brincidofovir|brincidofovir|mesh-list
139401554|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
139401555|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401556|NCT00758563|Triclosan|triclosan|mesh-list
139651717|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139651718|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
139401557|NCT00758563|Fluorides|fluorides|mesh-list
139401558|NCT00758563|Cariostatic Agents|cariostatic agents|mesh-ancestor
139401559|NCT00758563|Protective Agents|protective agents|mesh-ancestor
139651719|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401560|NCT00758563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401561|NCT00758563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139401562|NCT00758563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401563|NCT00758563|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139401564|NCT00758563|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139401565|NCT00758563|Antimetabolites|antimetabolites|mesh-ancestor
139401566|NCT00758563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401567|NCT00758563|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139401568|NCT02171585|Clarithromycin|clarithromycin|mesh-list
139401569|NCT02171585|Dabigatran|dabigatran|mesh-list
139401570|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139401571|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401572|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139401573|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401574|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401575|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139401576|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139401577|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
139401578|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139401579|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
139401580|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
139401581|NCT03134443|Andrographolide|andrographolide|mesh-list
139401582|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401583|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139401584|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139401585|NCT03134443|Analgesics|analgesics|mesh-ancestor
139401586|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
139401587|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401588|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401589|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139401590|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139401591|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139401592|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401593|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
139401594|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139401595|NCT02171663|Afatinib|afatinib|mesh-list
139401596|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401597|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139401598|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401599|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401600|NCT02171741|Docetaxel|docetaxel|mesh-list
139401601|NCT02171741|Afatinib|afatinib|mesh-list
139401602|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401603|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
139401604|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
139401605|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
139401606|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401607|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139401608|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741412|NCT05793060|BB 1101|bb 1101|mesh-list
139401609|NCT00835705|Amoxicillin|amoxicillin|mesh-list
139401610|NCT00835705|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139401611|NCT00835705|Clavulanic Acids|clavulanic acids|mesh-list
139401612|NCT00835705|Clavulanic Acid|clavulanic acid|mesh-list
139401613|NCT00835705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139401614|NCT00835705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401615|NCT00835705|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139401616|NCT00835705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401617|NCT00835705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401618|NCT00713401|Esmolol|esmolol|mesh-list
139401619|NCT00713401|Tecadenoson|tecadenoson|mesh-list
139401620|NCT00713401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139401621|NCT00713401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139401622|NCT00713401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139401623|NCT00713401|Adrenergic Agents|adrenergic agents|mesh-ancestor
139401624|NCT00713401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139401625|NCT00713401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401626|NCT00713401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401627|NCT00713401|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139401628|NCT00713401|Purinergic Agonists|purinergic agonists|mesh-ancestor
139401629|NCT00713401|Purinergic Agents|purinergic agents|mesh-ancestor
139401630|NCT02171975|Anesthetics|anesthetics|mesh-list
139401631|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139401632|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401633|NCT00835549|Cefdinir|cefdinir|mesh-list
139401634|NCT00835549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139401635|NCT00835549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401636|NCT02164253|Deferiprone|deferiprone|mesh-list
139401637|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139401638|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
139401639|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
139401640|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401641|NCT00755287|Metformin|metformin|mesh-list
139401642|NCT00755287|Insulin Glargine|insulin glargine|mesh-list
139401643|NCT00755287|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139401644|NCT00755287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139401645|NCT00755287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401646|NCT00755287|Incretins|incretins|mesh-ancestor
139401647|NCT00755287|Hormones|hormones|mesh-ancestor
139401648|NCT00755287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139401649|NCT02168075|Mannitol|mannitol|mesh-list
139401650|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139401651|NCT02168075|Diuretics|diuretics|mesh-ancestor
139401652|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
139401653|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401654|NCT00712699|Adderall|adderall|mesh-list
139401655|NCT00712699|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139401656|NCT00712699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401657|NCT03945825|Vaccines|vaccines|mesh-list
139401658|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
139401659|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401660|NCT02759315|Ruzasvir|ruzasvir|mesh-list
139401661|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
139401662|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
139401663|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401664|NCT00697099|Enoxaparin|enoxaparin|mesh-list
139401665|NCT00697099|Semuloparin|semuloparin|mesh-list
139401666|NCT00697099|Enoxaparin sodium|enoxaparin sodium|mesh-list
139401667|NCT00697099|Anticoagulants|anticoagulants|mesh-ancestor
139401668|NCT00697099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139401669|NCT00697099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139401670|NCT00697099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401671|NCT02172131|Olodaterol|olodaterol|mesh-list
139401672|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139401673|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
139401674|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401675|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401676|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139401677|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
139401678|NCT05435768|Denosumab|denosumab|mesh-list
139401679|NCT05435768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139401680|NCT05435768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401681|NCT00835081|Cefadroxil|cefadroxil|mesh-list
139401682|NCT00835081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139401683|NCT00835081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401684|NCT02543918|Ixekizumab|ixekizumab|mesh-list
139401685|NCT02543918|Vaccines|vaccines|mesh-list
139401686|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139401687|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
139401688|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401689|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
139401690|NCT03539003|Remifentanil|remifentanil|mesh-list
139401691|NCT03539003|Propofol|propofol|mesh-list
139401692|NCT03539003|Sevoflurane|sevoflurane|mesh-list
139401693|NCT03539003|Desflurane|desflurane|mesh-list
139401694|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138741617|NCT05247320|Sympatholytics|sympatholytics|mesh-ancestor
139401695|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139401696|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401697|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139401698|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
139401699|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
139401700|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139401701|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139401702|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139401703|NCT03539003|Narcotics|narcotics|mesh-ancestor
139401704|NCT03539003|Analgesics|analgesics|mesh-ancestor
139401705|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
139401706|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401707|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
139401708|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139401709|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139140049|NCT03777345|Trace Elements|trace elements|mesh-ancestor
139651720|NCT01533207|Gemcitabine|gemcitabine|mesh-list
139651721|NCT01533207|Docetaxel|docetaxel|mesh-list
139401710|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401711|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
139401712|NCT02164565|Coagulants|coagulants|mesh-ancestor
139058513|NCT03974360|Analgesics|analgesics|mesh-ancestor
139401713|NCT04265534|Folic Acid|folic acid|mesh-list
139401714|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
139401715|NCT04265534|Dexamethasone|dexamethasone|mesh-list
139401716|NCT04265534|Carboplatin|carboplatin|mesh-list
139401717|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
139401718|NCT04265534|Pemetrexed|pemetrexed|mesh-list
139401719|NCT04265534|Vitamins|vitamins|mesh-ancestor
139401720|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
139401721|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401722|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401723|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
139401724|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
139401725|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401726|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139401727|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
139401728|NCT04265534|Hormones|hormones|mesh-ancestor
139401729|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139401730|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139401731|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401732|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139401733|NCT04265534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139401734|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401735|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401736|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139401737|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139401738|NCT04265534|Hematinics|hematinics|mesh-ancestor
139401739|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
139401740|NCT00750295|Ferric Compounds|ferric compounds|mesh-list
139401741|NCT00750295|Hematinics|hematinics|mesh-ancestor
139401742|NCT02172209|Empagliflozin|empagliflozin|mesh-list
139401743|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139401744|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401745|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139401746|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401747|NCT02168543|Alendronate|alendronate|mesh-list
139401748|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139401749|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401750|NCT01372995|Vitamin D|vitamin d|mesh-list
139401751|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
139401752|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
139401753|NCT01372995|Vitamins|vitamins|mesh-list
139401754|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
139401755|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401756|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139401757|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139401758|NCT04239859|Cyclosporine|cyclosporine|mesh-list
139401759|NCT04239859|Methotrexate|methotrexate|mesh-list
139401760|NCT04239859|Acitretin|acitretin|mesh-list
139401761|NCT04239859|Cyclosporins|cyclosporins|mesh-list
139401762|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139401763|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
139401764|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139401765|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401766|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139401767|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
139401768|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401769|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401770|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
139401771|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401772|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139401773|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139401774|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
139401775|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139401776|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139401777|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
139401778|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401779|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139401780|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
139401781|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
139651722|NCT01533207|Doxorubicin|doxorubicin|mesh-list
139401782|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139401783|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
139401784|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
139651723|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139401785|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139401786|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401787|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139401788|NCT02757521|Analgesics|analgesics|mesh-ancestor
139401789|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
139401790|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401791|NCT00744367|Metformin|metformin|mesh-list
139401792|NCT00744367|Pioglitazone|pioglitazone|mesh-list
139401793|NCT00744367|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139401794|NCT00744367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139401795|NCT00744367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401796|NCT00744367|Incretins|incretins|mesh-ancestor
139401797|NCT00744367|Hormones|hormones|mesh-ancestor
139401798|NCT00744367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139401799|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
139401800|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139401801|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139401802|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
139401803|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401804|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401805|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139401806|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
139401807|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
139401808|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139401809|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
139401810|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139401811|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401812|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139401813|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139401814|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139401815|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
139401816|NCT02261129|Telmisartan|telmisartan|mesh-list
139401817|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139401818|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139401819|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139401820|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401821|NCT00694135|Dexamethasone|dexamethasone|mesh-list
139401822|NCT00694135|Dexamethasone acetate|dexamethasone acetate|mesh-list
139401823|NCT00694135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139401824|NCT00694135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139401825|NCT00694135|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139401826|NCT00694135|BB 1101|bb 1101|mesh-list
139401827|NCT00694135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401828|NCT00694135|Antiemetics|antiemetics|mesh-ancestor
139401829|NCT00694135|Autonomic Agents|autonomic agents|mesh-ancestor
139401830|NCT00694135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401831|NCT00694135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401832|NCT00694135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139401833|NCT00694135|Glucocorticoids|glucocorticoids|mesh-ancestor
139401834|NCT00694135|Hormones|hormones|mesh-ancestor
139401835|NCT00694135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139401836|NCT00694135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139401837|NCT00694135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401838|NCT00694135|Protease Inhibitors|protease inhibitors|mesh-ancestor
139401839|NCT00694135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401840|NCT00694135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401841|NCT03540095|Bupivacaine|bupivacaine|mesh-list
139401842|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
139401843|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
139401844|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139401845|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401846|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
139401847|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401848|NCT03071185|Dexmedetomidine|dexmedetomidine|mesh-list
139401849|NCT03071185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139401850|NCT03071185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139401851|NCT03071185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401852|NCT03071185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139401853|NCT03071185|Analgesics|analgesics|mesh-ancestor
139401854|NCT03071185|Sensory System Agents|sensory system agents|mesh-ancestor
139401855|NCT03071185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401856|NCT03071185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139401857|NCT03071185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139401858|NCT03071185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139401859|NCT03071185|Adrenergic Agents|adrenergic agents|mesh-ancestor
139401860|NCT03071185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139401861|NCT03071185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401862|NCT00741715|Atorvastatin|atorvastatin|mesh-list
139401863|NCT00741715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139401864|NCT00741715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139401865|NCT00741715|Antimetabolites|antimetabolites|mesh-ancestor
139401866|NCT00741715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401867|NCT00741715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139401868|NCT00741715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139401869|NCT00741715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401870|NCT02169167|Octenidine|octenidine|mesh-list
139401871|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401872|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139401873|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
139401874|NCT02172443|Ipratropium|ipratropium|mesh-list
139401875|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139401876|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
139401877|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401878|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401879|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139401880|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
139401881|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
139401882|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139401883|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
139401884|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139401885|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401886|NCT00834613|Metformin|metformin|mesh-list
139401887|NCT00834613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139401888|NCT00834613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401889|NCT02172521|Bromides|bromides|mesh-list
139401890|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
139401891|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139401892|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
139401893|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401894|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401895|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139401896|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
139401897|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
139401898|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139401899|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
139401900|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139401901|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401902|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
139401903|NCT00834535|Cefdinir|cefdinir|mesh-list
139401904|NCT00834535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139401905|NCT00834535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139401906|NCT00691717|Hydrocortisone|hydrocortisone|mesh-list
139401907|NCT00691717|Anecortave|anecortave|mesh-list
139401908|NCT00691717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139401909|NCT00691717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139401910|NCT00691717|Growth Substances|growth substances|mesh-ancestor
139401911|NCT00691717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401912|NCT00691717|Growth Inhibitors|growth inhibitors|mesh-ancestor
139401913|NCT00691717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401914|NCT00691717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401915|NCT00834067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139401916|NCT00834067|Moexipril|moexipril|mesh-list
139401917|NCT00834067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139401918|NCT00834067|Diuretics|diuretics|mesh-ancestor
139401919|NCT00834067|Natriuretic Agents|natriuretic agents|mesh-ancestor
139401920|NCT00834067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401921|NCT00834067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139401922|NCT00834067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139401923|NCT00834067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401924|NCT00834067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139401925|NCT00834067|Protease Inhibitors|protease inhibitors|mesh-ancestor
139401926|NCT00834067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401927|NCT00682981|Carboplatin|carboplatin|mesh-list
139401928|NCT00682981|Etoposide|etoposide|mesh-list
139401929|NCT00682981|Obatoclax|obatoclax|mesh-list
139401930|NCT00682981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401931|NCT00682981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139401932|NCT00682981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139401933|NCT00682981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139401934|NCT00682981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139401935|NCT00682981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401936|NCT00833521|Zolpidem|zolpidem|mesh-list
139401937|NCT00833521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139401938|NCT00833521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139401939|NCT00833521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139401940|NCT00833521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401942|NCT00833521|GABA Agonists|gaba agonists|mesh-ancestor
139401943|NCT00833521|GABA Agents|gaba agents|mesh-ancestor
139401944|NCT00833521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139401945|NCT00833521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401946|NCT00832507|Cicletanine|cicletanine|mesh-list
139401947|NCT00832507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139401948|NCT00832507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139401949|NCT00832507|Diuretics|diuretics|mesh-ancestor
139401950|NCT00832507|Natriuretic Agents|natriuretic agents|mesh-ancestor
139401951|NCT00832507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401952|NCT04862143|Fulvestrant|fulvestrant|mesh-list
139401953|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139401954|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401955|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139401956|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139401957|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
139401958|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139401959|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401960|NCT02802943|Imiquimod|imiquimod|mesh-list
139401961|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139401962|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
139401963|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401964|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139401965|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
139401966|NCT02165033|Budesonide|budesonide|mesh-list
139401967|NCT02165033|Procaterol|procaterol|mesh-list
139401968|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139401969|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139401970|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
139401971|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401972|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401973|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139401974|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
139401975|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
139401976|NCT02165033|Hormones|hormones|mesh-ancestor
139401977|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139401978|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
139401979|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139401980|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139401981|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139401982|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
139401983|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139401984|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139401985|NCT00734461|Naltrexone|naltrexone|mesh-list
139401986|NCT00734461|Oxycodone|oxycodone|mesh-list
139401987|NCT00734461|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139401988|NCT00734461|Narcotics|narcotics|mesh-ancestor
139401989|NCT00734461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139401990|NCT00734461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139401991|NCT00734461|Analgesics|analgesics|mesh-ancestor
139401992|NCT00734461|Sensory System Agents|sensory system agents|mesh-ancestor
139401993|NCT00734461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139401994|NCT00734461|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139401995|NCT00734461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139401996|NCT02169713|Tamsulosin|tamsulosin|mesh-list
139401997|NCT02169713|Mirabegron|mirabegron|mesh-list
139401998|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
139401999|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139402000|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139402001|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139402002|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
139402003|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402004|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402005|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402006|NCT02169713|Urological Agents|urological agents|mesh-ancestor
139402007|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139651724|NCT01533207|Lenograstim|lenograstim|mesh-list
139402008|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139402009|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139402010|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139402011|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139402012|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
139402013|NCT03980041|Nivolumab|nivolumab|mesh-list
139402014|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139402015|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402016|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139402017|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402018|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139402019|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139402020|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139402021|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402022|NCT00829309|Pravastatin|pravastatin|mesh-list
139402023|NCT00829309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139402024|NCT00829309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139402025|NCT00829309|Antimetabolites|antimetabolites|mesh-ancestor
139402026|NCT00829309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402027|NCT00829309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139402028|NCT00829309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139402029|NCT00829309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402030|NCT02165189|Ribavirin|ribavirin|mesh-list
139402031|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
139402032|NCT02165189|Simeprevir|simeprevir|mesh-list
139402033|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
139402034|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402035|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
139402036|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402037|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
139402038|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402039|NCT00725881|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
139402040|NCT00725881|Antioxidants|antioxidants|mesh-ancestor
139402041|NCT00725881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402042|NCT00725881|Protective Agents|protective agents|mesh-ancestor
139402043|NCT00725881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402044|NCT00725881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139402045|NCT00725881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402046|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
139402047|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139402048|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402049|NCT00677053|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
139402050|NCT00677053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139402051|NCT00677053|Antithrombins|antithrombins|mesh-ancestor
139402052|NCT00677053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139402053|NCT00677053|Protease Inhibitors|protease inhibitors|mesh-ancestor
139402054|NCT00677053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402055|NCT00677053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402056|NCT00677053|Anticoagulants|anticoagulants|mesh-ancestor
139402057|NCT01950403|Linaclotide|linaclotide|mesh-list
139402058|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139402059|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
139402060|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402061|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139402062|NCT03607539|Pemetrexed|pemetrexed|mesh-list
139402063|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402064|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402065|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402066|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139402067|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139402068|NCT00629941|Azithromycin|azithromycin|mesh-list
139402069|NCT00629941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139402070|NCT00629941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402071|NCT02404779|Cisatracurium|cisatracurium|mesh-list
139402072|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139402073|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139402074|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402075|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402076|NCT00629551|Paroxetine|paroxetine|mesh-list
139402077|NCT00629551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139402078|NCT00629551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139402079|NCT00629551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139651725|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139402080|NCT00629551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651726|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
139402081|NCT00629551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402082|NCT00629551|Serotonin Agents|serotonin agents|mesh-ancestor
139402083|NCT00629551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402084|NCT00629551|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139402085|NCT00629551|Antidepressive Agents|antidepressive agents|mesh-ancestor
139402086|NCT00629551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139402087|NCT00629551|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139402088|NCT00629551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139402089|NCT00629551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402090|NCT00625651|Bevacizumab|bevacizumab|mesh-list
139402091|NCT00625651|Conatumumab|conatumumab|mesh-list
139402092|NCT00625651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139402093|NCT00625651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402094|NCT00625651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139402095|NCT00625651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139402096|NCT00625651|Growth Substances|growth substances|mesh-ancestor
139402097|NCT00625651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402098|NCT00625651|Growth Inhibitors|growth inhibitors|mesh-ancestor
139402099|NCT00672997|Timolol|timolol|mesh-list
139402100|NCT00672997|Travoprost|travoprost|mesh-list
139402101|NCT00672997|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139402102|NCT00672997|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139402103|NCT00672997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139402104|NCT00672997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139402105|NCT00672997|Adrenergic Agents|adrenergic agents|mesh-ancestor
139402106|NCT00672997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402107|NCT00672997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402108|NCT00672997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742321|NCT01650701|Rituximab|rituximab|mesh-list
139402109|NCT00672997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139402110|NCT00672997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139402111|NCT02669043|Ketamine|ketamine|mesh-list
139402112|NCT02669043|Analgesics|analgesics|mesh-ancestor
139402113|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
139402114|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402115|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402116|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139402117|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139402118|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
139402119|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
139402120|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139402121|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139402122|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139402123|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402124|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402125|NCT02281045|Citric Acid|citric acid|mesh-list
139402126|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
139402127|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
139402128|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139402129|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
139402130|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
139402131|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402132|NCT04472689|Lidocaine|lidocaine|mesh-list
139402133|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
139402134|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
139402135|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139402136|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402137|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
139402138|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402139|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139402140|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139402141|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139402142|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139402143|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402144|NCT02405013|Ribavirin|ribavirin|mesh-list
139402145|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
139402146|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139402147|NCT02405013|Ledipasvir|ledipasvir|mesh-list
139402148|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
139402149|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402150|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
139402151|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402152|NCT02173145|Azithromycin|azithromycin|mesh-list
139402153|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139402154|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402155|NCT00670033|Travoprost|travoprost|mesh-list
139402156|NCT00670033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139402157|NCT00670033|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139402158|NCT00670033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139402159|NCT02283775|Dexamethasone|dexamethasone|mesh-list
139402160|NCT02283775|Pomalidomide|pomalidomide|mesh-list
139402161|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139402162|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
139402163|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
139402164|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402165|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402166|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139402167|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
139402169|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138742673|NCT02873026|Hormones|hormones|mesh-ancestor
139402170|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139402171|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402172|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
139402173|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139402174|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139402175|NCT02283775|Growth Substances|growth substances|mesh-ancestor
139402176|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
139402177|NCT04479891|Itraconazole|itraconazole|mesh-list
139402178|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
139402179|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402180|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139402181|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139402182|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402183|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402184|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139402185|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
139402186|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139402187|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402188|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139402189|NCT02281201|Thrombin|thrombin|mesh-list
139402190|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
139402191|NCT02281201|Coagulants|coagulants|mesh-ancestor
139402192|NCT02281279|Rituximab|rituximab|mesh-list
139402193|NCT02281279|Lenalidomide|lenalidomide|mesh-list
139402194|NCT02281279|Romidepsin|romidepsin|mesh-list
139402195|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139402196|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402197|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
139402198|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402199|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139402200|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139402201|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139402202|NCT02281279|Growth Substances|growth substances|mesh-ancestor
139402203|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
139402204|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139402205|NCT02281279|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139402206|NCT02281279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402207|NCT02281279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402208|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139402209|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139402210|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402211|NCT02173457|Incretins|incretins|mesh-ancestor
139402212|NCT02173457|Hormones|hormones|mesh-ancestor
139402213|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139402214|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139402215|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
139402216|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402217|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402218|NCT00805129|Everolimus|everolimus|mesh-list
139402219|NCT00805129|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139402220|NCT00805129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139402221|NCT00805129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402222|NCT00805129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402223|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139402224|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
139402225|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402226|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651727|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402227|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
139402228|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139402229|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402231|NCT00501709|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139402232|NCT00501709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139402233|NCT00501709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402234|NCT00501709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139402235|NCT00501709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402236|NCT00501709|Immunologic Factors|immunologic factors|mesh-ancestor
139402237|NCT00501709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402238|NCT00501709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139402239|NCT02273635|Andrographolide|andrographolide|mesh-list
139402240|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139402241|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139402242|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139402244|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
139402245|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743048|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
139402246|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402247|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139402248|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139402249|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139402250|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402251|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
139402252|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139402253|NCT02170415|Pregabalin|pregabalin|mesh-list
139402254|NCT02170415|Anesthetics|anesthetics|mesh-list
139402255|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
139402256|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139402257|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402258|NCT02170415|Analgesics|analgesics|mesh-ancestor
139402259|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
139402260|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402261|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
139402262|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139402263|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139402264|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402265|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139402266|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139402267|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139402268|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139402269|NCT00622063|Beta-lapachone|beta-lapachone|mesh-list
139402270|NCT00622063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402271|NCT00622063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139402272|NCT00622063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139402273|NCT00622063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402274|NCT00622063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402275|NCT00622063|Antiviral Agents|antiviral agents|mesh-ancestor
139402276|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
139402277|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139402278|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139402279|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
139402280|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402281|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402282|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139402283|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
139402284|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
139402285|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139402286|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
139402287|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402288|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402289|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139402290|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139402291|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139402292|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
139402293|NCT02274259|Ranibizumab|ranibizumab|mesh-list
139402294|NCT02274259|Aflibercept|aflibercept|mesh-list
139402295|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139402296|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139402297|NCT02274259|Growth Substances|growth substances|mesh-ancestor
139402298|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402299|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
139402300|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402301|NCT05571111|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139402302|NCT05571111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139402303|NCT05571111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402305|NCT02404623|Vitamins|vitamins|mesh-ancestor
139402306|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
139402307|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402308|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139402309|NCT02170571|Dabigatran|dabigatran|mesh-list
139402310|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
139402311|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139402312|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
139402313|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402314|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402315|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
139402317|NCT04481841|Vitamin E|vitamin e|mesh-list
139402318|NCT04481841|Riboflavin|riboflavin|mesh-list
139402319|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
139402320|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402321|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
139402322|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
139402323|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402324|NCT04481841|Protective Agents|protective agents|mesh-ancestor
139402325|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139402326|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
139402327|NCT02388477|Doxycycline|doxycycline|mesh-list
139402328|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139402329|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402330|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
139402331|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139402332|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139402333|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139402334|NCT02166359|Icodextrin|icodextrin|mesh-list
139402335|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
139402336|NCT00488839|Baclofen|baclofen|mesh-list
139402337|NCT00488839|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139402338|NCT00488839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402339|NCT00488839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139402340|NCT00488839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402341|NCT00488839|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139402342|NCT00488839|GABA Agonists|gaba agonists|mesh-ancestor
139402343|NCT00488839|GABA Agents|gaba agents|mesh-ancestor
139402344|NCT00488839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402345|NCT00488839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402346|NCT02255747|Lactulose|lactulose|mesh-list
139402347|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139402348|NCT01654731|Bezafibrate|bezafibrate|mesh-list
139402349|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139402350|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
139402351|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402352|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139402353|NCT00485563|Folic Acid|folic acid|mesh-list
139402354|NCT00485563|Vitamin B Complex|vitamin b complex|mesh-list
139402355|NCT00485563|Interferons|interferons|mesh-list
139402356|NCT00485563|Interferon-alpha|interferon-alpha|mesh-list
139402357|NCT00485563|Interleukin-2|interleukin-2|mesh-list
139402358|NCT00485563|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
139402359|NCT00485563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402360|NCT00485563|Antiviral Agents|antiviral agents|mesh-ancestor
139402361|NCT00485563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402362|NCT00485563|Immunologic Factors|immunologic factors|mesh-ancestor
139402363|NCT00485563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402364|NCT00485563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139402365|NCT00485563|Analgesics|analgesics|mesh-ancestor
139402366|NCT00485563|Sensory System Agents|sensory system agents|mesh-ancestor
139402367|NCT00485563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402368|NCT00485563|Hematinics|hematinics|mesh-ancestor
139402369|NCT00485563|Vitamins|vitamins|mesh-ancestor
139402370|NCT00485563|Micronutrients|micronutrients|mesh-ancestor
139402371|NCT00485563|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139402372|NCT02170805|Pantoprazole|pantoprazole|mesh-list
139402373|NCT02170805|Dabigatran|dabigatran|mesh-list
139402374|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139402375|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139402376|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139402377|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402378|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402379|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
139402380|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139402381|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
139402383|NCT00606697|Vofopitant|vofopitant|mesh-list
139402384|NCT00606697|Vestipitant|vestipitant|mesh-list
139402385|NCT00606697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139402386|NCT00606697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402387|NCT00606697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402388|NCT00606697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402389|NCT00606697|Antiemetics|antiemetics|mesh-ancestor
139402390|NCT00606697|Autonomic Agents|autonomic agents|mesh-ancestor
139402391|NCT00606697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402392|NCT00606697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139402394|NCT02404077|Analgesics|analgesics|mesh-ancestor
139402395|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
139402396|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402397|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402398|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138744436|NCT00977431|Afatinib|afatinib|mesh-list
139402399|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
139402400|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
139402401|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139402402|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139402403|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139402404|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
139402405|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402406|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402407|NCT02174939|Cilostazol|cilostazol|mesh-list
139402408|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139402409|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
139402410|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402411|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402412|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139402413|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
139402414|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139402415|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139402416|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402417|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139402418|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
139402419|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139402420|NCT02174939|Protective Agents|protective agents|mesh-ancestor
139402421|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139402422|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139402423|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402424|NCT02404233|Darunavir|darunavir|mesh-list
139402425|NCT02404233|Cobicistat|cobicistat|mesh-list
139402426|NCT02404233|Rilpivirine|rilpivirine|mesh-list
139402427|NCT02404233|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139402428|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139402429|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139402430|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
139402431|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402432|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402433|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139402434|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139402435|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
139402436|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402437|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139402438|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139402439|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139402440|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139402441|NCT00603577|Xaliproden|xaliproden|mesh-list
139402442|NCT00603577|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139402443|NCT00603577|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139402444|NCT00603577|Serotonin Agents|serotonin agents|mesh-ancestor
139402445|NCT00603577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402446|NCT00603577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402447|NCT00603577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402448|NCT02178293|Ketoprofen|ketoprofen|mesh-list
139402449|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
139402450|NCT02178293|Benzydamine|benzydamine|mesh-list
139402451|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139402452|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139402453|NCT02178293|Analgesics|analgesics|mesh-ancestor
139402454|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
139402455|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907148|NCT00853580|Lovastatin|lovastatin|mesh-list
139651728|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402456|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402457|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139402458|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139402459|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139402460|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402461|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402462|NCT03170895|Sorafenib|sorafenib|mesh-list
139402463|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
139402464|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402465|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139402466|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402467|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402468|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139402469|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139402470|NCT02277847|Cytarabine|cytarabine|mesh-list
139402471|NCT02277847|Idarubicin|idarubicin|mesh-list
139402472|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139402473|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
139402474|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402475|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402476|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
139402477|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402478|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139402479|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
139402480|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402481|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139402482|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139402483|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139402484|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402485|NCT01457781|Nitric Oxide|nitric oxide|mesh-list
139402486|NCT01457781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139402487|NCT01457781|Autonomic Agents|autonomic agents|mesh-ancestor
139402488|NCT01457781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402489|NCT01457781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402490|NCT01457781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139402491|NCT01457781|Respiratory System Agents|respiratory system agents|mesh-ancestor
139402492|NCT01457781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139402493|NCT01457781|Antioxidants|antioxidants|mesh-ancestor
139402494|NCT01457781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402495|NCT01457781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402496|NCT01457781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139402497|NCT01457781|Vasodilator Agents|vasodilator agents|mesh-ancestor
139402498|NCT01457781|Gasotransmitters|gasotransmitters|mesh-ancestor
139402499|NCT01457781|Protective Agents|protective agents|mesh-ancestor
139402500|NCT00468403|Mycophenolic Acid|mycophenolic acid|mesh-list
139402501|NCT00468403|Abatacept|abatacept|mesh-list
139402502|NCT00468403|Tacrolimus|tacrolimus|mesh-list
139402503|NCT00468403|Basiliximab|basiliximab|mesh-list
139402504|NCT00468403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139402505|NCT00468403|Immunologic Factors|immunologic factors|mesh-ancestor
139402506|NCT00468403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402507|NCT00468403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139402508|NCT00468403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402509|NCT00468403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402510|NCT00468403|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139402511|NCT00468403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402512|NCT00468403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139402513|NCT00468403|Antitubercular Agents|antitubercular agents|mesh-ancestor
139402514|NCT00468403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139402515|NCT00468403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402516|NCT00468403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139402517|NCT00468403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139402518|NCT00468403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139402519|NCT02175017|Nivolumab|nivolumab|mesh-list
139402520|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139402521|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402522|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139402523|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402524|NCT02178449|Dexamethasone|dexamethasone|mesh-list
139402525|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
139402526|NCT02178449|Ropivacaine|ropivacaine|mesh-list
139402527|NCT02178449|BB 1101|bb 1101|mesh-list
139402528|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139402529|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
139402530|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
139402531|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402532|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402533|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139402534|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
139402535|NCT02178449|Hormones|hormones|mesh-ancestor
139402536|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139402537|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139402538|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402539|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
139402540|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
139402541|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139402542|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
139402543|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
139402544|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402545|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402546|NCT02387931|Vitamin D|vitamin d|mesh-list
139402547|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
139402548|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
139402549|NCT02387931|Vitamins|vitamins|mesh-list
139402550|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
139402551|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402552|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139402553|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139402554|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
139402555|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139402556|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139402557|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402558|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
139402559|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139402560|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
139402561|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
139402562|NCT02178683|Tacrolimus|tacrolimus|mesh-list
139402563|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139402564|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
139402565|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402566|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139402567|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402568|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402569|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139402570|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402571|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139402572|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
139402573|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139402574|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402575|NCT03170739|Dopamine|dopamine|mesh-list
139402576|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
139402577|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139402578|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139402579|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402580|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139402581|NCT03170739|Analgesics|analgesics|mesh-ancestor
139402582|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
139402583|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402584|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139402585|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139402586|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139402587|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
139402588|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402589|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402590|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139402591|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
139402592|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
139402593|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
139402594|NCT03170739|Protective Agents|protective agents|mesh-ancestor
139402595|NCT00459745|Fenofibrate|fenofibrate|mesh-list
139402596|NCT00459745|Pravastatin|pravastatin|mesh-list
139402597|NCT00459745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139402598|NCT00459745|Antimetabolites|antimetabolites|mesh-ancestor
139402599|NCT00459745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402600|NCT00459745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139402601|NCT00459745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139402602|NCT00459745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139402603|NCT00459745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402604|NCT02178761|Chromium|chromium|mesh-list
139402605|NCT02178761|Everolimus|everolimus|mesh-list
139651729|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
139402606|NCT02178761|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139402607|NCT02178761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139402608|NCT02178761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745835|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139402609|NCT02178761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402610|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139402611|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
139402612|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402613|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402614|NCT02178761|Trace Elements|trace elements|mesh-ancestor
139402615|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
139402616|NCT02742181|Alvimopan|alvimopan|mesh-list
139402617|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139402618|NCT02175407|Itraconazole|itraconazole|mesh-list
139402619|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
139402620|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402621|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139402622|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139402623|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402624|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402625|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139402626|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
139402627|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139402628|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402629|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139402630|NCT02182193|Nintedanib|nintedanib|mesh-list
139402631|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402632|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139402633|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402634|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402635|NCT02175485|Fexofenadine|fexofenadine|mesh-list
139402636|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139402637|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139402638|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139402639|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
139402640|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
139402641|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402642|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746448|NCT00966355|Hormones|hormones|mesh-ancestor
139402643|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402644|NCT04575779|Cyclosporine|cyclosporine|mesh-list
139402645|NCT04575779|Cyclosporins|cyclosporins|mesh-list
139402646|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402647|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402648|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139402649|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
139402650|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402651|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
139402652|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402653|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
139402654|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139402655|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139402656|NCT02741713|Lidocaine|lidocaine|mesh-list
139402657|NCT02741713|Clonidine|clonidine|mesh-list
139402658|NCT02741713|Epinephrine|epinephrine|mesh-list
139402659|NCT02741713|Racepinephrine|racepinephrine|mesh-list
139402660|NCT02741713|Bupivacaine|bupivacaine|mesh-list
139402661|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139402662|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
139402663|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
139402664|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
139402665|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139402666|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402667|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
139402668|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402669|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139402670|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139402671|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139402672|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139402673|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402674|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139402675|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139402676|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
139402677|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651730|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
139651731|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
139402678|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139402679|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139402680|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
139402681|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139402682|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
139402683|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
139402684|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
139402685|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139402686|NCT02741713|Analgesics|analgesics|mesh-ancestor
139402687|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139402688|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
139402689|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139402691|NCT00459277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139402692|NCT00459277|Narcotics|narcotics|mesh-ancestor
139402693|NCT00459277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139402694|NCT00459277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402695|NCT00459277|Analgesics|analgesics|mesh-ancestor
139402696|NCT00459277|Sensory System Agents|sensory system agents|mesh-ancestor
139402697|NCT00459277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402698|NCT00459277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139402699|NCT00459277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139402700|NCT00459277|Anesthetics, General|anesthetics, general|mesh-ancestor
139402701|NCT00459277|Anesthetics|anesthetics|mesh-ancestor
139402702|NCT00602329|Leucovorin|leucovorin|mesh-list
139402703|NCT00602329|Bevacizumab|bevacizumab|mesh-list
139402704|NCT00602329|Fluorouracil|fluorouracil|mesh-list
139402705|NCT00602329|Oxaliplatin|oxaliplatin|mesh-list
139402706|NCT00602329|Calcium|calcium|mesh-list
139402707|NCT00602329|Levoleucovorin|levoleucovorin|mesh-list
139402708|NCT00602329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139402709|NCT00602329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402710|NCT00602329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139402711|NCT00602329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139402712|NCT00602329|Growth Substances|growth substances|mesh-ancestor
139402713|NCT00602329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402714|NCT00602329|Growth Inhibitors|growth inhibitors|mesh-ancestor
139402715|NCT00602329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139402716|NCT00602329|Antimetabolites|antimetabolites|mesh-ancestor
139402717|NCT00602329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402718|NCT00602329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139402719|NCT00602329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139402720|NCT00602329|Immunologic Factors|immunologic factors|mesh-ancestor
139402721|NCT00602329|Antidotes|antidotes|mesh-ancestor
139402722|NCT00602329|Protective Agents|protective agents|mesh-ancestor
139402723|NCT00602329|Vitamin B Complex|vitamin b complex|mesh-ancestor
139402724|NCT00602329|Vitamins|vitamins|mesh-ancestor
139402725|NCT00602329|Micronutrients|micronutrients|mesh-ancestor
139402726|NCT02182505|Fenoterol|fenoterol|mesh-list
139402727|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139402728|NCT02182505|Ipratropium|ipratropium|mesh-list
139402729|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139402730|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
139402731|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402732|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402733|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139402734|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
139402735|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
139402736|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
139402737|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139402738|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139402739|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139402740|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139402741|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
139402742|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402743|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402744|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139402745|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
139402746|NCT02387619|Amlodipine|amlodipine|mesh-list
139402747|NCT02387619|Telmisartan|telmisartan|mesh-list
139402748|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139402749|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139402750|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139402751|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139402752|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139402753|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402754|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139402755|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402756|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
139402757|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139402758|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139402759|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
139402760|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139402761|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139402762|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402763|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139402764|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139059572|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
139402766|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
139402767|NCT03537443|Vitamins|vitamins|mesh-ancestor
139402768|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
139402769|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402770|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139402771|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139402772|NCT00595699|Escitalopram|escitalopram|mesh-list
139402773|NCT00595699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139402774|NCT00595699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139402775|NCT00595699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138748032|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139402776|NCT00595699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402777|NCT00595699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402778|NCT00595699|Serotonin Agents|serotonin agents|mesh-ancestor
139402779|NCT00595699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402780|NCT02256215|Vitamin D|vitamin d|mesh-list
139402781|NCT02256215|Vitamins|vitamins|mesh-ancestor
139402782|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
139402783|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402784|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139402785|NCT02182583|Oxitropium|oxitropium|mesh-list
139402786|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
139402787|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
139402788|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402789|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402790|NCT03133975|Vitamin D|vitamin d|mesh-list
139402791|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
139402792|NCT03133975|Vitamins|vitamins|mesh-ancestor
139402793|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
139402794|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402795|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139402796|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139402797|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139402798|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139402799|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402800|NCT02182661|Oxitropium|oxitropium|mesh-list
139402801|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
139402802|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
139402803|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402804|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402805|NCT02663271|Bevacizumab|bevacizumab|mesh-list
139402806|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139402807|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139402808|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139402809|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139402810|NCT02663271|Growth Substances|growth substances|mesh-ancestor
139402811|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402812|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
139402813|NCT00659191|Cabotegravir|cabotegravir|mesh-list
139402814|NCT00659191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139402815|NCT00659191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139402816|NCT00659191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402817|NCT00659191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402818|NCT00659191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139402819|NCT00659191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139402820|NCT00659191|Antiviral Agents|antiviral agents|mesh-ancestor
139402821|NCT00659191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402822|NCT02182739|Meloxicam|meloxicam|mesh-list
139402823|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139402824|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139402825|NCT02182739|Analgesics|analgesics|mesh-ancestor
139402826|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
139651732|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139651733|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139402827|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402828|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402829|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139402830|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139402831|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139402832|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139402833|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402834|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402835|NCT00583609|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139402837|NCT00583609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139059643|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
139402838|NCT03170115|Aspirin|aspirin|mesh-list
139402839|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139402840|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139402841|NCT03170115|Analgesics|analgesics|mesh-ancestor
139402842|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
139402843|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402844|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402845|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139402846|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139402847|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139402848|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139402849|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402850|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139402851|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139402852|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402853|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
139402854|NCT03169959|Metformin|metformin|mesh-list
139402855|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
139402856|NCT03169959|Saxagliptin|saxagliptin|mesh-list
139402857|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139402858|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402859|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139402860|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402861|NCT03169959|Incretins|incretins|mesh-ancestor
139402862|NCT03169959|Hormones|hormones|mesh-ancestor
139402863|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139402864|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139402865|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
139402866|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402867|NCT02176187|Fenoterol|fenoterol|mesh-list
139402868|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139402869|NCT02176187|Ipratropium|ipratropium|mesh-list
139402870|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138748983|NCT05408065|Cortisone|cortisone|mesh-list
138748984|NCT05408065|Hyaluronic Acid|hyaluronic acid|mesh-list
138748985|NCT05408065|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139402871|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
139402872|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402873|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402874|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139402875|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
139402876|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
139402877|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
139402878|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139402879|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139402880|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139402881|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139402882|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
139402883|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402884|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402885|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139402886|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
139402887|NCT02176499|Telmisartan|telmisartan|mesh-list
139402888|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139402889|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139402890|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139402891|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402892|NCT02176733|Cyclosporine|cyclosporine|mesh-list
139402893|NCT02176733|Cyclosporins|cyclosporins|mesh-list
139402894|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402895|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402896|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139402897|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
139402898|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402899|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
139402900|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139402901|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
139402902|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139402903|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139402904|NCT03536741|Anesthetics|anesthetics|mesh-list
139402905|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
139402906|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139402907|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402908|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
139402909|NCT02403687|Topiramate|topiramate|mesh-list
139402910|NCT02403687|Diclofenac|diclofenac|mesh-list
139402911|NCT02403687|Meloxicam|meloxicam|mesh-list
139402912|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
139402913|NCT02403687|Lidocaine|lidocaine|mesh-list
139402914|NCT02403687|Clonidine|clonidine|mesh-list
139402915|NCT02403687|Sumatriptan|sumatriptan|mesh-list
139402916|NCT02403687|Ketamine|ketamine|mesh-list
139402917|NCT02403687|Gabapentin|gabapentin|mesh-list
139402918|NCT02403687|Amitriptyline|amitriptyline|mesh-list
139402919|NCT02403687|Tizanidine|tizanidine|mesh-list
139402920|NCT02403687|Bupivacaine|bupivacaine|mesh-list
139402921|NCT02403687|Prilocaine|prilocaine|mesh-list
139402922|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
139402923|NCT02403687|Baclofen|baclofen|mesh-list
139402924|NCT02403687|Capsaicin|capsaicin|mesh-list
139402925|NCT02403687|Menthol|menthol|mesh-list
139402926|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
139402927|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
139402928|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139402929|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402930|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
139402931|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402932|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139402933|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139402934|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139402935|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139402936|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402937|NCT02403687|Analgesics|analgesics|mesh-ancestor
139402938|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139402939|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139402940|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
139402941|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139402942|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139402943|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402944|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
139402945|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139402946|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139402947|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139402948|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
139402949|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139402950|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139402951|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139402952|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139402953|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139402954|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139402955|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139402956|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
139402957|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
139402958|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139402959|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139402960|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139402961|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
139402962|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
139402963|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139402964|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139402965|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139402966|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
139402967|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139402968|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139402969|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
139402970|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139402971|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139402972|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
139402973|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
139651734|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139402974|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
139402975|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139402976|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139402977|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139402978|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139402979|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
139402980|NCT02742649|Timolol|timolol|mesh-list
139402981|NCT02742649|Bimatoprost|bimatoprost|mesh-list
139402982|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139402983|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139402984|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
139402985|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139402986|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139402987|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402988|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139402989|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139402990|NCT02183051|Ibuprofen|ibuprofen|mesh-list
139402991|NCT02183051|Meloxicam|meloxicam|mesh-list
139402992|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139402994|NCT02183051|Analgesics|analgesics|mesh-ancestor
139402995|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
139402996|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139402997|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139402998|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139402999|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139403000|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139403001|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403002|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403003|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139403004|NCT03169725|Vaccines|vaccines|mesh-list
139403005|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
139403006|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403007|NCT02403531|Docetaxel|docetaxel|mesh-list
139403008|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403009|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
139403010|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
139403011|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
138751334|NCT05330065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403012|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403013|NCT02279953|Vortioxetine|vortioxetine|mesh-list
139403014|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
139403015|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139403016|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139403017|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139403018|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139403019|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403020|NCT02279953|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139403021|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139403022|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139403023|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403024|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403025|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
139403026|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139403027|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139403028|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139403029|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139403030|NCT00578773|Moxifloxacin|moxifloxacin|mesh-list
139403031|NCT00578773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139403032|NCT00578773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139403033|NCT00578773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403034|NCT00578773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139403035|NCT00578773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139403036|NCT00578773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403037|NCT00578773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403038|NCT00578773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403039|NCT02387307|Interferons|interferons|mesh-list
139403040|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403041|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
139403042|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403043|NCT02183363|Linagliptin|linagliptin|mesh-list
139403044|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139403045|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403046|NCT02183363|Incretins|incretins|mesh-ancestor
139403047|NCT02183363|Hormones|hormones|mesh-ancestor
139403048|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403049|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139403050|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
139651735|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403051|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403052|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403053|NCT02183441|Linagliptin|linagliptin|mesh-list
139403054|NCT02183441|Ritonavir|ritonavir|mesh-list
139403055|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139403056|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139403057|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
139403058|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403059|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403060|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139403061|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139403062|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
139403063|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139059878|NCT03933982|Vinorelbine|vinorelbine|mesh-list
139403064|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139403065|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139403066|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139403067|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403068|NCT02183441|Incretins|incretins|mesh-ancestor
139403069|NCT02183441|Hormones|hormones|mesh-ancestor
139403070|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403071|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139403072|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139403073|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
139403074|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139403075|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139403076|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139403077|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139403078|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403079|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
139403080|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403081|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403082|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139403083|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403084|NCT03537287|Progesterone|progesterone|mesh-list
139403085|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
139403086|NCT03537287|Progestins|progestins|mesh-ancestor
139403087|NCT03537287|Hormones|hormones|mesh-ancestor
139403088|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403089|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403090|NCT02280031|Aspirin|aspirin|mesh-list
139403091|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139403092|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139403093|NCT02280031|Analgesics|analgesics|mesh-ancestor
139403094|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
139403095|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403096|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403097|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403098|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139403099|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139403100|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139403101|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403102|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139403103|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139403104|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403105|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
139403106|NCT00449605|Metformin|metformin|mesh-list
139403107|NCT00449605|Glimepiride|glimepiride|mesh-list
139403108|NCT00449605|Rimonabant|rimonabant|mesh-list
139403109|NCT00449605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139403110|NCT00449605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403111|NCT00449605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139403112|NCT00449605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139403113|NCT00449605|Immunologic Factors|immunologic factors|mesh-ancestor
139403114|NCT00449605|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139403115|NCT00449605|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
139403116|NCT00449605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139403117|NCT00449605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403118|NCT00449605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403119|NCT00449605|Hormones|hormones|mesh-ancestor
139403120|NCT00449605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403121|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
138751462|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
139403122|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139651736|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139403123|NCT02774239|Antibodies|antibodies|mesh-list
139403124|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
139403125|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
139403126|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403127|NCT02280109|Tenofovir|tenofovir|mesh-list
139403128|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
139403129|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403130|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139403131|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139403132|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403133|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403134|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139403135|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139403136|NCT00576667|Rimonabant|rimonabant|mesh-list
139403137|NCT00576667|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139403138|NCT00576667|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
139403139|NCT00576667|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139403140|NCT00576667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403141|NCT00576667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403142|NCT00576667|Hormones|hormones|mesh-ancestor
139403143|NCT00576667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403144|NCT00576667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403145|NCT02403063|Neostigmine|neostigmine|mesh-list
139403146|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139403147|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403148|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403149|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
139403150|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403151|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403152|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139403153|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
139403154|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403155|NCT02177357|Pramipexole|pramipexole|mesh-list
139403156|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
138751554|NCT04435015|Camostat|camostat|mesh-list
139403157|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403158|NCT02177357|Protective Agents|protective agents|mesh-ancestor
139403159|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403160|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139403161|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139403162|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
139403163|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
139403164|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403165|NCT02386449|Mannitol|mannitol|mesh-list
139403166|NCT02386449|Bisacodyl|bisacodyl|mesh-list
139403167|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
139403168|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
139403169|NCT02386449|Citric Acid|citric acid|mesh-list
139403170|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
139403171|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139403172|NCT02386449|Diuretics|diuretics|mesh-ancestor
139403173|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
139403174|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403175|NCT02386449|Cathartics|cathartics|mesh-ancestor
139403176|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139403177|NCT02386449|Laxatives|laxatives|mesh-ancestor
139403178|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
139403179|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139403180|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
139403181|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
139403182|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403183|NCT02386449|Antacids|antacids|mesh-ancestor
139403184|NCT00656539|Azithromycin|azithromycin|mesh-list
139403185|NCT00656539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139403186|NCT00656539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403187|NCT02179775|Propranolol|propranolol|mesh-list
139403188|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139403189|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139403190|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
139403191|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403192|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403193|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403194|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139403195|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139403196|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
139403197|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139403198|NCT02177435|Telmisartan|telmisartan|mesh-list
139403199|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
139403200|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139403201|NCT02177435|Diuretics|diuretics|mesh-ancestor
139403202|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
139403203|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403204|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139403205|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139403206|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403207|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139403208|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139403209|NCT02280265|Factor VIII|factor viii|mesh-list
139403210|NCT02280265|Coagulants|coagulants|mesh-ancestor
139403211|NCT02179931|Flupenthixol|flupenthixol|mesh-list
139403212|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
139403213|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139403214|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139403215|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139403216|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403217|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139403218|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139403219|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
139403220|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403221|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403222|NCT02184065|Meloxicam|meloxicam|mesh-list
139403223|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139403224|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139403225|NCT02184065|Analgesics|analgesics|mesh-ancestor
139403226|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
139403227|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403228|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403229|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403230|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139403231|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139403232|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139403233|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403234|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403235|NCT00564421|Epinastine|epinastine|mesh-list
139403236|NCT00564421|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139403237|NCT00564421|Histamine Antagonists|histamine antagonists|mesh-ancestor
139403238|NCT00564421|Histamine Agents|histamine agents|mesh-ancestor
139403239|NCT00564421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403240|NCT00564421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403241|NCT00564421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403242|NCT02665689|Ranibizumab|ranibizumab|mesh-list
139403243|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139403244|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139403245|NCT02665689|Growth Substances|growth substances|mesh-ancestor
139403246|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403247|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
139403248|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403249|NCT02386293|Irbesartan|irbesartan|mesh-list
139403250|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139403251|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139403252|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139403253|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403254|NCT00563563|Naltrexone|naltrexone|mesh-list
139403255|NCT00563563|Bupropion|bupropion|mesh-list
139403256|NCT00563563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139403257|NCT00563563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139403258|NCT00563563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403259|NCT00563563|Sensory System Agents|sensory system agents|mesh-ancestor
139403260|NCT00563563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403261|NCT00563563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139403262|NCT00563563|Antidepressive Agents|antidepressive agents|mesh-ancestor
139403263|NCT00563563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139403264|NCT00563563|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139403265|NCT00563563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139403266|NCT00563563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139403267|NCT00563563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403268|NCT00563563|Dopamine Agents|dopamine agents|mesh-ancestor
139403269|NCT00563563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403270|NCT00563563|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138907969|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139651737|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
139403271|NCT00563563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139403272|NCT00563563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403273|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139403274|NCT05149365|Cyclosporine|cyclosporine|mesh-list
139403275|NCT05149365|Methotrexate|methotrexate|mesh-list
139403276|NCT05149365|Cyclosporins|cyclosporins|mesh-list
139403277|NCT05149365|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139403278|NCT05149365|Abortifacient Agents|abortifacient agents|mesh-ancestor
139403279|NCT05149365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139403280|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403281|NCT05149365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139403282|NCT05149365|Antimetabolites|antimetabolites|mesh-ancestor
139403283|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403284|NCT05149365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403285|NCT05149365|Dermatologic Agents|dermatologic agents|mesh-ancestor
139060092|NCT03933280|Analgesics|analgesics|mesh-ancestor
139403287|NCT05149365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139403288|NCT05149365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139403289|NCT05149365|Immunologic Factors|immunologic factors|mesh-ancestor
139403290|NCT05149365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139403291|NCT05149365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139403292|NCT05149365|Antifungal Agents|antifungal agents|mesh-ancestor
139403293|NCT05149365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403294|NCT05149365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139403295|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139403296|NCT05149365|Incretins|incretins|mesh-ancestor
139403298|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403299|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139403300|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
139403301|NCT02180087|Ketoprofen|ketoprofen|mesh-list
138751665|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139403302|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139403303|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139403304|NCT02180087|Analgesics|analgesics|mesh-ancestor
139403305|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
139403306|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403307|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403308|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403309|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139403310|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139403311|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403312|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403313|NCT02184299|Nevirapine|nevirapine|mesh-list
139403314|NCT02184299|Prednisone|prednisone|mesh-list
139403315|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403316|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
139403317|NCT02184299|Hormones|hormones|mesh-ancestor
139403318|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403319|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403320|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139403321|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403322|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139403323|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139403324|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403325|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403326|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
139403327|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403328|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139403329|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139403330|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139403331|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139403332|NCT00549679|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
139403333|NCT00549679|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139403334|NCT00549679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139403335|NCT00549679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403336|NCT00549679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403337|NCT02282371|Cetuximab|cetuximab|mesh-list
139403338|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139403339|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403340|NCT02402595|Itraconazole|itraconazole|mesh-list
139403341|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
139403342|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403344|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139403345|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403346|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751699|NCT01282463|Docetaxel|docetaxel|mesh-list
139403347|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139403348|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
139403349|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403350|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403351|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139403352|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
139403353|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139403354|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139060162|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
139403355|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403356|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
139403357|NCT02180321|Coagulants|coagulants|mesh-ancestor
139403359|NCT00547651|Amrubicin|amrubicin|mesh-list
139403360|NCT00547651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139403361|NCT00547651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139403362|NCT00547651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403363|NCT00547651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403364|NCT00547651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403365|NCT00546793|Veltuzumab|veltuzumab|mesh-list
139403366|NCT00546793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403367|NCT02402283|Metronidazole|metronidazole|mesh-list
139403368|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403369|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139403370|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139403371|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139403372|NCT02184533|Selenious Acid|selenious acid|mesh-list
139403373|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
139403374|NCT02184533|Trace Elements|trace elements|mesh-ancestor
139403375|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
139403376|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403377|NCT02386059|Dexamethasone|dexamethasone|mesh-list
139403378|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
139403379|NCT02386059|Ondansetron|ondansetron|mesh-list
139403380|NCT02386059|BB 1101|bb 1101|mesh-list
139403381|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403382|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
139403383|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
139403384|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403385|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751827|NCT01266317|Rituximab|rituximab|mesh-list
139403386|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139403387|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
139403388|NCT02386059|Hormones|hormones|mesh-ancestor
139403389|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403390|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139403391|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403392|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
139403393|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403394|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403395|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
139403396|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
139403397|NCT02386059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139403398|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139403399|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
139403400|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403401|NCT00443287|Cilostazol|cilostazol|mesh-list
139403402|NCT00443287|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
139403403|NCT00443287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139403404|NCT00443287|Autonomic Agents|autonomic agents|mesh-ancestor
139403405|NCT00443287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403406|NCT00443287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403407|NCT00443287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139403408|NCT00443287|Respiratory System Agents|respiratory system agents|mesh-ancestor
139403409|NCT00443287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139403410|NCT00443287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139403411|NCT00443287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403412|NCT00443287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139403413|NCT00443287|Vasodilator Agents|vasodilator agents|mesh-ancestor
139403414|NCT00443287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139403415|NCT00443287|Protective Agents|protective agents|mesh-ancestor
139403416|NCT00443287|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139403417|NCT00443287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139403418|NCT00443287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403419|NCT00443287|Enzyme Activators|enzyme activators|mesh-ancestor
139403420|NCT00442039|Lithium Carbonate|lithium carbonate|mesh-list
139403421|NCT00442039|Antidepressive Agents|antidepressive agents|mesh-ancestor
139403422|NCT00442039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139403423|NCT00442039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403424|NCT00442039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403425|NCT00442039|Antimanic Agents|antimanic agents|mesh-ancestor
139403426|NCT00442039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139403427|NCT00442039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139403428|NCT00442039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403429|NCT02390739|Aldesleukin|aldesleukin|mesh-list
139403430|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
139403431|NCT02390739|Fludarabine|fludarabine|mesh-list
139403432|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139403433|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
139403434|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403435|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139403436|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139403437|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
139403438|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403439|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403440|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139403441|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139403442|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139403443|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
139403444|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403445|NCT02385825|Vaccines|vaccines|mesh-list
139403446|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
139403447|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403448|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
139403449|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403450|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138751936|NCT04321655|Ibuprofen|ibuprofen|mesh-list
139403451|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403452|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403453|NCT02390817|Neostigmine|neostigmine|mesh-list
139403454|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139403455|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403456|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403457|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
139403458|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403459|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403460|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139403461|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
139403462|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403463|NCT00537043|Carvedilol|carvedilol|mesh-list
139403464|NCT00537043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139403465|NCT00537043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139403466|NCT00537043|Adrenergic Agents|adrenergic agents|mesh-ancestor
139403467|NCT00537043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403468|NCT00537043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403469|NCT00537043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403470|NCT00537043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139403471|NCT00537043|Antioxidants|antioxidants|mesh-ancestor
139403472|NCT00537043|Protective Agents|protective agents|mesh-ancestor
139403473|NCT00537043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139403474|NCT00537043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139403475|NCT00537043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139403476|NCT00537043|Vasodilator Agents|vasodilator agents|mesh-ancestor
139403477|NCT00537043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139403478|NCT00537043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139403479|NCT00387907|Trastuzumab|trastuzumab|mesh-list
139403480|NCT00387907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139403481|NCT00387907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403482|NCT02180789|Tamsulosin|tamsulosin|mesh-list
139403483|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139403484|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139403485|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139403486|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
139403487|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751985|NCT00624143|Amebicides|amebicides|mesh-ancestor
139140060|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139651738|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403488|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403489|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403490|NCT02180789|Urological Agents|urological agents|mesh-ancestor
139403491|NCT02282683|Prednisone|prednisone|mesh-list
139403492|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403493|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
139403494|NCT02282683|Hormones|hormones|mesh-ancestor
139403495|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403496|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403497|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139403498|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403499|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139403500|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139403501|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139403502|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
139403503|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403505|NCT00375193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403506|NCT00151411|Metformin|metformin|mesh-list
139403507|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139403508|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403509|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
139403510|NCT04471441|Everolimus|everolimus|mesh-list
139403511|NCT04471441|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139403512|NCT04471441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139403513|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403514|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403515|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139403516|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
139403517|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403518|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403519|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139403520|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139403521|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
139403522|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139403523|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403524|NCT02662569|Atorvastatin|atorvastatin|mesh-list
139403525|NCT02662569|Evolocumab|evolocumab|mesh-list
139403526|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139403527|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139403528|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
139403529|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403530|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139403531|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139403532|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403533|NCT02662569|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139403534|NCT02662569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139403535|NCT02662569|Protease Inhibitors|protease inhibitors|mesh-ancestor
139403536|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
139403537|NCT02178137|Astringents|astringents|mesh-ancestor
139403538|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403539|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
139403540|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
139403541|NCT02181023|Bromides|bromides|mesh-list
139403542|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
139403543|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139403544|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139403545|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139403546|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
139403547|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403548|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403549|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403550|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
139403551|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139403552|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139403553|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403554|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
139403555|NCT02286973|Coagulants|coagulants|mesh-ancestor
139403556|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
139403557|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139403558|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403559|NCT02256683|Dabigatran|dabigatran|mesh-list
139403560|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
139403561|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
139651739|NCT00182767|Doxorubicin|doxorubicin|mesh-list
139403562|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139403563|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
139403564|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403565|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403566|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
139403567|NCT00411385|Interferons|interferons|mesh-list
139403568|NCT00411385|Ribavirin|ribavirin|mesh-list
139403569|NCT00411385|Interferon-alpha|interferon-alpha|mesh-list
139403570|NCT00411385|Interferon alpha-2|interferon alpha-2|mesh-list
139403571|NCT00411385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139403572|NCT00411385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403573|NCT00411385|Antiviral Agents|antiviral agents|mesh-ancestor
139403574|NCT00411385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403575|NCT00411385|Antimetabolites|antimetabolites|mesh-ancestor
139403576|NCT00411385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403577|NCT00411385|Immunologic Factors|immunologic factors|mesh-ancestor
139060388|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403578|NCT00411385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403579|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139403580|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
139403581|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403583|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
139403584|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139403585|NCT02185547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139403586|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139403587|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139403588|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403589|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403590|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
139403591|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403592|NCT02030483|Dexamethasone|dexamethasone|mesh-list
139403593|NCT02030483|Lenalidomide|lenalidomide|mesh-list
139403594|NCT02030483|Palbociclib|palbociclib|mesh-list
139403595|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403596|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
139403597|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
139403598|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403599|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403600|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139403601|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
139403602|NCT02030483|Hormones|hormones|mesh-ancestor
139403603|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403604|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139403605|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403606|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
139403607|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139403608|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139403609|NCT02030483|Growth Substances|growth substances|mesh-ancestor
139403610|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
139403611|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139403612|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403613|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403614|NCT00528697|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139403615|NCT00528697|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139403616|NCT00528697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139403617|NCT00528697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139403618|NCT00528697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403619|NCT00528697|Adrenergic Agents|adrenergic agents|mesh-ancestor
139403620|NCT00528697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403621|NCT00528697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403622|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
139403623|NCT02385435|Bupivacaine|bupivacaine|mesh-list
139403624|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
139403625|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
139403626|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139403627|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403628|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
139403629|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403630|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139403631|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139403632|NCT02385435|Analgesics|analgesics|mesh-ancestor
139403633|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139403634|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139403635|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139403636|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
139403637|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403638|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403639|NCT02753075|Fluorides|fluorides|mesh-list
139403640|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
139403641|NCT02753075|Protective Agents|protective agents|mesh-ancestor
139403642|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403643|NCT03133897|Dexamethasone|dexamethasone|mesh-list
139403644|NCT03133897|Prednisone|prednisone|mesh-list
139403645|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403646|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
139403647|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
139403648|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403649|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403650|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139403651|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
139403652|NCT03133897|Hormones|hormones|mesh-ancestor
139403653|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403654|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139403655|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752145|NCT01256879|Cimetidine|cimetidine|mesh-list
139403656|NCT05443425|Cholestyramine Resin|cholestyramine resin|mesh-list
139403657|NCT05443425|Leflunomide|leflunomide|mesh-list
139403658|NCT05443425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403659|NCT05443425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403660|NCT05443425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139403661|NCT05443425|Immunologic Factors|immunologic factors|mesh-ancestor
139403662|NCT05443425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403663|NCT05443425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139403664|NCT05443425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139403665|NCT05443425|Antimetabolites|antimetabolites|mesh-ancestor
139403666|NCT05443425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139403667|NCT02190149|Factor VIII|factor viii|mesh-list
139403668|NCT02190149|Coagulants|coagulants|mesh-ancestor
139403669|NCT00366145|Remestemcel-l|remestemcel-l|mesh-list
139403670|NCT00366145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403671|NCT00366145|Antiviral Agents|antiviral agents|mesh-ancestor
139403672|NCT00366145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403673|NCT02185859|Lidocaine|lidocaine|mesh-list
139403674|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
139403675|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
139403676|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
139403677|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139403678|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403679|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
139403680|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403681|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139403682|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139403683|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139403684|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139403685|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403686|NCT02185859|Analgesics|analgesics|mesh-ancestor
139403687|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
139403688|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139403689|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139403690|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
139403691|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139403692|NCT02332720|Ribavirin|ribavirin|mesh-list
139403693|NCT02332720|Grazoprevir|grazoprevir|mesh-list
139403694|NCT02332720|Ruzasvir|ruzasvir|mesh-list
139403695|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
139403696|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
139403697|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403698|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
139403699|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403700|NCT05089175|Aspirin|aspirin|mesh-list
139403701|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139403702|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139403703|NCT05089175|Analgesics|analgesics|mesh-ancestor
139403704|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
139403705|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403706|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403707|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403708|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139403709|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139403710|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139403711|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908431|NCT00786370|Propofol|propofol|mesh-list
139651740|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139403712|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139403713|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139403714|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403715|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
139403716|NCT02181335|Budesonide|budesonide|mesh-list
139403717|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403718|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139403719|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
139403720|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403721|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403722|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139403723|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
139403724|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
139403725|NCT02181335|Hormones|hormones|mesh-ancestor
139403726|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403727|NCT00517153|Miglustat|miglustat|mesh-list
139060538|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403728|NCT00517153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403729|NCT00517153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403730|NCT00517153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139403731|NCT00517153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139403732|NCT00517153|Antiviral Agents|antiviral agents|mesh-ancestor
139403733|NCT00517153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403734|NCT00517153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139403735|NCT00517153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139403736|NCT00517153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403737|NCT02285101|BCT-100|bct-100|mesh-list
139403738|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403739|NCT00359437|Satavaptan|satavaptan|mesh-list
139403740|NCT00359437|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139403741|NCT00359437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403742|NCT00359437|Natriuretic Agents|natriuretic agents|mesh-ancestor
139403743|NCT00359437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403744|NCT00401011|Dexamethasone|dexamethasone|mesh-list
139403745|NCT00401011|Bortezomib|bortezomib|mesh-list
139403746|NCT00401011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403747|NCT00401011|Antiemetics|antiemetics|mesh-ancestor
139403748|NCT00401011|Autonomic Agents|autonomic agents|mesh-ancestor
139403749|NCT00401011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403750|NCT00401011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403751|NCT00401011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139403752|NCT00401011|Glucocorticoids|glucocorticoids|mesh-ancestor
139403753|NCT00401011|Hormones|hormones|mesh-ancestor
139403754|NCT00401011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403755|NCT00401011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139403756|NCT00401011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403757|NCT01645930|Dexamethasone|dexamethasone|mesh-list
139403758|NCT01645930|Lenalidomide|lenalidomide|mesh-list
139403759|NCT01645930|Ixazomib|ixazomib|mesh-list
139403760|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403761|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
139403762|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
139403763|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403764|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403765|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138752295|NCT01123395|Colchicine|colchicine|mesh-list
139403766|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
139403767|NCT01645930|Hormones|hormones|mesh-ancestor
139403768|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403769|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139403770|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403771|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
139403772|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139403773|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139403774|NCT01645930|Growth Substances|growth substances|mesh-ancestor
139403775|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
139403776|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
139403777|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403778|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403779|NCT02190695|Carboplatin|carboplatin|mesh-list
139403780|NCT02190695|Decitabine|decitabine|mesh-list
139403781|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
139403782|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403783|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139403784|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
139403785|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403786|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651741|NCT00182767|Epothilone B|epothilone b|mesh-list
139403787|NCT00514267|Prednisone|prednisone|mesh-list
139403788|NCT00514267|Docetaxel|docetaxel|mesh-list
139403789|NCT00514267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403790|NCT00514267|Tubulin Modulators|tubulin modulators|mesh-ancestor
139403791|NCT00514267|Antimitotic Agents|antimitotic agents|mesh-ancestor
139403792|NCT00514267|Mitosis Modulators|mitosis modulators|mesh-ancestor
138752336|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403793|NCT00514267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403794|NCT00514267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403795|NCT00514267|Glucocorticoids|glucocorticoids|mesh-ancestor
139403796|NCT00514267|Hormones|hormones|mesh-ancestor
139403797|NCT00514267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403798|NCT00514267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403799|NCT00514267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139060614|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403800|NCT02384967|Darunavir|darunavir|mesh-list
139403801|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139403802|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139403803|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
139403804|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403805|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403807|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139403808|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
139403809|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403810|NCT02186249|Nivolumab|nivolumab|mesh-list
139403811|NCT02186249|Ipilimumab|ipilimumab|mesh-list
139403812|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139403813|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403814|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139403815|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403816|NCT00511459|Paclitaxel|paclitaxel|mesh-list
139403817|NCT00511459|Bevacizumab|bevacizumab|mesh-list
139403818|NCT00511459|Trebananib|trebananib|mesh-list
139403819|NCT00511459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139403820|NCT00511459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403821|NCT00511459|Tubulin Modulators|tubulin modulators|mesh-ancestor
139403822|NCT00511459|Antimitotic Agents|antimitotic agents|mesh-ancestor
139403823|NCT00511459|Mitosis Modulators|mitosis modulators|mesh-ancestor
139403824|NCT00511459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403825|NCT00511459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139403826|NCT00511459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139403827|NCT00511459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139403828|NCT00511459|Growth Substances|growth substances|mesh-ancestor
139403829|NCT00511459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403830|NCT00511459|Growth Inhibitors|growth inhibitors|mesh-ancestor
139403831|NCT02384889|Eflornithine|eflornithine|mesh-list
139403832|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403833|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139403834|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139403835|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139403836|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403837|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139403838|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403839|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403840|NCT02299336|Aflibercept|aflibercept|mesh-list
139403841|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139403842|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139403843|NCT02299336|Growth Substances|growth substances|mesh-ancestor
139403844|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403845|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
139403846|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403847|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
139403848|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139403849|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403850|NCT02186483|Metformin|metformin|mesh-list
139403851|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139403852|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139403853|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403854|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139403855|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139403856|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
139403857|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403858|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139403859|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139651742|NCT00182767|Epothilones|epothilones|mesh-list
139651743|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139403860|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403861|NCT02256605|Vitamin D|vitamin d|mesh-list
139403862|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
139403863|NCT02256605|Vitamins|vitamins|mesh-ancestor
139403864|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
139403865|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403866|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139403867|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139403868|NCT00393991|Fluticasone|fluticasone|mesh-list
139403869|NCT00393991|Xhance|xhance|mesh-list
139403870|NCT00393991|Formoterol Fumarate|formoterol fumarate|mesh-list
139403871|NCT00393991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403872|NCT00393991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139403873|NCT00393991|Autonomic Agents|autonomic agents|mesh-ancestor
139403874|NCT00393991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403875|NCT00393991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403876|NCT00393991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139403877|NCT00393991|Respiratory System Agents|respiratory system agents|mesh-ancestor
139403878|NCT00393991|Dermatologic Agents|dermatologic agents|mesh-ancestor
139403879|NCT00393991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139403880|NCT00393991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139403881|NCT00393991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139403882|NCT00393991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139403883|NCT00393991|Adrenergic Agents|adrenergic agents|mesh-ancestor
139403884|NCT00393991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403885|NCT00393991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403886|NCT02664441|Exenatide|exenatide|mesh-list
139403887|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139403888|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403889|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139403890|NCT02664441|Incretins|incretins|mesh-ancestor
139403891|NCT02664441|Hormones|hormones|mesh-ancestor
139403892|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403893|NCT02191007|Calcitriol|calcitriol|mesh-list
139403894|NCT02191007|Betamethasone|betamethasone|mesh-list
139403895|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
139403896|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139403897|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
139403898|NCT02191007|Calcipotriene|calcipotriene|mesh-list
139403899|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139403900|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139403901|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
139403902|NCT02191007|Hormones|hormones|mesh-ancestor
139403903|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403904|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403905|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139403906|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
139403907|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
139403908|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139403909|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139403910|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139403911|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403912|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139403913|NCT02191007|Vitamins|vitamins|mesh-ancestor
139403914|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
139403915|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139403916|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
139403917|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139403918|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
139403919|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403920|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139403921|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139403922|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
139403923|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403924|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403925|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139403926|NCT04470115|Anesthetics|anesthetics|mesh-list
139403927|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139403928|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403929|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
139403930|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139403931|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139403932|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651744|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403934|NCT02384343|Analgesics|analgesics|mesh-ancestor
139403935|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
139403936|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139403937|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139403938|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139403939|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139403940|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
139403941|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139403942|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403943|NCT05033639|Melatonin|melatonin|mesh-list
139403944|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
139403945|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403946|NCT05033639|Protective Agents|protective agents|mesh-ancestor
138752534|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
139403947|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403948|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139403949|NCT02328040|Insulin|insulin|mesh-list
139403950|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139403951|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139403952|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
139403953|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139403954|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403955|NCT02328040|Incretins|incretins|mesh-ancestor
139403956|NCT02328040|Hormones|hormones|mesh-ancestor
139403957|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139403958|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139403959|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
139403960|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403961|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403962|NCT00355849|Insulin|insulin|mesh-list
139403963|NCT00355849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139403964|NCT00355849|Insulin Glargine|insulin glargine|mesh-list
139403965|NCT00355849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139403966|NCT00355849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403967|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139403968|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
139403969|NCT02384499|Coagulants|coagulants|mesh-ancestor
139403970|NCT02186951|Amoxicillin|amoxicillin|mesh-list
139403971|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
139403972|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
139403973|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139403974|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403975|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403976|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403977|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139403978|NCT02285413|Cisplatin|cisplatin|mesh-list
139403979|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139403980|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139403981|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
139403982|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403983|NCT02187107|Darunavir|darunavir|mesh-list
139403984|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139403985|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139403986|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
139403987|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139403988|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139403989|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139403990|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139403991|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
139403992|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139403993|NCT02285491|Bupivacaine|bupivacaine|mesh-list
139403994|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
139403995|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
139403996|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139403997|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139403998|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
139403999|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404000|NCT02298868|Baclofen|baclofen|mesh-list
139404001|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139404002|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404003|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139404004|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404005|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139404006|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
139404007|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
139404008|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651745|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139404009|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404010|NCT02389179|Vitamin D|vitamin d|mesh-list
139404011|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
139404012|NCT02389179|Vitamins|vitamins|mesh-ancestor
139404013|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
139404014|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404015|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139404016|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139404017|NCT02285647|Rolapitant|rolapitant|mesh-list
139404018|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139404019|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404020|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404021|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404022|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139404023|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139404024|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404025|NCT02187497|Telmisartan|telmisartan|mesh-list
139404026|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139404027|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139404028|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139404029|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404030|NCT04195750|Everolimus|everolimus|mesh-list
139404031|NCT04195750|Belzutifan|belzutifan|mesh-list
139404032|NCT04195750|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139404033|NCT04195750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139404034|NCT04195750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404035|NCT04195750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404036|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139404037|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
139404038|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404039|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404040|NCT00099853|Pioglitazone|pioglitazone|mesh-list
139404041|NCT00099853|Vildagliptin|vildagliptin|mesh-list
139404042|NCT00099853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139404043|NCT00099853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404044|NCT00099853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139404045|NCT00099853|Protease Inhibitors|protease inhibitors|mesh-ancestor
139404046|NCT00099853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404047|NCT00099853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404048|NCT02381145|Resveratrol|resveratrol|mesh-list
139404049|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
139404050|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404051|NCT02381145|Protective Agents|protective agents|mesh-ancestor
139404052|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404053|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404054|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139404055|NCT00097357|Enoxaparin|enoxaparin|mesh-list
139404056|NCT00097357|Warfarin|warfarin|mesh-list
139404057|NCT00097357|Enoxaparin sodium|enoxaparin sodium|mesh-list
139404058|NCT00097357|Apixaban|apixaban|mesh-list
139404059|NCT00097357|Anticoagulants|anticoagulants|mesh-ancestor
139404060|NCT00097357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139404061|NCT00097357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139404062|NCT00097357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404063|NCT00097357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139404064|NCT00097357|Antithrombins|antithrombins|mesh-ancestor
139404065|NCT00097357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139404066|NCT00097357|Protease Inhibitors|protease inhibitors|mesh-ancestor
139404067|NCT00097357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404068|NCT02296840|Acetaminophen|acetaminophen|mesh-list
139404069|NCT02296840|Ibuprofen|ibuprofen|mesh-list
139404070|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139404071|NCT02296840|Hydrocodone|hydrocodone|mesh-list
139404072|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139404073|NCT02296840|Analgesics|analgesics|mesh-ancestor
139404074|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
139404075|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404076|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404077|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
139404078|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139404079|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139404080|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139404081|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139404082|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404083|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404084|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139404085|NCT02296840|Narcotics|narcotics|mesh-ancestor
139404086|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139404087|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
139404088|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
139404090|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139404091|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139404092|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404093|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752646|NCT01207440|Ponatinib|ponatinib|mesh-list
139404094|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
139404095|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404096|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139404097|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139404098|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139404099|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139404100|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139404101|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139404102|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404103|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139404104|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404105|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404106|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
139404107|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
139404108|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
139404109|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139404110|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139404111|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404112|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404113|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404114|NCT00326287|Ceftriaxone|ceftriaxone|mesh-list
139404115|NCT00326287|Linezolid|linezolid|mesh-list
139404116|NCT00326287|Ceftobiprole|ceftobiprole|mesh-list
139404117|NCT00326287|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
139404118|NCT00326287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139404119|NCT00326287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404120|NCT00326287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139404121|NCT00326287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404122|NCT00326287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404123|NCT02191943|Fluorides|fluorides|mesh-list
139404124|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
139404125|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
139404126|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
139404127|NCT02191943|Protective Agents|protective agents|mesh-ancestor
139404128|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404129|NCT02663895|Treprostinil|treprostinil|mesh-list
139404130|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139404131|NCT00320203|Hydrocortisone|hydrocortisone|mesh-list
139404132|NCT00320203|Anecortave|anecortave|mesh-list
139404133|NCT00320203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139404134|NCT00320203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139404135|NCT00320203|Growth Substances|growth substances|mesh-ancestor
139404136|NCT00320203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404137|NCT00320203|Growth Inhibitors|growth inhibitors|mesh-ancestor
139404138|NCT00320203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404139|NCT00320203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139404140|NCT00071461|Bosentan|bosentan|mesh-list
139404141|NCT00071461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139404142|NCT00071461|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139404143|NCT00071461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404144|NCT00069745|Prednisone|prednisone|mesh-list
139404145|NCT00069745|Satraplatin|satraplatin|mesh-list
139404146|NCT00069745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139404147|NCT00069745|Glucocorticoids|glucocorticoids|mesh-ancestor
139404148|NCT00069745|Hormones|hormones|mesh-ancestor
139404149|NCT00069745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139404150|NCT00069745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404151|NCT00069745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139404152|NCT00069745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404153|NCT02192411|Lidocaine|lidocaine|mesh-list
139404154|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
139651746|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139651747|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404155|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
139404156|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139404157|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404158|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
139404159|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404160|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139404161|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139404162|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139404163|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139404164|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404165|NCT02193893|Coal Tar|coal tar|mesh-list
139404166|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
139404167|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
139404168|NCT02384187|Gabapentin|gabapentin|mesh-list
139404169|NCT02384187|Analgesics|analgesics|mesh-ancestor
139404170|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
139404171|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404172|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404173|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
139404174|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139404175|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139404176|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060989|NCT01130662|Decitabine|decitabine|mesh-list
139404177|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139404178|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139404179|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139404180|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404181|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404182|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
139404183|NCT02192723|Olanzapine|olanzapine|mesh-list
139404184|NCT02192723|Risperidone|risperidone|mesh-list
139404185|NCT02192723|Aripiprazole|aripiprazole|mesh-list
139404186|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139404187|NCT02192723|Ziprasidone|ziprasidone|mesh-list
139404188|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
139404189|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139404190|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
139404191|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404192|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404193|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404194|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139404195|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139404196|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139404197|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139404198|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
139404199|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
139404200|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
139404201|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404202|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139404203|NCT02192723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139404204|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139404205|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139404206|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
139404207|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
139404208|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139404209|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139404210|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139404211|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139404212|NCT00319969|Topotecan|topotecan|mesh-list
139404213|NCT00319969|Amrubicin|amrubicin|mesh-list
139404214|NCT00319969|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139404215|NCT00319969|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139404216|NCT00319969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404217|NCT00319969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404218|NCT00319969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404219|NCT00317395|Heparin|heparin|mesh-list
139404220|NCT00317395|Calcium heparin|calcium heparin|mesh-list
139404221|NCT00317395|Otamixaban|otamixaban|mesh-list
139404222|NCT00317395|Eptifibatide|eptifibatide|mesh-list
139404223|NCT00317395|Anticoagulants|anticoagulants|mesh-ancestor
139404224|NCT00317395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139404225|NCT00317395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139404226|NCT00317395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651748|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140067|NCT02061124|Sevelamer|sevelamer|mesh-list
139404227|NCT00317395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139404228|NCT00317395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139404230|NCT00317395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139404231|NCT00317395|Protease Inhibitors|protease inhibitors|mesh-ancestor
139404232|NCT00317395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404233|NCT02383563|Metformin|metformin|mesh-list
139404234|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139404235|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404236|NCT03535961|Etoposide|etoposide|mesh-list
139404237|NCT03535961|Apatinib|apatinib|mesh-list
139404238|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139404239|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404240|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139404241|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139404242|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404243|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404244|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139404245|NCT02380755|Clomiphene|clomiphene|mesh-list
139404246|NCT02380755|Enclomiphene|enclomiphene|mesh-list
139404247|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
139404248|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139404249|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
139404250|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139404251|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404252|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139404253|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
138752794|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139404254|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139404255|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139404256|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139404257|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
139404258|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139404259|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139404260|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139404261|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139404262|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139404263|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404264|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
139404265|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404266|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404267|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139404268|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404269|NCT02380521|Exenatide|exenatide|mesh-list
139404270|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139404271|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404272|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139404273|NCT02380521|Incretins|incretins|mesh-ancestor
139404274|NCT02380521|Hormones|hormones|mesh-ancestor
139404275|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139404276|NCT00315757|Bortezomib|bortezomib|mesh-list
139404277|NCT00315757|Mapatumumab|mapatumumab|mesh-list
139404278|NCT00315757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139404279|NCT00315757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404280|NCT00315757|Immunologic Factors|immunologic factors|mesh-ancestor
139404281|NCT00315757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404282|NCT02377401|Zanamivir|zanamivir|mesh-list
139404283|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
139404284|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404285|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404286|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404287|NCT00312091|Lamivudine|lamivudine|mesh-list
139404288|NCT00312091|Nevirapine|nevirapine|mesh-list
139404289|NCT00312091|Stavudine|stavudine|mesh-list
139404290|NCT00312091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139404291|NCT00312091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139404292|NCT00312091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404293|NCT00312091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404294|NCT00312091|Antiviral Agents|antiviral agents|mesh-ancestor
139404295|NCT00312091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404296|NCT00312091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139404297|NCT00312091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139404298|NCT00312091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139404299|NCT00312091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139404300|NCT00312091|Antimetabolites|antimetabolites|mesh-ancestor
139404301|NCT00389779|Guanfacine|guanfacine|mesh-list
139404302|NCT00389779|Darusentan|darusentan|mesh-list
139651749|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
139404303|NCT00389779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139404304|NCT00389779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139404305|NCT00389779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139404306|NCT00389779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139404307|NCT00389779|Adrenergic Agents|adrenergic agents|mesh-ancestor
139404308|NCT00389779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404309|NCT00389779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404310|NCT00389779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404311|NCT00389779|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139404312|NCT00389155|Gemcitabine|gemcitabine|mesh-list
139404313|NCT00389155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139404314|NCT00389155|Antimetabolites|antimetabolites|mesh-ancestor
139404315|NCT00389155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404316|NCT00389155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404317|NCT02188511|Nicotine|nicotine|mesh-list
139404318|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139404319|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
139404320|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404321|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404322|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139404323|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139404324|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
139404325|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404326|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061141|NCT01134484|Bortezomib|bortezomib|mesh-list
139404327|NCT02380131|Capecitabine|capecitabine|mesh-list
139404328|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
139404329|NCT02380131|Trastuzumab|trastuzumab|mesh-list
139404330|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139404331|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
139404332|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404333|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752889|NCT02888990|Dasatinib|dasatinib|mesh-list
139404334|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139404335|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139404336|NCT03535103|Hormones|hormones|mesh-ancestor
139404337|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139404338|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404339|NCT04551365|Chitosan|chitosan|mesh-list
139404340|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139404341|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139404342|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
139404343|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404344|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139404345|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
139404346|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
139404347|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
139404348|NCT04551365|Coagulants|coagulants|mesh-ancestor
139404349|NCT00028639|Bortezomib|bortezomib|mesh-list
139404350|NCT00028639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404351|NCT00298987|Dasatinib|dasatinib|mesh-list
139404352|NCT00298987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404353|NCT00298987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139404354|NCT00298987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404355|NCT00298987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404356|NCT02380053|Celiprolol|celiprolol|mesh-list
139404357|NCT02380053|Bisoprolol|bisoprolol|mesh-list
139404358|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139404359|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
139404360|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
139404361|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404362|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404363|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139404364|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139404365|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139404366|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
139404367|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404368|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404369|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139651750|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
139651751|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
139651752|NCT01533597|Tamsulosin|tamsulosin|mesh-list
139651753|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
139651754|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139651755|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139404371|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
139404372|NCT02371707|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
139404373|NCT02371707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139404374|NCT02371707|Serotonin Agents|serotonin agents|mesh-ancestor
139404375|NCT02371707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404376|NCT02371707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404377|NCT02371707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404378|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139404379|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139404380|NCT00004915|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139404381|NCT00004915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139404382|NCT00004915|Hormone Antagonists|hormone antagonists|mesh-ancestor
139404383|NCT00004915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139404384|NCT00004915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404385|NCT00004915|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139404386|NCT00004915|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139404387|NCT00004915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139404388|NCT03535415|Hormones|hormones|mesh-list
139404389|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139404390|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404391|NCT02030717|Clonidine|clonidine|mesh-list
139404392|NCT02030717|Anesthetics|anesthetics|mesh-list
139404393|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139404394|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404395|NCT02030717|Analgesics|analgesics|mesh-ancestor
139404396|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
139404397|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404398|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139404399|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
139404400|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
139404401|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139404402|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139404403|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139404404|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
139404405|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404406|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404407|NCT02371473|Acetazolamide|acetazolamide|mesh-list
139404408|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
139404409|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139404410|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404411|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404412|NCT02371473|Diuretics|diuretics|mesh-ancestor
139404413|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
139404414|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404415|NCT04301661|Tenofovir|tenofovir|mesh-list
139404416|NCT04301661|Lamivudine|lamivudine|mesh-list
139404417|NCT04301661|Emtricitabine|emtricitabine|mesh-list
139404418|NCT04301661|Abacavir|abacavir|mesh-list
139404419|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
139404420|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404421|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138551247|NCT00424086|Vaccines|vaccines|mesh-list
139404422|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139404423|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404424|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404425|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139404426|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139404427|NCT02194049|Etoposide|etoposide|mesh-list
139404428|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
139404429|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404430|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139404431|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139404432|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139404433|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404434|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404435|NCT02379663|Enoxaparin|enoxaparin|mesh-list
139404436|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
139404437|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139404438|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
139404439|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139404440|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
139404441|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909145|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
139651756|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139404442|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404443|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
139404444|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139404445|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139404446|NCT02030639|ON 01910|on 01910|mesh-list
139404447|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404448|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139404449|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404450|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404451|NCT00004897|Leucovorin|leucovorin|mesh-list
139404452|NCT00004897|Interferons|interferons|mesh-list
139404453|NCT00004897|Interferon-alpha|interferon-alpha|mesh-list
139404454|NCT00004897|Fluorouracil|fluorouracil|mesh-list
139404455|NCT00004897|Hydroxyurea|hydroxyurea|mesh-list
139404456|NCT00004897|Calcium|calcium|mesh-list
139404457|NCT00004897|Levoleucovorin|levoleucovorin|mesh-list
139404458|NCT00004897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404459|NCT00004897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139404460|NCT00004897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404461|NCT00004897|Antimetabolites|antimetabolites|mesh-ancestor
139404462|NCT00004897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404463|NCT00004897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139404464|NCT00004897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139404465|NCT00004897|Immunologic Factors|immunologic factors|mesh-ancestor
139404466|NCT00004897|Antiviral Agents|antiviral agents|mesh-ancestor
139404467|NCT00004897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404468|NCT00004897|Antidotes|antidotes|mesh-ancestor
139404469|NCT00004897|Protective Agents|protective agents|mesh-ancestor
139404470|NCT00004897|Vitamin B Complex|vitamin b complex|mesh-ancestor
139404471|NCT00004897|Vitamins|vitamins|mesh-ancestor
139404472|NCT00004897|Micronutrients|micronutrients|mesh-ancestor
139404473|NCT00004897|Antisickling Agents|antisickling agents|mesh-ancestor
139404474|NCT00004897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404475|NCT00004897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139404476|NCT00004231|Leucovorin|leucovorin|mesh-list
139404477|NCT00004231|Interferons|interferons|mesh-list
139404478|NCT00004231|Cytarabine|cytarabine|mesh-list
139404479|NCT00004231|Interferon-alpha|interferon-alpha|mesh-list
139404480|NCT00004231|Aldesleukin|aldesleukin|mesh-list
139404481|NCT00004231|Prednisone|prednisone|mesh-list
139404482|NCT00004231|Cyclophosphamide|cyclophosphamide|mesh-list
139404483|NCT00004231|Busulfan|busulfan|mesh-list
139404484|NCT00004231|Doxorubicin|doxorubicin|mesh-list
139404485|NCT00004231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139404486|NCT00004231|Methotrexate|methotrexate|mesh-list
139404487|NCT00004231|Vincristine|vincristine|mesh-list
139404488|NCT00004231|Teniposide|teniposide|mesh-list
139404489|NCT00004231|Levoleucovorin|levoleucovorin|mesh-list
139404490|NCT00004231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139404491|NCT00004231|Immunologic Factors|immunologic factors|mesh-ancestor
139404492|NCT00004231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404493|NCT00004231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139404494|NCT00004231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139404495|NCT00004231|Alkylating Agents|alkylating agents|mesh-ancestor
139404496|NCT00004231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404497|NCT00004231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404498|NCT00004231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139404499|NCT00004231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139404500|NCT00004231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139404501|NCT00004231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139404502|NCT00004231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404503|NCT00004231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138753047|NCT00980980|Mupirocin|mupirocin|mesh-list
139404504|NCT00004231|Glucocorticoids|glucocorticoids|mesh-ancestor
139404505|NCT00004231|Hormones|hormones|mesh-ancestor
139404506|NCT00004231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139404507|NCT00004231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139404508|NCT00004231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139404509|NCT00004231|Abortifacient Agents|abortifacient agents|mesh-ancestor
139404510|NCT00004231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139404511|NCT00004231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139404512|NCT00004231|Antimetabolites|antimetabolites|mesh-ancestor
139404513|NCT00004231|Dermatologic Agents|dermatologic agents|mesh-ancestor
139404514|NCT00004231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139404515|NCT00004231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139404516|NCT00004231|Antiviral Agents|antiviral agents|mesh-ancestor
139404517|NCT00004231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404518|NCT00004231|Antidotes|antidotes|mesh-ancestor
139404519|NCT00004231|Protective Agents|protective agents|mesh-ancestor
139651757|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
139404520|NCT00004231|Vitamin B Complex|vitamin b complex|mesh-ancestor
139404522|NCT00004231|Micronutrients|micronutrients|mesh-ancestor
139404523|NCT00004231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139404524|NCT00004231|Tubulin Modulators|tubulin modulators|mesh-ancestor
139404525|NCT00004231|Antimitotic Agents|antimitotic agents|mesh-ancestor
139404526|NCT00004231|Mitosis Modulators|mitosis modulators|mesh-ancestor
139404527|NCT00004231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139404528|NCT00004231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139404529|NCT00004171|Cyclophosphamide|cyclophosphamide|mesh-list
139404530|NCT00004171|Busulfan|busulfan|mesh-list
139404531|NCT00004171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139404532|NCT00004171|Immunologic Factors|immunologic factors|mesh-ancestor
139404533|NCT00004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404534|NCT00004171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139404535|NCT00004171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139404536|NCT00004171|Alkylating Agents|alkylating agents|mesh-ancestor
139404537|NCT00004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404538|NCT00004171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404539|NCT00004171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139404540|NCT00004165|Melphalan|melphalan|mesh-list
139404541|NCT00004165|Immunologic Factors|immunologic factors|mesh-ancestor
139404542|NCT00004165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404543|NCT00004165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139404544|NCT00004165|Alkylating Agents|alkylating agents|mesh-ancestor
139404545|NCT00004165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404546|NCT00004165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404547|NCT00004165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139404548|NCT00004165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139404549|NCT00004093|Paclitaxel|paclitaxel|mesh-list
139404550|NCT00004093|Vinorelbine|vinorelbine|mesh-list
139404551|NCT00004093|Carboplatin|carboplatin|mesh-list
139404552|NCT00004093|Gemcitabine|gemcitabine|mesh-list
139404553|NCT00004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139404554|NCT00004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404555|NCT00004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
139404556|NCT00004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
139404557|NCT00004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
139404558|NCT00004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404559|NCT00004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139404560|NCT00004093|Antimetabolites|antimetabolites|mesh-ancestor
139404561|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139404562|NCT02193269|Minocycline|minocycline|mesh-list
139404563|NCT02193269|Tetracycline|tetracycline|mesh-list
139404564|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404565|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139404566|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404567|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404568|NCT00002479|Tretinoin|tretinoin|mesh-list
139404569|NCT00002479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404570|NCT00002479|Keratolytic Agents|keratolytic agents|mesh-ancestor
139404571|NCT00002479|Dermatologic Agents|dermatologic agents|mesh-ancestor
139404572|NCT00002371|Lamivudine|lamivudine|mesh-list
139404573|NCT00002371|Zidovudine|zidovudine|mesh-list
139404574|NCT00002371|Stavudine|stavudine|mesh-list
139404575|NCT00002371|Indinavir|indinavir|mesh-list
139404576|NCT00002371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139404577|NCT00002371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139404578|NCT00002371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404579|NCT00002371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404580|NCT00002371|Antiviral Agents|antiviral agents|mesh-ancestor
139404581|NCT00002371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404582|NCT00002371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139404583|NCT00002371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139404584|NCT00002371|Antimetabolites|antimetabolites|mesh-ancestor
139404585|NCT00002371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139404586|NCT00002371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139404587|NCT00002371|Protease Inhibitors|protease inhibitors|mesh-ancestor
139404588|NCT02189681|Anesthetics|anesthetics|mesh-list
139404589|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139404590|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404591|NCT05715385|Bromfenac|bromfenac|mesh-list
139404592|NCT05715385|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139404593|NCT05715385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139404594|NCT05715385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139404595|NCT05715385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139404596|NCT05715385|Analgesics|analgesics|mesh-ancestor
139404597|NCT05715385|Sensory System Agents|sensory system agents|mesh-ancestor
139404598|NCT05715385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404599|NCT05715385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404600|NCT05715385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139404601|NCT05715385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139404602|NCT04182633|Vancomycin|vancomycin|mesh-list
139404603|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139404604|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139404605|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404606|NCT04182633|Laxatives|laxatives|mesh-ancestor
139404607|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139404608|NCT02194283|Ambroxol|ambroxol|mesh-list
139404609|NCT02194283|Expectorants|expectorants|mesh-ancestor
139404610|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
139404611|NCT00263341|Contraceptive Agents|contraceptive agents|mesh-list
139404612|NCT00263341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139404613|NCT00263341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139404614|NCT00263341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404615|NCT00263341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139404616|NCT00263341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139404617|NCT00263341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139404618|NCT00263341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139404619|NCT00263341|Estrogens|estrogens|mesh-ancestor
139404620|NCT00263341|Hormones|hormones|mesh-ancestor
139404621|NCT00263341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139404622|NCT03534869|Analgesics|analgesics|mesh-list
139404623|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
139404624|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404625|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404626|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
139404627|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404628|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139404629|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
139404630|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
139404631|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139404632|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139404633|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404634|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404635|NCT02378649|Urological Agents|urological agents|mesh-ancestor
139404636|NCT02197169|Interferons|interferons|mesh-list
139404637|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
139404638|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404639|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
139404640|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404641|NCT02376309|Nandrolone|nandrolone|mesh-list
138753155|NCT01257698|Timolol|timolol|mesh-list
139404642|NCT02376309|Androgens|androgens|mesh-ancestor
139404643|NCT02376309|Hormones|hormones|mesh-ancestor
139404644|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139404645|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404646|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
139404647|NCT00232141|Pregabalin|pregabalin|mesh-list
139404648|NCT00232141|Analgesics|analgesics|mesh-ancestor
139404649|NCT00232141|Sensory System Agents|sensory system agents|mesh-ancestor
139404650|NCT00232141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404651|NCT00232141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404652|NCT00232141|Anticonvulsants|anticonvulsants|mesh-ancestor
139404653|NCT00232141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139404654|NCT00232141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139404655|NCT00232141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404656|NCT00232141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139404657|NCT00232141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139404658|NCT00232141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139404659|NCT00232141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139404660|NCT00232141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139404661|NCT02378415|Ketamine|ketamine|mesh-list
139404662|NCT02378415|Analgesics|analgesics|mesh-ancestor
139404663|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
139404664|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404665|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404666|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139404667|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139404668|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
139404669|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
139404670|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139404671|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139404672|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139404673|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404674|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404675|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
139404677|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139404678|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139404679|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404680|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139404681|NCT02197403|Analgesics|analgesics|mesh-ancestor
139404682|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
139404683|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404684|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139404685|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139404686|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139404687|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
139404688|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404689|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404690|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139404691|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
139404692|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
139404693|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139404694|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
139404695|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404696|NCT02376075|Linagliptin|linagliptin|mesh-list
138753179|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
139404697|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139404698|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404699|NCT02376075|Incretins|incretins|mesh-ancestor
139404700|NCT02376075|Hormones|hormones|mesh-ancestor
139404701|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139404702|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139404703|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
139404704|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404705|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404706|NCT02197637|Vinorelbine|vinorelbine|mesh-list
139404707|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139404708|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404709|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
139404710|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
139404711|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
139404712|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404713|NCT04469413|Acetaminophen|acetaminophen|mesh-list
139404714|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139404715|NCT04469413|Analgesics|analgesics|mesh-ancestor
139404716|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
139404717|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404718|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404719|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
139404720|NCT03532087|Denosumab|denosumab|mesh-list
139404721|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139404722|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404723|NCT02288923|Acetaminophen|acetaminophen|mesh-list
139404724|NCT02288923|Ibuprofen|ibuprofen|mesh-list
139404725|NCT02288923|Morphine|morphine|mesh-list
139404726|NCT02288923|Antiemetics|antiemetics|mesh-list
139404727|NCT02288923|Anesthetics|anesthetics|mesh-list
139404728|NCT02288923|Emetics|emetics|mesh-list
139404729|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139404730|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404731|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139404732|NCT02288923|Narcotics|narcotics|mesh-ancestor
139404733|NCT02288923|Analgesics|analgesics|mesh-ancestor
139404734|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
139404735|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404736|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139404737|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139404738|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139404739|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139404740|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139404741|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753219|NCT01204398|Amlodipine|amlodipine|mesh-list
139404742|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404743|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
139651758|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404744|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
139140078|NCT03560440|Vancomycin|vancomycin|mesh-list
139651759|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404745|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139404746|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139404747|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139404748|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
139404749|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404750|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404751|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139404752|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
139404753|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
139404755|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139404756|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
139404757|NCT03531931|Apatinib|apatinib|mesh-list
139404758|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404759|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139404760|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404761|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404762|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139404763|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139404764|NCT02369133|Acetaminophen|acetaminophen|mesh-list
139404765|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139404766|NCT02369133|Analgesics|analgesics|mesh-ancestor
139404767|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
139404768|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404769|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404770|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
139404771|NCT02377635|Selenious Acid|selenious acid|mesh-list
139404772|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
139404773|NCT02377635|Trace Elements|trace elements|mesh-ancestor
139404774|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
139404775|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404776|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
139404777|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
139404778|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404779|NCT02198027|Bupivacaine|bupivacaine|mesh-list
139404780|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
139404781|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
139404782|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139404783|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404784|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
139404785|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404786|NCT02257463|Theophylline|theophylline|mesh-list
139404787|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
139404788|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
139404789|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404790|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404791|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139404792|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
139404793|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404794|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404795|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139404796|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404797|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
139404798|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139404799|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139404800|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
139404801|NCT02198261|Minoxidil|minoxidil|mesh-list
139404802|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139404803|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
139404804|NCT03533699|Propranolol|propranolol|mesh-list
139404805|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139404806|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139404807|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
139404808|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404809|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404810|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753325|NCT01203072|Edoxaban|edoxaban|mesh-list
139404811|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139404812|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139404813|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
139404814|NCT00135421|Escitalopram|escitalopram|mesh-list
139404815|NCT00135421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139404816|NCT00135421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139404817|NCT00135421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139404818|NCT00135421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404819|NCT00135421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404821|NCT00135421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404822|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
139404823|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139404824|NCT02200991|Lixisenatide|lixisenatide|mesh-list
139404825|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139404826|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404827|NCT02200991|Incretins|incretins|mesh-ancestor
139404828|NCT02200991|Hormones|hormones|mesh-ancestor
139404829|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139404830|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139404831|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
139404832|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404833|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404834|NCT02368743|Mesalamine|mesalamine|mesh-list
139404835|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139404836|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139404837|NCT02368743|Analgesics|analgesics|mesh-ancestor
139404838|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
139404839|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404840|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404841|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139404842|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139404843|NCT00135343|Ritonavir|ritonavir|mesh-list
139404844|NCT00135343|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139404845|NCT00135343|Efavirenz|efavirenz|mesh-list
139404846|NCT00135343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139404847|NCT00135343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139404848|NCT00135343|Protease Inhibitors|protease inhibitors|mesh-ancestor
139404849|NCT00135343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404850|NCT00135343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404851|NCT00135343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139404852|NCT00135343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139404853|NCT00135343|Antiviral Agents|antiviral agents|mesh-ancestor
139404854|NCT00135343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404855|NCT00135343|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139404856|NCT00135343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139404857|NCT00135343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139404858|NCT00135343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139404859|NCT00135343|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139404860|NCT00135343|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139404861|NCT00135343|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139404862|NCT00135343|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139404863|NCT00135343|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139404864|NCT02201225|Micronutrients|micronutrients|mesh-list
139404865|NCT02201225|Trace Elements|trace elements|mesh-list
139404866|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404867|NCT02365155|Vitamin D|vitamin d|mesh-list
139404868|NCT02365155|Vitamins|vitamins|mesh-ancestor
139404869|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
139404870|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404871|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139404872|NCT05724745|Albuterol|albuterol|mesh-list
139404873|NCT05724745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139404874|NCT05724745|Autonomic Agents|autonomic agents|mesh-ancestor
139404875|NCT05724745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404876|NCT05724745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404877|NCT05724745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139404878|NCT05724745|Respiratory System Agents|respiratory system agents|mesh-ancestor
139404879|NCT05724745|Tocolytic Agents|tocolytic agents|mesh-ancestor
139404880|NCT05724745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139404881|NCT05724745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139404882|NCT05724745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139404883|NCT05724745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139404884|NCT05724745|Adrenergic Agents|adrenergic agents|mesh-ancestor
139404885|NCT05724745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404886|NCT05724745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404887|NCT02198339|Olcegepant|olcegepant|mesh-list
139404888|NCT02198339|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139404889|NCT02198339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404890|NCT02198339|Analgesics|analgesics|mesh-ancestor
139404891|NCT02198339|Sensory System Agents|sensory system agents|mesh-ancestor
139404892|NCT02198339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404893|NCT02198339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404894|NCT02198807|Piperaquine|piperaquine|mesh-list
139404895|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
139404896|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
139404897|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139404898|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139404899|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404900|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139404901|NCT02198417|Metformin|metformin|mesh-list
139404902|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139404903|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404904|NCT02201459|Interferons|interferons|mesh-list
139404905|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
139404906|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
139404907|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139404908|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404909|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
139404910|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404911|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
139404912|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404913|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139404914|NCT02198495|Hematinics|hematinics|mesh-ancestor
139404915|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139404916|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
139404917|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139404918|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
139404919|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404920|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
139404921|NCT02375217|Neostigmine|neostigmine|mesh-list
139404922|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139404923|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404924|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404925|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
139404926|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404927|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404928|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139404929|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
139404930|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404931|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139404932|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139404933|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139404934|NCT02206295|Selexipag|selexipag|mesh-list
139404935|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139404936|NCT02375139|Metformin|metformin|mesh-list
139404937|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139404938|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404939|NCT02202005|Nevirapine|nevirapine|mesh-list
139404940|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139404941|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139404942|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404943|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753477|NCT01109979|Estradiol|estradiol|mesh-list
139404944|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
139404945|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139404946|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139404947|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139404948|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139404949|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139404950|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139404951|NCT02741245|Ezetimibe|ezetimibe|mesh-list
139404952|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139404953|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139404954|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
139404955|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404956|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139404957|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139404958|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139404959|NCT02202239|Midazolam|midazolam|mesh-list
139404960|NCT02202239|Fentanyl|fentanyl|mesh-list
139404961|NCT02202239|Remifentanil|remifentanil|mesh-list
139404962|NCT02202239|Propofol|propofol|mesh-list
139404963|NCT02202239|Etomidate|etomidate|mesh-list
139404964|NCT02202239|Sevoflurane|sevoflurane|mesh-list
139651760|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404965|NCT02202239|Cisatracurium|cisatracurium|mesh-list
139404966|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139404967|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139404968|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139404969|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139404970|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
139404971|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
139404972|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139404973|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139404974|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139404975|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139404976|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
139404977|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
139404978|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139404979|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404980|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139404981|NCT02202239|Narcotics|narcotics|mesh-ancestor
139404982|NCT02202239|Analgesics|analgesics|mesh-ancestor
139404983|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
139404984|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139404985|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139404986|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139404987|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139404988|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139404990|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139404991|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139404992|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
139404993|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
139404994|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
139404995|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139404996|NCT02364765|Remifentanil|remifentanil|mesh-list
139404997|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139404998|NCT02364765|Narcotics|narcotics|mesh-ancestor
139404999|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405000|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405001|NCT02364765|Analgesics|analgesics|mesh-ancestor
139405002|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
139405003|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405004|NCT04547049|Cytarabine|cytarabine|mesh-list
139405005|NCT04547049|Cyclosporine|cyclosporine|mesh-list
139405006|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
139405007|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
139405008|NCT04547049|Busulfan|busulfan|mesh-list
139405009|NCT04547049|Cyclosporins|cyclosporins|mesh-list
139405010|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139405011|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
139405012|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139405013|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
139405014|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405015|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139405016|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139405017|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
139405018|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405019|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405020|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139405021|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139405023|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
139405024|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405025|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405026|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
139405027|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
139405028|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139405029|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139405030|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139405031|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
139405032|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139405033|NCT05647291|Methylprednisolone|methylprednisolone|mesh-list
139405034|NCT05647291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139405035|NCT05647291|Antiemetics|antiemetics|mesh-ancestor
139405036|NCT05647291|Autonomic Agents|autonomic agents|mesh-ancestor
139405037|NCT05647291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405038|NCT05647291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405039|NCT05647291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139405040|NCT05647291|Glucocorticoids|glucocorticoids|mesh-ancestor
139405041|NCT05647291|Hormones|hormones|mesh-ancestor
138753578|NCT01108341|Ofatumumab|ofatumumab|mesh-list
139405042|NCT05647291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139405043|NCT05647291|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139405044|NCT05647291|Protective Agents|protective agents|mesh-ancestor
139405045|NCT03105765|Ketamine|ketamine|mesh-list
139405046|NCT03105765|Analgesics|analgesics|mesh-ancestor
139405047|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
139405048|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405049|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405050|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139405051|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139405052|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
139405053|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
139405054|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405055|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139405056|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139405057|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139405058|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405059|NCT02202473|Lamivudine|lamivudine|mesh-list
139405060|NCT02202473|Oxymatrine|oxymatrine|mesh-list
139405061|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139405062|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139405063|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405064|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405065|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
139405066|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405067|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139405068|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139405069|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139405070|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
139405071|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405072|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139405073|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405074|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405075|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
139405076|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139405077|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405078|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139405079|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139405080|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
139405081|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405082|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139405083|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061890|NCT01763866|Ezetimibe|ezetimibe|mesh-list
139405084|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405085|NCT02202707|Gabapentin|gabapentin|mesh-list
139405086|NCT02202707|Analgesics|analgesics|mesh-ancestor
139405087|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
139405088|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405089|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405090|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
139405091|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139405092|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139405093|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405094|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139405095|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139405096|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139405097|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139405098|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405099|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
139405100|NCT02367807|Tenofovir|tenofovir|mesh-list
139405101|NCT02367807|Emtricitabine|emtricitabine|mesh-list
139405102|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
139405103|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405104|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139405105|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139405106|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405107|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405108|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139405109|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139405110|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
139405111|NCT02364609|Afatinib|afatinib|mesh-list
139405112|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139405113|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405114|NCT02364609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139405115|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651761|NCT01533597|Urological Agents|urological agents|mesh-ancestor
139405116|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139405118|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
139405119|NCT02364453|Growth Substances|growth substances|mesh-ancestor
139405120|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405121|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
139405122|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753656|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139405123|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405124|NCT02258009|Ranibizumab|ranibizumab|mesh-list
139405125|NCT02258009|Aflibercept|aflibercept|mesh-list
139405126|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139405127|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139405128|NCT02258009|Growth Substances|growth substances|mesh-ancestor
139405129|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405130|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
139405131|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405132|NCT02203097|Propofol|propofol|mesh-list
139405133|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139405134|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405135|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405136|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139405137|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
139405138|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
139405139|NCT04439487|Anesthetics|anesthetics|mesh-list
139405140|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405141|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405142|NCT03528967|Aspirin|aspirin|mesh-list
139405143|NCT03528967|Enoxaparin|enoxaparin|mesh-list
139405144|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139405145|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139405146|NCT03528967|Analgesics|analgesics|mesh-ancestor
139405147|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
139405148|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405149|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405150|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139405151|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139405152|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139405153|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139405154|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405155|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139405156|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139405157|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405159|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
139405160|NCT02363985|Vitamin A|vitamin a|mesh-list
139405161|NCT02363985|Vitamins|vitamins|mesh-ancestor
139405162|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
139405163|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405164|NCT05723731|Laxatives|laxatives|mesh-list
139405165|NCT05723731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139405166|NCT02363829|Nelfinavir|nelfinavir|mesh-list
139405167|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139405168|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139405169|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
139405170|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405171|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405172|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139405173|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139405174|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
139405175|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405176|NCT03113019|Immunomodulating Agents|immunomodulating agents|mesh-list
139405177|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
139405178|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405179|NCT02363751|Bevacizumab|bevacizumab|mesh-list
139405180|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139405181|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405182|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139405183|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139405184|NCT02363751|Growth Substances|growth substances|mesh-ancestor
139405185|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405186|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
139405187|NCT03527251|Ipilimumab|ipilimumab|mesh-list
139405188|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139405189|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651762|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139405190|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139405191|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405192|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
139405193|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
139405194|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405195|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
139405196|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
139405197|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
139405198|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405199|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405200|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
139405201|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405202|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
139405203|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405204|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139405205|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405206|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405207|NCT04594915|Edoxaban|edoxaban|mesh-list
139405208|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139405209|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
139405210|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139405211|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
139405212|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405213|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405214|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
139405215|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
139405216|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139405217|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
139405218|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139405219|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
139405220|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405221|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405222|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
139405223|NCT02366949|Paclitaxel|paclitaxel|mesh-list
138753737|NCT01251146|Atenolol|atenolol|mesh-list
139405224|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139405225|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405226|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
139405227|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
139405228|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
139405229|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405230|NCT03532919|Cystatins|cystatins|mesh-list
139405231|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139405232|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
139405233|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405234|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405235|NCT05503225|Colchicine|colchicine|mesh-list
139405236|NCT05503225|Gout Suppressants|gout suppressants|mesh-ancestor
139405237|NCT05503225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139405238|NCT05503225|Tubulin Modulators|tubulin modulators|mesh-ancestor
139405239|NCT05503225|Antimitotic Agents|antimitotic agents|mesh-ancestor
139405240|NCT05503225|Mitosis Modulators|mitosis modulators|mesh-ancestor
139405241|NCT05503225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405242|NCT05503225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405243|NCT02203175|Fentanyl|fentanyl|mesh-list
139405244|NCT02203175|Propofol|propofol|mesh-list
139405245|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139405246|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405247|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405248|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139405249|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
139405250|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
139405251|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139405252|NCT02203175|Narcotics|narcotics|mesh-ancestor
139405253|NCT02203175|Analgesics|analgesics|mesh-ancestor
139405254|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
139405255|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405256|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139405257|NCT05791799|Etonogestrel|etonogestrel|mesh-list
139405258|NCT05791799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139405259|NCT05791799|Contraceptive Agents|contraceptive agents|mesh-ancestor
139405260|NCT05791799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139405261|NCT05791799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405262|NCT05791799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139405263|NCT05791721|Dexamethasone|dexamethasone|mesh-list
139651763|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139405264|NCT05791721|Etoricoxib|etoricoxib|mesh-list
139651764|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
139405265|NCT05791721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138753765|NCT01096017|Albuterol|albuterol|mesh-list
139405266|NCT05791721|Antiemetics|antiemetics|mesh-ancestor
139405267|NCT05791721|Autonomic Agents|autonomic agents|mesh-ancestor
139405268|NCT05791721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405269|NCT05791721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405270|NCT05791721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139405271|NCT05791721|Glucocorticoids|glucocorticoids|mesh-ancestor
139405272|NCT05791721|Hormones|hormones|mesh-ancestor
139405273|NCT05791721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139405274|NCT05791721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139405275|NCT05791721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405276|NCT05791721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139405277|NCT05791721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139405278|NCT05791721|Analgesics|analgesics|mesh-ancestor
139405279|NCT05791721|Sensory System Agents|sensory system agents|mesh-ancestor
139405280|NCT05791721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139405281|NCT05791721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139405282|NCT05791721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139405283|NCT05791721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405284|NCT05791721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405285|NCT05791669|Listerine|listerine|mesh-list
139405286|NCT05791669|Fluorides|fluorides|mesh-list
139405287|NCT05791669|Sodium Fluoride|sodium fluoride|mesh-list
139405288|NCT05791669|Fluorides, Topical|fluorides, topical|mesh-list
139405289|NCT05791669|Cariostatic Agents|cariostatic agents|mesh-ancestor
139405290|NCT05791669|Protective Agents|protective agents|mesh-ancestor
139405291|NCT05791669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405292|NCT05791669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139405293|NCT05791669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405294|NCT05791487|Budesonide|budesonide|mesh-list
139405295|NCT05791487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139405296|NCT05791487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139405297|NCT05791487|Autonomic Agents|autonomic agents|mesh-ancestor
139405298|NCT05791487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405299|NCT05791487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405300|NCT05791487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139405301|NCT05791487|Respiratory System Agents|respiratory system agents|mesh-ancestor
139405302|NCT05791487|Glucocorticoids|glucocorticoids|mesh-ancestor
139405303|NCT05791487|Hormones|hormones|mesh-ancestor
139405304|NCT05791487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139405305|NCT05791409|Venetoclax|venetoclax|mesh-list
139405306|NCT05791409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405307|NCT05791331|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139405308|NCT05791331|Respiratory System Agents|respiratory system agents|mesh-ancestor
139405309|NCT05791136|Immunomodulating Agents|immunomodulating agents|mesh-list
139405310|NCT05791136|Immunologic Factors|immunologic factors|mesh-ancestor
139405311|NCT05791136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405312|NCT05791058|Anesthetics|anesthetics|mesh-list
139405313|NCT05791058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405314|NCT05791058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405315|NCT05790941|Minoxidil|minoxidil|mesh-list
139405316|NCT05790941|Latanoprost|latanoprost|mesh-list
139405317|NCT05790941|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139405318|NCT05790941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139405319|NCT05790941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139405320|NCT05790941|Vasodilator Agents|vasodilator agents|mesh-ancestor
139405321|NCT05790902|Tamsulosin|tamsulosin|mesh-list
139405322|NCT05790902|Silodosin|silodosin|mesh-list
139405323|NCT05790902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139405324|NCT05790902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139405325|NCT05790902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139405326|NCT05790902|Adrenergic Agents|adrenergic agents|mesh-ancestor
139405327|NCT05790902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139405328|NCT05790902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405329|NCT05790902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405330|NCT05790902|Urological Agents|urological agents|mesh-ancestor
139405331|NCT05790629|Calcium, Dietary|calcium, dietary|mesh-list
139405332|NCT05790629|Calcium|calcium|mesh-list
139405333|NCT05790629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139405334|NCT05790629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405335|NCT05790629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139405336|NCT05790603|Hemostatics|hemostatics|mesh-list
139405337|NCT05790603|Coagulants|coagulants|mesh-ancestor
139405338|NCT05790447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139405339|NCT05790447|Thymalfasin|thymalfasin|mesh-list
139405340|NCT05790447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139405341|NCT05790447|Immunologic Factors|immunologic factors|mesh-ancestor
139405342|NCT05790447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405343|NCT05790447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405344|NCT05790447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139405345|NCT05790447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405347|NCT05790330|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139405348|NCT05790330|Abortifacient Agents|abortifacient agents|mesh-ancestor
139405349|NCT05790330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139405350|NCT05790330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405351|NCT05790330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139405352|NCT05790330|Antimetabolites|antimetabolites|mesh-ancestor
139405353|NCT05790330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405354|NCT05790330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405355|NCT05790330|Dermatologic Agents|dermatologic agents|mesh-ancestor
139405356|NCT05790330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405357|NCT05790330|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139405358|NCT05790330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139405359|NCT05790330|Immunologic Factors|immunologic factors|mesh-ancestor
139405360|NCT05790330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138753806|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
139405361|NCT05790330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139405362|NCT05790239|Amphetamine|amphetamine|mesh-list
139405363|NCT05790239|Dextroamphetamine|dextroamphetamine|mesh-list
139405364|NCT05790239|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139405365|NCT05790239|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139405366|NCT05790239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405367|NCT05790239|Sympathomimetics|sympathomimetics|mesh-ancestor
139405368|NCT05790239|Autonomic Agents|autonomic agents|mesh-ancestor
139405369|NCT05790239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405370|NCT05790239|Dopamine Agents|dopamine agents|mesh-ancestor
139405371|NCT05790239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139405372|NCT05790239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405373|NCT05790239|Adrenergic Agents|adrenergic agents|mesh-ancestor
139405374|NCT05790239|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139405375|NCT05790239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139405376|NCT05790239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139405377|NCT05790239|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139405378|NCT05790239|Hallucinogens|hallucinogens|mesh-ancestor
139405379|NCT05790239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139405380|NCT05790239|Serotonin Agents|serotonin agents|mesh-ancestor
139405381|NCT05786599|Methadone|methadone|mesh-list
139405382|NCT05786599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139405383|NCT05786599|Narcotics|narcotics|mesh-ancestor
139062190|NCT00422903|Lapatinib|lapatinib|mesh-list
139405384|NCT05786599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405385|NCT05786599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405386|NCT05786599|Analgesics|analgesics|mesh-ancestor
139405387|NCT05786599|Sensory System Agents|sensory system agents|mesh-ancestor
139405388|NCT05786599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405389|NCT05786599|Antitussive Agents|antitussive agents|mesh-ancestor
139405390|NCT05786599|Respiratory System Agents|respiratory system agents|mesh-ancestor
139405391|NCT05683444|Octreotide|octreotide|mesh-list
139405392|NCT05683444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139405393|NCT05683444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139405394|NCT05683444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405395|NCT05669274|Caseins|caseins|mesh-list
139405396|NCT05669274|Chelating Agents|chelating agents|mesh-ancestor
139405397|NCT05669274|Sequestering Agents|sequestering agents|mesh-ancestor
139405398|NCT05669274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405399|NCT05667090|Vitamin D|vitamin d|mesh-list
139405400|NCT05667090|Vitamins|vitamins|mesh-ancestor
139405401|NCT05667090|Micronutrients|micronutrients|mesh-ancestor
139405402|NCT05667090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405403|NCT05667090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139405404|NCT05647343|Ciclopirox|ciclopirox|mesh-list
139405405|NCT05647343|Antifungal Agents|antifungal agents|mesh-ancestor
139405406|NCT05647343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405407|NCT05553392|Petrolatum|petrolatum|mesh-list
139405408|NCT05553392|Emollients|emollients|mesh-ancestor
139405409|NCT05553392|Dermatologic Agents|dermatologic agents|mesh-ancestor
139405410|NCT05530421|Dexamethasone|dexamethasone|mesh-list
139405411|NCT05530421|Venetoclax|venetoclax|mesh-list
139405412|NCT05530421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139405413|NCT05530421|Antiemetics|antiemetics|mesh-ancestor
139405414|NCT05530421|Autonomic Agents|autonomic agents|mesh-ancestor
139405415|NCT05530421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651766|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139651767|NCT03006627|Narcotics|narcotics|mesh-ancestor
139405416|NCT05530421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405417|NCT05530421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139405418|NCT05530421|Glucocorticoids|glucocorticoids|mesh-ancestor
139405419|NCT05530421|Hormones|hormones|mesh-ancestor
139405420|NCT05530421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139405421|NCT05530421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139405422|NCT05530421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405423|NCT05518734|Itraconazole|itraconazole|mesh-list
139405424|NCT05518734|Midazolam|midazolam|mesh-list
139405425|NCT05518734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139405426|NCT05518734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139405427|NCT05518734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405428|NCT05518734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405429|NCT05518734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139405430|NCT05518734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139405431|NCT05518734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139405432|NCT05518734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139405433|NCT05518734|Anesthetics, General|anesthetics, general|mesh-ancestor
139405434|NCT05518734|Anesthetics|anesthetics|mesh-ancestor
139405435|NCT05518734|GABA Modulators|gaba modulators|mesh-ancestor
139405436|NCT05518734|GABA Agents|gaba agents|mesh-ancestor
139405437|NCT05518734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139405438|NCT05518734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405439|NCT05518734|Antifungal Agents|antifungal agents|mesh-ancestor
139405440|NCT05518734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405441|NCT05518734|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138753891|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139405442|NCT05518734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139405443|NCT05518734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405444|NCT05518734|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139405445|NCT05518734|Hormone Antagonists|hormone antagonists|mesh-ancestor
139405446|NCT05518734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139405447|NCT05518734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139405448|NCT05513365|Goserelin|goserelin|mesh-list
139405449|NCT05513365|Bicalutamide|bicalutamide|mesh-list
139405450|NCT05513365|Dutasteride|dutasteride|mesh-list
139405451|NCT05513365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139405452|NCT05513365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405453|NCT05513365|Androgen Antagonists|androgen antagonists|mesh-ancestor
139405454|NCT05513365|Hormone Antagonists|hormone antagonists|mesh-ancestor
139405455|NCT05513365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139405456|NCT05513365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405457|NCT05513365|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139405458|NCT05513365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139405459|NCT05513365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405460|NCT05513365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405461|NCT05442749|Niraparib|niraparib|mesh-list
139405462|NCT05442749|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139405463|NCT05442749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405464|NCT05442749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405465|NCT05442749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405466|NCT05361655|Palbociclib|palbociclib|mesh-list
139405467|NCT05361655|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139405468|NCT05361655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405469|NCT05361655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138753926|NCT00626535|Esomeprazole|esomeprazole|mesh-list
139405470|NCT05361655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405471|NCT05361655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405472|NCT05361655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139405473|NCT05361655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139405474|NCT05361655|Hormone Antagonists|hormone antagonists|mesh-ancestor
139405475|NCT05361655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139405476|NCT05361655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405477|NCT05355740|Chlorhexidine|chlorhexidine|mesh-list
139405478|NCT05355740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139405479|NCT05355740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405480|NCT05355740|Disinfectants|disinfectants|mesh-ancestor
139405481|NCT05316831|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139405482|NCT05316831|Immunologic Factors|immunologic factors|mesh-ancestor
139405483|NCT05316831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405484|NCT05308056|Anesthetics|anesthetics|mesh-list
139405485|NCT05308056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405486|NCT05308056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651768|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405487|NCT05276284|Atezolizumab|atezolizumab|mesh-list
139405488|NCT05276284|Mercaptopurine|mercaptopurine|mesh-list
139405489|NCT05276284|Thioguanine|thioguanine|mesh-list
139405490|NCT05276284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139405491|NCT05276284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405492|NCT05276284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139405493|NCT05276284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405494|NCT05276284|Antimetabolites|antimetabolites|mesh-ancestor
139405495|NCT05276284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139405496|NCT05276284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139405497|NCT05276284|Immunologic Factors|immunologic factors|mesh-ancestor
139405498|NCT05276284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405499|NCT05276284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139405500|NCT05276284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405501|NCT05237960|Metformin|metformin|mesh-list
139405502|NCT05237960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139405503|NCT05237960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405504|NCT05144698|Sirolimus|sirolimus|mesh-list
139405505|NCT05144698|Temsirolimus|temsirolimus|mesh-list
139405506|NCT05144698|MTOR Inhibitors|mtor inhibitors|mesh-list
139405507|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139405508|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405509|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139405510|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405511|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
139405512|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139405513|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
139405514|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405515|NCT05144698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139405516|NCT05144698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405517|NCT05144698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405518|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
139405519|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
139405520|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
139405521|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405522|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405523|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
139405524|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405525|NCT04910061|Niacinamide|niacinamide|mesh-list
139405526|NCT04910061|Niacin|niacin|mesh-list
139405527|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
139405528|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
139405529|NCT04910061|Vitamins|vitamins|mesh-ancestor
139405530|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
139405531|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405532|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139405533|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
139405534|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405535|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139405537|NCT04887467|Apomorphine|apomorphine|mesh-list
139405538|NCT04887467|Emetics|emetics|mesh-ancestor
139405539|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405540|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
139405541|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405542|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139405543|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
139405544|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
139405545|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139405546|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405547|NCT04861064|Sirolimus|sirolimus|mesh-list
139405548|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139405549|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405550|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139405551|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405552|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
139405553|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139405554|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
139405555|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405556|NCT04846335|Doxycycline|doxycycline|mesh-list
139405557|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139405558|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405559|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
139405560|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139405561|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139405562|NCT04796220|Gemcitabine|gemcitabine|mesh-list
139405563|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139651769|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405564|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
139405565|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405566|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405567|NCT04777045|Diltiazem|diltiazem|mesh-list
139405568|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139405569|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139405570|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139405571|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405572|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139405573|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405574|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
139405575|NCT04577638|Nivolumab|nivolumab|mesh-list
139405576|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139405577|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405578|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139405579|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405580|NCT04517799|Cannabidiol|cannabidiol|mesh-list
139405581|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
139405582|NCT04495296|Paclitaxel|paclitaxel|mesh-list
139405583|NCT04495296|Gemcitabine|gemcitabine|mesh-list
139405584|NCT04495296|Capecitabine|capecitabine|mesh-list
139405585|NCT04495296|Oxaliplatin|oxaliplatin|mesh-list
139405586|NCT04495296|Nivolumab|nivolumab|mesh-list
139405587|NCT04495296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139405588|NCT04495296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405589|NCT04495296|Tubulin Modulators|tubulin modulators|mesh-ancestor
139405590|NCT04495296|Antimitotic Agents|antimitotic agents|mesh-ancestor
139405591|NCT04495296|Mitosis Modulators|mitosis modulators|mesh-ancestor
139405592|NCT04495296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405593|NCT04495296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139405594|NCT04495296|Antimetabolites|antimetabolites|mesh-ancestor
139405595|NCT04495296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139405596|NCT04495296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139405597|NCT04404062|Antibodies|antibodies|mesh-list
139405598|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
139405599|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
139405600|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405601|NCT04352777|Fulvestrant|fulvestrant|mesh-list
139405602|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139405603|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139405604|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405605|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139405606|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139405607|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
139405608|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139405609|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062413|NCT01147354|Trace Elements|trace elements|mesh-ancestor
139405610|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139405611|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405612|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405613|NCT04276363|Nicotine|nicotine|mesh-list
139405614|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139405615|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
139405616|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405617|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405618|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138754110|NCT01250873|Sertraline|sertraline|mesh-list
139405619|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139405620|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
139405621|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139405622|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405623|NCT04147546|Artenimol|artenimol|mesh-list
139405624|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
139405625|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139405626|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139405627|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405628|NCT04141579|Evolocumab|evolocumab|mesh-list
139405629|NCT04141579|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139405630|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139405631|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139405632|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
139405633|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405634|NCT04141579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139405635|NCT04141579|Protease Inhibitors|protease inhibitors|mesh-ancestor
139405636|NCT04141579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405637|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139405639|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139405640|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405641|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405642|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139405643|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139405644|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405645|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
139405646|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139405647|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
139405648|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139405649|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405650|NCT03867175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139405651|NCT03867175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405652|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139405653|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
139405654|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405655|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
139405656|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139405657|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405658|NCT03849469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139405659|NCT03849469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405660|NCT03805607|Ketorolac|ketorolac|mesh-list
139405661|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139405662|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139405663|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139405664|NCT03805607|Analgesics|analgesics|mesh-ancestor
139405665|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
139405666|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405667|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405668|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139405669|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139405670|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139405671|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405672|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405673|NCT03496766|Tipifarnib|tipifarnib|mesh-list
139405674|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405675|NCT03406715|Nivolumab|nivolumab|mesh-list
139405676|NCT03406715|Ipilimumab|ipilimumab|mesh-list
139405677|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139405678|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405679|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139405680|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062506|NCT01251172|Melphalan|melphalan|mesh-list
139405681|NCT03363763|Sirolimus|sirolimus|mesh-list
139405682|NCT03363763|Temsirolimus|temsirolimus|mesh-list
139405683|NCT03363763|MTOR Inhibitors|mtor inhibitors|mesh-list
139405684|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139405685|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405686|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139405687|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405688|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
139405689|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139405690|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
139405691|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405692|NCT03363763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139405693|NCT03363763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405694|NCT03363763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405695|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
139405696|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139405697|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139405698|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405699|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
139405700|NCT03182751|Coagulants|coagulants|mesh-ancestor
139405701|NCT03105245|Thiopental|thiopental|mesh-list
139405702|NCT03105245|Anesthetics|anesthetics|mesh-list
139405703|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405704|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405705|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
139405706|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138754186|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
139405707|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139405708|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
139651770|NCT03006627|Analgesics|analgesics|mesh-ancestor
139405709|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
139405710|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
139405711|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139405712|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405713|NCT03019588|Paclitaxel|paclitaxel|mesh-list
139405714|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
139405715|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139405716|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405717|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
139405718|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
139405719|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
139405720|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405721|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139405722|NCT03019588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139405723|NCT02959944|Prednisone|prednisone|mesh-list
139405724|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139405725|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
139405726|NCT02959944|Hormones|hormones|mesh-ancestor
139405727|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139405728|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405729|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139405730|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405731|NCT02823002|Lidocaine|lidocaine|mesh-list
139405732|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
139405733|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
139405734|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405735|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405736|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
139405737|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405738|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139405739|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139405740|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139405741|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139405742|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405743|NCT02806687|Gemcitabine|gemcitabine|mesh-list
139405744|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139405745|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
138754235|NCT01080807|Modafinil|modafinil|mesh-list
139405746|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405747|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405748|NCT02559180|Aflibercept|aflibercept|mesh-list
139405749|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139405750|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139405751|NCT02559180|Growth Substances|growth substances|mesh-ancestor
139405752|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405753|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
139405754|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405755|NCT02539966|Sirolimus|sirolimus|mesh-list
139405756|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139405757|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405758|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139405759|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405760|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
139405761|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139405762|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
139405763|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405764|NCT02455557|Temozolomide|temozolomide|mesh-list
139405765|NCT02455557|Sargramostim|sargramostim|mesh-list
139405766|NCT02455557|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139405767|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139405768|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
139405769|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405770|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405771|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
139405772|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405773|NCT02455557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139405774|NCT02401139|Ketamine|ketamine|mesh-list
139405775|NCT02401139|Analgesics|analgesics|mesh-ancestor
139405776|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
139405777|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405778|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405779|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139405780|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139651771|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
139651772|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405781|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
139405782|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
139405783|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139405784|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139405785|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139405786|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139405787|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405788|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
139405789|NCT02367846|NuvaRing|nuvaring|mesh-list
139405790|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
139405791|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139405792|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139405793|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405794|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139405795|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139405796|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
139405797|NCT02195895|Vitamin D|vitamin d|mesh-list
139405798|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
139405799|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
139405800|NCT02195895|Alendronate|alendronate|mesh-list
139405801|NCT02195895|Vitamins|vitamins|mesh-list
139405802|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
139405803|NCT02195895|Antacids|antacids|mesh-list
139405804|NCT02195895|Calcium|calcium|mesh-list
139405805|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
139405806|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405807|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139405808|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139405809|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405810|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139405811|NCT01970722|Paclitaxel|paclitaxel|mesh-list
139405812|NCT01970722|Cisplatin|cisplatin|mesh-list
139405813|NCT01970722|Carboplatin|carboplatin|mesh-list
139405814|NCT01970722|Gemcitabine|gemcitabine|mesh-list
139405815|NCT01970722|Doxorubicin|doxorubicin|mesh-list
139405816|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139405817|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139405818|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139405819|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405820|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
139405821|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
139405822|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
139405823|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405824|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139405825|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
139405826|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139405827|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139405828|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139405829|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405830|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
139405831|NCT01953900|Fludarabine|fludarabine|mesh-list
139405832|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062632|NCT03906838|Ropivacaine|ropivacaine|mesh-list
139405833|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
139405834|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405835|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138754368|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139405836|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139405837|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
139405838|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405839|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405840|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139405841|NCT01913951|Azacitidine|azacitidine|mesh-list
139405842|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139405843|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
139405844|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405845|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405846|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405847|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
139405848|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139405849|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139405850|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
139405851|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405852|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139405853|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139405854|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140089|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
139651773|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
139405855|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405856|NCT01709136|Sirolimus|sirolimus|mesh-list
139405857|NCT01709136|Temsirolimus|temsirolimus|mesh-list
139405858|NCT01709136|MTOR Inhibitors|mtor inhibitors|mesh-list
139405859|NCT01709136|Tacrolimus|tacrolimus|mesh-list
139405860|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139405861|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
139405862|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405863|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139405864|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405865|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405866|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139405867|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405868|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139405869|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405870|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
139405871|NCT01709136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139405872|NCT01565499|Paclitaxel|paclitaxel|mesh-list
139405873|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139405874|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405875|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
138754434|NCT04220203|Capecitabine|capecitabine|mesh-list
139405876|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
139405877|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
139405878|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405879|NCT01036087|Paclitaxel|paclitaxel|mesh-list
139405880|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139405881|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
139405882|NCT01036087|Carboplatin|carboplatin|mesh-list
139405883|NCT01036087|Fluorouracil|fluorouracil|mesh-list
139405884|NCT01036087|Epirubicin|epirubicin|mesh-list
139405885|NCT01036087|Panitumumab|panitumumab|mesh-list
139405886|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139405887|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405888|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
139405889|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
139405890|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
139405891|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405892|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139405893|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
139405894|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405895|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139405896|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139405897|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
139405898|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139405899|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
139405900|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139405901|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139405902|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139405903|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139405904|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405905|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139405906|NCT00783367|Dexamethasone|dexamethasone|mesh-list
139405907|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
139405908|NCT00783367|Rituximab|rituximab|mesh-list
139062708|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139405909|NCT00783367|Lenalidomide|lenalidomide|mesh-list
139405910|NCT00783367|BB 1101|bb 1101|mesh-list
139405911|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139405912|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
139405913|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
139405914|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405915|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405916|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139405917|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
139405918|NCT00783367|Hormones|hormones|mesh-ancestor
139405919|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139405920|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139405921|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405922|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
139405923|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405924|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405925|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139405926|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
139405927|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139405928|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139405929|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139405930|NCT00783367|Growth Substances|growth substances|mesh-ancestor
139405931|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
139405933|NCT00572156|Growth Substances|growth substances|mesh-ancestor
139405934|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405935|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
139405936|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139405937|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139405938|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139405939|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139405940|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405941|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
139405942|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139405943|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405944|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139405945|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405946|NCT00255216|Policosanol|policosanol|mesh-list
139405947|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139405948|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139405949|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
139405950|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405951|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139405952|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139405953|NCT02257697|Mizoribine|mizoribine|mesh-list
139405954|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
139405955|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139405956|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
139405957|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405958|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139405959|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139405960|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
139405961|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405962|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139405963|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139405964|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139405965|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139405966|NCT02257697|Analgesics|analgesics|mesh-ancestor
139405967|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
139405968|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139405969|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139405970|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139405971|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139405972|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139405973|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
139405974|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139405975|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139405976|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405977|NCT04468711|Vitamin D|vitamin d|mesh-list
139405978|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
139405979|NCT04468711|Vitamins|vitamins|mesh-ancestor
139405980|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
139405981|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405982|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139405983|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139405984|NCT02207387|Rasagiline|rasagiline|mesh-list
139405985|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139405986|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139405987|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139405988|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139405989|NCT02207387|Protective Agents|protective agents|mesh-ancestor
139405990|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405991|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
139405992|NCT03528421|Fludarabine|fludarabine|mesh-list
139405993|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139405994|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
139405995|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139405996|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139405997|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139405998|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
139405999|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406000|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406001|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139651774|NCT04796688|Fludarabine|fludarabine|mesh-list
139406002|NCT02374047|Atorvastatin|atorvastatin|mesh-list
139406003|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139406004|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139406005|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
139406006|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406007|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139406008|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139406009|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406010|NCT02203253|Thalidomide|thalidomide|mesh-list
139406011|NCT02203253|Dexamethasone|dexamethasone|mesh-list
139406012|NCT02203253|Palonosetron|palonosetron|mesh-list
139406013|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139406014|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
139406015|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
139406016|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406017|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406018|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139406019|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
139406020|NCT02203253|Hormones|hormones|mesh-ancestor
139406021|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139406022|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139406023|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406024|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139406025|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
139406026|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
139406027|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139406028|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406029|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139406030|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139406031|NCT02203253|Growth Substances|growth substances|mesh-ancestor
139406032|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
139406033|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139406034|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139406035|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
139406036|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406037|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406038|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
139406039|NCT02207699|Benzonatate|benzonatate|mesh-list
139406040|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139406041|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406042|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139406043|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139406044|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406045|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406046|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406047|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
139406048|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
139406049|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
139406050|NCT02296138|Olodaterol|olodaterol|mesh-list
139406051|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139406052|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
139406053|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406054|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406055|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139062857|NCT03901768|Hormones|hormones|mesh-ancestor
139406056|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
139406057|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
139406058|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139406059|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
139406060|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406061|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406063|NCT01306942|Trastuzumab|trastuzumab|mesh-list
139406064|NCT01306942|Dasatinib|dasatinib|mesh-list
139406065|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139406066|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406067|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
139406068|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
139406069|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
139406070|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406071|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139406072|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139406073|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406074|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
139406075|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
139406076|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
139651775|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139406077|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139651776|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
139406078|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406079|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
139406080|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406081|NCT03532841|Tramadol|tramadol|mesh-list
139406082|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139406083|NCT03532841|Narcotics|narcotics|mesh-ancestor
138754685|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
139406084|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139406085|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406086|NCT03532841|Analgesics|analgesics|mesh-ancestor
139406087|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
139406088|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406089|NCT02199431|Itraconazole|itraconazole|mesh-list
139406090|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
139406091|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406092|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139406093|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139406094|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406095|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406096|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139406097|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
139406098|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139406099|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406100|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139406101|NCT03532763|Tocotrienols|tocotrienols|mesh-list
139406102|NCT03532763|Vitamin E|vitamin e|mesh-list
139406103|NCT03532763|Tocopherols|tocopherols|mesh-list
139406104|NCT03532763|Tocovid|tocovid|mesh-list
139406105|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
139406106|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406107|NCT03532763|Protective Agents|protective agents|mesh-ancestor
139406108|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406109|NCT03532763|Vitamins|vitamins|mesh-ancestor
139406110|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
139406111|NCT02208245|Ropivacaine|ropivacaine|mesh-list
139406112|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
139406113|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
139406114|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139406115|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406116|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
139406117|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406118|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
139406119|NCT03514901|Nivolumab|nivolumab|mesh-list
139406120|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139406121|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406122|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139406123|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406124|NCT04441021|Penicillins|penicillins|mesh-list
139406125|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139406126|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406127|NCT03533387|Ibudilast|ibudilast|mesh-list
139406128|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139406129|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
139406130|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406131|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062931|NCT01150630|Gemcitabine|gemcitabine|mesh-list
139406132|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139406133|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
139406134|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139406135|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406136|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406137|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139406138|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
139406139|NCT02324842|Liraglutide|liraglutide|mesh-list
139406140|NCT02324842|Canagliflozin|canagliflozin|mesh-list
139406141|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139406142|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406143|NCT02324842|Incretins|incretins|mesh-ancestor
139406144|NCT02324842|Hormones|hormones|mesh-ancestor
139406145|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139406146|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139406147|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406148|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
139406149|NCT02295280|Promethazine|promethazine|mesh-list
139406150|NCT02295280|Codeine|codeine|mesh-list
139406151|NCT02295280|Metoclopramide|metoclopramide|mesh-list
139406152|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139406153|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139406154|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139406155|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406156|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
139406157|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
139406158|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
139406159|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406160|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
139406161|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
139406162|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139406163|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139406164|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
139406165|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
139406166|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406167|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406168|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139406169|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
139406170|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
139406171|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139406172|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139406173|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
139406174|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139406175|NCT02295280|Narcotics|narcotics|mesh-ancestor
139406176|NCT02295280|Analgesics|analgesics|mesh-ancestor
139406177|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
139406178|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
139406179|NCT05263505|Methotrexate|methotrexate|mesh-list
139406180|NCT05263505|Azathioprine|azathioprine|mesh-list
139406181|NCT05263505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139406182|NCT05263505|Abortifacient Agents|abortifacient agents|mesh-ancestor
139406183|NCT05263505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139406184|NCT05263505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406185|NCT05263505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139406186|NCT05263505|Antimetabolites|antimetabolites|mesh-ancestor
139406187|NCT05263505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406188|NCT05263505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406189|NCT05263505|Dermatologic Agents|dermatologic agents|mesh-ancestor
139406190|NCT05263505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406191|NCT05263505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139406192|NCT05263505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139406193|NCT05263505|Immunologic Factors|immunologic factors|mesh-ancestor
139406194|NCT05263505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139406195|NCT05263505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139406196|NCT02204501|Midazolam|midazolam|mesh-list
139406197|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139406198|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139406199|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139406200|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406201|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139406202|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139406203|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139406204|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139406205|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
139406206|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
139406207|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
139406209|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406210|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406211|NCT02294734|Nemiralisib|nemiralisib|mesh-list
139406212|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139406213|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406214|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406215|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139406216|NCT03533231|Metronidazole|metronidazole|mesh-list
139406217|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
139406218|NCT03533231|Propolis|propolis|mesh-list
139406219|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406220|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139406221|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139406222|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139406223|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139406224|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406225|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651777|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406226|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406227|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139406228|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139406229|NCT02200757|Topotecan|topotecan|mesh-list
139406230|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139406231|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139406232|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406233|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406234|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406235|NCT02208791|Sirolimus|sirolimus|mesh-list
139406236|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139406237|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406238|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139406239|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406240|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
139406241|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139406242|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
139406243|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406244|NCT05223101|Telmisartan|telmisartan|mesh-list
139406245|NCT05223101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139406246|NCT05223101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139406247|NCT05223101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139406248|NCT05223101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406249|NCT02852057|Timolol|timolol|mesh-list
139406250|NCT02852057|Dorzolamide|dorzolamide|mesh-list
139406251|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406252|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406253|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139406254|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139406255|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
139406256|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406257|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406258|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139406259|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139406260|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139406261|NCT04020445|Insulin|insulin|mesh-list
139406262|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139406263|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406264|NCT03524833|Amoxicillin|amoxicillin|mesh-list
139406265|NCT03524833|Metronidazole|metronidazole|mesh-list
139406266|NCT03524833|Lansoprazole|lansoprazole|mesh-list
139406267|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
139406268|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139406269|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406270|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139406271|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139406272|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139406273|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139406274|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139406275|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406276|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406277|NCT02220647|Metformin|metformin|mesh-list
139406278|NCT02220647|Linagliptin|linagliptin|mesh-list
139406279|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139406280|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406281|NCT02220647|Incretins|incretins|mesh-ancestor
139406282|NCT02220647|Hormones|hormones|mesh-ancestor
139406283|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139406284|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139406285|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
139406286|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406287|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406288|NCT05426395|Vitamins|vitamins|mesh-list
139406289|NCT05426395|Hydroxocobalamin|hydroxocobalamin|mesh-list
139406290|NCT05426395|Vitamin B 12|vitamin b 12|mesh-list
139406291|NCT05426395|Vitamin B Complex|vitamin b complex|mesh-list
139406292|NCT05426395|Micronutrients|micronutrients|mesh-ancestor
139406293|NCT05426395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406294|NCT05426395|Hematinics|hematinics|mesh-ancestor
139406295|NCT03544567|Paclitaxel|paclitaxel|mesh-list
139406296|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139406297|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406298|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
139406299|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
139406300|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
139651778|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139651779|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139651780|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
139406301|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406302|NCT02209025|Theobromine|theobromine|mesh-list
139406303|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139406304|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
139406305|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406306|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406307|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139406308|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
139406309|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
139406310|NCT02220803|Acetazolamide|acetazolamide|mesh-list
139406311|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
139406312|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139406313|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406314|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406315|NCT02220803|Diuretics|diuretics|mesh-ancestor
139406316|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
139406317|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406318|NCT02322892|Thiamine|thiamine|mesh-list
139406319|NCT02322892|Vitamins|vitamins|mesh-ancestor
139406320|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
139406321|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406322|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
139406323|NCT03274375|Rituximab|rituximab|mesh-list
139406324|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139406325|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406326|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
139406327|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406328|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139406329|NCT02739997|Metronidazole|metronidazole|mesh-list
139406330|NCT02739997|Tazobactam|tazobactam|mesh-list
139406331|NCT02739997|Ceftolozane|ceftolozane|mesh-list
139406332|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406333|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139406334|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139406335|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139406336|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139406337|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406338|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406339|NCT04467931|Losartan|losartan|mesh-list
139406340|NCT04467931|Timolol|timolol|mesh-list
139406341|NCT04467931|Propranolol|propranolol|mesh-list
139406342|NCT04467931|Metoprolol|metoprolol|mesh-list
139406343|NCT04467931|Atenolol|atenolol|mesh-list
139406344|NCT04467931|Verapamil|verapamil|mesh-list
139406345|NCT04467931|Felodipine|felodipine|mesh-list
139406346|NCT04467931|Nadolol|nadolol|mesh-list
139406347|NCT04467931|Acebutolol|acebutolol|mesh-list
139406348|NCT04467931|Amlodipine|amlodipine|mesh-list
139406349|NCT04467931|Valsartan|valsartan|mesh-list
139406350|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139406351|NCT04467931|Telmisartan|telmisartan|mesh-list
139406352|NCT04467931|Clonidine|clonidine|mesh-list
139406353|NCT04467931|Carvedilol|carvedilol|mesh-list
139406354|NCT04467931|Candesartan|candesartan|mesh-list
139406355|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
139406356|NCT04467931|Ramipril|ramipril|mesh-list
139406357|NCT04467931|Olmesartan|olmesartan|mesh-list
139406358|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139406359|NCT04467931|Enalapril|enalapril|mesh-list
139406360|NCT04467931|Enalaprilat|enalaprilat|mesh-list
139406361|NCT04467931|Lisinopril|lisinopril|mesh-list
139406362|NCT04467931|Irbesartan|irbesartan|mesh-list
139406363|NCT04467931|Eplerenone|eplerenone|mesh-list
139406364|NCT04467931|Nebivolol|nebivolol|mesh-list
139406365|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
139406367|NCT04467931|Perindopril|perindopril|mesh-list
139406368|NCT04467931|Diltiazem|diltiazem|mesh-list
139406369|NCT04467931|Minoxidil|minoxidil|mesh-list
139406370|NCT04467931|Guanfacine|guanfacine|mesh-list
139406371|NCT04467931|Prazosin|prazosin|mesh-list
139406372|NCT04467931|Doxazosin|doxazosin|mesh-list
139406373|NCT04467931|Captopril|captopril|mesh-list
139406374|NCT04467931|Benazepril|benazepril|mesh-list
139406375|NCT04467931|Labetalol|labetalol|mesh-list
139406376|NCT04467931|Hydralazine|hydralazine|mesh-list
139406377|NCT04467931|Indapamide|indapamide|mesh-list
139406378|NCT04467931|Nicardipine|nicardipine|mesh-list
139406379|NCT04467931|Torsemide|torsemide|mesh-list
139406380|NCT04467931|Quinapril|quinapril|mesh-list
139406381|NCT04467931|Metolazone|metolazone|mesh-list
139406382|NCT04467931|Trandolapril|trandolapril|mesh-list
139406383|NCT04467931|Methyldopa|methyldopa|mesh-list
139406384|NCT04467931|Fosinopril|fosinopril|mesh-list
139406385|NCT04467931|Isradipine|isradipine|mesh-list
139406386|NCT04467931|Pindolol|pindolol|mesh-list
139406387|NCT04467931|Eprosartan|eprosartan|mesh-list
139406388|NCT04467931|Reserpine|reserpine|mesh-list
139406389|NCT04467931|Betaxolol|betaxolol|mesh-list
139406390|NCT04467931|Moexipril|moexipril|mesh-list
139406391|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
139406393|NCT04467931|Guanabenz|guanabenz|mesh-list
139406394|NCT04467931|Nisoldipine|nisoldipine|mesh-list
139406395|NCT04467931|Penbutolol|penbutolol|mesh-list
139406396|NCT04467931|Nifedipine|nifedipine|mesh-list
139406397|NCT04467931|Amiloride|amiloride|mesh-list
139406398|NCT04467931|Triamterene|triamterene|mesh-list
139406399|NCT04467931|Furosemide|furosemide|mesh-list
139406400|NCT04467931|Spironolactone|spironolactone|mesh-list
139406401|NCT04467931|Bumetanide|bumetanide|mesh-list
139406402|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
139406403|NCT04467931|Terazosin|terazosin|mesh-list
139406404|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139406405|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139406406|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139406407|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139406408|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139406409|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406410|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139406411|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406412|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
139406413|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139406414|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139406415|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139406416|NCT04467931|Diuretics|diuretics|mesh-ancestor
139406417|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
139406418|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139406419|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139406420|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139406421|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
139406422|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406423|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139406424|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
139406425|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
139406426|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406427|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139406428|NCT04467931|Analgesics|analgesics|mesh-ancestor
139406429|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
139406430|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139406431|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139406432|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139406433|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139406434|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
139406435|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139406436|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139406437|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
139406438|NCT04467931|Protective Agents|protective agents|mesh-ancestor
139406439|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139406440|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139406441|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
139406442|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406443|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
139406444|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139406445|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139406446|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139406447|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139406448|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139406449|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139406450|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139406452|NCT04467931|Urological Agents|urological agents|mesh-ancestor
139406453|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139406454|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
139406455|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
139406456|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139406457|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139406458|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139406459|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139406460|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139406461|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139406462|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
139406463|NCT03705559|Narcotics|narcotics|mesh-ancestor
139406464|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139406465|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406467|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
139406468|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406469|NCT03522649|Leucovorin|leucovorin|mesh-list
139406470|NCT03522649|Fluorouracil|fluorouracil|mesh-list
139406471|NCT03522649|Irinotecan|irinotecan|mesh-list
139406472|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
139406473|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406474|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139406475|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406476|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139406477|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
139406478|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406479|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139406480|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139406481|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406482|NCT03522649|Antidotes|antidotes|mesh-ancestor
139406483|NCT03522649|Protective Agents|protective agents|mesh-ancestor
139406484|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
139406485|NCT03522649|Vitamins|vitamins|mesh-ancestor
139406486|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
139406487|NCT02366481|Vitamins|vitamins|mesh-list
139406488|NCT02366481|Vitamin K|vitamin k|mesh-list
139406489|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
139406490|NCT02366481|Menaquinone 7|menaquinone 7|mesh-list
139406491|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
139406492|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406493|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139406494|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139406495|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406496|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
139406497|NCT02366481|Coagulants|coagulants|mesh-ancestor
139406498|NCT02366247|Adefovir|adefovir|mesh-list
139406499|NCT02366247|Thymalfasin|thymalfasin|mesh-list
139406500|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
139406501|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406502|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139406503|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139406504|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406505|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406506|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139406507|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
139406508|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406509|NCT02373735|Mannitol|mannitol|mesh-list
139406510|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139406511|NCT02373735|Diuretics|diuretics|mesh-ancestor
139406512|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
139406513|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406514|NCT03526315|Fluorides|fluorides|mesh-list
139406515|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
139406516|NCT03526315|Protective Agents|protective agents|mesh-ancestor
139406517|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406518|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
139406519|NCT03112551|Analgesics|analgesics|mesh-ancestor
139406520|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
139406521|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406522|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406523|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
139406524|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139406525|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139406526|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
139406527|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139406528|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139406529|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406530|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139406531|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
139406532|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139406533|NCT05373433|Ritonavir|ritonavir|mesh-list
139406534|NCT05373433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139406535|NCT05373433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139406536|NCT05373433|Protease Inhibitors|protease inhibitors|mesh-ancestor
139406537|NCT05373433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406538|NCT05373433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406539|NCT05373433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139406540|NCT05373433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139406541|NCT05373433|Antiviral Agents|antiviral agents|mesh-ancestor
139406542|NCT05373433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406543|NCT05373433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139406544|NCT05373433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139406546|NCT02363127|Progestins|progestins|mesh-ancestor
139406547|NCT02363127|Hormones|hormones|mesh-ancestor
139406548|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139406549|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406550|NCT03526159|Gentamicins|gentamicins|mesh-list
139406551|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139406552|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406553|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139406554|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406555|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406556|NCT03523741|Clozapine|clozapine|mesh-list
139406557|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139406558|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
139406559|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406560|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406561|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406562|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139406563|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139406564|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139406565|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139406566|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
139406567|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
139406568|NCT02362581|Factor VIII|factor viii|mesh-list
139406569|NCT02362581|Coagulants|coagulants|mesh-ancestor
139406570|NCT03525925|Nivolumab|nivolumab|mesh-list
139406571|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139406572|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406573|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139406574|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406575|NCT02373579|Methotrexate|methotrexate|mesh-list
139406576|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139406577|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
139406578|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139406579|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406580|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139406581|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
139406582|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406583|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406584|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
139406585|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406586|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139406587|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139406588|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
139406589|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139406590|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139406591|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
139406592|NCT02365857|Bupivacaine|bupivacaine|mesh-list
139406593|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
139406594|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
139406595|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139406596|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406597|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
139406598|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406599|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139406600|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139406601|NCT02365857|Analgesics|analgesics|mesh-ancestor
139406602|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139406603|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139406604|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139406605|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
139406606|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406607|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406608|NCT02365935|Paclitaxel|paclitaxel|mesh-list
139406609|NCT02365935|Cisplatin|cisplatin|mesh-list
139406610|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139406611|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406612|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
139406613|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
139406614|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
139406615|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406616|NCT02365623|Bedaquiline|bedaquiline|mesh-list
139406617|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
139406618|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
139406619|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139406620|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406621|NCT03112707|Aspirin|aspirin|mesh-list
139406622|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139406623|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139406624|NCT03112707|Analgesics|analgesics|mesh-ancestor
139406625|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
139406626|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406627|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406628|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139406629|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139406630|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139406631|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139406632|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406633|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139406634|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139406635|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406636|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
139406637|NCT05262413|Lenvatinib|lenvatinib|mesh-list
139406638|NCT05262413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406639|NCT05262413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139406640|NCT05262413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406641|NCT05262413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406642|NCT02209649|Telmisartan|telmisartan|mesh-list
139406643|NCT02209649|Lacidipine|lacidipine|mesh-list
139406644|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139406645|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139406646|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139406647|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406648|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139406649|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139406650|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139406651|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406652|NCT02361567|Acetaminophen|acetaminophen|mesh-list
139406653|NCT02361567|Oxycodone|oxycodone|mesh-list
139406654|NCT02361567|Tramadol|tramadol|mesh-list
139406655|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139406656|NCT02361567|Narcotics|narcotics|mesh-ancestor
139406657|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139406658|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406659|NCT02361567|Analgesics|analgesics|mesh-ancestor
139406660|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
139406661|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406662|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139406663|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
139406664|NCT03112785|Cimetidine|cimetidine|mesh-list
139406665|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139406666|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139406667|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139406668|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
139406669|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
139406670|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406671|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406672|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063468|NCT01152346|Azacitidine|azacitidine|mesh-list
139406673|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139406674|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139406675|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406676|NCT02361879|Leuprolide|leuprolide|mesh-list
139406677|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
139406678|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139406679|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
139406680|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139406681|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406682|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139406683|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406684|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139406685|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
139406686|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139406687|NCT02361645|Ketorolac|ketorolac|mesh-list
139406688|NCT02361645|Indomethacin|indomethacin|mesh-list
139406689|NCT02361645|Nepafenac|nepafenac|mesh-list
139406690|NCT02361645|Bromfenac|bromfenac|mesh-list
139651781|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406691|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139406692|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139406693|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139406695|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
139406696|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406697|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406698|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139406699|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139406700|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139406701|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406702|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406703|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
139406704|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
139406705|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139406706|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139406707|NCT03522181|Insulin|insulin|mesh-list
139406708|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139406709|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139406710|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406711|NCT02373033|Folic Acid|folic acid|mesh-list
139406712|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
139406713|NCT02373033|Hematinics|hematinics|mesh-ancestor
139406714|NCT02373033|Vitamins|vitamins|mesh-ancestor
139406715|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
139406716|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406717|NCT05186129|Clopidogrel|clopidogrel|mesh-list
139406718|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139406719|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139406720|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139406721|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139406722|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
139406723|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406724|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406725|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406726|NCT02361723|Pamiparib|pamiparib|mesh-list
139406727|NCT02361723|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139406728|NCT02361723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406729|NCT02361723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406730|NCT02361723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406731|NCT03596281|Bevacizumab|bevacizumab|mesh-list
139406732|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
139406733|NCT03596281|Doxorubicin|doxorubicin|mesh-list
139406734|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139406735|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139406736|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406737|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139406738|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139406739|NCT03596281|Growth Substances|growth substances|mesh-ancestor
139406740|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406741|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
139406742|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138755344|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
139406743|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139406744|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139406745|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406746|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406747|NCT03596281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139406748|NCT05172167|Antibodies|antibodies|mesh-list
139406749|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
139406750|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406751|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
139406752|NCT02359149|Growth Substances|growth substances|mesh-ancestor
139406753|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406754|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
139406755|NCT02221583|Tacrolimus|tacrolimus|mesh-list
139406756|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139406757|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
139406758|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406759|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139406760|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406761|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406762|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138911470|NCT00448435|Hormones|hormones|mesh-ancestor
139406763|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406764|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139406765|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
139406766|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139406767|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406768|NCT02751359|Cannabidiol|cannabidiol|mesh-list
139406769|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
139406770|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
139406771|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
139406772|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
139406773|NCT02358993|Methenamine|methenamine|mesh-list
139406774|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139406775|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406776|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139406777|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139406778|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406779|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406780|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406781|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139406782|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139406783|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139406784|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
139406785|NCT04059445|Calcium|calcium|mesh-list
139406786|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139406787|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406788|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139406789|NCT05092841|Naltrexone|naltrexone|mesh-list
139406790|NCT05092841|Baclofen|baclofen|mesh-list
139406791|NCT05092841|Sorbitol|sorbitol|mesh-list
139406792|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139406793|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139406794|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406795|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
139406796|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406797|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139406798|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139406799|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139406800|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
139406801|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
139406802|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406803|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406804|NCT05092841|Cathartics|cathartics|mesh-ancestor
139406805|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139406806|NCT02224937|Melatonin|melatonin|mesh-list
139406807|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
139406808|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406809|NCT02224937|Protective Agents|protective agents|mesh-ancestor
139406810|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406811|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139406812|NCT02290327|Pantoprazole|pantoprazole|mesh-list
139406813|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139406814|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139406815|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139406816|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406817|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406818|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
139406819|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139406820|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406821|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139406822|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406823|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
139406824|NCT02358057|Alfentanil|alfentanil|mesh-list
139406825|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138755450|NCT00973102|Estrogens|estrogens|mesh-list
139406826|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139406827|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406828|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139406829|NCT02358057|Analgesics|analgesics|mesh-ancestor
139406830|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
139406831|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406832|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139406833|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139406834|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139406835|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
139406836|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651782|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651783|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139406837|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406838|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139406839|NCT02358057|Narcotics|narcotics|mesh-ancestor
139406840|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139406841|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
139406842|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
139406843|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
139406845|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139406846|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406847|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139406848|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406849|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406850|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139406851|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139406852|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
139406853|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406854|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
139406855|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
139406856|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139406857|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139406858|NCT02212535|Plerixafor|plerixafor|mesh-list
139406859|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139406860|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139406861|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
139406862|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406863|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
139406864|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406865|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
139406866|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139406867|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139406868|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755494|NCT00705211|Ezetimibe|ezetimibe|mesh-list
139406869|NCT02372487|Urological Agents|urological agents|mesh-ancestor
139406870|NCT02361177|Oxytocin|oxytocin|mesh-list
139406871|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
139406872|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139406873|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406874|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139406875|NCT05055713|Somatostatin|somatostatin|mesh-list
139406876|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139406877|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
139406878|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406879|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406880|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406881|NCT05055713|Hormones|hormones|mesh-ancestor
139406882|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139406883|NCT02360709|Sirolimus|sirolimus|mesh-list
139406884|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139406885|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139406886|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139406887|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406888|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
139406889|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139406890|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
139406891|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406892|NCT05030519|Trastuzumab|trastuzumab|mesh-list
139406893|NCT05030519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139406894|NCT05030519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406895|NCT02357277|Budesonide|budesonide|mesh-list
139406896|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139406897|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139406898|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
139406899|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406900|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406901|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139406902|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
139406903|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
139406904|NCT02357277|Hormones|hormones|mesh-ancestor
139406905|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139406906|NCT02222441|Pioglitazone|pioglitazone|mesh-list
139406907|NCT02222441|Palbociclib|palbociclib|mesh-list
139406908|NCT02222441|Modafinil|modafinil|mesh-list
139406909|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139406910|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406911|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406912|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139406913|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406914|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406915|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139406916|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139406917|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139406918|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139406919|NCT02290717|Fluticasone|fluticasone|mesh-list
139406921|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139406922|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139406923|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
139406924|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406925|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406926|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139406927|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
139406928|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
139406929|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139406930|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
139406931|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139406932|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
139406933|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139406934|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
139406935|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406936|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139406937|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139406938|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
139406939|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406940|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139406941|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139406942|NCT02360007|Buprenorphine|buprenorphine|mesh-list
139406943|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139406944|NCT02360007|Narcotics|narcotics|mesh-ancestor
139406945|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138755574|NCT00095017|Analgesics|analgesics|mesh-ancestor
139406946|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406947|NCT02360007|Analgesics|analgesics|mesh-ancestor
139406948|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
139406949|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406950|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139406951|NCT02294305|Vortioxetine|vortioxetine|mesh-list
139406952|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
139406953|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139406954|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139406955|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139406956|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139406957|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406958|NCT02294305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139406959|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139406960|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139406961|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406962|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406963|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
139406964|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139406965|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139406966|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139406967|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139406968|NCT01672255|Fluoxetine|fluoxetine|mesh-list
139406969|NCT01672255|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139406970|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139406971|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139406972|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139406973|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139406974|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
139406975|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406976|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139406977|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
139406978|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139406979|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139406980|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139406981|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139406982|NCT02222519|Bromides|bromides|mesh-list
139651784|NCT01535001|Acetaminophen|acetaminophen|mesh-list
139406983|NCT02222519|Rocuronium|rocuronium|mesh-list
139406984|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
139406985|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139406986|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139406987|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139406988|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406989|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406990|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
139406991|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139406992|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
139406993|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139406994|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139406995|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139406996|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
139406997|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139406998|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
139406999|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407000|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407001|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139407002|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
139407003|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
139407004|NCT02220023|Protective Agents|protective agents|mesh-ancestor
139407005|NCT02356965|Ketamine|ketamine|mesh-list
139407006|NCT02356965|Analgesics|analgesics|mesh-ancestor
139407007|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
139407008|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407009|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407010|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139407011|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139407012|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
139407013|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
139407014|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407015|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139407016|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139407017|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407018|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407019|NCT02359695|Hormones|hormones|mesh-list
139407020|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407021|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407022|NCT02294539|Losartan|losartan|mesh-list
139407023|NCT02294539|Amlodipine|amlodipine|mesh-list
139407024|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139407025|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139407026|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139407027|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139407028|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407029|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139407030|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407031|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
139407032|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139407033|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139407034|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139407035|NCT02294539|Diuretics|diuretics|mesh-ancestor
139407036|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
139407037|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139407038|NCT02359617|Insulin|insulin|mesh-list
139407039|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139407040|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407041|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139407042|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
139407043|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139407044|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139407045|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139407046|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
139407047|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139407048|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407049|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139407050|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139407051|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139407052|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139407053|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407054|NCT02294617|Nicotine|nicotine|mesh-list
139407055|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139407056|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
139407057|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407058|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407059|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139407060|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139407061|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
139407062|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407063|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407064|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139407065|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139407066|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139407067|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139407068|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407069|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407070|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407071|NCT02291341|Analgesics|analgesics|mesh-ancestor
139407072|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
139407073|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407074|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
139407075|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139407076|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
139407077|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
139407078|NCT02352987|Salicylates|salicylates|mesh-list
139407079|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139407080|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
139407081|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
139407082|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
139407083|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139407084|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139407085|NCT02352987|Analgesics|analgesics|mesh-ancestor
139407086|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
139407087|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407088|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407089|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139407090|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139407091|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139407092|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407093|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407094|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
139407095|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139407096|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139407097|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407098|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139407099|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
139407100|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139407101|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139407102|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407103|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407105|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407106|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407107|NCT02222987|Clopidogrel|clopidogrel|mesh-list
139407108|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139407109|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139407110|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139407111|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139407112|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
139407113|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407114|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407115|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407116|NCT03521245|Trastuzumab|trastuzumab|mesh-list
139407117|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139407118|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407119|NCT02481245|Bezafibrate|bezafibrate|mesh-list
139407120|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139407121|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
139407122|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407123|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139407124|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139407125|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139407127|NCT02352597|Enclomiphene|enclomiphene|mesh-list
139651785|NCT01535001|Pantoprazole|pantoprazole|mesh-list
139407129|NCT02352597|Estradiol|estradiol|mesh-list
139407130|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139407131|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
139407132|NCT02352597|Estrogens|estrogens|mesh-ancestor
139407133|NCT02352597|Hormones|hormones|mesh-ancestor
139407134|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407135|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407136|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139407137|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
139407138|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139407139|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139407140|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139407141|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
139407142|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139407143|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
139407144|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139407145|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139407146|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139407147|NCT03521167|Acetaminophen|acetaminophen|mesh-list
139407148|NCT03521167|Lidocaine|lidocaine|mesh-list
139407149|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
139407150|NCT03521167|Ketamine|ketamine|mesh-list
139407151|NCT03521167|Gabapentin|gabapentin|mesh-list
139407152|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
139407153|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
139407154|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407155|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407156|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
139407157|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407158|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139407159|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139407160|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139407161|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139407162|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407163|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139407164|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139407165|NCT03521167|Analgesics|analgesics|mesh-ancestor
139407166|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139407167|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139407168|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139407169|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
139407170|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407171|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139407172|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139407173|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
139407174|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139407175|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139407176|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
138755741|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
139407177|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139407178|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139407179|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139407180|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
139407181|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
139407182|NCT02352519|Anesthetics|anesthetics|mesh-list
139407183|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
139407184|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407185|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407186|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
139407187|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407188|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
139407189|NCT02356419|Hematinics|hematinics|mesh-ancestor
139407190|NCT02220335|Digoxin|digoxin|mesh-list
139407191|NCT02220335|Diuretics|diuretics|mesh-list
139063981|NCT01266694|Colchicine|colchicine|mesh-list
139407192|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139407193|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139407194|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139407195|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139407196|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407197|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407198|NCT02220335|Protective Agents|protective agents|mesh-ancestor
139407199|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407200|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
139407201|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
139407202|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
139407203|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407204|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139407205|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139407206|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139407207|NCT02223299|Tryptophan|tryptophan|mesh-list
139407208|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139407209|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
139407210|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139407211|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139407212|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139407213|NCT02291887|Ranibizumab|ranibizumab|mesh-list
139407214|NCT02291887|Aflibercept|aflibercept|mesh-list
139407215|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139407216|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139407217|NCT02291887|Growth Substances|growth substances|mesh-ancestor
139407218|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407219|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
139407220|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407221|NCT02352285|Tolvaptan|tolvaptan|mesh-list
139407222|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139407223|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407224|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
139407225|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407226|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
139407227|NCT03521713|Hematinics|hematinics|mesh-ancestor
139407228|NCT02223533|Morphine|morphine|mesh-list
139407229|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139407230|NCT02223533|Narcotics|narcotics|mesh-ancestor
139407231|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407232|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407233|NCT02223533|Analgesics|analgesics|mesh-ancestor
139407234|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
139407235|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407236|NCT02231021|Pioglitazone|pioglitazone|mesh-list
139407237|NCT02231021|Alogliptin|alogliptin|mesh-list
139407238|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139407239|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407240|NCT02231021|Incretins|incretins|mesh-ancestor
139407241|NCT02231021|Hormones|hormones|mesh-ancestor
139407242|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407243|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139407244|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
139407245|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407246|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407247|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139407248|NCT04465123|Spironolactone|spironolactone|mesh-list
139407249|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139407250|NCT04465123|Diuretics|diuretics|mesh-ancestor
139407251|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
139407252|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407253|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139407254|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139407255|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407256|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139407257|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
139407258|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407259|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139407260|NCT02401347|Talazoparib|talazoparib|mesh-list
139407261|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139407262|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407263|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064057|NCT01160302|Analgesics|analgesics|mesh-ancestor
139407264|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407266|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
139407267|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407268|NCT02231255|Protective Agents|protective agents|mesh-ancestor
139407269|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407270|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139407271|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139407272|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
139407273|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
139407274|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407275|NCT02352051|Methylphenidate|methylphenidate|mesh-list
139407276|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139407277|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139407278|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407279|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139407280|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139407281|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139407282|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407283|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
139407284|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407285|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139407286|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
139407287|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139407288|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
139407289|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
139407290|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139407291|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407292|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
139407293|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
139407294|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407295|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139407296|NCT02292121|Mannitol|mannitol|mesh-list
139407297|NCT02292121|Lactitol|lactitol|mesh-list
139407298|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139407299|NCT02292121|Diuretics|diuretics|mesh-ancestor
139407300|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
139407301|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407302|NCT02292121|Cathartics|cathartics|mesh-ancestor
139407303|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139407304|NCT02223611|Cisplatin|cisplatin|mesh-list
139407305|NCT02223611|Vinorelbine|vinorelbine|mesh-list
139407306|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407307|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139407308|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
139407309|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
139407310|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
139407311|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407312|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
139407313|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139407314|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407315|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407316|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139407317|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139407318|NCT02231333|Protective Agents|protective agents|mesh-ancestor
139407319|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407320|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
139407321|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139407322|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
139407323|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139407324|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139407325|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407326|NCT02227433|Immunotoxins|immunotoxins|mesh-ancestor
139407327|NCT02227433|Immunoconjugates|immunoconjugates|mesh-ancestor
139407328|NCT02227433|Immunologic Factors|immunologic factors|mesh-ancestor
139407329|NCT02227433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407330|NCT02351973|Amiloride|amiloride|mesh-list
139407331|NCT02351973|Diuretics|diuretics|mesh-ancestor
139407332|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
139407333|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407334|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139407335|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139407336|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139407337|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407338|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139064126|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407340|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
139407341|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139407342|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139407343|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407344|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
139407345|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
139407346|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139407347|NCT03520543|Clonidine|clonidine|mesh-list
139407348|NCT03520543|Yohimbine|yohimbine|mesh-list
139407349|NCT03520543|Analgesics|analgesics|mesh-ancestor
139407350|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
139407351|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407352|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407353|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139407354|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
139407355|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
139407356|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139407357|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139407358|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139407359|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
139407360|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755902|NCT00968812|Glimepiride|glimepiride|mesh-list
139407361|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407362|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
139407363|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139407364|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139407365|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139407366|NCT03520543|Urological Agents|urological agents|mesh-ancestor
139407367|NCT02355639|Betamethasone|betamethasone|mesh-list
139407368|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
139407369|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139407370|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
139407371|NCT02355639|Clobetasol|clobetasol|mesh-list
139407372|NCT02355639|Petrolatum|petrolatum|mesh-list
139407373|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139407374|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139407375|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
139407376|NCT02355639|Hormones|hormones|mesh-ancestor
139407377|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407378|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407379|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139407380|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
139407381|NCT02355639|Emollients|emollients|mesh-ancestor
139407382|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
139407383|NCT02351895|Copper|copper|mesh-list
139407384|NCT02351895|Trace Elements|trace elements|mesh-ancestor
139407385|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
139407386|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407387|NCT00503035|Celecoxib|celecoxib|mesh-list
139407388|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139407389|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139407390|NCT00503035|Analgesics|analgesics|mesh-ancestor
139407391|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
139407392|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407393|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407394|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139407395|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139407396|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139407397|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139407398|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407399|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407400|NCT02227745|Dorzolamide|dorzolamide|mesh-list
139407401|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
139407402|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139407403|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
139407404|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407405|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
139407406|NCT02227745|Protective Agents|protective agents|mesh-ancestor
139407407|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139407408|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139407409|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407410|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407411|NCT03517033|Nebivolol|nebivolol|mesh-list
139407412|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139407413|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
139064203|NCT01159210|Thrombin|thrombin|mesh-list
139407414|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139407415|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139407416|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139407417|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
139407418|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407419|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407420|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407421|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139407422|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139407423|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139651786|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139407424|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
139140098|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139651787|NCT01535001|Analgesics|analgesics|mesh-ancestor
139407425|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407426|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139407427|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139407428|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407429|NCT02259179|Naltrexone|naltrexone|mesh-list
139407430|NCT02259179|Bupropion|bupropion|mesh-list
139407431|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139407432|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139407433|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407434|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
139407435|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407436|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139407437|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
139407438|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139407439|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139407440|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139407441|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139407442|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407443|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
139407444|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407445|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139407446|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139407447|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407448|NCT02355093|Ropivacaine|ropivacaine|mesh-list
139407449|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
139407450|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
139407451|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407452|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407453|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
139407454|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407455|NCT02227901|Temozolomide|temozolomide|mesh-list
139407456|NCT02227901|Tipifarnib|tipifarnib|mesh-list
139407457|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139407458|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
139407459|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407460|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407461|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
139407462|NCT03146793|Antidotes|antidotes|mesh-ancestor
139407463|NCT03146793|Protective Agents|protective agents|mesh-ancestor
139407464|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407465|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
139407466|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407467|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
139407468|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139407469|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139407470|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
139407471|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
139407472|NCT03133195|Vitamin D|vitamin d|mesh-list
139407473|NCT03133195|Teriparatide|teriparatide|mesh-list
139407474|NCT03133195|Calcium|calcium|mesh-list
139407475|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
139407476|NCT03133195|Vitamins|vitamins|mesh-ancestor
139407477|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
139407478|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407479|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138756012|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139407480|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139407481|NCT03159741|Glucagon|glucagon|mesh-list
139407482|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139407483|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139407484|NCT03159741|Hormones|hormones|mesh-ancestor
139407485|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407486|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407487|NCT03159741|Incretins|incretins|mesh-ancestor
139407488|NCT02292277|Ticagrelor|ticagrelor|mesh-list
139407489|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139407490|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139407491|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139407492|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139407493|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
139407494|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407495|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407496|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651788|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
139407497|NCT02228135|Dexamethasone|dexamethasone|mesh-list
139651789|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407498|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139407499|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
139407500|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
139407501|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407502|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407503|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139407504|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
139407505|NCT02228135|Hormones|hormones|mesh-ancestor
139407506|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407507|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139407508|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407509|NCT03152877|Bupivacaine|bupivacaine|mesh-list
139407510|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
139407511|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
139407512|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407513|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407514|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
139407515|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407516|NCT02295709|Dexamethasone|dexamethasone|mesh-list
139407517|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
139407518|NCT02295709|BB 1101|bb 1101|mesh-list
139407519|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139407520|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
139407521|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
139407522|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407523|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407524|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139407525|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
139407526|NCT02295709|Hormones|hormones|mesh-ancestor
139407527|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407528|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139407529|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407530|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
139407531|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407532|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407533|NCT02354937|Cabotegravir|cabotegravir|mesh-list
139407534|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139407535|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139407536|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407537|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407538|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139407539|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139407540|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
139407541|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139407542|NCT02295787|Ketamine|ketamine|mesh-list
139407543|NCT02295787|Analgesics|analgesics|mesh-ancestor
139407544|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
139407545|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407546|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407547|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139407548|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139407549|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
139407550|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
139407551|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407552|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139407553|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139407554|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407555|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407556|NCT04464967|Trastuzumab|trastuzumab|mesh-list
139407557|NCT04464967|Cetuximab|cetuximab|mesh-list
139407558|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139407559|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407560|NCT02228369|Osimertinib|osimertinib|mesh-list
139407561|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756102|NCT02863276|Insulin|insulin|mesh-list
139407562|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139407563|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407564|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407565|NCT03146871|Azacitidine|azacitidine|mesh-list
139407566|NCT03146871|Decitabine|decitabine|mesh-list
139407567|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139407568|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
139407569|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407570|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407571|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407572|NCT02231957|Vaccines|vaccines|mesh-list
139407573|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
139407574|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407575|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
139407576|NCT02354547|Topotecan|topotecan|mesh-list
139407577|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139407578|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
139407579|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407580|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139407581|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139407582|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
139407583|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407584|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407585|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139407586|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139407587|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139407588|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407589|NCT02232035|Diazepam|diazepam|mesh-list
139407590|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139407591|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
139407592|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
139407593|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
139407594|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407595|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407596|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139407597|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139407598|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407599|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139407600|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139407601|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139407602|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139407603|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139407604|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139407605|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
139407606|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
139407607|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
139407608|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
139407609|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407610|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407611|NCT02296021|Amoxicillin|amoxicillin|mesh-list
139407612|NCT02296021|Clarithromycin|clarithromycin|mesh-list
139407613|NCT02296021|Esomeprazole|esomeprazole|mesh-list
139407614|NCT02296021|Bismuth|bismuth|mesh-list
139407615|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139407616|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139407617|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139407618|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139407619|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139407620|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407621|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407622|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139407623|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139407624|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139407625|NCT02296021|Antacids|antacids|mesh-ancestor
139407626|NCT02289391|Anesthetics|anesthetics|mesh-list
139407627|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407628|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407629|NCT02354313|Lenalidomide|lenalidomide|mesh-list
139407630|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
139407631|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407632|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139407633|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139407634|NCT02354313|Growth Substances|growth substances|mesh-ancestor
139407635|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
139407636|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407637|NCT02292667|Acetaminophen|acetaminophen|mesh-list
139064449|NCT03871114|Triamcinolone|triamcinolone|mesh-list
139407638|NCT02292667|Morphine|morphine|mesh-list
139407639|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139407640|NCT02292667|Narcotics|narcotics|mesh-ancestor
139407641|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407642|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407643|NCT02292667|Analgesics|analgesics|mesh-ancestor
139651790|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407644|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
139407645|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407646|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139407647|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
139407648|NCT02232269|Felodipine|felodipine|mesh-list
139407649|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139407650|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139407651|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139407652|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139407653|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407654|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139407655|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407656|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
139407657|NCT04486313|Nitazoxanide|nitazoxanide|mesh-list
139407658|NCT04486313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139407659|NCT04486313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139407660|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139407661|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139407662|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
139407663|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407664|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407665|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139407666|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139407667|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139407668|NCT02347839|Gefitinib|gefitinib|mesh-list
139407669|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407670|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139407671|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407672|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407673|NCT02289547|Capecitabine|capecitabine|mesh-list
139407674|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139407675|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
139407676|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407677|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407678|NCT02351427|Bortezomib|bortezomib|mesh-list
139407679|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407680|NCT02232971|Glucagon|glucagon|mesh-list
139407681|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139407682|NCT02232971|Hormones|hormones|mesh-ancestor
139407683|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407684|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407685|NCT02296333|Ondansetron|ondansetron|mesh-list
139407686|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
139407687|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
139407688|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407689|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407690|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139407691|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
139407692|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
139407693|NCT02296333|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139407694|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139407695|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
139407696|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407697|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407698|NCT03149913|Paclitaxel|paclitaxel|mesh-list
138756217|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139407699|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139407700|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407701|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
139407702|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
139407703|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
139407704|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407705|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
139407706|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139407707|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
139407708|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139407709|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
139407710|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407711|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407712|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
139407713|NCT02232347|Sufentanil|sufentanil|mesh-list
139407714|NCT02232347|Ketamine|ketamine|mesh-list
139407715|NCT02232347|Analgesics|analgesics|mesh-ancestor
139407716|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
139407717|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407718|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407719|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139651792|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139407720|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139407721|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
139407722|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
139407723|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407724|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139407725|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139407726|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407727|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407728|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139407729|NCT02232347|Narcotics|narcotics|mesh-ancestor
139407730|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139407731|NCT03542669|Doxorubicin|doxorubicin|mesh-list
139407732|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139407733|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407734|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139407735|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139407736|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407737|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407738|NCT03146481|Aceclofenac|aceclofenac|mesh-list
139407739|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139407740|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139407741|NCT03146481|Analgesics|analgesics|mesh-ancestor
139407742|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
139407743|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407744|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407745|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139407746|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139407747|NCT03541655|Celecoxib|celecoxib|mesh-list
139407748|NCT03541655|Bupivacaine|bupivacaine|mesh-list
139407749|NCT03541655|Anesthetics, Local|anesthetics, local|mesh-ancestor
139407750|NCT03541655|Anesthetics|anesthetics|mesh-ancestor
139407751|NCT03541655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407752|NCT03541655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407753|NCT03541655|Sensory System Agents|sensory system agents|mesh-ancestor
139407754|NCT03541655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407755|NCT03541655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139407756|NCT03541655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139407757|NCT03541655|Analgesics|analgesics|mesh-ancestor
139407758|NCT03541655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139407759|NCT03541655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139407760|NCT03541655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139407761|NCT03541655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139407762|NCT03541655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407763|NCT03541655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407764|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
139407765|NCT02296411|Bromides|bromides|mesh-list
139407766|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
139407767|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139407768|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139407769|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139407770|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
139407771|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407772|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407773|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407774|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
139407775|NCT02229617|Testosterone|testosterone|mesh-list
139407776|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
139407777|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
139407778|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139407779|NCT02229617|Androgens|androgens|mesh-ancestor
139407780|NCT02229617|Hormones|hormones|mesh-ancestor
139407781|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407782|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407783|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139407784|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407785|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
138756285|NCT01226459|Minoxidil|minoxidil|mesh-list
139407786|NCT02347059|Dopamine|dopamine|mesh-list
139407787|NCT02347059|Levodopa|levodopa|mesh-list
139407788|NCT02347059|Pramipexole|pramipexole|mesh-list
139407790|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139407791|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139407792|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
139407793|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407794|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407795|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407796|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
139407797|NCT02347059|Protective Agents|protective agents|mesh-ancestor
139407798|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139407799|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
139407800|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
139407801|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407802|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139407803|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139407804|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139407805|NCT02296567|Bevacizumab|bevacizumab|mesh-list
139407806|NCT02296567|Ranibizumab|ranibizumab|mesh-list
139407807|NCT02296567|Aflibercept|aflibercept|mesh-list
139407808|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139407809|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407810|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139407811|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139407812|NCT02296567|Growth Substances|growth substances|mesh-ancestor
139407813|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407814|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
139407815|NCT02296723|Valganciclovir|valganciclovir|mesh-list
139407816|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
139407817|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139407818|NCT02289937|Ropivacaine|ropivacaine|mesh-list
139407819|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
139407820|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
139407821|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407822|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407823|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
139407824|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407825|NCT03446807|Droxidopa|droxidopa|mesh-list
139407826|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139407827|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139407828|NCT03519061|Budesonide|budesonide|mesh-list
139407829|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139407830|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139407831|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
139407832|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407833|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407834|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139407835|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
139407836|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
139407837|NCT03519061|Hormones|hormones|mesh-ancestor
138756317|NCT02860780|Prexasertib|prexasertib|mesh-list
139407838|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407839|NCT02229773|Pravastatin|pravastatin|mesh-list
139407840|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139407841|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139407842|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
139407843|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407844|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139407845|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139407846|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407847|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
139407848|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
139407849|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139407850|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407851|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407852|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
139407853|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139407854|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407855|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407856|NCT03515707|Etoposide|etoposide|mesh-list
139407857|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
139407858|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
139407859|NCT03515707|Busulfan|busulfan|mesh-list
139407860|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139407861|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407862|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139407863|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139407864|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407865|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407866|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
139407867|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139407868|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
139407869|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407870|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139407872|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
139407873|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
139407874|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
139407875|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
139407876|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
139407877|NCT02298205|Beclomethasone|beclomethasone|mesh-list
139407878|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139407879|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
139407881|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407882|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407883|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139407884|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
139407885|NCT03514771|Valacyclovir|valacyclovir|mesh-list
139407886|NCT03514771|Isotretinoin|isotretinoin|mesh-list
139407887|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
139407888|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139407889|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
139407890|NCT02298283|Prednisone|prednisone|mesh-list
139407891|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
139407892|NCT02298283|Doxorubicin|doxorubicin|mesh-list
139407893|NCT02298283|Etoposide|etoposide|mesh-list
139407894|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139407895|NCT02298283|Vincristine|vincristine|mesh-list
139407896|NCT02298283|Bleomycin|bleomycin|mesh-list
139407897|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139407898|NCT02298283|Procarbazine|procarbazine|mesh-list
139407899|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139407900|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
139407901|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407902|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139407903|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139407904|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
139407905|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407906|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407907|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139407908|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139407909|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139407910|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139407911|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407912|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139407913|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
139407914|NCT02298283|Hormones|hormones|mesh-ancestor
139407915|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139407916|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139407917|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139407918|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
139407919|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
139407920|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
139407921|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139407922|NCT02298283|Immunotoxins|immunotoxins|mesh-ancestor
139407923|NCT02298283|Immunoconjugates|immunoconjugates|mesh-ancestor
139407924|NCT02346357|Ropivacaine|ropivacaine|mesh-list
139407925|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
139407926|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
139407927|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139407928|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407929|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
139407930|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407931|NCT03146247|Apremilast|apremilast|mesh-list
139407932|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139407933|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139407934|NCT03146247|Analgesics|analgesics|mesh-ancestor
139407935|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
139407936|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407937|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407938|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139407939|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139407940|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139407941|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139407942|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407943|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407944|NCT03263273|Minocycline|minocycline|mesh-list
139407945|NCT03263273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139407946|NCT03263273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139407947|NCT03146325|Metronidazole|metronidazole|mesh-list
139407948|NCT03146325|Tetracycline|tetracycline|mesh-list
139407950|NCT03146325|Bismuth|bismuth|mesh-list
139407951|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139407952|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139407953|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139407954|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139407955|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139407956|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139407957|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139407958|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407959|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407960|NCT03146325|Antacids|antacids|mesh-ancestor
139407961|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139407962|NCT02233049|Everolimus|everolimus|mesh-list
139407963|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139407964|NCT02233049|Dasatinib|dasatinib|mesh-list
139407965|NCT02233049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139407966|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139407967|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407968|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407969|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139407970|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
139407971|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407972|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139407973|NCT02350725|Furosemide|furosemide|mesh-list
139407974|NCT02350725|Diuretics|diuretics|mesh-ancestor
139407975|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
139407976|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407977|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139407978|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139407979|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407980|NCT02350959|Atorvastatin|atorvastatin|mesh-list
139407981|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139407982|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139407983|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
139407984|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407985|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139407986|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139407987|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139407988|NCT02350335|Nicotine|nicotine|mesh-list
139407989|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139407990|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
139407991|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139407992|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139407993|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139407994|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139407995|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
139407996|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139407997|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139407998|NCT02293447|Lidocaine|lidocaine|mesh-list
139407999|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
139408000|NCT02293447|Anesthetics|anesthetics|mesh-list
139408001|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408002|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408003|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
139408004|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408005|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139408006|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139408007|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139408008|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139408009|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408010|NCT04464811|Furosemide|furosemide|mesh-list
139408011|NCT04464811|Diuretics|diuretics|mesh-ancestor
139408012|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
139064804|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
139408013|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408014|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139408015|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139408016|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408017|NCT02293525|Morphine|morphine|mesh-list
139408018|NCT02293525|Oxycodone|oxycodone|mesh-list
139408019|NCT02293525|Ropivacaine|ropivacaine|mesh-list
139408020|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139408021|NCT02293525|Narcotics|narcotics|mesh-ancestor
139408022|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408023|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408024|NCT02293525|Analgesics|analgesics|mesh-ancestor
139408025|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
139408026|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408027|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
139408028|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
139408029|NCT02298595|Cetuximab|cetuximab|mesh-list
139408030|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408031|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139408032|NCT02345343|Apixaban|apixaban|mesh-list
139408033|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139408034|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
139408035|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139408036|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
139408037|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408038|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408039|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
139408040|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
139408041|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139408042|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139408043|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408044|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
139408045|NCT02350179|Coagulants|coagulants|mesh-ancestor
139408046|NCT02233205|Gemcitabine|gemcitabine|mesh-list
139408047|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139408048|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
139408049|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408050|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408051|NCT02843633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139408052|NCT02293681|Infliximab|infliximab|mesh-list
139408053|NCT02293681|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139408054|NCT02293681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139408055|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
139408056|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139408057|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139408058|NCT02259491|Calcium|calcium|mesh-list
139408059|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139408060|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408061|NCT05255523|Capecitabine|capecitabine|mesh-list
139408062|NCT05255523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139408063|NCT05255523|Antimetabolites|antimetabolites|mesh-ancestor
139408064|NCT05255523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408065|NCT05255523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408066|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
139408067|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139408068|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
139408069|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408070|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139408071|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139408072|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
139408073|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408074|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408075|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139408076|NCT02298985|Curcumin|curcumin|mesh-list
139408077|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
139408078|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139408079|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139408080|NCT02298985|Analgesics|analgesics|mesh-ancestor
139408081|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
139408082|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408083|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408084|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139408085|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139408086|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408087|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408088|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408089|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139408090|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408091|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139408092|NCT03149445|Metoprolol|metoprolol|mesh-list
139408093|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139408094|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139651793|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139408095|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
139408097|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408098|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408099|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139408100|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139408101|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139408102|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
139408103|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408104|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408105|NCT02345187|Micronutrients|micronutrients|mesh-list
139408106|NCT02345187|Trace Elements|trace elements|mesh-list
139408107|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408108|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
139408109|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139408110|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408111|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408112|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139408113|NCT02299063|Analgesics|analgesics|mesh-ancestor
139408114|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
139408115|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408116|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139408117|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139408118|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139408119|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
139408120|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408121|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408122|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
139408123|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408124|NCT05624801|Vitamin D|vitamin d|mesh-list
139408125|NCT05624801|Vitamins|vitamins|mesh-ancestor
139408126|NCT05624801|Micronutrients|micronutrients|mesh-ancestor
139408127|NCT05624801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408128|NCT05624801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139408129|NCT05255211|Propofol|propofol|mesh-list
139408130|NCT05255211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139408131|NCT05255211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408132|NCT05255211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408133|NCT05255211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139408134|NCT05255211|Anesthetics, General|anesthetics, general|mesh-ancestor
139408135|NCT05255211|Anesthetics|anesthetics|mesh-ancestor
139408136|NCT03514381|Doxorubicin|doxorubicin|mesh-list
139408137|NCT03514381|Ifosfamide|ifosfamide|mesh-list
139408138|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139408139|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408140|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139408141|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139408142|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408143|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408144|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139408145|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
139408146|NCT02343393|Hydralazine|hydralazine|mesh-list
139408147|NCT02343393|Isosorbide|isosorbide|mesh-list
139408148|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139408149|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139408150|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139408151|NCT02343393|Diuretics|diuretics|mesh-ancestor
139408152|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
139408153|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408154|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
139408155|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139408156|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408157|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139408158|NCT02344875|Dotinurad|dotinurad|mesh-list
139408159|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
139408160|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
139408161|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139408162|NCT03145623|Grazoprevir|grazoprevir|mesh-list
139408163|NCT03145623|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139408164|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
139064953|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139408165|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408166|NCT02294071|Acetaminophen|acetaminophen|mesh-list
139408167|NCT02294071|Ibuprofen|ibuprofen|mesh-list
139408168|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139408169|NCT02294071|Analgesics|analgesics|mesh-ancestor
139408170|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
139408171|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408172|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408173|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
138756572|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
139408174|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139408175|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139408176|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139408177|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139408178|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408179|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408180|NCT02233439|Galactogogues|galactogogues|mesh-list
139408181|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408182|NCT02350023|Betamethasone|betamethasone|mesh-list
139408183|NCT02350023|Latanoprost|latanoprost|mesh-list
139408184|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139408185|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139408186|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139408187|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
139408188|NCT02350023|Hormones|hormones|mesh-ancestor
139408189|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139408190|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408191|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139408192|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
139408193|NCT02342925|Metformin|metformin|mesh-list
139408194|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139408195|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408196|NCT03879863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139408197|NCT03879863|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139408198|NCT02344641|Exenatide|exenatide|mesh-list
139408199|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139408200|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408201|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139408202|NCT02344641|Incretins|incretins|mesh-ancestor
139408203|NCT02344641|Hormones|hormones|mesh-ancestor
139408204|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139408205|NCT03798743|Docetaxel|docetaxel|mesh-list
139408206|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408207|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
139408208|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
139408209|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
139408210|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408211|NCT02342769|Dolutegravir|dolutegravir|mesh-list
139408212|NCT02342769|Abacavir|abacavir|mesh-list
139408213|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139408214|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139408215|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408216|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408217|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139408218|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139408219|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
139408220|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408221|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139408222|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139408223|NCT03766295|Gemcitabine|gemcitabine|mesh-list
139408224|NCT03766295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139408225|NCT03766295|Antimetabolites|antimetabolites|mesh-ancestor
139408226|NCT03766295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408227|NCT03766295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408228|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139408229|NCT02349945|Hormones|hormones|mesh-ancestor
139408230|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139408231|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408232|NCT02302495|Prednisone|prednisone|mesh-list
139408233|NCT02302495|Melphalan|melphalan|mesh-list
139408234|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139408235|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
139408236|NCT02302495|Hormones|hormones|mesh-ancestor
139408237|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139408238|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408239|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139408240|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408241|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139651794|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139408242|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
139140105|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139651795|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408243|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408244|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139408245|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139408246|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
139408247|NCT02813447|Sertraline|sertraline|mesh-list
139408248|NCT02813447|Antidepressive Agents|antidepressive agents|mesh-ancestor
139408249|NCT02813447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139408250|NCT02813447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139408251|NCT02813447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139408252|NCT02813447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139408253|NCT02813447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408254|NCT02813447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408255|NCT02813447|Serotonin Agents|serotonin agents|mesh-ancestor
138756684|NCT00890929|Azacitidine|azacitidine|mesh-list
139408256|NCT02813447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408257|NCT02342145|Cyclosporine|cyclosporine|mesh-list
139408258|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
139408259|NCT02342145|Methotrexate|methotrexate|mesh-list
139408260|NCT02342145|Cyclosporins|cyclosporins|mesh-list
139408261|NCT02342145|Basiliximab|basiliximab|mesh-list
139408262|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139408263|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
139408264|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139408265|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408266|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139408267|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
139408268|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408269|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408270|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
139408271|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408272|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139408273|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139408274|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
139408275|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139408276|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139408277|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
139408278|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408279|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139408280|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139408281|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139408282|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
139408283|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139408284|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
139408285|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139408286|NCT02349399|Cyproterone|cyproterone|mesh-list
139408287|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
139408288|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139408289|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139408290|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139408291|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
139408292|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139408293|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408294|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139408295|NCT02349399|Estrogens|estrogens|mesh-ancestor
139408296|NCT02349399|Hormones|hormones|mesh-ancestor
139408297|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139408298|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
139408299|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
139408300|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408301|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139408302|NCT02306473|Mannitol|mannitol|mesh-list
139408303|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139408304|NCT02306473|Diuretics|diuretics|mesh-ancestor
139408305|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
139408306|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408307|NCT03709121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139408308|NCT03709121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139408309|NCT02344095|Paclitaxel|paclitaxel|mesh-list
139408310|NCT02344095|Cisplatin|cisplatin|mesh-list
139408311|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139408312|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408313|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
139408314|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
139651796|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408315|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
139651797|NCT03000777|Melatonin|melatonin|mesh-list
139408316|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408318|NCT00157339|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139408319|NCT00157339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139408320|NCT00157339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408321|NCT02342067|Pioglitazone|pioglitazone|mesh-list
139408322|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
139408323|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139408324|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408325|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139408326|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408327|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139408328|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139408329|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
139408330|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408331|NCT02344017|Prednisone|prednisone|mesh-list
139408332|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139408333|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
139408334|NCT02344017|Hormones|hormones|mesh-ancestor
139408335|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139408336|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408337|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139408338|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408339|NCT02343861|Emollients|emollients|mesh-list
139408340|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
139408341|NCT03676751|Azithromycin|azithromycin|mesh-list
139408342|NCT03676751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139408343|NCT03676751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408344|NCT02302729|Micronutrients|micronutrients|mesh-list
139408345|NCT02302729|Trace Elements|trace elements|mesh-list
139408346|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408347|NCT03513601|Rituximab|rituximab|mesh-list
139408348|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139408349|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408350|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
139408351|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408352|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139408353|NCT03507829|Insulin|insulin|mesh-list
139408354|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139408355|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
139408356|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
139408357|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
139408358|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
139408359|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139408360|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408361|NCT02232581|Alovudine|alovudine|mesh-list
139408362|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
139408363|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
139408364|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408365|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
139408366|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408367|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139408368|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139408369|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408370|NCT02341833|Sevoflurane|sevoflurane|mesh-list
139408371|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139408372|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139408373|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
139408374|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
139408375|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408376|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408377|NCT02337231|Borage oil|borage oil|mesh-list
139408378|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139408379|NCT02306629|Epratuzumab|epratuzumab|mesh-list
139408380|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139408381|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408382|NCT03510793|Anesthetics|anesthetics|mesh-list
139408383|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408384|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408386|NCT05230797|Propolis|propolis|mesh-list
139408387|NCT05230797|Eugenol|eugenol|mesh-list
139408388|NCT05230797|Zinc Oxide|zinc oxide|mesh-list
139408389|NCT05230797|Trace Elements|trace elements|mesh-ancestor
139408390|NCT05230797|Micronutrients|micronutrients|mesh-ancestor
139408391|NCT05230797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065182|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139408392|NCT05230797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408393|NCT05230797|Dermatologic Agents|dermatologic agents|mesh-ancestor
139408394|NCT05230797|Sunscreening Agents|sunscreening agents|mesh-ancestor
139408395|NCT05230797|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139408396|NCT05230797|Protective Agents|protective agents|mesh-ancestor
139408397|NCT02341365|Vitamin D|vitamin d|mesh-list
139408398|NCT02341365|Vitamins|vitamins|mesh-ancestor
139408399|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
139408400|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408401|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139408402|NCT02299687|Omeprazole|omeprazole|mesh-list
139408403|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139408404|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139408405|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139408406|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408407|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408408|NCT02349243|Entacapone|entacapone|mesh-list
139408409|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139408410|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139408411|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139408412|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408413|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408414|NCT02341209|Doxycycline|doxycycline|mesh-list
139408415|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139408416|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408417|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
139408418|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139408419|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139408420|NCT02349165|Riboflavin|riboflavin|mesh-list
139408421|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
139408422|NCT02349165|Vitamins|vitamins|mesh-ancestor
139408423|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
139408424|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408425|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139408426|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
139408427|NCT03112005|Mydriatics|mydriatics|mesh-list
139408428|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
139408429|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408430|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408431|NCT02306785|Mesalamine|mesalamine|mesh-list
139408432|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139408433|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139408434|NCT02306785|Analgesics|analgesics|mesh-ancestor
139408435|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
139408436|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408437|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408438|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139408439|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139408440|NCT02299765|Carboplatin|carboplatin|mesh-list
139408441|NCT02299765|Gemcitabine|gemcitabine|mesh-list
139408442|NCT02299765|Gefitinib|gefitinib|mesh-list
139408443|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408444|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139408445|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
139408446|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408447|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139408448|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408449|NCT04771923|Epinephrine|epinephrine|mesh-list
139408450|NCT04771923|Racepinephrine|racepinephrine|mesh-list
139408451|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
139408452|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
139408453|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139408454|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139408455|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408456|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
139408457|NCT04771923|Coagulants|coagulants|mesh-ancestor
139408458|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139408459|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139408460|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
139408461|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408462|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408463|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139408464|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139408465|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
139651798|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
139408466|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408467|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139408468|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
139408469|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
139651799|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408470|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
139408471|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139408472|NCT05254899|Gemcitabine|gemcitabine|mesh-list
139408473|NCT05254899|Oxaliplatin|oxaliplatin|mesh-list
139408474|NCT05254899|Tislelizumab|tislelizumab|mesh-list
139408475|NCT05254899|Pegaspargase|pegaspargase|mesh-list
139408477|NCT05254899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139408478|NCT05254899|Immunologic Factors|immunologic factors|mesh-ancestor
139408479|NCT05254899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408480|NCT05254899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139408481|NCT05254899|Antimetabolites|antimetabolites|mesh-ancestor
139408482|NCT05254899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408483|NCT05254899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408484|NCT05254899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139408485|NCT03148509|Risperidone|risperidone|mesh-list
139408486|NCT03148509|Aripiprazole|aripiprazole|mesh-list
139408487|NCT03148509|Bupropion|bupropion|mesh-list
139408488|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139408489|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
139408490|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408491|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408492|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408493|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139408494|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139408495|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408496|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139408497|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139408498|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
139408499|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139408500|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
139408501|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139408502|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139408503|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139408504|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139408505|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139408506|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408507|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
139408508|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139408509|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139408510|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139408511|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139408512|NCT05254665|Docetaxel|docetaxel|mesh-list
139408513|NCT05254665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408514|NCT05254665|Tubulin Modulators|tubulin modulators|mesh-ancestor
139408515|NCT05254665|Antimitotic Agents|antimitotic agents|mesh-ancestor
139408516|NCT05254665|Mitosis Modulators|mitosis modulators|mesh-ancestor
139408517|NCT05254665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408518|NCT03513055|Insulin|insulin|mesh-list
139408519|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139408520|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408521|NCT03510325|Olanzapine|olanzapine|mesh-list
139408522|NCT03510325|Risperidone|risperidone|mesh-list
139408523|NCT03510325|Aripiprazole|aripiprazole|mesh-list
139408524|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139408525|NCT03510325|Amisulpride|amisulpride|mesh-list
139408526|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139408527|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
139408528|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408529|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408530|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408531|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139408532|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139408533|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408534|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139408535|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139408536|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
139408537|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
139408538|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
139408539|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408540|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139408541|NCT03510325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139408542|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139408543|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139651800|NCT03000777|Protective Agents|protective agents|mesh-ancestor
139408544|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
139408545|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
139408547|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139408548|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139408549|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139408550|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139408552|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139408553|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139408554|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
139408555|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408556|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408557|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408558|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139408559|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139408560|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139408561|NCT02336529|Bupivacaine|bupivacaine|mesh-list
139408562|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
139408563|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
139408564|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408565|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408566|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
139408567|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408568|NCT02307487|Mitomycins|mitomycins|mesh-list
139408569|NCT02307487|Mitomycin|mitomycin|mesh-list
139408570|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139408571|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408572|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
139408573|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408574|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139408575|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408576|NCT02307565|Midodrine|midodrine|mesh-list
139408577|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
139408578|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
139408579|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408580|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408581|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139408582|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139408583|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139408584|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139408585|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
139408586|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408587|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408588|NCT03510013|Anesthetics|anesthetics|mesh-list
139408589|NCT03510013|Sevoflurane|sevoflurane|mesh-list
139408590|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
139408591|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408592|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408593|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139408594|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
139408595|NCT02307721|Remifentanil|remifentanil|mesh-list
139408596|NCT02307721|Naloxone|naloxone|mesh-list
139408597|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139408598|NCT02307721|Narcotics|narcotics|mesh-ancestor
139408599|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408600|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408601|NCT02307721|Analgesics|analgesics|mesh-ancestor
139408602|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
139408603|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408604|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139408605|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
139408606|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139408607|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
139408608|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139408609|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
139408610|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408611|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408612|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
139408613|NCT02348463|Clindamycin|clindamycin|mesh-list
139408614|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
139408615|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
139408616|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139408617|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408618|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139408619|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140110|NCT03308786|Aldesleukin|aldesleukin|mesh-list
139408620|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408622|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139408623|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139408624|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
139408625|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408626|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408627|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408628|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
139408629|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
139408630|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408631|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
139408632|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138756996|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408633|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
139408634|NCT02300623|Lamivudine|lamivudine|mesh-list
139408635|NCT02300623|Stavudine|stavudine|mesh-list
139408636|NCT02300623|Indinavir|indinavir|mesh-list
139408637|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139408638|NCT02300623|Interleukin-2|interleukin-2|mesh-list
139408639|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139408640|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139408641|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408642|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408643|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
139408644|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408645|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139408646|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408647|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139408648|NCT02300623|Analgesics|analgesics|mesh-ancestor
139408649|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
139408650|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408651|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408652|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
139408653|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139408654|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139408655|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
139408656|NCT04463953|Dexamethasone|dexamethasone|mesh-list
139408657|NCT04463953|Ixazomib|ixazomib|mesh-list
139408658|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
139408659|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139408660|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
139408661|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
139408662|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408663|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408664|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139408665|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
139408666|NCT04463953|Hormones|hormones|mesh-ancestor
139408667|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139408668|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139408669|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408670|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
139408671|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408672|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408673|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139408674|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
139408675|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
139408676|NCT02307955|Protective Agents|protective agents|mesh-ancestor
139408677|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408678|NCT03147963|Docetaxel|docetaxel|mesh-list
139408679|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408680|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
139408681|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
139408682|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
139408683|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408684|NCT02348307|Dotinurad|dotinurad|mesh-list
139408685|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
139408686|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
139408687|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139408688|NCT02340117|Paclitaxel|paclitaxel|mesh-list
139408689|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139408690|NCT02340117|Gemcitabine|gemcitabine|mesh-list
139408691|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139408692|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408693|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
139408694|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
139408695|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
139140111|NCT03308786|Interleukin-2|interleukin-2|mesh-list
139651801|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651802|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408696|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408697|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139408698|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
139408700|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139408701|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139408702|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
139408703|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
139408704|NCT02336139|Velpatasvir|velpatasvir|mesh-list
139408705|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
139408706|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408707|NCT02340195|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
139408708|NCT02340195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139408709|NCT02340195|Serotonin Agents|serotonin agents|mesh-ancestor
139408710|NCT02340195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408711|NCT02340195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408712|NCT02340195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408713|NCT02300935|Paclitaxel|paclitaxel|mesh-list
139408714|NCT02300935|Trametinib|trametinib|mesh-list
139408715|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139408716|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408717|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
139408718|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
139408719|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
139408720|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408721|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139408722|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408723|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139408724|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139408725|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408726|NCT02301091|Mitomycins|mitomycins|mesh-list
139408727|NCT02301091|Mitomycin|mitomycin|mesh-list
139408728|NCT02301091|Pirarubicin|pirarubicin|mesh-list
139408729|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139408730|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408731|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
139408732|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408733|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139408734|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408735|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
139408736|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
139408737|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139408738|NCT02335593|Hematinics|hematinics|mesh-ancestor
139408739|NCT02335593|Astringents|astringents|mesh-ancestor
139408740|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408741|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
139408742|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139408743|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139408744|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
139408745|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408746|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139408747|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139408748|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
139408749|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408750|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408751|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139408752|NCT02309281|Aflibercept|aflibercept|mesh-list
139408753|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139408754|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139408755|NCT02309281|Growth Substances|growth substances|mesh-ancestor
139408756|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408757|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
139408758|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408759|NCT02335281|Mesalamine|mesalamine|mesh-list
139408760|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139408761|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139408762|NCT02335281|Analgesics|analgesics|mesh-ancestor
139408763|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
139408764|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408765|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408766|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139408767|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139408768|NCT02309437|Oxycodone|oxycodone|mesh-list
139408769|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139065556|NCT03862768|Growth Substances|growth substances|mesh-ancestor
139408770|NCT02309437|Narcotics|narcotics|mesh-ancestor
139408771|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139408772|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408773|NCT02309437|Analgesics|analgesics|mesh-ancestor
139408774|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
139408775|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408776|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
139408777|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139408778|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139408779|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408780|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
139408781|NCT02335359|Coagulants|coagulants|mesh-ancestor
139408782|NCT03511261|Curcumin|curcumin|mesh-list
139408783|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139408784|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139408785|NCT03511261|Analgesics|analgesics|mesh-ancestor
139408786|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
139408787|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408788|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408789|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139408790|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139408791|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408792|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408793|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408794|NCT03509701|Antibodies|antibodies|mesh-list
139408795|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
139408796|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408797|NCT03511183|Bevacizumab|bevacizumab|mesh-list
139408798|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139408799|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408800|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139408801|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139408802|NCT03511183|Growth Substances|growth substances|mesh-ancestor
139408803|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408804|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
139408805|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
139408806|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139408807|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139408808|NCT02303587|Prednisolone|prednisolone|mesh-list
139408809|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
139408810|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139408811|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
139408812|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139408813|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
139408814|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
139408815|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408816|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408817|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139408818|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
139408819|NCT02303587|Hormones|hormones|mesh-ancestor
139408820|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139408821|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139408822|NCT02303587|Protective Agents|protective agents|mesh-ancestor
139408823|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139408824|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408825|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
139408826|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408827|NCT03107871|Valganciclovir|valganciclovir|mesh-list
139408828|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
139408829|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408830|NCT03064113|Ipratropium|ipratropium|mesh-list
139408831|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139408832|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
139408833|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408834|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408835|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139408836|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
139408837|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139408838|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
139408839|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408840|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408841|NCT02301715|Oxytocin|oxytocin|mesh-list
138757223|NCT01238588|Sevelamer|sevelamer|mesh-list
139651803|NCT03006003|Alendronate|alendronate|mesh-list
139651804|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139408842|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
139408843|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139065636|NCT00149994|Protective Agents|protective agents|mesh-ancestor
139408844|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408846|NCT03509545|Furosemide|furosemide|mesh-list
139408847|NCT03509545|Diuretics|diuretics|mesh-ancestor
139408848|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
139408849|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408850|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139408851|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139408852|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408853|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139408854|NCT02301949|Thalidomide|thalidomide|mesh-list
139408855|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139408856|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
139408857|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408858|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
139408859|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139408860|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408861|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139408862|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139408863|NCT02301949|Growth Substances|growth substances|mesh-ancestor
139408864|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
139408865|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408866|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139408867|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
139408868|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139408869|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139408870|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139408871|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
139408872|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139408873|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408874|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139408875|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139408876|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139408877|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139408878|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408879|NCT02303899|Gemcitabine|gemcitabine|mesh-list
139408880|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
138757264|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408881|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139408882|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
139408883|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408884|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408885|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139408886|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408887|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139408888|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139408889|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139408890|NCT03510871|Nivolumab|nivolumab|mesh-list
139408891|NCT03510871|Ipilimumab|ipilimumab|mesh-list
139408892|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139408893|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408894|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139408895|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408896|NCT02331771|Donepezil|donepezil|mesh-list
139408897|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139408898|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408899|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408900|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
139408901|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408902|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408903|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
139408904|NCT02334501|Lansoprazole|lansoprazole|mesh-list
139408905|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
139408906|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139408907|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139408908|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139408909|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408910|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408911|NCT02331927|Aflibercept|aflibercept|mesh-list
139408912|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139408913|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139408914|NCT02331927|Growth Substances|growth substances|mesh-ancestor
139408915|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408916|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
139651805|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139408917|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408919|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139408920|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
139408922|NCT02304055|Carbetocin|carbetocin|mesh-list
139408923|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
139408924|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139408925|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408926|NCT03505489|Mannitol|mannitol|mesh-list
139408927|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
139408928|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139408929|NCT03505489|Diuretics|diuretics|mesh-ancestor
139408930|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
139408931|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408932|NCT03505489|Miotics|miotics|mesh-ancestor
139408933|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
139408934|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408935|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139408936|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139408937|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
139408938|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139408939|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139408940|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
139408941|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408942|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408943|NCT02310373|Nicotine|nicotine|mesh-list
139408944|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139408945|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
139408946|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139408947|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408948|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139408949|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139408950|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
139408951|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139408952|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408953|NCT02338323|Febuxostat|febuxostat|mesh-list
139408954|NCT02338323|Benzbromarone|benzbromarone|mesh-list
139408955|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
139408956|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139408957|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
139408958|NCT02321800|Imipenem|imipenem|mesh-list
139408959|NCT02321800|Cilastatin|cilastatin|mesh-list
139408960|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139408961|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139408962|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
139408963|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408964|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408965|NCT02310295|Triamcinolone|triamcinolone|mesh-list
139408966|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139408967|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139408968|NCT02310295|Bevacizumab|bevacizumab|mesh-list
139408969|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139408970|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139408971|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408972|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139408973|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139408974|NCT02310295|Growth Substances|growth substances|mesh-ancestor
139408975|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408976|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
139408977|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139408978|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
139408979|NCT02310295|Hormones|hormones|mesh-ancestor
139408980|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139408981|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139408982|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
139408983|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408984|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408985|NCT02338089|Oxytocin|oxytocin|mesh-list
139408986|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
139408987|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139408988|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139408989|NCT02338245|Capecitabine|capecitabine|mesh-list
139408990|NCT02338245|Lapatinib|lapatinib|mesh-list
139408991|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139408992|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
139408993|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139408994|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139408995|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139408996|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139408997|NCT02332005|Choline|choline|mesh-list
139408998|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
139408999|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139409000|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
139409001|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409002|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139409003|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139409004|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
139409005|NCT02304211|Insulin|insulin|mesh-list
139409006|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139409007|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409008|NCT02311777|Pregabalin|pregabalin|mesh-list
139409009|NCT02311777|Ketamine|ketamine|mesh-list
139409010|NCT02311777|Analgesics|analgesics|mesh-ancestor
139409011|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
139409012|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409013|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409014|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139409015|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139409016|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
139409017|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
139409018|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409019|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139409020|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139409021|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409022|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409023|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
139409024|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139409025|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139409026|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139409027|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139409028|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139409029|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139409030|NCT03504865|Bupivacaine|bupivacaine|mesh-list
139409031|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
139409032|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
139409033|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409034|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409035|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
139409036|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409037|NCT02304289|Artesunate|artesunate|mesh-list
139409038|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
139409039|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139409040|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139409041|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409042|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409043|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
139409044|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
139409045|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139409046|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
139409047|NCT02292784|Atosiban|atosiban|mesh-list
139409048|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
139409049|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139409050|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409051|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
139409052|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139409053|NCT02338011|Gefitinib|gefitinib|mesh-list
139409054|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409055|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139409056|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409057|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409058|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139409059|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139409060|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
138757450|NCT00627081|Remifentanil|remifentanil|mesh-list
139409061|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409062|NCT02337855|Antacids|antacids|mesh-ancestor
139409063|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409064|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139651806|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409065|NCT02320396|Desloratadine|desloratadine|mesh-list
139409066|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139651807|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139409067|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
139409068|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409069|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409070|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065882|NCT00114738|Rituximab|rituximab|mesh-list
139409071|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139409072|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139409073|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
139409074|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
139409075|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
139409076|NCT02310997|Melphalan|melphalan|mesh-list
139409077|NCT02310997|Busulfan|busulfan|mesh-list
139409078|NCT02310997|Fludarabine|fludarabine|mesh-list
139409079|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139409080|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
139409081|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409082|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139409083|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139409084|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
139409085|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409086|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409087|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139409088|NCT03505411|Melatonin|melatonin|mesh-list
139409089|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
139409090|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409091|NCT03505411|Protective Agents|protective agents|mesh-ancestor
139409092|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409093|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409094|NCT02292238|Benphothiamine|benphothiamine|mesh-list
139409095|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139409096|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
139409097|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409098|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
139409099|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
139409100|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409101|NCT03867123|Temozolomide|temozolomide|mesh-list
139409102|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139409103|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
139409104|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409105|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409106|NCT03504475|Paroxetine|paroxetine|mesh-list
139409107|NCT03504475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139409108|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139409109|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139409110|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409111|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409112|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
139409113|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409114|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139409115|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
139409116|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139409117|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139409118|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139409119|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409120|NCT02327247|Felodipine|felodipine|mesh-list
139409121|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139409122|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139409123|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139409124|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139409125|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409126|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139409127|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409128|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
139409129|NCT03505255|Neostigmine|neostigmine|mesh-list
139409130|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139409131|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409132|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409133|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
139409134|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409135|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409136|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139409137|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
139409138|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651808|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
139409139|NCT02333799|Linezolid|linezolid|mesh-list
139409140|NCT02333799|Bedaquiline|bedaquiline|mesh-list
139409141|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139409142|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065935|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
139409143|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139409144|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409145|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409146|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
139409147|NCT02311231|Heparin|heparin|mesh-list
139409148|NCT02311231|Calcium heparin|calcium heparin|mesh-list
139409149|NCT02311231|Bivalirudin|bivalirudin|mesh-list
139409150|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
139409151|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139409152|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139409153|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409154|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
139409155|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139409156|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
139409157|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409158|NCT03508999|Metronidazole|metronidazole|mesh-list
139409159|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409160|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139409161|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139409162|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139409163|NCT03105375|Omeprazole|omeprazole|mesh-list
139409164|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139409165|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139409166|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139409167|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409168|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409169|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
139409170|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139409171|NCT02304445|Estrogens|estrogens|mesh-ancestor
139409172|NCT02304445|Hormones|hormones|mesh-ancestor
139409173|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139409174|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409175|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139409176|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409177|NCT02316301|Misoprostol|misoprostol|mesh-list
139409178|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139409179|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
139409180|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139409181|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409182|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139409183|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139409184|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
139409185|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
139409186|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139409187|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139409188|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409189|NCT02327091|Vitamins|vitamins|mesh-ancestor
139409190|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
139409191|NCT02316535|Capecitabine|capecitabine|mesh-list
139409192|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139409193|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
139409194|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409195|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409196|NCT02333253|Cetrorelix|cetrorelix|mesh-list
139409197|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139409198|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
139409199|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139409200|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409201|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
138757535|NCT02858206|Paclitaxel|paclitaxel|mesh-list
139409202|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139409203|NCT02039661|Lidocaine|lidocaine|mesh-list
139409204|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
139409205|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
139409206|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409207|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409208|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
139409209|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409210|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139409211|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139409212|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139409213|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139409214|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409216|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139409217|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139409219|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
139409220|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409221|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409222|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139409223|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139409224|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139409225|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139409226|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409227|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139409228|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139409229|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409230|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
139409231|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139409232|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409233|NCT02312635|Cycloserine|cycloserine|mesh-list
139409234|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139409235|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409236|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139409237|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
139409238|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139409239|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
139409240|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409241|NCT03144453|Atropine|atropine|mesh-list
139409242|NCT03144453|Neostigmine|neostigmine|mesh-list
139409243|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139409244|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139409245|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139409246|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
138757565|NCT02809963|Diuretics|diuretics|mesh-ancestor
139409247|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409248|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409249|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139409250|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
139409251|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
139409252|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
139409253|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139409254|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139409255|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
139409256|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409257|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409258|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139409259|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409260|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139409261|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
139409262|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409263|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139409264|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409265|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409266|NCT02332941|Rituximab|rituximab|mesh-list
139409267|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139409268|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409269|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
139409270|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409271|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139409272|NCT03503227|Aspirin|aspirin|mesh-list
139409273|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
139409274|NCT03503227|Prednisolone|prednisolone|mesh-list
139409275|NCT03503227|Salicylates|salicylates|mesh-list
139409276|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139409277|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
139409278|NCT03503227|Hormones|hormones|mesh-ancestor
139409279|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139409280|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409281|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139409282|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409283|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409284|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409285|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
139409286|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
139409287|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
138913979|NCT00773838|Dexamethasone|dexamethasone|mesh-list
139409288|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139409289|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139409290|NCT03503227|Analgesics|analgesics|mesh-ancestor
139409291|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
139066083|NCT00146640|Prednisone|prednisone|mesh-list
139409292|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139409293|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139409294|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409295|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409296|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139409297|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139409298|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139409299|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
139409300|NCT02305069|Pioglitazone|pioglitazone|mesh-list
139409302|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139409303|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409304|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139409305|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139409306|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409307|NCT02317237|Anesthetics|anesthetics|mesh-list
139409308|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409309|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409310|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139409311|NCT02332473|Molgramostim|molgramostim|mesh-list
139409312|NCT02332473|Sargramostim|sargramostim|mesh-list
139409313|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
139409314|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409315|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
139409316|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409317|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409318|NCT03501433|Niacinamide|niacinamide|mesh-list
139409319|NCT03501433|Niacin|niacin|mesh-list
139409320|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
139409321|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
139409322|NCT03501433|Vitamins|vitamins|mesh-ancestor
139409323|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
139409324|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409325|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139409326|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
139409327|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409328|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139409329|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
139409330|NCT02313103|Lofexidine|lofexidine|mesh-list
139409331|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139409332|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139409333|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409334|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
139409335|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409336|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139409337|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139409338|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139409339|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
139409340|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409341|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409342|NCT01959633|Interferons|interferons|mesh-list
139409343|NCT01959633|Vemurafenib|vemurafenib|mesh-list
139409344|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409345|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
139409346|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409347|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139409348|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409349|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409350|NCT02326623|Anesthetics|anesthetics|mesh-list
139409351|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
139409352|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409353|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409354|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
139409355|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409356|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
139409357|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409358|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
139409359|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139409360|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139409361|NCT02332629|Prednisolone|prednisolone|mesh-list
139409362|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
139409363|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139409364|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
139409365|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139409366|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
139066160|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
139409367|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
139409368|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409369|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409370|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139409371|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
139409372|NCT02332629|Hormones|hormones|mesh-ancestor
139409373|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139409374|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139409375|NCT02332629|Protective Agents|protective agents|mesh-ancestor
139409376|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139409377|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409378|NCT02313337|Midazolam|midazolam|mesh-list
139409379|NCT02313337|Fentanyl|fentanyl|mesh-list
139409380|NCT02313337|Anesthetics|anesthetics|mesh-list
139409381|NCT02313337|Propofol|propofol|mesh-list
139409382|NCT02313337|Atracurium|atracurium|mesh-list
139409383|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409384|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409385|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139409386|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139409387|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
138757672|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
139409388|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139409389|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139409390|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139409391|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139409392|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
139409393|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
139409394|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409395|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409396|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139409397|NCT02313337|Narcotics|narcotics|mesh-ancestor
139409398|NCT02313337|Analgesics|analgesics|mesh-ancestor
139409399|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
139409400|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409401|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139409402|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139409403|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139409404|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139409405|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139409406|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
139409407|NCT02305615|Bevacizumab|bevacizumab|mesh-list
139409408|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139409409|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409410|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139409411|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139409412|NCT02305615|Growth Substances|growth substances|mesh-ancestor
139409413|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409414|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
139409415|NCT02305693|Letrozole|letrozole|mesh-list
139409416|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409417|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139409418|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139409419|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409420|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409421|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139409422|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
139409423|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139409424|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409425|NCT02317861|Febuxostat|febuxostat|mesh-list
139409426|NCT02317861|Verinurad|verinurad|mesh-list
139409427|NCT02317861|Benzbromarone|benzbromarone|mesh-list
139409428|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
139409429|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139409430|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
139409431|NCT02318017|Methylphenidate|methylphenidate|mesh-list
139409432|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139409433|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409434|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139409435|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139409436|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139409437|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409438|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
139409439|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409440|NCT02313727|Pamidronate|pamidronate|mesh-list
139409441|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139409442|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409444|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139409445|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409446|NCT03132493|Nivolumab|nivolumab|mesh-list
139409447|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139409448|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409449|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139409450|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409451|NCT02313883|Taurolidine|taurolidine|mesh-list
139409452|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409453|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139409454|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409455|NCT03500653|Curcumin|curcumin|mesh-list
139409456|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139409457|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139409458|NCT03500653|Analgesics|analgesics|mesh-ancestor
139409459|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
139409460|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409461|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409462|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139409463|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139409464|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409465|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409466|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409467|NCT02305927|Vitamin D|vitamin d|mesh-list
139409468|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
139409469|NCT02305927|Vitamins|vitamins|mesh-ancestor
139409470|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
139409471|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409472|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139409473|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139409474|NCT02440009|Itraconazole|itraconazole|mesh-list
139409475|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
139409476|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
139409477|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409478|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138757720|NCT02812147|Droxidopa|droxidopa|mesh-list
139409479|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139409480|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409481|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409482|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139409483|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
139409484|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139409485|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409486|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139409487|NCT02440009|Hormones|hormones|mesh-ancestor
139409488|NCT02318563|Cannabidiol|cannabidiol|mesh-list
139409489|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139409490|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
139409491|NCT02314195|Serotonin|serotonin|mesh-list
139409492|NCT02314195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139409493|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139409494|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
139409495|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409496|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409497|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409498|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139409499|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139409500|NCT02314273|Oprelvekin|oprelvekin|mesh-list
139409501|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409502|NCT02314351|Fentanyl|fentanyl|mesh-list
139409503|NCT02314351|Metoclopramide|metoclopramide|mesh-list
139409504|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139409505|NCT02314351|Narcotics|narcotics|mesh-ancestor
139409506|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409507|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409508|NCT02314351|Analgesics|analgesics|mesh-ancestor
139409509|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
139409510|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409511|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139409512|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139409513|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
139409514|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
139409515|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
139409516|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
139409517|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139409518|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139409519|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139409520|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
139409521|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409522|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409523|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
139409524|NCT04463875|Riboflavin|riboflavin|mesh-list
139409525|NCT04463875|Ubiquinone|ubiquinone|mesh-list
139409526|NCT04463875|Andrographolide|andrographolide|mesh-list
139409527|NCT04463875|Vitamins|vitamins|mesh-ancestor
139409528|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
139409529|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409530|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
139409531|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139409532|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
139409533|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139409534|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139409535|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139409536|NCT04463875|Analgesics|analgesics|mesh-ancestor
139409537|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
139409538|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409539|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139409540|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139409541|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139409542|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409543|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
139409544|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139409545|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
139409546|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139409547|NCT04462939|Micronutrients|micronutrients|mesh-list
139409548|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409549|NCT02306239|Terlipressin|terlipressin|mesh-list
139409550|NCT02306239|Norepinephrine|norepinephrine|mesh-list
139409551|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139409552|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139409553|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
139409554|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409555|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409556|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409557|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
139409558|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
139409559|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409560|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139409561|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139409562|NCT02319187|Irinotecan|irinotecan|mesh-list
139409563|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139409564|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139409565|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409566|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409567|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409568|NCT02319265|Melatonin|melatonin|mesh-list
139409569|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
139409570|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409571|NCT02319265|Protective Agents|protective agents|mesh-ancestor
139409572|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409573|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409574|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
139409575|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139409576|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139409577|NCT02319343|Prednisolone|prednisolone|mesh-list
139409578|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
139409579|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139409580|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
139409581|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139409582|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
139409583|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
139409584|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409585|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409586|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139409587|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
139409588|NCT02319343|Hormones|hormones|mesh-ancestor
139140119|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139409589|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139409590|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139409591|NCT02319343|Protective Agents|protective agents|mesh-ancestor
139409592|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139409593|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409594|NCT02319499|Vitamin A|vitamin a|mesh-list
139409595|NCT02319499|Iron|iron|mesh-list
139409596|NCT02319499|Zinc|zinc|mesh-list
139409597|NCT02319499|Vitamins|vitamins|mesh-ancestor
139409598|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
139409599|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409600|NCT02319499|Trace Elements|trace elements|mesh-ancestor
139409601|NCT03499639|Ritonavir|ritonavir|mesh-list
139409602|NCT03499639|Ribavirin|ribavirin|mesh-list
139409603|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139409604|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139409605|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
139409606|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409607|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409608|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139409609|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139409610|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
139409611|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409612|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139409613|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139409614|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
139409615|NCT03502135|Phenylephrine|phenylephrine|mesh-list
139409616|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
139409617|NCT03502135|Tetracaine|tetracaine|mesh-list
139409618|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
139409619|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
139409620|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409621|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409622|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
139409623|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409624|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138757820|NCT02814409|Plasminogen|plasminogen|mesh-list
139409625|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139409626|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
139409627|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409628|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409629|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
139409630|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
139409631|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
139409632|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139409633|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
139409634|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139409635|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
139409636|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139409637|NCT03502135|Protective Agents|protective agents|mesh-ancestor
139409638|NCT02315287|Pioglitazone|pioglitazone|mesh-list
139409639|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139409640|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409641|NCT02319577|Vinorelbine|vinorelbine|mesh-list
139409642|NCT02319577|Gefitinib|gefitinib|mesh-list
139409643|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139409644|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409645|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
139409646|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
139409647|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
139409648|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409649|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139409650|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409651|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139409652|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409653|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
139409654|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139409655|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409656|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409657|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139409658|NCT03132259|Analgesics|analgesics|mesh-ancestor
139409659|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
139409660|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409661|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139409662|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139409663|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139409664|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
139409665|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409666|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409668|NCT03499171|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139409669|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139409670|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138757850|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139409671|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409672|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409673|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
139409674|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409675|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139409676|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
139409677|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139409678|NCT02447419|Gefitinib|gefitinib|mesh-list
139409679|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409680|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139409681|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409682|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409683|NCT02319889|Paclitaxel|paclitaxel|mesh-list
139409684|NCT02319889|Carboplatin|carboplatin|mesh-list
139409685|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139409686|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139409687|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409688|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
139409689|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
139409690|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
139409691|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409692|NCT02324413|Clonidine|clonidine|mesh-list
139409693|NCT02324413|Analgesics|analgesics|mesh-ancestor
139409694|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
139409695|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409696|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409697|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139409698|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
139409699|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
139409700|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139409701|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139409702|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139409703|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
139409704|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409705|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409706|NCT03498703|Azathioprine|azathioprine|mesh-list
139409707|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
139409708|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409709|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139409710|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409711|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139409712|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
139409713|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409714|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139409715|NCT02324491|CKD732|ckd732|mesh-list
139409716|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139409717|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139409718|NCT02324491|Growth Substances|growth substances|mesh-ancestor
139409719|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409720|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
139409721|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409722|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139409723|NCT03494257|Brinzolamide|brinzolamide|mesh-list
139409724|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139409725|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139409726|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139409727|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139409728|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
139409729|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409730|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409731|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409732|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139409733|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409734|NCT03132181|Empagliflozin|empagliflozin|mesh-list
139409735|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139409736|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409738|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409739|NCT02320045|Exenatide|exenatide|mesh-list
139409740|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139409741|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409742|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139409743|NCT02320045|Incretins|incretins|mesh-ancestor
139409744|NCT02320045|Hormones|hormones|mesh-ancestor
139409745|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139409747|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139409748|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139409749|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139409750|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139409751|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
139409752|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409753|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409754|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409755|NCT03498235|Propofol|propofol|mesh-list
139409756|NCT03498235|Sevoflurane|sevoflurane|mesh-list
139409757|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139409758|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409759|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409760|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139409761|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
139409762|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
139409763|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139409764|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139409765|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
139409766|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139409767|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
139409768|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409769|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
139409770|NCT03491761|Protective Agents|protective agents|mesh-ancestor
139409771|NCT03132103|Vitamin D|vitamin d|mesh-list
139409772|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
139409773|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
139409774|NCT03132103|Vitamins|vitamins|mesh-list
139409775|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
139409776|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409777|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139409778|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139409779|NCT04635943|Ivermectin|ivermectin|mesh-list
139409780|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139409781|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409782|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139409783|NCT04461925|Azithromycin|azithromycin|mesh-list
139409784|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
139409785|NCT04461925|Dexamethasone|dexamethasone|mesh-list
139409786|NCT04461925|Enoxaparin|enoxaparin|mesh-list
139409787|NCT04461925|Anticoagulants|anticoagulants|mesh-list
139409788|NCT04461925|Hormones|hormones|mesh-list
139409789|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139409790|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
139409791|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
139409792|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409793|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409794|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139409795|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
139409796|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139409797|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139409798|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409799|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409800|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409801|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139409802|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139409803|NCT02325583|Midazolam|midazolam|mesh-list
139409804|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139409805|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139409806|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409807|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409808|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139409809|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139409810|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139409811|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139409812|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
139409813|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
139651809|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139409814|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
139409815|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
139409816|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409817|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409818|NCT02321293|Curcumin|curcumin|mesh-list
139409819|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139066619|NCT03848806|Calcitriol|calcitriol|mesh-list
139409820|NCT02321293|Gefitinib|gefitinib|mesh-list
139409821|NCT02321293|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139409823|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139409824|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409825|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409826|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139409827|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139409828|NCT02321293|Analgesics|analgesics|mesh-ancestor
139409829|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
139409830|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409831|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409832|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139409833|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139409834|NCT02321371|Rifaximin|rifaximin|mesh-list
139409835|NCT02321371|Lactulose|lactulose|mesh-list
139409836|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139409837|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409838|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139409839|NCT03491371|Apatinib|apatinib|mesh-list
139409840|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409841|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139409842|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409843|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409844|NCT03546829|Vancomycin|vancomycin|mesh-list
139409845|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139409846|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409847|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
139409848|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139409849|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139409850|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139409851|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139409852|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409853|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
139409854|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409855|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409856|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139409857|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409858|NCT03493087|Vitamin K|vitamin k|mesh-list
139409859|NCT03493087|Vitamins|vitamins|mesh-ancestor
139409860|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
139409861|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409862|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139409863|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139409864|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409865|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
139409866|NCT03493087|Coagulants|coagulants|mesh-ancestor
139409867|NCT03136627|Nivolumab|nivolumab|mesh-list
139409868|NCT03136627|Tivozanib|tivozanib|mesh-list
139409869|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139409870|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409871|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139409872|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409873|NCT03136627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139409874|NCT03136627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409875|NCT02922985|Acetaminophen|acetaminophen|mesh-list
139409876|NCT02922985|Ketorolac|ketorolac|mesh-list
139409877|NCT02922985|Bupivacaine|bupivacaine|mesh-list
139409878|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
139409879|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
139409880|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409881|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409882|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
139409883|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409884|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139409885|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139409886|NCT02922985|Analgesics|analgesics|mesh-ancestor
139409887|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139140122|NCT03776409|Vancomycin|vancomycin|mesh-list
139409888|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139409889|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139409890|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409891|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409892|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
138758039|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
139409894|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139409895|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139409896|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409897|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409898|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139409899|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139409900|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
139409901|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409902|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409903|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
139409904|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139409905|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
139409906|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139409907|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
139409908|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409909|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409910|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
139409911|NCT03492931|Ticagrelor|ticagrelor|mesh-list
139409912|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139409913|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139409914|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139409915|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139409916|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
139409917|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409918|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409919|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409920|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
139409921|NCT02234921|Imiquimod|imiquimod|mesh-list
139409922|NCT02234921|Vaccines|vaccines|mesh-list
139409923|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
139409924|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409925|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139409926|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139409927|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139409928|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
139409929|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409930|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409931|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139409932|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139409933|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
139409934|NCT02321761|Amantadine|amantadine|mesh-list
139409935|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139409936|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139409937|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
139409938|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409939|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
139409940|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409941|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758115|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
139409942|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409943|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139409944|NCT02321761|Analgesics|analgesics|mesh-ancestor
139409945|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
139409946|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409947|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
139409948|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139409949|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139409950|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409951|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139409952|NCT04674241|Analgesics|analgesics|mesh-ancestor
139409953|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
139409954|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139409955|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139409956|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139409957|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139409958|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
139409959|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139409960|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409961|NCT02259647|Sorafenib|sorafenib|mesh-list
139409962|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409963|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139409964|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409965|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409966|NCT02321839|Ranibizumab|ranibizumab|mesh-list
139409967|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139409968|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139409969|NCT02321839|Growth Substances|growth substances|mesh-ancestor
139066773|NCT00146328|Tipranavir|tipranavir|mesh-list
139409970|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139409971|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
139409972|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409973|NCT03490279|Lactoferrin|lactoferrin|mesh-list
139409974|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409975|NCT02750345|Nitisinone|nitisinone|mesh-list
139409976|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409977|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409978|NCT01329263|Menthol|menthol|mesh-list
139409979|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
139409980|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
139409981|NCT03490123|Azithromycin|azithromycin|mesh-list
139409982|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139409983|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139409984|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
139409985|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139409986|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409987|NCT02182687|Doxorubicin|doxorubicin|mesh-list
139409988|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139409989|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139409990|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139409991|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139409992|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139409993|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139409994|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409995|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139409996|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139409997|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139409998|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139409999|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139410000|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139410001|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139410002|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139410003|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139410004|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139410005|NCT01388491|Desogestrel|desogestrel|mesh-list
139410006|NCT01388491|Estradiol|estradiol|mesh-list
139410007|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139410008|NCT01388491|Estrogens|estrogens|mesh-ancestor
139410009|NCT01388491|Hormones|hormones|mesh-ancestor
139410010|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139410011|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410012|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139410013|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
139410014|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139410015|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139410016|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139410017|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139410018|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139410019|NCT01388491|Progestins|progestins|mesh-ancestor
139410020|NCT02236169|Bromides|bromides|mesh-list
139410021|NCT02236169|Norflurane|norflurane|mesh-list
139410022|NCT02236169|Ipratropium|ipratropium|mesh-list
139410023|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
139410024|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139410025|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
139410026|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410027|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410028|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139410029|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
139410030|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139410031|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
139410032|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138758396|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139651810|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139651811|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139410033|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410034|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
139410035|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139410036|NCT02749799|Betamethasone|betamethasone|mesh-list
139410037|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
139410038|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139410039|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
139410040|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139410041|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410042|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
139066842|NCT01588522|Vitamins|vitamins|mesh-ancestor
139410043|NCT02749799|Hormones|hormones|mesh-ancestor
139410044|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139410045|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410046|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139410047|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
139410048|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139410049|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139410050|NCT03492385|Ticagrelor|ticagrelor|mesh-list
139410051|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139410052|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139410053|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139410054|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139410055|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
139410056|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410057|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410058|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410059|NCT03736265|Carvedilol|carvedilol|mesh-list
139410060|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139410061|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138758535|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
139410062|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
139410063|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410064|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410065|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410066|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139410067|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
139410068|NCT03736265|Protective Agents|protective agents|mesh-ancestor
139410069|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139410070|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139410071|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139410072|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
139410073|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139410074|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139410075|NCT04939363|Venetoclax|venetoclax|mesh-list
139410076|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
139410077|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410078|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139410079|NCT02236403|Metronidazole|metronidazole|mesh-list
139410080|NCT02236403|Ivermectin|ivermectin|mesh-list
139410081|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410082|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139410083|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139410084|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139410085|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139410086|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139410087|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
139410088|NCT03491527|Pemetrexed|pemetrexed|mesh-list
139410089|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410090|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410091|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410092|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139410093|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139410094|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410095|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
139410096|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
139410097|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
139410098|NCT02638805|Metformin|metformin|mesh-list
139410099|NCT02638805|Liraglutide|liraglutide|mesh-list
139410100|NCT02638805|Exenatide|exenatide|mesh-list
139410101|NCT02638805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139651812|NCT04426734|Dexamethasone|dexamethasone|mesh-list
139651813|NCT04426734|Prednisolone|prednisolone|mesh-list
139410102|NCT02638805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410103|NCT02638805|Incretins|incretins|mesh-ancestor
139410104|NCT02638805|Hormones|hormones|mesh-ancestor
139410105|NCT02638805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139410106|NCT02638805|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139410107|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
139410108|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139410109|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139410110|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410111|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139410112|NCT02261675|Analgesics|analgesics|mesh-ancestor
139410113|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
139410114|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410115|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139410116|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139410117|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139410118|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
139066921|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
139410119|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410120|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410121|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139410122|NCT02262143|Fenofibrate|fenofibrate|mesh-list
139410123|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139410124|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139410125|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
139410126|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410127|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139410128|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139410129|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410131|NCT02620553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139410132|NCT02620553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139410133|NCT02620553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410134|NCT02262299|Pirfenidone|pirfenidone|mesh-list
139410135|NCT02262299|Analgesics|analgesics|mesh-ancestor
139410136|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
139410137|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410138|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410139|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139410140|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139410141|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410142|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139410143|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410144|NCT02608697|Atorvastatin|atorvastatin|mesh-list
139410145|NCT02608697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139410146|NCT02608697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139410147|NCT02608697|Antimetabolites|antimetabolites|mesh-ancestor
139410148|NCT02608697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410149|NCT02608697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139410150|NCT02608697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139410151|NCT02608697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410152|NCT02262455|Doxorubicin|doxorubicin|mesh-list
139410153|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139410154|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139410155|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410156|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139410157|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139410158|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410159|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410160|NCT02262533|Atenolol|atenolol|mesh-list
139410161|NCT02262533|Apixaban|apixaban|mesh-list
139410162|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139410163|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
139410164|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139410165|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
139410166|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410167|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410168|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
139410169|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139410170|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139410171|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
139410172|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
139410173|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410174|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410175|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139410176|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139410177|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139410178|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
139410179|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410180|NCT02262611|Telmisartan|telmisartan|mesh-list
139410181|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
139410182|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139410183|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139410184|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139410185|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410186|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139410187|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139410188|NCT02262611|Diuretics|diuretics|mesh-ancestor
139410189|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
139410190|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410191|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
139410193|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
139410194|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410195|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410196|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139410197|NCT02589275|Cyclobenzaprine|cyclobenzaprine|mesh-list
139410198|NCT02589275|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139410199|NCT02589275|Antidepressive Agents|antidepressive agents|mesh-ancestor
139410200|NCT02589275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139410201|NCT02589275|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139410202|NCT02589275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410203|NCT02589275|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139410204|NCT02589275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410205|NCT02589275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139410206|NCT02589275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139410207|NCT02515175|Vaccines|vaccines|mesh-list
139410208|NCT02515175|Immunologic Factors|immunologic factors|mesh-ancestor
139410209|NCT02515175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410210|NCT02513303|Sirolimus|sirolimus|mesh-list
139410211|NCT02513303|Temsirolimus|temsirolimus|mesh-list
139410212|NCT02513303|MTOR Inhibitors|mtor inhibitors|mesh-list
139410213|NCT02513303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139410214|NCT02513303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410215|NCT02513303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139410216|NCT02513303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410217|NCT02513303|Antifungal Agents|antifungal agents|mesh-ancestor
139410218|NCT02513303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139410219|NCT02513303|Immunologic Factors|immunologic factors|mesh-ancestor
139410220|NCT02513303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410221|NCT02513303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139410222|NCT02513303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410223|NCT02513303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410224|NCT01616303|Paclitaxel|paclitaxel|mesh-list
139410225|NCT01616303|Carboplatin|carboplatin|mesh-list
139410226|NCT01616303|Oregovomab|oregovomab|mesh-list
138759046|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
139410227|NCT01616303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139410228|NCT01616303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410229|NCT01616303|Tubulin Modulators|tubulin modulators|mesh-ancestor
139410230|NCT01616303|Antimitotic Agents|antimitotic agents|mesh-ancestor
139410231|NCT01616303|Mitosis Modulators|mitosis modulators|mesh-ancestor
139410232|NCT01616303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410233|NCT01616303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139410234|NCT01590719|Leucovorin|leucovorin|mesh-list
139410235|NCT01590719|Folic Acid|folic acid|mesh-list
139410236|NCT01590719|Fluorouracil|fluorouracil|mesh-list
139410237|NCT01590719|Oxaliplatin|oxaliplatin|mesh-list
139410238|NCT01590719|Levoleucovorin|levoleucovorin|mesh-list
139410239|NCT01590719|Antimetabolites|antimetabolites|mesh-ancestor
139410240|NCT01590719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410241|NCT01590719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139410242|NCT01590719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410243|NCT01590719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139410244|NCT01590719|Immunologic Factors|immunologic factors|mesh-ancestor
139410245|NCT01590719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410246|NCT01590719|Antidotes|antidotes|mesh-ancestor
139410247|NCT01590719|Protective Agents|protective agents|mesh-ancestor
139410248|NCT01590719|Vitamin B Complex|vitamin b complex|mesh-ancestor
139410249|NCT01590719|Vitamins|vitamins|mesh-ancestor
139410250|NCT01590719|Micronutrients|micronutrients|mesh-ancestor
139410251|NCT01590719|Hematinics|hematinics|mesh-ancestor
139410252|NCT01536041|Montelukast|montelukast|mesh-list
139410253|NCT01536041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139410254|NCT01536041|Respiratory System Agents|respiratory system agents|mesh-ancestor
139410255|NCT01536041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139410256|NCT01536041|Hormone Antagonists|hormone antagonists|mesh-ancestor
139410258|NCT01536041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410259|NCT01536041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139410260|NCT01536041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139410261|NCT01536041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410263|NCT01534403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139410264|NCT01534403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410267|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
139410269|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410270|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139410271|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139410272|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410273|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410274|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410275|NCT02264093|Propranolol|propranolol|mesh-list
139410276|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139410277|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139410278|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
139410279|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410280|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410281|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410282|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139410283|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139410284|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
139410285|NCT01516541|Dalcetrapib|dalcetrapib|mesh-list
139410286|NCT01516541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139410287|NCT01516541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139410288|NCT01516541|Antimetabolites|antimetabolites|mesh-ancestor
139410289|NCT01516541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410290|NCT01516541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139410291|NCT01516307|Cyclophosphamide|cyclophosphamide|mesh-list
139410292|NCT01516307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139410293|NCT01516307|Immunologic Factors|immunologic factors|mesh-ancestor
139410294|NCT01516307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410295|NCT01516307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139410296|NCT01516307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139410297|NCT01516307|Alkylating Agents|alkylating agents|mesh-ancestor
139410298|NCT01516307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410299|NCT01516307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410300|NCT01516307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139410301|NCT01516073|Fluticasone|fluticasone|mesh-list
139410302|NCT01516073|Xhance|xhance|mesh-list
139410303|NCT01516073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410304|NCT01516073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139410305|NCT01516073|Autonomic Agents|autonomic agents|mesh-ancestor
139410306|NCT01516073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410307|NCT01516073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410308|NCT01516073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139410309|NCT01516073|Respiratory System Agents|respiratory system agents|mesh-ancestor
138759283|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
139410310|NCT01516073|Dermatologic Agents|dermatologic agents|mesh-ancestor
139410311|NCT01516073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139410312|NCT01495247|Paclitaxel|paclitaxel|mesh-list
139410313|NCT01495247|Dactolisib|dactolisib|mesh-list
139410314|NCT01495247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139410315|NCT01495247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410316|NCT01495247|Tubulin Modulators|tubulin modulators|mesh-ancestor
139410317|NCT01495247|Antimitotic Agents|antimitotic agents|mesh-ancestor
139410318|NCT01495247|Mitosis Modulators|mitosis modulators|mesh-ancestor
139410319|NCT01495247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410320|NCT01495013|Glimepiride|glimepiride|mesh-list
139410321|NCT01495013|Atorvastatin|atorvastatin|mesh-list
139410322|NCT01495013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139410323|NCT01495013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139410324|NCT01495013|Antimetabolites|antimetabolites|mesh-ancestor
138759340|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
139410325|NCT01495013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410326|NCT01495013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139410327|NCT01495013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139410328|NCT01495013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410329|NCT01495013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139410330|NCT01495013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139651814|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139410331|NCT01495013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410332|NCT01495013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139410333|NCT01495013|Immunologic Factors|immunologic factors|mesh-ancestor
139410334|NCT02264171|Ketoconazole|ketoconazole|mesh-list
139410335|NCT02264171|Tamsulosin|tamsulosin|mesh-list
138759443|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410336|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139410337|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139410338|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139410339|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
139067142|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
139410340|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410341|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410342|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410343|NCT02264171|Urological Agents|urological agents|mesh-ancestor
139410344|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
139410345|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410346|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139410347|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139410348|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410349|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139410350|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
139410351|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139410352|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139410353|NCT01481051|Latanoprost|latanoprost|mesh-list
139410354|NCT01481051|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139410355|NCT01481051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139410356|NCT01480583|Alovudine|alovudine|mesh-list
139410357|NCT01480583|Trastuzumab|trastuzumab|mesh-list
139410358|NCT01480583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139410359|NCT01480583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410360|NCT01480583|Antiviral Agents|antiviral agents|mesh-ancestor
139410361|NCT01480583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410362|NCT01470131|Dexamethasone|dexamethasone|mesh-list
139410363|NCT01470131|Bortezomib|bortezomib|mesh-list
139410364|NCT01470131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410365|NCT01470131|Antiemetics|antiemetics|mesh-ancestor
139410366|NCT01470131|Autonomic Agents|autonomic agents|mesh-ancestor
139410367|NCT01470131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410368|NCT01470131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410369|NCT01470131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139410370|NCT01470131|Glucocorticoids|glucocorticoids|mesh-ancestor
139410371|NCT01470131|Hormones|hormones|mesh-ancestor
139410372|NCT01470131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139410373|NCT01470131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139410374|NCT01470131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410375|NCT02264561|Caffeine|caffeine|mesh-list
139410376|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139410377|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410378|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139410379|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410380|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410381|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139410382|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139410383|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
139410384|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410385|NCT01464437|Metformin|metformin|mesh-list
139410386|NCT01464437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139410387|NCT01464437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410388|NCT01461317|Etrolizumab|etrolizumab|mesh-list
139410389|NCT01461317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139410390|NCT01461317|Immunologic Factors|immunologic factors|mesh-ancestor
139410391|NCT01461317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410392|NCT01449071|Epratuzumab|epratuzumab|mesh-list
139410393|NCT01449071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139410394|NCT01449071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410395|NCT01445795|Ribavirin|ribavirin|mesh-list
139410396|NCT01445795|Antimetabolites|antimetabolites|mesh-ancestor
139410397|NCT01445795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410398|NCT01445795|Antiviral Agents|antiviral agents|mesh-ancestor
139410399|NCT01445795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410400|NCT02264795|Lidocaine|lidocaine|mesh-list
139410401|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
139410402|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
139410403|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139651815|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
139410404|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410405|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
139410406|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410407|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139410408|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139410409|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139410410|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139410411|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410413|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139410414|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
139410415|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410416|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410417|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410418|NCT00156533|Zolpidem|zolpidem|mesh-list
139410419|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139410420|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139410421|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139410422|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410423|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139410424|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
139410425|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
139410426|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410427|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410428|NCT01410695|Methotrexate|methotrexate|mesh-list
139410429|NCT01410695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139410430|NCT01410695|Abortifacient Agents|abortifacient agents|mesh-ancestor
139410431|NCT01410695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139410432|NCT01410695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410433|NCT01410695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139410434|NCT01410695|Antimetabolites|antimetabolites|mesh-ancestor
139410435|NCT01410695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410436|NCT01410695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410437|NCT01410695|Dermatologic Agents|dermatologic agents|mesh-ancestor
139410438|NCT01410695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410439|NCT01410695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139410440|NCT01410695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139410441|NCT01410695|Immunologic Factors|immunologic factors|mesh-ancestor
139410442|NCT01410695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139410443|NCT01410695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139410444|NCT01660022|Piperaquine|piperaquine|mesh-list
139410445|NCT01660022|Artefenomel|artefenomel|mesh-list
139410446|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
139410447|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139410448|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139410449|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410450|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
139410451|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139410452|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
139410453|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410454|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
139410455|NCT02265575|Protective Agents|protective agents|mesh-ancestor
139410456|NCT02265731|Rituximab|rituximab|mesh-list
139410457|NCT02265731|Venetoclax|venetoclax|mesh-list
139410458|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139410459|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410460|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
139410461|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410462|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139410463|NCT02265809|Aldesleukin|aldesleukin|mesh-list
139410464|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410465|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139410466|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139410467|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
139410468|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410469|NCT01372475|Hyaluronic Acid|hyaluronic acid|mesh-list
139410470|NCT01372475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139410471|NCT01372475|Immunologic Factors|immunologic factors|mesh-ancestor
139410472|NCT01372475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410473|NCT01372475|Viscosupplements|viscosupplements|mesh-ancestor
139410474|NCT01372475|Protective Agents|protective agents|mesh-ancestor
139410475|NCT00156065|Haloperidol|haloperidol|mesh-list
139410476|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
139410477|NCT00156065|Asenapine|asenapine|mesh-list
139410478|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
139410480|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410481|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410482|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139410483|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138759778|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
139410484|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139410485|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139410486|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139410487|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139410488|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
139410489|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410490|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410491|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139410492|NCT01554956|Plasminogen|plasminogen|mesh-list
139410493|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139410494|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139410495|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410496|NCT01360853|Gemcitabine|gemcitabine|mesh-list
139410497|NCT01360853|ON 01910|on 01910|mesh-list
139410498|NCT01360853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139410499|NCT01360853|Antimetabolites|antimetabolites|mesh-ancestor
139410500|NCT01360853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410501|NCT01360853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410502|NCT01360853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139410503|NCT01360853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410504|NCT01355393|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
139410505|NCT01355393|Sargramostim|sargramostim|mesh-list
139410506|NCT01355393|Immunologic Factors|immunologic factors|mesh-ancestor
139410507|NCT01355393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410508|NCT01355393|Antiviral Agents|antiviral agents|mesh-ancestor
139410509|NCT01355393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410510|NCT02266355|Omalizumab|omalizumab|mesh-list
139410511|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139410512|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139410513|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
139410514|NCT02266511|Tamsulosin|tamsulosin|mesh-list
139410515|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139410516|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139410517|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139410518|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
139410519|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410520|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410521|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410522|NCT02266511|Urological Agents|urological agents|mesh-ancestor
139410523|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
139410524|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410525|NCT01330979|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139410526|NCT01330979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139410527|NCT01298687|Travoprost|travoprost|mesh-list
139410528|NCT01298687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139410529|NCT01298687|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139410530|NCT01298687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139410531|NCT02267057|Acetaminophen|acetaminophen|mesh-list
139410532|NCT02267057|Buprenorphine|buprenorphine|mesh-list
139410533|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139410534|NCT02267057|Analgesics|analgesics|mesh-ancestor
139410535|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
139410536|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410537|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410538|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
139410539|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139410540|NCT02267057|Narcotics|narcotics|mesh-ancestor
139410541|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139410542|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139410543|NCT05260541|Pramoxine|pramoxine|mesh-list
139410544|NCT05260541|Anesthetics, Local|anesthetics, local|mesh-ancestor
139410545|NCT05260541|Anesthetics|anesthetics|mesh-ancestor
139410546|NCT05260541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139410547|NCT05260541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410548|NCT05260541|Sensory System Agents|sensory system agents|mesh-ancestor
139410549|NCT05260541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410550|NCT01262261|Buprenorphine|buprenorphine|mesh-list
139410551|NCT01262261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139410552|NCT01262261|Narcotics|narcotics|mesh-ancestor
139410553|NCT01262261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140128|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139651816|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139410554|NCT01262261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410555|NCT01262261|Analgesics|analgesics|mesh-ancestor
139410556|NCT01262261|Sensory System Agents|sensory system agents|mesh-ancestor
139410557|NCT01262261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410558|NCT01262261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139410559|NCT02267681|Fentanyl|fentanyl|mesh-list
139410560|NCT02267681|Alfentanil|alfentanil|mesh-list
139410561|NCT02267681|Propofol|propofol|mesh-list
139410562|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139410563|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139410564|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410565|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139410566|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
139410567|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
139410568|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139410569|NCT02267681|Narcotics|narcotics|mesh-ancestor
139410570|NCT02267681|Analgesics|analgesics|mesh-ancestor
139410571|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
139410572|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410573|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139410574|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
139410575|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139410576|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139410577|NCT05177939|Prednisolone|prednisolone|mesh-list
139410578|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
139410579|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139410580|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
139410581|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
139410582|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139410583|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
139410584|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139410585|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410586|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
139410587|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
139410588|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410589|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410590|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139410591|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
139410592|NCT05177939|Hormones|hormones|mesh-ancestor
139410593|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139410594|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139410595|NCT05177939|Protective Agents|protective agents|mesh-ancestor
139410596|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139410597|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410598|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
139410599|NCT05174507|Empagliflozin|empagliflozin|mesh-list
139410600|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139410601|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139410602|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410603|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139410604|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410605|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139410606|NCT02267915|Rituximab|rituximab|mesh-list
139410607|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139410608|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410609|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
139410610|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410611|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139410612|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
139410613|NCT02268149|Prednisone|prednisone|mesh-list
139410614|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410615|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
139410616|NCT02268149|Hormones|hormones|mesh-ancestor
139410617|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139410618|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410619|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139410620|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410621|NCT01258907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139410622|NCT01258907|Immunologic Factors|immunologic factors|mesh-ancestor
139410623|NCT01258907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651817|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
139410624|NCT01255709|Epinephrine|epinephrine|mesh-list
139410625|NCT01255709|Racepinephrine|racepinephrine|mesh-list
139410626|NCT01255709|Epinephryl borate|epinephryl borate|mesh-list
139410627|NCT01255709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139410628|NCT01255709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139651818|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139410629|NCT01255709|Adrenergic Agents|adrenergic agents|mesh-ancestor
139410630|NCT01255709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410631|NCT01255709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410632|NCT01255709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410633|NCT01255709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139410634|NCT01255709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139410635|NCT01255709|Autonomic Agents|autonomic agents|mesh-ancestor
139410636|NCT01255709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410637|NCT01255709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139410638|NCT01255709|Respiratory System Agents|respiratory system agents|mesh-ancestor
139410639|NCT01255709|Mydriatics|mydriatics|mesh-ancestor
139410640|NCT01255709|Sympathomimetics|sympathomimetics|mesh-ancestor
139410641|NCT01255709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139410642|NCT02233907|Oxitropium|oxitropium|mesh-list
139410643|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
139410644|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
139067428|NCT03828838|177Lu-PSMA-617|177lu-psma-617|mesh-list
139410645|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410646|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410647|NCT01253603|Fluticasone|fluticasone|mesh-list
139410648|NCT01253603|Xhance|xhance|mesh-list
139410649|NCT01253603|Indoleacetic Acids|indoleacetic acids|mesh-list
139410650|NCT01253603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410651|NCT01253603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139410652|NCT01253603|Autonomic Agents|autonomic agents|mesh-ancestor
139410653|NCT01253603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410654|NCT01253603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410655|NCT01253603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139410656|NCT01253603|Respiratory System Agents|respiratory system agents|mesh-ancestor
139410657|NCT01253603|Dermatologic Agents|dermatologic agents|mesh-ancestor
139410658|NCT01253603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139410659|NCT01253603|Plant Growth Regulators|plant growth regulators|mesh-ancestor
139410660|NCT01253603|Growth Substances|growth substances|mesh-ancestor
139410661|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
139410662|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410663|NCT02268383|Luspatercept|luspatercept|mesh-list
139410664|NCT02268383|Hematinics|hematinics|mesh-ancestor
139410665|NCT01329419|Adefovir|adefovir|mesh-list
139410666|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139410667|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
139410668|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410669|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139410670|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139410671|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410672|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410673|NCT01235039|Insulin|insulin|mesh-list
139410674|NCT01235039|Insulin Lispro|insulin lispro|mesh-list
139410675|NCT01235039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139410676|NCT01235039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139410677|NCT01235039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410678|NCT01221077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139410679|NCT01221077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410680|NCT01221077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139410681|NCT01221077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410682|NCT01221077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410683|NCT01207115|Naproxen|naproxen|mesh-list
139410684|NCT01207115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139410685|NCT01207115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139410686|NCT01207115|Analgesics|analgesics|mesh-ancestor
139410687|NCT01207115|Sensory System Agents|sensory system agents|mesh-ancestor
139410688|NCT01207115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410689|NCT01207115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410690|NCT01207115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410691|NCT01207115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139410692|NCT01207115|Gout Suppressants|gout suppressants|mesh-ancestor
139410693|NCT01207115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139410694|NCT01207115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410695|NCT01207115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410696|NCT01186991|Paclitaxel|paclitaxel|mesh-list
139410697|NCT01186991|Bevacizumab|bevacizumab|mesh-list
139410698|NCT01186991|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139410699|NCT01186991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139410700|NCT01186991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410701|NCT01186991|Tubulin Modulators|tubulin modulators|mesh-ancestor
139410702|NCT01186991|Antimitotic Agents|antimitotic agents|mesh-ancestor
139410703|NCT01186991|Mitosis Modulators|mitosis modulators|mesh-ancestor
139410704|NCT01186991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410705|NCT01186991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139410706|NCT01186991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139410707|NCT01186991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139410708|NCT01186991|Growth Substances|growth substances|mesh-ancestor
139410709|NCT01186991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410710|NCT01186991|Growth Inhibitors|growth inhibitors|mesh-ancestor
139410711|NCT01186991|Immunologic Factors|immunologic factors|mesh-ancestor
139410712|NCT02268773|Aspirin|aspirin|mesh-list
139410713|NCT02268773|Dipyridamole|dipyridamole|mesh-list
139410714|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
139410715|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139410716|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139410717|NCT02268773|Analgesics|analgesics|mesh-ancestor
139410718|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
139410719|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410720|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410721|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410722|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139410723|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139410724|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139410725|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410726|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139410727|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139410728|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410729|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
139410730|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139410731|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
139410733|NCT01183949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410734|NCT01092065|Levodopa|levodopa|mesh-list
139410735|NCT01092065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139410736|NCT01092065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139410737|NCT01092065|Dopamine Agents|dopamine agents|mesh-ancestor
139410738|NCT01092065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410739|NCT01092065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410740|NCT01092065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410741|NCT01173497|Irinotecan|irinotecan|mesh-list
139410742|NCT01173497|Iniparib|iniparib|mesh-list
139410743|NCT01173497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139410744|NCT01173497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139410745|NCT01173497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410746|NCT01173497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410747|NCT01173497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410748|NCT01173497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139410749|NCT01171313|Carbidopa|carbidopa|mesh-list
139410750|NCT01171313|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139410751|NCT01171313|Levodopa|levodopa|mesh-list
139410752|NCT01171313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139410753|NCT01171313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139410754|NCT01171313|Dopamine Agents|dopamine agents|mesh-ancestor
139410755|NCT01171313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410756|NCT01171313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410757|NCT01171313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410758|NCT01171313|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139410759|NCT01171313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410760|NCT01171313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139410761|NCT01171313|Immunologic Factors|immunologic factors|mesh-ancestor
139410762|NCT01171313|Dopamine Agonists|dopamine agonists|mesh-ancestor
139410763|NCT01071239|Cyclophosphamide|cyclophosphamide|mesh-list
139410764|NCT01071239|Busulfan|busulfan|mesh-list
139410765|NCT01071239|Fludarabine|fludarabine|mesh-list
139410766|NCT01071239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139410767|NCT01071239|Immunologic Factors|immunologic factors|mesh-ancestor
139410768|NCT01071239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410769|NCT01071239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138760168|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
139410770|NCT01071239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139410771|NCT01071239|Alkylating Agents|alkylating agents|mesh-ancestor
139410772|NCT01071239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410773|NCT01071239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410774|NCT01071239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139410775|NCT01156415|Agomelatine|agomelatine|mesh-list
139410776|NCT01156415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139410777|NCT01156415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139410778|NCT01156415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651819|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
139410779|NCT01057667|Ribavirin|ribavirin|mesh-list
139410780|NCT01057667|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139410781|NCT01057667|Antimetabolites|antimetabolites|mesh-ancestor
139410782|NCT01057667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410783|NCT01057667|Antiviral Agents|antiviral agents|mesh-ancestor
139410784|NCT01057667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410785|NCT01027013|Rebamipide|rebamipide|mesh-list
139410786|NCT01027013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139410787|NCT01027013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139410788|NCT01027013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139410789|NCT01027013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139410790|NCT01027013|Antioxidants|antioxidants|mesh-ancestor
139410791|NCT01027013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410792|NCT01027013|Protective Agents|protective agents|mesh-ancestor
139410793|NCT01027013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410794|NCT01027013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410795|NCT04197076|Immunomodulating Agents|immunomodulating agents|mesh-list
139410796|NCT04197076|Immunologic Factors|immunologic factors|mesh-ancestor
139410797|NCT04197076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410798|NCT01138163|Docetaxel|docetaxel|mesh-list
139410799|NCT01138163|Bavituximab|bavituximab|mesh-list
139410800|NCT01138163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410801|NCT01138163|Tubulin Modulators|tubulin modulators|mesh-ancestor
139410802|NCT01138163|Antimitotic Agents|antimitotic agents|mesh-ancestor
139410803|NCT01138163|Mitosis Modulators|mitosis modulators|mesh-ancestor
139410804|NCT01138163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410805|NCT01138163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139410806|NCT01022801|Entecavir|entecavir|mesh-list
139410807|NCT01022801|Antiviral Agents|antiviral agents|mesh-ancestor
139410808|NCT01022801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410809|NCT05628467|Antidepressive Agents|antidepressive agents|mesh-list
139410810|NCT05628467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139410811|NCT05628389|Nicotine|nicotine|mesh-list
138760216|NCT00604396|Insulin|insulin|mesh-list
139410812|NCT05628389|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139410813|NCT05628389|Autonomic Agents|autonomic agents|mesh-ancestor
139410814|NCT05628389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410815|NCT05628389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410816|NCT05628389|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139410817|NCT05628389|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139410818|NCT05628389|Cholinergic Agents|cholinergic agents|mesh-ancestor
139410819|NCT05628389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410820|NCT05628389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410821|NCT01128335|Tacrolimus|tacrolimus|mesh-list
139410822|NCT01128335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139410823|NCT01128335|Immunologic Factors|immunologic factors|mesh-ancestor
139410824|NCT01128335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410825|NCT01128335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139410826|NCT01128335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410827|NCT01128335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410828|NCT01012895|Interferons|interferons|mesh-list
139410829|NCT01012895|Ribavirin|ribavirin|mesh-list
139410830|NCT01012895|Interferon-alpha|interferon-alpha|mesh-list
139410831|NCT01012895|Interferon alpha-2|interferon alpha-2|mesh-list
139410832|NCT01012895|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139410833|NCT01012895|Asunaprevir|asunaprevir|mesh-list
139410834|NCT01012895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410835|NCT01012895|Antiviral Agents|antiviral agents|mesh-ancestor
139410836|NCT01012895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410837|NCT01012895|Antimetabolites|antimetabolites|mesh-ancestor
139410838|NCT01012895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410839|NCT01012895|Immunologic Factors|immunologic factors|mesh-ancestor
139410840|NCT01012895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410841|NCT01012895|Protease Inhibitors|protease inhibitors|mesh-ancestor
139410842|NCT01012895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410843|NCT01009775|Docetaxel|docetaxel|mesh-list
139410844|NCT01009775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410845|NCT01009775|Tubulin Modulators|tubulin modulators|mesh-ancestor
139410846|NCT01009775|Antimitotic Agents|antimitotic agents|mesh-ancestor
139410847|NCT01009775|Mitosis Modulators|mitosis modulators|mesh-ancestor
139410848|NCT01009775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410849|NCT02319148|Itraconazole|itraconazole|mesh-list
139410850|NCT02319148|Verapamil|verapamil|mesh-list
139410851|NCT02319148|Diltiazem|diltiazem|mesh-list
139410852|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
139410853|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410854|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139410855|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139410856|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410857|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410858|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139410859|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
139410860|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139410861|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410862|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139410863|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139410864|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139410865|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139410866|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139410867|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
139410868|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139410870|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139410871|NCT02526212|Narcotics|narcotics|mesh-ancestor
139410872|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139410874|NCT02526212|Analgesics|analgesics|mesh-ancestor
139410875|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
139410876|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410877|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139410878|NCT05627843|Curcumin|curcumin|mesh-list
139410879|NCT05627843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139410880|NCT05627843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139410881|NCT05627843|Analgesics|analgesics|mesh-ancestor
139410882|NCT05627843|Sensory System Agents|sensory system agents|mesh-ancestor
139410883|NCT05627843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410884|NCT05627843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410885|NCT05627843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410886|NCT05627843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139410887|NCT05627843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410888|NCT05627843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410889|NCT05627843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410890|NCT01004081|Exemestane|exemestane|mesh-list
139410891|NCT01004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410892|NCT01004081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139410893|NCT01004081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139410894|NCT01004081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410895|NCT01004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410896|NCT01004081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139410897|NCT01004081|Hormone Antagonists|hormone antagonists|mesh-ancestor
138760313|NCT05380960|Coagulants|coagulants|mesh-ancestor
139410898|NCT01004081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139410899|NCT01004081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410900|NCT01113593|Formoterol Fumarate|formoterol fumarate|mesh-list
139410901|NCT01113593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139410902|NCT01113593|Autonomic Agents|autonomic agents|mesh-ancestor
139410903|NCT01113593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410904|NCT01113593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410905|NCT01113593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139410906|NCT01113593|Respiratory System Agents|respiratory system agents|mesh-ancestor
139410907|NCT01113593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139410908|NCT01113593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139410909|NCT01113593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139410910|NCT01113593|Adrenergic Agents|adrenergic agents|mesh-ancestor
139410911|NCT01113593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410912|NCT01113593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410913|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139410914|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
139410915|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410916|NCT02532374|Nicotine|nicotine|mesh-list
139410917|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139410918|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
139410919|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410920|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410921|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139410922|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139410923|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
139410924|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139410925|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410926|NCT05398874|Acetaminophen|acetaminophen|mesh-list
139410927|NCT05398874|Diclofenac|diclofenac|mesh-list
139410928|NCT05398874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139410929|NCT05398874|Analgesics|analgesics|mesh-ancestor
139410930|NCT05398874|Sensory System Agents|sensory system agents|mesh-ancestor
139410931|NCT05398874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410932|NCT05398874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410933|NCT05398874|Antipyretics|antipyretics|mesh-ancestor
139410934|NCT05398874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139410935|NCT05398874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410936|NCT05398874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139410937|NCT05398874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139410938|NCT05398874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410939|NCT05398874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410940|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
139084229|NCT01127672|Hormones|hormones|mesh-ancestor
139410941|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139410942|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410943|NCT00152477|Paclitaxel|paclitaxel|mesh-list
139410944|NCT00152477|Carboplatin|carboplatin|mesh-list
139410945|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139410946|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139410947|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
139410948|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
139410949|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
139410950|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410951|NCT01111955|Metformin|metformin|mesh-list
139410952|NCT01111955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139410953|NCT01111955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410954|NCT01106807|Adapalene|adapalene|mesh-list
139410955|NCT01106807|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
139410956|NCT01106807|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139410957|NCT01106807|Dermatologic Agents|dermatologic agents|mesh-ancestor
139410958|NCT01106807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139410959|NCT01106807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139410960|NCT01106807|Analgesics|analgesics|mesh-ancestor
139410961|NCT01106807|Sensory System Agents|sensory system agents|mesh-ancestor
139410962|NCT01106807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410963|NCT01106807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410964|NCT01106807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139410965|NCT01106807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139410966|NCT05533229|Fentanyl|fentanyl|mesh-list
139410967|NCT05533229|Morphine|morphine|mesh-list
139410968|NCT05533229|Bupivacaine|bupivacaine|mesh-list
139410969|NCT05533229|Anesthetics, Local|anesthetics, local|mesh-ancestor
139410970|NCT05533229|Anesthetics|anesthetics|mesh-ancestor
139410971|NCT05533229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139410972|NCT05533229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139410973|NCT05533229|Sensory System Agents|sensory system agents|mesh-ancestor
139410974|NCT05533229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139410975|NCT05533229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139410976|NCT05533229|Narcotics|narcotics|mesh-ancestor
139410977|NCT05533229|Analgesics|analgesics|mesh-ancestor
139410978|NCT05533229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139410979|NCT05533229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139410980|NCT05533229|Anesthetics, General|anesthetics, general|mesh-ancestor
139410981|NCT00153179|Acipimox|acipimox|mesh-list
139410982|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139410983|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
139410984|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410985|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139410986|NCT02743949|Esomeprazole|esomeprazole|mesh-list
139410987|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139410988|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138760408|NCT01034631|Everolimus|everolimus|mesh-list
139410989|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139410990|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410991|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410992|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
139410993|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139410994|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139410995|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139410996|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139410997|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139410998|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139410999|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411000|NCT02289898|Gemcitabine|gemcitabine|mesh-list
139411001|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139411002|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139411003|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
139411004|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411005|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411007|NCT01659554|Doxorubicin|doxorubicin|mesh-list
139411008|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139411009|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411010|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139411011|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139411012|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139411013|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411014|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411015|NCT05355350|Meropenem|meropenem|mesh-list
139411016|NCT05355350|Tazobactam|tazobactam|mesh-list
139411017|NCT05355350|Piperacillin|piperacillin|mesh-list
139411018|NCT05355350|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139411019|NCT05355350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139411020|NCT05355350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411021|NCT05355350|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139411022|NCT05355350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411023|NCT05355350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411024|NCT01054196|Lenalidomide|lenalidomide|mesh-list
139411025|NCT01054196|Melphalan|melphalan|mesh-list
139411026|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
139411027|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411028|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139411029|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139411030|NCT01054196|Growth Substances|growth substances|mesh-ancestor
139411031|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
139411032|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411033|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139411034|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
139411035|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411036|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139411037|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139411038|NCT01659320|Minocycline|minocycline|mesh-list
139411039|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139411040|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411042|NCT05414084|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139411043|NCT05414084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411044|NCT05414084|Disinfectants|disinfectants|mesh-ancestor
139411045|NCT05414084|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139411046|NCT05414084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139411047|NCT01660334|Voriconazole|voriconazole|mesh-list
139411048|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
139411049|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411050|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139411051|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139411052|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411053|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411054|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139411055|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
139411056|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139411057|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411058|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139411059|NCT01660256|Rebamipide|rebamipide|mesh-list
139411060|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139411061|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139411062|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
139411063|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411064|NCT01660256|Protective Agents|protective agents|mesh-ancestor
139411065|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411066|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411067|NCT02330367|Abivertinib|abivertinib|mesh-list
139411068|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139411069|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411070|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411071|NCT02318602|Cannabidiol|cannabidiol|mesh-list
139411072|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
139411073|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139411074|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139411075|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139411076|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139411077|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915744|NCT00753714|Gemcitabine|gemcitabine|mesh-list
139651820|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139411078|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411079|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411080|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
139411081|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139411082|NCT05559008|Azacitidine|azacitidine|mesh-list
139411083|NCT05559008|Apatinib|apatinib|mesh-list
139411084|NCT05559008|Dasatinib|dasatinib|mesh-list
139411085|NCT05559008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139411086|NCT05559008|Antimetabolites|antimetabolites|mesh-ancestor
139411087|NCT05559008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411088|NCT05559008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411089|NCT05559008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411090|NCT05559008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139411091|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139411092|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411093|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139411094|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411095|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411096|NCT05053425|Cytarabine|cytarabine|mesh-list
139411097|NCT05053425|Azacitidine|azacitidine|mesh-list
139411098|NCT05053425|Venetoclax|venetoclax|mesh-list
139411099|NCT05053425|Idarubicin|idarubicin|mesh-list
139411100|NCT05053425|Cladribine|cladribine|mesh-list
139411101|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139411102|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
139411103|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411104|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411105|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
139411106|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411107|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139411108|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
139411109|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411110|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411111|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139411112|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139411113|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139411114|NCT02317510|Anesthetics|anesthetics|mesh-list
139411115|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139411116|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411117|NCT05350124|Vitamins|vitamins|mesh-list
139411118|NCT05350124|Ascorbic Acid|ascorbic acid|mesh-list
139411119|NCT05350124|Vitamin E|vitamin e|mesh-list
139411120|NCT05350124|Tocopherols|tocopherols|mesh-list
139411121|NCT05350124|Micronutrients|micronutrients|mesh-ancestor
139411122|NCT05350124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411123|NCT05350124|Antioxidants|antioxidants|mesh-ancestor
139411124|NCT05350124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411125|NCT05350124|Protective Agents|protective agents|mesh-ancestor
139411126|NCT04925427|Naloxone|naloxone|mesh-list
139411127|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139411128|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411129|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
139411130|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411131|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
139411132|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139411133|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139411134|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411135|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
139411136|NCT04803591|Coagulants|coagulants|mesh-ancestor
139411137|NCT04735263|Atorvastatin|atorvastatin|mesh-list
139411138|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139411139|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139411140|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
139411141|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411142|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139411143|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139411144|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411145|NCT00493298|Natalizumab|natalizumab|mesh-list
139411146|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
139411147|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411148|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139411149|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139411150|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411151|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
139411152|NCT04662723|Empagliflozin|empagliflozin|mesh-list
139411153|NCT04662723|Canagliflozin|canagliflozin|mesh-list
139651821|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
139651822|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
139411154|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139411155|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
139411156|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139411157|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139411158|NCT04662723|Prednisolone|prednisolone|mesh-list
139411159|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
139411160|NCT04662723|Losartan|losartan|mesh-list
139411161|NCT04662723|Ramipril|ramipril|mesh-list
139411162|NCT04662723|Lisinopril|lisinopril|mesh-list
139411163|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139411164|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
139411165|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139411166|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
139411167|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
139411168|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411169|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411170|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139411171|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
139411172|NCT04662723|Hormones|hormones|mesh-ancestor
139411173|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139411174|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139411175|NCT04662723|Protective Agents|protective agents|mesh-ancestor
139411176|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139411177|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411178|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411179|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139411180|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139411181|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139411182|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139411183|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139411184|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139411185|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
139411186|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411187|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139411188|NCT05307926|Lenvatinib|lenvatinib|mesh-list
139411189|NCT05307926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139411190|NCT05307926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411191|NCT05307926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139411192|NCT05307926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411193|NCT05307926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411194|NCT05307926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139411195|NCT04026945|Lidocaine|lidocaine|mesh-list
139411196|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
139411197|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
139411198|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139411199|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411200|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
139411201|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411202|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139411203|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139411204|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139411205|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139411206|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411207|NCT02328729|Epinephrine|epinephrine|mesh-list
139411208|NCT02328729|Racepinephrine|racepinephrine|mesh-list
139411209|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
139411210|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139411211|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139411212|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
139411213|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411214|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760616|NCT02760979|Denosumab|denosumab|mesh-list
139411215|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411216|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139411217|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139411218|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
139411219|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411220|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139411221|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
139411222|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
139411223|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
139411224|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139411225|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
139651823|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411227|NCT02328963|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139411228|NCT02328963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139411229|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411230|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411231|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139411232|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
139411233|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411234|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411235|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139411236|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139411237|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
139411238|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139411239|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411240|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
139411241|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139411242|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139411243|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068039|NCT01080534|Tacrolimus|tacrolimus|mesh-list
139411244|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
139411245|NCT03353259|Coagulants|coagulants|mesh-ancestor
139411246|NCT02328651|Ribavirin|ribavirin|mesh-list
139411247|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
139411248|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411249|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
139411250|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411251|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139411252|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139411253|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139411254|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139411255|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139411256|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
139411257|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411258|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411259|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411260|NCT02328495|Misoprostol|misoprostol|mesh-list
138760850|NCT02750917|Etoricoxib|etoricoxib|mesh-list
139411261|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139411262|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
139411263|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139411264|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411265|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139411266|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139411267|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
139411268|NCT02287402|Voglibose|voglibose|mesh-list
139411269|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139411270|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411271|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139411272|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411273|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411274|NCT02913495|Progesterone|progesterone|mesh-list
139411275|NCT02913495|Progestins|progestins|mesh-ancestor
139411276|NCT02913495|Hormones|hormones|mesh-ancestor
139411277|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139411278|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411279|NCT03111069|Doxorubicin|doxorubicin|mesh-list
139411280|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139411281|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139411282|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411283|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139411284|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139411285|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411286|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411287|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139411288|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139411289|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
139411290|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411291|NCT03110757|Antacids|antacids|mesh-ancestor
139411292|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411293|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139411294|NCT05080569|Progesterone|progesterone|mesh-list
139411295|NCT05080569|Progestins|progestins|mesh-ancestor
139411296|NCT05080569|Hormones|hormones|mesh-ancestor
139411297|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760936|NCT02760043|Dexamethasone|dexamethasone|mesh-list
139651824|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651825|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139411298|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411299|NCT03145467|Acetaminophen|acetaminophen|mesh-list
139411300|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
139411301|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139411302|NCT03145467|Analgesics|analgesics|mesh-ancestor
139411303|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
139411304|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411305|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411306|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
139411307|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139411308|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139411309|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
139411310|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411311|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411312|NCT05302856|Antibodies|antibodies|mesh-list
139411313|NCT05302856|Testosterone|testosterone|mesh-list
139411314|NCT05302856|Immunologic Factors|immunologic factors|mesh-ancestor
139411315|NCT05302856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411316|NCT05302856|Androgens|androgens|mesh-ancestor
139411317|NCT05302856|Hormones|hormones|mesh-ancestor
139411318|NCT05302856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139411319|NCT02328183|Polymyxins|polymyxins|mesh-list
139411320|NCT02328183|Polymyxin B|polymyxin b|mesh-list
139411321|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139411322|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411323|NCT05610488|Faricimab|faricimab|mesh-list
139411324|NCT05610488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139411325|NCT05610488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139411326|NCT05610488|Growth Substances|growth substances|mesh-ancestor
139411327|NCT05610488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411328|NCT05610488|Growth Inhibitors|growth inhibitors|mesh-ancestor
139411329|NCT05610488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411330|NCT01646398|Vaccines|vaccines|mesh-list
139411331|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139411332|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
139411333|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411334|NCT05382104|Maribavir|maribavir|mesh-list
139411335|NCT05382104|Antiviral Agents|antiviral agents|mesh-ancestor
139411336|NCT05382104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411337|NCT01646320|Metformin|metformin|mesh-list
139411338|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
139411339|NCT01646320|Saxagliptin|saxagliptin|mesh-list
139411340|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139411341|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411342|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139411343|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411344|NCT01646320|Incretins|incretins|mesh-ancestor
139411345|NCT01646320|Hormones|hormones|mesh-ancestor
139411346|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139411347|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139411348|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
138761028|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411349|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411350|NCT03141645|Ondansetron|ondansetron|mesh-list
139411351|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
139411352|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
139411353|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411354|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411355|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139411356|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
139411357|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
139411358|NCT03141645|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139411359|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139411360|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
139411361|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411362|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411363|NCT01658150|Isradipine|isradipine|mesh-list
139411364|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139411365|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139411366|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139411367|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411368|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139411369|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411370|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
139411371|NCT02285998|Vaccines|vaccines|mesh-list
139411372|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
139411373|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411374|NCT02285920|Spironolactone|spironolactone|mesh-list
139411375|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139411376|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
139411377|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139411378|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411379|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139411380|NCT02285920|Diuretics|diuretics|mesh-ancestor
139411381|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
139411382|NCT05292872|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139411383|NCT05292872|Cathartics|cathartics|mesh-ancestor
139411384|NCT05292872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139411385|NCT02035137|Irinotecan|irinotecan|mesh-list
139411386|NCT02035137|Vincristine|vincristine|mesh-list
139411387|NCT02035137|Vorinostat|vorinostat|mesh-list
139411388|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139411389|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139411390|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139411391|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411392|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411393|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411394|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139411395|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
139411396|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
139411397|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
139411398|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139411399|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139411400|NCT05264870|Norepinephrine|norepinephrine|mesh-list
139411401|NCT05264870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139411402|NCT05264870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139411403|NCT05264870|Adrenergic Agents|adrenergic agents|mesh-ancestor
139411404|NCT05264870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411405|NCT05264870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411406|NCT05264870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411407|NCT05264870|Sympathomimetics|sympathomimetics|mesh-ancestor
139411408|NCT05264870|Autonomic Agents|autonomic agents|mesh-ancestor
139411409|NCT05264870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411410|NCT05264870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139411411|NCT04249232|Abaloparatide|abaloparatide|mesh-list
139411412|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139411413|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411414|NCT05079087|Midazolam|midazolam|mesh-list
139411415|NCT05079087|Ketamine|ketamine|mesh-list
139411416|NCT05079087|Analgesics|analgesics|mesh-ancestor
139411417|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
139411418|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411419|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411420|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139411421|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139411422|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
139411423|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
139411424|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139411425|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139411426|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139411427|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411428|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411429|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139411430|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139411431|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139411432|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139411433|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139411434|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
139411435|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
139411436|NCT02522780|Mesalamine|mesalamine|mesh-list
139411437|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139411438|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139411439|NCT02522780|Analgesics|analgesics|mesh-ancestor
139411440|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
139411441|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411442|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411443|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139411444|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139411445|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139411446|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138761429|NCT00636415|Morphine|morphine|mesh-list
139411447|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139411448|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139411449|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411450|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411451|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411452|NCT03618225|Analgesics|analgesics|mesh-ancestor
139411453|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
139411454|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411455|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
139411456|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139411457|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
139411458|NCT03566199|Panobinostat|panobinostat|mesh-list
139411459|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411460|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139411461|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411462|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411463|NCT03561831|Propofol|propofol|mesh-list
139411464|NCT03561831|Sevoflurane|sevoflurane|mesh-list
139411465|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139411466|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139411467|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411468|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139411469|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
139411470|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
139411471|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139411472|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139411473|NCT03144843|Apatinib|apatinib|mesh-list
139411474|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411475|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139411476|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411477|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411478|NCT05288348|Sufentanil|sufentanil|mesh-list
139411479|NCT05288348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139411480|NCT05288348|Narcotics|narcotics|mesh-ancestor
139411481|NCT05288348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139411482|NCT05288348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411483|NCT05288348|Analgesics|analgesics|mesh-ancestor
139411484|NCT05288348|Sensory System Agents|sensory system agents|mesh-ancestor
139411485|NCT05288348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411486|NCT05288348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139411487|NCT05288348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139411488|NCT05288348|Anesthetics, General|anesthetics, general|mesh-ancestor
139411489|NCT05288348|Anesthetics|anesthetics|mesh-ancestor
139411490|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138761586|NCT02690389|Flumazenil|flumazenil|mesh-list
139411491|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139411492|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411493|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411494|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139411495|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
139411496|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139411497|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411498|NCT03199755|Lumefantrine|lumefantrine|mesh-list
139411499|NCT03199755|Artemether|artemether|mesh-list
139411500|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139411501|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
139411502|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139411503|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139411504|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411505|NCT05318066|Norepinephrine|norepinephrine|mesh-list
139411506|NCT05318066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139411507|NCT05318066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139411508|NCT05318066|Adrenergic Agents|adrenergic agents|mesh-ancestor
139411509|NCT05318066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411510|NCT05318066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411511|NCT05318066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411512|NCT05318066|Sympathomimetics|sympathomimetics|mesh-ancestor
139411513|NCT05318066|Autonomic Agents|autonomic agents|mesh-ancestor
139411514|NCT05318066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411515|NCT05318066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139411516|NCT02327793|Labetalol|labetalol|mesh-list
139411517|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
139411518|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
139411519|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139411520|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139651826|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
139411521|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
139651827|NCT04426734|Hormones|hormones|mesh-ancestor
139411522|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411523|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411524|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411525|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139411527|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
139411528|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411529|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139411530|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139411531|NCT02327715|Emtricitabine|emtricitabine|mesh-list
139411532|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
139411533|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411534|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139411535|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139411536|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411537|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411538|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139411539|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139411540|NCT02951013|Chrysarobin|chrysarobin|mesh-list
139411541|NCT02951013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139411542|NCT02951013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139411543|NCT02951013|Analgesics|analgesics|mesh-ancestor
139411544|NCT02951013|Sensory System Agents|sensory system agents|mesh-ancestor
139411545|NCT02951013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411546|NCT02951013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411547|NCT02951013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139411548|NCT02951013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139411549|NCT02285062|Prednisone|prednisone|mesh-list
139411550|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
139411551|NCT02285062|Rituximab|rituximab|mesh-list
139411552|NCT02285062|Doxorubicin|doxorubicin|mesh-list
139411553|NCT02285062|Vincristine|vincristine|mesh-list
139411554|NCT02285062|Lenalidomide|lenalidomide|mesh-list
139411555|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139411556|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
139411557|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761806|NCT02685709|Octreotide|octreotide|mesh-list
139411558|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139411559|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139411560|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
139411561|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411562|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411563|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139411564|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139411565|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139411566|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139411567|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139411568|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411569|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139411570|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
139411571|NCT02285062|Hormones|hormones|mesh-ancestor
139411572|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139411573|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139411574|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139411575|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
139411576|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
139411577|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
139411578|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139411579|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139411580|NCT02285062|Growth Substances|growth substances|mesh-ancestor
139411581|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
139411582|NCT02431767|Interleukin-12|interleukin-12|mesh-list
139411583|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139411584|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
139411585|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411586|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139411587|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139411588|NCT02431767|Growth Substances|growth substances|mesh-ancestor
139411589|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
139411590|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411591|NCT04571697|Methotrexate|methotrexate|mesh-list
139411592|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139411593|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
139411594|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138916258|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139411595|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411596|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139411598|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411599|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411600|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
139411601|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411602|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139411603|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139411604|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
139411605|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139411606|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139411607|NCT05253794|Colchicine|colchicine|mesh-list
139411608|NCT05253794|Gout Suppressants|gout suppressants|mesh-ancestor
139411609|NCT05253794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139411610|NCT05253794|Tubulin Modulators|tubulin modulators|mesh-ancestor
139411611|NCT05253794|Antimitotic Agents|antimitotic agents|mesh-ancestor
139411612|NCT05253794|Mitosis Modulators|mitosis modulators|mesh-ancestor
139411613|NCT05253794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411614|NCT05253794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411615|NCT03140943|Thalidomide|thalidomide|mesh-list
139411616|NCT03140943|Dexamethasone|dexamethasone|mesh-list
139411617|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068408|NCT01304212|Narcotics|narcotics|mesh-ancestor
139411618|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
139411619|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
139411620|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411621|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411622|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139411623|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
139411624|NCT03140943|Hormones|hormones|mesh-ancestor
139411625|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139411626|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139411627|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411628|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139411629|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
139411630|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
139411631|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139411632|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411633|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139411634|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139411635|NCT03140943|Growth Substances|growth substances|mesh-ancestor
139411636|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
139411637|NCT02038257|Petrolatum|petrolatum|mesh-list
139411638|NCT02038257|Emollients|emollients|mesh-ancestor
139411639|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
139411640|NCT05311436|Iron|iron|mesh-list
139411641|NCT05311436|Folic Acid|folic acid|mesh-list
139411642|NCT05311436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411643|NCT05311436|Trace Elements|trace elements|mesh-ancestor
139411644|NCT05311436|Micronutrients|micronutrients|mesh-ancestor
139411645|NCT05311436|Hematinics|hematinics|mesh-ancestor
139411646|NCT05311436|Vitamin B Complex|vitamin b complex|mesh-ancestor
139411647|NCT05311436|Vitamins|vitamins|mesh-ancestor
139411648|NCT01352741|Pregabalin|pregabalin|mesh-list
139411649|NCT01352741|Tapentadol|tapentadol|mesh-list
139411650|NCT01352741|Analgesics|analgesics|mesh-ancestor
139411651|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
139411652|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411653|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411654|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
139411655|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139411656|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139411657|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411658|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139411659|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139411660|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139411661|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138762059|NCT01222403|Vaccines|vaccines|mesh-list
139411662|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139411663|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139411664|NCT01352741|Narcotics|narcotics|mesh-ancestor
139411665|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139411666|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139411667|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
139411668|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411669|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
138916333|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
139411670|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139411671|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411673|NCT00911963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139411674|NCT00911963|Antimetabolites|antimetabolites|mesh-ancestor
139411675|NCT00911963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411676|NCT00911963|Antiviral Agents|antiviral agents|mesh-ancestor
139411677|NCT00911963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411678|NCT01657292|Octenidine|octenidine|mesh-list
139411679|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411680|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139411681|NCT00907907|Mycophenolic Acid|mycophenolic acid|mesh-list
139411682|NCT00907907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139411683|NCT00907907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411684|NCT00907907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139411685|NCT00907907|Antitubercular Agents|antitubercular agents|mesh-ancestor
139411686|NCT00907907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139411687|NCT00907907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411688|NCT00907907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411689|NCT00907907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411690|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
139411691|NCT03140553|Carboplatin|carboplatin|mesh-list
139411692|NCT03140553|Docetaxel|docetaxel|mesh-list
139411693|NCT03140553|Trastuzumab|trastuzumab|mesh-list
139411694|NCT03140553|Epirubicin|epirubicin|mesh-list
138762196|NCT01220297|Sirolimus|sirolimus|mesh-list
139411695|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139411696|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
139411697|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411698|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139411699|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139411700|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
139411701|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411702|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411703|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139411704|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
139411705|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
139411706|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
139411707|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139411708|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139411709|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139411710|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139411711|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411713|NCT00905567|Anticonvulsants|anticonvulsants|mesh-ancestor
139411714|NCT00905567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139411715|NCT00905567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411716|NCT02282020|Olaparib|olaparib|mesh-list
139411717|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139411718|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411719|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411720|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411721|NCT05249972|Calcitriol|calcitriol|mesh-list
139411722|NCT05249972|Betamethasone|betamethasone|mesh-list
139411723|NCT05249972|Betamethasone Valerate|betamethasone valerate|mesh-list
139411724|NCT05249972|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139411725|NCT05249972|Betamethasone benzoate|betamethasone benzoate|mesh-list
139411726|NCT05249972|Calcipotriene|calcipotriene|mesh-list
139411727|NCT05249972|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139411728|NCT05249972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139411729|NCT05249972|Glucocorticoids|glucocorticoids|mesh-ancestor
139411730|NCT05249972|Hormones|hormones|mesh-ancestor
139411731|NCT05249972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139411732|NCT05249972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411733|NCT05249972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139411734|NCT05249972|Respiratory System Agents|respiratory system agents|mesh-ancestor
139411735|NCT05249972|Dermatologic Agents|dermatologic agents|mesh-ancestor
139411736|NCT05249972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139411737|NCT05249972|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139411738|NCT05249972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139411739|NCT05249972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411740|NCT05249972|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139411741|NCT05249972|Vitamins|vitamins|mesh-ancestor
139411742|NCT05249972|Micronutrients|micronutrients|mesh-ancestor
139411743|NCT05249972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139411744|NCT00904943|Topiramate|topiramate|mesh-list
139411745|NCT00904943|Anticonvulsants|anticonvulsants|mesh-ancestor
139411746|NCT00904943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139411747|NCT00904943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411748|NCT00902291|Gemcitabine|gemcitabine|mesh-list
139411749|NCT00902291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139411750|NCT00902291|Antimetabolites|antimetabolites|mesh-ancestor
139411751|NCT00902291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411752|NCT00902291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411753|NCT02281552|Tofacitinib|tofacitinib|mesh-list
139411754|NCT02281552|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139411755|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139411756|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411757|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411758|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
139411759|NCT03832647|Salicylates|salicylates|mesh-list
139411760|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411761|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
139411762|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
139411763|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
139411764|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139411765|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139411766|NCT03832647|Analgesics|analgesics|mesh-ancestor
139411767|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
139411768|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411769|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411770|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139411771|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139411772|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139411773|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411774|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411775|NCT00901979|Metformin|metformin|mesh-list
139411776|NCT00901979|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139411777|NCT00901979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139411778|NCT00901979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411779|NCT00901979|Incretins|incretins|mesh-ancestor
139411780|NCT00901979|Hormones|hormones|mesh-ancestor
139411781|NCT00901979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139411782|NCT00901979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139411783|NCT00901979|Protease Inhibitors|protease inhibitors|mesh-ancestor
139411784|NCT00901979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411785|NCT00901979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411786|NCT03778671|Fentanyl|fentanyl|mesh-list
139411787|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
139411788|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
139411789|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139411790|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139411791|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411792|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139411793|NCT03778671|Analgesics|analgesics|mesh-ancestor
138762394|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
139411794|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
139411795|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411796|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139411797|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139411798|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139411799|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
139411800|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411801|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411802|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139411803|NCT03778671|Narcotics|narcotics|mesh-ancestor
139411804|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139411805|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139411806|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
139411807|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
139411808|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
139411809|NCT00978497|Ribavirin|ribavirin|mesh-list
139411810|NCT00978497|Antimetabolites|antimetabolites|mesh-ancestor
139411811|NCT00978497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411812|NCT00978497|Antiviral Agents|antiviral agents|mesh-ancestor
139411813|NCT00978497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411814|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
139411815|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139411816|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411817|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139411818|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139411819|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411820|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651828|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139411821|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411822|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139411823|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139411824|NCT00890591|Amlodipine|amlodipine|mesh-list
139411825|NCT00890591|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139411826|NCT00890591|Olmesartan|olmesartan|mesh-list
139411827|NCT00890591|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139411828|NCT00890591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139411829|NCT00890591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139411830|NCT00890591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139411831|NCT00890591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411832|NCT00890591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139411833|NCT00890591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411834|NCT00890591|Vasodilator Agents|vasodilator agents|mesh-ancestor
139411835|NCT00890591|Diuretics|diuretics|mesh-ancestor
139411836|NCT00890591|Natriuretic Agents|natriuretic agents|mesh-ancestor
139411837|NCT00890591|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139411838|NCT00890591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139411839|NCT00890591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139411840|NCT05248334|Ranibizumab|ranibizumab|mesh-list
139411841|NCT05248334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139411842|NCT05248334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139411843|NCT05248334|Growth Substances|growth substances|mesh-ancestor
139411844|NCT05248334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411845|NCT05248334|Growth Inhibitors|growth inhibitors|mesh-ancestor
139411846|NCT05248334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411847|NCT03140787|Lidocaine|lidocaine|mesh-list
139411848|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
139411849|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
139411850|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139411851|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411852|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
139411853|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411854|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139411855|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139411856|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139411857|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139411858|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411859|NCT00889967|Ciprofloxacin|ciprofloxacin|mesh-list
139411860|NCT00889967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139411861|NCT00889967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411862|NCT00889967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139411863|NCT00889967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139411864|NCT00889967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411865|NCT00889967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411866|NCT00889967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411867|NCT00889967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139411868|NCT00889967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139411869|NCT03317223|Amoxicillin|amoxicillin|mesh-list
139411870|NCT03317223|Clarithromycin|clarithromycin|mesh-list
139411871|NCT03317223|Lansoprazole|lansoprazole|mesh-list
139411872|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139411873|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762570|NCT00605410|Bromides|bromides|mesh-list
139411874|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139411875|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411876|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411877|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139411878|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139411879|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139411880|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139411881|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139411882|NCT02284906|Pioglitazone|pioglitazone|mesh-list
139411883|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139411884|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411885|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
139411886|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139411887|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139411888|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762662|NCT00604084|Ivermectin|ivermectin|mesh-list
139411889|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139411890|NCT02566863|Analgesics|analgesics|mesh-ancestor
139651829|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139411891|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
139411892|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411893|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139411894|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139411895|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139411896|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
139411897|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411898|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411899|NCT00968825|Botulinum Toxins|botulinum toxins|mesh-list
139411900|NCT00968825|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139411901|NCT00968825|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139411902|NCT00968825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139411903|NCT00968825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139411904|NCT00968825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411905|NCT00968825|Cholinergic Agents|cholinergic agents|mesh-ancestor
139411906|NCT00968825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411907|NCT00968825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411908|NCT00968825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139411909|NCT00968825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139411910|NCT04474457|Favipiravir|favipiravir|mesh-list
139411911|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
139411912|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411913|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139411914|NCT00880217|Methylphenidate|methylphenidate|mesh-list
139411915|NCT00880217|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139411916|NCT00880217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139411917|NCT00880217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411918|NCT00880217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139411919|NCT00880217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139411920|NCT00880217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139411921|NCT00880217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411922|NCT00880217|Dopamine Agents|dopamine agents|mesh-ancestor
139411923|NCT00880217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411924|NCT00880217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139411925|NCT00880217|Adrenergic Agents|adrenergic agents|mesh-ancestor
139411926|NCT01657760|Citalopram|citalopram|mesh-list
139411927|NCT01657760|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139411928|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139411929|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139411930|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411931|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139411932|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
139411933|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411934|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139411935|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
139411936|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139411937|NCT00966953|Honokiol|honokiol|mesh-list
139411938|NCT00966953|Triclosan|triclosan|mesh-list
139411939|NCT00966953|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139411940|NCT00966953|Fluorides|fluorides|mesh-list
139411941|NCT00966953|Cariostatic Agents|cariostatic agents|mesh-ancestor
139411942|NCT00966953|Protective Agents|protective agents|mesh-ancestor
139411943|NCT00966953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411944|NCT00966953|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139411945|NCT00966953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411946|NCT00966953|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139411947|NCT00966953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139411948|NCT00966953|Antimetabolites|antimetabolites|mesh-ancestor
139411949|NCT00966953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411950|NCT00966953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139411951|NCT00966953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139411952|NCT00966953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139411953|NCT00966953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411954|NCT00966953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139411955|NCT00966953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411956|NCT00966953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139411957|NCT00966953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139411958|NCT00966953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139411959|NCT00966953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139411960|NCT00966953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139411961|NCT05084079|Insulin|insulin|mesh-list
139140137|NCT03782805|Vitamins|vitamins|mesh-ancestor
139651830|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411962|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139411963|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139411964|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411965|NCT05084001|Listerine|listerine|mesh-list
139411966|NCT05084001|Fluorides|fluorides|mesh-list
139411967|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
139411968|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
139411969|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
139411970|NCT05084001|Protective Agents|protective agents|mesh-ancestor
139411971|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411972|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139411973|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139411974|NCT00875459|Insulin|insulin|mesh-list
139411975|NCT00875459|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139411976|NCT00875459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139411977|NCT00875459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411978|NCT03140709|Oxytocin|oxytocin|mesh-list
139411979|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
139411980|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139411981|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411982|NCT02283658|Everolimus|everolimus|mesh-list
139411983|NCT02283658|Letrozole|letrozole|mesh-list
139411984|NCT02283658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139411985|NCT02283658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139411986|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139411987|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139411988|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139411989|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
139411990|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139411991|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139411992|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139411993|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139411994|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139411995|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
139411996|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139411997|NCT00872885|Morphine|morphine|mesh-list
139411998|NCT00872885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139411999|NCT00872885|Narcotics|narcotics|mesh-ancestor
139412000|NCT00872885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139412001|NCT00872885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412002|NCT00872885|Analgesics|analgesics|mesh-ancestor
139412003|NCT00872885|Sensory System Agents|sensory system agents|mesh-ancestor
139412004|NCT00872885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412005|NCT00871481|Aldesleukin|aldesleukin|mesh-list
139412006|NCT00871481|Cyclophosphamide|cyclophosphamide|mesh-list
139412007|NCT00871481|Ipilimumab|ipilimumab|mesh-list
139412008|NCT00871481|Interleukin-2|interleukin-2|mesh-list
139412009|NCT00871481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139412010|NCT00871481|Antibodies|antibodies|mesh-list
139412011|NCT00871481|Immunoglobulins|immunoglobulins|mesh-list
139412012|NCT00871481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139412013|NCT00871481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139412014|NCT00871481|Immunologic Factors|immunologic factors|mesh-ancestor
139412015|NCT00871481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412016|NCT00871481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139412017|NCT00871481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139412018|NCT00871481|Alkylating Agents|alkylating agents|mesh-ancestor
139412019|NCT00871481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412020|NCT00871481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412021|NCT00871481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139412022|NCT00871481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139412023|NCT00871481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139412024|NCT00871481|Analgesics|analgesics|mesh-ancestor
139412025|NCT00871481|Sensory System Agents|sensory system agents|mesh-ancestor
139412026|NCT00871481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762998|NCT04297215|Chitosan|chitosan|mesh-list
139412027|NCT00871481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139412028|NCT00871481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139412029|NCT00871481|Antiviral Agents|antiviral agents|mesh-ancestor
139412030|NCT00871481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412031|NCT05456165|Ipilimumab|ipilimumab|mesh-list
139412032|NCT05456165|Atezolizumab|atezolizumab|mesh-list
139412033|NCT05456165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139412034|NCT05456165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412035|NCT05456165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139651831|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139412036|NCT05456165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412037|NCT05083689|Bevacizumab|bevacizumab|mesh-list
139412038|NCT05083689|Timolol|timolol|mesh-list
139412039|NCT05083689|Dorzolamide|dorzolamide|mesh-list
139412040|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
139412041|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139412042|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412043|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139412044|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139412045|NCT05083689|Growth Substances|growth substances|mesh-ancestor
139412046|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412047|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
139412048|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139412049|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139412050|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
139412051|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139412052|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412053|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139412054|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139412055|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139412056|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139412057|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139412058|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412059|NCT05165966|Vaccines|vaccines|mesh-list
139412060|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
139412061|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412062|NCT05165732|Vaccines|vaccines|mesh-list
139412063|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
139412064|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412065|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
139412066|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
139412067|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139412068|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139412069|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763092|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
139412070|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412071|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412072|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139412073|NCT03138759|Probenecid|probenecid|mesh-list
139412074|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
139412075|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
139412076|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139412077|NCT03079921|Propranolol|propranolol|mesh-list
139412078|NCT03079921|Phentolamine|phentolamine|mesh-list
139412079|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139412080|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139412081|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
139412082|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139412083|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412084|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412085|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139412086|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139412087|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
139412088|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139412089|NCT04473989|Teriparatide|teriparatide|mesh-list
139412090|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139412091|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412092|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139412093|NCT05209490|Iodine|iodine|mesh-list
139412094|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139412095|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412096|NCT05209490|Trace Elements|trace elements|mesh-ancestor
139412097|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
139412098|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412099|NCT05162222|Itraconazole|itraconazole|mesh-list
139412100|NCT05162222|Diltiazem|diltiazem|mesh-list
139412101|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
139412102|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412103|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139412104|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139412105|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412106|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412107|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139412108|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
139412109|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139412110|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412111|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139412112|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139412113|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139412114|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139412115|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139412116|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
139412117|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
139412118|NCT05088057|Docetaxel|docetaxel|mesh-list
139412119|NCT05088057|Doxorubicin|doxorubicin|mesh-list
139412120|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139412121|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
138763223|NCT04074187|Hormones|hormones|mesh-ancestor
139412122|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412123|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139412124|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139412125|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
139412126|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412127|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412128|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139412129|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
139412130|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
139412131|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
139412132|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139412133|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139412134|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139412135|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412136|NCT03132025|Capecitabine|capecitabine|mesh-list
139412137|NCT03132025|Apatinib|apatinib|mesh-list
139412138|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139412139|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
139412140|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412141|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412142|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139412143|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068933|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139412145|NCT00857285|Olmesartan|olmesartan|mesh-list
139412146|NCT00857285|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139412147|NCT00857285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139412148|NCT00857285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139412149|NCT00857285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139412150|NCT00857285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139412151|NCT00857285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412152|NCT04461379|Vaccines|vaccines|mesh-list
139412153|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
139412154|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
139412155|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412156|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139412157|NCT00854945|ON 01910|on 01910|mesh-list
139412158|NCT00854945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412159|NCT00854945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139412160|NCT00854945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412161|NCT00854945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412162|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
139412163|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139412164|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139412165|NCT04876534|Prednisolone|prednisolone|mesh-list
139412166|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
139412167|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139412168|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139412169|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
139412170|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139412171|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
139412172|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
139412173|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412174|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412175|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139412176|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
139412177|NCT04876534|Hormones|hormones|mesh-ancestor
139412178|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139412179|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139412180|NCT04876534|Protective Agents|protective agents|mesh-ancestor
139412181|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139412182|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412183|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
139412184|NCT02443831|Fludarabine|fludarabine|mesh-list
139412185|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139412186|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
139412187|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412188|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139651832|NCT04426734|Protective Agents|protective agents|mesh-ancestor
139412189|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139412190|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
139412191|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412192|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412193|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139412194|NCT00851045|Leucovorin|leucovorin|mesh-list
139412195|NCT00851045|Bevacizumab|bevacizumab|mesh-list
139412196|NCT00851045|Fluorouracil|fluorouracil|mesh-list
139412197|NCT00851045|Irinotecan|irinotecan|mesh-list
139412198|NCT00851045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139412199|NCT00851045|Calcium|calcium|mesh-list
139412200|NCT00851045|Levoleucovorin|levoleucovorin|mesh-list
139412201|NCT00851045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139412202|NCT00851045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412203|NCT00851045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139412204|NCT00851045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139412205|NCT00851045|Growth Substances|growth substances|mesh-ancestor
139412206|NCT00851045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412207|NCT00851045|Growth Inhibitors|growth inhibitors|mesh-ancestor
139412208|NCT00851045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139412209|NCT00851045|Antimetabolites|antimetabolites|mesh-ancestor
139412210|NCT00851045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763487|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139412211|NCT00851045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139412212|NCT00851045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139412213|NCT00851045|Immunologic Factors|immunologic factors|mesh-ancestor
139412214|NCT00851045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139412215|NCT00851045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139412216|NCT00851045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412217|NCT00851045|Antidotes|antidotes|mesh-ancestor
139412218|NCT00851045|Protective Agents|protective agents|mesh-ancestor
139069014|NCT01035281|Nabilone|nabilone|mesh-list
139412219|NCT00851045|Vitamin B Complex|vitamin b complex|mesh-ancestor
139412220|NCT00851045|Vitamins|vitamins|mesh-ancestor
139412221|NCT00851045|Micronutrients|micronutrients|mesh-ancestor
139412222|NCT00850577|Paclitaxel|paclitaxel|mesh-list
139412223|NCT00850577|Bevacizumab|bevacizumab|mesh-list
139412224|NCT00850577|Carboplatin|carboplatin|mesh-list
139412225|NCT00850577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139412226|NCT00850577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139412227|NCT00850577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412228|NCT00850577|Tubulin Modulators|tubulin modulators|mesh-ancestor
139412229|NCT00850577|Antimitotic Agents|antimitotic agents|mesh-ancestor
139412230|NCT00850577|Mitosis Modulators|mitosis modulators|mesh-ancestor
139412231|NCT00850577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412232|NCT00850577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139412233|NCT00850577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139412234|NCT00850577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139412235|NCT00850577|Growth Substances|growth substances|mesh-ancestor
139412236|NCT00850577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763537|NCT04215835|Letrozole|letrozole|mesh-list
139412237|NCT00850577|Growth Inhibitors|growth inhibitors|mesh-ancestor
139412238|NCT00838981|Methadone|methadone|mesh-list
139412239|NCT00838981|Modafinil|modafinil|mesh-list
139412240|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139412241|NCT00838981|Narcotics|narcotics|mesh-ancestor
139412242|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139412243|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412244|NCT00838981|Analgesics|analgesics|mesh-ancestor
139412245|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
139412246|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412247|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
139412248|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
139412249|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139412250|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139412251|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139412252|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139412253|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412254|NCT00849797|Oxcarbazepine|oxcarbazepine|mesh-list
139412255|NCT00849797|Anticonvulsants|anticonvulsants|mesh-ancestor
139412256|NCT00849797|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139412257|NCT00849797|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139412258|NCT00849797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139412259|NCT00849797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412260|NCT00849797|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139412261|NCT00849797|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139651833|NCT03006081|Aflibercept|aflibercept|mesh-list
139651834|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139412263|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
139412264|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
139412265|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139412266|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412267|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
139412268|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412269|NCT00950885|Melatonin|melatonin|mesh-list
139412270|NCT00950885|Antioxidants|antioxidants|mesh-ancestor
139412271|NCT00950885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412272|NCT00950885|Protective Agents|protective agents|mesh-ancestor
139412273|NCT00950885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412274|NCT00950885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139412275|NCT00849485|Levetiracetam|levetiracetam|mesh-list
139412276|NCT00849485|Anticonvulsants|anticonvulsants|mesh-ancestor
139412277|NCT00849485|Nootropic Agents|nootropic agents|mesh-ancestor
139412278|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
139412279|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
139412280|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139412281|NCT03140397|Estrogens|estrogens|mesh-ancestor
139412282|NCT03140397|Hormones|hormones|mesh-ancestor
139412283|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139412284|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412285|NCT05047445|Vaccines|vaccines|mesh-list
139412286|NCT05047445|Immunologic Factors|immunologic factors|mesh-ancestor
139412287|NCT05047445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412288|NCT05235542|Paclitaxel|paclitaxel|mesh-list
139412289|NCT05235542|Docetaxel|docetaxel|mesh-list
139412290|NCT05235542|Capecitabine|capecitabine|mesh-list
139412291|NCT05235542|Oxaliplatin|oxaliplatin|mesh-list
139412292|NCT05235542|Irinotecan|irinotecan|mesh-list
139412293|NCT05235542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139412294|NCT05235542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412295|NCT05235542|Tubulin Modulators|tubulin modulators|mesh-ancestor
139412296|NCT05235542|Antimitotic Agents|antimitotic agents|mesh-ancestor
139412297|NCT05235542|Mitosis Modulators|mitosis modulators|mesh-ancestor
139412298|NCT05235542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412299|NCT05235542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139412300|NCT05235542|Antimetabolites|antimetabolites|mesh-ancestor
139412301|NCT05235542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139412302|NCT05235542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139412303|NCT05235542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412305|NCT00840281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139412306|NCT00840281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412307|NCT00840203|Mesalamine|mesalamine|mesh-list
139412308|NCT00840203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139412309|NCT00840203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139412310|NCT00840203|Analgesics|analgesics|mesh-ancestor
139412311|NCT00840203|Sensory System Agents|sensory system agents|mesh-ancestor
139412312|NCT00840203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412313|NCT00840203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412314|NCT00840203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139412315|NCT00840203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139412316|NCT00838799|Pregabalin|pregabalin|mesh-list
139412317|NCT00838799|Analgesics|analgesics|mesh-ancestor
139412318|NCT00838799|Sensory System Agents|sensory system agents|mesh-ancestor
139412319|NCT00838799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412320|NCT00838799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412321|NCT00838799|Anticonvulsants|anticonvulsants|mesh-ancestor
139412322|NCT00838799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139412323|NCT00838799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139412324|NCT00838799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412325|NCT00838799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139412326|NCT00838799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139412327|NCT00838799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139412328|NCT00838799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139412329|NCT00838799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139412330|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
139412331|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139412332|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412333|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139412334|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412335|NCT00836069|Paroxetine|paroxetine|mesh-list
139412336|NCT00836069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139412337|NCT00836069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139412338|NCT00836069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139412339|NCT00836069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412340|NCT00836069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139412342|NCT00836069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412343|NCT00836069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139412344|NCT00836069|Antidepressive Agents|antidepressive agents|mesh-ancestor
139412345|NCT00836069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139412346|NCT00836069|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139412347|NCT00836069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139412348|NCT00836069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412349|NCT03134729|Ropivacaine|ropivacaine|mesh-list
139412350|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
139412351|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
139412352|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139412353|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412354|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
139412355|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412356|NCT03134651|Propofol|propofol|mesh-list
139412357|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139412358|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139412359|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412360|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139412361|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
139412362|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
139412363|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
139412364|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412365|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139412366|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069159|NCT02043587|Cytarabine|cytarabine|mesh-list
139412367|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412368|NCT00935987|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
139412369|NCT00935987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139412370|NCT00935987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412371|NCT00935987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412372|NCT05155124|Cetuximab|cetuximab|mesh-list
139412373|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139412374|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412375|NCT00927641|Ketoprofen|ketoprofen|mesh-list
139412376|NCT00927641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139412377|NCT00927641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139412378|NCT00927641|Analgesics|analgesics|mesh-ancestor
139412379|NCT00927641|Sensory System Agents|sensory system agents|mesh-ancestor
139412380|NCT00927641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412381|NCT00927641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412382|NCT00927641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139412383|NCT00927641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139412384|NCT00927641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139412385|NCT00927641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412386|NCT00927641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412387|NCT05200364|Bevacizumab|bevacizumab|mesh-list
139412388|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139412389|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412390|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139412391|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139412392|NCT05200364|Growth Substances|growth substances|mesh-ancestor
139412393|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412394|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
139412395|NCT00835991|Metformin|metformin|mesh-list
139412396|NCT00835991|Glyburide|glyburide|mesh-list
139412397|NCT00835991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139412398|NCT00835991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412399|NCT05200052|Colchicine|colchicine|mesh-list
139412400|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
139412401|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139412402|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
139412403|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
139412404|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
139412405|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412406|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412407|NCT00925535|Rifabutin|rifabutin|mesh-list
138917074|NCT00589472|Vorinostat|vorinostat|mesh-list
139412409|NCT00925535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412410|NCT00925535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139412411|NCT00925535|Antitubercular Agents|antitubercular agents|mesh-ancestor
139412412|NCT02276872|Treprostinil|treprostinil|mesh-list
139412413|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139412414|NCT00835367|Amlodipine|amlodipine|mesh-list
139412415|NCT00835367|Benazepril|benazepril|mesh-list
139412416|NCT00835367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139412417|NCT00835367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139412418|NCT00835367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139412419|NCT00835367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412420|NCT00835367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139412421|NCT00835367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763937|NCT02700217|Narcotics|narcotics|mesh-ancestor
139412422|NCT00835367|Vasodilator Agents|vasodilator agents|mesh-ancestor
139412423|NCT00835367|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139412424|NCT00835367|Protease Inhibitors|protease inhibitors|mesh-ancestor
139412425|NCT00835367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412426|NCT02276560|Paclitaxel|paclitaxel|mesh-list
139412427|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139412428|NCT02276560|Cisplatin|cisplatin|mesh-list
139412429|NCT02276560|Gemcitabine|gemcitabine|mesh-list
139412430|NCT02276560|Pemetrexed|pemetrexed|mesh-list
139412431|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139412432|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412433|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
139412434|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
139412435|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
139412436|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412437|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139412438|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
139412439|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412440|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139412441|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139412442|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139412443|NCT02276482|Metronidazole|metronidazole|mesh-list
139412444|NCT02276482|Vancomycin|vancomycin|mesh-list
139412445|NCT02276482|Clindamycin|clindamycin|mesh-list
139412446|NCT02276482|Cefazolin|cefazolin|mesh-list
139412447|NCT02276482|Linezolid|linezolid|mesh-list
139412448|NCT02276482|Cephalexin|cephalexin|mesh-list
139412449|NCT02276482|Aztreonam|aztreonam|mesh-list
139412450|NCT02276482|Tedizolid|tedizolid|mesh-list
139412451|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412452|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139412453|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139412454|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139412455|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412456|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412457|NCT00924833|Carvedilol|carvedilol|mesh-list
139412458|NCT00924833|Nebivolol|nebivolol|mesh-list
139412459|NCT00924833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139412460|NCT00924833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139412461|NCT00924833|Adrenergic Agents|adrenergic agents|mesh-ancestor
139412462|NCT00924833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139412463|NCT00924833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412464|NCT00924833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412465|NCT00924833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139412466|NCT00924833|Antioxidants|antioxidants|mesh-ancestor
139412467|NCT00924833|Protective Agents|protective agents|mesh-ancestor
139412468|NCT00924833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139412469|NCT00924833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139412470|NCT00924833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139412471|NCT00924833|Vasodilator Agents|vasodilator agents|mesh-ancestor
139412472|NCT00924833|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139412473|NCT00924833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139412474|NCT00924833|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139412475|NCT00924833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139412476|NCT00924833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139412477|NCT00835211|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139412478|NCT00835211|Hemostatics|hemostatics|mesh-ancestor
139412479|NCT00835211|Coagulants|coagulants|mesh-ancestor
139412480|NCT00835211|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139412481|NCT00835211|Natriuretic Agents|natriuretic agents|mesh-ancestor
139412482|NCT00835211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412483|NCT00834977|Amlodipine|amlodipine|mesh-list
139412484|NCT00834977|Benazepril|benazepril|mesh-list
139412485|NCT00834977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139412486|NCT00834977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139412487|NCT00834977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139412488|NCT00834977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412489|NCT00834977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139412490|NCT00834977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412491|NCT00834977|Vasodilator Agents|vasodilator agents|mesh-ancestor
139412492|NCT00834977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139412493|NCT00834977|Protease Inhibitors|protease inhibitors|mesh-ancestor
138764091|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
139412494|NCT00834977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412496|NCT05227664|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139412497|NCT05227664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139412498|NCT05227664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412499|NCT05227664|Tubulin Modulators|tubulin modulators|mesh-ancestor
139412500|NCT05227664|Antimitotic Agents|antimitotic agents|mesh-ancestor
139412501|NCT05227664|Mitosis Modulators|mitosis modulators|mesh-ancestor
139412502|NCT05227664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412503|NCT00834743|Metformin|metformin|mesh-list
139412504|NCT00834743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139412505|NCT00834743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412506|NCT00834587|Metformin|metformin|mesh-list
139412507|NCT00834587|Glipizide|glipizide|mesh-list
139412508|NCT00834587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139412509|NCT00834587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412510|NCT00834431|Famciclovir|famciclovir|mesh-list
139412511|NCT00834431|Antiviral Agents|antiviral agents|mesh-ancestor
139412512|NCT00834431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412513|NCT00834431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139412514|NCT00834431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412515|NCT00834431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412516|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139069312|NCT03783754|Amlodipine|amlodipine|mesh-list
139412517|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139412518|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412519|NCT00834275|Cefadroxil|cefadroxil|mesh-list
139412520|NCT00834275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139412521|NCT00834275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412522|NCT00834197|Mirtazapine|mirtazapine|mesh-list
139412523|NCT00834197|Antidepressive Agents|antidepressive agents|mesh-ancestor
139412524|NCT00834197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139412525|NCT00834197|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139412526|NCT00834197|Histamine Antagonists|histamine antagonists|mesh-ancestor
139412527|NCT00834197|Histamine Agents|histamine agents|mesh-ancestor
139412528|NCT00834197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139412529|NCT00834197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412530|NCT00834197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764142|NCT04213495|Anesthetics|anesthetics|mesh-list
139412531|NCT00834197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139412532|NCT00834197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139412533|NCT00834197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139412534|NCT00834197|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139412535|NCT00834197|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139412536|NCT00834197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139412537|NCT00834197|Adrenergic Agents|adrenergic agents|mesh-ancestor
139412538|NCT00834197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139412539|NCT00834197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139412540|NCT00834197|Serotonin Agents|serotonin agents|mesh-ancestor
139412541|NCT00834197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139412542|NCT00833495|Prednisolone|prednisolone|mesh-list
139412543|NCT00833495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139412544|NCT00833495|Methylprednisolone|methylprednisolone|mesh-list
139412545|NCT00833495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139412546|NCT00833495|Prednisolone acetate|prednisolone acetate|mesh-list
139412547|NCT00833495|Prednisone|prednisone|mesh-list
139412548|NCT00833495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139412549|NCT00833495|Prednisolone phosphate|prednisolone phosphate|mesh-list
139412550|NCT00833495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139412551|NCT00833495|Glucocorticoids|glucocorticoids|mesh-ancestor
139412552|NCT00833495|Hormones|hormones|mesh-ancestor
139412553|NCT00833495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139412554|NCT00833495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412555|NCT00833495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139412556|NCT00833495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917230|NCT00801632|Hormones|hormones|mesh-ancestor
139412557|NCT00833495|Antiemetics|antiemetics|mesh-ancestor
139412558|NCT00833495|Autonomic Agents|autonomic agents|mesh-ancestor
139412559|NCT00833495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412560|NCT00833495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139412561|NCT00833495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139412562|NCT00833495|Protective Agents|protective agents|mesh-ancestor
139412563|NCT00830219|Ropinirole|ropinirole|mesh-list
139412564|NCT00830219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139412565|NCT00830219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139412566|NCT00830219|Dopamine Agonists|dopamine agonists|mesh-ancestor
139412567|NCT00830219|Dopamine Agents|dopamine agents|mesh-ancestor
139412568|NCT00830219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139412569|NCT00830219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412570|NCT00830219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412571|NCT02274766|Amantadine|amantadine|mesh-list
139412572|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139412573|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139412574|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
139412575|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412576|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
139412577|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139412578|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412579|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412580|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139412581|NCT02274766|Analgesics|analgesics|mesh-ancestor
139412582|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
139412583|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412584|NCT00829673|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
139412585|NCT00829673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139412586|NCT00829673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412587|NCT00829673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139412588|NCT00829673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139412589|NCT00829673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139412590|NCT00829673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412591|NCT00829673|Dopamine Agents|dopamine agents|mesh-ancestor
139412592|NCT00829673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139412593|NCT05221658|Cisplatin|cisplatin|mesh-list
139412594|NCT05221658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412595|NCT05132114|Lugol's solution|lugol's solution|mesh-list
139412596|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
139412597|NCT05132114|Coagulants|coagulants|mesh-ancestor
139412598|NCT02370238|Paclitaxel|paclitaxel|mesh-list
139412599|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139412600|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412601|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
139412602|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
139412603|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
139412604|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412605|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
139412606|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139412607|NCT05109104|Protective Agents|protective agents|mesh-ancestor
139412608|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412609|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
139412610|NCT05126342|Niraparib|niraparib|mesh-list
139412611|NCT05126342|Dostarlimab|dostarlimab|mesh-list
139412612|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139412613|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412614|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412615|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412616|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
139412617|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139412618|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412619|NCT05180708|Sirolimus|sirolimus|mesh-list
139412620|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139412621|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412622|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139412623|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412624|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
139412625|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139412626|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
139412627|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412628|NCT02273752|Everolimus|everolimus|mesh-list
139412629|NCT02273752|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139651835|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139412630|NCT02273752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139412631|NCT02273752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412632|NCT02273752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412633|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139412634|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
139412635|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412636|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412637|NCT05102552|Huperzine A|huperzine a|mesh-list
139412638|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139412639|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412640|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412641|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
139412642|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139412643|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412644|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139412645|NCT05102552|Protective Agents|protective agents|mesh-ancestor
139412646|NCT02273050|Metformin|metformin|mesh-list
139412647|NCT02273050|Saxagliptin|saxagliptin|mesh-list
139412648|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139412649|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412650|NCT02273050|Incretins|incretins|mesh-ancestor
139412651|NCT02273050|Hormones|hormones|mesh-ancestor
138764446|NCT04293549|Mitogens|mitogens|mesh-list
139412652|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139412653|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139412654|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
139412655|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412656|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412657|NCT02272816|Carboplatin|carboplatin|mesh-list
139412658|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412659|NCT05170256|Trastuzumab|trastuzumab|mesh-list
139412660|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139412661|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412662|NCT05386979|Analgesics, Opioid|analgesics, opioid|mesh-list
139412663|NCT05386979|Anesthetics|anesthetics|mesh-list
139412664|NCT05386979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139412665|NCT05386979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412666|NCT05386979|Narcotics|narcotics|mesh-ancestor
139412667|NCT05386979|Analgesics|analgesics|mesh-ancestor
139412668|NCT05386979|Sensory System Agents|sensory system agents|mesh-ancestor
138764500|NCT00620971|Growth Substances|growth substances|mesh-ancestor
139412669|NCT05386979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412670|NCT02367352|Paclitaxel|paclitaxel|mesh-list
139412671|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139412672|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412673|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
139412674|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
139412675|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
139412676|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412677|NCT02270944|Vaccines|vaccines|mesh-list
139412678|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
139412679|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412680|NCT05648734|Pirfenidone|pirfenidone|mesh-list
139412681|NCT05648734|Colchicine|colchicine|mesh-list
139412682|NCT05648734|Gout Suppressants|gout suppressants|mesh-ancestor
139412683|NCT05648734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139412684|NCT05648734|Tubulin Modulators|tubulin modulators|mesh-ancestor
139412685|NCT05648734|Antimitotic Agents|antimitotic agents|mesh-ancestor
139412686|NCT05648734|Mitosis Modulators|mitosis modulators|mesh-ancestor
139412687|NCT05648734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412688|NCT05648734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412689|NCT05648734|Analgesics|analgesics|mesh-ancestor
138764557|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764558|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138764559|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
138764560|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764568|NCT00629031|Paromomycin|paromomycin|mesh-list
138764569|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138764570|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412690|NCT05648734|Sensory System Agents|sensory system agents|mesh-ancestor
139412691|NCT05648734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412692|NCT05648734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412693|NCT05648734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139412694|NCT05648734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139412695|NCT05648734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139412696|NCT02365558|Omeprazole|omeprazole|mesh-list
139412697|NCT02365558|Evacetrapib|evacetrapib|mesh-list
139412698|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139412699|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139412700|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139412701|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412702|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412703|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139651836|NCT03006081|Growth Substances|growth substances|mesh-ancestor
139651837|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651838|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
139412704|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139412705|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
139412706|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139412708|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
139412709|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
139412710|NCT02270242|Aspirin|aspirin|mesh-list
139412711|NCT02270242|Ticagrelor|ticagrelor|mesh-list
139412712|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139412713|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139412714|NCT02270242|Analgesics|analgesics|mesh-ancestor
139412715|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
139412716|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412717|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412718|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139412719|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139412720|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139412721|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139412722|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412723|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139412724|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139412725|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412726|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
139412727|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139412728|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139412729|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139412730|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
139412731|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139412732|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
139412733|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139412734|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412735|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139412736|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412737|NCT05648266|Analgesics|analgesics|mesh-list
139412738|NCT05648266|Sensory System Agents|sensory system agents|mesh-ancestor
139412739|NCT05648266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412740|NCT05648266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412741|NCT04992026|Prednisone|prednisone|mesh-list
139069535|NCT00142298|Telbivudine|telbivudine|mesh-list
139412742|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
139412743|NCT04992026|Hormones|hormones|mesh-list
139412744|NCT04992026|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139412745|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139412746|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
139412747|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139412748|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412749|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139412750|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412751|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139412752|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412753|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412754|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
139412755|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139412756|NCT05036798|Lenvatinib|lenvatinib|mesh-list
139412757|NCT05036798|Tislelizumab|tislelizumab|mesh-list
139412758|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412759|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139412760|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412761|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412762|NCT05036798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139412763|NCT04209218|Dexamethasone|dexamethasone|mesh-list
139412764|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
139412765|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139412766|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
139412767|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
139412768|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412769|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412770|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139412771|NCT04209218|Hormones|hormones|mesh-ancestor
139412772|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139412773|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139412774|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412775|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
139412776|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139412777|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412778|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139412779|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412780|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139412781|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
139412782|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139412783|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139412784|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
139412785|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412786|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
139412787|NCT04421300|Protective Agents|protective agents|mesh-ancestor
139412788|NCT02268058|Acetaminophen|acetaminophen|mesh-list
139412789|NCT02268058|Ibuprofen|ibuprofen|mesh-list
139412790|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139412791|NCT02268058|Analgesics|analgesics|mesh-ancestor
139412792|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
139412793|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412794|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412795|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
139412796|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139412797|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139412798|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139412799|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139412800|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412801|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412802|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
139412803|NCT02267746|Tazarotene|tazarotene|mesh-list
139412804|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
139412805|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
139412806|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
139412807|NCT02267746|Vitamins|vitamins|mesh-ancestor
139412808|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
139412809|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412810|NCT04421534|Lactoferrin|lactoferrin|mesh-list
139412811|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412812|NCT05059028|Oxytocin|oxytocin|mesh-list
139412813|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
139412814|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139412815|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412816|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139412817|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139412818|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139412819|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412820|NCT04215848|Budesonide|budesonide|mesh-list
139412821|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
139412822|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139412823|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139412824|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
139412825|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412826|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412827|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139412828|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
139412829|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
139412830|NCT04215848|Hormones|hormones|mesh-ancestor
139412831|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139412832|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139412833|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139412834|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139412835|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
139412836|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139412837|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412838|NCT04215146|Paclitaxel|paclitaxel|mesh-list
139412839|NCT04215146|Avelumab|avelumab|mesh-list
139412840|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139412841|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412842|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
139412843|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
139412844|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
139412845|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412846|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139651839|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651840|NCT01535937|Midazolam|midazolam|mesh-list
139412847|NCT04959266|Itraconazole|itraconazole|mesh-list
139651841|NCT01535937|Ketamine|ketamine|mesh-list
139651842|NCT01535937|Analgesics|analgesics|mesh-ancestor
139412849|NCT04959266|Omeprazole|omeprazole|mesh-list
139412850|NCT04959266|Adavosertib|adavosertib|mesh-list
139412851|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139412852|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139412853|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139412854|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412855|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412856|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
139412857|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412858|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139412859|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139412860|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139412861|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
139412862|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139412863|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412864|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139412865|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139412866|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
139412867|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139412868|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
139412869|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139412870|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139412871|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139412872|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139412873|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138764846|NCT00639925|Gemcitabine|gemcitabine|mesh-list
139412874|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139412875|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139412876|NCT04945148|Metformin|metformin|mesh-list
139412877|NCT04945148|Temozolomide|temozolomide|mesh-list
139412878|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139412879|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412880|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139412881|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
139412882|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412883|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412884|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139412885|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139412886|NCT05003570|Fentanyl|fentanyl|mesh-list
139412887|NCT05003570|Remifentanil|remifentanil|mesh-list
139412888|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139069687|NCT01039181|Calcitriol|calcitriol|mesh-list
139412890|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139412891|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412892|NCT05003570|Analgesics|analgesics|mesh-ancestor
139412893|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
139412894|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412895|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139412896|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139412897|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
139412898|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
139412899|NCT02483078|Leronlimab|leronlimab|mesh-list
139412900|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138764888|NCT01202279|Guaifenesin|guaifenesin|mesh-list
139412901|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139412902|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412903|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139412904|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139412905|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
139412906|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412907|NCT02452190|Reslizumab|reslizumab|mesh-list
139412908|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139412909|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
139412910|NCT02514122|Ketamine|ketamine|mesh-list
139412911|NCT02514122|Analgesics|analgesics|mesh-ancestor
139412912|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
139412913|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412914|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412915|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139412916|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139412917|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
139412918|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
139412919|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139412920|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138917609|NCT00798590|Glucagon|glucagon|mesh-list
139412921|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139412922|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139412923|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412925|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139412926|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764925|NCT02687347|Analgesics|analgesics|mesh-ancestor
139412927|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139412928|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412929|NCT04462003|Enoxaparin|enoxaparin|mesh-list
139412930|NCT04462003|Apixaban|apixaban|mesh-list
139412931|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
139412932|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139412933|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139412934|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412935|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139412936|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
139412937|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139412938|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
139412939|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412940|NCT03489265|Eluxadoline|eluxadoline|mesh-list
139412941|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139412942|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
139412943|NCT03344341|Acarbose|acarbose|mesh-list
139412944|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139412945|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412946|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139412947|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412948|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139412949|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412950|NCT03238495|Metformin|metformin|mesh-list
139412951|NCT03238495|Carboplatin|carboplatin|mesh-list
139412952|NCT03238495|Docetaxel|docetaxel|mesh-list
139412953|NCT03238495|Trastuzumab|trastuzumab|mesh-list
139412954|NCT03238495|Pertuzumab|pertuzumab|mesh-list
139412955|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412956|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139412957|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412958|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
139412959|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
139412960|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
139412961|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412962|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139412963|NCT02536339|Trastuzumab|trastuzumab|mesh-list
139412964|NCT02536339|Pertuzumab|pertuzumab|mesh-list
139412965|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139412966|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412967|NCT01869361|Indomethacin|indomethacin|mesh-list
139412968|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139412969|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139412970|NCT01869361|Analgesics|analgesics|mesh-ancestor
139412971|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
139412972|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139412973|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412974|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139412975|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139412976|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
139412977|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
139412978|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139412979|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139412980|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412981|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412982|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
139412983|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139412984|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139412985|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139412986|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139412987|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139412988|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139412989|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412990|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139412991|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139412992|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139412993|NCT01578967|Immunotoxins|immunotoxins|mesh-ancestor
139412994|NCT01578967|Immunoconjugates|immunoconjugates|mesh-ancestor
139412995|NCT01578967|Immunologic Factors|immunologic factors|mesh-ancestor
139412996|NCT01578967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139412998|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139412999|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413001|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139413002|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
139413003|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413004|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413005|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139413006|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413007|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139413008|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139413009|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139413010|NCT03488719|Metoprolol|metoprolol|mesh-list
139413011|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139413012|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139413013|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
139413014|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
139413015|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413016|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413017|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139413018|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139413019|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139413020|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
139413021|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139413022|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413023|NCT03496831|Adalimumab|adalimumab|mesh-list
139413024|NCT03496831|Infliximab|infliximab|mesh-list
139413025|NCT03496831|Golimumab|golimumab|mesh-list
139413026|NCT03496831|Etanercept|etanercept|mesh-list
139413027|NCT03496831|Abatacept|abatacept|mesh-list
139413028|NCT03496831|Ustekinumab|ustekinumab|mesh-list
139413029|NCT03496831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413030|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413031|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
139413032|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413033|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139413034|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139413035|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139413036|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
139413037|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139413038|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139413039|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139413040|NCT03496831|Analgesics|analgesics|mesh-ancestor
139413041|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
139413042|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413043|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139413044|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139413045|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413046|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
139413047|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
139413048|NCT03488485|Ledipasvir|ledipasvir|mesh-list
139413049|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139413050|NCT00821249|Dexamethasone|dexamethasone|mesh-list
139413051|NCT00821249|Filanesib|filanesib|mesh-list
139413052|NCT00821249|Lenograstim|lenograstim|mesh-list
139413053|NCT00821249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139413054|NCT00821249|Antiemetics|antiemetics|mesh-ancestor
139413055|NCT00821249|Autonomic Agents|autonomic agents|mesh-ancestor
139413056|NCT00821249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413057|NCT00821249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413058|NCT00821249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139413059|NCT00821249|Glucocorticoids|glucocorticoids|mesh-ancestor
139413060|NCT00821249|Hormones|hormones|mesh-ancestor
139413061|NCT00821249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413062|NCT00821249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139413063|NCT00821249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413064|NCT00821249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139413065|NCT00821249|Immunologic Factors|immunologic factors|mesh-ancestor
139413066|NCT00821249|Antimitotic Agents|antimitotic agents|mesh-ancestor
139413067|NCT00821249|Mitosis Modulators|mitosis modulators|mesh-ancestor
139413068|NCT00821249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413069|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
139413070|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
139413071|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139413072|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
139413073|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413074|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139413075|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139413076|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
139413077|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413078|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413079|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139413080|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413081|NCT03752723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139413082|NCT04472585|Ivermectin|ivermectin|mesh-list
139413083|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139413084|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139413085|NCT03496519|Durvalumab|durvalumab|mesh-list
139413086|NCT03496519|Trabectedin|trabectedin|mesh-list
139413087|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139413088|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413089|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413090|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
139413091|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413092|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139413093|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
139413094|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413095|NCT00813605|Conatumumab|conatumumab|mesh-list
139413096|NCT00813605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413097|NCT00813605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413098|NCT00724841|Temozolomide|temozolomide|mesh-list
139413099|NCT00724841|Obatoclax|obatoclax|mesh-list
139413100|NCT00724841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139413101|NCT00724841|Alkylating Agents|alkylating agents|mesh-ancestor
139413102|NCT00724841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413103|NCT00724841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413104|NCT00724841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413105|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
139413106|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139413107|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139413108|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139413109|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139413110|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413111|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
139413112|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069912|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
139413113|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413114|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139413115|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413116|NCT00805805|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
139413117|NCT00805805|Chelating Agents|chelating agents|mesh-ancestor
139413118|NCT00805805|Sequestering Agents|sequestering agents|mesh-ancestor
139413119|NCT00805805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413120|NCT00805805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413121|NCT00805805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139413122|NCT00805805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139413123|NCT00805805|Growth Substances|growth substances|mesh-ancestor
139413124|NCT00805805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413125|NCT00805805|Growth Inhibitors|growth inhibitors|mesh-ancestor
139413126|NCT00805805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413127|NCT03488173|Lansoprazole|lansoprazole|mesh-list
139413128|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
139413129|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138765187|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
139413130|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139413131|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139413132|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413133|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413134|NCT04750759|Niclosamide|niclosamide|mesh-list
139413135|NCT04750759|Camostat|camostat|mesh-list
139413136|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
139413137|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413138|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413139|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139413140|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139413141|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
139413142|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139413143|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
139413144|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139413145|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139413146|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
139413147|NCT03382925|Triamcinolone|triamcinolone|mesh-list
139413148|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139413149|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139413150|NCT03382925|Lidocaine|lidocaine|mesh-list
139413151|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139413152|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
139413153|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
139413154|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139413155|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413156|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
139413157|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413158|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139413159|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139413160|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139413161|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139413162|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413163|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139413164|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
139413165|NCT03382925|Hormones|hormones|mesh-ancestor
139413166|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413167|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679939|NCT01248260|Folic Acid|folic acid|mesh-list
139413168|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
139413169|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413170|NCT03487939|Fluorouracil|fluorouracil|mesh-list
139413171|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
139413172|NCT03487939|Irinotecan|irinotecan|mesh-list
139413173|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
139413174|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413175|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139413176|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413177|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139413178|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
139413179|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413180|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139413181|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139413182|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413183|NCT00796289|Citric Acid|citric acid|mesh-list
139413184|NCT00796289|Sodium Citrate|sodium citrate|mesh-list
139413185|NCT00796289|Clomiphene|clomiphene|mesh-list
139413186|NCT00796289|Enclomiphene|enclomiphene|mesh-list
139413187|NCT00796289|Zuclomiphene|zuclomiphene|mesh-list
139413188|NCT00796289|Hormones|hormones|mesh-list
139069993|NCT03766984|Diclofenac|diclofenac|mesh-list
139413190|NCT00796289|Anticoagulants|anticoagulants|mesh-ancestor
139413191|NCT00796289|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139413192|NCT00796289|Chelating Agents|chelating agents|mesh-ancestor
139413193|NCT00796289|Sequestering Agents|sequestering agents|mesh-ancestor
139413194|NCT00796289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413195|NCT00796289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413196|NCT00796289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413197|NCT00796289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139413198|NCT00796289|Hormone Antagonists|hormone antagonists|mesh-ancestor
139413199|NCT00796289|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139413200|NCT00796289|Fertility Agents|fertility agents|mesh-ancestor
139413201|NCT00796289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139413202|NCT00796289|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139413203|NCT00796289|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139413204|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
139413205|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
139413206|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139413207|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
139413208|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139413209|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
139413210|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139413211|NCT04460521|Expectorants|expectorants|mesh-ancestor
139413212|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
139413213|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139413214|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
139413215|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413216|NCT04460521|Protective Agents|protective agents|mesh-ancestor
139413217|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413218|NCT04460521|Antidotes|antidotes|mesh-ancestor
139413219|NCT00698789|Metformin|metformin|mesh-list
139413220|NCT00698789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139413221|NCT00698789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651843|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
139413223|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139413224|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
139413225|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139413226|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139413227|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139413228|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138765257|NCT01158534|Interferons|interferons|mesh-list
139413229|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413230|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
139413231|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
139413232|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139413233|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413234|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139413235|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139413236|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
139413237|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139413238|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139413239|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139413240|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139413241|NCT03495739|Dabigatran|dabigatran|mesh-list
139413242|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
139413243|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139413244|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
139413245|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413246|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413247|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
139413248|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139413249|NCT04071613|Plasminogen|plasminogen|mesh-list
139413250|NCT04071613|Tenecteplase|tenecteplase|mesh-list
139413251|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139413252|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139413253|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413254|NCT00678119|Sunitinib|sunitinib|mesh-list
139413255|NCT00678119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413256|NCT00678119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139413257|NCT00678119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139413258|NCT00678119|Growth Substances|growth substances|mesh-ancestor
139413259|NCT00678119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413260|NCT00678119|Growth Inhibitors|growth inhibitors|mesh-ancestor
139413261|NCT00678119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139413262|NCT00678119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413263|NCT00678119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413265|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413266|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413267|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139413268|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413269|NCT02011321|Clevidipine|clevidipine|mesh-list
139413270|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139413271|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139413272|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413273|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139413274|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413275|NCT01352585|Anagrelide|anagrelide|mesh-list
139413276|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139413277|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139413278|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413279|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139413280|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
139413281|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
139413282|NCT03484507|Prednisolone|prednisolone|mesh-list
139413283|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139413284|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
139413285|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139413286|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
139413287|NCT03484507|Povidone|povidone|mesh-list
139413288|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139413289|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
139413290|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139413291|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
139413292|NCT03484507|Hormones|hormones|mesh-ancestor
139413293|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413294|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651844|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413295|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139413296|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413297|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
139413298|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
139413299|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413300|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139413301|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139413302|NCT03484507|Protective Agents|protective agents|mesh-ancestor
139413303|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139413304|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139413305|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
139413306|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
139413307|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
139413308|NCT02773355|Liraglutide|liraglutide|mesh-list
139413309|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139413310|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413311|NCT02773355|Incretins|incretins|mesh-ancestor
139413312|NCT02773355|Hormones|hormones|mesh-ancestor
139413313|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413314|NCT02744183|Benzocaine|benzocaine|mesh-list
139413315|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
139413316|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
139413317|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139413318|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413319|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
139413320|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413321|NCT03484195|Fluorouracil|fluorouracil|mesh-list
139413322|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
139413323|NCT03484195|Irinotecan|irinotecan|mesh-list
139413324|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
139413325|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413326|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139413327|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413328|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139413329|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
139413330|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413331|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139413332|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139413333|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413334|NCT04526821|Lactoferrin|lactoferrin|mesh-list
139413335|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139413336|NCT02323399|Phenylephrine|phenylephrine|mesh-list
139413337|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
139413338|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139413340|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
139413341|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413342|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413343|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
139413344|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139413345|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
139413346|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
139413347|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139413348|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139413349|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139413350|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
139413351|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139413352|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413353|NCT02323399|Protective Agents|protective agents|mesh-ancestor
139413354|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
139413355|NCT01352507|Tadalafil|tadalafil|mesh-list
139413356|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
139413357|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139413358|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139413359|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413360|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413361|NCT01352507|Urological Agents|urological agents|mesh-ancestor
139413362|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
139413363|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139413364|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139413365|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
139413366|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765385|NCT02683291|Tacrolimus|tacrolimus|mesh-list
139413367|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413368|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139413369|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
139413370|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139651845|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651846|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139651847|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139651848|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
139651849|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
139651850|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139651851|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139413371|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
139413372|NCT04460963|Protective Agents|protective agents|mesh-ancestor
139413373|NCT00873275|Leucovorin|leucovorin|mesh-list
139413374|NCT00873275|Bevacizumab|bevacizumab|mesh-list
139413375|NCT00873275|Fluorouracil|fluorouracil|mesh-list
139413376|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
139413377|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139413378|NCT00873275|Calcium|calcium|mesh-list
139413379|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
139413380|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413381|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413382|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139413383|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139413384|NCT00873275|Growth Substances|growth substances|mesh-ancestor
139413385|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413386|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
139413387|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139413388|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
139413389|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413390|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139413391|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139413392|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
139413393|NCT00873275|Antidotes|antidotes|mesh-ancestor
139413394|NCT00873275|Protective Agents|protective agents|mesh-ancestor
139413395|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
139413396|NCT00873275|Vitamins|vitamins|mesh-ancestor
139413397|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
139413398|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139413399|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139413400|NCT04403243|Colchicine|colchicine|mesh-list
139413401|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
139413402|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139413403|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
139413404|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
139413405|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
139413406|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413407|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413408|NCT05648032|Triamcinolone|triamcinolone|mesh-list
138765478|NCT02683759|Analgesics|analgesics|mesh-ancestor
139413409|NCT05648032|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139413410|NCT05648032|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139413411|NCT05648032|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139413412|NCT05648032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139413413|NCT05648032|Glucocorticoids|glucocorticoids|mesh-ancestor
139413414|NCT05648032|Hormones|hormones|mesh-ancestor
139413415|NCT05648032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413416|NCT05648032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413417|NCT05648032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139413418|NCT05648032|Immunologic Factors|immunologic factors|mesh-ancestor
139413419|NCT05648032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413420|NCT05648032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413421|NCT00774761|Fluticasone|fluticasone|mesh-list
139413423|NCT00774761|Formoterol Fumarate|formoterol fumarate|mesh-list
139413424|NCT00774761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139413425|NCT00774761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139413426|NCT00774761|Autonomic Agents|autonomic agents|mesh-ancestor
139413427|NCT00774761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413428|NCT00774761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413429|NCT00774761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139413430|NCT00774761|Respiratory System Agents|respiratory system agents|mesh-ancestor
139413431|NCT00774761|Dermatologic Agents|dermatologic agents|mesh-ancestor
139413432|NCT00774761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139413433|NCT00774761|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139413434|NCT00774761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139413435|NCT00774761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139413436|NCT00774761|Adrenergic Agents|adrenergic agents|mesh-ancestor
139413437|NCT00774761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139413438|NCT00774761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765539|NCT05663749|Metformin|metformin|mesh-list
139651852|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139413439|NCT00772343|Vaccines|vaccines|mesh-list
139413441|NCT00772343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413442|NCT05647954|Pembrolizumab|pembrolizumab|mesh-list
139413443|NCT05647954|Temozolomide|temozolomide|mesh-list
139413444|NCT05647954|Chlorotrianisene|chlorotrianisene|mesh-list
139413445|NCT05647954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413446|NCT05647954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413447|NCT05647954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139413448|NCT05647954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413449|NCT05647954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139413450|NCT05647954|Alkylating Agents|alkylating agents|mesh-ancestor
139413451|NCT05647954|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139413452|NCT05647954|Estrogens|estrogens|mesh-ancestor
139413453|NCT05647954|Hormones|hormones|mesh-ancestor
139413454|NCT05647954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413455|NCT05647954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413456|NCT05647954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139413457|NCT00770081|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139413458|NCT00770081|Vildagliptin|vildagliptin|mesh-list
139413459|NCT00770081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139413460|NCT00770081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413461|NCT00770081|Incretins|incretins|mesh-ancestor
139413462|NCT00770081|Hormones|hormones|mesh-ancestor
138765580|NCT02683603|Imipenem|imipenem|mesh-list
139413463|NCT00770081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413464|NCT00770081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139413465|NCT00770081|Protease Inhibitors|protease inhibitors|mesh-ancestor
139413466|NCT00770081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413467|NCT00770081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413468|NCT02360098|Anesthetics|anesthetics|mesh-list
139413469|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139413470|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413471|NCT02273609|Vitamin K|vitamin k|mesh-list
139413472|NCT02273609|Warfarin|warfarin|mesh-list
139413473|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
139413474|NCT02273609|Vitamins|vitamins|mesh-ancestor
139413475|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
139413476|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413477|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
139413478|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139413479|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139413480|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413481|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
139413482|NCT02273609|Coagulants|coagulants|mesh-ancestor
139413483|NCT02273843|Vitamin D|vitamin d|mesh-list
139413484|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
139413485|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
139413486|NCT02273843|Vitamins|vitamins|mesh-list
139413487|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
139413488|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413489|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139413490|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139413491|NCT00666497|Azacitidine|azacitidine|mesh-list
139413492|NCT00666497|Mocetinostat|mocetinostat|mesh-list
139413493|NCT00666497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139413494|NCT00666497|Antimetabolites|antimetabolites|mesh-ancestor
139413495|NCT00666497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413496|NCT00666497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413497|NCT00666497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413498|NCT00666497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139413499|NCT02274077|Bupivacaine|bupivacaine|mesh-list
139413500|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
139413501|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
139413502|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139413503|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413504|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
139413505|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413506|NCT00765323|Octreotide|octreotide|mesh-list
139413507|NCT00765323|Somatostatin|somatostatin|mesh-list
139413508|NCT00765323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139413509|NCT00765323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139413510|NCT00765323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413511|NCT00765323|Hormones|hormones|mesh-ancestor
139413512|NCT00765323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413513|NCT00765323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413514|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
139413515|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139651853|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139413516|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139413517|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139413518|NCT02277587|Cortisone|cortisone|mesh-list
139413519|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
139413520|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139413521|NCT02277587|Hormones|hormones|mesh-ancestor
139413522|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413523|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413524|NCT00663767|Celecoxib|celecoxib|mesh-list
139413525|NCT00663767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
139413526|NCT00663767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139413527|NCT00663767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139413528|NCT00663767|Analgesics|analgesics|mesh-ancestor
139413529|NCT00663767|Sensory System Agents|sensory system agents|mesh-ancestor
139413530|NCT00663767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413531|NCT00663767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413532|NCT00663767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139413533|NCT00663767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139413534|NCT00663767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139413535|NCT00663767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413536|NCT00663767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413537|NCT00662597|Paclitaxel|paclitaxel|mesh-list
139413538|NCT00662597|Carboplatin|carboplatin|mesh-list
139413539|NCT00662597|Vadimezan|vadimezan|mesh-list
139413540|NCT00662597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139413541|NCT00662597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413542|NCT00662597|Tubulin Modulators|tubulin modulators|mesh-ancestor
139413543|NCT00662597|Antimitotic Agents|antimitotic agents|mesh-ancestor
139413544|NCT00662597|Mitosis Modulators|mitosis modulators|mesh-ancestor
139413545|NCT00662597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413546|NCT02266888|Rituximab|rituximab|mesh-list
139413547|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413548|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413549|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
139413550|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413551|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139413552|NCT01641952|Rituximab|rituximab|mesh-list
139413553|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413554|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413555|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
139413556|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413557|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139413558|NCT00660881|Epratuzumab|epratuzumab|mesh-list
139413559|NCT00660881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413560|NCT00660881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413561|NCT02359552|Rasagiline|rasagiline|mesh-list
139413562|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139070360|NCT01079286|MTOR Inhibitors|mtor inhibitors|mesh-list
139413563|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413564|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413565|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139413566|NCT02359552|Protective Agents|protective agents|mesh-ancestor
139413567|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413568|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
139413569|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139413570|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139413571|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139413572|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139413573|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413574|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
139413575|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139413576|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413577|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139413578|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413579|NCT00752297|Botulinum Toxins|botulinum toxins|mesh-list
139413580|NCT00752297|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139413581|NCT00752297|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139413582|NCT00752297|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139413583|NCT00752297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139413584|NCT00752297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413585|NCT00752297|Cholinergic Agents|cholinergic agents|mesh-ancestor
139413586|NCT00752297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139413588|NCT00752297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139413589|NCT00752297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413591|NCT00656357|Anesthetics, Local|anesthetics, local|mesh-ancestor
139413592|NCT00656357|Anesthetics|anesthetics|mesh-ancestor
139413593|NCT00656357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139413594|NCT00656357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413595|NCT00656357|Sensory System Agents|sensory system agents|mesh-ancestor
139413596|NCT00656357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413597|NCT00656357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139413598|NCT00656357|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139413599|NCT00656357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139413600|NCT00656357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139413601|NCT00656357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413602|NCT00656357|Dopamine Agents|dopamine agents|mesh-ancestor
139413603|NCT00656357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139413604|NCT02280629|Mesalamine|mesalamine|mesh-list
139413605|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139413606|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139413607|NCT02280629|Analgesics|analgesics|mesh-ancestor
139413608|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
139413609|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413610|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413611|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139413612|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139413613|NCT03134573|Interferons|interferons|mesh-list
139413614|NCT03134573|Interferon-beta|interferon-beta|mesh-list
139413615|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
139413616|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413617|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
139413618|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139413619|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
139413620|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413621|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139413622|NCT00743795|Ribavirin|ribavirin|mesh-list
139413623|NCT00743795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139413624|NCT00743795|Antimetabolites|antimetabolites|mesh-ancestor
139413625|NCT00743795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413626|NCT00743795|Antiviral Agents|antiviral agents|mesh-ancestor
139413627|NCT00743795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139413628|NCT04232033|Mitogens|mitogens|mesh-list
139413629|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
139413630|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413631|NCT03134417|Vitamin D|vitamin d|mesh-list
139413632|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
139413633|NCT03134417|Cholecalciferol|cholecalciferol|mesh-list
139413634|NCT03134417|Vitamins|vitamins|mesh-list
139413635|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
139413636|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070434|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139413637|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139413638|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139413639|NCT00649025|Fluticasone|fluticasone|mesh-list
139413640|NCT00649025|Xhance|xhance|mesh-list
139413641|NCT00649025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139413642|NCT00649025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139413643|NCT00649025|Autonomic Agents|autonomic agents|mesh-ancestor
139413644|NCT00649025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413645|NCT00649025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413646|NCT00649025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139413647|NCT00649025|Respiratory System Agents|respiratory system agents|mesh-ancestor
139413648|NCT00649025|Dermatologic Agents|dermatologic agents|mesh-ancestor
139413649|NCT00649025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139413650|NCT00647231|Ketoprofen|ketoprofen|mesh-list
139413651|NCT00647231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139413652|NCT00647231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139413653|NCT00647231|Analgesics|analgesics|mesh-ancestor
138765930|NCT01181921|Galantamine|galantamine|mesh-list
139413654|NCT00647231|Sensory System Agents|sensory system agents|mesh-ancestor
139413655|NCT00647231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413656|NCT00647231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413657|NCT00647231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139413658|NCT00647231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139413659|NCT00647231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139413660|NCT00647231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140158|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651854|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413661|NCT00647231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413663|NCT00739349|Cyclosporins|cyclosporins|mesh-list
139413664|NCT00739349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413665|NCT00739349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413666|NCT00739349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139413667|NCT00739349|Immunologic Factors|immunologic factors|mesh-ancestor
139413668|NCT00739349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413669|NCT00739349|Antifungal Agents|antifungal agents|mesh-ancestor
139413670|NCT00739349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139413671|NCT00739349|Dermatologic Agents|dermatologic agents|mesh-ancestor
139413672|NCT00739349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139413673|NCT00739349|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139413674|NCT00152009|Guanfacine|guanfacine|mesh-list
139413675|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139413676|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139413677|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139413678|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139413679|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
139413680|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139413681|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413682|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413683|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139413684|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413685|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413686|NCT02280785|Immunotoxins|immunotoxins|mesh-ancestor
139413687|NCT02280785|Immunoconjugates|immunoconjugates|mesh-ancestor
139413688|NCT02280785|Immunologic Factors|immunologic factors|mesh-ancestor
139413689|NCT02280785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413690|NCT00734435|Zonisamide|zonisamide|mesh-list
139413691|NCT00734435|Olanzapine|olanzapine|mesh-list
139413692|NCT00734435|Antiemetics|antiemetics|mesh-ancestor
139413693|NCT00734435|Autonomic Agents|autonomic agents|mesh-ancestor
139413694|NCT00734435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413695|NCT00734435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413696|NCT00734435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139413697|NCT00734435|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139413698|NCT00734435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139413699|NCT00734435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139413700|NCT00734435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139413701|NCT00734435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139413702|NCT00734435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139413703|NCT00734435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139413704|NCT00734435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413705|NCT00734435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139413706|NCT00734435|Serotonin Agents|serotonin agents|mesh-ancestor
139413707|NCT00734435|Anticonvulsants|anticonvulsants|mesh-ancestor
139413708|NCT00734435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139413709|NCT00734435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139413710|NCT00728351|Metformin|metformin|mesh-list
139413711|NCT00728351|Vildagliptin|vildagliptin|mesh-list
139413712|NCT00728351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139413713|NCT00728351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413714|NCT00728351|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139413715|NCT00728351|Protease Inhibitors|protease inhibitors|mesh-ancestor
139413716|NCT00728351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413717|NCT00728351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413718|NCT00616811|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139413719|NCT00616811|Vildagliptin|vildagliptin|mesh-list
139413720|NCT00616811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139413721|NCT00616811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413722|NCT00616811|Incretins|incretins|mesh-ancestor
139413723|NCT00616811|Hormones|hormones|mesh-ancestor
139413724|NCT00616811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413725|NCT00616811|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139413726|NCT00616811|Protease Inhibitors|protease inhibitors|mesh-ancestor
139413727|NCT00616811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413728|NCT00616811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413729|NCT00615251|Progesterone|progesterone|mesh-list
139413730|NCT00615251|Progestins|progestins|mesh-ancestor
139413731|NCT00615251|Hormones|hormones|mesh-ancestor
139413732|NCT00615251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413733|NCT00615251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413735|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139413736|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139413737|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413738|NCT05647642|Midazolam|midazolam|mesh-list
139413739|NCT05647642|Dexmedetomidine|dexmedetomidine|mesh-list
139413740|NCT05647642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139413741|NCT05647642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139413742|NCT05647642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413743|NCT05647642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139413744|NCT05647642|Analgesics|analgesics|mesh-ancestor
139413745|NCT05647642|Sensory System Agents|sensory system agents|mesh-ancestor
139413746|NCT05647642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413747|NCT05647642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139413748|NCT05647642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139413749|NCT05647642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139413750|NCT05647642|Adrenergic Agents|adrenergic agents|mesh-ancestor
139413751|NCT05647642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139413752|NCT05647642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413753|NCT05647642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139413754|NCT05647642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139413755|NCT05647642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139413756|NCT05647642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139413757|NCT05647642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139413758|NCT05647642|Anesthetics, General|anesthetics, general|mesh-ancestor
139413759|NCT05647642|Anesthetics|anesthetics|mesh-ancestor
139413760|NCT05647642|GABA Modulators|gaba modulators|mesh-ancestor
139413761|NCT05647642|GABA Agents|gaba agents|mesh-ancestor
139413762|NCT02357368|Copper|copper|mesh-list
139413763|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139413764|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
139413765|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
139413766|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
139413767|NCT02357368|Etonogestrel|etonogestrel|mesh-list
139413768|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139413769|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413770|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139413771|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139413772|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139413773|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139413774|NCT02357368|Trace Elements|trace elements|mesh-ancestor
139413775|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
139413776|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139413777|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139413778|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139413779|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413780|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
139413781|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139413782|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139413783|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139413784|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139413785|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070588|NCT05050318|Vaccines|vaccines|mesh-list
139413786|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413787|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413789|NCT05647408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139413790|NCT05647408|Antiemetics|antiemetics|mesh-ancestor
139413791|NCT05647408|Autonomic Agents|autonomic agents|mesh-ancestor
139413792|NCT05647408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413793|NCT05647408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413794|NCT05647408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139413795|NCT05647408|Glucocorticoids|glucocorticoids|mesh-ancestor
139413796|NCT05647408|Hormones|hormones|mesh-ancestor
139413797|NCT05647408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413798|NCT05647408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139413799|NCT05647408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413800|NCT05984953|Evolocumab|evolocumab|mesh-list
139413801|NCT05984953|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139413802|NCT05984953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139413803|NCT05984953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139413804|NCT05984953|Antimetabolites|antimetabolites|mesh-ancestor
139413805|NCT05984953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413806|NCT05984953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139413807|NCT05984953|Protease Inhibitors|protease inhibitors|mesh-ancestor
139413808|NCT05984953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413809|NCT05984953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139413810|NCT05984745|Ubiquinone|ubiquinone|mesh-list
139413811|NCT05984745|Coenzyme Q10|coenzyme q10|mesh-list
139413812|NCT05984745|Micronutrients|micronutrients|mesh-ancestor
139413813|NCT05984745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413814|NCT05984745|Vitamins|vitamins|mesh-ancestor
139413815|NCT05984602|Paclitaxel|paclitaxel|mesh-list
139413816|NCT05984602|Gemcitabine|gemcitabine|mesh-list
139413817|NCT05984602|Tislelizumab|tislelizumab|mesh-list
139413818|NCT05984602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139413819|NCT05984602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413820|NCT05984602|Tubulin Modulators|tubulin modulators|mesh-ancestor
139413821|NCT05984602|Antimitotic Agents|antimitotic agents|mesh-ancestor
139413822|NCT05984602|Mitosis Modulators|mitosis modulators|mesh-ancestor
139413823|NCT05984602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413824|NCT05984602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139413825|NCT05984602|Antimetabolites|antimetabolites|mesh-ancestor
139413826|NCT05984602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413827|NCT05984537|Heparin|heparin|mesh-list
139413828|NCT05984537|Calcium heparin|calcium heparin|mesh-list
139413829|NCT05984537|Hirudins|hirudins|mesh-list
139413830|NCT05984537|Bivalirudin|bivalirudin|mesh-list
139413831|NCT05984537|Anticoagulants|anticoagulants|mesh-ancestor
139413832|NCT05984537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139413833|NCT05984537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139413834|NCT05984537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413835|NCT05984537|Antithrombins|antithrombins|mesh-ancestor
139413836|NCT05984537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139413837|NCT05984537|Protease Inhibitors|protease inhibitors|mesh-ancestor
139413838|NCT05984537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413839|NCT05984420|Emollients|emollients|mesh-list
139413840|NCT05984420|Dermatologic Agents|dermatologic agents|mesh-ancestor
139413841|NCT05984342|Paclitaxel|paclitaxel|mesh-list
139413842|NCT05984342|Cisplatin|cisplatin|mesh-list
139413843|NCT05984342|Tislelizumab|tislelizumab|mesh-list
139413844|NCT05984342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139413845|NCT05984342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413846|NCT05984342|Tubulin Modulators|tubulin modulators|mesh-ancestor
139413847|NCT05984342|Antimitotic Agents|antimitotic agents|mesh-ancestor
139413848|NCT05984342|Mitosis Modulators|mitosis modulators|mesh-ancestor
139413849|NCT05984342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413850|NCT05984342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413851|NCT05984264|Lidocaine|lidocaine|mesh-list
139413852|NCT05984264|Prilocaine|prilocaine|mesh-list
139413853|NCT05984264|Anesthetics, Local|anesthetics, local|mesh-ancestor
139413854|NCT05984264|Anesthetics|anesthetics|mesh-ancestor
139413855|NCT05984264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139413856|NCT05984264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413857|NCT05984264|Sensory System Agents|sensory system agents|mesh-ancestor
139413858|NCT05984264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413859|NCT05984264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139413860|NCT05984264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139413861|NCT05984264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139413862|NCT05984264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139413863|NCT05984264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413865|NCT05984212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139413866|NCT05984212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139413867|NCT05984212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413868|NCT05984212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139413869|NCT05984212|Analgesics|analgesics|mesh-ancestor
139413870|NCT05984212|Sensory System Agents|sensory system agents|mesh-ancestor
139413871|NCT05984212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413872|NCT05984212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139413873|NCT05984212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139413874|NCT05984212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139413875|NCT05984212|Adrenergic Agents|adrenergic agents|mesh-ancestor
139413876|NCT05984212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139413877|NCT05984212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413878|NCT05984173|Vitamin E|vitamin e|mesh-list
139413879|NCT05984173|Tocopherols|tocopherols|mesh-list
139413880|NCT05984173|Vitamins|vitamins|mesh-ancestor
139413881|NCT05984173|Micronutrients|micronutrients|mesh-ancestor
139413882|NCT05984173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651855|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139413883|NCT05984173|Antioxidants|antioxidants|mesh-ancestor
139413884|NCT05984173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651856|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139413885|NCT05984173|Protective Agents|protective agents|mesh-ancestor
139413886|NCT05983874|MEDI9197|medi9197|mesh-list
139413887|NCT05983874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139413888|NCT05983874|Immunologic Factors|immunologic factors|mesh-ancestor
139413889|NCT05983874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413890|NCT05983783|Docetaxel|docetaxel|mesh-list
139413891|NCT05983783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413892|NCT05983783|Tubulin Modulators|tubulin modulators|mesh-ancestor
139413893|NCT05983783|Antimitotic Agents|antimitotic agents|mesh-ancestor
139413894|NCT05983783|Mitosis Modulators|mitosis modulators|mesh-ancestor
139413895|NCT05983783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413896|NCT05983471|Suplatast tosilate|suplatast tosilate|mesh-list
139413897|NCT05983471|Histamine Antagonists|histamine antagonists|mesh-ancestor
139413898|NCT05983471|Histamine Agents|histamine agents|mesh-ancestor
139413899|NCT05983471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139413900|NCT05983471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413901|NCT05983471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413902|NCT05983471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138766341|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413903|NCT05983445|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
139413904|NCT05983445|Betamethasone|betamethasone|mesh-list
139413905|NCT05983445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139413906|NCT05983445|Glucocorticoids|glucocorticoids|mesh-ancestor
139413907|NCT05983445|Hormones|hormones|mesh-ancestor
139413908|NCT05983445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139413909|NCT05983445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413910|NCT05983445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139413911|NCT05983445|Respiratory System Agents|respiratory system agents|mesh-ancestor
139413912|NCT05983276|Paclitaxel|paclitaxel|mesh-list
139413913|NCT05983276|Carboplatin|carboplatin|mesh-list
139413914|NCT05983276|Decitabine|decitabine|mesh-list
139413915|NCT05983276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139413916|NCT05983276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413917|NCT05983276|Tubulin Modulators|tubulin modulators|mesh-ancestor
139413918|NCT05983276|Antimitotic Agents|antimitotic agents|mesh-ancestor
139413919|NCT05983276|Mitosis Modulators|mitosis modulators|mesh-ancestor
139413920|NCT05983276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413921|NCT05983276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139413922|NCT05983276|Antimetabolites|antimetabolites|mesh-ancestor
139413923|NCT05983276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413924|NCT05983263|Capsaicin|capsaicin|mesh-list
139413925|NCT05983263|Antipruritics|antipruritics|mesh-ancestor
139413926|NCT05983263|Dermatologic Agents|dermatologic agents|mesh-ancestor
139413927|NCT05983263|Sensory System Agents|sensory system agents|mesh-ancestor
139413928|NCT05983263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413929|NCT05983263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413930|NCT05983107|Everolimus|everolimus|mesh-list
139413931|NCT05983107|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139413932|NCT05983107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139413933|NCT05983107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413934|NCT05983107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413935|NCT05983107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070737|NCT03966326|Narcotics|narcotics|mesh-ancestor
139413936|NCT05983107|Immunologic Factors|immunologic factors|mesh-ancestor
139413937|NCT05983107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413938|NCT05983107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413939|NCT05983094|Carboplatin|carboplatin|mesh-list
139413940|NCT05983094|Trastuzumab|trastuzumab|mesh-list
139413941|NCT05983094|Epirubicin|epirubicin|mesh-list
139413942|NCT05983094|Pertuzumab|pertuzumab|mesh-list
139413943|NCT05983094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413944|NCT05983094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413945|NCT05983094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139413946|NCT05983094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139413947|NCT05983094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139413948|NCT05983094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413949|NCT05983094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413950|NCT05983042|Ibuprofen|ibuprofen|mesh-list
139413951|NCT05983042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139413952|NCT05983042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139413953|NCT05983042|Analgesics|analgesics|mesh-ancestor
139413954|NCT05983042|Sensory System Agents|sensory system agents|mesh-ancestor
139413955|NCT05983042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413956|NCT05983042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413957|NCT05983042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139651857|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139413958|NCT05983042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139413959|NCT05983042|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139413960|NCT05983042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413961|NCT05983042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413963|NCT05982834|Disitamab vedotin|disitamab vedotin|mesh-list
139413964|NCT05982834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413965|NCT05982834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413966|NCT05982834|Immunoconjugates|immunoconjugates|mesh-ancestor
139413967|NCT05982834|Immunologic Factors|immunologic factors|mesh-ancestor
139413968|NCT05982834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413969|NCT05982756|Bortezomib|bortezomib|mesh-list
139413970|NCT05982756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413971|NCT05969626|Vaccines|vaccines|mesh-list
139413972|NCT05969626|Immunologic Factors|immunologic factors|mesh-ancestor
139413973|NCT05969626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413974|NCT05913284|Morphine|morphine|mesh-list
139413975|NCT05913284|Methadone|methadone|mesh-list
139413976|NCT05913284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139413977|NCT05913284|Narcotics|narcotics|mesh-ancestor
139413978|NCT05913284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139413979|NCT05913284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413980|NCT05913284|Analgesics|analgesics|mesh-ancestor
139413981|NCT05913284|Sensory System Agents|sensory system agents|mesh-ancestor
139413982|NCT05913284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139413983|NCT05913284|Antitussive Agents|antitussive agents|mesh-ancestor
139413984|NCT05913284|Respiratory System Agents|respiratory system agents|mesh-ancestor
139413985|NCT05904106|Azacitidine|azacitidine|mesh-list
139413986|NCT05904106|Venetoclax|venetoclax|mesh-list
139413987|NCT05904106|Gemtuzumab|gemtuzumab|mesh-list
139413988|NCT05904106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139413989|NCT05904106|Antimetabolites|antimetabolites|mesh-ancestor
139413990|NCT05904106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139413991|NCT05904106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139413992|NCT05904106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139413993|NCT05904106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139413994|NCT05904106|Immunotoxins|immunotoxins|mesh-ancestor
139413995|NCT05904106|Immunoconjugates|immunoconjugates|mesh-ancestor
139413996|NCT05904106|Immunologic Factors|immunologic factors|mesh-ancestor
139413997|NCT05904106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139413998|NCT05831774|Vancomycin|vancomycin|mesh-list
139413999|NCT05831774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138766471|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
139414000|NCT05831774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414001|NCT05824299|Anesthetics|anesthetics|mesh-list
139414002|NCT05824299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139414003|NCT05824299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414004|NCT05817461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139414005|NCT05815173|Sotorasib|sotorasib|mesh-list
139414006|NCT05815173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139414007|NCT05815173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414008|NCT05815173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414009|NCT05815173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414010|NCT05782972|Dapagliflozin|dapagliflozin|mesh-list
139070813|NCT01076582|Hormones|hormones|mesh-ancestor
139414011|NCT05782972|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139414012|NCT05782972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414013|NCT05782972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139414014|NCT05782972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414015|NCT05736419|Mycophenolic Acid|mycophenolic acid|mesh-list
139414016|NCT05736419|Dexamethasone|dexamethasone|mesh-list
139414017|NCT05736419|Cyclophosphamide|cyclophosphamide|mesh-list
139414018|NCT05736419|Rituximab|rituximab|mesh-list
139414019|NCT05736419|Fludarabine|fludarabine|mesh-list
139414020|NCT05736419|Bortezomib|bortezomib|mesh-list
139414021|NCT05736419|Tacrolimus|tacrolimus|mesh-list
139414022|NCT05736419|Thymoglobulin|thymoglobulin|mesh-list
139414023|NCT05736419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139414024|NCT05736419|Immunologic Factors|immunologic factors|mesh-ancestor
139414025|NCT05736419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414026|NCT05736419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139414027|NCT05736419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139414028|NCT05736419|Alkylating Agents|alkylating agents|mesh-ancestor
139414029|NCT05736419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414030|NCT05736419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414031|NCT05736419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139414032|NCT05736419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139414033|NCT05736419|Antiemetics|antiemetics|mesh-ancestor
139414034|NCT05736419|Autonomic Agents|autonomic agents|mesh-ancestor
139414035|NCT05736419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414036|NCT05736419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139414037|NCT05736419|Glucocorticoids|glucocorticoids|mesh-ancestor
139414038|NCT05736419|Hormones|hormones|mesh-ancestor
139414039|NCT05736419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139414040|NCT05736419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139414041|NCT05736419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414042|NCT05736419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139414043|NCT05736419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414044|NCT05736419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139414045|NCT05736419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139414046|NCT05736419|Antitubercular Agents|antitubercular agents|mesh-ancestor
139414047|NCT05736419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139414048|NCT05736419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414049|NCT05729139|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139414050|NCT05729139|Interferon alpha-2|interferon alpha-2|mesh-list
139414051|NCT05729139|Cemiplimab|cemiplimab|mesh-list
139414052|NCT05729139|Antiviral Agents|antiviral agents|mesh-ancestor
139414053|NCT05729139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414054|NCT05729139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414055|NCT05729139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414056|NCT05694260|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139414057|NCT05694260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139414058|NCT05694260|Antimetabolites|antimetabolites|mesh-ancestor
139414059|NCT05694260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414060|NCT05694260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138766576|NCT00641329|Clonidine|clonidine|mesh-list
139414061|NCT05694260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414062|NCT05694260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139414063|NCT05694260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414064|NCT05688020|Epinephrine|epinephrine|mesh-list
139414065|NCT05688020|Tranexamic Acid|tranexamic acid|mesh-list
139414066|NCT05688020|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139414067|NCT05688020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139414068|NCT05688020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414069|NCT05688020|Hemostatics|hemostatics|mesh-ancestor
139414070|NCT05688020|Coagulants|coagulants|mesh-ancestor
139414071|NCT05688020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139414072|NCT05688020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139414073|NCT05688020|Adrenergic Agents|adrenergic agents|mesh-ancestor
139414074|NCT05688020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139414075|NCT05688020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414076|NCT05688020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139414077|NCT05688020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139414078|NCT05688020|Autonomic Agents|autonomic agents|mesh-ancestor
139414079|NCT05688020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414080|NCT05688020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139414081|NCT05688020|Respiratory System Agents|respiratory system agents|mesh-ancestor
139414082|NCT05688020|Mydriatics|mydriatics|mesh-ancestor
139414083|NCT05688020|Sympathomimetics|sympathomimetics|mesh-ancestor
139414084|NCT05688020|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139414085|NCT05668455|Dexamethasone|dexamethasone|mesh-list
139070884|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
139414086|NCT05668455|Hydrocortisone|hydrocortisone|mesh-list
139414087|NCT05668455|Povidone|povidone|mesh-list
139414088|NCT05668455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139414089|NCT05668455|Antiemetics|antiemetics|mesh-ancestor
139414090|NCT05668455|Autonomic Agents|autonomic agents|mesh-ancestor
139414091|NCT05668455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414092|NCT05668455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414093|NCT05668455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139414094|NCT05668455|Glucocorticoids|glucocorticoids|mesh-ancestor
139414095|NCT05668455|Hormones|hormones|mesh-ancestor
139414096|NCT05668455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139414097|NCT05668455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139414098|NCT05668455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414099|NCT05668455|Plasma Substitutes|plasma substitutes|mesh-ancestor
139414100|NCT05668455|Blood Substitutes|blood substitutes|mesh-ancestor
139414101|NCT05653492|Sulforaphane|sulforaphane|mesh-list
139414102|NCT05653492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139414103|NCT05653492|Protective Agents|protective agents|mesh-ancestor
139651858|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139414104|NCT05653492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414105|NCT05653492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414106|NCT05517668|Acetylcysteine|acetylcysteine|mesh-list
139414107|NCT05517668|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139414108|NCT05517668|Fomepizole|fomepizole|mesh-list
139414109|NCT05517668|Antiviral Agents|antiviral agents|mesh-ancestor
139414110|NCT05517668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414111|NCT05517668|Expectorants|expectorants|mesh-ancestor
139414112|NCT05517668|Respiratory System Agents|respiratory system agents|mesh-ancestor
139414113|NCT05517668|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139414114|NCT05517668|Antioxidants|antioxidants|mesh-ancestor
139414115|NCT05517668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414116|NCT05517668|Protective Agents|protective agents|mesh-ancestor
139414117|NCT05517668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414118|NCT05517668|Antidotes|antidotes|mesh-ancestor
139414119|NCT05517668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414120|NCT05435729|Levodopa|levodopa|mesh-list
139414121|NCT05435729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139414122|NCT05435729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139414123|NCT05435729|Dopamine Agents|dopamine agents|mesh-ancestor
139414124|NCT05435729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139414125|NCT05435729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414126|NCT05435729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414127|NCT05430750|Nitrous Oxide|nitrous oxide|mesh-list
139414128|NCT05430750|Sevoflurane|sevoflurane|mesh-list
139414129|NCT05430750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139414130|NCT05430750|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139414131|NCT05430750|Anesthetics, General|anesthetics, general|mesh-ancestor
139414132|NCT05430750|Anesthetics|anesthetics|mesh-ancestor
139414133|NCT05430750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139414134|NCT05430750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414135|NCT05430750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139414136|NCT05430750|Analgesics|analgesics|mesh-ancestor
139414137|NCT05430750|Sensory System Agents|sensory system agents|mesh-ancestor
139414138|NCT05430750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414139|NCT05429593|Dapagliflozin|dapagliflozin|mesh-list
139414140|NCT05429593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139414141|NCT05429593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414142|NCT05429593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139414143|NCT05429593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414144|NCT05394350|Pembrolizumab|pembrolizumab|mesh-list
139414145|NCT05394350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414146|NCT05394350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414147|NCT05394350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139414148|NCT05394350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414149|NCT05346224|Pertuzumab|pertuzumab|mesh-list
139414150|NCT05346224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138766632|NCT00931762|Panobinostat|panobinostat|mesh-list
139414151|NCT05346224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414152|NCT05302804|Menthol|menthol|mesh-list
139414153|NCT05302804|Antipruritics|antipruritics|mesh-ancestor
139414154|NCT05302804|Dermatologic Agents|dermatologic agents|mesh-ancestor
139414155|NCT05298202|Capsaicin|capsaicin|mesh-list
139414156|NCT05298202|Antipruritics|antipruritics|mesh-ancestor
139414157|NCT05298202|Dermatologic Agents|dermatologic agents|mesh-ancestor
139414158|NCT05298202|Sensory System Agents|sensory system agents|mesh-ancestor
139414159|NCT05298202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414160|NCT05298202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414161|NCT05285644|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139414162|NCT05285644|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139414163|NCT05283304|Buprenorphine|buprenorphine|mesh-list
139414164|NCT05283304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139414165|NCT05283304|Narcotics|narcotics|mesh-ancestor
139414166|NCT05283304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139414167|NCT05283304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414168|NCT05283304|Analgesics|analgesics|mesh-ancestor
139414169|NCT05283304|Sensory System Agents|sensory system agents|mesh-ancestor
139414170|NCT05283304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414171|NCT05283304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139414172|NCT05208307|Dexamethasone|dexamethasone|mesh-list
139414173|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
139414174|NCT05208307|Pomalidomide|pomalidomide|mesh-list
139414175|NCT05208307|Ichthammol|ichthammol|mesh-list
139414176|NCT05208307|BB 1101|bb 1101|mesh-list
139414177|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139414178|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
139414179|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
139414180|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414181|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414182|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139414183|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
139414184|NCT05208307|Hormones|hormones|mesh-ancestor
139414185|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139414186|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139414187|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414188|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
139414189|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414190|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414191|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
139414192|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139414193|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139414194|NCT05208307|Growth Substances|growth substances|mesh-ancestor
139414195|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
139414196|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
139414197|NCT05156658|Etonogestrel|etonogestrel|mesh-list
139414198|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139414199|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
139414200|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139414201|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414202|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139414203|NCT05095961|Prednisone|prednisone|mesh-list
139414204|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139414205|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
139414206|NCT05095961|Hormones|hormones|mesh-ancestor
139414207|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139414208|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414209|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139414210|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414211|NCT04998617|Curcumin|curcumin|mesh-list
139414212|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139414213|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139414214|NCT04998617|Analgesics|analgesics|mesh-ancestor
139414215|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
138766692|NCT00931528|Urological Agents|urological agents|mesh-ancestor
139414216|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414217|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414218|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139414219|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139414220|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414221|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414222|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414223|NCT04914247|Selexipag|selexipag|mesh-list
139414224|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139414225|NCT04908449|Bupivacaine|bupivacaine|mesh-list
139414226|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
139414227|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
139414228|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139414229|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414230|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
139414231|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414232|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139414233|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139414234|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139414235|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
139414236|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414237|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139414238|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139414239|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414240|NCT04883281|Paclitaxel|paclitaxel|mesh-list
139414241|NCT04883281|Carboplatin|carboplatin|mesh-list
139414242|NCT04883281|Cetuximab|cetuximab|mesh-list
139414243|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139414244|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414245|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
139414246|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
139414247|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
139414248|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414249|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414250|NCT04657068|Gemcitabine|gemcitabine|mesh-list
139414251|NCT04657068|Irinotecan|irinotecan|mesh-list
139414252|NCT04657068|Camptothecin|camptothecin|mesh-list
139414253|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139414254|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
139414255|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414256|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414257|NCT04657068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139414258|NCT04657068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139651859|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139651860|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
139414259|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414260|NCT04657068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139414261|NCT04640636|Midazolam|midazolam|mesh-list
139414262|NCT04640636|Ketamine|ketamine|mesh-list
139414263|NCT04640636|Analgesics|analgesics|mesh-ancestor
139414264|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
139414265|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414266|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414267|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139414268|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139414269|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
139414270|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
139414271|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139414272|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139414273|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139414274|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139414275|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414276|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139414277|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139414278|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139414279|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139414280|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139414281|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
139414282|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
139414283|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
139414284|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139414285|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
139414286|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414287|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139414288|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139414289|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
139414290|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414291|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414292|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139414293|NCT04573946|Vitamin D|vitamin d|mesh-list
139414294|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
139414295|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
139414296|NCT04573946|Vitamins|vitamins|mesh-list
139414297|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
139414298|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414299|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139414300|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139414301|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
139414302|NCT04558359|Giapreza|giapreza|mesh-list
139414303|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
139414304|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139414305|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139414306|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
139414307|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414308|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414309|NCT04538053|Cefazolin|cefazolin|mesh-list
139414310|NCT04538053|Cephalexin|cephalexin|mesh-list
139414311|NCT04538053|Floxacillin|floxacillin|mesh-list
139414312|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139414313|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414314|NCT04495179|Durvalumab|durvalumab|mesh-list
139414315|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414316|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414317|NCT04385290|Cytarabine|cytarabine|mesh-list
139414318|NCT04385290|Daunorubicin|daunorubicin|mesh-list
139414319|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
139414320|NCT04385290|Midostaurin|midostaurin|mesh-list
139414321|NCT04385290|Staurosporine|staurosporine|mesh-list
139414322|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139414323|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
139414324|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414325|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414326|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
139414327|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414328|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139414329|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
139414330|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414331|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139414332|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139414333|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139414334|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414335|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414337|NCT04385290|Immunoconjugates|immunoconjugates|mesh-ancestor
139414338|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139414339|NCT04336241|Nivolumab|nivolumab|mesh-list
139414340|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414341|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414342|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139414343|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414344|NCT04313712|Ibogaine|ibogaine|mesh-list
139414345|NCT04313712|Hallucinogens|hallucinogens|mesh-ancestor
139414346|NCT04313712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414347|NCT04313712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139414348|NCT04313712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139414349|NCT04313712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139414350|NCT04313712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139414351|NCT04313712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414352|NCT04272242|Pyridoxine|pyridoxine|mesh-list
139414353|NCT04272242|Pyridoxal|pyridoxal|mesh-list
139414354|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
139414355|NCT04272242|Isoniazid|isoniazid|mesh-list
139414356|NCT04272242|Rifapentine|rifapentine|mesh-list
139414357|NCT04272242|Dolutegravir|dolutegravir|mesh-list
139414358|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139414359|NCT04272242|Vitamins|vitamins|mesh-ancestor
139414360|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
139414361|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414362|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
139414363|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
139414364|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139414365|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414366|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139414367|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139414368|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
139414369|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414370|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139414371|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139414372|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139414373|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414374|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139414375|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
139414376|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139414377|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
139414378|NCT04241549|Azacitidine|azacitidine|mesh-list
139414379|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139414380|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
139414381|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414382|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414383|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414384|NCT04240626|Acetaminophen|acetaminophen|mesh-list
139414385|NCT04240626|Scopolamine|scopolamine|mesh-list
139414386|NCT04240626|Oxycodone|oxycodone|mesh-list
139414387|NCT04240626|Gabapentin|gabapentin|mesh-list
139414388|NCT04240626|Hydromorphone|hydromorphone|mesh-list
139414389|NCT04240626|Hydrocodone|hydrocodone|mesh-list
139414390|NCT04240626|Bupivacaine|bupivacaine|mesh-list
139414391|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
139414392|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139414393|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139414394|NCT04240626|Analgesics|analgesics|mesh-ancestor
139414395|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
139414396|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414397|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414398|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
139414399|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139414400|NCT04240626|Narcotics|narcotics|mesh-ancestor
139414401|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139414402|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
139414403|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139414404|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139414405|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139414406|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139414407|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139414408|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139414409|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414410|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
139414411|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
139414412|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
139414413|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
139414414|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
139414415|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139414416|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
138767033|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
139414417|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
139414418|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139414419|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
139414420|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139414421|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
139414422|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139414423|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
139414424|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139414425|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
139414426|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139414427|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139414428|NCT04231318|Triamcinolone|triamcinolone|mesh-list
139414429|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139414430|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139414431|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139414432|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139414433|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
139414434|NCT04231318|Hormones|hormones|mesh-ancestor
139414435|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139414436|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414437|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139414438|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
139414439|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414440|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414441|NCT04201262|Ravulizumab|ravulizumab|mesh-list
139414442|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139414443|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139414444|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
139414445|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414446|NCT04150887|Azacitidine|azacitidine|mesh-list
139414447|NCT04150887|Venetoclax|venetoclax|mesh-list
139414448|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139414449|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
139414450|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414451|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414452|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414453|NCT04072445|Trifluridine|trifluridine|mesh-list
139414454|NCT04072445|Irinotecan|irinotecan|mesh-list
139414455|NCT04072445|Camptothecin|camptothecin|mesh-list
139414456|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139414457|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139414458|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414459|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414460|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414461|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
139414462|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
139414463|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414464|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139414465|NCT04050540|Doxycycline|doxycycline|mesh-list
139414466|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139414467|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414468|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
139414469|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139414470|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139414471|NCT04023526|Azacitidine|azacitidine|mesh-list
139414472|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139414473|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
139414474|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414475|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414476|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414477|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
139414478|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414479|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414480|NCT03957551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139414481|NCT03957551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414482|NCT03862495|Azithromycin|azithromycin|mesh-list
139414483|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139414484|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414485|NCT03691662|Timolol|timolol|mesh-list
139414486|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139414487|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138767126|NCT05908305|Respiratory System Agents|respiratory system agents|mesh-ancestor
139414488|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651861|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
139414489|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139414490|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139414491|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
139414492|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139414493|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414494|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139414495|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139414496|NCT03689244|Selexipag|selexipag|mesh-list
139414497|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139414498|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139414499|NCT03594175|Reteplase|reteplase|mesh-list
139414500|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139414501|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139414502|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414503|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
139414504|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414505|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414506|NCT03414229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139414507|NCT03414229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414508|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
139414509|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414510|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414511|NCT03338959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139414512|NCT03338959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414513|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139414514|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
139414515|NCT03278782|Romidepsin|romidepsin|mesh-list
139414516|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414517|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414518|NCT03278782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139414519|NCT03278782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414520|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414521|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139414522|NCT03278782|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139414523|NCT03278782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414524|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139414525|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414526|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414527|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139414528|NCT03104491|Immunotoxins|immunotoxins|mesh-ancestor
139414529|NCT03104491|Immunoconjugates|immunoconjugates|mesh-ancestor
139414530|NCT03104491|Immunologic Factors|immunologic factors|mesh-ancestor
139414531|NCT03104491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414532|NCT02977780|Temozolomide|temozolomide|mesh-list
139414533|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139414534|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
139414535|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414536|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414537|NCT02897063|Midodrine|midodrine|mesh-list
139414538|NCT02897063|Droxidopa|droxidopa|mesh-list
139414539|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
139414540|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
139414541|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414542|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414543|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139414544|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139414545|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139414546|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139414547|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
139414548|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139414549|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414550|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139414551|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139414553|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139414554|NCT02804022|Narcotics|narcotics|mesh-ancestor
139414555|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139414556|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414557|NCT02804022|Analgesics|analgesics|mesh-ancestor
139414558|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
139414559|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414560|NCT02792413|Denosumab|denosumab|mesh-list
139414561|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139414562|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651862|NCT04813848|Fluorides|fluorides|mesh-list
139414563|NCT02714439|Proflavine|proflavine|mesh-list
139414564|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139414565|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414566|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
139414567|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
139414568|NCT02220985|Thiotepa|thiotepa|mesh-list
139414569|NCT02220985|Methotrexate|methotrexate|mesh-list
139414570|NCT02220985|Fludarabine|fludarabine|mesh-list
139414571|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
139414572|NCT02220985|Tacrolimus|tacrolimus|mesh-list
139414573|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139414574|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
139414575|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414576|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139414577|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139414578|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
139414579|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414580|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414581|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139414582|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139414583|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
139414584|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139414585|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139414586|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
139414587|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
139414588|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414589|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139414590|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139414591|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139414592|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139414593|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139414594|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
139414595|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139414596|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414597|NCT02133573|Progesterone|progesterone|mesh-list
139414598|NCT02133573|Progestins|progestins|mesh-ancestor
139414599|NCT02133573|Hormones|hormones|mesh-ancestor
139414600|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139414601|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414602|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
139414603|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139414604|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
139414605|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414606|NCT01878669|Expectorants|expectorants|mesh-ancestor
139414607|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
139414608|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139414609|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
139414610|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414611|NCT01878669|Protective Agents|protective agents|mesh-ancestor
139414612|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414613|NCT01878669|Antidotes|antidotes|mesh-ancestor
139414614|NCT01704859|Vitamin D|vitamin d|mesh-list
139414615|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
139414616|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
139414617|NCT01704859|Vitamins|vitamins|mesh-list
139414618|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
139414619|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414620|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139071425|NCT01077986|Cetuximab|cetuximab|mesh-list
139414621|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139414622|NCT00869232|Thalidomide|thalidomide|mesh-list
139414623|NCT00869232|Dexamethasone|dexamethasone|mesh-list
139414624|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
139414625|NCT00869232|Melphalan|melphalan|mesh-list
139414626|NCT00869232|Doxorubicin|doxorubicin|mesh-list
139414627|NCT00869232|Etoposide|etoposide|mesh-list
139414628|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139414629|NCT00869232|Bortezomib|bortezomib|mesh-list
139414630|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139414631|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
139414632|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414633|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139414634|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139651863|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
139414635|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
139414636|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414637|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414638|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139651864|NCT04813848|Protective Agents|protective agents|mesh-ancestor
139414639|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139414640|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
139414641|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
139414642|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414643|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139414644|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
139414645|NCT00869232|Hormones|hormones|mesh-ancestor
139414646|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139414647|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139414648|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139414649|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139414650|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139414651|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414652|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139414653|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
139414654|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139414655|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414656|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139414657|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139414658|NCT00869232|Growth Substances|growth substances|mesh-ancestor
139414659|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
139414660|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
139414661|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
139414662|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139414663|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139414664|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414665|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414666|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414667|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139414668|NCT00734877|Thalidomide|thalidomide|mesh-list
139414669|NCT00734877|Dexamethasone|dexamethasone|mesh-list
139414670|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
139414671|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
139414672|NCT00734877|Melphalan|melphalan|mesh-list
139414673|NCT00734877|Cisplatin|cisplatin|mesh-list
139414674|NCT00734877|Etoposide|etoposide|mesh-list
139414675|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
139414676|NCT00734877|Doxorubicin|doxorubicin|mesh-list
139414677|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139414678|NCT00734877|Bortezomib|bortezomib|mesh-list
139414679|NCT00734877|BB 1101|bb 1101|mesh-list
139414680|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139414681|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
139414682|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414683|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139414684|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139414685|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
139414686|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414687|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414688|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139414689|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139414690|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
139414691|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
139414692|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414693|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139414694|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
139414695|NCT00734877|Hormones|hormones|mesh-ancestor
139414696|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139414697|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139414698|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
139414699|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414700|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139414701|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139414702|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139414703|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139414704|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
139414705|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139414706|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414707|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139414708|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139414709|NCT00734877|Growth Substances|growth substances|mesh-ancestor
139414710|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
139414711|NCT00686595|Infliximab|infliximab|mesh-list
139414712|NCT00686595|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139414713|NCT00686595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139414714|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
139651865|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414715|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139414716|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139414717|NCT00640159|Selegiline|selegiline|mesh-list
139414718|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
139414719|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139414720|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139414721|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139414722|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139414723|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414724|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414725|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139414726|NCT00640159|Protective Agents|protective agents|mesh-ancestor
139414727|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414728|NCT03483415|Morphine|morphine|mesh-list
139414729|NCT03483415|Bupivacaine|bupivacaine|mesh-list
139414730|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
139414731|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
139414732|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139414733|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414734|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
139414735|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414736|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139414737|NCT03483415|Narcotics|narcotics|mesh-ancestor
139414738|NCT03483415|Analgesics|analgesics|mesh-ancestor
139414739|NCT03487003|Bromides|bromides|mesh-list
139414740|NCT03487003|Rocuronium|rocuronium|mesh-list
139414741|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
139414742|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139414743|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139414744|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139414745|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414746|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414747|NCT03486925|Oxytocin|oxytocin|mesh-list
139414748|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
139414749|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139414750|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414751|NCT02262754|Naproxen|naproxen|mesh-list
139414752|NCT02262754|PF-06372865|pf-06372865|mesh-list
139414753|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139414754|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139414755|NCT02262754|Analgesics|analgesics|mesh-ancestor
139414756|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
139414757|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414758|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414759|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139414760|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139414761|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
139414762|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139414763|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414764|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414765|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
139414766|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
139414767|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139414768|NCT03483181|Enoxaparin|enoxaparin|mesh-list
139414769|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
139414770|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139414771|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
139414772|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139414773|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
139414774|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414775|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414777|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139414778|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139414779|NCT02356588|Sufentanil|sufentanil|mesh-list
139414780|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139414781|NCT02356588|Narcotics|narcotics|mesh-ancestor
139414782|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139414783|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414784|NCT02356588|Analgesics|analgesics|mesh-ancestor
138767515|NCT04205838|Vidarabine|vidarabine|mesh-list
139414785|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
139414786|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414787|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139414788|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139414789|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
139414790|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
139414791|NCT04445389|Vaccines|vaccines|mesh-list
139414792|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
139651866|NCT02999841|Vildagliptin|vildagliptin|mesh-list
139414793|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414794|NCT02355028|Ranibizumab|ranibizumab|mesh-list
139414795|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139414796|NCT02355028|Acrizanib|acrizanib|mesh-list
139414797|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139414798|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139414799|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139414800|NCT02355028|Growth Substances|growth substances|mesh-ancestor
139414801|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414802|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
139414803|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414804|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139414805|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414806|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414807|NCT05647330|Hydroxychloroquine|hydroxychloroquine|mesh-list
139414808|NCT05647330|Chloroquine|chloroquine|mesh-list
139414809|NCT05647330|Gemcitabine|gemcitabine|mesh-list
139414810|NCT05647330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139414811|NCT05647330|Antimetabolites|antimetabolites|mesh-ancestor
139414812|NCT05647330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414813|NCT05647330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414814|NCT05647330|Antimalarials|antimalarials|mesh-ancestor
139414815|NCT05647330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139414816|NCT05647330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139414817|NCT05647330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414818|NCT05647330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414819|NCT05647330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139414820|NCT05647330|Amebicides|amebicides|mesh-ancestor
139414821|NCT01643668|Busulfan|busulfan|mesh-list
139414822|NCT01643668|Clofarabine|clofarabine|mesh-list
139414823|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
139414824|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414825|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139414826|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
139414827|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414828|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139414829|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414830|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139414831|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139414832|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
139414833|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139414834|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
139414835|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414836|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
139414837|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
139414838|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414839|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414840|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139414841|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
139414842|NCT02260804|Rituximab|rituximab|mesh-list
139414843|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414844|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414845|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
139414846|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414847|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139414848|NCT03486457|Tofacitinib|tofacitinib|mesh-list
139414849|NCT03486457|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139414850|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139414851|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414852|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414853|NCT02260648|Atorvastatin|atorvastatin|mesh-list
139414854|NCT02260648|Ezetimibe|ezetimibe|mesh-list
139414855|NCT02260648|Evacetrapib|evacetrapib|mesh-list
139414856|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139414857|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139414858|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
139414859|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414860|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139414861|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139414862|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414863|NCT02260492|Fluticasone|fluticasone|mesh-list
139414864|NCT02260492|Xhance|xhance|mesh-list
139414865|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139414866|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139651867|NCT02999841|Acarbose|acarbose|mesh-list
138767608|NCT03711279|Apatinib|apatinib|mesh-list
139414868|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139414869|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
139414870|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414871|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414872|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139414873|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
139414874|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
139414875|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139414876|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139414877|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139414878|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139414879|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
139414880|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139414881|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414882|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
139414883|NCT02260492|Hormones|hormones|mesh-ancestor
139414884|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139414885|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
139414886|NCT03966625|Autoantibodies|autoantibodies|mesh-list
139414887|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
139414888|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414889|NCT02260258|Rocuronium|rocuronium|mesh-list
139414890|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139414891|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139414892|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139414893|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414894|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414895|NCT05151679|Iron|iron|mesh-list
139414896|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139414897|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
139414898|NCT05151679|Trace Elements|trace elements|mesh-ancestor
139414899|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
139414900|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414901|NCT05151679|Hematinics|hematinics|mesh-ancestor
139414902|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
139414903|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
139414904|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414905|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
139414906|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139414907|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414908|NCT02353468|Dexamethasone|dexamethasone|mesh-list
139414909|NCT02353468|Lenalidomide|lenalidomide|mesh-list
139414910|NCT02353468|Bortezomib|bortezomib|mesh-list
139414911|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139414912|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
139414913|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
139414914|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414915|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414916|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139414917|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
139414918|NCT02353468|Hormones|hormones|mesh-ancestor
139414919|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139414920|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139414921|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414922|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
139414923|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139414924|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139414925|NCT02353468|Growth Substances|growth substances|mesh-ancestor
139414926|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
139414927|NCT04459663|Axitinib|axitinib|mesh-list
139414928|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414929|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139414930|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414931|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414932|NCT05150899|Fexofenadine|fexofenadine|mesh-list
139414933|NCT05150899|Tamsulosin|tamsulosin|mesh-list
139414934|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139414935|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139414936|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139414937|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
139414938|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139414939|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140165|NCT01320111|Paclitaxel|paclitaxel|mesh-list
139651868|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139414940|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414942|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139414943|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139414944|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139414945|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
139414946|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
139414947|NCT01530997|Cisplatin|cisplatin|mesh-list
139414948|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414949|NCT00593905|Bosentan|bosentan|mesh-list
139414950|NCT00593905|Ambrisentan|ambrisentan|mesh-list
139414951|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
139414952|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139414953|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139414954|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414955|NCT02259088|Ranibizumab|ranibizumab|mesh-list
139414956|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139414957|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139414958|NCT02259088|Growth Substances|growth substances|mesh-ancestor
139414959|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414960|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
139414961|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414962|NCT02259010|Itraconazole|itraconazole|mesh-list
139414963|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
139414964|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139414965|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139414966|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139414967|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139414968|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414969|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139414970|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
139414971|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139414972|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414973|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139414974|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139414975|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
139414976|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414977|NCT05153785|Lidocaine|lidocaine|mesh-list
139414978|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
139414979|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
139414980|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139414981|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414982|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
139414983|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139414984|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139414985|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139414986|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139414987|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139414988|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414989|NCT00151775|Olmesartan|olmesartan|mesh-list
139414990|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139414991|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139414992|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139414993|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138767682|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139414994|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139414995|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139414996|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139414997|NCT03476941|Clindamycin|clindamycin|mesh-list
139414998|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
139414999|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
139071795|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
139415000|NCT03476941|Gentamicins|gentamicins|mesh-list
139415001|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139415002|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139415003|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139415004|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415005|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415006|NCT00609323|Lidocaine|lidocaine|mesh-list
139415007|NCT00609323|Tetracaine|tetracaine|mesh-list
139415008|NCT00609323|Anesthetics, Local|anesthetics, local|mesh-ancestor
139415009|NCT00609323|Anesthetics|anesthetics|mesh-ancestor
139415010|NCT00609323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139415011|NCT00609323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651869|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415013|NCT00609323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415014|NCT00609323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139415015|NCT00609323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139415016|NCT00609323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139415017|NCT00609323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139415018|NCT00609323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415019|NCT02682901|Bromocriptine|bromocriptine|mesh-list
139415020|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139415021|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139415022|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
139415023|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139415024|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415025|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
139415026|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
139415027|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415028|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415029|NCT02258074|Niacinamide|niacinamide|mesh-list
139415030|NCT02258074|Niacin|niacin|mesh-list
139415031|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
139415032|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
139415033|NCT02258074|Vitamins|vitamins|mesh-ancestor
139415034|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
139415035|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415036|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139415037|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
139415038|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415039|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139415040|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
139415041|NCT02281643|Doxycycline|doxycycline|mesh-list
139415042|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139415043|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139415044|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
139415045|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139415046|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139415047|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
139415048|NCT02281721|Antacids|antacids|mesh-ancestor
139415049|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415050|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139415051|NCT01642732|Everolimus|everolimus|mesh-list
139415052|NCT01642732|Leuprolide|leuprolide|mesh-list
139415053|NCT01642732|Bicalutamide|bicalutamide|mesh-list
139415054|NCT01642732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139415055|NCT01642732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139415056|NCT01642732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415057|NCT01642732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767777|NCT02547987|Docetaxel|docetaxel|mesh-list
139415058|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139415059|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
139415060|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415061|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415062|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139415063|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
139415064|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139415065|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139415066|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
139415067|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
139415068|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139415069|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
139415070|NCT02281799|Azathioprine|azathioprine|mesh-list
139415071|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
139415072|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415073|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139071869|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415074|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415075|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139415076|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
139415077|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415078|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139415079|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415080|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139415081|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139415082|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139415083|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139651870|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139651871|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
139415084|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
139415085|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415086|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139415087|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139415088|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415089|NCT00589823|Fentanyl|fentanyl|mesh-list
139415090|NCT00589823|Morphine|morphine|mesh-list
139415091|NCT00589823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139415092|NCT00589823|Narcotics|narcotics|mesh-ancestor
139415093|NCT00589823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139415094|NCT00589823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415095|NCT00589823|Analgesics|analgesics|mesh-ancestor
139415096|NCT00589823|Sensory System Agents|sensory system agents|mesh-ancestor
139415097|NCT00589823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415098|NCT00589823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139415099|NCT00589823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139415100|NCT00589823|Anesthetics, General|anesthetics, general|mesh-ancestor
139415101|NCT00589823|Anesthetics|anesthetics|mesh-ancestor
139415102|NCT02190721|Lenograstim|lenograstim|mesh-list
139415103|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139415104|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
139415105|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415106|NCT00581477|Droxidopa|droxidopa|mesh-list
139415107|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139415108|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139415109|NCT03134339|Nicotine|nicotine|mesh-list
139415110|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139415111|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
139415112|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415113|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415114|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139415115|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139415116|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
139415117|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415118|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415119|NCT02282267|Gefitinib|gefitinib|mesh-list
139415120|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415121|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139415122|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415123|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415124|NCT02283905|Voriconazole|voriconazole|mesh-list
139415125|NCT02283905|Amphotericin B|amphotericin b|mesh-list
139415126|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139415127|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
139415128|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139415129|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139415130|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139415131|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415132|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415133|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139415134|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
139415135|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139415136|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415137|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139415138|NCT02283905|Amebicides|amebicides|mesh-ancestor
139415139|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139415140|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139415141|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139415142|NCT03480997|Bromides|bromides|mesh-list
139415143|NCT03480997|Albuterol|albuterol|mesh-list
139415144|NCT03480997|Ipratropium|ipratropium|mesh-list
139415145|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
139415146|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139071945|NCT04470622|Aprepitant|aprepitant|mesh-list
139415147|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
139415148|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415149|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415151|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
139415152|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
139415153|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139415154|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139415155|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139415156|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139415157|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
139415158|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415159|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415160|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139415161|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
139415162|NCT04660747|Anticoagulants|anticoagulants|mesh-list
139415163|NCT02348008|Bevacizumab|bevacizumab|mesh-list
139415164|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
139415165|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139415166|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415167|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139415168|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139415169|NCT02348008|Growth Substances|growth substances|mesh-ancestor
139415170|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415171|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
139415172|NCT02348008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139415173|NCT02348008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415174|NCT00569387|Vaccines|vaccines|mesh-list
139415175|NCT00569387|Immunologic Factors|immunologic factors|mesh-ancestor
139415176|NCT00569387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415177|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139415178|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139415179|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139415180|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
139415181|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415182|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415183|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139415184|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139415185|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
138768059|NCT00642733|Gemcitabine|gemcitabine|mesh-list
138768062|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
139415186|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139415187|NCT05944783|Dasatinib|dasatinib|mesh-list
139415188|NCT05944783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415189|NCT05944783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139415190|NCT05944783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415191|NCT05944783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415192|NCT05944393|Ropivacaine|ropivacaine|mesh-list
139415193|NCT05944393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139415194|NCT05944393|Anesthetics, Local|anesthetics, local|mesh-ancestor
139415195|NCT05944393|Anesthetics|anesthetics|mesh-ancestor
139415196|NCT05944393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139415197|NCT05944393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415198|NCT05944393|Sensory System Agents|sensory system agents|mesh-ancestor
139415199|NCT05944393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415200|NCT05944380|Ropivacaine|ropivacaine|mesh-list
139415201|NCT05944380|Anesthetics, Local|anesthetics, local|mesh-ancestor
139415202|NCT05944380|Anesthetics|anesthetics|mesh-ancestor
139415203|NCT05944380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139415204|NCT05944380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415205|NCT05944380|Sensory System Agents|sensory system agents|mesh-ancestor
139415206|NCT05944380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415207|NCT05944341|Lidocaine|lidocaine|mesh-list
139415208|NCT05944341|Epinephrine|epinephrine|mesh-list
139415209|NCT05944341|Racepinephrine|racepinephrine|mesh-list
139415210|NCT05944341|Carticaine|carticaine|mesh-list
139415211|NCT05944341|Epinephryl borate|epinephryl borate|mesh-list
139415212|NCT05944341|Anesthetics, Local|anesthetics, local|mesh-ancestor
138768117|NCT05336968|Triamcinolone|triamcinolone|mesh-list
139415213|NCT05944341|Anesthetics|anesthetics|mesh-ancestor
139415214|NCT05944341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139415215|NCT05944341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415216|NCT05944341|Sensory System Agents|sensory system agents|mesh-ancestor
139415217|NCT05944341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415218|NCT05944341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139415219|NCT05944341|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139415220|NCT05944341|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139415221|NCT05944341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139415222|NCT05944341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415223|NCT05944341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139415224|NCT05944341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139415225|NCT05944341|Adrenergic Agents|adrenergic agents|mesh-ancestor
139415226|NCT05944341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415227|NCT05944341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139415228|NCT05944341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139415229|NCT05944341|Autonomic Agents|autonomic agents|mesh-ancestor
139651872|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415230|NCT05944341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139415231|NCT05944341|Respiratory System Agents|respiratory system agents|mesh-ancestor
139415233|NCT05944341|Sympathomimetics|sympathomimetics|mesh-ancestor
139415234|NCT05944341|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139415235|NCT05944146|Dobutamine|dobutamine|mesh-list
139415236|NCT05944146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139415237|NCT05944146|Sympathomimetics|sympathomimetics|mesh-ancestor
139415238|NCT05944146|Autonomic Agents|autonomic agents|mesh-ancestor
139415239|NCT05944146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415240|NCT05944146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415241|NCT05944146|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139415242|NCT05944146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139415243|NCT05944146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139415244|NCT05944146|Adrenergic Agents|adrenergic agents|mesh-ancestor
139415245|NCT05944146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415246|NCT05944146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415247|NCT05944146|Protective Agents|protective agents|mesh-ancestor
139415248|NCT05943990|Cyclophosphamide|cyclophosphamide|mesh-list
139415249|NCT05943990|Fludarabine|fludarabine|mesh-list
139415250|NCT05943990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139415251|NCT05943990|Immunologic Factors|immunologic factors|mesh-ancestor
139415252|NCT05943990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415253|NCT05943990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139415254|NCT05943990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139415255|NCT05943990|Alkylating Agents|alkylating agents|mesh-ancestor
138768218|NCT00976677|Bevacizumab|bevacizumab|mesh-list
139415256|NCT05943990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415257|NCT05943990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415258|NCT05943990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139415259|NCT05943613|Clonidine|clonidine|mesh-list
139415260|NCT05943613|Analgesics|analgesics|mesh-ancestor
139415261|NCT05943613|Sensory System Agents|sensory system agents|mesh-ancestor
139415262|NCT05943613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415263|NCT05943613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415264|NCT05943613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139415265|NCT05943613|Sympatholytics|sympatholytics|mesh-ancestor
139415266|NCT05943613|Autonomic Agents|autonomic agents|mesh-ancestor
139415267|NCT05943613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139415268|NCT05943613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139415269|NCT05943613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139415270|NCT05943613|Adrenergic Agents|adrenergic agents|mesh-ancestor
139415271|NCT05943613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415272|NCT05943613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415273|NCT05943470|Icodextrin|icodextrin|mesh-list
139415274|NCT05943470|Dialysis Solutions|dialysis solutions|mesh-list
139415275|NCT05943470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139415276|NCT05943457|Vitamin K|vitamin k|mesh-list
139415277|NCT05943457|Vitamin K 2|vitamin k 2|mesh-list
139415278|NCT05943457|Menaquinone 7|menaquinone 7|mesh-list
139415279|NCT05943457|Vitamins|vitamins|mesh-ancestor
139415280|NCT05943457|Micronutrients|micronutrients|mesh-ancestor
139415281|NCT05943457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415282|NCT05943457|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139415283|NCT05943457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139415284|NCT05943457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415285|NCT05943457|Hemostatics|hemostatics|mesh-ancestor
138768326|NCT04259476|Ketamine|ketamine|mesh-list
139415286|NCT05943457|Coagulants|coagulants|mesh-ancestor
139415287|NCT05943379|Gemcitabine|gemcitabine|mesh-list
139415288|NCT05943379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139415289|NCT05943379|Antimetabolites|antimetabolites|mesh-ancestor
139415290|NCT05943379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415291|NCT05943379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415292|NCT05943353|Pentoxifylline|pentoxifylline|mesh-list
139415293|NCT05943353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139415294|NCT05943353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415295|NCT05943353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415296|NCT05943353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139415297|NCT05943353|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139072091|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
139415298|NCT05943353|Protective Agents|protective agents|mesh-ancestor
139415299|NCT05943353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415300|NCT05943353|Vasodilator Agents|vasodilator agents|mesh-ancestor
139415301|NCT05943353|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139415302|NCT05943353|Antioxidants|antioxidants|mesh-ancestor
139415303|NCT05943223|Metronidazole|metronidazole|mesh-list
139415304|NCT05943223|Ceftriaxone|ceftriaxone|mesh-list
139415305|NCT05943223|Tazobactam|tazobactam|mesh-list
139415306|NCT05943223|Piperacillin|piperacillin|mesh-list
139415307|NCT05943223|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139415308|NCT05943223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139415315|NCT05943158|Folic Acid|folic acid|mesh-list
139415316|NCT05943158|Vitamin B Complex|vitamin b complex|mesh-list
139415317|NCT05943158|Inositol|inositol|mesh-list
139415318|NCT05943158|Hematinics|hematinics|mesh-ancestor
139415319|NCT05943158|Vitamins|vitamins|mesh-ancestor
139415320|NCT05943158|Micronutrients|micronutrients|mesh-ancestor
139415321|NCT05943158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415322|NCT05941949|Vitamins|vitamins|mesh-list
139415323|NCT05941949|Vitamin E|vitamin e|mesh-list
139415324|NCT05941949|Tocopherols|tocopherols|mesh-list
139415325|NCT05941949|Tocotrienols|tocotrienols|mesh-list
139415326|NCT05941949|alpha-Tocopherol|alpha-tocopherol|mesh-list
139415327|NCT05941949|Micronutrients|micronutrients|mesh-ancestor
139415328|NCT05941949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415329|NCT05941949|Antioxidants|antioxidants|mesh-ancestor
139415330|NCT05941949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415331|NCT05941949|Protective Agents|protective agents|mesh-ancestor
139415340|NCT05939622|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
139415341|NCT05939622|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139415342|NCT05939622|Immunologic Factors|immunologic factors|mesh-ancestor
139415343|NCT05939622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415344|NCT05939544|Milk fat globule|milk fat globule|mesh-list
139415345|NCT05939544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139415346|NCT05920213|Lactulose|lactulose|mesh-list
139415347|NCT05920213|N-Methylaspartate|n-methylaspartate|mesh-list
139415348|NCT05920213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139415349|NCT05920213|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
139415350|NCT05920213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139415351|NCT05920213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415352|NCT05920213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415353|NCT05920213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415354|NCT05901714|Phenytoin|phenytoin|mesh-list
139415355|NCT05901714|Midazolam|midazolam|mesh-list
139415356|NCT05901714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139415357|NCT05901714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139415358|NCT05901714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139415359|NCT05901714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415360|NCT05901714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139415361|NCT05901714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139415362|NCT05901714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139415363|NCT05901714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139415364|NCT05901714|Anesthetics, General|anesthetics, general|mesh-ancestor
139415365|NCT05901714|Anesthetics|anesthetics|mesh-ancestor
139415366|NCT05901714|GABA Modulators|gaba modulators|mesh-ancestor
139415367|NCT05901714|GABA Agents|gaba agents|mesh-ancestor
139415368|NCT05901714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415369|NCT05901714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415370|NCT05901714|Anticonvulsants|anticonvulsants|mesh-ancestor
139415371|NCT05901714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139415372|NCT05901714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139415373|NCT05901714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139415374|NCT05901714|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139415375|NCT05901714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139415376|NCT05898399|Olaparib|olaparib|mesh-list
139415377|NCT05898399|Talazoparib|talazoparib|mesh-list
139415378|NCT05898399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139415379|NCT05898399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415380|NCT05898399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415381|NCT05898399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415382|NCT05838391|Capecitabine|capecitabine|mesh-list
139415383|NCT05838391|Fluorouracil|fluorouracil|mesh-list
139415384|NCT05838391|Mitomycins|mitomycins|mesh-list
139415385|NCT05838391|Mitomycin|mitomycin|mesh-list
139415386|NCT05838391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139415387|NCT05838391|Antimetabolites|antimetabolites|mesh-ancestor
139415388|NCT05838391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415389|NCT05838391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415390|NCT05838391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139415391|NCT05838391|Immunologic Factors|immunologic factors|mesh-ancestor
139415392|NCT05838391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415393|NCT05838391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139415394|NCT05838391|Alkylating Agents|alkylating agents|mesh-ancestor
139415395|NCT05838391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139415396|NCT05838391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415397|NCT05797506|Sulforaphane|sulforaphane|mesh-list
139415398|NCT05797506|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139415399|NCT05797506|Protective Agents|protective agents|mesh-ancestor
139415400|NCT05797506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415401|NCT05797506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415402|NCT05768360|Metformin|metformin|mesh-list
139415403|NCT05768360|Digoxin|digoxin|mesh-list
139415404|NCT05768360|Furosemide|furosemide|mesh-list
139415405|NCT05768360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139415406|NCT05768360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139415407|NCT05768360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415408|NCT05768360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139415409|NCT05768360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139415410|NCT05768360|Antimetabolites|antimetabolites|mesh-ancestor
139415411|NCT05768360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415412|NCT05768360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139415413|NCT05768360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139415414|NCT05768360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415415|NCT05768360|Diuretics|diuretics|mesh-ancestor
139415416|NCT05768360|Natriuretic Agents|natriuretic agents|mesh-ancestor
139415417|NCT05768360|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139415418|NCT05768360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139415419|NCT05768360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139415420|NCT05768360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138768597|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
139415421|NCT05768360|Protective Agents|protective agents|mesh-ancestor
139415422|NCT05756972|Carboplatin|carboplatin|mesh-list
139415423|NCT05756972|Pemetrexed|pemetrexed|mesh-list
139415424|NCT05756972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415425|NCT05756972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415426|NCT05756972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415427|NCT05756972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139415428|NCT05756972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139415429|NCT05708950|Pembrolizumab|pembrolizumab|mesh-list
139415430|NCT05708950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139415431|NCT05708950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415432|NCT05708950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139415433|NCT05708950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415434|NCT05689827|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
139415435|NCT05689827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139415436|NCT05689827|Immunologic Factors|immunologic factors|mesh-ancestor
139415437|NCT05689827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415438|NCT05653050|Insulin|insulin|mesh-list
139415439|NCT05653050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139415440|NCT05653050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415441|NCT05624528|Tolcapone|tolcapone|mesh-list
139415442|NCT05624528|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139415443|NCT05624528|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138768641|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
139415444|NCT05624528|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139415445|NCT05624528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415446|NCT05624528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415447|NCT05602818|Alprazolam|alprazolam|mesh-list
139415448|NCT05602818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139415449|NCT05602818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139415450|NCT05602818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415451|NCT05602818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139415452|NCT05602818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139415453|NCT05602818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139415454|NCT05602818|GABA Modulators|gaba modulators|mesh-ancestor
139415455|NCT05602818|GABA Agents|gaba agents|mesh-ancestor
139415456|NCT05602818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415457|NCT05602818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651874|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139651875|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
139415458|NCT05568407|Avelumab|avelumab|mesh-list
139415459|NCT05568407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139415460|NCT05568407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415461|NCT05463744|Insulin|insulin|mesh-list
139415462|NCT05463744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139415463|NCT05463744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139415464|NCT05463744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415465|NCT05430399|Docetaxel|docetaxel|mesh-list
139415466|NCT05430399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415467|NCT05430399|Tubulin Modulators|tubulin modulators|mesh-ancestor
139415468|NCT05430399|Antimitotic Agents|antimitotic agents|mesh-ancestor
139415469|NCT05430399|Mitosis Modulators|mitosis modulators|mesh-ancestor
139415470|NCT05430399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415471|NCT05399329|Palbociclib|palbociclib|mesh-list
139415472|NCT05399329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415473|NCT05399329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139415474|NCT05399329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768691|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415475|NCT05399329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415476|NCT05386888|Paclitaxel|paclitaxel|mesh-list
139415477|NCT05386888|Carboplatin|carboplatin|mesh-list
139415478|NCT05386888|Pemetrexed|pemetrexed|mesh-list
139415479|NCT05386888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139415480|NCT05386888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415481|NCT05386888|Tubulin Modulators|tubulin modulators|mesh-ancestor
139415482|NCT05386888|Antimitotic Agents|antimitotic agents|mesh-ancestor
139415483|NCT05386888|Mitosis Modulators|mitosis modulators|mesh-ancestor
139415484|NCT05386888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415485|NCT05386888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415486|NCT05386888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139415487|NCT05386888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139415488|NCT05354674|Bevacizumab|bevacizumab|mesh-list
139415489|NCT05354674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139415490|NCT05354674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415491|NCT05354674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139415492|NCT05354674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139415493|NCT05354674|Growth Substances|growth substances|mesh-ancestor
139415494|NCT05354674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415495|NCT05354674|Growth Inhibitors|growth inhibitors|mesh-ancestor
139415496|NCT05334329|Cyclophosphamide|cyclophosphamide|mesh-list
139415497|NCT05334329|Fludarabine|fludarabine|mesh-list
139415498|NCT05334329|Atezolizumab|atezolizumab|mesh-list
139415499|NCT05334329|Antineoplastic Agents|antineoplastic agents|mesh-list
139415500|NCT05334329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139415501|NCT05334329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139415502|NCT05334329|Immunologic Factors|immunologic factors|mesh-ancestor
139415503|NCT05334329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415504|NCT05334329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139415505|NCT05334329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139415506|NCT05334329|Alkylating Agents|alkylating agents|mesh-ancestor
139415507|NCT05334329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415508|NCT05334329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139415509|NCT05334329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139415510|NCT05334329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139415511|NCT05293041|Arginine Vasopressin|arginine vasopressin|mesh-list
139415512|NCT05293041|Hemostatics|hemostatics|mesh-ancestor
139415513|NCT05293041|Coagulants|coagulants|mesh-ancestor
139415514|NCT05293041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139415515|NCT05293041|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139415516|NCT05293041|Natriuretic Agents|natriuretic agents|mesh-ancestor
139415517|NCT05293041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415518|NCT05255653|Cisplatin|cisplatin|mesh-list
139415519|NCT05255653|Carboplatin|carboplatin|mesh-list
139415520|NCT05255653|Durvalumab|durvalumab|mesh-list
139415521|NCT05255653|Olaparib|olaparib|mesh-list
139415522|NCT05255653|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139415523|NCT05255653|Megestrol|megestrol|mesh-list
139415524|NCT05255653|Megestrol Acetate|megestrol acetate|mesh-list
139072318|NCT01080482|Tacrolimus|tacrolimus|mesh-list
139415525|NCT05255653|Medroxyprogesterone|medroxyprogesterone|mesh-list
139415526|NCT05255653|Progestins|progestins|mesh-list
139415527|NCT05255653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415528|NCT05255653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415529|NCT05255653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139415530|NCT05255653|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139415531|NCT05255653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415532|NCT05255653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139415533|NCT05255653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139415534|NCT05255653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139415535|NCT05255653|Contraceptive Agents|contraceptive agents|mesh-ancestor
139415536|NCT05255653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139415537|NCT05255653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415538|NCT05255653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139415539|NCT05255653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139415540|NCT05255653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139415541|NCT05255653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139415542|NCT05255653|Appetite Stimulants|appetite stimulants|mesh-ancestor
139415543|NCT05255653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139415544|NCT05255653|Hormones|hormones|mesh-ancestor
139415545|NCT05255653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139415546|NCT05236894|Nicotine|nicotine|mesh-list
139415547|NCT05236894|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139415548|NCT05236894|Autonomic Agents|autonomic agents|mesh-ancestor
139415549|NCT05236894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415550|NCT05236894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415551|NCT05236894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139415552|NCT05236894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139415553|NCT05236894|Cholinergic Agents|cholinergic agents|mesh-ancestor
139415554|NCT05236894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415555|NCT05236894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415556|NCT05109052|Bevacizumab|bevacizumab|mesh-list
139415557|NCT05109052|Atezolizumab|atezolizumab|mesh-list
139415558|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139415559|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415560|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139415561|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139415562|NCT05109052|Growth Substances|growth substances|mesh-ancestor
139415563|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415564|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
139415565|NCT05109052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139415566|NCT05109052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415567|NCT05072314|Lidocaine|lidocaine|mesh-list
139415568|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
139415569|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
139415570|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139415571|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415572|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
139415573|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415574|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139415575|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139415576|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139415577|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139415578|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415579|NCT05006079|Morphine|morphine|mesh-list
139415580|NCT05006079|Alprazolam|alprazolam|mesh-list
139415581|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139415582|NCT05006079|Narcotics|narcotics|mesh-ancestor
139415583|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139415584|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415585|NCT05006079|Analgesics|analgesics|mesh-ancestor
139415586|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
139415587|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415588|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139415589|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139415590|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139415591|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139415592|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
139415593|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
139415594|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415595|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415596|NCT04962022|Ritonavir|ritonavir|mesh-list
139415597|NCT04962022|Itraconazole|itraconazole|mesh-list
139415598|NCT04962022|Nirmatrelvir|nirmatrelvir|mesh-list
139415599|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139415600|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139415601|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
139415602|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415603|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415604|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139651876|NCT01537029|Doxorubicin|doxorubicin|mesh-list
139651877|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139415605|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139415606|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
139415607|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139415608|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138768920|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139415609|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139415610|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
139415611|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139415612|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139415613|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
139415614|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139415615|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415616|NCT04929808|Emollients|emollients|mesh-list
139415617|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
139415618|NCT04910386|Cisplatin|cisplatin|mesh-list
139415619|NCT04910386|Gemcitabine|gemcitabine|mesh-list
139415620|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415621|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139415622|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
139415623|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415624|NCT04895137|Bevacizumab|bevacizumab|mesh-list
139415625|NCT04895137|Antibodies|antibodies|mesh-list
139415626|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139415627|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139415628|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415629|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139415630|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139415631|NCT04895137|Growth Substances|growth substances|mesh-ancestor
139415632|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415633|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
139415634|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
139415635|NCT04744545|Curcumin|curcumin|mesh-list
139415636|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139415637|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139415638|NCT04744545|Analgesics|analgesics|mesh-ancestor
139415639|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
139415640|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415641|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415642|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139415643|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139415644|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415645|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415646|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415647|NCT04742751|Metformin|metformin|mesh-list
139415648|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139415649|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415650|NCT04740905|Aflibercept|aflibercept|mesh-list
139415651|NCT04740905|Faricimab|faricimab|mesh-list
139415652|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139415653|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139415654|NCT04740905|Growth Substances|growth substances|mesh-ancestor
138768976|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415655|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415656|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
139415657|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415658|NCT04667117|Ofatumumab|ofatumumab|mesh-list
139415659|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415660|NCT04594551|Vaccines|vaccines|mesh-list
139415661|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
139415662|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139415663|NCT04594551|Antibodies|antibodies|mesh-list
139415664|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
139415665|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415666|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139415667|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
139415668|NCT04510194|Metformin|metformin|mesh-list
139415669|NCT04510194|Ivermectin|ivermectin|mesh-list
139415670|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
139415671|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139415672|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415673|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139415674|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139415675|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139415676|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139415677|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139415678|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139651878|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
139415679|NCT04510194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139651879|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415680|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139415681|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139415682|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415683|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415684|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
139415685|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139415686|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
138769065|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139415687|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139415688|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139415689|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415690|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139415691|NCT04502966|Immunomodulating Agents|immunomodulating agents|mesh-list
139415692|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
139415693|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139415694|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415695|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139415696|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139415697|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
139415698|NCT04482803|Hormones|hormones|mesh-ancestor
139415699|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139415700|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415701|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415702|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415703|NCT04419519|Venetoclax|venetoclax|mesh-list
139415704|NCT04419519|Antibodies|antibodies|mesh-list
139415705|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139415706|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
139415707|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415708|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415709|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
139415710|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415711|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139415712|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139415713|NCT04335461|Anesthetics|anesthetics|mesh-list
139415714|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
139415715|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139415716|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415717|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
139415718|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415719|NCT04300192|Vaccines|vaccines|mesh-list
139415720|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
139415721|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415722|NCT04188665|Lectins|lectins|mesh-list
139415723|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
139415724|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
139415725|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415726|NCT04188665|Coagulants|coagulants|mesh-ancestor
139415727|NCT04064294|Levodopa|levodopa|mesh-list
139415728|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139415729|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139415730|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
139415731|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415732|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415733|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415734|NCT04009044|Tamoxifen|tamoxifen|mesh-list
139415735|NCT04009044|Afimoxifene|afimoxifene|mesh-list
139415736|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139415737|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
139415738|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139415739|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415740|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139415741|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415742|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139415743|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139415744|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139415745|NCT03699319|Leucovorin|leucovorin|mesh-list
139415746|NCT03699319|Folic Acid|folic acid|mesh-list
139415747|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
139415748|NCT03699319|Irinotecan|irinotecan|mesh-list
139415749|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
139415750|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072543|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415751|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415752|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139415753|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139415754|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415755|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415757|NCT03699319|Protective Agents|protective agents|mesh-ancestor
139415758|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
139415759|NCT03699319|Vitamins|vitamins|mesh-ancestor
139415760|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
139415761|NCT03699319|Hematinics|hematinics|mesh-ancestor
139415762|NCT03594435|Ibudilast|ibudilast|mesh-list
139415763|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139415764|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
139415765|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415766|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415767|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139415768|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
139415769|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139415770|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415771|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415772|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139415773|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
139415774|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
139415775|NCT03563729|Nivolumab|nivolumab|mesh-list
139415776|NCT03563729|Ipilimumab|ipilimumab|mesh-list
139415777|NCT03563729|Trametinib|trametinib|mesh-list
139415778|NCT03563729|Dabrafenib|dabrafenib|mesh-list
139415779|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139415780|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415781|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139415782|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415783|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139415784|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415785|NCT03539822|Durvalumab|durvalumab|mesh-list
139415786|NCT03539822|Tremelimumab|tremelimumab|mesh-list
139415787|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139415788|NCT03539822|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139415789|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139415790|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415791|NCT03539822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139415792|NCT03539822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415793|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415794|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139415795|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415796|NCT03291028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139415797|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415798|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
139415799|NCT03257163|Capecitabine|capecitabine|mesh-list
139415800|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139415801|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415802|NCT03257163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139415803|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415804|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139415805|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
139415806|NCT02885974|Celecoxib|celecoxib|mesh-list
139415807|NCT02885974|Gemcitabine|gemcitabine|mesh-list
139415808|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415809|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139415810|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
139415811|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415812|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139415813|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139415814|NCT02885974|Analgesics|analgesics|mesh-ancestor
139415815|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
139415816|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415817|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415818|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139415819|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139415820|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139415821|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139415822|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415823|NCT02861300|Capecitabine|capecitabine|mesh-list
139415824|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139415826|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415827|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651880|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139415829|NCT02611960|Capecitabine|capecitabine|mesh-list
139415830|NCT02611960|Docetaxel|docetaxel|mesh-list
139415831|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
139415832|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139415833|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
139415834|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415835|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415836|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
138769304|NCT00647491|Adalimumab|adalimumab|mesh-list
139415837|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
139415838|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
139415839|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139415840|NCT02611960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139415841|NCT02358850|Acetaminophen|acetaminophen|mesh-list
139415842|NCT02358850|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139415843|NCT02358850|Oxycodone|oxycodone|mesh-list
139415844|NCT02358850|Hydromorphone|hydromorphone|mesh-list
139415845|NCT02358850|Hydrocodone|hydrocodone|mesh-list
139415846|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139415847|NCT02358850|Analgesics|analgesics|mesh-ancestor
139415848|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
139415849|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415850|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415851|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
139415852|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139415853|NCT02358850|Narcotics|narcotics|mesh-ancestor
139415854|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139415855|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
139415856|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
139415857|NCT02358850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139415858|NCT02358850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139415859|NCT02358850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139415860|NCT01784159|Aspirin|aspirin|mesh-list
139415861|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139415862|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139415863|NCT01784159|Analgesics|analgesics|mesh-ancestor
139415864|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
139415865|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415866|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415867|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139415868|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139415869|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139415870|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139415871|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415872|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139415873|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139415874|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139415875|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
139415876|NCT01749969|Dexamethasone|dexamethasone|mesh-list
139415877|NCT01749969|Lenalidomide|lenalidomide|mesh-list
139415878|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139415879|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
139415880|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
139415881|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415882|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415883|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139415884|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
139415885|NCT01749969|Hormones|hormones|mesh-ancestor
139415886|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139415887|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139415888|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415889|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
139415890|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139415891|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139415892|NCT01749969|Growth Substances|growth substances|mesh-ancestor
139415893|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
139415894|NCT01203020|Fludarabine|fludarabine|mesh-list
139415895|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
139415896|NCT01203020|Busulfan|busulfan|mesh-list
139415897|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415898|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139415899|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
139072693|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
139415900|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415901|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139415902|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
139651881|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139415903|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415904|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
139415905|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139415906|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139415907|NCT00006256|Paclitaxel|paclitaxel|mesh-list
139415908|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139415909|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415910|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
139415911|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
139415912|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
139415913|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415914|NCT00495131|Interferons|interferons|mesh-list
139415915|NCT00495131|Ribavirin|ribavirin|mesh-list
139415916|NCT00495131|Interferon-alpha|interferon-alpha|mesh-list
139415917|NCT00495131|Interferon alpha-2|interferon alpha-2|mesh-list
139415918|NCT00495131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139415919|NCT00495131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415920|NCT00495131|Antiviral Agents|antiviral agents|mesh-ancestor
139415921|NCT00495131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139415922|NCT00495131|Antimetabolites|antimetabolites|mesh-ancestor
139415923|NCT00495131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415924|NCT00495131|Immunologic Factors|immunologic factors|mesh-ancestor
139415925|NCT00495131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415926|NCT02257372|Albuterol|albuterol|mesh-list
139415927|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139415928|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
139415929|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415930|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415931|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139415932|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
139415933|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
139415934|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139415935|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139415936|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139415937|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139415938|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
139415939|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415940|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415941|NCT02256982|Cisplatin|cisplatin|mesh-list
139415942|NCT02256982|Gemcitabine|gemcitabine|mesh-list
139415943|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769492|NCT01217060|Dexamethasone|dexamethasone|mesh-list
139415944|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139415945|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
139415946|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415947|NCT03480607|Dexamethasone|dexamethasone|mesh-list
139415948|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
139415949|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139415950|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
139415951|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
139415952|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139415953|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415954|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139415955|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
139415956|NCT03480607|Hormones|hormones|mesh-ancestor
139415957|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139415958|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139415959|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415960|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139415961|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139415962|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139415963|NCT03480607|Analgesics|analgesics|mesh-ancestor
139415964|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
139415965|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139415966|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139415967|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139415968|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
139415969|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139415970|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415971|NCT00489203|Beclomethasone|beclomethasone|mesh-list
139415972|NCT00489203|Methotrexate|methotrexate|mesh-list
139415973|NCT00489203|Tacrolimus|tacrolimus|mesh-list
139415974|NCT00489203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139415975|NCT00489203|Abortifacient Agents|abortifacient agents|mesh-ancestor
139415976|NCT00489203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139651882|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
139415977|NCT00489203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139415978|NCT00489203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139415979|NCT00489203|Antimetabolites|antimetabolites|mesh-ancestor
139415980|NCT00489203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139415981|NCT00489203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139415982|NCT00489203|Dermatologic Agents|dermatologic agents|mesh-ancestor
139415983|NCT00489203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769534|NCT00966693|Hormones|hormones|mesh-ancestor
139415984|NCT00489203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139415985|NCT00489203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139415986|NCT00489203|Immunologic Factors|immunologic factors|mesh-ancestor
139415987|NCT00489203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139415988|NCT00489203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139415989|NCT00489203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139415990|NCT00489203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139415991|NCT00489203|Glucocorticoids|glucocorticoids|mesh-ancestor
139415992|NCT00489203|Hormones|hormones|mesh-ancestor
139415993|NCT00489203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139415994|NCT00489203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139415995|NCT00489203|Respiratory System Agents|respiratory system agents|mesh-ancestor
139415996|NCT05646394|Aspirin|aspirin|mesh-list
139415997|NCT05646394|Vitamins|vitamins|mesh-list
139415998|NCT05646394|Vitamin K|vitamin k|mesh-list
139415999|NCT05646394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139416000|NCT05646394|Micronutrients|micronutrients|mesh-ancestor
139416001|NCT05646394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416002|NCT05646394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139416003|NCT05646394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139416004|NCT05646394|Analgesics|analgesics|mesh-ancestor
139416005|NCT05646394|Sensory System Agents|sensory system agents|mesh-ancestor
139416006|NCT05646394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416007|NCT05646394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416008|NCT05646394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139416009|NCT05646394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139416010|NCT05646394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139416011|NCT05646394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416012|NCT05646394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139416013|NCT05646394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416014|NCT05646394|Antipyretics|antipyretics|mesh-ancestor
139416015|NCT05646394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139416016|NCT05646394|Hemostatics|hemostatics|mesh-ancestor
139416017|NCT05646394|Coagulants|coagulants|mesh-ancestor
139416018|NCT00563459|Topiramate|topiramate|mesh-list
139416019|NCT00563459|Levetiracetam|levetiracetam|mesh-list
139416020|NCT00563459|Anticonvulsants|anticonvulsants|mesh-ancestor
139416021|NCT00563459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139416022|NCT00563459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416023|NCT00563459|Nootropic Agents|nootropic agents|mesh-ancestor
139416024|NCT00561743|Dexamethasone|dexamethasone|mesh-list
139416025|NCT00561743|Doxorubicin|doxorubicin|mesh-list
139416026|NCT00561743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139416027|NCT00561743|Bortezomib|bortezomib|mesh-list
139416028|NCT00561743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416029|NCT00561743|Antiemetics|antiemetics|mesh-ancestor
139416030|NCT00561743|Autonomic Agents|autonomic agents|mesh-ancestor
139416031|NCT00561743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416032|NCT00561743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416033|NCT00561743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139416034|NCT00561743|Glucocorticoids|glucocorticoids|mesh-ancestor
139416035|NCT00561743|Hormones|hormones|mesh-ancestor
139416036|NCT00561743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139416037|NCT00561743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139416038|NCT00561743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416039|NCT00561743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139416040|NCT00561743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139416041|NCT00561743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139416042|NCT00561743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416043|NCT00561743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416044|NCT00488267|Ketoprofen|ketoprofen|mesh-list
139416045|NCT00488267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139416046|NCT00488267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139416047|NCT00488267|Analgesics|analgesics|mesh-ancestor
139416048|NCT00488267|Sensory System Agents|sensory system agents|mesh-ancestor
139416049|NCT00488267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416050|NCT00488267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416051|NCT00488267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416052|NCT00488267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139416053|NCT00488267|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139416054|NCT00488267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416055|NCT00488267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416056|NCT00560183|Morphine|morphine|mesh-list
139416057|NCT00560183|Oxycodone|oxycodone|mesh-list
139416058|NCT00560183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139416059|NCT00560183|Narcotics|narcotics|mesh-ancestor
139416060|NCT00560183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416061|NCT00560183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416062|NCT00560183|Analgesics|analgesics|mesh-ancestor
139416063|NCT00560183|Sensory System Agents|sensory system agents|mesh-ancestor
139416064|NCT00560183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416065|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139416066|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
139416067|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416068|NCT00542633|Insulin|insulin|mesh-list
139416069|NCT00542633|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139416070|NCT00542633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139416071|NCT00542633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416072|NCT02523547|Entecavir|entecavir|mesh-list
139416073|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
139416074|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416075|NCT00483977|Oxycodone|oxycodone|mesh-list
139416076|NCT00483977|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139416077|NCT00483977|Narcotics|narcotics|mesh-ancestor
139416078|NCT00483977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416079|NCT00483977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416080|NCT00483977|Analgesics|analgesics|mesh-ancestor
139416081|NCT00483977|Sensory System Agents|sensory system agents|mesh-ancestor
139416082|NCT00483977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416083|NCT00481325|Escitalopram|escitalopram|mesh-list
139416084|NCT00481325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139416085|NCT00481325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139416086|NCT00481325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139416087|NCT00481325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416088|NCT00481325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416089|NCT00481325|Serotonin Agents|serotonin agents|mesh-ancestor
139416090|NCT00481325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416091|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
139416092|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
139416093|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139416094|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416095|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416096|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416097|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
139416098|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139416099|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
139416100|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416101|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
139416102|NCT03480295|Protective Agents|protective agents|mesh-ancestor
139416103|NCT03472963|Darunavir|darunavir|mesh-list
139416104|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139416105|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139416106|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139416107|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
139416108|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416109|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416110|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139416111|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139416112|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
139416113|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416114|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
139416115|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139416116|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416117|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416118|NCT00465959|Trospium chloride|trospium chloride|mesh-list
139416119|NCT00465959|Parasympatholytics|parasympatholytics|mesh-ancestor
139416120|NCT00465959|Autonomic Agents|autonomic agents|mesh-ancestor
139416121|NCT00465959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416122|NCT00465959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416123|NCT00465959|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139651883|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651884|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416125|NCT00465959|Cholinergic Agents|cholinergic agents|mesh-ancestor
139416126|NCT00465959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416127|NCT00465959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416128|NCT00465959|Urological Agents|urological agents|mesh-ancestor
139416129|NCT00465803|Timolol|timolol|mesh-list
139416130|NCT00465803|Travoprost|travoprost|mesh-list
139416131|NCT00465803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139416132|NCT00465803|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139416133|NCT00465803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416134|NCT00465803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139416135|NCT00465803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139416136|NCT00465803|Adrenergic Agents|adrenergic agents|mesh-ancestor
139416137|NCT00465803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416138|NCT00465803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416139|NCT00465803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139416140|NCT00465803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139416141|NCT02282891|Ketamine|ketamine|mesh-list
139416142|NCT02282891|Propofol|propofol|mesh-list
139416143|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139416144|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416145|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416146|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139416147|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
139416148|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
139416149|NCT02282891|Analgesics|analgesics|mesh-ancestor
139416150|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
139416151|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416152|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139416153|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139416154|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139416155|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416156|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416157|NCT00464633|Alvocidib|alvocidib|mesh-list
139416158|NCT00464633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416159|NCT00464633|Growth Inhibitors|growth inhibitors|mesh-ancestor
139416160|NCT00464633|Growth Substances|growth substances|mesh-ancestor
139416161|NCT00464633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416162|NCT00464633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139416163|NCT00464633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416164|NCT00464633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416165|NCT00464555|Sirolimus|sirolimus|mesh-list
139416166|NCT00464555|Lisofylline|lisofylline|mesh-list
139416167|NCT00464555|Tacrolimus|tacrolimus|mesh-list
139416168|NCT00464555|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138769822|NCT01215032|Metformin|metformin|mesh-list
139416169|NCT00464555|Basiliximab|basiliximab|mesh-list
139416170|NCT00464555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139416171|NCT00464555|Immunologic Factors|immunologic factors|mesh-ancestor
139416172|NCT00464555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416173|NCT00464555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139416174|NCT00464555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416175|NCT00464555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416176|NCT00464555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139416177|NCT00464555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416178|NCT00464555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139416179|NCT00464555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416180|NCT00464555|Antifungal Agents|antifungal agents|mesh-ancestor
139416181|NCT00464555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139416182|NCT00464555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139416183|NCT00464555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139416184|NCT00464555|Analgesics|analgesics|mesh-ancestor
139416185|NCT00464555|Sensory System Agents|sensory system agents|mesh-ancestor
139416186|NCT00464555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416187|NCT00464555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416188|NCT00464555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139416189|NCT00464243|Volinanserin|volinanserin|mesh-list
139416190|NCT00464243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139416191|NCT00464243|Serotonin Agents|serotonin agents|mesh-ancestor
139416192|NCT00464243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416193|NCT00464243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416194|NCT00464243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416195|NCT03336541|Ketamine|ketamine|mesh-list
139416196|NCT03336541|Analgesics|analgesics|mesh-ancestor
139416197|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
138920866|NCT04108637|Penicillins|penicillins|mesh-list
139416198|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416199|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416200|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139416201|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139416202|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
139416203|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
138769884|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139416204|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416205|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139416206|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139416207|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416208|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416209|NCT00525941|Indiplon|indiplon|mesh-list
139416210|NCT00525941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139416211|NCT00525941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416212|NCT00525941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416213|NCT00525941|GABA Modulators|gaba modulators|mesh-ancestor
139416214|NCT00525941|GABA Agents|gaba agents|mesh-ancestor
139416215|NCT00525941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416216|NCT00525941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416217|NCT03476083|Tenofovir|tenofovir|mesh-list
139416218|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
139416219|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416220|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139416221|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139416222|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416223|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416224|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139416225|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139416226|NCT02738203|Lidocaine|lidocaine|mesh-list
139416227|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
139416228|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
138769940|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
139416229|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416230|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416231|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
139416232|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416233|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139416234|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139416235|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139416236|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139416237|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416238|NCT00457457|Tamsulosin|tamsulosin|mesh-list
139416239|NCT00457457|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139416240|NCT00457457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139416241|NCT00457457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139416242|NCT00457457|Adrenergic Agents|adrenergic agents|mesh-ancestor
139416243|NCT00457457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416244|NCT00457457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416245|NCT00457457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416246|NCT00457457|Urological Agents|urological agents|mesh-ancestor
139416247|NCT00517439|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139416248|NCT00517439|Interferon-alpha|interferon-alpha|mesh-list
139416249|NCT00517439|Antiviral Agents|antiviral agents|mesh-ancestor
139416250|NCT00517439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416251|NCT00517439|Immunologic Factors|immunologic factors|mesh-ancestor
139416252|NCT00517439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416253|NCT03472651|Flupenthixol|flupenthixol|mesh-list
139416254|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
139416255|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139416256|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139416257|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416258|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416259|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139416260|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139416261|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
139416262|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416263|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416264|NCT00517049|Rituximab|rituximab|mesh-list
139416265|NCT00517049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139416266|NCT00517049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416267|NCT00517049|Immunologic Factors|immunologic factors|mesh-ancestor
139416268|NCT00517049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416269|NCT00517049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139416270|NCT02283203|Acetaminophen|acetaminophen|mesh-list
139416271|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139416272|NCT02283203|Analgesics|analgesics|mesh-ancestor
139416273|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
139416274|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416275|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416277|NCT02523313|Nivolumab|nivolumab|mesh-list
139416278|NCT02523313|Ipilimumab|ipilimumab|mesh-list
139416279|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139416280|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416281|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139416282|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416283|NCT02452034|Posaconazole|posaconazole|mesh-list
139416284|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
139416285|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416286|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139416287|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139416288|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139416289|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139416290|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139416291|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416292|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416293|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139416294|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
139416295|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139416296|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416297|NCT02283359|Irinotecan|irinotecan|mesh-list
139416298|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139416299|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139416300|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416301|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416302|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416303|NCT00511043|Vatalanib|vatalanib|mesh-list
139416304|NCT00511043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139416305|NCT00511043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416306|NCT00511043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416307|NCT00508625|Paclitaxel|paclitaxel|mesh-list
139416308|NCT00508625|Bevacizumab|bevacizumab|mesh-list
139416309|NCT00508625|Carboplatin|carboplatin|mesh-list
139416310|NCT00508625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139416311|NCT00508625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416312|NCT00508625|Tubulin Modulators|tubulin modulators|mesh-ancestor
139416313|NCT00508625|Antimitotic Agents|antimitotic agents|mesh-ancestor
139416314|NCT00508625|Mitosis Modulators|mitosis modulators|mesh-ancestor
139416315|NCT00508625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416316|NCT00508625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139416317|NCT00508625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139416318|NCT00508625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139416319|NCT00508625|Growth Substances|growth substances|mesh-ancestor
139416320|NCT00508625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416321|NCT00508625|Growth Inhibitors|growth inhibitors|mesh-ancestor
139416322|NCT02284529|Leucovorin|leucovorin|mesh-list
139416323|NCT02284529|Fluorouracil|fluorouracil|mesh-list
139416324|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
139416325|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416326|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139416327|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416328|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139416329|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
139416330|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416331|NCT02284529|Antidotes|antidotes|mesh-ancestor
139416332|NCT02284529|Protective Agents|protective agents|mesh-ancestor
139416333|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
139416334|NCT02284529|Vitamins|vitamins|mesh-ancestor
139416335|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
139416336|NCT02482298|Ticagrelor|ticagrelor|mesh-list
139416337|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139416338|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139416339|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139416340|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139416341|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
139416342|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140179|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651885|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139651886|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139416343|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416344|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416346|NCT04470479|Miotics|miotics|mesh-ancestor
139073209|NCT00384293|Niacin|niacin|mesh-list
139416347|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
139416348|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416349|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416350|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139416351|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139416352|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
139416353|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416354|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416355|NCT00383513|Epratuzumab|epratuzumab|mesh-list
139416356|NCT00383513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139416357|NCT00383513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416358|NCT00382811|Carboplatin|carboplatin|mesh-list
138770107|NCT00650065|Cetirizine|cetirizine|mesh-list
139416359|NCT00382811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416360|NCT02286635|Clarithromycin|clarithromycin|mesh-list
139416361|NCT02286635|Rifampin|rifampin|mesh-list
139416362|NCT02286635|Deflazacort|deflazacort|mesh-list
139416363|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139416364|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416365|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139416366|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416367|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416368|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139416369|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139416370|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139416371|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
139416372|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
139416373|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139416374|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139416375|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139416376|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139416377|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139416378|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139416379|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139416380|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138770150|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
139416381|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139416382|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
139416383|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416384|NCT00440531|Vaccines|vaccines|mesh-list
139416385|NCT00440531|Immunologic Factors|immunologic factors|mesh-ancestor
139416386|NCT00440531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416387|NCT00437021|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139416388|NCT00437021|Antiviral Agents|antiviral agents|mesh-ancestor
139416389|NCT00437021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416390|NCT00375791|Dexamethasone|dexamethasone|mesh-list
139416391|NCT00375791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416392|NCT00375791|Antiemetics|antiemetics|mesh-ancestor
139416393|NCT00375791|Autonomic Agents|autonomic agents|mesh-ancestor
139416394|NCT00375791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416395|NCT00375791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416396|NCT00375791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139416397|NCT00375791|Glucocorticoids|glucocorticoids|mesh-ancestor
139416398|NCT00375791|Hormones|hormones|mesh-ancestor
139416399|NCT00375791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139416400|NCT00375791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139416401|NCT00375791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416402|NCT00431873|Mocetinostat|mocetinostat|mesh-list
139416403|NCT00431873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139416404|NCT00431873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416405|NCT00431873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039585|NCT01047774|Caseins|caseins|mesh-list
139416406|NCT02287181|Remifentanil|remifentanil|mesh-list
139416407|NCT02287181|Propofol|propofol|mesh-list
139416408|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139416409|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416410|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416411|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139416412|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
139416413|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
139416414|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139651887|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139416415|NCT02287181|Narcotics|narcotics|mesh-ancestor
139416416|NCT02287181|Analgesics|analgesics|mesh-ancestor
139416417|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
139416418|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416420|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
139416421|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
139416422|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416423|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416424|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139416425|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139416426|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139416427|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416428|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139416429|NCT02287259|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139416430|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139416431|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139416432|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416433|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416434|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
139416435|NCT00429923|Fluprednisolone|fluprednisolone|mesh-list
139416436|NCT00429923|Difluprednate|difluprednate|mesh-list
139416437|NCT00429923|Glucocorticoids|glucocorticoids|mesh-ancestor
139416439|NCT00429923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139416440|NCT00429923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416441|NCT00429923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416442|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
139416443|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139416444|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139416445|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416446|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
139416447|NCT04470557|Coagulants|coagulants|mesh-ancestor
139416448|NCT00372437|Gemcitabine|gemcitabine|mesh-list
139416449|NCT00372437|Mocetinostat|mocetinostat|mesh-list
139416450|NCT00372437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139416451|NCT00372437|Antimetabolites|antimetabolites|mesh-ancestor
139416452|NCT00372437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416453|NCT00372437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416454|NCT00372437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139416455|NCT00372437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416456|NCT00369473|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139416457|NCT00369473|Immunologic Factors|immunologic factors|mesh-ancestor
139416458|NCT00369473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416459|NCT04470791|Antivenins|antivenins|mesh-list
139416460|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
139416461|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416462|NCT00364247|Tapentadol|tapentadol|mesh-list
139416463|NCT00364247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139416464|NCT00364247|Narcotics|narcotics|mesh-ancestor
139416465|NCT00364247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416466|NCT00364247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416467|NCT00364247|Analgesics|analgesics|mesh-ancestor
139416468|NCT00364247|Sensory System Agents|sensory system agents|mesh-ancestor
139416469|NCT00364247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416470|NCT00364247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139416471|NCT00364247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139416472|NCT00364247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139416473|NCT00364247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416474|NCT00364247|Adrenergic Agents|adrenergic agents|mesh-ancestor
139416475|NCT00364247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416476|NCT00424697|Lorazepam|lorazepam|mesh-list
139416477|NCT00424697|Anticonvulsants|anticonvulsants|mesh-ancestor
139416478|NCT00424697|Antiemetics|antiemetics|mesh-ancestor
139416479|NCT00424697|Autonomic Agents|autonomic agents|mesh-ancestor
139416480|NCT00424697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416481|NCT00424697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416482|NCT00424697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139416483|NCT00424697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139416484|NCT00424697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416485|NCT00424697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139416486|NCT00424697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139416487|NCT00424697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139416488|NCT00424697|GABA Modulators|gaba modulators|mesh-ancestor
139416489|NCT00424697|GABA Agents|gaba agents|mesh-ancestor
139416490|NCT00424697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416491|NCT00424697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416492|NCT00360035|Obatoclax|obatoclax|mesh-list
139416493|NCT00360035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416494|NCT00360035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416496|NCT00356681|Paclitaxel|paclitaxel|mesh-list
139416497|NCT00356681|Bevacizumab|bevacizumab|mesh-list
139416498|NCT00356681|Motesanib diphosphate|motesanib diphosphate|mesh-list
139416499|NCT00356681|Imetelstat|imetelstat|mesh-list
139416500|NCT00356681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139416501|NCT00356681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416502|NCT00356681|Tubulin Modulators|tubulin modulators|mesh-ancestor
139416503|NCT00356681|Antimitotic Agents|antimitotic agents|mesh-ancestor
139416504|NCT00356681|Mitosis Modulators|mitosis modulators|mesh-ancestor
139416505|NCT00356681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416506|NCT00356681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139416507|NCT00356681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139416508|NCT00356681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139416509|NCT00356681|Growth Substances|growth substances|mesh-ancestor
139416510|NCT00356681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416511|NCT00356681|Growth Inhibitors|growth inhibitors|mesh-ancestor
139416512|NCT00356681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139416513|NCT00356681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416514|NCT00356681|Vitamin B Complex|vitamin b complex|mesh-ancestor
139416515|NCT00356681|Vitamins|vitamins|mesh-ancestor
139416516|NCT00356681|Micronutrients|micronutrients|mesh-ancestor
139416517|NCT00417209|Capecitabine|capecitabine|mesh-list
139416518|NCT00417209|Fluorouracil|fluorouracil|mesh-list
139416519|NCT00417209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139416520|NCT00417209|Antimetabolites|antimetabolites|mesh-ancestor
139416521|NCT00417209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416522|NCT00417209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416523|NCT00417209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139416524|NCT00417209|Immunologic Factors|immunologic factors|mesh-ancestor
139416525|NCT00417209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416526|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139416527|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139416528|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139416529|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139416530|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416531|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
139416532|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416533|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416534|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139416535|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416536|NCT00355355|Talaporfin|talaporfin|mesh-list
139416537|NCT00355355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416538|NCT00355355|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139416539|NCT00355355|Dermatologic Agents|dermatologic agents|mesh-ancestor
139416540|NCT00407303|Bortezomib|bortezomib|mesh-list
139416541|NCT00407303|Obatoclax|obatoclax|mesh-list
139416542|NCT00407303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416543|NCT00407303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416544|NCT00407303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416545|NCT00344045|Acetaminophen|acetaminophen|mesh-list
139416546|NCT00344045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139416547|NCT00344045|Analgesics|analgesics|mesh-ancestor
139416548|NCT00344045|Sensory System Agents|sensory system agents|mesh-ancestor
139416549|NCT00344045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416550|NCT00344045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416551|NCT00344045|Antipyretics|antipyretics|mesh-ancestor
139416552|NCT02256436|Paclitaxel|paclitaxel|mesh-list
139416553|NCT02256436|Docetaxel|docetaxel|mesh-list
139416554|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
139416555|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139416556|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416557|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
139416558|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
139416559|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
139416560|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416561|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139416562|NCT02256436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139651888|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139416563|NCT00343109|Sargramostim|sargramostim|mesh-list
139651889|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651890|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139651891|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416565|NCT00343109|Immunologic Factors|immunologic factors|mesh-ancestor
139416566|NCT00343109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416567|NCT00405743|Cytarabine|cytarabine|mesh-list
139416568|NCT00405743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139416569|NCT00405743|Antimetabolites|antimetabolites|mesh-ancestor
139416570|NCT00405743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416571|NCT00405743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416572|NCT00405743|Antiviral Agents|antiviral agents|mesh-ancestor
139416573|NCT00405743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416574|NCT00405743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139416575|NCT00405743|Immunologic Factors|immunologic factors|mesh-ancestor
139416576|NCT00405743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416577|NCT00403169|Lenalidomide|lenalidomide|mesh-list
139416578|NCT00403169|Immunologic Factors|immunologic factors|mesh-ancestor
139416579|NCT00403169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416580|NCT00403169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139416581|NCT00403169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139416582|NCT00403169|Growth Substances|growth substances|mesh-ancestor
139416583|NCT00403169|Growth Inhibitors|growth inhibitors|mesh-ancestor
139416584|NCT00403169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416585|NCT00332657|Hydrocortisone|hydrocortisone|mesh-list
139416586|NCT00332657|Anecortave|anecortave|mesh-list
139416587|NCT00332657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139416588|NCT00332657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139416589|NCT00332657|Growth Substances|growth substances|mesh-ancestor
139416590|NCT00332657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416591|NCT00332657|Growth Inhibitors|growth inhibitors|mesh-ancestor
139416592|NCT00332657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416593|NCT00332657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416594|NCT00330473|Insulin|insulin|mesh-list
139416595|NCT00330473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139416596|NCT00330473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139416597|NCT00330473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416598|NCT00327743|Capecitabine|capecitabine|mesh-list
139416599|NCT00327743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139416600|NCT00327743|Antimetabolites|antimetabolites|mesh-ancestor
139416601|NCT00327743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416602|NCT00327743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416603|NCT02285075|Temocillin|temocillin|mesh-list
139416604|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139416605|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416606|NCT00321815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138790682|NCT02613247|Hylan|hylan|mesh-list
139416607|NCT00321815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416608|NCT00321815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139416609|NCT00321815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416610|NCT00321815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416611|NCT00398879|Capecitabine|capecitabine|mesh-list
139416612|NCT00398879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139416613|NCT00398879|Antimetabolites|antimetabolites|mesh-ancestor
139416614|NCT00398879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416615|NCT00398879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416616|NCT00309179|Cetuximab|cetuximab|mesh-list
139416617|NCT00309179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139416618|NCT00309179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416619|NCT00394199|Fluticasone|fluticasone|mesh-list
139416620|NCT00394199|Xhance|xhance|mesh-list
139416621|NCT00394199|Formoterol Fumarate|formoterol fumarate|mesh-list
139416622|NCT00394199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416623|NCT00394199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139416624|NCT00394199|Autonomic Agents|autonomic agents|mesh-ancestor
139416625|NCT00394199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416626|NCT00394199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416627|NCT00394199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139416628|NCT00394199|Respiratory System Agents|respiratory system agents|mesh-ancestor
139416629|NCT00394199|Dermatologic Agents|dermatologic agents|mesh-ancestor
139416630|NCT00394199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139416631|NCT00394199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139416632|NCT00394199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139416633|NCT00394199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139416634|NCT00394199|Adrenergic Agents|adrenergic agents|mesh-ancestor
139416635|NCT00394199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416636|NCT00394199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416637|NCT00394121|Fluticasone|fluticasone|mesh-list
139416638|NCT00394121|Xhance|xhance|mesh-list
139416639|NCT00394121|Formoterol Fumarate|formoterol fumarate|mesh-list
139040035|NCT00203476|Niacin|niacin|mesh-list
139416640|NCT00394121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416641|NCT00394121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139416642|NCT00394121|Autonomic Agents|autonomic agents|mesh-ancestor
139416643|NCT00394121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416644|NCT00394121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416645|NCT00394121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139416646|NCT00394121|Respiratory System Agents|respiratory system agents|mesh-ancestor
139416647|NCT00394121|Dermatologic Agents|dermatologic agents|mesh-ancestor
139416648|NCT00394121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139416649|NCT00394121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139416650|NCT00394121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139416651|NCT00394121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139416652|NCT00394121|Adrenergic Agents|adrenergic agents|mesh-ancestor
139416653|NCT00394121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416654|NCT00394121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416655|NCT02480114|Acetaminophen|acetaminophen|mesh-list
139416657|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139416658|NCT02480114|Fentanyl|fentanyl|mesh-list
139416659|NCT02480114|Oxycodone|oxycodone|mesh-list
139416660|NCT02480114|Hydrocodone|hydrocodone|mesh-list
139416661|NCT02480114|Gabapentin|gabapentin|mesh-list
139416662|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139416663|NCT02480114|Narcotics|narcotics|mesh-ancestor
139416664|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416665|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416666|NCT02480114|Analgesics|analgesics|mesh-ancestor
139416667|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
139416668|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040072|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
139416669|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139416670|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139416671|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
139416672|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
139416673|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139416674|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
139416675|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139416676|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416677|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139416678|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139416679|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416680|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416681|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
139416682|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139416683|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139416684|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139416685|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139416686|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139040115|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139416687|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416688|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
139416689|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
139416690|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
139416691|NCT00299507|Hydrocortisone|hydrocortisone|mesh-list
139416692|NCT00299507|Anecortave|anecortave|mesh-list
139416693|NCT00299507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139416694|NCT00299507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139416695|NCT00299507|Growth Substances|growth substances|mesh-ancestor
139416696|NCT00299507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416697|NCT00299507|Growth Inhibitors|growth inhibitors|mesh-ancestor
139416698|NCT00299507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416699|NCT00299507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416700|NCT02285309|Enoximone|enoximone|mesh-list
139416701|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139416702|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
139416703|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139416704|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139416705|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416706|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416707|NCT02285309|Protective Agents|protective agents|mesh-ancestor
139416708|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416709|NCT02479880|Tenofovir|tenofovir|mesh-list
139416710|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
139416711|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416712|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139040173|NCT01070745|Ibuprofen|ibuprofen|mesh-list
139416713|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139416714|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651892|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139416715|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416716|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139416717|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139416718|NCT00297401|Ruboxistaurin|ruboxistaurin|mesh-list
139416719|NCT00297401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416720|NCT00297401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416721|NCT00297089|Pemetrexed|pemetrexed|mesh-list
139416722|NCT00297089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416723|NCT00297089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416724|NCT00297089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416725|NCT00297089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139416726|NCT00297089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139416727|NCT00286793|Gossypol acetic acid|gossypol acetic acid|mesh-list
139416728|NCT00286793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139416729|NCT00286793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416730|NCT00286793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139416731|NCT00286793|Contraceptive Agents|contraceptive agents|mesh-ancestor
139416732|NCT00286793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139416733|NCT00286793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416734|NCT00286793|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
139416735|NCT00286793|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
139416736|NCT00286793|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139416737|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
139416738|NCT02285699|Citalopram|citalopram|mesh-list
139416739|NCT02285699|Fluoxetine|fluoxetine|mesh-list
139416740|NCT02285699|Paroxetine|paroxetine|mesh-list
139416741|NCT02285699|Sertraline|sertraline|mesh-list
139416742|NCT02285699|Escitalopram|escitalopram|mesh-list
139416743|NCT02285699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139416744|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139416745|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139416746|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416747|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416748|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
139416749|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416750|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139416751|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
139416752|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139416753|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139416754|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139416755|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416756|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139416757|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139416758|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416759|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139416760|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139416761|NCT02288429|Colistin|colistin|mesh-list
139416762|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139416763|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416764|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
139416765|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139416766|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416767|NCT00265655|Satraplatin|satraplatin|mesh-list
139416768|NCT00265655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416769|NCT00254891|Paclitaxel|paclitaxel|mesh-list
139416770|NCT00254891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139416771|NCT00254891|Carboplatin|carboplatin|mesh-list
139416772|NCT00254891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139416773|NCT00254891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416774|NCT00254891|Tubulin Modulators|tubulin modulators|mesh-ancestor
139416775|NCT00254891|Antimitotic Agents|antimitotic agents|mesh-ancestor
139416776|NCT00254891|Mitosis Modulators|mitosis modulators|mesh-ancestor
139416777|NCT00254891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416778|NCT02479412|Albuterol|albuterol|mesh-list
139416779|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139416780|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
139416781|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416782|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416783|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139416784|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
139416785|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
139416786|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139416787|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138921462|NCT00769184|Hormones|hormones|mesh-ancestor
139651893|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416788|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139416789|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139416790|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
139416791|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416792|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416793|NCT00254579|Tremelimumab|tremelimumab|mesh-list
139416794|NCT00254579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416795|NCT00252005|Apixaban|apixaban|mesh-list
139416796|NCT00252005|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139073632|NCT03739294|Xhance|xhance|mesh-list
139416798|NCT00252005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139416799|NCT00252005|Protease Inhibitors|protease inhibitors|mesh-ancestor
139416800|NCT00252005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416801|NCT00252005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416802|NCT00252005|Anticoagulants|anticoagulants|mesh-ancestor
139416803|NCT02288507|Sorafenib|sorafenib|mesh-list
139416804|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416805|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139416806|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416807|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416808|NCT00231257|Sirolimus|sirolimus|mesh-list
139416809|NCT00231257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139416810|NCT00231257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416811|NCT00231257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139416812|NCT00231257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416813|NCT00231257|Antifungal Agents|antifungal agents|mesh-ancestor
139416814|NCT00231257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139416815|NCT00231257|Immunologic Factors|immunologic factors|mesh-ancestor
139416816|NCT00231257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416817|NCT00224003|Ferric gluconate|ferric gluconate|mesh-list
139416818|NCT00224003|Hematinics|hematinics|mesh-ancestor
139416819|NCT00216593|Galantamine|galantamine|mesh-list
139416820|NCT00216593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139416821|NCT00216593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416822|NCT00216593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416823|NCT00216593|Cholinergic Agents|cholinergic agents|mesh-ancestor
139416824|NCT00216593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416825|NCT00216593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416826|NCT00216593|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139416827|NCT00216593|Autonomic Agents|autonomic agents|mesh-ancestor
139416828|NCT00216593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416829|NCT00216593|Nootropic Agents|nootropic agents|mesh-ancestor
139416830|NCT00389675|Guanfacine|guanfacine|mesh-list
139416831|NCT00389675|Darusentan|darusentan|mesh-list
139416832|NCT00389675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139416833|NCT00389675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139416834|NCT00389675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139416835|NCT00389675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139416836|NCT00389675|Adrenergic Agents|adrenergic agents|mesh-ancestor
139416837|NCT00389675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416838|NCT00389675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416839|NCT00389675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416840|NCT00389675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139416841|NCT02288741|Dexamethasone|dexamethasone|mesh-list
139416842|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
139416843|NCT02288741|Melphalan|melphalan|mesh-list
139416844|NCT02288741|BB 1101|bb 1101|mesh-list
139416845|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416846|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
139416847|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
139416848|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416849|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416850|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139416851|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
139416852|NCT02288741|Hormones|hormones|mesh-ancestor
139416853|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139416854|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139416855|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416856|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
139416857|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416858|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416859|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139416860|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
139416861|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139416862|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139416864|NCT02450552|Ezogabine|ezogabine|mesh-list
139416865|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
139416866|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139416867|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416868|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
139416869|NCT02508428|Diuretics|diuretics|mesh-ancestor
139416870|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
139416871|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416872|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139416873|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139416874|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416875|NCT02448446|Ranibizumab|ranibizumab|mesh-list
139416876|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139416877|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139416878|NCT02448446|Growth Substances|growth substances|mesh-ancestor
139416879|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416880|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
139416881|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416882|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
139416884|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139416885|NCT02478398|Epinephrine|epinephrine|mesh-list
139416886|NCT02478398|Albuterol|albuterol|mesh-list
139416887|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139416888|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139416889|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
139416890|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416891|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416892|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416893|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139416894|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139416895|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
139416896|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416897|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139416898|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
139416899|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
139416900|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
139416901|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139416902|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
139416903|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139416904|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139416905|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416906|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
139416907|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139416908|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
139416909|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139416910|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139416911|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
139416912|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
139416913|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139416914|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139416915|NCT02478398|Analgesics|analgesics|mesh-ancestor
139416916|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
139416917|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139416918|NCT02478164|Ponatinib|ponatinib|mesh-list
139416919|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416920|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139416921|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416922|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416923|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139416924|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139416925|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139416926|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139416927|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
139416928|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139416929|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416930|NCT05259007|Amoxicillin|amoxicillin|mesh-list
139416931|NCT05259007|Clarithromycin|clarithromycin|mesh-list
139416932|NCT05259007|Propolis|propolis|mesh-list
139416933|NCT05259007|Lansoprazole|lansoprazole|mesh-list
139416934|NCT05259007|Dexlansoprazole|dexlansoprazole|mesh-list
139416935|NCT05259007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139416936|NCT05259007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139416937|NCT05259007|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139416938|NCT05259007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651894|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416939|NCT05259007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416940|NCT05259007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139416941|NCT05259007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139416942|NCT05259007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139416943|NCT05259007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139416944|NCT05259007|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139416945|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
139040615|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
139073749|NCT00372593|Immunotoxins|immunotoxins|mesh-ancestor
139416946|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139416947|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416949|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139416950|NCT03472339|Diclofenac|diclofenac|mesh-list
139416951|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139416952|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139416953|NCT03472339|Analgesics|analgesics|mesh-ancestor
139416954|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
139416955|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416956|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416957|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139416958|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139416959|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139416960|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139416961|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416962|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
139416963|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139416964|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139416965|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139416966|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139416967|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416968|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
139416969|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139416970|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416971|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139416972|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416973|NCT03951025|Melatonin|melatonin|mesh-list
139416974|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
139416975|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139416976|NCT03951025|Protective Agents|protective agents|mesh-ancestor
139416977|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416978|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416979|NCT02255500|Bupivacaine|bupivacaine|mesh-list
139416980|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
139416981|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
139416982|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139416983|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416984|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
139416985|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416986|NCT03475693|Acetaminophen|acetaminophen|mesh-list
139416987|NCT03475693|Ondansetron|ondansetron|mesh-list
139416988|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
139416989|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139416990|NCT03475693|Analgesics|analgesics|mesh-ancestor
139416991|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
139416992|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139416993|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139416994|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
139416995|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
139416996|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
139416997|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139416998|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
139416999|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
139417000|NCT03475693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139417001|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139417002|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
139417003|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417004|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417005|NCT03475693|Antacids|antacids|mesh-ancestor
139417006|NCT03475615|Paclitaxel|paclitaxel|mesh-list
139417007|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
139417008|NCT03475615|Tegafur|tegafur|mesh-list
139417009|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139417010|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417011|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
139417012|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
139651895|NCT04803318|Everolimus|everolimus|mesh-list
139417013|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
139417014|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417015|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139417016|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
139417017|NCT03478423|Oxycodone|oxycodone|mesh-list
139417018|NCT03478423|Hydromorphone|hydromorphone|mesh-list
139417019|NCT03478423|Codeine|codeine|mesh-list
139417020|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139417021|NCT03478423|Narcotics|narcotics|mesh-ancestor
139417022|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417023|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417024|NCT03478423|Analgesics|analgesics|mesh-ancestor
139417025|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
139417026|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417027|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
139417028|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
139417029|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
139417030|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417031|NCT03130933|Amoxicillin|amoxicillin|mesh-list
139417032|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139417033|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417034|NCT05155969|Ketamine|ketamine|mesh-list
139417035|NCT05155969|Esketamine|esketamine|mesh-list
139417036|NCT05155969|Analgesics|analgesics|mesh-ancestor
139417037|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
139417038|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417039|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417040|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139417041|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139417042|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
139417043|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
139417044|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417045|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139417046|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139417047|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417048|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417049|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
139417050|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139417051|NCT05112913|Vaccines|vaccines|mesh-list
139417052|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
139417053|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417054|NCT03475459|Melatonin|melatonin|mesh-list
139417055|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
139417056|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417057|NCT03475459|Protective Agents|protective agents|mesh-ancestor
139417058|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417059|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417060|NCT03478111|Infliximab|infliximab|mesh-list
139417061|NCT03478111|Methotrexate|methotrexate|mesh-list
139417062|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139417063|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
139417064|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139417065|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417066|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139417067|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
139417068|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417069|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417070|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
139417071|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417072|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139417073|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139417074|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
139417075|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139417076|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139417077|NCT03478111|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139417078|NCT03478111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139417079|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139417080|NCT03478033|Rifampin|rifampin|mesh-list
139417081|NCT03478033|Rifabutin|rifabutin|mesh-list
139417082|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139417083|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
139417084|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139417085|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417086|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
139417087|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139417088|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417089|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417090|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139417091|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139417092|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139417093|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139417094|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139417095|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139417097|NCT03477955|Trace Elements|trace elements|mesh-ancestor
139417098|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
139417099|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417100|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
139417101|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417102|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139417103|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417104|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417105|NCT05084599|Metaraminol|metaraminol|mesh-list
139417106|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
139417107|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
139417108|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417109|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417110|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139417111|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139417112|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139417113|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139417114|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
139417115|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417116|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417117|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
139417118|NCT02505542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139417119|NCT02505542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139417120|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139417121|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
139417122|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417123|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139417124|NCT00701623|Heparin|heparin|mesh-list
139417125|NCT00701623|Calcium heparin|calcium heparin|mesh-list
139417126|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
139417127|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139417128|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139417129|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417130|NCT04456153|Atovaquone|atovaquone|mesh-list
139417131|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417132|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
139417133|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139417134|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139417135|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417136|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417137|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
139417138|NCT04403971|Listerine|listerine|mesh-list
139417139|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139417140|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417141|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
139417142|NCT02447432|Vaccines|vaccines|mesh-list
139417143|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139417144|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
139417145|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417146|NCT02446886|Hormones|hormones|mesh-list
139417147|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139417148|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139417149|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
139417150|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139040934|NCT00367458|Atorvastatin|atorvastatin|mesh-list
139417151|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417152|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417153|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417154|NCT04351243|Gimsilumab|gimsilumab|mesh-list
139417155|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139417156|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
139417157|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417158|NCT05008003|Vitamin D|vitamin d|mesh-list
139417159|NCT05008003|Cholecalciferol|cholecalciferol|mesh-list
139417160|NCT05008003|Vitamins|vitamins|mesh-ancestor
139417161|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
138921833|NCT04089176|Oxytocin|oxytocin|mesh-list
139417162|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417163|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139417164|NCT05008003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139417165|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
139417166|NCT03475225|Vitamin D|vitamin d|mesh-list
139417167|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139417168|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417169|NCT03475225|Vitamins|vitamins|mesh-ancestor
139417170|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
139417171|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139417172|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139417173|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
139417174|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
139417175|NCT02504294|Hematinics|hematinics|mesh-ancestor
139417176|NCT02446418|Fluticasone|fluticasone|mesh-list
139417178|NCT02446418|Budesonide|budesonide|mesh-list
139417179|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
139417180|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139417181|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139417182|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139417183|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
139417184|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417185|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417186|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139417187|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
139417188|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
139417189|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139417190|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
139417191|NCT02446418|Hormones|hormones|mesh-ancestor
139417192|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139417193|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139417194|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139417195|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139417196|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
139417197|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417198|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417199|NCT04859062|Lidocaine|lidocaine|mesh-list
139417200|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
139417201|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
139417202|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417203|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417204|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
139417205|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417206|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139417207|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139417208|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139417209|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139417210|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417211|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
139417212|NCT01641640|Ribavirin|ribavirin|mesh-list
139417213|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
139417214|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417215|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
139417216|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417217|NCT05650216|Paclitaxel|paclitaxel|mesh-list
139417218|NCT05650216|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139417219|NCT05650216|Carboplatin|carboplatin|mesh-list
139417220|NCT05650216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139417221|NCT05650216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417222|NCT05650216|Tubulin Modulators|tubulin modulators|mesh-ancestor
139417223|NCT05650216|Antimitotic Agents|antimitotic agents|mesh-ancestor
139417224|NCT05650216|Mitosis Modulators|mitosis modulators|mesh-ancestor
139417225|NCT05650216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417226|NCT05369650|Lidocaine|lidocaine|mesh-list
139417227|NCT05369650|Anesthetics, Local|anesthetics, local|mesh-ancestor
139417228|NCT05369650|Anesthetics|anesthetics|mesh-ancestor
139417229|NCT05369650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417230|NCT05369650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417231|NCT05369650|Sensory System Agents|sensory system agents|mesh-ancestor
139417232|NCT05369650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417233|NCT05369650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139417234|NCT05369650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139651896|NCT04803318|Lenvatinib|lenvatinib|mesh-list
139651897|NCT04803318|Trametinib|trametinib|mesh-list
139417235|NCT05369650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139651898|NCT04803318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139417236|NCT05369650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139417237|NCT05369650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041061|NCT00373490|Vorinostat|vorinostat|mesh-list
139417238|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139417239|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139417240|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139417241|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139417242|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417243|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
139417244|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074052|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
139417245|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417246|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139417247|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139417248|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139417249|NCT05069740|Analgesics|analgesics|mesh-ancestor
139417250|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
139417251|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417252|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417253|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139417254|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139417255|NCT01601626|Pyridoxine|pyridoxine|mesh-list
139417256|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
139417257|NCT01601626|Ritonavir|ritonavir|mesh-list
139417258|NCT01601626|Lopinavir|lopinavir|mesh-list
139417259|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
139417260|NCT01601626|Rifampin|rifampin|mesh-list
139417261|NCT01601626|Isoniazid|isoniazid|mesh-list
139417262|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
139417263|NCT01601626|Ethambutol|ethambutol|mesh-list
139417264|NCT01601626|Rifabutin|rifabutin|mesh-list
139417265|NCT01601626|Vitamins|vitamins|mesh-ancestor
139417266|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
139417267|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417268|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139417269|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139417270|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
139417271|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417272|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417273|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139417274|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139417275|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
139417276|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417277|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139417278|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139417279|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
139417280|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139417281|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139417282|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139417283|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
139041174|NCT00348816|Prednisone|prednisone|mesh-list
139417284|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139417285|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
139417286|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139417287|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139417288|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139417289|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139417290|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139417291|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139417292|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139417293|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139417294|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139417295|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
139417296|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139417297|NCT05428150|Pirfenidone|pirfenidone|mesh-list
139417298|NCT05428150|Analgesics|analgesics|mesh-ancestor
139417299|NCT05428150|Sensory System Agents|sensory system agents|mesh-ancestor
139417300|NCT05428150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417301|NCT05428150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417302|NCT05428150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139417303|NCT05428150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139417304|NCT05428150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139417305|NCT05428150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139417306|NCT05428150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417307|NCT02737501|Crizotinib|crizotinib|mesh-list
139417308|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651899|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139417309|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139417310|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417311|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417313|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
139417314|NCT05641480|Donepezil|donepezil|mesh-list
139417315|NCT05641480|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139417316|NCT05641480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417317|NCT05641480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417318|NCT05641480|Cholinergic Agents|cholinergic agents|mesh-ancestor
139417319|NCT05641480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417320|NCT05641480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417321|NCT05641480|Nootropic Agents|nootropic agents|mesh-ancestor
139417322|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139417323|NCT03377803|Cantharidin|cantharidin|mesh-list
139417324|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417325|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417326|NCT03471325|Methamphetamine|methamphetamine|mesh-list
139417327|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139417328|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417329|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
139417330|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
139417331|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417332|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
139417333|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417334|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417335|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
139417336|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139417337|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139417338|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139041261|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139417339|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139417340|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
139417341|NCT04844164|Vitamin D|vitamin d|mesh-list
139417342|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139417343|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417344|NCT04844164|Vitamins|vitamins|mesh-ancestor
139417345|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
139417346|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139417347|NCT05392972|Anesthetics|anesthetics|mesh-list
139417348|NCT05392972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417349|NCT05392972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417350|NCT03474601|Hormones|hormones|mesh-list
139417351|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139417352|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417353|NCT04984798|Vitamin E|vitamin e|mesh-list
139417354|NCT04984798|Tocopherols|tocopherols|mesh-list
139417355|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
139417356|NCT04984798|Vitamins|vitamins|mesh-ancestor
139417357|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
139417358|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417359|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
139417360|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417361|NCT04984798|Protective Agents|protective agents|mesh-ancestor
139417362|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
139417363|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139417364|NCT02230163|Antibodies|antibodies|mesh-list
139417365|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
139417366|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417367|NCT02230319|Paclitaxel|paclitaxel|mesh-list
139417368|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139417369|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417370|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
139417371|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
139417372|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
139417373|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417374|NCT00135395|Ritonavir|ritonavir|mesh-list
139417375|NCT00135395|Lopinavir|lopinavir|mesh-list
139417376|NCT00135395|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139417377|NCT00135395|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139417378|NCT00135395|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139417379|NCT00135395|Protease Inhibitors|protease inhibitors|mesh-ancestor
139417380|NCT00135395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417381|NCT00135395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417382|NCT00135395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139651900|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417383|NCT00135395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139417384|NCT00135395|Antiviral Agents|antiviral agents|mesh-ancestor
139417385|NCT00135395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417386|NCT00135395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139417387|NCT00135395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139417388|NCT02230553|Lapatinib|lapatinib|mesh-list
139417389|NCT02230553|Trametinib|trametinib|mesh-list
139417390|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417391|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139417392|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417393|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417394|NCT04261049|Triamcinolone|triamcinolone|mesh-list
139417395|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139074204|NCT00116649|Imiquimod|imiquimod|mesh-list
139417396|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139417397|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139417398|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139417399|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
139417400|NCT04261049|Hormones|hormones|mesh-ancestor
139417401|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139417402|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417403|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139417404|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
139417405|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417406|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417407|NCT00057473|Carboplatin|carboplatin|mesh-list
139417408|NCT00057473|Irinotecan|irinotecan|mesh-list
139417409|NCT00057473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417410|NCT00057473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139417411|NCT00057473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139417412|NCT00057473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417413|NCT00057473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417414|NCT00035789|Entecavir|entecavir|mesh-list
139417415|NCT00035789|Antiviral Agents|antiviral agents|mesh-ancestor
139417416|NCT00035789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417417|NCT00035633|Entecavir|entecavir|mesh-list
139417418|NCT00035633|Antiviral Agents|antiviral agents|mesh-ancestor
139417419|NCT00035633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417420|NCT00028301|Ritonavir|ritonavir|mesh-list
139417421|NCT00028301|Lopinavir|lopinavir|mesh-list
139417422|NCT00028301|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139417423|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139417424|NCT00028301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139417425|NCT00028301|Protease Inhibitors|protease inhibitors|mesh-ancestor
139417426|NCT00028301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417427|NCT00028301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417428|NCT00028301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139417429|NCT00028301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139417430|NCT00028301|Antiviral Agents|antiviral agents|mesh-ancestor
139417431|NCT00028301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417432|NCT00028301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139417433|NCT00028301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139417434|NCT00028067|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139417435|NCT00028067|Nelfinavir|nelfinavir|mesh-list
139417436|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139417437|NCT00028067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139417438|NCT00028067|Protease Inhibitors|protease inhibitors|mesh-ancestor
139417439|NCT00028067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417440|NCT00028067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417441|NCT00028067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139417442|NCT00028067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139417443|NCT00028067|Antiviral Agents|antiviral agents|mesh-ancestor
139417444|NCT00028067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417445|NCT00005795|Arsenic Trioxide|arsenic trioxide|mesh-list
139417446|NCT00005795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417447|NCT00004907|Cyclophosphamide|cyclophosphamide|mesh-list
139417448|NCT00004907|Busulfan|busulfan|mesh-list
139417449|NCT00004907|Etoposide|etoposide|mesh-list
139417450|NCT00004907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139417451|NCT00004907|Immunologic Factors|immunologic factors|mesh-ancestor
139417452|NCT00004907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417453|NCT00004907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139417454|NCT00004907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139417455|NCT00004907|Alkylating Agents|alkylating agents|mesh-ancestor
139041430|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417456|NCT00004907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417457|NCT00004907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417458|NCT00004907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139417459|NCT00004907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139417460|NCT00004907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139417461|NCT00004907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139417462|NCT00004907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417463|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
139417464|NCT04469777|Hematinics|hematinics|mesh-ancestor
139417465|NCT00004895|Octreotide|octreotide|mesh-list
139417466|NCT00004895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139417467|NCT00004895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139417468|NCT00004895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417469|NCT00004181|Cyclophosphamide|cyclophosphamide|mesh-list
139417470|NCT00004181|Busulfan|busulfan|mesh-list
139417471|NCT00004181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139074280|NCT03599362|Nivolumab|nivolumab|mesh-list
139417472|NCT00004181|Immunologic Factors|immunologic factors|mesh-ancestor
139417473|NCT00004181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417474|NCT00004181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139417475|NCT00004181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139417476|NCT00004181|Alkylating Agents|alkylating agents|mesh-ancestor
139417477|NCT00004181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417478|NCT00004181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417479|NCT00004181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139417480|NCT00004175|Cyclophosphamide|cyclophosphamide|mesh-list
139417481|NCT00004175|Docetaxel|docetaxel|mesh-list
139417482|NCT00004175|Doxorubicin|doxorubicin|mesh-list
139417483|NCT00004175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139417484|NCT00004175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139417485|NCT00004175|Immunologic Factors|immunologic factors|mesh-ancestor
139417486|NCT00004175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417487|NCT00004175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139417488|NCT00004175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139417489|NCT00004175|Alkylating Agents|alkylating agents|mesh-ancestor
139417490|NCT00004175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417491|NCT00004175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417492|NCT00004175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139417493|NCT00004175|Tubulin Modulators|tubulin modulators|mesh-ancestor
139417494|NCT00004175|Antimitotic Agents|antimitotic agents|mesh-ancestor
139417495|NCT00004175|Mitosis Modulators|mitosis modulators|mesh-ancestor
139417496|NCT00004175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139417497|NCT00004175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139417498|NCT00004175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139417499|NCT00004175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417500|NCT05708573|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139417501|NCT05708573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139417502|NCT05708573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139417503|NCT05708573|Antimetabolites|antimetabolites|mesh-ancestor
139417504|NCT05708573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417505|NCT05708573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139417506|NCT05708573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139417507|NCT05708573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417508|NCT00004169|Cyclophosphamide|cyclophosphamide|mesh-list
139417509|NCT00004169|Carboplatin|carboplatin|mesh-list
139417510|NCT00004169|Etoposide|etoposide|mesh-list
139417511|NCT00004169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139417512|NCT00004169|Immunologic Factors|immunologic factors|mesh-ancestor
139417513|NCT00004169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417514|NCT00004169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139417515|NCT00004169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139417516|NCT00004169|Alkylating Agents|alkylating agents|mesh-ancestor
139417517|NCT00004169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041527|NCT00392990|Cytarabine|cytarabine|mesh-list
139417518|NCT00004169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417519|NCT00004169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139417520|NCT00004169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139417521|NCT00004169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139417522|NCT00004169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139417523|NCT00004169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417524|NCT00002429|Lamivudine|lamivudine|mesh-list
139417525|NCT00002429|Zidovudine|zidovudine|mesh-list
139417526|NCT00002429|Stavudine|stavudine|mesh-list
139417527|NCT00002429|Didanosine|didanosine|mesh-list
139417528|NCT00002429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139417529|NCT00002429|Nelfinavir|nelfinavir|mesh-list
139417530|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139417531|NCT00002429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139651901|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651902|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139651903|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
139417532|NCT00002429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417533|NCT00002429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417534|NCT00002429|Antiviral Agents|antiviral agents|mesh-ancestor
139417535|NCT00002429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417536|NCT00002429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139417537|NCT00002429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139417538|NCT00002429|Antimetabolites|antimetabolites|mesh-ancestor
139417539|NCT00002429|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139417540|NCT00002429|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139417541|NCT00002429|Protease Inhibitors|protease inhibitors|mesh-ancestor
139417542|NCT00002411|Lamivudine|lamivudine|mesh-list
139417543|NCT00002411|Zidovudine|zidovudine|mesh-list
139417544|NCT00002411|Stavudine|stavudine|mesh-list
139417545|NCT00002411|Didanosine|didanosine|mesh-list
139417546|NCT00002411|Nelfinavir|nelfinavir|mesh-list
139417547|NCT00002411|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139417548|NCT00002411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139417550|NCT00002411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417551|NCT00002411|Antiviral Agents|antiviral agents|mesh-ancestor
139417552|NCT00002411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417553|NCT00002411|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139417554|NCT00002411|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139417555|NCT00002411|Antimetabolites|antimetabolites|mesh-ancestor
139417556|NCT00002411|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139417557|NCT00002411|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139417558|NCT00002411|Protease Inhibitors|protease inhibitors|mesh-ancestor
139417559|NCT03530033|Lidocaine|lidocaine|mesh-list
139417560|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
139417561|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
139417562|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417563|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417564|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
139417565|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417566|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139041612|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
139417567|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139417568|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139417569|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139417570|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417571|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
139417572|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139417573|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417574|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417575|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139417576|NCT03529643|Analgesics|analgesics|mesh-ancestor
139417577|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
139417578|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417579|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139417580|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139417581|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139417582|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
139417583|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417584|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417585|NCT03529331|Acetaminophen|acetaminophen|mesh-list
139041669|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139417586|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139417587|NCT03529331|Morphine|morphine|mesh-list
139417588|NCT03529331|Oxycodone|oxycodone|mesh-list
139417589|NCT03529331|Hydrocodone|hydrocodone|mesh-list
139417590|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139417591|NCT03529331|Narcotics|narcotics|mesh-ancestor
139417592|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417593|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417594|NCT03529331|Analgesics|analgesics|mesh-ancestor
139417595|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
139417596|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417597|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139417598|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
139417599|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
139417600|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
139417601|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139417602|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139417603|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139417604|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139417605|NCT03529253|Alirocumab|alirocumab|mesh-list
139417606|NCT03529253|Calcium|calcium|mesh-list
139417607|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139417608|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417609|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139417610|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139417611|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
139417612|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417613|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139417614|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139417615|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417616|NCT03529253|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139417617|NCT03529253|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139417618|NCT03529253|Protease Inhibitors|protease inhibitors|mesh-ancestor
139417619|NCT03529175|Paclitaxel|paclitaxel|mesh-list
139417620|NCT03529175|Gemcitabine|gemcitabine|mesh-list
139417621|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139074424|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139417622|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139417623|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417624|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
139417625|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
139417626|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
139417627|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417628|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139417629|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
139417630|NCT00002207|Stavudine|stavudine|mesh-list
139417631|NCT00002207|Didanosine|didanosine|mesh-list
139417632|NCT00002207|Antimetabolites|antimetabolites|mesh-ancestor
139417633|NCT00002207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417634|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139417635|NCT00002207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139417636|NCT00002207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417637|NCT00002207|Antiviral Agents|antiviral agents|mesh-ancestor
139417638|NCT00002207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417639|NCT00002207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139417640|NCT00002207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139417641|NCT03529097|Dipyrone|dipyrone|mesh-list
139417642|NCT03529097|Diclofenac|diclofenac|mesh-list
139417643|NCT03529097|Morphine|morphine|mesh-list
139417644|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139417645|NCT03529097|Narcotics|narcotics|mesh-ancestor
139417646|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417647|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417648|NCT03529097|Analgesics|analgesics|mesh-ancestor
139417649|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
139417650|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417651|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139417652|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139417653|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139417654|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139417655|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139417656|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417657|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417658|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
139417659|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
139417660|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
139417661|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417662|NCT03531749|Protective Agents|protective agents|mesh-ancestor
139417663|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417664|NCT03531749|Vitamins|vitamins|mesh-ancestor
139417665|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
139417666|NCT03528785|Leucovorin|leucovorin|mesh-list
139417667|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
139417668|NCT03528785|Irinotecan|irinotecan|mesh-list
139417669|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
139417670|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417671|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139417672|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139417673|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417674|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417675|NCT03528785|Antidotes|antidotes|mesh-ancestor
139417676|NCT03528785|Protective Agents|protective agents|mesh-ancestor
139417677|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417678|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
139417679|NCT03528785|Vitamins|vitamins|mesh-ancestor
139417680|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
139417681|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139417682|NCT03531437|Gestodene|gestodene|mesh-list
139417683|NCT03531437|Estradiol|estradiol|mesh-list
139417684|NCT03531437|Estrogens|estrogens|mesh-ancestor
139417685|NCT03531437|Hormones|hormones|mesh-ancestor
139417686|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139417687|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417688|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139417689|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
139417690|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139417691|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139417692|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139417693|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139417694|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139417695|NCT03531437|Progestins|progestins|mesh-ancestor
139417696|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
139417697|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139417698|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
139417699|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417700|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417701|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139417702|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
139417703|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139417704|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
139417705|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417706|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417707|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139417708|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
139417709|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
139417710|NCT03527381|Protective Agents|protective agents|mesh-ancestor
139417711|NCT04441385|Maraviroc|maraviroc|mesh-list
139417712|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139417713|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139417714|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417715|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139417716|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139417717|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
139417718|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417719|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139417720|NCT03531359|Midazolam|midazolam|mesh-list
139417721|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139417722|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139417723|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417724|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417725|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139417726|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139417727|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139417728|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139417729|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
139417730|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
139417731|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
139417732|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
139417733|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417734|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417735|NCT03531281|Sirolimus|sirolimus|mesh-list
139417736|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
139417737|NCT03531281|Etoposide|etoposide|mesh-list
139417738|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
139417739|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
139417740|NCT03531281|Tacrolimus|tacrolimus|mesh-list
139417741|NCT03531281|Mitogens|mitogens|mesh-list
139417742|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139417743|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
139417744|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417745|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139417746|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139417747|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
139417748|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417749|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417750|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139417751|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139417752|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139417753|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139417754|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417755|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139417756|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139651904|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417757|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651905|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417758|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139417759|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
139417760|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
139417761|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
139417762|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
139417763|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
139417764|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
139417765|NCT04468685|Ondansetron|ondansetron|mesh-list
139417766|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
139417767|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
139417768|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417769|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417770|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139417771|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
139417772|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
139417773|NCT04468685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139417774|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139417775|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
139417776|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417777|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417778|NCT03531047|Riboflavin|riboflavin|mesh-list
139417779|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
139417780|NCT03531047|Vitamins|vitamins|mesh-ancestor
139417781|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
139417782|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417783|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139041937|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139417784|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
139417785|NCT04440917|Apatinib|apatinib|mesh-list
139417786|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139417787|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417788|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139417789|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417790|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417791|NCT04440917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139417792|NCT05455931|Mogamulizumab|mogamulizumab|mesh-list
139417793|NCT05455931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417794|NCT04468139|Quercetin|quercetin|mesh-list
139417795|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417796|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
139417797|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417798|NCT04468139|Protective Agents|protective agents|mesh-ancestor
139417799|NCT03526445|Glucagon|glucagon|mesh-list
139417800|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139417801|NCT03526445|Hormones|hormones|mesh-ancestor
139417802|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139417803|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417804|NCT04939649|Midazolam|midazolam|mesh-list
139417805|NCT04939649|Ketamine|ketamine|mesh-list
139417806|NCT04939649|Analgesics|analgesics|mesh-ancestor
139417807|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
139417808|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417809|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417810|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139417811|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139417812|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
139417813|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
139417814|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417815|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139417816|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139417817|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417818|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417819|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139417820|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139417821|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139417822|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139417823|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139417824|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
139417825|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
139417826|NCT04927949|Cangrelor|cangrelor|mesh-list
139417827|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139417828|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139417829|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139417830|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139417831|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
139417832|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417833|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417834|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417836|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139417837|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417838|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139417839|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139417840|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139417841|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139417842|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
139417843|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417844|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139417845|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139417846|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417847|NCT04467983|Denosumab|denosumab|mesh-list
139417848|NCT04467983|Abaloparatide|abaloparatide|mesh-list
139417849|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139417850|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417851|NCT04839731|Fluorouracil|fluorouracil|mesh-list
139417852|NCT04839731|Calcipotriene|calcipotriene|mesh-list
139417853|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
139417854|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417855|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139417856|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417857|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139417858|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
139417859|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417860|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
139417861|NCT03525509|Morphine|morphine|mesh-list
139417862|NCT03525509|Methadone|methadone|mesh-list
139417863|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139417864|NCT03525509|Narcotics|narcotics|mesh-ancestor
139417865|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417866|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417867|NCT03525509|Analgesics|analgesics|mesh-ancestor
139417868|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
139417869|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417870|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
139417871|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
139417872|NCT04699721|Paclitaxel|paclitaxel|mesh-list
139417873|NCT04699721|Carboplatin|carboplatin|mesh-list
139417874|NCT04699721|Nivolumab|nivolumab|mesh-list
139417875|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139417876|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417877|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
139417878|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
139417879|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
139417880|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417881|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139417882|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139417883|NCT03525821|Ketamine|ketamine|mesh-list
139417884|NCT03525821|Analgesics|analgesics|mesh-ancestor
139417885|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
139417886|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417887|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417888|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139417889|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139417890|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
139417891|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
139417892|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417893|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139417894|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139417895|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417896|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417897|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
139417898|NCT04221035|Temozolomide|temozolomide|mesh-list
139417899|NCT04221035|Melphalan|melphalan|mesh-list
139417900|NCT04221035|Busulfan|busulfan|mesh-list
139417901|NCT04221035|Ifosfamide|ifosfamide|mesh-list
139417902|NCT04221035|Thiotepa|thiotepa|mesh-list
139417903|NCT04221035|Dacarbazine|dacarbazine|mesh-list
139042076|NCT00390416|Vitamins|vitamins|mesh-ancestor
139417904|NCT04221035|Carboplatin|carboplatin|mesh-list
139417905|NCT04221035|Doxorubicin|doxorubicin|mesh-list
139417906|NCT04221035|Irinotecan|irinotecan|mesh-list
139417907|NCT04221035|Etoposide|etoposide|mesh-list
139417908|NCT04221035|Vincristine|vincristine|mesh-list
139417909|NCT04221035|Vindesine|vindesine|mesh-list
139417910|NCT04221035|Dinutuximab|dinutuximab|mesh-list
139417911|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139417912|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
139417913|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417914|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139417915|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139417916|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
139417917|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417918|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417919|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139417920|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139417921|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139417922|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139417923|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417924|NCT04221035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139417925|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139417926|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
139417927|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
139417928|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
139417929|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
139417930|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139417931|NCT04842682|Diazepam|diazepam|mesh-list
139417932|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139417933|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
139417934|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
139417935|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
139417936|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417937|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417938|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139417939|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139417940|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139417941|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139417942|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139417943|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139417944|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139417945|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139417946|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139417947|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
139417948|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
139417949|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
139417950|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
139417951|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417952|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417953|NCT04890106|Bimatoprost|bimatoprost|mesh-list
139417954|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139417955|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139417956|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139417957|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139417958|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139417959|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139417960|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417961|NCT05198362|Metoprolol|metoprolol|mesh-list
139417962|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139417963|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139417964|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
139417965|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
139417966|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139417967|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417968|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139417969|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139417970|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139417971|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
139417972|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139417973|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417974|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
139417975|NCT04810156|Prednisone|prednisone|mesh-list
139417976|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
139417977|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139417978|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139417979|NCT04810156|Prednisolone|prednisolone|mesh-list
139417980|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
139417981|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139417982|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139417983|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
139417984|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139417985|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
139417986|NCT04810156|Hormones|hormones|mesh-ancestor
139417987|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139417988|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139417989|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139417990|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139417991|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139417992|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139417993|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
139417994|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139417995|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139417996|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139417997|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139417998|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
139417999|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
139418000|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418001|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139418002|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139074810|NCT01084473|Morphine|morphine|mesh-list
139418003|NCT04810156|Protective Agents|protective agents|mesh-ancestor
139418004|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139418005|NCT04837924|Acetaminophen|acetaminophen|mesh-list
139418006|NCT04837924|Tramadol|tramadol|mesh-list
139418007|NCT04837924|Analgesics|analgesics|mesh-list
139418008|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
139418009|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139418010|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
139418011|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418012|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418013|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
139418014|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139418015|NCT04837924|Narcotics|narcotics|mesh-ancestor
139418016|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139418017|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
139418018|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
139418019|NCT05406466|Lenvatinib|lenvatinib|mesh-list
139418020|NCT05406466|Tislelizumab|tislelizumab|mesh-list
139418021|NCT05406466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418022|NCT05406466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139418023|NCT05406466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418024|NCT05406466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418025|NCT05406466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139418026|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
139418027|NCT05152420|Apixaban|apixaban|mesh-list
139418028|NCT05152420|Edoxaban|edoxaban|mesh-list
139418029|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139418030|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
139418031|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139418032|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
139418033|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418034|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418035|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
139418036|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
139418037|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139418038|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
139418039|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139418040|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139418041|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418042|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418043|NCT01601470|Urological Agents|urological agents|mesh-ancestor
139418044|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139418045|NCT04418908|Cetrorelix|cetrorelix|mesh-list
139418046|NCT04418908|Estradiol|estradiol|mesh-list
139418047|NCT04418908|Estrogens|estrogens|mesh-ancestor
139418048|NCT04418908|Hormones|hormones|mesh-ancestor
139418049|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139418050|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418051|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139418052|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139418053|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
139418054|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
139418055|NCT04831450|Cemiplimab|cemiplimab|mesh-list
139418056|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139418057|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418058|NCT04830982|Diazoxide|diazoxide|mesh-list
139651906|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
139651907|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139651908|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
139418059|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139418060|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
139418061|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
139418062|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418063|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
139418064|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139418065|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418066|NCT04508140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139418067|NCT04508140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418068|NCT04820452|Aflibercept|aflibercept|mesh-list
139418069|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139418070|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139418071|NCT04820452|Growth Substances|growth substances|mesh-ancestor
139418072|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418073|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
139418074|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418075|NCT01637272|Pasireotide|pasireotide|mesh-list
139418076|NCT01637272|Hormones|hormones|mesh-ancestor
139418077|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139418078|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418079|NCT03178864|Heparin|heparin|mesh-list
139418080|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
139418081|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
139418082|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139418083|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139418084|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418085|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139418086|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
139418087|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139418088|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
139418089|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418090|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139418091|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
139418092|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418093|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
139418094|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418095|NCT05309902|Moxifloxacin|moxifloxacin|mesh-list
139418096|NCT05309902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139418097|NCT05309902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418098|NCT05309902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139418099|NCT05309902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139418100|NCT05309902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418101|NCT05309902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418102|NCT05309902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418104|NCT02987686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139418105|NCT02987686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139418106|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
139418107|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139418108|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139418109|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
139418110|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139418111|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
139418112|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139418113|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
139418114|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418115|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418116|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
139418117|NCT05277922|Nitroprusside|nitroprusside|mesh-list
139418118|NCT05277922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139418119|NCT05277922|Vasodilator Agents|vasodilator agents|mesh-ancestor
139418120|NCT05277922|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139418121|NCT05277922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418122|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
139418123|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
139418124|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139418125|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139418126|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418127|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418128|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418129|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139418130|NCT04194424|Metformin|metformin|mesh-list
139418131|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139418132|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418133|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
139418134|NCT02473640|Esomeprazole|esomeprazole|mesh-list
139418135|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139651909|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418136|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139418137|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139418138|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418139|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418140|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139418141|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418142|NCT01637584|Prazosin|prazosin|mesh-list
139418143|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139418144|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139418145|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139418146|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139418147|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
139418148|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418149|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418150|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418151|NCT02502734|Fluticasone|fluticasone|mesh-list
139074959|NCT03586726|Rifampin|rifampin|mesh-list
139418152|NCT02502734|Xhance|xhance|mesh-list
139418153|NCT02502734|Albuterol|albuterol|mesh-list
139418154|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139418155|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139418156|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
139418157|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418158|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418159|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139418160|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
139418161|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
139418162|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139418163|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
139418164|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139418165|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139418166|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139418167|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139418168|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
139418169|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418170|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418171|NCT04193878|Budesonide|budesonide|mesh-list
139418172|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
139418173|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139418174|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139418175|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
139418176|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418177|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418178|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139418179|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
139418180|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
139418181|NCT04193878|Hormones|hormones|mesh-ancestor
139418182|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139418183|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139418184|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139418185|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139418186|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
139418187|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418188|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418189|NCT02473250|Fluoxetine|fluoxetine|mesh-list
139418190|NCT02473250|Citalopram|citalopram|mesh-list
139418191|NCT02473250|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139418192|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139418193|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139418194|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418195|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418196|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
139418197|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418198|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139418199|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
139418200|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139418201|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139418202|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139418203|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418204|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139418205|NCT04253626|Hematinics|hematinics|mesh-ancestor
139418206|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139651910|NCT04803162|Omeprazole|omeprazole|mesh-list
139651911|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139418207|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139418208|NCT03840148|Meropenem|meropenem|mesh-list
139418209|NCT03840148|Cefepime|cefepime|mesh-list
139418210|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139418211|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418212|NCT04821778|Paclitaxel|paclitaxel|mesh-list
139418213|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
139418214|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139418215|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418216|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
139418217|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
139418218|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
139418219|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418220|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139418221|NCT02611024|Irinotecan|irinotecan|mesh-list
139418222|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139418223|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139418224|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418225|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042466|NCT03966118|Paclitaxel|paclitaxel|mesh-list
139418226|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418227|NCT02500706|Insulin|insulin|mesh-list
139418228|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139418229|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
139418230|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
139418231|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139418232|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139418233|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418234|NCT04201496|Empagliflozin|empagliflozin|mesh-list
139418235|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139418236|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418237|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139418238|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418239|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
139418240|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
139418241|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139418242|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139418243|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418244|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418245|NCT04797286|Urological Agents|urological agents|mesh-ancestor
139418246|NCT03682276|Nivolumab|nivolumab|mesh-list
139418247|NCT03682276|Ipilimumab|ipilimumab|mesh-list
139418248|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139418249|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418250|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139418251|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418252|NCT02499770|Carboplatin|carboplatin|mesh-list
139418253|NCT02499770|Etoposide|etoposide|mesh-list
139418254|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418255|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139418256|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139418257|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139418258|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418259|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418260|NCT04418674|Fentanyl|fentanyl|mesh-list
139418261|NCT04418674|Ketamine|ketamine|mesh-list
139418262|NCT04418674|Analgesics|analgesics|mesh-ancestor
139418263|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
139042574|NCT00127192|Incretins|incretins|mesh-ancestor
139418264|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418265|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418266|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139418267|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139418268|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
139418269|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
139418270|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139418271|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139418272|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139418273|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418274|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418275|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139418276|NCT04418674|Narcotics|narcotics|mesh-ancestor
139418277|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139418278|NCT02442284|Ritonavir|ritonavir|mesh-list
139418279|NCT02442284|Ribavirin|ribavirin|mesh-list
139418280|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139418281|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139418282|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
139418283|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418284|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418285|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139418286|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139418287|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
139418288|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418289|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139418290|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139418291|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
139418292|NCT03781960|Nivolumab|nivolumab|mesh-list
139418293|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139418294|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418295|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139418296|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418297|NCT02499146|Letrozole|letrozole|mesh-list
139418298|NCT02499146|Palbociclib|palbociclib|mesh-list
139418299|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418300|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139418301|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139418302|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418303|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418304|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139418305|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
139418306|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139418307|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418308|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139418309|NCT01634854|Misoprostol|misoprostol|mesh-list
139418310|NCT01634854|Oxytocin|oxytocin|mesh-list
139418311|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
139418312|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139418313|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418314|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139418315|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
139418316|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139418317|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139418318|NCT05651464|Vancomycin|vancomycin|mesh-list
139042675|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
139418319|NCT05651464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139418320|NCT05651464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418321|NCT02441114|Fluticasone|fluticasone|mesh-list
139418322|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
139418323|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139418324|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139418325|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139418326|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139418327|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
139418328|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418329|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418330|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139418331|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
139418332|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
139418333|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139418334|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
139418335|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139418336|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
139418337|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418338|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418339|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139418340|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139418341|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139418342|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
139418343|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
139418344|NCT02441114|Hormones|hormones|mesh-ancestor
139418345|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139418346|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
139418347|NCT02498444|Treprostinil|treprostinil|mesh-list
139418348|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139418349|NCT05235256|Dexamethasone|dexamethasone|mesh-list
139418350|NCT05235256|Lidocaine|lidocaine|mesh-list
139651912|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139651913|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139651914|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651915|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418351|NCT05235256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139140206|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139651916|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139651917|NCT02999217|Hematinics|hematinics|mesh-ancestor
139651918|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139651919|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139651920|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
139651921|NCT02980965|Docetaxel|docetaxel|mesh-list
139651922|NCT02980965|Fluorouracil|fluorouracil|mesh-list
139651923|NCT02980965|Letrozole|letrozole|mesh-list
139651924|NCT02980965|Epirubicin|epirubicin|mesh-list
139651925|NCT02980965|Leuprolide|leuprolide|mesh-list
139651926|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139651927|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
139651928|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651929|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139651930|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139651931|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
139651932|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651933|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139651934|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139651935|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
139651936|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
139651937|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
139651938|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
139651939|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139651940|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139651941|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139651942|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139651943|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139651944|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
139651945|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139651946|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139651947|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139651948|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139651949|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139651950|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
139651951|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139651952|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139651953|NCT01538745|Ketamine|ketamine|mesh-list
139651954|NCT01538745|Morphine|morphine|mesh-list
139651955|NCT01538745|Analgesics|analgesics|mesh-ancestor
139651956|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
139651957|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139651958|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651959|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139651960|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139651961|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
139651962|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
139651963|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139651964|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139651965|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139651966|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139651967|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651968|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139651969|NCT01538745|Narcotics|narcotics|mesh-ancestor
139651970|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
139651971|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139651972|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
139651973|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651974|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
139651975|NCT04803240|Protective Agents|protective agents|mesh-ancestor
139651976|NCT01539135|Methylene Blue|methylene blue|mesh-list
139651977|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042798|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
139651978|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651979|NCT04426578|Perhexiline|perhexiline|mesh-list
139651980|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139651981|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139651982|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651983|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139651984|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139651985|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
139651986|NCT04802928|Isoniazid|isoniazid|mesh-list
139651987|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
139651988|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139651989|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139651990|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139651991|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139651992|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
139651993|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139651994|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139651996|NCT05365425|Policosanol|policosanol|mesh-list
139651997|NCT05365425|Fenofibrate|fenofibrate|mesh-list
139651998|NCT05365425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139651999|NCT05365425|Antimetabolites|antimetabolites|mesh-ancestor
139652000|NCT05365425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652001|NCT05365425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139652002|NCT05365425|Lipotropic Agents|lipotropic agents|mesh-ancestor
139652003|NCT05365425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139652004|NCT05365425|Nootropic Agents|nootropic agents|mesh-ancestor
139652005|NCT05365425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139652006|NCT05365425|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139652007|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139652008|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652009|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139652010|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652011|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652012|NCT04794738|Morphine|morphine|mesh-list
139652013|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139652014|NCT04794738|Narcotics|narcotics|mesh-ancestor
139652015|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652016|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652017|NCT04794738|Analgesics|analgesics|mesh-ancestor
139652018|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
139652019|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652020|NCT04794426|Fluorides|fluorides|mesh-list
139652021|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
139652022|NCT04794426|Protective Agents|protective agents|mesh-ancestor
139652023|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652024|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139652025|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139652026|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652027|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652028|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139652029|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139652030|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652031|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
139652032|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652033|NCT05073315|Adalimumab|adalimumab|mesh-list
139652034|NCT05073315|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139652035|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139652036|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139652037|NCT02591238|Melatonin|melatonin|mesh-list
139652038|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
139652039|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652040|NCT02591238|Protective Agents|protective agents|mesh-ancestor
139652041|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652042|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652043|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
139652044|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139652045|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
139652046|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652047|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652048|NCT04793256|Listerine|listerine|mesh-list
139652049|NCT04793256|Fluorides|fluorides|mesh-list
139652050|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
139652051|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
139652052|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
139652053|NCT04793256|Protective Agents|protective agents|mesh-ancestor
139652054|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652055|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139652056|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652057|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139652058|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
139652059|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139652060|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139652061|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139652062|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652063|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652064|NCT04792710|Metronidazole|metronidazole|mesh-list
139418352|NCT05235256|Antiemetics|antiemetics|mesh-ancestor
139418353|NCT05235256|Autonomic Agents|autonomic agents|mesh-ancestor
139652065|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652066|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139652067|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139652068|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139652069|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139652070|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139652071|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652072|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652073|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139652074|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139652075|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652076|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
139652077|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652079|NCT03004209|Hematinics|hematinics|mesh-ancestor
139652080|NCT04800978|Durvalumab|durvalumab|mesh-list
139652081|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139652082|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652083|NCT04791774|Caseins|caseins|mesh-list
139652084|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
139652085|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
139652086|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652087|NCT00183469|Lamotrigine|lamotrigine|mesh-list
139652088|NCT00183469|Valproic Acid|valproic acid|mesh-list
139652089|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
139652090|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139652091|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139652092|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652093|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139652094|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652095|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139652096|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139652097|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652098|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139652099|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139652100|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652101|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
139652102|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652103|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
139652104|NCT02248155|Pramipexole|pramipexole|mesh-list
139652105|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
139652106|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652107|NCT02248155|Protective Agents|protective agents|mesh-ancestor
139652108|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652109|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139652110|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139652111|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
139652112|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
139652113|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652114|NCT02597946|Paclitaxel|paclitaxel|mesh-list
139652115|NCT02597946|Afatinib|afatinib|mesh-list
139043047|NCT00384956|Azacitidine|azacitidine|mesh-list
139652116|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139652117|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652118|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
139652119|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
139652120|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
139652121|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652122|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139652123|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652124|NCT02248233|Nimodipine|nimodipine|mesh-list
139652125|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139652126|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
139652127|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139652128|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139652129|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139652130|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652131|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139652132|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652133|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
139652134|NCT04790838|Fluticasone|fluticasone|mesh-list
139652135|NCT04790838|Xhance|xhance|mesh-list
139652136|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139652137|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139140354|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
139652138|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139043081|NCT00526799|Sorafenib|sorafenib|mesh-list
139652139|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139652140|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
139652141|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652142|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652143|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139652144|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
139652145|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
139652146|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139652147|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139652148|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139652149|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139652150|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
139652151|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652152|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652153|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
139652154|NCT04790838|Hormones|hormones|mesh-ancestor
139652155|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139652156|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
139043135|NCT01259648|Analgesics|analgesics|mesh-ancestor
139652157|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139652158|NCT03003273|Amoxicillin|amoxicillin|mesh-list
139652159|NCT03003273|Levofloxacin|levofloxacin|mesh-list
139652160|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
139652161|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
139652162|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652163|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139652164|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139652165|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139652166|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652167|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652168|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652169|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139652170|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139652171|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139652172|NCT05571345|Oxycodone|oxycodone|mesh-list
139652173|NCT05571345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139652174|NCT05571345|Narcotics|narcotics|mesh-ancestor
139652175|NCT05571345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652176|NCT05571345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652177|NCT05571345|Analgesics|analgesics|mesh-ancestor
139652178|NCT05571345|Sensory System Agents|sensory system agents|mesh-ancestor
139652179|NCT05571345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652180|NCT02981121|Metformin|metformin|mesh-list
139652181|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139652182|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652183|NCT02597478|Fentanyl|fentanyl|mesh-list
139652184|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139652185|NCT02597478|Narcotics|narcotics|mesh-ancestor
139652186|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652187|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652188|NCT02597478|Analgesics|analgesics|mesh-ancestor
139652189|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
139652190|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652191|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139652192|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139652193|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
139652194|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
139652195|NCT04811274|Dimercaprol|dimercaprol|mesh-list
139652196|NCT04811274|Chelating Agents|chelating agents|mesh-ancestor
139652197|NCT04811274|Sequestering Agents|sequestering agents|mesh-ancestor
139652198|NCT04811274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652199|NCT04799184|Epinephrine|epinephrine|mesh-list
139652200|NCT04799184|Racepinephrine|racepinephrine|mesh-list
139652201|NCT04799184|Bupivacaine|bupivacaine|mesh-list
139652202|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
139652203|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
139652204|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
139652205|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
139652206|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652207|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652208|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
139652209|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652210|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139652211|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139652212|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
139652213|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140427|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139652214|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652215|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139652216|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139652217|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
139652218|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139652219|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
139652220|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
139652221|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
139652222|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139652223|NCT05562297|Paclitaxel|paclitaxel|mesh-list
139652224|NCT05562297|Gemcitabine|gemcitabine|mesh-list
139652225|NCT05562297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139652226|NCT05562297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652227|NCT05562297|Tubulin Modulators|tubulin modulators|mesh-ancestor
139652228|NCT05562297|Antimitotic Agents|antimitotic agents|mesh-ancestor
139652229|NCT05562297|Mitosis Modulators|mitosis modulators|mesh-ancestor
139652230|NCT05562297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652231|NCT05562297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139652232|NCT05562297|Antimetabolites|antimetabolites|mesh-ancestor
139652233|NCT03003195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139652234|NCT03003195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139652235|NCT03003195|Immunologic Factors|immunologic factors|mesh-ancestor
139652236|NCT03003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652237|NCT04790136|Cannabidiol|cannabidiol|mesh-list
139652238|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
139652239|NCT03003039|Rituximab|rituximab|mesh-list
139652240|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139652241|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652242|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
139652243|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652244|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139652245|NCT03002961|Buprenorphine|buprenorphine|mesh-list
139652246|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139652247|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139652248|NCT03002961|Narcotics|narcotics|mesh-ancestor
139652249|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652250|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652251|NCT03002961|Analgesics|analgesics|mesh-ancestor
139652252|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
139652253|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652254|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139652255|NCT03002805|Doxorubicin|doxorubicin|mesh-list
139652256|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139652257|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652258|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139652259|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139652260|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652261|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652262|NCT04214691|Acetaminophen|acetaminophen|mesh-list
139652263|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139652264|NCT04214691|Analgesics|analgesics|mesh-ancestor
139043285|NCT00524303|Paclitaxel|paclitaxel|mesh-list
139652265|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
139652266|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652267|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652268|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
139652269|NCT04786158|Apomorphine|apomorphine|mesh-list
139652270|NCT04786158|Emetics|emetics|mesh-ancestor
139652271|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652272|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
139652273|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652274|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139652275|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
139652276|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
139652277|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652278|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652279|NCT03002493|Rifampin|rifampin|mesh-list
139652280|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139652281|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
139652282|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139652283|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652284|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
139652285|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139652286|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140502|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139652287|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652288|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139418354|NCT05235256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652289|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139652290|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139652291|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139652292|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139652293|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139652294|NCT04786470|Ropivacaine|ropivacaine|mesh-list
139652295|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
139652296|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
139652297|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652298|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652299|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
139652300|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652301|NCT02219997|Methamphetamine|methamphetamine|mesh-list
139652302|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
139652303|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139652304|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139652305|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139652306|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652307|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
139652308|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
139652309|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652310|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
139652311|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652312|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652313|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
139652314|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139652315|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139652316|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139652317|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139652318|NCT02219997|Hormones|hormones|mesh-ancestor
139652319|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139652320|NCT04786002|Busulfan|busulfan|mesh-list
139652321|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
139652322|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652323|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139652324|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
139652325|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652326|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139652327|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652328|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139652329|NCT04785768|Morphine|morphine|mesh-list
139652330|NCT04785768|Hydromorphone|hydromorphone|mesh-list
139652331|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139652332|NCT04785768|Narcotics|narcotics|mesh-ancestor
139652333|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652334|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652335|NCT04785768|Analgesics|analgesics|mesh-ancestor
139652336|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
139652337|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652338|NCT02223351|Ritonavir|ritonavir|mesh-list
139652339|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139652340|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139652341|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
139652342|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652343|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652344|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139652345|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139652346|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
139652347|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652348|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139652349|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139652350|NCT02223429|Vasopressins|vasopressins|mesh-list
139652351|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
139652352|NCT02223429|Oxytocin|oxytocin|mesh-list
139652353|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652354|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
139652355|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139418355|NCT05235256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418356|NCT05235256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139418357|NCT05235256|Glucocorticoids|glucocorticoids|mesh-ancestor
139418358|NCT05235256|Hormones|hormones|mesh-ancestor
139418359|NCT05235256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139652356|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
139652357|NCT02223429|Coagulants|coagulants|mesh-ancestor
139652358|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139652359|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139652360|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
139652361|NCT03002649|Tofacitinib|tofacitinib|mesh-list
139652362|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652363|NCT03002649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139652364|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139652365|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652366|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
139652367|NCT04785222|Bupivacaine|bupivacaine|mesh-list
139652368|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
139652369|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
139652370|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652371|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652372|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
139652373|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652374|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139652375|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139652376|NCT04785222|Analgesics|analgesics|mesh-ancestor
139652377|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139652378|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139652379|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139652380|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
139652381|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652382|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652383|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
139652384|NCT04808856|Hormones|hormones|mesh-list
139652385|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139652386|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139652387|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
139652388|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139652389|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652390|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139652391|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
139652392|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
139652393|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652394|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139652395|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
139652396|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139652397|NCT04808856|Protective Agents|protective agents|mesh-ancestor
139652398|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652399|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652400|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
139652401|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139652402|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
139652403|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139652404|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139652405|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
139043425|NCT01059552|Vorinostat|vorinostat|mesh-list
139652406|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652407|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139652408|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139652409|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652410|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652411|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139652412|NCT04784988|BAX 855|bax 855|mesh-list
139652413|NCT04784988|Coagulants|coagulants|mesh-ancestor
139652414|NCT04784910|Lansoprazole|lansoprazole|mesh-list
139652415|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
139652416|NCT04784910|Fexuprazan|fexuprazan|mesh-list
139652417|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139652418|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139652419|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139652420|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652421|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652422|NCT01625013|Hylan|hylan|mesh-list
139652423|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
139652424|NCT01625013|Protective Agents|protective agents|mesh-ancestor
139652425|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652426|NCT00083551|Interferons|interferons|mesh-list
139652427|NCT00083551|Cytarabine|cytarabine|mesh-list
139652428|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
139652429|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
139652430|NCT00083551|Thalidomide|thalidomide|mesh-list
139652431|NCT00083551|Dexamethasone|dexamethasone|mesh-list
139652432|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
139652433|NCT00083551|Melphalan|melphalan|mesh-list
139418360|NCT05235256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139652434|NCT00083551|Carmustine|carmustine|mesh-list
139652435|NCT00083551|Cisplatin|cisplatin|mesh-list
139652436|NCT00083551|Doxorubicin|doxorubicin|mesh-list
139652437|NCT00083551|Etoposide|etoposide|mesh-list
139652438|NCT00083551|Vincristine|vincristine|mesh-list
139652439|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139652440|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
139652441|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652442|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139652443|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139652444|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
139652445|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652446|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652447|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139652448|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139652449|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
139652450|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
139652451|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652452|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139652453|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
139652454|NCT00083551|Hormones|hormones|mesh-ancestor
139652455|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139652456|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139652457|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139652458|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139652459|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139652460|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652461|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139652462|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
139652463|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652464|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139652465|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
139652466|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
139043505|NCT00112294|Carboplatin|carboplatin|mesh-list
139652467|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
139652468|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
139652469|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
139652470|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139652471|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139652472|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139652473|NCT00083551|Growth Substances|growth substances|mesh-ancestor
139652474|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
139652475|NCT01625169|Etravirine|etravirine|mesh-list
139652476|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139652477|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139652478|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652479|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652480|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
139652481|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652482|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139652483|NCT03933813|Hematinics|hematinics|mesh-ancestor
139652484|NCT01628601|Timolol|timolol|mesh-list
139652485|NCT01628601|Bimatoprost|bimatoprost|mesh-list
139652486|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139652487|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139652488|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
139652489|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652490|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652491|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652492|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139652493|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139652494|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
139652495|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652496|NCT01490918|Metformin|metformin|mesh-list
139652497|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139652498|NCT01490918|Acarbose|acarbose|mesh-list
139652499|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139652500|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652501|NCT01490918|Incretins|incretins|mesh-ancestor
139652502|NCT01490918|Hormones|hormones|mesh-ancestor
139652503|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139652504|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139652505|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
139652506|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652507|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652508|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139652509|NCT02230995|Metformin|metformin|mesh-list
139652510|NCT02230995|Empagliflozin|empagliflozin|mesh-list
139652511|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139652512|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652513|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139652514|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652515|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
139652516|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139652517|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139652518|NCT02995083|Prednisolone|prednisolone|mesh-list
139652519|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
139652520|NCT02995083|Lidocaine|lidocaine|mesh-list
139652521|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139652522|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
139652523|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
139652524|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
139652525|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652526|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652527|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
139652528|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652529|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139652530|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139652531|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139652532|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139652533|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652534|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139652535|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
139652536|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
139652537|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139652538|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
139652539|NCT02995083|Hormones|hormones|mesh-ancestor
139652540|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139652541|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139652542|NCT02995083|Protective Agents|protective agents|mesh-ancestor
139652543|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139652544|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652545|NCT04426422|Metformin|metformin|mesh-list
139652546|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139652547|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652548|NCT01632423|Bimatoprost|bimatoprost|mesh-list
139652549|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139652550|NCT05466318|Cytarabine|cytarabine|mesh-list
139652551|NCT05466318|Gemcitabine|gemcitabine|mesh-list
139652552|NCT05466318|Etoposide|etoposide|mesh-list
139652553|NCT05466318|Melphalan|melphalan|mesh-list
139652554|NCT05466318|Busulfan|busulfan|mesh-list
139652555|NCT05466318|Carmustine|carmustine|mesh-list
139652556|NCT05466318|Cladribine|cladribine|mesh-list
139652557|NCT05466318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139652558|NCT05466318|Antimetabolites|antimetabolites|mesh-ancestor
139652559|NCT05466318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652560|NCT05466318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652561|NCT05466318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139652562|NCT05466318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139652563|NCT05466318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139652564|NCT05466318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652565|NCT05466318|Antiviral Agents|antiviral agents|mesh-ancestor
139652566|NCT05466318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652567|NCT05466318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139652568|NCT05466318|Immunologic Factors|immunologic factors|mesh-ancestor
139652569|NCT05466318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652570|NCT05466318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139652571|NCT05466318|Alkylating Agents|alkylating agents|mesh-ancestor
139652572|NCT05466318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139652573|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139652574|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652575|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652576|NCT01469546|Axitinib|axitinib|mesh-list
139652577|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652578|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139652579|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652580|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140794|NCT05320107|Analgesics|analgesics|mesh-ancestor
139652581|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139652582|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139652583|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
139652584|NCT05613894|177Lu-PSMA-617|177lu-psma-617|mesh-list
139652585|NCT05613894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139652586|NCT05613894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652587|NCT00081263|Celecoxib|celecoxib|mesh-list
139652588|NCT00081263|Benzenesulfonamide|benzenesulfonamide|mesh-list
139652589|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139652590|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139652591|NCT00081263|Analgesics|analgesics|mesh-ancestor
139652592|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
139652593|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652594|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652595|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139652596|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139652597|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139652598|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139652599|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652600|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652601|NCT00081263|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139652602|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
139652603|NCT05087381|Niclosamide|niclosamide|mesh-list
139652604|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
139652605|NCT05087381|Bromhexine|bromhexine|mesh-list
139652606|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652607|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652608|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139652609|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139652610|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652611|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652612|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139652613|NCT05087381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139652614|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139652615|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139652616|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652617|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
139652618|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139652619|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
139652620|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139652621|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139652622|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139652623|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
139652624|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139652625|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
139652626|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139652627|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652628|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
139652629|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
139652630|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
139652631|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139652632|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139652633|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
139652634|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
139652635|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139652636|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139652637|NCT05087381|Expectorants|expectorants|mesh-ancestor
139652638|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
139652639|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
139652640|NCT00080483|Testosterone|testosterone|mesh-list
139652641|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
139652642|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
139652643|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139652644|NCT00080483|Androgens|androgens|mesh-ancestor
139652645|NCT00080483|Hormones|hormones|mesh-ancestor
139652646|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139652647|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652648|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139652649|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652650|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
139652651|NCT05248620|Amoxicillin|amoxicillin|mesh-list
139652652|NCT05248620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139652653|NCT05248620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652654|NCT01639599|Dexamethasone|dexamethasone|mesh-list
139652655|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
139652656|NCT01639599|Haloperidol|haloperidol|mesh-list
139652657|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
139652658|NCT01639599|BB 1101|bb 1101|mesh-list
139418361|NCT05235256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652659|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139652660|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
139652661|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
139652662|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652663|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652664|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139652665|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
139652666|NCT01639599|Hormones|hormones|mesh-ancestor
139652667|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139652668|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139652669|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652670|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
139652671|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652672|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652673|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139652674|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139652675|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652676|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139652677|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139652678|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
139652679|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652680|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139652681|NCT00089141|Mycophenolic Acid|mycophenolic acid|mesh-list
139652682|NCT00089141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139652683|NCT00089141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652684|NCT00089141|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139652685|NCT00089141|Antitubercular Agents|antitubercular agents|mesh-ancestor
139652686|NCT00089141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139652687|NCT00089141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652688|NCT00089141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652689|NCT00089141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652690|NCT02227329|Ethanol|ethanol|mesh-list
139652691|NCT02227329|Heparin|heparin|mesh-list
139652692|NCT02227329|Calcium heparin|calcium heparin|mesh-list
139652693|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
139652694|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139652695|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139652696|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652697|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139652698|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652699|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652700|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652701|NCT05615142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139652702|NCT05615142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652703|NCT05615142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139652704|NCT05615142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652705|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
139652706|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139652707|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652708|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
139652709|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
139652710|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139652711|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652712|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652713|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139652714|NCT03172897|Analgesics|analgesics|mesh-ancestor
139652715|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
139652716|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652717|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139652718|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139652719|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139043929|NCT06142396|Bortezomib|bortezomib|mesh-list
139652720|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
139652721|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652722|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652723|NCT00086723|Captopril|captopril|mesh-list
139652724|NCT00086723|Plasminogen|plasminogen|mesh-list
139652725|NCT00086723|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139652726|NCT00086723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139652727|NCT00086723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139652728|NCT00086723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418363|NCT05235256|Anesthetics|anesthetics|mesh-ancestor
139140943|NCT05280873|Prednisolone acetate|prednisolone acetate|mesh-list
139418364|NCT05235256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652729|NCT00086723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139652730|NCT00086723|Protease Inhibitors|protease inhibitors|mesh-ancestor
139652731|NCT00086723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652732|NCT00086723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139652733|NCT05346419|Vitamin D|vitamin d|mesh-list
139652734|NCT05346419|Risedronic Acid|risedronic acid|mesh-list
139652735|NCT05346419|Vitamins|vitamins|mesh-ancestor
139652736|NCT05346419|Micronutrients|micronutrients|mesh-ancestor
139652737|NCT05346419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652738|NCT05346419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139652739|NCT05346419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139652740|NCT05346419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139652741|NCT05346419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652742|NCT05346419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139652743|NCT00084409|Iloprost|iloprost|mesh-list
139652744|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139652745|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
139652746|NCT03831165|Acyclovir|acyclovir|mesh-list
139652747|NCT03831165|Melatonin|melatonin|mesh-list
139652748|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
139652749|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652750|NCT03831165|Protective Agents|protective agents|mesh-ancestor
139652751|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652752|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652753|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
139652754|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652755|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139652756|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139652757|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139652758|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652759|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652760|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139043969|NCT06112379|Alkylating Agents|alkylating agents|mesh-ancestor
139652761|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139652762|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139652763|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139652764|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
139652765|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652766|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652767|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139652768|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139652769|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
139652770|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139652771|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139652772|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
139652773|NCT05574985|Vaccines|vaccines|mesh-list
139652774|NCT05574985|Immunologic Factors|immunologic factors|mesh-ancestor
139652775|NCT05574985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652776|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
139652777|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139652778|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652779|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139652780|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652781|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139652782|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139652783|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652784|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652785|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652786|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139652787|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
139652788|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139652789|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139652790|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139652791|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139652792|NCT04773366|Cytarabine|cytarabine|mesh-list
139652793|NCT04773366|Prednisone|prednisone|mesh-list
139652794|NCT04773366|Vincristine|vincristine|mesh-list
139652795|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
139652796|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139652797|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
139652798|NCT04773366|Hormones|hormones|mesh-ancestor
139652799|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139652800|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652801|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139652802|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652803|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139652804|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
139652805|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652806|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
139652807|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652808|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139652809|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
139652810|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139652811|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
139652812|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
139652813|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
139652814|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139652815|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652816|NCT04714541|Ketamine|ketamine|mesh-list
139652817|NCT04714541|Analgesics|analgesics|mesh-ancestor
139652818|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
139652819|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652820|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652821|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139652822|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139652823|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
139652824|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
139652825|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652826|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139652827|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139652828|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652829|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652830|NCT02414724|Gemcitabine|gemcitabine|mesh-list
139652831|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139652832|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
139652833|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652834|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652835|NCT00187681|Metformin|metformin|mesh-list
139652836|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139652837|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652838|NCT00083759|Natalizumab|natalizumab|mesh-list
139652839|NCT00083759|Immunologic Factors|immunologic factors|mesh-ancestor
139652840|NCT00083759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652841|NCT02412228|Dexamethasone|dexamethasone|mesh-list
139652842|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
139652843|NCT02412228|Ixazomib|ixazomib|mesh-list
139652844|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139652845|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
139652846|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652847|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139652848|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139652849|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
139652850|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652851|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652852|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139652853|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139652854|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
139652855|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
139652856|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652857|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139652858|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
139652859|NCT02412228|Hormones|hormones|mesh-ancestor
139652860|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139652861|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139652862|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
139652863|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652864|NCT01646151|Bimatoprost|bimatoprost|mesh-list
139652865|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139652866|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139652867|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139652868|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652869|NCT01828710|Folic Acid|folic acid|mesh-list
139652870|NCT01828710|Inositol|inositol|mesh-list
139652871|NCT01828710|Hematinics|hematinics|mesh-ancestor
139652872|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
139652873|NCT01828710|Vitamins|vitamins|mesh-ancestor
139652874|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
139652875|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652876|NCT00088699|Ketamine|ketamine|mesh-list
139652877|NCT00088699|Analgesics|analgesics|mesh-ancestor
139418365|NCT05235256|Sensory System Agents|sensory system agents|mesh-ancestor
139044080|NCT06071442|Metformin|metformin|mesh-list
139418366|NCT05235256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139652878|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
139652879|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139652880|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652881|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139652882|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139652883|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
139652884|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
139652885|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139652886|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139652887|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139652888|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139652889|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652890|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
139652891|NCT00089011|Fludarabine|fludarabine|mesh-list
139652892|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
139652893|NCT00089011|Tacrolimus|tacrolimus|mesh-list
139652894|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652895|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139652896|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
139652897|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652898|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139652899|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
139652900|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652901|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139652902|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652903|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139652904|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139652905|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
139652906|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139652907|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652908|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
139652909|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
139652910|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139652911|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652912|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139652913|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
139652914|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139652915|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652916|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652917|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652918|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139652919|NCT00347412|Paclitaxel|paclitaxel|mesh-list
139652920|NCT00347412|Carboplatin|carboplatin|mesh-list
139652921|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139652922|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652923|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
139652924|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
139652925|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
139652926|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652927|NCT00189475|Montelukast|montelukast|mesh-list
139652928|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139652929|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
139652930|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139652931|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
139652932|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139652933|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652934|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139652935|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139652936|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652937|NCT00091273|Sargramostim|sargramostim|mesh-list
139652938|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
139652939|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
139652940|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652941|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139652942|NCT00193375|Bevacizumab|bevacizumab|mesh-list
139652943|NCT00193375|Carboplatin|carboplatin|mesh-list
139652944|NCT00193375|Irinotecan|irinotecan|mesh-list
139652945|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139652946|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652947|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139652948|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139652949|NCT00193375|Growth Substances|growth substances|mesh-ancestor
139652950|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652951|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
139652952|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139652953|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139652954|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139652955|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652956|NCT00193453|Gemcitabine|gemcitabine|mesh-list
139652957|NCT00193453|Docetaxel|docetaxel|mesh-list
139652958|NCT00193453|Cetuximab|cetuximab|mesh-list
139652959|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139652960|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
139652961|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652962|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139652963|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
139652964|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
139652965|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
139652966|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139652967|NCT05614518|Methylene diphosphonate|methylene diphosphonate|mesh-list
139652968|NCT05614518|Listerine|listerine|mesh-list
139652969|NCT05614518|Fluorides|fluorides|mesh-list
139652970|NCT05614518|Sodium Fluoride|sodium fluoride|mesh-list
139044191|NCT05886244|Eculizumab|eculizumab|mesh-list
139652971|NCT05614518|Cariostatic Agents|cariostatic agents|mesh-ancestor
139652972|NCT05614518|Protective Agents|protective agents|mesh-ancestor
139652973|NCT05614518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652974|NCT05614518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139652975|NCT05614518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652976|NCT05614518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139652977|NCT00091507|Insulin|insulin|mesh-list
139652978|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139652979|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652980|NCT05611086|Acetylcysteine|acetylcysteine|mesh-list
139652981|NCT05611086|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139652982|NCT05611086|Antiviral Agents|antiviral agents|mesh-ancestor
139652983|NCT05611086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139652984|NCT05611086|Expectorants|expectorants|mesh-ancestor
139652985|NCT05611086|Respiratory System Agents|respiratory system agents|mesh-ancestor
139652986|NCT05611086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139652987|NCT05611086|Antioxidants|antioxidants|mesh-ancestor
139652988|NCT05611086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139652989|NCT05611086|Protective Agents|protective agents|mesh-ancestor
139652990|NCT05611086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652991|NCT05611086|Antidotes|antidotes|mesh-ancestor
139652992|NCT05614440|Tramadol|tramadol|mesh-list
139652993|NCT05614440|Anesthetics|anesthetics|mesh-list
139652994|NCT05614440|Anesthetics, Local|anesthetics, local|mesh-list
139652995|NCT05614440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139044231|NCT05820685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139652996|NCT05614440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139652997|NCT05614440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139652998|NCT05614440|Narcotics|narcotics|mesh-ancestor
139652999|NCT05614440|Analgesics|analgesics|mesh-ancestor
139653000|NCT05614440|Sensory System Agents|sensory system agents|mesh-ancestor
139653001|NCT05614440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653002|NCT05613192|Vitamin D|vitamin d|mesh-list
139653003|NCT05613192|Cholecalciferol|cholecalciferol|mesh-list
139653004|NCT05613192|Vitamins|vitamins|mesh-ancestor
139653005|NCT05613192|Micronutrients|micronutrients|mesh-ancestor
139653006|NCT05613192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653007|NCT05613192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139653008|NCT05613192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139653009|NCT00194779|Tamoxifen|tamoxifen|mesh-list
139653010|NCT00194779|Vinorelbine|vinorelbine|mesh-list
139653011|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
139653012|NCT00194779|Doxorubicin|doxorubicin|mesh-list
139653013|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139653014|NCT00194779|Capecitabine|capecitabine|mesh-list
139653015|NCT00194779|Methotrexate|methotrexate|mesh-list
139653016|NCT00194779|Trastuzumab|trastuzumab|mesh-list
139653017|NCT00194779|Letrozole|letrozole|mesh-list
139653018|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139653019|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141240|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139653020|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
139653021|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
139653022|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
139653023|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653024|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139653025|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
139653026|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653027|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653028|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139653029|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
139653030|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139653031|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139653032|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139653033|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139653034|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653035|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139653036|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
139653037|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139653038|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
139653039|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139653040|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
139653041|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139653042|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139653043|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139653044|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139653045|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139653046|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139653047|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
139653048|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139653049|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139653050|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139653051|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139653052|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139653053|NCT05474664|Camostat|camostat|mesh-list
139653054|NCT05474664|Protease Inhibitors|protease inhibitors|mesh-ancestor
139653055|NCT05474664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653056|NCT05474664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653057|NCT05474664|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139653058|NCT05474664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139653059|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
139653060|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139653061|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
139653062|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
139653063|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139044329|NCT05664789|Antidotes|antidotes|mesh-ancestor
139653064|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653065|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139653066|NCT02096575|Analgesics|analgesics|mesh-ancestor
139653067|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
139653068|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653069|NCT04338984|Fentanyl|fentanyl|mesh-list
139653070|NCT04338984|Ropivacaine|ropivacaine|mesh-list
139653071|NCT04338984|Anesthetics|anesthetics|mesh-list
139653072|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
139653073|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
139653074|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139653075|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653076|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
139653077|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653078|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139653079|NCT04338984|Narcotics|narcotics|mesh-ancestor
139653080|NCT04338984|Analgesics|analgesics|mesh-ancestor
139653081|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139653082|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139653083|NCT00095563|Lapatinib|lapatinib|mesh-list
139653084|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653085|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139653086|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653087|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653088|NCT05473806|Pioglitazone|pioglitazone|mesh-list
139653089|NCT05473806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139653090|NCT05473806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653091|NCT00089609|Thalidomide|thalidomide|mesh-list
139653092|NCT00089609|Prednisone|prednisone|mesh-list
139653093|NCT00089609|Bevacizumab|bevacizumab|mesh-list
139653094|NCT00089609|Docetaxel|docetaxel|mesh-list
139653095|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139653096|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653097|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139653098|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139653099|NCT00089609|Growth Substances|growth substances|mesh-ancestor
139141316|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139653100|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653101|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
139653103|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
139653104|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
139653105|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653106|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653107|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
139653108|NCT00089609|Hormones|hormones|mesh-ancestor
139653109|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139653110|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139653111|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139653112|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
139653113|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
139653114|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139653115|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653116|NCT04661514|Psilocybin|psilocybin|mesh-list
139653117|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
139653118|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653119|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139653120|NCT00195403|Etanercept|etanercept|mesh-list
139653121|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139653122|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139653123|NCT00195403|Analgesics|analgesics|mesh-ancestor
139653124|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
139653125|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653126|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653127|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653128|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653129|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139653130|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139653131|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
139653132|NCT04643327|Levetiracetam|levetiracetam|mesh-list
139653133|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
139653134|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
139653135|NCT00095875|Carboplatin|carboplatin|mesh-list
139653136|NCT00095875|Docetaxel|docetaxel|mesh-list
139653137|NCT00095875|Fluorouracil|fluorouracil|mesh-list
139653138|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653139|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
139653140|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
139653141|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
139653142|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653143|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
139653144|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139653145|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139653146|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
139653147|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653148|NCT03086993|Gemcitabine|gemcitabine|mesh-list
139653149|NCT03086993|Melphalan|melphalan|mesh-list
139653150|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653151|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139653152|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
139653153|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653154|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139653155|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
139653156|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139653157|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139044474|NCT05229653|Ketamine|ketamine|mesh-list
139653158|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
139653159|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653160|NCT04089072|Phenylephrine|phenylephrine|mesh-list
139653161|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
139653162|NCT04089072|Methylene Blue|methylene blue|mesh-list
139653163|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139653164|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
139653165|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
139653166|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653167|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653168|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
139653169|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139653170|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
139653171|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
139653172|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139653173|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139653174|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139141389|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139653175|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
139653176|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653177|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653178|NCT04089072|Protective Agents|protective agents|mesh-ancestor
139653179|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653180|NCT00006227|Paclitaxel|paclitaxel|mesh-list
139653181|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139653182|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653183|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
139653184|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
139653185|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
139653186|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653187|NCT00097669|Folic Acid|folic acid|mesh-list
139653188|NCT00097669|Hematinics|hematinics|mesh-ancestor
139653189|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
139653190|NCT00097669|Vitamins|vitamins|mesh-ancestor
139653191|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
139653192|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653193|NCT00010439|Alendronate|alendronate|mesh-list
139653194|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139653195|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653196|NCT05468892|Trifluridine|trifluridine|mesh-list
139653197|NCT05468892|Panitumumab|panitumumab|mesh-list
139653198|NCT05468892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139653199|NCT05468892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653200|NCT05468892|Antimetabolites|antimetabolites|mesh-ancestor
139653201|NCT05468892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653202|NCT05468892|Antiviral Agents|antiviral agents|mesh-ancestor
139653203|NCT05468892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653204|NCT00200161|Temozolomide|temozolomide|mesh-list
139653205|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139653206|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
139653207|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653208|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653209|NCT00016913|Paclitaxel|paclitaxel|mesh-list
139653210|NCT00016913|Carboplatin|carboplatin|mesh-list
139653211|NCT00016913|Leuprolide|leuprolide|mesh-list
139653212|NCT00016913|Goserelin|goserelin|mesh-list
139653213|NCT00016913|Estramustine|estramustine|mesh-list
139653214|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139653215|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653216|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
139653217|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
139653218|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
139653219|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653220|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139653221|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
139653222|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139653223|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653224|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139653225|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139653226|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
139653227|NCT00023309|Lamivudine|lamivudine|mesh-list
139653228|NCT00023309|Adefovir|adefovir|mesh-list
139653229|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139653230|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139653231|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139653232|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653233|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653234|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
139653235|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653236|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139653237|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139653238|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
139653239|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139653240|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139653241|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653242|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
139653243|NCT02233101|Coagulants|coagulants|mesh-ancestor
139653244|NCT00098059|Famciclovir|famciclovir|mesh-list
139653245|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
139653246|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653247|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139653248|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653249|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653250|NCT02440581|Alendronate|alendronate|mesh-list
139653251|NCT02440581|Teriparatide|teriparatide|mesh-list
139653252|NCT02440581|Cinacalcet|cinacalcet|mesh-list
139141466|NCT04439253|Crizotinib|crizotinib|mesh-list
139141541|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
139653253|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139653254|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653255|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139653256|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139653257|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
139653258|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139653259|NCT01359150|Tofacitinib|tofacitinib|mesh-list
139653260|NCT01359150|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139653261|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139653262|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653263|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653264|NCT00098371|Alvocidib|alvocidib|mesh-list
139653265|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653266|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
139653267|NCT00098371|Growth Substances|growth substances|mesh-ancestor
139653268|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653269|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139653270|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653271|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653272|NCT04745988|Leucovorin|leucovorin|mesh-list
139653273|NCT04745988|Docetaxel|docetaxel|mesh-list
139653274|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
139653275|NCT04745988|Fluorouracil|fluorouracil|mesh-list
139653276|NCT04745988|Oxaliplatin|oxaliplatin|mesh-list
139653277|NCT04745988|Lenvatinib|lenvatinib|mesh-list
139653278|NCT04745988|Levoleucovorin|levoleucovorin|mesh-list
139653279|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653280|NCT04745988|Tubulin Modulators|tubulin modulators|mesh-ancestor
139653281|NCT04745988|Antimitotic Agents|antimitotic agents|mesh-ancestor
139653282|NCT04745988|Mitosis Modulators|mitosis modulators|mesh-ancestor
139653283|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653284|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139653285|NCT04745988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139653286|NCT04745988|Antimetabolites|antimetabolites|mesh-ancestor
139653287|NCT04745988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139653288|NCT04745988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139653289|NCT04745988|Immunologic Factors|immunologic factors|mesh-ancestor
139653290|NCT04745988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653291|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139653292|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653293|NCT04745988|Antidotes|antidotes|mesh-ancestor
139653294|NCT04745988|Protective Agents|protective agents|mesh-ancestor
139653295|NCT04745988|Vitamin B Complex|vitamin b complex|mesh-ancestor
139653296|NCT04745988|Vitamins|vitamins|mesh-ancestor
139653297|NCT04745988|Micronutrients|micronutrients|mesh-ancestor
139653298|NCT01647945|Tacrolimus|tacrolimus|mesh-list
139653299|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139653300|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
139653301|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653302|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139653303|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653304|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653305|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
139653306|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138691026|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
139653307|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139653308|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
139653309|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653310|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653311|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653312|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
139653313|NCT04351191|Chloroquine|chloroquine|mesh-list
139653314|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
139653315|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139653316|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139653317|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653318|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653319|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653320|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653321|NCT04351191|Amebicides|amebicides|mesh-ancestor
139653322|NCT01469000|Pemetrexed|pemetrexed|mesh-list
139653323|NCT01469000|Gefitinib|gefitinib|mesh-list
139653324|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653325|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653326|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653327|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139653328|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139653329|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139653330|NCT00201877|Rituximab|rituximab|mesh-list
139653331|NCT00201877|Bortezomib|bortezomib|mesh-list
139653332|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139653333|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653334|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
139653335|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653336|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653337|NCT05399628|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139653338|NCT05399628|Respiratory System Agents|respiratory system agents|mesh-ancestor
139653339|NCT01490060|Dexamethasone|dexamethasone|mesh-list
139653340|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
139653341|NCT01490060|Doxorubicin|doxorubicin|mesh-list
139653342|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139653343|NCT01490060|Vincristine|vincristine|mesh-list
139653344|NCT01490060|Ifosfamide|ifosfamide|mesh-list
139653345|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
139653346|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
139653347|NCT01490060|Aprepitant|aprepitant|mesh-list
139653348|NCT01490060|BB 1101|bb 1101|mesh-list
139653349|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653350|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
139653351|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
139653352|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653353|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653354|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139653355|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
139653356|NCT01490060|Hormones|hormones|mesh-ancestor
139653357|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139653358|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139653359|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653360|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
139653361|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653362|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653363|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139653364|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139653365|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139653366|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139653367|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
139653368|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
139653369|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
139653370|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139653371|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
139653372|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139653373|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653374|NCT04090736|Azacitidine|azacitidine|mesh-list
139653375|NCT04090736|Pevonedistat|pevonedistat|mesh-list
139653376|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139653377|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
139653378|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653379|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653380|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653381|NCT05557344|Acetaminophen|acetaminophen|mesh-list
139653382|NCT05557344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139653383|NCT05557344|Analgesics|analgesics|mesh-ancestor
139653384|NCT05557344|Sensory System Agents|sensory system agents|mesh-ancestor
139653385|NCT05557344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653386|NCT05557344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653387|NCT05557344|Antipyretics|antipyretics|mesh-ancestor
139653388|NCT00101413|Sorafenib|sorafenib|mesh-list
139653389|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653390|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139653391|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653392|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653393|NCT01246869|Deoxyglucose|deoxyglucose|mesh-list
139653394|NCT01246869|Imidazole|imidazole|mesh-list
139653395|NCT01246869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653396|NCT01246869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653397|NCT01246869|Antimetabolites|antimetabolites|mesh-ancestor
139653398|NCT01246869|Antiviral Agents|antiviral agents|mesh-ancestor
139653399|NCT01246869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653400|NCT01452152|Clopidogrel|clopidogrel|mesh-list
139653401|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139653402|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139653403|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139653404|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139141696|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139653405|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139653406|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
139653407|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653408|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653409|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653410|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
139653411|NCT01451762|Promethazine|promethazine|mesh-list
139653412|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139653413|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139653414|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139653415|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653416|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
139653417|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
139653418|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
139653419|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653420|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
139653421|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
139653422|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139653423|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139653424|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
139653425|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
139653426|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653427|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653428|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139653429|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
139653430|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
139653431|NCT01654107|Nicotine|nicotine|mesh-list
139653432|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139653433|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
139653434|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653435|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653436|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139653437|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139653438|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
139653439|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653440|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653441|NCT03085680|Curcumin|curcumin|mesh-list
139653442|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139653443|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139653444|NCT03085680|Analgesics|analgesics|mesh-ancestor
139653445|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
139653446|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653447|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653448|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653449|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653450|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653451|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653452|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653453|NCT01468844|Minocycline|minocycline|mesh-list
139653454|NCT01468844|Bevacizumab|bevacizumab|mesh-list
139653455|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139653456|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653457|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139653458|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139653459|NCT01468844|Growth Substances|growth substances|mesh-ancestor
139653460|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653461|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
139653462|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139653463|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653464|NCT03029598|Carboplatin|carboplatin|mesh-list
139653465|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
139653466|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653467|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139653468|NCT03029598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139653469|NCT03029598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044832|NCT04396821|Nivolumab|nivolumab|mesh-list
139653470|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139653471|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139653472|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139653473|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139653474|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653475|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653476|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418367|NCT05235256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139653477|NCT01451606|Analgesics|analgesics|mesh-ancestor
139653478|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
139653479|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653480|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
139653481|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139653482|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
139653483|NCT00204373|Lansoprazole|lansoprazole|mesh-list
139653484|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
139653485|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139653486|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139653487|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139653488|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653489|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653490|NCT01655043|Regadenoson|regadenoson|mesh-list
139653491|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139653492|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139653493|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
139653494|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
139653495|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653496|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653497|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653498|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139653499|NCT00473343|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139653500|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139653501|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
139653502|NCT00032591|Thrombin|thrombin|mesh-list
139653503|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
139653504|NCT00032591|Coagulants|coagulants|mesh-ancestor
139653505|NCT01660191|Atorvastatin|atorvastatin|mesh-list
139653506|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139044868|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
139653507|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139653508|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139653509|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
139653510|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653511|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139653512|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139653513|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653514|NCT00033917|Indomethacin|indomethacin|mesh-list
139653515|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139653516|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139653517|NCT00033917|Analgesics|analgesics|mesh-ancestor
139653518|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
139653519|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653520|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653521|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653522|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653523|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
139653524|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
139653525|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139653526|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139653527|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653528|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653529|NCT00036569|Interferons|interferons|mesh-list
139653530|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
139653531|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653532|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
139653533|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653534|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
139653535|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653536|NCT01660893|Phenylephrine|phenylephrine|mesh-list
139653537|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
139653538|NCT01660893|Tetracaine|tetracaine|mesh-list
139653539|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
139653540|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
139653541|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139044904|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139653542|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653543|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
139653544|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653545|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139653546|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139653547|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
139653548|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653549|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418368|NCT05235256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139653550|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
139653551|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
139653552|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
139653553|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139653554|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
139653555|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139653556|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
139653557|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139653558|NCT01660893|Protective Agents|protective agents|mesh-ancestor
139653559|NCT01661283|Bevacizumab|bevacizumab|mesh-list
139653560|NCT01661283|Everolimus|everolimus|mesh-list
139653561|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139653562|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653563|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139653564|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139653565|NCT01661283|Growth Substances|growth substances|mesh-ancestor
139653566|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653567|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
139653568|NCT01661283|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139653569|NCT01661283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139653570|NCT01661283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653571|NCT01661283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653572|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139653573|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
139653574|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
139653575|NCT01946373|Fludarabine|fludarabine|mesh-list
139653576|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
139653577|NCT01946373|Interleukin-2|interleukin-2|mesh-list
139653578|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139653579|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
139653580|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653581|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653582|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139653583|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
139653584|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653585|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653586|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139653587|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139653588|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
139653589|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139653590|NCT01946373|Analgesics|analgesics|mesh-ancestor
139653591|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
139653592|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653593|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139653594|NCT01662297|Trazodone|trazodone|mesh-list
139653595|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
139653596|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139653597|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139653598|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139653599|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139653600|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653601|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139653602|NCT01662297|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139653603|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139653604|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139653605|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653606|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653607|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
139653608|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139653609|NCT01600287|Propofol|propofol|mesh-list
139653610|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139653611|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139653612|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653613|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139653614|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
139653615|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
139653616|NCT00040937|Thalidomide|thalidomide|mesh-list
139653617|NCT00040937|Dexamethasone|dexamethasone|mesh-list
139653618|NCT00040937|Prednisone|prednisone|mesh-list
139653619|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
139653620|NCT00040937|Melphalan|melphalan|mesh-list
139653621|NCT00040937|Sargramostim|sargramostim|mesh-list
139653622|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139653623|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
139653624|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418369|NCT05235256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139653625|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653626|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139653627|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
139653628|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653629|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653630|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139653631|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653632|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
139653633|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
139653634|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653635|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139653636|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
139653637|NCT00040937|Hormones|hormones|mesh-ancestor
139653638|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139653639|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139653640|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
139653641|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139653642|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653643|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139653644|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139653645|NCT00040937|Growth Substances|growth substances|mesh-ancestor
139653646|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
139653647|NCT04756895|Vancomycin|vancomycin|mesh-list
139653648|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139653649|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653650|NCT02234115|Leuprolide|leuprolide|mesh-list
139653651|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139653652|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
139653653|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139653654|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653655|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139045086|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
139653656|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653657|NCT02234427|Aspirin|aspirin|mesh-list
139653658|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139653659|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139653660|NCT02234427|Analgesics|analgesics|mesh-ancestor
139653661|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
139653662|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653663|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653664|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653665|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653666|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139653667|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139653668|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653669|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139653670|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139653671|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653672|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
139653673|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
139653674|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139653675|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139653676|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653677|NCT01663935|Levodopa|levodopa|mesh-list
139653678|NCT01663935|Carbidopa|carbidopa|mesh-list
139653679|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139653680|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139653681|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
139653682|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653683|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653684|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653685|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139653686|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653687|NCT01664559|Ketorolac|ketorolac|mesh-list
139653688|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139653689|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139653690|NCT01664559|Analgesics|analgesics|mesh-ancestor
139653691|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
139653692|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653693|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653694|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653695|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653696|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139653697|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653698|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141918|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
139653700|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
139653701|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
139653702|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653703|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653704|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139653705|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139653706|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139653707|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139653708|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
139653709|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653710|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653711|NCT01894685|Mesalamine|mesalamine|mesh-list
139653712|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139653713|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139653714|NCT01894685|Analgesics|analgesics|mesh-ancestor
139653715|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
139653716|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653717|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653718|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653719|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653720|NCT01695291|Minocycline|minocycline|mesh-list
139653721|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139653722|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139045229|NCT02972840|Rituximab|rituximab|mesh-list
139653723|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
139653724|NCT00048737|Rituximab|rituximab|mesh-list
139653725|NCT00048737|Fludarabine|fludarabine|mesh-list
139653726|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
139653727|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139653728|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
139653729|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653730|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653731|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139653732|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
139653733|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653734|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653735|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139653736|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139653737|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139653738|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
139653739|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
139653740|NCT01604109|Caseins|caseins|mesh-list
139653741|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139653742|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
139653743|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653744|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653745|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653746|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
139653747|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
139653748|NCT01666197|Diclofenac|diclofenac|mesh-list
139653749|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139653750|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139653751|NCT01666197|Analgesics|analgesics|mesh-ancestor
139653752|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
139653753|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653754|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653755|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653756|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653757|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139653758|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653759|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653760|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139653761|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
139653762|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139653763|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139653764|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139653765|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139653766|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653767|NCT00048815|Citalopram|citalopram|mesh-list
139653768|NCT00048815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139653769|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139653770|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139418370|NCT05235256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653771|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653772|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653773|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
139653774|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653775|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139653776|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
139653777|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139653778|NCT01605903|Acetaminophen|acetaminophen|mesh-list
139653779|NCT01605903|Ibuprofen|ibuprofen|mesh-list
139653780|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139653781|NCT01605903|Analgesics|analgesics|mesh-ancestor
139653782|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
139653783|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653784|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653785|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
139653786|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139653787|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653788|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653789|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139653790|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653791|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653792|NCT00048893|Metronidazole|metronidazole|mesh-list
139653793|NCT00048893|Paclitaxel|paclitaxel|mesh-list
139653794|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
139653795|NCT00048893|Doxorubicin|doxorubicin|mesh-list
139653796|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139653797|NCT00048893|Fludarabine|fludarabine|mesh-list
139653798|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
139653799|NCT00048893|Vaccines|vaccines|mesh-list
139653800|NCT00048893|Sargramostim|sargramostim|mesh-list
139653801|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
139653802|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653803|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139653804|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653805|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
139653806|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
139653807|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
139653808|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653809|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139653810|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653811|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139653812|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
139653813|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139653814|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139653815|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139653816|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139653817|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653818|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139653819|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
139653820|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653821|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139653822|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139653823|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139653824|NCT01607853|Calcitriol|calcitriol|mesh-list
139653825|NCT01607853|Betamethasone|betamethasone|mesh-list
139653826|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653827|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
139653828|NCT01607853|Hormones|hormones|mesh-ancestor
139653829|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139653830|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653831|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139653832|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
139653833|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139653834|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139653835|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139653836|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653837|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139653838|NCT01607853|Vitamins|vitamins|mesh-ancestor
139653839|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
139653840|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139653841|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139653842|NCT01700517|Anesthetics|anesthetics|mesh-list
139653843|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139653844|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653845|NCT00101647|Dasatinib|dasatinib|mesh-list
139142072|NCT00187889|Eplerenone|eplerenone|mesh-list
139653846|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653847|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139653848|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653849|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653850|NCT01669785|Listerine|listerine|mesh-list
139653851|NCT01669785|Fluorides|fluorides|mesh-list
139653852|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
139653853|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
139653854|NCT01669785|Protective Agents|protective agents|mesh-ancestor
139653855|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653856|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139653857|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653858|NCT03089645|Docetaxel|docetaxel|mesh-list
139653859|NCT03089645|Durvalumab|durvalumab|mesh-list
139653860|NCT03089645|Tremelimumab|tremelimumab|mesh-list
139653861|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139653862|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653863|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
139653864|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
139653865|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
139653866|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653867|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139653868|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
139653869|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653870|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
139653871|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139653872|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653873|NCT02587962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139653874|NCT02587962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653875|NCT01671423|Prednisone|prednisone|mesh-list
139045469|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
139653876|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653877|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
139653878|NCT01671423|Hormones|hormones|mesh-ancestor
139653879|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139653880|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653881|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139653882|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653883|NCT02092181|Mirabegron|mirabegron|mesh-list
139653884|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139653885|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139653886|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139653887|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
139653888|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139653889|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653890|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653891|NCT02092181|Urological Agents|urological agents|mesh-ancestor
139653892|NCT01672827|Flutemetamol|flutemetamol|mesh-list
139653893|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139653894|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653895|NCT01700907|Sevoflurane|sevoflurane|mesh-list
139653896|NCT01700907|Desflurane|desflurane|mesh-list
139653897|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139653898|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139653899|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
139653900|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
139653901|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139653902|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653903|NCT03089567|Listerine|listerine|mesh-list
139653904|NCT03089567|Fluorides|fluorides|mesh-list
139653905|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
139653906|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
139653907|NCT03089567|Protective Agents|protective agents|mesh-ancestor
139653908|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653909|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139653910|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653911|NCT03431987|Ethanol|ethanol|mesh-list
139653912|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139653913|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653914|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139653915|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653916|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
139653917|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139418371|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
139653918|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
139653919|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142135|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
139418372|NCT02497976|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139653920|NCT01612221|Expectorants|expectorants|mesh-ancestor
139653921|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
139653922|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139653923|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
139653924|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653925|NCT01612221|Protective Agents|protective agents|mesh-ancestor
139653926|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653927|NCT01612221|Antidotes|antidotes|mesh-ancestor
139653928|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
139653929|NCT00105001|Sirolimus|sirolimus|mesh-list
139653930|NCT00105001|Fludarabine|fludarabine|mesh-list
139653931|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
139653932|NCT00105001|Tacrolimus|tacrolimus|mesh-list
139653933|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653934|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139653935|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
139653936|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653937|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139653938|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
139653939|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653940|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139653941|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653942|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139653943|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139653944|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
139045555|NCT00231777|Ondansetron|ondansetron|mesh-list
139653945|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139653946|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139653947|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
139653948|NCT02642640|Melatonin|melatonin|mesh-list
139653949|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
139653950|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653951|NCT02642640|Protective Agents|protective agents|mesh-ancestor
139653952|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653953|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139653954|NCT01701375|Palbociclib|palbociclib|mesh-list
139653955|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653956|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139653957|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653958|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653959|NCT05556408|Propofol|propofol|mesh-list
139653960|NCT05556408|Succinylcholine|succinylcholine|mesh-list
139653961|NCT05556408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139653962|NCT05556408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139653963|NCT05556408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653964|NCT05556408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139653965|NCT05556408|Anesthetics, General|anesthetics, general|mesh-ancestor
139653966|NCT05556408|Anesthetics|anesthetics|mesh-ancestor
139653967|NCT05556408|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139653968|NCT05556408|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139653969|NCT05556408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139653970|NCT05556408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139653971|NCT00054353|Cyclosporine|cyclosporine|mesh-list
139653972|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
139653973|NCT00054353|Fludarabine|fludarabine|mesh-list
139653974|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
139653975|NCT00054353|Melphalan|melphalan|mesh-list
139653976|NCT00054353|Cyclosporins|cyclosporins|mesh-list
139653977|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139653978|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139653979|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
139653980|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139653981|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139653982|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
139653983|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139653984|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139653985|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
139653986|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142215|NCT01075841|Cetuximab|cetuximab|mesh-list
139653987|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
139653988|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139653989|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139653990|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139653991|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139653992|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
139653993|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139045590|NCT00231465|Docetaxel|docetaxel|mesh-list
139418373|NCT02497976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139653994|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139653995|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
139653996|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139653997|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
139653999|NCT00208975|Fludarabine|fludarabine|mesh-list
139654000|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
139654001|NCT00208975|Sargramostim|sargramostim|mesh-list
139654002|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139654003|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
139654004|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654005|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139654006|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139654007|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
139654008|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654009|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654010|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139654011|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139654012|NCT00208975|Analgesics|analgesics|mesh-ancestor
139654013|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
139654014|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654015|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139654016|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139654017|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654018|NCT01702233|Dexamethasone|dexamethasone|mesh-list
139654019|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
139654020|NCT01702233|BB 1101|bb 1101|mesh-list
139654021|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139654022|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
139654023|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
139654024|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654025|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654026|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139654027|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
139654028|NCT01702233|Hormones|hormones|mesh-ancestor
139654029|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654030|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139654031|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654032|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
139045609|NCT00254163|Pentostatin|pentostatin|mesh-list
139654033|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654034|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654035|NCT05555628|Salicylic Acid|salicylic acid|mesh-list
139654036|NCT05555628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139654037|NCT05555628|Antifungal Agents|antifungal agents|mesh-ancestor
139654038|NCT05555628|Keratolytic Agents|keratolytic agents|mesh-ancestor
139654039|NCT05555628|Dermatologic Agents|dermatologic agents|mesh-ancestor
139654040|NCT00217399|Sorafenib|sorafenib|mesh-list
139654041|NCT00217399|Anastrozole|anastrozole|mesh-list
139654042|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654043|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139654044|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654045|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654046|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139654047|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139654048|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139654049|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139654050|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
139654051|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654052|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654053|NCT04739670|Bevacizumab|bevacizumab|mesh-list
139654054|NCT04739670|Atezolizumab|atezolizumab|mesh-list
139654055|NCT04739670|Carboplatin|carboplatin|mesh-list
139654056|NCT04739670|Gemcitabine|gemcitabine|mesh-list
139654057|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139654058|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654059|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139654060|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139654061|NCT04739670|Growth Substances|growth substances|mesh-ancestor
139654062|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654063|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
139654064|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139654065|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
139654066|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654067|NCT04739670|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139654068|NCT05286619|Carboplatin|carboplatin|mesh-list
139654069|NCT05286619|Gemcitabine|gemcitabine|mesh-list
139654070|NCT05286619|Pembrolizumab|pembrolizumab|mesh-list
139654071|NCT05286619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045648|NCT01072071|Furosemide|furosemide|mesh-list
139654072|NCT05286619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139654073|NCT05286619|Antimetabolites|antimetabolites|mesh-ancestor
139654074|NCT05286619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654075|NCT05286619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139654076|NCT05286619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139654077|NCT04329624|Simendan|simendan|mesh-list
139654078|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139654079|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
139654080|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139654081|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139654082|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654083|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654084|NCT04329624|Protective Agents|protective agents|mesh-ancestor
139654085|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654086|NCT00559182|Omeprazole|omeprazole|mesh-list
139654087|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139654088|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139654089|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139654090|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654091|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654092|NCT00218023|Naltrexone|naltrexone|mesh-list
139654093|NCT00218023|Levodopa|levodopa|mesh-list
139654094|NCT00218023|Carbidopa|carbidopa|mesh-list
139654095|NCT00218023|Modafinil|modafinil|mesh-list
139654096|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139654097|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139654098|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654099|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
139654100|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654101|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139654102|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139654103|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
139654104|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654105|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654106|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139654107|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654108|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139654109|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139654110|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139654111|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139654112|NCT00054665|Prednisone|prednisone|mesh-list
139654113|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
139654114|NCT00054665|Doxorubicin|doxorubicin|mesh-list
139654115|NCT00054665|Etoposide|etoposide|mesh-list
139654116|NCT00054665|Vincristine|vincristine|mesh-list
139654117|NCT00054665|Bortezomib|bortezomib|mesh-list
139654118|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139654119|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
139654120|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654121|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139654122|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139654123|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
139045727|NCT01060488|Hormones|hormones|mesh-ancestor
139654124|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654125|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654126|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139654127|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139654128|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139654129|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139654130|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654131|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139654132|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
139654133|NCT00054665|Hormones|hormones|mesh-ancestor
139654134|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654135|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139654136|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139654137|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
139654138|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
139654139|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
139418374|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139418375|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
139654140|NCT00476190|Cytarabine|cytarabine|mesh-list
139654141|NCT00476190|Dexamethasone|dexamethasone|mesh-list
139142430|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139654142|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
139654143|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139654144|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139654145|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139654146|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
139654147|NCT00476190|Doxorubicin|doxorubicin|mesh-list
139654148|NCT00476190|Methotrexate|methotrexate|mesh-list
139654149|NCT00476190|Etoposide|etoposide|mesh-list
139654150|NCT00476190|Vincristine|vincristine|mesh-list
139654151|NCT00476190|Asparaginase|asparaginase|mesh-list
139654152|NCT00476190|Pegaspargase|pegaspargase|mesh-list
139654153|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139654154|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
139654155|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654156|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139654157|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139654158|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
139654159|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654160|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654161|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139654162|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139654163|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
139654164|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
139045777|NCT01045304|Carboplatin|carboplatin|mesh-list
139654165|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654166|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139654167|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
139654168|NCT00476190|Hormones|hormones|mesh-ancestor
139654169|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654170|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139654171|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139654172|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139654173|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139654174|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654175|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139654176|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
139654177|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139654178|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139654179|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
139654180|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
139654181|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139654182|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139654183|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139654184|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
139654185|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139654186|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
139654187|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
139045820|NCT00362414|Mitogens|mitogens|mesh-list
139654188|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
139654189|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
139654190|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139654191|NCT05555316|Lenvatinib|lenvatinib|mesh-list
139654192|NCT05555316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654193|NCT05555316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139654194|NCT05555316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654195|NCT05555316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654196|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
139654197|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139654198|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
139654199|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139654200|NCT00218491|Expectorants|expectorants|mesh-ancestor
139654201|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
139654202|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139654203|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
139654204|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654205|NCT00218491|Protective Agents|protective agents|mesh-ancestor
139654206|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654207|NCT00218491|Antidotes|antidotes|mesh-ancestor
139654208|NCT05700864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139654209|NCT05700864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139654210|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
139654211|NCT00221299|Hormones|hormones|mesh-list
139654212|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
139654213|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654214|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654215|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139654216|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139418376|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654217|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654218|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139654219|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139654220|NCT05554848|Magnesium Sulfate|magnesium sulfate|mesh-list
139654221|NCT05554848|Dexmedetomidine|dexmedetomidine|mesh-list
139654222|NCT05554848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139654223|NCT05554848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139654224|NCT05554848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654225|NCT05554848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139654226|NCT05554848|Analgesics|analgesics|mesh-ancestor
139654227|NCT05554848|Sensory System Agents|sensory system agents|mesh-ancestor
139654228|NCT05554848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654229|NCT05554848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139654230|NCT05554848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139654231|NCT05554848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139654232|NCT05554848|Adrenergic Agents|adrenergic agents|mesh-ancestor
139654233|NCT05554848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654234|NCT05554848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654235|NCT05554848|Anesthetics|anesthetics|mesh-ancestor
139654236|NCT05554848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139654237|NCT05554848|Anticonvulsants|anticonvulsants|mesh-ancestor
139654238|NCT05554848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139654239|NCT05554848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139654240|NCT05554848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139654241|NCT05554848|Tocolytic Agents|tocolytic agents|mesh-ancestor
139654242|NCT05554848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139654243|NCT00057785|Fluorouracil|fluorouracil|mesh-list
139654244|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654245|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
139654246|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654247|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139654248|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139654249|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
139654250|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654251|NCT05554224|Liver Extracts|liver extracts|mesh-list
139654252|NCT05554224|Hematinics|hematinics|mesh-ancestor
139654253|NCT05548998|Anesthetics|anesthetics|mesh-list
139654254|NCT05548998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139654255|NCT05548998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654256|NCT01666782|Vaccines|vaccines|mesh-list
139654257|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
139654258|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654259|NCT00058019|Epothilones|epothilones|mesh-list
139654260|NCT00058019|Epothilone B|epothilone b|mesh-list
139654261|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
139045886|NCT01078714|Bumetanide|bumetanide|mesh-list
139654262|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
139654263|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
139654264|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654265|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654266|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139654267|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
139654268|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654269|NCT00110461|Aripiprazole|aripiprazole|mesh-list
139654270|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
139654271|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139654272|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139654273|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139654274|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139654275|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654276|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
139654277|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
139654278|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654279|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654280|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139654281|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139654282|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
139045933|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045934|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139045935|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139045936|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
139045937|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139045944|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139045945|NCT01078870|Escitalopram|escitalopram|mesh-list
139654283|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139654284|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139654285|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139654286|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139654287|NCT00061373|Aspirin|aspirin|mesh-list
139654288|NCT00061373|Tinzaparin|tinzaparin|mesh-list
139654289|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139654291|NCT00061373|Eptifibatide|eptifibatide|mesh-list
139654292|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139654293|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139654294|NCT00061373|Analgesics|analgesics|mesh-ancestor
139654295|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
139654296|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654297|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654298|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139654299|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139654300|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139654301|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139654302|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654303|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139045989|NCT00104572|Hormones|hormones|mesh-ancestor
139654304|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139654305|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654306|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
139654307|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
139654308|NCT01897337|Aprepitant|aprepitant|mesh-list
139654309|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
139654310|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
139654311|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654312|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654313|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139654314|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139654315|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654316|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654317|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
139654318|NCT03089333|Glyburide|glyburide|mesh-list
139654319|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139654320|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654321|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139654322|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654323|NCT00112723|Alvocidib|alvocidib|mesh-list
139654324|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654325|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
139654326|NCT00112723|Growth Substances|growth substances|mesh-ancestor
139654327|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654328|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139654329|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654330|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654331|NCT04327206|Vaccines|vaccines|mesh-list
139654332|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
139654333|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
139654334|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654335|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139654336|NCT00115297|Montelukast|montelukast|mesh-list
139654337|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139654338|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
139046038|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
139654339|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139654340|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
139654341|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654342|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654343|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139654344|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139654345|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654346|NCT00116857|Sertraline|sertraline|mesh-list
139654347|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
139654348|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139654349|NCT00116857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139654350|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139654351|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139654352|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654353|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654354|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
139654355|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654356|NCT05547828|Tislelizumab|tislelizumab|mesh-list
139654357|NCT05547828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139654358|NCT05547828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654359|NCT01672983|Ritonavir|ritonavir|mesh-list
139654360|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139418377|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139418378|NCT04810546|Lactoferrin|lactoferrin|mesh-list
139654361|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139654362|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
139654363|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046077|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654364|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654365|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139654366|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139654367|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
139654368|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139654369|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139654370|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139654371|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
139654372|NCT00117715|Caffeine|caffeine|mesh-list
139654373|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139654374|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654375|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139654376|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654377|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654378|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139654379|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139654380|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
139654381|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654382|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
139654383|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
139654384|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139654385|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139654386|NCT00228943|Tryptophan|tryptophan|mesh-list
139654387|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139654388|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
139654389|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139654390|NCT01879085|Gemcitabine|gemcitabine|mesh-list
139654391|NCT01879085|Docetaxel|docetaxel|mesh-list
139654392|NCT01879085|Vorinostat|vorinostat|mesh-list
139654393|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139654394|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
139654395|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654396|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654397|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
139654398|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
139654399|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
139046136|NCT00511355|Estradiol|estradiol|mesh-list
139654400|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139654401|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654402|NCT01439204|Abatacept|abatacept|mesh-list
139654403|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139654404|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654405|NCT01439204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139654406|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654407|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139654408|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
139654409|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654410|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139654411|NCT00063635|Vitamin E|vitamin e|mesh-list
139654412|NCT00063635|Metformin|metformin|mesh-list
139654413|NCT00063635|Vitamins|vitamins|mesh-ancestor
139654414|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
139654415|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654416|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139654417|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
139654418|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654419|NCT00063635|Protective Agents|protective agents|mesh-ancestor
139654420|NCT01439126|Clonidine|clonidine|mesh-list
139654421|NCT01439126|Analgesics|analgesics|mesh-ancestor
139654422|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
139654423|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654424|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654425|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139654426|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
139654427|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
139654428|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139654429|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139654430|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139654431|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
139654432|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654433|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654434|NCT00066677|Docetaxel|docetaxel|mesh-list
139654435|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654436|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
139654437|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
139654438|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
139654439|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654440|NCT01615731|Digoxin|digoxin|mesh-list
139654441|NCT01615731|Misoprostol|misoprostol|mesh-list
139654442|NCT01615731|Mifepristone|mifepristone|mesh-list
139654443|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139654444|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
139654445|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139654446|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654447|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139654448|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139654449|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
139654450|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139654451|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139654452|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654453|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654454|NCT01615731|Protective Agents|protective agents|mesh-ancestor
139654455|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139654456|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139654457|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139654458|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139654459|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
139654460|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139654461|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139654462|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
139654463|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654464|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
139654465|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139654466|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139654467|NCT02334800|Palbociclib|palbociclib|mesh-list
139654468|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654469|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139654470|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654471|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654472|NCT01675635|Morphine|morphine|mesh-list
139654473|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139654474|NCT01675635|Narcotics|narcotics|mesh-ancestor
139654475|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139654476|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654477|NCT01675635|Analgesics|analgesics|mesh-ancestor
139654478|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
139654479|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654480|NCT01615809|Amphotericin B|amphotericin b|mesh-list
139654481|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139654482|NCT01615809|Amebicides|amebicides|mesh-ancestor
139654483|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139654484|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139654485|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139654486|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139654487|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
139654488|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
139654489|NCT01676415|Prednisone|prednisone|mesh-list
139654490|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
139654491|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139654492|NCT01676415|Hormones|hormones|mesh-ancestor
139654493|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654494|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654495|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139654496|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654497|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
139654498|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139654499|NCT05547516|Gemcitabine|gemcitabine|mesh-list
139654500|NCT05547516|Epirubicin|epirubicin|mesh-list
139654501|NCT05547516|Mitomycins|mitomycins|mesh-list
139654502|NCT05547516|Mitomycin|mitomycin|mesh-list
139654503|NCT05547516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139654504|NCT05547516|Antimetabolites|antimetabolites|mesh-ancestor
139654505|NCT05547516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654506|NCT05547516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418379|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139654507|NCT05547516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139654508|NCT05547516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139654509|NCT05547516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139654510|NCT05547516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654511|NCT05547516|Alkylating Agents|alkylating agents|mesh-ancestor
139654512|NCT05547516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139654513|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139654515|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
139654516|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139654517|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
139654518|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654519|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654520|NCT01707225|Octreotide|octreotide|mesh-list
139654521|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139654522|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139654523|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654524|NCT01707381|Timolol|timolol|mesh-list
139654525|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654526|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139654527|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139654528|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
139654529|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654530|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654531|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139654532|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139654533|NCT05552586|Melatonin|melatonin|mesh-list
139654534|NCT05552586|Antioxidants|antioxidants|mesh-ancestor
139654535|NCT05552586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654536|NCT05552586|Protective Agents|protective agents|mesh-ancestor
139654537|NCT05552586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654538|NCT05552586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139654539|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139654540|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139654541|NCT00072449|Rituximab|rituximab|mesh-list
139654542|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139654543|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654544|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
139654545|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654546|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139654547|NCT04756661|Misoprostol|misoprostol|mesh-list
139654548|NCT04756661|Oxytocin|oxytocin|mesh-list
139654549|NCT04756661|Carbetocin|carbetocin|mesh-list
139654550|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
139654551|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139654552|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654553|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139654554|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
139654555|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139654556|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139654557|NCT01708629|Ustekinumab|ustekinumab|mesh-list
139654558|NCT01708629|Brodalumab|brodalumab|mesh-list
139654559|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139654560|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
139654561|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
139654562|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654563|NCT00073073|Vitamin D|vitamin d|mesh-list
139654564|NCT00073073|Exemestane|exemestane|mesh-list
139654565|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
139654566|NCT00073073|Calcium|calcium|mesh-list
139654567|NCT00073073|Vitamins|vitamins|mesh-ancestor
139046407|NCT00504725|Ketamine|ketamine|mesh-list
139654568|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
139654569|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654570|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139654571|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139654572|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654573|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139654574|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139654575|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654576|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654577|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139654578|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
139654579|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654580|NCT00073073|Antacids|antacids|mesh-ancestor
139654581|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139654582|NCT01466660|Gefitinib|gefitinib|mesh-list
139654583|NCT01466660|Afatinib|afatinib|mesh-list
139654584|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418380|NCT04596826|Dronabinol|dronabinol|mesh-list
139654585|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139654586|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654587|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654588|NCT00075335|Plerixafor|plerixafor|mesh-list
139654589|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139654590|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139654591|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
139654592|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139654593|NCT01680549|Gabapentin|gabapentin|mesh-list
139654594|NCT01680549|Analgesics|analgesics|mesh-ancestor
139654595|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
139654596|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654597|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654598|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
139654599|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139654600|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139654601|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139654602|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139654603|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139654604|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139654605|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654606|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654607|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
139654608|NCT01466348|Acetaminophen|acetaminophen|mesh-list
139654609|NCT01466348|Caffeine|caffeine|mesh-list
139654610|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139654611|NCT01466348|Analgesics|analgesics|mesh-ancestor
139654612|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
139654613|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654614|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654615|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
139654616|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139654617|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139654618|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654619|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654620|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139654621|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139654622|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
139654623|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654624|NCT01466270|Donepezil|donepezil|mesh-list
139046500|NCT00361634|Etanercept|etanercept|mesh-list
139654625|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139654626|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654627|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654628|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
139654629|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654630|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654631|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
139654632|NCT02235987|Octreotide|octreotide|mesh-list
139654633|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139654634|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139654635|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654636|NCT01466192|Ribavirin|ribavirin|mesh-list
139654637|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139654638|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
139654639|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654640|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
139654641|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139654642|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
139654643|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139654644|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139654645|NCT00120523|Analgesics|analgesics|mesh-ancestor
139046541|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654646|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
139654647|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654648|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654649|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139654650|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139654651|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
139654652|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139654653|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
139654654|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139654655|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654656|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418382|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654657|NCT01438814|Metformin|metformin|mesh-list
139654658|NCT01438814|Linagliptin|linagliptin|mesh-list
139654659|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139654660|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654661|NCT01438814|Incretins|incretins|mesh-ancestor
139654662|NCT01438814|Hormones|hormones|mesh-ancestor
139654663|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654664|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139654665|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
139654666|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654667|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654668|NCT04425876|Fluzoparib|fluzoparib|mesh-list
139654669|NCT04425876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139654670|NCT04425876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654671|NCT04425876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654672|NCT04425876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654673|NCT01681095|Tryptophan|tryptophan|mesh-list
139654674|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139654675|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
139654676|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139654677|NCT00121225|Vorinostat|vorinostat|mesh-list
139654678|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654679|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139654680|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654681|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654682|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
139654683|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139654684|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654685|NCT05545800|Insulin|insulin|mesh-list
139654686|NCT05545800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139654687|NCT05545800|Metformin|metformin|mesh-list
139654688|NCT05545800|Insulin Glargine|insulin glargine|mesh-list
139654689|NCT05545800|Empagliflozin|empagliflozin|mesh-list
139654690|NCT05545800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139654691|NCT05545800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654692|NCT05545800|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139654693|NCT05545800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654694|NCT00230737|Melatonin|melatonin|mesh-list
139654695|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
139654696|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654697|NCT00230737|Protective Agents|protective agents|mesh-ancestor
139654698|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654699|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139654700|NCT04425564|Capecitabine|capecitabine|mesh-list
139654701|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
139654702|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139654703|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
139654704|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654705|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654706|NCT01686165|Rituximab|rituximab|mesh-list
139654707|NCT01686165|Belinostat|belinostat|mesh-list
139654708|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139654709|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139654710|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654711|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
139654712|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654713|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139654714|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139654715|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654716|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654717|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
139654718|NCT00123643|Glyburide|glyburide|mesh-list
139654719|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139654720|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654721|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
139654722|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
139654723|NCT00235573|Vitamins|vitamins|mesh-ancestor
139654724|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
139654725|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654726|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
139654727|NCT00235573|Hematinics|hematinics|mesh-ancestor
139654728|NCT01687179|Sirolimus|sirolimus|mesh-list
139654729|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
139654730|NCT01687179|Temsirolimus|temsirolimus|mesh-list
139418383|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139418384|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139654731|NCT01687179|MTOR Inhibitors|mtor inhibitors|mesh-list
139654732|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139654733|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139654735|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654736|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
139654737|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139654738|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
139654739|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046677|NCT01053338|Ibuprofen|ibuprofen|mesh-list
139654740|NCT01687179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139654741|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654742|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654743|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
139654744|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139654745|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139654746|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139654747|NCT00124579|Thalidomide|thalidomide|mesh-list
139654748|NCT00124579|Dexamethasone|dexamethasone|mesh-list
139654749|NCT00124579|Bortezomib|bortezomib|mesh-list
139654750|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139654751|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
139654752|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
139654753|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654754|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654755|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139654756|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
139654757|NCT00124579|Hormones|hormones|mesh-ancestor
139654758|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654759|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139654760|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654761|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139654762|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
139654763|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
139654764|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139654765|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139654766|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139654767|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139654768|NCT00124579|Growth Substances|growth substances|mesh-ancestor
139654769|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
139654770|NCT05550090|Immunomodulating Agents|immunomodulating agents|mesh-list
139654771|NCT05550090|Immunologic Factors|immunologic factors|mesh-ancestor
139654772|NCT05550090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654773|NCT00124735|Rocuronium|rocuronium|mesh-list
139654774|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139654775|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139654776|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139654777|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654778|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654779|NCT05340309|Atezolizumab|atezolizumab|mesh-list
139654780|NCT05340309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139654781|NCT05340309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139654782|NCT05340309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654783|NCT05340309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139654784|NCT05340309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654785|NCT05340309|Immunologic Factors|immunologic factors|mesh-ancestor
139654786|NCT05340309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654787|NCT00125515|Naltrexone|naltrexone|mesh-list
139654788|NCT00125515|Memantine|memantine|mesh-list
139654789|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139654790|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139654791|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654792|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
139654793|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654794|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139654795|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139654796|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
139654797|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654798|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418385|NCT04596826|Analgesics|analgesics|mesh-ancestor
139418386|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
139418387|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418388|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139418389|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139418390|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418391|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418392|NCT04596826|Hormones|hormones|mesh-ancestor
139143022|NCT02110966|Tramadol|tramadol|mesh-list
139143100|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
139654799|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139654800|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139654801|NCT00125593|Simvastatin|simvastatin|mesh-list
139654802|NCT00125593|Ezetimibe|ezetimibe|mesh-list
139654803|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139654804|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139654805|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
139654806|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654807|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139654808|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139654809|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654810|NCT01689441|Calcitriol|calcitriol|mesh-list
139654811|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139654812|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654813|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139654814|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139654815|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654816|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139654817|NCT01689441|Vitamins|vitamins|mesh-ancestor
139654818|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
139654819|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139654820|NCT00236977|Iron|iron|mesh-list
139046762|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
139654821|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139654822|NCT00236977|Trace Elements|trace elements|mesh-ancestor
139654823|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
139654824|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654825|NCT00236977|Hematinics|hematinics|mesh-ancestor
139654826|NCT04753177|Paclitaxel|paclitaxel|mesh-list
139654827|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
139654828|NCT04753177|Doxorubicin|doxorubicin|mesh-list
139654829|NCT04753177|Fulvestrant|fulvestrant|mesh-list
139654830|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139654831|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139654832|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654833|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
139654834|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
139654835|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
139654836|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654837|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139654838|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
139654839|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654840|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139654841|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139654842|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
139654843|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139654844|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139654845|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139654846|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139654847|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654848|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139654849|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139654850|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139654851|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
139654852|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654853|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
139654854|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139654855|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
139654856|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139654857|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139654858|NCT01691313|Vanoxerine|vanoxerine|mesh-list
139654859|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139654860|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139654861|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139654862|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654863|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
139654864|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143101|NCT03745599|Benzydamine|benzydamine|mesh-list
139143102|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139143103|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139143104|NCT03745599|Analgesics|analgesics|mesh-ancestor
139143105|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
139143106|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143167|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
139654865|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654866|NCT00079001|Vitamin D|vitamin d|mesh-list
139654867|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
139654868|NCT00079001|Calcium|calcium|mesh-list
139654869|NCT00079001|Androgens|androgens|mesh-list
139654870|NCT00079001|Vitamins|vitamins|mesh-ancestor
139654871|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
139654872|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654873|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139654874|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139654875|NCT00079001|Hormones|hormones|mesh-ancestor
139654876|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654877|NCT05234307|Nivolumab|nivolumab|mesh-list
139654878|NCT05234307|Adenosine|adenosine|mesh-list
139654879|NCT05234307|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-list
139654880|NCT05234307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139654881|NCT05234307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654882|NCT05234307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139654883|NCT05234307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654884|NCT05234307|Analgesics|analgesics|mesh-ancestor
139654885|NCT05234307|Sensory System Agents|sensory system agents|mesh-ancestor
139654886|NCT05234307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046886|NCT01073319|Rivastigmine|rivastigmine|mesh-list
139654887|NCT05234307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654888|NCT05234307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139654889|NCT05234307|Vasodilator Agents|vasodilator agents|mesh-ancestor
139654890|NCT05234307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139654891|NCT05234307|Purinergic Agonists|purinergic agonists|mesh-ancestor
139654892|NCT05234307|Purinergic Agents|purinergic agents|mesh-ancestor
139654893|NCT05234307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654894|NCT05234307|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139654895|NCT05234307|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139654896|NCT00238615|Carboplatin|carboplatin|mesh-list
139654897|NCT00238615|Docetaxel|docetaxel|mesh-list
139654898|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654899|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
139654900|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
139654901|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
139654902|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654903|NCT02243943|Neostigmine|neostigmine|mesh-list
139654904|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139654905|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654906|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654907|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
139654908|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654909|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654910|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139654911|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
139654912|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654913|NCT03088631|Metformin|metformin|mesh-list
139654914|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139654915|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654916|NCT00131677|Tenofovir|tenofovir|mesh-list
139654917|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
139654918|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139654919|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139654920|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139654921|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654922|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654923|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139654924|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139654925|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
139654926|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139654927|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
139654928|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654929|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654930|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139654931|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
139654932|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139654933|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
139654934|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654935|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139654936|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139654937|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
139143168|NCT02109718|Petrolatum|petrolatum|mesh-list
139418393|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139418394|NCT02440568|Cytarabine|cytarabine|mesh-list
139418395|NCT02440568|Idarubicin|idarubicin|mesh-list
139418396|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
139654938|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
139654939|NCT00240487|Protective Agents|protective agents|mesh-ancestor
139654940|NCT02126917|Ethanol|ethanol|mesh-list
139654941|NCT02126917|Hydrocodone|hydrocodone|mesh-list
139654942|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139654943|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139654944|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139654945|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654946|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139654947|NCT02126917|Narcotics|narcotics|mesh-ancestor
139654948|NCT02126917|Analgesics|analgesics|mesh-ancestor
139654949|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
139654950|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654951|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
139654952|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
139654953|NCT01895075|Budesonide|budesonide|mesh-list
139654954|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139654955|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139654956|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
139654957|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139654958|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047051|NCT04331717|Leuprolide|leuprolide|mesh-list
139654959|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139654960|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
139654961|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
139654962|NCT01895075|Hormones|hormones|mesh-ancestor
139654963|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654964|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
139654965|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
139654966|NCT03088709|Tacrolimus|tacrolimus|mesh-list
139654967|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139654968|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
139654969|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654970|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139654971|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139654972|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
139654973|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139654974|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139654975|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139654976|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139654977|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654978|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139654979|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139654980|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
139654981|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139654982|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139654983|NCT03139305|Glucagon|glucagon|mesh-list
139654984|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139654985|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139654986|NCT03139305|Hormones|hormones|mesh-ancestor
139654987|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139654988|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139654989|NCT03139305|Incretins|incretins|mesh-ancestor
139654990|NCT00084149|Ritonavir|ritonavir|mesh-list
139654991|NCT00084149|Lopinavir|lopinavir|mesh-list
139654992|NCT00084149|Lamivudine|lamivudine|mesh-list
139654993|NCT00084149|Zidovudine|zidovudine|mesh-list
139654994|NCT00084149|Abacavir|abacavir|mesh-list
139654995|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139654996|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139654997|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
139654998|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139654999|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655000|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139655001|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139655002|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
139655003|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655004|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139047080|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
139655005|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139655006|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139418397|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139655007|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139655008|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
139655009|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
139655010|NCT02959905|Fludarabine|fludarabine|mesh-list
139418398|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
139655011|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
139655012|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655013|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
139655014|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655015|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655016|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139655017|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
139655018|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655019|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655020|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139655021|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139655022|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
139655023|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
139655025|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655026|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
139655027|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655028|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655029|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139655030|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
139655031|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655032|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655033|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139655034|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
139655035|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
139655036|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139655037|NCT04783051|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139655038|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
139655039|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139655040|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139655041|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655042|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139655043|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655044|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655045|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139655046|NCT04783051|Antiviral Agents|antiviral agents|mesh-ancestor
139655047|NCT00243061|Cediranib|cediranib|mesh-list
139655048|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655049|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655050|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655051|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139655052|NCT00245557|Sertraline|sertraline|mesh-list
139655053|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
139655054|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139655055|NCT00245557|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139655056|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139655057|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139655058|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655059|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139655060|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
139655061|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655062|NCT00245635|Fluoxetine|fluoxetine|mesh-list
139655063|NCT00245635|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139655064|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139655065|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139655066|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655067|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139655068|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
139655069|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655070|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139655071|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
139655072|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139655073|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139655074|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139655075|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655076|NCT00141115|Levetiracetam|levetiracetam|mesh-list
139655077|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
139655078|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
139655079|NCT00249379|Acamprosate|acamprosate|mesh-list
139418399|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418400|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047234|NCT00503009|Xhance|xhance|mesh-list
139655080|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139655081|NCT00141739|Etanercept|etanercept|mesh-list
139418401|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
139655082|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139655083|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139655084|NCT00141739|Analgesics|analgesics|mesh-ancestor
139655085|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
139655086|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655087|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655088|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139655089|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655090|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139655091|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655092|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
139655093|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139655094|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
139655095|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655096|NCT00086957|Docetaxel|docetaxel|mesh-list
139655097|NCT00086957|Trastuzumab|trastuzumab|mesh-list
139655098|NCT00086957|Gefitinib|gefitinib|mesh-list
139655099|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655100|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
139655101|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
139655102|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
139655103|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655104|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139655105|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139655106|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655107|NCT00144391|Testosterone|testosterone|mesh-list
139655108|NCT00144391|Androgens|androgens|mesh-ancestor
139655109|NCT00144391|Hormones|hormones|mesh-ancestor
139655110|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139655111|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655112|NCT00145249|Fluconazole|fluconazole|mesh-list
139655113|NCT00145249|Amphotericin B|amphotericin b|mesh-list
139655114|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139655115|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
139655116|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655117|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139655118|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139655119|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655120|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655121|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139655122|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
139655123|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139655124|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655125|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139655126|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139655127|NCT00145249|Amebicides|amebicides|mesh-ancestor
139655128|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139655129|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139655130|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139655131|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139655132|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655133|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139655134|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655135|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655136|NCT00252967|Atorvastatin|atorvastatin|mesh-list
139655137|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139655138|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139655139|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
139655140|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655141|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139655142|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139655143|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655144|NCT00088985|Trastuzumab|trastuzumab|mesh-list
139655145|NCT00088985|Vinorelbine|vinorelbine|mesh-list
139655146|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139655147|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655148|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139655149|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
139655150|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
139418402|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655151|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
139655152|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655154|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139655155|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139655156|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655157|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
139655158|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655159|NCT00093041|Zalutumumab|zalutumumab|mesh-list
139655160|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139655161|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655162|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139655163|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
139655164|NCT01769885|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139655165|NCT01769885|Tivozanib|tivozanib|mesh-list
139655166|NCT01769885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139655167|NCT01769885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655168|NCT01769885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655169|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139655170|NCT01895231|Hematinics|hematinics|mesh-ancestor
139655171|NCT04745663|Iodine|iodine|mesh-list
139655172|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
139655173|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
139655174|NCT04745663|Povidone|povidone|mesh-list
139655175|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139655176|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655177|NCT04745663|Trace Elements|trace elements|mesh-ancestor
139655178|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
139655179|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655180|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
139655181|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
139655182|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
139655183|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139655184|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139655185|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
139655186|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139655187|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655188|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655189|NCT01747577|Urological Agents|urological agents|mesh-ancestor
139655190|NCT00159263|Budesonide|budesonide|mesh-list
139655191|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
139655192|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139655193|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139655194|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
139655195|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655196|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655197|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139655198|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
139655199|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
139655200|NCT00159263|Hormones|hormones|mesh-ancestor
139655201|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139655202|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139655203|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139655204|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139655205|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
139655206|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139655207|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655208|NCT00159419|Alendronate|alendronate|mesh-list
139655209|NCT00159419|Pamidronate|pamidronate|mesh-list
139655210|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139655211|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655212|NCT00159965|Sertraline|sertraline|mesh-list
139655213|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
139655214|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139655215|NCT00159965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139655216|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139655217|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139655218|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655219|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139655220|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
139047439|NCT00376220|Riluzole|riluzole|mesh-list
139655221|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655222|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
139655223|NCT02926833|Fludarabine|fludarabine|mesh-list
139655224|NCT02926833|Atezolizumab|atezolizumab|mesh-list
139655225|NCT02926833|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139418403|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655226|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655227|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
139655228|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655229|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655230|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139655231|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
139655232|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655233|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655234|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139655235|NCT02926833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139655236|NCT02926833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139655237|NCT00096161|Cyclosporine|cyclosporine|mesh-list
139047478|NCT01013987|Ritonavir|ritonavir|mesh-list
139655238|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
139655239|NCT00096161|Vidarabine|vidarabine|mesh-list
139655240|NCT00096161|Pentostatin|pentostatin|mesh-list
139655241|NCT00096161|Cyclosporins|cyclosporins|mesh-list
139655242|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655243|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655244|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655245|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
139655246|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655247|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
139655248|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655249|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
139655250|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655251|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139655252|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139655253|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655254|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139655255|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
139655256|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139655257|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139655258|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
139655259|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
139655260|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
139655261|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655262|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
139655263|NCT01898039|Vaccines|vaccines|mesh-list
139655264|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
139655265|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655266|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655267|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655268|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139655269|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
139047532|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
139655270|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655271|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655272|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139655273|NCT00099047|Celecoxib|celecoxib|mesh-list
139655274|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139655275|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139655276|NCT00099047|Analgesics|analgesics|mesh-ancestor
139655277|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
139655278|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655279|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655280|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139655281|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655282|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139655283|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139655284|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655285|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655286|NCT02851797|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
139655287|NCT02851797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139655288|NCT02851797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655289|NCT02851797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655290|NCT00253435|Carboplatin|carboplatin|mesh-list
139655291|NCT00253435|Etoposide|etoposide|mesh-list
139655292|NCT00253435|Melphalan|melphalan|mesh-list
139655293|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655294|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139655295|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139655296|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139655297|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655298|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655299|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
139655300|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655301|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139655302|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
139047634|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
139655303|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139655304|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655305|NCT00253513|Fludarabine|fludarabine|mesh-list
139655306|NCT00253513|Treosulfan|treosulfan|mesh-list
139655307|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655308|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655309|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139655310|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
139655311|NCT05033847|Vaccines|vaccines|mesh-list
139655312|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
139655313|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655314|NCT02098993|Heparin|heparin|mesh-list
139655315|NCT02098993|Calcium heparin|calcium heparin|mesh-list
139655316|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
139655317|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139655318|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139655319|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655320|NCT04930107|Fluconazole|fluconazole|mesh-list
139655321|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
139047702|NCT01062048|Hormones|hormones|mesh-ancestor
139655322|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655323|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139655324|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139655325|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655326|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655327|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139655328|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
139655329|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139655330|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655331|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139655332|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139655333|NCT00100841|Leucovorin|leucovorin|mesh-list
139655334|NCT00100841|Bevacizumab|bevacizumab|mesh-list
139655335|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139655336|NCT00100841|Cetuximab|cetuximab|mesh-list
139655337|NCT00100841|Fluorouracil|fluorouracil|mesh-list
139655338|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
139655339|NCT00100841|Antibodies|antibodies|mesh-list
139655340|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
139655341|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139655342|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
139655343|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655344|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139655345|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139655346|NCT00100841|Growth Substances|growth substances|mesh-ancestor
139655347|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655348|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
139655349|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
139655350|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
139655351|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655352|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139655353|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655354|NCT00100841|Antidotes|antidotes|mesh-ancestor
139655355|NCT00100841|Protective Agents|protective agents|mesh-ancestor
139655356|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
139655357|NCT00100841|Vitamins|vitamins|mesh-ancestor
139655358|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
139655359|NCT00149227|Valsartan|valsartan|mesh-list
139655360|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
139655361|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139655362|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139655363|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655364|NCT00445965|Antibodies|antibodies|mesh-list
139655365|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139655366|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
139655367|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655368|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
139418404|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
139418405|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655369|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139143611|NCT02113072|Hormones|hormones|mesh-ancestor
139655370|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139655371|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139655372|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139655373|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139655374|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655375|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
139655376|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139655377|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655378|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139655379|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655381|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139655382|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139655383|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
139655384|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139655385|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655386|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655387|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139655388|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139655389|NCT00258349|Trastuzumab|trastuzumab|mesh-list
139655390|NCT00258349|Vorinostat|vorinostat|mesh-list
139655391|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139655392|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655393|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139655394|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655395|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655396|NCT01713621|Artefenomel|artefenomel|mesh-list
139655397|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
139655398|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139655399|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139655400|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655401|NCT00258817|Vaccines|vaccines|mesh-list
139655402|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
139655403|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655404|NCT00259285|Pemetrexed|pemetrexed|mesh-list
139655405|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655406|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655407|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655408|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139655409|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139655410|NCT01716039|Adalimumab|adalimumab|mesh-list
139655411|NCT01716039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139655412|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139655413|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655414|NCT01716195|Paclitaxel|paclitaxel|mesh-list
139655415|NCT01716195|Carboplatin|carboplatin|mesh-list
139655416|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139655417|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655418|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
139655419|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
139655420|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
139655421|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655422|NCT02249481|Bupivacaine|bupivacaine|mesh-list
139655423|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
139655424|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
139655425|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139655426|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655427|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
139655428|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655429|NCT01717053|Prednisone|prednisone|mesh-list
139655430|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
139655431|NCT01717053|Androgens|androgens|mesh-list
139655432|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139655433|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
139655434|NCT01717053|Hormones|hormones|mesh-ancestor
139655435|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139655436|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655437|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139655438|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655439|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139655440|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655441|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655442|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
139418406|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139418407|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139143678|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
139655443|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139655444|NCT01666314|Prednisone|prednisone|mesh-list
139655445|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139655446|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
139655447|NCT01666314|Hormones|hormones|mesh-ancestor
139655448|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139655449|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655450|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139655451|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655452|NCT01717209|Epoprostenol|epoprostenol|mesh-list
139655453|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
139655454|NCT01717209|Tezosentan|tezosentan|mesh-list
139655455|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139655456|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
139655457|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655458|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655459|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139655460|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
139655461|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139655462|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
139655463|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655464|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139655465|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139655466|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
139047997|NCT00350870|Disulfiram|disulfiram|mesh-list
139655467|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
139655468|NCT01717209|Protective Agents|protective agents|mesh-ancestor
139655469|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139655470|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139655471|NCT00260689|Cyclosporine|cyclosporine|mesh-list
139655472|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
139655473|NCT00260689|Cyclosporins|cyclosporins|mesh-list
139655474|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139655475|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
139655476|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655477|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655478|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655479|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
139655480|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655481|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
139655482|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655483|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
139655484|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655485|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139655486|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139655487|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655488|NCT00262639|Gabapentin|gabapentin|mesh-list
139655489|NCT00262639|Flumazenil|flumazenil|mesh-list
139655490|NCT00262639|Analgesics|analgesics|mesh-ancestor
139655491|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
139655492|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655493|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655494|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
139655495|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139655496|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139655497|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139655498|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139655499|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139655500|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139655501|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139655502|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655503|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
139655504|NCT00262639|Antidotes|antidotes|mesh-ancestor
139655505|NCT00262639|Protective Agents|protective agents|mesh-ancestor
139655506|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
139655507|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
139655508|NCT01062451|Candesartan|candesartan|mesh-list
139655509|NCT01062451|Candesartan cilexetil|candesartan cilexetil|mesh-list
139655510|NCT01062451|Perindopril|perindopril|mesh-list
139655511|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139655512|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139655513|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139418408|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139418409|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655514|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655515|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139655516|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
139655517|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655519|NCT04639843|Romidepsin|romidepsin|mesh-list
139655520|NCT04639843|Azacitidine|azacitidine|mesh-list
139655521|NCT04639843|Cc-486|cc-486|mesh-list
139655522|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139655523|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655524|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139655525|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139655526|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655527|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655528|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139655529|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
139655530|NCT04639843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139655531|NCT01718691|Rituximab|rituximab|mesh-list
139655532|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139655533|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655534|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
139655535|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655536|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655537|NCT05699148|Ivacaftor|ivacaftor|mesh-list
139655538|NCT05699148|Elexacaftor|elexacaftor|mesh-list
139655539|NCT05699148|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139655540|NCT05699148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139655541|NCT05699148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655542|NCT04425642|Methamphetamine|methamphetamine|mesh-list
139655543|NCT04425642|SMOFlipid|smoflipid|mesh-list
139655544|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139048224|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139655545|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655546|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
139655547|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
139655548|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655549|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
139655550|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139655551|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655552|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
139655553|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139655554|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139655555|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139655556|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139655557|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139655558|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139655559|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139655560|NCT00266851|Azithromycin|azithromycin|mesh-list
139655561|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139655562|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655563|NCT00015847|Interferons|interferons|mesh-list
139655564|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
139655565|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
139655566|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655567|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
139655568|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655569|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
139655570|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655571|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139655572|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655573|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655574|NCT01665768|Rituximab|rituximab|mesh-list
139655575|NCT01665768|Everolimus|everolimus|mesh-list
139655576|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139655577|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655578|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
139655579|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655580|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655581|NCT01665768|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139655582|NCT01665768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139655583|NCT01665768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655584|NCT01665768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655585|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655586|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
139655587|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
139655588|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655589|NCT00017563|Docetaxel|docetaxel|mesh-list
139655590|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
139418410|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139655591|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655592|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
139655593|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
139655594|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
139655595|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655596|NCT00017563|Analgesics|analgesics|mesh-ancestor
139655597|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
139655598|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655599|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655600|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139655601|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139655602|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655603|NCT00018031|Ribavirin|ribavirin|mesh-list
139655604|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139655605|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
139655606|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
139048385|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
139655607|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655608|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
139655609|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655610|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
139655611|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655612|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
139655613|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655614|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139655615|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655616|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655617|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
139655618|NCT04476511|Vitamin D|vitamin d|mesh-list
139655619|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139655620|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655621|NCT04476511|Vitamins|vitamins|mesh-ancestor
139655622|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
139655623|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139655624|NCT00026221|Interferons|interferons|mesh-list
139655625|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
139655626|NCT00026221|Bevacizumab|bevacizumab|mesh-list
139655627|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139655628|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655629|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139655630|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139655631|NCT00026221|Growth Substances|growth substances|mesh-ancestor
139655632|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655633|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
139655634|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
139655635|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655636|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
139655637|NCT00028093|Ribavirin|ribavirin|mesh-list
139655638|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139655639|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
139655640|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
139655641|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655642|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
139655643|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655644|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
139655645|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655646|NCT01721967|Ranolazine|ranolazine|mesh-list
139655647|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139655648|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139655649|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655650|NCT04026451|Propofol|propofol|mesh-list
139655651|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139048498|NCT00314808|Hormones|hormones|mesh-ancestor
139655652|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139655653|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655654|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139655655|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
139655656|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
139655657|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
139655658|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139655659|NCT01722435|Narcotics|narcotics|mesh-ancestor
139655660|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139655661|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418411|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139655662|NCT01722435|Analgesics|analgesics|mesh-ancestor
139655663|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
139655664|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655665|NCT00029107|Rituximab|rituximab|mesh-list
139655666|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139655667|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655668|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
139655669|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655670|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655671|NCT04389229|Aldesleukin|aldesleukin|mesh-list
139655672|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
139655673|NCT04389229|Fludarabine|fludarabine|mesh-list
139655674|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655675|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
139655676|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655677|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655678|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139655679|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
139655680|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655681|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655682|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139655683|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139655684|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139655685|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
139655686|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655687|NCT00271219|Buprenorphine|buprenorphine|mesh-list
139655688|NCT00271219|Methadone|methadone|mesh-list
139655689|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139655690|NCT00271219|Narcotics|narcotics|mesh-ancestor
139655691|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139655692|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655693|NCT00271219|Analgesics|analgesics|mesh-ancestor
139655694|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
139655695|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655696|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139655697|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
139048601|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139655698|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
139655699|NCT02240667|Vitamin K|vitamin k|mesh-list
139655700|NCT02240667|Dabigatran|dabigatran|mesh-list
139655701|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
139655702|NCT02240667|Vitamins|vitamins|mesh-ancestor
139655703|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
139655704|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655705|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
139655706|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139655707|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
139655708|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655709|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655710|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
139655711|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139655712|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139655713|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
139655714|NCT02240667|Coagulants|coagulants|mesh-ancestor
139655715|NCT00272311|Aspirin|aspirin|mesh-list
139655716|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139655717|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139655718|NCT00272311|Analgesics|analgesics|mesh-ancestor
139655719|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
139655720|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655721|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655722|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139655723|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655724|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139655725|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139655726|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655727|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139048646|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139655728|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139655729|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655730|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
139655731|NCT00038857|Fludarabine|fludarabine|mesh-list
139655732|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
139655733|NCT00038857|Melphalan|melphalan|mesh-list
139655734|NCT00038857|Thiotepa|thiotepa|mesh-list
139655735|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
139655736|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139655737|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655738|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139655739|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
139655740|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655741|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655742|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
139655743|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655744|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139655745|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
139655746|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139655747|NCT03097068|Ranibizumab|ranibizumab|mesh-list
139655748|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139655749|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139655750|NCT03097068|Growth Substances|growth substances|mesh-ancestor
139048692|NCT03984110|Growth Substances|growth substances|mesh-ancestor
139655751|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655752|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
139655753|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655754|NCT01729845|Cytarabine|cytarabine|mesh-list
139655755|NCT01729845|Etoposide|etoposide|mesh-list
139655756|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
139655757|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
139655758|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
139655759|NCT01729845|Decitabine|decitabine|mesh-list
139655760|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139655761|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655762|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139655763|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139655764|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655765|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655766|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139655767|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
139655768|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
139655769|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655770|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655771|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
139655772|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655773|NCT01729845|Analgesics|analgesics|mesh-ancestor
139655774|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
139655775|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655776|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
139655777|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
139655778|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
139655779|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
139655780|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
139655781|NCT01729923|Celecoxib|celecoxib|mesh-list
139655782|NCT01729923|Capecitabine|capecitabine|mesh-list
139655783|NCT01729923|Benzenesulfonamide|benzenesulfonamide|mesh-list
139655784|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139655785|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
139655786|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655787|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655788|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139655789|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139655790|NCT01729923|Analgesics|analgesics|mesh-ancestor
139655791|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
139655792|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655793|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655794|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139655795|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655796|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139655797|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139655798|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655799|NCT01729923|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139655800|NCT02584452|Dexamethasone|dexamethasone|mesh-list
139655801|NCT02584452|Fentanyl|fentanyl|mesh-list
139655802|NCT02584452|Bupivacaine|bupivacaine|mesh-list
139655803|NCT02584452|Ropivacaine|ropivacaine|mesh-list
139655804|NCT02584452|Mepivacaine|mepivacaine|mesh-list
139655805|NCT02584452|Propofol|propofol|mesh-list
139655806|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139655807|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
139655808|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
139655809|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655810|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655811|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139655812|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
139655813|NCT02584452|Hormones|hormones|mesh-ancestor
139655814|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139655815|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139655816|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655817|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
139655818|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
139144043|NCT02126644|Glycolic acid|glycolic acid|mesh-list
139655819|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139655820|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
139655821|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139655822|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139655823|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
139655824|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139655825|NCT02584452|Narcotics|narcotics|mesh-ancestor
139655826|NCT02584452|Analgesics|analgesics|mesh-ancestor
139655827|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139655828|NCT05679102|Amlodipine|amlodipine|mesh-list
139655829|NCT05679102|Atorvastatin|atorvastatin|mesh-list
139655830|NCT05679102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139655831|NCT05679102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139655832|NCT05679102|Antimetabolites|antimetabolites|mesh-ancestor
139655833|NCT05679102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655834|NCT05679102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139655835|NCT05679102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139655836|NCT05679102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655837|NCT05679102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139655838|NCT05679102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139655839|NCT05679102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139655840|NCT05679102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139655841|NCT05679102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655842|NCT05679102|Vasodilator Agents|vasodilator agents|mesh-ancestor
139655843|NCT03520491|Nivolumab|nivolumab|mesh-list
139655844|NCT03520491|Ipilimumab|ipilimumab|mesh-list
139655845|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139655846|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655847|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139655848|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655849|NCT05588934|Caffeine|caffeine|mesh-list
139655850|NCT05588934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139655851|NCT05588934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655852|NCT05588934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139655853|NCT05588934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048957|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655854|NCT05588934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655855|NCT05588934|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139655856|NCT05588934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139655857|NCT05588934|Purinergic Agents|purinergic agents|mesh-ancestor
139655858|NCT05588934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139655859|NCT02243007|Paclitaxel|paclitaxel|mesh-list
139655860|NCT02243007|Gemcitabine|gemcitabine|mesh-list
139655861|NCT02243007|Capecitabine|capecitabine|mesh-list
139655862|NCT02243007|Folfirinox|folfirinox|mesh-list
139655863|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139655864|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655865|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
139655866|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
139655867|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
139655868|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655869|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139655870|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
139655871|NCT05536596|Hydroxocobalamin|hydroxocobalamin|mesh-list
139655872|NCT05536596|Vitamin B 12|vitamin b 12|mesh-list
139655873|NCT05536596|Melatonin|melatonin|mesh-list
139655874|NCT05536596|Antioxidants|antioxidants|mesh-ancestor
139655875|NCT05536596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655876|NCT05536596|Protective Agents|protective agents|mesh-ancestor
139655877|NCT05536596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655878|NCT05536596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139655879|NCT05536596|Hematinics|hematinics|mesh-ancestor
139655880|NCT05536596|Vitamin B Complex|vitamin b complex|mesh-ancestor
139655881|NCT05536596|Vitamins|vitamins|mesh-ancestor
139655882|NCT05536596|Micronutrients|micronutrients|mesh-ancestor
139655883|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
139655884|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655885|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139655886|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049069|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655887|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655888|NCT03430791|Nivolumab|nivolumab|mesh-list
139655889|NCT03430791|Ipilimumab|ipilimumab|mesh-list
139655890|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139655891|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655892|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139655893|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418412|NCT04420624|Colchicine|colchicine|mesh-list
139655894|NCT05536128|Fulvestrant|fulvestrant|mesh-list
139418413|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
139655895|NCT05536128|Olaparib|olaparib|mesh-list
139655896|NCT05536128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139655897|NCT05536128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655898|NCT05536128|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139655899|NCT05536128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139655900|NCT05536128|Hormone Antagonists|hormone antagonists|mesh-ancestor
139655901|NCT05536128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139655902|NCT05536128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655903|NCT05536128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139655904|NCT05536128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655905|NCT05536128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655906|NCT04790175|Tolvaptan|tolvaptan|mesh-list
139655907|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139655908|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655909|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
139655910|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655911|NCT05316675|Isotretinoin|isotretinoin|mesh-list
139655912|NCT05316675|Dermatologic Agents|dermatologic agents|mesh-ancestor
139655913|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
139655914|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139655915|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655916|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139655917|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655918|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
139655919|NCT01736865|Vitamin D|vitamin d|mesh-list
139655920|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139655921|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655922|NCT01736865|Vitamins|vitamins|mesh-ancestor
139655923|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
139655924|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139655925|NCT01736943|Doxorubicin|doxorubicin|mesh-list
139655926|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139655927|NCT01736943|Bortezomib|bortezomib|mesh-list
139655928|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139655929|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655930|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139655931|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139655932|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655933|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655934|NCT01739361|Acetaminophen|acetaminophen|mesh-list
139655935|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139655936|NCT01739361|Analgesics|analgesics|mesh-ancestor
139655937|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
139655938|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139655939|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655940|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
139655941|NCT01743729|Lifitegrast|lifitegrast|mesh-list
139655942|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139655943|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139655944|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
139655945|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139655946|NCT01744353|Paclitaxel|paclitaxel|mesh-list
139655947|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655948|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655949|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139655950|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
139655951|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
139655952|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
139655953|NCT01744821|Vitamin D|vitamin d|mesh-list
139655954|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
139655955|NCT01744821|Vitamins|vitamins|mesh-ancestor
139655956|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
139655957|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655958|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139655959|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139655960|NCT04369365|Azithromycin|azithromycin|mesh-list
139655961|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139655962|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139655963|NCT01745055|Methotrexate|methotrexate|mesh-list
139655964|NCT01745055|Tofacitinib|tofacitinib|mesh-list
139655965|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139655966|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
139655967|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139655968|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418414|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139418415|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
139655969|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139655970|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
139655971|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655972|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139655973|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
139655974|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139655975|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139049175|NCT03982862|Lidocaine|lidocaine|mesh-list
139655976|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139655977|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
139655978|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139655979|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139655980|NCT01745055|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139655981|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139655982|NCT01745133|Calcitriol|calcitriol|mesh-list
139655983|NCT01745133|Clobetasol|clobetasol|mesh-list
139655984|NCT01745133|Calcipotriene|calcipotriene|mesh-list
139655985|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139655986|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
139655987|NCT01745133|Hormones|hormones|mesh-ancestor
139655988|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139655989|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139655990|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
139655991|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139655992|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139655993|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139655994|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139655995|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139655996|NCT01745133|Vitamins|vitamins|mesh-ancestor
139655997|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
139049185|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139655998|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139655999|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
139656000|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139656001|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656002|NCT04246359|Interferons|interferons|mesh-list
139656003|NCT04246359|Rituximab|rituximab|mesh-list
139656004|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139656005|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656006|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
139656007|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656008|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656009|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
139656010|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656011|NCT05213169|Apomorphine|apomorphine|mesh-list
139656012|NCT05213169|Emetics|emetics|mesh-ancestor
139656013|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656014|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
139656015|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656016|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139656017|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
139656018|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
139656019|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656020|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656021|NCT05192265|Artesunate|artesunate|mesh-list
139656022|NCT05192265|Lumefantrine|lumefantrine|mesh-list
139656023|NCT05192265|Artemether|artemether|mesh-list
139656024|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139656025|NCT05192265|Pyronaridine|pyronaridine|mesh-list
139656026|NCT05192265|Antimalarials|antimalarials|mesh-list
139656027|NCT05192265|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139656028|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139656029|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139656030|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656031|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656032|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
139656033|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
139656034|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139656035|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
139656036|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
139656037|NCT01748643|Rocuronium|rocuronium|mesh-list
139656038|NCT01748643|Neostigmine|neostigmine|mesh-list
139656039|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139656040|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139656041|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139418416|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
139656042|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656043|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418417|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
139656044|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139656045|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656046|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656047|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
139656048|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656049|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139656050|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
139656051|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139656052|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139656053|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139656054|NCT00106535|Methotrexate|methotrexate|mesh-list
139656055|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139656056|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
139656057|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139656058|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656059|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139656060|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
139656061|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656062|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656063|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
139656064|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656065|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139656066|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139656067|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
139049290|NCT01063556|Donepezil|donepezil|mesh-list
139656068|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656069|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139656070|NCT01748799|Ethanol|ethanol|mesh-list
139656071|NCT01748799|Nabiximols|nabiximols|mesh-list
139656072|NCT01748799|Dronabinol|dronabinol|mesh-list
139656073|NCT01748799|Cannabidiol|cannabidiol|mesh-list
139656074|NCT01748799|Peppermint oil|peppermint oil|mesh-list
139656075|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
139656076|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139656077|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656078|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656079|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656080|NCT01748799|Analgesics|analgesics|mesh-ancestor
139656081|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
139656082|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656083|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
139656084|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139656085|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139656086|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139656087|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139656088|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656089|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656090|NCT01748799|Hormones|hormones|mesh-ancestor
139656091|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139656092|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
139656093|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
139656094|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139656095|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
139656096|NCT04107051|Nalmefene|nalmefene|mesh-list
139656097|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139656098|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656099|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
139656100|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656101|NCT05696886|Meperidine|meperidine|mesh-list
139656102|NCT05696886|Tramadol|tramadol|mesh-list
139049320|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
139656103|NCT05696886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139656104|NCT05696886|Narcotics|narcotics|mesh-ancestor
139656105|NCT05696886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656106|NCT05696886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656107|NCT05696886|Analgesics|analgesics|mesh-ancestor
139656108|NCT05696886|Sensory System Agents|sensory system agents|mesh-ancestor
139656109|NCT05696886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656110|NCT05696886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139656111|NCT01748955|Bupropion|bupropion|mesh-list
139656112|NCT01748955|Paroxetine|paroxetine|mesh-list
139656113|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139656114|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
139656115|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139656116|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139656117|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139656118|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139656119|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418418|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418419|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418420|NCT04782778|Bupivacaine|bupivacaine|mesh-list
139418421|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
139418422|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
139418423|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139418424|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418425|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
139418426|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418427|NCT00434434|Omalizumab|omalizumab|mesh-list
139418428|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139418429|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139418430|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139418431|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
139656120|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
139656121|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656122|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049380|NCT00309608|Hormones|hormones|mesh-ancestor
139656123|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139656124|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139656125|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656126|NCT01748955|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139656127|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
139656128|NCT05687448|Warfarin|warfarin|mesh-list
139656129|NCT05687448|Apixaban|apixaban|mesh-list
139656130|NCT05687448|Anticoagulants|anticoagulants|mesh-ancestor
139656131|NCT05687448|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139656132|NCT05687448|Antithrombins|antithrombins|mesh-ancestor
139656133|NCT05687448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139656134|NCT05687448|Protease Inhibitors|protease inhibitors|mesh-ancestor
139656135|NCT05687448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656136|NCT05687448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656137|NCT01749501|Rocuronium|rocuronium|mesh-list
139656138|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139656139|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139656140|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139656141|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656142|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656143|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139656144|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139656145|NCT02255175|Estradiol|estradiol|mesh-list
139656146|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139656147|NCT02255175|Progesterone|progesterone|mesh-list
139656148|NCT02255175|Estrogens|estrogens|mesh-ancestor
139656149|NCT02255175|Hormones|hormones|mesh-ancestor
139656150|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139656151|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656152|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139656153|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
139656154|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139656155|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139656156|NCT02255175|Progestins|progestins|mesh-ancestor
139656157|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139656158|NCT02585778|Alirocumab|alirocumab|mesh-list
139656159|NCT02585778|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139656160|NCT02585778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139656161|NCT02585778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139049405|NCT00481247|Dasatinib|dasatinib|mesh-list
139656162|NCT02585778|Antimetabolites|antimetabolites|mesh-ancestor
139656163|NCT02585778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656164|NCT02585778|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139656165|NCT02585778|Protease Inhibitors|protease inhibitors|mesh-ancestor
139656166|NCT02585778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656167|NCT02585778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139656168|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656169|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
139656170|NCT03899103|Rituximab|rituximab|mesh-list
139656171|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139656172|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656173|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
139656174|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656175|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656176|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139656177|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139656178|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
139656179|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139656180|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656181|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656182|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656183|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
139656184|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656185|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139656186|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656187|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656188|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
139656189|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139656190|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656191|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139656192|NCT01438424|Lamivudine|lamivudine|mesh-list
139656193|NCT01438424|Entecavir|entecavir|mesh-list
139656194|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139656195|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139656196|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656197|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656198|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
139656199|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656200|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139656201|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139656202|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
139656203|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139656204|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139656205|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
139656206|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139656207|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
139656208|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
139656209|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656210|NCT05299866|Ketamine|ketamine|mesh-list
139656211|NCT05299866|Esketamine|esketamine|mesh-list
139656212|NCT05299866|Analgesics|analgesics|mesh-ancestor
139656213|NCT05299866|Sensory System Agents|sensory system agents|mesh-ancestor
139656214|NCT05299866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656215|NCT05299866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049564|NCT00294762|Paclitaxel|paclitaxel|mesh-list
139656216|NCT05299866|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139656217|NCT05299866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139656218|NCT05299866|Anesthetics, General|anesthetics, general|mesh-ancestor
139656219|NCT05299866|Anesthetics|anesthetics|mesh-ancestor
139656220|NCT05299866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656221|NCT05299866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139656222|NCT05299866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139656223|NCT05299866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656224|NCT05299866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656225|NCT05299866|Antidepressive Agents|antidepressive agents|mesh-ancestor
139656226|NCT05299866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139656227|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
139656228|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139656229|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
139656230|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656231|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656232|NCT05267886|Dobutamine|dobutamine|mesh-list
139656233|NCT05267886|Milrinone|milrinone|mesh-list
139656234|NCT05267886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139656235|NCT05267886|Sympathomimetics|sympathomimetics|mesh-ancestor
139049605|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
139656236|NCT05267886|Autonomic Agents|autonomic agents|mesh-ancestor
139656237|NCT05267886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656238|NCT05267886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656239|NCT05267886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139656240|NCT05267886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139656241|NCT05267886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139656242|NCT05267886|Adrenergic Agents|adrenergic agents|mesh-ancestor
139656243|NCT05267886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656244|NCT05267886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656245|NCT05267886|Protective Agents|protective agents|mesh-ancestor
139656246|NCT05267886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139656247|NCT05267886|Vasodilator Agents|vasodilator agents|mesh-ancestor
139656248|NCT05267886|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139656249|NCT05267886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139656250|NCT05267886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656251|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
139656252|NCT02250807|Simeprevir|simeprevir|mesh-list
139656253|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
139656254|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656255|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
139656256|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656257|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656258|NCT00168389|Dexamethasone|dexamethasone|mesh-list
139656259|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139656260|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
139656261|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
139656262|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656263|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656264|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139656265|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
139656266|NCT00168389|Hormones|hormones|mesh-ancestor
139656267|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139656268|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139656269|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656270|NCT02252445|Propofol|propofol|mesh-list
139656271|NCT02252445|Sevoflurane|sevoflurane|mesh-list
139656272|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139656273|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656274|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656275|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139656276|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
139656277|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
139656278|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139656279|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139656280|NCT04592952|Calcitonin|calcitonin|mesh-list
139656281|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
139656282|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139656283|NCT04592952|Erenumab|erenumab|mesh-list
139656284|NCT04592952|Katacalcin|katacalcin|mesh-list
139656285|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139656286|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656287|NCT04592952|Analgesics|analgesics|mesh-ancestor
139656288|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
139656289|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656290|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656291|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139656292|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139656293|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
139656294|NCT00176423|Galantamine|galantamine|mesh-list
139656295|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139656296|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656297|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656298|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
139656299|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656300|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049699|NCT01066572|Lisinopril|lisinopril|mesh-list
139656301|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139656302|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
139656303|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656304|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
139656305|NCT02094443|Ribavirin|ribavirin|mesh-list
139656306|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
139656307|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656308|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
139656309|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656310|NCT00110513|Antithrombins|antithrombins|mesh-list
139656311|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
139656312|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139656313|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
139656314|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656315|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656316|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
139656317|NCT05691426|Nitric Oxide|nitric oxide|mesh-list
139656318|NCT05691426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139656319|NCT05691426|Autonomic Agents|autonomic agents|mesh-ancestor
139656320|NCT05691426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656321|NCT05691426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656322|NCT05691426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139656323|NCT05691426|Respiratory System Agents|respiratory system agents|mesh-ancestor
139656324|NCT05691426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139656325|NCT05691426|Antioxidants|antioxidants|mesh-ancestor
139656326|NCT05691426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656327|NCT05691426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656328|NCT05691426|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139656329|NCT05691426|Vasodilator Agents|vasodilator agents|mesh-ancestor
139656330|NCT05691426|Gasotransmitters|gasotransmitters|mesh-ancestor
139656331|NCT05691426|Protective Agents|protective agents|mesh-ancestor
139656332|NCT05696574|Misoprostol|misoprostol|mesh-list
139656333|NCT05696574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139656334|NCT05696574|Abortifacient Agents|abortifacient agents|mesh-ancestor
139656335|NCT05696574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139656336|NCT05696574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656337|NCT05696574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139656338|NCT05696574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139656339|NCT05696574|Oxytocics|oxytocics|mesh-ancestor
139656340|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
139656341|NCT00112151|Testosterone|testosterone|mesh-list
139656342|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
139656343|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
139656344|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139656345|NCT00112151|Androgens|androgens|mesh-ancestor
139656346|NCT00112151|Hormones|hormones|mesh-ancestor
139656347|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139656348|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656349|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139656350|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656351|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
139656352|NCT05162742|Colchicine|colchicine|mesh-list
139656353|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
139656354|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656355|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
139656356|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
139656357|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
139656358|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656359|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656360|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
139656361|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139656362|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656363|NCT00113321|Decitabine|decitabine|mesh-list
139656364|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139656365|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
139656366|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656367|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656368|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656369|NCT05669742|Empagliflozin|empagliflozin|mesh-list
139656370|NCT05669742|Olanzapine|olanzapine|mesh-list
139656371|NCT05669742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139656372|NCT05669742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656373|NCT05669742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139656374|NCT05669742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656375|NCT05669742|Antiemetics|antiemetics|mesh-ancestor
139656376|NCT05669742|Autonomic Agents|autonomic agents|mesh-ancestor
139656377|NCT05669742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049911|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
139656378|NCT05669742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139656379|NCT05669742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139656380|NCT05669742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139656381|NCT05669742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656382|NCT05669742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139656383|NCT05669742|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139656384|NCT05669742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139656385|NCT05669742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139656386|NCT05669742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656387|NCT05669742|Serotonin Agents|serotonin agents|mesh-ancestor
139656388|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
139656389|NCT00177047|Melphalan|melphalan|mesh-list
139656390|NCT00177047|Lenograstim|lenograstim|mesh-list
139656391|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139656392|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
139656393|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656394|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656395|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139656396|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
139656397|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656398|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656399|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139418433|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656400|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139418434|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
139656402|NCT00178841|Bexarotene|bexarotene|mesh-list
139656403|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139656404|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656405|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656406|NCT01756209|Acetaminophen|acetaminophen|mesh-list
139656407|NCT01756209|Ibuprofen|ibuprofen|mesh-list
139656408|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139656409|NCT01756209|Analgesics|analgesics|mesh-ancestor
139656410|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
139656411|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656412|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656413|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
139656414|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139656415|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139656416|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656417|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139656418|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656419|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656420|NCT00116207|Niacinamide|niacinamide|mesh-list
139656421|NCT00116207|Allopurinol|allopurinol|mesh-list
139656422|NCT00116207|Antioxidants|antioxidants|mesh-list
139656423|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
139656424|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656425|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656426|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
139656427|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656428|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139656429|NCT00116207|Protective Agents|protective agents|mesh-ancestor
139656430|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656431|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
139656432|NCT00116207|Vitamins|vitamins|mesh-ancestor
139656433|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
139656434|NCT04129398|Letermovir|letermovir|mesh-list
139656435|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139656436|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656437|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656438|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656439|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
139656440|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656441|NCT00178919|Trimethaphan|trimethaphan|mesh-list
139656442|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
139656443|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656444|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139656445|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139656446|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
139656447|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
139656448|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656449|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656450|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139656451|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139656452|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
139656453|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656454|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
139656455|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139656456|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656457|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656458|NCT00122447|Aspirin|aspirin|mesh-list
139656459|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
139656460|NCT00122447|Olmesartan|olmesartan|mesh-list
139656461|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139656462|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139656463|NCT00122447|Analgesics|analgesics|mesh-ancestor
139656464|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
139656465|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656466|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656467|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139656468|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656469|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139656470|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139656471|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656472|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139656473|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139656474|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656475|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
139418435|NCT04002401|Rituximab|rituximab|mesh-list
139418436|NCT04002401|Fludarabine|fludarabine|mesh-list
139418437|NCT04002401|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139656476|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139656477|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139050050|NCT01067898|Antacids|antacids|mesh-ancestor
139656478|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139656479|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
139656480|NCT00122447|Protective Agents|protective agents|mesh-ancestor
139656481|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
139656482|NCT00122447|Vitamins|vitamins|mesh-ancestor
139656483|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
139656484|NCT00125957|Bupropion|bupropion|mesh-list
139656485|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139656486|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
139656487|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139656488|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139656489|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139656490|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139656491|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656492|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
139656493|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656494|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656495|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139656496|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139656497|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656498|NCT00183443|Valproic Acid|valproic acid|mesh-list
139656499|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139656500|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
139656501|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139656502|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139656503|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139656504|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656505|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656506|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656507|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656508|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
139656509|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
139656510|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
139656511|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656512|NCT02579928|Midazolam|midazolam|mesh-list
139656513|NCT02579928|Ketamine|ketamine|mesh-list
139656514|NCT02579928|Analgesics|analgesics|mesh-ancestor
139656515|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
139656516|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656517|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656518|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139656519|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139656520|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
139656521|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
139656522|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656523|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139656524|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139656525|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656526|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656527|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139656528|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139656529|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139656530|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139656531|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139656532|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
139656533|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
139656534|NCT00183677|Escitalopram|escitalopram|mesh-list
139656535|NCT00183677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139656536|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139656537|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139656538|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656539|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656540|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
139656541|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656542|NCT00186017|Olanzapine|olanzapine|mesh-list
139656543|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
139656544|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
139656545|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656546|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656547|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139656548|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139656549|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139656550|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656551|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139656552|NCT00186017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139656553|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139656554|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139656555|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656556|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656557|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
139656559|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
139656560|NCT00041119|Doxorubicin|doxorubicin|mesh-list
139656561|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139656562|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139656563|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656564|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
139656565|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
139656566|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
139656567|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656568|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139656569|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
139656570|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656571|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656572|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139656573|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
139656574|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139656575|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139656576|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139656577|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139656578|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656579|NCT00186875|Cytarabine|cytarabine|mesh-list
139656580|NCT00186875|Dexamethasone|dexamethasone|mesh-list
139656581|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
139656582|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
139656583|NCT00186875|Methotrexate|methotrexate|mesh-list
139656584|NCT00186875|Etoposide|etoposide|mesh-list
139656585|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
139656586|NCT00186875|Vincristine|vincristine|mesh-list
139656587|NCT00186875|Asparaginase|asparaginase|mesh-list
139656588|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
139656589|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
139656590|NCT00186875|Vinblastine|vinblastine|mesh-list
139656591|NCT00186875|Pegaspargase|pegaspargase|mesh-list
139656592|NCT00186875|Teniposide|teniposide|mesh-list
139656593|NCT00186875|BB 1101|bb 1101|mesh-list
139050231|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
139656594|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139656595|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
139656596|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656597|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656598|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139656599|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
139656600|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656601|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656602|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139656603|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139656604|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
139656605|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
139656606|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656607|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139656608|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
139656609|NCT00186875|Hormones|hormones|mesh-ancestor
139656610|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139656611|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139656612|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
139656613|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656614|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139656615|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
139656616|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139656617|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139656618|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
139050278|NCT00296244|Tacrolimus|tacrolimus|mesh-list
139656619|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
139656620|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139418438|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139656621|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139656622|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139656623|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139656625|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
139656626|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656627|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
139656628|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
139656629|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
139656630|NCT00186875|Analgesics|analgesics|mesh-ancestor
139656631|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
139656632|NCT00551460|Methotrexate|methotrexate|mesh-list
139656633|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
139656634|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
139656635|NCT00551460|Tretinoin|tretinoin|mesh-list
139656636|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
139656637|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139656638|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
139656639|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139656640|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656641|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139656642|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
139656643|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656644|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656645|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
139656646|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656647|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139656648|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139656649|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
139656650|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656651|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139656652|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
139656653|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139656654|NCT00551460|Immunotoxins|immunotoxins|mesh-ancestor
139656655|NCT00551460|Immunoconjugates|immunoconjugates|mesh-ancestor
139656656|NCT04751227|Modafinil|modafinil|mesh-list
139656657|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139656658|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656659|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139656660|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139656661|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139656662|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656663|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
139656664|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139656665|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
139656666|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656667|NCT02579772|Expectorants|expectorants|mesh-ancestor
139656668|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
139656669|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139656670|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
139656671|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656672|NCT02579772|Protective Agents|protective agents|mesh-ancestor
139656673|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656674|NCT02579772|Antidotes|antidotes|mesh-ancestor
139656675|NCT05535036|Dexamethasone|dexamethasone|mesh-list
139656676|NCT05535036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139656677|NCT05535036|Antiemetics|antiemetics|mesh-ancestor
139656678|NCT05535036|Autonomic Agents|autonomic agents|mesh-ancestor
139656679|NCT05535036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656680|NCT05535036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656681|NCT05535036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139656682|NCT05535036|Glucocorticoids|glucocorticoids|mesh-ancestor
139656683|NCT05535036|Hormones|hormones|mesh-ancestor
139656684|NCT05535036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139656685|NCT05535036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139656686|NCT05535036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656687|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139656688|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139656689|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139656690|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656691|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656692|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139656693|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139656694|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139656695|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139656696|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
139656697|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144930|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
139656698|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656700|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139656701|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
139656702|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139656703|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139656704|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
139656705|NCT02989701|Plerixafor|plerixafor|mesh-list
139656706|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139656707|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139656708|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
139656709|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656710|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
139656711|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139656712|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
139656713|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656714|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656715|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139656716|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
139656717|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656718|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656719|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139656720|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
139656721|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
139656722|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139656723|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656724|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656725|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139656726|NCT04953156|Analgesics|analgesics|mesh-ancestor
139656727|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
139656728|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656729|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139656730|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139656731|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139656732|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
139656733|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656734|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656735|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
139656736|NCT01761747|Ponatinib|ponatinib|mesh-list
139656737|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656738|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139656739|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656740|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656741|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139656742|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656743|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139656744|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656745|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656746|NCT00278863|Capecitabine|capecitabine|mesh-list
139656747|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139656748|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
139656749|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656750|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656751|NCT01762059|Pancrelipase|pancrelipase|mesh-list
139656752|NCT01762059|Pancreatin|pancreatin|mesh-list
139656753|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139656754|NCT01808547|Bromfenac|bromfenac|mesh-list
139656755|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139656756|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139656757|NCT01808547|Analgesics|analgesics|mesh-ancestor
139656758|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
139656759|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656760|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656761|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139656762|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656763|NCT00187655|Cefotaxime|cefotaxime|mesh-list
139656764|NCT00187655|Cefoxitin|cefoxitin|mesh-list
139656765|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139656766|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656767|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139656768|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656769|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139656770|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418439|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
139656771|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656773|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656774|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139656775|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656776|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656777|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139656778|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139656779|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139656780|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139656781|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656782|NCT01790893|Aflibercept|aflibercept|mesh-list
139656783|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139656784|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139656785|NCT01790893|Growth Substances|growth substances|mesh-ancestor
139656786|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656787|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
139656788|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656789|NCT02256111|Androgens|androgens|mesh-list
139656790|NCT02256111|Hormones|hormones|mesh-ancestor
139656791|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139656792|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656793|NCT01790971|Morphine|morphine|mesh-list
139656794|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139656795|NCT01790971|Narcotics|narcotics|mesh-ancestor
139656796|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656797|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656798|NCT01790971|Analgesics|analgesics|mesh-ancestor
139656799|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
139656800|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656801|NCT00189137|Gemcitabine|gemcitabine|mesh-list
139656802|NCT00189137|Docetaxel|docetaxel|mesh-list
139656803|NCT00189137|Doxorubicin|doxorubicin|mesh-list
139656804|NCT00189137|Ifosfamide|ifosfamide|mesh-list
139656805|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139656806|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
139656807|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656808|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656809|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
139656810|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
139656811|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
139656812|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139656813|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139656814|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139656815|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656816|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139656817|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
139656818|NCT02099461|Denosumab|denosumab|mesh-list
139656819|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139656820|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656821|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139656822|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139656823|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656824|NCT02256189|Incretins|incretins|mesh-ancestor
139656825|NCT02256189|Hormones|hormones|mesh-ancestor
139656826|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139656827|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139656828|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
139656829|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656830|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656831|NCT00193037|Docetaxel|docetaxel|mesh-list
139656832|NCT00193037|Doxorubicin|doxorubicin|mesh-list
139656833|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139656834|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656835|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
139656836|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
139656837|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
139656838|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656839|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139656840|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139656841|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139656842|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656843|NCT02100007|Topotecan|topotecan|mesh-list
139656844|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139145080|NCT04599933|Pilocarpine|pilocarpine|mesh-list
139656845|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139656846|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656847|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656848|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656849|NCT05392764|Empagliflozin|empagliflozin|mesh-list
139656850|NCT05392764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139656851|NCT05392764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656852|NCT05392764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139656853|NCT05392764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656854|NCT01809639|Progesterone|progesterone|mesh-list
139656855|NCT01809639|Progestins|progestins|mesh-ancestor
139656856|NCT01809639|Hormones|hormones|mesh-ancestor
139656857|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139656858|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656859|NCT05391750|Venetoclax|venetoclax|mesh-list
139656860|NCT05391750|Immunoglobulins|immunoglobulins|mesh-list
139656861|NCT05391750|Immunoglobulin G|immunoglobulin g|mesh-list
139656862|NCT05391750|Immunologic Factors|immunologic factors|mesh-ancestor
139656863|NCT05391750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656864|NCT05391750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656865|NCT01763931|Digoxin|digoxin|mesh-list
139656866|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139656867|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139656868|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656869|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656870|NCT01763931|Protective Agents|protective agents|mesh-ancestor
139656871|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656872|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139656873|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656874|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656875|NCT02783859|Amoxicillin|amoxicillin|mesh-list
139656876|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
139656877|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
139656878|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139656879|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139656880|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656881|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139656882|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656883|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139656884|NCT01765803|Thioridazine|thioridazine|mesh-list
139656885|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139656886|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139656887|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139050817|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
139656888|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656889|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139656890|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139656891|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
139656892|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656893|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656894|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
139656895|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139656896|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
139656897|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656898|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656899|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139656900|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
139656901|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656902|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656903|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139656904|NCT01811355|Mexiletine|mexiletine|mesh-list
139656905|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139656906|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139656907|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139656908|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139656909|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656910|NCT05534334|Hydrocortisone|hydrocortisone|mesh-list
139656911|NCT05534334|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139656912|NCT05534334|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139656913|NCT05534334|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139656914|NCT05534334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139656915|NCT01767285|Etonogestrel|etonogestrel|mesh-list
139656916|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139145160|NCT04203056|Aripiprazole|aripiprazole|mesh-list
139656917|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
139656918|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139656919|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656920|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139656921|NCT02100891|Immunomodulating Agents|immunomodulating agents|mesh-list
139656922|NCT02100891|Immunologic Factors|immunologic factors|mesh-ancestor
139656923|NCT02100891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656925|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
139656926|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139656927|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139656928|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
139656929|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139656930|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139656931|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139656932|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
139656933|NCT01465802|Hormones|hormones|mesh-ancestor
139656934|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139656935|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656936|NCT01813149|Clonidine|clonidine|mesh-list
139656937|NCT01813149|Phenylephrine|phenylephrine|mesh-list
139656938|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
139656939|NCT01813149|Anesthetics|anesthetics|mesh-list
139656940|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
139656941|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656942|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656943|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
139656944|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656945|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139656946|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
139656947|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
139656948|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
139656949|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139656950|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
139656951|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
139656952|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139656953|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139656954|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139656955|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
139656956|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656957|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656958|NCT01813149|Protective Agents|protective agents|mesh-ancestor
139656959|NCT01813149|Analgesics|analgesics|mesh-ancestor
139656960|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139656961|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
139656962|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139656963|NCT00137969|Acetaminophen|acetaminophen|mesh-list
139656964|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
139656965|NCT00137969|Promethazine|promethazine|mesh-list
139656966|NCT00137969|Prednisone|prednisone|mesh-list
139656967|NCT00137969|Rituximab|rituximab|mesh-list
139656968|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139656969|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139656970|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
139656971|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139656972|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139656973|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139656974|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
139656975|NCT00137969|Hormones|hormones|mesh-ancestor
139656976|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139656977|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139656978|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139656979|NCT00137969|Analgesics|analgesics|mesh-ancestor
139656980|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
139656981|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139656982|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
139656983|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139656984|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139656985|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139656986|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
139656987|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
139656988|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
139656989|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
139656990|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139656991|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139656992|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
139656993|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
139656994|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139656995|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139656996|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139656998|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
139656999|NCT01437878|Iloprost|iloprost|mesh-list
139657000|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139657001|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
139657002|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
139657003|NCT04767308|Fludarabine|fludarabine|mesh-list
139657004|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139657005|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
139657006|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657007|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139657008|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139657009|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
139051040|NCT00296816|Docetaxel|docetaxel|mesh-list
139657010|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657011|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657012|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139657013|NCT00138125|Trastuzumab|trastuzumab|mesh-list
139657014|NCT00138125|Fulvestrant|fulvestrant|mesh-list
139657015|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139657016|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657017|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139657018|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139657019|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139657020|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
139657021|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657022|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657023|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139657024|NCT01815333|Hematinics|hematinics|mesh-ancestor
139657025|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139657026|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139657027|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
139657028|NCT01465178|Vitamin D|vitamin d|mesh-list
139051055|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139657029|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139657030|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657031|NCT01465178|Vitamins|vitamins|mesh-ancestor
139657032|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
139657033|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139657034|NCT00138203|Vorinostat|vorinostat|mesh-list
139657035|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657036|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139657037|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657038|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657039|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139657040|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139657041|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139657042|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657043|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657044|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139657045|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139657046|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657047|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
139657048|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657049|NCT00194129|Valproic Acid|valproic acid|mesh-list
139657050|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
139657051|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
139657052|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139657053|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657054|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657055|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
139657056|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139657057|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139657058|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657059|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
139657060|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
139657061|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657062|NCT01817907|Trazodone|trazodone|mesh-list
139657063|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139657064|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139657065|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139657066|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145305|NCT03738228|Cisplatin|cisplatin|mesh-list
139051176|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
139657067|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139657068|NCT01817907|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139657069|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139657070|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139657071|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657072|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657073|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
139657074|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139657075|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
139657076|NCT01445678|Metronidazole|metronidazole|mesh-list
139657077|NCT01445678|Meropenem|meropenem|mesh-list
139657078|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657079|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139657080|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139657081|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139657082|NCT01818063|Paclitaxel|paclitaxel|mesh-list
139657083|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
139657084|NCT01818063|Carboplatin|carboplatin|mesh-list
139657085|NCT01818063|Doxorubicin|doxorubicin|mesh-list
139657086|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139657087|NCT01818063|Veliparib|veliparib|mesh-list
139657088|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139657089|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657090|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
139657091|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
139657092|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
139657093|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657094|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139657095|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
139657096|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657097|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139657098|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139657099|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
139657100|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139657101|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139657102|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139657103|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139657104|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657105|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139657106|NCT01465022|Estrogens|estrogens|mesh-list
139657107|NCT01465022|Progestins|progestins|mesh-list
139657108|NCT01465022|Hormones|hormones|mesh-ancestor
139657109|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657110|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657111|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139657112|NCT02258217|Hormones|hormones|mesh-ancestor
139657113|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657114|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657115|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139657116|NCT01464788|Argatroban|argatroban|mesh-list
139657117|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139657118|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139657119|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657120|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
139657121|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139657122|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
139657123|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657124|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
139657125|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139657126|NCT01444898|Exenatide|exenatide|mesh-list
139657127|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139657128|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657129|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139657130|NCT01444898|Incretins|incretins|mesh-ancestor
139657131|NCT01444898|Hormones|hormones|mesh-ancestor
139657132|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657133|NCT00201773|Celecoxib|celecoxib|mesh-list
139657134|NCT00201773|Exemestane|exemestane|mesh-list
139657135|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139657136|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139657137|NCT00201773|Analgesics|analgesics|mesh-ancestor
139657138|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
139657139|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418440|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418441|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139657141|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657142|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139657143|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139657144|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139657145|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657146|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657147|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657148|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139657149|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139657150|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139657151|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
139657152|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657153|NCT00256217|Anastrozole|anastrozole|mesh-list
139657154|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139657155|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657156|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139657157|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139657158|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657159|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657160|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139657161|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
139657162|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657163|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657164|NCT00256451|Ethanol|ethanol|mesh-list
139657165|NCT00256451|Naltrexone|naltrexone|mesh-list
139657166|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139657167|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657168|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139657169|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657170|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139657171|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139657172|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
139657173|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657174|NCT03582618|Sorafenib|sorafenib|mesh-list
139657175|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657176|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139657177|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657178|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657179|NCT00257309|Tenecteplase|tenecteplase|mesh-list
139657180|NCT00257309|Clopidogrel|clopidogrel|mesh-list
139657181|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139657182|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139657183|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139657184|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139657185|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
139657186|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657187|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657188|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657189|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139657190|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139657191|NCT01444742|Cytarabine|cytarabine|mesh-list
139657192|NCT01444742|Clofarabine|clofarabine|mesh-list
139657193|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139657194|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
139657195|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657196|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657197|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
139657198|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657199|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139657200|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
139657201|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657202|NCT01770483|Interferons|interferons|mesh-list
139657203|NCT01770483|Ribavirin|ribavirin|mesh-list
139657204|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
139657205|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
139657206|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657207|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
139657208|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657209|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
139418442|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139418443|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
139145452|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
139418444|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657210|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657211|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
139657212|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657213|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139657214|NCT00257933|Prednisolone|prednisolone|mesh-list
139657215|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139657216|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
139657217|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139657218|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
139657219|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139657220|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
139657221|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657222|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
139657223|NCT00257933|Hormones|hormones|mesh-ancestor
139657224|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657225|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657226|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139657227|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657228|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
139657229|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
139657230|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657231|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139657232|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139657233|NCT00257933|Protective Agents|protective agents|mesh-ancestor
139657234|NCT01734525|Anidulafungin|anidulafungin|mesh-list
139657235|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
139657236|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657237|NCT01819935|Vancomycin|vancomycin|mesh-list
139657238|NCT01819935|Linezolid|linezolid|mesh-list
139657239|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139657240|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657241|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139657242|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657243|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657244|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139657245|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139657246|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657247|NCT00264641|Insulin|insulin|mesh-list
139657248|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139657249|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139657250|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657251|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
139657252|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657253|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
139657254|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139657255|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139657256|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657257|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
139657258|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657259|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657260|NCT00266279|Capecitabine|capecitabine|mesh-list
139657261|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
139657262|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139657263|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
139657264|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657265|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657266|NCT01736085|Nicotine|nicotine|mesh-list
139657267|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139657268|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
139657269|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657270|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657271|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139657272|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139657273|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
139657274|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657275|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657276|NCT00210353|Rituximab|rituximab|mesh-list
139657277|NCT00210353|Chlorambucil|chlorambucil|mesh-list
139657278|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139657279|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657280|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
139418445|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657281|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657282|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139657283|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139657284|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
139657285|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657286|NCT00267059|Lenalidomide|lenalidomide|mesh-list
139657287|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
139657288|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657289|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139657290|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139657291|NCT00267059|Growth Substances|growth substances|mesh-ancestor
139657292|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
139657293|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657294|NCT00213239|Remifentanil|remifentanil|mesh-list
139657295|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139657296|NCT00213239|Narcotics|narcotics|mesh-ancestor
139657297|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139657298|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657299|NCT00213239|Analgesics|analgesics|mesh-ancestor
139657300|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
139657301|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657302|NCT01444430|Budesonide|budesonide|mesh-list
139657303|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139657304|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657305|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139657306|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
139657307|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657308|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657309|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139657310|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
139657311|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
139657312|NCT01444430|Hormones|hormones|mesh-ancestor
139051685|NCT00464087|PENTA|penta|mesh-list
139657313|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657314|NCT01774149|Diazepam|diazepam|mesh-list
139657315|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139657316|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
139657317|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
139657318|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
139657319|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657320|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657321|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139657322|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139657323|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139657324|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139657325|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139657326|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139657327|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139657328|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139657329|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139657330|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
139657331|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
139657332|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
139657333|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
139657334|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139051716|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139657335|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657336|NCT01898507|Nicotine|nicotine|mesh-list
139657337|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139657338|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
139657339|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657340|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657341|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139657342|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139657343|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
139657344|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657345|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657346|NCT00267293|Acetaminophen|acetaminophen|mesh-list
139657347|NCT00267293|Ibuprofen|ibuprofen|mesh-list
139657348|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139657349|NCT00267293|Analgesics|analgesics|mesh-ancestor
139657350|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
139657351|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657352|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657353|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
139657354|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139657355|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657356|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139657357|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139657358|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657359|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657360|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139657361|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
139657362|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139657363|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139657364|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657365|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139657366|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139657367|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139657368|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657369|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
139657370|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657371|NCT02579382|Vesatolimod|vesatolimod|mesh-list
139657372|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
139657373|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657374|NCT01774851|Paclitaxel|paclitaxel|mesh-list
139657375|NCT01774851|Trastuzumab|trastuzumab|mesh-list
139657376|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139657377|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657378|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
139657379|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
139657380|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
139657381|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657382|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139657383|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
139657384|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
139657385|NCT02990013|Povidone|povidone|mesh-list
139657386|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139657387|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657388|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
139657389|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
139657390|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
139657391|NCT03440112|Clarithromycin|clarithromycin|mesh-list
139657392|NCT03440112|Flumazenil|flumazenil|mesh-list
139657393|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139657394|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657395|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139657396|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657397|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657398|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139657399|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139657400|NCT03440112|Antidotes|antidotes|mesh-ancestor
139657401|NCT03440112|Protective Agents|protective agents|mesh-ancestor
139657402|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657403|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
139657404|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
139657405|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657406|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139657407|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
139657408|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139657409|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139657410|NCT01775865|Analgesics|analgesics|mesh-ancestor
139657411|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
139657412|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657413|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657414|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657415|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139657416|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139657417|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657418|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657419|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139657420|NCT01419236|Testosterone|testosterone|mesh-list
139657421|NCT01419236|Androgens|androgens|mesh-ancestor
139657422|NCT01419236|Hormones|hormones|mesh-ancestor
139657423|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657424|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657425|NCT03323658|Bexarotene|bexarotene|mesh-list
139657426|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657427|NCT01443026|Lycopene|lycopene|mesh-list
139657428|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657429|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
139657430|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657431|NCT01443026|Protective Agents|protective agents|mesh-ancestor
139145674|NCT02428192|Nivolumab|nivolumab|mesh-list
139657432|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657433|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139657434|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139657435|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657436|NCT01879371|Ibuprofen|ibuprofen|mesh-list
139657437|NCT01879371|Caffeine|caffeine|mesh-list
139657438|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139657439|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139657440|NCT01879371|Analgesics|analgesics|mesh-ancestor
139657441|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
139657442|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657443|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657444|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657445|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139657446|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139657447|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657448|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657449|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139657450|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139657451|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139657452|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139657453|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
139657454|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657455|NCT01733745|Vitamins|vitamins|mesh-list
139657456|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139657457|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
139657458|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657459|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139657460|NCT03276468|Atezolizumab|atezolizumab|mesh-list
139657461|NCT03276468|Venetoclax|venetoclax|mesh-list
139657462|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
139657463|NCT03276468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139657464|NCT03276468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657465|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139657466|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657467|NCT01442714|Lenalidomide|lenalidomide|mesh-list
139657468|NCT01442714|Azacitidine|azacitidine|mesh-list
139657469|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
139657470|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657471|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139657472|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139657473|NCT01442714|Growth Substances|growth substances|mesh-ancestor
139657474|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
139657475|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657476|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139657477|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
139657478|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657479|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657480|NCT05328921|Antihypertensive Agents|antihypertensive agents|mesh-list
139657481|NCT05328921|Histamine Antagonists|histamine antagonists|mesh-list
139657482|NCT05328921|Histamine Agents|histamine agents|mesh-ancestor
139657483|NCT05328921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657484|NCT05328921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657485|NCT05328921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657486|NCT05532852|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139657487|NCT05532852|Antiviral Agents|antiviral agents|mesh-ancestor
139657488|NCT05532852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657489|NCT05501574|Tacrolimus|tacrolimus|mesh-list
139657490|NCT05501574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139657491|NCT05501574|Immunologic Factors|immunologic factors|mesh-ancestor
139657492|NCT05501574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657493|NCT05501574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139657494|NCT05501574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657495|NCT05501574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657496|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139657497|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139657498|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139657499|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139657500|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657501|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139657502|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139657503|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139657504|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139657505|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
139145750|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
139657506|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657507|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657508|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139657509|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139657510|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
139657511|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139657512|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139657513|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
139657514|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
139657515|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
139657516|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657517|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
139657518|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139657519|NCT01828515|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139657520|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139657521|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139657522|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657523|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657524|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
139657525|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657526|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139657527|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139657528|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
139657529|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139657530|NCT01828593|Antibodies|antibodies|mesh-list
139657531|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
139657532|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657533|NCT01781169|Vitamin D|vitamin d|mesh-list
139657534|NCT01781169|Vitamins|vitamins|mesh-ancestor
139657535|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
139657536|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657537|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139657538|NCT00216125|Docetaxel|docetaxel|mesh-list
139657539|NCT00216125|Etoposide|etoposide|mesh-list
139657540|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657541|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
139657542|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
139657543|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
139657544|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657545|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139657546|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139657547|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139657548|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657549|NCT01781403|Capecitabine|capecitabine|mesh-list
139657550|NCT01781403|Temozolomide|temozolomide|mesh-list
139657551|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139657552|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
139657553|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052101|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
139657554|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657555|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139657556|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
139657557|NCT00218387|Modafinil|modafinil|mesh-list
139657558|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139657559|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657560|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139657561|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139657562|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139657563|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657564|NCT00218465|Glycine|glycine|mesh-list
139657565|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
139657566|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657567|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657568|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657569|NCT01898585|Vemurafenib|vemurafenib|mesh-list
139657570|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657571|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139657572|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657573|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657574|NCT00220961|Pioglitazone|pioglitazone|mesh-list
139657575|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139657576|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657577|NCT00222131|Esomeprazole|esomeprazole|mesh-list
139418446|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139145855|NCT02252302|Albuterol|albuterol|mesh-list
139657578|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139657579|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139657580|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139657581|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657582|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657583|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139657584|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139657585|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139657586|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139657587|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
139657588|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657589|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657590|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139657591|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
139657592|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657593|NCT01782963|Dexamethasone|dexamethasone|mesh-list
139657594|NCT01782963|Lenalidomide|lenalidomide|mesh-list
139657595|NCT01782963|Bortezomib|bortezomib|mesh-list
139657596|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657597|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
139657598|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
139657599|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657600|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657601|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139657602|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
139657603|NCT01782963|Hormones|hormones|mesh-ancestor
139657604|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657605|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139657606|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657607|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
139657608|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139657609|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139657610|NCT01782963|Growth Substances|growth substances|mesh-ancestor
139657611|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
139657612|NCT01829217|Sunitinib|sunitinib|mesh-list
139657613|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657614|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139657615|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139657616|NCT01829217|Growth Substances|growth substances|mesh-ancestor
139657617|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657618|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
139657619|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139657620|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657621|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657622|NCT05327751|Celecoxib|celecoxib|mesh-list
139657623|NCT05327751|Capecitabine|capecitabine|mesh-list
139657624|NCT05327751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139657625|NCT05327751|Antimetabolites|antimetabolites|mesh-ancestor
139657626|NCT05327751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657627|NCT05327751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657628|NCT05327751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139657629|NCT05327751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139657630|NCT05327751|Analgesics|analgesics|mesh-ancestor
139657631|NCT05327751|Sensory System Agents|sensory system agents|mesh-ancestor
139657632|NCT05327751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657633|NCT05327751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657634|NCT05327751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657635|NCT05327751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139657636|NCT05327751|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139657637|NCT05327751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139657638|NCT05327751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657639|NCT02096861|Infliximab|infliximab|mesh-list
139657640|NCT02096861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139657641|NCT02096861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657642|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
139657643|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139657644|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139657645|NCT01829919|Paroxetine|paroxetine|mesh-list
139657646|NCT01829919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139657647|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139657648|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139657649|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657650|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657651|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
139145895|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418447|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139657652|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657653|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139657654|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
139657655|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139657656|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139657657|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139657658|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657659|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
139657660|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139657661|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139657662|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
139657663|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
139657664|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657665|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139657666|NCT00274781|Immunotoxins|immunotoxins|mesh-ancestor
139657667|NCT00274781|Immunoconjugates|immunoconjugates|mesh-ancestor
139657668|NCT00274781|Immunologic Factors|immunologic factors|mesh-ancestor
139052279|NCT01581320|Vitamins|vitamins|mesh-ancestor
139657669|NCT00274781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657670|NCT00226577|Gemcitabine|gemcitabine|mesh-list
139657671|NCT00226577|Pemetrexed|pemetrexed|mesh-list
139657672|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139657673|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
139657674|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657675|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657676|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657677|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139657678|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139657679|NCT01830699|Triamcinolone|triamcinolone|mesh-list
139657680|NCT01830699|Rilonacept|rilonacept|mesh-list
139657681|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657682|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
139657683|NCT01830699|Hormones|hormones|mesh-ancestor
139657684|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657685|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657686|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
139657687|NCT00280241|Rituximab|rituximab|mesh-list
139657688|NCT00280241|Fludarabine|fludarabine|mesh-list
139657689|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139657690|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
139657691|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657692|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139052330|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
139657693|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139657694|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
139657695|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657696|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657697|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139657698|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139657699|NCT01899755|Adalimumab|adalimumab|mesh-list
139657700|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139657701|NCT01899755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139657702|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657703|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139657704|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
139657705|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139657706|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657707|NCT00229619|Rituximab|rituximab|mesh-list
139657708|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139657709|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657710|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
139657711|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657712|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139657713|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139657714|NCT00281021|Digoxin|digoxin|mesh-list
139657715|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657716|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139657717|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657718|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657719|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139657720|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139657721|NCT00281021|Protective Agents|protective agents|mesh-ancestor
139657722|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657723|NCT01786161|Vancomycin|vancomycin|mesh-list
139657724|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139657725|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657726|NCT01786239|Risperidone|risperidone|mesh-list
139657727|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139657728|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
139657729|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657730|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657731|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657732|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139657733|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139657734|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139657735|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139657736|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139657737|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
139657738|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
139657739|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
139657740|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657741|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052431|NCT03956212|Doxycycline|doxycycline|mesh-list
139657742|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139657743|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
139657744|NCT01833741|Bimatoprost|bimatoprost|mesh-list
139657745|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139657746|NCT02261727|Prednisone|prednisone|mesh-list
139657747|NCT02261727|Cortisone|cortisone|mesh-list
139657748|NCT02261727|Theophylline|theophylline|mesh-list
139657749|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657750|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
139657751|NCT02261727|Hormones|hormones|mesh-ancestor
139657752|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657753|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657754|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139657755|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657756|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139657757|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
139657758|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657759|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139657760|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
139657761|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139657762|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657763|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657764|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
139657765|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139657766|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139657767|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
139657768|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657769|NCT02261805|Doxorubicin|doxorubicin|mesh-list
139657770|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139657771|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657772|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139657773|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139657774|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657775|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657776|NCT05300841|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139657777|NCT05300841|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139657778|NCT05300841|Estradiol|estradiol|mesh-list
139657779|NCT05300841|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139657780|NCT05300841|Dydrogesterone|dydrogesterone|mesh-list
139657781|NCT05300841|Estrogens|estrogens|mesh-ancestor
139657782|NCT05300841|Hormones|hormones|mesh-ancestor
139657783|NCT05300841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657784|NCT05300841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657785|NCT05300841|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139657786|NCT05300841|Contraceptive Agents|contraceptive agents|mesh-ancestor
139657787|NCT05300841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139657788|NCT05300841|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139657789|NCT05300841|Progestins|progestins|mesh-ancestor
139657790|NCT00232505|Carboplatin|carboplatin|mesh-list
139657791|NCT00232505|Cetuximab|cetuximab|mesh-list
139657792|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657793|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139657794|NCT00232583|Metformin|metformin|mesh-list
139657795|NCT00232583|Pioglitazone|pioglitazone|mesh-list
139657796|NCT00232583|Glyburide|glyburide|mesh-list
139657797|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139657798|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657799|NCT00232739|Sirolimus|sirolimus|mesh-list
139657800|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139418448|NCT03046511|Cefazolin|cefazolin|mesh-list
139657801|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052530|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
139657802|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139657803|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657804|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
139657805|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139657806|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
139657807|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657808|NCT01789905|Tigecycline|tigecycline|mesh-list
139657809|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139657810|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657811|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139657812|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657813|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657814|NCT01790685|Dexamethasone|dexamethasone|mesh-list
139657815|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657816|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
139657817|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
139657818|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657819|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657820|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139657821|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
139657822|NCT01790685|Hormones|hormones|mesh-ancestor
139657823|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657824|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139657825|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657826|NCT01838655|Nitisinone|nitisinone|mesh-list
139657827|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657828|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657829|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139657830|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
139657831|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657832|NCT00282971|Insulin|insulin|mesh-list
139657833|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139657834|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657835|NCT01791465|Exenatide|exenatide|mesh-list
139657836|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139657837|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657838|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139657839|NCT01791465|Incretins|incretins|mesh-ancestor
139657840|NCT01791465|Hormones|hormones|mesh-ancestor
139657841|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657842|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139657843|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139657844|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657845|NCT00285467|Vitamin D|vitamin d|mesh-list
139657846|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
139657847|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
139657848|NCT00285467|Vitamins|vitamins|mesh-ancestor
139657849|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
139657850|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657851|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139657852|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139657853|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139657854|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
139657855|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657856|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
139657857|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139657858|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657859|NCT01676753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139657860|NCT01676753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657861|NCT01794039|Dexamethasone|dexamethasone|mesh-list
139657862|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
139657863|NCT01794039|Lenalidomide|lenalidomide|mesh-list
139657864|NCT01794039|Pomalidomide|pomalidomide|mesh-list
139657865|NCT01794039|Ichthammol|ichthammol|mesh-list
139657866|NCT01794039|BB 1101|bb 1101|mesh-list
139657867|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657868|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
139657869|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
139657870|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657871|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657872|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139657873|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
139657874|NCT01794039|Hormones|hormones|mesh-ancestor
139657875|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139657876|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139657877|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657878|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
139657879|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139657880|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139657881|NCT01794039|Growth Substances|growth substances|mesh-ancestor
139657882|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
139657883|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
139052657|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657884|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657885|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657886|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
139657887|NCT00281827|Thalidomide|thalidomide|mesh-list
139657888|NCT00281827|Carboplatin|carboplatin|mesh-list
139657889|NCT00281827|Gemcitabine|gemcitabine|mesh-list
139657890|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657891|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139657892|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
139657893|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657894|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139657895|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
139657896|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657897|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
139657898|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139657899|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139657900|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139657901|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139657902|NCT00281827|Growth Substances|growth substances|mesh-ancestor
139657903|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
139657904|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
139657905|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139657906|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139657907|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657908|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139657909|NCT01898819|Analgesics|analgesics|mesh-ancestor
139657910|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
139657911|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052717|NCT00063154|Pertuzumab|pertuzumab|mesh-list
139657912|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139657913|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139657914|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139657915|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
139657916|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657917|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657918|NCT01794741|Fluticasone|fluticasone|mesh-list
139657919|NCT01794741|Xhance|xhance|mesh-list
139657920|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657921|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139657922|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
139657923|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657924|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657925|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139657926|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
139657927|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
139657928|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139657929|NCT04446871|Methylene Blue|methylene blue|mesh-list
139657930|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657931|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657932|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
139657933|NCT04085419|Denosumab|denosumab|mesh-list
139657934|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139657935|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657936|NCT02989623|Copper|copper|mesh-list
139657937|NCT02989623|Trace Elements|trace elements|mesh-ancestor
139657938|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
139657939|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657940|NCT00052429|Fluorouracil|fluorouracil|mesh-list
139657941|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657942|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
139657943|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657944|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139657945|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139657946|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
139657947|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657948|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
139657949|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139657950|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657951|NCT03972397|Bupivacaine|bupivacaine|mesh-list
139657952|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
139657953|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
139657954|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139657955|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657956|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
139657957|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657958|NCT00287053|Valproic Acid|valproic acid|mesh-list
139657959|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
139657960|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139657961|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657962|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
139657963|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657964|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657965|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
139657966|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139657967|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139657968|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139657969|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139657970|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139657971|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139657972|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139657973|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139657974|NCT01435460|Analgesics|analgesics|mesh-ancestor
139657975|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
139657976|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139657977|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657978|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139657979|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139657980|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139657981|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139657982|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
139657983|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
139657984|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139657985|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139657986|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
139657987|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139657988|NCT00236951|Hematinics|hematinics|mesh-ancestor
139657989|NCT00287287|Lenalidomide|lenalidomide|mesh-list
139657990|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
139657991|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139657992|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139657993|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139657994|NCT00287287|Growth Substances|growth substances|mesh-ancestor
139657995|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
139657996|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139657997|NCT04871061|Fentanyl|fentanyl|mesh-list
139657998|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139657999|NCT04871061|Narcotics|narcotics|mesh-ancestor
139658000|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139658001|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658002|NCT04871061|Analgesics|analgesics|mesh-ancestor
139658003|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
139658004|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658005|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139658006|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139658007|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
139658008|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
139658009|NCT00287989|Paclitaxel|paclitaxel|mesh-list
139658010|NCT00287989|Carboplatin|carboplatin|mesh-list
139658011|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139658012|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139658013|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658014|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
139658015|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
139658016|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
139658017|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658018|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139658019|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658020|NCT00288067|Rituximab|rituximab|mesh-list
139658021|NCT00288067|Fenretinide|fenretinide|mesh-list
139658022|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139658023|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658024|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
139658025|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658026|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139418449|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139658027|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139658028|NCT00288067|Protective Agents|protective agents|mesh-ancestor
139658029|NCT00285779|Etanercept|etanercept|mesh-list
139658030|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139052905|NCT06201676|Ketorolac|ketorolac|mesh-list
139052906|NCT06201676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139052907|NCT06201676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139052908|NCT06201676|Analgesics|analgesics|mesh-ancestor
139052909|NCT06201676|Sensory System Agents|sensory system agents|mesh-ancestor
139052910|NCT06201676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052911|NCT06201676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052912|NCT06201676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139052913|NCT06201676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139052914|NCT06201676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139052915|NCT06201676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658031|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139658032|NCT00285779|Analgesics|analgesics|mesh-ancestor
139658033|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
139658034|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658035|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658036|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139658037|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139658038|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658039|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139658040|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
139658041|NCT01435382|Bococizumab|bococizumab|mesh-list
139658042|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139658043|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139658044|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
139658045|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658046|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139658047|NCT01801449|Rilonacept|rilonacept|mesh-list
139658048|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139658049|NCT00286325|Rituximab|rituximab|mesh-list
139658050|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139658051|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658052|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
139658053|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658054|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139658055|NCT00238355|Voriconazole|voriconazole|mesh-list
139658056|NCT00238355|Caspofungin|caspofungin|mesh-list
139658057|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
139658058|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139658059|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139658060|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139658061|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658062|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658063|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139658064|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
139658065|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139658066|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658067|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139658068|NCT01791439|Lidocaine|lidocaine|mesh-list
139658069|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
139658070|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
139658071|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139658072|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658073|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
139658074|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658075|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139658076|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139658077|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139658078|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139658079|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658080|NCT00290329|Vaccines|vaccines|mesh-list
139658081|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
139658082|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658083|NCT04058678|Danazol|danazol|mesh-list
139658084|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139658085|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
139658086|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139658087|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658088|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139658089|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139658090|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139658091|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139658092|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658093|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
139658094|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658095|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658096|NCT00287339|Esomeprazole|esomeprazole|mesh-list
139658097|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139658098|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658099|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139658100|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418450|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139658101|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658102|NCT00291655|Levetiracetam|levetiracetam|mesh-list
139658103|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
139658104|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
139658105|NCT01846455|Promethazine|promethazine|mesh-list
139658106|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
139658107|NCT01846455|Buprenorphine|buprenorphine|mesh-list
139658108|NCT01846455|Naloxone|naloxone|mesh-list
139658109|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139658110|NCT01846455|Narcotics|narcotics|mesh-ancestor
139658111|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139658112|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658113|NCT01846455|Analgesics|analgesics|mesh-ancestor
139658114|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
139658115|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658116|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139658117|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
139658118|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
139658119|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139658120|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
139658121|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
139658122|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658123|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658124|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139658125|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139658126|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139658127|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
139658128|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
139658129|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
139658130|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
139658131|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658132|NCT03366415|Cisplatin|cisplatin|mesh-list
139658133|NCT03366415|Gemcitabine|gemcitabine|mesh-list
139658134|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658135|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139658136|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
139658137|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658138|NCT00292591|Vitamin D|vitamin d|mesh-list
139658139|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
139658140|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
139658141|NCT00292591|Vitamins|vitamins|mesh-list
139658142|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
139658143|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658144|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139658145|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139658146|NCT01847001|Paclitaxel|paclitaxel|mesh-list
139658147|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139658148|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
139658149|NCT01847001|Doxorubicin|doxorubicin|mesh-list
139658150|NCT01847001|Trastuzumab|trastuzumab|mesh-list
139658151|NCT01847001|Pertuzumab|pertuzumab|mesh-list
139658152|NCT01847001|Propranolol|propranolol|mesh-list
139658153|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139658154|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658155|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
139658156|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
139658157|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
139658158|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658159|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139053076|NCT06200584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139053077|NCT06200584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139053078|NCT06200584|Antidepressive Agents|antidepressive agents|mesh-ancestor
139053079|NCT06200584|Antioxidants|antioxidants|mesh-ancestor
139053080|NCT06200584|Protective Agents|protective agents|mesh-ancestor
139053081|NCT06200402|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139053082|NCT06200402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053083|NCT06200298|Ropivacaine|ropivacaine|mesh-list
139053084|NCT06200298|Anesthetics, Local|anesthetics, local|mesh-ancestor
139053085|NCT06200298|Anesthetics|anesthetics|mesh-ancestor
139053086|NCT06200298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139658160|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
139658161|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658162|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139658163|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139658164|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
139658165|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139658166|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139658167|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139658168|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139658169|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658170|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139658171|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139658172|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139658173|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
139658174|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658175|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139146426|NCT03965819|Acetaminophen|acetaminophen|mesh-list
139658176|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139658177|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
139658178|NCT01847469|Zonisamide|zonisamide|mesh-list
139658179|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
139658180|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139658181|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139658182|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658183|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139658184|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658185|NCT01804101|Cytarabine|cytarabine|mesh-list
139658186|NCT01804101|Daunorubicin|daunorubicin|mesh-list
139053116|NCT06195540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139053117|NCT06195540|Antithrombins|antithrombins|mesh-ancestor
139053118|NCT06195540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139053119|NCT06195540|Protease Inhibitors|protease inhibitors|mesh-ancestor
139053120|NCT06195540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053121|NCT06184659|Meropenem|meropenem|mesh-list
139053122|NCT06184659|Tazobactam|tazobactam|mesh-list
139053123|NCT06184659|Piperacillin|piperacillin|mesh-list
139053124|NCT06184659|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139053125|NCT06184659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139053126|NCT06184659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053128|NCT06184659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658187|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139658188|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
139658189|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658190|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658191|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
139658192|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139658193|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139658194|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
139658195|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658196|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139658197|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139658198|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139658199|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658200|NCT00287729|Pirfenidone|pirfenidone|mesh-list
139658201|NCT00287729|Analgesics|analgesics|mesh-ancestor
139658202|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
139658203|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658204|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658205|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139658206|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139658207|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139658208|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139658209|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658210|NCT01433978|Maleic acid|maleic acid|mesh-list
139658211|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658212|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658213|NCT00289211|Complement C1s|complement c1s|mesh-list
139658214|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139658215|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
139658216|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
139658217|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658218|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139658219|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139658220|NCT01619111|Lapatinib|lapatinib|mesh-list
139658221|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658222|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139658223|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658224|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658225|NCT01727193|Azathioprine|azathioprine|mesh-list
139658226|NCT01727193|Leflunomide|leflunomide|mesh-list
139658227|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
139658228|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658229|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139658230|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658231|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139658232|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
139658233|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658234|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139658235|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658236|NCT00181701|Paclitaxel|paclitaxel|mesh-list
139658237|NCT00181701|Carboplatin|carboplatin|mesh-list
139658238|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139658239|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658240|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
139658241|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
139658242|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
139658243|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658244|NCT01849419|Oxytocin|oxytocin|mesh-list
139658245|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
139658246|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139658247|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658248|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
139658249|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139658250|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658251|NCT05098067|Ondansetron|ondansetron|mesh-list
139658252|NCT05098067|Metoclopramide|metoclopramide|mesh-list
139418451|NCT02439320|Lasmiditan|lasmiditan|mesh-list
139658253|NCT05098067|Capsaicin|capsaicin|mesh-list
139658254|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
139658255|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
139658256|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658257|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658258|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658259|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
139658260|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
139658261|NCT05098067|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139658262|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139658263|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
139658264|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658265|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658266|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
139658267|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139658268|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139658269|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
139658270|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139658271|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139658272|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139658273|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139658274|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658275|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658276|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658277|NCT01852383|Analgesics|analgesics|mesh-ancestor
139658278|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
139658279|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658280|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
139658281|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139658282|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
139658283|NCT04272333|Nivolumab|nivolumab|mesh-list
139658284|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139658285|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658286|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139658287|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658288|NCT02273115|Oxytocin|oxytocin|mesh-list
139658289|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
139658290|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139658291|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658292|NCT01853085|Bimatoprost|bimatoprost|mesh-list
139658293|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139658294|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139658295|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139658296|NCT02989467|Aprepitant|aprepitant|mesh-list
139658297|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
139658298|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
139658299|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658300|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658301|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658302|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139658303|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658304|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658305|NCT01853553|Spironolactone|spironolactone|mesh-list
139658306|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139658307|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
139658308|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139658309|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658310|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139658311|NCT01853553|Diuretics|diuretics|mesh-ancestor
139658312|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
139658313|NCT05748561|Methylprednisolone|methylprednisolone|mesh-list
139658314|NCT05748561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139658315|NCT05748561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139658316|NCT05748561|Prednisolone|prednisolone|mesh-list
139658317|NCT05748561|Prednisolone acetate|prednisolone acetate|mesh-list
139658318|NCT05748561|Epoetin Alfa|epoetin alfa|mesh-list
139658319|NCT05748561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139658320|NCT05748561|Prednisolone phosphate|prednisolone phosphate|mesh-list
139658321|NCT05748561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139658322|NCT05748561|Antiemetics|antiemetics|mesh-ancestor
139418452|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139418453|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
139658323|NCT05748561|Autonomic Agents|autonomic agents|mesh-ancestor
139658324|NCT05748561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075250|NCT05518799|Midazolam|midazolam|mesh-list
139053352|NCT05997433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139658325|NCT05748561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658326|NCT05748561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658327|NCT05748561|Glucocorticoids|glucocorticoids|mesh-ancestor
139658328|NCT05748561|Hormones|hormones|mesh-ancestor
139658329|NCT05748561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139658330|NCT05748561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139658331|NCT05748561|Protective Agents|protective agents|mesh-ancestor
139658332|NCT05748561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139658333|NCT05748561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658334|NCT05748561|Hematinics|hematinics|mesh-ancestor
139658335|NCT00290537|Paclitaxel|paclitaxel|mesh-list
139658336|NCT00290537|Carboplatin|carboplatin|mesh-list
139658337|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139658338|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658339|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
139658340|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
139658341|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
139658342|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658343|NCT00290615|Bevacizumab|bevacizumab|mesh-list
139658344|NCT00290615|Cetuximab|cetuximab|mesh-list
139658345|NCT00290615|Capecitabine|capecitabine|mesh-list
139658346|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
139658347|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139658348|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658349|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139658350|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139658351|NCT00290615|Growth Substances|growth substances|mesh-ancestor
139658352|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658353|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
139658354|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139658355|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
139658356|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658357|NCT01854177|Aprepitant|aprepitant|mesh-list
139658358|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
139658359|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
139658360|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
139658361|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658362|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658363|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658364|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139658365|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658366|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053422|NCT05888493|Hormones|hormones|mesh-ancestor
139658367|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
139658368|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658369|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139658370|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658371|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658372|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
139658373|NCT00299221|Tacrolimus|tacrolimus|mesh-list
139658374|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139658375|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
139658376|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658377|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139658378|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658379|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658380|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139658381|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658382|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139658383|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
139658384|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139658385|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139658386|NCT03799731|Trifluridine|trifluridine|mesh-list
139658387|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
139053445|NCT05882214|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139658388|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658389|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
139658390|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139658391|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
139658392|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658393|NCT00244985|Rituximab|rituximab|mesh-list
139658394|NCT00244985|Doxorubicin|doxorubicin|mesh-list
139658395|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139658396|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139658397|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658398|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
139146648|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139146722|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
139658399|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658400|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139658401|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139658402|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139658403|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139658404|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658405|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658406|NCT01857297|Vaccines|vaccines|mesh-list
139658407|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
139658408|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658409|NCT00300391|Haloperidol|haloperidol|mesh-list
139658410|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
139658411|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
139658412|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
139658413|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658414|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658415|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658416|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139658417|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139658418|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139658419|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139658420|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139658421|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
139658422|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658423|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658424|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139658425|NCT01859013|Topiramate|topiramate|mesh-list
139658426|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
139658427|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139658428|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658429|NCT00294515|Valganciclovir|valganciclovir|mesh-list
139658430|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
139658431|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139658432|NCT00300469|Atorvastatin|atorvastatin|mesh-list
139658433|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139658434|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139658435|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
139658436|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658437|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139658438|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139658439|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658440|NCT01859637|Lenograstim|lenograstim|mesh-list
139658441|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139658442|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
139658443|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658444|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
139658445|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139658446|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
139658447|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658448|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658449|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139658450|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139658451|NCT02117141|Hydrocodone|hydrocodone|mesh-list
139658452|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139658453|NCT02117141|Narcotics|narcotics|mesh-ancestor
139658454|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139658455|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658456|NCT02117141|Analgesics|analgesics|mesh-ancestor
139658457|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
139658458|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658459|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
139658460|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
139658461|NCT00299741|Sunitinib|sunitinib|mesh-list
139658462|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658463|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139658464|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139658465|NCT00299741|Growth Substances|growth substances|mesh-ancestor
139658466|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658467|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
139658468|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139658469|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658470|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658471|NCT00328861|Aldesleukin|aldesleukin|mesh-list
139658472|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
139658473|NCT00328861|Fludarabine|fludarabine|mesh-list
139658474|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139658475|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
139658476|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658477|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139658478|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139658479|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
139658480|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658481|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658482|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139658483|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139658484|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139658485|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
139658486|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139658487|NCT00248807|Enalaprilat|enalaprilat|mesh-list
139658488|NCT00248807|Enalapril|enalapril|mesh-list
139658489|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139658490|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
139658491|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658492|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658493|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139658494|NCT01860807|Ibudilast|ibudilast|mesh-list
139658495|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139658496|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
139658497|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658498|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658499|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139658500|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
139658501|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139658502|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658503|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658504|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139658505|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
139658506|NCT00330421|Sorafenib|sorafenib|mesh-list
139658507|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658508|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139658509|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658510|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658511|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
139658512|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139658513|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139658514|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658515|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
139658516|NCT04350645|Coagulants|coagulants|mesh-ancestor
139658517|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139658518|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139658519|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139658520|NCT00330733|Analgesics|analgesics|mesh-ancestor
139658521|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
139658522|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658523|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658524|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139658525|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139658526|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
139658527|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139658528|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139658529|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139658530|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139658531|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658532|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658533|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658534|NCT05185973|Micronutrients|micronutrients|mesh-list
139658535|NCT05185973|Trace Elements|trace elements|mesh-list
139658536|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658537|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
139658538|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139658539|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658540|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
139658541|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139658542|NCT00251225|Docetaxel|docetaxel|mesh-list
139658543|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
139658544|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658545|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
139658546|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
139658547|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
139146798|NCT03866980|Carboplatin|carboplatin|mesh-list
139658548|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658549|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139053757|NCT05330429|Leucovorin|leucovorin|mesh-list
139658550|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658551|NCT02979327|Adderall|adderall|mesh-list
139658552|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139658553|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658554|NCT05951075|Vitamins|vitamins|mesh-list
139658555|NCT05951075|Micronutrients|micronutrients|mesh-ancestor
139658556|NCT05951075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658557|NCT05951062|Antihypertensive Agents|antihypertensive agents|mesh-list
139658558|NCT05950997|Obinutuzumab|obinutuzumab|mesh-list
139658559|NCT05950997|Acalabrutinib|acalabrutinib|mesh-list
139658560|NCT05950997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139658561|NCT05950997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658562|NCT05950971|Amiodarone|amiodarone|mesh-list
139658563|NCT05950971|Diltiazem|diltiazem|mesh-list
139658564|NCT05950971|Esmolol|esmolol|mesh-list
139658565|NCT05950971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139658566|NCT05950971|Vasodilator Agents|vasodilator agents|mesh-ancestor
139658567|NCT05950971|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139658568|NCT05950971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139658569|NCT05950971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658570|NCT05950971|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139053807|NCT05178472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658571|NCT05950971|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139658572|NCT05950971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139658573|NCT05950971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658574|NCT05950971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139658575|NCT05950971|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139658576|NCT05950971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139658577|NCT05950971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139658578|NCT05950971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139658579|NCT05950971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139658580|NCT05950971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658581|NCT05950971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139658582|NCT05950971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139658583|NCT05950971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139658584|NCT05950971|Adrenergic Agents|adrenergic agents|mesh-ancestor
139658585|NCT05950971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658586|NCT05950711|Ketamine|ketamine|mesh-list
139658587|NCT05950711|Analgesics|analgesics|mesh-ancestor
139658588|NCT05950711|Sensory System Agents|sensory system agents|mesh-ancestor
139658589|NCT05950711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658590|NCT05950711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658591|NCT05950711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139658592|NCT05950711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139658593|NCT05950711|Anesthetics, General|anesthetics, general|mesh-ancestor
139658594|NCT05950711|Anesthetics|anesthetics|mesh-ancestor
139053865|NCT05094336|Docetaxel|docetaxel|mesh-list
139658595|NCT05950711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139658596|NCT05950711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139658597|NCT05950711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139658598|NCT05950711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658599|NCT05950711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658600|NCT05950555|Dexmedetomidine|dexmedetomidine|mesh-list
139658601|NCT05950555|Ketamine|ketamine|mesh-list
139658602|NCT05950555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139658603|NCT05950555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139658604|NCT05950555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658605|NCT05950555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139658606|NCT05950555|Analgesics|analgesics|mesh-ancestor
139658607|NCT05950555|Sensory System Agents|sensory system agents|mesh-ancestor
139658608|NCT05950555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658609|NCT05950555|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139658610|NCT05950555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139658611|NCT05950555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139658612|NCT05950555|Adrenergic Agents|adrenergic agents|mesh-ancestor
139658613|NCT05950555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658614|NCT05950555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658615|NCT05950555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139658616|NCT05950555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139658617|NCT05950555|Anesthetics, General|anesthetics, general|mesh-ancestor
139658618|NCT05950555|Anesthetics|anesthetics|mesh-ancestor
139658619|NCT05950555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139658620|NCT05950555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139146944|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658621|NCT05950529|Sorbitol|sorbitol|mesh-list
139658622|NCT05950529|Cathartics|cathartics|mesh-ancestor
139658623|NCT05950529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658624|NCT05950490|Methotrexate|methotrexate|mesh-list
139658625|NCT05950490|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139658626|NCT05950490|Abortifacient Agents|abortifacient agents|mesh-ancestor
139658627|NCT05950490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139658628|NCT05950490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658629|NCT05950490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139658630|NCT05950490|Antimetabolites|antimetabolites|mesh-ancestor
139658631|NCT05950490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658632|NCT05950490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658633|NCT05950490|Dermatologic Agents|dermatologic agents|mesh-ancestor
139658634|NCT05950490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658635|NCT05950490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139658636|NCT05950490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139658637|NCT05950490|Immunologic Factors|immunologic factors|mesh-ancestor
139658638|NCT05950490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139658639|NCT05950490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139658640|NCT05950204|Calcium, Dietary|calcium, dietary|mesh-list
139658641|NCT05950204|Vitamin D|vitamin d|mesh-list
139658642|NCT05950204|Ergocalciferols|ergocalciferols|mesh-list
139658643|NCT05950204|Cholecalciferol|cholecalciferol|mesh-list
139658644|NCT05950204|Vitamins|vitamins|mesh-list
139658645|NCT05950204|Calcium Carbonate|calcium carbonate|mesh-list
139658646|NCT05950204|Calcium|calcium|mesh-list
139658647|NCT05950204|Micronutrients|micronutrients|mesh-ancestor
139658648|NCT05950204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658649|NCT05950204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139658650|NCT05950204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139658651|NCT05950204|Antacids|antacids|mesh-ancestor
139658652|NCT05950204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658653|NCT05950204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658654|NCT05950152|Meloxicam|meloxicam|mesh-list
139658655|NCT05950152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139658656|NCT05950152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139658657|NCT05950152|Analgesics|analgesics|mesh-ancestor
139658658|NCT05950152|Sensory System Agents|sensory system agents|mesh-ancestor
139658659|NCT05950152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658660|NCT05950152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658661|NCT05950152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139658662|NCT05950152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139658663|NCT05950152|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139658664|NCT05950152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139658665|NCT05950152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658666|NCT05950152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658667|NCT05950061|Dexetimide|dexetimide|mesh-list
139658668|NCT05950061|Citalopram|citalopram|mesh-list
139658669|NCT05950061|Sertraline|sertraline|mesh-list
139658670|NCT05950061|Escitalopram|escitalopram|mesh-list
139658671|NCT05950061|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139658672|NCT05950061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139658673|NCT05950061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139658674|NCT05950061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658675|NCT05950061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658676|NCT05950061|Serotonin Agents|serotonin agents|mesh-ancestor
139658677|NCT05950061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658678|NCT05950061|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139658679|NCT05950061|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139658680|NCT05950061|Parasympatholytics|parasympatholytics|mesh-ancestor
139658681|NCT05950061|Autonomic Agents|autonomic agents|mesh-ancestor
139658682|NCT05950061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658683|NCT05950061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139658684|NCT05950061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139658685|NCT05950061|Cholinergic Agents|cholinergic agents|mesh-ancestor
139658686|NCT05950061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139658687|NCT05950061|Antidepressive Agents|antidepressive agents|mesh-ancestor
139658688|NCT05950061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139658689|NCT05949762|Azacitidine|azacitidine|mesh-list
139658690|NCT05949762|Venetoclax|venetoclax|mesh-list
139658691|NCT05949762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139658692|NCT05949762|Antimetabolites|antimetabolites|mesh-ancestor
139658693|NCT05949762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658694|NCT05949762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147019|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139658695|NCT05949762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658697|NCT05949554|Analgesics|analgesics|mesh-ancestor
139658698|NCT05949554|Sensory System Agents|sensory system agents|mesh-ancestor
139658699|NCT05949554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658700|NCT05949554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658701|NCT05949554|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139658702|NCT05949554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139658703|NCT05949554|Anesthetics, General|anesthetics, general|mesh-ancestor
139658704|NCT05949554|Anesthetics|anesthetics|mesh-ancestor
139658705|NCT05949554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139658706|NCT05949554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139658707|NCT05949554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139658708|NCT05949554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658709|NCT05949554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658710|NCT05949541|Everolimus|everolimus|mesh-list
139658711|NCT05949541|Fulvestrant|fulvestrant|mesh-list
139658712|NCT05949541|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139658713|NCT05949541|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139658714|NCT05949541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139658715|NCT05949541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658716|NCT05949541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658717|NCT05949541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139658718|NCT05949541|Immunologic Factors|immunologic factors|mesh-ancestor
139658719|NCT05949541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658720|NCT05949541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658721|NCT05949541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139658722|NCT05949541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139658723|NCT05949541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139658724|NCT05949541|Hormone Antagonists|hormone antagonists|mesh-ancestor
139658725|NCT05949541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139658726|NCT05949541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139658727|NCT05949411|Lactulose|lactulose|mesh-list
139658728|NCT05949411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658729|NCT05949385|Itraconazole|itraconazole|mesh-list
139658730|NCT05949385|Antifungal Agents|antifungal agents|mesh-ancestor
139658731|NCT05949385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139658732|NCT05949385|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139658733|NCT05949385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139658734|NCT05949385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658735|NCT05949385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658736|NCT05949385|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139658737|NCT05949385|Hormone Antagonists|hormone antagonists|mesh-ancestor
139658738|NCT05949385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139658739|NCT05949385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658740|NCT05949385|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139658741|NCT05915442|Quemliclustat|quemliclustat|mesh-list
139658742|NCT05915442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139658743|NCT05915442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658744|NCT05915442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139658745|NCT05915442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658746|NCT05701956|Tenecteplase|tenecteplase|mesh-list
139658747|NCT05701956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139658748|NCT05701956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139658749|NCT05701956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658750|NCT05662228|Lorazepam|lorazepam|mesh-list
139658751|NCT05662228|Immunoglobulins|immunoglobulins|mesh-list
139658752|NCT05662228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139658753|NCT05662228|Antibodies|antibodies|mesh-list
139658754|NCT05662228|gamma-Globulins|gamma-globulins|mesh-list
139658755|NCT05662228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139658756|NCT05662228|Tofacitinib|tofacitinib|mesh-list
139658757|NCT05662228|Immunologic Factors|immunologic factors|mesh-ancestor
139658758|NCT05662228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658759|NCT05662228|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139658760|NCT05662228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139658761|NCT05662228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658762|NCT05662228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658763|NCT05662228|Anticonvulsants|anticonvulsants|mesh-ancestor
139658764|NCT05662228|Antiemetics|antiemetics|mesh-ancestor
139658765|NCT05662228|Autonomic Agents|autonomic agents|mesh-ancestor
139658766|NCT05662228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658768|NCT05662228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139658769|NCT05662228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139658770|NCT05662228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139658771|NCT05662228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139658772|NCT05662228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139658773|NCT05662228|GABA Modulators|gaba modulators|mesh-ancestor
139658774|NCT05662228|GABA Agents|gaba agents|mesh-ancestor
139658775|NCT05662228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658776|NCT05593627|Lithium Carbonate|lithium carbonate|mesh-list
139658777|NCT05593627|Calcium Carbonate|calcium carbonate|mesh-list
139658778|NCT05593627|Calcium|calcium|mesh-list
139658779|NCT05593627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139658780|NCT05593627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658781|NCT05593627|Antidepressive Agents|antidepressive agents|mesh-ancestor
139658782|NCT05593627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139658783|NCT05593627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658784|NCT05593627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658785|NCT05593627|Antimanic Agents|antimanic agents|mesh-ancestor
139658786|NCT05593627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139658787|NCT05593627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139658788|NCT05593627|Antacids|antacids|mesh-ancestor
139658789|NCT05593627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658790|NCT05582096|Tirzepatide|tirzepatide|mesh-list
139658791|NCT05582096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139658792|NCT05582096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658793|NCT05582096|Incretins|incretins|mesh-ancestor
139658794|NCT05582096|Hormones|hormones|mesh-ancestor
139658795|NCT05582096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139658796|NCT05577715|Farletuzumab|farletuzumab|mesh-list
139658797|NCT05577715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658798|NCT05527834|Ceftibuten|ceftibuten|mesh-list
139658799|NCT05527834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139658800|NCT05527834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139658801|NCT05502250|Gemcitabine|gemcitabine|mesh-list
139658802|NCT05502250|Tislelizumab|tislelizumab|mesh-list
139658803|NCT05502250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658804|NCT05502250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139658805|NCT05502250|Antimetabolites|antimetabolites|mesh-ancestor
139658806|NCT05502250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658807|NCT05502250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139658808|NCT05457868|Albuterol|albuterol|mesh-list
139658809|NCT05457868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139658810|NCT05457868|Autonomic Agents|autonomic agents|mesh-ancestor
139658811|NCT05457868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658812|NCT05457868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658813|NCT05457868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139658814|NCT05457868|Respiratory System Agents|respiratory system agents|mesh-ancestor
139658815|NCT05457868|Tocolytic Agents|tocolytic agents|mesh-ancestor
139658816|NCT05457868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139658817|NCT05457868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139658818|NCT05457868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139658819|NCT05457868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139658820|NCT05457868|Adrenergic Agents|adrenergic agents|mesh-ancestor
139658821|NCT05457868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658822|NCT05457868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658823|NCT05434065|Celecoxib|celecoxib|mesh-list
139658824|NCT05434065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139658825|NCT05434065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139658826|NCT05434065|Analgesics|analgesics|mesh-ancestor
139658827|NCT05434065|Sensory System Agents|sensory system agents|mesh-ancestor
139658828|NCT05434065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658829|NCT05434065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658830|NCT05434065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139658831|NCT05434065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139658832|NCT05434065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139658833|NCT05434065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139658834|NCT05434065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658835|NCT05434065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658836|NCT05425979|Bupivacaine|bupivacaine|mesh-list
139658837|NCT05425979|Mepivacaine|mepivacaine|mesh-list
139658838|NCT05425979|Anesthetics, Local|anesthetics, local|mesh-ancestor
139658839|NCT05425979|Anesthetics|anesthetics|mesh-ancestor
139658840|NCT05425979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147092|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418455|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658841|NCT05425979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658842|NCT05425979|Sensory System Agents|sensory system agents|mesh-ancestor
139658843|NCT05425979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658844|NCT05398757|Midazolam|midazolam|mesh-list
139658845|NCT05398757|Dexmedetomidine|dexmedetomidine|mesh-list
139658846|NCT05398757|Propofol|propofol|mesh-list
139658847|NCT05398757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139658848|NCT05398757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139658849|NCT05398757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658850|NCT05398757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139658851|NCT05398757|Anesthetics, General|anesthetics, general|mesh-ancestor
139658852|NCT05398757|Anesthetics|anesthetics|mesh-ancestor
139658853|NCT05398757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139658854|NCT05398757|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139658855|NCT05398757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139658856|NCT05398757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139658857|NCT05398757|GABA Modulators|gaba modulators|mesh-ancestor
139658858|NCT05398757|GABA Agents|gaba agents|mesh-ancestor
139658859|NCT05398757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658860|NCT05398757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658861|NCT05398757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139658862|NCT05398757|Analgesics|analgesics|mesh-ancestor
139658863|NCT05398757|Sensory System Agents|sensory system agents|mesh-ancestor
139658864|NCT05398757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658865|NCT05398757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139658866|NCT05398757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139658867|NCT05398757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139658868|NCT05398757|Adrenergic Agents|adrenergic agents|mesh-ancestor
139658869|NCT05378269|Tamoxifen|tamoxifen|mesh-list
139658870|NCT05378269|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139658871|NCT05378269|Hormone Antagonists|hormone antagonists|mesh-ancestor
139658872|NCT05378269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139658873|NCT05378269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658874|NCT05378269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139658875|NCT05378269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658876|NCT05378269|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139054119|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139054120|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054121|NCT04624217|Paclitaxel|paclitaxel|mesh-list
139054122|NCT04624217|Gemcitabine|gemcitabine|mesh-list
139054123|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139658877|NCT05378269|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139658878|NCT05378269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139658879|NCT05323552|Curare|curare|mesh-list
139658880|NCT05323552|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139658881|NCT05323552|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139658882|NCT05323552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139658883|NCT05323552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658884|NCT05323552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658885|NCT05323552|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139658886|NCT05323552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139658887|NCT05323552|Cholinergic Agents|cholinergic agents|mesh-ancestor
139658888|NCT05323552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658889|NCT05323552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658890|NCT05322954|Psilocybin|psilocybin|mesh-list
139658891|NCT05322954|Hallucinogens|hallucinogens|mesh-ancestor
139658892|NCT05322954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658893|NCT05322954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139658894|NCT05310253|Fludrocortisone|fludrocortisone|mesh-list
139658895|NCT05310253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139658896|NCT05291039|Adalimumab|adalimumab|mesh-list
139658897|NCT05291039|Infliximab|infliximab|mesh-list
139658898|NCT05291039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139658899|NCT05291039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139658900|NCT05291039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139658901|NCT05291039|Dermatologic Agents|dermatologic agents|mesh-ancestor
139658902|NCT05291039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658903|NCT05274633|Ravulizumab|ravulizumab|mesh-list
139658904|NCT05274633|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139658905|NCT05274633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139658906|NCT05274633|Immunologic Factors|immunologic factors|mesh-ancestor
139658907|NCT05274633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658908|NCT05224089|Dexamethasone|dexamethasone|mesh-list
139658909|NCT05224089|Epinephrine|epinephrine|mesh-list
139658910|NCT05224089|Bupivacaine|bupivacaine|mesh-list
139658911|NCT05224089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139147167|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
139658912|NCT05224089|Antiemetics|antiemetics|mesh-ancestor
139658913|NCT05224089|Autonomic Agents|autonomic agents|mesh-ancestor
139658914|NCT05224089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147235|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
139658915|NCT05224089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658916|NCT05224089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658917|NCT05224089|Glucocorticoids|glucocorticoids|mesh-ancestor
139658918|NCT05224089|Hormones|hormones|mesh-ancestor
139658919|NCT05224089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139658920|NCT05224089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139658921|NCT05224089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658922|NCT05224089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658923|NCT05224089|Anesthetics, Local|anesthetics, local|mesh-ancestor
139658924|NCT05224089|Anesthetics|anesthetics|mesh-ancestor
139658925|NCT05224089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139658926|NCT05224089|Sensory System Agents|sensory system agents|mesh-ancestor
139658927|NCT05224089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139658928|NCT05224089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139658929|NCT05224089|Adrenergic Agents|adrenergic agents|mesh-ancestor
139658930|NCT05224089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139658931|NCT05224089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139658932|NCT05224089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139658933|NCT05224089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139658934|NCT05224089|Respiratory System Agents|respiratory system agents|mesh-ancestor
139658935|NCT05224089|Mydriatics|mydriatics|mesh-ancestor
139658936|NCT05224089|Sympathomimetics|sympathomimetics|mesh-ancestor
139658937|NCT05224089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139658938|NCT05205252|Dexamethasone|dexamethasone|mesh-list
139658939|NCT05205252|Lenalidomide|lenalidomide|mesh-list
139658940|NCT05205252|Daratumumab|daratumumab|mesh-list
139658941|NCT05205252|Pomalidomide|pomalidomide|mesh-list
139658942|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
139658943|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139658944|NCT05205252|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139658945|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139658946|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
139658947|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
139658948|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139658949|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658950|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139658951|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
139658952|NCT05205252|Hormones|hormones|mesh-ancestor
139658953|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139658954|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139658955|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658956|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
139658957|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139658958|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139658959|NCT05205252|Growth Substances|growth substances|mesh-ancestor
139658960|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
139658961|NCT05205252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139658962|NCT05205252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658963|NCT05205252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658964|NCT05125237|Amiloride|amiloride|mesh-list
139658965|NCT05125237|Triamterene|triamterene|mesh-list
139658966|NCT05125237|Diuretics|diuretics|mesh-ancestor
139658967|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
139658968|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658969|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139658970|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139658971|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139658972|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658973|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139658974|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139658975|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139658976|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
139658977|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
139658978|NCT05125224|Calcium|calcium|mesh-list
139658979|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139658980|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139658981|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139658982|NCT05125224|Diuretics|diuretics|mesh-ancestor
139658983|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
139658984|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139658985|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139658986|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658987|NCT06232564|Carboplatin|carboplatin|mesh-list
139658988|NCT06232564|Pembrolizumab|pembrolizumab|mesh-list
139658990|NCT06232564|Lenvatinib|lenvatinib|mesh-list
139658991|NCT06232564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139658992|NCT06232564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139658993|NCT06232564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139658994|NCT06232564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139658995|NCT06232564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139658996|NCT06232564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139658997|NCT06232564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139658998|NCT06232564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139658999|NCT06232564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139659000|NCT06232473|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139659001|NCT06232473|Benztropine|benztropine|mesh-list
139659002|NCT06232473|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139659003|NCT06232473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139659004|NCT06232473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139659005|NCT06232473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659006|NCT06232473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659007|NCT06232473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659008|NCT06232473|Analgesics|analgesics|mesh-ancestor
139659009|NCT06232473|Sensory System Agents|sensory system agents|mesh-ancestor
139659010|NCT06232473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659011|NCT06232473|Antidepressive Agents|antidepressive agents|mesh-ancestor
139659012|NCT06232473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139659013|NCT06232473|Dopamine Agents|dopamine agents|mesh-ancestor
139659014|NCT06232473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139659015|NCT06232473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139659016|NCT06232473|Parasympatholytics|parasympatholytics|mesh-ancestor
139659017|NCT06232473|Autonomic Agents|autonomic agents|mesh-ancestor
139659018|NCT06232473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139659019|NCT06232473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139659020|NCT06232473|Cholinergic Agents|cholinergic agents|mesh-ancestor
139659021|NCT06232473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139659022|NCT06232239|Empagliflozin|empagliflozin|mesh-list
139659023|NCT06232239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139659024|NCT06232239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659025|NCT06232239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139659026|NCT06232239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659027|NCT06232122|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139659028|NCT06232122|FAPI-46|fapi-46|mesh-list
139659029|NCT06232122|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139659030|NCT06232122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659031|NCT06232109|Itraconazole|itraconazole|mesh-list
139659032|NCT06232109|Fluvoxamine|fluvoxamine|mesh-list
139659033|NCT06232109|Paroxetine|paroxetine|mesh-list
139659034|NCT06232109|Antifungal Agents|antifungal agents|mesh-ancestor
139659035|NCT06232109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139659036|NCT06232109|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139054262|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
139659037|NCT06232109|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139659038|NCT06232109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659039|NCT06232109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659040|NCT06232109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139659041|NCT06232109|Hormone Antagonists|hormone antagonists|mesh-ancestor
139659042|NCT06232109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139659043|NCT06232109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659044|NCT06232109|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139659045|NCT06232109|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139659046|NCT06232109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139659047|NCT06232109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139659048|NCT06232109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659049|NCT06232109|Serotonin Agents|serotonin agents|mesh-ancestor
139659050|NCT06232109|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139659051|NCT06232109|Antidepressive Agents|antidepressive agents|mesh-ancestor
139659052|NCT06232109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139659053|NCT06232109|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139659054|NCT06232109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139659055|NCT06232109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139659056|NCT06232109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659057|NCT06232109|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139659058|NCT06232109|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139147310|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
139659059|NCT06232044|Dexamethasone|dexamethasone|mesh-list
139659060|NCT06232044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139659061|NCT06232044|Antiemetics|antiemetics|mesh-ancestor
139659062|NCT06232044|Autonomic Agents|autonomic agents|mesh-ancestor
139659063|NCT06232044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659064|NCT06232044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659065|NCT06232044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139659066|NCT06232044|Glucocorticoids|glucocorticoids|mesh-ancestor
139659067|NCT06232044|Hormones|hormones|mesh-ancestor
139659068|NCT06232044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139659069|NCT06232044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139659070|NCT06232044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659071|NCT06232005|Mitomycins|mitomycins|mesh-list
139659072|NCT06232005|Mitomycin|mitomycin|mesh-list
139659073|NCT06232005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139659074|NCT06232005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659075|NCT06232005|Alkylating Agents|alkylating agents|mesh-ancestor
139054307|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139054308|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
139054309|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139054310|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054311|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139054312|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
139054313|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139659076|NCT06232005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659077|NCT06232005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139659078|NCT06232005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659079|NCT06231992|Analgesics, Opioid|analgesics, opioid|mesh-list
139659080|NCT06231992|Anesthetics|anesthetics|mesh-list
139659081|NCT06231992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659082|NCT06231992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659083|NCT06231992|Narcotics|narcotics|mesh-ancestor
139659084|NCT06231992|Analgesics|analgesics|mesh-ancestor
139659085|NCT06231992|Sensory System Agents|sensory system agents|mesh-ancestor
139659086|NCT06231992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659087|NCT06231979|Dexmedetomidine|dexmedetomidine|mesh-list
139659088|NCT06231979|Bupivacaine|bupivacaine|mesh-list
139659089|NCT06231979|Anesthetics, Local|anesthetics, local|mesh-ancestor
139659090|NCT06231979|Anesthetics|anesthetics|mesh-ancestor
139659091|NCT06231979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659092|NCT06231979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659093|NCT06231979|Sensory System Agents|sensory system agents|mesh-ancestor
139659094|NCT06231979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659095|NCT06231979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139659096|NCT06231979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139659097|NCT06231979|Analgesics|analgesics|mesh-ancestor
139659098|NCT06231979|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139659099|NCT06231979|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139659100|NCT06231979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139659101|NCT06231979|Adrenergic Agents|adrenergic agents|mesh-ancestor
139659102|NCT06231979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659103|NCT06231979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659104|NCT06231966|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139659105|NCT06231966|Ezetimibe|ezetimibe|mesh-list
139659106|NCT06231966|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139659107|NCT06231966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139659108|NCT06231966|Antimetabolites|antimetabolites|mesh-ancestor
139659109|NCT06231966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659110|NCT06231966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139659111|NCT06231966|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139659112|NCT06231966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659113|NCT06231758|Metformin|metformin|mesh-list
139659114|NCT06231758|Celecoxib|celecoxib|mesh-list
139659115|NCT06231758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139659116|NCT06231758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659117|NCT06231758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139659118|NCT06231758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139659119|NCT06231758|Analgesics|analgesics|mesh-ancestor
139659120|NCT06231758|Sensory System Agents|sensory system agents|mesh-ancestor
139659121|NCT06231758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659122|NCT06231758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139659123|NCT06231758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659124|NCT06231758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139659125|NCT06231758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139659126|NCT06231758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659127|NCT06231758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659128|NCT06231745|Methotrexate|methotrexate|mesh-list
139659129|NCT06231745|Paroxetine|paroxetine|mesh-list
139659130|NCT06231745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139659131|NCT06231745|Abortifacient Agents|abortifacient agents|mesh-ancestor
139659132|NCT06231745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139659133|NCT06231745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659134|NCT06231745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139659135|NCT06231745|Antimetabolites|antimetabolites|mesh-ancestor
139659136|NCT06231745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659137|NCT06231745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659138|NCT06231745|Dermatologic Agents|dermatologic agents|mesh-ancestor
139659139|NCT06231745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659140|NCT06231745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139054365|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054366|NCT04042701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139054367|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659141|NCT06231745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139659142|NCT06231745|Immunologic Factors|immunologic factors|mesh-ancestor
139659143|NCT06231745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659144|NCT06231745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139659145|NCT06231745|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139659146|NCT06231745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139659147|NCT06231745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139659148|NCT06231745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659149|NCT06231745|Serotonin Agents|serotonin agents|mesh-ancestor
139659150|NCT06231745|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139659151|NCT06231745|Antidepressive Agents|antidepressive agents|mesh-ancestor
139659152|NCT06231745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139659153|NCT06231745|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139659154|NCT06231745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139659155|NCT06231693|Trastuzumab|trastuzumab|mesh-list
139659156|NCT06231693|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139659157|NCT06231693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659158|NCT06231693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659159|NCT06231693|Immunoconjugates|immunoconjugates|mesh-ancestor
139659160|NCT06231693|Immunologic Factors|immunologic factors|mesh-ancestor
139659161|NCT06231693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659162|NCT06231680|Thalidomide|thalidomide|mesh-list
139659163|NCT06231680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139659164|NCT06231680|Immunologic Factors|immunologic factors|mesh-ancestor
139659165|NCT06231680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659166|NCT06231680|Leprostatic Agents|leprostatic agents|mesh-ancestor
139659167|NCT06231680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139659168|NCT06231680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139659169|NCT06231680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139659170|NCT06231680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139659171|NCT06231680|Growth Substances|growth substances|mesh-ancestor
139659172|NCT06231680|Growth Inhibitors|growth inhibitors|mesh-ancestor
139659173|NCT06231680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659174|NCT06231641|Lemborexant|lemborexant|mesh-list
139659175|NCT06231641|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139659176|NCT06231641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659177|NCT06231641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659178|NCT06231641|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139659179|NCT06231641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139659180|NCT06231641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659181|NCT06231641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659183|NCT06231563|Analgesics|analgesics|mesh-ancestor
139659184|NCT06231563|Sensory System Agents|sensory system agents|mesh-ancestor
139659185|NCT06231563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659186|NCT06231563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659187|NCT06231563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139659188|NCT06231563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139659189|NCT06231563|Anesthetics, General|anesthetics, general|mesh-ancestor
139659190|NCT06231563|Anesthetics|anesthetics|mesh-ancestor
139659191|NCT06231563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659192|NCT06231563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139659193|NCT06231563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139659194|NCT06231563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659195|NCT06231563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659196|NCT06231459|Evolocumab|evolocumab|mesh-list
139659197|NCT06231459|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139659198|NCT06231459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139659199|NCT06231459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139659200|NCT06231459|Antimetabolites|antimetabolites|mesh-ancestor
139659201|NCT06231459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659202|NCT06231459|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139659203|NCT06231459|Protease Inhibitors|protease inhibitors|mesh-ancestor
139659204|NCT06231459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659205|NCT06231459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139659206|NCT06231355|Bupivacaine|bupivacaine|mesh-list
139659207|NCT06231355|Anesthetics, Local|anesthetics, local|mesh-ancestor
139659208|NCT06231355|Anesthetics|anesthetics|mesh-ancestor
139659209|NCT06231355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659210|NCT06231355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659211|NCT06231355|Sensory System Agents|sensory system agents|mesh-ancestor
139659212|NCT06231355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659213|NCT06231316|Norepinephrine|norepinephrine|mesh-list
139659214|NCT06231316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139659215|NCT06231316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139659216|NCT06231316|Adrenergic Agents|adrenergic agents|mesh-ancestor
139054532|NCT03400332|Nivolumab|nivolumab|mesh-list
139659217|NCT06231316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659218|NCT06231316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659219|NCT06231316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659220|NCT06231316|Sympathomimetics|sympathomimetics|mesh-ancestor
139659221|NCT06231316|Autonomic Agents|autonomic agents|mesh-ancestor
139659222|NCT06231316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659223|NCT06231316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139659224|NCT06231212|Ibuprofen|ibuprofen|mesh-list
139659225|NCT06231212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139659226|NCT06231212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139659227|NCT06231212|Analgesics|analgesics|mesh-ancestor
139659228|NCT06231212|Sensory System Agents|sensory system agents|mesh-ancestor
139659229|NCT06231212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659230|NCT06231212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659231|NCT06231212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139659232|NCT06231212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659233|NCT06231212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139659234|NCT06231212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659235|NCT06231212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659236|NCT06231121|Faricimab|faricimab|mesh-list
139659237|NCT06231121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139659238|NCT06231121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139659239|NCT06231121|Growth Substances|growth substances|mesh-ancestor
139659240|NCT06231121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659241|NCT06231121|Growth Inhibitors|growth inhibitors|mesh-ancestor
139659242|NCT06231121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659243|NCT06231043|Diclofenac|diclofenac|mesh-list
139659244|NCT06231043|Tramadol|tramadol|mesh-list
139659245|NCT06231043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139659246|NCT06231043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139659247|NCT06231043|Analgesics|analgesics|mesh-ancestor
139659248|NCT06231043|Sensory System Agents|sensory system agents|mesh-ancestor
139659249|NCT06231043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659250|NCT06231043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659251|NCT06231043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139659252|NCT06231043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659253|NCT06231043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139659254|NCT06231043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659255|NCT06231043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659256|NCT06231043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139659257|NCT06231043|Narcotics|narcotics|mesh-ancestor
139659258|NCT06231043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659259|NCT06231017|Cetuximab|cetuximab|mesh-list
139659260|NCT06231017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659261|NCT06231017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659262|NCT06230861|Quercetin|quercetin|mesh-list
139659263|NCT06230861|Antioxidants|antioxidants|mesh-ancestor
139659264|NCT06230861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659265|NCT06230861|Protective Agents|protective agents|mesh-ancestor
139659266|NCT06230861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659267|NCT06230757|Psilocybin|psilocybin|mesh-list
139659268|NCT06230757|Hallucinogens|hallucinogens|mesh-ancestor
139659269|NCT06230757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659270|NCT06230757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139659271|NCT06230640|Hemostatics|hemostatics|mesh-list
139659272|NCT06230640|Coagulants|coagulants|mesh-ancestor
139659273|NCT06230614|Colistin|colistin|mesh-list
139659274|NCT06230614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139659275|NCT06230614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139659276|NCT06230471|Gemcitabine|gemcitabine|mesh-list
139659277|NCT06230471|Pembrolizumab|pembrolizumab|mesh-list
139659278|NCT06230471|Oxaliplatin|oxaliplatin|mesh-list
139659279|NCT06230471|Lenvatinib|lenvatinib|mesh-list
139659280|NCT06230471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139659281|NCT06230471|Antimetabolites|antimetabolites|mesh-ancestor
139659282|NCT06230471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418456|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659283|NCT06230471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659284|NCT06230471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659285|NCT06230471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139659286|NCT06230471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139659287|NCT06230471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659288|NCT06230224|Cytarabine|cytarabine|mesh-list
139659289|NCT06230224|Dexamethasone|dexamethasone|mesh-list
139659290|NCT06230224|Rituximab|rituximab|mesh-list
139659291|NCT06230224|Carboplatin|carboplatin|mesh-list
139659292|NCT06230224|Gemcitabine|gemcitabine|mesh-list
139659293|NCT06230224|Etoposide|etoposide|mesh-list
139659294|NCT06230224|Ifosfamide|ifosfamide|mesh-list
139659295|NCT06230224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139659296|NCT06230224|Antiemetics|antiemetics|mesh-ancestor
139659297|NCT06230224|Autonomic Agents|autonomic agents|mesh-ancestor
139659298|NCT06230224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659299|NCT06230224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659300|NCT06230224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139659301|NCT06230224|Glucocorticoids|glucocorticoids|mesh-ancestor
139659302|NCT06230224|Hormones|hormones|mesh-ancestor
139659303|NCT06230224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139659304|NCT06230224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139659305|NCT06230224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659306|NCT06230224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659307|NCT06230224|Immunologic Factors|immunologic factors|mesh-ancestor
139659308|NCT06230224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659309|NCT06230224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139659310|NCT06230224|Antimetabolites|antimetabolites|mesh-ancestor
139659311|NCT06230224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659312|NCT06230224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139659313|NCT06230224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139659314|NCT06230224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139659315|NCT06230224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659316|NCT06230224|Antiviral Agents|antiviral agents|mesh-ancestor
139659317|NCT06230224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139659318|NCT06230224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139659319|NCT06230224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139659320|NCT06230224|Alkylating Agents|alkylating agents|mesh-ancestor
139659321|NCT06230159|Menthol|menthol|mesh-list
139659322|NCT06230159|Antipruritics|antipruritics|mesh-ancestor
139659323|NCT06230159|Dermatologic Agents|dermatologic agents|mesh-ancestor
139659324|NCT06230146|Triamcinolone|triamcinolone|mesh-list
139659325|NCT06230146|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139659326|NCT06230146|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139659327|NCT06230146|Botulinum Toxins|botulinum toxins|mesh-list
139659328|NCT06230146|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139659329|NCT06230146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659330|NCT06230146|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139659331|NCT06230146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139659332|NCT06230146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659333|NCT06230146|Cholinergic Agents|cholinergic agents|mesh-ancestor
139659334|NCT06230146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659335|NCT06230146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139659336|NCT06230146|Glucocorticoids|glucocorticoids|mesh-ancestor
139659337|NCT06230146|Hormones|hormones|mesh-ancestor
139659338|NCT06230146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139659339|NCT06230146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139659340|NCT06230146|Immunologic Factors|immunologic factors|mesh-ancestor
139659341|NCT06230146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659342|NCT06230081|Clonidine|clonidine|mesh-list
139659343|NCT06230081|Analgesics|analgesics|mesh-ancestor
139659344|NCT06230081|Sensory System Agents|sensory system agents|mesh-ancestor
139659345|NCT06230081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659346|NCT06230081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659347|NCT06230081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139659348|NCT06230081|Sympatholytics|sympatholytics|mesh-ancestor
139659349|NCT06230081|Autonomic Agents|autonomic agents|mesh-ancestor
139659350|NCT06230081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139659351|NCT06230081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139659352|NCT06230081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139659353|NCT06230081|Adrenergic Agents|adrenergic agents|mesh-ancestor
139659354|NCT06230081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659355|NCT06230081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659356|NCT06228911|Triamcinolone|triamcinolone|mesh-list
139659357|NCT06228911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139418457|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
139418458|NCT02468648|Velpatasvir|velpatasvir|mesh-list
139659358|NCT06228911|Glucocorticoids|glucocorticoids|mesh-ancestor
139659359|NCT06228911|Hormones|hormones|mesh-ancestor
139659360|NCT06228911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139659361|NCT06228911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659362|NCT06228066|Avelumab|avelumab|mesh-list
139659363|NCT06228066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659364|NCT06228066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659365|NCT06226896|Dapagliflozin|dapagliflozin|mesh-list
139659366|NCT06226896|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139659367|NCT06226896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659368|NCT06226896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139659369|NCT06226896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659370|NCT06226415|Lidocaine|lidocaine|mesh-list
139659371|NCT06226415|Anesthetics, Local|anesthetics, local|mesh-ancestor
139659372|NCT06226415|Anesthetics|anesthetics|mesh-ancestor
139659373|NCT06226415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659374|NCT06226415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659375|NCT06226415|Sensory System Agents|sensory system agents|mesh-ancestor
139659376|NCT06226415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659377|NCT06226415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139659378|NCT06226415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139659379|NCT06226415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139659380|NCT06226415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139659381|NCT06226415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659382|NCT06226025|Melatonin|melatonin|mesh-list
139659383|NCT06226025|Antioxidants|antioxidants|mesh-ancestor
139659384|NCT06226025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659385|NCT06226025|Protective Agents|protective agents|mesh-ancestor
139659386|NCT06226025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659387|NCT06226025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659388|NCT06225323|Lidocaine|lidocaine|mesh-list
139659389|NCT06225323|Anesthetics, Local|anesthetics, local|mesh-ancestor
139659390|NCT06225323|Anesthetics|anesthetics|mesh-ancestor
139659391|NCT06225323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659392|NCT06225323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659393|NCT06225323|Sensory System Agents|sensory system agents|mesh-ancestor
139659394|NCT06225323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659395|NCT06225323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139659396|NCT06225323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139659397|NCT06225323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139659398|NCT06225323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139659399|NCT06225323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659400|NCT06225284|Leuprolide|leuprolide|mesh-list
139659401|NCT06225284|Goserelin|goserelin|mesh-list
139659402|NCT06225284|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139659403|NCT06225284|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139659404|NCT06225284|Fertility Agents|fertility agents|mesh-ancestor
139659405|NCT06225284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139659406|NCT06225284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659407|NCT06225284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139659408|NCT06225284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659409|NCT06225284|Luteolytic Agents|luteolytic agents|mesh-ancestor
139659410|NCT06225284|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139659411|NCT06225284|Contraceptive Agents|contraceptive agents|mesh-ancestor
139659412|NCT06225284|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139659413|NCT06225076|Lidocaine|lidocaine|mesh-list
139659414|NCT06225076|Anesthetics, Local|anesthetics, local|mesh-ancestor
139659415|NCT06225076|Anesthetics|anesthetics|mesh-ancestor
139659416|NCT06225076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659417|NCT06225076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659418|NCT06225076|Sensory System Agents|sensory system agents|mesh-ancestor
139659419|NCT06225076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659420|NCT06225076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139659421|NCT06225076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139659422|NCT06225076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139659423|NCT06225076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139659424|NCT06225076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418459|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
139418460|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418461|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139659425|NCT06225024|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139418462|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139659426|NCT06225024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139659427|NCT06225024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659428|NCT06225024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659429|NCT06225024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139659430|NCT06225024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139659431|NCT06225024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659432|NCT06225024|Cholinergic Agents|cholinergic agents|mesh-ancestor
139659433|NCT06225024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659434|NCT06223568|Docetaxel|docetaxel|mesh-list
139659435|NCT06223568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659436|NCT06223568|Tubulin Modulators|tubulin modulators|mesh-ancestor
139659437|NCT06223568|Antimitotic Agents|antimitotic agents|mesh-ancestor
139659438|NCT06223568|Mitosis Modulators|mitosis modulators|mesh-ancestor
139659439|NCT06223568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659440|NCT06220266|Phytoestrogens|phytoestrogens|mesh-list
139659441|NCT06220266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139659442|NCT06220266|Estrogens|estrogens|mesh-ancestor
139659443|NCT06220266|Hormones|hormones|mesh-ancestor
139659444|NCT06220266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139659445|NCT06220266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659446|NCT06218823|Nicotine|nicotine|mesh-list
139659447|NCT06218823|Varenicline|varenicline|mesh-list
139659448|NCT06218823|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139659449|NCT06218823|Autonomic Agents|autonomic agents|mesh-ancestor
139659450|NCT06218823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659451|NCT06218823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659452|NCT06218823|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139659453|NCT06218823|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139659454|NCT06218823|Cholinergic Agents|cholinergic agents|mesh-ancestor
139659455|NCT06218823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659456|NCT06218823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659457|NCT06216665|Insulin|insulin|mesh-list
139659458|NCT06216665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139659459|NCT06216665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139659460|NCT06216665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659461|NCT06215833|Propofol|propofol|mesh-list
139659462|NCT06215833|Sevoflurane|sevoflurane|mesh-list
139659463|NCT06215833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139659464|NCT06215833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659465|NCT06215833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659466|NCT06215833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139659467|NCT06215833|Anesthetics, General|anesthetics, general|mesh-ancestor
139659468|NCT06215833|Anesthetics|anesthetics|mesh-ancestor
139659469|NCT06215833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139659470|NCT06215833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139659471|NCT06213454|Bupivacaine|bupivacaine|mesh-list
139659472|NCT06213454|Anesthetics, Local|anesthetics, local|mesh-list
139659473|NCT06213454|Anesthetics|anesthetics|mesh-list
139659474|NCT06213454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659475|NCT06213454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659476|NCT06213454|Sensory System Agents|sensory system agents|mesh-ancestor
139659477|NCT06213454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659478|NCT06201793|Minocycline|minocycline|mesh-list
139659479|NCT06201793|Mesalamine|mesalamine|mesh-list
139659480|NCT06201793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139659481|NCT06201793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139659482|NCT06201793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139054805|NCT00237263|Entacapone|entacapone|mesh-list
139659483|NCT06201793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139659484|NCT06201793|Analgesics|analgesics|mesh-ancestor
139659485|NCT06201793|Sensory System Agents|sensory system agents|mesh-ancestor
139659486|NCT06201793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659487|NCT06201793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659488|NCT06201793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139659489|NCT06201793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659490|NCT06199778|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139659491|NCT06199778|Levofloxacin|levofloxacin|mesh-list
139659492|NCT06199778|Reserpine|reserpine|mesh-list
139659493|NCT06199778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139659494|NCT06199778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139659495|NCT06199778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139659496|NCT06199778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139659497|NCT06199778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659498|NCT06199778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659499|NCT06199778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418463|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659500|NCT06199778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139659501|NCT06199778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139659502|NCT06199778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139659504|NCT06199778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139659505|NCT06199778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659506|NCT06199778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659507|NCT06199778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139659508|NCT06199778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139659509|NCT06199778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139659510|NCT06199778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139659511|NCT06199778|Adrenergic Agents|adrenergic agents|mesh-ancestor
139659512|NCT06199778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659513|NCT06199713|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139659514|NCT06199713|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139659515|NCT06199713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659516|NCT06197308|Amoxicillin|amoxicillin|mesh-list
139659517|NCT06197308|Vancomycin|vancomycin|mesh-list
139659518|NCT06197308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139659519|NCT06197308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139659520|NCT06197295|Solifenacin Succinate|solifenacin succinate|mesh-list
139659521|NCT06197295|Estrogens|estrogens|mesh-list
139659522|NCT06197295|Hormones|hormones|mesh-ancestor
139659523|NCT06197295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139659524|NCT06197295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659525|NCT06197295|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139659526|NCT06197295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139659527|NCT06197295|Cholinergic Agents|cholinergic agents|mesh-ancestor
139659528|NCT06197295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659529|NCT06197295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659530|NCT06197295|Urological Agents|urological agents|mesh-ancestor
139659531|NCT06190197|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139659532|NCT06190197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139659533|NCT06190067|Azacitidine|azacitidine|mesh-list
139659534|NCT06190067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139659535|NCT06190067|Antimetabolites|antimetabolites|mesh-ancestor
139659536|NCT06190067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659537|NCT06190067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659538|NCT06190067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659539|NCT06186115|Hyaluronic Acid|hyaluronic acid|mesh-list
139659540|NCT06186115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139659541|NCT06186115|Immunologic Factors|immunologic factors|mesh-ancestor
139659542|NCT06186115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659543|NCT06186115|Viscosupplements|viscosupplements|mesh-ancestor
139659544|NCT06186115|Protective Agents|protective agents|mesh-ancestor
139659545|NCT06176027|Azacitidine|azacitidine|mesh-list
139659546|NCT06176027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139659547|NCT06176027|Antimetabolites|antimetabolites|mesh-ancestor
139659548|NCT06176027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659549|NCT06176027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659550|NCT06176027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659551|NCT06161558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139659552|NCT06161558|Lenvatinib|lenvatinib|mesh-list
139659553|NCT06161558|Axitinib|axitinib|mesh-list
139659554|NCT06161558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659555|NCT06161558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139659556|NCT06161558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659557|NCT06161558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659558|NCT06161545|Pembrolizumab|pembrolizumab|mesh-list
139659559|NCT06161545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659560|NCT06161545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659561|NCT06161545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139054956|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659562|NCT06161545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659563|NCT06161532|Atezolizumab|atezolizumab|mesh-list
139659564|NCT06161532|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139659565|NCT06161532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139659566|NCT06161532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659567|NCT06161532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659568|NCT06161532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659569|NCT06161532|Immunoconjugates|immunoconjugates|mesh-ancestor
139659570|NCT06161532|Immunologic Factors|immunologic factors|mesh-ancestor
139147824|NCT03728829|Trastuzumab|trastuzumab|mesh-list
139659571|NCT06161532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659572|NCT06158542|Anesthetics|anesthetics|mesh-list
139659573|NCT06158542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659574|NCT06158542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659575|NCT06154226|Pantoprazole|pantoprazole|mesh-list
139659576|NCT06154226|Famotidine|famotidine|mesh-list
139659577|NCT06154226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139659578|NCT06154226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139659579|NCT06154226|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139659580|NCT06154226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659581|NCT06154226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659582|NCT06154226|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139659583|NCT06154226|Histamine Antagonists|histamine antagonists|mesh-ancestor
139659584|NCT06154226|Histamine Agents|histamine agents|mesh-ancestor
139659585|NCT06154226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659586|NCT06154226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659587|NCT06151288|Vaccines|vaccines|mesh-list
139659588|NCT06151288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139659589|NCT06151288|Immunologic Factors|immunologic factors|mesh-ancestor
139659590|NCT06151288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659591|NCT06145282|Abatacept|abatacept|mesh-list
139659592|NCT06145282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139659593|NCT06145282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659594|NCT06145282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659595|NCT06145282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659596|NCT06145282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139659597|NCT06145282|Immunologic Factors|immunologic factors|mesh-ancestor
139659598|NCT06145282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659599|NCT06145282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659600|NCT06137287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139659601|NCT06137287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139659602|NCT06137287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139659603|NCT06137287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659604|NCT06137287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659605|NCT06137287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139659606|NCT06137287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139659607|NCT06137287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659608|NCT06137287|Cholinergic Agents|cholinergic agents|mesh-ancestor
139659609|NCT06137287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659610|NCT06128044|Cyclophosphamide|cyclophosphamide|mesh-list
139659611|NCT06128044|Fludarabine|fludarabine|mesh-list
139659612|NCT06128044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139659613|NCT06128044|Immunologic Factors|immunologic factors|mesh-ancestor
139659614|NCT06128044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659615|NCT06128044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659616|NCT06128044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139659617|NCT06128044|Alkylating Agents|alkylating agents|mesh-ancestor
139659618|NCT06128044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659619|NCT06128044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659620|NCT06128044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139659621|NCT06120491|Abiraterone Acetate|abiraterone acetate|mesh-list
139659622|NCT06120491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659623|NCT06120491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139659624|NCT06120491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659625|NCT06120491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659626|NCT06120491|Hormone Antagonists|hormone antagonists|mesh-ancestor
139659627|NCT06120491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139659628|NCT06120491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659629|NCT06120491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139659630|NCT06119685|Cyclophosphamide|cyclophosphamide|mesh-list
139659631|NCT06119685|Rituximab|rituximab|mesh-list
139659632|NCT06119685|Fludarabine|fludarabine|mesh-list
139659633|NCT06119685|Interleukin-2|interleukin-2|mesh-list
139659634|NCT06119685|Daratumumab|daratumumab|mesh-list
139659635|NCT06119685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139659636|NCT06119685|Immunologic Factors|immunologic factors|mesh-ancestor
139659637|NCT06119685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659638|NCT06119685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659639|NCT06119685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139659640|NCT06119685|Alkylating Agents|alkylating agents|mesh-ancestor
139659641|NCT06119685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659642|NCT06119685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147904|NCT03557307|Benralizumab|benralizumab|mesh-list
139659643|NCT06119685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139659644|NCT06119685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659645|NCT06119685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139659646|NCT06119685|Analgesics|analgesics|mesh-ancestor
139659647|NCT06119685|Sensory System Agents|sensory system agents|mesh-ancestor
139659648|NCT06119685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659649|NCT06111586|Insulin|insulin|mesh-list
139659650|NCT06111586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139659651|NCT06111586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659652|NCT06103838|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139659653|NCT06103838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139659654|NCT06103838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659655|NCT06097728|Carboplatin|carboplatin|mesh-list
139659656|NCT06097728|Nivolumab|nivolumab|mesh-list
139659657|NCT06097728|Pemetrexed|pemetrexed|mesh-list
139659658|NCT06097728|Ipilimumab|ipilimumab|mesh-list
139659659|NCT06097728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659660|NCT06097728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659661|NCT06097728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139659662|NCT06097728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659663|NCT06097728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659664|NCT06097728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139659665|NCT06097728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139659666|NCT06095765|Colchicine|colchicine|mesh-list
139659667|NCT06095765|Gout Suppressants|gout suppressants|mesh-ancestor
139659668|NCT06095765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659669|NCT06095765|Tubulin Modulators|tubulin modulators|mesh-ancestor
139659670|NCT06095765|Antimitotic Agents|antimitotic agents|mesh-ancestor
139659671|NCT06095765|Mitosis Modulators|mitosis modulators|mesh-ancestor
139659672|NCT06095765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659673|NCT06095765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659674|NCT06092333|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139659675|NCT06092333|Antiviral Agents|antiviral agents|mesh-ancestor
139659676|NCT06092333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139659677|NCT06086704|Anastrozole|anastrozole|mesh-list
139659678|NCT06086704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139659679|NCT06086704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659680|NCT06086704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139659681|NCT06086704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139659682|NCT06086704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659683|NCT06086704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659684|NCT06086704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139659685|NCT06086704|Hormone Antagonists|hormone antagonists|mesh-ancestor
139659686|NCT06086704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139659687|NCT06086704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659688|NCT06084676|Immunomodulating Agents|immunomodulating agents|mesh-list
139659689|NCT06084676|Immunologic Factors|immunologic factors|mesh-ancestor
139659690|NCT06084676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659691|NCT06082271|Cortisone|cortisone|mesh-list
139659692|NCT06082271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139659693|NCT06072534|Mivacurium|mivacurium|mesh-list
139659694|NCT06072534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139659695|NCT06072534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139659696|NCT06072534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139659697|NCT06072534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659698|NCT06072534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659699|NCT06069063|Zafirlukast|zafirlukast|mesh-list
139659700|NCT06069063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139659701|NCT06069063|Respiratory System Agents|respiratory system agents|mesh-ancestor
139659702|NCT06069063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139659703|NCT06069063|Hormone Antagonists|hormone antagonists|mesh-ancestor
139055175|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139659704|NCT06069063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139659705|NCT06069063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659706|NCT06068855|Botulinum Toxins|botulinum toxins|mesh-list
139659707|NCT06068855|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139659708|NCT06068855|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139659709|NCT06068855|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139659710|NCT06068855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139659711|NCT06068855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659712|NCT06068855|Cholinergic Agents|cholinergic agents|mesh-ancestor
139659713|NCT06068855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659714|NCT06068855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659715|NCT06068855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139418464|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139659716|NCT06068855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659717|NCT06066138|Atezolizumab|atezolizumab|mesh-list
139659718|NCT06066138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139659719|NCT06066138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659720|NCT06066138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659721|NCT06066138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659722|NCT06059391|Vaccines|vaccines|mesh-list
139659723|NCT06059391|Lenograstim|lenograstim|mesh-list
139659724|NCT06059391|Immunologic Factors|immunologic factors|mesh-ancestor
139659725|NCT06059391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659726|NCT06059391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139659727|NCT06056102|Cyclophosphamide|cyclophosphamide|mesh-list
139659728|NCT06056102|Fludarabine|fludarabine|mesh-list
139659729|NCT06056102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139659730|NCT06056102|Immunologic Factors|immunologic factors|mesh-ancestor
139659731|NCT06056102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659732|NCT06056102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659733|NCT06056102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139659734|NCT06056102|Alkylating Agents|alkylating agents|mesh-ancestor
139659735|NCT06056102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659736|NCT06056102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659737|NCT06056102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139659738|NCT06051474|Nicotine|nicotine|mesh-list
139659739|NCT06051474|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139659740|NCT06051474|Autonomic Agents|autonomic agents|mesh-ancestor
139659741|NCT06051474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659742|NCT06051474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659743|NCT06051474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139659744|NCT06051474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139659745|NCT06051474|Cholinergic Agents|cholinergic agents|mesh-ancestor
139659746|NCT06051474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659747|NCT06051474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659748|NCT06042569|Cyclophosphamide|cyclophosphamide|mesh-list
139659749|NCT06042569|Docetaxel|docetaxel|mesh-list
139659750|NCT06042569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139659751|NCT06042569|Immunologic Factors|immunologic factors|mesh-ancestor
139659752|NCT06042569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659753|NCT06042569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659754|NCT06042569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139659755|NCT06042569|Alkylating Agents|alkylating agents|mesh-ancestor
139659756|NCT06042569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659757|NCT06042569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659758|NCT06042569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139659759|NCT06042569|Tubulin Modulators|tubulin modulators|mesh-ancestor
139659760|NCT06042569|Antimitotic Agents|antimitotic agents|mesh-ancestor
139659761|NCT06042569|Mitosis Modulators|mitosis modulators|mesh-ancestor
139659762|NCT06041503|Pembrolizumab|pembrolizumab|mesh-list
139659763|NCT06041503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659764|NCT06041503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659765|NCT06041503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139659766|NCT06041503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659767|NCT06035393|Glycopyrrolate|glycopyrrolate|mesh-list
139659768|NCT06035393|Bromides|bromides|mesh-list
139659769|NCT06035393|Maleic acid|maleic acid|mesh-list
139659770|NCT06035393|Anticonvulsants|anticonvulsants|mesh-ancestor
139659771|NCT06035393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659772|NCT06035393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659773|NCT06035393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139659774|NCT06035393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139659775|NCT06035393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139659776|NCT06035393|Cholinergic Agents|cholinergic agents|mesh-ancestor
139659777|NCT06035393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659778|NCT06035393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659779|NCT06032923|Niacinamide|niacinamide|mesh-list
139659780|NCT06032923|Niacin|niacin|mesh-list
139659781|NCT06032923|Nicotinic Acids|nicotinic acids|mesh-list
139659782|NCT06032923|Vitamin B Complex|vitamin b complex|mesh-ancestor
139659783|NCT06032923|Vitamins|vitamins|mesh-ancestor
139659784|NCT06032923|Micronutrients|micronutrients|mesh-ancestor
139659785|NCT06032923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148047|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
139659786|NCT06032923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139659787|NCT06032923|Antimetabolites|antimetabolites|mesh-ancestor
139659788|NCT06032923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659789|NCT06032923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139659790|NCT06032923|Vasodilator Agents|vasodilator agents|mesh-ancestor
139659791|NCT06016972|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139659792|NCT06016972|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139659793|NCT06016738|Letrozole|letrozole|mesh-list
139659794|NCT06016738|Fulvestrant|fulvestrant|mesh-list
139659795|NCT06016738|Anastrozole|anastrozole|mesh-list
139659796|NCT06016738|Exemestane|exemestane|mesh-list
139659797|NCT06016738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659798|NCT06016738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139659799|NCT06016738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139659800|NCT06016738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659801|NCT06016738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659802|NCT06016738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139659803|NCT06016738|Hormone Antagonists|hormone antagonists|mesh-ancestor
139659804|NCT06016738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139055441|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
139659805|NCT06016738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659806|NCT06016738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139659807|NCT06016738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139659808|NCT06012240|Upadacitinib|upadacitinib|mesh-list
139659809|NCT06012240|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139659810|NCT06012240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139659811|NCT06012240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659812|NCT06012240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659813|NCT06012240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659814|NCT05997056|Sirolimus|sirolimus|mesh-list
139659815|NCT05997056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139659816|NCT05997056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139659817|NCT05997056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139659818|NCT05997056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659819|NCT05997056|Antifungal Agents|antifungal agents|mesh-ancestor
139659820|NCT05997056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139659821|NCT05997056|Immunologic Factors|immunologic factors|mesh-ancestor
139659822|NCT05997056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659823|NCT05995353|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139659824|NCT05995353|Immunologic Factors|immunologic factors|mesh-ancestor
139659825|NCT05995353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659826|NCT05980000|Pembrolizumab|pembrolizumab|mesh-list
139659827|NCT05980000|Ramucirumab|ramucirumab|mesh-list
139659828|NCT05980000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659829|NCT05980000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659830|NCT05980000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139659831|NCT05980000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659832|NCT05977738|Pitavastatin|pitavastatin|mesh-list
139659833|NCT05977738|Calcium|calcium|mesh-list
139659834|NCT05977738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139659835|NCT05977738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659836|NCT05977738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139659837|NCT05977738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139659838|NCT05977738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139659839|NCT05977738|Antimetabolites|antimetabolites|mesh-ancestor
139659840|NCT05977738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659841|NCT05977738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659842|NCT05977738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139659843|NCT05969496|Pembrolizumab|pembrolizumab|mesh-list
139659844|NCT05969496|Axitinib|axitinib|mesh-list
139659845|NCT05969496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659846|NCT05969496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659847|NCT05969496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139659848|NCT05969496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659849|NCT05969496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139659850|NCT05969496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659851|NCT05960929|Calfactant|calfactant|mesh-list
139659852|NCT05960929|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139659853|NCT05960929|Respiratory System Agents|respiratory system agents|mesh-ancestor
139659854|NCT05960773|Decitabine|decitabine|mesh-list
139659855|NCT05960773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139659856|NCT05960773|Antimetabolites|antimetabolites|mesh-ancestor
139659857|NCT05960773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659858|NCT05960773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659859|NCT05960773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659860|NCT05954910|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139659861|NCT05954910|Immunoconjugates|immunoconjugates|mesh-ancestor
139659862|NCT05954910|Immunologic Factors|immunologic factors|mesh-ancestor
139659863|NCT05954910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659864|NCT05953142|Dobutamine|dobutamine|mesh-list
139659865|NCT05953142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139659866|NCT05953142|Sympathomimetics|sympathomimetics|mesh-ancestor
139659867|NCT05953142|Autonomic Agents|autonomic agents|mesh-ancestor
139659868|NCT05953142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659869|NCT05953142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659870|NCT05953142|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139659871|NCT05953142|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139659872|NCT05953142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139659873|NCT05953142|Adrenergic Agents|adrenergic agents|mesh-ancestor
139659874|NCT05953142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659875|NCT05953142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659876|NCT05953142|Protective Agents|protective agents|mesh-ancestor
139659877|NCT05939635|Morphine|morphine|mesh-list
139659878|NCT05939635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139659879|NCT05939635|Narcotics|narcotics|mesh-ancestor
139659880|NCT05939635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659881|NCT05939635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659882|NCT05939635|Analgesics|analgesics|mesh-ancestor
139659883|NCT05939635|Sensory System Agents|sensory system agents|mesh-ancestor
139659884|NCT05939635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659885|NCT05936190|Lidocaine|lidocaine|mesh-list
139659886|NCT05936190|Anesthetics, Local|anesthetics, local|mesh-ancestor
139659887|NCT05936190|Anesthetics|anesthetics|mesh-ancestor
139659888|NCT05936190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139659889|NCT05936190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659890|NCT05936190|Sensory System Agents|sensory system agents|mesh-ancestor
139659891|NCT05936190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139659892|NCT05936190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139659893|NCT05936190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139659894|NCT05936190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139659895|NCT05936190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139659896|NCT05936190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659897|NCT05924880|Durvalumab|durvalumab|mesh-list
139659898|NCT05924880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659899|NCT05924880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659900|NCT05907759|Daratumumab|daratumumab|mesh-list
139659901|NCT05907759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659902|NCT05907746|Mycophenolic Acid|mycophenolic acid|mesh-list
139659903|NCT05907746|Cyclophosphamide|cyclophosphamide|mesh-list
139659904|NCT05907746|Fludarabine|fludarabine|mesh-list
139659905|NCT05907746|Tacrolimus|tacrolimus|mesh-list
139659906|NCT05907746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139659907|NCT05907746|Immunologic Factors|immunologic factors|mesh-ancestor
139659908|NCT05907746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659909|NCT05907746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659910|NCT05907746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139659911|NCT05907746|Alkylating Agents|alkylating agents|mesh-ancestor
139659912|NCT05907746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659913|NCT05907746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659914|NCT05907746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139659915|NCT05907746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139659916|NCT05907746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659917|NCT05907746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139659918|NCT05907746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139659919|NCT05907746|Antitubercular Agents|antitubercular agents|mesh-ancestor
139659920|NCT05907746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139659921|NCT05907746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139659922|NCT05898828|Nivolumab|nivolumab|mesh-list
139659923|NCT05898828|Entinostat|entinostat|mesh-list
139659924|NCT05898828|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139659925|NCT05898828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659926|NCT05898828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659927|NCT05898828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139659928|NCT05898828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659929|NCT05898828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139055626|NCT06186063|Pramlintide|pramlintide|mesh-list
139055627|NCT06186063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139055628|NCT06186063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055629|NCT06186037|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139055630|NCT06186037|Ezetimibe|ezetimibe|mesh-list
139055631|NCT06186037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139659930|NCT05898828|Immunologic Factors|immunologic factors|mesh-ancestor
139659931|NCT05898828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659932|NCT05898828|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139659933|NCT05898828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659934|NCT05879484|Pembrolizumab|pembrolizumab|mesh-list
139659935|NCT05879484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659936|NCT05879484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659937|NCT05879484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139148197|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
139659938|NCT05879484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659940|NCT05872867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659941|NCT05872867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659942|NCT05872867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139659943|NCT05872867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659944|NCT05858216|Chlorpheniramine|chlorpheniramine|mesh-list
139659945|NCT05858216|Antipruritics|antipruritics|mesh-ancestor
139659946|NCT05858216|Dermatologic Agents|dermatologic agents|mesh-ancestor
139659947|NCT05858216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139659948|NCT05858216|Histamine Antagonists|histamine antagonists|mesh-ancestor
139659949|NCT05858216|Histamine Agents|histamine agents|mesh-ancestor
139659950|NCT05858216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139659951|NCT05858216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659952|NCT05858216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659953|NCT05858216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139659954|NCT05849480|Capecitabine|capecitabine|mesh-list
139659955|NCT05849480|Oxaliplatin|oxaliplatin|mesh-list
139659956|NCT05849480|Pembrolizumab|pembrolizumab|mesh-list
139659957|NCT05849480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139659958|NCT05849480|Antimetabolites|antimetabolites|mesh-ancestor
139659959|NCT05849480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659960|NCT05849480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055668|NCT06185400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139659961|NCT05849480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139659962|NCT05849480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139659963|NCT05849298|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139659964|NCT05849298|177Lu-PSMA-617|177lu-psma-617|mesh-list
139659965|NCT05849298|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139659966|NCT05849298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659967|NCT05843643|Upadacitinib|upadacitinib|mesh-list
139659968|NCT05843643|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139659969|NCT05843643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139659970|NCT05843643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659971|NCT05843643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659972|NCT05843643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659973|NCT05820451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139659974|NCT05814627|Adalimumab|adalimumab|mesh-list
139659975|NCT05814627|Upadacitinib|upadacitinib|mesh-list
139659976|NCT05814627|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139659977|NCT05814627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139659978|NCT05814627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139659979|NCT05814627|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139659980|NCT05814627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139659981|NCT05814627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139659982|NCT05814627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139659983|NCT05807711|Vitamin B 12|vitamin b 12|mesh-list
139659984|NCT05807711|Vitamin B Complex|vitamin b complex|mesh-ancestor
139659985|NCT05807711|Vitamins|vitamins|mesh-ancestor
139659986|NCT05807711|Micronutrients|micronutrients|mesh-ancestor
139659987|NCT05807711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659988|NCT05807139|Spironolactone|spironolactone|mesh-list
139659989|NCT05807139|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139659990|NCT05807139|Hormone Antagonists|hormone antagonists|mesh-ancestor
139659991|NCT05807139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139659992|NCT05807139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139659993|NCT05807139|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139659994|NCT05807139|Diuretics|diuretics|mesh-ancestor
139659995|NCT05807139|Natriuretic Agents|natriuretic agents|mesh-ancestor
139659996|NCT05803096|Nitrous Oxide|nitrous oxide|mesh-list
139659997|NCT05803096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139659998|NCT05803096|Anesthetics, General|anesthetics, general|mesh-ancestor
139659999|NCT05803096|Anesthetics|anesthetics|mesh-ancestor
139660000|NCT05803096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139660001|NCT05803096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660002|NCT05803096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139660003|NCT05803096|Analgesics|analgesics|mesh-ancestor
139660004|NCT05803096|Sensory System Agents|sensory system agents|mesh-ancestor
139660005|NCT05803096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660006|NCT05787574|Dexamethasone|dexamethasone|mesh-list
139660007|NCT05787574|Fludarabine|fludarabine|mesh-list
139660008|NCT05787574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660009|NCT05787574|Antiemetics|antiemetics|mesh-ancestor
139148272|NCT03032510|Levofloxacin|levofloxacin|mesh-list
139660010|NCT05787574|Autonomic Agents|autonomic agents|mesh-ancestor
139660011|NCT05787574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660012|NCT05787574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660013|NCT05787574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139660014|NCT05787574|Glucocorticoids|glucocorticoids|mesh-ancestor
139660015|NCT05787574|Hormones|hormones|mesh-ancestor
139660016|NCT05787574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660017|NCT05787574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139660018|NCT05787574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660019|NCT05785832|Insulin|insulin|mesh-list
139660020|NCT05785832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139660021|NCT05785832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660022|NCT05782907|Upadacitinib|upadacitinib|mesh-list
139055746|NCT06184958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139660023|NCT05782907|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139660024|NCT05782907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139660025|NCT05782907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660026|NCT05782907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660027|NCT05782907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139660028|NCT05777603|Vancomycin|vancomycin|mesh-list
139660029|NCT05777603|Aztreonam|aztreonam|mesh-list
139660030|NCT05777603|Pembrolizumab|pembrolizumab|mesh-list
139660031|NCT05777603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660032|NCT05777603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660033|NCT05777603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139660034|NCT05777603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660035|NCT05777603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139660036|NCT05777603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660037|NCT05769153|Aflibercept|aflibercept|mesh-list
139660038|NCT05769153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139660039|NCT05769153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139660040|NCT05769153|Growth Substances|growth substances|mesh-ancestor
139660041|NCT05769153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660042|NCT05769153|Growth Inhibitors|growth inhibitors|mesh-ancestor
139660043|NCT05769153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660044|NCT05768139|Fulvestrant|fulvestrant|mesh-list
139660045|NCT05768139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139660046|NCT05768139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660047|NCT05768139|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139660048|NCT05768139|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139660049|NCT05768139|Hormone Antagonists|hormone antagonists|mesh-ancestor
139660050|NCT05768139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660051|NCT05768139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660052|NCT05765812|Temozolomide|temozolomide|mesh-list
139660053|NCT05765812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139660054|NCT05765812|Alkylating Agents|alkylating agents|mesh-ancestor
139660055|NCT05765812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660056|NCT05765812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660057|NCT05748483|Topiramate|topiramate|mesh-list
139660058|NCT05748483|Anticonvulsants|anticonvulsants|mesh-ancestor
139660059|NCT05748483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139660060|NCT05748483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660061|NCT05742607|Paclitaxel|paclitaxel|mesh-list
139660062|NCT05742607|Cisplatin|cisplatin|mesh-list
139660063|NCT05742607|Carboplatin|carboplatin|mesh-list
139660064|NCT05742607|Pemetrexed|pemetrexed|mesh-list
139660065|NCT05742607|Durvalumab|durvalumab|mesh-list
139055852|NCT06149104|Valsartan|valsartan|mesh-list
139660066|NCT05742607|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139660067|NCT05742607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139660068|NCT05742607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660069|NCT05742607|Tubulin Modulators|tubulin modulators|mesh-ancestor
139660070|NCT05742607|Antimitotic Agents|antimitotic agents|mesh-ancestor
139660071|NCT05742607|Mitosis Modulators|mitosis modulators|mesh-ancestor
139660072|NCT05742607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660073|NCT05742607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660074|NCT05742607|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139660075|NCT05742607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139660076|NCT05742607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660077|NCT05742607|Immunologic Factors|immunologic factors|mesh-ancestor
139660078|NCT05742607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660079|NCT05735184|Cytarabine|cytarabine|mesh-list
139660080|NCT05735184|Azacitidine|azacitidine|mesh-list
139660081|NCT05735184|Daunorubicin|daunorubicin|mesh-list
139660082|NCT05735184|Venetoclax|venetoclax|mesh-list
139660083|NCT05735184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139660084|NCT05735184|Antimetabolites|antimetabolites|mesh-ancestor
139055903|NCT06047457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660085|NCT05735184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418465|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139660086|NCT05735184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660087|NCT05735184|Antiviral Agents|antiviral agents|mesh-ancestor
139418466|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139660088|NCT05735184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660089|NCT05735184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139660090|NCT05735184|Immunologic Factors|immunologic factors|mesh-ancestor
139660091|NCT05735184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660092|NCT05735184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660093|NCT05735184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139660094|NCT05735184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139660095|NCT05735184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139660096|NCT05716009|Gemtuzumab|gemtuzumab|mesh-list
139660097|NCT05716009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660098|NCT05716009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660099|NCT05716009|Immunotoxins|immunotoxins|mesh-ancestor
139660100|NCT05716009|Immunoconjugates|immunoconjugates|mesh-ancestor
139660101|NCT05716009|Immunologic Factors|immunologic factors|mesh-ancestor
139660102|NCT05716009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660103|NCT05713799|Thioctic Acid|thioctic acid|mesh-list
139660104|NCT05713799|Mirabegron|mirabegron|mesh-list
139660105|NCT05713799|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139660106|NCT05713799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139660107|NCT05713799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139660108|NCT05713799|Adrenergic Agents|adrenergic agents|mesh-ancestor
139660109|NCT05713799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139660110|NCT05713799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660111|NCT05713799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660112|NCT05713799|Urological Agents|urological agents|mesh-ancestor
139660113|NCT05713799|Antioxidants|antioxidants|mesh-ancestor
139660114|NCT05713799|Protective Agents|protective agents|mesh-ancestor
139660115|NCT05713799|Vitamin B Complex|vitamin b complex|mesh-ancestor
139660116|NCT05713799|Vitamins|vitamins|mesh-ancestor
139660117|NCT05713799|Micronutrients|micronutrients|mesh-ancestor
139660118|NCT05679401|Cyclophosphamide|cyclophosphamide|mesh-list
139660119|NCT05679401|Glucocorticoids|glucocorticoids|mesh-list
139660120|NCT05679401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139660121|NCT05679401|Immunologic Factors|immunologic factors|mesh-ancestor
139660122|NCT05679401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660123|NCT05679401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139660124|NCT05679401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139660125|NCT05679401|Alkylating Agents|alkylating agents|mesh-ancestor
139660126|NCT05679401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660127|NCT05679401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660128|NCT05679401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139660129|NCT05679401|Hormones|hormones|mesh-ancestor
139660130|NCT05679401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660131|NCT05672251|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139660132|NCT05672251|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139660133|NCT05672251|Immunologic Factors|immunologic factors|mesh-ancestor
139660134|NCT05672251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660135|NCT05672251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660136|NCT05672251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660137|NCT05670743|Fluorides|fluorides|mesh-list
139660138|NCT05670743|Cariostatic Agents|cariostatic agents|mesh-ancestor
139660139|NCT05670743|Protective Agents|protective agents|mesh-ancestor
139660140|NCT05670743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660141|NCT05662189|Exenatide|exenatide|mesh-list
139660142|NCT05662189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139660143|NCT05662189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660144|NCT05662189|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139660145|NCT05662189|Incretins|incretins|mesh-ancestor
139660146|NCT05662189|Hormones|hormones|mesh-ancestor
139660147|NCT05662189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660148|NCT05652478|Tenofovir|tenofovir|mesh-list
139660149|NCT05652478|Dolutegravir|dolutegravir|mesh-list
139660150|NCT05652478|Antiviral Agents|antiviral agents|mesh-ancestor
139660151|NCT05652478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660152|NCT05652478|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139660153|NCT05652478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139660154|NCT05652478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660155|NCT05652478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660156|NCT05652478|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139660157|NCT05652478|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139660158|NCT05652478|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139660159|NCT05652478|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139660160|NCT05645692|Atezolizumab|atezolizumab|mesh-list
139660161|NCT05645692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139660162|NCT05645692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660163|NCT05645692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660164|NCT05645692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660165|NCT05642195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139660166|NCT05642195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139660167|NCT05642195|Immunologic Factors|immunologic factors|mesh-ancestor
139660168|NCT05642195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660170|NCT05600894|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139660171|NCT05600894|Venetoclax|venetoclax|mesh-list
139660172|NCT05600894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139660173|NCT05600894|Antimetabolites|antimetabolites|mesh-ancestor
139660174|NCT05600894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660175|NCT05600894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660176|NCT05600894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660177|NCT05599984|Carboplatin|carboplatin|mesh-list
139660178|NCT05599984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660179|NCT05580562|TIC10 compound|tic10 compound|mesh-list
139660180|NCT05580562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660181|NCT05579223|Hydromorphone|hydromorphone|mesh-list
139660182|NCT05579223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139660183|NCT05579223|Narcotics|narcotics|mesh-ancestor
139660184|NCT05579223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139660185|NCT05579223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660186|NCT05579223|Analgesics|analgesics|mesh-ancestor
139660187|NCT05579223|Sensory System Agents|sensory system agents|mesh-ancestor
139660188|NCT05579223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660189|NCT05578976|Prednisone|prednisone|mesh-list
139660190|NCT05578976|Cyclophosphamide|cyclophosphamide|mesh-list
139660191|NCT05578976|Rituximab|rituximab|mesh-list
139660192|NCT05578976|Doxorubicin|doxorubicin|mesh-list
139660193|NCT05578976|Vincristine|vincristine|mesh-list
139660194|NCT05578976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139660195|NCT05578976|Immunologic Factors|immunologic factors|mesh-ancestor
139660196|NCT05578976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660197|NCT05578976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139660198|NCT05578976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139660199|NCT05578976|Alkylating Agents|alkylating agents|mesh-ancestor
139660200|NCT05578976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660201|NCT05578976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660202|NCT05578976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139660203|NCT05578976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660204|NCT05578976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139660205|NCT05578976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139660206|NCT05578976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139660207|NCT05578976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660208|NCT05578976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660209|NCT05578976|Glucocorticoids|glucocorticoids|mesh-ancestor
139660210|NCT05578976|Hormones|hormones|mesh-ancestor
139660211|NCT05578976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660212|NCT05578976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139660213|NCT05578976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139660214|NCT05578976|Tubulin Modulators|tubulin modulators|mesh-ancestor
139660215|NCT05578976|Antimitotic Agents|antimitotic agents|mesh-ancestor
139660216|NCT05578976|Mitosis Modulators|mitosis modulators|mesh-ancestor
139660217|NCT05558761|Pentoxifylline|pentoxifylline|mesh-list
139660218|NCT05558761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139660219|NCT05558761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660220|NCT05558761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660221|NCT05558761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139660222|NCT05558761|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139660223|NCT05558761|Protective Agents|protective agents|mesh-ancestor
139660224|NCT05558761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660225|NCT05558761|Vasodilator Agents|vasodilator agents|mesh-ancestor
139660226|NCT05558761|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139660227|NCT05558761|Antioxidants|antioxidants|mesh-ancestor
139660228|NCT05557838|Durvalumab|durvalumab|mesh-list
139660229|NCT05557838|Tremelimumab|tremelimumab|mesh-list
139660230|NCT05557838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660231|NCT05557838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660232|NCT05556681|Sirolimus|sirolimus|mesh-list
139660233|NCT05556681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139660234|NCT05556681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660235|NCT05556681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139418467|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660236|NCT05556681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418468|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
139660237|NCT05556681|Antifungal Agents|antifungal agents|mesh-ancestor
139660238|NCT05556681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139660239|NCT05556681|Immunologic Factors|immunologic factors|mesh-ancestor
139660240|NCT05556681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660242|NCT05554380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139660243|NCT05554380|Ipatasertib|ipatasertib|mesh-list
139660244|NCT05554380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139660245|NCT05554380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660246|NCT05554380|Tubulin Modulators|tubulin modulators|mesh-ancestor
139660247|NCT05554380|Antimitotic Agents|antimitotic agents|mesh-ancestor
139660248|NCT05554380|Mitosis Modulators|mitosis modulators|mesh-ancestor
139660249|NCT05554380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660250|NCT05554380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139660251|NCT05554380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660252|NCT05548296|Gemcitabine|gemcitabine|mesh-list
139660253|NCT05548296|Prexasertib|prexasertib|mesh-list
139660254|NCT05548296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139660255|NCT05548296|Antimetabolites|antimetabolites|mesh-ancestor
139660256|NCT05548296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660257|NCT05548296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660258|NCT05548296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139660259|NCT05548296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660260|NCT05545969|Pembrolizumab|pembrolizumab|mesh-list
139660261|NCT05545969|Lenvatinib|lenvatinib|mesh-list
139660262|NCT05545969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660263|NCT05545969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660264|NCT05545969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139660265|NCT05545969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660266|NCT05545969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139660267|NCT05545969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660268|NCT05544136|Carboplatin|carboplatin|mesh-list
139660269|NCT05544136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660270|NCT05537220|Acetylcysteine|acetylcysteine|mesh-list
139660271|NCT05537220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139660272|NCT05537220|Antiviral Agents|antiviral agents|mesh-ancestor
139660273|NCT05537220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660274|NCT05537220|Expectorants|expectorants|mesh-ancestor
139660275|NCT05537220|Respiratory System Agents|respiratory system agents|mesh-ancestor
139660276|NCT05537220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139660277|NCT05537220|Antioxidants|antioxidants|mesh-ancestor
139660278|NCT05537220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660279|NCT05537220|Protective Agents|protective agents|mesh-ancestor
139660280|NCT05537220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660281|NCT05537220|Antidotes|antidotes|mesh-ancestor
139660282|NCT05521152|Norepinephrine|norepinephrine|mesh-list
139660283|NCT05521152|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139660284|NCT05521152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139660285|NCT05521152|Adrenergic Agents|adrenergic agents|mesh-ancestor
139660286|NCT05521152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139660287|NCT05521152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660288|NCT05521152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660289|NCT05521152|Sympathomimetics|sympathomimetics|mesh-ancestor
139660290|NCT05521152|Autonomic Agents|autonomic agents|mesh-ancestor
139660291|NCT05521152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660292|NCT05521152|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139660293|NCT05519085|Dexamethasone|dexamethasone|mesh-list
139660294|NCT05519085|Bortezomib|bortezomib|mesh-list
139660295|NCT05519085|Pomalidomide|pomalidomide|mesh-list
139660296|NCT05519085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660297|NCT05519085|Antiemetics|antiemetics|mesh-ancestor
139660298|NCT05519085|Autonomic Agents|autonomic agents|mesh-ancestor
139660299|NCT05519085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660300|NCT05519085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660301|NCT05519085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139660302|NCT05519085|Glucocorticoids|glucocorticoids|mesh-ancestor
139660303|NCT05519085|Hormones|hormones|mesh-ancestor
139660304|NCT05519085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660305|NCT05519085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139660306|NCT05519085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660307|NCT05519085|Immunologic Factors|immunologic factors|mesh-ancestor
139660308|NCT05519085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139660309|NCT05519085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139660310|NCT05519085|Growth Substances|growth substances|mesh-ancestor
139660311|NCT05519085|Growth Inhibitors|growth inhibitors|mesh-ancestor
139660312|NCT05517590|Tranexamic Acid|tranexamic acid|mesh-list
139660313|NCT05517590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139660314|NCT05517590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139660315|NCT05517590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660316|NCT05517590|Hemostatics|hemostatics|mesh-ancestor
139660317|NCT05517590|Coagulants|coagulants|mesh-ancestor
139660318|NCT05504252|Fluorouracil|fluorouracil|mesh-list
139660319|NCT05504252|Oxaliplatin|oxaliplatin|mesh-list
139660320|NCT05504252|Nivolumab|nivolumab|mesh-list
139660321|NCT05504252|Antimetabolites|antimetabolites|mesh-ancestor
139660322|NCT05504252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660323|NCT05504252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139660324|NCT05504252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660325|NCT05504252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139660326|NCT05504252|Immunologic Factors|immunologic factors|mesh-ancestor
139660327|NCT05504252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056197|NCT04931511|Hormones|hormones|mesh-ancestor
139660328|NCT05504252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660329|NCT05504252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139660330|NCT05494697|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
139660331|NCT05494697|Antiviral Agents|antiviral agents|mesh-ancestor
139660332|NCT05494697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660333|NCT05468320|Prednisone|prednisone|mesh-list
139660334|NCT05468320|Prednisolone|prednisolone|mesh-list
139660335|NCT05468320|Antibodies|antibodies|mesh-list
139660336|NCT05468320|Immunologic Factors|immunologic factors|mesh-ancestor
139660337|NCT05468320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660338|NCT05468320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660339|NCT05468320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660340|NCT05468320|Glucocorticoids|glucocorticoids|mesh-ancestor
139660341|NCT05468320|Hormones|hormones|mesh-ancestor
139660342|NCT05468320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660343|NCT05468320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139660344|NCT05459571|Dexamethasone|dexamethasone|mesh-list
139660345|NCT05459571|Cyclophosphamide|cyclophosphamide|mesh-list
139660346|NCT05459571|Fludarabine|fludarabine|mesh-list
139660347|NCT05459571|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139660348|NCT05459571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139660349|NCT05459571|Immunologic Factors|immunologic factors|mesh-ancestor
139660350|NCT05459571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660351|NCT05459571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139660352|NCT05459571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139660353|NCT05459571|Alkylating Agents|alkylating agents|mesh-ancestor
139660354|NCT05459571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660355|NCT05459571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660356|NCT05459571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139660357|NCT05459571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660358|NCT05459571|Antiemetics|antiemetics|mesh-ancestor
139660359|NCT05459571|Autonomic Agents|autonomic agents|mesh-ancestor
139660360|NCT05459571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660361|NCT05459571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139660362|NCT05459571|Glucocorticoids|glucocorticoids|mesh-ancestor
139660363|NCT05459571|Hormones|hormones|mesh-ancestor
139660364|NCT05459571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660365|NCT05459571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139660366|NCT05459571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660367|NCT05435235|Dapagliflozin|dapagliflozin|mesh-list
139660368|NCT05435235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139660369|NCT05435235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660370|NCT05435235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139660371|NCT05435235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660372|NCT05422521|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139660373|NCT05422521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139660374|NCT05422521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660375|NCT05411094|Durvalumab|durvalumab|mesh-list
139660376|NCT05411094|Olaparib|olaparib|mesh-list
139660377|NCT05411094|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139660378|NCT05411094|Immunoglobulins|immunoglobulins|mesh-list
139660379|NCT05411094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139660380|NCT05411094|Immunoglobulin G|immunoglobulin g|mesh-list
139660381|NCT05411094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660382|NCT05411094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660383|NCT05411094|Immunologic Factors|immunologic factors|mesh-ancestor
139660384|NCT05411094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660385|NCT05411094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660386|NCT05411094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660387|NCT05410418|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139660388|NCT05410418|Immunoconjugates|immunoconjugates|mesh-ancestor
139660389|NCT05410418|Immunologic Factors|immunologic factors|mesh-ancestor
139660390|NCT05410418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660391|NCT05409066|Rituximab|rituximab|mesh-list
139660392|NCT05409066|Lenalidomide|lenalidomide|mesh-list
139660393|NCT05409066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660394|NCT05409066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660395|NCT05409066|Immunologic Factors|immunologic factors|mesh-ancestor
139660396|NCT05409066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660397|NCT05409066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139660398|NCT05409066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139660399|NCT05409066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139660400|NCT05409066|Growth Substances|growth substances|mesh-ancestor
139660401|NCT05409066|Growth Inhibitors|growth inhibitors|mesh-ancestor
139660402|NCT05408910|Rifaximin|rifaximin|mesh-list
139660403|NCT05408910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139660404|NCT05408910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660405|NCT05408910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139660406|NCT05407675|Nivolumab|nivolumab|mesh-list
139660407|NCT05407675|Ipilimumab|ipilimumab|mesh-list
139660408|NCT05407675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660409|NCT05407675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660410|NCT05407675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139660411|NCT05407675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660412|NCT05395065|Listerine|listerine|mesh-list
139660413|NCT05395065|Fluorides|fluorides|mesh-list
139660414|NCT05395065|Sodium Fluoride|sodium fluoride|mesh-list
139660415|NCT05395065|Fluorides, Topical|fluorides, topical|mesh-list
139660416|NCT05395065|Cariostatic Agents|cariostatic agents|mesh-ancestor
139660417|NCT05395065|Protective Agents|protective agents|mesh-ancestor
139660418|NCT05395065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660419|NCT05395065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139660420|NCT05395065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660421|NCT05387811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139660422|NCT05387811|Diuretics|diuretics|mesh-list
139660423|NCT05387811|Natriuretic Agents|natriuretic agents|mesh-ancestor
139660424|NCT05387811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660425|NCT05382728|Osimertinib|osimertinib|mesh-list
139660426|NCT05382728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660427|NCT05382728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139660428|NCT05382728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660429|NCT05382728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660430|NCT05375825|LMB-100|lmb-100|mesh-list
139660431|NCT05375825|Immunoconjugates|immunoconjugates|mesh-ancestor
139660432|NCT05375825|Immunologic Factors|immunologic factors|mesh-ancestor
139660433|NCT05375825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660434|NCT05373901|Tretinoin|tretinoin|mesh-list
139660435|NCT05373901|Dinutuximab|dinutuximab|mesh-list
139660436|NCT05373901|Isotretinoin|isotretinoin|mesh-list
139660437|NCT05373901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660438|NCT05373901|Keratolytic Agents|keratolytic agents|mesh-ancestor
139660439|NCT05373901|Dermatologic Agents|dermatologic agents|mesh-ancestor
139660440|NCT05370326|Analgesics, Opioid|analgesics, opioid|mesh-list
139660441|NCT05370326|Narcotics|narcotics|mesh-ancestor
139660442|NCT05370326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139660443|NCT05370326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660444|NCT05370326|Analgesics|analgesics|mesh-ancestor
139660445|NCT05370326|Sensory System Agents|sensory system agents|mesh-ancestor
139660446|NCT05370326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660447|NCT05325177|Ibuprofen|ibuprofen|mesh-list
139660448|NCT05325177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139660449|NCT05325177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139660450|NCT05325177|Analgesics|analgesics|mesh-ancestor
139660451|NCT05325177|Sensory System Agents|sensory system agents|mesh-ancestor
139660452|NCT05325177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660453|NCT05325177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660454|NCT05325177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660455|NCT05325177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139660456|NCT05325177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139660457|NCT05325177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660458|NCT05325177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418469|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418470|NCT01633060|Fulvestrant|fulvestrant|mesh-list
139660459|NCT05304039|Nitric Oxide|nitric oxide|mesh-list
139660460|NCT05304039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139660461|NCT05304039|Autonomic Agents|autonomic agents|mesh-ancestor
139660462|NCT05304039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660463|NCT05304039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660464|NCT05304039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139660465|NCT05304039|Respiratory System Agents|respiratory system agents|mesh-ancestor
139660466|NCT05304039|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139660467|NCT05304039|Antioxidants|antioxidants|mesh-ancestor
139660468|NCT05304039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660469|NCT05304039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139660470|NCT05304039|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139660471|NCT05304039|Vasodilator Agents|vasodilator agents|mesh-ancestor
139660472|NCT05304039|Gasotransmitters|gasotransmitters|mesh-ancestor
139660473|NCT05304039|Protective Agents|protective agents|mesh-ancestor
139660474|NCT05299164|Mitoxantrone|mitoxantrone|mesh-list
139660475|NCT05299164|Analgesics|analgesics|mesh-ancestor
139660476|NCT05299164|Sensory System Agents|sensory system agents|mesh-ancestor
139660477|NCT05299164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660478|NCT05299164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660479|NCT05299164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660480|NCT05299164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139660481|NCT05299164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139660482|NCT05299164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660483|NCT05299164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660484|NCT05299008|Bethanechol|bethanechol|mesh-list
139660485|NCT05299008|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139660486|NCT05299008|Autonomic Agents|autonomic agents|mesh-ancestor
139660487|NCT05299008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660488|NCT05299008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660489|NCT05299008|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139660490|NCT05299008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139660491|NCT05299008|Cholinergic Agents|cholinergic agents|mesh-ancestor
139660492|NCT05299008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139660493|NCT05299008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660494|NCT05285982|Nintedanib|nintedanib|mesh-list
139660495|NCT05285982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660496|NCT05285982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139660497|NCT05285982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660498|NCT05285982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660499|NCT05283720|Prednisone|prednisone|mesh-list
139660500|NCT05283720|Cyclophosphamide|cyclophosphamide|mesh-list
139660501|NCT05283720|Rituximab|rituximab|mesh-list
139660502|NCT05283720|Doxorubicin|doxorubicin|mesh-list
139660503|NCT05283720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139660504|NCT05283720|Lenalidomide|lenalidomide|mesh-list
139660505|NCT05283720|Venetoclax|venetoclax|mesh-list
139660506|NCT05283720|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139660507|NCT05283720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139660508|NCT05283720|Immunologic Factors|immunologic factors|mesh-ancestor
139660509|NCT05283720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660510|NCT05283720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139660511|NCT05283720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139660512|NCT05283720|Alkylating Agents|alkylating agents|mesh-ancestor
139660513|NCT05283720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660514|NCT05283720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660515|NCT05283720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139660516|NCT05283720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660517|NCT05283720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139660518|NCT05283720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139660519|NCT05283720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139660520|NCT05283720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660521|NCT05283720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660522|NCT05283720|Glucocorticoids|glucocorticoids|mesh-ancestor
139660523|NCT05283720|Hormones|hormones|mesh-ancestor
139660524|NCT05283720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660525|NCT05283720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139660526|NCT05283720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139660527|NCT05283720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139660528|NCT05283720|Growth Substances|growth substances|mesh-ancestor
139660529|NCT05283720|Growth Inhibitors|growth inhibitors|mesh-ancestor
139660530|NCT05283720|Immunoconjugates|immunoconjugates|mesh-ancestor
139660531|NCT05281861|Lithium Carbonate|lithium carbonate|mesh-list
139660532|NCT05281861|Antidepressive Agents|antidepressive agents|mesh-ancestor
139660533|NCT05281861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139660534|NCT05281861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660535|NCT05281861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660536|NCT05281861|Antimanic Agents|antimanic agents|mesh-ancestor
139660537|NCT05281861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139148869|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
139660538|NCT05281861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139660539|NCT05281861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660540|NCT05260528|Cytarabine|cytarabine|mesh-list
139660541|NCT05260528|Idarubicin|idarubicin|mesh-list
139660542|NCT05260528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139660543|NCT05260528|Antimetabolites|antimetabolites|mesh-ancestor
139056506|NCT02520063|Everolimus|everolimus|mesh-list
139660544|NCT05260528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660545|NCT05260528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660546|NCT05260528|Antiviral Agents|antiviral agents|mesh-ancestor
139660547|NCT05260528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660548|NCT05260528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139660549|NCT05260528|Immunologic Factors|immunologic factors|mesh-ancestor
139660550|NCT05260528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660551|NCT05260528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139660552|NCT05260528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139660553|NCT05260528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139660554|NCT05260528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660555|NCT05259839|Dexamethasone|dexamethasone|mesh-list
139660556|NCT05259839|Lenalidomide|lenalidomide|mesh-list
139660557|NCT05259839|Daratumumab|daratumumab|mesh-list
139660558|NCT05259839|Pomalidomide|pomalidomide|mesh-list
139660559|NCT05259839|Nirogacestat|nirogacestat|mesh-list
139660560|NCT05259839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660561|NCT05259839|Antiemetics|antiemetics|mesh-ancestor
139660562|NCT05259839|Autonomic Agents|autonomic agents|mesh-ancestor
139660563|NCT05259839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660564|NCT05259839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660565|NCT05259839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139660566|NCT05259839|Glucocorticoids|glucocorticoids|mesh-ancestor
139660567|NCT05259839|Hormones|hormones|mesh-ancestor
139660568|NCT05259839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660569|NCT05259839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139660570|NCT05259839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660571|NCT05259839|Immunologic Factors|immunologic factors|mesh-ancestor
139660572|NCT05259839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139660573|NCT05259839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139660574|NCT05259839|Growth Substances|growth substances|mesh-ancestor
139660575|NCT05259839|Growth Inhibitors|growth inhibitors|mesh-ancestor
139660576|NCT05259839|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139660577|NCT05259839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660578|NCT05259839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660579|NCT05246670|Palmidrol|palmidrol|mesh-list
139660580|NCT05246670|Analgesics|analgesics|mesh-ancestor
139660581|NCT05246670|Sensory System Agents|sensory system agents|mesh-ancestor
139660582|NCT05246670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660583|NCT05246670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660584|NCT05246670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139660585|NCT05246670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139660586|NCT05246670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660587|NCT05246670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139660588|NCT05246670|Antiviral Agents|antiviral agents|mesh-ancestor
139660589|NCT05246670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660590|NCT05246670|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139660591|NCT05246670|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139660592|NCT05246670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139660593|NCT05246670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660594|NCT05246670|Hormones|hormones|mesh-ancestor
139660595|NCT05246670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660596|NCT05220046|Psilocybin|psilocybin|mesh-list
139660597|NCT05220046|Hallucinogens|hallucinogens|mesh-ancestor
139660598|NCT05220046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660599|NCT05220046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139660600|NCT05209360|Carbon Fiber|carbon fiber|mesh-list
139660601|NCT05209360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139660602|NCT05209360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660603|NCT05199662|Tenecteplase|tenecteplase|mesh-list
139660604|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139660605|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139660606|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660607|NCT05199194|Tenecteplase|tenecteplase|mesh-list
139660608|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139660609|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139660610|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660611|NCT05192213|Thiamine|thiamine|mesh-list
139148944|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139660612|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
139660613|NCT05192213|Vitamins|vitamins|mesh-ancestor
139660614|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
139660615|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660616|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660617|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
139660618|NCT05183984|Bevacizumab|bevacizumab|mesh-list
139660619|NCT05183984|Niraparib|niraparib|mesh-list
139660620|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660621|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660622|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139660623|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139660624|NCT05183984|Growth Substances|growth substances|mesh-ancestor
139660625|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660626|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
139660627|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139660628|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660629|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660630|NCT05182151|Istradefylline|istradefylline|mesh-list
139660631|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
139660632|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139660633|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139660634|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
139660635|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139660636|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660637|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660638|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
139660639|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139660640|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139660641|NCT05150704|Prednisolone|prednisolone|mesh-list
139660642|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
139660643|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139660644|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
139660645|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660646|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
139660647|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
139660648|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660649|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660650|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139660651|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
139660652|NCT05150704|Hormones|hormones|mesh-ancestor
139660653|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660654|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139660655|NCT05150704|Protective Agents|protective agents|mesh-ancestor
139660656|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139660657|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660658|NCT05150652|Tamoxifen|tamoxifen|mesh-list
139660659|NCT05150652|Letrozole|letrozole|mesh-list
139660660|NCT05150652|Anastrozole|anastrozole|mesh-list
139660661|NCT05150652|Exemestane|exemestane|mesh-list
139660662|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660663|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139660664|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139660665|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660666|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660667|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139660668|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
139660669|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660670|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660671|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139660672|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139660673|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139660674|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139660675|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
139660676|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139660677|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139660678|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139660679|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139660680|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660681|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
139660682|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139660683|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660684|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139660685|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660687|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660688|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660689|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139660690|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660691|NCT05111353|Poly ICLC|poly iclc|mesh-list
139660692|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
139660693|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
139660694|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660695|NCT05044819|Cannabidiol|cannabidiol|mesh-list
139660696|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
139660697|NCT05030311|Remibrutinib|remibrutinib|mesh-list
139660698|NCT05030311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139660699|NCT05030311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660700|NCT05030311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660701|NCT05008926|Naloxegol|naloxegol|mesh-list
139660702|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139660703|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660704|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
139660705|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660706|NCT05008224|Prednisone|prednisone|mesh-list
139660707|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
139660708|NCT05008224|Dacarbazine|dacarbazine|mesh-list
139660709|NCT05008224|Doxorubicin|doxorubicin|mesh-list
139660710|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
139660711|NCT05008224|Etoposide|etoposide|mesh-list
139660712|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
139660713|NCT05008224|Vincristine|vincristine|mesh-list
139660714|NCT05008224|Bleomycin|bleomycin|mesh-list
139660715|NCT05008224|Vinblastine|vinblastine|mesh-list
139660716|NCT05008224|Procarbazine|procarbazine|mesh-list
139660717|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139660718|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
139660719|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660720|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139660721|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139660722|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
139660723|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660724|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660725|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139660726|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139660727|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139660728|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139660729|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660730|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660731|NCT05008224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139660732|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660733|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
139660734|NCT05008224|Hormones|hormones|mesh-ancestor
139660735|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660736|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139660737|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139660738|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
139660739|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
139660740|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
139660741|NCT04993677|Carboplatin|carboplatin|mesh-list
139660742|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
139660743|NCT04993677|Pemetrexed|pemetrexed|mesh-list
139660744|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660745|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660746|NCT04993677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139660747|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660748|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660749|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139660750|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139660751|NCT04980222|Prednisone|prednisone|mesh-list
139660752|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
139660753|NCT04980222|Rituximab|rituximab|mesh-list
139660754|NCT04980222|Doxorubicin|doxorubicin|mesh-list
139660755|NCT04980222|Vincristine|vincristine|mesh-list
139660756|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139660757|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
139418471|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139149030|NCT02171416|Rilonacept|rilonacept|mesh-list
139660758|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660759|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139660761|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
139660762|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660763|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660764|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139660765|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660766|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139660767|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139660768|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139660769|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660770|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660771|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
139660772|NCT04980222|Hormones|hormones|mesh-ancestor
139660773|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660774|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139660775|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139660776|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
139660777|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
139056879|NCT03965871|Esketamine|esketamine|mesh-list
139660778|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
139660779|NCT04972292|Dipyrone|dipyrone|mesh-list
139660780|NCT04972292|Codeine|codeine|mesh-list
139660781|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139660782|NCT04972292|Narcotics|narcotics|mesh-ancestor
139660783|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139660784|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660785|NCT04972292|Analgesics|analgesics|mesh-ancestor
139660786|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
139660787|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660788|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
139660789|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
139660790|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139660791|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139660792|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660793|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139660794|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
139660795|NCT04968509|Ezetimibe|ezetimibe|mesh-list
139660796|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139660797|NCT04968509|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139660798|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139660799|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139660800|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
139660801|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660802|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139660803|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660804|NCT04968509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139660805|NCT04968509|Protease Inhibitors|protease inhibitors|mesh-ancestor
139660806|NCT04964960|Paclitaxel|paclitaxel|mesh-list
139660807|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139660808|NCT04964960|Carboplatin|carboplatin|mesh-list
139660809|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
139660810|NCT04964960|Pemetrexed|pemetrexed|mesh-list
139660811|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139660812|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660813|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
139660814|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
139660815|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
139660816|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660817|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660818|NCT04964960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139660819|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660820|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139660821|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139660822|NCT04945213|Biperiden|biperiden|mesh-list
139660823|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139660824|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139660825|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
139660826|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
139660827|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660828|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660829|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139660830|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139660831|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
139660832|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418472|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418473|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139660833|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660834|NCT04933539|Dexamethasone|dexamethasone|mesh-list
139660835|NCT04933539|Daratumumab|daratumumab|mesh-list
139660836|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660837|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
139660838|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
139660839|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660840|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660841|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139660842|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
139660843|NCT04933539|Hormones|hormones|mesh-ancestor
139660844|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139660845|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139660846|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660847|NCT04928846|Docetaxel|docetaxel|mesh-list
139660848|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660849|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
139660850|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
139660851|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
139660852|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660853|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
139660854|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660855|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660856|NCT04925986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139660857|NCT04925986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660858|NCT04915183|Atorvastatin|atorvastatin|mesh-list
139660859|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139660860|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139660861|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
139660862|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660863|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139660864|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139660865|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660866|NCT04910815|Rifaximin|rifaximin|mesh-list
139660867|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139660868|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660869|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139660870|NCT04890093|Vincristine|vincristine|mesh-list
139660871|NCT04890093|Temozolomide|temozolomide|mesh-list
139660872|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139660873|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660874|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
139660875|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
139660876|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
139660877|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660878|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139660879|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
139660880|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
139660881|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660882|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660883|NCT04875195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139660884|NCT04875195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660885|NCT04870671|Tenofovir|tenofovir|mesh-list
139660886|NCT04870671|Emtricitabine|emtricitabine|mesh-list
139660887|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
139660888|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660889|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139660890|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139660891|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660892|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660893|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139660894|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139660895|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
139660896|NCT04847063|Doxorubicin|doxorubicin|mesh-list
139660897|NCT04847063|Fluorouracil|fluorouracil|mesh-list
139660898|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
139660899|NCT04847063|Mitomycins|mitomycins|mesh-list
139660900|NCT04847063|Mitomycin|mitomycin|mesh-list
139660901|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660902|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139660903|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139660904|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139418474|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139660905|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418475|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
139660906|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660908|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139660909|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139660910|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
139660911|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660912|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
139660913|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139660914|NCT04847063|Antidotes|antidotes|mesh-ancestor
139660915|NCT04847063|Protective Agents|protective agents|mesh-ancestor
139660916|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
139660917|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
139660918|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139660919|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660920|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
139660921|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
139660922|NCT04844866|Rituximab|rituximab|mesh-list
139660923|NCT04844866|Gemcitabine|gemcitabine|mesh-list
139660924|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
139660925|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139660926|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139660927|NCT04844866|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139660928|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
139660929|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139660930|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660931|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
139660932|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660933|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139660934|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139660935|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
139660936|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660937|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139660938|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
139660939|NCT04770623|Docetaxel|docetaxel|mesh-list
139660940|NCT04770623|Irinotecan|irinotecan|mesh-list
139660941|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660942|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
139660943|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
139660944|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
139660945|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660946|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139660947|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139660948|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139660949|NCT04765514|Temozolomide|temozolomide|mesh-list
139660950|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139660951|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
139057156|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
139660952|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660953|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660954|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
139660955|NCT04756063|Vitamins|vitamins|mesh-ancestor
139660956|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
139660957|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660958|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
139660959|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660960|NCT04756063|Protective Agents|protective agents|mesh-ancestor
139660961|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
139660962|NCT04725422|Pamidronate|pamidronate|mesh-list
139660963|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
139660964|NCT04725422|Adalimumab|adalimumab|mesh-list
139660965|NCT04725422|Infliximab|infliximab|mesh-list
139660966|NCT04725422|Golimumab|golimumab|mesh-list
139660967|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
139660968|NCT04725422|Etanercept|etanercept|mesh-list
139660969|NCT04725422|Methotrexate|methotrexate|mesh-list
139660970|NCT04725422|Leflunomide|leflunomide|mesh-list
139660971|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139660972|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
139660973|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139660974|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139660975|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139660976|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
139149238|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057195|NCT00006916|Bleomycin|bleomycin|mesh-list
139660977|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139660978|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139660979|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
139660980|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149312|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139660981|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139660982|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139660983|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
139660984|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139660985|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139660986|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139660987|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139660988|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139660989|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139660990|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139660991|NCT04725422|Analgesics|analgesics|mesh-ancestor
139660992|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
139660993|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139660994|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139660995|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139660996|NCT04720131|Capecitabine|capecitabine|mesh-list
139660997|NCT04720131|Apatinib|apatinib|mesh-list
139057239|NCT01323257|Ritonavir|ritonavir|mesh-list
139660998|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139660999|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
139661000|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661001|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661002|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139661003|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661004|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
139661005|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139661006|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661007|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139661008|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661009|NCT04665765|Rituximab|rituximab|mesh-list
139661010|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139661011|NCT04665765|Carboplatin|carboplatin|mesh-list
139661012|NCT04665765|Etoposide|etoposide|mesh-list
139661013|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
139661014|NCT04665765|Ifosfamide|ifosfamide|mesh-list
139661015|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
139661016|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
139661017|NCT04665765|Antibodies|antibodies|mesh-list
139661018|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
139661019|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139661020|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
139661021|NCT04665765|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139661022|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
139661023|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661024|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661025|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139661026|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139661027|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139661028|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139661029|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661030|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661031|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139661032|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
139661033|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
139661034|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
139661035|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
139661036|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
139661037|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
139661038|NCT04665570|Metformin|metformin|mesh-list
139661039|NCT04665570|Acarbose|acarbose|mesh-list
139661040|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139661041|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661042|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139661043|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661044|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661045|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
139661046|NCT04657094|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139661047|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661048|NCT04657094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139661049|NCT04657094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661050|NCT04657094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149317|NCT02173132|Vitamins|vitamins|mesh-ancestor
139661051|NCT04655144|Dexamethasone|dexamethasone|mesh-list
139661052|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661053|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
139661054|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
139661055|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661056|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661057|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139661058|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
139661059|NCT04655144|Hormones|hormones|mesh-ancestor
139661060|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139661061|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139661062|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661063|NCT04644237|Trastuzumab|trastuzumab|mesh-list
139661064|NCT04644237|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139661065|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661066|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661067|NCT04644237|Immunoconjugates|immunoconjugates|mesh-ancestor
139661068|NCT04644237|Immunologic Factors|immunologic factors|mesh-ancestor
139661069|NCT04644237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661070|NCT04633252|Prednisone|prednisone|mesh-list
139661071|NCT04633252|Docetaxel|docetaxel|mesh-list
139661072|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661073|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
139661074|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
139661075|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
139661076|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661077|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661078|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
139661079|NCT04633252|Hormones|hormones|mesh-ancestor
139661080|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139661081|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661082|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139661083|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
139661084|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661085|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661086|NCT04609579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661087|NCT04609579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661088|NCT04605731|Durvalumab|durvalumab|mesh-list
139661089|NCT04605731|Ipilimumab|ipilimumab|mesh-list
139661090|NCT04605731|Tremelimumab|tremelimumab|mesh-list
139661091|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
139661092|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139661093|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
139661094|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661095|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661096|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
139661097|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661098|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661099|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661100|NCT04599634|Venetoclax|venetoclax|mesh-list
139661101|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
139661102|NCT04599634|Magrolimab|magrolimab|mesh-list
139661103|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661104|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661105|NCT04594733|Minocycline|minocycline|mesh-list
139661106|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139661107|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139661108|NCT04589143|Agomelatine|agomelatine|mesh-list
139661109|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139661110|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139661111|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661112|NCT04578756|Cariprazine|cariprazine|mesh-list
139661113|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139661114|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139661115|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139661116|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661117|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139661118|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
139661119|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661120|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661121|NCT04576091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661122|NCT04576091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661123|NCT04556773|Paclitaxel|paclitaxel|mesh-list
139661124|NCT04556773|Capecitabine|capecitabine|mesh-list
139661125|NCT04556773|Trastuzumab|trastuzumab|mesh-list
139661126|NCT04556773|Durvalumab|durvalumab|mesh-list
139661127|NCT04556773|Fulvestrant|fulvestrant|mesh-list
139661128|NCT04556773|Anastrozole|anastrozole|mesh-list
139661129|NCT04556773|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139661130|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139661131|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661132|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
139661133|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
139661134|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
139661135|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661136|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139661137|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
139661138|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661139|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139661140|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139661141|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139661142|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
139661143|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139661144|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661145|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139661146|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139661147|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661148|NCT04556773|Immunoconjugates|immunoconjugates|mesh-ancestor
139661149|NCT04556773|Immunologic Factors|immunologic factors|mesh-ancestor
139661150|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
139661151|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
139661152|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
139661153|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139661154|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661155|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
139661156|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
139661157|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661158|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661159|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139661160|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
139661161|NCT04544436|Hormones|hormones|mesh-ancestor
139661162|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139661163|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139661164|NCT04544436|Protective Agents|protective agents|mesh-ancestor
139661165|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
139661166|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
139661167|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139661168|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661169|NCT04526899|Cemiplimab|cemiplimab|mesh-list
139661170|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661171|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661172|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139661173|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
139661174|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139661175|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139661176|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139661177|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139661178|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661179|NCT04402788|Atezolizumab|atezolizumab|mesh-list
139661180|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139661181|NCT04402788|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661182|NCT04402788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661183|NCT04402788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661184|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661185|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
139661186|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661187|NCT04370795|Sirolimus|sirolimus|mesh-list
139661188|NCT04370795|Busulfan|busulfan|mesh-list
139661189|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139661190|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139661191|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139661192|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661193|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
139661194|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139661195|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
139661196|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661197|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661198|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
139661199|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139661200|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139661201|NCT04339751|Vorinostat|vorinostat|mesh-list
139418476|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139418477|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661202|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661203|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139661204|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057546|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661205|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661206|NCT04303195|Metopimazine|metopimazine|mesh-list
139661207|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
139661208|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
139661209|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661210|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661211|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139661212|NCT04298567|Aspirin|aspirin|mesh-list
139661213|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
139661214|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139661215|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
139661216|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139661217|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
139661218|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661219|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661220|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
139661221|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139661222|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139661223|NCT04298567|Analgesics|analgesics|mesh-ancestor
139661224|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
139661225|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661226|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661227|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661228|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139661229|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139661230|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139661231|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139057588|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661232|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139661233|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
139661234|NCT04284774|Tipifarnib|tipifarnib|mesh-list
139661235|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661236|NCT04220489|Ketamine|ketamine|mesh-list
139661237|NCT04220489|Analgesics|analgesics|mesh-ancestor
139661238|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
139661239|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661240|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661241|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139661242|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139661243|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
139661244|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
139661245|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139661246|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139661247|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139661248|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139661249|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661250|NCT04219540|Buprenorphine|buprenorphine|mesh-list
139661251|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139661252|NCT04219540|Narcotics|narcotics|mesh-ancestor
139661253|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139661254|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661255|NCT04219540|Analgesics|analgesics|mesh-ancestor
139661256|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
139661257|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661258|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139661259|NCT04206319|Listerine|listerine|mesh-list
139661260|NCT04206319|Fluorides|fluorides|mesh-list
139661261|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
139661262|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
139661263|NCT04206319|Protective Agents|protective agents|mesh-ancestor
139661264|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661265|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139661266|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139661267|NCT04195555|Ivosidenib|ivosidenib|mesh-list
139661268|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661269|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661270|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661271|NCT04177004|Sirolimus|sirolimus|mesh-list
139661272|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
139661273|NCT04177004|Etoposide|etoposide|mesh-list
139661274|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
139661275|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
139661276|NCT04177004|Tacrolimus|tacrolimus|mesh-list
139661277|NCT04177004|Mitogens|mitogens|mesh-list
139149534|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
139661278|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139661279|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
139661280|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661281|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139661282|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139661283|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
139661284|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661285|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661286|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139661287|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139661288|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139661289|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139661290|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661291|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139661292|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139661293|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139661294|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139661295|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
139661296|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
139661297|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
139661298|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
139661299|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
139661300|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
139661301|NCT04168112|Dexamethasone|dexamethasone|mesh-list
139661302|NCT04168112|Prednisolone|prednisolone|mesh-list
139661303|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139661304|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
139661305|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139661306|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
139661307|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139661308|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
139661309|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661310|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
139661311|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
139661312|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661313|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661314|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139661315|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
139661316|NCT04168112|Hormones|hormones|mesh-ancestor
139661317|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139057739|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139661318|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139661319|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661320|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139661321|NCT04168112|Protective Agents|protective agents|mesh-ancestor
139661322|NCT04143724|Luspatercept|luspatercept|mesh-list
139661323|NCT04143724|Hematinics|hematinics|mesh-ancestor
139661324|NCT04131504|Adalimumab|adalimumab|mesh-list
139661325|NCT04131504|Infliximab|infliximab|mesh-list
139661326|NCT04131504|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139661327|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661328|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139661329|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
139661330|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139661331|NCT04102436|Aldesleukin|aldesleukin|mesh-list
139661332|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
139661333|NCT04102436|Fludarabine|fludarabine|mesh-list
139661334|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139661335|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
139661336|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661337|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139661338|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139661339|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
139661340|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661341|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661342|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139661343|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139661344|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139661345|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
139661346|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139661347|NCT04096170|Lidocaine|lidocaine|mesh-list
139661348|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
139661349|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
139418478|NCT03906695|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139418479|NCT03906695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139661350|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139661351|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661352|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
139418480|NCT03906695|Antimetabolites|antimetabolites|mesh-ancestor
139418481|NCT03906695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661353|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661354|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139661355|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139661356|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139057830|NCT00429299|Paclitaxel|paclitaxel|mesh-list
139661357|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139661358|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661359|NCT04093323|Interferons|interferons|mesh-list
139661360|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
139661361|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
139661362|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
139661363|NCT04093323|Celecoxib|celecoxib|mesh-list
139661364|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139661365|NCT04093323|Benzenesulfonamide|benzenesulfonamide|mesh-list
139661366|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661367|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
139661368|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139661369|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
139661370|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661371|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139661372|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139661373|NCT04093323|Analgesics|analgesics|mesh-ancestor
139661374|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
139661375|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661376|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661377|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139661378|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139661379|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139661380|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661381|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661382|NCT04093323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661383|NCT04093323|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139661384|NCT04036461|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139661385|NCT04036461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661386|NCT04036461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661387|NCT04005352|Aflibercept|aflibercept|mesh-list
139661388|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139661389|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139661390|NCT04005352|Growth Substances|growth substances|mesh-ancestor
139661391|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661392|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
139661393|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661394|NCT03983824|Cytarabine|cytarabine|mesh-list
139661395|NCT03983824|Etoposide|etoposide|mesh-list
139661396|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
139661397|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
139661398|NCT03983824|Peposertib|peposertib|mesh-list
139661399|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139661400|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661401|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139661402|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139661403|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661404|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661405|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139661406|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
139661407|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
139661408|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139661409|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139661410|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
139661411|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661412|NCT03983824|Analgesics|analgesics|mesh-ancestor
139661413|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
139661414|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661415|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139661416|NCT03964727|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139661417|NCT03964727|Immunoconjugates|immunoconjugates|mesh-ancestor
139418482|NCT03906695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418483|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
139418484|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418485|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
139418486|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418487|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661418|NCT03964727|Immunologic Factors|immunologic factors|mesh-ancestor
139661419|NCT03964727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661420|NCT03962920|Tigecycline|tigecycline|mesh-list
139661421|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139661422|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139661423|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139661424|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661425|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661426|NCT03949517|Piperidine|piperidine|mesh-list
139661427|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139661428|NCT03949517|Bombesin|bombesin|mesh-list
139661429|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057984|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
139661430|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139661431|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139661432|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661433|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139661434|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139661435|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139661436|NCT03940586|Letermovir|letermovir|mesh-list
139661437|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139661438|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661439|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661440|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661441|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
139661442|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139661443|NCT03912428|Celecoxib|celecoxib|mesh-list
139661444|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139661445|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139661446|NCT03912428|Analgesics|analgesics|mesh-ancestor
139661447|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
139661448|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661449|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661450|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661451|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139661452|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139661453|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139661454|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661455|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661456|NCT03865992|Curcumin|curcumin|mesh-list
139661457|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139661458|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139661459|NCT03865992|Analgesics|analgesics|mesh-ancestor
139661460|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
139661461|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661462|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661463|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661464|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139661465|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661466|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661467|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661468|NCT03856216|Rituximab|rituximab|mesh-list
139661469|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139661470|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139661471|NCT03856216|Methotrexate|methotrexate|mesh-list
139661472|NCT03856216|Fludarabine|fludarabine|mesh-list
139661473|NCT03856216|Melphalan|melphalan|mesh-list
139661474|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139661475|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
139661476|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139661477|NCT03856216|Antibodies|antibodies|mesh-list
139661478|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
139661479|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139661480|NCT03856216|Lenograstim|lenograstim|mesh-list
139661481|NCT03856216|Tacrolimus|tacrolimus|mesh-list
139661482|NCT03856216|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139661483|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
139661484|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661485|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418488|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139418489|NCT04467125|Lidocaine|lidocaine|mesh-list
139418490|NCT04467125|Prilocaine|prilocaine|mesh-list
139418491|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139418492|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
139418493|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
139418494|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139418495|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661486|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139418497|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661487|NCT03856216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139661488|NCT03856216|Abortifacient Agents|abortifacient agents|mesh-ancestor
139661489|NCT03856216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139661490|NCT03856216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139661491|NCT03856216|Antimetabolites|antimetabolites|mesh-ancestor
139058067|NCT01087840|Tenofovir|tenofovir|mesh-list
139661492|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661493|NCT03856216|Dermatologic Agents|dermatologic agents|mesh-ancestor
139661494|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661495|NCT03856216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139661496|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139661497|NCT03856216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139661498|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139661499|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139661500|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139661501|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
139661502|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139661503|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139661504|NCT03856216|Immunotoxins|immunotoxins|mesh-ancestor
139661505|NCT03856216|Immunoconjugates|immunoconjugates|mesh-ancestor
139661506|NCT03845582|Vitamin A|vitamin a|mesh-list
139661507|NCT03845582|Retinol acetate|retinol acetate|mesh-list
139661508|NCT03845582|Vitamins|vitamins|mesh-ancestor
139661509|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
139661510|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661511|NCT03845582|Protective Agents|protective agents|mesh-ancestor
139661512|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139661513|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661514|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139661515|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
139661516|NCT03841617|Hormones|hormones|mesh-list
139661517|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139661518|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661519|NCT03789240|Rituximab|rituximab|mesh-list
139058113|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
139661520|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661521|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661522|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
139661523|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661524|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139661525|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
139661526|NCT03789097|Poly ICLC|poly iclc|mesh-list
139661527|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661528|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661529|NCT03789097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661530|NCT03789097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661531|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
139661532|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
139661533|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661534|NCT03775265|Cisplatin|cisplatin|mesh-list
139661535|NCT03775265|Gemcitabine|gemcitabine|mesh-list
139661536|NCT03775265|Fluorouracil|fluorouracil|mesh-list
139661537|NCT03775265|Atezolizumab|atezolizumab|mesh-list
139661538|NCT03775265|Mitomycins|mitomycins|mesh-list
139661539|NCT03775265|Mitomycin|mitomycin|mesh-list
139661540|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139661541|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661542|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139661543|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
139058160|NCT00003298|Leucovorin|leucovorin|mesh-list
139661544|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661545|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139661546|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
139661547|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661548|NCT03775265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661549|NCT03775265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661550|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139661551|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
139661552|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139661553|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661554|NCT03769298|Tacrolimus|tacrolimus|mesh-list
139661555|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139661556|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
139661557|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661558|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139661559|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661560|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661561|NCT03718767|Nivolumab|nivolumab|mesh-list
139661562|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661563|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661564|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661565|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661566|NCT03703297|Durvalumab|durvalumab|mesh-list
139661567|NCT03703297|Tremelimumab|tremelimumab|mesh-list
139661568|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661569|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661570|NCT03693677|Paclitaxel|paclitaxel|mesh-list
139661571|NCT03693677|Gemcitabine|gemcitabine|mesh-list
139661572|NCT03693677|Irinotecan|irinotecan|mesh-list
139661573|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139661574|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661575|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
139661576|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
139661577|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
139058215|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
139661578|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661579|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139661580|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
139661581|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139661582|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139661583|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661584|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
139661585|NCT03684213|Norepinephrine|norepinephrine|mesh-list
139661586|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
139661587|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
139661588|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661589|NCT03684213|Protective Agents|protective agents|mesh-ancestor
139661590|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661591|NCT03684213|Vitamins|vitamins|mesh-ancestor
139661592|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
139661593|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139661594|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139661595|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
139661596|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139661597|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
139661598|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
139661599|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139058254|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661600|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139661601|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661602|NCT03678883|Paclitaxel|paclitaxel|mesh-list
139661603|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139661604|NCT03678883|Carboplatin|carboplatin|mesh-list
139661605|NCT03678883|Gemcitabine|gemcitabine|mesh-list
139661606|NCT03678883|Doxorubicin|doxorubicin|mesh-list
139661607|NCT03678883|Irinotecan|irinotecan|mesh-list
139661608|NCT03678883|Lomustine|lomustine|mesh-list
139661609|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139661610|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661611|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
139661612|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
139661613|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
139661614|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661615|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139661616|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
139661617|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139661618|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139661619|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139661620|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661621|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139661622|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139661623|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
139661624|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
139661625|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
139661626|NCT03674411|Melphalan|melphalan|mesh-list
139661627|NCT03674411|Busulfan|busulfan|mesh-list
139661628|NCT03674411|Fludarabine|fludarabine|mesh-list
139661629|NCT03674411|Tacrolimus|tacrolimus|mesh-list
139661630|NCT03674411|Lenograstim|lenograstim|mesh-list
139661631|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139661632|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
139149883|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661633|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661634|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139661635|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139661636|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
139418498|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139661637|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661638|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661639|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139661640|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139661641|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661642|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139661643|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139661644|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
139661645|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139661646|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139661647|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139661648|NCT03661320|Gemcitabine|gemcitabine|mesh-list
139661649|NCT03661320|Nivolumab|nivolumab|mesh-list
139661650|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661651|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139661652|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
139661653|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661654|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661655|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661656|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
139661657|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661658|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661659|NCT03634241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661660|NCT03634241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661661|NCT03571568|Rituximab|rituximab|mesh-list
139661662|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661663|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661664|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
139661665|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661666|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139661667|NCT03570619|Nivolumab|nivolumab|mesh-list
139661668|NCT03570619|Ipilimumab|ipilimumab|mesh-list
139661669|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139058416|NCT00141453|Olmesartan|olmesartan|mesh-list
139661670|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661671|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661672|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661673|NCT03568461|Tisagenlecleucel|tisagenlecleucel|mesh-list
139661674|NCT03568461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661675|NCT03568461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661676|NCT03559049|Carboplatin|carboplatin|mesh-list
139661677|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
139661678|NCT03559049|Pemetrexed|pemetrexed|mesh-list
139661679|NCT03559049|Rucaparib|rucaparib|mesh-list
139661680|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661681|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661682|NCT03559049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661683|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661684|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661685|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139661686|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139661687|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139661688|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
139661689|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139661690|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139661691|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139661692|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139661693|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661694|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
139661695|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139661696|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661697|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139661698|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661699|NCT03539744|Dexamethasone|dexamethasone|mesh-list
139661700|NCT03539744|Venetoclax|venetoclax|mesh-list
139661701|NCT03539744|Pomalidomide|pomalidomide|mesh-list
139661702|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661703|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
139661704|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
139661705|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661706|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661707|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139661708|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
139418499|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139661709|NCT03539744|Hormones|hormones|mesh-ancestor
139661710|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139661711|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139661712|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661713|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
139661714|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139661715|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139661716|NCT03539744|Growth Substances|growth substances|mesh-ancestor
139661717|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
139661718|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139661719|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
139661720|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139661721|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
139661722|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139661723|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139661724|NCT03511625|Prednisolone|prednisolone|mesh-list
139661725|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
139661726|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139661727|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
139661728|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139661729|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661730|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
139661731|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
139661732|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661733|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661734|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139661735|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
139661736|NCT03511625|Hormones|hormones|mesh-ancestor
139661737|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139661738|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139661739|NCT03511625|Protective Agents|protective agents|mesh-ancestor
139661740|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139661741|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661742|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
139661743|NCT03486873|Lenvatinib|lenvatinib|mesh-list
139058494|NCT01582646|Terbutaline|terbutaline|mesh-list
139661744|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661745|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661746|NCT03486873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661747|NCT03486873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661748|NCT03486873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139661749|NCT03486873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661750|NCT03388190|Leucovorin|leucovorin|mesh-list
139661751|NCT03388190|Fluorouracil|fluorouracil|mesh-list
139661752|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
139661753|NCT03388190|Nivolumab|nivolumab|mesh-list
139661754|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
139661755|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
139661756|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661757|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139661758|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661759|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139661760|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
139661761|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661762|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661763|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661764|NCT03388190|Antidotes|antidotes|mesh-ancestor
139661765|NCT03388190|Protective Agents|protective agents|mesh-ancestor
139661766|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
139661767|NCT03388190|Vitamins|vitamins|mesh-ancestor
139661768|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
139661769|NCT03306472|Letrozole|letrozole|mesh-list
139661770|NCT03306472|Megestrol|megestrol|mesh-list
139661771|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
139661772|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058534|NCT03815175|Aspirin|aspirin|mesh-list
139661773|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139661774|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139661775|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661776|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661777|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139661778|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
139661779|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139661780|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150044|NCT02185066|Metformin|metformin|mesh-list
139661781|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139661782|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139661783|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139418500|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139418501|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139661784|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
139661785|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139661786|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139661787|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139661788|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139661789|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
139661790|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139661791|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139661792|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661794|NCT03288675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139661795|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139661796|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
139661797|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139661798|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661799|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661800|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139661801|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139661802|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139661803|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
139661804|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661805|NCT03278925|Protective Agents|protective agents|mesh-ancestor
139661806|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661807|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139661808|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139661809|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661810|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139661811|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
139661812|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661813|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661814|NCT03267888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661815|NCT03267888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661816|NCT03252938|Avelumab|avelumab|mesh-list
139661817|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661818|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661819|NCT03151811|Dexamethasone|dexamethasone|mesh-list
139661820|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
139661821|NCT03151811|Melphalan|melphalan|mesh-list
139661822|NCT03151811|Pomalidomide|pomalidomide|mesh-list
139661823|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661824|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
139661825|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
139661826|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661827|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661828|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139058632|NCT00180674|Warfarin|warfarin|mesh-list
139661829|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
139661830|NCT03151811|Hormones|hormones|mesh-ancestor
139661831|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139661832|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139661833|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661834|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139661835|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
139661836|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661837|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139661838|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139661839|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
139661840|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139661841|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139661842|NCT03151811|Growth Substances|growth substances|mesh-ancestor
139661843|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
139661844|NCT03141970|Prednisone|prednisone|mesh-list
139661845|NCT03141970|Prednisolone|prednisolone|mesh-list
139661846|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661847|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
139661848|NCT03141970|Hormones|hormones|mesh-ancestor
139661849|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139661850|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661851|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139661852|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661853|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139661854|NCT03084523|Hematinics|hematinics|mesh-ancestor
139661855|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139661856|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139661857|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
139661858|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661859|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661861|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139661862|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139661863|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661864|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
139661865|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
139661866|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
139661867|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661868|NCT03016338|Niraparib|niraparib|mesh-list
139661869|NCT03016338|Dostarlimab|dostarlimab|mesh-list
139661870|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139661871|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661872|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661873|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661874|NCT03011814|Lenalidomide|lenalidomide|mesh-list
139661875|NCT03011814|Durvalumab|durvalumab|mesh-list
139661876|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
139661877|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139661878|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
139661879|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
139661880|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661881|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139661882|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139661883|NCT03011814|Growth Substances|growth substances|mesh-ancestor
139661884|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
139661885|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661886|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661887|NCT02979873|Sirolimus|sirolimus|mesh-list
139661888|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139661889|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139661890|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139661891|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661892|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
139661893|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139661894|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
139661895|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661896|NCT02970448|Temozolomide|temozolomide|mesh-list
139661897|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139661898|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
139661899|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661900|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661901|NCT02950259|Indomethacin|indomethacin|mesh-list
139661902|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
139661903|NCT02950259|Omeprazole|omeprazole|mesh-list
139661904|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139661905|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
139661906|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661907|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139661908|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139661909|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
139661910|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661911|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661912|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139661913|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139661914|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139661915|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139661916|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661917|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139661918|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139661919|NCT02950259|Analgesics|analgesics|mesh-ancestor
139661920|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
139661921|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139661922|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139661923|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
139661924|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
139661925|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139661926|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139661927|NCT02947685|Trastuzumab|trastuzumab|mesh-list
139661928|NCT02947685|Pertuzumab|pertuzumab|mesh-list
139150177|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
139661929|NCT02947685|Letrozole|letrozole|mesh-list
139661930|NCT02947685|Fulvestrant|fulvestrant|mesh-list
139661931|NCT02947685|Palbociclib|palbociclib|mesh-list
139661932|NCT02947685|Anastrozole|anastrozole|mesh-list
139661933|NCT02947685|Exemestane|exemestane|mesh-list
139661934|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661935|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661936|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139661937|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139661938|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661939|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661940|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139661941|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
139661942|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139661943|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661944|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139661945|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139661946|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139661947|NCT02941783|Factor VIII|factor viii|mesh-list
139661948|NCT02941783|Coagulants|coagulants|mesh-ancestor
139661949|NCT02865564|Gentamicins|gentamicins|mesh-list
139661950|NCT02865564|Ampicillin|ampicillin|mesh-list
139661951|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139661952|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139661953|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139661954|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661955|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661956|NCT02849496|Atezolizumab|atezolizumab|mesh-list
139661957|NCT02849496|Olaparib|olaparib|mesh-list
139661958|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139661959|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139661960|NCT02849496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139661961|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661962|NCT02849496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661963|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661964|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661965|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
139661966|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661967|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139661968|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661969|NCT02706951|Methotrexate|methotrexate|mesh-list
139661970|NCT02706951|Upadacitinib|upadacitinib|mesh-list
139661971|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139661972|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
139661973|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139661974|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139661975|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139661976|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
139661977|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661978|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661979|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
139661980|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139661981|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139058780|NCT00073918|Iodine|iodine|mesh-list
139661982|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139661983|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
139661984|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139661985|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139661986|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139661987|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139661988|NCT02651662|Cemiplimab|cemiplimab|mesh-list
139661989|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139661990|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661991|NCT02632305|Paclitaxel|paclitaxel|mesh-list
139661992|NCT02632305|Gemcitabine|gemcitabine|mesh-list
139661993|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139661994|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139661995|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
139661996|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
139661997|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
139661998|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139661999|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139662000|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
139662001|NCT02628405|Rituximab|rituximab|mesh-list
139662002|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139662003|NCT02628405|Carboplatin|carboplatin|mesh-list
139150252|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139418502|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662004|NCT02628405|Etoposide|etoposide|mesh-list
139662005|NCT02628405|Lenalidomide|lenalidomide|mesh-list
139662006|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
139662007|NCT02628405|Ifosfamide|ifosfamide|mesh-list
139662008|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
139662009|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
139662010|NCT02628405|Antibodies|antibodies|mesh-list
139662011|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
139662012|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139662013|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
139662014|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662015|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662016|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662017|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139662018|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139662019|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139662020|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662021|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662022|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139662023|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139662024|NCT02628405|Growth Substances|growth substances|mesh-ancestor
139662025|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
139662026|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139662027|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
139662028|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
139662029|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
139662030|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
139662031|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
139662032|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
139662033|NCT02609386|Zinc|zinc|mesh-list
139662034|NCT02609386|Indomethacin|indomethacin|mesh-list
139662035|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
139662036|NCT02609386|Omeprazole|omeprazole|mesh-list
139662037|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139662038|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139662039|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
139662040|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662041|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662042|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139662043|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
139662044|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662045|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662046|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139662047|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
139662048|NCT02609386|Trace Elements|trace elements|mesh-ancestor
139662049|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139662050|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139662051|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662052|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139662053|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139662054|NCT02609386|Analgesics|analgesics|mesh-ancestor
139662055|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
139662056|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139662057|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139662058|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
139662059|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
139662060|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139662061|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139662062|NCT02576717|Ozanimod|ozanimod|mesh-list
139662063|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139662064|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662065|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139662066|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
139662067|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662068|NCT02517307|Heparin|heparin|mesh-list
139662069|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139662070|NCT02517307|Glycerol|glycerol|mesh-list
139662071|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
139662072|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139662073|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139662074|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662075|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139662076|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139662077|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139662078|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139662079|NCT02517307|Protective Agents|protective agents|mesh-ancestor
139662080|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662082|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139662083|NCT02499354|Trace Elements|trace elements|mesh-ancestor
139662084|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
139662085|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662086|NCT02499354|Hematinics|hematinics|mesh-ancestor
139662087|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139662088|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139662089|NCT02488967|Paclitaxel|paclitaxel|mesh-list
139662090|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
139662091|NCT02488967|Carboplatin|carboplatin|mesh-list
139662092|NCT02488967|Doxorubicin|doxorubicin|mesh-list
139662093|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139662094|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139662095|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139662096|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662097|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
139662098|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
139662099|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
139662100|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662101|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139662102|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
139662103|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662104|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662105|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139662106|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
139662107|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139662108|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139662109|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139662110|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139662111|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662112|NCT02399410|Bevacizumab|bevacizumab|mesh-list
139662113|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
139662114|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139662115|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662116|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139662117|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139662118|NCT02399410|Growth Substances|growth substances|mesh-ancestor
139662119|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662120|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
139662121|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139662122|NCT02369835|Eusol|eusol|mesh-list
139662123|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139662124|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
139662125|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139662126|NCT02367859|Trametinib|trametinib|mesh-list
139058932|NCT00072280|Mesna|mesna|mesh-list
139662127|NCT02367859|Dabrafenib|dabrafenib|mesh-list
139662128|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662129|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139662130|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662131|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662132|NCT02362503|Fostemsavir|fostemsavir|mesh-list
139662133|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139662134|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139662135|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
139662136|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139662137|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139662138|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139662139|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662140|NCT02356159|Rituximab|rituximab|mesh-list
139662141|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139662142|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662143|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
139662144|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662145|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662146|NCT02337985|Prednisone|prednisone|mesh-list
139662147|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
139662148|NCT02337985|Rituximab|rituximab|mesh-list
139662149|NCT02337985|Doxorubicin|doxorubicin|mesh-list
139662150|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139662151|NCT02337985|Etoposide|etoposide|mesh-list
139662152|NCT02337985|Vincristine|vincristine|mesh-list
139662153|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139662154|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
139662155|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418503|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139662156|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662157|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139662158|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
139662159|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662160|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662161|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139662162|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139662163|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139662164|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139662165|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139662166|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662167|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139662168|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
139662169|NCT02337985|Hormones|hormones|mesh-ancestor
139662170|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139662171|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139662172|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139662173|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
139662174|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
139662175|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
139662176|NCT02211755|Bortezomib|bortezomib|mesh-list
139662177|NCT02211755|Clofarabine|clofarabine|mesh-list
139662178|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662179|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139662180|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
139662181|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662182|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
139662183|NCT02159495|Fludarabine|fludarabine|mesh-list
139662184|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
139662185|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139662186|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
139662187|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662188|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662189|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139662190|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
139662191|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662192|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662193|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139662194|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139662195|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
139662196|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
139662197|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139662198|NCT02153580|Fludarabine|fludarabine|mesh-list
139662199|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
139662200|NCT02153580|Etoposide|etoposide|mesh-list
139662201|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
139662202|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
139662203|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139662204|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
139662205|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662206|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662207|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139662208|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
139662209|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662210|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662211|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139662212|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139662213|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
139662214|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139662215|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139662216|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139662217|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662218|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
139662219|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
139662220|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
139662221|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
139662222|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
139662223|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139662224|NCT02127164|Eusol|eusol|mesh-list
139662225|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
139662226|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139662227|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
139662228|NCT02081755|Everolimus|everolimus|mesh-list
139418504|NCT02692313|Epinephrine|epinephrine|mesh-list
139662229|NCT02081755|Azathioprine|azathioprine|mesh-list
139418505|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139662231|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139662232|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
139662233|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662234|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139662235|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662236|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662237|NCT02081755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139662238|NCT02081755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139662239|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662240|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139662241|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139662242|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
139662243|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139662244|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139662245|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
139662246|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139662247|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662248|NCT02015013|Plerixafor|plerixafor|mesh-list
139662249|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139059173|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
139662250|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139662251|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
139662252|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139662253|NCT01996696|Metformin|metformin|mesh-list
139662254|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139662255|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662256|NCT01984138|Estradiol|estradiol|mesh-list
139662257|NCT01984138|Estrogens|estrogens|mesh-ancestor
139662258|NCT01984138|Hormones|hormones|mesh-ancestor
139662259|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139662260|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662261|NCT01907074|Cholic Acids|cholic acids|mesh-list
139662262|NCT01907074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139662263|NCT01811498|Bevacizumab|bevacizumab|mesh-list
139662264|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139662265|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662266|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139662267|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139662268|NCT01811498|Growth Substances|growth substances|mesh-ancestor
139662269|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662270|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
139662271|NCT01799538|Albuterol|albuterol|mesh-list
139662272|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139662273|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
139662274|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139662275|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662276|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139662277|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
139662278|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
139662279|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139662280|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139662281|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139662282|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139662283|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
139662284|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139662285|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662286|NCT01760226|Prednisone|prednisone|mesh-list
139662287|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
139662288|NCT01760226|Rituximab|rituximab|mesh-list
139662289|NCT01760226|Doxorubicin|doxorubicin|mesh-list
139662290|NCT01760226|Methotrexate|methotrexate|mesh-list
139662291|NCT01760226|Etoposide|etoposide|mesh-list
139662292|NCT01760226|Vincristine|vincristine|mesh-list
139662293|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139662294|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
139662295|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662296|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662297|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139662298|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
139662299|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418506|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139662300|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662301|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139662302|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139662303|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139662304|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139662305|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139662306|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662307|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139662308|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
139662309|NCT01760226|Hormones|hormones|mesh-ancestor
139662310|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139662311|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139662312|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139662313|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
139662314|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139662315|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139662316|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
139662317|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
139662318|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139662319|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139059266|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139662320|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139662321|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
139662322|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
139662323|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
139662324|NCT01553149|Lenalidomide|lenalidomide|mesh-list
139662325|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
139662326|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662327|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139662328|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139662329|NCT01553149|Growth Substances|growth substances|mesh-ancestor
139662330|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
139662331|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662332|NCT01522469|Crenolanib|crenolanib|mesh-list
139662333|NCT01522469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662334|NCT01478737|Dexamethasone|dexamethasone|mesh-list
139662335|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
139662336|NCT01478737|BB 1101|bb 1101|mesh-list
139662337|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139662338|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
139662339|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
139662340|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139662341|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662342|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139662343|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
139662344|NCT01478737|Hormones|hormones|mesh-ancestor
139662345|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139662346|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139662347|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662348|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
139662349|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662350|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662351|NCT01468337|Interferons|interferons|mesh-list
139662352|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
139662353|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662354|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
139662355|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139662356|NCT01437449|Carboplatin|carboplatin|mesh-list
139662357|NCT01437449|Docetaxel|docetaxel|mesh-list
139662358|NCT01437449|Cetuximab|cetuximab|mesh-list
139662359|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662360|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
139662361|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
139662362|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
139662363|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662364|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139662365|NCT01437189|Sertraline|sertraline|mesh-list
139662366|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
139662367|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139662368|NCT01437189|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139662369|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139662370|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139662371|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662372|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139662373|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
139662374|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662375|NCT01356290|Cytarabine|cytarabine|mesh-list
139662376|NCT01356290|Thalidomide|thalidomide|mesh-list
139418507|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
139418508|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139662377|NCT01356290|Celecoxib|celecoxib|mesh-list
139662378|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
139662379|NCT01356290|Bevacizumab|bevacizumab|mesh-list
139662381|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
139662382|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
139662383|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139662384|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
139662385|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662386|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662387|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139662388|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
139662389|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662390|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662391|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139662392|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139662393|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139662394|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139662395|NCT01356290|Growth Substances|growth substances|mesh-ancestor
139662396|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
139662397|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139662398|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139662399|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139662400|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662401|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139662402|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
139662403|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
139662404|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139662405|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139662406|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139662407|NCT01356290|Analgesics|analgesics|mesh-ancestor
139662408|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
139662409|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139662410|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139662411|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139662412|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139662413|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
139662414|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139662415|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139662416|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139662417|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139662418|NCT01341600|Omeprazole|omeprazole|mesh-list
139662419|NCT01341600|Clopidogrel|clopidogrel|mesh-list
139662420|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139662421|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139662422|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139662423|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139662424|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
139662425|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059362|NCT01209130|Pinatuzumab vedotin|pinatuzumab vedotin|mesh-list
139662426|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662427|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662428|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139662429|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139662430|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139662431|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662432|NCT01311713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139662433|NCT01311713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662434|NCT01311713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662435|NCT01311713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662436|NCT01306019|Busulfan|busulfan|mesh-list
139662437|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
139662438|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662439|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139662440|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
139662441|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662442|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139662443|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662444|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139662445|NCT01260870|Paclitaxel|paclitaxel|mesh-list
139662446|NCT01260870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139662447|NCT01260870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662448|NCT01260870|Tubulin Modulators|tubulin modulators|mesh-ancestor
139418509|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150698|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139150771|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139662450|NCT01260870|Mitosis Modulators|mitosis modulators|mesh-ancestor
139059418|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
139662451|NCT01260870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662452|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
139662453|NCT01176006|Busulfan|busulfan|mesh-list
139662454|NCT01176006|Fludarabine|fludarabine|mesh-list
139662455|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
139662456|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139662457|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
139662458|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662459|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662460|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139662461|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
139662462|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662463|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662464|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139662465|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139662466|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
139662467|NCT01120795|Interferons|interferons|mesh-list
139662468|NCT01120795|Ribavirin|ribavirin|mesh-list
139662469|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139662470|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
139662471|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662472|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
139662473|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139662474|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
139662475|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662476|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
139662477|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662478|NCT01013649|Gemcitabine|gemcitabine|mesh-list
139662479|NCT01013649|Capecitabine|capecitabine|mesh-list
139662480|NCT01013649|Fluorouracil|fluorouracil|mesh-list
139662481|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139662482|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139662483|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
139662484|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662485|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662486|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139662487|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
139662488|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662489|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139662490|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662491|NCT00977977|Cyclosporine|cyclosporine|mesh-list
139662492|NCT00977977|Rituximab|rituximab|mesh-list
139662493|NCT00977977|Cyclosporins|cyclosporins|mesh-list
139662494|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139662495|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662496|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
139662497|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662498|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662499|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662500|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662501|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139662502|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
139662503|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139662504|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
139662505|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139662506|NCT00890604|Acetaminophen|acetaminophen|mesh-list
139662507|NCT00890604|Ibuprofen|ibuprofen|mesh-list
139662508|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139662509|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139662510|NCT00890604|Analgesics|analgesics|mesh-ancestor
139662511|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
139662512|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139662513|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662514|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139662515|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662516|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139662517|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662518|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662519|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
139662520|NCT00720785|Bortezomib|bortezomib|mesh-list
139662521|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662522|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139662523|NCT00659776|Hematinics|hematinics|mesh-ancestor
139662524|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139662525|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139662526|NCT00617656|Cisplatin|cisplatin|mesh-list
139662527|NCT00617656|Gemcitabine|gemcitabine|mesh-list
139662528|NCT00617656|Docetaxel|docetaxel|mesh-list
139662529|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662530|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139662531|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
139662532|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662533|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
139662534|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
139662535|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
139662536|NCT00445627|Metformin|metformin|mesh-list
139059508|NCT01210066|Fentanyl|fentanyl|mesh-list
139662537|NCT00445627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139662538|NCT00445627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662539|NCT00359684|Cysteamine|cysteamine|mesh-list
139662540|NCT00359684|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
139662541|NCT00359684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662542|NCT00353158|Doxycycline|doxycycline|mesh-list
139662543|NCT00353158|Voriconazole|voriconazole|mesh-list
139662544|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139662545|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139662546|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
139662547|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139662548|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139662549|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
139662550|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139662551|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139662552|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662553|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662554|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139662555|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
139662556|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139662557|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662558|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139662559|NCT00235053|Fluticasone|fluticasone|mesh-list
139662560|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139662561|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139662562|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139662563|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139662564|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
139662565|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139662566|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662567|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139662568|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
139662569|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
139662570|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139662571|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139662572|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139662573|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139662574|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
139662575|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139662576|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662577|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
139662578|NCT00235053|Hormones|hormones|mesh-ancestor
139662579|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139662580|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
139662581|NCT00092222|Interferons|interferons|mesh-list
139662582|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
139662583|NCT00092222|Zidovudine|zidovudine|mesh-list
139662584|NCT00092222|Valganciclovir|valganciclovir|mesh-list
139662585|NCT00092222|Sirolimus|sirolimus|mesh-list
139662586|NCT00092222|Prednisone|prednisone|mesh-list
139662587|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
139662588|NCT00092222|Rituximab|rituximab|mesh-list
139662589|NCT00092222|Doxorubicin|doxorubicin|mesh-list
139662590|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139662591|NCT00092222|Etoposide|etoposide|mesh-list
139662592|NCT00092222|Vincristine|vincristine|mesh-list
139662593|NCT00092222|Bortezomib|bortezomib|mesh-list
139662594|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139150846|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
139662595|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
139662596|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662597|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139662598|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139662599|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
139418510|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662600|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662601|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139662602|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139662603|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139662604|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139662605|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139662606|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139662607|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662608|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139662609|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
139662610|NCT00092222|Hormones|hormones|mesh-ancestor
139662611|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139662612|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139662613|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139662614|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
139662615|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139662616|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
139662617|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
139662618|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
139662619|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139662620|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
139662621|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
139662622|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139662623|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139662624|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139662625|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139662626|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139662627|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139662628|NCT00080756|Estradiol|estradiol|mesh-list
139662629|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139662630|NCT00080756|Testosterone|testosterone|mesh-list
139662631|NCT00080756|Deslorelin|deslorelin|mesh-list
139662632|NCT00080756|Estrogens|estrogens|mesh-ancestor
139662633|NCT00080756|Hormones|hormones|mesh-ancestor
139662634|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139662635|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662636|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139662637|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
139662638|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139662639|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139662640|NCT00080756|Androgens|androgens|mesh-ancestor
139662641|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662642|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662643|NCT00065676|Quercetin|quercetin|mesh-list
139662644|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
139662645|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662646|NCT00065676|Protective Agents|protective agents|mesh-ancestor
139662647|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662648|NCT00024622|Levodopa|levodopa|mesh-list
139662649|NCT00024622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139662650|NCT00024622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139662651|NCT00024622|Dopamine Agents|dopamine agents|mesh-ancestor
139662652|NCT00024622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139662653|NCT00024622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662654|NCT00024622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662655|NCT00018057|Fluoxetine|fluoxetine|mesh-list
139662656|NCT00018057|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139662657|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139662658|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139059610|NCT01116310|Glycine|glycine|mesh-list
139662659|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139662660|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139662661|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
139662662|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139662663|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139662664|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
139662665|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139662666|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139662667|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139662668|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139662669|NCT00006421|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139662670|NCT00006421|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139662671|NCT00006421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418512|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139418513|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
139418514|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418515|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139418516|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
139418517|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
139418518|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
139151441|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
139418519|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139418520|NCT02465528|Ceritinib|ceritinib|mesh-list
139418521|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151589|NCT04174612|Cytarabine|cytarabine|mesh-list
138902171|NCT03874052|Venetoclax|venetoclax|mesh-list
139151734|NCT01082705|Lumefantrine|lumefantrine|mesh-list
139418522|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139418523|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075321|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139418524|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418525|NCT03524261|Antibodies|antibodies|mesh-list
139152032|NCT02580370|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139418526|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139418527|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
139418528|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418530|NCT03386721|Atezolizumab|atezolizumab|mesh-list
139418531|NCT03386721|Vinorelbine|vinorelbine|mesh-list
139418532|NCT03386721|Antibodies|antibodies|mesh-list
139418533|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
139418534|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152560|NCT01096277|Incretins|incretins|mesh-ancestor
139418535|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139152636|NCT00043979|Hormones|hormones|mesh-ancestor
139152697|NCT01619332|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139152770|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
139152844|NCT01527916|Nootropic Agents|nootropic agents|mesh-ancestor
139152926|NCT01357642|Mydriatics|mydriatics|mesh-ancestor
139152993|NCT01313572|Adenosine|adenosine|mesh-list
139153069|NCT00039377|Leucovorin|leucovorin|mesh-list
139153070|NCT00039377|Cytarabine|cytarabine|mesh-list
139153221|NCT01198834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139418537|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418538|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418539|NCT03386721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139153593|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
139153666|NCT01129648|Allopurinol|allopurinol|mesh-list
139153743|NCT00890968|Glucocorticoids|glucocorticoids|mesh-ancestor
139418541|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139418542|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
139418543|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
139418544|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
139418545|NCT02462720|Polidocanol|polidocanol|mesh-list
139418546|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139418547|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139418548|NCT02246218|Glycerol|glycerol|mesh-list
139418549|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139418550|NCT02246218|Protective Agents|protective agents|mesh-ancestor
139418551|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418552|NCT05073939|Oxytocin|oxytocin|mesh-list
139418553|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
139418554|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139418555|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418556|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
139418557|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139153957|NCT00872014|Sorafenib|sorafenib|mesh-list
139418558|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
139154032|NCT02576444|Olaparib|olaparib|mesh-list
139418559|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418560|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
139418561|NCT04192630|Protective Agents|protective agents|mesh-ancestor
139418562|NCT00159783|Olanzapine|olanzapine|mesh-list
139418563|NCT00159783|Asenapine|asenapine|mesh-list
139418564|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
139418565|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
139418566|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418567|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418568|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139418569|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139418570|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139418571|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139418572|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139418573|NCT00159783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139418574|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139418575|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139418576|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418577|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418578|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
139418579|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
139418580|NCT01023737|Vorinostat|vorinostat|mesh-list
139418581|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
139418582|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139418583|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139418584|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418585|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418586|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418587|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139418588|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418589|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139418590|NCT00646204|Memantine|memantine|mesh-list
139418591|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139418592|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139418593|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
139418594|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418595|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418596|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418597|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139418598|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139418599|NCT02243176|Saxagliptin|saxagliptin|mesh-list
139418600|NCT02243176|Acarbose|acarbose|mesh-list
139418601|NCT02243176|Incretins|incretins|mesh-ancestor
139418602|NCT02243176|Hormones|hormones|mesh-ancestor
139418603|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139418604|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418605|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139418606|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
139418607|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418608|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418609|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139418610|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139418611|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
139418612|NCT00692939|Melphalan|melphalan|mesh-list
139418613|NCT00692939|Thiotepa|thiotepa|mesh-list
139418614|NCT00692939|Rituximab|rituximab|mesh-list
139418615|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
139418616|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
139418617|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139418618|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139418619|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
139418620|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418621|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139418622|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139418623|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
139418624|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418625|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418626|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139418627|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139418628|NCT04551261|Ritonavir|ritonavir|mesh-list
139418629|NCT04551261|Tenofovir|tenofovir|mesh-list
139418630|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139418631|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139418632|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
139418633|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418634|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418635|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139418636|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139418637|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
139418638|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418639|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139418640|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139418641|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139418642|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139418643|NCT04534257|Sirolimus|sirolimus|mesh-list
139418644|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139418645|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418646|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139418647|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418648|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
139418649|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139418650|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
139418651|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418652|NCT03522935|Elafin|elafin|mesh-list
139418653|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
139418654|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418655|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418656|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
139418657|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139418658|NCT03138681|Protective Agents|protective agents|mesh-ancestor
139418659|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418660|NCT05392257|Rituximab|rituximab|mesh-list
139418661|NCT05392257|Lenalidomide|lenalidomide|mesh-list
139418662|NCT05392257|Zanubrutinib|zanubrutinib|mesh-list
139418663|NCT05392257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139418664|NCT05392257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418665|NCT05392257|Immunologic Factors|immunologic factors|mesh-ancestor
139418666|NCT05392257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418667|NCT05392257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139418668|NCT05392257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139418669|NCT05392257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139418670|NCT05392257|Growth Substances|growth substances|mesh-ancestor
139418671|NCT05392257|Growth Inhibitors|growth inhibitors|mesh-ancestor
139418672|NCT05392257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139418673|NCT05392257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418674|NCT05392257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418675|NCT02240680|Linagliptin|linagliptin|mesh-list
139418676|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139418677|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418678|NCT02240680|Incretins|incretins|mesh-ancestor
139418679|NCT02240680|Hormones|hormones|mesh-ancestor
139418680|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139418681|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139418682|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
139418683|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418684|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418685|NCT05391867|Sorafenib|sorafenib|mesh-list
139418686|NCT05391867|Lenvatinib|lenvatinib|mesh-list
139418687|NCT05391867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418688|NCT05391867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139418689|NCT05391867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418690|NCT05391867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418691|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
139418692|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139418693|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
139418694|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418695|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
139418696|NCT03110679|Protective Agents|protective agents|mesh-ancestor
139418697|NCT05391789|Urinastatin|urinastatin|mesh-list
139418698|NCT05391789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139418699|NCT05391789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139418700|NCT05391789|Protease Inhibitors|protease inhibitors|mesh-ancestor
139418701|NCT05391789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418702|NCT05391789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418703|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
139418704|NCT04699071|Lenvatinib|lenvatinib|mesh-list
139418705|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139418706|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418707|NCT04699071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139418708|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418709|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139418710|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418711|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
139418712|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
139418713|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139418714|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
139418715|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418716|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139418717|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139418718|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
139418719|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418720|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418721|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139418722|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139418723|NCT03139851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139418724|NCT03962062|Moxidectin|moxidectin|mesh-list
139418725|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
139418726|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139418727|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418728|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
139418729|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139418730|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418731|NCT02239510|Linaclotide|linaclotide|mesh-list
139418732|NCT02239510|Sennosides|sennosides|mesh-list
139418733|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139418734|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
139418735|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418736|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139418737|NCT02239510|Laxatives|laxatives|mesh-ancestor
139418738|NCT04507581|Anesthetics|anesthetics|mesh-list
139418739|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139418740|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418741|NCT02291471|T0001|t0001|mesh-list
139418742|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
139418743|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139418744|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
139418745|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418746|NCT03899961|Oxytocin|oxytocin|mesh-list
139418747|NCT03899961|Carbetocin|carbetocin|mesh-list
139418748|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
139418749|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139418750|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418751|NCT02462486|Ranibizumab|ranibizumab|mesh-list
139418752|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139418753|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139418754|NCT02462486|Growth Substances|growth substances|mesh-ancestor
139418755|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418756|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
139418757|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418758|NCT03521219|Apatinib|apatinib|mesh-list
139418759|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418760|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139418761|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418762|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418763|NCT05318157|Emedastine|emedastine|mesh-list
139418764|NCT05318157|Budesonide|budesonide|mesh-list
139418765|NCT05318157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139418766|NCT05318157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139418767|NCT05318157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139418768|NCT05318157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139418769|NCT05318157|Autonomic Agents|autonomic agents|mesh-ancestor
139418770|NCT05318157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418771|NCT05318157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418772|NCT05318157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139418773|NCT05318157|Respiratory System Agents|respiratory system agents|mesh-ancestor
139418774|NCT05318157|Glucocorticoids|glucocorticoids|mesh-ancestor
139418775|NCT05318157|Hormones|hormones|mesh-ancestor
139418776|NCT05318157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139418777|NCT05318157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139418778|NCT05318157|Histamine Antagonists|histamine antagonists|mesh-ancestor
139418779|NCT05318157|Histamine Agents|histamine agents|mesh-ancestor
139418780|NCT05318157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418781|NCT05318157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418782|NCT05318157|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139418783|NCT02294279|Beclomethasone|beclomethasone|mesh-list
139418785|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
139418786|NCT02294279|Hormones|hormones|mesh-ancestor
139060104|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139418787|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139418788|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418789|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139418790|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
139418791|NCT03880539|Vancomycin|vancomycin|mesh-list
139418792|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139418793|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418794|NCT03518021|Naloxone|naloxone|mesh-list
139418795|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139418796|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418797|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
139418798|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418799|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139418800|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139418801|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139418802|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418803|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
139418804|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139418805|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
139418806|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418807|NCT02294591|Expectorants|expectorants|mesh-ancestor
139418808|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
139418809|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139418810|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
139418811|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418812|NCT02294591|Protective Agents|protective agents|mesh-ancestor
139418813|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418814|NCT02294591|Antidotes|antidotes|mesh-ancestor
139418815|NCT03521063|Budesonide|budesonide|mesh-list
139418816|NCT03521063|Poractant alfa|poractant alfa|mesh-list
139418817|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139418818|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139418819|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
139418820|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418821|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418822|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139418823|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
139418824|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
139418825|NCT03521063|Hormones|hormones|mesh-ancestor
139418826|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139075619|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139418827|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139418828|NCT03520985|Dexamethasone|dexamethasone|mesh-list
139418829|NCT03520985|Pomalidomide|pomalidomide|mesh-list
139418830|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139418831|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
139418832|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
139418833|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418834|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418835|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139418836|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
139418837|NCT03520985|Hormones|hormones|mesh-ancestor
139418838|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139418839|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139418840|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418841|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
139418842|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139418843|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139418844|NCT03520985|Growth Substances|growth substances|mesh-ancestor
139418845|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
139418846|NCT03517943|Loratadine|loratadine|mesh-list
139418847|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
139418848|NCT03517943|Ephedrine|ephedrine|mesh-list
139418849|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
139418850|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
139418851|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139060225|NCT01222312|Docetaxel|docetaxel|mesh-list
139418852|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139418853|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139418854|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
139418855|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
139418856|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418857|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154094|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
139418858|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418859|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139418860|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
139418861|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418862|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139418863|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
139418864|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
139418865|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139418866|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139418867|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
139418868|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
139418869|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
139418870|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139418871|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139418872|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139418873|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139418874|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139418875|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418876|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
139418877|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418878|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418879|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139418880|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418881|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
139418882|NCT04465175|Analgesics|analgesics|mesh-ancestor
139418883|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
139418884|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418885|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418886|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
139418887|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139418888|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139418889|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
139418890|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139418891|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139418892|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418893|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139418894|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
139418895|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139418896|NCT03158883|Avelumab|avelumab|mesh-list
139418897|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139060246|NCT00141219|Analgesics|analgesics|mesh-ancestor
139418898|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418899|NCT03138447|Insulin|insulin|mesh-list
139418900|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139418901|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418903|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139418904|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418905|NCT03520595|Diclofenac|diclofenac|mesh-list
139418906|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139418907|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139418908|NCT03520595|Analgesics|analgesics|mesh-ancestor
139418909|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
139418910|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418911|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418912|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139418913|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139418914|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139418915|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418916|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418917|NCT03520439|Mifepristone|mifepristone|mesh-list
139418918|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139418919|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
139418920|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139418921|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418922|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139418923|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139418924|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139418925|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
139418926|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139418927|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139418928|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
139418929|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139418931|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139418932|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139418933|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
139418934|NCT04543227|Narcotics|narcotics|mesh-ancestor
139418935|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139418936|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418937|NCT04543227|Analgesics|analgesics|mesh-ancestor
139418938|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
139418939|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418940|NCT04542993|Zinc|zinc|mesh-list
139418941|NCT04542993|Resveratrol|resveratrol|mesh-list
139418942|NCT04542993|Picolinic acid|picolinic acid|mesh-list
139418943|NCT04542993|Trace Elements|trace elements|mesh-ancestor
139418944|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
139418945|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418946|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
139418947|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418948|NCT04542993|Protective Agents|protective agents|mesh-ancestor
139418949|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418950|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139418951|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139418952|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
139418953|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
139418954|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139418955|NCT02292173|Sorafenib|sorafenib|mesh-list
139418956|NCT02292173|Trametinib|trametinib|mesh-list
139418957|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418958|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139418959|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418960|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418961|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
139418962|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139418963|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139418964|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139418965|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139418966|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418967|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
139418968|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139418969|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418970|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139418971|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139418972|NCT03520049|Oseltamivir|oseltamivir|mesh-list
139418973|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
139418974|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139418975|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139418976|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418977|NCT03517631|Busulfan|busulfan|mesh-list
139418978|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
139418979|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139418980|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139418981|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
139060362|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
139418982|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418983|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139418984|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139418985|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139418986|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
139418987|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139418988|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418989|NCT02461160|Midazolam|midazolam|mesh-list
139418990|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139418991|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139418992|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139418993|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139418994|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139418995|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139418996|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139418997|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139418998|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
139418999|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
139419000|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
139419001|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
139419002|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419003|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419004|NCT02296073|Midazolam|midazolam|mesh-list
139419005|NCT02296073|Fentanyl|fentanyl|mesh-list
139419006|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
139419007|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139419008|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139419009|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419010|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139419011|NCT02296073|Analgesics|analgesics|mesh-ancestor
139419012|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
139419013|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419014|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139419015|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139419016|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139419017|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
139419018|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419019|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419020|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139419021|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139419022|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139419023|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139419024|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139419025|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
139419026|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
139419027|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
139419028|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
139419029|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139060468|NCT01126528|Vitamin D|vitamin d|mesh-list
139419030|NCT02296073|Narcotics|narcotics|mesh-ancestor
139419031|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139419032|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139419033|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139419034|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139419035|NCT02293187|Vitamin D|vitamin d|mesh-list
139419036|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
139419037|NCT02293187|Vitamins|vitamins|mesh-ancestor
139419038|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
139419039|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419040|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139419041|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139419042|NCT02296463|Vaccines|vaccines|mesh-list
139419043|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
139419044|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419045|NCT02495168|Budesonide|budesonide|mesh-list
139419046|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
139419047|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139419048|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139419049|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139419050|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
139075846|NCT05532358|Anesthetics|anesthetics|mesh-ancestor
139419051|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419052|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419053|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139419054|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
139419055|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
139419056|NCT02495168|Hormones|hormones|mesh-ancestor
139419057|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139419058|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139419059|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139419060|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139419061|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
139419062|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419063|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419064|NCT04934072|Denosumab|denosumab|mesh-list
139419065|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139419066|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419067|NCT03518489|Lappaconitine|lappaconitine|mesh-list
139419068|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139419069|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139419070|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139419071|NCT03518489|Analgesics|analgesics|mesh-ancestor
139419072|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
139419073|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419074|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419075|NCT04933526|Dasatinib|dasatinib|mesh-list
139419076|NCT04933526|Flumatinib|flumatinib|mesh-list
139419077|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419078|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139419079|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419080|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419081|NCT02293889|Vitamin D|vitamin d|mesh-list
139419082|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
139419083|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
139419084|NCT02293889|Vitamins|vitamins|mesh-list
139419085|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
139419086|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419087|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139419088|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139419089|NCT02298335|Prednisone|prednisone|mesh-list
139419090|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139419091|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
139419092|NCT02298335|Hormones|hormones|mesh-ancestor
139419093|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139419094|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419095|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139419096|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419097|NCT03514667|Curcumin|curcumin|mesh-list
139419098|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139419099|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139419100|NCT03514667|Analgesics|analgesics|mesh-ancestor
139419101|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
139419102|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419103|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419104|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139419105|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139419106|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419107|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419108|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419109|NCT02493764|Tazobactam|tazobactam|mesh-list
139419110|NCT02493764|Linezolid|linezolid|mesh-list
139419111|NCT02493764|Piperacillin|piperacillin|mesh-list
139419112|NCT02493764|Imipenem|imipenem|mesh-list
139419113|NCT02493764|Relebactam|relebactam|mesh-list
139419114|NCT02493764|Cilastatin|cilastatin|mesh-list
139419115|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139419116|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419117|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139419118|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419119|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419120|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139419121|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
139419122|NCT02297477|Artesunate|artesunate|mesh-list
139419123|NCT02297477|Atovaquone|atovaquone|mesh-list
139419124|NCT02297477|Proguanil|proguanil|mesh-list
139419125|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
139419126|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
139419127|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139419128|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139419129|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419130|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419131|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
139419132|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
139419133|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139419134|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
139419135|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419136|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419137|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
139419138|NCT02460380|Vitamin D|vitamin d|mesh-list
139419139|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
139419140|NCT02460380|Vitamins|vitamins|mesh-ancestor
139419141|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
139419142|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419143|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139419144|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139419145|NCT02299115|Prednisolone|prednisolone|mesh-list
139419146|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139419147|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
139419148|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139419149|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
139419150|NCT02299115|Vigabatrin|vigabatrin|mesh-list
139419151|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139419152|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
139419153|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139419154|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
139419155|NCT02299115|Hormones|hormones|mesh-ancestor
139419156|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139419157|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419158|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139419159|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419160|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
139419161|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
139419162|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419163|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139419164|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139419165|NCT02299115|Protective Agents|protective agents|mesh-ancestor
139419166|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
139419167|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419168|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419169|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
139419170|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419171|NCT02297945|Metyrapone|metyrapone|mesh-list
139419172|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
139419173|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419174|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419175|NCT02492984|Factor VIII|factor viii|mesh-list
139419176|NCT02492984|Coagulants|coagulants|mesh-ancestor
139419177|NCT03132623|Andrographolide|andrographolide|mesh-list
139419178|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139419179|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139419180|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139419181|NCT03132623|Analgesics|analgesics|mesh-ancestor
139419182|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
139419183|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419184|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419185|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139419186|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139419187|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139419188|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419189|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
139419190|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139419191|NCT03514979|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139419192|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
139419193|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419194|NCT02298101|Edetic Acid|edetic acid|mesh-list
139419195|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
139419196|NCT02298101|Antidotes|antidotes|mesh-ancestor
139419197|NCT02298101|Protective Agents|protective agents|mesh-ancestor
139419198|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419199|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
139419200|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
139075995|NCT04991974|Buprenorphine|buprenorphine|mesh-list
139419201|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419202|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139419203|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
139419204|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139419205|NCT02491892|Pertuzumab|pertuzumab|mesh-list
139419206|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139419207|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419208|NCT03476811|Analgesics|analgesics|mesh-list
139419209|NCT03476811|Bupivacaine|bupivacaine|mesh-list
139419210|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
139419211|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
139419212|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139419213|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419214|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
139419215|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419216|NCT02299271|Ropivacaine|ropivacaine|mesh-list
139419217|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
139419218|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
139419219|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139419220|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419221|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
139419222|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419223|NCT02302469|Lenalidomide|lenalidomide|mesh-list
139419224|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
139419225|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419226|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139419227|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139419228|NCT02302469|Growth Substances|growth substances|mesh-ancestor
139419230|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419231|NCT02302547|Ritonavir|ritonavir|mesh-list
139419232|NCT02302547|Lopinavir|lopinavir|mesh-list
139419233|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139419234|NCT02302547|Darunavir|darunavir|mesh-list
139419235|NCT02302547|Indinavir|indinavir|mesh-list
139419236|NCT02302547|Saquinavir|saquinavir|mesh-list
139419237|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
139419238|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139419239|NCT02302547|Tenofovir|tenofovir|mesh-list
139419240|NCT02302547|Emtricitabine|emtricitabine|mesh-list
139419241|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
139419242|NCT02302547|Nevirapine|nevirapine|mesh-list
139419243|NCT02302547|Dolutegravir|dolutegravir|mesh-list
139419244|NCT02302547|Maraviroc|maraviroc|mesh-list
139419245|NCT02302547|Cobicistat|cobicistat|mesh-list
139419246|NCT02302547|Rilpivirine|rilpivirine|mesh-list
139419247|NCT02302547|Tipranavir|tipranavir|mesh-list
139419248|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
139419249|NCT02302547|Elvitegravir|elvitegravir|mesh-list
139419250|NCT02302547|Efavirenz|efavirenz|mesh-list
139419251|NCT02302547|Etravirine|etravirine|mesh-list
139419252|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139419253|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
139419254|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
139419255|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139419256|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419257|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419258|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139419259|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139419260|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
139419261|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419262|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139419263|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139419264|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139419265|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139419266|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139419267|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139419268|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139419269|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139419270|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139419271|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139419272|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139419273|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139419274|NCT03515369|Liver Extracts|liver extracts|mesh-list
139419275|NCT03515369|Hematinics|hematinics|mesh-ancestor
139419276|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139419277|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139419278|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419279|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
139419280|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
139419281|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139419282|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419283|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
139419284|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139419285|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419286|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
139419287|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139419288|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
139419289|NCT03510611|Ensartinib|ensartinib|mesh-list
139419290|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419291|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139419292|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419293|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419294|NCT02299817|Denosumab|denosumab|mesh-list
139419295|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139419296|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419297|NCT01679613|Ketoconazole|ketoconazole|mesh-list
139419298|NCT01679613|Nintedanib|nintedanib|mesh-list
139419299|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
139419300|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419301|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139419302|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139419303|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419304|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419305|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139419306|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
139419307|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139419309|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139419310|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419311|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139419312|NCT02489630|Ketamine|ketamine|mesh-list
139419313|NCT02489630|Analgesics|analgesics|mesh-list
139419314|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
139419315|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419316|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419317|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139419318|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139419319|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
139419320|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
139419321|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139419322|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139419323|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139419324|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419325|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419326|NCT05089539|Valsartan|valsartan|mesh-list
139419327|NCT05089539|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139419328|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139419329|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139419330|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139419331|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419332|NCT05089383|Progesterone|progesterone|mesh-list
139419333|NCT05089383|Progestins|progestins|mesh-ancestor
139419334|NCT05089383|Hormones|hormones|mesh-ancestor
139419335|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139419336|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419337|NCT03510533|Autoantibodies|autoantibodies|mesh-list
139419338|NCT03510533|alpha-MSH|alpha-msh|mesh-list
139419339|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
139419340|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419341|NCT03510533|Hormones|hormones|mesh-ancestor
139419342|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139419343|NCT03512873|Tranilast|tranilast|mesh-list
139419344|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139419345|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139419346|NCT03512873|Analgesics|analgesics|mesh-ancestor
139419347|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
139419348|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419349|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419350|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139419351|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139419352|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139419353|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139419354|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419355|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139419357|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
139419358|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
139419359|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419360|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139419361|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139419362|NCT01678911|Gabapentin|gabapentin|mesh-list
139419363|NCT01678911|Analgesics|analgesics|mesh-ancestor
139419364|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
139419365|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419366|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419367|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
139419368|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139419369|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139419370|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139419371|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139419372|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139419373|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139419374|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419375|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419376|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
139419377|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
139419378|NCT03132701|Analgesics|analgesics|mesh-ancestor
139419379|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
139419380|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419381|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419382|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
139419383|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139419384|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139419385|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
139419386|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139419387|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139419388|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419389|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139419390|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
139419391|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139419392|NCT02322099|Alendronate|alendronate|mesh-list
139419393|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
139419394|NCT02322099|Vitamin D|vitamin d|mesh-list
139419395|NCT02322099|Tenofovir|tenofovir|mesh-list
139419396|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
139419397|NCT02322099|Calcium|calcium|mesh-list
139419398|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139419399|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419400|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
139060888|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419401|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419402|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139419403|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139419404|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419405|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419406|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139419407|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139419408|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139419409|NCT02322099|Antacids|antacids|mesh-ancestor
139419410|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139419411|NCT02322099|Vitamins|vitamins|mesh-ancestor
139419412|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
139419413|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
139419414|NCT02487446|Bromides|bromides|mesh-list
139419415|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
139419416|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419417|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139419418|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139419419|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139419420|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
139419421|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419422|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419423|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
139419424|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419425|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
139419426|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419427|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419428|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139419429|NCT02303327|Androgens|androgens|mesh-list
139419430|NCT02303327|Hormones|hormones|mesh-ancestor
139419431|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139419432|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419433|NCT03510221|Antioxidants|antioxidants|mesh-list
139419434|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419435|NCT03510221|Protective Agents|protective agents|mesh-ancestor
139419436|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419437|NCT03509831|Irsogladine|irsogladine|mesh-list
139419439|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419440|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139419441|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139419442|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139419443|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
139419444|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
139419445|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419446|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419447|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419448|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139419449|NCT03509831|Protective Agents|protective agents|mesh-ancestor
139419450|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139419451|NCT02303483|Niacinamide|niacinamide|mesh-list
139419452|NCT02303483|Niacin|niacin|mesh-list
139419453|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
139419454|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
139419455|NCT02303483|Vitamins|vitamins|mesh-ancestor
139419457|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419458|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139419459|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
139419460|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419461|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139419462|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
139419463|NCT05378061|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
139419464|NCT05378061|Growth Substances|growth substances|mesh-ancestor
139419465|NCT05378061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419466|NCT05378061|Vasodilator Agents|vasodilator agents|mesh-ancestor
139419467|NCT05378061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419468|NCT05378061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419469|NCT02303639|Amiodarone|amiodarone|mesh-list
139419470|NCT02303639|Sotalol|sotalol|mesh-list
139419471|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139419472|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
139419473|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139419474|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139419475|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419476|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139419477|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139419478|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139419479|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419480|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139419481|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139419482|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139419483|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139419484|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139419485|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
139419486|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419487|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419488|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
139419489|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
139419490|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419491|NCT02303873|Alendronate|alendronate|mesh-list
139419492|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139419493|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419494|NCT04757493|Prucalopride|prucalopride|mesh-list
139419495|NCT04757493|Laxatives|laxatives|mesh-ancestor
139419496|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139419497|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139419498|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139419499|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
139419500|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419501|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419502|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419503|NCT02303951|Atezolizumab|atezolizumab|mesh-list
139419505|NCT02303951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139419506|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419507|NCT02303951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139419508|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419509|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139419510|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419511|NCT04406415|Nafamostat|nafamostat|mesh-list
139419512|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139419513|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139419514|NCT04406415|Analgesics|analgesics|mesh-ancestor
139419515|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
139419516|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419517|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419518|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139419519|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139419520|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
139419521|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
139419522|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419523|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419524|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139419525|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139419526|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139419527|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139419528|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
139419529|NCT02304107|Letrozole|letrozole|mesh-list
139419530|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419531|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139419532|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139419533|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419534|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419535|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139419536|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
139419537|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139419538|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419539|NCT03509285|Cenobamate|cenobamate|mesh-list
139419540|NCT03509285|Alprazolam|alprazolam|mesh-list
139419541|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139419542|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139419543|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419544|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139419545|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139419546|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139419547|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
139419548|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
139419549|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419550|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419551|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
139419552|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139419553|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139419554|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139419555|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139419556|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
139419557|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419558|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139419559|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139419560|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419561|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139419562|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139419563|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419564|NCT03135795|Parecoxib|parecoxib|mesh-list
139419565|NCT03135795|Sufentanil|sufentanil|mesh-list
139419566|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
139419567|NCT03135795|Remifentanil|remifentanil|mesh-list
139419568|NCT03135795|Dsuvia|dsuvia|mesh-list
139419569|NCT03135795|Bromides|bromides|mesh-list
139419570|NCT03135795|Propofol|propofol|mesh-list
139419571|NCT03135795|Sevoflurane|sevoflurane|mesh-list
139419572|NCT03135795|Citric Acid|citric acid|mesh-list
139419573|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
139419574|NCT03135795|Rocuronium|rocuronium|mesh-list
139419575|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139419576|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139419577|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419578|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139419579|NCT03135795|Analgesics|analgesics|mesh-ancestor
139419580|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
139419581|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419582|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139419583|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139419584|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139419585|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
139419586|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419587|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419588|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139419589|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
139419590|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
139419591|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
139419592|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139419593|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
139419594|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
139419595|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139419596|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139419597|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139419598|NCT03135795|Narcotics|narcotics|mesh-ancestor
139419599|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
139419600|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139419601|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139419602|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139419603|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139419604|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139419605|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139419606|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419607|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139419608|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139419609|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139419610|NCT04958967|Aflutinib|aflutinib|mesh-list
139419611|NCT04958967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139419612|NCT04958967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419613|NCT04958967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419614|NCT03469531|Cisplatin|cisplatin|mesh-list
139419615|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
139419616|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419617|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139419618|NCT03508817|Atropine|atropine|mesh-list
139419619|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139419620|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139419621|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139419622|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139419623|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139419624|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
139419625|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419626|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419627|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139419628|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
139419629|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
139419630|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
139419631|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139419632|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139419633|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
139419634|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419635|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419636|NCT01678209|Methylphenidate|methylphenidate|mesh-list
139419637|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139419638|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139419639|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419640|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139419641|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139419642|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139419643|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419644|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
139419645|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419646|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139419647|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
139419648|NCT02239120|Dabigatran|dabigatran|mesh-list
139419649|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
139419650|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139419651|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
139419652|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419653|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419654|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
139419655|NCT04464863|Metronidazole|metronidazole|mesh-list
139419656|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419657|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139419658|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139419659|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139419660|NCT05158699|Dexamethasone|dexamethasone|mesh-list
139419661|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
139419662|NCT05158699|Triamcinolone|triamcinolone|mesh-list
139419663|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139419664|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139419665|NCT05158699|Ketorolac|ketorolac|mesh-list
139419666|NCT05158699|Bromfenac|bromfenac|mesh-list
139419667|NCT05158699|Phenylephrine|phenylephrine|mesh-list
139419668|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139419669|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139419670|NCT05158699|BB 1101|bb 1101|mesh-list
139419671|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139419672|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139419673|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
139419674|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
139419675|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419676|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419677|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139419678|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
139419680|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139419681|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139419682|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419683|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
139419684|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419685|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419686|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139419687|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
139419688|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139419689|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139419690|NCT05158699|Analgesics|analgesics|mesh-ancestor
139419691|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
139419692|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139419693|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139419694|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139419695|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
139419696|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
139419697|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139419698|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
139419699|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
139419700|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139419701|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139419702|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139419703|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
139419704|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419705|NCT05158699|Protective Agents|protective agents|mesh-ancestor
139419706|NCT02304887|Denosumab|denosumab|mesh-list
139419707|NCT02304887|Teriparatide|teriparatide|mesh-list
139060957|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139419708|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139419709|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419710|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139419711|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139419712|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139419713|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419714|NCT03474133|Immunotoxins|immunotoxins|mesh-ancestor
139419715|NCT03474133|Immunoconjugates|immunoconjugates|mesh-ancestor
139419716|NCT03474133|Immunologic Factors|immunologic factors|mesh-ancestor
139419717|NCT03474133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419718|NCT03512171|Amphetamine|amphetamine|mesh-list
139419719|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
139419720|NCT03512171|Fallypride|fallypride|mesh-list
139419721|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139419722|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419723|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
139419724|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
139419725|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419726|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
139419727|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419728|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419729|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
139419730|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139419731|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139419732|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139419733|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139419734|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139419735|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139419736|NCT03739099|Pancrelipase|pancrelipase|mesh-list
139419737|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139419738|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139419739|NCT03469375|Folfirinox|folfirinox|mesh-list
139419740|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419741|NCT01603407|Prednisone|prednisone|mesh-list
139419742|NCT01603407|Deflazacort|deflazacort|mesh-list
139419743|NCT01603407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139419744|NCT01603407|Glucocorticoids|glucocorticoids|mesh-ancestor
139419745|NCT01603407|Hormones|hormones|mesh-ancestor
139419746|NCT01603407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139419747|NCT01603407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419748|NCT01603407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139419749|NCT01603407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419750|NCT01603407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139419751|NCT01603407|Immunologic Factors|immunologic factors|mesh-ancestor
139419752|NCT02305355|Atorvastatin|atorvastatin|mesh-list
139419753|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139419754|NCT02305355|Simvastatin|simvastatin|mesh-list
139419755|NCT02305355|Pravastatin|pravastatin|mesh-list
139419756|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139419757|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139419758|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
139419759|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419760|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139419761|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139419762|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419763|NCT03511703|Apatinib|apatinib|mesh-list
139419764|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419765|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139419766|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419767|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419768|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139419769|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139419770|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139419771|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419772|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419773|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139060968|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
139419774|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139419775|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419776|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
139419777|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419778|NCT02301221|Vancomycin|vancomycin|mesh-list
139419779|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139419780|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419781|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
139419782|NCT03122431|Thalidomide|thalidomide|mesh-list
139419783|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
139419784|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139419785|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139419786|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419787|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419788|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419789|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139419790|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139419791|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
139419792|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419793|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
139419794|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139419795|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139419796|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139419797|NCT03122431|Growth Substances|growth substances|mesh-ancestor
139419798|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
139419799|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419800|NCT05248360|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139419801|NCT05248360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139419802|NCT05248360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139419803|NCT02305823|Aripiprazole|aripiprazole|mesh-list
139419804|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139419805|NCT02305823|Ziprasidone|ziprasidone|mesh-list
139419806|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
139419807|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139419808|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139419809|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139419810|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139419811|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419812|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
139419813|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
139419814|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419815|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419816|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139419817|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139419818|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
139419819|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139419820|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139419821|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139419822|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139419823|NCT05376189|Vitamin D|vitamin d|mesh-list
139419824|NCT05376189|Ergocalciferols|ergocalciferols|mesh-list
139419825|NCT05376189|Cholecalciferol|cholecalciferol|mesh-list
139419826|NCT05376189|Vitamins|vitamins|mesh-list
139419827|NCT05376189|Micronutrients|micronutrients|mesh-ancestor
139419828|NCT05376189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419829|NCT05376189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139419830|NCT05376189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139419831|NCT02235298|Metformin|metformin|mesh-list
139419832|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
139419833|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139419834|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419835|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139419836|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419837|NCT02305901|Repaglinide|repaglinide|mesh-list
139419838|NCT02305901|Bupropion|bupropion|mesh-list
139419839|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139419840|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
139419841|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139060977|NCT01130506|Vorinostat|vorinostat|mesh-list
139419842|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139419843|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139419844|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139419845|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419846|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
139419847|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419848|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419849|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139419850|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139419851|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419852|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139419853|NCT02234596|Nintedanib|nintedanib|mesh-list
139419854|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419855|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139419856|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419857|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419858|NCT02305979|Loratadine|loratadine|mesh-list
139419859|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
139419860|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
139419861|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139419862|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139419863|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139419864|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
139419865|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
139419866|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419867|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419868|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419869|NCT04539951|Memantine|memantine|mesh-list
139419870|NCT04539951|Aripiprazole|aripiprazole|mesh-list
139419871|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
139419872|NCT04539951|Sertraline|sertraline|mesh-list
139419873|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139419874|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
139419875|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139419876|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139419877|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139419878|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139419879|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419880|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
139419881|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
139419882|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419883|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419884|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139419885|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139419886|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
139419887|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139419888|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139419889|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139419890|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139419891|NCT04539951|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139419892|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139419893|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139419894|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139419895|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139419896|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139419897|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139419898|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139419899|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139419900|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139419901|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139419902|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139419903|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419904|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139419906|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139419907|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419908|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419909|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419911|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
139419912|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139419913|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139419914|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139419915|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139419916|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419917|NCT02234362|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139419918|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139419919|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139419920|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419921|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419922|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
139419923|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139419924|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139419925|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139419926|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139419927|NCT05091177|Acetylcholine|acetylcholine|mesh-list
139419928|NCT05091177|Antibodies|antibodies|mesh-list
139419929|NCT05091177|Neostigmine|neostigmine|mesh-list
139419930|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
139419931|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419932|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139419933|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419934|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419935|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
139419936|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139419937|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139419938|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
139419939|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419940|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
139419941|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139419942|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
139419943|NCT05091099|Alendronate|alendronate|mesh-list
139419944|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139419945|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419946|NCT03505151|BI 409306|bi 409306|mesh-list
139419947|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139419948|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139419949|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419950|NCT02232880|Abatacept|abatacept|mesh-list
139419951|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139419952|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419953|NCT02232880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139419954|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419955|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139419957|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419958|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139419959|NCT02896855|Docetaxel|docetaxel|mesh-list
139419960|NCT02896855|Trastuzumab|trastuzumab|mesh-list
139419961|NCT02896855|Pertuzumab|pertuzumab|mesh-list
139419962|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419963|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
139419964|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
139419965|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
139419966|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419967|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139419968|NCT02311439|Folfirinox|folfirinox|mesh-list
139419969|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419970|NCT02311517|Ropivacaine|ropivacaine|mesh-list
139419971|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
139419972|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
139419973|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139419974|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419975|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
139419976|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139419978|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
139419979|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
139419980|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139419981|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139419982|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419983|NCT04463459|Vitamins|vitamins|mesh-list
139419984|NCT04463459|Vitamin E|vitamin e|mesh-list
139419985|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
139419986|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419987|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
139419988|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139419989|NCT04463459|Protective Agents|protective agents|mesh-ancestor
139419990|NCT02434328|Aflibercept|aflibercept|mesh-list
139419991|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139419992|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139419993|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139419994|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139419995|NCT02434328|Growth Substances|growth substances|mesh-ancestor
139419996|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139419997|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
139419998|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139419999|NCT04785274|Chrysarobin|chrysarobin|mesh-list
139420000|NCT04785274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139420001|NCT04785274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139420002|NCT04785274|Analgesics|analgesics|mesh-ancestor
139420003|NCT04785274|Sensory System Agents|sensory system agents|mesh-ancestor
139420004|NCT04785274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420005|NCT04785274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420006|NCT04785274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139420007|NCT04785274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139420008|NCT04778176|Levodopa|levodopa|mesh-list
139420009|NCT04778176|Carbidopa|carbidopa|mesh-list
139420010|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139420011|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139420012|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
139420013|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420014|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420015|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420016|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139420017|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420018|NCT05076253|Ivermectin|ivermectin|mesh-list
139420019|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139420020|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420021|NCT05077839|Trifluridine|trifluridine|mesh-list
139420022|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
139420023|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420024|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
139420025|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420026|NCT03132233|Calcium|calcium|mesh-list
139420027|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139420028|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420029|NCT02307227|Paclitaxel|paclitaxel|mesh-list
139420030|NCT02307227|Docetaxel|docetaxel|mesh-list
139420031|NCT02307227|Trastuzumab|trastuzumab|mesh-list
139420032|NCT02307227|Epirubicin|epirubicin|mesh-list
139420033|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139420034|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420035|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
139420036|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
139420037|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
139420038|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420039|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139420040|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139420041|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139420042|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139420043|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420044|NCT02307305|Acetaminophen|acetaminophen|mesh-list
139420045|NCT02307305|Celecoxib|celecoxib|mesh-list
139420046|NCT02307305|Naproxen|naproxen|mesh-list
139420047|NCT02307305|Oxycodone|oxycodone|mesh-list
139420048|NCT02307305|Tramadol|tramadol|mesh-list
139420049|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139420050|NCT02307305|Naloxone|naloxone|mesh-list
139420051|NCT02307305|Esomeprazole|esomeprazole|mesh-list
138924714|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139420052|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139420053|NCT02307305|Analgesics|analgesics|mesh-ancestor
139420054|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
139420055|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420056|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420057|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
139420058|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139420059|NCT02307305|Narcotics|narcotics|mesh-ancestor
139420060|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420061|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139420062|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139420063|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139420064|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139420065|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139420066|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420067|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420068|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139420069|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139420070|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139420071|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139420072|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139420073|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139420074|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420075|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
139420076|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139420077|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
139420078|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
139420079|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139420080|NCT02660229|Morphine|morphine|mesh-list
139420081|NCT02660229|Oxycodone|oxycodone|mesh-list
139420082|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139420083|NCT02660229|Narcotics|narcotics|mesh-ancestor
139420084|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420085|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420086|NCT02660229|Analgesics|analgesics|mesh-ancestor
139420087|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
139420088|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420089|NCT02307383|Lactitol|lactitol|mesh-list
139420090|NCT02307383|Cathartics|cathartics|mesh-ancestor
139420091|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139420092|NCT02232178|Bupivacaine|bupivacaine|mesh-list
139420093|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
139420094|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
139420095|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420096|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420097|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
139420098|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420099|NCT04457323|Metoprolol|metoprolol|mesh-list
139420100|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139420101|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139420102|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
139420103|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
139420104|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420105|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420106|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139420107|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139420108|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139420109|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
139420110|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420111|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420112|NCT04448431|Vortioxetine|vortioxetine|mesh-list
139420113|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139420114|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
139420115|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139420116|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139420117|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139420118|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420119|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420120|NCT04448431|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139420121|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139420122|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139420123|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420124|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420125|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
139420126|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139420127|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139420128|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139420129|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139420130|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139420131|NCT05713149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139420132|NCT05713149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420134|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139420135|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139420136|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420137|NCT02307695|Incretins|incretins|mesh-ancestor
139420138|NCT02307695|Hormones|hormones|mesh-ancestor
139420139|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420140|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
139420141|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420142|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420143|NCT05161975|Vitamin K|vitamin k|mesh-list
139420144|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
139420145|NCT05161975|Vitamins|vitamins|mesh-ancestor
139420146|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
139420147|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420148|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139420149|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139420150|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420151|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
139420152|NCT05161975|Coagulants|coagulants|mesh-ancestor
139420153|NCT03504527|Budesonide|budesonide|mesh-list
139420154|NCT03504527|Bromides|bromides|mesh-list
139420155|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
139420156|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139420157|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139420158|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
139420159|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420160|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420161|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139420162|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
139420163|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
139420164|NCT03504527|Hormones|hormones|mesh-ancestor
139420165|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420166|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
139420167|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139420168|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
139420169|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061022|NCT03923842|Denosumab|denosumab|mesh-list
139420170|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420171|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
139420172|NCT01678131|Ribavirin|ribavirin|mesh-list
139420173|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139420174|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
139420175|NCT01678131|Liver Extracts|liver extracts|mesh-list
139420176|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
139420177|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420178|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
139420179|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420180|NCT01678131|Hematinics|hematinics|mesh-ancestor
139420181|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420182|NCT04579783|Triamcinolone|triamcinolone|mesh-list
139420183|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139420184|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139420185|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139420186|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139420187|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
139420188|NCT04579783|Hormones|hormones|mesh-ancestor
139420189|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420190|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420191|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139420192|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
139420193|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420194|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420195|NCT02231164|Docetaxel|docetaxel|mesh-list
139420196|NCT02231164|Nintedanib|nintedanib|mesh-list
139420197|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420198|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
139420199|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
139420200|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
139420201|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420202|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139420203|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420205|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139420206|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
139420207|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
139420208|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420209|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420210|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139420211|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
139420212|NCT03506789|Hormones|hormones|mesh-ancestor
139420213|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420214|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139420215|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420216|NCT02312297|Minocycline|minocycline|mesh-list
139420217|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139420218|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420219|NCT03473431|Ketamine|ketamine|mesh-list
139420220|NCT03473431|Analgesics|analgesics|mesh-ancestor
139420221|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
139420222|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420223|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420224|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139420225|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139420226|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
139420227|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
139420228|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420229|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139420230|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139420231|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420232|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420233|NCT02378805|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139420234|NCT02378805|Ramipril|ramipril|mesh-list
139420235|NCT02378805|Spironolactone|spironolactone|mesh-list
139420236|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139420237|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139420238|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
139061033|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
139420239|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420240|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420241|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139420242|NCT02378805|Diuretics|diuretics|mesh-ancestor
139420243|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
139420244|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
139420245|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420246|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420247|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139420248|NCT02378805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139420249|NCT05094375|Misoprostol|misoprostol|mesh-list
139420250|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139420251|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
139420252|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139420253|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420254|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139420255|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139420256|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
139420257|NCT04345861|Azithromycin|azithromycin|mesh-list
139420258|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
139420259|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139420260|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420261|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
139420262|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139420263|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139420264|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420265|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420266|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139420267|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
139420268|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420269|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
139420270|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
139420271|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
139420272|NCT02230306|Vemurafenib|vemurafenib|mesh-list
139420273|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420274|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139420275|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420276|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420277|NCT04266379|Insulin|insulin|mesh-list
139420278|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139420279|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139420280|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420281|NCT02308319|Tenofovir|tenofovir|mesh-list
139420282|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
139420283|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420284|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139420285|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139420286|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420287|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420288|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139420289|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139420290|NCT02312375|Amlodipine|amlodipine|mesh-list
139420291|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139420292|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139420293|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139420294|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420295|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139420296|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420297|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
139420298|NCT05062174|Mifepristone|mifepristone|mesh-list
139420299|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139420300|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
139420301|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139420302|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420303|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139420304|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139420305|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139420306|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
139420307|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139420308|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139420309|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
139420310|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420311|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
139420312|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139420313|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139420314|NCT05095467|Paclitaxel|paclitaxel|mesh-list
139420315|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139420316|NCT05095467|Tegafur|tegafur|mesh-list
139420317|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139420318|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420319|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
139420320|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
139420321|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
139420322|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420323|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139420324|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
139420325|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
139420326|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139077116|NCT04992065|Evolocumab|evolocumab|mesh-list
139420327|NCT02312531|Antibodies|antibodies|mesh-list
139420328|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
139420329|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420330|NCT04234477|Metoprolol|metoprolol|mesh-list
139420331|NCT04234477|Verapamil|verapamil|mesh-list
139420332|NCT04234477|Diltiazem|diltiazem|mesh-list
139420333|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
139420334|NCT04234477|Calcium|calcium|mesh-list
139420335|NCT04234477|Esmolol|esmolol|mesh-list
139420336|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139420337|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139420338|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420339|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139420340|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139420341|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
139420342|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
139420343|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420344|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139420345|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139420346|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
139420347|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420348|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420349|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139420350|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
139420352|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139420353|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420354|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
139420355|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
139420356|NCT01680861|Everolimus|everolimus|mesh-list
139420357|NCT01680861|Tacrolimus|tacrolimus|mesh-list
139420358|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139420359|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
139420360|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420361|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139420362|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420363|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420364|NCT01680861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139420365|NCT01680861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139420366|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420367|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139420368|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139420369|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
139420370|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139420371|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420372|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139420373|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
139420374|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
139420375|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420376|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139420377|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
139420378|NCT01680861|Hormones|hormones|mesh-ancestor
139420379|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420380|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139420381|NCT01680861|Protective Agents|protective agents|mesh-ancestor
139420382|NCT02229214|Topiramate|topiramate|mesh-list
139420383|NCT02229214|Phentermine|phentermine|mesh-list
139420384|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
139420385|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139420386|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420387|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139420388|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
139420389|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139420390|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
139420391|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
139420392|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420393|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
139420394|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420395|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420396|NCT02308553|Paclitaxel|paclitaxel|mesh-list
139420397|NCT02308553|Nintedanib|nintedanib|mesh-list
139420398|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139420399|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420400|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
139420401|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
139420402|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
139420403|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420404|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139420405|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420406|NCT05093907|Capecitabine|capecitabine|mesh-list
139420407|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139420408|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
139420409|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420410|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420411|NCT02228980|Vaccines|vaccines|mesh-list
139420412|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
139420413|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420414|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
139420415|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
139420416|NCT03783091|Hematinics|hematinics|mesh-ancestor
139420417|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
139420418|NCT03783091|Vitamins|vitamins|mesh-ancestor
139420419|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
139420420|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420421|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
139420422|NCT05057481|Rituximab|rituximab|mesh-list
139420423|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138925089|NCT00738374|Rituximab|rituximab|mesh-list
139420424|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420425|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
139420426|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420427|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139420428|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139420429|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139420430|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
139420431|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139420432|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420433|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420434|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420435|NCT02312609|Minocycline|minocycline|mesh-list
139420436|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139420437|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420438|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
139420439|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139420440|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
139420441|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
139420442|NCT03506399|Estradiol|estradiol|mesh-list
139420443|NCT03506399|Estrogens|estrogens|mesh-ancestor
139420444|NCT03506399|Hormones|hormones|mesh-ancestor
139420445|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420446|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420447|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139420448|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139420449|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139420450|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139420451|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139420452|NCT02228590|Apomorphine|apomorphine|mesh-list
139420453|NCT02228590|Emetics|emetics|mesh-ancestor
139420454|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420455|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
139420456|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420457|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139420458|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
139420459|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
139420460|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420461|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420462|NCT03503201|Chromium|chromium|mesh-list
139420463|NCT03503201|Trace Elements|trace elements|mesh-ancestor
139420464|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
139420465|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420466|NCT05095077|Tadalafil|tadalafil|mesh-list
139420467|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
139420468|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139420469|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139420470|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420471|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420472|NCT05095077|Urological Agents|urological agents|mesh-ancestor
139420473|NCT02309177|Paclitaxel|paclitaxel|mesh-list
139420474|NCT02309177|Carboplatin|carboplatin|mesh-list
139420475|NCT02309177|Gemcitabine|gemcitabine|mesh-list
139420476|NCT02309177|Nivolumab|nivolumab|mesh-list
139420477|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139420478|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420479|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
139077264|NCT04543383|Thrombin|thrombin|mesh-list
139420480|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
139420481|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
139420482|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420483|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139420484|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
139420485|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139420486|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139420487|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
139420488|NCT02227108|Immunotoxins|immunotoxins|mesh-ancestor
139420489|NCT02227108|Immunoconjugates|immunoconjugates|mesh-ancestor
139420490|NCT02227108|Immunologic Factors|immunologic factors|mesh-ancestor
139420491|NCT02227108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420492|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420493|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139420494|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
139420495|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
139420496|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139420497|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139420498|NCT04863261|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
139420499|NCT04863261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139420500|NCT04863261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139420501|NCT04863261|Antiviral Agents|antiviral agents|mesh-ancestor
139420502|NCT04863261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420503|NCT02313077|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139420504|NCT02313077|Antiviral Agents|antiviral agents|mesh-ancestor
139420505|NCT02313077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420506|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
139420507|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139420508|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139420509|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420510|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139420511|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420512|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139420513|NCT03423355|Diuretics|diuretics|mesh-ancestor
139420514|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
139420515|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139420516|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139420518|NCT02226562|Fluorides|fluorides|mesh-list
139420519|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
139420520|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
139420521|NCT02226562|Protective Agents|protective agents|mesh-ancestor
139420522|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420523|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139420524|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420525|NCT04430985|Leucovorin|leucovorin|mesh-list
139420526|NCT04430985|Fluorouracil|fluorouracil|mesh-list
139420527|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
139420528|NCT04430985|Nivolumab|nivolumab|mesh-list
139420529|NCT04430985|Ipilimumab|ipilimumab|mesh-list
139420530|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
139420531|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420532|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139420533|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420534|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139420535|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
139420536|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420537|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139420538|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139420539|NCT04430985|Antidotes|antidotes|mesh-ancestor
139420540|NCT04430985|Protective Agents|protective agents|mesh-ancestor
139420541|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
139420542|NCT04430985|Vitamins|vitamins|mesh-ancestor
139420543|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
139420544|NCT03365635|Ribavirin|ribavirin|mesh-list
139420545|NCT03365635|Grazoprevir|grazoprevir|mesh-list
139420546|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139420547|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
139420548|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420549|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
139420550|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420551|NCT04658277|Clarithromycin|clarithromycin|mesh-list
139420552|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139420553|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420554|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139420555|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061090|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
139420556|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420557|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139420558|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139420559|NCT04456777|Vortioxetine|vortioxetine|mesh-list
139420560|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
139420561|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139420562|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139420563|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139420564|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420565|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420566|NCT04456777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139420567|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139420568|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139420569|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420570|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420571|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
139420572|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139420573|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139420574|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139420575|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139420576|NCT02874430|Metformin|metformin|mesh-list
139420577|NCT02874430|Doxycycline|doxycycline|mesh-list
139420578|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139420579|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420580|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139420581|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420582|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
139420583|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139420584|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139420585|NCT05160727|Irinotecan|irinotecan|mesh-list
139420586|NCT05160727|Tislelizumab|tislelizumab|mesh-list
139420587|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139420588|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139420589|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420590|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420591|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420592|NCT05160727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139420593|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139420594|NCT03506009|Argatroban|argatroban|mesh-list
139420595|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139420596|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139420597|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420598|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
139420599|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139420600|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
139420601|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420602|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
139420603|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139420604|NCT03130855|Carticaine|carticaine|mesh-list
139420605|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
139420606|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
139420607|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420608|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420609|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
139420610|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420611|NCT02309801|Daidzin|daidzin|mesh-list
139420612|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139420613|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420614|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420615|NCT02309879|Lidocaine|lidocaine|mesh-list
139420616|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
139420617|NCT02309879|Remifentanil|remifentanil|mesh-list
139420618|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
139420619|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
139420620|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420621|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420622|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
139420623|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420624|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139420625|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139420626|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139420627|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139420628|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420629|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139077416|NCT04242238|Avelumab|avelumab|mesh-list
139420630|NCT02309879|Narcotics|narcotics|mesh-ancestor
139420631|NCT02309879|Analgesics|analgesics|mesh-ancestor
139420632|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
139420633|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139420634|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139420635|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
139420636|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139420637|NCT02820961|Exemestane|exemestane|mesh-list
139420638|NCT02820961|Entinostat|entinostat|mesh-list
139420639|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420640|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139420641|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139420642|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420643|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420644|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139420645|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
139420646|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420647|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420648|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139420650|NCT04658173|Propofol|propofol|mesh-list
139420651|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139420652|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420653|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420654|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139420655|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
139420656|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
139420657|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139420658|NCT04658173|Narcotics|narcotics|mesh-ancestor
139420659|NCT04658173|Analgesics|analgesics|mesh-ancestor
139420660|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
139420661|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420662|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
139420663|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139420664|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139420665|NCT03636165|Prednisolone|prednisolone|mesh-list
139420666|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
139420667|NCT03636165|Ropivacaine|ropivacaine|mesh-list
139420668|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139420669|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
139420670|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
139420671|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
139420672|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420673|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420674|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
139420675|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420676|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139420677|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
139420678|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
139420679|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139420680|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
139420681|NCT03636165|Hormones|hormones|mesh-ancestor
139420682|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420683|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139420684|NCT03636165|Protective Agents|protective agents|mesh-ancestor
139420685|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139420686|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420687|NCT02310347|Dronabinol|dronabinol|mesh-list
139420688|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
139420689|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420690|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139420691|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139420692|NCT02310347|Analgesics|analgesics|mesh-ancestor
139420693|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
139420694|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420695|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139420696|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139420697|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420698|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420699|NCT02310347|Hormones|hormones|mesh-ancestor
139420700|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420701|NCT04429425|Anesthetics|anesthetics|mesh-list
139420702|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420703|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420704|NCT03502889|Ropivacaine|ropivacaine|mesh-list
139420705|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
139420707|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420708|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420709|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
139420710|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420711|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139420712|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
139420713|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139420714|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139420715|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139420716|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420717|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420718|NCT05098119|Paclitaxel|paclitaxel|mesh-list
139420719|NCT05098119|Carboplatin|carboplatin|mesh-list
139420720|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139420721|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420722|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
139420723|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
139420724|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
139420725|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420726|NCT02738879|Metformin|metformin|mesh-list
139420727|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
139420728|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139420729|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139420730|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420731|NCT02738879|Incretins|incretins|mesh-ancestor
139420732|NCT02738879|Hormones|hormones|mesh-ancestor
139420733|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420734|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139420735|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
139420736|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420737|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420738|NCT03253913|Sirolimus|sirolimus|mesh-list
139420739|NCT03253913|Resveratrol|resveratrol|mesh-list
139420740|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139420741|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420742|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139420743|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420744|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
139420745|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139420746|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
139420747|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420748|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420749|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420750|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
139420751|NCT03253913|Protective Agents|protective agents|mesh-ancestor
139420752|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139420753|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
139420754|NCT03237819|Analgesics|analgesics|mesh-ancestor
139420755|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
139420756|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420757|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420758|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
139420759|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420760|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139420761|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
139420762|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139420763|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139420764|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420765|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139420766|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
139420767|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139420768|NCT03468907|Tenofovir|tenofovir|mesh-list
139420769|NCT03468907|Telbivudine|telbivudine|mesh-list
139420770|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
139420771|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420772|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139420773|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139420774|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420775|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420776|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139420777|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139420778|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
139077566|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139420779|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
139420780|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139420781|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139420782|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139420783|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139420784|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420785|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
139420786|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420787|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420788|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139420789|NCT05089851|Protective Agents|protective agents|mesh-ancestor
139420790|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
139420791|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139420798|NCT05350917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420799|NCT02311205|Sorafenib|sorafenib|mesh-list
139420800|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420801|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139420802|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420803|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420804|NCT05390749|Rituximab|rituximab|mesh-list
139420805|NCT05390749|Methotrexate|methotrexate|mesh-list
139420806|NCT05390749|Pomalidomide|pomalidomide|mesh-list
139420807|NCT05390749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139420808|NCT05390749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420809|NCT05390749|Immunologic Factors|immunologic factors|mesh-ancestor
139420810|NCT05390749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420811|NCT05390749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139420812|NCT05390749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139420813|NCT05390749|Abortifacient Agents|abortifacient agents|mesh-ancestor
139420814|NCT05390749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139420815|NCT05390749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139420816|NCT05390749|Antimetabolites|antimetabolites|mesh-ancestor
139061135|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139420817|NCT05390749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420818|NCT05390749|Dermatologic Agents|dermatologic agents|mesh-ancestor
139420819|NCT05390749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420820|NCT05390749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139420821|NCT05390749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139420822|NCT05390749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139420823|NCT05390749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139420824|NCT05390749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139420825|NCT05390749|Growth Substances|growth substances|mesh-ancestor
139420826|NCT05390749|Growth Inhibitors|growth inhibitors|mesh-ancestor
139420827|NCT03468829|Gontivimab|gontivimab|mesh-list
139420828|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
139420829|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420830|NCT04912791|Anesthetics|anesthetics|mesh-list
139420831|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420832|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420833|NCT02316197|Peposertib|peposertib|mesh-list
139420834|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139420835|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420836|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420837|NCT02314013|Metronidazole|metronidazole|mesh-list
139420838|NCT02314013|Cephalosporins|cephalosporins|mesh-list
139420839|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420840|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139420841|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139420842|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139420843|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
139420844|NCT01677195|Antacids|antacids|mesh-ancestor
139420845|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420846|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139420847|NCT05331807|Vitamin D|vitamin d|mesh-list
139420848|NCT05331807|Ergocalciferols|ergocalciferols|mesh-list
139420849|NCT05331807|Cholecalciferol|cholecalciferol|mesh-list
139420850|NCT05331807|Vitamins|vitamins|mesh-list
139420851|NCT05331807|Micronutrients|micronutrients|mesh-ancestor
139420852|NCT05331807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420853|NCT05331807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139420854|NCT05331807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139420855|NCT02314325|Factor VIII|factor viii|mesh-list
139420856|NCT02314325|Coagulants|coagulants|mesh-ancestor
139420862|NCT03502421|Ketamine|ketamine|mesh-list
139420863|NCT03502421|Analgesics|analgesics|mesh-ancestor
139420864|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
139420865|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420866|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420867|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139420869|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
139420870|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
139420871|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420872|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139420873|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139420874|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420875|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420876|NCT03502343|Paclitaxel|paclitaxel|mesh-list
139420877|NCT03502343|Gemcitabine|gemcitabine|mesh-list
139420878|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139420879|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420880|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
139420881|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
139420882|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
139420883|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420884|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139420885|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
139420886|NCT04345887|Spironolactone|spironolactone|mesh-list
139420887|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139420888|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
139420889|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420890|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420891|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139420892|NCT04345887|Diuretics|diuretics|mesh-ancestor
139420893|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
139420894|NCT02316899|Linaclotide|linaclotide|mesh-list
139420895|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139420896|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
139420897|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420898|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139420899|NCT02314871|Morphine|morphine|mesh-list
139420900|NCT02314871|Pirinitramide|pirinitramide|mesh-list
139420901|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139420902|NCT02314871|Narcotics|narcotics|mesh-ancestor
139420903|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420904|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420905|NCT02314871|Analgesics|analgesics|mesh-ancestor
139420906|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
139420907|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420908|NCT02224846|Tadalafil|tadalafil|mesh-list
139420909|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
139420910|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139420911|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139420912|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420913|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420914|NCT02224846|Urological Agents|urological agents|mesh-ancestor
139420915|NCT03470077|Nalbuphine|nalbuphine|mesh-list
139420916|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139420917|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420918|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139420919|NCT03470077|Narcotics|narcotics|mesh-ancestor
139420920|NCT03470077|Analgesics|analgesics|mesh-ancestor
139420921|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
139420922|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420923|NCT02224690|Cannabidiol|cannabidiol|mesh-list
139420924|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
139420925|NCT03501251|Albendazole|albendazole|mesh-list
139420926|NCT03501251|Moxidectin|moxidectin|mesh-list
139420927|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
139420928|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139420929|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139420930|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
139420931|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139420933|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
139420934|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
139420935|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
139420936|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420937|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420938|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
139420939|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
139420940|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
139420941|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420942|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139420943|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139420945|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420946|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420947|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139420948|NCT05390203|Testosterone|testosterone|mesh-list
139420949|NCT05390203|Androgens|androgens|mesh-ancestor
139420950|NCT05390203|Hormones|hormones|mesh-ancestor
139420951|NCT05390203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420952|NCT05390203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420953|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
139420954|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139420955|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
139420956|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420957|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420958|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139420959|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
139420960|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
139420961|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139420962|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
139420963|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139420964|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420965|NCT02315495|Saxagliptin|saxagliptin|mesh-list
139420966|NCT02315495|Acarbose|acarbose|mesh-list
139420967|NCT02315495|Incretins|incretins|mesh-ancestor
139420968|NCT02315495|Hormones|hormones|mesh-ancestor
139420969|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420970|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420971|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139420972|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
139420973|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139420974|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139420975|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139420976|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139420977|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
139420978|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139420979|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139420980|NCT02317601|Prednisolone|prednisolone|mesh-list
139420981|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
139420982|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139420983|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
139420984|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139420985|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
139420986|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
139420987|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139420988|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139420989|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139420990|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
139420991|NCT02317601|Hormones|hormones|mesh-ancestor
139420992|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139420993|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139420994|NCT02317601|Protective Agents|protective agents|mesh-ancestor
139420995|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139420996|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139420997|NCT05101785|Lidocaine|lidocaine|mesh-list
139420998|NCT05101785|Epinephrine|epinephrine|mesh-list
139420999|NCT05101785|Racepinephrine|racepinephrine|mesh-list
139421000|NCT05101785|Carticaine|carticaine|mesh-list
139421001|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
139421002|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
139421003|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
139421004|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139421005|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421006|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
139421007|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421008|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139421009|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139421010|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139421011|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139421012|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421013|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139421014|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139421015|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
139421016|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421017|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139421020|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139421021|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
139421022|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
139421023|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
139421024|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139421025|NCT02315573|Lidocaine|lidocaine|mesh-list
139421026|NCT02315573|Epinephrine|epinephrine|mesh-list
139421027|NCT02315573|Racepinephrine|racepinephrine|mesh-list
139421028|NCT02315573|Bupivacaine|bupivacaine|mesh-list
139421029|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
139421030|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
139421031|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
139061162|NCT01133470|Fexofenadine|fexofenadine|mesh-list
139421032|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139421033|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421034|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
139421035|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421036|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139421037|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139421038|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139421039|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139421040|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421041|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139421042|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139421043|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
139421044|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421045|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139421046|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139421047|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
139421048|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139421049|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
139421050|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
139421051|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
139421052|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139421053|NCT02724241|Nicotine|nicotine|mesh-list
139421054|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139421055|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
139421056|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421057|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421058|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139421059|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139421060|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
139421061|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421062|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421063|NCT02315651|Ubiquinone|ubiquinone|mesh-list
139421064|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
139421065|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
139421066|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421067|NCT02315651|Vitamins|vitamins|mesh-ancestor
139421068|NCT05366725|Avelumab|avelumab|mesh-list
139421069|NCT05366725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421070|NCT05366725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421071|NCT06230003|Ropivacaine|ropivacaine|mesh-list
139421072|NCT06230003|Anesthetics, Local|anesthetics, local|mesh-ancestor
139421073|NCT06230003|Anesthetics|anesthetics|mesh-ancestor
139421074|NCT06230003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139421075|NCT06230003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421076|NCT06230003|Sensory System Agents|sensory system agents|mesh-ancestor
139421077|NCT06230003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421078|NCT06229990|Furosemide|furosemide|mesh-list
139421079|NCT06229990|Diuretics|diuretics|mesh-ancestor
139421080|NCT06229990|Natriuretic Agents|natriuretic agents|mesh-ancestor
139421081|NCT06229990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421082|NCT06229990|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139421083|NCT06229990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139421084|NCT06229990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421086|NCT06229977|Analgesics|analgesics|mesh-ancestor
139421087|NCT06229977|Sensory System Agents|sensory system agents|mesh-ancestor
139421088|NCT06229977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421089|NCT06229977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421090|NCT06229977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139421091|NCT06229977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139421092|NCT06229977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139421093|NCT06229977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139421094|NCT06229977|Antiviral Agents|antiviral agents|mesh-ancestor
139421095|NCT06229977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139421096|NCT06229977|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139421097|NCT06229977|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139421098|NCT06229977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421099|NCT06229977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421100|NCT06229977|Hormones|hormones|mesh-ancestor
139421101|NCT06229977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139421102|NCT06229795|Metformin|metformin|mesh-list
139421103|NCT06229795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139421104|NCT06229795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421105|NCT06229678|Empagliflozin|empagliflozin|mesh-list
139421106|NCT06229678|Acipimox|acipimox|mesh-list
139421107|NCT06229678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139421108|NCT06229678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421109|NCT06229678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139421110|NCT06229678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421111|NCT06229678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139421112|NCT06229678|Antimetabolites|antimetabolites|mesh-ancestor
139421113|NCT06229678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139421114|NCT06229496|Paclitaxel|paclitaxel|mesh-list
139421115|NCT06229496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139421116|NCT06229496|Gemcitabine|gemcitabine|mesh-list
139421117|NCT06229496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139421118|NCT06229496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421119|NCT06229496|Tubulin Modulators|tubulin modulators|mesh-ancestor
139421120|NCT06229496|Antimitotic Agents|antimitotic agents|mesh-ancestor
139421121|NCT06229496|Mitosis Modulators|mitosis modulators|mesh-ancestor
139421122|NCT06229496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421123|NCT06229496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139421124|NCT06229496|Antimetabolites|antimetabolites|mesh-ancestor
139421125|NCT06229483|Tranexamic Acid|tranexamic acid|mesh-list
139421126|NCT06229483|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139421127|NCT06229483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139421128|NCT06229483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421129|NCT06229483|Hemostatics|hemostatics|mesh-ancestor
139421130|NCT06229483|Coagulants|coagulants|mesh-ancestor
139421131|NCT06229353|Vaccines|vaccines|mesh-list
139421132|NCT06229353|Immunologic Factors|immunologic factors|mesh-ancestor
139421133|NCT06229353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421134|NCT06229340|Hydroxychloroquine|hydroxychloroquine|mesh-list
139421135|NCT06229340|Bevacizumab|bevacizumab|mesh-list
139421136|NCT06229340|Leflunomide|leflunomide|mesh-list
139421137|NCT06229340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421138|NCT06229340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421139|NCT06229340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139421140|NCT06229340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139421141|NCT06229340|Growth Substances|growth substances|mesh-ancestor
139421142|NCT06229340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421143|NCT06229340|Growth Inhibitors|growth inhibitors|mesh-ancestor
139421144|NCT06229340|Antimalarials|antimalarials|mesh-ancestor
139421145|NCT06229340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139421146|NCT06229340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139421147|NCT06229340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139421148|NCT06229340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421149|NCT06229340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421150|NCT06229340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139421151|NCT06229340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139421152|NCT06229340|Immunologic Factors|immunologic factors|mesh-ancestor
139421153|NCT06229288|Amoxicillin|amoxicillin|mesh-list
139421154|NCT06229288|Clavulanic Acid|clavulanic acid|mesh-list
139421155|NCT06229288|Clavulanic Acids|clavulanic acids|mesh-list
139421156|NCT06229288|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139421157|NCT06229288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139421158|NCT06229288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139421159|NCT06229288|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139421160|NCT06229288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421161|NCT06229288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421163|NCT06229145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139421164|NCT06229145|Abortifacient Agents|abortifacient agents|mesh-ancestor
139421165|NCT06229145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139421166|NCT06229145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421167|NCT06229145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139421168|NCT06229145|Antimetabolites|antimetabolites|mesh-ancestor
139421175|NCT06229145|Immunologic Factors|immunologic factors|mesh-ancestor
139421176|NCT06229145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139421177|NCT06229145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139421178|NCT06229067|Cyclophosphamide|cyclophosphamide|mesh-list
139421179|NCT06229067|Capecitabine|capecitabine|mesh-list
139421180|NCT06229067|Vinorelbine|vinorelbine|mesh-list
139421181|NCT06229067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139421182|NCT06229067|Immunologic Factors|immunologic factors|mesh-ancestor
139421183|NCT06229067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421184|NCT06229067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139421185|NCT06229067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139421186|NCT06229067|Alkylating Agents|alkylating agents|mesh-ancestor
139421187|NCT06229067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421188|NCT06229067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421189|NCT06229067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139421190|NCT06229067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139421191|NCT06229067|Antimetabolites|antimetabolites|mesh-ancestor
139421192|NCT06229067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139421193|NCT06229067|Tubulin Modulators|tubulin modulators|mesh-ancestor
139421194|NCT06229067|Antimitotic Agents|antimitotic agents|mesh-ancestor
139421195|NCT06229067|Mitosis Modulators|mitosis modulators|mesh-ancestor
139421196|NCT06229054|Dexmedetomidine|dexmedetomidine|mesh-list
139421197|NCT06229054|Bupivacaine|bupivacaine|mesh-list
139421198|NCT06229054|Anesthetics, Local|anesthetics, local|mesh-ancestor
139421199|NCT06229054|Anesthetics|anesthetics|mesh-ancestor
139421200|NCT06229054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139421201|NCT06229054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421202|NCT06229054|Sensory System Agents|sensory system agents|mesh-ancestor
139421203|NCT06229054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421204|NCT06229054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139421205|NCT06229054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139421206|NCT06229054|Analgesics|analgesics|mesh-ancestor
139421207|NCT06229054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139421208|NCT06229054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139421209|NCT06229054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139421210|NCT06229054|Adrenergic Agents|adrenergic agents|mesh-ancestor
139421211|NCT06229054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421212|NCT06229054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421213|NCT06229041|Immunomodulating Agents|immunomodulating agents|mesh-list
139421214|NCT06229041|Immunologic Factors|immunologic factors|mesh-ancestor
139421215|NCT06229041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421222|NCT06228820|Aspirin|aspirin|mesh-list
139421223|NCT06228820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139421224|NCT06228820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139421225|NCT06228820|Analgesics|analgesics|mesh-ancestor
139421226|NCT06228820|Sensory System Agents|sensory system agents|mesh-ancestor
139421227|NCT06228820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421228|NCT06228820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421229|NCT06228820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139421230|NCT06228820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139421231|NCT06228820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139421232|NCT06228820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139421233|NCT06228820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421234|NCT06228820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139421235|NCT06228820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139421236|NCT06228820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421238|NCT06228677|Epinephrine|epinephrine|mesh-list
139421239|NCT06228677|Racepinephrine|racepinephrine|mesh-list
139421240|NCT06228677|Epinephryl borate|epinephryl borate|mesh-list
139421241|NCT06228677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139421242|NCT06228677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139421243|NCT06228677|Adrenergic Agents|adrenergic agents|mesh-ancestor
139421244|NCT06228677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421245|NCT06228677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421246|NCT06228677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421247|NCT06228677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139421248|NCT06228677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139421249|NCT06228677|Autonomic Agents|autonomic agents|mesh-ancestor
139421250|NCT06228677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421251|NCT06228677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139421252|NCT06228677|Respiratory System Agents|respiratory system agents|mesh-ancestor
139421253|NCT06228677|Mydriatics|mydriatics|mesh-ancestor
139421254|NCT06228677|Sympathomimetics|sympathomimetics|mesh-ancestor
139421255|NCT06228677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139421257|NCT06228586|Immunologic Factors|immunologic factors|mesh-ancestor
139421258|NCT06228586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421259|NCT06228560|Omalizumab|omalizumab|mesh-list
139421260|NCT06228560|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139421261|NCT06228560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139421262|NCT06228560|Respiratory System Agents|respiratory system agents|mesh-ancestor
139421263|NCT06228482|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
139421264|NCT06228482|Chelating Agents|chelating agents|mesh-ancestor
139421265|NCT06228482|Sequestering Agents|sequestering agents|mesh-ancestor
139421266|NCT06228482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421267|NCT06228456|Clopidogrel|clopidogrel|mesh-list
139421268|NCT06228456|Ticagrelor|ticagrelor|mesh-list
139421269|NCT06228456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139421270|NCT06228456|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139421271|NCT06228456|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139421272|NCT06228456|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139421273|NCT06228456|Purinergic Agents|purinergic agents|mesh-ancestor
139421274|NCT06228456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421275|NCT06228456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421276|NCT06228456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421277|NCT06228443|Leflunomide|leflunomide|mesh-list
139421278|NCT06228443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421279|NCT06228443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421280|NCT06228443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139421281|NCT06228443|Immunologic Factors|immunologic factors|mesh-ancestor
139421282|NCT06228443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421283|NCT06228430|Acyclovir|acyclovir|mesh-list
139421284|NCT06228430|Antiviral Agents|antiviral agents|mesh-ancestor
139421285|NCT06228430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139421286|NCT06228391|Midazolam|midazolam|mesh-list
139421287|NCT06228391|Ketamine|ketamine|mesh-list
139421288|NCT06228391|Analgesics|analgesics|mesh-ancestor
139421289|NCT06228391|Sensory System Agents|sensory system agents|mesh-ancestor
139421290|NCT06228391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421291|NCT06228391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421292|NCT06228391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139421293|NCT06228391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139421294|NCT06228391|Anesthetics, General|anesthetics, general|mesh-ancestor
139421295|NCT06228391|Anesthetics|anesthetics|mesh-ancestor
139421296|NCT06228391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139421297|NCT06228391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139421298|NCT06228391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139421299|NCT06228391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061195|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421300|NCT06228391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421301|NCT06228391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139421302|NCT06228391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139421303|NCT06228391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139421304|NCT06228391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139421305|NCT06228391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139421306|NCT06228391|GABA Modulators|gaba modulators|mesh-ancestor
139421307|NCT06228391|GABA Agents|gaba agents|mesh-ancestor
139421308|NCT06228339|Alfuzosin|alfuzosin|mesh-list
139421309|NCT06228339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139421310|NCT06228339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139421311|NCT06228339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139421312|NCT06228339|Adrenergic Agents|adrenergic agents|mesh-ancestor
139421313|NCT06228339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421314|NCT06228339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421315|NCT06228339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421316|NCT06228339|Urological Agents|urological agents|mesh-ancestor
139421317|NCT06228092|Glycopyrrolate|glycopyrrolate|mesh-list
139421321|NCT06228092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421322|NCT06228092|Cholinergic Agents|cholinergic agents|mesh-ancestor
139421323|NCT06228092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421324|NCT06228092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421325|NCT06228092|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139421326|NCT06228092|Autonomic Agents|autonomic agents|mesh-ancestor
139421327|NCT06228092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421328|NCT06228092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139421329|NCT06228092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139421330|NCT06228092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139421331|NCT06228079|Gemcitabine|gemcitabine|mesh-list
139421332|NCT06228079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139421333|NCT06228079|Antimetabolites|antimetabolites|mesh-ancestor
139421334|NCT06228079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421335|NCT06228079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421339|NCT06227988|Liver Extracts|liver extracts|mesh-list
139421340|NCT06227988|Hematinics|hematinics|mesh-ancestor
139421341|NCT06227910|Upadacitinib|upadacitinib|mesh-list
139421342|NCT06227910|Vedolizumab|vedolizumab|mesh-list
139421343|NCT06227910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139421344|NCT06227910|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139421345|NCT06227910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139421346|NCT06227910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061208|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
139421347|NCT06227910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421348|NCT06227910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139421349|NCT06227832|Metformin|metformin|mesh-list
139421350|NCT06227832|Clarithromycin|clarithromycin|mesh-list
139421351|NCT06227832|Midazolam|midazolam|mesh-list
139421352|NCT06227832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139421353|NCT06227832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421354|NCT06227832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139421355|NCT06227832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139421356|NCT06227832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139421357|NCT06227832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139421358|NCT06227832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139421359|NCT06227832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139421360|NCT06227832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139421361|NCT06227832|Anesthetics, General|anesthetics, general|mesh-ancestor
139421362|NCT06227832|Anesthetics|anesthetics|mesh-ancestor
139421363|NCT06227832|GABA Modulators|gaba modulators|mesh-ancestor
139421364|NCT06227832|GABA Agents|gaba agents|mesh-ancestor
139421365|NCT06227832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421366|NCT06227832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421367|NCT06227832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139421368|NCT06227832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139421369|NCT06227832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139421370|NCT06227832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421371|NCT06227832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139421372|NCT06227832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139421373|NCT06227689|Vaccines|vaccines|mesh-list
139421374|NCT06227689|Immunologic Factors|immunologic factors|mesh-ancestor
139421375|NCT06227689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421376|NCT06227624|Zinc Sulfate|zinc sulfate|mesh-list
139421377|NCT06227624|Astringents|astringents|mesh-ancestor
139421378|NCT06227624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078171|NCT00309985|Hormones|hormones|mesh-ancestor
139421379|NCT06227624|Dermatologic Agents|dermatologic agents|mesh-ancestor
139421381|NCT06227533|Mitosis Modulators|mitosis modulators|mesh-ancestor
139421382|NCT06227533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421383|NCT06227377|Cetuximab|cetuximab|mesh-list
139421384|NCT06227377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421385|NCT06227377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421386|NCT06226857|Cetuximab|cetuximab|mesh-list
139421387|NCT06226857|Panitumumab|panitumumab|mesh-list
139421388|NCT06226857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421389|NCT06226857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421390|NCT06226753|Anesthetics|anesthetics|mesh-list
139421391|NCT06226753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139421392|NCT06226753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421393|NCT06225947|Lemborexant|lemborexant|mesh-list
139421394|NCT06225947|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139421400|NCT06225947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421401|NCT06225492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139421402|NCT06225492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139421403|NCT06225492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139421404|NCT06225492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421405|NCT06225492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421406|NCT06225492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139421407|NCT06225492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139421408|NCT06225492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421409|NCT06225492|Cholinergic Agents|cholinergic agents|mesh-ancestor
139421410|NCT06225492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421412|NCT06224140|Anticoagulants|anticoagulants|mesh-ancestor
139421413|NCT06224140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139421414|NCT06224140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139421415|NCT06224140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421422|NCT06198686|Nalmefene|nalmefene|mesh-list
139421423|NCT06198686|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139421424|NCT06198686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421425|NCT06198686|Sensory System Agents|sensory system agents|mesh-ancestor
139421426|NCT06198686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421427|NCT06194864|Itraconazole|itraconazole|mesh-list
139421428|NCT06194864|Rifampin|rifampin|mesh-list
139421429|NCT06194864|Ecopipam|ecopipam|mesh-list
139421430|NCT06194864|Antifungal Agents|antifungal agents|mesh-ancestor
139421431|NCT06194864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139421432|NCT06194864|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139421433|NCT06194864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139421434|NCT06194864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421435|NCT06194864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421436|NCT06194864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139421437|NCT06194864|Hormone Antagonists|hormone antagonists|mesh-ancestor
139421438|NCT06194864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139421439|NCT06194864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421440|NCT06194864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139421441|NCT06194864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139421442|NCT06194864|Antitubercular Agents|antitubercular agents|mesh-ancestor
139421443|NCT06194864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139421444|NCT06194864|Leprostatic Agents|leprostatic agents|mesh-ancestor
139421445|NCT06194864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139421446|NCT06194864|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139421447|NCT06194864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139421448|NCT06194864|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139421449|NCT06194864|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139421450|NCT06194864|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139421451|NCT06194864|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139421452|NCT06194864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139421453|NCT06194864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139421454|NCT06194864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139421455|NCT06194864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139421456|NCT06194864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139421457|NCT06194864|Dopamine Agents|dopamine agents|mesh-ancestor
139421458|NCT06194864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421459|NCT06193811|Esomeprazole|esomeprazole|mesh-list
139421460|NCT06193811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139421461|NCT06193811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139421462|NCT06193811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139421463|NCT06193811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421464|NCT06193811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421465|NCT06192186|Oxaliplatin|oxaliplatin|mesh-list
138926142|NCT00690573|Adalimumab|adalimumab|mesh-list
139421511|NCT06132113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139421512|NCT06132113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421513|NCT06132113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421514|NCT06121349|Ofatumumab|ofatumumab|mesh-list
139421515|NCT06121349|Ocrelizumab|ocrelizumab|mesh-list
139421516|NCT06121349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421517|NCT06121349|Immunologic Factors|immunologic factors|mesh-ancestor
139421518|NCT06121349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421519|NCT06120504|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139421520|NCT06120504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421521|NCT06120504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421522|NCT06120504|Immunotoxins|immunotoxins|mesh-ancestor
139421523|NCT06120504|Immunoconjugates|immunoconjugates|mesh-ancestor
139078324|NCT00046930|Cytarabine|cytarabine|mesh-list
139421524|NCT06120504|Immunologic Factors|immunologic factors|mesh-ancestor
139061259|NCT03921736|Diuretics|diuretics|mesh-ancestor
139421525|NCT06120504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421563|NCT06088199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139421564|NCT06088199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139421566|NCT06088199|Sensory System Agents|sensory system agents|mesh-ancestor
139421567|NCT06088199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421568|NCT06088199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421569|NCT06088199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139421570|NCT06088199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139421571|NCT06088199|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139421572|NCT06088199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139421573|NCT06088199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421574|NCT06088199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421575|NCT06081946|Histamine|histamine|mesh-list
139421576|NCT06081946|Histamine Agonists|histamine agonists|mesh-ancestor
139421577|NCT06081946|Histamine Agents|histamine agents|mesh-ancestor
139421578|NCT06081946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421579|NCT06081946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421580|NCT06081946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421581|NCT06075095|Budesonide|budesonide|mesh-list
139421582|NCT06075095|Glycopyrrolate|glycopyrrolate|mesh-list
139421583|NCT06075095|Formoterol Fumarate|formoterol fumarate|mesh-list
139421584|NCT06075095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139421585|NCT06075095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139421586|NCT06075095|Autonomic Agents|autonomic agents|mesh-ancestor
139421587|NCT06075095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421588|NCT06075095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421589|NCT06075095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139421590|NCT06075095|Respiratory System Agents|respiratory system agents|mesh-ancestor
139421591|NCT06075095|Glucocorticoids|glucocorticoids|mesh-ancestor
139421592|NCT06075095|Hormones|hormones|mesh-ancestor
139421593|NCT06075095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139421594|NCT06075095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139421595|NCT06075095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139421596|NCT06075095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139421597|NCT06075095|Adrenergic Agents|adrenergic agents|mesh-ancestor
139078398|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139421598|NCT06075095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421599|NCT06075095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421600|NCT06075095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139421601|NCT06075095|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139421602|NCT06075095|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139421603|NCT06075095|Cholinergic Agents|cholinergic agents|mesh-ancestor
139421609|NCT06065748|Fulvestrant|fulvestrant|mesh-list
139421610|NCT06065748|Palbociclib|palbociclib|mesh-list
139421621|NCT06054555|Nivolumab|nivolumab|mesh-list
139421622|NCT06054555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421623|NCT06054555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421624|NCT06054555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139421625|NCT06054555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421626|NCT06046287|Daratumumab|daratumumab|mesh-list
139421627|NCT06046287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421645|NCT06030193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139421646|NCT06030193|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139421647|NCT06021678|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139421648|NCT06021678|Immunologic Factors|immunologic factors|mesh-ancestor
139421649|NCT06021678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421658|NCT05997901|Varenicline|varenicline|mesh-list
139421659|NCT05997901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139421660|NCT05997901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139421661|NCT05997901|Cholinergic Agents|cholinergic agents|mesh-ancestor
139421662|NCT05997901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421663|NCT05997901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421664|NCT05997901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421668|NCT05991284|Valsartan|valsartan|mesh-list
139061266|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
139421669|NCT05991284|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139421670|NCT05991284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139421671|NCT05991284|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139421672|NCT05991284|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139421673|NCT05991284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421674|NCT05987241|Nivolumab|nivolumab|mesh-list
139421675|NCT05987241|Relatlimab|relatlimab|mesh-list
139421676|NCT05987241|Immunoglobulins|immunoglobulins|mesh-list
139421677|NCT05987241|Immunoglobulin G|immunoglobulin g|mesh-list
139421678|NCT05987241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421679|NCT05987241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421680|NCT05987241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139421681|NCT05987241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421682|NCT05987241|Immunologic Factors|immunologic factors|mesh-ancestor
139421695|NCT05957367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421696|NCT05957367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421697|NCT05954624|Itraconazole|itraconazole|mesh-list
139421698|NCT05954624|Probenecid|probenecid|mesh-list
139421699|NCT05954624|Digoxin|digoxin|mesh-list
139421700|NCT05954624|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139421701|NCT05954624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139421702|NCT05954624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139421703|NCT05954624|Antimetabolites|antimetabolites|mesh-ancestor
139421704|NCT05954624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421705|NCT05954624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139421706|NCT05954624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139421707|NCT05954624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421708|NCT05954624|Antifungal Agents|antifungal agents|mesh-ancestor
139421709|NCT05954624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139421710|NCT05954624|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139421711|NCT05954624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139421712|NCT05954624|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139421713|NCT05954624|Hormone Antagonists|hormone antagonists|mesh-ancestor
139421714|NCT05954624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139421715|NCT05954624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421716|NCT05954624|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139421717|NCT05954624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139421718|NCT05954624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139421719|NCT05954624|Protective Agents|protective agents|mesh-ancestor
139421720|NCT05954624|Uricosuric Agents|uricosuric agents|mesh-ancestor
139421721|NCT05954624|Gout Suppressants|gout suppressants|mesh-ancestor
139421722|NCT05954624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139421723|NCT05948579|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
139421724|NCT05948579|Antidepressive Agents|antidepressive agents|mesh-ancestor
139421725|NCT05948579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139421726|NCT05948579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139421727|NCT05948579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139421728|NCT05948579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139421729|NCT05948579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421730|NCT05948579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421731|NCT05948579|Serotonin Agents|serotonin agents|mesh-ancestor
139421732|NCT05948579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421733|NCT05948579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139421734|NCT05948579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139421735|NCT05948553|Fluoxetine|fluoxetine|mesh-list
139421736|NCT05948553|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139421737|NCT05948553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139421738|NCT05948553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139421739|NCT05948553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421740|NCT05948553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421741|NCT05948553|Serotonin Agents|serotonin agents|mesh-ancestor
139078552|NCT03955978|Dostarlimab|dostarlimab|mesh-list
139421742|NCT05948553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421743|NCT05948553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139421744|NCT05948553|Antidepressive Agents|antidepressive agents|mesh-ancestor
139421745|NCT05948553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139421746|NCT05948553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139421747|NCT05948553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139421748|NCT05948553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421749|NCT05924672|Diphosphonates|diphosphonates|mesh-list
139421750|NCT05924672|Methylene diphosphonate|methylene diphosphonate|mesh-list
139421751|NCT05924672|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139421752|NCT05924672|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
139421753|NCT05924672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421754|NCT05924672|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139421755|NCT05924672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421756|NCT05924672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139421757|NCT05924672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421759|NCT05920356|Sotorasib|sotorasib|mesh-list
139421760|NCT05920356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421761|NCT05920356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421762|NCT05920356|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139421763|NCT05920356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421766|NCT05907122|Nivolumab|nivolumab|mesh-list
139421767|NCT05907122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421768|NCT05907122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421769|NCT05907122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139421770|NCT05907122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421771|NCT05904080|Nivolumab|nivolumab|mesh-list
139421772|NCT05904080|Ipilimumab|ipilimumab|mesh-list
139421773|NCT05904080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421774|NCT05904080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421775|NCT05904080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139421776|NCT05904080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421777|NCT05899816|KHK4083|khk4083|mesh-list
139421778|NCT05899816|Dermatologic Agents|dermatologic agents|mesh-ancestor
139421779|NCT05899608|Pembrolizumab|pembrolizumab|mesh-list
139421780|NCT05899608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421781|NCT05899608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421782|NCT05899608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139421783|NCT05899608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421796|NCT05891119|Vitamin K|vitamin k|mesh-list
139421797|NCT05891119|Metoprolol|metoprolol|mesh-list
139421798|NCT05891119|Midazolam|midazolam|mesh-list
139421799|NCT05891119|Caffeine|caffeine|mesh-list
139421800|NCT05891119|Caffeine citrate|caffeine citrate|mesh-list
139421801|NCT05891119|Omeprazole|omeprazole|mesh-list
139421802|NCT05891119|Warfarin|warfarin|mesh-list
139421803|NCT05891119|Vitamins|vitamins|mesh-ancestor
139421804|NCT05891119|Micronutrients|micronutrients|mesh-ancestor
139421805|NCT05891119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421806|NCT05891119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139421807|NCT05891119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139421808|NCT05891119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139421809|NCT05891119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139421810|NCT05891119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139421811|NCT05891119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139421812|NCT05891119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139421813|NCT05891119|Anesthetics, General|anesthetics, general|mesh-ancestor
139421814|NCT05891119|Anesthetics|anesthetics|mesh-ancestor
139421815|NCT05891119|GABA Modulators|gaba modulators|mesh-ancestor
139421816|NCT05891119|GABA Agents|gaba agents|mesh-ancestor
139421817|NCT05891119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421818|NCT05891119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421819|NCT05891119|Anticoagulants|anticoagulants|mesh-ancestor
139421820|NCT05891119|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139421821|NCT05891119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139421822|NCT05891119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139421823|NCT05891119|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139421824|NCT05891119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139421825|NCT05891119|Purinergic Agents|purinergic agents|mesh-ancestor
139421826|NCT05891119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139421827|NCT05891119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139421828|NCT05891119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139061282|NCT01231594|Trametinib|trametinib|mesh-list
139421844|NCT05886036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139421845|NCT05886036|Antibodies|antibodies|mesh-list
139421846|NCT05886036|Immunoglobulins|immunoglobulins|mesh-list
139421847|NCT05886036|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139421848|NCT05886036|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139421849|NCT05886036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139421850|NCT05886036|Immunologic Factors|immunologic factors|mesh-ancestor
139421851|NCT05886036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421852|NCT05886036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421853|NCT05886036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139421854|NCT05886036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139421855|NCT05886036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421856|NCT05886036|Antimetabolites|antimetabolites|mesh-ancestor
139421857|NCT05886036|Antiviral Agents|antiviral agents|mesh-ancestor
139421858|NCT05886036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139421864|NCT05872932|Botulinum Toxins|botulinum toxins|mesh-list
139421865|NCT05872932|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139421866|NCT05872932|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139421867|NCT05872932|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139421868|NCT05872932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139421869|NCT05872932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421870|NCT05872932|Cholinergic Agents|cholinergic agents|mesh-ancestor
139421871|NCT05872932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139421872|NCT05872932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421873|NCT05872932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139421874|NCT05872932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421890|NCT05840718|Thiamine|thiamine|mesh-list
139421891|NCT05840718|Vitamin B Complex|vitamin b complex|mesh-ancestor
139421892|NCT05840718|Vitamins|vitamins|mesh-ancestor
139421893|NCT05840718|Micronutrients|micronutrients|mesh-ancestor
139421894|NCT05840718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421895|NCT05837624|Drospirenone|drospirenone|mesh-list
139421896|NCT05837624|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139421897|NCT05837624|Hormone Antagonists|hormone antagonists|mesh-ancestor
139421898|NCT05837624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139421899|NCT05837624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421900|NCT05837624|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139421901|NCT05837624|Diuretics|diuretics|mesh-ancestor
139421902|NCT05837624|Natriuretic Agents|natriuretic agents|mesh-ancestor
139421903|NCT05818150|Methylprednisolone|methylprednisolone|mesh-list
139421944|NCT05773274|Immunologic Factors|immunologic factors|mesh-ancestor
139421945|NCT05773274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421946|NCT05773274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421947|NCT05773274|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139421948|NCT05766371|Pembrolizumab|pembrolizumab|mesh-list
139421949|NCT05766371|177Lu-PSMA-617|177lu-psma-617|mesh-list
139421950|NCT05766371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421951|NCT05766371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421952|NCT05766371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139421953|NCT05766371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139421954|NCT05766371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139421955|NCT05757843|Durvalumab|durvalumab|mesh-list
139421956|NCT05757843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139421957|NCT05757843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139421973|NCT05711940|Psilocybin|psilocybin|mesh-list
139421974|NCT05711940|Hallucinogens|hallucinogens|mesh-ancestor
139421975|NCT05711940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421976|NCT05711940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139421977|NCT05696093|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138926658|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
139421978|NCT05696093|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139421979|NCT05696093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139421980|NCT05696093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139421981|NCT05696093|Antimalarials|antimalarials|mesh-ancestor
139421982|NCT05696093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139421983|NCT05696093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139421984|NCT05685225|Acetaminophen|acetaminophen|mesh-list
139421986|NCT05685225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139421987|NCT05685225|Analgesics|analgesics|mesh-ancestor
139421988|NCT05685225|Sensory System Agents|sensory system agents|mesh-ancestor
139421989|NCT05685225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139421990|NCT05685225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139421991|NCT05685225|Antipyretics|antipyretics|mesh-ancestor
139421992|NCT05685225|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139421993|NCT05685225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139421994|NCT05683574|Etoricoxib|etoricoxib|mesh-list
139421995|NCT05683574|Amitriptyline|amitriptyline|mesh-list
139421996|NCT05683574|Cyclobenzaprine|cyclobenzaprine|mesh-list
139421997|NCT05683574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139421998|NCT05683574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139421999|NCT05683574|Analgesics|analgesics|mesh-ancestor
139422000|NCT05683574|Sensory System Agents|sensory system agents|mesh-ancestor
139422001|NCT05683574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139422002|NCT05683574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422003|NCT05683574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139422004|NCT05683574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139422005|NCT05683574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139422006|NCT05683574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139422007|NCT05683574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422008|NCT05683574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422009|NCT05683574|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139422010|NCT05683574|Antidepressive Agents|antidepressive agents|mesh-ancestor
139422011|NCT05683574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139422012|NCT05683574|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139422013|NCT05683574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139422014|NCT05683574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139422015|NCT05683574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139422016|NCT05683574|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139422017|NCT05683574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139422018|NCT05683574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139422019|NCT05683574|Adrenergic Agents|adrenergic agents|mesh-ancestor
139422020|NCT05683574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139422021|NCT05675410|Deoxyglucose|deoxyglucose|mesh-list
139422022|NCT05675410|Prednisone|prednisone|mesh-list
139422023|NCT05675410|Prednisolone|prednisolone|mesh-list
139422024|NCT05675410|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139422025|NCT05675410|Methylprednisolone|methylprednisolone|mesh-list
139422026|NCT05675410|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139422027|NCT05675410|Prednisolone acetate|prednisolone acetate|mesh-list
139422028|NCT05675410|Hydrocortisone|hydrocortisone|mesh-list
139422029|NCT05675410|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139422030|NCT05675410|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139422031|NCT05675410|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139422032|NCT05675410|Cortisone|cortisone|mesh-list
139422033|NCT05675410|Cyclophosphamide|cyclophosphamide|mesh-list
139422034|NCT05675410|Dacarbazine|dacarbazine|mesh-list
139422035|NCT05675410|Doxorubicin|doxorubicin|mesh-list
139422036|NCT05675410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139422037|NCT05675410|Nivolumab|nivolumab|mesh-list
139422038|NCT05675410|Etoposide|etoposide|mesh-list
139422039|NCT05675410|Etoposide phosphate|etoposide phosphate|mesh-list
139078847|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
139422040|NCT05675410|Vincristine|vincristine|mesh-list
139422041|NCT05675410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139422042|NCT05675410|Bleomycin|bleomycin|mesh-list
139422043|NCT05675410|Vinblastine|vinblastine|mesh-list
139422044|NCT05675410|Podophyllotoxin|podophyllotoxin|mesh-list
139422045|NCT05675410|Procarbazine|procarbazine|mesh-list
139422046|NCT05675410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139422048|NCT05675410|Immunoglobulins|immunoglobulins|mesh-list
139422049|NCT05675410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139422050|NCT05675410|Imidazole|imidazole|mesh-list
139422051|NCT05675410|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139422052|NCT05675410|Prednisolone phosphate|prednisolone phosphate|mesh-list
139422053|NCT05675410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139422054|NCT05675410|Immunoconjugates|immunoconjugates|mesh-list
139422055|NCT05675410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139422056|NCT05675410|Immunologic Factors|immunologic factors|mesh-ancestor
139422067|NCT05675410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422068|NCT05675410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139422069|NCT05675410|Glucocorticoids|glucocorticoids|mesh-ancestor
139422071|NCT05675410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139422072|NCT05675410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139422073|NCT05675410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422074|NCT05675410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139422075|NCT05675410|Tubulin Modulators|tubulin modulators|mesh-ancestor
139422076|NCT05675410|Antimitotic Agents|antimitotic agents|mesh-ancestor
139422077|NCT05675410|Mitosis Modulators|mitosis modulators|mesh-ancestor
139422078|NCT05675410|Antiemetics|antiemetics|mesh-ancestor
139422079|NCT05675410|Autonomic Agents|autonomic agents|mesh-ancestor
139422080|NCT05675410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139422081|NCT05675410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139422082|NCT05675410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139422083|NCT05675410|Protective Agents|protective agents|mesh-ancestor
139422084|NCT05675410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139422085|NCT05675410|Immunotoxins|immunotoxins|mesh-ancestor
139422086|NCT05675410|Keratolytic Agents|keratolytic agents|mesh-ancestor
139422087|NCT05675410|Dermatologic Agents|dermatologic agents|mesh-ancestor
139422088|NCT05675410|Antimetabolites|antimetabolites|mesh-ancestor
139422089|NCT05675410|Antiviral Agents|antiviral agents|mesh-ancestor
139422090|NCT05675410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139422107|NCT05622708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139422108|NCT05622708|Immunologic Factors|immunologic factors|mesh-ancestor
139422109|NCT05622708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422110|NCT05618925|Cyclophosphamide|cyclophosphamide|mesh-list
139422111|NCT05618925|Rituximab|rituximab|mesh-list
139422112|NCT05618925|Fludarabine|fludarabine|mesh-list
139422113|NCT05618925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139422114|NCT05618925|Immunologic Factors|immunologic factors|mesh-ancestor
139422115|NCT05618925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422116|NCT05618925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139422117|NCT05618925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139422118|NCT05618925|Alkylating Agents|alkylating agents|mesh-ancestor
139422119|NCT05618925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422120|NCT05618925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422121|NCT05618925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139422122|NCT05618925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422123|NCT05610826|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139422124|NCT05610826|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139422125|NCT05610826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422127|NCT05607004|Goserelin|goserelin|mesh-list
139422128|NCT05607004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422129|NCT05607004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139422130|NCT05607004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139422131|NCT05607004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422132|NCT05607004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422133|NCT05607004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139422134|NCT05607004|Hormone Antagonists|hormone antagonists|mesh-ancestor
139422135|NCT05607004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139422136|NCT05607004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422137|NCT05607004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139422139|NCT05605964|Relugolix|relugolix|mesh-list
139422140|NCT05605964|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139422141|NCT05605964|Fertility Agents|fertility agents|mesh-ancestor
139422142|NCT05605964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139422143|NCT05605964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422144|NCT05605964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139422145|NCT05605964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422146|NCT05605964|Androgen Antagonists|androgen antagonists|mesh-ancestor
139422147|NCT05605964|Hormone Antagonists|hormone antagonists|mesh-ancestor
139422148|NCT05605964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139422179|NCT05564403|Calcium, Dietary|calcium, dietary|mesh-list
139422180|NCT05564403|Leucovorin|leucovorin|mesh-list
139422181|NCT05564403|Folic Acid|folic acid|mesh-list
139422182|NCT05564403|Fluorouracil|fluorouracil|mesh-list
139422183|NCT05564403|Oxaliplatin|oxaliplatin|mesh-list
139422184|NCT05564403|Calcium|calcium|mesh-list
139422185|NCT05564403|Levoleucovorin|levoleucovorin|mesh-list
139422186|NCT05564403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139422187|NCT05564403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422188|NCT05564403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139422189|NCT05564403|Antimetabolites|antimetabolites|mesh-ancestor
139422190|NCT05564403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422191|NCT05564403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139422192|NCT05564403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422193|NCT05564403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139422194|NCT05564403|Immunologic Factors|immunologic factors|mesh-ancestor
139422195|NCT05564403|Antidotes|antidotes|mesh-ancestor
139422196|NCT05564403|Protective Agents|protective agents|mesh-ancestor
139422197|NCT05564403|Vitamin B Complex|vitamin b complex|mesh-ancestor
139422199|NCT05564403|Micronutrients|micronutrients|mesh-ancestor
139422200|NCT05564403|Hematinics|hematinics|mesh-ancestor
139422201|NCT05564377|Leucovorin|leucovorin|mesh-list
139422202|NCT05564377|Paclitaxel|paclitaxel|mesh-list
139422203|NCT05564377|Fluorouracil|fluorouracil|mesh-list
139422204|NCT05564377|Oxaliplatin|oxaliplatin|mesh-list
139422205|NCT05564377|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139422206|NCT05564377|Fulvestrant|fulvestrant|mesh-list
139422207|NCT05564377|Olaparib|olaparib|mesh-list
139422208|NCT05564377|Palbociclib|palbociclib|mesh-list
139422209|NCT05564377|Panitumumab|panitumumab|mesh-list
139422210|NCT05564377|Ipatasertib|ipatasertib|mesh-list
139422211|NCT05564377|Sotorasib|sotorasib|mesh-list
139422212|NCT05564377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139422213|NCT05564377|Antibodies|antibodies|mesh-list
139422214|NCT05564377|Immunoglobulins|immunoglobulins|mesh-list
139422215|NCT05564377|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139422216|NCT05564377|Maleic acid|maleic acid|mesh-list
139422217|NCT05564377|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
139422218|NCT05564377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139422219|NCT05564377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422220|NCT05564377|Tubulin Modulators|tubulin modulators|mesh-ancestor
139422221|NCT05564377|Antimitotic Agents|antimitotic agents|mesh-ancestor
139422222|NCT05564377|Mitosis Modulators|mitosis modulators|mesh-ancestor
139422223|NCT05564377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422224|NCT05564377|Immunologic Factors|immunologic factors|mesh-ancestor
139422225|NCT05564377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422226|NCT05564377|Antimetabolites|antimetabolites|mesh-ancestor
139422227|NCT05564377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139422228|NCT05564377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139422229|NCT05564377|Antidotes|antidotes|mesh-ancestor
139422230|NCT05564377|Protective Agents|protective agents|mesh-ancestor
139422231|NCT05564377|Vitamin B Complex|vitamin b complex|mesh-ancestor
139422232|NCT05564377|Vitamins|vitamins|mesh-ancestor
139422233|NCT05564377|Micronutrients|micronutrients|mesh-ancestor
139422234|NCT05564377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139422235|NCT05564377|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139422236|NCT05564377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139422237|NCT05564377|Hormone Antagonists|hormone antagonists|mesh-ancestor
139422238|NCT05564377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139422239|NCT05564377|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139422240|NCT05564377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422241|NCT05564377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139422242|NCT05564377|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422243|NCT05556746|Rifampin|rifampin|mesh-list
139422244|NCT05556746|Clofazimine|clofazimine|mesh-list
139422245|NCT05556746|Isoniazid|isoniazid|mesh-list
139422246|NCT05556746|Pyrazinamide|pyrazinamide|mesh-list
139422247|NCT05556746|Ethambutol|ethambutol|mesh-list
139422248|NCT05556746|Bedaquiline|bedaquiline|mesh-list
139422249|NCT05556746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139422250|NCT05556746|Antitubercular Agents|antitubercular agents|mesh-ancestor
139422251|NCT05556746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139422252|NCT05556746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139422253|NCT05556746|Leprostatic Agents|leprostatic agents|mesh-ancestor
139422254|NCT05556746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139422255|NCT05556746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422256|NCT05556746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422257|NCT05556746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139422258|NCT05556746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139422259|NCT05556746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139422260|NCT05556746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139422261|NCT05556746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139422262|NCT05556746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139422263|NCT05556746|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139422264|NCT05556746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139422265|NCT05556746|Antimetabolites|antimetabolites|mesh-ancestor
139422266|NCT05556746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139422267|NCT05556746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139422268|NCT05554367|Palbociclib|palbociclib|mesh-list
139422269|NCT05554367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422270|NCT05554367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139422271|NCT05554367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079072|NCT03469258|Pancreatin|pancreatin|mesh-list
139422272|NCT05554367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422273|NCT05539872|Insulin|insulin|mesh-list
139422274|NCT05539872|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139422275|NCT05539872|Insulin Aspart|insulin aspart|mesh-list
139422276|NCT05539872|Insulin, Long-Acting|insulin, long-acting|mesh-list
139422277|NCT05539872|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139422278|NCT05539872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139422279|NCT05539872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422280|NCT05537740|Pembrolizumab|pembrolizumab|mesh-list
139422281|NCT05537740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422282|NCT05537740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422283|NCT05537740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422284|NCT05537740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422285|NCT05513001|Remibrutinib|remibrutinib|mesh-list
139422286|NCT05513001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139422287|NCT05513001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422288|NCT05513001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422289|NCT05501756|Alemtuzumab|alemtuzumab|mesh-list
139422290|NCT05501756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422291|NCT05501756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422292|NCT05482893|Paclitaxel|paclitaxel|mesh-list
139422293|NCT05482893|Gemcitabine|gemcitabine|mesh-list
139422294|NCT05482893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139422295|NCT05482893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139422296|NCT05482893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422297|NCT05482893|Tubulin Modulators|tubulin modulators|mesh-ancestor
139422298|NCT05482893|Antimitotic Agents|antimitotic agents|mesh-ancestor
139422299|NCT05482893|Mitosis Modulators|mitosis modulators|mesh-ancestor
139422300|NCT05482893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422301|NCT05482893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139422302|NCT05482893|Antimetabolites|antimetabolites|mesh-ancestor
139422303|NCT05468619|Valacyclovir|valacyclovir|mesh-list
139422304|NCT05468619|Antiviral Agents|antiviral agents|mesh-ancestor
139422305|NCT05468619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139422306|NCT05463848|Pembrolizumab|pembrolizumab|mesh-list
139422307|NCT05463848|Temozolomide|temozolomide|mesh-list
139422308|NCT05463848|Olaparib|olaparib|mesh-list
139422309|NCT05463848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422310|NCT05463848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422311|NCT05463848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422312|NCT05463848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422313|NCT05463848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139422314|NCT05463848|Alkylating Agents|alkylating agents|mesh-ancestor
139422315|NCT05463848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139422316|NCT05463848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422317|NCT05456490|Bupivacaine|bupivacaine|mesh-list
139422318|NCT05456490|Anesthetics, Local|anesthetics, local|mesh-ancestor
139422319|NCT05456490|Anesthetics|anesthetics|mesh-ancestor
139422320|NCT05456490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139422321|NCT05456490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422322|NCT05456490|Sensory System Agents|sensory system agents|mesh-ancestor
139422323|NCT05456490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139422324|NCT05431322|Dexmedetomidine|dexmedetomidine|mesh-list
139422325|NCT05431322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139422326|NCT05431322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139422327|NCT05431322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422328|NCT05431322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139422329|NCT05431322|Analgesics|analgesics|mesh-ancestor
139422330|NCT05431322|Sensory System Agents|sensory system agents|mesh-ancestor
139422331|NCT05431322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139422332|NCT05431322|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139422333|NCT05431322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139422334|NCT05431322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139422335|NCT05431322|Adrenergic Agents|adrenergic agents|mesh-ancestor
139422336|NCT05431322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139422337|NCT05431322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422338|NCT05431270|Tislelizumab|tislelizumab|mesh-list
139422339|NCT05431270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422340|NCT05431270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422341|NCT05422612|Fluoxetine|fluoxetine|mesh-list
139422342|NCT05422612|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
139422343|NCT05422612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139422344|NCT05422612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139061474|NCT05195944|Hormones|hormones|mesh-ancestor
139422345|NCT05422612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139422346|NCT05422612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422347|NCT05422612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139422348|NCT05422612|Serotonin Agents|serotonin agents|mesh-ancestor
139422349|NCT05422612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422350|NCT05422612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139422351|NCT05422612|Antidepressive Agents|antidepressive agents|mesh-ancestor
139422352|NCT05422612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139422353|NCT05422612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139422354|NCT05422612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139422355|NCT05422612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422356|NCT05422612|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139422361|NCT05411081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422362|NCT05411081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422363|NCT05411081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422364|NCT05411081|Immunologic Factors|immunologic factors|mesh-ancestor
139422365|NCT05411081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422377|NCT05406622|Sirolimus|sirolimus|mesh-list
139422378|NCT05406622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139422379|NCT05406622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139422380|NCT05406622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139422381|NCT05406622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422382|NCT05406622|Antifungal Agents|antifungal agents|mesh-ancestor
139422383|NCT05406622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139422384|NCT05406622|Immunologic Factors|immunologic factors|mesh-ancestor
139422385|NCT05406622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422386|NCT05378425|Pembrolizumab|pembrolizumab|mesh-list
139422387|NCT05378425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422388|NCT05378425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422389|NCT05378425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422390|NCT05378425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422395|NCT05325866|Bemarituzumab|bemarituzumab|mesh-list
139422396|NCT05325866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422397|NCT05325866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422398|NCT05282901|Pembrolizumab|pembrolizumab|mesh-list
139422399|NCT05282901|Lenvatinib|lenvatinib|mesh-list
139422400|NCT05282901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422401|NCT05282901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422402|NCT05282901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422403|NCT05282901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422404|NCT05282901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139422405|NCT05282901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422406|NCT05281510|Vesatolimod|vesatolimod|mesh-list
139422407|NCT05281510|Antiviral Agents|antiviral agents|mesh-ancestor
139422408|NCT05281510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139422409|NCT05281471|Paclitaxel|paclitaxel|mesh-list
139422410|NCT05281471|Docetaxel|docetaxel|mesh-list
139422411|NCT05281471|Bevacizumab|bevacizumab|mesh-list
139422412|NCT05281471|Carboplatin|carboplatin|mesh-list
139422413|NCT05281471|Gemcitabine|gemcitabine|mesh-list
139422414|NCT05281471|Doxorubicin|doxorubicin|mesh-list
139422415|NCT05281471|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139422416|NCT05281471|Taxane|taxane|mesh-list
139422417|NCT05281471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139422418|NCT05281471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422419|NCT05281471|Tubulin Modulators|tubulin modulators|mesh-ancestor
139422420|NCT05281471|Antimitotic Agents|antimitotic agents|mesh-ancestor
139422421|NCT05281471|Mitosis Modulators|mitosis modulators|mesh-ancestor
139422422|NCT05281471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422423|NCT05281471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422424|NCT05281471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139422425|NCT05281471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139422426|NCT05281471|Growth Substances|growth substances|mesh-ancestor
139422427|NCT05281471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422428|NCT05281471|Growth Inhibitors|growth inhibitors|mesh-ancestor
139422429|NCT05281471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139422430|NCT05281471|Antimetabolites|antimetabolites|mesh-ancestor
139422431|NCT05281471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139422432|NCT05281471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139422434|NCT05281471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422435|NCT05271318|Pembrolizumab|pembrolizumab|mesh-list
139422436|NCT05271318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422437|NCT05271318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422438|NCT05271318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422439|NCT05271318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422440|NCT05266066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139422441|NCT05266066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139422442|NCT05266066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139422443|NCT05266066|Antitubercular Agents|antitubercular agents|mesh-ancestor
139422444|NCT05257408|Paclitaxel|paclitaxel|mesh-list
139422445|NCT05257408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139422446|NCT05257408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139422447|NCT05257408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422448|NCT05257408|Tubulin Modulators|tubulin modulators|mesh-ancestor
139422449|NCT05257408|Antimitotic Agents|antimitotic agents|mesh-ancestor
139422450|NCT05257408|Mitosis Modulators|mitosis modulators|mesh-ancestor
139422451|NCT05257408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422452|NCT05256745|Paclitaxel|paclitaxel|mesh-list
139422453|NCT05256745|Docetaxel|docetaxel|mesh-list
139422454|NCT05256745|Cyclophosphamide|cyclophosphamide|mesh-list
139422455|NCT05256745|Carboplatin|carboplatin|mesh-list
139422456|NCT05256745|Doxorubicin|doxorubicin|mesh-list
139422457|NCT05256745|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139422458|NCT05256745|Trastuzumab|trastuzumab|mesh-list
139422459|NCT05256745|Pertuzumab|pertuzumab|mesh-list
139422460|NCT05256745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139422461|NCT05256745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422462|NCT05256745|Tubulin Modulators|tubulin modulators|mesh-ancestor
139422463|NCT05256745|Antimitotic Agents|antimitotic agents|mesh-ancestor
139422464|NCT05256745|Mitosis Modulators|mitosis modulators|mesh-ancestor
139422465|NCT05256745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422466|NCT05256745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139422467|NCT05256745|Immunologic Factors|immunologic factors|mesh-ancestor
139422468|NCT05256745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422469|NCT05256745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139422470|NCT05256745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139422471|NCT05256745|Alkylating Agents|alkylating agents|mesh-ancestor
139422472|NCT05256745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139422473|NCT05256745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139422474|NCT05256745|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139422475|NCT05256745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139422476|NCT05256745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422477|NCT05256745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422478|NCT05209984|Topiramate|topiramate|mesh-list
139422479|NCT05209984|Sibutramine|sibutramine|mesh-list
139422480|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
139422481|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139422482|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422483|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
139422484|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139422485|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
139422486|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139422487|NCT05200442|Cetuximab|cetuximab|mesh-list
139422488|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422489|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422490|NCT05185999|Icodextrin|icodextrin|mesh-list
139422491|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
139422492|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139422493|NCT05179005|Imidacloprid|imidacloprid|mesh-list
139422494|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
139422495|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139422496|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079300|NCT00031694|Paclitaxel|paclitaxel|mesh-list
139422497|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422498|NCT05176925|Tislelizumab|tislelizumab|mesh-list
139422499|NCT05176925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422500|NCT05176925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422501|NCT05147272|Gemcitabine|gemcitabine|mesh-list
139422502|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139422503|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
139422504|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422505|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422506|NCT05139225|Daratumumab|daratumumab|mesh-list
139422521|NCT05111626|Nivolumab|nivolumab|mesh-list
139422522|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
139422523|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422524|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422525|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422526|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422527|NCT05091203|Vitamin D|vitamin d|mesh-list
139422528|NCT05091203|Vitamins|vitamins|mesh-ancestor
139422529|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
139422530|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422531|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139422532|NCT05074810|Sotorasib|sotorasib|mesh-list
139422533|NCT05074810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422534|NCT05074810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422535|NCT05074810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422536|NCT05074810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422537|NCT05064878|Fenfluramine|fenfluramine|mesh-list
139422538|NCT05064878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139422539|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139422540|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139061835|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
139422541|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422542|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139422543|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
139422544|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422545|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
139422546|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422547|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422552|NCT05028634|Vaccines|vaccines|mesh-list
139422553|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139422554|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
139422555|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422556|NCT04994717|Blinatumomab|blinatumomab|mesh-list
139422557|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422558|NCT04950764|Seladelpar|seladelpar|mesh-list
139422559|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139422560|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
139422561|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422562|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139422563|NCT04950608|Psilocybin|psilocybin|mesh-list
139422564|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
139422565|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422566|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139422567|NCT04940065|Ofatumumab|ofatumumab|mesh-list
139422568|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079372|NCT03802994|Vaccines|vaccines|mesh-list
139422603|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139422604|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
139422605|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422606|NCT04915768|Antacids|antacids|mesh-ancestor
139422607|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422608|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139422617|NCT04895748|Everolimus|everolimus|mesh-list
139422618|NCT04895748|Spartalizumab|spartalizumab|mesh-list
139422619|NCT04895748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139422620|NCT04895748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139422621|NCT04895748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422622|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422623|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139422624|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
139422625|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422626|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422627|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422628|NCT04895748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422639|NCT04835441|ALPN-101|alpn-101|mesh-list
139422640|NCT04835441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139422641|NCT04835441|Immunologic Factors|immunologic factors|mesh-ancestor
139422642|NCT04835441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422643|NCT04827030|Ropivacaine|ropivacaine|mesh-list
139422644|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
139422645|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
139422646|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139422647|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422648|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
139422649|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139422650|NCT04813926|Riociguat|riociguat|mesh-list
139422651|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
139422652|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422653|NCT04804553|Apremilast|apremilast|mesh-list
139422654|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139422656|NCT04804553|Analgesics|analgesics|mesh-ancestor
139422657|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
139422658|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139422659|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422660|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139422661|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139422662|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139422663|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139422664|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422665|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422666|NCT04801641|Nabilone|nabilone|mesh-list
139422667|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
139422668|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
139422669|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139422670|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422671|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139422672|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139422673|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139422674|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139422675|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139422676|NCT04796012|Irinotecan|irinotecan|mesh-list
139422677|NCT04796012|Vincristine|vincristine|mesh-list
139422678|NCT04796012|Temozolomide|temozolomide|mesh-list
139422679|NCT04796012|Atezolizumab|atezolizumab|mesh-list
139422680|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139422681|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139422682|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422683|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422684|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422685|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139422686|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
139422687|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
139422688|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
139422689|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139422690|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
139422691|NCT04796012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422692|NCT04796012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422693|NCT04781972|Methylphenidate|methylphenidate|mesh-list
139422694|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139422695|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422696|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139422697|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139422698|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139422699|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422700|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
139422701|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139422702|NCT04759586|Prednisone|prednisone|mesh-list
139422703|NCT04759586|Prednisolone|prednisolone|mesh-list
139422704|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139422705|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
139422706|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139422707|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
139422708|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
139422709|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139422710|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139422711|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139422712|NCT04759586|Cortisone|cortisone|mesh-list
139422713|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
139422714|NCT04759586|Rituximab|rituximab|mesh-list
139422715|NCT04759586|Doxorubicin|doxorubicin|mesh-list
139422716|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139422717|NCT04759586|Nivolumab|nivolumab|mesh-list
139422718|NCT04759586|Etoposide|etoposide|mesh-list
139422719|NCT04759586|Vincristine|vincristine|mesh-list
139422720|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
139422721|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139422723|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
139422724|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139422725|NCT04759586|Lenograstim|lenograstim|mesh-list
139422726|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139422727|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
139422728|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139422729|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
139422730|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422731|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139422744|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139422746|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422747|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139422748|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139422749|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
139422750|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
139422751|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
139422752|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
139422753|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
139422754|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139422755|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139422756|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139422757|NCT04759586|Protective Agents|protective agents|mesh-ancestor
139422758|NCT04679389|Acetazolamide|acetazolamide|mesh-list
139422759|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
139422760|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139422761|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422762|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422763|NCT04679389|Diuretics|diuretics|mesh-ancestor
139422764|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
139422765|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422766|NCT04649489|Bevacizumab|bevacizumab|mesh-list
139422767|NCT04649489|Atezolizumab|atezolizumab|mesh-list
139422768|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139422769|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422770|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422771|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139422772|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139422773|NCT04649489|Growth Substances|growth substances|mesh-ancestor
139422774|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422775|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
139422776|NCT04649489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422777|NCT04649489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422778|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
139422792|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
139422793|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139422794|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
139422795|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139422796|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
139422797|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422798|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422799|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422800|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
139422801|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422802|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422803|NCT04570332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422804|NCT04570332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422805|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
139422807|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139422808|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422809|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422810|NCT04548752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422811|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422812|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422813|NCT04547777|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
139422814|NCT04547777|Immunoconjugates|immunoconjugates|mesh-ancestor
139422815|NCT04547777|Immunologic Factors|immunologic factors|mesh-ancestor
139422816|NCT04547777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422817|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139422818|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422819|NCT04521231|Blinatumomab|blinatumomab|mesh-list
139422820|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422821|NCT04518228|Ritonavir|ritonavir|mesh-list
139422822|NCT04518228|Lopinavir|lopinavir|mesh-list
139422823|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139422824|NCT04518228|Darunavir|darunavir|mesh-list
139422825|NCT04518228|Tenofovir|tenofovir|mesh-list
139422826|NCT04518228|Dolutegravir|dolutegravir|mesh-list
139422827|NCT04518228|Cobicistat|cobicistat|mesh-list
139422828|NCT04518228|Cabotegravir|cabotegravir|mesh-list
139422829|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139422830|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139422831|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
139422832|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062091|NCT00845026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139422833|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422834|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139422835|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139422836|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
139422837|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139422838|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139422839|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139422840|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139422841|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139422842|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139422843|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139422844|NCT04506086|Blinatumomab|blinatumomab|mesh-list
139422845|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422846|NCT04491682|Megestrol|megestrol|mesh-list
139422847|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
139422848|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139422849|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139422850|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139422851|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
139422852|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422853|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139422854|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139422855|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422856|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139422857|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139422858|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139422859|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
139422860|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139422861|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422862|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139422863|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139422864|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139422865|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422866|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
139422867|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139422868|NCT04491643|Megestrol|megestrol|mesh-list
139422869|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
139422870|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139079671|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
139422871|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139422872|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139422873|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
139422874|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062129|NCT01145950|Etanercept|etanercept|mesh-list
139422875|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139422876|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139422877|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422878|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139422887|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422888|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
139422889|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139422890|NCT04464980|Naltrexone|naltrexone|mesh-list
139422891|NCT04464980|Buprenorphine|buprenorphine|mesh-list
139422892|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139422893|NCT04464980|Narcotics|narcotics|mesh-ancestor
139422894|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139422895|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422896|NCT04464980|Analgesics|analgesics|mesh-ancestor
139422897|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
139422898|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139422899|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139422900|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139422901|NCT04454203|Anesthetics|anesthetics|mesh-list
139422902|NCT04454203|Mepivacaine|mepivacaine|mesh-list
139422903|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
139422904|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139422905|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422906|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
139422907|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139422916|NCT04394546|Anticoagulants|anticoagulants|mesh-list
139422931|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
139422932|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
139422933|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139422934|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139422935|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139422936|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422937|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422938|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139079748|NCT01100372|Gemcitabine|gemcitabine|mesh-list
139422944|NCT04327063|Ropivacaine|ropivacaine|mesh-list
139422945|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
139422946|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
139422947|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139422948|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422949|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
139422950|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139422951|NCT04310020|Atezolizumab|atezolizumab|mesh-list
138927632|NCT00673179|Vitamins|vitamins|mesh-ancestor
139422952|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139422953|NCT04310020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422954|NCT04310020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422955|NCT04310020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422956|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422957|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
139422958|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422959|NCT04293809|Bupivacaine|bupivacaine|mesh-list
139422960|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
139422961|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
139422962|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139422963|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139422964|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
139422965|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139422966|NCT04287049|Azithromycin|azithromycin|mesh-list
139422967|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139422968|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139422970|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
139422971|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422972|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422974|NCT04267848|Cisplatin|cisplatin|mesh-list
139422975|NCT04267848|Carboplatin|carboplatin|mesh-list
139422976|NCT04267848|Gemcitabine|gemcitabine|mesh-list
139422977|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
139422978|NCT04267848|Pemetrexed|pemetrexed|mesh-list
139422979|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139422980|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139422981|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422982|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
139422983|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
139422984|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
139422985|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139422986|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139422987|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
139422988|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139422989|NCT04267848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139422990|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139422991|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139422992|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139422993|NCT04226950|Interferons|interferons|mesh-list
139422994|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
139422995|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
139422996|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139422997|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139422998|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
139422999|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139423000|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
139423001|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423002|NCT04216329|Temozolomide|temozolomide|mesh-list
139423003|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139423004|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
139423005|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423006|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423007|NCT04214262|Deoxyglucose|deoxyglucose|mesh-list
139423008|NCT04214262|Atezolizumab|atezolizumab|mesh-list
139423009|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139423010|NCT04214262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139423011|NCT04214262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423012|NCT04214262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423013|NCT04214262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423014|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423015|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
139423016|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079827|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
139423017|NCT04214262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139423018|NCT04214262|Antimetabolites|antimetabolites|mesh-ancestor
139423019|NCT04214262|Antiviral Agents|antiviral agents|mesh-ancestor
139423020|NCT04214262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139423021|NCT04209504|Bupivacaine|bupivacaine|mesh-list
139423022|NCT04209504|Ropivacaine|ropivacaine|mesh-list
139423023|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
139423024|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
139423025|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139423026|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423027|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
139423030|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139423032|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
139423033|NCT04181060|Antibodies|antibodies|mesh-list
139423034|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
139423035|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139423036|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
139423037|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423038|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139423039|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139423040|NCT04181060|Growth Substances|growth substances|mesh-ancestor
139423041|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423042|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
139423043|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
139423044|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423045|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139423046|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423047|NCT04170855|Furosemide|furosemide|mesh-list
139423048|NCT04170855|Diuretics|diuretics|mesh-ancestor
139423049|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
139423050|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423051|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139423052|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139423053|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423054|NCT04166409|Carboplatin|carboplatin|mesh-list
139423055|NCT04166409|Vincristine|vincristine|mesh-list
139062283|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
139423056|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423057|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139423058|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
139423059|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
139423060|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
139423061|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423062|NCT04161885|Azacitidine|azacitidine|mesh-list
139423063|NCT04161885|Venetoclax|venetoclax|mesh-list
139423064|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139423065|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
139423066|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423067|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423068|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423069|NCT04160494|Atezolizumab|atezolizumab|mesh-list
139423070|NCT04160494|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
139423071|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
139423072|NCT04160494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423073|NCT04160494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423074|NCT04160494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423075|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423076|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
139423077|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423078|NCT04143711|Paclitaxel|paclitaxel|mesh-list
139423079|NCT04143711|Nivolumab|nivolumab|mesh-list
139423080|NCT04143711|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139423081|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139423082|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423083|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
139423084|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
139423085|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
139423086|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423087|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423088|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423089|NCT04143711|Immunoconjugates|immunoconjugates|mesh-ancestor
139423090|NCT04143711|Immunologic Factors|immunologic factors|mesh-ancestor
139423091|NCT04143711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423092|NCT04140721|Moxonidine|moxonidine|mesh-list
139423093|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139423094|NCT04124757|Rocuronium|rocuronium|mesh-list
139423095|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139423096|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139423097|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139423098|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139423099|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423138|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
139423139|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423140|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423141|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139423142|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423143|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139423144|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139423145|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139423146|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423147|NCT03995147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423148|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139423149|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
139423150|NCT03995147|Hormones|hormones|mesh-ancestor
139423151|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139423152|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139423153|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139423154|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
139423155|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
139423156|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
139079969|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
139423181|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423182|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
139423183|NCT03914625|Leucovorin|leucovorin|mesh-list
139423184|NCT03914625|Folic Acid|folic acid|mesh-list
139423185|NCT03914625|Cytarabine|cytarabine|mesh-list
139423186|NCT03914625|Dexamethasone|dexamethasone|mesh-list
139423187|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
139423188|NCT03914625|Prednisone|prednisone|mesh-list
139423189|NCT03914625|Prednisolone|prednisolone|mesh-list
139423190|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139423191|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
139423192|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139423193|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
139423194|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
139423195|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139423196|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139423197|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139423198|NCT03914625|Cortisone|cortisone|mesh-list
139423199|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
139423200|NCT03914625|Doxorubicin|doxorubicin|mesh-list
139423201|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139423202|NCT03914625|Methotrexate|methotrexate|mesh-list
139423203|NCT03914625|Vincristine|vincristine|mesh-list
139423204|NCT03914625|Asparaginase|asparaginase|mesh-list
139423205|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
139423206|NCT03914625|Pegaspargase|pegaspargase|mesh-list
139423207|NCT03914625|Thioguanine|thioguanine|mesh-list
139423208|NCT03914625|Blinatumomab|blinatumomab|mesh-list
139423209|NCT03914625|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
139423210|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139423211|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
139423212|NCT03914625|Antibodies|antibodies|mesh-list
139423213|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
139423214|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139423215|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139423216|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139423217|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
139423218|NCT03914625|BB 1101|bb 1101|mesh-list
139423219|NCT03914625|Calcium|calcium|mesh-list
139423220|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
139423221|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
139423222|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423223|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
139423224|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423225|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139423226|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139423227|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
139423228|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423229|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423230|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139423231|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139423232|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
139423233|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
139423234|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139423235|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139423236|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
139423237|NCT03914625|Hormones|hormones|mesh-ancestor
139423238|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139423239|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139423240|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
139423241|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423242|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139423243|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139423244|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139423245|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139423246|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139423247|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139423248|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
139423249|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139423250|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139423251|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
139423252|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
139423253|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139423254|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139423255|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
139423256|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139423257|NCT03914625|Antidotes|antidotes|mesh-ancestor
139423285|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139423286|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423287|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423288|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139423290|NCT03879629|Protective Agents|protective agents|mesh-ancestor
139423291|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139423292|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139423293|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139423294|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
139423295|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139423296|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139423297|NCT03878979|Nivolumab|nivolumab|mesh-list
139423298|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423299|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423300|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423301|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423302|NCT03872947|Leucovorin|leucovorin|mesh-list
139423303|NCT03872947|Bevacizumab|bevacizumab|mesh-list
139423304|NCT03872947|Carboplatin|carboplatin|mesh-list
139423305|NCT03872947|Gemcitabine|gemcitabine|mesh-list
139423306|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
139423307|NCT03872947|Nivolumab|nivolumab|mesh-list
139423308|NCT03872947|Irinotecan|irinotecan|mesh-list
139423309|NCT03872947|Imiquimod|imiquimod|mesh-list
139423310|NCT03872947|Ramucirumab|ramucirumab|mesh-list
139423311|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423312|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423313|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423314|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139423315|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139423316|NCT03872947|Growth Substances|growth substances|mesh-ancestor
139423317|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423318|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
139423319|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139423320|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
139423321|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423322|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139423323|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139423324|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423325|NCT03872947|Antidotes|antidotes|mesh-ancestor
139423327|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
139423328|NCT03872947|Vitamins|vitamins|mesh-ancestor
139423329|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
139423330|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139423331|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
139423332|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
139423333|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
139423334|NCT03805594|177Lu-PSMA-617|177lu-psma-617|mesh-list
138928021|NCT00767481|Travoprost|travoprost|mesh-list
139423340|NCT03793179|Carboplatin|carboplatin|mesh-list
139423341|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
139423342|NCT03793179|Pemetrexed|pemetrexed|mesh-list
139423343|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423344|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423345|NCT03793179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423346|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423347|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423348|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139423349|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139423376|NCT03718884|Mirikizumab|mirikizumab|mesh-list
139423377|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139423378|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139423379|NCT03718884|Analgesics|analgesics|mesh-ancestor
139423380|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
139423381|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139423382|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423383|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139423384|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139423385|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139423386|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139423392|NCT03598257|Olaparib|olaparib|mesh-list
139423393|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139423394|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423395|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423396|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423397|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
139423398|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423399|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423400|NCT03595683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423401|NCT03595683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423402|NCT03473756|Atezolizumab|atezolizumab|mesh-list
139423403|NCT03473756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423404|NCT03473756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423405|NCT03473756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423406|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423408|NCT03436485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139423409|NCT03436485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139423410|NCT03436485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139423411|NCT03436485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423412|NCT03436485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139423413|NCT03436485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139423414|NCT03436485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139423415|NCT03436485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139423416|NCT03436485|Anesthetics, General|anesthetics, general|mesh-ancestor
139423417|NCT03436485|Anesthetics|anesthetics|mesh-ancestor
139423418|NCT03436485|GABA Modulators|gaba modulators|mesh-ancestor
139423419|NCT03436485|GABA Agents|gaba agents|mesh-ancestor
139423420|NCT03436485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139423421|NCT03436485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423422|NCT03423264|Gabapentin|gabapentin|mesh-list
139423423|NCT03423264|Analgesics|analgesics|mesh-ancestor
139423424|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
139423425|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139423426|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423427|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
139423428|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139423429|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139423430|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139423431|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139423432|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139423433|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139423434|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139423435|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423436|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
139423437|NCT03406156|Venetoclax|venetoclax|mesh-list
139423438|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139423439|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
139423440|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423441|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139423442|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
139423443|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423444|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423445|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
139423446|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423447|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423448|NCT03283137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423449|NCT03283137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423450|NCT03223155|Nivolumab|nivolumab|mesh-list
139423451|NCT03223155|Ipilimumab|ipilimumab|mesh-list
139423452|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423453|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423454|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423455|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423456|NCT03194815|Rituximab|rituximab|mesh-list
139423457|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
139423458|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139423459|NCT03194815|Antibodies|antibodies|mesh-list
139423460|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
139423461|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139423462|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423463|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423464|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
139423465|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423466|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139423467|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
139423468|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
139423469|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423470|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
139423471|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423472|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139423473|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139423474|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
139423475|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423476|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423477|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139423478|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423479|NCT03153410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423480|NCT03025256|Nivolumab|nivolumab|mesh-list
139423481|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423482|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423483|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423484|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423485|NCT03000387|Nicotine|nicotine|mesh-list
139423486|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139423487|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
139423488|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139423489|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423490|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139423491|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139423492|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
139423493|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139423494|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423495|NCT02994927|Prednisone|prednisone|mesh-list
139423496|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
139423497|NCT02994927|Rituximab|rituximab|mesh-list
139423498|NCT02994927|Azathioprine|azathioprine|mesh-list
139423499|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423500|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
139423501|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423502|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139423503|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139423504|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
139423505|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423506|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423507|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139423508|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423509|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139423510|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
139423511|NCT02994927|Hormones|hormones|mesh-ancestor
139423512|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139423513|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139423514|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
139423515|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139423516|NCT02721459|Vemurafenib|vemurafenib|mesh-list
139423517|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423518|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139423519|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423520|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423521|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
139423522|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423523|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
139423524|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423525|NCT02629120|Sirolimus|sirolimus|mesh-list
139423526|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
139423527|NCT02629120|Busulfan|busulfan|mesh-list
139423528|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
139423529|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423530|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
139423531|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423532|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139423533|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139423534|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
139423535|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423536|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423537|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139423538|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139423539|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139423540|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139423541|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
139423542|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423543|NCT02513186|Dexamethasone|dexamethasone|mesh-list
139423544|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
139423545|NCT02513186|Lenalidomide|lenalidomide|mesh-list
139423546|NCT02513186|Bortezomib|bortezomib|mesh-list
139423547|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423548|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
139423549|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423550|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139423551|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139423552|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
139423553|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423554|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423555|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139423556|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139423558|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
139423559|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139423560|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139423561|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
139423562|NCT02513186|Hormones|hormones|mesh-ancestor
139423563|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139423564|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139423565|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139423566|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139423567|NCT02513186|Growth Substances|growth substances|mesh-ancestor
139423568|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
139423569|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139423570|NCT02511028|Hematinics|hematinics|mesh-ancestor
139423571|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139423572|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139423573|NCT02428985|Riociguat|riociguat|mesh-list
139423574|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
139423575|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423576|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139423577|NCT02379377|Fluorides|fluorides|mesh-list
139423578|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139423579|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423580|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
139423581|NCT02379377|Protective Agents|protective agents|mesh-ancestor
139423582|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423589|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
139423590|NCT02333162|Fludarabine|fludarabine|mesh-list
139423591|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
139423592|NCT02333162|Melphalan|melphalan|mesh-list
139423593|NCT02333162|Tacrolimus|tacrolimus|mesh-list
139423594|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423595|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139423596|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
139423597|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423598|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423599|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
139423600|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423601|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139423602|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423603|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139423604|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139423605|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
139423606|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139423607|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139423608|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139423609|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
139423610|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139423611|NCT02310867|Abatacept|abatacept|mesh-list
139423612|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423613|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423614|NCT02310867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423615|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423616|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423617|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
139423618|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423619|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139423620|NCT02296918|Rituximab|rituximab|mesh-list
139423621|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
139423622|NCT02296918|Venetoclax|venetoclax|mesh-list
139423623|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
139423624|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423625|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423626|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
139423627|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423628|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139423630|NCT02194738|Cisplatin|cisplatin|mesh-list
139423631|NCT02194738|Carboplatin|carboplatin|mesh-list
139423632|NCT02194738|Gemcitabine|gemcitabine|mesh-list
139423633|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
139423634|NCT02194738|Nivolumab|nivolumab|mesh-list
139423635|NCT02194738|Pemetrexed|pemetrexed|mesh-list
139423636|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139423637|NCT02194738|Crizotinib|crizotinib|mesh-list
139062659|NCT01148446|Prednisone|prednisone|mesh-list
139423638|NCT02194738|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139423639|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139423640|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423641|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
139423642|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
139423643|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
139423644|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423645|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139423646|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
139423647|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139423648|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139423649|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423650|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139423651|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139423652|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139423653|NCT02117791|Riociguat|riociguat|mesh-list
139423654|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
139423655|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423656|NCT02032823|Olaparib|olaparib|mesh-list
139423657|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139423658|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423659|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423660|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423661|NCT01847326|Paclitaxel|paclitaxel|mesh-list
139423662|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139423663|NCT01847326|Carboplatin|carboplatin|mesh-list
139423664|NCT01847326|Fluorouracil|fluorouracil|mesh-list
139423665|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
139423666|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139423667|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423668|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
139423669|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
139423670|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
139423671|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423672|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
139062692|NCT03914404|Protective Agents|protective agents|mesh-ancestor
139423673|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139423674|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423675|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
139423676|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423677|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
139423678|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423679|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139423680|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139423681|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423682|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139423683|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423684|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423685|NCT01693718|Fluorouracil|fluorouracil|mesh-list
139423686|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
139423687|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423688|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
139423689|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423690|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139423691|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423692|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
139423693|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423694|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
139423695|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423696|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139423697|NCT01631617|Doxycycline|doxycycline|mesh-list
139423698|NCT01631617|Cephalexin|cephalexin|mesh-list
139423699|NCT01631617|Trimethoprim|trimethoprim|mesh-list
139423700|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
139423701|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139423702|NCT01631617|Eusol|eusol|mesh-list
139423703|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139423704|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139423705|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
139423706|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139423707|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139423708|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139423709|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139423710|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423711|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423712|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139423713|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139423714|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139423715|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
139423716|NCT01553214|Dexamethasone|dexamethasone|mesh-list
139423717|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139423718|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
139423719|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
139423720|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139423721|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423722|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139423723|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
139423725|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139423726|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139423727|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423728|NCT01526096|Plerixafor|plerixafor|mesh-list
139423729|NCT01526096|Melphalan|melphalan|mesh-list
139423730|NCT01526096|Basiliximab|basiliximab|mesh-list
139423731|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139423732|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
139423733|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423734|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423735|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139423736|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423737|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
139423738|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423739|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139423740|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139423741|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
139423742|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139423743|NCT01251861|Bicalutamide|bicalutamide|mesh-list
139423744|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
139423745|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
139423746|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139423747|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423748|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423749|NCT01125228|Interferons|interferons|mesh-list
139423750|NCT01125228|Interferon-alpha|interferon-alpha|mesh-list
139423751|NCT01125228|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139423752|NCT01125228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423753|NCT01125228|Antiviral Agents|antiviral agents|mesh-ancestor
139423754|NCT01125228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139423755|NCT01125228|Immunologic Factors|immunologic factors|mesh-ancestor
139423756|NCT01125228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423757|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
139423758|NCT00961792|Promethazine|promethazine|mesh-list
139423759|NCT00961792|Ethanol|ethanol|mesh-list
139423760|NCT00961792|Caffeine|caffeine|mesh-list
139423761|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139423762|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423763|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139423764|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423765|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423766|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139423767|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139423768|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
139423769|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139423770|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139423771|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139423772|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139423773|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139423774|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139423775|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
139423776|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
139423777|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
139423779|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
139423780|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
139423781|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139423782|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139423783|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
139423784|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
139423785|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139423786|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
139423787|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
139423789|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
139423790|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139423791|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139423792|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139423793|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423794|NCT00630565|Dexamethasone|dexamethasone|mesh-list
139423795|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
139423796|NCT00630565|Busulfan|busulfan|mesh-list
139423797|NCT00630565|Etoposide|etoposide|mesh-list
139423798|NCT00630565|Sargramostim|sargramostim|mesh-list
139423799|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423800|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
139423801|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423802|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139423803|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139423804|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
139423805|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423806|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423807|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139423808|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139423809|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
139423810|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
139423811|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139423812|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139423813|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
139423814|NCT00630565|Hormones|hormones|mesh-ancestor
139423815|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139423816|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139423817|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139423818|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139423819|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139423820|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139423821|NCT00598481|Busulfan|busulfan|mesh-list
139423822|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
139423823|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139423824|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139423825|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
139423826|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139423827|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139423828|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139423829|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139080645|NCT04814602|Proglumide|proglumide|mesh-list
139196899|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196900|NCT01291121|Ranibizumab|ranibizumab|mesh-list
139196901|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139196902|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139196903|NCT01291121|Growth Substances|growth substances|mesh-ancestor
139196904|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196905|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
139196906|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196908|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139196909|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196910|NCT04522882|Insulin|insulin|mesh-list
139196911|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139196912|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196913|NCT03123718|Methotrexate|methotrexate|mesh-list
139196914|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139196915|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
139062835|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
139196916|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139196917|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196918|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139196919|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
139196921|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196922|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
139196923|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196924|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139196925|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139196926|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
139196927|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196928|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139196929|NCT01185743|Olanzapine|olanzapine|mesh-list
139196930|NCT01185743|Ziprasidone|ziprasidone|mesh-list
139196931|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
139196932|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
139196933|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196934|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196935|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139196936|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139196937|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139196938|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196939|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139196940|NCT01185743|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139196941|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139196942|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139196943|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196944|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196945|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
139196946|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139196947|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139196948|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
139196949|NCT01188005|Vitamins|vitamins|mesh-list
139196950|NCT01188005|Vitamin E|vitamin e|mesh-list
139196951|NCT01188005|Vitamin A|vitamin a|mesh-list
139196952|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
139196953|NCT01188005|Allopurinol|allopurinol|mesh-list
139196954|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139196955|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
139196956|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196957|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
139196958|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196959|NCT01188005|Protective Agents|protective agents|mesh-ancestor
139196960|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
139196961|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196962|NCT01188005|Expectorants|expectorants|mesh-ancestor
139196963|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
139196964|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139196965|NCT01188005|Antidotes|antidotes|mesh-ancestor
139196966|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
139196967|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196968|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
139196969|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196970|NCT04445194|Vaccines|vaccines|mesh-list
139196971|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
139196972|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196973|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139196974|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
139196975|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139196976|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139196977|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196978|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196979|NCT01291199|Urological Agents|urological agents|mesh-ancestor
139196980|NCT04444726|Betamethasone|betamethasone|mesh-list
139196981|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
139196982|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139196983|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
139196984|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139196985|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139196986|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
139196987|NCT04444726|Hormones|hormones|mesh-ancestor
139196988|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139196989|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196990|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139196991|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
139196992|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
139196993|NCT03733327|Busulfan|busulfan|mesh-list
139196994|NCT03733327|Etoposide|etoposide|mesh-list
139196995|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139196996|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
139196997|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196998|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196999|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139197000|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
139197001|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197002|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197003|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139197004|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139197005|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139197006|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139197007|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197008|NCT03733171|Epinephrine|epinephrine|mesh-list
139197009|NCT03733171|Hemostatics|hemostatics|mesh-list
139197010|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139197011|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139197012|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
139197013|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197014|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197015|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197016|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139197017|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139197018|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
139197019|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197020|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139197021|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
139197022|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
139197023|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
139197024|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139197025|NCT03733171|Coagulants|coagulants|mesh-ancestor
139197026|NCT03207750|Vaccines|vaccines|mesh-list
139197027|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139197028|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
139197029|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197030|NCT01185977|Fluoxetine|fluoxetine|mesh-list
139197031|NCT01185977|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139197032|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139197033|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139197034|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197035|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197036|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
139197037|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197038|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139197039|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
139197040|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139197041|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139197042|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139197043|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197044|NCT03857399|Caspofungin|caspofungin|mesh-list
139197045|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
139197046|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197047|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197048|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197049|NCT04520620|Enoxaparin|enoxaparin|mesh-list
139197050|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
139197051|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139197052|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139197053|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197054|NCT03857711|Amiodarone|amiodarone|mesh-list
139197055|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139197056|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
139197057|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139197058|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139197059|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197060|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139197061|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139197062|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139197063|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197064|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139197065|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139197066|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139197067|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139197068|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139197070|NCT03847896|Albuterol|albuterol|mesh-list
139197071|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139197072|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139197073|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
139197074|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197075|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197076|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139197077|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
139197078|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
139197079|NCT03847896|Hormones|hormones|mesh-ancestor
139197080|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139197081|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
139197082|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139197083|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139197084|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139197085|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139197086|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
139197087|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197088|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197089|NCT01186289|Atorvastatin|atorvastatin|mesh-list
139197090|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139197091|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139197092|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
139197093|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197094|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139197095|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139197096|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197097|NCT01291823|Gefitinib|gefitinib|mesh-list
139197098|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197099|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139197100|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197101|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197102|NCT01181765|Infliximab|infliximab|mesh-list
139197103|NCT01181765|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139197104|NCT01181765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139197105|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
139197106|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139197107|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139197108|NCT01186445|Morphine|morphine|mesh-list
139197109|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139197110|NCT01186445|Narcotics|narcotics|mesh-ancestor
139197111|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197112|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197114|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
139197115|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197116|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
139197117|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139197118|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197119|NCT04520230|Budesonide|budesonide|mesh-list
139197120|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
139197121|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
139197122|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139197123|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139197124|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139197125|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
139197126|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197127|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197128|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139197129|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
139197130|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
139197131|NCT04520230|Hormones|hormones|mesh-ancestor
139197132|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139197133|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139197134|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139197135|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139197136|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
139197137|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197138|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197139|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
139197140|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139197141|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
139197142|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
139197143|NCT03619837|Velpatasvir|velpatasvir|mesh-list
139197144|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139197145|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
139197146|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197147|NCT03852563|Petrolatum|petrolatum|mesh-list
139197148|NCT03852563|Emollients|emollients|mesh-ancestor
139197149|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
139197150|NCT01188317|Ibuprofen|ibuprofen|mesh-list
138947612|NCT00953134|Trace Elements|trace elements|mesh-list
139197151|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139197152|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139197153|NCT01188317|Analgesics|analgesics|mesh-ancestor
139197154|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
139197155|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197156|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197157|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139197158|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139197159|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139197160|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197161|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197162|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
139197163|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197164|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139197165|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197166|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197167|NCT03739021|Ropivacaine|ropivacaine|mesh-list
139197168|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
139197169|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
139197170|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197171|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197172|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
139197173|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197174|NCT03738943|Pyridoxine|pyridoxine|mesh-list
139197175|NCT03738943|Pyridoxal|pyridoxal|mesh-list
139197176|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
139197177|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
139197178|NCT03738943|Adenosine|adenosine|mesh-list
139197179|NCT03738943|Nitroprusside|nitroprusside|mesh-list
139197180|NCT03738943|Acetylcholine|acetylcholine|mesh-list
139197181|NCT03738943|Vitamins|vitamins|mesh-ancestor
139197182|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
139197183|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197184|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
139197185|NCT03738943|Analgesics|analgesics|mesh-ancestor
139197186|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
139197187|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197188|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139197189|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
139197190|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139197191|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
139197192|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
139197193|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197194|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197195|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139197196|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139197197|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139197198|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
139197199|NCT03178851|Atezolizumab|atezolizumab|mesh-list
139197200|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139197201|NCT03178851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139197202|NCT03178851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197203|NCT03178851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139197204|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197205|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
139197206|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197207|NCT01291979|Lidocaine|lidocaine|mesh-list
139197208|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
139197209|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
139197210|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197211|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197212|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
139197213|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197214|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139197215|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139197216|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139197217|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139197218|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197220|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
139197221|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
139197222|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197223|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197224|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
139063118|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197225|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197226|NCT03643159|Aripiprazole|aripiprazole|mesh-list
139197227|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
139197228|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
139197229|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139197230|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139197231|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197232|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197233|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
139197234|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
139197235|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197236|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197237|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139197238|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139197239|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
139197240|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139197241|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139197242|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139197243|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139197244|NCT03205566|Lamivudine|lamivudine|mesh-list
139197245|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
139197246|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139197247|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139197248|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197249|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197250|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
139197251|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197252|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139197253|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139197254|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139197255|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139197256|NCT01181999|Rituximab|rituximab|mesh-list
139197257|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139197258|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197259|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
139197260|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197261|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139197262|NCT04509232|Fluorides|fluorides|mesh-list
139197263|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
139197264|NCT04509232|Protective Agents|protective agents|mesh-ancestor
139197265|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197266|NCT03732235|Bevacizumab|bevacizumab|mesh-list
139197267|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
139197268|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139197269|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197270|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139197271|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139197272|NCT03732235|Growth Substances|growth substances|mesh-ancestor
139197273|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197274|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
139197275|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139197276|NCT03732235|Estrogens|estrogens|mesh-ancestor
139197277|NCT03732235|Hormones|hormones|mesh-ancestor
139197278|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139197279|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139197280|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
139197281|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139197282|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139197283|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
139197284|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197285|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139197286|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139197287|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197288|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197290|NCT01182077|Peficitinib|peficitinib|mesh-list
139197291|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139197292|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139197293|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197294|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197295|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139197296|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139197297|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139197298|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139197299|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
139197300|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
138947785|NCT02566928|Bacitracin|bacitracin|mesh-list
139197301|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
139197303|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197304|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197305|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197306|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139197307|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
139197308|NCT03618823|Acetaminophen|acetaminophen|mesh-list
139197309|NCT03618823|Ibuprofen|ibuprofen|mesh-list
139197310|NCT03618823|Oxycodone|oxycodone|mesh-list
139197311|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139197312|NCT03618823|Analgesics|analgesics|mesh-ancestor
139197313|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
139197314|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197315|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197316|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
139197317|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139197318|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139197319|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139197320|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139197321|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197322|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197323|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139197324|NCT03618823|Narcotics|narcotics|mesh-ancestor
139197325|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197326|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139197327|NCT01188707|Belinostat|belinostat|mesh-list
139197328|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197329|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139197330|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197331|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197332|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139197333|NCT03356158|Cetuximab|cetuximab|mesh-list
139197334|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139197335|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197336|NCT03356080|Cytarabine|cytarabine|mesh-list
139197337|NCT03356080|Decitabine|decitabine|mesh-list
139197338|NCT03356080|Tretinoin|tretinoin|mesh-list
139197339|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139197340|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
139197341|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197342|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197343|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
139197344|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197345|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139197346|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
139197347|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197348|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197349|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
139197350|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
139197351|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
139197352|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139197353|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197354|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
139197355|NCT02937636|Fluorides|fluorides|mesh-list
139197356|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
139197357|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
139197358|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
139197359|NCT02937636|Protective Agents|protective agents|mesh-ancestor
139197360|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197361|NCT03638635|Bupivacaine|bupivacaine|mesh-list
139197362|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
139197363|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
139197364|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197365|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197366|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
139197367|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197369|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139197370|NCT02518516|Simvastatin|simvastatin|mesh-list
139197371|NCT02518516|Pravastatin|pravastatin|mesh-list
139197372|NCT02518516|Lovastatin|lovastatin|mesh-list
139197373|NCT02518516|L 647318|l 647318|mesh-list
139197374|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
139197375|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139197376|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139197377|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
139197378|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197379|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139197380|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139197381|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197382|NCT04508686|Capecitabine|capecitabine|mesh-list
139197383|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139197384|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
139063264|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197385|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197386|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197387|NCT02518438|Tramadol|tramadol|mesh-list
139197388|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139197389|NCT02518438|Narcotics|narcotics|mesh-ancestor
139197390|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197391|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197392|NCT02518438|Analgesics|analgesics|mesh-ancestor
139197393|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
139197394|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197395|NCT04521556|Morphine|morphine|mesh-list
139197396|NCT04521556|Tramadol|tramadol|mesh-list
139197397|NCT04521556|Anesthetics|anesthetics|mesh-list
139197398|NCT04521556|Ropivacaine|ropivacaine|mesh-list
139197399|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197400|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197401|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139197402|NCT04521556|Narcotics|narcotics|mesh-ancestor
139197403|NCT04521556|Analgesics|analgesics|mesh-ancestor
139197404|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
139197405|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197407|NCT03204279|Palonosetron|palonosetron|mesh-list
139197408|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
139197409|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
139197410|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197411|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197412|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139197413|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139197414|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139197415|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
139197416|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197417|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197418|NCT02524301|Diprenorphine|diprenorphine|mesh-list
139197419|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139197420|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197421|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
139197422|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197423|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
139197424|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139197425|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139197426|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197427|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
139197428|NCT03122782|Coagulants|coagulants|mesh-ancestor
139197429|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
139197430|NCT01291433|Tocopherols|tocopherols|mesh-list
139197431|NCT01291433|Vitamin E|vitamin e|mesh-list
139197432|NCT01291433|Tocotrienols|tocotrienols|mesh-list
139197433|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
139197434|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
139197435|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139197436|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197437|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197438|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139197439|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139197440|NCT01291433|Protective Agents|protective agents|mesh-ancestor
139197441|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197442|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
139197443|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139197444|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
139197445|NCT01291433|Vitamins|vitamins|mesh-ancestor
139197446|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
139197447|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139197448|NCT01314144|Bupivacaine|bupivacaine|mesh-list
139197449|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
139197450|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
139197451|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197452|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197453|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
138947914|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197454|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197455|NCT02954653|Cytarabine|cytarabine|mesh-list
139197456|NCT02954653|Azacitidine|azacitidine|mesh-list
139197457|NCT02954653|Decitabine|decitabine|mesh-list
139197458|NCT02954653|Daunorubicin|daunorubicin|mesh-list
139197459|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139197460|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
139197461|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197462|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197463|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
139197464|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197465|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139197466|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
139197467|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197468|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197469|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139197470|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139197471|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139197472|NCT04508452|Bevacizumab|bevacizumab|mesh-list
139197473|NCT04508452|Capecitabine|capecitabine|mesh-list
139197474|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
139197475|NCT04508452|Irinotecan|irinotecan|mesh-list
139197476|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139197477|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197478|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139197479|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139197480|NCT04508452|Growth Substances|growth substances|mesh-ancestor
139197481|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197482|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
139197483|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139197484|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
139197485|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197486|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139197487|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139197488|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197489|NCT03856853|Pirfenidone|pirfenidone|mesh-list
139197490|NCT03856853|Analgesics|analgesics|mesh-ancestor
139197491|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
139197492|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197493|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197494|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139197495|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139197496|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139197497|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139197498|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197499|NCT03732703|Thalidomide|thalidomide|mesh-list
139197500|NCT03732703|Dexamethasone|dexamethasone|mesh-list
139197501|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
139197502|NCT03732703|Venetoclax|venetoclax|mesh-list
139197503|NCT03732703|Daratumumab|daratumumab|mesh-list
139197504|NCT03732703|Pomalidomide|pomalidomide|mesh-list
139197505|NCT03732703|Ixazomib|ixazomib|mesh-list
139197506|NCT03732703|BB 1101|bb 1101|mesh-list
139197507|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139197508|NCT03732703|Glycine|glycine|mesh-list
139197509|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139197510|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
139197511|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
139197512|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197513|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197514|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139197515|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
139197516|NCT03732703|Hormones|hormones|mesh-ancestor
139197517|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139197518|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139197519|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197520|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
139197521|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197522|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197523|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
139197524|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139197525|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139197526|NCT03732703|Growth Substances|growth substances|mesh-ancestor
139197527|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
139197528|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139197529|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
139197530|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139197531|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197532|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
139197533|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197536|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139197537|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197538|NCT03123016|Apremilast|apremilast|mesh-list
139197539|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139197540|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139197541|NCT03123016|Analgesics|analgesics|mesh-ancestor
139197542|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
139197543|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197544|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197545|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139197546|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139197547|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139197548|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139197549|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197550|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197551|NCT03636477|Nivolumab|nivolumab|mesh-list
139197552|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139197553|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197554|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139197555|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197556|NCT03732001|Docetaxel|docetaxel|mesh-list
139197557|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197558|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
139197559|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
139197560|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
139197561|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197562|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
139197563|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139197564|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139197565|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
139197566|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139197567|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139197568|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197569|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
139197570|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197571|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197572|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139197573|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
139197574|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
139197575|NCT01186835|Protective Agents|protective agents|mesh-ancestor
139197576|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139197577|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197578|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
139197579|NCT04812951|Cyclosporine|cyclosporine|mesh-list
139197580|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139197581|NCT04812951|Cyclosporins|cyclosporins|mesh-list
139197582|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197583|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197584|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139197585|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
139197586|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197587|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
139197588|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197589|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
139197590|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139197591|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138929264|NCT00782301|Maraviroc|maraviroc|mesh-list
139197592|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139197594|NCT05666089|Calcium|calcium|mesh-list
139197595|NCT05666089|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139197596|NCT05666089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139197597|NCT05666089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197598|NCT05666089|Antiviral Agents|antiviral agents|mesh-ancestor
139197599|NCT05666089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197600|NCT05666089|Expectorants|expectorants|mesh-ancestor
139197601|NCT05666089|Respiratory System Agents|respiratory system agents|mesh-ancestor
139197602|NCT05666089|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139197603|NCT05666089|Antioxidants|antioxidants|mesh-ancestor
139197604|NCT05666089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197605|NCT05666089|Protective Agents|protective agents|mesh-ancestor
139197606|NCT05666089|Antidotes|antidotes|mesh-ancestor
139197607|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
139197608|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139197609|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139197610|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
139197611|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197612|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139197613|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139197614|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197615|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197616|NCT04597476|Fucoidan|fucoidan|mesh-list
139197617|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139197618|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139197619|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
139197620|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197621|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139197622|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139197623|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197624|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139197625|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197626|NCT02730208|Ivacaftor|ivacaftor|mesh-list
139197627|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139197628|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139197629|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197630|NCT01291511|Iloperidone|iloperidone|mesh-list
139197632|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139197633|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197634|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197635|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139197636|NCT01292213|Dimercaprol|dimercaprol|mesh-list
139197637|NCT01292213|Chelating Agents|chelating agents|mesh-ancestor
139197638|NCT01292213|Sequestering Agents|sequestering agents|mesh-ancestor
139197639|NCT01292213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197640|NCT03122938|Lactoferrin|lactoferrin|mesh-list
139197641|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197642|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
139197643|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
139197644|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139197645|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197646|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
139197647|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197648|NCT03782532|Prednisone|prednisone|mesh-list
139197649|NCT03782532|Prednisolone|prednisolone|mesh-list
139197650|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139197651|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
139197652|NCT03782532|Hormones|hormones|mesh-ancestor
139197653|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139197654|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197655|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139197656|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197657|NCT03355768|Romidepsin|romidepsin|mesh-list
139197658|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139197659|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197660|NCT03355768|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139197661|NCT03355768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197662|NCT03355768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197663|NCT03349840|Insulin|insulin|mesh-list
139197664|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139197665|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
139197666|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139197667|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197668|NCT03170271|Benralizumab|benralizumab|mesh-list
139197669|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139197670|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
139197671|NCT03355612|Capecitabine|capecitabine|mesh-list
139197672|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
139197674|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139197675|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
139197676|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197677|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197678|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139197679|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197680|NCT03732547|Poly I-C|poly i-c|mesh-list
139197681|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
139197682|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197683|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
139197684|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
139197685|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197687|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
139197688|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139197689|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139197690|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139197691|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
139197692|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197693|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197694|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197695|NCT04503850|Urological Agents|urological agents|mesh-ancestor
139197696|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139197697|NCT03349684|Metformin|metformin|mesh-list
139197698|NCT03349684|Acarbose|acarbose|mesh-list
139197699|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139197700|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197701|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139197702|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197703|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197704|NCT03856697|Gefitinib|gefitinib|mesh-list
139197705|NCT03856697|Maleic acid|maleic acid|mesh-list
139197706|NCT03856697|Abivertinib|abivertinib|mesh-list
139197707|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197708|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197709|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197710|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139197711|NCT03349606|Amphetamine|amphetamine|mesh-list
139197712|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
139197713|NCT03349606|FLB 457|flb 457|mesh-list
139197714|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139197715|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197716|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
139197717|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
139197718|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197719|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
139197720|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197721|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197722|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
139197723|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139197724|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139197725|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139197726|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139197727|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139197728|NCT02843451|Silymarin|silymarin|mesh-list
139197729|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
139197730|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197731|NCT02843451|Protective Agents|protective agents|mesh-ancestor
139197732|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197733|NCT01292525|Tacrolimus|tacrolimus|mesh-list
139197734|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139197735|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
139197736|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197737|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139197738|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197739|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197740|NCT01189019|Ranibizumab|ranibizumab|mesh-list
139197741|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139197742|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139197743|NCT01189019|Growth Substances|growth substances|mesh-ancestor
139197744|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197745|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
139197746|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197747|NCT01183247|Sirolimus|sirolimus|mesh-list
139197748|NCT01183247|Prednisone|prednisone|mesh-list
139197749|NCT01183247|Everolimus|everolimus|mesh-list
139197750|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139197751|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
139197752|NCT01183247|Hormones|hormones|mesh-ancestor
139197753|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139197754|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197755|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139197756|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197757|NCT01183247|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139197758|NCT01183247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139197759|NCT01183247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197760|NCT01183247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197761|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139197762|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
139197763|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139197764|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197765|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139197766|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
139197767|NCT03349216|Anesthetics|anesthetics|mesh-list
139197768|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197769|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197770|NCT04507750|Apatinib|apatinib|mesh-list
139197771|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197772|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139197773|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197774|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197775|NCT03633331|Letrozole|letrozole|mesh-list
139197776|NCT03633331|Fulvestrant|fulvestrant|mesh-list
139197777|NCT03633331|Palbociclib|palbociclib|mesh-list
139197778|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197779|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139197780|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139197781|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197782|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197783|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139197784|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
139197785|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139197786|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197787|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139197788|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139197789|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139197790|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
139197791|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
139197792|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
139197793|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139197794|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139197795|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197796|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197797|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197799|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197800|NCT01187459|Vitamin D|vitamin d|mesh-list
139197801|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
139197802|NCT01187459|Cholecalciferol|cholecalciferol|mesh-list
139197803|NCT01187459|Vitamins|vitamins|mesh-list
139197804|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
139197805|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197806|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139197807|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139197808|NCT01187537|Bupivacaine|bupivacaine|mesh-list
139197809|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
139197810|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
139197811|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197812|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197813|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
139197814|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197815|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139197816|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139197817|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139197818|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139197819|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197820|NCT01290419|Vaccines|vaccines|mesh-list
139197821|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
139197822|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197823|NCT03737773|Methamphetamine|methamphetamine|mesh-list
139197824|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139197825|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197826|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
139197827|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
139197828|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197829|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
139197830|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197831|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197832|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
139197833|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139197834|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139197835|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139197836|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139197837|NCT01060579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139197838|NCT01060579|Latanoprost|latanoprost|mesh-list
139197839|NCT01060579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139197840|NCT04443946|Sufentanil|sufentanil|mesh-list
139197841|NCT04443946|Propofol|propofol|mesh-list
139197842|NCT04443946|Sevoflurane|sevoflurane|mesh-list
139197843|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139197844|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197845|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197846|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139197847|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
139197848|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
139197849|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139197850|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139197851|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139197852|NCT04443946|Narcotics|narcotics|mesh-ancestor
139197853|NCT04443946|Analgesics|analgesics|mesh-ancestor
139197855|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197856|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139197857|NCT03729973|Lidocaine|lidocaine|mesh-list
139197858|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
139197859|NCT03729973|Ketamine|ketamine|mesh-list
139197860|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139197861|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
139197862|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
139197863|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197864|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197865|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
139197866|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197867|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139197868|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139197869|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139197870|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139197871|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197872|NCT03729973|Analgesics|analgesics|mesh-ancestor
139197873|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139197874|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139197875|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
139063755|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197876|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139197877|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139197878|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197879|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
139197880|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139197881|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139197882|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
139197883|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139197884|NCT01189253|Doxorubicin|doxorubicin|mesh-list
139197885|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139197886|NCT01189253|Trabectedin|trabectedin|mesh-list
139197887|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139197888|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197889|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139197890|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139197891|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197892|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197893|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139197894|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
139197896|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139197897|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
139197898|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197899|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197900|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139197901|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
139197902|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139197903|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
139197904|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197905|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139197906|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139197907|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
139197908|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
139197909|NCT04443868|Protective Agents|protective agents|mesh-ancestor
139197910|NCT03851393|Citric Acid|citric acid|mesh-list
139197911|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
139197912|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
139197913|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139197914|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
139197915|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
139197916|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197917|NCT04443556|Tramadol|tramadol|mesh-list
139197918|NCT04443556|Anesthetics|anesthetics|mesh-list
139197919|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
139197920|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197921|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197922|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139197923|NCT04443556|Narcotics|narcotics|mesh-ancestor
139197924|NCT04443556|Analgesics|analgesics|mesh-ancestor
139197925|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
139197926|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197927|NCT01187615|Cisplatin|cisplatin|mesh-list
139197928|NCT01187615|Pemetrexed|pemetrexed|mesh-list
139197929|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197930|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197931|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197932|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139197933|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139197935|NCT05375097|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139197936|NCT05375097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197937|NCT05375097|Analgesics|analgesics|mesh-ancestor
139197938|NCT05375097|Sensory System Agents|sensory system agents|mesh-ancestor
139197939|NCT05375097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197940|NCT05375097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197941|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139197942|NCT02752191|Hematinics|hematinics|mesh-ancestor
139197943|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139197944|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139197945|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
139197946|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139197947|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
139197948|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197949|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
139197950|NCT01290497|Protective Agents|protective agents|mesh-ancestor
139197951|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
139197952|NCT04509466|Pegaspargase|pegaspargase|mesh-list
139197953|NCT04509466|Asparaginase|asparaginase|mesh-list
139197954|NCT04509466|Analgesics|analgesics|mesh-ancestor
139197955|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
139197956|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139197957|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197958|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063824|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197959|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139197960|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139197961|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197962|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197963|NCT03738215|Cariprazine|cariprazine|mesh-list
139197964|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139197965|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139197966|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139197967|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197968|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139197969|NCT05352321|Gemcitabine|gemcitabine|mesh-list
139197970|NCT05352321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197971|NCT05352321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139197972|NCT05352321|Antimetabolites|antimetabolites|mesh-ancestor
139197973|NCT05352321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197974|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139197975|NCT03199911|Erythromycin|erythromycin|mesh-list
139197976|NCT03199911|Bacitracin|bacitracin|mesh-list
139197977|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139197978|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139197979|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139197980|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139197981|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139197982|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139197983|NCT02517814|Vitamin D|vitamin d|mesh-list
139197984|NCT02517814|Vitamins|vitamins|mesh-ancestor
139197985|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
139197986|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139197987|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139197988|NCT05349201|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139197989|NCT05349201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139197990|NCT05349201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139197991|NCT05303727|Cyclosporine|cyclosporine|mesh-list
139197992|NCT05303727|Mycophenolic Acid|mycophenolic acid|mesh-list
139197993|NCT05303727|Cyclophosphamide|cyclophosphamide|mesh-list
139197994|NCT05303727|Melphalan|melphalan|mesh-list
139197995|NCT05303727|Busulfan|busulfan|mesh-list
139197996|NCT05303727|Thiotepa|thiotepa|mesh-list
139197997|NCT05303727|Methotrexate|methotrexate|mesh-list
139197998|NCT05303727|Fludarabine|fludarabine|mesh-list
139197999|NCT05303727|Topotecan|topotecan|mesh-list
139198000|NCT05303727|Tacrolimus|tacrolimus|mesh-list
139198001|NCT05303727|Cyclosporins|cyclosporins|mesh-list
139198002|NCT05303727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139198003|NCT05303727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139198004|NCT05303727|Immunologic Factors|immunologic factors|mesh-ancestor
139198005|NCT05303727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198006|NCT05303727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139198007|NCT05303727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139198008|NCT05303727|Alkylating Agents|alkylating agents|mesh-ancestor
139198009|NCT05303727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198010|NCT05303727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198011|NCT05303727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139198012|NCT05303727|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139198013|NCT05303727|Abortifacient Agents|abortifacient agents|mesh-ancestor
139198014|NCT05303727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139198015|NCT05303727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139198016|NCT05303727|Antimetabolites|antimetabolites|mesh-ancestor
139198017|NCT05303727|Dermatologic Agents|dermatologic agents|mesh-ancestor
139198018|NCT05303727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198019|NCT05303727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139198020|NCT05303727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139198021|NCT05303727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139198022|NCT05303727|Antifungal Agents|antifungal agents|mesh-ancestor
139198023|NCT05303727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198024|NCT05303727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139198025|NCT05303727|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139198026|NCT05303727|Antitubercular Agents|antitubercular agents|mesh-ancestor
139198027|NCT05303727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139198028|NCT05303727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139198029|NCT05303727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139198030|NCT04502368|Dimercaprol|dimercaprol|mesh-list
139198031|NCT04502368|Chelating Agents|chelating agents|mesh-ancestor
139198032|NCT04502368|Sequestering Agents|sequestering agents|mesh-ancestor
139198033|NCT04502368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198034|NCT04984083|Vitamin K|vitamin k|mesh-list
139198035|NCT04984083|Vitamins|vitamins|mesh-ancestor
139198036|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
139198037|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198038|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139198039|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139198040|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198041|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
139198042|NCT04984083|Coagulants|coagulants|mesh-ancestor
139198043|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139198044|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
139198045|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198047|NCT01581203|Ribavirin|ribavirin|mesh-list
139198048|NCT01581203|Interferon-alpha|interferon-alpha|mesh-list
139198049|NCT01581203|Interferon alpha-2|interferon alpha-2|mesh-list
139198050|NCT01581203|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139198051|NCT01581203|Asunaprevir|asunaprevir|mesh-list
139198052|NCT01581203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198053|NCT01581203|Antiviral Agents|antiviral agents|mesh-ancestor
139198054|NCT01581203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198055|NCT01581203|Antimetabolites|antimetabolites|mesh-ancestor
139198056|NCT01581203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198057|NCT01581203|Immunologic Factors|immunologic factors|mesh-ancestor
139198058|NCT01581203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198059|NCT01581203|Protease Inhibitors|protease inhibitors|mesh-ancestor
139198060|NCT01581203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198061|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139198062|NCT03168555|Cathartics|cathartics|mesh-ancestor
139198063|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139198064|NCT03235050|Liraglutide|liraglutide|mesh-list
139198065|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139198066|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198067|NCT03235050|Incretins|incretins|mesh-ancestor
139198068|NCT03235050|Hormones|hormones|mesh-ancestor
139198069|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139198070|NCT04933149|Ketamine|ketamine|mesh-list
139198071|NCT04933149|Analgesics|analgesics|mesh-ancestor
139198072|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
139198073|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198074|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198075|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139198076|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139198077|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
139198078|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
139198079|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198080|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139198081|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139198082|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198083|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198084|NCT01189721|Propofol|propofol|mesh-list
139198085|NCT01189721|Sevoflurane|sevoflurane|mesh-list
139198086|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139198087|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198088|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198089|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139198090|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
139198091|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
139198092|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138254618|NCT01632709|Bupivacaine|bupivacaine|mesh-list
139198093|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139198094|NCT03167619|Durvalumab|durvalumab|mesh-list
139198095|NCT03167619|Olaparib|olaparib|mesh-list
139198096|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139198097|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198098|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139198099|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198100|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198101|NCT03198507|Amoxicillin|amoxicillin|mesh-list
139198102|NCT03198507|Rifabutin|rifabutin|mesh-list
139198103|NCT03198507|Omeprazole|omeprazole|mesh-list
139198104|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139198105|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198106|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139198107|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139198108|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139198109|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198110|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198111|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139198112|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
139198113|NCT03850769|Paclitaxel|paclitaxel|mesh-list
139198114|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139198115|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198116|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
139198117|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
139198118|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
139198119|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198120|NCT04663464|Abaloparatide|abaloparatide|mesh-list
139198121|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
139198122|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139198123|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198124|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139198125|NCT01292993|Metformin|metformin|mesh-list
139198126|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139198127|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139198128|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198129|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139198130|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198131|NCT03849833|Vitamin D|vitamin d|mesh-list
139198132|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
139198133|NCT03849833|Vitamins|vitamins|mesh-ancestor
139198134|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
139198135|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198136|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139198137|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139198138|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
139198139|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139198140|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198141|NCT03167151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139198142|NCT03167151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198143|NCT01191203|Copper|copper|mesh-list
139198144|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139198145|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
139198146|NCT01191203|Trace Elements|trace elements|mesh-ancestor
139198147|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
139198148|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198149|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139198150|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139198151|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139198152|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
139198153|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139198154|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139198155|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139198156|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139198157|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139198158|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198159|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
139198160|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139198161|NCT03197883|Protective Agents|protective agents|mesh-ancestor
139198162|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198163|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
139198164|NCT03729505|Lidocaine|lidocaine|mesh-list
139198165|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
139198166|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
139198167|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
139198168|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198169|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198170|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
139198171|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198172|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139198173|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139198174|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139198175|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139198176|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198177|NCT03729505|Analgesics|analgesics|mesh-ancestor
139198178|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
139198179|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139198180|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139198181|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
139198182|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139198183|NCT03234036|Ritonavir|ritonavir|mesh-list
139198184|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
139198185|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139198186|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139198187|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
139198188|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198189|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198190|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139198191|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139198192|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
139198193|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063896|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198194|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139198195|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139198197|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139198198|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139198199|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198200|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
139198201|NCT03606109|Coagulants|coagulants|mesh-ancestor
139198202|NCT01191359|Immunomodulating Agents|immunomodulating agents|mesh-list
139198203|NCT01191359|Immunologic Factors|immunologic factors|mesh-ancestor
139198204|NCT01191359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198205|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139198206|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139198207|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198208|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
139198209|NCT01193855|Dutasteride|dutasteride|mesh-list
139198210|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139198211|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139198212|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198213|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198214|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
139198215|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139198216|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198217|NCT01190345|Bevacizumab|bevacizumab|mesh-list
139198218|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139198219|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198220|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139198221|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139198222|NCT01190345|Growth Substances|growth substances|mesh-ancestor
139198223|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198224|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
139198225|NCT02729896|Rituximab|rituximab|mesh-list
139198226|NCT02729896|Atezolizumab|atezolizumab|mesh-list
139198228|NCT02729896|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139198229|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139198230|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198231|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
139198232|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198233|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139198234|NCT02729896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139198235|NCT02729896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198236|NCT02729896|Immunoconjugates|immunoconjugates|mesh-ancestor
139198237|NCT04506034|Lidocaine|lidocaine|mesh-list
139198238|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
139198239|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
139198240|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198241|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198242|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
139198243|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198244|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139198245|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139198246|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139198247|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139198248|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198249|NCT01294631|Canagliflozin|canagliflozin|mesh-list
139198250|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139198251|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198252|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139198253|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198254|NCT03849209|Pancrelipase|pancrelipase|mesh-list
139198255|NCT03849209|Pancreatin|pancreatin|mesh-list
139198256|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139198257|NCT05342662|Methamphetamine|methamphetamine|mesh-list
139198258|NCT05342662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139198259|NCT05342662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198260|NCT05342662|Sympathomimetics|sympathomimetics|mesh-ancestor
139198261|NCT05342662|Autonomic Agents|autonomic agents|mesh-ancestor
139198262|NCT05342662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198263|NCT05342662|Dopamine Agents|dopamine agents|mesh-ancestor
139198264|NCT05342662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198265|NCT05342662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198266|NCT05342662|Adrenergic Agents|adrenergic agents|mesh-ancestor
139198267|NCT05342662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139198268|NCT05342662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139198269|NCT05342662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139198270|NCT05342662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139198271|NCT03847571|Acetazolamide|acetazolamide|mesh-list
139198272|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
139198273|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139198274|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198275|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198276|NCT03847571|Diuretics|diuretics|mesh-ancestor
139198277|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
139198278|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198279|NCT01293149|Clonidine|clonidine|mesh-list
138948761|NCT00863577|Bemiparin|bemiparin|mesh-list
139198281|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
139198282|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
139198283|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198284|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198285|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
139198286|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198287|NCT01293149|Analgesics|analgesics|mesh-ancestor
139198288|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139198289|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
139198290|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
139198291|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139198292|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139198293|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139198294|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
139198295|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198296|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198297|NCT03575065|Pamiparib|pamiparib|mesh-list
139198298|NCT03575065|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139198299|NCT03575065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198300|NCT03575065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198302|NCT04454424|Midazolam|midazolam|mesh-list
139198303|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139198304|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139198305|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198306|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198307|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139198308|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139198309|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139198310|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139198311|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
139198312|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
139198313|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
139198314|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
139198315|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198316|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198317|NCT03348046|Infliximab|infliximab|mesh-list
139198318|NCT03348046|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139198319|NCT03348046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139198320|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
139198321|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139198322|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139198323|NCT04505644|Lidocaine|lidocaine|mesh-list
139198324|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
139198325|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
139198326|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198327|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198328|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
139198329|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198330|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139198331|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139198332|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139198333|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139198334|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198335|NCT04505800|Tryptophan|tryptophan|mesh-list
139198336|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139198337|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
139198338|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139198339|NCT05200156|Choline|choline|mesh-list
139198340|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
139198341|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139198342|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
139198343|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198344|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139198345|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139198346|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
139198347|NCT03347968|Warfarin|warfarin|mesh-list
139198348|NCT03347968|Esmolol|esmolol|mesh-list
139198349|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
139198350|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139198351|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139198352|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139198353|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
139198354|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198355|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198357|NCT01191593|Ropivacaine|ropivacaine|mesh-list
139198358|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
139198359|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
139198360|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198361|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198362|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
139198363|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198364|NCT03347890|Liraglutide|liraglutide|mesh-list
139198365|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139198366|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198367|NCT03347890|Incretins|incretins|mesh-ancestor
139198368|NCT03347890|Hormones|hormones|mesh-ancestor
139198369|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139198370|NCT01296503|Thalidomide|thalidomide|mesh-list
139198371|NCT01296503|Dexamethasone|dexamethasone|mesh-list
139198372|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
139198373|NCT01296503|BB 1101|bb 1101|mesh-list
139198374|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139198375|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
139198376|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
139198377|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198378|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198379|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139198380|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
139198381|NCT01296503|Hormones|hormones|mesh-ancestor
139198382|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139198383|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139198384|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198385|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
139198386|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198387|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198388|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139198389|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
139198390|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
139198391|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139198392|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198393|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139198394|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139198395|NCT01296503|Growth Substances|growth substances|mesh-ancestor
139198396|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
139198397|NCT01295099|Triamcinolone|triamcinolone|mesh-list
139198398|NCT01295099|Fluorouracil|fluorouracil|mesh-list
139198399|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
139198400|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198401|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139198402|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198403|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139198404|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
139198405|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198406|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139198407|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
139198408|NCT01295099|Hormones|hormones|mesh-ancestor
139198409|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139198410|NCT01426529|Norepinephrine|norepinephrine|mesh-list
139198411|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
139198412|NCT01426529|Giapreza|giapreza|mesh-list
139198413|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
139198414|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139198415|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139198416|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
139198417|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198418|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198419|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198420|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
139198421|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
139198422|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198423|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139198424|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139198425|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
139198426|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198427|NCT03122158|Escitalopram|escitalopram|mesh-list
138948894|NCT00863889|Hormones|hormones|mesh-ancestor
139198428|NCT03122158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139198429|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139198430|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139198431|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198432|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198433|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
139198434|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198435|NCT01190735|Caffeine|caffeine|mesh-list
139198436|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139198437|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198438|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139198439|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198440|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198441|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139198442|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139198443|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
139198444|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198445|NCT05097118|Ketamine|ketamine|mesh-list
139198446|NCT05097118|Bupivacaine|bupivacaine|mesh-list
139198447|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
139198448|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
139198449|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198450|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198451|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
139198452|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198453|NCT05097118|Analgesics|analgesics|mesh-ancestor
139198454|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139198455|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139198456|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
139198457|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139198458|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139198459|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198460|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198461|NCT01194791|Dexamethasone|dexamethasone|mesh-list
139198462|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
139198463|NCT01194791|Lenalidomide|lenalidomide|mesh-list
139198464|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139198465|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
139198466|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198467|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139198468|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139198469|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
139198470|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198471|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198472|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139198473|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139198474|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
139198475|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
139198476|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198477|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139198478|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
139198479|NCT01194791|Hormones|hormones|mesh-ancestor
139198480|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139198481|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139198482|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139198483|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139198484|NCT01194791|Growth Substances|growth substances|mesh-ancestor
139198485|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
139198486|NCT03351322|Minoxidil|minoxidil|mesh-list
139198487|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139198488|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
139198489|NCT01296971|Ribavirin|ribavirin|mesh-list
139198490|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139198491|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
139198492|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198493|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
139198494|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198495|NCT01195181|Ribavirin|ribavirin|mesh-list
139198496|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
139198497|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198498|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
139198499|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198500|NCT01197053|Immunomodulating Agents|immunomodulating agents|mesh-list
139198501|NCT01197053|Immunologic Factors|immunologic factors|mesh-ancestor
139198502|NCT01197053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198503|NCT03845699|Fentanyl|fentanyl|mesh-list
139198504|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139198505|NCT03845699|Narcotics|narcotics|mesh-ancestor
139198506|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198507|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198508|NCT03845699|Analgesics|analgesics|mesh-ancestor
139198509|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
139198510|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198511|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139198512|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139198513|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
139198514|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
139198515|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139198516|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198517|NCT00709618|Vinorelbine|vinorelbine|mesh-list
139198518|NCT00709618|Lapatinib|lapatinib|mesh-list
139198519|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139198520|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198521|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
139198522|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
139198523|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
139198524|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198525|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139198526|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198527|NCT01195259|Metformin|metformin|mesh-list
139198528|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
139198529|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139198530|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198531|NCT05584228|Infliximab|infliximab|mesh-list
139198532|NCT05584228|Azathioprine|azathioprine|mesh-list
139198533|NCT05584228|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139198534|NCT05584228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139198535|NCT05584228|Dermatologic Agents|dermatologic agents|mesh-ancestor
139198536|NCT05584228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139198537|NCT05584228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139198538|NCT05584228|Antimetabolites|antimetabolites|mesh-ancestor
139198539|NCT05584228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198540|NCT05584228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139198541|NCT05584228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198542|NCT05584228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139198543|NCT05584228|Immunologic Factors|immunologic factors|mesh-ancestor
139198544|NCT05584228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198545|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139198546|NCT03193047|Evolocumab|evolocumab|mesh-list
139198547|NCT03193047|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139198548|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139198549|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139198550|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
139198551|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198552|NCT03193047|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139198553|NCT03193047|Protease Inhibitors|protease inhibitors|mesh-ancestor
139198554|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198555|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139198556|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139198557|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198558|NCT04504552|Avelumab|avelumab|mesh-list
139198559|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139198560|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198561|NCT03845387|Pramipexole|pramipexole|mesh-list
139198562|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
139198563|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198564|NCT03845387|Protective Agents|protective agents|mesh-ancestor
139198565|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198566|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139198567|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139198568|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
139198569|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
139198570|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198571|NCT01295177|Insulin|insulin|mesh-list
139198572|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139198573|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139198574|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198575|NCT02918019|Astegolimab|astegolimab|mesh-list
139198576|NCT02918019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139198577|NCT02918019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139198578|NCT02918019|Antiviral Agents|antiviral agents|mesh-ancestor
139198579|NCT02918019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198580|NCT04848454|Vinorelbine|vinorelbine|mesh-list
139198581|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198582|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139198583|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
139198584|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
139198585|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
139198586|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198587|NCT04842292|Heparin|heparin|mesh-list
139198588|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
139198589|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139198590|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139198591|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198592|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
139198593|NCT01191983|Hematinics|hematinics|mesh-ancestor
139198594|NCT03055988|Fluticasone|fluticasone|mesh-list
139198596|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
139198597|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139198598|NCT03055988|Olodaterol|olodaterol|mesh-list
139198599|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139198600|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139198601|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
139198602|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198603|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198604|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139198605|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
139198606|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
139198607|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139198608|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
139198609|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139198610|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
139198611|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198612|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198613|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139198614|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139198615|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139198616|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
139198617|NCT03346642|Decitabine|decitabine|mesh-list
139198618|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139198619|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139198620|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
139198621|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198622|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198623|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198624|NCT03346642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139198625|NCT02912949|Immunoglobulin G|immunoglobulin g|mesh-list
139198626|NCT02912949|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139198627|NCT02912949|Immunologic Factors|immunologic factors|mesh-ancestor
139198628|NCT02912949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198629|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139198630|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198631|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198632|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198633|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139198634|NCT04789304|Midazolam|midazolam|mesh-list
139198635|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139198636|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139198637|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198638|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198639|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139198640|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139198641|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139198642|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139198643|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
139198644|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
139198645|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
139198646|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
139198647|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198648|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198649|NCT04780724|Nitrox|nitrox|mesh-list
139198650|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139198651|NCT04780724|Protective Agents|protective agents|mesh-ancestor
139198652|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198653|NCT05583214|Dexamethasone|dexamethasone|mesh-list
139198654|NCT05583214|Ondansetron|ondansetron|mesh-list
138949108|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139198655|NCT05583214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139198657|NCT05583214|Autonomic Agents|autonomic agents|mesh-ancestor
139198658|NCT05583214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198659|NCT05583214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198660|NCT05583214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139198661|NCT05583214|Glucocorticoids|glucocorticoids|mesh-ancestor
139198662|NCT05583214|Hormones|hormones|mesh-ancestor
139198663|NCT05583214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139198664|NCT05583214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139198665|NCT05583214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198666|NCT05583214|Antipruritics|antipruritics|mesh-ancestor
139198667|NCT05583214|Dermatologic Agents|dermatologic agents|mesh-ancestor
139198668|NCT05583214|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139198669|NCT05583214|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139198670|NCT05583214|Serotonin Agents|serotonin agents|mesh-ancestor
139198671|NCT05583214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198672|NCT05583214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198673|NCT02871297|Vortioxetine|vortioxetine|mesh-list
139198674|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
139198675|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139198676|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139198677|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139198678|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198679|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198680|NCT02871297|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139198681|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139198682|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139198683|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198684|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198685|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
139198686|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139198687|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139198688|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139198689|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139198690|NCT03628430|Lidocaine|lidocaine|mesh-list
139198691|NCT03628430|Epinephrine|epinephrine|mesh-list
139198692|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
139198693|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
139198694|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198695|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198696|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
139198697|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198698|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139198699|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139198700|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139198701|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139198702|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198703|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139198704|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139198705|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
139198706|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198707|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139198708|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139198709|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
139198710|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139198712|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
139198713|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
139198714|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139198715|NCT03121846|Apatinib|apatinib|mesh-list
139198716|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198717|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139198718|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198719|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198720|NCT03122314|Acetaminophen|acetaminophen|mesh-list
139198721|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139198722|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139198723|NCT03122314|Analgesics|analgesics|mesh-ancestor
139198724|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
139198725|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198726|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198727|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
138949254|NCT00877539|Xhance|xhance|mesh-list
139198728|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139198729|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139198730|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139198731|NCT03554005|Acetaminophen|acetaminophen|mesh-list
139198732|NCT03554005|Interferons|interferons|mesh-list
139198733|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
139198734|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
139198735|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139198736|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198737|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
139198738|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198739|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139198740|NCT03554005|Analgesics|analgesics|mesh-ancestor
139198741|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
139198742|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198743|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198744|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
139198745|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
139198746|NCT00709228|Ribavirin|ribavirin|mesh-list
139198747|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139198748|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
139198749|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198750|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
139198751|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198752|NCT01584557|Tolvaptan|tolvaptan|mesh-list
139198753|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139198754|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198755|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
139198756|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198757|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139198758|NCT05214872|Calcium|calcium|mesh-list
139198759|NCT05214872|Mitogens|mitogens|mesh-list
139198760|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139198761|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198762|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
139198763|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198764|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
139198765|NCT01195571|Vaccines|vaccines|mesh-list
139198766|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
139198767|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198768|NCT03219372|Pravastatin|pravastatin|mesh-list
139198769|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139198770|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139198771|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
139198772|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198773|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139198774|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139198775|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198776|NCT02422641|Methotrexate|methotrexate|mesh-list
139198777|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139198778|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
139198779|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139198780|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198781|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139198782|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
139198783|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198784|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198785|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
139198786|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198787|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139198788|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139198789|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
139198790|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139198791|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139198793|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
139198794|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
139198795|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198796|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198797|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
139198798|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198799|NCT04715763|Telmisartan|telmisartan|mesh-list
139198800|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139198801|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139198802|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139198803|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198804|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
139198805|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139198806|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
139198807|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198808|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198809|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139198810|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
139198811|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139198812|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
139198813|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198814|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198815|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139198816|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
139198817|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
139198818|NCT04338828|Protective Agents|protective agents|mesh-ancestor
139198819|NCT01295567|Dipyridamole|dipyridamole|mesh-list
139198820|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139198821|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198822|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198823|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139198824|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
139198825|NCT01192529|Phentermine|phentermine|mesh-list
139198826|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139198827|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198828|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
139198829|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139198830|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
139198831|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
139198832|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198833|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
139198834|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198835|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198836|NCT01195649|Sorafenib|sorafenib|mesh-list
139198837|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198838|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139198839|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198840|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198841|NCT01195727|Apixaban|apixaban|mesh-list
139198842|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139198843|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
139198844|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139198845|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
139198846|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198847|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198848|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
139198849|NCT04958876|Naltrexone|naltrexone|mesh-list
139198850|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139198851|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139198852|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198853|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
139198854|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198855|NCT01195805|Amiloride|amiloride|mesh-list
139198856|NCT01195805|Spironolactone|spironolactone|mesh-list
139198857|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139198858|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
139198859|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139198860|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198862|NCT01195805|Diuretics|diuretics|mesh-ancestor
139198863|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
139198864|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139198865|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139198866|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139198867|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198868|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139198869|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
139198870|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139198871|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198872|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
139198873|NCT03845153|Metformin|metformin|mesh-list
139198874|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139198875|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198876|NCT00198718|Vitamin A|vitamin a|mesh-list
139198878|NCT00198718|Vitamins|vitamins|mesh-ancestor
139198879|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
139198880|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198881|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
139198882|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198883|NCT00198718|Protective Agents|protective agents|mesh-ancestor
139198884|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139198885|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198886|NCT04500808|Macitentan|macitentan|mesh-list
139198887|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139198888|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139198889|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198890|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139198891|NCT01192763|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139198892|NCT01192763|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139198893|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198894|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198895|NCT04539548|Prednisolone|prednisolone|mesh-list
139198896|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139198897|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
139198898|NCT04539548|Hormones|hormones|mesh-ancestor
139198899|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139198900|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198901|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139198902|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198903|NCT00708916|Apremilast|apremilast|mesh-list
139198904|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139198905|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139198906|NCT00708916|Analgesics|analgesics|mesh-ancestor
139198907|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
139198908|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198909|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198910|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139198911|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139198912|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139198913|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139198914|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198915|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198916|NCT02352753|Denosumab|denosumab|mesh-list
139198917|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139198918|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198919|NCT02517736|Sorafenib|sorafenib|mesh-list
139198920|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139198921|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139198922|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198923|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198924|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
139198925|NCT03844841|Propofol|propofol|mesh-list
139198926|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139198927|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198928|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198929|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139198930|NCT03844841|Analgesics|analgesics|mesh-ancestor
139198931|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
139198932|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198933|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139198934|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139198935|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139198936|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
139198937|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198938|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198939|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139198940|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
139198941|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
139198942|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
139198943|NCT03197766|Natriuretic Agents|natriuretic agents|mesh-ancestor
139198944|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198945|NCT04501900|Clopidogrel|clopidogrel|mesh-list
139198946|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138949415|NCT00369967|NuvaRing|nuvaring|mesh-list
139198947|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139198948|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139198949|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139198950|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
139198951|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198952|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198953|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198954|NCT03637556|Deferasirox|deferasirox|mesh-list
139198955|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139198956|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
139198957|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
138787660|NCT01008150|Paclitaxel|paclitaxel|mesh-list
139198958|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198960|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139198961|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
139198962|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139198963|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198964|NCT01198223|Nystatin|nystatin|mesh-list
139198965|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139198966|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139198967|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
139198968|NCT01198223|Ionophores|ionophores|mesh-ancestor
139198969|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139198970|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198971|NCT01193465|Anesthetics|anesthetics|mesh-list
139198972|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139198973|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198974|NCT03347344|Riluzole|riluzole|mesh-list
139198975|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
139198976|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139198977|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139198978|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139198979|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198980|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198981|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139198982|NCT03347344|Protective Agents|protective agents|mesh-ancestor
139198983|NCT03173456|Acetaminophen|acetaminophen|mesh-list
139198984|NCT03173456|Ibuprofen|ibuprofen|mesh-list
139198985|NCT03173456|Oxycodone|oxycodone|mesh-list
139198986|NCT03173456|Hydrocodone|hydrocodone|mesh-list
139198987|NCT03173456|Codeine|codeine|mesh-list
139198988|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139198989|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139198990|NCT03173456|Analgesics|analgesics|mesh-ancestor
139198991|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
139198992|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139198993|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139198994|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139198995|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139198996|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139198997|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139198998|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139198999|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139199000|NCT03173456|Narcotics|narcotics|mesh-ancestor
139199001|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199002|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
139199003|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
139199004|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
139199006|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
139199007|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
139199008|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
139199009|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199010|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199011|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139199012|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139199013|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139199014|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199015|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139199016|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139199017|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
139199018|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139199019|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199020|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139199021|NCT02517424|Dronabinol|dronabinol|mesh-list
139199022|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
139199023|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199025|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139199026|NCT02517424|Analgesics|analgesics|mesh-ancestor
139199027|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
139199028|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199029|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139199030|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139199031|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139199032|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199033|NCT02517424|Hormones|hormones|mesh-ancestor
139199034|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139199036|NCT01567904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139199037|NCT01567904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139199038|NCT01567904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199039|NCT01196507|Carvedilol|carvedilol|mesh-list
139199040|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139199041|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139199042|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
139199043|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139199044|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199045|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199046|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139199047|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
139199048|NCT01196507|Protective Agents|protective agents|mesh-ancestor
139199049|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139199050|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139199051|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139199052|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
139199053|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139199054|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139199055|NCT05670509|Midazolam|midazolam|mesh-list
139199056|NCT05670509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139199057|NCT05670509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139199058|NCT05670509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199059|NCT05670509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199060|NCT05670509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139199061|NCT05670509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139199062|NCT05670509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139199063|NCT05670509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139199064|NCT05670509|Anesthetics, General|anesthetics, general|mesh-ancestor
139199065|NCT05670509|Anesthetics|anesthetics|mesh-ancestor
139199066|NCT05670509|GABA Modulators|gaba modulators|mesh-ancestor
139199067|NCT05670509|GABA Agents|gaba agents|mesh-ancestor
139199068|NCT05670509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139199069|NCT05670509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199070|NCT05282771|Nicotinic Acids|nicotinic acids|mesh-list
139199071|NCT05282771|Clobetasol|clobetasol|mesh-list
139199072|NCT05282771|Halobetasol|halobetasol|mesh-list
139199073|NCT05282771|Tazarotene|tazarotene|mesh-list
139199074|NCT05282771|Dermatologic Agents|dermatologic agents|mesh-ancestor
139199075|NCT05282771|Keratolytic Agents|keratolytic agents|mesh-ancestor
139199076|NCT05282771|Vitamin B Complex|vitamin b complex|mesh-ancestor
139199077|NCT05282771|Vitamins|vitamins|mesh-ancestor
139199078|NCT05282771|Micronutrients|micronutrients|mesh-ancestor
139199079|NCT05282771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199080|NCT05282771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139199081|NCT05282771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139199083|NCT05282771|Hormones|hormones|mesh-ancestor
139199084|NCT05282771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139199085|NCT05487833|Insulin|insulin|mesh-list
139199086|NCT05487833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139199087|NCT05487833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199088|NCT03600805|Prednisone|prednisone|mesh-list
139199089|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139199090|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
139199091|NCT03600805|Hormones|hormones|mesh-ancestor
139199092|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139199093|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199094|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139199095|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199096|NCT01198379|Aspirin|aspirin|mesh-list
138949556|NCT02534623|Fentanyl|fentanyl|mesh-list
139199097|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139199098|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139199099|NCT01198379|Analgesics|analgesics|mesh-ancestor
139199100|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
139199101|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199102|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199103|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139199104|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139199105|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139199106|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139199107|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199108|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139199109|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139199110|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199111|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
139199112|NCT03848039|Vaccines|vaccines|mesh-list
139199113|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
139199114|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199115|NCT01296269|Vasopressins|vasopressins|mesh-list
139199116|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
139199117|NCT01296269|Oxytocin|oxytocin|mesh-list
139199118|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
139199119|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139199120|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199121|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
139199122|NCT01296269|Coagulants|coagulants|mesh-ancestor
139199123|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139199124|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139199125|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
139199126|NCT05595772|Mitogens|mitogens|mesh-list
139199127|NCT05595772|Mitosis Modulators|mitosis modulators|mesh-ancestor
139199128|NCT05595772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199129|NCT03844451|Epinephrine|epinephrine|mesh-list
139199130|NCT03844451|Bupivacaine|bupivacaine|mesh-list
139199131|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
139199132|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
139199133|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199134|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199135|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
139199136|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199137|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139199138|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139199139|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
139199140|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139199141|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199142|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139199143|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139199144|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
139199145|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139199146|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
139199147|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
139199148|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
139199149|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139199150|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
139199151|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139199152|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199153|NCT03386214|Pevonedistat|pevonedistat|mesh-list
139199154|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199155|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199156|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139199157|NCT01198535|Cetuximab|cetuximab|mesh-list
139199158|NCT01198535|Antibodies|antibodies|mesh-list
139199159|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
139199160|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139199161|NCT01198535|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139199162|NCT01198535|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139199163|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
139199164|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199165|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199166|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199167|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199168|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
139199169|NCT03844763|Avelumab|avelumab|mesh-list
139199170|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139199171|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
139199172|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199173|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139199174|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139199175|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
139199176|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199177|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199178|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139199179|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139199180|NCT01198925|Piperacillin|piperacillin|mesh-list
139199181|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139199182|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199183|NCT03844139|Glycerol|glycerol|mesh-list
139199184|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139199185|NCT03844139|Protective Agents|protective agents|mesh-ancestor
139199186|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199187|NCT04500496|Isoniazid|isoniazid|mesh-list
139199188|NCT04500496|Dinoprostone|dinoprostone|mesh-list
139199189|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
139199190|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139199191|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199192|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
139199193|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139199194|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199195|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139199196|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139199197|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
139199198|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199199|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139199200|NCT01199081|Dronedarone|dronedarone|mesh-list
139199201|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139199202|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139199203|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139199204|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139199205|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199206|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139199207|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
139199208|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199209|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
139199210|NCT05670353|Contraceptive Agents|contraceptive agents|mesh-list
139199211|NCT05670353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-list
139199212|NCT05670353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139199213|NCT05670353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199214|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
139199215|NCT01199159|Pyridoxal|pyridoxal|mesh-list
139199216|NCT01199159|Pyridoxine|pyridoxine|mesh-list
139199217|NCT01199159|Misoprostol|misoprostol|mesh-list
139199218|NCT01199159|Vitamins|vitamins|mesh-ancestor
139199219|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
139199220|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199221|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139199222|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
139199223|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139199224|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139199225|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139199226|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
139199227|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
139199228|NCT05669963|Lactoferrin|lactoferrin|mesh-list
139199229|NCT05669963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199231|NCT02507440|Propofol|propofol|mesh-list
139199232|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
139199233|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
139199234|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199235|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199236|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
139199237|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199238|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139199239|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139199240|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139199241|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139199242|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199243|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139199244|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138949707|NCT00875355|Temozolomide|temozolomide|mesh-list
139199245|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
139199246|NCT02507362|Riboflavin|riboflavin|mesh-list
139199247|NCT02507362|Dextrans|dextrans|mesh-list
139199248|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
139199249|NCT02507362|Vitamins|vitamins|mesh-ancestor
139199250|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
139199251|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199252|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139199253|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
139199254|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
139199255|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
139199256|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
139199257|NCT05640830|Paclitaxel|paclitaxel|mesh-list
139199258|NCT05640830|Bevacizumab|bevacizumab|mesh-list
139199259|NCT05640830|Trastuzumab|trastuzumab|mesh-list
139199260|NCT05640830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139199261|NCT05640830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199262|NCT05640830|Tubulin Modulators|tubulin modulators|mesh-ancestor
139199263|NCT05640830|Antimitotic Agents|antimitotic agents|mesh-ancestor
139199264|NCT05640830|Mitosis Modulators|mitosis modulators|mesh-ancestor
139199265|NCT05640830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199266|NCT05640830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139199267|NCT05640830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139199268|NCT05640830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139199269|NCT05640830|Growth Substances|growth substances|mesh-ancestor
139199270|NCT05640830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199271|NCT05640830|Growth Inhibitors|growth inhibitors|mesh-ancestor
139199272|NCT03730961|Furosemide|furosemide|mesh-list
139199273|NCT03730961|Diuretics|diuretics|mesh-ancestor
139199274|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
139199275|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199276|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139199277|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139199278|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199279|NCT01078454|Dexamethasone|dexamethasone|mesh-list
139199280|NCT01078454|Bortezomib|bortezomib|mesh-list
139199281|NCT01078454|Melphalan|melphalan|mesh-list
139199282|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139199283|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
139199284|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
139199285|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199286|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199287|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139199288|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
139199289|NCT01078454|Hormones|hormones|mesh-ancestor
139199290|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139199291|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139199292|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199293|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139199294|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
139199295|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199296|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139199297|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139199298|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
139199299|NCT02968602|Minocycline|minocycline|mesh-list
139199300|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139199301|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199302|NCT03345004|Vitamin D|vitamin d|mesh-list
139199303|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
139199304|NCT03345004|Cholecalciferol|cholecalciferol|mesh-list
139199305|NCT03345004|Vitamins|vitamins|mesh-list
139199306|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
139199307|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199308|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139199309|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139199310|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
139199311|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139199312|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199313|NCT03003468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139199314|NCT03003468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199315|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139199316|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199317|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199318|NCT03552523|Pancrelipase|pancrelipase|mesh-list
139199319|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139199320|NCT03728101|Dabigatran|dabigatran|mesh-list
139199321|NCT03728101|Simvastatin|simvastatin|mesh-list
139199322|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139199323|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139199324|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
139199325|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199326|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139199327|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139199328|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199329|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
139199330|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139199331|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
139199332|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
139199334|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139199335|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
139199336|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139199337|NCT04170972|Insulin|insulin|mesh-list
139199338|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139199339|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199340|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
139199341|NCT02515864|Dotinurad|dotinurad|mesh-list
139199342|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139199343|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139199344|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199345|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139199346|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139199347|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199348|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199349|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064318|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
139199350|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139199351|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
139199352|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139199353|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199354|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139199355|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139199356|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139199357|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
139199358|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
139199359|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139199360|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
139199361|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
139199362|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
139199363|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139199364|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199365|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199366|NCT02892409|Amoxicillin|amoxicillin|mesh-list
139199367|NCT02892409|Clarithromycin|clarithromycin|mesh-list
139199368|NCT02892409|Lansoprazole|lansoprazole|mesh-list
139199369|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
139199370|NCT02892409|Bismuth|bismuth|mesh-list
139199371|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139199372|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199373|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139199374|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199375|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199376|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139199377|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139199378|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139199379|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139199380|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139199381|NCT02892409|Antacids|antacids|mesh-ancestor
139199382|NCT02507128|Liraglutide|liraglutide|mesh-list
139199383|NCT02507128|Glucagon|glucagon|mesh-list
139199384|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139199385|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139199386|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199387|NCT02507128|Incretins|incretins|mesh-ancestor
139199388|NCT02507128|Hormones|hormones|mesh-ancestor
139199389|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139199390|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139199391|NCT03844529|Lidocaine|lidocaine|mesh-list
139199392|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
139199393|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
139199394|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138949856|NCT00548548|Capecitabine|capecitabine|mesh-list
139199395|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199396|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
139199397|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199398|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139199399|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139199400|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139199401|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139199402|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199403|NCT02292758|Bevacizumab|bevacizumab|mesh-list
139199404|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139199406|NCT02292758|Irinotecan|irinotecan|mesh-list
139199407|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
139199408|NCT02292758|Antibodies|antibodies|mesh-list
139199409|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
139199410|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139199411|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
139199412|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199413|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139199414|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139199415|NCT02292758|Growth Substances|growth substances|mesh-ancestor
139199416|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199417|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
139199418|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
139199419|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139199420|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139199421|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199422|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199423|NCT03727867|Mitogens|mitogens|mesh-list
139199424|NCT03727867|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139199425|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
139199426|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199427|NCT03727867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139199428|NCT03727867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199429|NCT02832648|Selenium|selenium|mesh-list
139199430|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
139199431|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199432|NCT02832648|Protective Agents|protective agents|mesh-ancestor
139199433|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199434|NCT02832648|Trace Elements|trace elements|mesh-ancestor
139199435|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
139199436|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
139199437|NCT04497766|Analgesics|analgesics|mesh-ancestor
139199438|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
139199439|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199440|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199441|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
139199442|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199443|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139199444|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
139199445|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139199446|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139199447|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199448|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139199449|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
139199450|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139199451|NCT03841721|Linezolid|linezolid|mesh-list
139199452|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139199453|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199454|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139199455|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199456|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199457|NCT03620526|Iloprost|iloprost|mesh-list
139199458|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139199459|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
139199460|NCT03843749|Trastuzumab|trastuzumab|mesh-list
139199461|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139199462|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199463|NCT01199783|Vancomycin|vancomycin|mesh-list
139199464|NCT01199783|Daptomycin|daptomycin|mesh-list
139199465|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139199466|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199467|NCT03192306|Ethanol|ethanol|mesh-list
139199468|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139199469|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199470|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199471|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199472|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
139199473|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139199475|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199476|NCT03216954|Expectorants|expectorants|mesh-ancestor
139199477|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
139199478|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139199479|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
139199480|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199481|NCT03216954|Protective Agents|protective agents|mesh-ancestor
139199482|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199483|NCT03216954|Antidotes|antidotes|mesh-ancestor
139199484|NCT05669807|Paclitaxel|paclitaxel|mesh-list
139199485|NCT05669807|Irinotecan|irinotecan|mesh-list
139199486|NCT05669807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139199487|NCT05669807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139199488|NCT05669807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199489|NCT05669807|Tubulin Modulators|tubulin modulators|mesh-ancestor
139199490|NCT05669807|Antimitotic Agents|antimitotic agents|mesh-ancestor
139199491|NCT05669807|Mitosis Modulators|mitosis modulators|mesh-ancestor
139199492|NCT05669807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199493|NCT05669807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139199494|NCT05669807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139199495|NCT05669807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199496|NCT03599089|Acetaminophen|acetaminophen|mesh-list
139199497|NCT03599089|Ketorolac|ketorolac|mesh-list
139199498|NCT03599089|Oxycodone|oxycodone|mesh-list
139199499|NCT03599089|Bupivacaine|bupivacaine|mesh-list
139199500|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
139199501|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
139199502|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199503|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199504|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
139199505|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199506|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139199507|NCT03599089|Analgesics|analgesics|mesh-ancestor
139199508|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
139199509|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139199510|NCT03599089|Narcotics|narcotics|mesh-ancestor
139199511|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139199512|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139199513|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139199514|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139199515|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199516|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199517|NCT03597529|Melatonin|melatonin|mesh-list
139199518|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
139199519|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199520|NCT03597529|Protective Agents|protective agents|mesh-ancestor
139199521|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199522|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199523|NCT05420454|Paclitaxel|paclitaxel|mesh-list
139199524|NCT05420454|Docetaxel|docetaxel|mesh-list
139199525|NCT05420454|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139199526|NCT05420454|Cyclophosphamide|cyclophosphamide|mesh-list
139199527|NCT05420454|Carboplatin|carboplatin|mesh-list
139199528|NCT05420454|Trastuzumab|trastuzumab|mesh-list
139199529|NCT05420454|Epirubicin|epirubicin|mesh-list
139199530|NCT05420454|Pertuzumab|pertuzumab|mesh-list
139199531|NCT05420454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139199532|NCT05420454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199533|NCT05420454|Tubulin Modulators|tubulin modulators|mesh-ancestor
139199534|NCT05420454|Antimitotic Agents|antimitotic agents|mesh-ancestor
139199535|NCT05420454|Mitosis Modulators|mitosis modulators|mesh-ancestor
139199536|NCT05420454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199537|NCT05420454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139199538|NCT05420454|Immunologic Factors|immunologic factors|mesh-ancestor
139199539|NCT05420454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199540|NCT05420454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139199541|NCT05420454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139199542|NCT05420454|Alkylating Agents|alkylating agents|mesh-ancestor
139199543|NCT05420454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139199544|NCT05420454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139199545|NCT05420454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139199546|NCT05420454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139199547|NCT05420454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139199548|NCT05420454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199549|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
139199550|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
139199551|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199552|NCT04667507|Dexamethasone|dexamethasone|mesh-list
139199553|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139199554|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
139199555|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
139199556|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199557|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199558|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139199559|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
139199560|NCT04667507|Hormones|hormones|mesh-ancestor
139199561|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139199562|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139199563|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199564|NCT01200251|Bimatoprost|bimatoprost|mesh-list
139199565|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139199566|NCT03597139|Cyclosporine|cyclosporine|mesh-list
139199567|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139199568|NCT03597139|Cyclosporins|cyclosporins|mesh-list
139199569|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199570|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199571|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139199572|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
139199573|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199574|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
139199575|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199576|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
139199577|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139199578|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139199579|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139199580|NCT01202435|Pregabalin|pregabalin|mesh-list
139199581|NCT01202435|Analgesics|analgesics|mesh-ancestor
139199582|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
139199583|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199584|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199585|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
139199586|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139199587|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139199588|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199589|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139199590|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139199591|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139199592|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199593|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139199594|NCT05406102|Propofol|propofol|mesh-list
139199595|NCT05406102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139199596|NCT05406102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199597|NCT05406102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199598|NCT05406102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139199599|NCT05406102|Anesthetics, General|anesthetics, general|mesh-ancestor
139199600|NCT05406102|Anesthetics|anesthetics|mesh-ancestor
139199601|NCT01204307|Cisplatin|cisplatin|mesh-list
139199602|NCT01204307|Docetaxel|docetaxel|mesh-list
139199603|NCT01204307|Pemetrexed|pemetrexed|mesh-list
139154142|NCT05376046|Hemostatics|hemostatics|mesh-ancestor
139199604|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199605|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
139199606|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
139199607|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
139199608|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199609|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199610|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139199611|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139199612|NCT00708214|Letrozole|letrozole|mesh-list
139199613|NCT00708214|Afatinib|afatinib|mesh-list
139199614|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199615|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139199616|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139199617|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199618|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199619|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139199620|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
139199621|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139064397|NCT01281514|Everolimus|everolimus|mesh-list
139199622|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199623|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139199624|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
138950077|NCT04722718|Paclitaxel|paclitaxel|mesh-list
139199625|NCT02506894|Analgesics|analgesics|mesh-ancestor
139199626|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
139199627|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199628|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199629|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
139199630|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199631|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139199632|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
139199633|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139199634|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139199635|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199636|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139199638|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139199639|NCT04891250|Ivermectin|ivermectin|mesh-list
139199640|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139199641|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199642|NCT03570697|Evolocumab|evolocumab|mesh-list
139199643|NCT03570697|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139199644|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139199645|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139199646|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
139199647|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199648|NCT03570697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139199649|NCT03570697|Protease Inhibitors|protease inhibitors|mesh-ancestor
139199650|NCT03570697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199651|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139199652|NCT02511574|Progesterone|progesterone|mesh-list
139199653|NCT02511574|Progestins|progestins|mesh-ancestor
139199654|NCT02511574|Hormones|hormones|mesh-ancestor
139199655|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139199656|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199657|NCT01200641|Gabapentin|gabapentin|mesh-list
139199658|NCT01200641|Melatonin|melatonin|mesh-list
139199659|NCT01200641|Analgesics|analgesics|mesh-ancestor
139199660|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
139199661|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199662|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199663|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
139199664|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139199665|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139199666|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199667|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139064450|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139199668|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139199669|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139199670|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139199671|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199672|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
139199673|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
139199674|NCT01200641|Protective Agents|protective agents|mesh-ancestor
139199675|NCT01856270|Amitriptyline|amitriptyline|mesh-list
139199676|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139199677|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
139199678|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139199679|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139199680|NCT01856270|Analgesics|analgesics|mesh-ancestor
139199681|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
139199682|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199683|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199684|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139199685|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139199686|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139199687|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199688|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
139199689|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139199690|NCT02511340|Flumatinib|flumatinib|mesh-list
139199691|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139199692|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199693|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199694|NCT02506348|Diclofenac|diclofenac|mesh-list
139199695|NCT02506348|Nepafenac|nepafenac|mesh-list
139199696|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139199697|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139199698|NCT02506348|Analgesics|analgesics|mesh-ancestor
139199699|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
139199700|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199701|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199702|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139199703|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139199704|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139199705|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199706|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199707|NCT01318070|Pioglitazone|pioglitazone|mesh-list
139199708|NCT01318070|Alogliptin|alogliptin|mesh-list
139199709|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139199710|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199711|NCT01318070|Incretins|incretins|mesh-ancestor
139199712|NCT01318070|Hormones|hormones|mesh-ancestor
139199713|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139199714|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139199715|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
139199716|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199717|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199718|NCT01202513|Bimatoprost|bimatoprost|mesh-list
139199719|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139199720|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139199721|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139199722|NCT03835715|Vortioxetine|vortioxetine|mesh-list
139199723|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
139199724|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139199725|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139199726|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139199727|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255418|NCT00000399|Hormones|hormones|mesh-list
139199728|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199729|NCT03835715|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139199730|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139199731|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139199732|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199733|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139199734|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
139199735|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139199736|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139199737|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139199738|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139199739|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
139199740|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139199741|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139199742|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139199743|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199744|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
139199745|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139199746|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199747|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139154144|NCT03034304|Carboplatin|carboplatin|mesh-list
139199748|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199749|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139199751|NCT03843281|Morphine|morphine|mesh-list
139199752|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139199753|NCT03843281|Narcotics|narcotics|mesh-ancestor
139199754|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199755|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199756|NCT03843281|Analgesics|analgesics|mesh-ancestor
139199757|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
139199758|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199759|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139199760|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
139199761|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139199762|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
139199763|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199764|NCT03843515|Nivolumab|nivolumab|mesh-list
139199765|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139199766|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199767|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139199768|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199769|NCT00245960|Etanercept|etanercept|mesh-list
139199770|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139199771|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139199772|NCT00245960|Analgesics|analgesics|mesh-ancestor
139199773|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
139199774|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199775|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199776|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139199777|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139199778|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139199779|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139199780|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
139199781|NCT04443322|Durvalumab|durvalumab|mesh-list
139199782|NCT04443322|Lenvatinib|lenvatinib|mesh-list
139199783|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139199784|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139199785|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199786|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
139199787|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199788|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139199789|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199790|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199791|NCT01202825|Simeprevir|simeprevir|mesh-list
139199792|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
139199793|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199794|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
139199795|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199796|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199797|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139199798|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139199799|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199800|NCT05222204|Paclitaxel|paclitaxel|mesh-list
139199801|NCT05222204|Gemcitabine|gemcitabine|mesh-list
139199802|NCT05222204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139199803|NCT05222204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199804|NCT05222204|Tubulin Modulators|tubulin modulators|mesh-ancestor
139199805|NCT05222204|Antimitotic Agents|antimitotic agents|mesh-ancestor
139199806|NCT05222204|Mitosis Modulators|mitosis modulators|mesh-ancestor
139199807|NCT05222204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199808|NCT05222204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139199809|NCT05222204|Antimetabolites|antimetabolites|mesh-ancestor
139199810|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
139199811|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139199812|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
139199813|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139199814|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
139199815|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199816|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199817|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
139199818|NCT05218616|Sunitinib|sunitinib|mesh-list
139199819|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199820|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139154146|NCT03034304|Doxorubicin|doxorubicin|mesh-list
139199821|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139199822|NCT05218616|Growth Substances|growth substances|mesh-ancestor
139199823|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199824|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
139199825|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139199826|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199827|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199828|NCT02505880|Anesthetics|anesthetics|mesh-list
139199829|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
139199830|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199831|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199832|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
139199833|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199834|NCT02510950|Temozolomide|temozolomide|mesh-list
139199835|NCT02510950|Poly ICLC|poly iclc|mesh-list
139199836|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139199837|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
139199838|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199839|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199840|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
139199841|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
139199842|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199843|NCT05221736|Ethanol|ethanol|mesh-list
139199844|NCT05221736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139199845|NCT05221736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199846|NCT05221736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950324|NCT02543073|Hormones|hormones|mesh-ancestor
139199847|NCT05221736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199848|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
139199849|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139199850|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199851|NCT02505568|Infliximab|infliximab|mesh-list
139199852|NCT02505568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139199853|NCT02505568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139199854|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
139199855|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139199856|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139199857|NCT05356728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139199858|NCT05356728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139199859|NCT05217836|Hepcidins|hepcidins|mesh-list
139199860|NCT05217836|Chrysarobin|chrysarobin|mesh-list
139199861|NCT05217836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139199862|NCT05217836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139199863|NCT05217836|Analgesics|analgesics|mesh-ancestor
139199864|NCT05217836|Sensory System Agents|sensory system agents|mesh-ancestor
139199865|NCT05217836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199866|NCT05217836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199867|NCT05217836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139199868|NCT05217836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139199869|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199870|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
139199871|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199872|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199873|NCT02514538|Acetaminophen|acetaminophen|mesh-list
139199874|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139199875|NCT02514538|Analgesics|analgesics|mesh-ancestor
139199876|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
139199877|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199878|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199879|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
139199880|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
139199881|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139199882|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199883|NCT03832673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139199884|NCT03832673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199885|NCT02504944|Propranolol|propranolol|mesh-list
139199886|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139199887|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139199888|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139199889|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139199890|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
139199891|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139199892|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199893|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199894|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139199895|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139199896|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
139199897|NCT01201499|Morphine|morphine|mesh-list
139199898|NCT01201499|Remifentanil|remifentanil|mesh-list
139199899|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139199900|NCT01201499|Narcotics|narcotics|mesh-ancestor
139199901|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199902|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199903|NCT01201499|Analgesics|analgesics|mesh-ancestor
139199904|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
139199905|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199906|NCT03473639|Capecitabine|capecitabine|mesh-list
139199907|NCT03473639|Entinostat|entinostat|mesh-list
139199908|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139199909|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
139199910|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199911|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199912|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139199913|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199914|NCT03121690|Prednisone|prednisone|mesh-list
139199915|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139199916|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
139199917|NCT03121690|Hormones|hormones|mesh-ancestor
139199918|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139199919|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199920|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139199921|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199922|NCT03831269|Azithromycin|azithromycin|mesh-list
139199923|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139199924|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199925|NCT02504476|Midazolam|midazolam|mesh-list
139199926|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139199927|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139199928|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139199929|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199930|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139199931|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139199932|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139199933|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139199934|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
139199936|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
139199937|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
139199938|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139199939|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199940|NCT02504398|Methamphetamine|methamphetamine|mesh-list
139199941|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139199942|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199943|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
139199944|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
139199945|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139199946|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
139199947|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139199948|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199949|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
139199950|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139199951|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139199952|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139199953|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139199954|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139199955|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139199956|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199957|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
139199958|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
139199959|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199960|NCT03830489|Protective Agents|protective agents|mesh-ancestor
139199961|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199962|NCT03830489|Vitamins|vitamins|mesh-ancestor
139199963|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
139199964|NCT02509468|Sirolimus|sirolimus|mesh-list
139199965|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139199966|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199967|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139199968|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199969|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
139199970|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139199971|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
139199972|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139199973|NCT03344614|Apatinib|apatinib|mesh-list
139199974|NCT03344614|Raltitrexed|raltitrexed|mesh-list
139199975|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139199976|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139199977|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199978|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199979|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139199980|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
139199981|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139199982|NCT01205087|Omeprazole|omeprazole|mesh-list
139199983|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139199984|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139199985|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139199986|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199987|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199988|NCT01205243|Abacavir|abacavir|mesh-list
139199989|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139199990|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139199991|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139199992|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139199993|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
138950474|NCT05895201|Bortezomib|bortezomib|mesh-list
139199994|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139199995|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139199996|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139199997|NCT02504164|Midazolam|midazolam|mesh-list
139199998|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139199999|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139200000|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139200001|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200003|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139200004|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139200005|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139200006|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
139200007|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
139200008|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
139200009|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
139200010|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200011|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200012|NCT02509234|Irinotecan|irinotecan|mesh-list
139200013|NCT02509234|Trabectedin|trabectedin|mesh-list
139200014|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139200015|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139200016|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200017|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200018|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200019|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139200020|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
139200021|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
139200022|NCT01205321|Bombesin|bombesin|mesh-list
139200023|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200024|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200025|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200026|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139200027|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
139200028|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139200029|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200030|NCT03566485|Atezolizumab|atezolizumab|mesh-list
139200031|NCT03566485|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139200032|NCT03566485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200033|NCT03566485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139200034|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200035|NCT02513290|Loratadine|loratadine|mesh-list
139200036|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
139200037|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
139200038|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139200039|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139200040|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139154149|NCT03034304|Antibodies|antibodies|mesh-list
139200042|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
139200043|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200044|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200045|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200046|NCT02501200|Ezetimibe|ezetimibe|mesh-list
139200047|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139200048|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139200049|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
139200050|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200051|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139200052|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139200053|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139200054|NCT02501278|Cisplatin|cisplatin|mesh-list
139200055|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200056|NCT03176238|Everolimus|everolimus|mesh-list
139200057|NCT03176238|Exemestane|exemestane|mesh-list
139200058|NCT03176238|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139200059|NCT03176238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139200060|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200061|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200062|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139200063|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
139200064|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200065|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200066|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139200067|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139200068|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139200069|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
139200070|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139200071|NCT01957332|Trastuzumab|trastuzumab|mesh-list
139200072|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139200073|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200074|NCT01205711|Leucovorin|leucovorin|mesh-list
139200075|NCT01205711|Fluorouracil|fluorouracil|mesh-list
139200076|NCT01205711|Irinotecan|irinotecan|mesh-list
139200077|NCT01205711|Calcium|calcium|mesh-list
139200078|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
139200079|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139200080|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200081|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
139200082|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200083|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139200084|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200085|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139200086|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
139200087|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139200088|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139200089|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200090|NCT01205711|Antidotes|antidotes|mesh-ancestor
139200091|NCT01205711|Protective Agents|protective agents|mesh-ancestor
139200092|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
139200093|NCT01205711|Vitamins|vitamins|mesh-ancestor
139200094|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
139200095|NCT02508922|Vitamin D|vitamin d|mesh-list
139064615|NCT03870490|Cefepime|cefepime|mesh-list
139200096|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
139200097|NCT02508922|Vitamins|vitamins|mesh-ancestor
139200098|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
139200099|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200100|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139200101|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139200102|NCT03730675|Sorafenib|sorafenib|mesh-list
139200103|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200104|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139200105|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200106|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200107|NCT01345682|Methotrexate|methotrexate|mesh-list
139200108|NCT01345682|Afatinib|afatinib|mesh-list
139200109|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139200110|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
139200111|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139200112|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200113|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139200114|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
139200115|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200116|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200117|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
139200118|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200119|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139200120|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139200121|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
139200122|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200123|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139200124|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139200125|NCT03562117|Gepotidacin|gepotidacin|mesh-list
139200126|NCT03562117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139200127|NCT03562117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200128|NCT03562117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200129|NCT03562117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200130|NCT02503462|Ritonavir|ritonavir|mesh-list
139200131|NCT02503462|Darunavir|darunavir|mesh-list
139200132|NCT02503462|Cobicistat|cobicistat|mesh-list
139200133|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139200134|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139200135|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
139200136|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200137|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200138|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139200139|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139200140|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
139200141|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064652|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
139200142|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139200143|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139200144|NCT03343678|Venetoclax|venetoclax|mesh-list
139200145|NCT03343678|BI 836826|bi 836826|mesh-list
139200146|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200147|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139200149|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
139200150|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139200151|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
139200152|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200153|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200154|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
139200155|NCT04498936|Ledipasvir|ledipasvir|mesh-list
139200156|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139200157|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
139200158|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
139200159|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200160|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139200161|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
139200162|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139200163|NCT03627260|Protective Agents|protective agents|mesh-ancestor
139200164|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200165|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
139200166|NCT05706038|Adalimumab|adalimumab|mesh-list
139200167|NCT05706038|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139200168|NCT05706038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139200169|NCT05706038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200170|NCT03546907|Cholinergic Agents|cholinergic agents|mesh-list
139200171|NCT03546907|Muscarinic Agonists|muscarinic agonists|mesh-list
139200172|NCT03546907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200173|NCT03546907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200174|NCT03546907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200175|NCT03546907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139200176|NCT05126264|Ibuprofen|ibuprofen|mesh-list
139200177|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139200178|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139200179|NCT05126264|Analgesics|analgesics|mesh-ancestor
139200180|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
139200181|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200182|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200183|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139200184|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200185|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139200186|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200187|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200188|NCT03001817|Fenofibrate|fenofibrate|mesh-list
139200189|NCT03001817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139064686|NCT00163020|Progestins|progestins|mesh-ancestor
139200190|NCT03001817|Antimetabolites|antimetabolites|mesh-ancestor
139200191|NCT03001817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200192|NCT03001817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139200193|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
139200194|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139200195|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139200196|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200197|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
139200198|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
139200199|NCT03590743|Apixaban|apixaban|mesh-list
139200200|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139200201|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
139200202|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139200203|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
139200204|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200205|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200206|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
139200207|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
139200208|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200209|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139200210|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200211|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200212|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139200213|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
139200214|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200215|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
139200216|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139200217|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
139200218|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200219|NCT03121222|Expectorants|expectorants|mesh-ancestor
139200220|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
139200221|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139200222|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
139200223|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200224|NCT03121222|Protective Agents|protective agents|mesh-ancestor
139200225|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200226|NCT03121222|Antidotes|antidotes|mesh-ancestor
139200227|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
139200228|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139200229|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139200230|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139200231|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
139200232|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200233|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139200234|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139200235|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200236|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139200238|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
139200239|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139200240|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200241|NCT03545503|Ketamine|ketamine|mesh-list
139200242|NCT03545503|Etomidate|etomidate|mesh-list
139200243|NCT03545503|Analgesics|analgesics|mesh-ancestor
139200244|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
139200245|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200246|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200247|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139200248|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139200249|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
139200250|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
139200251|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139200252|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139200253|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139200254|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200255|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200256|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139200257|NCT01297829|Ibuprofen|ibuprofen|mesh-list
139200258|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139200259|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139200260|NCT01297829|Analgesics|analgesics|mesh-ancestor
139200261|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
139200262|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200263|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200264|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139200265|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200266|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139200267|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200268|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200269|NCT03829943|Vitamin D|vitamin d|mesh-list
139200270|NCT03829943|Vitamins|vitamins|mesh-ancestor
139200271|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
139200272|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200273|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139200274|NCT02508142|Scopolamine|scopolamine|mesh-list
139200275|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139200276|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139200277|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
139200278|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
139200279|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200280|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200281|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139200282|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
139200283|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139200284|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
139200285|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200286|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200287|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139200288|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
139200289|NCT02508220|Oxytocin|oxytocin|mesh-list
139200290|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
139200291|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139200292|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200293|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
139200294|NCT01297907|Miotics|miotics|mesh-ancestor
139200295|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
139200296|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200297|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200298|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139200299|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139200300|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
139200301|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139200302|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139200303|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
139200304|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200305|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200306|NCT02508064|Fostemsavir|fostemsavir|mesh-list
139200307|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139200308|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139200309|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
139200310|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200311|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139200312|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139200313|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200314|NCT05705570|Cyclophosphamide|cyclophosphamide|mesh-list
139200315|NCT05705570|Fludarabine|fludarabine|mesh-list
139200316|NCT05705570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139200317|NCT05705570|Immunologic Factors|immunologic factors|mesh-ancestor
139200318|NCT05705570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200319|NCT05705570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200320|NCT05705570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139200321|NCT05705570|Alkylating Agents|alkylating agents|mesh-ancestor
139200322|NCT05705570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200323|NCT05705570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200324|NCT05705570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139200325|NCT03214380|Insulin|insulin|mesh-list
139200326|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139200327|NCT03214380|Metformin|metformin|mesh-list
139200328|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
139200329|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
139200330|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139200331|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139200332|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200333|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200334|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
139200335|NCT03343444|Ledipasvir|ledipasvir|mesh-list
139200336|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
139200337|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200338|NCT03819101|Aspirin|aspirin|mesh-list
139200339|NCT03819101|Atorvastatin|atorvastatin|mesh-list
139200340|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139200341|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139200342|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
139200343|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200344|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139200345|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139200346|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200347|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139200348|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139200349|NCT03819101|Analgesics|analgesics|mesh-ancestor
139200350|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
139200351|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200352|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200353|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139200354|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200355|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139200356|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139200357|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139200358|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139200359|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
139200360|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139200361|NCT03343366|Metronidazole|metronidazole|mesh-list
139200362|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200363|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139200364|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139200365|NCT01298297|Morphine|morphine|mesh-list
139200366|NCT01298297|Buprenorphine|buprenorphine|mesh-list
139200367|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139200368|NCT01298297|Narcotics|narcotics|mesh-ancestor
139200369|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139200370|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200371|NCT01298297|Analgesics|analgesics|mesh-ancestor
139200372|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
138570398|NCT00403065|Hormones|hormones|mesh-ancestor
139200373|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200374|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139200376|NCT03818945|Fluorides|fluorides|mesh-list
139200377|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
139200378|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
139200379|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
139200380|NCT03818945|Protective Agents|protective agents|mesh-ancestor
139200381|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200382|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139200383|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200384|NCT03842423|Anesthetics|anesthetics|mesh-list
139200385|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139200387|NCT03172026|Maraviroc|maraviroc|mesh-list
139200388|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139200389|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139200390|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200391|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139200392|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139200393|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
139200394|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200395|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139200396|NCT01201577|Azithromycin|azithromycin|mesh-list
139200397|NCT01201577|Sulfalene|sulfalene|mesh-list
139200398|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139200399|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200400|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139200401|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
139064720|NCT01169740|Bilirubin|bilirubin|mesh-list
139200402|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139200403|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139200404|NCT04496050|Alprostadil|alprostadil|mesh-list
139200405|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139200406|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
139200407|NCT04496050|Urological Agents|urological agents|mesh-ancestor
139200408|NCT01300793|Rituximab|rituximab|mesh-list
139200409|NCT01300793|Carboplatin|carboplatin|mesh-list
139200410|NCT01300793|Etoposide|etoposide|mesh-list
139200411|NCT01300793|Bortezomib|bortezomib|mesh-list
139200412|NCT01300793|Ifosfamide|ifosfamide|mesh-list
139200413|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
139200414|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139200415|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200416|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
139200417|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200418|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200419|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139200420|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139200421|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139200422|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200423|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200424|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139200425|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
139200426|NCT03342040|Bupivacaine|bupivacaine|mesh-list
139200427|NCT03342040|Ropivacaine|ropivacaine|mesh-list
139200428|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
139200429|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
139200430|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139200431|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200432|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
139200433|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200434|NCT01298843|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139200435|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139200436|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200437|NCT03336970|Calcium|calcium|mesh-list
139200438|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139200439|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200440|NCT03336814|Terlipressin|terlipressin|mesh-list
139200441|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139200442|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139200443|NCT02495584|Vitamin D|vitamin d|mesh-list
139200444|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
139200445|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
139200446|NCT02495584|Vitamins|vitamins|mesh-list
139200447|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
139200448|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200449|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139200450|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139200451|NCT02495818|Lidocaine|lidocaine|mesh-list
139200452|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
139200453|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
139200454|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139200455|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200456|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
139200457|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200458|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139200459|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139200460|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139200461|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139200462|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200464|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139200465|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
139200466|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139200467|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
139200468|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139200469|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
139200470|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139200471|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
139200472|NCT02495662|Hormones|hormones|mesh-ancestor
139200473|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139200474|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200475|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139200476|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200477|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
139200478|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
139200479|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200480|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139200481|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139200482|NCT02495662|Protective Agents|protective agents|mesh-ancestor
139200483|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139200484|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139200485|NCT02496052|Estradiol|estradiol|mesh-list
139200486|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139200487|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
139200488|NCT02496052|Estrogens|estrogens|mesh-ancestor
139200489|NCT02496052|Hormones|hormones|mesh-ancestor
139200490|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139200491|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200492|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139200493|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
139200494|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139200495|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139200496|NCT02496052|Progestins|progestins|mesh-ancestor
139200497|NCT01206569|Tacrolimus|tacrolimus|mesh-list
139200498|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139200499|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
139200500|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200501|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139200502|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200503|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200504|NCT01206647|Metformin|metformin|mesh-list
139200505|NCT01206647|Saxagliptin|saxagliptin|mesh-list
139200506|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139200507|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200508|NCT01206647|Incretins|incretins|mesh-ancestor
139200509|NCT01206647|Hormones|hormones|mesh-ancestor
139200510|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139200511|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139200512|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
139200513|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200514|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200515|NCT03341884|Ipatasertib|ipatasertib|mesh-list
139200516|NCT03341884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200517|NCT03341884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139200518|NCT03341884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200519|NCT03341884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200520|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
139200521|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139200522|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
139200523|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200524|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200525|NCT02495272|Oxytocin|oxytocin|mesh-list
139200526|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
139200527|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139200528|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200529|NCT03336346|Efavirenz|efavirenz|mesh-list
139200530|NCT03336346|Dolutegravir|dolutegravir|mesh-list
139200531|NCT03336346|Etonogestrel|etonogestrel|mesh-list
139200532|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139200533|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139200534|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200535|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200536|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
139200537|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200538|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139200539|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139200540|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139200541|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139200542|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139200543|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139200544|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139200545|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139200546|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139200547|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139200548|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139200549|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
139200550|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139200551|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200552|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139200553|NCT03841292|Varenicline|varenicline|mesh-list
139200554|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139200555|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139200556|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
139200557|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200558|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200559|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200560|NCT03814577|Antioxidants|antioxidants|mesh-list
139200561|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200562|NCT03814577|Protective Agents|protective agents|mesh-ancestor
139200563|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200564|NCT03730363|Pentamidine|pentamidine|mesh-list
139200565|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
139200566|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200567|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139200568|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139200569|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139200570|NCT01206803|Ganirelix|ganirelix|mesh-list
139200571|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
139200572|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139200573|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200574|NCT03335956|Pioglitazone|pioglitazone|mesh-list
139200575|NCT03335956|Prednisone|prednisone|mesh-list
139200576|NCT03335956|Cortisone|cortisone|mesh-list
139200577|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139200578|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
139200579|NCT03335956|Hormones|hormones|mesh-ancestor
139064765|NCT01172782|Analgesics|analgesics|mesh-ancestor
139200580|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139200581|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200582|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139200583|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200584|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139200585|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
139200586|NCT03817931|Mirabegron|mirabegron|mesh-list
139200587|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139200588|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
139200589|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
139200590|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
139200591|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139200592|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
139200593|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200594|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200595|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200596|NCT03817931|Urological Agents|urological agents|mesh-ancestor
139200597|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139200598|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
139200599|NCT01206881|Docetaxel|docetaxel|mesh-list
139200600|NCT01206881|Doxorubicin|doxorubicin|mesh-list
139200601|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139200602|NCT01206881|Trastuzumab|trastuzumab|mesh-list
139200603|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139200604|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
139200605|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200606|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200607|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139200608|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
139200609|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200610|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200611|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139200612|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
139200613|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
139200614|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
139200615|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139200616|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139200617|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139200618|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200619|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139200621|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139200622|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
139200623|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200624|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200625|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139200626|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
139200627|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200628|NCT03814343|Amphotericin B|amphotericin b|mesh-list
139200629|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139200630|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139200631|NCT03814343|Amebicides|amebicides|mesh-ancestor
139200632|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139200633|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139200634|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200635|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139200636|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
139200637|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139200638|NCT03814343|Protective Agents|protective agents|mesh-ancestor
139200639|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200640|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139200641|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
139200642|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200643|NCT03817541|Propofol|propofol|mesh-list
139200644|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139064771|NCT03866746|Growth Substances|growth substances|mesh-ancestor
139200645|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139200646|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200647|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139200648|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
139200649|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
139200650|NCT03341494|Thalidomide|thalidomide|mesh-list
139200651|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139200652|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
139200653|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200654|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
139200655|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139200656|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200657|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139200658|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139200659|NCT03341494|Growth Substances|growth substances|mesh-ancestor
139200660|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
139200661|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200662|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139200663|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
139200664|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200665|NCT03725995|Lidocaine|lidocaine|mesh-list
139200666|NCT03725995|Midazolam|midazolam|mesh-list
139200667|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
139200668|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
139200669|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139200670|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200671|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
139200672|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200673|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139200674|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139200675|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139200676|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139200677|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200678|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139200679|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139200680|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139200681|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139200682|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139200683|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139200684|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
139200686|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
139200687|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200688|NCT03341260|Diclofenac|diclofenac|mesh-list
139200689|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139200690|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139200691|NCT03341260|Analgesics|analgesics|mesh-ancestor
139200692|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
139200693|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200694|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200695|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139200696|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200697|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139200698|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200699|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200700|NCT03052400|Mifepristone|mifepristone|mesh-list
139200701|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139200702|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
139200703|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139200704|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200705|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139200706|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139064781|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139200707|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139200708|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
139200709|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139200710|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139200711|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
139200712|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139200713|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
139200714|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139200715|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139200716|NCT03341104|Bupivacaine|bupivacaine|mesh-list
139200717|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
139200718|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
139200719|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139200720|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200721|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
139200722|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200723|NCT03335098|Thalidomide|thalidomide|mesh-list
139200724|NCT03335098|Dexamethasone|dexamethasone|mesh-list
139200725|NCT03335098|Bortezomib|bortezomib|mesh-list
139200726|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139200727|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
139200728|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
139200729|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200730|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200731|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139200732|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
139200733|NCT03335098|Hormones|hormones|mesh-ancestor
139200734|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139200735|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139200736|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200737|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139200738|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
139200739|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
139200740|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139200741|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200742|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139200743|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139200744|NCT03335098|Growth Substances|growth substances|mesh-ancestor
139200745|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
139200746|NCT03639571|Ibuprofen|ibuprofen|mesh-list
139200747|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139200748|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139200749|NCT03639571|Analgesics|analgesics|mesh-ancestor
139200750|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
139200751|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200752|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200753|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139200754|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200755|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139200756|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200757|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200758|NCT03052322|Adalimumab|adalimumab|mesh-list
139200759|NCT03052322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139200760|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139200761|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200762|NCT03521791|Bromfenac|bromfenac|mesh-list
139200763|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139200764|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139200765|NCT03521791|Analgesics|analgesics|mesh-ancestor
139200766|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
139200767|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200768|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200769|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139200770|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200771|NCT03521635|Pramipexole|pramipexole|mesh-list
139200772|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
139200773|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200774|NCT03521635|Protective Agents|protective agents|mesh-ancestor
139200775|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200776|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139200777|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139200778|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
139200779|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
139200780|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200781|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
139200782|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139200783|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200784|NCT03813641|Capecitabine|capecitabine|mesh-list
139200785|NCT03813641|Raltitrexed|raltitrexed|mesh-list
139200786|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139200787|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
139200788|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200789|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200790|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139200791|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200792|NCT02492464|Red yeast rice|red yeast rice|mesh-list
139200793|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139200794|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139200795|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139200796|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
139200797|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200798|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200799|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139200800|NCT03340558|Atezolizumab|atezolizumab|mesh-list
139200801|NCT03340558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139200802|NCT03340558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200803|NCT03340558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139200804|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200805|NCT04905108|Riboflavin|riboflavin|mesh-list
139200806|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
139200807|NCT04905108|Vitamins|vitamins|mesh-ancestor
139200808|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
139200809|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200810|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139200811|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
139200812|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
139200813|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139200814|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
139200815|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200816|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
139200817|NCT04443166|Protective Agents|protective agents|mesh-ancestor
139200818|NCT01560221|Buprenorphine|buprenorphine|mesh-list
139200819|NCT01560221|Methadone|methadone|mesh-list
139200820|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139200821|NCT01560221|Narcotics|narcotics|mesh-ancestor
139200822|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139200823|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200824|NCT01560221|Analgesics|analgesics|mesh-ancestor
139200826|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200827|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139200828|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
139200829|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
139200830|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
139200831|NCT03813329|Calcium|calcium|mesh-list
139200832|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139200833|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200834|NCT03813329|Antacids|antacids|mesh-ancestor
139200835|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200836|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139200837|NCT03639415|Oxycodone|oxycodone|mesh-list
139200838|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139200839|NCT03639415|Narcotics|narcotics|mesh-ancestor
139200840|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139200841|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200842|NCT03639415|Analgesics|analgesics|mesh-ancestor
139200843|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
139200844|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200845|NCT02492386|Everolimus|everolimus|mesh-list
139200846|NCT02492386|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139200847|NCT02492386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139200848|NCT02492386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200849|NCT02492386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200850|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139200851|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
139200852|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200853|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200854|NCT03340168|Bisphenol A|bisphenol a|mesh-list
139200855|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139200856|NCT03340168|Estrogens|estrogens|mesh-ancestor
139200857|NCT03340168|Hormones|hormones|mesh-ancestor
139200858|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139200859|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200860|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139200861|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
139200862|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200863|NCT03340168|Protective Agents|protective agents|mesh-ancestor
139200864|NCT01299701|Vadimezan|vadimezan|mesh-list
139200865|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200866|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139200867|NCT01299779|Laxatives|laxatives|mesh-ancestor
139200868|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139200869|NCT03812939|Octreotide|octreotide|mesh-list
139200870|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139200871|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139200872|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200873|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
139200874|NCT03339700|Busulfan|busulfan|mesh-list
139200875|NCT03339700|Gemcitabine|gemcitabine|mesh-list
139200876|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139200877|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
139200878|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200879|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200880|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139200881|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
139200882|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200883|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200884|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139200885|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139200886|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
139200887|NCT01299857|Rituximab|rituximab|mesh-list
139200888|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139200889|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200890|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
139200891|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200892|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200893|NCT03478969|Insulin|insulin|mesh-list
139200894|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139200895|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200896|NCT03812783|Sorafenib|sorafenib|mesh-list
139200897|NCT03812783|Folfirinox|folfirinox|mesh-list
139200898|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200899|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139200900|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200901|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200903|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139200904|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200905|NCT02500498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139200906|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200907|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139200908|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
139200909|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200910|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139200912|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
139200913|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
139200914|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200915|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200916|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139200917|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139200918|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
139200919|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200920|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200921|NCT02499874|Tenofovir|tenofovir|mesh-list
139200922|NCT02499874|Lamivudine|lamivudine|mesh-list
139200923|NCT02499874|Emtricitabine|emtricitabine|mesh-list
139200924|NCT02499874|Zidovudine|zidovudine|mesh-list
139200925|NCT02499874|Efavirenz|efavirenz|mesh-list
139200926|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139200927|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
139200928|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139200929|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139200930|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139200931|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200932|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200933|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139200934|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139200935|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
139200936|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139200937|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139200938|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139200939|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139200940|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139200941|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139200942|NCT02492308|Basiliximab|basiliximab|mesh-list
139200943|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139200944|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
139200945|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200946|NCT05865470|Dronabinol|dronabinol|mesh-list
139200947|NCT05865470|Hallucinogens|hallucinogens|mesh-ancestor
139200948|NCT05865470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200949|NCT05865470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139200950|NCT05865470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139200951|NCT05865470|Analgesics|analgesics|mesh-ancestor
139200952|NCT05865470|Sensory System Agents|sensory system agents|mesh-ancestor
139200953|NCT05865470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200954|NCT05865470|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139200955|NCT05865470|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139200956|NCT05865470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139200957|NCT05865470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200958|NCT05865470|Hormones|hormones|mesh-ancestor
139200959|NCT05865470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139200960|NCT05865431|Zinc Oxide|zinc oxide|mesh-list
139200961|NCT05865431|Avobenzone|avobenzone|mesh-list
139200962|NCT05865431|Dermatologic Agents|dermatologic agents|mesh-ancestor
139200963|NCT05865431|Sunscreening Agents|sunscreening agents|mesh-ancestor
139200964|NCT05865431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139200965|NCT05865431|Protective Agents|protective agents|mesh-ancestor
139200966|NCT05865431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200967|NCT05865288|Oxytocin|oxytocin|mesh-list
139200968|NCT05865288|Oxytocics|oxytocics|mesh-ancestor
139200969|NCT05865288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139200970|NCT05865288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200971|NCT05865132|Palbociclib|palbociclib|mesh-list
139200972|NCT05865132|Afatinib|afatinib|mesh-list
139200973|NCT05865132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139200974|NCT05865132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139200975|NCT05865132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139200976|NCT05865132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139200977|NCT05864885|Minoxidil|minoxidil|mesh-list
139200978|NCT05864885|Latanoprost|latanoprost|mesh-list
139200979|NCT05864885|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139200980|NCT05864885|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139200981|NCT05864885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139200982|NCT05864885|Vasodilator Agents|vasodilator agents|mesh-ancestor
139200983|NCT05864664|Anesthetics|anesthetics|mesh-list
139200984|NCT05864664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139200985|NCT05864664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200986|NCT05864508|Oxytocin|oxytocin|mesh-list
139200987|NCT05864508|Oxytocics|oxytocics|mesh-ancestor
139200988|NCT05864508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139200989|NCT05864508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200990|NCT05864053|Ketamine|ketamine|mesh-list
139200991|NCT05864053|Analgesics|analgesics|mesh-ancestor
139200992|NCT05864053|Sensory System Agents|sensory system agents|mesh-ancestor
139200993|NCT05864053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139200994|NCT05864053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139200995|NCT05864053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139200996|NCT05864053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139200997|NCT05864053|Anesthetics, General|anesthetics, general|mesh-ancestor
139200998|NCT05864053|Anesthetics|anesthetics|mesh-ancestor
139200999|NCT05864053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139201000|NCT05864053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139201001|NCT05864053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139201002|NCT05864053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139201003|NCT05864053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201004|NCT05863975|Interferons|interferons|mesh-list
139201005|NCT05863975|Interferon-alpha|interferon-alpha|mesh-list
139201006|NCT05863975|Interferon alpha-2|interferon alpha-2|mesh-list
139201007|NCT05863975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201008|NCT05863975|Antiviral Agents|antiviral agents|mesh-ancestor
139201009|NCT05863975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201010|NCT05863975|Immunologic Factors|immunologic factors|mesh-ancestor
139201011|NCT05863975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201012|NCT05863949|Vitamin D|vitamin d|mesh-list
139201013|NCT05863949|Calcium|calcium|mesh-list
139201014|NCT05863949|Vitamins|vitamins|mesh-ancestor
139201015|NCT05863949|Micronutrients|micronutrients|mesh-ancestor
139201016|NCT05863949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201017|NCT05863949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139201018|NCT05863949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139201019|NCT05863936|Methylprednisolone|methylprednisolone|mesh-list
139201020|NCT05863936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139201021|NCT05863936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139201022|NCT05863936|Prednisolone|prednisolone|mesh-list
139201023|NCT05863936|Prednisolone acetate|prednisolone acetate|mesh-list
139201024|NCT05863936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139201025|NCT05863936|Prednisolone phosphate|prednisolone phosphate|mesh-list
139201026|NCT05863936|Belimumab|belimumab|mesh-list
139201027|NCT05863936|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139201028|NCT05863936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201029|NCT05863936|Antiemetics|antiemetics|mesh-ancestor
139201030|NCT05863936|Autonomic Agents|autonomic agents|mesh-ancestor
139201031|NCT05863936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201032|NCT05863936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201033|NCT05863936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139201034|NCT05863936|Glucocorticoids|glucocorticoids|mesh-ancestor
139201035|NCT05863936|Hormones|hormones|mesh-ancestor
139201036|NCT05863936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139201037|NCT05863936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139201038|NCT05863936|Protective Agents|protective agents|mesh-ancestor
139201039|NCT05863936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139201040|NCT05863936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201041|NCT05863936|Immunologic Factors|immunologic factors|mesh-ancestor
139201042|NCT05863858|Amoxicillin|amoxicillin|mesh-list
139201043|NCT05863858|Moxifloxacin|moxifloxacin|mesh-list
139201044|NCT05863858|Levofloxacin|levofloxacin|mesh-list
139201045|NCT05863858|Ofloxacin|ofloxacin|mesh-list
139201046|NCT05863858|Tinidazole|tinidazole|mesh-list
139201047|NCT05863858|Omeprazole|omeprazole|mesh-list
139201048|NCT05863858|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139201049|NCT05863858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139201050|NCT05863858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201051|NCT05863858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139201052|NCT05863858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138951529|NCT00612105|Ezogabine|ezogabine|mesh-list
139201053|NCT05863858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201054|NCT05863858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201055|NCT05863858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201056|NCT05863858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139201058|NCT05863858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139201059|NCT05863858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201060|NCT05863858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139201061|NCT05863858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139201062|NCT05863858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139201063|NCT05863858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139201064|NCT05863858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139201065|NCT05863858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139201066|NCT05863858|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139201067|NCT05863858|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139201068|NCT05863858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139201069|NCT05863858|Alkylating Agents|alkylating agents|mesh-ancestor
139201070|NCT05863858|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139201071|NCT05863858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139201072|NCT05863858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139201073|NCT05863845|Cytarabine|cytarabine|mesh-list
139201074|NCT05863845|Etoposide|etoposide|mesh-list
139201075|NCT05863845|Melphalan|melphalan|mesh-list
139201076|NCT05863845|Venetoclax|venetoclax|mesh-list
139201077|NCT05863845|Carmustine|carmustine|mesh-list
139201078|NCT05863845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139201079|NCT05863845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201080|NCT05863845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139201081|NCT05863845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139201082|NCT05863845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201083|NCT05863845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201084|NCT05863845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139201085|NCT05863845|Antimetabolites|antimetabolites|mesh-ancestor
139201086|NCT05863845|Antiviral Agents|antiviral agents|mesh-ancestor
139201087|NCT05863845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201088|NCT05863845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139201089|NCT05863845|Immunologic Factors|immunologic factors|mesh-ancestor
139201090|NCT05863845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201091|NCT05863845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139201092|NCT05863845|Alkylating Agents|alkylating agents|mesh-ancestor
139201093|NCT05863845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139201094|NCT05863832|Metronidazole|metronidazole|mesh-list
139201095|NCT05863832|Ciprofloxacin|ciprofloxacin|mesh-list
139201096|NCT05863832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201097|NCT05863832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139201098|NCT05863832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139201099|NCT05863832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139201100|NCT05863832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139201101|NCT05863832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139201102|NCT05863832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201103|NCT05863832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201104|NCT05863832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201105|NCT05863832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139201106|NCT05863832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139201107|NCT05863585|MEDI9197|medi9197|mesh-list
139201108|NCT05863585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139201109|NCT05863585|Immunologic Factors|immunologic factors|mesh-ancestor
139201110|NCT05863585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201111|NCT05863455|Midazolam|midazolam|mesh-list
139201112|NCT05863455|Sufentanil|sufentanil|mesh-list
139201113|NCT05863455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139201114|NCT05863455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139201115|NCT05863455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139201116|NCT05863455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201117|NCT05863455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139201118|NCT05863455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139201119|NCT05863455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139201120|NCT05863455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139201121|NCT05863455|Anesthetics, General|anesthetics, general|mesh-ancestor
139201122|NCT05863455|Anesthetics|anesthetics|mesh-ancestor
139201123|NCT05863455|GABA Modulators|gaba modulators|mesh-ancestor
139201124|NCT05863455|GABA Agents|gaba agents|mesh-ancestor
139201125|NCT05863455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139201126|NCT05863455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201127|NCT05863455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139201128|NCT05863455|Narcotics|narcotics|mesh-ancestor
138951592|NCT04392921|Amiodarone|amiodarone|mesh-list
139201129|NCT05863455|Analgesics|analgesics|mesh-ancestor
139201130|NCT05863455|Sensory System Agents|sensory system agents|mesh-ancestor
139201131|NCT05863455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201132|NCT05863416|Dexmedetomidine|dexmedetomidine|mesh-list
139201133|NCT05863416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139201134|NCT05863416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139201135|NCT05863416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201136|NCT05863416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139201137|NCT05863416|Analgesics|analgesics|mesh-ancestor
139201138|NCT05863416|Sensory System Agents|sensory system agents|mesh-ancestor
139201139|NCT05863416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201141|NCT05863416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139201142|NCT05863416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139201143|NCT05863416|Adrenergic Agents|adrenergic agents|mesh-ancestor
139201144|NCT05863416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139201145|NCT05863416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201146|NCT05863273|Apremilast|apremilast|mesh-list
139201147|NCT05863273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139201148|NCT05863273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139201149|NCT05863273|Analgesics|analgesics|mesh-ancestor
139201150|NCT05863273|Sensory System Agents|sensory system agents|mesh-ancestor
139201151|NCT05863273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201152|NCT05863273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201153|NCT05863273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201154|NCT05863273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139201155|NCT05863273|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139201156|NCT05863273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139201157|NCT05863273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201158|NCT05863273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201159|NCT05860998|Antibodies|antibodies|mesh-list
139201160|NCT05860998|Immunoglobulin G|immunoglobulin g|mesh-list
139201161|NCT05860998|Immunologic Factors|immunologic factors|mesh-ancestor
139201162|NCT05860998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201163|NCT05856500|Curcumin|curcumin|mesh-list
139201164|NCT05856500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139201165|NCT05856500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139201166|NCT05856500|Analgesics|analgesics|mesh-ancestor
139201167|NCT05856500|Sensory System Agents|sensory system agents|mesh-ancestor
139201168|NCT05856500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201169|NCT05856500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201170|NCT05856500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201171|NCT05856500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139201172|NCT05856500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201173|NCT05856500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201174|NCT05856500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201175|NCT05828303|Metformin|metformin|mesh-list
139201176|NCT05828303|Digoxin|digoxin|mesh-list
139201177|NCT05828303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139201178|NCT05828303|Calcium|calcium|mesh-list
139201179|NCT05828303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139201180|NCT05828303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201181|NCT05828303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139201182|NCT05828303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139201183|NCT05828303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139201184|NCT05828303|Antimetabolites|antimetabolites|mesh-ancestor
139201185|NCT05828303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201186|NCT05828303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139201187|NCT05828303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139201188|NCT05828303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201189|NCT05828303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139201190|NCT05828303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139201191|NCT05828303|Protective Agents|protective agents|mesh-ancestor
139201192|NCT05801705|Tamoxifen|tamoxifen|mesh-list
139201193|NCT05801705|Toremifene|toremifene|mesh-list
139201194|NCT05801705|Hormones|hormones|mesh-list
139201195|NCT05801705|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139201196|NCT05801705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139201197|NCT05801705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201198|NCT05801705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139201199|NCT05801705|Hormone Antagonists|hormone antagonists|mesh-ancestor
139201200|NCT05801705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139201201|NCT05801705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201202|NCT05801705|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139201203|NCT05801705|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139201204|NCT05801705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139201205|NCT05801705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139201206|NCT05801705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201207|NCT05801705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201208|NCT05778617|Ambroxol|ambroxol|mesh-list
139201209|NCT05778617|Expectorants|expectorants|mesh-ancestor
139201210|NCT05778617|Respiratory System Agents|respiratory system agents|mesh-ancestor
139201211|NCT05756153|Cetuximab|cetuximab|mesh-list
139201212|NCT05756153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201213|NCT05756153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201214|NCT05743777|Pembrolizumab|pembrolizumab|mesh-list
139201215|NCT05743777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201216|NCT05743777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201217|NCT05743777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139201218|NCT05743777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201219|NCT05676203|Docetaxel|docetaxel|mesh-list
139201220|NCT05676203|Androgens|androgens|mesh-list
139201221|NCT05676203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201222|NCT05676203|Tubulin Modulators|tubulin modulators|mesh-ancestor
139201223|NCT05676203|Antimitotic Agents|antimitotic agents|mesh-ancestor
139201224|NCT05676203|Mitosis Modulators|mitosis modulators|mesh-ancestor
139201225|NCT05676203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201226|NCT05676203|Hormones|hormones|mesh-ancestor
139201227|NCT05676203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139201228|NCT05676203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201229|NCT05489796|Ketorolac|ketorolac|mesh-list
139201230|NCT05489796|Fentanyl|fentanyl|mesh-list
139201231|NCT05489796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139201232|NCT05489796|Narcotics|narcotics|mesh-ancestor
139201233|NCT05489796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139201234|NCT05489796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201235|NCT05489796|Analgesics|analgesics|mesh-ancestor
139201236|NCT05489796|Sensory System Agents|sensory system agents|mesh-ancestor
139201237|NCT05489796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201238|NCT05489796|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139201239|NCT05489796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139201240|NCT05489796|Anesthetics, General|anesthetics, general|mesh-ancestor
139201241|NCT05489796|Anesthetics|anesthetics|mesh-ancestor
139201242|NCT05489796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139201243|NCT05489796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139201244|NCT05489796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201245|NCT05489796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139201246|NCT05489796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139201247|NCT05489796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201248|NCT05489796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201249|NCT05422131|Clozapine|clozapine|mesh-list
139201250|NCT05422131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139201251|NCT05422131|Serotonin Agents|serotonin agents|mesh-ancestor
139201252|NCT05422131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139201253|NCT05422131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201254|NCT05422131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201255|NCT05422131|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139201256|NCT05422131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139201257|NCT05422131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139201258|NCT05422131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139201259|NCT05422131|GABA Antagonists|gaba antagonists|mesh-ancestor
139201260|NCT05422131|GABA Agents|gaba agents|mesh-ancestor
139201261|NCT05415228|Edetic Acid|edetic acid|mesh-list
139201262|NCT05415228|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139201263|NCT05415228|Chelating Agents|chelating agents|mesh-ancestor
139201264|NCT05415228|Sequestering Agents|sequestering agents|mesh-ancestor
139201265|NCT05415228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201266|NCT05415228|Anticoagulants|anticoagulants|mesh-ancestor
139201267|NCT05415228|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139201268|NCT05415228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139201269|NCT05357079|Tranexamic Acid|tranexamic acid|mesh-list
139201270|NCT05357079|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139201271|NCT05357079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139201272|NCT05357079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201273|NCT05357079|Hemostatics|hemostatics|mesh-ancestor
139201274|NCT05357079|Coagulants|coagulants|mesh-ancestor
139201275|NCT05326997|Tranexamic Acid|tranexamic acid|mesh-list
139201276|NCT05326997|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139201277|NCT05326997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139201278|NCT05326997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201279|NCT05326997|Hemostatics|hemostatics|mesh-ancestor
139201280|NCT05326997|Coagulants|coagulants|mesh-ancestor
139201281|NCT05309629|Carboplatin|carboplatin|mesh-list
139201282|NCT05309629|Etoposide|etoposide|mesh-list
139201283|NCT05309629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201284|NCT05309629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139201285|NCT05309629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139201286|NCT05309629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139154186|NCT00057941|Fulvestrant|fulvestrant|mesh-list
139201287|NCT05309629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201288|NCT05309629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201289|NCT05209620|Pemetrexed|pemetrexed|mesh-list
139201290|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201291|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201292|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201293|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139201294|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139201295|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
139201296|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139201297|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201298|NCT05184062|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139201299|NCT05184062|Antiviral Agents|antiviral agents|mesh-ancestor
139201300|NCT05184062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201301|NCT05153304|Nivolumab|nivolumab|mesh-list
139201302|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201303|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201304|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139201305|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201306|NCT04973748|Analgesics, Opioid|analgesics, opioid|mesh-list
139201307|NCT04973748|Narcotics|narcotics|mesh-ancestor
139201308|NCT04973748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139201309|NCT04973748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201310|NCT04973748|Analgesics|analgesics|mesh-ancestor
139201311|NCT04973748|Sensory System Agents|sensory system agents|mesh-ancestor
139201312|NCT04973748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201313|NCT04967495|Lenvatinib|lenvatinib|mesh-list
139201314|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
139201315|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201316|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139201317|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201318|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201319|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139201320|NCT04967495|Estrogens|estrogens|mesh-ancestor
139201321|NCT04967495|Hormones|hormones|mesh-ancestor
139201322|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139201323|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201324|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139201325|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
139201326|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201327|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201328|NCT04933721|Berotralstat|berotralstat|mesh-list
139201329|NCT04933721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139201330|NCT04933721|Protease Inhibitors|protease inhibitors|mesh-ancestor
139201331|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201332|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201333|NCT04828135|Xenon|xenon|mesh-list
139201334|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139201335|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
139201336|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
139201337|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139201338|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201339|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
139201340|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201341|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201342|NCT04815720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139064891|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
139201343|NCT04815720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201344|NCT04737889|Rituximab|rituximab|mesh-list
139201345|NCT04737889|Methotrexate|methotrexate|mesh-list
139201346|NCT04737889|Lenalidomide|lenalidomide|mesh-list
139201348|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201349|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201350|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
139201351|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201352|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139201353|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139201354|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
139201355|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139201356|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139201357|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
139201358|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201359|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
139201360|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201361|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139201362|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139201363|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139201364|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139201365|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139201366|NCT04737889|Growth Substances|growth substances|mesh-ancestor
139201367|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
139201368|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139201369|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
139201370|NCT04735354|Valsartan|valsartan|mesh-list
139201371|NCT04735354|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139201372|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139201373|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139201374|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139201375|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201376|NCT04679740|Sirolimus|sirolimus|mesh-list
139201377|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139201378|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201379|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139201380|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201381|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
139201382|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139201383|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
139201384|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201385|NCT04672291|Poly I-C|poly i-c|mesh-list
139201386|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139201387|NCT04672291|Poly ICLC|poly iclc|mesh-list
139201388|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
139201389|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
139201390|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201391|NCT04672291|Laxatives|laxatives|mesh-ancestor
139201392|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139201393|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
139201394|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201395|NCT04668365|Prednisone|prednisone|mesh-list
139201396|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
139201397|NCT04668365|Rituximab|rituximab|mesh-list
139201398|NCT04668365|Vincristine|vincristine|mesh-list
139201399|NCT04668365|Epirubicin|epirubicin|mesh-list
139201400|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
139201401|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139201402|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
139201403|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201404|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139201405|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139201406|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
139201407|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201408|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201409|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139201410|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201411|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201412|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
139201413|NCT04668365|Hormones|hormones|mesh-ancestor
139201414|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139201415|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139201416|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139201417|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
139201418|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
139201419|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
139201420|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139201422|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139201423|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201424|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139201425|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139201426|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
139201427|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139201428|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
138951889|NCT00966082|Propranolol|propranolol|mesh-list
139201429|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139201430|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201431|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139201432|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139201433|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201434|NCT04496401|Tacrolimus|tacrolimus|mesh-list
139201435|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139201436|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
139201437|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201438|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139201439|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201440|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201441|NCT04433156|Prednisone|prednisone|mesh-list
139201442|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
139201443|NCT04433156|Rituximab|rituximab|mesh-list
139201444|NCT04433156|Bortezomib|bortezomib|mesh-list
139201445|NCT04433156|Epirubicin|epirubicin|mesh-list
139201446|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139201447|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
139201448|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201449|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139201450|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139201451|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
139201452|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201453|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201454|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139201455|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201456|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201457|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
139201458|NCT04433156|Hormones|hormones|mesh-ancestor
139201459|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139201460|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139201461|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139201462|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139201463|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139201464|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201465|NCT04388176|Compound 21|compound 21|mesh-list
139201466|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201467|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
139201468|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
139201469|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201470|NCT04311489|Ularitide|ularitide|mesh-list
139201471|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139201472|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
139201473|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201474|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201475|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139201476|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
139201477|NCT04311489|Diuretics|diuretics|mesh-ancestor
139201478|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
139201479|NCT04305405|Benralizumab|benralizumab|mesh-list
139201480|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139201481|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
139201482|NCT04255134|Adalimumab|adalimumab|mesh-list
139201483|NCT04255134|Abatacept|abatacept|mesh-list
139201484|NCT04255134|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139201485|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201486|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139201487|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139201488|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201489|NCT04255134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201490|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201491|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139201492|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
139201493|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201494|NCT04192370|Cannabidiol|cannabidiol|mesh-list
139201496|NCT04180371|Nivolumab|nivolumab|mesh-list
139201497|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201498|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201499|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139201500|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201501|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
139201502|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139201503|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
139201504|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139201505|NCT04125472|Lumasiran|lumasiran|mesh-list
139201506|NCT04125472|Renal Agents|renal agents|mesh-ancestor
139201507|NCT04067037|Vincristine|vincristine|mesh-list
139201508|NCT04067037|Epirubicin|epirubicin|mesh-list
139201509|NCT04067037|Dacarbazine|dacarbazine|mesh-list
138933182|NCT05765578|Vaccines|vaccines|mesh-list
139201510|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139201511|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201512|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
139201513|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
139201514|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
139201515|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201516|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139201517|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139201518|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139201519|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201520|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139201521|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
139201522|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
139201523|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201524|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201525|NCT03632941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139201526|NCT03632941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201527|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
139201528|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201529|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201530|NCT03502785|Atezolizumab|atezolizumab|mesh-list
139201531|NCT03502785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139201532|NCT03502785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201533|NCT03502785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201534|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201535|NCT03495960|Rituximab|rituximab|mesh-list
139201536|NCT03495960|Methotrexate|methotrexate|mesh-list
139201537|NCT03495960|Lenalidomide|lenalidomide|mesh-list
139201538|NCT03495960|Temozolomide|temozolomide|mesh-list
139201539|NCT03495960|Procarbazine|procarbazine|mesh-list
139201540|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201541|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201542|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
139201543|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201544|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139201545|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139201546|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
139201547|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139201548|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139201549|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
139201550|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201551|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
139201552|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201553|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139201554|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139201555|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139201556|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139201557|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139201558|NCT03495960|Growth Substances|growth substances|mesh-ancestor
139201559|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
139201560|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139201561|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
139201562|NCT03491683|Temozolomide|temozolomide|mesh-list
139201563|NCT03491683|Cemiplimab|cemiplimab|mesh-list
139201564|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139201565|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
139201566|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201567|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201568|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201569|NCT03351296|Bevacizumab|bevacizumab|mesh-list
139201570|NCT03351296|Capecitabine|capecitabine|mesh-list
139201571|NCT03351296|Temozolomide|temozolomide|mesh-list
139201572|NCT03351296|Streptozocin|streptozocin|mesh-list
139201573|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201574|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201575|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139201576|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139201577|NCT03351296|Growth Substances|growth substances|mesh-ancestor
138952029|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139201578|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201579|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
139201580|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139201581|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
139201582|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201583|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139201584|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
139201585|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139201587|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139201588|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139201589|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201590|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201591|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139201592|NCT03138161|Nivolumab|nivolumab|mesh-list
139201593|NCT03138161|Ipilimumab|ipilimumab|mesh-list
139201594|NCT03138161|Trabectedin|trabectedin|mesh-list
139201595|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201596|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201597|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139201598|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201599|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139201600|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
139201601|NCT03031821|Metformin|metformin|mesh-list
139201602|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139201603|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201604|NCT02907359|Guadecitabine|guadecitabine|mesh-list
139201605|NCT02907359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201606|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
139201607|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
139201608|NCT02647437|Levetiracetam|levetiracetam|mesh-list
139201609|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
139201610|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
139201611|NCT02329080|Cytarabine|cytarabine|mesh-list
139201612|NCT02329080|Rituximab|rituximab|mesh-list
139201613|NCT02329080|Methotrexate|methotrexate|mesh-list
139201614|NCT02329080|Etoposide|etoposide|mesh-list
139201615|NCT02329080|Ifosfamide|ifosfamide|mesh-list
139201616|NCT02329080|Thiotepa|thiotepa|mesh-list
139201617|NCT02329080|Carmustine|carmustine|mesh-list
139201618|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201619|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201620|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
139201621|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201622|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139201623|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139201624|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
139201625|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139201626|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139201627|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
139201628|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201629|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
139201630|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201631|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139201632|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139201633|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139201634|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139201635|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139201636|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139201637|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
139201638|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201639|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139201640|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
139201641|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139201642|NCT02227927|Domperidone|domperidone|mesh-list
139201643|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
139201644|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
139201645|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201646|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201647|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139201648|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139201649|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
139201650|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139201651|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201652|NCT01820910|Doxycycline|doxycycline|mesh-list
139201653|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138952104|NCT00967954|Hormones|hormones|mesh-list
139201654|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201655|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
138933326|NCT05027308|Teduglutide|teduglutide|mesh-list
139201657|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139201659|NCT01808599|Chlorambucil|chlorambucil|mesh-list
139201660|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201661|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201662|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
139201663|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201664|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139201665|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139201666|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
139201667|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201668|NCT00071071|Zanolimumab|zanolimumab|mesh-list
139201669|NCT00071071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139201670|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201671|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201672|NCT00071071|Immunologic Factors|immunologic factors|mesh-ancestor
139201673|NCT00071071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201674|NCT05465278|Alirocumab|alirocumab|mesh-list
139201675|NCT05465278|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139201676|NCT05465278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139201677|NCT05465278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139201678|NCT05465278|Antimetabolites|antimetabolites|mesh-ancestor
139201679|NCT05465278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201680|NCT05465278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139201681|NCT05465278|Protease Inhibitors|protease inhibitors|mesh-ancestor
139201682|NCT05465278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201683|NCT05465278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139201684|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
139201685|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
139201686|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139201687|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139201688|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139201689|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201690|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139201691|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139201692|NCT03339544|Celecoxib|celecoxib|mesh-list
139201693|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139201694|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139201695|NCT03339544|Analgesics|analgesics|mesh-ancestor
139201696|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
139201697|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201698|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201699|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201700|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139201701|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139201702|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139201703|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201704|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201705|NCT03332602|Vitamins|vitamins|mesh-list
139201706|NCT03332602|Folic Acid|folic acid|mesh-list
139201707|NCT03332602|Vitamin A|vitamin a|mesh-list
139201708|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
139201709|NCT03332602|Fesoterodine|fesoterodine|mesh-list
139201710|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
139201711|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
139201712|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201713|NCT03332602|Hematinics|hematinics|mesh-ancestor
139201714|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
139201715|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139201716|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
139201717|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
139201718|NCT03332602|Protective Agents|protective agents|mesh-ancestor
139201720|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201721|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139201722|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201723|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139201724|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139201725|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
139201726|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139201727|NCT03332602|Urological Agents|urological agents|mesh-ancestor
139201728|NCT01302353|Isoflurane|isoflurane|mesh-list
139201729|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139201730|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
139201731|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
139201732|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139201733|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201734|NCT03812315|Propolis|propolis|mesh-list
139201735|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201736|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
139201737|NCT03332524|Ibuprofen|ibuprofen|mesh-list
139201738|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139201739|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139201740|NCT03332524|Analgesics|analgesics|mesh-ancestor
139201741|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
139201742|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201743|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201744|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201745|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139201746|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139201747|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201748|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201749|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
139201750|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
139201751|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139201752|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
139201753|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
139201754|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139201755|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139201756|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
139201757|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
139201758|NCT03812003|Remifentanil|remifentanil|mesh-list
139201759|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139201760|NCT03812003|Narcotics|narcotics|mesh-ancestor
139201761|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139201762|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201763|NCT03812003|Analgesics|analgesics|mesh-ancestor
139201764|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
139201765|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201766|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
139201767|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139201768|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139201769|NCT04874610|Prednisolone|prednisolone|mesh-list
139201770|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
139201771|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139201772|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
139201773|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201774|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
139201775|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
139201776|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201777|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201778|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139201779|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
139201780|NCT04874610|Hormones|hormones|mesh-ancestor
139201781|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139201782|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139201783|NCT04874610|Protective Agents|protective agents|mesh-ancestor
139201784|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139201785|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201786|NCT03518125|Vaccines|vaccines|mesh-list
139201787|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
139201788|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201789|NCT02492230|Warfarin|warfarin|mesh-list
139201790|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
139201791|NCT03169530|Ethanol|ethanol|mesh-list
139201792|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139201793|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201794|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139201795|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201796|NCT02440230|Anastrozole|anastrozole|mesh-list
139201797|NCT02440230|Exemestane|exemestane|mesh-list
139201798|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139201799|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201800|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139201801|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139201802|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201803|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201804|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139201805|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
139201806|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139201807|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201808|NCT03478891|Ansuvimab|ansuvimab|mesh-list
139201809|NCT03478891|Antiviral Agents|antiviral agents|mesh-ancestor
139201810|NCT03478891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201812|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139201813|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139201814|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201815|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201816|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
139201817|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139201818|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201819|NCT01330524|Triamcinolone|triamcinolone|mesh-list
139201820|NCT01330524|Bevacizumab|bevacizumab|mesh-list
139201821|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201822|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201823|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139201824|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139201825|NCT01330524|Growth Substances|growth substances|mesh-ancestor
139201826|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201827|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
139201828|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201829|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
139201830|NCT01330524|Hormones|hormones|mesh-ancestor
139201831|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139201832|NCT01560065|Folic Acid|folic acid|mesh-list
139201833|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
139201834|NCT01560065|Inositol|inositol|mesh-list
139201835|NCT01560065|Hematinics|hematinics|mesh-ancestor
139201836|NCT01560065|Vitamins|vitamins|mesh-ancestor
139201837|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
139201838|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201839|NCT01302587|Albuterol|albuterol|mesh-list
139201840|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139201841|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
139201842|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201843|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201844|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139201845|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
139201846|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
139201847|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139201848|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139201849|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139201850|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139201851|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
139201852|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139201853|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201854|NCT03723109|Anesthetics|anesthetics|mesh-list
139201855|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139201856|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201857|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
139201858|NCT03018288|Temozolomide|temozolomide|mesh-list
139201859|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201860|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201861|NCT03018288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139201862|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201863|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139201864|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
139201865|NCT03515941|Leucovorin|leucovorin|mesh-list
139201866|NCT03515941|Capecitabine|capecitabine|mesh-list
139201867|NCT03515941|Fluorouracil|fluorouracil|mesh-list
139201868|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
139201869|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139201870|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
139201871|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201872|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201873|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139201874|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
139201875|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201876|NCT03515941|Antidotes|antidotes|mesh-ancestor
139201877|NCT03515941|Protective Agents|protective agents|mesh-ancestor
139201878|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
139201879|NCT03515941|Vitamins|vitamins|mesh-ancestor
139201880|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
139201881|NCT03819647|Stiripentol|stiripentol|mesh-list
139201882|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
139201883|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
139201884|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933548|NCT03976258|Narcotics|narcotics|mesh-ancestor
139201885|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201887|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201888|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201889|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201890|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139201891|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139201892|NCT03011034|Daratumumab|daratumumab|mesh-list
139201893|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201894|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
139201895|NCT03515629|Cemiplimab|cemiplimab|mesh-list
139201896|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139201897|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201898|NCT03515629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139201899|NCT03515629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201900|NCT01302821|Tryptophan|tryptophan|mesh-list
139201901|NCT01302821|Vaccines|vaccines|mesh-list
139201902|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
139201903|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201904|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139201905|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
139201906|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139201907|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
139201908|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
139201909|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201910|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139201911|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139201912|NCT03512353|Dexamethasone|dexamethasone|mesh-list
139201913|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201914|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
139201915|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
139201916|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201917|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256290|NCT02974439|Amlodipine|amlodipine|mesh-list
139201918|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139201919|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
139201920|NCT03512353|Hormones|hormones|mesh-ancestor
139201921|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139201922|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139201923|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139201924|NCT04959006|Antioxidants|antioxidants|mesh-list
139201925|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201926|NCT04959006|Protective Agents|protective agents|mesh-ancestor
139201927|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201928|NCT01300637|Metformin|metformin|mesh-list
139201929|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139201930|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201931|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139201932|NCT04851522|Eusol|eusol|mesh-list
139201933|NCT04851522|Petrolatum|petrolatum|mesh-list
139201934|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
139201935|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201936|NCT04851522|Emollients|emollients|mesh-ancestor
139201937|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
139201938|NCT03512275|Antibodies|antibodies|mesh-list
139201939|NCT03512275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139201940|NCT03512275|Immunologic Factors|immunologic factors|mesh-ancestor
139201941|NCT03512275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201942|NCT03809897|Nicotine|nicotine|mesh-list
139201943|NCT03809897|Varenicline|varenicline|mesh-list
139201944|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139201945|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
139201946|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201947|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201948|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139201949|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139201950|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
139201951|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139201952|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201953|NCT03473197|Diacerein|diacerein|mesh-list
139201954|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138952407|NCT00609609|Hormones|hormones|mesh-ancestor
139201955|NCT01560299|Methimazole|methimazole|mesh-list
139201956|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
139201957|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
139201958|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139201959|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201960|NCT03337828|Ethanol|ethanol|mesh-list
139201961|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139201962|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139201963|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139201964|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201965|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
139201966|NCT03510715|Niacin|niacin|mesh-list
139201967|NCT03510715|Niacinamide|niacinamide|mesh-list
139201968|NCT03510715|Atorvastatin|atorvastatin|mesh-list
139201969|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139201970|NCT03510715|Simvastatin|simvastatin|mesh-list
139201971|NCT03510715|Ezetimibe|ezetimibe|mesh-list
139201972|NCT03510715|Pravastatin|pravastatin|mesh-list
139201973|NCT03510715|Alirocumab|alirocumab|mesh-list
139201974|NCT03510715|Lovastatin|lovastatin|mesh-list
139201975|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
139201976|NCT03510715|Fenofibrate|fenofibrate|mesh-list
139201977|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139201978|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139201979|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
139201980|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139201981|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139201982|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139201983|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139201984|NCT03510715|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139201985|NCT03510715|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139201986|NCT03510715|Protease Inhibitors|protease inhibitors|mesh-ancestor
139201987|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
139201988|NCT03510715|Vitamins|vitamins|mesh-ancestor
139201989|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
139201990|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201991|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
139201992|NCT03815279|Dexamethasone|dexamethasone|mesh-list
139201993|NCT03815279|Lenalidomide|lenalidomide|mesh-list
139201994|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139201995|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
139201996|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
139201997|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139201998|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139201999|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139202000|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
139202001|NCT03815279|Hormones|hormones|mesh-ancestor
139202002|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139202003|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139202004|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202005|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
139202006|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139202007|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139202008|NCT03815279|Growth Substances|growth substances|mesh-ancestor
139202009|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
139202010|NCT03814733|Ketamine|ketamine|mesh-list
139202011|NCT03814733|Alprazolam|alprazolam|mesh-list
139202012|NCT03814733|Analgesics|analgesics|mesh-ancestor
139202013|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
139202014|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202015|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202016|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139202017|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139202018|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
139202019|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
139202020|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202021|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139202022|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139202023|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202024|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202025|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139202026|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139202027|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139202028|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139202029|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
139202030|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
139202032|NCT03721627|Ledipasvir|ledipasvir|mesh-list
139202033|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139202034|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
139202035|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139202036|NCT03811223|Evolocumab|evolocumab|mesh-list
139202037|NCT03811223|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139202038|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139202039|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139202040|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
139202041|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202042|NCT03811223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139202043|NCT03811223|Protease Inhibitors|protease inhibitors|mesh-ancestor
139202044|NCT03811223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202045|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139202046|NCT03723031|Misoprostol|misoprostol|mesh-list
139202047|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139202048|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
139202049|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139202050|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202051|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139202052|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139202053|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
139202054|NCT03722875|Apatinib|apatinib|mesh-list
139202055|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202056|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139202057|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202058|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202059|NCT04860713|Aspirin|aspirin|mesh-list
139202060|NCT04860713|Ketamine|ketamine|mesh-list
139202061|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139202062|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139202063|NCT04860713|Analgesics|analgesics|mesh-ancestor
139202064|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
139202065|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202066|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202067|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139202068|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139202069|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139202070|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139202071|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202072|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139202073|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139202074|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202075|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
139202076|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139202077|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139202078|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
139202079|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
139202080|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202081|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139202082|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139202083|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202084|NCT03528577|Albuterol|albuterol|mesh-list
139202085|NCT03528577|Procaterol|procaterol|mesh-list
139202086|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139202087|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
139202088|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202089|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202090|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139202091|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
139202092|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
139202093|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139202094|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139202095|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139202096|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139202097|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
139202098|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202099|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202100|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
139202101|NCT05432414|Dexamethasone|dexamethasone|mesh-list
139202102|NCT05432414|Bortezomib|bortezomib|mesh-list
139202103|NCT05432414|Pomalidomide|pomalidomide|mesh-list
139202104|NCT05432414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139202105|NCT05432414|Antiemetics|antiemetics|mesh-ancestor
139202106|NCT05432414|Autonomic Agents|autonomic agents|mesh-ancestor
139202107|NCT05432414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202108|NCT05432414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202109|NCT05432414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138952550|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139202110|NCT05432414|Glucocorticoids|glucocorticoids|mesh-ancestor
139202111|NCT05432414|Hormones|hormones|mesh-ancestor
139202112|NCT05432414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139202113|NCT05432414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139202114|NCT05432414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202115|NCT05432414|Immunologic Factors|immunologic factors|mesh-ancestor
139202116|NCT05432414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139202117|NCT05432414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139202118|NCT05432414|Growth Substances|growth substances|mesh-ancestor
139202119|NCT05432414|Growth Inhibitors|growth inhibitors|mesh-ancestor
139202120|NCT03796403|Diclofenac|diclofenac|mesh-list
139202121|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139202122|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139202123|NCT03796403|Analgesics|analgesics|mesh-ancestor
139202124|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
139202125|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202126|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202127|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139202128|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139202129|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139202130|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202131|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202132|NCT00706654|Aripiprazole|aripiprazole|mesh-list
139202133|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
139202134|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139202135|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139202136|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139202137|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202138|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202139|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
139202140|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
139202141|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202142|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202143|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139202144|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139202145|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
139202146|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139202147|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139202148|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139202149|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139202150|NCT03471871|Lemborexant|lemborexant|mesh-list
139202151|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139202152|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202153|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202154|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139202155|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139202156|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202157|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202158|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
139202159|NCT04313153|Hematinics|hematinics|mesh-ancestor
139202160|NCT03337672|Midazolam|midazolam|mesh-list
139202161|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
139202162|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139202163|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202164|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202165|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139202166|NCT03337672|Analgesics|analgesics|mesh-ancestor
139202167|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
139202168|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202169|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139202170|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139202171|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139202172|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
139202173|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202174|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202175|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139202176|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139202177|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139202178|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139202179|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139202180|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
139202181|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
139202182|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
139202183|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
139202184|NCT03330808|Anesthetics|anesthetics|mesh-list
139202185|NCT03330808|Ropivacaine|ropivacaine|mesh-list
139202186|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202187|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202188|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
139202189|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
139202190|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202191|NCT01303055|Metformin|metformin|mesh-list
139202192|NCT01303055|Alogliptin|alogliptin|mesh-list
139202193|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139202194|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202195|NCT01303055|Incretins|incretins|mesh-ancestor
139202196|NCT01303055|Hormones|hormones|mesh-ancestor
139202197|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139202198|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139202199|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
139202200|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202201|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202202|NCT03636048|Bupivacaine|bupivacaine|mesh-list
139202203|NCT03636048|Anesthetics|anesthetics|mesh-list
139202204|NCT03636048|Propofol|propofol|mesh-list
139202205|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
139202206|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202207|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202208|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
139202209|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202210|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139202211|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139202212|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
139202213|NCT03527173|Vaccines|vaccines|mesh-list
139202214|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
139202215|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202216|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
139202217|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139202218|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139202219|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139202220|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
139202221|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
139202222|NCT01303601|Olanzapine|olanzapine|mesh-list
139202223|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
139202224|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
139202225|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202226|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202227|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139202228|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139202229|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139202230|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202231|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139202232|NCT01303601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139202233|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139202234|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139202235|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202236|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202237|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
139202238|NCT00707980|Vortioxetine|vortioxetine|mesh-list
139202239|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
139202240|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139202241|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139202242|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139202243|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202244|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202245|NCT00707980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139202246|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139202247|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139202248|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202249|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202250|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
139202251|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139202252|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139202253|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139202254|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139202255|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139202256|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
139202257|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139202258|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139202259|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
139202261|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202262|NCT03051620|Alendronate|alendronate|mesh-list
139202263|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139202264|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202265|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
139202266|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139202267|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
139202268|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202269|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
139202270|NCT02861183|Protective Agents|protective agents|mesh-ancestor
139202271|NCT02498002|Lidocaine|lidocaine|mesh-list
139202272|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
139202273|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
139202274|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202275|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202276|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
139202277|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202278|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139202279|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139202280|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139202281|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139202282|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202283|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
139202284|NCT03810209|Analgesics|analgesics|mesh-ancestor
139202285|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
139202286|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202287|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202288|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
139202289|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202290|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139202291|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
139202292|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139202293|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139202294|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202295|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139202296|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
139202297|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139202298|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
139202299|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202300|NCT03337282|Anesthetics|anesthetics|mesh-list
139202301|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202302|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202303|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
139202304|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139202305|NCT03801707|Velpatasvir|velpatasvir|mesh-list
139202306|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
139202307|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139202308|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
139202309|NCT04239872|Calcium|calcium|mesh-list
139202310|NCT04239872|Fluorides|fluorides|mesh-list
139202311|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139202312|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202313|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139202314|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
139202315|NCT04239872|Protective Agents|protective agents|mesh-ancestor
139202316|NCT03164772|Durvalumab|durvalumab|mesh-list
139202317|NCT03164772|Tremelimumab|tremelimumab|mesh-list
139202318|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139202319|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202320|NCT03801317|Micronutrients|micronutrients|mesh-list
139202321|NCT03801317|Trace Elements|trace elements|mesh-list
139202322|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202323|NCT03337126|Metronidazole|metronidazole|mesh-list
139202324|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139202325|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139202326|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139202327|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139202328|NCT04710732|Enoxaparin|enoxaparin|mesh-list
139202329|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
139202330|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
139202331|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139202332|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139202333|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202334|NCT05014334|Amoxicillin|amoxicillin|mesh-list
139202335|NCT05014334|Clarithromycin|clarithromycin|mesh-list
139202336|NCT05014334|Rabeprazole|rabeprazole|mesh-list
139202338|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139202339|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139202340|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139202341|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202342|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202343|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139202344|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139202345|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139202346|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139202347|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139202348|NCT05014334|Antacids|antacids|mesh-ancestor
139202349|NCT02497378|Dexamethasone|dexamethasone|mesh-list
139202350|NCT02497378|Bortezomib|bortezomib|mesh-list
139202351|NCT02497378|Daratumumab|daratumumab|mesh-list
139202352|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139202353|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
139202354|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
139202355|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202356|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202357|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139202358|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
139202359|NCT02497378|Hormones|hormones|mesh-ancestor
139202360|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139202361|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139202362|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202363|NCT02497222|RNS60|rns60|mesh-list
139202364|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139202365|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139202366|NCT02497222|Analgesics|analgesics|mesh-ancestor
139202367|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
139202368|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202369|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202370|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139202371|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139202372|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139202373|NCT02491606|Tafenoquine|tafenoquine|mesh-list
139202374|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
139202375|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139202376|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139202377|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139202378|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139202379|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139202380|NCT03050450|Lenalidomide|lenalidomide|mesh-list
139202381|NCT03050450|Vorinostat|vorinostat|mesh-list
139202382|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
139202383|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202384|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139202385|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139202386|NCT03050450|Growth Substances|growth substances|mesh-ancestor
139202387|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
139202388|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202389|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139202390|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202391|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202392|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
139202393|NCT03505021|Simendan|simendan|mesh-list
139202394|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139202395|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
139202396|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139202397|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139202398|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202399|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202400|NCT03505021|Protective Agents|protective agents|mesh-ancestor
139202401|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202402|NCT03793283|Insulin|insulin|mesh-list
139202403|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139202404|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139202405|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202406|NCT02496988|Temozolomide|temozolomide|mesh-list
139202407|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139202408|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
139202409|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202410|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202411|NCT03793205|Lenograstim|lenograstim|mesh-list
139202412|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139202413|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
139202414|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202416|NCT03329248|Paclitaxel|paclitaxel|mesh-list
139202417|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
139202418|NCT03329248|Bevacizumab|bevacizumab|mesh-list
139202419|NCT03329248|Capecitabine|capecitabine|mesh-list
139202420|NCT03329248|Fluorouracil|fluorouracil|mesh-list
139202421|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
139202422|NCT03329248|Avelumab|avelumab|mesh-list
139202423|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139202424|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202425|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
139202426|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
139202427|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
139202428|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202429|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139202430|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
139202431|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202432|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139202433|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139202434|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
139202435|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139202436|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139202437|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139202438|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139202439|NCT03329248|Growth Substances|growth substances|mesh-ancestor
139202440|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
139202441|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139202442|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
139202443|NCT03329248|Antidotes|antidotes|mesh-ancestor
139202444|NCT03329248|Protective Agents|protective agents|mesh-ancestor
139202445|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
139202446|NCT03329248|Vitamins|vitamins|mesh-ancestor
139202447|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
139202448|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
139202449|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
139202450|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
139202451|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
139202452|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139202453|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139202454|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202455|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202456|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202457|NCT03792971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139202458|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
139202459|NCT03792971|Protective Agents|protective agents|mesh-ancestor
139202460|NCT03328936|Melphalan|melphalan|mesh-list
139202461|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139202462|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
139202463|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202464|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202465|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139202466|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139202467|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
139202468|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202469|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139202470|NCT02496754|Hormones|hormones|mesh-ancestor
139202471|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139202472|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202473|NCT02496910|Amlodipine|amlodipine|mesh-list
139202474|NCT02496910|Telmisartan|telmisartan|mesh-list
139202475|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
139202476|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139202477|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139202478|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139202479|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139202480|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202481|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139202482|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202483|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
139202484|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139202485|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139202486|NCT02496910|Diuretics|diuretics|mesh-ancestor
139202487|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
139202488|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139202489|NCT03342352|Carboplatin|carboplatin|mesh-list
139202490|NCT03342352|Fluorouracil|fluorouracil|mesh-list
139202491|NCT03342352|Nivolumab|nivolumab|mesh-list
139202492|NCT03342352|Cetuximab|cetuximab|mesh-list
139202493|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202494|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
139202495|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202496|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139202497|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139202498|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
139202499|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202500|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139202501|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139202502|NCT03120442|Fentanyl|fentanyl|mesh-list
139202503|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
139202504|NCT03120442|Propofol|propofol|mesh-list
139202505|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139202506|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202507|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202508|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139202509|NCT03120442|Analgesics|analgesics|mesh-ancestor
139202510|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
139202511|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202512|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139202513|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139202514|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139202515|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
139202516|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202517|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202518|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139202519|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
139202520|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
139202521|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139202522|NCT03120442|Narcotics|narcotics|mesh-ancestor
139202523|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139202524|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
139202525|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139202526|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139202527|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139202528|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
139202529|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202530|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202531|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202532|NCT00852696|Urological Agents|urological agents|mesh-ancestor
139202533|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
139202534|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139202535|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202536|NCT03324490|Fentanyl|fentanyl|mesh-list
139202537|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
139202538|NCT03324490|Bupivacaine|bupivacaine|mesh-list
139202539|NCT03324490|Anesthetics|anesthetics|mesh-list
139202540|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
139202541|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202542|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202543|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
139202544|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202545|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139202546|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139202547|NCT03324490|Analgesics|analgesics|mesh-ancestor
139202548|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139202549|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139202550|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139202551|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
139202552|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202553|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202554|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139202555|NCT03324490|Narcotics|narcotics|mesh-ancestor
139202556|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139202557|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139202558|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
139202559|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
139202560|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139202561|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
139202562|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
139202563|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202564|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202565|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
139202566|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139202567|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202568|NCT03274661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139202569|NCT03274661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202570|NCT03798821|Sulfalene|sulfalene|mesh-list
139202571|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139202572|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139202573|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
139202574|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139202575|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139202576|NCT03324334|Antibodies|antibodies|mesh-list
139202577|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
139202578|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202579|NCT03792815|Etoposide|etoposide|mesh-list
139202580|NCT03792815|Melphalan|melphalan|mesh-list
139202581|NCT03792815|Busulfan|busulfan|mesh-list
139202582|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139202583|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202584|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139202585|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139202586|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202587|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202588|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139202589|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
139202590|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139202591|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139202592|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
139202593|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202594|NCT04381364|Ciclesonide|ciclesonide|mesh-list
139202595|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
139202596|NCT04381364|Hormones|hormones|mesh-ancestor
139202597|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139202598|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202599|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139202600|NCT01331382|Resveratrol|resveratrol|mesh-list
139202601|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
139202602|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202603|NCT01331382|Protective Agents|protective agents|mesh-ancestor
139202604|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202605|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065514|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139202606|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139202607|NCT03794765|Metronidazole|metronidazole|mesh-list
139202608|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
139202609|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139202610|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139202611|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139202612|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139202613|NCT02496286|Bevacizumab|bevacizumab|mesh-list
139202614|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139202615|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202616|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139202617|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139202618|NCT02496286|Growth Substances|growth substances|mesh-ancestor
139202619|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202620|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
139202621|NCT01489176|Regadenoson|regadenoson|mesh-list
139202622|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139202623|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139202624|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
139202625|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
139202626|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202627|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202628|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202629|NCT03792503|Pemetrexed|pemetrexed|mesh-list
139202630|NCT03792503|Apatinib|apatinib|mesh-list
139202631|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202632|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202633|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202634|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139202635|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139202636|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139202637|NCT03794843|Nimodipine|nimodipine|mesh-list
139202638|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139202639|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139202640|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139202641|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202642|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139202643|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202644|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
139202645|NCT01333800|Ciclesonide|ciclesonide|mesh-list
139202646|NCT01333800|Beclomethasone|beclomethasone|mesh-list
139202647|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139202648|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
139202649|NCT01333800|Hormones|hormones|mesh-ancestor
139202650|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139202651|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202652|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139202653|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
139202654|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139202655|NCT04494100|Lidocaine|lidocaine|mesh-list
139202656|NCT04494100|Epinephrine|epinephrine|mesh-list
139202657|NCT04494100|Ropivacaine|ropivacaine|mesh-list
139202658|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
139202659|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
139202660|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202661|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202662|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
139202663|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202664|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139202665|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139202666|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139202667|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139202668|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202669|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139202670|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139202671|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
139202672|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202673|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139202674|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139202675|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
139202676|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139202677|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
139202678|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
139202679|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
139202680|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139202681|NCT01333878|Abatacept|abatacept|mesh-list
139202682|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139202683|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202684|NCT01333878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139202685|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202686|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139202687|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
139202688|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202689|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139202691|NCT03328312|Neostigmine|neostigmine|mesh-list
139202692|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139202693|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139202694|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139202695|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
139202696|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202697|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065578|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
139202698|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139202699|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
139202700|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
139202701|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
139202702|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139202703|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139202704|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
139202705|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202706|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202707|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139202708|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202709|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139202710|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
139202711|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139202712|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139202714|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139202715|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139202716|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202717|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
139202718|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
139202719|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
139202720|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202722|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139202723|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202724|NCT03323710|Sunitinib|sunitinib|mesh-list
139202725|NCT03323710|Propranolol|propranolol|mesh-list
139202726|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202727|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139202728|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139202729|NCT03323710|Growth Substances|growth substances|mesh-ancestor
139202730|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202731|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
139202732|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139202733|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202734|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202735|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139202736|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139202737|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
139202738|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202739|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139202740|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139202741|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
139202742|NCT03792269|Capecitabine|capecitabine|mesh-list
139202743|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
139202744|NCT03792269|Irinotecan|irinotecan|mesh-list
139202745|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139202746|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
139202747|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202748|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202749|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139202750|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139202751|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202752|NCT02488564|Metformin|metformin|mesh-list
139202753|NCT02488564|Docetaxel|docetaxel|mesh-list
139202754|NCT02488564|Doxorubicin|doxorubicin|mesh-list
139202755|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139202756|NCT02488564|Trastuzumab|trastuzumab|mesh-list
139202757|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139202758|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202759|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202760|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
139202761|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
139202762|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
139202763|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202764|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139202765|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139202766|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139202767|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202768|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139202769|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
139202770|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139202771|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
139202772|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139202773|NCT02966873|Expectorants|expectorants|mesh-ancestor
139202774|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
139202775|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139202776|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
139202777|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202778|NCT02966873|Protective Agents|protective agents|mesh-ancestor
139202779|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202780|NCT02966873|Antidotes|antidotes|mesh-ancestor
139202781|NCT04697186|Amoxicillin|amoxicillin|mesh-list
139202782|NCT04697186|Clarithromycin|clarithromycin|mesh-list
139202783|NCT04697186|Rabeprazole|rabeprazole|mesh-list
139202784|NCT04697186|Bismuth|bismuth|mesh-list
139202785|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139202786|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139202787|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139202788|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202789|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202790|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139202791|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139202792|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139202793|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139202794|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139202795|NCT04697186|Antacids|antacids|mesh-ancestor
139202796|NCT02488642|Isosorbide|isosorbide|mesh-list
139202797|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139202798|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139202799|NCT02488642|Misoprostol|misoprostol|mesh-list
139202800|NCT02488642|Oxytocin|oxytocin|mesh-list
139202801|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
139202802|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139202803|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202804|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139202805|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
139202806|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139202807|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139202808|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139202809|NCT02488642|Diuretics|diuretics|mesh-ancestor
139202810|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
139202811|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
139202812|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139202813|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202814|NCT02488486|Remifentanil|remifentanil|mesh-list
139202815|NCT02488486|Propofol|propofol|mesh-list
139202816|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139202817|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202818|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202819|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139202820|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
139202821|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
139202822|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139202823|NCT02488486|Narcotics|narcotics|mesh-ancestor
139202824|NCT02488486|Analgesics|analgesics|mesh-ancestor
139202825|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
139202826|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202827|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
139202828|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202829|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
139202830|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202831|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202832|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139202833|NCT03327766|Calcifediol|calcifediol|mesh-list
139202834|NCT03327766|Vitamins|vitamins|mesh-ancestor
139202835|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
139202836|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202837|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139202838|NCT03798119|Tenofovir|tenofovir|mesh-list
139202839|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
139202840|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139202841|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139065605|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
139202842|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139202843|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202844|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202845|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139202846|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139202847|NCT03794219|Naproxen|naproxen|mesh-list
139202848|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139202849|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139202850|NCT03794219|Analgesics|analgesics|mesh-ancestor
139202851|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
139202852|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202853|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202854|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139202855|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139202856|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
139202857|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139202858|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202859|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202860|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
139202861|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139202862|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202864|NCT03050060|Pembrolizumab|pembrolizumab|mesh-list
139202865|NCT03050060|Nivolumab|nivolumab|mesh-list
139202866|NCT03050060|Atezolizumab|atezolizumab|mesh-list
139202867|NCT03050060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139202868|NCT03050060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139202869|NCT03050060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202870|NCT03050060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139202871|NCT03050060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202872|NCT03050060|Immunologic Factors|immunologic factors|mesh-ancestor
139202873|NCT03050060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202874|NCT03050060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139202875|NCT03050060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139202876|NCT03050060|Protease Inhibitors|protease inhibitors|mesh-ancestor
139202877|NCT03050060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202878|NCT03050060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139202879|NCT03050060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139202880|NCT03050060|Antiviral Agents|antiviral agents|mesh-ancestor
139202881|NCT03050060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139202882|NCT01334112|Axitinib|axitinib|mesh-list
139202883|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202884|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139202885|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202886|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202887|NCT03791957|Chrysarobin|chrysarobin|mesh-list
139202888|NCT03791957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139202889|NCT03791957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139202890|NCT03791957|Analgesics|analgesics|mesh-ancestor
139202891|NCT03791957|Sensory System Agents|sensory system agents|mesh-ancestor
139202892|NCT03791957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202893|NCT03791957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202894|NCT03791957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139202895|NCT03791957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139202896|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
139202897|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
139202898|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139202899|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139202900|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
139202901|NCT03792113|Coagulants|coagulants|mesh-ancestor
139202902|NCT01304927|Vitamin D|vitamin d|mesh-list
139202903|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
139202904|NCT01304927|Calcium|calcium|mesh-list
139202905|NCT01304927|Vitamins|vitamins|mesh-ancestor
139202906|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
139202907|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202908|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139202909|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139202910|NCT05464940|Caffeine|caffeine|mesh-list
139202911|NCT05464940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139202912|NCT05464940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202913|NCT05464940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139202914|NCT05464940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202915|NCT05464940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202916|NCT05464940|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139202917|NCT05464940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139202918|NCT05464940|Purinergic Agents|purinergic agents|mesh-ancestor
139202919|NCT05464940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139202920|NCT01305551|Metformin|metformin|mesh-list
139202921|NCT01305551|Saxagliptin|saxagliptin|mesh-list
139202922|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139202923|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202924|NCT01305551|Incretins|incretins|mesh-ancestor
139202925|NCT01305551|Hormones|hormones|mesh-ancestor
139202926|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139202927|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139202928|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
139202929|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202930|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202931|NCT03799757|Bupivacaine|bupivacaine|mesh-list
139202932|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
139202933|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
139202934|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202935|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202936|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
139202937|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202938|NCT03327454|Etanercept|etanercept|mesh-list
139202939|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139202940|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139202941|NCT03327454|Analgesics|analgesics|mesh-ancestor
139202942|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
139202943|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202944|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202945|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139202946|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139202947|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139202948|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139202949|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
139202950|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
139202951|NCT03799913|Fludarabine|fludarabine|mesh-list
139202952|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139202953|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
139202954|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202955|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139202956|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139202957|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
139202958|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202959|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202960|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139202961|NCT01304069|Etoricoxib|etoricoxib|mesh-list
139202962|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139202963|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139202964|NCT01304069|Analgesics|analgesics|mesh-ancestor
139202965|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
139202966|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202967|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202968|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139202969|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139202970|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139202971|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139202972|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139202973|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202974|NCT05459402|Methadone|methadone|mesh-list
139202975|NCT05459402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139202976|NCT05459402|Narcotics|narcotics|mesh-ancestor
139202977|NCT05459402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139202978|NCT05459402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202979|NCT05459402|Analgesics|analgesics|mesh-ancestor
139202980|NCT05459402|Sensory System Agents|sensory system agents|mesh-ancestor
139202981|NCT05459402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202982|NCT05459402|Antitussive Agents|antitussive agents|mesh-ancestor
139202983|NCT05459402|Respiratory System Agents|respiratory system agents|mesh-ancestor
139202984|NCT03799601|Carboplatin|carboplatin|mesh-list
139202985|NCT03799601|Docetaxel|docetaxel|mesh-list
139202986|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139202987|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
139202988|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
139202989|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
139202990|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139202991|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
139202992|NCT03791801|Rocuronium|rocuronium|mesh-list
139202993|NCT03791801|Neostigmine|neostigmine|mesh-list
139202994|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139202995|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139202996|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139202997|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139202998|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139202999|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139203000|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203001|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203002|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
139203003|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203004|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139203005|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
139203006|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139203007|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139203008|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139203009|NCT01305083|Udenafil|udenafil|mesh-list
139203010|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139203011|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139203012|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203013|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203014|NCT03791723|Valsartan|valsartan|mesh-list
138953451|NCT00902031|Sennosides|sennosides|mesh-list
139203015|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139203016|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139203017|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139203018|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139203019|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203020|NCT05452070|Lidocaine|lidocaine|mesh-list
139203021|NCT05452070|Anesthetics, Local|anesthetics, local|mesh-ancestor
139203022|NCT05452070|Anesthetics|anesthetics|mesh-ancestor
139203023|NCT05452070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203024|NCT05452070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203025|NCT05452070|Sensory System Agents|sensory system agents|mesh-ancestor
139203026|NCT05452070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203027|NCT05452070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139203028|NCT05452070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139203029|NCT05452070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139203030|NCT05452070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139203031|NCT05452070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203032|NCT03920657|Deferasirox|deferasirox|mesh-list
139203033|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139203034|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
139203035|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
139203036|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203037|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139203038|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203039|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203040|NCT03501277|Pioglitazone|pioglitazone|mesh-list
139203041|NCT03501277|Alogliptin|alogliptin|mesh-list
139203042|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139203043|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203044|NCT03501277|Incretins|incretins|mesh-ancestor
139203045|NCT03501277|Hormones|hormones|mesh-ancestor
139203046|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139203047|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139203048|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
139203049|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203050|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203051|NCT03797729|Tirofiban|tirofiban|mesh-list
139203052|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139203053|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139203054|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203055|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139203056|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139203057|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139203058|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139203059|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139203060|NCT02487706|Dolutegravir|dolutegravir|mesh-list
139203061|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139203062|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139203063|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203064|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203065|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139203066|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139203067|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
139203068|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139203069|NCT04551950|Paclitaxel|paclitaxel|mesh-list
139203070|NCT04551950|Bevacizumab|bevacizumab|mesh-list
139203071|NCT04551950|Carboplatin|carboplatin|mesh-list
139203072|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139203073|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203074|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
139203075|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
139203076|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
139203077|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203078|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139203079|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139203080|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139203081|NCT04551950|Growth Substances|growth substances|mesh-ancestor
139203082|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203083|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
139203084|NCT03326752|Nivolumab|nivolumab|mesh-list
139203085|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139203086|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139203087|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203088|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203089|NCT03326674|Capecitabine|capecitabine|mesh-list
139203090|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139203091|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
139203092|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203093|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203094|NCT01316900|Bromides|bromides|mesh-list
139203095|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
139203096|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139203097|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
139203098|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203099|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203100|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139203101|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
139203102|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
139203103|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139203104|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
139203105|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203106|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203107|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
139203108|NCT02490982|Teriflunomide|teriflunomide|mesh-list
139203109|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139203110|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139203111|NCT02490982|Analgesics|analgesics|mesh-ancestor
139203112|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
139203113|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203114|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203115|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139203116|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139203117|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139203118|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
139203119|NCT03322150|Atropine|atropine|mesh-list
139203120|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
139203121|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139203122|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139203123|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139203124|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
139203125|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203126|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203127|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139203128|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
139203129|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
139203130|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
139203131|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139203132|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139203133|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
139203134|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203135|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203136|NCT03499873|Nepafenac|nepafenac|mesh-list
139203137|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139203138|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139203140|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
139203141|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203142|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203143|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139203144|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139203145|NCT01305707|Diazepam|diazepam|mesh-list
139203146|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139203147|NCT01305707|Lorazepam|lorazepam|mesh-list
139203148|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
139203149|NCT01305707|Dexetimide|dexetimide|mesh-list
139203150|NCT01305707|Olanzapine|olanzapine|mesh-list
139203151|NCT01305707|Risperidone|risperidone|mesh-list
139203152|NCT01305707|Aripiprazole|aripiprazole|mesh-list
139203153|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139203154|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
139203155|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
139203156|NCT01305707|Mirtazapine|mirtazapine|mesh-list
139203157|NCT01305707|Citalopram|citalopram|mesh-list
139203158|NCT01305707|Sertraline|sertraline|mesh-list
139203159|NCT01305707|Fluoxetine|fluoxetine|mesh-list
139203160|NCT01305707|Paroxetine|paroxetine|mesh-list
139203161|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139203162|NCT01305707|Nortriptyline|nortriptyline|mesh-list
139203163|NCT01305707|Imipramine|imipramine|mesh-list
139203164|NCT01305707|Clomipramine|clomipramine|mesh-list
139203165|NCT01305707|Mianserin|mianserin|mesh-list
139203166|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
139203167|NCT01305707|Escitalopram|escitalopram|mesh-list
139203168|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139203169|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
139203170|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203171|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203172|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203173|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139203174|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203175|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138913518|NCT00821080|Sirolimus|sirolimus|mesh-list
139203176|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139203177|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
139203178|NCT01305707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139203179|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139203180|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139203181|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139203182|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139203183|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
139203184|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
139203185|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203186|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139203187|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139203188|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
139203189|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139203190|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
139203191|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139203192|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
139203193|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139203194|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139203195|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139203196|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139203197|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139203198|NCT01305707|Analgesics|analgesics|mesh-ancestor
139203199|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
139203200|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139203201|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139203202|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203203|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
139203204|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
139203205|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139203206|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139203207|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
139203208|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
139203209|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139203210|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
139203211|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
139203212|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139203213|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139203214|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139203215|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
139203216|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139203218|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139203219|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139203220|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139203221|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
139203222|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
139203223|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139203224|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139203225|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139203226|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
139203227|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139203228|NCT03722329|Eculizumab|eculizumab|mesh-list
139203229|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139203230|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139203231|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
139203232|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203233|NCT03467971|Metformin|metformin|mesh-list
139203234|NCT03467971|Gliclazide|gliclazide|mesh-list
139203235|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139203236|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203237|NCT03791099|Metronidazole|metronidazole|mesh-list
139203238|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139203239|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138953693|NCT01052623|Clonidine|clonidine|mesh-list
139203240|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139203241|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139203242|NCT03185000|Immunomodulating Agents|immunomodulating agents|mesh-list
139203243|NCT03185000|Immunologic Factors|immunologic factors|mesh-ancestor
139203244|NCT03185000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203245|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
139203246|NCT03791255|Calcium|calcium|mesh-list
139203247|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139203248|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203249|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139203250|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139203251|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139203252|NCT03794297|Trametinib|trametinib|mesh-list
139203253|NCT03794297|Dabrafenib|dabrafenib|mesh-list
139203254|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139203255|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203256|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139203257|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203258|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203259|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139203260|NCT03794297|Protective Agents|protective agents|mesh-ancestor
139203261|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203262|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139203263|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
139203264|NCT03048500|Metformin|metformin|mesh-list
139203265|NCT03048500|Nivolumab|nivolumab|mesh-list
139203266|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139203267|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203268|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139203269|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203270|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139203271|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203272|NCT03790787|Empagliflozin|empagliflozin|mesh-list
139203273|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139203274|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203275|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139203276|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203277|NCT01334268|Paclitaxel|paclitaxel|mesh-list
139203278|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139203279|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203280|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
139203281|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
139203282|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
139203283|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203284|NCT04493398|Erythritol|erythritol|mesh-list
139203285|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
139203286|NCT00908076|Lubiprostone|lubiprostone|mesh-list
139203287|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139203288|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139203289|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203290|NCT01305317|Atorvastatin|atorvastatin|mesh-list
139203291|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139203292|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139203293|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
139203294|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203295|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139203296|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139203297|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203298|NCT02613416|Denosumab|denosumab|mesh-list
139203299|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139203300|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203301|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
139203302|NCT03326050|Rifampin|rifampin|mesh-list
139203303|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
139203304|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139203305|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139203306|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139203307|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139203308|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203309|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203310|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203311|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139203312|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139203313|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139203314|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
139203315|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
139203316|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139203317|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139203318|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139203319|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139203320|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139203321|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139203322|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139203324|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139203325|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203326|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203327|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139203328|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
139203329|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
139203330|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139203331|NCT05664685|Bismuth|bismuth|mesh-list
139203332|NCT05664685|Antacids|antacids|mesh-ancestor
139203333|NCT05664685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203334|NCT05664685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139203335|NCT03793517|Decitabine|decitabine|mesh-list
139203336|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139203337|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
139203338|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203339|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203340|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203341|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
139203342|NCT02886702|Tazarotene|tazarotene|mesh-list
139203343|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
139203344|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
139203345|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
139203346|NCT02886702|Vitamins|vitamins|mesh-ancestor
139203347|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
139203348|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203349|NCT03498313|Estradiol|estradiol|mesh-list
139203350|NCT03498313|Progesterone|progesterone|mesh-list
139203351|NCT03498313|Estrogens|estrogens|mesh-ancestor
139203352|NCT03498313|Hormones|hormones|mesh-ancestor
139203353|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139203354|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203355|NCT03498313|Progestins|progestins|mesh-ancestor
139203356|NCT03721081|Lidocaine|lidocaine|mesh-list
139203357|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
139203358|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
139203359|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203360|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203361|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
139203362|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203363|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139203364|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139203365|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139203366|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139203367|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203369|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
139203370|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
139203371|NCT04493554|Coagulants|coagulants|mesh-ancestor
139203372|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139203373|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139203374|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
139203375|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203376|NCT02601014|Nivolumab|nivolumab|mesh-list
139203377|NCT02601014|Ipilimumab|ipilimumab|mesh-list
139203378|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139203379|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203380|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139203381|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203382|NCT01307046|Losartan|losartan|mesh-list
139203383|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139203384|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139203385|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138953826|NCT00605865|Sertraline|sertraline|mesh-list
139203386|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139203387|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203388|NCT05419115|Furosemide|furosemide|mesh-list
139203389|NCT05419115|Diuretics|diuretics|mesh-ancestor
139203390|NCT05419115|Natriuretic Agents|natriuretic agents|mesh-ancestor
139203391|NCT05419115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203392|NCT05419115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139203393|NCT05419115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139203394|NCT05419115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203395|NCT02490592|Fluorides|fluorides|mesh-list
139203396|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
139203397|NCT02490592|Protective Agents|protective agents|mesh-ancestor
139203398|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203399|NCT03075462|Apatinib|apatinib|mesh-list
139203400|NCT03075462|Fluzoparib|fluzoparib|mesh-list
139203401|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203402|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139203403|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203404|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203405|NCT03075462|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139203406|NCT01305395|Sirolimus|sirolimus|mesh-list
139203407|NCT01305395|Temsirolimus|temsirolimus|mesh-list
139203408|NCT01305395|MTOR Inhibitors|mtor inhibitors|mesh-list
139203409|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139203410|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139203411|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139203412|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203413|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
139203414|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139203415|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
139203416|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203417|NCT01305395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139203418|NCT01305395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203419|NCT01305395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203420|NCT02886624|Grazoprevir|grazoprevir|mesh-list
139203421|NCT02886624|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139203422|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
139203423|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139203424|NCT02487316|Crizotinib|crizotinib|mesh-list
139203425|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203426|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139203427|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203428|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203429|NCT02490436|Cetuximab|cetuximab|mesh-list
139203430|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139203431|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203432|NCT03318718|Rocuronium|rocuronium|mesh-list
139203433|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203434|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139203435|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138573408|NCT00404586|Fluticasone|fluticasone|mesh-list
139203436|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139203437|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203438|NCT03325348|Labetalol|labetalol|mesh-list
139203439|NCT03325348|Nifedipine|nifedipine|mesh-list
139203440|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139203441|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139065676|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
139203442|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203443|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139203444|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203445|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
139203446|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
139203447|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139203448|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139203449|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139203450|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
139203451|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203452|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139203453|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
139203454|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
139203455|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203456|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139203457|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139203458|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
139203459|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
139203460|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
139203461|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203462|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203463|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
139203464|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203465|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
139203466|NCT03325270|Trace Elements|trace elements|mesh-ancestor
139203467|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
139203468|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203469|NCT02963766|Dulaglutide|dulaglutide|mesh-list
139203470|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139203471|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203473|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
139203474|NCT01334502|Rituximab|rituximab|mesh-list
139203475|NCT01334502|Doxorubicin|doxorubicin|mesh-list
139203476|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139203477|NCT01334502|Vincristine|vincristine|mesh-list
139203478|NCT01334502|Everolimus|everolimus|mesh-list
139203479|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139203480|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
139203481|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203482|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139203483|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139203484|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
139203485|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203486|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203487|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139203488|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139203489|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139203490|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139203491|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139203492|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203493|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139203494|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
139203495|NCT01334502|Hormones|hormones|mesh-ancestor
139203496|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139203497|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139203498|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139203499|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
139203500|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
139203501|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
139203502|NCT01334502|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139203503|NCT01334502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139203504|NCT02487082|Melatonin|melatonin|mesh-list
139203505|NCT02487082|Donepezil|donepezil|mesh-list
139203506|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
139203507|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203508|NCT02487082|Protective Agents|protective agents|mesh-ancestor
139203509|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203510|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203511|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139203512|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203513|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
139203514|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203515|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
139203516|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139203517|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139203518|NCT03788681|Estradiol|estradiol|mesh-list
139203519|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139203520|NCT03788681|Estrogens|estrogens|mesh-ancestor
139203521|NCT03788681|Hormones|hormones|mesh-ancestor
139203522|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139203523|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203524|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139203525|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
139203526|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139203527|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139203528|NCT03790085|Olanzapine|olanzapine|mesh-list
139203529|NCT03790085|Risperidone|risperidone|mesh-list
139203530|NCT03790085|Aripiprazole|aripiprazole|mesh-list
139203531|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139203532|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
139203533|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203534|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203535|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203536|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139203537|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139203538|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203540|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139203541|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
139203542|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
139203543|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
139203544|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203545|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139203546|NCT03790085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139203547|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139203548|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139203549|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
139203550|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
139203551|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139203552|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139203553|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139203554|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139203556|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
139203557|NCT01306097|Trace Elements|trace elements|mesh-ancestor
139203558|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
139203559|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203560|NCT01306097|Astringents|astringents|mesh-ancestor
139203561|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
139203562|NCT03790007|Bupivacaine|bupivacaine|mesh-list
139203563|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
139203564|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
139203565|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203566|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203567|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
139203568|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203569|NCT03789695|Dabigatran|dabigatran|mesh-list
139203570|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
139203571|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139203572|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
139203573|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203574|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203575|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
139203576|NCT00739674|Losartan|losartan|mesh-list
139203577|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139203578|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
139203579|NCT00739674|Calcium|calcium|mesh-list
139203580|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139203581|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203582|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139203583|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139203584|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139203585|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139203586|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203587|NCT00739674|Diuretics|diuretics|mesh-ancestor
139203588|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
139203589|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139203590|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139203591|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
139203592|NCT01306409|Hematinics|hematinics|mesh-ancestor
139203593|NCT01331928|Docetaxel|docetaxel|mesh-list
139203594|NCT01331928|Capecitabine|capecitabine|mesh-list
139203595|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
139203596|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203597|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
139203598|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
139203599|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
139203600|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203601|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139203602|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
139203603|NCT01334580|Methadone|methadone|mesh-list
139203604|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139203605|NCT01334580|Narcotics|narcotics|mesh-ancestor
139203606|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203607|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203608|NCT01334580|Analgesics|analgesics|mesh-ancestor
139203609|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
139203610|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203611|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
139203612|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
139203613|NCT02694588|Infliximab|infliximab|mesh-list
139203615|NCT02694588|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139203616|NCT02694588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139203617|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
139203618|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139203619|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139203620|NCT03789539|Vaccines|vaccines|mesh-list
139203621|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
139203622|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203623|NCT00400218|Losartan|losartan|mesh-list
139203624|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139203625|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139203626|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139203627|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139203628|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139203629|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203630|NCT00400218|Diuretics|diuretics|mesh-ancestor
139203631|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
139203632|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203633|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139203634|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139203635|NCT02486848|Minoxidil|minoxidil|mesh-list
139203636|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139203637|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139203638|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
139203639|NCT01306565|Atorvastatin|atorvastatin|mesh-list
139203640|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139203641|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139203642|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
139203643|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203644|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139203645|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139203646|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203647|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
139203648|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139203649|NCT03786029|Acetaminophen|acetaminophen|mesh-list
139203650|NCT03786029|Ibuprofen|ibuprofen|mesh-list
139203651|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139203652|NCT03786029|Analgesics|analgesics|mesh-ancestor
139203653|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
139203654|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203655|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203656|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
139203657|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139203658|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139203659|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139203660|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139203661|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203662|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203663|NCT01334892|Cyclosporine|cyclosporine|mesh-list
139203664|NCT01334892|Cyclosporins|cyclosporins|mesh-list
139203665|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203666|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203667|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139203668|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
139203669|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203670|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
139203671|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139203672|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
139203673|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139203674|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139203675|NCT04730219|Paclitaxel|paclitaxel|mesh-list
139203676|NCT04730219|Tislelizumab|tislelizumab|mesh-list
139203677|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139203678|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203679|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
139203680|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
139203681|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
139203682|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203683|NCT04730219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139203684|NCT04492774|Dexamethasone|dexamethasone|mesh-list
139203685|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139203686|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
139203687|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
139203688|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203690|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139203691|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
139203692|NCT04492774|Hormones|hormones|mesh-ancestor
139203693|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139203694|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139203695|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203696|NCT03321292|Aspirin|aspirin|mesh-list
139203697|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139203698|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139203699|NCT03321292|Analgesics|analgesics|mesh-ancestor
139203700|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
139203701|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203702|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203703|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139203704|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139203705|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139203706|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139203707|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203708|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139203709|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139203710|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203711|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
139203712|NCT01306721|Fexofenadine|fexofenadine|mesh-list
139203713|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
139203714|NCT01306721|Ephedrine|ephedrine|mesh-list
139203715|NCT01306721|Terfenadine|terfenadine|mesh-list
139203716|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139203717|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139203718|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139203719|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
139203720|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
139203721|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203722|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203723|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203724|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139203725|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
139203726|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203727|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139203728|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
139203729|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
139203730|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139203731|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139203732|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
139203733|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
139203734|NCT01337466|Fialuridine|fialuridine|mesh-list
139203735|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
139203736|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139203737|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139203738|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203739|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203741|NCT02486926|Alfentanil|alfentanil|mesh-list
139203742|NCT02486926|Thiopental|thiopental|mesh-list
139203743|NCT02486926|Sevoflurane|sevoflurane|mesh-list
139203744|NCT02486926|Rocuronium|rocuronium|mesh-list
139203745|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139203746|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139203747|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
139203748|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
139203749|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203750|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203751|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139203752|NCT02486926|Narcotics|narcotics|mesh-ancestor
139203753|NCT02486926|Analgesics|analgesics|mesh-ancestor
139203754|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
139203755|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203756|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139203757|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139203758|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139203759|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139203760|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
139203761|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139203762|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
139203763|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
139203764|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203765|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203767|NCT01335048|Atorvastatin|atorvastatin|mesh-list
139203768|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139203769|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139203770|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
139203771|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203772|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139203773|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139203774|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203775|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139203776|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139065720|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
139203777|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139203778|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139203779|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
139203780|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203781|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203782|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
139203783|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139203784|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139203785|NCT01567475|Rituximab|rituximab|mesh-list
139203786|NCT01567475|Everolimus|everolimus|mesh-list
139203787|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139203788|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203789|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
139203790|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203791|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139203792|NCT01567475|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139203793|NCT01567475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139203794|NCT01567475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203795|NCT01567475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203796|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139203797|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
139203798|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139203799|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
139203800|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
139203801|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203802|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203803|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139203804|NCT03435055|Analgesics|analgesics|mesh-ancestor
139203805|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
139203806|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203807|NCT03316066|Ropivacaine|ropivacaine|mesh-list
139203808|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
139203809|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
139203810|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203811|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203812|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
139203813|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203814|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
139203815|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139203816|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
139203817|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203818|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139203819|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139203820|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
139203821|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203822|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203823|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139203824|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139203825|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139203826|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139203827|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203828|NCT01335360|Nevirapine|nevirapine|mesh-list
139203829|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139203830|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139203831|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203832|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203833|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
139203834|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139203835|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139203836|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139203837|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139203838|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139203840|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
139203841|NCT02489266|Fludarabine|fludarabine|mesh-list
139203842|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139203843|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
139203844|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203845|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139203846|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139203847|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
139203848|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203849|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203850|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139203851|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139203852|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139203853|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
139203854|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139203855|NCT03434119|Insulin|insulin|mesh-list
139203856|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139203857|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
139203858|NCT03434119|Lixisenatide|lixisenatide|mesh-list
139203859|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139203860|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203861|NCT02484352|Oxycodone|oxycodone|mesh-list
139203862|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139203863|NCT02484352|Narcotics|narcotics|mesh-ancestor
139203864|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203865|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203866|NCT02484352|Analgesics|analgesics|mesh-ancestor
139203867|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
139203868|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203869|NCT01308671|Varenicline|varenicline|mesh-list
139203870|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139203871|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139203872|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
139203873|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203874|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203875|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203876|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
139203877|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139203878|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
139203879|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139203880|NCT03315676|Esomeprazole|esomeprazole|mesh-list
139203881|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139203882|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139203883|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139203884|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203885|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203886|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
139203887|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139203888|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
139203889|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203890|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203891|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139203892|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
139203893|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
139203894|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139203895|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
139203896|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203897|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203898|NCT02486458|Listerine|listerine|mesh-list
139203899|NCT02486458|Fluorides|fluorides|mesh-list
139203900|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
139065737|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203901|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
139203902|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
139203903|NCT02486458|Protective Agents|protective agents|mesh-ancestor
139203904|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203905|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139203906|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139203907|NCT01335516|Terlipressin|terlipressin|mesh-list
139203908|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139203909|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139203910|NCT05694923|Empagliflozin|empagliflozin|mesh-list
139203911|NCT05694923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139203912|NCT05694923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203914|NCT05694923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203915|NCT01332396|Lapatinib|lapatinib|mesh-list
139203916|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203917|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139203918|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203919|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203920|NCT03719053|Tenofovir|tenofovir|mesh-list
139203921|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
139203922|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139203923|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139203924|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139203925|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203926|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203927|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139203928|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139203929|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139203930|NCT03526848|Antibodies|antibodies|mesh-list
139203931|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
139203932|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139203933|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
139203934|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203935|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139203936|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139203937|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
139203938|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203939|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139203940|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139203941|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
139203942|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203943|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203944|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139203945|NCT01332552|Ritonavir|ritonavir|mesh-list
139203946|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139203947|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139203948|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
139203949|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203950|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203951|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139203952|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139203953|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
139203954|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139203955|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139203956|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139203957|NCT03720223|Bupivacaine|bupivacaine|mesh-list
139203958|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
139203959|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
139203960|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203961|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203962|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
139203963|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203964|NCT03160716|Lidocaine|lidocaine|mesh-list
139203965|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
139203966|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
139203967|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139203968|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203969|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
139203970|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139203971|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139203972|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139203973|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139203974|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139203975|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203976|NCT00092664|Simvastatin|simvastatin|mesh-list
139203977|NCT00092664|Ezetimibe|ezetimibe|mesh-list
139203978|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139203979|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139203980|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
139203981|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203982|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139203983|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139203984|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139203985|NCT02483884|Bombesin|bombesin|mesh-list
139203986|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139203987|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203988|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203990|NCT03317548|Progestins|progestins|mesh-ancestor
139203991|NCT03317548|Hormones|hormones|mesh-ancestor
139203992|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139203993|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139203994|NCT00092586|Ezetimibe|ezetimibe|mesh-list
139203995|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139203996|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139203997|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
139203998|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139203999|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139204000|NCT03786887|Nalbuphine|nalbuphine|mesh-list
139204001|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139204002|NCT03786887|Narcotics|narcotics|mesh-ancestor
139204003|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139204004|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204005|NCT03786887|Analgesics|analgesics|mesh-ancestor
139204006|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
139204007|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204008|NCT03787043|Metformin|metformin|mesh-list
139204009|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139204010|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204011|NCT00090168|Atorvastatin|atorvastatin|mesh-list
139204012|NCT00090168|Simvastatin|simvastatin|mesh-list
139204013|NCT00090168|Ezetimibe|ezetimibe|mesh-list
139204014|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139204015|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139204016|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
139204017|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204018|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139204019|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139204020|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204021|NCT01332786|Tigecycline|tigecycline|mesh-list
139204022|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139204023|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204024|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139204025|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204026|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204027|NCT01338090|Bevacizumab|bevacizumab|mesh-list
139204028|NCT01338090|Everolimus|everolimus|mesh-list
139204029|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
139204030|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139204031|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204032|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139204033|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139204034|NCT01338090|Growth Substances|growth substances|mesh-ancestor
139204035|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204036|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
139204037|NCT01338090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139204038|NCT01338090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139204039|NCT01338090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204040|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204041|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139204042|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
139204043|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139204044|NCT01307969|Lidocaine|lidocaine|mesh-list
139204045|NCT01307969|Epinephrine|epinephrine|mesh-list
139204046|NCT01307969|Racepinephrine|racepinephrine|mesh-list
139204047|NCT01307969|Ropivacaine|ropivacaine|mesh-list
139204048|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
139204049|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
139204050|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
139204051|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139204052|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204053|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
139204054|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204055|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139204056|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139204057|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139204058|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139204059|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935736|NCT02571426|Propofol|propofol|mesh-list
139204061|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139204062|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
139204063|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204064|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139204065|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139204066|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
139204067|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139204068|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
139204069|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
139204070|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
139204071|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139204072|NCT03786419|Atezolizumab|atezolizumab|mesh-list
139204073|NCT03786419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139204074|NCT03786419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204075|NCT03786419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139204076|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204077|NCT01338324|Simvastatin|simvastatin|mesh-list
139204078|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139204079|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139204080|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
139204081|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204082|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139204083|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139204084|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204085|NCT01336062|Paclitaxel|paclitaxel|mesh-list
139204086|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139204087|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139204088|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204089|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
139204090|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
139204091|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
139204092|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204093|NCT05694221|Metformin|metformin|mesh-list
139204094|NCT05694221|Digoxin|digoxin|mesh-list
139204095|NCT05694221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139204096|NCT05694221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204097|NCT05694221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139204098|NCT05694221|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139204099|NCT05694221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204100|NCT05694221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204101|NCT05694221|Protective Agents|protective agents|mesh-ancestor
139204102|NCT01308047|Bupivacaine|bupivacaine|mesh-list
139204103|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
139204104|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
139204105|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139204106|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204107|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
139204108|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204109|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
139204110|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
139204111|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
139204113|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139204114|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204115|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139204116|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139204117|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204118|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204119|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204120|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139204121|NCT01316861|Acarbose|acarbose|mesh-list
139204122|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139204123|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204124|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204125|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139204126|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204127|NCT01336218|Rifampin|rifampin|mesh-list
139204128|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139204129|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
139204130|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139204131|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204132|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
139204133|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139204134|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204135|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204136|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139204137|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139204138|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139204139|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139204140|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139204141|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139204142|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139204143|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204145|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204147|NCT03776279|Analgesics|analgesics|mesh-ancestor
139204148|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
139204149|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204150|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204151|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204152|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139204153|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139204154|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204155|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204156|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
139204157|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139204158|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139204159|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204160|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139204161|NCT03775655|Analgesics|analgesics|mesh-ancestor
139204162|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
139204163|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204164|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139204165|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139204166|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139204167|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
139204168|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204169|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204170|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
139204171|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139204172|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204173|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
139204174|NCT03781895|Vitamin D|vitamin d|mesh-list
139204175|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139204176|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204177|NCT03781895|Vitamins|vitamins|mesh-ancestor
139204178|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
139204179|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139204180|NCT00706030|Vinorelbine|vinorelbine|mesh-list
139204181|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139204182|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204183|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
139204184|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
139204185|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
139204186|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204188|NCT03781505|Ropivacaine|ropivacaine|mesh-list
139204189|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
139204190|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
139204191|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139204192|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204193|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
139204194|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204195|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139204196|NCT03781505|Analgesics|analgesics|mesh-ancestor
139204197|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
139204198|NCT03781115|Olanzapine|olanzapine|mesh-list
139204199|NCT03781115|Ziprasidone|ziprasidone|mesh-list
139204200|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
139204201|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
139204202|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204203|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204204|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139204205|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139204206|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139204207|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139204208|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139204209|NCT03781115|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139204210|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139204211|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139204212|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204213|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204215|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139204216|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139204217|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
139204218|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139204219|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
139204220|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139204221|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139204222|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139204223|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139204224|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204226|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
139204227|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139204228|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
139204229|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204230|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139204231|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139204232|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
139204233|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204234|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204235|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139204236|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139204237|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139204238|NCT01313429|Analgesics|analgesics|mesh-ancestor
139204239|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
139204240|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204241|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204242|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139204243|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139204244|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204245|NCT03488251|Gemcitabine|gemcitabine|mesh-list
139204246|NCT03488251|Oxaliplatin|oxaliplatin|mesh-list
139204247|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139204248|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
139204249|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204250|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204251|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
139204252|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139204253|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204254|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139204255|NCT03315520|Cytarabine|cytarabine|mesh-list
139204256|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
139204257|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139204258|NCT03315520|Etoposide|etoposide|mesh-list
139204259|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139204260|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
139204261|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204262|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139204263|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139204264|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
139204265|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204266|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204267|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139204268|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139204269|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139204270|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139204271|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204272|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139204273|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
139204274|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
139204275|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204276|NCT02483182|Acyclovir|acyclovir|mesh-list
139204277|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
139204278|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204279|NCT01338558|Bevacizumab|bevacizumab|mesh-list
139204280|NCT01338558|Cetuximab|cetuximab|mesh-list
139204281|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139204282|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204283|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139204285|NCT01338558|Growth Substances|growth substances|mesh-ancestor
139204286|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204287|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
139204288|NCT03780569|Temozolomide|temozolomide|mesh-list
139204289|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139204290|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
139204291|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204292|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204293|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139204294|NCT03487549|Cantharidin|cantharidin|mesh-list
139204295|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204296|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204297|NCT01313585|Beclomethasone|beclomethasone|mesh-list
139204299|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139204300|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
139204301|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065798|NCT00129402|Simvastatin|simvastatin|mesh-list
139204302|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204303|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139204304|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
139204305|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
139204306|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139204307|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139204308|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139204309|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139204310|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
139204311|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204312|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204313|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204314|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
139204315|NCT01313585|Hormones|hormones|mesh-ancestor
139204316|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139204317|NCT01561235|Hormones|hormones|mesh-list
139204318|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139204319|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204320|NCT02485990|Olaparib|olaparib|mesh-list
139204321|NCT02485990|Tremelimumab|tremelimumab|mesh-list
139204322|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139204323|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204324|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204325|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204326|NCT01313819|Amantadine|amantadine|mesh-list
139204327|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139204328|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139204329|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
139204330|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204331|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
139204332|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204333|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204334|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204335|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139204337|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
139204338|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204339|NCT03315442|Caffeine|caffeine|mesh-list
139204340|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139204341|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204342|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139204343|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204344|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204345|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139204346|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139204347|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
139204348|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204349|NCT03464383|Escitalopram|escitalopram|mesh-list
139204350|NCT03464383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139204351|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139204352|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139204353|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204354|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204355|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
139204356|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204357|NCT03779633|Estradiol|estradiol|mesh-list
139204358|NCT03779633|Estrogens|estrogens|mesh-ancestor
139204359|NCT03779633|Hormones|hormones|mesh-ancestor
139204360|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139204362|NCT03720067|Propranolol|propranolol|mesh-list
139204363|NCT03720067|Carvedilol|carvedilol|mesh-list
139204364|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139204365|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139204366|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139204367|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
139204368|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204369|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139204370|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139204371|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204372|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139204373|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139204374|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
139204375|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204376|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204377|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139204378|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139204379|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
139204380|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
139204381|NCT03720067|Protective Agents|protective agents|mesh-ancestor
139204382|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139204383|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139204384|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139204385|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139204386|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139204387|NCT01444092|Budesonide|budesonide|mesh-list
139204388|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204389|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139204390|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
139204391|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204392|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204393|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139204394|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
139204395|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
139204396|NCT01444092|Hormones|hormones|mesh-ancestor
139204397|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139204398|NCT03719989|Azacitidine|azacitidine|mesh-list
139204399|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139204400|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
139204401|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204402|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204403|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204404|NCT05462470|Liver Extracts|liver extracts|mesh-list
139204405|NCT05462470|Hematinics|hematinics|mesh-ancestor
139204406|NCT01265784|Ertapenem|ertapenem|mesh-list
139204407|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139204408|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204409|NCT03774953|Vitamins|vitamins|mesh-list
139204410|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
139204411|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204412|NCT02483026|Vitamin D|vitamin d|mesh-list
139204413|NCT02483026|Vitamins|vitamins|mesh-list
139204414|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
139204415|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204416|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139204417|NCT02483104|Paclitaxel|paclitaxel|mesh-list
139204418|NCT02483104|Carboplatin|carboplatin|mesh-list
139204419|NCT02483104|Veliparib|veliparib|mesh-list
139204420|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139204421|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204422|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
139204423|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
139204424|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
139204425|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204426|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139204427|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204428|NCT00116220|Goserelin|goserelin|mesh-list
139204429|NCT00116220|Flutamide|flutamide|mesh-list
139204430|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204431|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139204432|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204433|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
139204434|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
139204435|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139204436|NCT03785015|Aspirin|aspirin|mesh-list
139204437|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139204438|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139204439|NCT03785015|Analgesics|analgesics|mesh-ancestor
139204440|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
139204441|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204442|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204443|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204444|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139204445|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139204446|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139204447|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204448|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139204449|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139204450|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204451|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
139204452|NCT05185518|Insulin|insulin|mesh-list
139204453|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139204454|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204455|NCT03316690|Metformin|metformin|mesh-list
139204456|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139204457|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204458|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
139204459|NCT03315052|Prednisone|prednisone|mesh-list
139204460|NCT03315052|Budesonide|budesonide|mesh-list
139204461|NCT03315052|Tacrolimus|tacrolimus|mesh-list
139204462|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204463|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
139204464|NCT03315052|Hormones|hormones|mesh-ancestor
139204465|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139204466|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204467|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139204468|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204469|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139204470|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
139204471|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139204472|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204473|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204474|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139204475|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139204476|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
139204477|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139204478|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204479|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139204480|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
139204481|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204482|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139204483|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
139204484|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
139204485|NCT03778619|Rituximab|rituximab|mesh-list
139204486|NCT03778619|Fludarabine|fludarabine|mesh-list
139204487|NCT03778619|Interleukin-2|interleukin-2|mesh-list
139204488|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139204489|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
139204490|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204491|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139204492|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139204493|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
139204494|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204495|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204496|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139204497|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139204498|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139204499|NCT03778619|Analgesics|analgesics|mesh-ancestor
139204500|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
139204501|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204502|NCT05714176|Lactoferrin|lactoferrin|mesh-list
139204503|NCT05714176|Dextrans|dextrans|mesh-list
139204504|NCT05714176|Iron-Dextran Complex|iron-dextran complex|mesh-list
139204505|NCT05714176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204506|NCT05714176|Anticoagulants|anticoagulants|mesh-ancestor
138867750|NCT03043547|Leucovorin|leucovorin|mesh-list
139204508|NCT05714176|Blood Substitutes|blood substitutes|mesh-ancestor
139204509|NCT05714176|Hematinics|hematinics|mesh-ancestor
139204510|NCT03156504|Ketamine|ketamine|mesh-list
139204511|NCT03156504|Analgesics|analgesics|mesh-ancestor
139204512|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
139204513|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204514|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204515|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139204516|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139204517|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
139204518|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
139204519|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139204520|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139204521|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139204522|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204523|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204524|NCT01333332|Capecitabine|capecitabine|mesh-list
139204525|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139204526|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
139204527|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204528|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204529|NCT03316534|Aspirin|aspirin|mesh-list
139204530|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139204531|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139204532|NCT03316534|Analgesics|analgesics|mesh-ancestor
139204533|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
139204534|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204535|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204536|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204537|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139204538|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139204539|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139204540|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204541|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139204542|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139204543|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204544|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
139204545|NCT04476420|Betamethasone|betamethasone|mesh-list
139204546|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
139204547|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139204548|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
139204549|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139204550|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204551|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
139204552|NCT04476420|Hormones|hormones|mesh-ancestor
139204553|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139204554|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204555|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139204556|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
139204557|NCT03778541|Temozolomide|temozolomide|mesh-list
139204558|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139204559|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
139204560|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204561|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204562|NCT02479828|Ropivacaine|ropivacaine|mesh-list
139204563|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
139204564|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
139204565|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139204566|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204567|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
139204568|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204569|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
139204570|NCT01320449|Hematinics|hematinics|mesh-ancestor
139204571|NCT03430063|Ipilimumab|ipilimumab|mesh-list
139204572|NCT03430063|Cemiplimab|cemiplimab|mesh-list
139204573|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139204574|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204575|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139204576|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204577|NCT03158220|Vaccines|vaccines|mesh-list
139204578|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
139204579|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204580|NCT01308983|Amiloride|amiloride|mesh-list
139204582|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
139204583|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204584|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139204585|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139204586|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139204587|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204588|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139204589|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139204590|NCT01336842|Pemetrexed|pemetrexed|mesh-list
139204591|NCT01336842|Panobinostat|panobinostat|mesh-list
139204592|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204593|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204594|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204595|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139204596|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139204597|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139204598|NCT01339026|Clopidogrel|clopidogrel|mesh-list
139204599|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139204600|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139204601|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139204602|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139204603|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139204604|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
139204605|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204606|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204607|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204608|NCT03314740|Paclitaxel|paclitaxel|mesh-list
139204609|NCT03314740|Olaparib|olaparib|mesh-list
139204610|NCT03314740|Cediranib|cediranib|mesh-list
139204611|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139204612|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204613|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
139204614|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
139204615|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
139204616|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204617|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139204618|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204619|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139204621|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139204622|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
139204623|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204624|NCT02482402|Iloprost|iloprost|mesh-list
139204625|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139204626|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
139204627|NCT03774095|Pycnogenols|pycnogenols|mesh-list
139204628|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139204629|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
139204630|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204631|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
139204632|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204633|NCT03774095|Protective Agents|protective agents|mesh-ancestor
139204634|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139204635|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
139204636|NCT01333410|Tacrolimus|tacrolimus|mesh-list
139204637|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139204638|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
139204639|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204640|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139204641|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204642|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204643|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204644|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
139204645|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139204646|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
139204647|NCT02482090|Fludarabine|fludarabine|mesh-list
139204648|NCT02482090|Interleukin-2|interleukin-2|mesh-list
139204649|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139204650|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
139204651|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204652|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139204653|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139204654|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
139065869|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
139204655|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204657|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139204658|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139204659|NCT02482090|Analgesics|analgesics|mesh-ancestor
139204660|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
139204661|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204662|NCT02482324|Ibuprofen|ibuprofen|mesh-list
139204663|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139204664|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139204665|NCT02482324|Analgesics|analgesics|mesh-ancestor
139204666|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
139204667|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204668|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204669|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204670|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139204671|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139204672|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204673|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204674|NCT05185284|Remdesivir|remdesivir|mesh-list
139204675|NCT05185284|Favipiravir|favipiravir|mesh-list
139204676|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
139204677|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204678|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
139204679|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204680|NCT03784703|Atorvastatin|atorvastatin|mesh-list
139204681|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139204682|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139204683|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139204684|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
139204685|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204686|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139204687|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139204688|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204689|NCT02724592|Fluorides|fluorides|mesh-list
139204690|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
139204691|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
139204692|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
139204693|NCT02724592|Protective Agents|protective agents|mesh-ancestor
139204694|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204695|NCT02476864|Macitentan|macitentan|mesh-list
139204696|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139204697|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139204698|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204699|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139204700|NCT05451550|Anesthetics|anesthetics|mesh-list
139204701|NCT05451550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139204702|NCT05451550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204703|NCT02476708|Curcumin|curcumin|mesh-list
139204704|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139204705|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139204706|NCT02476708|Analgesics|analgesics|mesh-ancestor
139204707|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
139204708|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204709|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204710|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204711|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139204712|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204713|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204714|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204715|NCT02479204|Atenolol|atenolol|mesh-list
139204716|NCT02479204|Diltiazem|diltiazem|mesh-list
139204717|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139204718|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139204719|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
139204720|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
139204721|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204722|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204723|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139065903|NCT00148122|Docetaxel|docetaxel|mesh-list
139204724|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139204725|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139204726|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
139204727|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204728|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204729|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139204730|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139204731|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139204732|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
139204734|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
139204735|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204736|NCT01339572|Plerixafor|plerixafor|mesh-list
139204737|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139204738|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139204739|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
139204740|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204741|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
139204742|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139204743|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
139204744|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204745|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204746|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139204747|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
139204748|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
139204749|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139204750|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
139204751|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204752|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204753|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
139204754|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
139204755|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139204756|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139204757|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204758|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204759|NCT03154476|Urological Agents|urological agents|mesh-ancestor
139204760|NCT03784391|Nifurtimox|nifurtimox|mesh-list
139204761|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139204762|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139204763|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139204764|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204765|NCT02476552|Niraparib|niraparib|mesh-list
139204766|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139204767|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204768|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204769|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204770|NCT01316718|Mesalamine|mesalamine|mesh-list
139204771|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139204772|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139204773|NCT01316718|Analgesics|analgesics|mesh-ancestor
139204774|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
139204775|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204776|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204777|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204778|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139204779|NCT01316952|Carvedilol|carvedilol|mesh-list
139204780|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139204781|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
139204782|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
139204783|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204784|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204785|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204786|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139204787|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
139204788|NCT01316952|Protective Agents|protective agents|mesh-ancestor
139204789|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139204790|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139204791|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139204792|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
139204793|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139204794|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139204795|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139204796|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139204797|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204798|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
139204799|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
139204800|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138936493|NCT00732914|Sorafenib|sorafenib|mesh-list
139204801|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
139204802|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139204803|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204804|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139204805|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139204806|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139204807|NCT03768713|Suvorexant|suvorexant|mesh-list
139204808|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139204809|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139204810|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139204811|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204812|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139204813|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204814|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204815|NCT02481076|Monensin|monensin|mesh-list
139204816|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
139204817|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204818|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139204819|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139204820|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
139204821|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
139204822|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
139204823|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204824|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204825|NCT02481076|Ionophores|ionophores|mesh-ancestor
139204826|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139204827|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
139204828|NCT05713396|Losartan|losartan|mesh-list
139204829|NCT05713396|Quinapril|quinapril|mesh-list
139204830|NCT05713396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139204831|NCT05713396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139204832|NCT05713396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139204833|NCT05713396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139204834|NCT05713396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204835|NCT05713396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139204836|NCT05713396|Protease Inhibitors|protease inhibitors|mesh-ancestor
139204837|NCT05713396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204838|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
139204839|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
139204840|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204841|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139204842|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204843|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204844|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
139204845|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139204846|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
139204847|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
139204848|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204849|NCT02475382|Nivolumab|nivolumab|mesh-list
139204850|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139204851|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204852|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139204853|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204854|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139204855|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
139204856|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139204857|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
139204858|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204859|NCT02478424|Cyclosporine|cyclosporine|mesh-list
139204860|NCT02478424|Methotrexate|methotrexate|mesh-list
139204861|NCT02478424|Cannabidiol|cannabidiol|mesh-list
139204862|NCT02478424|Cyclosporins|cyclosporins|mesh-list
139204863|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139204864|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
139204865|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139204866|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204867|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139204868|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
139204869|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204870|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204871|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
139204872|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204873|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139204874|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139204875|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
139204877|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139204878|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
139204879|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204880|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139204881|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
139204882|NCT03712787|Tilavonemab|tilavonemab|mesh-list
139204883|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
139204884|NCT02478268|Xenon|xenon|mesh-list
139204885|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139204886|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
139204887|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
139204888|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139204889|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204890|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
139204891|NCT04053881|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139204892|NCT04053881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204893|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139204894|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
139204895|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204896|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139204897|NCT03768557|Minocycline|minocycline|mesh-list
139204898|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139204899|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204900|NCT03783845|Amoxicillin|amoxicillin|mesh-list
139204901|NCT03783845|Metronidazole|metronidazole|mesh-list
139204902|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139204903|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139204904|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139204905|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139204906|NCT01560689|Budesonide|budesonide|mesh-list
139204907|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
139204908|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204909|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139204910|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
139204911|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204912|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204913|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139204914|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
139204915|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
139204916|NCT01560689|Hormones|hormones|mesh-ancestor
139204917|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139204918|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139204919|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139204920|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139204921|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
139204922|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139204923|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204924|NCT02474914|Octreotide|octreotide|mesh-list
139204925|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139204926|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139204927|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204928|NCT03769103|Osimertinib|osimertinib|mesh-list
139204929|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204930|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139204931|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204932|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204933|NCT04998214|Thrombin|thrombin|mesh-list
139204934|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
139204935|NCT04998214|Coagulants|coagulants|mesh-ancestor
139204936|NCT01309607|Paclitaxel|paclitaxel|mesh-list
139204937|NCT01309607|Carboplatin|carboplatin|mesh-list
139204938|NCT01309607|Lapatinib|lapatinib|mesh-list
139204939|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139204940|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139204941|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
139204942|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
139204943|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
139204944|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204945|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139204946|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204947|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
139204948|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139204949|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
139204950|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204951|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
139204952|NCT03783455|Protective Agents|protective agents|mesh-ancestor
139204953|NCT05305066|Adalimumab|adalimumab|mesh-list
139204954|NCT05305066|Golimumab|golimumab|mesh-list
139204955|NCT05305066|Etanercept|etanercept|mesh-list
139204956|NCT05305066|Upadacitinib|upadacitinib|mesh-list
139204957|NCT05305066|Tofacitinib|tofacitinib|mesh-list
139204958|NCT05305066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138955418|NCT00743990|Camphor|camphor|mesh-list
139204959|NCT05305066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204960|NCT05305066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139204961|NCT05305066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139204962|NCT05305066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139204963|NCT05305066|Analgesics|analgesics|mesh-ancestor
139204964|NCT05305066|Sensory System Agents|sensory system agents|mesh-ancestor
139204965|NCT05305066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139204966|NCT05305066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204967|NCT05305066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139204968|NCT05305066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139204969|NCT05305066|Immunologic Factors|immunologic factors|mesh-ancestor
139204970|NCT05305066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139204971|NCT05305066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139204972|NCT05305066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204973|NCT05305066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204974|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
139204975|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139204976|NCT02477956|Vitamin D|vitamin d|mesh-list
139204977|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
139204978|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
139204979|NCT02477956|Vitamins|vitamins|mesh-list
139204980|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
139204981|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204982|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139204983|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139204984|NCT02472574|Plasminogen|plasminogen|mesh-list
139065946|NCT03862144|Palonosetron|palonosetron|mesh-list
139204985|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139204986|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139204987|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139204988|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204989|NCT05708248|Pentoxifylline|pentoxifylline|mesh-list
139204990|NCT05708248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139204991|NCT05708248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139204992|NCT05708248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139204993|NCT05708248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139204994|NCT05708248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139204995|NCT05708248|Protective Agents|protective agents|mesh-ancestor
139204996|NCT05708248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139204997|NCT05708248|Vasodilator Agents|vasodilator agents|mesh-ancestor
139204998|NCT05708248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139204999|NCT05708248|Antioxidants|antioxidants|mesh-ancestor
139205000|NCT03772223|Budesonide|budesonide|mesh-list
139205001|NCT03772223|Albuterol|albuterol|mesh-list
139205002|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139205003|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139205004|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
139205005|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205006|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205007|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139205008|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
139205009|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
139205010|NCT03772223|Hormones|hormones|mesh-ancestor
139205011|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139205012|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
139205013|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139205014|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139205015|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139205016|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139205017|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
139205018|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205019|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205020|NCT03783299|Lumefantrine|lumefantrine|mesh-list
139205021|NCT03783299|Artemether|artemether|mesh-list
139205022|NCT03783299|Primaquine|primaquine|mesh-list
139205023|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139205024|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
139205025|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139205026|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139205027|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205028|NCT03771755|Acetaminophen|acetaminophen|mesh-list
139205029|NCT03771755|Ibuprofen|ibuprofen|mesh-list
139205030|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139205031|NCT03771755|Analgesics|analgesics|mesh-ancestor
139205032|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
138955481|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205033|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205034|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205035|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
139205036|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139205037|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139205038|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139205039|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139205040|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205041|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205042|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139205043|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
139205044|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139205045|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
139205046|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139205047|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205048|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139205049|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139205050|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205052|NCT05432531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139205053|NCT05432531|Immunologic Factors|immunologic factors|mesh-ancestor
139205054|NCT05432531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205055|NCT05432531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139205056|NCT05432531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139205057|NCT05432531|Alkylating Agents|alkylating agents|mesh-ancestor
139205058|NCT05432531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205059|NCT05432531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205060|NCT05432531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139205061|NCT01309685|Varenicline|varenicline|mesh-list
139205062|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139205063|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139205064|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
139205065|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205066|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205067|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205068|NCT03772067|Insulin|insulin|mesh-list
139205069|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139205070|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139205071|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139205072|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205073|NCT03772067|Incretins|incretins|mesh-ancestor
139205074|NCT03772067|Hormones|hormones|mesh-ancestor
139205075|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139205076|NCT03783065|Propranolol|propranolol|mesh-list
139205077|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139205078|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139205079|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
139205080|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205081|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205082|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205083|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139205084|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139205085|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
139205086|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
139205087|NCT03766997|Betamethasone|betamethasone|mesh-list
139205088|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
139205089|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139205090|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
139205091|NCT03766997|Hormones|hormones|mesh-ancestor
139205092|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139205093|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205094|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139205095|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
139205096|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
139205097|NCT03782831|Antibodies|antibodies|mesh-list
139205098|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
139205099|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205100|NCT03766607|Paclitaxel|paclitaxel|mesh-list
139205101|NCT03766607|Trastuzumab|trastuzumab|mesh-list
139205102|NCT03766607|Ramucirumab|ramucirumab|mesh-list
139205103|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139205104|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205106|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
139205107|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
139205108|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205109|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139205110|NCT01567709|Vorinostat|vorinostat|mesh-list
139205111|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205112|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139205113|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205114|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205115|NCT03765827|Vitamins|vitamins|mesh-list
139205116|NCT03765827|Vitamin E|vitamin e|mesh-list
139205117|NCT03765827|Tocopherols|tocopherols|mesh-list
139205118|NCT03765827|Tocotrienols|tocotrienols|mesh-list
139205119|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
139205120|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
139205121|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205122|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
139205123|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205124|NCT03765827|Protective Agents|protective agents|mesh-ancestor
139205125|NCT03771053|Simvastatin|simvastatin|mesh-list
139205126|NCT03771053|Ezetimibe|ezetimibe|mesh-list
139205127|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139205128|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139205129|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
139205130|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205131|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139205132|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139205133|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205134|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
139205135|NCT03770663|Azathioprine|azathioprine|mesh-list
139205136|NCT03770663|Tacrolimus|tacrolimus|mesh-list
139205137|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139205138|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
139205139|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205140|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139205141|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139205142|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
139205143|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205144|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205145|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139205146|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139205147|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205148|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
139205149|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139205150|NCT03048422|Tenofovir|tenofovir|mesh-list
139205151|NCT03048422|Emtricitabine|emtricitabine|mesh-list
139205152|NCT03048422|Efavirenz|efavirenz|mesh-list
139205153|NCT03048422|Dolutegravir|dolutegravir|mesh-list
139205154|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139205155|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139205156|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139205157|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
139205158|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205159|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139205160|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139205161|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205162|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205163|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139205164|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139205165|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139205166|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139205167|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139205168|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139205169|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139205170|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139065984|NCT01184560|Orlistat|orlistat|mesh-list
139205171|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139205172|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139205173|NCT01561781|Digoxin|digoxin|mesh-list
139205174|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139205175|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139205176|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205177|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205178|NCT01561781|Protective Agents|protective agents|mesh-ancestor
139205179|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205181|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139205182|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205183|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205184|NCT01321775|Paclitaxel|paclitaxel|mesh-list
139205185|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
139205186|NCT01321775|Bevacizumab|bevacizumab|mesh-list
139205187|NCT01321775|Trastuzumab|trastuzumab|mesh-list
139205188|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139205189|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205190|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
139205191|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
139205192|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
139205193|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205194|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139205195|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
139205196|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205197|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139205198|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139205199|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
139205200|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139205201|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139205202|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139205203|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139205204|NCT01321775|Growth Substances|growth substances|mesh-ancestor
139205205|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
139205207|NCT03764267|Remifentanil|remifentanil|mesh-list
139205208|NCT03764267|Anesthetics|anesthetics|mesh-list
139205209|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
139205210|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
139205211|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205212|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205213|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
139205214|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205215|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139205216|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139205217|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139205218|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139205219|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205220|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139205221|NCT03764267|Narcotics|narcotics|mesh-ancestor
139205222|NCT03764267|Analgesics|analgesics|mesh-ancestor
139205223|NCT01321931|Nicotine|nicotine|mesh-list
139205224|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139205225|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
139205226|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205227|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205228|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139205229|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139205230|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
139205231|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205232|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205233|NCT03763409|Losartan|losartan|mesh-list
139205234|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139205235|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139205236|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139205237|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139205238|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205239|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139205240|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139205241|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205242|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
139205243|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139205244|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205245|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205246|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139205247|NCT03762785|Analgesics|analgesics|mesh-ancestor
139205248|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
139205249|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205250|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139205251|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139205252|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139205253|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
139205254|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205255|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205256|NCT03758729|Nivolumab|nivolumab|mesh-list
139205257|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139205258|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205259|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139205260|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205261|NCT03756623|Metformin|metformin|mesh-list
139205262|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139205263|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205264|NCT03756233|Remifentanil|remifentanil|mesh-list
139205265|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139205266|NCT03756233|Narcotics|narcotics|mesh-ancestor
139205267|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205268|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205269|NCT03756233|Analgesics|analgesics|mesh-ancestor
139205270|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
139205271|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205273|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205274|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139205275|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205276|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205277|NCT05085665|Ivermectin|ivermectin|mesh-list
139205278|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139205279|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205280|NCT03755609|Fentanyl|fentanyl|mesh-list
139205281|NCT03755609|Oxycodone|oxycodone|mesh-list
139205282|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139205283|NCT03755609|Narcotics|narcotics|mesh-ancestor
139205284|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205285|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205286|NCT03755609|Analgesics|analgesics|mesh-ancestor
139205287|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
139205288|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205289|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139205290|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139205291|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
139205292|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
139205293|NCT03760445|Cytarabine|cytarabine|mesh-list
139205294|NCT03760445|Posaconazole|posaconazole|mesh-list
139205295|NCT03760445|Daunorubicin|daunorubicin|mesh-list
139205296|NCT03760445|Idarubicin|idarubicin|mesh-list
139205297|NCT03760445|Midostaurin|midostaurin|mesh-list
139205298|NCT03760445|Midazolam|midazolam|mesh-list
139205299|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139205300|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
139205301|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205302|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205303|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
139205304|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205305|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139205306|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
139205307|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205308|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139205309|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139205310|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205311|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139205312|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139205313|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139205314|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139205315|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
139205316|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
139205317|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
139205318|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
139205319|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205320|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139205321|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139205322|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139205323|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205324|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
139205325|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139205326|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139205327|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139205328|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139205329|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139205330|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139205331|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
139205332|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955781|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205333|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139205334|NCT05460377|Vaccines|vaccines|mesh-list
139205335|NCT05460377|Immunologic Factors|immunologic factors|mesh-ancestor
139205336|NCT05460377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205337|NCT05692856|Clenbuterol|clenbuterol|mesh-list
139205338|NCT05692856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139205339|NCT05692856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139205340|NCT05692856|Adrenergic Agents|adrenergic agents|mesh-ancestor
139205341|NCT05692856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205342|NCT05692856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205343|NCT05692856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205344|NCT05692856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139205345|NCT05692856|Autonomic Agents|autonomic agents|mesh-ancestor
139205346|NCT05692856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205347|NCT05692856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139205348|NCT05692856|Respiratory System Agents|respiratory system agents|mesh-ancestor
139205349|NCT05692856|Sympathomimetics|sympathomimetics|mesh-ancestor
139205350|NCT03755531|Oxytocin|oxytocin|mesh-list
139205351|NCT03755531|Carbetocin|carbetocin|mesh-list
139205352|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
139205353|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139205354|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205355|NCT04854707|Menotropins|menotropins|mesh-list
139205356|NCT04854707|Hormones|hormones|mesh-list
139205357|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139205358|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139205359|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205360|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139205361|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
139205362|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139205363|NCT03215069|Empagliflozin|empagliflozin|mesh-list
139205364|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139205365|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205366|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139205367|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205368|NCT03759353|Lactoferrin|lactoferrin|mesh-list
139205369|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205370|NCT03757559|Hydromorphone|hydromorphone|mesh-list
139205371|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139205372|NCT03757559|Narcotics|narcotics|mesh-ancestor
139205373|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205374|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205375|NCT03757559|Analgesics|analgesics|mesh-ancestor
139205376|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
139205377|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205378|NCT02658929|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
139205379|NCT02658929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139205380|NCT02658929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205381|NCT04784897|Brilacidin|brilacidin|mesh-list
139205382|NCT04784897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205383|NCT01322711|Atorvastatin|atorvastatin|mesh-list
139205384|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139205385|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139205386|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
139205387|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205388|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139205389|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139205390|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205391|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139205392|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139205393|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205394|NCT03041792|Liraglutide|liraglutide|mesh-list
139205395|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139205396|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205397|NCT03041792|Incretins|incretins|mesh-ancestor
139205398|NCT03041792|Hormones|hormones|mesh-ancestor
139205399|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139205400|NCT03753581|Cytarabine|cytarabine|mesh-list
139205401|NCT03753581|Methotrexate|methotrexate|mesh-list
139205402|NCT03753581|Etoposide|etoposide|mesh-list
139205403|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139205405|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205406|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205407|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
139205408|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205409|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139205410|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
139205411|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205412|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139205413|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139205414|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139205415|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205416|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139205417|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
139205418|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139205419|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
139205420|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139205421|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139205422|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139205423|NCT04507763|Etanercept|etanercept|mesh-list
139205424|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139205425|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139205426|NCT04507763|Analgesics|analgesics|mesh-ancestor
139205427|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
139205428|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205429|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205430|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139205431|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139205432|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139205433|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139205434|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
139205435|NCT00705484|Infliximab|infliximab|mesh-list
139205436|NCT00705484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139205437|NCT00705484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139205438|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
139205439|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139205440|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139205441|NCT05459597|Anticonvulsants|anticonvulsants|mesh-list
139205442|NCT05358626|Antibodies|antibodies|mesh-list
139205443|NCT05358626|Immunoglobulin G|immunoglobulin g|mesh-list
139205444|NCT05358626|Immunologic Factors|immunologic factors|mesh-ancestor
139205445|NCT05358626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205446|NCT03753269|Fasudil|fasudil|mesh-list
139205447|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139205448|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139205449|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205450|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139205451|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205452|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
139205453|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139205454|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205455|NCT05459441|Pemetrexed|pemetrexed|mesh-list
139205456|NCT05459441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205457|NCT05459441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205458|NCT05459441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205459|NCT05459441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139205460|NCT05459441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139205461|NCT04523831|Doxycycline|doxycycline|mesh-list
139205462|NCT04523831|Ivermectin|ivermectin|mesh-list
139205463|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139205464|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205465|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
139205466|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139205467|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139205468|NCT05691764|Cyclosporine|cyclosporine|mesh-list
139205469|NCT05691764|Cyclosporins|cyclosporins|mesh-list
139205470|NCT05691764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205471|NCT05691764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205472|NCT05691764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139205473|NCT05691764|Immunologic Factors|immunologic factors|mesh-ancestor
139205474|NCT05691764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205475|NCT05691764|Antifungal Agents|antifungal agents|mesh-ancestor
139205476|NCT05691764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205477|NCT05691764|Dermatologic Agents|dermatologic agents|mesh-ancestor
139205478|NCT05691764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139205479|NCT05691764|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139205480|NCT04707664|Sargramostim|sargramostim|mesh-list
139205481|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
139205482|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955934|NCT00744536|Melphalan|melphalan|mesh-list
139205483|NCT01316276|Amikacin|amikacin|mesh-list
139205484|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139205485|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205486|NCT02474290|Sorafenib|sorafenib|mesh-list
139205487|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205488|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139205489|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205490|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205491|NCT02474212|Enoxaparin|enoxaparin|mesh-list
139205492|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
139205493|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139205494|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139205495|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205496|NCT05200286|Olorofim|olorofim|mesh-list
139205497|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
139205498|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205499|NCT02474446|Vitamin D|vitamin d|mesh-list
139205500|NCT02474446|Vitamins|vitamins|mesh-ancestor
139205501|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
139205502|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205503|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139205504|NCT05199818|Palonosetron|palonosetron|mesh-list
139205505|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
139205506|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
139205507|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205508|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205509|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139205510|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139205511|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139205512|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
139205513|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205514|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205515|NCT02474134|Interferons|interferons|mesh-list
139205516|NCT02474134|Interferon-beta|interferon-beta|mesh-list
139205517|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
139205518|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205519|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
139205520|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205521|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
139205522|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205523|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139205524|NCT02473900|Oseltamivir|oseltamivir|mesh-list
139205525|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
139205526|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205527|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205528|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205529|NCT02471950|Isoflurane|isoflurane|mesh-list
139205530|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139205531|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
139205532|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
139205533|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205534|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205535|NCT01322867|Alprazolam|alprazolam|mesh-list
139205536|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139205537|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205538|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205539|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139205540|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139205541|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139205542|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
139205543|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
139205544|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205545|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205546|NCT04624828|Androgens|androgens|mesh-list
139205547|NCT04624828|Hormones|hormones|mesh-ancestor
139205548|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139205549|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205550|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139205551|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
139205552|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139205553|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
139205554|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205556|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
139205557|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205558|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205559|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
139205560|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139205561|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138956003|NCT00931437|Vitamin K|vitamin k|mesh-list
139205562|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
139205563|NCT02477488|Protective Agents|protective agents|mesh-ancestor
139205564|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205565|NCT05163106|Letrozole|letrozole|mesh-list
139205566|NCT05163106|Goserelin|goserelin|mesh-list
139205567|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205568|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139205569|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139205570|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205571|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205572|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139205573|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
139205574|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139205575|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205576|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139205577|NCT02477098|Ropivacaine|ropivacaine|mesh-list
139205578|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
139205579|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
139205580|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205581|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205582|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
139205583|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205584|NCT02473354|Remifentanil|remifentanil|mesh-list
139205585|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139205586|NCT02473354|Narcotics|narcotics|mesh-ancestor
139205587|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205588|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205589|NCT02473354|Analgesics|analgesics|mesh-ancestor
139205590|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
139205591|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205592|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
139205593|NCT02470858|Asunaprevir|asunaprevir|mesh-list
139205594|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
139205595|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205596|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
139205597|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205598|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205599|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139205600|NCT02473198|Morphine|morphine|mesh-list
139205601|NCT02473198|Bupivacaine|bupivacaine|mesh-list
139205602|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
139205603|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
139205604|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205605|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205606|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
139205607|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205608|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139205609|NCT02473198|Narcotics|narcotics|mesh-ancestor
139205610|NCT02473198|Analgesics|analgesics|mesh-ancestor
139205611|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139205612|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139205613|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139205614|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139205615|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139205616|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205617|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205618|NCT03614728|Azacitidine|azacitidine|mesh-list
139205619|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
139205620|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139205621|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
139205622|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205623|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205624|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205626|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139205627|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205628|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139205629|NCT05180292|Carvedilol|carvedilol|mesh-list
139205630|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139205632|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
139205633|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205634|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205635|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956080|NCT00921674|Ivermectin|ivermectin|mesh-list
139205636|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139205637|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
139205638|NCT05180292|Protective Agents|protective agents|mesh-ancestor
139205639|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139205640|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139205641|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139205642|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
139205643|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139205644|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139205645|NCT01315938|Abatacept|abatacept|mesh-list
139205646|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139205647|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205648|NCT01315938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139205649|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205650|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139205651|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
139205652|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205653|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139205654|NCT01339884|Resveratrol|resveratrol|mesh-list
139205655|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
139205656|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205657|NCT01339884|Protective Agents|protective agents|mesh-ancestor
139205658|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205659|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205660|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139205661|NCT04736394|Epirubicin|epirubicin|mesh-list
139205662|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139205663|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205664|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139205665|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139205666|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205667|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205668|NCT01341834|Everolimus|everolimus|mesh-list
139205669|NCT01341834|Panobinostat|panobinostat|mesh-list
139205670|NCT01341834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139205671|NCT01341834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139205672|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205673|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205674|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139205675|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
139205676|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205677|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205678|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139205679|NCT01340118|Budesonide|budesonide|mesh-list
139205680|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139205681|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139205682|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
139205683|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205684|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205685|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139205686|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
139205687|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
139205688|NCT01340118|Hormones|hormones|mesh-ancestor
139205689|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139205690|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
139205691|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139205692|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139205693|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139205694|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139205695|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139205696|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
139205697|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139205698|NCT04409964|Lidocaine|lidocaine|mesh-list
139205699|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
139205700|NCT04409964|Remifentanil|remifentanil|mesh-list
139205701|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
139205702|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
138937378|NCT06135259|Hematinics|hematinics|mesh-ancestor
139205703|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205704|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205705|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
139205706|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205707|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139205708|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139205709|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139205710|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139205711|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205713|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139205715|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139205716|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139205717|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139205718|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
139205719|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205720|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139205721|NCT04409964|Narcotics|narcotics|mesh-ancestor
139205722|NCT01342146|Hormones|hormones|mesh-list
139205723|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139205724|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205725|NCT03212716|Oseltamivir|oseltamivir|mesh-list
139205726|NCT03212716|Diltiazem|diltiazem|mesh-list
139205727|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
139205728|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205729|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205730|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205731|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139205732|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139205733|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139205734|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139205735|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205736|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
139205737|NCT04762836|Cycloserine|cycloserine|mesh-list
139205738|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139205739|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205740|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139205741|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
139205742|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139205743|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
139205744|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205745|NCT00705406|Peramivir|peramivir|mesh-list
139205746|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
139205747|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139066086|NCT00146640|Hormones|hormones|mesh-ancestor
139205748|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205749|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205750|NCT01342224|Gemcitabine|gemcitabine|mesh-list
139205751|NCT01342224|Tadalafil|tadalafil|mesh-list
139205752|NCT01342224|Sargramostim|sargramostim|mesh-list
139205753|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
139205754|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205755|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139205756|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
139205757|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205758|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205759|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
139205760|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139205761|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139205762|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205763|NCT01342224|Urological Agents|urological agents|mesh-ancestor
139205764|NCT03155178|Ethanol|ethanol|mesh-list
139205765|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
139205766|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139205767|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139205768|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205769|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205770|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205772|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
139205773|NCT02470546|Metformin|metformin|mesh-list
139205774|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139205775|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205776|NCT03310762|Silicon|silicon|mesh-list
139205777|NCT03310762|Trace Elements|trace elements|mesh-ancestor
139205778|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
139205779|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205780|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139205781|NCT03310606|Lactams|lactams|mesh-list
139205782|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205783|NCT01315704|Vitamin D|vitamin d|mesh-list
138956229|NCT00666198|Urological Agents|urological agents|mesh-ancestor
139205784|NCT01315704|Vitamins|vitamins|mesh-ancestor
139205785|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
139205786|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205787|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139205788|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
139205789|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139205790|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
139205791|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205792|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139205793|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139205794|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
139205795|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205796|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205797|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139205798|NCT03310372|Temozolomide|temozolomide|mesh-list
139205799|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139205800|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
139205801|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205802|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066091|NCT01185418|Haloperidol|haloperidol|mesh-list
139205803|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139205804|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139205805|NCT01342614|Metformin|metformin|mesh-list
139205806|NCT01342614|Fosinopril|fosinopril|mesh-list
139205807|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139205808|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205809|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139205810|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
139205811|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205812|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205813|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139205814|NCT01342692|Lenalidomide|lenalidomide|mesh-list
139205815|NCT01342692|Azacitidine|azacitidine|mesh-list
139205816|NCT01342692|Idarubicin|idarubicin|mesh-list
139205817|NCT01342692|Valproic Acid|valproic acid|mesh-list
139205818|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
139205819|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205820|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139205821|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139205822|NCT01342692|Growth Substances|growth substances|mesh-ancestor
139205823|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
139205824|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205825|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139205826|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
139205827|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205828|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205829|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
139205830|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
139205831|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205832|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
139205833|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139205834|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205835|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139205836|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139205837|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139205838|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139205839|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
139205840|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139205841|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139205842|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139205843|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205844|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
139205845|NCT03310060|Coagulants|coagulants|mesh-ancestor
139205846|NCT03740958|Argatroban|argatroban|mesh-list
139205847|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
139205848|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139205849|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
139205850|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205851|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205852|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
139205853|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139205855|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139205856|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
139205857|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205858|NCT05251584|Gentamicins|gentamicins|mesh-list
139205859|NCT05251584|Mupirocin|mupirocin|mesh-list
139205860|NCT05251584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139205861|NCT05251584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205862|NCT05251584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139205863|NCT05251584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205864|NCT05251584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205865|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
139205866|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139205867|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139205868|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139205869|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
139205870|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205871|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205872|NCT03309592|Ambrisentan|ambrisentan|mesh-list
139205873|NCT03309592|Tadalafil|tadalafil|mesh-list
139205874|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
139205875|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139205876|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139205877|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205878|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205879|NCT03309592|Urological Agents|urological agents|mesh-ancestor
139205880|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139205881|NCT04641312|Dulaglutide|dulaglutide|mesh-list
139205882|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139205883|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205884|NCT06209567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139205885|NCT06209567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139205886|NCT06209567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205887|NCT06209398|Vaccines|vaccines|mesh-list
139205888|NCT06209398|Immunologic Factors|immunologic factors|mesh-ancestor
139205889|NCT06209398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205890|NCT06209320|Atropine|atropine|mesh-list
139205891|NCT06209320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139205892|NCT06209320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139205893|NCT06209320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139205894|NCT06209320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139205895|NCT06209320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139205896|NCT06209320|Autonomic Agents|autonomic agents|mesh-ancestor
139205897|NCT06209320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205898|NCT06209320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205899|NCT06209320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139205900|NCT06209320|Respiratory System Agents|respiratory system agents|mesh-ancestor
139205901|NCT06209320|Mydriatics|mydriatics|mesh-ancestor
139205902|NCT06209320|Parasympatholytics|parasympatholytics|mesh-ancestor
139205903|NCT06209320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139205904|NCT06209320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139205905|NCT06209320|Cholinergic Agents|cholinergic agents|mesh-ancestor
139205906|NCT06209320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205907|NCT06209320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205908|NCT06209294|Paclitaxel|paclitaxel|mesh-list
139205909|NCT06209294|Carboplatin|carboplatin|mesh-list
139205910|NCT06209294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139205911|NCT06209294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205912|NCT06209294|Tubulin Modulators|tubulin modulators|mesh-ancestor
139205913|NCT06209294|Antimitotic Agents|antimitotic agents|mesh-ancestor
139205914|NCT06209294|Mitosis Modulators|mitosis modulators|mesh-ancestor
139205915|NCT06209294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205916|NCT06209281|Atropine|atropine|mesh-list
139205917|NCT06209281|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139205918|NCT06209281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139205919|NCT06209281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139205920|NCT06209281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139205921|NCT06209281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139205922|NCT06209281|Autonomic Agents|autonomic agents|mesh-ancestor
139205923|NCT06209281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205924|NCT06209281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205925|NCT06209281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139205926|NCT06209281|Respiratory System Agents|respiratory system agents|mesh-ancestor
139205927|NCT06209281|Mydriatics|mydriatics|mesh-ancestor
139205928|NCT06209281|Parasympatholytics|parasympatholytics|mesh-ancestor
139205929|NCT06209281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139205930|NCT06209281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139205931|NCT06209281|Cholinergic Agents|cholinergic agents|mesh-ancestor
139205932|NCT06209281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205933|NCT06209281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205934|NCT06209229|Cholecalciferol|cholecalciferol|mesh-list
139205935|NCT06209229|Pyridoxine|pyridoxine|mesh-list
139205936|NCT06209229|Vitamin B 6|vitamin b 6|mesh-list
139205937|NCT06209229|Sodium nucleinate|sodium nucleinate|mesh-list
139205939|NCT06209229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139205940|NCT06209229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205941|NCT06209229|Vitamins|vitamins|mesh-ancestor
139205942|NCT06209229|Micronutrients|micronutrients|mesh-ancestor
139205943|NCT06209229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139205944|NCT06209229|Vitamin B Complex|vitamin b complex|mesh-ancestor
139205945|NCT06209229|Antioxidants|antioxidants|mesh-ancestor
139205946|NCT06209229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205947|NCT06209229|Protective Agents|protective agents|mesh-ancestor
139205948|NCT06209229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139205949|NCT06209229|Immunologic Factors|immunologic factors|mesh-ancestor
139205950|NCT06209229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139205951|NCT06209229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139205952|NCT06209229|Interferon Inducers|interferon inducers|mesh-ancestor
139205953|NCT06209203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139205954|NCT06209203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139205955|NCT06209138|Fluorouracil|fluorouracil|mesh-list
139205956|NCT06209138|Antimetabolites|antimetabolites|mesh-ancestor
139205957|NCT06209138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205958|NCT06209138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139205959|NCT06209138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205960|NCT06209138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139205961|NCT06209138|Immunologic Factors|immunologic factors|mesh-ancestor
139205962|NCT06209138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205963|NCT06209047|Gentamicins|gentamicins|mesh-list
139205964|NCT06209047|Dexamethasone|dexamethasone|mesh-list
139205965|NCT06209047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139205966|NCT06209047|Antiemetics|antiemetics|mesh-ancestor
139205967|NCT06209047|Autonomic Agents|autonomic agents|mesh-ancestor
139205968|NCT06209047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205969|NCT06209047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205970|NCT06209047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139205971|NCT06209047|Glucocorticoids|glucocorticoids|mesh-ancestor
139205972|NCT06209047|Hormones|hormones|mesh-ancestor
139205973|NCT06209047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139205974|NCT06209047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139205975|NCT06209047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139205976|NCT06209047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139205977|NCT06209047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139205978|NCT06209047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139205979|NCT06209047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139205980|NCT06209047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205981|NCT06208956|Dexmedetomidine|dexmedetomidine|mesh-list
139205982|NCT06208956|Propofol|propofol|mesh-list
139205983|NCT06208956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139205984|NCT06208956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139205985|NCT06208956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139205986|NCT06208956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139205987|NCT06208956|Analgesics|analgesics|mesh-ancestor
139205988|NCT06208956|Sensory System Agents|sensory system agents|mesh-ancestor
139205989|NCT06208956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139205990|NCT06208956|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139205991|NCT06208956|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139205992|NCT06208956|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139205993|NCT06208956|Adrenergic Agents|adrenergic agents|mesh-ancestor
139205994|NCT06208956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139205995|NCT06208956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139205996|NCT06208956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139205997|NCT06208956|Anesthetics, General|anesthetics, general|mesh-ancestor
139205998|NCT06208956|Anesthetics|anesthetics|mesh-ancestor
139205999|NCT06208917|Dexamethasone|dexamethasone|mesh-list
139206000|NCT06208917|Dexamethasone acetate|dexamethasone acetate|mesh-list
139206001|NCT06208917|Ondansetron|ondansetron|mesh-list
139206002|NCT06208917|BB 1101|bb 1101|mesh-list
139206003|NCT06208917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139206004|NCT06208917|Antiemetics|antiemetics|mesh-ancestor
139206005|NCT06208917|Autonomic Agents|autonomic agents|mesh-ancestor
139206006|NCT06208917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206007|NCT06208917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206008|NCT06208917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139206010|NCT06208917|Hormones|hormones|mesh-ancestor
139206011|NCT06208917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139206012|NCT06208917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139206013|NCT06208917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206014|NCT06208917|Protease Inhibitors|protease inhibitors|mesh-ancestor
139206015|NCT06208917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206016|NCT06208917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206017|NCT06208917|Antipruritics|antipruritics|mesh-ancestor
139206018|NCT06208917|Dermatologic Agents|dermatologic agents|mesh-ancestor
139206019|NCT06208917|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139206020|NCT06208917|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139206021|NCT06208917|Serotonin Agents|serotonin agents|mesh-ancestor
139206022|NCT06208917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206023|NCT06208839|Ethanol|ethanol|mesh-list
139206024|NCT06208839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139206025|NCT06208839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206026|NCT06208839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206027|NCT06208839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206028|NCT06208826|Cisplatin|cisplatin|mesh-list
139206029|NCT06208826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206030|NCT06208748|Sunitinib|sunitinib|mesh-list
139206031|NCT06208748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206032|NCT06208748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139206033|NCT06208748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139206034|NCT06208748|Growth Substances|growth substances|mesh-ancestor
139206035|NCT06208748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206036|NCT06208748|Growth Inhibitors|growth inhibitors|mesh-ancestor
139206037|NCT06208748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139206038|NCT06208748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206039|NCT06208748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206040|NCT06208683|Vaccines|vaccines|mesh-list
139206041|NCT06208683|Immunologic Factors|immunologic factors|mesh-ancestor
139206042|NCT06208683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206043|NCT06208657|Irinotecan|irinotecan|mesh-list
139206044|NCT06208657|Temozolomide|temozolomide|mesh-list
139206045|NCT06208657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139206046|NCT06208657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139206047|NCT06208657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066163|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
139206048|NCT06208657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206049|NCT06208657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206050|NCT06208657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139206051|NCT06208657|Alkylating Agents|alkylating agents|mesh-ancestor
139206052|NCT06208540|Cerebrolysin|cerebrolysin|mesh-list
139206053|NCT06208540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139206054|NCT06208540|Protective Agents|protective agents|mesh-ancestor
139206055|NCT06208540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206056|NCT06208540|Nootropic Agents|nootropic agents|mesh-ancestor
139206057|NCT06208527|Niacinamide|niacinamide|mesh-list
139206058|NCT06208527|Niacin|niacin|mesh-list
139206059|NCT06208527|Nicotinic Acids|nicotinic acids|mesh-list
139206060|NCT06208527|Vitamin B Complex|vitamin b complex|mesh-ancestor
139206061|NCT06208527|Vitamins|vitamins|mesh-ancestor
139206062|NCT06208527|Micronutrients|micronutrients|mesh-ancestor
139206063|NCT06208527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206064|NCT06208527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139206065|NCT06208527|Antimetabolites|antimetabolites|mesh-ancestor
139206066|NCT06208527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206067|NCT06208527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139206068|NCT06208527|Vasodilator Agents|vasodilator agents|mesh-ancestor
139206069|NCT06208462|Gemcitabine|gemcitabine|mesh-list
139206070|NCT06208462|Lenvatinib|lenvatinib|mesh-list
139206071|NCT06208462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206072|NCT06208462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139206073|NCT06208462|Antimetabolites|antimetabolites|mesh-ancestor
139206074|NCT06208462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206075|NCT06208462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139206076|NCT06208462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206078|NCT06208410|Capecitabine|capecitabine|mesh-list
139206079|NCT06208410|Fulvestrant|fulvestrant|mesh-list
139206080|NCT06208410|Fluzoparib|fluzoparib|mesh-list
139206081|NCT06208410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138867756|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
139206082|NCT06208410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206083|NCT06208410|Tubulin Modulators|tubulin modulators|mesh-ancestor
139206084|NCT06208410|Antimitotic Agents|antimitotic agents|mesh-ancestor
139206085|NCT06208410|Mitosis Modulators|mitosis modulators|mesh-ancestor
139206086|NCT06208410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206087|NCT06208410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139206089|NCT06208410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139206090|NCT06208410|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139206091|NCT06208410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139206092|NCT06208410|Hormone Antagonists|hormone antagonists|mesh-ancestor
139206093|NCT06208410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139206094|NCT06208410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206095|NCT06208410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206096|NCT06208410|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139206097|NCT06208384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139206098|NCT06208384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139206099|NCT06208280|Cyclophosphamide|cyclophosphamide|mesh-list
139206100|NCT06208280|Fludarabine|fludarabine|mesh-list
139206101|NCT06208280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139206102|NCT06208280|Immunologic Factors|immunologic factors|mesh-ancestor
139206103|NCT06208280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206104|NCT06208280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139206105|NCT06208280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139206106|NCT06208280|Alkylating Agents|alkylating agents|mesh-ancestor
139206107|NCT06208280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206108|NCT06208280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206109|NCT06208280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139206110|NCT06208267|Tranexamic Acid|tranexamic acid|mesh-list
139206111|NCT06208267|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139206112|NCT06208267|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139206113|NCT06208267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206114|NCT06208267|Hemostatics|hemostatics|mesh-ancestor
139206115|NCT06208267|Coagulants|coagulants|mesh-ancestor
139206116|NCT06208150|Dexamethasone|dexamethasone|mesh-list
139206117|NCT06208150|Bortezomib|bortezomib|mesh-list
139206118|NCT06208150|Pomalidomide|pomalidomide|mesh-list
139206119|NCT06208150|Elotuzumab|elotuzumab|mesh-list
139206120|NCT06208150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139206121|NCT06208150|Antiemetics|antiemetics|mesh-ancestor
139206122|NCT06208150|Autonomic Agents|autonomic agents|mesh-ancestor
139206123|NCT06208150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206124|NCT06208150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206125|NCT06208150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139206126|NCT06208150|Glucocorticoids|glucocorticoids|mesh-ancestor
139206127|NCT06208150|Hormones|hormones|mesh-ancestor
139206128|NCT06208150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139206129|NCT06208150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139206130|NCT06208150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206131|NCT06208150|Immunologic Factors|immunologic factors|mesh-ancestor
139206132|NCT06208150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139206133|NCT06208150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139206134|NCT06208150|Growth Substances|growth substances|mesh-ancestor
139206135|NCT06208150|Growth Inhibitors|growth inhibitors|mesh-ancestor
139206136|NCT06208098|Hydrocortisone|hydrocortisone|mesh-list
139206137|NCT06208098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139206138|NCT06208072|Irbesartan|irbesartan|mesh-list
139206139|NCT06208072|Eplerenone|eplerenone|mesh-list
139206140|NCT06208072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139206141|NCT06208072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139206142|NCT06208072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139206143|NCT06208072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206144|NCT06208072|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139206145|NCT06208072|Hormone Antagonists|hormone antagonists|mesh-ancestor
139206146|NCT06208072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139206148|NCT06208072|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139206149|NCT06208072|Diuretics|diuretics|mesh-ancestor
139206150|NCT06208072|Natriuretic Agents|natriuretic agents|mesh-ancestor
139206151|NCT06208033|Paclitaxel|paclitaxel|mesh-list
139206152|NCT06208033|Docetaxel|docetaxel|mesh-list
139206153|NCT06208033|Cisplatin|cisplatin|mesh-list
139206154|NCT06208033|Carboplatin|carboplatin|mesh-list
139206155|NCT06208033|Pemetrexed|pemetrexed|mesh-list
139206156|NCT06208033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138867757|NCT00905255|Lixisenatide|lixisenatide|mesh-list
139206158|NCT06208033|Tubulin Modulators|tubulin modulators|mesh-ancestor
139206159|NCT06208033|Antimitotic Agents|antimitotic agents|mesh-ancestor
139206160|NCT06208033|Mitosis Modulators|mitosis modulators|mesh-ancestor
139206161|NCT06208033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206162|NCT06208033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206163|NCT06208033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139206164|NCT06208033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139206165|NCT06207955|Botulinum Toxins|botulinum toxins|mesh-list
139206166|NCT06207955|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139206167|NCT06207955|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139206168|NCT06207955|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139206169|NCT06207955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139206170|NCT06207955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206171|NCT06207955|Cholinergic Agents|cholinergic agents|mesh-ancestor
139206172|NCT06207955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206173|NCT06207955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206174|NCT06207955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139066182|NCT01290406|Dactolisib|dactolisib|mesh-list
139206175|NCT06207955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206177|NCT06207799|Lenalidomide|lenalidomide|mesh-list
139206178|NCT06207799|Melphalan|melphalan|mesh-list
139206179|NCT06207799|Busulfan|busulfan|mesh-list
139206180|NCT06207799|Immunologic Factors|immunologic factors|mesh-ancestor
139206181|NCT06207799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206182|NCT06207799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139206183|NCT06207799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139206184|NCT06207799|Growth Substances|growth substances|mesh-ancestor
139206185|NCT06207799|Growth Inhibitors|growth inhibitors|mesh-ancestor
139206186|NCT06207799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206187|NCT06207799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139206188|NCT06207799|Alkylating Agents|alkylating agents|mesh-ancestor
139206189|NCT06207799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206190|NCT06207799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139206191|NCT06207799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139206192|NCT06207799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139206193|NCT06207799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139206194|NCT06207799|Antiviral Agents|antiviral agents|mesh-ancestor
139206195|NCT06207799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206196|NCT06207786|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139206197|NCT06207786|Amoxicillin|amoxicillin|mesh-list
139206198|NCT06207786|Azithromycin|azithromycin|mesh-list
139206199|NCT06207786|Clarithromycin|clarithromycin|mesh-list
139206200|NCT06207786|Clindamycin|clindamycin|mesh-list
139206201|NCT06207786|Cephalexin|cephalexin|mesh-list
139206202|NCT06207786|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139206203|NCT06207786|Povidone-Iodine|povidone-iodine|mesh-list
139206204|NCT06207786|Trimethoprim|trimethoprim|mesh-list
139206205|NCT06207786|Sulfamethoxazole|sulfamethoxazole|mesh-list
139206206|NCT06207786|Povidone|povidone|mesh-list
139206207|NCT06207786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206208|NCT06207786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139206209|NCT06207786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206210|NCT06207786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206211|NCT06207786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139206212|NCT06207786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139206213|NCT06207786|Plasma Substitutes|plasma substitutes|mesh-ancestor
139206214|NCT06207786|Blood Substitutes|blood substitutes|mesh-ancestor
139206215|NCT06207786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139206216|NCT06207786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139206217|NCT06207786|Antimalarials|antimalarials|mesh-ancestor
139206218|NCT06207786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139206219|NCT06207786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139206220|NCT06207786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139206221|NCT06207786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139206222|NCT06207786|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139206223|NCT06207760|Minocycline|minocycline|mesh-list
139206224|NCT06207760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139206225|NCT06207760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206226|NCT06207682|Simvastatin|simvastatin|mesh-list
139206227|NCT06207682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139206228|NCT06207682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139206229|NCT06207682|Antimetabolites|antimetabolites|mesh-ancestor
139206230|NCT06207682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206231|NCT06207682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138867758|NCT00905255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139206232|NCT06207682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139206233|NCT06207682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206234|NCT06207539|Scopolamine|scopolamine|mesh-list
139206235|NCT06207539|Bromides|bromides|mesh-list
139206236|NCT06207539|Misoprostol|misoprostol|mesh-list
139206237|NCT06207539|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139206238|NCT06207539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139206239|NCT06207539|Abortifacient Agents|abortifacient agents|mesh-ancestor
138956676|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139206240|NCT06207539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139206241|NCT06207539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206242|NCT06207539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139206243|NCT06207539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139206244|NCT06207539|Oxytocics|oxytocics|mesh-ancestor
139206245|NCT06207539|Anticonvulsants|anticonvulsants|mesh-ancestor
139206246|NCT06207539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139206247|NCT06207539|Antiemetics|antiemetics|mesh-ancestor
139206248|NCT06207539|Autonomic Agents|autonomic agents|mesh-ancestor
139206249|NCT06207539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206250|NCT06207539|Mydriatics|mydriatics|mesh-ancestor
139206251|NCT06207539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139206252|NCT06207539|Cholinergic Agents|cholinergic agents|mesh-ancestor
139206253|NCT06207539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206254|NCT06207539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206255|NCT06207539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139206256|NCT06207539|Parasympatholytics|parasympatholytics|mesh-ancestor
139206257|NCT06207513|Chlorhexidine|chlorhexidine|mesh-list
139206258|NCT06207513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139206259|NCT06207513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206260|NCT06207513|Disinfectants|disinfectants|mesh-ancestor
139206261|NCT06207370|Tafenoquine|tafenoquine|mesh-list
139206262|NCT06207370|Antimalarials|antimalarials|mesh-ancestor
139206263|NCT06207370|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139206264|NCT06207370|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139206265|NCT06207370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206266|NCT06207344|Dexmedetomidine|dexmedetomidine|mesh-list
139206267|NCT06207344|Propofol|propofol|mesh-list
139206268|NCT06207344|Desflurane|desflurane|mesh-list
139206269|NCT06207344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139206270|NCT06207344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206271|NCT06207344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206272|NCT06207344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139206273|NCT06207344|Analgesics|analgesics|mesh-ancestor
139206274|NCT06207344|Sensory System Agents|sensory system agents|mesh-ancestor
139206275|NCT06207344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206276|NCT06207344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139206277|NCT06207344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139206278|NCT06207344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139206279|NCT06207344|Adrenergic Agents|adrenergic agents|mesh-ancestor
139206280|NCT06207344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206281|NCT06207344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206282|NCT06207344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139206283|NCT06207344|Anesthetics, General|anesthetics, general|mesh-ancestor
139206284|NCT06207344|Anesthetics|anesthetics|mesh-ancestor
139206285|NCT06207344|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139206286|NCT06207331|Dexmedetomidine|dexmedetomidine|mesh-list
139206287|NCT06207331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139206288|NCT06207331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206289|NCT06207331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206290|NCT06207331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139206291|NCT06207331|Analgesics|analgesics|mesh-ancestor
139206292|NCT06207331|Sensory System Agents|sensory system agents|mesh-ancestor
139206293|NCT06207331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206294|NCT06207331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139206295|NCT06207331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139206296|NCT06207331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139206297|NCT06207331|Adrenergic Agents|adrenergic agents|mesh-ancestor
139206298|NCT06207331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066207|NCT01186120|Umirolimus|umirolimus|mesh-list
139206299|NCT06207331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206300|NCT06207305|Diphenhydramine|diphenhydramine|mesh-list
139206301|NCT06207305|Promethazine|promethazine|mesh-list
139206302|NCT06207305|Dexamethasone|dexamethasone|mesh-list
139206303|NCT06207305|Paclitaxel|paclitaxel|mesh-list
139206304|NCT06207305|Famotidine|famotidine|mesh-list
139206305|NCT06207305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139206306|NCT06207305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206307|NCT06207305|Tubulin Modulators|tubulin modulators|mesh-ancestor
139206308|NCT06207305|Antimitotic Agents|antimitotic agents|mesh-ancestor
139206309|NCT06207305|Mitosis Modulators|mitosis modulators|mesh-ancestor
139206310|NCT06207305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206311|NCT06207305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139206312|NCT06207305|Antiemetics|antiemetics|mesh-ancestor
139206313|NCT06207305|Autonomic Agents|autonomic agents|mesh-ancestor
139206314|NCT06207305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206315|NCT06207305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206316|NCT06207305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139206317|NCT06207305|Glucocorticoids|glucocorticoids|mesh-ancestor
139206318|NCT06207305|Hormones|hormones|mesh-ancestor
139206319|NCT06207305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139206320|NCT06207305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139206321|NCT06207305|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139206322|NCT06207305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139206323|NCT06207305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206324|NCT06207305|Anesthetics, Local|anesthetics, local|mesh-ancestor
139206325|NCT06207305|Anesthetics|anesthetics|mesh-ancestor
139206326|NCT06207305|Sensory System Agents|sensory system agents|mesh-ancestor
139206327|NCT06207305|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139206328|NCT06207305|Histamine Antagonists|histamine antagonists|mesh-ancestor
139206329|NCT06207305|Histamine Agents|histamine agents|mesh-ancestor
139206330|NCT06207305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206331|NCT06207305|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139206332|NCT06207305|Antipruritics|antipruritics|mesh-ancestor
139206333|NCT06207305|Dermatologic Agents|dermatologic agents|mesh-ancestor
139206334|NCT06207305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139206335|NCT06207305|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139206336|NCT06207292|Immunomodulating Agents|immunomodulating agents|mesh-list
139206337|NCT06207292|Immunologic Factors|immunologic factors|mesh-ancestor
139206338|NCT06207292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206339|NCT06207253|Diclofenac|diclofenac|mesh-list
139206340|NCT06207253|Calcium|calcium|mesh-list
139206341|NCT06207253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139206342|NCT06207253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206343|NCT06207253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139206344|NCT06207253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139206345|NCT06207253|Analgesics|analgesics|mesh-ancestor
139206346|NCT06207253|Sensory System Agents|sensory system agents|mesh-ancestor
139206347|NCT06207253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206348|NCT06207253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139206349|NCT06207253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139206350|NCT06207253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139206351|NCT06207253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206352|NCT06207253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206353|NCT06207123|Dexamethasone|dexamethasone|mesh-list
139206354|NCT06207123|Methotrexate|methotrexate|mesh-list
139206355|NCT06207123|Vincristine|vincristine|mesh-list
139206356|NCT06207123|Ponatinib|ponatinib|mesh-list
139206357|NCT06207123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139206358|NCT06207123|Antiemetics|antiemetics|mesh-ancestor
139206359|NCT06207123|Autonomic Agents|autonomic agents|mesh-ancestor
139206360|NCT06207123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206361|NCT06207123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206362|NCT06207123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139206363|NCT06207123|Glucocorticoids|glucocorticoids|mesh-ancestor
139206364|NCT06207123|Hormones|hormones|mesh-ancestor
139206365|NCT06207123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139206366|NCT06207123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139206367|NCT06207123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206368|NCT06207123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139206369|NCT06207123|Abortifacient Agents|abortifacient agents|mesh-ancestor
139206370|NCT06207123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139206371|NCT06207123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139206372|NCT06207123|Antimetabolites|antimetabolites|mesh-ancestor
139206373|NCT06207123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206374|NCT06207123|Dermatologic Agents|dermatologic agents|mesh-ancestor
139206375|NCT06207123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206376|NCT06207123|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139206377|NCT06207123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139206378|NCT06207123|Immunologic Factors|immunologic factors|mesh-ancestor
139206379|NCT06207123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139206380|NCT06207123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139206381|NCT06207123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139206382|NCT06207123|Tubulin Modulators|tubulin modulators|mesh-ancestor
139206383|NCT06207123|Antimitotic Agents|antimitotic agents|mesh-ancestor
139206384|NCT06207123|Mitosis Modulators|mitosis modulators|mesh-ancestor
139206385|NCT06207123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139206387|NCT06206733|Oxaliplatin|oxaliplatin|mesh-list
139206388|NCT06206733|Tislelizumab|tislelizumab|mesh-list
139206389|NCT06206733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139206390|NCT06206733|Antimetabolites|antimetabolites|mesh-ancestor
139206391|NCT06206733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206392|NCT06206733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206393|NCT06206733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139206394|NCT06206564|Artesunate|artesunate|mesh-list
139206395|NCT06206564|Artenimol|artenimol|mesh-list
139206396|NCT06206564|Artemisinins|artemisinins|mesh-list
139206397|NCT06206564|Artemisinin|artemisinin|mesh-list
139206398|NCT06206564|Antimalarials|antimalarials|mesh-ancestor
139206399|NCT06206564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139206400|NCT06206564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139206401|NCT06206564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206402|NCT06206564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206403|NCT06206564|Antiviral Agents|antiviral agents|mesh-ancestor
139206404|NCT06206564|Schistosomicides|schistosomicides|mesh-ancestor
139206405|NCT06206564|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139206406|NCT06206564|Anthelmintics|anthelmintics|mesh-ancestor
139206407|NCT06206512|Torsemide|torsemide|mesh-list
139206408|NCT06206512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139206409|NCT06206512|Diuretics|diuretics|mesh-ancestor
139206410|NCT06206512|Natriuretic Agents|natriuretic agents|mesh-ancestor
139206411|NCT06206512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206412|NCT06206512|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139206413|NCT06206512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139206414|NCT06206512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206415|NCT06206278|Infigratinib|infigratinib|mesh-list
139206416|NCT06206278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206417|NCT06206096|Bevacizumab|bevacizumab|mesh-list
139206418|NCT06206096|Capecitabine|capecitabine|mesh-list
139206419|NCT06206096|Oxaliplatin|oxaliplatin|mesh-list
139206420|NCT06206096|Antibodies|antibodies|mesh-list
139206421|NCT06206096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139206422|NCT06206096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206423|NCT06206096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139206424|NCT06206096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139206425|NCT06206096|Growth Substances|growth substances|mesh-ancestor
139206426|NCT06206096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206427|NCT06206096|Growth Inhibitors|growth inhibitors|mesh-ancestor
139206428|NCT06206096|Immunologic Factors|immunologic factors|mesh-ancestor
139206429|NCT06206096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139206430|NCT06206096|Antimetabolites|antimetabolites|mesh-ancestor
139206431|NCT06206096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206432|NCT06205979|Ranibizumab|ranibizumab|mesh-list
139206433|NCT06205979|Aflibercept|aflibercept|mesh-list
139206434|NCT06205979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139206435|NCT06205979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139206436|NCT06205979|Growth Substances|growth substances|mesh-ancestor
139206437|NCT06205979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206438|NCT06205979|Growth Inhibitors|growth inhibitors|mesh-ancestor
139206439|NCT06205979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206440|NCT06205888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139206441|NCT06205888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139206442|NCT06205888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206443|NCT06205875|Morphine|morphine|mesh-list
139206444|NCT06205875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139206445|NCT06205875|Narcotics|narcotics|mesh-ancestor
139206446|NCT06205875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206447|NCT06205875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206449|NCT06205875|Sensory System Agents|sensory system agents|mesh-ancestor
139206450|NCT06205875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206451|NCT06205849|Antibodies|antibodies|mesh-list
139206452|NCT06205849|Immunologic Factors|immunologic factors|mesh-ancestor
139206453|NCT06205849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206454|NCT06205836|Cemiplimab|cemiplimab|mesh-list
139206455|NCT06205836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139206456|NCT06205836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206457|NCT06205823|Immunomodulating Agents|immunomodulating agents|mesh-list
139206458|NCT06205823|Immunologic Factors|immunologic factors|mesh-ancestor
139206460|NCT06205797|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139206461|NCT06205797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139206462|NCT06205797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206463|NCT06205797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206464|NCT06205797|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139206465|NCT06205797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139206466|NCT06205797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206467|NCT06205797|Cholinergic Agents|cholinergic agents|mesh-ancestor
139206468|NCT06205797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206469|NCT06205732|Immunomodulating Agents|immunomodulating agents|mesh-list
139206470|NCT06205732|Immunologic Factors|immunologic factors|mesh-ancestor
139206471|NCT06205732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206472|NCT06205719|Remifentanil|remifentanil|mesh-list
139206473|NCT06205719|Flumazenil|flumazenil|mesh-list
139206474|NCT06205719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139206475|NCT06205719|Narcotics|narcotics|mesh-ancestor
139206476|NCT06205719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206477|NCT06205719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206478|NCT06205719|Analgesics|analgesics|mesh-ancestor
139206479|NCT06205719|Sensory System Agents|sensory system agents|mesh-ancestor
139206480|NCT06205719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206481|NCT06205719|Antidotes|antidotes|mesh-ancestor
139206482|NCT06205719|Protective Agents|protective agents|mesh-ancestor
139206483|NCT06205719|GABA Modulators|gaba modulators|mesh-ancestor
139206484|NCT06205719|GABA Agents|gaba agents|mesh-ancestor
139206485|NCT06205719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206486|NCT06205719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206487|NCT06205706|Pembrolizumab|pembrolizumab|mesh-list
139206488|NCT06205706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139206489|NCT06205706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206490|NCT06205706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139206491|NCT06205706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206492|NCT06205680|Anesthetics|anesthetics|mesh-list
139206493|NCT06205680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206494|NCT06205680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206495|NCT06205641|Baloxavir|baloxavir|mesh-list
139206496|NCT06205641|Antiviral Agents|antiviral agents|mesh-ancestor
139206497|NCT06205641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206498|NCT06205641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206499|NCT06205641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206500|NCT06205589|Vaccines|vaccines|mesh-list
139206501|NCT06205589|Immunologic Factors|immunologic factors|mesh-ancestor
139206502|NCT06205589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206503|NCT06205550|Flecainide|flecainide|mesh-list
139206504|NCT06205550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139206505|NCT06205550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139206506|NCT06205550|Adrenergic Agents|adrenergic agents|mesh-ancestor
139206507|NCT06205550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206508|NCT06205550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206509|NCT06205550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206510|NCT06205550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139206511|NCT06205550|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139206512|NCT06205550|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139206513|NCT06205550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139206514|NCT06205498|Acalabrutinib|acalabrutinib|mesh-list
139206515|NCT06205498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206516|NCT06205485|Leucovorin|leucovorin|mesh-list
139206517|NCT06205485|Capecitabine|capecitabine|mesh-list
139206518|NCT06205485|Fluorouracil|fluorouracil|mesh-list
139206519|NCT06205485|Oxaliplatin|oxaliplatin|mesh-list
139206520|NCT06205485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139206521|NCT06205485|Antimetabolites|antimetabolites|mesh-ancestor
138787759|NCT00638638|Abciximab|abciximab|mesh-list
139206522|NCT06205485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206523|NCT06205485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206524|NCT06205485|Antidotes|antidotes|mesh-ancestor
139206525|NCT06205485|Protective Agents|protective agents|mesh-ancestor
139206526|NCT06205485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206527|NCT06205485|Vitamin B Complex|vitamin b complex|mesh-ancestor
139206528|NCT06205485|Vitamins|vitamins|mesh-ancestor
139206529|NCT06205485|Micronutrients|micronutrients|mesh-ancestor
139206530|NCT06205485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139206531|NCT06205485|Immunologic Factors|immunologic factors|mesh-ancestor
139206532|NCT06205381|Fexofenadine|fexofenadine|mesh-list
139206534|NCT06205381|Midazolam|midazolam|mesh-list
139206535|NCT06205381|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139206536|NCT06205381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139206537|NCT06205381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206538|NCT06205381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206539|NCT06205381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139206540|NCT06205381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139206541|NCT06205381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139206542|NCT06205381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139206543|NCT06205381|Anesthetics, General|anesthetics, general|mesh-ancestor
139206544|NCT06205381|Anesthetics|anesthetics|mesh-ancestor
139206545|NCT06205381|GABA Modulators|gaba modulators|mesh-ancestor
139206546|NCT06205381|GABA Agents|gaba agents|mesh-ancestor
139206547|NCT06205381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206548|NCT06205381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206549|NCT06205381|Antifungal Agents|antifungal agents|mesh-ancestor
139206550|NCT06205381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206551|NCT06205381|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139206552|NCT06205381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139206553|NCT06205381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206554|NCT06205381|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139206555|NCT06205381|Hormone Antagonists|hormone antagonists|mesh-ancestor
139206556|NCT06205381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139206557|NCT06205381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139206558|NCT06205381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139206559|NCT06205381|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139206560|NCT06205381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139206561|NCT06205381|Histamine Antagonists|histamine antagonists|mesh-ancestor
139206562|NCT06205381|Histamine Agents|histamine agents|mesh-ancestor
139206563|NCT06205329|Ritonavir|ritonavir|mesh-list
139206564|NCT06205329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139206565|NCT06205329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139206566|NCT06205329|Protease Inhibitors|protease inhibitors|mesh-ancestor
139206567|NCT06205329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206568|NCT06205329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206569|NCT06205329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139206570|NCT06205329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139206571|NCT06205329|Antiviral Agents|antiviral agents|mesh-ancestor
139206572|NCT06205329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206573|NCT06205329|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139206574|NCT06205329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139206575|NCT06205030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139206576|NCT06205030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206577|NCT06201715|Tofacitinib|tofacitinib|mesh-list
139206578|NCT06201715|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139206579|NCT06201715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139206580|NCT06201715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206581|NCT06201715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206582|NCT06201000|Dapagliflozin|dapagliflozin|mesh-list
139206583|NCT06201000|Empagliflozin|empagliflozin|mesh-list
139206584|NCT06201000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139206585|NCT06201000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206586|NCT06201000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139206587|NCT06201000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206588|NCT06200545|Antibodies|antibodies|mesh-list
139206589|NCT06200545|HIV Antibodies|hiv antibodies|mesh-list
139206590|NCT06200545|Immunologic Factors|immunologic factors|mesh-ancestor
139206591|NCT06200545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206592|NCT06200155|Niacin|niacin|mesh-list
139206593|NCT06200155|Psilocybin|psilocybin|mesh-list
139206594|NCT06200155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139206595|NCT06200155|Antimetabolites|antimetabolites|mesh-ancestor
138576539|NCT00449137|Vitamins|vitamins|mesh-ancestor
139206596|NCT06200155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206597|NCT06200155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139206598|NCT06200155|Vasodilator Agents|vasodilator agents|mesh-ancestor
139206599|NCT06200155|Vitamin B Complex|vitamin b complex|mesh-ancestor
139206600|NCT06200155|Vitamins|vitamins|mesh-ancestor
139206601|NCT06200155|Micronutrients|micronutrients|mesh-ancestor
139206602|NCT06200155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206603|NCT06200155|Hallucinogens|hallucinogens|mesh-ancestor
139206604|NCT06200155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139206605|NCT06196320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139206606|NCT06196320|Tenecteplase|tenecteplase|mesh-list
139206608|NCT06196320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139206609|NCT06196320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206610|NCT06195228|Lenvatinib|lenvatinib|mesh-list
139206611|NCT06195228|Trametinib|trametinib|mesh-list
139206612|NCT06195228|Dabrafenib|dabrafenib|mesh-list
139206613|NCT06195228|Pralsetinib|pralsetinib|mesh-list
139206614|NCT06195228|Antibodies|antibodies|mesh-list
139206615|NCT06195228|Immunoglobulins|immunoglobulins|mesh-list
139206616|NCT06195228|Entrectinib|entrectinib|mesh-list
139206617|NCT06195228|Immunologic Factors|immunologic factors|mesh-ancestor
139206618|NCT06195228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206619|NCT06195228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206620|NCT06195228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139206621|NCT06195228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206622|NCT06195228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206623|NCT06191848|Tirzepatide|tirzepatide|mesh-list
139206624|NCT06191848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139206625|NCT06191848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206626|NCT06191848|Incretins|incretins|mesh-ancestor
139206627|NCT06191848|Hormones|hormones|mesh-ancestor
139206628|NCT06191848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139206629|NCT06185452|Rilpivirine|rilpivirine|mesh-list
139206630|NCT06185452|Cabotegravir|cabotegravir|mesh-list
139206631|NCT06185452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139206632|NCT06185452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139206633|NCT06185452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206634|NCT06185452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206635|NCT06185452|Antiviral Agents|antiviral agents|mesh-ancestor
139206636|NCT06185452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206637|NCT06185452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139206638|NCT06185452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139206639|NCT06185452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139206640|NCT06185452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139206641|NCT06179446|Vaccines|vaccines|mesh-list
139206642|NCT06179446|Immunologic Factors|immunologic factors|mesh-ancestor
139206643|NCT06179446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206644|NCT06177457|Midazolam|midazolam|mesh-list
139206645|NCT06177457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139206646|NCT06177457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139206647|NCT06177457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206648|NCT06177457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206649|NCT06177457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139206650|NCT06177457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139206651|NCT06177457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139206652|NCT06177457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139206653|NCT06177457|Anesthetics, General|anesthetics, general|mesh-ancestor
139206654|NCT06177457|Anesthetics|anesthetics|mesh-ancestor
139206655|NCT06177457|GABA Modulators|gaba modulators|mesh-ancestor
139206656|NCT06177457|GABA Agents|gaba agents|mesh-ancestor
139206657|NCT06177457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206658|NCT06177457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206659|NCT06177301|Tislelizumab|tislelizumab|mesh-list
139206660|NCT06177301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139206661|NCT06177301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206662|NCT06175832|Desogestrel|desogestrel|mesh-list
139206663|NCT06175832|Ganirelix|ganirelix|mesh-list
139206664|NCT06175832|Hormone Antagonists|hormone antagonists|mesh-ancestor
139206665|NCT06175832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139206666|NCT06175832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206667|NCT06175832|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139206668|NCT06175832|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139206669|NCT06175832|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139206670|NCT06175832|Contraceptive Agents|contraceptive agents|mesh-ancestor
139206671|NCT06175832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139206672|NCT06175832|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139206673|NCT06175832|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139206674|NCT06175832|Progestins|progestins|mesh-ancestor
139206675|NCT06175832|Hormones|hormones|mesh-ancestor
139206676|NCT06173505|Carboplatin|carboplatin|mesh-list
139206677|NCT06173505|Pembrolizumab|pembrolizumab|mesh-list
139206678|NCT06173505|Pemetrexed|pemetrexed|mesh-list
139206679|NCT06173505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206680|NCT06173505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139206681|NCT06173505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139206682|NCT06173505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206684|NCT06173505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139066284|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
139206685|NCT06173505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139206686|NCT06166381|Vancomycin|vancomycin|mesh-list
139206687|NCT06166381|Ceftriaxone|ceftriaxone|mesh-list
139206688|NCT06166381|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139206689|NCT06166381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206690|NCT06164743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139206691|NCT06164743|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139206692|NCT06164314|Dexmedetomidine|dexmedetomidine|mesh-list
139206693|NCT06164314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139206694|NCT06164314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206695|NCT06164314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206696|NCT06164314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139206697|NCT06164314|Analgesics|analgesics|mesh-ancestor
139206698|NCT06164314|Sensory System Agents|sensory system agents|mesh-ancestor
139206699|NCT06164314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206700|NCT06164314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139206701|NCT06164314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139206702|NCT06164314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139206703|NCT06164314|Adrenergic Agents|adrenergic agents|mesh-ancestor
139206704|NCT06164314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206705|NCT06164314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206706|NCT06156982|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139206707|NCT06156982|Antiviral Agents|antiviral agents|mesh-ancestor
139206708|NCT06156982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206709|NCT06155123|Antibodies|antibodies|mesh-list
139206710|NCT06155123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139206711|NCT06155123|Immunologic Factors|immunologic factors|mesh-ancestor
139206712|NCT06155123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206713|NCT06141473|Teriflunomide|teriflunomide|mesh-list
139206714|NCT06141473|Cholestyramine Resin|cholestyramine resin|mesh-list
139206715|NCT06141473|Charcoal|charcoal|mesh-list
139206716|NCT06141473|Antidotes|antidotes|mesh-ancestor
139206717|NCT06141473|Protective Agents|protective agents|mesh-ancestor
139206718|NCT06141473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206719|NCT06141473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139206720|NCT06141473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139206721|NCT06141473|Analgesics|analgesics|mesh-ancestor
139206722|NCT06141473|Sensory System Agents|sensory system agents|mesh-ancestor
139206723|NCT06141473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206724|NCT06141473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139206725|NCT06141473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139206726|NCT06141473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139206727|NCT06141473|Immunologic Factors|immunologic factors|mesh-ancestor
139206728|NCT06141473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139206729|NCT06141473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139206730|NCT06141473|Antimetabolites|antimetabolites|mesh-ancestor
139206731|NCT06141473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206732|NCT06141473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139206733|NCT06140537|Dapagliflozin|dapagliflozin|mesh-list
139206734|NCT06140537|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139206735|NCT06140537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206736|NCT06140537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139206737|NCT06140537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206738|NCT06132087|Pancrelipase|pancrelipase|mesh-list
139206739|NCT06132087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139206740|NCT06130566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139206741|NCT06130566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206742|NCT06130566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206743|NCT06123494|Paclitaxel|paclitaxel|mesh-list
139206744|NCT06123494|Docetaxel|docetaxel|mesh-list
139206745|NCT06123494|Irinotecan|irinotecan|mesh-list
139206746|NCT06123494|Ramucirumab|ramucirumab|mesh-list
139206747|NCT06123494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139206749|NCT06123494|Tubulin Modulators|tubulin modulators|mesh-ancestor
139206750|NCT06123494|Antimitotic Agents|antimitotic agents|mesh-ancestor
139206751|NCT06123494|Mitosis Modulators|mitosis modulators|mesh-ancestor
139206752|NCT06123494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206753|NCT06123494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139206754|NCT06123494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139206755|NCT06123494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206756|NCT06121362|Protocatechuic acid|protocatechuic acid|mesh-list
139206757|NCT06121362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139206758|NCT06121362|Protective Agents|protective agents|mesh-ancestor
139206759|NCT06121362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206760|NCT06121362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206768|NCT06118255|Fenfluramine|fenfluramine|mesh-list
139206769|NCT06118255|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139206770|NCT06118255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139206771|NCT06118255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139206772|NCT06118255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206773|NCT06118255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206774|NCT06118255|Serotonin Agents|serotonin agents|mesh-ancestor
139206775|NCT06118255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206776|NCT06109272|Bevacizumab|bevacizumab|mesh-list
139206777|NCT06109272|Atezolizumab|atezolizumab|mesh-list
139206778|NCT06109272|Durvalumab|durvalumab|mesh-list
139206779|NCT06109272|Tremelimumab|tremelimumab|mesh-list
139206780|NCT06109272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139206781|NCT06109272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206782|NCT06109272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139206783|NCT06109272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139206784|NCT06109272|Growth Substances|growth substances|mesh-ancestor
139206785|NCT06109272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206786|NCT06109272|Growth Inhibitors|growth inhibitors|mesh-ancestor
139206787|NCT06109272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139206788|NCT06109272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206789|NCT06107543|Lidocaine|lidocaine|mesh-list
139206790|NCT06107543|Anesthetics, Local|anesthetics, local|mesh-ancestor
139206791|NCT06107543|Anesthetics|anesthetics|mesh-ancestor
139206792|NCT06107543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206793|NCT06107543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206794|NCT06107543|Sensory System Agents|sensory system agents|mesh-ancestor
139206795|NCT06107543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206796|NCT06107543|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139206797|NCT06107543|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139206798|NCT06107543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139206799|NCT06107543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139206800|NCT06107543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206801|NCT06107153|Metformin|metformin|mesh-list
139206802|NCT06107153|Insulin Glargine|insulin glargine|mesh-list
139206803|NCT06107153|Pioglitazone|pioglitazone|mesh-list
139206804|NCT06107153|Saxagliptin|saxagliptin|mesh-list
139206805|NCT06107153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139206806|NCT06107153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206807|NCT06107153|Incretins|incretins|mesh-ancestor
139206808|NCT06107153|Hormones|hormones|mesh-ancestor
139206809|NCT06107153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139206810|NCT06107153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139206811|NCT06107153|Protease Inhibitors|protease inhibitors|mesh-ancestor
139206812|NCT06107153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206813|NCT06107153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206814|NCT06106880|Aspirin|aspirin|mesh-list
139206815|NCT06106880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139206816|NCT06106880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139206817|NCT06106880|Analgesics|analgesics|mesh-ancestor
139206818|NCT06106880|Sensory System Agents|sensory system agents|mesh-ancestor
139206819|NCT06106880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206820|NCT06106880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206822|NCT06106880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139206823|NCT06106880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139206824|NCT06106880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139206825|NCT06106880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206826|NCT06106880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139206827|NCT06106880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139206828|NCT06106880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206829|NCT06106880|Antipyretics|antipyretics|mesh-ancestor
139206830|NCT06106334|Itraconazole|itraconazole|mesh-list
139206831|NCT06106334|Antifungal Agents|antifungal agents|mesh-ancestor
139206832|NCT06106334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206833|NCT06106334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139206834|NCT06106334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139206835|NCT06106334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206836|NCT06106334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206837|NCT06106334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139206838|NCT06106334|Hormone Antagonists|hormone antagonists|mesh-ancestor
139206839|NCT06106334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139206840|NCT06106334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206841|NCT06106334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139206842|NCT06106295|Metyrapone|metyrapone|mesh-list
139206843|NCT06106295|Antimetabolites|antimetabolites|mesh-ancestor
138957274|NCT00788580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206844|NCT06106295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206845|NCT06106295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206846|NCT06101342|Tenofovir|tenofovir|mesh-list
139206847|NCT06101342|Emtricitabine|emtricitabine|mesh-list
139206848|NCT06101342|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139206849|NCT06101342|Antiviral Agents|antiviral agents|mesh-ancestor
139206850|NCT06101342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206851|NCT06101342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139206852|NCT06101342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139206853|NCT06101342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206854|NCT06101342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206855|NCT06101342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139206856|NCT06101342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139206857|NCT06100705|Methyltestosterone|methyltestosterone|mesh-list
139206858|NCT06100705|Testosterone|testosterone|mesh-list
139206859|NCT06100705|Testosterone undecanoate|testosterone undecanoate|mesh-list
139206860|NCT06100705|Testosterone enanthate|testosterone enanthate|mesh-list
139206861|NCT06100705|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139206862|NCT06100705|Androgens|androgens|mesh-ancestor
139206863|NCT06100705|Hormones|hormones|mesh-ancestor
139206864|NCT06100705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139206865|NCT06100705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206866|NCT06100705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139206867|NCT06100705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206868|NCT06100705|Anabolic Agents|anabolic agents|mesh-ancestor
139206869|NCT06091189|Ethanol|ethanol|mesh-list
139206870|NCT06091189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139206871|NCT06091189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206872|NCT06091189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206873|NCT06091189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206874|NCT06089434|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139206875|NCT06089434|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139206876|NCT06089434|beta-Endorphin|beta-endorphin|mesh-list
139206877|NCT06089434|Hormones|hormones|mesh-ancestor
139206878|NCT06089434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139206879|NCT06089434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206880|NCT06089434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206881|NCT06089434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206882|NCT06080178|Norepinephrine|norepinephrine|mesh-list
139206883|NCT06080178|Plasma-lyte 148|plasma-lyte 148|mesh-list
139206884|NCT06080178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139206885|NCT06080178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139206886|NCT06080178|Adrenergic Agents|adrenergic agents|mesh-ancestor
139206887|NCT06080178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206888|NCT06080178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206889|NCT06080178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206890|NCT06080178|Sympathomimetics|sympathomimetics|mesh-ancestor
139206891|NCT06080178|Autonomic Agents|autonomic agents|mesh-ancestor
139206892|NCT06080178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206893|NCT06080178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139206894|NCT06080178|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139206895|NCT06080178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139206897|NCT06068530|Antimalarials|antimalarials|mesh-ancestor
139206898|NCT06068530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139206899|NCT06068530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139206900|NCT06068530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206901|NCT06064929|Felzartamab|felzartamab|mesh-list
139206902|NCT06064929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206903|NCT06064929|Immunologic Factors|immunologic factors|mesh-ancestor
139206904|NCT06064929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206905|NCT06064877|Cetuximab|cetuximab|mesh-list
139206906|NCT06064877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139206907|NCT06064877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206908|NCT06059846|Imipenem|imipenem|mesh-list
139206909|NCT06059846|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
139206910|NCT06059846|Cilastatin|cilastatin|mesh-list
139206911|NCT06059846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139206912|NCT06059846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139206913|NCT06059846|Protease Inhibitors|protease inhibitors|mesh-ancestor
139206914|NCT06059846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139206915|NCT06059846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206916|NCT06057675|Lidocaine|lidocaine|mesh-list
138957364|NCT00754910|Trioxsalen|trioxsalen|mesh-list
139206917|NCT06057675|Epinephrine|epinephrine|mesh-list
139206918|NCT06057675|Racepinephrine|racepinephrine|mesh-list
139206919|NCT06057675|Tranexamic Acid|tranexamic acid|mesh-list
139206920|NCT06057675|Epinephryl borate|epinephryl borate|mesh-list
139206921|NCT06057675|Anesthetics, Local|anesthetics, local|mesh-ancestor
139206922|NCT06057675|Anesthetics|anesthetics|mesh-ancestor
139206923|NCT06057675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206924|NCT06057675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206925|NCT06057675|Sensory System Agents|sensory system agents|mesh-ancestor
139206926|NCT06057675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206927|NCT06057675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139206928|NCT06057675|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139206929|NCT06057675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139206930|NCT06057675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139206931|NCT06057675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206932|NCT06057675|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139206933|NCT06057675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139206934|NCT06057675|Hemostatics|hemostatics|mesh-ancestor
139206935|NCT06057675|Coagulants|coagulants|mesh-ancestor
139206936|NCT06057675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139206937|NCT06057675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139206938|NCT06057675|Adrenergic Agents|adrenergic agents|mesh-ancestor
139206939|NCT06057675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206940|NCT06057675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139206941|NCT06057675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139206942|NCT06057675|Autonomic Agents|autonomic agents|mesh-ancestor
139206943|NCT06057675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139206944|NCT06057675|Respiratory System Agents|respiratory system agents|mesh-ancestor
139206945|NCT06057675|Mydriatics|mydriatics|mesh-ancestor
139206946|NCT06057675|Sympathomimetics|sympathomimetics|mesh-ancestor
139206947|NCT06057675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139206948|NCT06056141|Misoprostol|misoprostol|mesh-list
139206949|NCT06056141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139206950|NCT06056141|Abortifacient Agents|abortifacient agents|mesh-ancestor
139206951|NCT06056141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139206952|NCT06056141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206953|NCT06056141|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139206954|NCT06056141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139206955|NCT06056141|Oxytocics|oxytocics|mesh-ancestor
139206956|NCT06054750|Ropivacaine|ropivacaine|mesh-list
139206957|NCT06054750|Anesthetics, Local|anesthetics, local|mesh-ancestor
139206958|NCT06054750|Anesthetics|anesthetics|mesh-ancestor
139206959|NCT06054750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139206960|NCT06054750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206961|NCT06054750|Sensory System Agents|sensory system agents|mesh-ancestor
139206962|NCT06054750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206963|NCT06054477|Pembrolizumab|pembrolizumab|mesh-list
139206964|NCT06054477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139206965|NCT06054477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139206966|NCT06054477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139206967|NCT06054477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206968|NCT06053801|Omalizumab|omalizumab|mesh-list
139206969|NCT06053801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139206970|NCT06053801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139206971|NCT06053801|Respiratory System Agents|respiratory system agents|mesh-ancestor
139206972|NCT06053398|Phenylephrine|phenylephrine|mesh-list
139206973|NCT06053398|Oxymetazoline|oxymetazoline|mesh-list
139206974|NCT06053398|Norepinephrine|norepinephrine|mesh-list
139206975|NCT06053398|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139206976|NCT06053398|Mydriatics|mydriatics|mesh-ancestor
139206977|NCT06053398|Autonomic Agents|autonomic agents|mesh-ancestor
139206978|NCT06053398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206979|NCT06053398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206980|NCT06053398|Sympathomimetics|sympathomimetics|mesh-ancestor
139206981|NCT06053398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139206982|NCT06053398|Nasal Decongestants|nasal decongestants|mesh-ancestor
139206983|NCT06053398|Respiratory System Agents|respiratory system agents|mesh-ancestor
139206984|NCT06053398|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139206985|NCT06053398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139206986|NCT06053398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139206987|NCT06053398|Adrenergic Agents|adrenergic agents|mesh-ancestor
139206988|NCT06053398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139206989|NCT06053398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139206990|NCT06053398|Protective Agents|protective agents|mesh-ancestor
139206991|NCT06052267|Albuterol|albuterol|mesh-list
138957421|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206992|NCT06052267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139206993|NCT06052267|Autonomic Agents|autonomic agents|mesh-ancestor
139206994|NCT06052267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139206995|NCT06052267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139206996|NCT06052267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139206997|NCT06052267|Respiratory System Agents|respiratory system agents|mesh-ancestor
139206998|NCT06052267|Tocolytic Agents|tocolytic agents|mesh-ancestor
139206999|NCT06052267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139207000|NCT06052267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139207001|NCT06052267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139207002|NCT06052267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139207003|NCT06052267|Adrenergic Agents|adrenergic agents|mesh-ancestor
139207004|NCT06052267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139207005|NCT06052267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207006|NCT06051227|Fentanyl|fentanyl|mesh-list
139207007|NCT06051227|Esketamine|esketamine|mesh-list
139207008|NCT06051227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139207009|NCT06051227|Narcotics|narcotics|mesh-ancestor
139207010|NCT06051227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139207011|NCT06051227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207012|NCT06051227|Analgesics|analgesics|mesh-ancestor
139207013|NCT06051227|Sensory System Agents|sensory system agents|mesh-ancestor
139207014|NCT06051227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207015|NCT06051227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139207016|NCT06051227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139207017|NCT06051227|Anesthetics, General|anesthetics, general|mesh-ancestor
139207018|NCT06051227|Anesthetics|anesthetics|mesh-ancestor
139207019|NCT06051227|Antidepressive Agents|antidepressive agents|mesh-ancestor
139207020|NCT06051227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139207021|NCT06049797|Clonidine|clonidine|mesh-list
139207022|NCT06049797|Pregabalin|pregabalin|mesh-list
139207023|NCT06049797|Gabapentin|gabapentin|mesh-list
139207024|NCT06049797|Citalopram|citalopram|mesh-list
139207025|NCT06049797|Paroxetine|paroxetine|mesh-list
139207026|NCT06049797|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139207027|NCT06049797|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139207028|NCT06049797|Oxybutynin|oxybutynin|mesh-list
139207029|NCT06049797|Escitalopram|escitalopram|mesh-list
139207030|NCT06049797|Analgesics|analgesics|mesh-ancestor
139207031|NCT06049797|Sensory System Agents|sensory system agents|mesh-ancestor
139207032|NCT06049797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207033|NCT06049797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207034|NCT06049797|Anticonvulsants|anticonvulsants|mesh-ancestor
139207035|NCT06049797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139207036|NCT06049797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139207037|NCT06049797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207038|NCT06049797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139207039|NCT06049797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139207040|NCT06049797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139207041|NCT06049797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139207042|NCT06049797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139207044|NCT06049797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139207045|NCT06049797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139207046|NCT06049797|Antimanic Agents|antimanic agents|mesh-ancestor
139207047|NCT06049797|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139066383|NCT01291654|Acetaminophen|acetaminophen|mesh-list
139207048|NCT06049797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139207049|NCT06049797|Serotonin Agents|serotonin agents|mesh-ancestor
139207050|NCT06049797|Parasympatholytics|parasympatholytics|mesh-ancestor
139207051|NCT06049797|Autonomic Agents|autonomic agents|mesh-ancestor
139207052|NCT06049797|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139207053|NCT06049797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139207054|NCT06049797|Cholinergic Agents|cholinergic agents|mesh-ancestor
139207055|NCT06049797|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139207056|NCT06049797|Antidepressive Agents|antidepressive agents|mesh-ancestor
139207057|NCT06049797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139207058|NCT06049797|Sympatholytics|sympatholytics|mesh-ancestor
139207059|NCT06049797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139207060|NCT06049797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139207061|NCT06049797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139207062|NCT06049797|Adrenergic Agents|adrenergic agents|mesh-ancestor
139207063|NCT06049797|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139207064|NCT06049797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139207065|NCT06049797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207066|NCT06049797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139207067|NCT06049797|Urological Agents|urological agents|mesh-ancestor
139207068|NCT06043713|Cyclophosphamide|cyclophosphamide|mesh-list
139207069|NCT06043713|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139207070|NCT06043713|Fludarabine|fludarabine|mesh-list
139207071|NCT06043713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139207072|NCT06043713|Immunologic Factors|immunologic factors|mesh-ancestor
139207073|NCT06043713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207074|NCT06043713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139207075|NCT06043713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139207076|NCT06043713|Alkylating Agents|alkylating agents|mesh-ancestor
139207077|NCT06043713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207078|NCT06043713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207079|NCT06043713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139207080|NCT06042517|Liver Extracts|liver extracts|mesh-list
139207081|NCT06042517|Hematinics|hematinics|mesh-ancestor
139207082|NCT06040320|Rituximab|rituximab|mesh-list
139207083|NCT06040320|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139207084|NCT06040320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207085|NCT06040320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207086|NCT06040320|Immunologic Factors|immunologic factors|mesh-ancestor
139207087|NCT06040320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207088|NCT06040320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139207089|NCT06040320|Immunoconjugates|immunoconjugates|mesh-ancestor
139207090|NCT06039878|Oxytocin|oxytocin|mesh-list
139207091|NCT06039878|Oxytocics|oxytocics|mesh-ancestor
139207092|NCT06039878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139207093|NCT06039878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207094|NCT06039371|Carboplatin|carboplatin|mesh-list
139207095|NCT06039371|Etoposide|etoposide|mesh-list
139207096|NCT06039371|Etoposide phosphate|etoposide phosphate|mesh-list
139207097|NCT06039371|Methyltestosterone|methyltestosterone|mesh-list
139207098|NCT06039371|Podophyllotoxin|podophyllotoxin|mesh-list
139207099|NCT06039371|Testosterone|testosterone|mesh-list
139207100|NCT06039371|Testosterone undecanoate|testosterone undecanoate|mesh-list
139207101|NCT06039371|Testosterone enanthate|testosterone enanthate|mesh-list
139207102|NCT06039371|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139207103|NCT06039371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207104|NCT06039371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139207105|NCT06039371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139207106|NCT06039371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139207107|NCT06039371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207108|NCT06039371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207109|NCT06039371|Androgens|androgens|mesh-ancestor
139207110|NCT06039371|Hormones|hormones|mesh-ancestor
139207111|NCT06039371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139207112|NCT06039371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207113|NCT06039371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139207114|NCT06039371|Anabolic Agents|anabolic agents|mesh-ancestor
139207115|NCT06039371|Keratolytic Agents|keratolytic agents|mesh-ancestor
139207116|NCT06039371|Dermatologic Agents|dermatologic agents|mesh-ancestor
139207117|NCT06039371|Tubulin Modulators|tubulin modulators|mesh-ancestor
139207118|NCT06039371|Antimitotic Agents|antimitotic agents|mesh-ancestor
139207119|NCT06039371|Mitosis Modulators|mitosis modulators|mesh-ancestor
139207120|NCT06038578|Paclitaxel|paclitaxel|mesh-list
139207121|NCT06038578|Ramucirumab|ramucirumab|mesh-list
139207122|NCT06038578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139207123|NCT06038578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207124|NCT06038578|Tubulin Modulators|tubulin modulators|mesh-ancestor
139207125|NCT06038578|Antimitotic Agents|antimitotic agents|mesh-ancestor
139207126|NCT06038578|Mitosis Modulators|mitosis modulators|mesh-ancestor
139207127|NCT06038578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207128|NCT06037252|Tirzepatide|tirzepatide|mesh-list
139207129|NCT06037252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139207130|NCT06037252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207131|NCT06037252|Incretins|incretins|mesh-ancestor
139207132|NCT06037252|Hormones|hormones|mesh-ancestor
139207133|NCT06037252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139207134|NCT06029894|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139207135|NCT06029894|Nootropic Agents|nootropic agents|mesh-ancestor
139207136|NCT06029673|Cabergoline|cabergoline|mesh-list
139207137|NCT06029673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139207138|NCT06029673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139207139|NCT06029673|Dopamine Agonists|dopamine agonists|mesh-ancestor
139207140|NCT06029673|Dopamine Agents|dopamine agents|mesh-ancestor
139207141|NCT06029673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139207142|NCT06029673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207143|NCT06029673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207144|NCT06016387|Capecitabine|capecitabine|mesh-list
139207145|NCT06016387|Trastuzumab|trastuzumab|mesh-list
139207146|NCT06016387|Tucatinib|tucatinib|mesh-list
139207147|NCT06016387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139207148|NCT06016387|Antimetabolites|antimetabolites|mesh-ancestor
139207149|NCT06016387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207150|NCT06016387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207151|NCT06016387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207152|NCT06016387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139207153|NCT06016387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207154|NCT06013865|Empagliflozin|empagliflozin|mesh-list
139207155|NCT06013865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139207156|NCT06013865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207157|NCT06013865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139207158|NCT06013865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207159|NCT06005688|Carbamazepine|carbamazepine|mesh-list
139207160|NCT06005688|Anticonvulsants|anticonvulsants|mesh-ancestor
139207161|NCT06005688|Antimanic Agents|antimanic agents|mesh-ancestor
139207162|NCT06005688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139207163|NCT06005688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139207164|NCT06005688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207165|NCT06005688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139207166|NCT06005688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139207167|NCT06005688|Analgesics|analgesics|mesh-ancestor
139207168|NCT06005688|Sensory System Agents|sensory system agents|mesh-ancestor
139207169|NCT06005688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207170|NCT06005688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139207171|NCT06005688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139207172|NCT06005688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207173|NCT06005688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139207174|NCT06005688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139207175|NCT06003621|Atezolizumab|atezolizumab|mesh-list
139207176|NCT06003621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139207177|NCT06003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207178|NCT06003621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207179|NCT06003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207180|NCT05995405|Nimodipine|nimodipine|mesh-list
139207181|NCT05995405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139207182|NCT05995405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139207183|NCT05995405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139207184|NCT05995405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207185|NCT05995405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139207186|NCT05995405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207187|NCT05995405|Vasodilator Agents|vasodilator agents|mesh-ancestor
139207188|NCT05985681|Vaccines|vaccines|mesh-list
139207189|NCT05985681|Immunologic Factors|immunologic factors|mesh-ancestor
139207190|NCT05985681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207191|NCT05978102|Pembrolizumab|pembrolizumab|mesh-list
139207192|NCT05978102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207193|NCT05978102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207194|NCT05978102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139207195|NCT05978102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207196|NCT05977907|Pembrolizumab|pembrolizumab|mesh-list
139207197|NCT05977907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207198|NCT05977907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207199|NCT05977907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139207200|NCT05977907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207205|NCT05972681|Epinephrine|epinephrine|mesh-list
139207206|NCT05972681|Bupivacaine|bupivacaine|mesh-list
139207207|NCT05972681|Anesthetics, Local|anesthetics, local|mesh-ancestor
139207208|NCT05972681|Anesthetics|anesthetics|mesh-ancestor
139207209|NCT05972681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139207210|NCT05972681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207211|NCT05972681|Sensory System Agents|sensory system agents|mesh-ancestor
139207212|NCT05972681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207213|NCT05972681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139207214|NCT05972681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139207215|NCT05972681|Adrenergic Agents|adrenergic agents|mesh-ancestor
139207216|NCT05972681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139207217|NCT05972681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207219|NCT05972681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139207220|NCT05972681|Autonomic Agents|autonomic agents|mesh-ancestor
139207221|NCT05972681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139207222|NCT05972681|Respiratory System Agents|respiratory system agents|mesh-ancestor
139207223|NCT05972681|Mydriatics|mydriatics|mesh-ancestor
139207224|NCT05972681|Sympathomimetics|sympathomimetics|mesh-ancestor
139207225|NCT05972681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139207226|NCT05969236|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139207227|NCT05969236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139207228|NCT05956509|Botulinum Toxins|botulinum toxins|mesh-list
139207229|NCT05956509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139207230|NCT05956509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139207231|NCT05956509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139207232|NCT05956509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139207233|NCT05956509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207234|NCT05956509|Cholinergic Agents|cholinergic agents|mesh-ancestor
139207235|NCT05956509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139207236|NCT05956509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207237|NCT05956509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139207238|NCT05956509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207240|NCT05954442|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139207241|NCT05954442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139207242|NCT05954442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207243|NCT05954442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207244|NCT05954442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139207245|NCT05954442|Immunologic Factors|immunologic factors|mesh-ancestor
139207246|NCT05954442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207247|NCT05954442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207248|NCT05951959|Rituximab|rituximab|mesh-list
139207249|NCT05951959|Venetoclax|venetoclax|mesh-list
139207250|NCT05951959|Acalabrutinib|acalabrutinib|mesh-list
139207251|NCT05951959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207252|NCT05951959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207253|NCT05951959|Immunologic Factors|immunologic factors|mesh-ancestor
139207254|NCT05951959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207255|NCT05951959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139207256|NCT05949684|Epoetin Alfa|epoetin alfa|mesh-list
139207257|NCT05949684|Luspatercept|luspatercept|mesh-list
139207258|NCT05949684|Hematinics|hematinics|mesh-ancestor
139207259|NCT05947500|Avelumab|avelumab|mesh-list
139207260|NCT05947500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139207261|NCT05947500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207262|NCT05947500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207263|NCT05947500|Immunologic Factors|immunologic factors|mesh-ancestor
139207264|NCT05947500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207265|NCT05944458|Acetylcysteine|acetylcysteine|mesh-list
139207266|NCT05944458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139207267|NCT05944458|Antiviral Agents|antiviral agents|mesh-ancestor
139207268|NCT05944458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139207269|NCT05944458|Expectorants|expectorants|mesh-ancestor
139207270|NCT05944458|Respiratory System Agents|respiratory system agents|mesh-ancestor
139207271|NCT05944458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139207272|NCT05944458|Antioxidants|antioxidants|mesh-ancestor
139207273|NCT05944458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207274|NCT05944458|Protective Agents|protective agents|mesh-ancestor
139207275|NCT05944458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207276|NCT05944458|Antidotes|antidotes|mesh-ancestor
139207277|NCT05943106|Durvalumab|durvalumab|mesh-list
139207278|NCT05943106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207279|NCT05943106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207280|NCT05932199|Carboplatin|carboplatin|mesh-list
139207281|NCT05932199|Pemetrexed|pemetrexed|mesh-list
139207282|NCT05932199|Durvalumab|durvalumab|mesh-list
139207283|NCT05932199|Tremelimumab|tremelimumab|mesh-list
139207284|NCT05932199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139207285|NCT05932199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207286|NCT05932199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207287|NCT05932199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207288|NCT05932199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139207289|NCT05932199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139207290|NCT05932199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207291|NCT05932199|Immunologic Factors|immunologic factors|mesh-ancestor
139207292|NCT05932199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207293|NCT05930782|Piperaquine|piperaquine|mesh-list
139207294|NCT05930782|Antimalarials|antimalarials|mesh-ancestor
139207295|NCT05930782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139207296|NCT05930782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139207297|NCT05930782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139207298|NCT05918211|Udenafil|udenafil|mesh-list
139207299|NCT05918211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139207300|NCT05918211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139207301|NCT05918211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207302|NCT05918211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207303|NCT05909397|Letrozole|letrozole|mesh-list
139207304|NCT05909397|Palbociclib|palbociclib|mesh-list
139207305|NCT05909397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207306|NCT05909397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139207307|NCT05909397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139207308|NCT05909397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207309|NCT05909397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207310|NCT05909397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139207311|NCT05909397|Hormone Antagonists|hormone antagonists|mesh-ancestor
139207312|NCT05909397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139207313|NCT05909397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207314|NCT05909397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139207315|NCT05905367|Fentanyl|fentanyl|mesh-list
139207316|NCT05905367|Morphine|morphine|mesh-list
139207317|NCT05905367|Methadone|methadone|mesh-list
139207318|NCT05905367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139207319|NCT05905367|Narcotics|narcotics|mesh-ancestor
139207320|NCT05905367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139207321|NCT05905367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207322|NCT05905367|Analgesics|analgesics|mesh-ancestor
139207323|NCT05905367|Sensory System Agents|sensory system agents|mesh-ancestor
139207324|NCT05905367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207325|NCT05905367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139207326|NCT05905367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139207327|NCT05905367|Anesthetics, General|anesthetics, general|mesh-ancestor
139207328|NCT05905367|Anesthetics|anesthetics|mesh-ancestor
139207329|NCT05905367|Antitussive Agents|antitussive agents|mesh-ancestor
139207330|NCT05905367|Respiratory System Agents|respiratory system agents|mesh-ancestor
139207331|NCT05898646|Daratumumab|daratumumab|mesh-list
139207332|NCT05898646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139207333|NCT05898646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207334|NCT05898646|Immunologic Factors|immunologic factors|mesh-ancestor
139207335|NCT05898646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207336|NCT05883449|Cyclophosphamide|cyclophosphamide|mesh-list
139207337|NCT05883449|Fludarabine|fludarabine|mesh-list
139207338|NCT05883449|Interleukin-2|interleukin-2|mesh-list
139207339|NCT05883449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139207340|NCT05883449|Immunologic Factors|immunologic factors|mesh-ancestor
139207341|NCT05883449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207342|NCT05883449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139207343|NCT05883449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139207344|NCT05883449|Alkylating Agents|alkylating agents|mesh-ancestor
139207345|NCT05883449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207346|NCT05883449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207347|NCT05883449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139207348|NCT05883449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139207349|NCT05883449|Analgesics|analgesics|mesh-ancestor
139207350|NCT05883449|Sensory System Agents|sensory system agents|mesh-ancestor
139207351|NCT05883449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207352|NCT05878522|Moxifloxacin|moxifloxacin|mesh-list
139207353|NCT05878522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139207354|NCT05878522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139066462|NCT02524210|Omeprazole|omeprazole|mesh-list
139207355|NCT05878522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139207356|NCT05878522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139207357|NCT05878522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207358|NCT05878522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207359|NCT05878522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207360|NCT05875727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139207361|NCT05875727|Immunologic Factors|immunologic factors|mesh-ancestor
139207362|NCT05875727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207363|NCT05872685|Oxaliplatin|oxaliplatin|mesh-list
139207364|NCT05872685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207365|NCT05867654|Amoxicillin|amoxicillin|mesh-list
139207366|NCT05867654|Levofloxacin|levofloxacin|mesh-list
139207367|NCT05867654|Clindamycin|clindamycin|mesh-list
138957801|NCT02554344|Curcumin|curcumin|mesh-list
139207368|NCT05867654|Clindamycin palmitate|clindamycin palmitate|mesh-list
139207369|NCT05867654|Clindamycin phosphate|clindamycin phosphate|mesh-list
139207370|NCT05867654|Clavulanic Acid|clavulanic acid|mesh-list
139207371|NCT05867654|Clavulanic Acids|clavulanic acids|mesh-list
139207372|NCT05867654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139207373|NCT05867654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139207374|NCT05867654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139207375|NCT05867654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139207376|NCT05867654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139207377|NCT05867654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139207378|NCT05867654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207379|NCT05867654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207380|NCT05867654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207381|NCT05867654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139207382|NCT05867654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139207383|NCT05867654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139207384|NCT05867654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139207385|NCT05865990|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
139207386|NCT05865990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207387|NCT05865990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207389|NCT05864144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207390|NCT05864144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207391|NCT05858957|Magnesium Sulfate|magnesium sulfate|mesh-list
139207392|NCT05858957|Analgesics|analgesics|mesh-ancestor
139207393|NCT05858957|Sensory System Agents|sensory system agents|mesh-ancestor
139207394|NCT05858957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207395|NCT05858957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207396|NCT05858957|Anesthetics|anesthetics|mesh-ancestor
139207397|NCT05858957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139207398|NCT05858957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139207399|NCT05858957|Anticonvulsants|anticonvulsants|mesh-ancestor
139207400|NCT05858957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139207401|NCT05858957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139207402|NCT05858957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207403|NCT05858957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139207404|NCT05858957|Tocolytic Agents|tocolytic agents|mesh-ancestor
139207405|NCT05858957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139207406|NCT05852002|Hyaluronic Acid|hyaluronic acid|mesh-list
139207407|NCT05852002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139207408|NCT05852002|Immunologic Factors|immunologic factors|mesh-ancestor
139207409|NCT05852002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207410|NCT05852002|Viscosupplements|viscosupplements|mesh-ancestor
139207420|NCT05843188|Fluorouracil|fluorouracil|mesh-list
139207421|NCT05843188|Irinotecan|irinotecan|mesh-list
139207422|NCT05843188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207423|NCT05843188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207424|NCT05843188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139207425|NCT05843188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139207426|NCT05843188|Growth Substances|growth substances|mesh-ancestor
139207427|NCT05843188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207428|NCT05843188|Growth Inhibitors|growth inhibitors|mesh-ancestor
139207429|NCT05843188|Antimetabolites|antimetabolites|mesh-ancestor
139207430|NCT05843188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207431|NCT05843188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139207432|NCT05843188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139207433|NCT05843188|Immunologic Factors|immunologic factors|mesh-ancestor
139207434|NCT05843188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139207435|NCT05843188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139207436|NCT05843188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207437|NCT05843188|Antidotes|antidotes|mesh-ancestor
139207438|NCT05843188|Protective Agents|protective agents|mesh-ancestor
139207439|NCT05843188|Vitamin B Complex|vitamin b complex|mesh-ancestor
139207440|NCT05843188|Vitamins|vitamins|mesh-ancestor
139207441|NCT05843188|Micronutrients|micronutrients|mesh-ancestor
139207442|NCT05843188|Antimalarials|antimalarials|mesh-ancestor
139207443|NCT05843188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139207444|NCT05843188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139207445|NCT05843188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139207446|NCT05843188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139207447|NCT05842954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139207448|NCT05842954|Antimalarials|antimalarials|mesh-ancestor
139207449|NCT05842954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139207450|NCT05842954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139207451|NCT05842954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139207453|NCT05840770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207454|NCT05840770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207463|NCT05834023|Lidocaine|lidocaine|mesh-list
139207464|NCT05834023|Bupivacaine|bupivacaine|mesh-list
139207465|NCT05834023|Anesthetics, Local|anesthetics, local|mesh-ancestor
139207466|NCT05834023|Anesthetics|anesthetics|mesh-ancestor
139207467|NCT05834023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139207468|NCT05834023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207469|NCT05834023|Sensory System Agents|sensory system agents|mesh-ancestor
139207470|NCT05834023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207471|NCT05834023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139207472|NCT05834023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139207473|NCT05834023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139207474|NCT05834023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139207475|NCT05834023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207476|NCT05829460|Progestins|progestins|mesh-list
139207477|NCT05829460|Hormones|hormones|mesh-ancestor
139207478|NCT05829460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139207479|NCT05829460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207480|NCT05826119|Magnesium Sulfate|magnesium sulfate|mesh-list
139207481|NCT05826119|Analgesics|analgesics|mesh-ancestor
139207482|NCT05826119|Sensory System Agents|sensory system agents|mesh-ancestor
139207483|NCT05826119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207484|NCT05826119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207485|NCT05826119|Anesthetics|anesthetics|mesh-ancestor
139207486|NCT05826119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139207487|NCT05826119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139207488|NCT05826119|Anticonvulsants|anticonvulsants|mesh-ancestor
139207489|NCT05826119|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139207490|NCT05826119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139207491|NCT05826119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207492|NCT05826119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139207493|NCT05826119|Tocolytic Agents|tocolytic agents|mesh-ancestor
139207494|NCT05826119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139207496|NCT05826015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139207497|NCT05826015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207498|NCT05826015|Tubulin Modulators|tubulin modulators|mesh-ancestor
139207499|NCT05826015|Antimitotic Agents|antimitotic agents|mesh-ancestor
139207500|NCT05826015|Mitosis Modulators|mitosis modulators|mesh-ancestor
139207501|NCT05826015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207502|NCT05819892|Paclitaxel|paclitaxel|mesh-list
139207503|NCT05819892|Cisplatin|cisplatin|mesh-list
139207504|NCT05819892|Carboplatin|carboplatin|mesh-list
139207505|NCT05819892|Dostarlimab|dostarlimab|mesh-list
139207506|NCT05819892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139207507|NCT05819892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207508|NCT05819892|Tubulin Modulators|tubulin modulators|mesh-ancestor
139207509|NCT05819892|Antimitotic Agents|antimitotic agents|mesh-ancestor
139207510|NCT05819892|Mitosis Modulators|mitosis modulators|mesh-ancestor
139207511|NCT05819892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207512|NCT05801978|Vaccines|vaccines|mesh-list
139207513|NCT05801978|Immunologic Factors|immunologic factors|mesh-ancestor
139207514|NCT05801978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207515|NCT05801146|Botulinum Toxins|botulinum toxins|mesh-list
139207516|NCT05801146|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139207517|NCT05801146|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139207518|NCT05801146|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139207519|NCT05801146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139207520|NCT05801146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207521|NCT05801146|Cholinergic Agents|cholinergic agents|mesh-ancestor
139207522|NCT05801146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139207523|NCT05801146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207524|NCT05801146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139207525|NCT05801146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207526|NCT05789524|Protein C|protein c|mesh-list
139207527|NCT05789524|Anticoagulants|anticoagulants|mesh-ancestor
139207528|NCT05789524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139207529|NCT05789524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139207530|NCT05789524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207531|NCT05786547|Varenicline|varenicline|mesh-list
139207532|NCT05786547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139207533|NCT05786547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138867760|NCT00905021|Sunitinib|sunitinib|mesh-list
139207534|NCT05786547|Cholinergic Agents|cholinergic agents|mesh-ancestor
139207535|NCT05786547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139207536|NCT05786547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207537|NCT05786547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207538|NCT05786417|Calcium Channel Blockers|calcium channel blockers|mesh-list
139207539|NCT05786417|Calcium|calcium|mesh-list
139207540|NCT05786417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139207541|NCT05786417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139207542|NCT05786417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207543|NCT05786417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139207544|NCT05786417|Adrenergic Agents|adrenergic agents|mesh-ancestor
139207545|NCT05786417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139207546|NCT05786417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207547|NCT05786417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139207548|NCT05780801|Glycerol|glycerol|mesh-list
139207549|NCT05780801|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139207550|NCT05780801|Protective Agents|protective agents|mesh-ancestor
139207551|NCT05780801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207552|NCT05775939|Deoxyglucose|deoxyglucose|mesh-list
139207553|NCT05775939|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139207554|NCT05775939|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139207555|NCT05775939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207556|NCT05775939|Antimetabolites|antimetabolites|mesh-ancestor
139207557|NCT05775939|Antiviral Agents|antiviral agents|mesh-ancestor
139207558|NCT05775939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139207559|NCT05775289|Paclitaxel|paclitaxel|mesh-list
139207560|NCT05775289|Carboplatin|carboplatin|mesh-list
139207561|NCT05775289|Pembrolizumab|pembrolizumab|mesh-list
139207562|NCT05775289|Pemetrexed|pemetrexed|mesh-list
139207563|NCT05775289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139207564|NCT05775289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207565|NCT05775289|Tubulin Modulators|tubulin modulators|mesh-ancestor
139207566|NCT05775289|Antimitotic Agents|antimitotic agents|mesh-ancestor
139207567|NCT05775289|Mitosis Modulators|mitosis modulators|mesh-ancestor
139207568|NCT05775289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207569|NCT05775289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207570|NCT05775289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139207571|NCT05775289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207572|NCT05775289|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139207573|NCT05775289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139207575|NCT05771480|Cisplatin|cisplatin|mesh-list
139207576|NCT05771480|Carboplatin|carboplatin|mesh-list
139207577|NCT05771480|Gemcitabine|gemcitabine|mesh-list
139207578|NCT05771480|Oxaliplatin|oxaliplatin|mesh-list
139207579|NCT05771480|Durvalumab|durvalumab|mesh-list
139207580|NCT05771480|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139207581|NCT05771480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139207582|NCT05771480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207583|NCT05771480|Tubulin Modulators|tubulin modulators|mesh-ancestor
139207584|NCT05771480|Antimitotic Agents|antimitotic agents|mesh-ancestor
139207585|NCT05771480|Mitosis Modulators|mitosis modulators|mesh-ancestor
139207586|NCT05771480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207587|NCT05771480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139207588|NCT05771480|Antimetabolites|antimetabolites|mesh-ancestor
139207589|NCT05771480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207590|NCT05767034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139207591|NCT05767034|Immunologic Factors|immunologic factors|mesh-ancestor
139207592|NCT05767034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207593|NCT05750628|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139207594|NCT05750628|Antimalarials|antimalarials|mesh-ancestor
139207595|NCT05750628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139207596|NCT05750628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139207597|NCT05750628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139207598|NCT05748990|Insulin|insulin|mesh-list
139207599|NCT05748990|Insulin Lispro|insulin lispro|mesh-list
139207600|NCT05748990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139207601|NCT05748990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207602|NCT05744479|Metformin|metformin|mesh-list
139207603|NCT05744479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139207604|NCT05744479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207605|NCT05743036|Cetuximab|cetuximab|mesh-list
139207606|NCT05743036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207607|NCT05743036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207608|NCT05729568|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139207609|NCT05729568|Antiviral Agents|antiviral agents|mesh-ancestor
139207610|NCT05729568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139207611|NCT05727761|Metformin|metformin|mesh-list
139207612|NCT05727761|Pioglitazone|pioglitazone|mesh-list
139207613|NCT05727761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139207614|NCT05727761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207615|NCT05727176|Futibatinib|futibatinib|mesh-list
139207616|NCT05727176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207617|NCT05715229|Paclitaxel|paclitaxel|mesh-list
139207618|NCT05715229|Carboplatin|carboplatin|mesh-list
139207619|NCT05715229|Nivolumab|nivolumab|mesh-list
139207620|NCT05715229|Pemetrexed|pemetrexed|mesh-list
139207621|NCT05715229|Ipilimumab|ipilimumab|mesh-list
139207622|NCT05715229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139207623|NCT05715229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207624|NCT05715229|Tubulin Modulators|tubulin modulators|mesh-ancestor
139207625|NCT05715229|Antimitotic Agents|antimitotic agents|mesh-ancestor
139207626|NCT05715229|Mitosis Modulators|mitosis modulators|mesh-ancestor
139207627|NCT05715229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207628|NCT05715229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207629|NCT05715229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139207630|NCT05715229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207631|NCT05715229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139207632|NCT05715229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139207633|NCT05708235|Inavolisib|inavolisib|mesh-list
139207634|NCT05708235|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139207635|NCT05708235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207636|NCT05708235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207637|NCT05705258|Aflibercept|aflibercept|mesh-list
139207638|NCT05705258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138787768|NCT01004250|Bevacizumab|bevacizumab|mesh-list
139207639|NCT05705258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139207640|NCT05705258|Growth Substances|growth substances|mesh-ancestor
139207641|NCT05705258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207642|NCT05705258|Growth Inhibitors|growth inhibitors|mesh-ancestor
139207643|NCT05705258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207644|NCT05704049|Dexamethasone|dexamethasone|mesh-list
139207645|NCT05704049|Dexamethasone acetate|dexamethasone acetate|mesh-list
139207646|NCT05704049|BB 1101|bb 1101|mesh-list
139207647|NCT05704049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139207648|NCT05704049|Antiemetics|antiemetics|mesh-ancestor
139207649|NCT05704049|Autonomic Agents|autonomic agents|mesh-ancestor
139207650|NCT05704049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207651|NCT05704049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207652|NCT05704049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139207653|NCT05704049|Glucocorticoids|glucocorticoids|mesh-ancestor
139207654|NCT05704049|Hormones|hormones|mesh-ancestor
139207655|NCT05704049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139207656|NCT05704049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139207657|NCT05704049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207658|NCT05704049|Protease Inhibitors|protease inhibitors|mesh-ancestor
139207659|NCT05704049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207660|NCT05704049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207661|NCT05700006|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139207662|NCT05700006|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139207663|NCT05700006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207664|NCT05700006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207665|NCT05700006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139207666|NCT05700006|Hormone Antagonists|hormone antagonists|mesh-ancestor
139207667|NCT05700006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139207668|NCT05700006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207669|NCT05699603|Fluorouracil|fluorouracil|mesh-list
139207670|NCT05699603|Calcipotriene|calcipotriene|mesh-list
139207671|NCT05699603|Antimetabolites|antimetabolites|mesh-ancestor
139207672|NCT05699603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207673|NCT05699603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139207674|NCT05699603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207675|NCT05699603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139207676|NCT05699603|Immunologic Factors|immunologic factors|mesh-ancestor
139207677|NCT05699603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207678|NCT05699603|Dermatologic Agents|dermatologic agents|mesh-ancestor
139207679|NCT05691400|Palbociclib|palbociclib|mesh-list
139207680|NCT05691400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207681|NCT05691400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139207682|NCT05691400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939316|NCT02923947|Osimertinib|osimertinib|mesh-list
139207683|NCT05691400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207685|NCT05669989|Lenalidomide|lenalidomide|mesh-list
139207686|NCT05669989|Pomalidomide|pomalidomide|mesh-list
139207687|NCT05669989|Cemiplimab|cemiplimab|mesh-list
139207688|NCT05669989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139207689|NCT05669989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139207690|NCT05669989|Antiemetics|antiemetics|mesh-ancestor
139207691|NCT05669989|Autonomic Agents|autonomic agents|mesh-ancestor
139207692|NCT05669989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207693|NCT05669989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207694|NCT05669989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139207695|NCT05669989|Glucocorticoids|glucocorticoids|mesh-ancestor
139207696|NCT05669989|Hormones|hormones|mesh-ancestor
139207697|NCT05669989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139207698|NCT05669989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139207699|NCT05669989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207700|NCT05669989|Immunologic Factors|immunologic factors|mesh-ancestor
139207701|NCT05669989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139207702|NCT05669989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139207703|NCT05669989|Growth Substances|growth substances|mesh-ancestor
139207704|NCT05669989|Growth Inhibitors|growth inhibitors|mesh-ancestor
139207705|NCT05669989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207706|NCT05666336|Mycophenolic Acid|mycophenolic acid|mesh-list
139207707|NCT05666336|Hydroxychloroquine|hydroxychloroquine|mesh-list
139207708|NCT05666336|Prednisone|prednisone|mesh-list
139207709|NCT05666336|Methylprednisolone|methylprednisolone|mesh-list
139207710|NCT05666336|Cyclophosphamide|cyclophosphamide|mesh-list
139207711|NCT05666336|Tacrolimus|tacrolimus|mesh-list
139207712|NCT05666336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139207713|NCT05666336|Immunologic Factors|immunologic factors|mesh-ancestor
139207714|NCT05666336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207715|NCT05666336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139207716|NCT05666336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139207717|NCT05666336|Alkylating Agents|alkylating agents|mesh-ancestor
139207718|NCT05666336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207719|NCT05666336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207720|NCT05666336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139207721|NCT05666336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139207722|NCT05666336|Glucocorticoids|glucocorticoids|mesh-ancestor
139207723|NCT05666336|Hormones|hormones|mesh-ancestor
139207724|NCT05666336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139207725|NCT05666336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139207726|NCT05666336|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139207727|NCT05666336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207728|NCT05666336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139207729|NCT05666336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139207730|NCT05666336|Antitubercular Agents|antitubercular agents|mesh-ancestor
139207731|NCT05666336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139207732|NCT05666336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139207733|NCT05666336|Antiemetics|antiemetics|mesh-ancestor
139207734|NCT05666336|Autonomic Agents|autonomic agents|mesh-ancestor
139207735|NCT05666336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207736|NCT05666336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139207737|NCT05666336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139207738|NCT05666336|Protective Agents|protective agents|mesh-ancestor
139207739|NCT05666336|Antimalarials|antimalarials|mesh-ancestor
139207740|NCT05666336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139207741|NCT05666336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139207742|NCT05665465|Nicotine|nicotine|mesh-list
139207743|NCT05665465|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139207744|NCT05665465|Autonomic Agents|autonomic agents|mesh-ancestor
139207745|NCT05665465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207746|NCT05665465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207747|NCT05665465|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139207748|NCT05665465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139207749|NCT05665465|Cholinergic Agents|cholinergic agents|mesh-ancestor
139207750|NCT05665465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139207751|NCT05665465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207752|NCT05661708|Chitosan|chitosan|mesh-list
139207753|NCT05661708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139207754|NCT05661708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139207755|NCT05661708|Antimetabolites|antimetabolites|mesh-ancestor
139207756|NCT05661708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207757|NCT05661708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139207758|NCT05661708|Chelating Agents|chelating agents|mesh-ancestor
139207759|NCT05661708|Sequestering Agents|sequestering agents|mesh-ancestor
139207760|NCT05661708|Hemostatics|hemostatics|mesh-ancestor
139207761|NCT05661708|Coagulants|coagulants|mesh-ancestor
139207763|NCT05660382|Clotrimazole|clotrimazole|mesh-list
139207764|NCT05660382|Mineral Oil|mineral oil|mesh-list
139207765|NCT05660382|Antifungal Agents|antifungal agents|mesh-ancestor
139207766|NCT05660382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139207767|NCT05660382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139207768|NCT05660382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139207769|NCT05660382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207770|NCT05660382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207771|NCT05660382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139207772|NCT05660382|Hormone Antagonists|hormone antagonists|mesh-ancestor
139207773|NCT05660382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139207774|NCT05660382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207775|NCT05660382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139207776|NCT05660382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139207777|NCT05660382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139207778|NCT05660382|Emollients|emollients|mesh-ancestor
139207779|NCT05660382|Dermatologic Agents|dermatologic agents|mesh-ancestor
139207780|NCT05656235|Pembrolizumab|pembrolizumab|mesh-list
139207781|NCT05656235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207782|NCT05656235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207783|NCT05656235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139207784|NCT05656235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207785|NCT05653258|Dasatinib|dasatinib|mesh-list
139207786|NCT05653258|Quercetin|quercetin|mesh-list
139207787|NCT05653258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207788|NCT05653258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139207789|NCT05653258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207790|NCT05653258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207791|NCT05653258|Antioxidants|antioxidants|mesh-ancestor
139207792|NCT05653258|Protective Agents|protective agents|mesh-ancestor
139207793|NCT05653258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207794|NCT05650879|Trastuzumab|trastuzumab|mesh-list
139207795|NCT05650879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139207796|NCT05650879|Maytansine|maytansine|mesh-list
139207797|NCT05650879|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139207798|NCT05650879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207799|NCT05650879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207800|NCT05650879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139207801|NCT05650879|Tubulin Modulators|tubulin modulators|mesh-ancestor
139207802|NCT05650879|Antimitotic Agents|antimitotic agents|mesh-ancestor
139207803|NCT05650879|Mitosis Modulators|mitosis modulators|mesh-ancestor
139207804|NCT05650879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207805|NCT05650879|Immunotoxins|immunotoxins|mesh-ancestor
139207806|NCT05650879|Immunoconjugates|immunoconjugates|mesh-ancestor
139207807|NCT05650879|Immunologic Factors|immunologic factors|mesh-ancestor
139207808|NCT05650879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207809|NCT05647122|Leucovorin|leucovorin|mesh-list
139207810|NCT05647122|Bevacizumab|bevacizumab|mesh-list
139207811|NCT05647122|Fluorouracil|fluorouracil|mesh-list
139207812|NCT05647122|Osimertinib|osimertinib|mesh-list
139207813|NCT05647122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207814|NCT05647122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207815|NCT05647122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139207816|NCT05647122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139207817|NCT05647122|Growth Substances|growth substances|mesh-ancestor
139207818|NCT05647122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207819|NCT05647122|Growth Inhibitors|growth inhibitors|mesh-ancestor
139207820|NCT05647122|Antimetabolites|antimetabolites|mesh-ancestor
139207821|NCT05647122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207822|NCT05647122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139207823|NCT05647122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139207824|NCT05647122|Immunologic Factors|immunologic factors|mesh-ancestor
139207825|NCT05647122|Antidotes|antidotes|mesh-ancestor
139207826|NCT05647122|Protective Agents|protective agents|mesh-ancestor
139207827|NCT05647122|Vitamin B Complex|vitamin b complex|mesh-ancestor
139207828|NCT05647122|Vitamins|vitamins|mesh-ancestor
139207829|NCT05647122|Micronutrients|micronutrients|mesh-ancestor
139207830|NCT05647122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139207831|NCT05647122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207832|NCT05645757|Ertapenem|ertapenem|mesh-list
139207833|NCT05645757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139207834|NCT05645757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139207835|NCT05645718|Cytarabine|cytarabine|mesh-list
139207836|NCT05645718|Dexamethasone|dexamethasone|mesh-list
139207837|NCT05645718|Prednisone|prednisone|mesh-list
139207838|NCT05645718|Cyclophosphamide|cyclophosphamide|mesh-list
139207839|NCT05645718|Rituximab|rituximab|mesh-list
139207840|NCT05645718|Methotrexate|methotrexate|mesh-list
139207841|NCT05645718|Vincristine|vincristine|mesh-list
139207842|NCT05645718|Mercaptopurine|mercaptopurine|mesh-list
139207843|NCT05645718|Blinatumomab|blinatumomab|mesh-list
139207844|NCT05645718|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139207845|NCT05645718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139207846|NCT05645718|Immunologic Factors|immunologic factors|mesh-ancestor
139207847|NCT05645718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207848|NCT05645718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139207849|NCT05645718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139207850|NCT05645718|Alkylating Agents|alkylating agents|mesh-ancestor
139207851|NCT05645718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207852|NCT05645718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207853|NCT05645718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139207854|NCT05645718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139207855|NCT05645718|Antiemetics|antiemetics|mesh-ancestor
139207856|NCT05645718|Autonomic Agents|autonomic agents|mesh-ancestor
139207857|NCT05645718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207858|NCT05645718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139207859|NCT05645718|Glucocorticoids|glucocorticoids|mesh-ancestor
139207860|NCT05645718|Hormones|hormones|mesh-ancestor
139207861|NCT05645718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139207862|NCT05645718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139207863|NCT05645718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207864|NCT05645718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139207865|NCT05645718|Abortifacient Agents|abortifacient agents|mesh-ancestor
139207866|NCT05645718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139207867|NCT05645718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139207868|NCT05645718|Antimetabolites|antimetabolites|mesh-ancestor
139207869|NCT05645718|Dermatologic Agents|dermatologic agents|mesh-ancestor
139207870|NCT05645718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207871|NCT05645718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139207872|NCT05645718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139207873|NCT05645718|Antiviral Agents|antiviral agents|mesh-ancestor
139207874|NCT05645718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139207875|NCT05645718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139207876|NCT05645718|Tubulin Modulators|tubulin modulators|mesh-ancestor
139207877|NCT05645718|Antimitotic Agents|antimitotic agents|mesh-ancestor
139207878|NCT05645718|Mitosis Modulators|mitosis modulators|mesh-ancestor
139207879|NCT05645718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139207880|NCT05645718|Immunotoxins|immunotoxins|mesh-ancestor
139207881|NCT05645718|Immunoconjugates|immunoconjugates|mesh-ancestor
139207882|NCT05638867|Aspirin|aspirin|mesh-list
139207883|NCT05638867|Rivaroxaban|rivaroxaban|mesh-list
139207884|NCT05638867|Clopidogrel|clopidogrel|mesh-list
139207885|NCT05638867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139207886|NCT05638867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139207887|NCT05638867|Analgesics|analgesics|mesh-ancestor
139207888|NCT05638867|Sensory System Agents|sensory system agents|mesh-ancestor
139207889|NCT05638867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207890|NCT05638867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207891|NCT05638867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139207892|NCT05638867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139207893|NCT05638867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139207894|NCT05638867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139207895|NCT05638867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207896|NCT05638867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139207897|NCT05638867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139207898|NCT05638867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207899|NCT05638867|Antipyretics|antipyretics|mesh-ancestor
139207900|NCT05638867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139207901|NCT05638867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139207902|NCT05638867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139207903|NCT05638867|Purinergic Agents|purinergic agents|mesh-ancestor
139207904|NCT05638867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139207905|NCT05638867|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139207906|NCT05638867|Antithrombins|antithrombins|mesh-ancestor
139207907|NCT05638867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139207908|NCT05638867|Protease Inhibitors|protease inhibitors|mesh-ancestor
139207909|NCT05638867|Anticoagulants|anticoagulants|mesh-ancestor
139207910|NCT05638087|Dexamethasone|dexamethasone|mesh-list
139207911|NCT05638087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139207912|NCT05638087|Antiemetics|antiemetics|mesh-ancestor
139207913|NCT05638087|Autonomic Agents|autonomic agents|mesh-ancestor
139207914|NCT05638087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207915|NCT05638087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207916|NCT05638087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139207917|NCT05638087|Glucocorticoids|glucocorticoids|mesh-ancestor
139207918|NCT05638087|Hormones|hormones|mesh-ancestor
139207919|NCT05638087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139207920|NCT05638087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139207921|NCT05638087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207922|NCT05633654|Pembrolizumab|pembrolizumab|mesh-list
139207923|NCT05633654|Capecitabine|capecitabine|mesh-list
139207924|NCT05633654|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139207925|NCT05633654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207926|NCT05633654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207927|NCT05633654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139207928|NCT05633654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207929|NCT05633654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139207930|NCT05633654|Antimetabolites|antimetabolites|mesh-ancestor
139207931|NCT05633654|Immunoconjugates|immunoconjugates|mesh-ancestor
139207932|NCT05633654|Immunologic Factors|immunologic factors|mesh-ancestor
139207933|NCT05633654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207934|NCT05629585|Pembrolizumab|pembrolizumab|mesh-list
139207935|NCT05629585|Durvalumab|durvalumab|mesh-list
139207936|NCT05629585|Capecitabine|capecitabine|mesh-list
139207937|NCT05629585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207938|NCT05629585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207939|NCT05629585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139207940|NCT05629585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207941|NCT05629585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139207942|NCT05629585|Antimetabolites|antimetabolites|mesh-ancestor
139207943|NCT05629429|Olaparib|olaparib|mesh-list
139207944|NCT05629429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139207945|NCT05629429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207946|NCT05629429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207947|NCT05629429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207948|NCT05609630|Upadacitinib|upadacitinib|mesh-list
139207949|NCT05609630|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139207950|NCT05609630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139207951|NCT05609630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207952|NCT05609630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207953|NCT05609630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139207954|NCT05605535|Paclitaxel|paclitaxel|mesh-list
139207955|NCT05605535|Carboplatin|carboplatin|mesh-list
139207956|NCT05605535|Oregovomab|oregovomab|mesh-list
139207957|NCT05605535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139207958|NCT05605535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207959|NCT05605535|Tubulin Modulators|tubulin modulators|mesh-ancestor
139207960|NCT05605535|Antimitotic Agents|antimitotic agents|mesh-ancestor
139207961|NCT05605535|Mitosis Modulators|mitosis modulators|mesh-ancestor
139207962|NCT05605535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207963|NCT05605535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207964|NCT05593328|Bevacizumab|bevacizumab|mesh-list
139207965|NCT05593328|Onvansertib|onvansertib|mesh-list
139207966|NCT05593328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139207967|NCT05593328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207968|NCT05593328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139207969|NCT05593328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139207970|NCT05593328|Growth Substances|growth substances|mesh-ancestor
139207971|NCT05593328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207972|NCT05593328|Growth Inhibitors|growth inhibitors|mesh-ancestor
139207973|NCT05593328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138958399|NCT01060969|Acetazolamide|acetazolamide|mesh-list
139207974|NCT05593328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207975|NCT05593328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207976|NCT05583617|Dexamethasone|dexamethasone|mesh-list
139207977|NCT05583617|Lenalidomide|lenalidomide|mesh-list
139207978|NCT05583617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139207979|NCT05583617|Antiemetics|antiemetics|mesh-ancestor
139207980|NCT05583617|Autonomic Agents|autonomic agents|mesh-ancestor
139207981|NCT05583617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139207982|NCT05583617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139207984|NCT05583617|Glucocorticoids|glucocorticoids|mesh-ancestor
139207985|NCT05583617|Hormones|hormones|mesh-ancestor
139207986|NCT05583617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139207987|NCT05583617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139207988|NCT05583617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139207989|NCT05583617|Immunologic Factors|immunologic factors|mesh-ancestor
139207990|NCT05583617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139207991|NCT05583617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139207992|NCT05583617|Growth Substances|growth substances|mesh-ancestor
139207993|NCT05583617|Growth Inhibitors|growth inhibitors|mesh-ancestor
139207994|NCT05583552|Imetelstat|imetelstat|mesh-list
139207995|NCT05583552|Motesanib diphosphate|motesanib diphosphate|mesh-list
139207996|NCT05583552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139207997|NCT05583552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139207998|NCT05583552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139207999|NCT05582590|Cyclophosphamide|cyclophosphamide|mesh-list
139208000|NCT05582590|Fludarabine|fludarabine|mesh-list
139208001|NCT05582590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139208002|NCT05582590|Immunologic Factors|immunologic factors|mesh-ancestor
139208003|NCT05582590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208004|NCT05582590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139208005|NCT05582590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139208006|NCT05582590|Alkylating Agents|alkylating agents|mesh-ancestor
139208007|NCT05582590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208008|NCT05582590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208009|NCT05582590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139208010|NCT05573724|Itraconazole|itraconazole|mesh-list
139208011|NCT05573724|Antifungal Agents|antifungal agents|mesh-ancestor
139208012|NCT05573724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139208013|NCT05573724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139208014|NCT05573724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139208015|NCT05573724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208016|NCT05573724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208017|NCT05573724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139208018|NCT05573724|Hormone Antagonists|hormone antagonists|mesh-ancestor
139208019|NCT05573724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139208020|NCT05573724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208021|NCT05573724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139208022|NCT05567835|Leucovorin|leucovorin|mesh-list
139208023|NCT05567835|Docetaxel|docetaxel|mesh-list
139208024|NCT05567835|Fluorouracil|fluorouracil|mesh-list
139208025|NCT05567835|Oxaliplatin|oxaliplatin|mesh-list
139208026|NCT05567835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208027|NCT05567835|Tubulin Modulators|tubulin modulators|mesh-ancestor
139208028|NCT05567835|Antimitotic Agents|antimitotic agents|mesh-ancestor
139208029|NCT05567835|Mitosis Modulators|mitosis modulators|mesh-ancestor
139208030|NCT05567835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208031|NCT05567835|Antimetabolites|antimetabolites|mesh-ancestor
139208032|NCT05567835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139208033|NCT05567835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139208034|NCT05567835|Immunologic Factors|immunologic factors|mesh-ancestor
139208035|NCT05567835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208036|NCT05567835|Antidotes|antidotes|mesh-ancestor
139208037|NCT05567835|Protective Agents|protective agents|mesh-ancestor
139208038|NCT05567835|Vitamin B Complex|vitamin b complex|mesh-ancestor
139208039|NCT05567835|Vitamins|vitamins|mesh-ancestor
139208040|NCT05567835|Micronutrients|micronutrients|mesh-ancestor
139208041|NCT05560399|Dexamethasone|dexamethasone|mesh-list
139208042|NCT05560399|Elotuzumab|elotuzumab|mesh-list
139208043|NCT05560399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139208044|NCT05560399|Antiemetics|antiemetics|mesh-ancestor
139208045|NCT05560399|Autonomic Agents|autonomic agents|mesh-ancestor
139208046|NCT05560399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208047|NCT05560399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208048|NCT05560399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139208049|NCT05560399|Glucocorticoids|glucocorticoids|mesh-ancestor
139208050|NCT05560399|Hormones|hormones|mesh-ancestor
139208051|NCT05560399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139208052|NCT05560399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139208053|NCT05560399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208054|NCT05555121|Progesterone|progesterone|mesh-list
139208055|NCT05555121|Progestins|progestins|mesh-ancestor
139208056|NCT05555121|Hormones|hormones|mesh-ancestor
139154200|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139208075|NCT05552976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139208076|NCT05552976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139208077|NCT05552976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208078|NCT05547386|Edetic Acid|edetic acid|mesh-list
139208079|NCT05547386|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139208080|NCT05547386|Chelating Agents|chelating agents|mesh-ancestor
139208081|NCT05547386|Sequestering Agents|sequestering agents|mesh-ancestor
139208082|NCT05547386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208083|NCT05547386|Anticoagulants|anticoagulants|mesh-ancestor
139208084|NCT05547386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139208085|NCT05547386|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139208086|NCT05541341|Tisagenlecleucel|tisagenlecleucel|mesh-list
139208087|NCT05541341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208088|NCT05541341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208089|NCT05541016|Cisplatin|cisplatin|mesh-list
139208090|NCT05541016|Docetaxel|docetaxel|mesh-list
139208091|NCT05541016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208092|NCT05541016|Tubulin Modulators|tubulin modulators|mesh-ancestor
139208093|NCT05541016|Antimitotic Agents|antimitotic agents|mesh-ancestor
139208094|NCT05541016|Mitosis Modulators|mitosis modulators|mesh-ancestor
139208095|NCT05541016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208096|NCT05524246|Pravastatin|pravastatin|mesh-list
139208097|NCT05524246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139208098|NCT05524246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139208099|NCT05524246|Antimetabolites|antimetabolites|mesh-ancestor
139208100|NCT05524246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208101|NCT05524246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139208102|NCT05524246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139208103|NCT05524246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208104|NCT05522673|Rolipram|rolipram|mesh-list
139208105|NCT05522673|Antidepressive Agents|antidepressive agents|mesh-ancestor
139208106|NCT05522673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139208107|NCT05522673|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139208108|NCT05522673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139208109|NCT05522673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208110|NCT05522673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208130|NCT05487859|Acarbose|acarbose|mesh-list
139208131|NCT05487859|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139208132|NCT05487859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208133|NCT05487859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208135|NCT05487859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208136|NCT05486481|Dexamethasone|dexamethasone|mesh-list
139208137|NCT05486481|Venetoclax|venetoclax|mesh-list
139208138|NCT05486481|Daratumumab|daratumumab|mesh-list
139208139|NCT05486481|Immunoglobulins|immunoglobulins|mesh-list
139208140|NCT05486481|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139208141|NCT05486481|Antibodies|antibodies|mesh-list
139208142|NCT05486481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139208143|NCT05486481|Immunoglobulin Heavy Chains|immunoglobulin heavy chains|mesh-list
139208144|NCT05486481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139208145|NCT05486481|Antiemetics|antiemetics|mesh-ancestor
139208146|NCT05486481|Autonomic Agents|autonomic agents|mesh-ancestor
139208147|NCT05486481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208148|NCT05486481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208149|NCT05486481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139208150|NCT05486481|Glucocorticoids|glucocorticoids|mesh-ancestor
139208151|NCT05486481|Hormones|hormones|mesh-ancestor
139208152|NCT05486481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139208153|NCT05486481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139208154|NCT05486481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208155|NCT05486481|Immunologic Factors|immunologic factors|mesh-ancestor
139208156|NCT05478837|Cyclophosphamide|cyclophosphamide|mesh-list
139208157|NCT05478837|Fludarabine|fludarabine|mesh-list
139208158|NCT05478837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139208159|NCT05478837|Immunologic Factors|immunologic factors|mesh-ancestor
139208160|NCT05478837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208161|NCT05478837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139208162|NCT05478837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139208163|NCT05478837|Alkylating Agents|alkylating agents|mesh-ancestor
139208164|NCT05478837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208165|NCT05478837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208166|NCT05478837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139208167|NCT05477953|Nifurtimox|nifurtimox|mesh-list
139208168|NCT05477953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139208169|NCT05477953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139208170|NCT05477953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139208171|NCT05477953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139208172|NCT05459129|Paclitaxel|paclitaxel|mesh-list
139208173|NCT05459129|Carboplatin|carboplatin|mesh-list
139208174|NCT05459129|Atezolizumab|atezolizumab|mesh-list
139208175|NCT05459129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139208176|NCT05459129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208177|NCT05459129|Tubulin Modulators|tubulin modulators|mesh-ancestor
139208178|NCT05459129|Antimitotic Agents|antimitotic agents|mesh-ancestor
139208179|NCT05459129|Mitosis Modulators|mitosis modulators|mesh-ancestor
139208180|NCT05459129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208181|NCT05459129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208182|NCT05459129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208183|NCT05451329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139208184|NCT05451329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139208185|NCT05450978|Lamotrigine|lamotrigine|mesh-list
139208186|NCT05450978|Levetiracetam|levetiracetam|mesh-list
139208187|NCT05450978|Anticonvulsants|anticonvulsants|mesh-list
139208188|NCT05450978|Nootropic Agents|nootropic agents|mesh-ancestor
139208189|NCT05450978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139208190|NCT05450978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139208191|NCT05450978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208192|NCT05450978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139208193|NCT05450978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208194|NCT05450978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139208195|NCT05450978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139208196|NCT05450978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139208197|NCT05450978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139208198|NCT05450978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139208199|NCT05450562|Atezolizumab|atezolizumab|mesh-list
139208200|NCT05450562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208201|NCT05450562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208202|NCT05450562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208203|NCT05450562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208204|NCT05428969|Azacitidine|azacitidine|mesh-list
139208206|NCT05428969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139208207|NCT05428969|Antimetabolites|antimetabolites|mesh-ancestor
139154201|NCT03005522|Dexamethasone|dexamethasone|mesh-list
139208208|NCT05428969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208210|NCT05428969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208211|NCT05425420|Methadone|methadone|mesh-list
139208212|NCT05425420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139208213|NCT05425420|Narcotics|narcotics|mesh-ancestor
139208214|NCT05425420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139208215|NCT05425420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208216|NCT05425420|Analgesics|analgesics|mesh-ancestor
139208217|NCT05425420|Sensory System Agents|sensory system agents|mesh-ancestor
139208218|NCT05425420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208219|NCT05425420|Antitussive Agents|antitussive agents|mesh-ancestor
139208220|NCT05425420|Respiratory System Agents|respiratory system agents|mesh-ancestor
139208221|NCT05405114|Decitabine|decitabine|mesh-list
139208222|NCT05405114|Hydroxyurea|hydroxyurea|mesh-list
139208223|NCT05405114|Tetrahydrouridine|tetrahydrouridine|mesh-list
139208224|NCT05405114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139208225|NCT05405114|Antimetabolites|antimetabolites|mesh-ancestor
139208226|NCT05405114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208227|NCT05405114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208228|NCT05405114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208229|NCT05405114|Antisickling Agents|antisickling agents|mesh-ancestor
139208230|NCT05405114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139208231|NCT05397639|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
139208232|NCT05397639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139208233|NCT05397639|Serotonin Agents|serotonin agents|mesh-ancestor
139208234|NCT05397639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139208235|NCT05397639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208236|NCT05397639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208237|NCT05392452|Insulin|insulin|mesh-list
139208238|NCT05392452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139208239|NCT05392452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208240|NCT05389046|Dexetimide|dexetimide|mesh-list
139208241|NCT05389046|Aripiprazole|aripiprazole|mesh-list
139208242|NCT05389046|Citalopram|citalopram|mesh-list
139208243|NCT05389046|Escitalopram|escitalopram|mesh-list
139208244|NCT05389046|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139208245|NCT05389046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139208246|NCT05389046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139208247|NCT05389046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208248|NCT05389046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139208249|NCT05389046|Serotonin Agents|serotonin agents|mesh-ancestor
139208250|NCT05389046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208251|NCT05389046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139208252|NCT05389046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139208253|NCT05389046|Parasympatholytics|parasympatholytics|mesh-ancestor
139208254|NCT05389046|Autonomic Agents|autonomic agents|mesh-ancestor
139208255|NCT05389046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208256|NCT05389046|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139208257|NCT05389046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139208258|NCT05389046|Cholinergic Agents|cholinergic agents|mesh-ancestor
139208259|NCT05389046|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139208260|NCT05389046|Antidepressive Agents|antidepressive agents|mesh-ancestor
139208261|NCT05389046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139208262|NCT05389046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139208263|NCT05389046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139208264|NCT05389046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139208265|NCT05389046|Dopamine Agonists|dopamine agonists|mesh-ancestor
139208266|NCT05389046|Dopamine Agents|dopamine agents|mesh-ancestor
139208267|NCT05389046|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139208268|NCT05389046|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139208269|NCT05389046|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139208270|NCT05389046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139208271|NCT05389046|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139208272|NCT05389046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139208273|NCT05388487|Complement Factor H|complement factor h|mesh-list
139208274|NCT05388487|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139208275|NCT05388487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139208276|NCT05388487|Immunologic Factors|immunologic factors|mesh-ancestor
139208277|NCT05388487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208278|NCT05385042|Vitamin B 12|vitamin b 12|mesh-list
139208279|NCT05385042|Thiamine|thiamine|mesh-list
139208280|NCT05385042|Vitamins|vitamins|mesh-ancestor
139208281|NCT05385042|Micronutrients|micronutrients|mesh-ancestor
139208282|NCT05385042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208283|NCT05385042|Vitamin B Complex|vitamin b complex|mesh-ancestor
139208284|NCT05374603|Durvalumab|durvalumab|mesh-list
139208285|NCT05374603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208286|NCT05374603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208287|NCT05374512|Paclitaxel|paclitaxel|mesh-list
139208288|NCT05374512|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139208289|NCT05374512|Carboplatin|carboplatin|mesh-list
139208290|NCT05374512|Capecitabine|capecitabine|mesh-list
139208291|NCT05374512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139208292|NCT05374512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208293|NCT05374512|Tubulin Modulators|tubulin modulators|mesh-ancestor
139208294|NCT05374512|Antimitotic Agents|antimitotic agents|mesh-ancestor
139208295|NCT05374512|Mitosis Modulators|mitosis modulators|mesh-ancestor
139208296|NCT05374512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208297|NCT05374512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139208298|NCT05374512|Antimetabolites|antimetabolites|mesh-ancestor
139208299|NCT05368558|Cariprazine|cariprazine|mesh-list
139208300|NCT05368558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139208301|NCT05368558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139208302|NCT05368558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139208303|NCT05368558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208304|NCT05368558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139208305|NCT05365035|Cytarabine|cytarabine|mesh-list
139208306|NCT05365035|Azacitidine|azacitidine|mesh-list
139208307|NCT05365035|Venetoclax|venetoclax|mesh-list
139208308|NCT05365035|Cladribine|cladribine|mesh-list
139208309|NCT05365035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139208310|NCT05365035|Antimetabolites|antimetabolites|mesh-ancestor
139208311|NCT05365035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208312|NCT05365035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208313|NCT05365035|Antiviral Agents|antiviral agents|mesh-ancestor
139208314|NCT05365035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139208315|NCT05365035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139208316|NCT05365035|Immunologic Factors|immunologic factors|mesh-ancestor
139208317|NCT05365035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208318|NCT05365035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208319|NCT05360511|Epoetin Alfa|epoetin alfa|mesh-list
139208320|NCT05360511|Hematinics|hematinics|mesh-ancestor
139208321|NCT05357846|Paclitaxel|paclitaxel|mesh-list
139208322|NCT05357846|Cisplatin|cisplatin|mesh-list
139208323|NCT05357846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139208324|NCT05357846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208325|NCT05357846|Tubulin Modulators|tubulin modulators|mesh-ancestor
139208326|NCT05357846|Antimitotic Agents|antimitotic agents|mesh-ancestor
139208327|NCT05357846|Mitosis Modulators|mitosis modulators|mesh-ancestor
139208328|NCT05357846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208329|NCT05355272|Hormones|hormones|mesh-list
139208330|NCT05355272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139208331|NCT05355272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208332|NCT05348577|Docetaxel|docetaxel|mesh-list
139208333|NCT05348577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208334|NCT05348577|Tubulin Modulators|tubulin modulators|mesh-ancestor
139208335|NCT05348577|Antimitotic Agents|antimitotic agents|mesh-ancestor
139208336|NCT05348577|Mitosis Modulators|mitosis modulators|mesh-ancestor
139208337|NCT05348577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208338|NCT05344417|Iodine|iodine|mesh-list
139208339|NCT05344417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139208340|NCT05344417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139208341|NCT05344417|Trace Elements|trace elements|mesh-ancestor
139208342|NCT05344417|Micronutrients|micronutrients|mesh-ancestor
139208343|NCT05344417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208344|NCT05335993|Niraparib|niraparib|mesh-list
139208345|NCT05335993|Oregovomab|oregovomab|mesh-list
139208346|NCT05335993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139208347|NCT05335993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958775|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
139208348|NCT05335993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208349|NCT05335993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208350|NCT05335993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208351|NCT05335941|Pemetrexed|pemetrexed|mesh-list
139208352|NCT05335941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208353|NCT05335941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208354|NCT05335941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154203|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
139208355|NCT05335941|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139208356|NCT05335941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139208358|NCT05319834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139208359|NCT05319834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139208360|NCT05319834|Analgesics|analgesics|mesh-ancestor
139208361|NCT05319834|Sensory System Agents|sensory system agents|mesh-ancestor
139208362|NCT05319834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208363|NCT05319834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208364|NCT05319834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139208365|NCT05319834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139208366|NCT05319834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139208367|NCT05319834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139208368|NCT05319834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208369|NCT05319834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139208370|NCT05319834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139208371|NCT05319834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208372|NCT05319834|Antipyretics|antipyretics|mesh-ancestor
139208373|NCT05319574|Tislelizumab|tislelizumab|mesh-list
139208374|NCT05319574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208375|NCT05319574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208376|NCT05318573|Gemcitabine|gemcitabine|mesh-list
139208377|NCT05318573|Pembrolizumab|pembrolizumab|mesh-list
139208378|NCT05318573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139208379|NCT05318573|Antimetabolites|antimetabolites|mesh-ancestor
139208380|NCT05318573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208381|NCT05318573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787776|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
139208382|NCT05318573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208383|NCT05318573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208384|NCT05296798|Paclitaxel|paclitaxel|mesh-list
139208385|NCT05296798|Docetaxel|docetaxel|mesh-list
139208386|NCT05296798|Trastuzumab|trastuzumab|mesh-list
139208387|NCT05296798|Pertuzumab|pertuzumab|mesh-list
139066611|NCT01297036|Donepezil|donepezil|mesh-list
139208388|NCT05296798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139208389|NCT05296798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208390|NCT05296798|Tubulin Modulators|tubulin modulators|mesh-ancestor
139208391|NCT05296798|Antimitotic Agents|antimitotic agents|mesh-ancestor
139208392|NCT05296798|Mitosis Modulators|mitosis modulators|mesh-ancestor
139208393|NCT05296798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208394|NCT05296798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208395|NCT05291325|Linaclotide|linaclotide|mesh-list
139208396|NCT05291325|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139208397|NCT05291325|Enzyme Activators|enzyme activators|mesh-ancestor
139208398|NCT05291325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208399|NCT05291325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139208400|NCT05286801|Deoxyglucose|deoxyglucose|mesh-list
139208401|NCT05286801|Atezolizumab|atezolizumab|mesh-list
139208402|NCT05286801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139208403|NCT05286801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139208404|NCT05286801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208405|NCT05286801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208406|NCT05286801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208407|NCT05286801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208408|NCT05286801|Immunologic Factors|immunologic factors|mesh-ancestor
139208409|NCT05286801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208410|NCT05286801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139208411|NCT05286801|Antimetabolites|antimetabolites|mesh-ancestor
139208412|NCT05286801|Antiviral Agents|antiviral agents|mesh-ancestor
139208413|NCT05286801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139208414|NCT05277636|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139208415|NCT05277636|Hallucinogens|hallucinogens|mesh-ancestor
139208416|NCT05277636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208417|NCT05277636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139208418|NCT05277636|Serotonin Agents|serotonin agents|mesh-ancestor
139208419|NCT05277636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139208420|NCT05277636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208421|NCT05277636|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139208422|NCT05277636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139208423|NCT05277636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139208424|NCT05277636|Adrenergic Agents|adrenergic agents|mesh-ancestor
139208425|NCT05267600|Prednisone|prednisone|mesh-list
139208426|NCT05267600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139208427|NCT05267600|Glucocorticoids|glucocorticoids|mesh-ancestor
139208428|NCT05267600|Hormones|hormones|mesh-ancestor
139208429|NCT05267600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139208430|NCT05267600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208431|NCT05267600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139208432|NCT05267600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208433|NCT05262270|Naltrexone|naltrexone|mesh-list
139208434|NCT05262270|Buprenorphine|buprenorphine|mesh-list
139208435|NCT05262270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139208436|NCT05262270|Narcotics|narcotics|mesh-ancestor
139208437|NCT05262270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139208438|NCT05262270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208439|NCT05262270|Analgesics|analgesics|mesh-ancestor
139066620|NCT03848806|Calcipotriene|calcipotriene|mesh-list
139208440|NCT05262270|Sensory System Agents|sensory system agents|mesh-ancestor
139208441|NCT05262270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208442|NCT05262270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139208443|NCT05262270|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139208444|NCT05254171|Paclitaxel|paclitaxel|mesh-list
139208445|NCT05254171|Gemcitabine|gemcitabine|mesh-list
139208446|NCT05254171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139208447|NCT05254171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208448|NCT05254171|Tubulin Modulators|tubulin modulators|mesh-ancestor
139208449|NCT05254171|Antimitotic Agents|antimitotic agents|mesh-ancestor
139208450|NCT05254171|Mitosis Modulators|mitosis modulators|mesh-ancestor
139208451|NCT05254171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208452|NCT05254171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139208453|NCT05254171|Antimetabolites|antimetabolites|mesh-ancestor
139208454|NCT05253833|Allopurinol|allopurinol|mesh-list
139208455|NCT05253833|Antimetabolites|antimetabolites|mesh-ancestor
139208456|NCT05253833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208457|NCT05253833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208458|NCT05253833|Gout Suppressants|gout suppressants|mesh-ancestor
139208459|NCT05253833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139208460|NCT05253833|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139208461|NCT05253833|Antioxidants|antioxidants|mesh-ancestor
139208462|NCT05253833|Protective Agents|protective agents|mesh-ancestor
139208463|NCT05253833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208464|NCT05252754|Indomethacin|indomethacin|mesh-list
139208465|NCT05252754|Tacrolimus|tacrolimus|mesh-list
139208466|NCT05252754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139208467|NCT05252754|Immunologic Factors|immunologic factors|mesh-ancestor
139208468|NCT05252754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208469|NCT05252754|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139208470|NCT05252754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208471|NCT05252754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208472|NCT05252754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139208473|NCT05252754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139208474|NCT05252754|Analgesics|analgesics|mesh-ancestor
139208475|NCT05252754|Sensory System Agents|sensory system agents|mesh-ancestor
139208476|NCT05252754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208477|NCT05252754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139208478|NCT05252754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139208479|NCT05252754|Gout Suppressants|gout suppressants|mesh-ancestor
139208480|NCT05252754|Tocolytic Agents|tocolytic agents|mesh-ancestor
139208481|NCT05252754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139208482|NCT05252754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139208483|NCT05249101|Capecitabine|capecitabine|mesh-list
139208484|NCT05249101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139208485|NCT05249101|Antimetabolites|antimetabolites|mesh-ancestor
139208486|NCT05249101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208487|NCT05249101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208488|NCT05243342|Daratumumab|daratumumab|mesh-list
139208489|NCT05243342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208490|NCT05241873|Carboplatin|carboplatin|mesh-list
139208491|NCT05241873|Pemetrexed|pemetrexed|mesh-list
139208492|NCT05241873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208493|NCT05241873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208494|NCT05241873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208495|NCT05241873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139208496|NCT05241873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139208497|NCT05241275|Xenon|xenon|mesh-list
139208498|NCT05241275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139208499|NCT05241275|Anesthetics, General|anesthetics, general|mesh-ancestor
139208500|NCT05241275|Anesthetics|anesthetics|mesh-ancestor
139208501|NCT05241275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139208502|NCT05241275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208504|NCT05222971|Olaparib|olaparib|mesh-list
139208505|NCT05222971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208506|NCT05222971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208507|NCT05222971|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139208508|NCT05222971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208509|NCT05222971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208510|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
139208511|NCT05217446|Cetuximab|cetuximab|mesh-list
139208512|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208513|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208514|NCT05217446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208515|NCT05217446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208516|NCT05208294|Sulpiride|sulpiride|mesh-list
139208517|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139208518|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139208519|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139208520|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208521|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139208522|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139208523|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
139208524|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139208525|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208526|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139208527|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
139208528|NCT05198830|Cisplatin|cisplatin|mesh-list
139208529|NCT05198830|Pemetrexed|pemetrexed|mesh-list
139208530|NCT05198830|Durvalumab|durvalumab|mesh-list
139208531|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
139208532|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139208533|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
139208534|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208535|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208536|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208537|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139208538|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139208539|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208540|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
139208541|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208542|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
139208543|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208544|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208545|NCT05166304|Rebamipide|rebamipide|mesh-list
139208546|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139208547|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139208548|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
139208549|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208550|NCT05166304|Protective Agents|protective agents|mesh-ancestor
139208551|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208552|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208553|NCT05127044|Bilirubin|bilirubin|mesh-list
139208554|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
139208555|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208556|NCT05127044|Protective Agents|protective agents|mesh-ancestor
139208557|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208558|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
139208559|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
139208560|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139208561|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139208562|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139208563|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066658|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139208564|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208565|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139208566|NCT05118399|Bupivacaine|bupivacaine|mesh-list
139208567|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
139208568|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
139208569|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139208570|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208571|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
139208572|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208573|NCT05115903|Adalimumab|adalimumab|mesh-list
139208574|NCT05115903|Infliximab|infliximab|mesh-list
138959002|NCT01063621|Emetics|emetics|mesh-ancestor
139208575|NCT05115903|Golimumab|golimumab|mesh-list
139208576|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
139208577|NCT05115903|Etanercept|etanercept|mesh-list
139208578|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139208579|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139208580|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139208581|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139208582|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
139208583|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139208584|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139208585|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139208586|NCT05115903|Analgesics|analgesics|mesh-ancestor
139208587|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
139208588|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208589|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208590|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139208591|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
139208592|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
139208593|NCT05114421|Lenvatinib|lenvatinib|mesh-list
139208594|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208595|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208596|NCT05114421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208597|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208598|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139208599|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208600|NCT05112601|Nivolumab|nivolumab|mesh-list
139208601|NCT05112601|Ipilimumab|ipilimumab|mesh-list
139208602|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208603|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208604|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208605|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208607|NCT05101551|Topotecan|topotecan|mesh-list
139208608|NCT05101551|Talazoparib|talazoparib|mesh-list
139208609|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139208610|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
139208611|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208612|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208613|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139208614|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139208615|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208616|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139208617|NCT05100862|Rituximab|rituximab|mesh-list
139208618|NCT05100862|Obinutuzumab|obinutuzumab|mesh-list
139208619|NCT05100862|Lenalidomide|lenalidomide|mesh-list
139208620|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
139066663|NCT01191892|Carboplatin|carboplatin|mesh-list
139208621|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208622|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208623|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
139208624|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208625|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139208626|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139208627|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139208628|NCT05100862|Growth Substances|growth substances|mesh-ancestor
139208629|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
139208630|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139208631|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208632|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208633|NCT05098938|Acyclovir|acyclovir|mesh-list
139208634|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
139208635|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139208636|NCT05092958|Avelumab|avelumab|mesh-list
139208637|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139208638|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208639|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208640|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
139208641|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208642|NCT05091424|Venetoclax|venetoclax|mesh-list
139208643|NCT05091424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208644|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
139208645|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208646|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208647|NCT05084430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208648|NCT05084430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208649|NCT05072236|Lidocaine|lidocaine|mesh-list
139208650|NCT05072236|Anesthetics, Local|anesthetics, local|mesh-ancestor
139208651|NCT05072236|Anesthetics|anesthetics|mesh-ancestor
139208652|NCT05072236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139208653|NCT05072236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208654|NCT05072236|Sensory System Agents|sensory system agents|mesh-ancestor
139208655|NCT05072236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208656|NCT05072236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139208657|NCT05072236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139208658|NCT05072236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139208659|NCT05072236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139208660|NCT05072236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208661|NCT05065021|Paclitaxel|paclitaxel|mesh-list
139208662|NCT05065021|Bevacizumab|bevacizumab|mesh-list
139208663|NCT05065021|Niraparib|niraparib|mesh-list
139208664|NCT05065021|Dostarlimab|dostarlimab|mesh-list
139208665|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139208666|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208667|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
139208668|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
139208669|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
139208670|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208671|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208672|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139208673|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139208674|NCT05065021|Growth Substances|growth substances|mesh-ancestor
139208675|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208676|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
139208677|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139208678|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208687|NCT05062083|11C-PS13|11c-ps13|mesh-list
139208688|NCT05062083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139208689|NCT05062083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208690|NCT05057494|Venetoclax|venetoclax|mesh-list
139208691|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
139208692|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
139208693|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208694|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208695|NCT05050916|Vitamin D|vitamin d|mesh-list
139208696|NCT05050916|Vitamins|vitamins|mesh-ancestor
139208697|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
139208698|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208699|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139208700|NCT05050136|Volixibat|volixibat|mesh-list
139208701|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139208702|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139208703|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139208704|NCT05039619|Acetaminophen|acetaminophen|mesh-list
139208705|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
139208706|NCT05039619|Promethazine|promethazine|mesh-list
139208707|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
139208708|NCT05039619|Prednisone|prednisone|mesh-list
139208709|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
139208710|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
139208711|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139208712|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
139208713|NCT05039619|Hormones|hormones|mesh-ancestor
139208714|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139208715|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208716|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139208717|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208718|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139208719|NCT05039619|Analgesics|analgesics|mesh-ancestor
139208720|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
139208721|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208722|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
139208723|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139208724|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139208725|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
139208726|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139208727|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139208728|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208729|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208731|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
139208732|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139208733|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139208734|NCT05039619|Protective Agents|protective agents|mesh-ancestor
139208735|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208736|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139208737|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139208738|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139208739|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
139208740|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
139208741|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139208742|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
139208743|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
139208744|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139208745|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139208746|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
139208747|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
139208748|NCT05037929|Astegolimab|astegolimab|mesh-list
139208749|NCT05037929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139208750|NCT05037929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139208751|NCT05037929|Antiviral Agents|antiviral agents|mesh-ancestor
139208752|NCT05037929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139208753|NCT05035316|Aspirin|aspirin|mesh-list
139208754|NCT05035316|Calcium|calcium|mesh-list
139208755|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139208756|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208757|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139208758|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139208759|NCT05035316|Analgesics|analgesics|mesh-ancestor
139208760|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
139208761|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208762|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139208763|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139208764|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139208765|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139208766|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208767|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139208768|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139208769|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208770|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
139208771|NCT05020860|Paclitaxel|paclitaxel|mesh-list
139208772|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
139208773|NCT05020860|Carboplatin|carboplatin|mesh-list
139208774|NCT05020860|Doxorubicin|doxorubicin|mesh-list
139208775|NCT05020860|Pembrolizumab|pembrolizumab|mesh-list
139208776|NCT05020860|Trastuzumab|trastuzumab|mesh-list
139208777|NCT05020860|Pertuzumab|pertuzumab|mesh-list
139208778|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139208779|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208780|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
139208781|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
139208782|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
139208783|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208784|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139208785|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
139208786|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208787|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139208788|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139208789|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
139208790|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139208791|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139208792|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139208793|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139208794|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208795|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208796|NCT05020860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208797|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
139208798|NCT05018585|Vitamin D|vitamin d|mesh-list
139208799|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139208800|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139208801|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
139208802|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208803|NCT05018585|Antacids|antacids|mesh-ancestor
139208804|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208805|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139208806|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139208807|NCT05018585|Vitamins|vitamins|mesh-ancestor
139208808|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
139208809|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139208810|NCT05011487|Pemetrexed|pemetrexed|mesh-list
139208811|NCT05011487|Osimertinib|osimertinib|mesh-list
139208812|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208813|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208814|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208815|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139208816|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139208817|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139208819|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208820|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208821|NCT04999202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208822|NCT04999202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208823|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139208824|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139208825|NCT04987203|Nivolumab|nivolumab|mesh-list
139208826|NCT04987203|Tivozanib|tivozanib|mesh-list
139208827|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208828|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208829|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208830|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208831|NCT04987203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139208832|NCT04987203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208833|NCT04978493|Ustekinumab|ustekinumab|mesh-list
139208834|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
139208835|NCT04975724|Citalopram|citalopram|mesh-list
139208836|NCT04975724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139208837|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139208838|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139208839|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208840|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139208841|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
139208842|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208843|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139208844|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
139208845|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139208846|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
139208847|NCT04971226|Dasatinib|dasatinib|mesh-list
139208848|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208849|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139208850|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208851|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208852|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
139208853|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
139208854|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208855|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
139208856|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208857|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208858|NCT04949191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208859|NCT04949191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208860|NCT04943224|Trametinib|trametinib|mesh-list
139208861|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208862|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139208863|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208864|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208865|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139208866|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139208867|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208868|NCT04943198|Vemurafenib|vemurafenib|mesh-list
139208869|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208870|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139208871|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208872|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208875|NCT04930562|Belumosudil|belumosudil|mesh-list
139208876|NCT04930562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139208877|NCT04930562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208878|NCT04930562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208879|NCT04929028|Capecitabine|capecitabine|mesh-list
139208880|NCT04929028|Fluorouracil|fluorouracil|mesh-list
139208881|NCT04929028|Nivolumab|nivolumab|mesh-list
139208882|NCT04929028|Mitomycins|mitomycins|mesh-list
139208883|NCT04929028|Mitomycin|mitomycin|mesh-list
139208884|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139208885|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
139208886|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208887|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208888|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139208889|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
139208890|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208891|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208892|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208893|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139208894|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
139208895|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139208896|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208898|NCT04910568|Daratumumab|daratumumab|mesh-list
139208899|NCT04910568|Pomalidomide|pomalidomide|mesh-list
139208900|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139208901|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
139208902|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
139208903|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208904|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208905|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139208906|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
139208907|NCT04910568|Hormones|hormones|mesh-ancestor
139208908|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139208909|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139208910|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208911|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
139208912|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139208913|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139208914|NCT04910568|Growth Substances|growth substances|mesh-ancestor
139208915|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
139208916|NCT04908787|Paclitaxel|paclitaxel|mesh-list
139208917|NCT04908787|Doxorubicin|doxorubicin|mesh-list
139208918|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139208919|NCT04908787|Topotecan|topotecan|mesh-list
139208920|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139208921|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208922|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
139208923|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
139208924|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
139208925|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208926|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139208927|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139208928|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139208929|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208930|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139208931|NCT04891289|Dexamethasone|dexamethasone|mesh-list
139208932|NCT04891289|Gemcitabine|gemcitabine|mesh-list
139208933|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
139208934|NCT04891289|Floxuridine|floxuridine|mesh-list
139208935|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139208936|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
139208937|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
139208938|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139208939|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208940|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139208941|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
139208942|NCT04891289|Hormones|hormones|mesh-ancestor
139208943|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139208944|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139208945|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208946|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139208947|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
139208948|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208949|NCT04887506|Prednisone|prednisone|mesh-list
139208950|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
139208951|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138959373|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
139208952|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
139208953|NCT04887506|Hormones|hormones|mesh-ancestor
139208954|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139208955|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208956|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139208957|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208958|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139208959|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208960|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208961|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
139208962|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139208963|NCT04884360|Olaparib|olaparib|mesh-list
139208964|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139208965|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208966|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208967|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208968|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
139208969|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139208970|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
139208971|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208972|NCT04879329|Pembrolizumab|pembrolizumab|mesh-list
139208973|NCT04879329|Disitamab vedotin|disitamab vedotin|mesh-list
139208974|NCT04879329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139208975|NCT04879329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208976|NCT04879329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139208977|NCT04879329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208978|NCT04879329|Immunoconjugates|immunoconjugates|mesh-ancestor
139208979|NCT04879329|Immunologic Factors|immunologic factors|mesh-ancestor
139208980|NCT04879329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208981|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
139208982|NCT04872595|Melphalan|melphalan|mesh-list
139208983|NCT04872595|Busulfan|busulfan|mesh-list
139208984|NCT04872595|Thiotepa|thiotepa|mesh-list
139208985|NCT04872595|Fludarabine|fludarabine|mesh-list
139208986|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139208987|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
139208988|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139208989|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139208990|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139208991|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
139208992|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208993|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139208994|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139208995|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
139208996|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139208997|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139208998|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139208999|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
139209000|NCT04848337|Lenvatinib|lenvatinib|mesh-list
139209001|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209002|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209003|NCT04848337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209004|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209005|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139209006|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209007|NCT04844606|Mirikizumab|mirikizumab|mesh-list
139209008|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139209009|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139209010|NCT04844606|Analgesics|analgesics|mesh-ancestor
139209011|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
139209012|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139209013|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209014|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139209015|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139209016|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139209017|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139209018|NCT04839328|Hemay005|hemay005|mesh-list
139209019|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
139209020|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139209021|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139209022|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209023|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209024|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
139209025|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209026|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209027|NCT04837196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209028|NCT04837196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209029|NCT04832854|Paclitaxel|paclitaxel|mesh-list
139209030|NCT04832854|Carboplatin|carboplatin|mesh-list
139209031|NCT04832854|Gemcitabine|gemcitabine|mesh-list
139209032|NCT04832854|Pemetrexed|pemetrexed|mesh-list
139209033|NCT04832854|Atezolizumab|atezolizumab|mesh-list
139209034|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139209035|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209036|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209037|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209038|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209039|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209040|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139209041|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
139209042|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209043|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139209044|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139209045|NCT04832854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209046|NCT04832854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209047|NCT04826341|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139209049|NCT04826341|Immunologic Factors|immunologic factors|mesh-ancestor
139209050|NCT04826341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209051|NCT04824794|Daratumumab|daratumumab|mesh-list
139209052|NCT04824794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209053|NCT04822337|Dexamethasone|dexamethasone|mesh-list
139209054|NCT04822337|Lenalidomide|lenalidomide|mesh-list
139209055|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139209056|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
139209057|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
139209058|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139209059|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209060|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139209061|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
139209062|NCT04822337|Hormones|hormones|mesh-ancestor
139209063|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139209064|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139209065|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209066|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
139209067|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139209068|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139209069|NCT04822337|Growth Substances|growth substances|mesh-ancestor
139209070|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
139209071|NCT04806386|Psyllium|psyllium|mesh-list
139209072|NCT04806386|Cathartics|cathartics|mesh-ancestor
139209073|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139209074|NCT04802759|Trastuzumab|trastuzumab|mesh-list
139209075|NCT04802759|Atezolizumab|atezolizumab|mesh-list
139209076|NCT04802759|Pertuzumab|pertuzumab|mesh-list
139209077|NCT04802759|Everolimus|everolimus|mesh-list
139209078|NCT04802759|Palbociclib|palbociclib|mesh-list
139209079|NCT04802759|Ipatasertib|ipatasertib|mesh-list
139209080|NCT04802759|Inavolisib|inavolisib|mesh-list
139209081|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209082|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209083|NCT04802759|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139209084|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139209085|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209086|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209087|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139209088|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
139209089|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209090|NCT04802759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209091|NCT04802759|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139209092|NCT04799249|Carboplatin|carboplatin|mesh-list
139209093|NCT04799249|Gemcitabine|gemcitabine|mesh-list
139209094|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209095|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139209096|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
139209097|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209098|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139209099|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209100|NCT04791761|Acetaminophen|acetaminophen|mesh-list
139209101|NCT04791761|Ibuprofen|ibuprofen|mesh-list
139209102|NCT04791761|Oxycodone|oxycodone|mesh-list
139209103|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
138959526|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
139209104|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139209106|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
139209107|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139209108|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209109|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
139209110|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139209111|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139209112|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139209113|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139209114|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209115|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209116|NCT04791761|Narcotics|narcotics|mesh-ancestor
139209117|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139209118|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
139209119|NCT04787991|Paclitaxel|paclitaxel|mesh-list
139209120|NCT04787991|Gemcitabine|gemcitabine|mesh-list
139209121|NCT04787991|Nivolumab|nivolumab|mesh-list
139209122|NCT04787991|Ipilimumab|ipilimumab|mesh-list
139209123|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139209124|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209125|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209126|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209127|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209128|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209129|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139209130|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
139209131|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209132|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209133|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
139209134|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139209135|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139209136|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139209137|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209138|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139209139|NCT04785547|Blinatumomab|blinatumomab|mesh-list
139209140|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209141|NCT04781322|Alirocumab|alirocumab|mesh-list
139209142|NCT04781322|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139209143|NCT04781322|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139209144|NCT04781322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139209145|NCT04781322|Antimetabolites|antimetabolites|mesh-ancestor
139209146|NCT04781322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209147|NCT04781322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139209148|NCT04781322|Protease Inhibitors|protease inhibitors|mesh-ancestor
139209149|NCT04781322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209150|NCT04781322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139209151|NCT04774380|Carboplatin|carboplatin|mesh-list
139209152|NCT04774380|Etoposide|etoposide|mesh-list
139209153|NCT04774380|Durvalumab|durvalumab|mesh-list
139209154|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209155|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139209156|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139209157|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139209158|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209159|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209160|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209161|NCT04773184|Capsaicin|capsaicin|mesh-list
139209162|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
139209163|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
139209164|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
139209165|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139209166|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209167|NCT04764942|Dexamethasone|dexamethasone|mesh-list
139209168|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
139209169|NCT04764942|Pomalidomide|pomalidomide|mesh-list
139209170|NCT04764942|Ichthammol|ichthammol|mesh-list
139209171|NCT04764942|BB 1101|bb 1101|mesh-list
139209172|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139209173|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
139209174|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
139209175|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139209176|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209177|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139209178|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
139209179|NCT04764942|Hormones|hormones|mesh-ancestor
139209180|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139209181|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139209182|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209183|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
139209184|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209185|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209186|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
139209187|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139209188|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139209189|NCT04764942|Growth Substances|growth substances|mesh-ancestor
139209190|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
139209191|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
139209192|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
139209193|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139209194|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
139209195|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139209196|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
139209197|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209198|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209199|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
139209200|NCT04754061|Psilocybin|psilocybin|mesh-list
139209202|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209203|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139209204|NCT04751383|Dinutuximab|dinutuximab|mesh-list
139209205|NCT04751383|Magrolimab|magrolimab|mesh-list
139209206|NCT04751383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139209207|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209208|NCT04751383|Immunologic Factors|immunologic factors|mesh-ancestor
139209209|NCT04751383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209210|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209211|NCT04736199|Androgens|androgens|mesh-list
139209212|NCT04736199|Hormones|hormones|mesh-ancestor
139209213|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139209214|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209215|NCT04729322|Metronidazole|metronidazole|mesh-list
139209216|NCT04729322|Vancomycin|vancomycin|mesh-list
139209217|NCT04729322|Neomycin|neomycin|mesh-list
139209218|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
139209219|NCT04729322|Nivolumab|nivolumab|mesh-list
139209220|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209221|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209222|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209223|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209224|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139209225|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139209226|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139209227|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139209228|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139209229|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209230|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
139209231|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139209232|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209233|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209234|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139209235|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139209236|NCT04712539|Oseltamivir|oseltamivir|mesh-list
139209237|NCT04712539|Baloxavir|baloxavir|mesh-list
139209238|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
139209239|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139209240|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209241|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209242|NCT04706091|Suvorexant|suvorexant|mesh-list
139209243|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139209244|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139209245|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139209246|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209247|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139209248|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139209249|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209250|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
139209251|NCT04704219|Lenvatinib|lenvatinib|mesh-list
138959673|NCT00946179|Vaccines|vaccines|mesh-list
139209252|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209253|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209254|NCT04704219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209255|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209256|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139209257|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209258|NCT04703920|Talazoparib|talazoparib|mesh-list
139209259|NCT04703920|Belinostat|belinostat|mesh-list
139209260|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139209261|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209262|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209263|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209264|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139209265|NCT04699188|Tislelizumab|tislelizumab|mesh-list
139209266|NCT04699188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209267|NCT04699188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209268|NCT04690192|Gemcitabine|gemcitabine|mesh-list
139209269|NCT04690192|Melphalan|melphalan|mesh-list
139209270|NCT04690192|Busulfan|busulfan|mesh-list
139209271|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139209272|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
139209273|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209274|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209275|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139209276|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
139209277|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139209278|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139209279|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
139209280|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209281|NCT04676477|Osimertinib|osimertinib|mesh-list
139209282|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
139209283|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139209284|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209285|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139209286|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209287|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209288|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
139209289|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209290|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209291|NCT04664361|Niacinamide|niacinamide|mesh-list
139209292|NCT04664361|Niacin|niacin|mesh-list
139209293|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
139209294|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
139209295|NCT04664361|Vitamins|vitamins|mesh-ancestor
139209296|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
139209297|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209298|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139209299|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
139209300|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209301|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139209302|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
139209303|NCT04656652|Docetaxel|docetaxel|mesh-list
139209304|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209305|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209306|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209307|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209308|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209309|NCT04611529|Ibuprofen|ibuprofen|mesh-list
139209310|NCT04611529|Diclofenac|diclofenac|mesh-list
139209311|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139209312|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139209313|NCT04611529|Analgesics|analgesics|mesh-ancestor
139209314|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
139209315|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139209316|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209317|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139209318|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139209319|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139209320|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209321|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209322|NCT04610866|Mitapivat|mitapivat|mesh-list
139209323|NCT04610866|Enzyme Activators|enzyme activators|mesh-ancestor
139209324|NCT04610866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209325|NCT04610580|Choline|choline|mesh-list
139209326|NCT04610580|Lipotropic Agents|lipotropic agents|mesh-ancestor
139209327|NCT04610580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139209328|NCT04610580|Antimetabolites|antimetabolites|mesh-ancestor
139209329|NCT04610580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209330|NCT04610580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139209331|NCT04610580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139209332|NCT04610580|Nootropic Agents|nootropic agents|mesh-ancestor
139209333|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139209334|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139209335|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
139209336|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139154209|NCT03005522|Hormones|hormones|mesh-ancestor
139209348|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139209349|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209350|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209351|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209352|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209353|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209354|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139209355|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139209356|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209357|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139209358|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
139209359|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139209360|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209361|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139209362|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139209363|NCT04601350|Midazolam|midazolam|mesh-list
139209364|NCT04601350|Anesthetics|anesthetics|mesh-ancestor
139209365|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139209366|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209367|NCT04601350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139209368|NCT04601350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139209369|NCT04601350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139209370|NCT04601350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139209371|NCT04601350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139209372|NCT04601350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139209373|NCT04601350|Anesthetics, General|anesthetics, general|mesh-ancestor
139209374|NCT04601350|GABA Modulators|gaba modulators|mesh-ancestor
139209375|NCT04601350|GABA Agents|gaba agents|mesh-ancestor
139209376|NCT04601350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139209377|NCT04601350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209378|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139209379|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209380|NCT04584853|Tamoxifen|tamoxifen|mesh-list
139209381|NCT04584853|Letrozole|letrozole|mesh-list
139066845|NCT01296178|Idarubicin|idarubicin|mesh-list
139209382|NCT04584853|Anastrozole|anastrozole|mesh-list
139209383|NCT04584853|Exemestane|exemestane|mesh-list
139209384|NCT04584853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209385|NCT04584853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139209386|NCT04584853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139209387|NCT04584853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209388|NCT04584853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209389|NCT04584853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139209390|NCT04584853|Hormone Antagonists|hormone antagonists|mesh-ancestor
139209391|NCT04584853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139209392|NCT04584853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209393|NCT04584853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139209394|NCT04584853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139209395|NCT04584853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139209396|NCT04584853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139209397|NCT04574856|Temozolomide|temozolomide|mesh-list
139209398|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139209399|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
139209400|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209401|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209402|NCT04573478|Atrasentan|atrasentan|mesh-list
139209403|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209404|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139209405|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139209406|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209408|NCT04569461|Androgens|androgens|mesh-list
139209409|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209410|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209411|NCT04569461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209412|NCT04569461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209413|NCT04569461|Hormones|hormones|mesh-ancestor
139209414|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139209415|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209416|NCT04565236|Factor VIII|factor viii|mesh-list
139209417|NCT04565236|Coagulants|coagulants|mesh-ancestor
139209418|NCT04554459|Ponatinib|ponatinib|mesh-list
139209419|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209420|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139209421|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209422|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209423|NCT04553692|Leucovorin|leucovorin|mesh-list
139209424|NCT04553692|Bevacizumab|bevacizumab|mesh-list
139209425|NCT04553692|Gemcitabine|gemcitabine|mesh-list
139209426|NCT04553692|Docetaxel|docetaxel|mesh-list
139209427|NCT04553692|Fluorouracil|fluorouracil|mesh-list
139209428|NCT04553692|Irinotecan|irinotecan|mesh-list
139209429|NCT04553692|Azacitidine|azacitidine|mesh-list
139209430|NCT04553692|Venetoclax|venetoclax|mesh-list
139209431|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209432|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209433|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139209434|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139209435|NCT04553692|Growth Substances|growth substances|mesh-ancestor
139209436|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209437|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
139209438|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139209439|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
139209440|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209441|NCT04553692|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209442|NCT04553692|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209443|NCT04553692|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209444|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139209445|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
139209446|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139209447|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139209448|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209449|NCT04553692|Antidotes|antidotes|mesh-ancestor
139209450|NCT04553692|Protective Agents|protective agents|mesh-ancestor
139209451|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
139209452|NCT04553692|Vitamins|vitamins|mesh-ancestor
139209453|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
139209454|NCT04552613|Carboplatin|carboplatin|mesh-list
139209455|NCT04552613|Pemetrexed|pemetrexed|mesh-list
139209456|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209457|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209458|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209459|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139209460|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139209461|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139209462|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
139209463|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209464|NCT04527380|Adalimumab|adalimumab|mesh-list
139209465|NCT04527380|Ixekizumab|ixekizumab|mesh-list
139209466|NCT04527380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139209467|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139209468|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139209469|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
139209470|NCT04519619|Aflibercept|aflibercept|mesh-list
139209471|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139209472|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139209473|NCT04519619|Growth Substances|growth substances|mesh-ancestor
139209474|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209475|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
139209476|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209477|NCT04501614|Ponatinib|ponatinib|mesh-list
138959894|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209478|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209479|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139209480|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209481|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209482|NCT04499248|Bimatoprost|bimatoprost|mesh-list
139209483|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139209484|NCT04497168|Citalopram|citalopram|mesh-list
139209485|NCT04497168|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138941104|NCT05733078|Micronutrients|micronutrients|mesh-ancestor
139209486|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139209487|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139209488|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209489|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139209490|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
139209491|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209492|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139209493|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
139209494|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139209495|NCT04490057|Bupropion|bupropion|mesh-list
139209496|NCT04490057|Nicotine|nicotine|mesh-list
139209497|NCT04490057|Varenicline|varenicline|mesh-list
139209499|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
139209500|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139209501|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209502|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139209503|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139209504|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
139209505|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139209506|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209507|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139209508|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
139209509|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139209510|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139209511|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139209512|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139209513|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
139209514|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139209515|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139209516|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209517|NCT04474600|Propofol|propofol|mesh-list
139209518|NCT04474600|Desflurane|desflurane|mesh-list
139209519|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139209520|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139209521|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209522|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139209523|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
139209524|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
139209525|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139209526|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
139209527|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139209528|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139209529|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209530|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139209531|NCT04454515|Analgesics|analgesics|mesh-ancestor
139209532|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
139209533|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139209534|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139209535|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139209536|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139209537|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
139209538|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139209539|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209540|NCT04408638|Gemcitabine|gemcitabine|mesh-list
139209541|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
139209542|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
139209543|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139209544|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
139209545|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209546|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209547|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209548|NCT04408625|Sirolimus|sirolimus|mesh-list
139209549|NCT04408625|Prednisone|prednisone|mesh-list
139209550|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
139209551|NCT04408625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139209552|NCT04408625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139209553|NCT04408625|Prednisolone|prednisolone|mesh-list
139209554|NCT04408625|Prednisolone acetate|prednisolone acetate|mesh-list
139209555|NCT04408625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139209556|NCT04408625|Prednisolone phosphate|prednisolone phosphate|mesh-list
139209557|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139209558|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
139209559|NCT04408625|Hormones|hormones|mesh-ancestor
138867762|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209560|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139209561|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209562|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139209563|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209564|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139209565|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139209566|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139209567|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
139209568|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139209569|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
139209570|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
139209571|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
139209572|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139209574|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139209575|NCT04408625|Protective Agents|protective agents|mesh-ancestor
139209576|NCT04398524|Cemiplimab|cemiplimab|mesh-list
139209577|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209578|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209579|NCT04398316|Lidocaine|lidocaine|mesh-list
139209580|NCT04398316|Hydromorphone|hydromorphone|mesh-list
139209581|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
139209582|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
139209583|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139209584|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209585|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
139209586|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139209587|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139209588|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139209589|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139209590|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139209591|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209592|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139209593|NCT04398316|Narcotics|narcotics|mesh-ancestor
139209594|NCT04398316|Analgesics|analgesics|mesh-ancestor
139209595|NCT04396574|Lasmiditan|lasmiditan|mesh-list
139209596|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139209597|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
139209598|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139209599|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209600|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209601|NCT04396236|Lasmiditan|lasmiditan|mesh-list
139209602|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139209603|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
139209604|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139209605|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209606|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209607|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
139209608|NCT04350021|Capecitabine|capecitabine|mesh-list
139209609|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139209610|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
139209611|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209612|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139209613|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139209614|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
139209615|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209616|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209617|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139209618|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139209619|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
139209620|NCT04319198|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139209621|NCT04319198|Immunoconjugates|immunoconjugates|mesh-ancestor
139209622|NCT04319198|Immunologic Factors|immunologic factors|mesh-ancestor
139209623|NCT04319198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209624|NCT04310943|Paclitaxel|paclitaxel|mesh-list
139209625|NCT04310943|Tislelizumab|tislelizumab|mesh-list
139209626|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139209627|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209628|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209629|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209630|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209631|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209632|NCT04310943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209633|NCT04308174|Durvalumab|durvalumab|mesh-list
139209634|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209635|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209636|NCT04301076|Prednisone|prednisone|mesh-list
139209637|NCT04301076|Cortisone|cortisone|mesh-list
139209638|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
139209639|NCT04301076|Doxorubicin|doxorubicin|mesh-list
139209640|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139209641|NCT04301076|Etoposide|etoposide|mesh-list
139209642|NCT04301076|Vincristine|vincristine|mesh-list
139209643|NCT04301076|Lenalidomide|lenalidomide|mesh-list
139209644|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
139209645|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
139209646|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139209647|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
139209648|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209650|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139209651|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
139209652|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209653|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209654|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139209655|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139209656|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139209657|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139209658|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209659|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139209660|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
139209661|NCT04301076|Hormones|hormones|mesh-ancestor
139209662|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139209663|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139209664|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139209665|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209666|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209667|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209668|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139209669|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139209670|NCT04301076|Growth Substances|growth substances|mesh-ancestor
139209671|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
139209672|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
139209673|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
139209674|NCT04290546|Cetuximab|cetuximab|mesh-list
139209675|NCT04290546|Ipilimumab|ipilimumab|mesh-list
139209676|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139209677|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209678|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209679|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209680|NCT04274426|Paclitaxel|paclitaxel|mesh-list
139209681|NCT04274426|Maytansine|maytansine|mesh-list
139209682|NCT04274426|Carboplatin|carboplatin|mesh-list
139209683|NCT04274426|Gemcitabine|gemcitabine|mesh-list
139209684|NCT04274426|Doxorubicin|doxorubicin|mesh-list
139209685|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139209686|NCT04274426|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139209687|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139209688|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209689|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209690|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209691|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209692|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209693|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139209694|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
139209695|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139209696|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139209697|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139209698|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209699|NCT04274426|Immunoconjugates|immunoconjugates|mesh-ancestor
139209700|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
139209701|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209702|NCT04272801|Tamoxifen|tamoxifen|mesh-list
139209703|NCT04272801|Letrozole|letrozole|mesh-list
139209704|NCT04272801|Anastrozole|anastrozole|mesh-list
139209705|NCT04272801|Exemestane|exemestane|mesh-list
139209706|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209707|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139209708|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139209709|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209710|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209711|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139209712|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
139209713|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139209714|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209715|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139209716|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139209717|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139209718|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139209720|NCT04261439|Spartalizumab|spartalizumab|mesh-list
139209721|NCT04261439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209722|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209723|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209724|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209725|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139209726|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209727|NCT04250155|Atezolizumab|atezolizumab|mesh-list
139209728|NCT04250155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209729|NCT04250155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209730|NCT04250155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209731|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209732|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
139209733|NCT04239092|Temozolomide|temozolomide|mesh-list
139209734|NCT04239092|Irinotecan|irinotecan|mesh-list
139209735|NCT04239092|Topotecan|topotecan|mesh-list
139209736|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139209737|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
139209738|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209739|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139209740|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139209741|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
139209742|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209743|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209744|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139209745|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139209746|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139209747|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209748|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139209749|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209750|NCT04232553|Mirikizumab|mirikizumab|mesh-list
139209751|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139209752|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139209753|NCT04232553|Analgesics|analgesics|mesh-ancestor
139209754|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
139209755|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139209756|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209757|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139209758|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139209759|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139209760|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139209761|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139209762|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
139209763|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139209764|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
139209765|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139209766|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139209767|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209768|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
139209769|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
139209770|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139209771|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139209772|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209773|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209774|NCT04213209|Immunotoxins|immunotoxins|mesh-ancestor
139209775|NCT04213209|Immunoconjugates|immunoconjugates|mesh-ancestor
139209776|NCT04213209|Immunologic Factors|immunologic factors|mesh-ancestor
139209777|NCT04213209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209778|NCT04203160|Cisplatin|cisplatin|mesh-list
139209779|NCT04203160|Gemcitabine|gemcitabine|mesh-list
139209780|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960195|NCT00571064|Donepezil|donepezil|mesh-list
139209781|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139209782|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
139209783|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209784|NCT04191499|Fulvestrant|fulvestrant|mesh-list
139209785|NCT04191499|Palbociclib|palbociclib|mesh-list
139209786|NCT04191499|Inavolisib|inavolisib|mesh-list
139209787|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139209788|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209789|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139209790|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139209791|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
139209792|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139209793|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209794|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139209795|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209796|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209797|NCT04191499|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139209799|NCT04187898|Docetaxel|docetaxel|mesh-list
139209800|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139209801|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
139209802|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209803|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139209804|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139209805|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
139209806|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209807|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209808|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139209809|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209810|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209811|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209812|NCT04186871|Abatacept|abatacept|mesh-list
139209813|NCT04186871|Branebrutinib|branebrutinib|mesh-list
139209814|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209815|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209816|NCT04186871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209817|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209818|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139209819|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
139209820|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209821|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139209822|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139209823|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209824|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
139209825|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209826|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209827|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209828|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209829|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
139209830|NCT04145349|Vinorelbine|vinorelbine|mesh-list
139209831|NCT04145349|Ramucirumab|ramucirumab|mesh-list
139209832|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139209833|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
139209834|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209835|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139209836|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139209837|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
139209838|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209839|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209840|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139209841|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139209842|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209843|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209844|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209845|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
139209846|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209847|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209848|NCT04140526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209849|NCT04140526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209850|NCT04134923|Corticosterone|corticosterone|mesh-list
139209851|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139209852|NCT04100018|Prednisone|prednisone|mesh-list
139209853|NCT04100018|Docetaxel|docetaxel|mesh-list
138960265|NCT00807690|Tacrolimus|tacrolimus|mesh-list
139209854|NCT04100018|Nivolumab|nivolumab|mesh-list
139209855|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209856|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209857|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209858|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209859|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209860|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139209861|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
139209863|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139209864|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209865|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139209866|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209867|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209868|NCT04097561|Belimumab|belimumab|mesh-list
139209869|NCT04097561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139209870|NCT04097561|Immunologic Factors|immunologic factors|mesh-ancestor
139209871|NCT04097561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209872|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139209873|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209874|NCT04058756|Spartalizumab|spartalizumab|mesh-list
139209875|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209876|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066922|NCT03842020|Amiodarone|amiodarone|mesh-list
139209877|NCT04058756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209878|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209879|NCT04058366|Ivacaftor|ivacaftor|mesh-list
139209880|NCT04058366|Elexacaftor|elexacaftor|mesh-list
139209881|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139209882|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139209883|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209884|NCT04053634|Benralizumab|benralizumab|mesh-list
139209885|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139209886|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
139209897|NCT04030455|Cisplatin|cisplatin|mesh-list
139209898|NCT04030455|Carboplatin|carboplatin|mesh-list
139209899|NCT04030455|Docetaxel|docetaxel|mesh-list
139209900|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
139209901|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209902|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209903|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209904|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209905|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209906|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209907|NCT04030455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209908|NCT04026113|Linaclotide|linaclotide|mesh-list
139209909|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139209910|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
139209911|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209912|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139209913|NCT04022980|Nivolumab|nivolumab|mesh-list
139209914|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209915|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209916|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209917|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209918|NCT04021108|Nivolumab|nivolumab|mesh-list
139209919|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209920|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209921|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139209922|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209923|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
139209924|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209925|NCT03997123|Paclitaxel|paclitaxel|mesh-list
139209926|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139209927|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209928|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209929|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209930|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209931|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209932|NCT03992131|Rucaparib|rucaparib|mesh-list
139209933|NCT03992131|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139209934|NCT03992131|Immunoconjugates|immunoconjugates|mesh-ancestor
139209935|NCT03992131|Immunologic Factors|immunologic factors|mesh-ancestor
139066948|NCT01198210|Dexamethasone|dexamethasone|mesh-list
139209936|NCT03992131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209937|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139209938|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209939|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209940|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209941|NCT03969004|Cemiplimab|cemiplimab|mesh-list
139209942|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209943|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209962|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209963|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139209964|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139209965|NCT03937830|Growth Substances|growth substances|mesh-ancestor
139209966|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209967|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
139209968|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139209969|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139209970|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139209971|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209972|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209973|NCT03903835|Prednisone|prednisone|mesh-list
139209974|NCT03903835|Carboplatin|carboplatin|mesh-list
139209975|NCT03903835|Docetaxel|docetaxel|mesh-list
139209976|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
139209977|NCT03903835|Niraparib|niraparib|mesh-list
139209978|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139209979|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139209980|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209981|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
139209982|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
139209983|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
139209984|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139209985|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139209986|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
139209987|NCT03903835|Hormones|hormones|mesh-ancestor
139209988|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139209989|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139209990|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139209991|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139209992|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139209993|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
139209994|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139209995|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139209996|NCT03881488|Pembrolizumab|pembrolizumab|mesh-list
139209997|NCT03881488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139209998|NCT03881488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139209999|NCT03881488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210000|NCT03881488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210017|NCT03875144|Cisplatin|cisplatin|mesh-list
139210018|NCT03875144|Doxorubicin|doxorubicin|mesh-list
139210020|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210021|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139210022|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139210023|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139210024|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210025|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066976|NCT03843736|Drospirenone|drospirenone|mesh-list
139210026|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139210027|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139210028|NCT03850691|Aldesleukin|aldesleukin|mesh-list
139210029|NCT03850691|Nivolumab|nivolumab|mesh-list
139210030|NCT03850691|Ipilimumab|ipilimumab|mesh-list
139210031|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210032|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210033|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210034|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210035|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139210036|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139210037|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
139210038|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139210039|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139210040|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
139210041|NCT03847857|Coagulants|coagulants|mesh-ancestor
139210042|NCT03840902|Paclitaxel|paclitaxel|mesh-list
139210043|NCT03840902|Etoposide|etoposide|mesh-list
139210044|NCT03840902|Carboplatin|carboplatin|mesh-list
139210045|NCT03840902|Pemetrexed|pemetrexed|mesh-list
139210046|NCT03840902|Durvalumab|durvalumab|mesh-list
139210047|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139210048|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210049|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
139210050|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210051|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
139210053|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139210054|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139210055|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210056|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139210057|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139210058|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210059|NCT03839446|Etoposide|etoposide|mesh-list
139210060|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
139210061|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
139210062|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139210063|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210064|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139210065|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139210066|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210067|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210068|NCT03839446|Analgesics|analgesics|mesh-ancestor
139210069|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
139210070|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210071|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210072|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210073|NCT03839446|Immunotoxins|immunotoxins|mesh-ancestor
139210074|NCT03839446|Immunoconjugates|immunoconjugates|mesh-ancestor
139210075|NCT03839446|Immunologic Factors|immunologic factors|mesh-ancestor
139210076|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
139210077|NCT03820986|Lenvatinib|lenvatinib|mesh-list
139210078|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210079|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960507|NCT05355610|BB 1101|bb 1101|mesh-list
139210080|NCT03820986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210081|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210082|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139210083|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210084|NCT03819088|Zinc|zinc|mesh-list
139210085|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
139210086|NCT03819088|Trace Elements|trace elements|mesh-ancestor
139210087|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
139210088|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210089|NCT03819088|Astringents|astringents|mesh-ancestor
139210090|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
139210091|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139210092|NCT03801902|Durvalumab|durvalumab|mesh-list
139210093|NCT03801902|Antibodies|antibodies|mesh-list
139210094|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
139210095|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139210096|NCT03801902|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139210097|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
139210098|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
139210099|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210100|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210101|NCT03779334|Risdiplam|risdiplam|mesh-list
139210102|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139210103|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210104|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210105|NCT03778957|Bevacizumab|bevacizumab|mesh-list
139210106|NCT03778957|Durvalumab|durvalumab|mesh-list
139210107|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210108|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210109|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139210110|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139210111|NCT03778957|Growth Substances|growth substances|mesh-ancestor
139210112|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210113|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
139210114|NCT03775486|Paclitaxel|paclitaxel|mesh-list
139210115|NCT03775486|Cisplatin|cisplatin|mesh-list
139210116|NCT03775486|Carboplatin|carboplatin|mesh-list
139210117|NCT03775486|Gemcitabine|gemcitabine|mesh-list
139210118|NCT03775486|Pemetrexed|pemetrexed|mesh-list
139210119|NCT03775486|Durvalumab|durvalumab|mesh-list
139210120|NCT03775486|Olaparib|olaparib|mesh-list
139210121|NCT03775486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139210122|NCT03775486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139210123|NCT03775486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210124|NCT03775486|Tubulin Modulators|tubulin modulators|mesh-ancestor
139210125|NCT03775486|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210126|NCT03775486|Mitosis Modulators|mitosis modulators|mesh-ancestor
139210127|NCT03775486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210129|NCT03775486|Antimetabolites|antimetabolites|mesh-ancestor
139210130|NCT03775486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210131|NCT03775486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139210132|NCT03775486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139210133|NCT03775486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210134|NCT03775486|Immunologic Factors|immunologic factors|mesh-ancestor
139210135|NCT03775486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210136|NCT03775486|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139210137|NCT03742102|Paclitaxel|paclitaxel|mesh-list
139210138|NCT03742102|Trastuzumab|trastuzumab|mesh-list
139210139|NCT03742102|Durvalumab|durvalumab|mesh-list
139210140|NCT03742102|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139210141|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139210142|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210143|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
139210144|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210145|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
139067007|NCT04638790|Dexamethasone|dexamethasone|mesh-list
139210146|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210147|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210148|NCT03742102|Immunoconjugates|immunoconjugates|mesh-ancestor
139210149|NCT03742102|Immunologic Factors|immunologic factors|mesh-ancestor
139210150|NCT03742102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210151|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139210152|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210153|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210154|NCT03729609|Immunotoxins|immunotoxins|mesh-ancestor
139210155|NCT03729609|Immunoconjugates|immunoconjugates|mesh-ancestor
138960563|NCT00772616|Analgesics|analgesics|mesh-ancestor
139210156|NCT03729609|Immunologic Factors|immunologic factors|mesh-ancestor
139210157|NCT03729609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210158|NCT03729401|Aspirin|aspirin|mesh-list
139210159|NCT03729401|Clopidogrel|clopidogrel|mesh-list
139210160|NCT03729401|Ticagrelor|ticagrelor|mesh-list
139210161|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139210162|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139210163|NCT03729401|Analgesics|analgesics|mesh-ancestor
139210164|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
139210165|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210166|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210167|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139210168|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139210169|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139210170|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139210171|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210172|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139210173|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139210174|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210175|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
139210176|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139210177|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139210178|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139210179|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
139210180|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139210181|NCT03729011|Propofol|propofol|mesh-list
139210182|NCT03729011|Sevoflurane|sevoflurane|mesh-list
139210183|NCT03729011|Desflurane|desflurane|mesh-list
139210184|NCT03729011|Isoflurane|isoflurane|mesh-list
139210185|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139210186|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139210187|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210188|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139210189|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
139210190|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
139210191|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139210192|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139210193|NCT03724747|BAY 2315497|bay 2315497|mesh-list
139210194|NCT03724747|Immunoconjugates|immunoconjugates|mesh-ancestor
139210195|NCT03724747|Immunologic Factors|immunologic factors|mesh-ancestor
139210196|NCT03724747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210197|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
139210198|NCT03721497|Testosterone|testosterone|mesh-list
139210199|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
139210200|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
139210201|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139210202|NCT03721497|Androgens|androgens|mesh-ancestor
139210245|NCT03675737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210246|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210247|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139210249|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139210250|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
139210251|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210252|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
139210253|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210254|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210255|NCT03666273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210256|NCT03666273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210257|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139210258|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
139210259|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210260|NCT03654053|Simvastatin|simvastatin|mesh-list
139210261|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139210262|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139210263|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
139210264|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210265|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139210266|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139210267|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210268|NCT03651271|Nivolumab|nivolumab|mesh-list
139210269|NCT03651271|Ipilimumab|ipilimumab|mesh-list
139210270|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210271|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210272|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210273|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210274|NCT03635567|Paclitaxel|paclitaxel|mesh-list
139210275|NCT03635567|Bevacizumab|bevacizumab|mesh-list
139210276|NCT03635567|Carboplatin|carboplatin|mesh-list
139210277|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
139210278|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139210279|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210280|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
139210281|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210282|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
139210283|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210284|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210285|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139210286|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139210287|NCT03635567|Growth Substances|growth substances|mesh-ancestor
139210288|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210289|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
139210290|NCT03635567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210292|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210293|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210294|NCT03610711|Nivolumab|nivolumab|mesh-list
139210295|NCT03610711|Relatlimab|relatlimab|mesh-list
139210296|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210297|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210298|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210299|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210300|NCT03606967|Poly I-C|poly i-c|mesh-list
139210301|NCT03606967|Paclitaxel|paclitaxel|mesh-list
139210302|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139210303|NCT03606967|Carboplatin|carboplatin|mesh-list
139210304|NCT03606967|Gemcitabine|gemcitabine|mesh-list
139210305|NCT03606967|Durvalumab|durvalumab|mesh-list
139210306|NCT03606967|Tremelimumab|tremelimumab|mesh-list
138960716|NCT00776672|Fosinopril|fosinopril|mesh-list
139210307|NCT03606967|Ipilimumab|ipilimumab|mesh-list
139210308|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139210309|NCT03606967|Vaccines|vaccines|mesh-list
139210310|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
139210311|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139210312|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
139210313|NCT03606967|Poly ICLC|poly iclc|mesh-list
139210314|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
139210315|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210316|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139210317|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210318|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
139210319|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210320|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
139210321|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210322|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139210323|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
139210324|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210325|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210326|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
139210327|NCT03606967|Laxatives|laxatives|mesh-ancestor
139210328|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139210329|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
139210330|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139210331|NCT03576547|Dexamethasone|dexamethasone|mesh-list
139210332|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
139210333|NCT03576547|Rituximab|rituximab|mesh-list
139210334|NCT03576547|Venetoclax|venetoclax|mesh-list
139210335|NCT03576547|Ponatinib|ponatinib|mesh-list
139210336|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139210337|NCT03576547|Antibodies|antibodies|mesh-list
139210338|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
139210339|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139210340|NCT03576547|BB 1101|bb 1101|mesh-list
138887256|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887257|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887258|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
138887259|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887260|NCT01004809|Dutasteride|dutasteride|mesh-list
138887261|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138887262|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138887263|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887264|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887265|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
138887266|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887267|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887269|NCT00883688|Lapatinib|lapatinib|mesh-list
138887270|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138887272|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138887273|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138887274|NCT00883688|Growth Substances|growth substances|mesh-ancestor
138887275|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887276|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
138887277|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138887278|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887279|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887280|NCT04191863|Valproic Acid|valproic acid|mesh-list
138887281|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
138887282|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887283|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887284|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
138887285|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887286|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887287|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
138887288|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138887289|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887290|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138887291|NCT02636348|Vitamin D|vitamin d|mesh-list
138887292|NCT02636348|Calcium|calcium|mesh-list
138887293|NCT02636348|Vitamins|vitamins|mesh-ancestor
138887294|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
138887295|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887296|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138887297|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139210341|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
139210342|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210343|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138837117|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837118|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837119|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138837120|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138837121|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
138837122|NCT00975611|Amantadine|amantadine|mesh-list
138837123|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139067039|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
138837124|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138837125|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
138837126|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837127|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
138837128|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837129|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837130|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837131|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138837132|NCT00975611|Analgesics|analgesics|mesh-ancestor
138837133|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
138837134|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837135|NCT02865005|Dapsone|dapsone|mesh-list
138837136|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837137|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
138837138|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138837139|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138837140|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138837141|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837142|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837143|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
138837144|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138837145|NCT02862977|Ketoprofen|ketoprofen|mesh-list
138837146|NCT02862977|Amitriptyline|amitriptyline|mesh-list
138837147|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
138837148|NCT02862977|Caffeine|caffeine|mesh-list
138837149|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138837150|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837151|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138837152|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837153|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837154|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138837155|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138837156|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
138837157|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837158|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138837159|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138837160|NCT02862977|Analgesics|analgesics|mesh-ancestor
138837161|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
138837162|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837163|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138837164|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138837165|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138837166|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138837167|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
138837168|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138837169|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138837170|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138837171|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138837172|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138837173|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138837174|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138837175|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138837176|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
138837177|NCT02864927|Vaccines|vaccines|mesh-list
138837178|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
138837179|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837180|NCT02618499|Oxytocin|oxytocin|mesh-list
138837181|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
138837182|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138837183|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837184|NCT04133961|Phenylephrine|phenylephrine|mesh-list
138837185|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
138837186|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138837187|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
138837188|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
138837189|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837190|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837191|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
138837192|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138837193|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
138837194|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
138837195|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138837196|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138837197|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138837198|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
138837199|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837200|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837201|NCT04133961|Protective Agents|protective agents|mesh-ancestor
138837203|NCT02618733|Ticagrelor|ticagrelor|mesh-list
138837204|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138837205|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138837206|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138837207|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138837208|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
138837209|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837210|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837211|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837212|NCT00970307|Vaccines|vaccines|mesh-list
138837213|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138837214|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
138837215|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837216|NCT00917384|Ramucirumab|ramucirumab|mesh-list
138837217|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837218|NCT04133571|Lidocaine|lidocaine|mesh-list
138837219|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
138837220|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
138837221|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138837222|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837223|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
138837224|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837225|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138837226|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138837227|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138837228|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138837229|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837230|NCT00629681|Pregabalin|pregabalin|mesh-list
138837231|NCT00629681|Analgesics|analgesics|mesh-ancestor
138837232|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
138837233|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837234|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837235|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
138837236|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138837237|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138837238|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837239|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138837240|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138837241|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138837242|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138837243|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138837244|NCT04289207|Danazol|danazol|mesh-list
138837245|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138837246|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
138837247|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138837248|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837249|NCT02863835|Albuterol|albuterol|mesh-list
138837250|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138837251|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
138837252|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837253|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837254|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138837255|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
138837256|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
138837257|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138837258|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138837259|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138837260|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138837261|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
138837262|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837263|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837264|NCT00697437|Ketoconazole|ketoconazole|mesh-list
138837265|NCT00697437|Docetaxel|docetaxel|mesh-list
138837266|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837267|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
138837268|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
138837269|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
138837270|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837271|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
138837272|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837273|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138837274|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138837275|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837276|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138837277|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
138837278|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138837279|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837280|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138837282|NCT04252274|Cobicistat|cobicistat|mesh-list
138837283|NCT04252274|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
138837284|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138837285|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138837286|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
138837287|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837288|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837289|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138837290|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138837291|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
138837292|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837293|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138837294|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138837295|NCT00864513|Pemetrexed|pemetrexed|mesh-list
138837296|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837297|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837298|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837299|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138837300|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138837301|NCT04128891|Valsartan|valsartan|mesh-list
139067068|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138837302|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138837303|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138837304|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138837305|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138837306|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837307|NCT04251962|Fentanyl|fentanyl|mesh-list
138837308|NCT04251962|Bupivacaine|bupivacaine|mesh-list
138837309|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
138837310|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
138837311|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138837312|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837313|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
138837314|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837315|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138837316|NCT04251962|Narcotics|narcotics|mesh-ancestor
138837317|NCT04251962|Analgesics|analgesics|mesh-ancestor
138837318|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138837319|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138837320|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
138837321|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
138837322|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138837323|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837324|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138837325|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837326|NCT05251766|Paclitaxel|paclitaxel|mesh-list
138837327|NCT05251766|Docetaxel|docetaxel|mesh-list
138837328|NCT05251766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138837329|NCT05251766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837330|NCT05251766|Tubulin Modulators|tubulin modulators|mesh-ancestor
138837331|NCT05251766|Antimitotic Agents|antimitotic agents|mesh-ancestor
138837332|NCT05251766|Mitosis Modulators|mitosis modulators|mesh-ancestor
138837333|NCT05251766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837334|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
138837335|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138837336|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837337|NCT00631514|Acetaminophen|acetaminophen|mesh-list
138837338|NCT00631514|Ibuprofen|ibuprofen|mesh-list
139210344|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
138837339|NCT00631514|Piroxicam|piroxicam|mesh-list
138837341|NCT00631514|Analgesics|analgesics|mesh-ancestor
138837342|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
138837343|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837344|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837345|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
138837346|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138837347|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138787791|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
138837348|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138837349|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138837350|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837351|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837352|NCT05253014|Acetaminophen|acetaminophen|mesh-list
138837353|NCT05253014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138837354|NCT05253014|Analgesics|analgesics|mesh-ancestor
138837355|NCT05253014|Sensory System Agents|sensory system agents|mesh-ancestor
138837356|NCT05253014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837357|NCT05253014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837358|NCT05253014|Antipyretics|antipyretics|mesh-ancestor
138837359|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
138837360|NCT00659425|Immunotoxins|immunotoxins|mesh-ancestor
138837361|NCT00659425|Immunoconjugates|immunoconjugates|mesh-ancestor
138837362|NCT00659425|Immunologic Factors|immunologic factors|mesh-ancestor
138837363|NCT00659425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837364|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837365|NCT00656851|Pioglitazone|pioglitazone|mesh-list
138837366|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138837367|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837368|NCT00803335|Estrogens|estrogens|mesh-list
138837369|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138837370|NCT00803335|Hormones|hormones|mesh-ancestor
139067088|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837371|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138837372|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837373|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
138837374|NCT00656617|Cytarabine|cytarabine|mesh-list
138837375|NCT00656617|Vorinostat|vorinostat|mesh-list
138837376|NCT00656617|Idarubicin|idarubicin|mesh-list
138837377|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138837378|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
138837379|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837380|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837381|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
138837382|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837383|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138837384|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
138837385|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837386|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138837387|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837388|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138837389|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138837390|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138837391|NCT00798343|Vaccines|vaccines|mesh-list
138837392|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
138837393|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837394|NCT00803725|Fentanyl|fentanyl|mesh-list
138837395|NCT00803725|Mepivacaine|mepivacaine|mesh-list
138837396|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138837397|NCT00803725|Narcotics|narcotics|mesh-ancestor
138837398|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138837399|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837400|NCT00803725|Analgesics|analgesics|mesh-ancestor
138837401|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
138837402|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837403|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138837404|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138837405|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
138837406|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
138837407|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
138837408|NCT00803803|Pilocarpine|pilocarpine|mesh-list
138837409|NCT00803803|Miotics|miotics|mesh-ancestor
138837410|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
138837411|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837412|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837413|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138837414|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138837415|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
138837416|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837417|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837419|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138837420|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837421|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138837422|NCT00659269|Vitamins|vitamins|mesh-list
138837423|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
138837424|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
138837425|NCT00659269|Pyridoxal|pyridoxal|mesh-list
138837426|NCT00659269|Pyridoxine|pyridoxine|mesh-list
138837427|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
138837428|NCT00659269|Vincristine|vincristine|mesh-list
138837429|NCT00659269|Vinorelbine|vinorelbine|mesh-list
138837430|NCT00659269|Docetaxel|docetaxel|mesh-list
138837431|NCT00659269|Cisplatin|cisplatin|mesh-list
138837432|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
138837433|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138837434|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837435|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
138837436|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
138837437|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
138837438|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837439|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
138837440|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837441|NCT00922129|Cyclosporine|cyclosporine|mesh-list
138837442|NCT00922129|Sirolimus|sirolimus|mesh-list
138837443|NCT00922129|Temsirolimus|temsirolimus|mesh-list
138837444|NCT00922129|MTOR Inhibitors|mtor inhibitors|mesh-list
138837445|NCT00922129|Tacrolimus|tacrolimus|mesh-list
138837446|NCT00922129|Cyclosporins|cyclosporins|mesh-list
138837447|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138837448|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
138837449|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837450|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138837451|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837452|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837453|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
138837454|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837455|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
138837456|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138837457|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138837458|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138837459|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837460|NCT00922129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138837461|NCT00806299|Loperamide|loperamide|mesh-list
138837462|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
138837463|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138837464|NCT00804115|Timolol|timolol|mesh-list
138837465|NCT00804115|Latanoprost|latanoprost|mesh-list
138837466|NCT00804115|Pilocarpine|pilocarpine|mesh-list
138837467|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138837468|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138837469|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
138837470|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837471|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837472|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837473|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138837474|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138837475|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138837476|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138837477|NCT00804115|Miotics|miotics|mesh-ancestor
138837478|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
138837479|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837480|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138837481|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138837482|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
138837483|NCT02554123|Vitamin E|vitamin e|mesh-list
138837484|NCT02554123|Petrolatum|petrolatum|mesh-list
138837485|NCT02554123|Vitamins|vitamins|mesh-ancestor
138837486|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
138837487|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837488|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
138837489|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837490|NCT02554123|Protective Agents|protective agents|mesh-ancestor
139210345|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
138837491|NCT02554123|Emollients|emollients|mesh-ancestor
138837492|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
138837493|NCT00799045|Clopidogrel|clopidogrel|mesh-list
138837494|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138837495|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138837496|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138837498|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
138837499|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837500|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837501|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837502|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
138837503|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138837504|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837505|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138837506|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
138837507|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138837508|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837509|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837510|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837511|NCT00804271|Memantine|memantine|mesh-list
138837512|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138837513|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138837514|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
138837515|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837516|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837517|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837518|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138837519|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138837520|NCT00799201|Naloxone|naloxone|mesh-list
138837521|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138837522|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837523|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
138837524|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837525|NCT00806611|Ethanol|ethanol|mesh-list
138837526|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138837527|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837528|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138837529|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837530|NCT00799513|Lenalidomide|lenalidomide|mesh-list
138837531|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
138837532|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837533|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138837534|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138837535|NCT00799513|Growth Substances|growth substances|mesh-ancestor
138837536|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
138837537|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837538|NCT00806767|Fludarabine|fludarabine|mesh-list
138837539|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
138837541|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
138837542|NCT00806767|Antibodies|antibodies|mesh-list
138837543|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
138837544|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138837545|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138837546|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837547|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138837548|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
138837549|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837550|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138837551|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
138837552|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837553|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
138837554|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138837555|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138837556|NCT00863655|Everolimus|everolimus|mesh-list
138837557|NCT00863655|Exemestane|exemestane|mesh-list
138837558|NCT00863655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139067119|NCT01198912|Doxycycline|doxycycline|mesh-list
138837559|NCT00863655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138837560|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837561|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837562|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138837563|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
138837564|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837565|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837566|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138837567|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138837568|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138837569|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
138489588|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
138837570|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138837571|NCT00806923|Bevacizumab|bevacizumab|mesh-list
138837572|NCT00806923|Gemcitabine|gemcitabine|mesh-list
138837573|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138837574|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837575|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138837576|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138837577|NCT00806923|Growth Substances|growth substances|mesh-ancestor
138837578|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837579|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
138837580|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138837581|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
138837582|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837583|NCT00698607|Sirolimus|sirolimus|mesh-list
138837584|NCT00698607|Everolimus|everolimus|mesh-list
138837585|NCT00698607|Clopidogrel|clopidogrel|mesh-list
138837586|NCT00698607|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138837587|NCT00698607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138837588|NCT00698607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837589|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837590|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138837591|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
138837592|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837593|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837594|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138837595|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138837596|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138837597|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138837598|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
138837599|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837600|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138837601|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837602|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138837603|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
138837610|NCT04123041|Nicotine|nicotine|mesh-list
138837611|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138837612|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
138837613|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837614|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837615|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138837616|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138837617|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
138837618|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837619|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837621|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138837622|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
138837623|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138837624|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138837625|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837626|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837627|NCT00698763|Protective Agents|protective agents|mesh-ancestor
138837628|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837629|NCT00804895|Cortivazol|cortivazol|mesh-list
138837630|NCT00804895|Verapamil|verapamil|mesh-list
138837631|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138837632|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138837633|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138837634|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837635|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138837636|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837637|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
138837638|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138837639|NCT00800137|Heparin|heparin|mesh-list
138837640|NCT00800137|Calcium heparin|calcium heparin|mesh-list
138837641|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138837642|NCT00800137|Tinzaparin|tinzaparin|mesh-list
138837643|NCT00800137|Dalteparin|dalteparin|mesh-list
138837644|NCT00800137|Warfarin|warfarin|mesh-list
138837645|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
138837646|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138837647|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138837648|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837649|NCT00807079|Carboplatin|carboplatin|mesh-list
138837650|NCT00807079|Topotecan|topotecan|mesh-list
138837652|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138837653|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138837654|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837655|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837656|NCT00800293|Betamethasone|betamethasone|mesh-list
138837657|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
138837658|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138837659|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
138837660|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138837661|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138837662|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
138837663|NCT00800293|Hormones|hormones|mesh-ancestor
138837664|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138837665|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837666|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138837667|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
138837668|NCT00658021|Exenatide|exenatide|mesh-list
138837669|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138837670|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837671|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138837672|NCT00658021|Incretins|incretins|mesh-ancestor
138837673|NCT00658021|Hormones|hormones|mesh-ancestor
138837674|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138837675|NCT00920816|Sorafenib|sorafenib|mesh-list
138837676|NCT00920816|Axitinib|axitinib|mesh-list
138837677|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837678|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138837679|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837680|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837681|NCT00631592|Dolutegravir|dolutegravir|mesh-list
138837682|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138837683|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138837684|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837685|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837686|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139067163|NCT01202734|Methylphenidate|methylphenidate|mesh-list
138837687|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138837688|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
138837689|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837690|NCT05251610|Propranolol|propranolol|mesh-list
138837691|NCT05251610|Oxytocin|oxytocin|mesh-list
138837692|NCT05251610|Oxytocics|oxytocics|mesh-ancestor
138837693|NCT05251610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138837694|NCT05251610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942528|NCT00821535|Maraviroc|maraviroc|mesh-list
138837695|NCT05251610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138837696|NCT05251610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138837697|NCT05251610|Adrenergic Agents|adrenergic agents|mesh-ancestor
138837698|NCT05251610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837699|NCT05251610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837700|NCT05251610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138837701|NCT05251610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138837702|NCT05251610|Vasodilator Agents|vasodilator agents|mesh-ancestor
138837703|NCT00657709|Vaccines|vaccines|mesh-list
138837704|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138837705|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
138837706|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837707|NCT00657553|Bortezomib|bortezomib|mesh-list
138837708|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837709|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
138837710|NCT04253912|Povidone|povidone|mesh-list
138837711|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
138837712|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
138837713|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138837714|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837715|NCT00800527|Diclofenac|diclofenac|mesh-list
138837716|NCT00800527|Gabapentin|gabapentin|mesh-list
138837717|NCT00800527|Analgesics|analgesics|mesh-ancestor
138837718|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
138837719|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837720|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837721|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
138837722|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138837723|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138837724|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138837725|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138837726|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138837727|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138837728|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837729|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837730|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
138837731|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138837732|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138837733|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138837734|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138837735|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138837736|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837737|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138837738|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138837739|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837740|NCT00862719|Incretins|incretins|mesh-ancestor
138837742|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138837743|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138837744|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
138837745|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837746|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837747|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
138837748|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837749|NCT00862641|Regadenoson|regadenoson|mesh-list
138837750|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138837751|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138837752|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
139067172|NCT02966314|Omalizumab|omalizumab|mesh-list
138837753|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
138837754|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837755|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837756|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837758|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138837759|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
138837760|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138837761|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138837762|NCT04119921|Analgesics|analgesics|mesh-ancestor
138837763|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
138837764|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837765|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837766|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138837767|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138837768|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138837769|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837770|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837771|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138837772|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138837773|NCT00861471|Docetaxel|docetaxel|mesh-list
138837774|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
138837775|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837776|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
138837777|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
138837778|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
138837779|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837780|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138837781|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837782|NCT02613585|Permethrin|permethrin|mesh-list
138837783|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837784|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837785|NCT04119297|Heparinoids|heparinoids|mesh-list
138837786|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138837787|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
138837788|NCT00699387|Benzonidazole|benzonidazole|mesh-list
138837789|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138837790|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
138837791|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837792|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138837793|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138837794|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138837795|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837796|NCT00699465|Enoxaparin|enoxaparin|mesh-list
138837797|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
138837798|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
138837799|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138837800|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138837801|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837802|NCT00858117|Rituximab|rituximab|mesh-list
138837803|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
138837804|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138837805|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837806|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
138837807|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837808|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138837809|NCT00700947|Metoprolol|metoprolol|mesh-list
138837810|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138837811|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138837812|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
138837813|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837814|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067176|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138837815|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837816|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138837817|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138837818|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
138837819|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
138837820|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837821|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138837822|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138837823|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
138837824|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837825|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
138837826|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837827|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
138837828|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
138837829|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
138837830|NCT00805519|Chloroquine|chloroquine|mesh-list
138837831|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138837832|NCT00805519|Prednisolone|prednisolone|mesh-list
138837833|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138837834|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
138837835|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138837836|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
138837837|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138837838|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
138837839|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138837840|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
138837841|NCT00805519|Hormones|hormones|mesh-ancestor
138837842|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138837843|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837844|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138837845|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837847|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
138837848|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837849|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138837850|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138837851|NCT00805519|Protective Agents|protective agents|mesh-ancestor
138837852|NCT00805519|Amebicides|amebicides|mesh-ancestor
138837853|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138837854|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138837855|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837856|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
138837857|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138837858|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138837859|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138837860|NCT00805519|Analgesics|analgesics|mesh-ancestor
138837861|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
138837862|NCT00805519|Filaricides|filaricides|mesh-ancestor
138837863|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
138837864|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
138837865|NCT00592683|Aripiprazole|aripiprazole|mesh-list
138837866|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
138837867|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138837868|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138837869|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138837870|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138489884|NCT01630213|Vitamin D|vitamin d|mesh-list
138837872|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
138837873|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
138837874|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887298|NCT04219865|Edaravone|edaravone|mesh-list
138837875|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837876|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138837877|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138837878|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
138837879|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138837880|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138837881|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138837882|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138837883|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
138837884|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
138837885|NCT02613039|Estrogens|estrogens|mesh-list
138837886|NCT02613039|Progestins|progestins|mesh-list
138837887|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138837888|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837889|NCT02613039|Hormones|hormones|mesh-ancestor
138837890|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138837891|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138837892|NCT00813475|Insulin|insulin|mesh-list
138837893|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138837894|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138837895|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837896|NCT00701259|Lansoprazole|lansoprazole|mesh-list
138837897|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
138837898|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138837899|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138837900|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138837901|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837902|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837903|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138837904|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138837905|NCT00701337|Estradiol|estradiol|mesh-list
138837906|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138837907|NCT00701337|Estrogens|estrogens|mesh-ancestor
138837908|NCT00701337|Hormones|hormones|mesh-ancestor
138837909|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138837910|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837911|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138837912|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
138837913|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138837914|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138837915|NCT00654901|Vaccines|vaccines|mesh-list
138837916|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
138837917|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837918|NCT00701493|Topiramate|topiramate|mesh-list
138837919|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
138837920|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138837921|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837923|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
138837924|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138837925|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138837926|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138837927|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138837928|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837929|NCT04253678|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138837930|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138837931|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138837932|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837933|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837934|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
138837935|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138837936|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138837937|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138837938|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138837939|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138837940|NCT00813631|Laxatives|laxatives|mesh-ancestor
138837941|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138837942|NCT02551861|Ribavirin|ribavirin|mesh-list
138837943|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
138837944|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
138837945|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837946|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
138837947|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837948|NCT00846495|Topiramate|topiramate|mesh-list
138837949|NCT00846495|Frovatriptan|frovatriptan|mesh-list
138837950|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
138837951|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138837952|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837953|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138837954|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
138837955|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837956|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837957|NCT00654745|Amlodipine|amlodipine|mesh-list
138837958|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138837959|NCT00654745|Olmesartan|olmesartan|mesh-list
138837960|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138837961|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138837962|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138837963|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138837964|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837965|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138837966|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837967|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
138837968|NCT00654745|Diuretics|diuretics|mesh-ancestor
138837969|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
138837970|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138837971|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138837972|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138837973|NCT00809887|Micafungin|micafungin|mesh-list
138837974|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
138837975|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837976|NCT00846027|Paclitaxel|paclitaxel|mesh-list
138837977|NCT00846027|Bevacizumab|bevacizumab|mesh-list
138837978|NCT00846027|Gemcitabine|gemcitabine|mesh-list
138837979|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138837980|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837981|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
138837982|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
138837983|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
138837984|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837985|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138837986|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138837987|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138837988|NCT00846027|Growth Substances|growth substances|mesh-ancestor
138837989|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837990|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
138837991|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138837992|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
138837994|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138837995|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
138837996|NCT00807625|Trace Elements|trace elements|mesh-ancestor
138837997|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
138837998|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837999|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138838000|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
138838001|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138838002|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138838003|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138838004|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138838005|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838006|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138838007|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138838008|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138838009|NCT02551549|Rezafungin|rezafungin|mesh-list
138838010|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
138838011|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138838012|NCT00810121|Ketoprofen|ketoprofen|mesh-list
138838013|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138838014|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138838015|NCT00810121|Analgesics|analgesics|mesh-ancestor
138838016|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
138838017|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838018|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838019|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138838020|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138838021|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138838022|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838023|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838024|NCT00652327|Atorvastatin|atorvastatin|mesh-list
138838025|NCT00652327|Simvastatin|simvastatin|mesh-list
138838027|NCT00652327|Pravastatin|pravastatin|mesh-list
138838028|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138838029|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138838030|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138838031|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
138838032|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838033|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138838034|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838035|NCT00814021|Sunitinib|sunitinib|mesh-list
138838036|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838037|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138838038|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138838039|NCT00814021|Growth Substances|growth substances|mesh-ancestor
138838040|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838041|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
138838042|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138838043|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838044|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838045|NCT00645853|Warfarin|warfarin|mesh-list
138838046|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
138838047|NCT00652093|Acetaminophen|acetaminophen|mesh-list
138838048|NCT00652093|Oxymorphone|oxymorphone|mesh-list
138838049|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
138838050|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
138838051|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
138838052|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138838053|NCT00652093|Analgesics|analgesics|mesh-ancestor
138838054|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
138838055|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838056|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838057|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
138838058|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138838059|NCT00652093|Narcotics|narcotics|mesh-ancestor
138838060|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838061|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138838062|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
138838063|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
138838064|NCT00651937|Melphalan|melphalan|mesh-list
138838065|NCT00651937|Lenograstim|lenograstim|mesh-list
138838066|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138838067|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
138838068|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838069|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838070|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138838071|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138838073|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838074|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138838075|NCT00654355|Tacrolimus|tacrolimus|mesh-list
138838076|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138838077|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
138838078|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838079|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138838080|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838081|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838082|NCT00651313|Lidocaine|lidocaine|mesh-list
138838083|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
138838084|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
138838085|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838086|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838087|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
138838088|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838089|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138838090|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138838091|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138838092|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838093|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838094|NCT00808171|Lidocaine|lidocaine|mesh-list
138838095|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
138838096|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
138838097|NCT00808171|Prilocaine|prilocaine|mesh-list
139210346|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838098|NCT00808171|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138838100|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838101|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838102|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
138838103|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838104|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138838105|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138838106|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138838107|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838108|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838109|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138838110|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
138838111|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138838112|NCT00808171|Analgesics|analgesics|mesh-ancestor
138838113|NCT00808171|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138838114|NCT04703257|Dipyrone|dipyrone|mesh-list
138838115|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138838116|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138838117|NCT04703257|Analgesics|analgesics|mesh-ancestor
138838118|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
138838119|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838120|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838121|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138838122|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138838123|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
138838124|NCT00808327|Fentanyl|fentanyl|mesh-list
138838125|NCT00808327|Bupivacaine|bupivacaine|mesh-list
138838126|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
138838127|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
138838128|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838129|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838130|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
138838131|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838132|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138838133|NCT00808327|Narcotics|narcotics|mesh-ancestor
138838134|NCT00808327|Analgesics|analgesics|mesh-ancestor
138838135|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138838136|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138838137|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
138838138|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138838139|NCT00814723|Ezetimibe|ezetimibe|mesh-list
138838140|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138838141|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138838142|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
139154220|NCT00075881|Bortezomib|bortezomib|mesh-list
138838143|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838144|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138838146|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138838147|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
138838148|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
138838149|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838150|NCT02864849|Capecitabine|capecitabine|mesh-list
138838151|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
138838152|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138838153|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
138838154|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838155|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838156|NCT00701961|Artesunate|artesunate|mesh-list
138838157|NCT00701961|Mefloquine|mefloquine|mesh-list
138838158|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
138838159|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138838160|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138838161|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138838162|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838163|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
138838164|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
138838165|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138817864|NCT00782626|Everolimus|everolimus|mesh-list
138838166|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
138838167|NCT04286711|Paclitaxel|paclitaxel|mesh-list
138838168|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138838169|NCT04286711|Apatinib|apatinib|mesh-list
138838170|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138838171|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838172|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
138838173|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
138838174|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257737|NCT04005079|Ofloxacin|ofloxacin|mesh-list
138838175|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838176|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138838177|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838178|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
138838180|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138838181|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
138838182|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838183|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138838184|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138838185|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
138838186|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838187|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838188|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138838189|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138838191|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
138838192|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838193|NCT02612649|Ramosetron|ramosetron|mesh-list
138838194|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
138838195|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
138838196|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838197|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838198|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138838199|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138838200|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
138838201|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838202|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838203|NCT00844857|Olanzapine|olanzapine|mesh-list
138838204|NCT00844857|Fluoxetine|fluoxetine|mesh-list
138838205|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
138838206|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
138838207|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838208|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838209|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138838210|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138838211|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138838212|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838213|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138838214|NCT00844857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138838215|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138838216|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838217|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838218|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838219|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
138838220|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138838221|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
138838222|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138838223|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138838224|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838225|NCT00702117|Flecainide|flecainide|mesh-list
138838226|NCT00702117|Procainamide|procainamide|mesh-list
138838227|NCT00702117|Ajmaline|ajmaline|mesh-list
138838228|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138838229|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138838230|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138838231|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838232|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838233|NCT00913107|Lamotrigine|lamotrigine|mesh-list
138838234|NCT00913107|Carbamazepine|carbamazepine|mesh-list
138838235|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
138838236|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138838237|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838238|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838239|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138838240|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838241|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138838242|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138838243|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838244|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138838245|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138838246|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
138838247|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138838248|NCT00913107|Analgesics|analgesics|mesh-ancestor
138838249|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
138838250|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838251|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138838252|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138838253|NCT00569803|Abatacept|abatacept|mesh-list
138838254|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138838255|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838256|NCT00569803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138838257|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838258|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138838259|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
138838260|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838261|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138838262|NCT00920426|Cabotegravir|cabotegravir|mesh-list
138838263|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138838264|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138838265|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838266|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838267|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138838268|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138838269|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
138838270|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138838271|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138838272|NCT04046185|Progesterone|progesterone|mesh-list
138838273|NCT04046185|Progestins|progestins|mesh-ancestor
138838274|NCT04046185|Hormones|hormones|mesh-ancestor
138838275|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138838276|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838277|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838278|NCT04046185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138838279|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838280|NCT00810589|Insulin|insulin|mesh-list
138838281|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138838282|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
138838283|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
138838284|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138838285|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838286|NCT00810667|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
138838287|NCT00810667|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138838288|NCT00810667|Serotonin Agents|serotonin agents|mesh-ancestor
138838289|NCT00810667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838290|NCT00810667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838291|NCT00810667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838292|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
138838293|NCT04253132|Analgesics|analgesics|mesh-ancestor
138838294|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
139067298|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
138838295|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838296|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838297|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138838298|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138838299|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138838300|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138838301|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138838302|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838303|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838304|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138838305|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
138838306|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
138838307|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138838308|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138838309|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
138838310|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838311|NCT00914966|Complement C1s|complement c1s|mesh-list
138838312|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138838313|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138838314|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
138838315|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838316|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138838317|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138838318|NCT00815269|Sevoflurane|sevoflurane|mesh-list
138838320|NCT00815269|Isoflurane|isoflurane|mesh-list
138838321|NCT00815269|Halothane|halothane|mesh-list
138838322|NCT00815269|Enflurane|enflurane|mesh-list
138838323|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139210347|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138838324|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138838325|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
138838326|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
138838327|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838328|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838329|NCT00914810|Vitamin D|vitamin d|mesh-list
138838330|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
138838331|NCT00914810|Vitamins|vitamins|mesh-ancestor
138838332|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
138838333|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838334|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138838335|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138838336|NCT00808717|Atorvastatin|atorvastatin|mesh-list
138838337|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138838338|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138838339|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
138838340|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838341|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138838342|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138838343|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838344|NCT00914732|Vaccines|vaccines|mesh-list
138838345|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
138838346|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838347|NCT00844545|Eculizumab|eculizumab|mesh-list
138838348|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138838349|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138838350|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
138838351|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838352|NCT00815503|Ropivacaine|ropivacaine|mesh-list
138838353|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
138838354|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
138838355|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838356|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838357|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
138838358|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838359|NCT00702819|Bevacizumab|bevacizumab|mesh-list
138838360|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138838361|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838362|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138838363|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138838364|NCT00702819|Growth Substances|growth substances|mesh-ancestor
138838365|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838366|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
138838367|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138838368|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
138838369|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
138838370|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838371|NCT00842985|Dronabinol|dronabinol|mesh-list
138838372|NCT00842985|Modafinil|modafinil|mesh-list
138838373|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138838374|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838375|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138838376|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138838377|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138838378|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838379|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
138838380|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138838381|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138838382|NCT00842985|Analgesics|analgesics|mesh-ancestor
138838383|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
138838384|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838385|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138838386|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138838387|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838388|NCT00842985|Hormones|hormones|mesh-ancestor
138838389|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138838390|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
138838391|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138838392|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
138838393|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138838394|NCT00808795|Expectorants|expectorants|mesh-ancestor
138838395|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
138838396|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138838397|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
138838398|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838399|NCT00808795|Protective Agents|protective agents|mesh-ancestor
138838400|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838401|NCT00808795|Antidotes|antidotes|mesh-ancestor
138838402|NCT00808951|Artesunate|artesunate|mesh-list
138838403|NCT00808951|Lumefantrine|lumefantrine|mesh-list
138838404|NCT00808951|Artemether|artemether|mesh-list
138838405|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138838406|NCT00808951|Amodiaquine|amodiaquine|mesh-list
138838407|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
138838408|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138838409|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138838410|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138838411|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838412|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
138838413|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
138838414|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138838415|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
138838416|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
138838417|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138838418|NCT00809029|Incretins|incretins|mesh-ancestor
138838419|NCT00809029|Hormones|hormones|mesh-ancestor
138838420|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138838421|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838422|NCT00842829|Fentanyl|fentanyl|mesh-list
138838423|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138838424|NCT00842829|Narcotics|narcotics|mesh-ancestor
138838425|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838426|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838427|NCT00842829|Analgesics|analgesics|mesh-ancestor
138838428|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
138838429|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838430|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138838431|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138838432|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
138838433|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
138838434|NCT04045093|Warfarin|warfarin|mesh-list
138838435|NCT04045093|Dabigatran|dabigatran|mesh-list
138838436|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
138838437|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
138838438|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138838439|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
138838440|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838441|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838442|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
138838443|NCT00811291|Folic Acid|folic acid|mesh-list
138838444|NCT00811291|Calcium|calcium|mesh-list
138838445|NCT00811291|Vitamins|vitamins|mesh-ancestor
138838446|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
138838447|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838448|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138838449|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138838450|NCT00811291|Hematinics|hematinics|mesh-ancestor
138838451|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
138838452|NCT00811369|Fulvestrant|fulvestrant|mesh-list
138838453|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138838454|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838455|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138838456|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138838457|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
138838458|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138838459|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838460|NCT00842361|Insulin|insulin|mesh-list
138838461|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138838462|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
138838463|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
138838464|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138838465|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
138787801|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838466|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138838467|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138838468|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838469|NCT00811447|Docetaxel|docetaxel|mesh-list
138838470|NCT00811447|Fluorouracil|fluorouracil|mesh-list
138838472|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
138838473|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
138838474|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
138838475|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838476|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
138838477|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138838478|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138838479|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
138838480|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838481|NCT00702975|Paclitaxel|paclitaxel|mesh-list
138838482|NCT00702975|Bevacizumab|bevacizumab|mesh-list
138838483|NCT00702975|Carboplatin|carboplatin|mesh-list
138838484|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138838485|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138838486|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838487|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
138838488|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
138838489|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
138838490|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067334|NCT01297192|Mirabegron|mirabegron|mesh-list
138838491|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138838492|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138838493|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138838494|NCT00702975|Growth Substances|growth substances|mesh-ancestor
138838495|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838496|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
138838497|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138838498|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838499|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138838500|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138838501|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838502|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
138838503|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138838504|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838505|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838506|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138838507|NCT02612181|Analgesics|analgesics|mesh-ancestor
138838508|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
138838509|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838510|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138838511|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138838512|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138838513|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
138838514|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838515|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838516|NCT02612259|Tryptophan|tryptophan|mesh-list
138838517|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138838518|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
138838519|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138838520|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138838521|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838522|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138838523|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838524|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838525|NCT00642811|Aspirin|aspirin|mesh-list
138838526|NCT00642811|Clopidogrel|clopidogrel|mesh-list
138838527|NCT00642811|Ticagrelor|ticagrelor|mesh-list
138838528|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138838529|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138838530|NCT00642811|Analgesics|analgesics|mesh-ancestor
138838531|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
138838532|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838533|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838534|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138838535|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138838536|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138838537|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138838538|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581739|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
138838539|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138838540|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138838541|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490566|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138838543|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138838544|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138838545|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138838546|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
138838547|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838548|NCT00838929|Vorinostat|vorinostat|mesh-list
138838549|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067346|NCT01205074|Ethanol|ethanol|mesh-list
138838550|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138838551|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838552|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838553|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138838554|NCT00811603|Cefazolin|cefazolin|mesh-list
138838555|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138838556|NCT00811681|Pioglitazone|pioglitazone|mesh-list
138838557|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138838558|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838559|NCT00811759|Temozolomide|temozolomide|mesh-list
138838560|NCT00811759|Sorafenib|sorafenib|mesh-list
138838561|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138838562|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
138838563|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838564|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838565|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138838566|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838567|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
138838568|NCT00815893|Propofol|propofol|mesh-list
138838569|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138838570|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838571|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838572|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138838573|NCT00815893|Analgesics|analgesics|mesh-ancestor
138838574|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
138838575|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838576|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138838577|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138838578|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138838579|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
138838580|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838581|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838582|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138838583|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
138838584|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
138838585|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
138838586|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
138838587|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838588|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138838589|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838590|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138838591|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
138838592|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838593|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138838594|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838595|NCT04648891|Lidocaine|lidocaine|mesh-list
138838596|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
138838597|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
138838598|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838599|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838600|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
138838601|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838602|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138838603|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138838604|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138838605|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838606|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838607|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
138838608|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138838609|NCT00811837|Midazolam|midazolam|mesh-list
138838610|NCT00811837|Remifentanil|remifentanil|mesh-list
138838611|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138838612|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138838613|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838614|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838615|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138490646|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
138838616|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138838617|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138838618|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138838619|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
138838620|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
138838621|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
138838622|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
138838623|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838624|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838625|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138838626|NCT00811837|Narcotics|narcotics|mesh-ancestor
138838627|NCT00811837|Analgesics|analgesics|mesh-ancestor
138838628|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
138838629|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838631|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138838632|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138838633|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138838634|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838635|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
138838636|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138838637|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
138838638|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838639|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138838640|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
138838641|NCT00816127|Coagulants|coagulants|mesh-ancestor
138838642|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138838643|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
138838644|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838645|NCT00916058|Melphalan|melphalan|mesh-list
138838646|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138838647|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138838648|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
138838649|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838650|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838651|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138838652|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138838653|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
138838654|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838655|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
138838656|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
138838657|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
138838658|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838659|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838660|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
138838661|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838662|NCT00912782|Vitamin D|vitamin d|mesh-list
138838663|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
138838664|NCT00912782|Vitamins|vitamins|mesh-ancestor
138838665|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
138838666|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838667|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138838668|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138838669|NCT04202978|Capecitabine|capecitabine|mesh-list
138838670|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
138838671|NCT04202978|Apatinib|apatinib|mesh-list
138838672|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139067361|NCT03722524|Perindopril|perindopril|mesh-list
138838673|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
138838674|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838675|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838676|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138838677|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838678|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
138838679|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138838680|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138838681|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138838682|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838683|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838684|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
138838685|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838686|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838687|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138838688|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838690|NCT04203368|Verapamil|verapamil|mesh-list
138838691|NCT04203368|Analgesics|analgesics|mesh-ancestor
138838692|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
138838693|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838694|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838695|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138838696|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
139210348|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
138838697|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138838698|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
138838699|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
138838700|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838701|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838702|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138838703|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838704|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138838705|NCT00911534|Rabeprazole|rabeprazole|mesh-list
138838706|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138838707|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138838708|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138838709|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838710|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838711|NCT00911300|Vitamin K|vitamin k|mesh-list
138838712|NCT00911300|Heparin|heparin|mesh-list
138838713|NCT00911300|Calcium heparin|calcium heparin|mesh-list
138838714|NCT00911300|PENTA|penta|mesh-list
138838715|NCT00911300|Fondaparinux|fondaparinux|mesh-list
138838716|NCT00911300|Vitamins|vitamins|mesh-ancestor
138838717|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
138838718|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838719|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
138838720|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138838721|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138838722|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838723|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138838724|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
138838725|NCT00911300|Coagulants|coagulants|mesh-ancestor
138838726|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138838727|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
138838728|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138838729|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
138838730|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838731|NCT00911144|Vaccines|vaccines|mesh-list
138838732|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138838733|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
138838734|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838735|NCT04395248|Anesthetics|anesthetics|mesh-list
138838736|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838737|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838738|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
138838739|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138838740|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838741|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838742|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138838743|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838744|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138838745|NCT04276298|Metronidazole|metronidazole|mesh-list
138838746|NCT04276298|Lidocaine|lidocaine|mesh-list
138838747|NCT04276298|Diltiazem|diltiazem|mesh-list
138838748|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
138838749|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
138838750|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838751|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838752|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
138838753|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838754|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138838755|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138838756|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138838757|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838758|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838759|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138838760|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138838761|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138838762|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138838763|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138838764|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138838765|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138490785|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138838766|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
138838767|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
138838768|NCT04273880|Methylphenidate|methylphenidate|mesh-list
138838770|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
139210349|NCT03576547|Hormones|hormones|mesh-ancestor
138838771|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838773|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838774|NCT04273880|Protective Agents|protective agents|mesh-ancestor
138838775|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138838776|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138838777|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138838778|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838779|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
138838780|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838781|NCT00910988|Olanzapine|olanzapine|mesh-list
138838782|NCT00910988|Ziprasidone|ziprasidone|mesh-list
138838783|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
138838784|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
138838785|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838786|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838787|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138838788|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138838789|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138838790|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138838791|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138838792|NCT00910988|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138838793|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138838794|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838795|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838796|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838797|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
138838798|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138838799|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138838800|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
138838801|NCT00644059|Vaccines|vaccines|mesh-list
138838802|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
138838803|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838804|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
138838805|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138838806|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838807|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138838808|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
138838809|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138838810|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138838811|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838812|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838813|NCT00811993|Etoposide|etoposide|mesh-list
138838814|NCT00811993|Docetaxel|docetaxel|mesh-list
138838815|NCT00811993|Bevacizumab|bevacizumab|mesh-list
138838816|NCT00811993|Carboplatin|carboplatin|mesh-list
138838817|NCT00811993|Gemcitabine|gemcitabine|mesh-list
138838818|NCT00811993|Capecitabine|capecitabine|mesh-list
138838819|NCT00811993|Trastuzumab|trastuzumab|mesh-list
138838820|NCT00811993|Irinotecan|irinotecan|mesh-list
138838821|NCT00811993|Cetuximab|cetuximab|mesh-list
138838822|NCT00811993|Temozolomide|temozolomide|mesh-list
138838823|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138838824|NCT00811993|Sorafenib|sorafenib|mesh-list
138838825|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138838826|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838827|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
138838828|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
138838829|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
138838830|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838831|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138838832|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138838833|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138838834|NCT00811993|Growth Substances|growth substances|mesh-ancestor
138838836|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
138838837|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138838838|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
138838839|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138838840|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138838841|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838842|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138838843|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138838844|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
138838845|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138838846|NCT00817765|Ritonavir|ritonavir|mesh-list
138838847|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
138838849|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138838850|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138838851|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
138838852|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838853|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838854|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138838855|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138838856|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
138838857|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138838858|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138838859|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138838860|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
138838861|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138838862|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138838863|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138838864|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138838865|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138838866|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
138838867|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138838868|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838869|NCT00816205|Nifedipine|nifedipine|mesh-list
138838870|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138838871|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838872|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838873|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138838874|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838875|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
138838876|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
138838877|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138838878|NCT00816283|Dasatinib|dasatinib|mesh-list
138838879|NCT00816283|Vorinostat|vorinostat|mesh-list
138838880|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838881|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138838882|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838883|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838884|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138838885|NCT00910910|Lenalidomide|lenalidomide|mesh-list
138838886|NCT00910910|Chlorambucil|chlorambucil|mesh-list
138838887|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
138838888|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838889|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138838890|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138838891|NCT00910910|Growth Substances|growth substances|mesh-ancestor
138838892|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
138838893|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838894|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138838895|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
138838896|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838897|NCT04384562|Methylphenidate|methylphenidate|mesh-list
138838898|NCT04384562|Reboxetine|reboxetine|mesh-list
138838899|NCT04384562|Nicotine|nicotine|mesh-list
138838900|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138838901|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
138838902|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838903|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838904|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138838905|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138838906|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
138838907|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838908|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838909|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138838910|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138838911|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138838912|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838913|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
138838914|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
138838915|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138838916|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138838917|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
138838918|NCT04515134|Ubiquinone|ubiquinone|mesh-list
138838919|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
138614529|NCT02664181|Nivolumab|nivolumab|mesh-list
138838920|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
138838921|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838922|NCT04515134|Vitamins|vitamins|mesh-ancestor
138838923|NCT04238390|Meropenem|meropenem|mesh-list
138838924|NCT04238390|Tazobactam|tazobactam|mesh-list
138838925|NCT04238390|Ceftolozane|ceftolozane|mesh-list
138838926|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
138838927|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138838928|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138838929|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138838930|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838931|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838932|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138838933|NCT04236830|Fluorides|fluorides|mesh-list
138838934|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
138838935|NCT04236830|Protective Agents|protective agents|mesh-ancestor
138838936|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838937|NCT04203212|Goserelin|goserelin|mesh-list
138838938|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138838939|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838940|NCT00637910|Docetaxel|docetaxel|mesh-list
138838941|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138838942|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838943|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
138838944|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
138838945|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
138838946|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838947|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138838948|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838949|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
138838950|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138838951|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138838952|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138838953|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138838954|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838955|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
138838956|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138838957|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838958|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138838959|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138838961|NCT04449536|Protective Agents|protective agents|mesh-ancestor
138838962|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838963|NCT03960554|Denosumab|denosumab|mesh-list
138838964|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138838965|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838966|NCT04084106|Amoxicillin|amoxicillin|mesh-list
138838967|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
138838968|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
138838969|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138838970|NCT04084106|Penicillin V|penicillin v|mesh-list
138838971|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138838972|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138838973|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138838974|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838975|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138838976|NCT02973542|Ethosuximide|ethosuximide|mesh-list
138838977|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
138838978|NCT02973386|Cisplatin|cisplatin|mesh-list
138838979|NCT02973386|Capecitabine|capecitabine|mesh-list
138838980|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138838981|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138838982|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
138838983|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838984|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
138838985|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138838986|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138838987|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
138838988|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491008|NCT05640609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138838989|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138838990|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838991|NCT00909428|Urological Agents|urological agents|mesh-ancestor
138838992|NCT03718130|Vaccines|vaccines|mesh-list
138838993|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
138838994|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138838995|NCT00908960|Enoxaparin|enoxaparin|mesh-list
138838996|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
138838997|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138838998|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138838999|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839000|NCT05332106|Dienogest|dienogest|mesh-list
138839001|NCT05332106|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138839002|NCT05332106|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138839003|NCT05332106|Estradiol|estradiol|mesh-list
138839004|NCT05332106|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138839005|NCT05332106|Nandrolone|nandrolone|mesh-list
138839006|NCT05332106|Estrogens|estrogens|mesh-ancestor
138839007|NCT05332106|Hormones|hormones|mesh-ancestor
138839008|NCT05332106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138839009|NCT05332106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839010|NCT05332106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138839011|NCT05332106|Contraceptive Agents|contraceptive agents|mesh-ancestor
138839012|NCT05332106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138839013|NCT05332106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138839014|NCT05332106|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138839015|NCT05332106|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138839016|NCT05332106|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138839017|NCT05332106|Hormone Antagonists|hormone antagonists|mesh-ancestor
138839018|NCT05332106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138839019|NCT05332106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839020|NCT05332106|Androgens|androgens|mesh-ancestor
138839021|NCT05332106|Anabolic Agents|anabolic agents|mesh-ancestor
138839022|NCT05332028|Fentanyl|fentanyl|mesh-list
138839023|NCT05332028|Bupivacaine|bupivacaine|mesh-list
138839024|NCT05332028|Propofol|propofol|mesh-list
138839025|NCT05332028|Anesthetics, Local|anesthetics, local|mesh-ancestor
138839026|NCT05332028|Anesthetics|anesthetics|mesh-ancestor
138839027|NCT05332028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138839028|NCT05332028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839029|NCT05332028|Sensory System Agents|sensory system agents|mesh-ancestor
138839030|NCT05332028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839031|NCT05332028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138839032|NCT05332028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138839033|NCT05332028|Anesthetics, General|anesthetics, general|mesh-ancestor
138839034|NCT05332028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138839036|NCT05332028|Analgesics|analgesics|mesh-ancestor
138839037|NCT05332028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138839038|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
138839039|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138839040|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138839041|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138839042|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839043|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839044|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
138839045|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839046|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839047|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138839048|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839049|NCT00643201|Enoxaparin|enoxaparin|mesh-list
138839050|NCT00643201|Warfarin|warfarin|mesh-list
138839051|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
138839052|NCT00643201|Apixaban|apixaban|mesh-list
138839053|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
138839054|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138839055|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138839056|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839057|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138839058|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
138839059|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138839061|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839062|NCT00643123|Allopurinol|allopurinol|mesh-list
138839063|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
138839064|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839065|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839066|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
138839067|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138839068|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138839069|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
138839070|NCT00643123|Protective Agents|protective agents|mesh-ancestor
138839071|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839072|NCT00816673|Melatonin|melatonin|mesh-list
138839073|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
138839074|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839076|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839077|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138839078|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138839079|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138839080|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138839081|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839082|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839083|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839084|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839085|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
138839086|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138839087|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138839088|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138839089|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138839090|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839091|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839092|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839093|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839094|NCT00641719|Analgesics|analgesics|mesh-ancestor
138839095|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
138839096|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839097|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
138839098|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138839099|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
138839100|NCT02863367|Gemcitabine|gemcitabine|mesh-list
138839101|NCT02863367|Apatinib|apatinib|mesh-list
138839102|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138839103|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
138839104|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839105|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839106|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138839107|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839108|NCT00648895|Metoprolol|metoprolol|mesh-list
138839109|NCT00648895|Nebivolol|nebivolol|mesh-list
138839110|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138839111|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138839112|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
138839113|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
138839114|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839115|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839116|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138839117|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138839118|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138839119|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
138839120|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839121|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839122|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
138839123|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138839124|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138839125|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138839127|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138839128|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839129|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138839130|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
138839131|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138839133|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
138839134|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
138839135|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138839136|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839137|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
138839138|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839139|NCT00906698|Vinorelbine|vinorelbine|mesh-list
138839140|NCT00906698|Afatinib|afatinib|mesh-list
138839141|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138839142|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839143|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
138839144|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
138839146|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839147|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138839148|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839149|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138839150|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138839151|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
138839152|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839153|NCT03396926|Bevacizumab|bevacizumab|mesh-list
138839154|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138839155|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
138839156|NCT03396926|Capecitabine|capecitabine|mesh-list
138839157|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
138839158|NCT03396926|Antibodies|antibodies|mesh-list
138839159|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
138839160|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138839161|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
138839162|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839163|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138839164|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138839165|NCT03396926|Growth Substances|growth substances|mesh-ancestor
138839166|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839167|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
138839168|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
138839169|NCT03396926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138839170|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839171|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138839172|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
138839173|NCT00971945|Paclitaxel|paclitaxel|mesh-list
138839174|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138839175|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839176|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
138839177|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
138839178|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
138839179|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839180|NCT03672500|Epinephrine|epinephrine|mesh-list
138839181|NCT03672500|Bupivacaine|bupivacaine|mesh-list
138839182|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
138839183|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
138839184|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138839185|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839186|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
138839187|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839188|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138839190|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
138839191|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839192|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839193|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138839194|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138839195|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
138839196|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138839197|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
138839198|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
138839199|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
138839200|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138839201|NCT00971867|Paclitaxel|paclitaxel|mesh-list
138839202|NCT00971867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138839203|NCT00971867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839204|NCT00971867|Tubulin Modulators|tubulin modulators|mesh-ancestor
138839205|NCT00971867|Antimitotic Agents|antimitotic agents|mesh-ancestor
138839206|NCT00971867|Mitosis Modulators|mitosis modulators|mesh-ancestor
138839207|NCT00971867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839208|NCT00812851|Dronabinol|dronabinol|mesh-list
138839209|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
138839210|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839211|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138839212|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138839213|NCT00812851|Analgesics|analgesics|mesh-ancestor
138839214|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
138839215|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839216|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138491232|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
138839217|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138839218|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839219|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839221|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138839222|NCT00648037|Rituximab|rituximab|mesh-list
138839223|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138839224|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839225|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
138839226|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839227|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138839228|NCT00817375|Milnacipran|milnacipran|mesh-list
138839229|NCT00817375|Mirtazapine|mirtazapine|mesh-list
138839230|NCT00817375|Sertraline|sertraline|mesh-list
138839231|NCT00817375|Fluoxetine|fluoxetine|mesh-list
138839232|NCT00817375|Paroxetine|paroxetine|mesh-list
138839233|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138839234|NCT00817375|Nortriptyline|nortriptyline|mesh-list
138839235|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
138839236|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138839237|NCT00817375|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138839238|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138839239|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839240|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839241|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839242|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
138839243|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839244|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138839245|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138839246|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138839247|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839248|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138839249|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138839250|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
138839251|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
138839252|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138839253|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138839254|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138839255|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138839256|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138839257|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138839258|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
138839259|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138839261|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138839262|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138839263|NCT00817375|Analgesics|analgesics|mesh-ancestor
138839264|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
138839265|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839266|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138839267|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138839268|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138839269|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
138839270|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
138839271|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138839272|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138839273|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839274|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839275|NCT00818701|Urological Agents|urological agents|mesh-ancestor
138839276|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
138839277|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839278|NCT00813241|Celecoxib|celecoxib|mesh-list
138839279|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138839280|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138839281|NCT00813241|Analgesics|analgesics|mesh-ancestor
138839282|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
138839283|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839284|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839285|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138839286|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138839287|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138839288|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138839290|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839291|NCT00640393|Etanercept|etanercept|mesh-list
138839292|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138839293|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138839295|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
138839296|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839297|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839298|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138839299|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138839300|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138839301|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138839302|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
138839303|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138839304|NCT05315024|Imiquimod|imiquimod|mesh-list
138839305|NCT05315024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138839306|NCT05315024|Immunologic Factors|immunologic factors|mesh-ancestor
138839307|NCT05315024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839308|NCT05315024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839309|NCT05315024|Interferon Inducers|interferon inducers|mesh-ancestor
138839310|NCT00627445|Insulin|insulin|mesh-list
138839311|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138839312|NCT00627445|Metformin|metformin|mesh-list
138839313|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
138839314|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
138839315|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138839316|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
138839317|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138839318|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138839319|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839320|NCT02030990|Fluorometholone|fluorometholone|mesh-list
138839321|NCT02030990|Mitomycins|mitomycins|mesh-list
138839322|NCT02030990|Mitomycin|mitomycin|mesh-list
138839323|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138839324|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839325|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
138839326|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839327|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138839328|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839329|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138839330|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
138839331|NCT02030990|Hormones|hormones|mesh-ancestor
138839332|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138839333|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839334|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138839335|NCT00822055|Timolol|timolol|mesh-list
138839336|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138839337|NCT00822055|Dorzolamide|dorzolamide|mesh-list
138839338|NCT00822055|Maleic acid|maleic acid|mesh-list
138839339|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
138839340|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839341|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839342|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138839343|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138839344|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
138839345|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839346|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839347|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138839348|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138839349|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138839350|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138839351|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138839352|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138839354|NCT00822133|Ketamine|ketamine|mesh-list
138839355|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
138839356|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
138839357|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138839358|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839359|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
138839360|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839361|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138839362|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138839363|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138839364|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839365|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839366|NCT00822133|Analgesics|analgesics|mesh-ancestor
138839367|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138839368|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138839369|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
138839370|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138839371|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138839372|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839373|NCT00822211|Vildagliptin|vildagliptin|mesh-list
138839374|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138839375|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839376|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138839377|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
138839378|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839379|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839380|NCT04018417|Amphotericin B|amphotericin b|mesh-list
138839381|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138839382|NCT04018417|Amebicides|amebicides|mesh-ancestor
138839383|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138839384|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138839385|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138839386|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138839387|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
138839388|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
138839389|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138839390|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139067485|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
138839391|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138839392|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839393|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839394|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
139154233|NCT00838630|Vasodilator Agents|vasodilator agents|mesh-ancestor
138839395|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839396|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839397|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138839398|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839399|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
138839400|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
138839402|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
138839403|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839404|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
138839405|NCT00826657|Hematinics|hematinics|mesh-ancestor
138839406|NCT03597776|Lidocaine|lidocaine|mesh-list
138839407|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
138839408|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
138839409|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138839410|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839411|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
138839412|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839413|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138839414|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138839415|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138839416|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839417|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839418|NCT00625183|Selenium|selenium|mesh-list
138839419|NCT00625183|Capecitabine|capecitabine|mesh-list
138839420|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
138839421|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138839422|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
138839423|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839424|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839425|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
138839426|NCT00625183|Protective Agents|protective agents|mesh-ancestor
138839427|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839428|NCT00625183|Trace Elements|trace elements|mesh-ancestor
138839429|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
138839431|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839432|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138839433|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138839434|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839435|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839436|NCT00826969|Ciclesonide|ciclesonide|mesh-list
138839437|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
138839438|NCT00826969|Hormones|hormones|mesh-ancestor
138839439|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138839440|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839441|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138839442|NCT03560882|Atorvastatin|atorvastatin|mesh-list
138839443|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138839444|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138839445|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
138839446|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839447|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138839448|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138839449|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839450|NCT04044547|Rotigotine|rotigotine|mesh-list
138839451|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
138839452|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
138839453|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839454|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839455|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839456|NCT02768948|Losartan|losartan|mesh-list
138839457|NCT02768948|Telmisartan|telmisartan|mesh-list
138839458|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138839459|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138839460|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138839461|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138839462|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839463|NCT00640315|Riociguat|riociguat|mesh-list
138839464|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
138839465|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839466|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
138839467|NCT00904748|Citric Acid|citric acid|mesh-list
138839468|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
138839469|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
138839470|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138944291|NCT01042951|Vaccines|vaccines|mesh-list
138839471|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
138839472|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
138839473|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839474|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
138839475|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138839476|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138839477|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839478|NCT00904748|Urological Agents|urological agents|mesh-ancestor
138839479|NCT00574405|Insulin|insulin|mesh-list
138839480|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138839481|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
138839482|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
138839483|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
138839484|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
138839485|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
138839486|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138839487|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839488|NCT00971243|Metformin|metformin|mesh-list
138839489|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138839490|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839491|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138839492|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138839493|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138839494|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839495|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839496|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138839497|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839498|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839499|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
138839500|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839501|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138839503|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
138839504|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138839505|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
138839506|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839507|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839508|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
138839509|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
138839510|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138839511|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138839512|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839513|NCT00568555|Naltrexone|naltrexone|mesh-list
138839514|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138839515|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138839516|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839517|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
138839518|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839519|NCT00819325|Pioglitazone|pioglitazone|mesh-list
138839520|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138839521|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839522|NCT00904670|Methylphenidate|methylphenidate|mesh-list
138839523|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138839524|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839525|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138839526|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139154246|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
138839527|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839528|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839529|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
138839530|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839531|NCT00827281|Cycloserine|cycloserine|mesh-list
138839532|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138839533|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138839534|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138839535|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
138839536|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138839537|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
138839538|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839539|NCT00823381|Resveratrol|resveratrol|mesh-list
138839540|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
138839541|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839542|NCT00823381|Protective Agents|protective agents|mesh-ancestor
138839543|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839544|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839545|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138839546|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
138839547|NCT00638443|Promethazine|promethazine|mesh-list
138839549|NCT00638443|Analgesics|analgesics|mesh-ancestor
138839550|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
138839551|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839552|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839553|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
138839554|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138839555|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839556|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839557|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138839558|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138839559|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138839560|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138839561|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138839562|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138839563|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138839564|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
138839565|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
138839566|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
138839567|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
138839568|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138839569|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138839570|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
138839571|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
138839572|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839573|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138839574|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
138839575|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
138839576|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
138839578|NCT00568399|Protective Agents|protective agents|mesh-ancestor
138839579|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839580|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
138839581|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839582|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
138839583|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138839584|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138839585|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
138839586|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
138839587|NCT00975143|Isotretinoin|isotretinoin|mesh-list
138839588|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
138839590|NCT04288349|Racepinephrine|racepinephrine|mesh-list
138839591|NCT04288349|Ropivacaine|ropivacaine|mesh-list
138839592|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
138839593|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
138839594|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
138839595|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138839596|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839597|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
138839598|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154267|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138839599|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138839601|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
138839602|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839603|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839604|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138839605|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138839606|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
138839607|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138839608|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
138839609|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
138839610|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
138839611|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138839612|NCT03667313|Sirolimus|sirolimus|mesh-list
138839613|NCT03667313|Paclitaxel|paclitaxel|mesh-list
138839614|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138839615|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839616|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
138839617|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
138839618|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
138839619|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839620|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138839621|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138839622|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138839623|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
138839624|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138839625|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
138839626|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839627|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138839628|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
138839629|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839630|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138839631|NCT04925531|Ampicillin|ampicillin|mesh-list
138839632|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138839633|NCT00634933|Prednisone|prednisone|mesh-list
138839634|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
138839635|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138839636|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138839637|NCT00634933|Prednisolone|prednisolone|mesh-list
138839638|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
138839639|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138839640|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
138839641|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138839642|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
138839643|NCT00634933|Hormones|hormones|mesh-ancestor
138839644|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138839645|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839646|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138839647|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839648|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
138839649|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
138839650|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067515|NCT01297894|Colistin|colistin|mesh-list
138839651|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138839652|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138582858|NCT00134693|Hormones|hormones|mesh-ancestor
138839653|NCT00634933|Protective Agents|protective agents|mesh-ancestor
138839654|NCT00967499|Ondansetron|ondansetron|mesh-list
138839655|NCT00967499|Palonosetron|palonosetron|mesh-list
138839656|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
138839657|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
138839658|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839659|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839660|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138839661|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
138839662|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
138839663|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138839664|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138839665|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
138839666|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839667|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839668|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138839669|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
138839670|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138839671|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138839672|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138839674|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
138839675|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839676|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839677|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839678|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138839679|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138839680|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
138839681|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839682|NCT00629837|Factor VIII|factor viii|mesh-list
138839683|NCT00629837|Coagulants|coagulants|mesh-ancestor
138839684|NCT00827671|Cetuximab|cetuximab|mesh-list
138839685|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138839686|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839687|NCT03643133|Mifamurtide|mifamurtide|mesh-list
138839688|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138839689|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
138839690|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839691|NCT00823849|Cilostazol|cilostazol|mesh-list
138839692|NCT00823849|Probucol|probucol|mesh-list
138839693|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138839694|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
138839695|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839696|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839697|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138839698|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
138839699|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138839700|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138839701|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839702|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138839703|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
138839704|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138839705|NCT00823849|Protective Agents|protective agents|mesh-ancestor
138839706|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138839707|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138839708|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839709|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138839710|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138839711|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
138839712|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138839713|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
138839714|NCT02550067|Copper|copper|mesh-list
138839715|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138839716|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
138839717|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
138839718|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138839719|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
138839720|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138839721|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839722|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138839723|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138839724|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138839725|NCT02550067|Trace Elements|trace elements|mesh-ancestor
138839726|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
138839727|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138839728|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138839729|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138839730|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839732|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138839733|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138839734|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
138839735|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839736|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839737|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138839738|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
138839739|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
138839740|NCT02862509|Hormones|hormones|mesh-ancestor
138491761|NCT01057069|Paclitaxel|paclitaxel|mesh-list
138839741|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138839742|NCT04285775|Chrysarobin|chrysarobin|mesh-list
138839743|NCT04285775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138839744|NCT04285775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138839745|NCT04285775|Analgesics|analgesics|mesh-ancestor
138839746|NCT04285775|Sensory System Agents|sensory system agents|mesh-ancestor
138839747|NCT04285775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839748|NCT04285775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839749|NCT04285775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138839750|NCT04285775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138839751|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138839752|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138839753|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138839754|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839755|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839756|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839757|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839758|NCT00965081|Analgesics|analgesics|mesh-ancestor
138839759|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
138839760|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839761|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
138839762|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138839763|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
138839764|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138839765|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138839766|NCT00961649|Brinzolamide|brinzolamide|mesh-list
138839767|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138839768|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138839769|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138839770|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138839771|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138839772|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
138839773|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839774|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839775|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839776|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138839777|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839778|NCT04267601|Anagliptin|anagliptin|mesh-list
138839779|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138839780|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
138839781|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839782|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839783|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138839784|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839785|NCT02861261|Promethazine|promethazine|mesh-list
138839786|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
138839787|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
138839788|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
138839789|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138839790|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
138839791|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
138839792|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839793|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839794|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839795|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138839796|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138839797|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138839798|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138839799|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
138839800|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
138839801|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
138839802|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839803|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
138839804|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
138839805|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138839806|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
138839807|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138839808|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138839809|NCT04283435|Estradiol|estradiol|mesh-list
138839810|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138839811|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839812|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491834|NCT05321160|Ketamine|ketamine|mesh-list
138839813|NCT04283435|Estrogens|estrogens|mesh-ancestor
138839814|NCT04283435|Hormones|hormones|mesh-ancestor
138839815|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138839816|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138839817|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
138839818|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138839819|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138839820|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
138839821|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138839822|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138839823|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839824|NCT04283435|Urological Agents|urological agents|mesh-ancestor
138839825|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
138839826|NCT00632125|Hematinics|hematinics|mesh-ancestor
138839827|NCT00903968|Plerixafor|plerixafor|mesh-list
138839828|NCT00903968|Dexamethasone|dexamethasone|mesh-list
138839829|NCT00903968|Bortezomib|bortezomib|mesh-list
138839830|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138839831|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
138839832|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
138839833|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839834|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839835|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138839836|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
138839837|NCT00903968|Hormones|hormones|mesh-ancestor
138839838|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138839839|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138839840|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839841|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138839842|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138839843|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
138839844|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138839845|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
138839846|NCT00632606|Metoclopramide|metoclopramide|mesh-list
138839847|NCT00632606|Analgesics|analgesics|mesh-ancestor
138839848|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
138839849|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839850|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839851|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
138839852|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138839853|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138839854|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
138839855|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138839856|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839857|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839858|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138839859|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
138839860|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138839861|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
138839862|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
138839863|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138839864|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138839865|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138839866|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
138839867|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839868|NCT00903344|Vitamin D|vitamin d|mesh-list
138839869|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
138839870|NCT00903344|Vitamins|vitamins|mesh-ancestor
138839871|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
138839872|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839873|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138839874|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138839875|NCT02847338|Amlodipine|amlodipine|mesh-list
138839876|NCT02847338|Lisinopril|lisinopril|mesh-list
138839878|NCT02847338|Amiloride|amiloride|mesh-list
138839879|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138839880|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138839881|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839882|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839883|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138839884|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839885|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
138839886|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138839887|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
138839888|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839889|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138839891|NCT02847338|Diuretics|diuretics|mesh-ancestor
138839892|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
138839893|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138839894|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138839895|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138839896|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138839897|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138839899|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138839900|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138839901|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839902|NCT02849366|Immunomodulating Agents|immunomodulating agents|mesh-list
138839903|NCT02849366|Immunologic Factors|immunologic factors|mesh-ancestor
138839904|NCT02849366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839905|NCT02849132|Entecavir|entecavir|mesh-list
138839906|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
138839907|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138839908|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
138839909|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138839910|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138839911|NCT02848508|Metformin|metformin|mesh-list
138839912|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138839913|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839914|NCT00902564|Escitalopram|escitalopram|mesh-list
138839915|NCT00902564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138839916|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138839917|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839918|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839919|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138839920|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
139154297|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
138839921|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839922|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
138839923|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
138839924|NCT00626197|Azathioprine|azathioprine|mesh-list
138839925|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
138839926|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138839927|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
138839928|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839929|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138839930|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138839931|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
138839932|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839933|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839934|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138839935|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138839936|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138839937|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
138839938|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138839939|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138839940|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839941|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
138839942|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138839943|NCT00626275|Naproxen|naproxen|mesh-list
138839944|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138839945|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138839946|NCT00626275|Analgesics|analgesics|mesh-ancestor
138839947|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
138839948|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839949|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839950|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138839951|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138839952|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
138839953|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138839954|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839955|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839957|NCT02847884|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138839958|NCT02847884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138839959|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
138839960|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138839961|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138839962|NCT00623935|Fludarabine|fludarabine|mesh-list
138839963|NCT00623935|Busulfan|busulfan|mesh-list
138839964|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067585|NCT00145626|Thiotepa|thiotepa|mesh-list
138839965|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839966|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138839967|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
138839968|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839969|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
138615572|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138839970|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138839971|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138839973|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138839974|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138839976|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
138839977|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839978|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839979|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138839980|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138839981|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138839982|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138839983|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138839984|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138839985|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138839986|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839987|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
138839988|NCT00828373|Lidocaine|lidocaine|mesh-list
138839989|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
138839990|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
138839991|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138839992|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138839993|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
138839994|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138839995|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138839996|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138839997|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138839998|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138839999|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840000|NCT00824239|Midazolam|midazolam|mesh-list
138840001|NCT00824239|Fentanyl|fentanyl|mesh-list
138840002|NCT00824239|Propofol|propofol|mesh-list
138840003|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138840004|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138840005|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840006|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138840007|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
138840008|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
138840009|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138840010|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138840011|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138840012|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138840013|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
138840014|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
138840015|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840016|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840017|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138840018|NCT00824239|Narcotics|narcotics|mesh-ancestor
138840019|NCT00824239|Analgesics|analgesics|mesh-ancestor
138840020|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
138840021|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840022|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138840023|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
138840024|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138840025|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138583229|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
138840026|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138840027|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138840028|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
139154340|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
138840029|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840030|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840031|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138840032|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138840033|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
138840034|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840035|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840036|NCT04044703|Vancomycin|vancomycin|mesh-list
138840037|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138840038|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840039|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
138840040|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138840041|NCT00824317|Methylphenidate|methylphenidate|mesh-list
138840042|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138840043|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840044|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138840045|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138840046|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138840047|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840048|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
138840049|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840050|NCT02847806|Insulin|insulin|mesh-list
138840051|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138840052|NCT02847806|Estradiol|estradiol|mesh-list
138840053|NCT02847806|Testosterone|testosterone|mesh-list
138840054|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138840055|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840056|NCT02847806|Estrogens|estrogens|mesh-ancestor
138840057|NCT02847806|Hormones|hormones|mesh-ancestor
138840058|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138840059|NCT02847806|Androgens|androgens|mesh-ancestor
138840060|NCT00828529|Bedaquiline|bedaquiline|mesh-list
138840061|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
138840062|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138840063|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840064|NCT00632762|Amantadine|amantadine|mesh-list
138840065|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138840066|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138840067|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
138840068|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840069|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
138840070|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840071|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840072|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840073|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138840074|NCT00632762|Analgesics|analgesics|mesh-ancestor
138840075|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
138840076|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840077|NCT01351766|Nicotine|nicotine|mesh-list
138840078|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138840079|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
138840080|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840081|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840082|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138840083|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138840084|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
138840085|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840086|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840087|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
138840088|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138840089|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138840090|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840091|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138840092|NCT02846090|Analgesics|analgesics|mesh-ancestor
138840093|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
138840094|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840095|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138840096|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138840097|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138840098|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
138840099|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840100|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840101|NCT00828763|Dolutegravir|dolutegravir|mesh-list
138840102|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138840103|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138840104|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840105|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840106|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138840107|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138840108|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
138840109|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840111|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
138840112|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840113|NCT00824785|Capecitabine|capecitabine|mesh-list
138840114|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
138840116|NCT00824785|Panitumumab|panitumumab|mesh-list
138840117|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138840118|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
138840119|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840120|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840121|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138840122|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138840123|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138840124|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840125|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138840126|NCT00824863|Ketoconazole|ketoconazole|mesh-list
138840127|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
138840128|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840129|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138840130|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138840131|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840132|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840133|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138840134|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
138840135|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138840136|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840137|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138840138|NCT02844530|Epratuzumab|epratuzumab|mesh-list
138840139|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138840140|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138840141|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840142|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
138840143|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
138840144|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840145|NCT00820417|Cetuximab|cetuximab|mesh-list
138840146|NCT00820417|Gefitinib|gefitinib|mesh-list
138840147|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138840148|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840149|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138840150|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840151|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840152|NCT04923620|Cetuximab|cetuximab|mesh-list
138840153|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138840154|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840155|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138840156|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
138840157|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840158|NCT02548741|Metformin|metformin|mesh-list
138840159|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
138840160|NCT02548741|Calcium|calcium|mesh-list
138840161|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138840162|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840163|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138840164|NCT02548741|Antacids|antacids|mesh-ancestor
138840165|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840166|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138840167|NCT02845856|Cetuximab|cetuximab|mesh-list
138840168|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138840169|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840170|NCT00825019|Paroxetine|paroxetine|mesh-list
138840171|NCT00825019|Amibegron|amibegron|mesh-list
138840172|NCT00825019|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138840173|NCT00825019|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138583390|NCT00159666|Pregabalin|pregabalin|mesh-list
138840174|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138840175|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138840176|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840177|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840178|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
138840179|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840180|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138840181|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
138840182|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138840183|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138840184|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138840185|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840186|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138840187|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138840188|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
138840189|NCT00825019|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138840191|NCT00929006|Progestins|progestins|mesh-ancestor
138840192|NCT00929006|Hormones|hormones|mesh-ancestor
138840193|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138840194|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840195|NCT00877214|Rituximab|rituximab|mesh-list
138840196|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138840197|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840198|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
138840199|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840200|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138840201|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
138840202|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138840203|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138840204|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840205|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
138840206|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840207|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840208|NCT05242718|Palmidrol|palmidrol|mesh-list
138840209|NCT05242718|Acetylcysteine|acetylcysteine|mesh-list
138840210|NCT05242718|Curcumin|curcumin|mesh-list
138840211|NCT05242718|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138840212|NCT05242718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138840213|NCT05242718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138840214|NCT05242718|Analgesics|analgesics|mesh-ancestor
138840215|NCT05242718|Sensory System Agents|sensory system agents|mesh-ancestor
138840216|NCT05242718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067627|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840217|NCT05242718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840218|NCT05242718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138840219|NCT05242718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138840220|NCT05242718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840221|NCT05242718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840222|NCT05242718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840223|NCT05242718|Antiviral Agents|antiviral agents|mesh-ancestor
138840224|NCT05242718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840225|NCT05242718|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138840226|NCT05242718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138840227|NCT05242718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840228|NCT05242718|Hormones|hormones|mesh-ancestor
138840229|NCT05242718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138840230|NCT05242718|Expectorants|expectorants|mesh-ancestor
138840231|NCT05242718|Respiratory System Agents|respiratory system agents|mesh-ancestor
138840232|NCT05242718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138840233|NCT05242718|Antioxidants|antioxidants|mesh-ancestor
138840234|NCT05242718|Protective Agents|protective agents|mesh-ancestor
138840235|NCT05242718|Antidotes|antidotes|mesh-ancestor
138840236|NCT00045968|Immunomodulating Agents|immunomodulating agents|mesh-list
138840237|NCT00045968|Immunologic Factors|immunologic factors|mesh-ancestor
138840238|NCT00045968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840239|NCT02845778|Melatonin|melatonin|mesh-list
138840240|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
138840241|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840242|NCT02845778|Protective Agents|protective agents|mesh-ancestor
138840243|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840244|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138840245|NCT05241938|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138840247|NCT05337332|Triamcinolone|triamcinolone|mesh-list
138840248|NCT05337332|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138840249|NCT05337332|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138840250|NCT05337332|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138840251|NCT05337332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138840252|NCT05337332|Glucocorticoids|glucocorticoids|mesh-ancestor
138840253|NCT05337332|Hormones|hormones|mesh-ancestor
138840254|NCT05337332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138840255|NCT05337332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840256|NCT05337332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138840257|NCT05337332|Immunologic Factors|immunologic factors|mesh-ancestor
138840258|NCT05337332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840259|NCT05337332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840260|NCT00901394|Folic Acid|folic acid|mesh-list
138492280|NCT00275938|Ribavirin|ribavirin|mesh-list
138840262|NCT00901394|Hematinics|hematinics|mesh-ancestor
138840263|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
138840264|NCT00901394|Vitamins|vitamins|mesh-ancestor
138840265|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
138615880|NCT00216294|Secretin|secretin|mesh-list
138840266|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840267|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138840268|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
138840269|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
138840270|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138840271|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138840272|NCT00901394|Analgesics|analgesics|mesh-ancestor
138840273|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
138840274|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840275|NCT05337254|Dihydroergotamine|dihydroergotamine|mesh-list
138840276|NCT05337254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138840277|NCT05337254|Dopamine Agonists|dopamine agonists|mesh-ancestor
138840278|NCT05337254|Dopamine Agents|dopamine agents|mesh-ancestor
138840279|NCT05337254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840280|NCT05337254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840281|NCT05337254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840282|NCT05337254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138840283|NCT05337254|Analgesics|analgesics|mesh-ancestor
138840284|NCT05337254|Sensory System Agents|sensory system agents|mesh-ancestor
138840285|NCT05337254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840286|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
138840287|NCT00896532|Denosumab|denosumab|mesh-list
138840288|NCT00896532|Alendronate|alendronate|mesh-list
138840289|NCT00896532|Teriparatide|teriparatide|mesh-list
138840290|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138840291|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138840292|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840293|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138840294|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
138840295|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
138840296|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840297|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138840298|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840299|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840300|NCT02843490|Ranibizumab|ranibizumab|mesh-list
138840301|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138840302|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138840303|NCT02843490|Growth Substances|growth substances|mesh-ancestor
138840304|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840305|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
138840306|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840307|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
138840308|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840309|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138840310|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840311|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840340|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840341|NCT02845388|Estrogens|estrogens|mesh-ancestor
138840342|NCT02845388|Hormones|hormones|mesh-ancestor
138840343|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138840344|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840345|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138840346|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
138840347|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138840348|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138840349|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
138840350|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138840351|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138840352|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840353|NCT02845388|Urological Agents|urological agents|mesh-ancestor
138840354|NCT02845466|Becaplermin|becaplermin|mesh-list
138840355|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
138840356|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
138840357|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138840358|NCT02845466|Growth Substances|growth substances|mesh-ancestor
138840359|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840360|NCT00623623|Enoxaparin|enoxaparin|mesh-list
138840361|NCT00623623|Tenecteplase|tenecteplase|mesh-list
138840362|NCT00623623|Clopidogrel|clopidogrel|mesh-list
138840363|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138840364|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138840365|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138840366|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138840367|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
138840368|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840369|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840370|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840371|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
138840372|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138840373|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138840374|NCT00896454|Denosumab|denosumab|mesh-list
138840376|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840377|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138840378|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138840379|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138840380|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138840381|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840382|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840383|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840384|NCT04224584|Analgesics|analgesics|mesh-ancestor
138840385|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
138840386|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840387|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
138840388|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138840389|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
138840390|NCT02993198|Carvedilol|carvedilol|mesh-list
138840391|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138840392|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138840393|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
138840394|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840395|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840396|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840397|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138840398|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
138840399|NCT02993198|Protective Agents|protective agents|mesh-ancestor
138840400|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138840401|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138840402|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138840403|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
138840404|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138840405|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138840407|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492432|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
138840408|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138840409|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840410|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840411|NCT00901628|Cefuroxime|cefuroxime|mesh-list
138840412|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
138840413|NCT00901628|Ketorolac|ketorolac|mesh-list
138840414|NCT00901628|Epinephrine|epinephrine|mesh-list
138840415|NCT00901628|Morphine|morphine|mesh-list
138840416|NCT00901628|Ropivacaine|ropivacaine|mesh-list
138840417|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138840418|NCT00901628|Narcotics|narcotics|mesh-ancestor
138840419|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138840420|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840421|NCT00901628|Analgesics|analgesics|mesh-ancestor
138840422|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
138840423|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840424|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
138840425|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
138840426|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138840427|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138840428|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
138840429|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840430|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840431|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138840432|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138840433|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
138840434|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138840435|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
138840436|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
138840437|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
139067663|NCT01301248|Cetuximab|cetuximab|mesh-list
138840438|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138840439|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138840440|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138840441|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138840442|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138840443|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138840444|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840445|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138840446|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840447|NCT00623545|Exenatide|exenatide|mesh-list
138840448|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138840449|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840451|NCT00623545|Incretins|incretins|mesh-ancestor
138840452|NCT00623545|Hormones|hormones|mesh-ancestor
138840453|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138840454|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
138840455|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138840456|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138840457|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840458|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
138840459|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840460|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840461|NCT02839668|Acetaminophen|acetaminophen|mesh-list
138840462|NCT02839668|Lidocaine|lidocaine|mesh-list
138840463|NCT02839668|Atropine|atropine|mesh-list
138840464|NCT02839668|Tramadol|tramadol|mesh-list
138840465|NCT02839668|Sevoflurane|sevoflurane|mesh-list
138840466|NCT02839668|Neostigmine|neostigmine|mesh-list
138840467|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
138840468|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
138840469|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138840470|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840471|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
138840472|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840473|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138840474|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138840475|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138840476|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138840477|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840478|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138840479|NCT02839668|Analgesics|analgesics|mesh-ancestor
138840480|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
138840481|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138492512|NCT00083824|Estrogens|estrogens|mesh-list
138840482|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138840483|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
138840485|NCT02839668|Narcotics|narcotics|mesh-ancestor
138840486|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138840487|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138840488|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
138840489|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138840490|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
138840491|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
138840492|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
138840493|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138840494|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138840495|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
138840496|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840497|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138840498|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840499|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138840500|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138840501|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
138840502|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840503|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138840504|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
138840505|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840506|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138840507|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
138840508|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840509|NCT02839356|Epinephrine|epinephrine|mesh-list
138840510|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138840511|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138840512|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
138840513|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840514|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840515|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840516|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138840517|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138840518|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
138840519|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840520|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138840521|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
138840522|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
138840523|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
138840535|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840536|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
138840537|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840538|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138840539|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138840540|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
138840541|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138840542|NCT02840526|Narcotics|narcotics|mesh-ancestor
138840543|NCT02840526|Analgesics|analgesics|mesh-ancestor
138840544|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138840545|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138840546|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
138840547|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138840548|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138840549|NCT00825253|Insulin|insulin|mesh-list
138840550|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138840551|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
138840552|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
138840553|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138840554|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138840555|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840556|NCT00820885|Teduglutide|teduglutide|mesh-list
138840557|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138840558|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138492590|NCT00084058|Ritonavir|ritonavir|mesh-list
138840559|NCT00820885|Protective Agents|protective agents|mesh-ancestor
138840560|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840571|NCT00820963|Temozolomide|temozolomide|mesh-list
138840572|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138840573|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
138840574|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840575|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840576|NCT02834676|Ethanol|ethanol|mesh-list
138840577|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138840578|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840579|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138840580|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840581|NCT00632840|Atorvastatin|atorvastatin|mesh-list
138840582|NCT00632840|Fenofibrate|fenofibrate|mesh-list
138840583|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138840584|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138840585|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
138840586|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840587|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138840588|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138840589|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840590|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138840591|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138840592|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138840593|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138840594|NCT00829777|Naloxone|naloxone|mesh-list
138840595|NCT00829777|Lactulose|lactulose|mesh-list
138840596|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139067681|NCT00152516|Levetiracetam|levetiracetam|mesh-list
138840597|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840598|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
138840599|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840600|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138840601|NCT02834754|Vedolizumab|vedolizumab|mesh-list
138840602|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138840603|NCT02839122|Tadalafil|tadalafil|mesh-list
138840604|NCT02839122|Dutasteride|dutasteride|mesh-list
138840605|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
138840606|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138840607|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138840608|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840609|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840610|NCT02839122|Urological Agents|urological agents|mesh-ancestor
138840611|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138840612|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138840613|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
138840614|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138840615|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840616|NCT00633282|Pioglitazone|pioglitazone|mesh-list
138840617|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
138840618|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138840619|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840620|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
138840621|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
138840623|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138840624|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840625|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
138840626|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840627|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138840628|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840629|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138840630|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840631|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840632|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
138840633|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138840634|NCT02838030|Aspirin|aspirin|mesh-list
138840635|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138840636|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138840637|NCT02838030|Analgesics|analgesics|mesh-ancestor
138840638|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
138840639|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840640|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840641|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138840642|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138840643|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138840644|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138840645|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840646|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138840647|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138840648|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840649|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
138840650|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
138840651|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138840652|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840653|NCT04044079|Misoprostol|misoprostol|mesh-list
138840654|NCT04044079|Dinoprostone|dinoprostone|mesh-list
138840655|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138840656|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
138840657|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138840658|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840659|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138840660|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138840661|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
138840662|NCT00830323|Oseltamivir|oseltamivir|mesh-list
138840663|NCT00830323|Amantadine|amantadine|mesh-list
138840664|NCT00830323|Zanamivir|zanamivir|mesh-list
138840665|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
138840666|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840667|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840668|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840669|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139154391|NCT00790660|Ipragliflozin|ipragliflozin|mesh-list
138840670|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138840671|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
138840672|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840673|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840674|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138840676|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
138840677|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840678|NCT00830401|Doxycycline|doxycycline|mesh-list
138840679|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138840680|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840681|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
138840682|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138840683|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138840684|NCT04249908|Maleic acid|maleic acid|mesh-list
138840685|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840686|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840687|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138840688|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138840689|NCT02837640|Levodopa|levodopa|mesh-list
138840690|NCT02837640|Carbidopa|carbidopa|mesh-list
138840691|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138840692|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138840693|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138840694|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
138840695|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067700|NCT05624008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138840696|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840697|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840698|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138840699|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840700|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138840701|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
138840702|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
138840704|NCT02834286|Rituximab|rituximab|mesh-list
138840705|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138840706|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
138840707|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
138840708|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840709|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840710|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138840711|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
138840713|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138840714|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138840715|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840716|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138840717|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
138840718|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138840719|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
138840720|NCT02839044|Vitamin K|vitamin k|mesh-list
138840721|NCT02839044|Menaquinone 7|menaquinone 7|mesh-list
138840722|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138840723|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138840724|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840725|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
138840726|NCT02839044|Coagulants|coagulants|mesh-ancestor
138840727|NCT02839044|Vitamins|vitamins|mesh-ancestor
138840728|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
138840729|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840730|NCT02833506|Sirolimus|sirolimus|mesh-list
138840731|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138840732|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840733|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138840734|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840735|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
138840736|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138840737|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
138840738|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840739|NCT02838576|Estrogens|estrogens|mesh-list
138840740|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138840741|NCT02838576|Hormones|hormones|mesh-ancestor
138840742|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138840743|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840744|NCT00838539|Sirolimus|sirolimus|mesh-list
138840745|NCT00838539|Temsirolimus|temsirolimus|mesh-list
138840746|NCT00838539|MTOR Inhibitors|mtor inhibitors|mesh-list
138840747|NCT00838539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138840748|NCT00838539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840749|NCT00838539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840750|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138840751|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
138840752|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840753|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840754|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138840755|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840756|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138840757|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
138840758|NCT02836548|Vorinostat|vorinostat|mesh-list
138840759|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138840760|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840761|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840762|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840763|NCT02836704|Metformin|metformin|mesh-list
138840764|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
138840765|NCT02836704|Acarbose|acarbose|mesh-list
138840766|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138840767|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840768|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138840770|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840771|NCT02833584|Acetaminophen|acetaminophen|mesh-list
138840772|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138840773|NCT02833584|Analgesics|analgesics|mesh-ancestor
138840774|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
138840775|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840776|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840777|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
138840778|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138840779|NCT00837759|Lansoprazole|lansoprazole|mesh-list
138840780|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
138840781|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138840782|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840783|NCT00837759|Incretins|incretins|mesh-ancestor
138840784|NCT00837759|Hormones|hormones|mesh-ancestor
138840785|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138840786|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138840787|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
138840788|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840789|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840790|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138840791|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138840792|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138840793|NCT00703365|Gemcitabine|gemcitabine|mesh-list
138840794|NCT00703365|Sorafenib|sorafenib|mesh-list
138840795|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138840796|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
138840797|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840798|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840799|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138840800|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840801|NCT05878899|Enoxaparin|enoxaparin|mesh-list
138840802|NCT05878899|Anticoagulants|anticoagulants|mesh-ancestor
138840803|NCT05878899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138840804|NCT05878899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138840805|NCT05878899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840806|NCT05878574|Heparin|heparin|mesh-list
138840807|NCT05878574|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138840808|NCT05878574|Tinzaparin|tinzaparin|mesh-list
138840809|NCT05878574|Dalteparin|dalteparin|mesh-list
138840810|NCT05878574|Anticoagulants|anticoagulants|mesh-ancestor
138840811|NCT05878574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138840812|NCT05878574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138840813|NCT05878574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840814|NCT05878561|Indapamide|indapamide|mesh-list
138840815|NCT05878561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138840816|NCT05878561|Diuretics|diuretics|mesh-ancestor
138840817|NCT05878561|Natriuretic Agents|natriuretic agents|mesh-ancestor
138840818|NCT05878561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840819|NCT05878561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138840820|NCT05878561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138840821|NCT05878561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840822|NCT05878379|Iron|iron|mesh-list
138840823|NCT05878379|Trace Elements|trace elements|mesh-ancestor
138840824|NCT05878379|Micronutrients|micronutrients|mesh-ancestor
138840825|NCT05878379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840826|NCT05878262|Ibuprofen|ibuprofen|mesh-list
138924157|NCT00737373|Vitamins|vitamins|mesh-ancestor
138840827|NCT05878262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138840828|NCT05878262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138840829|NCT05878262|Analgesics|analgesics|mesh-ancestor
138840830|NCT05878262|Sensory System Agents|sensory system agents|mesh-ancestor
138840831|NCT05878262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840832|NCT05878262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840833|NCT05878262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138840834|NCT05878262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138840835|NCT05878262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138840836|NCT05878262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840837|NCT05878262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840838|NCT05878158|Simvastatin|simvastatin|mesh-list
138840839|NCT05878158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138840840|NCT05878158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138840841|NCT05878158|Antimetabolites|antimetabolites|mesh-ancestor
138840842|NCT05878158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840844|NCT05878158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138840845|NCT05878158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840846|NCT05878028|Docetaxel|docetaxel|mesh-list
138840847|NCT05878028|Tislelizumab|tislelizumab|mesh-list
138840848|NCT05878028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840849|NCT05878028|Tubulin Modulators|tubulin modulators|mesh-ancestor
138840850|NCT05878028|Antimitotic Agents|antimitotic agents|mesh-ancestor
138840851|NCT05878028|Mitosis Modulators|mitosis modulators|mesh-ancestor
138840852|NCT05878028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840853|NCT05878028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138840854|NCT05877911|Sodium sulfate|sodium sulfate|mesh-list
138840855|NCT05877911|Cathartics|cathartics|mesh-ancestor
138840856|NCT05877911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138840857|NCT05877872|Immunomodulating Agents|immunomodulating agents|mesh-list
138840858|NCT05877872|Immunologic Factors|immunologic factors|mesh-ancestor
138840859|NCT05877872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840860|NCT05877781|Palmidrol|palmidrol|mesh-list
138840861|NCT05877781|Analgesics|analgesics|mesh-ancestor
138840862|NCT05877781|Sensory System Agents|sensory system agents|mesh-ancestor
138840863|NCT05877781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840864|NCT05877781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840865|NCT05877781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138840866|NCT05877781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138840867|NCT05877781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138840868|NCT05877781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138840869|NCT05877781|Antiviral Agents|antiviral agents|mesh-ancestor
138840870|NCT05877781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840871|NCT05877781|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138840872|NCT05877781|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138840873|NCT05877781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840874|NCT05877781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840875|NCT05877781|Hormones|hormones|mesh-ancestor
138840876|NCT05877781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138840877|NCT05877690|Bupivacaine|bupivacaine|mesh-list
138840878|NCT05877690|Prilocaine|prilocaine|mesh-list
138840879|NCT05877690|Anesthetics, Local|anesthetics, local|mesh-ancestor
138840880|NCT05877690|Anesthetics|anesthetics|mesh-ancestor
138840881|NCT05877690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138840882|NCT05877690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840883|NCT05877690|Sensory System Agents|sensory system agents|mesh-ancestor
138840884|NCT05877690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840885|NCT05877638|Sulfadiazine|sulfadiazine|mesh-list
138840886|NCT05877638|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138840887|NCT05877638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138840888|NCT05877638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138840889|NCT05877638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138840890|NCT05877638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138840891|NCT05877638|Coccidiostats|coccidiostats|mesh-ancestor
138840892|NCT05877638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138840893|NCT05877235|Quercetin|quercetin|mesh-list
138840894|NCT05877235|Antioxidants|antioxidants|mesh-ancestor
138840895|NCT05877235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840896|NCT05877235|Protective Agents|protective agents|mesh-ancestor
138840897|NCT05877235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840898|NCT05877131|Ropivacaine|ropivacaine|mesh-list
138840899|NCT05877131|Levobupivacaine|levobupivacaine|mesh-list
138840900|NCT05877131|Anesthetics, Local|anesthetics, local|mesh-ancestor
138840901|NCT05877131|Anesthetics|anesthetics|mesh-ancestor
138840902|NCT05877131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138840903|NCT05877131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840904|NCT05877131|Sensory System Agents|sensory system agents|mesh-ancestor
138840905|NCT05877131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840906|NCT05877079|Menthol|menthol|mesh-list
138840907|NCT05877079|Antipruritics|antipruritics|mesh-ancestor
138840908|NCT05877079|Dermatologic Agents|dermatologic agents|mesh-ancestor
138840909|NCT05877040|Rituximab|rituximab|mesh-list
138840910|NCT05877040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138840911|NCT05877040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840912|NCT05877040|Immunologic Factors|immunologic factors|mesh-ancestor
138840913|NCT05877040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840914|NCT05877040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138840915|NCT05877001|Tislelizumab|tislelizumab|mesh-list
138584110|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840916|NCT05877001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138840917|NCT05877001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840918|NCT05873777|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138840919|NCT05873777|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138840920|NCT05873777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840921|NCT05790707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138840922|NCT05737121|Lidocaine|lidocaine|mesh-list
138840923|NCT05737121|Heparin|heparin|mesh-list
138840924|NCT05737121|Calcium heparin|calcium heparin|mesh-list
138840925|NCT05737121|Anesthetics, Local|anesthetics, local|mesh-ancestor
138840926|NCT05737121|Anesthetics|anesthetics|mesh-ancestor
138840927|NCT05737121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138840928|NCT05737121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840929|NCT05737121|Sensory System Agents|sensory system agents|mesh-ancestor
138840930|NCT05737121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840931|NCT05737121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138840932|NCT05737121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138840933|NCT05737121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138840934|NCT05737121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138840935|NCT05737121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840936|NCT05737121|Anticoagulants|anticoagulants|mesh-ancestor
138840937|NCT05737121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138840938|NCT05737121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138840939|NCT05663658|Morphine|morphine|mesh-list
138840940|NCT05663658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138840941|NCT05663658|Narcotics|narcotics|mesh-ancestor
138840942|NCT05663658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067856|NCT05034562|Edetic Acid|edetic acid|mesh-list
138840943|NCT05663658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840944|NCT05663658|Analgesics|analgesics|mesh-ancestor
138840945|NCT05663658|Sensory System Agents|sensory system agents|mesh-ancestor
138840946|NCT05663658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840948|NCT05660135|Olmesartan|olmesartan|mesh-list
138840949|NCT05660135|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138840950|NCT05660135|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138840951|NCT05660135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138840952|NCT05660135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138840953|NCT05660135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138840954|NCT05660135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840955|NCT05660135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138840956|NCT05660135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840957|NCT05660135|Vasodilator Agents|vasodilator agents|mesh-ancestor
138840958|NCT05660135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138840959|NCT05660135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138840960|NCT05660135|Antimetabolites|antimetabolites|mesh-ancestor
138840961|NCT05660135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138840962|NCT05660135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138840963|NCT05660135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138840964|NCT05660135|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138840965|NCT05660135|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138840966|NCT05606263|Nimotuzumab|nimotuzumab|mesh-list
138840967|NCT05606263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138840968|NCT05606263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138840969|NCT05599451|Pyrithione zinc|pyrithione zinc|mesh-list
138840970|NCT05599451|Keratolytic Agents|keratolytic agents|mesh-ancestor
138840971|NCT05599451|Dermatologic Agents|dermatologic agents|mesh-ancestor
138840976|NCT05597722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840977|NCT05597722|Sympathomimetics|sympathomimetics|mesh-ancestor
138840978|NCT05597722|Autonomic Agents|autonomic agents|mesh-ancestor
138840979|NCT05597722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138840980|NCT05597722|Dopamine Agents|dopamine agents|mesh-ancestor
138840981|NCT05597722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840982|NCT05597722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138840983|NCT05597722|Adrenergic Agents|adrenergic agents|mesh-ancestor
138840984|NCT05597722|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138840985|NCT05597722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138840986|NCT05597722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138840987|NCT05597722|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138840989|NCT05555667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138840990|NCT05555667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138840991|NCT05555667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138840992|NCT05555667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138840993|NCT05555667|Anesthetics, General|anesthetics, general|mesh-ancestor
138840994|NCT05555667|Anesthetics|anesthetics|mesh-ancestor
138840996|NCT05411887|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138840997|NCT05411887|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138840998|NCT05411887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138840999|NCT05411887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138841000|NCT05411887|Antimetabolites|antimetabolites|mesh-ancestor
138841001|NCT05411887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841002|NCT05411887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138841003|NCT05411887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138841004|NCT05411887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841005|NCT05411887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138841006|NCT05411887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138841007|NCT05411887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138841008|NCT05398081|Ceftriaxone|ceftriaxone|mesh-list
138841009|NCT05398081|Cefuroxime|cefuroxime|mesh-list
138841010|NCT05398081|Cefuroxime axetil|cefuroxime axetil|mesh-list
138841011|NCT05398081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138841012|NCT05398081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841013|NCT05364008|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138841014|NCT05364008|Antioxidants|antioxidants|mesh-ancestor
138841015|NCT05364008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841016|NCT05364008|Protective Agents|protective agents|mesh-ancestor
138841017|NCT05364008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616623|NCT00126230|Docetaxel|docetaxel|mesh-list
138841018|NCT05364008|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138841019|NCT05364008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138841020|NCT05364008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841021|NCT05364008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138841022|NCT05307770|Melatonin|melatonin|mesh-list
138841023|NCT05307770|Antioxidants|antioxidants|mesh-ancestor
138841024|NCT05307770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841025|NCT05307770|Protective Agents|protective agents|mesh-ancestor
138841026|NCT05307770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841027|NCT05307770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841028|NCT05307458|Buprenorphine|buprenorphine|mesh-list
138841029|NCT05307458|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138841030|NCT05307458|Naloxone|naloxone|mesh-list
138841031|NCT05307458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138841032|NCT05307458|Narcotics|narcotics|mesh-ancestor
138841033|NCT05307458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841034|NCT05307458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841035|NCT05307458|Analgesics|analgesics|mesh-ancestor
138841036|NCT05307458|Sensory System Agents|sensory system agents|mesh-ancestor
138841037|NCT05307458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841038|NCT05307458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138841043|NCT05123053|Amifampridine|amifampridine|mesh-list
138841044|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138841045|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841046|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841047|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138841048|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138841049|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841050|NCT05060744|Antacids|antacids|mesh-list
138841051|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
138841052|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841053|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138841054|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
138841055|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138841056|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138841057|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138841058|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138841059|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841060|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
138841061|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841062|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841063|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138841064|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841065|NCT05047939|Propofol|propofol|mesh-list
138841066|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138841067|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841068|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841069|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138841070|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
138841071|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
138841072|NCT04926285|Venetoclax|venetoclax|mesh-list
138841073|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
138841074|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841075|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138841076|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138841077|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841078|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841079|NCT04858854|Sulforaphane|sulforaphane|mesh-list
138841080|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138841081|NCT04858854|Protective Agents|protective agents|mesh-ancestor
138841082|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841083|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841084|NCT04856566|Ethanol|ethanol|mesh-list
138841085|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138841086|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841087|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841088|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841089|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
138841090|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138841091|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841092|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841093|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138841095|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
138841096|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841097|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138841098|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138841100|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
138841101|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841102|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841103|NCT04774250|Zonisamide|zonisamide|mesh-list
138841104|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
138841105|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138841106|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138841107|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841108|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138841109|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841110|NCT04669457|Midazolam|midazolam|mesh-list
138841111|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
138841112|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138841113|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841114|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841115|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138841116|NCT04669457|Analgesics|analgesics|mesh-ancestor
138841117|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
138841118|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841119|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138841120|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138841121|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138841122|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
138841123|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841124|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841125|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138841126|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138841127|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138841128|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138841129|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138841130|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
138841132|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
138841133|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
138841134|NCT04537715|Itraconazole|itraconazole|mesh-list
138841135|NCT04537715|Rifampin|rifampin|mesh-list
138841136|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
138841137|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841138|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138841139|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138841140|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841141|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841142|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138841143|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
138841144|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138841145|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841146|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138841147|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138841148|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
138841149|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138841150|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
138841151|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138841152|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138841153|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138841154|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138841155|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138841156|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138841157|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138841158|NCT04532528|Dabigatran|dabigatran|mesh-list
138493197|NCT00087802|Paclitaxel|paclitaxel|mesh-list
138841159|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
138841160|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138841161|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
138841162|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616768|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841163|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841165|NCT04427956|Riboflavin|riboflavin|mesh-list
138841166|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
138841167|NCT04427956|Vitamins|vitamins|mesh-ancestor
138841168|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
138841169|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841170|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138841171|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
138841172|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
138841173|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138841174|NCT04427241|Protective Agents|protective agents|mesh-ancestor
138841175|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841176|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
138841177|NCT04315701|Cemiplimab|cemiplimab|mesh-list
138841178|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138841179|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841180|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
138841181|NCT04240093|Narcotics|narcotics|mesh-ancestor
138841182|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841183|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841184|NCT04240093|Analgesics|analgesics|mesh-ancestor
138841185|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
138841186|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841187|NCT04115774|Diphosphonates|diphosphonates|mesh-list
138841188|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138841189|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841190|NCT04025359|Dronabinol|dronabinol|mesh-list
138841191|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
138841192|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841193|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139154397|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
138841194|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138841195|NCT04025359|Analgesics|analgesics|mesh-ancestor
138841196|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
138841197|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841198|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138841199|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138841200|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841201|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841203|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138841204|NCT04005716|Cisplatin|cisplatin|mesh-list
138841205|NCT04005716|Carboplatin|carboplatin|mesh-list
138841206|NCT04005716|Etoposide|etoposide|mesh-list
138841207|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
138841208|NCT04005716|Tislelizumab|tislelizumab|mesh-list
138841209|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841210|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138584409|NCT00504946|Vitamins|vitamins|mesh-ancestor
138841211|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138841212|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138841214|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841215|NCT04005716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138841216|NCT03972280|Antibodies|antibodies|mesh-list
138841217|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138841218|NCT03972280|Lenograstim|lenograstim|mesh-list
138841219|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
138841220|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841221|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138841222|NCT03961568|Cenobamate|cenobamate|mesh-list
138841223|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
138841224|NCT03813108|Lumefantrine|lumefantrine|mesh-list
138841225|NCT03813108|Artemether|artemether|mesh-list
138841226|NCT03813108|Mefloquine|mefloquine|mesh-list
138841227|NCT03813108|Atovaquone|atovaquone|mesh-list
138841228|NCT03813108|Proguanil|proguanil|mesh-list
138841229|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138841230|NCT03813108|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138841231|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
138841232|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139067943|NCT00255164|Lansoprazole|lansoprazole|mesh-list
138841233|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138841234|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841235|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841236|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841237|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
138841238|NCT03621748|Anesthetics|anesthetics|mesh-list
138841239|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841240|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841241|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
138841242|NCT03417154|Nivolumab|nivolumab|mesh-list
138841243|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138841244|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
138841245|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841246|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138841247|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138841248|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
138841249|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841250|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841251|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138841252|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138841253|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138841254|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
138841255|NCT03396315|Alendronate|alendronate|mesh-list
138841256|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138841257|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841258|NCT03221036|Vedolizumab|vedolizumab|mesh-list
138841259|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138841260|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
138841261|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
138841262|NCT03032783|Tacrolimus|tacrolimus|mesh-list
138841263|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138841264|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
138841265|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841266|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138841267|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138841268|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
138841269|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841270|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841271|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138841272|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138841273|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841274|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138841275|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138841276|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
138841277|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138841278|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841280|NCT02740985|Durvalumab|durvalumab|mesh-list
138841281|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
138841282|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841283|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
138841284|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
138841285|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
138841286|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841287|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138841288|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138841290|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
138841291|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138841292|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841293|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138841294|NCT02723331|Paclitaxel|paclitaxel|mesh-list
138841295|NCT02723331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138841296|NCT02723331|Gemcitabine|gemcitabine|mesh-list
138841297|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138841298|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841299|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
138841300|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
138841301|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
138841302|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841303|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138841304|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
138841305|NCT02484677|Docetaxel|docetaxel|mesh-list
138841306|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841307|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
138841308|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
138841309|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
138841310|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493336|NCT00088816|Tegafur|tegafur|mesh-list
138841311|NCT02476097|Esomeprazole|esomeprazole|mesh-list
138841312|NCT02476097|Omeprazole|omeprazole|mesh-list
138841313|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138841314|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138841315|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138841316|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841317|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841318|NCT03946358|Atezolizumab|atezolizumab|mesh-list
138841319|NCT03946358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138841320|NCT03946358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841321|NCT03946358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138841322|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841323|NCT02106507|Everolimus|everolimus|mesh-list
138841324|NCT02106507|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138841325|NCT02106507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138841326|NCT02106507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841327|NCT02106507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841328|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138841329|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
138841330|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841331|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841332|NCT02051218|Denosumab|denosumab|mesh-list
138841333|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138841334|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841335|NCT01905046|Metformin|metformin|mesh-list
138841336|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138841337|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841338|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138841339|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138841340|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
138841341|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841342|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841343|NCT01264315|Lenalidomide|lenalidomide|mesh-list
138841344|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
139067984|NCT03967392|Lidocaine|lidocaine|mesh-list
138841345|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841346|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138841347|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138841348|NCT01264315|Growth Substances|growth substances|mesh-ancestor
138841349|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
138841350|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841351|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
138841352|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138841353|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
138841354|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841355|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841356|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138841357|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
138841358|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138841359|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138841360|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138841361|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
138841362|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841363|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841364|NCT00890149|Ondansetron|ondansetron|mesh-list
138841365|NCT00890149|Antiemetics|antiemetics|mesh-ancestor
138841366|NCT00890149|Autonomic Agents|autonomic agents|mesh-ancestor
138841367|NCT00890149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841368|NCT00890149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841369|NCT00890149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138841370|NCT00890149|Antipruritics|antipruritics|mesh-ancestor
138841371|NCT00890149|Dermatologic Agents|dermatologic agents|mesh-ancestor
138841372|NCT00890149|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138841373|NCT00890149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138841374|NCT00890149|Serotonin Agents|serotonin agents|mesh-ancestor
138841375|NCT00890149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841376|NCT00890149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841378|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138841379|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
138841380|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841381|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841382|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138841383|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493418|NCT00006155|Semaxinib|semaxinib|mesh-list
138841384|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
138841385|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841387|NCT00248287|Irinotecan|irinotecan|mesh-list
138841388|NCT00248287|Cetuximab|cetuximab|mesh-list
138841389|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841390|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138841391|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138841392|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841393|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841394|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138841395|NCT04249284|Deucravacitinib|deucravacitinib|mesh-list
138841396|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
138841397|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138841398|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841399|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841400|NCT04474938|Dexamethasone|dexamethasone|mesh-list
138841401|NCT04474938|Bortezomib|bortezomib|mesh-list
138841402|NCT04474938|Daratumumab|daratumumab|mesh-list
138841403|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138841404|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
138841405|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
138841406|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841407|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841408|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138841409|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
138841410|NCT04474938|Hormones|hormones|mesh-ancestor
138841411|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138841412|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138841413|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841414|NCT00837213|Doxycycline|doxycycline|mesh-list
138841415|NCT00837213|Clindamycin|clindamycin|mesh-list
138841416|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
138841417|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
138841418|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138841419|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138841420|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841421|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
138841422|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138841423|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138841424|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138841425|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841426|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841427|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
138841428|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
138841429|NCT02833038|Analgesics|analgesics|mesh-ancestor
138841430|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
138841431|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841432|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841433|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
138584625|NCT00155376|Hormones|hormones|mesh-ancestor
138841434|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841435|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138841436|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
138841437|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138841438|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138841439|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841440|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138841441|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
138841442|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138841443|NCT00703755|Metformin|metformin|mesh-list
138841444|NCT00703755|Fenofibrate|fenofibrate|mesh-list
138841445|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138841446|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841447|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138841448|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
138841449|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841450|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138841451|NCT02838342|Interferons|interferons|mesh-list
138841452|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
138841453|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
138841454|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493504|NCT00423865|Everolimus|everolimus|mesh-list
138841455|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
138841456|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841457|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138841458|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138841459|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
138841460|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841461|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841462|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138841463|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
138841464|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841465|NCT05333640|Sirolimus|sirolimus|mesh-list
138841466|NCT05333640|Paclitaxel|paclitaxel|mesh-list
138841467|NCT05333640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138841468|NCT05333640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841469|NCT05333640|Tubulin Modulators|tubulin modulators|mesh-ancestor
138841470|NCT05333640|Antimitotic Agents|antimitotic agents|mesh-ancestor
138841471|NCT05333640|Mitosis Modulators|mitosis modulators|mesh-ancestor
138841472|NCT05333640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841473|NCT05333640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138841474|NCT05333640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841475|NCT05333640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138841476|NCT05333640|Antifungal Agents|antifungal agents|mesh-ancestor
138841477|NCT05333640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138841478|NCT05333640|Immunologic Factors|immunologic factors|mesh-ancestor
138841479|NCT05333640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841480|NCT02838264|Itraconazole|itraconazole|mesh-list
138841481|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
138841482|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841483|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138841484|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138841485|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841486|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841487|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138841488|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
138841489|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138841490|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841491|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138841493|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138841494|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138841495|NCT00633438|Analgesics|analgesics|mesh-ancestor
138841496|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
138841497|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841498|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841499|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138841500|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138841501|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138841502|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138841503|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841504|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841505|NCT02833116|Dexamethasone|dexamethasone|mesh-list
138841506|NCT02833116|Betamethasone|betamethasone|mesh-list
138841507|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138841508|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
138841509|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
138841510|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841511|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841512|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138841513|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
138841514|NCT02833116|Hormones|hormones|mesh-ancestor
138841515|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138841516|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138841517|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841518|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138841519|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
138841520|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
138841521|NCT00703989|Benphothiamine|benphothiamine|mesh-list
138841522|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
138841523|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841524|NCT00703989|Protective Agents|protective agents|mesh-ancestor
138841525|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841526|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
138841527|NCT00703989|Vitamins|vitamins|mesh-ancestor
138841528|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
138841529|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138841530|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
138841531|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
138493559|NCT00390156|Growth Substances|growth substances|mesh-ancestor
138841532|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
138841533|NCT05335460|Capecitabine|capecitabine|mesh-list
138841534|NCT05335460|Oxaliplatin|oxaliplatin|mesh-list
138841535|NCT05335460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138841536|NCT05335460|Antimetabolites|antimetabolites|mesh-ancestor
138841537|NCT05335460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841538|NCT05335460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841539|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
138841540|NCT02836002|Piperaquine|piperaquine|mesh-list
138841541|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
138841542|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138841544|NCT02836002|Proguanil|proguanil|mesh-list
138841545|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138841546|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
138841547|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138841548|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138841549|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841550|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138841551|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841552|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841553|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138841554|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
138841555|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
138841556|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138841557|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
138841558|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138841559|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138841560|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841561|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
138841562|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841563|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841564|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138841565|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
138841566|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
139154398|NCT00835354|Cefprozil|cefprozil|mesh-list
138841567|NCT02297516|Protective Agents|protective agents|mesh-ancestor
138841568|NCT02842580|Leucovorin|leucovorin|mesh-list
138841569|NCT02842580|Bevacizumab|bevacizumab|mesh-list
138841570|NCT02842580|Capecitabine|capecitabine|mesh-list
138841571|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
138841572|NCT02842580|Irinotecan|irinotecan|mesh-list
138841573|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
138841574|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138841575|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841576|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138841577|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138841578|NCT02842580|Growth Substances|growth substances|mesh-ancestor
138841579|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841580|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
138841581|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138841582|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
138841583|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841584|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138841585|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138841586|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841587|NCT02842580|Antidotes|antidotes|mesh-ancestor
138841588|NCT02842580|Protective Agents|protective agents|mesh-ancestor
138841589|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
138841590|NCT02842580|Vitamins|vitamins|mesh-ancestor
138841591|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
138841592|NCT00836277|Irinotecan|irinotecan|mesh-list
138841593|NCT00836277|Panitumumab|panitumumab|mesh-list
138841594|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138841595|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138841596|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841597|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841598|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841599|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138841600|NCT00831025|Immunomodulating Agents|immunomodulating agents|mesh-list
138841601|NCT00831025|Immunologic Factors|immunologic factors|mesh-ancestor
138841602|NCT00831025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841603|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
138841604|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
138841605|NCT00835731|Misoprostol|misoprostol|mesh-list
138841606|NCT00835731|Vitamins|vitamins|mesh-ancestor
138841607|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
138841608|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841609|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138841610|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
138841611|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138841612|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138841613|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138841614|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
138841615|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
138841616|NCT00835731|Hematinics|hematinics|mesh-ancestor
138841617|NCT03721406|Ropivacaine|ropivacaine|mesh-list
138841618|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
138841619|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
138841620|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841621|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841622|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
138841623|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841625|NCT00751166|Desloratadine|desloratadine|mesh-list
138841626|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138841627|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138841628|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138841629|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
138841630|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
138841631|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841632|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841633|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841634|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138841635|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
138841636|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138841637|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
138841638|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138841639|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138841640|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138841641|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841642|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841643|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
138841644|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138841645|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
138841646|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138841647|NCT00704145|Paclitaxel|paclitaxel|mesh-list
138841648|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138841649|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841650|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
138841651|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
138841652|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
138841653|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841654|NCT03508232|Doxycycline|doxycycline|mesh-list
138841655|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138841656|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841657|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
138841658|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138841659|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138841660|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
138841661|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
138841662|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138841663|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841664|NCT00704301|Rivastigmine|rivastigmine|mesh-list
138841665|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138841666|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068090|NCT01300312|Analgesics|analgesics|mesh-ancestor
138841667|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841668|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
138841669|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841670|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841671|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138841672|NCT00704301|Protective Agents|protective agents|mesh-ancestor
138841673|NCT00831103|Valacyclovir|valacyclovir|mesh-list
138841674|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
138841675|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841676|NCT00704444|Ezetimibe|ezetimibe|mesh-list
138841677|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138841678|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138841679|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
138841680|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841681|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138841682|NCT00704691|Lenalidomide|lenalidomide|mesh-list
138841683|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
138841684|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493715|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
138841685|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138841686|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138841687|NCT00704691|Growth Substances|growth substances|mesh-ancestor
138841688|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
138841689|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210350|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138841690|NCT00704925|Amifampridine|amifampridine|mesh-list
138841691|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138841692|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841693|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841694|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138841695|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138841696|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841697|NCT00574249|Adalimumab|adalimumab|mesh-list
138841698|NCT00574249|Betamethasone|betamethasone|mesh-list
138841699|NCT00574249|Calcipotriene|calcipotriene|mesh-list
138841700|NCT00574249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138841701|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138841702|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138841703|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
138841704|NCT00574249|Hormones|hormones|mesh-ancestor
138841705|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138841706|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841707|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138841708|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
138841709|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
138841710|NCT00891228|ST 1435|st 1435|mesh-list
138841711|NCT00891228|Testosterone|testosterone|mesh-list
138841712|NCT00891228|Androgens|androgens|mesh-ancestor
138841713|NCT00891228|Hormones|hormones|mesh-ancestor
138841714|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138841715|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841716|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138841717|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
138841718|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138841719|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138841720|NCT00896168|Infliximab|infliximab|mesh-list
138841721|NCT00896168|Methotrexate|methotrexate|mesh-list
138841722|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138841723|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
138841724|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138841725|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068124|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138841726|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138841727|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
138841728|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841729|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841730|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
138841731|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841732|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138841733|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138841734|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
138841735|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138841736|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138841737|NCT00896168|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138841738|NCT00896168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138841739|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138841740|NCT00833703|Clopidogrel|clopidogrel|mesh-list
138841741|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138841742|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138841743|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138841744|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138841745|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
138841746|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841747|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841748|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841749|NCT00833547|Eszopiclone|eszopiclone|mesh-list
138841750|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138841751|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841752|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841753|NCT00833469|Escitalopram|escitalopram|mesh-list
138841754|NCT00833469|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138841755|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138841756|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138841757|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841758|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841759|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
138841760|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841761|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
138841762|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138841763|NCT02831478|Protective Agents|protective agents|mesh-ancestor
138841764|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841765|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
138841766|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
138841768|NCT00837655|Sevelamer|sevelamer|mesh-list
138841769|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138841770|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841771|NCT00837655|Antacids|antacids|mesh-ancestor
138841772|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841773|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138841774|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
138841775|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
138841776|NCT00843661|Ezetimibe|ezetimibe|mesh-list
138841777|NCT00843661|Pravastatin|pravastatin|mesh-list
138841778|NCT00843661|Fenofibrate|fenofibrate|mesh-list
138841779|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138841780|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138841781|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
138841782|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841783|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138841784|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138841785|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841786|NCT00832377|Timolol|timolol|mesh-list
138841787|NCT00832377|Dorzolamide|dorzolamide|mesh-list
138841788|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138841789|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138841790|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
138841791|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841792|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841793|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841794|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138841795|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138841796|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138841797|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841798|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138841799|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
138841800|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841801|NCT00705315|Bevacizumab|bevacizumab|mesh-list
138841802|NCT00705315|Docetaxel|docetaxel|mesh-list
138841803|NCT00705315|Epirubicin|epirubicin|mesh-list
138841804|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138841805|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584998|NCT00505843|Carbidopa|carbidopa|mesh-list
138841806|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138841807|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138841808|NCT00705315|Growth Substances|growth substances|mesh-ancestor
138841809|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841810|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
138841811|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
138841812|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
138841813|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
138841814|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841815|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138841816|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138841817|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138841818|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841819|NCT00892008|Pregabalin|pregabalin|mesh-list
138841820|NCT00892008|Analgesics|analgesics|mesh-ancestor
138841821|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
138841822|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841823|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841824|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
138841825|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138841826|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138841827|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841828|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138841829|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139068159|NCT01560052|Prednisolone|prednisolone|mesh-list
138841830|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138841831|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841832|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138493862|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
138841833|NCT00623233|Bevacizumab|bevacizumab|mesh-list
138841834|NCT00623233|Gemcitabine|gemcitabine|mesh-list
138841835|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138841837|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138841838|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138841839|NCT00623233|Growth Substances|growth substances|mesh-ancestor
138841840|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841841|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
138841842|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138841843|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
138841844|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841845|NCT00837889|Diuretics|diuretics|mesh-list
138841846|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
138841847|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841848|NCT02841488|Fentanyl|fentanyl|mesh-list
138841849|NCT02841488|Ropivacaine|ropivacaine|mesh-list
138841850|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
138841851|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
138841852|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841853|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841854|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
138841855|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841856|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138841857|NCT02841488|Narcotics|narcotics|mesh-ancestor
138841858|NCT02841488|Analgesics|analgesics|mesh-ancestor
138841859|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138841860|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138841861|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
138841862|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
138841863|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
138841864|NCT02832726|Vitamins|vitamins|mesh-ancestor
138841865|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
138841866|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841868|NCT02832726|Hematinics|hematinics|mesh-ancestor
138841869|NCT00202904|Ezetimibe|ezetimibe|mesh-list
138841870|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138841871|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138841872|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
138841873|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841874|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138841875|NCT02690870|Tamoxifen|tamoxifen|mesh-list
138841876|NCT02690870|Clomiphene|clomiphene|mesh-list
138841877|NCT02690870|Enclomiphene|enclomiphene|mesh-list
138841878|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
138841879|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138841880|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
138841881|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138841882|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841883|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139068182|NCT05622994|Hormones|hormones|mesh-ancestor
138841884|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841885|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138841886|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138841887|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138841888|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138841889|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
138841890|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138841892|NCT00844207|Chloroquine|chloroquine|mesh-list
138841893|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138841894|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138841895|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841896|NCT00844207|Amebicides|amebicides|mesh-ancestor
138841897|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138841898|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138841899|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
138841900|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138841901|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138841902|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138841903|NCT00844207|Analgesics|analgesics|mesh-ancestor
138841904|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
138841905|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841906|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841907|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138493940|NCT00092404|Vaccines|vaccines|mesh-list
138841908|NCT00844207|Filaricides|filaricides|mesh-ancestor
138841909|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
138841910|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
138841912|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138841913|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
138841914|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841915|NCT02548117|Finasteride|finasteride|mesh-list
138841916|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138841917|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138841918|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841919|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841920|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
138841921|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138841922|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841923|NCT02548117|Urological Agents|urological agents|mesh-ancestor
138841924|NCT02841800|Phenobarbital|phenobarbital|mesh-list
138841925|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
138841926|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138841927|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841928|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841929|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138841930|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138841931|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841932|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841933|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
138841934|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
138841935|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138841936|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138841937|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138841938|NCT02832336|Caffeine|caffeine|mesh-list
138841939|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
138841940|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841941|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139068201|NCT04246762|Omeprazole|omeprazole|mesh-list
138841942|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841943|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138841944|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841945|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138841946|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138841947|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
138841948|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138841950|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
138841951|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
138841952|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138841953|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138841954|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841955|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138841956|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138841957|NCT00621751|Analgesics|analgesics|mesh-ancestor
138841958|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
138841959|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841960|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138841961|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138841962|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841963|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138841964|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138841965|NCT02690792|Vitamin E|vitamin e|mesh-list
138841966|NCT02690792|Vitamins|vitamins|mesh-ancestor
138841967|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
138841968|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841969|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
138841970|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138841971|NCT02690792|Protective Agents|protective agents|mesh-ancestor
138841972|NCT00831649|Natalizumab|natalizumab|mesh-list
138841973|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
138841974|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841975|NCT02841332|Misonidazole|misonidazole|mesh-list
138841976|NCT02841332|Bevacizumab|bevacizumab|mesh-list
138841977|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138841978|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138841979|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138841980|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138841981|NCT02841332|Growth Substances|growth substances|mesh-ancestor
138841982|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841984|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138841985|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138841986|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841988|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138841989|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138841990|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
138841991|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138841992|NCT00156104|Haloperidol|haloperidol|mesh-list
138841993|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
138841994|NCT00156104|Asenapine|asenapine|mesh-list
138841995|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
138841996|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
138841997|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138841998|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841999|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138842000|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138842001|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138842002|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842003|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138842004|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138842005|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
138842006|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842007|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842008|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138842009|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138842010|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138842011|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138842012|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138842013|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842014|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
138842015|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842016|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842017|NCT00891930|Irinotecan|irinotecan|mesh-list
138842018|NCT00891930|Panitumumab|panitumumab|mesh-list
138842019|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138842020|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138842021|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842022|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842023|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842024|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138842025|NCT02831088|Salicylates|salicylates|mesh-list
138842026|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138842027|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138842028|NCT02831088|Analgesics|analgesics|mesh-ancestor
138842029|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
138842030|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842031|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842032|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842033|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138842034|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138842035|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842036|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842038|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138842039|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842040|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138842041|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
138842042|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842043|NCT01615874|Prednisone|prednisone|mesh-list
138842044|NCT01615874|Prednisolone|prednisolone|mesh-list
138842045|NCT01615874|Montelukast|montelukast|mesh-list
138842046|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
138842047|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842048|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
138842049|NCT01615874|Hormones|hormones|mesh-ancestor
138842050|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138842051|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842052|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138842053|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842054|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
138842055|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842056|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138842057|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
138842058|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138842059|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
138842060|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138842061|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138842062|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842063|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138842064|NCT00891462|Bromides|bromides|mesh-list
138842065|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
138842066|NCT04248348|Heparin|heparin|mesh-list
138842067|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138842068|NCT04248348|Tinzaparin|tinzaparin|mesh-list
138842069|NCT04248348|Dalteparin|dalteparin|mesh-list
138842070|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
138842071|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138842072|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138842073|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842074|NCT04245774|Bupivacaine|bupivacaine|mesh-list
138842075|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
138842076|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
138842077|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
138842078|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842079|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842080|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
138842081|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842082|NCT00900146|Metformin|metformin|mesh-list
138842083|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138842084|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842085|NCT00140972|Diclofenac|diclofenac|mesh-list
138842086|NCT00140972|Etoricoxib|etoricoxib|mesh-list
138842087|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138842088|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138842089|NCT00140972|Analgesics|analgesics|mesh-ancestor
138842090|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
138842091|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842092|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842093|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842094|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138842095|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138842096|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842097|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842098|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138842099|NCT02830932|Vaccines|vaccines|mesh-list
138842100|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
138842101|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842102|NCT00895310|Ketoconazole|ketoconazole|mesh-list
138842103|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
138842104|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842105|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
138842106|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842107|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138842108|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138842109|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842110|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842111|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138842112|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
138842113|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138842114|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842115|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138842116|NCT04245618|Cisplatin|cisplatin|mesh-list
138842117|NCT04245618|Gemcitabine|gemcitabine|mesh-list
138842118|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842119|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138842120|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
138842121|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842122|NCT00092768|Celecoxib|celecoxib|mesh-list
138842123|NCT00092768|Etoricoxib|etoricoxib|mesh-list
138842124|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138842125|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138842126|NCT00092768|Analgesics|analgesics|mesh-ancestor
138842127|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
139068330|NCT03799900|Ketamine|ketamine|mesh-list
138842128|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842129|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842130|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842131|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138842132|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138842133|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138842134|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842135|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842136|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
138842137|NCT02831712|Trace Elements|trace elements|mesh-ancestor
138842138|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
138842139|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842141|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842142|NCT02840708|Sargramostim|sargramostim|mesh-list
138842143|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
138842144|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842145|NCT00817076|Desloratadine|desloratadine|mesh-list
138842146|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138842147|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
138842148|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842149|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842150|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842151|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138842152|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138842153|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
138842154|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
138842155|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
138842156|NCT02844062|Fludarabine|fludarabine|mesh-list
138842157|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138842158|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
138842159|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842160|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138842161|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138842162|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
138842163|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842164|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842165|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138842166|NCT02830230|Azithromycin|azithromycin|mesh-list
138842167|NCT02830230|Cefixime|cefixime|mesh-list
138842168|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138842169|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842170|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
138842171|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138842172|NCT00888654|Protective Agents|protective agents|mesh-ancestor
138842173|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842174|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842175|NCT03238430|Morphine|morphine|mesh-list
138842176|NCT03238430|Ropivacaine|ropivacaine|mesh-list
138842178|NCT03238430|Narcotics|narcotics|mesh-ancestor
138842179|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842180|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842181|NCT03238430|Analgesics|analgesics|mesh-ancestor
138842182|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
138842183|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842184|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
138842185|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
138842186|NCT02829840|Azacitidine|azacitidine|mesh-list
138842187|NCT02829840|Ponatinib|ponatinib|mesh-list
138842188|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138842189|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
138842190|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842191|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842192|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842193|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138842194|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138842195|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138842196|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842197|NCT02827890|Incretins|incretins|mesh-ancestor
138842198|NCT02827890|Hormones|hormones|mesh-ancestor
138842199|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138842200|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138842201|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
138842202|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842203|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842204|NCT04250792|Naltrexone|naltrexone|mesh-list
138842205|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138494241|NCT00095134|Risperidone|risperidone|mesh-list
138842206|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138842208|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
138842209|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842210|NCT02840162|Celecoxib|celecoxib|mesh-list
138842211|NCT02840162|Benzenesulfonamide|benzenesulfonamide|mesh-list
138842212|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138842213|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138842214|NCT02840162|Analgesics|analgesics|mesh-ancestor
138842215|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
138842216|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842217|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842218|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842219|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138842220|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138842221|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138842222|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842223|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842224|NCT02840162|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138842225|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138842226|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
138842227|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138842228|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
138842229|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138842230|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842231|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138842232|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138842233|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842234|NCT02827578|Tamsulosin|tamsulosin|mesh-list
138842235|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
138842236|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138842237|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138842238|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138842239|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
138842240|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842241|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842242|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842243|NCT02827578|Urological Agents|urological agents|mesh-ancestor
138842244|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138842245|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138842246|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
138842247|NCT02829372|Antibodies|antibodies|mesh-list
138842248|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138842249|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138842250|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
138842251|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842252|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
138842253|NCT00899678|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138842254|NCT00899678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842255|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138842256|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
138842257|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842258|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138842259|NCT00887484|Clindamycin|clindamycin|mesh-list
138842260|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
138842261|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
138842262|NCT00887484|Adapalene|adapalene|mesh-list
138842263|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138842264|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138842265|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842266|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138842267|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842268|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842269|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
138842270|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138842271|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138842272|NCT00887484|Analgesics|analgesics|mesh-ancestor
138842273|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
138842274|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842275|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842276|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842277|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138842278|NCT00794378|Cetirizine|cetirizine|mesh-list
138842279|NCT00794378|Desloratadine|desloratadine|mesh-list
138842280|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138842281|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138842282|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138842283|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
138842284|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
138842285|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842286|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842287|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842288|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138842289|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
138842290|NCT00789152|Levocetirizine|levocetirizine|mesh-list
138842291|NCT00789152|Desloratadine|desloratadine|mesh-list
138842292|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138842293|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138842294|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
138842295|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
138842296|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842297|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842298|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842299|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138842300|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
138842301|NCT00783458|Fluticasone|fluticasone|mesh-list
138842302|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
138842303|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842304|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138842305|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
138842306|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842307|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842308|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138842309|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
138842310|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
138842311|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138842312|NCT00620659|Modafinil|modafinil|mesh-list
138842313|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138842314|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842315|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138947110|NCT00849615|Antidotes|antidotes|mesh-ancestor
138842316|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138842317|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138842318|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842319|NCT02829060|Gentamicins|gentamicins|mesh-list
138842320|NCT02829060|Ampicillin|ampicillin|mesh-list
138842321|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
138842322|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138842323|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842324|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138842325|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842326|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842327|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138842329|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138842330|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138842331|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842332|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842333|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138842334|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138842335|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138842336|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
138842337|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842338|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842339|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138842340|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138842341|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
138842342|NCT00783146|Fexofenadine|fexofenadine|mesh-list
138842343|NCT00783146|Desloratadine|desloratadine|mesh-list
138842344|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138842345|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
138842346|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842347|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842348|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842349|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138842350|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138842351|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
138842352|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
138494388|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
138842353|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138842354|NCT00844675|Rabeprazole|rabeprazole|mesh-list
138842355|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138842356|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138842357|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138842358|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842359|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842361|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842362|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842363|NCT02826252|Iloprost|iloprost|mesh-list
138842364|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138842365|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
138842366|NCT02839928|Ketamine|ketamine|mesh-list
138842367|NCT02839928|Analgesics|analgesics|mesh-list
138842368|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138842369|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
138842370|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842371|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842372|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138842373|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138842374|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
138842375|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
138842376|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842377|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138842378|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138842379|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842380|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842381|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
138842382|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138842383|NCT05018520|Prednisone|prednisone|mesh-list
138842384|NCT05018520|Rituximab|rituximab|mesh-list
138842385|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
138842386|NCT05018520|Vincristine|vincristine|mesh-list
138842387|NCT05018520|Doxorubicin|doxorubicin|mesh-list
138842388|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138842389|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842390|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
138842391|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842392|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138842393|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138842394|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138842395|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
139068426|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
138842396|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842397|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138842398|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842399|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
138842400|NCT05018520|Hormones|hormones|mesh-ancestor
138842401|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138842402|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138842403|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138842404|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
138842405|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
138842406|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
138842407|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138842408|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138842409|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138842410|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842411|NCT04321746|Ketamine|ketamine|mesh-list
138842412|NCT04321746|Analgesics|analgesics|mesh-ancestor
138842413|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
138842414|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842415|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842416|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138842417|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138842418|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
138842419|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
138842420|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842421|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138842422|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138842423|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842424|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842425|NCT02839694|Celecoxib|celecoxib|mesh-list
138842426|NCT02839694|Decitabine|decitabine|mesh-list
138494463|NCT00096304|Docetaxel|docetaxel|mesh-list
138842427|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
138842428|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138842429|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138842430|NCT02839694|Analgesics|analgesics|mesh-ancestor
138842431|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
138842432|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842433|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842435|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138842436|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138842437|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138842438|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842439|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842440|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138842441|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
138842442|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842443|NCT04243434|Prednisone|prednisone|mesh-list
138842444|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
138842445|NCT04243434|Doxorubicin|doxorubicin|mesh-list
138842446|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138842447|NCT04243434|Vincristine|vincristine|mesh-list
138842448|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138842449|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
138842450|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842451|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138842452|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138842453|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
138842454|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842455|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842456|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138842457|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138842458|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138842459|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138842460|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842461|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842462|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
138842463|NCT04243434|Hormones|hormones|mesh-ancestor
138842464|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138842465|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138842466|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138842467|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
138842468|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
138842469|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
138842471|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
138842472|NCT00832039|Trace Elements|trace elements|mesh-ancestor
138842473|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
138842474|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842475|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
138842476|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138842477|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842478|NCT02826564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138842479|NCT02826564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842480|NCT00839059|Lenalidomide|lenalidomide|mesh-list
138842481|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
138842482|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842483|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138842484|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138842485|NCT00839059|Growth Substances|growth substances|mesh-ancestor
138842486|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
138842487|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842488|NCT02839538|Anesthetics|anesthetics|mesh-list
138842489|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842490|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842491|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138842492|NCT02826174|Anesthetics|anesthetics|mesh-list
138842493|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842494|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842495|NCT00621517|Bupropion|bupropion|mesh-list
138842496|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138842497|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
138842498|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138842499|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138842500|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138842501|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138842502|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842503|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
138842504|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842505|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842506|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138842507|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138842509|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
138842510|NCT02827266|Hematinics|hematinics|mesh-ancestor
138842511|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
138842512|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842513|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138842514|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842515|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842516|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
138842517|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138842518|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842519|NCT02826876|Ropivacaine|ropivacaine|mesh-list
138842520|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
138842521|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
138842522|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842523|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842524|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
138842525|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842526|NCT04244448|Emtricitabine|emtricitabine|mesh-list
138842527|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
138842528|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842529|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138842530|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138842531|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842532|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842533|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138842534|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138842535|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
138842536|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138842537|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138842538|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
138842539|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842540|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138842541|NCT00839371|Midazolam|midazolam|mesh-list
138842542|NCT00839371|Propofol|propofol|mesh-list
138842543|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138842544|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842545|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842546|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138842547|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
138842548|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
138842549|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138842550|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138842551|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138842552|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138842553|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
138842554|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
138842555|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842556|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842557|NCT02826408|Rabeprazole|rabeprazole|mesh-list
138842558|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138842559|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138842560|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138842561|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842562|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842563|NCT00573937|Morphine|morphine|mesh-list
138842564|NCT00573937|Methadone|methadone|mesh-list
138842565|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138842566|NCT00573937|Narcotics|narcotics|mesh-ancestor
138842567|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842568|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842569|NCT00573937|Analgesics|analgesics|mesh-ancestor
138842570|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
138842571|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842572|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
138842573|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
138842574|NCT00845533|Piperaquine|piperaquine|mesh-list
138842575|NCT00845533|Artenimol|artenimol|mesh-list
138842576|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
138842578|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138842579|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842580|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138618202|NCT02963324|Ivermectin|ivermectin|mesh-list
138842581|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138842582|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138842583|NCT04958538|Methotrexate|methotrexate|mesh-list
138842584|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138842585|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
138842586|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138842587|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842588|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138842589|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
138842590|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842591|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842592|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
138842593|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842594|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138842595|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138842596|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
138842597|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138842598|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138842599|NCT02548195|Gemcitabine|gemcitabine|mesh-list
138842600|NCT02548195|Capecitabine|capecitabine|mesh-list
138842601|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
138842602|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138842603|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
138842604|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842605|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842606|NCT00573859|Methylphenidate|methylphenidate|mesh-list
138842607|NCT00573859|Amphetamine|amphetamine|mesh-list
138842608|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138842609|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
138842610|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138842611|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138842612|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842613|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138842614|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138842615|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138842616|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842617|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
138842618|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842619|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138842620|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
138842621|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
138842623|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842624|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
138842625|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138842626|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
138842627|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138842628|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842629|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842630|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138842631|NCT00839605|Analgesics|analgesics|mesh-ancestor
138842632|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
138842633|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842634|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138842635|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138842636|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138842637|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
138842638|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842639|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842640|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
138842641|NCT00839683|Valsartan|valsartan|mesh-list
138842642|NCT00839683|Simvastatin|simvastatin|mesh-list
138842643|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138842644|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138842645|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
138842646|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842647|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138842648|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138842649|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842650|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138842652|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842653|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138842654|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138842655|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138842657|NCT00839761|Trace Elements|trace elements|mesh-ancestor
138842658|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
138842659|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842660|NCT02825394|Ecarin|ecarin|mesh-list
138842661|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138842662|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138842663|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842664|NCT00845611|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138842665|NCT00845611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138842666|NCT00845611|Immunologic Factors|immunologic factors|mesh-ancestor
138842667|NCT00845611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842668|NCT00845689|Adenosine|adenosine|mesh-list
138842669|NCT00845689|Analgesics|analgesics|mesh-ancestor
138842670|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
138842671|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842672|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842673|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138842674|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
138842675|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138842676|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
138842677|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
138842678|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842679|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842680|NCT05660694|Vitamin E|vitamin e|mesh-list
138842681|NCT05660694|Triamcinolone|triamcinolone|mesh-list
138842682|NCT05660694|Pentoxifylline|pentoxifylline|mesh-list
138842683|NCT05660694|Vitamins|vitamins|mesh-ancestor
138842684|NCT05660694|Micronutrients|micronutrients|mesh-ancestor
138842685|NCT05660694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842686|NCT05660694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842687|NCT05660694|Glucocorticoids|glucocorticoids|mesh-ancestor
138842688|NCT05660694|Hormones|hormones|mesh-ancestor
139154402|NCT00698230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138842689|NCT05660694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138842690|NCT05660694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842691|NCT05660694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842692|NCT05660694|Antioxidants|antioxidants|mesh-ancestor
138842693|NCT05660694|Protective Agents|protective agents|mesh-ancestor
138842694|NCT05660694|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138842695|NCT05660694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138842696|NCT05660694|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138842698|NCT05660694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138842700|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
138842701|NCT00840229|Triamcinolone|triamcinolone|mesh-list
138842702|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138842703|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138842704|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138842705|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842706|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
138842707|NCT00840229|Hormones|hormones|mesh-ancestor
138842708|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138842709|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842710|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138842711|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
138842712|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842713|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842714|NCT00831441|Apixaban|apixaban|mesh-list
138842715|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138842716|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
138842717|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138842718|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
138842719|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842720|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842721|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
138842722|NCT00840385|Vidarabine|vidarabine|mesh-list
138842723|NCT00840385|Fludarabine|fludarabine|mesh-list
138842724|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
138494781|NCT00387920|Sunitinib|sunitinib|mesh-list
138842725|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842726|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138842727|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
138842728|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842729|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138842730|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
138842731|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842732|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
138842733|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842734|NCT02824458|Apatinib|apatinib|mesh-list
138842735|NCT02824458|Gefitinib|gefitinib|mesh-list
138842736|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842737|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138842738|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842739|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842740|NCT00840931|Lenalidomide|lenalidomide|mesh-list
138842741|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
138842742|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842743|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138842744|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138842745|NCT00840931|Growth Substances|growth substances|mesh-ancestor
138842746|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
138842747|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842748|NCT05659992|Cytarabine|cytarabine|mesh-list
138842749|NCT05659992|Azacitidine|azacitidine|mesh-list
138842750|NCT05659992|Venetoclax|venetoclax|mesh-list
138842751|NCT05659992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138842752|NCT05659992|Antimetabolites|antimetabolites|mesh-ancestor
138842753|NCT05659992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842754|NCT05659992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842755|NCT05659992|Antiviral Agents|antiviral agents|mesh-ancestor
138842756|NCT05659992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842757|NCT05659992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138842758|NCT05659992|Immunologic Factors|immunologic factors|mesh-ancestor
138842759|NCT05659992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842760|NCT05659992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842761|NCT00834379|Pravastatin|pravastatin|mesh-list
138842762|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138842763|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138842764|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
138842765|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842766|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138842767|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138842768|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842769|NCT00834457|Ritonavir|ritonavir|mesh-list
138842770|NCT00834457|Lopinavir|lopinavir|mesh-list
138842771|NCT00834457|Zidovudine|zidovudine|mesh-list
138842772|NCT00834457|Lamivudine|lamivudine|mesh-list
138842773|NCT00834457|Abacavir|abacavir|mesh-list
138842774|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
138842775|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138842776|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138842777|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
138842778|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842779|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842780|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138842781|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138842782|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
138842783|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842784|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138842785|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138842786|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
138842787|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138842788|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138842789|NCT03851965|Plasminogen|plasminogen|mesh-list
138842790|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138842791|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138842792|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842793|NCT02611635|Warfarin|warfarin|mesh-list
138842794|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
138842795|NCT02611635|Dabigatran|dabigatran|mesh-list
138842796|NCT02611635|Apixaban|apixaban|mesh-list
138842797|NCT02611635|Edoxaban|edoxaban|mesh-list
138494843|NCT00099619|Insulin|insulin|mesh-list
138842798|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
138842799|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138842800|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
138842801|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138842803|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842804|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842805|NCT02824926|Ketoconazole|ketoconazole|mesh-list
138842806|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
138842807|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842808|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138842809|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138842810|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842811|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842812|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138842813|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
138842814|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138842815|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842816|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138842817|NCT00705471|Infliximab|infliximab|mesh-list
138842818|NCT00705471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138842819|NCT00705471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842820|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
138842821|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138842822|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138842823|NCT00705549|Cisplatin|cisplatin|mesh-list
138842824|NCT00705549|Gemcitabine|gemcitabine|mesh-list
138842825|NCT00705549|Docetaxel|docetaxel|mesh-list
138842826|NCT00705549|Vinorelbine|vinorelbine|mesh-list
138842827|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842828|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138842829|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
138842830|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842831|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
138842832|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
138842833|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
138842834|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138842835|NCT02824770|Tramadol|tramadol|mesh-list
138842836|NCT02824770|Bupivacaine|bupivacaine|mesh-list
138842837|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
138842838|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
138842839|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842840|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842841|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
138842842|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842843|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138842844|NCT02824770|Narcotics|narcotics|mesh-ancestor
138842845|NCT02824770|Analgesics|analgesics|mesh-ancestor
138842846|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138842847|NCT02824536|Antibodies|antibodies|mesh-list
138842848|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
138842849|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138842850|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
138842851|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842852|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842853|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
138842854|NCT00831129|Simvastatin|simvastatin|mesh-list
138842855|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138842856|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138842857|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
138842858|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842859|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138842860|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138842861|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842862|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138842863|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842864|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
138842865|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138842866|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
138842867|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842868|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138842869|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842870|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
138842871|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842872|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
138842873|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138842874|NCT00637962|Protective Agents|protective agents|mesh-ancestor
138842875|NCT00913341|Alprazolam|alprazolam|mesh-list
138842876|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138842877|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138842878|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842879|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138842880|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138842881|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138842882|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
138842884|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887299|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138842885|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842886|NCT00620113|Vitamin D|vitamin d|mesh-list
138842887|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
138842888|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
138842889|NCT00620113|Calcium|calcium|mesh-list
138842890|NCT00620113|Vitamins|vitamins|mesh-ancestor
138842891|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
138842892|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842893|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138842894|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138842895|NCT00620113|Antacids|antacids|mesh-ancestor
138842896|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842897|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138842898|NCT00830115|Pantoprazole|pantoprazole|mesh-list
138842899|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138842900|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138842901|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138842902|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842903|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842904|NCT00633672|Esomeprazole|esomeprazole|mesh-list
138842905|NCT00633672|Ranitidine|ranitidine|mesh-list
138842906|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138842907|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138842908|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138842909|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138842910|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842911|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842912|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138842913|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
138842914|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
138842915|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842916|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842917|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
138842918|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138842919|NCT02547103|Mupirocin|mupirocin|mesh-list
138842920|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138842921|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842922|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
138842923|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
138842924|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138842925|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138842926|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842927|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842928|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138842929|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138842930|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842931|NCT02822586|Immunotoxins|immunotoxins|mesh-ancestor
138842932|NCT02822586|Immunoconjugates|immunoconjugates|mesh-ancestor
138842933|NCT02822586|Immunologic Factors|immunologic factors|mesh-ancestor
138842934|NCT02822586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842935|NCT00848809|Vancomycin|vancomycin|mesh-list
138842936|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138842937|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138842938|NCT00834847|Pravastatin|pravastatin|mesh-list
138842939|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138842940|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138842941|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
138842942|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842943|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138842944|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138842945|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842946|NCT00841477|Vaccines|vaccines|mesh-list
138842947|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
138842948|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842949|NCT00834925|Diltiazem|diltiazem|mesh-list
138842950|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138842951|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138842952|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138842953|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842954|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138842955|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842956|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
138842957|NCT00841633|Norepinephrine|norepinephrine|mesh-list
138842958|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138842959|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138842960|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
138842961|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138842962|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842963|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842964|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
138842965|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
138842966|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842967|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138842969|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
138842970|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
138842971|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
138842972|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
138842973|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138842974|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842975|NCT02823912|Antacids|antacids|mesh-ancestor
138842976|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842977|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138842978|NCT00841945|Prednisone|prednisone|mesh-list
138842979|NCT00841945|Rituximab|rituximab|mesh-list
138842980|NCT00841945|Doxorubicin|doxorubicin|mesh-list
138842981|NCT00841945|Vincristine|vincristine|mesh-list
138842982|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138842983|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138842984|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
138842985|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842986|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138842987|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138842988|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138842989|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138842990|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138842991|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842992|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138842994|NCT00841945|Hormones|hormones|mesh-ancestor
138842995|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138842996|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138842997|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138842998|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
138842999|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
138843000|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
138843001|NCT02822196|Lidocaine|lidocaine|mesh-list
138843002|NCT02822196|Bupivacaine|bupivacaine|mesh-list
138843003|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
138843004|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
138843005|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843006|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843007|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
138843008|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843009|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138843010|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138843011|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138843012|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843013|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843014|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
138843015|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138843016|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843017|NCT00829179|Omalizumab|omalizumab|mesh-list
138843018|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138843019|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138843020|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
138843021|NCT00849355|Rituximab|rituximab|mesh-list
138843022|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138843023|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843024|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
138843025|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843026|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138843028|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138843029|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138843030|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138843031|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843032|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843033|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
138843034|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138843035|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138843036|NCT02822742|Latanoprost|latanoprost|mesh-list
138843037|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138843038|NCT00835471|Docetaxel|docetaxel|mesh-list
138843039|NCT00835471|Pemetrexed|pemetrexed|mesh-list
138843040|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138843041|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843042|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
138843043|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
138843044|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
138843045|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843046|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843047|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138843048|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138843049|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138843050|NCT00849511|Melatonin|melatonin|mesh-list
138843051|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
138843052|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843053|NCT00849511|Protective Agents|protective agents|mesh-ancestor
138843054|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843055|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843056|NCT02546791|Dasatinib|dasatinib|mesh-list
138843057|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843058|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138843059|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843060|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843061|NCT00966875|Ixekizumab|ixekizumab|mesh-list
138843062|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
138843063|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
138843064|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138843065|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843066|NCT00835627|Sertraline|sertraline|mesh-list
138843067|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
138843068|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138843069|NCT00835627|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138843070|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138843071|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843072|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843073|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843074|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
138843075|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843076|NCT00842491|Cisplatin|cisplatin|mesh-list
138843077|NCT00842491|Capecitabine|capecitabine|mesh-list
138843078|NCT00842491|Endostar protein|endostar protein|mesh-list
138843079|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843080|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138843081|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
138843082|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843083|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138843084|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138843085|NCT00842491|Growth Substances|growth substances|mesh-ancestor
138843086|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843087|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
138843088|NCT05659212|Lidocaine|lidocaine|mesh-list
138843089|NCT05659212|Magnesium Sulfate|magnesium sulfate|mesh-list
138843090|NCT05659212|Dexmedetomidine|dexmedetomidine|mesh-list
138843091|NCT05659212|Anesthetics, Local|anesthetics, local|mesh-ancestor
138843092|NCT05659212|Anesthetics|anesthetics|mesh-ancestor
138843093|NCT05659212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843094|NCT05659212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843095|NCT05659212|Sensory System Agents|sensory system agents|mesh-ancestor
138843096|NCT05659212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843097|NCT05659212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138843098|NCT05659212|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138843099|NCT05659212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138495151|NCT00400855|Xhance|xhance|mesh-list
138843100|NCT05659212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843101|NCT05659212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843102|NCT05659212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138843103|NCT05659212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138843104|NCT05659212|Analgesics|analgesics|mesh-ancestor
138843105|NCT05659212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138843106|NCT05659212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138843107|NCT05659212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138843108|NCT05659212|Adrenergic Agents|adrenergic agents|mesh-ancestor
138843109|NCT05659212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843110|NCT05659212|Anticonvulsants|anticonvulsants|mesh-ancestor
138843111|NCT05659212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138843112|NCT05659212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138843113|NCT05659212|Tocolytic Agents|tocolytic agents|mesh-ancestor
138843114|NCT05659212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138843115|NCT00835939|Lidocaine|lidocaine|mesh-list
138843116|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
138843117|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
138843118|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843119|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843120|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
138843121|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843122|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138843123|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138843124|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138843125|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843126|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843127|NCT05659368|Tirzepatide|tirzepatide|mesh-list
138843128|NCT05659368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138843129|NCT05659368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843130|NCT05659368|Incretins|incretins|mesh-ancestor
138843131|NCT05659368|Hormones|hormones|mesh-ancestor
138843132|NCT05659368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138843133|NCT00818649|Bortezomib|bortezomib|mesh-list
138843134|NCT00818649|Vorinostat|vorinostat|mesh-list
138843135|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843136|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138843137|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843138|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843139|NCT02861105|Enoxaparin|enoxaparin|mesh-list
138843140|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138843141|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
138843142|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138843143|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138843144|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843145|NCT02820558|Substance P|substance p|mesh-list
138843146|NCT02820558|Neurokinin A|neurokinin a|mesh-list
138843147|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843148|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843149|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843152|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138843153|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
138843154|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843155|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843156|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139068563|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138843157|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138843158|NCT00961571|Growth Substances|growth substances|mesh-ancestor
138843159|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843160|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
138843161|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138843162|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843163|NCT02820948|Vitamins|vitamins|mesh-list
138843164|NCT02820948|Vitamin E|vitamin e|mesh-list
138843165|NCT02820948|Tocopherols|tocopherols|mesh-list
138843166|NCT02820948|Tocotrienols|tocotrienols|mesh-list
138843167|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
138843168|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
138843169|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843170|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
138843171|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843172|NCT02820948|Protective Agents|protective agents|mesh-ancestor
138843173|NCT02860949|Ketorolac|ketorolac|mesh-list
138843174|NCT02860949|Epinephrine|epinephrine|mesh-list
138843175|NCT02860949|Morphine|morphine|mesh-list
138843176|NCT02860949|Bupivacaine|bupivacaine|mesh-list
138843177|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
138843178|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
138843179|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843180|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843181|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
138843182|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843183|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138843184|NCT02860949|Narcotics|narcotics|mesh-ancestor
138843185|NCT02860949|Analgesics|analgesics|mesh-ancestor
138843186|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138843187|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138843188|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
138843189|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843190|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843191|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138843192|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138843193|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
138843194|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138843195|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
138843197|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
138843198|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138843199|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138843200|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139068586|NCT01306318|Diclofenac|diclofenac|mesh-list
138843201|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138843202|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138843203|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138843204|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843205|NCT00964223|Clindamycin|clindamycin|mesh-list
138843206|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
138843207|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
138843208|NCT00964223|Adapalene|adapalene|mesh-list
138843209|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
138843210|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138843211|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138843212|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138843213|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138843214|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843215|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843216|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
138843217|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138843218|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138843220|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
138843221|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843222|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843223|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138586435|NCT06182774|Hormones|hormones|mesh-ancestor
138843224|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138843225|NCT00620815|Vaccines|vaccines|mesh-list
138843226|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
138843227|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
138843228|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843229|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138843230|NCT04238988|Paclitaxel|paclitaxel|mesh-list
138843231|NCT04238988|Carboplatin|carboplatin|mesh-list
138843232|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
138843233|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138843234|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843235|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
138843236|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
138843237|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
138843238|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843239|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138843240|NCT04238988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138843241|NCT04284215|Paclitaxel|paclitaxel|mesh-list
138843242|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138843243|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138843244|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843245|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
138843246|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
138843247|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
138843248|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843249|NCT02816970|Vildagliptin|vildagliptin|mesh-list
138843250|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138495291|NCT00102583|Cyclosporine|cyclosporine|mesh-list
138843251|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843252|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138843253|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
138843254|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843255|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843256|NCT03372941|Dalbavancin|dalbavancin|mesh-list
138843257|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138843258|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138843259|NCT04238832|Nicotine|nicotine|mesh-list
138843260|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138843261|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
138843262|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843263|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843264|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138843265|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138843266|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
138843267|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843268|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843270|NCT04622904|Ketamine|ketamine|mesh-list
138843271|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
138843272|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
138843273|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843274|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843275|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
138843276|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843277|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138843278|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138843279|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138843280|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843281|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843282|NCT04622904|Analgesics|analgesics|mesh-ancestor
138843283|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138843284|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138843285|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
138843286|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138843287|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138843288|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843289|NCT00634062|Lamotrigine|lamotrigine|mesh-list
138843290|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
138948082|NCT00753168|Timolol|timolol|mesh-list
138843291|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138843292|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843293|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843294|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138843295|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843296|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138843297|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138843298|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843299|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138843300|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138843301|NCT00634140|Ezetimibe|ezetimibe|mesh-list
138843302|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138843303|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138843304|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
138843305|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843306|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138843307|NCT02819544|Ropivacaine|ropivacaine|mesh-list
138843308|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
138843309|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
138843310|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843311|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843312|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
138843313|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843314|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
138843315|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138843316|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843317|NCT02818140|Ropivacaine|ropivacaine|mesh-list
138843318|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
138843319|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
138843320|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843321|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843322|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
138843323|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843324|NCT04238208|Lidocaine|lidocaine|mesh-list
138843325|NCT04238208|Capsaicin|capsaicin|mesh-list
138843326|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
138843327|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
138843328|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843329|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843330|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
138843331|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843332|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138843333|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138843334|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138843335|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843336|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843337|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
138843338|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
138843339|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
138843340|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139068620|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
138843341|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138843342|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138843343|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138843344|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843345|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843346|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843347|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138843348|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138843349|NCT02815722|Simvastatin|simvastatin|mesh-list
138843350|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138843351|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138843352|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
138843353|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843354|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138843355|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138843356|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843357|NCT02817750|Zolpidem|zolpidem|mesh-list
138843358|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138843359|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138843360|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843361|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843362|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138843363|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
138843364|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
138843365|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843366|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843367|NCT02815410|Levetiracetam|levetiracetam|mesh-list
138843368|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
138843369|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
138843371|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138843372|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138843373|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
138843374|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
138843375|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138843376|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843377|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843378|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138843379|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843380|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138843381|NCT00961415|Bevacizumab|bevacizumab|mesh-list
138843382|NCT00961415|Pemetrexed|pemetrexed|mesh-list
138843383|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138843384|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843385|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138843386|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138843387|NCT00961415|Growth Substances|growth substances|mesh-ancestor
138843388|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843389|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
138843390|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843391|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843392|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138843393|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138843394|NCT00851227|Conivaptan|conivaptan|mesh-list
138843395|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138843396|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843397|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
138843398|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843399|NCT03365609|Bismuth|bismuth|mesh-list
138843400|NCT03365609|Antacids|antacids|mesh-ancestor
138843401|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843402|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138843403|NCT00963599|Loratadine|loratadine|mesh-list
138843404|NCT00963599|Montelukast|montelukast|mesh-list
138843405|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138843406|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
138843407|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138843408|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
138843409|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138843410|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843411|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138843412|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138843413|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843414|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
138843415|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
138843416|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138843417|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138843418|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138843419|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
138843420|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
138843421|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843422|NCT05636592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138843423|NCT05636592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843424|NCT05636592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138843425|NCT05636592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843426|NCT00851461|Goserelin|goserelin|mesh-list
138843427|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138843428|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843429|NCT04205136|Spironolactone|spironolactone|mesh-list
138843430|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138843431|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
138843432|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138843433|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843434|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138843435|NCT04205136|Diuretics|diuretics|mesh-ancestor
138843436|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
138843437|NCT02815332|Minocycline|minocycline|mesh-list
138843438|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138843439|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138843440|NCT02811354|Osimertinib|osimertinib|mesh-list
138586670|NCT06181032|Cisplatin|cisplatin|mesh-list
138843442|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138843443|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843444|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843445|NCT02810808|Ranibizumab|ranibizumab|mesh-list
138843446|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138843447|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138843448|NCT02810808|Growth Substances|growth substances|mesh-ancestor
138843449|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843450|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
138843451|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843452|NCT00619801|Levocetirizine|levocetirizine|mesh-list
138843453|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138843454|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138843455|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
138843456|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
138843457|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843458|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843459|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843460|NCT02545777|Diclofenac|diclofenac|mesh-list
138843461|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139068645|NCT01306708|Amitriptyline|amitriptyline|mesh-list
138843462|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138843463|NCT02545777|Analgesics|analgesics|mesh-ancestor
138843464|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
138843465|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843466|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843467|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138843468|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138843469|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138843470|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843471|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843473|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138843474|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843475|NCT00962741|Etanercept|etanercept|mesh-list
138843476|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138843477|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138843478|NCT00962741|Analgesics|analgesics|mesh-ancestor
138843479|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
138843480|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887300|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
138843481|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843482|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138843483|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138843484|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138843485|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138843486|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
138843487|NCT00851929|Ambrisentan|ambrisentan|mesh-list
138843488|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138843489|NCT02813382|Bupivacaine|bupivacaine|mesh-list
138843490|NCT02813382|Prilocaine|prilocaine|mesh-list
138843491|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
138843492|NCT02813382|Procaine|procaine|mesh-list
138843493|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
138843494|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
138843495|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843496|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843497|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
138843498|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843499|NCT00619645|Cyclosporine|cyclosporine|mesh-list
138843500|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
138843501|NCT00619645|Fludarabine|fludarabine|mesh-list
138843502|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
138843503|NCT00619645|Busulfan|busulfan|mesh-list
138843504|NCT00619645|Cyclosporins|cyclosporins|mesh-list
138843505|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843506|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138843507|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
138843508|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843510|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
138843511|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843512|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843513|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
138843514|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138843515|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
138843516|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138843517|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138843518|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138843519|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138843520|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
138843521|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138843522|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
138843523|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138843524|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138843525|NCT00852163|Busulfan|busulfan|mesh-list
138843526|NCT00852163|Clofarabine|clofarabine|mesh-list
138843527|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
138843528|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843529|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138843530|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
138843531|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843532|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138843533|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843534|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138843535|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138843536|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
138843537|NCT00855517|Latanoprost|latanoprost|mesh-list
138843538|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138843539|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138843540|NCT02544919|SMOFlipid|smoflipid|mesh-list
138843541|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138843542|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138843543|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138843544|NCT00818259|Dexamethasone|dexamethasone|mesh-list
138843545|NCT00818259|Ondansetron|ondansetron|mesh-list
138843546|NCT00818259|Aprepitant|aprepitant|mesh-list
138843547|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
138843548|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138843549|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
138843550|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
138843551|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843552|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843553|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138843554|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
138843556|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138843557|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138843558|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843559|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
138843560|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
138843561|NCT00818259|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138843562|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138843563|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
138843564|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843565|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843566|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138843567|NCT05578482|Mometasone Furoate|mometasone furoate|mesh-list
138843568|NCT05578482|Dicloxacillin|dicloxacillin|mesh-list
138843569|NCT05578482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138843570|NCT05578482|Dermatologic Agents|dermatologic agents|mesh-ancestor
138843571|NCT05578482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138843572|NCT05578482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138843573|NCT05578482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138843574|NCT02809404|Everolimus|everolimus|mesh-list
138843575|NCT02809404|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138843576|NCT02809404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138843577|NCT02809404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843578|NCT02809404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843579|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138843580|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
138843581|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843582|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843583|NCT00619099|Decitabine|decitabine|mesh-list
138843584|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138843585|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
138843586|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843587|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843588|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843589|NCT02812992|Paclitaxel|paclitaxel|mesh-list
138843590|NCT02812992|Gemcitabine|gemcitabine|mesh-list
138843591|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138843592|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843593|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
138843594|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
138843595|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
138843596|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843597|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138843598|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
138843599|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138843600|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138843601|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138843602|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843603|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843604|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
138843605|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843606|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843607|NCT02812602|Lidocaine|lidocaine|mesh-list
138843608|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
138843609|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
138843610|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843611|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843612|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
138843613|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843614|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138843615|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138843616|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138843617|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843618|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843619|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
138495659|NCT00006470|Vaccines|vaccines|mesh-list
138843620|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138843621|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843622|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843623|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138843624|NCT00837187|Analgesics|analgesics|mesh-ancestor
138843625|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
138843626|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843627|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138843628|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138843629|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138843630|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
138843631|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843632|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843634|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
138843635|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138843636|NCT00962585|Estrogens|estrogens|mesh-ancestor
138843637|NCT00962585|Hormones|hormones|mesh-ancestor
138843638|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138843639|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843640|NCT00621985|Dexamethasone|dexamethasone|mesh-list
138843641|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
138843642|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138843643|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
138843644|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
138843645|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843646|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843647|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138843648|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
138843649|NCT00621985|Hormones|hormones|mesh-ancestor
138843650|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138843651|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138843652|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843653|NCT02812368|Clonidine|clonidine|mesh-list
138843654|NCT02812368|Analgesics|analgesics|mesh-ancestor
138843655|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
138843656|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843657|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843659|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
138843660|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
138843661|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138843662|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138843663|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138843664|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
138843665|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843666|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843668|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138843669|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138843670|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138843671|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
138843672|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843673|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843674|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138843675|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
138843676|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
138843677|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
138843678|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138843679|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138843680|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
138843681|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843682|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843683|NCT00856687|Montelukast|montelukast|mesh-list
138843684|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138843685|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
138843686|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138843687|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
138843688|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138843689|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843690|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138843691|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138843692|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843693|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138843694|NCT02862665|Hematinics|hematinics|mesh-ancestor
138843695|NCT02807922|Zopiclone|zopiclone|mesh-list
138843696|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138843697|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843698|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843699|NCT00861367|Aspirin|aspirin|mesh-list
138843700|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138843701|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138843702|NCT00861367|Analgesics|analgesics|mesh-ancestor
138843703|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
138843704|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619312|NCT01081873|Leuprolide|leuprolide|mesh-list
138843706|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138843707|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138843708|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138843709|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138843710|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843711|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138843712|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138843713|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843714|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
138843715|NCT04285073|Paclitaxel|paclitaxel|mesh-list
138843716|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138843717|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843718|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
138843719|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
138843720|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
138843721|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843722|NCT00861445|Lacosamide|lacosamide|mesh-list
138843723|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
138843724|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138843725|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138843726|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843727|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843728|NCT04284059|Vitamin D|vitamin d|mesh-list
138843729|NCT04284059|Vitamins|vitamins|mesh-list
138843730|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
138843732|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138843733|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
138843734|NCT00852709|Clofarabine|clofarabine|mesh-list
138843735|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138843736|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
138843737|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843738|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138843739|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138843740|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
138843741|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843742|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843743|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138843744|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138843745|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
138843746|NCT00861523|Thiamine|thiamine|mesh-list
138843747|NCT00861523|Promethazine|promethazine|mesh-list
138843748|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
138843749|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
138843750|NCT00861523|Vitamins|vitamins|mesh-ancestor
138843751|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
138843752|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843753|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
138843754|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
138843755|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138843756|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
138843757|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
138843758|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843759|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843760|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138843761|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138843762|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138843763|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843764|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
138843765|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
138843766|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
138843767|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843768|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
138843769|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
138843770|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138843771|NCT02811978|Dexamethasone|dexamethasone|mesh-list
138843772|NCT02811978|Bortezomib|bortezomib|mesh-list
138843773|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138843774|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
138843775|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
138843776|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843777|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843778|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138843779|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
138843780|NCT02811978|Hormones|hormones|mesh-ancestor
138843781|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139068695|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138843782|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138843783|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843785|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843786|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843787|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843788|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138843789|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138843790|NCT04204577|Apatinib|apatinib|mesh-list
138843791|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843792|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138843793|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843794|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843795|NCT00852787|Digoxin|digoxin|mesh-list
138843796|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138843797|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138843798|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843799|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843800|NCT00852787|Protective Agents|protective agents|mesh-ancestor
138843801|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843802|NCT02545465|Riociguat|riociguat|mesh-list
138843803|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
138843804|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843805|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
138843806|NCT00961259|Fenofibrate|fenofibrate|mesh-list
138843807|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138843808|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138843809|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
138843810|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843811|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138843812|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
138843813|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138843814|NCT04283747|Antibodies|antibodies|mesh-list
138843815|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
138843816|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843817|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
138843818|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138843819|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843820|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843821|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138843822|NCT04111926|Analgesics|analgesics|mesh-ancestor
138843823|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
138843824|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843825|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138843826|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138843827|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138843828|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
138843829|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843830|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843831|NCT04041349|Mitogens|mitogens|mesh-list
138843832|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
138843833|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843834|NCT00961181|Paclitaxel|paclitaxel|mesh-list
138843835|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138843836|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843837|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
138843838|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
138843839|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
138843840|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843841|NCT02807610|Propofol|propofol|mesh-list
138843842|NCT02807610|Etomidate|etomidate|mesh-list
138843843|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138843844|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843845|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843846|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138843847|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
138843849|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
138843850|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
138843851|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138843852|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
138843853|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138843854|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138619475|NCT00237627|Bortezomib|bortezomib|mesh-list
138843855|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138843856|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138843857|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843858|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843859|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138843860|NCT00857155|Clopidogrel|clopidogrel|mesh-list
138843861|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138843862|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138843863|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138843864|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138843865|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
138843866|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843867|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843868|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843869|NCT00817635|Eplerenone|eplerenone|mesh-list
138843870|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138843871|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
138843872|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138843873|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843874|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138843875|NCT00817635|Diuretics|diuretics|mesh-ancestor
138843876|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
138843877|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138843878|NCT00853177|Lidocaine|lidocaine|mesh-list
138843879|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
138843881|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843882|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843883|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
138843884|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843885|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138843886|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138843887|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138843888|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843889|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843890|NCT00924079|Nalbuphine|nalbuphine|mesh-list
138843891|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138843892|NCT00924079|Narcotics|narcotics|mesh-ancestor
138843893|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843894|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843895|NCT00924079|Analgesics|analgesics|mesh-ancestor
138843896|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
138843897|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843898|NCT00817479|Dexamethasone|dexamethasone|mesh-list
138843899|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138843900|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
138843901|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
138843902|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843903|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843904|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138843905|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
138843906|NCT00817479|Hormones|hormones|mesh-ancestor
138843907|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138843908|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138843909|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843910|NCT00853411|Prednisone|prednisone|mesh-list
138843911|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138843912|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
138843913|NCT00853411|Hormones|hormones|mesh-ancestor
138843914|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138843915|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843916|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138495963|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
138843917|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843918|NCT04030533|Ustekinumab|ustekinumab|mesh-list
138843919|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138843920|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
138843921|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
138843922|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843923|NCT02807298|Lidocaine|lidocaine|mesh-list
138843924|NCT02807298|Epinephrine|epinephrine|mesh-list
138843925|NCT02807298|Carticaine|carticaine|mesh-list
138843926|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138843927|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138843928|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
138843929|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843930|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843931|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843932|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138843933|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138843934|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
138843935|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138843936|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138843937|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
138843938|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
138843939|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
138843940|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138843941|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
138843942|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
138843943|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843944|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
138843945|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138843946|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138843947|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138843948|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843949|NCT04041427|Albendazole|albendazole|mesh-list
138843950|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
138843951|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138843952|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138843953|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
138843954|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138843955|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138843956|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
138843957|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
138843958|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
138843959|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843960|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138843961|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
138843963|NCT00961961|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138843964|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138843965|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138843966|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843967|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843968|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
138843969|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843970|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138843971|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
138843972|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138843973|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138843974|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138843975|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843976|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
138843977|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138843978|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138843979|NCT02610933|Vitamin K|vitamin k|mesh-list
138843980|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
138843981|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
138843982|NCT02610933|Vitamins|vitamins|mesh-ancestor
138843983|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
138843984|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138843985|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138843986|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
138843987|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138843988|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
138843989|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138843990|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138843991|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
138843992|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138843993|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138843994|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
138843995|NCT02610933|Coagulants|coagulants|mesh-ancestor
138843996|NCT04042441|Insulin|insulin|mesh-list
138843997|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
138843998|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138843999|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844000|NCT00817089|Naltrexone|naltrexone|mesh-list
138844001|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138844002|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138844003|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210351|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138844004|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
138844005|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844006|NCT00857779|Immunomodulating Agents|immunomodulating agents|mesh-list
138844007|NCT00857779|Immunologic Factors|immunologic factors|mesh-ancestor
138844008|NCT00857779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844009|NCT00857935|Permethrin|permethrin|mesh-list
138844010|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844011|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844012|NCT00853879|Vitamins|vitamins|mesh-list
138844013|NCT00853879|Folic Acid|folic acid|mesh-list
138844014|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
138844015|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
138844016|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
138844017|NCT00853879|Pyridoxal|pyridoxal|mesh-list
138844018|NCT00853879|Pyridoxine|pyridoxine|mesh-list
138844019|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
138844020|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
138844021|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844022|NCT00853879|Hematinics|hematinics|mesh-ancestor
138844023|NCT00815919|Prednisone|prednisone|mesh-list
138844024|NCT00815919|Bortezomib|bortezomib|mesh-list
138844025|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138844026|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
138844027|NCT00815919|Hormones|hormones|mesh-ancestor
138844028|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138844029|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844030|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138844031|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844032|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138844033|NCT02545153|Aprotinin|aprotinin|mesh-list
138844034|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
138844035|NCT02545153|Coagulants|coagulants|mesh-ancestor
138844036|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138844037|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138844038|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
138844039|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844040|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844041|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138844042|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138844043|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844044|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138844045|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138844046|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844047|NCT00854035|Incretins|incretins|mesh-ancestor
138844048|NCT00854035|Hormones|hormones|mesh-ancestor
138844049|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138844050|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138844051|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
138844052|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844053|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844054|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
138844055|NCT00957905|Leucovorin|leucovorin|mesh-list
138844056|NCT00957905|Folic Acid|folic acid|mesh-list
138844057|NCT00957905|Fluorouracil|fluorouracil|mesh-list
138844058|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
138844059|NCT00957905|Alvocidib|alvocidib|mesh-list
138844060|NCT00957905|Calcium|calcium|mesh-list
138844061|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
138844062|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138844063|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844064|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138844065|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
138844066|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844067|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138844068|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844069|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138844070|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
138844071|NCT00957905|Antidotes|antidotes|mesh-ancestor
138844072|NCT00957905|Protective Agents|protective agents|mesh-ancestor
138844073|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
138844074|NCT00957905|Vitamins|vitamins|mesh-ancestor
138844075|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
138844076|NCT00957905|Hematinics|hematinics|mesh-ancestor
138844077|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
138844078|NCT00957905|Growth Substances|growth substances|mesh-ancestor
138844079|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138844080|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844081|NCT02804646|Carboplatin|carboplatin|mesh-list
138844082|NCT02804646|Pemetrexed|pemetrexed|mesh-list
138844083|NCT02804646|Endostatins|endostatins|mesh-list
138844084|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844085|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844086|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844087|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138844088|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138844089|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138844090|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138844091|NCT02804646|Growth Substances|growth substances|mesh-ancestor
138844092|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844093|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
138844094|NCT02858297|Triamcinolone|triamcinolone|mesh-list
138844095|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138844096|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138844097|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138844098|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138844099|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
138844100|NCT02858297|Hormones|hormones|mesh-ancestor
138844101|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138844102|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844103|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138844104|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
138844105|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844106|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844107|NCT00858325|Daptomycin|daptomycin|mesh-list
138844108|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138844109|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138844110|NCT02804490|Vitamin A|vitamin a|mesh-list
138844111|NCT02804490|Beta Carotene|beta carotene|mesh-list
138844112|NCT02804490|Provitamins|provitamins|mesh-list
138844113|NCT02804490|Carotenoids|carotenoids|mesh-list
138844114|NCT02804490|Vitamins|vitamins|mesh-ancestor
138844115|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
138844116|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844117|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
139068738|NCT01304836|Tacrolimus|tacrolimus|mesh-list
138844118|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844119|NCT02804490|Protective Agents|protective agents|mesh-ancestor
138844120|NCT00960323|Colchicine|colchicine|mesh-list
138844121|NCT00960323|Atorvastatin|atorvastatin|mesh-list
138844122|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138844123|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138844124|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
138844125|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844126|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138844127|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138844128|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844129|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
138844130|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138844131|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
138844132|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
138844133|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
138844134|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844135|NCT00617929|Rituximab|rituximab|mesh-list
138844136|NCT00617929|Clofarabine|clofarabine|mesh-list
138844137|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
138844138|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138844139|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138844140|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844141|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
138844142|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844143|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138844144|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138844145|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138844146|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
138844147|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844148|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
138844149|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138844150|NCT02800590|Abp-700|abp-700|mesh-list
138844151|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138844152|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
138844153|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
138844154|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844155|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844156|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844157|NCT00815295|Cetuximab|cetuximab|mesh-list
138844158|NCT00815295|Sorafenib|sorafenib|mesh-list
138844159|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138844160|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844161|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138844162|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844163|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844164|NCT00630383|Histamine|histamine|mesh-list
138844165|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
138844166|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
138844167|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844168|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844169|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844170|NCT02806752|Triamcinolone|triamcinolone|mesh-list
138844171|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138844172|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138844173|NCT02806752|Ranibizumab|ranibizumab|mesh-list
138844174|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138844175|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138844176|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138844177|NCT02806752|Growth Substances|growth substances|mesh-ancestor
138844178|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844179|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
138844180|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844181|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138844182|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
138844184|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138844185|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138844186|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
138844187|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844188|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844189|NCT00854425|Asparaginase|asparaginase|mesh-list
138844190|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844191|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138844192|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138844193|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138844194|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
138844195|NCT02544529|Laxatives|laxatives|mesh-ancestor
138844196|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138844197|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138844198|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844199|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844200|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
138844201|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844202|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844203|NCT02544529|Miotics|miotics|mesh-ancestor
138844204|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
138844205|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844206|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138844207|NCT02806596|Sevoflurane|sevoflurane|mesh-list
138844208|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138844209|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138844210|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
138844211|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
138844212|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138844213|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844214|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138844215|NCT00854503|Simvastatin|simvastatin|mesh-list
138844216|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138844217|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138844218|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
138844219|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844220|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138844221|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138844222|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844223|NCT00858715|Aspirin|aspirin|mesh-list
138844224|NCT00858715|Clopidogrel|clopidogrel|mesh-list
138844225|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138844226|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138844227|NCT00858715|Analgesics|analgesics|mesh-ancestor
138844228|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
138844229|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844230|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844231|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138844232|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138844233|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138844234|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138844235|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844236|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138844237|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138844238|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844239|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
138844240|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138844241|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138844242|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138844243|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
138844244|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844245|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138844246|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
138844247|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844248|NCT00960869|Aspirin|aspirin|mesh-list
138844249|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138844250|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138844251|NCT00960869|Analgesics|analgesics|mesh-ancestor
138844252|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
139154412|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138844253|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844254|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844255|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138844256|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138844257|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138844258|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138844259|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844260|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138844261|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138844262|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844263|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
138844264|NCT02799888|Cyclosporine|cyclosporine|mesh-list
138844266|NCT02799888|Methotrexate|methotrexate|mesh-list
138844267|NCT02799888|Tacrolimus|tacrolimus|mesh-list
138844268|NCT02799888|Cyclosporins|cyclosporins|mesh-list
138844269|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138844270|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
138844271|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138844272|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844273|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138844274|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
138844275|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844276|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844277|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
138844278|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844279|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138844280|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138844281|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
139068807|NCT01306006|Vaccines|vaccines|mesh-list
138844282|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138844283|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138844284|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138844285|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
138844286|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138844287|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138844288|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138844289|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138844290|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138844291|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
138844292|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138844293|NCT00859105|Imiquimod|imiquimod|mesh-list
138844294|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138844295|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
138844296|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844297|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496331|NCT00401479|Solabegron|solabegron|mesh-list
138844298|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
138844299|NCT00859183|Sirolimus|sirolimus|mesh-list
138844300|NCT00859183|Temsirolimus|temsirolimus|mesh-list
138844301|NCT00859183|MTOR Inhibitors|mtor inhibitors|mesh-list
138844302|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138844303|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138844304|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138844305|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844306|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
138844307|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138844308|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
138844309|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844310|NCT00859183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138844312|NCT00859183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844313|NCT02803944|Azithromycin|azithromycin|mesh-list
138844314|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138844315|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138844316|NCT05980260|Analgesics, Opioid|analgesics, opioid|mesh-list
138844317|NCT05980260|Narcotics|narcotics|mesh-ancestor
138844318|NCT05980260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138844319|NCT05980260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844320|NCT05980260|Analgesics|analgesics|mesh-ancestor
138844321|NCT05980260|Sensory System Agents|sensory system agents|mesh-ancestor
138844322|NCT05980260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844323|NCT05980156|Hydroxychloroquine|hydroxychloroquine|mesh-list
138844324|NCT05980156|Chloroquine|chloroquine|mesh-list
138844325|NCT05980156|Pyrimethamine|pyrimethamine|mesh-list
138844326|NCT05980156|Piperaquine|piperaquine|mesh-list
138844327|NCT05980156|Sulfadoxine|sulfadoxine|mesh-list
138844328|NCT05980156|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138844329|NCT05980156|Artenimol|artenimol|mesh-list
138844330|NCT05980156|Antimalarials|antimalarials|mesh-ancestor
138844331|NCT05980156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138844332|NCT05980156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138844333|NCT05980156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138844334|NCT05980156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844335|NCT05980156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844336|NCT05980156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138844338|NCT05980156|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138844339|NCT05980156|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138844341|NCT05979961|Gemcitabine|gemcitabine|mesh-list
138844342|NCT05979961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844343|NCT05979961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138844344|NCT05979961|Antimetabolites|antimetabolites|mesh-ancestor
138844345|NCT05979961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844346|NCT05979909|Mitomycins|mitomycins|mesh-list
138844347|NCT05979909|Mitomycin|mitomycin|mesh-list
138844348|NCT05979909|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138844349|NCT05979909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844350|NCT05979909|Alkylating Agents|alkylating agents|mesh-ancestor
138844351|NCT05979909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068810|NCT03794440|Sorafenib|sorafenib|mesh-list
138844352|NCT05979909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138844353|NCT05979909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844354|NCT05979636|Fluorides|fluorides|mesh-list
138844355|NCT05979636|Cariostatic Agents|cariostatic agents|mesh-ancestor
138844356|NCT05979636|Protective Agents|protective agents|mesh-ancestor
138844357|NCT05979636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844358|NCT05979558|Dexmedetomidine|dexmedetomidine|mesh-list
138844359|NCT05979558|Ropivacaine|ropivacaine|mesh-list
138844360|NCT05979558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138844361|NCT05979558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138844362|NCT05979558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844363|NCT05979558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138844364|NCT05979558|Analgesics|analgesics|mesh-ancestor
138844365|NCT05979558|Sensory System Agents|sensory system agents|mesh-ancestor
138844366|NCT05979558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844367|NCT05979558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138844368|NCT05979558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138844369|NCT05979558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138844370|NCT05979558|Adrenergic Agents|adrenergic agents|mesh-ancestor
138844371|NCT05979558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844372|NCT05979558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844373|NCT05979558|Anesthetics, Local|anesthetics, local|mesh-ancestor
138496405|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138844374|NCT05979558|Anesthetics|anesthetics|mesh-ancestor
138844375|NCT05979324|Coal Tar|coal tar|mesh-list
138844376|NCT05979324|Keratolytic Agents|keratolytic agents|mesh-ancestor
138844377|NCT05979324|Dermatologic Agents|dermatologic agents|mesh-ancestor
138844378|NCT05979298|Gemcitabine|gemcitabine|mesh-list
138844379|NCT05979298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138844380|NCT05979298|Antimetabolites|antimetabolites|mesh-ancestor
138844381|NCT05979298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844382|NCT05979298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844383|NCT05979220|Letrozole|letrozole|mesh-list
138844384|NCT05979220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844385|NCT05979220|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138844386|NCT05979220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138844387|NCT05979220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844388|NCT05979220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844389|NCT05979220|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138844390|NCT05979220|Hormone Antagonists|hormone antagonists|mesh-ancestor
138844391|NCT05979220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138844392|NCT05979220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844393|NCT05978726|Aspirin|aspirin|mesh-list
138844394|NCT05978726|Clopidogrel|clopidogrel|mesh-list
138844395|NCT05978726|Ticagrelor|ticagrelor|mesh-list
138844396|NCT05978726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138844397|NCT05978726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138844398|NCT05978726|Analgesics|analgesics|mesh-ancestor
138844399|NCT05978726|Sensory System Agents|sensory system agents|mesh-ancestor
138844400|NCT05978726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844401|NCT05978726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844402|NCT05978726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138844403|NCT05978726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138844404|NCT05978726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138844405|NCT05978726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138844406|NCT05978726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844407|NCT05978726|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138844408|NCT05978726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138844409|NCT05978726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844410|NCT05978726|Antipyretics|antipyretics|mesh-ancestor
138844411|NCT05978726|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138844412|NCT05978726|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138844413|NCT05978726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138844414|NCT05978726|Purinergic Agents|purinergic agents|mesh-ancestor
138844415|NCT05978726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844416|NCT05978609|Gemcitabine|gemcitabine|mesh-list
138844417|NCT05978609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844418|NCT05978609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138844419|NCT05978609|Antimetabolites|antimetabolites|mesh-ancestor
138844420|NCT05978609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844421|NCT05978505|Reboxetine|reboxetine|mesh-list
138844422|NCT05978505|Antidepressive Agents|antidepressive agents|mesh-ancestor
138844423|NCT05978505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138844424|NCT05978505|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138844425|NCT05978505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138844426|NCT05978505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138844427|NCT05978505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844428|NCT05978505|Adrenergic Agents|adrenergic agents|mesh-ancestor
138844429|NCT05978505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844430|NCT05978505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844431|NCT05978401|Paclitaxel|paclitaxel|mesh-list
138844432|NCT05978401|Carboplatin|carboplatin|mesh-list
138844433|NCT05978401|Pemetrexed|pemetrexed|mesh-list
138844434|NCT05978401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138844435|NCT05978401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844436|NCT05978401|Tubulin Modulators|tubulin modulators|mesh-ancestor
138844437|NCT05978401|Antimitotic Agents|antimitotic agents|mesh-ancestor
138844438|NCT05978401|Mitosis Modulators|mitosis modulators|mesh-ancestor
138844439|NCT05978401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844440|NCT05978401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844441|NCT05978401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138844442|NCT05978401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138844443|NCT05978193|Immunomodulating Agents|immunomodulating agents|mesh-list
138844444|NCT05978193|Immunologic Factors|immunologic factors|mesh-ancestor
138844445|NCT05978193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844446|NCT05978167|Methylphenidate|methylphenidate|mesh-list
138844447|NCT05978167|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138844448|NCT05978167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844449|NCT05978167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138844450|NCT05978167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138844451|NCT05978167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138844452|NCT05978167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844454|NCT05978167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844455|NCT05978050|Paclitaxel|paclitaxel|mesh-list
138844456|NCT05978050|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138844457|NCT05978050|Nimotuzumab|nimotuzumab|mesh-list
138844458|NCT05978050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138844459|NCT05978050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844460|NCT05978050|Tubulin Modulators|tubulin modulators|mesh-ancestor
138844461|NCT05978050|Antimitotic Agents|antimitotic agents|mesh-ancestor
138844462|NCT05978050|Mitosis Modulators|mitosis modulators|mesh-ancestor
138844463|NCT05978050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844464|NCT05978050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138844466|NCT05977868|Moxifloxacin|moxifloxacin|mesh-list
138844467|NCT05977868|Metronidazole|metronidazole|mesh-list
138844468|NCT05977868|Vancomycin|vancomycin|mesh-list
138844469|NCT05977868|Doxycycline|doxycycline|mesh-list
138844470|NCT05977868|Ciprofloxacin|ciprofloxacin|mesh-list
138844471|NCT05977868|Levofloxacin|levofloxacin|mesh-list
138844472|NCT05977868|Rifampin|rifampin|mesh-list
138844473|NCT05977868|Meropenem|meropenem|mesh-list
138844474|NCT05977868|Cefazolin|cefazolin|mesh-list
138844475|NCT05977868|Tazobactam|tazobactam|mesh-list
138844476|NCT05977868|Linezolid|linezolid|mesh-list
138844477|NCT05977868|Piperacillin|piperacillin|mesh-list
138844478|NCT05977868|Clavulanic Acid|clavulanic acid|mesh-list
138844479|NCT05977868|Daptomycin|daptomycin|mesh-list
138844480|NCT05977868|Penicillins|penicillins|mesh-list
138844481|NCT05977868|Ceftazidime|ceftazidime|mesh-list
138844482|NCT05977868|Cephalexin|cephalexin|mesh-list
138844484|NCT05977868|Cefepime|cefepime|mesh-list
138844485|NCT05977868|Ertapenem|ertapenem|mesh-list
138844486|NCT05977868|Tigecycline|tigecycline|mesh-list
138844487|NCT05977868|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138587705|NCT05108974|Choline|choline|mesh-list
138844488|NCT05977868|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138844489|NCT05977868|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138844490|NCT05977868|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138844491|NCT05977868|Avibactam|avibactam|mesh-list
138844492|NCT05977868|Sulbactam|sulbactam|mesh-list
138844493|NCT05977868|Dalbavancin|dalbavancin|mesh-list
138844494|NCT05977868|Oritavancin|oritavancin|mesh-list
138844495|NCT05977868|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
138844496|NCT05977868|Oxacillin|oxacillin|mesh-list
138844497|NCT05977868|Cefadroxil|cefadroxil|mesh-list
138844498|NCT05977868|Cefpodoxime|cefpodoxime|mesh-list
138844499|NCT05977868|Sultamicillin|sultamicillin|mesh-list
138844500|NCT05977868|Trimethoprim|trimethoprim|mesh-list
138844501|NCT05977868|Sulfamethoxazole|sulfamethoxazole|mesh-list
138844502|NCT05977868|Delafloxacin|delafloxacin|mesh-list
138844503|NCT05977868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138844504|NCT05977868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138844505|NCT05977868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138844506|NCT05977868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138844507|NCT05977868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844508|NCT05977868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844509|NCT05977868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844510|NCT05977868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138844511|NCT05977868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138844512|NCT05977868|Antimalarials|antimalarials|mesh-ancestor
138844513|NCT05977868|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138844514|NCT05977868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138844515|NCT05977868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138844516|NCT05977868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138844517|NCT05977868|Antitubercular Agents|antitubercular agents|mesh-ancestor
138844518|NCT05977868|Leprostatic Agents|leprostatic agents|mesh-ancestor
138844519|NCT05977868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138844520|NCT05977868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138844521|NCT05977868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138844522|NCT05977868|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138496557|NCT00401674|Carboplatin|carboplatin|mesh-list
138844523|NCT05977868|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138844524|NCT05977868|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138844525|NCT05977868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138844526|NCT05977868|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138844527|NCT05977868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138844528|NCT05977868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138844529|NCT05977868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138844530|NCT05977868|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138844531|NCT05974241|Aripiprazole|aripiprazole|mesh-list
138844532|NCT05974241|Methylphenidate|methylphenidate|mesh-list
138844533|NCT05974241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138844534|NCT05974241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844535|NCT05974241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138844536|NCT05974241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138844537|NCT05974241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138844538|NCT05974241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844539|NCT05974241|Dopamine Agents|dopamine agents|mesh-ancestor
138844540|NCT05974241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844541|NCT05974241|Antidepressive Agents|antidepressive agents|mesh-ancestor
138844542|NCT05974241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138844543|NCT05974241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138844544|NCT05974241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138844545|NCT05974241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138844546|NCT05974241|Dopamine Agonists|dopamine agonists|mesh-ancestor
139068833|NCT03713320|Vorinostat|vorinostat|mesh-list
138844547|NCT05974241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138844548|NCT05974241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138844549|NCT05974241|Serotonin Agents|serotonin agents|mesh-ancestor
138844550|NCT05974241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138844551|NCT05974241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138844552|NCT05974241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138844553|NCT05974241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138844554|NCT05969587|Cysteamine|cysteamine|mesh-list
138844555|NCT05969587|Hydroquinone|hydroquinone|mesh-list
138844556|NCT05969587|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138844557|NCT05969587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844558|NCT05969587|Antioxidants|antioxidants|mesh-ancestor
138844559|NCT05969587|Protective Agents|protective agents|mesh-ancestor
138844576|NCT05929898|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138844577|NCT05929898|Sympathomimetics|sympathomimetics|mesh-ancestor
138844578|NCT05929898|Autonomic Agents|autonomic agents|mesh-ancestor
138844579|NCT05929898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844580|NCT05929898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844581|NCT05929898|Dopamine Agents|dopamine agents|mesh-ancestor
138844582|NCT05929898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844583|NCT05929898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844584|NCT05929898|Protective Agents|protective agents|mesh-ancestor
138844590|NCT05836740|Minocycline|minocycline|mesh-list
138844591|NCT05836740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138844592|NCT05836740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138844593|NCT05825430|Bupivacaine|bupivacaine|mesh-list
138844594|NCT05825430|Anesthetics|anesthetics|mesh-list
138844595|NCT05825430|Anesthetics, General|anesthetics, general|mesh-list
138844596|NCT05825430|Anesthetics, Local|anesthetics, local|mesh-ancestor
138844597|NCT05825430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138844598|NCT05825430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844599|NCT05825430|Sensory System Agents|sensory system agents|mesh-ancestor
138844600|NCT05825430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844602|NCT05782270|Anticoagulants|anticoagulants|mesh-ancestor
138844603|NCT05780710|Antihypertensive Agents|antihypertensive agents|mesh-list
138844605|NCT05602519|Propofol|propofol|mesh-list
138844606|NCT05602519|Rocuronium|rocuronium|mesh-list
138844607|NCT05602519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138844608|NCT05602519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138844609|NCT05602519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844610|NCT05602519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138844611|NCT05602519|Anesthetics, General|anesthetics, general|mesh-ancestor
138844613|NCT05602519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138844614|NCT05602519|Narcotics|narcotics|mesh-ancestor
138844615|NCT05602519|Analgesics|analgesics|mesh-ancestor
138844616|NCT05602519|Sensory System Agents|sensory system agents|mesh-ancestor
138844617|NCT05602519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844618|NCT05602519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138844619|NCT05602519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138844620|NCT05602519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138844621|NCT05602519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138844622|NCT05487885|Ketamine|ketamine|mesh-list
138844623|NCT05487885|Analgesics|analgesics|mesh-ancestor
138844624|NCT05487885|Sensory System Agents|sensory system agents|mesh-ancestor
138844625|NCT05487885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844626|NCT05487885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844627|NCT05487885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138844628|NCT05487885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138844629|NCT05487885|Anesthetics, General|anesthetics, general|mesh-ancestor
138844630|NCT05487885|Anesthetics|anesthetics|mesh-ancestor
138844631|NCT05487885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138844632|NCT05487885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138844633|NCT05487885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138844634|NCT05487885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844635|NCT05487885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844636|NCT05445609|Nivolumab|nivolumab|mesh-list
138844637|NCT05445609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138844638|NCT05445609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844639|NCT05445609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138844640|NCT05445609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844641|NCT05442060|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138844642|NCT05442060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844643|NCT05442060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138844644|NCT05442060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844645|NCT05442060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844646|NCT05406388|Fentanyl|fentanyl|mesh-list
138844647|NCT05406388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138844648|NCT05406388|Narcotics|narcotics|mesh-ancestor
138844649|NCT05406388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138844650|NCT05406388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844651|NCT05406388|Analgesics|analgesics|mesh-ancestor
138844652|NCT05406388|Sensory System Agents|sensory system agents|mesh-ancestor
138844653|NCT05406388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844654|NCT05406388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138844655|NCT05406388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138844656|NCT05406388|Anesthetics, General|anesthetics, general|mesh-ancestor
138844657|NCT05406388|Anesthetics|anesthetics|mesh-ancestor
138844658|NCT05403502|Insulin|insulin|mesh-list
138844659|NCT05403502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138844660|NCT05403502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844661|NCT05399550|Balovaptan|balovaptan|mesh-list
138844662|NCT05399550|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138844663|NCT05399550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844664|NCT05399550|Natriuretic Agents|natriuretic agents|mesh-ancestor
138844665|NCT05399550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844666|NCT05239468|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138844667|NCT05239468|Bezafibrate|bezafibrate|mesh-list
138844668|NCT05239468|Cathartics|cathartics|mesh-ancestor
138844669|NCT05239468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138844670|NCT05239468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138844671|NCT05239468|Antimetabolites|antimetabolites|mesh-ancestor
138844672|NCT05239468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844673|NCT05239468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138844674|NCT05230810|Fulvestrant|fulvestrant|mesh-list
138844675|NCT05230810|Tucatinib|tucatinib|mesh-list
138496641|NCT00007592|Furosemide|furosemide|mesh-list
138844676|NCT05230810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138844677|NCT05230810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844678|NCT05230810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138844679|NCT05230810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138844680|NCT05230810|Hormone Antagonists|hormone antagonists|mesh-ancestor
138844681|NCT05230810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138844682|NCT05230810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844683|NCT05230810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138844684|NCT05230810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844685|NCT05230810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844687|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
138844688|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844689|NCT05168657|Pancrelipase|pancrelipase|mesh-list
138844690|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138844691|NCT05135910|Terbinafine|terbinafine|mesh-list
138844692|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
138844693|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138844694|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844695|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844696|NCT05105035|Meropenem|meropenem|mesh-list
138844697|NCT05105035|Ceftazidime|ceftazidime|mesh-list
138844698|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138844699|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138844700|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
138844701|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138844702|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
138844703|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138844704|NCT05074121|Expectorants|expectorants|mesh-ancestor
138844705|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
138844706|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138844707|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
139068855|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844708|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844709|NCT05074121|Protective Agents|protective agents|mesh-ancestor
138844710|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844711|NCT05074121|Antidotes|antidotes|mesh-ancestor
138844712|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
138844713|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138844714|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844715|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844716|NCT04960618|Gemcitabine|gemcitabine|mesh-list
138844717|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
138844718|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138844719|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
138844720|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844721|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844722|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138844723|NCT04960618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138844724|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
138844725|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
138844726|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
138844727|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844728|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844729|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138844730|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138844731|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
138844732|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
138844733|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844734|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844736|NCT04900792|Temozolomide|temozolomide|mesh-list
138844737|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138844738|NCT04900792|Vitamins|vitamins|mesh-ancestor
138844739|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
138844740|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844741|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138844742|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
138844743|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844744|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844745|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
138844746|NCT04900792|Protective Agents|protective agents|mesh-ancestor
138844747|NCT04900792|Hematinics|hematinics|mesh-ancestor
138844748|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138844749|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138844750|NCT04882202|Acetaminophen|acetaminophen|mesh-list
138844751|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138844752|NCT04882202|Analgesics|analgesics|mesh-ancestor
138844753|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
138844754|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844755|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844756|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
138844757|NCT04822350|Avelumab|avelumab|mesh-list
138844758|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138844759|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844760|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
138844761|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138844762|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844763|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138844764|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844766|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844767|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
138844768|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844769|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844770|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138844771|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138844772|NCT04594694|Bezafibrate|bezafibrate|mesh-list
138844773|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138844774|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
138844775|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844776|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138844777|NCT04586504|Midazolam|midazolam|mesh-list
138844778|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138844779|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138844780|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138844781|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844782|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138844783|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138844784|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138844785|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138844786|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
138844787|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
138844788|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
138844789|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
138844790|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844791|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844792|NCT04544995|Niraparib|niraparib|mesh-list
138844793|NCT04544995|Dostarlimab|dostarlimab|mesh-list
138844794|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138844795|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844796|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844797|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844798|NCT04479306|Osimertinib|osimertinib|mesh-list
138844799|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844800|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138844801|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844802|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844803|NCT04449952|Listerine|listerine|mesh-list
138844804|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
138844805|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
138844806|NCT04449952|Protective Agents|protective agents|mesh-ancestor
138844807|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844808|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138844809|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138844810|NCT04419389|Rituximab|rituximab|mesh-list
138844811|NCT04419389|Venetoclax|venetoclax|mesh-list
138844812|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
138844813|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138844814|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844815|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
138844816|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844817|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138844818|NCT04410991|Teriflunomide|teriflunomide|mesh-list
138844819|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138844820|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138844821|NCT04410991|Analgesics|analgesics|mesh-ancestor
138844822|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
138844823|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844824|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496796|NCT00113503|Azathioprine|azathioprine|mesh-list
138844825|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138844826|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138844827|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138844828|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
138844829|NCT04410978|Teriflunomide|teriflunomide|mesh-list
138844830|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138844831|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138844832|NCT04410978|Analgesics|analgesics|mesh-ancestor
138844833|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
138844834|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844835|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844836|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138844837|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138844838|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138844839|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
138844840|NCT04373707|Enoxaparin|enoxaparin|mesh-list
138844841|NCT04373707|Dalteparin|dalteparin|mesh-list
138844842|NCT04373707|Tinzaparin|tinzaparin|mesh-list
138844843|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138844844|NCT04373707|Nadroparin|nadroparin|mesh-list
138844845|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
138844846|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
138844847|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138844848|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138844849|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844850|NCT04335383|Antibodies|antibodies|mesh-list
138844851|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
138844852|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844853|NCT04211259|Loratadine|loratadine|mesh-list
138844854|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
138844855|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
138844856|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138844857|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138844858|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138844859|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
138844860|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
138844861|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844862|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844863|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844864|NCT04116320|Poly ICLC|poly iclc|mesh-list
138844865|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
138844866|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
138844867|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844868|NCT04094311|Tisagenlecleucel|tisagenlecleucel|mesh-list
139068909|NCT01305148|Warfarin|warfarin|mesh-list
138844869|NCT04094311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138844870|NCT04094311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844871|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138844872|NCT03934905|Sulforaphane|sulforaphane|mesh-list
138844873|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138844874|NCT03934905|Protective Agents|protective agents|mesh-ancestor
138844875|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844876|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844877|NCT03916263|Metformin|metformin|mesh-list
138844878|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138844879|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844880|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
138844881|NCT03889418|Narcotics|narcotics|mesh-ancestor
138844882|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138844883|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844884|NCT03889418|Analgesics|analgesics|mesh-ancestor
138844885|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
138844886|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844887|NCT03788694|Ketamine|ketamine|mesh-list
138844888|NCT03788694|Analgesics|analgesics|mesh-ancestor
138844889|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
138844890|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844891|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844892|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138844893|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138844894|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
138844895|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
138844896|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138844897|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138844898|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138844899|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844900|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844901|NCT03749109|Quinagolide|quinagolide|mesh-list
138844902|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
138844903|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
138844904|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844905|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844906|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844907|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
138844908|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138844909|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844910|NCT03709706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138844911|NCT03709706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844912|NCT03555188|Ondansetron|ondansetron|mesh-list
138844913|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
138844914|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
138844915|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844916|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844917|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138844918|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
138844919|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
138844920|NCT03555188|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138844921|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138844922|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
138844923|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844924|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844925|NCT03547115|Venetoclax|venetoclax|mesh-list
138844926|NCT03547115|Voruciclib|voruciclib|mesh-list
139068931|NCT01308346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844927|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844928|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138844929|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844930|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844931|NCT03497689|Treprostinil|treprostinil|mesh-list
138844932|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138844933|NCT03492437|Tepotinib|tepotinib|mesh-list
138844934|NCT03492437|Dabigatran|dabigatran|mesh-list
138844935|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
138844936|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138844937|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
138844938|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844939|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844940|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
138844941|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844942|NCT03466294|Azacitidine|azacitidine|mesh-list
138844943|NCT03466294|Venetoclax|venetoclax|mesh-list
138844944|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138844945|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
138844946|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844947|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844948|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844949|NCT03363867|Bevacizumab|bevacizumab|mesh-list
138844950|NCT03363867|Atezolizumab|atezolizumab|mesh-list
138844951|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138844952|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844953|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138844954|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138844955|NCT03363867|Growth Substances|growth substances|mesh-ancestor
139154414|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
138844956|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138844957|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
138844958|NCT03363867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138844959|NCT03363867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844960|NCT03310125|Colchicine|colchicine|mesh-list
138844961|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
138844962|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138844963|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
138844964|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
138844965|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
138844966|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844967|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844968|NCT03193853|Paclitaxel|paclitaxel|mesh-list
138844969|NCT03193853|Serabelisib|serabelisib|mesh-list
138844970|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138844971|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138844972|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
138844973|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
138844974|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
138844975|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844976|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138844977|NCT03191084|Dronabinol|dronabinol|mesh-list
138844978|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
138844980|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138844981|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138844982|NCT03191084|Analgesics|analgesics|mesh-ancestor
138844983|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
138844984|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138844985|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138844986|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138844987|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138844988|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844989|NCT03191084|Hormones|hormones|mesh-ancestor
138844990|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138844991|NCT03005366|Flecainide|flecainide|mesh-list
138844992|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138844993|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138844994|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138844995|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138844996|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138844997|NCT02738866|Fulvestrant|fulvestrant|mesh-list
138844998|NCT02738866|Palbociclib|palbociclib|mesh-list
138844999|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138845000|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845001|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138845002|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138845003|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
138845004|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138845005|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845006|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138845007|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588236|NCT04072497|Vaccines|vaccines|mesh-list
138845008|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845009|NCT02576912|Dronabinol|dronabinol|mesh-list
138845010|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
138845011|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845012|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845013|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138845014|NCT02576912|Analgesics|analgesics|mesh-ancestor
138845015|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
138845016|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845017|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138845018|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138845019|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845020|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845021|NCT02576912|Hormones|hormones|mesh-ancestor
138845022|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138845023|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
138845024|NCT02232152|Fluorouracil|fluorouracil|mesh-list
138845025|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
138845026|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845027|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138845028|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845029|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138845030|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
138845031|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845032|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
138845033|NCT02232152|Protective Agents|protective agents|mesh-ancestor
138845034|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
138845036|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
138845037|NCT02102113|Dronabinol|dronabinol|mesh-list
138845038|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
138845039|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845040|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845041|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138845042|NCT02102113|Analgesics|analgesics|mesh-ancestor
138845043|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
138845044|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845045|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138845046|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138845047|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845048|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845049|NCT02102113|Hormones|hormones|mesh-ancestor
138497085|NCT00008177|Iodine|iodine|mesh-list
138845050|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138845051|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138845052|NCT02070705|Hematinics|hematinics|mesh-ancestor
138845053|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138845054|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138845055|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
138845056|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138845057|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138845058|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845059|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
138845060|NCT01980355|Coagulants|coagulants|mesh-ancestor
138845061|NCT01758432|Apixaban|apixaban|mesh-list
138845063|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
138845064|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138845065|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
138845066|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845067|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845068|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
138845069|NCT01583218|Enoxaparin|enoxaparin|mesh-list
138845070|NCT01583218|Betrixaban|betrixaban|mesh-list
138845071|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
138845072|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138845073|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138845074|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845075|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138845076|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
138845077|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138845078|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
138845079|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845080|NCT00742859|Warfarin|warfarin|mesh-list
138845081|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
138845082|NCT00742859|Betrixaban|betrixaban|mesh-list
138845083|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
138845084|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138845085|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
138845086|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138845087|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
138845088|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845089|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845090|NCT00667342|Bevacizumab|bevacizumab|mesh-list
138845091|NCT00667342|Doxorubicin|doxorubicin|mesh-list
138845092|NCT00667342|Methotrexate|methotrexate|mesh-list
138845093|NCT00667342|Etoposide|etoposide|mesh-list
138845094|NCT00667342|Ifosfamide|ifosfamide|mesh-list
138845095|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138845096|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845097|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138845098|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138845099|NCT00667342|Growth Substances|growth substances|mesh-ancestor
138845100|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845101|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
138845102|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138845103|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138845104|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138845106|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845107|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138845108|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
138845109|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138845110|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138845111|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
138845112|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
138845113|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138845114|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138845115|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
138845116|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138845117|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138845118|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138845119|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138845120|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
138845121|NCT00375609|Enoxaparin|enoxaparin|mesh-list
138845122|NCT00375609|Betrixaban|betrixaban|mesh-list
138845123|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
138845124|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138845125|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138845126|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845127|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138845128|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
138845129|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138845130|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
138845131|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845132|NCT02545231|Pitavastatin|pitavastatin|mesh-list
138845133|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138845134|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138845135|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138845136|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
138845137|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845138|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845139|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138845141|NCT02803788|Ondansetron|ondansetron|mesh-list
138845142|NCT02803788|Ramosetron|ramosetron|mesh-list
138845143|NCT02803788|Antiemetics|antiemetics|mesh-list
138845144|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138845145|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
138845146|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069001|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845147|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845148|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138845149|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
138845150|NCT02803788|Hormones|hormones|mesh-ancestor
138845151|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138845152|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138845153|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845154|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
138845155|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
138845156|NCT02803788|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138845157|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138845158|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
138845159|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845160|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845162|NCT02610153|Vitamins|vitamins|mesh-ancestor
138845163|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
138845164|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845165|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138845166|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138845167|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845168|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
138845169|NCT02610153|Coagulants|coagulants|mesh-ancestor
138845170|NCT00862693|Calcitriol|calcitriol|mesh-list
138845171|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138845172|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845173|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138845174|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138845175|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845176|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138845177|NCT00862693|Vitamins|vitamins|mesh-ancestor
138845178|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
138845179|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138845180|NCT02799498|Etanercept|etanercept|mesh-list
138845181|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138845183|NCT02799498|Analgesics|analgesics|mesh-ancestor
138845184|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
138845185|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845186|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845187|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138845188|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138845189|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138845190|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138845191|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
138845192|NCT00617851|Vaccines|vaccines|mesh-list
138845193|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
138845194|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845195|NCT02806440|Naltrexone|naltrexone|mesh-list
138845196|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138845197|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138845198|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845199|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
138845200|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845201|NCT00913809|Desipramine|desipramine|mesh-list
138845202|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138845203|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
138845204|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845205|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845206|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845207|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138845208|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138845209|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138845210|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
138845211|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845212|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845214|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138845215|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138845216|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
138845217|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845218|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845219|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138845220|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138845221|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
138845222|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845223|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138845224|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138845225|NCT00855049|Acetaminophen|acetaminophen|mesh-list
138845226|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138845227|NCT00855049|Analgesics|analgesics|mesh-ancestor
138845228|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
138845229|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845230|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845231|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
138845232|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138845233|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138845234|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
138845236|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138845237|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138845238|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
138845239|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845240|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138845241|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138845242|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845243|NCT04235478|Triamcinolone|triamcinolone|mesh-list
138845244|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138845245|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138845246|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
138845247|NCT04235478|Hormones|hormones|mesh-ancestor
138845248|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138845249|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845250|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138845251|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
138845252|NCT00619489|Vedolizumab|vedolizumab|mesh-list
138845253|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138845254|NCT02806206|Prucalopride|prucalopride|mesh-list
138845255|NCT02806206|Laxatives|laxatives|mesh-ancestor
138845256|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138845257|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138845258|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138845260|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845261|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845262|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845263|NCT00855205|Rituximab|rituximab|mesh-list
138845264|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138845265|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845266|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
138845267|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845268|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138845269|NCT00859807|Amodiaquine|amodiaquine|mesh-list
138845270|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
138845271|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138845272|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138845273|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845274|NCT00859885|Clopidogrel|clopidogrel|mesh-list
138845275|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845276|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845277|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138845278|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138845279|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138845280|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138845281|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
138845282|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845283|NCT02798874|Clopidogrel|clopidogrel|mesh-list
138845285|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138845286|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138845287|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138845288|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138845289|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
138845290|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845291|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845292|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845293|NCT02799264|Cabotegravir|cabotegravir|mesh-list
138845294|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138845295|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138845296|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845297|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845298|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138845299|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138845300|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
138845301|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845302|NCT00959699|Interferons|interferons|mesh-list
138845304|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
138845305|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
138845306|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138845307|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845308|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
138845309|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845310|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
138845311|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845313|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845314|NCT02806128|Kallikreins|kallikreins|mesh-list
138845315|NCT02806128|Coagulants|coagulants|mesh-ancestor
138845316|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
138845317|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
138845318|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138845319|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845320|NCT00860119|Alprazolam|alprazolam|mesh-list
138845321|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138845322|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845323|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845324|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138845325|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138845326|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845327|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
138845328|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
138845329|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845330|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845331|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
138845332|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138845333|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138845334|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138845335|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
138845336|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845337|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845338|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845339|NCT02805738|Tenofovir|tenofovir|mesh-list
138845340|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
138845341|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845342|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138845343|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138845344|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845345|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845346|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138845347|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138845348|NCT00855361|Rabeprazole|rabeprazole|mesh-list
138845349|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138845350|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138845351|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138845352|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845353|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845354|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
138845355|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138845356|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845357|NCT02798406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138845358|NCT02798406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845359|NCT05550636|Midazolam|midazolam|mesh-list
138845360|NCT05550636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138845361|NCT05550636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138845362|NCT05550636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138620961|NCT00239538|Valsartan|valsartan|mesh-list
138845363|NCT05550636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845365|NCT05550636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138845366|NCT05550636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845367|NCT05550636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138845368|NCT05550636|Anesthetics, General|anesthetics, general|mesh-ancestor
138845369|NCT05550636|Anesthetics|anesthetics|mesh-ancestor
138845370|NCT05550636|GABA Modulators|gaba modulators|mesh-ancestor
138845371|NCT05550636|GABA Agents|gaba agents|mesh-ancestor
138845372|NCT05550636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845373|NCT05550636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845374|NCT02857829|Caffeine|caffeine|mesh-list
138845375|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138845376|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845377|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138845378|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845379|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845380|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138845381|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138845382|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
138845383|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845384|NCT00860275|Fluconazole|fluconazole|mesh-list
138845385|NCT00860275|Ketoconazole|ketoconazole|mesh-list
138845386|NCT00860275|BMS 708163|bms 708163|mesh-list
138845387|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
138845388|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845389|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138845390|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138845391|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845392|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845393|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138845394|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
138845395|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138845396|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845397|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138845398|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138845399|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138845400|NCT00860275|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138845401|NCT02798250|Insulin|insulin|mesh-list
138845402|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138845403|NCT02798250|Glucagon|glucagon|mesh-list
138845404|NCT02798250|Hormones|hormones|mesh-list
138845405|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138845406|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845407|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138845408|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138845409|NCT00865111|Bupropion|bupropion|mesh-list
138845410|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138845411|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
138845412|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845413|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138845414|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138845415|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138845416|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845417|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
138845418|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845419|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845420|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138845421|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138845422|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845423|NCT02802696|Furosemide|furosemide|mesh-list
138845424|NCT02802696|Diuretics|diuretics|mesh-ancestor
138845425|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
138845426|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845427|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138845428|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138845429|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845430|NCT00865267|Halobetasol|halobetasol|mesh-list
138845431|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138845432|NCT02798172|Metformin|metformin|mesh-list
138845433|NCT02798172|Alogliptin|alogliptin|mesh-list
138845434|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138845435|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845437|NCT02798172|Hormones|hormones|mesh-ancestor
138845438|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138845439|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138845440|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
138845441|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845442|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845443|NCT00865423|Gabapentin|gabapentin|mesh-list
138845444|NCT00865423|Analgesics|analgesics|mesh-ancestor
138845445|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
138845446|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845447|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845448|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
138845449|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138845450|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138845451|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845452|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845453|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138845454|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138845455|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845456|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845457|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
138845458|NCT00955721|Gemcitabine|gemcitabine|mesh-list
138845459|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
138845460|NCT00955721|Sorafenib|sorafenib|mesh-list
138845461|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138845462|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
138845463|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845464|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845465|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138845466|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845467|NCT02802540|Nabilone|nabilone|mesh-list
138845468|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
138845469|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
138845470|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845471|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845472|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138845473|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138845474|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138845475|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845476|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845477|NCT00865501|Spironolactone|spironolactone|mesh-list
138845478|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138845479|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
138845480|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138845481|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845482|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138845483|NCT00865501|Diuretics|diuretics|mesh-ancestor
138845484|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
138845485|NCT02797704|Aflibercept|aflibercept|mesh-list
138845486|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138845487|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138845488|NCT02797704|Growth Substances|growth substances|mesh-ancestor
138845489|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845490|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
138845491|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845492|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
138845493|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138845494|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138845495|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138845496|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138845497|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845498|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
138845499|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845500|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845501|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138845502|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845503|NCT00863161|Lesogaberan|lesogaberan|mesh-list
138845504|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138845505|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138845506|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
138845507|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
138845508|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845509|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845510|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845511|NCT00863239|Interferons|interferons|mesh-list
138845513|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
138845514|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
138845515|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138845516|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845517|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
138845518|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845519|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
138845520|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845521|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
138845522|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845523|NCT02802072|Aspirin|aspirin|mesh-list
138845524|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138845525|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138845526|NCT02802072|Analgesics|analgesics|mesh-ancestor
138845527|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
138845528|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845529|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845531|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138845532|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138845533|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138845534|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845535|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138845536|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138845537|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845538|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
138845539|NCT00865657|Alprazolam|alprazolam|mesh-list
138845540|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138845541|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845542|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845543|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138845544|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138845545|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845546|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
138845547|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
138845548|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845549|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845550|NCT00863395|Lidocaine|lidocaine|mesh-list
138845551|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
138845552|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
138845553|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845554|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845555|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
138845557|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138845558|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138845559|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138845560|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138845561|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845562|NCT02939183|Dexamethasone|dexamethasone|mesh-list
138845563|NCT02939183|Pomalidomide|pomalidomide|mesh-list
138845564|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138845565|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
138845566|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
138845567|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845568|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845569|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138845570|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
138845571|NCT02939183|Hormones|hormones|mesh-ancestor
138845572|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138845573|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138845574|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845575|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
138845576|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138845577|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138845578|NCT02939183|Growth Substances|growth substances|mesh-ancestor
138845579|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
138845580|NCT02801838|Morphine|morphine|mesh-list
138845581|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138845582|NCT02801838|Narcotics|narcotics|mesh-ancestor
139210352|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845583|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845584|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845585|NCT02801838|Analgesics|analgesics|mesh-ancestor
138845586|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
138845587|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845588|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138845589|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138845590|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845591|NCT02797860|Rocuronium|rocuronium|mesh-list
138845592|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138845593|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138845594|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138845595|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845596|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845597|NCT00860899|Clonidine|clonidine|mesh-list
138845598|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
138845599|NCT00860899|Analgesics|analgesics|mesh-ancestor
138845600|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
138845601|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845603|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138845604|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
138845605|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
138845606|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138845607|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138845608|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138845609|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
138845610|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845611|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845612|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
138845613|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
138845614|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845615|NCT02797782|Antibodies|antibodies|mesh-list
138845616|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
138845617|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845618|NCT00863629|Insulin|insulin|mesh-list
138845619|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138845620|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845621|NCT00860977|Valacyclovir|valacyclovir|mesh-list
138845622|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
138845623|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845624|NCT00865891|Nifedipine|nifedipine|mesh-list
138845625|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138845626|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138845627|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845628|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138845629|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845630|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
138845631|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
138845632|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138845633|NCT02797236|Vaccines|vaccines|mesh-list
138845634|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
138845635|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845636|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
138845637|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138845638|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
138845639|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845640|NCT00863785|Expectorants|expectorants|mesh-ancestor
138845641|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
138845642|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138845643|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
138845644|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845645|NCT00863785|Protective Agents|protective agents|mesh-ancestor
138845646|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845647|NCT00863785|Antidotes|antidotes|mesh-ancestor
138845648|NCT02801526|Amlodipine|amlodipine|mesh-list
138845649|NCT02801526|Candesartan|candesartan|mesh-list
138845650|NCT02801526|Candesartan cilexetil|candesartan cilexetil|mesh-list
138845651|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138845652|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138845653|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138845654|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845655|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138845656|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845657|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
138845658|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138845659|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138845660|NCT02805426|Misoprostol|misoprostol|mesh-list
138845661|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
138845662|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138845663|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138845664|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845665|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
138845666|NCT02805426|Coagulants|coagulants|mesh-ancestor
138845667|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138845668|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
138845669|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138845670|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845671|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138845672|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138845673|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
138845674|NCT02801292|Ketamine|ketamine|mesh-list
138845675|NCT02801292|Analgesics|analgesics|mesh-ancestor
138845676|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
138845677|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845678|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845679|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138845680|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138845682|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
138845683|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845684|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138845685|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138845686|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845687|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845688|NCT02544061|Interleukin-12|interleukin-12|mesh-list
138845689|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138845690|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
138845691|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845692|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138845693|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138845694|NCT02544061|Growth Substances|growth substances|mesh-ancestor
138845695|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
138845696|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845697|NCT00863863|Griseofulvin|griseofulvin|mesh-list
138845698|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
138845699|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845700|NCT03853044|Prednisone|prednisone|mesh-list
138845701|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
138845702|NCT03853044|Doxorubicin|doxorubicin|mesh-list
138845703|NCT03853044|Vincristine|vincristine|mesh-list
138845704|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138845705|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
138845706|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845707|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138845708|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138845709|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
138845710|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845711|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845712|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138845713|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138845714|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138845715|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138845716|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845717|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138845718|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
138845720|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138845721|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138845722|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138845723|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
138845724|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
138845725|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
138845726|NCT00870337|Everolimus|everolimus|mesh-list
138845727|NCT00870337|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138845728|NCT00870337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138845729|NCT00870337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845730|NCT00870337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845731|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138845732|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
138845733|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845734|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845735|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138845736|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138845737|NCT00866437|Estropipate|estropipate|mesh-list
138845738|NCT00866437|Estradiol|estradiol|mesh-list
138845739|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138845740|NCT00866437|Estrone|estrone|mesh-list
138845741|NCT00866437|Progesterone|progesterone|mesh-list
138845742|NCT00866437|Estrogens|estrogens|mesh-ancestor
138845743|NCT00866437|Hormones|hormones|mesh-ancestor
138845744|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138845745|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845746|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138845747|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
138845748|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138845749|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138845750|NCT00866437|Progestins|progestins|mesh-ancestor
138845751|NCT00863941|Bupropion|bupropion|mesh-list
138845752|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138845753|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
138845754|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845755|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138845756|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138845757|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138845758|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845759|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
138845760|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845761|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845762|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138845763|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138845764|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845765|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
138845766|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138845767|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138845768|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
138845769|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845771|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
138845772|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845773|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138845774|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138845775|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845776|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845777|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138950535|NCT05814354|Paclitaxel|paclitaxel|mesh-list
138845778|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
138845779|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138845780|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845781|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138845782|NCT02795754|Ritonavir|ritonavir|mesh-list
138845783|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
138845784|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138845785|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138845786|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
138845787|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845788|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845789|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138845790|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138845791|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
138845792|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845793|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138845794|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138845795|NCT00864019|Sertraline|sertraline|mesh-list
138845796|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
138845797|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845798|NCT00864019|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138845799|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138845800|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138845801|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845802|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845803|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
138845804|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845805|NCT00812487|Insulin|insulin|mesh-list
138845806|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138845807|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138845808|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845809|NCT04235868|Mitogens|mitogens|mesh-list
138845810|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
138845811|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845812|NCT02800902|Atorvastatin|atorvastatin|mesh-list
138845813|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138845814|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138845815|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138845816|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
138845817|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845818|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138845819|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138845820|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845821|NCT05756595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138845822|NCT00617461|Gabapentin|gabapentin|mesh-list
138845823|NCT00617461|Analgesics|analgesics|mesh-ancestor
138845824|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
138845825|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845826|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845827|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
138845828|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138845829|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138845830|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845831|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845832|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138845833|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138845834|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845835|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845836|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
138845837|NCT00812331|Simeprevir|simeprevir|mesh-list
138845838|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
138845839|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845840|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
138845841|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845842|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845843|NCT04233996|Meropenem|meropenem|mesh-list
138845844|NCT04233996|Tazobactam|tazobactam|mesh-list
138845845|NCT04233996|Piperacillin|piperacillin|mesh-list
138845846|NCT04233996|Cefepime|cefepime|mesh-list
138845847|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138845848|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138845849|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138845850|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138845851|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845852|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845853|NCT00812253|Insulin|insulin|mesh-list
138845854|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138845855|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138845856|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845857|NCT00870571|Amlodipine|amlodipine|mesh-list
138845858|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138845859|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138845860|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138845861|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845862|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138845863|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845864|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
138845865|NCT05756439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138845866|NCT05756439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845867|NCT05756439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845868|NCT00616759|Propofol|propofol|mesh-list
138845869|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138497861|NCT00120484|Vitamins|vitamins|mesh-ancestor
138845870|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845871|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845872|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138845873|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
138845874|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
138845875|NCT00866593|Dexetimide|dexetimide|mesh-list
138845876|NCT00866593|Citalopram|citalopram|mesh-list
138845877|NCT00866593|Escitalopram|escitalopram|mesh-list
138845878|NCT00866593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138845879|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138845880|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138845881|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845882|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845883|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
138845884|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845885|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138845886|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138845887|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
138845888|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
138845889|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845890|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138845891|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138845892|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
138845893|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138845895|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845896|NCT02796378|Ubiquinone|ubiquinone|mesh-list
138845897|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
138845898|NCT02796378|Simvastatin|simvastatin|mesh-list
138845899|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138845900|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138845901|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
138845902|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845903|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138845904|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138845905|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845906|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
138845907|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845908|NCT02796378|Vitamins|vitamins|mesh-ancestor
138845909|NCT00864409|Ropivacaine|ropivacaine|mesh-list
138845910|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
138845911|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
138845912|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845913|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845914|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
138845915|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845916|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
138845917|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
138845918|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138845919|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138845920|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845921|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845922|NCT00866983|Urological Agents|urological agents|mesh-ancestor
138845923|NCT05226013|Rasburicase|rasburicase|mesh-list
138845924|NCT05226013|Gout Suppressants|gout suppressants|mesh-ancestor
138845925|NCT05226013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138845926|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
138845927|NCT00870961|Vitamin D|vitamin d|mesh-list
138845928|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138845929|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845930|NCT00870961|Vitamins|vitamins|mesh-ancestor
138845931|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
138845932|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138845933|NCT00811941|Nalmefene|nalmefene|mesh-list
138845934|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138845935|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845936|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
138845937|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845938|NCT00864565|Fentanyl|fentanyl|mesh-list
138845939|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138845940|NCT00864565|Narcotics|narcotics|mesh-ancestor
138845941|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845942|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845943|NCT00864565|Analgesics|analgesics|mesh-ancestor
138845944|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
138845945|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845946|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138845947|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138845948|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
138845950|NCT00864643|Atorvastatin|atorvastatin|mesh-list
138845951|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138845952|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138845953|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
138845954|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845955|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139210353|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138845956|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138845957|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845959|NCT00871039|Propofol|propofol|mesh-list
138845960|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138845961|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845962|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845963|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138845964|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
138845965|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
138845966|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138845967|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138845968|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138845969|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138845970|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
138845971|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
138845972|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138845973|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845975|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138845976|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138845977|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138845978|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138845979|NCT00864799|Misoprostol|misoprostol|mesh-list
138845980|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138845981|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
138845982|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138845983|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845984|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138845985|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138845986|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
138845987|NCT04234776|Ketamine|ketamine|mesh-list
138845988|NCT04234776|Aripiprazole|aripiprazole|mesh-list
138845989|NCT04234776|Escitalopram|escitalopram|mesh-list
138845990|NCT04234776|Analgesics|analgesics|mesh-ancestor
138845991|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
138845992|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138845993|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845994|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138845995|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138845996|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
138845997|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
138845998|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138845999|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138846000|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138846001|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846002|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950770|NCT05148962|Vaccines|vaccines|mesh-list
138846003|NCT04234776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138846004|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138846005|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138846006|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
138846007|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
138846008|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138846009|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138846010|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138846011|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
138846012|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
138846013|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138846014|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138846015|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138846016|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138846017|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138846018|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138498005|NCT00121615|Etanercept|etanercept|mesh-list
138846019|NCT05756049|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138846020|NCT05756049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846021|NCT00871273|Capecitabine|capecitabine|mesh-list
138846022|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138846023|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
138846024|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846025|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846026|NCT00867295|Cefazolin|cefazolin|mesh-list
138846027|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138846028|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846029|NCT02794506|Propolis|propolis|mesh-list
139210354|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
138846030|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846031|NCT04040491|Gemcitabine|gemcitabine|mesh-list
138846032|NCT04040491|Lenalidomide|lenalidomide|mesh-list
138846033|NCT04040491|Antibodies|antibodies|mesh-list
138846034|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
138846035|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
138846036|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846037|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138846038|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
138846039|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846040|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846041|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138846042|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138846044|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
138846045|NCT02794584|Sufentanil|sufentanil|mesh-list
138846046|NCT02794584|Dsuvia|dsuvia|mesh-list
138846047|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
138846048|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846049|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846050|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138846051|NCT02794584|Narcotics|narcotics|mesh-ancestor
138846052|NCT02794584|Analgesics|analgesics|mesh-ancestor
138846053|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
138846054|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846055|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138846056|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138846057|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
138846058|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138846059|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
138846060|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138846061|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138846062|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138846063|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846064|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846065|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138846066|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138846067|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846068|NCT00871507|Incretins|incretins|mesh-ancestor
138846069|NCT00871507|Hormones|hormones|mesh-ancestor
138846070|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138846071|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138846072|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
138846073|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069278|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
138846074|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846075|NCT00865033|Metformin|metformin|mesh-list
138846076|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138846077|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846079|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138846080|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138846081|NCT02789592|Clonazepam|clonazepam|mesh-list
138846082|NCT02789592|Melatonin|melatonin|mesh-list
138846083|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
138846084|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846085|NCT02789592|Protective Agents|protective agents|mesh-ancestor
138846086|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846087|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846088|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
138846089|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
138846090|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
138846091|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846092|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138846093|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138846094|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138498114|NCT00122512|Tenofovir|tenofovir|mesh-list
138846095|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
138846096|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846097|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846098|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846099|NCT00876421|Urological Agents|urological agents|mesh-ancestor
138846100|NCT00872131|Sertraline|sertraline|mesh-list
138846101|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
138846102|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138846103|NCT00872131|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138846104|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138846105|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138846106|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846107|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846108|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
138846109|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846110|NCT04233294|Decitabine|decitabine|mesh-list
138846111|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138846112|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
138846113|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846114|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846115|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846116|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
138846117|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138846118|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846119|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138846120|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138846121|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846122|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846123|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846124|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138846125|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138846126|NCT00872365|Micronutrients|micronutrients|mesh-list
138846127|NCT00872365|Trace Elements|trace elements|mesh-list
138846128|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846129|NCT02793648|Vitamins|vitamins|mesh-list
138846130|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
138846131|NCT02793648|Vitamin E|vitamin e|mesh-list
138846132|NCT02793648|Tocopherols|tocopherols|mesh-list
138846133|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
138846134|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
138846135|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846136|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
138846137|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846138|NCT02793648|Protective Agents|protective agents|mesh-ancestor
138846139|NCT02789358|Adenosine|adenosine|mesh-list
138846140|NCT02789358|Analgesics|analgesics|mesh-ancestor
138846141|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
138846142|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846143|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846144|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138846145|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
138846146|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138846147|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
138846148|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
138846149|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846150|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846151|NCT03847506|Amlodipine|amlodipine|mesh-list
138846153|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
138846154|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138846155|NCT03847506|Ezetimibe|ezetimibe|mesh-list
138846156|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138846157|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138846158|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138846159|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846160|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138846161|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846162|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
138846163|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138846164|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138846165|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
138846166|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138846167|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138846168|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846169|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138846170|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138846171|NCT00617305|Ambrisentan|ambrisentan|mesh-list
138846172|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
138846173|NCT00617305|Tadalafil|tadalafil|mesh-list
138846174|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
138846175|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138846176|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138846177|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846178|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846179|NCT00617305|Urological Agents|urological agents|mesh-ancestor
138846180|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138846181|NCT02792712|Clopidogrel|clopidogrel|mesh-list
138846182|NCT02792712|Ticagrelor|ticagrelor|mesh-list
138846183|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138846184|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138846185|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138846186|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138846187|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
138846188|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846189|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846190|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846191|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
138846192|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138846193|NCT00870883|Deferoxamine|deferoxamine|mesh-list
138846194|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
138846195|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846196|NCT00870883|Expectorants|expectorants|mesh-ancestor
138846197|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
138846198|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138846199|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
138846200|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846201|NCT00870883|Protective Agents|protective agents|mesh-ancestor
138846202|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846203|NCT00870883|Antidotes|antidotes|mesh-ancestor
138846204|NCT00870883|Siderophores|siderophores|mesh-ancestor
138846205|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138846206|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
138846207|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
138846209|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
138846210|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
138846211|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
138846212|NCT02789202|Protective Agents|protective agents|mesh-ancestor
138846213|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846214|NCT00811395|Interferons|interferons|mesh-list
138846215|NCT00811395|Interferon-beta|interferon-beta|mesh-list
138846216|NCT00811395|Teriflunomide|teriflunomide|mesh-list
138846217|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
138846218|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
138846219|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
138846220|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846221|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
138846222|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846223|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138846224|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
138846225|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846226|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138846227|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138846228|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138846229|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138846230|NCT00811395|Analgesics|analgesics|mesh-ancestor
138846231|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
138846232|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846233|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138846234|NCT02792946|Ambroxol|ambroxol|mesh-list
138846235|NCT02792946|Expectorants|expectorants|mesh-ancestor
138846236|NCT02792946|Respiratory System Agents|respiratory system agents|mesh-ancestor
138846237|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
139069343|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
138846238|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138846239|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138846240|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846241|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138846242|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138846243|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498226|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
138846244|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846245|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846246|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138846247|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
138846249|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846250|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138846251|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138846252|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138846253|NCT02787798|Valsartan|valsartan|mesh-list
138846254|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138846255|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139210355|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846256|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138846257|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138846258|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846259|NCT02609997|Dexamethasone|dexamethasone|mesh-list
138846260|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
138846261|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138846262|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
138846263|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
138846264|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589511|NCT05262452|Folfirinox|folfirinox|mesh-list
138846265|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846266|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138846267|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
138846268|NCT02609997|Hormones|hormones|mesh-ancestor
138846269|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139069373|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138846270|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138846271|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846272|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
138846273|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
138846274|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846275|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
138846276|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
138846277|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138846278|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846279|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138846280|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
138846281|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
138846282|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846283|NCT04114500|Estradiol|estradiol|mesh-list
138846284|NCT04114500|Progesterone|progesterone|mesh-list
138846285|NCT04114500|Estrogens|estrogens|mesh-ancestor
138846286|NCT04114500|Hormones|hormones|mesh-ancestor
138846287|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138846288|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846289|NCT04114500|Progestins|progestins|mesh-ancestor
138846290|NCT05755659|Fosaprepitant|fosaprepitant|mesh-list
138846291|NCT05755659|Aprepitant|aprepitant|mesh-list
138846292|NCT05755659|Antiemetics|antiemetics|mesh-ancestor
138846293|NCT05755659|Autonomic Agents|autonomic agents|mesh-ancestor
138846294|NCT05755659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846295|NCT05755659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846296|NCT05755659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139069414|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138846297|NCT05755659|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138846298|NCT05755659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846299|NCT05755659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846301|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138846302|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138846303|NCT00913887|Analgesics|analgesics|mesh-ancestor
138846304|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
138846305|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846306|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846307|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138846308|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138846309|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138846310|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846311|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846312|NCT02792400|Empagliflozin|empagliflozin|mesh-list
138846313|NCT02792400|Linagliptin|linagliptin|mesh-list
138846314|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138846315|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846316|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138846317|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846318|NCT02792400|Incretins|incretins|mesh-ancestor
138846319|NCT02792400|Hormones|hormones|mesh-ancestor
138846320|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138846321|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138846322|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
138846323|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846325|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
138846326|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846327|NCT05755581|Antineoplastic Agents|antineoplastic agents|mesh-list
138846328|NCT05755581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
138846329|NCT05017155|Mexiletine|mexiletine|mesh-list
138846330|NCT05017155|Lamotrigine|lamotrigine|mesh-list
138846331|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
138846332|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138846333|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138846334|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846335|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138846336|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846337|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138846338|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138846339|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846340|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138846341|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138846342|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138846343|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138846344|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
138846345|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138846346|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
138846347|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138846348|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846349|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138846350|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138846351|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138846353|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
138846354|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138846355|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138846356|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846357|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846358|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846359|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138846360|NCT00876889|Protective Agents|protective agents|mesh-ancestor
138846361|NCT00868465|Lumefantrine|lumefantrine|mesh-list
138846362|NCT00868465|Artemether|artemether|mesh-list
138846363|NCT00868465|Piperaquine|piperaquine|mesh-list
138846364|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138846365|NCT00868465|Artenimol|artenimol|mesh-list
138846366|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
138846367|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138846368|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138846369|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846370|NCT02689986|Rituximab|rituximab|mesh-list
138846371|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138846372|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138846373|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846375|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846376|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138846377|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138846378|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
138846379|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846380|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
138846381|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
138846382|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
138846383|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
138846384|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138846385|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
138846386|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846387|NCT00877123|Vitamin D|vitamin d|mesh-list
138846388|NCT00877123|Vitamins|vitamins|mesh-ancestor
138846389|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
138846390|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846391|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138846392|NCT00873223|Liraglutide|liraglutide|mesh-list
138846393|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
138846394|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138846395|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846397|NCT00873223|Hormones|hormones|mesh-ancestor
138846398|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138846399|NCT00873379|Melatonin|melatonin|mesh-list
138846400|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
138846401|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846402|NCT00873379|Protective Agents|protective agents|mesh-ancestor
138846403|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846404|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846406|NCT00868855|Kininogens|kininogens|mesh-list
138846407|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
138846408|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138846409|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
138846410|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846411|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846412|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
138846413|NCT00615901|Fluorouracil|fluorouracil|mesh-list
138846414|NCT00615901|Methotrexate|methotrexate|mesh-list
138846415|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138846416|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
138846417|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846418|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138846419|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138846420|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
138846421|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846422|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846423|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138846424|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
138846425|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138846426|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138846427|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
138846428|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138846429|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
138846430|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846431|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138846432|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138846433|NCT00616603|Dexamethasone|dexamethasone|mesh-list
138846434|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
138846435|NCT00616603|Ropivacaine|ropivacaine|mesh-list
138846436|NCT00616603|BB 1101|bb 1101|mesh-list
138846437|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138846438|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
138846439|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
138846440|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846441|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846442|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138846443|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
138846444|NCT00616603|Hormones|hormones|mesh-ancestor
138846445|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138846446|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138846447|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846448|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
138846449|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846450|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846452|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
138846453|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846454|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
138846455|NCT00873535|Varenicline|varenicline|mesh-list
138846456|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138846457|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138846458|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
138846459|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846460|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846461|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846462|NCT02790996|Vancomycin|vancomycin|mesh-list
138846463|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138846464|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846465|NCT02790840|Omeprazole|omeprazole|mesh-list
138846466|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138846467|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138846468|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138846469|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846470|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846471|NCT02790684|Firuglipel|firuglipel|mesh-list
138846472|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138846473|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846474|NCT02790450|Benzbromarone|benzbromarone|mesh-list
138846475|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
138846476|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
138846477|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138846478|NCT02790528|Atorvastatin|atorvastatin|mesh-list
138846479|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138846480|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138846481|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
138846482|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846483|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138846484|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138846485|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846487|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138846488|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
138846489|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846490|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
138846492|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846493|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138846494|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138846495|NCT00953615|Growth Substances|growth substances|mesh-ancestor
138846496|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
138846497|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846498|NCT00873769|Loxapine|loxapine|mesh-list
138846499|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138846500|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138846501|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846502|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846503|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138846504|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138846505|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
138846506|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846507|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846508|NCT02785614|Trazodone|trazodone|mesh-list
138846509|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138846510|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138846511|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846512|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846513|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138846514|NCT02785614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138846515|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138846516|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138846517|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846518|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846519|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
138846520|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138846521|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
138846522|NCT02787018|Dexamethasone|dexamethasone|mesh-list
138846523|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
138846524|NCT02787018|Ropivacaine|ropivacaine|mesh-list
138846525|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138846526|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
138846527|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
138846528|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846529|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846530|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138846531|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
138846532|NCT02787018|Hormones|hormones|mesh-ancestor
138846533|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138846534|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138846535|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846536|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138846537|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846538|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138846539|NCT02787018|Analgesics|analgesics|mesh-ancestor
138846540|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
138846541|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138846542|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138846543|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138846544|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
138846545|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846546|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846547|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
138264272|NCT02412644|Apremilast|apremilast|mesh-list
138846548|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
138846549|NCT00873925|Vitamin D|vitamin d|mesh-list
138846550|NCT00873925|Vitamins|vitamins|mesh-ancestor
138846551|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
138846552|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846553|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138846554|NCT03412266|Cytarabine|cytarabine|mesh-list
138846556|NCT03412266|Busulfan|busulfan|mesh-list
138846557|NCT03412266|Semustine|semustine|mesh-list
138846558|NCT03412266|Fludarabine|fludarabine|mesh-list
138846559|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138846560|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138846561|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
138846562|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846563|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138846564|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138846565|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
138589838|NCT00509743|Diclofenac|diclofenac|mesh-list
138846566|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846567|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846568|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138846569|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138846570|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
138846571|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
138846572|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846573|NCT00877591|Ritonavir|ritonavir|mesh-list
138846574|NCT00877591|Darunavir|darunavir|mesh-list
138846575|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
138846576|NCT00877591|Rifampin|rifampin|mesh-list
138846577|NCT00877591|Rifabutin|rifabutin|mesh-list
138846578|NCT00877591|Buprenorphine|buprenorphine|mesh-list
138846579|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138846580|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138846581|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
138846582|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846583|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846584|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138846585|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138846586|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
138846587|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846588|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138846589|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138846590|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138846591|NCT00877591|Narcotics|narcotics|mesh-ancestor
138846592|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846593|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846594|NCT00877591|Analgesics|analgesics|mesh-ancestor
138846595|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
138846596|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846597|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138846598|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138846599|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
138846600|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138846601|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
138846602|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138846603|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138846604|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138846605|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138846606|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138846607|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138846608|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138846610|NCT04200222|Trace Elements|trace elements|mesh-ancestor
138846611|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
138846612|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846613|NCT00874003|Mirtazapine|mirtazapine|mesh-list
138846614|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
138846615|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138846616|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138846617|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
138846618|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
138846619|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846620|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846621|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846623|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138846624|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846625|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138846626|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138846627|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138846628|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
138846629|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138846630|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138846631|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
138846632|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138846633|NCT04915365|Acetazolamide|acetazolamide|mesh-list
138846634|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
138846635|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138846636|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846637|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846638|NCT04915365|Diuretics|diuretics|mesh-ancestor
138846639|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
138846640|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846642|NCT02785146|Leucovorin|leucovorin|mesh-list
138846643|NCT02785146|Fluorouracil|fluorouracil|mesh-list
138846644|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
139069697|NCT03770026|Clomiphene|clomiphene|mesh-list
138846645|NCT02785146|Calcium|calcium|mesh-list
138846646|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
138846647|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138846648|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846649|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138846650|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
138846651|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846652|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138846653|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846654|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138846655|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
138846656|NCT02785146|Antidotes|antidotes|mesh-ancestor
138846657|NCT02785146|Protective Agents|protective agents|mesh-ancestor
138846658|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
138846659|NCT02785146|Vitamins|vitamins|mesh-ancestor
138846660|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
138846661|NCT00913965|Atenolol|atenolol|mesh-list
138846662|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138846663|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138846664|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
138846665|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
138846666|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846667|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846668|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138846669|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138846670|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138846671|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
138846672|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846673|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846674|NCT05753865|Paclitaxel|paclitaxel|mesh-list
138846675|NCT05753865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138846676|NCT05753865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846677|NCT05753865|Tubulin Modulators|tubulin modulators|mesh-ancestor
138846678|NCT05753865|Antimitotic Agents|antimitotic agents|mesh-ancestor
138846680|NCT05753865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846681|NCT00869869|Melatonin|melatonin|mesh-list
138846682|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
138846683|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846684|NCT00869869|Protective Agents|protective agents|mesh-ancestor
138846685|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846686|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846687|NCT00874315|Cyclosporine|cyclosporine|mesh-list
138846688|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
138846689|NCT00874315|Fludarabine|fludarabine|mesh-list
138846690|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
138846691|NCT00874315|Busulfan|busulfan|mesh-list
138846692|NCT00874315|Tacrolimus|tacrolimus|mesh-list
138846693|NCT00874315|Cyclosporins|cyclosporins|mesh-list
138846694|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
138846695|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138846696|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846697|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138846698|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
138846699|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846700|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138846701|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
138846702|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846703|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138846704|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846705|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
138846706|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846707|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
138846708|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138846709|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138846710|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138846711|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
138846712|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138846713|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
138846714|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138846715|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138846717|NCT00874393|Dopamine|dopamine|mesh-list
138846718|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138846719|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138846720|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
138846721|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
138846722|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846723|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846724|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
138846725|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846726|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846727|NCT00874393|Protective Agents|protective agents|mesh-ancestor
138846728|NCT04199364|Poractant alfa|poractant alfa|mesh-list
138846729|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138846730|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
138846731|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138846732|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138846733|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846734|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
138846735|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138846736|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846737|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
138846738|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138846739|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138846740|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138846741|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138846742|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846743|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
138846744|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846745|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846746|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138846747|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846748|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
138846749|NCT02784054|Melphalan|melphalan|mesh-list
138846750|NCT02784054|Thiotepa|thiotepa|mesh-list
138846751|NCT02784054|Carboplatin|carboplatin|mesh-list
138846752|NCT02784054|Etoposide|etoposide|mesh-list
138846753|NCT02784054|Bleomycin|bleomycin|mesh-list
138846754|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138846756|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846757|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138846758|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138846759|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
138846760|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846761|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846762|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138846763|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138846764|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138846765|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138846766|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846767|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138846768|NCT00874861|Poly ICLC|poly iclc|mesh-list
138846769|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
138846770|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
138498740|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846771|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846772|NCT04038853|Vitamin D|vitamin d|mesh-list
138846773|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
138846774|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138846775|NCT04038853|Calcitriol|calcitriol|mesh-list
138846776|NCT04038853|Vitamins|vitamins|mesh-ancestor
138846777|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
138846778|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846779|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138846780|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138846781|NCT04038853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138846782|NCT04038853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138846783|NCT04038853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846784|NCT04038853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138846785|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
138846787|NCT02066220|Cisplatin|cisplatin|mesh-list
138846788|NCT02066220|Carboplatin|carboplatin|mesh-list
138846789|NCT02066220|Vincristine|vincristine|mesh-list
138846790|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138846791|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
138846792|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846793|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138846794|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138846795|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
138846796|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846797|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846798|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138846799|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138846800|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
138846801|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
138846802|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
138846803|NCT00573391|Thalidomide|thalidomide|mesh-list
138846804|NCT00573391|Dexamethasone|dexamethasone|mesh-list
138846805|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
138846806|NCT00573391|Melphalan|melphalan|mesh-list
138846807|NCT00573391|Bortezomib|bortezomib|mesh-list
138846808|NCT00573391|BB 1101|bb 1101|mesh-list
138846809|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138846810|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
138846811|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
138846812|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846813|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846814|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138846815|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
138846816|NCT00573391|Hormones|hormones|mesh-ancestor
138846817|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138846818|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138846819|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846820|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
138846821|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846822|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846823|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138846824|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
138846825|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138846826|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138846827|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
138846828|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
138846829|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138846830|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846831|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138846832|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138846833|NCT00573391|Growth Substances|growth substances|mesh-ancestor
138846834|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
138846835|NCT00590967|Cisplatin|cisplatin|mesh-list
138846836|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846837|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
138846838|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
138846839|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846840|NCT00878371|Morphine|morphine|mesh-list
138846841|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138846842|NCT00878371|Narcotics|narcotics|mesh-ancestor
139069793|NCT03763084|Analgesics|analgesics|mesh-ancestor
138846843|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846844|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846845|NCT00878371|Analgesics|analgesics|mesh-ancestor
138846846|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
138846847|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846848|NCT00923299|Trastuzumab|trastuzumab|mesh-list
138846849|NCT00923299|Cetuximab|cetuximab|mesh-list
138846850|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138846851|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846852|NCT05753397|Ropivacaine|ropivacaine|mesh-list
138846853|NCT05753397|Anesthetics, Local|anesthetics, local|mesh-ancestor
138846854|NCT05753397|Anesthetics|anesthetics|mesh-ancestor
138846855|NCT05753397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846856|NCT05753397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846857|NCT05753397|Sensory System Agents|sensory system agents|mesh-ancestor
138846858|NCT05753397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846860|NCT00875173|Antioxidants|antioxidants|mesh-list
138846861|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846862|NCT00875173|Protective Agents|protective agents|mesh-ancestor
138846863|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846864|NCT00875173|Trace Elements|trace elements|mesh-ancestor
138846865|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
138846866|NCT04029831|Ketamine|ketamine|mesh-list
138846867|NCT04029831|Propofol|propofol|mesh-list
138846868|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138846869|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846870|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846871|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138846872|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
138846873|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
138846874|NCT04029831|Analgesics|analgesics|mesh-ancestor
138846875|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
138846876|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846877|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138846878|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138846879|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138846880|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846881|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846882|NCT00878449|Etoposide|etoposide|mesh-list
138846883|NCT00878449|Navitoclax|navitoclax|mesh-list
138846884|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846885|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138846886|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138846887|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138846888|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846889|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846890|NCT06167759|Analgesics, Opioid|analgesics, opioid|mesh-list
138846891|NCT06167759|Narcotics|narcotics|mesh-ancestor
138846892|NCT06167759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846893|NCT06167759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846894|NCT06167759|Analgesics|analgesics|mesh-ancestor
138846895|NCT06167759|Sensory System Agents|sensory system agents|mesh-ancestor
138846896|NCT06167759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846897|NCT06167707|Furosemide|furosemide|mesh-list
138846898|NCT06167707|Diuretics|diuretics|mesh-ancestor
138846899|NCT06167707|Natriuretic Agents|natriuretic agents|mesh-ancestor
138846900|NCT06167707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846901|NCT06167707|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138846902|NCT06167707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138846903|NCT06167707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846904|NCT06167642|Ofatumumab|ofatumumab|mesh-list
139069832|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
138846905|NCT06167642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846906|NCT06167265|Cilostazol|cilostazol|mesh-list
138846907|NCT06167265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138846908|NCT06167265|Autonomic Agents|autonomic agents|mesh-ancestor
138846909|NCT06167265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846910|NCT06167265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846911|NCT06167265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138846912|NCT06167265|Respiratory System Agents|respiratory system agents|mesh-ancestor
138846913|NCT06167265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138846914|NCT06167265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138846915|NCT06167265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846916|NCT06167265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138846917|NCT06167265|Vasodilator Agents|vasodilator agents|mesh-ancestor
138846918|NCT06167265|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138846919|NCT06167265|Protective Agents|protective agents|mesh-ancestor
138846920|NCT06167265|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138846921|NCT06167265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138846922|NCT06167265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846923|NCT06167187|Ketorolac|ketorolac|mesh-list
138846924|NCT06167187|Fentanyl|fentanyl|mesh-list
138846925|NCT06167187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138846926|NCT06167187|Narcotics|narcotics|mesh-ancestor
138846927|NCT06167187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138846928|NCT06167187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846929|NCT06167187|Analgesics|analgesics|mesh-ancestor
138846930|NCT06167187|Sensory System Agents|sensory system agents|mesh-ancestor
138846931|NCT06167187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846932|NCT06167187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138622534|NCT00218621|Analgesics|analgesics|mesh-ancestor
138846933|NCT06167187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138846934|NCT06167187|Anesthetics, General|anesthetics, general|mesh-ancestor
138846935|NCT06167187|Anesthetics|anesthetics|mesh-ancestor
138846936|NCT06167187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138846937|NCT06167187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138846938|NCT06167187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138846939|NCT06167187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138846940|NCT06167187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138846941|NCT06167187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846942|NCT06167187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846943|NCT06166849|Fluorides|fluorides|mesh-list
138846944|NCT06166849|Cariostatic Agents|cariostatic agents|mesh-ancestor
138846945|NCT06166849|Protective Agents|protective agents|mesh-ancestor
138846946|NCT06166849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846947|NCT06166615|Ramosetron|ramosetron|mesh-list
138846948|NCT06166615|Psyllium|psyllium|mesh-list
138846949|NCT06166615|Antiemetics|antiemetics|mesh-ancestor
138846950|NCT06166615|Autonomic Agents|autonomic agents|mesh-ancestor
138846951|NCT06166615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138846952|NCT06166615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846953|NCT06166615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138846954|NCT06166615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138846955|NCT06166615|Serotonin Agents|serotonin agents|mesh-ancestor
138846956|NCT06166615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138846957|NCT06166615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846958|NCT06166615|Cathartics|cathartics|mesh-ancestor
138846959|NCT06166589|Oxaliplatin|oxaliplatin|mesh-list
138846960|NCT06166589|Irinotecan|irinotecan|mesh-list
138846961|NCT06166589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846962|NCT06166589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138846963|NCT06166589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138846964|NCT06166589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846965|NCT06166589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846966|NCT06165965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139069843|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138846967|NCT06165965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846968|NCT06165965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138846969|NCT06165965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846970|NCT06165822|Itraconazole|itraconazole|mesh-list
138846971|NCT06165822|Rifampin|rifampin|mesh-list
138846972|NCT06165822|Antifungal Agents|antifungal agents|mesh-ancestor
138846973|NCT06165822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138846974|NCT06165822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138846975|NCT06165822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138846976|NCT06165822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138846977|NCT06165822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846978|NCT06165822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138846979|NCT06165822|Hormone Antagonists|hormone antagonists|mesh-ancestor
138846980|NCT06165822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138846981|NCT06165822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846982|NCT06165822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138846983|NCT06165822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138846984|NCT06165822|Antitubercular Agents|antitubercular agents|mesh-ancestor
138846985|NCT06165822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138846986|NCT06165822|Leprostatic Agents|leprostatic agents|mesh-ancestor
138846987|NCT06165822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138846988|NCT06165822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138846989|NCT06165822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138846990|NCT06165822|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138846991|NCT06165822|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138846992|NCT06165822|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138846993|NCT06165822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138846994|NCT06157541|Pembrolizumab|pembrolizumab|mesh-list
138846995|NCT06157541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138846996|NCT06157541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138846997|NCT06157541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138846998|NCT06157541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138846999|NCT06151483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138847000|NCT06151483|Adrenergic Agents|adrenergic agents|mesh-list
138847001|NCT06151483|Adrenergic Agonists|adrenergic agonists|mesh-list
138847002|NCT06151483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847003|NCT06151483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847004|NCT06151483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847006|NCT06124118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138847007|NCT06124118|Carboplatin|carboplatin|mesh-list
138847008|NCT06124118|Durvalumab|durvalumab|mesh-list
138847009|NCT06124118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138847010|NCT06124118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847011|NCT06124118|Tubulin Modulators|tubulin modulators|mesh-ancestor
138847012|NCT06124118|Antimitotic Agents|antimitotic agents|mesh-ancestor
138847013|NCT06124118|Mitosis Modulators|mitosis modulators|mesh-ancestor
138847014|NCT06124118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847015|NCT06124118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847016|NCT06107036|Moxifloxacin|moxifloxacin|mesh-list
138847017|NCT06107036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138847018|NCT06107036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138847019|NCT06107036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138847020|NCT06107036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138847021|NCT06107036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847022|NCT06107036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847023|NCT06107036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847024|NCT06102902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138847025|NCT06102902|Cetuximab|cetuximab|mesh-list
138847026|NCT06102902|Antibodies|antibodies|mesh-list
138847027|NCT06102902|Immunoglobulins|immunoglobulins|mesh-list
138847028|NCT06102902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138847029|NCT06102902|Immunologic Factors|immunologic factors|mesh-ancestor
138847030|NCT06102902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847031|NCT06102902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847032|NCT06101589|Vitamin D|vitamin d|mesh-list
138847033|NCT06101589|Cholecalciferol|cholecalciferol|mesh-list
138847034|NCT06101589|Calcifediol|calcifediol|mesh-list
138847035|NCT06101589|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138847036|NCT06101589|Alfacalcidol|alfacalcidol|mesh-list
138847037|NCT06101589|Vitamins|vitamins|mesh-ancestor
138847038|NCT06101589|Micronutrients|micronutrients|mesh-ancestor
138847039|NCT06101589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847040|NCT06101589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138847041|NCT06101589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138847042|NCT06076694|Amoxicillin|amoxicillin|mesh-list
138847043|NCT06076694|Rabeprazole|rabeprazole|mesh-list
138847044|NCT06076694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138847045|NCT06076694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138847047|NCT06076694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138847048|NCT06076694|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138847049|NCT06076694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847050|NCT06076694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847051|NCT06076213|Artesunate|artesunate|mesh-list
138847052|NCT06076213|Lumefantrine|lumefantrine|mesh-list
138847053|NCT06076213|Artemether|artemether|mesh-list
138847054|NCT06076213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138847055|NCT06076213|Amodiaquine|amodiaquine|mesh-list
138847056|NCT06076213|Antimalarials|antimalarials|mesh-ancestor
138847057|NCT06076213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138847058|NCT06076213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138847059|NCT06076213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138847060|NCT06076213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847061|NCT06076213|Antiviral Agents|antiviral agents|mesh-ancestor
138847062|NCT06076213|Schistosomicides|schistosomicides|mesh-ancestor
138847063|NCT06076213|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138847064|NCT06076213|Anthelmintics|anthelmintics|mesh-ancestor
138847065|NCT06045689|Luspatercept|luspatercept|mesh-list
138847066|NCT06045689|Hematinics|hematinics|mesh-ancestor
138847069|NCT06027619|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138847070|NCT06027619|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138847071|NCT06027619|Dermatologic Agents|dermatologic agents|mesh-ancestor
138847084|NCT06000787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847085|NCT06000787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847086|NCT06000787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847087|NCT06000787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138847088|NCT05997225|Varenicline|varenicline|mesh-list
138847089|NCT05997225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138847090|NCT05997225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138847091|NCT05997225|Cholinergic Agents|cholinergic agents|mesh-ancestor
138847092|NCT05997225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847093|NCT05997225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847094|NCT05997225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847095|NCT05969730|Azathioprine|azathioprine|mesh-list
138847096|NCT05969730|Antimetabolites|antimetabolites|mesh-ancestor
138847097|NCT05969730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847098|NCT05969730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138847099|NCT05969730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847100|NCT05969730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138847101|NCT05969730|Immunologic Factors|immunologic factors|mesh-ancestor
138847102|NCT05969730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069873|NCT03762538|Propofol|propofol|mesh-list
138847103|NCT05969730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138847104|NCT05953584|Hydroxyurea|hydroxyurea|mesh-list
138847105|NCT05953584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847106|NCT05953584|Antisickling Agents|antisickling agents|mesh-ancestor
138847107|NCT05953584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847108|NCT05953584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847109|NCT05953584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138847110|NCT05950802|Cyclophosphamide|cyclophosphamide|mesh-list
138847111|NCT05950802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138847112|NCT05950802|Immunologic Factors|immunologic factors|mesh-ancestor
138847113|NCT05950802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847114|NCT05950802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138847115|NCT05950802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138847116|NCT05950802|Alkylating Agents|alkylating agents|mesh-ancestor
138847117|NCT05950802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847118|NCT05950802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847119|NCT05950802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138847134|NCT05928689|Propranolol|propranolol|mesh-list
138847135|NCT05928689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138847136|NCT05928689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138847137|NCT05928689|Adrenergic Agents|adrenergic agents|mesh-ancestor
138847138|NCT05928689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847139|NCT05928689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847140|NCT05928689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847141|NCT05928689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138847142|NCT05928689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138847143|NCT05928689|Vasodilator Agents|vasodilator agents|mesh-ancestor
138847144|NCT05904912|Bupivacaine|bupivacaine|mesh-list
138847145|NCT05904912|Anesthetics, Local|anesthetics, local|mesh-ancestor
138847146|NCT05904912|Anesthetics|anesthetics|mesh-ancestor
138847148|NCT05904912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847149|NCT05904912|Sensory System Agents|sensory system agents|mesh-ancestor
138847150|NCT05904912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138847151|NCT05903131|Levonorgestrel|levonorgestrel|mesh-list
138847152|NCT05903131|Progestins|progestins|mesh-list
138847153|NCT05903131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138847154|NCT05903131|Contraceptive Agents|contraceptive agents|mesh-ancestor
138847155|NCT05903131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138847156|NCT05903131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847158|NCT05903131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138847159|NCT05903131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138847160|NCT05903131|Hormones|hormones|mesh-ancestor
138847161|NCT05903131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138847162|NCT05882604|Mesna|mesna|mesh-list
138847163|NCT05882604|Protective Agents|protective agents|mesh-ancestor
138847164|NCT05882604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847165|NCT05860452|Ropivacaine|ropivacaine|mesh-list
138847166|NCT05860452|Anesthetics, Local|anesthetics, local|mesh-ancestor
138847167|NCT05860452|Anesthetics|anesthetics|mesh-ancestor
138847168|NCT05860452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138847169|NCT05860452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847170|NCT05860452|Sensory System Agents|sensory system agents|mesh-ancestor
138847171|NCT05860452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138847172|NCT05852262|Cephalexin|cephalexin|mesh-list
138847173|NCT05852262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138847174|NCT05852262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138847175|NCT05832047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138847176|NCT05831176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138847177|NCT05831176|Immunologic Factors|immunologic factors|mesh-ancestor
138847178|NCT05831176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847179|NCT05737628|Rituximab|rituximab|mesh-list
138847180|NCT05737628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847181|NCT05737628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847182|NCT05737628|Immunologic Factors|immunologic factors|mesh-ancestor
138847183|NCT05737628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847184|NCT05737628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138847185|NCT05705505|Letrozole|letrozole|mesh-list
138847186|NCT05705505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847187|NCT05705505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138847188|NCT05705505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138847189|NCT05705505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847190|NCT05705505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847191|NCT05705505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138847192|NCT05705505|Hormone Antagonists|hormone antagonists|mesh-ancestor
138847193|NCT05705505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138847194|NCT05705505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847195|NCT05681650|Paclitaxel|paclitaxel|mesh-list
138847196|NCT05681650|Cyclophosphamide|cyclophosphamide|mesh-list
138847197|NCT05681650|Fludarabine|fludarabine|mesh-list
138847198|NCT05681650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138847199|NCT05681650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138847200|NCT05681650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847201|NCT05681650|Tubulin Modulators|tubulin modulators|mesh-ancestor
138847202|NCT05681650|Antimitotic Agents|antimitotic agents|mesh-ancestor
138847203|NCT05681650|Mitosis Modulators|mitosis modulators|mesh-ancestor
138847204|NCT05681650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847205|NCT05681650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138847206|NCT05681650|Immunologic Factors|immunologic factors|mesh-ancestor
138847207|NCT05681650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847208|NCT05681650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138847209|NCT05681650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138847210|NCT05681650|Alkylating Agents|alkylating agents|mesh-ancestor
138847211|NCT05681650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138847212|NCT05672459|Cyclophosphamide|cyclophosphamide|mesh-list
138847213|NCT05672459|Fludarabine|fludarabine|mesh-list
138847214|NCT05672459|Fludarabine phosphate|fludarabine phosphate|mesh-list
138847215|NCT05672459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138847216|NCT05672459|Immunologic Factors|immunologic factors|mesh-ancestor
138847217|NCT05672459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847218|NCT05672459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138847219|NCT05672459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138847220|NCT05672459|Alkylating Agents|alkylating agents|mesh-ancestor
138847221|NCT05672459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847222|NCT05672459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847223|NCT05672459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138847224|NCT05672459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138847225|NCT05672459|Antimetabolites|antimetabolites|mesh-ancestor
138847226|NCT05630768|Vitamin D|vitamin d|mesh-list
138847227|NCT05630768|Risedronic Acid|risedronic acid|mesh-list
138847228|NCT05630768|Calcium|calcium|mesh-list
138847229|NCT05630768|Vitamins|vitamins|mesh-ancestor
138847230|NCT05630768|Micronutrients|micronutrients|mesh-ancestor
138847231|NCT05630768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847232|NCT05630768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138847233|NCT05630768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138847235|NCT05630768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138847236|NCT05630768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847237|NCT05610969|Midazolam|midazolam|mesh-list
138847238|NCT05610969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138847239|NCT05610969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138847240|NCT05610969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138847241|NCT05610969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847242|NCT05610969|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138847243|NCT05610969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138847244|NCT05610969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138847245|NCT05610969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138847246|NCT05610969|Anesthetics, General|anesthetics, general|mesh-ancestor
138847247|NCT05610969|Anesthetics|anesthetics|mesh-ancestor
138847248|NCT05610969|GABA Modulators|gaba modulators|mesh-ancestor
138847249|NCT05610969|GABA Agents|gaba agents|mesh-ancestor
138847250|NCT05610969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847251|NCT05610969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847252|NCT05605509|Gemcitabine|gemcitabine|mesh-list
138847253|NCT05605509|Trastuzumab|trastuzumab|mesh-list
138847254|NCT05605509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138847255|NCT05605509|Antimetabolites|antimetabolites|mesh-ancestor
138847256|NCT05605509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847257|NCT05605509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847258|NCT05605509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847259|NCT05551858|Proglumide|proglumide|mesh-list
138847260|NCT05551858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138847261|NCT05551858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138847262|NCT05545020|Chromium|chromium|mesh-list
138847263|NCT05545020|Trace Elements|trace elements|mesh-ancestor
138847264|NCT05545020|Micronutrients|micronutrients|mesh-ancestor
138847265|NCT05545020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847266|NCT05490381|Ethiodized Oil|ethiodized oil|mesh-list
138847267|NCT05490381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847268|NCT05481736|Psilocybin|psilocybin|mesh-list
138847269|NCT05481736|Hallucinogens|hallucinogens|mesh-ancestor
138847270|NCT05481736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847271|NCT05481736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138847272|NCT05481489|Atropine|atropine|mesh-list
138847273|NCT05481489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138847274|NCT05481489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138847275|NCT05481489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138847276|NCT05481489|Autonomic Agents|autonomic agents|mesh-ancestor
138847277|NCT05481489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138847278|NCT05481489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847279|NCT05481489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138847280|NCT05481489|Respiratory System Agents|respiratory system agents|mesh-ancestor
138847281|NCT05481489|Mydriatics|mydriatics|mesh-ancestor
138847282|NCT05481489|Parasympatholytics|parasympatholytics|mesh-ancestor
138847283|NCT05481489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138847284|NCT05481489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138847285|NCT05481489|Cholinergic Agents|cholinergic agents|mesh-ancestor
138847286|NCT05481489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847287|NCT05481489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847288|NCT05471830|Apixaban|apixaban|mesh-list
138847289|NCT05471830|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138847290|NCT05471830|Antithrombins|antithrombins|mesh-ancestor
138847291|NCT05471830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138847292|NCT05471830|Protease Inhibitors|protease inhibitors|mesh-ancestor
138847293|NCT05471830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847294|NCT05471830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847295|NCT05471830|Anticoagulants|anticoagulants|mesh-ancestor
138847296|NCT05470868|Naphazoline|naphazoline|mesh-list
138847297|NCT05470868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138847298|NCT05470868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138847299|NCT05470868|Adrenergic Agents|adrenergic agents|mesh-ancestor
138847300|NCT05470868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847301|NCT05470868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847303|NCT05470868|Nasal Decongestants|nasal decongestants|mesh-ancestor
138847304|NCT05470868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138847305|NCT05470868|Respiratory System Agents|respiratory system agents|mesh-ancestor
138847306|NCT05465941|Irinotecan|irinotecan|mesh-list
138847307|NCT05465941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138847308|NCT05465941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138847309|NCT05465941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847310|NCT05465941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847311|NCT05465941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847312|NCT05440864|Durvalumab|durvalumab|mesh-list
138847313|NCT05440864|Tremelimumab|tremelimumab|mesh-list
138847314|NCT05440864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847315|NCT05440864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847333|NCT05383560|Vaccines|vaccines|mesh-list
138847334|NCT05383560|Immunologic Factors|immunologic factors|mesh-ancestor
138847335|NCT05383560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847336|NCT05360277|Capecitabine|capecitabine|mesh-list
138847337|NCT05360277|Tislelizumab|tislelizumab|mesh-list
138847338|NCT05360277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138847339|NCT05360277|Antimetabolites|antimetabolites|mesh-ancestor
138847340|NCT05360277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847341|NCT05360277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847342|NCT05360277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847343|NCT05335122|Bimatoprost|bimatoprost|mesh-list
138847344|NCT05335122|Travoprost|travoprost|mesh-list
138847345|NCT05335122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138847346|NCT05305313|Propofol|propofol|mesh-list
138847347|NCT05305313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138847348|NCT05305313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138847349|NCT05305313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847350|NCT05305313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138847351|NCT05305313|Anesthetics, General|anesthetics, general|mesh-ancestor
138847352|NCT05305313|Anesthetics|anesthetics|mesh-ancestor
138847353|NCT05261399|Carboplatin|carboplatin|mesh-list
138847354|NCT05261399|Pemetrexed|pemetrexed|mesh-list
138847355|NCT05261399|Osimertinib|osimertinib|mesh-list
138847356|NCT05261399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847357|NCT05261399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847358|NCT05261399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847359|NCT05261399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138847360|NCT05261399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138847361|NCT05261399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138847362|NCT05247424|Heparin|heparin|mesh-list
138847363|NCT05247424|Calcium heparin|calcium heparin|mesh-list
138847364|NCT05247424|Anticoagulants|anticoagulants|mesh-ancestor
138847365|NCT05247424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138847366|NCT05247424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138847367|NCT05247424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847368|NCT05180097|Dexamethasone|dexamethasone|mesh-list
138847369|NCT05180097|Gemcitabine|gemcitabine|mesh-list
138847370|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
138847371|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138499350|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
138847372|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138847373|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
138847374|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
138847375|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138847376|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847377|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138847378|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
138847379|NCT05180097|Hormones|hormones|mesh-ancestor
138847380|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138847381|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138847382|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847383|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138847385|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847386|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847387|NCT05180097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138847388|NCT05180097|Immunotoxins|immunotoxins|mesh-ancestor
138847389|NCT05180097|Immunoconjugates|immunoconjugates|mesh-ancestor
138847390|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
138847391|NCT05169957|Nivolumab|nivolumab|mesh-list
138847392|NCT05169957|Ipilimumab|ipilimumab|mesh-list
138847393|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847394|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847395|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138847396|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847398|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138847399|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847400|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138847401|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138847402|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
138847403|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138847404|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847405|NCT05147662|Factor VIII|factor viii|mesh-list
138847406|NCT05147662|Coagulants|coagulants|mesh-ancestor
138847407|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
138847408|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847409|NCT05136898|Mitomycins|mitomycins|mesh-list
138847410|NCT05136898|Mitomycin|mitomycin|mesh-list
138847411|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138847412|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847413|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
138847414|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847415|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138847416|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847417|NCT05132166|Sirolimus|sirolimus|mesh-list
138847418|NCT05132166|Everolimus|everolimus|mesh-list
138847419|NCT05132166|MTOR Inhibitors|mtor inhibitors|mesh-list
138847420|NCT05132166|Temsirolimus|temsirolimus|mesh-list
138847421|NCT05132166|Vedolizumab|vedolizumab|mesh-list
138847422|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138847423|NCT05132166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138847424|NCT05132166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847425|NCT05132166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847426|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138847427|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
138847428|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847429|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847430|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138847431|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138847432|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138847433|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
138847434|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138847435|NCT05102162|Meropenem|meropenem|mesh-list
138847436|NCT05102162|Tazobactam|tazobactam|mesh-list
138847437|NCT05102162|Piperacillin|piperacillin|mesh-list
138847438|NCT05102162|Cefepime|cefepime|mesh-list
138847439|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138847440|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138847441|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138847442|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138847443|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847444|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847445|NCT05081180|Lenvatinib|lenvatinib|mesh-list
138847446|NCT05081180|Avelumab|avelumab|mesh-list
138847447|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847448|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138847449|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847450|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847451|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847452|NCT05058404|Prednisone|prednisone|mesh-list
138847453|NCT05058404|Rituximab|rituximab|mesh-list
138847454|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138847455|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
138847456|NCT05058404|Vincristine|vincristine|mesh-list
138847457|NCT05058404|Doxorubicin|doxorubicin|mesh-list
138847458|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847459|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847460|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
138847461|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847462|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138847463|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138847464|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
138847465|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847466|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138847467|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138847468|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138847469|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
138847470|NCT05058404|Hormones|hormones|mesh-ancestor
138847471|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138847473|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138847474|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
138847475|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
138847476|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
138847477|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138847478|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138847479|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138847480|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847481|NCT04983849|Metronidazole|metronidazole|mesh-list
138847482|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138847483|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138847484|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138847485|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138847486|NCT04974398|Cisplatin|cisplatin|mesh-list
138847487|NCT04974398|Gemcitabine|gemcitabine|mesh-list
138847488|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847489|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138847490|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
138847491|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847492|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
138847493|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138847494|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847495|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138847496|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847497|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138847498|NCT04915729|Tenecteplase|tenecteplase|mesh-list
138847499|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138847500|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138847501|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847502|NCT04901702|Irinotecan|irinotecan|mesh-list
138847503|NCT04901702|Temozolomide|temozolomide|mesh-list
138847504|NCT04901702|Talazoparib|talazoparib|mesh-list
138847505|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138847506|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138847507|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847508|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847509|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847510|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138847511|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
138847512|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138847513|NCT04899349|Metformin|metformin|mesh-list
138847514|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
138847515|NCT04899349|Fulvestrant|fulvestrant|mesh-list
138847516|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138847517|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847518|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138847519|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847520|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138847521|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847522|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138847523|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138847524|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
138847525|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138847526|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
138847527|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138847528|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
138847529|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847530|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847533|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847534|NCT04859764|Betamethasone|betamethasone|mesh-list
138847535|NCT04859764|Bupivacaine|bupivacaine|mesh-list
138847536|NCT04859764|Anesthetics, Local|anesthetics, local|mesh-ancestor
138847537|NCT04859764|Anesthetics|anesthetics|mesh-ancestor
138847538|NCT04859764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138847539|NCT04859764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847540|NCT04859764|Sensory System Agents|sensory system agents|mesh-ancestor
138847541|NCT04859764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138847542|NCT04859764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138847543|NCT04859764|Glucocorticoids|glucocorticoids|mesh-ancestor
138847545|NCT04859764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138847546|NCT04859764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138847547|NCT04859764|Respiratory System Agents|respiratory system agents|mesh-ancestor
138847548|NCT04848220|APD791|apd791|mesh-list
138847549|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138847550|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138847551|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
138847552|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847553|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847554|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847555|NCT04843904|Rituximab|rituximab|mesh-list
138847556|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
138847557|NCT04843904|Venetoclax|venetoclax|mesh-list
138847558|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847559|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847560|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
138847561|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847562|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138847563|NCT04814433|Lidocaine|lidocaine|mesh-list
138847564|NCT04814433|Epinephrine|epinephrine|mesh-list
138847565|NCT04814433|Racepinephrine|racepinephrine|mesh-list
138847566|NCT04814433|Bupivacaine|bupivacaine|mesh-list
138847567|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
138847568|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
138847569|NCT04814433|Thrombin|thrombin|mesh-list
138847570|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
138847571|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
138847572|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
138847573|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138847574|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847575|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
138847576|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138847577|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138847578|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138847579|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138847580|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138847581|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847582|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138847583|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138847584|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
138847585|NCT04814433|Coagulants|coagulants|mesh-ancestor
138847586|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138847587|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138847588|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
138847589|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847590|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138847591|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138847592|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
138847593|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138847594|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
138499575|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
138847595|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
138847596|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
138847597|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138847598|NCT04803084|TEMPO|tempo|mesh-list
138847599|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
138847600|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847601|NCT04803084|Protective Agents|protective agents|mesh-ancestor
138847602|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847603|NCT04786067|Abatacept|abatacept|mesh-list
138847604|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138847605|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623198|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
138847606|NCT04786067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847607|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847608|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138847609|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
138847610|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847611|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138847612|NCT04780932|Macitentan|macitentan|mesh-list
138847613|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138847614|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138847615|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847616|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138847618|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138847619|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138847620|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
138847621|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847622|NCT04739813|Prednisone|prednisone|mesh-list
138847623|NCT04739813|Lenalidomide|lenalidomide|mesh-list
138847624|NCT04739813|Venetoclax|venetoclax|mesh-list
138847625|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
138847626|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138847627|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
138847628|NCT04739813|Hormones|hormones|mesh-ancestor
138847629|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138847630|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847631|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138847632|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847633|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
138847634|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138847635|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138847636|NCT04739813|Growth Substances|growth substances|mesh-ancestor
138847637|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
138847638|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847639|NCT04728217|Factor VIII|factor viii|mesh-list
138847640|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
138847641|NCT04728217|Coagulants|coagulants|mesh-ancestor
138847642|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
138847643|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847644|NCT04727008|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
138847645|NCT04727008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847646|NCT04727008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847647|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
138847648|NCT04724044|Clarithromycin|clarithromycin|mesh-list
138847649|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
138847650|NCT04724044|Lactams|lactams|mesh-list
138847651|NCT04724044|beta-Lactams|beta-lactams|mesh-list
138847652|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138847653|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138847654|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138847655|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138847656|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138847657|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847658|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847659|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847660|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138847661|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
138847662|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138847663|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847664|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138847665|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138847666|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138847667|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138847668|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138847669|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138847670|NCT04707794|Sevoflurane|sevoflurane|mesh-list
138847671|NCT04707794|Desflurane|desflurane|mesh-list
138847672|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138847673|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138847674|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
138847675|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
138847676|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138847677|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847678|NCT04702789|Timolol|timolol|mesh-list
138847679|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138847680|NCT04702789|Dorzolamide|dorzolamide|mesh-list
138847681|NCT04702789|Latanoprost|latanoprost|mesh-list
138847682|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138847683|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138847684|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
138847685|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847686|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847687|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847688|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138847689|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138847690|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138847691|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138847693|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138847694|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138847695|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138847696|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847697|NCT04659161|Xanomeline|xanomeline|mesh-list
138847698|NCT04659161|Trospium chloride|trospium chloride|mesh-list
138847699|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
138847700|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
138847701|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138847702|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847703|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138847704|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138847705|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
138847706|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847707|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847708|NCT04659161|Urological Agents|urological agents|mesh-ancestor
138847709|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138847710|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138847711|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138847712|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138847713|NCT04655976|Docetaxel|docetaxel|mesh-list
138847714|NCT04655976|Dostarlimab|dostarlimab|mesh-list
138847715|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847716|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
138847717|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
138847718|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
138847719|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847720|NCT04642820|Methamphetamine|methamphetamine|mesh-list
138847721|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138847722|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847723|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
138847724|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
138847725|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138847726|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
138847727|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847728|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847729|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
138847730|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138847731|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138847732|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138847733|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138847734|NCT04580121|Acetaminophen|acetaminophen|mesh-list
138847735|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
138847736|NCT04580121|Promethazine|promethazine|mesh-list
138847737|NCT04580121|Dexamethasone|dexamethasone|mesh-list
138847738|NCT04580121|Dasatinib|dasatinib|mesh-list
138847739|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138847740|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
138847741|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
138847742|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138847743|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847744|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138847745|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
138499727|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
138847746|NCT04580121|Hormones|hormones|mesh-ancestor
138847747|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138847748|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138847749|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847750|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138847751|NCT04580121|Analgesics|analgesics|mesh-ancestor
138847753|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
138847754|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138847755|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847756|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847757|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138847758|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138847759|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138847760|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
138847761|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
138847762|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138847763|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
138847764|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
138847765|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847766|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138847767|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
138847768|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
138847769|NCT04497116|Gemcitabine|gemcitabine|mesh-list
138847770|NCT04497116|Talazoparib|talazoparib|mesh-list
138847771|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138847772|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
138847773|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847774|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847775|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138847776|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847777|NCT04495855|Dienogest|dienogest|mesh-list
138847778|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138847779|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
138847780|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138847781|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847782|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138847783|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138847784|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138847785|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138847786|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
138847787|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138847788|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138847789|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847790|NCT04471727|Atezolizumab|atezolizumab|mesh-list
138847791|NCT04471727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138847792|NCT04471727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847793|NCT04471727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847794|NCT04471727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847795|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
138847796|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847797|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
138847798|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138847799|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138847800|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847801|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
138847802|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847803|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847804|NCT04430738|Leucovorin|leucovorin|mesh-list
138847805|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
138847806|NCT04430738|Trastuzumab|trastuzumab|mesh-list
138847807|NCT04430738|Capecitabine|capecitabine|mesh-list
138847808|NCT04430738|Fluorouracil|fluorouracil|mesh-list
138847809|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
138847810|NCT04430738|Tucatinib|tucatinib|mesh-list
138847811|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847812|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847813|NCT04430738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138847814|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847815|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138847816|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
138847817|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138847818|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
138847819|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847820|NCT04430738|Antidotes|antidotes|mesh-ancestor
138847821|NCT04430738|Protective Agents|protective agents|mesh-ancestor
138847822|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
138847824|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
138847825|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138847826|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847827|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
138847828|NCT04416984|Fludarabine|fludarabine|mesh-list
138847829|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138847830|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
138847831|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847832|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138847833|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138847834|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
138847835|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847836|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847837|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138847839|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847840|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847841|NCT04373265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138847842|NCT04373265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847843|NCT04294160|Tislelizumab|tislelizumab|mesh-list
138847844|NCT04294160|Spartalizumab|spartalizumab|mesh-list
138847845|NCT04294160|Trametinib|trametinib|mesh-list
138847846|NCT04294160|Dabrafenib|dabrafenib|mesh-list
138847847|NCT04294160|Naporafenib|naporafenib|mesh-list
138847848|NCT04294160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847849|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847850|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138847851|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847852|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847853|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138847854|NCT04278768|Venetoclax|venetoclax|mesh-list
138847855|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847856|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
138847857|NCT04258475|Calcium Carbonate|calcium carbonate|mesh-list
138847858|NCT04258475|Antacids|antacids|mesh-list
138847859|NCT04258475|Calcium|calcium|mesh-list
138847860|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138847861|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847862|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138847863|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138847864|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
138847865|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138847866|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138847867|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138847868|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847869|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847870|NCT04258475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138847871|NCT04227847|Azacitidine|azacitidine|mesh-list
138847872|NCT04227847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138847873|NCT04227847|Antimetabolites|antimetabolites|mesh-ancestor
138847874|NCT04227847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847875|NCT04227847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847876|NCT04227847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847877|NCT04214288|Fulvestrant|fulvestrant|mesh-list
138847878|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138847879|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847880|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138847881|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138847882|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
138847883|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138847884|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847885|NCT04188418|Fentanyl|fentanyl|mesh-list
138847886|NCT04188418|Morphine|morphine|mesh-list
138847887|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138847888|NCT04188418|Narcotics|narcotics|mesh-ancestor
138847889|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138847890|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847891|NCT04188418|Analgesics|analgesics|mesh-ancestor
138847892|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
138499879|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138847893|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138847894|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138847895|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138847896|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
138847897|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
138847898|NCT04166721|Atezolizumab|atezolizumab|mesh-list
138847899|NCT04166721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138847900|NCT04166721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847901|NCT04166721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847902|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847904|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138847905|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
138847906|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
138847907|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138847908|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847909|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138847910|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138847911|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138847912|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
138847913|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138847914|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847915|NCT04166331|Protective Agents|protective agents|mesh-ancestor
138847917|NCT04164069|Leucovorin|leucovorin|mesh-list
138847918|NCT04164069|Folic Acid|folic acid|mesh-list
138847919|NCT04164069|Bevacizumab|bevacizumab|mesh-list
138847920|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138847921|NCT04164069|Fluorouracil|fluorouracil|mesh-list
138847922|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
138847923|NCT04164069|Dasatinib|dasatinib|mesh-list
138847924|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
138847925|NCT04164069|Antibodies|antibodies|mesh-list
138847926|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
139070007|NCT03766984|Narcotics|narcotics|mesh-ancestor
138847927|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138847928|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
138847929|NCT04164069|Calcium|calcium|mesh-list
138847930|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
138847931|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847932|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138847933|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138847934|NCT04164069|Growth Substances|growth substances|mesh-ancestor
138847935|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847936|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
138847937|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
138847938|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138847939|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138847940|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
138847941|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847942|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138847943|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138847944|NCT04164069|Antidotes|antidotes|mesh-ancestor
138847945|NCT04164069|Protective Agents|protective agents|mesh-ancestor
138847946|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
138847947|NCT04164069|Vitamins|vitamins|mesh-ancestor
138847948|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
138847949|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138847950|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138847951|NCT04164069|Hematinics|hematinics|mesh-ancestor
138847952|NCT04120246|Acetic Acid|acetic acid|mesh-list
138847953|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138847954|NCT04120246|Trastuzumab|trastuzumab|mesh-list
138847955|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
138847956|NCT04120246|Antibodies|antibodies|mesh-list
138847957|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
138847958|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138847959|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
138847960|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138847961|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847962|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138847963|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138847964|NCT04118166|Nivolumab|nivolumab|mesh-list
138847965|NCT04118166|Ipilimumab|ipilimumab|mesh-list
138847966|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138847967|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847968|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138847969|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847970|NCT04085250|Nivolumab|nivolumab|mesh-list
138847971|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138499954|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
138847972|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847973|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138847974|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847975|NCT04034251|Paclitaxel|paclitaxel|mesh-list
138847976|NCT04034251|Capecitabine|capecitabine|mesh-list
138847977|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138847978|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138847979|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
138847980|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
138847981|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
138847982|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138847983|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138847984|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
138847985|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
138847986|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
138847987|NCT04022239|Melphalan|melphalan|mesh-list
138847988|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138847989|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
138847990|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138847991|NCT04022239|Rituximab|rituximab|mesh-list
138847992|NCT04022239|Fludarabine|fludarabine|mesh-list
138847993|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138847994|NCT04022239|Tacrolimus|tacrolimus|mesh-list
138847995|NCT04022239|Antibodies|antibodies|mesh-list
138847996|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
138847997|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138847998|NCT04022239|Lenograstim|lenograstim|mesh-list
138847999|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138848000|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
138848001|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848002|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138848003|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138848004|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
138848005|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848006|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848007|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138848008|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138848009|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138848010|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848011|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138848012|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138848013|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
138848014|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138848015|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848016|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
138848017|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
138848018|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848019|NCT03954990|Metronidazole|metronidazole|mesh-list
138848020|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848021|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138848022|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138848023|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138848024|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138848025|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138848026|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848027|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138848028|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138848029|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138848030|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848031|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
138848032|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848033|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
138848034|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
138848035|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848036|NCT03859687|Vitamins|vitamins|mesh-list
138848037|NCT03859687|Vitamin A|vitamin a|mesh-list
138848038|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
138848039|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
138848040|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848041|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
138848042|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848043|NCT03859687|Protective Agents|protective agents|mesh-ancestor
138848044|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138848045|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848046|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
138848047|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
138848048|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848050|NCT03847428|Durvalumab|durvalumab|mesh-list
138848051|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848052|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848053|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138848054|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138848055|NCT03847428|Growth Substances|growth substances|mesh-ancestor
138848056|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848057|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
138848058|NCT03840421|Cisplatin|cisplatin|mesh-list
138848059|NCT03840421|Gemcitabine|gemcitabine|mesh-list
138848060|NCT03840421|Fluorouracil|fluorouracil|mesh-list
138848061|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848062|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138848063|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
138848064|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848065|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138848066|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
138848067|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848068|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
138848069|NCT03840226|Antacids|antacids|mesh-ancestor
138848070|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848071|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138848072|NCT03822351|Durvalumab|durvalumab|mesh-list
138848073|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138848074|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848075|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848076|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
138848077|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848078|NCT03810794|Donepezil|donepezil|mesh-list
138848079|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138848080|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848081|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848082|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
138848083|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848084|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848085|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
138848086|NCT03783429|Digoxin|digoxin|mesh-list
138848087|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138848088|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138848089|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848090|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848091|NCT03783429|Protective Agents|protective agents|mesh-ancestor
138848092|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848093|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
138848094|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848095|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848096|NCT03783078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138848097|NCT03783078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848098|NCT03778294|Temozolomide|temozolomide|mesh-list
138848099|NCT03778294|Levodopa|levodopa|mesh-list
138848100|NCT03778294|Fluorides|fluorides|mesh-list
138848101|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138848102|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
138848103|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848104|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848105|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
138848106|NCT03778294|Protective Agents|protective agents|mesh-ancestor
138848107|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848108|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
138848109|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848110|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138848111|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138848112|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
138848113|NCT03734601|Tacrolimus|tacrolimus|mesh-list
138848114|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138848115|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138848116|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
138848117|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848118|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138848119|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848120|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848121|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138848122|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848123|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138848124|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
138848125|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138848126|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848127|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138848128|NCT03697031|Hormones|hormones|mesh-ancestor
138787868|NCT05663944|Sirolimus|sirolimus|mesh-list
138848129|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138848130|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848131|NCT03662542|Golimumab|golimumab|mesh-list
138848132|NCT03662542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138848133|NCT03662542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138848134|NCT03662542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138848135|NCT03662542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138848136|NCT03662542|Immunologic Factors|immunologic factors|mesh-ancestor
138848137|NCT03662542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848138|NCT03660553|Insulin|insulin|mesh-list
138848139|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138848140|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
138848141|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
138848142|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
138848143|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138848144|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848145|NCT03654989|Treprostinil|treprostinil|mesh-list
138848146|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138848148|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
138848149|NCT03638375|Nivolumab|nivolumab|mesh-list
138848150|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848151|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848152|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138848153|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848154|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
138848155|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848156|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
138848157|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848158|NCT03635333|Nicotine|nicotine|mesh-list
138848159|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138848160|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
138848161|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848162|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848163|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138848164|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138848165|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
138848166|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848167|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848168|NCT03617666|Avelumab|avelumab|mesh-list
138848169|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848170|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848171|NCT03589339|Pembrolizumab|pembrolizumab|mesh-list
138848172|NCT03589339|Nivolumab|nivolumab|mesh-list
138848173|NCT03589339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848174|NCT03589339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848175|NCT03589339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138848176|NCT03589339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848177|NCT03571945|Anesthetics|anesthetics|mesh-list
138848178|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138848179|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848180|NCT03552692|Venetoclax|venetoclax|mesh-list
138848181|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848182|NCT03541902|Sunitinib|sunitinib|mesh-list
138848183|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848184|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138848185|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138848186|NCT03541902|Growth Substances|growth substances|mesh-ancestor
138848187|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848188|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
138848189|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138848190|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848191|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848192|NCT03496662|Paclitaxel|paclitaxel|mesh-list
138848193|NCT03496662|Gemcitabine|gemcitabine|mesh-list
138848194|NCT03496662|Nivolumab|nivolumab|mesh-list
138848195|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138848196|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848197|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
138500195|NCT00025636|Hormones|hormones|mesh-ancestor
138848198|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
138848199|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
138848200|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848201|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138848202|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
138848203|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848205|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
138848206|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139070030|NCT01446016|Paclitaxel|paclitaxel|mesh-list
138848207|NCT03480698|Protective Agents|protective agents|mesh-ancestor
139210356|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848208|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848209|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
138848211|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138848212|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138848213|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
138848214|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848215|NCT03440385|Ozanimod|ozanimod|mesh-list
138848216|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138848217|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848218|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138848219|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
138848220|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848221|NCT03424525|Trimethoprim|trimethoprim|mesh-list
138848222|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138848223|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848224|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
138848225|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138848226|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138848227|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138848228|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848229|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848230|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138848231|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138848232|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138848233|NCT03289299|Dexamethasone|dexamethasone|mesh-list
138848234|NCT03289299|Lenalidomide|lenalidomide|mesh-list
138848235|NCT03289299|Daratumumab|daratumumab|mesh-list
138848236|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138848237|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
138848238|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
138848239|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848240|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848241|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138848242|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
138848243|NCT03289299|Hormones|hormones|mesh-ancestor
138848244|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138848245|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138848246|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848247|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
138848248|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138848249|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138848250|NCT03289299|Growth Substances|growth substances|mesh-ancestor
138848251|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
138848252|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
138848253|NCT03169881|Hematinics|hematinics|mesh-ancestor
138848254|NCT03167437|Vorinostat|vorinostat|mesh-list
138848255|NCT03167437|Ustekinumab|ustekinumab|mesh-list
138848256|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848257|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138848258|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848259|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848260|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
138848261|NCT03121261|Clonidine|clonidine|mesh-list
138848262|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
138848263|NCT03121261|Analgesics|analgesics|mesh-ancestor
138848264|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
138848265|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848266|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848267|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138848268|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
138848269|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
138848270|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138848271|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138848272|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138848273|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
138848274|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848275|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848277|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
138848278|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138848280|NCT03117049|Bevacizumab|bevacizumab|mesh-list
138848281|NCT03117049|Carboplatin|carboplatin|mesh-list
138848282|NCT03117049|Nivolumab|nivolumab|mesh-list
138848283|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138848284|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848285|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
138848286|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
138848287|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
138848288|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848289|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848290|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138848291|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138848292|NCT03117049|Growth Substances|growth substances|mesh-ancestor
138848293|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848294|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
138848295|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138848296|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
138848298|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848299|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848300|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848301|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138848302|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
138848303|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848304|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848305|NCT03108495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138848306|NCT03108495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848307|NCT03069183|Ropivacaine|ropivacaine|mesh-list
138848308|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
138848309|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
138848310|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138848311|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848312|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
138848313|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848314|NCT02917096|Vidarabine|vidarabine|mesh-list
138848315|NCT02917096|Sirolimus|sirolimus|mesh-list
138848316|NCT02917096|Fludarabine|fludarabine|mesh-list
138848317|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
138848318|NCT02917096|Melphalan|melphalan|mesh-list
138848319|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
138848320|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138848321|NCT02917096|Tacrolimus|tacrolimus|mesh-list
138848322|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848323|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138848324|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
138848325|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848326|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138848327|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
138848328|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848329|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
138848330|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848331|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138848332|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848333|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138848334|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138848335|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
138848336|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138848337|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
138848338|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138848339|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138848340|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848341|NCT02821013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848342|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848343|NCT02771093|Alogliptin|alogliptin|mesh-list
138848344|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138848345|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848346|NCT02771093|Incretins|incretins|mesh-ancestor
138848347|NCT02771093|Hormones|hormones|mesh-ancestor
138848348|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138848349|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138848350|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
138848352|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848353|NCT02716038|Paclitaxel|paclitaxel|mesh-list
138848354|NCT02716038|Carboplatin|carboplatin|mesh-list
138848355|NCT02716038|Atezolizumab|atezolizumab|mesh-list
138848356|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138848357|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848358|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
138848359|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
138848360|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
138848361|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848362|NCT02716038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138848363|NCT02716038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848365|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138848366|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848367|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
138848368|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848369|NCT02494258|Azacitidine|azacitidine|mesh-list
138848370|NCT02494258|Cc-486|cc-486|mesh-list
138848371|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138848372|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
139297262|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139297263|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139297264|NCT04066348|Analgesics|analgesics|mesh-ancestor
139297265|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
139297266|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297267|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297268|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139297269|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139297270|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139297271|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139297272|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
139297273|NCT03915678|Atezolizumab|atezolizumab|mesh-list
139297274|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139297275|NCT03915678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139297276|NCT03915678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297277|NCT03915678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297278|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297279|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
139297280|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297282|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
139297283|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139297284|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
139297285|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
139297286|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
139297287|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297288|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297289|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
139297290|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
139297291|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
139297292|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297293|NCT03854110|Gemcitabine|gemcitabine|mesh-list
139297294|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139297295|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
139297296|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297297|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297298|NCT03829462|Irinotecan|irinotecan|mesh-list
139297299|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139297300|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139297301|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297302|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297303|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297304|NCT03828799|Folfirinox|folfirinox|mesh-list
139297305|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297306|NCT03825796|Cytarabine|cytarabine|mesh-list
139297307|NCT03825796|Daunorubicin|daunorubicin|mesh-list
139297308|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139297309|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
139297310|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297311|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297312|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
139297313|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297314|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139297315|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
139297316|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297317|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139297318|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139297319|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139297320|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297321|NCT03818061|Bevacizumab|bevacizumab|mesh-list
139297322|NCT03818061|Atezolizumab|atezolizumab|mesh-list
139297323|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297324|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297325|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139297326|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139297327|NCT03818061|Growth Substances|growth substances|mesh-ancestor
139297328|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297329|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
139297330|NCT03818061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139297331|NCT03818061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297332|NCT03783351|Clopidogrel|clopidogrel|mesh-list
139297333|NCT03783351|Ticagrelor|ticagrelor|mesh-list
139297334|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139297335|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139297336|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139297337|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139297338|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
139297339|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297340|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297341|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297342|NCT03729869|Progesterone|progesterone|mesh-list
139297343|NCT03729869|Progestins|progestins|mesh-ancestor
139297344|NCT03729869|Hormones|hormones|mesh-ancestor
139297345|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139297346|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297347|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
139297348|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297349|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139297350|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297351|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297352|NCT03713437|Insulin|insulin|mesh-list
139297353|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139297354|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297355|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139297356|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139297357|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297358|NCT03683069|Amlodipine|amlodipine|mesh-list
139297359|NCT03683069|Eplerenone|eplerenone|mesh-list
139297360|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139297361|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139297362|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139297363|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297364|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139297365|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297366|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
139297367|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139297368|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
139297369|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139297370|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139297371|NCT03683069|Diuretics|diuretics|mesh-ancestor
139297372|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
139297373|NCT03581240|Eflornithine|eflornithine|mesh-list
139297374|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297375|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139297376|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139297377|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139297378|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297379|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139297380|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297381|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297382|NCT03573297|Cariprazine|cariprazine|mesh-list
139297383|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139297384|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139297385|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139297386|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297387|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139297388|NCT03535116|Ketorolac|ketorolac|mesh-list
139297389|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139297390|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139297391|NCT03535116|Analgesics|analgesics|mesh-ancestor
139297392|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
139297393|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297394|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297395|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139297396|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139297397|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139297398|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297399|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297400|NCT03519295|Cisplatin|cisplatin|mesh-list
139297401|NCT03519295|Docetaxel|docetaxel|mesh-list
139297402|NCT03519295|Fluorouracil|fluorouracil|mesh-list
139297403|NCT03519295|Atezolizumab|atezolizumab|mesh-list
139297404|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297405|NCT03519295|Tubulin Modulators|tubulin modulators|mesh-ancestor
139297406|NCT03519295|Antimitotic Agents|antimitotic agents|mesh-ancestor
139297407|NCT03519295|Mitosis Modulators|mitosis modulators|mesh-ancestor
138953209|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
139297408|NCT03519295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297409|NCT03519295|Antimetabolites|antimetabolites|mesh-ancestor
139297410|NCT03519295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139297411|NCT03519295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139297412|NCT03519295|Immunologic Factors|immunologic factors|mesh-ancestor
139297413|NCT03519295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297414|NCT03519295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139297415|NCT03519295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297416|NCT03515213|Fenofibrate|fenofibrate|mesh-list
139297417|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139297418|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
139297419|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297420|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139297421|NCT03446040|Nivolumab|nivolumab|mesh-list
139297422|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297423|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297424|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139297425|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297426|NCT03406286|Tolvaptan|tolvaptan|mesh-list
139297427|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139297428|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297429|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
139297430|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297431|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139297432|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139297433|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297434|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139297435|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139297436|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139297437|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297438|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
139297439|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297440|NCT03326921|Vidarabine|vidarabine|mesh-list
139297441|NCT03326921|Fludarabine|fludarabine|mesh-list
139297442|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
139297443|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070122|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139297444|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139297445|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
139297446|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297447|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139297448|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
139297449|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297450|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
139297451|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297452|NCT03189641|Cilostazol|cilostazol|mesh-list
139297453|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139297454|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
139297455|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297456|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297457|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139297458|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
139297459|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139297460|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139297461|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297462|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139297463|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
139297464|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139297465|NCT03189641|Protective Agents|protective agents|mesh-ancestor
139297466|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139297467|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139297468|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297470|NCT03158389|Atezolizumab|atezolizumab|mesh-list
139297471|NCT03158389|Palbociclib|palbociclib|mesh-list
139297472|NCT03158389|Temsirolimus|temsirolimus|mesh-list
139297473|NCT03158389|MTOR Inhibitors|mtor inhibitors|mesh-list
139297474|NCT03158389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139297475|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297476|NCT03158389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297477|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297478|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139297479|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297480|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139297481|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
139297482|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297483|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139297484|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297485|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139297486|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
139297487|NCT03140670|Rucaparib|rucaparib|mesh-list
139297488|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139297489|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297490|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297491|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297492|NCT02945280|Apixaban|apixaban|mesh-list
139297493|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139297494|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
139297495|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139297496|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
139297497|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297498|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297499|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
139297500|NCT02779855|Paclitaxel|paclitaxel|mesh-list
139297501|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139297502|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139297503|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297504|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
139297505|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
139297506|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
139297507|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297508|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297509|NCT02687906|Meropenem|meropenem|mesh-list
139297510|NCT02687906|Vaborbactam|vaborbactam|mesh-list
139297511|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
139297512|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139297513|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297514|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297515|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297516|NCT02684474|HBOC 201|hboc 201|mesh-list
139297517|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
139297518|NCT02682927|Fenfluramine|fenfluramine|mesh-list
139297519|NCT02682927|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139297520|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139297521|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139297522|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297523|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297524|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
139297525|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297526|NCT02677493|Vaccines|vaccines|mesh-list
139297527|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
139297528|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297529|NCT02633059|Dexamethasone|dexamethasone|mesh-list
139297530|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
139297531|NCT02633059|Ixazomib|ixazomib|mesh-list
139297532|NCT02633059|Ichthammol|ichthammol|mesh-list
139297533|NCT02633059|BB 1101|bb 1101|mesh-list
139297534|NCT02633059|Glycine|glycine|mesh-list
139297535|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139297536|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
138880984|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139297537|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
139297538|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297539|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297540|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139297541|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
139297542|NCT02633059|Hormones|hormones|mesh-ancestor
139297543|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139297544|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139297545|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297546|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297547|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
139297548|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297549|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
139297550|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
139297551|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297552|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
139297553|NCT02630043|Tolcapone|tolcapone|mesh-list
139297554|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297555|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139297556|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139297557|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139297558|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297559|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297560|NCT02614534|Mitomycins|mitomycins|mesh-list
139297561|NCT02614534|Mitomycin|mitomycin|mesh-list
139297562|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139297563|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297564|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
139297565|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297566|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139297567|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297568|NCT02460692|Dronabinol|dronabinol|mesh-list
139297569|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
139070151|NCT00106704|Pioglitazone|pioglitazone|mesh-list
139297570|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297571|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139297572|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139297573|NCT02460692|Analgesics|analgesics|mesh-ancestor
139297574|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
139297575|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297576|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139297577|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139297578|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297579|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297580|NCT02460692|Hormones|hormones|mesh-ancestor
139297581|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139297582|NCT02408120|Insulin|insulin|mesh-list
139297583|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139297584|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
139297585|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
139297586|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
139297587|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139297588|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139297589|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297590|NCT02393183|Selenium|selenium|mesh-list
139297591|NCT02393183|Antioxidants|antioxidants|mesh-list
139297592|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297593|NCT02393183|Protective Agents|protective agents|mesh-ancestor
139297594|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297595|NCT02393183|Trace Elements|trace elements|mesh-ancestor
139297596|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
139297597|NCT02391545|Rituximab|rituximab|mesh-list
139297598|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
139297599|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297600|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297601|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
139297602|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297603|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139297604|NCT02295475|Warfarin|warfarin|mesh-list
139297605|NCT02295475|Apixaban|apixaban|mesh-list
139297606|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
139297607|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139297608|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
139297609|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139297610|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
139297611|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297612|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297613|NCT02156739|Edetic Acid|edetic acid|mesh-list
138881058|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
139297614|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
139297615|NCT02156739|Antidotes|antidotes|mesh-ancestor
139297616|NCT02156739|Protective Agents|protective agents|mesh-ancestor
139297617|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297618|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
139297619|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
139297620|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297621|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139297622|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
139297623|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139297624|NCT01920932|Prednisone|prednisone|mesh-list
139297625|NCT01920932|Prednisolone|prednisolone|mesh-list
139297626|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
139297627|NCT01920932|Dacarbazine|dacarbazine|mesh-list
139297628|NCT01920932|Doxorubicin|doxorubicin|mesh-list
139297629|NCT01920932|Etoposide|etoposide|mesh-list
139297630|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139297631|NCT01920932|Imidazole|imidazole|mesh-list
139297632|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139297633|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
139070162|NCT03759886|Metronidazole|metronidazole|mesh-list
139297634|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297635|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139297636|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139297637|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
139297638|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297639|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297640|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139297641|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139297642|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139297643|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139297644|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297645|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139297646|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
139297647|NCT01920932|Hormones|hormones|mesh-ancestor
139297648|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139297649|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139297650|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139297651|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297652|NCT01920932|Immunotoxins|immunotoxins|mesh-ancestor
139297653|NCT01920932|Immunoconjugates|immunoconjugates|mesh-ancestor
139297654|NCT01505608|Irinotecan|irinotecan|mesh-list
139297655|NCT01505608|Temozolomide|temozolomide|mesh-list
139297656|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139297657|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139297658|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297659|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297660|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297661|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139297662|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
139297663|NCT01491893|Vaccines|vaccines|mesh-list
139297664|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
139297665|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297666|NCT01143766|Gabapentin|gabapentin|mesh-list
139297667|NCT01143766|Analgesics|analgesics|mesh-ancestor
139297668|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
139297669|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297670|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297671|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
139297672|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139297673|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139297674|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139297675|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139297676|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139297677|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139297678|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297679|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297680|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
139297681|NCT01106898|Paclitaxel|paclitaxel|mesh-list
139297682|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
139297683|NCT01106898|Trastuzumab|trastuzumab|mesh-list
139297684|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139297685|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297686|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
139297687|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
139297688|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
139297689|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297690|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139297691|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
139297692|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297693|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139297694|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139297695|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
139297696|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139070173|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
139297697|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297698|NCT01059071|Eflornithine|eflornithine|mesh-list
139297700|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139297701|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297702|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139297703|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139297704|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297705|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297706|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139297707|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139297708|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139297709|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297710|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139297712|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139297713|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139297714|NCT01001637|Analgesics|analgesics|mesh-ancestor
139297715|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
139297716|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297717|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297718|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139297719|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139297720|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297721|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297722|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297723|NCT00601003|Nifurtimox|nifurtimox|mesh-list
139297724|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
139297725|NCT00601003|Topotecan|topotecan|mesh-list
139297726|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139297727|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
139297728|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297729|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139297730|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139297731|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
139297732|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297733|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297734|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139297735|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139297736|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139297737|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297738|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139297739|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139297740|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139297741|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297742|NCT00575718|Nicotine|nicotine|mesh-list
139297743|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139297744|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
139297745|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297746|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297747|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139297748|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139297749|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
139297750|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297751|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297752|NCT00571493|Cytarabine|cytarabine|mesh-list
139297753|NCT00571493|Etoposide|etoposide|mesh-list
139297754|NCT00571493|Etoposide phosphate|etoposide phosphate|mesh-list
139297755|NCT00571493|Bortezomib|bortezomib|mesh-list
139297756|NCT00571493|Melphalan|melphalan|mesh-list
139297757|NCT00571493|Carmustine|carmustine|mesh-list
139297758|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139297759|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297760|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139297761|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139297762|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881205|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139297763|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297764|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139297765|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
139297766|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
139297767|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297768|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070184|NCT00105066|Metformin|metformin|mesh-list
139297769|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
139297770|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297771|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139297772|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
139297773|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139297774|NCT00552461|Rituximab|rituximab|mesh-list
139297775|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297776|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297777|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
139297778|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297779|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139297780|NCT00479128|Gemcitabine|gemcitabine|mesh-list
139297781|NCT00479128|Doxorubicin|doxorubicin|mesh-list
139297782|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139297784|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139297785|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
139297786|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297787|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297788|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139297789|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139297790|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139297791|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297792|NCT04428814|Ustekinumab|ustekinumab|mesh-list
139297793|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
139297794|NCT03036514|Sufentanil|sufentanil|mesh-list
139297795|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139297796|NCT03036514|Narcotics|narcotics|mesh-ancestor
139297797|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139297798|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297799|NCT03036514|Analgesics|analgesics|mesh-ancestor
139297800|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
139297801|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297802|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139297803|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139297804|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
139297805|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
139297806|NCT04835896|Paclitaxel|paclitaxel|mesh-list
139297807|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139297808|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297809|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
139297810|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
139297811|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
139297812|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297813|NCT01668004|Golimumab|golimumab|mesh-list
139297814|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139297815|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139297816|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139297817|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
139297818|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297819|NCT04835350|Pancrelipase|pancrelipase|mesh-list
139297820|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139297821|NCT01667926|Ketamine|ketamine|mesh-list
139297822|NCT01667926|Analgesics|analgesics|mesh-ancestor
139297823|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
139297824|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297825|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297826|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139297827|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139297828|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
139297829|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
139297830|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139297831|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139297832|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139297833|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297834|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297835|NCT03039478|Erythritol|erythritol|mesh-list
139070187|NCT01322308|Pioglitazone|pioglitazone|mesh-list
139297836|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
139297837|NCT04832776|Bevacizumab|bevacizumab|mesh-list
139297838|NCT04832776|Cetuximab|cetuximab|mesh-list
139297839|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297840|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297841|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139297842|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139297843|NCT04832776|Growth Substances|growth substances|mesh-ancestor
139297844|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297845|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
139297846|NCT04835116|Acetaminophen|acetaminophen|mesh-list
139297847|NCT04835116|Tramadol|tramadol|mesh-list
139297848|NCT04835116|Analgesics|analgesics|mesh-list
139297849|NCT04835116|Orphenadrine|orphenadrine|mesh-list
139297850|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
139297851|NCT04835116|Bupivacaine|bupivacaine|mesh-list
139297852|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
139297853|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
139297854|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139297855|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297856|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
139297857|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297858|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139297859|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
139297860|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139297861|NCT04835116|Narcotics|narcotics|mesh-ancestor
139297862|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139297863|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139297864|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139297865|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139297866|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
139297867|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
139297868|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139297869|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139297870|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
139297871|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297872|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297873|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
139297874|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139297875|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297876|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
139297877|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139297878|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139297879|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
139297880|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
139297881|NCT03036826|Meropenem|meropenem|mesh-list
139297882|NCT03036826|Tazobactam|tazobactam|mesh-list
139297883|NCT03036826|Piperacillin|piperacillin|mesh-list
139297884|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139297885|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139297886|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297887|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139297888|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297889|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297890|NCT03036046|Fluconazole|fluconazole|mesh-list
139297891|NCT03036046|Posaconazole|posaconazole|mesh-list
139297892|NCT03036046|Olorofim|olorofim|mesh-list
139297893|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
139297894|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297895|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139297896|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139297897|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297898|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297899|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139297900|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
139297901|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139297902|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070196|NCT03759262|Vitamin D|vitamin d|mesh-list
139297903|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139297904|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139297905|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139297906|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139297907|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139297908|NCT04831528|Bevacizumab|bevacizumab|mesh-list
139297909|NCT04831528|Trastuzumab|trastuzumab|mesh-list
139297910|NCT04831528|Cetuximab|cetuximab|mesh-list
139297911|NCT04831528|Pertuzumab|pertuzumab|mesh-list
139297912|NCT04831528|Lapatinib|lapatinib|mesh-list
139297913|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139297914|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297915|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139297916|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139297917|NCT04831528|Growth Substances|growth substances|mesh-ancestor
139297918|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297919|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
139297920|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139297921|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297922|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297923|NCT04824586|Insulin|insulin|mesh-list
139297924|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139297925|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139297926|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297927|NCT04824898|Simvastatin|simvastatin|mesh-list
139297928|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139297929|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139297930|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
139297931|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297932|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138953734|NCT04034823|Docetaxel|docetaxel|mesh-list
139297933|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139297934|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297935|NCT04824352|Apatinib|apatinib|mesh-list
139297936|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297937|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139297938|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297939|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297940|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
139297941|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139297942|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139297943|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297944|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
139297945|NCT04319614|Coagulants|coagulants|mesh-ancestor
139297946|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
139297947|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139297948|NCT04823260|Niacinamide|niacinamide|mesh-list
139297949|NCT04823260|Niacin|niacin|mesh-list
139297950|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
139297951|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
139297952|NCT04823260|Vitamins|vitamins|mesh-ancestor
139297953|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
139297954|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297955|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139297956|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
139297957|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297958|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139297959|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
139297960|NCT04816240|Midodrine|midodrine|mesh-list
139297961|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
139297962|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
139297963|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139297964|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297965|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139297966|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139297967|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139297968|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139297969|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
139297970|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297971|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297972|NCT04822012|Antibodies|antibodies|mesh-list
139297973|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
139297974|NCT04822012|Progesterone|progesterone|mesh-list
139297975|NCT04822012|Estrogens|estrogens|mesh-list
139297976|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
139297977|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297978|NCT04822012|Progestins|progestins|mesh-ancestor
139297979|NCT04822012|Hormones|hormones|mesh-ancestor
139297980|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139297981|NCT05399732|Cyclosporine|cyclosporine|mesh-list
139297982|NCT05399732|Luspatercept|luspatercept|mesh-list
139297983|NCT05399732|Cyclosporins|cyclosporins|mesh-list
139297984|NCT05399732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297985|NCT05399732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297986|NCT05399732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139297987|NCT05399732|Immunologic Factors|immunologic factors|mesh-ancestor
139297988|NCT05399732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297989|NCT05399732|Antifungal Agents|antifungal agents|mesh-ancestor
139297990|NCT05399732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297991|NCT05399732|Dermatologic Agents|dermatologic agents|mesh-ancestor
139297992|NCT05399732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139297993|NCT05399732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139297994|NCT05399732|Hematinics|hematinics|mesh-ancestor
139297995|NCT05399576|Nicorandil|nicorandil|mesh-list
139297996|NCT05399576|Verapamil|verapamil|mesh-list
139297997|NCT05399576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139297998|NCT05399576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139297999|NCT05399576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139298000|NCT05399576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298001|NCT05399576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139298002|NCT05399576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298003|NCT05399576|Vasodilator Agents|vasodilator agents|mesh-ancestor
139298004|NCT05399576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139298005|NCT05399576|Vitamin B Complex|vitamin b complex|mesh-ancestor
139298006|NCT05399576|Vitamins|vitamins|mesh-ancestor
139298007|NCT05399576|Micronutrients|micronutrients|mesh-ancestor
139298008|NCT05398718|Sotrovimab|sotrovimab|mesh-list
139298009|NCT05398718|Antiviral Agents|antiviral agents|mesh-ancestor
139298010|NCT05398718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139298011|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139298012|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139298013|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139298014|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
139298015|NCT05397938|Alendronate|alendronate|mesh-list
139298016|NCT05397938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139298017|NCT05397938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298018|NCT05133674|Tamoxifen|tamoxifen|mesh-list
139298019|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139298020|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
139298021|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139298022|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298023|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139298024|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298025|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139298026|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139298027|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139298028|NCT02522936|Muramidase|muramidase|mesh-list
139298029|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139298030|NCT04525898|Methadone|methadone|mesh-list
139298031|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139298032|NCT04525898|Narcotics|narcotics|mesh-ancestor
139298033|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298034|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298035|NCT04525898|Analgesics|analgesics|mesh-ancestor
139298036|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
139298037|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298038|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
139298039|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
139298040|NCT04282070|Paclitaxel|paclitaxel|mesh-list
139298041|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139298042|NCT04282070|Cisplatin|cisplatin|mesh-list
139298043|NCT04282070|Gemcitabine|gemcitabine|mesh-list
139298044|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139298045|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298046|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
139298047|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
139298048|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
139298049|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298050|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139298051|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
139298052|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
139298053|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139298054|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139298055|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298056|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
139298057|NCT04347122|Coagulants|coagulants|mesh-ancestor
139298058|NCT03467438|Polaprezinc|polaprezinc|mesh-list
139298059|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139298060|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139298061|NCT05397236|Dexamethasone|dexamethasone|mesh-list
139298062|NCT05397236|Bupivacaine|bupivacaine|mesh-list
139298063|NCT05397236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139298064|NCT05397236|Antiemetics|antiemetics|mesh-ancestor
139298065|NCT05397236|Autonomic Agents|autonomic agents|mesh-ancestor
139298066|NCT05397236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298067|NCT05397236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298068|NCT05397236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138881508|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139298069|NCT05397236|Glucocorticoids|glucocorticoids|mesh-ancestor
139298070|NCT05397236|Hormones|hormones|mesh-ancestor
139298071|NCT05397236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139298072|NCT05397236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139298073|NCT05397236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298074|NCT05397236|Anesthetics, Local|anesthetics, local|mesh-ancestor
139298075|NCT05397236|Anesthetics|anesthetics|mesh-ancestor
139298076|NCT05397236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298077|NCT05397236|Sensory System Agents|sensory system agents|mesh-ancestor
139298078|NCT05439278|Temozolomide|temozolomide|mesh-list
139298079|NCT05439278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139298080|NCT05439278|Alkylating Agents|alkylating agents|mesh-ancestor
139298081|NCT05439278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298082|NCT05439278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298083|NCT03130010|Nefopam|nefopam|mesh-list
139298084|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139298085|NCT03130010|Analgesics|analgesics|mesh-ancestor
139298086|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
139298087|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298088|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298089|NCT05396144|Nitrous Oxide|nitrous oxide|mesh-list
139298090|NCT05396144|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139298091|NCT05396144|Anesthetics, General|anesthetics, general|mesh-ancestor
139298092|NCT05396144|Anesthetics|anesthetics|mesh-ancestor
139298093|NCT05396144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298094|NCT05396144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298095|NCT05396144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139298096|NCT05396144|Analgesics|analgesics|mesh-ancestor
139298097|NCT05396144|Sensory System Agents|sensory system agents|mesh-ancestor
139298098|NCT05396144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298099|NCT06150898|Ketorolac|ketorolac|mesh-list
139298100|NCT06150898|Pregabalin|pregabalin|mesh-list
139298101|NCT06150898|Analgesics|analgesics|mesh-ancestor
139298102|NCT06150898|Sensory System Agents|sensory system agents|mesh-ancestor
139298103|NCT06150898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298104|NCT06150898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298105|NCT06150898|Anticonvulsants|anticonvulsants|mesh-ancestor
139298106|NCT06150898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139298107|NCT06150898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139298108|NCT06150898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298109|NCT06150898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139298110|NCT06150898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139298111|NCT06150898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139298112|NCT06150898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298113|NCT06150898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139298114|NCT06150898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139298115|NCT06150898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139298116|NCT06150898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139298117|NCT06150898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139298118|NCT06150898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139298119|NCT06150898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298120|NCT06150833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139298121|NCT06150833|Immunologic Factors|immunologic factors|mesh-ancestor
139298122|NCT06150833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298123|NCT06150781|Erenumab|erenumab|mesh-list
139298124|NCT06150781|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139298125|NCT06150781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298126|NCT06150781|Analgesics|analgesics|mesh-ancestor
139298127|NCT06150781|Sensory System Agents|sensory system agents|mesh-ancestor
139298128|NCT06150781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298129|NCT06150781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298130|NCT06150703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139298131|NCT06150703|Nafarelin|nafarelin|mesh-list
139298132|NCT06150703|Progesterone|progesterone|mesh-list
139298133|NCT06150703|Progestins|progestins|mesh-ancestor
139298134|NCT06150703|Hormones|hormones|mesh-ancestor
139298135|NCT06150703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139298136|NCT06150703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298137|NCT06150703|Luteolytic Agents|luteolytic agents|mesh-ancestor
139298138|NCT06150703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139298139|NCT06150703|Contraceptive Agents|contraceptive agents|mesh-ancestor
139298140|NCT06150703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139298141|NCT06150703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139298142|NCT06150703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139298143|NCT06150703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298144|NCT06150703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139298145|NCT06150703|Fertility Agents|fertility agents|mesh-ancestor
139298147|NCT06150560|Amlodipine|amlodipine|mesh-list
139298148|NCT06150560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139298149|NCT06150560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139298150|NCT06150560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139298151|NCT06150560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298152|NCT06150560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139298153|NCT06150560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298154|NCT06150560|Vasodilator Agents|vasodilator agents|mesh-ancestor
139298155|NCT06150560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139298156|NCT06150560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139298157|NCT06150560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139298159|NCT06150547|Dopamine Agents|dopamine agents|mesh-ancestor
139298160|NCT06150547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139298161|NCT06150547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298162|NCT06150547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298163|NCT06150417|Ascorbic Acid|ascorbic acid|mesh-list
139298164|NCT06150417|Methyltestosterone|methyltestosterone|mesh-list
139298165|NCT06150417|Androgens|androgens|mesh-list
139298166|NCT06150417|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139298167|NCT06150417|Hormones|hormones|mesh-ancestor
139070231|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139298168|NCT06150417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139298169|NCT06150417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298170|NCT06150417|Antioxidants|antioxidants|mesh-ancestor
139298171|NCT06150417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298172|NCT06150417|Protective Agents|protective agents|mesh-ancestor
139298173|NCT06150417|Vitamins|vitamins|mesh-ancestor
139298174|NCT06150417|Micronutrients|micronutrients|mesh-ancestor
139298175|NCT06150417|Estrogens|estrogens|mesh-ancestor
139298176|NCT06150417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139298177|NCT06150417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298178|NCT06150417|Anabolic Agents|anabolic agents|mesh-ancestor
139298179|NCT06150001|Lidocaine|lidocaine|mesh-list
139298180|NCT06150001|Rocuronium|rocuronium|mesh-list
139298181|NCT06150001|Anesthetics, Local|anesthetics, local|mesh-ancestor
139298182|NCT06150001|Anesthetics|anesthetics|mesh-ancestor
139298183|NCT06150001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298184|NCT06150001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298185|NCT06150001|Sensory System Agents|sensory system agents|mesh-ancestor
139298186|NCT06150001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298187|NCT06150001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139298188|NCT06150001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139298189|NCT06150001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139298190|NCT06150001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139298191|NCT06150001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298192|NCT06150001|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139298193|NCT06150001|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139298194|NCT06150001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139298195|NCT06149988|Dronabinol|dronabinol|mesh-list
139298196|NCT06149988|Hallucinogens|hallucinogens|mesh-ancestor
139298197|NCT06149988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298198|NCT06149988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139298199|NCT06149988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139298200|NCT06149988|Analgesics|analgesics|mesh-ancestor
139298201|NCT06149988|Sensory System Agents|sensory system agents|mesh-ancestor
139298202|NCT06149988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298203|NCT06149988|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139298204|NCT06149988|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139298205|NCT06149988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139298206|NCT06149988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298207|NCT06149988|Hormones|hormones|mesh-ancestor
139298208|NCT06149988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139298209|NCT06149806|Valsartan|valsartan|mesh-list
139298210|NCT06149806|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139298211|NCT06149806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139298212|NCT06149806|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139298213|NCT06149806|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139298214|NCT06149806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298215|NCT06149767|Paclitaxel|paclitaxel|mesh-list
139298216|NCT06149767|Cisplatin|cisplatin|mesh-list
139298217|NCT06149767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139298218|NCT06149767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298220|NCT06149767|Antimitotic Agents|antimitotic agents|mesh-ancestor
139298221|NCT06149767|Mitosis Modulators|mitosis modulators|mesh-ancestor
139298222|NCT06149767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298223|NCT06149676|Ciprofloxacin|ciprofloxacin|mesh-list
139298224|NCT06149676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139298225|NCT06149676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139298226|NCT06149676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139298227|NCT06149676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139298228|NCT06149676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298229|NCT06149676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298230|NCT06149676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298231|NCT06149676|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139298232|NCT06149676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139298233|NCT06149533|Edoxaban|edoxaban|mesh-list
139298234|NCT06149533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139298235|NCT06149533|Antithrombins|antithrombins|mesh-ancestor
139298236|NCT06149533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139298237|NCT06149533|Protease Inhibitors|protease inhibitors|mesh-ancestor
139298238|NCT06149533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298239|NCT06149533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298240|NCT06149533|Anticoagulants|anticoagulants|mesh-ancestor
139298241|NCT06149455|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139298242|NCT06149455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139298243|NCT06146777|Pembrolizumab|pembrolizumab|mesh-list
139298244|NCT06146777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298245|NCT06146777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298246|NCT06146777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139298247|NCT06146777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298248|NCT06144567|Upadacitinib|upadacitinib|mesh-list
139298249|NCT06144567|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139298250|NCT06144567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139298251|NCT06144567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298252|NCT06144567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298253|NCT06144567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139298254|NCT06143410|Lidocaine|lidocaine|mesh-list
139298255|NCT06143410|Propofol|propofol|mesh-list
139298256|NCT06143410|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139298257|NCT06143410|Anesthetics, Local|anesthetics, local|mesh-ancestor
139298258|NCT06143410|Anesthetics|anesthetics|mesh-ancestor
139298259|NCT06143410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298260|NCT06143410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298261|NCT06143410|Sensory System Agents|sensory system agents|mesh-ancestor
139298262|NCT06143410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298263|NCT06143410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139298264|NCT06143410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139298265|NCT06143410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139298266|NCT06143410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139298267|NCT06143410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298268|NCT06143410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139298269|NCT06143410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139298270|NCT06143410|Anesthetics, General|anesthetics, general|mesh-ancestor
139298271|NCT06142656|Metformin|metformin|mesh-list
139298272|NCT06142656|Vildagliptin|vildagliptin|mesh-list
139298273|NCT06142656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139298274|NCT06142656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298275|NCT06142656|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139298276|NCT06142656|Protease Inhibitors|protease inhibitors|mesh-ancestor
139298277|NCT06142656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298278|NCT06142656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298279|NCT06141876|Psilocybin|psilocybin|mesh-list
139298280|NCT06141876|Hallucinogens|hallucinogens|mesh-ancestor
139298281|NCT06141876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298282|NCT06141876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139298283|NCT06139133|Vitamin D|vitamin d|mesh-list
139298284|NCT06139133|Vitamins|vitamins|mesh-ancestor
139298285|NCT06139133|Micronutrients|micronutrients|mesh-ancestor
139298286|NCT06139133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298287|NCT06139133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139298288|NCT06136403|Deucravacitinib|deucravacitinib|mesh-list
139298289|NCT06136403|Dermatologic Agents|dermatologic agents|mesh-ancestor
139298290|NCT06136403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139298291|NCT06136403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298292|NCT06136403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298294|NCT06136351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139298295|NCT06136351|Zanubrutinib|zanubrutinib|mesh-list
139298296|NCT06136351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298297|NCT06136351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298298|NCT06136351|Immunologic Factors|immunologic factors|mesh-ancestor
139298299|NCT06136351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298300|NCT06136351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139070244|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
139298301|NCT06136351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139298302|NCT06136351|Alkylating Agents|alkylating agents|mesh-ancestor
139298303|NCT06136351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298304|NCT06136351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139298305|NCT06136351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298306|NCT06128954|Trientine|trientine|mesh-list
139298307|NCT06128954|Chelating Agents|chelating agents|mesh-ancestor
139298308|NCT06128954|Sequestering Agents|sequestering agents|mesh-ancestor
139298309|NCT06128954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298310|NCT06113302|Luspatercept|luspatercept|mesh-list
139298311|NCT06113302|Hematinics|hematinics|mesh-ancestor
139298312|NCT06082856|Sufentanil|sufentanil|mesh-list
139298313|NCT06082856|Dexmedetomidine|dexmedetomidine|mesh-list
139298314|NCT06082856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139298315|NCT06082856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298316|NCT06082856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298317|NCT06082856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139298318|NCT06082856|Analgesics|analgesics|mesh-ancestor
139298319|NCT06082856|Sensory System Agents|sensory system agents|mesh-ancestor
139298320|NCT06082856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298321|NCT06082856|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139298322|NCT06082856|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139298323|NCT06082856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139298324|NCT06082856|Adrenergic Agents|adrenergic agents|mesh-ancestor
139298325|NCT06082856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139298326|NCT06082856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298327|NCT06082856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139298328|NCT06082856|Narcotics|narcotics|mesh-ancestor
139298329|NCT06082856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139298330|NCT06082856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139298331|NCT06082856|Anesthetics, General|anesthetics, general|mesh-ancestor
139298332|NCT06082856|Anesthetics|anesthetics|mesh-ancestor
139298333|NCT06081283|Lacosamide|lacosamide|mesh-list
139298334|NCT06081283|Levetiracetam|levetiracetam|mesh-list
139298335|NCT06081283|Valproic Acid|valproic acid|mesh-list
139298336|NCT06081283|Phenobarbital|phenobarbital|mesh-list
139298337|NCT06081283|Anticonvulsants|anticonvulsants|mesh-ancestor
139298338|NCT06081283|Nootropic Agents|nootropic agents|mesh-ancestor
139298339|NCT06081283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298340|NCT06081283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298341|NCT06081283|GABA Agents|gaba agents|mesh-ancestor
139298342|NCT06081283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139298343|NCT06081283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298344|NCT06081283|Antimanic Agents|antimanic agents|mesh-ancestor
139298345|NCT06081283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139298346|NCT06081283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298347|NCT06081283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139298348|NCT06081283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139298349|NCT06081283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139298350|NCT06081283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139298351|NCT06081283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139298352|NCT06081283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139298353|NCT06081283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139298354|NCT06081283|GABA Modulators|gaba modulators|mesh-ancestor
139298355|NCT06081283|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139298356|NCT06081283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139298357|NCT06081283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139298358|NCT06066424|Cyclophosphamide|cyclophosphamide|mesh-list
139298359|NCT06066424|Fludarabine|fludarabine|mesh-list
139298360|NCT06066424|Fludarabine phosphate|fludarabine phosphate|mesh-list
139298361|NCT06066424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139298362|NCT06066424|Immunologic Factors|immunologic factors|mesh-ancestor
139298363|NCT06066424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298364|NCT06066424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139298365|NCT06066424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138881809|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139298366|NCT06066424|Alkylating Agents|alkylating agents|mesh-ancestor
139298367|NCT06066424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298368|NCT06066424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298369|NCT06066424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139298370|NCT06066424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139298371|NCT06066424|Antimetabolites|antimetabolites|mesh-ancestor
139298372|NCT06065462|Dostarlimab|dostarlimab|mesh-list
139298373|NCT06065462|LB100|lb100|mesh-list
139298374|NCT06065462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298375|NCT06065462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298376|NCT06065462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298377|NCT06061848|Vitamin D|vitamin d|mesh-list
139298378|NCT06061848|Vitamins|vitamins|mesh-ancestor
139298379|NCT06061848|Micronutrients|micronutrients|mesh-ancestor
139298380|NCT06061848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298381|NCT06061848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139154508|NCT00679588|Enoxaparin|enoxaparin|mesh-list
139298397|NCT06034366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139298398|NCT06034366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139298399|NCT06034366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139298400|NCT06034366|Autonomic Agents|autonomic agents|mesh-ancestor
139298401|NCT06034366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298402|NCT06034366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298403|NCT06034366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139155092|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298404|NCT06034366|Respiratory System Agents|respiratory system agents|mesh-ancestor
139298406|NCT06034366|Parasympatholytics|parasympatholytics|mesh-ancestor
139298407|NCT06034366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139298408|NCT06034366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139298409|NCT06034366|Cholinergic Agents|cholinergic agents|mesh-ancestor
139298410|NCT06034366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139298411|NCT06034366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298412|NCT06027801|Vaccines|vaccines|mesh-list
139298413|NCT06027801|Immunologic Factors|immunologic factors|mesh-ancestor
139155382|NCT00629590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139298414|NCT06027801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298416|NCT06021977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298417|NCT06021977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139298418|NCT06021977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298419|NCT06021977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298421|NCT06005532|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139298422|NCT06005532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139298423|NCT06005532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139298424|NCT05998863|Magnesium citrate|magnesium citrate|mesh-list
139298425|NCT05998863|Cathartics|cathartics|mesh-ancestor
139298426|NCT05998863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139155740|NCT02280148|Propofol|propofol|mesh-list
139155812|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
139298428|NCT05995249|Erythromycin|erythromycin|mesh-list
139298429|NCT05995249|Erythromycin Estolate|erythromycin estolate|mesh-list
139155976|NCT01107067|Hormones|hormones|mesh-ancestor
139298430|NCT05995249|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139298431|NCT05995249|Erythromycin stearate|erythromycin stearate|mesh-list
139298432|NCT05995249|Phenytoin|phenytoin|mesh-list
139298433|NCT05995249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139298434|NCT05995249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139298435|NCT05995249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298436|NCT05995249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298437|NCT05995249|Antiviral Agents|antiviral agents|mesh-ancestor
139298438|NCT05995249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139298439|NCT05995249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139298440|NCT05995249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139298441|NCT05995249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139298442|NCT05995249|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139298443|NCT05995249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139298444|NCT05995249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139298445|NCT05995249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139298446|NCT05995249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139298448|NCT05995249|Anticonvulsants|anticonvulsants|mesh-ancestor
139156845|NCT05909267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298449|NCT05995249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139298451|NCT05995249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139298452|NCT05995249|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139298453|NCT05980481|Capecitabine|capecitabine|mesh-list
139298454|NCT05980481|Oxaliplatin|oxaliplatin|mesh-list
139298455|NCT05980481|Trastuzumab|trastuzumab|mesh-list
139298456|NCT05980481|Disitamab vedotin|disitamab vedotin|mesh-list
139298457|NCT05980481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139298458|NCT05980481|Antimetabolites|antimetabolites|mesh-ancestor
139298459|NCT05980481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298460|NCT05980481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298461|NCT05980481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298462|NCT05980481|Immunoconjugates|immunoconjugates|mesh-ancestor
139298463|NCT05980481|Immunologic Factors|immunologic factors|mesh-ancestor
139298464|NCT05980481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298465|NCT05977699|Albuterol|albuterol|mesh-list
139298466|NCT05977699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139298467|NCT05977699|Autonomic Agents|autonomic agents|mesh-ancestor
139298468|NCT05977699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298469|NCT05977699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298470|NCT05977699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139298471|NCT05977699|Respiratory System Agents|respiratory system agents|mesh-ancestor
139298472|NCT05977699|Tocolytic Agents|tocolytic agents|mesh-ancestor
139298473|NCT05977699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139298474|NCT05977699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139298475|NCT05977699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139298476|NCT05977699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139298477|NCT05977699|Adrenergic Agents|adrenergic agents|mesh-ancestor
139298478|NCT05977699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139298479|NCT05977699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298480|NCT05976451|Melatonin|melatonin|mesh-list
139298481|NCT05976451|Antioxidants|antioxidants|mesh-ancestor
139298482|NCT05976451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298483|NCT05976451|Protective Agents|protective agents|mesh-ancestor
139298484|NCT05976451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298485|NCT05976451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298486|NCT05974462|Methylprednisolone|methylprednisolone|mesh-list
139298487|NCT05974462|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139298488|NCT05974462|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139298489|NCT05974462|Prednisolone|prednisolone|mesh-list
139157172|NCT06092684|Ketamine|ketamine|mesh-list
139298490|NCT05974462|Prednisolone acetate|prednisolone acetate|mesh-list
139298491|NCT05974462|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139298492|NCT05974462|Prednisolone phosphate|prednisolone phosphate|mesh-list
139298493|NCT05974462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139298494|NCT05974462|Antiemetics|antiemetics|mesh-ancestor
139298495|NCT05974462|Autonomic Agents|autonomic agents|mesh-ancestor
139298496|NCT05974462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298497|NCT05974462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298498|NCT05974462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139298499|NCT05974462|Glucocorticoids|glucocorticoids|mesh-ancestor
139298500|NCT05974462|Hormones|hormones|mesh-ancestor
139298501|NCT05974462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139298502|NCT05974462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139298503|NCT05974462|Protective Agents|protective agents|mesh-ancestor
139298504|NCT05974462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139298505|NCT05974462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298506|NCT05965479|Trastuzumab|trastuzumab|mesh-list
139298507|NCT05965479|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139298508|NCT05965479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298509|NCT05965479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298510|NCT05965479|Immunoconjugates|immunoconjugates|mesh-ancestor
139298511|NCT05965479|Immunologic Factors|immunologic factors|mesh-ancestor
139298512|NCT05965479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298513|NCT05965440|Dapagliflozin|dapagliflozin|mesh-list
139298514|NCT05965440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139298515|NCT05965440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298516|NCT05965440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139298517|NCT05965440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298519|NCT05964686|Pentetic Acid|pentetic acid|mesh-list
139298520|NCT05964686|Anticoagulants|anticoagulants|mesh-ancestor
139298521|NCT05964686|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139298522|NCT05964686|Chelating Agents|chelating agents|mesh-ancestor
139298523|NCT05964686|Sequestering Agents|sequestering agents|mesh-ancestor
139298524|NCT05964686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298525|NCT05964686|Antidotes|antidotes|mesh-ancestor
139298526|NCT05964686|Protective Agents|protective agents|mesh-ancestor
139298527|NCT05964686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298528|NCT05964686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139298529|NCT05959252|Heparin|heparin|mesh-list
139298530|NCT05959252|Calcium heparin|calcium heparin|mesh-list
139298531|NCT05959252|Bivalirudin|bivalirudin|mesh-list
139298532|NCT05959252|Anticoagulants|anticoagulants|mesh-ancestor
139298533|NCT05959252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139298534|NCT05959252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139298535|NCT05959252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298536|NCT05959252|Antithrombins|antithrombins|mesh-ancestor
139298537|NCT05959252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139298538|NCT05959252|Protease Inhibitors|protease inhibitors|mesh-ancestor
139298539|NCT05959252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298540|NCT05949424|Sunitinib|sunitinib|mesh-list
139298541|NCT05949424|Lenvatinib|lenvatinib|mesh-list
139298542|NCT05949424|Olaparib|olaparib|mesh-list
139298543|NCT05949424|Palbociclib|palbociclib|mesh-list
139298544|NCT05949424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298545|NCT05949424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139157818|NCT06203912|Glucocorticoids|glucocorticoids|mesh-ancestor
139298546|NCT05949424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139298547|NCT05949424|Growth Substances|growth substances|mesh-ancestor
139298548|NCT05949424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298549|NCT05949424|Growth Inhibitors|growth inhibitors|mesh-ancestor
139298550|NCT05949424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139298551|NCT05949424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298552|NCT05949424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298553|NCT05949424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139298554|NCT05926258|Chloroprocaine|chloroprocaine|mesh-list
139298555|NCT05926258|Benoxinate|benoxinate|mesh-list
139298556|NCT05926258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139298557|NCT05926258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139298558|NCT05926258|Anesthetics, Local|anesthetics, local|mesh-ancestor
139298559|NCT05926258|Anesthetics|anesthetics|mesh-ancestor
139298560|NCT05926258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298561|NCT05926258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298562|NCT05926258|Sensory System Agents|sensory system agents|mesh-ancestor
139298564|NCT05920122|Chlorhexidine|chlorhexidine|mesh-list
139298565|NCT05920122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139298566|NCT05920122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139298567|NCT05920122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139298568|NCT05920122|Disinfectants|disinfectants|mesh-ancestor
139298569|NCT05920122|Dermatologic Agents|dermatologic agents|mesh-ancestor
139298570|NCT05915884|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139298571|NCT05915884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298572|NCT05915884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139298573|NCT05915884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298574|NCT05893771|Methylprednisolone|methylprednisolone|mesh-list
139298575|NCT05893771|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139298576|NCT05893771|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139298577|NCT05893771|Prednisolone|prednisolone|mesh-list
139298578|NCT05893771|Prednisolone acetate|prednisolone acetate|mesh-list
139298579|NCT05893771|Bupivacaine|bupivacaine|mesh-list
139298580|NCT05893771|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139298581|NCT05893771|Prednisolone phosphate|prednisolone phosphate|mesh-list
139298582|NCT05893771|Anesthetics, Local|anesthetics, local|mesh-ancestor
139298583|NCT05893771|Anesthetics|anesthetics|mesh-ancestor
139298584|NCT05893771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298585|NCT05893771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298586|NCT05893771|Sensory System Agents|sensory system agents|mesh-ancestor
138882035|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139298587|NCT05893771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298588|NCT05893771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139298589|NCT05893771|Antiemetics|antiemetics|mesh-ancestor
139298590|NCT05893771|Autonomic Agents|autonomic agents|mesh-ancestor
139298591|NCT05893771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139298592|NCT05893771|Glucocorticoids|glucocorticoids|mesh-ancestor
139298593|NCT05893771|Hormones|hormones|mesh-ancestor
139298594|NCT05893771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139298595|NCT05893771|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139298596|NCT05893771|Protective Agents|protective agents|mesh-ancestor
139298597|NCT05893771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139298598|NCT05893771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298599|NCT05892341|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139298600|NCT05892341|Laxatives|laxatives|mesh-ancestor
139298601|NCT05892341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139298602|NCT05889741|Ropivacaine|ropivacaine|mesh-list
139298603|NCT05889741|Anesthetics, Local|anesthetics, local|mesh-ancestor
139298604|NCT05889741|Anesthetics|anesthetics|mesh-ancestor
139298605|NCT05889741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298606|NCT05889741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298607|NCT05889741|Sensory System Agents|sensory system agents|mesh-ancestor
139298608|NCT05889741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298609|NCT05874154|Botulinum Toxins|botulinum toxins|mesh-list
139298610|NCT05874154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139298611|NCT05874154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139298612|NCT05874154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298613|NCT05874154|Cholinergic Agents|cholinergic agents|mesh-ancestor
139298614|NCT05874154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139298615|NCT05874154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298616|NCT05859269|Methylprednisolone|methylprednisolone|mesh-list
139298617|NCT05859269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139298618|NCT05859269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139298619|NCT05859269|Prednisolone|prednisolone|mesh-list
139298620|NCT05859269|Prednisolone acetate|prednisolone acetate|mesh-list
139298621|NCT05859269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139298622|NCT05859269|Prednisolone phosphate|prednisolone phosphate|mesh-list
139298623|NCT05859269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139298624|NCT05859269|Antiemetics|antiemetics|mesh-ancestor
139298625|NCT05859269|Autonomic Agents|autonomic agents|mesh-ancestor
139298626|NCT05859269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298627|NCT05859269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298628|NCT05859269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139298630|NCT05859269|Hormones|hormones|mesh-ancestor
139298631|NCT05859269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139298632|NCT05859269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139298633|NCT05859269|Protective Agents|protective agents|mesh-ancestor
139298634|NCT05859269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139298635|NCT05859269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298636|NCT05851781|Propranolol|propranolol|mesh-list
139298637|NCT05851781|Lacosamide|lacosamide|mesh-list
139158429|NCT05286827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298638|NCT05851781|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139298639|NCT05851781|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139298640|NCT05851781|Adrenergic Agents|adrenergic agents|mesh-ancestor
139298641|NCT05851781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139298642|NCT05851781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298643|NCT05851781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298644|NCT05851781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139298645|NCT05851781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139298646|NCT05851781|Vasodilator Agents|vasodilator agents|mesh-ancestor
139298647|NCT05851781|Anticonvulsants|anticonvulsants|mesh-ancestor
139298648|NCT05851781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139298649|NCT05851781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139298650|NCT05851781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139298651|NCT05849610|Lenalidomide|lenalidomide|mesh-list
139298653|NCT05849610|Daratumumab|daratumumab|mesh-list
139298654|NCT05849610|Immunologic Factors|immunologic factors|mesh-ancestor
139158501|NCT05074056|Ketorolac|ketorolac|mesh-list
139298655|NCT05849610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298656|NCT05849610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139298657|NCT05849610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139298658|NCT05849610|Growth Substances|growth substances|mesh-ancestor
139298659|NCT05849610|Growth Inhibitors|growth inhibitors|mesh-ancestor
139298660|NCT05849610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298662|NCT05848765|Cyclophosphamide|cyclophosphamide|mesh-list
139298663|NCT05848765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139298664|NCT05848765|Rituximab|rituximab|mesh-list
139298665|NCT05848765|Doxorubicin|doxorubicin|mesh-list
139298666|NCT05848765|Vincristine|vincristine|mesh-list
139298667|NCT05848765|Lenalidomide|lenalidomide|mesh-list
139298668|NCT05848765|Obinutuzumab|obinutuzumab|mesh-list
139298669|NCT05848765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070341|NCT01076790|Analgesics|analgesics|mesh-ancestor
139298670|NCT05848765|Immunologic Factors|immunologic factors|mesh-ancestor
139298671|NCT05848765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298672|NCT05848765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139298673|NCT05848765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139298674|NCT05848765|Alkylating Agents|alkylating agents|mesh-ancestor
139298675|NCT05848765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298676|NCT05848765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298677|NCT05848765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139298678|NCT05848765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298679|NCT05848765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139298680|NCT05848765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139298681|NCT05848765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139298682|NCT05848765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298683|NCT05848765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139298684|NCT05848765|Glucocorticoids|glucocorticoids|mesh-ancestor
139298685|NCT05848765|Hormones|hormones|mesh-ancestor
139298686|NCT05848765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139298687|NCT05848765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139298688|NCT05848765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139298689|NCT05848765|Tubulin Modulators|tubulin modulators|mesh-ancestor
139298690|NCT05848765|Antimitotic Agents|antimitotic agents|mesh-ancestor
139298691|NCT05848765|Mitosis Modulators|mitosis modulators|mesh-ancestor
139298692|NCT05848765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139298693|NCT05848765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139298694|NCT05848765|Growth Substances|growth substances|mesh-ancestor
139298695|NCT05848765|Growth Inhibitors|growth inhibitors|mesh-ancestor
139298696|NCT05829434|Cytarabine|cytarabine|mesh-list
139298697|NCT05829434|Magrolimab|magrolimab|mesh-list
139298698|NCT05829434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139298699|NCT05829434|Antimetabolites|antimetabolites|mesh-ancestor
139298700|NCT05829434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298701|NCT05829434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298702|NCT05829434|Antiviral Agents|antiviral agents|mesh-ancestor
139298703|NCT05829434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158907|NCT04450173|Venetoclax|venetoclax|mesh-list
139298704|NCT05829434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139298705|NCT05829434|Immunologic Factors|immunologic factors|mesh-ancestor
139298706|NCT05829434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298707|NCT05829434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298708|NCT05816733|Dapagliflozin|dapagliflozin|mesh-list
139298709|NCT05816733|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139298710|NCT05816733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298711|NCT05816733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139298712|NCT05816733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298713|NCT05794425|Cyclosporine|cyclosporine|mesh-list
139298714|NCT05794425|Cyclosporins|cyclosporins|mesh-list
139298715|NCT05794425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298716|NCT05794425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298717|NCT05794425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139298718|NCT05794425|Immunologic Factors|immunologic factors|mesh-ancestor
139298719|NCT05794425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298720|NCT05794425|Antifungal Agents|antifungal agents|mesh-ancestor
139298721|NCT05794425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139298722|NCT05794425|Dermatologic Agents|dermatologic agents|mesh-ancestor
139298723|NCT05794425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139298724|NCT05794425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139298725|NCT05791565|Norflurane|norflurane|mesh-list
139298726|NCT05791565|Albuterol|albuterol|mesh-list
139298727|NCT05791565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139298728|NCT05791565|Autonomic Agents|autonomic agents|mesh-ancestor
139298729|NCT05791565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298730|NCT05791565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298731|NCT05791565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139298732|NCT05791565|Respiratory System Agents|respiratory system agents|mesh-ancestor
139298733|NCT05791565|Tocolytic Agents|tocolytic agents|mesh-ancestor
139298734|NCT05791565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139298735|NCT05791565|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139298736|NCT05791565|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139298737|NCT05791565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139298738|NCT05791565|Adrenergic Agents|adrenergic agents|mesh-ancestor
139298739|NCT05791565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139298740|NCT05791565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298741|NCT05791565|Anesthetics|anesthetics|mesh-ancestor
139298742|NCT05791565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298743|NCT05785897|Sirolimus|sirolimus|mesh-list
139298744|NCT05785897|Ticagrelor|ticagrelor|mesh-list
139298745|NCT05785897|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139298746|NCT05785897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298747|NCT05785897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298748|NCT05785897|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139298749|NCT05785897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139298750|NCT05785897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139298751|NCT05785897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139298752|NCT05785897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298753|NCT05785897|Antifungal Agents|antifungal agents|mesh-ancestor
139298754|NCT05785897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139298755|NCT05785897|Immunologic Factors|immunologic factors|mesh-ancestor
139298756|NCT05785897|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139298757|NCT05785897|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139298758|NCT05785897|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139298759|NCT05785897|Purinergic Agents|purinergic agents|mesh-ancestor
139298760|NCT05785897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139298761|NCT05776459|Prednisolone|prednisolone|mesh-list
139298762|NCT05776459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139298763|NCT05776459|Glucocorticoids|glucocorticoids|mesh-ancestor
139298764|NCT05776459|Hormones|hormones|mesh-ancestor
139298765|NCT05776459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139298766|NCT05776459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298767|NCT05776459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139298768|NCT05776459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298769|NCT05739981|Paclitaxel|paclitaxel|mesh-list
139298770|NCT05739981|Bevacizumab|bevacizumab|mesh-list
139298771|NCT05739981|Carboplatin|carboplatin|mesh-list
139298772|NCT05739981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139298773|NCT05739981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298774|NCT05739981|Tubulin Modulators|tubulin modulators|mesh-ancestor
139298775|NCT05739981|Antimitotic Agents|antimitotic agents|mesh-ancestor
139298776|NCT05739981|Mitosis Modulators|mitosis modulators|mesh-ancestor
139298777|NCT05739981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159640|NCT03007147|Vitamins|vitamins|mesh-ancestor
139298778|NCT05739981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298779|NCT05739981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139298780|NCT05739981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139298781|NCT05739981|Growth Substances|growth substances|mesh-ancestor
139298782|NCT05739981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298783|NCT05739981|Growth Inhibitors|growth inhibitors|mesh-ancestor
139298784|NCT05738057|Cisplatin|cisplatin|mesh-list
139298785|NCT05738057|Gemcitabine|gemcitabine|mesh-list
139298786|NCT05738057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298787|NCT05738057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139298788|NCT05738057|Antimetabolites|antimetabolites|mesh-ancestor
139298789|NCT05738057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298790|NCT05732948|Cyclophosphamide|cyclophosphamide|mesh-list
139298791|NCT05732948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139298792|NCT05732948|Immunologic Factors|immunologic factors|mesh-ancestor
139298793|NCT05732948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298794|NCT05732948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139298795|NCT05732948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139298796|NCT05732948|Alkylating Agents|alkylating agents|mesh-ancestor
139298797|NCT05732948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159717|NCT02802241|Peppermint oil|peppermint oil|mesh-list
139298798|NCT05732948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298799|NCT05732948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139298800|NCT05715073|Caffeine|caffeine|mesh-list
139298801|NCT05715073|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139298802|NCT05715073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298803|NCT05715073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139298804|NCT05715073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159939|NCT05822830|Hormones|hormones|mesh-ancestor
139298805|NCT05715073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298806|NCT05715073|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139298807|NCT05715073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139298808|NCT05715073|Purinergic Agents|purinergic agents|mesh-ancestor
139298809|NCT05715073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139298810|NCT05710666|Trastuzumab|trastuzumab|mesh-list
139298811|NCT05710666|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139298812|NCT05710666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298813|NCT05710666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298814|NCT05710666|Immunoconjugates|immunoconjugates|mesh-ancestor
139298815|NCT05710666|Immunologic Factors|immunologic factors|mesh-ancestor
139298816|NCT05710666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298817|NCT05710185|Deucravacitinib|deucravacitinib|mesh-list
139298818|NCT05710185|Dermatologic Agents|dermatologic agents|mesh-ancestor
139298819|NCT05710185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139298820|NCT05710185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298821|NCT05710185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298822|NCT05707208|Lidocaine|lidocaine|mesh-list
139298823|NCT05707208|Anesthetics, Local|anesthetics, local|mesh-ancestor
139298824|NCT05707208|Anesthetics|anesthetics|mesh-ancestor
139298825|NCT05707208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298826|NCT05707208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298827|NCT05707208|Sensory System Agents|sensory system agents|mesh-ancestor
139298828|NCT05707208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298829|NCT05707208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139298830|NCT05707208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139298831|NCT05707208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139298832|NCT05707208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139298833|NCT05707208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298834|NCT05694858|Lidocaine|lidocaine|mesh-list
139298835|NCT05694858|Anesthetics, Local|anesthetics, local|mesh-ancestor
139298836|NCT05694858|Anesthetics|anesthetics|mesh-ancestor
139298837|NCT05694858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298838|NCT05694858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298839|NCT05694858|Sensory System Agents|sensory system agents|mesh-ancestor
139298840|NCT05694858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160500|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298841|NCT05694858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139298842|NCT05694858|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139298843|NCT05694858|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139298844|NCT05694858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139298845|NCT05694858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298846|NCT05680857|Ubiquinone|ubiquinone|mesh-list
139298847|NCT05680857|Coenzyme Q10|coenzyme q10|mesh-list
139298848|NCT05680857|Micronutrients|micronutrients|mesh-ancestor
139298849|NCT05680857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298850|NCT05680857|Vitamins|vitamins|mesh-ancestor
139298851|NCT05680545|Sevoflurane|sevoflurane|mesh-list
139298852|NCT05680545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139298853|NCT05680545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139298854|NCT05680545|Anesthetics, General|anesthetics, general|mesh-ancestor
139298855|NCT05680545|Anesthetics|anesthetics|mesh-ancestor
139298856|NCT05680545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139160788|NCT04303780|Docetaxel|docetaxel|mesh-list
139160857|NCT04110301|Lenalidomide|lenalidomide|mesh-list
139298864|NCT05668026|Venetoclax|venetoclax|mesh-list
139298865|NCT05668026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298866|NCT05663268|Infliximab|infliximab|mesh-list
139298867|NCT05663268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139298868|NCT05663268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139161219|NCT02535312|Cisplatin|cisplatin|mesh-list
139298869|NCT05663268|Dermatologic Agents|dermatologic agents|mesh-ancestor
139298870|NCT05663268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139298871|NCT05663268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139298872|NCT05654454|Paclitaxel|paclitaxel|mesh-list
139298873|NCT05654454|Bevacizumab|bevacizumab|mesh-list
139298874|NCT05654454|Carboplatin|carboplatin|mesh-list
139298875|NCT05654454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139298876|NCT05654454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298877|NCT05654454|Tubulin Modulators|tubulin modulators|mesh-ancestor
139298878|NCT05654454|Antimitotic Agents|antimitotic agents|mesh-ancestor
139298879|NCT05654454|Mitosis Modulators|mitosis modulators|mesh-ancestor
139161515|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139298880|NCT05654454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298881|NCT05654454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298882|NCT05654454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139298883|NCT05654454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139298885|NCT05654454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298886|NCT05654454|Growth Inhibitors|growth inhibitors|mesh-ancestor
139298887|NCT05653713|Lenograstim|lenograstim|mesh-list
139298888|NCT05653713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139298889|NCT05653713|Immunologic Factors|immunologic factors|mesh-ancestor
139298890|NCT05653713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298891|NCT05653024|Albuterol|albuterol|mesh-list
139298892|NCT05653024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139298893|NCT05653024|Autonomic Agents|autonomic agents|mesh-ancestor
139298894|NCT05653024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298895|NCT05653024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298896|NCT05653024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139298897|NCT05653024|Respiratory System Agents|respiratory system agents|mesh-ancestor
139298899|NCT05653024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139298900|NCT05653024|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139298901|NCT05653024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139298902|NCT05653024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139298903|NCT05653024|Adrenergic Agents|adrenergic agents|mesh-ancestor
139298904|NCT05653024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162087|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
139298905|NCT05653024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298906|NCT05648006|Bevacizumab|bevacizumab|mesh-list
139298907|NCT05648006|Capecitabine|capecitabine|mesh-list
139298908|NCT05648006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298909|NCT05648006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298910|NCT05648006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139162306|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139298911|NCT05648006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139298912|NCT05648006|Growth Substances|growth substances|mesh-ancestor
139298913|NCT05648006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298914|NCT05648006|Growth Inhibitors|growth inhibitors|mesh-ancestor
139298915|NCT05648006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139162452|NCT00315640|Hydrocortisone|hydrocortisone|mesh-list
139298916|NCT05648006|Antimetabolites|antimetabolites|mesh-ancestor
139298917|NCT05648006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162541|NCT00313222|Bosentan|bosentan|mesh-list
139298918|NCT05644626|Tislelizumab|tislelizumab|mesh-list
139070381|NCT00141518|Carbidopa|carbidopa|mesh-list
139298919|NCT05644626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298920|NCT05644626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298921|NCT05636111|Paclitaxel|paclitaxel|mesh-list
139298922|NCT05636111|Bevacizumab|bevacizumab|mesh-list
139298923|NCT05636111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139162726|NCT00393952|Xhance|xhance|mesh-list
139298924|NCT05636111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298925|NCT05636111|Tubulin Modulators|tubulin modulators|mesh-ancestor
139298926|NCT05636111|Antimitotic Agents|antimitotic agents|mesh-ancestor
139298927|NCT05636111|Mitosis Modulators|mitosis modulators|mesh-ancestor
139162743|NCT02285374|Tenofovir|tenofovir|mesh-list
139298928|NCT05636111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298929|NCT05636111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298930|NCT05636111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139298931|NCT05636111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139298932|NCT05636111|Growth Substances|growth substances|mesh-ancestor
139298933|NCT05636111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298934|NCT05636111|Growth Inhibitors|growth inhibitors|mesh-ancestor
139298935|NCT05627115|Tislelizumab|tislelizumab|mesh-list
139298936|NCT05627115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298937|NCT05627115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163238|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139298948|NCT05559879|Dostarlimab|dostarlimab|mesh-list
139298949|NCT05559879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298950|NCT05545527|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139298951|NCT05545527|Ferric Compounds|ferric compounds|mesh-list
139298952|NCT05545527|Hematinics|hematinics|mesh-ancestor
139298953|NCT05538091|Atezolizumab|atezolizumab|mesh-list
139298954|NCT05538091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139298955|NCT05538091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298956|NCT05538091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139298957|NCT05538091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139298958|NCT05521880|Oritavancin|oritavancin|mesh-list
139298959|NCT05521880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139298960|NCT05521880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139298961|NCT05512013|Ibuprofen|ibuprofen|mesh-list
139298962|NCT05512013|Celecoxib|celecoxib|mesh-list
139298963|NCT05512013|Flurbiprofen|flurbiprofen|mesh-list
139298964|NCT05512013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139163739|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139163813|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298965|NCT05512013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139298966|NCT05512013|Analgesics|analgesics|mesh-ancestor
139298967|NCT05512013|Sensory System Agents|sensory system agents|mesh-ancestor
139298968|NCT05512013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298969|NCT05512013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298970|NCT05512013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139298971|NCT05512013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139298972|NCT05512013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139164107|NCT03522532|Zinc|zinc|mesh-list
139298973|NCT05512013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139298974|NCT05512013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298975|NCT05512013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139298976|NCT05504863|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139298977|NCT05504863|Ferric Compounds|ferric compounds|mesh-list
139298978|NCT05504863|Hematinics|hematinics|mesh-ancestor
139298979|NCT05464264|Ketamine|ketamine|mesh-list
139298980|NCT05464264|Analgesics|analgesics|mesh-ancestor
139298981|NCT05464264|Sensory System Agents|sensory system agents|mesh-ancestor
139298982|NCT05464264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139298983|NCT05464264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298984|NCT05464264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139298985|NCT05464264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139298986|NCT05464264|Anesthetics, General|anesthetics, general|mesh-ancestor
139298987|NCT05464264|Anesthetics|anesthetics|mesh-ancestor
139298988|NCT05464264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298989|NCT05464264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139298990|NCT05464264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139298991|NCT05464264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139298992|NCT05464264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139298993|NCT05443009|Lidocaine|lidocaine|mesh-list
139298994|NCT05443009|Carticaine|carticaine|mesh-list
139298995|NCT05443009|Anesthetics, Local|anesthetics, local|mesh-ancestor
139298996|NCT05443009|Anesthetics|anesthetics|mesh-ancestor
139298997|NCT05443009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139298998|NCT05443009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139298999|NCT05443009|Sensory System Agents|sensory system agents|mesh-ancestor
139299000|NCT05443009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299001|NCT05443009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139299002|NCT05443009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139299003|NCT05443009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139299004|NCT05443009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139164522|NCT02529241|Delpazolid|delpazolid|mesh-list
139299005|NCT05443009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299006|NCT05441410|Artesunate|artesunate|mesh-list
139299007|NCT05441410|Pyronaridine|pyronaridine|mesh-list
139299008|NCT05441410|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139299009|NCT05441410|Antimalarials|antimalarials|mesh-ancestor
139299010|NCT05441410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139299011|NCT05441410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139164741|NCT06128070|Methotrexate|methotrexate|mesh-list
139299012|NCT05441410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139299013|NCT05441410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299014|NCT05441410|Antiviral Agents|antiviral agents|mesh-ancestor
139299015|NCT05441410|Schistosomicides|schistosomicides|mesh-ancestor
139299016|NCT05441410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139299017|NCT05441410|Anthelmintics|anthelmintics|mesh-ancestor
139299018|NCT05440916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139164804|NCT06086171|Narcotics|narcotics|mesh-ancestor
139299019|NCT05440916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164872|NCT05867329|Prednisone|prednisone|mesh-list
139299020|NCT05440916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165010|NCT05382312|GSK656|gsk656|mesh-list
139299021|NCT05440916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299022|NCT05430152|Naltrexone|naltrexone|mesh-list
139299023|NCT05430152|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139299024|NCT05430152|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139299025|NCT05430152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299026|NCT05430152|Sensory System Agents|sensory system agents|mesh-ancestor
139299027|NCT05430152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299028|NCT05418777|Trimethoprim|trimethoprim|mesh-list
139299029|NCT05418777|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139299030|NCT05418777|Sulfamethoxazole|sulfamethoxazole|mesh-list
139299031|NCT05418777|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139299032|NCT05418777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139299033|NCT05418777|Antimalarials|antimalarials|mesh-ancestor
139299034|NCT05418777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139299035|NCT05418777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139299036|NCT05418777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139299037|NCT05418777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299038|NCT05418777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299039|NCT05418777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139299040|NCT05418777|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139299041|NCT05418777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139299042|NCT05418777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139299043|NCT05414292|Sirolimus|sirolimus|mesh-list
139299044|NCT05414292|Temsirolimus|temsirolimus|mesh-list
139299046|NCT05414292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139299047|NCT05414292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139299048|NCT05414292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139299049|NCT05414292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299050|NCT05414292|Antifungal Agents|antifungal agents|mesh-ancestor
139299051|NCT05414292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139299052|NCT05414292|Immunologic Factors|immunologic factors|mesh-ancestor
139299053|NCT05414292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299054|NCT05414292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139299055|NCT05414292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299056|NCT05414292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299057|NCT05404048|Atezolizumab|atezolizumab|mesh-list
139299058|NCT05404048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139299059|NCT05404048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165661|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299060|NCT05404048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139299061|NCT05404048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299062|NCT05372393|Anesthetics|anesthetics|mesh-list
139299063|NCT05372393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139165879|NCT05499832|Tenecteplase|tenecteplase|mesh-list
139299064|NCT05372393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299065|NCT05371054|Prednisone|prednisone|mesh-list
139299066|NCT05371054|Venetoclax|venetoclax|mesh-list
139299067|NCT05371054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139299068|NCT05371054|Glucocorticoids|glucocorticoids|mesh-ancestor
139299069|NCT05371054|Hormones|hormones|mesh-ancestor
139299070|NCT05371054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139299071|NCT05371054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299072|NCT05371054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139299073|NCT05371054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299074|NCT05358509|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139299075|NCT05358509|Ferric Compounds|ferric compounds|mesh-list
139299076|NCT05358509|Hematinics|hematinics|mesh-ancestor
139299077|NCT05354986|Povidone|povidone|mesh-list
139299078|NCT05354986|Plasma Substitutes|plasma substitutes|mesh-ancestor
139299079|NCT05354986|Blood Substitutes|blood substitutes|mesh-ancestor
139299080|NCT05331521|Vincristine|vincristine|mesh-list
139299081|NCT05331521|Temozolomide|temozolomide|mesh-list
139299082|NCT05331521|Lomustine|lomustine|mesh-list
139165965|NCT05072249|Naloxone|naloxone|mesh-list
139299083|NCT05331521|Procarbazine|procarbazine|mesh-list
139299084|NCT05331521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139299085|NCT05331521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299086|NCT05331521|Tubulin Modulators|tubulin modulators|mesh-ancestor
139299087|NCT05331521|Antimitotic Agents|antimitotic agents|mesh-ancestor
139299088|NCT05331521|Mitosis Modulators|mitosis modulators|mesh-ancestor
139299089|NCT05331521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299090|NCT05331521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139299091|NCT05331521|Alkylating Agents|alkylating agents|mesh-ancestor
139299092|NCT05327426|Vaccines|vaccines|mesh-list
139299093|NCT05327426|Immunologic Factors|immunologic factors|mesh-ancestor
139299094|NCT05327426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299095|NCT05326776|Oxytocin|oxytocin|mesh-list
139299096|NCT05326776|Oxytocics|oxytocics|mesh-ancestor
139299097|NCT05326776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139299098|NCT05326776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299099|NCT05323656|Pembrolizumab|pembrolizumab|mesh-list
139299100|NCT05323656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139299101|NCT05323656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299102|NCT05323656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139299103|NCT05323656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299104|NCT05322512|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139299105|NCT05322512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139299106|NCT05322512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299107|NCT05321043|Riboflavin|riboflavin|mesh-list
139299109|NCT05321043|Micronutrients|micronutrients|mesh-ancestor
139299110|NCT05321043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299111|NCT05321043|Vitamin B Complex|vitamin b complex|mesh-ancestor
139299112|NCT05321043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139299113|NCT05321043|Dermatologic Agents|dermatologic agents|mesh-ancestor
139299114|NCT05289869|Oxytocin|oxytocin|mesh-list
139299115|NCT05289869|Oxytocics|oxytocics|mesh-ancestor
139299116|NCT05289869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139299117|NCT05289869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299118|NCT05289804|Lidocaine|lidocaine|mesh-list
139299119|NCT05289804|Anesthetics, Local|anesthetics, local|mesh-list
139299120|NCT05289804|Prilocaine|prilocaine|mesh-list
139299121|NCT05289804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139299122|NCT05289804|Anesthetics|anesthetics|mesh-list
139299123|NCT05289804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139299124|NCT05289804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299125|NCT05289804|Sensory System Agents|sensory system agents|mesh-ancestor
139299126|NCT05289804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299127|NCT05289804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139299128|NCT05289804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139299129|NCT05289804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139299130|NCT05289804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139299131|NCT05289804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166425|NCT03228693|Triamcinolone|triamcinolone|mesh-list
139299132|NCT05289804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139299134|NCT05271162|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139299135|NCT05271162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299136|NCT05271162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139299137|NCT05271162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299138|NCT05259943|Psilocybin|psilocybin|mesh-list
139299139|NCT05259943|Hallucinogens|hallucinogens|mesh-ancestor
139299140|NCT05259943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299141|NCT05259943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139299142|NCT05236842|Sulthiame|sulthiame|mesh-list
139299143|NCT05236842|Anticonvulsants|anticonvulsants|mesh-ancestor
139299144|NCT05217498|Istradefylline|istradefylline|mesh-list
139299145|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
139299146|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139299147|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139299148|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
139299149|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139299150|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166486|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
139299151|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299153|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
139299154|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299155|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139299156|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
139299157|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299158|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139299159|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139299160|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
139299161|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139299162|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299163|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139299164|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
139299165|NCT05162417|Methylene Blue|methylene blue|mesh-list
139299166|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299167|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299168|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
139299169|NCT05162417|Coagulants|coagulants|mesh-ancestor
139299170|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
139299171|NCT05156749|Calpastatin|calpastatin|mesh-list
139299172|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139299173|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
139299174|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299175|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299176|NCT05149092|Caseins|caseins|mesh-list
139299177|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
139299178|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
139166541|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
139299179|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299180|NCT05122546|Nivolumab|nivolumab|mesh-list
139299181|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139299182|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299183|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139070424|NCT00130442|Dacarbazine|dacarbazine|mesh-list
139299184|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299185|NCT05078866|Vaccines|vaccines|mesh-list
139299186|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
139299187|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299188|NCT05071937|Talazoparib|talazoparib|mesh-list
139299189|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139299190|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299191|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299192|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299193|NCT05069051|Belimumab|belimumab|mesh-list
139299194|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139299195|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
139299196|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299197|NCT05067387|Dronabinol|dronabinol|mesh-list
139299198|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
139299199|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299200|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139299201|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139299202|NCT05067387|Analgesics|analgesics|mesh-ancestor
139299203|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
139299204|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299205|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139299206|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139299207|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139299208|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299210|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139299211|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
139299212|NCT05064280|Lenvatinib|lenvatinib|mesh-list
139299213|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139299214|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299215|NCT05064280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139299216|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166712|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299217|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139299218|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299220|NCT05051449|Analgesics|analgesics|mesh-ancestor
139299221|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
139299222|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299223|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299224|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139299225|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139299226|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
139299227|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
139299228|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139299229|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139299230|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139299231|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139299232|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299233|NCT05044611|Amiloride|amiloride|mesh-list
139299234|NCT05044611|Diuretics|diuretics|mesh-ancestor
139299235|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
139299236|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299237|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139299238|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139299239|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139299240|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299241|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139299242|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139299243|NCT05030298|Temozolomide|temozolomide|mesh-list
139299244|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139299245|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
139299246|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299247|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299248|NCT04984733|Nivolumab|nivolumab|mesh-list
139299249|NCT04984733|Temozolomide|temozolomide|mesh-list
139299250|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139299251|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299252|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139166895|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
139299253|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299254|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139299255|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
139299256|NCT04975958|Atezolizumab|atezolizumab|mesh-list
139299257|NCT04975958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139299258|NCT04975958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299259|NCT04975958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139299260|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299261|NCT04944173|Durvalumab|durvalumab|mesh-list
139299262|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139299263|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299264|NCT04927052|Lidocaine|lidocaine|mesh-list
139299265|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
139299266|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
139299267|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139299268|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299269|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
139299270|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299271|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139299272|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139299273|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139166960|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139299274|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139299275|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299277|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
139299278|NCT04899583|Sirolimus|sirolimus|mesh-list
139299279|NCT04899583|Paclitaxel|paclitaxel|mesh-list
139299280|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139299281|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299282|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
139299283|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
139299284|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
139299285|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299286|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139299287|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139299288|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139299289|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
139299290|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139167072|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
139299291|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
139299292|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299293|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
139299294|NCT04877834|Lansoprazole|lansoprazole|mesh-list
139299296|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139299297|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139299298|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299299|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299300|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139299301|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139299302|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139299303|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139299304|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299305|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139299306|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299307|NCT04870957|Analgesics|analgesics|mesh-ancestor
139299308|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
139299309|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299310|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
139299311|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139299312|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
139299313|NCT04853251|Ranibizumab|ranibizumab|mesh-list
139299314|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139299315|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139299316|NCT04853251|Growth Substances|growth substances|mesh-ancestor
139299317|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299318|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
139299319|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299320|NCT04844333|Anesthetics|anesthetics|mesh-list
139299321|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139299322|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299323|NCT04838613|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139299324|NCT04838613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139299325|NCT04838613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299326|NCT04824092|Prednisone|prednisone|mesh-list
139299327|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
139299328|NCT04824092|Rituximab|rituximab|mesh-list
139299329|NCT04824092|Doxorubicin|doxorubicin|mesh-list
139299330|NCT04824092|Vincristine|vincristine|mesh-list
139299331|NCT04824092|Lenalidomide|lenalidomide|mesh-list
139299332|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139167263|NCT06142591|Oxycodone|oxycodone|mesh-list
139299333|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
138882780|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
139299334|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299335|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139299336|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139299337|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
139299338|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299339|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299340|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139299341|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139299342|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139299343|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139299344|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139299345|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299346|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139299347|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
139299349|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139299350|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139299351|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139299352|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
139299353|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
139299354|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
139299355|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139299356|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139299357|NCT04824092|Growth Substances|growth substances|mesh-ancestor
139299358|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
139299359|NCT04819503|Anesthetics|anesthetics|mesh-list
139299360|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139299361|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299362|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
139299363|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139299364|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
139299365|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299366|NCT04767022|Paclitaxel|paclitaxel|mesh-list
139299367|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139299368|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139299369|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299370|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
139299371|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
139299372|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
139299373|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299374|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139167678|NCT05665062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167679|NCT05665062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167680|NCT05665062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139167681|NCT05658861|Caseins|caseins|mesh-list
139167682|NCT05658861|Chelating Agents|chelating agents|mesh-ancestor
139167683|NCT05658861|Sequestering Agents|sequestering agents|mesh-ancestor
139167684|NCT05658861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167685|NCT05634759|Azithromycin|azithromycin|mesh-list
139167686|NCT05634759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139167687|NCT05634759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167699|NCT05562492|Insulin|insulin|mesh-list
139299376|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299377|NCT04752696|Leucovorin|leucovorin|mesh-list
139299378|NCT04752696|Fluorouracil|fluorouracil|mesh-list
139299379|NCT04752696|Irinotecan|irinotecan|mesh-list
139299380|NCT04752696|Onvansertib|onvansertib|mesh-list
139299381|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
139299382|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299383|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139299384|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299385|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139299386|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
139299387|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299388|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139299389|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139299390|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299392|NCT04752696|Protective Agents|protective agents|mesh-ancestor
139299393|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
139299394|NCT04752696|Vitamins|vitamins|mesh-ancestor
139299395|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
139299396|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139299397|NCT04739371|Insulin|insulin|mesh-list
139299398|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139299399|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139299400|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299401|NCT04732507|Lidocaine|lidocaine|mesh-list
139299402|NCT04732507|Bupivacaine|bupivacaine|mesh-list
139299403|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
139299404|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
139299405|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139299406|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299407|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
139167854|NCT05275439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299408|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299409|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139299410|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139299411|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139299412|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139299413|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299415|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139299416|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139299417|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
139299418|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299419|NCT04717765|Vitamin E|vitamin e|mesh-list
139299420|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
139299421|NCT04717765|Tocopherols|tocopherols|mesh-list
139299422|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
139299423|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299424|NCT04717765|Protective Agents|protective agents|mesh-ancestor
139299425|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299426|NCT04717765|Vitamins|vitamins|mesh-ancestor
139299427|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
139299428|NCT04713969|Pantoprazole|pantoprazole|mesh-list
139299429|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139299430|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139299431|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139168061|NCT04677972|Ebselen|ebselen|mesh-list
139299432|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299433|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299435|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
139299436|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
139299437|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299439|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139299440|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139299441|NCT04697719|Analgesics|analgesics|mesh-ancestor
139299442|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
139299443|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299444|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299445|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139299446|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139299447|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139299448|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139299449|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299450|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139299451|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139299452|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299453|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
139299454|NCT04659174|Xanomeline|xanomeline|mesh-list
139299455|NCT04659174|Trospium chloride|trospium chloride|mesh-list
139299456|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
139299457|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
139299458|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299459|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299460|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139299461|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139299462|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
139299463|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139299464|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299465|NCT04659174|Urological Agents|urological agents|mesh-ancestor
139299466|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139168269|NCT04079621|Primaquine|primaquine|mesh-list
139299468|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139299469|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139299470|NCT04628338|Interferons|interferons|mesh-list
139299471|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
139299472|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299473|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
139299474|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139299475|NCT04622020|Anesthetics|anesthetics|mesh-list
139299476|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139299477|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299478|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
139299479|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138882930|NCT05590117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139299480|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139299481|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299482|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139299483|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
139299484|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139299485|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299486|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299487|NCT04516993|Aspirin|aspirin|mesh-list
139299488|NCT04516993|Plasminogen|plasminogen|mesh-list
139299489|NCT04516993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139299490|NCT04516993|Tenecteplase|tenecteplase|mesh-list
139299491|NCT04516993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139299492|NCT04516993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139299493|NCT04516993|Analgesics|analgesics|mesh-ancestor
139299494|NCT04516993|Sensory System Agents|sensory system agents|mesh-ancestor
139168448|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299495|NCT04516993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299496|NCT04516993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299498|NCT04516993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139299499|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139299500|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139299501|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299502|NCT04516993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139299503|NCT04516993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139299504|NCT04516993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299505|NCT04516993|Antipyretics|antipyretics|mesh-ancestor
139299506|NCT04513015|Antioxidants|antioxidants|mesh-list
139299507|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299508|NCT04513015|Protective Agents|protective agents|mesh-ancestor
139299509|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299510|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139299511|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139168582|NCT02555839|Thalidomide|thalidomide|mesh-list
139299512|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299513|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
139299514|NCT04478942|Misoprostol|misoprostol|mesh-list
139299515|NCT04478942|Oxytocin|oxytocin|mesh-list
139299516|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
139299517|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139299518|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299519|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139299520|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
139299521|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139299522|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139299523|NCT04472416|Analgesics|analgesics|mesh-list
139299524|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
139299525|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299526|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299527|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
139299528|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139299529|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
139299530|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139299531|NCT04459052|Expectorants|expectorants|mesh-ancestor
139168791|NCT01236560|Bevacizumab|bevacizumab|mesh-list
139299532|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
139299533|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139299535|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299536|NCT04459052|Protective Agents|protective agents|mesh-ancestor
139169012|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
139299537|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299538|NCT04459052|Antidotes|antidotes|mesh-ancestor
139299539|NCT04447716|Rituximab|rituximab|mesh-list
139299540|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139299541|NCT04447716|Lenalidomide|lenalidomide|mesh-list
139299542|NCT04447716|Venetoclax|venetoclax|mesh-list
139299543|NCT04447716|Piperidine|piperidine|mesh-list
139299544|NCT04447716|Antibodies|antibodies|mesh-list
139299545|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
139299546|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139299547|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
139299548|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299549|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299550|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139299551|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139299552|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139169440|NCT02296996|Trametinib|trametinib|mesh-list
139299554|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
139299555|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299556|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139169585|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
139299557|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139299558|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139299560|NCT04447027|Lenalidomide|lenalidomide|mesh-list
139299561|NCT04447027|Azacitidine|azacitidine|mesh-list
139299563|NCT04447027|Cc-486|cc-486|mesh-list
139169807|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
139299564|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139299565|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
139299566|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
139299567|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299568|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169950|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139299569|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139299570|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
139299571|NCT04447027|Hormones|hormones|mesh-ancestor
139299572|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139299573|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139299575|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
139299576|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139299577|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139299578|NCT04447027|Growth Substances|growth substances|mesh-ancestor
139299579|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
139170242|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299580|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139299581|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
139299582|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299583|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299584|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139299585|NCT04447027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139299586|NCT04427826|Morphine|morphine|mesh-list
139299587|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139299589|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139299590|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299591|NCT04427826|Analgesics|analgesics|mesh-ancestor
139299592|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
139299593|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299594|NCT04424511|Azithromycin|azithromycin|mesh-list
139299595|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139299596|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170543|NCT01233895|Bortezomib|bortezomib|mesh-list
139299598|NCT04315948|Ritonavir|ritonavir|mesh-list
139299599|NCT04315948|Lopinavir|lopinavir|mesh-list
139299600|NCT04315948|Interferon-beta|interferon-beta|mesh-list
139299601|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
139299602|NCT04315948|Remdesivir|remdesivir|mesh-list
139299603|NCT04315948|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139170679|NCT01142869|Cetuximab|cetuximab|mesh-list
139299604|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
139299605|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299606|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
139299607|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139299608|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139299609|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139299610|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
139299611|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299612|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299613|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139170886|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139299614|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139170964|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139299615|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139299616|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139171042|NCT01359020|Dipyrone|dipyrone|mesh-list
139299617|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
139299618|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139299619|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139299620|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139299621|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
139299622|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299623|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139299624|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
139299625|NCT04310059|Folic Acid|folic acid|mesh-list
139299626|NCT04310059|Hematinics|hematinics|mesh-ancestor
139299627|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
139299628|NCT04310059|Vitamins|vitamins|mesh-ancestor
139299629|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
139299630|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299632|NCT04302870|Memantine|memantine|mesh-list
139299633|NCT04302870|Trazodone|trazodone|mesh-list
139299634|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138883099|NCT02744339|Riociguat|riociguat|mesh-list
139299635|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139299636|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139299637|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
139299638|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139299639|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299640|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299641|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139299642|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139299643|NCT04302870|Antiviral Agents|antiviral agents|mesh-ancestor
139299644|NCT04302870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139299645|NCT04302870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139299646|NCT04302870|Analgesics|analgesics|mesh-ancestor
139299647|NCT04302870|Sensory System Agents|sensory system agents|mesh-ancestor
139299648|NCT04302870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299649|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139299650|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139171906|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299651|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139299652|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139299653|NCT04302870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139299654|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139299655|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139299656|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
139299657|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139299658|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
139299659|NCT04298203|Topiramate|topiramate|mesh-list
139299660|NCT04298203|Phentermine|phentermine|mesh-list
139299661|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
139299662|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139299663|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299664|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139299665|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
139299666|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139299667|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
139299668|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
139299669|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299670|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
139299672|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299673|NCT04290429|Teduglutide|teduglutide|mesh-list
139299674|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139299675|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139299676|NCT04290429|Protective Agents|protective agents|mesh-ancestor
139299677|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299679|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
139299680|NCT04280692|Artemether|artemether|mesh-list
139299681|NCT04280692|Piperaquine|piperaquine|mesh-list
139299682|NCT04280692|Primaquine|primaquine|mesh-list
139299683|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
139299684|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139299685|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139299686|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
139299687|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139299688|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139299689|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139299690|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139299691|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172836|NCT00783536|Etanercept|etanercept|mesh-list
139299692|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299693|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139299694|NCT04276857|Leucovorin|leucovorin|mesh-list
139299695|NCT04276857|Paclitaxel|paclitaxel|mesh-list
139299696|NCT04276857|Gemcitabine|gemcitabine|mesh-list
139299697|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
139299698|NCT04276857|Irinotecan|irinotecan|mesh-list
139299699|NCT04276857|Folfirinox|folfirinox|mesh-list
139299700|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139299701|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299702|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
139299703|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
139299704|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
139299705|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299706|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139299708|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139299709|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139299710|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299711|NCT04276857|Antidotes|antidotes|mesh-ancestor
139299712|NCT04276857|Protective Agents|protective agents|mesh-ancestor
139299713|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299714|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
139299716|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
139299717|NCT04268277|Rituximab|rituximab|mesh-list
139299718|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
139299719|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139299720|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299721|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
139299722|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299723|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139299724|NCT04268277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139173406|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139299725|NCT04268277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299726|NCT04246684|Leucovorin|leucovorin|mesh-list
139299727|NCT04246684|Folic Acid|folic acid|mesh-list
139299728|NCT04246684|Capecitabine|capecitabine|mesh-list
139299729|NCT04246684|Fluorouracil|fluorouracil|mesh-list
139299730|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
139299731|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
139299732|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139299733|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
139299734|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299735|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299736|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139299738|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299739|NCT04246684|Antidotes|antidotes|mesh-ancestor
139299740|NCT04246684|Protective Agents|protective agents|mesh-ancestor
139299741|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
139299742|NCT04246684|Vitamins|vitamins|mesh-ancestor
139299743|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
139299744|NCT04246684|Hematinics|hematinics|mesh-ancestor
139299745|NCT04234997|Suvorexant|suvorexant|mesh-list
139299746|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139299747|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139299748|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139299749|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299750|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139299751|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139299752|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299753|NCT04187404|Nivolumab|nivolumab|mesh-list
139299754|NCT04187404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139299755|NCT04187404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299756|NCT04187404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139299757|NCT04187404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299758|NCT04177498|ON 01910|on 01910|mesh-list
139299759|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299760|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139299761|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299762|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299763|NCT04151472|Ubiquinone|ubiquinone|mesh-list
139299764|NCT04151472|Idebenone|idebenone|mesh-list
139299765|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
139299766|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299767|NCT04151472|Protective Agents|protective agents|mesh-ancestor
139299768|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299769|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
139299770|NCT04130438|Nebivolol|nebivolol|mesh-list
139299771|NCT04130438|Diltiazem|diltiazem|mesh-list
139299772|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139299773|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
139299774|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139299775|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139299776|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139299777|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
139299778|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139299779|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299780|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299781|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139299782|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139299783|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139299784|NCT04128722|Sirolimus|sirolimus|mesh-list
139299785|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139299786|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139299787|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139299788|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299789|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
139299790|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139299791|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
139299792|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299794|NCT04120805|Coagulants|coagulants|mesh-ancestor
139299795|NCT04119180|Midazolam|midazolam|mesh-list
139299796|NCT04119180|Ketamine|ketamine|mesh-list
139299797|NCT04119180|Analgesics|analgesics|mesh-ancestor
139299798|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
139299799|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299800|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299801|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139299802|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139299803|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
139299804|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
139299805|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139299806|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139299807|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139299808|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139299809|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299810|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139299811|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139299812|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139299813|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139299814|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139299815|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
139299816|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
139299817|NCT04083118|Listerine|listerine|mesh-list
139299818|NCT04083118|Fluorides|fluorides|mesh-list
139299819|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
139299820|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
139299821|NCT04083118|Protective Agents|protective agents|mesh-ancestor
139299822|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299823|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139299824|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139299825|NCT04070378|Daratumumab|daratumumab|mesh-list
139299826|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299827|NCT04037527|Gemcitabine|gemcitabine|mesh-list
139299828|NCT04037527|Docetaxel|docetaxel|mesh-list
139299829|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139299830|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
139299831|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299832|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299833|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
139299834|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
139299835|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
139299836|NCT03979885|Nicotine|nicotine|mesh-list
139299837|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139299838|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
139299839|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299840|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299841|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139299842|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139299843|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
139299844|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139299845|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299846|NCT03966014|Amoxicillin|amoxicillin|mesh-list
139299847|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139299848|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139299849|NCT03941886|Aspirin|aspirin|mesh-list
139299850|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139299851|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139299852|NCT03941886|Analgesics|analgesics|mesh-ancestor
139299853|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
139299854|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299855|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299856|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139299857|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139299858|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139299859|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139299860|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299861|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139299862|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139299863|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299864|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
139299865|NCT03934710|Serotonin|serotonin|mesh-list
138883310|NCT00684372|Leflunomide|leflunomide|mesh-list
139299866|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
139299867|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
139299868|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139299869|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299870|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299871|NCT03878524|Vitamins|vitamins|mesh-list
139299872|NCT03878524|Leucovorin|leucovorin|mesh-list
139299873|NCT03878524|Vitamin A|vitamin a|mesh-list
139299874|NCT03878524|Sirolimus|sirolimus|mesh-list
139299875|NCT03878524|Celecoxib|celecoxib|mesh-list
139299876|NCT03878524|Paclitaxel|paclitaxel|mesh-list
139299877|NCT03878524|Maytansine|maytansine|mesh-list
139299878|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139299879|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139299880|NCT03878524|Bevacizumab|bevacizumab|mesh-list
139299881|NCT03878524|Carboplatin|carboplatin|mesh-list
139299882|NCT03878524|Doxorubicin|doxorubicin|mesh-list
139299883|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139299884|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
139299885|NCT03878524|Capecitabine|capecitabine|mesh-list
139299886|NCT03878524|Fluorouracil|fluorouracil|mesh-list
139299887|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
139299888|NCT03878524|Nivolumab|nivolumab|mesh-list
139299889|NCT03878524|Trastuzumab|trastuzumab|mesh-list
139299890|NCT03878524|Everolimus|everolimus|mesh-list
139299891|NCT03878524|Bortezomib|bortezomib|mesh-list
139299892|NCT03878524|Ipilimumab|ipilimumab|mesh-list
139299893|NCT03878524|Sorafenib|sorafenib|mesh-list
139299894|NCT03878524|Temsirolimus|temsirolimus|mesh-list
139299895|NCT03878524|Durvalumab|durvalumab|mesh-list
139299896|NCT03878524|Sunitinib|sunitinib|mesh-list
139299897|NCT03878524|Daunorubicin|daunorubicin|mesh-list
139299898|NCT03878524|Venetoclax|venetoclax|mesh-list
139299899|NCT03878524|Lenvatinib|lenvatinib|mesh-list
139299900|NCT03878524|Dasatinib|dasatinib|mesh-list
139299901|NCT03878524|Olaparib|olaparib|mesh-list
139299902|NCT03878524|Palbociclib|palbociclib|mesh-list
139299903|NCT03878524|Pertuzumab|pertuzumab|mesh-list
139299904|NCT03878524|Vorinostat|vorinostat|mesh-list
139299905|NCT03878524|Trametinib|trametinib|mesh-list
139299906|NCT03878524|Tretinoin|tretinoin|mesh-list
139299907|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
139299908|NCT03878524|Bicalutamide|bicalutamide|mesh-list
139299909|NCT03878524|Afatinib|afatinib|mesh-list
139299910|NCT03878524|Vemurafenib|vemurafenib|mesh-list
139299911|NCT03878524|Dabrafenib|dabrafenib|mesh-list
139299912|NCT03878524|Panobinostat|panobinostat|mesh-list
139299913|NCT03878524|Ponatinib|ponatinib|mesh-list
139299914|NCT03878524|Idelalisib|idelalisib|mesh-list
139299915|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139299916|NCT03878524|MTOR Inhibitors|mtor inhibitors|mesh-list
139299917|NCT03878524|Losartan|losartan|mesh-list
139299918|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
139299919|NCT03878524|Antibodies|antibodies|mesh-list
139299920|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
139299921|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139299922|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139299923|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
139299924|NCT03878524|Entrectinib|entrectinib|mesh-list
139299925|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
139299926|NCT03878524|Benzenesulfonamide|benzenesulfonamide|mesh-list
139299927|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139299928|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299929|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
139299930|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
139299931|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
139299932|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299933|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139299934|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139299935|NCT03878524|Growth Substances|growth substances|mesh-ancestor
139299936|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299937|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
139299938|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
139299939|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
139299940|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139299941|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139299942|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138883387|NCT02736071|Narcotics|narcotics|mesh-ancestor
139299943|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299944|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139299945|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139299946|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
139299947|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139299948|NCT03878524|Antidotes|antidotes|mesh-ancestor
139299949|NCT03878524|Protective Agents|protective agents|mesh-ancestor
139299950|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
139299951|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139299952|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139299953|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139299954|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
139299955|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139299956|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139299957|NCT03878524|Analgesics|analgesics|mesh-ancestor
139299958|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
139299959|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139299960|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139299961|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139299962|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139299963|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139299964|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139299965|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139299966|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139299967|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139299968|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139299969|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139299970|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
139299971|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
139299972|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
139299973|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139299974|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
139299975|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
139299976|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139299977|NCT03878524|Immunotoxins|immunotoxins|mesh-ancestor
139299978|NCT03878524|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139299980|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139299981|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299982|NCT03867370|Lenvatinib|lenvatinib|mesh-list
139299983|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299984|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139299985|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299986|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299987|NCT03866525|Irinotecan|irinotecan|mesh-list
139299988|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139299989|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139299990|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139299991|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139299992|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139299993|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
139299994|NCT03859921|Progestins|progestins|mesh-ancestor
139299995|NCT03859921|Hormones|hormones|mesh-ancestor
139299996|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139299997|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139299998|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139299999|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139300000|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300001|NCT03844412|Lidocaine|lidocaine|mesh-list
139300002|NCT03844412|Nortriptyline|nortriptyline|mesh-list
139300003|NCT03844412|Estradiol|estradiol|mesh-list
139300004|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
139300005|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
139300006|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139300007|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300008|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
139300009|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300010|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139300011|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139300012|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139300013|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139300014|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300015|NCT03844412|Estrogens|estrogens|mesh-ancestor
139300016|NCT03844412|Hormones|hormones|mesh-ancestor
139300017|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139300018|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139300019|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
139300020|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139300021|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139300022|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139300023|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
138883464|NCT00690846|Adalimumab|adalimumab|mesh-list
139300024|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139300026|NCT03829410|Onvansertib|onvansertib|mesh-list
139300027|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139300028|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300029|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139300030|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139300031|NCT03829410|Growth Substances|growth substances|mesh-ancestor
139300032|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070549|NCT00119262|Lenograstim|lenograstim|mesh-list
139300033|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
139300034|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300035|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300036|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300037|NCT03826875|Fluoxetine|fluoxetine|mesh-list
139300038|NCT03826875|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139300039|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139300040|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139300041|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300042|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139300043|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
139300044|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300045|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139300046|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
139300047|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139300048|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139300049|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139300050|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300051|NCT03802591|Capecitabine|capecitabine|mesh-list
139300052|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
139300053|NCT03802591|Antibodies|antibodies|mesh-list
139300054|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139300055|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
139173596|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
139300056|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300057|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139300058|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
139300059|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300060|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300062|NCT03793114|Hormones|hormones|mesh-ancestor
139300063|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139300064|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300065|NCT03753074|Tenofovir|tenofovir|mesh-list
139300066|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
139300067|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300068|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139300069|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139300070|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300071|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300072|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139300073|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139300074|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
139300075|NCT03739853|Adalimumab|adalimumab|mesh-list
139300076|NCT03739853|Methotrexate|methotrexate|mesh-list
139300077|NCT03739853|Leflunomide|leflunomide|mesh-list
139300078|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139300079|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
139300080|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139300081|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300082|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139300083|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
139300084|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300085|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300086|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
139300087|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300088|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139300089|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139300090|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
139300091|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139300092|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139300093|NCT03739853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139300094|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139070562|NCT00119262|Growth Substances|growth substances|mesh-ancestor
139300095|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883537|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
138883611|NCT05265247|Esomeprazole|esomeprazole|mesh-list
139300096|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139300097|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139300098|NCT03739853|Analgesics|analgesics|mesh-ancestor
139300099|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
139300100|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300101|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139300102|NCT03653832|Clonidine|clonidine|mesh-list
139300103|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
139300104|NCT03653832|Propofol|propofol|mesh-list
139300105|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139300106|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139300107|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300108|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139300109|NCT03653832|Analgesics|analgesics|mesh-ancestor
139300110|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
139300111|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300112|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139300113|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139300114|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139300115|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
139300116|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139300117|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300118|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139300119|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
139300120|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
139300121|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139300122|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
139300123|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
139300124|NCT03643276|Cytarabine|cytarabine|mesh-list
139300125|NCT03643276|Dexamethasone|dexamethasone|mesh-list
139300126|NCT03643276|Prednisone|prednisone|mesh-list
139300127|NCT03643276|Prednisolone|prednisolone|mesh-list
139300128|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
139300129|NCT03643276|Ifosfamide|ifosfamide|mesh-list
139300130|NCT03643276|Doxorubicin|doxorubicin|mesh-list
139300131|NCT03643276|Methotrexate|methotrexate|mesh-list
139300132|NCT03643276|Fludarabine|fludarabine|mesh-list
139300133|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
139300134|NCT03643276|Etoposide|etoposide|mesh-list
139300135|NCT03643276|Vincristine|vincristine|mesh-list
139300136|NCT03643276|Bortezomib|bortezomib|mesh-list
139300137|NCT03643276|Daunorubicin|daunorubicin|mesh-list
139300138|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
139300139|NCT03643276|Pegaspargase|pegaspargase|mesh-list
139300140|NCT03643276|Blinatumomab|blinatumomab|mesh-list
139300141|NCT03643276|Vindesine|vindesine|mesh-list
139300142|NCT03643276|Asparaginase|asparaginase|mesh-list
139300143|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139300144|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
139300145|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300146|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139300147|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139300148|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
139300149|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300150|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300151|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139300152|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139300153|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
139300154|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
139300155|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300156|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139300157|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
139300158|NCT03643276|Hormones|hormones|mesh-ancestor
139300159|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139300160|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139300161|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139300162|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139300163|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139300164|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300165|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139300166|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
139300167|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139300168|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139300169|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
139300170|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
139300171|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139300172|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139300173|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139300175|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300176|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
139300177|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
139300178|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
139300179|NCT03617471|Acetaminophen|acetaminophen|mesh-list
139300180|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139300181|NCT03617471|Analgesics|analgesics|mesh-ancestor
139300182|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
139300183|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300184|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300185|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
139300186|NCT03611595|Tretinoin|tretinoin|mesh-list
139300187|NCT03611595|Isotretinoin|isotretinoin|mesh-list
139300188|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300189|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
139300190|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
139300191|NCT03586284|Valganciclovir|valganciclovir|mesh-list
139300192|NCT03586284|Ganciclovir|ganciclovir|mesh-list
139300193|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139300194|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
139300195|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300196|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139300197|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300198|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300199|NCT03571321|Cytarabine|cytarabine|mesh-list
139300200|NCT03571321|Dexamethasone|dexamethasone|mesh-list
139300201|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
139300202|NCT03571321|Rituximab|rituximab|mesh-list
139300203|NCT03571321|Doxorubicin|doxorubicin|mesh-list
139300204|NCT03571321|Methotrexate|methotrexate|mesh-list
139300205|NCT03571321|Vincristine|vincristine|mesh-list
139300206|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
139300207|NCT03571321|Pegaspargase|pegaspargase|mesh-list
139300208|NCT03571321|Thioguanine|thioguanine|mesh-list
139300209|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139300210|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
139300211|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300212|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139300213|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139300214|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
139300215|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300216|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300217|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139300218|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139300219|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
139300220|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
139300221|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300222|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139300223|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
139300224|NCT03571321|Hormones|hormones|mesh-ancestor
139300225|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139300226|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139300227|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139300228|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139300229|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139300230|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139300231|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300232|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139300233|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
139173632|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
139300234|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139300235|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139300236|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
139300237|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
139300238|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139300239|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139300240|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
139300241|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300242|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139300243|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
139300244|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
139300245|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
139300246|NCT03531073|Methotrexate|methotrexate|mesh-list
139300247|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139300248|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
139300249|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139300250|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300251|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139300252|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
139300253|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300254|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300255|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
139300256|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300257|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139300258|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139300259|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
139300260|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139300261|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139300262|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
139300263|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
139300264|NCT03516617|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139300265|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139300266|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300267|NCT03516617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300268|NCT03516617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300269|NCT03516617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300270|NCT03472586|Nivolumab|nivolumab|mesh-list
139300271|NCT03472586|Ipilimumab|ipilimumab|mesh-list
139300272|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139300273|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300274|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139300275|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300276|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139300277|NCT03462329|Doxycycline|doxycycline|mesh-list
139300278|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300279|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
139300280|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139300281|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139300282|NCT03451370|Bevacizumab|bevacizumab|mesh-list
139300283|NCT03451370|Capecitabine|capecitabine|mesh-list
139300284|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
139300285|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139300286|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300287|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139300288|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139300289|NCT03451370|Growth Substances|growth substances|mesh-ancestor
139300290|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300291|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
139300292|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139300293|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
138821159|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139300294|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300295|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
139300296|NCT03678350|Trioxsalen|trioxsalen|mesh-list
139300297|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300298|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
139300299|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139300300|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
139300301|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139300302|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139300303|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300304|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139300305|NCT03437421|Vitamin D|vitamin d|mesh-list
139300306|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
139300307|NCT03437421|Vitamins|vitamins|mesh-ancestor
139300308|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
139300309|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300310|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139300311|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139300312|NCT03401294|Leucovorin|leucovorin|mesh-list
139300313|NCT03401294|Bevacizumab|bevacizumab|mesh-list
139300314|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
139300315|NCT03401294|Irinotecan|irinotecan|mesh-list
139300316|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139300317|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300318|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139300319|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139300320|NCT03401294|Growth Substances|growth substances|mesh-ancestor
139300321|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300322|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
139300323|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139300324|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138883778|NCT05493995|Paclitaxel|paclitaxel|mesh-list
139300325|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173707|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139300326|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300328|NCT03401294|Protective Agents|protective agents|mesh-ancestor
139300329|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
139300330|NCT03401294|Vitamins|vitamins|mesh-ancestor
139300331|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
139300332|NCT03393884|Paclitaxel|paclitaxel|mesh-list
139300333|NCT03393884|Carboplatin|carboplatin|mesh-list
139300334|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139300335|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300336|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
139300337|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
139300338|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
139300339|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300340|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139300341|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
139300342|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300343|NCT03347838|Nivolumab|nivolumab|mesh-list
139300344|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139300345|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300346|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139300347|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300348|NCT03337932|Doxycycline|doxycycline|mesh-list
139300349|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139300350|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300351|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
139300352|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139300353|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139300354|NCT03279471|Sertraline|sertraline|mesh-list
139300355|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
139300356|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139300357|NCT03279471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139300358|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139300359|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139300360|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300361|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139300362|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
139300363|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300364|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
139300365|NCT03193281|Dasatinib|dasatinib|mesh-list
139300366|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300367|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300368|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300369|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300370|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139300371|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139300372|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300373|NCT03150173|Buprenorphine|buprenorphine|mesh-list
139300374|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139300375|NCT03150173|Narcotics|narcotics|mesh-ancestor
139300376|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139300377|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300378|NCT03150173|Analgesics|analgesics|mesh-ancestor
139300379|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
139300380|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300381|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139300382|NCT03134196|Valacyclovir|valacyclovir|mesh-list
139300383|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
139300384|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300385|NCT03000569|Levodopa|levodopa|mesh-list
139300386|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
139300387|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139300388|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
139300389|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139300390|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300391|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300392|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139300393|NCT02997761|Blinatumomab|blinatumomab|mesh-list
139300394|NCT02997761|Antibodies|antibodies|mesh-list
139300396|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139300397|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
139300398|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139300399|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
139300400|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300401|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300402|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139300403|NCT02949921|Lidocaine|lidocaine|mesh-list
139300404|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
139300405|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
139300406|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139300407|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300408|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
139300409|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300410|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139300411|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139300412|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139300413|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139300414|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300415|NCT02935205|Indomethacin|indomethacin|mesh-list
139300416|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139300417|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139300418|NCT02935205|Analgesics|analgesics|mesh-ancestor
139300419|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
139300420|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300421|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300422|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139300423|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139300424|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
139300425|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
139300426|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139300427|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139300428|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300429|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300430|NCT02860091|Ropivacaine|ropivacaine|mesh-list
139300431|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
139300432|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
139300433|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139300434|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300435|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
139300436|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300437|NCT02835222|Cytarabine|cytarabine|mesh-list
139300438|NCT02835222|Daunorubicin|daunorubicin|mesh-list
139300439|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139300440|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
139300441|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300442|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300443|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
139300444|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300445|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139300446|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
139300447|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300448|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139300449|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139070662|NCT00131352|Hylan|hylan|mesh-list
139300450|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139300451|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300452|NCT02807805|Niclosamide|niclosamide|mesh-list
139300453|NCT02807805|Prednisone|prednisone|mesh-list
139300454|NCT02807805|Cortisone|cortisone|mesh-list
139300455|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
139300456|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139300457|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
139300458|NCT02807805|Hormones|hormones|mesh-ancestor
139300459|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139300460|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300461|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139300462|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300463|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139300464|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300465|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300466|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
139300467|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139300468|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
139300469|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139300470|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
139300471|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139300472|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300473|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
139300474|NCT02783092|Cannabidiol|cannabidiol|mesh-list
139300475|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
138883913|NCT04069078|Scopolamine|scopolamine|mesh-list
139300477|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300478|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300479|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300480|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300481|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
139300482|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139300483|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300484|NCT02775851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139300485|NCT02775851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300486|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
139300487|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139300488|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300489|NCT02733159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139300490|NCT02733159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300491|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139300492|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139300493|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139300494|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139300495|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300496|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139300497|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139300498|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139300499|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139300500|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
139300501|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139300502|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300503|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139173746|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
139300504|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139300505|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
139070666|NCT00136916|Insulin|insulin|mesh-list
139300506|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139300507|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139300508|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
139300509|NCT02594072|Goserelin|goserelin|mesh-list
139300510|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139300511|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300512|NCT02541955|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139300513|NCT02541955|Hormones|hormones|mesh-ancestor
139300514|NCT02541955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139300515|NCT02541955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300516|NCT02486133|Ritonavir|ritonavir|mesh-list
139300517|NCT02486133|Darunavir|darunavir|mesh-list
139300518|NCT02486133|Tenofovir|tenofovir|mesh-list
139300519|NCT02486133|Lamivudine|lamivudine|mesh-list
139300520|NCT02486133|Emtricitabine|emtricitabine|mesh-list
139300521|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139300522|NCT02486133|Dolutegravir|dolutegravir|mesh-list
139300523|NCT02486133|Abacavir|abacavir|mesh-list
139300524|NCT02486133|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139300525|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139300526|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139300527|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
139300528|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300529|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300530|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139300531|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139300532|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
139300533|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300534|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139300535|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139300536|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139300537|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139300538|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139300539|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139300540|NCT02457442|Remifentanil|remifentanil|mesh-list
139300541|NCT02457442|Propofol|propofol|mesh-list
139300542|NCT02457442|Sevoflurane|sevoflurane|mesh-list
139300543|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139300544|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139300545|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300546|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139300547|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
139300548|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
139300549|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139300550|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139300551|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139300553|NCT02457442|Analgesics|analgesics|mesh-ancestor
139300554|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
139300555|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300556|NCT02347111|Flecainide|flecainide|mesh-list
139300557|NCT02347111|Sotalol|sotalol|mesh-list
139300558|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139300559|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139300560|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139300561|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139300562|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300563|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139300564|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139300565|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
139300566|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139300567|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300568|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
139300569|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
139300570|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300571|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
139300572|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139300573|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300574|NCT02183883|Afatinib|afatinib|mesh-list
139300575|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300576|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300577|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300578|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300579|NCT02101775|Gemcitabine|gemcitabine|mesh-list
139300580|NCT02101775|Adavosertib|adavosertib|mesh-list
139300581|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139300582|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
139300583|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300584|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300585|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300586|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
139300587|NCT02088645|Gastrins|gastrins|mesh-list
139300588|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139300589|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139300590|NCT02088645|Hormones|hormones|mesh-ancestor
139300591|NCT02088645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139300592|NCT02088645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300593|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
139300594|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139300595|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139300596|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300597|NCT02013648|Cytarabine|cytarabine|mesh-list
139300598|NCT02013648|Daunorubicin|daunorubicin|mesh-list
139300599|NCT02013648|Dasatinib|dasatinib|mesh-list
139300600|NCT02013648|Idarubicin|idarubicin|mesh-list
139300601|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139300602|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
139300603|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300604|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300605|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
139300606|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300607|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139300608|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
139300609|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300610|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139300611|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139300612|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139300613|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300614|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300615|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
139300616|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
139300617|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
139300618|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139300619|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300620|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
139300621|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300622|NCT01979536|Cytarabine|cytarabine|mesh-list
139300623|NCT01979536|Dexamethasone|dexamethasone|mesh-list
139300624|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
139300625|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
139300626|NCT01979536|Ifosfamide|ifosfamide|mesh-list
138934969|NCT00578448|Abatacept|abatacept|mesh-list
139300627|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
139300628|NCT01979536|Doxorubicin|doxorubicin|mesh-list
139300629|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139300630|NCT01979536|Methotrexate|methotrexate|mesh-list
139300631|NCT01979536|Etoposide|etoposide|mesh-list
139300632|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
139300633|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139300634|NCT01979536|Crizotinib|crizotinib|mesh-list
139300635|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
139300636|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139300637|NCT01979536|Antibodies|antibodies|mesh-list
139300638|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
139300639|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139300640|NCT01979536|BB 1101|bb 1101|mesh-list
139300641|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
139300642|NCT01979536|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139300643|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139300644|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
139300645|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300646|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139300647|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139300648|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
139300649|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300650|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300651|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139300652|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139300653|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
139300654|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
139300655|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300656|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139300657|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
139300658|NCT01979536|Hormones|hormones|mesh-ancestor
139300659|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139300660|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139300661|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
139300662|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300663|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139300664|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139300665|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139300666|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139300667|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
139300668|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139300669|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139300670|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
139300671|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
139300672|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139300673|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139300674|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139300675|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
139300676|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300677|NCT01979536|Immunotoxins|immunotoxins|mesh-ancestor
139300678|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300679|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
139300680|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
139300681|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
139300682|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
139300683|NCT01880723|Albuterol|albuterol|mesh-list
139300684|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139300685|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
139300686|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300687|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300688|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139300689|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
139300690|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
139300691|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139300692|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139300693|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139300694|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139300695|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
138884136|NCT00653510|Insulin|insulin|mesh-list
139300696|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139300697|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300698|NCT01824836|Anastrozole|anastrozole|mesh-list
139300699|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139300700|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300701|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139300702|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139300703|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300704|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300705|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139300706|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
139300707|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139300708|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300709|NCT01798992|Metoprolol|metoprolol|mesh-list
139300710|NCT01798992|Carvedilol|carvedilol|mesh-list
139300711|NCT01798992|Doxazosin|doxazosin|mesh-list
139300712|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139300713|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139300714|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
139300715|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
139300716|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300717|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300718|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139300719|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139300720|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139300721|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
139300722|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139300723|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300724|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
139300725|NCT01798992|Protective Agents|protective agents|mesh-ancestor
139300726|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139300727|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139300728|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139300729|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
139300730|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139300731|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139300732|NCT01746836|Ponatinib|ponatinib|mesh-list
139300733|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300734|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300735|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300736|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300737|NCT01570868|Ponatinib|ponatinib|mesh-list
139300738|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300739|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300740|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300741|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300742|NCT01424982|Cytarabine|cytarabine|mesh-list
139300743|NCT01424982|Dexamethasone|dexamethasone|mesh-list
139300744|NCT01424982|Prednisone|prednisone|mesh-list
139300745|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
139300746|NCT01424982|Cortisone|cortisone|mesh-list
139300747|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
139300748|NCT01424982|Rituximab|rituximab|mesh-list
139300749|NCT01424982|Doxorubicin|doxorubicin|mesh-list
139300750|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139300751|NCT01424982|Methotrexate|methotrexate|mesh-list
139300752|NCT01424982|Vincristine|vincristine|mesh-list
139300754|NCT01424982|Ponatinib|ponatinib|mesh-list
139300755|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139300756|NCT01424982|Antibodies|antibodies|mesh-list
139300757|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
139300758|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139300759|NCT01424982|BB 1101|bb 1101|mesh-list
139300760|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139300761|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
139300762|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300763|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139300764|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139300765|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
139300766|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300767|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300768|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139300769|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139300770|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
139300771|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
139300772|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300773|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139300774|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
139300775|NCT01424982|Hormones|hormones|mesh-ancestor
139300776|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139300777|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139300778|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139300779|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139300780|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139300781|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300782|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139300783|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
139300784|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139300785|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139300786|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
139300787|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
139300788|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139300789|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139300790|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
139300791|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300792|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139300793|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
139300794|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
139300795|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
139300796|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
139070752|NCT03758014|Lomustine|lomustine|mesh-list
139300797|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300799|NCT01415752|Lenalidomide|lenalidomide|mesh-list
139300800|NCT01415752|Bortezomib|bortezomib|mesh-list
139300801|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139300802|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139300803|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300804|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
139300805|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300806|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139300807|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139300808|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139300809|NCT01415752|Growth Substances|growth substances|mesh-ancestor
139300810|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
139300811|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139300812|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
139300813|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300814|NCT01391962|Sunitinib|sunitinib|mesh-list
139300815|NCT01391962|Cediranib|cediranib|mesh-list
139300816|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300817|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139300818|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139300819|NCT01391962|Growth Substances|growth substances|mesh-ancestor
139300820|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300821|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
139300822|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300823|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173817|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139300824|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300825|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
139300826|NCT01187485|Testosterone|testosterone|mesh-list
139300827|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
139300828|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
139300829|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139300830|NCT01187485|Androgens|androgens|mesh-ancestor
139300831|NCT01187485|Hormones|hormones|mesh-ancestor
139300832|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139300833|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300834|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139300835|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300836|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
139300837|NCT01185158|Gefitinib|gefitinib|mesh-list
139300838|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300839|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300840|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300841|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300842|NCT01172470|Carboplatin|carboplatin|mesh-list
139300843|NCT01172470|Gemcitabine|gemcitabine|mesh-list
139300844|NCT01172470|Pemetrexed|pemetrexed|mesh-list
139300845|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300846|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139300847|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
139300848|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300849|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300850|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138884284|NCT02641652|Sertraline|sertraline|mesh-list
139300851|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139300852|NCT01085617|Cytarabine|cytarabine|mesh-list
139300853|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
139300854|NCT01085617|Melphalan|melphalan|mesh-list
139300855|NCT01085617|Rituximab|rituximab|mesh-list
139300856|NCT01085617|Methotrexate|methotrexate|mesh-list
139300857|NCT01085617|Fludarabine|fludarabine|mesh-list
139300858|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
139300859|NCT01085617|Etoposide|etoposide|mesh-list
139300860|NCT01085617|Vincristine|vincristine|mesh-list
139300861|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
139300862|NCT01085617|Daunorubicin|daunorubicin|mesh-list
139300863|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
139300864|NCT01085617|Pegaspargase|pegaspargase|mesh-list
139300865|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139300866|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
139300867|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300868|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139300869|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139300870|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
139300871|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300872|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300873|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139300874|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139300875|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139300876|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
139300877|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139300878|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139300879|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
139300880|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
139300881|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300882|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139300883|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139300884|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139300885|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139300886|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139300887|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
139300888|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300889|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
139300890|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
139300891|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
139173821|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
139300892|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300893|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139300895|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300896|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139300897|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300898|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300899|NCT00594542|Lidocaine|lidocaine|mesh-list
139300900|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
139300901|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
139300902|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139300903|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300904|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
139300905|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300906|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139300907|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139300908|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139300909|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139300910|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300911|NCT00542451|Paclitaxel|paclitaxel|mesh-list
139300912|NCT00542451|Trastuzumab|trastuzumab|mesh-list
139300913|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139300914|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139300915|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
139300916|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
139300917|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
139300918|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300919|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139300920|NCT00336232|Vitamin K|vitamin k|mesh-list
139300921|NCT00336232|Vitamin K 1|vitamin k 1|mesh-list
139300922|NCT00336232|Vitamins|vitamins|mesh-ancestor
139300923|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
139300924|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884365|NCT00686556|Cyclosporine|cyclosporine|mesh-list
139300925|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139300926|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139070777|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
139300927|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300928|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
139300929|NCT00336232|Coagulants|coagulants|mesh-ancestor
139300930|NCT00153075|Fenoterol|fenoterol|mesh-list
139300931|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139300932|NCT00153075|Ipratropium|ipratropium|mesh-list
139300933|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139300934|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
139300935|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300936|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300937|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139300938|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
139300939|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
139300940|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
139300941|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139300942|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139300943|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139300944|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139300945|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
139300946|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139300947|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300948|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139300949|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
139300950|NCT00131235|Azithromycin|azithromycin|mesh-list
139300951|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
139300952|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
139300953|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139300954|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139300955|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139300956|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
139300957|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139300958|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139300959|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139300960|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300961|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300962|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139300964|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
139300965|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139300966|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
139300967|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139300968|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300969|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
139300970|NCT02504580|Bupivacaine|bupivacaine|mesh-list
139300971|NCT02504580|Anesthetics, Local|anesthetics, local|mesh-ancestor
139300972|NCT02504580|Anesthetics|anesthetics|mesh-ancestor
139300973|NCT02504580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139300974|NCT02504580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300975|NCT02504580|Sensory System Agents|sensory system agents|mesh-ancestor
139300976|NCT02504580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139300977|NCT02235402|Lacidipine|lacidipine|mesh-list
139300978|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
139300979|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139300980|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139300981|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139300982|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300983|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139300984|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300985|NCT02235402|Diuretics|diuretics|mesh-ancestor
139300986|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
139300987|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139300988|NCT02235480|Tazarotene|tazarotene|mesh-list
139300989|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
139300990|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
139300991|NCT02235558|Verapamil|verapamil|mesh-list
139300992|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139300993|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139300994|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139300995|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139300996|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139300997|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139300998|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
139300999|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
139301000|NCT04214418|Atezolizumab|atezolizumab|mesh-list
139301001|NCT04214418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139301002|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301003|NCT04214418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139301004|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301005|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
139301006|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139301007|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139301008|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301009|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301010|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139301011|NCT02233920|Oxitropium|oxitropium|mesh-list
139301012|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
139301013|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
139301014|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301015|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301016|NCT02235948|Folic Acid|folic acid|mesh-list
139301017|NCT02235948|Hematinics|hematinics|mesh-ancestor
139301018|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
139301019|NCT02235948|Vitamins|vitamins|mesh-ancestor
139301020|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
139301021|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301022|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
139301023|NCT02236026|ST 1435|st 1435|mesh-list
139301024|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139301025|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301026|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139301027|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139301028|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301029|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301030|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301031|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139301032|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
139301033|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139301034|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301035|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139301036|NCT02236182|Bromides|bromides|mesh-list
139301037|NCT02236182|Ipratropium|ipratropium|mesh-list
139301038|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
139301039|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139301040|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
139301041|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301042|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301043|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139301044|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
139301045|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139301046|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
139301047|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301048|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301049|NCT04453280|Antibodies|antibodies|mesh-list
139301050|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
139301051|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301052|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139301053|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139301054|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301055|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139301056|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139301057|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139301058|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301059|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
139301060|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301061|NCT05392634|Amoxicillin|amoxicillin|mesh-list
139301062|NCT05392634|Meropenem|meropenem|mesh-list
139301063|NCT05392634|Clavulanic Acids|clavulanic acids|mesh-list
139301064|NCT05392634|Clavulanic Acid|clavulanic acid|mesh-list
139301065|NCT05392634|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139301066|NCT05392634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139301067|NCT05392634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301068|NCT05392634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301069|NCT05392634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301070|NCT05392634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139301071|NCT01593228|Paclitaxel|paclitaxel|mesh-list
139301072|NCT01593228|Carboplatin|carboplatin|mesh-list
139301073|NCT01593228|Gemcitabine|gemcitabine|mesh-list
139301074|NCT01593228|Doxorubicin|doxorubicin|mesh-list
139301075|NCT01593228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139301076|NCT01593228|Irinotecan|irinotecan|mesh-list
139301077|NCT01593228|Topotecan|topotecan|mesh-list
139301078|NCT01593228|Iniparib|iniparib|mesh-list
139301079|NCT01593228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139301080|NCT01593228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301081|NCT01593228|Tubulin Modulators|tubulin modulators|mesh-ancestor
139301082|NCT01593228|Antimitotic Agents|antimitotic agents|mesh-ancestor
139301083|NCT01593228|Mitosis Modulators|mitosis modulators|mesh-ancestor
139301084|NCT01593228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301085|NCT01593228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139301086|NCT01593228|Antimetabolites|antimetabolites|mesh-ancestor
139301087|NCT01593228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139301088|NCT01593228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139301089|NCT01593228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139301090|NCT01593228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301091|NCT01593228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139301092|NCT01593228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139301093|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139301094|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139301095|NCT02236260|Lidocaine|lidocaine|mesh-list
139301096|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
139301097|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
139301098|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301099|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301100|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
139301101|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301102|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139301103|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139301104|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139301105|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139301106|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301107|NCT01555554|Propranolol|propranolol|mesh-list
139301108|NCT01555554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139301109|NCT01555554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139301110|NCT01555554|Adrenergic Agents|adrenergic agents|mesh-ancestor
139301111|NCT01555554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301112|NCT01555554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301113|NCT01555554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301114|NCT01555554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139301115|NCT01555554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139301116|NCT01555554|Vasodilator Agents|vasodilator agents|mesh-ancestor
139301117|NCT01435044|Sofosbuvir|sofosbuvir|mesh-list
139301118|NCT01435044|Ribavirin|ribavirin|mesh-list
139301119|NCT01435044|Antiviral Agents|antiviral agents|mesh-ancestor
139301120|NCT01435044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301121|NCT01435044|Antimetabolites|antimetabolites|mesh-ancestor
139301122|NCT01435044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301123|NCT01434498|Ribavirin|ribavirin|mesh-list
139301124|NCT01434498|Ledipasvir|ledipasvir|mesh-list
139301125|NCT01434498|Antimetabolites|antimetabolites|mesh-ancestor
139301126|NCT01434498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301127|NCT01434498|Antiviral Agents|antiviral agents|mesh-ancestor
139301128|NCT01434498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301129|NCT03735966|Carboplatin|carboplatin|mesh-list
139301130|NCT03735966|Docetaxel|docetaxel|mesh-list
139301131|NCT03735966|Trastuzumab|trastuzumab|mesh-list
139301132|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301133|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
139301134|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
139070861|NCT00129272|Bupropion|bupropion|mesh-list
139301135|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
139301136|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301137|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139301138|NCT01554696|Methotrexate|methotrexate|mesh-list
139301139|NCT01554696|Peficitinib|peficitinib|mesh-list
139301140|NCT01554696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139301141|NCT01554696|Abortifacient Agents|abortifacient agents|mesh-ancestor
139301142|NCT01554696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139301143|NCT01554696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301144|NCT01554696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139301145|NCT01554696|Antimetabolites|antimetabolites|mesh-ancestor
139173865|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301146|NCT01554696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301147|NCT01554696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301148|NCT01554696|Dermatologic Agents|dermatologic agents|mesh-ancestor
139301149|NCT01554696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301150|NCT01554696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139301151|NCT01554696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139301152|NCT01554696|Immunologic Factors|immunologic factors|mesh-ancestor
139301154|NCT01554696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139301155|NCT02265276|Pioglitazone|pioglitazone|mesh-list
139301156|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139301157|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301158|NCT02263872|Minocycline|minocycline|mesh-list
139301159|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139301160|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301161|NCT02261376|DS-1971a|ds-1971a|mesh-list
139301162|NCT02261376|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139301163|NCT02261376|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139301164|NCT02261376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139301165|NCT02261376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301166|NCT01535508|Vitamin D|vitamin d|mesh-list
139301167|NCT01535508|Vitamins|vitamins|mesh-ancestor
139301168|NCT01535508|Micronutrients|micronutrients|mesh-ancestor
139301169|NCT01535508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301170|NCT01535508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139301171|NCT01416402|Colchicine|colchicine|mesh-list
139301172|NCT01416402|Febuxostat|febuxostat|mesh-list
139301173|NCT01416402|Gout Suppressants|gout suppressants|mesh-ancestor
139301174|NCT01416402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139301175|NCT01416402|Tubulin Modulators|tubulin modulators|mesh-ancestor
139301176|NCT01416402|Antimitotic Agents|antimitotic agents|mesh-ancestor
139301177|NCT01416402|Mitosis Modulators|mitosis modulators|mesh-ancestor
139301178|NCT01416402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301179|NCT01416402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301180|NCT01414920|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139301181|NCT01414920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139301182|NCT01414920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301183|NCT01414920|Incretins|incretins|mesh-ancestor
139301184|NCT01414920|Hormones|hormones|mesh-ancestor
139301185|NCT01414920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139301186|NCT01414920|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139301187|NCT01414920|Protease Inhibitors|protease inhibitors|mesh-ancestor
139301188|NCT01414920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301189|NCT01414920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301190|NCT02263950|Artemether|artemether|mesh-list
139301191|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
139301192|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139301193|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139301194|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301195|NCT02261844|Resveratrol|resveratrol|mesh-list
139301196|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
139301197|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301198|NCT02261844|Protective Agents|protective agents|mesh-ancestor
139070880|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
139301199|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301200|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301201|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139301202|NCT02261922|Ticagrelor|ticagrelor|mesh-list
139301203|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139301204|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139301205|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139301206|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139301207|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139301208|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
139301209|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301210|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301211|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301212|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139301213|NCT02264106|Pantoprazole|pantoprazole|mesh-list
139301214|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139301215|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139301216|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139301217|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301218|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301219|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
139301220|NCT02262156|Serotonin|serotonin|mesh-list
139301221|NCT02262156|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139301222|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139301223|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139301224|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
139301225|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301226|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301227|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301228|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139301229|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139301230|NCT02612922|Nitazoxanide|nitazoxanide|mesh-list
139301231|NCT02612922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139301232|NCT02612922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301233|NCT01516476|Liraglutide|liraglutide|mesh-list
139301234|NCT01516476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139301235|NCT01516476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301236|NCT01516476|Incretins|incretins|mesh-ancestor
139301237|NCT01516476|Hormones|hormones|mesh-ancestor
139301238|NCT01516476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139301239|NCT01516086|Fluticasone|fluticasone|mesh-list
139301241|NCT01516086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139301242|NCT01516086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139301243|NCT01516086|Autonomic Agents|autonomic agents|mesh-ancestor
139301244|NCT01516086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301245|NCT01516086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301246|NCT01516086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139301247|NCT01516086|Respiratory System Agents|respiratory system agents|mesh-ancestor
139301248|NCT01516086|Dermatologic Agents|dermatologic agents|mesh-ancestor
139301249|NCT01516086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139301250|NCT01497834|Asunaprevir|asunaprevir|mesh-list
139301251|NCT01497834|Protease Inhibitors|protease inhibitors|mesh-ancestor
139301252|NCT01497834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301253|NCT01497834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301254|NCT02265822|Midazolam|midazolam|mesh-list
139301255|NCT02265822|Melatonin|melatonin|mesh-list
139301256|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139301257|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139301258|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301259|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301260|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139301261|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139301262|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139301263|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139301264|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
139301265|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
139301266|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
139301267|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
139301268|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173882|NCT03528174|Pancrelipase|pancrelipase|mesh-list
139301269|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301270|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
139301271|NCT02265822|Protective Agents|protective agents|mesh-ancestor
139301272|NCT02607930|Lamivudine|lamivudine|mesh-list
139301273|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139301274|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139301275|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301276|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301277|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
139301278|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301279|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139301280|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139301281|NCT02264184|Paroxetine|paroxetine|mesh-list
139301282|NCT02264184|Tamsulosin|tamsulosin|mesh-list
139301283|NCT02264184|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139301284|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139301285|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139301286|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301287|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301288|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
139301289|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301290|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139301291|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
139301292|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139301293|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139301294|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139301295|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301296|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139301297|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139301298|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139301299|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
139301300|NCT02264184|Urological Agents|urological agents|mesh-ancestor
138884729|NCT02640794|Aspirin|aspirin|mesh-list
139301302|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139301303|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139301304|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139301305|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301306|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301307|NCT01482390|Ribavirin|ribavirin|mesh-list
139301308|NCT01482390|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139301309|NCT01482390|Antimetabolites|antimetabolites|mesh-ancestor
139301310|NCT01482390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301311|NCT01482390|Antiviral Agents|antiviral agents|mesh-ancestor
139301312|NCT01482390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301313|NCT01478178|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
139301314|NCT01478178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139301315|NCT01478178|Alkylating Agents|alkylating agents|mesh-ancestor
139301316|NCT01478178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301317|NCT01478178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301318|NCT01366014|Oxycodone|oxycodone|mesh-list
139301319|NCT01366014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139301320|NCT01366014|Narcotics|narcotics|mesh-ancestor
139301321|NCT01366014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301322|NCT01366014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301323|NCT01366014|Analgesics|analgesics|mesh-ancestor
139301324|NCT01366014|Sensory System Agents|sensory system agents|mesh-ancestor
139301325|NCT01366014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301326|NCT01361802|Ambroxol|ambroxol|mesh-list
139301327|NCT01361802|Expectorants|expectorants|mesh-ancestor
139301328|NCT01361802|Respiratory System Agents|respiratory system agents|mesh-ancestor
139301329|NCT01235754|Methyltestosterone|methyltestosterone|mesh-list
139301330|NCT01235754|Testosterone|testosterone|mesh-list
139301331|NCT01235754|Testosterone undecanoate|testosterone undecanoate|mesh-list
139301332|NCT01235754|Testosterone enanthate|testosterone enanthate|mesh-list
139301333|NCT01235754|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139301334|NCT01235754|Androgens|androgens|mesh-ancestor
139301335|NCT01235754|Hormones|hormones|mesh-ancestor
139301336|NCT01235754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139301337|NCT01235754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301339|NCT01235754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301340|NCT01235754|Anabolic Agents|anabolic agents|mesh-ancestor
139301341|NCT01234038|Paclitaxel|paclitaxel|mesh-list
139301342|NCT01234038|Carboplatin|carboplatin|mesh-list
139301343|NCT01234038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139301344|NCT01234038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301345|NCT01234038|Tubulin Modulators|tubulin modulators|mesh-ancestor
139301346|NCT01234038|Antimitotic Agents|antimitotic agents|mesh-ancestor
139301347|NCT01234038|Mitosis Modulators|mitosis modulators|mesh-ancestor
139301348|NCT01234038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301349|NCT01233960|Remestemcel-l|remestemcel-l|mesh-list
139301350|NCT01233960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139301351|NCT01233960|Antiviral Agents|antiviral agents|mesh-ancestor
139301352|NCT01233960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301353|NCT01229982|Latanoprost|latanoprost|mesh-list
139301354|NCT01229982|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139301355|NCT01229982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139301356|NCT01225380|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139301357|NCT01225380|Interferon-alpha|interferon-alpha|mesh-list
139301358|NCT01225380|Ribavirin|ribavirin|mesh-list
139301359|NCT01225380|Antiviral Agents|antiviral agents|mesh-ancestor
139301360|NCT01225380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301361|NCT01225380|Immunologic Factors|immunologic factors|mesh-ancestor
139301362|NCT01225380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301363|NCT01225380|Antimetabolites|antimetabolites|mesh-ancestor
139301364|NCT01225380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301365|NCT01349868|Formoterol Fumarate|formoterol fumarate|mesh-list
139301366|NCT01349868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139301367|NCT01349868|Autonomic Agents|autonomic agents|mesh-ancestor
139301368|NCT01349868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301369|NCT01349868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301370|NCT01349868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139301371|NCT01349868|Respiratory System Agents|respiratory system agents|mesh-ancestor
139301372|NCT01349868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139301373|NCT01349868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139301374|NCT01349868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139301375|NCT01349868|Adrenergic Agents|adrenergic agents|mesh-ancestor
139301376|NCT01349868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301377|NCT01349868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301378|NCT02266524|Tamsulosin|tamsulosin|mesh-list
139301379|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139301380|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139301381|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139301382|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
139301383|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301384|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301385|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301386|NCT02266524|Urological Agents|urological agents|mesh-ancestor
139301387|NCT01336686|Colchicine|colchicine|mesh-list
139301388|NCT01336686|Gout Suppressants|gout suppressants|mesh-ancestor
139301389|NCT01336686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139301390|NCT01336686|Tubulin Modulators|tubulin modulators|mesh-ancestor
139301391|NCT01336686|Antimitotic Agents|antimitotic agents|mesh-ancestor
139301392|NCT01336686|Mitosis Modulators|mitosis modulators|mesh-ancestor
139301393|NCT01336686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173920|NCT01883804|Methyldopa|methyldopa|mesh-list
139301394|NCT01336686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301395|NCT01455090|Ribavirin|ribavirin|mesh-list
139301396|NCT01455090|Asunaprevir|asunaprevir|mesh-list
139301397|NCT01455090|Antimetabolites|antimetabolites|mesh-ancestor
139301398|NCT01455090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301399|NCT01455090|Antiviral Agents|antiviral agents|mesh-ancestor
139301400|NCT01455090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301401|NCT01455090|Protease Inhibitors|protease inhibitors|mesh-ancestor
139301402|NCT01455090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301403|NCT02056782|Heparin|heparin|mesh-list
139301404|NCT02056782|Anticoagulants|anticoagulants|mesh-ancestor
139301405|NCT02056782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139301406|NCT02056782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139301407|NCT02056782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301408|NCT01198626|Moxifloxacin|moxifloxacin|mesh-list
139301409|NCT01198626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139301410|NCT01198626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301411|NCT01198626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139301412|NCT01198626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139301413|NCT01198626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301414|NCT01198626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301415|NCT01198626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301416|NCT01194960|Docetaxel|docetaxel|mesh-list
139301417|NCT01194960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301418|NCT01194960|Tubulin Modulators|tubulin modulators|mesh-ancestor
139301419|NCT01194960|Antimitotic Agents|antimitotic agents|mesh-ancestor
139301420|NCT01194960|Mitosis Modulators|mitosis modulators|mesh-ancestor
139301421|NCT01194960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301422|NCT01331850|Ritonavir|ritonavir|mesh-list
139301423|NCT01331850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139301424|NCT01331850|Interferon-alpha|interferon-alpha|mesh-list
139301425|NCT01331850|Ribavirin|ribavirin|mesh-list
139301426|NCT01331850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139301427|NCT01331850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139301428|NCT01331850|Protease Inhibitors|protease inhibitors|mesh-ancestor
139301429|NCT01331850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301430|NCT01331850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301431|NCT01331850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139301432|NCT01331850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139301433|NCT01331850|Antiviral Agents|antiviral agents|mesh-ancestor
139301434|NCT01331850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301435|NCT01331850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139301436|NCT01331850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139301437|NCT01331850|Immunologic Factors|immunologic factors|mesh-ancestor
139301438|NCT01331850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301439|NCT01331850|Antimetabolites|antimetabolites|mesh-ancestor
139301440|NCT01328808|Acetaminophen|acetaminophen|mesh-list
139301441|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139301442|NCT01328808|Analgesics|analgesics|mesh-ancestor
139301443|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
139301444|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301445|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301446|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
139301447|NCT01968590|Vitamin D|vitamin d|mesh-list
139301448|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
139301449|NCT01968590|Vitamins|vitamins|mesh-ancestor
139301450|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
139301451|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301452|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139301453|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139301455|NCT01314222|Analgesics|analgesics|mesh-ancestor
139301456|NCT01314222|Sensory System Agents|sensory system agents|mesh-ancestor
139301457|NCT01314222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301458|NCT01314222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301459|NCT01314222|Anticonvulsants|anticonvulsants|mesh-ancestor
139301460|NCT01314222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139301461|NCT01314222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139301462|NCT01314222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301463|NCT01314222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139301464|NCT01314222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139301465|NCT01314222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139301466|NCT01314222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301467|NCT01314222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139301468|NCT01309932|Interferons|interferons|mesh-list
139301469|NCT01309932|Ribavirin|ribavirin|mesh-list
139301470|NCT01309932|Interferon-alpha|interferon-alpha|mesh-list
139301471|NCT01309932|Interferon alpha-2|interferon alpha-2|mesh-list
139301472|NCT01309932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139301473|NCT01309932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139301474|NCT01309932|Protease Inhibitors|protease inhibitors|mesh-list
139301475|NCT01309932|Asunaprevir|asunaprevir|mesh-list
139301476|NCT01309932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301477|NCT01309932|Antiviral Agents|antiviral agents|mesh-ancestor
139301478|NCT01309932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301479|NCT01309932|Antimetabolites|antimetabolites|mesh-ancestor
139301480|NCT01309932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301481|NCT01309932|Immunologic Factors|immunologic factors|mesh-ancestor
139301482|NCT01309932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301483|NCT01309932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301484|NCT01309932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139301485|NCT01309932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139301486|NCT01309932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139301487|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139301488|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139301489|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301490|NCT01181622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139301491|NCT01101594|Doxorubicin|doxorubicin|mesh-list
139301492|NCT01101594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139301493|NCT01101594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301494|NCT01101594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139301495|NCT01101594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139301496|NCT01101594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301497|NCT01101594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301498|NCT02269176|Losartan|losartan|mesh-list
139301499|NCT02269176|Telmisartan|telmisartan|mesh-list
139301500|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139301501|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139301502|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139301503|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139301504|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301505|NCT01094262|Oxycodone|oxycodone|mesh-list
139301506|NCT01094262|Analgesics|analgesics|mesh-list
139301507|NCT01094262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139301508|NCT01094262|Narcotics|narcotics|mesh-ancestor
139301509|NCT01094262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301510|NCT01094262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301511|NCT01094262|Sensory System Agents|sensory system agents|mesh-ancestor
139301512|NCT01094262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301513|NCT04476186|Acyclovir|acyclovir|mesh-list
139301514|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
139301515|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301516|NCT03440216|Meropenem|meropenem|mesh-list
139301517|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
139301518|NCT03440216|Temocillin|temocillin|mesh-list
139301519|NCT03440216|Penicillins|penicillins|mesh-list
139301520|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139301521|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301522|NCT01166412|Levonorgestrel|levonorgestrel|mesh-list
139301523|NCT01166412|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139301524|NCT01166412|Contraceptive Agents|contraceptive agents|mesh-ancestor
139301525|NCT01166412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139301526|NCT01166412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301527|NCT01166412|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139301528|NCT01166412|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139301530|NCT05370716|Pregabalin|pregabalin|mesh-list
139301531|NCT05370716|Analgesics|analgesics|mesh-ancestor
139301532|NCT05370716|Sensory System Agents|sensory system agents|mesh-ancestor
139301533|NCT05370716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301534|NCT05370716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301535|NCT05370716|Anticonvulsants|anticonvulsants|mesh-ancestor
139301536|NCT05370716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139301537|NCT05370716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139301538|NCT05370716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301539|NCT05370716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139301540|NCT05370716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139301541|NCT05370716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139301542|NCT05370716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301543|NCT05370716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139301544|NCT01038804|Docetaxel|docetaxel|mesh-list
139301545|NCT01038804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301546|NCT01038804|Tubulin Modulators|tubulin modulators|mesh-ancestor
139301547|NCT01038804|Antimitotic Agents|antimitotic agents|mesh-ancestor
139301548|NCT01038804|Mitosis Modulators|mitosis modulators|mesh-ancestor
139301549|NCT01038804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301550|NCT05118776|Bevacizumab|bevacizumab|mesh-list
139301551|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139301552|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301553|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139301554|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139301555|NCT05118776|Growth Substances|growth substances|mesh-ancestor
139301556|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301557|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
139301558|NCT02269644|Azithromycin|azithromycin|mesh-list
139301559|NCT02269644|Linezolid|linezolid|mesh-list
139301560|NCT02269644|Dalbavancin|dalbavancin|mesh-list
139301561|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139301562|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301563|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139301564|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301565|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301566|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
139301567|NCT03367988|Anesthetics|anesthetics|mesh-list
139301568|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301569|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301570|NCT03367988|Narcotics|narcotics|mesh-ancestor
139301571|NCT03367988|Analgesics|analgesics|mesh-ancestor
139301572|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
139301573|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301574|NCT03465488|Albendazole|albendazole|mesh-list
139301575|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
139301576|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139301577|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301578|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
139301579|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139301580|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139301581|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
139301582|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
139301583|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
139301584|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301585|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301586|NCT02267304|Morphine|morphine|mesh-list
139301587|NCT02267304|Naloxone|naloxone|mesh-list
139301588|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139301589|NCT02267304|Narcotics|narcotics|mesh-ancestor
139301590|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301591|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301592|NCT02267304|Analgesics|analgesics|mesh-ancestor
139301593|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
139301594|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301595|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139301596|NCT03465410|Tacrolimus|tacrolimus|mesh-list
139301597|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139301598|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
139301599|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301600|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139301601|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301602|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301603|NCT02522234|Lenograstim|lenograstim|mesh-list
138885028|NCT00675246|Hormones|hormones|mesh-ancestor
139301604|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139301605|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
139301606|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301607|NCT00154284|Cyclosporine|cyclosporine|mesh-list
139301608|NCT00154284|Prednisone|prednisone|mesh-list
139301609|NCT00154284|Everolimus|everolimus|mesh-list
139301610|NCT00154284|Cyclosporins|cyclosporins|mesh-list
139301611|NCT00154284|Basiliximab|basiliximab|mesh-list
139301612|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139301613|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
139301614|NCT00154284|Hormones|hormones|mesh-ancestor
139301615|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139301616|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301617|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139301618|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301619|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301620|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301621|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139301622|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
139301623|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
139301624|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301625|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
139301626|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139301627|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139301628|NCT00154284|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139301629|NCT00154284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139301630|NCT04973306|Tislelizumab|tislelizumab|mesh-list
139301631|NCT04973306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139301632|NCT04973306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301633|NCT01037166|Entecavir|entecavir|mesh-list
139301634|NCT01037166|Antiviral Agents|antiviral agents|mesh-ancestor
139301635|NCT01037166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301636|NCT04491032|Anesthetics|anesthetics|mesh-list
139301637|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301638|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301639|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
139301640|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139301641|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301642|NCT04487756|Carboplatin|carboplatin|mesh-list
139301643|NCT04487756|Atezolizumab|atezolizumab|mesh-list
139301644|NCT04487756|Vaccines|vaccines|mesh-list
139301645|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
139301646|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301647|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301648|NCT04487756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139301649|NCT04487756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173955|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
139301650|NCT04487756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139301651|NCT01281462|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139301653|NCT01281462|Avibactam|avibactam|mesh-list
139301654|NCT01281462|Doripenem|doripenem|mesh-list
139301655|NCT01281462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139301656|NCT01281462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301657|NCT01281462|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139301658|NCT01281462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301659|NCT01281462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301660|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139301661|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301662|NCT01024062|Paclitaxel|paclitaxel|mesh-list
139301663|NCT01024062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139301664|NCT01024062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301665|NCT01024062|Tubulin Modulators|tubulin modulators|mesh-ancestor
139301666|NCT01024062|Antimitotic Agents|antimitotic agents|mesh-ancestor
139301667|NCT01024062|Mitosis Modulators|mitosis modulators|mesh-ancestor
139301668|NCT01024062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301669|NCT04453436|Tenofovir|tenofovir|mesh-list
139301670|NCT04453436|Lamivudine|lamivudine|mesh-list
139301671|NCT04453436|Dolutegravir|dolutegravir|mesh-list
139301672|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
139301673|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301674|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139301675|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139301676|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301677|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301678|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139301679|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139301680|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139301681|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139301682|NCT02267616|Etonogestrel|etonogestrel|mesh-list
139301683|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139301684|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
139301685|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139301686|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301687|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139301688|NCT05232734|Caffeine|caffeine|mesh-list
139301689|NCT05232734|Caffeine citrate|caffeine citrate|mesh-list
139301690|NCT05232734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301691|NCT05232734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139301692|NCT05232734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301693|NCT05232734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139301694|NCT05232734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301695|NCT05232734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139301696|NCT05232734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139301697|NCT05232734|Purinergic Agents|purinergic agents|mesh-ancestor
139301698|NCT05232734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301699|NCT01023204|Paclitaxel|paclitaxel|mesh-list
139301700|NCT01023204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139301701|NCT01023204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301702|NCT01023204|Tubulin Modulators|tubulin modulators|mesh-ancestor
139301703|NCT01023204|Antimitotic Agents|antimitotic agents|mesh-ancestor
139301704|NCT01023204|Mitosis Modulators|mitosis modulators|mesh-ancestor
139301705|NCT01023204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301706|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
139301707|NCT04460456|Cemiplimab|cemiplimab|mesh-list
139301708|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139301709|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301710|NCT04460456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139301711|NCT04460456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301712|NCT02268006|Capecitabine|capecitabine|mesh-list
139301713|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139301714|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
139301715|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301716|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301717|NCT03462212|Paclitaxel|paclitaxel|mesh-list
139301718|NCT03462212|Bevacizumab|bevacizumab|mesh-list
139301719|NCT03462212|Carboplatin|carboplatin|mesh-list
139301720|NCT03462212|Rucaparib|rucaparib|mesh-list
139301721|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139301722|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301723|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
139301724|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
139301725|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
139301726|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301727|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139301728|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139301729|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139301730|NCT03462212|Growth Substances|growth substances|mesh-ancestor
139301731|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301732|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
139301733|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139301734|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301735|NCT01016808|Morphine|morphine|mesh-list
139301736|NCT01016808|Oxycodone|oxycodone|mesh-list
139301737|NCT01016808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139301738|NCT01016808|Narcotics|narcotics|mesh-ancestor
139301739|NCT01016808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301740|NCT01016808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301741|NCT01016808|Analgesics|analgesics|mesh-ancestor
139301742|NCT01016808|Sensory System Agents|sensory system agents|mesh-ancestor
139301743|NCT01016808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301744|NCT01014078|Azithromycin|azithromycin|mesh-list
139301745|NCT01014078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139301746|NCT01014078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139301747|NCT01014078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139301748|NCT01014078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301749|NCT02522078|Misoprostol|misoprostol|mesh-list
139301750|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139301751|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
139301752|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139301753|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301754|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139301755|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139301756|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
139301757|NCT00911274|Mycophenolic Acid|mycophenolic acid|mesh-list
139301758|NCT00911274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139301759|NCT00911274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301760|NCT00911274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139301761|NCT00911274|Antitubercular Agents|antitubercular agents|mesh-ancestor
139301762|NCT00911274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139301763|NCT00911274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301764|NCT00911274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301765|NCT00911274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301766|NCT03468296|Aflibercept|aflibercept|mesh-list
139301767|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139301768|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139301769|NCT03468296|Growth Substances|growth substances|mesh-ancestor
139301770|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301771|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
139301772|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301773|NCT01130142|Gemcitabine|gemcitabine|mesh-list
139301774|NCT01130142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139301775|NCT01130142|Antimetabolites|antimetabolites|mesh-ancestor
139301776|NCT01130142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301777|NCT01130142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301778|NCT03464864|Treprostinil|treprostinil|mesh-list
139301779|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139301780|NCT03468140|Eculizumab|eculizumab|mesh-list
139301781|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139301782|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139301783|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
139301784|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301786|NCT01009242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139301787|NCT01009242|Abortifacient Agents|abortifacient agents|mesh-ancestor
139301788|NCT01009242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139301789|NCT01009242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301790|NCT01009242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139301791|NCT01009242|Antimetabolites|antimetabolites|mesh-ancestor
139301792|NCT01009242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301793|NCT01009242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301794|NCT01009242|Dermatologic Agents|dermatologic agents|mesh-ancestor
139301795|NCT01009242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301796|NCT01009242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139301797|NCT01009242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139301798|NCT01009242|Immunologic Factors|immunologic factors|mesh-ancestor
139301799|NCT01009242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139301800|NCT01009242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139301801|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
139301802|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139301803|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301804|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301805|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139301806|NCT03468062|Analgesics|analgesics|mesh-ancestor
139301807|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
139301808|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301809|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139301810|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139301811|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139301812|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
139301813|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301814|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301815|NCT03464552|Celecoxib|celecoxib|mesh-list
139301816|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139301817|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139301818|NCT03464552|Analgesics|analgesics|mesh-ancestor
139301819|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
139301820|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301821|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301822|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139301823|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139301824|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139301825|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139301826|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301827|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301828|NCT05628558|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139301829|NCT05628558|Hemostatics|hemostatics|mesh-ancestor
139301831|NCT05628558|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139301832|NCT05628558|Natriuretic Agents|natriuretic agents|mesh-ancestor
139301833|NCT05628558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301835|NCT01007292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139301836|NCT01007292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301837|NCT01007292|Immunologic Factors|immunologic factors|mesh-ancestor
139301838|NCT01007292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301839|NCT01007292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139301840|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139301841|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
139301842|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301843|NCT01005108|Gabapentin|gabapentin|mesh-list
139301844|NCT01005108|Analgesics|analgesics|mesh-ancestor
139301845|NCT01005108|Sensory System Agents|sensory system agents|mesh-ancestor
139301846|NCT01005108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301847|NCT01005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301848|NCT01005108|Anticonvulsants|anticonvulsants|mesh-ancestor
139301849|NCT01005108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139301850|NCT01005108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139301851|NCT01005108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301852|NCT01005108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139301853|NCT01005108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139301854|NCT01005108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139301855|NCT01005108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301856|NCT01005108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301857|NCT01005108|Antimanic Agents|antimanic agents|mesh-ancestor
139301858|NCT00905346|Topiramate|topiramate|mesh-list
139301859|NCT00905346|Anticonvulsants|anticonvulsants|mesh-ancestor
139301860|NCT00905346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139301861|NCT00905346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301862|NCT00902928|Enoxaparin|enoxaparin|mesh-list
139301863|NCT00902928|Anticoagulants|anticoagulants|mesh-ancestor
139301864|NCT00902928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139301865|NCT00902928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139301866|NCT00902928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301867|NCT01129674|Olanzapine|olanzapine|mesh-list
139301868|NCT01129674|Risperidone|risperidone|mesh-list
139301869|NCT01129674|Aripiprazole|aripiprazole|mesh-list
139301870|NCT01129674|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139301871|NCT01129674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139301872|NCT01129674|Serotonin Agents|serotonin agents|mesh-ancestor
139301873|NCT01129674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301874|NCT01129674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301875|NCT01129674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301876|NCT01129674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139301877|NCT01129674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139301878|NCT01129674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301879|NCT01129674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139301880|NCT01129674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139301881|NCT01129674|Dopamine Agents|dopamine agents|mesh-ancestor
139301882|NCT01129674|Antiemetics|antiemetics|mesh-ancestor
139301883|NCT01129674|Autonomic Agents|autonomic agents|mesh-ancestor
139301884|NCT01129674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301885|NCT01129674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139301886|NCT01129674|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139301887|NCT01129674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139301888|NCT01129674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139301889|NCT01129674|Antidepressive Agents|antidepressive agents|mesh-ancestor
139301890|NCT01129674|Dopamine Agonists|dopamine agonists|mesh-ancestor
139301891|NCT01129674|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139301892|NCT01129674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139301893|NCT01129674|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139301894|NCT01129674|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139301895|NCT05045378|Midazolam|midazolam|mesh-list
139301896|NCT05045378|Ketamine|ketamine|mesh-list
139301897|NCT05045378|Analgesics|analgesics|mesh-ancestor
139301898|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
139301899|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301900|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301901|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139301902|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139301903|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
139301905|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301906|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139301907|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139301908|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301909|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301910|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139301911|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139301912|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139301913|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139301914|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139301915|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
139301916|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
139301917|NCT03460964|Pilocarpine|pilocarpine|mesh-list
139301918|NCT03460964|Miotics|miotics|mesh-ancestor
139301919|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
139301920|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301921|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301922|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139301923|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139301924|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
139301925|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139301926|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301927|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
139301928|NCT03460808|Atorvastatin|atorvastatin|mesh-list
139301929|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139301930|NCT03460808|Danazol|danazol|mesh-list
139301931|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139301932|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139301933|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
139301934|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301935|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139301936|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139301937|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301938|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
139301939|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139301940|NCT03460808|Expectorants|expectorants|mesh-ancestor
139301941|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
139301942|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139301943|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
139301944|NCT03460808|Protective Agents|protective agents|mesh-ancestor
139301945|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301946|NCT03460808|Antidotes|antidotes|mesh-ancestor
139301947|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139301948|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
139301949|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139301950|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139301951|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139301952|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
139301953|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301954|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301955|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139301956|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
139301957|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
139301958|NCT04946630|Hormones|hormones|mesh-ancestor
139301959|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139301960|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
139301961|NCT00900900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139301962|NCT00900900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139301963|NCT00900900|Immunologic Factors|immunologic factors|mesh-ancestor
139301964|NCT00900900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301965|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139301966|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
139301967|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301968|NCT05627778|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139301969|NCT05627778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139301970|NCT05627778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301971|NCT01120470|Prednisone|prednisone|mesh-list
139301972|NCT01120470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139301973|NCT01120470|Glucocorticoids|glucocorticoids|mesh-ancestor
139301974|NCT01120470|Hormones|hormones|mesh-ancestor
139301975|NCT01120470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139301976|NCT01120470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301977|NCT01120470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139301978|NCT01120470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301980|NCT01117584|Ipragliflozin|ipragliflozin|mesh-list
139301981|NCT01117584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139301982|NCT01117584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301983|NCT01117584|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139301984|NCT01117584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301985|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
139301986|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139301987|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139301988|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139301989|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139301990|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139301991|NCT00991068|Lidocaine|lidocaine|mesh-list
139301992|NCT00991068|Tetracaine|tetracaine|mesh-list
139301993|NCT00991068|Anesthetics, Local|anesthetics, local|mesh-ancestor
139301994|NCT00991068|Anesthetics|anesthetics|mesh-ancestor
139071066|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
139301995|NCT00991068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139301996|NCT00991068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139301997|NCT00991068|Sensory System Agents|sensory system agents|mesh-ancestor
139301998|NCT00991068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139301999|NCT00991068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139302000|NCT00991068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139302001|NCT00991068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139302002|NCT00991068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139302003|NCT00991068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302004|NCT01114698|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139302005|NCT01114698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139302006|NCT01114698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139302007|NCT01114698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139302008|NCT01114698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302009|NCT01114698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302010|NCT01114698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302011|NCT01114698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139302012|NCT01114698|Antidepressive Agents|antidepressive agents|mesh-ancestor
139302013|NCT01114698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139302014|NCT01114308|Buprenorphine|buprenorphine|mesh-list
139302015|NCT01114308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139302016|NCT01114308|Narcotics|narcotics|mesh-ancestor
139302017|NCT01114308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139302018|NCT01114308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302019|NCT01114308|Analgesics|analgesics|mesh-ancestor
139302020|NCT01114308|Sensory System Agents|sensory system agents|mesh-ancestor
139302021|NCT01114308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302022|NCT01114308|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139302023|NCT05469126|Clarithromycin|clarithromycin|mesh-list
139302024|NCT05469126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139302025|NCT05469126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302026|NCT05469126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139302027|NCT05469126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302028|NCT05469126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302029|NCT05469126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139302030|NCT05469126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139302031|NCT00887250|Losartan|losartan|mesh-list
139302032|NCT00887250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139174031|NCT03720288|Acetazolamide|acetazolamide|mesh-list
139302033|NCT00887250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139302034|NCT00887250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139302035|NCT00887250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139302036|NCT00887250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302037|NCT00990912|Carboplatin|carboplatin|mesh-list
139302038|NCT00990912|Irinotecan|irinotecan|mesh-list
139302039|NCT00990912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302040|NCT00990912|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139302041|NCT00990912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139302042|NCT00990912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302043|NCT00990912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302044|NCT00973284|Mannitol|mannitol|mesh-list
139302045|NCT00973284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139302046|NCT00973284|Diuretics|diuretics|mesh-ancestor
139302047|NCT00973284|Natriuretic Agents|natriuretic agents|mesh-ancestor
139302048|NCT00973284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302049|NCT02599402|Nivolumab|nivolumab|mesh-list
139302050|NCT02599402|Ipilimumab|ipilimumab|mesh-list
139302051|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139302052|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302053|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139302054|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302055|NCT00879762|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139302056|NCT00879762|Antiviral Agents|antiviral agents|mesh-ancestor
139302057|NCT00879762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302058|NCT04768166|Miglustat|miglustat|mesh-list
139302059|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071084|NCT04532164|Miconazole|miconazole|mesh-list
139302060|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302061|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139302062|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139302063|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
139302064|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302065|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139302066|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139302067|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302068|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
139302069|NCT04822090|Antibodies|antibodies|mesh-list
139302070|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
139302071|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139302072|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139302073|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
139302074|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302075|NCT03463382|Bupivacaine|bupivacaine|mesh-list
139302076|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
139302077|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
139302078|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139302079|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302080|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
139302081|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302082|NCT00872430|Laxatives|laxatives|mesh-list
139302083|NCT00872430|Cathartics|cathartics|mesh-list
139302084|NCT00872430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139302085|NCT00871182|Tiotropium Bromide|tiotropium bromide|mesh-list
139302086|NCT00871182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139302087|NCT00871182|Autonomic Agents|autonomic agents|mesh-ancestor
139302088|NCT00871182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302089|NCT00871182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302090|NCT00871182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139302091|NCT00871182|Respiratory System Agents|respiratory system agents|mesh-ancestor
139302092|NCT00871182|Parasympatholytics|parasympatholytics|mesh-ancestor
139302093|NCT00871182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139302094|NCT00871182|Cholinergic Agents|cholinergic agents|mesh-ancestor
139302095|NCT00871182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302096|NCT00871182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302097|NCT04814056|Afatinib|afatinib|mesh-list
139302098|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302099|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139302100|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174039|NCT03916393|Denatonium|denatonium|mesh-list
139302101|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302102|NCT05627154|Citalopram|citalopram|mesh-list
139302103|NCT05627154|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139302104|NCT05627154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139302105|NCT05627154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139302106|NCT05627154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302107|NCT05627154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302108|NCT05627154|Serotonin Agents|serotonin agents|mesh-ancestor
139302109|NCT05627154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302110|NCT05627154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139302111|NCT05627154|Antidepressive Agents|antidepressive agents|mesh-ancestor
139302112|NCT05627154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139302113|NCT00957918|Nicotine|nicotine|mesh-list
139302114|NCT00957918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139302115|NCT00957918|Autonomic Agents|autonomic agents|mesh-ancestor
139302116|NCT00957918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302117|NCT00957918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302118|NCT00957918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139302119|NCT00957918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139302120|NCT00957918|Cholinergic Agents|cholinergic agents|mesh-ancestor
139302121|NCT00957918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302122|NCT00957918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302123|NCT02734862|Fluconazole|fluconazole|mesh-list
139302124|NCT02734862|Caspofungin|caspofungin|mesh-list
139302125|NCT02734862|Rezafungin|rezafungin|mesh-list
139302126|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
139302127|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071090|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302128|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139302129|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139302130|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302131|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302132|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139302133|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
139302134|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139302135|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302136|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139302137|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139302138|NCT00818844|Nepafenac|nepafenac|mesh-list
139302139|NCT00818844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139302140|NCT00818844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139302141|NCT00818844|Analgesics|analgesics|mesh-ancestor
139302142|NCT00818844|Sensory System Agents|sensory system agents|mesh-ancestor
139302143|NCT00818844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302144|NCT00818844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302145|NCT00818844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139302146|NCT00818844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139302147|NCT00862524|Gemcitabine|gemcitabine|mesh-list
139302148|NCT00862524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139302149|NCT00862524|Antimetabolites|antimetabolites|mesh-ancestor
139302150|NCT00862524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302151|NCT00862524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302152|NCT00858702|Olmesartan|olmesartan|mesh-list
139302153|NCT00858702|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139302154|NCT00858702|Diuretics|diuretics|mesh-list
139302155|NCT00858702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139302156|NCT00858702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139302157|NCT00858702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139302158|NCT00858702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302159|NCT00858702|Natriuretic Agents|natriuretic agents|mesh-ancestor
139302160|NCT00858702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302161|NCT00817986|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
139302162|NCT00817986|Baclofen|baclofen|mesh-list
139302163|NCT00817986|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139302164|NCT00817986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302165|NCT00817986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139302166|NCT00817986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302167|NCT00817986|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139302168|NCT00817986|GABA Agonists|gaba agonists|mesh-ancestor
139302169|NCT00817986|GABA Agents|gaba agents|mesh-ancestor
139302170|NCT00817986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302171|NCT00817986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302172|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
139302173|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139302174|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302175|NCT00817362|Trastuzumab|trastuzumab|mesh-list
139302176|NCT00817362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139302177|NCT00817362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302179|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139302180|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302181|NCT04163978|Budesonide|budesonide|mesh-list
139302182|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
139302183|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139302184|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139302185|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
139302186|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302187|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302188|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139302189|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
139302190|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
139302191|NCT04163978|Hormones|hormones|mesh-ancestor
139302192|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139302193|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139302194|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
139071093|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
139302195|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302196|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302197|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139302198|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
139302199|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
139302200|NCT04163978|Protective Agents|protective agents|mesh-ancestor
139302201|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
139302202|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
139302203|NCT02598622|Vitamins|vitamins|mesh-ancestor
139302204|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
139302205|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302206|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
139302207|NCT03463070|Misoprostol|misoprostol|mesh-list
139302208|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139302209|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
139302210|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139302211|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302212|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139302213|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139302214|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
139302215|NCT00807612|Paclitaxel|paclitaxel|mesh-list
139302216|NCT00807612|Carboplatin|carboplatin|mesh-list
139302217|NCT00807612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139302218|NCT00807612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139302219|NCT00807612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302220|NCT00807612|Tubulin Modulators|tubulin modulators|mesh-ancestor
139302221|NCT00807612|Antimitotic Agents|antimitotic agents|mesh-ancestor
139302222|NCT00807612|Mitosis Modulators|mitosis modulators|mesh-ancestor
139302223|NCT00807612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302224|NCT00807612|Immunologic Factors|immunologic factors|mesh-ancestor
139302225|NCT00807612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302226|NCT00805350|SR 46349B|sr 46349b|mesh-list
139302227|NCT00805350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139302228|NCT00805350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139302229|NCT00805350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302230|NCT00805350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139302231|NCT00805350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139302232|NCT00805350|Serotonin Agents|serotonin agents|mesh-ancestor
139302233|NCT00805350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302234|NCT00805350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302235|NCT03462836|Lidocaine|lidocaine|mesh-list
139302236|NCT03462836|Ketamine|ketamine|mesh-list
139302237|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
139302238|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
139174053|NCT00938912|Lacosamide|lacosamide|mesh-list
139302239|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139302240|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302241|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
139302242|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302243|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139302244|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139302245|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139302246|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139302247|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302248|NCT03462836|Analgesics|analgesics|mesh-ancestor
139302249|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139302250|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139302251|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
139071098|NCT04531540|Butenafine|butenafine|mesh-list
139302252|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139302253|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139302254|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302255|NCT00849576|Insulin|insulin|mesh-list
139302256|NCT00849576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139302257|NCT00849576|Insulin Lispro|insulin lispro|mesh-list
139302258|NCT00849576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139302259|NCT00849576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302260|NCT00841698|Paroxetine|paroxetine|mesh-list
139302261|NCT00841698|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139302262|NCT00841698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139302263|NCT00841698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139302264|NCT00841698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302265|NCT00841698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302266|NCT00841698|Serotonin Agents|serotonin agents|mesh-ancestor
139302267|NCT00841698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302268|NCT00841698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139302269|NCT00841698|Antidepressive Agents|antidepressive agents|mesh-ancestor
139302270|NCT00841698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139302271|NCT00841698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138885711|NCT02636816|Carbetocin|carbetocin|mesh-list
139302272|NCT00841698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139302274|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
139302275|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139302276|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
139302277|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302278|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302279|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139302280|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
139302281|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139302282|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
139302283|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302284|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302285|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139302286|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
139302287|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
139302288|NCT04383002|Protective Agents|protective agents|mesh-ancestor
139302289|NCT00841542|Amlodipine|amlodipine|mesh-list
139302290|NCT00841542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139302291|NCT00841542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139302292|NCT00841542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139302293|NCT00841542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302294|NCT00841542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139302295|NCT00841542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302296|NCT00841542|Vasodilator Agents|vasodilator agents|mesh-ancestor
139302297|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
139302298|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139302299|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
139302300|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302301|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139302302|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139302303|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
139174056|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139302304|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302305|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302306|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139302308|NCT00840840|Clavulanic Acid|clavulanic acid|mesh-list
139302309|NCT00840840|Clavulanic Acids|clavulanic acids|mesh-list
139302310|NCT00840840|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139302311|NCT00840840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139302312|NCT00840840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302313|NCT00840840|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139302314|NCT00840840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302315|NCT00840840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302316|NCT03595982|Nifedipine|nifedipine|mesh-list
139302317|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139302318|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139302319|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302320|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139302321|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302322|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
139302323|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
139302324|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139302325|NCT00944970|Adenosine|adenosine|mesh-list
139302326|NCT00944970|Binodenoson|binodenoson|mesh-list
139302327|NCT00944970|Analgesics|analgesics|mesh-ancestor
139302328|NCT00944970|Sensory System Agents|sensory system agents|mesh-ancestor
139302329|NCT00944970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302330|NCT00944970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302331|NCT00944970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139302332|NCT00944970|Vasodilator Agents|vasodilator agents|mesh-ancestor
139302333|NCT00944970|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139302334|NCT00944970|Purinergic Agonists|purinergic agonists|mesh-ancestor
139302335|NCT00944970|Purinergic Agents|purinergic agents|mesh-ancestor
139302336|NCT00944970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302337|NCT00944970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302338|NCT00840216|Clarithromycin|clarithromycin|mesh-list
139302339|NCT00840216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139302340|NCT00840216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302341|NCT00840216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139302342|NCT00840216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302343|NCT00840216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302344|NCT00840216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139302345|NCT00840216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139302346|NCT03462446|Vitamin K|vitamin k|mesh-list
139302347|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
139302348|NCT03462446|Vitamins|vitamins|mesh-ancestor
139302349|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
139302350|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302351|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139302352|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
139302353|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139302354|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
139302355|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302356|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302357|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
139302358|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139302359|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139302360|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
139302361|NCT03462446|Coagulants|coagulants|mesh-ancestor
139302362|NCT00944892|Fasinumab|fasinumab|mesh-list
139302363|NCT00944892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139302364|NCT00944892|Analgesics|analgesics|mesh-ancestor
139302365|NCT00944892|Sensory System Agents|sensory system agents|mesh-ancestor
139302366|NCT00944892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302367|NCT00944892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302369|NCT00939276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139302370|NCT00939276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139302371|NCT00939276|Analgesics|analgesics|mesh-ancestor
139302372|NCT00939276|Sensory System Agents|sensory system agents|mesh-ancestor
139302373|NCT00939276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302374|NCT00939276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302375|NCT00939276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139302376|NCT00939276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139302377|NCT03455426|Letrozole|letrozole|mesh-list
139302378|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302379|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139302380|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139302381|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302382|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302383|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139302384|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
139302385|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139302386|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302387|NCT00791154|Carboplatin|carboplatin|mesh-list
139302388|NCT00791154|Etoposide|etoposide|mesh-list
139302389|NCT00791154|Rilotumumab|rilotumumab|mesh-list
139302390|NCT00791154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302391|NCT00791154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139302392|NCT00791154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139302393|NCT00791154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139302394|NCT00791154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302395|NCT00791154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302396|NCT00791154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139302397|NCT00938652|Carboplatin|carboplatin|mesh-list
139302398|NCT00938652|Gemcitabine|gemcitabine|mesh-list
139302399|NCT00938652|Iniparib|iniparib|mesh-list
139302400|NCT00938652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302401|NCT00938652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139302402|NCT00938652|Antimetabolites|antimetabolites|mesh-ancestor
139302403|NCT00938652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302404|NCT00938652|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139302405|NCT00938652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302406|NCT00928590|Timolol|timolol|mesh-list
139302407|NCT00928590|Travoprost|travoprost|mesh-list
139302408|NCT00928590|Cloprostenol|cloprostenol|mesh-list
139302409|NCT00928590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302410|NCT00928590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139302411|NCT00928590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139302412|NCT00928590|Adrenergic Agents|adrenergic agents|mesh-ancestor
139302413|NCT00928590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302414|NCT00928590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302415|NCT00928590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139302416|NCT00928590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139302417|NCT00928590|Luteolytic Agents|luteolytic agents|mesh-ancestor
139302418|NCT00928590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139302419|NCT00928590|Contraceptive Agents|contraceptive agents|mesh-ancestor
139302420|NCT00928590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139302421|NCT00928590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139302423|NCT03512756|Gemcitabine|gemcitabine|mesh-list
139302424|NCT03512756|Capecitabine|capecitabine|mesh-list
139302425|NCT03512756|Phenytoin|phenytoin|mesh-list
139302426|NCT03512756|Methoxsalen|methoxsalen|mesh-list
139302427|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139302428|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
139302429|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302430|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302431|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139302432|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302433|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139302434|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
139302435|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139302436|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
139302437|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302438|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
139302439|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139302440|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139302441|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139302442|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139302443|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139302444|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139302445|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
139302446|NCT04697940|Cyclophosphamide|cyclophosphamide|mesh-list
139302447|NCT04697940|Fludarabine|fludarabine|mesh-list
139302448|NCT04697940|Fludarabine phosphate|fludarabine phosphate|mesh-list
139302449|NCT04697940|Decitabine|decitabine|mesh-list
139302450|NCT04697940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139302451|NCT04697940|Immunologic Factors|immunologic factors|mesh-ancestor
139302452|NCT04697940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302453|NCT04697940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139302454|NCT04697940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139302455|NCT04697940|Alkylating Agents|alkylating agents|mesh-ancestor
139302456|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302457|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302458|NCT04697940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139302459|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139302460|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
139302461|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302462|NCT00836706|Clarithromycin|clarithromycin|mesh-list
139302463|NCT00836706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139302464|NCT00836706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302465|NCT00836706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139302466|NCT00836706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302467|NCT00836706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302468|NCT00836706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139302469|NCT00836706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139302470|NCT00836472|Metformin|metformin|mesh-list
139302471|NCT00836472|Glyburide|glyburide|mesh-list
139302472|NCT00836472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139302473|NCT00836472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302474|NCT04473846|Anesthetics|anesthetics|mesh-list
139302475|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139302476|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302477|NCT03129698|Apatinib|apatinib|mesh-list
139302478|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302479|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139302480|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302481|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302482|NCT03355118|Anesthetics|anesthetics|mesh-list
139302483|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139302484|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302485|NCT03263078|Propofol|propofol|mesh-list
139302486|NCT03263078|Sevoflurane|sevoflurane|mesh-list
139302487|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139302488|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139302489|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302490|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139302491|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
139302492|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
139302493|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138885939|NCT00689832|Fluticasone|fluticasone|mesh-list
138886009|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
139302494|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139302496|NCT05349006|Antimetabolites|antimetabolites|mesh-ancestor
139302497|NCT05349006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302498|NCT05349006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139302499|NCT05349006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302500|NCT05349006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139302501|NCT05349006|Immunologic Factors|immunologic factors|mesh-ancestor
139302502|NCT05349006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302503|NCT05349006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139302504|NCT00785226|Sorafenib|sorafenib|mesh-list
139302505|NCT00785226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302506|NCT00785226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139302507|NCT00785226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302508|NCT00785226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302509|NCT02598388|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139302510|NCT02598388|Antiviral Agents|antiviral agents|mesh-ancestor
139302511|NCT02598388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302512|NCT03448640|Tropicamide|tropicamide|mesh-list
139302513|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
139302514|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
139302515|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302516|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302517|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139302518|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139302519|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
139302520|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302521|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302522|NCT00836004|Clindamycin|clindamycin|mesh-list
139302523|NCT00836004|Clindamycin palmitate|clindamycin palmitate|mesh-list
139302524|NCT00836004|Clindamycin phosphate|clindamycin phosphate|mesh-list
139302525|NCT00836004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139071176|NCT03757156|Aspirin|aspirin|mesh-list
139302526|NCT00836004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302527|NCT00836004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139302528|NCT00836004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302529|NCT00836004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302530|NCT00917826|Valganciclovir|valganciclovir|mesh-list
139302531|NCT00917826|Ganciclovir|ganciclovir|mesh-list
139302532|NCT00917826|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139302533|NCT00917826|Arginine butyrate|arginine butyrate|mesh-list
139302534|NCT00917826|Antiviral Agents|antiviral agents|mesh-ancestor
139302535|NCT00917826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302536|NCT00917826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139302537|NCT00917826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302538|NCT00917826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302539|NCT00917826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302540|NCT03102320|Gemcitabine|gemcitabine|mesh-list
139302541|NCT03102320|Maytansine|maytansine|mesh-list
139302542|NCT03102320|Anetumab ravtansine|anetumab ravtansine|mesh-list
139302543|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302544|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139302545|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
139302546|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302547|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139302548|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
139302549|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
139302550|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
139302551|NCT03102320|Immunoconjugates|immunoconjugates|mesh-ancestor
139302552|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
139302553|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302554|NCT00835692|Clarithromycin|clarithromycin|mesh-list
139302555|NCT00835692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139302556|NCT00835692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302557|NCT00835692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139302558|NCT00835692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302559|NCT00835692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302560|NCT00835692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139302561|NCT00835692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139302562|NCT00835614|Cefprozil|cefprozil|mesh-list
139302563|NCT00835614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139302564|NCT00835614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302565|NCT00835536|Ribavirin|ribavirin|mesh-list
139302566|NCT00835536|Antimetabolites|antimetabolites|mesh-ancestor
139302567|NCT00835536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302568|NCT00835536|Antiviral Agents|antiviral agents|mesh-ancestor
139174081|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
139302569|NCT00835536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302570|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139302571|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
139302572|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139302573|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
139302574|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139302575|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302576|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139302577|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139302578|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302581|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139302582|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302583|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
139302584|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302585|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139302586|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302587|NCT04819438|Riluzole|riluzole|mesh-list
139302588|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
139302589|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139302590|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139302591|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071209|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302592|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302593|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302594|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139302595|NCT04819438|Protective Agents|protective agents|mesh-ancestor
139302596|NCT04819828|Diclofenac|diclofenac|mesh-list
139302597|NCT04819828|Tamsulosin|tamsulosin|mesh-list
139302598|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139302599|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139302600|NCT04819828|Analgesics|analgesics|mesh-ancestor
139302601|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
139302602|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302603|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302604|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139302605|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139302606|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139302607|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302608|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302609|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139302610|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139302611|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139302612|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
139302613|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302614|NCT04819828|Urological Agents|urological agents|mesh-ancestor
139302615|NCT02602288|Nicotine|nicotine|mesh-list
139302616|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139302617|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
139302618|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302619|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302620|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139302621|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139302622|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
139302623|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302624|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302625|NCT03745352|Azacitidine|azacitidine|mesh-list
139302626|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139302627|NCT03745352|Pevonedistat|pevonedistat|mesh-list
139302628|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139302629|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
139174093|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
139302630|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302631|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302632|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139302633|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139302634|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302635|NCT05617690|Propofol|propofol|mesh-list
139302636|NCT05617690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139302637|NCT05617690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139302638|NCT05617690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886084|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302639|NCT05617690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139302640|NCT05617690|Anesthetics, General|anesthetics, general|mesh-ancestor
139302642|NCT03448094|Resveratrol|resveratrol|mesh-list
139302643|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
139302644|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302645|NCT03448094|Protective Agents|protective agents|mesh-ancestor
139302646|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302647|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302648|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139302649|NCT04819204|Cetrorelix|cetrorelix|mesh-list
139302650|NCT04819204|Testosterone|testosterone|mesh-list
139302651|NCT04819204|Androgens|androgens|mesh-ancestor
139302652|NCT04819204|Hormones|hormones|mesh-ancestor
139302653|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139302654|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302655|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139302656|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
139302657|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139302658|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
139302659|NCT02807454|Dexamethasone|dexamethasone|mesh-list
139302660|NCT02807454|Durvalumab|durvalumab|mesh-list
139302661|NCT02807454|Daratumumab|daratumumab|mesh-list
139302662|NCT02807454|Pomalidomide|pomalidomide|mesh-list
139302663|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139302664|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
139302665|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
139302666|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302667|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302668|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139302669|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
139302670|NCT02807454|Hormones|hormones|mesh-ancestor
139302671|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139302672|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139302673|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302674|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139302675|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
139302676|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139302677|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139302678|NCT02807454|Growth Substances|growth substances|mesh-ancestor
139302679|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
139302680|NCT03718286|Alirocumab|alirocumab|mesh-list
139302681|NCT03718286|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139302682|NCT03718286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139302683|NCT03718286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139302684|NCT03718286|Antimetabolites|antimetabolites|mesh-ancestor
139302685|NCT03718286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302686|NCT03718286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139302687|NCT03718286|Protease Inhibitors|protease inhibitors|mesh-ancestor
139302688|NCT03718286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302689|NCT03718286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139302690|NCT05320874|Antibodies|antibodies|mesh-list
139302691|NCT05320874|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139302692|NCT05320874|Immunologic Factors|immunologic factors|mesh-ancestor
139302693|NCT05320874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302694|NCT05320640|Decitabine|decitabine|mesh-list
139302695|NCT05320640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139302696|NCT05320640|Antibodies|antibodies|mesh-list
139302697|NCT05320640|Immunologic Factors|immunologic factors|mesh-ancestor
139302698|NCT05320640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302699|NCT05320640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139302700|NCT05320640|Antimetabolites|antimetabolites|mesh-ancestor
139302701|NCT05320640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302702|NCT05320640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302703|NCT05320640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302704|NCT05320640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139302705|NCT00835146|Ribavirin|ribavirin|mesh-list
139302706|NCT00835146|Antimetabolites|antimetabolites|mesh-ancestor
139302707|NCT00835146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302708|NCT00835146|Antiviral Agents|antiviral agents|mesh-ancestor
139302709|NCT00835146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302710|NCT04818736|Vaccines|vaccines|mesh-list
139302711|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
139302712|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302713|NCT03719430|Doxorubicin|doxorubicin|mesh-list
139302714|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139302715|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302716|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139302717|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139302718|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302719|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302720|NCT04811326|Latanoprost|latanoprost|mesh-list
139302721|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139302722|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139302723|NCT00834990|Valproic Acid|valproic acid|mesh-list
139302724|NCT00834990|Anticonvulsants|anticonvulsants|mesh-ancestor
139302725|NCT00834990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302726|NCT00834990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302727|NCT00834990|GABA Agents|gaba agents|mesh-ancestor
139302728|NCT00834990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302729|NCT00834990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302730|NCT00834990|Antimanic Agents|antimanic agents|mesh-ancestor
139302731|NCT00834990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139302732|NCT00834990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139302733|NCT00834990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139302734|NCT04479072|Aspirin|aspirin|mesh-list
139302735|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139302736|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139302737|NCT04479072|Analgesics|analgesics|mesh-ancestor
139302738|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
139302739|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302740|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302741|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139302742|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139302743|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139302744|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139302745|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174128|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
139302746|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139302747|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139302748|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302749|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
139302750|NCT03036202|Epinephrine|epinephrine|mesh-list
139302751|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139302752|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139302753|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
139302754|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302755|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302756|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302757|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139302758|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139302759|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
139302760|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302761|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139302762|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
139302763|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
139302764|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
139302765|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139302766|NCT03245918|Aprepitant|aprepitant|mesh-list
139302767|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
139302768|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
139302769|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
139302770|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302771|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302772|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139302773|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139302774|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302775|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302776|NCT00834756|Azithromycin|azithromycin|mesh-list
139302777|NCT00834756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139302778|NCT00834756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302779|NCT00828854|Entinostat|entinostat|mesh-list
139302780|NCT00828854|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139302781|NCT00828854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139302782|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302783|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302784|NCT00828854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139302785|NCT00828854|Hormone Antagonists|hormone antagonists|mesh-ancestor
139302786|NCT00828854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139302787|NCT00828854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302788|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302789|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139302790|NCT00834522|Granisetron|granisetron|mesh-list
139302791|NCT00834522|Antiemetics|antiemetics|mesh-ancestor
139302792|NCT00834522|Autonomic Agents|autonomic agents|mesh-ancestor
139071234|NCT00096018|Growth Substances|growth substances|mesh-ancestor
139302793|NCT00834522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302794|NCT00834522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302795|NCT00834522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139302796|NCT00834522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139302797|NCT00834522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139302798|NCT00834522|Serotonin Agents|serotonin agents|mesh-ancestor
139302799|NCT00834522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302800|NCT00834522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302801|NCT00834444|Famciclovir|famciclovir|mesh-list
139302802|NCT00834444|Antiviral Agents|antiviral agents|mesh-ancestor
139302803|NCT00834444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302804|NCT00834444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139302805|NCT00834444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302806|NCT00834444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302807|NCT05174858|Hemostatics|hemostatics|mesh-list
139302808|NCT05174858|Coagulants|coagulants|mesh-ancestor
139302809|NCT00834132|Azithromycin|azithromycin|mesh-list
139302810|NCT00834132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139302811|NCT00834132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302812|NCT00833586|Terbinafine|terbinafine|mesh-list
139302813|NCT00833586|Antifungal Agents|antifungal agents|mesh-ancestor
139302814|NCT00833586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139174143|NCT03472014|Antiviral Agents|antiviral agents|mesh-ancestor
139302815|NCT00833586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302816|NCT00833586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302817|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139302818|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
139302819|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302820|NCT03447470|Nivolumab|nivolumab|mesh-list
139302821|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139302822|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302823|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139302824|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302825|NCT00765804|Dexamethasone|dexamethasone|mesh-list
139302826|NCT00765804|Citric Acid|citric acid|mesh-list
139302827|NCT00765804|Sodium Citrate|sodium citrate|mesh-list
139302828|NCT00765804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139302829|NCT00765804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139302830|NCT00765804|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139302831|NCT00765804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139302832|NCT00765804|Antiemetics|antiemetics|mesh-ancestor
139302833|NCT00765804|Autonomic Agents|autonomic agents|mesh-ancestor
139302834|NCT00765804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302835|NCT00765804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302836|NCT00765804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139302837|NCT00765804|Glucocorticoids|glucocorticoids|mesh-ancestor
139302838|NCT00765804|Hormones|hormones|mesh-ancestor
139302839|NCT00765804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139302840|NCT00765804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139302841|NCT00765804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302842|NCT00765804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302843|NCT00765804|Anticoagulants|anticoagulants|mesh-ancestor
139302844|NCT00765804|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139302845|NCT00765804|Chelating Agents|chelating agents|mesh-ancestor
139302846|NCT00765804|Sequestering Agents|sequestering agents|mesh-ancestor
139302847|NCT00764634|Vaccines|vaccines|mesh-list
139302848|NCT00764634|Immunologic Factors|immunologic factors|mesh-ancestor
139302849|NCT00764634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302850|NCT03443726|Epinephrine|epinephrine|mesh-list
139302851|NCT03443726|Carticaine|carticaine|mesh-list
139071241|NCT01079754|Analgesics|analgesics|mesh-ancestor
139302852|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139302853|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139302854|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
139302855|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302856|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302857|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302858|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139302859|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139302860|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
139302861|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302862|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139302863|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
139302864|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
139302865|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
139302866|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139302867|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
139302868|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
139302869|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139302870|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
139302871|NCT00760344|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139302872|NCT00760344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139302873|NCT00760344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302874|NCT00760344|Incretins|incretins|mesh-ancestor
139302875|NCT00760344|Hormones|hormones|mesh-ancestor
139302876|NCT00760344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139302877|NCT00760344|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139302878|NCT00760344|Protease Inhibitors|protease inhibitors|mesh-ancestor
139302879|NCT00760344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302880|NCT00760344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302881|NCT03443570|Rituximab|rituximab|mesh-list
139302882|NCT03443570|Bortezomib|bortezomib|mesh-list
139302883|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139302884|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302885|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
139302886|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302887|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139302888|NCT02718404|Analgesics|analgesics|mesh-list
139302889|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
139302890|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302891|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302892|NCT03443492|Leucovorin|leucovorin|mesh-list
139302893|NCT03443492|Gemcitabine|gemcitabine|mesh-list
139302894|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
139302895|NCT03443492|Irinotecan|irinotecan|mesh-list
139302896|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
139302897|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139302898|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
139302899|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302900|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302901|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139302902|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139302903|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302904|NCT03443492|Antidotes|antidotes|mesh-ancestor
139302905|NCT03443492|Protective Agents|protective agents|mesh-ancestor
139302906|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302907|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
139302908|NCT03443492|Vitamins|vitamins|mesh-ancestor
139302909|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
139302910|NCT00724698|Desloratadine|desloratadine|mesh-list
139302911|NCT00724698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139302912|NCT00724698|Cholinergic Agents|cholinergic agents|mesh-ancestor
139302913|NCT00724698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302914|NCT00724698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302915|NCT00724698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302916|NCT00724698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139302917|NCT00724698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139302918|NCT00724698|Histamine Antagonists|histamine antagonists|mesh-ancestor
139302919|NCT00724698|Histamine Agents|histamine agents|mesh-ancestor
139302920|NCT00722592|Doxorubicin|doxorubicin|mesh-list
139302921|NCT00722592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139302922|NCT00722592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139302923|NCT00722592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302924|NCT00722592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139302925|NCT00722592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139302926|NCT00722592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302927|NCT00722592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302928|NCT00829998|Zaleplon|zaleplon|mesh-list
139302929|NCT00829998|Anticonvulsants|anticonvulsants|mesh-ancestor
139174160|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
139302930|NCT00829998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139302931|NCT00829998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139302932|NCT00829998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302933|NCT00829998|GABA Modulators|gaba modulators|mesh-ancestor
139302934|NCT00829998|GABA Agents|gaba agents|mesh-ancestor
139302935|NCT00829998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302936|NCT00829998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302937|NCT00722358|Asunaprevir|asunaprevir|mesh-list
139302938|NCT00722358|Protease Inhibitors|protease inhibitors|mesh-ancestor
139302939|NCT00722358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302940|NCT00722358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302941|NCT00719550|Capecitabine|capecitabine|mesh-list
139302943|NCT00719550|Rilotumumab|rilotumumab|mesh-list
139302944|NCT00719550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302945|NCT00719550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139302946|NCT00719550|Antimetabolites|antimetabolites|mesh-ancestor
139302947|NCT00719550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302948|NCT00719550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139302949|NCT00719550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139302950|NCT00719550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139302951|NCT00719550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302952|NCT00719550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139302953|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
139302954|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139302955|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
139302956|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139302957|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302958|NCT05016518|Propofol|propofol|mesh-list
139302959|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139302960|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139302961|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302962|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139302963|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
139302964|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
139302965|NCT03446534|Amoxicillin|amoxicillin|mesh-list
139174188|NCT03525834|Everolimus|everolimus|mesh-list
139302966|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139302967|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302968|NCT00829764|Doxycycline|doxycycline|mesh-list
139302969|NCT00829764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139302970|NCT00829764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139302971|NCT00829764|Antimalarials|antimalarials|mesh-ancestor
139302972|NCT00829764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139302973|NCT00829764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139302974|NCT00718224|Enoxaparin|enoxaparin|mesh-list
139302975|NCT00718224|Semuloparin|semuloparin|mesh-list
139302976|NCT00718224|Anticoagulants|anticoagulants|mesh-ancestor
139302977|NCT00718224|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139302978|NCT00718224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139302979|NCT00718224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302980|NCT03129542|Midodrine|midodrine|mesh-list
139302981|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
139302982|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
139302983|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139302984|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139302985|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139302986|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139302987|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139302988|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139302989|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
139302990|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139302991|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302992|NCT03129074|Capecitabine|capecitabine|mesh-list
139302993|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139302994|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
139302995|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139302996|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139302997|NCT03449654|Liraglutide|liraglutide|mesh-list
139302998|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139302999|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303000|NCT03449654|Incretins|incretins|mesh-ancestor
139303001|NCT03449654|Hormones|hormones|mesh-ancestor
139303002|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139303003|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
139303004|NCT03388008|Prednisone|prednisone|mesh-list
139303005|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
139303006|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139303007|NCT03388008|Abatacept|abatacept|mesh-list
139303008|NCT03388008|Tacrolimus|tacrolimus|mesh-list
139303009|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
139303010|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303011|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
139303012|NCT03388008|Hormones|hormones|mesh-ancestor
139303013|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139303014|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303015|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139303016|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886466|NCT00999505|Analgesics|analgesics|mesh-ancestor
139303017|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139303018|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
139303019|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139303020|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303021|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303022|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139303023|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139303024|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
139303025|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139303026|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303027|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
139303028|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
139303029|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303030|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139303031|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139303032|NCT03388008|Protective Agents|protective agents|mesh-ancestor
139303033|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139303034|NCT03388008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139303035|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139303036|NCT00710580|Etanercept|etanercept|mesh-list
139303037|NCT00710580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139303038|NCT00710580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139303039|NCT00710580|Analgesics|analgesics|mesh-ancestor
139303040|NCT00710580|Sensory System Agents|sensory system agents|mesh-ancestor
139303041|NCT00710580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303042|NCT00710580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303043|NCT00710580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303044|NCT00710580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139303045|NCT00710580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139303046|NCT00710580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139303047|NCT00710580|Immunologic Factors|immunologic factors|mesh-ancestor
139303048|NCT00829686|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139303049|NCT00829686|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139303050|NCT00829686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303051|NCT00829686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139303052|NCT00829686|Antimalarials|antimalarials|mesh-ancestor
139303053|NCT00829686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139303054|NCT00829686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139303055|NCT00829530|Ramipril|ramipril|mesh-list
139303056|NCT00829530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139303057|NCT00829530|Protease Inhibitors|protease inhibitors|mesh-ancestor
139303058|NCT00829530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303059|NCT00829530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303060|NCT00829530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139303061|NCT01377194|Milnacipran|milnacipran|mesh-list
139303062|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
139303063|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139303064|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139303065|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139303066|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303067|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303068|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303069|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
139303070|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139303071|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139303072|NCT01377194|Analgesics|analgesics|mesh-ancestor
139303073|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
139303074|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303075|NCT00829452|Ramipril|ramipril|mesh-list
139303076|NCT00829452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139303077|NCT00829452|Protease Inhibitors|protease inhibitors|mesh-ancestor
139303078|NCT00829452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303079|NCT00829452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303080|NCT00829452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139303081|NCT00747318|Fluticasone|fluticasone|mesh-list
139303082|NCT00747318|Xhance|xhance|mesh-list
139303083|NCT00747318|Formoterol Fumarate|formoterol fumarate|mesh-list
139303084|NCT00747318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303085|NCT00747318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139303086|NCT00747318|Autonomic Agents|autonomic agents|mesh-ancestor
139303087|NCT00747318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303088|NCT00747318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303089|NCT00747318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139303090|NCT00747318|Respiratory System Agents|respiratory system agents|mesh-ancestor
139303091|NCT00747318|Dermatologic Agents|dermatologic agents|mesh-ancestor
139303092|NCT00747318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139303093|NCT00747318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139303094|NCT00747318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139303095|NCT00747318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139303096|NCT00747318|Adrenergic Agents|adrenergic agents|mesh-ancestor
139303097|NCT00747318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303098|NCT00747318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303099|NCT00744276|Danazol|danazol|mesh-list
139303100|NCT00744276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139303101|NCT00744276|Hormone Antagonists|hormone antagonists|mesh-ancestor
139303102|NCT00744276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139303103|NCT00744276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303104|NCT03438344|Vaccines|vaccines|mesh-list
139303105|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
139303106|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303107|NCT04640402|Vaccines|vaccines|mesh-list
139303108|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
139303109|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303110|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139303111|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139303112|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303113|NCT00646542|Vildagliptin|vildagliptin|mesh-list
139303114|NCT00646542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139303115|NCT00646542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303116|NCT00646542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139303117|NCT00646542|Protease Inhibitors|protease inhibitors|mesh-ancestor
139303118|NCT00646542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303119|NCT00646542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303120|NCT03256344|Atezolizumab|atezolizumab|mesh-list
139303121|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139303122|NCT03256344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139303123|NCT03256344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303124|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139303125|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303126|NCT02063139|Fluticasone|fluticasone|mesh-list
139303127|NCT02063139|Beclomethasone|beclomethasone|mesh-list
139303128|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303129|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139303130|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
139303131|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303132|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303133|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139303134|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
139303135|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
139303136|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139303137|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
139303138|NCT02063139|Hormones|hormones|mesh-ancestor
139303139|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139303140|NCT00690456|Metformin|metformin|mesh-list
139303141|NCT00690456|Rimonabant|rimonabant|mesh-list
139303142|NCT00690456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139303143|NCT00690456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303144|NCT00690456|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139303145|NCT00690456|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
139303146|NCT00690456|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139303147|NCT00690456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303148|NCT00690456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303149|NCT00690456|Hormones|hormones|mesh-ancestor
139303150|NCT00690456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139303151|NCT01370499|Serotonin|serotonin|mesh-list
139303152|NCT01370499|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139303153|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139303154|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
139303155|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071307|NCT01082744|Sufentanil|sufentanil|mesh-list
139303156|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303157|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303158|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139303159|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139303160|NCT03445286|Fluorides|fluorides|mesh-list
139303161|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
139303162|NCT03445286|Protective Agents|protective agents|mesh-ancestor
139303163|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303164|NCT00626106|Fulvestrant|fulvestrant|mesh-list
139303165|NCT00626106|Exemestane|exemestane|mesh-list
139174236|NCT01251835|Rifampin|rifampin|mesh-list
139303166|NCT00626106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139303167|NCT00626106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139303168|NCT00626106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303169|NCT00626106|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139303170|NCT00626106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139303171|NCT00626106|Hormone Antagonists|hormone antagonists|mesh-ancestor
139303172|NCT00626106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139303173|NCT00626106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303174|NCT00626106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139303175|NCT00626106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139303176|NCT00626106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303177|NCT00626106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303178|NCT00626106|Immunologic Factors|immunologic factors|mesh-ancestor
139303179|NCT02064465|Lamotrigine|lamotrigine|mesh-list
139303180|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
139303181|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139303182|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139303183|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303184|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139303185|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303186|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139303187|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139303188|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303189|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139303190|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139303191|NCT04530656|Vaccines|vaccines|mesh-list
139303192|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
139303193|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303194|NCT00690066|Remestemcel-l|remestemcel-l|mesh-list
139303195|NCT00690066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303196|NCT00690066|Antiviral Agents|antiviral agents|mesh-ancestor
139303197|NCT00690066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303198|NCT01370265|Adenosine|adenosine|mesh-list
139303199|NCT01370265|Regadenoson|regadenoson|mesh-list
139303200|NCT01370265|Analgesics|analgesics|mesh-ancestor
139303201|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
139303202|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937570|NCT05949008|Metformin|metformin|mesh-list
139303203|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303204|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139303205|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
139303206|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139303207|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
139303208|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
139303209|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303210|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303211|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139303212|NCT00734292|Fluticasone|fluticasone|mesh-list
139303213|NCT00734292|Xhance|xhance|mesh-list
139303214|NCT00734292|Formoterol Fumarate|formoterol fumarate|mesh-list
139303215|NCT00734292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303216|NCT00734292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139303217|NCT00734292|Autonomic Agents|autonomic agents|mesh-ancestor
139303218|NCT00734292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303219|NCT00734292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303220|NCT00734292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139303221|NCT00734292|Respiratory System Agents|respiratory system agents|mesh-ancestor
139303222|NCT00734292|Dermatologic Agents|dermatologic agents|mesh-ancestor
139303223|NCT00734292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139303224|NCT00734292|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139303225|NCT00734292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139303226|NCT00734292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139303227|NCT00734292|Adrenergic Agents|adrenergic agents|mesh-ancestor
139303228|NCT00734292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303229|NCT00734292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303230|NCT00687882|Anticoagulants|anticoagulants|mesh-list
139303231|NCT02064621|Amlodipine|amlodipine|mesh-list
139303232|NCT02064621|Candesartan|candesartan|mesh-list
139303233|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
139303234|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139303235|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139303236|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138886689|NCT00856323|Emtricitabine|emtricitabine|mesh-list
139303237|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303238|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139303239|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303240|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
139303241|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139303242|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139303243|NCT00684918|Obatoclax|obatoclax|mesh-list
139303244|NCT00684918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303245|NCT00684918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303246|NCT00726336|Tenofovir|tenofovir|mesh-list
139303247|NCT00726336|Dolutegravir|dolutegravir|mesh-list
139303248|NCT00726336|Antiviral Agents|antiviral agents|mesh-ancestor
139303249|NCT00726336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303250|NCT00726336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139303251|NCT00726336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139303252|NCT00726336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303253|NCT00726336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303254|NCT00726336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139303255|NCT00726336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139303256|NCT00726336|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139303257|NCT00726336|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139303258|NCT02280720|Tryptophan|tryptophan|mesh-list
139303259|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139303260|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
139303261|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139303262|NCT02068131|Capecitabine|capecitabine|mesh-list
139303263|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139303264|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
139303265|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303266|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303267|NCT02068209|Tramadol|tramadol|mesh-list
139303268|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139303269|NCT02068209|Narcotics|narcotics|mesh-ancestor
139303270|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303271|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303272|NCT02068209|Analgesics|analgesics|mesh-ancestor
139303273|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
139303274|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303275|NCT00680784|Ketoprofen|ketoprofen|mesh-list
139303276|NCT00680784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139303277|NCT00680784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139303278|NCT00680784|Analgesics|analgesics|mesh-ancestor
139303279|NCT00680784|Sensory System Agents|sensory system agents|mesh-ancestor
139303280|NCT00680784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303281|NCT00680784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303282|NCT00680784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303283|NCT00680784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139303284|NCT00680784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139303285|NCT00680784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303286|NCT00680784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303287|NCT02068287|Esmolol|esmolol|mesh-list
139303288|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139303289|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139303290|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139303291|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
139303292|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303293|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303294|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303295|NCT02280876|Andrographolide|andrographolide|mesh-list
139303296|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303297|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139303298|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139303299|NCT02280876|Analgesics|analgesics|mesh-ancestor
139303300|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
139303301|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303302|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303303|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139303304|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139303305|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139303306|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303307|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
139303308|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139303309|NCT00680472|Ketoprofen|ketoprofen|mesh-list
139303310|NCT00680472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139303311|NCT00680472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139303312|NCT00680472|Analgesics|analgesics|mesh-ancestor
139303313|NCT00680472|Sensory System Agents|sensory system agents|mesh-ancestor
139303314|NCT00680472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303315|NCT00680472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303316|NCT00680472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303317|NCT00680472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139303318|NCT00680472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139303319|NCT00680472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303320|NCT00680472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303321|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139303322|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
139303323|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139303324|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139303325|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139303326|NCT03444506|Analgesics|analgesics|mesh-ancestor
139303327|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
139303328|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303329|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303330|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303331|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139303332|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139303333|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139303334|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139303335|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
139303336|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
139303337|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303338|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303339|NCT02065947|Lidocaine|lidocaine|mesh-list
139303340|NCT02065947|Epinephrine|epinephrine|mesh-list
139303341|NCT02065947|Racepinephrine|racepinephrine|mesh-list
139303342|NCT02065947|Midazolam|midazolam|mesh-list
139303343|NCT02065947|Fentanyl|fentanyl|mesh-list
139303344|NCT02065947|Ketamine|ketamine|mesh-list
139303345|NCT02065947|Bupivacaine|bupivacaine|mesh-list
139303346|NCT02065947|Propofol|propofol|mesh-list
139303347|NCT02065947|Sevoflurane|sevoflurane|mesh-list
139303348|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
139303349|NCT02065947|Atracurium|atracurium|mesh-list
139303350|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
139303351|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
139303352|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303353|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303354|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
139303355|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303356|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139303357|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139303358|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139303359|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139303360|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303361|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139303362|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139303363|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
139303364|NCT02065947|Analgesics|analgesics|mesh-ancestor
139303365|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139303366|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139303367|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139303368|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303369|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139303370|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139303371|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139303372|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139303373|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
139303374|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
139303375|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139303376|NCT02065947|Narcotics|narcotics|mesh-ancestor
138959026|NCT05589454|Atorvastatin|atorvastatin|mesh-list
139303377|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139303378|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139303379|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139303380|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139303381|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
139303382|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139303383|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139303384|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
139303385|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139303386|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
138886839|NCT05170789|Elotuzumab|elotuzumab|mesh-list
139303387|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
139303389|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139303390|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139303391|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139303392|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139303393|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139303394|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139303395|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
139303396|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
139303397|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139303398|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303399|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303400|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139303401|NCT03436472|Analgesics|analgesics|mesh-ancestor
139303402|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
139303403|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303404|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139303405|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139303406|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139303407|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
139303408|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303409|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303410|NCT02066103|Paclitaxel|paclitaxel|mesh-list
139303411|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139303412|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303413|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
139303414|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
139303415|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
139303416|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303417|NCT04809532|Tramadol|tramadol|mesh-list
139303418|NCT04809532|Bupivacaine|bupivacaine|mesh-list
139303419|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
139303420|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
139303421|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303422|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303423|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
139303424|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303425|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139303426|NCT04809532|Narcotics|narcotics|mesh-ancestor
139303427|NCT04809532|Analgesics|analgesics|mesh-ancestor
139303428|NCT04809142|Gemcitabine|gemcitabine|mesh-list
139303429|NCT04809142|Capecitabine|capecitabine|mesh-list
139303430|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
139303431|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139303432|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
139303433|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303434|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303435|NCT02064777|Tacrolimus|tacrolimus|mesh-list
139303436|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139303437|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
139303438|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303439|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139303440|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303441|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303442|NCT02069145|Sorafenib|sorafenib|mesh-list
139303443|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
139303444|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303445|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139303446|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303447|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303448|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
139303449|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303450|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139303451|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
139303452|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303454|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
139303455|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303456|NCT03347331|Befiradol|befiradol|mesh-list
139303457|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139303458|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139303459|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
139303460|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303461|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303462|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303463|NCT05573373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139303464|NCT05573373|Antineoplastic Agents|antineoplastic agents|mesh-list
139303465|NCT05573373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303466|NCT05573373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303467|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
139303468|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139303469|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139303470|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303471|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
139303472|NCT03109652|Coagulants|coagulants|mesh-ancestor
139303473|NCT02069301|Fluoxetine|fluoxetine|mesh-list
139303474|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
139303475|NCT02069301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139303476|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139303477|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139303478|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303479|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303480|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
139303481|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303482|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139303483|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139303484|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139303485|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139303486|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303487|NCT03035656|Ropivacaine|ropivacaine|mesh-list
139303488|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
139303489|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
139303490|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303491|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303492|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
139303493|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303494|NCT03443960|Amitriptyline|amitriptyline|mesh-list
139303495|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
139303496|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139303497|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
139303498|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139303499|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139303500|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303501|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139303502|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303503|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139303504|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303505|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139303506|NCT03443960|Analgesics|analgesics|mesh-ancestor
139303507|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
139303508|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139303509|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139303510|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174261|NCT03632876|Vitamins|vitamins|mesh-ancestor
139303511|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303512|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
139303513|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303514|NCT05616754|Vaccines|vaccines|mesh-list
139303515|NCT05616754|Immunologic Factors|immunologic factors|mesh-ancestor
139303516|NCT05616754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303517|NCT03440996|Listerine|listerine|mesh-list
139303518|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
139303519|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
139303520|NCT03440996|Protective Agents|protective agents|mesh-ancestor
139303521|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303522|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139303523|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303524|NCT04451174|Prednisone|prednisone|mesh-list
139303525|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303526|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
139303527|NCT04451174|Hormones|hormones|mesh-ancestor
139071438|NCT03963024|Treosulfan|treosulfan|mesh-list
139303528|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139303529|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303530|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139303531|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303532|NCT04828642|Vitamins|vitamins|mesh-list
139303533|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
139303534|NCT04828642|Vitamin E|vitamin e|mesh-list
139303535|NCT04828642|Tocopherols|tocopherols|mesh-list
139303536|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
139303537|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303538|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
139303539|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303540|NCT04828642|Protective Agents|protective agents|mesh-ancestor
139303541|NCT03433352|Methimazole|methimazole|mesh-list
139303542|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
139303543|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
139303544|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
139303545|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139303546|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303547|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
139303548|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303549|NCT04828564|Ribavirin|ribavirin|mesh-list
139303550|NCT04828564|Favipiravir|favipiravir|mesh-list
139303551|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
139303552|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303553|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
139303554|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303555|NCT03435302|Temozolomide|temozolomide|mesh-list
139303556|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303557|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139303558|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
139303559|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303560|NCT04973150|Anesthetics|anesthetics|mesh-list
139303561|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303562|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303563|NCT03433196|Atorvastatin|atorvastatin|mesh-list
139303564|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139303565|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139303566|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
139303567|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303568|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139303569|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139303570|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303571|NCT02792829|Lenvatinib|lenvatinib|mesh-list
139303572|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303573|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139303574|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303575|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303576|NCT02066571|Droxidopa|droxidopa|mesh-list
139303577|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139303578|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139303579|NCT02066649|Carvedilol|carvedilol|mesh-list
139303580|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139303581|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139303582|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
139303583|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303584|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303585|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303586|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139303587|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
139303588|NCT02066649|Protective Agents|protective agents|mesh-ancestor
139303589|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139303590|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139303591|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139303592|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
139303593|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139303594|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139303595|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
139303596|NCT02070003|Narcotics|narcotics|mesh-ancestor
139303597|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303598|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303599|NCT02070003|Analgesics|analgesics|mesh-ancestor
139303600|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
139303601|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303602|NCT02070159|Clopidogrel|clopidogrel|mesh-list
139303603|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139303604|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139303605|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139303606|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139303607|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138887064|NCT00998101|Cetuximab|cetuximab|mesh-list
138887143|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
139303608|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
139303609|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303610|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303611|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303612|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
139303613|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
139303614|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139303615|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303616|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139303617|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139303618|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303619|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303620|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303621|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139303622|NCT04827784|Anesthetics|anesthetics|mesh-list
139303623|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
139303624|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303625|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303626|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
139303627|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303628|NCT03986996|Amoxicillin|amoxicillin|mesh-list
139303629|NCT03986996|Metronidazole|metronidazole|mesh-list
139303630|NCT03986996|Doxycycline|doxycycline|mesh-list
139303631|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139303632|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303633|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139303634|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139303635|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
139303637|NCT04827472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139174276|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
139303639|NCT04796428|Empagliflozin|empagliflozin|mesh-list
139303640|NCT04796428|Canagliflozin|canagliflozin|mesh-list
139303641|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139303642|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303643|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139303644|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303645|NCT03432728|Anesthetics|anesthetics|mesh-list
139303646|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303647|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303648|NCT04450160|Temozolomide|temozolomide|mesh-list
139303649|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139303650|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
139303651|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303652|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303653|NCT03432572|Riboflavin|riboflavin|mesh-list
139303654|NCT03432572|Thiamine|thiamine|mesh-list
139303655|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
139303656|NCT03432572|Vitamins|vitamins|mesh-ancestor
139303657|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
139303658|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303659|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139303660|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
139303661|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
139303662|NCT02805504|Bupivacaine|bupivacaine|mesh-list
139303663|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
139303664|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
139303665|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303666|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303667|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
139303668|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303669|NCT02783508|Meperidine|meperidine|mesh-list
139303670|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
139303671|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139303672|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
139303673|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
139303674|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303675|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303676|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139303677|NCT02783508|Analgesics|analgesics|mesh-ancestor
139303678|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
139303679|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303680|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139303681|NCT02783508|Narcotics|narcotics|mesh-ancestor
139303682|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139303683|NCT02071407|Midazolam|midazolam|mesh-list
139303684|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139303685|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139303686|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303687|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303688|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139303689|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139303690|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139303691|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139303692|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
139303693|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
139303694|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
139303695|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
139303696|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303697|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303698|NCT02281266|Entecavir|entecavir|mesh-list
139303699|NCT02281266|Thymalfasin|thymalfasin|mesh-list
139303700|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
139303701|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303702|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139303703|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
139303704|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303705|NCT00625326|Calcipotriene|calcipotriene|mesh-list
139303706|NCT00625326|Dermatologic Agents|dermatologic agents|mesh-ancestor
139303707|NCT03434054|Losartan|losartan|mesh-list
139303708|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139303709|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139303710|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139303711|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139303712|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303713|NCT03433976|Anesthetics|anesthetics|mesh-list
139303714|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303715|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303716|NCT04473144|Urinastatin|urinastatin|mesh-list
139303717|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139303718|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139303719|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
139303720|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303721|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303722|NCT02605642|Infliximab|infliximab|mesh-list
139303723|NCT02605642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139303724|NCT02605642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303725|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
139303726|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139303727|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139303728|NCT00624858|Naltrexone|naltrexone|mesh-list
139303729|NCT00624858|Bupropion|bupropion|mesh-list
139303730|NCT00624858|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139303731|NCT00624858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139303732|NCT00624858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303733|NCT00624858|Sensory System Agents|sensory system agents|mesh-ancestor
139303734|NCT00624858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303735|NCT00624858|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139303736|NCT00624858|Antidepressive Agents|antidepressive agents|mesh-ancestor
139303737|NCT00624858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139303738|NCT00624858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139303739|NCT00624858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139303740|NCT00624858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139303741|NCT00624858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303742|NCT00624858|Dopamine Agents|dopamine agents|mesh-ancestor
139303743|NCT00624858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303744|NCT00624858|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139303745|NCT00624858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139303746|NCT00624858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303747|NCT03128528|Empagliflozin|empagliflozin|mesh-list
139303748|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139303749|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303750|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139303751|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303752|NCT02071641|Sunitinib|sunitinib|mesh-list
139303753|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303754|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139303755|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139303756|NCT02071641|Growth Substances|growth substances|mesh-ancestor
139303757|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303758|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
139303759|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139303760|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303761|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303762|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
139303763|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139303764|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139303765|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303766|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
139303767|NCT02253810|Coagulants|coagulants|mesh-ancestor
139303768|NCT03298893|Nivolumab|nivolumab|mesh-list
139303769|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303770|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139303771|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139303772|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303773|NCT00673062|Pseudoephedrine|pseudoephedrine|mesh-list
139303774|NCT00673062|Ephedrine|ephedrine|mesh-list
139303775|NCT00673062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139303776|NCT00673062|Autonomic Agents|autonomic agents|mesh-ancestor
139303777|NCT00673062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303778|NCT00673062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303779|NCT00673062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139303780|NCT00673062|Respiratory System Agents|respiratory system agents|mesh-ancestor
139303781|NCT00673062|Nasal Decongestants|nasal decongestants|mesh-ancestor
139303782|NCT00673062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139303783|NCT00673062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139303784|NCT00673062|Sympathomimetics|sympathomimetics|mesh-ancestor
139303785|NCT00673062|Adrenergic Agents|adrenergic agents|mesh-ancestor
139303786|NCT00673062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303787|NCT00673062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303788|NCT03559803|Cisplatin|cisplatin|mesh-list
139303789|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303790|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
139303791|NCT03439358|Analgesics|analgesics|mesh-ancestor
139303792|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
139303793|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303794|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303795|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
139303796|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303797|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139303798|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
139303799|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139303800|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139303801|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303802|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139303803|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
139303804|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139303805|NCT02072031|Sunitinib|sunitinib|mesh-list
139303806|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303807|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139303808|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139303809|NCT02072031|Growth Substances|growth substances|mesh-ancestor
139303810|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303811|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
139303812|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139303813|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303814|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303815|NCT05616442|Vitamin E|vitamin e|mesh-list
139303816|NCT05616442|Ketotifen|ketotifen|mesh-list
139303817|NCT05616442|Vitamins|vitamins|mesh-ancestor
139303818|NCT05616442|Micronutrients|micronutrients|mesh-ancestor
139303819|NCT05616442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303820|NCT05616442|Antioxidants|antioxidants|mesh-ancestor
139303821|NCT05616442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303822|NCT05616442|Protective Agents|protective agents|mesh-ancestor
139303823|NCT05616442|Antipruritics|antipruritics|mesh-ancestor
139303824|NCT05616442|Dermatologic Agents|dermatologic agents|mesh-ancestor
139303825|NCT05616442|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139303826|NCT05616442|Histamine Antagonists|histamine antagonists|mesh-ancestor
139303827|NCT05616442|Histamine Agents|histamine agents|mesh-ancestor
139303828|NCT05616442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303829|NCT05616442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139303830|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139303831|NCT02065401|Antacids|antacids|mesh-ancestor
139303832|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303834|NCT00620256|Timolol|timolol|mesh-list
139303835|NCT00620256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139303836|NCT00620256|Latanoprost|latanoprost|mesh-list
139303837|NCT00620256|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139303838|NCT00620256|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139303839|NCT00620256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139303840|NCT00620256|Adrenergic Agents|adrenergic agents|mesh-ancestor
139303841|NCT00620256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303842|NCT00620256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303843|NCT00620256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303844|NCT00620256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139303845|NCT00620256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139303847|NCT04805710|Clopidogrel|clopidogrel|mesh-list
139303848|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139303849|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139303850|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139303851|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139303852|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
139303853|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139303854|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303855|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303856|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139303857|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
139303858|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139303859|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
139303860|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303861|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
139303862|NCT02076477|Docetaxel|docetaxel|mesh-list
139303863|NCT02076477|Pemetrexed|pemetrexed|mesh-list
139303864|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303865|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
139303866|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
139303867|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
139303868|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303869|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303870|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139303871|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139303872|NCT04472832|Mitapivat|mitapivat|mesh-list
139303873|NCT04472832|Enzyme Activators|enzyme activators|mesh-ancestor
139303874|NCT04472832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303875|NCT04879550|Antithrombins|antithrombins|mesh-list
139303876|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
139303877|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139303878|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
139303879|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303880|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303881|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
139303882|NCT00613002|Testosterone|testosterone|mesh-list
139303883|NCT00613002|Androgens|androgens|mesh-ancestor
139303884|NCT00613002|Hormones|hormones|mesh-ancestor
139303885|NCT00613002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139303886|NCT00613002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303887|NCT02076945|Lidocaine|lidocaine|mesh-list
139303888|NCT02076945|Bupivacaine|bupivacaine|mesh-list
139303889|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
139303890|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
139303891|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303892|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303893|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
139303894|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303895|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139091695|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091697|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091698|NCT04348045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139091699|NCT04348045|Immunologic Factors|immunologic factors|mesh-ancestor
139091700|NCT04348045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091701|NCT04348045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139091702|NCT04348045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139091703|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091704|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091705|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139091706|NCT04277637|Obinutuzumab|obinutuzumab|mesh-list
139086473|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139174307|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
139086474|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139086475|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086476|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086478|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086479|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139086480|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139086481|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139086482|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139086483|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086484|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
139086485|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086486|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086487|NCT01144676|Dapivirine|dapivirine|mesh-list
139086488|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139086489|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139086490|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
139086491|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086492|NCT00316199|Paclitaxel|paclitaxel|mesh-list
139086493|NCT00316199|Gemcitabine|gemcitabine|mesh-list
139086494|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139086495|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086496|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
139086497|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
139086498|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
139086499|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086500|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139086501|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
139086502|NCT01147718|Digoxin|digoxin|mesh-list
139086503|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
139086504|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139086505|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139086506|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086507|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086508|NCT01147718|Protective Agents|protective agents|mesh-ancestor
139086509|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086510|NCT01147718|Incretins|incretins|mesh-ancestor
139086511|NCT01147718|Hormones|hormones|mesh-ancestor
139086512|NCT01147718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139086513|NCT03913052|Viscosupplements|viscosupplements|mesh-list
139086514|NCT03913052|Protective Agents|protective agents|mesh-ancestor
139086515|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086516|NCT03915938|Ketamine|ketamine|mesh-list
139086517|NCT03915938|Analgesics|analgesics|mesh-ancestor
139086518|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
139086519|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086520|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086521|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139086522|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139086523|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
139086524|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
139086525|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086526|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139086527|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139086528|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086529|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086530|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139086531|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
139086532|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086533|NCT01251458|Temsirolimus|temsirolimus|mesh-list
139086534|NCT01251458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139086535|NCT01251458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139086536|NCT01251458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086537|NCT01251458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086538|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139086539|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
139086540|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086541|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086542|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
139086543|NCT03912740|Remifentanil|remifentanil|mesh-list
139086544|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139086545|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086546|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086547|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139086549|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
139086550|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086551|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139086552|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139086553|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139086554|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
139086555|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086556|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086557|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139086558|NCT03912740|Narcotics|narcotics|mesh-ancestor
139086559|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139086560|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139086561|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139086562|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
139086563|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086564|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139086565|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139086566|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086567|NCT01144754|Rituximab|rituximab|mesh-list
139086568|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139086569|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086570|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
139086571|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086572|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139086573|NCT01144832|Ebastine|ebastine|mesh-list
139086574|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139086575|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
139086576|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
139086577|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086578|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086579|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086580|NCT01251848|Ritonavir|ritonavir|mesh-list
139086581|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
139086582|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139086583|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139086584|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
139086585|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086586|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086587|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139086588|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139086589|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
139086590|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086591|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139086592|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139086593|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139086594|NCT01251926|Bevacizumab|bevacizumab|mesh-list
139086595|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139086596|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086597|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139086598|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139086599|NCT01251926|Growth Substances|growth substances|mesh-ancestor
139086600|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086601|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
139086602|NCT03911648|Lidocaine|lidocaine|mesh-list
139086603|NCT03911648|Bupivacaine|bupivacaine|mesh-list
139086604|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
139086605|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
139086606|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086607|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086608|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
139086609|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086610|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139086611|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139086612|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139086613|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139086614|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086615|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139086616|NCT01237730|Cefuroxime|cefuroxime|mesh-list
139086617|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
139086618|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086619|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139086621|NCT01252160|Capsaicin|capsaicin|mesh-list
139086622|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
139086623|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
139086624|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
139086625|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086626|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086627|NCT00337103|Capecitabine|capecitabine|mesh-list
139086628|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139086629|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
139086630|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086631|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086632|NCT03911570|Acetaminophen|acetaminophen|mesh-list
139086633|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139086634|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139086635|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139086636|NCT03911570|Analgesics|analgesics|mesh-ancestor
139086637|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
139086638|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086639|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086640|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
139086641|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139086642|NCT01250366|Ribavirin|ribavirin|mesh-list
139086643|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
139086644|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086645|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
139086646|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086647|NCT00075504|Gemcitabine|gemcitabine|mesh-list
139086648|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139086649|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
139086650|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086651|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086652|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
139086653|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139086654|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139086655|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
139086656|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086657|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086658|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086659|NCT01092624|Urological Agents|urological agents|mesh-ancestor
139086660|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
139086661|NCT00321464|Denosumab|denosumab|mesh-list
139086662|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139086663|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086664|NCT02889796|Adalimumab|adalimumab|mesh-list
139086665|NCT02889796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139086666|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139086667|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139086668|NCT01237808|Cytarabine|cytarabine|mesh-list
139086669|NCT01237808|Etoposide|etoposide|mesh-list
139086670|NCT01237808|Tretinoin|tretinoin|mesh-list
139086671|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139086672|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086673|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139086674|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139086675|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086676|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086677|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139086678|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
139086679|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
139086680|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086681|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139086682|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
139086683|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071614|NCT04131556|Maribavir|maribavir|mesh-list
139086684|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
139086685|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
139086686|NCT03910634|Carboplatin|carboplatin|mesh-list
139086687|NCT03910634|Fluorouracil|fluorouracil|mesh-list
139086688|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086689|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
139086690|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086691|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139086692|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139086693|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
139086694|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086695|NCT03910712|Trastuzumab|trastuzumab|mesh-list
139086696|NCT03910712|Letrozole|letrozole|mesh-list
139086697|NCT03910712|Anastrozole|anastrozole|mesh-list
139086698|NCT03910712|Exemestane|exemestane|mesh-list
139086699|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139086700|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139086701|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086702|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139086703|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086704|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086705|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139086706|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
139086707|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139086708|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086709|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139086710|NCT03910556|Propofol|propofol|mesh-list
139086711|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139086712|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086713|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086714|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139086715|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
139086716|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
139086717|NCT03659578|Thymalfasin|thymalfasin|mesh-list
139086718|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139086719|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
139086720|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086721|NCT02889562|Warfarin|warfarin|mesh-list
139086722|NCT02889562|Apixaban|apixaban|mesh-list
139086723|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
139086724|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139086725|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
139086726|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139086727|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
139086728|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086729|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086730|NCT03323164|Timolol|timolol|mesh-list
139086731|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139086732|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086733|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139086734|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139086735|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
139086736|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086737|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086738|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139086739|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139086740|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139086741|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139086742|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139086743|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
139086744|NCT03914690|Hematinics|hematinics|mesh-ancestor
139086745|NCT03914534|Valproic Acid|valproic acid|mesh-list
139086746|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
139086747|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086748|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086749|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
139086750|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086751|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086752|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
139086753|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139086754|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086755|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139086756|NCT03910088|Acetaminophen|acetaminophen|mesh-list
139086757|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
139086758|NCT03910088|Diclofenac|diclofenac|mesh-list
139086759|NCT03910088|Pregabalin|pregabalin|mesh-list
139086760|NCT03910088|Caffeine|caffeine|mesh-list
139086761|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139086762|NCT03910088|Analgesics|analgesics|mesh-ancestor
139086763|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
139086764|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086765|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086766|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
139086767|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
139086768|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139086769|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139086770|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086771|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138837340|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139086772|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139086773|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139086774|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086775|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139086776|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139086777|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139086778|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139086779|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086780|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139086781|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139086782|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
139086783|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086784|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139086785|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139086786|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139086787|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139086788|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139086789|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086790|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139086792|NCT03610438|Immunoconjugates|immunoconjugates|mesh-ancestor
139086793|NCT03610438|Immunologic Factors|immunologic factors|mesh-ancestor
139086794|NCT03610438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086796|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086797|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
139086798|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
139086799|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
139086800|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086801|NCT05617664|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139086802|NCT05617664|Mirabegron|mirabegron|mesh-list
139086803|NCT05617664|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139086804|NCT05617664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139086805|NCT05617664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139086806|NCT05617664|Adrenergic Agents|adrenergic agents|mesh-ancestor
139086807|NCT05617664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086808|NCT05617664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071631|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086809|NCT05617664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086810|NCT05617664|Urological Agents|urological agents|mesh-ancestor
139086811|NCT05617664|Hemostatics|hemostatics|mesh-ancestor
139086812|NCT05617664|Coagulants|coagulants|mesh-ancestor
139086813|NCT05617664|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139086814|NCT05617664|Natriuretic Agents|natriuretic agents|mesh-ancestor
139086815|NCT03909776|Cisplatin|cisplatin|mesh-list
139086816|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086817|NCT01148264|Olanzapine|olanzapine|mesh-list
139086818|NCT01148264|Metoclopramide|metoclopramide|mesh-list
139086819|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
139086820|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
139086821|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086822|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086823|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139086824|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139086825|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139086826|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086827|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139086828|NCT01148264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139086829|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139086830|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139086831|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086832|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086833|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
139086834|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139086835|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139086836|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
139086837|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139086838|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139086839|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086840|NCT00086580|Vidarabine|vidarabine|mesh-list
139086841|NCT00086580|Fludarabine|fludarabine|mesh-list
139086842|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
139086843|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
139086844|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086845|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138837418|NCT04775329|Rifaximin|rifaximin|mesh-list
139086847|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086849|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
139086850|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086851|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
139086852|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086853|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139086854|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
139086855|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
139086856|NCT03908528|Doxorubicin|doxorubicin|mesh-list
139086857|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139086858|NCT03908528|Paclitaxel|paclitaxel|mesh-list
139086859|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139086860|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139086861|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
139086862|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086863|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139086864|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139086865|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
139086866|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086867|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086868|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139086869|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139086870|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139086871|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139086872|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086873|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139086874|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
139086875|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
139086876|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
139086877|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
139086878|NCT03908528|Protective Agents|protective agents|mesh-ancestor
139086879|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
139086880|NCT03908528|Vitamins|vitamins|mesh-ancestor
139086881|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
139086882|NCT03903458|Nivolumab|nivolumab|mesh-list
139086883|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139086884|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086885|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139086886|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086887|NCT00086502|Metformin|metformin|mesh-list
139086888|NCT00086502|Pioglitazone|pioglitazone|mesh-list
139086889|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139086890|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139086891|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086892|NCT00086502|Incretins|incretins|mesh-ancestor
139086893|NCT00086502|Hormones|hormones|mesh-ancestor
139086894|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139086895|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139086896|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
139086897|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086898|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086899|NCT03903302|Valproic Acid|valproic acid|mesh-list
139086900|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
139086901|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086902|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086903|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
139086904|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086905|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086906|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
139086907|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139086908|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086909|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139086910|NCT03636542|Bupivacaine|bupivacaine|mesh-list
139086911|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
139086912|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
139086913|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086914|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086915|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
139086916|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086917|NCT00086190|Paroxetine|paroxetine|mesh-list
139086918|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138837497|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139086919|NCT00086190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139091707|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
139086920|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139086921|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139086922|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086923|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086924|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
139086925|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086926|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139086927|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
139086928|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139086929|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139086930|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139086931|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086932|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139086933|NCT03275350|Naltrexone|naltrexone|mesh-list
139086934|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139086935|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139086936|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086937|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
139086938|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086939|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139086940|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
139086941|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086942|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139086943|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
139086944|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086945|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086946|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139086947|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139086948|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139086949|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
139086950|NCT03557242|Aspirin|aspirin|mesh-list
139086951|NCT03557242|Warfarin|warfarin|mesh-list
139086952|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139086953|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139086954|NCT03557242|Analgesics|analgesics|mesh-ancestor
139086955|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
139086956|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086957|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086958|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139086959|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139086960|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139086961|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139086962|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086963|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139086964|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139086965|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086966|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
139086967|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
139086968|NCT04774666|Antibodies|antibodies|mesh-list
139086969|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
139086970|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086971|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139086972|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139086973|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139086974|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086975|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086976|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139086977|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139086978|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139086979|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
139086980|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086981|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086982|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139086983|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139086984|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
139086985|NCT03898466|Fluticasone|fluticasone|mesh-list
139086986|NCT03898466|Xhance|xhance|mesh-list
139086987|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139086988|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139086989|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
139174377|NCT03904849|Cannabidiol|cannabidiol|mesh-list
139086990|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086991|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086992|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139086993|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
139086994|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
139086995|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139086997|NCT02527772|Gemcitabine|gemcitabine|mesh-list
139086998|NCT02527772|Fluorouracil|fluorouracil|mesh-list
139086999|NCT02527772|Doxorubicin|doxorubicin|mesh-list
139087000|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139087001|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
139087002|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139087003|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
139087004|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087005|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087006|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139087007|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139087008|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139087009|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087010|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139087011|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
139087012|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087013|NCT02527772|Antidotes|antidotes|mesh-ancestor
139087014|NCT02527772|Protective Agents|protective agents|mesh-ancestor
139087015|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
139087016|NCT02527772|Vitamins|vitamins|mesh-ancestor
139087017|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
139087018|NCT03273946|Fluticasone|fluticasone|mesh-list
139087019|NCT03273946|Xhance|xhance|mesh-list
139087020|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139087021|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139087022|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
139087023|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087024|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087025|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139087026|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
139087027|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
139087028|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139087029|NCT00660218|Paclitaxel|paclitaxel|mesh-list
139087030|NCT00660218|Cetuximab|cetuximab|mesh-list
139087031|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
139087032|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139087033|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087034|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
139087035|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
139087036|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
139071704|NCT01078142|Temsirolimus|temsirolimus|mesh-list
139087037|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087038|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139087039|NCT00314951|Vancomycin|vancomycin|mesh-list
139087040|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
139087041|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139087042|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087043|NCT00085644|Adalimumab|adalimumab|mesh-list
139087044|NCT00085644|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139087045|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139087046|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139087047|NCT01257074|Acyclovir|acyclovir|mesh-list
139087048|NCT01257074|Penciclovir|penciclovir|mesh-list
139087049|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
139087050|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087051|NCT01149278|Benzocaine|benzocaine|mesh-list
139087052|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
139087053|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
139087054|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139087055|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087056|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
139087057|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087058|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139087059|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
139087060|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139087062|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139087063|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139087064|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087065|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139087066|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139087067|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
139087068|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087069|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
139087070|NCT01092858|Testosterone|testosterone|mesh-list
139087071|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
139087072|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
139087073|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139087074|NCT01092858|Androgens|androgens|mesh-ancestor
139087075|NCT01092858|Hormones|hormones|mesh-ancestor
139087076|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139087077|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087078|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139087079|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087080|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
139087081|NCT00314327|Risperidone|risperidone|mesh-list
139087082|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139087083|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
139087084|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087085|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087086|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087087|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139087088|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139087089|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139087090|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139087091|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139087092|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
139087093|NCT03897452|Fentanyl|fentanyl|mesh-list
139087094|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139087095|NCT03897452|Narcotics|narcotics|mesh-ancestor
139087096|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139087097|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087098|NCT03897452|Analgesics|analgesics|mesh-ancestor
139087099|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
139087100|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087101|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139087102|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139087103|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
139087104|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
139087105|NCT01151072|Insulin|insulin|mesh-list
139087106|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139087107|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087108|NCT01257386|Mesalamine|mesalamine|mesh-list
139087109|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139087110|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139087111|NCT01257386|Analgesics|analgesics|mesh-ancestor
139087112|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
139087113|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174425|NCT02892604|Insulin|insulin|mesh-list
139087114|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087115|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139087116|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139087117|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139087118|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139087119|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139087120|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087121|NCT01257464|Incretins|incretins|mesh-ancestor
139087122|NCT01257464|Hormones|hormones|mesh-ancestor
139087123|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139087124|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
139087125|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087126|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087127|NCT01255046|Donepezil|donepezil|mesh-list
139087128|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139087129|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087130|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087131|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
139087132|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087133|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087134|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
139087135|NCT01149356|Exemestane|exemestane|mesh-list
139087136|NCT01149356|Goserelin|goserelin|mesh-list
139087137|NCT01149356|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139087138|NCT01149356|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139087139|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087140|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139087141|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139087142|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087143|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087144|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138837741|NCT00862719|Hormones|hormones|mesh-ancestor
139087145|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
139087146|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139087147|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087148|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139087150|NCT01148576|Entecavir|entecavir|mesh-list
139087151|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
139087152|NCT01148576|Vitamins|vitamins|mesh-ancestor
139087153|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
139087154|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087155|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
139087156|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087157|NCT01148576|Protective Agents|protective agents|mesh-ancestor
139087158|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
139087159|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087160|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139087161|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
139087162|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139087163|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139087164|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
139087165|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139087166|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139087167|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
139087168|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139087169|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139087170|NCT03905486|Pregabalin|pregabalin|mesh-list
139087171|NCT03905486|Analgesics|analgesics|mesh-ancestor
139087172|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
139087173|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087174|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087175|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
139087176|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139087177|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087178|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087179|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139087180|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139174429|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
139087181|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139087182|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139087183|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139087185|NCT03901118|Etoposide|etoposide|mesh-list
139087186|NCT03901118|Chiauranib|chiauranib|mesh-list
139087187|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139087188|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087189|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
139087190|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
139087191|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
139087192|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087193|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139087194|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139087195|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087196|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139087197|NCT03895892|Caffeine|caffeine|mesh-list
139087198|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139087199|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087200|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139087201|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087202|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087203|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139087204|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139087205|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
139087206|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087207|NCT01151306|Simvastatin|simvastatin|mesh-list
139087208|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139087209|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139087210|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
139087211|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087212|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139087213|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139087214|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087215|NCT05570786|Gestrinone|gestrinone|mesh-list
139087216|NCT05570786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139087217|NCT05570786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139087218|NCT05570786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139087219|NCT05570786|Contraceptive Agents|contraceptive agents|mesh-ancestor
139087220|NCT05570786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139087221|NCT05570786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087222|NCT05570786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139087223|NCT05570786|Progestins|progestins|mesh-ancestor
139087225|NCT05570786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139087226|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
139087227|NCT03895970|Lenvatinib|lenvatinib|mesh-list
139087228|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139087229|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087230|NCT03895970|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139087231|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087232|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139087233|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087234|NCT00336479|Interferons|interferons|mesh-list
139087235|NCT00336479|Ribavirin|ribavirin|mesh-list
139087236|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
139087237|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
139087238|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139087239|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087240|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
139087241|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087242|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
139087243|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087244|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
139087245|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087246|NCT03905564|Pyridoxine|pyridoxine|mesh-list
139087247|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
139087248|NCT03905564|Doxylamine|doxylamine|mesh-list
139174434|NCT03103100|Lidocaine|lidocaine|mesh-list
139087249|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
139087250|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
139087251|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
139087253|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
139087254|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087255|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
139087256|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
139087257|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087258|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139087259|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139087260|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
139087261|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
139087262|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087263|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087264|NCT01151384|Docetaxel|docetaxel|mesh-list
139087265|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087266|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
139087267|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
139087268|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
139087269|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087270|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
139087271|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139087272|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139087273|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087274|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
139087275|NCT01258010|Coagulants|coagulants|mesh-ancestor
139087276|NCT00314249|Milnacipran|milnacipran|mesh-list
139087277|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
139087278|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139087279|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139087280|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087281|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087282|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087283|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071877|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
139087284|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139087285|NCT00314249|Analgesics|analgesics|mesh-ancestor
139087286|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
139087287|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087288|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
139087289|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139087290|NCT03905018|Tadalafil|tadalafil|mesh-list
139087291|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
138837871|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087292|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139087293|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139087294|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087295|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087296|NCT03905018|Urological Agents|urological agents|mesh-ancestor
139087297|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
139087298|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139087299|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087300|NCT03894800|Fentanyl|fentanyl|mesh-list
139087301|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
139087302|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139087303|NCT03894800|Narcotics|narcotics|mesh-ancestor
139087304|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139087305|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087306|NCT03894800|Analgesics|analgesics|mesh-ancestor
139087307|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
139087308|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087309|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139087310|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139087311|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
139087312|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
139087313|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139087314|NCT03900026|Evolocumab|evolocumab|mesh-list
139087315|NCT03900026|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139087316|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139087317|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139087318|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
139087319|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087320|NCT03900026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139087321|NCT03900026|Protease Inhibitors|protease inhibitors|mesh-ancestor
139087322|NCT03900026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087323|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139087324|NCT01149668|Abexinostat|abexinostat|mesh-list
139087325|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139087326|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087327|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087329|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139087330|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139087331|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139087332|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
139087333|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087334|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087335|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087336|NCT01149746|Urological Agents|urological agents|mesh-ancestor
139087337|NCT01149824|Salvinorin A|salvinorin a|mesh-list
139087338|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
139087339|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087340|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139087341|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
139087342|NCT01149902|Docetaxel|docetaxel|mesh-list
139087343|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139087344|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
139087345|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087346|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139087347|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139087348|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
139087349|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087350|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087351|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139087352|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
139087353|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
139087354|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
139087355|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
139087356|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
139087357|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
139087358|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139087359|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
139087360|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
139087361|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087362|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087363|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087364|NCT01149980|Dexetimide|dexetimide|mesh-list
139087365|NCT01149980|Citalopram|citalopram|mesh-list
139087366|NCT01149980|Escitalopram|escitalopram|mesh-list
139087367|NCT01149980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139087368|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139087369|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087370|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087371|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087373|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087374|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139087375|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
139087376|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139087377|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139087378|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139087379|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
139087380|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
139087381|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087382|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139087383|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139087384|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
139087385|NCT01258322|Pioglitazone|pioglitazone|mesh-list
139087387|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087388|NCT01255358|Dexamethasone|dexamethasone|mesh-list
139087389|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
139087390|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139087391|NCT01255358|BB 1101|bb 1101|mesh-list
139087392|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139087393|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
139087394|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
139087395|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087396|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087397|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139087398|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
139087399|NCT01255358|Hormones|hormones|mesh-ancestor
139087400|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139087401|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139087402|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087403|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
139087404|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087405|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087406|NCT03899246|Capsaicin|capsaicin|mesh-list
139087407|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
139087408|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
139087409|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
139087410|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087411|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087412|NCT03893864|Ubiquinone|ubiquinone|mesh-list
139087413|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
139087414|NCT03893864|Antioxidants|antioxidants|mesh-list
139087415|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087416|NCT03893864|Protective Agents|protective agents|mesh-ancestor
139087417|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087418|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
139087419|NCT03893864|Vitamins|vitamins|mesh-ancestor
139087420|NCT03899324|Bumetanide|bumetanide|mesh-list
139087421|NCT03899324|Diuretics|diuretics|mesh-ancestor
139087422|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
139087423|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087424|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139087425|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087426|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087427|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139087428|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139087429|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
139087430|NCT01258634|Leucovorin|leucovorin|mesh-list
139087431|NCT01258634|Doxorubicin|doxorubicin|mesh-list
139087432|NCT01258634|Etoposide|etoposide|mesh-list
139087433|NCT01258634|Ifosfamide|ifosfamide|mesh-list
139087434|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
139087435|NCT01258634|Razoxane|razoxane|mesh-list
139087436|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087437|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139087438|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139087439|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139087440|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087441|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087442|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139087443|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087444|NCT01258634|Antidotes|antidotes|mesh-ancestor
139087445|NCT01258634|Protective Agents|protective agents|mesh-ancestor
139087446|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
139087447|NCT01258634|Vitamins|vitamins|mesh-ancestor
139087449|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139087451|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139087452|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
139087453|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
139087454|NCT01258712|Methotrexate|methotrexate|mesh-list
139087455|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139087456|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
139087457|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139087458|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087459|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139087460|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
139087461|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087462|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087463|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
139087464|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087465|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139087466|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139087467|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
139087468|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139087469|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139087470|NCT01258868|Celecoxib|celecoxib|mesh-list
139087471|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139087472|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139087473|NCT01258868|Analgesics|analgesics|mesh-ancestor
139087474|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
139087475|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087476|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087477|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139087478|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139087479|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139087480|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139087481|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087482|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087483|NCT01254578|Lenalidomide|lenalidomide|mesh-list
139087484|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
139087485|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087486|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139087487|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139087488|NCT01254578|Growth Substances|growth substances|mesh-ancestor
139087489|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
139087490|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087491|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
139087492|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139087493|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087494|NCT03341806|Avelumab|avelumab|mesh-list
139087495|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139087496|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087497|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
139087498|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139087499|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087500|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087501|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
139087502|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087503|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087504|NCT01149122|Gemcitabine|gemcitabine|mesh-list
139087505|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
139087506|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139087507|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139087508|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
139087509|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087510|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087511|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139087512|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087513|NCT01152398|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139087514|NCT01152398|Antiviral Agents|antiviral agents|mesh-ancestor
139087515|NCT01152398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087516|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139087518|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139087520|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
139087521|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707623|NCT04679064|Paclitaxel|paclitaxel|mesh-list
139087522|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139087523|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087524|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087525|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139087526|NCT01152476|Remifentanil|remifentanil|mesh-list
139087527|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139087528|NCT01152476|Narcotics|narcotics|mesh-ancestor
139087529|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139087530|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087531|NCT01152476|Analgesics|analgesics|mesh-ancestor
139087532|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
139087533|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087534|NCT03892070|Mannitol|mannitol|mesh-list
139087535|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139087536|NCT03892070|Diuretics|diuretics|mesh-ancestor
139087537|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
139087538|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087539|NCT01155440|Lidocaine|lidocaine|mesh-list
139087540|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
139087541|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
139087542|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139072033|NCT00095238|Irbesartan|irbesartan|mesh-list
139087543|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087544|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
139087545|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087546|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139087547|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139087548|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139087549|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087550|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087551|NCT01259336|Itraconazole|itraconazole|mesh-list
139087552|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
139087553|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087554|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139087555|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139087556|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087557|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087558|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139087559|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
139087560|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139087561|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087562|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139087563|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
139087564|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087565|NCT03314662|Vaccines|vaccines|mesh-list
139087566|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
139087567|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
139087568|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087569|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139087570|NCT01152710|Capecitabine|capecitabine|mesh-list
139087571|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139087572|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
139072042|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139087573|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087574|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087575|NCT03271528|Lacosamide|lacosamide|mesh-list
139087576|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
139087577|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139087578|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139087579|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087580|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087581|NCT04480372|Gemcitabine|gemcitabine|mesh-list
139087582|NCT04480372|Atezolizumab|atezolizumab|mesh-list
139087583|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139087584|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
139087585|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087586|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087587|NCT04480372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139087588|NCT04480372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139087589|NCT04462276|Atezolizumab|atezolizumab|mesh-list
138838179|NCT02863913|Interleukin-2|interleukin-2|mesh-list
139087591|NCT04462276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087592|NCT04462276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139087593|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087595|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139087596|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087597|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139087598|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139087599|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087600|NCT01153568|Vitamin D|vitamin d|mesh-list
139087601|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
139087602|NCT01153568|Vitamins|vitamins|mesh-ancestor
139087603|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
139087604|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087605|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139087606|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139087607|NCT03889808|Antitoxins|antitoxins|mesh-list
139087608|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
139087609|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087610|NCT03890042|Dienogest|dienogest|mesh-list
139087611|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139087612|NCT03890042|Gestodene|gestodene|mesh-list
139087613|NCT03890042|Femovan|femovan|mesh-list
139087614|NCT03890042|Estradiol|estradiol|mesh-list
139087615|NCT03890042|Estrogens|estrogens|mesh-ancestor
139087616|NCT03890042|Hormones|hormones|mesh-ancestor
139087617|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139087618|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087619|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139087620|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
139087621|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139087622|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139087623|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139087624|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139087625|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139087626|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
139087627|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139087628|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087629|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139087630|NCT03890042|Progestins|progestins|mesh-ancestor
139087631|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139087632|NCT01153802|Dopamine|dopamine|mesh-list
139087633|NCT01153802|Norepinephrine|norepinephrine|mesh-list
139087634|NCT01153802|Serotonin|serotonin|mesh-list
139087635|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
139087636|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139087637|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139087638|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
139087639|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087640|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087641|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
139087642|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
139087643|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087644|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139087645|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139087646|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
139087647|NCT01153802|Protective Agents|protective agents|mesh-ancestor
139087648|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139087649|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
139087650|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
139087651|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139087652|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087653|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
139087654|NCT01153256|Analgesics|analgesics|mesh-ancestor
139087655|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
139087656|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087657|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087658|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
139087659|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139072130|NCT00069108|Vitamins|vitamins|mesh-ancestor
139087660|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139087661|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
139087662|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139087663|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087664|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087665|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139087666|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
139087667|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139087668|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139087669|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139087670|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139087671|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
139087672|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087673|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139087674|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139087675|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087676|NCT01259804|Immunomodulating Agents|immunomodulating agents|mesh-list
139087677|NCT01259804|Immunologic Factors|immunologic factors|mesh-ancestor
139087678|NCT01259804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087680|NCT01153880|Retapamulin|retapamulin|mesh-list
139087681|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139087682|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087683|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139087684|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087685|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087686|NCT01260506|Bevacizumab|bevacizumab|mesh-list
139087687|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139087688|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087689|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139087690|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139087691|NCT01260506|Growth Substances|growth substances|mesh-ancestor
139087692|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087693|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
139087694|NCT01154114|Darapladib|darapladib|mesh-list
139087695|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
139087696|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087697|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087698|NCT01157312|Citric Acid|citric acid|mesh-list
139087699|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
139087700|NCT01157312|Clomiphene|clomiphene|mesh-list
139087701|NCT01157312|Enclomiphene|enclomiphene|mesh-list
139087702|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
139087703|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
139087704|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139087705|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
139087706|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
139087707|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087708|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139087709|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
139087710|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139087711|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087712|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139087713|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
139087714|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139087715|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138960794|NCT00776828|Cilostazol|cilostazol|mesh-list
139087716|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139087717|NCT01157546|Lidocaine|lidocaine|mesh-list
139087718|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
139087719|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
139087720|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139087721|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087722|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
139087723|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087724|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139087725|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139087726|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139087727|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087728|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087729|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139087730|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139087731|NCT01263860|Ribavirin|ribavirin|mesh-list
139087732|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139087733|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
139087734|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
139087735|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087736|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
139087737|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087738|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
139087739|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087740|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
139087741|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087742|NCT01154348|Metformin|metformin|mesh-list
139087743|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139087744|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087745|NCT00075270|Paclitaxel|paclitaxel|mesh-list
139087746|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139087747|NCT00075270|Lapatinib|lapatinib|mesh-list
139087748|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139087749|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087750|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
139087751|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
139087752|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
139087753|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087754|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139087755|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087756|NCT01264094|Clevudine|clevudine|mesh-list
139087757|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
139087758|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087759|NCT03884348|Amoxicillin|amoxicillin|mesh-list
139087760|NCT03884348|Metronidazole|metronidazole|mesh-list
139087761|NCT03884348|Clarithromycin|clarithromycin|mesh-list
139087762|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139087763|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139087764|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087765|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139087766|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139087767|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139087768|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087769|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087770|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139087771|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139087772|NCT01154426|Gemcitabine|gemcitabine|mesh-list
139087773|NCT01154426|Veliparib|veliparib|mesh-list
139087774|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139087775|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
139087776|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087777|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087778|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139087779|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087780|NCT01589744|Hemostatics|hemostatics|mesh-list
139087781|NCT01589744|Coagulants|coagulants|mesh-ancestor
139087782|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
139087783|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139087784|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139087785|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
139087786|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072199|NCT00409331|Amifostine|amifostine|mesh-list
139087787|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087788|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139087789|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
139087790|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139087791|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
139087792|NCT01154504|Protective Agents|protective agents|mesh-ancestor
139087793|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139087794|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139087795|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139087796|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087797|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087798|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087799|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087800|NCT03880916|Analgesics|analgesics|mesh-ancestor
139087801|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
139087802|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087803|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
139087804|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139087805|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
139087806|NCT01155908|Amlodipine|amlodipine|mesh-list
139087807|NCT01155908|Benazepril|benazepril|mesh-list
139087808|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139087809|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139087810|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087811|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087812|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139087813|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087814|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
139087815|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139087816|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
139087817|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087819|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087820|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139087822|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139087823|NCT03887858|Tamsulosin|tamsulosin|mesh-list
139087824|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139087825|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139087826|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139087827|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
139087828|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087829|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087830|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087831|NCT03887858|Urological Agents|urological agents|mesh-ancestor
139087832|NCT02940574|Oxytocin|oxytocin|mesh-list
139087833|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
139087834|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139087835|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087836|NCT01264328|Paclitaxel|paclitaxel|mesh-list
139087837|NCT01264328|Panitumumab|panitumumab|mesh-list
139087838|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139087839|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087840|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
139087841|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
139087842|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
139087843|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087844|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139087845|NCT01157858|Everolimus|everolimus|mesh-list
139087846|NCT01157858|Octreotide|octreotide|mesh-list
139087847|NCT01157858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139087848|NCT01157858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139087849|NCT01157858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174506|NCT03718806|Zoliflodacin|zoliflodacin|mesh-list
139174507|NCT03718806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139174508|NCT03718806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139174509|NCT03718806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174510|NCT03718806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655884|NCT00346827|Emetics|emetics|mesh-ancestor
139087850|NCT01157858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087851|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139087852|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
139087853|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087854|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087855|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139087856|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139087857|NCT01157936|Allopurinol|allopurinol|mesh-list
139087858|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
139087859|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087860|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087861|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
139087862|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139087863|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139087864|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
139087865|NCT01157936|Protective Agents|protective agents|mesh-ancestor
139087866|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087867|NCT01264484|Imidacloprid|imidacloprid|mesh-list
139087868|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
139087869|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087870|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087871|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087872|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
139087873|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139087874|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139087875|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087876|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
139087877|NCT01260818|Coagulants|coagulants|mesh-ancestor
139087878|NCT01262612|Cediranib|cediranib|mesh-list
139087879|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087880|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139087881|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087882|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087883|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139087884|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
139087885|NCT01158014|Coagulants|coagulants|mesh-ancestor
138838471|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087886|NCT03884036|Vitamin D|vitamin d|mesh-list
139087887|NCT03884036|Vitamins|vitamins|mesh-ancestor
139087888|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
139087889|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087890|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139087891|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139087892|NCT01158170|Gefitinib|gefitinib|mesh-list
138708010|NCT00538811|Interferons|interferons|mesh-list
139087893|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087894|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139087896|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087897|NCT01260974|Caspofungin|caspofungin|mesh-list
139087898|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
139087899|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139087900|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087901|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087902|NCT01264640|Aspirin|aspirin|mesh-list
139087903|NCT01264640|Clopidogrel|clopidogrel|mesh-list
139087904|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139087905|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139087906|NCT01264640|Analgesics|analgesics|mesh-ancestor
139087907|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
139087908|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087909|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087910|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139087911|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139087912|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139087913|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139087914|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174512|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
139087915|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139087916|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139087917|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087918|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
139087919|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139087920|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139087921|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139087922|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
139087923|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087924|NCT01155986|Lidocaine|lidocaine|mesh-list
139087925|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
139087926|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
139087927|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139087928|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087929|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
139087930|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087931|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139087932|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139087933|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139087934|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087935|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087936|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139087937|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139087938|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
139087939|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087940|NCT01261130|Antacids|antacids|mesh-ancestor
139087941|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087942|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139087943|NCT01158248|Panitumumab|panitumumab|mesh-list
139087944|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139087945|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139087946|NCT01264874|Vitamin D|vitamin d|mesh-list
139087947|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
139087948|NCT01264874|Vitamins|vitamins|mesh-ancestor
139087949|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
139087950|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087951|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139087952|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139087953|NCT01262924|Vaccines|vaccines|mesh-list
139087954|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
139087955|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087956|NCT01158560|Vitamin D|vitamin d|mesh-list
139087957|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
139087958|NCT01158560|Vitamins|vitamins|mesh-ancestor
139087959|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
139087960|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087961|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139087962|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139087963|NCT03879746|Paroxetine|paroxetine|mesh-list
139087964|NCT03879746|Tamsulosin|tamsulosin|mesh-list
139087965|NCT03879746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138708080|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139087966|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139087967|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139087968|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087969|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139087970|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
139087971|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087972|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139087973|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
139087974|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139087975|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139087976|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139087977|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087978|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139087979|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139087980|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139087981|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
139087982|NCT03879746|Urological Agents|urological agents|mesh-ancestor
139087983|NCT03879590|Budesonide|budesonide|mesh-list
139087984|NCT03879590|Doxofylline|doxofylline|mesh-list
139087985|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139087986|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139087987|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
139087988|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139087989|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139087990|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139087991|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
139087992|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
139087993|NCT03879590|Hormones|hormones|mesh-ancestor
139087994|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139087995|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
139087996|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139087997|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139087998|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139087999|NCT01265108|Iron|iron|mesh-list
139088000|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139088001|NCT01265108|Trace Elements|trace elements|mesh-ancestor
139088002|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
139088003|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088004|NCT01265108|Hematinics|hematinics|mesh-ancestor
139088005|NCT01154738|Lidocaine|lidocaine|mesh-list
139088006|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
139088007|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
139088008|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139088009|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088010|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
139088011|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088012|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139088013|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139088014|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139088015|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139088016|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088017|NCT01263002|Adefovir|adefovir|mesh-list
139088018|NCT01263002|Clevudine|clevudine|mesh-list
139088019|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
139088020|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088021|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139088022|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139088023|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088024|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088025|NCT01261286|Verapamil|verapamil|mesh-list
139088026|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139088027|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139088028|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139088029|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088030|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139088031|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088032|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
139088033|NCT01263080|Folic Acid|folic acid|mesh-list
139088034|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
139088035|NCT01263080|Mirtazapine|mirtazapine|mesh-list
139088036|NCT01263080|Vitamins|vitamins|mesh-ancestor
139088037|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
139088038|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088039|NCT01263080|Hematinics|hematinics|mesh-ancestor
139088040|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
139088041|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139088042|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139088043|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
139088044|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
139088045|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088046|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088047|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139088048|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139088049|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139088050|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139088051|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139088052|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139088053|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
139088054|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139088055|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139088056|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
139088057|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139088058|NCT01263158|Oxytocin|oxytocin|mesh-list
139088059|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
139088060|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139088061|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088062|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
139088063|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139088064|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
139088065|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088066|NCT03879356|Expectorants|expectorants|mesh-ancestor
139088067|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
139088068|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139088069|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
139088070|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088071|NCT03879356|Protective Agents|protective agents|mesh-ancestor
139088072|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088073|NCT03879356|Antidotes|antidotes|mesh-ancestor
139088074|NCT01159418|Paclitaxel|paclitaxel|mesh-list
139088075|NCT01159418|Carboplatin|carboplatin|mesh-list
139088076|NCT01159418|Panobinostat|panobinostat|mesh-list
139088077|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139088078|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088079|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
139088080|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
139088081|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
139088082|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088083|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139088084|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088085|NCT03886766|Efavirenz|efavirenz|mesh-list
139088086|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139088087|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139088088|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088089|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088090|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
139088091|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088092|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139072342|NCT00094328|Anastrozole|anastrozole|mesh-list
139088093|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139088094|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139088095|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139088096|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139088097|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139088098|NCT01265342|Beclomethasone|beclomethasone|mesh-list
139088099|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139088100|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
139088101|NCT01265342|Hormones|hormones|mesh-ancestor
139088102|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139088103|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088104|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139088105|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
139088106|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
139088107|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139088108|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
139088109|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088110|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
139088111|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088112|NCT01265576|Etodolac|etodolac|mesh-list
139088113|NCT01265576|Sorafenib|sorafenib|mesh-list
139088114|NCT01265576|Propranolol|propranolol|mesh-list
139088115|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088116|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139088117|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088118|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072355|NCT00094172|Atorvastatin|atorvastatin|mesh-list
139088119|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139088120|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139088121|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
139088122|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088123|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088124|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139088125|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139088126|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
139088127|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139088128|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139088129|NCT01265576|Analgesics|analgesics|mesh-ancestor
139088130|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
139088131|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088132|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139088133|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139088134|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139088135|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139088136|NCT03883022|Vancomycin|vancomycin|mesh-list
139088137|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139088138|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088139|NCT01159652|Zaleplon|zaleplon|mesh-list
139088140|NCT01159652|Zolpidem|zolpidem|mesh-list
139088141|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139088142|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139088143|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139088144|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088145|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139088146|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
139088147|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
139088148|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088149|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088150|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
139088151|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
139088152|NCT01261832|Cilostazol|cilostazol|mesh-list
139088153|NCT01261832|Clopidogrel|clopidogrel|mesh-list
139088154|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139088155|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139088156|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139088157|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139088158|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
139088159|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088160|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088161|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088162|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139088163|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
139088164|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088165|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139088166|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
139072394|NCT00093470|Tipifarnib|tipifarnib|mesh-list
139088167|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139088168|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139088169|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
139088170|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139088171|NCT01261832|Protective Agents|protective agents|mesh-ancestor
139088172|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139088173|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139088174|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088175|NCT01265810|Calcium|calcium|mesh-list
139088176|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139088177|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088178|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
139088179|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139088180|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
139088181|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088182|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088183|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139088184|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
139088185|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139088187|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088188|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088189|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139088190|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
139088191|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
139088192|NCT01265888|Protective Agents|protective agents|mesh-ancestor
139088193|NCT01155206|Glucagon|glucagon|mesh-list
139088194|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139088195|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139088196|NCT01155206|Hormones|hormones|mesh-ancestor
139088197|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139088198|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088199|NCT01155206|Incretins|incretins|mesh-ancestor
139088200|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
139088201|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
139088202|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
139088203|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088204|NCT03878888|Bupivacaine|bupivacaine|mesh-list
139088205|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
139088206|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
139088207|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139088208|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088209|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
139088210|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088211|NCT03882710|Metoprolol|metoprolol|mesh-list
139088212|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139088213|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139088214|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
139088215|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
139088216|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088217|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088218|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139088219|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139088220|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139088221|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
139088222|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088223|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088224|NCT01161836|Iniparib|iniparib|mesh-list
139088225|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139088226|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072419|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
139088227|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088228|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088229|NCT01266434|Simvastatin|simvastatin|mesh-list
139088230|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139088231|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139088232|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
139088233|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088234|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139088235|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139088236|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088237|NCT01266512|Docetaxel|docetaxel|mesh-list
139088238|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088239|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
139088240|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
139088241|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
139088242|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088243|NCT01160042|Metformin|metformin|mesh-list
139088244|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139174551|NCT05667415|Disulfiram|disulfiram|mesh-list
139088245|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088247|NCT03882788|Isoflurane|isoflurane|mesh-list
139088248|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139088249|NCT03882788|Narcotics|narcotics|mesh-ancestor
139088250|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139088251|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088252|NCT03882788|Analgesics|analgesics|mesh-ancestor
139088253|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
139088254|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088255|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139088256|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139088257|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
139088258|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
139088259|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139088260|NCT01156688|Misoprostol|misoprostol|mesh-list
139088261|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139088262|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
139088263|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139088264|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088265|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139088266|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139088267|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
139088269|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
139088270|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088271|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
139088272|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
139088273|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088274|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139088275|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139088276|NCT03878264|Cortisone|cortisone|mesh-list
139088277|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139088278|NCT03882164|Tacrolimus|tacrolimus|mesh-list
139088279|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139088280|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
139088281|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088282|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139088283|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088284|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088285|NCT01160276|Cyclosporine|cyclosporine|mesh-list
139088286|NCT01160276|Colchicine|colchicine|mesh-list
139088287|NCT01160276|Tacrolimus|tacrolimus|mesh-list
139088288|NCT01160276|Cyclosporins|cyclosporins|mesh-list
139088289|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139088290|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
139088291|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088292|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139088293|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088294|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088295|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
139088296|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088297|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
139088298|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139088299|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
139174559|NCT01586143|Analgesics|analgesics|mesh-ancestor
139088300|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
139088301|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
139088302|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
139088303|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088304|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139088305|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139088306|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088307|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139088308|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139088309|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139088310|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088311|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
139088312|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088313|NCT01160432|Methadone|methadone|mesh-list
139088314|NCT01160432|Naloxone|naloxone|mesh-list
139088315|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139088316|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088317|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
139088318|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088319|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139088320|NCT01160432|Narcotics|narcotics|mesh-ancestor
139088321|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139088322|NCT01160432|Analgesics|analgesics|mesh-ancestor
139088323|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
139088324|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
139088325|NCT03877718|Promethazine|promethazine|mesh-list
139088326|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
139088327|NCT03877718|Sumatriptan|sumatriptan|mesh-list
139088328|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139088329|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139088330|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139088331|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
139088332|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088333|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088334|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088335|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
139088336|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
138838960|NCT04449536|Mesna|mesna|mesh-list
139088337|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139088338|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
139088339|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
139088340|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139088341|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139088342|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139088343|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139088344|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
139088345|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
139088346|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
139088347|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088348|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
139088349|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
139088350|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139088351|NCT01267058|Vaccines|vaccines|mesh-list
139088352|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
139088353|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088354|NCT02526914|Vasopressins|vasopressins|mesh-list
139088355|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
139088356|NCT02526914|Oxytocin|oxytocin|mesh-list
139088357|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
139088358|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139088359|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088360|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
139088361|NCT02526914|Coagulants|coagulants|mesh-ancestor
139088362|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139088363|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139088364|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
139088365|NCT03876938|Olanzapine|olanzapine|mesh-list
139088366|NCT03876938|Aprepitant|aprepitant|mesh-list
139088367|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
139088368|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
139088369|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706929|NCT01780428|Anesthetics|anesthetics|mesh-ancestor
139088370|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088371|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139088372|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139088373|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139088374|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139088375|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139088376|NCT03876938|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139088377|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139088378|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139088379|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088380|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088381|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
139088382|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139088383|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139088384|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
139088385|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139088386|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139088387|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139088388|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088389|NCT03882008|Abatacept|abatacept|mesh-list
139088390|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139088391|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088392|NCT03882008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139088393|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088394|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139088395|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
139088396|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088397|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139088398|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
139088399|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139088400|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
139088401|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088402|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
139088403|NCT01267214|Protective Agents|protective agents|mesh-ancestor
139088404|NCT01156922|Rituximab|rituximab|mesh-list
139088405|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139088406|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088407|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
139088408|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088409|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139088410|NCT03877874|Terbutaline|terbutaline|mesh-list
139088411|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139088412|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
139088413|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088414|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088415|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139088416|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
139088417|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
139088418|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
139088419|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139088420|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139088421|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139088422|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139088423|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
139088424|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088425|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088426|NCT01160588|Sertraline|sertraline|mesh-list
139088427|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
139088428|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139088429|NCT01160588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139088430|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139088431|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139088432|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088433|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088434|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
139088435|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088436|NCT03877562|Olanzapine|olanzapine|mesh-list
139088437|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
139088438|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
139088439|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088440|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088441|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139088442|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139088443|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139088444|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139088445|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139088446|NCT03877562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139088447|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139088448|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139088449|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088450|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088451|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
139088452|NCT01160666|Belimumab|belimumab|mesh-list
139088453|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139088454|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
139088455|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088456|NCT03876548|Iodine|iodine|mesh-list
139088457|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
139088458|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139088459|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088460|NCT03876548|Trace Elements|trace elements|mesh-ancestor
139088461|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
139088462|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088463|NCT03760250|Imiquimod|imiquimod|mesh-list
139088464|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139088465|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
139088466|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088467|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088468|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
139088469|NCT01157000|Canagliflozin|canagliflozin|mesh-list
139088470|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139088471|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088472|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139174601|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139088473|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088474|NCT01160900|Bivalirudin|bivalirudin|mesh-list
139088475|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139088476|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139088477|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
139088478|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139088479|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
139088480|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088481|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088482|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
139088483|NCT01160978|Simvastatin|simvastatin|mesh-list
139088484|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139088485|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139088486|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
139088487|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088488|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139088489|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139088490|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088491|NCT01161134|Meloxicam|meloxicam|mesh-list
139088492|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139088493|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139088494|NCT01161134|Analgesics|analgesics|mesh-ancestor
139088495|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
139088496|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088497|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088498|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139088499|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139088500|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139088501|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139088502|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088503|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088504|NCT01268384|Gemcitabine|gemcitabine|mesh-list
139088505|NCT01268384|Capecitabine|capecitabine|mesh-list
139088506|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139088507|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
139088508|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088509|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088510|NCT01269476|Fluorides|fluorides|mesh-list
139088511|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
139088512|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
139088513|NCT01269476|Protective Agents|protective agents|mesh-ancestor
139088514|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088515|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139088516|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088517|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088518|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
139088519|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088520|NCT01161368|Vinorelbine|vinorelbine|mesh-list
139088521|NCT01161368|Lapatinib|lapatinib|mesh-list
139088522|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139088523|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088524|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
139088525|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
139088526|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
139088527|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088528|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139088529|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088530|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
139088531|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139088532|NCT01280162|Piperaquine|piperaquine|mesh-list
139088533|NCT01280162|Artenimol|artenimol|mesh-list
139088534|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
139088535|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139088536|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139088537|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088538|NCT01167062|Tamsulosin|tamsulosin|mesh-list
139088539|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139088540|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139088541|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139088542|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
139088543|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088544|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088545|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088546|NCT01167062|Urological Agents|urological agents|mesh-ancestor
139088547|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139088548|NCT01280240|Hematinics|hematinics|mesh-ancestor
139088549|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
139088550|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139088551|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088552|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139088553|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088554|NCT03874364|Lidocaine|lidocaine|mesh-list
139088555|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
139088556|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
139088557|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139088558|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088559|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
139088560|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088561|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139088562|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139088563|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139088564|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139088565|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088567|NCT01163396|Bevacizumab|bevacizumab|mesh-list
139088568|NCT01163396|Fluorouracil|fluorouracil|mesh-list
139088569|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
139088570|NCT01163396|Irinotecan|irinotecan|mesh-list
139088571|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139088572|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088573|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139088574|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139088575|NCT01163396|Growth Substances|growth substances|mesh-ancestor
139088576|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088577|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
139088578|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
139088579|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088580|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139088581|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139088582|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
139088583|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139088584|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139088586|NCT01163396|Antidotes|antidotes|mesh-ancestor
139088587|NCT01163396|Protective Agents|protective agents|mesh-ancestor
139088588|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
139088589|NCT01163396|Vitamins|vitamins|mesh-ancestor
139088590|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
139088591|NCT01269788|Fluoxetine|fluoxetine|mesh-list
139088592|NCT01269788|Omeprazole|omeprazole|mesh-list
139088593|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139088594|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139088595|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139088596|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088597|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088598|NCT01269788|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139088599|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139088600|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139088601|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088602|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
139088603|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088604|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139088605|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
139088606|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139088607|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139088608|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139088609|NCT01163630|Esomeprazole|esomeprazole|mesh-list
139088610|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139088611|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139088612|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139088613|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088614|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088615|NCT03874130|Scopolamine|scopolamine|mesh-list
139088616|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139088617|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139088618|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
139088619|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
139088620|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088621|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088622|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139088623|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
139088624|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139088625|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
139088626|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088627|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088628|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139088629|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
139088630|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139088631|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139088632|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138839220|NCT00812851|Hormones|hormones|mesh-ancestor
139088633|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139088634|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088635|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088636|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088637|NCT01269866|Analgesics|analgesics|mesh-ancestor
139088638|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
139088639|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088640|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
139088641|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139088642|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
139088643|NCT05387642|Pramoxine|pramoxine|mesh-list
139088644|NCT05387642|Anesthetics, Local|anesthetics, local|mesh-ancestor
139088645|NCT05387642|Anesthetics|anesthetics|mesh-ancestor
139088646|NCT05387642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139088647|NCT05387642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088648|NCT05387642|Sensory System Agents|sensory system agents|mesh-ancestor
139088649|NCT05387642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088650|NCT03871322|Vitamin D|vitamin d|mesh-list
139088651|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
139088652|NCT03871322|Cholecalciferol|cholecalciferol|mesh-list
139088653|NCT03871322|Vitamins|vitamins|mesh-list
139088654|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
139088655|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088656|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139088657|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139088658|NCT00313781|Prednisone|prednisone|mesh-list
139088659|NCT00313781|Docetaxel|docetaxel|mesh-list
139088660|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088661|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
139088662|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
139088663|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
139088664|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088665|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139088666|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
139088667|NCT00313781|Hormones|hormones|mesh-ancestor
139088668|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139088669|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088670|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139088671|NCT03871478|Lidocaine|lidocaine|mesh-list
139088672|NCT03871478|Bupivacaine|bupivacaine|mesh-list
139088673|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
139088674|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
139088675|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139088676|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088677|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
139088678|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088679|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139088680|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139088681|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139174707|NCT02874794|Valsartan|valsartan|mesh-list
139088682|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139088683|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088685|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139088686|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139088687|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139088688|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
139088689|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088690|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088691|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088692|NCT00368537|Ampicillin|ampicillin|mesh-list
139088693|NCT00368537|Tigecycline|tigecycline|mesh-list
139088694|NCT00368537|Sulbactam|sulbactam|mesh-list
139088695|NCT00368537|Sultamicillin|sultamicillin|mesh-list
139088696|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139088697|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088698|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139088699|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088700|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088701|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139088702|NCT01165580|Valganciclovir|valganciclovir|mesh-list
139088703|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
139088704|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088705|NCT01048619|ON 01910|on 01910|mesh-list
139088706|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138839289|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088707|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139088708|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088709|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088710|NCT01281800|Gemcitabine|gemcitabine|mesh-list
139088711|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139088712|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
139088713|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088715|NCT03982121|Nivolumab|nivolumab|mesh-list
139088716|NCT03982121|Ipilimumab|ipilimumab|mesh-list
139088717|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139088718|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088719|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139088720|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088721|NCT01167530|Everolimus|everolimus|mesh-list
139088722|NCT01167530|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139088723|NCT01167530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139088724|NCT01167530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088725|NCT01167530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088726|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139088727|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
139088728|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088729|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088730|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
139088731|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139088732|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139088733|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088734|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
139088735|NCT01167764|Coagulants|coagulants|mesh-ancestor
139088736|NCT01164176|Everolimus|everolimus|mesh-list
139088737|NCT01164176|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139174721|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
139088738|NCT01164176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139088739|NCT01164176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088740|NCT01164176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088741|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139088742|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
139088743|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088744|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088746|NCT00313313|Saxagliptin|saxagliptin|mesh-list
139088747|NCT00313313|Glyburide|glyburide|mesh-list
139088748|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139088749|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088750|NCT00313313|Incretins|incretins|mesh-ancestor
139088751|NCT00313313|Hormones|hormones|mesh-ancestor
139088752|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139088753|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139088754|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
139088755|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088756|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088757|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
139088758|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
139088759|NCT01167920|Diuretics|diuretics|mesh-list
139088760|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139088761|NCT01167920|Renin Inhibitors|renin inhibitors|mesh-list
139088762|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139088763|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088764|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
139088765|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
139088766|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088767|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088768|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139088769|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139088770|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
139088771|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
139088772|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
139088773|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088774|NCT01268930|Hemostatics|hemostatics|mesh-list
139088776|NCT02526758|Budesonide|budesonide|mesh-list
139088777|NCT02526758|Beclomethasone|beclomethasone|mesh-list
139088778|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
139088779|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139088780|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139088781|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
139088782|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088783|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088784|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139088785|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
139088786|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
139088787|NCT02526758|Hormones|hormones|mesh-ancestor
139088788|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139088789|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139072596|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
139088790|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139088791|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139088792|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
139088793|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088794|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088795|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
139088796|NCT01281878|Pyridoxal|pyridoxal|mesh-list
139088797|NCT01281878|Pyridoxine|pyridoxine|mesh-list
139088798|NCT01281878|Vitamins|vitamins|mesh-ancestor
139088799|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
139088800|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088801|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
139088802|NCT01164488|Ritonavir|ritonavir|mesh-list
139088803|NCT01164488|Ketoconazole|ketoconazole|mesh-list
139088804|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139088805|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139088806|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
139088807|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088808|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088809|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139088810|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139088811|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
139088812|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088813|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139088814|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139088815|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
139088816|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139088817|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139088818|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
139088819|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139088820|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088821|NCT00312845|Rituximab|rituximab|mesh-list
139088822|NCT00312845|Bortezomib|bortezomib|mesh-list
139088823|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139088824|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088825|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
139088826|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088827|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139088828|NCT01168544|Vitamin D|vitamin d|mesh-list
139088829|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
139088830|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
139088831|NCT01168544|Vitamins|vitamins|mesh-list
139088832|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
139088833|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088834|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139088835|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139088836|NCT00368069|Levetiracetam|levetiracetam|mesh-list
139088837|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
139088838|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
139088839|NCT01165814|Naproxen|naproxen|mesh-list
139088840|NCT01165814|Tramadol|tramadol|mesh-list
139088841|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139088842|NCT01165814|Narcotics|narcotics|mesh-ancestor
139088843|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139088844|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088845|NCT01165814|Analgesics|analgesics|mesh-ancestor
139088846|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
139088847|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088848|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139072619|NCT00401843|Dexamethasone|dexamethasone|mesh-list
139088849|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139088850|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139088851|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139088852|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
139088853|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139088854|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088855|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088856|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
139088857|NCT00367991|Hematinics|hematinics|mesh-ancestor
139088858|NCT00367835|Guanfacine|guanfacine|mesh-list
139088859|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139088860|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139088861|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139088862|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139088863|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
139088864|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091708|NCT04277637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139088865|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088866|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088867|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
139088868|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139088869|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
139088870|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
139088871|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088872|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088873|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088874|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139088875|NCT03874832|Analgesics|analgesics|mesh-ancestor
139088876|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
139088877|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088878|NCT01164800|Trandolapril|trandolapril|mesh-list
139088879|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139088880|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
139088881|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088882|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088883|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139088884|NCT01169012|Clofarabine|clofarabine|mesh-list
139088885|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139088886|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
139174787|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
139088887|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088888|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088889|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139088890|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139088891|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088892|NCT01169090|Incretins|incretins|mesh-ancestor
139088893|NCT01169090|Hormones|hormones|mesh-ancestor
139088894|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139088895|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139088896|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
139088897|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088898|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088899|NCT01282502|Midostaurin|midostaurin|mesh-list
139088900|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088901|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139088902|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088903|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088904|NCT01269242|Bindarit|bindarit|mesh-list
139088905|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139088906|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139088907|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088908|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088909|NCT01169792|Tamoxifen|tamoxifen|mesh-list
139088910|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139088911|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
139088912|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139088913|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088914|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139088915|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088916|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139088917|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139088918|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139088919|NCT01169402|Fluconazole|fluconazole|mesh-list
139088920|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
139088921|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088922|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139088923|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139088924|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088925|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088926|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139088927|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
139088928|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139088929|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088930|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138839548|NCT00638443|Pregabalin|pregabalin|mesh-list
139088931|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139088932|NCT01274780|Ritonavir|ritonavir|mesh-list
139088933|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139088934|NCT01274780|Darunavir|darunavir|mesh-list
139088935|NCT01274780|Tenofovir|tenofovir|mesh-list
139088936|NCT01274780|Emtricitabine|emtricitabine|mesh-list
139088937|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139088938|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139088939|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
139088940|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139088941|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088942|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139088943|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139088944|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
139088945|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139088946|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139088947|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139088948|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139088949|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139088950|NCT01169870|Paclitaxel|paclitaxel|mesh-list
139088951|NCT01169870|genexol-PM|genexol-pm|mesh-list
139088952|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139088953|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088954|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
139088955|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
139088956|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
139088957|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088958|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139088959|NCT01165970|Laxatives|laxatives|mesh-ancestor
139088960|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139088961|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139088962|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139088963|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139088964|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139088965|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088966|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088967|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088968|NCT01166048|Analgesics|analgesics|mesh-ancestor
139088969|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
139088970|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139088971|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
139088972|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139088973|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
139088974|NCT03869762|Denosumab|denosumab|mesh-list
139088975|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139088976|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088977|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139088978|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088979|NCT01283048|Bevacizumab|bevacizumab|mesh-list
139088980|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139088981|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139088982|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139088983|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139088984|NCT01283048|Growth Substances|growth substances|mesh-ancestor
139174859|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139088985|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088986|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
139088987|NCT03873740|Vaccines|vaccines|mesh-list
139088988|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
139088989|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139088990|NCT01172756|Riociguat|riociguat|mesh-list
139088991|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
139088992|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139088993|NCT02525822|Tazarotene|tazarotene|mesh-list
139088994|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
139088995|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
139088996|NCT01172912|Dexamethasone|dexamethasone|mesh-list
139088997|NCT01172912|Carboplatin|carboplatin|mesh-list
139088998|NCT01172912|Etoposide|etoposide|mesh-list
139088999|NCT01172912|Ifosfamide|ifosfamide|mesh-list
139089000|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139089001|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
139089002|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
139089003|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089004|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089005|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138839589|NCT04288349|Epinephrine|epinephrine|mesh-list
139089006|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
139089007|NCT01172912|Hormones|hormones|mesh-ancestor
139089008|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089009|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139089010|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089011|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139089012|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139089013|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139089014|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089015|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089016|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139089017|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
139089018|NCT01283204|Leucovorin|leucovorin|mesh-list
139089019|NCT01283204|Paclitaxel|paclitaxel|mesh-list
139089020|NCT01283204|Docetaxel|docetaxel|mesh-list
139089021|NCT01283204|Cisplatin|cisplatin|mesh-list
139089022|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
139089023|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
139089024|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139089025|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089026|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
139089027|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
139089028|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
139089029|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089030|NCT01283204|Antidotes|antidotes|mesh-ancestor
139089031|NCT01283204|Protective Agents|protective agents|mesh-ancestor
139089032|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089033|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
139089034|NCT01283204|Vitamins|vitamins|mesh-ancestor
139089035|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
139089036|NCT03869528|Lidocaine|lidocaine|mesh-list
139089037|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
139089038|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
139089039|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139089040|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089041|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
139089042|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089043|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139089044|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139089045|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139089046|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139089047|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089048|NCT01283360|Tenofovir|tenofovir|mesh-list
139089049|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
139089050|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089051|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139089052|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139089053|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089054|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089056|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139089057|NCT01173068|Ertapenem|ertapenem|mesh-list
139089058|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139089059|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089060|NCT03267940|Atezolizumab|atezolizumab|mesh-list
139089061|NCT03267940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139089062|NCT03267940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089063|NCT03267940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139089064|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089065|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
139089066|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139089067|NCT01170104|Sorafenib|sorafenib|mesh-list
139089068|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089069|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139089070|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089071|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089072|NCT01284764|Mosapride|mosapride|mesh-list
139089073|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139089074|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139089075|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
139089076|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089077|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089078|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089079|NCT01170182|Omeprazole|omeprazole|mesh-list
139089080|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139089081|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139089082|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139089083|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089084|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089085|NCT01170260|Ethanol|ethanol|mesh-list
139089086|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139089087|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089088|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139089089|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089090|NCT00312377|Docetaxel|docetaxel|mesh-list
139089091|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089092|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
139089093|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
139089094|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
139089095|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089096|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
139089097|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139089098|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089099|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139089100|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139089101|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072670|NCT01044251|Frovatriptan|frovatriptan|mesh-list
139089102|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089103|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089104|NCT01580891|Naftifine|naftifine|mesh-list
139089105|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
139089106|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089107|NCT01059383|Esomeprazole|esomeprazole|mesh-list
139089108|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139089109|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139089110|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139089111|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089112|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089113|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139089114|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139089115|NCT01170338|Varenicline|varenicline|mesh-list
139089116|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139089117|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139089118|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
139089119|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089120|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089121|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089122|NCT00312221|Oxycodone|oxycodone|mesh-list
139089123|NCT00312221|Buprenorphine|buprenorphine|mesh-list
139089124|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139089125|NCT00312221|Narcotics|narcotics|mesh-ancestor
139089126|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139089127|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089128|NCT00312221|Analgesics|analgesics|mesh-ancestor
139089129|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
139089130|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089131|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139089132|NCT03872570|Phenylephrine|phenylephrine|mesh-list
139089133|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
139089134|NCT03872570|Norepinephrine|norepinephrine|mesh-list
139089135|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139089136|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
139089137|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
139089138|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089139|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089140|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
139089141|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139089142|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
139089143|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
139089144|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139089145|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139089146|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139089147|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
139089148|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089149|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089150|NCT03872570|Protective Agents|protective agents|mesh-ancestor
139089151|NCT01173926|Insulin|insulin|mesh-list
139089152|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139089153|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
139089154|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
139089155|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139089156|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139089157|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089158|NCT03349268|Xenon|xenon|mesh-list
139089159|NCT03349268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139089161|NCT03349268|Anesthetics|anesthetics|mesh-ancestor
139089162|NCT03349268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139089163|NCT03349268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089165|NCT01170494|Vitamin D|vitamin d|mesh-list
139089166|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
139089167|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139072679|NCT01044329|Bevacizumab|bevacizumab|mesh-list
139089168|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089169|NCT01170494|Vitamins|vitamins|mesh-ancestor
139089170|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
139089171|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139089172|NCT01587326|Escitalopram|escitalopram|mesh-list
139089173|NCT01587326|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139089174|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139089175|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139089176|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089177|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089178|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
139089179|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089180|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139089181|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139089182|NCT03294538|Estradiol|estradiol|mesh-list
139089183|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139089184|NCT03294538|Estrogens|estrogens|mesh-ancestor
139089185|NCT03294538|Hormones|hormones|mesh-ancestor
139089186|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089187|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089188|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139089189|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
139089190|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139089191|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139089192|NCT03872336|Labetalol|labetalol|mesh-list
139089193|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139089194|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139089195|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
139089196|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089197|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089198|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089199|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139089200|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
139089201|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
139089202|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089203|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139089204|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139089205|NCT02987530|Tenofovir|tenofovir|mesh-list
139089206|NCT02987530|Emtricitabine|emtricitabine|mesh-list
139089207|NCT02987530|Dolutegravir|dolutegravir|mesh-list
139089208|NCT02987530|Darunavir|darunavir|mesh-list
139089209|NCT02987530|Cobicistat|cobicistat|mesh-list
139089210|NCT02987530|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139089211|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
139089212|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089213|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139089214|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139089215|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089216|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089217|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139089218|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139089219|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139089220|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139089221|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139089222|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139089223|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
139089224|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139089225|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139089226|NCT03865550|Ketamine|ketamine|mesh-list
139089227|NCT03865550|Analgesics|analgesics|mesh-ancestor
139089228|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
139174912|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139089229|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089230|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089231|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139089232|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139089234|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
139089235|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139089236|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139089237|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139089238|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089239|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089240|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
139089241|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089242|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139089243|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139089244|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089245|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089246|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
139089247|NCT01285466|Paclitaxel|paclitaxel|mesh-list
139089248|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139089249|NCT01285466|Trastuzumab|trastuzumab|mesh-list
139089250|NCT01285466|Dactolisib|dactolisib|mesh-list
139089251|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139089252|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089253|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
139089254|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
139089255|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
139089256|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089257|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139089258|NCT01285544|Atorvastatin|atorvastatin|mesh-list
139089259|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139089260|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139089261|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
139089262|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089263|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139089264|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139089265|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089266|NCT01174394|Fluoxetine|fluoxetine|mesh-list
139089267|NCT01174394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139089268|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139089269|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139089270|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089271|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089272|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
139089273|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089274|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139089275|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
139089276|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139072711|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
139089277|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139089278|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139089279|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089280|NCT01174472|Paclitaxel|paclitaxel|mesh-list
139089281|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139174919|NCT03896113|Analgesics|analgesics|mesh-ancestor
139089282|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089283|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
139089284|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
139089285|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
139089286|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089287|NCT00335153|Levodopa|levodopa|mesh-list
139089288|NCT00335153|Carbidopa|carbidopa|mesh-list
139089289|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139089290|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139089291|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139089292|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
139089293|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089294|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089295|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089296|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139089297|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089298|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139089299|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
139089300|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
139089301|NCT01170806|Orlistat|orlistat|mesh-list
139089302|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138839890|NCT02847338|Protective Agents|protective agents|mesh-ancestor
139089303|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089304|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139089305|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139089307|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139089308|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
139089309|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
139089310|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139089311|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089312|NCT02965690|Cimetidine|cimetidine|mesh-list
139089313|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139089314|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139089315|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139089316|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
139089317|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
139089318|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089319|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089320|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089321|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139089322|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139089323|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089324|NCT01280006|Celecoxib|celecoxib|mesh-list
139089325|NCT01280006|Indomethacin|indomethacin|mesh-list
139089326|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139089327|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139089328|NCT01280006|Analgesics|analgesics|mesh-ancestor
139089329|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
139089330|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089331|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089332|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139089333|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139089334|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139089335|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139089336|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089337|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089338|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
139089339|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
139174942|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
139089340|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139089341|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139089342|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139089344|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139089345|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139089346|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139089347|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139089348|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139089349|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
139089350|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089351|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089352|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139089353|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
139089354|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
139089355|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
139089356|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139089357|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139089358|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
139089359|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089360|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089361|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
139089362|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139089363|NCT01059461|Protective Agents|protective agents|mesh-ancestor
139089364|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089365|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
139089366|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139089367|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
139089368|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089369|NCT01286246|Progesterone|progesterone|mesh-list
139089370|NCT01286246|Progestins|progestins|mesh-ancestor
139089371|NCT01286246|Hormones|hormones|mesh-ancestor
139089372|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089373|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089374|NCT03981887|Nafithromycin|nafithromycin|mesh-list
139089375|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139089376|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138839972|NCT00623779|Aspirin|aspirin|mesh-list
139089377|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139089378|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709509|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
139089379|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089381|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139089382|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089383|NCT03865004|Acetaminophen|acetaminophen|mesh-list
139089384|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139089385|NCT03865004|Morphine|morphine|mesh-list
139089386|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139089387|NCT03865004|Narcotics|narcotics|mesh-ancestor
139089388|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139089389|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089390|NCT03865004|Analgesics|analgesics|mesh-ancestor
139089391|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
139089392|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089393|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139089394|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
139089395|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139089396|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139089397|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139089398|NCT00334295|Fulvestrant|fulvestrant|mesh-list
139089399|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139089400|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089401|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139089402|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139089403|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
139089404|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089405|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089406|NCT01285778|Panitumumab|panitumumab|mesh-list
139089407|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139089408|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089409|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
139089410|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139089411|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
139089412|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089413|NCT01063205|Expectorants|expectorants|mesh-ancestor
139089414|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
139089415|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139089416|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
139089417|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089418|NCT01063205|Protective Agents|protective agents|mesh-ancestor
139089419|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089420|NCT01063205|Antidotes|antidotes|mesh-ancestor
139089421|NCT01175096|Everolimus|everolimus|mesh-list
139089422|NCT01175096|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139089423|NCT01175096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139089424|NCT01175096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089425|NCT01175096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089426|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139089427|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
139089428|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089429|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089430|NCT01285934|Insulin|insulin|mesh-list
139089431|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139089432|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089433|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
139089434|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139089435|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139089436|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089437|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
139089438|NCT01060163|Coagulants|coagulants|mesh-ancestor
139089439|NCT01063439|Cytarabine|cytarabine|mesh-list
139089440|NCT01063439|Etoposide|etoposide|mesh-list
139089441|NCT01063439|Melphalan|melphalan|mesh-list
139089442|NCT01063439|Busulfan|busulfan|mesh-list
139089443|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139089444|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089445|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139089446|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139089447|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089448|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089449|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139089450|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
139089451|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
139089452|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089453|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139089454|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
139174964|NCT03480750|Carboplatin|carboplatin|mesh-list
139089455|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089456|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139089457|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
139089458|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139089460|NCT05275270|Oxytocics|oxytocics|mesh-ancestor
139089461|NCT05275270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139089462|NCT05275270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089463|NCT03868202|Estradiol|estradiol|mesh-list
139089464|NCT03868202|Progesterone|progesterone|mesh-list
139089465|NCT03868202|Estrogens|estrogens|mesh-ancestor
139089466|NCT03868202|Hormones|hormones|mesh-ancestor
139089467|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089468|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089469|NCT03868202|Progestins|progestins|mesh-ancestor
139089470|NCT00311363|Gabapentin|gabapentin|mesh-list
139089471|NCT00311363|Analgesics|analgesics|mesh-ancestor
139089472|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
139089473|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089474|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089475|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
139089476|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139089477|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139089478|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139089479|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139089480|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139089481|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139089482|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089483|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089484|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
139089485|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139089486|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139089487|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139089488|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139089489|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139089490|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139089491|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
139089492|NCT01286090|Cisapride|cisapride|mesh-list
139089493|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139089494|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139089495|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139089496|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
139089497|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089498|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089499|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089500|NCT00310817|Vaccines|vaccines|mesh-list
139089501|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
139089502|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089503|NCT03783286|Ivacaftor|ivacaftor|mesh-list
139089504|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139089505|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139089506|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089507|NCT03863366|Prucalopride|prucalopride|mesh-list
139089508|NCT03863366|Laxatives|laxatives|mesh-ancestor
139089509|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139089510|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139089511|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139089512|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
139089513|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139174987|NCT03892447|Protective Agents|protective agents|mesh-ancestor
139089514|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089515|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089516|NCT01175486|Pioglitazone|pioglitazone|mesh-list
139089517|NCT01175486|Acarbose|acarbose|mesh-list
139089518|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139089519|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089520|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139089521|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089522|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089523|NCT01177904|Progesterone|progesterone|mesh-list
139089524|NCT01177904|Progestins|progestins|mesh-ancestor
139089525|NCT01177904|Hormones|hormones|mesh-ancestor
139089526|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089527|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089528|NCT02940886|Iron|iron|mesh-list
139089529|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139089530|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139089531|NCT02940886|Trace Elements|trace elements|mesh-ancestor
139089532|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
139089533|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089534|NCT02940886|Hematinics|hematinics|mesh-ancestor
139089535|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
139089536|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139089537|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139089538|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139089539|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089540|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139089541|NCT05216614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139089542|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139089543|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139089544|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089545|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089546|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
139089547|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139089548|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
139089549|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139089550|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139089551|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089552|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139089553|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139089554|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139089555|NCT03860636|Estradiol|estradiol|mesh-list
139089556|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139089557|NCT03860636|Progesterone|progesterone|mesh-list
139089558|NCT03860636|Estrogens|estrogens|mesh-ancestor
139089559|NCT03860636|Hormones|hormones|mesh-ancestor
139089560|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089561|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089562|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139089563|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
139089564|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139089565|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139089566|NCT03860636|Progestins|progestins|mesh-ancestor
139089567|NCT03860480|Bupivacaine|bupivacaine|mesh-list
139089568|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
139089569|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
139089570|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139089571|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089572|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
139089573|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089574|NCT03285646|Fasinumab|fasinumab|mesh-list
139089575|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139089576|NCT03285646|Analgesics|analgesics|mesh-ancestor
139089577|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
139089578|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089579|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089580|NCT03860012|Folic Acid|folic acid|mesh-list
139089581|NCT03860012|Hematinics|hematinics|mesh-ancestor
139089582|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
139089583|NCT03860012|Vitamins|vitamins|mesh-ancestor
139089584|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
139089585|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089586|NCT03859934|Melatonin|melatonin|mesh-list
139089587|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
139089588|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089589|NCT03859934|Protective Agents|protective agents|mesh-ancestor
139089590|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089591|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139089592|NCT01178372|Lactulose|lactulose|mesh-list
139089593|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139089594|NCT01178450|Cinacalcet|cinacalcet|mesh-list
139089595|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139089596|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089597|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139089598|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
139089599|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089600|NCT00074490|Prednisone|prednisone|mesh-list
139089601|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
139089602|NCT00074490|Rituximab|rituximab|mesh-list
139089604|NCT00074490|Fludarabine|fludarabine|mesh-list
139089605|NCT00074490|Etoposide|etoposide|mesh-list
139089606|NCT00074490|Vincristine|vincristine|mesh-list
139089607|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139089608|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
139089609|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089610|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139089611|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139089612|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
139089613|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089614|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089615|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139089616|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139089617|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139089618|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139089619|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139089620|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089621|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139089622|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
139089623|NCT00074490|Hormones|hormones|mesh-ancestor
139089624|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089625|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139089626|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139089628|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
139089629|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
139089630|NCT03859856|Hormones|hormones|mesh-list
139089631|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089632|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089633|NCT01094028|Oxytocin|oxytocin|mesh-list
139089634|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
139089635|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139089636|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089637|NCT01288508|Psyllium|psyllium|mesh-list
139089638|NCT01288508|Cathartics|cathartics|mesh-ancestor
139089639|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139089640|NCT01175954|Lacosamide|lacosamide|mesh-list
139089641|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
139089642|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139089643|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139089644|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139089645|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089646|NCT01288664|Tacrolimus|tacrolimus|mesh-list
139089647|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139089648|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
139089649|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089650|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139089651|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089652|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089653|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
139089654|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089655|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089656|NCT02525276|Hormones|hormones|mesh-list
139089657|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089658|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089659|NCT01172444|Mesalamine|mesalamine|mesh-list
139089660|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139089661|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139089662|NCT01172444|Analgesics|analgesics|mesh-ancestor
139089663|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
139089664|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089665|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089666|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139089667|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139089668|NCT01288742|Simeprevir|simeprevir|mesh-list
139089669|NCT01288742|Digoxin|digoxin|mesh-list
139089670|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139089671|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139089672|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139089673|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
139089674|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089675|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138840261|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
139089676|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139089677|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089678|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139089679|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139303896|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139089680|NCT01288742|Protective Agents|protective agents|mesh-ancestor
139089681|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089682|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
139089683|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089684|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
139089685|NCT01178996|Ribavirin|ribavirin|mesh-list
139089686|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139089687|NCT01178996|Thymalfasin|thymalfasin|mesh-list
139089688|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
139089689|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089690|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
139089691|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089692|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139089693|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
139089694|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089695|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
139089696|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139089697|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
139089698|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089699|NCT03862586|Expectorants|expectorants|mesh-ancestor
139089700|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
139089701|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139089702|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
139089703|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089704|NCT03862586|Protective Agents|protective agents|mesh-ancestor
139089705|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089706|NCT03862586|Antidotes|antidotes|mesh-ancestor
139089707|NCT01180946|Vitamin D|vitamin d|mesh-list
139089708|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
139089709|NCT01180946|Vitamins|vitamins|mesh-ancestor
139089710|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
139089711|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089712|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139089713|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139089714|NCT01179152|Budesonide|budesonide|mesh-list
139089715|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
139089716|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139089717|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139089718|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
139089719|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089720|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089721|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139089722|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
139089723|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
139089724|NCT01179152|Hormones|hormones|mesh-ancestor
139089725|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089726|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139089727|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139089728|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139089729|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
139089730|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089731|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089732|NCT01179230|Dipyridamole|dipyridamole|mesh-list
139089733|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139089734|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089735|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089736|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139089737|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
139089738|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
139089739|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139089740|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
139089741|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139089742|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089743|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139089744|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139089745|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139089746|NCT01179308|Anesthetics|anesthetics|mesh-list
139089747|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139089748|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089749|NCT03088826|Acetaminophen|acetaminophen|mesh-list
139089750|NCT03088826|Morphine|morphine|mesh-list
139089751|NCT03088826|Oxycodone|oxycodone|mesh-list
139089752|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139089753|NCT03088826|Narcotics|narcotics|mesh-ancestor
139089754|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303897|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139089755|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089756|NCT03088826|Analgesics|analgesics|mesh-ancestor
139089757|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
139089758|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089759|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139089760|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
139089761|NCT00367133|Triamcinolone|triamcinolone|mesh-list
139089762|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139089763|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139089764|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139089765|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139089766|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
139089767|NCT00367133|Hormones|hormones|mesh-ancestor
139089768|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089769|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089770|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139089771|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
139089772|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089773|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089774|NCT01179464|Simvastatin|simvastatin|mesh-list
139089775|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139089776|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139089777|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
139089778|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089779|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139089780|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139089781|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089782|NCT01179620|Certoparin|certoparin|mesh-list
139089783|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
139089784|NCT01288820|Artesunate|artesunate|mesh-list
139089785|NCT01288820|Piperaquine|piperaquine|mesh-list
139089786|NCT01288820|Primaquine|primaquine|mesh-list
139089787|NCT01288820|Amodiaquine|amodiaquine|mesh-list
139089788|NCT01288820|Artenimol|artenimol|mesh-list
139089789|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
139089790|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139089791|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139089792|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089793|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089794|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
139089795|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
139089796|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139089797|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
139089798|NCT00367055|Metformin|metformin|mesh-list
139089799|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
139089800|NCT00367055|Gliclazide|gliclazide|mesh-list
139089801|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139089802|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089803|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
139089804|NCT00057330|Vaccines|vaccines|mesh-list
139089805|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
139089806|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
139089807|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089808|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139089809|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139089810|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089811|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
139089812|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089813|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
139089814|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139089815|NCT00057330|Protective Agents|protective agents|mesh-ancestor
139089816|NCT03283696|Doxorubicin|doxorubicin|mesh-list
139089817|NCT03283696|Ifosfamide|ifosfamide|mesh-list
139089818|NCT03283696|Olaratumab|olaratumab|mesh-list
139089819|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139089820|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089821|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139089822|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139089823|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175061|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
139089824|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089825|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139089826|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
139089827|NCT01176344|Vitamin D|vitamin d|mesh-list
139089828|NCT01176344|Vitamins|vitamins|mesh-ancestor
139089829|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
139089830|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089831|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139089832|NCT02530788|Selenium|selenium|mesh-list
139089833|NCT02530788|Selenious Acid|selenious acid|mesh-list
139089834|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
139089835|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
139089836|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089837|NCT02530788|Protective Agents|protective agents|mesh-ancestor
139089838|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089839|NCT02530788|Trace Elements|trace elements|mesh-ancestor
139089840|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
139089841|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
139089842|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139089843|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089844|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139089845|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089846|NCT01089192|Metformin|metformin|mesh-list
139089847|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139089848|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089849|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
139089850|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139089851|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089852|NCT02564380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139089853|NCT02564380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089854|NCT01093092|Calcitriol|calcitriol|mesh-list
139089855|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
139089856|NCT01093092|Gemcitabine|gemcitabine|mesh-list
139089857|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089858|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139089859|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
139089860|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089861|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139089862|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089863|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139089864|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139089865|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139089866|NCT01093092|Vitamins|vitamins|mesh-ancestor
139089867|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
139072855|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089868|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139089869|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
139089870|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089871|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139089872|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089873|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089874|NCT01179776|Iloprost|iloprost|mesh-list
139089875|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139089876|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
139089877|NCT01181414|Amiodarone|amiodarone|mesh-list
139089878|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139089879|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139089880|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
139089881|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139089882|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089883|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089884|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139089885|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
139089886|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139089887|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139089888|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139089889|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139089890|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139089891|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089892|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139089893|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139089894|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139089895|NCT01094340|Thalidomide|thalidomide|mesh-list
139089896|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139089897|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
139089898|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089899|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
139089900|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139089901|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089902|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138840484|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139089903|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139303898|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139089904|NCT01094340|Growth Substances|growth substances|mesh-ancestor
139089905|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
139089906|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089907|NCT00056862|Ribavirin|ribavirin|mesh-list
139089908|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139089909|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
139089910|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
139089911|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089912|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
139089913|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089914|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
139089915|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089916|NCT01289132|Candesartan|candesartan|mesh-list
139089917|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
139089918|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139089919|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139089920|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139089921|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139089922|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089923|NCT01287260|Nifedipine|nifedipine|mesh-list
139072881|NCT01086254|Gemcitabine|gemcitabine|mesh-list
139089924|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139089925|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139089926|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089927|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139089928|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089929|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
139089930|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
139089931|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139089932|NCT01181570|Adalimumab|adalimumab|mesh-list
139089933|NCT01181570|Mannitol|mannitol|mesh-list
139089934|NCT01181570|Citric Acid|citric acid|mesh-list
139089935|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
139089936|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
139089937|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139089938|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
139089939|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
139089940|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089941|NCT01181570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139089942|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139089943|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139089944|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139089945|NCT01181570|Diuretics|diuretics|mesh-ancestor
139089946|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
139089947|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089948|NCT05200312|Prednisone|prednisone|mesh-list
139089949|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
139089950|NCT05200312|Rituximab|rituximab|mesh-list
139089951|NCT05200312|Doxorubicin|doxorubicin|mesh-list
139089952|NCT05200312|Vincristine|vincristine|mesh-list
139089953|NCT05200312|Lenalidomide|lenalidomide|mesh-list
139089954|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
139089955|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139089956|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
139089957|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139089958|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139089959|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139089960|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
139089961|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139089962|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089963|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139089964|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139089965|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139089966|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139089967|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139089968|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139089969|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139089970|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
139089971|NCT05200312|Hormones|hormones|mesh-ancestor
139089972|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139089973|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139089974|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139089975|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
139089976|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
139089977|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
139089978|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139089979|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139089980|NCT05200312|Growth Substances|growth substances|mesh-ancestor
139089981|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
139089982|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139089983|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
139089984|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139089985|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139089986|NCT02940730|Dalbavancin|dalbavancin|mesh-list
139089987|NCT02940730|Teicoplanin|teicoplanin|mesh-list
139089988|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139089989|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139089990|NCT01587638|Metoprolol|metoprolol|mesh-list
139089991|NCT01587638|Atenolol|atenolol|mesh-list
139089992|NCT01587638|Carvedilol|carvedilol|mesh-list
139089993|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
139089994|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139089995|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139089996|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
139089997|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
139089998|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139089999|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090000|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139090001|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139090002|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
139090003|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139090004|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090005|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
139090006|NCT01587638|Protective Agents|protective agents|mesh-ancestor
139090007|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139090008|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139090009|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139090010|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
139090011|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139090012|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139090013|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139090014|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139090015|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139090016|NCT01287338|Analgesics|analgesics|mesh-ancestor
139090017|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
139090018|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090019|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090020|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139090021|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139090022|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139090023|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139090024|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139090025|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
139090026|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
139090027|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139090028|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090030|NCT01180322|Etoposide|etoposide|mesh-list
139090031|NCT01180322|Idarubicin|idarubicin|mesh-list
139090032|NCT01180322|Azacitidine|azacitidine|mesh-list
139090033|NCT01180322|Lenograstim|lenograstim|mesh-list
139090034|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139090035|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090036|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139090037|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139090038|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090039|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090040|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139090041|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
139090042|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
139090043|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139090044|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090045|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
139090046|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090047|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139090048|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139090049|NCT01287494|Sertraline|sertraline|mesh-list
139090050|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
139090051|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139090052|NCT01287494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139090053|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139090054|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139090055|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090056|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139090058|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090059|NCT02524964|Tanshinone|tanshinone|mesh-list
139090060|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139090061|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139090062|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139090063|NCT02524964|Analgesics|analgesics|mesh-ancestor
139090064|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
139090065|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090066|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090067|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139090068|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139090069|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
139090070|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139090071|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090072|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090073|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
139090074|NCT01289756|Clarithromycin|clarithromycin|mesh-list
139090075|NCT01289756|Paroxetine|paroxetine|mesh-list
139090076|NCT01289756|Clomiphene|clomiphene|mesh-list
139090077|NCT01289756|Enclomiphene|enclomiphene|mesh-list
139090078|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
139090079|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139090080|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139090081|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139090082|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090083|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090084|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139090085|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139090086|NCT01289756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139090087|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139090088|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139090089|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139090090|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
139090091|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090092|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139090093|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
139090094|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139175084|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139090095|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139090096|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139090097|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
139090098|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139090099|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139090100|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
139090101|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139090102|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139090103|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139090104|NCT01181882|Aspirin|aspirin|mesh-list
139090105|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139090106|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139090107|NCT01181882|Analgesics|analgesics|mesh-ancestor
139090108|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
139090109|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090110|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090111|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139090112|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139090113|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139090114|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139090115|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090116|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139090117|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139090118|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090119|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
139090120|NCT01181960|Risperidone|risperidone|mesh-list
139090121|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139090122|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
139090123|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139090124|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
139090125|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138840712|NCT02834286|Hormones|hormones|mesh-ancestor
139090126|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090127|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090128|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139090129|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139090130|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139090131|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139090132|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
139090133|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139090134|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139090135|NCT03858062|Insulin|insulin|mesh-list
139090136|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139090137|NCT03858062|Pancrelipase|pancrelipase|mesh-list
139090138|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139090139|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090140|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139090141|NCT03307174|Fentanyl|fentanyl|mesh-list
139090142|NCT03307174|Bupivacaine|bupivacaine|mesh-list
139090143|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
139090144|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
139090145|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139090146|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090147|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
139090148|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090149|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139090150|NCT03307174|Narcotics|narcotics|mesh-ancestor
139090151|NCT03307174|Analgesics|analgesics|mesh-ancestor
139090152|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139090153|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139090154|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
139090155|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
139090156|NCT03448978|Fludarabine|fludarabine|mesh-list
139090157|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090158|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
139090159|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090160|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139090161|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139090162|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
139090163|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090164|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090165|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139090166|NCT01290926|Sorafenib|sorafenib|mesh-list
139090167|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090168|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139090169|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090170|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090171|NCT01185236|Atorvastatin|atorvastatin|mesh-list
139090172|NCT01185236|Simvastatin|simvastatin|mesh-list
139090173|NCT01185236|Ezetimibe|ezetimibe|mesh-list
139090174|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139090175|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139090176|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
139090177|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090178|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139090179|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139090180|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090181|NCT02524652|Ropivacaine|ropivacaine|mesh-list
139090182|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
139090183|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
139090184|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139090185|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090186|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
139090187|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090188|NCT01182272|Sorafenib|sorafenib|mesh-list
139090189|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090190|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139090191|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090192|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090193|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139090194|NCT01185470|Morphine|morphine|mesh-list
139090195|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139090196|NCT01185470|Narcotics|narcotics|mesh-ancestor
139090197|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139090198|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090199|NCT01185470|Analgesics|analgesics|mesh-ancestor
139090200|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
139090201|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090203|NCT00056160|Lenalidomide|lenalidomide|mesh-list
139090204|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139090205|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
139090207|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090208|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090209|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139090210|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
139090211|NCT00056160|Hormones|hormones|mesh-ancestor
139090212|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139175121|NCT03891277|Hematinics|hematinics|mesh-ancestor
139090213|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139090214|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090215|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
139090216|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139090217|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139090218|NCT00056160|Growth Substances|growth substances|mesh-ancestor
139090219|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
139090220|NCT01290146|Simendan|simendan|mesh-list
139090221|NCT01290146|Diuretics|diuretics|mesh-list
139090222|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
139090223|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090224|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139090225|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
139090226|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139090227|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139090228|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090229|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090230|NCT01290146|Protective Agents|protective agents|mesh-ancestor
139090231|NCT00061932|Irinotecan|irinotecan|mesh-list
139090232|NCT00061932|Bortezomib|bortezomib|mesh-list
139090233|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139090234|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139090235|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090236|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090237|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090238|NCT03856970|Glyburide|glyburide|mesh-list
139090239|NCT03856970|Digoxin|digoxin|mesh-list
139090240|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139090241|NCT03856970|Norethindrone|norethindrone|mesh-list
139090242|NCT03856970|Estradiol|estradiol|mesh-list
139090243|NCT03856970|Estrogens|estrogens|mesh-ancestor
139090244|NCT03856970|Hormones|hormones|mesh-ancestor
139090245|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139090246|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090247|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139090248|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
139090249|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139090250|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139090251|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139090252|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139090253|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139090254|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139090255|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090256|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090257|NCT03856970|Protective Agents|protective agents|mesh-ancestor
139090258|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139090259|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139090260|NCT06193837|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139090261|NCT06193837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139090262|NCT06193837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139090263|NCT06193837|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139090264|NCT06193837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090265|NCT06193837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090266|NCT06193616|Octreotide|octreotide|mesh-list
139090267|NCT06193616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139090268|NCT06193616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139090269|NCT06193616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090270|NCT06193525|Talazoparib|talazoparib|mesh-list
139090271|NCT06193525|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139090272|NCT06193525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090273|NCT06193525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090274|NCT06193525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090275|NCT06193486|Cyclophosphamide|cyclophosphamide|mesh-list
139090276|NCT06193486|Fludarabine|fludarabine|mesh-list
139090277|NCT06193486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090278|NCT06193486|Immunologic Factors|immunologic factors|mesh-ancestor
139090279|NCT06193486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090281|NCT06193486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139090282|NCT06193486|Alkylating Agents|alkylating agents|mesh-ancestor
139175125|NCT03888157|Incretins|incretins|mesh-ancestor
139090283|NCT06193486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090284|NCT06193486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090285|NCT06193486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139090286|NCT06193421|Ambroxol|ambroxol|mesh-list
139090287|NCT06193421|Expectorants|expectorants|mesh-ancestor
139090288|NCT06193421|Respiratory System Agents|respiratory system agents|mesh-ancestor
139090289|NCT06193330|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139090290|NCT06193330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139090291|NCT06193304|Eliglustat|eliglustat|mesh-list
139090292|NCT06193304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090293|NCT06193304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090294|NCT06193187|Valsartan|valsartan|mesh-list
139090295|NCT06193187|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139090296|NCT06193187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139090297|NCT06193187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139090298|NCT06193187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139090299|NCT06193187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090300|NCT06193031|Treprostinil|treprostinil|mesh-list
139090301|NCT06193031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139090302|NCT06192979|Dexamethasone|dexamethasone|mesh-list
139090303|NCT06192979|Bortezomib|bortezomib|mesh-list
139090304|NCT06192979|Venetoclax|venetoclax|mesh-list
139090305|NCT06192979|Daratumumab|daratumumab|mesh-list
139090306|NCT06192979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139090307|NCT06192979|Antiemetics|antiemetics|mesh-ancestor
139090308|NCT06192979|Autonomic Agents|autonomic agents|mesh-ancestor
139090309|NCT06192979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090310|NCT06192979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090311|NCT06192979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139090312|NCT06192979|Glucocorticoids|glucocorticoids|mesh-ancestor
139090313|NCT06192979|Hormones|hormones|mesh-ancestor
139090314|NCT06192979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139090315|NCT06192979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139090316|NCT06192979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090317|NCT06192849|Aflutinib|aflutinib|mesh-list
139090318|NCT06192849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139090319|NCT06192849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090320|NCT06192849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090321|NCT06192797|Lenvatinib|lenvatinib|mesh-list
139090322|NCT06192797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090323|NCT06192797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139090324|NCT06192797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090325|NCT06192797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090326|NCT06192693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139090327|NCT06192641|Melatonin|melatonin|mesh-list
139090328|NCT06192641|Antioxidants|antioxidants|mesh-ancestor
139090329|NCT06192641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090330|NCT06192641|Protective Agents|protective agents|mesh-ancestor
139090331|NCT06192641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090332|NCT06192641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139090333|NCT06192615|Dexmedetomidine|dexmedetomidine|mesh-list
139090334|NCT06192615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139090335|NCT06192615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139090336|NCT06192615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090337|NCT06192615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139090338|NCT06192615|Analgesics|analgesics|mesh-ancestor
139090339|NCT06192615|Sensory System Agents|sensory system agents|mesh-ancestor
139090340|NCT06192615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090341|NCT06192615|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139090342|NCT06192615|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139090343|NCT06192615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139090344|NCT06192615|Adrenergic Agents|adrenergic agents|mesh-ancestor
139090345|NCT06192615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139090346|NCT06192615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090347|NCT06192472|Polidocanol|polidocanol|mesh-list
139090348|NCT06192472|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
139090349|NCT06192472|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139090350|NCT06192472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139090351|NCT06192420|Diclofenac|diclofenac|mesh-list
139090352|NCT06192420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139090355|NCT06192420|Sensory System Agents|sensory system agents|mesh-ancestor
139090356|NCT06192420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090357|NCT06192420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090358|NCT06192420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139090359|NCT06192420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139090360|NCT06192420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139090361|NCT06192420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090362|NCT06192420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090363|NCT06192407|Palmitic Acid|palmitic acid|mesh-list
139090364|NCT06192407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090365|NCT06192407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090366|NCT06192303|Dimercaprol|dimercaprol|mesh-list
139090367|NCT06192303|Chelating Agents|chelating agents|mesh-ancestor
139090368|NCT06192303|Sequestering Agents|sequestering agents|mesh-ancestor
139090369|NCT06192303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090370|NCT06192277|Penicillins|penicillins|mesh-list
139090371|NCT06192277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139090372|NCT06192277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139090375|NCT06192147|Vitamin D|vitamin d|mesh-list
139090376|NCT06192147|Vitamins|vitamins|mesh-ancestor
139090377|NCT06192147|Micronutrients|micronutrients|mesh-ancestor
139090378|NCT06192147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090379|NCT06192147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139090380|NCT06192082|Anesthetics|anesthetics|mesh-list
139090381|NCT06192082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139090382|NCT06192082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090383|NCT06191991|Atorvastatin|atorvastatin|mesh-list
139090384|NCT06191991|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139090385|NCT06191991|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139090386|NCT06191991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139090387|NCT06191991|Antimetabolites|antimetabolites|mesh-ancestor
139090388|NCT06191991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090389|NCT06191991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139073022|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
139090390|NCT06191991|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139090391|NCT06191991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090392|NCT06191978|Venetoclax|venetoclax|mesh-list
139090393|NCT06191978|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139090394|NCT06191978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090395|NCT06191978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139090396|NCT06191978|Antimetabolites|antimetabolites|mesh-ancestor
139090397|NCT06191978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090398|NCT06191887|Cyclophosphamide|cyclophosphamide|mesh-list
139090399|NCT06191887|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139090400|NCT06191887|Fludarabine|fludarabine|mesh-list
139090401|NCT06191887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090402|NCT06191887|Immunologic Factors|immunologic factors|mesh-ancestor
139090403|NCT06191887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090404|NCT06191887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139090405|NCT06191887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139090406|NCT06191887|Alkylating Agents|alkylating agents|mesh-ancestor
139090407|NCT06191887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090408|NCT06191887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090409|NCT06191887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139090410|NCT06191796|Nivolumab|nivolumab|mesh-list
139090411|NCT06191796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139090412|NCT06191796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090413|NCT06191796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139090414|NCT06191796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090415|NCT06191770|Morphine|morphine|mesh-list
139090416|NCT06191770|Nalbuphine|nalbuphine|mesh-list
139090417|NCT06191770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139090418|NCT06191770|Narcotics|narcotics|mesh-ancestor
139090419|NCT06191770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139090420|NCT06191770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090421|NCT06191770|Analgesics|analgesics|mesh-ancestor
139175142|NCT01260727|Vaccines|vaccines|mesh-list
139090422|NCT06191770|Sensory System Agents|sensory system agents|mesh-ancestor
139090423|NCT06191770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090424|NCT06191744|Prednisone|prednisone|mesh-list
139090425|NCT06191744|Cyclophosphamide|cyclophosphamide|mesh-list
139090426|NCT06191744|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139090427|NCT06191744|Rituximab|rituximab|mesh-list
139090429|NCT06191744|Vincristine|vincristine|mesh-list
139090430|NCT06191744|Lenalidomide|lenalidomide|mesh-list
139090431|NCT06191744|Obinutuzumab|obinutuzumab|mesh-list
139090432|NCT06191744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090433|NCT06191744|Immunologic Factors|immunologic factors|mesh-ancestor
139090434|NCT06191744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090435|NCT06191744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139090436|NCT06191744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139090437|NCT06191744|Alkylating Agents|alkylating agents|mesh-ancestor
139090438|NCT06191744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090439|NCT06191744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090440|NCT06191744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139090441|NCT06191744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139090442|NCT06191744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139090443|NCT06191744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139090444|NCT06191744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139090445|NCT06191744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090446|NCT06191744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139090447|NCT06191744|Glucocorticoids|glucocorticoids|mesh-ancestor
139090448|NCT06191744|Hormones|hormones|mesh-ancestor
139090449|NCT06191744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139090450|NCT06191744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139090451|NCT06191744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139090452|NCT06191744|Tubulin Modulators|tubulin modulators|mesh-ancestor
139090453|NCT06191744|Antimitotic Agents|antimitotic agents|mesh-ancestor
139090454|NCT06191744|Mitosis Modulators|mitosis modulators|mesh-ancestor
139090455|NCT06191744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139090456|NCT06191744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139090457|NCT06191744|Growth Substances|growth substances|mesh-ancestor
139090458|NCT06191744|Growth Inhibitors|growth inhibitors|mesh-ancestor
139090459|NCT06188728|Psyllium|psyllium|mesh-list
139090460|NCT06188728|Calcium polycarbophil|calcium polycarbophil|mesh-list
139090461|NCT06188728|Cathartics|cathartics|mesh-ancestor
139090462|NCT06188728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139090463|NCT06188728|Antidiarrheals|antidiarrheals|mesh-ancestor
139090464|NCT06188585|Epinephrine|epinephrine|mesh-list
139090465|NCT06188585|Racepinephrine|racepinephrine|mesh-list
139090466|NCT06188585|Hemostatics|hemostatics|mesh-list
139090467|NCT06188585|Epinephryl borate|epinephryl borate|mesh-list
139090468|NCT06188585|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139090469|NCT06188585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139090470|NCT06188585|Adrenergic Agents|adrenergic agents|mesh-ancestor
139090471|NCT06188585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139090472|NCT06188585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090473|NCT06188585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090474|NCT06188585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139090475|NCT06188585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139090476|NCT06188585|Autonomic Agents|autonomic agents|mesh-ancestor
139090477|NCT06188585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090478|NCT06188585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139090479|NCT06188585|Respiratory System Agents|respiratory system agents|mesh-ancestor
139090480|NCT06188585|Mydriatics|mydriatics|mesh-ancestor
139090481|NCT06188585|Sympathomimetics|sympathomimetics|mesh-ancestor
139090482|NCT06188585|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139090483|NCT06188585|Coagulants|coagulants|mesh-ancestor
139090484|NCT06187285|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139090485|NCT06187285|Empagliflozin|empagliflozin|mesh-list
139090486|NCT06187285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139090487|NCT06187285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090488|NCT06187285|Incretins|incretins|mesh-ancestor
139090489|NCT06187285|Hormones|hormones|mesh-ancestor
139090490|NCT06187285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139090491|NCT06187285|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139090492|NCT06187285|Protease Inhibitors|protease inhibitors|mesh-ancestor
139090493|NCT06187285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090494|NCT06187285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090495|NCT06187285|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139090496|NCT06184750|Tamoxifen|tamoxifen|mesh-list
138841094|NCT04798482|Analgesics|analgesics|mesh-ancestor
139090497|NCT06184750|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139090498|NCT06184750|Hormone Antagonists|hormone antagonists|mesh-ancestor
139090499|NCT06184750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139090500|NCT06184750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090501|NCT06184750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139090502|NCT06184750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090503|NCT06184750|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139090504|NCT06184750|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139090505|NCT06184750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139090506|NCT06182839|Canagliflozin|canagliflozin|mesh-list
139090507|NCT06182839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139090508|NCT06182839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090509|NCT06182839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139090510|NCT06182839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090511|NCT06181734|Ivosidenib|ivosidenib|mesh-list
139090512|NCT06181734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090513|NCT06181734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090514|NCT06181734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090515|NCT06179290|Menthol|menthol|mesh-list
139090516|NCT06179290|Antipruritics|antipruritics|mesh-ancestor
139090517|NCT06179290|Dermatologic Agents|dermatologic agents|mesh-ancestor
139090518|NCT06162221|Carboplatin|carboplatin|mesh-list
139090519|NCT06162221|Pembrolizumab|pembrolizumab|mesh-list
139090520|NCT06162221|Pemetrexed|pemetrexed|mesh-list
139090521|NCT06162221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090522|NCT06162221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139090523|NCT06162221|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139090524|NCT06162221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090525|NCT06162221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090526|NCT06162221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139090527|NCT06162221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139090528|NCT06159647|Liver Extracts|liver extracts|mesh-list
139090529|NCT06159647|Hematinics|hematinics|mesh-ancestor
139090530|NCT06152575|Dexamethasone|dexamethasone|mesh-list
139090531|NCT06152575|Bortezomib|bortezomib|mesh-list
139090532|NCT06152575|Pomalidomide|pomalidomide|mesh-list
139090533|NCT06152575|Elotuzumab|elotuzumab|mesh-list
139090534|NCT06152575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139090535|NCT06152575|Antiemetics|antiemetics|mesh-ancestor
139090536|NCT06152575|Autonomic Agents|autonomic agents|mesh-ancestor
139090537|NCT06152575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090538|NCT06152575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090539|NCT06152575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139090540|NCT06152575|Glucocorticoids|glucocorticoids|mesh-ancestor
139090541|NCT06152575|Hormones|hormones|mesh-ancestor
139090542|NCT06152575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139090543|NCT06152575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139090544|NCT06152575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090545|NCT06152575|Immunologic Factors|immunologic factors|mesh-ancestor
139090546|NCT06152575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139090547|NCT06152575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139090548|NCT06152575|Growth Substances|growth substances|mesh-ancestor
139090549|NCT06152575|Growth Inhibitors|growth inhibitors|mesh-ancestor
139090560|NCT06125054|Analgesics|analgesics|mesh-ancestor
139090561|NCT06125054|Sensory System Agents|sensory system agents|mesh-ancestor
139090562|NCT06125054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090563|NCT06125054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090564|NCT06125054|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139090565|NCT06125054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139090566|NCT06125054|Anesthetics, General|anesthetics, general|mesh-ancestor
139090567|NCT06125054|Anesthetics|anesthetics|mesh-ancestor
139090568|NCT06125054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139090569|NCT06125054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139090570|NCT06125054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139090571|NCT06125054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139090572|NCT06125054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090573|NCT06120283|Letrozole|letrozole|mesh-list
139090574|NCT06120283|Fulvestrant|fulvestrant|mesh-list
139090575|NCT06120283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090577|NCT06120283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139090578|NCT06120283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090579|NCT06120283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090580|NCT06120283|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139090581|NCT06120283|Hormone Antagonists|hormone antagonists|mesh-ancestor
139090582|NCT06120283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139090583|NCT06120283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090584|NCT06120283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139090585|NCT06120283|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139090586|NCT06101329|Tenofovir|tenofovir|mesh-list
139090587|NCT06101329|Emtricitabine|emtricitabine|mesh-list
139090588|NCT06101329|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139090589|NCT06101329|Antiviral Agents|antiviral agents|mesh-ancestor
139090590|NCT06101329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139090591|NCT06101329|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139090592|NCT06101329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139090593|NCT06101329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090594|NCT06101329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090595|NCT06101329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139090596|NCT06101329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139090597|NCT06090669|Imatinib Mesylate|imatinib mesylate|mesh-list
139090598|NCT06090669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090599|NCT06090669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139090600|NCT06090669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090601|NCT06090669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090602|NCT06079879|Interferons|interferons|mesh-list
139090603|NCT06079879|Interferon-alpha|interferon-alpha|mesh-list
139090604|NCT06079879|Busulfan|busulfan|mesh-list
139090605|NCT06079879|Anagrelide|anagrelide|mesh-list
139090606|NCT06079879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090607|NCT06079879|Antiviral Agents|antiviral agents|mesh-ancestor
139090608|NCT06079879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139090609|NCT06079879|Immunologic Factors|immunologic factors|mesh-ancestor
139090610|NCT06079879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090611|NCT06079879|Alkylating Agents|alkylating agents|mesh-ancestor
139090612|NCT06079879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090613|NCT06079879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090614|NCT06079879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139090615|NCT06079879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139090616|NCT06079879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139090617|NCT06079879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139090618|NCT06079879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139090619|NCT06076135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139090620|NCT06076135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090621|NCT06076135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139090622|NCT06076135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090623|NCT06070649|Diphenhydramine|diphenhydramine|mesh-list
139090624|NCT06070649|Promethazine|promethazine|mesh-list
139090625|NCT06070649|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
139090626|NCT06070649|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139090627|NCT06070649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139090628|NCT06070649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139090629|NCT06070649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090630|NCT06070649|Anesthetics, Local|anesthetics, local|mesh-ancestor
139090631|NCT06070649|Anesthetics|anesthetics|mesh-ancestor
139090632|NCT06070649|Sensory System Agents|sensory system agents|mesh-ancestor
139090633|NCT06070649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090634|NCT06070649|Antiemetics|antiemetics|mesh-ancestor
139090635|NCT06070649|Autonomic Agents|autonomic agents|mesh-ancestor
139090636|NCT06070649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139090637|NCT06070649|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139090638|NCT06070649|Histamine Antagonists|histamine antagonists|mesh-ancestor
139090639|NCT06070649|Histamine Agents|histamine agents|mesh-ancestor
139090640|NCT06070649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139090641|NCT06070649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090642|NCT06070649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139090643|NCT06070649|Antipruritics|antipruritics|mesh-ancestor
139090644|NCT06070649|Dermatologic Agents|dermatologic agents|mesh-ancestor
139090645|NCT06070649|Hallucinogens|hallucinogens|mesh-ancestor
139090646|NCT06070649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139090647|NCT06070649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139090648|NCT06070649|Serotonin Agents|serotonin agents|mesh-ancestor
139090649|NCT06070649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139090651|NCT06047379|Bevacizumab|bevacizumab|mesh-list
139090652|NCT06047379|Carboplatin|carboplatin|mesh-list
139090653|NCT06047379|Pembrolizumab|pembrolizumab|mesh-list
139090654|NCT06047379|Nivolumab|nivolumab|mesh-list
139090655|NCT06047379|Ipilimumab|ipilimumab|mesh-list
139090656|NCT06047379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139090657|NCT06047379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090658|NCT06047379|Tubulin Modulators|tubulin modulators|mesh-ancestor
139090659|NCT06047379|Antimitotic Agents|antimitotic agents|mesh-ancestor
139090660|NCT06047379|Mitosis Modulators|mitosis modulators|mesh-ancestor
139090661|NCT06047379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090662|NCT06047379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139090663|NCT06047379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139090664|NCT06047379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139090665|NCT06047379|Growth Substances|growth substances|mesh-ancestor
139090666|NCT06047379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090667|NCT06047379|Growth Inhibitors|growth inhibitors|mesh-ancestor
139090668|NCT06047379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139090669|NCT06042270|Betaine|betaine|mesh-list
139090670|NCT06042270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139090671|NCT06042270|Lipotropic Agents|lipotropic agents|mesh-ancestor
139090672|NCT06042270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139090673|NCT06042270|Antimetabolites|antimetabolites|mesh-ancestor
139090674|NCT06042270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090675|NCT06042270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139090676|NCT06039384|Adagrasib|adagrasib|mesh-list
139090677|NCT06039384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090678|NCT06036914|Furosemide|furosemide|mesh-list
139090679|NCT06036914|Bumetanide|bumetanide|mesh-list
139090680|NCT06036914|Diuretics|diuretics|mesh-list
139090681|NCT06036914|Natriuretic Agents|natriuretic agents|mesh-ancestor
139090682|NCT06036914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090683|NCT06036914|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139090684|NCT06036914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139090685|NCT06036914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090686|NCT06023862|Paclitaxel|paclitaxel|mesh-list
139090687|NCT06023862|Bevacizumab|bevacizumab|mesh-list
139090688|NCT06023862|Gemcitabine|gemcitabine|mesh-list
139090689|NCT06023862|Doxorubicin|doxorubicin|mesh-list
139090693|NCT06023862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090694|NCT06023862|Tubulin Modulators|tubulin modulators|mesh-ancestor
139090695|NCT06023862|Antimitotic Agents|antimitotic agents|mesh-ancestor
139090696|NCT06023862|Mitosis Modulators|mitosis modulators|mesh-ancestor
139090697|NCT06023862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090698|NCT06023862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139090699|NCT06023862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139090700|NCT06023862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139090701|NCT06023862|Growth Substances|growth substances|mesh-ancestor
139090702|NCT06023862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090703|NCT06023862|Growth Inhibitors|growth inhibitors|mesh-ancestor
139090704|NCT06023862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139090705|NCT06023862|Antimetabolites|antimetabolites|mesh-ancestor
139090706|NCT06023862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139090707|NCT06023862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139090708|NCT06023862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139090709|NCT06023862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090710|NCT06001385|Mycophenolic Acid|mycophenolic acid|mesh-list
139090711|NCT06001385|Cyclophosphamide|cyclophosphamide|mesh-list
139090712|NCT06001385|Melphalan|melphalan|mesh-list
139090713|NCT06001385|Busulfan|busulfan|mesh-list
139090714|NCT06001385|Fludarabine|fludarabine|mesh-list
139090715|NCT06001385|Tacrolimus|tacrolimus|mesh-list
139090716|NCT06001385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090717|NCT06001385|Immunologic Factors|immunologic factors|mesh-ancestor
139090718|NCT06001385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090719|NCT06001385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139090720|NCT06001385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139090721|NCT06001385|Alkylating Agents|alkylating agents|mesh-ancestor
139090722|NCT06001385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090723|NCT06001385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090724|NCT06001385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139090725|NCT06001385|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139090726|NCT06001385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090727|NCT06001385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139090728|NCT06001385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139090729|NCT06001385|Antitubercular Agents|antitubercular agents|mesh-ancestor
139090730|NCT06001385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139090731|NCT06001385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139090732|NCT05981703|Tislelizumab|tislelizumab|mesh-list
139090733|NCT05981703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139090734|NCT05981703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090735|NCT05935098|Tislelizumab|tislelizumab|mesh-list
139090736|NCT05935098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139090737|NCT05935098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090741|NCT05906836|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139090742|NCT05906836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139090743|NCT05906836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139090744|NCT05906836|Antimetabolites|antimetabolites|mesh-ancestor
139090745|NCT05906836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090746|NCT05906836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139090747|NCT05906836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139090748|NCT05906836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090749|NCT05904496|Tislelizumab|tislelizumab|mesh-list
139090750|NCT05904496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139090751|NCT05904496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090752|NCT05895955|Vaccines|vaccines|mesh-list
139090753|NCT05895955|Immunologic Factors|immunologic factors|mesh-ancestor
139090754|NCT05895955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090755|NCT05878717|Belimumab|belimumab|mesh-list
139090756|NCT05878717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090757|NCT05878717|Immunologic Factors|immunologic factors|mesh-ancestor
139090758|NCT05878717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090759|NCT05869955|Cyclophosphamide|cyclophosphamide|mesh-list
139090760|NCT05869955|Fludarabine|fludarabine|mesh-list
139090761|NCT05869955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090762|NCT05869955|Immunologic Factors|immunologic factors|mesh-ancestor
139090763|NCT05869955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090764|NCT05869955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139090765|NCT05869955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139090766|NCT05869955|Alkylating Agents|alkylating agents|mesh-ancestor
139090767|NCT05869955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090768|NCT05869955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090769|NCT05869955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139090770|NCT05862285|Ipatasertib|ipatasertib|mesh-list
139090771|NCT05862285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090772|NCT05862285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139090773|NCT05862285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090774|NCT05862285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090775|NCT05859412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139090776|NCT05859412|Methylprednisolone|methylprednisolone|mesh-list
139090777|NCT05859412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139090778|NCT05859412|Prednisolone|prednisolone|mesh-list
139090779|NCT05859412|Prednisolone acetate|prednisolone acetate|mesh-list
139090780|NCT05859412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139090781|NCT05859412|Prednisolone phosphate|prednisolone phosphate|mesh-list
139090782|NCT05859412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139090783|NCT05859412|Antiemetics|antiemetics|mesh-ancestor
139090784|NCT05859412|Autonomic Agents|autonomic agents|mesh-ancestor
139090785|NCT05859412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073097|NCT01045889|Vincristine|vincristine|mesh-list
139090786|NCT05859412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090787|NCT05859412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139090788|NCT05859412|Glucocorticoids|glucocorticoids|mesh-ancestor
139090789|NCT05859412|Hormones|hormones|mesh-ancestor
139090790|NCT05859412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139090791|NCT05859412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139090792|NCT05859412|Protective Agents|protective agents|mesh-ancestor
139090793|NCT05859412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139090794|NCT05859412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090795|NCT05851547|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139090796|NCT05851547|Androgens|androgens|mesh-list
139090797|NCT05851547|Hormones|hormones|mesh-ancestor
139090798|NCT05851547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139090799|NCT05851547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138841386|NCT00248287|Carboplatin|carboplatin|mesh-list
139090800|NCT05851547|Luteolytic Agents|luteolytic agents|mesh-ancestor
139090801|NCT05851547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139090802|NCT05851547|Contraceptive Agents|contraceptive agents|mesh-ancestor
139090804|NCT05851547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139090805|NCT05851547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139090806|NCT05851547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090807|NCT05824871|Bedaquiline|bedaquiline|mesh-list
139090808|NCT05824871|Antitubercular Agents|antitubercular agents|mesh-ancestor
139090809|NCT05824871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139090810|NCT05824871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139090811|NCT05776056|Methylphenidate|methylphenidate|mesh-list
139090812|NCT05776056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139090813|NCT05776056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090814|NCT05776056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139090815|NCT05776056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139090816|NCT05776056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139090817|NCT05776056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090818|NCT05776056|Dopamine Agents|dopamine agents|mesh-ancestor
139090819|NCT05776056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139090820|NCT05772169|Mifepristone|mifepristone|mesh-list
139090821|NCT05772169|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139090822|NCT05772169|Abortifacient Agents|abortifacient agents|mesh-ancestor
139090823|NCT05772169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139090824|NCT05772169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090825|NCT05772169|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139090826|NCT05772169|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139090827|NCT05772169|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139090828|NCT05772169|Contraceptive Agents|contraceptive agents|mesh-ancestor
139090829|NCT05772169|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139090830|NCT05772169|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139090831|NCT05772169|Hormone Antagonists|hormone antagonists|mesh-ancestor
139090832|NCT05772169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139090833|NCT05772169|Luteolytic Agents|luteolytic agents|mesh-ancestor
139090834|NCT05772169|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139090835|NCT05772169|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139090836|NCT05770102|Atezolizumab|atezolizumab|mesh-list
139090837|NCT05770102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139090838|NCT05770102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090839|NCT05770102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139090840|NCT05770102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090841|NCT05750056|Lidocaine|lidocaine|mesh-list
139090842|NCT05750056|Sufentanil|sufentanil|mesh-list
139090843|NCT05750056|Dsuvia|dsuvia|mesh-list
139090844|NCT05750056|Propofol|propofol|mesh-list
139090845|NCT05750056|Anesthetics, Local|anesthetics, local|mesh-ancestor
139090846|NCT05750056|Anesthetics|anesthetics|mesh-ancestor
139090847|NCT05750056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139073103|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
139090848|NCT05750056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090849|NCT05750056|Sensory System Agents|sensory system agents|mesh-ancestor
139090850|NCT05750056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090851|NCT05750056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139090852|NCT05750056|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139090853|NCT05750056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139090854|NCT05750056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139090855|NCT05750056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090856|NCT05750056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139090857|NCT05750056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139090858|NCT05750056|Anesthetics, General|anesthetics, general|mesh-ancestor
139090859|NCT05750056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139090860|NCT05750056|Narcotics|narcotics|mesh-ancestor
139090861|NCT05750056|Analgesics|analgesics|mesh-ancestor
139090862|NCT05750056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139090863|NCT05741164|Pembrolizumab|pembrolizumab|mesh-list
139090864|NCT05741164|Propranolol|propranolol|mesh-list
139090865|NCT05741164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139090866|NCT05741164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090867|NCT05741164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139090868|NCT05741164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090869|NCT05741164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139090870|NCT05741164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139090871|NCT05741164|Adrenergic Agents|adrenergic agents|mesh-ancestor
139090872|NCT05741164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139090873|NCT05741164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090874|NCT05741164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139090875|NCT05741164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139090876|NCT05741164|Vasodilator Agents|vasodilator agents|mesh-ancestor
139090877|NCT05731973|Sufentanil|sufentanil|mesh-list
139090878|NCT05731973|Oxycodone|oxycodone|mesh-list
139090879|NCT05731973|Analgesics, Opioid|analgesics, opioid|mesh-list
139090880|NCT05731973|Bupivacaine|bupivacaine|mesh-list
139090881|NCT05731973|Anesthetics, Local|anesthetics, local|mesh-ancestor
139090882|NCT05731973|Anesthetics|anesthetics|mesh-ancestor
139090883|NCT05731973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139090884|NCT05731973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090885|NCT05731973|Sensory System Agents|sensory system agents|mesh-ancestor
139090886|NCT05731973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090887|NCT05731973|Narcotics|narcotics|mesh-ancestor
139090888|NCT05731973|Analgesics|analgesics|mesh-ancestor
139090889|NCT05731973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139090890|NCT05731973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139090891|NCT05731973|Anesthetics, General|anesthetics, general|mesh-ancestor
139090892|NCT05722418|Cyclophosphamide|cyclophosphamide|mesh-list
139090893|NCT05722418|Fludarabine|fludarabine|mesh-list
139090894|NCT05722418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090895|NCT05722418|Immunologic Factors|immunologic factors|mesh-ancestor
139090896|NCT05722418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090897|NCT05722418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139090898|NCT05722418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139090899|NCT05722418|Alkylating Agents|alkylating agents|mesh-ancestor
139090900|NCT05722418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090901|NCT05722418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090902|NCT05722418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139090903|NCT05718583|Butyric Acid|butyric acid|mesh-list
139090904|NCT05718583|Histamine Antagonists|histamine antagonists|mesh-ancestor
139090905|NCT05718583|Histamine Agents|histamine agents|mesh-ancestor
139090906|NCT05718583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139090907|NCT05718583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073114|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139090908|NCT05718583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090909|NCT05702229|Capecitabine|capecitabine|mesh-list
139090910|NCT05702229|Fluorouracil|fluorouracil|mesh-list
139090911|NCT05702229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139090912|NCT05702229|Antimetabolites|antimetabolites|mesh-ancestor
139090913|NCT05702229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090914|NCT05702229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090915|NCT05702229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090916|NCT05702229|Immunologic Factors|immunologic factors|mesh-ancestor
139090917|NCT05702229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090918|NCT05701995|Deucravacitinib|deucravacitinib|mesh-list
139090919|NCT05701995|Dermatologic Agents|dermatologic agents|mesh-ancestor
139090920|NCT05701995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139090921|NCT05701995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090922|NCT05701995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090923|NCT05688111|Tranexamic Acid|tranexamic acid|mesh-list
139090924|NCT05688111|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139090925|NCT05688111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139090926|NCT05688111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090927|NCT05688111|Hemostatics|hemostatics|mesh-ancestor
139090928|NCT05688111|Coagulants|coagulants|mesh-ancestor
139090929|NCT05687344|Nifedipine|nifedipine|mesh-list
139090930|NCT05687344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139090931|NCT05687344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139090932|NCT05687344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090933|NCT05687344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139090934|NCT05687344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090935|NCT05687344|Vasodilator Agents|vasodilator agents|mesh-ancestor
139090936|NCT05687344|Tocolytic Agents|tocolytic agents|mesh-ancestor
139090937|NCT05687344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139090938|NCT05643066|Ketamine|ketamine|mesh-list
139090939|NCT05643066|Propofol|propofol|mesh-list
139090940|NCT05643066|Esketamine|esketamine|mesh-list
139090941|NCT05643066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139090942|NCT05643066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139090943|NCT05643066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090944|NCT05643066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139090945|NCT05643066|Anesthetics, General|anesthetics, general|mesh-ancestor
139090946|NCT05643066|Anesthetics|anesthetics|mesh-ancestor
139090947|NCT05643066|Analgesics|analgesics|mesh-ancestor
139090948|NCT05643066|Sensory System Agents|sensory system agents|mesh-ancestor
139090949|NCT05643066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090950|NCT05643066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139090952|NCT05643066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139090953|NCT05643066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139090954|NCT05643066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090955|NCT05643066|Antidepressive Agents|antidepressive agents|mesh-ancestor
139090956|NCT05643066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139090957|NCT05627245|Belinostat|belinostat|mesh-list
139090958|NCT05627245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090959|NCT05627245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139090960|NCT05627245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090961|NCT05627245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090962|NCT05627232|Diphenhydramine|diphenhydramine|mesh-list
139090963|NCT05627232|Promethazine|promethazine|mesh-list
139090964|NCT05627232|Cytarabine|cytarabine|mesh-list
139090965|NCT05627232|Daunorubicin|daunorubicin|mesh-list
139090966|NCT05627232|Palbociclib|palbociclib|mesh-list
139090967|NCT05627232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139090968|NCT05627232|Antimetabolites|antimetabolites|mesh-ancestor
139090969|NCT05627232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139090970|NCT05627232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139090971|NCT05627232|Antiviral Agents|antiviral agents|mesh-ancestor
139090972|NCT05627232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139090973|NCT05627232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139090974|NCT05627232|Immunologic Factors|immunologic factors|mesh-ancestor
139090975|NCT05627232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139090976|NCT05627232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139090977|NCT05627232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139090978|NCT05627232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139090979|NCT05627232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139090980|NCT05627232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139090981|NCT05627232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139090982|NCT05627232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139090983|NCT05627232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139090984|NCT05627232|Anesthetics, Local|anesthetics, local|mesh-ancestor
139090985|NCT05627232|Anesthetics|anesthetics|mesh-ancestor
139090986|NCT05627232|Sensory System Agents|sensory system agents|mesh-ancestor
139090987|NCT05627232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139090988|NCT05627232|Antiemetics|antiemetics|mesh-ancestor
139090989|NCT05627232|Autonomic Agents|autonomic agents|mesh-ancestor
139090990|NCT05627232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139090991|NCT05627232|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139090992|NCT05627232|Histamine Antagonists|histamine antagonists|mesh-ancestor
139090993|NCT05627232|Histamine Agents|histamine agents|mesh-ancestor
139090994|NCT05627232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139090995|NCT05627232|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139090996|NCT05627232|Antipruritics|antipruritics|mesh-ancestor
139090997|NCT05627232|Dermatologic Agents|dermatologic agents|mesh-ancestor
139090998|NCT05614102|Pembrolizumab|pembrolizumab|mesh-list
139090999|NCT05614102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091000|NCT05614102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091001|NCT05614102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139091002|NCT05614102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091003|NCT05595642|Astegolimab|astegolimab|mesh-list
139091004|NCT05595642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139091005|NCT05595642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139091006|NCT05595642|Antiviral Agents|antiviral agents|mesh-ancestor
139091007|NCT05595642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091008|NCT05592223|Rifampin|rifampin|mesh-list
139091009|NCT05592223|Isoniazid|isoniazid|mesh-list
139091010|NCT05592223|BCG Vaccine|bcg vaccine|mesh-list
139091011|NCT05592223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139091012|NCT05592223|Antitubercular Agents|antitubercular agents|mesh-ancestor
139091013|NCT05592223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139091014|NCT05592223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091015|NCT05592223|Leprostatic Agents|leprostatic agents|mesh-ancestor
139091016|NCT05592223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139091017|NCT05592223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073138|NCT00373295|Baclofen|baclofen|mesh-list
139091018|NCT05592223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091019|NCT05592223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139091020|NCT05592223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139091021|NCT05592223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139091022|NCT05592223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138841624|NCT00751166|Cetirizine|cetirizine|mesh-list
139091023|NCT05592223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139091024|NCT05592223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139091025|NCT05592223|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139091026|NCT05592223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139091027|NCT05592223|Antimetabolites|antimetabolites|mesh-ancestor
139091028|NCT05592223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139091029|NCT05592223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139091030|NCT05592223|Immunologic Factors|immunologic factors|mesh-ancestor
139091031|NCT05592223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091032|NCT05590689|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139091033|NCT05590689|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139091034|NCT05590689|Dermatologic Agents|dermatologic agents|mesh-ancestor
139091035|NCT05588102|Fluvoxamine|fluvoxamine|mesh-list
139091036|NCT05588102|Citalopram|citalopram|mesh-list
139091037|NCT05588102|Fluoxetine|fluoxetine|mesh-list
139091038|NCT05588102|Paroxetine|paroxetine|mesh-list
139091039|NCT05588102|Sertraline|sertraline|mesh-list
139091040|NCT05588102|Escitalopram|escitalopram|mesh-list
139091041|NCT05588102|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139091042|NCT05588102|Serotonin|serotonin|mesh-list
139091043|NCT05588102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139091044|NCT05588102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139091045|NCT05588102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091046|NCT05588102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091047|NCT05588102|Serotonin Agents|serotonin agents|mesh-ancestor
139091048|NCT05588102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091049|NCT05588102|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139091050|NCT05588102|Antidepressive Agents|antidepressive agents|mesh-ancestor
139091051|NCT05588102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139091052|NCT05588102|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139091053|NCT05588102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139073166|NCT01044719|Meropenem|meropenem|mesh-list
139091054|NCT05588102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091055|NCT05588102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139091056|NCT05588102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139091057|NCT05588102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139091058|NCT05588102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139175257|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
139091059|NCT05588102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139091060|NCT05588102|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139091062|NCT05582811|Enzyme Activators|enzyme activators|mesh-ancestor
139091063|NCT05582811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091064|NCT05554627|Aripiprazole|aripiprazole|mesh-list
139091065|NCT05554627|Esketamine|esketamine|mesh-list
139091066|NCT05554627|Antidepressive Agents|antidepressive agents|mesh-ancestor
139091067|NCT05554627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139091068|NCT05554627|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139091069|NCT05554627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139091070|NCT05554627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139091071|NCT05554627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091072|NCT05554627|Dopamine Agonists|dopamine agonists|mesh-ancestor
139091073|NCT05554627|Dopamine Agents|dopamine agents|mesh-ancestor
139091074|NCT05554627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091075|NCT05554627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091076|NCT05554627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139091077|NCT05554627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139091078|NCT05554627|Serotonin Agents|serotonin agents|mesh-ancestor
139091079|NCT05554627|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139091080|NCT05554627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139091081|NCT05554627|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139091082|NCT05554627|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139091083|NCT05550714|Anesthetics|anesthetics|mesh-list
139091084|NCT05550714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139091085|NCT05550714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091086|NCT05546866|Osimertinib|osimertinib|mesh-list
139091087|NCT05546866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091088|NCT05546866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139091089|NCT05546866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091090|NCT05546866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091091|NCT05536037|Metformin|metformin|mesh-list
139091092|NCT05536037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139091093|NCT05536037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091094|NCT05518032|Pembrolizumab|pembrolizumab|mesh-list
139091095|NCT05518032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091096|NCT05518032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091097|NCT05518032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139091098|NCT05518032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091100|NCT05508074|Anticonvulsants|anticonvulsants|mesh-ancestor
139091101|NCT05508074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139091102|NCT05508074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139091103|NCT05508074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091104|NCT05508074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091105|NCT05508074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091106|NCT05508074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139091107|NCT05508074|Protective Agents|protective agents|mesh-ancestor
139091108|NCT05485155|Protease Inhibitors|protease inhibitors|mesh-list
139091109|NCT05485155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091110|NCT05485155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091111|NCT05467891|Letrozole|letrozole|mesh-list
139091112|NCT05467891|Fulvestrant|fulvestrant|mesh-list
139091113|NCT05467891|Anastrozole|anastrozole|mesh-list
139091114|NCT05467891|Exemestane|exemestane|mesh-list
139091115|NCT05467891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091116|NCT05467891|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139091117|NCT05467891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139091118|NCT05467891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091119|NCT05467891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091120|NCT05467891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139091121|NCT05467891|Hormone Antagonists|hormone antagonists|mesh-ancestor
139091122|NCT05467891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139091123|NCT05467891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091124|NCT05467891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139091125|NCT05467891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139091126|NCT05417100|Methadone|methadone|mesh-list
139091127|NCT05417100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139091128|NCT05417100|Narcotics|narcotics|mesh-ancestor
139091129|NCT05417100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139091130|NCT05417100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091131|NCT05417100|Analgesics|analgesics|mesh-ancestor
139091132|NCT05417100|Sensory System Agents|sensory system agents|mesh-ancestor
139091133|NCT05417100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139091134|NCT05417100|Antitussive Agents|antitussive agents|mesh-ancestor
139091135|NCT05417100|Respiratory System Agents|respiratory system agents|mesh-ancestor
139091136|NCT05407961|Dulaglutide|dulaglutide|mesh-list
139091137|NCT05407961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139091138|NCT05407961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091139|NCT05369819|Midazolam|midazolam|mesh-list
139091140|NCT05369819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139091141|NCT05369819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139091142|NCT05369819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139091143|NCT05369819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091144|NCT05369819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139091145|NCT05369819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139091146|NCT05369819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139091147|NCT05369819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139091148|NCT05369819|Anesthetics, General|anesthetics, general|mesh-ancestor
139091149|NCT05369819|Anesthetics|anesthetics|mesh-ancestor
139091150|NCT05369819|GABA Modulators|gaba modulators|mesh-ancestor
139091151|NCT05369819|GABA Agents|gaba agents|mesh-ancestor
139091152|NCT05369819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091153|NCT05369819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091154|NCT05358587|Anesthetics|anesthetics|mesh-list
139091155|NCT05358587|Anesthetics, Local|anesthetics, local|mesh-list
139091156|NCT05358587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139091157|NCT05358587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139091158|NCT05358587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091159|NCT05358587|Sensory System Agents|sensory system agents|mesh-ancestor
139091160|NCT05358587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139091161|NCT05345171|Prednisolone|prednisolone|mesh-list
139091162|NCT05345171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139091163|NCT05345171|Glucocorticoids|glucocorticoids|mesh-ancestor
139091164|NCT05345171|Hormones|hormones|mesh-ancestor
139091165|NCT05345171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139091166|NCT05345171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091167|NCT05345171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139091168|NCT05345171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091169|NCT05342597|Edaravone|edaravone|mesh-list
139091170|NCT05342597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139091171|NCT05342597|Antioxidants|antioxidants|mesh-ancestor
139091172|NCT05342597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091173|NCT05342597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139091174|NCT05342597|Protective Agents|protective agents|mesh-ancestor
139091175|NCT05342597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091176|NCT05315947|Brivaracetam|brivaracetam|mesh-list
139091177|NCT05315947|Anticonvulsants|anticonvulsants|mesh-ancestor
139091178|NCT05273827|Paclitaxel|paclitaxel|mesh-list
139091179|NCT05273827|Pemetrexed|pemetrexed|mesh-list
139091180|NCT05273827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139091181|NCT05273827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091182|NCT05273827|Tubulin Modulators|tubulin modulators|mesh-ancestor
139091183|NCT05273827|Antimitotic Agents|antimitotic agents|mesh-ancestor
139091184|NCT05273827|Mitosis Modulators|mitosis modulators|mesh-ancestor
139091185|NCT05273827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091186|NCT05273827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091187|NCT05273827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139091188|NCT05273827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139091189|NCT05223647|Carboplatin|carboplatin|mesh-list
139091190|NCT05223647|Etoposide|etoposide|mesh-list
139091191|NCT05223647|Durvalumab|durvalumab|mesh-list
139091192|NCT05223647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091193|NCT05223647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139091194|NCT05223647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139091195|NCT05223647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139091196|NCT05223647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091197|NCT05223647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091198|NCT05223647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091199|NCT05198843|Dasatinib|dasatinib|mesh-list
139091200|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139091201|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091202|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139091203|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091204|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091205|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139091206|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139091207|NCT05180318|Ketamine|ketamine|mesh-list
139091208|NCT05180318|Esketamine|esketamine|mesh-list
139091209|NCT05180318|Analgesics|analgesics|mesh-ancestor
139091210|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
139091211|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139091212|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091213|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139091214|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139091215|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
139091216|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
139091217|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139091218|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139091219|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139091220|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091221|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091222|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
139091223|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139091224|NCT05169437|Niraparib|niraparib|mesh-list
139091225|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139091226|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091227|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091228|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091229|NCT05151328|Plecanatide|plecanatide|mesh-list
139091230|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139091231|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
139091232|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091233|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139091234|NCT05119907|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139091235|NCT05119907|Immunoconjugates|immunoconjugates|mesh-ancestor
139091236|NCT05119907|Immunologic Factors|immunologic factors|mesh-ancestor
139091237|NCT05119907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091238|NCT05109234|Brivaracetam|brivaracetam|mesh-list
139091239|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
139091240|NCT05096442|Paclitaxel|paclitaxel|mesh-list
139091241|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139091242|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139091243|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091244|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
139091245|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
139091246|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
139175276|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
139091247|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091250|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139091252|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139091253|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091254|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139091255|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139091256|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
139091257|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139091258|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139091259|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139091260|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139091261|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091262|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091263|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
139091264|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091265|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139091266|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139091267|NCT05055050|Imiquimod|imiquimod|mesh-list
139091268|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139091269|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
139091270|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091271|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091272|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
139091273|NCT05053503|Lofexidine|lofexidine|mesh-list
139091274|NCT05053503|Naltrexone|naltrexone|mesh-list
139091275|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139091276|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139091277|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091278|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
139091279|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139091280|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139091281|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139091282|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139091283|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139091284|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
139091285|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091286|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091287|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
139091288|NCT05047055|Rifampin|rifampin|mesh-list
139091289|NCT05047055|Isoniazid|isoniazid|mesh-list
139091290|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
139091291|NCT05047055|Ethambutol|ethambutol|mesh-list
139091292|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139091293|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091294|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139091295|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139091296|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091297|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091298|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091299|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139091300|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
139091301|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
139091302|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139091303|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139091304|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139091305|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139091306|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139091307|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139091308|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139091309|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139091310|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139091311|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
139091312|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139091313|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
139091314|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
139091315|NCT05031897|Melphalan|melphalan|mesh-list
139091316|NCT05031897|Fludarabine|fludarabine|mesh-list
139091317|NCT05031897|Tacrolimus|tacrolimus|mesh-list
139091318|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139091319|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
138841911|NCT02841722|Lenograstim|lenograstim|mesh-list
138711434|NCT05387408|Analgesics|analgesics|mesh-ancestor
139091320|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091321|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139091322|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139091323|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
139091324|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091325|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091326|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139091327|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139091328|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091329|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139091330|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139091331|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
139091332|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139091333|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091334|NCT05015439|Cannabidiol|cannabidiol|mesh-list
139091335|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
139091337|NCT05006794|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139091338|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091339|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
139091340|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
139091341|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
139091342|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091343|NCT05006794|Immunoconjugates|immunoconjugates|mesh-ancestor
139091344|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
139091345|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091346|NCT04984889|Protein C|protein c|mesh-list
139091347|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
139091348|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139091349|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139091350|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091351|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
139091352|NCT04983238|Trastuzumab|trastuzumab|mesh-list
139091353|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091354|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091355|NCT04983238|Antidotes|antidotes|mesh-ancestor
139091356|NCT04983238|Protective Agents|protective agents|mesh-ancestor
139091357|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091358|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
139091359|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091360|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
139091361|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139091362|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091363|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
139091364|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
139091365|NCT04940689|Lidocaine|lidocaine|mesh-list
139091366|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
139091367|NCT04940689|Remifentanil|remifentanil|mesh-list
139091368|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
139091369|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
139091370|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139091371|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091372|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
139091373|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139091374|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139091375|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139091376|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139091377|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139091378|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091379|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139091380|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139091381|NCT04940689|Analgesics|analgesics|mesh-ancestor
139091382|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139091383|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139091384|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139091385|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
139091386|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091387|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139091388|NCT04940689|Narcotics|narcotics|mesh-ancestor
139091389|NCT04887792|Acetazolamide|acetazolamide|mesh-list
139091390|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
139091391|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139091392|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138841983|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
139091393|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091394|NCT04887792|Diuretics|diuretics|mesh-ancestor
139091395|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
139091396|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091397|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
139091398|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139091399|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139091400|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091401|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139091402|NCT04878510|Analgesics|analgesics|mesh-ancestor
139091403|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
139091404|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139091405|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139091406|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139091407|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139091408|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
139091409|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091410|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091411|NCT04821089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139091412|NCT04821089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139091413|NCT04821089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139073286|NCT01084902|Latanoprost|latanoprost|mesh-list
139091414|NCT04821089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091415|NCT04821089|Cholinergic Agents|cholinergic agents|mesh-ancestor
139091416|NCT04821089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091417|NCT04821089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091418|NCT04760288|Pralsetinib|pralsetinib|mesh-list
139091419|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091420|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
139091421|NCT04746924|Tislelizumab|tislelizumab|mesh-list
139091422|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091423|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091424|NCT04746924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139091425|NCT04746924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091426|NCT04729179|Cannabidiol|cannabidiol|mesh-list
139091427|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
139091428|NCT04716686|Niraparib|niraparib|mesh-list
139091429|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139091430|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091431|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091432|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091433|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
139091434|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139091435|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
139091436|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091437|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
139091438|NCT04702776|Protective Agents|protective agents|mesh-ancestor
139091439|NCT04696822|Epinephrine|epinephrine|mesh-list
139091440|NCT04696822|Racepinephrine|racepinephrine|mesh-list
139091441|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
139091442|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139091443|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139091444|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
139091445|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091446|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091447|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091448|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139091449|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139091450|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
139091451|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139091452|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139091453|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
139091454|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
139091455|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
139091456|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139091457|NCT04694586|Rifampin|rifampin|mesh-list
139091458|NCT04694586|Isoniazid|isoniazid|mesh-list
139091459|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
139091460|NCT04694586|Ethambutol|ethambutol|mesh-list
139091461|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139091462|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
139091463|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139091464|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091465|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
139091466|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139091467|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091468|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091470|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139091471|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139091472|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139091473|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139091474|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139091475|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139091476|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139091477|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
139091478|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139091479|NCT04665037|Posaconazole|posaconazole|mesh-list
139091480|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
139091481|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091482|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139091483|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139091484|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139091485|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139091486|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139091487|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091488|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091489|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139091490|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
139091491|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139091492|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091493|NCT04661137|Dexamethasone|dexamethasone|mesh-list
139091494|NCT04661137|Daratumumab|daratumumab|mesh-list
139091495|NCT04661137|Pomalidomide|pomalidomide|mesh-list
139091496|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139091497|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
139091498|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
139091499|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139091500|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091501|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139091502|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
139091503|NCT04661137|Hormones|hormones|mesh-ancestor
139091504|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139091505|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139091506|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091507|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
139091508|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139091509|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139091510|NCT04661137|Growth Substances|growth substances|mesh-ancestor
139091511|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
139091512|NCT04649385|Tislelizumab|tislelizumab|mesh-list
139091513|NCT04649385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091514|NCT04649385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091515|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139091516|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139091517|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
139091518|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
139091519|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
139091520|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091521|NCT04603898|Protective Agents|protective agents|mesh-ancestor
139091522|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091523|NCT04603898|Vitamins|vitamins|mesh-ancestor
139091524|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
139091525|NCT04597437|Zanamivir|zanamivir|mesh-list
139091526|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
139091527|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091528|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091529|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091530|NCT04570150|Neostigmine|neostigmine|mesh-list
139091531|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139091532|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091533|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091534|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
139091535|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091536|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091537|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139091538|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
139091539|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139091540|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
139091541|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
139303899|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303900|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
139303901|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139303902|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303903|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
139303904|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139303905|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139303906|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
139303907|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303908|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139175354|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303909|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139303910|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139303911|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
139303912|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303913|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139303914|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139303915|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303917|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139303918|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139303919|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303920|NCT02792517|Erenumab|erenumab|mesh-list
139303921|NCT02792517|Norgestimate|norgestimate|mesh-list
139303922|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
139303923|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
139303924|NCT02792517|Estradiol|estradiol|mesh-list
139303925|NCT02792517|Estrogens|estrogens|mesh-ancestor
139303926|NCT02792517|Hormones|hormones|mesh-ancestor
139303927|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139303928|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303929|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139303930|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139303931|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139303932|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139303933|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303934|NCT02792517|Analgesics|analgesics|mesh-ancestor
139303935|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
139303936|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303937|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139303938|NCT03431714|Artesunate|artesunate|mesh-list
139303939|NCT03431714|Piperaquine|piperaquine|mesh-list
139303940|NCT03431714|Amodiaquine|amodiaquine|mesh-list
139303941|NCT03431714|Artenimol|artenimol|mesh-list
139303942|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
139303943|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139303944|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139303945|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303946|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303947|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
139303948|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
139303949|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139303950|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
139303951|NCT03433586|Aspirin|aspirin|mesh-list
139175363|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303952|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139303953|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139303954|NCT03433586|Analgesics|analgesics|mesh-ancestor
139303955|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
139303956|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139303957|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303958|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139303959|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139303960|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139303961|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139303962|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303963|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139303964|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139303965|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139303966|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
139303967|NCT03431558|Lactoferrin|lactoferrin|mesh-list
139303968|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303969|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
139303970|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303971|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
139303972|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303973|NCT02273622|Protective Agents|protective agents|mesh-ancestor
138960816|NCT02556866|Prednisone|prednisone|mesh-list
139303974|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303975|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139303976|NCT02077803|Metformin|metformin|mesh-list
139303977|NCT02077803|Canagliflozin|canagliflozin|mesh-list
139303978|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139303979|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303980|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139303981|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303982|NCT02072811|Cytarabine|cytarabine|mesh-list
139303983|NCT02072811|Daunorubicin|daunorubicin|mesh-list
139303984|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
139303985|NCT02072811|Cladribine|cladribine|mesh-list
139303986|NCT02072811|Lenograstim|lenograstim|mesh-list
139303987|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139303988|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
139303989|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139303990|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139303991|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
139303992|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139303993|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139303994|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
139303995|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139303996|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139303997|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139303998|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139303999|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304000|NCT02072811|Analgesics|analgesics|mesh-ancestor
139304001|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
139304002|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304003|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139304004|NCT02080377|Glyburide|glyburide|mesh-list
139304005|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139304006|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304007|NCT02072967|Rituximab|rituximab|mesh-list
139304008|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139304009|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139304010|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304011|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
139304012|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304013|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139304014|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139304015|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
139304016|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304017|NCT02073357|Anesthetics|anesthetics|mesh-list
139304018|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304019|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304020|NCT02073669|Interferons|interferons|mesh-list
139304021|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
139304022|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304023|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
139304024|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304025|NCT03428282|Anesthetics|anesthetics|mesh-list
139304026|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304027|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304028|NCT00463242|Agomelatine|agomelatine|mesh-list
139304029|NCT00463242|Paroxetine|paroxetine|mesh-list
139304030|NCT00463242|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139304031|NCT00463242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139304032|NCT00463242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139304033|NCT00463242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304034|NCT00463242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304035|NCT00463242|Serotonin Agents|serotonin agents|mesh-ancestor
139304036|NCT00463242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304037|NCT00463242|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139304038|NCT00463242|Antidepressive Agents|antidepressive agents|mesh-ancestor
139304039|NCT00463242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139304040|NCT00463242|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139304041|NCT00463242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139304042|NCT00463242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304043|NCT00463242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139304044|NCT00463242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304045|NCT02074137|Prednisone|prednisone|mesh-list
139304046|NCT02074137|Prednisolone|prednisolone|mesh-list
139304047|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138960904|NCT00671060|Misoprostol|misoprostol|mesh-list
139304048|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
139304050|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139304051|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304052|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139304053|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304054|NCT00600288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139304055|NCT00600288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139304056|NCT00594984|Irinotecan|irinotecan|mesh-list
139304057|NCT00594984|Cetuximab|cetuximab|mesh-list
139304058|NCT00594984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139304059|NCT00594984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139304060|NCT00594984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304061|NCT00594984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304062|NCT00594984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304063|NCT00594984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139304064|NCT01369485|Caffeine|caffeine|mesh-list
139304065|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139304066|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304067|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139304068|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304069|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304070|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139304071|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139304072|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
139304073|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304074|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
139304075|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139304076|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139073352|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
139304077|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304078|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139304079|NCT03422978|Analgesics|analgesics|mesh-ancestor
139304080|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
139304081|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304082|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139304083|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139304084|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139304085|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
139304086|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304087|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304088|NCT02278692|Vitamin K|vitamin k|mesh-list
139304089|NCT02278692|Vitamins|vitamins|mesh-ancestor
139304090|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
139304091|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304092|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139304093|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139304094|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304095|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
139304096|NCT02278692|Coagulants|coagulants|mesh-ancestor
139304097|NCT02281968|Naproxen|naproxen|mesh-list
139304098|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139304099|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139304100|NCT02281968|Analgesics|analgesics|mesh-ancestor
139304101|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
139304102|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304103|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304104|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304105|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139304106|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
139304107|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139304108|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304109|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304110|NCT02080845|Theobromine|theobromine|mesh-list
139304111|NCT02080845|Caffeine|caffeine|mesh-list
139304112|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139304113|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304114|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139304115|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304116|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304117|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139304118|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139304119|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
138960986|NCT00808002|Tenofovir|tenofovir|mesh-list
139304120|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304121|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139304122|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
139304123|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304124|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139304125|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
139304126|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
139304127|NCT02284230|Liraglutide|liraglutide|mesh-list
139304128|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139304129|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304130|NCT02284230|Incretins|incretins|mesh-ancestor
139304131|NCT02284230|Hormones|hormones|mesh-ancestor
139304132|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139304133|NCT02792088|Tenofovir|tenofovir|mesh-list
139304134|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
139304135|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304136|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139304137|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139304138|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304139|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304140|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139304141|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139304142|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139304143|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139304144|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139304145|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304146|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304147|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139304148|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139304149|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304150|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
139304151|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304152|NCT00451152|Hydrocortisone|hydrocortisone|mesh-list
139304153|NCT00451152|Anecortave|anecortave|mesh-list
139304154|NCT00451152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139304155|NCT00451152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139304156|NCT00451152|Growth Substances|growth substances|mesh-ancestor
139304157|NCT00451152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304158|NCT00451152|Growth Inhibitors|growth inhibitors|mesh-ancestor
139304159|NCT00451152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304160|NCT00451152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304161|NCT02078583|Fentanyl|fentanyl|mesh-list
139304162|NCT02078583|Remifentanil|remifentanil|mesh-list
139304163|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139304164|NCT02078583|Narcotics|narcotics|mesh-ancestor
139304165|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304166|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304167|NCT02078583|Analgesics|analgesics|mesh-ancestor
139304168|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
139304169|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304170|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139304171|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139304172|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
139304173|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
139304174|NCT02948660|Zolpidem|zolpidem|mesh-list
139304175|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139304176|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139304177|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304178|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304179|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139304180|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
139304181|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
139304182|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304183|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304184|NCT02074605|Interferons|interferons|mesh-list
139304185|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
139304186|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304187|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
139304188|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304189|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
139304190|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304191|NCT00448422|Prulifloxacin|prulifloxacin|mesh-list
139304192|NCT00448422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138961040|NCT00762359|Lansoprazole|lansoprazole|mesh-list
139304193|NCT00448422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304194|NCT00448422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139304195|NCT00448422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139304196|NCT00448422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304197|NCT00448422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304198|NCT00448422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304199|NCT00583830|Paclitaxel|paclitaxel|mesh-list
139304200|NCT00583830|Carboplatin|carboplatin|mesh-list
139304201|NCT00583830|Mapatumumab|mapatumumab|mesh-list
139304202|NCT00583830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139304203|NCT00583830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139304204|NCT00583830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304205|NCT00583830|Tubulin Modulators|tubulin modulators|mesh-ancestor
139304206|NCT00583830|Antimitotic Agents|antimitotic agents|mesh-ancestor
139304207|NCT00583830|Mitosis Modulators|mitosis modulators|mesh-ancestor
139304208|NCT00583830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304209|NCT00583830|Immunologic Factors|immunologic factors|mesh-ancestor
139304210|NCT00583830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304211|NCT03430544|Cariprazine|cariprazine|mesh-list
139304212|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139304213|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139304214|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304215|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304216|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139304217|NCT00583674|Cisplatin|cisplatin|mesh-list
139304218|NCT00583674|Capecitabine|capecitabine|mesh-list
139304219|NCT00583674|Trebananib|trebananib|mesh-list
139304220|NCT00583674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304221|NCT00583674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139304222|NCT00583674|Antimetabolites|antimetabolites|mesh-ancestor
139304223|NCT00583674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304224|NCT00583674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139304225|NCT00583674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139304226|NCT00583674|Growth Substances|growth substances|mesh-ancestor
139304227|NCT00583674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304228|NCT00583674|Growth Inhibitors|growth inhibitors|mesh-ancestor
139304230|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304231|NCT03430466|Fulvestrant|fulvestrant|mesh-list
139304232|NCT03430466|Tremelimumab|tremelimumab|mesh-list
139304233|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139304234|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304235|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139304236|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139304237|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
139304238|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139304239|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304240|NCT02280174|Linagliptin|linagliptin|mesh-list
139304241|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139304242|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304243|NCT02280174|Incretins|incretins|mesh-ancestor
139304244|NCT02280174|Hormones|hormones|mesh-ancestor
139304245|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139304246|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139304247|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
139304248|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304249|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304250|NCT00447564|Buprenorphine|buprenorphine|mesh-list
139304251|NCT00447564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139304252|NCT00447564|Narcotics|narcotics|mesh-ancestor
139304253|NCT00447564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304254|NCT00447564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304255|NCT00447564|Analgesics|analgesics|mesh-ancestor
139304256|NCT00447564|Sensory System Agents|sensory system agents|mesh-ancestor
139304257|NCT00447564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304258|NCT00447564|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139304259|NCT00576810|Picosulfate sodium|picosulfate sodium|mesh-list
139304260|NCT00576810|Cathartics|cathartics|mesh-ancestor
139304261|NCT00576810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139304262|NCT00576342|Timolol|timolol|mesh-list
139304263|NCT00576342|Dorzolamide|dorzolamide|mesh-list
139304264|NCT00576342|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139304265|NCT00576342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139304266|NCT00576342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139304267|NCT00576342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139304268|NCT00576342|Adrenergic Agents|adrenergic agents|mesh-ancestor
139304269|NCT00576342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304270|NCT00576342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304271|NCT00576342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304272|NCT00576342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139304273|NCT00576342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139304274|NCT00576342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139304275|NCT00576342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304276|NCT02282280|Prilocaine|prilocaine|mesh-list
139304277|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
139175434|NCT03884881|Meropenem|meropenem|mesh-list
139304278|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
139304279|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304280|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304281|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
139304282|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304283|NCT03429998|Evolocumab|evolocumab|mesh-list
139304284|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139304285|NCT03429998|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139304286|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139304287|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139304288|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
139304289|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304290|NCT03429998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139304291|NCT03429998|Protease Inhibitors|protease inhibitors|mesh-ancestor
139304292|NCT03429998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073490|NCT04116398|Dexamethasone|dexamethasone|mesh-list
139304293|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139304294|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
139304295|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304296|NCT00658008|Paroxetine|paroxetine|mesh-list
139304297|NCT00658008|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139304298|NCT00658008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139304299|NCT00658008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139304300|NCT00658008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304301|NCT00658008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304302|NCT00658008|Serotonin Agents|serotonin agents|mesh-ancestor
139304303|NCT00658008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304304|NCT00658008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139304305|NCT00658008|Antidepressive Agents|antidepressive agents|mesh-ancestor
139304306|NCT00658008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139304307|NCT00658008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139304308|NCT00658008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139304309|NCT00658008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304310|NCT03427502|Epinephrine|epinephrine|mesh-list
139304311|NCT03427502|Bupivacaine|bupivacaine|mesh-list
139304312|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
139304313|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
139304314|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304315|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304316|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
139304317|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304318|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139304319|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139304320|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
139304321|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304322|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304323|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139304324|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139304325|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
139304326|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139304327|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
139304328|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
139304329|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
139304330|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139304331|NCT00440388|Rituximab|rituximab|mesh-list
139304332|NCT00440388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139304333|NCT00440388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304334|NCT00440388|Immunologic Factors|immunologic factors|mesh-ancestor
139304335|NCT00440388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304336|NCT00440388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139304337|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139304338|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139304339|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304340|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
139304341|NCT04449224|Etanercept|etanercept|mesh-list
139304342|NCT04449224|Abatacept|abatacept|mesh-list
139304343|NCT04449224|Tofacitinib|tofacitinib|mesh-list
139304344|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139304345|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139304347|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
139304348|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304349|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304350|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304351|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139304352|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139304353|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139304354|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
139304355|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139304356|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304357|NCT04449224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139304358|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304359|NCT04449224|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139304360|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139304361|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304362|NCT00437112|Insulin|insulin|mesh-list
139304363|NCT00437112|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139304364|NCT00437112|Insulin Glargine|insulin glargine|mesh-list
139304365|NCT00437112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139304366|NCT00437112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304367|NCT00434850|Gusperimus|gusperimus|mesh-list
139304368|NCT00434850|Sirolimus|sirolimus|mesh-list
139304369|NCT00434850|Etanercept|etanercept|mesh-list
139304370|NCT00434850|Tacrolimus|tacrolimus|mesh-list
139304371|NCT00434850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139304372|NCT00434850|Basiliximab|basiliximab|mesh-list
139304373|NCT00434850|Daclizumab|daclizumab|mesh-list
139304374|NCT00434850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139304375|NCT00434850|Immunologic Factors|immunologic factors|mesh-ancestor
139304376|NCT00434850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304377|NCT00434850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139304378|NCT00434850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304379|NCT00434850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304380|NCT00434850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139304381|NCT00434850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304382|NCT00434850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139304383|NCT00434850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304384|NCT00434850|Antifungal Agents|antifungal agents|mesh-ancestor
139304385|NCT00434850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139304386|NCT00434850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139304387|NCT00434850|Analgesics|analgesics|mesh-ancestor
139304388|NCT00434850|Sensory System Agents|sensory system agents|mesh-ancestor
139304389|NCT00434850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304390|NCT00434850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304391|NCT00434850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139304392|NCT00434850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139304393|NCT00434850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139304394|NCT00434850|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139304395|NCT00434850|Protective Agents|protective agents|mesh-ancestor
139304396|NCT04449380|Interferons|interferons|mesh-list
139304397|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304398|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
139304399|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304400|NCT03128216|Bupivacaine|bupivacaine|mesh-list
139304402|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
139304403|NCT03128216|Anesthetics|anesthetics|mesh-list
139304404|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304405|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304406|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
139304407|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304408|NCT00566202|Escitalopram|escitalopram|mesh-list
139304409|NCT00566202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139304410|NCT00566202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139304411|NCT00566202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139304412|NCT00566202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304413|NCT00566202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304414|NCT00566202|Serotonin Agents|serotonin agents|mesh-ancestor
139304415|NCT00566202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304416|NCT02280486|Glimepiride|glimepiride|mesh-list
139304417|NCT02280486|Saxagliptin|saxagliptin|mesh-list
139304418|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139304419|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139304420|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304421|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139304422|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
139304423|NCT02280486|Incretins|incretins|mesh-ancestor
139304424|NCT02280486|Hormones|hormones|mesh-ancestor
139304425|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139304426|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139304427|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
139304428|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304429|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304430|NCT00434226|Paclitaxel|paclitaxel|mesh-list
139304431|NCT00434226|Bevacizumab|bevacizumab|mesh-list
139304432|NCT00434226|Carboplatin|carboplatin|mesh-list
139304433|NCT00434226|Sunitinib|sunitinib|mesh-list
139175477|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
139304434|NCT00434226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139304435|NCT00434226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304436|NCT00434226|Tubulin Modulators|tubulin modulators|mesh-ancestor
139304437|NCT00434226|Antimitotic Agents|antimitotic agents|mesh-ancestor
139304438|NCT00434226|Mitosis Modulators|mitosis modulators|mesh-ancestor
139304439|NCT00434226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304440|NCT00434226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139304441|NCT00434226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139304442|NCT00434226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139304443|NCT00434226|Growth Substances|growth substances|mesh-ancestor
139304444|NCT00434226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304445|NCT00434226|Growth Inhibitors|growth inhibitors|mesh-ancestor
139304446|NCT00434226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139304447|NCT00434226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304448|NCT00430950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139304449|NCT00430950|Olmesartan|olmesartan|mesh-list
139304450|NCT00430950|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139304451|NCT00430950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139304452|NCT00430950|Diuretics|diuretics|mesh-ancestor
139304453|NCT00430950|Natriuretic Agents|natriuretic agents|mesh-ancestor
139304454|NCT00430950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304455|NCT00430950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139304456|NCT00430950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139304457|NCT00430950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304458|NCT00430950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139304459|NCT00430950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139304460|NCT00549744|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
139304461|NCT00549744|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139304462|NCT00549744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139304463|NCT00549744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304464|NCT00549744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304465|NCT02081391|Tapentadol|tapentadol|mesh-list
139304466|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139304467|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139304468|NCT02081391|Narcotics|narcotics|mesh-ancestor
139304469|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304470|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304471|NCT02081391|Analgesics|analgesics|mesh-ancestor
139304472|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
139304473|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304474|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139304475|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139304476|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139304477|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175508|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
139073539|NCT01081652|Progesterone|progesterone|mesh-list
139304478|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
139304479|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304480|NCT00549510|Lisinopril|lisinopril|mesh-list
139304481|NCT00549510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139304482|NCT00549510|Protease Inhibitors|protease inhibitors|mesh-ancestor
139304483|NCT00549510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304484|NCT00549510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304485|NCT00549510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139304486|NCT00549510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139304487|NCT00549510|Protective Agents|protective agents|mesh-ancestor
139304488|NCT00549510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304489|NCT00430092|Fluprednisolone|fluprednisolone|mesh-list
139304490|NCT00430092|Difluprednate|difluprednate|mesh-list
139304491|NCT00430092|Glucocorticoids|glucocorticoids|mesh-ancestor
139304492|NCT00430092|Hormones|hormones|mesh-ancestor
139304493|NCT00430092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139304494|NCT00430092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304495|NCT00430092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304496|NCT00427440|Rilotumumab|rilotumumab|mesh-list
139304497|NCT00427440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139304498|NCT00427440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139304499|NCT00427440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304500|NCT00427440|Immunologic Factors|immunologic factors|mesh-ancestor
139304501|NCT00427440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304502|NCT00650832|Darunavir|darunavir|mesh-list
139304503|NCT00650832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139304504|NCT00650832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139304505|NCT00650832|Protease Inhibitors|protease inhibitors|mesh-ancestor
139304506|NCT00650832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304507|NCT00650832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304508|NCT00650832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139304509|NCT00650832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139304510|NCT00650832|Antiviral Agents|antiviral agents|mesh-ancestor
139304511|NCT00650832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304512|NCT00425100|Fesoterodine|fesoterodine|mesh-list
139304513|NCT00425100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139304514|NCT00425100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139304515|NCT00425100|Cholinergic Agents|cholinergic agents|mesh-ancestor
139304516|NCT00425100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304517|NCT00425100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304518|NCT00425100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304519|NCT00425100|Urological Agents|urological agents|mesh-ancestor
139304520|NCT00546780|Bortezomib|bortezomib|mesh-list
139304521|NCT00546780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304522|NCT00420888|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139304523|NCT00420888|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
139304524|NCT00420888|Immunoconjugates|immunoconjugates|mesh-list
139304525|NCT00420888|Immunologic Factors|immunologic factors|mesh-ancestor
139304526|NCT00420888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304527|NCT00543582|Azacitidine|azacitidine|mesh-list
139304528|NCT00543582|Mocetinostat|mocetinostat|mesh-list
139304529|NCT00543582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139304530|NCT00543582|Antimetabolites|antimetabolites|mesh-ancestor
139304531|NCT00543582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304532|NCT00543582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304533|NCT00543582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304534|NCT00543582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139304535|NCT00542724|Insulin|insulin|mesh-list
139304536|NCT00542724|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139304537|NCT00542724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139304538|NCT00542724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304539|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139304540|NCT00412932|Olmesartan|olmesartan|mesh-list
139304541|NCT00412932|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139304542|NCT00412932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139304543|NCT00412932|Diuretics|diuretics|mesh-ancestor
139304544|NCT00412932|Natriuretic Agents|natriuretic agents|mesh-ancestor
139304545|NCT00412932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304546|NCT00412932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139304547|NCT00412932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139073553|NCT01087580|Hormones|hormones|mesh-ancestor
139304548|NCT00412932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304549|NCT00412932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139304550|NCT00412932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139304551|NCT00411528|Prednisone|prednisone|mesh-list
139304552|NCT00411528|Docetaxel|docetaxel|mesh-list
139304553|NCT00411528|Epothilone B|epothilone b|mesh-list
139304554|NCT00411528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304555|NCT00411528|Tubulin Modulators|tubulin modulators|mesh-ancestor
139304556|NCT00411528|Antimitotic Agents|antimitotic agents|mesh-ancestor
139304557|NCT00411528|Mitosis Modulators|mitosis modulators|mesh-ancestor
139304558|NCT00411528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304559|NCT00411528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304560|NCT00411528|Glucocorticoids|glucocorticoids|mesh-ancestor
139304561|NCT00411528|Hormones|hormones|mesh-ancestor
139304562|NCT00411528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139304563|NCT00411528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304564|NCT00411528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139304565|NCT00384150|Galiximab|galiximab|mesh-list
139304566|NCT00384150|Rituximab|rituximab|mesh-list
139304567|NCT00384150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139304568|NCT00384150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304569|NCT00384150|Immunologic Factors|immunologic factors|mesh-ancestor
139304570|NCT00384150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304571|NCT00384150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139304572|NCT00384150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304574|NCT00532038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139304575|NCT00532038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139304576|NCT00532038|Analgesics|analgesics|mesh-ancestor
139304577|NCT00532038|Sensory System Agents|sensory system agents|mesh-ancestor
139304578|NCT00532038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304579|NCT00532038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304580|NCT00532038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304581|NCT00532038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139304582|NCT00532038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139304583|NCT00532038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304584|NCT00532038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304585|NCT00403416|Mycophenolic Acid|mycophenolic acid|mesh-list
139304586|NCT00403416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139304587|NCT00403416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304588|NCT00403416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139304589|NCT00403416|Antitubercular Agents|antitubercular agents|mesh-ancestor
139304590|NCT00403416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139304591|NCT00403416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304592|NCT00403416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304593|NCT00403416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304594|NCT00401388|Allopurinol|allopurinol|mesh-list
139304595|NCT00401388|Antiemetics|antiemetics|mesh-list
139304596|NCT00401388|Loperamide|loperamide|mesh-list
139304597|NCT00401388|Antidiarrheals|antidiarrheals|mesh-list
139304598|NCT00401388|Antimetabolites|antimetabolites|mesh-ancestor
139304599|NCT00401388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304600|NCT00401388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304601|NCT00401388|Gout Suppressants|gout suppressants|mesh-ancestor
139304602|NCT00401388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139304603|NCT00401388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139304604|NCT00401388|Antioxidants|antioxidants|mesh-ancestor
139304605|NCT00401388|Protective Agents|protective agents|mesh-ancestor
139304606|NCT00401388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304607|NCT00401388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139304608|NCT00401388|Autonomic Agents|autonomic agents|mesh-ancestor
139304609|NCT00401388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304610|NCT02282826|Acyclovir|acyclovir|mesh-list
139304611|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
139304612|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304613|NCT00374166|Paroxetine|paroxetine|mesh-list
139304614|NCT00374166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139304615|NCT00374166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139304616|NCT00374166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139304617|NCT00374166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304618|NCT00374166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304619|NCT00374166|Serotonin Agents|serotonin agents|mesh-ancestor
139304620|NCT00374166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304621|NCT00374166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139304622|NCT00374166|Antidepressive Agents|antidepressive agents|mesh-ancestor
139304623|NCT00374166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139304624|NCT00374166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139304625|NCT00374166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139304626|NCT00374166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304627|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
139304628|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139304629|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139304630|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139304631|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139304632|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304633|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
139304634|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304635|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304636|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139304637|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304638|NCT02078973|Tolvaptan|tolvaptan|mesh-list
139304639|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139304640|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304641|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
139304642|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304643|NCT00397254|Rizatriptan|rizatriptan|mesh-list
139304644|NCT00397254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139304645|NCT00397254|Serotonin Agents|serotonin agents|mesh-ancestor
139304646|NCT00397254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304647|NCT00397254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304648|NCT00397254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304649|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
139304650|NCT01369641|Cisplatin|cisplatin|mesh-list
139304651|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304652|NCT01369641|Antidotes|antidotes|mesh-ancestor
139304653|NCT01369641|Protective Agents|protective agents|mesh-ancestor
139304654|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304655|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
139304656|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304657|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
139304658|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139304659|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304660|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
139304661|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
139304662|NCT02283060|Tenofovir|tenofovir|mesh-list
139304663|NCT02283060|Emtricitabine|emtricitabine|mesh-list
139304664|NCT02283060|Efavirenz|efavirenz|mesh-list
139304665|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139304666|NCT02283060|Cobicistat|cobicistat|mesh-list
139304667|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139304668|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139304669|NCT02283060|Elvitegravir|elvitegravir|mesh-list
139304670|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
139304671|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304672|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139304673|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139304674|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304675|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304676|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139304677|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139304678|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139073564|NCT01081730|Ustekinumab|ustekinumab|mesh-list
139304679|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139304680|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139304681|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139304682|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139304683|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139304684|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139304685|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139304686|NCT03559725|Menthol|menthol|mesh-list
139304687|NCT03559725|Nicotine|nicotine|mesh-list
139304688|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139304689|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
139304690|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304691|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304692|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139304693|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139304694|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
139304695|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304696|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304697|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
139304698|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
139304699|NCT00529152|Deferiprone|deferiprone|mesh-list
139304700|NCT00529152|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139304701|NCT00529152|Chelating Agents|chelating agents|mesh-ancestor
139304702|NCT00529152|Sequestering Agents|sequestering agents|mesh-ancestor
139304703|NCT00529152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304704|NCT00525330|Metformin|metformin|mesh-list
139304705|NCT00525330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139304706|NCT00525330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304707|NCT02287272|Cimetidine|cimetidine|mesh-list
139304708|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139304709|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139304710|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139304711|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
139304712|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
139304713|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304714|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304715|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304716|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139304717|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139304718|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304720|NCT00392574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139304721|NCT00392574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304722|NCT00392574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139304723|NCT00392574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139304724|NCT00392574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304725|NCT00392574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304726|NCT00392574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304727|NCT04470414|Antibodies|antibodies|mesh-list
139304728|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
139304729|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
139304730|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304731|NCT00363636|Galiximab|galiximab|mesh-list
139304732|NCT00363636|Rituximab|rituximab|mesh-list
139304733|NCT00363636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139304734|NCT00363636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304735|NCT00363636|Immunologic Factors|immunologic factors|mesh-ancestor
139304736|NCT00363636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304737|NCT00363636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139304738|NCT00363636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304739|NCT02605174|Lasmiditan|lasmiditan|mesh-list
139304740|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139304741|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
139304742|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304743|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304744|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304745|NCT00522834|Paclitaxel|paclitaxel|mesh-list
139304746|NCT00522834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139304747|NCT00522834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304748|NCT00522834|Tubulin Modulators|tubulin modulators|mesh-ancestor
139304749|NCT00522834|Antimitotic Agents|antimitotic agents|mesh-ancestor
139304750|NCT00522834|Mitosis Modulators|mitosis modulators|mesh-ancestor
139304751|NCT00522834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304752|NCT02075619|Amlodipine|amlodipine|mesh-list
139304753|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139304754|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139304755|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139304756|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139304757|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304758|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139304759|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304760|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
139304761|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139304762|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139304763|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
139304764|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139304765|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139304766|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304767|NCT00358878|Satavaptan|satavaptan|mesh-list
139304768|NCT00358878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139304769|NCT00358878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304770|NCT00358878|Natriuretic Agents|natriuretic agents|mesh-ancestor
139304771|NCT00358878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304772|NCT02283372|Paclitaxel|paclitaxel|mesh-list
139304773|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139304774|NCT02283372|Gemcitabine|gemcitabine|mesh-list
139304775|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139304776|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304777|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
139304778|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
139304779|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
139304780|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304781|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139304782|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
139304783|NCT00507936|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139304784|NCT00507936|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139304785|NCT00507936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139304786|NCT00507936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139304787|NCT00507936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304788|NCT00507936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304789|NCT00507936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304790|NCT00507936|Analgesics|analgesics|mesh-ancestor
139304791|NCT00507936|Sensory System Agents|sensory system agents|mesh-ancestor
139304792|NCT00507936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304793|NCT00507936|Antidepressive Agents|antidepressive agents|mesh-ancestor
139304794|NCT00507936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139304795|NCT00507936|Dopamine Agents|dopamine agents|mesh-ancestor
139304796|NCT04427020|Caseins|caseins|mesh-list
139304797|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
139304798|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
139304799|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304800|NCT02083575|Vitamins|vitamins|mesh-list
139304801|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
139304802|NCT02083575|Deferiprone|deferiprone|mesh-list
139304803|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
139304804|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304805|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
139304806|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304807|NCT02083575|Protective Agents|protective agents|mesh-ancestor
139304808|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139304809|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
139304810|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
139304811|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
139304812|NCT02286258|Edetic Acid|edetic acid|mesh-list
139304813|NCT02286258|Calcium|calcium|mesh-list
139304814|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139304815|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304816|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139304817|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
139304818|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
139304819|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304820|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
139304821|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139304822|NCT02088411|Diclofenac|diclofenac|mesh-list
139304823|NCT02088411|Wobenzym|wobenzym|mesh-list
139304824|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139304825|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139304826|NCT02088411|Analgesics|analgesics|mesh-ancestor
139304827|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
139304828|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304829|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304830|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304831|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139304832|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139304833|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304834|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304835|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139304836|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
139304837|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
139304838|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
139304839|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304840|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304841|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304842|NCT02604550|Naproxen|naproxen|mesh-list
139304843|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139304844|NCT02604550|Ropivacaine|ropivacaine|mesh-list
139304845|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
139304846|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
139304847|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304848|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304849|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
139304850|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304851|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139304852|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139304853|NCT02604550|Analgesics|analgesics|mesh-ancestor
139304854|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304855|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139304856|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
139304857|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139304858|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304859|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304860|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139304862|NCT02084043|Amikacin|amikacin|mesh-list
139304863|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139304864|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304865|NCT03530670|Midazolam|midazolam|mesh-list
139304866|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139304867|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139304868|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304869|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304870|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139304871|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139304872|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139304873|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139304874|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
139304875|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
139304876|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
139304877|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
139304878|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304879|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304880|NCT00120042|Misoprostol|misoprostol|mesh-list
139304881|NCT00120042|Oxytocin|oxytocin|mesh-list
139304882|NCT00120042|Oxytocics|oxytocics|mesh-ancestor
139304883|NCT00120042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139304884|NCT00120042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304885|NCT00120042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139304886|NCT00120042|Abortifacient Agents|abortifacient agents|mesh-ancestor
139304887|NCT00120042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139304888|NCT00120042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139304889|NCT02084355|Fentanyl|fentanyl|mesh-list
139304890|NCT02084355|Oxycodone|oxycodone|mesh-list
139304891|NCT02084355|Hydromorphone|hydromorphone|mesh-list
139304892|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139304893|NCT02084355|Narcotics|narcotics|mesh-ancestor
139304894|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304895|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304896|NCT02084355|Analgesics|analgesics|mesh-ancestor
139304897|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
139304898|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304899|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139304900|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139304901|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
139304902|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
139304903|NCT00353574|Darusentan|darusentan|mesh-list
139304904|NCT00353574|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139304905|NCT00353574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304906|NCT02082405|Dexamethasone|dexamethasone|mesh-list
139304907|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
139304908|NCT02082405|Bortezomib|bortezomib|mesh-list
139304909|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139304910|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
139304911|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304912|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139304913|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139304914|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
139304915|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304916|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139304917|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139304918|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304919|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
139304920|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
139304921|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304922|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139304923|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
139304924|NCT02082405|Hormones|hormones|mesh-ancestor
139304925|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139304926|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139304927|NCT04428268|Chloroquine|chloroquine|mesh-list
139304928|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139304929|NCT04428268|Losartan|losartan|mesh-list
139304930|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139304931|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139304932|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139304933|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139304934|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304935|NCT04428268|Amebicides|amebicides|mesh-ancestor
139304936|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139304937|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139304939|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
139304940|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139304941|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139304942|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139304943|NCT04428268|Analgesics|analgesics|mesh-ancestor
139304944|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
139304945|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304946|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304947|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139304948|NCT04428268|Filaricides|filaricides|mesh-ancestor
139304949|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
139304950|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
139304951|NCT02084433|Anesthetics|anesthetics|mesh-list
139304952|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139304953|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304954|NCT04427098|Enoxaparin|enoxaparin|mesh-list
139304955|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
139304956|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
139304957|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139304958|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139304959|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304960|NCT00352560|Irbesartan|irbesartan|mesh-list
139304961|NCT00352560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139304962|NCT00352560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139304963|NCT00352560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139304964|NCT00352560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304965|NCT00115050|Darunavir|darunavir|mesh-list
139304966|NCT00115050|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139304967|NCT00115050|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139304968|NCT00115050|Protease Inhibitors|protease inhibitors|mesh-ancestor
139304969|NCT00115050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139304970|NCT00115050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304971|NCT00115050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139304972|NCT00115050|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139304973|NCT00115050|Antiviral Agents|antiviral agents|mesh-ancestor
139304974|NCT00115050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139304975|NCT05616364|Dexmedetomidine|dexmedetomidine|mesh-list
139304976|NCT05616364|Tramadol|tramadol|mesh-list
139304977|NCT05616364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139304978|NCT05616364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139175614|NCT01155895|Amlodipine|amlodipine|mesh-list
139304979|NCT05616364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139304980|NCT05616364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139304981|NCT05616364|Analgesics|analgesics|mesh-ancestor
139304982|NCT05616364|Sensory System Agents|sensory system agents|mesh-ancestor
139304983|NCT05616364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139304984|NCT05616364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139304985|NCT05616364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139304986|NCT05616364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139304987|NCT05616364|Adrenergic Agents|adrenergic agents|mesh-ancestor
139304988|NCT05616364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139304989|NCT05616364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139304990|NCT05616364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139304991|NCT05616364|Narcotics|narcotics|mesh-ancestor
139304993|NCT00345618|Enoxaparin|enoxaparin|mesh-list
139304994|NCT00345618|Warfarin|warfarin|mesh-list
139304995|NCT00345618|Idraparinux|idraparinux|mesh-list
139304996|NCT00345618|Idrabiotaparinux|idrabiotaparinux|mesh-list
139304997|NCT00345618|Anticoagulants|anticoagulants|mesh-ancestor
139304998|NCT00345618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139304999|NCT00345618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139305000|NCT00345618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305001|NCT00345618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139305002|NCT00345618|Antithrombins|antithrombins|mesh-ancestor
139305003|NCT00345618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139305004|NCT00345618|Protease Inhibitors|protease inhibitors|mesh-ancestor
139305005|NCT00345618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305006|NCT00345618|Vitamin B Complex|vitamin b complex|mesh-ancestor
139305007|NCT00345618|Vitamins|vitamins|mesh-ancestor
139305008|NCT00345618|Micronutrients|micronutrients|mesh-ancestor
139305009|NCT00345618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305010|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
139305011|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139305012|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305013|NCT03611868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139305014|NCT03611868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305015|NCT00116298|Lamivudine|lamivudine|mesh-list
139305016|NCT00116298|Efavirenz|efavirenz|mesh-list
139305017|NCT00116298|Stavudine|stavudine|mesh-list
139305018|NCT00116298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139305019|NCT00116298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139305020|NCT00116298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305021|NCT00116298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305022|NCT00116298|Antiviral Agents|antiviral agents|mesh-ancestor
139305023|NCT00116298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139305024|NCT00116298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139305025|NCT00116298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139305026|NCT00116298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139305027|NCT00116298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139305028|NCT00116298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139305029|NCT00116298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139305030|NCT00116298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139305031|NCT00116298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139305032|NCT00116298|Antimetabolites|antimetabolites|mesh-ancestor
139305033|NCT01866111|Cenobamate|cenobamate|mesh-list
139305034|NCT01866111|Anticonvulsants|anticonvulsants|mesh-ancestor
139305035|NCT02084589|Fentanyl|fentanyl|mesh-list
139305036|NCT02084589|Ropivacaine|ropivacaine|mesh-list
139305037|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
139305038|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
139305039|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305040|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305041|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
139305042|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305043|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139305044|NCT02084589|Narcotics|narcotics|mesh-ancestor
139305045|NCT02084589|Analgesics|analgesics|mesh-ancestor
139305046|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139305047|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139305048|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
139305049|NCT03557853|Golimumab|golimumab|mesh-list
139305050|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139305051|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139305052|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139305053|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
139305054|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305055|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
139305056|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139305057|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305058|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305059|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139305060|NCT04346290|Analgesics|analgesics|mesh-ancestor
139305061|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
139305062|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305063|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139305064|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139305065|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139305066|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
139305067|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305068|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305069|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
139305070|NCT04426552|Sevoflurane|sevoflurane|mesh-list
139305071|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139305072|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305073|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305074|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139305075|NCT04426552|Analgesics|analgesics|mesh-ancestor
139305076|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
139073625|NCT03992885|Pemetrexed|pemetrexed|mesh-list
139305077|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305078|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139305079|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139305080|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139305081|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
139305082|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305083|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305084|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139305085|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139305086|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
139305087|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
139305088|NCT04803370|Antibodies|antibodies|mesh-list
139305089|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
139305090|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305091|NCT01369329|Ustekinumab|ustekinumab|mesh-list
139305092|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
139305093|NCT04802980|Paclitaxel|paclitaxel|mesh-list
139305094|NCT04802980|Carboplatin|carboplatin|mesh-list
139305095|NCT04802980|Gemcitabine|gemcitabine|mesh-list
139305096|NCT04802980|Capecitabine|capecitabine|mesh-list
139305097|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
139305098|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139305099|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305100|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
139305101|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
139305102|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
139305103|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305104|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139305105|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
139305106|NCT03558477|Esomeprazole|esomeprazole|mesh-list
139305107|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139305108|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139305109|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139305110|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305111|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305112|NCT04792840|Letrozole|letrozole|mesh-list
139305113|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305114|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139305115|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139305116|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175637|NCT01589809|Vitamins|vitamins|mesh-ancestor
139305117|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305119|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
139305120|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139305121|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305122|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
139305123|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
139305124|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
139305125|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
139305126|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
139305127|NCT02085291|Norepinephrine|norepinephrine|mesh-list
139305128|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139305129|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139305130|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
139305131|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305132|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305133|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305134|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
139305135|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
139305136|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305137|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139305138|NCT04792138|Phenobarbital|phenobarbital|mesh-list
139305139|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
139305140|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139305141|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305142|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305143|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139073631|NCT03739294|Fluticasone|fluticasone|mesh-list
139305144|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139305145|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305146|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305147|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
139305148|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
139305149|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139305150|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139305151|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139305152|NCT04802122|Propofol|propofol|mesh-list
139305153|NCT04802122|Sevoflurane|sevoflurane|mesh-list
139305154|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139305155|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305156|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305157|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139305158|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
139305159|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
139305160|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139305161|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139305162|NCT04784728|Lidocaine|lidocaine|mesh-list
138962021|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
139305163|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
139305165|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305166|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305167|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
139305168|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305169|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139305170|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139305171|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139305172|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139305173|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305174|NCT02085603|Saracatinib|saracatinib|mesh-list
139305175|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305176|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305177|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305178|NCT02090829|Oxytocin|oxytocin|mesh-list
139305179|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
139305180|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139305181|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305182|NCT04801888|Vaccines|vaccines|mesh-list
139305183|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
139305184|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305185|NCT02089503|Ranibizumab|ranibizumab|mesh-list
139305186|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139305187|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139305188|NCT02089503|Growth Substances|growth substances|mesh-ancestor
139305189|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305190|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
139305191|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305192|NCT02091063|Ricolinostat|ricolinostat|mesh-list
139305193|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305194|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139305195|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305196|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305197|NCT02091219|Vitamin D|vitamin d|mesh-list
139305198|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
139305199|NCT02091219|Calcifediol|calcifediol|mesh-list
139305200|NCT02091219|Vitamins|vitamins|mesh-ancestor
139305201|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
139305202|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305203|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139305204|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139305205|NCT02091297|Acetaminophen|acetaminophen|mesh-list
139305206|NCT02091297|Morphine|morphine|mesh-list
139305207|NCT02091297|Ropivacaine|ropivacaine|mesh-list
139305208|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139305209|NCT02091297|Narcotics|narcotics|mesh-ancestor
139305210|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305211|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305212|NCT02091297|Analgesics|analgesics|mesh-ancestor
139305213|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
139305214|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305215|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
139305216|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
139305217|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139305218|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
139305219|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
139305220|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139305221|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139305222|NCT04791202|Prednisolone|prednisolone|mesh-list
139305223|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
139305224|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139305225|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
139305226|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139305227|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
139305228|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
139305229|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305230|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305231|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139305232|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
139305233|NCT04791202|Hormones|hormones|mesh-ancestor
139305234|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139305235|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139305236|NCT04791202|Protective Agents|protective agents|mesh-ancestor
139305237|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139305238|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305239|NCT04801342|Memantine|memantine|mesh-list
139305240|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139305241|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139305242|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
139305243|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305244|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305245|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305246|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139305247|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139305248|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139305249|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
139305250|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139305251|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305252|NCT02590588|Idelalisib|idelalisib|mesh-list
139305253|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305254|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305255|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305256|NCT02086227|Glucagon|glucagon|mesh-list
139175649|NCT01264237|Analgesics|analgesics|mesh-ancestor
139305257|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139305258|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139305259|NCT02086227|Hormones|hormones|mesh-ancestor
139305260|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139305261|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305262|NCT02086227|Incretins|incretins|mesh-ancestor
139305263|NCT02086929|Trazodone|trazodone|mesh-list
139305264|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139073657|NCT00112437|Vitamin D|vitamin d|mesh-list
139305265|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139305266|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139305267|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139305268|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305269|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305270|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305271|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139305272|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
139305273|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139305274|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139305275|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139305276|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305277|NCT02086929|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139305278|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
139305279|NCT02249013|Paclitaxel|paclitaxel|mesh-list
139305280|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139305281|NCT02249013|Carboplatin|carboplatin|mesh-list
139305282|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139305283|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305284|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
139305285|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
139305286|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
139305287|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305288|NCT02249871|Omeprazole|omeprazole|mesh-list
139305289|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139305290|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139305291|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139305292|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305293|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305294|NCT02087007|Cilostazol|cilostazol|mesh-list
139305295|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139305296|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
139305297|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305298|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305299|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139305300|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
139305301|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139305302|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139305303|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305304|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139305305|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
139305306|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139305307|NCT02087007|Protective Agents|protective agents|mesh-ancestor
139305308|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139305309|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139305310|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305311|NCT01434602|Everolimus|everolimus|mesh-list
139305312|NCT01434602|Sorafenib|sorafenib|mesh-list
139305313|NCT01434602|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139305314|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139305315|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305316|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305317|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139305318|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
139305319|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305320|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305321|NCT02087475|Fluorouracil|fluorouracil|mesh-list
139305322|NCT02087475|Irinotecan|irinotecan|mesh-list
139305323|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
139073668|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139305324|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305325|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139305326|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305327|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139305328|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
139305329|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305330|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139305331|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139305332|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305333|NCT05486949|Itraconazole|itraconazole|mesh-list
139305334|NCT05486949|Carbamazepine|carbamazepine|mesh-list
139305335|NCT05486949|Antifungal Agents|antifungal agents|mesh-ancestor
139305336|NCT05486949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139305337|NCT05486949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139305338|NCT05486949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139305339|NCT05486949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305340|NCT05486949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305341|NCT05486949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139305342|NCT05486949|Hormone Antagonists|hormone antagonists|mesh-ancestor
139305343|NCT05486949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139305344|NCT05486949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305345|NCT05486949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139305346|NCT05486949|Anticonvulsants|anticonvulsants|mesh-ancestor
139305347|NCT05486949|Antimanic Agents|antimanic agents|mesh-ancestor
139305348|NCT05486949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139305349|NCT05486949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305350|NCT05486949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139305351|NCT05486949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139305352|NCT05486949|Analgesics|analgesics|mesh-ancestor
139305353|NCT05486949|Sensory System Agents|sensory system agents|mesh-ancestor
139305354|NCT05486949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305355|NCT05486949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139305356|NCT05486949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139305357|NCT05486949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139305358|NCT05486949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139305359|NCT03558243|Hemostatics|hemostatics|mesh-list
139305360|NCT03558243|Coagulants|coagulants|mesh-ancestor
139305361|NCT03426956|Canagliflozin|canagliflozin|mesh-list
139305362|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139305363|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305364|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139305365|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305366|NCT03557229|Vitamins|vitamins|mesh-list
139305367|NCT03557229|Vitamin E|vitamin e|mesh-list
139305368|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
139305369|NCT03557229|Melatonin|melatonin|mesh-list
139305370|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139305371|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
139305372|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305373|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
139305374|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305375|NCT03557229|Protective Agents|protective agents|mesh-ancestor
139305376|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305377|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
139305378|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139305379|NCT03557229|Expectorants|expectorants|mesh-ancestor
139305380|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
139305381|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139305382|NCT03557229|Antidotes|antidotes|mesh-ancestor
139305383|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139305384|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
139305385|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139305386|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139305387|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139305388|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305389|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305390|NCT00940940|Vaccines|vaccines|mesh-list
139305391|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
139305392|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305393|NCT03557840|Temocillin|temocillin|mesh-list
139305394|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139305395|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139305396|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
139305397|NCT02092701|Vitamin D|vitamin d|mesh-list
139305398|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139305399|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305400|NCT02092701|Vitamins|vitamins|mesh-ancestor
139305401|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
139305402|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139305403|NCT01767129|Quinidine|quinidine|mesh-list
139305404|NCT01767129|Dextromethorphan|dextromethorphan|mesh-list
139305405|NCT01767129|Antitussive Agents|antitussive agents|mesh-ancestor
139305406|NCT01767129|Respiratory System Agents|respiratory system agents|mesh-ancestor
139305407|NCT01767129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139305408|NCT01767129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139305409|NCT01767129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305410|NCT01767129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305411|NCT01767129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305412|NCT01767129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139305413|NCT01767129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139305414|NCT01767129|Adrenergic Agents|adrenergic agents|mesh-ancestor
139305415|NCT01767129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139305416|NCT01767129|Antimalarials|antimalarials|mesh-ancestor
139305417|NCT01767129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139305418|NCT01767129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139305419|NCT01767129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139305420|NCT01767129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305421|NCT01767129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139305422|NCT01767129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139305423|NCT01767129|Cholinergic Agents|cholinergic agents|mesh-ancestor
139305424|NCT01767129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139305425|NCT01767129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139305426|NCT01767129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139305427|NCT01767129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139305428|NCT01767129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139305429|NCT01309191|Minoxidil|minoxidil|mesh-list
139305430|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139305431|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
139305432|NCT03420638|Epinephrine|epinephrine|mesh-list
139305433|NCT03420638|Bupivacaine|bupivacaine|mesh-list
139305434|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
139305435|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
139305436|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305437|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305438|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
139305439|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305440|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139305441|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139305442|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
139305443|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305444|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305445|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139305446|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139305447|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
139305448|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139305449|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
139305450|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
139305451|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
139305452|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139305453|NCT00715988|Methadone|methadone|mesh-list
139305454|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139305455|NCT00715988|Narcotics|narcotics|mesh-ancestor
139305456|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305457|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305458|NCT00715988|Analgesics|analgesics|mesh-ancestor
139305459|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
139305460|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305461|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
139305462|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
139305463|NCT02093091|Vitremer|vitremer|mesh-list
139305465|NCT02093091|Protective Agents|protective agents|mesh-ancestor
139305466|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305467|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139305468|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
139305469|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139305471|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139305472|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305473|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139305474|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305475|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305476|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139305477|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139305478|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
139305479|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305480|NCT02090439|Silodosin|silodosin|mesh-list
139305481|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139305482|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139305483|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139305484|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
139305485|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305486|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305487|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305488|NCT02090439|Urological Agents|urological agents|mesh-ancestor
139305489|NCT02696564|Losartan|losartan|mesh-list
139305490|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139305491|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139305492|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139305493|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139305494|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305495|NCT02093403|Decitabine|decitabine|mesh-list
139305496|NCT02093403|Azacitidine|azacitidine|mesh-list
139305497|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139305498|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
139305499|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305500|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305501|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305502|NCT03426176|Oxytocin|oxytocin|mesh-list
139305503|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
139305504|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139305505|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305506|NCT02095899|Rufinamide|rufinamide|mesh-list
139305507|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
139305508|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139305509|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139305510|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139305511|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305512|NCT03525002|Bromocriptine|bromocriptine|mesh-list
139305513|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139305514|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139305515|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
139305516|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139305517|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305518|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
139305519|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
139305520|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305521|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305522|NCT03426020|Midazolam|midazolam|mesh-list
139305523|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139305524|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139305525|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305526|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305528|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139305529|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139305530|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139305531|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
139305532|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
139305533|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
139305534|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
139305535|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962396|NCT01001962|Empagliflozin|empagliflozin|mesh-list
139305536|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305537|NCT03428906|Oxytocin|oxytocin|mesh-list
139305538|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
139305539|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139305540|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305541|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139305542|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
139305543|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139305544|NCT02521298|Prednisolone|prednisolone|mesh-list
139305545|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
139305546|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139305547|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
139305548|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139305549|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
139305550|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
139305551|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305552|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305553|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139305554|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
139305555|NCT02521298|Hormones|hormones|mesh-ancestor
139305556|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139305557|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139305558|NCT02521298|Protective Agents|protective agents|mesh-ancestor
139305559|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139305560|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305561|NCT00389870|Cyclosporine|cyclosporine|mesh-list
139305562|NCT00389870|Irinotecan|irinotecan|mesh-list
139305563|NCT00389870|Panitumumab|panitumumab|mesh-list
139305564|NCT00389870|Cyclosporins|cyclosporins|mesh-list
139305565|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139305566|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139305567|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305568|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305569|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305570|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139305571|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
139305572|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305573|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
139305574|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139305575|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
139305576|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139305577|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139305578|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139305579|NCT03419858|Naloxone|naloxone|mesh-list
139305580|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139305581|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305582|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
139305583|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305584|NCT03417206|Remifentanil|remifentanil|mesh-list
139305585|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139305586|NCT03417206|Narcotics|narcotics|mesh-ancestor
139305587|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305588|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305589|NCT03417206|Analgesics|analgesics|mesh-ancestor
139305590|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
139305591|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305592|NCT00003716|Rituximab|rituximab|mesh-list
139305593|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139305594|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305595|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
139305596|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305597|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139305598|NCT02593786|Nivolumab|nivolumab|mesh-list
139305599|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139305600|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305601|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139305602|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305603|NCT03425708|Febuxostat|febuxostat|mesh-list
139305604|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
139305605|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139305606|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139305607|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139305608|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139305609|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305610|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305611|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139305612|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139305613|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139305615|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305616|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305617|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139305618|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139305619|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
139305620|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
139305621|NCT03425474|Propofol|propofol|mesh-list
139305622|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139305623|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305624|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305625|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139305626|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
139305627|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
139305628|NCT03419624|Metformin|metformin|mesh-list
139305629|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
139305630|NCT03419624|Exenatide|exenatide|mesh-list
139305631|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139305632|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305633|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139305634|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305635|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139305636|NCT03419624|Incretins|incretins|mesh-ancestor
139305637|NCT03419624|Hormones|hormones|mesh-ancestor
139305638|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139305639|NCT03425162|Morphine|morphine|mesh-list
139305640|NCT03425162|Bupivacaine|bupivacaine|mesh-list
139305641|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
139305642|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
139305643|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305644|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305645|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
139305646|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305647|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139305648|NCT03425162|Narcotics|narcotics|mesh-ancestor
139305649|NCT03425162|Analgesics|analgesics|mesh-ancestor
139305650|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
139305651|NCT02096133|Vitamin D|vitamin d|mesh-list
139305652|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139305653|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305654|NCT02096133|Vitamins|vitamins|mesh-ancestor
139305655|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
139305656|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139305657|NCT02096289|Thioridazine|thioridazine|mesh-list
139305658|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139305659|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139305660|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305661|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305662|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139305663|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139305664|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
139305665|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305666|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305667|NCT02090673|Exenatide|exenatide|mesh-list
139305668|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139305669|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305670|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139305671|NCT02090673|Incretins|incretins|mesh-ancestor
139305672|NCT02090673|Hormones|hormones|mesh-ancestor
139305673|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139305674|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
139305675|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139305676|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
139305677|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139305678|NCT03556371|Expectorants|expectorants|mesh-ancestor
139305679|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
139305680|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139305681|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
139305682|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305683|NCT03556371|Protective Agents|protective agents|mesh-ancestor
139305684|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305685|NCT03556371|Antidotes|antidotes|mesh-ancestor
138962560|NCT03999580|Vitamin D|vitamin d|mesh-list
139305686|NCT02827526|Ketamine|ketamine|mesh-list
139305687|NCT02827526|Analgesics|analgesics|mesh-ancestor
139305688|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
139305689|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305690|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305691|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139305692|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139305693|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
139305694|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
139305695|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305696|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139305697|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139305698|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305699|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305700|NCT04799314|Tislelizumab|tislelizumab|mesh-list
139305701|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138824323|NCT02568943|Panobinostat|panobinostat|mesh-list
139305702|NCT04799314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139305703|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305704|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305705|NCT03425084|Morphine|morphine|mesh-list
139305706|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139305707|NCT03425084|Narcotics|narcotics|mesh-ancestor
139305708|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305709|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305710|NCT03425084|Analgesics|analgesics|mesh-ancestor
139305711|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
139305712|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305713|NCT03424928|Thalidomide|thalidomide|mesh-list
139305714|NCT03424928|Pomalidomide|pomalidomide|mesh-list
139305715|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
139305716|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305717|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139305718|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139305719|NCT03424928|Growth Substances|growth substances|mesh-ancestor
139305720|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
139305721|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305722|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139305723|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
139305724|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139305725|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139305726|NCT04799002|Melphalan|melphalan|mesh-list
139305727|NCT04799002|Topotecan|topotecan|mesh-list
139305728|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139305729|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
139305730|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305731|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305732|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139305733|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139305734|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
139175691|NCT01266031|Growth Substances|growth substances|mesh-ancestor
139305735|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305736|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139305737|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139305738|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305739|NCT02098785|Caffeine|caffeine|mesh-list
139305740|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
139305741|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305742|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139305743|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305744|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139305745|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305746|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139305747|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139305748|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
139305749|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305750|NCT02521064|Prednisone|prednisone|mesh-list
139305751|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139305752|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
139305753|NCT02521064|Hormones|hormones|mesh-ancestor
139305754|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139305755|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305756|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139305757|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305758|NCT02096913|Ibuprofen|ibuprofen|mesh-list
139305759|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139305760|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139305761|NCT02096913|Analgesics|analgesics|mesh-ancestor
139305762|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
139305763|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305764|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305765|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139305766|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139305767|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139305768|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305769|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305770|NCT03418610|Azelaic acid|azelaic acid|mesh-list
139305771|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305772|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
139305773|NCT04604366|Alprostadil|alprostadil|mesh-list
139305774|NCT04604366|Misoprostol|misoprostol|mesh-list
139305775|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139305776|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
139305777|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139305778|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305779|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139305780|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139305781|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
139305782|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139305783|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
139305784|NCT04604366|Urological Agents|urological agents|mesh-ancestor
139305785|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
139305786|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139305787|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305788|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305789|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139305790|NCT02099253|Analgesics|analgesics|mesh-ancestor
139305791|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
139305792|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305793|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139305794|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139305795|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139305796|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
139305797|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305798|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305799|NCT05818111|Lidocaine|lidocaine|mesh-list
139305800|NCT05818111|Anesthetics, Local|anesthetics, local|mesh-ancestor
139305801|NCT05818111|Anesthetics|anesthetics|mesh-ancestor
139305802|NCT05818111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305803|NCT05818111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305804|NCT05818111|Sensory System Agents|sensory system agents|mesh-ancestor
139305805|NCT05818111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305806|NCT05818111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139305807|NCT05818111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139305808|NCT05818111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139305809|NCT05818111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139305810|NCT05818111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305811|NCT05818007|Hyaluronic Acid|hyaluronic acid|mesh-list
139305812|NCT05818007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139305813|NCT05818007|Immunologic Factors|immunologic factors|mesh-ancestor
139305814|NCT05818007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305815|NCT05818007|Viscosupplements|viscosupplements|mesh-ancestor
139305816|NCT05818007|Protective Agents|protective agents|mesh-ancestor
139305817|NCT05817955|Azacitidine|azacitidine|mesh-list
139305818|NCT05817955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139305819|NCT05817955|Antimetabolites|antimetabolites|mesh-ancestor
139305820|NCT05817955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305821|NCT05817955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305822|NCT05817955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305823|NCT05817409|Baclofen|baclofen|mesh-list
139305824|NCT05817409|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139305825|NCT05817409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305826|NCT05817409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139305827|NCT05817409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305828|NCT05817409|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139305829|NCT05817409|GABA Agonists|gaba agonists|mesh-ancestor
139305830|NCT05817409|GABA Agents|gaba agents|mesh-ancestor
139305831|NCT05817409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305832|NCT05817409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305833|NCT05817253|Coal Tar|coal tar|mesh-list
139305834|NCT05817253|Keratolytic Agents|keratolytic agents|mesh-ancestor
139305835|NCT05817253|Dermatologic Agents|dermatologic agents|mesh-ancestor
139305836|NCT05817201|Tegafur|tegafur|mesh-list
139305837|NCT05817201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139305838|NCT05817201|Antimetabolites|antimetabolites|mesh-ancestor
139305839|NCT05817201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305840|NCT05817201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305841|NCT05817019|Neostigmine|neostigmine|mesh-list
139305842|NCT05817019|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139305843|NCT05817019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305844|NCT05817019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305845|NCT05817019|Cholinergic Agents|cholinergic agents|mesh-ancestor
139305846|NCT05817019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305847|NCT05817019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305848|NCT05817019|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139305849|NCT05817019|Autonomic Agents|autonomic agents|mesh-ancestor
139305850|NCT05817019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305851|NCT05816772|Calcium|calcium|mesh-list
139305852|NCT05816772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139305853|NCT05816772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305854|NCT05816720|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139305855|NCT05816720|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139305856|NCT05816720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305857|NCT05816707|Turmeric extract|turmeric extract|mesh-list
139305858|NCT05816707|Antioxidants|antioxidants|mesh-ancestor
139305859|NCT05816707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305860|NCT05816707|Protective Agents|protective agents|mesh-ancestor
139305861|NCT05816707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305862|NCT05816694|Paclitaxel|paclitaxel|mesh-list
139305863|NCT05816694|Cyclophosphamide|cyclophosphamide|mesh-list
139305864|NCT05816694|Cisplatin|cisplatin|mesh-list
139305865|NCT05816694|Epirubicin|epirubicin|mesh-list
139305866|NCT05816694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139175707|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
139305867|NCT05816694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305868|NCT05816694|Tubulin Modulators|tubulin modulators|mesh-ancestor
139305869|NCT05816694|Antimitotic Agents|antimitotic agents|mesh-ancestor
139305870|NCT05816694|Mitosis Modulators|mitosis modulators|mesh-ancestor
139073790|NCT00381797|Irinotecan|irinotecan|mesh-list
139305871|NCT05816694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305872|NCT05816694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139305873|NCT05816694|Immunologic Factors|immunologic factors|mesh-ancestor
139305874|NCT05816694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305875|NCT05816694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139305876|NCT05816694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139305877|NCT05816694|Alkylating Agents|alkylating agents|mesh-ancestor
139305878|NCT05816694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139305879|NCT05816694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139305880|NCT05816694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139305881|NCT05816694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139305882|NCT05816694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305883|NCT05816668|Tranexamic Acid|tranexamic acid|mesh-list
139305884|NCT05816668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139305885|NCT05816668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139305886|NCT05816668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305887|NCT05816668|Hemostatics|hemostatics|mesh-ancestor
139305888|NCT05816668|Coagulants|coagulants|mesh-ancestor
139305889|NCT05816642|Sunitinib|sunitinib|mesh-list
139305890|NCT05816642|Axitinib|axitinib|mesh-list
139305891|NCT05816642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139305892|NCT05816642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305893|NCT05816642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139305894|NCT05816642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139305895|NCT05816642|Growth Substances|growth substances|mesh-ancestor
139305896|NCT05816642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305897|NCT05816642|Growth Inhibitors|growth inhibitors|mesh-ancestor
139305898|NCT05816642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139305899|NCT05816642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305900|NCT05816642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305901|NCT05816642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139305902|NCT05816538|Anesthetics|anesthetics|mesh-list
139305903|NCT05816538|Levobupivacaine|levobupivacaine|mesh-list
139305904|NCT05816538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305905|NCT05816538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305906|NCT05816538|Anesthetics, Local|anesthetics, local|mesh-ancestor
139305907|NCT05816538|Sensory System Agents|sensory system agents|mesh-ancestor
139305908|NCT05816538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305909|NCT05809583|Ozanimod|ozanimod|mesh-list
138962770|NCT00303667|Cyclosporine|cyclosporine|mesh-list
139305910|NCT05809583|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139305911|NCT05809583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305912|NCT05809583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139305913|NCT05809583|Immunologic Factors|immunologic factors|mesh-ancestor
139305914|NCT05809583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305915|NCT05803629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139305916|NCT05803629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139305917|NCT05803629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305918|NCT05803434|Cannabidiol|cannabidiol|mesh-list
139305919|NCT05803434|Anticonvulsants|anticonvulsants|mesh-ancestor
139305921|NCT05777226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305922|NCT05777226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305923|NCT05769920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139175715|NCT01266187|Leucovorin|leucovorin|mesh-list
139305924|NCT05769920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139305925|NCT05716607|Hydrocortisone|hydrocortisone|mesh-list
139305926|NCT05716607|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139305927|NCT05716607|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139305928|NCT05716607|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139305929|NCT05716607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139305930|NCT05688579|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139305931|NCT05688579|Mineralocorticoids|mineralocorticoids|mesh-list
139305932|NCT05688579|Hormone Antagonists|hormone antagonists|mesh-ancestor
139305933|NCT05688579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139305934|NCT05688579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305935|NCT05688579|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139305936|NCT05688579|Diuretics|diuretics|mesh-ancestor
139305937|NCT05688579|Natriuretic Agents|natriuretic agents|mesh-ancestor
139305938|NCT05688579|Hormones|hormones|mesh-ancestor
139305939|NCT05675501|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139305940|NCT05675501|Dermatologic Agents|dermatologic agents|mesh-ancestor
139305941|NCT05662111|Etidronic Acid|etidronic acid|mesh-list
139305942|NCT05662111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139305943|NCT05662111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305944|NCT05659927|Antibodies|antibodies|mesh-list
139305945|NCT05659927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139305946|NCT05659927|Immunologic Factors|immunologic factors|mesh-ancestor
139305947|NCT05659927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305948|NCT05659823|Fentanyl|fentanyl|mesh-list
139305949|NCT05659823|Morphine|morphine|mesh-list
139305950|NCT05659823|Bupivacaine|bupivacaine|mesh-list
139305951|NCT05659823|Anesthetics, Local|anesthetics, local|mesh-ancestor
139305952|NCT05659823|Anesthetics|anesthetics|mesh-ancestor
139305953|NCT05659823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305954|NCT05659823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305955|NCT05659823|Sensory System Agents|sensory system agents|mesh-ancestor
139305956|NCT05659823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305957|NCT05659823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139305958|NCT05659823|Narcotics|narcotics|mesh-ancestor
139305959|NCT05659823|Analgesics|analgesics|mesh-ancestor
139305960|NCT05659823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139305961|NCT05659823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139305962|NCT05659823|Anesthetics, General|anesthetics, general|mesh-ancestor
139305963|NCT05640453|Pregabalin|pregabalin|mesh-list
139305964|NCT05640453|Dexmedetomidine|dexmedetomidine|mesh-list
139305965|NCT05640453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139305966|NCT05640453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139305967|NCT05640453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139305968|NCT05640453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139305969|NCT05640453|Analgesics|analgesics|mesh-ancestor
139305970|NCT05640453|Sensory System Agents|sensory system agents|mesh-ancestor
139305971|NCT05640453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139305972|NCT05640453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139305973|NCT05640453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139305974|NCT05640453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139305975|NCT05640453|Adrenergic Agents|adrenergic agents|mesh-ancestor
139305976|NCT05640453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139305977|NCT05640453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305978|NCT05640453|Anticonvulsants|anticonvulsants|mesh-ancestor
139305979|NCT05640453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139305980|NCT05640453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139305981|NCT05640453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139305982|NCT05640453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139305983|NCT05640453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138962846|NCT00302731|Progestins|progestins|mesh-ancestor
139305984|NCT05640453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139305986|NCT05635851|Vasodilator Agents|vasodilator agents|mesh-ancestor
139305987|NCT05599789|Docetaxel|docetaxel|mesh-list
139305988|NCT05599789|Pembrolizumab|pembrolizumab|mesh-list
139305989|NCT05599789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139305990|NCT05599789|Tubulin Modulators|tubulin modulators|mesh-ancestor
139305991|NCT05599789|Antimitotic Agents|antimitotic agents|mesh-ancestor
139305992|NCT05599789|Mitosis Modulators|mitosis modulators|mesh-ancestor
139073828|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139305993|NCT05599789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139305994|NCT05599789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139305995|NCT05599789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139305996|NCT05581901|Methadone|methadone|mesh-list
139305997|NCT05581901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139305998|NCT05581901|Narcotics|narcotics|mesh-ancestor
139305999|NCT05581901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306000|NCT05581901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306001|NCT05581901|Analgesics|analgesics|mesh-ancestor
139306002|NCT05581901|Sensory System Agents|sensory system agents|mesh-ancestor
139306003|NCT05581901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306004|NCT05581901|Antitussive Agents|antitussive agents|mesh-ancestor
139306005|NCT05581901|Respiratory System Agents|respiratory system agents|mesh-ancestor
139306006|NCT05508061|Insulin|insulin|mesh-list
139306007|NCT05508061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139306008|NCT05508061|Insulin Lispro|insulin lispro|mesh-list
139306009|NCT05508061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139306010|NCT05508061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306011|NCT05504642|Nivolumab|nivolumab|mesh-list
139306012|NCT05504642|Ipilimumab|ipilimumab|mesh-list
139306013|NCT05504642|Immunomodulating Agents|immunomodulating agents|mesh-list
139306014|NCT05504642|Immunologic Factors|immunologic factors|mesh-list
139306015|NCT05504642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306016|NCT05504642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306017|NCT05504642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139306018|NCT05504642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306019|NCT05504642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306020|NCT05490953|Pentoxifylline|pentoxifylline|mesh-list
139306021|NCT05490953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139306022|NCT05490953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306023|NCT05490953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306024|NCT05490953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139306025|NCT05490953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139306026|NCT05490953|Protective Agents|protective agents|mesh-ancestor
139306027|NCT05490953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306028|NCT05490953|Vasodilator Agents|vasodilator agents|mesh-ancestor
139306029|NCT05490953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139306030|NCT05490953|Antioxidants|antioxidants|mesh-ancestor
139306031|NCT05475483|Bevantolol|bevantolol|mesh-list
139306032|NCT05475483|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139306033|NCT05475483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139306034|NCT05475483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139306035|NCT05475483|Adrenergic Agents|adrenergic agents|mesh-ancestor
139306036|NCT05475483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306037|NCT05475483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306038|NCT05475483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306039|NCT05474729|Minocycline|minocycline|mesh-list
139306040|NCT05474729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139306041|NCT05474729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139306042|NCT05474001|Fentanyl|fentanyl|mesh-list
139306043|NCT05474001|Bupivacaine|bupivacaine|mesh-list
139306044|NCT05474001|Anesthetics, Local|anesthetics, local|mesh-ancestor
139306045|NCT05474001|Anesthetics|anesthetics|mesh-ancestor
139306046|NCT05474001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306047|NCT05474001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306048|NCT05474001|Sensory System Agents|sensory system agents|mesh-ancestor
139306049|NCT05474001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306050|NCT05474001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139306051|NCT05474001|Narcotics|narcotics|mesh-ancestor
139306052|NCT05474001|Analgesics|analgesics|mesh-ancestor
139306053|NCT05474001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139306054|NCT05474001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139306055|NCT05474001|Anesthetics, General|anesthetics, general|mesh-ancestor
139306056|NCT05445232|Midazolam|midazolam|mesh-list
139306057|NCT05445232|Caffeine|caffeine|mesh-list
139306058|NCT05445232|Warfarin|warfarin|mesh-list
139306059|NCT05445232|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139306060|NCT05445232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139306061|NCT05445232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306062|NCT05445232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306063|NCT05445232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139306064|NCT05445232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139306065|NCT05445232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139306066|NCT05445232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139306067|NCT05445232|Anesthetics, General|anesthetics, general|mesh-ancestor
139306068|NCT05445232|Anesthetics|anesthetics|mesh-ancestor
139306069|NCT05445232|GABA Modulators|gaba modulators|mesh-ancestor
139306070|NCT05445232|GABA Agents|gaba agents|mesh-ancestor
139306071|NCT05445232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306072|NCT05445232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306073|NCT05445232|Anticoagulants|anticoagulants|mesh-ancestor
139306074|NCT05445232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139306075|NCT05445232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139306076|NCT05445232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306077|NCT05445232|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139306078|NCT05445232|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139306079|NCT05445232|Purinergic Agents|purinergic agents|mesh-ancestor
139306080|NCT05420805|Zinc Oxide|zinc oxide|mesh-list
139306081|NCT05420805|Butyric Acid|butyric acid|mesh-list
139306082|NCT05420805|Dermatologic Agents|dermatologic agents|mesh-ancestor
139306083|NCT05420805|Sunscreening Agents|sunscreening agents|mesh-ancestor
139306084|NCT05420805|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139306085|NCT05420805|Protective Agents|protective agents|mesh-ancestor
139306086|NCT05420805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306087|NCT05420805|Histamine Antagonists|histamine antagonists|mesh-ancestor
139306088|NCT05420805|Histamine Agents|histamine agents|mesh-ancestor
139306089|NCT05420805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306090|NCT05420805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306091|NCT05395533|Antibodies|antibodies|mesh-list
139306092|NCT05395533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139306093|NCT05395533|Immunologic Factors|immunologic factors|mesh-ancestor
139306094|NCT05395533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306095|NCT05355974|Norepinephrine|norepinephrine|mesh-list
139306096|NCT05355974|Plasma-lyte 148|plasma-lyte 148|mesh-list
139306097|NCT05355974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139306098|NCT05355974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139306099|NCT05355974|Adrenergic Agents|adrenergic agents|mesh-ancestor
139306100|NCT05355974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306101|NCT05355974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306102|NCT05355974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306103|NCT05355974|Sympathomimetics|sympathomimetics|mesh-ancestor
139306104|NCT05355974|Autonomic Agents|autonomic agents|mesh-ancestor
139306105|NCT05355974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306106|NCT05355974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139306107|NCT05355974|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139306108|NCT05355974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139306109|NCT05340413|Olaparib|olaparib|mesh-list
139306110|NCT05340413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139306111|NCT05340413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306112|NCT05340413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306113|NCT05340413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306114|NCT05323955|Trastuzumab|trastuzumab|mesh-list
139306115|NCT05323955|Pertuzumab|pertuzumab|mesh-list
139306116|NCT05323955|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139306117|NCT05323955|Maytansine|maytansine|mesh-list
139306118|NCT05323955|Tucatinib|tucatinib|mesh-list
139306119|NCT05323955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306120|NCT05323955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306121|NCT05323955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139306122|NCT05323955|Tubulin Modulators|tubulin modulators|mesh-ancestor
139306123|NCT05323955|Antimitotic Agents|antimitotic agents|mesh-ancestor
139306124|NCT05323955|Mitosis Modulators|mitosis modulators|mesh-ancestor
139306125|NCT05323955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306126|NCT05323955|Immunotoxins|immunotoxins|mesh-ancestor
139306127|NCT05323955|Immunoconjugates|immunoconjugates|mesh-ancestor
139306128|NCT05323955|Immunologic Factors|immunologic factors|mesh-ancestor
139306129|NCT05323955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306130|NCT05323955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139306131|NCT05323955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306132|NCT05312385|Propofol|propofol|mesh-list
139306133|NCT05312385|Isoflurane|isoflurane|mesh-list
139306134|NCT05312385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139306135|NCT05312385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139091542|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306136|NCT05312385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306137|NCT05312385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139306138|NCT05312385|Anesthetics, General|anesthetics, general|mesh-ancestor
139306139|NCT05312385|Anesthetics|anesthetics|mesh-ancestor
139306140|NCT05312385|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139306141|NCT05289193|Nivolumab|nivolumab|mesh-list
139306142|NCT05289193|Ipilimumab|ipilimumab|mesh-list
139306143|NCT05289193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306144|NCT05289193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306145|NCT05289193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139306146|NCT05289193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306147|NCT05259137|Enalaprilat|enalaprilat|mesh-list
139306148|NCT05259137|Enalapril|enalapril|mesh-list
139306149|NCT05259137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139306150|NCT05259137|Protease Inhibitors|protease inhibitors|mesh-ancestor
139306151|NCT05259137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306152|NCT05259137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306153|NCT05259137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139306154|NCT05159830|Cannabidiol|cannabidiol|mesh-list
139306155|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
139306156|NCT05112211|Doxycycline|doxycycline|mesh-list
139306157|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139306158|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139306159|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
139306160|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139306161|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139306162|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139306163|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
139306164|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306165|NCT05107427|Avelumab|avelumab|mesh-list
139306166|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306167|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306168|NCT05036226|Metformin|metformin|mesh-list
139306169|NCT05036226|Sirolimus|sirolimus|mesh-list
139306170|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
139306171|NCT05036226|Nelfinavir|nelfinavir|mesh-list
139306172|NCT05036226|Temsirolimus|temsirolimus|mesh-list
139306173|NCT05036226|Dasatinib|dasatinib|mesh-list
139306174|NCT05036226|MTOR Inhibitors|mtor inhibitors|mesh-list
139306175|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139306176|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306177|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139306178|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139306179|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139306180|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306181|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
139306182|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139306183|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
139306184|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139306185|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306186|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306187|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
139306188|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139306189|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139306190|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139306191|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139306192|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139306193|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
139306194|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139306195|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139306196|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
139306198|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139306199|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306200|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306201|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306202|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
139306203|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
139306204|NCT05005897|Vitamins|vitamins|mesh-ancestor
139306205|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
139306206|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306207|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
139306208|NCT05005897|Hematinics|hematinics|mesh-ancestor
139306209|NCT04994977|Carboplatin|carboplatin|mesh-list
139306210|NCT04994977|Melphalan|melphalan|mesh-list
139306211|NCT04994977|Topotecan|topotecan|mesh-list
139306212|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306213|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139306214|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
139306215|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306216|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139306217|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139306218|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
139306219|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306220|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139306221|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139306222|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306223|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
139306224|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139306225|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
139306226|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306227|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
139306228|NCT04866706|Protective Agents|protective agents|mesh-ancestor
139306229|NCT04846478|Talazoparib|talazoparib|mesh-list
139306230|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139306231|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306232|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306233|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306234|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
139306235|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306236|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306237|NCT04834973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139306238|NCT04834973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306239|NCT04764825|Morphine|morphine|mesh-list
139306240|NCT04764825|Methadone|methadone|mesh-list
139306241|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139306242|NCT04764825|Narcotics|narcotics|mesh-ancestor
139306243|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306244|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306245|NCT04764825|Analgesics|analgesics|mesh-ancestor
139306246|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
139306247|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306248|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
139306249|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
139306250|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
139306251|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139306252|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
139306253|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306254|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139306255|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
139306256|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139306257|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
139306258|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306259|NCT04706910|Furosemide|furosemide|mesh-list
139306260|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
139306261|NCT04706910|Diuretics|diuretics|mesh-ancestor
139306262|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
139306263|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306264|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139306265|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306266|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306267|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
139306268|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306269|NCT04704271|Dronabinol|dronabinol|mesh-list
139306270|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
139306271|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306272|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139306273|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139306274|NCT04704271|Analgesics|analgesics|mesh-ancestor
139306275|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
139306276|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306277|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139306278|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139306279|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306280|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306281|NCT04704271|Hormones|hormones|mesh-ancestor
139306282|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139306283|NCT04680286|Methadone|methadone|mesh-list
139306284|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139306285|NCT04680286|Narcotics|narcotics|mesh-ancestor
139306286|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306287|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306288|NCT04680286|Analgesics|analgesics|mesh-ancestor
139306289|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
139306290|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306291|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
139306292|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
139306293|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139306294|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139306295|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306296|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139306297|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
139306298|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306299|NCT04672018|Omeprazole|omeprazole|mesh-list
139306300|NCT04672018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139306301|NCT04672018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139306302|NCT04672018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139306303|NCT04672018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073948|NCT03615040|Astegolimab|astegolimab|mesh-list
139306304|NCT04672018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306305|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
139306306|NCT04638881|Analgesics|analgesics|mesh-ancestor
139306307|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
139306308|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306309|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306310|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
139306311|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306312|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139306313|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
139306314|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139306315|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306316|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306317|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139306318|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
139306319|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139306320|NCT04627753|Rituximab|rituximab|mesh-list
139306321|NCT04627753|Lenalidomide|lenalidomide|mesh-list
139306322|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306323|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306324|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
139306325|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306326|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139306327|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139306328|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139306329|NCT04627753|Growth Substances|growth substances|mesh-ancestor
139306330|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
139306331|NCT04564612|Itraconazole|itraconazole|mesh-list
139306332|NCT04564612|Rabeprazole|rabeprazole|mesh-list
139306333|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
139306334|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139306335|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139306336|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139306337|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306338|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306339|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139306340|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
139306341|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139306342|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306343|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139306344|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139306345|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139306346|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139306347|NCT04518319|Olanzapine|olanzapine|mesh-list
139306348|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
139306349|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
139306350|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306351|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306352|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139306353|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139306354|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139306355|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306356|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139306357|NCT04518319|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139306358|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139306359|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306360|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306361|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306362|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
139306363|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
139306364|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139306365|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139306366|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139306367|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
139306368|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
139306369|NCT04495868|Lidocaine|lidocaine|mesh-list
139306370|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
139306371|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
139306372|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306373|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306374|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
139306375|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306376|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139306377|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139306378|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139306379|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306380|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306381|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
139306382|NCT04483544|Olaparib|olaparib|mesh-list
139306383|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306384|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175795|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306385|NCT04483544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139306386|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306387|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139306388|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306389|NCT04475029|Morphine|morphine|mesh-list
139306390|NCT04475029|Methadone|methadone|mesh-list
139306391|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139306392|NCT04475029|Narcotics|narcotics|mesh-ancestor
139306393|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306394|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306395|NCT04475029|Analgesics|analgesics|mesh-ancestor
139306396|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
139306397|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306398|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
139306399|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
139306400|NCT04457089|Simvastatin|simvastatin|mesh-list
139306401|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139306402|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139306403|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
139306404|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306405|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139306406|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139306407|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306408|NCT04289467|Fenfluramine|fenfluramine|mesh-list
139306409|NCT04289467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139306410|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139306411|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306412|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306413|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306414|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
139306415|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306416|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
139306417|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
139306418|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139306419|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306420|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306421|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
139306422|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139306423|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306424|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306425|NCT04253561|Trastuzumab|trastuzumab|mesh-list
139306426|NCT04253561|Pertuzumab|pertuzumab|mesh-list
139306427|NCT04253561|Ipatasertib|ipatasertib|mesh-list
139306428|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306429|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306430|NCT04253561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139306431|NCT04253561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306432|NCT04253561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306433|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
139306434|NCT04240171|Glimepiride|glimepiride|mesh-list
139306435|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139306436|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306437|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139306438|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306439|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139306440|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139306441|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
139306443|NCT04170738|Adderall|adderall|mesh-list
139306444|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
139306445|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139306446|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306447|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
139306448|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
139306449|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306450|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
139306451|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306452|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306453|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
139306454|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139306455|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139306456|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306457|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139306458|NCT04094142|Lenalidomide|lenalidomide|mesh-list
139306459|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
139306460|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306461|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
139306462|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306463|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139306464|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139306465|NCT04094142|Growth Substances|growth substances|mesh-ancestor
139306466|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
139306467|NCT04089514|Adalimumab|adalimumab|mesh-list
139306468|NCT04089514|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139306469|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139306470|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139306471|NCT04088409|Adalimumab|adalimumab|mesh-list
139306472|NCT04088409|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139306473|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139306474|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139306475|NCT04084314|Erenumab|erenumab|mesh-list
139306476|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139306477|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306478|NCT04084314|Analgesics|analgesics|mesh-ancestor
139306479|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
139306480|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306481|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306482|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
139306483|NCT04024761|Fludarabine|fludarabine|mesh-list
139306484|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139306485|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
139306486|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306487|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139306488|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139306489|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
139306490|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306491|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306492|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139306493|NCT04004988|Tirzepatide|tirzepatide|mesh-list
139306494|NCT04004988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139306495|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306496|NCT04004988|Incretins|incretins|mesh-ancestor
139306497|NCT04004988|Hormones|hormones|mesh-ancestor
139306498|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139306499|NCT03934840|Prednisone|prednisone|mesh-list
139306500|NCT03934840|Carboplatin|carboplatin|mesh-list
139306501|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306502|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139306503|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
139306504|NCT03934840|Hormones|hormones|mesh-ancestor
139306505|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139306506|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306507|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139306508|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
139306509|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139306510|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
139306511|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
139306512|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306513|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306514|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139306515|NCT03879538|Analgesics|analgesics|mesh-ancestor
139306516|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
139306517|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306518|NCT03781765|Methylphenidate|methylphenidate|mesh-list
139306519|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139306520|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139306521|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306522|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139306523|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139306524|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306525|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306526|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
139306527|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306528|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139306529|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
139306530|NCT03781752|Methylphenidate|methylphenidate|mesh-list
139306531|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139306532|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306533|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139306534|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139306535|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306536|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306537|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
139306538|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306539|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
139306540|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139306541|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
139074020|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
139306542|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139306543|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
139306544|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306545|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306546|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
139306547|NCT03714958|Trametinib|trametinib|mesh-list
139306548|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306549|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139306550|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306551|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306552|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
139306553|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139306554|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306555|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306556|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139306557|NCT03708315|Analgesics|analgesics|mesh-ancestor
139306558|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
139306559|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306560|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139306561|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139306562|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139306563|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
139306564|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306565|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306566|NCT03579966|Amifampridine|amifampridine|mesh-list
139306567|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139306568|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306569|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306570|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139306571|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306572|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306573|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139306574|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139306575|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139306576|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139306577|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139306578|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139306579|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139306580|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
139306581|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306582|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306583|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306584|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139306585|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306586|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
139306587|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139175811|NCT00075725|Antidotes|antidotes|mesh-ancestor
139306588|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306590|NCT03507699|Ipilimumab|ipilimumab|mesh-list
139306591|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306592|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306593|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139306594|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306595|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
139306596|NCT03497923|Analgesics|analgesics|mesh-ancestor
139306597|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
139306598|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306599|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306600|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
139306601|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306602|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139306603|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
139306604|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139306605|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306606|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306607|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139306608|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
139306609|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139306610|NCT03377387|Capecitabine|capecitabine|mesh-list
139306611|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139306612|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
139306613|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306614|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306615|NCT03372837|Rituximab|rituximab|mesh-list
139306616|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306617|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306618|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
139306619|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306620|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139306621|NCT03312699|Vaccines|vaccines|mesh-list
139306622|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
139306623|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306624|NCT03261284|Heparin|heparin|mesh-list
139306625|NCT03261284|Calcium heparin|calcium heparin|mesh-list
139306626|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
139306627|NCT03261284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139306628|NCT03261284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139306629|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306630|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
139306631|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
139306632|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
139306633|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306634|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139306635|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139306636|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139306637|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
139306638|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306639|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306640|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139306641|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306642|NCT03219450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139306643|NCT03127267|Riluzole|riluzole|mesh-list
139306644|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
139306645|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139306646|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139306647|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306648|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306649|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306650|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139306651|NCT03127267|Protective Agents|protective agents|mesh-ancestor
139306652|NCT03092466|Ropivacaine|ropivacaine|mesh-list
139091543|NCT04542733|Everolimus|everolimus|mesh-list
139306654|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
139306655|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306656|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306657|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
139306658|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306659|NCT03017872|Ritonavir|ritonavir|mesh-list
139306660|NCT03017872|Darunavir|darunavir|mesh-list
139306661|NCT03017872|Dolutegravir|dolutegravir|mesh-list
139306662|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139306663|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139306664|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
139306665|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306666|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306667|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139306668|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139306669|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
139306670|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139306671|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139306672|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139306673|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139306674|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139306675|NCT03000205|Lidocaine|lidocaine|mesh-list
139306676|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
139306677|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
139306678|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306679|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306680|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
139306681|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306682|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139306683|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139306684|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139306685|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306686|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306687|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139306688|NCT02942095|Ixazomib|ixazomib|mesh-list
139306689|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306690|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139306691|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306692|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306693|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
139306694|NCT02872467|Oxytocin|oxytocin|mesh-list
139306695|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
139306696|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139306697|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306698|NCT02781519|Dronabinol|dronabinol|mesh-list
139306699|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
139306700|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306701|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139306702|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139306703|NCT02781519|Analgesics|analgesics|mesh-ancestor
139306704|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
139306705|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306706|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139306707|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139306708|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306709|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306710|NCT02781519|Hormones|hormones|mesh-ancestor
139306711|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139306712|NCT02536664|Rituximab|rituximab|mesh-list
139306713|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306714|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306715|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
139306716|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306717|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139306718|NCT02426892|Nivolumab|nivolumab|mesh-list
139306719|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306720|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306721|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139306722|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306723|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
139306724|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139306725|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
138963599|NCT02889523|Hormones|hormones|mesh-ancestor
139306726|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139306727|NCT02094625|Expectorants|expectorants|mesh-ancestor
139306728|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
139306729|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139306730|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
139306731|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306732|NCT02094625|Protective Agents|protective agents|mesh-ancestor
139306733|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306734|NCT02094625|Antidotes|antidotes|mesh-ancestor
139306735|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
139306736|NCT02054520|Nivolumab|nivolumab|mesh-list
139306737|NCT02054520|Ipilimumab|ipilimumab|mesh-list
139306738|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139306739|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306740|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139306741|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306742|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
139306743|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139306744|NCT01922921|Trastuzumab|trastuzumab|mesh-list
139306745|NCT01922921|Pertuzumab|pertuzumab|mesh-list
139306746|NCT01922921|Antibodies|antibodies|mesh-list
139306747|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
139306748|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139306749|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
139306750|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306751|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306752|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139306753|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139306754|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
139306755|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139306756|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
139306757|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139306758|NCT01922921|Protective Agents|protective agents|mesh-ancestor
139306759|NCT01546987|Leuprolide|leuprolide|mesh-list
139306760|NCT01546987|Goserelin|goserelin|mesh-list
139306761|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139306762|NCT01546987|Flutamide|flutamide|mesh-list
139306763|NCT01546987|Bicalutamide|bicalutamide|mesh-list
139306764|NCT01546987|Buserelin|buserelin|mesh-list
139306765|NCT01546987|Androgens|androgens|mesh-list
139306766|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-list
139306767|NCT01546987|Hormones|hormones|mesh-ancestor
139306768|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139306769|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306770|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139306771|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
139306772|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139306773|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139306774|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306775|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
139306776|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
139306777|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139306778|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
139306779|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139306780|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
139306781|NCT00588185|Testosterone|testosterone|mesh-list
139306782|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
139306783|NCT00588185|Androgens|androgens|mesh-ancestor
139306784|NCT00588185|Hormones|hormones|mesh-ancestor
139306785|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139306786|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306787|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
139306788|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306789|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
139306790|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139306791|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
139306792|NCT00268476|Metformin|metformin|mesh-list
139306793|NCT00268476|Prednisone|prednisone|mesh-list
139306794|NCT00268476|Prednisolone|prednisolone|mesh-list
139306795|NCT00268476|Celecoxib|celecoxib|mesh-list
139306796|NCT00268476|Docetaxel|docetaxel|mesh-list
139306797|NCT00268476|Estradiol|estradiol|mesh-list
139306798|NCT00268476|Androgens|androgens|mesh-list
139306799|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139306800|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306801|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306802|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
139306803|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
139306804|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
139306805|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306806|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139306807|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
139306808|NCT00268476|Hormones|hormones|mesh-ancestor
139306809|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139306810|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139306811|NCT00268476|Estrogens|estrogens|mesh-ancestor
139306812|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306813|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139306814|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139306815|NCT00268476|Analgesics|analgesics|mesh-ancestor
139306816|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
139306817|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139306818|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139306819|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139306820|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306821|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139306822|NCT00261443|Valproic Acid|valproic acid|mesh-list
139306823|NCT00261443|Aripiprazole|aripiprazole|mesh-list
139306824|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
139306825|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
139306826|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139306827|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139306828|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139306829|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306830|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306831|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
139306832|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
139306833|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306834|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306835|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139306836|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139306837|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
139306838|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139306839|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139306840|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139306841|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139306842|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306843|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
139306844|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
139306845|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
139306846|NCT00093379|Capecitabine|capecitabine|mesh-list
139306847|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
139306848|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139306849|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
139306850|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306851|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306852|NCT00000524|Cyclosporine|cyclosporine|mesh-list
139306853|NCT00000524|Prednisone|prednisone|mesh-list
139306854|NCT00000524|Cyclosporins|cyclosporins|mesh-list
139306855|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139306856|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
139306857|NCT00000524|Hormones|hormones|mesh-ancestor
139306858|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139306859|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306860|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139306861|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306862|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306863|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306864|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139306865|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
139306866|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
139306867|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139306868|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
139306869|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139306870|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139306871|NCT02099331|Melatonin|melatonin|mesh-list
139306872|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
139306873|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306874|NCT02099331|Protective Agents|protective agents|mesh-ancestor
139306875|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306876|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306877|NCT05328388|Lycopene|lycopene|mesh-list
139306878|NCT05328388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139306879|NCT05328388|Antioxidants|antioxidants|mesh-ancestor
139306880|NCT05328388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306881|NCT05328388|Protective Agents|protective agents|mesh-ancestor
139306882|NCT05328388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306883|NCT05328388|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139306884|NCT05328388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139306885|NCT05328388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306886|NCT02097069|Folic Acid|folic acid|mesh-list
139306887|NCT02097069|Inositol|inositol|mesh-list
139306888|NCT02097069|Hematinics|hematinics|mesh-ancestor
139306889|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
139306890|NCT02097069|Vitamins|vitamins|mesh-ancestor
139306891|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
139306892|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306893|NCT03424226|Acetazolamide|acetazolamide|mesh-list
139306894|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
139306895|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139306896|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306897|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306898|NCT03424226|Diuretics|diuretics|mesh-ancestor
139306899|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
139306900|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306901|NCT02250729|Pholcodine|pholcodine|mesh-list
139306902|NCT02250729|Analgesics|analgesics|mesh-ancestor
139306903|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
139306904|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306905|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306906|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
139306907|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
139306908|NCT02097147|Paroxetine|paroxetine|mesh-list
139306909|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
139306910|NCT02097147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139306911|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139306912|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139306913|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306914|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139306915|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
139306916|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306917|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139306918|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
139306919|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139306920|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139306921|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139306922|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074157|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
139306923|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139306924|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139306925|NCT03415802|Paclitaxel|paclitaxel|mesh-list
139306926|NCT03415802|Tegafur|tegafur|mesh-list
139306927|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139306928|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306929|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
139306930|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
139306931|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
139306932|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306933|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139306934|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
139306935|NCT02099877|Fentanyl|fentanyl|mesh-list
139306936|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139306937|NCT02099877|Narcotics|narcotics|mesh-ancestor
139306938|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139306939|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306940|NCT02099877|Analgesics|analgesics|mesh-ancestor
139306941|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
139306942|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139306943|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139306944|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139306945|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
139306946|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
139306947|NCT02097381|Ritonavir|ritonavir|mesh-list
139306948|NCT02097381|Lopinavir|lopinavir|mesh-list
139306949|NCT02097381|Darunavir|darunavir|mesh-list
139306950|NCT02097381|Tenofovir|tenofovir|mesh-list
139306951|NCT02097381|Emtricitabine|emtricitabine|mesh-list
139306952|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139306953|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139306954|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
139306955|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306956|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306957|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139306958|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139306959|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
139306960|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139306961|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139306962|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139306963|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139306964|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139306965|NCT02099955|Vitamin D|vitamin d|mesh-list
139306966|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
139306967|NCT02099955|Vitamins|vitamins|mesh-ancestor
139306968|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
139306969|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306970|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139306971|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139306972|NCT02097459|Tamoxifen|tamoxifen|mesh-list
139306973|NCT02097459|Toremifene|toremifene|mesh-list
139306974|NCT02097459|Anastrozole|anastrozole|mesh-list
139306975|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139306976|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
139306977|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139306978|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139306979|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139306980|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139306981|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139074181|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139306982|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139306983|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139306984|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139306985|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139306986|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139306987|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306988|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
139306989|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139306990|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139306991|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139306992|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
139306993|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
139306994|NCT02590432|Linaclotide|linaclotide|mesh-list
139306995|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139306996|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
139306997|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139306998|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139306999|NCT02094339|Analgesics|analgesics|mesh-list
139307000|NCT02094339|Ropivacaine|ropivacaine|mesh-list
139307001|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
139307002|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
139307003|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307004|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307005|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
139307006|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307007|NCT03415646|Morphine|morphine|mesh-list
139307008|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139307009|NCT03415646|Narcotics|narcotics|mesh-ancestor
139307010|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307011|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307012|NCT03415646|Analgesics|analgesics|mesh-ancestor
139307013|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
139307014|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307015|NCT03417518|Propofol|propofol|mesh-list
139307016|NCT03417518|Desflurane|desflurane|mesh-list
139307017|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139307018|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307019|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307020|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139307021|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
139307022|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
139307023|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139307024|NCT02094651|Valproic Acid|valproic acid|mesh-list
139307025|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
139307026|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307027|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307028|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
139307029|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307030|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307031|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
138963890|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
139307032|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139307033|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307034|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139307035|NCT02094807|Acetaminophen|acetaminophen|mesh-list
139307036|NCT02094807|Diclofenac|diclofenac|mesh-list
139307037|NCT02094807|Oxycodone|oxycodone|mesh-list
139307038|NCT02094807|Tramadol|tramadol|mesh-list
139307039|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307040|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307041|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139307042|NCT02094807|Analgesics|analgesics|mesh-ancestor
139307043|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
139307044|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307045|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
138946515|NCT02546349|Hormones|hormones|mesh-ancestor
139307046|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139307047|NCT02094807|Narcotics|narcotics|mesh-ancestor
139307048|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139307049|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139307050|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139307051|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139307052|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307053|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307054|NCT05139472|Empagliflozin|empagliflozin|mesh-list
139307055|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139307056|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307057|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139307058|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307059|NCT04757090|Trastuzumab|trastuzumab|mesh-list
139307060|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139307061|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307062|NCT03397862|Donepezil|donepezil|mesh-list
139307063|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139307065|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307066|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
139307067|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307068|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307069|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
139307070|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
139307071|NCT02100267|Miotics|miotics|mesh-ancestor
139307072|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
139307073|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307074|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307075|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139307076|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139307077|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
139307078|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139307079|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139307080|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
139307081|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307082|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307083|NCT02094963|Clopidogrel|clopidogrel|mesh-list
139307084|NCT02094963|Ticagrelor|ticagrelor|mesh-list
139307085|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139307086|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139307087|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139307088|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139307089|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
139307090|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307091|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307092|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307093|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139307094|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139307095|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139307096|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
139307097|NCT02098317|Vitamin D|vitamin d|mesh-list
139307098|NCT02098317|Vitamins|vitamins|mesh-ancestor
139307099|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
139307100|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307101|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139307102|NCT02100423|Vitamin D|vitamin d|mesh-list
139307103|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
139307104|NCT02100423|Curcumin|curcumin|mesh-list
139307105|NCT02100423|Vitamins|vitamins|mesh-ancestor
139307106|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
139307107|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091544|NCT04542733|Tacrolimus|tacrolimus|mesh-list
139307108|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139074208|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307109|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139307110|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139307112|NCT02100423|Analgesics|analgesics|mesh-ancestor
139307113|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
139307114|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307115|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139307116|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139307117|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307118|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307119|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307120|NCT02520752|Midazolam|midazolam|mesh-list
139307121|NCT02520752|Caffeine|caffeine|mesh-list
139307122|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139307123|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139307124|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307125|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307126|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139307127|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139307128|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139307129|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139307130|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
139307131|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
139307132|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
139307133|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
139307134|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307135|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307136|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139307137|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139307138|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307139|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139307140|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139307141|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
139307142|NCT02095119|Gemcitabine|gemcitabine|mesh-list
139307143|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
139307144|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307145|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139307146|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
139307147|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307148|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139307149|NCT02098629|Milrinone|milrinone|mesh-list
139307150|NCT02098629|Esmolol|esmolol|mesh-list
139307151|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139307152|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139307153|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139307154|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
139307155|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307156|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307157|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307158|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139307159|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139307160|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
139307161|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139307162|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139307163|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307164|NCT02098629|Protective Agents|protective agents|mesh-ancestor
139307165|NCT02095509|Enoxaparin|enoxaparin|mesh-list
139307166|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
139307167|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139307168|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139307169|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307170|NCT03397082|Lidocaine|lidocaine|mesh-list
139307171|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
139307172|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
139307173|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307174|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307175|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
139307176|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307177|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139307178|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139307179|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139307180|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139307181|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307183|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
139307184|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139307185|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
139307186|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
139307187|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307188|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307189|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
139307190|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139307191|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
139307192|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
139307193|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139307194|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139307195|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139307196|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
139175887|NCT00074711|Antacids|antacids|mesh-ancestor
139307197|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307198|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307199|NCT02101047|Protective Agents|protective agents|mesh-ancestor
139307201|NCT02095665|Tamsulosin|tamsulosin|mesh-list
139307202|NCT02095665|Mirabegron|mirabegron|mesh-list
139307203|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139307204|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139307205|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139307206|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
139307207|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307208|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307209|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307210|NCT02095665|Urological Agents|urological agents|mesh-ancestor
139307211|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139307212|NCT02095665|Analgesics|analgesics|mesh-ancestor
139307213|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
139307214|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307215|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
139307216|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139307217|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139307218|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139307219|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139307220|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139307221|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139307222|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
139307223|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307224|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139307225|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139307226|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307227|NCT02101203|Buspirone|buspirone|mesh-list
139307228|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139307229|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139307230|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307231|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307232|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139307233|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139307234|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
139307235|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307236|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307237|NCT04523246|Vaccines|vaccines|mesh-list
139307238|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
139307239|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307240|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
139307241|NCT03396380|Vitamin D|vitamin d|mesh-list
139307242|NCT03396380|Citric Acid|citric acid|mesh-list
139307243|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
139307244|NCT03396380|Clomiphene|clomiphene|mesh-list
139307245|NCT03396380|Enclomiphene|enclomiphene|mesh-list
139307246|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
139307247|NCT03396380|Calcium|calcium|mesh-list
139307248|NCT03396380|Vitamins|vitamins|mesh-ancestor
139307249|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
139307250|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307251|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139307252|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139307253|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
139307254|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139307255|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
139307256|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
139307257|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307258|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139307259|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
139307260|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139307261|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139307263|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139307264|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139307265|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139307266|NCT03414164|Procyanidin|procyanidin|mesh-list
139307267|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
139175889|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139307268|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307269|NCT03414164|Protective Agents|protective agents|mesh-ancestor
139307270|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307271|NCT05613478|Apatinib|apatinib|mesh-list
139307272|NCT05613478|Chlorotrianisene|chlorotrianisene|mesh-list
139307273|NCT05613478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307274|NCT05613478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139307275|NCT05613478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307276|NCT05613478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307277|NCT05613478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139307278|NCT05613478|Estrogens|estrogens|mesh-ancestor
139307279|NCT05613478|Hormones|hormones|mesh-ancestor
139307280|NCT05613478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139307281|NCT05613478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307282|NCT05613478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139307283|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139307284|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139307285|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139307286|NCT03406988|Nifedipine|nifedipine|mesh-list
139307287|NCT03406988|Iloprost|iloprost|mesh-list
139307288|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139307289|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139307290|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307291|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139307292|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307293|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
139307294|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
139307295|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139307296|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139307297|NCT03406832|Nitroprusside|nitroprusside|mesh-list
139307298|NCT03406832|Tirofiban|tirofiban|mesh-list
139307299|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139307300|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
139307301|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139307302|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307303|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139307304|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139307305|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139307306|NCT03405974|Aspirin|aspirin|mesh-list
139307307|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139307308|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139307309|NCT03405974|Analgesics|analgesics|mesh-ancestor
139307310|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
139307311|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307312|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307313|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139307314|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139307315|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139307316|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139307317|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307318|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139307319|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139307320|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307321|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
139307322|NCT04337060|Lidocaine|lidocaine|mesh-list
139307323|NCT04337060|Morphine|morphine|mesh-list
139307324|NCT04337060|Bupivacaine|bupivacaine|mesh-list
139307325|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
139307326|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
139307327|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307328|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307329|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
139307330|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307331|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139307332|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139307333|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139307334|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139307335|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307336|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139307339|NCT04447274|Apatinib|apatinib|mesh-list
139307340|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307341|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139307342|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307343|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307344|NCT02977156|Ipilimumab|ipilimumab|mesh-list
139307345|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139307346|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307347|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139307348|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307349|NCT02413138|Hormones|hormones|mesh-list
139307350|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139307351|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307352|NCT01014598|Cisplatin|cisplatin|mesh-list
139307353|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307354|NCT03404804|Amoxicillin|amoxicillin|mesh-list
139307355|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139307356|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139307357|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
139307358|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
139307359|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
139307360|NCT05611372|Rasagiline|rasagiline|mesh-list
139307361|NCT05611372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139307362|NCT05611372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307363|NCT05611372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307364|NCT05611372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139307365|NCT05611372|Protective Agents|protective agents|mesh-ancestor
139307366|NCT05611372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307367|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139307368|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
139307369|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139307370|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139307371|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139307372|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
139307373|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139307374|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307375|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139307376|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139307377|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139307378|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139307379|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307380|NCT05613166|Everolimus|everolimus|mesh-list
139307381|NCT05613166|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139307382|NCT05613166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139307383|NCT05613166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307384|NCT05613166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307385|NCT05613166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139307386|NCT05613166|Immunologic Factors|immunologic factors|mesh-ancestor
139307387|NCT05613166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307388|NCT05613166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307389|NCT05166668|Letrozole|letrozole|mesh-list
139307390|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307391|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139307392|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139307393|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307394|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307395|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139307396|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
139307397|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139307398|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307399|NCT05558176|Sildenafil Citrate|sildenafil citrate|mesh-list
139307400|NCT05558176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307401|NCT05558176|Vasodilator Agents|vasodilator agents|mesh-ancestor
139307402|NCT05558176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139307403|NCT05558176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139307404|NCT05558176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307405|NCT05558176|Urological Agents|urological agents|mesh-ancestor
139307406|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
139307407|NCT04748224|Bupivacaine|bupivacaine|mesh-list
139307408|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
139307409|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
139307410|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307411|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307412|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
139307413|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307414|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139307415|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139307416|NCT04748224|Analgesics|analgesics|mesh-ancestor
139307417|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139307418|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139307419|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139307420|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
139307421|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307422|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307423|NCT03413150|Amiodarone|amiodarone|mesh-list
139307424|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139307425|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
139307426|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139307427|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139307428|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307429|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139307430|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139307431|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139307432|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307433|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139307434|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139307435|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139307436|NCT05474716|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139307437|NCT05474716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139307438|NCT05474716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139307439|NCT05474716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139307440|NCT05474716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139307441|NCT05474716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139307442|NCT05474716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139307443|NCT05474716|Adrenergic Agents|adrenergic agents|mesh-ancestor
139307444|NCT05474716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307445|NCT05474716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307446|NCT05474716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307447|NCT03126578|Midazolam|midazolam|mesh-list
139307448|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139307449|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139307450|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307451|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307452|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139307453|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139307454|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139307455|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139307456|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
139307457|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
139307458|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
139307459|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
139307460|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307461|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307462|NCT03412994|Apatinib|apatinib|mesh-list
139307463|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307464|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139307465|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307466|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307467|NCT02588248|Peppermint oil|peppermint oil|mesh-list
139307468|NCT02588248|Menthol|menthol|mesh-list
139307469|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
139307470|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
139307471|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
139307472|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
139307473|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307474|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307475|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139307476|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
139307477|NCT03412682|Budesonide|budesonide|mesh-list
139307478|NCT03412682|Mesalamine|mesalamine|mesh-list
139307479|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139307480|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139307481|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
139307482|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307483|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307484|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139307485|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
139307486|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
139307487|NCT03412682|Hormones|hormones|mesh-ancestor
139307488|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139307489|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139307490|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139307491|NCT03412682|Analgesics|analgesics|mesh-ancestor
139307492|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
139307493|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139307494|NCT03412526|Fludarabine|fludarabine|mesh-list
139307495|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307496|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
139307497|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139307498|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307499|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307500|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139307501|NCT03126422|Analgesics|analgesics|mesh-ancestor
139307502|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
139307503|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307504|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139307505|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139307506|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139307507|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
139307508|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307509|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307510|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
139307511|NCT03395132|Betamethasone|betamethasone|mesh-list
139307512|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139307513|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
139307514|NCT03395132|Hormones|hormones|mesh-ancestor
139307515|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139307516|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307517|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139307518|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
139307519|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139307520|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139307521|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139307522|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307523|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307524|NCT03127124|Leucovorin|leucovorin|mesh-list
139307525|NCT03127124|Fluorouracil|fluorouracil|mesh-list
139307526|NCT03127124|Bevacizumab|bevacizumab|mesh-list
139307527|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
139307528|NCT03127124|Calcium|calcium|mesh-list
139307529|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
139307530|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139307531|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307532|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
139307533|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307534|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139307535|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307536|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139307537|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
139307538|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139307539|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139307540|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139307541|NCT03127124|Growth Substances|growth substances|mesh-ancestor
139307542|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
139307543|NCT03127124|Antidotes|antidotes|mesh-ancestor
139307544|NCT03127124|Protective Agents|protective agents|mesh-ancestor
139307545|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
139307546|NCT03127124|Vitamins|vitamins|mesh-ancestor
139307547|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
139307548|NCT03399110|Capecitabine|capecitabine|mesh-list
139091545|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139307549|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
139307550|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139307552|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307553|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307554|NCT03127046|Aceclofenac|aceclofenac|mesh-list
139307555|NCT03127046|Diclofenac|diclofenac|mesh-list
139307556|NCT03127046|Esomeprazole|esomeprazole|mesh-list
139307557|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139307558|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139307559|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139307560|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307561|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307562|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139307563|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139307564|NCT03127046|Analgesics|analgesics|mesh-ancestor
139307565|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
139307566|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307567|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307568|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139307569|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139307570|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139307571|NCT05105672|Cisplatin|cisplatin|mesh-list
139307572|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307573|NCT03394820|Dexamethasone|dexamethasone|mesh-list
139307574|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139307575|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
139307576|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
139307577|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307578|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307579|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139307580|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
139307581|NCT03394820|Hormones|hormones|mesh-ancestor
139307582|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139307583|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139307584|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307585|NCT01328054|Lapatinib|lapatinib|mesh-list
139307586|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307587|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139307588|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307589|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307590|NCT05067920|Antibodies|antibodies|mesh-list
139307591|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
139175936|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
139307592|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307594|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139307595|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139307596|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139307597|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
139307598|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307599|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139307600|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139307601|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307602|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139307603|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139307604|NCT03398876|Nicotine|nicotine|mesh-list
139307605|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139307606|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
139307607|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307608|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307609|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139307610|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139307611|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
139307612|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307613|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307614|NCT03394586|Golimumab|golimumab|mesh-list
139307615|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139307616|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139307617|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139307618|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
139307619|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307620|NCT03394430|Midazolam|midazolam|mesh-list
139307621|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
139307622|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139307623|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307624|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307625|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139307626|NCT03394430|Analgesics|analgesics|mesh-ancestor
139307627|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
139307628|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307629|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139307630|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139307631|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139307632|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
139307633|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307634|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307635|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139307636|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139307637|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139307638|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139307639|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139307640|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
139307641|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
139307642|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
139307643|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
139307644|NCT03394196|Ritonavir|ritonavir|mesh-list
139307645|NCT03394196|Lopinavir|lopinavir|mesh-list
139307646|NCT03394196|Darunavir|darunavir|mesh-list
139307647|NCT03394196|Tenofovir|tenofovir|mesh-list
139307648|NCT03394196|Lamivudine|lamivudine|mesh-list
139307649|NCT03394196|Emtricitabine|emtricitabine|mesh-list
139307650|NCT03394196|Zidovudine|zidovudine|mesh-list
139307651|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
139307652|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139307653|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139307654|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
139307655|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307656|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307657|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139307658|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139307659|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
139307660|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139307661|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139307662|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139307663|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139307664|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139307665|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
139307666|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139307667|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139307668|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139307669|NCT03398018|Hormones|hormones|mesh-ancestor
139307670|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139307671|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307672|NCT03411434|Methylphenidate|methylphenidate|mesh-list
139307673|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139307674|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307675|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139307676|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139307677|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139307678|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307679|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
139307680|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307681|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
139307682|NCT03126656|Testosterone|testosterone|mesh-list
139307683|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
139307684|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
139307685|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139307686|NCT03126656|Androgens|androgens|mesh-ancestor
139307687|NCT03126656|Hormones|hormones|mesh-ancestor
139307688|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139307689|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307690|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139307691|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307692|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
139307693|NCT03385382|Dexamethasone|dexamethasone|mesh-list
139307694|NCT03385382|Ranibizumab|ranibizumab|mesh-list
139307695|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139307696|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
139307697|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
139307698|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307699|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307700|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139307701|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
139307702|NCT03385382|Hormones|hormones|mesh-ancestor
139307703|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139307704|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139307705|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307706|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139307707|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139307708|NCT03385382|Growth Substances|growth substances|mesh-ancestor
139307709|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
139307710|NCT03394118|Osimertinib|osimertinib|mesh-list
139307711|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307712|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139307713|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307714|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307715|NCT03389672|Anesthetics|anesthetics|mesh-list
139307716|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307717|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307718|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
139307719|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139307720|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139307721|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139307722|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139307723|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307724|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307725|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307726|NCT01907360|Methylphenidate|methylphenidate|mesh-list
139307727|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139307728|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307729|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139307730|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139307731|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139307732|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307733|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
139307734|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307735|NCT03126188|Sertraline|sertraline|mesh-list
139307736|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139307737|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
139307738|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139307739|NCT03126188|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139307740|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139307741|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139307742|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307743|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307744|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
139307745|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307746|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139307747|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139307748|NCT04446338|Antibodies|antibodies|mesh-list
139307749|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
139307750|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307751|NCT03393728|Propranolol|propranolol|mesh-list
139307752|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139307753|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139307754|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
139307755|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307756|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307757|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307758|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139307759|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139307760|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
139307761|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
139307762|NCT03393572|Nalbuphine|nalbuphine|mesh-list
139307763|NCT03393572|Bupivacaine|bupivacaine|mesh-list
139307764|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
139307765|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
139307766|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307767|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307768|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
139307769|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307770|NCT03393572|Analgesics|analgesics|mesh-ancestor
139307771|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139307772|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
139091546|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
139307773|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139307774|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139307775|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307776|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139307778|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139307779|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139307780|NCT03393572|Narcotics|narcotics|mesh-ancestor
139307781|NCT03393416|Antibodies|antibodies|mesh-list
139307782|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
139307783|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307784|NCT04445948|Amoxicillin|amoxicillin|mesh-list
139307785|NCT04445948|Metronidazole|metronidazole|mesh-list
139307786|NCT04445948|Clarithromycin|clarithromycin|mesh-list
139307787|NCT04445948|Lactoferrin|lactoferrin|mesh-list
139307788|NCT04445948|Esomeprazole|esomeprazole|mesh-list
139307789|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139307790|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139307791|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139307792|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139307793|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139307794|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139307795|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139307796|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307797|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307798|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139307799|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139307800|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139307801|NCT02479646|Lenograstim|lenograstim|mesh-list
139307802|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139307803|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
139307804|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307805|NCT02467868|Lenograstim|lenograstim|mesh-list
139307806|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139307807|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
139307808|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307809|NCT02103465|Rotigotine|rotigotine|mesh-list
139307810|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
139307811|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
139307812|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307813|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307814|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307815|NCT02102139|Propofol|propofol|mesh-list
139307816|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139307817|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307818|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307819|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139307820|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
139307821|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
139307822|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
139307823|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
139307824|NCT02102295|Fluorides|fluorides|mesh-list
139307825|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
139307826|NCT02102295|Protective Agents|protective agents|mesh-ancestor
139307827|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307828|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
139307829|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307830|NCT02102295|Vitamins|vitamins|mesh-ancestor
139307831|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
139307832|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307833|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139307834|NCT02102373|Laxatives|laxatives|mesh-ancestor
139307835|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139307836|NCT02103777|Caffeine|caffeine|mesh-list
139307837|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
139307838|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307839|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139307840|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307841|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139307842|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307843|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139307844|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139307845|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
139307846|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307847|NCT02104011|Propranolol|propranolol|mesh-list
139307849|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139307850|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
139307851|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307852|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307853|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307854|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139307855|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139307856|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
139307857|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
139307858|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139307859|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307860|NCT02251041|Tocopherols|tocopherols|mesh-list
139307861|NCT02251041|Vitamin E|vitamin e|mesh-list
139307862|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
139307863|NCT02251041|Infliximab|infliximab|mesh-list
139307864|NCT02251041|Epoprostenol|epoprostenol|mesh-list
139307865|NCT02251041|Tezosentan|tezosentan|mesh-list
139307866|NCT02251041|Melatonin|melatonin|mesh-list
139307867|NCT02251041|Antithrombins|antithrombins|mesh-list
139307868|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
139307869|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
139307870|NCT02251041|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139307871|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
139307872|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307873|NCT02251041|Protective Agents|protective agents|mesh-ancestor
139307874|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307875|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307876|NCT02251041|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139307877|NCT02251041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139307878|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
139307879|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139307880|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139307881|NCT02251041|Hematinics|hematinics|mesh-ancestor
139307882|NCT02251041|Vitamins|vitamins|mesh-ancestor
139307883|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
139307884|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139307885|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
139307886|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307887|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
139307888|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139307889|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139307890|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
139307891|NCT02251041|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139307892|NCT02251041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139307893|NCT02251041|Immunologic Factors|immunologic factors|mesh-ancestor
139307894|NCT02104323|Endostatins|endostatins|mesh-list
139307895|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307896|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139307897|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139307898|NCT02104323|Growth Substances|growth substances|mesh-ancestor
139307899|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307900|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
139307901|NCT02107365|Interferons|interferons|mesh-list
139307902|NCT02107365|Ribavirin|ribavirin|mesh-list
139307903|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
139307904|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
139307905|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139307906|NCT02107365|Asunaprevir|asunaprevir|mesh-list
139307907|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307908|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
139307909|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139307910|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
139307911|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307912|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
139307913|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307914|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
139307915|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307916|NCT02110719|Acetaminophen|acetaminophen|mesh-list
139307917|NCT02110719|Dexamethasone|dexamethasone|mesh-list
139307918|NCT02110719|Ibuprofen|ibuprofen|mesh-list
139307919|NCT02110719|Celecoxib|celecoxib|mesh-list
139307920|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139307921|NCT02110719|Oxycodone|oxycodone|mesh-list
139307922|NCT02110719|Gabapentin|gabapentin|mesh-list
139307923|NCT02110719|Hydromorphone|hydromorphone|mesh-list
139307924|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139307925|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
139307926|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
139307927|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139307928|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307929|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139307930|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
139307931|NCT02110719|Hormones|hormones|mesh-ancestor
139307932|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139307933|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139307934|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307935|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139307936|NCT02110719|Analgesics|analgesics|mesh-ancestor
139307937|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
139307938|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
139307939|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139307940|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139307941|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139307942|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307943|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307944|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139307945|NCT02110719|Narcotics|narcotics|mesh-ancestor
139307946|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139307947|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
139307948|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139307949|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139307950|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139307951|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139307952|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139307953|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139307954|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
139307955|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139307956|NCT02105103|Insulin|insulin|mesh-list
139307957|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139307958|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307959|NCT03012165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139307960|NCT03012165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139307961|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139307962|NCT02107755|Ipilimumab|ipilimumab|mesh-list
139307963|NCT02107755|Antibodies|antibodies|mesh-list
139307964|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
139307965|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139307966|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
139307967|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307968|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307969|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139307970|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307971|NCT02110953|Irinotecan|irinotecan|mesh-list
139307972|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139307973|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139307974|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139307975|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307976|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307977|NCT03554109|Leucovorin|leucovorin|mesh-list
139307978|NCT03554109|Paclitaxel|paclitaxel|mesh-list
139307979|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139307980|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
139307981|NCT03554109|Doxorubicin|doxorubicin|mesh-list
139307982|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139307983|NCT03554109|Fluorouracil|fluorouracil|mesh-list
139307984|NCT03554109|Avelumab|avelumab|mesh-list
139307985|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139074390|NCT03642262|Guaifenesin|guaifenesin|mesh-list
139307986|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139307987|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
139307988|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
139307989|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
139307990|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139307991|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139307992|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
139307993|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139307994|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139307995|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139307996|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
139307997|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139307998|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139307999|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139308000|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139308001|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308002|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
139308003|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139308004|NCT03554109|Antidotes|antidotes|mesh-ancestor
139308006|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
139308007|NCT03554109|Vitamins|vitamins|mesh-ancestor
139308008|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
139308009|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139308010|NCT03554031|Hormones|hormones|mesh-list
139308011|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139308012|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308013|NCT02111265|Sufentanil|sufentanil|mesh-list
139308014|NCT02111265|Remifentanil|remifentanil|mesh-list
139308015|NCT02111265|Cisatracurium|cisatracurium|mesh-list
139308016|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139308017|NCT02111265|Narcotics|narcotics|mesh-ancestor
139308018|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308019|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308020|NCT02111265|Analgesics|analgesics|mesh-ancestor
139308021|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
139308022|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308023|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139308024|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139308025|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
139308026|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
139308027|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139308028|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139308029|NCT02251119|Ritonavir|ritonavir|mesh-list
139308030|NCT02251119|Tipranavir|tipranavir|mesh-list
139308031|NCT02251119|Loperamide|loperamide|mesh-list
139308032|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
139308033|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139308034|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139308035|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
139308036|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308037|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308038|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139308039|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139308040|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
139308041|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308042|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139308043|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139308044|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139308045|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
139308046|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
139308047|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
139308048|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139308049|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308050|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308051|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139308052|NCT02111421|Analgesics|analgesics|mesh-ancestor
139308053|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
139308054|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308055|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139308056|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139308057|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139308058|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
139308059|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308060|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308061|NCT02108301|Cyclosporine|cyclosporine|mesh-list
139308062|NCT02108301|Tacrolimus|tacrolimus|mesh-list
139308063|NCT02108301|Cyclosporins|cyclosporins|mesh-list
139308064|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139308065|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
139308066|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308067|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139308068|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308069|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308070|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
139308071|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308072|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
139308073|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139308074|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
139308075|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
139308076|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139308077|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308078|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138964945|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
139308079|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139308080|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
139308081|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139308083|NCT02114073|Betamethasone|betamethasone|mesh-list
139308084|NCT02114073|Cyclosporins|cyclosporins|mesh-list
139308085|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308086|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308087|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139308088|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
139308089|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308090|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
139308091|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308092|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
139308093|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139308094|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139308095|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139308096|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
139308097|NCT02114073|Hormones|hormones|mesh-ancestor
139308098|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139308099|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139308100|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
139308101|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
139308102|NCT02114463|Analgesics|analgesics|mesh-list
139308103|NCT02114463|Ropivacaine|ropivacaine|mesh-list
139308104|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
139308105|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
139308106|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308107|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308108|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
139308109|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308110|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139308111|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139308112|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139308113|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139074418|NCT01087593|Hormones|hormones|mesh-ancestor
139308114|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139308115|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308116|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308117|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139308118|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139308119|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139308120|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
139308121|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308122|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139308123|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139308124|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308125|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
139308126|NCT02114775|Hormones|hormones|mesh-list
139308127|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139308128|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308129|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
139308130|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139308131|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139308132|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308133|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308134|NCT02114775|Urological Agents|urological agents|mesh-ancestor
139308135|NCT02108847|Ropivacaine|ropivacaine|mesh-list
139308136|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
139308137|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
139308138|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308139|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308140|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
139308141|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308142|NCT03553329|Trametinib|trametinib|mesh-list
139308143|NCT03553329|Dabrafenib|dabrafenib|mesh-list
139308144|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308145|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139308146|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308147|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308148|NCT02115087|Morphine|morphine|mesh-list
139308149|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139308150|NCT02115087|Narcotics|narcotics|mesh-ancestor
139308151|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308152|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308153|NCT02115087|Analgesics|analgesics|mesh-ancestor
139308154|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
139308155|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308156|NCT02115243|Ipilimumab|ipilimumab|mesh-list
139308157|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139308158|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308159|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139308160|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308161|NCT02109315|Liraglutide|liraglutide|mesh-list
139308162|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308163|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139308164|NCT02109315|Incretins|incretins|mesh-ancestor
139308165|NCT02109315|Hormones|hormones|mesh-ancestor
139308166|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139308167|NCT02112903|Vortioxetine|vortioxetine|mesh-list
139308168|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
139308169|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139308170|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139308171|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139308172|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308173|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308174|NCT02112903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139308175|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139308176|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139308177|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308178|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308179|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
139308180|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139308181|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139308182|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139308183|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139308184|NCT02112981|Sirolimus|sirolimus|mesh-list
139308185|NCT02112981|Everolimus|everolimus|mesh-list
139308186|NCT02112981|MTOR Inhibitors|mtor inhibitors|mesh-list
139308187|NCT02112981|Temsirolimus|temsirolimus|mesh-list
139308188|NCT02112981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139308189|NCT02112981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308190|NCT02112981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308191|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139308192|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
139308193|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308194|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308195|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139308196|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308197|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139308198|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
139308199|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
139308200|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
139308201|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
139308202|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308203|NCT02116257|Propacetamol|propacetamol|mesh-list
139308204|NCT02116257|Analgesics|analgesics|mesh-ancestor
139308205|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
139308206|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308207|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308208|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139308209|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139308210|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139308211|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139308212|NCT02109627|Cytarabine|cytarabine|mesh-list
139308213|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139308214|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
139308215|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308216|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308217|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
139308218|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308219|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139308220|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
139308221|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308222|NCT02116569|Daratumumab|daratumumab|mesh-list
139308223|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308224|NCT02109783|Caffeine|caffeine|mesh-list
139308225|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139308226|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308227|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138965082|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
139308228|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308229|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308230|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139308231|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139308232|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
139308233|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308234|NCT02109861|Dexamethasone|dexamethasone|mesh-list
139308235|NCT02109861|Bortezomib|bortezomib|mesh-list
139308236|NCT02109861|Melphalan|melphalan|mesh-list
139308237|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139308238|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
139308239|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
139308240|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308241|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308242|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139308243|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
139308244|NCT02109861|Hormones|hormones|mesh-ancestor
139308245|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139308246|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139308247|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308248|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139308249|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
139308250|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308251|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139308252|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139308253|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
139308254|NCT02118753|Eplerenone|eplerenone|mesh-list
139308255|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139308256|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
139308257|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139308258|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308259|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139308260|NCT02118753|Diuretics|diuretics|mesh-ancestor
139308261|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
139308262|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139308263|NCT02118909|Itraconazole|itraconazole|mesh-list
139308264|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
139308265|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
139308266|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308267|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139308268|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139308269|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308270|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308271|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139308272|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
139308273|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139308274|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308275|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139308276|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139308277|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139308278|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139074451|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
139308279|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308280|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139308281|NCT02118987|Omalizumab|omalizumab|mesh-list
139308282|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139308283|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139308284|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
139308285|NCT02119143|Vitamins|vitamins|mesh-list
139308286|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
139308287|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308288|NCT02116959|Carboplatin|carboplatin|mesh-list
139308289|NCT02116959|Etoposide|etoposide|mesh-list
139308290|NCT02116959|Vincristine|vincristine|mesh-list
139308291|NCT02116959|Melphalan|melphalan|mesh-list
139308292|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308293|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139308294|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139308295|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139308296|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308297|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308298|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
139308299|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
139308300|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
138965159|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
139308301|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139308302|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
139308303|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139308304|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139308305|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
139308306|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308307|NCT03553173|Bupropion|bupropion|mesh-list
139308308|NCT03553173|Varenicline|varenicline|mesh-list
139308309|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139308310|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
139308311|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139308312|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139308313|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139308314|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139308315|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308316|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
139308317|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308318|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308319|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139308320|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139308321|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308322|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139308323|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139308324|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
139308325|NCT01330017|Loratadine|loratadine|mesh-list
139308326|NCT01330017|Phenylephrine|phenylephrine|mesh-list
139308327|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
139308328|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139308329|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
139308330|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
139308331|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308332|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308333|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
139308334|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139308335|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
139308336|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
139308337|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139308338|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139308339|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139308340|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
139308341|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308342|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308343|NCT01330017|Protective Agents|protective agents|mesh-ancestor
139308344|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
139308345|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
139308346|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139308347|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139308348|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139308349|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
139308350|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
139308351|NCT02117583|Oxycodone|oxycodone|mesh-list
139308352|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139308353|NCT02117583|Narcotics|narcotics|mesh-ancestor
139308354|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308355|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308356|NCT02117583|Analgesics|analgesics|mesh-ancestor
139308357|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
139308358|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308359|NCT02117739|Dapsone|dapsone|mesh-list
139308360|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308361|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
139308362|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139308363|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139308364|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139308365|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308366|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308367|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
139308368|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139308369|NCT02251509|Metoprolol|metoprolol|mesh-list
139308370|NCT02251509|Carvedilol|carvedilol|mesh-list
139308371|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139308372|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139308373|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
139308374|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
139308375|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308376|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308377|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139308378|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139308379|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139308380|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
139308381|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308382|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308383|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
139308384|NCT02251509|Protective Agents|protective agents|mesh-ancestor
139308385|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139308386|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139308387|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139308388|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
139308389|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139308390|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139308391|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139308392|NCT02118051|Progesterone|progesterone|mesh-list
139308394|NCT02118051|Progestins|progestins|mesh-ancestor
139308395|NCT02118051|Hormones|hormones|mesh-ancestor
139308396|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139308397|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308398|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
139308399|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139308400|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
139308401|NCT02123355|Remifentanil|remifentanil|mesh-list
139308402|NCT02123355|Sevoflurane|sevoflurane|mesh-list
139308403|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
139308404|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
139308405|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308406|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308407|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139308408|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139308409|NCT02123355|Analgesics|analgesics|mesh-ancestor
139308410|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
139308411|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308412|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139308413|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139308414|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139308415|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
139308416|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308417|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308418|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139308419|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139308420|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
139308421|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139308422|NCT02123355|Narcotics|narcotics|mesh-ancestor
139308423|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139308424|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139308425|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139308426|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139308427|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139308428|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
139308429|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139308430|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
139308431|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308432|NCT02123589|Midazolam|midazolam|mesh-list
139308433|NCT02123589|Fentanyl|fentanyl|mesh-list
139308434|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139308435|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139308436|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308437|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308438|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139308439|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139308440|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139308441|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139308442|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
139308443|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
139308444|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
139308445|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
139308446|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308447|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308448|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139308449|NCT02123589|Narcotics|narcotics|mesh-ancestor
139308450|NCT02123589|Analgesics|analgesics|mesh-ancestor
139308451|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
139308452|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308453|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
139308454|NCT02120547|Liver Extracts|liver extracts|mesh-list
139308455|NCT02120547|Hematinics|hematinics|mesh-ancestor
139308456|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139308457|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308458|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139308459|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139308460|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
139308461|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308462|NCT02120703|Pregabalin|pregabalin|mesh-list
139308463|NCT02120703|Gabapentin|gabapentin|mesh-list
139308464|NCT02120703|Analgesics|analgesics|mesh-ancestor
139308465|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
139308466|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308467|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308468|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
139308469|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139308470|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139308471|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308472|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139308473|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139074504|NCT00079040|Etoposide|etoposide|mesh-list
139308474|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139308475|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308476|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139308477|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139308478|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139308479|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308480|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
139308481|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
139308482|NCT02118285|Fludarabine|fludarabine|mesh-list
139308483|NCT02118285|Interleukin-2|interleukin-2|mesh-list
139308484|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139308485|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
139308486|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308487|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139308488|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139308489|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
139308490|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308491|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308492|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139308493|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139308494|NCT02118285|Analgesics|analgesics|mesh-ancestor
139308495|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
139308496|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308497|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
139308498|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308499|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139308500|NCT02118675|Protective Agents|protective agents|mesh-ancestor
139308501|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308502|NCT02123979|Rotigotine|rotigotine|mesh-list
139308503|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
139308504|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
139308505|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308506|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308507|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308508|NCT03552315|Chromium|chromium|mesh-list
139308509|NCT03552315|Trace Elements|trace elements|mesh-ancestor
139308510|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
139308511|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308512|NCT02120859|Paclitaxel|paclitaxel|mesh-list
139308513|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139308514|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308515|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
139308516|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
139308517|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
139308518|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308519|NCT02126943|Macitentan|macitentan|mesh-list
139308520|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139308521|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139308522|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308523|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139308524|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139308525|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139308526|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308527|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
139308528|NCT00150462|Dexamethasone|dexamethasone|mesh-list
139308529|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139308530|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
139308531|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
139308532|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308533|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308534|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139308535|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
139308536|NCT00150462|Hormones|hormones|mesh-ancestor
139308537|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139308538|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139308539|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308540|NCT00095550|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139308541|NCT00095550|Irbesartan|irbesartan|mesh-list
139308542|NCT00095550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139308543|NCT00095550|Diuretics|diuretics|mesh-ancestor
139308544|NCT00095550|Natriuretic Agents|natriuretic agents|mesh-ancestor
139308545|NCT00095550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308546|NCT00095550|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139308547|NCT00095550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139308548|NCT00095550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308549|NCT00095550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139308550|NCT00095550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139308551|NCT00095394|Irbesartan|irbesartan|mesh-list
139308552|NCT00095394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139308553|NCT00095394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139308554|NCT00095394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139176099|NCT01160419|Leucovorin|leucovorin|mesh-list
139308555|NCT00095394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308556|NCT00093132|Satraplatin|satraplatin|mesh-list
139308557|NCT00093132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308558|NCT00080106|Vaccines|vaccines|mesh-list
139308559|NCT00080106|Immunologic Factors|immunologic factors|mesh-ancestor
139308560|NCT00080106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308561|NCT00333216|Hydrocortisone|hydrocortisone|mesh-list
139308562|NCT00333216|Anecortave|anecortave|mesh-list
139308563|NCT00333216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139308564|NCT00333216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139308565|NCT00333216|Growth Substances|growth substances|mesh-ancestor
139308566|NCT00333216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308567|NCT00333216|Growth Inhibitors|growth inhibitors|mesh-ancestor
139308568|NCT00333216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308569|NCT00333216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139308570|NCT00332748|Taxane|taxane|mesh-list
139308571|NCT00332748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308572|NCT03530436|Curcumin|curcumin|mesh-list
139308573|NCT03530436|Turmeric extract|turmeric extract|mesh-list
139308574|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139308575|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139308576|NCT03530436|Analgesics|analgesics|mesh-ancestor
139308577|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
139308578|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308579|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308580|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139308581|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139308582|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308583|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308584|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308585|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
139308586|NCT03530436|Protective Agents|protective agents|mesh-ancestor
139308587|NCT03530280|Pregabalin|pregabalin|mesh-list
139308588|NCT03530280|Bupivacaine|bupivacaine|mesh-list
139308589|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
139308590|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
139308591|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308592|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308593|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
139308594|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308595|NCT03530280|Analgesics|analgesics|mesh-ancestor
139308596|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
139308597|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139308598|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139308599|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308600|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139308601|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139308602|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139308603|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139308604|NCT00079482|Cytarabine|cytarabine|mesh-list
139308605|NCT00079482|Etoposide|etoposide|mesh-list
139308606|NCT00079482|Mitoxantrone|mitoxantrone|mesh-list
139308607|NCT00079482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139308608|NCT00079482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308609|NCT00079482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139308610|NCT00079482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139308611|NCT00079482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308612|NCT00079482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308613|NCT00079482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139308614|NCT00079482|Antimetabolites|antimetabolites|mesh-ancestor
139308615|NCT00079482|Antiviral Agents|antiviral agents|mesh-ancestor
139308616|NCT00079482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308617|NCT00079482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139308618|NCT00079482|Immunologic Factors|immunologic factors|mesh-ancestor
139308619|NCT00079482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308620|NCT00079482|Analgesics|analgesics|mesh-ancestor
139308621|NCT00079482|Sensory System Agents|sensory system agents|mesh-ancestor
139308622|NCT00079482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308623|NCT00073866|Celecoxib|celecoxib|mesh-list
139308624|NCT00073866|Docetaxel|docetaxel|mesh-list
139308625|NCT00073866|Irinotecan|irinotecan|mesh-list
139308626|NCT00073866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308627|NCT00073866|Tubulin Modulators|tubulin modulators|mesh-ancestor
138926585|NCT00718718|Methotrexate|methotrexate|mesh-list
139308628|NCT00073866|Antimitotic Agents|antimitotic agents|mesh-ancestor
139308629|NCT00073866|Mitosis Modulators|mitosis modulators|mesh-ancestor
139308630|NCT00073866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308631|NCT00073866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139308632|NCT00073866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139308633|NCT00073866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308634|NCT00073866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139308635|NCT00073866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139308636|NCT00073866|Analgesics|analgesics|mesh-ancestor
139308637|NCT00073866|Sensory System Agents|sensory system agents|mesh-ancestor
139308638|NCT00073866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308639|NCT00073866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308640|NCT00073866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139308641|NCT00073866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139308642|NCT00073866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139308643|NCT00073866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139308645|NCT00325650|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139308646|NCT00325650|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
139308647|NCT00325650|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139308648|NCT00325650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308649|NCT00325650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308650|NCT00325650|Hormones|hormones|mesh-ancestor
139308651|NCT00325650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139308652|NCT00325650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308653|NCT00070590|Bosentan|bosentan|mesh-list
139308654|NCT00070590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139308655|NCT00070590|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139308656|NCT00070590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308657|NCT00067782|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139308658|NCT00067782|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139308659|NCT00067782|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139308660|NCT00067782|Protease Inhibitors|protease inhibitors|mesh-ancestor
139308661|NCT00067782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308662|NCT00067782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308663|NCT00067782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139308664|NCT00067782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139308665|NCT00067782|Antiviral Agents|antiviral agents|mesh-ancestor
139308666|NCT00067782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308667|NCT00058266|Genistein|genistein|mesh-list
139308668|NCT00058266|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139308669|NCT00058266|Protective Agents|protective agents|mesh-ancestor
139308670|NCT00058266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308671|NCT00058266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308672|NCT00058266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139308673|NCT00058266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965541|NCT00954135|Sorafenib|sorafenib|mesh-list
139308674|NCT00058266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308675|NCT00058266|Phytoestrogens|phytoestrogens|mesh-ancestor
139308676|NCT00058266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139308677|NCT00058266|Estrogens|estrogens|mesh-ancestor
139308678|NCT00058266|Hormones|hormones|mesh-ancestor
139308679|NCT00058266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139308680|NCT00313794|Tremelimumab|tremelimumab|mesh-list
139308681|NCT00313794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308682|NCT00313248|Sagopilone|sagopilone|mesh-list
139308683|NCT00313248|Epothilones|epothilones|mesh-list
139308684|NCT00313248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308685|NCT00313248|Tubulin Modulators|tubulin modulators|mesh-ancestor
139308686|NCT00313248|Antimitotic Agents|antimitotic agents|mesh-ancestor
139308687|NCT00313248|Mitosis Modulators|mitosis modulators|mesh-ancestor
139308688|NCT00313248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308689|NCT00310830|Bosentan|bosentan|mesh-list
139308690|NCT00310830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139308691|NCT00310830|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139176113|NCT01160419|Vitamins|vitamins|mesh-ancestor
139308692|NCT00310830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308693|NCT00035568|Metformin|metformin|mesh-list
139308694|NCT00035568|Glyburide|glyburide|mesh-list
139308695|NCT00035568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139308696|NCT00035568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308697|NCT00031512|Pleconaril|pleconaril|mesh-list
139308698|NCT00031512|Antiviral Agents|antiviral agents|mesh-ancestor
139308699|NCT00031512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308700|NCT00307398|Hydrocortisone|hydrocortisone|mesh-list
139308701|NCT00307398|Anecortave|anecortave|mesh-list
139308702|NCT00307398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139308703|NCT00307398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139308704|NCT00307398|Growth Substances|growth substances|mesh-ancestor
139308705|NCT00307398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308706|NCT00307398|Growth Inhibitors|growth inhibitors|mesh-ancestor
139308707|NCT00307398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308708|NCT00307398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139308709|NCT01368081|Metformin|metformin|mesh-list
139308710|NCT01368081|Empagliflozin|empagliflozin|mesh-list
139308711|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139308712|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308713|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139308714|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308715|NCT02127489|Bupivacaine|bupivacaine|mesh-list
139308716|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
139308717|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
139308718|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308719|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308720|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
139308721|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308722|NCT00004914|Epoetin Alfa|epoetin alfa|mesh-list
139308723|NCT00004914|Hematinics|hematinics|mesh-ancestor
139308724|NCT00286806|Gossypol acetic acid|gossypol acetic acid|mesh-list
139308725|NCT00286806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139308726|NCT00286806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308727|NCT00286806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139308728|NCT00286806|Contraceptive Agents|contraceptive agents|mesh-ancestor
139308729|NCT00286806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139308730|NCT00286806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308731|NCT00286806|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
139308732|NCT00286806|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
139308733|NCT00286806|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139308734|NCT00004908|Cyclophosphamide|cyclophosphamide|mesh-list
139308735|NCT00004908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139308736|NCT00004908|Immunologic Factors|immunologic factors|mesh-ancestor
139308737|NCT00004908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308738|NCT00004908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139308739|NCT00004908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139308740|NCT00004908|Alkylating Agents|alkylating agents|mesh-ancestor
139308741|NCT00004908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308742|NCT00004908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308743|NCT00004908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139308744|NCT00004902|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
139308745|NCT00004902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308746|NCT00004902|Immunologic Factors|immunologic factors|mesh-ancestor
139308747|NCT00004902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308748|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
139308749|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139308750|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308751|NCT03551067|Midazolam|midazolam|mesh-list
139308752|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
139308753|NCT03551067|Ketamine|ketamine|mesh-list
139308754|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139308755|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308756|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308757|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139308758|NCT03551067|Analgesics|analgesics|mesh-ancestor
139308759|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
139308760|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308761|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139308762|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139308763|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139308764|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
139308765|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308766|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308767|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139308768|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139308769|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
139308771|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139308772|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139308773|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139308774|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139308775|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139308776|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139308777|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
139308778|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
139308779|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139308780|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
139308781|NCT03529266|Coagulants|coagulants|mesh-ancestor
139308782|NCT02128191|Ibuprofen|ibuprofen|mesh-list
139308783|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139308784|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139308785|NCT02128191|Analgesics|analgesics|mesh-ancestor
139308786|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
139308787|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308788|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308789|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139308790|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139308791|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139308792|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308793|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308794|NCT00004896|Cyclophosphamide|cyclophosphamide|mesh-list
139308795|NCT00004896|Busulfan|busulfan|mesh-list
139308796|NCT00004896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139308797|NCT00004896|Immunologic Factors|immunologic factors|mesh-ancestor
139308798|NCT00004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308799|NCT00004896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139308800|NCT00004896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139308801|NCT00004896|Alkylating Agents|alkylating agents|mesh-ancestor
139308802|NCT00004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308803|NCT00004896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308804|NCT00004896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139308805|NCT02121951|Lidocaine|lidocaine|mesh-list
139308806|NCT02121951|Midazolam|midazolam|mesh-list
139308807|NCT02121951|Fentanyl|fentanyl|mesh-list
139308808|NCT02121951|Anesthetics|anesthetics|mesh-list
139308809|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
139308810|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
139308811|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139308812|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139308813|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308814|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308815|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139308816|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139308817|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139308818|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139308819|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
139308820|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
139308821|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
139176132|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
139308822|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308823|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965681|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
139308824|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139308825|NCT02121951|Narcotics|narcotics|mesh-ancestor
139308826|NCT02121951|Analgesics|analgesics|mesh-ancestor
139308827|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
139308828|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308829|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139308830|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139308831|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139308832|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139308834|NCT05473858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139308835|NCT05473858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139308836|NCT05473858|Adrenergic Agents|adrenergic agents|mesh-ancestor
139308837|NCT05473858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308838|NCT05473858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308839|NCT05473858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308840|NCT05473858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139308841|NCT00004584|Ritonavir|ritonavir|mesh-list
139308842|NCT00004584|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139308843|NCT00004584|Saquinavir|saquinavir|mesh-list
139308844|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139308845|NCT00004584|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139308846|NCT00004584|Protease Inhibitors|protease inhibitors|mesh-ancestor
139308847|NCT00004584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308848|NCT00004584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308849|NCT00004584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139308850|NCT00004584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139308851|NCT00004584|Antiviral Agents|antiviral agents|mesh-ancestor
139308852|NCT00004584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308853|NCT00004584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139308854|NCT00004584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139308855|NCT00004230|Cyclophosphamide|cyclophosphamide|mesh-list
139308856|NCT00004230|Captopril|captopril|mesh-list
139308857|NCT00004230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139308858|NCT00004230|Immunologic Factors|immunologic factors|mesh-ancestor
139308859|NCT00004230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308860|NCT00004230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139308861|NCT00004230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139308862|NCT00004230|Alkylating Agents|alkylating agents|mesh-ancestor
139308863|NCT00004230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308864|NCT00004230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308865|NCT00004230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139308866|NCT00004230|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139308867|NCT00004230|Protease Inhibitors|protease inhibitors|mesh-ancestor
139308868|NCT00004230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308869|NCT00004230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139308870|NCT02252367|Tadalafil|tadalafil|mesh-list
139308871|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
139308872|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139308873|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139308874|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308875|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308876|NCT02252367|Urological Agents|urological agents|mesh-ancestor
139308877|NCT00004182|Irinotecan|irinotecan|mesh-list
139308878|NCT00004182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139308879|NCT00004182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139308880|NCT00004182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308881|NCT00004182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308882|NCT00004182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308883|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
139308884|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139308885|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
139308886|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308887|NCT02124525|Expectorants|expectorants|mesh-ancestor
139308888|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
139308889|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139308890|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
139308891|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308892|NCT02124525|Protective Agents|protective agents|mesh-ancestor
139308893|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308894|NCT02124525|Antidotes|antidotes|mesh-ancestor
139308895|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
139308896|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
139308897|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139308898|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139308899|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308900|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308901|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308902|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139308903|NCT02128425|Leucovorin|leucovorin|mesh-list
139308904|NCT02128425|Fluorouracil|fluorouracil|mesh-list
139308905|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
139308906|NCT02128425|Irinotecan|irinotecan|mesh-list
139308907|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
139308908|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
139308909|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308910|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139308911|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308912|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139308913|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
139308914|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308915|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139308916|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139308917|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308918|NCT02128425|Antidotes|antidotes|mesh-ancestor
139308919|NCT02128425|Protective Agents|protective agents|mesh-ancestor
139308920|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
139308921|NCT02128425|Vitamins|vitamins|mesh-ancestor
139308922|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
139308923|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
139308924|NCT03532620|Atorvastatin|atorvastatin|mesh-list
139308925|NCT03532620|Pitavastatin|pitavastatin|mesh-list
139308926|NCT03532620|Calcium|calcium|mesh-list
139308927|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139308928|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308929|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139308930|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139308931|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139308932|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
139308933|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308934|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139308935|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139308936|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308937|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
139308938|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139308939|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
139308940|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139308941|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308942|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139308943|NCT03529032|Methadone|methadone|mesh-list
139308944|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139308945|NCT03529032|Narcotics|narcotics|mesh-ancestor
139308946|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139308947|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308948|NCT03529032|Analgesics|analgesics|mesh-ancestor
139308949|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
139308950|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139308951|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
139308952|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
139308953|NCT02122731|Amiloride|amiloride|mesh-list
139308954|NCT02122731|Diuretics|diuretics|mesh-ancestor
139308955|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
139308956|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308957|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139308958|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139308959|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139308960|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176148|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308961|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139308962|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139308964|NCT05458726|Carboplatin|carboplatin|mesh-list
139308965|NCT05458726|Pemetrexed|pemetrexed|mesh-list
139308966|NCT05458726|Osimertinib|osimertinib|mesh-list
139308967|NCT05458726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139308968|NCT05458726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308969|NCT05458726|Tubulin Modulators|tubulin modulators|mesh-ancestor
139308970|NCT05458726|Antimitotic Agents|antimitotic agents|mesh-ancestor
139308971|NCT05458726|Mitosis Modulators|mitosis modulators|mesh-ancestor
139308972|NCT05458726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308973|NCT05458726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308974|NCT05458726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139308975|NCT05458726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139308976|NCT05458726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139308977|NCT02122809|Chiauranib|chiauranib|mesh-list
139308978|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139308979|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139308980|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139308981|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308982|NCT00150618|Guanfacine|guanfacine|mesh-list
139308983|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139308984|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139308985|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139308986|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139308987|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
139308988|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139308989|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139308990|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139308991|NCT03532464|Azithromycin|azithromycin|mesh-list
139308992|NCT03532464|Doxycycline|doxycycline|mesh-list
139308993|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139308994|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139308995|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
139308996|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139308997|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139308998|NCT02128893|Isavuconazole|isavuconazole|mesh-list
139308999|NCT02128893|Esomeprazole|esomeprazole|mesh-list
139309000|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139309001|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139309002|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139309003|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309004|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309005|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
139309006|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309007|NCT02124369|Paclitaxel|paclitaxel|mesh-list
139309008|NCT02124369|Gemcitabine|gemcitabine|mesh-list
139309009|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139309010|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139309011|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309012|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
139309013|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
139309014|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
139309015|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309016|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139309017|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
139309018|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
139309019|NCT02128971|Trace Elements|trace elements|mesh-ancestor
139309020|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
139309021|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309022|NCT02288208|Tenofovir|tenofovir|mesh-list
139309023|NCT02288208|Entecavir|entecavir|mesh-list
139309024|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
139309025|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309026|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139309027|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139309028|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309029|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309030|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139309031|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139309032|NCT02288286|Vaccines|vaccines|mesh-list
139309033|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
139309034|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309035|NCT02251977|Leucovorin|leucovorin|mesh-list
139309036|NCT02251977|Capecitabine|capecitabine|mesh-list
139309037|NCT02251977|Fluorouracil|fluorouracil|mesh-list
139309038|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309039|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139309040|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
139309041|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309042|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309043|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139309044|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
139309045|NCT02251977|Antidotes|antidotes|mesh-ancestor
139309046|NCT02251977|Protective Agents|protective agents|mesh-ancestor
139309047|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
139309048|NCT02251977|Vitamins|vitamins|mesh-ancestor
139309049|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
139309050|NCT03528954|Propofol|propofol|mesh-list
139309051|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139309052|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139309053|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309054|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139309055|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
139309056|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
139309057|NCT02125227|Metformin|metformin|mesh-list
139309058|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139309059|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139309060|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309061|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139309062|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139309063|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
139309064|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309065|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139309066|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139309067|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309068|NCT02129127|Paclitaxel|paclitaxel|mesh-list
139309069|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139309070|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309071|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
139309072|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
139309073|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
139309074|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309075|NCT05554822|Aspirin|aspirin|mesh-list
139309076|NCT05554822|Clopidogrel|clopidogrel|mesh-list
139309077|NCT05554822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139309078|NCT05554822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139309079|NCT05554822|Analgesics|analgesics|mesh-ancestor
139309080|NCT05554822|Sensory System Agents|sensory system agents|mesh-ancestor
139309081|NCT05554822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309082|NCT05554822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309083|NCT05554822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139309084|NCT05554822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139309085|NCT05554822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139309086|NCT05554822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139309087|NCT05554822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309088|NCT05554822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139309089|NCT05554822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139309090|NCT05554822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309091|NCT05554822|Antipyretics|antipyretics|mesh-ancestor
139309092|NCT05554822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139309093|NCT05554822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139309094|NCT05554822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139309095|NCT05554822|Purinergic Agents|purinergic agents|mesh-ancestor
139309096|NCT05554822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309097|NCT02125305|Metformin|metformin|mesh-list
139309098|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139309099|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309100|NCT00254904|Cisplatin|cisplatin|mesh-list
139309101|NCT00254904|Gemcitabine|gemcitabine|mesh-list
139309102|NCT00254904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309103|NCT00254904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139309105|NCT00254904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309106|NCT05725122|Tamsulosin|tamsulosin|mesh-list
139309107|NCT05725122|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139309108|NCT05725122|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139309109|NCT05725122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139309110|NCT05725122|Adrenergic Agents|adrenergic agents|mesh-ancestor
139309111|NCT05725122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309112|NCT05725122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309113|NCT05725122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309114|NCT05725122|Urological Agents|urological agents|mesh-ancestor
139309115|NCT03880396|Cisplatin|cisplatin|mesh-list
139309116|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309117|NCT00253968|SR 46349B|sr 46349b|mesh-list
139309118|NCT00253968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139309119|NCT00253968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139309120|NCT00253968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309121|NCT00253968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139309122|NCT00253968|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139309123|NCT00253968|Serotonin Agents|serotonin agents|mesh-ancestor
139309124|NCT00253968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309125|NCT00253968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309126|NCT03544606|Pyridoxine|pyridoxine|mesh-list
139309127|NCT03544606|Isosorbide|isosorbide|mesh-list
139309128|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139309129|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139309130|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139309131|NCT03544606|Diuretics|diuretics|mesh-ancestor
139309132|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
139309133|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309134|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
139309135|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139309136|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309137|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
139309138|NCT03544606|Vitamins|vitamins|mesh-ancestor
139309139|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
139309140|NCT02741310|Sumatriptan|sumatriptan|mesh-list
139309141|NCT02741310|Erenumab|erenumab|mesh-list
139309142|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139309143|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139309144|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139309145|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
139309146|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309147|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309148|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309149|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139309150|NCT02741310|Analgesics|analgesics|mesh-ancestor
139309151|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
139309152|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309153|NCT00243906|Plasminogen|plasminogen|mesh-list
139309154|NCT00243906|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139309155|NCT00243906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139309156|NCT00243906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139309157|NCT00243906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309158|NCT03532360|Immunomodulating Agents|immunomodulating agents|mesh-list
139309159|NCT03532360|Immunologic Factors|immunologic factors|mesh-ancestor
139309160|NCT03532360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309161|NCT01367457|Sirolimus|sirolimus|mesh-list
139309162|NCT01367457|Temsirolimus|temsirolimus|mesh-list
139309163|NCT01367457|MTOR Inhibitors|mtor inhibitors|mesh-list
139309164|NCT01367457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139309165|NCT01367457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309166|NCT01367457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309167|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139309168|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
139309169|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309170|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309171|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139309172|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309173|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139309174|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
139309175|NCT05553496|Cyclosporine|cyclosporine|mesh-list
139309176|NCT05553496|Dexamethasone|dexamethasone|mesh-list
139309177|NCT05553496|Dexamethasone acetate|dexamethasone acetate|mesh-list
139309178|NCT05553496|Cyclophosphamide|cyclophosphamide|mesh-list
139309179|NCT05553496|Rituximab|rituximab|mesh-list
139309180|NCT05553496|Tacrolimus|tacrolimus|mesh-list
139309181|NCT05553496|Cyclosporins|cyclosporins|mesh-list
139309182|NCT05553496|BB 1101|bb 1101|mesh-list
139309183|NCT05553496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139309184|NCT05553496|Immunologic Factors|immunologic factors|mesh-ancestor
139309185|NCT05553496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309186|NCT05553496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139309187|NCT05553496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139309188|NCT05553496|Alkylating Agents|alkylating agents|mesh-ancestor
139309189|NCT05553496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309190|NCT05553496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309191|NCT05553496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139309192|NCT05553496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139309193|NCT05553496|Antiemetics|antiemetics|mesh-ancestor
139309194|NCT05553496|Autonomic Agents|autonomic agents|mesh-ancestor
139309195|NCT05553496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309196|NCT05553496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139309197|NCT05553496|Glucocorticoids|glucocorticoids|mesh-ancestor
139309198|NCT05553496|Hormones|hormones|mesh-ancestor
139309199|NCT05553496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139309200|NCT05553496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139309201|NCT05553496|Protease Inhibitors|protease inhibitors|mesh-ancestor
139309202|NCT05553496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309203|NCT05553496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139309204|NCT05553496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139309205|NCT05553496|Antifungal Agents|antifungal agents|mesh-ancestor
139309206|NCT05553496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309207|NCT05553496|Dermatologic Agents|dermatologic agents|mesh-ancestor
139309208|NCT00239694|Vaccines|vaccines|mesh-list
139309209|NCT00239694|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139309210|NCT00239694|Immunologic Factors|immunologic factors|mesh-ancestor
139309211|NCT00239694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309212|NCT05549284|Rituximab|rituximab|mesh-list
139309213|NCT05549284|Methotrexate|methotrexate|mesh-list
139309214|NCT05549284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139309215|NCT05549284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309216|NCT05549284|Immunologic Factors|immunologic factors|mesh-ancestor
139309217|NCT05549284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309218|NCT05549284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139309219|NCT05549284|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139309220|NCT05549284|Abortifacient Agents|abortifacient agents|mesh-ancestor
139309221|NCT05549284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139309222|NCT05549284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139309223|NCT05549284|Antimetabolites|antimetabolites|mesh-ancestor
139309224|NCT05549284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309225|NCT05549284|Dermatologic Agents|dermatologic agents|mesh-ancestor
139309226|NCT05549284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309227|NCT05549284|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139309228|NCT05549284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139309229|NCT05549284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139309230|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
139309231|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139309232|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309233|NCT00232752|Sirolimus|sirolimus|mesh-list
139309234|NCT00232752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139309235|NCT00232752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309236|NCT00232752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139309237|NCT00232752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309238|NCT00232752|Antifungal Agents|antifungal agents|mesh-ancestor
139309239|NCT00232752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139309240|NCT00232752|Immunologic Factors|immunologic factors|mesh-ancestor
139309241|NCT00232752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309242|NCT02125617|Prednisolone|prednisolone|mesh-list
139309243|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139309244|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
139309245|NCT02125617|Hormones|hormones|mesh-ancestor
139074631|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309246|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139309247|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309248|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139309249|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309250|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139309251|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
139309252|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139309253|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139309254|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139309255|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139309256|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309257|NCT00229008|Linezolid|linezolid|mesh-list
139309258|NCT00229008|Ceftazidime|ceftazidime|mesh-list
139309259|NCT00229008|Ceftobiprole|ceftobiprole|mesh-list
139309260|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
139309261|NCT00229008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139309262|NCT00229008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309263|NCT00229008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139309264|NCT00229008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309265|NCT00229008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309266|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
139309267|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139309268|NCT03528564|Hematinics|hematinics|mesh-ancestor
139309269|NCT03531372|Antacids|antacids|mesh-list
139309270|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309271|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139309272|NCT02129595|Resveratrol|resveratrol|mesh-list
139309273|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
139309274|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309275|NCT02129595|Protective Agents|protective agents|mesh-ancestor
139309276|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309277|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309278|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139309279|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139309280|NCT02129673|Latanoprost|latanoprost|mesh-list
139309281|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139309283|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139309284|NCT02129829|Tenofovir|tenofovir|mesh-list
139309285|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
139309286|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309287|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139309288|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139309289|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309290|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309291|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139309292|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139309293|NCT02129985|Metformin|metformin|mesh-list
139309294|NCT02129985|Exenatide|exenatide|mesh-list
139309295|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139309296|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309297|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139309298|NCT02129985|Incretins|incretins|mesh-ancestor
139309299|NCT02129985|Hormones|hormones|mesh-ancestor
139309300|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139309301|NCT01730638|Histamine|histamine|mesh-list
139309302|NCT01730638|Glycine|glycine|mesh-list
139309303|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
139309304|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
139309305|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309306|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309307|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309308|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
139309309|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
139309310|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139309311|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139309312|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074638|NCT00095199|Cetuximab|cetuximab|mesh-list
139309313|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139309314|NCT02252523|Analgesics|analgesics|mesh-ancestor
139309315|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
139309316|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309317|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139309318|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139309319|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139309320|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
139309321|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309322|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309323|NCT02132091|Vitamins|vitamins|mesh-list
139309324|NCT02132091|Vitamin E|vitamin e|mesh-list
139309325|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
139309326|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309327|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
139309328|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309329|NCT02132091|Protective Agents|protective agents|mesh-ancestor
139309330|NCT05548348|Aflutinib|aflutinib|mesh-list
139309331|NCT05548348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139309332|NCT05548348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309333|NCT05548348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309334|NCT04469010|Iron|iron|mesh-list
139309335|NCT04469010|Chelating Agents|chelating agents|mesh-list
139309336|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
139309337|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309338|NCT04469010|Trace Elements|trace elements|mesh-ancestor
139309339|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309340|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
139309341|NCT01121224|Clopidogrel|clopidogrel|mesh-list
139309342|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139309343|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139309344|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139309345|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139309346|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
139309347|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309348|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309349|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309350|NCT00138762|Atorvastatin|atorvastatin|mesh-list
139309351|NCT00138762|Torcetrapib|torcetrapib|mesh-list
139309352|NCT00138762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139309353|NCT00138762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139309354|NCT00138762|Antimetabolites|antimetabolites|mesh-ancestor
139309355|NCT00138762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309356|NCT00138762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139309357|NCT00138762|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139309358|NCT00138762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309359|NCT03531294|Aflibercept|aflibercept|mesh-list
139309360|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139309361|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139309362|NCT03531294|Growth Substances|growth substances|mesh-ancestor
139309363|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309364|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
139309365|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309366|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
139309367|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139309368|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139309369|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139309370|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139309371|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309372|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
139309373|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309374|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309375|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139309376|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309377|NCT05551624|Acetylcysteine|acetylcysteine|mesh-list
139309378|NCT05551624|Atorvastatin|atorvastatin|mesh-list
139309379|NCT05551624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139309380|NCT05551624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139309381|NCT05551624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139309382|NCT05551624|Antimetabolites|antimetabolites|mesh-ancestor
139309383|NCT05551624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309384|NCT05551624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139309385|NCT05551624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139309386|NCT05551624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309387|NCT05551624|Antiviral Agents|antiviral agents|mesh-ancestor
139309388|NCT05551624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309389|NCT05551624|Expectorants|expectorants|mesh-ancestor
139309390|NCT05551624|Respiratory System Agents|respiratory system agents|mesh-ancestor
139309391|NCT05551624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139309392|NCT05551624|Antioxidants|antioxidants|mesh-ancestor
139309393|NCT05551624|Protective Agents|protective agents|mesh-ancestor
139309394|NCT05551624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309395|NCT05551624|Antidotes|antidotes|mesh-ancestor
139309396|NCT00134238|Atorvastatin|atorvastatin|mesh-list
139309397|NCT00134238|Torcetrapib|torcetrapib|mesh-list
139309398|NCT00134238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139309399|NCT00134238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139309400|NCT00134238|Antimetabolites|antimetabolites|mesh-ancestor
139309401|NCT00134238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309402|NCT00134238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139309403|NCT00134238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139309404|NCT00134238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309405|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139309406|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139309407|NCT03550677|Anesthetics|anesthetics|mesh-list
139309408|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139309409|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309410|NCT02132403|Milk fat globule|milk fat globule|mesh-list
139309411|NCT02132403|Gemcitabine|gemcitabine|mesh-list
139309412|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139309413|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
139309414|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309415|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309416|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309417|NCT04264806|Azacitidine|azacitidine|mesh-list
139309418|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139309419|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
139309420|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309421|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309422|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309423|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139309424|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139309425|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
139309426|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309427|NCT00126984|Vaccines|vaccines|mesh-list
139309428|NCT00126984|Immunologic Factors|immunologic factors|mesh-ancestor
139309429|NCT00126984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309430|NCT05699746|Capecitabine|capecitabine|mesh-list
138966284|NCT00837174|Bortezomib|bortezomib|mesh-list
139309431|NCT05699746|Oxaliplatin|oxaliplatin|mesh-list
139309432|NCT05699746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139309433|NCT05699746|Antimetabolites|antimetabolites|mesh-ancestor
139309434|NCT05699746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309435|NCT05699746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309436|NCT03549897|Albuterol|albuterol|mesh-list
139309437|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139309438|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
139309439|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309440|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309441|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139309442|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
139309443|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
139309444|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139309445|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139309446|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139309447|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139309448|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
139309449|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309450|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309451|NCT02133105|Simendan|simendan|mesh-list
139309452|NCT02133105|Dobutamine|dobutamine|mesh-list
139309453|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139309454|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
139309455|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139309456|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139309457|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309458|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309459|NCT02133105|Protective Agents|protective agents|mesh-ancestor
139309460|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309461|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
139309462|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
139309463|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309464|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139309465|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139309466|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139309467|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
139309468|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309469|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
139309470|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309471|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
139309472|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
139309473|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
139309474|NCT02136693|Psyllium|psyllium|mesh-list
139309475|NCT02136693|Cathartics|cathartics|mesh-ancestor
139309476|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139309477|NCT02136771|Vitamin D|vitamin d|mesh-list
139309478|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
139309479|NCT02136771|Vitamins|vitamins|mesh-ancestor
139309480|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
139309481|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309482|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139309483|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139309484|NCT00125970|Vaccines|vaccines|mesh-list
139309485|NCT00125970|Immunologic Factors|immunologic factors|mesh-ancestor
139309486|NCT00125970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309487|NCT03549663|Prednisone|prednisone|mesh-list
139309488|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
139309489|NCT03549663|Tacrolimus|tacrolimus|mesh-list
139309490|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139309491|NCT03549663|Hormones|hormones|mesh-ancestor
139309492|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139309493|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309494|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139309495|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309496|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139309497|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
139309498|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139309499|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309500|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309501|NCT02137083|Docetaxel|docetaxel|mesh-list
139309502|NCT02137083|Fulvestrant|fulvestrant|mesh-list
139309503|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309504|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
138966368|NCT00844740|Cinacalcet|cinacalcet|mesh-list
139309505|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
139309506|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
139309507|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309508|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139309509|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139309510|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139309511|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
139309512|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139309513|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309514|NCT02137161|Tobramycin|tobramycin|mesh-list
139309515|NCT02137161|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
139309516|NCT02137161|Dexamethasone|dexamethasone|mesh-list
139309517|NCT02137161|Bromfenac|bromfenac|mesh-list
139309518|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139309519|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139309520|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
139309521|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
139309522|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309523|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309524|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139309525|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
139309526|NCT02137161|Hormones|hormones|mesh-ancestor
139309527|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139309528|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139309529|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309530|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139309531|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139309532|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309533|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139309534|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139309535|NCT02137161|Analgesics|analgesics|mesh-ancestor
139309536|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
139309537|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139309538|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139309539|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309540|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
139309541|NCT03527628|Dacarbazine|dacarbazine|mesh-list
139309542|NCT03527628|Doxorubicin|doxorubicin|mesh-list
139309543|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139309544|NCT03527628|Bleomycin|bleomycin|mesh-list
139309545|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139309546|NCT03527628|Vinblastine|vinblastine|mesh-list
139309547|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139309548|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
139309549|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309550|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139309551|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139309552|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
139309553|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309554|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309555|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139309556|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139309557|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139309558|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139309559|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309560|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139309561|NCT03527628|Immunotoxins|immunotoxins|mesh-ancestor
139309562|NCT03527628|Immunoconjugates|immunoconjugates|mesh-ancestor
139309563|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139309564|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
139309565|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
139309566|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
139309567|NCT04466670|Aspirin|aspirin|mesh-list
139309568|NCT04466670|Heparin|heparin|mesh-list
139309569|NCT04466670|Calcium heparin|calcium heparin|mesh-list
139309570|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139309571|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139309572|NCT04466670|Analgesics|analgesics|mesh-ancestor
139309573|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
139309574|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309575|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309576|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139309577|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139176208|NCT01156909|Rituximab|rituximab|mesh-list
139309578|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139309579|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139309580|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309581|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139309582|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139309584|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
139309585|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
139309586|NCT04468542|Triamcinolone|triamcinolone|mesh-list
139309587|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139309588|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139309589|NCT04468542|Bupivacaine|bupivacaine|mesh-list
139309590|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139309591|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
139309592|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
139309593|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139309594|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309595|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
139309596|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309597|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139309598|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
139309599|NCT04468542|Hormones|hormones|mesh-ancestor
139309600|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139309601|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139309602|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
139309603|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309604|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309605|NCT03525522|Betamethasone|betamethasone|mesh-list
139309606|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139309607|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139309608|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
139309609|NCT03525522|Hormones|hormones|mesh-ancestor
139309610|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139309611|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309612|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139309613|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
139309614|NCT03228732|Fluoxetine|fluoxetine|mesh-list
139309615|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139309616|NCT03228732|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139309617|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139309618|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139309619|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309620|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309621|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
139309622|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309623|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139309624|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
139309625|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139309626|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139309627|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139309628|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309629|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139309630|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
139309631|NCT04466436|Tryptophan|tryptophan|mesh-list
139309632|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139309633|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
139309634|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139309635|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139309636|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
139309637|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139309638|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139309639|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139309640|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139309641|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309642|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
139309643|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309644|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309645|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139309646|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309647|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139309649|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139309650|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139309651|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
139309652|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
139309653|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309654|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309655|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139309656|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139309657|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139309658|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
139309659|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309660|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309661|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
139309663|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
139309664|NCT02137239|Everolimus|everolimus|mesh-list
139309665|NCT02137239|Abatacept|abatacept|mesh-list
139309666|NCT02137239|Tacrolimus|tacrolimus|mesh-list
139309667|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
139309668|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139309669|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
139309670|NCT02137239|Hormones|hormones|mesh-ancestor
139309671|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139309672|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309673|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139309674|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309675|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139309676|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
139309677|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139309678|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309679|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309680|NCT02137239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139309681|NCT02137239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139309682|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139309683|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139309684|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
139309685|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139309686|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309687|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
139309688|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
139309689|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309690|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139309691|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139309692|NCT02137239|Protective Agents|protective agents|mesh-ancestor
139309693|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139309694|NCT02137239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139309695|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139309696|NCT02137395|Dexamethasone|dexamethasone|mesh-list
139309697|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139309698|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
139309699|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
139309700|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309701|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309702|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139309703|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
139309704|NCT02137395|Hormones|hormones|mesh-ancestor
139309705|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139309706|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139309707|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309708|NCT02137629|Azacitidine|azacitidine|mesh-list
139309709|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139309710|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
139309711|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309712|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309713|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309714|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139309715|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139309716|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309717|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139309718|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
139309719|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309720|NCT02261025|Aspirin|aspirin|mesh-list
139309721|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139309722|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139309723|NCT02261025|Analgesics|analgesics|mesh-ancestor
139309724|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
139309725|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309726|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309727|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139309728|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139309730|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139309731|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309732|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139309733|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139309734|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309735|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
139309736|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
139309737|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139309738|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139309739|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309740|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139309741|NCT02137863|Analgesics|analgesics|mesh-ancestor
139309742|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
139309743|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309744|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139309745|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139309746|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139309747|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
139309748|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309749|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309750|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139309751|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
139309752|NCT02138019|Coagulants|coagulants|mesh-ancestor
139309753|NCT02133885|Minocycline|minocycline|mesh-list
139309754|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139309755|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309756|NCT02138409|Fentanyl|fentanyl|mesh-list
139309757|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139309758|NCT02138409|Narcotics|narcotics|mesh-ancestor
139309759|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139309760|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309761|NCT02138409|Analgesics|analgesics|mesh-ancestor
139309762|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
139309763|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309764|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139309765|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139309766|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
139309767|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
139309768|NCT02138799|Rifampin|rifampin|mesh-list
139309769|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139309770|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
139309771|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139309772|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309773|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
139309774|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139309775|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309776|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309777|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139309778|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139309779|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139309780|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139309781|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139309782|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139309783|NCT02975271|Serlopitant|serlopitant|mesh-list
139309784|NCT02975271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139309785|NCT02975271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309786|NCT02975271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309787|NCT02975271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309788|NCT02741076|Oxymorphone|oxymorphone|mesh-list
139309789|NCT02741076|Morphine|morphine|mesh-list
139309790|NCT02741076|Oxycodone|oxycodone|mesh-list
139309792|NCT02741076|Narcotics|narcotics|mesh-ancestor
139309793|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139309794|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309795|NCT02741076|Analgesics|analgesics|mesh-ancestor
139309796|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
139309797|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309798|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139309799|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139309800|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
139309801|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
139309802|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309804|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139309805|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139309806|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309807|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139309808|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139309809|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309810|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309811|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139309812|NCT05120934|Amitriptyline|amitriptyline|mesh-list
139309813|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139309814|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139309815|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139309816|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309817|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309818|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309819|NCT05120934|Analgesics|analgesics|mesh-ancestor
139309820|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
139309821|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309822|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
139309823|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139309824|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
139309825|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139309826|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139309827|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139309828|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
139309829|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
139309830|NCT03548493|Fentanyl|fentanyl|mesh-list
139309831|NCT03548493|Propofol|propofol|mesh-list
139309832|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139309833|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139309834|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309835|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139309836|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
139309837|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
139309838|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139309839|NCT03548493|Narcotics|narcotics|mesh-ancestor
139309840|NCT03548493|Analgesics|analgesics|mesh-ancestor
139309841|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
139309842|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309843|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139309844|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139309845|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
139309846|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139309847|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139309848|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309849|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139309850|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
139309851|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139309852|NCT02139267|Vaccines|vaccines|mesh-list
139309853|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
139309854|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309855|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139309856|NCT03549819|Cannabidiol|cannabidiol|mesh-list
139309857|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
139309858|NCT03549741|Cabergoline|cabergoline|mesh-list
139309859|NCT03549741|Clomiphene|clomiphene|mesh-list
139309860|NCT03549741|Enclomiphene|enclomiphene|mesh-list
139309861|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
139309862|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309863|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139309864|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
139309865|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139309866|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309867|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139309868|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
139309869|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139309870|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139309871|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139309872|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139309873|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139309874|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
139309875|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
139309876|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309877|NCT03522402|Sevoflurane|sevoflurane|mesh-list
139309878|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139309879|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139309880|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
139309881|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
139309882|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139309883|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309884|NCT02134899|Everolimus|everolimus|mesh-list
139309885|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139309886|NCT02134899|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139309887|NCT02134899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139309888|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139309889|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309890|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139309891|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
139309892|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309893|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309894|NCT02135055|Midazolam|midazolam|mesh-list
139309895|NCT02135055|Morphine|morphine|mesh-list
139309896|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139309897|NCT02135055|Narcotics|narcotics|mesh-ancestor
139309898|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139309899|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309900|NCT02135055|Analgesics|analgesics|mesh-ancestor
139309901|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
139309902|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309903|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139309904|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139309905|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139309906|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139309907|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139309908|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139309909|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
139309910|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
139309911|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
139309912|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
139309913|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309914|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309915|NCT02139579|Bevacizumab|bevacizumab|mesh-list
139309916|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139309917|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309918|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139309919|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139309920|NCT02139579|Growth Substances|growth substances|mesh-ancestor
139309921|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309922|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
139309923|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
139309924|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
139309925|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309926|NCT05550064|Contraceptive Agents|contraceptive agents|mesh-list
139309927|NCT05550064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139309928|NCT05550064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309929|NCT04076826|Midazolam|midazolam|mesh-list
139309930|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
139309931|NCT04076826|Propofol|propofol|mesh-list
139309932|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139309933|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139309934|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309935|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139309936|NCT04076826|Analgesics|analgesics|mesh-ancestor
138716133|NCT00583518|Hormones|hormones|mesh-list
139309937|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
139309938|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309939|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139309940|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139309941|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139309942|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
139309943|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309944|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309945|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139309946|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
139309947|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
139309948|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139309949|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139309950|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139309951|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138966813|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
139309952|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
139309954|NCT05577585|Midazolam|midazolam|mesh-list
139309955|NCT05577585|Ketamine|ketamine|mesh-list
139309956|NCT05577585|Analgesics|analgesics|mesh-ancestor
139309957|NCT05577585|Sensory System Agents|sensory system agents|mesh-ancestor
139309958|NCT05577585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139309959|NCT05577585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309960|NCT05577585|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139309961|NCT05577585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139309962|NCT05577585|Anesthetics, General|anesthetics, general|mesh-ancestor
139309963|NCT05577585|Anesthetics|anesthetics|mesh-ancestor
139309964|NCT05577585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139309965|NCT05577585|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139309966|NCT05577585|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139309967|NCT05577585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139309968|NCT05577585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309969|NCT05577585|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139309970|NCT05577585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139309971|NCT05577585|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139309972|NCT05577585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139309973|NCT05577585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139309974|NCT05577585|GABA Modulators|gaba modulators|mesh-ancestor
139309975|NCT05577585|GABA Agents|gaba agents|mesh-ancestor
139309976|NCT04465968|Durvalumab|durvalumab|mesh-list
139309977|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139309978|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139309979|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139309980|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
139309981|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309982|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
139309983|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139309984|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139309985|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
139309986|NCT05577507|Calcium Carbonate|calcium carbonate|mesh-list
139309987|NCT05577507|Cholestyramine Resin|cholestyramine resin|mesh-list
139309988|NCT05577507|Calcium|calcium|mesh-list
139309989|NCT05577507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139309990|NCT05577507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139309991|NCT05577507|Antacids|antacids|mesh-ancestor
139309992|NCT05577507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139309993|NCT05577507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139309994|NCT05577507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139309995|NCT05577507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139309996|NCT05577507|Antimetabolites|antimetabolites|mesh-ancestor
139309997|NCT05577507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139309998|NCT01565655|Peficitinib|peficitinib|mesh-list
139309999|NCT01565655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310000|NCT01565655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310001|NCT01565655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139310002|NCT01565655|Immunologic Factors|immunologic factors|mesh-ancestor
139310003|NCT01565655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310004|NCT05535322|Insulin|insulin|mesh-list
139310005|NCT05535322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139310006|NCT05535322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310007|NCT05577273|Trimethoprim|trimethoprim|mesh-list
139310008|NCT05577273|Sulfamethoxazole|sulfamethoxazole|mesh-list
139310009|NCT05577273|Penicillins|penicillins|mesh-list
139310010|NCT05577273|Cefuroxime|cefuroxime|mesh-list
138716214|NCT00568568|Hormones|hormones|mesh-list
139310011|NCT05577273|Cefuroxime axetil|cefuroxime axetil|mesh-list
139310012|NCT05577273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139310013|NCT05577273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310014|NCT05577273|Antimalarials|antimalarials|mesh-ancestor
139310015|NCT05577273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139310016|NCT05577273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139310017|NCT05577273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139310018|NCT05577273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310019|NCT05577273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310020|NCT05577273|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139310021|NCT05577273|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139310022|NCT05577273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139310023|NCT05577273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139310024|NCT02252913|Docetaxel|docetaxel|mesh-list
139310025|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310026|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
139310027|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
139310028|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
139310029|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310030|NCT02253459|Capecitabine|capecitabine|mesh-list
139310031|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139310032|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
139310033|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310034|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310035|NCT02140047|Vaccines|vaccines|mesh-list
139310036|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
139310037|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310038|NCT02135913|Vitamin D|vitamin d|mesh-list
139310039|NCT02135913|Vitamins|vitamins|mesh-ancestor
139310040|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
139310041|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310042|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139310043|NCT02140125|ASP2408|asp2408|mesh-list
139310044|NCT02140125|Immunoconjugates|immunoconjugates|mesh-ancestor
139310045|NCT02140125|Immunologic Factors|immunologic factors|mesh-ancestor
139310046|NCT02140125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310047|NCT05541640|Lidocaine|lidocaine|mesh-list
139310048|NCT05541640|Anesthetics, Local|anesthetics, local|mesh-ancestor
139310049|NCT05541640|Anesthetics|anesthetics|mesh-ancestor
139310050|NCT05541640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139310051|NCT05541640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310052|NCT05541640|Sensory System Agents|sensory system agents|mesh-ancestor
139310053|NCT05541640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310054|NCT05541640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139310055|NCT05541640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139310056|NCT05541640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139310057|NCT05541640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139310058|NCT05541640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310059|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
139310060|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
139310061|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139310062|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310063|NCT05545618|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139310064|NCT05545618|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139310065|NCT05545618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310066|NCT02140281|Cefadroxil|cefadroxil|mesh-list
139310067|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139310068|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310069|NCT05541328|Tisagenlecleucel|tisagenlecleucel|mesh-list
139310070|NCT05541328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139310071|NCT05541328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310072|NCT05545462|Doxycycline|doxycycline|mesh-list
139310073|NCT05545462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139310074|NCT05545462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310075|NCT05545462|Antimalarials|antimalarials|mesh-ancestor
139310076|NCT05545462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139310077|NCT05545462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139310078|NCT05541172|Methyltestosterone|methyltestosterone|mesh-list
139310079|NCT05541172|Testosterone|testosterone|mesh-list
139310080|NCT05541172|Testosterone undecanoate|testosterone undecanoate|mesh-list
139310081|NCT05541172|Testosterone enanthate|testosterone enanthate|mesh-list
139310082|NCT05541172|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139310083|NCT05541172|Androgens|androgens|mesh-ancestor
139310084|NCT05541172|Hormones|hormones|mesh-ancestor
139310085|NCT05541172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310086|NCT05541172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310087|NCT05541172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139310088|NCT05541172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310089|NCT05541172|Anabolic Agents|anabolic agents|mesh-ancestor
139310090|NCT05478993|Dexamethasone|dexamethasone|mesh-list
139310091|NCT05478993|Pomalidomide|pomalidomide|mesh-list
139310092|NCT05478993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139310093|NCT05478993|Antiemetics|antiemetics|mesh-ancestor
139310094|NCT05478993|Autonomic Agents|autonomic agents|mesh-ancestor
139310095|NCT05478993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310096|NCT05478993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310097|NCT05478993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139310098|NCT05478993|Glucocorticoids|glucocorticoids|mesh-ancestor
139310099|NCT05478993|Hormones|hormones|mesh-ancestor
139310100|NCT05478993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310101|NCT05478993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138966962|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310102|NCT05478993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310103|NCT05478993|Immunologic Factors|immunologic factors|mesh-ancestor
139310104|NCT05478993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139310105|NCT05478993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139310106|NCT05478993|Growth Substances|growth substances|mesh-ancestor
139310107|NCT05478993|Growth Inhibitors|growth inhibitors|mesh-ancestor
139310108|NCT05699356|Estrogens|estrogens|mesh-list
139310109|NCT05699356|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139310110|NCT05699356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310111|NCT05699356|Hormones|hormones|mesh-ancestor
139310112|NCT05699356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310113|NCT05699356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139310114|NCT05699356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310115|NCT05699356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310116|NCT05699356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139310117|NCT05699356|Hormone Antagonists|hormone antagonists|mesh-ancestor
139310118|NCT02140437|Fulvestrant|fulvestrant|mesh-list
139310119|NCT02140437|Anastrozole|anastrozole|mesh-list
139310120|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139310121|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310122|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139310123|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139310124|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
139310125|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310126|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310127|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139310128|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139310129|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310130|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310131|NCT05591560|Itraconazole|itraconazole|mesh-list
139310132|NCT05591560|Antifungal Agents|antifungal agents|mesh-ancestor
139310133|NCT05591560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310134|NCT05591560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139310135|NCT05591560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139310136|NCT05591560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310137|NCT05591560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310138|NCT05591560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139310139|NCT05591560|Hormone Antagonists|hormone antagonists|mesh-ancestor
139310140|NCT05591560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310141|NCT05591560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310142|NCT05591560|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139310143|NCT05540470|Chloroquine|chloroquine|mesh-list
139310144|NCT05540470|Primaquine|primaquine|mesh-list
139310145|NCT05540470|Tafenoquine|tafenoquine|mesh-list
139310146|NCT05540470|Amebicides|amebicides|mesh-ancestor
139310147|NCT05540470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139310148|NCT05540470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139310149|NCT05540470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310150|NCT05540470|Antimalarials|antimalarials|mesh-ancestor
139310151|NCT05540470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139310152|NCT02140515|Hormones|hormones|mesh-list
139310153|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139310154|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310155|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310157|NCT02260947|Pregabalin|pregabalin|mesh-list
139310158|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139310159|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139310160|NCT02260947|Analgesics|analgesics|mesh-ancestor
139310161|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
139310162|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310163|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310164|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139310165|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139310166|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139310167|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310168|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310169|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
139310170|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139310171|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139310172|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139310173|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139310174|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139310175|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967040|NCT00855660|Riociguat|riociguat|mesh-list
139310176|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139310177|NCT03547791|Betamethasone|betamethasone|mesh-list
139310178|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
139310179|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139310180|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
139310181|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139310182|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
139310183|NCT03547791|Hormones|hormones|mesh-ancestor
139310184|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310185|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310186|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139310187|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139310188|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
139310189|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
139310190|NCT04818177|Antibodies|antibodies|mesh-list
139310191|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
139310192|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139310193|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139310194|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
139310195|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310196|NCT05544292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139310197|NCT04425460|Favipiravir|favipiravir|mesh-list
139310198|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
139310199|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310200|NCT05576272|Gemcitabine|gemcitabine|mesh-list
139310201|NCT05576272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310202|NCT05576272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139310203|NCT05576272|Antimetabolites|antimetabolites|mesh-ancestor
139310204|NCT05576272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310205|NCT05576116|Pancrelipase|pancrelipase|mesh-list
139310206|NCT05576116|Pancreatin|pancreatin|mesh-list
139310207|NCT05576116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139310208|NCT05543824|Levobupivacaine|levobupivacaine|mesh-list
139310209|NCT05543824|Anesthetics, Local|anesthetics, local|mesh-ancestor
139310210|NCT05543824|Anesthetics|anesthetics|mesh-ancestor
139310211|NCT05543824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139310212|NCT05543824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310213|NCT05543824|Sensory System Agents|sensory system agents|mesh-ancestor
139310214|NCT05543824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310215|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
139310216|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
139310217|NCT04703673|Ephedrine|ephedrine|mesh-list
139310218|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
139310219|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139310220|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
139310221|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139310222|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310223|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
139310224|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310225|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
139310226|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139310227|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310228|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139310229|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139310230|NCT05543746|Brexanolone|brexanolone|mesh-list
139310231|NCT05543746|Neurosteroids|neurosteroids|mesh-ancestor
139310232|NCT05543746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139310233|NCT05543746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310234|NCT05543746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310235|NCT05543746|GABA Modulators|gaba modulators|mesh-ancestor
139310236|NCT05543746|GABA Agents|gaba agents|mesh-ancestor
139310237|NCT03526536|Insulin|insulin|mesh-list
139310238|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139310239|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139310240|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310241|NCT05306301|Ponatinib|ponatinib|mesh-list
139310242|NCT05306301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310243|NCT05306301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139310244|NCT05306301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310245|NCT05306301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310246|NCT05543434|Hyaluronic Acid|hyaluronic acid|mesh-list
139310247|NCT05543434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139310248|NCT05543434|Immunologic Factors|immunologic factors|mesh-ancestor
139310249|NCT05543434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310250|NCT05543434|Viscosupplements|viscosupplements|mesh-ancestor
139310251|NCT05543434|Protective Agents|protective agents|mesh-ancestor
138967110|NCT00854256|Mitomycins|mitomycins|mesh-list
139310252|NCT01858896|Glucagon|glucagon|mesh-list
139310253|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139310254|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139310255|NCT01858896|Hormones|hormones|mesh-ancestor
139310256|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310257|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310258|NCT01858896|Incretins|incretins|mesh-ancestor
139310259|NCT05538988|Cemiplimab|cemiplimab|mesh-list
139310260|NCT05538988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139310261|NCT05538988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310262|NCT04667637|Edaravone|edaravone|mesh-list
139310263|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139310264|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
139310265|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310266|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139310267|NCT04667637|Protective Agents|protective agents|mesh-ancestor
139310268|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310269|NCT02253927|Ritonavir|ritonavir|mesh-list
139310270|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139310271|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139310272|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
139310273|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310274|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310275|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139310276|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139310277|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
139310278|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310279|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139310280|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139310281|NCT03745144|Cladribine|cladribine|mesh-list
139310282|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139310283|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
139310284|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310285|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139310286|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
139074868|NCT00104247|Verapamil|verapamil|mesh-list
139310287|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310288|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139310289|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
139310290|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139310291|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139310292|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139310293|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139310294|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139310295|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139310296|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
139310297|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139310298|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139310299|NCT05697016|Sivelestat|sivelestat|mesh-list
139310300|NCT05697016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139310301|NCT05697016|Protease Inhibitors|protease inhibitors|mesh-ancestor
139310302|NCT05697016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310303|NCT05697016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310304|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
139310305|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139310306|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
139310307|NCT01567995|Hormones|hormones|mesh-ancestor
139310308|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310309|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310310|NCT05567523|Midazolam|midazolam|mesh-list
139310311|NCT05567523|Dexmedetomidine|dexmedetomidine|mesh-list
139310312|NCT05567523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139310313|NCT05567523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139310314|NCT05567523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310315|NCT05567523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139310316|NCT05567523|Analgesics|analgesics|mesh-ancestor
139310317|NCT05567523|Sensory System Agents|sensory system agents|mesh-ancestor
139310318|NCT05567523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310319|NCT05567523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139310320|NCT05567523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139310321|NCT05567523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139310322|NCT05567523|Adrenergic Agents|adrenergic agents|mesh-ancestor
139310323|NCT05567523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967184|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310324|NCT05567523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310325|NCT05567523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139310326|NCT05567523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139310327|NCT05567523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139310328|NCT05567523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139310329|NCT05567523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139310330|NCT05567523|Anesthetics, General|anesthetics, general|mesh-ancestor
139310331|NCT05567523|Anesthetics|anesthetics|mesh-ancestor
139310332|NCT05567523|GABA Modulators|gaba modulators|mesh-ancestor
139310333|NCT05567523|GABA Agents|gaba agents|mesh-ancestor
139310334|NCT02584504|Atorvastatin|atorvastatin|mesh-list
139310335|NCT02584504|Alirocumab|alirocumab|mesh-list
139310336|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139310337|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139310338|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
139310339|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310340|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139310341|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139310342|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310343|NCT02584504|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139310344|NCT02584504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139310345|NCT02584504|Protease Inhibitors|protease inhibitors|mesh-ancestor
139310346|NCT04599777|Sorafenib|sorafenib|mesh-list
139310347|NCT04599777|Tislelizumab|tislelizumab|mesh-list
139310348|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310349|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139310350|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310351|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310352|NCT04599777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139310353|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
139310354|NCT05007262|Calcium|calcium|mesh-list
139310355|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139310356|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310357|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
139310358|NCT05007262|Coagulants|coagulants|mesh-ancestor
139310359|NCT03546075|Resveratrol|resveratrol|mesh-list
139310360|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
139310361|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310362|NCT03546075|Protective Agents|protective agents|mesh-ancestor
139310363|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310364|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310365|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139310366|NCT05537584|Bupropion|bupropion|mesh-list
139310367|NCT05537584|Sertraline|sertraline|mesh-list
139310368|NCT05537584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139310369|NCT05537584|Antidepressive Agents|antidepressive agents|mesh-ancestor
139310370|NCT05537584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139310371|NCT05537584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139310372|NCT05537584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139310373|NCT05537584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139310374|NCT05537584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310376|NCT05537584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139310377|NCT05537584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310378|NCT05537584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139310379|NCT05537584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139310380|NCT05537584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310381|NCT05537584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139310382|NCT05537584|Serotonin Agents|serotonin agents|mesh-ancestor
139310383|NCT04459377|Ketamine|ketamine|mesh-list
139310384|NCT04459377|Esketamine|esketamine|mesh-list
139310385|NCT04459377|Analgesics|analgesics|mesh-ancestor
139310386|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
139310387|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310388|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310389|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139310390|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139310391|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
139310392|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
139310393|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139310394|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139310395|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139310396|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139310397|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310398|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
139310399|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139310400|NCT00748618|Vitamin D|vitamin d|mesh-list
139310401|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
139310402|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
139310403|NCT00748618|Vitamins|vitamins|mesh-list
139310404|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
139310405|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310406|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139310407|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139310408|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
139310409|NCT04404387|Vitamins|vitamins|mesh-ancestor
139310410|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
139310411|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310412|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
139310413|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310414|NCT04404387|Protective Agents|protective agents|mesh-ancestor
139310415|NCT03546855|Apatinib|apatinib|mesh-list
139310416|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310417|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139310418|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310419|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310420|NCT05679310|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
139310421|NCT05679310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310422|NCT05679310|Antioxidants|antioxidants|mesh-ancestor
139310423|NCT05679310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310424|NCT05679310|Protective Agents|protective agents|mesh-ancestor
139310425|NCT05679310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310426|NCT05679310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139310427|NCT05537272|Ascorbic Acid|ascorbic acid|mesh-list
139310428|NCT05537272|Tadalafil|tadalafil|mesh-list
139310429|NCT05537272|Tamsulosin|tamsulosin|mesh-list
139310430|NCT05537272|Vitamins|vitamins|mesh-ancestor
139310431|NCT05537272|Micronutrients|micronutrients|mesh-ancestor
139310432|NCT05537272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310433|NCT05537272|Antioxidants|antioxidants|mesh-ancestor
139310434|NCT05537272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310435|NCT05537272|Protective Agents|protective agents|mesh-ancestor
139310436|NCT05537272|Vasodilator Agents|vasodilator agents|mesh-ancestor
139310437|NCT05537272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139310438|NCT05537272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139310439|NCT05537272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310440|NCT05537272|Urological Agents|urological agents|mesh-ancestor
139176314|NCT01164943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310441|NCT05537272|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139310442|NCT05537272|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139310443|NCT05537272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139310444|NCT05537272|Adrenergic Agents|adrenergic agents|mesh-ancestor
139310445|NCT05537272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139310446|NCT05537194|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
139310447|NCT05537194|Calcium|calcium|mesh-list
139310448|NCT05537194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139310449|NCT05537194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310450|NCT05537194|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139310451|NCT05537194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139310452|NCT05537194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310453|NCT05536882|Adapalene|adapalene|mesh-list
139310454|NCT05536882|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139310455|NCT05536882|Dermatologic Agents|dermatologic agents|mesh-ancestor
139310456|NCT05536882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139310457|NCT05536882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139310458|NCT05536882|Analgesics|analgesics|mesh-ancestor
139310459|NCT05536882|Sensory System Agents|sensory system agents|mesh-ancestor
139310460|NCT05536882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310461|NCT05536882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310462|NCT05536882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139310463|NCT05536882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139310464|NCT03931161|Evolocumab|evolocumab|mesh-list
139310465|NCT03931161|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139310466|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139310467|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139310468|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
139310469|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310470|NCT03931161|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139310471|NCT03931161|Protease Inhibitors|protease inhibitors|mesh-ancestor
139310472|NCT03931161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310473|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138967336|NCT00959517|Artesunate|artesunate|mesh-list
139310474|NCT05037123|Ketamine|ketamine|mesh-list
139310475|NCT05037123|Analgesics|analgesics|mesh-ancestor
139310476|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
139310477|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310478|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310479|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139310480|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139310481|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
139310482|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
139310483|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139310484|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139310485|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139310486|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139310487|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310488|NCT04354155|Enoxaparin|enoxaparin|mesh-list
139310489|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
139310490|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139310491|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139310492|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310493|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139310494|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
139310495|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310496|NCT05536570|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139310497|NCT05536570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139310498|NCT05536570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310499|NCT05536570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310500|NCT05536570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139310501|NCT05536570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139310502|NCT05536570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310503|NCT05536570|Cholinergic Agents|cholinergic agents|mesh-ancestor
139310504|NCT05536570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139310505|NCT03877965|Digoxin|digoxin|mesh-list
139310506|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139310507|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139310508|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310509|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310510|NCT03877965|Protective Agents|protective agents|mesh-ancestor
139310511|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310512|NCT02253849|Ritonavir|ritonavir|mesh-list
139310513|NCT02253849|Tipranavir|tipranavir|mesh-list
139310514|NCT02253849|Carbamazepine|carbamazepine|mesh-list
139310515|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139310516|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139310517|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
139310518|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310519|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310520|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139310521|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139310522|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
139310523|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310524|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139310525|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139310526|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
139310527|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
139310528|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139310529|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139310530|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310531|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139310532|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139310533|NCT02253849|Analgesics|analgesics|mesh-ancestor
139310534|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
139310535|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310536|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139310537|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139310538|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139310539|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139310540|NCT03545997|Montelukast|montelukast|mesh-list
139310541|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139310542|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
139310543|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139310544|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
139310545|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310546|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967412|NCT03861052|Dulaglutide|dulaglutide|mesh-list
139310548|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139310549|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310550|NCT05696548|Nivolumab|nivolumab|mesh-list
139310551|NCT05696548|Lenvatinib|lenvatinib|mesh-list
139310552|NCT05696548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139310553|NCT05696548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310554|NCT05696548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139310555|NCT05696548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310556|NCT05696548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139310557|NCT05696548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310558|NCT03810495|Naltrexone|naltrexone|mesh-list
139310559|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139310560|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139310561|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310562|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
139310563|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310564|NCT04980885|Azacitidine|azacitidine|mesh-list
139310565|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139310566|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
139310567|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310568|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310569|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310570|NCT04184505|Azacitidine|azacitidine|mesh-list
139310571|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139310572|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
139310573|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310574|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310575|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310576|NCT03760458|Lamivudine|lamivudine|mesh-list
139310577|NCT03760458|Abacavir|abacavir|mesh-list
139310578|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
139310579|NCT03760458|Dolutegravir|dolutegravir|mesh-list
139310580|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139310581|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139310582|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310583|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310584|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
139310585|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310586|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139310587|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139310588|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139310589|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139310590|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
139310591|NCT02066415|Erenumab|erenumab|mesh-list
139310592|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139310593|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310594|NCT02066415|Analgesics|analgesics|mesh-ancestor
139310595|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
139310596|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310597|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310598|NCT04467918|Cannabidiol|cannabidiol|mesh-list
139310599|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
139310600|NCT04720612|Omalizumab|omalizumab|mesh-list
139310601|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139310602|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139310603|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
139310604|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
139310605|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139310606|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
139310607|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139310608|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
139310609|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310610|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310611|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
139310612|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139310613|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
139310614|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310615|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139310616|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139310617|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310618|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139310619|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967485|NCT05179239|Cisplatin|cisplatin|mesh-list
139310620|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310621|NCT04466904|Dulaglutide|dulaglutide|mesh-list
139310622|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139310623|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310625|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139310626|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
139310627|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310628|NCT02143479|Tacrolimus|tacrolimus|mesh-list
139310629|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139310630|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
139310631|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310632|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139310633|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310634|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310635|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139310636|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139310637|NCT02254239|Everolimus|everolimus|mesh-list
139310638|NCT02254239|Antibodies|antibodies|mesh-list
139310639|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
139310640|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139310641|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
139310642|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
139310643|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310644|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310645|NCT02254239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139310646|NCT02254239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139310647|NCT02254239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310648|NCT02254239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310649|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139310650|NCT02254239|Immunotoxins|immunotoxins|mesh-ancestor
139310651|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
139310652|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139310653|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139310654|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
139310655|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310656|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310657|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139310658|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
139310659|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139310660|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
139310661|NCT05088369|Protective Agents|protective agents|mesh-ancestor
139310662|NCT05681182|Amiodarone|amiodarone|mesh-list
139310663|NCT05681182|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139310664|NCT05681182|Vasodilator Agents|vasodilator agents|mesh-ancestor
139310665|NCT05681182|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139310666|NCT05681182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139074924|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
139310667|NCT05681182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310668|NCT05681182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139310669|NCT05681182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139310670|NCT05681182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139310671|NCT05681182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310672|NCT05681182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139310673|NCT05681182|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139310674|NCT05681182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139310675|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139310676|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139310677|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139310678|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
139310679|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310680|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139310681|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139310682|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310683|NCT02144025|Cyclosporine|cyclosporine|mesh-list
139310684|NCT02144025|Cyclosporins|cyclosporins|mesh-list
139310685|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310686|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310687|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139310688|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
139310689|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310690|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
139310691|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310692|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
139310693|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139310694|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139310695|NCT03523650|Propranolol|propranolol|mesh-list
139310696|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139310697|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139310698|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
139310699|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074934|NCT03730402|Bupivacaine|bupivacaine|mesh-list
139310700|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310701|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310702|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139310703|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139310704|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
139310705|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
139310706|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310707|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139310708|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310709|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310710|NCT02582632|Ritonavir|ritonavir|mesh-list
139310711|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139310712|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139310713|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
139310714|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310715|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310716|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139176332|NCT03877003|Choline|choline|mesh-list
139310717|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139310718|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
139310719|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310720|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139310721|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139310722|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
139310723|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139310724|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310725|NCT02178722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139310726|NCT02178722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310727|NCT03523572|Nivolumab|nivolumab|mesh-list
139310728|NCT03523572|Trastuzumab|trastuzumab|mesh-list
139310729|NCT03523572|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139310730|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139310731|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310732|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139310733|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310734|NCT03523572|Immunoconjugates|immunoconjugates|mesh-ancestor
139310735|NCT03523572|Immunologic Factors|immunologic factors|mesh-ancestor
139310736|NCT03523572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310737|NCT00972309|Vaccines|vaccines|mesh-list
139310738|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
139310739|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310740|NCT03526224|Teriflunomide|teriflunomide|mesh-list
139310741|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139310742|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
139310743|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139310744|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
139310745|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310746|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139310747|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139310748|NCT03526224|Analgesics|analgesics|mesh-ancestor
139310749|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
139310750|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310751|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139310752|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139310753|NCT03639246|Paclitaxel|paclitaxel|mesh-list
139310754|NCT03639246|Doxorubicin|doxorubicin|mesh-list
139310755|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139310756|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139310757|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310758|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
139310759|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
139310760|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
139310761|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310762|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139310763|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139310764|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139310765|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310766|NCT00545324|Fluticasone|fluticasone|mesh-list
139310767|NCT00545324|Montelukast|montelukast|mesh-list
139310768|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139310769|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139310770|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
139310771|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310772|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310773|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139310774|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
139310775|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
139310776|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139310777|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310778|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139310779|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
139310780|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310781|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139310782|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139310784|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
139310785|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139310786|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139310787|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310788|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
139310789|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139310790|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
139310791|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310792|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
139310793|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310794|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
139310795|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310796|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310797|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139310798|NCT03389126|Avelumab|avelumab|mesh-list
139310799|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139310800|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310801|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
139310802|NCT04446104|Ivermectin|ivermectin|mesh-list
139310803|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
139310804|NCT04446104|Povidone|povidone|mesh-list
139310805|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
139310806|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139310807|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139310808|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310809|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310810|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310811|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139310812|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
139310813|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
139310814|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139310815|NCT03388970|Vitamin K|vitamin k|mesh-list
139310816|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
139310817|NCT03388970|Vitamins|vitamins|mesh-ancestor
139310818|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
139310819|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310820|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139310821|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139310822|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310823|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
139310824|NCT03388970|Coagulants|coagulants|mesh-ancestor
139310825|NCT00616941|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139310826|NCT00616941|Poly ICLC|poly iclc|mesh-list
139310827|NCT00616941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139310828|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
139310829|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310830|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
139310831|NCT03388892|Paclitaxel|paclitaxel|mesh-list
139310832|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139310833|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310834|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
139310835|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
139310836|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
139310837|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310838|NCT02577718|Ethanol|ethanol|mesh-list
139310839|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
139310840|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139310841|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139310842|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139091547|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310843|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310844|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
139310845|NCT00520533|Sunitinib|sunitinib|mesh-list
139310846|NCT00520533|Antibodies|antibodies|mesh-list
139310847|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139310848|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
139310849|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310850|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310851|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139310852|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139310853|NCT00520533|Growth Substances|growth substances|mesh-ancestor
139310854|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
139310855|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139310856|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310857|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310858|NCT03388814|Bupivacaine|bupivacaine|mesh-list
139310859|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
139310860|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
139310861|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139310862|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310863|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
139310864|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310866|NCT04680988|Gemcitabine|gemcitabine|mesh-list
139310867|NCT04680988|Pemetrexed|pemetrexed|mesh-list
139310868|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139310869|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139310870|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310871|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
139310872|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
139310873|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
139310874|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310875|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139310876|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
139310877|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310878|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139310879|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139310880|NCT02289144|Ceritinib|ceritinib|mesh-list
139310881|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139310882|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139310883|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310884|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310885|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139310886|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139310887|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139310888|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139310889|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310890|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139310891|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139310892|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139310893|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139310894|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
139310895|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139310896|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310897|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139310898|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139310899|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
139310900|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139310901|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139310902|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
139310903|NCT02144415|Amphetamine|amphetamine|mesh-list
139310904|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139310905|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
139310906|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139310907|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310908|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
139310909|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
139310910|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310911|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
139310912|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139310913|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310914|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
139310915|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139310916|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139310917|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139310918|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139310919|NCT02739984|Evolocumab|evolocumab|mesh-list
139310920|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139310921|NCT02739984|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139310922|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139310923|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139310924|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
139310925|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310926|NCT02739984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139310927|NCT02739984|Protease Inhibitors|protease inhibitors|mesh-ancestor
139310928|NCT02739984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310929|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139310930|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
139310931|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310932|NCT00496730|Atorvastatin|atorvastatin|mesh-list
139310933|NCT00496730|Simvastatin|simvastatin|mesh-list
139310934|NCT00496730|Ezetimibe|ezetimibe|mesh-list
139310935|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139310936|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139310937|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
139310938|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310939|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139310940|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139310941|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074999|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139310943|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310944|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310945|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
139310946|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139310947|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139310948|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
139310949|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310950|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139310951|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139310952|NCT02140983|Liraglutide|liraglutide|mesh-list
139310953|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139310954|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310955|NCT02140983|Incretins|incretins|mesh-ancestor
139310956|NCT02140983|Hormones|hormones|mesh-ancestor
139310957|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310958|NCT00394160|Montelukast|montelukast|mesh-list
139310959|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139310960|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
139310961|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139310962|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
139310963|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139310964|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310965|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139310966|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139310967|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310968|NCT03392792|Plasminogen|plasminogen|mesh-list
139310969|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139310970|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139310971|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139310972|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310973|NCT02739828|Adalimumab|adalimumab|mesh-list
139310974|NCT02739828|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139310975|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139310976|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139310977|NCT02141139|Ibuprofen|ibuprofen|mesh-list
139310978|NCT02141139|Ketorolac|ketorolac|mesh-list
139310979|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139310980|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139310981|NCT02141139|Analgesics|analgesics|mesh-ancestor
139310982|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
139310983|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139310984|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310985|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139310986|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139310987|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139310988|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139310989|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310990|NCT05297032|Quercetin|quercetin|mesh-list
139310991|NCT05297032|Antioxidants|antioxidants|mesh-ancestor
139310992|NCT05297032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310993|NCT05297032|Protective Agents|protective agents|mesh-ancestor
139310994|NCT05297032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139310995|NCT03388580|Dimercaprol|dimercaprol|mesh-list
139310996|NCT03388580|Chelating Agents|chelating agents|mesh-ancestor
139310997|NCT03388580|Sequestering Agents|sequestering agents|mesh-ancestor
139310998|NCT03388580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139310999|NCT03525912|Ketamine|ketamine|mesh-list
139311000|NCT03525912|Analgesics|analgesics|mesh-list
139311001|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
139311002|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075027|NCT05782426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311003|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311004|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139311005|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139311006|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
139311007|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
139311008|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311009|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139311010|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139311011|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311012|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311013|NCT02289378|Docetaxel|docetaxel|mesh-list
139311014|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
139311015|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311016|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
139311017|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
139311018|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
139311019|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311020|NCT03851614|Durvalumab|durvalumab|mesh-list
139311021|NCT03851614|Olaparib|olaparib|mesh-list
139311022|NCT03851614|Cediranib|cediranib|mesh-list
139311023|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139311024|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311025|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139311026|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311027|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311028|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139311029|NCT04565600|Etoricoxib|etoricoxib|mesh-list
139311030|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139311031|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139311032|NCT04565600|Analgesics|analgesics|mesh-ancestor
139311033|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
139311034|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311035|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311036|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139311037|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139311038|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139311039|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139311040|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311041|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311042|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
139311043|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
139311044|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139311045|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139311046|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311047|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311048|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311049|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139311050|NCT03388346|Edetic Acid|edetic acid|mesh-list
139311051|NCT03388346|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139311052|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
139311053|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
139311054|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311055|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
139311056|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139311057|NCT03388346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139311058|NCT05631730|Metoprolol|metoprolol|mesh-list
139311059|NCT05631730|Flecainide|flecainide|mesh-list
139311060|NCT05631730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139311061|NCT05631730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139311062|NCT05631730|Sympatholytics|sympatholytics|mesh-ancestor
139311063|NCT05631730|Autonomic Agents|autonomic agents|mesh-ancestor
139311064|NCT05631730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311065|NCT05631730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311066|NCT05631730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139311067|NCT05631730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139311068|NCT05631730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139311069|NCT05631730|Adrenergic Agents|adrenergic agents|mesh-ancestor
139311070|NCT05631730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075039|NCT05782192|Alogliptin|alogliptin|mesh-list
139311071|NCT05631730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311072|NCT05631730|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139311073|NCT05631730|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139311074|NCT05631730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139311075|NCT00092144|Montelukast|montelukast|mesh-list
139311076|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311077|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311078|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
139311079|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139311080|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139311081|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
139311082|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139311083|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139311084|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139311085|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
139311086|NCT02289768|Salicylates|salicylates|mesh-list
139311087|NCT02289768|Fluorouracil|fluorouracil|mesh-list
139311088|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
139311089|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311090|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139311091|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311092|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139311093|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
139311094|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311095|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311096|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
139311097|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
139311098|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
139311099|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139311100|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139311101|NCT02289768|Analgesics|analgesics|mesh-ancestor
139311102|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
139311103|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311104|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139311105|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139311106|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139311107|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311108|NCT04330430|Nivolumab|nivolumab|mesh-list
139311109|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139311110|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311111|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139311112|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311113|NCT03387956|Dexamethasone|dexamethasone|mesh-list
139311114|NCT03387956|Atropine|atropine|mesh-list
139311115|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139311116|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
139311117|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
139311118|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311119|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311120|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139311121|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
139311122|NCT03387956|Hormones|hormones|mesh-ancestor
139311123|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139311124|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139311125|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311126|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139311127|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139311128|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139311129|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139311130|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
139311131|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
139311132|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
139311133|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139311134|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139311135|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
139311136|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311137|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311138|NCT03384524|Metoprolol|metoprolol|mesh-list
139311139|NCT03384524|Bromocriptine|bromocriptine|mesh-list
139311140|NCT03384524|Tamsulosin|tamsulosin|mesh-list
139311141|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139311142|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139311143|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
139311144|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
139311145|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311146|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311147|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139311148|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139311149|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139311150|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
139311151|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311152|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311153|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139311154|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139311155|NCT03384524|Urological Agents|urological agents|mesh-ancestor
139311156|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139311157|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139311158|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
139311159|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139311160|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
139311161|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
139311163|NCT03387644|Analgesics|analgesics|mesh-ancestor
139311164|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
139311165|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311166|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311167|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
139311168|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139311169|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139311170|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311171|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139311172|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139311173|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139311174|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311175|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139311176|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
139311177|NCT02290002|Calcium|calcium|mesh-list
139311178|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139311179|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311180|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
139311181|NCT02290002|Coagulants|coagulants|mesh-ancestor
139311182|NCT02294292|Carvedilol|carvedilol|mesh-list
139311183|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139311184|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139311185|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
139311186|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311187|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311188|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311189|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139311190|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
139311191|NCT02294292|Protective Agents|protective agents|mesh-ancestor
139311192|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139311193|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139311194|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139311195|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
139311196|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139311197|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139311198|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
139311199|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
139311200|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
139311201|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311202|NCT03387566|Growth Substances|growth substances|mesh-ancestor
139311203|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
139311204|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139311205|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
139311206|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311207|NCT03391856|Expectorants|expectorants|mesh-ancestor
139311208|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
139311209|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139311210|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
139311211|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968089|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
139311212|NCT03391856|Protective Agents|protective agents|mesh-ancestor
139311213|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311214|NCT03391856|Antidotes|antidotes|mesh-ancestor
139311215|NCT01664494|Capecitabine|capecitabine|mesh-list
139311216|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139311217|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
139311218|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311220|NCT02290470|Dexamethasone|dexamethasone|mesh-list
139311221|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
139311222|NCT02290470|Paclitaxel|paclitaxel|mesh-list
139311223|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139311224|NCT02290470|Carboplatin|carboplatin|mesh-list
139311225|NCT02290470|Olanzapine|olanzapine|mesh-list
139311226|NCT02290470|Palonosetron|palonosetron|mesh-list
139311227|NCT02290470|BB 1101|bb 1101|mesh-list
139311228|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139311229|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311230|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
139311231|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
139311232|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
139311233|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311234|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139311235|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
139311236|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
139311237|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311238|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311239|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139311240|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
139311241|NCT02290470|Hormones|hormones|mesh-ancestor
139311242|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139311243|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139311244|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
139311245|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311246|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139311247|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139311248|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311249|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139311250|NCT02290470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139311251|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139311252|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139311253|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311254|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
139311255|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139311256|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139311257|NCT05172518|Capecitabine|capecitabine|mesh-list
139311259|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139311260|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
139311261|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311262|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311263|NCT03724084|Cytarabine|cytarabine|mesh-list
139311264|NCT03724084|Daunorubicin|daunorubicin|mesh-list
139311265|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139311266|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
139311267|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311268|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311269|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
139311270|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311271|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139311272|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
139311273|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311274|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139311275|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139311276|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139311277|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311278|NCT05172440|Tislelizumab|tislelizumab|mesh-list
139311279|NCT05172440|Axitinib|axitinib|mesh-list
139311280|NCT05172440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139311281|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311282|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139311283|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311284|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311285|NCT02298582|Fentanyl|fentanyl|mesh-list
139311286|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138968166|NCT02555696|Paclitaxel|paclitaxel|mesh-list
139311287|NCT02298582|Narcotics|narcotics|mesh-ancestor
139311288|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311289|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311290|NCT02298582|Analgesics|analgesics|mesh-ancestor
139311291|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
139176348|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139311293|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139311294|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139311295|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
139311296|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
139311297|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
139311298|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139311299|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139311300|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139311301|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139311302|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311303|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
139311304|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311305|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311306|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139311307|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311308|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139311309|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139311310|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311311|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311312|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139311313|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139311314|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311315|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
139311316|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311318|NCT02291094|Remifentanil|remifentanil|mesh-list
139311319|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
139311320|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
139311321|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311322|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311323|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
139311324|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311325|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139311326|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139311327|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139311328|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139311329|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311330|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139311331|NCT02291094|Narcotics|narcotics|mesh-ancestor
139311332|NCT02291094|Analgesics|analgesics|mesh-ancestor
139311333|NCT03387098|Leucovorin|leucovorin|mesh-list
139311334|NCT03387098|Paclitaxel|paclitaxel|mesh-list
139311335|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
139311336|NCT03387098|Bevacizumab|bevacizumab|mesh-list
139311337|NCT03387098|Capecitabine|capecitabine|mesh-list
139311338|NCT03387098|Fluorouracil|fluorouracil|mesh-list
139311339|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
139311340|NCT03387098|Avelumab|avelumab|mesh-list
139311341|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139311342|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311343|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
139311344|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
139311345|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
139311346|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311347|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139311348|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
139311349|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311350|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139311351|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139311352|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
139311353|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139311354|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139311355|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139311356|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139311357|NCT03387098|Growth Substances|growth substances|mesh-ancestor
139311358|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
139311359|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139311360|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
139311361|NCT03387098|Antidotes|antidotes|mesh-ancestor
139311362|NCT03387098|Protective Agents|protective agents|mesh-ancestor
139311363|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
139311364|NCT03387098|Vitamins|vitamins|mesh-ancestor
139311365|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
139311366|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139311367|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
139311369|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311370|NCT02577016|Incretins|incretins|mesh-ancestor
139311371|NCT02577016|Hormones|hormones|mesh-ancestor
139311372|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139311373|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139311374|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
139311375|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311376|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311377|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139311378|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
139311379|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139311380|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311381|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
139311382|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311383|NCT04465110|Protective Agents|protective agents|mesh-ancestor
139311384|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311385|NCT03391700|Rocuronium|rocuronium|mesh-list
139311386|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139311387|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139311388|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139311389|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311390|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311391|NCT02294838|Citric Acid|citric acid|mesh-list
139311392|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
139311393|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
139311394|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139311395|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
139311396|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
139311397|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311398|NCT03383822|Insulin|insulin|mesh-list
139311399|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139311400|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139311401|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311402|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139311403|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311404|NCT03383744|Vitamin A|vitamin a|mesh-list
139311405|NCT03383744|Vitamins|vitamins|mesh-ancestor
139311406|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
139311407|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311408|NCT05662358|Denosumab|denosumab|mesh-list
139311409|NCT05662358|Alendronate|alendronate|mesh-list
139311410|NCT05662358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139311411|NCT05662358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311412|NCT02294994|Tirofiban|tirofiban|mesh-list
139311413|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139311414|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139311415|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311416|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139311417|NCT03386630|Sufentanil|sufentanil|mesh-list
139311418|NCT03386630|Morphine|morphine|mesh-list
139311419|NCT03386630|Dsuvia|dsuvia|mesh-list
139311420|NCT03386630|Bupivacaine|bupivacaine|mesh-list
139311421|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
139311422|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
139311423|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311424|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311425|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
139311426|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311427|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139311428|NCT03386630|Narcotics|narcotics|mesh-ancestor
139311429|NCT03386630|Analgesics|analgesics|mesh-ancestor
139311430|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139311431|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139311432|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
139311433|NCT03132714|Amoxicillin|amoxicillin|mesh-list
139311434|NCT03132714|Metronidazole|metronidazole|mesh-list
139311435|NCT03132714|Clarithromycin|clarithromycin|mesh-list
139311436|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139311437|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311438|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139311439|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139311440|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139311441|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311442|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311443|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139311444|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139311445|NCT03386318|Oxycodone|oxycodone|mesh-list
139311446|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139311447|NCT03386318|Narcotics|narcotics|mesh-ancestor
139311448|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311449|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311450|NCT03386318|Analgesics|analgesics|mesh-ancestor
139311451|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
139311452|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311453|NCT03339284|Dexamethasone|dexamethasone|mesh-list
139311454|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
139311455|NCT03339284|Ropivacaine|ropivacaine|mesh-list
139311456|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139311457|NCT03339284|BB 1101|bb 1101|mesh-list
139311458|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139311459|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
139311460|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
139311461|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311462|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311463|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139311464|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
139311465|NCT03339284|Hormones|hormones|mesh-ancestor
139311466|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139311467|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139311468|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311469|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
139311470|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
139311471|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311472|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
139311473|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
139311474|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311475|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311476|NCT02291562|Dronabinol|dronabinol|mesh-list
139311477|NCT02291562|Cannabidiol|cannabidiol|mesh-list
139311478|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
139311479|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
139311480|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311481|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139311482|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139311483|NCT02291562|Analgesics|analgesics|mesh-ancestor
139311484|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
139311485|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311486|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139311487|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139311488|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311489|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311490|NCT02291562|Hormones|hormones|mesh-ancestor
139311491|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139311492|NCT03316586|Nivolumab|nivolumab|mesh-list
139311493|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139311494|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311495|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139311496|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311497|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139311498|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139311499|NCT02295150|Nadroparin|nadroparin|mesh-list
139311500|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
139311501|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139311502|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139311503|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311504|NCT03390608|Trastuzumab|trastuzumab|mesh-list
139311505|NCT03390608|Estrogens|estrogens|mesh-list
139311506|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139311507|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311508|NCT03390608|Hormones|hormones|mesh-ancestor
139311509|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139311510|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311511|NCT03513822|Midazolam|midazolam|mesh-list
139311512|NCT03513822|Ketamine|ketamine|mesh-list
139311513|NCT03513822|Analgesics|analgesics|mesh-ancestor
139311514|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
139311515|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311516|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311517|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139311518|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139311521|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311522|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139311523|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139311524|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311525|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311526|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139311527|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139311528|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139311529|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139311530|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139311531|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
139311532|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
139311533|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139311534|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311535|NCT03513432|Ethanol|ethanol|mesh-list
139311536|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139311537|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311538|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311539|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311540|NCT02299440|Ketamine|ketamine|mesh-list
139311541|NCT02299440|Analgesics|analgesics|mesh-ancestor
139311542|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
139311543|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311544|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311545|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139311546|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139311547|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
139311548|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
139311549|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311550|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139311551|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139311552|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311553|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311554|NCT02145195|Vitamin D|vitamin d|mesh-list
139311555|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
139311556|NCT02145195|Vitamins|vitamins|mesh-ancestor
139311557|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
139311558|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311559|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139311560|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139311561|NCT03517020|Nebivolol|nebivolol|mesh-list
139311562|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139311563|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
139311564|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139311565|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139311566|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139311567|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
139311568|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311569|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311570|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311571|NCT02254629|Laxatives|laxatives|mesh-list
139311572|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139311573|NCT02145585|Anesthetics|anesthetics|mesh-list
139075124|NCT05869097|Growth Inhibitors|growth inhibitors|mesh-ancestor
139311574|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311575|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311576|NCT02291796|Bezafibrate|bezafibrate|mesh-list
139311577|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139311578|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
139311579|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311580|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139311581|NCT03544827|Atropine|atropine|mesh-list
139311582|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139311583|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139311584|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139311585|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
139311586|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311587|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311588|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139311589|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
139311591|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
139311592|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139311593|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139311594|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
139311595|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311596|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311597|NCT00107991|Etanercept|etanercept|mesh-list
139311598|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139311599|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139311600|NCT00107991|Analgesics|analgesics|mesh-ancestor
139311601|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
139311602|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311603|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311604|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139311605|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139311606|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139311607|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139311608|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
139311609|NCT03513276|Epinephrine|epinephrine|mesh-list
139311610|NCT03513276|Racepinephrine|racepinephrine|mesh-list
139311611|NCT03513276|Ropivacaine|ropivacaine|mesh-list
139311612|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
139311613|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
139311614|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
139311615|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311616|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311617|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
139311618|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311619|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139311620|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139311621|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
139311622|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311623|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311624|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139311625|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139311626|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
139311627|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139311628|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
139311629|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
139311630|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
139311631|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139311632|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
139311633|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139311634|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311635|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139311636|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311637|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
139311638|NCT03516630|Trazodone|trazodone|mesh-list
139311639|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139311640|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311641|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139311642|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139311643|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311644|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311645|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311646|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311647|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139311648|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139311649|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311650|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139311651|NCT03516630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139311652|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139311653|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139311654|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311655|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
139311656|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139311657|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
139311658|NCT02142075|Daptomycin|daptomycin|mesh-list
139311659|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139311660|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311661|NCT02145975|Fentanyl|fentanyl|mesh-list
139311662|NCT02145975|Morphine|morphine|mesh-list
139311663|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
139311664|NCT02145975|Narcotics|narcotics|mesh-ancestor
139311665|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311666|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311667|NCT02145975|Analgesics|analgesics|mesh-ancestor
139311668|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
139311669|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311670|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139311671|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139311672|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
139311673|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
139311674|NCT02295852|Calcium|calcium|mesh-list
139311675|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139311676|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311677|NCT02295930|Bevacizumab|bevacizumab|mesh-list
139311678|NCT02295930|Cetuximab|cetuximab|mesh-list
139311679|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139311680|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311681|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139311682|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139311683|NCT02295930|Growth Substances|growth substances|mesh-ancestor
139311684|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311685|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
139311686|NCT02142309|Pioglitazone|pioglitazone|mesh-list
139311687|NCT02142309|Glimepiride|glimepiride|mesh-list
139311688|NCT02142309|Vildagliptin|vildagliptin|mesh-list
139311689|NCT02142309|Canagliflozin|canagliflozin|mesh-list
139311690|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139311691|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311692|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139311693|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139311694|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
139311695|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139311696|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
139311697|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311698|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311699|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139311700|NCT02146209|Metronidazole|metronidazole|mesh-list
139311701|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311702|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139311703|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139311704|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139311705|NCT02299908|Bupivacaine|bupivacaine|mesh-list
139311706|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
139311707|NCT02299908|Anesthetics|anesthetics|mesh-list
139311708|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139311709|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311710|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311711|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
139311712|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311713|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
139311714|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
139311715|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
139311716|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139311717|NCT02142543|Protective Agents|protective agents|mesh-ancestor
139311718|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311719|NCT03390374|Nystatin|nystatin|mesh-list
139311720|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139311721|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311722|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
139311723|NCT03390374|Ionophores|ionophores|mesh-ancestor
139311724|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139311725|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311726|NCT03545373|Amoxicillin|amoxicillin|mesh-list
139311727|NCT03545373|Azithromycin|azithromycin|mesh-list
139311728|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139311729|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311730|NCT00492856|Methotrexate|methotrexate|mesh-list
139311731|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
139311732|NCT00492856|Tretinoin|tretinoin|mesh-list
139311733|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139311734|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
139311735|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139311736|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311737|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139311738|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
139311739|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311740|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311741|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
139311742|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311743|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139311744|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139311745|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
139311746|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139311747|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139311748|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
139311749|NCT02142777|Equol|equol|mesh-list
139311750|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
139311751|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139311752|NCT02142777|Estrogens|estrogens|mesh-ancestor
139311753|NCT02142777|Hormones|hormones|mesh-ancestor
139311754|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139311755|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311756|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
139311757|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139311758|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139311759|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311760|NCT03544671|Vitamin D|vitamin d|mesh-list
139311761|NCT03544671|Vitamins|vitamins|mesh-ancestor
139311762|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
139311763|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311764|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139311765|NCT03390062|Apatinib|apatinib|mesh-list
139311766|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311767|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139311768|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311769|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311770|NCT03382886|Bevacizumab|bevacizumab|mesh-list
139311771|NCT03382886|Nivolumab|nivolumab|mesh-list
139311772|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139311773|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311774|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139311775|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139311776|NCT03382886|Growth Substances|growth substances|mesh-ancestor
139311777|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311778|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
139311779|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139311780|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311781|NCT03125486|Belimumab|belimumab|mesh-list
139311782|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139311783|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
139311784|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311785|NCT02147925|Metformin|metformin|mesh-list
139311786|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
139311787|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139311788|NCT02147925|Liraglutide|liraglutide|mesh-list
139311789|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139311790|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311791|NCT02147925|Incretins|incretins|mesh-ancestor
139311792|NCT02147925|Hormones|hormones|mesh-ancestor
139311793|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139311794|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139311795|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
139311796|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311797|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311798|NCT03544047|Paclitaxel|paclitaxel|mesh-list
139311799|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139311800|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311801|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
139311802|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
139311803|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
139311804|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311805|NCT03544125|Durvalumab|durvalumab|mesh-list
139311806|NCT03544125|Olaparib|olaparib|mesh-list
139311807|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139311808|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
139311809|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139311810|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
139311812|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311813|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
139311814|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968688|NCT00984633|Bromides|bromides|mesh-list
139311815|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311816|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311817|NCT02146911|Bupropion|bupropion|mesh-list
139311818|NCT02146911|Varenicline|varenicline|mesh-list
139311819|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139311820|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
139311821|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139311822|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139311823|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139311824|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139311825|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311826|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
139311827|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311828|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311829|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139311830|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139311831|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311832|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139311833|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139311834|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
139311835|NCT02776683|Bevacizumab|bevacizumab|mesh-list
139311836|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139311837|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311838|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139311839|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139311840|NCT02776683|Growth Substances|growth substances|mesh-ancestor
139311841|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311842|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
139311843|NCT02963714|Vaccines|vaccines|mesh-list
139311844|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
139311845|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311846|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139311847|NCT02148393|Estradiol|estradiol|mesh-list
139311848|NCT02148393|Progesterone|progesterone|mesh-list
139311849|NCT02148393|Estrogens|estrogens|mesh-ancestor
139311850|NCT02148393|Hormones|hormones|mesh-ancestor
139311851|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139311852|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311853|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139311854|NCT02148393|Progestins|progestins|mesh-ancestor
139311855|NCT00104871|Bortezomib|bortezomib|mesh-list
139311856|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311857|NCT03385538|Clopidogrel|clopidogrel|mesh-list
139311858|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139311859|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139311860|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139311861|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139311862|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
139311863|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311864|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311865|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311866|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139311867|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139311868|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139311869|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139311870|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311871|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139311872|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139311873|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139311874|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139311875|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
139311876|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311877|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311878|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139311879|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139311880|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
139311881|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139311882|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139311883|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
139311884|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
139311885|NCT02148549|Irinotecan|irinotecan|mesh-list
139311886|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311887|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139311888|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139311889|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311890|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311892|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139311893|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311894|NCT02147535|Methylphenidate|methylphenidate|mesh-list
139311895|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139311896|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311897|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139311898|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139311899|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139311900|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311901|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
139311902|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311903|NCT03446612|Nitroprusside|nitroprusside|mesh-list
139311904|NCT03446612|Acetylcholine|acetylcholine|mesh-list
139311905|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
139311906|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
139311907|NCT03446612|Hematinics|hematinics|mesh-ancestor
139311908|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139311909|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
139311910|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139311911|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311912|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139311913|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
139311914|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311915|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311916|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311917|NCT02148783|Methylphenidate|methylphenidate|mesh-list
139311918|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139311919|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311920|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139311921|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139311922|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139311923|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311924|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
139311925|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311926|NCT02155803|Hormones|hormones|mesh-list
139311927|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139311928|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139311929|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
139311930|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139311931|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311932|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139311933|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311934|NCT02148861|Insulin|insulin|mesh-list
139311935|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139311936|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139311937|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311938|NCT02152059|Nintedanib|nintedanib|mesh-list
139311939|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311940|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139311941|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311942|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311943|NCT02149095|Treprostinil|treprostinil|mesh-list
139311944|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139311945|NCT02149329|Meropenem|meropenem|mesh-list
139311946|NCT02149329|Imipenem|imipenem|mesh-list
139311947|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
139311948|NCT02149329|Cilastatin|cilastatin|mesh-list
139311949|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139311950|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139311951|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
139311952|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139311953|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311954|NCT03255512|Isosorbide|isosorbide|mesh-list
139311955|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139311956|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139311957|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139311958|NCT03255512|Diuretics|diuretics|mesh-ancestor
139311959|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
139311960|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311961|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
139311962|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139311963|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139311965|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139311966|NCT02149407|Protective Agents|protective agents|mesh-ancestor
139311967|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311968|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
139311969|NCT03543657|Hematinics|hematinics|mesh-ancestor
139311970|NCT04925193|Dexamethasone|dexamethasone|mesh-list
139311971|NCT04925193|Daratumumab|daratumumab|mesh-list
139311972|NCT04925193|Pomalidomide|pomalidomide|mesh-list
139311973|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139311974|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
139311975|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
139311976|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311977|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311978|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139311979|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
139311980|NCT04925193|Hormones|hormones|mesh-ancestor
139311981|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139311982|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139311983|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139311984|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
139311985|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139311986|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139311987|NCT04925193|Growth Substances|growth substances|mesh-ancestor
139311988|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
139311989|NCT03542955|Etoricoxib|etoricoxib|mesh-list
139311990|NCT03542955|Analgesics|analgesics|mesh-list
139311991|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
139311992|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139311993|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139311994|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139311995|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139311996|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139311997|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139311998|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139311999|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139312000|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312001|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312002|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
139312003|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312004|NCT04988074|Cemiplimab|cemiplimab|mesh-list
139312005|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139312006|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312007|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
139312008|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312009|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
139312010|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139312011|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139312012|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312013|NCT00104637|Urological Agents|urological agents|mesh-ancestor
139312014|NCT04810208|Docetaxel|docetaxel|mesh-list
139312015|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312016|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
139312017|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
139312018|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
139312019|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312020|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
139312021|NCT04445636|Morphine|morphine|mesh-list
139312022|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139312023|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139312024|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312025|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139312026|NCT04445636|Analgesics|analgesics|mesh-ancestor
139312027|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
139312028|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312029|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139312030|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139312031|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139312032|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
139312033|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312034|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312035|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139312036|NCT04445636|Narcotics|narcotics|mesh-ancestor
139312037|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
139312038|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139312039|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139312040|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312041|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
139312042|NCT02152917|Coagulants|coagulants|mesh-ancestor
139312043|NCT03111212|Iloprost|iloprost|mesh-list
139312044|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139312045|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
139312046|NCT03170206|Palbociclib|palbociclib|mesh-list
139312047|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312048|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139312049|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312050|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312051|NCT02149953|Glycine|glycine|mesh-list
139312052|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
139312053|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312054|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312055|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312056|NCT03380936|Tacrolimus|tacrolimus|mesh-list
139312057|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
139312058|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139312059|NCT03380936|Antibodies|antibodies|mesh-list
139312060|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
139312061|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139312062|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139312063|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
139312064|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312065|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139312066|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312067|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312068|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
139312069|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139312070|NCT02150031|Lidocaine|lidocaine|mesh-list
139312071|NCT02150031|Epinephrine|epinephrine|mesh-list
139312072|NCT02150031|Racepinephrine|racepinephrine|mesh-list
139312073|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
139312074|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
139312075|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
139312076|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139312077|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312078|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
139312079|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312080|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139312081|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139312082|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139312083|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139312084|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312085|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139312086|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312087|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
139312088|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
139312089|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139312090|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139312091|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
139312092|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312093|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139312094|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139312095|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
139312096|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139312097|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
139312098|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
139312099|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
139312100|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139312101|NCT04655170|Albuterol|albuterol|mesh-list
139312102|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
139312103|NCT04655170|Ipratropium|ipratropium|mesh-list
139312104|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139312105|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139312106|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
139312107|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312108|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312109|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138968991|NCT00861120|Doxorubicin|doxorubicin|mesh-list
139312110|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
139312111|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139312112|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139312113|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139312114|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
139075265|NCT05447702|Paclitaxel|paclitaxel|mesh-list
139312115|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312116|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312117|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
139312118|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139312119|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
139312120|NCT02156661|Oxytocin|oxytocin|mesh-list
139312121|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
139312122|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139312123|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312124|NCT03065062|Palbociclib|palbociclib|mesh-list
139312125|NCT03065062|Gedatolisib|gedatolisib|mesh-list
139312126|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312127|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139312128|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312129|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312130|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139312131|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139312132|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312133|NCT03374540|Vitamin K|vitamin k|mesh-list
139312134|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
139312135|NCT03374540|Vitamins|vitamins|mesh-ancestor
139312136|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
139312137|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312138|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139312139|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
139312140|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139312141|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
139312142|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312143|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312144|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
139312145|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139312146|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139312147|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
139312148|NCT03374540|Coagulants|coagulants|mesh-ancestor
139312149|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139312150|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139312151|NCT03378674|Remifentanil|remifentanil|mesh-list
139312152|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139312153|NCT03378674|Narcotics|narcotics|mesh-ancestor
139312154|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139312155|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312156|NCT03378674|Analgesics|analgesics|mesh-ancestor
139312157|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
139312158|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312159|NCT02157207|Vitamins|vitamins|mesh-list
139312160|NCT02157207|Vitamin E|vitamin e|mesh-list
139312161|NCT02157207|Antioxidants|antioxidants|mesh-list
139312162|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
139312163|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312164|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312165|NCT02157207|Protective Agents|protective agents|mesh-ancestor
139312166|NCT02261103|Pramipexole|pramipexole|mesh-list
139312167|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
139312168|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312169|NCT02261103|Protective Agents|protective agents|mesh-ancestor
139312170|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312171|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139312172|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139312173|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
139312174|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
139312175|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312176|NCT02766777|Lubiprostone|lubiprostone|mesh-list
139312177|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139312178|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139312179|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312181|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
139312182|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139312183|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139312184|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139312185|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
139312186|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312187|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312188|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139312189|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
139312190|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
139312191|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
139312192|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139312193|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139312194|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
139312195|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312196|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312197|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139312198|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139312199|NCT05534230|Dexmedetomidine|dexmedetomidine|mesh-list
139312200|NCT05534230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139312201|NCT05534230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139312202|NCT05534230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139312203|NCT05534230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312204|NCT05534230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139312205|NCT05534230|Analgesics|analgesics|mesh-ancestor
139312206|NCT05534230|Sensory System Agents|sensory system agents|mesh-ancestor
139312207|NCT05534230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312208|NCT05534230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139312209|NCT05534230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139312210|NCT05534230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139312211|NCT05534230|Adrenergic Agents|adrenergic agents|mesh-ancestor
139312212|NCT05534230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312213|NCT05534230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312214|NCT03369782|Rocuronium|rocuronium|mesh-list
139312215|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139312216|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139312217|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139312218|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312219|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312220|NCT00157014|Cyclosporine|cyclosporine|mesh-list
139312221|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
139312222|NCT00157014|Prednisone|prednisone|mesh-list
139312223|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
139312224|NCT00157014|Tacrolimus|tacrolimus|mesh-list
139312225|NCT00157014|Cyclosporins|cyclosporins|mesh-list
139312226|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139312227|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
139312228|NCT00157014|Hormones|hormones|mesh-ancestor
139312229|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139312230|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075297|NCT05323396|Metronidazole|metronidazole|mesh-list
139312231|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139312232|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312233|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139312234|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
139312235|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139312236|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312237|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312238|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
139312239|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312240|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
139312241|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139312242|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139312243|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139312244|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
139312245|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139312246|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
139312247|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
139312248|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312249|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139312250|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139312251|NCT00157014|Protective Agents|protective agents|mesh-ancestor
139312252|NCT03374228|Linrodostat|linrodostat|mesh-list
139312253|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312254|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312255|NCT02778867|Fluticasone|fluticasone|mesh-list
139312256|NCT02778867|Xhance|xhance|mesh-list
139312257|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139312258|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139312259|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
139312260|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312261|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312262|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139312263|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
139312264|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
139312265|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139312266|NCT04232072|Ibuprofen|ibuprofen|mesh-list
139312267|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139312269|NCT04232072|Analgesics|analgesics|mesh-ancestor
139312270|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
139312271|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312272|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312273|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139312274|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139312275|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139312276|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312277|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312278|NCT02300064|Antioxidants|antioxidants|mesh-list
139312279|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312280|NCT02300064|Protective Agents|protective agents|mesh-ancestor
139312281|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312282|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139312283|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139312284|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312285|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
139312286|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
139312287|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139312288|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139312289|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139312290|NCT02519582|Niclosamide|niclosamide|mesh-list
139312291|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
139312292|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139312293|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
139312294|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139312295|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312296|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
139312297|NCT05467462|Tranexamic Acid|tranexamic acid|mesh-list
139312298|NCT05467462|Oxytocin|oxytocin|mesh-list
139312299|NCT05467462|Carbetocin|carbetocin|mesh-list
139312300|NCT05467462|Oxytocics|oxytocics|mesh-ancestor
139312301|NCT05467462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139312302|NCT05467462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312303|NCT05467462|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139312304|NCT05467462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139312305|NCT05467462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312306|NCT05467462|Hemostatics|hemostatics|mesh-ancestor
139312307|NCT05467462|Coagulants|coagulants|mesh-ancestor
139312308|NCT03369002|Seladelpar|seladelpar|mesh-list
139312309|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139312310|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
139312311|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312312|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139312313|NCT02300376|Edetic Acid|edetic acid|mesh-list
139312314|NCT02300376|Calcium|calcium|mesh-list
139312315|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
139312316|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139312317|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312318|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
139312319|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139312320|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
139312321|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
139312322|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312323|NCT02300376|Antidotes|antidotes|mesh-ancestor
139312324|NCT02300376|Protective Agents|protective agents|mesh-ancestor
139312325|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139312326|NCT02296398|Romidepsin|romidepsin|mesh-list
139312327|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139312328|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312329|NCT02296398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139312330|NCT02296398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312331|NCT02296398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312332|NCT03520062|Liraglutide|liraglutide|mesh-list
139312333|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139312334|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312335|NCT03520062|Incretins|incretins|mesh-ancestor
139312336|NCT03520062|Hormones|hormones|mesh-ancestor
139312337|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139312338|NCT02206984|Tamoxifen|tamoxifen|mesh-list
139312339|NCT02206984|Fulvestrant|fulvestrant|mesh-list
139312340|NCT02206984|Anastrozole|anastrozole|mesh-list
139312341|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139312342|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
139312343|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139312344|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312345|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139312346|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312347|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139312348|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139312349|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139312350|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139312351|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139312352|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139312353|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312354|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312355|NCT03512574|Pregabalin|pregabalin|mesh-list
139312356|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
139312357|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139312358|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139312359|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312360|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139312361|NCT03512574|Analgesics|analgesics|mesh-ancestor
139312362|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
139312363|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312364|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139312365|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139312366|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139312367|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
139312368|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312369|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312370|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
139312371|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139312372|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139312373|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139312374|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139312375|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139312376|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139312377|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139312378|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139312379|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312380|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
139312381|NCT03377348|Triamcinolone|triamcinolone|mesh-list
139312382|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139312383|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139312384|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139312385|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139312386|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
139312387|NCT03377348|Hormones|hormones|mesh-ancestor
139312388|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139312389|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312390|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139312391|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
139312392|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312393|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312394|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139312395|NCT02255253|Telmisartan|telmisartan|mesh-list
139312396|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139312397|NCT02255253|Diuretics|diuretics|mesh-ancestor
139312398|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
139312399|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312400|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139312401|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139312402|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312403|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139312404|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139312405|NCT02300688|Maleic acid|maleic acid|mesh-list
139312406|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312407|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312408|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139312409|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312410|NCT02151279|Chitosan|chitosan|mesh-list
139312411|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139312412|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139312413|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
138969291|NCT00802802|Efavirenz|efavirenz|mesh-list
139312414|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312415|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139312416|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
139312417|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
139312418|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
139312419|NCT02151279|Coagulants|coagulants|mesh-ancestor
139312420|NCT02159313|Riociguat|riociguat|mesh-list
139312421|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
139312422|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312423|NCT03515772|Darunavir|darunavir|mesh-list
139312424|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139312425|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139312426|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
139312427|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312428|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312429|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139312430|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139312431|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
139075388|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
139312432|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312433|NCT03519750|Melatonin|melatonin|mesh-list
139312434|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
139312435|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312436|NCT03519750|Protective Agents|protective agents|mesh-ancestor
139312437|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312438|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139312439|NCT02158143|Vitamin D|vitamin d|mesh-list
139312440|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
139312441|NCT02158143|Vitamins|vitamins|mesh-ancestor
139312442|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
139312443|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312444|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139312445|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139312446|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
139312447|NCT02158221|Growth Substances|growth substances|mesh-ancestor
139312448|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312449|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
139312450|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312451|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312452|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
139312453|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139312454|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139312455|NCT02301000|Metronidazole|metronidazole|mesh-list
139312456|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312457|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139312458|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139312459|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139312460|NCT02292732|Trametinib|trametinib|mesh-list
139312461|NCT02292732|Norinyl|norinyl|mesh-list
139312462|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312463|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139312464|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312465|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312466|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139312467|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139312468|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139312469|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
139312470|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139312471|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312472|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139312473|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139312474|NCT03376958|Apatinib|apatinib|mesh-list
139312475|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312476|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139312477|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312478|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312479|NCT03367676|Docetaxel|docetaxel|mesh-list
139312480|NCT03367676|Trastuzumab|trastuzumab|mesh-list
139312481|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312482|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
139312483|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
139312484|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
139312485|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312486|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139312487|NCT03515538|Cisplatin|cisplatin|mesh-list
139312488|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312490|NCT02158689|Menotropins|menotropins|mesh-list
139312491|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312492|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139312493|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139312494|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312495|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312496|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139312497|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
139312498|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139312499|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312500|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139312501|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
139312502|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139312503|NCT03372200|Febuxostat|febuxostat|mesh-list
139312504|NCT03372200|Dotinurad|dotinurad|mesh-list
139312505|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
139312506|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139312507|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
139312508|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
139312509|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139312510|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139312511|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312512|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
139312513|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
139312514|NCT02158845|Leuprolide|leuprolide|mesh-list
139312515|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
139312516|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139312517|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
139312518|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139312519|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312520|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139312521|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312522|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139312523|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
139312524|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139312525|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139312526|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139312527|NCT02292966|Asunaprevir|asunaprevir|mesh-list
139312528|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
139312529|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312530|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312531|NCT02519660|Lidocaine|lidocaine|mesh-list
139312532|NCT02519660|Tetracaine|tetracaine|mesh-list
139312533|NCT02519660|Prilocaine|prilocaine|mesh-list
139312534|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139312535|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
139312536|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
139312537|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139312538|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312539|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
139312540|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312541|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139312542|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139312543|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138718754|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
139312544|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139312545|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312546|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139312547|NCT02297490|Immunomodulating Agents|immunomodulating agents|mesh-list
139312548|NCT02297490|Immunologic Factors|immunologic factors|mesh-ancestor
139312549|NCT02297490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312550|NCT02297568|Vitamin D|vitamin d|mesh-list
139312551|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
139312552|NCT02297568|Vitamins|vitamins|mesh-ancestor
139312553|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
139312554|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312555|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139312556|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139312557|NCT03515382|Itraconazole|itraconazole|mesh-list
139312558|NCT03515382|Voriconazole|voriconazole|mesh-list
139312559|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
139312560|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312561|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139312562|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139312563|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969434|NCT00544557|Etanercept|etanercept|mesh-list
139312564|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312565|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139312566|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
139312567|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139312568|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312569|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139312570|NCT03511560|Tacrolimus|tacrolimus|mesh-list
139312571|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139312572|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
139312573|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312574|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139312575|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312576|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312577|NCT03688802|Varenicline|varenicline|mesh-list
139312578|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139312579|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139312580|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
139312581|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312582|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312583|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312584|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
139312585|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139312586|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312587|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
139312588|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139312589|NCT03376178|Lidocaine|lidocaine|mesh-list
139312590|NCT03376178|Ropivacaine|ropivacaine|mesh-list
139312591|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
139312592|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
139312593|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139312594|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312595|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
139312596|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312597|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139312598|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139312599|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139312600|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139312601|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312602|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
139312603|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139312604|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
139312605|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312606|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139312607|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139312608|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
139312609|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312610|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312611|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139312612|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139312613|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139312614|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312615|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312616|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139312617|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139312618|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312619|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
139312620|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312621|NCT02302326|Folic Acid|folic acid|mesh-list
139312622|NCT02302326|Inositol|inositol|mesh-list
139312623|NCT02302326|Metformin|metformin|mesh-list
139312624|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139312625|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312626|NCT02302326|Hematinics|hematinics|mesh-ancestor
139312627|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
139312628|NCT02302326|Vitamins|vitamins|mesh-ancestor
139312629|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
139312630|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
139312631|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
139312632|NCT02293590|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139312633|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139312634|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139312635|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
139312636|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312637|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139312638|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312639|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139312640|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139312641|NCT02293590|Analgesics|analgesics|mesh-ancestor
139312642|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
139312643|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312644|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139312645|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139312646|NCT03124082|Lidocaine|lidocaine|mesh-list
139312647|NCT03124082|Clonidine|clonidine|mesh-list
139312648|NCT03124082|Ketamine|ketamine|mesh-list
139312649|NCT03124082|Remifentanil|remifentanil|mesh-list
139312650|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
139312651|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
139312652|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139312653|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312654|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
139312655|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312656|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139312657|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139312658|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139312659|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139075471|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
139312660|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312661|NCT03124082|Analgesics|analgesics|mesh-ancestor
139312662|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139312663|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139312664|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
139312665|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139312666|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139312667|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312668|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139312669|NCT03124082|Narcotics|narcotics|mesh-ancestor
139312670|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139312671|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
139312672|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
139312673|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139312674|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139312675|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139312676|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
139312677|NCT03518502|Sorafenib|sorafenib|mesh-list
139312678|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312679|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139312680|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312681|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312682|NCT02301780|Aspirin|aspirin|mesh-list
139312683|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139312684|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139312685|NCT02301780|Analgesics|analgesics|mesh-ancestor
139312686|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
139312687|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312688|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312689|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139312690|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139312691|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139312692|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139312693|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312694|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139312695|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139312696|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312697|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
139312698|NCT04527068|Bevacizumab|bevacizumab|mesh-list
139312699|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139312700|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312701|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139312702|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139312703|NCT04527068|Growth Substances|growth substances|mesh-ancestor
139312704|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312705|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
139312706|NCT02739360|Idelalisib|idelalisib|mesh-list
139312707|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312708|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312709|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312710|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
139312711|NCT03123770|Docetaxel|docetaxel|mesh-list
139312712|NCT03123770|Doxorubicin|doxorubicin|mesh-list
139312713|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139312714|NCT03123770|Epirubicin|epirubicin|mesh-list
139312715|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139312716|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
139312717|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312718|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139312719|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139312720|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
139312721|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312722|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312723|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139312724|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
139312725|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
139312726|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
139312727|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139312728|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139312729|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139312730|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312731|NCT04464642|Methotrexate|methotrexate|mesh-list
139312732|NCT04464642|Tofacitinib|tofacitinib|mesh-list
139312733|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139312734|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
139312735|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139312736|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312737|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139312738|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
139312739|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312740|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312741|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
139312742|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312743|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139312744|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139312745|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
139312746|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139312747|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139312748|NCT04464642|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139312749|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139312750|NCT02293668|Letrozole|letrozole|mesh-list
139312751|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312752|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139312753|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139312754|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312755|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312756|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139312757|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
139312758|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139312759|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312760|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
139312761|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
139312762|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
139312763|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312765|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
139312766|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
139312767|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139312768|NCT02302170|Vaccines|vaccines|mesh-list
139312769|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
139312770|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312771|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
139312772|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139312773|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312774|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
139312775|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139312776|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139312777|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
139312778|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312779|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139312780|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139312781|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312782|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312783|NCT02293824|Caffeine|caffeine|mesh-list
139312784|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
139312785|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969661|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
139312786|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139312787|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312788|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139312789|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312790|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139312791|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139312792|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
139312793|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312795|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
139312796|NCT03366584|Beta Carotene|beta carotene|mesh-list
139312797|NCT03366584|Zinc|zinc|mesh-list
139312798|NCT03366584|Dexamethasone|dexamethasone|mesh-list
139312799|NCT03366584|Carotenoids|carotenoids|mesh-list
139312800|NCT03366584|Picolinic acid|picolinic acid|mesh-list
139312801|NCT03366584|Vitamins|vitamins|mesh-ancestor
139312802|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
139312803|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312804|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139312805|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
139312806|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
139312807|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312808|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139312809|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
139312810|NCT03366584|Hormones|hormones|mesh-ancestor
139312811|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139312812|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139312813|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312814|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139312815|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139312816|NCT03366584|Trace Elements|trace elements|mesh-ancestor
139312817|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
139312818|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312819|NCT03366584|Protective Agents|protective agents|mesh-ancestor
139312820|NCT03366584|Provitamins|provitamins|mesh-ancestor
139312821|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139312822|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
139312823|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
139312824|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
139312825|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139312826|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139312827|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312828|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139312829|NCT03370562|Analgesics|analgesics|mesh-ancestor
139312830|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
139312831|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312832|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139312833|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139312834|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139312835|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
139312836|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312837|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312838|NCT03370328|Peppermint oil|peppermint oil|mesh-list
139312839|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
139312840|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
139312841|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312842|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312843|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139312844|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
139312845|NCT02303106|Lamotrigine|lamotrigine|mesh-list
139312846|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
139312847|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139312848|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139312849|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312850|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139312851|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312852|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139312853|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139312854|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139312855|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139312856|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139312857|NCT04525664|Amoxicillin|amoxicillin|mesh-list
139312858|NCT04525664|Clarithromycin|clarithromycin|mesh-list
139312859|NCT04525664|Omeprazole|omeprazole|mesh-list
139312860|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139312861|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312862|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139312863|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139312864|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139312865|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312866|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312867|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139312868|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139312869|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139312870|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139312871|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139312872|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312873|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312874|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
139312875|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312876|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312878|NCT03505008|Methotrexate|methotrexate|mesh-list
139312879|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139312880|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
139312881|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139312882|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312883|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139312884|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
139312885|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312886|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312887|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
139312888|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312889|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139312890|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139312891|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
139312892|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139312893|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139312894|NCT03505008|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139312895|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139312896|NCT03507426|Ketamine|ketamine|mesh-list
139312897|NCT03507426|Analgesics|analgesics|mesh-ancestor
139312898|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
139075525|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312899|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312900|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312901|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139312902|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139312903|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
139312904|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
139312905|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139312906|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139312907|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139312908|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312909|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312910|NCT02311530|Felodipine|felodipine|mesh-list
139312911|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139312912|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139312913|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139312914|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139312915|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312916|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139312917|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312918|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
139312919|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
139312920|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
139312921|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139312922|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139312923|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312924|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312925|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312926|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139312927|NCT02306772|Mesalamine|mesalamine|mesh-list
139312928|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139312929|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139312930|NCT02306772|Analgesics|analgesics|mesh-ancestor
139312931|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
139312932|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312933|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312934|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139312935|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139312936|NCT03507348|Rituximab|rituximab|mesh-list
139312937|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139312938|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312939|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
139312940|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312941|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139312942|NCT02518802|Pemetrexed|pemetrexed|mesh-list
139312943|NCT02518802|Gefitinib|gefitinib|mesh-list
139312944|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312945|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312946|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312947|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139312948|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139312949|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139312950|NCT04524026|Letrozole|letrozole|mesh-list
139312951|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139312952|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312953|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139312954|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139312955|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312956|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139312957|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
139312958|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139312959|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312960|NCT02311608|Octreotide|octreotide|mesh-list
139312961|NCT02311608|Terlipressin|terlipressin|mesh-list
139312962|NCT02311608|Somatostatin|somatostatin|mesh-list
139312963|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139312964|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139312965|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312966|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139312967|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139312968|NCT02311608|Hormones|hormones|mesh-ancestor
139312969|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139312970|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312971|NCT02307006|Vancomycin|vancomycin|mesh-list
139312972|NCT02307006|Cefazolin|cefazolin|mesh-list
139312973|NCT02307006|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139312974|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139312975|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312976|NCT03362684|Cetuximab|cetuximab|mesh-list
139312977|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139312978|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312979|NCT02311686|Ethanol|ethanol|mesh-list
139312980|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139312981|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139312982|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139312983|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312984|NCT02311764|Carboplatin|carboplatin|mesh-list
139312985|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139312986|NCT03365726|Dobutamine|dobutamine|mesh-list
139312987|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139312988|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
139312989|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
139312990|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139312991|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139312992|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139312993|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139312994|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139312995|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
139312996|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139312997|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139312998|NCT03365726|Protective Agents|protective agents|mesh-ancestor
139312999|NCT02303418|Oxytocin|oxytocin|mesh-list
139313000|NCT02303418|Carbetocin|carbetocin|mesh-list
139313001|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
139313002|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139313003|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313004|NCT03510000|Empagliflozin|empagliflozin|mesh-list
139313005|NCT03510000|Pancrelipase|pancrelipase|mesh-list
139313006|NCT03510000|Hormones|hormones|mesh-list
139313007|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313008|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313009|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139313010|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313011|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139313012|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139313013|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
139313014|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139313015|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139313016|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139313017|NCT03358082|Tacrolimus|tacrolimus|mesh-list
139313018|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139313019|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
139313020|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313021|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139313022|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313023|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313024|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139313025|NCT03358004|Capecitabine|capecitabine|mesh-list
139313026|NCT03358004|Vinorelbine|vinorelbine|mesh-list
139313027|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139313028|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
139313029|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313030|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313031|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139313032|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
139313033|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
139313034|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
139313035|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
139313036|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139313037|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139313038|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313039|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139313040|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139313041|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
139313042|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139313043|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313044|NCT03365336|Oseltamivir|oseltamivir|mesh-list
139313045|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
139313046|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313047|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313048|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313049|NCT03362216|Diclofenac|diclofenac|mesh-list
139313050|NCT03362216|Salicylates|salicylates|mesh-list
139313051|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
139313052|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139313053|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139313054|NCT03362216|Analgesics|analgesics|mesh-ancestor
139313055|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
139313056|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313057|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313058|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139313059|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139313060|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139313061|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313062|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313063|NCT02307396|Haloperidol|haloperidol|mesh-list
139313064|NCT02307396|Pimozide|pimozide|mesh-list
139313065|NCT02307396|Olanzapine|olanzapine|mesh-list
139313066|NCT02307396|Risperidone|risperidone|mesh-list
139313067|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139313068|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139313069|NCT02307396|Ziprasidone|ziprasidone|mesh-list
139313070|NCT02307396|Amisulpride|amisulpride|mesh-list
139313071|NCT02307396|Perphenazine|perphenazine|mesh-list
139313072|NCT02307396|Sertindole|sertindole|mesh-list
139313073|NCT02307396|Sulpiride|sulpiride|mesh-list
139313074|NCT02307396|Fluphenazine|fluphenazine|mesh-list
139313075|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
139313076|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
139313077|NCT02307396|Thioridazine|thioridazine|mesh-list
139313078|NCT02307396|Clopenthixol|clopenthixol|mesh-list
139313079|NCT02307396|Fluspirilene|fluspirilene|mesh-list
139313080|NCT02307396|Perazine|perazine|mesh-list
139313081|NCT02307396|Bromperidol|bromperidol|mesh-list
139313082|NCT02307396|Benperidol|benperidol|mesh-list
139313083|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139313084|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
139313085|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139313086|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313087|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313089|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139313090|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313091|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139313092|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139313093|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
139313094|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
139313095|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
139313096|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313097|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139313098|NCT02307396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139313099|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139313100|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139313101|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
139313102|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139075549|NCT03560934|Dronabinol|dronabinol|mesh-list
139313103|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139313104|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139313105|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139313106|NCT03509688|Entecavir|entecavir|mesh-list
139313107|NCT03509688|Resveratrol|resveratrol|mesh-list
139313108|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
139313109|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313110|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
139313111|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313112|NCT03509688|Protective Agents|protective agents|mesh-ancestor
139313113|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313114|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313115|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139313116|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
139313117|NCT02303730|Exenatide|exenatide|mesh-list
139313118|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139313119|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313120|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139313121|NCT02303730|Incretins|incretins|mesh-ancestor
139313122|NCT02303730|Hormones|hormones|mesh-ancestor
139313123|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313124|NCT04524728|Letrozole|letrozole|mesh-list
139313125|NCT04524728|Fulvestrant|fulvestrant|mesh-list
139313126|NCT04524728|Palbociclib|palbociclib|mesh-list
139313127|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313128|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139313129|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139313130|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176386|NCT01347762|Nabilone|nabilone|mesh-list
139313131|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313132|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139313133|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
139313134|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313135|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313136|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139313137|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139313138|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139313139|NCT04523792|Buprenorphine|buprenorphine|mesh-list
139313140|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139313141|NCT04523792|Narcotics|narcotics|mesh-ancestor
139313142|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313143|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313144|NCT04523792|Analgesics|analgesics|mesh-ancestor
139313145|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
139313146|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313147|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139313148|NCT02312232|Levodopa|levodopa|mesh-list
139313149|NCT02312232|Carbidopa|carbidopa|mesh-list
139313150|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139313151|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139313152|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
139313153|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139313154|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313155|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313156|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139313157|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313158|NCT02303886|Methylene Blue|methylene blue|mesh-list
139313159|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313160|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313161|NCT02518958|Nivolumab|nivolumab|mesh-list
139313162|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139313163|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313164|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139313165|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313167|NCT03506802|Plerixafor|plerixafor|mesh-list
139313168|NCT03506802|Lenalidomide|lenalidomide|mesh-list
139313169|NCT03506802|Melphalan|melphalan|mesh-list
139313170|NCT03506802|Interleukin-2|interleukin-2|mesh-list
139313171|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
139313172|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139313173|NCT03506802|Lenograstim|lenograstim|mesh-list
139313174|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139313175|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
139313176|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313177|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139313178|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139313179|NCT03506802|Growth Substances|growth substances|mesh-ancestor
139313180|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
139313181|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313182|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139313183|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
139313184|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313185|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139313186|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139313187|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139313188|NCT03506802|Analgesics|analgesics|mesh-ancestor
139313189|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
139313190|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313191|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139313192|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139313193|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
139313194|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313195|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
139313196|NCT02307864|Tramadol|tramadol|mesh-list
139313197|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139313198|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139313199|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313200|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139313201|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139313202|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313203|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313204|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313205|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139313206|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
139313207|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139313208|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313209|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139313210|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139313211|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139313212|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139313213|NCT02307864|Narcotics|narcotics|mesh-ancestor
139570339|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570340|NCT03032601|Protective Agents|protective agents|mesh-ancestor
139570341|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570342|NCT03032601|Antidotes|antidotes|mesh-ancestor
139570343|NCT05603013|Vinorelbine|vinorelbine|mesh-list
139570344|NCT05603013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139570345|NCT05603013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139570346|NCT05603013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570347|NCT05603013|Tubulin Modulators|tubulin modulators|mesh-ancestor
139570348|NCT05603013|Antimitotic Agents|antimitotic agents|mesh-ancestor
139570349|NCT05603013|Mitosis Modulators|mitosis modulators|mesh-ancestor
139570350|NCT05603013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570351|NCT05603013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139570352|NCT00983073|Tapentadol|tapentadol|mesh-list
139570353|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139570354|NCT00983073|Narcotics|narcotics|mesh-ancestor
139570355|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139570356|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570357|NCT00983073|Analgesics|analgesics|mesh-ancestor
139570358|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
139570359|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570360|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139570361|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139570362|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139570363|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570364|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
139570365|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570366|NCT05603715|Bromides|bromides|mesh-list
139570367|NCT05603715|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139570368|NCT05603715|Anticonvulsants|anticonvulsants|mesh-ancestor
139570369|NCT05603715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139570370|NCT05603715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570371|NCT05603715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570372|NCT05603715|Cholinergic Agents|cholinergic agents|mesh-ancestor
139570373|NCT05603715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570374|NCT05603715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570375|NCT00981747|Losartan|losartan|mesh-list
139570376|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
139570377|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139570378|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139570379|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139570380|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139570381|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570382|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
139570383|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139570384|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139570385|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570386|NCT00981747|Urological Agents|urological agents|mesh-ancestor
139570387|NCT03046251|Natalizumab|natalizumab|mesh-list
139570388|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
139570389|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570390|NCT03029169|Amiodarone|amiodarone|mesh-list
139570391|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139570392|NCT03029169|Propafenone|propafenone|mesh-list
139570393|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
139570394|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139570395|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139570396|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570397|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139570398|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139570399|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139570400|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570401|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139570402|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139570403|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139570404|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139570405|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
139570406|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139570407|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
139570408|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570409|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139570410|NCT01353976|Econazole|econazole|mesh-list
139570411|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
139570412|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570413|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139570414|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139570415|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570416|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570417|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139570418|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
139570419|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139570420|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570421|NCT01354444|Carvedilol|carvedilol|mesh-list
139570422|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139570423|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139570424|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
139570425|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570426|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570427|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570428|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139570429|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
139570430|NCT01354444|Protective Agents|protective agents|mesh-ancestor
139570431|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139570432|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139570433|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139570434|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
139570435|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139570436|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139570437|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
139570438|NCT03009526|Piperaquine|piperaquine|mesh-list
139570439|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
139570440|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139570441|NCT03009526|Artenimol|artenimol|mesh-list
139570442|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
139570443|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139570444|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139570445|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570446|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139570447|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570448|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570449|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139570450|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139570451|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139570452|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570453|NCT01354990|Incretins|incretins|mesh-ancestor
139570454|NCT01354990|Hormones|hormones|mesh-ancestor
139570455|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139570456|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139570457|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
139570458|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570459|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570460|NCT01260454|Capsaicin|capsaicin|mesh-list
139570461|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
139570462|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
139570463|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
139570464|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570465|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570467|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139570468|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139570469|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570470|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
139570471|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570472|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139570473|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139570474|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
139570475|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139570476|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
139570477|NCT01297348|Norinyl|norinyl|mesh-list
139570478|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
139570479|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
139570480|NCT01297348|Estradiol|estradiol|mesh-list
139570481|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139570482|NCT01297348|Estrogens|estrogens|mesh-ancestor
139570483|NCT01297348|Hormones|hormones|mesh-ancestor
139570484|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139570485|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570486|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139570487|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139570488|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139570489|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139570490|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139570491|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139570492|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
139570493|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139570494|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
139570495|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570496|NCT01260688|Dasatinib|dasatinib|mesh-list
139570497|NCT01260688|Cediranib|cediranib|mesh-list
139570498|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570499|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139570500|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570501|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570502|NCT01298128|NuvaRing|nuvaring|mesh-list
139570503|NCT01298128|Desogestrel|desogestrel|mesh-list
139570504|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139570505|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
139570506|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139570507|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570508|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139570509|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139570510|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139570511|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139570512|NCT01298128|Progestins|progestins|mesh-ancestor
139570513|NCT01298128|Hormones|hormones|mesh-ancestor
139570514|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139570515|NCT02199964|Cyclosporine|cyclosporine|mesh-list
139570516|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
139570517|NCT02199964|Cyclosporins|cyclosporins|mesh-list
139570518|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570519|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570520|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139570521|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
139570522|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570523|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
139570524|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570525|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
139570526|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139570527|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139570528|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139570529|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139570530|NCT02323048|Methamphetamine|methamphetamine|mesh-list
139570531|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139570532|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570533|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
139570534|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
139570535|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570536|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
139570537|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570538|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570539|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
139570540|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139570541|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139570542|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139570543|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139570544|NCT01265446|Lidocaine|lidocaine|mesh-list
139570545|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
139570546|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
139570547|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139570548|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570549|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
139570550|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570551|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139570552|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139570553|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139570554|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139570555|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570556|NCT04352062|Amoxicillin|amoxicillin|mesh-list
139570557|NCT04352062|Levofloxacin|levofloxacin|mesh-list
139570558|NCT04352062|Ofloxacin|ofloxacin|mesh-list
139570559|NCT04352062|Melatonin|melatonin|mesh-list
139570560|NCT04352062|Pantoprazole|pantoprazole|mesh-list
139570561|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139570562|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570563|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
139570564|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570565|NCT04352062|Protective Agents|protective agents|mesh-ancestor
139570566|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570567|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139570568|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139570569|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139570570|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139570571|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570572|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570573|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139570574|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139570575|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139570576|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139570577|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139570578|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139570579|NCT01302808|Romidepsin|romidepsin|mesh-list
139570580|NCT01302808|Antiemetics|antiemetics|mesh-list
139570581|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570582|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139570583|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570584|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570585|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139570586|NCT01302808|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139570587|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
139570588|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570589|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570590|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139570591|NCT01267240|Capecitabine|capecitabine|mesh-list
139570592|NCT01267240|Vorinostat|vorinostat|mesh-list
139570593|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139570594|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
139570595|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570596|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570597|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139570598|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570599|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139570600|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139570601|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139570602|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139570603|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570604|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570605|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570606|NCT01855919|Analgesics|analgesics|mesh-ancestor
139570607|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
139570608|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570609|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
139570610|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139570611|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
139570612|NCT01871285|Morphine|morphine|mesh-list
139570613|NCT01871285|Oxycodone|oxycodone|mesh-list
139570614|NCT01871285|Buprenorphine|buprenorphine|mesh-list
139570615|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139570616|NCT01871285|Narcotics|narcotics|mesh-ancestor
139570617|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139570618|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570619|NCT01871285|Analgesics|analgesics|mesh-ancestor
139570620|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
139570621|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570622|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139570623|NCT01358266|Sirolimus|sirolimus|mesh-list
139570624|NCT01358266|Temsirolimus|temsirolimus|mesh-list
139570625|NCT01358266|MTOR Inhibitors|mtor inhibitors|mesh-list
139570626|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139570627|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570628|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139570629|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570630|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
139570631|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139570632|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
139570633|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570634|NCT01358266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139570635|NCT01358266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570636|NCT01358266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570637|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139570638|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139570639|NCT01870973|Analgesics|analgesics|mesh-list
139570640|NCT01870973|Anesthetics|anesthetics|mesh-list
139570641|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139570642|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570643|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570644|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
139570645|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
139570646|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570647|NCT01267864|Ketorolac|ketorolac|mesh-list
139570648|NCT01267864|Valproic Acid|valproic acid|mesh-list
139570649|NCT01267864|Metoclopramide|metoclopramide|mesh-list
139570650|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139570651|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139570652|NCT01267864|Analgesics|analgesics|mesh-ancestor
139570653|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
139570654|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570655|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570656|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139570657|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139570658|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139570659|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570660|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570661|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
139570662|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
139570663|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570664|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
139570665|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139570666|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139570667|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139570668|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
139570669|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
139570670|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139570671|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139570672|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139570673|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
139570674|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
139570675|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139570676|NCT01854827|Antibodies|antibodies|mesh-list
139570677|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
139570678|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139570679|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
139570680|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570681|NCT01360450|Clonidine|clonidine|mesh-list
139570682|NCT01360450|Analgesics|analgesics|mesh-ancestor
139570683|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
139570684|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570685|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570686|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139570687|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
139352443|NCT04112043|Niacin|niacin|mesh-list
139570688|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
139570689|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139570690|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139570691|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139570692|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
139570693|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570694|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570695|NCT01303744|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
139570696|NCT01303744|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139570697|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570698|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570699|NCT01361620|Aspirin|aspirin|mesh-list
139570700|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139570701|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139570702|NCT01361620|Analgesics|analgesics|mesh-ancestor
139570703|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
139570704|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570705|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570706|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139570707|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139570708|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139570709|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139570710|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570711|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139570712|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139570713|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570714|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
139570715|NCT01305772|Panitumumab|panitumumab|mesh-list
139570716|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139570717|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570718|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
139570719|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139570720|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139570721|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139570722|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139570723|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570724|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
139570725|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570726|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570727|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139570728|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570729|NCT01271686|Bimatoprost|bimatoprost|mesh-list
139570730|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139570731|NCT01854047|Albuterol|albuterol|mesh-list
139570732|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139570733|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
139570734|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570735|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570736|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139570737|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
139570738|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
139570739|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139570740|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139570741|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139570742|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139570743|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
139570744|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570745|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570746|NCT01870739|Amlodipine|amlodipine|mesh-list
139570747|NCT01870739|Valsartan|valsartan|mesh-list
139570748|NCT01870739|Olmesartan|olmesartan|mesh-list
139570749|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139570750|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139570751|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139570752|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139570753|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139570754|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570755|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139570756|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570757|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
139570758|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139570759|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139352449|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139570760|NCT01272388|Tadalafil|tadalafil|mesh-list
139570761|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
139570762|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139570763|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139570764|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570765|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570766|NCT01272388|Urological Agents|urological agents|mesh-ancestor
139570767|NCT01870583|Iodine|iodine|mesh-list
139570768|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
139570769|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139570770|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
139570771|NCT01870583|Povidone|povidone|mesh-list
139570772|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139570773|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570774|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
139570775|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
139570776|NCT01870583|Trace Elements|trace elements|mesh-ancestor
139570777|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
139570778|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570779|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
139570780|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
139570781|NCT04351594|Menthol|menthol|mesh-list
139570782|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
139570783|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
139570784|NCT01308814|Estradiol|estradiol|mesh-list
139570785|NCT01308814|Estrogens|estrogens|mesh-ancestor
139570786|NCT01308814|Hormones|hormones|mesh-ancestor
139570787|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139570788|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570789|NCT03009604|Simethicone|simethicone|mesh-list
139570790|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
139570791|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570792|NCT03009604|Emollients|emollients|mesh-ancestor
139570793|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
139570794|NCT01275664|Dexamethasone|dexamethasone|mesh-list
139570795|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
139570796|NCT01275664|Cisplatin|cisplatin|mesh-list
139570797|NCT01275664|Carboplatin|carboplatin|mesh-list
139570798|NCT01275664|Aprepitant|aprepitant|mesh-list
139570799|NCT01275664|Granisetron|granisetron|mesh-list
139570800|NCT01275664|Ichthammol|ichthammol|mesh-list
139570801|NCT01275664|BB 1101|bb 1101|mesh-list
139570802|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139570803|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
139570804|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
139570805|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570806|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570807|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139570808|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
139570809|NCT01275664|Hormones|hormones|mesh-ancestor
139570810|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139570811|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139570812|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570813|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
139570814|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570815|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570816|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139570817|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570818|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
139570819|NCT01275664|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139570820|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139570821|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
139570822|NCT01613027|Rituximab|rituximab|mesh-list
139570823|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139570824|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570825|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
139570826|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570827|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139570828|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
139570829|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139570830|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139570831|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139570832|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139570833|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570834|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
139570835|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570836|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570837|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139570838|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570839|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
139570840|NCT01369732|Hematinics|hematinics|mesh-ancestor
139570841|NCT01869725|Octreotide|octreotide|mesh-list
139570842|NCT01869725|Edotreotide|edotreotide|mesh-list
139570843|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
139570844|NCT01869725|Somatostatin|somatostatin|mesh-list
139570845|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139570846|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139570847|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570848|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570849|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570850|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139570851|NCT01869725|Hormones|hormones|mesh-ancestor
139570852|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139570853|NCT01309360|Midazolam|midazolam|mesh-list
139570854|NCT01309360|Prilocaine|prilocaine|mesh-list
139570855|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139570856|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139570857|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139570858|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570859|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139570860|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139570861|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139570862|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139570863|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
139570864|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
139570865|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
139570866|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
139570867|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570868|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570869|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
139570870|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
139570871|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570872|NCT01851863|Flupenthixol|flupenthixol|mesh-list
139570873|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
139570874|NCT01851863|Omeprazole|omeprazole|mesh-list
139570875|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139570876|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139570877|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139570878|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570879|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570880|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139570881|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139570882|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139570883|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570884|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139570885|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139570886|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
139570887|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139570888|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
139570889|NCT01369888|Fludarabine|fludarabine|mesh-list
139570890|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139570891|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
139570892|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570893|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139570894|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139570895|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
139570896|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570897|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570898|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139570899|NCT01850615|Insulin|insulin|mesh-list
139570900|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139570901|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
139570902|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139570903|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570904|NCT04602221|Lamotrigine|lamotrigine|mesh-list
139570905|NCT04602221|BI 425809|bi 425809|mesh-list
139570906|NCT04602221|BI 409306|bi 409306|mesh-list
139570907|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
139570908|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139570909|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139570910|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570911|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139570912|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570913|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139570914|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139570915|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139570916|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139570917|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139570918|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139570919|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570920|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
139570921|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139570922|NCT01280110|Laxatives|laxatives|mesh-ancestor
139570923|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139570924|NCT01374802|Ritonavir|ritonavir|mesh-list
139570925|NCT01374802|Darunavir|darunavir|mesh-list
139570926|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139570927|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139570928|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
139570929|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570930|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570931|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139570932|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139570933|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
139570934|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570935|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139570936|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139570937|NCT01375660|Vitamin D|vitamin d|mesh-list
139570938|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
139570939|NCT01375660|Vitamins|vitamins|mesh-ancestor
139570940|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
139570941|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570942|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139570943|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139570944|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
139570945|NCT01868477|Deferasirox|deferasirox|mesh-list
139570946|NCT01868477|Hematinics|hematinics|mesh-ancestor
139570947|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139570948|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
139570949|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
139570950|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570951|NCT01849289|Insulin|insulin|mesh-list
139570952|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139570953|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
139570954|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139570955|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570956|NCT01868243|Warfarin|warfarin|mesh-list
139570957|NCT01868243|Dabigatran|dabigatran|mesh-list
139570958|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
139570959|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
139570960|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139570961|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
139570962|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570963|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570964|NCT01611935|Vasopressins|vasopressins|mesh-list
139570965|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
139570966|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
139570967|NCT01611935|Coagulants|coagulants|mesh-ancestor
139570968|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139570969|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139570970|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
139570971|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570972|NCT02201212|Everolimus|everolimus|mesh-list
139570973|NCT02201212|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139570974|NCT02201212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139570975|NCT02201212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570976|NCT02201212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570977|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139570978|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
139570979|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570980|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570981|NCT01376362|Interferons|interferons|mesh-list
139570982|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
139570983|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570984|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
139570985|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139570986|NCT03009292|Lenvatinib|lenvatinib|mesh-list
139570987|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139570988|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139570989|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139570990|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139570991|NCT01962792|Dexamethasone|dexamethasone|mesh-list
139570992|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139570993|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
139570994|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
139570995|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139570996|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139570997|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139570998|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
139570999|NCT01962792|Hormones|hormones|mesh-ancestor
139571000|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139571001|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139571002|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571003|NCT01849055|Celecoxib|celecoxib|mesh-list
139571004|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139571005|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139571006|NCT01849055|Analgesics|analgesics|mesh-ancestor
139571007|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
139571008|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571009|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571010|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139571011|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139571012|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139571013|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139571014|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571015|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571016|NCT01404832|Lansoprazole|lansoprazole|mesh-list
139571017|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
139571018|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139571019|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139571020|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139571021|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571022|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571023|NCT03420534|Iloperidone|iloperidone|mesh-list
139571024|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139571025|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139571026|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571027|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571028|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139571029|NCT01313494|Albuterol|albuterol|mesh-list
139571030|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139571031|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
139571032|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571033|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571034|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139571035|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
139571036|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
139571037|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139571038|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139571039|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139571040|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139571041|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
139571042|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571043|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571044|NCT01407094|Sertraline|sertraline|mesh-list
139571045|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
139571046|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139571047|NCT01407094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139571048|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139571049|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139571050|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571051|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571052|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
139571053|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571054|NCT01867307|Empagliflozin|empagliflozin|mesh-list
139571055|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139571056|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571057|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139571058|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571059|NCT01845077|Metformin|metformin|mesh-list
139571060|NCT01845077|Linagliptin|linagliptin|mesh-list
139571061|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139571062|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571063|NCT01845077|Incretins|incretins|mesh-ancestor
139571064|NCT01845077|Hormones|hormones|mesh-ancestor
139571065|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139571066|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139571067|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
139571068|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571069|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571070|NCT01866917|Ropivacaine|ropivacaine|mesh-list
139571071|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
139571072|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
139571073|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571074|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571075|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
139571076|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571077|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139571078|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139571079|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139571080|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139571081|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571082|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571083|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571084|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
139571085|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139571087|NCT01410058|Nevirapine|nevirapine|mesh-list
139571088|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139571089|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139571090|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571091|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571092|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
139571093|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139571094|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139571095|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139571096|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139571097|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139571098|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139571099|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139571100|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139571101|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139571102|NCT01380106|Lenalidomide|lenalidomide|mesh-list
139571103|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
139571104|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571105|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139571106|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139571107|NCT01380106|Growth Substances|growth substances|mesh-ancestor
139571108|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
139571109|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571110|NCT01381120|Acetaminophen|acetaminophen|mesh-list
139571111|NCT01381120|Oxycodone|oxycodone|mesh-list
139571112|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
139571113|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139571114|NCT01381120|Analgesics|analgesics|mesh-ancestor
139571115|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
139571116|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571117|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571118|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
139571119|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139571120|NCT01381120|Narcotics|narcotics|mesh-ancestor
139571121|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571122|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139571123|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139571124|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
139571125|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571126|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571127|NCT01381120|Urological Agents|urological agents|mesh-ancestor
139571128|NCT01316770|Dexamethasone|dexamethasone|mesh-list
139571129|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139571130|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
139571131|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
139571132|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571133|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571134|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139571135|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
139571136|NCT01316770|Hormones|hormones|mesh-ancestor
139571137|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139571138|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139571139|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571140|NCT01318408|Levetiracetam|levetiracetam|mesh-list
139571141|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
139571142|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
139571143|NCT01319110|Ubiquinone|ubiquinone|mesh-list
139571144|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
139571145|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
139571146|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571147|NCT01319110|Vitamins|vitamins|mesh-ancestor
139571148|NCT03008512|Paclitaxel|paclitaxel|mesh-list
139571149|NCT03008512|genexol-PM|genexol-pm|mesh-list
139571150|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139571151|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571152|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
139571153|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
139571154|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
139571155|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571156|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
139571157|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
139571158|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139571159|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139571160|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139571161|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571162|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571163|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139571164|NCT01411696|Dexamethasone|dexamethasone|mesh-list
139571165|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139571166|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
139571167|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
139571168|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571169|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571170|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139571171|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
139571172|NCT01411696|Hormones|hormones|mesh-ancestor
139571173|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139571174|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139571175|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571176|NCT01412164|Sirolimus|sirolimus|mesh-list
139571177|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139571178|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139571179|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139571180|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571181|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
139571182|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139571183|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
139571184|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571185|NCT01844687|Cannabidiol|cannabidiol|mesh-list
139571186|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
139571187|NCT01844531|Metformin|metformin|mesh-list
139571188|NCT01844531|Empagliflozin|empagliflozin|mesh-list
139571189|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139571190|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571191|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139571192|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571193|NCT02367456|Azacitidine|azacitidine|mesh-list
139571194|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139571195|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
139571196|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571197|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571198|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571199|NCT03420378|Vitamin D|vitamin d|mesh-list
139571200|NCT03420378|Vitamins|vitamins|mesh-ancestor
139571201|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
139571202|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571203|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139571204|NCT03425448|Heparin|heparin|mesh-list
139571205|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
139571206|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139571207|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139571208|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571209|NCT03419910|Cyclosporine|cyclosporine|mesh-list
139571210|NCT03419910|Deucravacitinib|deucravacitinib|mesh-list
139571211|NCT03419910|Cyclosporins|cyclosporins|mesh-list
139571212|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571213|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352895|NCT05487794|Testosterone|testosterone|mesh-list
139571214|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139571215|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
139571216|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571217|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
139571218|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139571219|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
139571220|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139571221|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139571222|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139571223|NCT03415386|Anticoagulants|anticoagulants|mesh-list
139571224|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139571225|NCT01865747|Everolimus|everolimus|mesh-list
139571226|NCT01865747|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139571227|NCT01865747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139571228|NCT01865747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571229|NCT01865747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571230|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139571231|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
139571232|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571233|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571234|NCT03424980|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139571235|NCT03424980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139571236|NCT03424980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571237|NCT03424980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571238|NCT03424746|Edetic Acid|edetic acid|mesh-list
139571239|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
139571240|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
139571241|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139571242|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
139571243|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
139571244|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571245|NCT03424746|Antidotes|antidotes|mesh-ancestor
139571246|NCT03424746|Protective Agents|protective agents|mesh-ancestor
139571247|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571248|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139571249|NCT03414918|Clarithromycin|clarithromycin|mesh-list
139571250|NCT03414918|Roxithromycin|roxithromycin|mesh-list
139571251|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139571252|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139571253|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139571254|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571255|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571256|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139571257|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139571258|NCT04448496|Dexamethasone|dexamethasone|mesh-list
139571259|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139571260|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
139571261|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
139571262|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571263|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571264|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139571265|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
139571266|NCT04448496|Hormones|hormones|mesh-ancestor
139571267|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139571268|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139571269|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571270|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
139571271|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
139571272|NCT03419442|Docetaxel|docetaxel|mesh-list
139571273|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571274|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
139571275|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
139571276|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
139571277|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571278|NCT01412710|Vitamin D|vitamin d|mesh-list
139571279|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
139571280|NCT01412710|Vitamins|vitamins|mesh-ancestor
139571281|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
139571282|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571283|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139571284|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139571285|NCT01843205|Methamphetamine|methamphetamine|mesh-list
139571286|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139571287|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571288|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
139571289|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
139571290|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571291|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
139571292|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571293|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571294|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
139571295|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139571296|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139571297|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139571298|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139571299|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
139571300|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139571301|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571302|NCT03419130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139571303|NCT03419130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571304|NCT03414840|Atorvastatin|atorvastatin|mesh-list
139571305|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139571306|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139571307|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
139571308|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571309|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139571310|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139571311|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571312|NCT03418974|Atorvastatin|atorvastatin|mesh-list
139571313|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139571314|NCT03418974|Pitavastatin|pitavastatin|mesh-list
139571315|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139571316|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139571317|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
139571318|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571319|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139571320|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139571321|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571322|NCT03424356|Fentanyl|fentanyl|mesh-list
139571323|NCT03424356|Narcotics|narcotics|mesh-list
139571324|NCT03424356|Analgesics|analgesics|mesh-list
139571325|NCT03424356|Bromides|bromides|mesh-list
139571326|NCT03424356|Propofol|propofol|mesh-list
139571327|NCT03424356|Rocuronium|rocuronium|mesh-list
139571328|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139571329|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571330|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571331|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139571332|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
139571333|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
139571334|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139571335|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
139571336|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571337|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139571338|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
139571339|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139571340|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139571341|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139571342|NCT03414450|Dasatinib|dasatinib|mesh-list
139571343|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571344|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139571345|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571346|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571347|NCT01389076|Methotrexate|methotrexate|mesh-list
139571348|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
139571349|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139571350|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
139571351|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139571352|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571353|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139571354|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
139571355|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571356|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571357|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
139571358|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571359|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139571360|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139571361|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
139571362|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139571363|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139571364|NCT03127800|Morphine|morphine|mesh-list
139571365|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139571366|NCT03127800|Narcotics|narcotics|mesh-ancestor
139571367|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571369|NCT03127800|Analgesics|analgesics|mesh-ancestor
139571370|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
139571371|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571372|NCT01389856|Bosentan|bosentan|mesh-list
139571373|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139571374|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139571375|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571376|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139571377|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139571378|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571379|NCT01323010|Albuterol|albuterol|mesh-list
139571380|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139571381|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
139571382|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571383|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571384|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139571385|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
139571386|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
139571387|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139571388|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139571389|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139571390|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139571391|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
139571392|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571393|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571394|NCT03423810|Hydralazine|hydralazine|mesh-list
139571395|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139571396|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
139571397|NCT01390246|Bupropion|bupropion|mesh-list
139571398|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139571399|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
139571400|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139571401|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139571402|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139571403|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139571404|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571405|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
139571406|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571407|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571408|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139571409|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139571410|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571411|NCT01390870|Alfuzosin|alfuzosin|mesh-list
139571412|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571413|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571414|NCT01390870|Urological Agents|urological agents|mesh-ancestor
139571415|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139571416|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139571417|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139571418|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
139571419|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571420|NCT03418506|Lobeline|lobeline|mesh-list
139571421|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139571422|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
139571423|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571424|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571425|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139571426|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139571427|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
139571428|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571429|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571430|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
139571431|NCT01842581|Rifaximin|rifaximin|mesh-list
139571432|NCT01842581|Lactulose|lactulose|mesh-list
139571433|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139571434|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139571435|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139571436|NCT04448028|Esomeprazole|esomeprazole|mesh-list
139571437|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139571438|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139571439|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139571440|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571441|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571442|NCT01833533|Ribavirin|ribavirin|mesh-list
139075834|NCT05532358|Midazolam|midazolam|mesh-list
139571443|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
139571444|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571445|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
139571446|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139571447|NCT03413436|Cisplatin|cisplatin|mesh-list
139571448|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571449|NCT01833455|Flecainide|flecainide|mesh-list
139571450|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139571451|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139571452|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139571453|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139571454|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571455|NCT03413358|Carboplatin|carboplatin|mesh-list
139571456|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571457|NCT01833143|Acyclovir|acyclovir|mesh-list
139571458|NCT01833143|Bortezomib|bortezomib|mesh-list
139571459|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571460|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
139571461|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139571462|NCT03417648|Vitamin E|vitamin e|mesh-list
139571463|NCT03417648|Vitamins|vitamins|mesh-ancestor
139571464|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
139571465|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571466|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
139571467|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571468|NCT03417648|Protective Agents|protective agents|mesh-ancestor
139571469|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
139571470|NCT01831817|Listerine|listerine|mesh-list
139571471|NCT01831817|Calcium|calcium|mesh-list
139571472|NCT01831817|Fluorides|fluorides|mesh-list
139571473|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
139571474|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
139571475|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139571476|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571477|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139571478|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
139571479|NCT01831817|Protective Agents|protective agents|mesh-ancestor
139571480|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139571481|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139571482|NCT03412500|Vancomycin|vancomycin|mesh-list
139571483|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139571484|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139571485|NCT01840943|Topotecan|topotecan|mesh-list
139571486|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139571487|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139571488|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571489|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571490|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571491|NCT05171400|Insulin|insulin|mesh-list
139571492|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139571493|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571494|NCT02203630|Phenylephrine|phenylephrine|mesh-list
139571495|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
139571496|NCT02203630|Norepinephrine|norepinephrine|mesh-list
139571497|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139571498|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
139571499|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
139571500|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571501|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571502|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
139571503|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139571504|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
139571505|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
139571506|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139571507|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139571508|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139571509|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
139571510|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571511|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571512|NCT02203630|Protective Agents|protective agents|mesh-ancestor
139571513|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139571514|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139571515|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571516|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139571517|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139571518|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139571519|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571520|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
139571521|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571522|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139571523|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139571524|NCT02520570|Urinastatin|urinastatin|mesh-list
139571525|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
139571526|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139571527|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
139571528|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571529|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571530|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
139571531|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
139571532|NCT03411798|Methotrexate|methotrexate|mesh-list
139571533|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139571534|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
139571535|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139571536|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571537|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139571538|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
139571539|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571540|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571541|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
139571542|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571543|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139571544|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139571545|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
139571546|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139571547|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139571548|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
139571549|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139571550|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139571551|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139571552|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139571553|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139571554|NCT03411798|Analgesics|analgesics|mesh-ancestor
139571555|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
139571556|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571557|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139571558|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139571559|NCT03408756|Methotrexate|methotrexate|mesh-list
139571560|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139571561|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
139571562|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139571563|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571564|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139571565|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
139571566|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571567|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571568|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
139571569|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571570|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139571571|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139571572|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
139571573|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139571574|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139571576|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
139571577|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571578|NCT04588818|Adalimumab|adalimumab|mesh-list
139571579|NCT04588818|Methotrexate|methotrexate|mesh-list
139571580|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139571581|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
139571582|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139571583|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571584|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139571585|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
139571586|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571587|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571588|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
139571589|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571590|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139571591|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139571592|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
139571593|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139571594|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139571595|NCT04588818|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139571596|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139571597|NCT01422226|Alprostadil|alprostadil|mesh-list
139571598|NCT01422226|Misoprostol|misoprostol|mesh-list
139571599|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139571600|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
139571601|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139571602|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571603|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139571604|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139571605|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
139571606|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139571607|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
139571608|NCT01422226|Urological Agents|urological agents|mesh-ancestor
139571609|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
139571610|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
139571611|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571612|NCT01423162|Protective Agents|protective agents|mesh-ancestor
139571613|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571615|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
139571616|NCT01328782|Acetaminophen|acetaminophen|mesh-list
139571617|NCT01328782|Oxycodone|oxycodone|mesh-list
139571618|NCT01328782|Bupivacaine|bupivacaine|mesh-list
139571619|NCT01328782|Ropivacaine|ropivacaine|mesh-list
139571620|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
139571621|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
139571622|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571623|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571624|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
139571625|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571626|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139571627|NCT01328782|Analgesics|analgesics|mesh-ancestor
139571628|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
139571629|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139571630|NCT01328782|Narcotics|narcotics|mesh-ancestor
139571631|NCT04447326|Endostar protein|endostar protein|mesh-list
139571632|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139571633|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139571634|NCT04447326|Growth Substances|growth substances|mesh-ancestor
139571635|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571636|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
139571637|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571638|NCT03411330|Lidocaine|lidocaine|mesh-list
139571639|NCT03411330|Bupivacaine|bupivacaine|mesh-list
139571640|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
139571641|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
139571642|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571643|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571644|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
139571645|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571646|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139571647|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139571648|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139571649|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139571650|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571651|NCT03411252|Mirabegron|mirabegron|mesh-list
139571652|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139571653|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139571654|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139571655|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
139571656|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571657|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571658|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571659|NCT03411252|Urological Agents|urological agents|mesh-ancestor
139571660|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139571661|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
139571662|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571663|NCT01830881|Ibuprofen|ibuprofen|mesh-list
139571664|NCT01830881|Lidocaine|lidocaine|mesh-list
139571665|NCT01830881|Midazolam|midazolam|mesh-list
139571666|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
139571667|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
139571668|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571669|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571670|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
139571671|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571672|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139571673|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139571674|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139571675|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139571676|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571677|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139571678|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139571679|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139571680|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139571681|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139571682|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139571683|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
139571684|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
139571685|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
139571686|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571687|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139571688|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139571689|NCT01830881|Analgesics|analgesics|mesh-ancestor
139571690|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139571691|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139571692|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139571693|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571695|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
139571696|NCT01396486|Vitamins|vitamins|mesh-ancestor
139571697|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
139571698|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571699|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
139571700|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
139571701|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571702|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571703|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571704|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
139571705|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
139571706|NCT03404544|Carbetocin|carbetocin|mesh-list
139571707|NCT03404544|Oxytocin|oxytocin|mesh-list
139571708|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
139571709|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139571710|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571711|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
139571712|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139571713|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139571714|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571715|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
139571716|NCT01398280|Coagulants|coagulants|mesh-ancestor
139571717|NCT03403842|Sufentanil|sufentanil|mesh-list
139571718|NCT03403842|Morphine|morphine|mesh-list
139571719|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139571720|NCT03403842|Narcotics|narcotics|mesh-ancestor
139571721|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571722|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571723|NCT03403842|Analgesics|analgesics|mesh-ancestor
139571724|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
139571725|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571726|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139571727|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139571728|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
139571729|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
139571730|NCT01398982|Bupivacaine|bupivacaine|mesh-list
139571731|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
139571732|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
139571733|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571734|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571735|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
139571736|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571737|NCT04447560|Bupivacaine|bupivacaine|mesh-list
139571738|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
139571739|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
139571740|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571741|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571742|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
139571743|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571744|NCT03401736|Midazolam|midazolam|mesh-list
139353418|NCT04078880|Protective Agents|protective agents|mesh-ancestor
139571746|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139571747|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571748|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571749|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139571750|NCT03401736|Analgesics|analgesics|mesh-ancestor
139571751|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
139571752|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571753|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139571754|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139571755|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139571756|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
139571757|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571758|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571759|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139571760|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139571761|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139571762|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139571763|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139571764|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
139571765|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
139571766|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
139571767|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
139571768|NCT02203786|Haloperidol|haloperidol|mesh-list
139571769|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
139571770|NCT02203786|Fluphenazine|fluphenazine|mesh-list
139571771|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
139571772|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
139571773|NCT02203786|Amphetamine|amphetamine|mesh-list
139571774|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
139571775|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
139571776|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
139571777|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571778|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571779|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139571780|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139571781|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139571782|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571783|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139571784|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139571785|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
139571786|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571787|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571788|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139571789|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139571790|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
139571791|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
139571792|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139571793|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139571794|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139571795|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139571796|NCT03009058|Leucovorin|leucovorin|mesh-list
139571797|NCT03009058|Folic Acid|folic acid|mesh-list
139571798|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
139571799|NCT03009058|Gemcitabine|gemcitabine|mesh-list
139571800|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
139571801|NCT03009058|Capecitabine|capecitabine|mesh-list
139571802|NCT03009058|Fluorouracil|fluorouracil|mesh-list
139571803|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
139571804|NCT03009058|Nivolumab|nivolumab|mesh-list
139571805|NCT03009058|Irinotecan|irinotecan|mesh-list
139571806|NCT03009058|Cetuximab|cetuximab|mesh-list
139571807|NCT03009058|Ipilimumab|ipilimumab|mesh-list
139571808|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139571809|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
139571810|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139571811|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
139571812|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571813|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139571814|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139571815|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
139571816|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571817|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571818|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139353497|NCT03915613|Insulin|insulin|mesh-list
139571819|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139571820|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
139571821|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139571822|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139571823|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139571824|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139571825|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571826|NCT03009058|Antidotes|antidotes|mesh-ancestor
139571827|NCT03009058|Protective Agents|protective agents|mesh-ancestor
139571828|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
139571829|NCT03009058|Vitamins|vitamins|mesh-ancestor
139571830|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
139571831|NCT03009058|Hematinics|hematinics|mesh-ancestor
139571832|NCT01611857|Leucovorin|leucovorin|mesh-list
139571833|NCT01611857|Fluorouracil|fluorouracil|mesh-list
139571834|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
139571835|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
139571836|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
139571837|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571838|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139571839|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571840|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139571841|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
139571842|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571843|NCT01611857|Antidotes|antidotes|mesh-ancestor
139571844|NCT01611857|Protective Agents|protective agents|mesh-ancestor
139571845|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
139571846|NCT01611857|Vitamins|vitamins|mesh-ancestor
139571847|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
139571848|NCT03393858|Antibodies|antibodies|mesh-list
139571849|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
139571850|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571851|NCT03393702|Gabapentin|gabapentin|mesh-list
139571852|NCT03393702|Analgesics|analgesics|mesh-ancestor
139571853|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
139571854|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571855|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571856|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
139571857|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139571858|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139571859|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571860|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139571861|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139571862|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139571863|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571864|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571865|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
139571866|NCT01829477|Glimepiride|glimepiride|mesh-list
139571867|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139571868|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139571869|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571870|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139571871|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
139571872|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
139571873|NCT03126864|Fludarabine|fludarabine|mesh-list
139571874|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
139571875|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139571876|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
139571877|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571878|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139571879|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139571880|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
139571881|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571882|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571883|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139571884|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139571885|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
139571886|NCT03399708|Apremilast|apremilast|mesh-list
139571887|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139571888|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139571889|NCT03399708|Analgesics|analgesics|mesh-ancestor
139571890|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
139571891|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571892|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571893|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139571894|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139571895|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139571896|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139571897|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571898|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571900|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
139571901|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139571902|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571903|NCT01334086|Aprepitant|aprepitant|mesh-list
139571904|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
139571905|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
139571906|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571907|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571908|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139571909|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139571910|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571911|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571912|NCT03399474|Lidocaine|lidocaine|mesh-list
139571913|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
139571914|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
139571915|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
139571916|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571917|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571918|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
139571919|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571920|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139571921|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139571922|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139571923|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139571924|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571925|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139571926|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139571927|NCT03399474|Analgesics|analgesics|mesh-ancestor
139571928|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139571929|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139571930|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139571931|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
139571932|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571933|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139571934|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139571935|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139571936|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139571937|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571938|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571939|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571940|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139571941|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
139571942|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139571943|NCT01430182|Morphine|morphine|mesh-list
139571944|NCT01430182|Methadone|methadone|mesh-list
139571945|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139571946|NCT01430182|Narcotics|narcotics|mesh-ancestor
139571947|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139571948|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571949|NCT01430182|Analgesics|analgesics|mesh-ancestor
139571950|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
139571951|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571952|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
139571953|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
139571954|NCT05097768|Dexamethasone|dexamethasone|mesh-list
139571955|NCT05097768|Ibuprofen|ibuprofen|mesh-list
139571956|NCT05097768|Ketorolac|ketorolac|mesh-list
139571957|NCT05097768|Meloxicam|meloxicam|mesh-list
139571958|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139571959|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
139571960|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
139571961|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571962|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571963|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139571964|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
139571965|NCT05097768|Hormones|hormones|mesh-ancestor
139571966|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139571967|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139571968|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139571969|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139571970|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139571971|NCT05097768|Analgesics|analgesics|mesh-ancestor
139571972|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
139571974|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139571975|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139571976|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571977|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139571978|NCT01829243|Milnacipran|milnacipran|mesh-list
139571979|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
139571980|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139571981|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139571982|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139571983|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139571984|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139571985|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571986|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139571987|NCT01829243|Analgesics|analgesics|mesh-ancestor
139571988|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
139571989|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139571990|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
139571991|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139571992|NCT01838447|Vitamin D|vitamin d|mesh-list
139571993|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
139571994|NCT01838447|Vitamins|vitamins|mesh-ancestor
139571995|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
139571996|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139571997|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139571998|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139571999|NCT03395574|Terlipressin|terlipressin|mesh-list
139572000|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139572001|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139572002|NCT04982172|Infliximab|infliximab|mesh-list
139572003|NCT04982172|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139572004|NCT04982172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572005|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
139572006|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139572007|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572008|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139572009|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139572010|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139572011|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
139572012|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572013|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139572014|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139572015|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572016|NCT03395262|Caffeine|caffeine|mesh-list
139572017|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139572018|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572019|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139572020|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572021|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572022|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139572023|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139572024|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
139572025|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572026|NCT03852888|Methotrexate|methotrexate|mesh-list
139572027|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
139572028|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139572029|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
139572030|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139572031|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572032|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139572033|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
139572034|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572035|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572036|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
139572037|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572038|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139572039|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139572040|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
139572041|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572042|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139572043|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
139572044|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139572045|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
139572046|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139572047|NCT04755972|Expectorants|expectorants|mesh-ancestor
139572048|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
139572049|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139572050|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
139572051|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572052|NCT04755972|Protective Agents|protective agents|mesh-ancestor
139572053|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572054|NCT04755972|Antidotes|antidotes|mesh-ancestor
139572055|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
139572056|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139572057|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139572058|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
139572059|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139572060|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139572061|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139572062|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572063|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572064|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139572065|NCT04697693|Escitalopram|escitalopram|mesh-list
139572066|NCT04697693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139572067|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139572068|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139572069|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572070|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572071|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
139572072|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572073|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572074|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
139572075|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139572076|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139572077|NCT04697693|Analgesics|analgesics|mesh-ancestor
139572078|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
139572079|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
139572080|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
139572081|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139572082|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
139572083|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139572084|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572085|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139572086|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139572087|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139572088|NCT01827839|Vaccines|vaccines|mesh-list
139572089|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
139572090|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572091|NCT04709250|Bupivacaine|bupivacaine|mesh-list
139572092|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
139572093|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
139572094|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139572095|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572096|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
139572097|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572098|NCT01401166|Trastuzumab|trastuzumab|mesh-list
139572099|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139572100|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572101|NCT03395028|Lenograstim|lenograstim|mesh-list
139572102|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139572103|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
139572104|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572105|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139572106|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139572107|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139572108|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572109|NCT04567992|Bupivacaine|bupivacaine|mesh-list
139572110|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
139572111|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
139572112|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139572113|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572114|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
139572115|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572116|NCT01335724|Diclofenac|diclofenac|mesh-list
139572117|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139572118|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139353795|NCT01738607|Psyllium|psyllium|mesh-list
139572119|NCT01335724|Analgesics|analgesics|mesh-ancestor
139572120|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
139572121|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572122|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572123|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572124|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572125|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139572126|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572127|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572128|NCT01476202|Nicotine|nicotine|mesh-list
139572129|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139572130|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
139572131|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572132|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572133|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139572134|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139572135|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
139572136|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572137|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572138|NCT01477762|Dexamethasone|dexamethasone|mesh-list
139572139|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572140|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
139572141|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
139572142|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572143|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572144|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139572145|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
139572146|NCT01477762|Hormones|hormones|mesh-ancestor
139572147|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572148|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139572149|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572150|NCT01434472|Vidarabine|vidarabine|mesh-list
139572151|NCT01434472|Cyclosporine|cyclosporine|mesh-list
139572152|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
139572153|NCT01434472|Rituximab|rituximab|mesh-list
139572154|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139572155|NCT01434472|Fludarabine|fludarabine|mesh-list
139572156|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
139572157|NCT01434472|Antibodies|antibodies|mesh-list
139572158|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
139572159|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139572160|NCT01434472|Cyclosporins|cyclosporins|mesh-list
139572161|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
139572162|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572163|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572164|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572165|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139572166|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
139572167|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572168|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139572169|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
139572170|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139572171|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572172|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
139572173|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
139572174|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139572175|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139572176|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139572177|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
139572178|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139572179|NCT01435174|Ranolazine|ranolazine|mesh-list
139572180|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
139572181|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139572182|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139572183|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139572184|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572185|NCT01436266|Folic Acid|folic acid|mesh-list
139572186|NCT01436266|Misoprostol|misoprostol|mesh-list
139572187|NCT01436266|Vitamins|vitamins|mesh-ancestor
139572188|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
139572189|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572190|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139572191|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
139572192|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139572193|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139572194|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139572195|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
139572196|NCT01436266|Hematinics|hematinics|mesh-ancestor
139572197|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
139572198|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139572199|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572200|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
139572201|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139572202|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572203|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139572204|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572205|NCT04409262|Remdesivir|remdesivir|mesh-list
139572206|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
139572207|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572208|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
139572209|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139572210|NCT01481740|Phenylephrine|phenylephrine|mesh-list
139572211|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
139572212|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139572213|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
139572214|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
139572215|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572216|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572217|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
139572218|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139572219|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
139572220|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
139572221|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139572222|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139572223|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139572224|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
139572225|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572226|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572227|NCT01481740|Protective Agents|protective agents|mesh-ancestor
139572228|NCT01544062|Acetaminophen|acetaminophen|mesh-list
139572229|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139572230|NCT01544062|Analgesics|analgesics|mesh-ancestor
139572231|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
139572232|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572233|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572234|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
139572235|NCT03126084|Acetaminophen|acetaminophen|mesh-list
139572236|NCT03126084|Tramadol|tramadol|mesh-list
139572237|NCT03126084|Bupivacaine|bupivacaine|mesh-list
139572238|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
139572239|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
139572240|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139572241|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572242|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
139572243|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572244|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139572245|NCT03126084|Analgesics|analgesics|mesh-ancestor
139572246|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
139572247|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139076019|NCT04881747|Lasmiditan|lasmiditan|mesh-list
139572248|NCT03126084|Narcotics|narcotics|mesh-ancestor
139572249|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139572250|NCT01544998|Tadalafil|tadalafil|mesh-list
139572251|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
139572252|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139572253|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139572254|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572255|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572256|NCT01544998|Urological Agents|urological agents|mesh-ancestor
139572257|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
139572258|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572259|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
139572260|NCT03391830|Atorvastatin|atorvastatin|mesh-list
139572261|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139572262|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139572263|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
139572264|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572265|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139572266|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139572267|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572268|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
139572269|NCT03391830|Protective Agents|protective agents|mesh-ancestor
139572270|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572271|NCT03391830|Vitamins|vitamins|mesh-ancestor
139572272|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
139572273|NCT01441570|Metoprolol|metoprolol|mesh-list
139572274|NCT01441570|Nebivolol|nebivolol|mesh-list
139572275|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139572276|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139572277|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
139572278|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
139572279|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572280|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572281|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139572282|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139572283|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139572284|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
139572285|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572286|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572287|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
139572288|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139572289|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139572290|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139572291|NCT05238012|Atorvastatin|atorvastatin|mesh-list
139572292|NCT05238012|Calcium|calcium|mesh-list
139572293|NCT05238012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139572294|NCT05238012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572295|NCT05238012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139572296|NCT05238012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139572297|NCT05238012|Antimetabolites|antimetabolites|mesh-ancestor
139572298|NCT05238012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572299|NCT05238012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139572300|NCT05238012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139572301|NCT05238012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572302|NCT01441882|Dasatinib|dasatinib|mesh-list
139076025|NCT04862949|Bevacizumab|bevacizumab|mesh-list
139572303|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572304|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139572305|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572306|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572307|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139572308|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139572309|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
139572310|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572311|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572312|NCT01545700|Dexamethasone|dexamethasone|mesh-list
139572313|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
139572314|NCT01545700|BB 1101|bb 1101|mesh-list
139572315|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572316|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
139572317|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
139572318|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572319|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572320|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139572321|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
139572322|NCT01545700|Hormones|hormones|mesh-ancestor
139572323|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572324|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139572325|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572326|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
139572327|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572328|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572329|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139572330|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139572331|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572332|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139572333|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139572334|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139572335|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572336|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
139572337|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572338|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139572339|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
139572340|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139572341|NCT01444924|Bupivacaine|bupivacaine|mesh-list
139572342|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
139572343|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
139572344|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139572345|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572346|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
139572347|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572349|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
139572350|NCT01546402|BB 1101|bb 1101|mesh-list
139572351|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572352|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
139572353|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
139572354|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572355|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572356|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139572357|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
139572358|NCT01546402|Hormones|hormones|mesh-ancestor
139572359|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572360|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139572361|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572362|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
139572363|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313214|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139572364|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572365|NCT03389490|Insulin|insulin|mesh-list
139572366|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139572367|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
139572368|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
139572369|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
139572370|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
139572371|NCT03389490|Protamines|protamines|mesh-list
139572372|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139572373|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572374|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
139572375|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572376|NCT03389490|Coagulants|coagulants|mesh-ancestor
139572377|NCT01547806|Plerixafor|plerixafor|mesh-list
139572378|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139572379|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139572380|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
139572381|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139572382|NCT01445626|Dexamethasone|dexamethasone|mesh-list
139572383|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572384|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
139572385|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
139572386|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572387|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572388|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139572389|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
139572390|NCT01445626|Hormones|hormones|mesh-ancestor
139572391|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572392|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139572393|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572394|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
139572395|NCT02744742|Busulfan|busulfan|mesh-list
139572396|NCT02744742|Decitabine|decitabine|mesh-list
139572397|NCT02744742|Lenograstim|lenograstim|mesh-list
139572398|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139572399|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
139572400|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572401|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572402|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139572403|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
139572404|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572405|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572406|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139572407|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139572408|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
139572409|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572410|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139572411|NCT03125772|Paclitaxel|paclitaxel|mesh-list
139572412|NCT03125772|Everolimus|everolimus|mesh-list
139572413|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139572414|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572415|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
139572416|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
139572417|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
139572418|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572419|NCT03125772|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139572420|NCT03125772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139354100|NCT04524897|Triamcinolone|triamcinolone|mesh-list
139572421|NCT03125772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572422|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139572423|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
139572424|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572425|NCT01447888|Morphine|morphine|mesh-list
139572426|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139572427|NCT01447888|Narcotics|narcotics|mesh-ancestor
139572428|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139572429|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572430|NCT01447888|Analgesics|analgesics|mesh-ancestor
139572431|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
139572432|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572433|NCT03389256|Apatinib|apatinib|mesh-list
139572434|NCT03389256|Gefitinib|gefitinib|mesh-list
139572435|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572436|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139572437|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572438|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572439|NCT01490788|Amitriptyline|amitriptyline|mesh-list
139572440|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
139572441|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139572442|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
139572443|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139572444|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139572445|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572446|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139572447|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572448|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139572449|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139572450|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139572451|NCT01490788|Analgesics|analgesics|mesh-ancestor
139572452|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
139572453|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139572454|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139572455|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139572456|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572457|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
139572458|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572459|NCT03391050|Dabrafenib|dabrafenib|mesh-list
139572460|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572461|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139572462|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572463|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572464|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
139572465|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139572466|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
139572467|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139572468|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139572469|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572470|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139572471|NCT03390972|Analgesics|analgesics|mesh-ancestor
139572472|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
139572473|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572474|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139572475|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139572476|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139572477|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
139572478|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572479|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572480|NCT01550224|Temozolomide|temozolomide|mesh-list
139572481|NCT01550224|Vorinostat|vorinostat|mesh-list
139572482|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139572483|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
139572484|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572485|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572486|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139572487|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572488|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
139572489|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139572490|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139572491|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572492|NCT00782184|Atorvastatin|atorvastatin|mesh-list
139572493|NCT00782184|Simvastatin|simvastatin|mesh-list
139572494|NCT00782184|Ezetimibe|ezetimibe|mesh-list
139572495|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
139572496|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139572497|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139572498|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
139572499|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572500|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139572501|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139572502|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572503|NCT03397914|Colistin|colistin|mesh-list
139572504|NCT03397914|Polymyxins|polymyxins|mesh-list
139572505|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139572506|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139572507|NCT01450306|Cycloserine|cycloserine|mesh-list
139572508|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139572509|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139572510|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139572511|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
139572512|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139572513|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
139572514|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572515|NCT03126708|Paclitaxel|paclitaxel|mesh-list
139572516|NCT03126708|Cetuximab|cetuximab|mesh-list
139572517|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139572518|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572519|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
139572520|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
139572521|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
139572522|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572523|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139572524|NCT03390738|Nivolumab|nivolumab|mesh-list
139572525|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139572526|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572527|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139572528|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572529|NCT03390582|Methimazole|methimazole|mesh-list
139572530|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
139572531|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
139572532|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572533|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572534|NCT03385356|Vitamin D|vitamin d|mesh-list
139572535|NCT03385356|Vitamins|vitamins|mesh-ancestor
139572536|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
139572537|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572538|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139572539|NCT03388866|Immunomodulating Agents|immunomodulating agents|mesh-list
139572540|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
139572541|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572542|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139572543|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
139572544|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
139572545|NCT01873170|Etonogestrel|etonogestrel|mesh-list
139572546|NCT01873170|Desogestrel|desogestrel|mesh-list
139572547|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
139572548|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139572549|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139572550|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572551|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139572552|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139572553|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139572554|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139572555|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139572556|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572557|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139572558|NCT01873170|Progestins|progestins|mesh-ancestor
139572559|NCT01873170|Hormones|hormones|mesh-ancestor
139572560|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572561|NCT03125694|Pioglitazone|pioglitazone|mesh-list
139572562|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139572563|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139572564|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572565|NCT03125694|Incretins|incretins|mesh-ancestor
139572566|NCT03125694|Hormones|hormones|mesh-ancestor
139572567|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572568|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139572569|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
139572570|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572571|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572572|NCT02731638|Voriconazole|voriconazole|mesh-list
139572573|NCT02731638|Natamycin|natamycin|mesh-list
139572574|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
139572575|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139572576|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139572577|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139572578|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572579|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572580|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139572581|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
139572582|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572583|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572584|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139572585|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139572586|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139572587|NCT01451632|Irinotecan|irinotecan|mesh-list
139572588|NCT01451632|Cetuximab|cetuximab|mesh-list
139572589|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139572590|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139572591|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572592|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572593|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572594|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139572595|NCT01491958|Methotrexate|methotrexate|mesh-list
139572596|NCT01491958|Atorvastatin|atorvastatin|mesh-list
139572597|NCT01491958|Tacrolimus|tacrolimus|mesh-list
139572598|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139572599|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
139572600|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139572601|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572602|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139572603|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
139572604|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572605|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572606|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
139572607|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572608|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139572609|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139572610|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
139572611|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572612|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139572613|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139572614|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139572615|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139572616|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139572617|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139572618|NCT01492582|Vaccines|vaccines|mesh-list
139572619|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
139572620|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572621|NCT02214628|Becaplermin|becaplermin|mesh-list
139572622|NCT02214628|Anticoagulants|anticoagulants|mesh-ancestor
139572623|NCT02214628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
139572624|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139572625|NCT02214628|Growth Substances|growth substances|mesh-ancestor
139572626|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572627|NCT01495858|Naproxen|naproxen|mesh-list
139572628|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139572629|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139572630|NCT01495858|Analgesics|analgesics|mesh-ancestor
139572631|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
139572632|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572633|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572634|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572635|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572636|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
139572637|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139572638|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572639|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572640|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
139572641|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139354328|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572642|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139572643|NCT01497496|Prednisolone|prednisolone|mesh-list
139572644|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
139572645|NCT01497496|Lenalidomide|lenalidomide|mesh-list
139572646|NCT01497496|Ofatumumab|ofatumumab|mesh-list
139572647|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139572648|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
139572649|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
139572650|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572651|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139572652|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139572653|NCT01497496|Growth Substances|growth substances|mesh-ancestor
139572654|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
139572655|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572656|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572657|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
139572658|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
139572659|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572660|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139572661|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
139572662|NCT01497496|Hormones|hormones|mesh-ancestor
139572663|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572664|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139572665|NCT01497496|Protective Agents|protective agents|mesh-ancestor
139572666|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139572667|NCT02208310|Vitamin D|vitamin d|mesh-list
139572668|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
139572669|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
139572670|NCT02208310|Vitamins|vitamins|mesh-list
139572671|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
139572672|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572673|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139572674|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139572675|NCT01454362|Nicotine|nicotine|mesh-list
139572676|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139572677|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
139572678|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572679|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572680|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139572681|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139572682|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
139572683|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572684|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572685|NCT01497808|Ipilimumab|ipilimumab|mesh-list
139572686|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139572687|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572688|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139572689|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572690|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
139572691|NCT01498588|Doxorubicin|doxorubicin|mesh-list
139572692|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139572693|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
139572694|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572695|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572696|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139572697|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
139572698|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572699|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572700|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139572701|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139572702|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139572703|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139572704|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572705|NCT01498744|Clindamycin|clindamycin|mesh-list
139572706|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
139572707|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
139572708|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139572709|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139572710|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139572711|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572712|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572713|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139572714|NCT01498978|Ipilimumab|ipilimumab|mesh-list
139572715|NCT01498978|Antibodies|antibodies|mesh-list
139354405|NCT03600493|Lidocaine|lidocaine|mesh-list
139572716|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
139572717|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139572718|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
139572719|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572720|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572721|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139572722|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572723|NCT01458418|Montelukast|montelukast|mesh-list
139572724|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139572725|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
139572726|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139572727|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
139572728|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572729|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572730|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139572731|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139572732|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572733|NCT01557322|Etanercept|etanercept|mesh-list
139572734|NCT01557322|Methotrexate|methotrexate|mesh-list
139572735|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139572736|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
139572737|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139572738|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572739|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139572740|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
139572741|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572742|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572743|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
139572744|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572745|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139572746|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139572747|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
139572748|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572749|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139572750|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139572751|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139572752|NCT01557322|Analgesics|analgesics|mesh-ancestor
139572753|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
139572754|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572755|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572756|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139572757|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139572758|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139572759|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
139572760|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139572761|NCT01459588|Laxatives|laxatives|mesh-ancestor
139572762|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139572763|NCT01501162|Ethanol|ethanol|mesh-list
139572764|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139572765|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139572766|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139572767|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572768|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
139572769|NCT01557868|Hylan|hylan|mesh-list
139572770|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139572771|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
139572772|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572773|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
139572774|NCT01557868|Protective Agents|protective agents|mesh-ancestor
139572775|NCT02208466|Fluoxetine|fluoxetine|mesh-list
139572776|NCT02208466|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139572777|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139572778|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139572779|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572780|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572781|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
139572782|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572783|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139572784|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
139572785|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139572786|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139572787|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139572788|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572789|NCT02209948|Temozolomide|temozolomide|mesh-list
139572790|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139572791|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
139572792|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572793|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572794|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
139572795|NCT02981212|Prednisolone|prednisolone|mesh-list
139572796|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139572797|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139572798|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572799|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139572800|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
139572801|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139572802|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139572803|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572804|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572805|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572806|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
139572807|NCT02981212|Hormones|hormones|mesh-ancestor
139572808|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572809|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572810|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139572811|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
139572812|NCT01464190|Sevelamer|sevelamer|mesh-list
139572813|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
139572814|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
139572815|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572816|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139572817|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572818|NCT01563406|Ethanol|ethanol|mesh-list
139572819|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
139572820|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139572821|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139572822|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139572823|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572824|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
139572825|NCT01468012|Levodopa|levodopa|mesh-list
139572826|NCT01468012|Carbidopa|carbidopa|mesh-list
139572827|NCT01468012|Entacapone|entacapone|mesh-list
139572828|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139572829|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139572830|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139572831|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
139572832|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572833|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572834|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572835|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139572836|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572837|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139572838|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139572839|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
139572840|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
139572841|NCT01468558|Ketoconazole|ketoconazole|mesh-list
139572842|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
139572843|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139572844|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139572845|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139572846|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572847|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572848|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139572849|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
139572850|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572851|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572852|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139572853|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
139572854|NCT03730662|Tirzepatide|tirzepatide|mesh-list
139572855|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139572856|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572857|NCT03730662|Incretins|incretins|mesh-ancestor
139572858|NCT03730662|Hormones|hormones|mesh-ancestor
139572859|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572860|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139572861|NCT01470118|Dextrans|dextrans|mesh-list
139572862|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139572863|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139572864|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
139572865|NCT01470118|Alcaftadine|alcaftadine|mesh-list
139572866|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
139572867|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
139572868|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
139572869|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139572870|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139572871|NCT01470118|Analgesics|analgesics|mesh-ancestor
139572872|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
139572873|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572874|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572875|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572876|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572877|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139572878|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139572879|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139572880|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
139572881|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
139572882|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572883|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572884|NCT01470196|Dexamethasone|dexamethasone|mesh-list
139572885|NCT01470196|Rituximab|rituximab|mesh-list
139572886|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572887|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
139572888|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
139572889|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572890|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572891|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139572892|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
139572893|NCT01470196|Hormones|hormones|mesh-ancestor
139572894|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139572895|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139572896|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139572897|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139572898|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
139572899|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572900|NCT03389958|Copper|copper|mesh-list
139572901|NCT03389958|Trace Elements|trace elements|mesh-ancestor
139572902|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
139572903|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572904|NCT04446234|Risperidone|risperidone|mesh-list
139572905|NCT04446234|Aripiprazole|aripiprazole|mesh-list
139572906|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139572907|NCT04446234|Ziprasidone|ziprasidone|mesh-list
139572908|NCT04446234|Amisulpride|amisulpride|mesh-list
139572909|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139572910|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
139572911|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572912|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572913|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572914|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139572915|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139572916|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139572917|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139572918|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139572919|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
139572920|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
139572921|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
139572922|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139572923|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139572924|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139572925|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139572926|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139572927|NCT03613506|Captopril|captopril|mesh-list
139572928|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139572929|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
139572930|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572931|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572932|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139572933|NCT01565902|Siponimod|siponimod|mesh-list
139572934|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139572935|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572936|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139572937|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
139572938|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572939|NCT01566448|Ketamine|ketamine|mesh-list
139572940|NCT01566448|Analgesics|analgesics|mesh-ancestor
139572941|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
139572942|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572943|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572944|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139572945|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139572946|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
139572947|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
139572948|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139572949|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139572950|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139572951|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572952|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572953|NCT05565976|Aspirin|aspirin|mesh-list
139572954|NCT05565976|Insulin|insulin|mesh-list
139572955|NCT05565976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139572956|NCT05565976|Insulin Glargine|insulin glargine|mesh-list
139572957|NCT05565976|Dapagliflozin|dapagliflozin|mesh-list
139572958|NCT05565976|Insulin Lispro|insulin lispro|mesh-list
139572959|NCT05565976|Biguanides|biguanides|mesh-list
139572960|NCT05565976|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139572961|NCT05565976|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
139572962|NCT05565976|Meglitinide|meglitinide|mesh-list
139572963|NCT05565976|Clopidogrel|clopidogrel|mesh-list
139572964|NCT05565976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139572965|NCT05565976|Atorvastatin|atorvastatin|mesh-list
139572966|NCT05565976|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139572967|NCT05565976|Pravastatin|pravastatin|mesh-list
139572968|NCT05565976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572969|NCT05565976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139572970|NCT05565976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139572971|NCT05565976|Antimetabolites|antimetabolites|mesh-ancestor
139572972|NCT05565976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139572973|NCT05565976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139572974|NCT05565976|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139572975|NCT05565976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139572976|NCT05565976|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139572977|NCT05565976|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139572978|NCT05565976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139572979|NCT05565976|Purinergic Agents|purinergic agents|mesh-ancestor
139572980|NCT05565976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139572981|NCT05565976|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139572982|NCT05565976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139572983|NCT05565976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139572984|NCT05565976|Analgesics|analgesics|mesh-ancestor
139572985|NCT05565976|Sensory System Agents|sensory system agents|mesh-ancestor
139572986|NCT05565976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572987|NCT05565976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572988|NCT05565976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139572989|NCT05565976|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139572990|NCT05565976|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139572991|NCT05565976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139572992|NCT05565976|Antipyretics|antipyretics|mesh-ancestor
139572993|NCT01566526|Dexamethasone|dexamethasone|mesh-list
139572994|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139572995|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
139572996|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
139572997|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139572998|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139572999|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139573000|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
139573001|NCT01566526|Hormones|hormones|mesh-ancestor
139573002|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139573003|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139573004|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573005|NCT01566838|Bupivacaine|bupivacaine|mesh-list
139573006|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
139573007|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
139573008|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139573009|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573010|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
139573011|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573012|NCT05565664|Magnesium Sulfate|magnesium sulfate|mesh-list
139573013|NCT05565664|Ketamine|ketamine|mesh-list
139573014|NCT05565664|Analgesics|analgesics|mesh-ancestor
139573015|NCT05565664|Sensory System Agents|sensory system agents|mesh-ancestor
139573016|NCT05565664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573017|NCT05565664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573018|NCT05565664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139573019|NCT05565664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139573020|NCT05565664|Anesthetics, General|anesthetics, general|mesh-ancestor
139573021|NCT05565664|Anesthetics|anesthetics|mesh-ancestor
139573022|NCT05565664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139573023|NCT05565664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139573024|NCT05565664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139573025|NCT05565664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573026|NCT05565664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573027|NCT05565664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139573028|NCT05565664|Anticonvulsants|anticonvulsants|mesh-ancestor
139573029|NCT05565664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139573030|NCT05565664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139573031|NCT05565664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139573032|NCT05565664|Tocolytic Agents|tocolytic agents|mesh-ancestor
139573033|NCT05565664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139573034|NCT03125616|Vaccines|vaccines|mesh-list
139573035|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
139573036|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573037|NCT01568008|Bimatoprost|bimatoprost|mesh-list
139573038|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139573039|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139573040|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139573041|NCT05658120|Epinephrine|epinephrine|mesh-list
139573042|NCT05658120|Racepinephrine|racepinephrine|mesh-list
139573043|NCT05658120|Norepinephrine|norepinephrine|mesh-list
139573044|NCT05658120|Epinephryl borate|epinephryl borate|mesh-list
139573045|NCT05658120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139573046|NCT05658120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139573047|NCT05658120|Adrenergic Agents|adrenergic agents|mesh-ancestor
139573048|NCT05658120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573049|NCT05658120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573050|NCT05658120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573051|NCT05658120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139573052|NCT05658120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139573053|NCT05658120|Autonomic Agents|autonomic agents|mesh-ancestor
139573054|NCT05658120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573055|NCT05658120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139573056|NCT05658120|Respiratory System Agents|respiratory system agents|mesh-ancestor
139573057|NCT05658120|Mydriatics|mydriatics|mesh-ancestor
139573058|NCT05658120|Sympathomimetics|sympathomimetics|mesh-ancestor
139573059|NCT05658120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139573060|NCT01514734|Timolol|timolol|mesh-list
139573061|NCT01514734|Brinzolamide|brinzolamide|mesh-list
139573062|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573063|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573064|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139573065|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139573066|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
139573067|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573068|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573069|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139573070|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139573071|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139573072|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
139573073|NCT01515046|Gemcitabine|gemcitabine|mesh-list
139573074|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139573075|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
139573076|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573077|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573078|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
139573079|NCT01515046|Protective Agents|protective agents|mesh-ancestor
139573080|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573081|NCT01515046|Vitamins|vitamins|mesh-ancestor
139573082|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
139573083|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139573084|NCT01568944|Lansoprazole|lansoprazole|mesh-list
139573085|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573086|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139573087|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139573088|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139573089|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573090|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573092|NCT05565274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139573093|NCT05565274|Narcotics|narcotics|mesh-ancestor
139573094|NCT05565274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139573095|NCT05565274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573096|NCT05565274|Analgesics|analgesics|mesh-ancestor
139573097|NCT05565274|Sensory System Agents|sensory system agents|mesh-ancestor
139573098|NCT05565274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573099|NCT05565274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139573100|NCT05565274|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139573101|NCT05173584|Albuterol|albuterol|mesh-list
139573102|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139573103|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
139573104|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573105|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573106|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139573107|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
139573108|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
139573109|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139573110|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139573111|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139573112|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139573113|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
139573114|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573115|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573116|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
139573117|NCT04671030|Neostigmine|neostigmine|mesh-list
139573118|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139573119|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573120|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573121|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
139573122|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573123|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573124|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139573125|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
139573126|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573127|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139573128|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139573129|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139573130|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
139573131|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139573132|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139573133|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573134|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139573135|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139573136|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573137|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573138|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573139|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139573140|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
139573141|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139573142|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573143|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139573144|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139573145|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139573146|NCT04632264|Oxytocin|oxytocin|mesh-list
139573147|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
139573148|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139573149|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573150|NCT04607928|Pirfenidone|pirfenidone|mesh-list
139573151|NCT04607928|Analgesics|analgesics|mesh-ancestor
139573152|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
139573153|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313215|NCT02307864|Analgesics|analgesics|mesh-ancestor
139573154|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573155|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139573156|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139573157|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139573158|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573159|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573160|NCT03380442|Ketamine|ketamine|mesh-list
139573161|NCT03380442|Psilocybin|psilocybin|mesh-list
139573162|NCT03380442|Analgesics|analgesics|mesh-ancestor
139573163|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
139573164|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573165|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573166|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139573167|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139573169|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
139573170|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139573171|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139573172|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139573173|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573174|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573175|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
139573176|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139573177|NCT05172570|Gabapentin|gabapentin|mesh-list
139573178|NCT05172570|Analgesics|analgesics|mesh-ancestor
139573179|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
139573180|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573181|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573182|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
139573183|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139573184|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139573185|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139573186|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139573187|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139573188|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139573189|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573190|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573191|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
139573192|NCT03380130|Nivolumab|nivolumab|mesh-list
139573193|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139573194|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573195|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139573196|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573197|NCT03386838|Carboplatin|carboplatin|mesh-list
139573198|NCT03386838|Fluorouracil|fluorouracil|mesh-list
139573199|NCT03386838|Nivolumab|nivolumab|mesh-list
139573200|NCT03386838|Cetuximab|cetuximab|mesh-list
139573201|NCT03386838|Linrodostat|linrodostat|mesh-list
139573202|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573203|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
139573204|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573205|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139573206|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139573207|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
139573208|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573209|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139573210|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139573211|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573212|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139573213|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
139573214|NCT03379974|Coagulants|coagulants|mesh-ancestor
139573215|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139573216|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
139573217|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573218|NCT01570036|Trastuzumab|trastuzumab|mesh-list
139573219|NCT01570036|Molgramostim|molgramostim|mesh-list
139573220|NCT01570036|Sargramostim|sargramostim|mesh-list
139573221|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139573222|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573223|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
139573224|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573225|NCT01516684|Lidocaine|lidocaine|mesh-list
139573226|NCT01516684|Fentanyl|fentanyl|mesh-list
139076231|NCT05932849|Benralizumab|benralizumab|mesh-list
139573227|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
139573228|NCT01516684|Prilocaine|prilocaine|mesh-list
139573229|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139573230|NCT01516684|Propofol|propofol|mesh-list
139573231|NCT01516684|Anesthetics|anesthetics|mesh-list
139573232|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139573233|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573234|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
139573235|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573236|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139573237|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139573238|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139573239|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139573240|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573241|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139573242|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139573243|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
139573244|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139573246|NCT01516684|Analgesics|analgesics|mesh-ancestor
139573247|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139573248|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139573249|NCT01517074|Sirolimus|sirolimus|mesh-list
139573250|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139573251|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573252|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139573253|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573254|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
139573255|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139573256|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
139573257|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573258|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
139573259|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
139573260|NCT01570348|Fludarabine|fludarabine|mesh-list
139573261|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
139573262|NCT01570348|Tacrolimus|tacrolimus|mesh-list
139573263|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139573264|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
139573265|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573266|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573267|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139573268|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
139573269|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573270|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573271|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139573272|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139573273|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
139573274|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139573275|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573276|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139573277|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139573278|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
139573279|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139573280|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573281|NCT03383406|Cytarabine|cytarabine|mesh-list
139573282|NCT03383406|Methotrexate|methotrexate|mesh-list
139573283|NCT03383406|Etoposide|etoposide|mesh-list
139573284|NCT03383406|Ifosfamide|ifosfamide|mesh-list
139573285|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139573286|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
139573287|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139573288|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573289|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139573290|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
139573291|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573292|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573293|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
139573294|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573295|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139573296|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139573297|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
139573298|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573299|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139573300|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139573301|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139573302|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139573303|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
139573304|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573305|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139573306|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
139573307|NCT04445922|Anastrozole|anastrozole|mesh-list
139573308|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139573309|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573310|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139573311|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139573312|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573313|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573314|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139573315|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
139573316|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139573317|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573318|NCT03383328|Prednisolone|prednisolone|mesh-list
139573319|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139573320|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
139573321|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139573322|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
139573323|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139573324|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139573325|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
139573326|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139573327|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
139573328|NCT03383328|Hormones|hormones|mesh-ancestor
139573329|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139573330|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573331|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139573332|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573333|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
139573334|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
139573335|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573336|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139573337|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139573338|NCT03383328|Protective Agents|protective agents|mesh-ancestor
139573339|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139573340|NCT03383328|Analgesics|analgesics|mesh-ancestor
139573341|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
139573342|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573343|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139573344|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573345|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139573346|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313216|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
139573347|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573348|NCT03093246|Aspirin|aspirin|mesh-list
139573349|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139573350|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139573351|NCT03093246|Analgesics|analgesics|mesh-ancestor
139573352|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
139573353|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573354|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573355|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139573356|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573357|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139573358|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139573359|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573360|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139573361|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139573362|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573363|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
139573364|NCT02969928|Amoxicillin|amoxicillin|mesh-list
139573365|NCT02969928|Metronidazole|metronidazole|mesh-list
139573366|NCT02969928|Clarithromycin|clarithromycin|mesh-list
139573367|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139573368|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573369|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139573370|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139573371|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139573372|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573373|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573374|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139573375|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139573376|NCT02968446|Vitamin D|vitamin d|mesh-list
139573377|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
139573378|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
139573379|NCT02968446|Vitamins|vitamins|mesh-ancestor
139573380|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
139573381|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573382|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139573383|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139573384|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
139573385|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573386|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139573387|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573388|NCT03378960|Omeprazole|omeprazole|mesh-list
139573389|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139573390|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139573391|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139573392|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573393|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573394|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
139573395|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
139573396|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573397|NCT03378726|Micronutrients|micronutrients|mesh-list
139573398|NCT03378726|Trace Elements|trace elements|mesh-list
139573399|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573400|NCT03378648|Bromides|bromides|mesh-list
139573401|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
139573402|NCT01519882|Rotigotine|rotigotine|mesh-list
139573403|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
139573404|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
139573405|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573406|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573407|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573408|NCT01576276|Ketorolac|ketorolac|mesh-list
139573409|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139573410|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139573411|NCT01576276|Analgesics|analgesics|mesh-ancestor
139573412|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
139573413|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573414|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573415|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139573416|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573417|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139573418|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573419|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573420|NCT01576588|Rituximab|rituximab|mesh-list
139573421|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
139573422|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139573423|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573424|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
139573425|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573426|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573427|NCT01576588|Hormones|hormones|mesh-ancestor
139573428|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139573429|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
139573430|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
139573431|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573432|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
139573433|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139573434|NCT02247154|Antibodies|antibodies|mesh-list
139573435|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
139573436|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573437|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
139573438|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139573439|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139573440|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
139573441|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573442|NCT03007810|Hemay005|hemay005|mesh-list
139573443|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
139573444|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139573445|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139573446|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573447|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573448|NCT01578772|Telmisartan|telmisartan|mesh-list
139573449|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139573450|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139573451|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139573452|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573453|NCT01804049|Metformin|metformin|mesh-list
139573454|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139573455|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573456|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139573457|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139573458|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573459|NCT02346630|Levodopa|levodopa|mesh-list
139573460|NCT02346630|Carbidopa|carbidopa|mesh-list
139573461|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139573462|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139573463|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
139573464|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573465|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573466|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573467|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139573469|NCT03385668|Pirfenidone|pirfenidone|mesh-list
139573470|NCT03385668|Analgesics|analgesics|mesh-ancestor
139573471|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
139573472|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573473|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573474|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139573475|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139573476|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139573477|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573478|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573479|NCT04947072|Anesthetics|anesthetics|mesh-list
139573480|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139573481|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573482|NCT04942158|Eugenol|eugenol|mesh-list
139573483|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
139573484|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
139573485|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
139573486|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139573487|NCT04942158|Protective Agents|protective agents|mesh-ancestor
139573488|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573489|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573490|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
139573491|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139573492|NCT03387774|Urinastatin|urinastatin|mesh-list
139573493|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139573494|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139573495|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
139573496|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573497|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573498|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
139573499|NCT03382314|Vitamin D|vitamin d|mesh-list
139573500|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
139573501|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139573502|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573503|NCT03382314|Vitamins|vitamins|mesh-ancestor
139573504|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
139573505|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139573506|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139573507|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139573508|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
139573509|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139573510|NCT03124524|Dienogest|dienogest|mesh-list
139573511|NCT03124524|Drospirenone|drospirenone|mesh-list
139573512|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139573513|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139573514|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139573515|NCT03124524|Estradiol|estradiol|mesh-list
139573516|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139573517|NCT03124524|Estrogens|estrogens|mesh-ancestor
139573518|NCT03124524|Hormones|hormones|mesh-ancestor
139573519|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139573520|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573521|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139573522|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
139573523|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139573524|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139573525|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139573526|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139573527|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139573528|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
139573529|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139573530|NCT03124524|Diuretics|diuretics|mesh-ancestor
139573531|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
139573532|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139573533|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139573534|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573535|NCT03377400|Cisplatin|cisplatin|mesh-list
139573536|NCT03377400|Durvalumab|durvalumab|mesh-list
139573537|NCT03377400|Tremelimumab|tremelimumab|mesh-list
139355234|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139573538|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573539|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139573540|NCT01803269|Topotecan|topotecan|mesh-list
139573541|NCT01803269|Camptothecin|camptothecin|mesh-list
139573542|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139573543|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139573544|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573545|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573546|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573547|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139573548|NCT01802879|Panobinostat|panobinostat|mesh-list
139573549|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573550|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139573551|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573552|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573553|NCT01825577|Methylphenidate|methylphenidate|mesh-list
139573554|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139573555|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573556|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139573557|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139573558|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139573559|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573560|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
139573561|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573562|NCT03375138|Abatacept|abatacept|mesh-list
139573563|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139573564|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573565|NCT03375138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139573566|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573567|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139573568|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
139573569|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573570|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573571|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
139573572|NCT03124680|Narcotics|narcotics|mesh-ancestor
139573573|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139573574|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573575|NCT03124680|Analgesics|analgesics|mesh-ancestor
139573576|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
139573577|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573578|NCT03374670|Aflibercept|aflibercept|mesh-list
139573579|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139573580|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139573581|NCT03374670|Growth Substances|growth substances|mesh-ancestor
139573582|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573583|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
139573584|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573585|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
139573586|NCT02963610|Lenalidomide|lenalidomide|mesh-list
139573587|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139573588|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573589|NCT02963610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139573590|NCT02963610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573591|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
139573592|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573593|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139573594|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139573595|NCT02963610|Growth Substances|growth substances|mesh-ancestor
139573596|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
139573597|NCT03376932|Albuterol|albuterol|mesh-list
139573598|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
139573599|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139573600|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
139573601|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573602|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573603|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139573604|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
139573605|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
139573606|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139573607|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
139573608|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573609|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573610|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
139355306|NCT00709059|Ribavirin|ribavirin|mesh-list
139573611|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139573612|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139573613|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139573614|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139573615|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
139573616|NCT03007342|Amoxicillin|amoxicillin|mesh-list
139573617|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
139573618|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
139573619|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139573620|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139573621|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573622|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139573623|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573624|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573625|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
139573626|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139573627|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573628|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573629|NCT01579162|Cholic Acids|cholic acids|mesh-list
139573630|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139573631|NCT03007654|Chitosan|chitosan|mesh-list
139573632|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139573633|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139573634|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
139573635|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573636|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139573637|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
139573638|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
139573639|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
139573640|NCT03007654|Coagulants|coagulants|mesh-ancestor
139573641|NCT03374514|Dexamethasone|dexamethasone|mesh-list
139573642|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139573643|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
139573644|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
139573645|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573646|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076313|NCT05932277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139573647|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139573648|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
139573649|NCT03374514|Hormones|hormones|mesh-ancestor
139573650|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139573651|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139573652|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573653|NCT01526356|Sirolimus|sirolimus|mesh-list
139573654|NCT01526356|Temsirolimus|temsirolimus|mesh-list
139573655|NCT01526356|MTOR Inhibitors|mtor inhibitors|mesh-list
139573656|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139573657|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573658|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139573659|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573660|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
139573661|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139573662|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
139573663|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573664|NCT01526356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139573665|NCT01526356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573666|NCT01526356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573667|NCT02903160|Prednisone|prednisone|mesh-list
139573668|NCT02903160|Carboplatin|carboplatin|mesh-list
139573669|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
139573670|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139573671|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573672|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139573673|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
139573674|NCT02903160|Hormones|hormones|mesh-ancestor
139573675|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139573676|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573677|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139573678|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139573679|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573680|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573681|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
139573682|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139573683|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139573684|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139573685|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573686|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573687|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139573688|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139573689|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573690|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
139573691|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573692|NCT03374280|Cisplatin|cisplatin|mesh-list
139573693|NCT03374280|Pemetrexed|pemetrexed|mesh-list
139573694|NCT03374280|Gefitinib|gefitinib|mesh-list
139573695|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573696|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573697|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573698|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139573699|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139573700|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139573701|NCT03381066|Cisplatin|cisplatin|mesh-list
139573702|NCT03381066|Pemetrexed|pemetrexed|mesh-list
139573703|NCT03381066|Vinorelbine|vinorelbine|mesh-list
139573704|NCT03381066|Gefitinib|gefitinib|mesh-list
139573705|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573706|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573707|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573708|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139573709|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139573710|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139573711|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
139573712|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
139573713|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
139573714|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139573715|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139573716|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
139573717|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139573718|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
139573719|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
139573720|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573721|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573722|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
139573723|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139573724|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139573725|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
139573726|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573727|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573728|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
139573729|NCT01580410|Mitomycins|mitomycins|mesh-list
139573730|NCT01580410|Mitomycin|mitomycin|mesh-list
139573731|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573732|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139573733|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
139573734|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573735|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139573736|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573737|NCT01581658|Empagliflozin|empagliflozin|mesh-list
139573738|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139573739|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573740|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139573741|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573742|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139573743|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139573744|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573745|NCT01530178|Incretins|incretins|mesh-ancestor
139573746|NCT01530178|Hormones|hormones|mesh-ancestor
139573747|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139573748|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139573749|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
139573750|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573751|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573752|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
139573753|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139573754|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139573755|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139573756|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139573757|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573758|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
139573759|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573760|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573761|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139573762|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573763|NCT03006874|Esomeprazole|esomeprazole|mesh-list
139573764|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139573765|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139573766|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139573767|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573768|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573769|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
139573770|NCT01581970|Cetuximab|cetuximab|mesh-list
139573771|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139573772|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
139573773|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573774|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573775|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139573776|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
139573777|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573778|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573779|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139573780|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139573781|NCT01583686|Aldesleukin|aldesleukin|mesh-list
139573782|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
139573783|NCT01583686|Fludarabine|fludarabine|mesh-list
139573784|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139573785|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
139573786|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573787|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573788|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139573789|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
139573790|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573791|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573792|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139573793|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139573794|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139573795|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
139573796|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573797|NCT01532128|Opicapone|opicapone|mesh-list
139573798|NCT01532128|Rasagiline|rasagiline|mesh-list
139573799|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139573800|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573801|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573802|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139573803|NCT01532128|Protective Agents|protective agents|mesh-ancestor
139573804|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573805|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139573806|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139573807|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139573808|NCT01584388|Rituximab|rituximab|mesh-list
139573809|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139573810|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573811|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
139573812|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573813|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573814|NCT01584544|Capecitabine|capecitabine|mesh-list
139573815|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139573816|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
139573817|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573818|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573819|NCT03006952|Losartan|losartan|mesh-list
139573820|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
139573821|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139573822|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139573823|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139573824|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139573825|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573826|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139573827|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573828|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139573829|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139573830|NCT03006952|Protective Agents|protective agents|mesh-ancestor
139573831|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573832|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
139573833|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139573835|NCT01802333|Cytarabine|cytarabine|mesh-list
139573836|NCT01802333|Daunorubicin|daunorubicin|mesh-list
139573837|NCT01802333|Vorinostat|vorinostat|mesh-list
139573838|NCT01802333|Idarubicin|idarubicin|mesh-list
139573839|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139573840|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
139573841|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573842|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573843|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
139573844|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573845|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139573846|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
139573847|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573848|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139573849|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139573850|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139573851|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573852|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139573853|NCT01585324|Ribavirin|ribavirin|mesh-list
139573854|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139573855|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
139573856|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573857|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
139573858|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573859|NCT01586962|Acetaminophen|acetaminophen|mesh-list
139573860|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
139573861|NCT01586962|Ephedrine|ephedrine|mesh-list
139573862|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139573863|NCT01586962|Analgesics|analgesics|mesh-ancestor
139573864|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
139573865|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573866|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573867|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
139573868|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139573869|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
139573870|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139573871|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
139573872|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
139573873|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139573874|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139573875|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
139573876|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
139573877|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573878|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573879|NCT03006250|Sevoflurane|sevoflurane|mesh-list
139573880|NCT03006250|Desflurane|desflurane|mesh-list
139573881|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139573882|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139573883|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
139573884|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
139573885|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139573886|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573887|NCT04129437|Ibuprofen|ibuprofen|mesh-list
139573888|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139573889|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139573890|NCT04129437|Analgesics|analgesics|mesh-ancestor
139573891|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
139573892|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573893|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573894|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139573895|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573896|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139573897|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573898|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573899|NCT04588259|Insulin|insulin|mesh-list
139573900|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139573901|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
139573902|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
139573903|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139573904|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139573905|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573906|NCT01801475|Ondansetron|ondansetron|mesh-list
139355601|NCT05599971|Digoxin|digoxin|mesh-list
139573907|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
139573908|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
139573909|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573910|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573911|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139573912|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
139573913|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
139573914|NCT01801475|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139573915|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139573916|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
139573917|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139573918|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573919|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
139573920|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139573921|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
139573922|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573923|NCT03063021|Expectorants|expectorants|mesh-ancestor
139573924|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
139573925|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139573926|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
139573927|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573928|NCT03063021|Protective Agents|protective agents|mesh-ancestor
139573929|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573930|NCT03063021|Antidotes|antidotes|mesh-ancestor
139573931|NCT02337933|Ursolic acid|ursolic acid|mesh-list
139573932|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573933|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573934|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139573935|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573936|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139573937|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573938|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139573939|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139573940|NCT02337933|Analgesics|analgesics|mesh-ancestor
139573941|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
139573942|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573943|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573944|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139573945|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139573946|NCT03062943|Nintedanib|nintedanib|mesh-list
139573947|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573948|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139573949|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573950|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573951|NCT01536886|Betamethasone|betamethasone|mesh-list
139573952|NCT01536886|Calcipotriene|calcipotriene|mesh-list
139573953|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139573954|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
139573955|NCT01536886|Hormones|hormones|mesh-ancestor
139573956|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139573957|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573958|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139573959|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
139573960|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
139573961|NCT02247310|Interferons|interferons|mesh-list
139573962|NCT02247310|Interferon-beta|interferon-beta|mesh-list
139573963|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
139573964|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573965|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
139573966|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573967|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
139573968|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573969|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139573970|NCT03061539|Nivolumab|nivolumab|mesh-list
139573971|NCT03061539|Ipilimumab|ipilimumab|mesh-list
139573972|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139573973|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139573974|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139573975|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573976|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
139573977|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139573978|NCT05609253|Itraconazole|itraconazole|mesh-list
139573979|NCT05609253|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139573980|NCT05609253|Antifungal Agents|antifungal agents|mesh-ancestor
139573981|NCT05609253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139573982|NCT05609253|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139573983|NCT05609253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139573984|NCT05609253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139573985|NCT05609253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139573986|NCT05609253|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139573987|NCT05609253|Hormone Antagonists|hormone antagonists|mesh-ancestor
139573988|NCT05609253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139573989|NCT05609253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573990|NCT05609253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139573991|NCT01822535|Midodrine|midodrine|mesh-list
139573992|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
139573993|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
139573994|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139573995|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139573996|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139573997|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139573998|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139573999|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139574000|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
139574001|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139574002|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574003|NCT01537666|Vancomycin|vancomycin|mesh-list
139574004|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139574005|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574006|NCT01537900|Grazoprevir|grazoprevir|mesh-list
139574007|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
139574008|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574009|NCT01799993|Amikacin|amikacin|mesh-list
139574010|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139574011|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574012|NCT01593592|Amoxicillin|amoxicillin|mesh-list
139574013|NCT01593592|Clarithromycin|clarithromycin|mesh-list
139574014|NCT01593592|Omeprazole|omeprazole|mesh-list
139574015|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139574016|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574017|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139574018|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139574019|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139076395|NCT05931458|Infliximab|infliximab|mesh-list
139574020|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574021|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574022|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139574023|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139574024|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139574025|NCT03001960|Clopidogrel|clopidogrel|mesh-list
139574026|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139574027|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139574028|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139574029|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139574030|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
139574031|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139574032|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574033|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574034|NCT01593670|Decitabine|decitabine|mesh-list
139574035|NCT01593670|Interleukin-2|interleukin-2|mesh-list
139574036|NCT01593670|Vorinostat|vorinostat|mesh-list
139574037|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139574038|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
139574039|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574040|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574041|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574042|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139574043|NCT01593670|Analgesics|analgesics|mesh-ancestor
139574044|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
139574045|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574046|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574047|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139574048|NCT01593748|Gemcitabine|gemcitabine|mesh-list
139574049|NCT01593748|Docetaxel|docetaxel|mesh-list
139574050|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139574051|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
139574052|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574053|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574054|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
139574055|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
139574056|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
139574057|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
139574058|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139574059|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
139574060|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574061|NCT03005704|Aspirin|aspirin|mesh-list
139574062|NCT03005704|Ticagrelor|ticagrelor|mesh-list
139574063|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139574064|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139574065|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139574066|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139574067|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
139574068|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139574069|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574070|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574071|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139574072|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139574073|NCT03005704|Analgesics|analgesics|mesh-ancestor
139574074|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
139574075|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574076|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139574077|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139574078|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139574079|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139574080|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139574081|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574082|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
139574083|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
139574084|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139574085|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139574086|NCT01595854|Dabigatran|dabigatran|mesh-list
139574087|NCT01595854|Ticagrelor|ticagrelor|mesh-list
139076415|NCT05931263|Cytarabine|cytarabine|mesh-list
139574088|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139574089|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139574090|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139574091|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139574092|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
139574093|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139574094|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574095|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574096|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
139574097|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139574098|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
139574099|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574100|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
139574101|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
139574102|NCT01596088|Razoxane|razoxane|mesh-list
139574103|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574104|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139574105|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139574106|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139574107|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574108|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574109|NCT01596088|Protective Agents|protective agents|mesh-ancestor
139574110|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574111|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
139574112|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
139574113|NCT02216422|Ritonavir|ritonavir|mesh-list
139574114|NCT02216422|Ribavirin|ribavirin|mesh-list
139574115|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139574116|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139574117|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
139574118|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574119|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574120|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139574121|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139574122|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
139574123|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574124|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139574125|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139574126|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
139574127|NCT03001570|Cetuximab|cetuximab|mesh-list
139574128|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139574129|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574130|NCT03005548|Morphine|morphine|mesh-list
139574131|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139574132|NCT03005548|Narcotics|narcotics|mesh-ancestor
139574133|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574134|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574135|NCT03005548|Analgesics|analgesics|mesh-ancestor
139574136|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
139574137|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574138|NCT03373266|Anesthetics|anesthetics|mesh-list
139574139|NCT03373266|Sevoflurane|sevoflurane|mesh-list
139574140|NCT03373266|Isoflurane|isoflurane|mesh-list
139574141|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574142|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574143|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139574144|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139574145|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
139574146|NCT02217904|Islatravir|islatravir|mesh-list
139574147|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
139574148|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574149|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574150|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574151|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139574152|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139574153|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139642390|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139642391|NCT03059238|Celecoxib|celecoxib|mesh-list
139642392|NCT03059238|Parecoxib|parecoxib|mesh-list
139642393|NCT03059238|Oxycodone|oxycodone|mesh-list
139642394|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139642395|NCT03059238|Narcotics|narcotics|mesh-ancestor
139642396|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139642397|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642398|NCT03059238|Analgesics|analgesics|mesh-ancestor
139642399|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
139642400|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642401|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139642402|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139642403|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139642404|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139642405|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139642406|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139642407|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139642408|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139642409|NCT01891201|Oxytocin|oxytocin|mesh-list
139642410|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
139642411|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139642412|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642413|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
139642414|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139642415|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139642416|NCT04942002|Prednisolone|prednisolone|mesh-list
139642417|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
139642418|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139642419|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
139642420|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139642421|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
139642422|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
139642423|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642424|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642425|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139642426|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
139642427|NCT04942002|Hormones|hormones|mesh-ancestor
139642428|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139642429|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139642430|NCT04942002|Protective Agents|protective agents|mesh-ancestor
139642431|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139642432|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139642433|NCT01891435|Acetaminophen|acetaminophen|mesh-list
139642434|NCT01891435|Diclofenac|diclofenac|mesh-list
139642435|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139642436|NCT01891435|Analgesics|analgesics|mesh-ancestor
139642437|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
139642438|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139642439|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139642440|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
139642441|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139642442|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139642443|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139076447|NCT05930912|Sertraline|sertraline|mesh-list
139642444|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139642445|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355913|NCT00406393|Sirolimus|sirolimus|mesh-list
139574154|NCT01900002|Sorafenib|sorafenib|mesh-list
139574155|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574156|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139574157|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574158|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574159|NCT03005002|Durvalumab|durvalumab|mesh-list
139574160|NCT03005002|Ipilimumab|ipilimumab|mesh-list
139574161|NCT03005002|Tremelimumab|tremelimumab|mesh-list
139574162|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
139574163|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139574164|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
139574165|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139574166|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574167|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
139574168|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574169|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139574170|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574171|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
139574172|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139574173|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
139574174|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139574175|NCT03001102|Povidone|povidone|mesh-list
139574176|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574177|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
139574178|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
139574179|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
139574180|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
139574181|NCT03000946|Octreotide|octreotide|mesh-list
139574182|NCT03000946|Somatostatin|somatostatin|mesh-list
139574183|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139574184|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139574185|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574186|NCT03000946|Hormones|hormones|mesh-ancestor
139574187|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139574188|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574189|NCT03004768|Deucravacitinib|deucravacitinib|mesh-list
139574190|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
139574191|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139574192|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574193|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574194|NCT03005236|Tacrolimus|tacrolimus|mesh-list
139574195|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139574196|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
139574197|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574198|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139574199|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574200|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574201|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
139574202|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574203|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
139574204|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
139574205|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
139574206|NCT02519010|Amlodipine|amlodipine|mesh-list
139574207|NCT02519010|Valsartan|valsartan|mesh-list
139574208|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
139574209|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139574210|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139574211|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139574212|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574213|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139574214|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574215|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
139574216|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139574217|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139574218|NCT03004612|Metformin|metformin|mesh-list
139574219|NCT03004612|Linagliptin|linagliptin|mesh-list
139574220|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139574221|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574222|NCT03004612|Incretins|incretins|mesh-ancestor
139574223|NCT03004612|Hormones|hormones|mesh-ancestor
139574224|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139574225|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139574226|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
139574227|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574228|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574229|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
139574230|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139574231|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
139574232|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139574233|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
139574234|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574235|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574236|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
139574237|NCT03372486|Bupivacaine|bupivacaine|mesh-list
139574238|NCT03372486|Naloxone|naloxone|mesh-list
139574239|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
139574240|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
139574241|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574242|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574243|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
139574244|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574245|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139574246|NCT05035888|Phenylephrine|phenylephrine|mesh-list
139574247|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
139574248|NCT05035888|Norepinephrine|norepinephrine|mesh-list
139574249|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139574250|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139574251|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
139574252|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
139574253|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574254|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574255|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
139574256|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
139574257|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
139574258|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139574259|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139574260|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139574261|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
139574262|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139574263|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574264|NCT05035888|Protective Agents|protective agents|mesh-ancestor
139574265|NCT03362814|Ritonavir|ritonavir|mesh-list
139574266|NCT03362814|Ribavirin|ribavirin|mesh-list
139574267|NCT03362814|Lactams|lactams|mesh-list
139076469|NCT05930665|Growth Substances|growth substances|mesh-ancestor
139574268|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139574269|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139574270|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
139574271|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574272|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574273|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139574274|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139574275|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
139574276|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574277|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139574278|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139574279|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
139574280|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139574281|NCT03004066|Daptomycin|daptomycin|mesh-list
139574282|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139574283|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574284|NCT03362736|Ustekinumab|ustekinumab|mesh-list
139574285|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
139574286|NCT03004222|Bupivacaine|bupivacaine|mesh-list
139574287|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
139574288|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
139574289|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574290|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574291|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
139574292|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574293|NCT03000634|Dexamethasone|dexamethasone|mesh-list
139574294|NCT03000634|Lenalidomide|lenalidomide|mesh-list
139574295|NCT03000634|Bortezomib|bortezomib|mesh-list
139574296|NCT03000634|Elotuzumab|elotuzumab|mesh-list
139574297|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139574298|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
139574299|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
139574300|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574301|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574302|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139574303|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
139574304|NCT03000634|Hormones|hormones|mesh-ancestor
139574305|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139574306|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139574307|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574308|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
139574309|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139574310|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139574311|NCT03000634|Growth Substances|growth substances|mesh-ancestor
139574312|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
139574313|NCT02520102|Sargramostim|sargramostim|mesh-list
139574314|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
139574315|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574316|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139574317|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
139574318|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139574319|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139574320|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
139574321|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574322|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
139574323|NCT03000556|Protective Agents|protective agents|mesh-ancestor
139574324|NCT03371862|Liraglutide|liraglutide|mesh-list
139574325|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139574326|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574327|NCT03371862|Incretins|incretins|mesh-ancestor
139574328|NCT03371862|Hormones|hormones|mesh-ancestor
139574329|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139574330|NCT03368430|Melatonin|melatonin|mesh-list
139574331|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
139574332|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574333|NCT03368430|Protective Agents|protective agents|mesh-ancestor
139574334|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574335|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574336|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
139574337|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139574338|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
139574339|NCT03003832|Analgesics|analgesics|mesh-list
139574340|NCT03003832|Narcotics|narcotics|mesh-ancestor
139574341|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574342|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574343|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
139574344|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574345|NCT03368352|Melatonin|melatonin|mesh-list
139574346|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
139574347|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574348|NCT03368352|Protective Agents|protective agents|mesh-ancestor
139574349|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574350|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574351|NCT02248012|Everolimus|everolimus|mesh-list
139574352|NCT02248012|Temozolomide|temozolomide|mesh-list
139574353|NCT02248012|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139574354|NCT02248012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139574355|NCT02248012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574356|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574357|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139574358|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
139574359|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574360|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574361|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139574362|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
139574363|NCT03362268|Omeprazole|omeprazole|mesh-list
139574364|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139574365|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139574366|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139574367|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574368|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574369|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139574370|NCT04523844|Brinzolamide|brinzolamide|mesh-list
139574371|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139574372|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139574373|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139574374|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139574375|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
139574376|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139574377|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574378|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574379|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139574380|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574381|NCT03361878|Metformin|metformin|mesh-list
139574382|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139574383|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574384|NCT03361800|Entinostat|entinostat|mesh-list
139574385|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574386|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139574387|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574388|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574389|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
139574390|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574391|NCT02998606|Naloxegol|naloxegol|mesh-list
139574392|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139574393|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574394|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
139574395|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574396|NCT05365438|Atorvastatin|atorvastatin|mesh-list
139574397|NCT05365438|Ezetimibe|ezetimibe|mesh-list
139574398|NCT05365438|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139574399|NCT05365438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139574400|NCT05365438|Antimetabolites|antimetabolites|mesh-ancestor
139574401|NCT05365438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574402|NCT05365438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139574403|NCT05365438|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139574404|NCT05365438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574405|NCT02248168|Pramipexole|pramipexole|mesh-list
139574406|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
139574407|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574408|NCT02248168|Protective Agents|protective agents|mesh-ancestor
139574409|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574410|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139574411|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139574412|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
139574413|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
139574414|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139574415|NCT03002428|Teriparatide|teriparatide|mesh-list
139574416|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139574417|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574418|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139574419|NCT03371550|Docetaxel|docetaxel|mesh-list
139574420|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574421|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
139574422|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
139574423|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
139574424|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574425|NCT05670028|Antihypertensive Agents|antihypertensive agents|mesh-list
139574426|NCT05669872|Ferric Compounds|ferric compounds|mesh-list
139574427|NCT05669872|Hematinics|hematinics|mesh-ancestor
139574428|NCT04861948|Bevacizumab|bevacizumab|mesh-list
139574429|NCT04861948|Carboplatin|carboplatin|mesh-list
139574430|NCT04861948|Pemetrexed|pemetrexed|mesh-list
139574431|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139574432|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574433|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139574434|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139574435|NCT04861948|Growth Substances|growth substances|mesh-ancestor
139574436|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574437|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
139574438|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574439|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574440|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139574441|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139574442|NCT04526028|Fulvestrant|fulvestrant|mesh-list
139574443|NCT04526028|Palbociclib|palbociclib|mesh-list
139574444|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139574445|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574446|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139574447|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139574448|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
139574449|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139574450|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574451|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139574452|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574453|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574454|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139574455|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356205|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
139574456|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
139574457|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139574459|NCT03368274|Hormones|hormones|mesh-ancestor
139574460|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139574461|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574462|NCT02247544|Trabectedin|trabectedin|mesh-list
139574463|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139574464|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
139574465|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574466|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574467|NCT03370848|Aspirin|aspirin|mesh-list
139574468|NCT03370848|Psyllium|psyllium|mesh-list
139574469|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139574470|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139574471|NCT03370848|Analgesics|analgesics|mesh-ancestor
139574472|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
139574473|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574474|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574475|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139574476|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139574477|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139574478|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139574479|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574480|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139574481|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139574482|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574483|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
139574484|NCT03370848|Cathartics|cathartics|mesh-ancestor
139574485|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139574486|NCT02248792|Methotrexate|methotrexate|mesh-list
139574487|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139574488|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
139574489|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139574490|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574491|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139574492|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
139574493|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574494|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574495|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
139574496|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574497|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139574498|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139574499|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
139574500|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139574501|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139574502|NCT03367728|Ropivacaine|ropivacaine|mesh-list
139574503|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
139574504|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
139574505|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574506|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574507|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
139574508|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574509|NCT02248870|Dexamethasone|dexamethasone|mesh-list
139574510|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139574511|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
139574512|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
139574513|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574514|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574515|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139574516|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
139574517|NCT02248870|Hormones|hormones|mesh-ancestor
139574518|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139574519|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139574520|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574521|NCT04073056|Bupivacaine|bupivacaine|mesh-list
139574522|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
139574523|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
139574524|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574525|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574526|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
139574527|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574528|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
139574529|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139574531|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574532|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139574533|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574534|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139574535|NCT03361098|Incretins|incretins|mesh-ancestor
139574536|NCT03361098|Hormones|hormones|mesh-ancestor
139574537|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139574538|NCT03367494|Bromides|bromides|mesh-list
139574539|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
139574540|NCT05594290|Etoposide|etoposide|mesh-list
139574541|NCT05594290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574542|NCT05594290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139574543|NCT05594290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139574544|NCT05594290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139574545|NCT05594290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574546|NCT05594290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574547|NCT03370380|Aflibercept|aflibercept|mesh-list
139574548|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139574549|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139574550|NCT03370380|Growth Substances|growth substances|mesh-ancestor
139574551|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574552|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
139574553|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574554|NCT04414540|Metformin|metformin|mesh-list
139574555|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
139574556|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139574557|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574558|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139574559|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574560|NCT04414540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139574561|NCT04414540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574562|NCT03367182|Paclitaxel|paclitaxel|mesh-list
139574563|NCT03367182|Bevacizumab|bevacizumab|mesh-list
139574564|NCT03367182|Doxorubicin|doxorubicin|mesh-list
139574565|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139574566|NCT03367182|Topotecan|topotecan|mesh-list
139574567|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139574568|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574569|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
139574570|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
139574571|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
139574572|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574573|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139574574|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139574575|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139574576|NCT03367182|Growth Substances|growth substances|mesh-ancestor
139574577|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574578|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
139574579|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139574580|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139574581|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139574582|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574583|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139574584|NCT05561764|Imipenem|imipenem|mesh-list
139574585|NCT05561764|Relebactam|relebactam|mesh-list
139574586|NCT05561764|Cilastatin|cilastatin|mesh-list
139574587|NCT05561764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139574588|NCT05561764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574589|NCT05561764|Protease Inhibitors|protease inhibitors|mesh-ancestor
139574590|NCT05561764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574591|NCT05561764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076524|NCT05930002|Antimitotic Agents|antimitotic agents|mesh-ancestor
139574592|NCT05561764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139574593|NCT03358212|Denosumab|denosumab|mesh-list
139574594|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139574595|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574596|NCT03109392|Lidocaine|lidocaine|mesh-list
139574597|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
139574598|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
139574599|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574600|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574601|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
139574602|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356359|NCT02500329|Acarbose|acarbose|mesh-list
139574603|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139574604|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139574605|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139574606|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139574607|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574608|NCT03357900|Remifentanil|remifentanil|mesh-list
139574609|NCT03357900|Propofol|propofol|mesh-list
139574610|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139574611|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574612|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574613|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139574614|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
139574615|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
139574616|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139574617|NCT03357900|Narcotics|narcotics|mesh-ancestor
139574618|NCT03357900|Analgesics|analgesics|mesh-ancestor
139574619|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
139574620|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574621|NCT04525326|Bevacizumab|bevacizumab|mesh-list
139574622|NCT04525326|Cetuximab|cetuximab|mesh-list
139574623|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139574624|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574625|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139574626|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139574627|NCT04525326|Growth Substances|growth substances|mesh-ancestor
139574628|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574629|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
139574630|NCT03357822|Interferons|interferons|mesh-list
139574631|NCT03357822|Tenofovir|tenofovir|mesh-list
139574632|NCT03357822|Entecavir|entecavir|mesh-list
139574633|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574634|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
139574635|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574636|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139574637|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139574638|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574639|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574640|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139574641|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139574642|NCT03359694|Docetaxel|docetaxel|mesh-list
139574643|NCT03359694|Doxorubicin|doxorubicin|mesh-list
139574644|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139574645|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574646|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
139574647|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
139574648|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
139574649|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574650|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139574651|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139574652|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139574653|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574654|NCT03123276|Gemcitabine|gemcitabine|mesh-list
139574655|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
139574656|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139574657|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
139574658|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574659|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574660|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139574661|NCT03123276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139574662|NCT03357276|Immunomodulating Agents|immunomodulating agents|mesh-list
139574663|NCT03357276|Immunologic Factors|immunologic factors|mesh-ancestor
139574664|NCT03357276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574665|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139574666|NCT02249026|Buprenorphine|buprenorphine|mesh-list
139574667|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
139574668|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139574669|NCT02249026|Narcotics|narcotics|mesh-ancestor
139574670|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574671|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574672|NCT02249026|Analgesics|analgesics|mesh-ancestor
139574673|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
139574674|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574675|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139574676|NCT04521192|Fluzoparib|fluzoparib|mesh-list
139574677|NCT04521192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139356429|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
139574678|NCT04521192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574679|NCT04521192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574680|NCT04521192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574681|NCT03359070|Miconazole|miconazole|mesh-list
139574682|NCT03359070|Clotrimazole|clotrimazole|mesh-list
139574683|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
139574684|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574685|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139574686|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139574687|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574688|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574689|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139574690|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
139574691|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139574692|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574693|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139574694|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139574695|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139574696|NCT03366246|Lidocaine|lidocaine|mesh-list
139574697|NCT03366246|Prilocaine|prilocaine|mesh-list
139574698|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139574699|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
139574700|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
139574701|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574702|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574703|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
139574704|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574705|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139574706|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139574707|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139574708|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139574709|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574710|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139574711|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
139574712|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
139574713|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139574714|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574715|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139574716|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139574717|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139574718|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139574719|NCT04520646|Empagliflozin|empagliflozin|mesh-list
139574720|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139574721|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574722|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139574723|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574724|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
139574725|NCT01624948|Everolimus|everolimus|mesh-list
139574726|NCT01624948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139574727|NCT01624948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139574728|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574729|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574730|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139574731|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
139574732|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574733|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574734|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139574735|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139574736|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
139574737|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139574738|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574739|NCT04520880|Antibodies|antibodies|mesh-list
139574740|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
139574741|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
139574742|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
139574743|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574744|NCT03365466|Aspirin|aspirin|mesh-list
139574745|NCT03365466|Heparin|heparin|mesh-list
139574746|NCT03365466|Calcium heparin|calcium heparin|mesh-list
139574747|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139574748|NCT03365466|Tinzaparin|tinzaparin|mesh-list
139574749|NCT03365466|Dalteparin|dalteparin|mesh-list
139574750|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139574751|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139574752|NCT03365466|Analgesics|analgesics|mesh-ancestor
139574753|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
139574754|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574755|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574756|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139574757|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139574758|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139574759|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139574760|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574761|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139574762|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139574763|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574764|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
139574765|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
139574766|NCT03356964|Hormones|hormones|mesh-list
139574767|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139574768|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139574769|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574770|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
139574771|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139574772|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139574773|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139574774|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139574775|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574776|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
139574777|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139574778|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574779|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139574780|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574781|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
139574782|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139574783|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
139574784|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574785|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
139574786|NCT03365388|Protective Agents|protective agents|mesh-ancestor
139574787|NCT03123744|Palbociclib|palbociclib|mesh-list
139574788|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574789|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139574790|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574791|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574792|NCT03358524|Vitamins|vitamins|mesh-list
139574793|NCT03358524|Vitamin E|vitamin e|mesh-list
139574794|NCT03358524|Tocopherols|tocopherols|mesh-list
139574795|NCT03358524|Tocotrienols|tocotrienols|mesh-list
139574796|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
139574797|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
139574798|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574799|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
139574800|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574801|NCT03358524|Protective Agents|protective agents|mesh-ancestor
139574802|NCT04444986|Favipiravir|favipiravir|mesh-list
139574803|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
139574804|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574805|NCT03356730|Vitamin D|vitamin d|mesh-list
139574806|NCT03356730|Vitamins|vitamins|mesh-ancestor
139574807|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
139574808|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574809|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139574810|NCT03364998|Factor VIII|factor viii|mesh-list
139574811|NCT03364998|Coagulants|coagulants|mesh-ancestor
139574812|NCT04508946|Thiamine|thiamine|mesh-list
139574813|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
139574814|NCT04508946|Vitamins|vitamins|mesh-ancestor
139574815|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
139574816|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574817|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138827172|NCT05188417|Tirofiban|tirofiban|mesh-list
139574818|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
139574819|NCT03364842|Furosemide|furosemide|mesh-list
139574820|NCT03364842|Diuretics|diuretics|mesh-ancestor
139574821|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
139574822|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574823|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139574824|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139574825|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574826|NCT03364764|Sirolimus|sirolimus|mesh-list
139574827|NCT03364764|Temsirolimus|temsirolimus|mesh-list
139574828|NCT03364764|MTOR Inhibitors|mtor inhibitors|mesh-list
139574829|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139574830|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574831|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139574832|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574833|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
139574834|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139574835|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
139574836|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574837|NCT03364764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139574838|NCT03364764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139574839|NCT03364764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574840|NCT02519400|Amitriptyline|amitriptyline|mesh-list
139574841|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139574842|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
139574843|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139574844|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139574845|NCT02519400|Analgesics|analgesics|mesh-ancestor
139574846|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
139574847|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574848|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574849|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139574850|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139574851|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139574852|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574853|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
139574854|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139574855|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
139574856|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
139574857|NCT04509258|Ondansetron|ondansetron|mesh-list
139574858|NCT04509258|Mineral Oil|mineral oil|mesh-list
139574859|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139574860|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
139574861|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
139574862|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574863|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574864|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139574865|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
139574866|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
139574867|NCT04509258|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139574868|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139574869|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
139574870|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139574871|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574872|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
139574873|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574874|NCT04509258|Expectorants|expectorants|mesh-ancestor
139574875|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
139574876|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139574877|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
139574878|NCT04509258|Protective Agents|protective agents|mesh-ancestor
139574879|NCT04509258|Antidotes|antidotes|mesh-ancestor
139574880|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
139574881|NCT04509258|Vitamins|vitamins|mesh-ancestor
139574882|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
139574883|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
139574884|NCT04509258|Emollients|emollients|mesh-ancestor
139574885|NCT03354624|Mitogens|mitogens|mesh-list
139574886|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
139574887|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574888|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
139574889|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139574890|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
139574891|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139574892|NCT03364218|Expectorants|expectorants|mesh-ancestor
139574893|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
139574894|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139574895|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
139574896|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574897|NCT03364218|Protective Agents|protective agents|mesh-ancestor
139574898|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574899|NCT03364218|Antidotes|antidotes|mesh-ancestor
139574900|NCT04444284|Vaccines|vaccines|mesh-list
139574901|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
139574902|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574903|NCT03354312|Lidocaine|lidocaine|mesh-list
139574904|NCT03354312|Epinephrine|epinephrine|mesh-list
139574905|NCT03354312|Racepinephrine|racepinephrine|mesh-list
139574906|NCT03354312|Carticaine|carticaine|mesh-list
139574907|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
139574908|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
139574909|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
139574910|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574911|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574912|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
139574913|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574914|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139574915|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139574916|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139574917|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139574918|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574919|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139574920|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139574921|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
139574922|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139574923|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139574924|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139574925|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
139574926|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139574927|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
139574928|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
139574929|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
139574930|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139574931|NCT03363984|Midazolam|midazolam|mesh-list
139574932|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139574933|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139574934|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574935|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574936|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139574937|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139574938|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139574939|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139574940|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
139574941|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
139574942|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
139574943|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
139574944|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139574945|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574946|NCT03355716|Fentanyl|fentanyl|mesh-list
139574947|NCT03355716|Ketamine|ketamine|mesh-list
139574948|NCT03355716|Morphine|morphine|mesh-list
139574949|NCT03355716|Bupivacaine|bupivacaine|mesh-list
139574950|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
139574951|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
139574952|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139574953|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574954|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
139574955|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574956|NCT03355716|Analgesics|analgesics|mesh-ancestor
139574957|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139574958|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139574959|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
139574960|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139574961|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139574962|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139574963|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574964|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139574965|NCT03355716|Narcotics|narcotics|mesh-ancestor
139574966|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139574967|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
139574968|NCT03355638|Aflibercept|aflibercept|mesh-list
139574969|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139574970|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139574971|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139574972|NCT03355638|Growth Substances|growth substances|mesh-ancestor
139574973|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139574974|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
139574975|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574976|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139574977|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139574978|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139574979|NCT03355638|Analgesics|analgesics|mesh-ancestor
139574980|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
139574981|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139574982|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139574983|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139574984|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
139574985|NCT01626664|Gemcitabine|gemcitabine|mesh-list
139574986|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
139574987|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
139574988|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139574989|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
139574990|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139574991|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139574992|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
139574993|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139574994|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139574995|NCT04515966|Prednisolone|prednisolone|mesh-list
139574996|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
139574997|NCT04515966|Lidocaine|lidocaine|mesh-list
139574998|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139574999|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
139575000|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
139575001|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
139575002|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139575003|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575004|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
139575005|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575006|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139575007|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139575008|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139575009|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139575010|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575011|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139575012|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
139575013|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
139575014|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139575015|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
139575016|NCT04515966|Hormones|hormones|mesh-ancestor
139575017|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139575018|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139575019|NCT04515966|Protective Agents|protective agents|mesh-ancestor
139575020|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139575021|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575022|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139575023|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139575024|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575025|NCT03355248|Acetaminophen|acetaminophen|mesh-list
139575026|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139575027|NCT03355248|Oxycodone|oxycodone|mesh-list
139575028|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139575029|NCT03355248|Analgesics|analgesics|mesh-ancestor
139575030|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
139575031|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575032|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575033|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
139575034|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139575035|NCT03355248|Narcotics|narcotics|mesh-ancestor
139575036|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139575037|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139575038|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139575039|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139575040|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139575041|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139575042|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139575043|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139575044|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575045|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575046|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575047|NCT03350334|Analgesics|analgesics|mesh-ancestor
139575048|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
139575049|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575050|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
139575051|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139575052|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
139575053|NCT02230696|Fluticasone|fluticasone|mesh-list
139575054|NCT02230696|Xhance|xhance|mesh-list
139575055|NCT02230696|Azelastine|azelastine|mesh-list
139575056|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139575057|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139575058|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
139575059|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575060|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575061|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139575062|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
139575063|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
139575064|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139575065|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139575066|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575067|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575068|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139575069|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139575070|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
139575071|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
139575072|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575073|NCT03355014|Metformin|metformin|mesh-list
139575074|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139575075|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575076|NCT02231086|Leucovorin|leucovorin|mesh-list
139575077|NCT02231086|Capecitabine|capecitabine|mesh-list
139575078|NCT02231086|Fluorouracil|fluorouracil|mesh-list
139575079|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
139575080|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139575081|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
139575082|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575083|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575084|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139575085|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
139575086|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575087|NCT02231086|Antidotes|antidotes|mesh-ancestor
139575088|NCT02231086|Protective Agents|protective agents|mesh-ancestor
139575089|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
139575090|NCT02231086|Vitamins|vitamins|mesh-ancestor
139575091|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
139575092|NCT03353298|Allopurinol|allopurinol|mesh-list
139575093|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
139575094|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575095|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575096|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
139575097|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139575098|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139575099|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
139575100|NCT03353298|Protective Agents|protective agents|mesh-ancestor
139575101|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575102|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139575103|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139575104|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575105|NCT03187210|Immunotoxins|immunotoxins|mesh-ancestor
139575106|NCT03187210|Immunoconjugates|immunoconjugates|mesh-ancestor
139575107|NCT03187210|Immunologic Factors|immunologic factors|mesh-ancestor
139575108|NCT03187210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575109|NCT03349866|Capecitabine|capecitabine|mesh-list
139575110|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
139575111|NCT03349866|Apatinib|apatinib|mesh-list
139575112|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139575113|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
139575114|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575115|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575116|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139575117|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575118|NCT01631110|Vaccines|vaccines|mesh-list
139575119|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
139575120|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575121|NCT01631656|Azelaic acid|azelaic acid|mesh-list
139575122|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575123|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
139575124|NCT02985190|Azacitidine|azacitidine|mesh-list
139575125|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139575126|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
139575127|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575128|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575129|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575130|NCT01376310|Paclitaxel|paclitaxel|mesh-list
139575131|NCT01376310|Docetaxel|docetaxel|mesh-list
139575132|NCT01376310|Carboplatin|carboplatin|mesh-list
139575133|NCT01376310|Gemcitabine|gemcitabine|mesh-list
139575134|NCT01376310|Pemetrexed|pemetrexed|mesh-list
139575135|NCT01376310|Everolimus|everolimus|mesh-list
139575136|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139575138|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139575139|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575140|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
139575141|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
139575142|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
139575143|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575144|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139575145|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
139575146|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575147|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139575148|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139575149|NCT01376310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139575150|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139575151|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139575152|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
139575153|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575154|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
139575155|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139575156|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575157|NCT01638052|Clonidine|clonidine|mesh-list
139575158|NCT01638052|Bupivacaine|bupivacaine|mesh-list
139575159|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
139575160|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
139575161|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139575162|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575163|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
139575164|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575165|NCT01638052|Analgesics|analgesics|mesh-ancestor
139575166|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139575167|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
139575168|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
139575169|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139575170|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139575171|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139575172|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
139575173|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575174|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575175|NCT02518152|Alendronate|alendronate|mesh-list
139575176|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139575177|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575178|NCT01229878|Vitamin D|vitamin d|mesh-list
139575179|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
139575180|NCT01229878|Vitamins|vitamins|mesh-ancestor
139575181|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
139575182|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575183|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139575184|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139575185|NCT03352674|Insulin|insulin|mesh-list
139575186|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139575187|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
139575188|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139575189|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575190|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
139575191|NCT01639222|Vitamin D|vitamin d|mesh-list
139575192|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
139575193|NCT01639222|Calcium|calcium|mesh-list
139575194|NCT01639222|Vitamins|vitamins|mesh-ancestor
139575195|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
139575196|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575197|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139575198|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139575199|NCT04443270|Chloroquine|chloroquine|mesh-list
139575200|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139575201|NCT04443270|Amebicides|amebicides|mesh-ancestor
139575202|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139575203|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139575204|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575205|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
139575206|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139575207|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139575208|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139575209|NCT04443270|Analgesics|analgesics|mesh-ancestor
139575210|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
139356985|NCT02733614|SRX246|srx246|mesh-list
139575211|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575212|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575213|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139575214|NCT04443270|Filaricides|filaricides|mesh-ancestor
139575215|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
139575216|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
139575217|NCT03349008|Entecavir|entecavir|mesh-list
139575218|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
139575219|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
139575220|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575221|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139575222|NCT03352362|Acetaminophen|acetaminophen|mesh-list
139575223|NCT03352362|Ibuprofen|ibuprofen|mesh-list
139575224|NCT03352362|Propacetamol|propacetamol|mesh-list
139575225|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139575226|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139575227|NCT03352362|Analgesics|analgesics|mesh-ancestor
139575228|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
139575229|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575230|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575231|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139575232|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139575233|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139575234|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575235|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575236|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
139575237|NCT01598740|Spironolactone|spironolactone|mesh-list
139575238|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139575239|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
139575240|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139575241|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575242|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139575243|NCT01598740|Diuretics|diuretics|mesh-ancestor
139575244|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
139575245|NCT00709098|Iloprost|iloprost|mesh-list
139575246|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139575247|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
139575248|NCT03348696|Dexamethasone|dexamethasone|mesh-list
139575249|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
139575250|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139575251|NCT03348696|BB 1101|bb 1101|mesh-list
139575252|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139575253|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
139575254|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
139575255|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575256|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575257|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139575258|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
139575259|NCT03348696|Hormones|hormones|mesh-ancestor
139575260|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139575261|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139575262|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575263|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
139575264|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575265|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575266|NCT04506450|Anesthetics|anesthetics|mesh-list
139575267|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139575268|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575269|NCT03352128|Calcium|calcium|mesh-list
139575270|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139575271|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575272|NCT03122730|Epoprostenol|epoprostenol|mesh-list
139575273|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139575274|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139575275|NCT04505904|Oxytocin|oxytocin|mesh-list
139575276|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
139575277|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139575278|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575279|NCT03348462|Anthralin|anthralin|mesh-list
139575280|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
139575281|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139575282|NCT04505514|Hematinics|hematinics|mesh-ancestor
139575283|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
139575284|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139575285|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139575286|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575287|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
139575288|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
139575290|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139575291|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139575292|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139575293|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139575294|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
139575295|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575296|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575297|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575298|NCT05584956|Sildenafil Citrate|sildenafil citrate|mesh-list
139575299|NCT05584956|Vasodilator Agents|vasodilator agents|mesh-ancestor
139575300|NCT05584956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139575301|NCT05584956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139575302|NCT05584956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575303|NCT05584956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575304|NCT05584956|Urological Agents|urological agents|mesh-ancestor
139575305|NCT01376700|Factor VIII|factor viii|mesh-list
139575306|NCT01376700|Coagulants|coagulants|mesh-ancestor
139575307|NCT01797965|Daclizumab|daclizumab|mesh-list
139575308|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139575309|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
139575310|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575311|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139575312|NCT01601236|Hormones|hormones|mesh-ancestor
139575313|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139575314|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575315|NCT05584878|Chitosan|chitosan|mesh-list
139575316|NCT05584878|Calcium|calcium|mesh-list
139575317|NCT05584878|Caseins|caseins|mesh-list
139575318|NCT05584878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139575319|NCT05584878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575320|NCT05584878|Chelating Agents|chelating agents|mesh-ancestor
139575321|NCT05584878|Sequestering Agents|sequestering agents|mesh-ancestor
139575322|NCT05584878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575323|NCT05584878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139575324|NCT05584878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139575325|NCT05584878|Antimetabolites|antimetabolites|mesh-ancestor
139575326|NCT05584878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139575327|NCT05584878|Hemostatics|hemostatics|mesh-ancestor
139575328|NCT05584878|Coagulants|coagulants|mesh-ancestor
139575329|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139575330|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139575331|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139575332|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575333|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
139575334|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139575335|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
139575336|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575337|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575338|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
139575339|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
139575340|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575341|NCT03347916|Gabapentin|gabapentin|mesh-list
139575342|NCT03347916|Analgesics|analgesics|mesh-ancestor
139575343|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
139575344|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575345|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575346|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
139575347|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139575348|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139575349|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139575350|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139575351|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139575352|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139575353|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575354|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575355|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
139575356|NCT01821677|Danazol|danazol|mesh-list
139575357|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139575358|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
139575359|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139575360|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575361|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
139575363|NCT00709722|Gusperimus|gusperimus|mesh-list
139575364|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139575365|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575366|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139575367|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575368|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139575369|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
139575370|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139575371|NCT00709722|Protective Agents|protective agents|mesh-ancestor
139575372|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139575373|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
139575374|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139575375|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139575376|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139575377|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575378|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
139575379|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139575380|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139575381|NCT02378298|Prednisolone|prednisolone|mesh-list
139575382|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
139575383|NCT02378298|Rituximab|rituximab|mesh-list
139575384|NCT02378298|Methotrexate|methotrexate|mesh-list
139575385|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139575386|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
139575387|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139575388|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575389|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
139575390|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575391|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139575392|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139575393|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
139575394|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139575395|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139575396|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
139575397|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575398|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
139575399|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575400|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139575401|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139575402|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139575403|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139575404|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
139575405|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
139575406|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575407|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139575408|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
139575409|NCT02378298|Hormones|hormones|mesh-ancestor
139575410|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139575411|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139575412|NCT02378298|Protective Agents|protective agents|mesh-ancestor
139575413|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139575414|NCT02253108|Everolimus|everolimus|mesh-list
139575415|NCT02253108|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139575416|NCT02253108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139575417|NCT02253108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575418|NCT02253108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575419|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139575420|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
139575421|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575422|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575423|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
139575424|NCT01603420|Docetaxel|docetaxel|mesh-list
139575425|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
139575426|NCT01603420|Hormones|hormones|mesh-list
139575427|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139575428|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139575429|NCT01603420|Androgens|androgens|mesh-list
139575430|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575431|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
139575432|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
139575433|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
139575434|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575435|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139575436|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575438|NCT01603420|Protective Agents|protective agents|mesh-ancestor
139575439|NCT01603420|Vitamins|vitamins|mesh-ancestor
139575440|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
139575441|NCT01603420|Estrogens|estrogens|mesh-ancestor
139575442|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139575443|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
139575444|NCT02064036|Leuprolide|leuprolide|mesh-list
139575445|NCT02064036|Goserelin|goserelin|mesh-list
139575446|NCT02064036|Bicalutamide|bicalutamide|mesh-list
139575447|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139575448|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
139575449|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139575450|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575451|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139575452|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575453|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
139575454|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
139575455|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139575456|NCT05645484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139575457|NCT05645484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139575458|NCT05645484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575459|NCT04551300|Sevelamer|sevelamer|mesh-list
139575460|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
139575461|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
139575462|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575463|NCT04974580|Nicotine|nicotine|mesh-list
139575464|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139575465|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
139575466|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575467|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575468|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139575469|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139575470|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
139575471|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575472|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575473|NCT01691326|Vaccines|vaccines|mesh-list
139575474|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
139575475|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575476|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
139575477|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139575478|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139575479|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575480|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139575481|NCT01606852|Analgesics|analgesics|mesh-ancestor
139575482|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
139575483|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575484|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139575485|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139575486|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139575487|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
139575488|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575489|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575490|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
139575491|NCT01691560|Listerine|listerine|mesh-list
139575492|NCT01691560|Calcium|calcium|mesh-list
139575493|NCT01691560|Fluorides|fluorides|mesh-list
139575494|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
139575495|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
139575496|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139575497|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575498|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139575499|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
139575500|NCT01691560|Protective Agents|protective agents|mesh-ancestor
139575501|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139575502|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575503|NCT03346200|Tamoxifen|tamoxifen|mesh-list
139575504|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139575505|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
139575506|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139575507|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575508|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139575509|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575510|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139575511|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139575512|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139575514|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139575515|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
139575516|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575517|NCT01692340|Protective Agents|protective agents|mesh-ancestor
139575518|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575519|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139575520|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139575521|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575522|NCT02517372|Pemirolast|pemirolast|mesh-list
139575523|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
139575524|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
139575525|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575526|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575527|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575528|NCT02516826|Olmesartan|olmesartan|mesh-list
139575529|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139575530|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139575531|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139575532|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139575533|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
139575534|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575535|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139575536|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139575537|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575538|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139575539|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139575540|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139575541|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
139575542|NCT01650298|Thrombin|thrombin|mesh-list
139575543|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
139575544|NCT01650298|Coagulants|coagulants|mesh-ancestor
139575545|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
139575546|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139575547|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
139575548|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575549|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575550|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
139575551|NCT01795937|Itraconazole|itraconazole|mesh-list
139575552|NCT01795937|Atorvastatin|atorvastatin|mesh-list
139575553|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139575554|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139575555|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139575556|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
139575557|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575558|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139575559|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139575560|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575561|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
139575562|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575563|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139575564|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139575565|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139575566|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
139575567|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139575568|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575569|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139575570|NCT04501224|Tenofovir|tenofovir|mesh-list
139575571|NCT04501224|Entecavir|entecavir|mesh-list
139575572|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
139575573|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575574|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139575575|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139575576|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575577|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575578|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139575579|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139575580|NCT01817777|Metformin|metformin|mesh-list
139575581|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139575582|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575583|NCT01795547|Aripiprazole|aripiprazole|mesh-list
139357334|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
139575584|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139575585|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
139575586|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139575587|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139575588|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139575589|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139575590|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575591|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
139575592|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
139575593|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575594|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575595|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139575596|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139575597|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
139575598|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139575599|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139575600|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139575601|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139575602|NCT02516904|Rezafungin|rezafungin|mesh-list
139575603|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
139575604|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575605|NCT01794845|Docetaxel|docetaxel|mesh-list
139575606|NCT01794845|Cetuximab|cetuximab|mesh-list
139575607|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575608|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
139575609|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
139575610|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
139575611|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575612|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139575613|NCT01794689|Morphine|morphine|mesh-list
139575614|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139575615|NCT01794689|Narcotics|narcotics|mesh-ancestor
139575616|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139575617|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575618|NCT01794689|Analgesics|analgesics|mesh-ancestor
139575619|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
139575620|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575621|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
139575622|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139575623|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139575624|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575625|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
139076760|NCT05595460|Carboplatin|carboplatin|mesh-list
139575626|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
139575627|NCT00708552|Donepezil|donepezil|mesh-list
139575628|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139575629|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575630|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575631|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
139575632|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575633|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575634|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
139575635|NCT02516436|Buprenorphine|buprenorphine|mesh-list
139575636|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139575637|NCT02516436|Narcotics|narcotics|mesh-ancestor
139575638|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139575639|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575640|NCT02516436|Analgesics|analgesics|mesh-ancestor
139575641|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
139575642|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575643|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139575644|NCT03347526|Vigabatrin|vigabatrin|mesh-list
139575645|NCT03347526|Cosyntropin|cosyntropin|mesh-list
139575646|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
139575647|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575648|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575649|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
139575650|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575651|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575652|NCT03347526|Hormones|hormones|mesh-ancestor
139575653|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139575654|NCT03347370|Interferons|interferons|mesh-list
139575655|NCT03347370|Interferon-beta|interferon-beta|mesh-list
139575656|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
139575657|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
139575658|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575659|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
139575660|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575661|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
139575662|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575663|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139575664|NCT02515968|Propofol|propofol|mesh-list
139575665|NCT02515968|Desflurane|desflurane|mesh-list
139575666|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139575667|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139575668|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575669|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139575670|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
139575671|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
139575672|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139575673|NCT03345966|Antibodies|antibodies|mesh-list
139575674|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
139575675|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575676|NCT02507700|Bupivacaine|bupivacaine|mesh-list
139575677|NCT02507700|Sevoflurane|sevoflurane|mesh-list
139575678|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
139575679|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
139575680|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139575681|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575682|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
139575683|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575684|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139575685|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139575686|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
139575687|NCT02513004|Clopidogrel|clopidogrel|mesh-list
139575688|NCT02513004|Ticagrelor|ticagrelor|mesh-list
139575689|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139575690|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139575691|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139575692|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139575693|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
139575694|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575695|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575696|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575697|NCT04500522|Isoniazid|isoniazid|mesh-list
139575698|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
139575699|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139575700|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575701|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139575702|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139575703|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
139575704|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575705|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139575706|NCT02507232|Temozolomide|temozolomide|mesh-list
139575707|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139575708|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
139575709|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575710|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575711|NCT02506998|Histamine|histamine|mesh-list
139575712|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
139575713|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139575714|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
139575715|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
139575716|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
139575717|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575718|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575719|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575720|NCT02507076|Melphalan|melphalan|mesh-list
139575721|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139575722|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
139575723|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575724|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575725|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139575726|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139575727|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
139575728|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575729|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139575730|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139575731|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139575732|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139575733|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575734|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575735|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575736|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139575737|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
139575738|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139575739|NCT04500678|Metformin|metformin|mesh-list
139575740|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139575741|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575742|NCT02507154|Cetuximab|cetuximab|mesh-list
139575743|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139575744|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575745|NCT02515734|Leucovorin|leucovorin|mesh-list
139575746|NCT02515734|Bevacizumab|bevacizumab|mesh-list
139575747|NCT02515734|Cetuximab|cetuximab|mesh-list
139575748|NCT02515734|Fluorouracil|fluorouracil|mesh-list
139575749|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
139575750|NCT02515734|Irinotecan|irinotecan|mesh-list
139575751|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139575752|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575753|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139575754|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139575755|NCT02515734|Growth Substances|growth substances|mesh-ancestor
139575756|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575757|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
139575758|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
139575759|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575760|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139575761|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139575762|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
139575763|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139575764|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139575765|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575766|NCT02515734|Antidotes|antidotes|mesh-ancestor
139575767|NCT02515734|Protective Agents|protective agents|mesh-ancestor
139575768|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
139575769|NCT02515734|Vitamins|vitamins|mesh-ancestor
139575770|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
139575771|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
139575772|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139575773|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139575774|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139575775|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139575776|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575777|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
139575778|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575779|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575780|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139575781|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575782|NCT02506842|Leucovorin|leucovorin|mesh-list
139575783|NCT02506842|Folic Acid|folic acid|mesh-list
139575784|NCT02506842|Gemcitabine|gemcitabine|mesh-list
139575785|NCT02506842|Fluorouracil|fluorouracil|mesh-list
139575786|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
139575787|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
139575788|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575789|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575790|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139575791|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
139575792|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139575793|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
139575794|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575795|NCT02506842|Antidotes|antidotes|mesh-ancestor
139575796|NCT02506842|Protective Agents|protective agents|mesh-ancestor
139575797|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
139575798|NCT02506842|Vitamins|vitamins|mesh-ancestor
139575799|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
139575800|NCT02506842|Hematinics|hematinics|mesh-ancestor
139575801|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
139575802|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139575803|NCT03345498|Entecavir|entecavir|mesh-list
139575804|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
139575805|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575806|NCT02506686|Meropenem|meropenem|mesh-list
139575807|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139575808|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575809|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
139575810|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139575811|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575812|NCT02512380|Docetaxel|docetaxel|mesh-list
139575813|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
139575814|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575815|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
139575816|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
139575817|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
139575818|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575819|NCT04497792|Metformin|metformin|mesh-list
139575820|NCT04497792|Empagliflozin|empagliflozin|mesh-list
139575821|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139575822|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575823|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139575824|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575825|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
139575826|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139575827|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139575828|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139575829|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139575830|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575831|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
139575832|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575833|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575834|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139575835|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575836|NCT02515422|Ketamine|ketamine|mesh-list
139575837|NCT02515422|Bupivacaine|bupivacaine|mesh-list
139575838|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
139575839|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
139575840|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139575841|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575842|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
139575843|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575844|NCT02515422|Analgesics|analgesics|mesh-ancestor
139575845|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139575846|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139575847|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
139575848|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139575849|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139575850|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575851|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575852|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139575853|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
139575854|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575855|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575856|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139575857|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575858|NCT02506140|Aspirin|aspirin|mesh-list
139575859|NCT02506140|Clopidogrel|clopidogrel|mesh-list
139575860|NCT02506140|Ticagrelor|ticagrelor|mesh-list
139575861|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139575862|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139575863|NCT02506140|Analgesics|analgesics|mesh-ancestor
139575864|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
139575865|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575866|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575867|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139575868|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139575869|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139575870|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139575871|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575872|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139575873|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139575874|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575875|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
139575876|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139575877|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139575878|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139575879|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
139575880|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575881|NCT02515188|Acetaminophen|acetaminophen|mesh-list
139575882|NCT02515188|Propacetamol|propacetamol|mesh-list
139575883|NCT02515188|Analgesics|analgesics|mesh-ancestor
139575884|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
139575885|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575886|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575887|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139575888|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139575889|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139575890|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139575891|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
139575892|NCT01696084|Cytarabine|cytarabine|mesh-list
139575893|NCT01696084|Daunorubicin|daunorubicin|mesh-list
139575894|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139575895|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
139575896|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575897|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575898|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
139575899|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575900|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139575901|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
139575902|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575903|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139575904|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139575905|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139575906|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575907|NCT02228824|Nicotine|nicotine|mesh-list
139575908|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139575909|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
139575910|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139575911|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575912|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139575913|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139575914|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
139575915|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575916|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575917|NCT02511366|Caseins|caseins|mesh-list
139575918|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
139575919|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
139076847|NCT05393271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575920|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575921|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
139575922|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139575923|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575924|NCT04443036|Paclitaxel|paclitaxel|mesh-list
139575925|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139575926|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139575927|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575928|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
139575929|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
139575930|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
139575931|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575932|NCT01653418|Cytarabine|cytarabine|mesh-list
139575933|NCT01653418|Etoposide|etoposide|mesh-list
139575934|NCT01653418|Bortezomib|bortezomib|mesh-list
139575935|NCT01653418|Melphalan|melphalan|mesh-list
139575936|NCT01653418|Carmustine|carmustine|mesh-list
139575937|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139575938|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575939|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139575940|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139575941|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575942|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575943|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139575944|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
139575945|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
139575946|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575947|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139575948|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
139575949|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575950|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139575951|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
139575952|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139575953|NCT02514642|Clopidogrel|clopidogrel|mesh-list
139575954|NCT02514642|Ticagrelor|ticagrelor|mesh-list
139575955|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139575956|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139575957|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139575958|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139575959|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
139575960|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139575961|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357713|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
139575962|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575963|NCT02511210|Anesthetics|anesthetics|mesh-list
139575964|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139575965|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139575966|NCT02237950|Metronidazole|metronidazole|mesh-list
139575967|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575968|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139575969|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139575970|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139575971|NCT02511054|Chloroquine|chloroquine|mesh-list
139575972|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
139575973|NCT02511054|Amebicides|amebicides|mesh-ancestor
139575974|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139575975|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139575976|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139575977|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
139575978|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139575979|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139575980|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575981|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575982|NCT04499118|Paclitaxel|paclitaxel|mesh-list
139575983|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139575984|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139575985|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575986|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
139575987|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
139575988|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
139575989|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575990|NCT01612546|Camptothecin|camptothecin|mesh-list
139575991|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139575992|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139575993|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139575994|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139575995|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139575996|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139575997|NCT04499898|Carvedilol|carvedilol|mesh-list
139575998|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139575999|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139576000|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
139576001|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576002|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076888|NCT05296837|Doxycycline|doxycycline|mesh-list
139576003|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576004|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139576005|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
139576006|NCT04499898|Protective Agents|protective agents|mesh-ancestor
139576007|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139576008|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139576009|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139576010|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
139576011|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139576012|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139576013|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
139576014|NCT02514330|Vitamins|vitamins|mesh-ancestor
139576015|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
139576016|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576017|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139576018|NCT02510976|Prucalopride|prucalopride|mesh-list
139576019|NCT02510976|Laxatives|laxatives|mesh-ancestor
139576020|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139576021|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139576022|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139576023|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
139576024|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576025|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576026|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576027|NCT02505516|Metformin|metformin|mesh-list
139576028|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139576029|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576030|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
139576031|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139576032|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
139576033|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576034|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
139576035|NCT02505360|Protective Agents|protective agents|mesh-ancestor
139576036|NCT04499586|Irinotecan|irinotecan|mesh-list
139576037|NCT04499586|Raltitrexed|raltitrexed|mesh-list
139576038|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139576039|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139576040|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576041|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576042|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576043|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139576044|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
139576045|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139576046|NCT02505282|Vitamin K|vitamin k|mesh-list
139576047|NCT02505282|Vitamins|vitamins|mesh-ancestor
139576048|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
139576049|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576050|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139576051|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139576052|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576053|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
139576054|NCT02505282|Coagulants|coagulants|mesh-ancestor
139576055|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
139576056|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139576057|NCT01816295|Testosterone|testosterone|mesh-list
139576058|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
139576059|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
139576060|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139576061|NCT01816295|Androgens|androgens|mesh-ancestor
139576062|NCT01816295|Hormones|hormones|mesh-ancestor
139576063|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576064|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576065|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139576066|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576067|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
139576068|NCT02514018|Vaccines|vaccines|mesh-list
139576069|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
139576070|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576071|NCT02513862|Heparin|heparin|mesh-list
139576072|NCT02513862|Protamines|protamines|mesh-list
139576073|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
139576074|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139576075|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139576076|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576077|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
139576078|NCT02513862|Coagulants|coagulants|mesh-ancestor
139576079|NCT02510586|Sevoflurane|sevoflurane|mesh-list
139576080|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139576081|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139576082|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
139576083|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
139576084|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576085|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576086|NCT01610297|Deferasirox|deferasirox|mesh-list
139576087|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139576088|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
139576089|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
139576090|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576091|NCT01660672|Levetiracetam|levetiracetam|mesh-list
139576092|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
139576093|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
139576094|NCT02505048|Rucaparib|rucaparib|mesh-list
139576095|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139576096|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576097|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576098|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576099|NCT01793051|Minocycline|minocycline|mesh-list
139576100|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139576101|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576102|NCT01792115|Vitamins|vitamins|mesh-list
139576103|NCT01792115|Vitamin E|vitamin e|mesh-list
139576104|NCT01792115|Tocopherols|tocopherols|mesh-list
139576105|NCT01792115|Tocotrienols|tocotrienols|mesh-list
139576106|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
139576107|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
139576108|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576109|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
139576110|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576111|NCT01792115|Protective Agents|protective agents|mesh-ancestor
139576112|NCT01791803|Nicotine|nicotine|mesh-list
139576113|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139576114|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
139576115|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576116|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576117|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139576118|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139576119|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
139576120|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576121|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576122|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139576123|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
139576124|NCT01662856|Coagulants|coagulants|mesh-ancestor
139576125|NCT04499976|Misoprostol|misoprostol|mesh-list
139576126|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139576127|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
139576128|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139576129|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576130|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139576131|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139576132|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
139576133|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139576134|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
139576135|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139576136|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139576137|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139576138|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
139576139|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139576140|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576141|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139576142|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139576143|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139576144|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139576145|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576146|NCT02509806|Apatinib|apatinib|mesh-list
139576147|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576148|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139576149|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576150|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576151|NCT02509728|Choline|choline|mesh-list
139576152|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
139576153|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139576154|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
139576155|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576156|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139576157|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139576158|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
139576159|NCT02501616|Metformin|metformin|mesh-list
139576160|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
139576161|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139576162|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576163|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139576164|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576165|NCT01788215|Doxycycline|doxycycline|mesh-list
139576166|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139576167|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576168|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
139576169|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139576170|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139576171|NCT01812707|Atorvastatin|atorvastatin|mesh-list
139576172|NCT01812707|Alirocumab|alirocumab|mesh-list
139576173|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139576174|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139576175|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139576176|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
139576177|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576178|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139576179|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139576180|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576181|NCT01812707|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139576182|NCT01812707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139576183|NCT01812707|Protease Inhibitors|protease inhibitors|mesh-ancestor
139576184|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
139576185|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576186|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139576187|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
139576188|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576189|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
139576190|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139576191|NCT02728206|Velpatasvir|velpatasvir|mesh-list
139576192|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
139576193|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576194|NCT01811225|Progesterone|progesterone|mesh-list
139576195|NCT01811225|Progestins|progestins|mesh-ancestor
139576196|NCT01811225|Hormones|hormones|mesh-ancestor
139576197|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576198|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576199|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139576200|NCT02508870|Azacitidine|azacitidine|mesh-list
139576201|NCT02508870|Atezolizumab|atezolizumab|mesh-list
139576202|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139576203|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
139576204|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576205|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576206|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576207|NCT02508870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139576208|NCT02508870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139576209|NCT01786109|Dronabinol|dronabinol|mesh-list
139576210|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
139576211|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576212|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139576213|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139576214|NCT01786109|Analgesics|analgesics|mesh-ancestor
139576215|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
139576216|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576217|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139576218|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139576219|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576220|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576221|NCT01786109|Hormones|hormones|mesh-ancestor
139576222|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576223|NCT02509104|Tamsulosin|tamsulosin|mesh-list
139576224|NCT02509104|Dutasteride|dutasteride|mesh-list
139576225|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139576226|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139576227|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139576228|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
139576229|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576230|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576231|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576232|NCT02509104|Urological Agents|urological agents|mesh-ancestor
139576233|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139576234|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139576235|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576236|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
139576237|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576238|NCT02500680|Vaccines|vaccines|mesh-list
139576239|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
139576240|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576241|NCT02500446|Dolutegravir|dolutegravir|mesh-list
139576242|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139576243|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139576244|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576245|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576246|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139576247|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139576248|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
139576249|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576250|NCT02500524|Permethrin|permethrin|mesh-list
139576251|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576252|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576253|NCT02508402|Dexamethasone|dexamethasone|mesh-list
139576254|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139576255|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
139576256|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
139576257|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576258|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576259|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139576260|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
139576261|NCT02508402|Hormones|hormones|mesh-ancestor
139576262|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576263|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139576264|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358021|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
139576265|NCT02500212|Tacrolimus|tacrolimus|mesh-list
139576266|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139576267|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
139576268|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576269|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139576270|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576271|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576272|NCT02508168|Metformin|metformin|mesh-list
139576273|NCT02508168|Alogliptin|alogliptin|mesh-list
139576274|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139576275|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576276|NCT02508168|Incretins|incretins|mesh-ancestor
139576277|NCT02508168|Hormones|hormones|mesh-ancestor
139576278|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576279|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139576280|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
139576281|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576282|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576283|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139576284|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139576285|NCT02508246|Cisplatin|cisplatin|mesh-list
139576286|NCT02508246|Docetaxel|docetaxel|mesh-list
139576287|NCT02508246|Adavosertib|adavosertib|mesh-list
139576288|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576289|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
139576290|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
139576291|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
139576292|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576293|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576294|NCT01617148|Aflibercept|aflibercept|mesh-list
139576295|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139576296|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139576297|NCT01617148|Growth Substances|growth substances|mesh-ancestor
139576298|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576299|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
139576300|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576301|NCT02499978|Dolutegravir|dolutegravir|mesh-list
139576302|NCT02499978|Darunavir|darunavir|mesh-list
139576303|NCT02499978|Cobicistat|cobicistat|mesh-list
139576304|NCT02499978|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139576305|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139576306|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139576307|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576308|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576309|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139576310|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139576311|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
139576312|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576313|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139576314|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139576315|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
139576316|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139576317|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139576318|NCT01620190|Paclitaxel|paclitaxel|mesh-list
139576319|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139576320|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139576321|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576322|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
139576323|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
139576324|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
139576325|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576326|NCT04498884|Insulin|insulin|mesh-list
139576327|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139576328|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139576329|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576330|NCT01621672|Lenalidomide|lenalidomide|mesh-list
139576331|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
139576332|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576333|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139576334|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139576335|NCT01621672|Growth Substances|growth substances|mesh-ancestor
139576336|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
139576337|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576338|NCT03344328|Bortezomib|bortezomib|mesh-list
139576339|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576340|NCT02499822|Ramipril|ramipril|mesh-list
139576341|NCT02499822|Nifedipine|nifedipine|mesh-list
139576342|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139077086|NCT05021913|Lidocaine|lidocaine|mesh-list
139576343|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
139576344|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576345|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576346|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139576347|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139576348|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139576349|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139576350|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576351|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
139576352|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
139576353|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139576354|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
139576355|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576356|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139576357|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139576358|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576359|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576360|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
139576361|NCT03343548|Analgesics|analgesics|mesh-ancestor
139576362|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
139576363|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576364|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576365|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
139576366|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576367|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139576368|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
139576369|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139576370|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139576371|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576372|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139576373|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
139576374|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139576375|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
139576376|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139576377|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
139576378|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576379|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
139576380|NCT02507934|Protective Agents|protective agents|mesh-ancestor
139576381|NCT01622296|Lidocaine|lidocaine|mesh-list
139576382|NCT01622296|Epinephrine|epinephrine|mesh-list
139576383|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
139576384|NCT01622296|Anesthetics|anesthetics|mesh-list
139576385|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576386|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576387|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
139576388|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576389|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139576390|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139576391|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139576392|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139576393|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576394|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139576395|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139576396|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
139576397|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576398|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139576399|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139576400|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
139576401|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139576402|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
139576403|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
139576404|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
139576405|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139576406|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
139576407|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139576408|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576409|NCT02728830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139576410|NCT02728830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576411|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139576412|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139576413|NCT01705288|Morphine|morphine|mesh-list
139576414|NCT01705288|Narcotics|narcotics|mesh-list
139576415|NCT01705288|Anesthetics|anesthetics|mesh-list
139576416|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576417|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576418|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139576419|NCT01705288|Analgesics|analgesics|mesh-ancestor
139576420|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
139576421|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576422|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139576423|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139576424|NCT03343002|Fentanyl|fentanyl|mesh-list
139576425|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139576426|NCT03343002|Narcotics|narcotics|mesh-ancestor
139576427|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576428|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576429|NCT03343002|Analgesics|analgesics|mesh-ancestor
139576430|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
139576431|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576432|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139576433|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139576434|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
139576435|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
139576436|NCT03120936|Tenofovir|tenofovir|mesh-list
139576437|NCT03120936|Emtricitabine|emtricitabine|mesh-list
139576438|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
139576439|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576440|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139576441|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139576442|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576443|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576444|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139576445|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139576446|NCT02234752|Memantine|memantine|mesh-list
139576447|NCT02234752|Galantamine|galantamine|mesh-list
139576448|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139576449|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139576450|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
139576451|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576452|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576453|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576454|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139576455|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139576456|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139576457|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576458|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
139576459|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139576460|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
139576461|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576462|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
139576463|NCT01665508|Nebivolol|nebivolol|mesh-list
139576464|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139576465|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
139576466|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139576467|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139576468|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139576469|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
139576470|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576471|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576472|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576473|NCT03344094|Interferons|interferons|mesh-list
139576474|NCT03344094|Interferon-beta|interferon-beta|mesh-list
139576475|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
139576476|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576477|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
139576478|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576479|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
139576480|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576481|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
139576482|NCT02498496|Analgesics|analgesics|mesh-ancestor
139576483|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
139576484|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576485|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576486|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
139576487|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576488|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139358313|NCT02489019|Fentanyl|fentanyl|mesh-list
139576489|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
139576490|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139576491|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139576492|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576493|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139576494|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
139576495|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139576496|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
139576497|NCT02502708|Temozolomide|temozolomide|mesh-list
139576498|NCT02502708|Etoposide|etoposide|mesh-list
139576499|NCT02502708|Tryptophan|tryptophan|mesh-list
139576500|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139576501|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
139576502|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576503|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139576504|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139576505|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
139576506|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576507|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576508|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139576509|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139576510|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139576511|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139576512|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576513|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139576514|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
139576515|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139576516|NCT01666210|Dexamethasone|dexamethasone|mesh-list
139576517|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139576518|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
139576519|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
139576520|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576521|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576522|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139576523|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
139576524|NCT01666210|Hormones|hormones|mesh-ancestor
139576525|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576526|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139576527|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576528|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
139576529|NCT01666912|Etonogestrel|etonogestrel|mesh-list
139576530|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139576531|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576532|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139576533|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139576534|NCT03341988|Ritonavir|ritonavir|mesh-list
139576535|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139576536|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139576537|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
139576538|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576539|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576540|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139576541|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139576542|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
139576543|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576544|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139576545|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139576546|NCT02501850|Metformin|metformin|mesh-list
139576547|NCT02501850|Liraglutide|liraglutide|mesh-list
139576548|NCT02501850|Exenatide|exenatide|mesh-list
139576549|NCT02501850|Lixisenatide|lixisenatide|mesh-list
139576550|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139576551|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576552|NCT02501850|Incretins|incretins|mesh-ancestor
139576553|NCT02501850|Hormones|hormones|mesh-ancestor
139576554|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576555|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139576556|NCT01709032|Deferasirox|deferasirox|mesh-list
139576557|NCT01709032|Deferiprone|deferiprone|mesh-list
139576558|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139576559|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
139576560|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
139576561|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576562|NCT02496078|Asunaprevir|asunaprevir|mesh-list
139576563|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
139576564|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576565|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576566|NCT02495922|Dexamethasone|dexamethasone|mesh-list
139576567|NCT02495922|Lenalidomide|lenalidomide|mesh-list
139576568|NCT02495922|Bortezomib|bortezomib|mesh-list
139576569|NCT02495922|Elotuzumab|elotuzumab|mesh-list
139576570|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139576571|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
139576572|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
139576573|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576574|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576575|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139576576|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
139576577|NCT02495922|Hormones|hormones|mesh-ancestor
139576578|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576579|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139576580|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576581|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
139576582|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139576583|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139576584|NCT02495922|Growth Substances|growth substances|mesh-ancestor
139576585|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
139576586|NCT01709422|Midazolam|midazolam|mesh-list
139576587|NCT01709422|Meperidine|meperidine|mesh-list
139576588|NCT01709422|Propofol|propofol|mesh-list
139576589|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139576590|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576591|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576592|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139576593|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
139576594|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
139576595|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139576596|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139576597|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139576598|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139576599|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
139576600|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
139576601|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576602|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576603|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139576604|NCT01709422|Narcotics|narcotics|mesh-ancestor
139576605|NCT01709422|Analgesics|analgesics|mesh-ancestor
139576606|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
139576607|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576608|NCT01669642|Ketamine|ketamine|mesh-list
139576609|NCT01669642|Analgesics|analgesics|mesh-ancestor
139576610|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
139576611|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576612|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576613|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139576614|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139576615|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
139576616|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
139576617|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576618|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139576619|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139576620|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576621|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576622|NCT01669720|Aflibercept|aflibercept|mesh-list
139576623|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139576624|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139576625|NCT01669720|Growth Substances|growth substances|mesh-ancestor
139576626|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576627|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
139576628|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576629|NCT01670110|Pasireotide|pasireotide|mesh-list
139576630|NCT01670110|Hormones|hormones|mesh-ancestor
139576631|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576632|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576633|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139576634|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139576635|NCT01677286|Doxycycline|doxycycline|mesh-list
139576636|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139576637|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576638|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
139576639|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139576640|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139576641|NCT04498260|Triamcinolone|triamcinolone|mesh-list
139576642|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139576643|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139576644|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139576646|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
139576647|NCT04498260|Hormones|hormones|mesh-ancestor
139576648|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576649|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576650|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139077235|NCT04718792|Psilocybin|psilocybin|mesh-list
139576651|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
139576652|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576653|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576654|NCT01680172|Ketamine|ketamine|mesh-list
139576655|NCT01680172|Analgesics|analgesics|mesh-ancestor
139576656|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
139576657|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576658|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576659|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139576660|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139576661|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
139576662|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
139576663|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576664|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139576665|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139576666|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576667|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576668|NCT02235064|Sertraline|sertraline|mesh-list
139576669|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
139576670|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139576671|NCT02235064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139576672|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139576673|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139576674|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576675|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576676|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
139576677|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576678|NCT05118490|Isoniazid|isoniazid|mesh-list
139576679|NCT05118490|Rifapentine|rifapentine|mesh-list
139576680|NCT05118490|Rifampin|rifampin|mesh-list
139576681|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
139576682|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139576683|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576684|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139576685|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139576686|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
139576687|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576688|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139576689|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139576690|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
139576691|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139576692|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576693|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139576694|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139576695|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139077266|NCT04543383|Coagulants|coagulants|mesh-ancestor
139576696|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139576697|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139576698|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139576699|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139576700|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
139576701|NCT01681030|Coagulants|coagulants|mesh-ancestor
139576702|NCT02249416|Ritonavir|ritonavir|mesh-list
139576703|NCT02249416|Zidovudine|zidovudine|mesh-list
139576704|NCT02249416|Tipranavir|tipranavir|mesh-list
139576705|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139576706|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139576707|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
139576708|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576709|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576710|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139576711|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139576712|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
139576713|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576714|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139576715|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139576716|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
139576717|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139576718|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139576719|NCT01685242|Cetirizine|cetirizine|mesh-list
139576720|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139576721|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139576722|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139576723|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
139576724|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
139576725|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576726|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576727|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576728|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
139576729|NCT00708162|Elvitegravir|elvitegravir|mesh-list
139576730|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139576731|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139576732|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
139576733|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576734|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139576735|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139576736|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576737|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576738|NCT04930042|Ustekinumab|ustekinumab|mesh-list
139576739|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
139576740|NCT04898920|Dexamethasone|dexamethasone|mesh-list
139576741|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139576742|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
139576743|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
139576744|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576745|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576746|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139576747|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
139576748|NCT04898920|Hormones|hormones|mesh-ancestor
139576749|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576750|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139576751|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139576752|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
139576753|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139576754|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576755|NCT01686646|Acetaminophen|acetaminophen|mesh-list
139576756|NCT01686646|Caffeine|caffeine|mesh-list
139576757|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139576758|NCT01686646|Analgesics|analgesics|mesh-ancestor
139576759|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
139576760|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576761|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576762|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
139576763|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139576764|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139576765|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576766|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576767|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139576768|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139576769|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
139576770|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576771|NCT02495688|Anesthetics|anesthetics|mesh-list
139576772|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576773|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576774|NCT01688596|Bupivacaine|bupivacaine|mesh-list
139576775|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
139576776|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
139576777|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576778|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576779|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
139576780|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576781|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139576782|NCT04869592|Vaccines|vaccines|mesh-list
139576783|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
139576784|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576785|NCT05709652|Ivermectin|ivermectin|mesh-list
139576786|NCT05709652|Selamectin|selamectin|mesh-list
139576787|NCT05709652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139576788|NCT05709652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576789|NCT01690000|Melatonin|melatonin|mesh-list
139576790|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
139576791|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576792|NCT01690000|Protective Agents|protective agents|mesh-ancestor
139576793|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576794|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576795|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
139576796|NCT02495220|Bupivacaine|bupivacaine|mesh-list
139576797|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
139576798|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
139576799|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576800|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576801|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
139576802|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576803|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139576804|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139576805|NCT02495220|Analgesics|analgesics|mesh-ancestor
139576806|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139576807|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139576808|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139576809|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
139576810|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576811|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576813|NCT01690546|Buprenorphine|buprenorphine|mesh-list
139576814|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139576815|NCT01690546|Naloxone|naloxone|mesh-list
139576816|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139576817|NCT01690546|Narcotics|narcotics|mesh-ancestor
139576818|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576819|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576820|NCT01690546|Analgesics|analgesics|mesh-ancestor
139576821|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
139576822|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576823|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139576824|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139576825|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
139576826|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576827|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
139576828|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139576829|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576830|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
139576831|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139576832|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576833|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576834|NCT02494830|Ketamine|ketamine|mesh-list
139576835|NCT02494830|Analgesics|analgesics|mesh-ancestor
139576836|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
139576837|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576838|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576839|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139576840|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139576841|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
139576842|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
139576843|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576844|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139576845|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139576846|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576847|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576848|NCT03336840|Metformin|metformin|mesh-list
139576849|NCT03336840|Promethazine|promethazine|mesh-list
139576850|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
139576851|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139576852|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576853|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
139576854|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
139576855|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139576856|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
139576857|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
139576858|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576859|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576860|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139576861|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139576862|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139576863|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576864|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
139576865|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
139576866|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
139576867|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576868|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
139576869|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
139576870|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139576871|NCT02497638|Metformin|metformin|mesh-list
139576872|NCT02497638|Biguanides|biguanides|mesh-list
139576873|NCT02497638|Atorvastatin|atorvastatin|mesh-list
139576874|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139576875|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576876|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139576877|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139576878|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
139576879|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576880|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139576881|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139576882|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576883|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
139576884|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139576885|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
139576886|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139576887|NCT02493192|Meperidine|meperidine|mesh-list
139576888|NCT02493192|Haloperidol|haloperidol|mesh-list
139576889|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
139576890|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
139576891|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
139576892|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576893|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576894|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139576895|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139576896|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139576897|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576898|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139576899|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139576900|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
139576901|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576902|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576903|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139576904|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139576905|NCT02493192|Narcotics|narcotics|mesh-ancestor
139576906|NCT02493192|Analgesics|analgesics|mesh-ancestor
139576907|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
139576908|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139576909|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
139576910|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139576911|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
139576912|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139576913|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
139576914|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576915|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576916|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
139576917|NCT02238808|Estradiol|estradiol|mesh-list
139576918|NCT02238808|Estrogens|estrogens|mesh-list
139576919|NCT02238808|Hormones|hormones|mesh-ancestor
139576920|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576921|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576922|NCT02497326|Heparin|heparin|mesh-list
139576923|NCT02497326|Tramadol|tramadol|mesh-list
139576924|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
139576925|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139576926|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139576927|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576928|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139576929|NCT02497326|Narcotics|narcotics|mesh-ancestor
139576930|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576931|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576932|NCT02497326|Analgesics|analgesics|mesh-ancestor
139576933|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
139576934|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576935|NCT02245672|Fluticasone|fluticasone|mesh-list
139576937|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139576938|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139576939|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139576940|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
139576941|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139576942|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576943|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139576944|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
139358690|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
139576945|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
139576947|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139576948|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139576949|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139576950|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
139576951|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576952|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576953|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
139576954|NCT04461418|Hormones|hormones|mesh-ancestor
139576955|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576956|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576957|NCT03335904|Losartan|losartan|mesh-list
139576958|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139576959|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139576960|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139576961|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139576962|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576963|NCT03335826|Anesthetics|anesthetics|mesh-list
139576964|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139576965|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576966|NCT03340740|Cetirizine|cetirizine|mesh-list
139576967|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139576968|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139576969|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139576970|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
139576971|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
139576972|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139576973|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576974|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576975|NCT03340662|Itraconazole|itraconazole|mesh-list
139576976|NCT03340662|Rifampin|rifampin|mesh-list
139576977|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
139576978|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
139576979|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139576980|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139576981|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139576982|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139576983|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139576984|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139576985|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
139576986|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139576987|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139576988|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139576989|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139576990|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
139576991|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139576992|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
139576993|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139576994|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139576995|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139576996|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139576997|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139576998|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139576999|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139577000|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139577001|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139577002|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577003|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139577004|NCT03340662|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139577005|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139577006|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139577007|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577008|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
139577009|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139577010|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
139577011|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139577012|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139577013|NCT03342300|Doxorubicin|doxorubicin|mesh-list
139577014|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139577015|NCT03342300|Pirarubicin|pirarubicin|mesh-list
139577016|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139577017|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577018|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139577019|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139577020|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577021|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577022|NCT01711918|Domperidone|domperidone|mesh-list
139577023|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
139577024|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
139577025|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577026|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577027|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139077391|NCT04267549|Paclitaxel|paclitaxel|mesh-list
139577028|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139577029|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
139577030|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577031|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577032|NCT03120468|Topiramate|topiramate|mesh-list
139577033|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
139577034|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139577035|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
139577036|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139577037|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577038|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
139577039|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577040|NCT03120468|Expectorants|expectorants|mesh-ancestor
139577041|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
139577042|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139577043|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
139577044|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577045|NCT03120468|Protective Agents|protective agents|mesh-ancestor
139577046|NCT03120468|Antidotes|antidotes|mesh-ancestor
139577047|NCT01712230|Leuprolide|leuprolide|mesh-list
139577048|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139577049|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
139577050|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139577051|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577052|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139577053|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577054|NCT03335436|Gabapentin|gabapentin|mesh-list
139577055|NCT03335436|Analgesics|analgesics|mesh-ancestor
139577056|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
139577057|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577058|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577059|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
139577060|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139577061|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139577062|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577063|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139577064|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139577065|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139577066|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577067|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577068|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
139577069|NCT02494284|Aspirin|aspirin|mesh-list
139577070|NCT02494284|Clopidogrel|clopidogrel|mesh-list
139577071|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139577072|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139577073|NCT02494284|Analgesics|analgesics|mesh-ancestor
139577074|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
139577075|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577076|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577077|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139577078|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139577079|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139577080|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139577081|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577082|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139577083|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139577084|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577085|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
139577086|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139577087|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139577088|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139577089|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
139577090|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577092|NCT01713400|Ustekinumab|ustekinumab|mesh-list
139577094|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139577095|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
139577096|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577097|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139577098|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313217|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577099|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577100|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139577101|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577102|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139577103|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577104|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
139577105|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
139577106|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
139577107|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139577108|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577109|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577110|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139577111|NCT04494828|Analgesics|analgesics|mesh-ancestor
139577112|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
139577113|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577114|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139577115|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139577116|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139577117|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
139577118|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577119|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577120|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
139577121|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139577122|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139577123|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577124|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
139577125|NCT01714336|Coagulants|coagulants|mesh-ancestor
139577126|NCT01716208|Ofatumumab|ofatumumab|mesh-list
139577127|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577128|NCT00706992|Aldesleukin|aldesleukin|mesh-list
139577129|NCT00706992|Vaccines|vaccines|mesh-list
139577130|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
139577131|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
139577132|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577133|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577134|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139577135|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139577136|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
139577137|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577138|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139577139|NCT03335124|Vitamins|vitamins|mesh-list
139577140|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
139577141|NCT03335124|Thiamine|thiamine|mesh-list
139577142|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
139577143|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
139577144|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577145|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139577146|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
139577147|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577148|NCT03335124|Protective Agents|protective agents|mesh-ancestor
139577149|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
139577150|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
139577151|NCT03339804|Doxorubicin|doxorubicin|mesh-list
139577152|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139577153|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
139577154|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577155|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139577156|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139577157|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
139577158|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577159|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577160|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139577161|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139577162|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139577163|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139577164|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577165|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
139577166|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577168|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
139577169|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577170|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577171|NCT02491320|Letrozole|letrozole|mesh-list
139577172|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577173|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139577174|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139577175|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577176|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577177|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139577178|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
139577179|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139577180|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577181|NCT02491242|Dolutegravir|dolutegravir|mesh-list
139577182|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139577183|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139577184|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577185|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577186|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139577187|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139577188|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
139577189|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577190|NCT03330990|Midazolam|midazolam|mesh-list
139577191|NCT03330990|Entrectinib|entrectinib|mesh-list
139577192|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139577193|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139577194|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577195|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577196|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139577197|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139577198|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139577199|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139577200|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
139577201|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
139577202|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
139577203|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
139577204|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577205|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577206|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139577207|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577208|NCT03339024|Oxytocin|oxytocin|mesh-list
139577209|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
139577210|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139577211|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577212|NCT06038526|Carbon Monoxide|carbon monoxide|mesh-list
139577213|NCT06038526|Antimetabolites|antimetabolites|mesh-ancestor
139577214|NCT06038526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577215|NCT06038526|Gasotransmitters|gasotransmitters|mesh-ancestor
139577216|NCT06038526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577217|NCT06038526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577218|NCT06038461|Temozolomide|temozolomide|mesh-list
139577219|NCT06038461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139577220|NCT06038461|Alkylating Agents|alkylating agents|mesh-ancestor
139577221|NCT06038461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577222|NCT06038461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577223|NCT06038409|Ketamine|ketamine|mesh-list
139577224|NCT06038409|Analgesics|analgesics|mesh-ancestor
139577225|NCT06038409|Sensory System Agents|sensory system agents|mesh-ancestor
139577226|NCT06038409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577227|NCT06038409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577228|NCT06038409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139577229|NCT06038409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139577230|NCT06038409|Anesthetics, General|anesthetics, general|mesh-ancestor
139577231|NCT06038409|Anesthetics|anesthetics|mesh-ancestor
139577232|NCT06038409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577233|NCT06038409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139577234|NCT06038409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139577235|NCT06038409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577236|NCT06038409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577237|NCT06037577|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
139577238|NCT06037577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577239|NCT06037473|Hormones|hormones|mesh-list
139577240|NCT06037473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139577241|NCT06037473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577242|NCT06037460|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139577243|NCT06037460|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139577244|NCT06037460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577245|NCT06037395|Denosumab|denosumab|mesh-list
139577246|NCT06037395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139577247|NCT06037395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577248|NCT06037330|Sufentanil|sufentanil|mesh-list
139577249|NCT06037330|Dsuvia|dsuvia|mesh-list
139577250|NCT06037330|Nalbuphine|nalbuphine|mesh-list
139577251|NCT06037330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139577252|NCT06037330|Narcotics|narcotics|mesh-ancestor
139577253|NCT06037330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577254|NCT06037330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577255|NCT06037330|Analgesics|analgesics|mesh-ancestor
139577256|NCT06037330|Sensory System Agents|sensory system agents|mesh-ancestor
139577257|NCT06037330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577258|NCT06037330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139577259|NCT06037330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139577260|NCT06037330|Anesthetics, General|anesthetics, general|mesh-ancestor
139577261|NCT06037330|Anesthetics|anesthetics|mesh-ancestor
139577262|NCT06036797|Sufentanil|sufentanil|mesh-list
139577263|NCT06036797|Hydromorphone|hydromorphone|mesh-list
139577264|NCT06036797|Ropivacaine|ropivacaine|mesh-list
139577265|NCT06036797|Anesthetics, Local|anesthetics, local|mesh-ancestor
139577266|NCT06036797|Anesthetics|anesthetics|mesh-ancestor
139577267|NCT06036797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577268|NCT06036797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577269|NCT06036797|Sensory System Agents|sensory system agents|mesh-ancestor
139577270|NCT06036797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577271|NCT06036797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139577272|NCT06036797|Narcotics|narcotics|mesh-ancestor
139577273|NCT06036797|Analgesics|analgesics|mesh-ancestor
139577274|NCT06036797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139577275|NCT06036797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139577276|NCT06036797|Anesthetics, General|anesthetics, general|mesh-ancestor
139577277|NCT06036745|Pembrolizumab|pembrolizumab|mesh-list
139577278|NCT06036745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577279|NCT06036745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577280|NCT06036745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139577281|NCT06036745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577282|NCT06033989|Hyaluronic Acid|hyaluronic acid|mesh-list
139577283|NCT06033989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139577284|NCT06033989|Immunologic Factors|immunologic factors|mesh-ancestor
139577285|NCT06033989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577286|NCT06033989|Viscosupplements|viscosupplements|mesh-ancestor
139577287|NCT06033989|Protective Agents|protective agents|mesh-ancestor
139577288|NCT06033846|Minocycline|minocycline|mesh-list
139577289|NCT06033846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139577290|NCT06033846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577291|NCT06033729|Midazolam|midazolam|mesh-list
139577292|NCT06033729|Fentanyl|fentanyl|mesh-list
139577293|NCT06033729|Remifentanil|remifentanil|mesh-list
139577294|NCT06033729|Propofol|propofol|mesh-list
139577295|NCT06033729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139577296|NCT06033729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577297|NCT06033729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577298|NCT06033729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139577299|NCT06033729|Anesthetics, General|anesthetics, general|mesh-ancestor
139577300|NCT06033729|Anesthetics|anesthetics|mesh-ancestor
139577301|NCT06033729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139577302|NCT06033729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139577303|NCT06033729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139577304|NCT06033729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139577305|NCT06033729|GABA Modulators|gaba modulators|mesh-ancestor
139577306|NCT06033729|GABA Agents|gaba agents|mesh-ancestor
139577307|NCT06033729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577308|NCT06033729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577309|NCT06033729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139577310|NCT06033729|Narcotics|narcotics|mesh-ancestor
139577311|NCT06033729|Analgesics|analgesics|mesh-ancestor
139577312|NCT06033729|Sensory System Agents|sensory system agents|mesh-ancestor
139577313|NCT06033729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577314|NCT06033612|Midazolam|midazolam|mesh-list
139577315|NCT06033612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139577316|NCT06033612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139577317|NCT06033612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577318|NCT06033612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577319|NCT06033612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139577320|NCT06033612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139577321|NCT06033612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139577322|NCT06033612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139577323|NCT06033612|Anesthetics, General|anesthetics, general|mesh-ancestor
139577324|NCT06033612|Anesthetics|anesthetics|mesh-ancestor
139577325|NCT06033612|GABA Modulators|gaba modulators|mesh-ancestor
139577326|NCT06033612|GABA Agents|gaba agents|mesh-ancestor
139577327|NCT06033612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577328|NCT06033612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577329|NCT06033547|Cabotegravir|cabotegravir|mesh-list
139577330|NCT06033547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139577331|NCT06033547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139577332|NCT06033547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577333|NCT06033547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577334|NCT06033547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139577335|NCT06033547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139577336|NCT06033547|Antiviral Agents|antiviral agents|mesh-ancestor
139577337|NCT06033547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577338|NCT06033521|Hormones|hormones|mesh-list
139577339|NCT06033521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139577340|NCT06033521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577341|NCT06033469|Adalimumab|adalimumab|mesh-list
139577342|NCT06033469|Infliximab|infliximab|mesh-list
139577343|NCT06033469|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139577344|NCT06033469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139577345|NCT06033469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139577346|NCT06033469|Dermatologic Agents|dermatologic agents|mesh-ancestor
139577347|NCT06033469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139577348|NCT06033118|Gemcitabine|gemcitabine|mesh-list
139577349|NCT06033118|Oxaliplatin|oxaliplatin|mesh-list
139577350|NCT06033118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139577351|NCT06033118|Antimetabolites|antimetabolites|mesh-ancestor
139577352|NCT06033118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577353|NCT06033118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577354|NCT06033092|Tamoxifen|tamoxifen|mesh-list
139577355|NCT06033092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139577356|NCT06033092|Hormone Antagonists|hormone antagonists|mesh-ancestor
139577357|NCT06033092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139577358|NCT06033092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577359|NCT06033092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139577360|NCT06033092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577361|NCT06033092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139577362|NCT06033092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139577363|NCT06033092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139577364|NCT06032936|Osimertinib|osimertinib|mesh-list
139577365|NCT06032936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577366|NCT06032936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139577367|NCT06032936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577368|NCT06032936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577369|NCT06032858|Apremilast|apremilast|mesh-list
139577370|NCT06032858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139577371|NCT06032858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139577372|NCT06032858|Analgesics|analgesics|mesh-ancestor
139577373|NCT06032858|Sensory System Agents|sensory system agents|mesh-ancestor
139577374|NCT06032858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577375|NCT06032858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577376|NCT06032858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139577377|NCT06032858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139577378|NCT06032858|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139577379|NCT06032858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139577380|NCT06032858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577381|NCT06032858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577382|NCT06032845|Lenvatinib|lenvatinib|mesh-list
139577383|NCT06032845|Tislelizumab|tislelizumab|mesh-list
139577384|NCT06032845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577385|NCT06032845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139577386|NCT06032845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577387|NCT06032845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577388|NCT06032845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577389|NCT06032728|Sunitinib|sunitinib|mesh-list
139577390|NCT06032728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577391|NCT06032728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139577392|NCT06032728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139577393|NCT06032728|Growth Substances|growth substances|mesh-ancestor
139577394|NCT06032728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577395|NCT06032728|Growth Inhibitors|growth inhibitors|mesh-ancestor
139577396|NCT06032728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139577397|NCT06032728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577398|NCT06032728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577399|NCT06031597|Cisplatin|cisplatin|mesh-list
139577400|NCT06031597|Pembrolizumab|pembrolizumab|mesh-list
139577401|NCT06031597|Nivolumab|nivolumab|mesh-list
139577402|NCT06031597|Atezolizumab|atezolizumab|mesh-list
139577403|NCT06031597|Durvalumab|durvalumab|mesh-list
139577404|NCT06031597|Tislelizumab|tislelizumab|mesh-list
139577405|NCT06031597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139577406|NCT06031597|Immunomodulating Agents|immunomodulating agents|mesh-list
139577407|NCT06031597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577408|NCT06031597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577409|NCT06031597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139577410|NCT06031597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577411|NCT06031597|Immunologic Factors|immunologic factors|mesh-ancestor
139577412|NCT06031597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577413|NCT06030843|Empagliflozin|empagliflozin|mesh-list
139577414|NCT06030843|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139577415|NCT06030843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577416|NCT06030843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139577417|NCT06030843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577418|NCT06016205|Morphine|morphine|mesh-list
139577419|NCT06016205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139577420|NCT06016205|Narcotics|narcotics|mesh-ancestor
139577421|NCT06016205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577422|NCT06016205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577423|NCT06016205|Analgesics|analgesics|mesh-ancestor
139577424|NCT06016205|Sensory System Agents|sensory system agents|mesh-ancestor
139577425|NCT06016205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577426|NCT06014983|Ferrous fumarate|ferrous fumarate|mesh-list
139577427|NCT06014983|Trace Elements|trace elements|mesh-ancestor
139577428|NCT06014983|Micronutrients|micronutrients|mesh-ancestor
139577429|NCT06014983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577430|NCT06000462|Metformin|metformin|mesh-list
139577431|NCT06000462|Dapagliflozin|dapagliflozin|mesh-list
139577432|NCT06000462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139577433|NCT06000462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577434|NCT06000462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139577435|NCT06000462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577436|NCT05994183|Dexamethasone|dexamethasone|mesh-list
139577437|NCT05994183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139577438|NCT05994183|Antiemetics|antiemetics|mesh-ancestor
139577439|NCT05994183|Autonomic Agents|autonomic agents|mesh-ancestor
139577440|NCT05994183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577441|NCT05994183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577442|NCT05994183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139577443|NCT05994183|Glucocorticoids|glucocorticoids|mesh-ancestor
139577444|NCT05994183|Hormones|hormones|mesh-ancestor
139577445|NCT05994183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139577446|NCT05994183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139577447|NCT05994183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577448|NCT05992584|Lenvatinib|lenvatinib|mesh-list
139577449|NCT05992584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577450|NCT05992584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139577451|NCT05992584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577452|NCT05992584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577453|NCT05979948|Rituximab|rituximab|mesh-list
139577454|NCT05979948|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139577455|NCT05979948|Zanubrutinib|zanubrutinib|mesh-list
139577456|NCT05979948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577457|NCT05979948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577458|NCT05979948|Immunologic Factors|immunologic factors|mesh-ancestor
139577459|NCT05979948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577460|NCT05979948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139577461|NCT05979948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139577462|NCT05979948|Alkylating Agents|alkylating agents|mesh-ancestor
139577463|NCT05979948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577464|NCT05979948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139577465|NCT05979948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577466|NCT05977998|Diphenhydramine|diphenhydramine|mesh-list
139577467|NCT05977998|Promethazine|promethazine|mesh-list
139577468|NCT05977998|Dexamethasone|dexamethasone|mesh-list
139577469|NCT05977998|Paclitaxel|paclitaxel|mesh-list
139577470|NCT05977998|Famotidine|famotidine|mesh-list
139577471|NCT05977998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139577472|NCT05977998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577473|NCT05977998|Tubulin Modulators|tubulin modulators|mesh-ancestor
139577474|NCT05977998|Antimitotic Agents|antimitotic agents|mesh-ancestor
139577475|NCT05977998|Mitosis Modulators|mitosis modulators|mesh-ancestor
139577476|NCT05977998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577477|NCT05977998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139577478|NCT05977998|Antiemetics|antiemetics|mesh-ancestor
139577479|NCT05977998|Autonomic Agents|autonomic agents|mesh-ancestor
139577480|NCT05977998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577481|NCT05977998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577482|NCT05977998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139577483|NCT05977998|Glucocorticoids|glucocorticoids|mesh-ancestor
139577484|NCT05977998|Hormones|hormones|mesh-ancestor
139577485|NCT05977998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139577486|NCT05977998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139577487|NCT05977998|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139577488|NCT05977998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139577489|NCT05977998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577490|NCT05977998|Anesthetics, Local|anesthetics, local|mesh-ancestor
139577491|NCT05977998|Anesthetics|anesthetics|mesh-ancestor
139577492|NCT05977998|Sensory System Agents|sensory system agents|mesh-ancestor
139577493|NCT05977998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139577494|NCT05977998|Histamine Antagonists|histamine antagonists|mesh-ancestor
139577495|NCT05977998|Histamine Agents|histamine agents|mesh-ancestor
139577496|NCT05977998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577497|NCT05977998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139577498|NCT05977998|Antipruritics|antipruritics|mesh-ancestor
139577499|NCT05977998|Dermatologic Agents|dermatologic agents|mesh-ancestor
139577500|NCT05977998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139577501|NCT05977998|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139577502|NCT05975671|Vancomycin|vancomycin|mesh-list
139577503|NCT05975671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139577504|NCT05975671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577505|NCT05967741|Erythritol|erythritol|mesh-list
139577506|NCT05967741|Vasodilator Agents|vasodilator agents|mesh-ancestor
139577507|NCT05965219|Metformin|metformin|mesh-list
139577508|NCT05965219|Itraconazole|itraconazole|mesh-list
139577509|NCT05965219|Carbamazepine|carbamazepine|mesh-list
139577510|NCT05965219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139577511|NCT05965219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577512|NCT05965219|Antifungal Agents|antifungal agents|mesh-ancestor
139577513|NCT05965219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577514|NCT05965219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139577515|NCT05965219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139577516|NCT05965219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577517|NCT05965219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577518|NCT05965219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139577519|NCT05965219|Hormone Antagonists|hormone antagonists|mesh-ancestor
139577520|NCT05965219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139577521|NCT05965219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139577522|NCT05965219|Anticonvulsants|anticonvulsants|mesh-ancestor
139577523|NCT05965219|Antimanic Agents|antimanic agents|mesh-ancestor
139577524|NCT05965219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139577525|NCT05965219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577526|NCT05965219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139577527|NCT05965219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139577528|NCT05965219|Analgesics|analgesics|mesh-ancestor
139577529|NCT05965219|Sensory System Agents|sensory system agents|mesh-ancestor
139577530|NCT05965219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577531|NCT05965219|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139577532|NCT05965219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139077520|NCT03991884|Hormones|hormones|mesh-ancestor
139577533|NCT05965219|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139577534|NCT05965219|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139577535|NCT05946798|Insulin Aspart|insulin aspart|mesh-list
139577536|NCT05946798|Acetylcholine|acetylcholine|mesh-list
139577537|NCT05946798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139577538|NCT05946798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577539|NCT05946798|Vasodilator Agents|vasodilator agents|mesh-ancestor
139577540|NCT05946798|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139577541|NCT05946798|Cholinergic Agents|cholinergic agents|mesh-ancestor
139359300|NCT05179733|Rituximab|rituximab|mesh-list
139577542|NCT05946798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577543|NCT05946798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577545|NCT05946785|Acetylcholine|acetylcholine|mesh-list
139577546|NCT05946785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139577547|NCT05946785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577548|NCT05946785|Vasodilator Agents|vasodilator agents|mesh-ancestor
139577549|NCT05946785|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139577550|NCT05946785|Cholinergic Agents|cholinergic agents|mesh-ancestor
139577551|NCT05946785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577552|NCT05946785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577553|NCT05940961|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139577554|NCT05940961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577555|NCT05940961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577556|NCT05940961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139577557|NCT05940961|Immunotoxins|immunotoxins|mesh-ancestor
139577558|NCT05940961|Immunoconjugates|immunoconjugates|mesh-ancestor
139577559|NCT05940961|Immunologic Factors|immunologic factors|mesh-ancestor
139577560|NCT05940961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577561|NCT05939518|Anesthetics|anesthetics|mesh-list
139577562|NCT05939518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577563|NCT05939518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577564|NCT05934500|Cannabidiol|cannabidiol|mesh-list
139577565|NCT05934500|Anticonvulsants|anticonvulsants|mesh-ancestor
139577566|NCT05920863|Lenvatinib|lenvatinib|mesh-list
139577567|NCT05920863|Tislelizumab|tislelizumab|mesh-list
139577568|NCT05920863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577569|NCT05920863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139577570|NCT05920863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577571|NCT05920863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577572|NCT05920863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577573|NCT05917587|Metformin|metformin|mesh-list
139577574|NCT05917587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139577575|NCT05917587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577576|NCT05908799|Pembrolizumab|pembrolizumab|mesh-list
139577577|NCT05908799|Pemetrexed|pemetrexed|mesh-list
139577578|NCT05908799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577579|NCT05908799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577580|NCT05908799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139577581|NCT05908799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577582|NCT05908799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577583|NCT05908799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139577584|NCT05908799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139577585|NCT05906303|Sodium Benzoate|sodium benzoate|mesh-list
139577586|NCT05906303|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
139577587|NCT05906303|Caffeine|caffeine|mesh-list
139577588|NCT05906303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139577589|NCT05906303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577590|NCT05906303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139577591|NCT05906303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577592|NCT05906303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577593|NCT05906303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139577594|NCT05906303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139577595|NCT05906303|Purinergic Agents|purinergic agents|mesh-ancestor
139577596|NCT05906303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577597|NCT05906303|Antifungal Agents|antifungal agents|mesh-ancestor
139577598|NCT05906303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577599|NCT05906303|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139577600|NCT05906303|Protective Agents|protective agents|mesh-ancestor
139577601|NCT05906303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139577602|NCT05906303|Analgesics|analgesics|mesh-ancestor
139577603|NCT05906303|Sensory System Agents|sensory system agents|mesh-ancestor
139577604|NCT05906303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577605|NCT05900427|Bupivacaine|bupivacaine|mesh-list
139577606|NCT05900427|Anesthetics, Local|anesthetics, local|mesh-ancestor
139577607|NCT05900427|Anesthetics|anesthetics|mesh-ancestor
139577608|NCT05900427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577609|NCT05900427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577610|NCT05900427|Sensory System Agents|sensory system agents|mesh-ancestor
139577611|NCT05900427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577612|NCT05897307|Ropivacaine|ropivacaine|mesh-list
139577613|NCT05897307|Anesthetics, Local|anesthetics, local|mesh-ancestor
139577614|NCT05897307|Anesthetics|anesthetics|mesh-ancestor
139577615|NCT05897307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577616|NCT05897307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577618|NCT05897307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577619|NCT05897086|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139577620|NCT05897086|Laxatives|laxatives|mesh-ancestor
139577621|NCT05897086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139577622|NCT05896683|Lazertinib|lazertinib|mesh-list
139577623|NCT05896683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139577624|NCT05896683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577625|NCT05896683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577626|NCT05875025|Norflurane|norflurane|mesh-list
139577627|NCT05875025|Anesthetics|anesthetics|mesh-ancestor
139577628|NCT05875025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577629|NCT05875025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577630|NCT05869760|Carotenoids|carotenoids|mesh-list
139577631|NCT05869760|Antioxidants|antioxidants|mesh-ancestor
139577632|NCT05869760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577633|NCT05869760|Protective Agents|protective agents|mesh-ancestor
139577634|NCT05869760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577635|NCT05843786|Interferons|interferons|mesh-list
139577636|NCT05843786|Interferon-gamma|interferon-gamma|mesh-list
139577637|NCT05843786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577638|NCT05843786|Antiviral Agents|antiviral agents|mesh-ancestor
139577639|NCT05843786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577640|NCT05823623|Vinorelbine|vinorelbine|mesh-list
139577641|NCT05823623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139577642|NCT05823623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577643|NCT05823623|Tubulin Modulators|tubulin modulators|mesh-ancestor
139577644|NCT05823623|Antimitotic Agents|antimitotic agents|mesh-ancestor
139577645|NCT05823623|Mitosis Modulators|mitosis modulators|mesh-ancestor
139577646|NCT05823623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577647|NCT05800366|Prednisone|prednisone|mesh-list
139577648|NCT05800366|Methylprednisolone|methylprednisolone|mesh-list
139577649|NCT05800366|Prednisolone|prednisolone|mesh-list
139577650|NCT05800366|Cyclophosphamide|cyclophosphamide|mesh-list
139577651|NCT05800366|Rituximab|rituximab|mesh-list
139577652|NCT05800366|Doxorubicin|doxorubicin|mesh-list
139577653|NCT05800366|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139577654|NCT05800366|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139577655|NCT05800366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139577656|NCT05800366|Immunologic Factors|immunologic factors|mesh-ancestor
139577657|NCT05800366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577658|NCT05800366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139577659|NCT05800366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139577660|NCT05800366|Alkylating Agents|alkylating agents|mesh-ancestor
139577661|NCT05800366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577662|NCT05800366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577663|NCT05800366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139577664|NCT05800366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577665|NCT05800366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139577666|NCT05800366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139577667|NCT05800366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139577668|NCT05800366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577669|NCT05800366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139577670|NCT05800366|Glucocorticoids|glucocorticoids|mesh-ancestor
139577671|NCT05800366|Hormones|hormones|mesh-ancestor
139577672|NCT05800366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139577673|NCT05800366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139577674|NCT05800366|Antiemetics|antiemetics|mesh-ancestor
139577675|NCT05800366|Autonomic Agents|autonomic agents|mesh-ancestor
139577676|NCT05800366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577677|NCT05800366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139577678|NCT05800366|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139577679|NCT05800366|Protective Agents|protective agents|mesh-ancestor
139577680|NCT05800366|Immunoconjugates|immunoconjugates|mesh-ancestor
139577681|NCT05795309|Insulin|insulin|mesh-list
139577682|NCT05795309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139577683|NCT05795309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577684|NCT05790486|Nicotine|nicotine|mesh-list
139577685|NCT05790486|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139577686|NCT05790486|Autonomic Agents|autonomic agents|mesh-ancestor
139577687|NCT05790486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577688|NCT05790486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577689|NCT05790486|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139577690|NCT05790486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139577691|NCT05790486|Cholinergic Agents|cholinergic agents|mesh-ancestor
139577692|NCT05790486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577693|NCT05790486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577694|NCT05750030|Bevacizumab|bevacizumab|mesh-list
139577695|NCT05750030|Atezolizumab|atezolizumab|mesh-list
139577696|NCT05750030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577697|NCT05750030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577698|NCT05750030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139577699|NCT05750030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139577700|NCT05750030|Growth Substances|growth substances|mesh-ancestor
139577701|NCT05750030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577702|NCT05750030|Growth Inhibitors|growth inhibitors|mesh-ancestor
139577703|NCT05750030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139577704|NCT05750030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577705|NCT05742958|Morphine|morphine|mesh-list
139577706|NCT05742958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139577707|NCT05742958|Narcotics|narcotics|mesh-ancestor
139577708|NCT05742958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577709|NCT05742958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577710|NCT05742958|Analgesics|analgesics|mesh-ancestor
139577711|NCT05742958|Sensory System Agents|sensory system agents|mesh-ancestor
139577712|NCT05742958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577713|NCT05742841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139577714|NCT05742841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139577715|NCT05742841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139577716|NCT05742841|Antimetabolites|antimetabolites|mesh-ancestor
139577717|NCT05742841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577718|NCT05742841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139577719|NCT05742841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139577720|NCT05742841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577721|NCT05735535|Antiviral Agents|antiviral agents|mesh-list
139577722|NCT05735535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577723|NCT05720715|Cyclosporine|cyclosporine|mesh-list
139577724|NCT05720715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139577725|NCT05720715|Cyclosporins|cyclosporins|mesh-list
139577726|NCT05720715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577727|NCT05720715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577728|NCT05720715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139577729|NCT05720715|Immunologic Factors|immunologic factors|mesh-ancestor
139577730|NCT05720715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577731|NCT05720715|Antifungal Agents|antifungal agents|mesh-ancestor
139577732|NCT05720715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577733|NCT05720715|Dermatologic Agents|dermatologic agents|mesh-ancestor
139577734|NCT05720715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139577735|NCT05720715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139577736|NCT05720715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139577737|NCT05680792|Ritonavir|ritonavir|mesh-list
139577738|NCT05680792|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139577739|NCT05680792|Nitazoxanide|nitazoxanide|mesh-list
139577740|NCT05680792|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139577741|NCT05680792|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139577742|NCT05680792|Protease Inhibitors|protease inhibitors|mesh-ancestor
139577743|NCT05680792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577744|NCT05680792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577745|NCT05680792|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139577746|NCT05680792|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139577747|NCT05680792|Antiviral Agents|antiviral agents|mesh-ancestor
139577748|NCT05680792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577749|NCT05680792|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139577750|NCT05680792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139577751|NCT05680792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139577752|NCT05663580|Rilpivirine|rilpivirine|mesh-list
139577753|NCT05663580|Cabotegravir|cabotegravir|mesh-list
139577754|NCT05663580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139577755|NCT05663580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139577756|NCT05663580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577757|NCT05663580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577758|NCT05663580|Antiviral Agents|antiviral agents|mesh-ancestor
139577759|NCT05663580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577760|NCT05663580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139577761|NCT05663580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139577762|NCT05663580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139577763|NCT05663580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139577764|NCT05655598|Palbociclib|palbociclib|mesh-list
139577765|NCT05655598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577766|NCT05655598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139577767|NCT05655598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577768|NCT05655598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577769|NCT05633602|Pembrolizumab|pembrolizumab|mesh-list
139577770|NCT05633602|Ramucirumab|ramucirumab|mesh-list
139577771|NCT05633602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577772|NCT05633602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577773|NCT05633602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139577774|NCT05633602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577775|NCT05617742|FAPI-46|fapi-46|mesh-list
139577776|NCT05617742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139313218|NCT02304042|Oxytocin|oxytocin|mesh-list
139577777|NCT05617742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577778|NCT05601440|Gemcitabine|gemcitabine|mesh-list
139577779|NCT05601440|Fulvestrant|fulvestrant|mesh-list
139577780|NCT05601440|Niraparib|niraparib|mesh-list
139577781|NCT05601440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139577782|NCT05601440|Antimetabolites|antimetabolites|mesh-ancestor
139577783|NCT05601440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577784|NCT05601440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577785|NCT05601440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139577786|NCT05601440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139577787|NCT05601440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139577788|NCT05601440|Hormone Antagonists|hormone antagonists|mesh-ancestor
139577789|NCT05601440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139577790|NCT05601440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577791|NCT05601440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139577792|NCT05601440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577793|NCT05599295|Oritavancin|oritavancin|mesh-list
139577794|NCT05599295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139577795|NCT05599295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577796|NCT05598580|Lenalidomide|lenalidomide|mesh-list
139577797|NCT05598580|Immunologic Factors|immunologic factors|mesh-ancestor
139577798|NCT05598580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577799|NCT05598580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139577800|NCT05598580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139577801|NCT05598580|Growth Substances|growth substances|mesh-ancestor
139577802|NCT05598580|Growth Inhibitors|growth inhibitors|mesh-ancestor
139577803|NCT05598580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577804|NCT05597280|Rifampin|rifampin|mesh-list
139577805|NCT05597280|Bedaquiline|bedaquiline|mesh-list
139577806|NCT05597280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139577807|NCT05597280|Antitubercular Agents|antitubercular agents|mesh-ancestor
139577808|NCT05597280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139577809|NCT05597280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577810|NCT05597280|Leprostatic Agents|leprostatic agents|mesh-ancestor
139577811|NCT05597280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139577812|NCT05597280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577813|NCT05597280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577814|NCT05597280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139577815|NCT05597280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139577816|NCT05597280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139577817|NCT05597280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139577818|NCT05597280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139577819|NCT05597280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139577820|NCT05593757|Quinidine|quinidine|mesh-list
139577821|NCT05593757|Verapamil|verapamil|mesh-list
139577822|NCT05593757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139577823|NCT05593757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139577824|NCT05593757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139577825|NCT05593757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577826|NCT05593757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139577827|NCT05593757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577828|NCT05593757|Vasodilator Agents|vasodilator agents|mesh-ancestor
139577829|NCT05593757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139577830|NCT05593757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139577831|NCT05593757|Adrenergic Agents|adrenergic agents|mesh-ancestor
139577832|NCT05593757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577833|NCT05593757|Antimalarials|antimalarials|mesh-ancestor
139577834|NCT05593757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139577835|NCT05593757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139577836|NCT05593757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577837|NCT05593757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577838|NCT05593757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139577839|NCT05593757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139359600|NCT03875378|Estrogens|estrogens|mesh-list
139577840|NCT05593757|Cholinergic Agents|cholinergic agents|mesh-ancestor
139577841|NCT05593757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139577842|NCT05593757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139577843|NCT05593757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139313219|NCT02304042|Carbetocin|carbetocin|mesh-list
139577844|NCT05593757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139577845|NCT05562713|Denatonium|denatonium|mesh-list
139577846|NCT05562713|Aversive Agents|aversive agents|mesh-ancestor
139577847|NCT05562713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577848|NCT05562713|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
139577849|NCT05562713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577850|NCT05562713|Sensory System Agents|sensory system agents|mesh-ancestor
139577851|NCT05562713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577852|NCT05548283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139577853|NCT05548283|Lactams|lactams|mesh-list
139577854|NCT05548283|beta-Lactams|beta-lactams|mesh-list
139577855|NCT05548283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577856|NCT05532618|Levobupivacaine|levobupivacaine|mesh-list
139577857|NCT05532618|Anesthetics, Local|anesthetics, local|mesh-ancestor
139577858|NCT05532618|Anesthetics|anesthetics|mesh-ancestor
139577859|NCT05532618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577860|NCT05532618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577861|NCT05532618|Sensory System Agents|sensory system agents|mesh-ancestor
139577862|NCT05532618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577863|NCT05527704|Albuterol|albuterol|mesh-list
139577864|NCT05527704|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139577865|NCT05527704|Autonomic Agents|autonomic agents|mesh-ancestor
139577866|NCT05527704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577867|NCT05527704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577868|NCT05527704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139577869|NCT05527704|Respiratory System Agents|respiratory system agents|mesh-ancestor
139577870|NCT05527704|Tocolytic Agents|tocolytic agents|mesh-ancestor
139577871|NCT05527704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139577872|NCT05527704|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139577873|NCT05527704|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139577874|NCT05527704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139577875|NCT05527704|Adrenergic Agents|adrenergic agents|mesh-ancestor
139577876|NCT05527704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577877|NCT05527704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577878|NCT05465954|Pembrolizumab|pembrolizumab|mesh-list
139577879|NCT05465954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577880|NCT05465954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577881|NCT05465954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139577882|NCT05465954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577883|NCT05462756|Insulin|insulin|mesh-list
139577884|NCT05462756|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139577885|NCT05462756|Insulin Glargine|insulin glargine|mesh-list
139577886|NCT05462756|Insulin Lispro|insulin lispro|mesh-list
139577887|NCT05462756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139577888|NCT05462756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577889|NCT05454358|Letrozole|letrozole|mesh-list
139577890|NCT05454358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577891|NCT05454358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139577892|NCT05454358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139577893|NCT05454358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577894|NCT05454358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577895|NCT05454358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139577896|NCT05454358|Hormone Antagonists|hormone antagonists|mesh-ancestor
139577897|NCT05454358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139577898|NCT05454358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577899|NCT05382091|Naltrexone|naltrexone|mesh-list
139577900|NCT05382091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139577901|NCT05382091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139577902|NCT05382091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577903|NCT05382091|Sensory System Agents|sensory system agents|mesh-ancestor
139577904|NCT05382091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577905|NCT05364190|Empagliflozin|empagliflozin|mesh-list
139577906|NCT05364190|Canagliflozin|canagliflozin|mesh-list
139313220|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
139577907|NCT05364190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139577908|NCT05364190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577909|NCT05364190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139577910|NCT05364190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577911|NCT05315479|Meloxicam|meloxicam|mesh-list
139577912|NCT05315479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139577913|NCT05315479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139577915|NCT05315479|Sensory System Agents|sensory system agents|mesh-ancestor
139577916|NCT05315479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577917|NCT05315479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577918|NCT05315479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139577919|NCT05315479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139577920|NCT05315479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139577921|NCT05315479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139577922|NCT05315479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577923|NCT05315479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577924|NCT05315206|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139577925|NCT05315206|Nootropic Agents|nootropic agents|mesh-ancestor
139577926|NCT05311254|Fosfomycin|fosfomycin|mesh-list
139577927|NCT05311254|Calcium|calcium|mesh-list
139577928|NCT05311254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139577929|NCT05311254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577930|NCT05311254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139577931|NCT05311254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577932|NCT05299580|Trametinib|trametinib|mesh-list
139577933|NCT05299580|Dabrafenib|dabrafenib|mesh-list
139577934|NCT05299580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577935|NCT05299580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139577936|NCT05299580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577937|NCT05299580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577938|NCT05278676|Dotinurad|dotinurad|mesh-list
139577939|NCT05278676|Uricosuric Agents|uricosuric agents|mesh-ancestor
139577940|NCT05278676|Gout Suppressants|gout suppressants|mesh-ancestor
139577941|NCT05278676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139577942|NCT05222438|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139577943|NCT05222438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577944|NCT05222438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577945|NCT05219487|Risdiplam|risdiplam|mesh-list
139577946|NCT05219487|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139577947|NCT05219487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577948|NCT05219487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577949|NCT05197075|Darunavir|darunavir|mesh-list
139577950|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139577951|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139577952|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
139577953|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577954|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577955|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139577956|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139577957|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
139577958|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577959|NCT05168735|Ketamine|ketamine|mesh-list
139577960|NCT05168735|Analgesics|analgesics|mesh-ancestor
139577961|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
139577962|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139577963|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577964|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139577965|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139577966|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
139577967|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
139577968|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139577969|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139577970|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139577971|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139577972|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577973|NCT05120960|Osimertinib|osimertinib|mesh-list
139577974|NCT05120960|Tepotinib|tepotinib|mesh-list
139577975|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577976|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139577977|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139577978|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139577979|NCT05070104|Bevacizumab|bevacizumab|mesh-list
139577980|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577981|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577982|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139577983|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139577984|NCT05070104|Growth Substances|growth substances|mesh-ancestor
139577985|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577986|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
139577987|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
139577988|NCT05063513|Rituximab|rituximab|mesh-list
139577989|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139577990|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139577991|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
139577992|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139577993|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139577994|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139577995|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139577996|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
139577997|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139577998|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139577999|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578000|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578001|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139578002|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578003|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578004|NCT04962009|Travoprost|travoprost|mesh-list
139578005|NCT04962009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139578006|NCT04954599|Carboplatin|carboplatin|mesh-list
139578007|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
139578008|NCT04954599|Nivolumab|nivolumab|mesh-list
139578009|NCT04954599|Ipilimumab|ipilimumab|mesh-list
139578010|NCT04954599|Atezolizumab|atezolizumab|mesh-list
139578011|NCT04954599|Durvalumab|durvalumab|mesh-list
139578012|NCT04954599|Avelumab|avelumab|mesh-list
139578013|NCT04954599|Cemiplimab|cemiplimab|mesh-list
139578014|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139578015|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578016|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578017|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578018|NCT04948697|Tislelizumab|tislelizumab|mesh-list
139578019|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578020|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578021|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139578022|NCT04926545|Fluorouracil|fluorouracil|mesh-list
139578023|NCT04926545|Irinotecan|irinotecan|mesh-list
139578024|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
139578025|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578026|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139578027|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578028|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139578029|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
139578030|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578031|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139578032|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139578033|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578034|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139578035|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
139578036|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139578037|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139578038|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139578039|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139578040|NCT04916548|Ketamine|ketamine|mesh-list
139578041|NCT04916548|Analgesics|analgesics|mesh-ancestor
139578042|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
139578043|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578044|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578045|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139578046|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139578047|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
139578048|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
139578049|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139578050|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139578051|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139578052|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578053|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578054|NCT04887831|Carboplatin|carboplatin|mesh-list
139578055|NCT04887831|Gemcitabine|gemcitabine|mesh-list
139578056|NCT04887831|Avelumab|avelumab|mesh-list
139578057|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578058|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139578059|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
139578060|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578061|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578062|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
139578063|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578064|NCT04874480|Decitabine|decitabine|mesh-list
139578065|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139578066|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
139578067|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578068|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578069|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578070|NCT04872543|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139578071|NCT04872543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139578072|NCT04872543|Antimetabolites|antimetabolites|mesh-ancestor
139578073|NCT04872543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578074|NCT04872543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578075|NCT04848480|Insulin|insulin|mesh-list
139578076|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139578077|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
139578078|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139578079|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578080|NCT04841018|Dexamethasone|dexamethasone|mesh-list
139578081|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
139578082|NCT04841018|BB 1101|bb 1101|mesh-list
139578083|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139578084|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
139578085|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
139578086|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578087|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578088|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139578089|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
139578090|NCT04841018|Hormones|hormones|mesh-ancestor
139578091|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139578092|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139578093|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578094|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
139578095|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578096|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578097|NCT04837859|Tislelizumab|tislelizumab|mesh-list
139578098|NCT04837859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578099|NCT04837859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578100|NCT04837066|Imidacloprid|imidacloprid|mesh-list
139578101|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
139578102|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578103|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578104|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578105|NCT04833855|Omalizumab|omalizumab|mesh-list
139578106|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139578107|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139578108|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139578109|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
139578110|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
139578111|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578112|NCT04788823|Prednisone|prednisone|mesh-list
139578113|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139578114|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
139578115|NCT04788823|Hormones|hormones|mesh-ancestor
139578116|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139578117|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578118|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139578119|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578120|NCT04747496|Edoxaban|edoxaban|mesh-list
139578121|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139578122|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
139578123|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139578124|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
139578125|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578126|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578127|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
139578128|NCT04747145|Temozolomide|temozolomide|mesh-list
139578129|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139578130|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
139578131|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578132|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578133|NCT04734535|Thrombin|thrombin|mesh-list
139578134|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139578135|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
139578136|NCT04734535|Coagulants|coagulants|mesh-ancestor
139578137|NCT04729205|Mitomycins|mitomycins|mesh-list
139578138|NCT04729205|Mitomycin|mitomycin|mesh-list
139578139|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139578140|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578141|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
139578142|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578143|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139578144|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578146|NCT04727151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578147|NCT04727151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578148|NCT04727151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139578149|NCT04727151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578150|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
139578151|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139578152|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139578153|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
139578154|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139578155|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139578156|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
139578157|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
139578158|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139578159|NCT04689828|177Lu-PSMA-617|177lu-psma-617|mesh-list
139578160|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139578161|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578162|NCT04665648|Nicorandil|nicorandil|mesh-list
139578163|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139578164|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139578165|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
139578166|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
139578167|NCT04665648|Vitamins|vitamins|mesh-ancestor
139578168|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
139578169|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578170|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
139578171|NCT04637594|Nivolumab|nivolumab|mesh-list
139578172|NCT04637594|Atezolizumab|atezolizumab|mesh-list
139578173|NCT04637594|Durvalumab|durvalumab|mesh-list
139578174|NCT04637594|Avelumab|avelumab|mesh-list
139578175|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578176|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578177|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139578178|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578179|NCT04625283|Ketamine|ketamine|mesh-list
139578180|NCT04625283|Analgesics|analgesics|mesh-ancestor
139578181|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
139578182|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578183|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578184|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139578185|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139578186|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
139578187|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
139578188|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139578189|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139578190|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139578191|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578192|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578193|NCT04623099|Escitalopram|escitalopram|mesh-list
139578194|NCT04623099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139578195|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139578196|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139578197|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578198|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578199|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
139578200|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578201|NCT04619680|Nintedanib|nintedanib|mesh-list
139578202|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578203|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139578204|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578205|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578206|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139578207|NCT04579367|Ezetimibe|ezetimibe|mesh-list
139578208|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139578209|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139578210|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
139578211|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578212|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139359974|NCT05124938|Hormones|hormones|mesh-list
139578214|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139578215|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578216|NCT04572256|Montelukast|montelukast|mesh-list
139578217|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139578218|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
139578219|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139578220|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
139578221|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139578222|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578223|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139578224|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139578225|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578226|NCT04571580|Reteplase|reteplase|mesh-list
139578227|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139578228|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139578229|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139578230|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578231|NCT04567108|Benzocaine|benzocaine|mesh-list
139578232|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
139578233|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
139578234|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139578235|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578236|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
139578237|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578238|NCT04542070|Rilpivirine|rilpivirine|mesh-list
139578239|NCT04542070|Cabotegravir|cabotegravir|mesh-list
139578240|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139578241|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139578242|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578243|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578244|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
139578245|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139578246|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139578247|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139578248|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139578249|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139578250|NCT04538950|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
139578251|NCT04538950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578252|NCT04530305|Upadacitinib|upadacitinib|mesh-list
139578253|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139578254|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139578255|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578256|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578257|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139578258|NCT04513951|Leucovorin|leucovorin|mesh-list
139578259|NCT04513951|Fluorouracil|fluorouracil|mesh-list
139578260|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
139578261|NCT04513951|Irinotecan|irinotecan|mesh-list
139578262|NCT04513951|Cetuximab|cetuximab|mesh-list
139578263|NCT04513951|Avelumab|avelumab|mesh-list
139578264|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
139578265|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
139578266|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578267|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139578268|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578269|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139578270|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
139578271|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578272|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139578273|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139578274|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578275|NCT04513951|Antidotes|antidotes|mesh-ancestor
139578276|NCT04513951|Protective Agents|protective agents|mesh-ancestor
139578277|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
139578278|NCT04513951|Vitamins|vitamins|mesh-ancestor
139578279|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
139578280|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578281|NCT04509596|Capecitabine|capecitabine|mesh-list
139578282|NCT04509596|Trastuzumab|trastuzumab|mesh-list
139578283|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139578284|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
139578285|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578286|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360047|NCT04500548|Nivolumab|nivolumab|mesh-list
139578287|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578289|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139578290|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
139578291|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139578292|NCT04476446|Esketamine|esketamine|mesh-list
139578293|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
139578294|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139578295|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139578296|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
139578297|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139578298|NCT04445688|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139578299|NCT04445688|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139578300|NCT04445688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139578301|NCT04445688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139578302|NCT04445688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578303|NCT04445688|Adrenergic Agents|adrenergic agents|mesh-ancestor
139578304|NCT04445688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578305|NCT04445688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578306|NCT04436250|Ketamine|ketamine|mesh-list
139578307|NCT04436250|Esketamine|esketamine|mesh-list
139578308|NCT04436250|Analgesics|analgesics|mesh-ancestor
139578309|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
139578310|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578311|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578312|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139578313|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139578314|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
139578315|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
139578316|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139578317|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139578318|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139578319|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578320|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578321|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
139578322|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139578323|NCT04355832|Glucagon|glucagon|mesh-list
139578324|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139578325|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139578326|NCT04355832|Hormones|hormones|mesh-ancestor
139578327|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139578328|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578329|NCT04355832|Incretins|incretins|mesh-ancestor
139578330|NCT04330820|Venetoclax|venetoclax|mesh-list
139578331|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578332|NCT04305327|Ustekinumab|ustekinumab|mesh-list
139578333|NCT04305327|Brodalumab|brodalumab|mesh-list
139578334|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
139578335|NCT04278144|Nivolumab|nivolumab|mesh-list
139578336|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578337|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578338|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139578339|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578340|NCT04250116|Apixaban|apixaban|mesh-list
139578341|NCT04250116|Clopidogrel|clopidogrel|mesh-list
139578342|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139578343|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139578344|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139578345|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139578346|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
139578347|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578348|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578349|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578350|NCT04250116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139578351|NCT04250116|Antithrombins|antithrombins|mesh-ancestor
139578352|NCT04250116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139578353|NCT04250116|Protease Inhibitors|protease inhibitors|mesh-ancestor
139578354|NCT04250116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578355|NCT04250116|Anticoagulants|anticoagulants|mesh-ancestor
139578356|NCT04249882|Naltrexone|naltrexone|mesh-list
139578357|NCT04249882|Varenicline|varenicline|mesh-list
139578358|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139578359|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139578360|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578361|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
139578362|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578363|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139578364|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139578365|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
139578366|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578367|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578368|NCT04249401|Warfarin|warfarin|mesh-list
139578369|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
139578370|NCT04249401|Dabigatran|dabigatran|mesh-list
139578371|NCT04249401|Apixaban|apixaban|mesh-list
139578372|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
139578373|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139578374|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
139578375|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139578376|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
139578377|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578378|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578379|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139578380|NCT04245748|Escitalopram|escitalopram|mesh-list
139578381|NCT04245748|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139578382|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139578383|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139578384|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578385|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578386|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
139578387|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578388|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578389|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
139578390|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139578391|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139578392|NCT04245748|Analgesics|analgesics|mesh-ancestor
139578393|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
139578394|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
139578395|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139578396|NCT04245436|Escitalopram|escitalopram|mesh-list
139578397|NCT04245436|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139578398|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139578399|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139578400|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578401|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578402|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
139578403|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578404|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578405|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
139578406|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139578407|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139578408|NCT04245436|Analgesics|analgesics|mesh-ancestor
139578409|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
139578410|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
139578411|NCT04221997|Sertraline|sertraline|mesh-list
139578412|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
139578413|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139578414|NCT04221997|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139578415|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139578416|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139578417|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578418|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578419|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
139578420|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578421|NCT04194554|Leuprolide|leuprolide|mesh-list
139578422|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
139578423|NCT04194554|Niraparib|niraparib|mesh-list
139578424|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139578425|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
139578426|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139578427|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578428|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139578429|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578430|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139578431|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578432|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578433|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
139578434|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139578435|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139578436|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139578438|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578439|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139578440|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578441|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578442|NCT04181255|Poractant alfa|poractant alfa|mesh-list
139578443|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139578444|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
139578445|NCT04169737|Venetoclax|venetoclax|mesh-list
139578446|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
139578447|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
139578448|NCT04169737|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139578449|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578450|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578451|NCT04169737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139578452|NCT04169737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578453|NCT04169737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578454|NCT04153760|Aspirin|aspirin|mesh-list
139578455|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139578456|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139578457|NCT04153760|Analgesics|analgesics|mesh-ancestor
139578458|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
139578459|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578460|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578461|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139578462|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139578463|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139578464|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139578465|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578466|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139578467|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139578468|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578469|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
139578470|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139578471|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139578472|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578473|NCT04094688|Vitamin D|vitamin d|mesh-list
139578474|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
139578475|NCT04094688|Leucovorin|leucovorin|mesh-list
139578476|NCT04094688|Bevacizumab|bevacizumab|mesh-list
139578477|NCT04094688|Fluorouracil|fluorouracil|mesh-list
139578478|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
139578479|NCT04094688|Irinotecan|irinotecan|mesh-list
139578480|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
139578481|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578482|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578483|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139578484|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139578485|NCT04094688|Growth Substances|growth substances|mesh-ancestor
139578486|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578487|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
139578488|NCT04094688|Vitamins|vitamins|mesh-ancestor
139578489|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
139578490|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139578491|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139578492|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
139578493|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578494|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139578495|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139578496|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
139578497|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139578498|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139578499|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578500|NCT04094688|Antidotes|antidotes|mesh-ancestor
139578501|NCT04094688|Protective Agents|protective agents|mesh-ancestor
139578502|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
139578503|NCT04085094|Pilocarpine|pilocarpine|mesh-list
139578504|NCT04085094|Miotics|miotics|mesh-ancestor
139578505|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
139578506|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578507|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360272|NCT02475135|Cobicistat|cobicistat|mesh-list
139578508|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139578509|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139578510|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
139578511|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578512|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578513|NCT04081805|Estradiol|estradiol|mesh-list
139578514|NCT04081805|Estrogens|estrogens|mesh-ancestor
139578515|NCT04081805|Hormones|hormones|mesh-ancestor
139578516|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139578517|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578518|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
139578519|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
139578520|NCT04002115|Busulfan|busulfan|mesh-list
139578521|NCT04002115|Fludarabine|fludarabine|mesh-list
139578522|NCT04002115|Clofarabine|clofarabine|mesh-list
139578523|NCT04002115|Tacrolimus|tacrolimus|mesh-list
139578524|NCT04002115|Lenograstim|lenograstim|mesh-list
139578525|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139578526|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
139578527|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578528|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139578529|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139578530|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
139578531|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578532|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578533|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139578534|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139578535|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
139578536|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139578537|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578538|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139578539|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139578540|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
139578541|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139578542|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139578543|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139578544|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139578545|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139578546|NCT03976544|Estradiol|estradiol|mesh-list
139578547|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139578548|NCT03976544|Progesterone|progesterone|mesh-list
139578549|NCT03976544|Estrogens|estrogens|mesh-ancestor
139578550|NCT03976544|Hormones|hormones|mesh-ancestor
139578551|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139578552|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578553|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139578554|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
139578555|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139578556|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139578557|NCT03976544|Progestins|progestins|mesh-ancestor
139578558|NCT03960866|Phentolamine|phentolamine|mesh-list
139578559|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139578560|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139578561|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139578562|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139578563|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
139578564|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578565|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578566|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578567|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139578568|NCT03953833|Antibodies|antibodies|mesh-list
139578569|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139578570|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
139578571|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578572|NCT03944512|Pravastatin|pravastatin|mesh-list
139578573|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139578574|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139578575|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
139578576|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578577|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139578578|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139578579|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578580|NCT04208516|Dexamethasone|dexamethasone|mesh-list
139578581|NCT04208516|Lidocaine|lidocaine|mesh-list
139578582|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
139360346|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139578583|NCT04208516|Ropivacaine|ropivacaine|mesh-list
139578584|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139578585|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
139578586|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
139578587|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578588|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578589|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139578590|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
139578591|NCT04208516|Hormones|hormones|mesh-ancestor
139578592|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139578593|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139578594|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578595|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
139578596|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
139578597|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139578598|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
139578599|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139578600|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139578601|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139578602|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139578603|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578604|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139578605|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139578606|NCT04208516|Analgesics|analgesics|mesh-ancestor
139578607|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139578608|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139578609|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139578610|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
139578611|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578612|NCT03860207|Antibodies|antibodies|mesh-list
139578613|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
139578614|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139297146|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139297147|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
139297148|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297149|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297150|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139297151|NCT04325503|Levodopa|levodopa|mesh-list
139297152|NCT04325503|Carbidopa|carbidopa|mesh-list
139297153|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139297154|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139297155|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
139297156|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139297157|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297158|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297159|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139297160|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297161|NCT04301843|Eflornithine|eflornithine|mesh-list
139297162|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297163|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139297164|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139297165|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139297166|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139297167|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139297168|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297169|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297170|NCT04282031|Letrozole|letrozole|mesh-list
139297171|NCT04282031|Fulvestrant|fulvestrant|mesh-list
139297172|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139297174|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139297175|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297176|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297177|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139297178|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
139297179|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139297180|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139297181|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139297182|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139297183|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
139297184|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139297185|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
139297186|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139297187|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
139297188|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139297189|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139297190|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
139578615|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
139578616|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578617|NCT03860038|Dexamethasone|dexamethasone|mesh-list
139578618|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139578619|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
139578620|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
139578621|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578622|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578623|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139578624|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
139578625|NCT03860038|Hormones|hormones|mesh-ancestor
139578626|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139578627|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139578628|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578629|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
139578630|NCT03844061|Rituximab|rituximab|mesh-list
139578631|NCT03844061|Belimumab|belimumab|mesh-list
139578632|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578633|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578634|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
139578635|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578636|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139578637|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139578638|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139578639|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
139578640|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139578641|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139578642|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578643|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578644|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139578645|NCT03807479|Ponatinib|ponatinib|mesh-list
139578646|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578647|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139578648|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578649|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578650|NCT03782415|Temozolomide|temozolomide|mesh-list
139578651|NCT03782415|Ibudilast|ibudilast|mesh-list
139578652|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139578653|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
139578654|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578655|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578656|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139578657|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
139578658|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578659|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578660|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139578661|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
139578662|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139578663|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578664|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139578665|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
139578666|NCT03782376|Ustekinumab|ustekinumab|mesh-list
139578667|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
139578668|NCT03757130|Liraglutide|liraglutide|mesh-list
139578669|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139578670|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578671|NCT03757130|Incretins|incretins|mesh-ancestor
139578672|NCT03757130|Hormones|hormones|mesh-ancestor
139578673|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139578674|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139578675|NCT03712202|Nivolumab|nivolumab|mesh-list
139578676|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139578677|NCT03712202|Doxorubicin|doxorubicin|mesh-list
139578678|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139578679|NCT03712202|Daunorubicin|daunorubicin|mesh-list
139578680|NCT03712202|Bleomycin|bleomycin|mesh-list
139578681|NCT03712202|Dacarbazine|dacarbazine|mesh-list
139578682|NCT03712202|Vinblastine|vinblastine|mesh-list
139578683|NCT03712202|Antibodies|antibodies|mesh-list
139578684|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
139578685|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139578686|NCT03712202|Imidazole|imidazole|mesh-list
139578687|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
139578688|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
139578689|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578690|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578691|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139578692|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139578693|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139578694|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578695|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578696|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139578697|NCT03712202|Immunotoxins|immunotoxins|mesh-ancestor
139578698|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139578699|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
139578700|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139578701|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
139578702|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
139578703|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
139578704|NCT03708341|Melatonin|melatonin|mesh-list
139578705|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
139578706|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578707|NCT03708341|Protective Agents|protective agents|mesh-ancestor
139578708|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578709|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139578710|NCT03692065|Apixaban|apixaban|mesh-list
139578711|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139578712|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
139578713|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139578714|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
139578715|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578716|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578717|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
139578718|NCT03682068|Carboplatin|carboplatin|mesh-list
139578719|NCT03682068|Gemcitabine|gemcitabine|mesh-list
139578720|NCT03682068|Durvalumab|durvalumab|mesh-list
139578721|NCT03682068|Tremelimumab|tremelimumab|mesh-list
139578722|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578723|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139578724|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
139578725|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578726|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578727|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139578728|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
139578729|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
139578730|NCT03660046|Etonogestrel|etonogestrel|mesh-list
139578731|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139578732|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
139578733|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139578734|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578735|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139578736|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139578737|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139578738|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139578739|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139578740|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139578741|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578742|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139578743|NCT03643198|Metronidazole|metronidazole|mesh-list
139578744|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
139578745|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139578746|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139578747|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139578748|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139578749|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139578750|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578751|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578752|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578753|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139578754|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139578755|NCT03598842|Metronidazole|metronidazole|mesh-list
139578756|NCT03598842|Ivermectin|ivermectin|mesh-list
139578757|NCT03598842|Albendazole|albendazole|mesh-list
139578758|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
139578759|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139578760|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139578761|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139578762|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
139578763|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
139578764|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139578765|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
139578766|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
139578767|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
139578768|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578769|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578770|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139077868|NCT02950051|Rituximab|rituximab|mesh-list
139578771|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139578773|NCT03555565|Alogliptin|alogliptin|mesh-list
139578774|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139578775|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578776|NCT03555565|Incretins|incretins|mesh-ancestor
139578777|NCT03555565|Hormones|hormones|mesh-ancestor
139578778|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139578779|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139578780|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
139578781|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578782|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578783|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
139578784|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578785|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578786|NCT03553836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139578787|NCT03553836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578788|NCT03519386|Travoprost|travoprost|mesh-list
139578789|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139578790|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139578791|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139578792|NCT03452332|Durvalumab|durvalumab|mesh-list
139578793|NCT03452332|Ipilimumab|ipilimumab|mesh-list
139578794|NCT03452332|Tremelimumab|tremelimumab|mesh-list
139578795|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
139578796|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139578797|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
139578798|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578799|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578800|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
139578801|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578802|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139578803|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578804|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
139578805|NCT03405792|Temozolomide|temozolomide|mesh-list
139578806|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578807|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578808|NCT03405792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139578809|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578810|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139578811|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
139578812|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
139578813|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578814|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578815|NCT03391973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139578816|NCT03391973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578817|NCT03385655|Carboplatin|carboplatin|mesh-list
139578818|NCT03385655|Durvalumab|durvalumab|mesh-list
139578819|NCT03385655|Tremelimumab|tremelimumab|mesh-list
139578820|NCT03385655|Ipatasertib|ipatasertib|mesh-list
139578821|NCT03385655|Adavosertib|adavosertib|mesh-list
139077873|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
139578822|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578823|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578824|NCT03385655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139578825|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578826|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578827|NCT03369665|Cladribine|cladribine|mesh-list
139578828|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578829|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139578830|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
139578831|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578832|NCT03361436|Halichondrin B|halichondrin b|mesh-list
139578833|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
139578834|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
139578835|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
139578836|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578837|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578838|NCT03317405|Tamoxifen|tamoxifen|mesh-list
139578839|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139578840|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
139578841|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139578842|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578843|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139578844|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578845|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139578846|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139578847|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139578848|NCT03226522|Bupropion|bupropion|mesh-list
139578849|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139578850|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
139578851|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139578852|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139578853|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139578854|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139578855|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578856|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
139578857|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578858|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578859|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139578860|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139578861|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578862|NCT03189706|Irinotecan|irinotecan|mesh-list
139578863|NCT03189706|Temozolomide|temozolomide|mesh-list
139578864|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139578865|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139578866|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578867|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578868|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578869|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139578870|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
139578871|NCT03157804|Plerixafor|plerixafor|mesh-list
139578872|NCT03157804|Lenograstim|lenograstim|mesh-list
139578873|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139578874|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
139578875|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578876|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139578877|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139578878|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
139578879|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139578880|NCT03128879|Venetoclax|venetoclax|mesh-list
139578881|NCT03128879|Acalabrutinib|acalabrutinib|mesh-list
139578882|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578883|NCT03077243|Cisplatin|cisplatin|mesh-list
139578884|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578885|NCT03064035|Thrombin|thrombin|mesh-list
139578886|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
139578887|NCT03064035|Coagulants|coagulants|mesh-ancestor
139578888|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
139578889|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
139578890|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578891|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
139578892|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139578893|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578894|NCT02971891|Furosemide|furosemide|mesh-list
139578895|NCT02971891|Diuretics|diuretics|mesh-ancestor
139578896|NCT02971891|Natriuretic Agents|natriuretic agents|mesh-ancestor
139578897|NCT02971891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578898|NCT02971891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139578899|NCT02971891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139578900|NCT02971891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578901|NCT02940301|Nivolumab|nivolumab|mesh-list
139578902|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578903|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578904|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139578905|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578906|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
139578907|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578908|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578909|NCT02872025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139578910|NCT02872025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578911|NCT02822573|Donepezil|donepezil|mesh-list
139578912|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139578913|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578914|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578915|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
139578916|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578917|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578918|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
139578919|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139578920|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139578921|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139578922|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139578923|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578924|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
139578925|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139578926|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578928|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139578929|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578930|NCT02639026|Durvalumab|durvalumab|mesh-list
139578931|NCT02639026|Tremelimumab|tremelimumab|mesh-list
139578932|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578933|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578934|NCT02632448|Gemcitabine|gemcitabine|mesh-list
139578935|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139578936|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
139578937|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578938|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578939|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139578940|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139578941|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578942|NCT02473276|Morphine|morphine|mesh-list
139578943|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139578944|NCT02473276|Narcotics|narcotics|mesh-ancestor
139578945|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139578946|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578947|NCT02473276|Analgesics|analgesics|mesh-ancestor
139578948|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
139578949|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578950|NCT02451423|Atezolizumab|atezolizumab|mesh-list
139578951|NCT02451423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139578952|NCT02451423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578953|NCT02451423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578954|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578955|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139578956|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578957|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578958|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578959|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139578960|NCT02189720|Amifampridine|amifampridine|mesh-list
139578961|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139578962|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139578963|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578964|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139578965|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139578966|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578967|NCT02184195|Olaparib|olaparib|mesh-list
139578968|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139578969|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578970|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578971|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578972|NCT02181413|Ixazomib|ixazomib|mesh-list
139578973|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578974|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578975|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
139578976|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578977|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139578978|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578979|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139578980|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139578981|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578982|NCT02151981|Osimertinib|osimertinib|mesh-list
139578983|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578984|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139578985|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360748|NCT02051569|Tryptophan|tryptophan|mesh-list
139578986|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139578987|NCT02138617|Leucovorin|leucovorin|mesh-list
139578988|NCT02138617|Bevacizumab|bevacizumab|mesh-list
139578989|NCT02138617|Fluorouracil|fluorouracil|mesh-list
139578990|NCT02138617|Irinotecan|irinotecan|mesh-list
139578991|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
139578992|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139578993|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139578994|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139578995|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139578996|NCT02138617|Growth Substances|growth substances|mesh-ancestor
139578997|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139578998|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
139578999|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
139579000|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579001|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139579002|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139579003|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
139579004|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139579005|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139579006|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579007|NCT02138617|Antidotes|antidotes|mesh-ancestor
139579008|NCT02138617|Protective Agents|protective agents|mesh-ancestor
139579009|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
139579010|NCT02138617|Vitamins|vitamins|mesh-ancestor
139579011|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
139579012|NCT02118584|Etrolizumab|etrolizumab|mesh-list
139579013|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139579014|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
139579015|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579016|NCT01996605|Oxytocin|oxytocin|mesh-list
139579017|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
139579018|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139579019|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579020|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
139579021|NCT01976182|Methotrexate|methotrexate|mesh-list
139579022|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139579023|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
139579024|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579025|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139579026|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139579027|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
139579028|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579029|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579030|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139579031|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139579032|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
139579033|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139579034|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139579035|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
139579036|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
139579037|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579038|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139579039|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139579040|NCT01974440|Prednisone|prednisone|mesh-list
139579041|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
139579042|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139579043|NCT01974440|Rituximab|rituximab|mesh-list
139579044|NCT01974440|Doxorubicin|doxorubicin|mesh-list
139579045|NCT01974440|Vincristine|vincristine|mesh-list
139579046|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139579047|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
139579048|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579049|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139579050|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139579051|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
139579052|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579053|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579054|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139579055|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139579056|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139579057|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139579058|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139579059|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579060|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139579061|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
139579062|NCT01974440|Hormones|hormones|mesh-ancestor
139579063|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139579064|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139579065|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139579066|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
139579067|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
139579068|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
139579070|NCT01921166|Clomiphene|clomiphene|mesh-list
139579071|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139579072|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
139579073|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139579074|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579075|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139579076|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579077|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139579078|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
139579079|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139579080|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139579081|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139579082|NCT01696461|Plerixafor|plerixafor|mesh-list
139579083|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139579084|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139579085|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
139579086|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139579087|NCT01688492|Ipilimumab|ipilimumab|mesh-list
139579088|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077973|NCT02527200|Liraglutide|liraglutide|mesh-list
139579089|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579090|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139579091|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579092|NCT01606098|Bevacizumab|bevacizumab|mesh-list
139579093|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139579094|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579095|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139579096|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139579097|NCT01606098|Growth Substances|growth substances|mesh-ancestor
139579098|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579099|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
139579100|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
139579101|NCT01568307|Serotonin|serotonin|mesh-list
139579102|NCT01568307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139579103|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139579104|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139579105|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
139579106|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579107|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579108|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579109|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139579110|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139579111|NCT01508221|Vitamin E|vitamin e|mesh-list
139579112|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
139579113|NCT01508221|Vitamins|vitamins|mesh-ancestor
139579114|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
139579115|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579116|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
139579117|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579118|NCT01508221|Protective Agents|protective agents|mesh-ancestor
139579119|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139579120|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579121|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139579122|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139579123|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
139579124|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139579125|NCT01485861|Prednisone|prednisone|mesh-list
139579126|NCT01485861|Prednisolone|prednisolone|mesh-list
139579127|NCT01485861|Ipatasertib|ipatasertib|mesh-list
139579128|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139579129|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
139579130|NCT01485861|Hormones|hormones|mesh-ancestor
139579131|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139579132|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579133|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139579134|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579135|NCT01485861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139360948|NCT02477397|Xhance|xhance|mesh-list
139579137|NCT01485861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579138|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
139579139|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
139579140|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139579141|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139579142|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
139579143|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579144|NCT01241734|Lenalidomide|lenalidomide|mesh-list
139579145|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
139579146|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579147|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139579148|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139579149|NCT01241734|Growth Substances|growth substances|mesh-ancestor
139579150|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
139579151|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579152|NCT01101438|Metformin|metformin|mesh-list
139579153|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139579154|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579155|NCT01094769|Moxonidine|moxonidine|mesh-list
139579156|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139579157|NCT01046825|Leucovorin|leucovorin|mesh-list
139579158|NCT01046825|Folic Acid|folic acid|mesh-list
139579159|NCT01046825|Cytarabine|cytarabine|mesh-list
139579160|NCT01046825|Prednisone|prednisone|mesh-list
139579161|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
139579162|NCT01046825|Doxorubicin|doxorubicin|mesh-list
139579163|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139579164|NCT01046825|Rituximab|rituximab|mesh-list
139579165|NCT01046825|Rasburicase|rasburicase|mesh-list
139579166|NCT01046825|Lenograstim|lenograstim|mesh-list
139579167|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
139579168|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139579169|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
139579170|NCT01046825|Hormones|hormones|mesh-ancestor
139579171|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139579172|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579173|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139579174|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579175|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139579176|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
139579177|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139579178|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139579179|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139579180|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
139579181|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579182|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139579183|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139579184|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139579185|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139579186|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579187|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139579188|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139579189|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
139579190|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
139579191|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139579192|NCT01046825|Antidotes|antidotes|mesh-ancestor
139579193|NCT01046825|Protective Agents|protective agents|mesh-ancestor
139579194|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
139579195|NCT01046825|Vitamins|vitamins|mesh-ancestor
139579196|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
139579197|NCT01046825|Hematinics|hematinics|mesh-ancestor
139579198|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
139579199|NCT01007773|Fentanyl|fentanyl|mesh-list
139579200|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
139579201|NCT01007773|Propofol|propofol|mesh-list
139579202|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139579203|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139579204|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579205|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139579206|NCT01007773|Analgesics|analgesics|mesh-ancestor
139579207|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
139579208|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579209|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139579210|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139579211|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139579212|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
139579213|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579214|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579215|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139579216|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
139579217|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
139579218|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139579219|NCT01007773|Narcotics|narcotics|mesh-ancestor
139579220|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139579221|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139579222|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139579223|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579224|NCT00936663|Incretins|incretins|mesh-ancestor
139579225|NCT00936663|Hormones|hormones|mesh-ancestor
139579226|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139579227|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139579228|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
139579229|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579230|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579231|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
139579232|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
139579233|NCT00681343|Daclizumab|daclizumab|mesh-list
139579234|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
139579235|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579236|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139579237|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139579238|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579239|NCT00665457|Celecoxib|celecoxib|mesh-list
139579240|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
139579241|NCT00665457|Docetaxel|docetaxel|mesh-list
139579242|NCT00665457|Doxorubicin|doxorubicin|mesh-list
139579243|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139579244|NCT00665457|Capecitabine|capecitabine|mesh-list
139579245|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139579246|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
139579247|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579248|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139579249|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139579250|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
139579251|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579252|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579253|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139579254|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
139579255|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
139579256|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
139579257|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139579258|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139579259|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139579260|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579261|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139579262|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
139579263|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139579264|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139579265|NCT00665457|Analgesics|analgesics|mesh-ancestor
139579266|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
139579267|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579268|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139579269|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139579270|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139579271|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139579272|NCT00574730|Rituximab|rituximab|mesh-list
139579273|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139579274|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579275|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
139579276|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579277|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139579278|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
139579279|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139579280|NCT00496756|Sorafenib|sorafenib|mesh-list
139579281|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579282|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139579283|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579284|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579285|NCT00483561|Etoposide|etoposide|mesh-list
139579286|NCT00483561|Gefitinib|gefitinib|mesh-list
139579287|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139579288|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579289|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139579290|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139579291|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579292|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579293|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139579294|NCT00483366|Gemcitabine|gemcitabine|mesh-list
139579295|NCT00483366|Capecitabine|capecitabine|mesh-list
139579296|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
139579297|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139579298|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
139579299|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579300|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579301|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139579302|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579303|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
139579304|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139579305|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
139579306|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579307|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579308|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139579309|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
139579310|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139579311|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
139579312|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579313|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579314|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139579315|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
139579316|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
139579317|NCT00278083|Protective Agents|protective agents|mesh-ancestor
139579318|NCT02492412|Cyclosporine|cyclosporine|mesh-list
139579319|NCT02492412|Cyclosporins|cyclosporins|mesh-list
139579320|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579321|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579322|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139579323|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
139579324|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579325|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
139579326|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139579327|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
139579328|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139579329|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139579330|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139579331|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139579332|NCT03329898|Estradiol|estradiol|mesh-list
139579333|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139579334|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
139579335|NCT03329898|Estrogens|estrogens|mesh-ancestor
139579336|NCT03329898|Hormones|hormones|mesh-ancestor
139579337|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139579338|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579339|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139579340|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
139579341|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139579342|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139579343|NCT03329898|Progestins|progestins|mesh-ancestor
139579344|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
139579345|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139579346|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579347|NCT02492568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139579348|NCT02492568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579349|NCT01722292|Carboplatin|carboplatin|mesh-list
139579350|NCT01722292|Etoposide|etoposide|mesh-list
139579351|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579352|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139579353|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139579354|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139579355|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579356|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579357|NCT02493894|Cefazolin|cefazolin|mesh-list
139579358|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139579359|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139579360|NCT02493738|Itraconazole|itraconazole|mesh-list
139579361|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
139579362|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139579363|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139579364|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139579365|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579366|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579367|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139579368|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
139579369|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139579370|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579371|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139579372|NCT03875638|Levetiracetam|levetiracetam|mesh-list
139579373|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
139579374|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
139579375|NCT02493582|Apatinib|apatinib|mesh-list
139579376|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579377|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139579378|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579379|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579380|NCT05560360|Efavirenz|efavirenz|mesh-list
139579381|NCT05560360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139579382|NCT05560360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139579383|NCT05560360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579384|NCT05560360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579385|NCT05560360|Antiviral Agents|antiviral agents|mesh-ancestor
139579386|NCT05560360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139579387|NCT05560360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139579388|NCT05560360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139579389|NCT05560360|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139579390|NCT05560360|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139579391|NCT05560360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139579392|NCT05560360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139579393|NCT03329118|Simvastatin|simvastatin|mesh-list
139579394|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139579395|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139579396|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
139579397|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579398|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139579399|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139579400|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579401|NCT01723384|Naltrexone|naltrexone|mesh-list
139579402|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139579403|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139579404|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579405|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
139579406|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579407|NCT02492490|Basiliximab|basiliximab|mesh-list
139579408|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139579409|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
139579410|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579411|NCT02493504|Heparin|heparin|mesh-list
139579412|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
139579413|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139579414|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139579415|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579416|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
139579417|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139579418|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
139579419|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579420|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579421|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139579422|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
139579423|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139579424|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139579425|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139579426|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
139579427|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579428|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579429|NCT03328728|Hylan|hylan|mesh-list
139579430|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
139579431|NCT03328728|Protective Agents|protective agents|mesh-ancestor
139579432|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579433|NCT03328494|Paclitaxel|paclitaxel|mesh-list
139579434|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139579435|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579436|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
139579437|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
139579438|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
139579439|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579440|NCT02491398|Rituximab|rituximab|mesh-list
139579441|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139579442|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139579443|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579444|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
139579445|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579446|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139579447|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139579448|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
139579449|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579450|NCT03333018|Bromides|bromides|mesh-list
139579451|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
139579452|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139579453|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
139579454|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579455|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579456|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139579457|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
139579458|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139579459|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139579460|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139579461|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
139579462|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579463|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579464|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
139579465|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
139579466|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139579467|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579468|NCT01723696|Vitamins|vitamins|mesh-list
139579469|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
139579470|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
139579471|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579472|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
139579473|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579474|NCT01723696|Protective Agents|protective agents|mesh-ancestor
139579475|NCT03327558|Mesalamine|mesalamine|mesh-list
139579476|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139579477|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139579478|NCT03327558|Analgesics|analgesics|mesh-ancestor
139579479|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
139579480|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579481|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579482|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139579483|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139579484|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
139579485|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139579486|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139579487|NCT02242630|Prednisolone|prednisolone|mesh-list
139579488|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
139579489|NCT02242630|Triamcinolone|triamcinolone|mesh-list
139579490|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139579491|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139579492|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139579493|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
139579494|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139579495|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139579496|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
139579497|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
139579498|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579499|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579500|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139579501|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
139579502|NCT02242630|Hormones|hormones|mesh-ancestor
139579503|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139579504|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139579505|NCT02242630|Protective Agents|protective agents|mesh-ancestor
139579506|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139579507|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579508|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139579509|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
139579510|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579511|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579512|NCT03109158|Cetuximab|cetuximab|mesh-list
139579513|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139579514|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579515|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
139579516|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
139579517|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
139579518|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139579519|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
139579520|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
139579521|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579522|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579523|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579524|NCT03327168|Adenosine|adenosine|mesh-list
139579525|NCT03327168|Analgesics|analgesics|mesh-ancestor
139579526|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
139579527|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579528|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579529|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139579530|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
139579531|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139579532|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
139579533|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
139579534|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579535|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579536|NCT01726738|Trametinib|trametinib|mesh-list
139579537|NCT01726738|Dabrafenib|dabrafenib|mesh-list
139579538|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579539|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139579540|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579541|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579542|NCT02492178|Artesunate|artesunate|mesh-list
139579543|NCT02492178|Quinine|quinine|mesh-list
139579544|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
139579545|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139579546|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139579547|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139579548|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579549|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
139579550|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
139579551|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139579552|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
139579553|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139579554|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579555|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139579556|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579557|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139579558|NCT02492178|Analgesics|analgesics|mesh-ancestor
139579559|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
139579560|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
139579561|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139579562|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139579563|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579564|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
139579565|NCT04494126|Coagulants|coagulants|mesh-ancestor
139579566|NCT01730872|Prednisolone|prednisolone|mesh-list
139579567|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139579568|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
139579569|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139579570|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
139579571|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139579572|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139579573|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139579574|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
139579575|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139579576|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
139579577|NCT01730872|Hormones|hormones|mesh-ancestor
139579578|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139579579|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579580|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139579581|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579582|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
139579583|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
139579584|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579585|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139579586|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139361346|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
139579587|NCT01730872|Protective Agents|protective agents|mesh-ancestor
139579588|NCT02491086|Nicotine|nicotine|mesh-list
139579589|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139579590|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
139579591|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579592|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579593|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139579594|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139579595|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
139579596|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579597|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579598|NCT03469492|Insulin|insulin|mesh-list
139579599|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139579600|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579601|NCT03331770|Latanoprost|latanoprost|mesh-list
139579602|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139579603|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139579604|NCT03331692|Anesthetics|anesthetics|mesh-list
139579605|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139579606|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579607|NCT04826692|Metformin|metformin|mesh-list
139579608|NCT04826692|Biguanides|biguanides|mesh-list
139078077|NCT01773707|Abatacept|abatacept|mesh-list
139579609|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139579610|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579611|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139579612|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139579613|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579614|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139579615|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
139579616|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579617|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
139579618|NCT04825990|Olaparib|olaparib|mesh-list
139579619|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139579620|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579621|NCT04825990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139579622|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579623|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139579624|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579626|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139579627|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
139579628|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
139579629|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139579630|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579631|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
139579632|NCT01738672|Entonox|entonox|mesh-list
139579633|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139579634|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
139579635|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
139579636|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139579637|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579638|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139579639|NCT01738672|Analgesics|analgesics|mesh-ancestor
139579640|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
139579641|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579642|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139579643|NCT02488512|Edotreotide|edotreotide|mesh-list
139579644|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139579645|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579646|NCT01808651|Fluoxetine|fluoxetine|mesh-list
139579647|NCT01808651|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139579648|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139579649|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139579650|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579651|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579652|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
139579653|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579654|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139579655|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
139579656|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139579657|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139579658|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139579659|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361429|NCT03313557|Adavosertib|adavosertib|mesh-list
139579660|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
139579661|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
139579662|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579663|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579664|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139579665|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
139579667|NCT05316376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139579668|NCT05316376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139579669|NCT05316376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579670|NCT05316376|Tubulin Modulators|tubulin modulators|mesh-ancestor
139579671|NCT05316376|Antimitotic Agents|antimitotic agents|mesh-ancestor
139579672|NCT05316376|Mitosis Modulators|mitosis modulators|mesh-ancestor
139579673|NCT05316376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579674|NCT01743976|Donepezil|donepezil|mesh-list
139579675|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139579676|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579677|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579678|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
139579679|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579680|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579681|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
139579682|NCT05315830|Vaccines|vaccines|mesh-list
139579683|NCT05315830|Immunologic Factors|immunologic factors|mesh-ancestor
139579684|NCT05315830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579685|NCT05463822|Botulinum Toxins|botulinum toxins|mesh-list
139579686|NCT05463822|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139579687|NCT05463822|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139579688|NCT05463822|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139579689|NCT05463822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139579690|NCT05463822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579691|NCT05463822|Cholinergic Agents|cholinergic agents|mesh-ancestor
139579692|NCT05463822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579693|NCT05463822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579694|NCT05463822|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139579695|NCT05463822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579696|NCT04639960|Risperidone|risperidone|mesh-list
139579697|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139579698|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
139579699|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579700|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579701|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579702|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139579703|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139579704|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139579705|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139579706|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139579707|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
139579708|NCT03109314|Donepezil|donepezil|mesh-list
139579709|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139579710|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579711|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579712|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
139579713|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579714|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579715|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
139579716|NCT04566016|Anesthetics|anesthetics|mesh-list
139579717|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139579718|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579719|NCT03320538|Rabeprazole|rabeprazole|mesh-list
139579720|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139579721|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139579722|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139579723|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579724|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579725|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
139579726|NCT03322878|Analgesics|analgesics|mesh-ancestor
139579727|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
139579728|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579729|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579730|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
139579731|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139579732|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139579733|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
139579734|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139579735|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139078089|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
139579736|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579737|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139579738|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
139579739|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139579740|NCT03322800|Ziresovir|ziresovir|mesh-list
139579741|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
139579742|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139579743|NCT03320460|Clobetasol|clobetasol|mesh-list
139579744|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139579745|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
139579746|NCT03320460|Hormones|hormones|mesh-ancestor
139579747|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139579748|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579749|NCT04471714|Baclofen|baclofen|mesh-list
139579750|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139579751|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579752|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139579753|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579754|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139579755|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
139579756|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
139579757|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579758|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579759|NCT03325686|Vitamin D|vitamin d|mesh-list
139579760|NCT03325686|Vitamins|vitamins|mesh-ancestor
139579761|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
139579762|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579763|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139579764|NCT05315128|Methotrexate|methotrexate|mesh-list
139579765|NCT05315128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139579766|NCT05315128|Abortifacient Agents|abortifacient agents|mesh-ancestor
139579767|NCT05315128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139579768|NCT05315128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579769|NCT05315128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139579770|NCT05315128|Antimetabolites|antimetabolites|mesh-ancestor
139579771|NCT05315128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579772|NCT05315128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579773|NCT05315128|Dermatologic Agents|dermatologic agents|mesh-ancestor
139579774|NCT05315128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579775|NCT05315128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139579776|NCT05315128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139579777|NCT05315128|Immunologic Factors|immunologic factors|mesh-ancestor
139579778|NCT05315128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139579779|NCT05315128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139579780|NCT03322488|Metronidazole|metronidazole|mesh-list
139579781|NCT03322488|Doxycycline|doxycycline|mesh-list
139579782|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
139579783|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139579784|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139579785|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139579786|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139579787|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
139579788|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139579789|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139579790|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579791|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579792|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579793|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139579794|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139579795|NCT01808573|Capecitabine|capecitabine|mesh-list
139579796|NCT01808573|Lapatinib|lapatinib|mesh-list
139579797|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139579798|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
139579799|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579800|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579801|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139579802|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579803|NCT01746940|Cocaine|cocaine|mesh-list
139579804|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139579805|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
139579806|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
139579807|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139579808|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579809|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
139579810|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579811|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139579812|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139579813|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139579814|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139579815|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579816|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
139579817|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579818|NCT01747330|Pancreatin|pancreatin|mesh-list
139579819|NCT01747330|Pancrelipase|pancrelipase|mesh-list
139579820|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139579821|NCT02990962|Triamcinolone|triamcinolone|mesh-list
139579822|NCT02990962|Lidocaine|lidocaine|mesh-list
139579823|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139579824|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
139579825|NCT02990962|Hormones|hormones|mesh-ancestor
139579826|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139579827|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579828|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579829|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
139579830|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
139579831|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139579832|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
139579833|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579834|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139579835|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139579836|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139579837|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139579838|NCT03322098|Atropine|atropine|mesh-list
139579839|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
139579840|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139579841|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139579842|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139579843|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
139579844|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579845|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579846|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139579847|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
139579848|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
139579849|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
139579850|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139579851|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139579852|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
139579853|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579854|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579855|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
139579856|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139579857|NCT01808339|Fluticasone|fluticasone|mesh-list
139579858|NCT01808339|Xhance|xhance|mesh-list
139579859|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139579860|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139579861|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
139579862|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579863|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579864|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139579865|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
139579866|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
139579867|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139579868|NCT01749904|Timolol|timolol|mesh-list
139579869|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139579870|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139579871|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
139579872|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579873|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579874|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579875|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139579876|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139579877|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139579878|NCT02484768|Hematinics|hematinics|mesh-ancestor
139579879|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
139579880|NCT03316326|Irinotecan|irinotecan|mesh-list
139579881|NCT03316326|Tegafur|tegafur|mesh-list
139579882|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579883|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139579884|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139579885|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579886|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579887|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139579888|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
139579889|NCT02487732|Ticagrelor|ticagrelor|mesh-list
139579890|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139579891|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139579892|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139579893|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139579894|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139579895|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
139579896|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579897|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579898|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579899|NCT03833362|Interferons|interferons|mesh-list
139579900|NCT03833362|Ritonavir|ritonavir|mesh-list
139579901|NCT03833362|Ribavirin|ribavirin|mesh-list
139579902|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
139579903|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
139579904|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139579905|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139579906|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139579907|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
139579908|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139579909|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139579910|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139579911|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
139579912|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139579913|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579914|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139579915|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139579916|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139579917|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139579918|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
139579919|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
139579920|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579921|NCT05463588|Methamphetamine|methamphetamine|mesh-list
139579922|NCT05463588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139579923|NCT05463588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579924|NCT05463588|Sympathomimetics|sympathomimetics|mesh-ancestor
139579925|NCT05463588|Autonomic Agents|autonomic agents|mesh-ancestor
139579926|NCT05463588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579927|NCT05463588|Dopamine Agents|dopamine agents|mesh-ancestor
139579928|NCT05463588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579929|NCT05463588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579930|NCT05463588|Adrenergic Agents|adrenergic agents|mesh-ancestor
139579931|NCT05463588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139579932|NCT05463588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139579933|NCT05463588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139579934|NCT05463588|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139579935|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
139579936|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139579937|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
139579938|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139579939|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579940|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139579941|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139579942|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139579943|NCT02490540|Sufentanil|sufentanil|mesh-list
139579944|NCT02490540|Dsuvia|dsuvia|mesh-list
139579945|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139579946|NCT02490540|Narcotics|narcotics|mesh-ancestor
139579947|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139579948|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579949|NCT02490540|Analgesics|analgesics|mesh-ancestor
139579950|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
139579951|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579952|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139579953|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139579954|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
139579955|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
139579956|NCT02484300|Melatonin|melatonin|mesh-list
139579957|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
139579958|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579959|NCT02484300|Protective Agents|protective agents|mesh-ancestor
139579960|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579961|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139579962|NCT02727660|Budesonide|budesonide|mesh-list
139579963|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
139579964|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139579965|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139579966|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
139579967|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579968|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579969|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139579970|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
139579971|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
139579972|NCT02727660|Hormones|hormones|mesh-ancestor
139579973|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139579974|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139579975|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139579976|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139579977|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
139579978|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579979|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579980|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
139579981|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139579982|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139579983|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579984|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139579985|NCT02490072|Analgesics|analgesics|mesh-ancestor
139579986|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
139579987|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139579988|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139579989|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139579990|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139579991|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
139579992|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139579993|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139579994|NCT02483598|Buspirone|buspirone|mesh-list
139579995|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139579996|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139579997|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139579998|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139579999|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139580000|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139580001|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
139580002|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580003|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580004|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
139580005|NCT03321318|Vitamin D|vitamin d|mesh-list
139580006|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
139580007|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139580008|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580009|NCT03321318|Vitamins|vitamins|mesh-ancestor
139580010|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
139580011|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139580012|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139580013|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139580014|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
139580015|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139580016|NCT01784861|Everolimus|everolimus|mesh-list
139580017|NCT01784861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139580018|NCT01784861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139580019|NCT01784861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580020|NCT01784861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580021|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139580022|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
139580023|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580024|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580025|NCT03318744|Aspirin|aspirin|mesh-list
139580026|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138828735|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
139580027|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139580028|NCT03318744|Analgesics|analgesics|mesh-ancestor
139580029|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
139580030|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580031|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580032|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139580033|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139580034|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139580035|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139580036|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580037|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139580038|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139580039|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580040|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
139580041|NCT01751386|Baclofen|baclofen|mesh-list
139580042|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139580043|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580044|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139580045|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580046|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139580047|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
139580048|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
139580049|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580050|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580051|NCT02489760|Adalimumab|adalimumab|mesh-list
139580052|NCT02489760|Etanercept|etanercept|mesh-list
139580053|NCT02489760|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139580054|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139580055|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139580056|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139580057|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139580058|NCT02489760|Analgesics|analgesics|mesh-ancestor
139580059|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
139580060|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580061|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580062|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139580063|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139580064|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
139580065|NCT01752712|Oxytocin|oxytocin|mesh-list
139580066|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
139580067|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139580068|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580069|NCT05127928|Vitamins|vitamins|mesh-list
139580070|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
139580071|NCT05127928|Vitamin E|vitamin e|mesh-list
139580072|NCT05127928|Tocopherols|tocopherols|mesh-list
139580073|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
139580074|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580075|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
139580076|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580077|NCT05127928|Protective Agents|protective agents|mesh-ancestor
139580078|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
139580079|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139580080|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
139580081|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580082|NCT02483130|Expectorants|expectorants|mesh-ancestor
139580083|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
139580084|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139580085|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
139580086|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580087|NCT02483130|Protective Agents|protective agents|mesh-ancestor
139580088|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580089|NCT02483130|Antidotes|antidotes|mesh-ancestor
139580090|NCT03318354|Olmesartan|olmesartan|mesh-list
139580091|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139580092|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139580093|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139580094|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139580095|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580096|NCT05093140|Prednisone|prednisone|mesh-list
139580097|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
139580098|NCT05093140|Vincristine|vincristine|mesh-list
139580099|NCT05093140|Doxorubicin|doxorubicin|mesh-list
139580100|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139580101|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139580102|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
139580103|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580104|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139580105|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139580106|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
139580107|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580108|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580109|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139580110|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139580111|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
139580112|NCT05093140|Hormones|hormones|mesh-ancestor
139580113|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139580114|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139580115|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139580116|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
139580117|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
139580118|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
139580119|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139580120|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139580121|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139580122|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580123|NCT00705666|Ribavirin|ribavirin|mesh-list
139580124|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139580125|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
139580126|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580127|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
139580128|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580129|NCT04955236|Fentanyl|fentanyl|mesh-list
139580130|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139580131|NCT04955236|Narcotics|narcotics|mesh-ancestor
139580132|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139580133|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580134|NCT04955236|Analgesics|analgesics|mesh-ancestor
139580135|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
139580136|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580137|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139580138|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139580139|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
139580140|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
139580141|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
139580142|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139580143|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139580144|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580145|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139580146|NCT03957304|Analgesics|analgesics|mesh-ancestor
139580147|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
139580148|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580149|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139580150|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139580151|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139580152|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
139580153|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580154|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580155|NCT03320928|Methotrexate|methotrexate|mesh-list
139580156|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139580157|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
139580158|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139580159|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580160|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139580161|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
139580162|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580163|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580164|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
139580165|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580166|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139580167|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139580168|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
139580169|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139580170|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139580171|NCT02488902|Mefloquine|mefloquine|mesh-list
139580172|NCT02488902|Tafenoquine|tafenoquine|mesh-list
139580173|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
139580174|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139580175|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139580176|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580177|NCT02253160|Lenograstim|lenograstim|mesh-list
139580178|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139580179|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
139580180|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580181|NCT02254252|Nicorandil|nicorandil|mesh-list
139580182|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
139580183|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
139580184|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139580185|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139580186|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
139580187|NCT02254252|Vitamins|vitamins|mesh-ancestor
139580188|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
139580189|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580190|NCT03315078|Busulfan|busulfan|mesh-list
139580191|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
139580192|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580193|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139580194|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
139580195|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580196|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139580197|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580198|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139580199|NCT02255110|Doxorubicin|doxorubicin|mesh-list
139580200|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139580201|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580202|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139580203|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139580204|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580205|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580206|NCT03320694|Insulin|insulin|mesh-list
139580207|NCT03320694|Metformin|metformin|mesh-list
139580208|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139580209|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
139580210|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139580211|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580212|NCT02482740|Tamoxifen|tamoxifen|mesh-list
139580213|NCT02482740|Letrozole|letrozole|mesh-list
139580214|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580215|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139580216|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139580217|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580218|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580219|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139580220|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
139580221|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139580222|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580223|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139580224|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139580225|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139580226|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139580227|NCT03315000|Fluticasone|fluticasone|mesh-list
139580228|NCT03315000|Xhance|xhance|mesh-list
139580229|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139580230|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139580231|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
139580232|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580233|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580234|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139580235|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
139580236|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
139580237|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139580238|NCT02482818|Pregabalin|pregabalin|mesh-list
139580239|NCT02482818|Analgesics|analgesics|mesh-ancestor
139580240|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
139580241|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580242|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580243|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
139580244|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139580245|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139580246|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580247|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139580248|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139580249|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139580250|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139580251|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139580252|NCT02989870|Sorafenib|sorafenib|mesh-list
139580253|NCT02989870|Bavituximab|bavituximab|mesh-list
139580254|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580255|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139580256|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580257|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580258|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139580259|NCT02480088|Palonosetron|palonosetron|mesh-list
139580260|NCT02480088|Ramosetron|ramosetron|mesh-list
139580261|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
139580262|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
139580263|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580264|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580265|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139580266|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139580267|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139580268|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
139580269|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580270|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580271|NCT01807624|Phenylephrine|phenylephrine|mesh-list
139580272|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
139580273|NCT01807624|Tetracaine|tetracaine|mesh-list
139580274|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
139580275|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
139580276|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139580277|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580278|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
139580279|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078222|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580280|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139580281|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139580282|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
139580283|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580284|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580285|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
139580286|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
139580287|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
139580288|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139580289|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
139580290|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139580291|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
139580292|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139580293|NCT01807624|Protective Agents|protective agents|mesh-ancestor
139580294|NCT01808326|Chlorambucil|chlorambucil|mesh-list
139580295|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139580296|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
139580297|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580298|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580299|NCT03317730|Oxycodone|oxycodone|mesh-list
139580300|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139580301|NCT03317730|Narcotics|narcotics|mesh-ancestor
139580302|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139580303|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580304|NCT03317730|Analgesics|analgesics|mesh-ancestor
139580305|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
139580306|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580307|NCT02486484|Aflibercept|aflibercept|mesh-list
139580308|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139580309|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139580310|NCT02486484|Growth Substances|growth substances|mesh-ancestor
139580311|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580312|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
139580313|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580314|NCT03317652|Nitroprusside|nitroprusside|mesh-list
139580315|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139580316|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
139580317|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139580318|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580319|NCT02479854|Montelukast|montelukast|mesh-list
139580320|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139580321|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
139580322|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139580323|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
139580324|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139580325|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580326|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139580327|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139580328|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580329|NCT01809106|Fentanyl|fentanyl|mesh-list
139580330|NCT01809106|Morphine|morphine|mesh-list
139580331|NCT01809106|Oxycodone|oxycodone|mesh-list
139580332|NCT01809106|Buprenorphine|buprenorphine|mesh-list
139580333|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139580334|NCT01809106|Narcotics|narcotics|mesh-ancestor
139580335|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139580336|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580337|NCT01809106|Analgesics|analgesics|mesh-ancestor
139580338|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
139580339|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580340|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139580341|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139580342|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
139580343|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
139580344|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139580345|NCT03804580|Osimertinib|osimertinib|mesh-list
139580346|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580347|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139580348|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580349|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580350|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
139580351|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139580352|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139580353|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139580354|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139580355|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580356|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
139580357|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580358|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580359|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139580360|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580361|NCT01810666|Factor VIII|factor viii|mesh-list
139580362|NCT01810666|Coagulants|coagulants|mesh-ancestor
139580363|NCT02482272|Lamivudine|lamivudine|mesh-list
139580364|NCT02482272|Adefovir|adefovir|mesh-list
139580365|NCT02482272|Entecavir|entecavir|mesh-list
139580366|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139580367|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139580368|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580369|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580370|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
139580371|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580372|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139580373|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139580374|NCT01766440|Calcitriol|calcitriol|mesh-list
139580375|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139580376|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580377|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139580378|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139580379|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580380|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139580381|NCT01766440|Vitamins|vitamins|mesh-ancestor
139580382|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
139580383|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139580384|NCT02479620|Dexamethasone|dexamethasone|mesh-list
139580385|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
139580386|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139580387|NCT02479620|BB 1101|bb 1101|mesh-list
139580388|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139580389|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
139580390|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
139580391|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580392|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580393|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139580394|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
139580395|NCT02479620|Hormones|hormones|mesh-ancestor
139580396|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139580397|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139580398|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580399|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
139580400|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580401|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580402|NCT02481960|Irinotecan|irinotecan|mesh-list
139580403|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139580404|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139580405|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580406|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580407|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580408|NCT02725866|Ritonavir|ritonavir|mesh-list
139580409|NCT02725866|Ribavirin|ribavirin|mesh-list
139580410|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139362172|NCT01673594|Naltrexone|naltrexone|mesh-list
139580411|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139580412|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
139580413|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580414|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580415|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139580416|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139580417|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
139580418|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580419|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139580420|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139580421|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
139580422|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139580423|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139580424|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580425|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
139580426|NCT03314298|Anastrozole|anastrozole|mesh-list
139580427|NCT03314298|Testosterone|testosterone|mesh-list
139580428|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
139580429|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
139580430|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139580431|NCT03314298|Androgens|androgens|mesh-ancestor
139580432|NCT03314298|Hormones|hormones|mesh-ancestor
139580433|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139580434|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580435|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139580436|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580437|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
139580438|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139580439|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139580440|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580441|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580442|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139580443|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
139580444|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
139580445|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139580446|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580447|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139580448|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139580449|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078253|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139580450|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580451|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580452|NCT05461560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139580453|NCT05713578|Docetaxel|docetaxel|mesh-list
139580454|NCT05713578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580455|NCT05713578|Tubulin Modulators|tubulin modulators|mesh-ancestor
139580456|NCT05713578|Antimitotic Agents|antimitotic agents|mesh-ancestor
139580457|NCT05713578|Mitosis Modulators|mitosis modulators|mesh-ancestor
139580458|NCT05713578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580459|NCT02485548|Fluorouracil|fluorouracil|mesh-list
139580460|NCT02485548|Raltitrexed|raltitrexed|mesh-list
139580461|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580462|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
139580463|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580464|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139580465|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139580466|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
139580467|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580468|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139580469|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580470|NCT02479074|Prednisolone|prednisolone|mesh-list
139580471|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139580472|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
139580473|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139580474|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
139580475|NCT02479074|Montelukast|montelukast|mesh-list
139580476|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139580477|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
139580478|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139580479|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
139580480|NCT02479074|Hormones|hormones|mesh-ancestor
139580481|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139580482|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580483|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139580484|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580485|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
139580486|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
139580487|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580488|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139580489|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139580490|NCT02479074|Protective Agents|protective agents|mesh-ancestor
139580491|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139580492|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
139580493|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139580494|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
139580495|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139580496|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139580497|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580499|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
139078291|NCT00059930|Antidotes|antidotes|mesh-ancestor
139580500|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580501|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139580502|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
139580503|NCT02480946|Methotrexate|methotrexate|mesh-list
139580504|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139580505|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
139580506|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139580507|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580508|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139580509|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
139580510|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580511|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580512|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
139580513|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580514|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139580515|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139580516|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
139580517|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139580518|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139580519|NCT01769170|Cidofovir|cidofovir|mesh-list
139580520|NCT01769170|Brincidofovir|brincidofovir|mesh-list
139580521|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
139580522|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580523|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580524|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580525|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
139580526|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139580527|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580528|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139580529|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139580530|NCT02726022|Ribavirin|ribavirin|mesh-list
139580531|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139580532|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
139580533|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580534|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
139580535|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580536|NCT02478294|Warfarin|warfarin|mesh-list
139580537|NCT02478294|Anticoagulants|anticoagulants|mesh-list
139580538|NCT01770652|Deferiprone|deferiprone|mesh-list
139580539|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139580540|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
139580541|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
139580542|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580543|NCT03316482|Leuprolide|leuprolide|mesh-list
139580544|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139580545|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
139580546|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139580547|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580548|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139580549|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580550|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
139580551|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139580552|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580553|NCT01772758|Antioxidants|antioxidants|mesh-list
139580554|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580555|NCT01772758|Protective Agents|protective agents|mesh-ancestor
139580556|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580557|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
139580558|NCT02485080|Simeprevir|simeprevir|mesh-list
139580559|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
139580560|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580561|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
139580562|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580563|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580564|NCT02480400|Dexetimide|dexetimide|mesh-list
139580565|NCT02480400|Citalopram|citalopram|mesh-list
139580566|NCT02480400|Escitalopram|escitalopram|mesh-list
139580567|NCT02480400|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139580568|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139580569|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139580570|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580571|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580572|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
139580573|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580574|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139580575|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139580576|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
139580577|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
139580578|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580579|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139580580|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139580581|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
139580582|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139580583|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
139580584|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139580585|NCT02725710|Gabapentin|gabapentin|mesh-list
139580586|NCT02725710|Analgesics|analgesics|mesh-ancestor
139580587|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
139580588|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580589|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580590|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
139580591|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139580592|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139580593|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139580594|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139580595|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139580596|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139580597|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580598|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580599|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
139580600|NCT02256358|Midazolam|midazolam|mesh-list
139580601|NCT02256358|Ketamine|ketamine|mesh-list
139580602|NCT02256358|Analgesics|analgesics|mesh-ancestor
139580603|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
139580604|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580605|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580606|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139580607|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139580608|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
139580609|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
139580610|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139580611|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139580612|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139580613|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580614|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580615|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139580616|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139580617|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139580618|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139580619|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139580620|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
139580621|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
139580622|NCT01825408|Azithromycin|azithromycin|mesh-list
139580623|NCT01825408|Doxycycline|doxycycline|mesh-list
139580624|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139580625|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139580626|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580627|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
139580628|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139580629|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139580630|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139580631|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580632|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580633|NCT04945824|Dexamethasone|dexamethasone|mesh-list
139580634|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139580635|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
139580636|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
139580637|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580638|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580639|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139580640|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
139580641|NCT04945824|Hormones|hormones|mesh-ancestor
139580642|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139580643|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139580644|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580645|NCT04937634|Melphalan|melphalan|mesh-list
139580646|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139580647|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
139580648|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580649|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580650|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139580651|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139580652|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
139580653|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580654|NCT02262130|Omalizumab|omalizumab|mesh-list
139580655|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139580656|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139580657|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
139580658|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
139580659|NCT04887870|Nivolumab|nivolumab|mesh-list
139580660|NCT04887870|Ipilimumab|ipilimumab|mesh-list
139580661|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139580662|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580663|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139580664|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078343|NCT00042939|Docetaxel|docetaxel|mesh-list
139580665|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
139580666|NCT01827358|Mupirocin|mupirocin|mesh-list
139580667|NCT01827358|Calcium|calcium|mesh-list
139580668|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139580669|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580670|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139580671|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139580672|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580673|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139580674|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580675|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580676|NCT01780324|Lidocaine|lidocaine|mesh-list
139580677|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
139580678|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
139580679|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139580680|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580681|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
139580682|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580683|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139580684|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139580685|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139580686|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139580687|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580688|NCT02472600|Colistin|colistin|mesh-list
139580689|NCT02472600|Polymyxins|polymyxins|mesh-list
139580690|NCT02472600|Neomycin|neomycin|mesh-list
139580691|NCT02472600|Omeprazole|omeprazole|mesh-list
139580692|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139580693|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139580694|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139580695|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580696|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580697|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139580698|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580699|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139580700|NCT01781806|Tenofovir|tenofovir|mesh-list
139580701|NCT01781806|Emtricitabine|emtricitabine|mesh-list
139580702|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
139580703|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580704|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139580705|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139580706|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580707|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580708|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139580709|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139580710|NCT02477514|Tedizolid|tedizolid|mesh-list
139580711|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
139580712|NCT02477514|Midazolam|midazolam|mesh-list
139580713|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139580714|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139580715|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139580716|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139580717|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580718|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139580719|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139580720|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139580721|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139580722|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
139580723|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
139580724|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
139580725|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
139580726|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580727|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580728|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139580729|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139580730|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
139580731|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139580732|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139580733|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580734|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139580735|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580736|NCT01746238|Bevacizumab|bevacizumab|mesh-list
139580737|NCT01746238|Doxorubicin|doxorubicin|mesh-list
139580738|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139580739|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580740|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139580741|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139580742|NCT01746238|Growth Substances|growth substances|mesh-ancestor
139580743|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580744|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
139580745|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139580746|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139580747|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139580748|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580749|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580750|NCT02472054|Cyclosporine|cyclosporine|mesh-list
139580751|NCT02472054|Prednisolone|prednisolone|mesh-list
139580752|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139580753|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
139580754|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139580755|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
139580756|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
139580757|NCT02472054|Cyclosporins|cyclosporins|mesh-list
139580758|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139580759|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
139580760|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580761|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580762|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139580763|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
139580764|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580765|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
139580766|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580767|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
139580768|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139580769|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139580770|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139580771|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
139580772|NCT02472054|Hormones|hormones|mesh-ancestor
139580773|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139580774|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139580775|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580776|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
139580777|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
139580778|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580779|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139580780|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139580781|NCT02472054|Protective Agents|protective agents|mesh-ancestor
139580782|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139580783|NCT01782898|Esmolol|esmolol|mesh-list
139580784|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139297191|NCT04235816|Azithromycin|azithromycin|mesh-list
139580785|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139580786|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139580788|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580789|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580790|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580791|NCT02475876|Clindamycin|clindamycin|mesh-list
139580792|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
139580793|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
139580794|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139580795|NCT02475876|Trimethoprim|trimethoprim|mesh-list
139580796|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
139580797|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139580798|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580799|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139580800|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580801|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580802|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139580803|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
139580804|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139580805|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139580806|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139580807|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139580808|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139580809|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139580810|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
139580811|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139580812|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139580813|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580814|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
139580815|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580816|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580817|NCT01783054|Gemcitabine|gemcitabine|mesh-list
139580818|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139580819|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
139580820|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580821|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580822|NCT02725008|Dexamethasone|dexamethasone|mesh-list
139580823|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139580824|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
139580825|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
139580826|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580827|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580828|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139580829|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
139580830|NCT02725008|Hormones|hormones|mesh-ancestor
139580831|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139580832|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139580833|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078404|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
139580834|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
139580835|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139580836|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580837|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580838|NCT02471820|Dexamethasone|dexamethasone|mesh-list
139580839|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
139580840|NCT02471820|Lenalidomide|lenalidomide|mesh-list
139580841|NCT02471820|Doxorubicin|doxorubicin|mesh-list
139580842|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139580843|NCT02471820|BB 1101|bb 1101|mesh-list
139580844|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139580845|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
139580846|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
139580847|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580848|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580849|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139580850|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
139580851|NCT02471820|Hormones|hormones|mesh-ancestor
139580852|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139580853|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139580854|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580855|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
139580856|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580857|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580858|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
139580859|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139580860|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139580861|NCT02471820|Growth Substances|growth substances|mesh-ancestor
139580862|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
139580863|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139580864|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139580865|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139580866|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
139580867|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139580868|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139580869|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139580870|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139580871|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580872|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
139580873|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580874|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580875|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139580876|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580877|NCT01783912|Nicotine|nicotine|mesh-list
139580878|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139580879|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
139580880|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580881|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580882|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139580883|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139580884|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
139580885|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580886|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580887|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
139580888|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139580889|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
139580890|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580891|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580892|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139580893|NCT01833988|Pancrelipase|pancrelipase|mesh-list
139580894|NCT01833988|Pancreatin|pancreatin|mesh-list
139580895|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139580896|NCT05363436|Oxycodone|oxycodone|mesh-list
139580897|NCT05363436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139580898|NCT05363436|Narcotics|narcotics|mesh-ancestor
139580899|NCT05363436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139580900|NCT05363436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580901|NCT05363436|Analgesics|analgesics|mesh-ancestor
139580902|NCT05363436|Sensory System Agents|sensory system agents|mesh-ancestor
139580903|NCT05363436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580904|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139580905|NCT02474706|Imipenem|imipenem|mesh-list
139580906|NCT02474706|Cefoxitin|cefoxitin|mesh-list
139580907|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139580908|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580909|NCT01784770|Azithromycin|azithromycin|mesh-list
139580910|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139580911|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139580912|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139580913|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139580914|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580915|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139580916|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580917|NCT04491786|Gabapentin|gabapentin|mesh-list
139580918|NCT04491786|Nefopam|nefopam|mesh-list
139580919|NCT04491786|Analgesics|analgesics|mesh-ancestor
139580920|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
139580921|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580922|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580923|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
139580924|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139580925|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139580926|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139580927|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139580928|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139580929|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139580930|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580931|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580932|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
139362695|NCT04478084|Vaccines|vaccines|mesh-list
139580933|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139580934|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139580935|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139580936|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580938|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
139580939|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
139580940|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580941|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580942|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139580943|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139580944|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139580945|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
139580946|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580947|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580948|NCT02470026|Urological Agents|urological agents|mesh-ancestor
139580949|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
139580950|NCT01807949|Ivacaftor|ivacaftor|mesh-list
139580951|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139580952|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139580953|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580954|NCT02989558|Aspirin|aspirin|mesh-list
139580955|NCT02989558|Clopidogrel|clopidogrel|mesh-list
139580956|NCT02989558|Ticagrelor|ticagrelor|mesh-list
139580957|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139580958|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139580959|NCT02989558|Analgesics|analgesics|mesh-ancestor
139580960|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
139580961|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580962|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580963|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139580964|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139580965|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139580966|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139580967|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580968|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139580969|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139580970|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580971|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
139580972|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139580973|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139580974|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139580975|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
139580976|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580977|NCT01806779|Bupropion|bupropion|mesh-list
139580978|NCT01806779|Nicotine|nicotine|mesh-list
139580979|NCT01806779|Varenicline|varenicline|mesh-list
139580980|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139580981|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
139580982|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139580983|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139580984|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139580985|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139580986|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
139580987|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139580988|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139580989|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139580990|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
139580991|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139580992|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139580993|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139580994|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139580995|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
139580996|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139580997|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139580998|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139580999|NCT01878526|Domperidone|domperidone|mesh-list
139581000|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
139581001|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
139581002|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581003|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581004|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139581005|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139581006|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
139581007|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581008|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581009|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
139581010|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
139581011|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581012|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139581013|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
139581014|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139581015|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
139581016|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139581017|NCT01806623|Fluconazole|fluconazole|mesh-list
139581018|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
139581019|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581020|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139581021|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139581022|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581023|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581024|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139581025|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
139313221|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139581026|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581027|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581028|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139581029|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139581030|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139581031|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
139581032|NCT01806545|Coagulants|coagulants|mesh-ancestor
139581033|NCT01847014|Macitentan|macitentan|mesh-list
139581034|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139581035|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139581036|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581037|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139581038|NCT01847638|Nepafenac|nepafenac|mesh-list
139581039|NCT01847638|Bromfenac|bromfenac|mesh-list
139581040|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139581041|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139581042|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139581043|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139581044|NCT01847638|Analgesics|analgesics|mesh-ancestor
139581045|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
139581046|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581047|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581048|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139581049|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139581050|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
139581051|NCT02474628|Calcium|calcium|mesh-list
139581052|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139581053|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581054|NCT02474628|Antacids|antacids|mesh-ancestor
139581055|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581056|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139581057|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
139581058|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139581059|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581060|NCT03099564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139581061|NCT03099564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581062|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
139581063|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139581064|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139581065|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139581066|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139581067|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581068|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
139581069|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581070|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581071|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139581072|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581073|NCT05328310|Nebivolol|nebivolol|mesh-list
139581074|NCT05328310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139581075|NCT05328310|Vasodilator Agents|vasodilator agents|mesh-ancestor
139581076|NCT05328310|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139581077|NCT05328310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139581078|NCT05328310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139581079|NCT05328310|Adrenergic Agents|adrenergic agents|mesh-ancestor
139581080|NCT05328310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581081|NCT05328310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581082|NCT05328310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581083|NCT01797484|Ranolazine|ranolazine|mesh-list
139581084|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139581085|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139581086|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581087|NCT01798264|Exenatide|exenatide|mesh-list
139581088|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139581089|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581090|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139581091|NCT01798264|Incretins|incretins|mesh-ancestor
139581092|NCT01798264|Hormones|hormones|mesh-ancestor
139581093|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581094|NCT05326984|Metformin|metformin|mesh-list
139581095|NCT05326984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139581096|NCT05326984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581097|NCT01800838|Silicon|silicon|mesh-list
139581098|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
139581099|NCT01800838|Trace Elements|trace elements|mesh-ancestor
139581100|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
139581101|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581102|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
139581103|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139581104|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139581105|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581106|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
139581107|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139581108|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
139581109|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
139581110|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581111|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139581112|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581113|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581114|NCT01855360|Doxycycline|doxycycline|mesh-list
139581115|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
139581116|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139581117|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581118|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
139581119|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139581120|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139581121|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
139581122|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139581123|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139581124|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
139581125|NCT04351126|Bromocriptine|bromocriptine|mesh-list
139581126|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139581127|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139581128|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
139581129|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581130|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581131|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
139581132|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
139581133|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581134|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581135|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139581136|NCT01804673|Fentanyl|fentanyl|mesh-list
139581137|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139581138|NCT01804673|Narcotics|narcotics|mesh-ancestor
139581139|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139581140|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581141|NCT01804673|Analgesics|analgesics|mesh-ancestor
139581142|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
139581143|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581144|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139581145|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139581146|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
139581147|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
139581148|NCT01856530|Oxytocin|oxytocin|mesh-list
139581149|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
139581150|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139581151|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581152|NCT05302336|Cyclophosphamide|cyclophosphamide|mesh-list
139581153|NCT05302336|Docetaxel|docetaxel|mesh-list
139362919|NCT02056899|Gabapentin|gabapentin|mesh-list
139581154|NCT05302336|Doxorubicin|doxorubicin|mesh-list
139581155|NCT05302336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139581156|NCT05302336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139581157|NCT05302336|Immunologic Factors|immunologic factors|mesh-ancestor
139581158|NCT05302336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581159|NCT05302336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139581160|NCT05302336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139581161|NCT05302336|Alkylating Agents|alkylating agents|mesh-ancestor
139581162|NCT05302336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581163|NCT05302336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581164|NCT05302336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139581165|NCT05302336|Tubulin Modulators|tubulin modulators|mesh-ancestor
139581166|NCT05302336|Antimitotic Agents|antimitotic agents|mesh-ancestor
139581167|NCT05302336|Mitosis Modulators|mitosis modulators|mesh-ancestor
139581168|NCT05302336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139581169|NCT05302336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139581170|NCT05302336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139581171|NCT05302336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581172|NCT01804036|Zolpidem|zolpidem|mesh-list
139581173|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139581174|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139581175|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139581176|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581177|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139581178|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
139581179|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
139581180|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581181|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581182|NCT01857232|Dexamethasone|dexamethasone|mesh-list
139581183|NCT01857232|Ondansetron|ondansetron|mesh-list
139581184|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
139581185|NCT01857232|Aprepitant|aprepitant|mesh-list
139581186|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139581187|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
139581188|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
139581189|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581190|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581191|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139581192|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
139581193|NCT01857232|Hormones|hormones|mesh-ancestor
139581194|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581195|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139581196|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581197|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
139581198|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
139581199|NCT01857232|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139581200|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139581201|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
139581202|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581203|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581204|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139581205|NCT01766128|Zonisamide|zonisamide|mesh-list
139581206|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
139581207|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139581208|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139581209|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581210|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139581211|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581212|NCT02859558|Tenofovir|tenofovir|mesh-list
139581213|NCT02859558|Emtricitabine|emtricitabine|mesh-list
139581214|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139581215|NCT02859558|Cobicistat|cobicistat|mesh-list
139581216|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139581217|NCT02859558|Elvitegravir|elvitegravir|mesh-list
139581218|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139581219|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
139581220|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581221|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139581222|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139581223|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581224|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581225|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139581226|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139581227|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139581228|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139581229|NCT01860586|Bevacizumab|bevacizumab|mesh-list
139581230|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139581231|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581232|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139581233|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139581234|NCT01860586|Growth Substances|growth substances|mesh-ancestor
139581235|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581236|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
139581237|NCT00705432|Ribavirin|ribavirin|mesh-list
139581238|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139581239|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
139581240|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581241|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
139581242|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581243|NCT00704964|Ribavirin|ribavirin|mesh-list
139581244|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139581245|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
139581246|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
139581247|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581248|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
139581249|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581250|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
139581251|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581252|NCT00704808|Temozolomide|temozolomide|mesh-list
139581253|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139581254|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
139581255|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581256|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581257|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139581258|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
139581259|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581260|NCT01862536|Tadalafil|tadalafil|mesh-list
139581261|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
139581262|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139581263|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139581264|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581265|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581266|NCT01862536|Urological Agents|urological agents|mesh-ancestor
139581267|NCT01862614|Epinephrine|epinephrine|mesh-list
139581268|NCT01862614|Racepinephrine|racepinephrine|mesh-list
139581269|NCT01862614|Carticaine|carticaine|mesh-list
139581270|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
139581271|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139581272|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139581273|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
139581274|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581275|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581276|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581277|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139581278|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139581279|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
139581280|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078489|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
139581281|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139581282|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
139581283|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
139581284|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
139581285|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139581286|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
139581287|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
139581288|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139581289|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
139581290|NCT02470650|Ritonavir|ritonavir|mesh-list
139581291|NCT02470650|Darunavir|darunavir|mesh-list
139581292|NCT02470650|Tenofovir|tenofovir|mesh-list
139581293|NCT02470650|Lamivudine|lamivudine|mesh-list
139581294|NCT02470650|Emtricitabine|emtricitabine|mesh-list
139581295|NCT02470650|Abacavir|abacavir|mesh-list
139581296|NCT02470650|Cobicistat|cobicistat|mesh-list
139581297|NCT02470650|Rilpivirine|rilpivirine|mesh-list
139581298|NCT02470650|Elvitegravir|elvitegravir|mesh-list
139581299|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139581300|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139581301|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
139581302|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581303|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581304|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139581305|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139581306|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
139581307|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581308|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139581309|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139581310|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139581311|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139581312|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139581313|NCT01866592|Adalimumab|adalimumab|mesh-list
139581314|NCT01866592|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139581315|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139581316|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139581317|NCT01375608|Decitabine|decitabine|mesh-list
139581318|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139581319|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
139581320|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581321|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581322|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581323|NCT01868776|Lidocaine|lidocaine|mesh-list
139581324|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
139581325|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
139581326|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139581327|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581328|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
139581329|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581330|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139581331|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139581332|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139581333|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139581334|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581335|NCT00704418|Bromfenac|bromfenac|mesh-list
139581336|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139581337|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139581338|NCT00704418|Analgesics|analgesics|mesh-ancestor
139581339|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
139581340|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581341|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581342|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139581343|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139581344|NCT01869634|Ritonavir|ritonavir|mesh-list
139581345|NCT01869634|Darunavir|darunavir|mesh-list
139581346|NCT01869634|Emtricitabine|emtricitabine|mesh-list
139581347|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139581348|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139581349|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
139581350|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581351|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581352|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139581353|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139581354|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
139581355|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581356|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139581357|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139581358|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139581359|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139581360|NCT02047578|Busulfan|busulfan|mesh-list
139581361|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
139581362|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581363|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139581364|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
139581365|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581366|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139581367|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581368|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139581369|NCT01874392|Insulin|insulin|mesh-list
139581370|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139581371|NCT01874392|Pancrelipase|pancrelipase|mesh-list
139581372|NCT01874392|Pancreatin|pancreatin|mesh-list
139581373|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139581374|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581375|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139581376|NCT00576654|Irinotecan|irinotecan|mesh-list
139581377|NCT00576654|Camptothecin|camptothecin|mesh-list
139581378|NCT00576654|Veliparib|veliparib|mesh-list
139363143|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
139581379|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139581380|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139581381|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581382|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581383|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581384|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139581385|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139581386|NCT03314064|Dolutegravir|dolutegravir|mesh-list
139581387|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139581388|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139581389|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581390|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581391|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139581392|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139581393|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
139581394|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581395|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
139581396|NCT00552058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139581397|NCT00552058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139581398|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139581399|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
139581400|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581401|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139581402|NCT02473302|Tocopherols|tocopherols|mesh-list
139581403|NCT02473302|Vitamin E|vitamin e|mesh-list
139581404|NCT02473302|Tocotrienols|tocotrienols|mesh-list
139581405|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
139581406|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
139581407|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581408|NCT02473302|Protective Agents|protective agents|mesh-ancestor
139581409|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581410|NCT02473302|Vitamins|vitamins|mesh-ancestor
139581411|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
139581412|NCT05747326|Capecitabine|capecitabine|mesh-list
139581413|NCT05747326|Vinorelbine|vinorelbine|mesh-list
139581414|NCT05747326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139581415|NCT05747326|Antimetabolites|antimetabolites|mesh-ancestor
139581416|NCT05747326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581417|NCT05747326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581418|NCT05747326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139581419|NCT05747326|Tubulin Modulators|tubulin modulators|mesh-ancestor
139581420|NCT05747326|Antimitotic Agents|antimitotic agents|mesh-ancestor
139581421|NCT05747326|Mitosis Modulators|mitosis modulators|mesh-ancestor
139581422|NCT03108300|Doxorubicin|doxorubicin|mesh-list
139581423|NCT03108300|Propranolol|propranolol|mesh-list
139581424|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139581425|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581426|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139581427|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139581428|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581429|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581430|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139581431|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139581432|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
139581433|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581434|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581435|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139581436|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139581437|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
139581438|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
139581439|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139581440|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581441|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139581442|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581443|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
139581444|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139581445|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581446|NCT02473146|Immunotoxins|immunotoxins|mesh-ancestor
139581447|NCT02473146|Immunoconjugates|immunoconjugates|mesh-ancestor
139581448|NCT02473146|Immunologic Factors|immunologic factors|mesh-ancestor
139581449|NCT02473146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581450|NCT02989012|Oseltamivir|oseltamivir|mesh-list
139581451|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
139581452|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581453|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581454|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581455|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139581456|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139581458|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139581459|NCT03832894|Progesterone|progesterone|mesh-list
139581460|NCT03832894|Estrogens|estrogens|mesh-ancestor
139581461|NCT03832894|Hormones|hormones|mesh-ancestor
139581462|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581463|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581464|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139581465|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
139581466|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139581467|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139581468|NCT03832894|Progestins|progestins|mesh-ancestor
139581469|NCT02989324|Misoprostol|misoprostol|mesh-list
139581470|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139581471|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
139581472|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139581473|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581474|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139581475|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139581476|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
139581477|NCT00550732|Posaconazole|posaconazole|mesh-list
139581478|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
139581479|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581480|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139581481|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139581482|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139581483|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139581484|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139581485|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581486|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581487|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139581488|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
139581489|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581490|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581491|NCT03311022|Nefopam|nefopam|mesh-list
139581492|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139581493|NCT03311022|Analgesics|analgesics|mesh-ancestor
139581494|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
139581495|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581496|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581497|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
139581498|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139581499|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581500|NCT00559936|Bevacizumab|bevacizumab|mesh-list
139581501|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139581502|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581503|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139581504|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139581505|NCT00559936|Growth Substances|growth substances|mesh-ancestor
139581506|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581507|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
139581508|NCT05353192|Hormones|hormones|mesh-list
139581509|NCT05353192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581510|NCT05353192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581511|NCT03310242|Vitamin D|vitamin d|mesh-list
139581512|NCT03310242|Vitamins|vitamins|mesh-ancestor
139581513|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
139581514|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581515|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139581516|NCT00557128|Lisinopril|lisinopril|mesh-list
139581517|NCT00557128|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139581518|NCT00557128|Protease Inhibitors|protease inhibitors|mesh-ancestor
139581519|NCT00557128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581520|NCT00557128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581521|NCT00557128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139581522|NCT00557128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139581523|NCT00557128|Protective Agents|protective agents|mesh-ancestor
139581524|NCT00557128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581525|NCT03312582|Metformin|metformin|mesh-list
139581526|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139581527|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581528|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
139581529|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139581530|NCT04350580|Antibodies|antibodies|mesh-list
139581531|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
139581532|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581533|NCT00558064|Amlodipine|amlodipine|mesh-list
139581534|NCT00558064|Telmisartan|telmisartan|mesh-list
139581535|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139581536|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139581537|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139581538|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139581539|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581540|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139581541|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581542|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
139581543|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139581544|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139581545|NCT03312426|Linrodostat|linrodostat|mesh-list
139581546|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581547|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581548|NCT03309618|Valsartan|valsartan|mesh-list
139581549|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139581550|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139581551|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139581552|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581553|NCT03303924|Sulbactam|sulbactam|mesh-list
139581554|NCT03303924|Durlobactam|durlobactam|mesh-list
139581555|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139581556|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581557|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139581558|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581559|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581560|NCT00557830|Sorafenib|sorafenib|mesh-list
139581561|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581562|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139581563|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581564|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581565|NCT00557440|Fluticasone|fluticasone|mesh-list
139581566|NCT00557440|Xhance|xhance|mesh-list
139581567|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
139581568|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139581569|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139581570|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139581571|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139581572|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
139581573|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581574|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581575|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139581576|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
139581577|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
139581578|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139581579|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139581580|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139581581|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139581582|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
139581583|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581584|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581585|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
139581586|NCT00557440|Hormones|hormones|mesh-ancestor
139581587|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581588|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
139581589|NCT03311178|Dobutamine|dobutamine|mesh-list
139581590|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139581591|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
139581592|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
139581593|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581594|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581595|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139581596|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139581597|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139581598|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
139581599|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581600|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581601|NCT03311178|Protective Agents|protective agents|mesh-ancestor
139581602|NCT02469012|Ribavirin|ribavirin|mesh-list
139581603|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
139581604|NCT02469012|Ledipasvir|ledipasvir|mesh-list
139581605|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
139581606|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581607|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
139581608|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581609|NCT02468856|Modafinil|modafinil|mesh-list
139581610|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139581611|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581612|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139581613|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139581614|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139581615|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581616|NCT03303378|Melatonin|melatonin|mesh-list
139581617|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
139581618|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581619|NCT03303378|Protective Agents|protective agents|mesh-ancestor
139581620|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581621|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139581622|NCT04491474|Lidocaine|lidocaine|mesh-list
139581623|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
139581624|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
139581625|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139581626|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581627|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
139581628|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581629|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139581630|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139581631|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139581632|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139581633|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581634|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
139581635|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139581636|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581637|NCT03308604|Cisplatin|cisplatin|mesh-list
139581638|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581639|NCT00553306|Aldesleukin|aldesleukin|mesh-list
139581640|NCT00553306|Cyclophosphamide|cyclophosphamide|mesh-list
139581641|NCT00553306|Interleukin-2|interleukin-2|mesh-list
139581642|NCT00553306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139581643|NCT00553306|Immunologic Factors|immunologic factors|mesh-ancestor
139581644|NCT00553306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581645|NCT00553306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139581646|NCT00553306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139581647|NCT00553306|Alkylating Agents|alkylating agents|mesh-ancestor
139581648|NCT00553306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581649|NCT00553306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581650|NCT00553306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139581651|NCT00553306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139581652|NCT00553306|Analgesics|analgesics|mesh-ancestor
139581653|NCT00553306|Sensory System Agents|sensory system agents|mesh-ancestor
139581654|NCT00553306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581655|NCT00553306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139581656|NCT00553306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139581657|NCT00553306|Antiviral Agents|antiviral agents|mesh-ancestor
139581658|NCT00553306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581659|NCT02722044|Adalimumab|adalimumab|mesh-list
139581660|NCT02722044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139581661|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139581662|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139581663|NCT05728008|Ustekinumab|ustekinumab|mesh-list
139581664|NCT05728008|Tofacitinib|tofacitinib|mesh-list
139581665|NCT05728008|Dermatologic Agents|dermatologic agents|mesh-ancestor
139581666|NCT05728008|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139581667|NCT05728008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139581668|NCT05728008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581669|NCT05728008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581670|NCT02988700|Bupivacaine|bupivacaine|mesh-list
139581671|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
139581672|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
139581673|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139581674|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581675|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
139581676|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581677|NCT03308214|Imipenem|imipenem|mesh-list
139581678|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139581679|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581680|NCT03308136|Lidocaine|lidocaine|mesh-list
139581681|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
139581682|NCT03308136|Anesthetics|anesthetics|mesh-list
139581683|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139581684|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581685|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
139581686|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581687|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139581688|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139581689|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139581690|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139581691|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581692|NCT02466984|Metoclopramide|metoclopramide|mesh-list
139581693|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
139581694|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
139581695|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581696|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581697|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139581698|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139581699|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139581700|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
139581701|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581702|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581703|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
139581704|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139581705|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581706|NCT03307902|Imiquimod|imiquimod|mesh-list
139581707|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139581708|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
139581709|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581710|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581711|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
139581712|NCT03302364|Risperidone|risperidone|mesh-list
139581713|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139581714|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
139581715|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581716|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581717|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581718|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139581719|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139581720|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139581721|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139581722|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139581723|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
139581724|NCT02467920|Exenatide|exenatide|mesh-list
139581725|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139581726|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581727|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139581728|NCT02467920|Incretins|incretins|mesh-ancestor
139581729|NCT02467920|Hormones|hormones|mesh-ancestor
139581730|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581731|NCT04927312|Metronidazole|metronidazole|mesh-list
139581732|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581733|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139581734|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139581735|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139581736|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
139581737|NCT03307590|Bupivacaine|bupivacaine|mesh-list
139581738|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
139581739|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
139581740|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139581741|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581742|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
139581743|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581744|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139581745|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139581746|NCT03307590|Analgesics|analgesics|mesh-ancestor
139581747|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139581748|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139581749|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139581750|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
139581751|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581752|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581753|NCT03302208|Pregabalin|pregabalin|mesh-list
139363521|NCT03298191|Ritodrine|ritodrine|mesh-list
139581754|NCT03302208|Analgesics|analgesics|mesh-ancestor
139581755|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
139581756|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581757|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581758|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
139581759|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139581760|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139581761|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581762|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139581763|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139581764|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139581765|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139581766|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139581767|NCT03307512|Insulin|insulin|mesh-list
139581768|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139581769|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
139581770|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139581771|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581772|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139581773|NCT02466828|Hematinics|hematinics|mesh-ancestor
139581774|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139581775|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139581776|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139581777|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
139581778|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581779|NCT00553462|Paclitaxel|paclitaxel|mesh-list
139581780|NCT00553462|Carboplatin|carboplatin|mesh-list
139581781|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139581782|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139581783|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139581784|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581785|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
139581786|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
139581787|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
139581788|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581789|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139581790|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581791|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139581792|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
139581793|NCT03301974|Coagulants|coagulants|mesh-ancestor
139581794|NCT03306732|Thiamine|thiamine|mesh-list
139581795|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
139581796|NCT03306732|Vitamins|vitamins|mesh-ancestor
139581797|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
139581798|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581799|NCT00553150|Everolimus|everolimus|mesh-list
139581800|NCT00553150|Temozolomide|temozolomide|mesh-list
139581801|NCT00553150|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139581802|NCT00553150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139581803|NCT00553150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581804|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581805|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139581806|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
139581807|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581808|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581809|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139581810|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
139581811|NCT04630834|Acetaminophen|acetaminophen|mesh-list
139581812|NCT04630834|Ibuprofen|ibuprofen|mesh-list
139581813|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139581814|NCT04630834|Analgesics|analgesics|mesh-ancestor
139581815|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
139581816|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581817|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581818|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
139581819|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139581820|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139581821|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139581822|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139581823|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581824|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581825|NCT03301350|Paclitaxel|paclitaxel|mesh-list
139581826|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
139581827|NCT03301350|Carboplatin|carboplatin|mesh-list
139363590|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139581828|NCT03301350|Doxorubicin|doxorubicin|mesh-list
139581829|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139581830|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581831|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
139581832|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
139581833|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
139581834|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581835|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139581836|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
139581837|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581838|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139581839|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139581840|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
139581841|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139581842|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139581843|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139581844|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139581845|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581846|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
139581847|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139581848|NCT02722278|Testosterone|testosterone|mesh-list
139581849|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
139581850|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
139581851|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139581852|NCT02722278|Androgens|androgens|mesh-ancestor
139581853|NCT02722278|Hormones|hormones|mesh-ancestor
139581854|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581855|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581856|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139581857|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581858|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
139581859|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139581860|NCT03300960|Ganirelix|ganirelix|mesh-list
139581861|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
139581862|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581863|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581864|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139581865|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
139581866|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139581867|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139581868|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139581869|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139581870|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581871|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
139581872|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581873|NCT02485444|Oxytocin|oxytocin|mesh-list
139581874|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
139581875|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139581876|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581877|NCT04490694|Lenvatinib|lenvatinib|mesh-list
139581878|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581879|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139581880|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581881|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581882|NCT04601584|Antibodies|antibodies|mesh-list
139581883|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
139581884|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
139581885|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581886|NCT02359474|Trabectedin|trabectedin|mesh-list
139581887|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139581888|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
139581889|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581890|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581891|NCT02467686|Tamoxifen|tamoxifen|mesh-list
139581892|NCT02467686|Exemestane|exemestane|mesh-list
139581893|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139581894|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139581895|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
139581896|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581897|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581898|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139581899|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581900|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139581901|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139581902|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139581903|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139363669|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
139581905|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581906|NCT05707962|Magnesium Sulfate|magnesium sulfate|mesh-list
139581907|NCT05707962|Neuroprotective Agents|neuroprotective agents|mesh-list
139581908|NCT05707962|Analgesics|analgesics|mesh-ancestor
139581909|NCT05707962|Sensory System Agents|sensory system agents|mesh-ancestor
139581910|NCT05707962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139581911|NCT05707962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581912|NCT05707962|Anesthetics|anesthetics|mesh-ancestor
139581913|NCT05707962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139581914|NCT05707962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139581915|NCT05707962|Anticonvulsants|anticonvulsants|mesh-ancestor
139581916|NCT05707962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139581917|NCT05707962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139581918|NCT05707962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581919|NCT05707962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139581920|NCT05707962|Tocolytic Agents|tocolytic agents|mesh-ancestor
139581921|NCT05707962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139581922|NCT05707962|Protective Agents|protective agents|mesh-ancestor
139581923|NCT05698680|Prednisolone|prednisolone|mesh-list
139581924|NCT05698680|Colchicine|colchicine|mesh-list
139581925|NCT05698680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139581926|NCT05698680|Glucocorticoids|glucocorticoids|mesh-ancestor
139581927|NCT05698680|Hormones|hormones|mesh-ancestor
139581928|NCT05698680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581929|NCT05698680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581930|NCT05698680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139581931|NCT05698680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581932|NCT05698680|Gout Suppressants|gout suppressants|mesh-ancestor
139581933|NCT05698680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139581934|NCT05698680|Tubulin Modulators|tubulin modulators|mesh-ancestor
139581935|NCT05698680|Antimitotic Agents|antimitotic agents|mesh-ancestor
139581936|NCT05698680|Mitosis Modulators|mitosis modulators|mesh-ancestor
139581937|NCT05698680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581938|NCT04058470|Prednisone|prednisone|mesh-list
139581939|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
139581940|NCT04058470|Rituximab|rituximab|mesh-list
139581941|NCT04058470|Doxorubicin|doxorubicin|mesh-list
139581942|NCT04058470|Vincristine|vincristine|mesh-list
139581943|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139581944|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
139581945|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581946|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139581947|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139581948|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
139581949|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581950|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581951|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139581952|NCT04058470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139581953|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139581954|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139581955|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139581956|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139581957|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139581958|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
139581959|NCT04058470|Hormones|hormones|mesh-ancestor
139581960|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581961|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139581962|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139581963|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
139581964|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
139581965|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
139581966|NCT02720484|Nivolumab|nivolumab|mesh-list
139581967|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139581968|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139581969|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139581970|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581971|NCT05447520|Montelukast|montelukast|mesh-list
139581972|NCT05447520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139581973|NCT05447520|Respiratory System Agents|respiratory system agents|mesh-ancestor
139581974|NCT05447520|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139581975|NCT05447520|Hormone Antagonists|hormone antagonists|mesh-ancestor
139581976|NCT05447520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139581977|NCT05447520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581978|NCT05447520|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139581979|NCT05447520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139581980|NCT05447520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581981|NCT05438550|Amoxicillin|amoxicillin|mesh-list
139581982|NCT05438550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139581983|NCT05438550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139581984|NCT05639946|Brivaracetam|brivaracetam|mesh-list
139581985|NCT05639946|Anticonvulsants|anticonvulsants|mesh-ancestor
139581986|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
139581987|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
139581988|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139581989|NCT03299712|Protective Agents|protective agents|mesh-ancestor
139581990|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139581991|NCT05327556|Epinephrine|epinephrine|mesh-list
139581992|NCT05327556|Racepinephrine|racepinephrine|mesh-list
139581993|NCT05327556|Epinephryl borate|epinephryl borate|mesh-list
139581994|NCT05327556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139581995|NCT05327556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139581996|NCT05327556|Adrenergic Agents|adrenergic agents|mesh-ancestor
139581997|NCT05327556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139581998|NCT05327556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139581999|NCT05327556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582000|NCT05327556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139582001|NCT05327556|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139582002|NCT05327556|Autonomic Agents|autonomic agents|mesh-ancestor
139582003|NCT05327556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582004|NCT05327556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139582005|NCT05327556|Respiratory System Agents|respiratory system agents|mesh-ancestor
139582006|NCT05327556|Mydriatics|mydriatics|mesh-ancestor
139582007|NCT05327556|Sympathomimetics|sympathomimetics|mesh-ancestor
139582008|NCT05327556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139582009|NCT02466438|Tazobactam|tazobactam|mesh-list
139582010|NCT02466438|Piperacillin|piperacillin|mesh-list
139582011|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139582012|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139582013|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582014|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139582015|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582016|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582017|NCT05587062|Aflibercept|aflibercept|mesh-list
139582018|NCT05587062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139582019|NCT05587062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139582020|NCT05587062|Growth Substances|growth substances|mesh-ancestor
139582021|NCT05587062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582022|NCT05587062|Growth Inhibitors|growth inhibitors|mesh-ancestor
139582023|NCT05587062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582024|NCT02463006|Methamphetamine|methamphetamine|mesh-list
139582025|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139582026|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582027|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
139582028|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
139582029|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582030|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
139582031|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582032|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582033|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
139582034|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139582035|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139582036|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139582037|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139582038|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139582039|NCT02466204|Hormones|hormones|mesh-ancestor
139582040|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139582041|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582042|NCT02715804|Paclitaxel|paclitaxel|mesh-list
139582043|NCT02715804|Gemcitabine|gemcitabine|mesh-list
139582044|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139582045|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582046|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
139582047|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
139582048|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
139582049|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582050|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139582052|NCT04745130|Cetuximab|cetuximab|mesh-list
139582053|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139582054|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582055|NCT02462304|Bevacizumab|bevacizumab|mesh-list
139582056|NCT02462304|Ranibizumab|ranibizumab|mesh-list
139582057|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139582058|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582059|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139582060|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139582061|NCT02462304|Growth Substances|growth substances|mesh-ancestor
139582062|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582063|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
139582064|NCT03501576|Vaccines|vaccines|mesh-list
139582065|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
139582066|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582067|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
139582068|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139582069|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
139582070|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139582071|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582072|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139582073|NCT04645212|Aflibercept|aflibercept|mesh-list
139582074|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139582075|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139582076|NCT04645212|Growth Substances|growth substances|mesh-ancestor
139582077|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582078|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
139582079|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582080|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
139582081|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
139582082|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139582083|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139582084|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582085|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582086|NCT04489446|Urological Agents|urological agents|mesh-ancestor
139582087|NCT02717754|Oseltamivir|oseltamivir|mesh-list
139582088|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
139582089|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582090|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582091|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582092|NCT02717130|Aripiprazole|aripiprazole|mesh-list
139582093|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
139582094|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139582095|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139582096|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139582097|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139582098|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582099|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
139582100|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
139582101|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582102|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582103|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139582104|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139582105|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
139582106|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139582107|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139582108|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139582109|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139582110|NCT02256696|Rifampin|rifampin|mesh-list
139582111|NCT02256696|Rifabutin|rifabutin|mesh-list
139582112|NCT02256696|Isoniazid|isoniazid|mesh-list
139582113|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
139582114|NCT02256696|Ethambutol|ethambutol|mesh-list
139582115|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139582116|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
139582117|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139582118|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582119|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
139582120|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139582121|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582122|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582123|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139582124|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139363886|NCT06126991|Cetirizine|cetirizine|mesh-list
139582125|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139582126|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139582127|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139582128|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139582129|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139582130|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139582131|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
139582132|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139582133|NCT01773473|Insulin|insulin|mesh-list
139582134|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139582135|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
139582136|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139582137|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582138|NCT01779869|Regadenoson|regadenoson|mesh-list
139582139|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139582140|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139582141|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
139582142|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
139582143|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582144|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582145|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582146|NCT01772537|Propofol|propofol|mesh-list
139582147|NCT01772537|Isoflurane|isoflurane|mesh-list
139582148|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139582149|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139582150|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582151|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139582152|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
139582153|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
139582154|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139582155|NCT01772147|Fluticasone|fluticasone|mesh-list
139582156|NCT01772147|Xhance|xhance|mesh-list
139582157|NCT01772147|Bromides|bromides|mesh-list
139582158|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139582159|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139582160|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139582161|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
139582162|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582163|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582164|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139582165|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
139582166|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
139582167|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139582168|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139582169|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139582170|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139582171|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
139582172|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582173|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582174|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
139582175|NCT01606787|Mannitol|mannitol|mesh-list
139582176|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139582177|NCT01606787|Diuretics|diuretics|mesh-ancestor
139582178|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
139582179|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582180|NCT01777997|Tenofovir|tenofovir|mesh-list
139582181|NCT01777997|Emtricitabine|emtricitabine|mesh-list
139582182|NCT01777997|Rilpivirine|rilpivirine|mesh-list
139582183|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
139582184|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582185|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139582186|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139582187|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582188|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582189|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139582190|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139582191|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139582192|NCT01770353|Hematinics|hematinics|mesh-ancestor
139582193|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139582194|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139582195|NCT01777763|Posaconazole|posaconazole|mesh-list
139582196|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
139582197|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582198|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139582199|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139582200|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139582201|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139582202|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139582203|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582204|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582205|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139582206|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
139582207|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139582208|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582209|NCT01769339|Miconazole|miconazole|mesh-list
139582210|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
139582211|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139582212|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
139582213|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582214|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139582215|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139582216|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582217|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582218|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139582219|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
139582220|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139582221|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582222|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139582223|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139582224|NCT01777139|Ezogabine|ezogabine|mesh-list
139582225|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
139582226|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139582227|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582228|NCT01768637|Aspirin|aspirin|mesh-list
139582229|NCT01768637|Clopidogrel|clopidogrel|mesh-list
139582230|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139582231|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139582232|NCT01768637|Analgesics|analgesics|mesh-ancestor
139582233|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
139582234|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582235|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582236|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139582237|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139582238|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139582239|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139582240|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582241|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139582242|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139582243|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582244|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
139582245|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139582246|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139582247|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139582248|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
139582249|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582250|NCT01768559|Insulin|insulin|mesh-list
139582251|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139582252|NCT01768559|Metformin|metformin|mesh-list
139582253|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
139582254|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
139582255|NCT01768559|Lixisenatide|lixisenatide|mesh-list
139582256|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139582257|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582258|NCT00983619|Rituximab|rituximab|mesh-list
139582259|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139582260|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582261|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
139582262|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582263|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139582264|NCT05608785|Capecitabine|capecitabine|mesh-list
139582265|NCT05608785|Oxaliplatin|oxaliplatin|mesh-list
139582266|NCT05608785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139582267|NCT05608785|Antimetabolites|antimetabolites|mesh-ancestor
139582268|NCT05608785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582269|NCT05608785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582270|NCT01775501|Leucovorin|leucovorin|mesh-list
139582271|NCT01775501|Fluorouracil|fluorouracil|mesh-list
139582272|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
139582273|NCT01775501|Sorafenib|sorafenib|mesh-list
139582274|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
139582275|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582276|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139582278|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139582279|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
139582280|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582281|NCT01775501|Antidotes|antidotes|mesh-ancestor
139582282|NCT01775501|Protective Agents|protective agents|mesh-ancestor
139582283|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
139582284|NCT01775501|Vitamins|vitamins|mesh-ancestor
139582285|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
139582286|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139582287|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582288|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
139582289|NCT04346667|Chloroquine|chloroquine|mesh-list
139582290|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
139582291|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139582292|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139582293|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582294|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313222|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582295|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582296|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139582297|NCT04346667|Amebicides|amebicides|mesh-ancestor
139582298|NCT03024489|Cetuximab|cetuximab|mesh-list
139582299|NCT03024489|Palbociclib|palbociclib|mesh-list
139582300|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139582301|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582302|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139582303|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582304|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582305|NCT01775189|Naltrexone|naltrexone|mesh-list
139582306|NCT01775189|Oxycodone|oxycodone|mesh-list
139582307|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139582308|NCT01775189|Narcotics|narcotics|mesh-ancestor
139582309|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139582310|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582311|NCT01775189|Analgesics|analgesics|mesh-ancestor
139582312|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
139582313|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582314|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139582315|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139582316|NCT01881412|Fluticasone|fluticasone|mesh-list
139582317|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139582318|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139582319|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
139582320|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582321|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582322|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139582323|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
139582324|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
139582325|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139582326|NCT03832816|Dronabinol|dronabinol|mesh-list
139582327|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
139582328|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582329|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139582330|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139582331|NCT03832816|Analgesics|analgesics|mesh-ancestor
139582332|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
139582333|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582334|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139582335|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139582336|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582337|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582338|NCT03832816|Hormones|hormones|mesh-ancestor
139582339|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139582340|NCT04231084|Epoprostenol|epoprostenol|mesh-list
139582341|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
139582342|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
139582343|NCT04231084|Tezosentan|tezosentan|mesh-list
139582344|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139582345|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
139582346|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582347|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582348|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139582349|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
139582350|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139364113|NCT06116955|Propofol|propofol|mesh-list
139582351|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
139582352|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582353|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582354|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139582355|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
139582356|NCT04231084|Protective Agents|protective agents|mesh-ancestor
139582357|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139582358|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139582359|NCT01770743|Vaccines|vaccines|mesh-list
139582360|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
139582361|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582362|NCT01884844|Vitamin D|vitamin d|mesh-list
139582363|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
139582364|NCT01884844|Vitamins|vitamins|mesh-ancestor
139582365|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
139582366|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582367|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139582368|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139582369|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139582370|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582371|NCT04127721|Methotrexate|methotrexate|mesh-list
139582372|NCT04127721|Fludarabine|fludarabine|mesh-list
139582373|NCT04127721|Busulfan|busulfan|mesh-list
139582374|NCT04127721|Tacrolimus|tacrolimus|mesh-list
139582375|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139582376|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
139582377|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139582378|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582379|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139582380|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
139582381|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582382|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582383|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
139582384|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582385|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139582386|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139582387|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
139582388|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139582389|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139582390|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139582391|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
139582392|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139582393|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139582394|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
139582395|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139582396|NCT04123743|Protective Agents|protective agents|mesh-ancestor
139582397|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582398|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
139582399|NCT02996721|Vitamin D|vitamin d|mesh-list
139582400|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
139582401|NCT02996721|Vitamins|vitamins|mesh-ancestor
139582402|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
139582403|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582404|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139582405|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139582406|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
139582407|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582408|NCT03926338|Celecoxib|celecoxib|mesh-list
139582409|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
139582410|NCT03926338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139582411|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139582412|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139582413|NCT03926338|Analgesics|analgesics|mesh-ancestor
139582414|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
139582415|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582416|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582417|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139582418|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139582419|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139582420|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582421|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582422|NCT03926338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139582423|NCT03926338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582424|NCT04126941|Calcium|calcium|mesh-list
139582425|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139582426|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582427|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
139582428|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
139582429|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139582430|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139582431|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582432|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582433|NCT04122105|Urological Agents|urological agents|mesh-ancestor
139582434|NCT04127019|Paclitaxel|paclitaxel|mesh-list
139582435|NCT04127019|Docetaxel|docetaxel|mesh-list
139582436|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
139582437|NCT04127019|Fluorouracil|fluorouracil|mesh-list
139582438|NCT04127019|Epirubicin|epirubicin|mesh-list
139582439|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139582440|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582441|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
139582442|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
139582443|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
139582444|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582445|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139582446|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
139582447|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582448|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139582449|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139582450|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
139582451|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139582452|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
139582453|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139582454|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139582455|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139582456|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139582457|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582458|NCT02076646|Interleukin-2|interleukin-2|mesh-list
139582459|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582460|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139582461|NCT02076646|Analgesics|analgesics|mesh-ancestor
139582462|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
139582463|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582464|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582465|NCT04121091|Pramipexole|pramipexole|mesh-list
139582466|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
139582467|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582468|NCT04121091|Protective Agents|protective agents|mesh-ancestor
139582469|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582470|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139582471|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139582472|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
139582473|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
139582474|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582475|NCT03283605|Durvalumab|durvalumab|mesh-list
139582476|NCT03283605|Tremelimumab|tremelimumab|mesh-list
139582477|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139582478|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582479|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
139582480|NCT01896544|Vitamin D|vitamin d|mesh-list
139582481|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139582482|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582483|NCT01896544|Vitamins|vitamins|mesh-ancestor
139582484|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
139582485|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139582486|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
139582487|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
139582488|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139582489|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582490|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139582491|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582492|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139582493|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139582494|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582495|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582496|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139582497|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139582498|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582499|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
139582500|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582501|NCT01932112|Adenosine|adenosine|mesh-list
139582502|NCT01932112|Analgesics|analgesics|mesh-ancestor
139582503|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
139582504|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582505|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582506|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139582507|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
139582508|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139582509|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
139582510|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
139582511|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582512|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582513|NCT01897402|Vaccines|vaccines|mesh-list
139582514|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
139582515|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582516|NCT01897792|Vitamins|vitamins|mesh-list
139582517|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
139582518|NCT01897792|Vitamin E|vitamin e|mesh-list
139582519|NCT01897792|Tocopherols|tocopherols|mesh-list
139582520|NCT01897792|Tocotrienols|tocotrienols|mesh-list
139582521|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
139582522|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
139582523|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582524|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
139582525|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582526|NCT01897792|Protective Agents|protective agents|mesh-ancestor
139582527|NCT01933984|Fluticasone|fluticasone|mesh-list
139582528|NCT01933984|Fenoterol|fenoterol|mesh-list
139582529|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139582530|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
139582531|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139582532|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
139582533|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582534|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582535|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139582536|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
139582537|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
139582538|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139582539|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139582540|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139582541|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139582542|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
139582543|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582544|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582545|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
139582546|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
139582547|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139582548|NCT04126083|Lofexidine|lofexidine|mesh-list
139582549|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139582550|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139582551|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582552|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
139582553|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582554|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139582555|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139582556|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139582557|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
139582558|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582559|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582560|NCT01935622|Doxycycline|doxycycline|mesh-list
139582561|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139582562|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582563|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
139582564|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139582565|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139582566|NCT03010917|Ethanol|ethanol|mesh-list
139582567|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139582568|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582569|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139582570|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582571|NCT02979561|Warfarin|warfarin|mesh-list
139582572|NCT02979561|Dabigatran|dabigatran|mesh-list
139582573|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
139582574|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
139582575|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139582576|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
139582577|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582578|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582579|NCT01937026|Probenecid|probenecid|mesh-list
139582580|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
139582581|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
139582582|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139582583|NCT01937260|Brodalumab|brodalumab|mesh-list
139582584|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
139582585|NCT01902004|Memantine|memantine|mesh-list
139582586|NCT01902004|Escitalopram|escitalopram|mesh-list
139582587|NCT01902004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139582588|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139582589|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139582590|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582591|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582592|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
139582593|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582594|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139582595|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139582596|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
139582597|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139582598|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139582599|NCT01938040|Ibuprofen|ibuprofen|mesh-list
139582600|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139582601|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139582602|NCT01938040|Analgesics|analgesics|mesh-ancestor
139582603|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
139582604|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313223|NCT02308098|Budesonide|budesonide|mesh-list
139582605|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582606|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139582607|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139582608|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139582609|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582610|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582611|NCT03829839|Lorazepam|lorazepam|mesh-list
139582612|NCT03829839|Oxytocin|oxytocin|mesh-list
139582613|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
139582614|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139582615|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582616|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
139582617|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
139582618|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
139582619|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582620|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139582621|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139582622|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139582623|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139582624|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139582625|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139582626|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
139582627|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
139582628|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582629|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582630|NCT01938664|Candesartan|candesartan|mesh-list
139582631|NCT01938664|Candesartan cilexetil|candesartan cilexetil|mesh-list
139582632|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139582633|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139582634|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139582635|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582636|NCT03829917|Paromomycin|paromomycin|mesh-list
139582637|NCT03829917|Miltefosine|miltefosine|mesh-list
139582638|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139582639|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582640|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139582641|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139582642|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
139582643|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582644|NCT02284126|Vancomycin|vancomycin|mesh-list
139582645|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139582646|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582647|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
139582648|NCT01736579|Antibodies|antibodies|mesh-list
139582649|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
139582650|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139582651|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139582652|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
139582653|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582654|NCT04124913|Progesterone|progesterone|mesh-list
139582655|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
139582656|NCT04124913|Progestins|progestins|mesh-ancestor
139582658|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139582659|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582660|NCT03828279|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139582661|NCT03828279|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139582662|NCT03828279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139582663|NCT03828279|Immunologic Factors|immunologic factors|mesh-ancestor
139582664|NCT03828279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582665|NCT02987920|Acetaminophen|acetaminophen|mesh-list
139582666|NCT02987920|Celecoxib|celecoxib|mesh-list
139582667|NCT02987920|Ketorolac|ketorolac|mesh-list
139582668|NCT02987920|Oxycodone|oxycodone|mesh-list
139582669|NCT02987920|Gabapentin|gabapentin|mesh-list
139582670|NCT02987920|Hydromorphone|hydromorphone|mesh-list
139582671|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
139582672|NCT02987920|Pantoprazole|pantoprazole|mesh-list
139078760|NCT02205762|Analgesics|analgesics|mesh-ancestor
139582673|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139582674|NCT02987920|Analgesics|analgesics|mesh-ancestor
139582675|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
139582676|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582677|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582678|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
139582679|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139582680|NCT02987920|Narcotics|narcotics|mesh-ancestor
139582681|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139582682|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139582683|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139582684|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139582685|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139582686|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139582687|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582688|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582689|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
139582690|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139582691|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139582692|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139582693|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139582694|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139582695|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582696|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
139582697|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139582698|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139582699|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139582700|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
139582701|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
139582702|NCT02974257|Thiamine|thiamine|mesh-list
139582703|NCT02974257|Vitamins|vitamins|mesh-ancestor
139582704|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
139582705|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582706|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
139582707|NCT01736189|Adalimumab|adalimumab|mesh-list
139582708|NCT01736189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139582709|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139582710|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139582711|NCT02970981|Nivolumab|nivolumab|mesh-list
139582712|NCT02970981|Ipilimumab|ipilimumab|mesh-list
139582713|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139582714|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582715|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139582716|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582717|NCT02983773|Dronabinol|dronabinol|mesh-list
139582718|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
139582719|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582720|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139582721|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139582722|NCT02983773|Analgesics|analgesics|mesh-ancestor
139582723|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
139582724|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582725|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139582726|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139582727|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582728|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582729|NCT02983773|Hormones|hormones|mesh-ancestor
139582730|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139582731|NCT01941628|Rocuronium|rocuronium|mesh-list
139582732|NCT01941628|Succinylcholine|succinylcholine|mesh-list
139582733|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139582734|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139582735|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139582736|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582737|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582738|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139582739|NCT02987218|Propofol|propofol|mesh-list
139582740|NCT02987218|Desflurane|desflurane|mesh-list
139582741|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139582742|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139582743|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582744|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139582745|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
139582746|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
139582747|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139582748|NCT01762943|Leuprolide|leuprolide|mesh-list
139582749|NCT01762943|Estradiol|estradiol|mesh-list
139582750|NCT01762943|Progesterone|progesterone|mesh-list
139582751|NCT01762943|Estrogens|estrogens|mesh-ancestor
139582752|NCT01762943|Hormones|hormones|mesh-ancestor
139582753|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139582754|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582755|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139582756|NCT01762943|Progestins|progestins|mesh-ancestor
139582757|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139582758|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
139582759|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139582760|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582761|NCT04392063|Melatonin|melatonin|mesh-list
139582762|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
139582763|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582764|NCT04392063|Protective Agents|protective agents|mesh-ancestor
139582765|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582766|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139582767|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
139582768|NCT01903798|Prednisolone|prednisolone|mesh-list
139582769|NCT01903798|Rilonacept|rilonacept|mesh-list
139582770|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139582771|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582772|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139582773|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
139582774|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139582775|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582776|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582777|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582778|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139582779|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
139582780|NCT01903798|Hormones|hormones|mesh-ancestor
139582781|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139582782|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582783|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139582784|NCT01945138|Insulin|insulin|mesh-list
139582785|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139582786|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139582787|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582788|NCT01734785|Empagliflozin|empagliflozin|mesh-list
139582789|NCT01734785|Linagliptin|linagliptin|mesh-list
139582790|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139582791|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582792|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139582793|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582794|NCT01734785|Incretins|incretins|mesh-ancestor
139582795|NCT01734785|Hormones|hormones|mesh-ancestor
139582796|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139582797|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139582798|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
139582799|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582800|NCT03821415|Estradiol|estradiol|mesh-list
139582801|NCT03821415|Estrogens|estrogens|mesh-ancestor
139582802|NCT03821415|Hormones|hormones|mesh-ancestor
139582803|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139582804|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582805|NCT01734395|Galantamine|galantamine|mesh-list
139582806|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139582807|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582808|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582809|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
139582810|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582811|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582812|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139582813|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
139582814|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582815|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
139582816|NCT01945294|Interferons|interferons|mesh-list
139582817|NCT01945294|Ribavirin|ribavirin|mesh-list
139582818|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
139582819|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
139582820|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139582821|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582822|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
139582823|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582824|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
139582825|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582826|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
139582827|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582828|NCT01947946|Benralizumab|benralizumab|mesh-list
139582829|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139582830|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
139582831|NCT02954055|Paclitaxel|paclitaxel|mesh-list
139582832|NCT02954055|Vinorelbine|vinorelbine|mesh-list
139582833|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139582834|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
139582835|NCT02954055|Capecitabine|capecitabine|mesh-list
139582836|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139582837|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582838|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
139582839|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
139582840|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
139582841|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582842|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139582843|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
139582844|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582845|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139582846|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139582847|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
139582848|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139582849|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139582850|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
139582851|NCT03313180|Nintedanib|nintedanib|mesh-list
139582852|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582853|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139582854|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582855|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582856|NCT03820245|Lycopene|lycopene|mesh-list
139582857|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139582858|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
139582859|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582860|NCT03820245|Protective Agents|protective agents|mesh-ancestor
139582861|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582862|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139582863|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139582864|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582865|NCT01597505|Vancomycin|vancomycin|mesh-list
139582866|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139582867|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582868|NCT03826485|Pranlukast|pranlukast|mesh-list
139582869|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139582870|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
139582871|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139582872|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
139582873|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139582874|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582875|NCT03823989|Mitomycins|mitomycins|mesh-list
139582876|NCT03823989|Mitomycin|mitomycin|mesh-list
139582877|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139582878|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582879|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
139582880|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582881|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139582882|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582883|NCT01951066|Dexamethasone|dexamethasone|mesh-list
139582884|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139582885|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
139582886|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
139582887|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582888|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582889|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139582890|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
139582892|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139582893|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139582894|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582895|NCT05735626|Capsaicin|capsaicin|mesh-list
139582896|NCT05735626|Piperine|piperine|mesh-list
139582897|NCT05735626|Antipruritics|antipruritics|mesh-ancestor
139582898|NCT05735626|Dermatologic Agents|dermatologic agents|mesh-ancestor
139582899|NCT05735626|Sensory System Agents|sensory system agents|mesh-ancestor
139582900|NCT05735626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582901|NCT05735626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582902|NCT05735626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139582903|NCT05735626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582904|NCT05735626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582905|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139582906|NCT01951768|Gentamicins|gentamicins|mesh-list
139582907|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582908|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139582909|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582910|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582911|NCT05735470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139582912|NCT05735470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139582913|NCT03825861|Folfirinox|folfirinox|mesh-list
139582914|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582915|NCT01760447|Metformin|metformin|mesh-list
139582916|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139582917|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139582918|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582919|NCT01760447|Incretins|incretins|mesh-ancestor
139582920|NCT01760447|Hormones|hormones|mesh-ancestor
139582921|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139582922|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139582923|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
139582924|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582925|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582926|NCT01915108|Remifentanil|remifentanil|mesh-list
139582927|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139582928|NCT01915108|Narcotics|narcotics|mesh-ancestor
139582929|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139582930|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582931|NCT01915108|Analgesics|analgesics|mesh-ancestor
139582932|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
139582933|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582934|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
139582935|NCT03825471|Anesthetics|anesthetics|mesh-list
139582936|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139582937|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582938|NCT03825471|Narcotics|narcotics|mesh-ancestor
139582939|NCT03825471|Analgesics|analgesics|mesh-ancestor
139582940|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
139582941|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139582942|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139582943|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139582944|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582945|NCT01450215|Lenalidomide|lenalidomide|mesh-list
139582946|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
139582947|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582948|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139582949|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139582950|NCT01450215|Growth Substances|growth substances|mesh-ancestor
139582951|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
139582952|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582953|NCT01917214|Sunitinib|sunitinib|mesh-list
139582954|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582955|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139582956|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139582957|NCT01917214|Growth Substances|growth substances|mesh-ancestor
139582958|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582959|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
139582960|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139582961|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582962|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582963|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
139582964|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139582965|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
139582966|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582967|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139582968|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139582969|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
139582970|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582971|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582972|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139582973|NCT01732913|Rituximab|rituximab|mesh-list
139582974|NCT01732913|Idelalisib|idelalisib|mesh-list
139582975|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139582976|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139582977|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
139582978|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582979|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139582980|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139582981|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582982|NCT03824925|Zinc|zinc|mesh-list
139582983|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
139582984|NCT03824925|Trace Elements|trace elements|mesh-ancestor
139582985|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
139582986|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582987|NCT03824925|Astringents|astringents|mesh-ancestor
139582988|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
139582989|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139582990|NCT03825081|Pilocarpine|pilocarpine|mesh-list
139582991|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139582992|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139582993|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139582994|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139582995|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
139582996|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139582997|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139582998|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139582999|NCT03825081|Miotics|miotics|mesh-ancestor
139583000|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
139583001|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583002|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139583003|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139583004|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
139583005|NCT01920802|Olanzapine|olanzapine|mesh-list
139583006|NCT01920802|Iloperidone|iloperidone|mesh-list
139583007|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
139583008|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
139583009|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583010|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583011|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139583012|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139583013|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139583014|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583015|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139583016|NCT01920802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139583017|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139583018|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139583019|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583020|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583021|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
139583022|NCT01451229|Higenamine|higenamine|mesh-list
139583023|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139583024|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139583025|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
139583026|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583027|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583028|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583029|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139583030|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139583031|NCT01451229|Analgesics|analgesics|mesh-ancestor
139583032|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
139583033|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583035|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139583036|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139583037|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139583038|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139583039|NCT01451229|Protective Agents|protective agents|mesh-ancestor
139583040|NCT03054519|Metformin|metformin|mesh-list
139583041|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139583042|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583043|NCT01921894|Vitamin D|vitamin d|mesh-list
139583044|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
139583045|NCT01921894|Vitamins|vitamins|mesh-ancestor
139583046|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
139583047|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583048|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139583049|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139583050|NCT01452009|Travoprost|travoprost|mesh-list
139583051|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139583052|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139583053|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139583054|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139583055|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
139583056|NCT03824379|Cathartics|cathartics|mesh-ancestor
139583057|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139583058|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583059|NCT01957930|Insulin|insulin|mesh-list
139583060|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139583061|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139583062|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583063|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139583064|NCT01732757|Dextrans|dextrans|mesh-list
139583065|NCT01732757|Alcaftadine|alcaftadine|mesh-list
139583066|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
139583067|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
139583068|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
139583069|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139583070|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139583071|NCT01732757|Analgesics|analgesics|mesh-ancestor
139583072|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
139583073|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583074|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583075|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139583076|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139583077|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139583078|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139583079|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139583080|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
139583081|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
139583082|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583083|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583084|NCT01758731|Cetuximab|cetuximab|mesh-list
139583085|NCT01758731|Olaparib|olaparib|mesh-list
139583086|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139583087|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583088|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139583089|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583090|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583091|NCT01452477|Tanshinone|tanshinone|mesh-list
139583092|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139583093|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139583094|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139583095|NCT01452477|Analgesics|analgesics|mesh-ancestor
139583096|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
139583097|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583098|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583099|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139583100|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139583101|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
139583102|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139583103|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583104|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139583105|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
139583106|NCT01452633|Bupivacaine|bupivacaine|mesh-list
139583107|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
139583108|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
139583109|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583110|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583111|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
139583112|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583114|NCT01606319|Ibuprofen|ibuprofen|mesh-list
139583115|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139583116|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139583117|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139583118|NCT01606319|Analgesics|analgesics|mesh-ancestor
139583119|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
139583120|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583121|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583122|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
139583123|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139583124|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139583125|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583126|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583127|NCT01452711|Lansoprazole|lansoprazole|mesh-list
139583128|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
139583129|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139583130|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139583131|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139583132|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583133|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583134|NCT02630121|Phenylephrine|phenylephrine|mesh-list
139583135|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
139583136|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139583137|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139583138|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
139583139|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583140|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583141|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583142|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
139583143|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
139583144|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583145|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
139583146|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139583147|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
139583148|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139583149|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
139583150|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139583151|NCT02630121|Protective Agents|protective agents|mesh-ancestor
139583152|NCT02956785|Dinoprostone|dinoprostone|mesh-list
139583153|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
139583154|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139583155|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583156|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
139583157|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139583158|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139583159|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
139583160|NCT02947581|Albendazole|albendazole|mesh-list
139583161|NCT02947581|Praziquantel|praziquantel|mesh-list
139583162|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
139583163|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139583164|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139583165|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
139583166|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139583167|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139583168|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
139583169|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
139583170|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
139583171|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583172|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583173|NCT01453881|Beclomethasone|beclomethasone|mesh-list
139583174|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
139583175|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139583176|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
139583177|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583178|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583179|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139583180|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
139583181|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139583182|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139583183|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139364950|NCT05289908|Hematinics|hematinics|mesh-ancestor
139583184|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
139583185|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583186|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583187|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139583188|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
139583190|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139583191|NCT04391361|Atropine|atropine|mesh-list
139583192|NCT04391361|Scopolamine|scopolamine|mesh-list
139583193|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
139583194|NCT04391361|Edaravone|edaravone|mesh-list
139583195|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139583196|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139583197|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583198|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583199|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139583200|NCT04391361|Analgesics|analgesics|mesh-ancestor
139583201|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
139583202|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583203|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139583204|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139583205|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139583206|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
139583207|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583208|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583209|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139583210|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139583211|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139583212|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
139583213|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139583214|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
139583215|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
139583216|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
139583217|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139583218|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139583219|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
139583220|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
139583221|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139583222|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139583223|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
139583224|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139583225|NCT04391361|Protective Agents|protective agents|mesh-ancestor
139583226|NCT04273191|Brexanolone|brexanolone|mesh-list
139583227|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
139583228|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583229|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583230|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583231|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
139583232|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
139583233|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
139583234|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
139583235|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139583236|NCT01454115|BMS 708163|bms 708163|mesh-list
139583237|NCT01454115|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139583238|NCT01454115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583239|NCT01454115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583240|NCT01455597|Estradiol|estradiol|mesh-list
139583241|NCT01455597|Estrogens|estrogens|mesh-ancestor
139583242|NCT01455597|Hormones|hormones|mesh-ancestor
139583243|NCT01455597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139583244|NCT01455597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583245|NCT01453101|Fludarabine|fludarabine|mesh-list
139583246|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
139583247|NCT01453101|Bortezomib|bortezomib|mesh-list
139583248|NCT01453101|Melphalan|melphalan|mesh-list
139583249|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583250|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139583251|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
139583252|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583253|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139583254|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
139583255|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583256|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139583257|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
139583258|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139583259|NCT02085447|Haloperidol|haloperidol|mesh-list
139583260|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139583261|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
139583262|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
139583263|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139583264|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583265|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583266|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139583267|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139583268|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139583269|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
139583270|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583271|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583272|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139583273|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139583274|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
139583275|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
139583276|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
139583277|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583278|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139583279|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139583280|NCT04847193|Xanthohumol|xanthohumol|mesh-list
139583281|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583282|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139583283|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139583284|NCT04847193|Growth Substances|growth substances|mesh-ancestor
139583285|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583286|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
139583287|NCT04273035|Midazolam|midazolam|mesh-list
139583288|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139583289|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139583290|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583291|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545750|NCT00226096|Metoprolol|metoprolol|mesh-list
139583292|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139583293|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139583294|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139583295|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139583296|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
139583297|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
139583298|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
139583299|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
139583300|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583301|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583302|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
139583303|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139583304|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
139583305|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583306|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583307|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139583308|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
139583309|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139583310|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
139583311|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583312|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583313|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139583314|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
139583315|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
139583316|NCT02836899|Protective Agents|protective agents|mesh-ancestor
139583317|NCT02902029|Atezolizumab|atezolizumab|mesh-list
139583318|NCT02902029|Vemurafenib|vemurafenib|mesh-list
139583319|NCT02902029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139583320|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583321|NCT02902029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139583322|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583323|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139583324|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583325|NCT02933697|Apixaban|apixaban|mesh-list
139583326|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
139583327|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139583328|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
139583329|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139583330|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
139583331|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583332|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583333|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
139365095|NCT05047770|Vaccines|vaccines|mesh-list
139583334|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
139583335|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139583336|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
139583337|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583338|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583339|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139583340|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
139583341|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
139583342|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139583343|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
139583344|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583345|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583346|NCT01455441|Liraglutide|liraglutide|mesh-list
139583347|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139583348|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583349|NCT01455441|Incretins|incretins|mesh-ancestor
139583350|NCT01455441|Hormones|hormones|mesh-ancestor
139583351|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139583352|NCT01455831|Tinzaparin|tinzaparin|mesh-list
139583353|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139583354|NCT01455831|Dalteparin|dalteparin|mesh-list
139583355|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
139583356|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139583357|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139583358|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583359|NCT04840641|Efavirenz|efavirenz|mesh-list
139583360|NCT04840641|Floxacillin|floxacillin|mesh-list
139583361|NCT04840641|Losartan|losartan|mesh-list
139583362|NCT04840641|Metoprolol|metoprolol|mesh-list
139583363|NCT04840641|Midazolam|midazolam|mesh-list
139583364|NCT04840641|Caffeine|caffeine|mesh-list
139583365|NCT04840641|Omeprazole|omeprazole|mesh-list
139583366|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139583367|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139583368|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583369|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583370|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139583371|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139583372|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139583373|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139583374|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
139583375|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
139583376|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
139583377|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
139583378|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583379|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583380|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139583381|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139583382|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139583383|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139583384|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139583385|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139583386|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583387|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139583388|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139583389|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
139583390|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139583391|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139583392|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139583393|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139583394|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139583395|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
139583396|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139583397|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139583398|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139583399|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139583400|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139583401|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139583402|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139583403|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
139583404|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
139583405|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583406|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139583407|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139365169|NCT04961190|Paroxetine|paroxetine|mesh-list
139583408|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139583409|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
139583410|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139583411|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139583413|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139583414|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583415|NCT01455909|Incretins|incretins|mesh-ancestor
139583416|NCT01455909|Hormones|hormones|mesh-ancestor
139583417|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139583418|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139583419|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
139583420|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583421|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583422|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139583423|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139583424|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139583425|NCT02555787|Tacrolimus|tacrolimus|mesh-list
139583426|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139583427|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
139583428|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583429|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139583430|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583431|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583432|NCT01730729|Cabergoline|cabergoline|mesh-list
139583433|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139583434|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139583435|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
139583436|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
139583437|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583438|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583439|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583440|NCT01756157|Complement C1s|complement c1s|mesh-list
139583441|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139583442|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
139583443|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
139583444|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583445|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139583446|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139583447|NCT01756079|Ribavirin|ribavirin|mesh-list
139583448|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139583449|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
139583450|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583451|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
139583452|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139583453|NCT04272645|Atezolizumab|atezolizumab|mesh-list
139583454|NCT04272645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139583455|NCT04272645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583456|NCT04272645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139583457|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583458|NCT04390815|Insulin|insulin|mesh-list
139583459|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139583460|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139583461|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583462|NCT01456611|Diclofenac|diclofenac|mesh-list
139583463|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139583464|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139583465|NCT01456611|Analgesics|analgesics|mesh-ancestor
139583466|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
139583467|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583468|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583469|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139583470|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139583471|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139583472|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583473|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583474|NCT01456689|Midazolam|midazolam|mesh-list
139583475|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139583476|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139583477|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583478|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583479|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139583480|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139583481|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139583482|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139583483|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
139583484|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
139583485|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
139583486|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
139583487|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583488|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583489|NCT05826821|Pirfenidone|pirfenidone|mesh-list
139583490|NCT05826821|Analgesics|analgesics|mesh-ancestor
139583491|NCT05826821|Sensory System Agents|sensory system agents|mesh-ancestor
139583492|NCT05826821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583493|NCT05826821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583494|NCT05826821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139583495|NCT05826821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139583496|NCT05826821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139583497|NCT05826821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139583498|NCT05826821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583499|NCT05826444|Calcium|calcium|mesh-list
139583500|NCT05826444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139583501|NCT05826444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583502|NCT05826249|Ritonavir|ritonavir|mesh-list
139583503|NCT05826249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139583504|NCT05826249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139583505|NCT05826249|Protease Inhibitors|protease inhibitors|mesh-ancestor
139583506|NCT05826249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583507|NCT05826249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583508|NCT05826249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139583509|NCT05826249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139583510|NCT05826249|Antiviral Agents|antiviral agents|mesh-ancestor
139583511|NCT05826249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139583512|NCT05826249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139583513|NCT05826249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139583514|NCT05825872|Lidocaine|lidocaine|mesh-list
139583515|NCT05825872|Bupivacaine|bupivacaine|mesh-list
139583516|NCT05825872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139583517|NCT05825872|Anesthetics, Local|anesthetics, local|mesh-ancestor
139583518|NCT05825872|Anesthetics|anesthetics|mesh-ancestor
139583519|NCT05825872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583520|NCT05825872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583521|NCT05825872|Sensory System Agents|sensory system agents|mesh-ancestor
139583522|NCT05825872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583523|NCT05825872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139583524|NCT05825872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139583525|NCT05825872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139583526|NCT05825872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139583527|NCT05825872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583528|NCT05825599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139583529|NCT05825599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139583530|NCT05825586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139583531|NCT05825586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139583532|NCT05825378|Dexamethasone|dexamethasone|mesh-list
139583533|NCT05825378|Ropivacaine|ropivacaine|mesh-list
139583534|NCT05825378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139583535|NCT05825378|Antiemetics|antiemetics|mesh-ancestor
139583536|NCT05825378|Autonomic Agents|autonomic agents|mesh-ancestor
139583537|NCT05825378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583538|NCT05825378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583539|NCT05825378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139583540|NCT05825378|Glucocorticoids|glucocorticoids|mesh-ancestor
139583541|NCT05825378|Hormones|hormones|mesh-ancestor
139583542|NCT05825378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139583543|NCT05825378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139583544|NCT05825378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583545|NCT05825378|Anesthetics, Local|anesthetics, local|mesh-ancestor
139583546|NCT05825378|Anesthetics|anesthetics|mesh-ancestor
139583547|NCT05825378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583548|NCT05825378|Sensory System Agents|sensory system agents|mesh-ancestor
139583549|NCT05824897|Vitamin D|vitamin d|mesh-list
139583550|NCT05824897|Vitamins|vitamins|mesh-ancestor
139583551|NCT05824897|Micronutrients|micronutrients|mesh-ancestor
139583552|NCT05824897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583553|NCT05824897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139583554|NCT05823844|Suvorexant|suvorexant|mesh-list
139583555|NCT05823844|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139583556|NCT05823844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139583557|NCT05823844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583558|NCT05823844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583559|NCT05823844|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139583560|NCT05823844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583561|NCT05823844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583562|NCT05823662|Silodosin|silodosin|mesh-list
139583563|NCT05823662|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139583564|NCT05823662|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139583565|NCT05823662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139583566|NCT05823662|Adrenergic Agents|adrenergic agents|mesh-ancestor
139583567|NCT05823662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583568|NCT05823662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583569|NCT05823662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583570|NCT05823662|Urological Agents|urological agents|mesh-ancestor
139583571|NCT05823363|Bupivacaine|bupivacaine|mesh-list
139583572|NCT05823363|Anesthetics, Local|anesthetics, local|mesh-ancestor
139583573|NCT05823363|Anesthetics|anesthetics|mesh-ancestor
139583574|NCT05823363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583575|NCT05823363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583576|NCT05823363|Sensory System Agents|sensory system agents|mesh-ancestor
139583577|NCT05823363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583578|NCT05822076|Ropivacaine|ropivacaine|mesh-list
139583579|NCT05822076|Anesthetics, Local|anesthetics, local|mesh-ancestor
139583580|NCT05822076|Anesthetics|anesthetics|mesh-ancestor
139078960|NCT03509350|Vitamins|vitamins|mesh-list
139583581|NCT05822076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583582|NCT05822076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583583|NCT05822076|Sensory System Agents|sensory system agents|mesh-ancestor
139583584|NCT05822076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583585|NCT05821543|Metformin|metformin|mesh-list
139583586|NCT05821543|Sibutramine|sibutramine|mesh-list
139583587|NCT05821543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139583588|NCT05821543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583589|NCT05821543|Antidepressive Agents|antidepressive agents|mesh-ancestor
139583590|NCT05821543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139583591|NCT05821543|Appetite Depressants|appetite depressants|mesh-ancestor
139583592|NCT05821543|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139583593|NCT05811949|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139583594|NCT05811949|Dermatologic Agents|dermatologic agents|mesh-ancestor
139583595|NCT05811949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139583596|NCT05811949|Immunologic Factors|immunologic factors|mesh-ancestor
139583597|NCT05811949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583598|NCT05800639|Anesthetics|anesthetics|mesh-list
139583599|NCT05800639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583600|NCT05800639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583601|NCT05753618|Lenograstim|lenograstim|mesh-list
139583602|NCT05753618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139583603|NCT05753618|Immunologic Factors|immunologic factors|mesh-ancestor
139583604|NCT05753618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583605|NCT05752461|Enoxaparin|enoxaparin|mesh-list
139583606|NCT05752461|Enoxaparin sodium|enoxaparin sodium|mesh-list
139583607|NCT05752461|Anticoagulants|anticoagulants|mesh-ancestor
139583608|NCT05752461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139583609|NCT05752461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139583610|NCT05752461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583611|NCT05733546|Psilocybin|psilocybin|mesh-list
139583612|NCT05733546|Hallucinogens|hallucinogens|mesh-ancestor
139583613|NCT05733546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583614|NCT05733546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139583615|NCT05724550|Neostigmine|neostigmine|mesh-list
139583616|NCT05724550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139583617|NCT05724550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583618|NCT05724550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583619|NCT05724550|Cholinergic Agents|cholinergic agents|mesh-ancestor
139583620|NCT05724550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583621|NCT05724550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583622|NCT05724550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139583623|NCT05724550|Autonomic Agents|autonomic agents|mesh-ancestor
139583624|NCT05724550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583625|NCT05659329|Gentamicins|gentamicins|mesh-list
139583626|NCT05659329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139583627|NCT05659329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139583628|NCT05659329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139583629|NCT05659329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583630|NCT05659329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583631|NCT05496036|Pembrolizumab|pembrolizumab|mesh-list
139583632|NCT05496036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139583633|NCT05496036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583634|NCT05496036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139583635|NCT05496036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583637|NCT05320068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139583638|NCT05320068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139583639|NCT05277402|Pembrolizumab|pembrolizumab|mesh-list
139583640|NCT05277402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139583641|NCT05277402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583642|NCT05277402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139583643|NCT05277402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583644|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
139583645|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139583646|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583647|NCT05204160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139583648|NCT05204160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583649|NCT05161637|Bupivacaine|bupivacaine|mesh-list
139583650|NCT05161637|Ropivacaine|ropivacaine|mesh-list
139583651|NCT05161637|Anesthetics, Local|anesthetics, local|mesh-ancestor
139583652|NCT05161637|Anesthetics|anesthetics|mesh-ancestor
139583653|NCT05161637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583654|NCT05161637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583655|NCT05161637|Sensory System Agents|sensory system agents|mesh-ancestor
139583656|NCT05161637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583657|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
139583658|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139583659|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139583660|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583661|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139583662|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583663|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139583664|NCT04911166|Atezolizumab|atezolizumab|mesh-list
139583665|NCT04911166|Interleukin-12|interleukin-12|mesh-list
139583666|NCT04911166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139583667|NCT04911166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583668|NCT04911166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139583669|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139583670|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139583671|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
139583672|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583673|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139583674|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139583675|NCT04911166|Growth Substances|growth substances|mesh-ancestor
139583676|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
139583677|NCT04903353|Risperidone|risperidone|mesh-list
139583678|NCT04903353|Aripiprazole|aripiprazole|mesh-list
139583679|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139583680|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
139583681|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583682|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583683|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583684|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139583685|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139583686|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583687|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139583688|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139583689|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
139583690|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
139583691|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
139583692|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139583693|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139583694|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139583695|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139583696|NCT04831047|Phenylephrine|phenylephrine|mesh-list
139583697|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
139583698|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139583699|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139583700|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139583701|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139583702|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
139583703|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583704|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583705|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583706|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
139583707|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
139583708|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583709|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
139583710|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139583711|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
139583712|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139583713|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
139583714|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139583715|NCT04831047|Protective Agents|protective agents|mesh-ancestor
139583716|NCT04775680|Antibodies|antibodies|mesh-list
139583717|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
139583718|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583719|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139583720|NCT04747314|Aripiprazole|aripiprazole|mesh-list
139583721|NCT04747314|Mirtazapine|mirtazapine|mesh-list
139583722|NCT04747314|Bupropion|bupropion|mesh-list
139583723|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139583724|NCT04747314|Sertraline|sertraline|mesh-list
139583725|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
139583726|NCT04747314|Escitalopram|escitalopram|mesh-list
139583727|NCT04747314|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139583728|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139583729|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139583730|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139583731|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139583732|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
139583733|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583734|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583735|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139583736|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139583737|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139583738|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
139583739|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139583740|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139583741|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139583742|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139583743|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139583744|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583745|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
139583746|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139583747|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139583748|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139583749|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139583750|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139583751|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139583752|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139583753|NCT04747314|Analgesics|analgesics|mesh-ancestor
139583754|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
139583755|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139583756|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
139583757|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
139583758|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139583759|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139583760|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139583761|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139583762|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
139583763|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139583764|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
139583765|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139583766|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139583767|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139583768|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139583769|NCT04700514|Analgesics|analgesics|mesh-ancestor
139583770|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
139583771|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139583772|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139583773|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139583774|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139583775|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
139583776|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139313224|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
139176050|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139176051|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
139176052|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
139176053|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
139176054|NCT01265173|Cefotaxime|cefotaxime|mesh-list
139176055|NCT01265173|Cefoxitin|cefoxitin|mesh-list
139176056|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139176057|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139176058|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139176059|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139176060|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176061|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176062|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176063|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139176064|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139176065|NCT01159327|Sorafenib|sorafenib|mesh-list
139176066|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176067|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139176068|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176069|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176070|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
139176071|NCT01160341|Testosterone|testosterone|mesh-list
139176072|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
139176073|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
139176074|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139176075|NCT01160341|Androgens|androgens|mesh-ancestor
139176076|NCT01160341|Hormones|hormones|mesh-ancestor
138714577|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176077|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139176078|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176079|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139176080|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176081|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
139176082|NCT03882775|Heparin|heparin|mesh-list
139176083|NCT03882775|Bivalirudin|bivalirudin|mesh-list
139176084|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
139176085|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139176086|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139176087|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176088|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
139176089|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139176090|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
139176091|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176092|NCT03877705|Listerine|listerine|mesh-list
139176093|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
138714713|NCT04583046|Iloprost|iloprost|mesh-list
139176094|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139176095|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139176096|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
139176097|NCT03877705|Protective Agents|protective agents|mesh-ancestor
139176098|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176100|NCT01160419|Folic Acid|folic acid|mesh-list
139176101|NCT01160419|Docetaxel|docetaxel|mesh-list
139176102|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
139176103|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
139176104|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176105|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
139176106|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
139176107|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
139176108|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176109|NCT01160419|Antidotes|antidotes|mesh-ancestor
139176110|NCT01160419|Protective Agents|protective agents|mesh-ancestor
139176111|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176112|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
139176114|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
139176115|NCT01160419|Hematinics|hematinics|mesh-ancestor
139176116|NCT02954172|Paclitaxel|paclitaxel|mesh-list
139176117|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139176118|NCT02954172|Bevacizumab|bevacizumab|mesh-list
139176119|NCT02954172|Carboplatin|carboplatin|mesh-list
139176120|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139176121|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176122|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
139176123|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
139176124|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
139176125|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176126|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139176127|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139176128|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139176129|NCT02954172|Growth Substances|growth substances|mesh-ancestor
139176130|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176131|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
139176133|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139176134|NCT02953938|Ranibizumab|ranibizumab|mesh-list
139176135|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139176136|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139176137|NCT02953938|Growth Substances|growth substances|mesh-ancestor
139176138|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176139|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
139176140|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176141|NCT01161667|Naratriptan|naratriptan|mesh-list
138715038|NCT04600115|Adenosine|adenosine|mesh-list
139176142|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139176143|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139176144|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139176145|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
139176146|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671409|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
139176147|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176149|NCT02526979|Mirabegron|mirabegron|mesh-list
139176150|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138715170|NCT00573690|Carboplatin|carboplatin|mesh-list
139176151|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139176152|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139176153|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
139176154|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176155|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176156|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176157|NCT02526979|Urological Agents|urological agents|mesh-ancestor
139176158|NCT03882541|Midazolam|midazolam|mesh-list
139176159|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139176160|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139176161|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139176162|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176163|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139176164|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139176165|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139176166|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139176167|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
139176168|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
139176169|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
139176170|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
139176171|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176172|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176173|NCT01267903|Vaccines|vaccines|mesh-list
139176174|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
139176175|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176176|NCT03576313|Ivermectin|ivermectin|mesh-list
139176177|NCT03576313|Piperaquine|piperaquine|mesh-list
139176178|NCT03576313|Artenimol|artenimol|mesh-list
139176179|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139176180|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139176181|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
139176182|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138926656|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139176183|NCT01161979|Zonisamide|zonisamide|mesh-list
139176184|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
139176185|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139176186|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139176187|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715505|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176188|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139176189|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176191|NCT01160731|Panobinostat|panobinostat|mesh-list
139176192|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
138715577|NCT00580242|Lenalidomide|lenalidomide|mesh-list
139176193|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176194|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139176195|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139176196|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139176197|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176198|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176199|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139176200|NCT01160965|Ropivacaine|ropivacaine|mesh-list
139176201|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
139176202|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
139176203|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
139176204|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139176205|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176206|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
139176207|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176209|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139176210|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176211|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
139176212|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176213|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139176214|NCT01162603|Latanoprost|latanoprost|mesh-list
139176215|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139176216|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139176217|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
139176218|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138715850|NCT04593108|Letrozole|letrozole|mesh-list
139176219|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176220|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
139176221|NCT02527213|Antidotes|antidotes|mesh-ancestor
138715965|NCT04584671|Xenon|xenon|mesh-list
139176222|NCT02527213|Protective Agents|protective agents|mesh-ancestor
139176223|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176224|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
139176225|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176226|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
139176227|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139176228|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139176229|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
139176230|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
139176231|NCT01161277|Haloperidol|haloperidol|mesh-list
139176232|NCT01161277|Aripiprazole|aripiprazole|mesh-list
139176233|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
139176234|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
139176235|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139176236|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139176237|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139176238|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139176239|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176240|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
139176241|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
139176242|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176243|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176244|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139176245|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139176246|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
139176247|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139176248|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139176249|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139176250|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139176251|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
139176252|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
139176253|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176254|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139176255|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139176256|NCT01268215|Budesonide|budesonide|mesh-list
139176257|NCT01268215|Calfactant|calfactant|mesh-list
139176258|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139176259|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139176260|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
139176261|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176262|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176263|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139176264|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
139176265|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
139176266|NCT01268215|Hormones|hormones|mesh-ancestor
139176267|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139176268|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139176269|NCT01269307|Ketamine|ketamine|mesh-list
139176270|NCT01269307|Propofol|propofol|mesh-list
139176271|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139176272|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139176273|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176274|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139176275|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
139176276|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
139176277|NCT01269307|Analgesics|analgesics|mesh-ancestor
139176279|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176280|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139176281|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139176282|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139176283|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176284|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176285|NCT03874585|Nicotine|nicotine|mesh-list
139176286|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139176287|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
139176288|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176289|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176290|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139176291|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139176292|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
139176293|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176294|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176295|NCT01268371|Everolimus|everolimus|mesh-list
139176296|NCT01268371|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138901146|NCT02632877|Pirfenidone|pirfenidone|mesh-list
139176297|NCT01268371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139176298|NCT01268371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716055|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139176299|NCT01268371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716057|NCT04591743|Nicotine|nicotine|mesh-list
139176300|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139176301|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
139176302|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176303|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176304|NCT01267669|Somatostatin|somatostatin|mesh-list
139176305|NCT01267669|Hormones|hormones|mesh-ancestor
139176306|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139176307|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176308|NCT05666869|Esketamine|esketamine|mesh-list
139176309|NCT05666869|Antidepressive Agents|antidepressive agents|mesh-ancestor
139176310|NCT05666869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138716421|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
139176311|NCT01164943|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139176312|NCT01164943|Hormones|hormones|mesh-ancestor
138716566|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139176313|NCT01164943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139176315|NCT01269541|Rifampin|rifampin|mesh-list
139176316|NCT01269541|Mupirocin|mupirocin|mesh-list
138716640|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139176317|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139176318|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
139176319|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139176320|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139176321|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
139176322|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139176323|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176324|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176325|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139176326|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139176327|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139176328|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139176329|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138716773|NCT01138657|Prednisone|prednisone|mesh-list
139176330|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138716845|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139176331|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139176333|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
139176334|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138926803|NCT02589782|Clofazimine|clofazimine|mesh-list
139176335|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
139176336|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717065|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176337|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138717141|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176338|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139176339|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
139176340|NCT01280149|Substance P|substance p|mesh-list
139176341|NCT01280149|Neurokinin A|neurokinin a|mesh-list
139176342|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176343|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717287|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139176344|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176345|NCT01165255|Bupropion|bupropion|mesh-list
138901163|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
139176346|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
138717358|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
139176347|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139176349|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139176350|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138717652|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139176351|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138717730|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717797|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139176352|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176353|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
139176354|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176355|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717944|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
138718019|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
138718092|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139176356|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139176357|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139176358|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176359|NCT01167049|Capecitabine|capecitabine|mesh-list
139176360|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139176361|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
138718311|NCT00585455|Sertraline|sertraline|mesh-list
139176362|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176363|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176364|NCT01311414|Urapidil|urapidil|mesh-list
139176365|NCT01311414|Theodrenaline|theodrenaline|mesh-list
139176366|NCT01311414|Cafedrine|cafedrine|mesh-list
139176367|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139176368|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
139176369|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139176370|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
139176371|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176372|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176373|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176374|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139176375|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139176376|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139176377|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
139176378|NCT03715296|Lenalidomide|lenalidomide|mesh-list
139176379|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
139176380|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176381|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138719187|NCT00195650|Adalimumab|adalimumab|mesh-list
139176382|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139176383|NCT03715296|Growth Substances|growth substances|mesh-ancestor
139176384|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
139176385|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176387|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
139176388|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
138719407|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
139176389|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176390|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176391|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138719475|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
139176392|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139176393|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138719548|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
139176394|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139176395|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138719707|NCT00478205|Donepezil|donepezil|mesh-list
139176396|NCT03874273|Crizotinib|crizotinib|mesh-list
139176397|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176398|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139176399|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719771|NCT00476957|Sirolimus|sirolimus|mesh-list
138719840|NCT00472199|Pramipexole|pramipexole|mesh-list
139176400|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176401|NCT01167127|Oxycodone|oxycodone|mesh-list
139176402|NCT01167127|Naloxone|naloxone|mesh-list
138719988|NCT04554615|Insulin|insulin|mesh-list
139176403|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139176404|NCT01167127|Narcotics|narcotics|mesh-ancestor
138720134|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139176405|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139176406|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176407|NCT01167127|Analgesics|analgesics|mesh-ancestor
138926880|NCT00916253|Modafinil|modafinil|mesh-list
138720287|NCT00178464|Aspirin|aspirin|mesh-list
139176408|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
139176409|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720360|NCT00177294|Escitalopram|escitalopram|mesh-list
139176410|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139176411|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139176412|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139176413|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
139176414|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139176415|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720503|NCT00171834|Epothilones|epothilones|mesh-list
139176416|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139176417|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139176418|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139176420|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
139176421|NCT03872011|Thiamine|thiamine|mesh-list
139176422|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
139176423|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
138720726|NCT00477750|Prednisone|prednisone|mesh-list
139176424|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176425|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139176426|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
138720791|NCT00556361|Ketamine|ketamine|mesh-list
139176427|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176428|NCT03872011|Protective Agents|protective agents|mesh-ancestor
138720863|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
139176429|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
139176430|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
138720935|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
139176431|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139176432|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721014|NCT00575861|Zileuton|zileuton|mesh-list
139176433|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
139176434|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139176435|NCT01163929|Paclitaxel|paclitaxel|mesh-list
139176436|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138721152|NCT01127893|Tanezumab|tanezumab|mesh-list
138721227|NCT00576329|Ketorolac|ketorolac|mesh-list
139176437|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176438|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
139176439|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
139176440|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
138553199|NCT00108420|Prazosin|prazosin|mesh-list
139176441|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176443|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139176444|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139176445|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
138721527|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
139176447|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176448|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139176449|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176450|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176451|NCT01270789|Liraglutide|liraglutide|mesh-list
139176452|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138721808|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
139176453|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176454|NCT01270789|Incretins|incretins|mesh-ancestor
139176455|NCT01270789|Hormones|hormones|mesh-ancestor
139176456|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139176457|NCT01164085|Ketorolac|ketorolac|mesh-list
139176458|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139176459|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139176460|NCT01164085|Analgesics|analgesics|mesh-ancestor
139176461|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
139176462|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176463|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176464|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139176465|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139176466|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139176467|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176468|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176469|NCT01271179|Insulin|insulin|mesh-list
139176470|NCT01271179|Allopurinol|allopurinol|mesh-list
139176471|NCT01271179|Adenosine|adenosine|mesh-list
139176472|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139176473|NCT01271179|Analgesics|analgesics|mesh-ancestor
139176474|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
139176475|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176476|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176477|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139176478|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
139176479|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139176480|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
139176481|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
139176482|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176483|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176484|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
139176486|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
139176487|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139176488|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139176490|NCT01271179|Protective Agents|protective agents|mesh-ancestor
139176491|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139176492|NCT03388164|Dexetimide|dexetimide|mesh-list
139176493|NCT03388164|Citalopram|citalopram|mesh-list
139176494|NCT03388164|Escitalopram|escitalopram|mesh-list
139176495|NCT03388164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139176496|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138722893|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
139176497|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139176498|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176499|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176500|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
139176501|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176502|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139176503|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139176504|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
139176505|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
138723253|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139176506|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176507|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139176508|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139176509|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
139176510|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139176511|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
139176513|NCT01268761|Cetrorelix|cetrorelix|mesh-list
139176514|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139176515|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
139176517|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176518|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
139176519|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139176520|NCT01268839|Efavirenz|efavirenz|mesh-list
139176521|NCT01268839|Rilpivirine|rilpivirine|mesh-list
138723775|NCT02279628|Morphine|morphine|mesh-list
139176522|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139176523|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139176524|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176525|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176526|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
139176527|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139176528|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139176529|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139176530|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139176531|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138680484|NCT00510939|Bortezomib|bortezomib|mesh-list
139176532|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139176533|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139176534|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139176535|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139176537|NCT03403374|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139176538|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139176539|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139176540|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
138724419|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
139176541|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176542|NCT03403374|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139176543|NCT03403374|Protease Inhibitors|protease inhibitors|mesh-ancestor
139176544|NCT03403374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176545|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139176548|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138724754|NCT02219867|Ketamine|ketamine|mesh-list
139176549|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176550|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139176551|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139176552|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
139176553|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176554|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176555|NCT03387462|Tenofovir|tenofovir|mesh-list
139176556|NCT03387462|Emtricitabine|emtricitabine|mesh-list
139176557|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
139176558|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139176559|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139176560|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139176561|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176562|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176563|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139176564|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139176565|NCT03756883|Fluticasone|fluticasone|mesh-list
139176567|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139176568|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139176569|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139176570|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139176571|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
139176572|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176573|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176574|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139176575|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
139176576|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
139176577|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139176578|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139176579|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139176580|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139176581|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
139176582|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176583|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176584|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
139176585|NCT03756883|Hormones|hormones|mesh-ancestor
139176586|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139176587|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
139176588|NCT01586611|Leucovorin|leucovorin|mesh-list
139176589|NCT01586611|Gemcitabine|gemcitabine|mesh-list
139176590|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
138725434|NCT06045156|Tirofiban|tirofiban|mesh-list
139176591|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139176592|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
139176593|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176594|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176595|NCT01586611|Antidotes|antidotes|mesh-ancestor
139176596|NCT01586611|Protective Agents|protective agents|mesh-ancestor
139176597|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176598|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
139176599|NCT01586611|Vitamins|vitamins|mesh-ancestor
139176600|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
139176601|NCT03386448|Scopolamine|scopolamine|mesh-list
139176602|NCT03386448|Naltrexone|naltrexone|mesh-list
138725853|NCT05885932|Analgesics|analgesics|mesh-ancestor
139176603|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139176604|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139176605|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138725927|NCT05801835|Antiviral Agents|antiviral agents|mesh-ancestor
139176606|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176607|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
139176608|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176609|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139176610|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
139176611|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
139176612|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139176613|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
139176614|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139176615|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
138726000|NCT05717049|Theophylline|theophylline|mesh-list
139176616|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176617|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176618|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138726068|NCT05654363|Morphine|morphine|mesh-list
139176619|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
139176621|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139176622|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139176623|NCT01280929|Growth Substances|growth substances|mesh-ancestor
139176624|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176625|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
139176626|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176627|NCT01268917|Aspirin|aspirin|mesh-list
139176628|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138726273|NCT05431920|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139176629|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139176630|NCT01268917|Analgesics|analgesics|mesh-ancestor
138726348|NCT05400863|Metformin|metformin|mesh-list
139176631|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
139176632|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176633|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176634|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139176635|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139176636|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138726572|NCT05201313|Lidocaine|lidocaine|mesh-list
138726643|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138442434|NCT01807832|Capsaicin|capsaicin|mesh-list
139176638|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176639|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138726791|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
139176640|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139176641|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176642|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
139176643|NCT01281163|Lapatinib|lapatinib|mesh-list
139176644|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176645|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139176646|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176647|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176649|NCT01268995|Tacrolimus|tacrolimus|mesh-list
139176650|NCT01268995|Cyclosporins|cyclosporins|mesh-list
139176651|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139176652|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
139176653|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176654|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139176655|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176656|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176657|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
139176658|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139176660|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139176661|NCT00009737|Leucovorin|leucovorin|mesh-list
139176662|NCT00009737|Capecitabine|capecitabine|mesh-list
139176663|NCT00009737|Fluorouracil|fluorouracil|mesh-list
139176664|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139176665|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
139176666|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176667|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176668|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139176669|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
139176670|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176671|NCT00009737|Antidotes|antidotes|mesh-ancestor
139176672|NCT00009737|Protective Agents|protective agents|mesh-ancestor
139176673|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
139176674|NCT00009737|Vitamins|vitamins|mesh-ancestor
139176675|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
139176676|NCT03711240|Leucovorin|leucovorin|mesh-list
139176677|NCT03711240|Bevacizumab|bevacizumab|mesh-list
139176678|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
139176679|NCT03711240|Irinotecan|irinotecan|mesh-list
139176680|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139176681|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176682|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139176683|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139176684|NCT03711240|Growth Substances|growth substances|mesh-ancestor
139176685|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176686|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
139176687|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139176688|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139176689|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176690|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176691|NCT03711240|Antidotes|antidotes|mesh-ancestor
139176692|NCT03711240|Protective Agents|protective agents|mesh-ancestor
139176693|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
139176694|NCT03711240|Vitamins|vitamins|mesh-ancestor
139176695|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
139176696|NCT01271881|Heparin|heparin|mesh-list
139176697|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
139176698|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139176699|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139176700|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176701|NCT05459844|Octreotide|octreotide|mesh-list
139176702|NCT05459844|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139176703|NCT05459844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139176704|NCT05459844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139176705|NCT05459844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176706|NCT05459844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139176707|NCT05459844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176708|NCT03874975|Vitamin D|vitamin d|mesh-list
139176709|NCT03874975|Vitamins|vitamins|mesh-ancestor
139176710|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
139176711|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176712|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139176714|NCT01164709|Bortezomib|bortezomib|mesh-list
139176715|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176716|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138965520|NCT00623766|Protective Agents|protective agents|mesh-ancestor
139176717|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139176718|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
139176719|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176720|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176721|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139176722|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139176723|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
139176724|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139176725|NCT03960671|Midazolam|midazolam|mesh-list
139176726|NCT03960671|Diazepam|diazepam|mesh-list
139176727|NCT03960671|Propofol|propofol|mesh-list
139176728|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139176729|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139176730|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727076|NCT04620746|Penicillins|penicillins|mesh-list
139176731|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139176732|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
139176733|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
139176734|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139176735|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139176736|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139176737|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139176738|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
139176739|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
139176740|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176741|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176742|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
139176743|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
139176744|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
139176745|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176746|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139176747|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139176748|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139176749|NCT01281553|Cisapride|cisapride|mesh-list
139176750|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139176751|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139176752|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139176753|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
139176754|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176755|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176756|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176757|NCT01164787|Trandolapril|trandolapril|mesh-list
139176758|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139176759|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
139176760|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176761|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176762|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139176763|NCT01269151|Ranibizumab|ranibizumab|mesh-list
139176764|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139176765|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139176766|NCT01269151|Growth Substances|growth substances|mesh-ancestor
139176767|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176768|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
139176769|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176770|NCT00028769|Paclitaxel|paclitaxel|mesh-list
139176771|NCT00028769|Etoposide|etoposide|mesh-list
139176772|NCT00028769|Leuprolide|leuprolide|mesh-list
139176773|NCT00028769|Goserelin|goserelin|mesh-list
139176774|NCT00028769|Bicalutamide|bicalutamide|mesh-list
139176775|NCT00028769|Flutamide|flutamide|mesh-list
139176776|NCT00028769|Estramustine|estramustine|mesh-list
139176777|NCT00028769|Nilutamide|nilutamide|mesh-list
139176778|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138965547|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
139176779|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176780|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
139176781|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
139176782|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
139176783|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176784|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139176785|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139176786|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176787|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139176788|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
139176789|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139176790|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176791|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139176792|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
139176793|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
139176794|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139176795|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139176796|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
139176797|NCT01281787|Losartan|losartan|mesh-list
139176798|NCT01281787|Metoprolol|metoprolol|mesh-list
139176799|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139176800|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139176801|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139176802|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139176803|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176804|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
139176805|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
139176806|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176807|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176808|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139176809|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139176810|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139176811|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
139176812|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176813|NCT02953314|Ivacaftor|ivacaftor|mesh-list
139176814|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139176815|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139176816|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176817|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
139176818|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139176819|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
139176820|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176821|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139176822|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139176823|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
139176824|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176825|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176826|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139176827|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
139176828|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139176829|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139176830|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176831|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
139176832|NCT03714360|Coagulants|coagulants|mesh-ancestor
139176833|NCT01169857|Bortezomib|bortezomib|mesh-list
139176834|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
139176835|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176836|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
139176837|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176838|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176840|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
139176841|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
139176842|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
139176843|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139176844|NCT01168063|Amoxicillin|amoxicillin|mesh-list
139176845|NCT01168063|Metronidazole|metronidazole|mesh-list
139176846|NCT01168063|Clarithromycin|clarithromycin|mesh-list
139176847|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139176848|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139176849|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
139176850|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139176851|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139176852|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139176853|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176854|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176855|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139176856|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139176857|NCT01166035|Lenalidomide|lenalidomide|mesh-list
139176858|NCT01166035|Cetuximab|cetuximab|mesh-list
139176859|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
139176860|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176861|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139176862|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139176863|NCT01166035|Growth Substances|growth substances|mesh-ancestor
139176864|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
139176865|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176866|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139176867|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139176868|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139176869|NCT03869281|Pancrelipase|pancrelipase|mesh-list
139176870|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139176871|NCT01281943|Sirolimus|sirolimus|mesh-list
139176872|NCT01281943|Doxorubicin|doxorubicin|mesh-list
139176873|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139176874|NCT01281943|Temsirolimus|temsirolimus|mesh-list
139176875|NCT01281943|MTOR Inhibitors|mtor inhibitors|mesh-list
139176876|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139176877|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176878|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139176879|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139176880|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176881|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176882|NCT01281943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139176883|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139176884|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
139176885|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176886|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139176888|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
139176889|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
139176890|NCT03869047|Bupivacaine|bupivacaine|mesh-list
139176891|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
139176892|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
139176893|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139176894|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176895|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
139176896|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176897|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139176898|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139176899|NCT03869047|Analgesics|analgesics|mesh-ancestor
139176900|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139176901|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139176902|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139176903|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
139176904|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176905|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176906|NCT01168531|Dexamethasone|dexamethasone|mesh-list
139176907|NCT01168531|Pregabalin|pregabalin|mesh-list
139176908|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139176909|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
139176910|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
139176911|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176912|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176913|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139176914|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
139176915|NCT01168531|Hormones|hormones|mesh-ancestor
139176916|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139176917|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139176918|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176919|NCT01168531|Analgesics|analgesics|mesh-ancestor
139176920|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
139176921|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
139176922|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139176923|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139176924|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176925|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139176926|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139176927|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139176928|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139176929|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139176930|NCT01170169|Omeprazole|omeprazole|mesh-list
139176931|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139176932|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139176933|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139176934|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176935|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176936|NCT01587313|Hydralazine|hydralazine|mesh-list
139176937|NCT01587313|Isosorbide|isosorbide|mesh-list
139176938|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139176939|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139176940|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139176941|NCT01587313|Diuretics|diuretics|mesh-ancestor
139176942|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
139176943|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176944|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
139176945|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139176946|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176947|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139176948|NCT01282333|Gemcitabine|gemcitabine|mesh-list
139176949|NCT01282333|Veliparib|veliparib|mesh-list
139176950|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176951|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139176952|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
139176953|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176954|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139176955|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176956|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
139176957|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
139176958|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139176959|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176960|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176961|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
139176962|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139176963|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139176964|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176966|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139176967|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139176968|NCT01311570|Buprenorphine|buprenorphine|mesh-list
139176969|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139176970|NCT01311570|Narcotics|narcotics|mesh-ancestor
139176971|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139176972|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176973|NCT01311570|Analgesics|analgesics|mesh-ancestor
139176974|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
139176975|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139176976|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139176977|NCT01170325|Valproic Acid|valproic acid|mesh-list
139176978|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
139176979|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176980|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176981|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
139176982|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176983|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176984|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
139176985|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139176986|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139176987|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139176988|NCT05542446|Colistin|colistin|mesh-list
139176989|NCT05542446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139176990|NCT05542446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139176991|NCT03355326|Glycerol|glycerol|mesh-list
139176992|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139176993|NCT03355326|Protective Agents|protective agents|mesh-ancestor
139176994|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176995|NCT01170637|Ibuprofen|ibuprofen|mesh-list
139176996|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
139176997|NCT01170637|Ephedrine|ephedrine|mesh-list
139176998|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139176999|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139177000|NCT01170637|Analgesics|analgesics|mesh-ancestor
139177001|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
139177002|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177003|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177004|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139177005|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139177006|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139177007|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177008|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177009|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139177010|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
139177011|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139177012|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
139177013|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
139177014|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139177015|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138927485|NCT04585022|Cimetidine|cimetidine|mesh-list
139177016|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
139177017|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
139177018|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177019|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
139177020|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139177021|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177022|NCT03873025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139177023|NCT03873025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177024|NCT02526745|Vaccines|vaccines|mesh-list
139177025|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
139177026|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177027|NCT01169389|Bupivacaine|bupivacaine|mesh-list
139177028|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
139177029|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
139177030|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138727150|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139177031|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177032|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
139177033|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177034|NCT01170871|Pemetrexed|pemetrexed|mesh-list
139177035|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177036|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177037|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177038|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139177039|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139177040|NCT03868111|Sufentanil|sufentanil|mesh-list
139177041|NCT03868111|Remifentanil|remifentanil|mesh-list
139177042|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139177043|NCT03868111|Narcotics|narcotics|mesh-ancestor
139177044|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139177045|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177046|NCT03868111|Analgesics|analgesics|mesh-ancestor
139177047|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
139177048|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177049|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139177050|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139177051|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
139177052|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
139177053|NCT01282879|Itraconazole|itraconazole|mesh-list
139177054|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
139177055|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177056|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139177057|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139177058|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177059|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177060|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139177061|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
138901401|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139177062|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139177063|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177064|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139177065|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
139177066|NCT03868033|Denosumab|denosumab|mesh-list
139177067|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139177068|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177069|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
139177070|NCT01166815|Astringents|astringents|mesh-ancestor
139177071|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177072|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
139177073|NCT03751657|Insulin|insulin|mesh-list
139177074|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139177075|NCT03751657|Metformin|metformin|mesh-list
139177076|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
139177077|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139177078|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139177079|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177080|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
139177081|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177082|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177083|NCT03873415|Deucravacitinib|deucravacitinib|mesh-list
139177084|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
139177085|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139177086|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177087|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177088|NCT00025259|Cytarabine|cytarabine|mesh-list
139177089|NCT00025259|Dexamethasone|dexamethasone|mesh-list
139177090|NCT00025259|Prednisone|prednisone|mesh-list
138927555|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139177091|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
139177092|NCT00025259|Cortisone|cortisone|mesh-list
139177093|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
139177094|NCT00025259|Cisplatin|cisplatin|mesh-list
139177095|NCT00025259|Doxorubicin|doxorubicin|mesh-list
139177096|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139177097|NCT00025259|Etoposide|etoposide|mesh-list
139177098|NCT00025259|Vincristine|vincristine|mesh-list
139177099|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
139177100|NCT00025259|Bleomycin|bleomycin|mesh-list
139177101|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
139177102|NCT00025259|Lenograstim|lenograstim|mesh-list
139177103|NCT00025259|BB 1101|bb 1101|mesh-list
139177104|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139177105|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
139177106|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177107|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139177108|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139177109|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
139177110|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177111|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177112|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139177113|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139177114|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
139177115|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
139177116|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177117|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139177118|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
139177119|NCT00025259|Hormones|hormones|mesh-ancestor
139177120|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139177121|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139177122|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139177123|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139177124|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139177125|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177126|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139177127|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139177128|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
139177129|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
139177130|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177131|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139177132|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
139177133|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
139177134|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
139177135|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
139177136|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
139177137|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
139177138|NCT01171651|Sorafenib|sorafenib|mesh-list
139177139|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177140|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139177141|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177142|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177143|NCT03866629|Lifitegrast|lifitegrast|mesh-list
139177144|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139177145|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139177146|NCT01280071|Aminophylline|aminophylline|mesh-list
139177147|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139177148|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
139177149|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177150|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177151|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139177152|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
139177153|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139177154|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139177155|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177156|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177157|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139177158|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139177159|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
139177160|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177161|NCT01280071|Protective Agents|protective agents|mesh-ancestor
139177162|NCT02526199|Dexamethasone|dexamethasone|mesh-list
139177163|NCT02526199|Epinephrine|epinephrine|mesh-list
139177164|NCT02526199|Bupivacaine|bupivacaine|mesh-list
139177165|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139177166|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
139177167|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
139177168|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177169|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177170|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139177171|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
139177172|NCT02526199|Hormones|hormones|mesh-ancestor
139177173|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139177174|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139177175|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177176|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
139177177|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
139177178|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139177179|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
139177180|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139177181|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139177182|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
139177183|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177184|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177185|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139177186|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139177187|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139177188|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
139177189|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
139177190|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
139177191|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139177192|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139177193|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139177194|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139177195|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139177196|NCT03863977|Dexamethasone|dexamethasone|mesh-list
139177197|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
139177198|NCT03863977|Bupivacaine|bupivacaine|mesh-list
139177199|NCT03863977|BB 1101|bb 1101|mesh-list
139177200|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139177201|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
139177202|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
139177203|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177204|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177205|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139177206|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
139177207|NCT03863977|Hormones|hormones|mesh-ancestor
139177208|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139177209|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139177210|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177211|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
139177212|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177213|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177214|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
139177215|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
139177216|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139177217|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
139177218|NCT01171807|Dexamethasone|dexamethasone|mesh-list
139177219|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139177220|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139177221|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
139177222|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
139177223|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177224|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177225|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139177226|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
139177227|NCT01171807|Hormones|hormones|mesh-ancestor
139177228|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139177229|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139177230|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177231|NCT05445648|Tislelizumab|tislelizumab|mesh-list
139177232|NCT05445648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139177233|NCT05445648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177234|NCT01171885|Ropivacaine|ropivacaine|mesh-list
139177235|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
139177236|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
139177237|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139177238|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177239|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
139177240|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177241|NCT01286233|Metformin|metformin|mesh-list
139177242|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138927733|NCT00764907|Leucovorin|leucovorin|mesh-list
139177243|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177245|NCT01175161|Trace Elements|trace elements|mesh-ancestor
139177246|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
139177247|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177248|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139177249|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139177250|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177251|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
139177253|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
139177254|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177255|NCT00024167|Ketoconazole|ketoconazole|mesh-list
139177256|NCT00024167|Dexamethasone|dexamethasone|mesh-list
139177257|NCT00024167|Prednisone|prednisone|mesh-list
139177258|NCT00024167|Estramustine|estramustine|mesh-list
139177259|NCT00024167|Docetaxel|docetaxel|mesh-list
139177260|NCT00024167|Doxorubicin|doxorubicin|mesh-list
139177261|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139177262|NCT00024167|Vinblastine|vinblastine|mesh-list
139177263|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139177264|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
139177265|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
139177266|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177267|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177268|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139177269|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
139177270|NCT00024167|Hormones|hormones|mesh-ancestor
139177271|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139177272|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139177273|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177274|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
139177275|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
139177276|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
139177277|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177278|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139177279|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139177280|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139177281|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177282|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
139177283|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177284|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139177285|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139177286|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139177287|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
139177288|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139177289|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139177290|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139177291|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
139177292|NCT03867097|Iloprost|iloprost|mesh-list
139177293|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139177294|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
139177295|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
139177296|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139177297|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139177298|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177299|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139177300|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139177301|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
139177302|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177303|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
139177304|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139177305|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
139177306|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177307|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139177308|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177309|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
139177310|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177311|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
139177312|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138965697|NCT00272779|Emtricitabine|emtricitabine|mesh-list
139177313|NCT01285141|Protective Agents|protective agents|mesh-ancestor
139177314|NCT01285219|Lenograstim|lenograstim|mesh-list
139177315|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139177316|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
139177317|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177318|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
139177319|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139177320|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
139177321|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177322|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
139177323|NCT01284439|Protective Agents|protective agents|mesh-ancestor
139177324|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139177325|NCT01172431|Indapamide|indapamide|mesh-list
139177326|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139177327|NCT01172431|Diuretics|diuretics|mesh-ancestor
139177328|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
139177329|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177330|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139177331|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139177332|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177333|NCT01172509|Baclofen|baclofen|mesh-list
139177334|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139177335|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177336|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139177337|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177338|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139177339|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
139177340|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
139177341|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177342|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177343|NCT01089959|Esomeprazole|esomeprazole|mesh-list
139177344|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139177345|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139177346|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139177347|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177348|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177349|NCT01090037|Epoprostenol|epoprostenol|mesh-list
139177350|NCT01090037|Beraprost|beraprost|mesh-list
139177351|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139177352|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
139177353|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139177354|NCT01285375|Curcumin|curcumin|mesh-list
139177355|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139177356|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139177357|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139177358|NCT01285375|Analgesics|analgesics|mesh-ancestor
139177359|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
139177360|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177361|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177362|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139177363|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139177364|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177365|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177366|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177367|NCT05625893|Bevacizumab|bevacizumab|mesh-list
139177368|NCT05625893|Atezolizumab|atezolizumab|mesh-list
139177369|NCT05625893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139177370|NCT05625893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177371|NCT05625893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139177372|NCT05625893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139177373|NCT05625893|Growth Substances|growth substances|mesh-ancestor
139177374|NCT05625893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177375|NCT05625893|Growth Inhibitors|growth inhibitors|mesh-ancestor
139177376|NCT05625893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139177377|NCT05625893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177379|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139177380|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177381|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177382|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139177383|NCT01178047|Protective Agents|protective agents|mesh-ancestor
139177384|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177385|NCT01101113|Cinacalcet|cinacalcet|mesh-list
139177386|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139177387|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177388|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139177389|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
139177390|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139177391|NCT01288261|Paclitaxel|paclitaxel|mesh-list
139177392|NCT01288261|Bavituximab|bavituximab|mesh-list
139177393|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139177394|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177395|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
139177396|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
139177397|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
139177398|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177399|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139177400|NCT01174303|Insulin|insulin|mesh-list
139177401|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139177402|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
139177403|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
139177404|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139177405|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
139177406|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139177407|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139177408|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177409|NCT01285453|Vadimezan|vadimezan|mesh-list
139177410|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177411|NCT01288339|Leucovorin|leucovorin|mesh-list
139177412|NCT01288339|Fluorouracil|fluorouracil|mesh-list
139177413|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
139177414|NCT01288339|Panitumumab|panitumumab|mesh-list
139177415|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
139177416|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177417|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139177418|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177419|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139177420|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
139177421|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177422|NCT01288339|Antidotes|antidotes|mesh-ancestor
139177423|NCT01288339|Protective Agents|protective agents|mesh-ancestor
139177424|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
139177425|NCT01288339|Vitamins|vitamins|mesh-ancestor
139177426|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
139177427|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139177428|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
139177429|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177430|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139177431|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
139177432|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177433|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
139177434|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139177435|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139177436|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139177437|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139177438|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139177439|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177440|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
139177441|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177442|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177443|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139177444|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177445|NCT01105481|Amisulpride|amisulpride|mesh-list
139177446|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139177447|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139177448|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139177449|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177450|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139177451|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139177452|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
139177453|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177454|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177455|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139177456|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
139177457|NCT01178203|Naproxen|naproxen|mesh-list
139177458|NCT01178203|Tramadol|tramadol|mesh-list
139177459|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139177460|NCT01178203|Narcotics|narcotics|mesh-ancestor
139177461|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139177462|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177463|NCT01178203|Analgesics|analgesics|mesh-ancestor
139177464|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
139177465|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177466|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139177467|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139177468|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139177470|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
139177471|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139177472|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177473|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177474|NCT01286701|Terbinafine|terbinafine|mesh-list
139177475|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
139177476|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177477|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177478|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177479|NCT00006305|Biguanides|biguanides|mesh-list
139177480|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
139177481|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
139177482|NCT00006305|Calcium|calcium|mesh-list
139177483|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139177484|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139177485|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139177486|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139177487|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177488|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139177489|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139177490|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
139177491|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177492|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177493|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
139177494|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177495|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139177497|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
139177498|NCT01284907|Vitamins|vitamins|mesh-ancestor
139177499|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
139177500|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177501|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139177502|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139177503|NCT01286857|Silicon|silicon|mesh-list
139177504|NCT01286857|Trace Elements|trace elements|mesh-ancestor
139177505|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
139177506|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177507|NCT01101269|Lisinopril|lisinopril|mesh-list
139177508|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139177509|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
139177510|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177511|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177512|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139177513|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139177514|NCT01101269|Protective Agents|protective agents|mesh-ancestor
139177515|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177516|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139177517|NCT01103375|Isotretinoin|isotretinoin|mesh-list
139177518|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177519|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139177520|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177521|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177522|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
139177523|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139177524|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
138901547|NCT00659321|Nicotine|nicotine|mesh-list
139177525|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
139177526|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139177527|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139177528|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
139177529|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177530|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139177531|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139177532|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177533|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177534|NCT01285765|Rituximab|rituximab|mesh-list
139177535|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139177536|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177537|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
139177538|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177539|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139177540|NCT03864913|Testosterone|testosterone|mesh-list
139177541|NCT03864913|Androgens|androgens|mesh-ancestor
139177542|NCT03864913|Hormones|hormones|mesh-ancestor
139177543|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139177544|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177545|NCT03865147|Acetaminophen|acetaminophen|mesh-list
139177546|NCT03865147|Cetrimonium|cetrimonium|mesh-list
139177547|NCT03865147|Ibuprofen|ibuprofen|mesh-list
139177548|NCT03865147|Lidocaine|lidocaine|mesh-list
139177549|NCT03865147|Epinephrine|epinephrine|mesh-list
139177550|NCT03865147|Racepinephrine|racepinephrine|mesh-list
139177551|NCT03865147|Bupivacaine|bupivacaine|mesh-list
139177552|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139177553|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
139177554|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
139177555|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
138727303|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139177556|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139177557|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177558|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
139177559|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177560|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139177561|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139177562|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138901557|NCT00659399|PENTA|penta|mesh-list
139177563|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139177564|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177565|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139177566|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139177567|NCT03865147|Analgesics|analgesics|mesh-ancestor
139177568|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139177569|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139177570|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139177571|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177572|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
139177573|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139177574|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139177575|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
139177576|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177577|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139177578|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139177579|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
139177580|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139177581|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
139177582|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
139177583|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
139177584|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139177585|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139177586|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139177587|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177588|NCT03722823|Tucatinib|tucatinib|mesh-list
139177589|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177590|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139177591|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177592|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177593|NCT03862651|Cangrelor|cangrelor|mesh-list
139177594|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139177595|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139177596|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139177597|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139177598|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
139177599|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177600|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177601|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177602|NCT03349710|Nivolumab|nivolumab|mesh-list
139177603|NCT03349710|Cetuximab|cetuximab|mesh-list
139177604|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177605|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139177606|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139177607|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177609|NCT01288495|Cathartics|cathartics|mesh-ancestor
139177610|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139177611|NCT01105793|Danazol|danazol|mesh-list
139177612|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139177613|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
139177614|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139177615|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928082|NCT00759993|Trace Elements|trace elements|mesh-ancestor
139177616|NCT04934579|Rituximab|rituximab|mesh-list
139177617|NCT04934579|Methotrexate|methotrexate|mesh-list
139177618|NCT04934579|Lenalidomide|lenalidomide|mesh-list
139177619|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139177620|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177621|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
139177622|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177623|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139177624|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139177625|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
139177626|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139177627|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139177628|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
139177629|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177630|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
139177631|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177632|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139177633|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139177634|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139177635|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139177636|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139177637|NCT04934579|Growth Substances|growth substances|mesh-ancestor
139177638|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
139177639|NCT03134131|TIC10 compound|tic10 compound|mesh-list
139177640|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177641|NCT01103609|Warfarin|warfarin|mesh-list
139177642|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
139177643|NCT03528369|Capsaicin|capsaicin|mesh-list
139177644|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
139177645|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
139177646|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
139177647|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177648|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177649|NCT01288573|Plerixafor|plerixafor|mesh-list
139177650|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139177651|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139177652|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
139177653|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177654|NCT01174693|Clopidogrel|clopidogrel|mesh-list
139177655|NCT01174693|Triflusal|triflusal|mesh-list
139177656|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139177657|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139177658|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139177659|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139177660|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
139177661|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177662|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177663|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177664|NCT00006011|Paclitaxel|paclitaxel|mesh-list
139177665|NCT00006011|Doxorubicin|doxorubicin|mesh-list
139177666|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139177667|NCT00006011|Lenograstim|lenograstim|mesh-list
139177668|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139177669|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177670|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
139177671|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
139177672|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
139177673|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177674|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139177675|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139177676|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139177677|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177678|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139177679|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
139177680|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177681|NCT01105871|Naloxone|naloxone|mesh-list
139177682|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139177683|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177684|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
139177685|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177686|NCT03377556|Talazoparib|talazoparib|mesh-list
139177687|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139177688|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177689|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177690|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177691|NCT05625581|Cyclophosphamide|cyclophosphamide|mesh-list
139177692|NCT05625581|Tofacitinib|tofacitinib|mesh-list
139177693|NCT05625581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139177694|NCT05625581|Immunologic Factors|immunologic factors|mesh-ancestor
139177695|NCT05625581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177696|NCT05625581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139177697|NCT05625581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139177698|NCT05625581|Alkylating Agents|alkylating agents|mesh-ancestor
139177699|NCT05625581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177700|NCT05625581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177701|NCT05625581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139177702|NCT05625581|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139177703|NCT05625581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139177704|NCT05625581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177706|NCT01176175|Progestins|progestins|mesh-ancestor
139177707|NCT01176175|Hormones|hormones|mesh-ancestor
139177708|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139177709|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177710|NCT05624099|Paclitaxel|paclitaxel|mesh-list
139177711|NCT05624099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139177712|NCT05624099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177713|NCT05624099|Tubulin Modulators|tubulin modulators|mesh-ancestor
139177714|NCT05624099|Antimitotic Agents|antimitotic agents|mesh-ancestor
139177715|NCT05624099|Mitosis Modulators|mitosis modulators|mesh-ancestor
139177716|NCT05624099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177717|NCT03864601|JNJ-56136379|jnj-56136379|mesh-list
139177718|NCT03864601|Antiviral Agents|antiviral agents|mesh-ancestor
139177719|NCT03864601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177720|NCT03864523|Pioglitazone|pioglitazone|mesh-list
139177721|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139177722|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177723|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139177724|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
139177725|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177726|NCT05619887|Fentanyl|fentanyl|mesh-list
139177727|NCT05619887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139177728|NCT05619887|Narcotics|narcotics|mesh-ancestor
139177729|NCT05619887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139177730|NCT05619887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177731|NCT05619887|Analgesics|analgesics|mesh-ancestor
139177733|NCT05619887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177734|NCT05619887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139177735|NCT05619887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139177736|NCT05619887|Anesthetics, General|anesthetics, general|mesh-ancestor
139177737|NCT05619887|Anesthetics|anesthetics|mesh-ancestor
139177738|NCT01174927|Heroin|heroin|mesh-list
139177739|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139177740|NCT01174927|Narcotics|narcotics|mesh-ancestor
139177741|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139177742|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177744|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
139177745|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177746|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
139177747|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139177748|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177749|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139177750|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139177751|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177752|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177753|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177754|NCT03948737|Tocopherols|tocopherols|mesh-list
139177755|NCT03948737|Vitamin E|vitamin e|mesh-list
139177756|NCT03948737|Tocotrienols|tocotrienols|mesh-list
139177757|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
139177758|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
139177759|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177760|NCT03948737|Protective Agents|protective agents|mesh-ancestor
139177761|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177762|NCT03948737|Vitamins|vitamins|mesh-ancestor
139177763|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
139177764|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
139177765|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139177766|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139177767|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138928230|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
139177768|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177769|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
139177770|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177771|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177772|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139177773|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177775|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139177776|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727345|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139177777|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177778|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
139177779|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177780|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177781|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
139177782|NCT01176409|Valacyclovir|valacyclovir|mesh-list
139177783|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
139177784|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177785|NCT03480009|Oxycodone|oxycodone|mesh-list
139177786|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
139177787|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139177788|NCT03480009|Narcotics|narcotics|mesh-ancestor
139177789|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139177790|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177791|NCT03480009|Analgesics|analgesics|mesh-ancestor
139177792|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
139177793|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177794|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
139177795|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
139177796|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139177797|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139177798|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177799|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177800|NCT03859375|Disinfectants|disinfectants|mesh-list
139177801|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177802|NCT01310751|Iloprost|iloprost|mesh-list
139177803|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139177804|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
139177805|NCT01180933|Folic Acid|folic acid|mesh-list
139177806|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
139177807|NCT01180933|Hematinics|hematinics|mesh-ancestor
139177808|NCT01180933|Vitamins|vitamins|mesh-ancestor
139177809|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
139177810|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177811|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
139177812|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139177813|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139177814|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177815|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
139177816|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
139177817|NCT03859141|Vaccines|vaccines|mesh-list
139177818|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
139177819|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177820|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
139177821|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139177822|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
139177823|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177824|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
139177825|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139177826|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139177827|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
139177828|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177829|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139177830|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139177831|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177832|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177833|NCT03711708|Sertraline|sertraline|mesh-list
139177834|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
139177835|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139177836|NCT03711708|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139177837|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139177838|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139177839|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177840|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177841|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
139177842|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177844|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139177845|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139177846|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
139177847|NCT00004859|Thalidomide|thalidomide|mesh-list
139177848|NCT00004859|Paclitaxel|paclitaxel|mesh-list
139177849|NCT00004859|Carboplatin|carboplatin|mesh-list
139177850|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139177851|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177852|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
139177853|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
138965825|NCT02547480|Irinotecan|irinotecan|mesh-list
139177855|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177856|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139177857|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
139177858|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177859|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
139177860|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139177861|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177862|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139177863|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139177864|NCT00004859|Growth Substances|growth substances|mesh-ancestor
139177865|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
139177866|NCT03348930|Tolcapone|tolcapone|mesh-list
139177867|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139177868|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139177869|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139177870|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177871|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177872|NCT03500211|Lidocaine|lidocaine|mesh-list
139177873|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
139177874|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
139177875|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139177876|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177877|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
139177878|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177879|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139177880|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139177881|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139177882|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139177883|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177884|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
139177885|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138727433|NCT04091490|Nivolumab|nivolumab|mesh-list
139177886|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177887|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139177888|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177889|NCT03478683|Budesonide|budesonide|mesh-list
139177890|NCT03478683|Albuterol|albuterol|mesh-list
139177891|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
139177892|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
139177893|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139177894|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139177895|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139177896|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
139177897|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177898|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177899|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139177900|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
139177901|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
139177902|NCT03478683|Hormones|hormones|mesh-ancestor
139177903|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139177904|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139177905|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139177906|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139177907|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
139177908|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727559|NCT03801876|Fluorouracil|fluorouracil|mesh-list
139177909|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727638|NCT03710772|Hormones|hormones|mesh-ancestor
139177911|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138727707|NCT03630991|Antidotes|antidotes|mesh-ancestor
139177912|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
139177913|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
139177914|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139177915|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
139177916|NCT01176799|Doxorubicin|doxorubicin|mesh-list
139177917|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139177918|NCT01176799|Sunitinib|sunitinib|mesh-list
139177919|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139177920|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
139177921|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177922|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139177923|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139177924|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
139177925|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177926|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177927|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139177928|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139177929|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139177930|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139177931|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139177932|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139177933|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139177934|NCT01176799|Growth Substances|growth substances|mesh-ancestor
139177935|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
139177936|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139177937|NCT03477903|Metoclopramide|metoclopramide|mesh-list
139177938|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
139177939|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
139177940|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177941|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177942|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139177943|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139177944|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139177946|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177947|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177948|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
139177949|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139177950|NCT04728425|Antibodies|antibodies|mesh-list
139177951|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
139177952|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139177953|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
139177954|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
138728118|NCT06080854|Paclitaxel|paclitaxel|mesh-list
139177955|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177956|NCT01181401|Cisplatin|cisplatin|mesh-list
139177957|NCT01181401|Docetaxel|docetaxel|mesh-list
139177958|NCT01181401|Cetuximab|cetuximab|mesh-list
139177959|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139177960|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
139177961|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
139177962|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
139177963|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177964|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728332|NCT06078592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139177966|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139177967|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139177969|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
139177970|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177971|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139177973|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139177974|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139177975|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139177976|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
139177977|NCT03474081|Albuterol|albuterol|mesh-list
138728488|NCT05721755|Paclitaxel|paclitaxel|mesh-list
139177978|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
139177979|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138728556|NCT05553145|Antibodies|antibodies|mesh-list
139177981|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139177982|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728614|NCT05314933|Deoxyglucose|deoxyglucose|mesh-list
139177983|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139177984|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
139177985|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
139177986|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139177987|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
139177988|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177989|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139177990|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
139177991|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139177992|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139177993|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138901676|NCT05862064|Epirubicin|epirubicin|mesh-list
139177994|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139177995|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
139177996|NCT03393000|Vitamin A|vitamin a|mesh-list
139177997|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
139177998|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
138728681|NCT05117554|Midazolam|midazolam|mesh-list
139177999|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178001|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178002|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139178003|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178005|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
139178006|NCT01311804|Parecoxib|parecoxib|mesh-list
139178007|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139178008|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139178009|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685195|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178010|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178011|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139178012|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139178013|NCT01311804|Analgesics|analgesics|mesh-ancestor
139178014|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
138728955|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139178015|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178016|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178018|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139178019|NCT03370770|Osimertinib|osimertinib|mesh-list
139178020|NCT03370770|Afatinib|afatinib|mesh-list
138729028|NCT04151342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178021|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178022|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139178023|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178024|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178025|NCT01180075|Ritonavir|ritonavir|mesh-list
139178026|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139178027|NCT01180075|Tenofovir|tenofovir|mesh-list
139178029|NCT01180075|Efavirenz|efavirenz|mesh-list
139178030|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139178031|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138729242|NCT03089905|Analgesics|analgesics|mesh-ancestor
139178032|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
139178033|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965864|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
139178034|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178035|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139178036|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139178037|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
139178038|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178039|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139178040|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139178041|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139178042|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139178043|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139178044|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139178045|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139178046|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139178047|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139178048|NCT01311882|Zopiclone|zopiclone|mesh-list
139178049|NCT01311882|Suvorexant|suvorexant|mesh-list
139178050|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139178051|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139178052|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178053|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139178054|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139178055|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178056|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178057|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
139178058|NCT01287793|Tigecycline|tigecycline|mesh-list
139178059|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139178060|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178061|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139178062|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139178063|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178064|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178065|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178066|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139178067|NCT03391284|Acetaminophen|acetaminophen|mesh-list
139178068|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139178069|NCT03391284|Analgesics|analgesics|mesh-ancestor
139178070|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
139178071|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178072|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178073|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
139178074|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
139178075|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178076|NCT03719625|Norepinephrine|norepinephrine|mesh-list
139178077|NCT03719625|Ephedrine|ephedrine|mesh-list
139178078|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139178079|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139178080|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
139178081|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178082|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178083|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178084|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
139178085|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
139178086|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178087|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139178088|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139178089|NCT01289743|Etanercept|etanercept|mesh-list
139178090|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139178091|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139178092|NCT01289743|Analgesics|analgesics|mesh-ancestor
139178093|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
139178094|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178095|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178096|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139178097|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139178098|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139178099|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139178100|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
139178101|NCT03390426|Anesthetics|anesthetics|mesh-list
139178102|NCT03390426|Mepivacaine|mepivacaine|mesh-list
139178103|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
139178104|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139178105|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178107|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178108|NCT03472521|Gabapentin|gabapentin|mesh-list
139178109|NCT03472521|Analgesics|analgesics|mesh-ancestor
139178110|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
139178111|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178112|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178113|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
139178114|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139178115|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139178116|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139178117|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139178118|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139178119|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139178120|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178121|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178122|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
139178123|NCT02906020|Venglustat|venglustat|mesh-list
139178124|NCT02906020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178125|NCT02906020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178126|NCT01177423|Anesthetics|anesthetics|mesh-list
139178127|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138729695|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
139178128|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178129|NCT01180231|Moxonidine|moxonidine|mesh-list
139178130|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139178131|NCT01177501|Topotecan|topotecan|mesh-list
139178132|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139178133|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139178134|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965913|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139178135|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178136|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178137|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
139178138|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
139178139|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
138928603|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178140|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139178141|NCT03478150|Protective Agents|protective agents|mesh-ancestor
139178142|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178143|NCT03499353|Talazoparib|talazoparib|mesh-list
139178144|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139178145|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729815|NCT02199184|Hormones|hormones|mesh-ancestor
139178146|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178147|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178148|NCT00004259|Carmustine|carmustine|mesh-list
139178149|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139178150|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
139178151|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178152|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178153|NCT01177579|Copper|copper|mesh-list
139178154|NCT01177579|Trace Elements|trace elements|mesh-ancestor
139178155|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
139178156|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178157|NCT03722355|Carmustine|carmustine|mesh-list
139178158|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139178159|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
139178160|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729885|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
139178161|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178162|NCT03857815|Antibodies|antibodies|mesh-list
139178163|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
139178164|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178165|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139178166|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178167|NCT03477994|Clonidine|clonidine|mesh-list
139178168|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
139178169|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138729940|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178170|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139178171|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178172|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139178173|NCT03477994|Analgesics|analgesics|mesh-ancestor
139178174|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
139178175|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178176|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139178177|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139178178|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139178179|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
139178180|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178181|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178182|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138730023|NCT01357161|Paclitaxel|paclitaxel|mesh-list
139178183|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
139178184|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
139178185|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139178186|NCT04668131|Lubricant Eye Drops|lubricant eye drops|mesh-list
139178187|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
139178188|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139178189|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139178190|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
139178191|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730073|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
139178192|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
139178193|NCT04668131|Protective Agents|protective agents|mesh-ancestor
139178194|NCT03857581|Olanzapine|olanzapine|mesh-list
139178195|NCT03857581|Clozapine|clozapine|mesh-list
139178196|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
139178197|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
139178198|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178199|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178200|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139178201|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139178202|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139178203|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139178204|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138730140|NCT00707473|Carboplatin|carboplatin|mesh-list
139178205|NCT03857581|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139178206|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139178207|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139178208|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178209|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178210|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
139178211|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139178212|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
139178213|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
139178214|NCT01103843|Clopidogrel|clopidogrel|mesh-list
139178215|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139178216|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139178217|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139178218|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139178219|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138730275|NCT06031090|Clonidine|clonidine|mesh-list
139178220|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
139178221|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178222|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178223|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178224|NCT03738865|Glucagon|glucagon|mesh-list
139178225|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139178226|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139178227|NCT03738865|Hormones|hormones|mesh-ancestor
139178228|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139178229|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178230|NCT03738865|Incretins|incretins|mesh-ancestor
139178231|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139178232|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139178233|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
139178234|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138965960|NCT00949377|Bromides|bromides|mesh-list
139178235|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
139178236|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178237|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
139178238|NCT03524157|Protective Agents|protective agents|mesh-ancestor
139178239|NCT03719391|Nicotine|nicotine|mesh-list
139178240|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139178241|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
139178242|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178243|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178244|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139178245|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139178246|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
139178247|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178248|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178249|NCT03468543|Memantine|memantine|mesh-list
139178250|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139178251|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139178252|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
139178253|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178254|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178255|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178256|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139178257|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139178258|NCT03467763|Metformin|metformin|mesh-list
139178259|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138730469|NCT05842759|Norepinephrine|norepinephrine|mesh-list
139178260|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178261|NCT00004031|Prednisone|prednisone|mesh-list
139178262|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
139178263|NCT00004031|Carmustine|carmustine|mesh-list
139178264|NCT00004031|Rituximab|rituximab|mesh-list
139178265|NCT00004031|Doxorubicin|doxorubicin|mesh-list
139178266|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139178267|NCT00004031|Etoposide|etoposide|mesh-list
139178268|NCT00004031|Vincristine|vincristine|mesh-list
139178269|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139178270|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
139178271|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178272|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139178273|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139178274|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
139178275|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178276|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178277|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139178278|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138730813|NCT04476173|Morphine|morphine|mesh-list
139178279|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139178280|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139178281|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138965967|NCT00290407|Rituximab|rituximab|mesh-list
139178283|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139178284|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
139178285|NCT00004031|Hormones|hormones|mesh-ancestor
139178286|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139178287|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139178288|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139178289|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
139178290|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
139178291|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
139178292|NCT01184443|Olanzapine|olanzapine|mesh-list
139178293|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
139178294|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
139178295|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178296|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178297|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139178298|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139178299|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139178300|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139178301|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139178302|NCT01184443|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139178303|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139178304|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139178305|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178306|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178307|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
139178308|NCT01180621|Vaccines|vaccines|mesh-list
139178309|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
139178310|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178311|NCT01290133|Vestipitant|vestipitant|mesh-list
139178312|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139178313|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731078|NCT03912818|Carboplatin|carboplatin|mesh-list
139178314|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178315|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178316|NCT03467217|Losartan|losartan|mesh-list
139178317|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139178318|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139178319|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139178320|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139178321|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178322|NCT00003875|Aldesleukin|aldesleukin|mesh-list
139178323|NCT00003875|Etoposide|etoposide|mesh-list
139178324|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
139178325|NCT00003875|Busulfan|busulfan|mesh-list
139178326|NCT00003875|Interleukin-2|interleukin-2|mesh-list
139178327|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139178328|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178329|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139178330|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139178331|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178332|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178334|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139178335|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
139178336|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178337|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139178338|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139178339|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139178340|NCT00003875|Analgesics|analgesics|mesh-ancestor
139178341|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
139178342|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178343|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139178344|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138965995|NCT00949455|Lapatinib|lapatinib|mesh-list
139178345|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
139178346|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178347|NCT01327625|Azithromycin|azithromycin|mesh-list
139178348|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139178349|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178350|NCT01290211|Ritonavir|ritonavir|mesh-list
139178352|NCT01290211|Maraviroc|maraviroc|mesh-list
139178353|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139178354|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139178355|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
139178356|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178357|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178358|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139178359|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139178360|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
139178361|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178362|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139178363|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139178364|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139178365|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139178366|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138731700|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
139178367|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138928831|NCT03410654|Tacrolimus|tacrolimus|mesh-list
139178369|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178370|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139178371|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178372|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178373|NCT01311960|Bevacizumab|bevacizumab|mesh-list
139178374|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139178375|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139178376|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178377|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139178378|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139178379|NCT01311960|Growth Substances|growth substances|mesh-ancestor
139178380|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178381|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
139178382|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139178384|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139178385|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139178386|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178387|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139178388|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
139178389|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
139178390|NCT05663307|Aspirin|aspirin|mesh-list
139178391|NCT05663307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139178392|NCT05663307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139178393|NCT05663307|Analgesics|analgesics|mesh-ancestor
139178394|NCT05663307|Sensory System Agents|sensory system agents|mesh-ancestor
139178395|NCT05663307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178396|NCT05663307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178397|NCT05663307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139178398|NCT05663307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139178399|NCT05663307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139178400|NCT05663307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139178401|NCT05663307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178402|NCT05663307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139178403|NCT05663307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139178404|NCT05663307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178405|NCT05663307|Antipyretics|antipyretics|mesh-ancestor
139178406|NCT01106495|Simvastatin|simvastatin|mesh-list
139178407|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139178408|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139178409|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
139178410|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178411|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139178412|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139178413|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178414|NCT01184833|Interferons|interferons|mesh-list
139178415|NCT01184833|Interferon-beta|interferon-beta|mesh-list
139178416|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
139178417|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178418|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
139178419|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178420|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
139178421|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178422|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139178423|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
139178424|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
139178425|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139178426|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
139178427|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138732006|NCT01648010|Mitomycins|mitomycins|mesh-list
139178428|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139178429|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178430|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139178431|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178432|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178433|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139178434|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
139178435|NCT01185067|Resveratrol|resveratrol|mesh-list
139178436|NCT01185067|Antioxidants|antioxidants|mesh-list
139178437|NCT01185067|Quercetin|quercetin|mesh-list
139178438|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178439|NCT01185067|Protective Agents|protective agents|mesh-ancestor
139178440|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178441|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178442|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139178443|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139178444|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178445|NCT03364686|Biotin|biotin|mesh-list
139178446|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
139178447|NCT03364686|Vitamins|vitamins|mesh-ancestor
139178448|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
139178449|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178450|NCT03437577|Tacrolimus|tacrolimus|mesh-list
139178451|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139178452|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
139178453|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178454|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139178455|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178456|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178457|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
139178458|NCT03336528|Insulin Aspart|insulin aspart|mesh-list
139178459|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139178460|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178462|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139178463|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
139178464|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178465|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178466|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139178467|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
139178468|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
139178469|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139178470|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139178471|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139178472|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139178473|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
139178474|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732485|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
139178475|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178476|NCT03719157|Anesthetics|anesthetics|mesh-list
139178477|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
139178478|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139178479|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178480|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
139178481|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178482|NCT01185223|Valganciclovir|valganciclovir|mesh-list
139178483|NCT01185223|Ganciclovir|ganciclovir|mesh-list
139178484|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139178485|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
139178486|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178487|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139178488|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178489|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178491|NCT03852979|Carboplatin|carboplatin|mesh-list
139178492|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139178493|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178494|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
139178495|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
139178496|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
139178497|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178498|NCT01188031|Alprazolam|alprazolam|mesh-list
139178499|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139178500|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732757|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
139178501|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178502|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139178503|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139178504|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139178505|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
139178506|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
139178507|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178508|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178509|NCT01182883|Sirolimus|sirolimus|mesh-list
139178510|NCT01182883|Temsirolimus|temsirolimus|mesh-list
139178511|NCT01182883|MTOR Inhibitors|mtor inhibitors|mesh-list
139178512|NCT01182883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139178513|NCT01182883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178514|NCT01182883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178515|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139178516|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
139178517|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178518|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178519|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139178520|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178521|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139178522|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
139178523|NCT01188265|Valproic Acid|valproic acid|mesh-list
139178524|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
139178525|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
139178526|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178527|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178528|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
139178529|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178530|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178531|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
139178532|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139178533|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139178534|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139178535|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
139178536|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
138732891|NCT05654064|Fentanyl|fentanyl|mesh-list
139178537|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139178538|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139178539|NCT01291069|Tadalafil|tadalafil|mesh-list
139178540|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178541|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
139178542|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139178543|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139178544|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178545|NCT01291069|Urological Agents|urological agents|mesh-ancestor
139178546|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
139178547|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178548|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139178549|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139178550|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178551|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139178552|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178553|NCT01588639|Insulin|insulin|mesh-list
139178554|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139178555|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139178556|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178557|NCT02524639|Sirolimus|sirolimus|mesh-list
138733071|NCT02995694|Estrogens|estrogens|mesh-ancestor
139178558|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139178559|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178560|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139178561|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733142|NCT01331109|Analgesics|analgesics|mesh-ancestor
139178563|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139178564|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
139178565|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178566|NCT01185535|Anesthetics|anesthetics|mesh-list
139178567|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139178568|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178569|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
139178570|NCT00003659|Rituximab|rituximab|mesh-list
139178571|NCT00003659|Fludarabine|fludarabine|mesh-list
139178572|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
139178573|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139178574|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
139178575|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178576|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966050|NCT00269113|Rituximab|rituximab|mesh-list
139178577|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139178578|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
139178579|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178580|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178581|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139178582|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139178583|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139178585|NCT01101581|Epratuzumab|epratuzumab|mesh-list
139178586|NCT01101581|Veltuzumab|veltuzumab|mesh-list
139178587|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
139178588|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138733425|NCT02893176|Macitentan|macitentan|mesh-list
139178590|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
139178591|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
139178592|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178594|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139178595|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139178597|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733559|NCT00592137|Calcium|calcium|mesh-list
139178598|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139178599|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139178600|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178601|NCT03494985|Muramidase|muramidase|mesh-list
139178602|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178603|NCT01185769|Tocotrienols|tocotrienols|mesh-list
139178604|NCT01185769|Vitamin E|vitamin e|mesh-list
139178605|NCT01185769|Tocopherols|tocopherols|mesh-list
139178606|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
139178607|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178608|NCT01185769|Protective Agents|protective agents|mesh-ancestor
139178609|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178611|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
139178612|NCT01185847|Gemcitabine|gemcitabine|mesh-list
139178613|NCT01185847|Pemetrexed|pemetrexed|mesh-list
138733699|NCT04328766|Fexuprazan|fexuprazan|mesh-list
139178615|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139178616|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
139178617|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178618|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178619|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139178620|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139178621|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
139178622|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139178623|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
139178624|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178625|NCT03720483|Expectorants|expectorants|mesh-ancestor
139178626|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
139178627|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139178628|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
139178629|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178630|NCT03720483|Protective Agents|protective agents|mesh-ancestor
139178631|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178632|NCT03720483|Antidotes|antidotes|mesh-ancestor
139178634|NCT01183663|Sirolimus|sirolimus|mesh-list
139178635|NCT01183663|Bevacizumab|bevacizumab|mesh-list
139178636|NCT01183663|Lenalidomide|lenalidomide|mesh-list
139178637|NCT01183663|Fluorouracil|fluorouracil|mesh-list
139178638|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
139178639|NCT01183663|Sorafenib|sorafenib|mesh-list
139178640|NCT01183663|Temsirolimus|temsirolimus|mesh-list
139178641|NCT01183663|MTOR Inhibitors|mtor inhibitors|mesh-list
139178642|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139178643|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178644|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139178645|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139178646|NCT01183663|Growth Substances|growth substances|mesh-ancestor
139178647|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178648|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
139178649|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
139178650|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178651|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139178652|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139178653|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
139178654|NCT01183663|Antidotes|antidotes|mesh-ancestor
139178655|NCT01183663|Protective Agents|protective agents|mesh-ancestor
139178656|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
139178657|NCT01183663|Vitamins|vitamins|mesh-ancestor
139178658|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
139178659|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139178660|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178661|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139178662|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178663|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139178664|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
139178665|NCT01291927|Pancrelipase|pancrelipase|mesh-list
139178666|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139178667|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
139178668|NCT03344172|Paclitaxel|paclitaxel|mesh-list
138734176|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
139178669|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139178671|NCT03344172|Avelumab|avelumab|mesh-list
139178672|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138508264|NCT06158698|Colchicine|colchicine|mesh-list
139178673|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178674|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
139178675|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
139178676|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
139178677|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178678|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139178680|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
139178681|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139178682|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139178683|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178684|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178685|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139178686|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139178688|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139178689|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139178690|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178691|NCT01101659|Ketamine|ketamine|mesh-list
139178693|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
139178694|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178695|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178696|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139178697|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138734520|NCT02270918|Apixaban|apixaban|mesh-list
139178698|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
139178700|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139178701|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139178702|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138734592|NCT01172938|Analgesics|analgesics|mesh-ancestor
139178703|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178704|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178706|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
139178708|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139178709|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138734731|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178710|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139178711|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734803|NCT02272868|Laxatives|laxatives|mesh-ancestor
139178712|NCT03855865|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139178713|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139178714|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139178715|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178716|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178717|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
138734947|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
139178718|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139178719|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139178720|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139178721|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139178722|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
139178723|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139178724|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
139178725|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178727|NCT01290367|Protective Agents|protective agents|mesh-ancestor
139178728|NCT03465891|Atezolizumab|atezolizumab|mesh-list
139178729|NCT03465891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139178730|NCT03465891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178731|NCT03465891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139178733|NCT03363906|Dulaglutide|dulaglutide|mesh-list
139178734|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
139178736|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178737|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
139178738|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
139178739|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
139178740|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139178741|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139178742|NCT03948191|Prednisolone|prednisolone|mesh-list
139178743|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
139178744|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139178745|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
139178746|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
139178748|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
139178749|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
139178750|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178751|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178752|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139178753|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
139178755|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139178756|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139178757|NCT03948191|Protective Agents|protective agents|mesh-ancestor
139178758|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139178759|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178760|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139178761|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139178762|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178763|NCT01292083|Azacitidine|azacitidine|mesh-list
139178764|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139178765|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
139178766|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178767|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178768|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178769|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
139178770|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139178771|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139178772|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178773|NCT01292161|Silymarin|silymarin|mesh-list
139178774|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
139178775|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178776|NCT01292161|Protective Agents|protective agents|mesh-ancestor
139178777|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178778|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
139178779|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
139178780|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139178781|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138735505|NCT00602004|Losartan|losartan|mesh-list
139178782|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178783|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178784|NCT01185925|Urological Agents|urological agents|mesh-ancestor
139178785|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
139178786|NCT01188889|Everolimus|everolimus|mesh-list
139178787|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178788|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139178789|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178790|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178791|NCT01188889|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139178792|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139178793|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
139178794|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178795|NCT01184287|Ranpirnase|ranpirnase|mesh-list
139178796|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178797|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139178798|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178799|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178801|NCT01107431|Trace Elements|trace elements|mesh-ancestor
139178802|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
139178803|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178804|NCT01186159|Parecoxib|parecoxib|mesh-list
139178805|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139178806|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139178807|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178808|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178809|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139178810|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139178811|NCT01186159|Analgesics|analgesics|mesh-ancestor
139178812|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
139178813|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735958|NCT00600158|Narcotics|narcotics|mesh-ancestor
139178814|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178815|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139178816|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139178817|NCT01107509|Everolimus|everolimus|mesh-list
139178818|NCT01107509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139178819|NCT01107509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139178820|NCT01107509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178821|NCT01107509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178822|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139178823|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
138966120|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
139178824|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178825|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178826|NCT01101815|Naltrexone|naltrexone|mesh-list
138736092|NCT01324310|Romidepsin|romidepsin|mesh-list
139178828|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139178829|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178830|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
139178831|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178833|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139178834|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178835|NCT01293643|Clindamycin|clindamycin|mesh-list
139178836|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
138901944|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
139178837|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
139178838|NCT01293643|Amphotericin B|amphotericin b|mesh-list
139178839|NCT01293643|Tetracycline|tetracycline|mesh-list
139178840|NCT01293643|Ketoconazole|ketoconazole|mesh-list
139178841|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139178842|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139178843|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178844|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139178845|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178846|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178847|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
139178848|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139178849|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139178850|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139178851|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
139178852|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139178853|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178854|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139178855|NCT01293643|Amebicides|amebicides|mesh-ancestor
139178856|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139178857|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139178858|NCT01105013|Clotrimazole|clotrimazole|mesh-list
139178859|NCT01105013|Miconazole|miconazole|mesh-list
139178860|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139178861|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178862|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
139178863|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139178864|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139178865|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178866|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178867|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139178868|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
139178869|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139178870|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178871|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139178872|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139178874|NCT03851731|Naloxone|naloxone|mesh-list
139178875|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139178876|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139178877|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178878|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
139178879|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178880|NCT03707652|Vitamins|vitamins|mesh-list
139178881|NCT03707652|Niacinamide|niacinamide|mesh-list
139178882|NCT03707652|Niacin|niacin|mesh-list
139178883|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
138966130|NCT00835848|Hormones|hormones|mesh-ancestor
139178884|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
139178885|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
139178886|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178887|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139178888|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
139178889|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178890|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139178891|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
138929374|NCT02557945|Gabapentin|gabapentin|mesh-list
139178893|NCT01588093|Growth Substances|growth substances|mesh-ancestor
139178894|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178895|NCT01186471|Nicotine|nicotine|mesh-list
139178896|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139178897|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
139178898|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178899|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178900|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139178901|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139178902|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
139178903|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178904|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178905|NCT01292551|Bosentan|bosentan|mesh-list
139178906|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139178907|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139178908|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178909|NCT03854383|Isosorbide|isosorbide|mesh-list
139178910|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139178911|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139178912|NCT03854383|Misoprostol|misoprostol|mesh-list
139178913|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139178914|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
139178915|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139178916|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178917|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139178918|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139178919|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
139178920|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139178921|NCT03854383|Diuretics|diuretics|mesh-ancestor
139178922|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
139178923|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
139178924|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139178925|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178926|NCT03854617|Vinorelbine|vinorelbine|mesh-list
139178927|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139178928|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178929|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
139178930|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
139178931|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
139178932|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178933|NCT01186549|Lidocaine|lidocaine|mesh-list
139178934|NCT01186549|Ephedrine|ephedrine|mesh-list
139178935|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
139178936|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
139178937|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
139178938|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139178939|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178940|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
139178941|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139178942|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139178943|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139178944|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139178945|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139178946|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178947|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139178948|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
139178949|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
139178950|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139178951|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
139178952|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178953|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139178954|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138736580|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
139178955|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
139178956|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
139178957|NCT03851341|Metformin|metformin|mesh-list
139178958|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139178959|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139178960|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178961|NCT03851341|Incretins|incretins|mesh-ancestor
139178962|NCT03851341|Hormones|hormones|mesh-ancestor
139178963|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139178964|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139178965|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
139178966|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178967|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178968|NCT03362190|Ranibizumab|ranibizumab|mesh-list
139178969|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139178970|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139178971|NCT03362190|Growth Substances|growth substances|mesh-ancestor
139178972|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178973|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
139178974|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178976|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139178977|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178978|NCT02323126|Nivolumab|nivolumab|mesh-list
139178979|NCT02323126|Nazartinib|nazartinib|mesh-list
139178980|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139178981|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178982|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139178983|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178984|NCT01291459|Tenofovir|tenofovir|mesh-list
139178985|NCT01291459|Emtricitabine|emtricitabine|mesh-list
139178986|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
139178987|NCT01291459|Maraviroc|maraviroc|mesh-list
139178988|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
139178989|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139178990|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139178991|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139178992|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178993|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736837|NCT01078441|Hormones|hormones|mesh-ancestor
139178994|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139178995|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139178996|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139178997|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139178998|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139178999|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139179000|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139179001|NCT00003377|Paclitaxel|paclitaxel|mesh-list
139179002|NCT00003377|Cisplatin|cisplatin|mesh-list
139179003|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139179004|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179005|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
139179006|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
139179007|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
139179008|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736886|NCT01077739|Vitamins|vitamins|mesh-ancestor
139179009|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139179010|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139179011|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
139179012|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179013|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139179014|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139179015|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
139179016|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
139179017|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179018|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179020|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139179021|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
139179022|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
139179023|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179024|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179025|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139179026|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
139179027|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179028|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179029|NCT01328015|Urological Agents|urological agents|mesh-ancestor
139179030|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
139179031|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139179032|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139179033|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
139179034|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179035|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139179036|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139179037|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737014|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
139179038|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179039|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139179042|NCT00002651|Bicalutamide|bicalutamide|mesh-list
139179043|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139179044|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179045|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
139179046|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
139179047|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139179048|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179049|NCT03853993|Vaccines|vaccines|mesh-list
139179050|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
139179051|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179052|NCT03473626|Alicaforsen|alicaforsen|mesh-list
139179053|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139179054|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139179055|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
139179056|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179057|NCT05154682|Acetaminophen|acetaminophen|mesh-list
139179058|NCT05154682|Naproxen|naproxen|mesh-list
139179059|NCT05154682|Oxycodone|oxycodone|mesh-list
139179060|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139179061|NCT05154682|Analgesics|analgesics|mesh-ancestor
139179062|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
139179063|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179064|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179065|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
139179066|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139179067|NCT05154682|Narcotics|narcotics|mesh-ancestor
139179068|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179069|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139179070|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139179071|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139179072|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
139179073|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139179074|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179075|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179076|NCT04312841|Acetic Acid|acetic acid|mesh-list
139179077|NCT04312841|Letermovir|letermovir|mesh-list
139179078|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139179079|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179080|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179081|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139179082|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179083|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179084|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
139179085|NCT01294735|Temozolomide|temozolomide|mesh-list
139179086|NCT01294735|Niraparib|niraparib|mesh-list
139179087|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139179088|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
139179089|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179090|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179091|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139179092|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179093|NCT03851263|Evolocumab|evolocumab|mesh-list
138737405|NCT04334837|Copper|copper|mesh-list
139179094|NCT03851263|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139179095|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139179096|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139179097|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
138966215|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179098|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179099|NCT03851263|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139179100|NCT03851263|Protease Inhibitors|protease inhibitors|mesh-ancestor
139179101|NCT03851263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179102|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139179104|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139179105|NCT03849235|Hormones|hormones|mesh-ancestor
138902032|NCT04560660|Ketamine|ketamine|mesh-list
139179106|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139179107|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179108|NCT03477448|Bleomycin|bleomycin|mesh-list
139179109|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139179110|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179111|NCT00002597|Leuprolide|leuprolide|mesh-list
139179112|NCT00002597|Goserelin|goserelin|mesh-list
138929577|NCT04038086|Insulin|insulin|mesh-list
139179113|NCT00002597|Flutamide|flutamide|mesh-list
139179114|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139179115|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
139179116|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139179117|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179118|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139179119|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179120|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
139179121|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
139179122|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139179123|NCT03853525|Petrolatum|petrolatum|mesh-list
139179124|NCT03853525|Emollients|emollients|mesh-ancestor
139179125|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
139179126|NCT03716583|Melatonin|melatonin|mesh-list
139179127|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139179128|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
139179129|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179130|NCT03716583|Protective Agents|protective agents|mesh-ancestor
139179131|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179132|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179133|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139179134|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139179135|NCT02738008|Tenofovir|tenofovir|mesh-list
139179136|NCT02738008|Entecavir|entecavir|mesh-list
139179137|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
139179138|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139179139|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
139179140|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179141|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139179142|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139179143|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179144|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179145|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139179146|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139179147|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
139179148|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179149|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179150|NCT03720249|Vitamins|vitamins|mesh-list
139179151|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
139179152|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
138737648|NCT00598169|Rituximab|rituximab|mesh-list
139179153|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
139179154|NCT03720249|Betaine|betaine|mesh-list
139179155|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
139179156|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179157|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139179158|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
139179159|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139179161|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179162|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138737855|NCT00601211|Miotics|miotics|mesh-ancestor
139179163|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139179164|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139179165|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139179166|NCT01294969|Analgesics|analgesics|mesh-ancestor
139179167|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
139179168|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179169|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179170|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139179171|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139179173|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139179174|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139179175|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
139179176|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
139179177|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179178|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179179|NCT03850561|Ubiquinone|ubiquinone|mesh-list
139179180|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
139179181|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
139179182|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179183|NCT03850561|Vitamins|vitamins|mesh-ancestor
139179184|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
139179185|NCT01190137|Vitamin D|vitamin d|mesh-list
139179186|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
139179187|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139179188|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179189|NCT01190137|Vitamins|vitamins|mesh-ancestor
139179190|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
139179191|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139179192|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
139179193|NCT02529839|Fludarabine|fludarabine|mesh-list
139179194|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
139179195|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138738060|NCT01100320|Oxycodone|oxycodone|mesh-list
139179196|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
139179197|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179198|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139179199|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139179200|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
139179201|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179202|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179203|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139179204|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139179205|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
139179206|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139179207|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
139179208|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179209|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179210|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139179211|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
139179212|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139179214|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179215|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179216|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139179217|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
139179218|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
139179219|NCT03473314|Protective Agents|protective agents|mesh-ancestor
139179220|NCT03945539|Itraconazole|itraconazole|mesh-list
139179221|NCT03945539|JNJ-56136379|jnj-56136379|mesh-list
139179222|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
139179223|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179224|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139179225|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139179226|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179227|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179228|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139179229|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
139179230|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139179231|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179232|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139179233|NCT03945539|Antiviral Agents|antiviral agents|mesh-ancestor
139179234|NCT01190293|Efavirenz|efavirenz|mesh-list
139179235|NCT01190293|Maraviroc|maraviroc|mesh-list
139179236|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139179237|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139179238|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179239|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179240|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
139179241|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179242|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139179243|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139179244|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139179245|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139179246|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139179247|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139179248|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139179249|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139179250|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139179251|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139179252|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139179253|NCT03945227|Spartalizumab|spartalizumab|mesh-list
139179254|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139179255|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179256|NCT03945227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139179258|NCT01108133|Dexamethasone|dexamethasone|mesh-list
139179259|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139179260|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
139179261|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
139179262|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179263|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179264|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139179265|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
139179266|NCT01108133|Hormones|hormones|mesh-ancestor
139179267|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139179268|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139179269|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738334|NCT01313117|Vitamins|vitamins|mesh-ancestor
139179271|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
138902104|NCT04142658|Apixaban|apixaban|mesh-list
138966270|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139179272|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139179273|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179275|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139179276|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139179277|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179278|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139179279|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139179280|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
139179281|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179282|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179283|NCT03947411|Oseltamivir|oseltamivir|mesh-list
139179284|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
139179285|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179286|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179287|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179288|NCT03257254|Polidocanol|polidocanol|mesh-list
139179290|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139179291|NCT01327469|Albendazole|albendazole|mesh-list
139179292|NCT01327469|Mebendazole|mebendazole|mesh-list
139179293|NCT01327469|Piperazine|piperazine|mesh-list
139179294|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
139179295|NCT01327469|Pyrantel|pyrantel|mesh-list
139179296|NCT01327469|Oxantel|oxantel|mesh-list
139179297|NCT01327469|DMP 777|dmp 777|mesh-list
139179298|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
139179299|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139179300|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179301|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
139179302|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139179303|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139179304|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
138738607|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139179305|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
139179306|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
139179307|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179308|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179309|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
139179310|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179311|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139179312|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139179313|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139179314|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179315|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179316|NCT03950141|Apatinib|apatinib|mesh-list
139179317|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179318|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139179319|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179320|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179321|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
139179322|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138902128|NCT04095442|Benzocaine|benzocaine|mesh-list
139179323|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179324|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139179325|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139179326|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179327|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179328|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179329|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139179330|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139179331|NCT03084718|Beclomethasone|beclomethasone|mesh-list
139179332|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139179333|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
139179334|NCT03084718|Hormones|hormones|mesh-ancestor
139179335|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139179336|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179337|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139179338|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
139179339|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
139179340|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139179341|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179342|NCT02938624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139179343|NCT02938624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179344|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
139179345|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139179346|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179347|NCT03469804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139179348|NCT03469804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179349|NCT03944291|Bupivacaine|bupivacaine|mesh-list
139179350|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
139179351|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
139179352|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179353|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179354|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
139179355|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179356|NCT01102439|Aspirin|aspirin|mesh-list
139179357|NCT01102439|Clopidogrel|clopidogrel|mesh-list
139179358|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139179359|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139179360|NCT01102439|Analgesics|analgesics|mesh-ancestor
139179361|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
139179362|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179363|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179364|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139179365|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139179366|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139179367|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139179368|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179369|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139179370|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139179371|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179372|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
139179373|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139179374|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139179375|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139179376|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
139179377|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179378|NCT03949985|Hemostatics|hemostatics|mesh-list
139179379|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
139179380|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139179381|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179382|NCT03949985|Coagulants|coagulants|mesh-ancestor
139179383|NCT01584791|Aspirin|aspirin|mesh-list
139179384|NCT01584791|Clopidogrel|clopidogrel|mesh-list
139179385|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139179386|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139179387|NCT01584791|Analgesics|analgesics|mesh-ancestor
139179388|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
139179389|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179390|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179391|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139179392|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139179393|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139179394|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139179395|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179396|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139179397|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139179398|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179399|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
139179400|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139179401|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139179402|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139179403|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
139179404|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179405|NCT04285684|Ketamine|ketamine|mesh-list
139179406|NCT04285684|Analgesics|analgesics|mesh-ancestor
139179407|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
139179408|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179409|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179410|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139179412|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
139179413|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
139179414|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179415|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139179416|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139179417|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179418|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179419|NCT01310985|Capecitabine|capecitabine|mesh-list
139179420|NCT01310985|Cetuximab|cetuximab|mesh-list
139179421|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139179422|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
139179423|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179424|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179425|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139179426|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
139179427|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138739005|NCT01281969|Antibodies|antibodies|mesh-list
139179428|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179429|NCT02492711|Trastuzumab|trastuzumab|mesh-list
139179430|NCT02492711|Margetuximab|margetuximab|mesh-list
139179431|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139179432|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179433|NCT03716427|Tolbutamide|tolbutamide|mesh-list
139179434|NCT03716427|Midazolam|midazolam|mesh-list
139179435|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
139179436|NCT03716427|Omeprazole|omeprazole|mesh-list
139179437|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139179438|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139179439|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179440|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179441|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139179442|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139179443|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139179444|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139179445|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
139179446|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
139179447|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
139179448|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
139179449|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179450|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179451|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139179452|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139179453|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139179454|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179455|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
139179456|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
139179457|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139179458|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139179460|NCT01147822|Sunitinib|sunitinib|mesh-list
139179461|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179462|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139179463|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139179464|NCT01147822|Growth Substances|growth substances|mesh-ancestor
139179465|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179466|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
139179467|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139179468|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179469|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179470|NCT03431337|Amoxicillin|amoxicillin|mesh-list
139179471|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139179472|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179473|NCT01293097|Atorvastatin|atorvastatin|mesh-list
139179474|NCT01293097|Pravastatin|pravastatin|mesh-list
139179475|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139179476|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139179477|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
138739199|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139179478|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179479|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139179480|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139179481|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179482|NCT03516292|Mitogens|mitogens|mesh-list
139179483|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
139179484|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179485|NCT01291615|Gemcitabine|gemcitabine|mesh-list
139179486|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139179487|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
139179488|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179489|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179491|NCT01295047|Verapamil|verapamil|mesh-list
139179492|NCT01295047|Perindopril|perindopril|mesh-list
139179493|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139179494|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139179495|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
139179496|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
139179497|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739306|NCT00628459|Micronutrients|micronutrients|mesh-list
139179498|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179499|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139179500|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139179501|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139179502|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
139179503|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179504|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179505|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139179506|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139179507|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139179508|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
139179509|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139179510|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
139179511|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179513|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139179514|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966402|NCT00964041|Cycloserine|cycloserine|mesh-list
139179515|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139179516|NCT01190371|Artesunate|artesunate|mesh-list
139179517|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
139179518|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139179519|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139179520|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179521|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179522|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
139179523|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
139179524|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139179525|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
139179526|NCT05158426|Propofol|propofol|mesh-list
139179527|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139179528|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179529|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179530|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139179531|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
139179532|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
139179533|NCT03853369|Nifekalant|nifekalant|mesh-list
139179534|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139179535|NCT05158348|Lidocaine|lidocaine|mesh-list
139179536|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
139179537|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
139179538|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
139179539|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179540|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179541|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
139179542|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179543|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139179544|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139179545|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139179546|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139179547|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179548|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139179549|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139179550|NCT05158348|Analgesics|analgesics|mesh-ancestor
139179551|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139179552|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139179553|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139179554|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
139179555|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179556|NCT01187719|Phenytoin|phenytoin|mesh-list
139179557|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
139179558|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139179559|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139179560|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138902205|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139179561|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179562|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139179563|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139179564|NCT01102595|Bevacizumab|bevacizumab|mesh-list
139179565|NCT01102595|Temozolomide|temozolomide|mesh-list
139179566|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138966415|NCT03641547|Capecitabine|capecitabine|mesh-list
139179586|NCT03848611|Vorolanib|vorolanib|mesh-list
139179587|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139179588|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179589|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179590|NCT01584947|Bupivacaine|bupivacaine|mesh-list
139179591|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
139179592|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
139179593|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179594|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179595|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
139179596|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179597|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
139179598|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139179599|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179600|NCT01109615|Gemcitabine|gemcitabine|mesh-list
139179601|NCT01109615|Pemetrexed|pemetrexed|mesh-list
139179602|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139179603|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
139179604|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179605|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179606|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179607|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139179608|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139179609|NCT01209065|Ritonavir|ritonavir|mesh-list
139179610|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
139179611|NCT01209065|Dolutegravir|dolutegravir|mesh-list
139179612|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139179613|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139179614|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
139179615|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179616|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179617|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139179618|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139179619|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
139179620|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179621|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139179622|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139179623|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139179624|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139179626|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139179627|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139179628|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179629|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
139179630|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179631|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179632|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
139179633|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179634|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179635|NCT03481725|Coal Tar|coal tar|mesh-list
139179636|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
139179637|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
139179639|NCT03472456|Carticaine|carticaine|mesh-list
139179640|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
139179641|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
139179642|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179643|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179644|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
139179645|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179646|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179647|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139179648|NCT01193881|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
138740192|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139179649|NCT01193881|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139179651|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139179652|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179653|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179654|NCT01194037|Interferons|interferons|mesh-list
139179655|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
139179656|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
139179657|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139179658|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179659|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
139179660|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179661|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
139179662|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179663|NCT03480243|Erythromycin|erythromycin|mesh-list
139179664|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
139179665|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139179666|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
139179667|NCT03480243|Padsevonil|padsevonil|mesh-list
139179668|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139179669|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179670|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139179671|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139179672|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179673|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179674|NCT03480243|Anticonvulsants|anticonvulsants|mesh-ancestor
139179675|NCT01109693|Mirtazapine|mirtazapine|mesh-list
139179676|NCT01109693|Sertraline|sertraline|mesh-list
139179677|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
139179678|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139179679|NCT01109693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139179680|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139179681|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139179682|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179683|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179684|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
139179685|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179686|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139179687|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
139179688|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
139179689|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139179690|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139179691|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179692|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139179693|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139179694|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139179695|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
139179696|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139179697|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139179698|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139179699|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
139179700|NCT01190683|Vitamin D|vitamin d|mesh-list
139179701|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
139179702|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
139179703|NCT01190683|Vitamins|vitamins|mesh-list
139179704|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
139179705|NCT01190683|Calcium|calcium|mesh-list
139179706|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
139179707|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179708|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139179709|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139179710|NCT01190683|Antacids|antacids|mesh-ancestor
138930176|NCT00711308|Coagulants|coagulants|mesh-ancestor
139179711|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179712|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139179713|NCT01190761|Galantamine|galantamine|mesh-list
139179714|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139179715|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179716|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179717|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
139179718|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179719|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179720|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139179721|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
139179722|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179723|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
139179724|NCT01209455|Acetaminophen|acetaminophen|mesh-list
139179725|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
139179726|NCT01209455|Ranitidine|ranitidine|mesh-list
139179727|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139179728|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139179729|NCT01209455|Analgesics|analgesics|mesh-ancestor
139179730|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
139179731|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179732|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179733|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
139179734|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139179735|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139179736|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139179737|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
139179738|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
139179739|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179740|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179741|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
139179742|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
139179743|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139179744|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139179746|NCT01194115|Cephalexin|cephalexin|mesh-list
139179747|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179748|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139179749|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139179750|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139179751|NCT01209533|Iloprost|iloprost|mesh-list
139179752|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139179753|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
139179754|NCT03847363|Anesthetics|anesthetics|mesh-list
139179755|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179756|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179757|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
139179758|NCT01207739|Doxycycline|doxycycline|mesh-list
139179759|NCT01207739|Clarithromycin|clarithromycin|mesh-list
139179761|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139179762|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139179763|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179764|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179765|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179766|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139179767|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139179768|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139179769|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139179770|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139179771|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
139179772|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139179773|NCT03847207|Pasireotide|pasireotide|mesh-list
139179774|NCT03847207|Hormones|hormones|mesh-ancestor
139179775|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139179776|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179777|NCT01192087|Cetuximab|cetuximab|mesh-list
139179778|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139179779|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179780|NCT03942029|Fluconazole|fluconazole|mesh-list
139179781|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
139179782|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179783|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139179784|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139179785|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179786|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179787|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139179788|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
139179789|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139179790|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179791|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139179792|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139179793|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139179794|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139179795|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
139179796|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179797|NCT01192165|Paclitaxel|paclitaxel|mesh-list
139179798|NCT01192165|Docetaxel|docetaxel|mesh-list
139179799|NCT01192165|Carboplatin|carboplatin|mesh-list
139179800|NCT01192165|Pemetrexed|pemetrexed|mesh-list
139179801|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139179802|NCT01192165|Trametinib|trametinib|mesh-list
139179803|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139179804|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179805|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
139179806|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
139179807|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
139179808|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179809|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179810|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139179811|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139179812|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139179813|NCT01192243|Carboplatin|carboplatin|mesh-list
139179814|NCT01192243|Pemetrexed|pemetrexed|mesh-list
139179815|NCT01192243|Gefitinib|gefitinib|mesh-list
139179816|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179817|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179818|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179819|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139179820|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139179821|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139179822|NCT01209845|Ketamine|ketamine|mesh-list
139179823|NCT01209845|Analgesics|analgesics|mesh-ancestor
139179824|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
139179825|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179826|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179827|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139179828|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139179829|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
139179830|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
139179831|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179832|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139179833|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139179834|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179835|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179836|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
139179837|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
139179838|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139179839|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179840|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179841|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
139179842|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139179843|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179844|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179845|NCT01196767|Ropivacaine|ropivacaine|mesh-list
139179846|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
139179847|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
139179848|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179849|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179850|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
139179851|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179852|NCT03451773|Gemcitabine|gemcitabine|mesh-list
139179853|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139179854|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
139179855|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179856|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179857|NCT01112891|Vitamin D|vitamin d|mesh-list
139179858|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
139179859|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
139179860|NCT01112891|Vitamins|vitamins|mesh-list
138930332|NCT03015792|Hormones|hormones|mesh-ancestor
139179862|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179863|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139179864|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139179865|NCT03847441|Vitamin D|vitamin d|mesh-list
139179866|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
139179867|NCT03847441|Calcipotriene|calcipotriene|mesh-list
139179868|NCT03847441|Vitamins|vitamins|mesh-ancestor
139179869|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
139179870|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179871|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139179872|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139179873|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
139179874|NCT02529683|NuvaRing|nuvaring|mesh-list
139179875|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139179876|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
139179877|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139179878|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179879|NCT05406895|Lidocaine|lidocaine|mesh-list
139179880|NCT05406895|Epinephrine|epinephrine|mesh-list
139179881|NCT05406895|Anesthetics, Local|anesthetics, local|mesh-ancestor
139179882|NCT05406895|Anesthetics|anesthetics|mesh-ancestor
139179883|NCT05406895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179884|NCT05406895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179885|NCT05406895|Sensory System Agents|sensory system agents|mesh-ancestor
139179886|NCT05406895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179887|NCT05406895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139179888|NCT05406895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139179889|NCT05406895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139179890|NCT05406895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139179891|NCT05406895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179892|NCT05406895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139179893|NCT05406895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139179894|NCT05406895|Adrenergic Agents|adrenergic agents|mesh-ancestor
139179895|NCT05406895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179896|NCT05406895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139179897|NCT05406895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139179898|NCT05406895|Autonomic Agents|autonomic agents|mesh-ancestor
139179899|NCT05406895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139179900|NCT05406895|Respiratory System Agents|respiratory system agents|mesh-ancestor
139179901|NCT05406895|Mydriatics|mydriatics|mesh-ancestor
139179902|NCT05406895|Sympathomimetics|sympathomimetics|mesh-ancestor
139179903|NCT05406895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139179904|NCT03425253|Lidocaine|lidocaine|mesh-list
139179905|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
139179906|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
139179907|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139179908|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179909|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
139179910|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179911|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139179912|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139179913|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139179914|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139179915|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179916|NCT03941561|Tegafur|tegafur|mesh-list
139179917|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139179918|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
139179919|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179920|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179921|NCT05403229|Topiramate|topiramate|mesh-list
139179922|NCT05403229|Anticonvulsants|anticonvulsants|mesh-ancestor
139179923|NCT05403229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139179924|NCT05403229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179925|NCT03424239|Vitamin D|vitamin d|mesh-list
139179926|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
139179927|NCT03424239|Cholecalciferol|cholecalciferol|mesh-list
139179928|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
139179929|NCT03424239|Vitamins|vitamins|mesh-list
139179930|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
139179931|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179932|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139179933|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139179934|NCT03941795|Axitinib|axitinib|mesh-list
138902298|NCT02578680|Hormones|hormones|mesh-ancestor
139179935|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139179937|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179938|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179939|NCT01197001|Losartan|losartan|mesh-list
139179940|NCT01197001|Amlodipine|amlodipine|mesh-list
139179941|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139179942|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139179943|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139179944|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179945|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139179946|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179947|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
139179948|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139179949|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139179950|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139179951|NCT01113047|Amlodipine|amlodipine|mesh-list
139179952|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139179953|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139179954|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139179955|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179956|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139179957|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179958|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
139179959|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
139179960|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139179961|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139179962|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139179963|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179964|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179965|NCT01210391|Caseins|caseins|mesh-list
139179966|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
139179967|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
139179968|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179969|NCT03846739|Oxytocin|oxytocin|mesh-list
139179970|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
139179971|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139179972|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179973|NCT03716115|Budesonide|budesonide|mesh-list
139179974|NCT03716115|Teduglutide|teduglutide|mesh-list
139179975|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139179976|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139179977|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
139179978|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139179979|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179980|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139179981|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
139179982|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
139179983|NCT03716115|Hormones|hormones|mesh-ancestor
139179984|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139179985|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139179986|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139179987|NCT03716115|Protective Agents|protective agents|mesh-ancestor
139179988|NCT01113281|Vaccines|vaccines|mesh-list
139179989|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
139179990|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179991|NCT01295593|Cladribine|cladribine|mesh-list
139179992|NCT01295593|Valproic Acid|valproic acid|mesh-list
139179993|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
139179994|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139179995|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139179996|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
139179997|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179998|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179999|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
139180000|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139180001|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180002|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139180003|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180004|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139180005|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
139180006|NCT03845881|Oxycodone|oxycodone|mesh-list
139180007|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139180008|NCT03845881|Narcotics|narcotics|mesh-ancestor
139180009|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180010|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180011|NCT03845881|Analgesics|analgesics|mesh-ancestor
139180012|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
139180013|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180014|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
139180015|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139180016|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180017|NCT01296997|Calcium|calcium|mesh-list
139180018|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139180019|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180020|NCT01114841|Tazarotene|tazarotene|mesh-list
139180021|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
139180022|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
139180023|NCT01113437|Omalizumab|omalizumab|mesh-list
139180024|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139180025|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139180026|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
139180027|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
139180028|NCT01197235|Hematinics|hematinics|mesh-ancestor
139180029|NCT01192789|Amoxicillin|amoxicillin|mesh-list
139180030|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139180031|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180032|NCT01211171|Telmisartan|telmisartan|mesh-list
139180033|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139180034|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139180035|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139180036|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180037|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
139180038|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139180039|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139180040|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180041|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
139180042|NCT03846973|Coagulants|coagulants|mesh-ancestor
139180043|NCT01113515|Esmolol|esmolol|mesh-list
138550084|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139180044|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139180045|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139180046|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139180047|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
139180048|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180049|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180050|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180051|NCT01211327|Cyclosporine|cyclosporine|mesh-list
139180052|NCT01211327|Dexamethasone|dexamethasone|mesh-list
139180053|NCT01211327|Cyclosporins|cyclosporins|mesh-list
139180054|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139180055|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
139180056|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
139180057|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180058|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180059|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139180060|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
139180061|NCT01211327|Hormones|hormones|mesh-ancestor
139180062|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139180063|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139180064|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180065|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180066|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180067|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139180068|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
139180069|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
139180070|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180071|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
139180072|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139180073|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139180074|NCT05601895|Sorafenib|sorafenib|mesh-list
139180075|NCT05601895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180076|NCT05601895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139180077|NCT05601895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180078|NCT05601895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180079|NCT01113671|Vitamin E|vitamin e|mesh-list
139180080|NCT01113671|Tocopherols|tocopherols|mesh-list
139180081|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
139180082|NCT01113671|Vitamins|vitamins|mesh-ancestor
139180083|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
139180084|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180085|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
138930552|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
139180086|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180088|NCT03943043|Paclitaxel|paclitaxel|mesh-list
139180089|NCT03943043|Gemcitabine|gemcitabine|mesh-list
139180090|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
139180091|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139180092|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180093|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
139180094|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
139180095|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
139180096|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180097|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139180098|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
139180100|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139180101|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180102|NCT01211795|Ketoprofen|ketoprofen|mesh-list
139180103|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139180104|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139180105|NCT01211795|Analgesics|analgesics|mesh-ancestor
139180106|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
138740853|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139180107|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180108|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180110|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139180111|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139180112|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180113|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180114|NCT01193491|Geldanamycin|geldanamycin|mesh-list
139180115|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139180116|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180117|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
139180118|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180119|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180120|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180121|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139180122|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
139180123|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139180124|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139180125|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139180126|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180127|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180128|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139180129|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139180130|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139180131|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
139180132|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180133|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180134|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139180135|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139180136|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
139180137|NCT01208285|Ivacaftor|ivacaftor|mesh-list
139180138|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139180139|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139180140|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180141|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
139180142|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139180143|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
139180144|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
139180145|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180146|NCT01208441|Letrozole|letrozole|mesh-list
139180147|NCT01208441|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139180148|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741114|NCT06054035|Dapagliflozin|dapagliflozin|mesh-list
139180150|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139180151|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180152|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180153|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139180154|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
139180159|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180160|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180162|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
139180163|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139180164|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139180165|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180166|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180167|NCT01197469|Urological Agents|urological agents|mesh-ancestor
139180168|NCT01211561|Selenium|selenium|mesh-list
139180169|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
139180170|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180171|NCT01211561|Protective Agents|protective agents|mesh-ancestor
139180172|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180173|NCT01211561|Trace Elements|trace elements|mesh-ancestor
139180174|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
139180175|NCT01213355|Scopolamine|scopolamine|mesh-list
139180176|NCT01213355|Donepezil|donepezil|mesh-list
139180177|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139180178|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139180179|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180180|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180181|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
139180182|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180183|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180184|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
139180185|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139180186|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
139180187|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
139180188|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180189|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139180190|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
139180191|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139180192|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139180193|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
139180194|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
139180195|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139180196|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139180197|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180198|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
139180199|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180200|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180201|NCT01110473|Azacitidine|azacitidine|mesh-list
139180202|NCT01110473|Ilorasertib|ilorasertib|mesh-list
139180203|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139180204|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
139180205|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180206|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180207|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180208|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138966598|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180227|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139180228|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139180229|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139180230|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
139180231|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
139180233|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
139180234|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180235|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180236|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
139180237|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
139180238|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139180239|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
139180240|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
138741645|NCT05178173|Ethanol|ethanol|mesh-list
139180241|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139180242|NCT03715881|Prednisolone|prednisolone|mesh-list
139180243|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
139180244|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139180245|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
139180247|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139180248|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180249|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139180250|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180251|NCT03715881|Hematinics|hematinics|mesh-ancestor
139180253|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139180254|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139180255|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138741847|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
139180256|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180257|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139180258|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180259|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
139180260|NCT01110551|Vaccines|vaccines|mesh-list
139180261|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
139180262|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741981|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
139180264|NCT01296139|Hematinics|hematinics|mesh-ancestor
139180265|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139180266|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139180267|NCT03940469|Dexamethasone|dexamethasone|mesh-list
139180268|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
139180269|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
139180270|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139180271|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
139180272|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
139180273|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180274|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180275|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139180276|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
139180278|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966609|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
139180279|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139180280|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180281|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139180282|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180283|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139180284|NCT03940469|Analgesics|analgesics|mesh-ancestor
139180285|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
139180286|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139180287|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139180289|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
139180290|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180291|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180292|NCT01110785|Panitumumab|panitumumab|mesh-list
139180293|NCT01110785|Simvastatin|simvastatin|mesh-list
139180294|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139180295|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139180296|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
138887245|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138887246|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138887247|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
138887248|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887249|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
138887250|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138887251|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138887252|NCT00656552|Escitalopram|escitalopram|mesh-list
138930776|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180297|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180298|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138742542|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
139180299|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139180300|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180301|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139180302|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180303|NCT03846271|Oxytocin|oxytocin|mesh-list
139180304|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
139180305|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139180306|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180307|NCT01110941|Leucovorin|leucovorin|mesh-list
139180308|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
139180309|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180310|NCT01110941|Antidotes|antidotes|mesh-ancestor
139180311|NCT01110941|Protective Agents|protective agents|mesh-ancestor
139180312|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180313|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
139180314|NCT01110941|Vitamins|vitamins|mesh-ancestor
139180315|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
139180316|NCT03448419|Empagliflozin|empagliflozin|mesh-list
139180317|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139180318|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180319|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139180320|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180321|NCT01118039|Sunitinib|sunitinib|mesh-list
139180322|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180323|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139180324|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139180325|NCT01118039|Growth Substances|growth substances|mesh-ancestor
139180326|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180327|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
139180328|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139180329|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742955|NCT01231659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139180330|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180332|NCT01213433|Amodiaquine|amodiaquine|mesh-list
139180333|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
139180334|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138743025|NCT01231581|Gemcitabine|gemcitabine|mesh-list
139180335|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139180336|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180337|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180338|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
139180339|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
139180340|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139180341|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
139180342|NCT06107894|Aldesleukin|aldesleukin|mesh-list
139180343|NCT06107894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180344|NCT06107894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139180345|NCT06107894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139180346|NCT06107894|Antiviral Agents|antiviral agents|mesh-ancestor
139180347|NCT06107894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180348|NCT06107868|Paclitaxel|paclitaxel|mesh-list
139180349|NCT06107868|Carboplatin|carboplatin|mesh-list
139180350|NCT06107868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139180351|NCT06107868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180352|NCT06107868|Tubulin Modulators|tubulin modulators|mesh-ancestor
139180353|NCT06107868|Antimitotic Agents|antimitotic agents|mesh-ancestor
139180354|NCT06107868|Mitosis Modulators|mitosis modulators|mesh-ancestor
139180355|NCT06107868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180356|NCT06107803|Olanzapine|olanzapine|mesh-list
139180357|NCT06107803|Antiemetics|antiemetics|mesh-ancestor
139180358|NCT06107803|Autonomic Agents|autonomic agents|mesh-ancestor
139180359|NCT06107803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180360|NCT06107803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180361|NCT06107803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139180362|NCT06107803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139180364|NCT06107803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180365|NCT06107803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139180366|NCT06107803|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139180367|NCT06107803|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139180368|NCT06107803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139180369|NCT06107803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180370|NCT06107803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180371|NCT06107803|Serotonin Agents|serotonin agents|mesh-ancestor
139180372|NCT06107790|Trastuzumab|trastuzumab|mesh-list
139180373|NCT06107790|Vinorelbine|vinorelbine|mesh-list
139180374|NCT06107790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138743358|NCT00993967|Idebenone|idebenone|mesh-list
139180375|NCT06107790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180376|NCT06107790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139180377|NCT06107790|Tubulin Modulators|tubulin modulators|mesh-ancestor
139180378|NCT06107790|Antimitotic Agents|antimitotic agents|mesh-ancestor
139180379|NCT06107790|Mitosis Modulators|mitosis modulators|mesh-ancestor
139180380|NCT06107790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180381|NCT06107673|Cyclophosphamide|cyclophosphamide|mesh-list
139180382|NCT06107673|Docetaxel|docetaxel|mesh-list
139180383|NCT06107673|Epirubicin|epirubicin|mesh-list
139180384|NCT06107673|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139180385|NCT06107673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139180386|NCT06107673|Immunologic Factors|immunologic factors|mesh-ancestor
139180387|NCT06107673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180388|NCT06107673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139180389|NCT06107673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139180390|NCT06107673|Alkylating Agents|alkylating agents|mesh-ancestor
139180391|NCT06107673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180392|NCT06107673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180393|NCT06107673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138743645|NCT00989833|Hormones|hormones|mesh-ancestor
139180394|NCT06107673|Tubulin Modulators|tubulin modulators|mesh-ancestor
139180395|NCT06107673|Antimitotic Agents|antimitotic agents|mesh-ancestor
139180396|NCT06107673|Mitosis Modulators|mitosis modulators|mesh-ancestor
139180397|NCT06107673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139180398|NCT06107673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139180399|NCT06107673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138743849|NCT04290793|Taxane|taxane|mesh-list
139180400|NCT06107673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180401|NCT06107673|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139180402|NCT06107673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139180403|NCT06107673|Hormone Antagonists|hormone antagonists|mesh-ancestor
139180404|NCT06107673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139180405|NCT06107660|Bupivacaine|bupivacaine|mesh-list
139180406|NCT06107660|Anesthetics, Local|anesthetics, local|mesh-ancestor
139180407|NCT06107660|Anesthetics|anesthetics|mesh-ancestor
139180408|NCT06107660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180409|NCT06107660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180410|NCT06107660|Sensory System Agents|sensory system agents|mesh-ancestor
139180411|NCT06107660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180412|NCT06107465|Nitroglycerin|nitroglycerin|mesh-list
139180413|NCT06107465|Vasodilator Agents|vasodilator agents|mesh-ancestor
139180414|NCT06107205|Edaravone|edaravone|mesh-list
139180415|NCT06107205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139180416|NCT06107205|Antioxidants|antioxidants|mesh-ancestor
138743921|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180417|NCT06107205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180418|NCT06107205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139180419|NCT06107205|Protective Agents|protective agents|mesh-ancestor
139180420|NCT06107205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180421|NCT06107062|Cannabidiol|cannabidiol|mesh-list
139180422|NCT06107062|Anticonvulsants|anticonvulsants|mesh-ancestor
138744083|NCT01211769|Naltrexone|naltrexone|mesh-list
139180423|NCT06106971|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
139180424|NCT06106971|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139180425|NCT06106971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139180427|NCT06106932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139180428|NCT06106932|Fertility Agents|fertility agents|mesh-ancestor
139180429|NCT06106932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139180430|NCT06106932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180431|NCT06106932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139180432|NCT06106932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180433|NCT06106802|Tepotinib|tepotinib|mesh-list
139180434|NCT06106802|Lazertinib|lazertinib|mesh-list
139180435|NCT06106802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138744205|NCT04287205|Progestins|progestins|mesh-ancestor
139180437|NCT06106802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180438|NCT06106802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180440|NCT06106789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180441|NCT06106789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139180442|NCT06106529|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139180443|NCT06106529|Oxybutynin|oxybutynin|mesh-list
139180444|NCT06106529|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139180445|NCT06106529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139180446|NCT06106529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139180447|NCT06106529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180448|NCT06106529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180449|NCT06106529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180450|NCT06106529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138744407|NCT01198275|Amiodarone|amiodarone|mesh-list
139180451|NCT06106529|Antidepressive Agents|antidepressive agents|mesh-ancestor
139180452|NCT06106529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139180453|NCT06106529|Parasympatholytics|parasympatholytics|mesh-ancestor
139180454|NCT06106529|Autonomic Agents|autonomic agents|mesh-ancestor
139180455|NCT06106529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744546|NCT05366049|Acetaminophen|acetaminophen|mesh-list
139180456|NCT06106529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139180457|NCT06106529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139180458|NCT06106529|Cholinergic Agents|cholinergic agents|mesh-ancestor
138744626|NCT01192191|Xhance|xhance|mesh-list
139180460|NCT06106308|Bevacizumab|bevacizumab|mesh-list
139180461|NCT06106308|Onvansertib|onvansertib|mesh-list
139180462|NCT06106308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139180463|NCT06106308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744690|NCT02890823|Vitamins|vitamins|mesh-ancestor
139180464|NCT06106308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139180465|NCT06106308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139180466|NCT06106308|Growth Substances|growth substances|mesh-ancestor
139180467|NCT06106308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180468|NCT06106308|Growth Inhibitors|growth inhibitors|mesh-ancestor
139180469|NCT06106308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139180470|NCT06106308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744761|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180471|NCT06106308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180472|NCT06106152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139180473|NCT06106152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966683|NCT00852228|Cetuximab|cetuximab|mesh-list
139180474|NCT06106152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139180475|NCT06106152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180476|NCT06105840|Turmeric extract|turmeric extract|mesh-list
139180477|NCT06105840|Antioxidants|antioxidants|mesh-ancestor
139180478|NCT06105840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180479|NCT06105840|Protective Agents|protective agents|mesh-ancestor
138902499|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180480|NCT06105840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180481|NCT06105827|Diclofenac|diclofenac|mesh-list
139180482|NCT06105827|Tamsulosin|tamsulosin|mesh-list
139180483|NCT06105827|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139180484|NCT06105827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139180485|NCT06105827|Analgesics|analgesics|mesh-ancestor
139180486|NCT06105827|Sensory System Agents|sensory system agents|mesh-ancestor
139180487|NCT06105827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744901|NCT05927818|Charcoal|charcoal|mesh-list
139180488|NCT06105827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180489|NCT06105827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139180490|NCT06105827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139180491|NCT06105827|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139180492|NCT06105827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180493|NCT06105827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180494|NCT06105827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138745027|NCT05736341|Anesthetics|anesthetics|mesh-ancestor
139180495|NCT06105827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139180496|NCT06105827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139180497|NCT06105827|Adrenergic Agents|adrenergic agents|mesh-ancestor
139180498|NCT06105827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180499|NCT06105827|Urological Agents|urological agents|mesh-ancestor
139180500|NCT06105671|Mannitol|mannitol|mesh-list
139180501|NCT06105671|Formoterol Fumarate|formoterol fumarate|mesh-list
139180502|NCT06105671|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139180503|NCT06105671|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139180504|NCT06105671|Autonomic Agents|autonomic agents|mesh-ancestor
139180505|NCT06105671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180506|NCT06105671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180507|NCT06105671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139180508|NCT06105671|Respiratory System Agents|respiratory system agents|mesh-ancestor
139180509|NCT06105671|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139180510|NCT06105671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139180511|NCT06105671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139180512|NCT06105671|Adrenergic Agents|adrenergic agents|mesh-ancestor
139180513|NCT06105671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180514|NCT06105671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180515|NCT06105671|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139180516|NCT06105671|Diuretics|diuretics|mesh-ancestor
139180517|NCT06105671|Natriuretic Agents|natriuretic agents|mesh-ancestor
139180518|NCT06105658|Azacitidine|azacitidine|mesh-list
139180519|NCT06105658|Venetoclax|venetoclax|mesh-list
139180520|NCT06105658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138931022|NCT00841126|Iron|iron|mesh-list
139180521|NCT06105658|Antimetabolites|antimetabolites|mesh-ancestor
139180522|NCT06105658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180523|NCT06105658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180524|NCT06105658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180525|NCT06105138|Cannabidiol|cannabidiol|mesh-list
139180526|NCT06105138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139180527|NCT06105138|Anticonvulsants|anticonvulsants|mesh-ancestor
139180528|NCT06104345|Vaccines|vaccines|mesh-list
139180529|NCT06104345|Immunologic Factors|immunologic factors|mesh-ancestor
139180530|NCT06104345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180531|NCT06103227|Prednisone|prednisone|mesh-list
139180532|NCT06103227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139180533|NCT06103227|Glucocorticoids|glucocorticoids|mesh-ancestor
139180534|NCT06103227|Hormones|hormones|mesh-ancestor
139180535|NCT06103227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139180536|NCT06103227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180537|NCT06103227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139180538|NCT06103227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180539|NCT06102811|Anesthetics|anesthetics|mesh-list
139180540|NCT06102811|Anesthetics, Local|anesthetics, local|mesh-list
139180541|NCT06102811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180542|NCT06102811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180543|NCT06102811|Sensory System Agents|sensory system agents|mesh-ancestor
139180544|NCT06102811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180545|NCT06102603|Calpastatin|calpastatin|mesh-list
139180546|NCT06102603|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139180547|NCT06102603|Protease Inhibitors|protease inhibitors|mesh-ancestor
139180548|NCT06102603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745212|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180549|NCT06102603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180551|NCT06102395|Docetaxel|docetaxel|mesh-list
139180552|NCT06102395|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139180553|NCT06102395|Carboplatin|carboplatin|mesh-list
139180554|NCT06102395|Pembrolizumab|pembrolizumab|mesh-list
139180555|NCT06102395|Fluorouracil|fluorouracil|mesh-list
139180556|NCT06102395|Nedaplatin|nedaplatin|mesh-list
139180557|NCT06102395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139180558|NCT06102395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180559|NCT06102395|Tubulin Modulators|tubulin modulators|mesh-ancestor
139180560|NCT06102395|Antimitotic Agents|antimitotic agents|mesh-ancestor
139180561|NCT06102395|Mitosis Modulators|mitosis modulators|mesh-ancestor
139180562|NCT06102395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745408|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
139180563|NCT06102395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139180564|NCT06102395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139180565|NCT06102395|Antimetabolites|antimetabolites|mesh-ancestor
139180566|NCT06102395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139180567|NCT06102395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139180568|NCT06102395|Immunologic Factors|immunologic factors|mesh-ancestor
139180569|NCT06102395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180571|NCT06102382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139180572|NCT06102382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139180573|NCT06102382|Adrenergic Agents|adrenergic agents|mesh-ancestor
139180574|NCT06102382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180575|NCT06102382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180576|NCT06102382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180577|NCT06102382|Sympathomimetics|sympathomimetics|mesh-ancestor
139180578|NCT06102382|Autonomic Agents|autonomic agents|mesh-ancestor
139180579|NCT06102382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180580|NCT06102382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139180581|NCT06100367|Metomidate|metomidate|mesh-list
139180582|NCT06100367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139180583|NCT06100367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180584|NCT06100367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180585|NCT06086197|Rituximab|rituximab|mesh-list
139180587|NCT06086197|Oxaliplatin|oxaliplatin|mesh-list
139180588|NCT06086197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139180589|NCT06086197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180590|NCT06086197|Immunologic Factors|immunologic factors|mesh-ancestor
139180591|NCT06086197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180592|NCT06086197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138745904|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139180593|NCT06086197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139180594|NCT06086197|Antimetabolites|antimetabolites|mesh-ancestor
139180595|NCT06086197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180596|NCT06081244|Pembrolizumab|pembrolizumab|mesh-list
139180597|NCT06081244|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139180598|NCT06081244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139180599|NCT06081244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745977|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
139180600|NCT06081244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139180601|NCT06081244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180602|NCT06081244|Immunoconjugates|immunoconjugates|mesh-ancestor
139180603|NCT06081244|Immunologic Factors|immunologic factors|mesh-ancestor
139180604|NCT06081244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180605|NCT06080165|Sirolimus|sirolimus|mesh-list
139180606|NCT06080165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139180607|NCT06080165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180608|NCT06080165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139180609|NCT06080165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180610|NCT06080165|Antifungal Agents|antifungal agents|mesh-ancestor
139180611|NCT06080165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139180612|NCT06080165|Immunologic Factors|immunologic factors|mesh-ancestor
138746183|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139180613|NCT06080165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180615|NCT06071260|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139180616|NCT06071260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139180617|NCT06071260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139180618|NCT06071260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139180619|NCT06071260|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139180620|NCT06071260|Autonomic Agents|autonomic agents|mesh-ancestor
139180621|NCT06071260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180622|NCT06071260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180623|NCT06071260|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139180624|NCT06071260|Respiratory System Agents|respiratory system agents|mesh-ancestor
139180625|NCT06071260|Mydriatics|mydriatics|mesh-ancestor
139180626|NCT06071260|Parasympatholytics|parasympatholytics|mesh-ancestor
139180627|NCT06071260|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139180628|NCT06071260|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139180629|NCT06071260|Cholinergic Agents|cholinergic agents|mesh-ancestor
139180630|NCT06071260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180631|NCT06071260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180633|NCT06062979|Cabotegravir|cabotegravir|mesh-list
138746543|NCT01294553|Metformin|metformin|mesh-list
139180634|NCT06062979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139180635|NCT06062979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139180636|NCT06062979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180637|NCT06062979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180638|NCT06062979|Antiviral Agents|antiviral agents|mesh-ancestor
139180639|NCT06062979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180640|NCT06062979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139180641|NCT06062979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139180642|NCT06062979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139180644|NCT06027983|Trastuzumab|trastuzumab|mesh-list
139180645|NCT06027983|Fludarabine|fludarabine|mesh-list
139180646|NCT06027983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139180647|NCT06027983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180648|NCT05999344|Ethanol|ethanol|mesh-list
139180649|NCT05999344|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139180650|NCT05999344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180651|NCT05999344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746813|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139180652|NCT05999344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180653|NCT05951283|Insulin|insulin|mesh-list
139180654|NCT05951283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139180655|NCT05951283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180656|NCT05945485|Vaccines|vaccines|mesh-list
139180657|NCT05945485|Immunologic Factors|immunologic factors|mesh-ancestor
138966736|NCT00848796|Heparin|heparin|mesh-list
139180661|NCT05935553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180663|NCT05935553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180664|NCT05935553|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139180665|NCT05935553|GABA Agonists|gaba agonists|mesh-ancestor
139180666|NCT05935553|GABA Agents|gaba agents|mesh-ancestor
139180667|NCT05935553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180668|NCT05935553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180669|NCT05932303|Itraconazole|itraconazole|mesh-list
139180670|NCT05932303|Carbamazepine|carbamazepine|mesh-list
139180671|NCT05932303|Gemfibrozil|gemfibrozil|mesh-list
139180672|NCT05932303|Antifungal Agents|antifungal agents|mesh-ancestor
139180673|NCT05932303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180674|NCT05932303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139180675|NCT05932303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139180677|NCT05932303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180678|NCT05932303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139180679|NCT05932303|Hormone Antagonists|hormone antagonists|mesh-ancestor
139180680|NCT05932303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139180681|NCT05932303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902533|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139180682|NCT05932303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139180683|NCT05932303|Anticonvulsants|anticonvulsants|mesh-ancestor
139180684|NCT05932303|Antimanic Agents|antimanic agents|mesh-ancestor
139180685|NCT05932303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139180686|NCT05932303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180687|NCT05932303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139180688|NCT05932303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139180689|NCT05932303|Analgesics|analgesics|mesh-ancestor
139180690|NCT05932303|Sensory System Agents|sensory system agents|mesh-ancestor
139180691|NCT05932303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180692|NCT05932303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139180693|NCT05932303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139180694|NCT05932303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139180695|NCT05932303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139180696|NCT05932303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139180697|NCT05932303|Antimetabolites|antimetabolites|mesh-ancestor
139180698|NCT05932303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139180699|NCT05932303|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139180701|NCT05922605|Ropivacaine|ropivacaine|mesh-list
139180702|NCT05922605|Esketamine|esketamine|mesh-list
139180703|NCT05922605|Analgesics|analgesics|mesh-ancestor
139180704|NCT05922605|Sensory System Agents|sensory system agents|mesh-ancestor
139180705|NCT05922605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180706|NCT05922605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180707|NCT05922605|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139180709|NCT05922605|Anesthetics, General|anesthetics, general|mesh-ancestor
139180710|NCT05922605|Anesthetics|anesthetics|mesh-ancestor
139180711|NCT05922605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180712|NCT05922605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138747498|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180713|NCT05922605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139180714|NCT05922605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180715|NCT05922605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180716|NCT05922605|Anesthetics, Local|anesthetics, local|mesh-ancestor
139180717|NCT05922605|Antidepressive Agents|antidepressive agents|mesh-ancestor
139180718|NCT05922605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139180725|NCT05872854|Antidepressive Agents|antidepressive agents|mesh-ancestor
139180726|NCT05872854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139180727|NCT05872854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180728|NCT05872854|Antiviral Agents|antiviral agents|mesh-ancestor
139180729|NCT05872854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180730|NCT05872854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747709|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
139180731|NCT05872854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180732|NCT05872854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139180733|NCT05872854|Immunologic Factors|immunologic factors|mesh-ancestor
139180734|NCT05872854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180736|NCT05797740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180737|NCT05797740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139180738|NCT05797740|Immunologic Factors|immunologic factors|mesh-ancestor
139180739|NCT05797740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180740|NCT05732727|Antihypertensive Agents|antihypertensive agents|mesh-list
139180741|NCT05729932|Analgesics, Opioid|analgesics, opioid|mesh-list
139180742|NCT05729932|Narcotics|narcotics|mesh-ancestor
138747920|NCT00943735|Fesoterodine|fesoterodine|mesh-list
139180743|NCT05729932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180744|NCT05729932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180746|NCT05729932|Sensory System Agents|sensory system agents|mesh-ancestor
139180747|NCT05729932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180749|NCT05696782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139180750|NCT05696782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180751|NCT05691699|Itraconazole|itraconazole|mesh-list
139180752|NCT05691699|Antifungal Agents|antifungal agents|mesh-ancestor
139180753|NCT05691699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747987|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
139180754|NCT05691699|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139180755|NCT05691699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139180756|NCT05691699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180757|NCT05691699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180758|NCT05691699|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139180759|NCT05691699|Hormone Antagonists|hormone antagonists|mesh-ancestor
139180760|NCT05691699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139180761|NCT05691699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180762|NCT05691699|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139180763|NCT05653193|Interferons|interferons|mesh-list
139180764|NCT05653193|Interferon-gamma|interferon-gamma|mesh-list
139180765|NCT05653193|Clotrimazole|clotrimazole|mesh-list
139180766|NCT05653193|Miconazole|miconazole|mesh-list
139180767|NCT05653193|Antifungal Agents|antifungal agents|mesh-list
139180768|NCT05653193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180769|NCT05653193|Antiviral Agents|antiviral agents|mesh-ancestor
139180770|NCT05653193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138748192|NCT01282424|Idelalisib|idelalisib|mesh-list
139180771|NCT05653193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139180772|NCT05653193|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139180773|NCT05653193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138748254|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180775|NCT05653193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180776|NCT05653193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138748328|NCT02691156|Bilirubin|bilirubin|mesh-list
139180777|NCT05653193|Hormone Antagonists|hormone antagonists|mesh-ancestor
139180778|NCT05653193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138748398|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180779|NCT05653193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180780|NCT05653193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139180781|NCT05653193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139180783|NCT05618236|Neostigmine|neostigmine|mesh-list
139180784|NCT05618236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138748468|NCT00934843|Prednisolone|prednisolone|mesh-list
139180785|NCT05618236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139180786|NCT05618236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139180787|NCT05618236|Autonomic Agents|autonomic agents|mesh-ancestor
139180788|NCT05618236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180789|NCT05618236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180790|NCT05618236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139180791|NCT05618236|Respiratory System Agents|respiratory system agents|mesh-ancestor
139180792|NCT05618236|Mydriatics|mydriatics|mesh-ancestor
139180793|NCT05618236|Parasympatholytics|parasympatholytics|mesh-ancestor
139180794|NCT05618236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139180795|NCT05618236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139180796|NCT05618236|Cholinergic Agents|cholinergic agents|mesh-ancestor
139180797|NCT05618236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180798|NCT05618236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180799|NCT05618236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139180800|NCT05618236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180801|NCT05618236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139180802|NCT05618210|Anesthetics|anesthetics|mesh-list
139180803|NCT05618210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180804|NCT05618210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180805|NCT05598255|Dexamethasone|dexamethasone|mesh-list
139180806|NCT05598255|Levobupivacaine|levobupivacaine|mesh-list
139180807|NCT05598255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139180808|NCT05598255|Antiemetics|antiemetics|mesh-ancestor
139180809|NCT05598255|Autonomic Agents|autonomic agents|mesh-ancestor
139180810|NCT05598255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180811|NCT05598255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180812|NCT05598255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139180813|NCT05598255|Glucocorticoids|glucocorticoids|mesh-ancestor
139180814|NCT05598255|Hormones|hormones|mesh-ancestor
139180815|NCT05598255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139180816|NCT05598255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139180817|NCT05598255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180818|NCT05598255|Anesthetics, Local|anesthetics, local|mesh-ancestor
139180819|NCT05598255|Anesthetics|anesthetics|mesh-ancestor
139180820|NCT05598255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180822|NCT05587894|Ritonavir|ritonavir|mesh-list
139180823|NCT05587894|Remdesivir|remdesivir|mesh-list
139180824|NCT05587894|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139180825|NCT05587894|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139180826|NCT05587894|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139180827|NCT05587894|Protease Inhibitors|protease inhibitors|mesh-ancestor
139180828|NCT05587894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180829|NCT05587894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180830|NCT05587894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139180831|NCT05587894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139180833|NCT05587894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180834|NCT05587894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139180836|NCT05587894|Antimetabolites|antimetabolites|mesh-ancestor
139180837|NCT05580861|Sulfasalazine|sulfasalazine|mesh-list
139180838|NCT05580861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180839|NCT05580861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139180840|NCT05580861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139180842|NCT05580861|Sensory System Agents|sensory system agents|mesh-ancestor
139180843|NCT05580861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180844|NCT05580861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180845|NCT05580861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139180847|NCT05580861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139180848|NCT05572476|Carboplatin|carboplatin|mesh-list
139180849|NCT05572476|Etoposide|etoposide|mesh-list
139180851|NCT05572476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180852|NCT05572476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139180853|NCT05572476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139180854|NCT05572476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139180855|NCT05572476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180856|NCT05572476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180857|NCT05572476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139180858|NCT05548062|Hydroxyurea|hydroxyurea|mesh-list
139180859|NCT05548062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180860|NCT05548062|Antisickling Agents|antisickling agents|mesh-ancestor
139180861|NCT05548062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180862|NCT05548062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180863|NCT05548062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139180864|NCT05545072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139180865|NCT05545072|Immunologic Factors|immunologic factors|mesh-ancestor
139180866|NCT05545072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180867|NCT05485012|Analgesics, Opioid|analgesics, opioid|mesh-list
139180868|NCT05485012|Narcotics|narcotics|mesh-ancestor
139180869|NCT05485012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180870|NCT05485012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180872|NCT05485012|Sensory System Agents|sensory system agents|mesh-ancestor
139180873|NCT05485012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180874|NCT05378932|Melatonin|melatonin|mesh-list
139180875|NCT05378932|Antioxidants|antioxidants|mesh-ancestor
139180876|NCT05378932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180877|NCT05378932|Protective Agents|protective agents|mesh-ancestor
139180878|NCT05378932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180879|NCT05378932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180880|NCT05322070|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139180881|NCT05322070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139180882|NCT05322070|Glucocorticoids|glucocorticoids|mesh-ancestor
139180883|NCT05322070|Hormones|hormones|mesh-ancestor
139180884|NCT05322070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139180885|NCT05322070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180886|NCT05273554|Pembrolizumab|pembrolizumab|mesh-list
139180887|NCT05273554|Lenvatinib|lenvatinib|mesh-list
139180888|NCT05273554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139180889|NCT05273554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180890|NCT05273554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139180891|NCT05273554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931366|NCT00806247|Analgesics|analgesics|mesh-ancestor
139180892|NCT05273554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139180893|NCT05273554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180894|NCT05198960|Aspirin|aspirin|mesh-list
139180895|NCT05198960|Anticoagulants|anticoagulants|mesh-list
139180896|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138749930|NCT05323981|Pertuzumab|pertuzumab|mesh-list
139180897|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139180898|NCT05198960|Analgesics|analgesics|mesh-ancestor
139180899|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
138749999|NCT05255146|Nitrous Oxide|nitrous oxide|mesh-list
139180900|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180901|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180902|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139180903|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139180904|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139180905|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138750075|NCT04952779|Incretins|incretins|mesh-ancestor
139180906|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180907|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139180908|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139180909|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180910|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
139180911|NCT05151471|Edaravone|edaravone|mesh-list
139180912|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139180913|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
138750211|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180914|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180916|NCT05151471|Protective Agents|protective agents|mesh-ancestor
138750282|NCT03750968|Carotenoids|carotenoids|mesh-list
139180917|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180919|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139180920|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
139180921|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180922|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180923|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180924|NCT05054374|Fulvestrant|fulvestrant|mesh-list
139180925|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139180926|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750353|NCT03262662|Varenicline|varenicline|mesh-list
139180927|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139180928|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139180929|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
139180930|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139180931|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180932|NCT05051436|Tadalafil|tadalafil|mesh-list
139180933|NCT05051436|Mirabegron|mirabegron|mesh-list
139180934|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
138902586|NCT00913224|Diclofenac|diclofenac|mesh-list
139180935|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138750490|NCT01359592|Vincristine|vincristine|mesh-list
139180936|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139180937|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180938|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180939|NCT05051436|Urological Agents|urological agents|mesh-ancestor
139180940|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139180941|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139180942|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139180943|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
139180944|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180945|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180946|NCT05045066|Vitamin D|vitamin d|mesh-list
139180947|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
139180948|NCT05045066|Vitamins|vitamins|mesh-ancestor
139180949|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
138750709|NCT00609817|Hormones|hormones|mesh-ancestor
139180950|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180951|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139180952|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139180954|NCT05037500|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139180955|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139180956|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
139180957|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180958|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180959|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139180960|NCT05035836|Tamoxifen|tamoxifen|mesh-list
139180961|NCT05035836|Letrozole|letrozole|mesh-list
139180962|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180963|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139180964|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139180965|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931447|NCT00439777|Enoxaparin|enoxaparin|mesh-list
139180966|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180967|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139180969|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139180970|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180971|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139180972|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139180973|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139180974|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139180975|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
139180977|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139180978|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
139180979|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180980|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139180981|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139180982|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
138751039|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
139180983|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180984|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180985|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139180986|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
138966823|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
139180987|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139180988|NCT04999020|Ravulizumab|ravulizumab|mesh-list
139180989|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139180990|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139180991|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
138751180|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139180992|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180993|NCT04986839|Acetaminophen|acetaminophen|mesh-list
139180994|NCT04986839|Ibuprofen|ibuprofen|mesh-list
139180995|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139180996|NCT04986839|Analgesics|analgesics|mesh-ancestor
138751324|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
139180997|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
139180998|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180999|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751401|NCT01214616|Afatinib|afatinib|mesh-list
139181000|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
139181001|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139181002|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139181003|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139181004|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139181005|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181006|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181007|NCT04983407|Paclitaxel|paclitaxel|mesh-list
139181008|NCT04983407|Gemcitabine|gemcitabine|mesh-list
139181009|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139181010|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181011|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
139181012|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
139181013|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
139181014|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181015|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139181018|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181019|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139181020|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
139181021|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751693|NCT01283009|Hormones|hormones|mesh-ancestor
139181022|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139181023|NCT04913311|Dimercaprol|dimercaprol|mesh-list
139181024|NCT04913311|Chelating Agents|chelating agents|mesh-ancestor
139181025|NCT04913311|Sequestering Agents|sequestering agents|mesh-ancestor
139181026|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181027|NCT04913311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139181028|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181029|NCT04897841|Bupivacaine|bupivacaine|mesh-list
139181030|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
139181031|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
139181032|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139181033|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181034|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
139181035|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181037|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139181038|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
139181039|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181040|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181041|NCT04875728|Cefazolin|cefazolin|mesh-list
139181042|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139181043|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139181044|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
138751967|NCT00623987|Warfarin|warfarin|mesh-list
139181045|NCT04841148|Palbociclib|palbociclib|mesh-list
139181046|NCT04841148|Avelumab|avelumab|mesh-list
139181047|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
139181048|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139181049|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139181051|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444203|NCT01820026|Amoxicillin|amoxicillin|mesh-list
139181052|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181053|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139181054|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181055|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139181056|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139181057|NCT04816214|Carboplatin|carboplatin|mesh-list
139181058|NCT04816214|Pemetrexed|pemetrexed|mesh-list
139181059|NCT04816214|Osimertinib|osimertinib|mesh-list
139181060|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181061|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181062|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181063|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138752156|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181064|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139181065|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139181066|NCT04767594|Palbociclib|palbociclib|mesh-list
139181067|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181068|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139181069|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181070|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181071|NCT04766684|Lidocaine|lidocaine|mesh-list
139181072|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
139181073|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
139181074|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139181075|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181076|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
139181077|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181078|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139181079|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139181080|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139181081|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139181082|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181083|NCT04729387|Paclitaxel|paclitaxel|mesh-list
139181084|NCT04729387|Doxorubicin|doxorubicin|mesh-list
139181085|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139181086|NCT04729387|Olaparib|olaparib|mesh-list
139181087|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139181088|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181089|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
139181090|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
139181091|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
139181092|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181093|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139181094|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139181095|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139181096|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181097|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139181098|NCT04686279|Tenofovir|tenofovir|mesh-list
139181099|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
139181100|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139181101|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139181102|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139181103|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181104|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181105|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139181106|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139181107|NCT04671615|Palbociclib|palbociclib|mesh-list
139181108|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752411|NCT01121913|Trazodone|trazodone|mesh-list
139181109|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139181110|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181111|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181113|NCT04639986|Capecitabine|capecitabine|mesh-list
139181115|NCT04639986|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139181116|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139181117|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
138752546|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139181118|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181119|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181120|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139181121|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
139181122|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
139181123|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
139181124|NCT04639986|Immunoconjugates|immunoconjugates|mesh-ancestor
139181125|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
138752767|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
139181126|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181127|NCT04594187|Immunomodulating Agents|immunomodulating agents|mesh-list
139181128|NCT04594187|Immunologic Factors|immunologic factors|mesh-ancestor
139181129|NCT04594187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181130|NCT04569084|Edaravone|edaravone|mesh-list
139181131|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139181133|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181134|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139181135|NCT04569084|Protective Agents|protective agents|mesh-ancestor
138752906|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139181136|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181138|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139181139|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
139181140|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181141|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181142|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181143|NCT04327791|Baloxavir|baloxavir|mesh-list
139181144|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
139181145|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139181146|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181147|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181148|NCT04323956|Prednisone|prednisone|mesh-list
139181149|NCT04323956|Cortisone|cortisone|mesh-list
139181150|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
139181152|NCT04323956|Doxorubicin|doxorubicin|mesh-list
139181153|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139181154|NCT04323956|Vincristine|vincristine|mesh-list
139181155|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139181156|NCT04323956|Antibodies|antibodies|mesh-list
139181157|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
139181158|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139181159|NCT04323956|Lenograstim|lenograstim|mesh-list
139181160|NCT04323956|Immunoconjugates|immunoconjugates|mesh-list
139181161|NCT04323956|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138753107|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139181162|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139181163|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
139181164|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181165|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139181166|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139181167|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
138902633|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139181168|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181169|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181170|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139181171|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139181172|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139181173|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139181174|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181175|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139181176|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
139181177|NCT04323956|Hormones|hormones|mesh-ancestor
138753177|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
139181178|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139181179|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139181180|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139181181|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139181182|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
139181183|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
139181184|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
139181186|NCT04303000|Naloxone|naloxone|mesh-list
139181187|NCT04303000|Narcotics|narcotics|mesh-ancestor
139181188|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139181190|NCT04303000|Analgesics|analgesics|mesh-ancestor
139181191|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
139181192|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181193|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139181194|NCT04300140|Nivolumab|nivolumab|mesh-list
139181195|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139181196|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181197|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139181198|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181199|NCT04259749|Menthol|menthol|mesh-list
139181200|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
139181201|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
139181202|NCT04245280|Ropivacaine|ropivacaine|mesh-list
139181203|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139181204|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
139181205|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
139181206|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139181207|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181208|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
139181209|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181211|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139181212|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138753645|NCT02878863|Silymarin|silymarin|mesh-list
139181213|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139181214|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139181215|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181216|NCT04194944|Carboplatin|carboplatin|mesh-list
139181217|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
139181218|NCT04194944|Pemetrexed|pemetrexed|mesh-list
139181219|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181220|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139181221|NCT04194944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139181222|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181223|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181224|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138753720|NCT01106625|Metformin|metformin|mesh-list
139181225|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139181227|NCT04172220|Anesthetics|anesthetics|mesh-list
139181228|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139181229|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181231|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139181232|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139181233|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139181234|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139181235|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139181236|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
139181237|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
139181238|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
138753944|NCT01200342|Oblimersen|oblimersen|mesh-list
139181239|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139181240|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181241|NCT04161248|Dexamethasone|dexamethasone|mesh-list
139181243|NCT04161248|Gemcitabine|gemcitabine|mesh-list
139181244|NCT04161248|Venetoclax|venetoclax|mesh-list
139181245|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139181246|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
139181247|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
139181248|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181249|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181250|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138754072|NCT02877771|Insulin|insulin|mesh-list
139181251|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
139181252|NCT04161248|Hormones|hormones|mesh-ancestor
139181253|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139181254|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138754128|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139181255|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181256|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139181257|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
139181258|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138754205|NCT01087203|Tanezumab|tanezumab|mesh-list
139181259|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139181260|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
139181261|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181262|NCT04154956|Docetaxel|docetaxel|mesh-list
139181263|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181264|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
139181265|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
139181266|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
139181267|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181268|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
138754336|NCT02864602|Dexamethasone|dexamethasone|mesh-list
139181269|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139181270|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181271|NCT04129515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139181272|NCT04129515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181273|NCT04095715|Hemostatics|hemostatics|mesh-list
139181274|NCT04095715|Coagulants|coagulants|mesh-ancestor
139181275|NCT04016090|Folic Acid|folic acid|mesh-list
139181276|NCT04016090|Hematinics|hematinics|mesh-ancestor
139181277|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
139181278|NCT04016090|Vitamins|vitamins|mesh-ancestor
139181279|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
139181280|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181281|NCT03998319|Tenecteplase|tenecteplase|mesh-list
139181282|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138754553|NCT00903409|Simvastatin|simvastatin|mesh-list
139181283|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139181284|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181286|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
139181287|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
139181288|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139181289|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181290|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181291|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139181292|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139181293|NCT03866772|Misoprostol|misoprostol|mesh-list
139181294|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139181295|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
139181296|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139181297|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181298|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139181299|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139181300|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
139181301|NCT03840200|Rucaparib|rucaparib|mesh-list
139181302|NCT03840200|Ipatasertib|ipatasertib|mesh-list
139181303|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139181304|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181305|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181306|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181307|NCT03840200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139181308|NCT03836105|Cemiplimab|cemiplimab|mesh-list
139181309|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138754676|NCT01072149|Fluticasone|fluticasone|mesh-list
139181310|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181312|NCT03595059|Docetaxel|docetaxel|mesh-list
139181313|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139181314|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181316|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
139181317|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
139181318|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181319|NCT03564678|Folic Acid|folic acid|mesh-list
139181320|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
139181322|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
139181323|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181324|NCT03564678|Hematinics|hematinics|mesh-ancestor
139181325|NCT03416153|Paclitaxel|paclitaxel|mesh-list
139181326|NCT03416153|Carboplatin|carboplatin|mesh-list
139181327|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139181328|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181329|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
139181330|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
139181331|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
139181332|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181334|NCT03263650|Carboplatin|carboplatin|mesh-list
139181335|NCT03263650|Olaparib|olaparib|mesh-list
139181336|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181337|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139181338|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
139181339|NCT03263650|Hormones|hormones|mesh-ancestor
139181340|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139181341|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181342|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138967020|NCT00965913|Nicotine|nicotine|mesh-list
139181343|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139181344|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181345|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181346|NCT03172299|Aflibercept|aflibercept|mesh-list
139181347|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139181348|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139181349|NCT03172299|Growth Substances|growth substances|mesh-ancestor
139181350|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181351|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
139181352|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181353|NCT03150914|Sirolimus|sirolimus|mesh-list
139181354|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139181355|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139181356|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139181357|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181358|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
139181359|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139181360|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
139181361|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181363|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
139181364|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139181365|NCT02924857|Paclitaxel|paclitaxel|mesh-list
139181366|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139181367|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181368|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
138755354|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
139181369|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
139181370|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
139181371|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181372|NCT02885311|Naltrexone|naltrexone|mesh-list
139181373|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139181374|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139181375|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181376|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
138755422|NCT05335837|Anesthetics|anesthetics|mesh-list
139181377|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181378|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139181379|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139181380|NCT02744612|Antibodies|antibodies|mesh-list
139181381|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
139181382|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139181383|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
139181384|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
139181385|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181386|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181387|NCT02744612|Immunotoxins|immunotoxins|mesh-ancestor
139181388|NCT02740192|Bupivacaine|bupivacaine|mesh-list
139181389|NCT02740192|Ropivacaine|ropivacaine|mesh-list
139181390|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
138755571|NCT00095017|Etoricoxib|etoricoxib|mesh-list
138967030|NCT00853866|Reboxetine|reboxetine|mesh-list
139181392|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139181393|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181394|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
139181395|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181396|NCT02717507|Carvedilol|carvedilol|mesh-list
139181397|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139181398|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139181399|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
139181400|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139181401|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181402|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181403|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139181404|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
139181405|NCT02717507|Protective Agents|protective agents|mesh-ancestor
139181406|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139181407|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139181408|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139181409|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
138755766|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139181410|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139181411|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139181412|NCT02699437|Antibodies|antibodies|mesh-list
139181413|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
139181414|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
139181415|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181416|NCT02547662|Dexamethasone|dexamethasone|mesh-list
139181417|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
139181418|NCT02547662|Pomalidomide|pomalidomide|mesh-list
139181419|NCT02547662|Ixazomib|ixazomib|mesh-list
139181420|NCT02547662|Ichthammol|ichthammol|mesh-list
139181421|NCT02547662|BB 1101|bb 1101|mesh-list
139181422|NCT02547662|Glycine|glycine|mesh-list
139181423|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139181424|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
139181425|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
139181426|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181427|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181428|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139181429|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
139181430|NCT02547662|Hormones|hormones|mesh-ancestor
139181431|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139181432|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139181433|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181434|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181435|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
139181436|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181437|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
139181438|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139181439|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139181440|NCT02547662|Growth Substances|growth substances|mesh-ancestor
138756172|NCT00961636|Niacin|niacin|mesh-list
139181441|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
139181442|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
139181443|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
139181445|NCT02470585|Paclitaxel|paclitaxel|mesh-list
139181446|NCT02470585|Carboplatin|carboplatin|mesh-list
139181447|NCT02470585|Veliparib|veliparib|mesh-list
139181448|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139181449|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181450|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
139181451|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
139181452|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
139181453|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181454|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139181455|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181456|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
139181457|NCT02425306|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139181458|NCT02425306|Poly ICLC|poly iclc|mesh-list
139181459|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
139181460|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181461|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139181462|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138756322|NCT01225835|Cetrorelix|cetrorelix|mesh-list
139181463|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139181464|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
139181465|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181466|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181467|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139181468|NCT02425306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139181469|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
139181470|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139181471|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139181472|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
139181473|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139181474|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
139181475|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139181476|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181477|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139181478|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138756528|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
139181479|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181480|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139181481|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139181482|NCT02330757|Clomiphene|clomiphene|mesh-list
139181483|NCT02330757|Enclomiphene|enclomiphene|mesh-list
139181484|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
139181485|NCT02330757|Estradiol|estradiol|mesh-list
139181486|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139181487|NCT02330757|Estrogens|estrogens|mesh-ancestor
139181488|NCT02330757|Hormones|hormones|mesh-ancestor
138756663|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181489|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139181490|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181491|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139181493|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139181494|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139181495|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139181496|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
139181497|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139181498|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
139181499|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139181500|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139181501|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139181502|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
139181503|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139181504|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
139181505|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139181506|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181507|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139181508|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139181509|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181510|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139181511|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
139181512|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139181513|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
139181514|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139181515|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181516|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139181517|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139181518|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181519|NCT02293954|Antibodies|antibodies|mesh-list
139181520|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139181521|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
139181522|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181523|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
139181524|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139181525|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139181526|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181527|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
139181528|NCT02199080|Coagulants|coagulants|mesh-ancestor
139181529|NCT02134925|Poly ICLC|poly iclc|mesh-list
139181530|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
139181531|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
138757017|NCT04642651|Analgesics|analgesics|mesh-ancestor
139181538|NCT02019706|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
139181539|NCT02019706|Dopamine Agents|dopamine agents|mesh-ancestor
139181540|NCT02019706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139181541|NCT02019706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181542|NCT02019706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181543|NCT01861314|Bortezomib|bortezomib|mesh-list
139181544|NCT01861314|Sorafenib|sorafenib|mesh-list
139181545|NCT01861314|Decitabine|decitabine|mesh-list
139181546|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181547|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139181548|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181549|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181550|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139181551|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
139181552|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139181553|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139181554|NCT01771107|Doxorubicin|doxorubicin|mesh-list
139181555|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139181556|NCT01771107|Dacarbazine|dacarbazine|mesh-list
139181557|NCT01771107|Vinblastine|vinblastine|mesh-list
139181558|NCT01771107|Antibodies|antibodies|mesh-list
139181559|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
139181560|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139181561|NCT01771107|Imidazole|imidazole|mesh-list
139181562|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
138757132|NCT05654077|Cyclophosphamide|cyclophosphamide|mesh-list
139181563|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
139181564|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181565|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181566|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139181567|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139181568|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139181569|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181570|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181571|NCT01771107|Immunotoxins|immunotoxins|mesh-ancestor
139181572|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139181573|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
139181574|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139181575|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
139181576|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
139181577|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
139181578|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
139181579|NCT00950846|Busulfan|busulfan|mesh-list
139181580|NCT00950846|Fludarabine|fludarabine|mesh-list
139181581|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139181582|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
139181583|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181584|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139181585|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139181586|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
139181587|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181588|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181589|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139181590|NCT00577278|Sirolimus|sirolimus|mesh-list
139181591|NCT00577278|Rituximab|rituximab|mesh-list
139181592|NCT00577278|Fludarabine|fludarabine|mesh-list
139181593|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
139181594|NCT00577278|Melphalan|melphalan|mesh-list
139181595|NCT00577278|Tacrolimus|tacrolimus|mesh-list
139181596|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139181597|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139181598|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181599|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
139181600|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181601|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139181602|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139181603|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
139181604|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181605|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139181606|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139181607|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757307|NCT02813863|Metformin|metformin|mesh-list
139181608|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139181609|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139181610|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139181611|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
139181612|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139181613|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
139181614|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139181615|NCT00007735|Doxycycline|doxycycline|mesh-list
139181616|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139181617|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139181618|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
139181619|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138967118|NCT00855972|Naltrexone|naltrexone|mesh-list
139181620|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139181622|NCT00007670|Carbamazepine|carbamazepine|mesh-list
139181623|NCT00007670|Gabapentin|gabapentin|mesh-list
139181624|NCT00007670|Analgesics|analgesics|mesh-ancestor
139181625|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
139181626|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181627|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181628|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
139181629|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139181630|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139181631|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139181632|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139181633|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139181634|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139181635|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139181636|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181637|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
139181638|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139181639|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139181640|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139181641|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139181642|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139181643|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139181644|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139181645|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139181646|NCT03848533|Metformin|metformin|mesh-list
139181647|NCT03848533|Melatonin|melatonin|mesh-list
139181648|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139181649|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181650|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
139181651|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181652|NCT03848533|Protective Agents|protective agents|mesh-ancestor
139181653|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139181654|NCT01111253|Amoxicillin|amoxicillin|mesh-list
139181655|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
139181656|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
139181657|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139181658|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139181659|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139181660|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139181661|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181662|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181663|NCT01213667|Ranibizumab|ranibizumab|mesh-list
139181664|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139181665|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139181667|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181668|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
139181669|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181670|NCT01196065|Memantine|memantine|mesh-list
139181671|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139181672|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139181673|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
139181674|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139181675|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757753|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
139181676|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181677|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138757817|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181678|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139181679|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139181680|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139181681|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139181682|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181683|NCT03845179|Incretins|incretins|mesh-ancestor
139181685|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139181686|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
139181687|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181688|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181689|NCT01121705|Interferons|interferons|mesh-list
139181690|NCT01121705|Ribavirin|ribavirin|mesh-list
139181691|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
139181692|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
139181693|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139181694|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181695|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
139181696|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139181697|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
139181698|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181699|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
139181700|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181701|NCT01196455|Capecitabine|capecitabine|mesh-list
139181702|NCT01196455|Mitomycins|mitomycins|mesh-list
139181704|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139181705|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
139181706|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181707|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181708|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139181709|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
139181710|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139181711|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181712|NCT03846583|Trastuzumab|trastuzumab|mesh-list
139181713|NCT03846583|Tucatinib|tucatinib|mesh-list
139181714|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139181715|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139181716|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181717|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139181718|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758238|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
139181719|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181720|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139181721|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
139181722|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139181723|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181724|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139181725|NCT01115543|Calcitriol|calcitriol|mesh-list
139181726|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
139181727|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139181728|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139181729|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181730|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139181731|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139181732|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181733|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139181734|NCT01115543|Vitamins|vitamins|mesh-ancestor
139181735|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
139181736|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139181737|NCT01216007|Propofol|propofol|mesh-list
139181738|NCT01216007|Sevoflurane|sevoflurane|mesh-list
139181739|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139181740|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139181741|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181742|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139181743|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
139181745|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139181746|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139181747|NCT01198249|Losartan|losartan|mesh-list
139181748|NCT01198249|Amlodipine|amlodipine|mesh-list
139181749|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139181750|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139181751|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139181752|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139181753|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181754|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139181755|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181756|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
139181757|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139181758|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139181759|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139181760|NCT01198249|Diuretics|diuretics|mesh-ancestor
139181761|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
139181762|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139181763|NCT02529761|Sorafenib|sorafenib|mesh-list
139181764|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181765|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139181766|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181767|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181768|NCT03844243|Mitogens|mitogens|mesh-list
139181769|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
139181770|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181771|NCT05479591|Xultophy|xultophy|mesh-list
139181772|NCT05479591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139181773|NCT05479591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181775|NCT05479591|Hormones|hormones|mesh-ancestor
139181776|NCT05479591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139181777|NCT01119209|Ropivacaine|ropivacaine|mesh-list
139181778|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
139181779|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
139181780|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139181781|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181782|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
139181783|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181784|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
139181785|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139181786|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181787|NCT01116167|Letrozole|letrozole|mesh-list
139181788|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181789|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139181790|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139181792|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181793|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139181794|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
139181795|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139181796|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181797|NCT01119521|Isoniazid|isoniazid|mesh-list
139181798|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
139181799|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139181800|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138554770|NCT00287443|Hormones|hormones|mesh-list
139181801|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139181803|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
138967158|NCT00856362|Moxidectin|moxidectin|mesh-list
139181804|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181805|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139181807|NCT01119599|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139181808|NCT01119599|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139181809|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138758536|NCT02787967|Hormones|hormones|mesh-ancestor
139181810|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
139181811|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181812|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181813|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181814|NCT03419403|Temozolomide|temozolomide|mesh-list
139181815|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139181816|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139181817|NCT03419403|ABT-414|abt-414|mesh-list
139181818|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139181819|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
139181820|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181821|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181822|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139181823|NCT03419403|Immunoconjugates|immunoconjugates|mesh-ancestor
139181824|NCT03419403|Immunologic Factors|immunologic factors|mesh-ancestor
139181825|NCT03419403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181826|NCT05156437|Amoxicillin|amoxicillin|mesh-list
139181827|NCT05156437|Vancomycin|vancomycin|mesh-list
139181828|NCT05156437|Levofloxacin|levofloxacin|mesh-list
139181829|NCT05156437|Rifampin|rifampin|mesh-list
139181830|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
139181831|NCT05156437|Linezolid|linezolid|mesh-list
139181832|NCT05156437|Daptomycin|daptomycin|mesh-list
139181833|NCT05156437|Cephalexin|cephalexin|mesh-list
139181834|NCT05156437|Ampicillin|ampicillin|mesh-list
139181835|NCT05156437|Cefepime|cefepime|mesh-list
139181836|NCT05156437|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139181837|NCT05156437|Oxacillin|oxacillin|mesh-list
139181838|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
139181839|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139181840|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139181841|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139181842|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138758591|NCT02785393|Doxazosin|doxazosin|mesh-list
139181843|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139181844|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181845|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181846|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181847|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139181848|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139181849|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139181850|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
139181851|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
139181852|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139181853|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139181854|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139181855|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139181856|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139181857|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139181858|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139181859|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139181860|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
139181861|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139181862|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
139181863|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181864|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181865|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
139181866|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139181867|NCT03715725|Warfarin|warfarin|mesh-list
139181868|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
139181869|NCT03715725|Dabigatran|dabigatran|mesh-list
139181870|NCT03715725|Apixaban|apixaban|mesh-list
139181871|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
139181872|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139181873|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
139181874|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139181875|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
139181876|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181877|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181879|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139181880|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139181881|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139181882|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
139181883|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181884|NCT01213979|Iron|iron|mesh-list
139181885|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139181886|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
139181887|NCT01213979|Trace Elements|trace elements|mesh-ancestor
139181888|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
139181889|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181890|NCT01213979|Hematinics|hematinics|mesh-ancestor
139181891|NCT05282719|Azacitidine|azacitidine|mesh-list
139181892|NCT05282719|Venetoclax|venetoclax|mesh-list
139181893|NCT05282719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139181894|NCT05282719|Antimetabolites|antimetabolites|mesh-ancestor
139181895|NCT05282719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181896|NCT05282719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181897|NCT05282719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181898|NCT01118429|Oxybutynin|oxybutynin|mesh-list
139181899|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
139181900|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
139181901|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181902|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181903|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139181904|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139181905|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
139181906|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139181907|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181908|NCT01118429|Urological Agents|urological agents|mesh-ancestor
139181909|NCT03447249|Ivacaftor|ivacaftor|mesh-list
139181910|NCT03447249|VX-659|vx-659|mesh-list
139181911|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139181912|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139181913|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181914|NCT04156555|Amoxicillin|amoxicillin|mesh-list
139181915|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
139181916|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
139181917|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139181918|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139181919|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139181920|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139181921|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181922|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181923|NCT01200121|Bevacizumab|bevacizumab|mesh-list
139181924|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139181925|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181926|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139181927|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139181928|NCT01200121|Growth Substances|growth substances|mesh-ancestor
139181929|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181930|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
139181932|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139181933|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181934|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139181935|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139181936|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
139181937|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139181938|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181939|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139181940|NCT01116635|Doxorubicin|doxorubicin|mesh-list
139181941|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139181942|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181943|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139181944|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139181945|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181946|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181947|NCT01566799|Metformin|metformin|mesh-list
139181948|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139181949|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181950|NCT04642807|Calpastatin|calpastatin|mesh-list
139181951|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139181952|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
139181953|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181954|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181955|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
139181956|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181957|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138758788|NCT02782897|Antibodies|antibodies|mesh-list
139181958|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181959|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181960|NCT01198639|Remifentanil|remifentanil|mesh-list
139181961|NCT01198639|Propofol|propofol|mesh-list
139181962|NCT01198639|Anesthetics|anesthetics|mesh-list
139181963|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139181964|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139181965|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181966|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139181967|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
139181968|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139181969|NCT01198639|Narcotics|narcotics|mesh-ancestor
139181970|NCT01198639|Analgesics|analgesics|mesh-ancestor
139181971|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
139181972|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181973|NCT01116713|Dexamethasone|dexamethasone|mesh-list
139181974|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139181975|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
139181976|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
139181977|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181978|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181979|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139181980|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
139181981|NCT01116713|Hormones|hormones|mesh-ancestor
139181982|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139181983|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138759018|NCT01194258|Insulin|insulin|mesh-list
139181984|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181985|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
139181986|NCT01202149|Emollients|emollients|mesh-list
139181987|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139181988|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139181989|NCT01202149|Analgesics|analgesics|mesh-ancestor
139181990|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
139181991|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181992|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181993|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139181994|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139181995|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
139181996|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139181997|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
139181998|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139181999|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182000|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182001|NCT01116791|Cisplatin|cisplatin|mesh-list
139182002|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182003|NCT03940001|Paclitaxel|paclitaxel|mesh-list
139182004|NCT03940001|Carboplatin|carboplatin|mesh-list
139182005|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139182006|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182007|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
139182008|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
139182009|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
139182010|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182011|NCT01120769|Acetaminophen|acetaminophen|mesh-list
139182012|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139182013|NCT01120769|Analgesics|analgesics|mesh-ancestor
139182014|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
139182015|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182016|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182017|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
139182018|NCT03715413|Tamoxifen|tamoxifen|mesh-list
139182019|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139182020|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
138759158|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139182021|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139182022|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182023|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139182025|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139182027|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139182028|NCT01122251|Valsartan|valsartan|mesh-list
139182029|NCT01122251|Lercanidipine|lercanidipine|mesh-list
139182030|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139182031|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139182032|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139182033|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182034|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139182035|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139182036|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139182037|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182038|NCT04600999|Favipiravir|favipiravir|mesh-list
139182039|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
139182040|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182041|NCT01199029|Prednisone|prednisone|mesh-list
139182042|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139182043|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
139182044|NCT01199029|Hormones|hormones|mesh-ancestor
139182045|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139182046|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182047|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139182048|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182049|NCT01200745|Capsaicin|capsaicin|mesh-list
139182050|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
139182051|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
139182052|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
139182053|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182054|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182056|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
139182057|NCT01585415|Fludarabine|fludarabine|mesh-list
139182058|NCT01585415|Vemurafenib|vemurafenib|mesh-list
139182059|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139182060|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
139182061|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182062|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139182063|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139182064|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
139182065|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182066|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182067|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139182068|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139182069|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139182070|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
139182071|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182072|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139182073|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182074|NCT01566643|Metronidazole|metronidazole|mesh-list
139182075|NCT01566643|Rabeprazole|rabeprazole|mesh-list
139182076|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182077|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139182078|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139182079|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139182080|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139182081|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139182082|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139182083|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182084|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182085|NCT03841747|Paclitaxel|paclitaxel|mesh-list
139182086|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
139182087|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139182088|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182089|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
139182090|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
139182091|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
139182092|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182093|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139182094|NCT03841747|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139182095|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
139182096|NCT01121237|Hematinics|hematinics|mesh-ancestor
139182097|NCT03841591|Metformin|metformin|mesh-list
139182098|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139182099|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182100|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139182101|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
139182102|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139182103|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139182104|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139182105|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182106|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182107|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
139182108|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139182109|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
139182110|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182111|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
139182112|NCT01212809|Protective Agents|protective agents|mesh-ancestor
139182113|NCT01214993|Dolutegravir|dolutegravir|mesh-list
139182114|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139182115|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139182116|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182117|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182118|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139182119|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139182120|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
139182121|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182123|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139182124|NCT03843229|Protective Agents|protective agents|mesh-ancestor
139182125|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182126|NCT01212887|Aldesleukin|aldesleukin|mesh-list
139182127|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
139182128|NCT01212887|Fludarabine|fludarabine|mesh-list
139182129|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
139182130|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139182131|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
139182132|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182133|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139182134|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139182135|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
138759331|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182136|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182138|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139182139|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139182140|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
139182142|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139182143|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
139182144|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182145|NCT01215149|Vaccines|vaccines|mesh-list
139182146|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
139182147|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182148|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
139182149|NCT03843307|Immunomodulating Agents|immunomodulating agents|mesh-list
139182150|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182151|NCT04961281|Triamcinolone|triamcinolone|mesh-list
139182152|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
139182153|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139182154|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182155|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182156|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139182157|NCT04961281|Analgesics|analgesics|mesh-ancestor
139182158|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
139182159|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182160|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139182161|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139182162|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139182163|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
139182164|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139182165|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182166|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139182167|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
139182168|NCT04961281|Hormones|hormones|mesh-ancestor
139182169|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139182170|NCT01212965|Selenium|selenium|mesh-list
139182171|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
139182172|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182173|NCT01212965|Protective Agents|protective agents|mesh-ancestor
139182174|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182175|NCT01212965|Trace Elements|trace elements|mesh-ancestor
139182176|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
139182177|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
139182178|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139182179|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182180|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139182181|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182182|NCT01216709|Iron|iron|mesh-list
139182183|NCT01216709|Trace Elements|trace elements|mesh-ancestor
139182184|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
139182185|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967300|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138967301|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182186|NCT01216787|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139182187|NCT01216787|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139182188|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182189|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182190|NCT05282251|Bupivacaine|bupivacaine|mesh-list
139182191|NCT05282251|Anesthetics, Local|anesthetics, local|mesh-ancestor
139182192|NCT05282251|Anesthetics|anesthetics|mesh-ancestor
139182193|NCT05282251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182194|NCT05282251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182195|NCT05282251|Sensory System Agents|sensory system agents|mesh-ancestor
138759584|NCT01193244|Prednisone|prednisone|mesh-list
139182196|NCT05282251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182197|NCT01199341|Warfarin|warfarin|mesh-list
139182198|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
139182199|NCT01215539|Panitumumab|panitumumab|mesh-list
139182200|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139182201|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182202|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
139182203|NCT01203709|Tacrolimus|tacrolimus|mesh-list
139182204|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139182205|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
139182206|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182207|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139182208|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182209|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182210|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139182211|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182212|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138759626|NCT02758249|Propofol|propofol|mesh-list
139182213|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
139182214|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139182215|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182216|NCT01122407|Trimethaphan|trimethaphan|mesh-list
139182217|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
139182218|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182219|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139182220|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139182221|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
139182222|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
139182223|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182224|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182225|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139182226|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139182227|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
139182228|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139182229|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
139182230|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139182231|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
139182232|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139182233|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138759687|NCT02757703|Hormones|hormones|mesh-ancestor
139182234|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139182235|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182236|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182237|NCT01124435|Celecoxib|celecoxib|mesh-list
139182238|NCT01124435|Carboplatin|carboplatin|mesh-list
139182239|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182240|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139182241|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139182242|NCT01124435|Analgesics|analgesics|mesh-ancestor
139182243|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
139182244|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182245|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182246|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138759777|NCT02757079|Melatonin|melatonin|mesh-list
139182247|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139182248|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139182249|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139182250|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182251|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182252|NCT03294304|Gemcitabine|gemcitabine|mesh-list
139182253|NCT03294304|Nivolumab|nivolumab|mesh-list
139182254|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182255|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139182256|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
139182257|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967351|NCT00959517|Amebicides|amebicides|mesh-ancestor
139182258|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139182259|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139182261|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
139182262|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182263|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182264|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
139182265|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182266|NCT03472378|Celecoxib|celecoxib|mesh-list
139182267|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139182268|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139182269|NCT03472378|Analgesics|analgesics|mesh-ancestor
139182270|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
139182271|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182272|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182273|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139182274|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139182275|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139182276|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139182277|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182278|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182279|NCT03408873|Aripiprazole|aripiprazole|mesh-list
139182280|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
138759853|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
139182281|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139182282|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139182283|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139182284|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182285|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182286|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
139182287|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
139182288|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139182289|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182290|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139182291|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139182292|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
139182293|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139182294|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139182295|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139182296|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139182297|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139182298|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139182299|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139182300|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
139182301|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182302|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139182303|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139182304|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182305|NCT03780959|Etanercept|etanercept|mesh-list
139182306|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139182307|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139182308|NCT03780959|Analgesics|analgesics|mesh-ancestor
139182309|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
139182310|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182311|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182312|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139182313|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139182314|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139182315|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139182316|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
139182317|NCT03838783|Insulin|insulin|mesh-list
139182318|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139182319|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902913|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138887253|NCT00656552|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139182320|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
139182321|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
139182322|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
139182324|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
139182325|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182326|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
139182327|NCT03408639|Hematinics|hematinics|mesh-ancestor
139182328|NCT01219205|Bevacizumab|bevacizumab|mesh-list
139182329|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139182330|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182331|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139182332|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139182333|NCT01219205|Growth Substances|growth substances|mesh-ancestor
139182334|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182335|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
139182336|NCT03810235|Lidocaine|lidocaine|mesh-list
139182337|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
139182338|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
139182339|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182340|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182341|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
139182342|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182343|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139182344|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139182345|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139182346|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139182347|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182348|NCT03408483|Epinephrine|epinephrine|mesh-list
139182349|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
139182350|NCT03408483|Bupivacaine|bupivacaine|mesh-list
139182351|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
139182352|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
139182353|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182354|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182355|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
139182356|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182357|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139182358|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139182359|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
139182360|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139182361|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182362|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139182363|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139182364|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
139182365|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139182366|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
139182367|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
139182368|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
139182369|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139182370|NCT03408483|Narcotics|narcotics|mesh-ancestor
139182371|NCT03408483|Analgesics|analgesics|mesh-ancestor
139182372|NCT03715023|PC-786|pc-786|mesh-list
139182373|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
139182374|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182375|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182376|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182377|NCT03714867|Pregabalin|pregabalin|mesh-list
139182378|NCT03714867|Analgesics|analgesics|mesh-ancestor
139182379|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
139182380|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182381|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182382|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
139182383|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139182384|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139182385|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182386|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139182387|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139182388|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139182389|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759956|NCT01187550|Hormones|hormones|mesh-list
139182390|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139182391|NCT01204177|Sorafenib|sorafenib|mesh-list
139182392|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182393|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139182394|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932868|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
139182395|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182397|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
139182398|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139182399|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139182400|NCT01217099|Prednisolone|prednisolone|mesh-list
139182401|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
139182402|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139182403|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
139182404|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139182405|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
139182406|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
139182407|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182408|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182409|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139182410|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
139182411|NCT01217099|Hormones|hormones|mesh-ancestor
139182412|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139182413|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139182414|NCT01217099|Protective Agents|protective agents|mesh-ancestor
139182415|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139182416|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182417|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139182418|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182419|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
139182420|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139182421|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
139182422|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182423|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182424|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139182425|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
138760062|NCT01184118|Fluticasone|fluticasone|mesh-list
139182426|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139182427|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
139182428|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182429|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139182430|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139182431|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
139182432|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
139182433|NCT04305457|Protective Agents|protective agents|mesh-ancestor
139182434|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
139182435|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139182436|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139182437|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
138434447|NCT04965155|Dexamethasone|dexamethasone|mesh-list
139182438|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139182439|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182440|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182441|NCT01122563|Urological Agents|urological agents|mesh-ancestor
139182442|NCT01217177|Everolimus|everolimus|mesh-list
139182443|NCT01217177|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139182444|NCT01217177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139182445|NCT01217177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182446|NCT01217177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182447|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139182448|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
139182449|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182450|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182451|NCT01204333|Heparin|heparin|mesh-list
139182452|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
139182453|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139182454|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139182455|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182456|NCT02529059|Tenofovir|tenofovir|mesh-list
139182457|NCT02529059|Emtricitabine|emtricitabine|mesh-list
139182458|NCT02529059|Rilpivirine|rilpivirine|mesh-list
139182459|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
139182460|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182461|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139182462|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139182463|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182464|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760185|NCT01189500|Tamoxifen|tamoxifen|mesh-list
139182465|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139182466|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139182467|NCT03100058|Licogliflozin|licogliflozin|mesh-list
139182468|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139182469|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182470|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139182471|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182473|NCT03933761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139182474|NCT03933761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182475|NCT03933761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182476|NCT03933761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182477|NCT03932123|Vancomycin|vancomycin|mesh-list
139182478|NCT03932123|Meropenem|meropenem|mesh-list
139182479|NCT03932123|Tazobactam|tazobactam|mesh-list
139182480|NCT03932123|Piperacillin|piperacillin|mesh-list
139182481|NCT03932123|Cefotaxime|cefotaxime|mesh-list
139182482|NCT03932123|Cefoxitin|cefoxitin|mesh-list
139182483|NCT03932123|Azlocillin|azlocillin|mesh-list
139182484|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139182485|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182486|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139182487|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182488|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182489|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
139182490|NCT02866279|Etonogestrel|etonogestrel|mesh-list
139182491|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139182492|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182493|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139182494|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139182495|NCT01222169|Propofol|propofol|mesh-list
139182496|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139182497|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182498|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182499|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139182500|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
139182501|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
139182502|NCT02871778|Ivacaftor|ivacaftor|mesh-list
139182503|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139182504|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139182505|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182506|NCT04947592|Fluconazole|fluconazole|mesh-list
139182507|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
139182508|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182509|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139182510|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139182511|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182512|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182513|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139182514|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
139182515|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139182516|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182517|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139182518|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139182519|NCT02735473|Choline|choline|mesh-list
139182520|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
139182521|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139182523|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182524|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139182525|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139182526|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
139182527|NCT01125059|Methadone|methadone|mesh-list
139182528|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139182529|NCT01125059|Narcotics|narcotics|mesh-ancestor
139182530|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138760253|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
139182531|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182532|NCT01125059|Analgesics|analgesics|mesh-ancestor
139182533|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
139182534|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182535|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
139182536|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
139182537|NCT01204411|Artesunate|artesunate|mesh-list
139182538|NCT01204411|Amodiaquine|amodiaquine|mesh-list
139182539|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
139182540|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139182541|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139182542|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933019|NCT06062953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139182543|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182544|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
139182545|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
139182546|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139182547|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
139182548|NCT01471444|Methotrexate|methotrexate|mesh-list
139182549|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
139182550|NCT01471444|Clofarabine|clofarabine|mesh-list
139182551|NCT01471444|Fludarabine|fludarabine|mesh-list
139182552|NCT01471444|Busulfan|busulfan|mesh-list
139182553|NCT01471444|Tacrolimus|tacrolimus|mesh-list
139182554|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
138967647|NCT00786110|Paclitaxel|paclitaxel|mesh-list
139182556|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139182557|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
139182558|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139182559|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182560|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139182561|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
139182562|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182563|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182564|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
139182565|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182566|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139182567|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139182568|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
139182569|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139182570|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139182571|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139182572|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
139182573|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139182574|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139182575|NCT05282407|Tenofovir|tenofovir|mesh-list
139182576|NCT05282407|Antiviral Agents|antiviral agents|mesh-ancestor
139182577|NCT05282407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182578|NCT05282407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138760378|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
139182579|NCT05282407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139182580|NCT05282407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182581|NCT05282407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182582|NCT05282407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139182583|NCT05282407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139182584|NCT01125215|Capsaicin|capsaicin|mesh-list
139182585|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
139182586|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
139182587|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
139182588|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182589|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182590|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
139182591|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139182592|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
139182593|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182594|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139182595|NCT05162872|Niraparib|niraparib|mesh-list
139182596|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139182597|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182598|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182599|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182600|NCT01567111|Metomidate|metomidate|mesh-list
139182601|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139182602|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182603|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182604|NCT03955211|Acetaminophen|acetaminophen|mesh-list
139182614|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139182615|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139182616|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182617|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182618|NCT03933605|Midazolam|midazolam|mesh-list
139182619|NCT03933605|Palonosetron|palonosetron|mesh-list
139182620|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139182621|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139182622|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182623|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182624|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139182625|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139182626|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139182627|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139182628|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
139182629|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
139182630|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
139182631|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
139182632|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139182633|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182634|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
139182635|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
139182636|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182637|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139182638|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139182639|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139182640|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
139182641|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
139182642|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139182643|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
139182644|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
139182645|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
139182655|NCT01311141|Doripenem|doripenem|mesh-list
139182656|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139182657|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182658|NCT01122641|Vildagliptin|vildagliptin|mesh-list
138760693|NCT04219579|Antithrombins|antithrombins|mesh-list
139182659|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139182660|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182661|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139182662|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
138760768|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
139182663|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182664|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182665|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
139182666|NCT01125449|Vitamins|vitamins|mesh-ancestor
139182667|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
139182668|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182669|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
139182670|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182671|NCT01125449|Protective Agents|protective agents|mesh-ancestor
139182672|NCT01206049|Bevacizumab|bevacizumab|mesh-list
139182673|NCT01206049|Panitumumab|panitumumab|mesh-list
139182674|NCT01206049|Gemcitabine|gemcitabine|mesh-list
139182675|NCT01206049|Capecitabine|capecitabine|mesh-list
139182676|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
139182677|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139182678|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182679|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139182680|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139182681|NCT01206049|Growth Substances|growth substances|mesh-ancestor
138760897|NCT04288713|Eculizumab|eculizumab|mesh-list
139182682|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182683|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
139182684|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139182685|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
139182686|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182687|NCT03931889|Vitamin D|vitamin d|mesh-list
139182688|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
139182689|NCT03931889|Vitamins|vitamins|mesh-ancestor
139182690|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
139182691|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182692|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139182693|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139182694|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138933166|NCT05795101|Immunoconjugates|immunoconjugates|mesh-ancestor
139182695|NCT02953821|Hormones|hormones|mesh-ancestor
138903003|NCT00833040|Analgesics|analgesics|mesh-ancestor
139182696|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139182697|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182698|NCT01206205|Lenalidomide|lenalidomide|mesh-list
139182699|NCT01206205|Bortezomib|bortezomib|mesh-list
139182700|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
139182701|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182702|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139182703|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139182704|NCT01206205|Growth Substances|growth substances|mesh-ancestor
139182705|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
139182706|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182707|NCT03783923|Deflazacort|deflazacort|mesh-list
139182708|NCT03783923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139182709|NCT03783923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139182710|NCT03783923|Immunologic Factors|immunologic factors|mesh-ancestor
139182711|NCT03783923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182712|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139182713|NCT03472144|Levofloxacin|levofloxacin|mesh-list
139182714|NCT03472144|Ofloxacin|ofloxacin|mesh-list
139182715|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139182716|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182717|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
139182718|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139182719|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139182720|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139182721|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761376|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
139182722|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182723|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182724|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138761446|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
139182725|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139182726|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
139182727|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
139182728|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182729|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139182730|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182731|NCT01219751|Sunitinib|sunitinib|mesh-list
139182732|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182733|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139182734|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139182735|NCT01219751|Growth Substances|growth substances|mesh-ancestor
139182736|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182737|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
139182738|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139182739|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182740|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182741|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
139182742|NCT04823091|Fludarabine|fludarabine|mesh-list
139182743|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139182744|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
139182745|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182746|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139182747|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139182748|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
139182749|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182750|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182751|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139182752|NCT01125527|Vaccines|vaccines|mesh-list
139182753|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
139182754|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182755|NCT01298401|Gemcitabine|gemcitabine|mesh-list
138761793|NCT02725099|Ticagrelor|ticagrelor|mesh-list
139182757|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139182758|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
139182759|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182760|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182761|NCT03931343|Epinephrine|epinephrine|mesh-list
139182762|NCT03931343|Racepinephrine|racepinephrine|mesh-list
139182763|NCT03931343|Bupivacaine|bupivacaine|mesh-list
139182764|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
139182765|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
139182766|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
139182767|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182768|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182769|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
139182770|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182771|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139182772|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139182773|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
139182774|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139182775|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182776|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139182777|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139182778|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
139182779|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139182780|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
139182781|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
139182782|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
139182783|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139182785|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
139182786|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139182787|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139182788|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139182789|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182790|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139182791|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139182793|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139182794|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182795|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182796|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
139182797|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139182798|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182799|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
139182800|NCT01127555|Leucovorin|leucovorin|mesh-list
139182801|NCT01127555|Fluorouracil|fluorouracil|mesh-list
139182802|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
139182803|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
139182804|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182805|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139182806|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182807|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139182808|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
139182809|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182810|NCT01127555|Antidotes|antidotes|mesh-ancestor
139182811|NCT01127555|Protective Agents|protective agents|mesh-ancestor
139182812|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
139182813|NCT01127555|Vitamins|vitamins|mesh-ancestor
139182814|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
139182815|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
139182816|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139182817|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
139182818|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182819|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139182820|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139182821|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
138903018|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182822|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182823|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762236|NCT02721511|Furosemide|furosemide|mesh-list
139182824|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139182825|NCT03471988|Voriconazole|voriconazole|mesh-list
139182826|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
139182827|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182828|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139182829|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139182830|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182831|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182832|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139182833|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
139182834|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139182835|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182836|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139182838|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139182839|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182841|NCT01123031|Lansoprazole|lansoprazole|mesh-list
139182842|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
138762457|NCT02711215|Analgesics|analgesics|mesh-ancestor
139182843|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139182844|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139182845|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139182846|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182847|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182849|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139182850|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139182851|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182852|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182853|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762596|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182855|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139182856|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182857|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139182858|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182860|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139182861|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139182862|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139182863|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182865|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139182866|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182867|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
139182868|NCT04249310|Olodaterol|olodaterol|mesh-list
139182869|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139182870|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
139182871|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182872|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182873|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139182874|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
139182875|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
139182876|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139182877|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
139182878|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139182879|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182880|NCT05665075|Cytarabine|cytarabine|mesh-list
139182881|NCT05665075|Cyclophosphamide|cyclophosphamide|mesh-list
139182882|NCT05665075|Fludarabine|fludarabine|mesh-list
139182883|NCT05665075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139182884|NCT05665075|Immunologic Factors|immunologic factors|mesh-ancestor
139182885|NCT05665075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763107|NCT04205565|Oxiracetam|oxiracetam|mesh-list
139182887|NCT05665075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139182888|NCT05665075|Alkylating Agents|alkylating agents|mesh-ancestor
139182889|NCT05665075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182890|NCT05665075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182891|NCT05665075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139182892|NCT05665075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139182893|NCT05665075|Antimetabolites|antimetabolites|mesh-ancestor
139182894|NCT05665075|Antiviral Agents|antiviral agents|mesh-ancestor
139182895|NCT05665075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182896|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139182898|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
139182899|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182900|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
139182901|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139182902|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
139182903|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
139182904|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182905|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182906|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139182907|NCT03932825|Analgesics|analgesics|mesh-ancestor
139182908|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
139182909|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182910|NCT03932981|Temozolomide|temozolomide|mesh-list
139182911|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139182912|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
138967823|NCT00972387|Hormones|hormones|mesh-ancestor
139182913|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182914|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182915|NCT01220219|Pregabalin|pregabalin|mesh-list
139182917|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
139182918|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182919|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182920|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
139182921|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139182922|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139182923|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182924|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139182925|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139182926|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139182927|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182928|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139182929|NCT03441789|Betamethasone|betamethasone|mesh-list
139182930|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
139182931|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139182932|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
139182933|NCT03441789|Calcipotriene|calcipotriene|mesh-list
139182934|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139182935|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139182936|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
139182938|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763793|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139182939|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182940|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139182941|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
139182942|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
139182944|NCT03359005|Temozolomide|temozolomide|mesh-list
139182945|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139182946|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182947|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
139182948|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
139182949|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138763925|NCT02700217|Bupivacaine|bupivacaine|mesh-list
139182950|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182951|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139182953|NCT04321174|Ritonavir|ritonavir|mesh-list
139182954|NCT04321174|Lopinavir|lopinavir|mesh-list
139182956|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139182957|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
139182958|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182959|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182960|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139182961|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139182962|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
139182963|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139182964|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139182965|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139182966|NCT01123265|Methotrexate|methotrexate|mesh-list
139182967|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139182968|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
139182969|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139182970|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182971|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139182972|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
139182973|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182974|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182975|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
139182976|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182977|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139182978|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139182979|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
139182980|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139182981|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139182982|NCT01204723|Aprepitant|aprepitant|mesh-list
139182983|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
139182984|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
139182985|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
139182986|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182987|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139182988|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139182989|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139182990|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139182991|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139182993|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139182994|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138967891|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
139182995|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182996|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139182997|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139182998|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182999|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183000|NCT04194814|Betamethasone|betamethasone|mesh-list
139183001|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
139183002|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139183003|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
139183004|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139183005|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139183006|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
139183007|NCT04194814|Hormones|hormones|mesh-ancestor
139183008|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139183009|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183010|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139183011|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
139183013|NCT03832621|Ipilimumab|ipilimumab|mesh-list
139183014|NCT03832621|Temozolomide|temozolomide|mesh-list
139183015|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139183016|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183017|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139183018|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183019|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139183020|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
139183022|NCT01220375|Vinorelbine|vinorelbine|mesh-list
139183023|NCT01220375|Lenograstim|lenograstim|mesh-list
139183024|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139183025|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
139183026|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183027|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139183028|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183029|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
139183030|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
139183031|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
139183032|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183033|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139183034|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138764600|NCT04208581|Hormones|hormones|mesh-ancestor
139183035|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
139183036|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183037|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
139183038|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
139183039|NCT01223729|Vitamins|vitamins|mesh-ancestor
139183040|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
139183041|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183042|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
139183044|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139183045|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
139183046|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183047|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139183048|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
139183049|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
139183050|NCT01126073|Vitamins|vitamins|mesh-ancestor
139183051|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
139183052|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183053|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
139183054|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139183055|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183056|NCT03287050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139183057|NCT03287050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183058|NCT03130504|Progesterone|progesterone|mesh-list
139183059|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
139183060|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
139183061|NCT03130504|Progestins|progestins|mesh-ancestor
139183062|NCT03130504|Hormones|hormones|mesh-ancestor
139183063|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139183064|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183065|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139183067|NCT03819127|Metformin|metformin|mesh-list
139183068|NCT03819127|Vildagliptin|vildagliptin|mesh-list
139183069|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139183070|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183071|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139183072|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
139183073|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903076|NCT00664703|Lobeline|lobeline|mesh-list
139183074|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183075|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
139183076|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139183077|NCT01299181|Atorvastatin|atorvastatin|mesh-list
139183078|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139183079|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139183080|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
139183081|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183082|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139183083|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139183084|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183085|NCT03930875|Aspirin|aspirin|mesh-list
139183086|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139183087|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139183088|NCT03930875|Analgesics|analgesics|mesh-ancestor
139183089|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
139183090|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183091|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183092|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139183093|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139183094|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139183095|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139183096|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183097|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139183098|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139183099|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183100|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
139183101|NCT01206907|Oxymorphone|oxymorphone|mesh-list
139183102|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139183103|NCT01206907|Narcotics|narcotics|mesh-ancestor
139183104|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139183105|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183106|NCT01206907|Analgesics|analgesics|mesh-ancestor
139183107|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
139183108|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183109|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139183110|NCT03925246|Nivolumab|nivolumab|mesh-list
138967971|NCT04008225|Chelating Agents|chelating agents|mesh-ancestor
139183111|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139183112|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183113|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139183114|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183115|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139183116|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139183117|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139183118|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
139183119|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183120|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139183121|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139183122|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183124|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
139183125|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183126|NCT01126229|Protective Agents|protective agents|mesh-ancestor
139183127|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183128|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183129|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139183130|NCT03474640|Antibodies|antibodies|mesh-list
139183131|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139183132|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
139183133|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183134|NCT01126307|Verapamil|verapamil|mesh-list
139183135|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139183136|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139183137|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138765465|NCT02680795|Belinostat|belinostat|mesh-list
139183138|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183139|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139183140|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183141|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
139183142|NCT04173338|Pemetrexed|pemetrexed|mesh-list
139183143|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183144|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183145|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183146|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139183147|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139183148|NCT03936491|Methylphenidate|methylphenidate|mesh-list
139183149|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139183150|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139183151|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183152|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139183153|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139183154|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139183155|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183156|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
139183157|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183158|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139183159|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
139183160|NCT00890617|Prednisone|prednisone|mesh-list
139183161|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139183162|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
139183164|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139183165|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183166|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138765813|NCT01149096|Lenograstim|lenograstim|mesh-list
139183167|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183169|NCT03468946|Citric Acid|citric acid|mesh-list
139183170|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139183171|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183172|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139183173|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183174|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183175|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139183176|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139183177|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
139183178|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183179|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
139183180|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139183182|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
139183183|NCT01218425|Levodopa|levodopa|mesh-list
139183185|NCT01218425|Domperidone|domperidone|mesh-list
139183186|NCT01218425|Methylphenidate|methylphenidate|mesh-list
139183187|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139183188|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183189|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138766166|NCT01173120|Abatacept|abatacept|mesh-list
139183190|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139183191|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903099|NCT00670787|Diuretics|diuretics|mesh-ancestor
139183192|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183193|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
139183194|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183195|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139183196|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139183197|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139183198|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183199|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
139183200|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
139183201|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183202|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139183204|NCT05621005|Rifaximin|rifaximin|mesh-list
139183205|NCT05621005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139183206|NCT05621005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183207|NCT05621005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139183208|NCT01224041|Tacrolimus|tacrolimus|mesh-list
139183209|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139183210|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
139183211|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183212|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139183214|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183215|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
139183217|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183218|NCT01123811|Cetuximab|cetuximab|mesh-list
139183219|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139183220|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183221|NCT01128101|Spironolactone|spironolactone|mesh-list
138766582|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
139183222|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139183223|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
138766651|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139183224|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139183225|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183226|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139183227|NCT01128101|Diuretics|diuretics|mesh-ancestor
139183228|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
139183229|NCT01299415|Vadimezan|vadimezan|mesh-list
139183230|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183231|NCT01123967|Nicotine|nicotine|mesh-list
139183232|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138766828|NCT00928486|Hormones|hormones|mesh-ancestor
139183233|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
138766865|NCT02675647|Protamines|protamines|mesh-list
139183234|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183235|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183237|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139183238|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
139183239|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183240|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183241|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
139183242|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183243|NCT01126697|Ubiquinone|ubiquinone|mesh-list
139183245|NCT01126697|Lisinopril|lisinopril|mesh-list
139183246|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139183247|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
139183248|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183249|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183250|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139183251|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139183252|NCT01126697|Protective Agents|protective agents|mesh-ancestor
139183253|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183254|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
139183255|NCT01126697|Vitamins|vitamins|mesh-ancestor
139183256|NCT01220843|Sevelamer|sevelamer|mesh-list
139183257|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
139183258|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
139183259|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183260|NCT02804932|Methamphetamine|methamphetamine|mesh-list
139183261|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139183262|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183263|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
139183264|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
138767378|NCT05290740|Norepinephrine|norepinephrine|mesh-list
139183265|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183266|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
139183267|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138767447|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
139183268|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183269|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
139183270|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139183271|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138767519|NCT04205838|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139183272|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139183273|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139183274|NCT03468790|Fluticasone|fluticasone|mesh-list
139183275|NCT03468790|Xhance|xhance|mesh-list
139183276|NCT03468790|Budesonide|budesonide|mesh-list
139183277|NCT03468790|Albuterol|albuterol|mesh-list
139183278|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
139183279|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139183280|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139183281|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139183282|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139183283|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139183284|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
139183285|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183286|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183287|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139183288|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
139183289|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
139183292|NCT03468790|Hormones|hormones|mesh-ancestor
139183293|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139183294|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139183295|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139183296|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138767872|NCT00544830|Goserelin|goserelin|mesh-list
139183297|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
139183298|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183299|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183300|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
139183301|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139183302|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
139183303|NCT01224197|Simeprevir|simeprevir|mesh-list
139183304|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
139183305|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183306|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
139183307|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183308|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183310|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
139183311|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183312|NCT01224353|Protective Agents|protective agents|mesh-ancestor
139183313|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183314|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
139183315|NCT01224353|Vitamins|vitamins|mesh-ancestor
139183316|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
139183317|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
139183318|NCT01207297|Tacrolimus|tacrolimus|mesh-list
139183319|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139183320|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
138903123|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183321|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183322|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139183323|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139183324|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
139183325|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183326|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183327|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139183328|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139183329|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183330|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
139183331|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139183332|NCT03720847|Estradiol|estradiol|mesh-list
139183333|NCT03720847|Progesterone|progesterone|mesh-list
139183334|NCT03720847|Estrogens|estrogens|mesh-ancestor
139183335|NCT03720847|Hormones|hormones|mesh-ancestor
138768361|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
138768434|NCT03695445|Norepinephrine|norepinephrine|mesh-list
139183336|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139183337|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183338|NCT03720847|Progestins|progestins|mesh-ancestor
139183339|NCT01128257|Alendronate|alendronate|mesh-list
139183340|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
139183341|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139183342|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183344|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139183345|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139183346|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
139183347|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183348|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139183349|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139183350|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183351|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
139183352|NCT01218737|Prednisolone|prednisolone|mesh-list
138768650|NCT04315493|Maleic acid|maleic acid|mesh-list
139183353|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139183354|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
139183355|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139183356|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
139183357|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139183358|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
139183359|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139183360|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
139183361|NCT01218737|Hormones|hormones|mesh-ancestor
139183362|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138933854|NCT00138216|Irinotecan|irinotecan|mesh-list
139183363|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183364|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139183365|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183366|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
139183367|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
139183368|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183369|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139183370|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139183371|NCT01218737|Protective Agents|protective agents|mesh-ancestor
139183372|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139183373|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183375|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139183376|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139183377|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139183378|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183379|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183380|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
139183381|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139183382|NCT01224509|Mifepristone|mifepristone|mesh-list
139183383|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139183384|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
139183385|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139183386|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768919|NCT02862327|BB 1101|bb 1101|mesh-list
139183387|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139183388|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139183389|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139183390|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
139183391|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139183392|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139183393|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
138769052|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139183394|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139183395|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
139183396|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139183397|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139183398|NCT01301053|Insulin|insulin|mesh-list
139183399|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139183400|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139183401|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183402|NCT01218581|Letrozole|letrozole|mesh-list
139183403|NCT01218581|Goserelin|goserelin|mesh-list
139183404|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183405|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139183406|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139183407|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769196|NCT00646321|Budesonide|budesonide|mesh-list
139183408|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183409|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139183410|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
139183411|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139183412|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183413|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139183414|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
139183415|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139183417|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183418|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
139183419|NCT03825133|Protective Agents|protective agents|mesh-ancestor
139183420|NCT03817567|Antibodies|antibodies|mesh-list
139183421|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139183422|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
139183423|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183424|NCT01127009|Cytarabine|cytarabine|mesh-list
139183425|NCT01127009|Etoposide|etoposide|mesh-list
139183426|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
139183427|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
139183428|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
139183429|NCT01127009|Bortezomib|bortezomib|mesh-list
139183430|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139183431|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183432|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139183433|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139183434|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183435|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183436|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139183437|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
139183438|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
139183439|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183440|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139183441|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
139183442|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183443|NCT01127009|Analgesics|analgesics|mesh-ancestor
139183444|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
139183445|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769676|NCT00648583|Ondansetron|ondansetron|mesh-list
139183447|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
139183448|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
139183449|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
139183450|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
139183452|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
139183453|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139183454|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
139183455|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183456|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183457|NCT01205737|Rituximab|rituximab|mesh-list
139183458|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139183459|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183460|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
139183461|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183462|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139183465|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
139183466|NCT01218893|Amebicides|amebicides|mesh-ancestor
139183467|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139183468|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139183469|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183470|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
139183471|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139183472|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
139183473|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183475|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139183476|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139183477|NCT03824119|Analgesics|analgesics|mesh-ancestor
139183478|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
139183479|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183480|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183481|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139183482|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139183483|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139183484|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770225|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139183485|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183486|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
139183487|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139183488|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139183489|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183490|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
139183491|NCT03823417|Coagulants|coagulants|mesh-ancestor
139183492|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
139183493|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770299|NCT02652091|Interferon-beta|interferon-beta|mesh-list
139183494|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139183495|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770365|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183496|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183497|NCT01224977|Azithromycin|azithromycin|mesh-list
139183498|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139183499|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183500|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
139183501|NCT01226069|Glycerol|glycerol|mesh-list
139183502|NCT01226069|Analgesics|analgesics|mesh-ancestor
138903150|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
139183503|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
139183504|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183505|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183506|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
139183507|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139183508|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139183509|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
139183510|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139183511|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139183512|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183513|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139183514|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
139183515|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139183516|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139183517|NCT01226069|Protective Agents|protective agents|mesh-ancestor
139183518|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
139183519|NCT03928691|Analgesics|analgesics|mesh-ancestor
139183520|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
139183521|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183522|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183523|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
138770555|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
139183524|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139183525|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139183526|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
139183527|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139183528|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139183529|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183530|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139183531|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
139183532|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139183534|NCT01297855|Colistin|colistin|mesh-list
139183535|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139183536|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
139183537|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139183538|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183539|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
139183540|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139183541|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183542|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183543|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139183544|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139183545|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139183546|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139183547|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139183548|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139183549|NCT02631070|Luspatercept|luspatercept|mesh-list
139183550|NCT02631070|Hematinics|hematinics|mesh-ancestor
139183551|NCT01298011|Paclitaxel|paclitaxel|mesh-list
139183552|NCT01298011|Gemcitabine|gemcitabine|mesh-list
139183553|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139183554|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139183555|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183556|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
139183557|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
139183558|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
138770827|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
139183559|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183560|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139183561|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
139183562|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139183563|NCT01221935|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138770893|NCT02648659|Amoxicillin|amoxicillin|mesh-list
139183564|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
139183565|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139183566|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139183567|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183568|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183570|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183571|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
139183572|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139183573|NCT05137678|Glyburide|glyburide|mesh-list
139183574|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138771029|NCT02647567|Caffeine|caffeine|mesh-list
139183575|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183576|NCT01226303|Tretinoin|tretinoin|mesh-list
139183577|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183578|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
139183579|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
139183580|NCT03814759|Cisplatin|cisplatin|mesh-list
139183581|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183582|NCT03929861|Fluconazole|fluconazole|mesh-list
139183583|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
139183584|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183585|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139183586|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139183587|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183588|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183589|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138771249|NCT02646397|Fosinopril|fosinopril|mesh-list
139183590|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
139183591|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139183592|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771310|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
139183593|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139183594|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139183595|NCT03821623|Niacinamide|niacinamide|mesh-list
139183596|NCT03821623|Niacin|niacin|mesh-list
139183597|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
139183598|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
139183599|NCT03821623|Vitamins|vitamins|mesh-ancestor
139183600|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
139183601|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183602|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139183603|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
139183604|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771462|NCT00910000|Vorinostat|vorinostat|mesh-list
139183605|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139183606|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
139183607|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139183608|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
139183609|NCT03928145|Amiloride|amiloride|mesh-list
139183610|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139183611|NCT03928145|Diuretics|diuretics|mesh-ancestor
139183612|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
139183613|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183614|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139183615|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139183616|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771587|NCT01124838|Hormones|hormones|mesh-ancestor
139183617|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139183618|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139183619|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138771653|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183620|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139183621|NCT01129271|Clopidogrel|clopidogrel|mesh-list
138968541|NCT00795314|Fentanyl|fentanyl|mesh-list
139183622|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139183623|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139183624|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139183625|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139183626|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
139183627|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183628|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183629|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183630|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
139183631|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183632|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139183633|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183634|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183635|NCT00741988|Bevacizumab|bevacizumab|mesh-list
139183636|NCT00741988|Carboplatin|carboplatin|mesh-list
139183637|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139183638|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183639|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139183640|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139183641|NCT00741988|Growth Substances|growth substances|mesh-ancestor
139183642|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183643|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
139183644|NCT01131377|Acetazolamide|acetazolamide|mesh-list
139183645|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
139183646|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139183647|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183648|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183649|NCT01131377|Diuretics|diuretics|mesh-ancestor
139183650|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
139183651|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183652|NCT04457050|Ribavirin|ribavirin|mesh-list
139183653|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
139183654|NCT04457050|Ledipasvir|ledipasvir|mesh-list
139183655|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
139183656|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183657|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
139183658|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183659|NCT01228409|Acitretin|acitretin|mesh-list
139183660|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
139183661|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
139183662|NCT03470350|Capecitabine|capecitabine|mesh-list
139183663|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139183664|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
139183665|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183666|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183668|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139183669|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139183670|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139183671|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
138772426|NCT01117350|Metformin|metformin|mesh-list
139183672|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
139183673|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183674|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183675|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138331573|NCT04378608|Ribavirin|ribavirin|mesh-list
139183676|NCT05654233|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
139183677|NCT05654233|Anticoagulants|anticoagulants|mesh-ancestor
139183678|NCT05654233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139183679|NCT05654233|Antimetabolites|antimetabolites|mesh-ancestor
139183680|NCT05654233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183681|NCT05654233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139183682|NCT05654233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139183683|NCT05654233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139183684|NCT05654233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139183685|NCT05654233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183686|NCT01226771|Ribavirin|ribavirin|mesh-list
139183687|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
139183688|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183690|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183691|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
139183692|NCT03814447|Fludarabine|fludarabine|mesh-list
139183693|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139183694|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
139183695|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183696|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139183697|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139183698|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
139183699|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183700|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183701|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139183702|NCT01129427|Pantoprazole|pantoprazole|mesh-list
139183703|NCT01129427|Clopidogrel|clopidogrel|mesh-list
139183704|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139183705|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139183706|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139183707|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139183708|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
139183709|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183710|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183711|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183713|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139183714|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139183715|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183716|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
139183717|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
138773123|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139183718|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183719|NCT03354429|Ticagrelor|ticagrelor|mesh-list
139183720|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138968601|NCT00788138|Vitamin D|vitamin d|mesh-list
139183721|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139183722|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139183723|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139183724|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
139183725|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773195|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139183726|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183727|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183728|NCT05164198|Adalimumab|adalimumab|mesh-list
139183729|NCT05164198|Infliximab|infliximab|mesh-list
139183730|NCT05164198|Golimumab|golimumab|mesh-list
139183731|NCT05164198|Etanercept|etanercept|mesh-list
139183732|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139183733|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139183734|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138934226|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
139183735|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
139183736|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139183737|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139183738|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139183739|NCT05164198|Analgesics|analgesics|mesh-ancestor
139183740|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
139183741|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183742|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183743|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139183744|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
139183745|NCT03740399|Anesthetics|anesthetics|mesh-list
139183746|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139183747|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183749|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
139183750|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183751|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139183752|NCT03924245|Olaparib|olaparib|mesh-list
139183753|NCT03924245|Entinostat|entinostat|mesh-list
139183754|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139183755|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183756|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183757|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183758|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139183759|NCT05647447|SR 142801|sr 142801|mesh-list
139183760|NCT05647447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139183761|NCT05647447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139183762|NCT05647447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139183763|NCT05647447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183764|NCT05647447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139183765|NCT01225445|Ramipril|ramipril|mesh-list
139183766|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139183767|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
139183768|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183769|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968626|NCT00961467|Thalidomide|thalidomide|mesh-list
139183771|NCT05555329|Thalidomide|thalidomide|mesh-list
139183772|NCT05555329|Pomalidomide|pomalidomide|mesh-list
139183773|NCT05555329|Immunologic Factors|immunologic factors|mesh-ancestor
139183774|NCT05555329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183775|NCT05555329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139183776|NCT05555329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139183777|NCT05555329|Growth Substances|growth substances|mesh-ancestor
139183778|NCT05555329|Growth Inhibitors|growth inhibitors|mesh-ancestor
139183779|NCT05555329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183780|NCT05555329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139183781|NCT05555329|Leprostatic Agents|leprostatic agents|mesh-ancestor
139183782|NCT05555329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139183783|NCT05555329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183785|NCT05390710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139183786|NCT05390710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139183787|NCT05390710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183789|NCT05390710|Antimitotic Agents|antimitotic agents|mesh-ancestor
139183790|NCT05390710|Mitosis Modulators|mitosis modulators|mesh-ancestor
139183791|NCT05390710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183792|NCT01228565|Cetuximab|cetuximab|mesh-list
139183793|NCT01228565|OTD70DERM|otd70derm|mesh-list
139183794|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139183795|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183796|NCT01228565|Protective Agents|protective agents|mesh-ancestor
139183797|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183798|NCT01226849|Rituximab|rituximab|mesh-list
139183799|NCT01226849|Carboplatin|carboplatin|mesh-list
139183800|NCT01226849|Etoposide|etoposide|mesh-list
139183801|NCT01226849|Bortezomib|bortezomib|mesh-list
139183802|NCT01226849|Ifosfamide|ifosfamide|mesh-list
139183803|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139183804|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183805|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
139183806|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183807|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139183808|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139183809|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139183810|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139183811|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183812|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773482|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
139183813|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139183814|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
139183815|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
139183817|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183818|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139183819|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139183821|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
139183822|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183823|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139183824|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139183825|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139183826|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
139183827|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183828|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183829|NCT03813979|Dolutegravir|dolutegravir|mesh-list
139183830|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139183831|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139183832|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183833|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183834|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139183835|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139183836|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
139183837|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183838|NCT05446467|Pembrolizumab|pembrolizumab|mesh-list
139183839|NCT05446467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183840|NCT05446467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139183841|NCT05446467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139183842|NCT05446467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183843|NCT03901144|Glycerol|glycerol|mesh-list
139183844|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139183845|NCT03901144|Protective Agents|protective agents|mesh-ancestor
138773753|NCT02837770|Diclofenac|diclofenac|mesh-list
139183846|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183847|NCT01129739|Cyclosporine|cyclosporine|mesh-list
139183848|NCT01129739|Cyclosporins|cyclosporins|mesh-list
139183849|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903253|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139183850|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183851|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139183852|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
139183853|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183854|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
139183855|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183856|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
139183857|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139183858|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139183859|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
139183860|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
139183861|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139183862|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
139183863|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968664|NCT00980109|Oseltamivir|oseltamivir|mesh-list
139183864|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183865|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183866|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139183867|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183868|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
139183869|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139183870|NCT03384693|Defibrotide|defibrotide|mesh-list
139183871|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139183872|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139183873|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183874|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139183875|NCT05533281|Dexamethasone|dexamethasone|mesh-list
139183876|NCT05533281|Metoclopramide|metoclopramide|mesh-list
139183877|NCT05533281|Tropisetron|tropisetron|mesh-list
138773949|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139183878|NCT05533281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139183879|NCT05533281|Antiemetics|antiemetics|mesh-ancestor
139183880|NCT05533281|Autonomic Agents|autonomic agents|mesh-ancestor
139183881|NCT05533281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183882|NCT05533281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183883|NCT05533281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139183884|NCT05533281|Glucocorticoids|glucocorticoids|mesh-ancestor
139183885|NCT05533281|Hormones|hormones|mesh-ancestor
138774139|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
138774140|NCT00668941|Vitamin D|vitamin d|mesh-list
139183886|NCT05533281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139183887|NCT05533281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139183888|NCT05533281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183889|NCT05533281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139183890|NCT05533281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139183891|NCT05533281|Dopamine Agents|dopamine agents|mesh-ancestor
139183892|NCT05533281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183893|NCT05533281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968690|NCT00984633|Sevoflurane|sevoflurane|mesh-list
139183894|NCT05533281|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139183895|NCT05533281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139183896|NCT05533281|Serotonin Agents|serotonin agents|mesh-ancestor
139183897|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
139183898|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139183899|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139183900|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183901|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139183902|NCT03923075|Analgesics|analgesics|mesh-ancestor
139183903|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
139183904|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183905|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139183906|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138903269|NCT00671801|Lenalidomide|lenalidomide|mesh-list
139183907|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139183908|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
139183909|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183910|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183912|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139183913|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139183914|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139183915|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
139183916|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183917|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183918|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139183919|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139183920|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
139183921|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183922|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139183923|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139183924|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
139183925|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183926|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
139183927|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139183928|NCT02618980|Hemostatics|hemostatics|mesh-list
139183929|NCT02618980|Coagulants|coagulants|mesh-ancestor
139183930|NCT02613598|Bortezomib|bortezomib|mesh-list
139183931|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183932|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
139183933|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138774619|NCT00891202|Eliglustat|eliglustat|mesh-list
139183934|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
139183935|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139183936|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
139183937|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183938|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183939|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
139183940|NCT01225523|Paclitaxel|paclitaxel|mesh-list
139183941|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139183942|NCT01225523|Cisplatin|cisplatin|mesh-list
139183944|NCT01225523|Fluorouracil|fluorouracil|mesh-list
139183945|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139183946|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183947|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
139183948|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
139183949|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
138774749|NCT05210764|Sevoflurane|sevoflurane|mesh-list
139183950|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183951|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139183952|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
139183953|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139183954|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
139183955|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183956|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
138774892|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
139183957|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139183958|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
138934458|NCT00856882|Caseins|caseins|mesh-list
139183959|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183960|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
139183961|NCT03815539|Protective Agents|protective agents|mesh-ancestor
139183962|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
139183963|NCT03922919|Cefotaxime|cefotaxime|mesh-list
139183964|NCT03922919|Cefoxitin|cefoxitin|mesh-list
139183965|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139183966|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139183967|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
138775108|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
139183968|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139183969|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139183970|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183971|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139183972|NCT03813277|Analgesics|analgesics|mesh-ancestor
139183973|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
139183974|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183975|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139183976|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139183977|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139183978|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
139183979|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139183980|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183981|NCT03815461|Paclitaxel|paclitaxel|mesh-list
139183982|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139183983|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183984|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
139183985|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
139183986|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
139183987|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183988|NCT01285102|Irinotecan|irinotecan|mesh-list
139183989|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139183990|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138968816|NCT01070407|Cloricromen|cloricromen|mesh-list
139183991|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183992|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775332|NCT00602589|Ofloxacin|ofloxacin|mesh-list
139183993|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139183995|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139183996|NCT03740243|Naloxone|naloxone|mesh-list
139183997|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139183998|NCT03740243|Narcotics|narcotics|mesh-ancestor
139183999|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184000|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184002|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
138775450|NCT01203878|Imiquimod|imiquimod|mesh-list
139184003|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184004|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139184005|NCT03813043|Midazolam|midazolam|mesh-list
139184006|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139184007|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139184008|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184009|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184010|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139184011|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139184012|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139184013|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139184014|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
139184015|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
139184016|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
139184017|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
139184018|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139184019|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184020|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
139184021|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139184022|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184023|NCT03382899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139184024|NCT03382899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184025|NCT03815305|Petrolatum|petrolatum|mesh-list
139184026|NCT03815305|Emollients|emollients|mesh-ancestor
139184027|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
139184028|NCT01560013|Naltrexone|naltrexone|mesh-list
139184029|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139184030|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139184031|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775673|NCT04241380|Heparin|heparin|mesh-list
139184032|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
139184033|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184034|NCT01302145|Metformin|metformin|mesh-list
139184036|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139184037|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184038|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139184039|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184040|NCT01560091|Tamsulosin|tamsulosin|mesh-list
139184041|NCT01560091|Silodosin|silodosin|mesh-list
139184042|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139184043|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139184044|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139184045|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
139184046|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775717|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
139184047|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184048|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184049|NCT01560091|Urological Agents|urological agents|mesh-ancestor
139184050|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
139184051|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139184052|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139184053|NCT03807271|Anesthetics|anesthetics|mesh-list
139184054|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184055|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184056|NCT03812731|Fentanyl|fentanyl|mesh-list
139184057|NCT03812731|Ropivacaine|ropivacaine|mesh-list
138775919|NCT02690506|Pregabalin|pregabalin|mesh-list
139184058|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
139184060|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184061|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184062|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
139184063|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184064|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139184065|NCT03812731|Narcotics|narcotics|mesh-ancestor
139184066|NCT03812731|Analgesics|analgesics|mesh-ancestor
139184067|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139184068|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139184069|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
139184070|NCT03351231|Nivolumab|nivolumab|mesh-list
139184071|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139184072|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184073|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139184074|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184076|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
139184077|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
139184078|NCT03709719|Blinatumomab|blinatumomab|mesh-list
139184079|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184080|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
139184081|NCT03926663|Bupivacaine|bupivacaine|mesh-list
139184082|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
139184083|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
139184084|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184085|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184086|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
139184087|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184088|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139184089|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139184090|NCT03926663|Analgesics|analgesics|mesh-ancestor
139184091|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139184092|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139184093|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139184094|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
139184095|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903302|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139184096|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184097|NCT05481775|Immunomodulating Agents|immunomodulating agents|mesh-list
139184098|NCT05481775|Immunologic Factors|immunologic factors|mesh-ancestor
139184099|NCT05481775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184100|NCT05165914|Midazolam|midazolam|mesh-list
139184101|NCT05165914|Anesthetics|anesthetics|mesh-list
139184102|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184103|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184104|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139184105|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139184106|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139184107|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139184108|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138776401|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
139184109|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139184110|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
139184111|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
139184112|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
139184113|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139184114|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184115|NCT01132157|Propofol|propofol|mesh-list
139184116|NCT01132157|Desflurane|desflurane|mesh-list
139184117|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139184118|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184119|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184120|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139184121|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
139184122|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
139184123|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139184124|NCT05389150|Pregabalin|pregabalin|mesh-list
139184125|NCT05389150|Tramadol|tramadol|mesh-list
139184126|NCT05389150|Analgesics|analgesics|mesh-ancestor
138776613|NCT00680329|Timolol|timolol|mesh-list
139184128|NCT05389150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184129|NCT05389150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184130|NCT05389150|Anticonvulsants|anticonvulsants|mesh-ancestor
139184131|NCT05389150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138776746|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
139184132|NCT05389150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139184133|NCT05389150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184134|NCT05389150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139184135|NCT05389150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139184136|NCT05389150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139184137|NCT05389150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184138|NCT05389150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139184139|NCT05389150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139184141|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139184142|NCT03806101|Abrocitinib|abrocitinib|mesh-list
139184143|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139184144|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139184145|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
139184146|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184147|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139184148|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139184149|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184150|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139184151|NCT03812419|Esomeprazole|esomeprazole|mesh-list
139184152|NCT03812419|Pantoprazole|pantoprazole|mesh-list
139184153|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139184154|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139184155|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139184156|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184157|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184159|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139184160|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139184161|NCT01132235|Analgesics|analgesics|mesh-ancestor
138777102|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
139184162|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
139184163|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184164|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184165|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139184166|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139184167|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139184168|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139184169|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
139184170|NCT01131689|Sorafenib|sorafenib|mesh-list
139184171|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184172|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139184174|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184175|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
139184176|NCT03401229|Benralizumab|benralizumab|mesh-list
138777308|NCT05538052|Narcotics|narcotics|mesh-ancestor
139184177|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139184178|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
139184179|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139184180|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139184181|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
139184183|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
139184184|NCT05281081|Morphine|morphine|mesh-list
138934687|NCT00720512|Antidotes|antidotes|mesh-ancestor
139184185|NCT05281081|Levobupivacaine|levobupivacaine|mesh-list
139184186|NCT05281081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139184187|NCT05281081|Narcotics|narcotics|mesh-ancestor
139184188|NCT05281081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184189|NCT05281081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184190|NCT05281081|Analgesics|analgesics|mesh-ancestor
139184191|NCT05281081|Sensory System Agents|sensory system agents|mesh-ancestor
139184192|NCT05281081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184193|NCT05281081|Anesthetics, Local|anesthetics, local|mesh-ancestor
139184194|NCT05281081|Anesthetics|anesthetics|mesh-ancestor
139184195|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
139184196|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139184197|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139184198|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139184199|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139184200|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184201|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
139184202|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139184203|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184204|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139184205|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184206|NCT01303237|Cetuximab|cetuximab|mesh-list
139184207|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139184208|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184209|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
139184211|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139184212|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139184213|NCT01227941|Doxorubicin|doxorubicin|mesh-list
139184214|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139184215|NCT01227941|Niraparib|niraparib|mesh-list
139184216|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139184217|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184218|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139184219|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139184220|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777501|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
139184221|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184222|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139184223|NCT03919565|Tenofovir|tenofovir|mesh-list
139184224|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139184225|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139184226|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
138968982|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138719814|NCT00474929|Everolimus|everolimus|mesh-list
138968989|NCT04088903|Daratumumab|daratumumab|mesh-list
138968990|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968992|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138968993|NCT00861120|Panitumumab|panitumumab|mesh-list
138968994|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139184227|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139184228|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139184229|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139184230|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184231|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184232|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139184233|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139184235|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
139184236|NCT03380091|Metformin|metformin|mesh-list
139184237|NCT03380091|Vitamins|vitamins|mesh-ancestor
139184238|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
139184239|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184240|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139184241|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139184242|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139184243|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
139184244|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139184245|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184246|NCT03919253|Paclitaxel|paclitaxel|mesh-list
138777692|NCT02620423|Leucovorin|leucovorin|mesh-list
139184248|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139184249|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184250|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
139184251|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
139184252|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
139184253|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184254|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777827|NCT01149863|Plerixafor|plerixafor|mesh-list
139184255|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139184256|NCT05165290|Latanoprost|latanoprost|mesh-list
139184257|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139184258|NCT01132703|Glyburide|glyburide|mesh-list
139184259|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139184260|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184261|NCT01377922|Amifampridine|amifampridine|mesh-list
139184262|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138777959|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139184264|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184265|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139184266|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138778032|NCT02789332|Paclitaxel|paclitaxel|mesh-list
138778036|NCT02789332|Epirubicin|epirubicin|mesh-list
139184267|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184269|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139184270|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184271|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
139184272|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184274|NCT01303471|Remifentanil|remifentanil|mesh-list
139184275|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139184276|NCT01303471|Narcotics|narcotics|mesh-ancestor
138778182|NCT02884115|Penicillins|penicillins|mesh-list
138778245|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
139184277|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184278|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184279|NCT01303471|Analgesics|analgesics|mesh-ancestor
139184280|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
139184281|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184282|NCT03804541|Ensartinib|ensartinib|mesh-list
138778334|NCT02786992|Oxytocin|oxytocin|mesh-list
139184283|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184284|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139184285|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778387|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139184286|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184288|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139184289|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184290|NCT03710811|Insulin|insulin|mesh-list
139184291|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139184292|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184294|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139184295|NCT01303549|Anidulafungin|anidulafungin|mesh-list
139184296|NCT01303549|Amebicides|amebicides|mesh-ancestor
139184297|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139184298|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139184299|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139184300|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139184301|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
139184302|NCT03796975|Metformin|metformin|mesh-list
139184303|NCT03796975|Pioglitazone|pioglitazone|mesh-list
139184304|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138778469|NCT02785666|Ribavirin|ribavirin|mesh-list
139184305|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184306|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138778540|NCT01144403|Rituximab|rituximab|mesh-list
139184307|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184308|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139184309|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184310|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184311|NCT01302613|Leucovorin|leucovorin|mesh-list
139184312|NCT01302613|Capecitabine|capecitabine|mesh-list
139184313|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
139184314|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139184315|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
139184316|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184317|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184318|NCT01302613|Antidotes|antidotes|mesh-ancestor
139184319|NCT01302613|Protective Agents|protective agents|mesh-ancestor
139184320|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184321|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
139184323|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
139184325|NCT03803371|Tramadol|tramadol|mesh-list
139184326|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139184327|NCT03803371|Analgesics|analgesics|mesh-ancestor
139184328|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
139184329|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184331|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
139184332|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139184333|NCT03803371|Narcotics|narcotics|mesh-ancestor
139184334|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184335|NCT01130909|Ketamine|ketamine|mesh-list
138934833|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
139184336|NCT01130909|Analgesics|analgesics|mesh-ancestor
139184337|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
139184338|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778930|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139184339|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184340|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138779009|NCT02615041|Meropenem|meropenem|mesh-list
139184341|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139184342|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
139184343|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
139184344|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184345|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139184346|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139184347|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139184348|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184350|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
139184351|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139184352|NCT04453930|Irinotecan|irinotecan|mesh-list
139184353|NCT04453930|Apatinib|apatinib|mesh-list
139184354|NCT04453930|Antibodies|antibodies|mesh-list
139184355|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
139184356|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779207|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139184357|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139184358|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139184359|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184360|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184361|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184362|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139184363|NCT03796507|Temozolomide|temozolomide|mesh-list
138779349|NCT02200978|Analgesics|analgesics|mesh-ancestor
139184364|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139184365|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
139184366|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184367|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184368|NCT01132781|Theophylline|theophylline|mesh-list
139184369|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139184370|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
139184371|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184372|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184373|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139184374|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
139184375|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139184376|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779492|NCT01194830|Incretins|incretins|mesh-ancestor
139184377|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184378|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
139184379|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139184380|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139184382|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139184384|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184385|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139184386|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184387|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184388|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
139184389|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138779698|NCT01192178|Hormones|hormones|mesh-ancestor
139184390|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
139184391|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184392|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139184393|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139184394|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
139184395|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184396|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184397|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139184398|NCT01134341|Vitamins|vitamins|mesh-list
139184399|NCT01134341|Folic Acid|folic acid|mesh-list
139184400|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
139184401|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
139184402|NCT01134341|Bexarotene|bexarotene|mesh-list
139184403|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
139184404|NCT01134341|Aminopterin|aminopterin|mesh-list
139184405|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
139184406|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184407|NCT01134341|Hematinics|hematinics|mesh-ancestor
139184408|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139184409|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184410|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184411|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934903|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184413|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139184414|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184415|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184416|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
139184417|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780049|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139184418|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184419|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
139184420|NCT05397262|Fluorouracil|fluorouracil|mesh-list
139184421|NCT05397262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184422|NCT05397262|Antimetabolites|antimetabolites|mesh-ancestor
138780113|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
139184423|NCT05397262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184424|NCT05397262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139184425|NCT05397262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139184426|NCT05397262|Immunologic Factors|immunologic factors|mesh-ancestor
139184427|NCT05397262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184428|NCT01230359|Pyridoxine|pyridoxine|mesh-list
139184429|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
139184430|NCT01230359|Vitamins|vitamins|mesh-ancestor
139184431|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
139184432|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184433|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
139184434|NCT05396326|Oxaliplatin|oxaliplatin|mesh-list
139184435|NCT05396326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184436|NCT03795571|Dexamethasone|dexamethasone|mesh-list
139184437|NCT03795571|Rituximab|rituximab|mesh-list
139184438|NCT03795571|Gemcitabine|gemcitabine|mesh-list
139184439|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
139184440|NCT03795571|Lenalidomide|lenalidomide|mesh-list
139184441|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139184442|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
139184443|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
139184444|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184445|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184447|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
139184448|NCT03795571|Hormones|hormones|mesh-ancestor
139184449|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139184450|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139184451|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184452|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139184453|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
139184454|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139184455|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139184456|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
139184457|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184458|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139184459|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139184460|NCT03795571|Growth Substances|growth substances|mesh-ancestor
139184461|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
139184462|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
139184463|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139184464|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139184465|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184466|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
139184467|NCT03795649|Coagulants|coagulants|mesh-ancestor
139184468|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
139184469|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139184470|NCT04211272|Macitentan|macitentan|mesh-list
139184471|NCT04211272|Riociguat|riociguat|mesh-list
139184472|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138454871|NCT01901692|Sorafenib|sorafenib|mesh-list
139184473|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139184474|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
139184475|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184476|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139184477|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139184478|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184479|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
138780512|NCT04316936|Hormones|hormones|mesh-ancestor
139184480|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139184481|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139184482|NCT04211272|Urological Agents|urological agents|mesh-ancestor
139184483|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138969083|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
139184484|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139184486|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
139184487|NCT05402189|Fentanyl|fentanyl|mesh-list
139184488|NCT05402189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139184489|NCT05402189|Narcotics|narcotics|mesh-ancestor
139184490|NCT05402189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184491|NCT05402189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184492|NCT05402189|Analgesics|analgesics|mesh-ancestor
139184493|NCT05402189|Sensory System Agents|sensory system agents|mesh-ancestor
139184494|NCT05402189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184495|NCT05402189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139184496|NCT05402189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139184497|NCT05402189|Anesthetics, General|anesthetics, general|mesh-ancestor
139184498|NCT05402189|Anesthetics|anesthetics|mesh-ancestor
139184499|NCT01304563|Vaccines|vaccines|mesh-list
139184500|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
139184501|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184502|NCT01231997|Udenafil|udenafil|mesh-list
138780649|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139184503|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139184504|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139184505|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184506|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184507|NCT03795805|Lidocaine|lidocaine|mesh-list
139184508|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
139184509|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
139184510|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184511|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184512|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
139184513|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184514|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139184515|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139184516|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139184517|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138780842|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139184518|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184519|NCT04072042|Apatinib|apatinib|mesh-list
139184520|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184521|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139184522|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184523|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184525|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139184526|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
139184527|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780977|NCT02758366|Doxorubicin|doxorubicin|mesh-list
139184528|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184530|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139184531|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
139184532|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781048|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184533|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184535|NCT05387200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139184536|NCT05387200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184538|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139184539|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139184540|NCT03442972|Protective Agents|protective agents|mesh-ancestor
139184541|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184542|NCT03921671|Paclitaxel|paclitaxel|mesh-list
139184543|NCT03921671|Carboplatin|carboplatin|mesh-list
139184544|NCT03921671|Ramucirumab|ramucirumab|mesh-list
138969111|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184545|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139184546|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184548|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
139184549|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
139184550|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184551|NCT03921593|Pancrelipase|pancrelipase|mesh-list
139184552|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139184553|NCT03369951|Minocycline|minocycline|mesh-list
139184554|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139184555|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139184556|NCT01131767|Naproxen|naproxen|mesh-list
139184557|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
139184558|NCT01131767|Ephedrine|ephedrine|mesh-list
139184559|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139184560|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139184561|NCT01131767|Analgesics|analgesics|mesh-ancestor
138935061|NCT00859534|Afamelanotide|afamelanotide|mesh-list
139184562|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
139184563|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184564|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184565|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139184566|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139184567|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
139184568|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139184569|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184570|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184571|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139184572|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
139184573|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139184574|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
139184575|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
139184576|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139184577|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139184578|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
138903403|NCT00672971|Permethrin|permethrin|mesh-list
139184579|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
139184580|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139184581|NCT03795259|Rocuronium|rocuronium|mesh-list
139184582|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139184583|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139184584|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139184585|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184586|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184588|NCT01229189|Vitamins|vitamins|mesh-ancestor
139184589|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
139184590|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184591|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139184592|NCT05341180|Lactulose|lactulose|mesh-list
139184593|NCT05341180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139184594|NCT05341180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139184595|NCT01133483|Fexofenadine|fexofenadine|mesh-list
139184596|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
139184597|NCT01133483|Ephedrine|ephedrine|mesh-list
139184598|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139184599|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139184600|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139184601|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
139184602|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
139184604|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781812|NCT02041234|Hormones|hormones|mesh-ancestor
139184605|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184606|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139184607|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
139184608|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184609|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139184610|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
139184612|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139184613|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138781945|NCT02744638|Metronidazole|metronidazole|mesh-list
139184614|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
139184615|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
139184616|NCT05401721|Arginine Vasopressin|arginine vasopressin|mesh-list
139184618|NCT05401721|Coagulants|coagulants|mesh-ancestor
139184619|NCT05401721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139184620|NCT05401721|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139184621|NCT05401721|Natriuretic Agents|natriuretic agents|mesh-ancestor
139184622|NCT05401721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184624|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139184625|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184626|NCT05238844|Tenofovir|tenofovir|mesh-list
139184627|NCT05238844|Antiviral Agents|antiviral agents|mesh-ancestor
139184628|NCT05238844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139184629|NCT05238844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139184630|NCT05238844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139184631|NCT05238844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184632|NCT05238844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184633|NCT05238844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139184634|NCT05238844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139184635|NCT04785625|Bupivacaine|bupivacaine|mesh-list
139184636|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
139184637|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
139184638|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184639|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184640|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
139184641|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184643|NCT03368859|Bevacizumab|bevacizumab|mesh-list
139184645|NCT03368859|Irinotecan|irinotecan|mesh-list
139184646|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139184647|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184648|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139184649|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139184650|NCT03368859|Growth Substances|growth substances|mesh-ancestor
139184651|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184652|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
139184653|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
139184654|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184655|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139184656|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139184657|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
139184658|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139184659|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139184660|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184661|NCT03368859|Antidotes|antidotes|mesh-ancestor
139184662|NCT03368859|Protective Agents|protective agents|mesh-ancestor
139184663|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
139184665|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
139184666|NCT01134965|Digoxin|digoxin|mesh-list
139184667|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138782359|NCT01126541|Rituximab|rituximab|mesh-list
139184668|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139184669|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184670|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184671|NCT01134965|Protective Agents|protective agents|mesh-ancestor
139184672|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184673|NCT03810547|Ketamine|ketamine|mesh-list
139184674|NCT03810547|Propofol|propofol|mesh-list
138782415|NCT02732314|Desonide|desonide|mesh-list
139184675|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139184676|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184677|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184678|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139184679|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
139184680|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
139184681|NCT03810547|Analgesics|analgesics|mesh-ancestor
139184682|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
139184683|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184684|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139184685|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139184686|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139184687|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139184688|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184689|NCT03096314|Vitamin D|vitamin d|mesh-list
139184690|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
139184691|NCT03096314|Vitamins|vitamins|mesh-ancestor
139184692|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
139184693|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184694|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139184695|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139184696|NCT03129646|Paromomycin|paromomycin|mesh-list
139184697|NCT03129646|Miltefosine|miltefosine|mesh-list
139184698|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
139184699|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139184700|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139184701|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139184702|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139184703|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
139184704|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184705|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
139184706|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139184707|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
139184708|NCT03710655|Histamine|histamine|mesh-list
139184709|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
139184710|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
139184711|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139184712|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935205|NCT00724022|Hormones|hormones|mesh-ancestor
139184713|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184714|NCT03917537|Nivolumab|nivolumab|mesh-list
139184715|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139184716|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184717|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138782820|NCT02725918|Pemetrexed|pemetrexed|mesh-list
139184718|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184721|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139184722|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184723|NCT04749602|Nivolumab|nivolumab|mesh-list
139184724|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139184725|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184726|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139184727|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184728|NCT03461302|Coal Tar|coal tar|mesh-list
139184729|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
139184730|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
139184732|NCT01232075|Citric Acid|citric acid|mesh-list
139184733|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
139184734|NCT01232075|Clomiphene|clomiphene|mesh-list
139184735|NCT01232075|Enclomiphene|enclomiphene|mesh-list
139184736|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
139184737|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
139184738|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139184739|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
139184740|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
139184741|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783115|NCT02714842|Diclofenac|diclofenac|mesh-list
139184742|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184743|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139184744|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139184745|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184746|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139184747|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
139184748|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139184749|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184750|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139184751|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
139184752|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139184753|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139184754|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139184755|NCT01131845|Treprostinil|treprostinil|mesh-list
139184756|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139184757|NCT03711422|Afatinib|afatinib|mesh-list
139184758|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184759|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139184760|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184761|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184762|NCT03460678|Pemetrexed|pemetrexed|mesh-list
139184763|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139184764|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184765|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184766|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184767|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139184768|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139184769|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139184770|NCT03810391|Butorphanol|butorphanol|mesh-list
139184771|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139184772|NCT03810391|Narcotics|narcotics|mesh-ancestor
139184773|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184774|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184775|NCT03810391|Analgesics|analgesics|mesh-ancestor
138903452|NCT02535299|Metformin|metformin|mesh-list
139184776|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
139184777|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184778|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
139184779|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
138783362|NCT00611962|Paclitaxel|paclitaxel|mesh-list
139184780|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139184781|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
139184782|NCT01229579|Astringents|astringents|mesh-ancestor
139184783|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184784|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
139184785|NCT01131923|Amlodipine|amlodipine|mesh-list
139184786|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139184787|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139184788|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139184789|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184790|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139184791|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184792|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
138783489|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
139184793|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
139184794|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
139184796|NCT01230983|Cytarabine|cytarabine|mesh-list
139184797|NCT01230983|Prednisone|prednisone|mesh-list
139184798|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
139184799|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139184800|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139184801|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138783564|NCT00612274|Sirolimus|sirolimus|mesh-list
139184802|NCT01230983|Doxorubicin|doxorubicin|mesh-list
139184803|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139184804|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
139184805|NCT01230983|Methotrexate|methotrexate|mesh-list
139184806|NCT01230983|Vincristine|vincristine|mesh-list
139184807|NCT01230983|Asparaginase|asparaginase|mesh-list
139184808|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
139184809|NCT01230983|Razoxane|razoxane|mesh-list
139184810|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
139184811|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139184812|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184813|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138783695|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
139184814|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139184815|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184816|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184817|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184818|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139184819|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
139184820|NCT01230983|Hormones|hormones|mesh-ancestor
139184821|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139184822|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139184823|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139184824|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
139184825|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139184826|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139184827|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
139184828|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
139184829|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138783842|NCT03808090|Calcium|calcium|mesh-list
139184830|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139184831|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
139184832|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139184833|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139184834|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
139184835|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139184836|NCT01230983|Antidotes|antidotes|mesh-ancestor
139184837|NCT01230983|Protective Agents|protective agents|mesh-ancestor
139184838|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
139184839|NCT01230983|Vitamins|vitamins|mesh-ancestor
139184840|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
139184841|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139184842|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
139184843|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
139184844|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
139184845|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139184846|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
139184847|NCT01304797|Trastuzumab|trastuzumab|mesh-list
139184848|NCT01304797|Doxorubicin|doxorubicin|mesh-list
139184849|NCT01304797|Gancotamab|gancotamab|mesh-list
139184850|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
139184851|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139184852|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
139184853|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184854|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139184855|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139184856|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
139184857|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184858|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184859|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139184860|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139184861|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139184862|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139184863|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139184864|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184865|NCT03707535|Infliximab|infliximab|mesh-list
139184866|NCT03707535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139184867|NCT03707535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139184868|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
139184870|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139184871|NCT01133795|Midodrine|midodrine|mesh-list
139184872|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
139184873|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
139184874|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184875|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184876|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139184877|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139184878|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139184879|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139184880|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
139184881|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139184882|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184883|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
139184884|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
139184885|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139184886|NCT01133873|Narcotics|narcotics|mesh-ancestor
139184887|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184888|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184890|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
139184891|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184892|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
139184893|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
139184894|NCT01229813|Bevacizumab|bevacizumab|mesh-list
139184895|NCT01229813|Capecitabine|capecitabine|mesh-list
139184896|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139184897|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139184898|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184899|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139184900|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139184901|NCT01229813|Growth Substances|growth substances|mesh-ancestor
139184902|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184903|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
139184904|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139184905|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
139184906|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184907|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139184908|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184909|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
139184910|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
139184911|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184912|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139184913|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184914|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139184915|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
139184916|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184917|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139184918|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184919|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
139184920|NCT01649947|Paclitaxel|paclitaxel|mesh-list
139184921|NCT01649947|Bevacizumab|bevacizumab|mesh-list
139184922|NCT01649947|Carboplatin|carboplatin|mesh-list
139184923|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139184924|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184925|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
139184926|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
139184927|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
139184928|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184929|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139184930|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138969247|NCT00796796|Sirolimus|sirolimus|mesh-list
139184931|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139184932|NCT01649947|Growth Substances|growth substances|mesh-ancestor
139184933|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184934|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
139184935|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
139184936|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139184937|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139184938|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784381|NCT03522064|Androgens|androgens|mesh-ancestor
139184939|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184940|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139184941|NCT03793075|Ketamine|ketamine|mesh-list
139184942|NCT03793075|Propofol|propofol|mesh-list
139184943|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139184944|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139184945|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184946|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139184947|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
139184948|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
139184949|NCT03793075|Analgesics|analgesics|mesh-ancestor
139184950|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
139184951|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139184952|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139184953|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139184954|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139184955|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139184956|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184957|NCT01233167|Clopidogrel|clopidogrel|mesh-list
138784584|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
139184958|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139184959|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139184960|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139184962|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
139184963|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139184964|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184965|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184966|NCT01304095|Ranolazine|ranolazine|mesh-list
139184967|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139184968|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139184969|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184970|NCT03707457|Nivolumab|nivolumab|mesh-list
139184971|NCT03707457|Ipilimumab|ipilimumab|mesh-list
139184972|NCT03707457|MK-4166|mk-4166|mesh-list
139184973|NCT03707457|Antibodies|antibodies|mesh-list
139184974|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139184975|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
139184976|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784854|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139184977|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139184978|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184979|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139184980|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184981|NCT01568294|Pomalidomide|pomalidomide|mesh-list
139184982|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
138784920|NCT02601586|Oxycodone|oxycodone|mesh-list
139184983|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184985|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139184986|NCT01568294|Growth Substances|growth substances|mesh-ancestor
139184987|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
139184988|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139184989|NCT03422666|Teduglutide|teduglutide|mesh-list
139184990|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139184991|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139184992|NCT03422666|Protective Agents|protective agents|mesh-ancestor
139184993|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184994|NCT03453190|Apremilast|apremilast|mesh-list
139184995|NCT03453190|Clobetasol|clobetasol|mesh-list
139184996|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139184997|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139184998|NCT03453190|Analgesics|analgesics|mesh-ancestor
139184999|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
139185000|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185001|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185002|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139185003|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139185004|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139185005|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139185006|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185007|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185008|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
139185009|NCT03453190|Hormones|hormones|mesh-ancestor
139185010|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139185011|NCT01231139|Acetaminophen|acetaminophen|mesh-list
139185012|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139185013|NCT01231139|Analgesics|analgesics|mesh-ancestor
138784991|NCT01027884|Idebenone|idebenone|mesh-list
139185014|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
139185015|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185016|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185017|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
139185018|NCT03382574|Denosumab|denosumab|mesh-list
139185019|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139185020|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185021|NCT01137695|Pramlintide|pramlintide|mesh-list
139185022|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
139185023|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139185024|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185025|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
139185026|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139185027|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
139185028|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185030|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139185031|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139185032|NCT02528825|Remifentanil|remifentanil|mesh-list
139185033|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139185034|NCT02528825|Narcotics|narcotics|mesh-ancestor
139185035|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185036|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185038|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
139185039|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185040|NCT01233245|Interferons|interferons|mesh-list
139185041|NCT01233245|Interferon-beta|interferon-beta|mesh-list
139185042|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
139185043|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185044|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
139185045|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185046|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
138969276|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
139185047|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185048|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139185050|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139185051|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138785241|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
139185052|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185053|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
139185054|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
139185055|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
138785302|NCT02705482|Durvalumab|durvalumab|mesh-list
139185056|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185058|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139185059|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185060|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185061|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139185062|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
139185063|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
139185064|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
139185065|NCT03794167|Melphalan|melphalan|mesh-list
139185066|NCT03794167|Busulfan|busulfan|mesh-list
139185067|NCT03794167|Etoposide|etoposide|mesh-list
139185069|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
139185070|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185071|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139185072|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139185073|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
138785579|NCT05329857|Vildagliptin|vildagliptin|mesh-list
139185074|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185075|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185076|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139185077|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139185078|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139185079|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139185081|NCT05332821|Bevacizumab|bevacizumab|mesh-list
139185082|NCT05332821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139185083|NCT05332821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139185084|NCT05332821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185085|NCT05332821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139185086|NCT05332821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139185087|NCT05332821|Growth Substances|growth substances|mesh-ancestor
139185088|NCT05332821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185089|NCT05332821|Growth Inhibitors|growth inhibitors|mesh-ancestor
139185090|NCT05332821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185091|NCT01134185|Prucalopride|prucalopride|mesh-list
139185092|NCT01134185|Laxatives|laxatives|mesh-ancestor
139185093|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139185094|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139185095|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139185096|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
139185097|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185098|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185099|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185100|NCT03829046|Evolocumab|evolocumab|mesh-list
139185101|NCT03829046|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139185102|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139185103|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139185104|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
139185105|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185106|NCT03829046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139185107|NCT03829046|Protease Inhibitors|protease inhibitors|mesh-ancestor
139185108|NCT03829046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185109|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139185110|NCT05320588|Pembrolizumab|pembrolizumab|mesh-list
139185111|NCT05320588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139185112|NCT05320588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185113|NCT05320588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139185114|NCT05320588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185115|NCT01231529|Dolutegravir|dolutegravir|mesh-list
139185116|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139185117|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139185118|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185119|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185120|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139185121|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139185122|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
139185123|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185124|NCT05306704|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139185125|NCT05306704|Calcifediol|calcifediol|mesh-list
139185126|NCT05306704|Vitamins|vitamins|mesh-ancestor
139185127|NCT05306704|Micronutrients|micronutrients|mesh-ancestor
139185128|NCT05306704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185129|NCT05306704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139185130|NCT01231685|Ritonavir|ritonavir|mesh-list
139185131|NCT01231685|Lopinavir|lopinavir|mesh-list
139185132|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139185133|NCT01231685|Darunavir|darunavir|mesh-list
139185134|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139185135|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
139185136|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
139185137|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139185138|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185139|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185140|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139185141|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139185142|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
139185143|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185144|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139185145|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139185146|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139185147|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139185148|NCT05402735|Uric Acid|uric acid|mesh-list
139185149|NCT05402735|Antioxidants|antioxidants|mesh-ancestor
139185150|NCT05402735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185151|NCT05402735|Protective Agents|protective agents|mesh-ancestor
139185152|NCT05402735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185153|NCT01138085|Trametinib|trametinib|mesh-list
139185154|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185155|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139185156|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185157|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185158|NCT05278858|Triamcinolone|triamcinolone|mesh-list
139185159|NCT05278858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139185160|NCT05278858|Glucocorticoids|glucocorticoids|mesh-ancestor
139185161|NCT05278858|Hormones|hormones|mesh-ancestor
139185162|NCT05278858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139185163|NCT05278858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185164|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139185166|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
139185167|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185168|NCT03359811|Bupivacaine|bupivacaine|mesh-list
139185169|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
139185171|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185172|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185173|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
139185174|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185175|NCT03728426|Letermovir|letermovir|mesh-list
139185176|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139185177|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185178|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185180|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
139185181|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185182|NCT01140581|Dronedarone|dronedarone|mesh-list
139185183|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139185184|NCT03792139|Itraconazole|itraconazole|mesh-list
139185185|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
139185186|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185187|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139185188|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139185189|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185190|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185191|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139185192|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
139185193|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139185194|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185195|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139185196|NCT03792295|Acetaminophen|acetaminophen|mesh-list
139185197|NCT03792295|Ibuprofen|ibuprofen|mesh-list
139185198|NCT03792295|Oxycodone|oxycodone|mesh-list
139185199|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139185200|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139185201|NCT03792295|Analgesics|analgesics|mesh-ancestor
139185202|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
139185203|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185204|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185205|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139185206|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139185207|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139185208|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185209|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185210|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139185211|NCT03792295|Narcotics|narcotics|mesh-ancestor
139185212|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185213|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
139185214|NCT03449056|Albuterol|albuterol|mesh-list
139185215|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139185216|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
139185217|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185218|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185219|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139185220|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
139185221|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
139185222|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139185223|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139185224|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139185225|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139185226|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
139185227|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185228|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185229|NCT01135433|Metformin|metformin|mesh-list
139185230|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
139185231|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139185232|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185233|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139185234|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185235|NCT04745273|Ondansetron|ondansetron|mesh-list
139185236|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
139185237|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
139185238|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185239|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185240|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139185241|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
139185242|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
139185243|NCT04745273|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139185244|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139185246|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185247|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185248|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
139185249|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139185250|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
139185251|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185252|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
139185253|NCT01305187|Protective Agents|protective agents|mesh-ancestor
139185254|NCT01138397|Vaccines|vaccines|mesh-list
139185255|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
139185256|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185258|NCT03448744|Thymalfasin|thymalfasin|mesh-list
139185259|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
139185260|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185261|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139185262|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
139185263|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185264|NCT03448588|Selenium|selenium|mesh-list
139185265|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
139185266|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185267|NCT03448588|Protective Agents|protective agents|mesh-ancestor
138903558|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
139185268|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185269|NCT03448588|Trace Elements|trace elements|mesh-ancestor
139185270|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
139185271|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
139185272|NCT03797443|Paclitaxel|paclitaxel|mesh-list
139185273|NCT03797443|Gemcitabine|gemcitabine|mesh-list
139185274|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139185275|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185276|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
139185277|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
139185278|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
139185279|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185280|NCT03797443|Vitamins|vitamins|mesh-ancestor
139185281|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
139185282|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185283|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139185284|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
139185285|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
139185286|NCT03797443|Protective Agents|protective agents|mesh-ancestor
139185287|NCT01135589|Micafungin|micafungin|mesh-list
139185288|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
139185289|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185290|NCT01140737|Axitinib|axitinib|mesh-list
139185291|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185292|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139185293|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185294|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185295|NCT05594095|Everolimus|everolimus|mesh-list
139185296|NCT05594095|Fulvestrant|fulvestrant|mesh-list
139185297|NCT05594095|Goserelin|goserelin|mesh-list
139185298|NCT05594095|Fluzoparib|fluzoparib|mesh-list
139185299|NCT05594095|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139185300|NCT05594095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139185301|NCT05594095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139185302|NCT05594095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185303|NCT05594095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185304|NCT05594095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139185305|NCT05594095|Immunologic Factors|immunologic factors|mesh-ancestor
139185306|NCT05594095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185307|NCT05594095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185308|NCT05594095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139185309|NCT05594095|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139185310|NCT05594095|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139185311|NCT05594095|Hormone Antagonists|hormone antagonists|mesh-ancestor
139185312|NCT05594095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139185313|NCT05594095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139185314|NCT05594095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139185315|NCT05624671|Fentanyl|fentanyl|mesh-list
139185316|NCT05624671|Bupivacaine|bupivacaine|mesh-list
139185317|NCT05624671|Anesthetics, Local|anesthetics, local|mesh-ancestor
139185318|NCT05624671|Anesthetics|anesthetics|mesh-ancestor
139185319|NCT05624671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185320|NCT05624671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185321|NCT05624671|Sensory System Agents|sensory system agents|mesh-ancestor
139185322|NCT05624671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185323|NCT05624671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139185324|NCT05624671|Narcotics|narcotics|mesh-ancestor
139185325|NCT05624671|Analgesics|analgesics|mesh-ancestor
139185326|NCT05624671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139185327|NCT05624671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139185329|NCT03578965|Cefazolin|cefazolin|mesh-list
139185330|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139185331|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185332|NCT03791905|Leucovorin|leucovorin|mesh-list
139185333|NCT03791905|Paclitaxel|paclitaxel|mesh-list
139185334|NCT03791905|Fluorouracil|fluorouracil|mesh-list
139185335|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
139185336|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139185337|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185338|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
139185339|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
139185340|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
139185341|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185342|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
139185343|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139185344|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139185345|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
139185346|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185347|NCT03791905|Antidotes|antidotes|mesh-ancestor
139185348|NCT03791905|Protective Agents|protective agents|mesh-ancestor
139185349|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
139185350|NCT03791905|Vitamins|vitamins|mesh-ancestor
139185351|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
139185352|NCT01138553|Mifepristone|mifepristone|mesh-list
139185353|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139185354|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
139185355|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139185356|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185357|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139185359|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139185360|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
139185361|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139185362|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139185363|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
139185364|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139185365|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
139185366|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139185367|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139185368|NCT05171374|Trametinib|trametinib|mesh-list
139185369|NCT05171374|Dabrafenib|dabrafenib|mesh-list
139185370|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185371|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139185372|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185373|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185374|NCT03447184|Androgens|androgens|mesh-list
139185375|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139185376|NCT03447184|Hormones|hormones|mesh-ancestor
139185377|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139185378|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185379|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139185380|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185381|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185382|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139185383|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
139185384|NCT03739541|Benzonidazole|benzonidazole|mesh-list
139185385|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139185386|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
139185387|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185388|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139185389|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139185390|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139185391|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185392|NCT01135667|Clopidogrel|clopidogrel|mesh-list
139185393|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139185394|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139185395|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139185396|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139185397|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139185398|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
138903584|NCT04151381|Aminophylline|aminophylline|mesh-list
139185399|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185400|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185401|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185402|NCT03446872|Leucovorin|leucovorin|mesh-list
139185403|NCT03446872|Fluorouracil|fluorouracil|mesh-list
139185404|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
139185405|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185406|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139185407|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185408|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139185409|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
139185410|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185411|NCT03446872|Antidotes|antidotes|mesh-ancestor
139185412|NCT03446872|Protective Agents|protective agents|mesh-ancestor
139185413|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
139185414|NCT03446872|Vitamins|vitamins|mesh-ancestor
139185415|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
139185416|NCT03446638|Cytarabine|cytarabine|mesh-list
139185417|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139185418|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
139185419|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185420|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185421|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
139185422|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185423|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139185424|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
139185425|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185427|NCT05401019|Risperidone|risperidone|mesh-list
139185428|NCT05401019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139185429|NCT05401019|Serotonin Agents|serotonin agents|mesh-ancestor
139185430|NCT05401019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185431|NCT05401019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185432|NCT05401019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185433|NCT05401019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139185434|NCT05401019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139185435|NCT05401019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185436|NCT05401019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139185437|NCT05401019|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139185438|NCT05401019|Dopamine Agents|dopamine agents|mesh-ancestor
139185439|NCT05401019|Antioxidants|antioxidants|mesh-ancestor
139185440|NCT05401019|Protective Agents|protective agents|mesh-ancestor
139185441|NCT05401019|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139185442|NCT05401019|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139185443|NCT05401019|Dopamine Agonists|dopamine agonists|mesh-ancestor
139185444|NCT03788863|Diflucortolone|diflucortolone|mesh-list
139185445|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
139185446|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139185447|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
139185448|NCT03788863|Hormones|hormones|mesh-ancestor
138903600|NCT00809133|Paclitaxel|paclitaxel|mesh-list
139185449|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139185450|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185451|NCT03129256|Apatinib|apatinib|mesh-list
139185452|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185453|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139185454|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185455|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185456|NCT05682807|Caffeine|caffeine|mesh-list
139185457|NCT05682807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139185458|NCT05682807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185459|NCT05682807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139185460|NCT05682807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785929|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139185461|NCT05682807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185462|NCT05682807|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139185464|NCT05682807|Purinergic Agents|purinergic agents|mesh-ancestor
139185465|NCT05682807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185466|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
139185467|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
139185468|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
139185469|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185470|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185471|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
139185472|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185473|NCT03445702|Metformin|metformin|mesh-list
139185474|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139185475|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185476|NCT03445624|Infliximab|infliximab|mesh-list
139185477|NCT03445624|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139185478|NCT03445624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139185479|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
139185480|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139185481|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139185482|NCT01312077|Morphine|morphine|mesh-list
139185483|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
139185484|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139185485|NCT01312077|Narcotics|narcotics|mesh-ancestor
138969382|NCT00518284|Paclitaxel|paclitaxel|mesh-list
139185486|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185487|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185488|NCT01312077|Analgesics|analgesics|mesh-ancestor
139185489|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
139185490|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185491|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
139185492|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
139185493|NCT03793309|Vitamin D|vitamin d|mesh-list
139185494|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
139185495|NCT03793309|Cholecalciferol|cholecalciferol|mesh-list
139185496|NCT03793309|Vitamins|vitamins|mesh-list
139185497|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
139185498|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185499|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139185500|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139185501|NCT01140893|Exenatide|exenatide|mesh-list
139185502|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139185503|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185504|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139185505|NCT01140893|Incretins|incretins|mesh-ancestor
139185506|NCT01140893|Hormones|hormones|mesh-ancestor
139185507|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139185508|NCT03445468|Vaccines|vaccines|mesh-list
139185509|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
139185510|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185511|NCT03791827|Cyclosporine|cyclosporine|mesh-list
139185512|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
139185513|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
139185514|NCT03791827|Prednisone|prednisone|mesh-list
139185515|NCT03791827|Prednisolone|prednisolone|mesh-list
139185516|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
139185517|NCT03791827|Rituximab|rituximab|mesh-list
139185518|NCT03791827|Azathioprine|azathioprine|mesh-list
139185519|NCT03791827|Tacrolimus|tacrolimus|mesh-list
139185520|NCT03791827|Cyclosporins|cyclosporins|mesh-list
139185521|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139185522|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
139185523|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185524|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139185525|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139185526|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
139185527|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185528|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185529|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139185530|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139185531|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139185532|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
139185533|NCT03791827|Hormones|hormones|mesh-ancestor
139185534|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139185535|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139185537|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185538|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
139185539|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185540|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
139185541|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139185542|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139185543|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
139185544|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139185545|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
139185546|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139185547|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139185548|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
139185549|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139185550|NCT03708861|Ritonavir|ritonavir|mesh-list
139185551|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139185552|NCT03708861|Maraviroc|maraviroc|mesh-list
139185553|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139185554|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139185555|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
139185556|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185557|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185558|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139185559|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139185560|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
139185561|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185562|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139185563|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139185564|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139185565|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139185566|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139185567|NCT01308229|Paclitaxel|paclitaxel|mesh-list
139185568|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138903632|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
139185569|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185570|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
139185571|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
139185572|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
139185573|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185574|NCT03445078|Selenium|selenium|mesh-list
139185575|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
139185576|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185577|NCT03445078|Protective Agents|protective agents|mesh-ancestor
139185578|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185579|NCT03445078|Trace Elements|trace elements|mesh-ancestor
139185580|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
139185581|NCT01233791|Diazepam|diazepam|mesh-list
139185582|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139185583|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
139185584|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
139185585|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
139185586|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185587|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185588|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139185589|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139185590|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185591|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139185592|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139185593|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139185594|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139185595|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139185596|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139185597|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
139185598|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
139185599|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
139185600|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
139185601|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185602|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185603|NCT01140971|Misoprostol|misoprostol|mesh-list
139185604|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139185605|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
139185606|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139185607|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185608|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139185609|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139185610|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
139185611|NCT03129022|Anesthetics|anesthetics|mesh-list
139185612|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185613|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185614|NCT03342963|Aripiprazole|aripiprazole|mesh-list
139185615|NCT03342963|Sertraline|sertraline|mesh-list
139185616|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
139185617|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139185618|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139185619|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138969407|NCT00727415|Fludarabine|fludarabine|mesh-list
139185620|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185621|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185622|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
139185623|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
139185624|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185625|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185626|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139185627|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139185628|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
139185629|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139185630|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139185631|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138903657|NCT00675545|Carboplatin|carboplatin|mesh-list
139185632|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139185633|NCT03342963|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139185634|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139185635|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139185636|NCT03706755|Norepinephrine|norepinephrine|mesh-list
139185637|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139185638|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139185639|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
139185640|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185641|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185642|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185643|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
139185644|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
139185645|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185646|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139185647|NCT03791515|Calcitonin|calcitonin|mesh-list
139185648|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
139185649|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139185650|NCT03791515|Katacalcin|katacalcin|mesh-list
139185651|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139185652|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185653|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139185654|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
139185655|NCT03361956|JNJ-56136379|jnj-56136379|mesh-list
139185656|NCT03361956|Antiviral Agents|antiviral agents|mesh-ancestor
139185657|NCT03361956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185658|NCT04595591|Remifentanil|remifentanil|mesh-list
139185660|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139185661|NCT04595591|Narcotics|narcotics|mesh-ancestor
139185662|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185663|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185664|NCT04595591|Analgesics|analgesics|mesh-ancestor
139185665|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
139185666|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185667|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139185668|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139185669|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139185670|NCT03709953|Apatinib|apatinib|mesh-list
139185671|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185672|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139185673|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185674|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185675|NCT03444142|Exenatide|exenatide|mesh-list
139185676|NCT03444142|Dulaglutide|dulaglutide|mesh-list
139185678|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185679|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139185680|NCT03444142|Incretins|incretins|mesh-ancestor
139185681|NCT03444142|Hormones|hormones|mesh-ancestor
138785944|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139185682|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139185683|NCT01305733|Ketorolac|ketorolac|mesh-list
139185684|NCT01305733|Epinephrine|epinephrine|mesh-list
139185685|NCT01305733|Racepinephrine|racepinephrine|mesh-list
139185686|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
139185687|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
138903662|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
139185688|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139185689|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139185690|NCT01305733|Analgesics|analgesics|mesh-ancestor
139185691|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
139185692|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185693|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185694|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139185695|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139185696|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139185697|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185698|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185699|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
139185700|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
139185701|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185702|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139185703|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139185704|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
139185705|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185706|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139185707|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139185708|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
139185709|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139185710|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
139185711|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
139185712|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
139185713|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139185714|NCT05210153|Sertraline|sertraline|mesh-list
139185715|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
139185716|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139185717|NCT05210153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139185718|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139185719|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139185720|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185721|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185722|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
139185723|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185724|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
139185725|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139185726|NCT04749459|Protective Agents|protective agents|mesh-ancestor
139185727|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185728|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
139185729|NCT01136213|Fluoxetine|fluoxetine|mesh-list
139185730|NCT01136213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139185731|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138887254|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139185732|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139185733|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903685|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
139185734|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185735|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
139185736|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185737|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139185738|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
139185739|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139185740|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139185741|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139185742|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185743|NCT03361176|Triamcinolone|triamcinolone|mesh-list
139185744|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139185745|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139185746|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
139185747|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139185748|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139185749|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
139185750|NCT03361176|Hormones|hormones|mesh-ancestor
139185751|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138555774|NCT00298714|Losartan|losartan|mesh-list
139185752|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185753|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139185754|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
139185755|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185756|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185757|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139185758|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139185759|NCT03438214|Vancomycin|vancomycin|mesh-list
139185760|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139185761|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185762|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
139185763|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139185764|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139185765|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185766|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
139185767|NCT01141127|Coagulants|coagulants|mesh-ancestor
139185768|NCT05280444|Idarubicin|idarubicin|mesh-list
139185769|NCT05280444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139185770|NCT05280444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185771|NCT05280444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139185772|NCT05280444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139185773|NCT05280444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185774|NCT05280444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185775|NCT01308541|Propofol|propofol|mesh-list
139185776|NCT01308541|Fospropofol|fospropofol|mesh-list
139185777|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139185778|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185779|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185780|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139185781|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
139185782|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
139185783|NCT05679765|Dexamethasone|dexamethasone|mesh-list
139185784|NCT05679765|Dexamethasone acetate|dexamethasone acetate|mesh-list
139185785|NCT05679765|Lidocaine|lidocaine|mesh-list
139185786|NCT05679765|BB 1101|bb 1101|mesh-list
139185787|NCT05679765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139185788|NCT05679765|Antiemetics|antiemetics|mesh-ancestor
138903717|NCT00808509|Adalimumab|adalimumab|mesh-list
139185789|NCT05679765|Autonomic Agents|autonomic agents|mesh-ancestor
139185790|NCT05679765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185791|NCT05679765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185792|NCT05679765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139185793|NCT05679765|Glucocorticoids|glucocorticoids|mesh-ancestor
139185794|NCT05679765|Hormones|hormones|mesh-ancestor
139185795|NCT05679765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139185796|NCT05679765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139185797|NCT05679765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185798|NCT05679765|Protease Inhibitors|protease inhibitors|mesh-ancestor
139185799|NCT05679765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185800|NCT05679765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185801|NCT05679765|Anesthetics, Local|anesthetics, local|mesh-ancestor
139185802|NCT05679765|Anesthetics|anesthetics|mesh-ancestor
139185803|NCT05679765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185804|NCT05679765|Sensory System Agents|sensory system agents|mesh-ancestor
139185805|NCT05679765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139185806|NCT05679765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139185807|NCT05679765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139185808|NCT05679765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139185810|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139185811|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185812|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185813|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139185814|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
139185816|NCT05176119|Ketamine|ketamine|mesh-list
139185817|NCT05176119|Nalbuphine|nalbuphine|mesh-list
139185818|NCT05176119|Analgesics|analgesics|mesh-ancestor
139185819|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
139185820|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185821|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185822|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138969471|NCT00789386|Midazolam|midazolam|mesh-list
139185823|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139185824|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
139185825|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
139185826|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185827|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139185828|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139185829|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185830|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185831|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139185832|NCT05176119|Narcotics|narcotics|mesh-ancestor
139185833|NCT03437902|Vitamins|vitamins|mesh-list
139185834|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
139185835|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
139185836|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185837|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
139185838|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185839|NCT03437902|Protective Agents|protective agents|mesh-ancestor
139185840|NCT05283499|Analgesics, Opioid|analgesics, opioid|mesh-list
139185841|NCT05283499|Analgesics|analgesics|mesh-list
139185842|NCT05283499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
139185843|NCT05283499|Narcotics|narcotics|mesh-ancestor
139185844|NCT05283499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139185845|NCT05283499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185846|NCT05283499|Sensory System Agents|sensory system agents|mesh-ancestor
139185847|NCT05283499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185848|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
139185849|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
139185850|NCT03437824|Vitamins|vitamins|mesh-ancestor
139185851|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
139185852|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185853|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
139185854|NCT03437824|Hematinics|hematinics|mesh-ancestor
139185855|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
139185856|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
139185857|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139185858|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139185859|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
139185860|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185861|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185862|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185863|NCT01136525|Valacyclovir|valacyclovir|mesh-list
139185864|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
139185865|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185866|NCT05632445|Apixaban|apixaban|mesh-list
139185867|NCT05632445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139185868|NCT05632445|Antithrombins|antithrombins|mesh-ancestor
139185869|NCT05632445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139185870|NCT05632445|Protease Inhibitors|protease inhibitors|mesh-ancestor
139185871|NCT05632445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185872|NCT05632445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185873|NCT05632445|Anticoagulants|anticoagulants|mesh-ancestor
139185874|NCT01235117|Azacitidine|azacitidine|mesh-list
139185875|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139185876|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
139185877|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185878|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185879|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185880|NCT01306591|Bevacizumab|bevacizumab|mesh-list
139185881|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139185882|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185883|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139185884|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139185885|NCT01306591|Growth Substances|growth substances|mesh-ancestor
139185886|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185887|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
139185888|NCT03098030|Irinotecan|irinotecan|mesh-list
139185889|NCT03098030|Topotecan|topotecan|mesh-list
139185890|NCT03098030|Dinutuximab|dinutuximab|mesh-list
139185891|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139185892|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139185893|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185894|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185895|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185896|NCT01233947|Fulvestrant|fulvestrant|mesh-list
139185897|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139185898|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185899|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139185900|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139185901|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
139185902|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139185903|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185904|NCT01139645|Esomeprazole|esomeprazole|mesh-list
139185905|NCT01139645|Rabeprazole|rabeprazole|mesh-list
139185906|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139185907|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139185908|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139185909|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185910|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185911|NCT03706287|Cisplatin|cisplatin|mesh-list
139185912|NCT03706287|Carboplatin|carboplatin|mesh-list
139185913|NCT03706287|Pemetrexed|pemetrexed|mesh-list
139185914|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185915|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185916|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185917|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139185918|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139185919|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139185920|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185922|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185923|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139185924|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185925|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185926|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139185927|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139185928|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
139185929|NCT02522650|Amiloride|amiloride|mesh-list
139185930|NCT02522650|Triamterene|triamterene|mesh-list
139185931|NCT02522650|Diuretics|diuretics|mesh-ancestor
139185932|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
139185933|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185934|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139185935|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139185936|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138785981|NCT00833053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138903775|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139185937|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185938|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139185940|NCT05681871|Folic Acid|folic acid|mesh-list
139185941|NCT05681871|Ferrous fumarate|ferrous fumarate|mesh-list
139185942|NCT05681871|Ferrous gluconate|ferrous gluconate|mesh-list
139185943|NCT05681871|Hematinics|hematinics|mesh-ancestor
139185944|NCT05681871|Vitamin B Complex|vitamin b complex|mesh-ancestor
139185945|NCT05681871|Vitamins|vitamins|mesh-ancestor
139185946|NCT05681871|Micronutrients|micronutrients|mesh-ancestor
139185947|NCT05681871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185948|NCT05681871|Trace Elements|trace elements|mesh-ancestor
139185949|NCT04455958|Ritonavir|ritonavir|mesh-list
139185950|NCT04455958|Lopinavir|lopinavir|mesh-list
139185951|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139185952|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139185953|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
139185954|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185955|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185956|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139185957|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139185958|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
139185959|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139185960|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139185961|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139185962|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
139185963|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139185964|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185965|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185966|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139185967|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
139185968|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139185969|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139185970|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139185971|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139185972|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185973|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
139185974|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185975|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185976|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139185977|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185978|NCT01378858|Varenicline|varenicline|mesh-list
139185979|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139185980|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138969571|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
139185981|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
139185982|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185983|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185984|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139185985|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
139185986|NCT02891850|Tadalafil|tadalafil|mesh-list
139185987|NCT02891850|Riociguat|riociguat|mesh-list
139185988|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
139185989|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139185990|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139185991|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185992|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139185993|NCT02891850|Urological Agents|urological agents|mesh-ancestor
139185994|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
139185995|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
139185996|NCT05175027|Povidone|povidone|mesh-list
139185997|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
139185998|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
139185999|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139186000|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139186001|NCT03707418|Heparin|heparin|mesh-list
139186002|NCT03707418|Calcium heparin|calcium heparin|mesh-list
139186003|NCT03707418|Bivalirudin|bivalirudin|mesh-list
138903806|NCT00702936|Telmisartan|telmisartan|mesh-list
139186004|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
139186005|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139186006|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139186007|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186008|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
139186009|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139186010|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
138785990|NCT00918645|Calcium|calcium|mesh-list
139186011|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186012|NCT03785041|Tramadol|tramadol|mesh-list
139186013|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
139186014|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139186015|NCT03785041|Narcotics|narcotics|mesh-ancestor
139186016|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186017|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186018|NCT03785041|Analgesics|analgesics|mesh-ancestor
139186019|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
139186020|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186021|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
139186022|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
139186023|NCT03710304|Misoprostol|misoprostol|mesh-list
139186024|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
139186025|NCT03710304|Oxytocin|oxytocin|mesh-list
139186026|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
139186027|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139186028|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186029|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139186030|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139186031|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186032|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
139186033|NCT03710304|Coagulants|coagulants|mesh-ancestor
139186034|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139186035|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
139186036|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139186037|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139186038|NCT03790345|Vitamins|vitamins|mesh-list
139186039|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
139186040|NCT03790345|Pyridoxine|pyridoxine|mesh-list
139186041|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
139186042|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
139186043|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
139186044|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186045|NCT05416190|Anticoagulants|anticoagulants|mesh-list
139186046|NCT05416190|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
139186047|NCT05416190|Immunologic Factors|immunologic factors|mesh-ancestor
139186048|NCT05416190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186049|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139186050|NCT04454788|Tenecteplase|tenecteplase|mesh-list
139186051|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139186052|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139186053|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186054|NCT05681403|Cytarabine|cytarabine|mesh-list
139186055|NCT05681403|Carmustine|carmustine|mesh-list
139186056|NCT05681403|Melphalan|melphalan|mesh-list
139186057|NCT05681403|Etoposide|etoposide|mesh-list
139186058|NCT05681403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139186059|NCT05681403|Alkylating Agents|alkylating agents|mesh-ancestor
139186060|NCT05681403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186061|NCT05681403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186062|NCT05681403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139186063|NCT05681403|Antimetabolites|antimetabolites|mesh-ancestor
139186064|NCT05681403|Antiviral Agents|antiviral agents|mesh-ancestor
139186065|NCT05681403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139186066|NCT05681403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139186067|NCT05681403|Immunologic Factors|immunologic factors|mesh-ancestor
139186068|NCT05681403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186069|NCT05681403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138785993|NCT01020474|Pregabalin|pregabalin|mesh-list
139186070|NCT05681403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139186071|NCT05681403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139186072|NCT05681403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186073|NCT05681403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139186074|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139186075|NCT01309009|MEN 11420|men 11420|mesh-list
139186076|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139186077|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
139186078|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186079|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186080|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139186081|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
139186082|NCT03339453|Glucagon|glucagon|mesh-list
139186083|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139186084|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139186085|NCT03339453|Hormones|hormones|mesh-ancestor
138903858|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
139186086|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139186087|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186088|NCT03339453|Incretins|incretins|mesh-ancestor
139186089|NCT05418686|Colchicine|colchicine|mesh-list
139186090|NCT05418686|Gout Suppressants|gout suppressants|mesh-ancestor
139186091|NCT05418686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139186092|NCT05418686|Tubulin Modulators|tubulin modulators|mesh-ancestor
139186093|NCT05418686|Antimitotic Agents|antimitotic agents|mesh-ancestor
139186094|NCT05418686|Mitosis Modulators|mitosis modulators|mesh-ancestor
139186095|NCT05418686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186096|NCT05418686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186097|NCT01306981|Ranibizumab|ranibizumab|mesh-list
139186098|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138585809|NCT03459859|Cytarabine|cytarabine|mesh-list
139186099|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139186100|NCT01306981|Growth Substances|growth substances|mesh-ancestor
139186101|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186102|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
139186103|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186104|NCT05552157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139186105|NCT05552157|Immunologic Factors|immunologic factors|mesh-ancestor
139186106|NCT05552157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186107|NCT05076799|Lactulose|lactulose|mesh-list
139186108|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139186109|NCT03784495|Melatonin|melatonin|mesh-list
139186110|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
139186111|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186112|NCT03784495|Protective Agents|protective agents|mesh-ancestor
139186113|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186114|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186115|NCT05659147|Secretin|secretin|mesh-list
139186116|NCT05659147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139186117|NCT05659147|Hormones|hormones|mesh-ancestor
139186118|NCT05659147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139186119|NCT05659147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186120|NCT05234697|Remifentanil|remifentanil|mesh-list
139186121|NCT05234697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139186122|NCT05234697|Narcotics|narcotics|mesh-ancestor
139186123|NCT05234697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186124|NCT05234697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186125|NCT05234697|Analgesics|analgesics|mesh-ancestor
139186126|NCT05234697|Sensory System Agents|sensory system agents|mesh-ancestor
139186127|NCT05234697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186128|NCT02133404|Cinacalcet|cinacalcet|mesh-list
139186129|NCT02133404|ASP7991|asp7991|mesh-list
139186130|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139186131|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186132|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139186133|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
139186134|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139186135|NCT01307215|Ropivacaine|ropivacaine|mesh-list
139186136|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
139186138|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186139|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186140|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
139186141|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186142|NCT03420794|Analgesics|analgesics|mesh-list
139186143|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
139186144|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
139186145|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186146|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186147|NCT01568450|Oxycodone|oxycodone|mesh-list
139186148|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139186149|NCT01568450|Narcotics|narcotics|mesh-ancestor
139186150|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186151|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186152|NCT01568450|Analgesics|analgesics|mesh-ancestor
139186153|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
139186154|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186155|NCT03784105|Codeine|codeine|mesh-list
139186156|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139186157|NCT03784105|Narcotics|narcotics|mesh-ancestor
139186158|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186159|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186160|NCT03784105|Analgesics|analgesics|mesh-ancestor
139186161|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
139186162|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186163|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
139186164|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
139186165|NCT03784261|Abatacept|abatacept|mesh-list
139186166|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139186167|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186168|NCT03784261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139186169|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186170|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139186171|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
139186172|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186173|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139186174|NCT02989402|Rivastigmine|rivastigmine|mesh-list
139186175|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139186176|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186177|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186178|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
139186179|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139186180|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186181|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139186182|NCT02989402|Protective Agents|protective agents|mesh-ancestor
139186184|NCT02861950|Ropivacaine|ropivacaine|mesh-list
139186185|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
139186186|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
139186187|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186188|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186189|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
139186190|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186192|NCT05681247|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139186193|NCT05681247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139186194|NCT05681247|Antimetabolites|antimetabolites|mesh-ancestor
139186195|NCT05681247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186196|NCT05681247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139186197|NCT03787927|Aspirin|aspirin|mesh-list
139186198|NCT03787927|Clopidogrel|clopidogrel|mesh-list
139186199|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139186200|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139186201|NCT03787927|Analgesics|analgesics|mesh-ancestor
139186202|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
139186203|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186204|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186205|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139186206|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139186207|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139186208|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138969640|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139186209|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186210|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139186211|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139186212|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186213|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
139186214|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139186215|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139186216|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139186217|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
139186218|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139186219|NCT00602576|Temozolomide|temozolomide|mesh-list
139186221|NCT00602576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139186222|NCT00602576|Alkylating Agents|alkylating agents|mesh-ancestor
138903931|NCT05958173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186223|NCT00602576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186224|NCT00602576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186225|NCT00602576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139186226|NCT00602576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186227|NCT03359850|Niraparib|niraparib|mesh-list
139186228|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139186229|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186230|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186231|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186232|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
139186233|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
139186234|NCT01306123|Vitamins|vitamins|mesh-ancestor
139186235|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
138786054|NCT04256733|Capsaicin|capsaicin|mesh-list
139186236|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186237|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
139186238|NCT01306123|Hematinics|hematinics|mesh-ancestor
139186239|NCT04803994|Bevacizumab|bevacizumab|mesh-list
139186240|NCT04803994|Atezolizumab|atezolizumab|mesh-list
139186241|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139186242|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186243|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139186244|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139186245|NCT04803994|Growth Substances|growth substances|mesh-ancestor
139186246|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186247|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
139186248|NCT04803994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139186249|NCT04803994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186250|NCT03130426|Insulin|insulin|mesh-list
139186251|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139186252|NCT03130426|Metformin|metformin|mesh-list
139186253|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
139186254|NCT03130426|Lixisenatide|lixisenatide|mesh-list
139186255|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139186256|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186257|NCT00114140|Temozolomide|temozolomide|mesh-list
139186258|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139186259|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
139186260|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186261|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186262|NCT03130582|Etoposide|etoposide|mesh-list
139186263|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139186264|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186265|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139186266|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139186267|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186268|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186269|NCT04752540|Olorofim|olorofim|mesh-list
139186270|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
139186271|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139186273|NCT04341454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139186274|NCT03712345|Vilobelimab|vilobelimab|mesh-list
139186275|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139186276|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139186277|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
139186278|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186279|NCT03130348|Dexamethasone|dexamethasone|mesh-list
139186280|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
139186281|NCT03130348|Bortezomib|bortezomib|mesh-list
139186282|NCT03130348|Ichthammol|ichthammol|mesh-list
139186283|NCT03130348|BB 1101|bb 1101|mesh-list
139186284|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139186285|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
139186286|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
139186287|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186289|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139186290|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
139186291|NCT03130348|Hormones|hormones|mesh-ancestor
139186292|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139186293|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139186294|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186295|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
139186296|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186297|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186298|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
139186299|NCT01307527|Riboflavin|riboflavin|mesh-list
139186300|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
139186301|NCT01307527|Vitamins|vitamins|mesh-ancestor
139186302|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
139186303|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186304|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139186305|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
139186306|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
139186307|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
139186308|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139186309|NCT03789799|Protective Agents|protective agents|mesh-ancestor
139186310|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186311|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
139186312|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139186313|NCT01309399|Teriparatide|teriparatide|mesh-list
139186314|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139186315|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186316|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139186317|NCT03311828|Daratumumab|daratumumab|mesh-list
139186318|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186319|NCT01309477|Tacrolimus|tacrolimus|mesh-list
139186320|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139186321|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
139186322|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186323|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139186324|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186325|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186326|NCT05438992|Bupivacaine|bupivacaine|mesh-list
139186327|NCT05438992|Anesthetics, Local|anesthetics, local|mesh-ancestor
139186328|NCT05438992|Anesthetics|anesthetics|mesh-ancestor
139186329|NCT05438992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186330|NCT05438992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186331|NCT05438992|Sensory System Agents|sensory system agents|mesh-ancestor
139186332|NCT05438992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186333|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
139186334|NCT03089216|Calcium|calcium|mesh-list
139186335|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139186336|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936852|NCT00808743|Analgesics|analgesics|mesh-ancestor
139186337|NCT03089216|Antacids|antacids|mesh-ancestor
139186338|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186339|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139186340|NCT03339726|Phenylephrine|phenylephrine|mesh-list
139186341|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
139186342|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139186343|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
139186344|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
139186345|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186346|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186347|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
139186348|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139186349|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
139186350|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
139186351|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139186352|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139186353|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139186354|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
139186355|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139186356|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186357|NCT03339726|Protective Agents|protective agents|mesh-ancestor
139186358|NCT03339297|Defibrotide|defibrotide|mesh-list
139186359|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139186360|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139186361|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186362|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139186363|NCT05434624|Midazolam|midazolam|mesh-list
139186364|NCT05434624|Propofol|propofol|mesh-list
139186365|NCT05434624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139186366|NCT05434624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186367|NCT05434624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186368|NCT05434624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139186369|NCT05434624|Anesthetics, General|anesthetics, general|mesh-ancestor
139186370|NCT05434624|Anesthetics|anesthetics|mesh-ancestor
139186371|NCT05434624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139186372|NCT05434624|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139186373|NCT05434624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139186374|NCT05434624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139186375|NCT05434624|GABA Modulators|gaba modulators|mesh-ancestor
139186376|NCT05434624|GABA Agents|gaba agents|mesh-ancestor
139186377|NCT05434624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969676|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
139186378|NCT05434624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186380|NCT01309633|Sunitinib|sunitinib|mesh-list
139186381|NCT01309633|Cisplatin|cisplatin|mesh-list
139186382|NCT01309633|Gemcitabine|gemcitabine|mesh-list
139186383|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139186384|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186385|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139186386|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139186387|NCT01309633|Growth Substances|growth substances|mesh-ancestor
139186388|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186389|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
139186390|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139186391|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
139186392|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186393|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139186394|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186395|NCT05215431|Antioxidants|antioxidants|mesh-list
139186396|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186397|NCT05215431|Protective Agents|protective agents|mesh-ancestor
139186398|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186399|NCT03706950|Elsulfavirine|elsulfavirine|mesh-list
139186400|NCT03706950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139186401|NCT03706950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139186402|NCT03706950|Antiviral Agents|antiviral agents|mesh-ancestor
139186403|NCT03706950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139186404|NCT01310647|Estradiol|estradiol|mesh-list
139186405|NCT01310647|Testosterone|testosterone|mesh-list
139186406|NCT01310647|Estrogens|estrogens|mesh-ancestor
139186407|NCT01310647|Hormones|hormones|mesh-ancestor
139186408|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139186409|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186410|NCT01310647|Androgens|androgens|mesh-ancestor
139186411|NCT02949024|Triamcinolone|triamcinolone|mesh-list
139186412|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139186413|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139186414|NCT02949024|Aflibercept|aflibercept|mesh-list
139186415|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138969711|NCT00981201|Analgesics|analgesics|mesh-ancestor
139186416|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139186417|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
139186419|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139186420|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186421|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139186422|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
139186423|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186424|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186425|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139186426|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139186427|NCT02949024|Growth Substances|growth substances|mesh-ancestor
139186428|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
139186429|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186430|NCT04394481|Dexamethasone|dexamethasone|mesh-list
139186431|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
139186432|NCT04394481|Ropivacaine|ropivacaine|mesh-list
139186433|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139186434|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
139186435|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
139186436|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186437|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186438|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139186439|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
139186440|NCT04394481|Hormones|hormones|mesh-ancestor
139186441|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139186442|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139186443|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186444|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139186445|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186446|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139186447|NCT04394481|Analgesics|analgesics|mesh-ancestor
139186448|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
139186449|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139186450|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139186451|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139186452|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
139186453|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139186454|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904032|NCT05957094|Citalopram|citalopram|mesh-list
139186455|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
139186456|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
139186457|NCT03782935|Choline|choline|mesh-list
139186458|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
139186459|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139186460|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
139186461|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186462|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139186463|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139186464|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
139186465|NCT04370847|Ephedrine|ephedrine|mesh-list
139186466|NCT04370847|Fentanyl|fentanyl|mesh-list
139186467|NCT04370847|Bupivacaine|bupivacaine|mesh-list
139186468|NCT04370847|Oxytocin|oxytocin|mesh-list
139186469|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
139186470|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
139186471|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186472|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186473|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
139186474|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186475|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139186476|NCT04370847|Narcotics|narcotics|mesh-ancestor
139186477|NCT04370847|Analgesics|analgesics|mesh-ancestor
139186478|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139186479|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139186480|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
139186481|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
139186482|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139186483|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139186484|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
139186485|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
139186486|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139186487|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
139186488|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139186489|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937002|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
139186490|NCT03708120|Insect Repellents|insect repellents|mesh-list
139186491|NCT03708120|Protective Agents|protective agents|mesh-ancestor
139186492|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186493|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
139186494|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139186495|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186496|NCT03093428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139186497|NCT03093428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186498|NCT02735980|Prexasertib|prexasertib|mesh-list
139186499|NCT02735980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139186500|NCT02735980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186501|NCT02735980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186502|NCT01309789|Prednisone|prednisone|mesh-list
139186503|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
139186504|NCT01309789|Doxorubicin|doxorubicin|mesh-list
139186505|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139186506|NCT01309789|Vincristine|vincristine|mesh-list
139186507|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139186508|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139186509|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139186510|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
139186511|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186512|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139186513|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139186514|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
139186515|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186516|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186517|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139186518|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139186519|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139186520|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139186521|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186522|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139186523|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
139186525|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139186526|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139186527|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139186528|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
139186529|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
139186530|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
139186531|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139186532|NCT01309789|Immunotoxins|immunotoxins|mesh-ancestor
139186533|NCT01309789|Immunoconjugates|immunoconjugates|mesh-ancestor
139186534|NCT03707847|Etoposide|etoposide|mesh-list
139186535|NCT03707847|Crizotinib|crizotinib|mesh-list
139186536|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139186537|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186538|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139186539|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139186541|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186542|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139186543|NCT03338400|Dexamethasone|dexamethasone|mesh-list
139186544|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139186545|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
139186546|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
139186547|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186548|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186549|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139186550|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
139186551|NCT03338400|Hormones|hormones|mesh-ancestor
139186552|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139186553|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139186554|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186555|NCT03787147|Lidocaine|lidocaine|mesh-list
139186556|NCT03787147|Bupivacaine|bupivacaine|mesh-list
139186557|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
139186558|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
139186559|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186560|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186561|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
139186562|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186563|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138969798|NCT00872586|Olmesartan|olmesartan|mesh-list
139186564|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138887255|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139186565|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139186566|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139186567|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186568|NCT02620306|Losartan|losartan|mesh-list
139186569|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139186570|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139186571|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139186572|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139186573|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186574|NCT03781843|Lidocaine|lidocaine|mesh-list
139186575|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
139186576|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
139186577|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186578|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186579|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
139186580|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186581|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139186582|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139186583|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139186584|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139186585|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186586|NCT05205447|Itraconazole|itraconazole|mesh-list
139186587|NCT05205447|Carbamazepine|carbamazepine|mesh-list
139186588|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
139186589|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139186590|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139186591|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139186592|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186593|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186594|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139186595|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
139186596|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139186597|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186598|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139186599|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
139186600|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
139186601|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139186602|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186603|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139186604|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139186605|NCT05205447|Analgesics|analgesics|mesh-ancestor
139186606|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
139186607|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186608|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139186609|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139186610|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139186611|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139186612|NCT03781687|Morphine|morphine|mesh-list
139186613|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139186614|NCT03781687|Narcotics|narcotics|mesh-ancestor
139186615|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186616|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186617|NCT03781687|Analgesics|analgesics|mesh-ancestor
139186618|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
139186619|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186620|NCT03092726|ASP8062|asp8062|mesh-list
139186621|NCT03092726|Analgesics|analgesics|mesh-ancestor
139186622|NCT03092726|Sensory System Agents|sensory system agents|mesh-ancestor
139186623|NCT03092726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904146|NCT05791097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139186624|NCT03092726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186625|NCT03092726|GABA Modulators|gaba modulators|mesh-ancestor
139186626|NCT03092726|GABA Agents|gaba agents|mesh-ancestor
139186627|NCT03092726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139186628|NCT03092726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186629|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
139186630|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139186631|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
139186632|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139186633|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
139186634|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186635|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186636|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
138937157|NCT06147050|Metformin|metformin|mesh-list
139186637|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139186638|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139186640|NCT05126511|Hormones|hormones|mesh-ancestor
139186641|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139186642|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186643|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139186644|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186645|NCT05598242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139186646|NCT05598242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139186647|NCT05598164|Botulinum Toxins|botulinum toxins|mesh-list
139186648|NCT05598164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139186649|NCT05598164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139186650|NCT05598164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139186651|NCT05598164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139186652|NCT05598164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186653|NCT05598164|Cholinergic Agents|cholinergic agents|mesh-ancestor
139186654|NCT05598164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139186655|NCT05598164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186656|NCT05598164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139186657|NCT05598164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186658|NCT03787069|Lidocaine|lidocaine|mesh-list
139186659|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
139186660|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
139186661|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186662|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186663|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
139186664|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186665|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139186666|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139186667|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139186668|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139186669|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186671|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186672|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
139186673|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
139186674|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
139186675|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186676|NCT01553032|Cetuximab|cetuximab|mesh-list
139186677|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139186678|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186679|NCT05181124|Naproxen|naproxen|mesh-list
139186680|NCT05181124|Meloxicam|meloxicam|mesh-list
139186681|NCT05181124|Aceclofenac|aceclofenac|mesh-list
139186682|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139186683|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139186684|NCT05181124|Analgesics|analgesics|mesh-ancestor
139186685|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
139186686|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186687|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186688|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139186689|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139186690|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
139186691|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139186692|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186693|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186694|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139186695|NCT02897648|Lactams|lactams|mesh-list
139186696|NCT02897648|beta-Lactams|beta-lactams|mesh-list
139186697|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139186698|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139186699|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
139186700|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139186701|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186702|NCT04959591|Acetaminophen|acetaminophen|mesh-list
139186703|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139186704|NCT04959591|Analgesics|analgesics|mesh-ancestor
139186705|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
139186706|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186707|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186708|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
139186709|NCT05598086|Tranexamic Acid|tranexamic acid|mesh-list
138937232|NCT06145633|Deoxyglucose|deoxyglucose|mesh-list
139186710|NCT05598086|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139186711|NCT05598086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139186712|NCT05598086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186713|NCT05598086|Hemostatics|hemostatics|mesh-ancestor
139186714|NCT05598086|Coagulants|coagulants|mesh-ancestor
139186716|NCT00753532|Tocopherols|tocopherols|mesh-list
139186717|NCT00753532|Tocotrienols|tocotrienols|mesh-list
139186718|NCT00753532|Tocovid|tocovid|mesh-list
139186719|NCT00753532|Vitamins|vitamins|mesh-ancestor
139186720|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
139186721|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186722|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
139186723|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186724|NCT00753532|Protective Agents|protective agents|mesh-ancestor
139186725|NCT03632408|Zopiclone|zopiclone|mesh-list
139186726|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139186727|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186728|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186729|NCT01307839|Lidocaine|lidocaine|mesh-list
139186730|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
139186731|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
139186732|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186733|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186734|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
139186735|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186736|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139186737|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139186738|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139186739|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138904194|NCT05481645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139186740|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186741|NCT03777085|Rituximab|rituximab|mesh-list
139186742|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139186743|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186744|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
139186745|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186746|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139186747|NCT01328548|Vaccines|vaccines|mesh-list
139186748|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
139186749|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186750|NCT04453306|Topiramate|topiramate|mesh-list
139186751|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
139186752|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139186753|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186754|NCT03777163|Vaccines|vaccines|mesh-list
139186755|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
139186756|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186757|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
139186758|NCT03786289|Hematinics|hematinics|mesh-ancestor
139186759|NCT05597540|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139186760|NCT05597540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139186761|NCT05597540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139186762|NCT05597540|Antitubercular Agents|antitubercular agents|mesh-ancestor
139186763|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
139186764|NCT03776851|Hematinics|hematinics|mesh-ancestor
139186765|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139186766|NCT03337308|Ezetimibe|ezetimibe|mesh-list
139186767|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139186768|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139186769|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
139186770|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186771|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139186772|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186773|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139186774|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186775|NCT03631862|Apatinib|apatinib|mesh-list
139186776|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186777|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139186778|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186779|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186780|NCT03468010|Paclitaxel|paclitaxel|mesh-list
139186781|NCT03468010|Cisplatin|cisplatin|mesh-list
139186782|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139186783|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186784|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
139186785|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
139186786|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
139186787|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186788|NCT03337152|Chloroquine|chloroquine|mesh-list
139186789|NCT03337152|Primaquine|primaquine|mesh-list
139186790|NCT03337152|Amebicides|amebicides|mesh-ancestor
139186791|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139186792|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139186793|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139186794|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
139186795|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139186796|NCT03467620|Cannabidiol|cannabidiol|mesh-list
139186797|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
139186798|NCT03780205|Methamphetamine|methamphetamine|mesh-list
139186799|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139186800|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186801|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
139186802|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
139186803|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186804|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
139186805|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139186806|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186807|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
139186808|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139186809|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139186810|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139186811|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139186813|NCT04305249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139186814|NCT04305249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186815|NCT04305249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139186816|NCT04305249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186817|NCT03707808|Nivolumab|nivolumab|mesh-list
139186818|NCT03707808|Ipilimumab|ipilimumab|mesh-list
139186819|NCT03707808|Avelumab|avelumab|mesh-list
139186820|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139186821|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186822|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139186823|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186824|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139186825|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139186826|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139186827|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139186828|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186829|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
139186830|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139186831|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186832|NCT02761070|Bevacizumab|bevacizumab|mesh-list
139186833|NCT02761070|Temozolomide|temozolomide|mesh-list
139186834|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139186835|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186836|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139186837|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139186838|NCT02761070|Growth Substances|growth substances|mesh-ancestor
139186839|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186840|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
139186841|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139186842|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
139186843|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186844|NCT03090152|Bupivacaine|bupivacaine|mesh-list
139186845|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
139186846|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
139186847|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186848|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186849|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
139186850|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186851|NCT03466528|Thiamine|thiamine|mesh-list
139186852|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
139186853|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
139186854|NCT03466528|Vitamins|vitamins|mesh-ancestor
139186855|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
139186856|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186857|NCT03466528|Analgesics|analgesics|mesh-ancestor
139186858|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
139186859|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186860|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
139186861|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139186863|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
139186864|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139186865|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139186866|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186867|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139186868|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
139186869|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139186870|NCT03466216|Octreotide|octreotide|mesh-list
139186871|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139186872|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139186873|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186874|NCT03098654|Metformin|metformin|mesh-list
139186875|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139186876|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186877|NCT05175066|Bisoprolol|bisoprolol|mesh-list
139186878|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139186879|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
139186880|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
139186881|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186882|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186883|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139186884|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139186885|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139186886|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
139186888|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186889|NCT03130114|Azithromycin|azithromycin|mesh-list
139186890|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139186891|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139186892|NCT03130270|Apatinib|apatinib|mesh-list
139186893|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186894|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139186895|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139186896|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186897|NCT03780361|Aflibercept|aflibercept|mesh-list
139186898|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139186899|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139186900|NCT03780361|Growth Substances|growth substances|mesh-ancestor
139186901|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186902|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
139186903|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186904|NCT02522572|Plerixafor|plerixafor|mesh-list
139186905|NCT02522572|Bortezomib|bortezomib|mesh-list
139186906|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186907|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139186908|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139186909|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
139186910|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139186911|NCT04602507|Ivermectin|ivermectin|mesh-list
139186912|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139186913|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139186914|NCT04645966|Acetaminophen|acetaminophen|mesh-list
139186915|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139186916|NCT04645966|Analgesics|analgesics|mesh-ancestor
139186917|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
139186918|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139186919|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186920|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
139186921|NCT03773809|Vitamin D|vitamin d|mesh-list
139186922|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
139186923|NCT03773809|Cholecalciferol|cholecalciferol|mesh-list
139186924|NCT03773809|Vitamins|vitamins|mesh-list
139186925|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
139186926|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186927|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139186928|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139186929|NCT01313611|Rituximab|rituximab|mesh-list
139186930|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139186931|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139186932|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186933|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
139186934|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186935|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139186936|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139186937|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
139186938|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186939|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139186940|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139186941|NCT04534582|Denosumab|denosumab|mesh-list
139186942|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139186943|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186944|NCT03780049|Leucovorin|leucovorin|mesh-list
139186945|NCT03780049|Fluorouracil|fluorouracil|mesh-list
139186946|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
139186947|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
139186948|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186949|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139186950|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186951|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139186953|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186954|NCT03780049|Antidotes|antidotes|mesh-ancestor
139186955|NCT03780049|Protective Agents|protective agents|mesh-ancestor
139186956|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
139186957|NCT03780049|Vitamins|vitamins|mesh-ancestor
139186958|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
139186959|NCT04252287|Canagliflozin|canagliflozin|mesh-list
139186960|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139186961|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186962|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139186963|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186964|NCT05681754|Calcium, Dietary|calcium, dietary|mesh-list
139186965|NCT05681754|Calcium|calcium|mesh-list
139186966|NCT05681754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139186967|NCT05681754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186968|NCT05681754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139186969|NCT03465202|Capecitabine|capecitabine|mesh-list
139186970|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139186971|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
139186972|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186973|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186974|NCT04195958|Omalizumab|omalizumab|mesh-list
139186975|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139186976|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139186977|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
139186978|NCT05540262|Edaravone|edaravone|mesh-list
139186979|NCT05540262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139186980|NCT05540262|Antioxidants|antioxidants|mesh-ancestor
139186981|NCT05540262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139186982|NCT05540262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139186983|NCT05540262|Protective Agents|protective agents|mesh-ancestor
139186984|NCT05540262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186985|NCT02735200|Vitamin D|vitamin d|mesh-list
139186986|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
139186987|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
139186988|NCT02735200|Vitamins|vitamins|mesh-list
139186989|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
139186990|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186991|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139186992|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139186993|NCT01312311|Docetaxel|docetaxel|mesh-list
139186994|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139186995|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
139186996|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
139186997|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
138969955|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
139186998|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187000|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
139187001|NCT03464968|Irinotecan|irinotecan|mesh-list
138904328|NCT05064319|Gabapentin|gabapentin|mesh-list
139187002|NCT03464968|Fluorouracil|fluorouracil|mesh-list
139187003|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
139187004|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187005|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139187006|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139187007|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187008|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187009|NCT03464968|Antidotes|antidotes|mesh-ancestor
139187010|NCT03464968|Protective Agents|protective agents|mesh-ancestor
139187011|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187012|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
139187013|NCT03464968|Vitamins|vitamins|mesh-ancestor
139187014|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
139187015|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
139187016|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139187017|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139187018|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
139187019|NCT05073744|Morphine|morphine|mesh-list
139187020|NCT05073744|Nalbuphine|nalbuphine|mesh-list
139187021|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139187022|NCT05073744|Narcotics|narcotics|mesh-ancestor
139187023|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139187024|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187025|NCT05073744|Analgesics|analgesics|mesh-ancestor
139187026|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
139187027|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187028|NCT05681598|Hydroxyurea|hydroxyurea|mesh-list
139187029|NCT05681598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187030|NCT05681598|Antisickling Agents|antisickling agents|mesh-ancestor
139187031|NCT05681598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187032|NCT05681598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187033|NCT05681598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139187034|NCT01312350|Docetaxel|docetaxel|mesh-list
139187035|NCT01312350|Fluorouracil|fluorouracil|mesh-list
139187036|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187037|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
139187038|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
139187039|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
139187040|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187041|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
139187042|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139187043|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139187044|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
139187045|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187046|NCT03464656|Antioxidants|antioxidants|mesh-list
139187047|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187048|NCT03464656|Protective Agents|protective agents|mesh-ancestor
139187049|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187050|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
139187051|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139187052|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187053|NCT03705858|Lintuzumab|lintuzumab|mesh-list
139187054|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187055|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187056|NCT03463642|Vitamin D|vitamin d|mesh-list
139187057|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
139187058|NCT03463642|Mineral Oil|mineral oil|mesh-list
139187059|NCT03463642|Vitamins|vitamins|mesh-ancestor
139187060|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
139187061|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904335|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139187062|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139187063|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139187064|NCT03463642|Emollients|emollients|mesh-ancestor
139187065|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
139187066|NCT03463564|Insulin|insulin|mesh-list
139187067|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139187068|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139187069|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187070|NCT05092386|Vaccines|vaccines|mesh-list
139187071|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
139187072|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187073|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139187074|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
139187075|NCT03463252|Progesterone|progesterone|mesh-list
139187076|NCT03463252|Progestins|progestins|mesh-ancestor
139187077|NCT03463252|Hormones|hormones|mesh-ancestor
139187078|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138786188|NCT05252325|Lidocaine|lidocaine|mesh-list
139187080|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139187081|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139187082|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139187083|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
139187084|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139187085|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139187086|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139187087|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139187088|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139187089|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187090|NCT05309538|Betahistine|betahistine|mesh-list
139187091|NCT05309538|Vasodilator Agents|vasodilator agents|mesh-ancestor
139187092|NCT05309538|Histamine Agonists|histamine agonists|mesh-ancestor
139187093|NCT05309538|Histamine Agents|histamine agents|mesh-ancestor
139187094|NCT05309538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187095|NCT05309538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187096|NCT05309538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187097|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
139187098|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
139187099|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187100|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139187101|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139187102|NCT03011450|Fenofibrate|fenofibrate|mesh-list
139187103|NCT03011450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139187104|NCT03011450|Antimetabolites|antimetabolites|mesh-ancestor
139187105|NCT03011450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187106|NCT03011450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139187107|NCT03638856|Misoprostol|misoprostol|mesh-list
139187108|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139187109|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
139187110|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139187111|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187112|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139187113|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139187114|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
139187115|NCT03705780|Fentanyl|fentanyl|mesh-list
139187116|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139187117|NCT03705780|Narcotics|narcotics|mesh-ancestor
139187118|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139187119|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187120|NCT03705780|Analgesics|analgesics|mesh-ancestor
139187121|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
139187122|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187123|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139187124|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139187125|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
139187127|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
139187128|NCT04976790|Analgesics|analgesics|mesh-ancestor
139187129|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
139187130|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187131|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187132|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139187133|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139187134|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139187135|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139187136|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139187137|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187138|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187139|NCT04452838|Fesoterodine|fesoterodine|mesh-list
139187140|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139187141|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139187142|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
139187143|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187144|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187145|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187146|NCT04452838|Urological Agents|urological agents|mesh-ancestor
139187147|NCT04188860|Paclitaxel|paclitaxel|mesh-list
139187148|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139187149|NCT04188860|Antibodies|antibodies|mesh-list
139187150|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139187151|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187152|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
139187153|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
139187154|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
139187155|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187156|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
139187157|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187158|NCT01383668|Sirolimus|sirolimus|mesh-list
139187159|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
139187160|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139187161|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187162|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139187163|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187164|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
139187165|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139187166|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
139187167|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187168|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139187170|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139187171|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187172|NCT01381796|Sumatriptan|sumatriptan|mesh-list
139187173|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139187174|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139187175|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139187176|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
139187177|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187178|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187179|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187180|NCT04375228|Rituximab|rituximab|mesh-list
139187181|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187182|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187183|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
139187184|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187185|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139187186|NCT02521714|Lenalidomide|lenalidomide|mesh-list
139187187|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
139187188|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187189|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139187190|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139187191|NCT02521714|Growth Substances|growth substances|mesh-ancestor
139187192|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
139187193|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187194|NCT03768089|Ivacaftor|ivacaftor|mesh-list
139187195|NCT03768089|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139187196|NCT03768089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139187197|NCT03768089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187198|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
139187199|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
139187200|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187201|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187202|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187203|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
139187204|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
139187205|NCT01381640|Acetaminophen|acetaminophen|mesh-list
138786223|NCT02872272|Amikacin|amikacin|mesh-list
139187206|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139187207|NCT01381640|Analgesics|analgesics|mesh-ancestor
139187208|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
139187209|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187210|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187211|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
139187212|NCT04483973|Ebselen|ebselen|mesh-list
139187213|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139187214|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139187215|NCT04483973|Analgesics|analgesics|mesh-ancestor
139187216|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
139187217|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187218|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187219|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139187220|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139187221|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139187222|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139187223|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
139187224|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187225|NCT04483973|Protective Agents|protective agents|mesh-ancestor
139187226|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139187227|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187228|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139187229|NCT04283890|Nivolumab|nivolumab|mesh-list
139187230|NCT04283890|Ipilimumab|ipilimumab|mesh-list
139187231|NCT04283890|Melphalan|melphalan|mesh-list
139187232|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187233|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187234|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139187235|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187236|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139187237|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
139187238|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139187239|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139187240|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
139187241|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187242|NCT01139723|Bevacizumab|bevacizumab|mesh-list
139187243|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187244|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187245|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139187246|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139187247|NCT01139723|Growth Substances|growth substances|mesh-ancestor
139187248|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187249|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
139187250|NCT05068037|Antiemetics|antiemetics|mesh-list
139187251|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
139187252|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187253|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187254|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139187256|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
139187257|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904418|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
139187258|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139187259|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139187260|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187261|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187262|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139187263|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139187264|NCT01141439|Fluticasone|fluticasone|mesh-list
139187265|NCT01141439|Xhance|xhance|mesh-list
139187266|NCT01141439|Beclomethasone|beclomethasone|mesh-list
139187267|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139187268|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139187269|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
139187270|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187271|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187272|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139187273|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
139187274|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
139187275|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139187276|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
139187277|NCT01141439|Hormones|hormones|mesh-ancestor
139187278|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139187279|NCT05549531|Itraconazole|itraconazole|mesh-list
139187280|NCT05549531|Antifungal Agents|antifungal agents|mesh-ancestor
139187281|NCT05549531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970075|NCT00881088|PENTA|penta|mesh-list
139187282|NCT05549531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139187283|NCT05549531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139187284|NCT05549531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187285|NCT05549531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187286|NCT05549531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139187287|NCT05549531|Hormone Antagonists|hormone antagonists|mesh-ancestor
139187288|NCT05549531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139187289|NCT05549531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187290|NCT05549531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139187292|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139187293|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187294|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139187295|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139187296|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187297|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187298|NCT01232777|Bevacizumab|bevacizumab|mesh-list
139187299|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187300|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187301|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139187302|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139187303|NCT01232777|Growth Substances|growth substances|mesh-ancestor
139187304|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187305|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
139187306|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
139187307|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139187308|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187309|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
139187310|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139187311|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187312|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139187313|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187314|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
139187315|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139187316|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187317|NCT04921995|Tislelizumab|tislelizumab|mesh-list
139187318|NCT04921995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187319|NCT04921995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187320|NCT03129867|Ticagrelor|ticagrelor|mesh-list
139187321|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138970079|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
139187322|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139187323|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139187324|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139187325|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
139187326|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187327|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187328|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187330|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139187331|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187332|NCT01140035|Insulin|insulin|mesh-list
139187333|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139187334|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187335|NCT00872950|Amifampridine|amifampridine|mesh-list
139187336|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139187337|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187338|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187339|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139187340|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139187341|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187342|NCT03233217|Vaccines|vaccines|mesh-list
139187343|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
139187344|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187345|NCT01568996|Sulforaphane|sulforaphane|mesh-list
139187346|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139187347|NCT01568996|Protective Agents|protective agents|mesh-ancestor
139187348|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187349|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187350|NCT02943993|Edoxaban|edoxaban|mesh-list
139187351|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139187352|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
139187353|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139187354|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
139187355|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187356|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187357|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
139187358|NCT02620150|Escitalopram|escitalopram|mesh-list
139187359|NCT02620150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139187360|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139187361|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139187362|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187363|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187364|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
139187365|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187366|NCT04098302|Dutasteride|dutasteride|mesh-list
139187367|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139187368|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139187369|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187370|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187371|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
138970112|NCT00881166|Docetaxel|docetaxel|mesh-list
139187372|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139187373|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187374|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139187376|NCT05488613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187377|NCT05488613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139187378|NCT05488613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187379|NCT05488613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187380|NCT05420168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139187381|NCT05420168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187382|NCT01137383|Interferons|interferons|mesh-list
139187383|NCT01137383|Ribavirin|ribavirin|mesh-list
139187384|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
139187385|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
138937900|NCT05545384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139187386|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139187387|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187388|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
139187389|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187390|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
139187391|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187392|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
139187393|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187394|NCT03449836|Fluticasone|fluticasone|mesh-list
139187395|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
139187396|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139187397|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139187398|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
139187399|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187400|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187401|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139187402|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
139187403|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
139187404|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139187405|NCT03449524|CXA-10|cxa-10|mesh-list
139187406|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139187407|NCT03961256|Exenatide|exenatide|mesh-list
139187408|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139187409|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187410|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139187411|NCT03961256|Incretins|incretins|mesh-ancestor
139187412|NCT03961256|Hormones|hormones|mesh-ancestor
138904513|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139187413|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139187414|NCT03443518|Remifentanil|remifentanil|mesh-list
139187415|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139187416|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187417|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139187418|NCT03443518|Narcotics|narcotics|mesh-ancestor
139187419|NCT03443518|Analgesics|analgesics|mesh-ancestor
139187420|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
139187421|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187422|NCT01142843|Propolis|propolis|mesh-list
139187423|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187424|NCT04330625|Volagidemab|volagidemab|mesh-list
139187425|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139187426|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187427|NCT03747497|Linezolid|linezolid|mesh-list
139187428|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139187429|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187430|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139187431|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187432|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187433|NCT03109600|Vaccines|vaccines|mesh-list
139187434|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139187435|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
139187436|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187437|NCT03679013|Acetaminophen|acetaminophen|mesh-list
139187438|NCT03679013|Gabapentin|gabapentin|mesh-list
139187439|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139187440|NCT03679013|Analgesics|analgesics|mesh-ancestor
139187441|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
139187442|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187443|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187444|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
139187445|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
139187446|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139187447|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139187448|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139187449|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139187450|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139187451|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139187452|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187453|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187454|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
139187455|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
139187456|NCT01140425|PF 232798|pf 232798|mesh-list
139187457|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139187458|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187459|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139187460|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139187461|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187462|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187463|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187464|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139187466|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139187467|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
139187468|NCT03991013|Dolutegravir|dolutegravir|mesh-list
139187469|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139187470|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139187471|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187472|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187473|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139187474|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139187475|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
139187476|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187477|NCT03441412|Metoprolol|metoprolol|mesh-list
139187478|NCT03441412|Epinephrine|epinephrine|mesh-list
139187479|NCT03441412|Ticagrelor|ticagrelor|mesh-list
139187480|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139187481|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139187482|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
139187483|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187484|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187485|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187486|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139187487|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139187488|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
139187489|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187490|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139187491|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
139187492|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
139187493|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
139187494|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139187495|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139187496|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139187497|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139187498|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139187499|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
139187500|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139187501|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139187502|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
139187503|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139187504|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139187505|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139187506|NCT01235819|Insulin|insulin|mesh-list
139187507|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139187508|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139187509|NCT01235819|Exenatide|exenatide|mesh-list
139187510|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139187511|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139187512|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187513|NCT01235819|Incretins|incretins|mesh-ancestor
139187514|NCT01235819|Hormones|hormones|mesh-ancestor
139187515|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139187516|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
139187517|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187518|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187519|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139187520|NCT05275569|Antiemetics|antiemetics|mesh-list
139187521|NCT05275569|Autonomic Agents|autonomic agents|mesh-ancestor
139187522|NCT05275569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187523|NCT05275569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187524|NCT05275569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139187525|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139187526|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187527|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187528|NCT03440788|Immunotoxins|immunotoxins|mesh-ancestor
139187529|NCT03440788|Immunoconjugates|immunoconjugates|mesh-ancestor
139187530|NCT03440788|Immunologic Factors|immunologic factors|mesh-ancestor
139187531|NCT03440788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187532|NCT02824575|Paclitaxel|paclitaxel|mesh-list
139187533|NCT02824575|Rebastinib|rebastinib|mesh-list
139187534|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139187535|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187536|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
139187537|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
139187538|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
139187539|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187540|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139187541|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187542|NCT03780608|Durvalumab|durvalumab|mesh-list
139187543|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187544|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187545|NCT03631316|Valganciclovir|valganciclovir|mesh-list
139187546|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
139187547|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187548|NCT03608865|Durvalumab|durvalumab|mesh-list
139187549|NCT03608865|Tremelimumab|tremelimumab|mesh-list
139187550|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187551|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187552|NCT03532451|Nivolumab|nivolumab|mesh-list
139187553|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187554|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187555|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139187556|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187557|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
139187558|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139187559|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
139187560|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187561|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
139187562|NCT04704531|Protective Agents|protective agents|mesh-ancestor
139187563|NCT02637531|Nivolumab|nivolumab|mesh-list
139187564|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187565|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187566|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139187567|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187568|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
139187569|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
139187570|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139187571|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
139187572|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
139187573|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187574|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904557|NCT03580369|Omalizumab|omalizumab|mesh-list
139187575|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187576|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
139187577|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
139187578|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139187579|NCT01380548|Iron|iron|mesh-list
139187580|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139187581|NCT01380548|Trace Elements|trace elements|mesh-ancestor
139187582|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
139187583|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187584|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139187585|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
139187586|NCT01313247|Acetaminophen|acetaminophen|mesh-list
139187587|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139187588|NCT01313247|Analgesics|analgesics|mesh-ancestor
139187589|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
139187590|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187591|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187592|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
139187593|NCT01142453|Interferons|interferons|mesh-list
139187594|NCT01142453|Interferon-beta|interferon-beta|mesh-list
139187595|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
139187596|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187597|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
139187598|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187599|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
139187600|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970253|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
139187601|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139187602|NCT04701424|Insulin|insulin|mesh-list
139187603|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139187604|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187605|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
139187606|NCT03560193|Ethanol|ethanol|mesh-list
139187607|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
139187608|NCT03560193|Povidone|povidone|mesh-list
139187609|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139187610|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187611|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
139187612|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139187613|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187614|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
139187615|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
139187616|NCT04451200|Busulfan|busulfan|mesh-list
139187617|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
139187618|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187619|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139187620|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
139187621|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187622|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139187623|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187624|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139187625|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139187626|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139187628|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
139187629|NCT02251821|Melphalan|melphalan|mesh-list
139187630|NCT02251821|Busulfan|busulfan|mesh-list
139187631|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
139187632|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139187633|NCT02251821|Methotrexate|methotrexate|mesh-list
139187634|NCT02251821|Fludarabine|fludarabine|mesh-list
139187635|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
139187636|NCT02251821|Tacrolimus|tacrolimus|mesh-list
139187637|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139187638|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
139187639|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187640|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139187641|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139187642|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
139187643|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187644|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187645|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138970289|NCT02553044|Vitamin D|vitamin d|mesh-list
139187646|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139187647|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
139187648|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139187649|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139187650|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
139187651|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
139187652|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187653|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139187654|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139187655|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139187656|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139187657|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139187658|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
139187659|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139187660|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187661|NCT03784781|Dimercaprol|dimercaprol|mesh-list
139187662|NCT03784781|Chelating Agents|chelating agents|mesh-ancestor
139187663|NCT03784781|Sequestering Agents|sequestering agents|mesh-ancestor
139187664|NCT03784781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187665|NCT03438604|Donepezil|donepezil|mesh-list
139187666|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139187667|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187668|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187669|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
139187670|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187671|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187672|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
139187673|NCT03433378|Tretinoin|tretinoin|mesh-list
139187674|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187675|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
139187676|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
139187677|NCT03433222|Coal Tar|coal tar|mesh-list
139187678|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
139187679|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
139187680|NCT05016076|Dexamethasone|dexamethasone|mesh-list
139187681|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139187682|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
139187683|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
139187684|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187685|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904622|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
139187686|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139187687|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
139187688|NCT05016076|Hormones|hormones|mesh-ancestor
139187689|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139187690|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139187691|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938201|NCT05083754|Temozolomide|temozolomide|mesh-list
139187692|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
139187693|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139187694|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139187695|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187696|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139187697|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
139187698|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139187699|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138786251|NCT02879981|Expectorants|expectorants|mesh-ancestor
139187700|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187701|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
139187702|NCT03433144|Coagulants|coagulants|mesh-ancestor
139187703|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
139187704|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139187705|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139187706|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139187707|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139187708|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187709|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
139187710|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187711|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187712|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139187713|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970317|NCT00809744|Vitamin D|vitamin d|mesh-list
139187714|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139187715|NCT02927834|Prednisone|prednisone|mesh-list
139187716|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139187717|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
139187718|NCT02927834|Hormones|hormones|mesh-ancestor
139187719|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139187720|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187721|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139187722|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187723|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139187724|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187725|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139187726|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187727|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187728|NCT03170180|Sunitinib|sunitinib|mesh-list
139187729|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
139187730|NCT03170180|Gefitinib|gefitinib|mesh-list
139187731|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187732|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139187733|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139187734|NCT03170180|Growth Substances|growth substances|mesh-ancestor
139187735|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187736|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
139187737|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139187738|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187739|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187740|NCT03319667|Dexamethasone|dexamethasone|mesh-list
139187741|NCT03319667|Lenalidomide|lenalidomide|mesh-list
139187742|NCT03319667|Bortezomib|bortezomib|mesh-list
139187743|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139187744|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
139187745|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
139187746|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187747|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187748|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139187749|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
139187750|NCT03319667|Hormones|hormones|mesh-ancestor
139187751|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139187752|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139187753|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187754|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
139187755|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139187756|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139187757|NCT03319667|Growth Substances|growth substances|mesh-ancestor
139187758|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
139187759|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
139187760|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187761|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187762|NCT03432676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139187763|NCT03432676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187764|NCT03432598|Paclitaxel|paclitaxel|mesh-list
139187765|NCT03432598|Etoposide|etoposide|mesh-list
139187766|NCT03432598|Carboplatin|carboplatin|mesh-list
139187767|NCT03432598|Gemcitabine|gemcitabine|mesh-list
139187768|NCT03432598|Pemetrexed|pemetrexed|mesh-list
139187769|NCT03432598|Tislelizumab|tislelizumab|mesh-list
139187770|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139187771|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557766|NCT00088491|Olanzapine|olanzapine|mesh-list
139187772|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
139187773|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
139187774|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
139187775|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187776|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139187777|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
139187778|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139187779|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139187780|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187781|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139187782|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139187783|NCT03432598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187784|NCT03432442|Ivermectin|ivermectin|mesh-list
139187785|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139187786|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187787|NCT01964547|Nabiximols|nabiximols|mesh-list
139187788|NCT01964547|Analgesics|analgesics|mesh-ancestor
139187789|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
139187790|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187791|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187792|NCT01380314|Miltefosine|miltefosine|mesh-list
139187793|NCT01380314|Imiquimod|imiquimod|mesh-list
139187794|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139187795|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
139187796|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187797|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187798|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
139187799|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
139187800|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187801|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139187802|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139187803|NCT03110510|Leucovorin|leucovorin|mesh-list
139187804|NCT03110510|Fluorouracil|fluorouracil|mesh-list
139187805|NCT03110510|Irinotecan|irinotecan|mesh-list
139187806|NCT03110510|Calcium|calcium|mesh-list
139187807|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
139187808|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139187809|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187810|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
139187811|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187812|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139187813|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187814|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139187815|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
139187816|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139187817|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139187818|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187819|NCT03110510|Antidotes|antidotes|mesh-ancestor
139187820|NCT03110510|Protective Agents|protective agents|mesh-ancestor
139187821|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
139187822|NCT03110510|Vitamins|vitamins|mesh-ancestor
139187823|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
139187824|NCT01238237|Cetuximab|cetuximab|mesh-list
139187825|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187826|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187827|NCT03319719|Lidocaine|lidocaine|mesh-list
139187828|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
139187829|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
139187830|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
139187831|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139187832|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187833|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
139187834|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187835|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139187836|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139187837|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139187838|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139187839|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187840|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139187841|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
139187842|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
139187843|NCT03319719|Protective Agents|protective agents|mesh-ancestor
139187844|NCT03128242|Oxytocin|oxytocin|mesh-list
139187845|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
139187846|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139187847|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187849|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187850|NCT03431272|Lifitegrast|lifitegrast|mesh-list
139187851|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139187852|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139187853|NCT02528513|Midazolam|midazolam|mesh-list
139187854|NCT02528513|Fentanyl|fentanyl|mesh-list
139187855|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
139187856|NCT02528513|Propofol|propofol|mesh-list
139187857|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139187858|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139187859|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904675|NCT03215810|Analgesics|analgesics|mesh-ancestor
139187860|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139187861|NCT02528513|Analgesics|analgesics|mesh-ancestor
139187862|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
139187863|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187864|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139187865|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139187866|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139187867|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
139187868|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187869|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187870|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139187871|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
139187872|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
139187873|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139187874|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139187875|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139187876|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139187877|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
139187878|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
139187879|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139187880|NCT02528513|Narcotics|narcotics|mesh-ancestor
139187881|NCT01320007|Furosemide|furosemide|mesh-list
139187882|NCT01320007|Diuretics|diuretics|mesh-ancestor
139187883|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
139187884|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187885|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139187886|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138970360|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187887|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187889|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
139187890|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187891|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
139187892|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139187893|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
139187894|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187895|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187896|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139187897|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
139187898|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139187899|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
139187900|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187901|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187902|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139187903|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
139187904|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
139187905|NCT04460183|Protective Agents|protective agents|mesh-ancestor
139187906|NCT01243697|Desogestrel|desogestrel|mesh-list
139187907|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139187908|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139187909|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139187910|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
139187911|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139187912|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187913|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139187914|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139187915|NCT01243697|Progestins|progestins|mesh-ancestor
139187916|NCT01243697|Hormones|hormones|mesh-ancestor
139187917|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139187918|NCT01145573|Calcium|calcium|mesh-list
139187919|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139187920|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187921|NCT01320709|Piroxicam|piroxicam|mesh-list
138904696|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
139187922|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139187923|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139187924|NCT01320709|Analgesics|analgesics|mesh-ancestor
139187925|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
139187926|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187927|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187928|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139187929|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139187930|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139187931|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187932|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187933|NCT01238393|Ranibizumab|ranibizumab|mesh-list
139187934|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139187935|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139187936|NCT01238393|Growth Substances|growth substances|mesh-ancestor
139187937|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187938|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
139187939|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187940|NCT03776305|Imipenem|imipenem|mesh-list
139187941|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139187942|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187943|NCT01146509|Donepezil|donepezil|mesh-list
139187944|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139187945|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139187946|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187947|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
139187948|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139187949|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187950|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
139187951|NCT03775993|Hormones|hormones|mesh-list
139187952|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139187953|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187954|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
139187955|NCT03316131|Febuxostat|febuxostat|mesh-list
139187956|NCT03316131|Verinurad|verinurad|mesh-list
139187957|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139187958|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187959|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139187960|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187961|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
139187962|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139187963|NCT03779659|Anesthetics|anesthetics|mesh-list
139187964|NCT03779659|Benzocaine|benzocaine|mesh-list
139187965|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
139187966|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139187967|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187968|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
139187969|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187970|NCT01145807|Terbinafine|terbinafine|mesh-list
139187971|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
139187972|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139187974|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187975|NCT03898895|Antibodies|antibodies|mesh-list
139187976|NCT03898895|Immunologic Factors|immunologic factors|mesh-ancestor
139187977|NCT03898895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187978|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139187979|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139187980|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
139187981|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139187982|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187983|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139187984|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
139187985|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
139187986|NCT01245569|Hormones|hormones|mesh-ancestor
139187987|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139187988|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
139187989|NCT01314859|Nifedipine|nifedipine|mesh-list
139187990|NCT01314859|Atosiban|atosiban|mesh-list
139187991|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139187992|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139187993|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139187994|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139187995|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139187996|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
139187998|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139187999|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
139188000|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139188001|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139188002|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
139188003|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139188004|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139188005|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188006|NCT01238627|Nicotine|nicotine|mesh-list
139188007|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139188008|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
139188009|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188010|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188011|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139188012|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139188013|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
139188014|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188015|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188016|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
139188017|NCT01321021|Promethazine|promethazine|mesh-list
139188018|NCT01321021|Losartan|losartan|mesh-list
139188019|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139188020|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139188021|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139188022|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139188023|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188024|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139188025|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139188026|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188027|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188028|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
139188029|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
139188030|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
139188031|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188032|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
139188033|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
139188034|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139188035|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139188036|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
139188037|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
139188038|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188039|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139188040|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
139188041|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
139188042|NCT01238705|Metoprolol|metoprolol|mesh-list
139188043|NCT01238705|Felodipine|felodipine|mesh-list
139188044|NCT01238705|Irbesartan|irbesartan|mesh-list
139188045|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139188046|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139188047|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
139188048|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
139188049|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188050|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188051|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139188052|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139188053|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139188054|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
139188055|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188056|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188057|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139188058|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139188059|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139188060|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139188061|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139188062|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
139188063|NCT03779347|Praziquantel|praziquantel|mesh-list
139188064|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
139188065|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139188066|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188067|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
139188068|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188069|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139188070|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
139188071|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
139188072|NCT01245725|Tirofiban|tirofiban|mesh-list
139188073|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139188074|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139188075|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188076|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139188077|NCT01143545|Celecoxib|celecoxib|mesh-list
139188078|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
139188079|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139188080|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
139188081|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188082|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139188083|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139188084|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
139188085|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188086|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188087|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139188088|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139188089|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139188090|NCT01143545|Analgesics|analgesics|mesh-ancestor
139188091|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
139188092|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188093|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139188094|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139188096|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188097|NCT03779035|Gemcitabine|gemcitabine|mesh-list
139188098|NCT03779035|Capecitabine|capecitabine|mesh-list
139188099|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139188100|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
139188101|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188102|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188103|NCT01586117|Amifostine|amifostine|mesh-list
139188104|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139188105|NCT01586117|Protective Agents|protective agents|mesh-ancestor
139188106|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188107|NCT03301415|Valganciclovir|valganciclovir|mesh-list
139188108|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
139188109|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188110|NCT05449015|Atropine|atropine|mesh-list
139188111|NCT05449015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139188112|NCT05449015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139188113|NCT05449015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139188114|NCT05449015|Autonomic Agents|autonomic agents|mesh-ancestor
139188115|NCT05449015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188116|NCT05449015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188117|NCT05449015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139188118|NCT05449015|Respiratory System Agents|respiratory system agents|mesh-ancestor
139188119|NCT05449015|Mydriatics|mydriatics|mesh-ancestor
139188120|NCT05449015|Parasympatholytics|parasympatholytics|mesh-ancestor
139188121|NCT05449015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139188122|NCT05449015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139188123|NCT05449015|Cholinergic Agents|cholinergic agents|mesh-ancestor
139188124|NCT05449015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188125|NCT05449015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188126|NCT01239017|Fasinumab|fasinumab|mesh-list
139188127|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139188128|NCT01239017|Analgesics|analgesics|mesh-ancestor
139188129|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
139188130|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188131|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188132|NCT02732938|Paclitaxel|paclitaxel|mesh-list
139188133|NCT02732938|Gemcitabine|gemcitabine|mesh-list
139188134|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139188135|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188136|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
139188137|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
139188138|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
139188139|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188140|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139188141|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
139188142|NCT03778723|Fentanyl|fentanyl|mesh-list
139188143|NCT03778723|Anesthetics|anesthetics|mesh-list
139188144|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188145|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188146|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139188147|NCT03778723|Narcotics|narcotics|mesh-ancestor
139188148|NCT03778723|Analgesics|analgesics|mesh-ancestor
139188149|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
139188150|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188151|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139188152|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139188153|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
139188154|NCT01245959|Cisplatin|cisplatin|mesh-list
139188155|NCT01245959|Docetaxel|docetaxel|mesh-list
139188156|NCT01245959|Fluorouracil|fluorouracil|mesh-list
139188157|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188158|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
139188159|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
139188160|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
139188161|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188162|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
139188163|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139188164|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139188165|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
139188166|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188167|NCT03778645|Epinephrine|epinephrine|mesh-list
139188168|NCT03778645|Racepinephrine|racepinephrine|mesh-list
139188169|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
139188170|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139188171|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139188172|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
139188173|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188174|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188175|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188176|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139188177|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139188178|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
139188179|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188180|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138786301|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
139188181|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
139188183|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
139188184|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139188185|NCT04326478|Azithromycin|azithromycin|mesh-list
139188186|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139188187|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188188|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
139188189|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188190|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139188191|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
139188192|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
139188193|NCT04647721|Protective Agents|protective agents|mesh-ancestor
139188194|NCT03470038|Mitogens|mitogens|mesh-list
139188195|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
139188196|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188197|NCT03778567|Lamivudine|lamivudine|mesh-list
139188198|NCT03778567|Telbivudine|telbivudine|mesh-list
139188199|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139188200|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139188201|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188202|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188203|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
139188204|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188205|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139188206|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139188207|NCT03784066|Durvalumab|durvalumab|mesh-list
139188208|NCT03784066|Tremelimumab|tremelimumab|mesh-list
139188209|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139188210|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139188211|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188212|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
139188213|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188214|NCT05168683|Rasburicase|rasburicase|mesh-list
139188215|NCT05168683|Uric Acid|uric acid|mesh-list
139188216|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
139188217|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188218|NCT05168683|Protective Agents|protective agents|mesh-ancestor
139188219|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938728|NCT04227483|Prednisolone|prednisolone|mesh-list
139188220|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
139188221|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139188222|NCT03113123|Tenofovir|tenofovir|mesh-list
139188223|NCT03113123|Emtricitabine|emtricitabine|mesh-list
139188224|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139188225|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
139188226|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188227|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139188228|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139188229|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188230|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188231|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139188232|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139188233|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
139188234|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139188235|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188236|NCT01143857|Varenicline|varenicline|mesh-list
139188237|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139188238|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139188239|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
139188240|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188241|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188242|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188243|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
139188244|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
139188245|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
139188246|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139188247|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139188248|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
139188249|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188250|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
139188251|NCT05159284|Protective Agents|protective agents|mesh-ancestor
139188252|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139188253|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139188254|NCT01239173|Propranolol|propranolol|mesh-list
139188255|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139188256|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139188257|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
139188258|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188259|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188260|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188261|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139188262|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139188263|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
139188264|NCT03063203|Decitabine|decitabine|mesh-list
139188265|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139188266|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
139188267|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188268|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188269|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188270|NCT03435094|Alendronate|alendronate|mesh-list
138970501|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
139188271|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139188272|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188273|NCT03772483|Anesthetics|anesthetics|mesh-list
139188274|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188275|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188276|NCT01236911|Calcium|calcium|mesh-list
139188277|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139188278|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188279|NCT03772561|Durvalumab|durvalumab|mesh-list
139188280|NCT03772561|Olaparib|olaparib|mesh-list
139188281|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139188282|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188283|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139188284|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188285|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188286|NCT01239485|Irinotecan|irinotecan|mesh-list
139188287|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139188288|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139188289|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188290|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188291|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188292|NCT01146041|Rivastigmine|rivastigmine|mesh-list
139188293|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139188294|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188295|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188296|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
139188297|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188298|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188299|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139188300|NCT01146041|Protective Agents|protective agents|mesh-ancestor
139188301|NCT04450576|Chrysarobin|chrysarobin|mesh-list
139188302|NCT04450576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139188303|NCT04450576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139188304|NCT04450576|Analgesics|analgesics|mesh-ancestor
139188305|NCT04450576|Sensory System Agents|sensory system agents|mesh-ancestor
139188306|NCT04450576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188307|NCT04450576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188308|NCT04450576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139188309|NCT04450576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139188310|NCT03430180|Naloxone|naloxone|mesh-list
139188311|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139188312|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188313|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
139188314|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188315|NCT03777787|Denatonium|denatonium|mesh-list
139188316|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
139188317|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188318|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
139188319|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188320|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
139188321|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188324|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139188325|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188327|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139188328|NCT03434782|Fluorides|fluorides|mesh-list
139188329|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
139188330|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
139188331|NCT03434782|Protective Agents|protective agents|mesh-ancestor
139188332|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188333|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139188334|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188335|NCT01320397|Losartan|losartan|mesh-list
139188336|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139188337|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139188338|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139188339|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139188340|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188341|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
139188342|NCT03434704|Clotrimazole|clotrimazole|mesh-list
139188343|NCT03434704|Miconazole|miconazole|mesh-list
139188344|NCT03434704|Fludarabine|fludarabine|mesh-list
139188345|NCT03434704|Thiotepa|thiotepa|mesh-list
139188346|NCT03434704|Treosulfan|treosulfan|mesh-list
139188347|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188348|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188349|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139188350|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
139188351|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188352|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139188353|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
139188354|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139188355|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188356|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139188357|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139188358|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139188359|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188360|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139188361|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
139188362|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139188363|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139188364|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139188365|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139188366|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188367|NCT04779151|Niraparib|niraparib|mesh-list
139188368|NCT04779151|Dostarlimab|dostarlimab|mesh-list
139188369|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139188370|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188371|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188372|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188373|NCT02891226|Mirikizumab|mirikizumab|mesh-list
139188374|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139188375|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139188376|NCT02891226|Analgesics|analgesics|mesh-ancestor
139188377|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
139188378|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188379|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188380|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139188381|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139188382|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139188383|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139188384|NCT03771781|Empagliflozin|empagliflozin|mesh-list
139188385|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139188386|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188387|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139188388|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188391|NCT03224104|Temozolomide|temozolomide|mesh-list
139188392|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139188393|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
139188394|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188396|NCT01320475|Sufentanil|sufentanil|mesh-list
139188397|NCT01320475|Ketamine|ketamine|mesh-list
139188398|NCT01320475|Analgesics|analgesics|mesh-ancestor
139188399|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
139188400|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188401|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188402|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139188403|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139188404|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
139188405|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
139188406|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188407|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139188408|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139188409|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188410|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188411|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139188412|NCT01320475|Narcotics|narcotics|mesh-ancestor
139188413|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139188414|NCT05177406|Erenumab|erenumab|mesh-list
139188415|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139188416|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188417|NCT05177406|Analgesics|analgesics|mesh-ancestor
139188418|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
139188419|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970566|NCT00652028|Analgesics|analgesics|mesh-ancestor
139188420|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188421|NCT02521246|Losartan|losartan|mesh-list
139188422|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139188423|NCT02521246|Candesartan|candesartan|mesh-list
139188424|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
139188425|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
139188426|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139188427|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139188428|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139188429|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139188430|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188431|NCT02521246|Diuretics|diuretics|mesh-ancestor
139188432|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
139188433|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188434|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139188435|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139188436|NCT05309070|Acetylcysteine|acetylcysteine|mesh-list
139188437|NCT05309070|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139188438|NCT05309070|Antiviral Agents|antiviral agents|mesh-ancestor
139188439|NCT05309070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188440|NCT05309070|Expectorants|expectorants|mesh-ancestor
139188441|NCT05309070|Respiratory System Agents|respiratory system agents|mesh-ancestor
139188442|NCT05309070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139188443|NCT05309070|Antioxidants|antioxidants|mesh-ancestor
139188444|NCT05309070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188445|NCT05309070|Protective Agents|protective agents|mesh-ancestor
139188446|NCT05309070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188447|NCT05309070|Antidotes|antidotes|mesh-ancestor
139188448|NCT04763928|Decitabine|decitabine|mesh-list
139188449|NCT04763928|Venetoclax|venetoclax|mesh-list
139188450|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139188451|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
139188452|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188453|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188454|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188455|NCT01567501|Cetirizine|cetirizine|mesh-list
139188456|NCT01567501|Levocetirizine|levocetirizine|mesh-list
139188457|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139188458|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139188459|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
139188460|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
139188461|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904950|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188462|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188463|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188464|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139188465|NCT01321957|Bevacizumab|bevacizumab|mesh-list
139188466|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
139188467|NCT01321957|Irinotecan|irinotecan|mesh-list
139188468|NCT01321957|Fluorouracil|fluorouracil|mesh-list
139188469|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139188470|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188471|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139188472|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139188473|NCT01321957|Growth Substances|growth substances|mesh-ancestor
139188474|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188475|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
139188476|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139188477|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139188478|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188479|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188480|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
138970596|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
139188481|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139188482|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139188483|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
139188484|NCT05363592|Metformin|metformin|mesh-list
139188485|NCT05363592|Alogliptin|alogliptin|mesh-list
139188486|NCT05363592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139188487|NCT05363592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188488|NCT05363592|Incretins|incretins|mesh-ancestor
139188489|NCT05363592|Hormones|hormones|mesh-ancestor
139188490|NCT05363592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139188491|NCT05363592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139188492|NCT05363592|Protease Inhibitors|protease inhibitors|mesh-ancestor
139188493|NCT05363592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188494|NCT05363592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188495|NCT03708211|Esomeprazole|esomeprazole|mesh-list
139188496|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139188497|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139188498|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139188499|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188500|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188501|NCT03770923|Montelukast|montelukast|mesh-list
139188502|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139188503|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
139188504|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139188505|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
139188506|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139188507|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188508|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139188509|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139188510|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188511|NCT03433534|Nivolumab|nivolumab|mesh-list
139188512|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139188513|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188514|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139188515|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188516|NCT05445895|Clopidogrel|clopidogrel|mesh-list
139188517|NCT05445895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139188518|NCT05445895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139188519|NCT05445895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139188520|NCT05445895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139188521|NCT05445895|Purinergic Agents|purinergic agents|mesh-ancestor
139188522|NCT05445895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188523|NCT05445895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188524|NCT05445895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188526|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188527|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
139188528|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139188529|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
139188530|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139188531|NCT04449718|Vitamin D|vitamin d|mesh-list
139188533|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
139188534|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188535|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139188536|NCT03763279|Triclosan|triclosan|mesh-list
139188537|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139188538|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188539|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139188541|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
139188542|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188543|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139188544|NCT03638037|Vitamin D|vitamin d|mesh-list
139188545|NCT03638037|Vitamins|vitamins|mesh-ancestor
139188546|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
139188547|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188548|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139188549|NCT03763123|Paclitaxel|paclitaxel|mesh-list
139188550|NCT03763123|Topotecan|topotecan|mesh-list
139188551|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139188552|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188553|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
139188554|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
139188555|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
139188556|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188557|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139188558|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139188559|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188560|NCT03429400|Morphine|morphine|mesh-list
139188561|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139188562|NCT03429400|Narcotics|narcotics|mesh-ancestor
139188563|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188564|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188565|NCT03429400|Analgesics|analgesics|mesh-ancestor
139188566|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
139188567|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188568|NCT03429010|Anesthetics|anesthetics|mesh-list
139188569|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188570|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188571|NCT02944656|Gabapentin|gabapentin|mesh-list
139188572|NCT02944656|Analgesics|analgesics|mesh-ancestor
139188573|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
139188574|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188575|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188576|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
139188577|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139188578|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139188579|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188580|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139188581|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139188582|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139188583|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188584|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188585|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
139188586|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
139188587|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139188588|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188589|NCT02713529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139188590|NCT02713529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188591|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
139188592|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
139188593|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139188594|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139188595|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188596|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188597|NCT03763045|Urological Agents|urological agents|mesh-ancestor
139188598|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
139188599|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188600|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
139188601|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139188602|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139188603|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188604|NCT01321489|Urological Agents|urological agents|mesh-ancestor
139188605|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
139188606|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139188607|NCT04800627|Pevonedistat|pevonedistat|mesh-list
139188608|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139188609|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188610|NCT04800627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139188611|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188612|NCT05308602|Vaccines|vaccines|mesh-list
139188613|NCT05308602|Immunologic Factors|immunologic factors|mesh-ancestor
139188614|NCT05308602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188615|NCT03768037|Pemetrexed|pemetrexed|mesh-list
139188616|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188617|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188618|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188619|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139188620|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139188621|NCT01146977|Cytarabine|cytarabine|mesh-list
139188622|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139188623|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
139188624|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188625|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188626|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
139188627|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188628|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139188629|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
139188630|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188631|NCT03762967|Hormones|hormones|mesh-list
138970655|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
139188632|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139188633|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188634|NCT03762889|Anesthetics|anesthetics|mesh-list
139188635|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188636|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188637|NCT03746041|Abaloparatide|abaloparatide|mesh-list
139188638|NCT03746041|Bevacizumab|bevacizumab|mesh-list
139188639|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139188640|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188641|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139188642|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139188643|NCT03746041|Growth Substances|growth substances|mesh-ancestor
139188644|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905071|NCT00758212|Vaccines|vaccines|mesh-list
139188645|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
139188646|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139188647|NCT01236989|Liver Extracts|liver extracts|mesh-list
139188648|NCT01236989|Hematinics|hematinics|mesh-ancestor
139188649|NCT03423472|Vitamin A|vitamin a|mesh-list
139188650|NCT03423472|Vitamins|vitamins|mesh-ancestor
139188651|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
139188652|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188653|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
139188654|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139188655|NCT01239563|Basiliximab|basiliximab|mesh-list
139188656|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
139188657|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188658|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139188659|NCT01321255|Aspirin|aspirin|mesh-list
139188660|NCT01321255|Ramipril|ramipril|mesh-list
139188661|NCT01321255|Simvastatin|simvastatin|mesh-list
139188662|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139188663|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139188664|NCT01321255|Analgesics|analgesics|mesh-ancestor
139188665|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
139188666|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188667|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188668|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139188669|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139188670|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139188671|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139188672|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188673|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139188674|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139188675|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188677|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139188678|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139188679|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
139188680|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139188681|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139188682|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139188683|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
139188684|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139188685|NCT01883297|Aldesleukin|aldesleukin|mesh-list
139188686|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
139188687|NCT01883297|Interleukin-2|interleukin-2|mesh-list
139188688|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139188689|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
139188690|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188691|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139188692|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139188693|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
139188694|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188695|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188696|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139188697|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139188698|NCT01883297|Analgesics|analgesics|mesh-ancestor
139188699|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
139188700|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188701|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139188702|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139188703|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
139188704|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188705|NCT04546581|Remdesivir|remdesivir|mesh-list
139188706|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
139188707|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139188708|NCT04546581|Antibodies|antibodies|mesh-list
139188709|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
139188710|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188711|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
139188712|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188713|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
139188714|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188715|NCT02204254|Doxycycline|doxycycline|mesh-list
139188716|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139188717|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188718|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
139188719|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139188720|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139188721|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
139188722|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139188723|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188724|NCT03164655|Leucovorin|leucovorin|mesh-list
139188725|NCT03164655|Bevacizumab|bevacizumab|mesh-list
139188726|NCT03164655|Cetuximab|cetuximab|mesh-list
139188727|NCT03164655|Panitumumab|panitumumab|mesh-list
139188728|NCT03164655|Fluorouracil|fluorouracil|mesh-list
139188729|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
139188730|NCT03164655|Irinotecan|irinotecan|mesh-list
139188731|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139188732|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188733|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139188734|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139188735|NCT03164655|Growth Substances|growth substances|mesh-ancestor
139188736|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188737|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
139188738|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
139188739|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188740|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139188741|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139188742|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
139188743|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139188744|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139188745|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188746|NCT03164655|Antidotes|antidotes|mesh-ancestor
139188747|NCT03164655|Protective Agents|protective agents|mesh-ancestor
138905136|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
139188748|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
139188749|NCT03164655|Vitamins|vitamins|mesh-ancestor
139188750|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
139188751|NCT02521012|Vitamin D|vitamin d|mesh-list
139188752|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
139188753|NCT02521012|Cholecalciferol|cholecalciferol|mesh-list
139188754|NCT02521012|Vitamins|vitamins|mesh-list
139188755|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
139188756|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188757|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139188758|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139188759|NCT04756128|Colchicine|colchicine|mesh-list
139188760|NCT04756128|Naltrexone|naltrexone|mesh-list
139188761|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139188762|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139188763|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188764|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
139188765|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188766|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
139188767|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139188768|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
139188769|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
139188770|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
139188771|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188772|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188773|NCT03427216|Diazepam|diazepam|mesh-list
139188774|NCT03427216|Baclofen|baclofen|mesh-list
139188775|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139188776|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188777|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139188778|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188779|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139188780|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
139188781|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
139188782|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188783|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188784|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139188785|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
139188786|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
139188787|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
139188788|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139188789|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139188790|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188791|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138970745|NCT00878904|Panobinostat|panobinostat|mesh-list
139188792|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139188793|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139188794|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139188795|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
139188796|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
139188797|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
139188798|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
139188799|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139188800|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188801|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188802|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139188803|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139188804|NCT01144091|Protective Agents|protective agents|mesh-ancestor
139188805|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188806|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
139188807|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139188808|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
139188809|NCT02392559|Evolocumab|evolocumab|mesh-list
139188810|NCT02392559|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139188811|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139188812|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139188813|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
139188814|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188815|NCT02392559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139188816|NCT02392559|Protease Inhibitors|protease inhibitors|mesh-ancestor
139188817|NCT02392559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188818|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139188819|NCT03332589|Dabrafenib|dabrafenib|mesh-list
139188820|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188821|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139188822|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188823|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188824|NCT03767569|Folic Acid|folic acid|mesh-list
139188826|NCT03767569|Hematinics|hematinics|mesh-ancestor
139188827|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
139188828|NCT03767569|Vitamins|vitamins|mesh-ancestor
139188829|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
139188830|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188831|NCT03620916|Morphine|morphine|mesh-list
139188832|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139188833|NCT03620916|Narcotics|narcotics|mesh-ancestor
139188834|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188835|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188836|NCT03620916|Analgesics|analgesics|mesh-ancestor
139188837|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
139188838|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188839|NCT01237067|Carboplatin|carboplatin|mesh-list
139188840|NCT01237067|Olaparib|olaparib|mesh-list
139188841|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139188842|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139188843|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188844|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188845|NCT03426982|Heparin|heparin|mesh-list
139188846|NCT03426982|Calcium heparin|calcium heparin|mesh-list
139188847|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
139188848|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139188849|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139188850|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188851|NCT01546948|Methadone|methadone|mesh-list
139188852|NCT01546948|Hydromorphone|hydromorphone|mesh-list
139188853|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139188854|NCT01546948|Narcotics|narcotics|mesh-ancestor
139188855|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188856|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188857|NCT01546948|Analgesics|analgesics|mesh-ancestor
139188858|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
139188859|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188860|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
139188861|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
139188863|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
139188864|NCT00458003|Ephedrine|ephedrine|mesh-list
139188865|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139188866|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
139188867|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
139188868|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188869|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188870|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
139188871|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138905159|NCT05747469|Lidocaine|lidocaine|mesh-list
139188872|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
139188873|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
139188874|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139188875|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139188876|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139188877|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
139188878|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188879|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188880|NCT00458003|Protective Agents|protective agents|mesh-ancestor
139188881|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139188882|NCT03008616|Digoxin|digoxin|mesh-list
139188883|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138786342|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
139188885|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188886|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188887|NCT03008616|Protective Agents|protective agents|mesh-ancestor
139188888|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188889|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
139188890|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139188891|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139188892|NCT03426592|Vitamin D|vitamin d|mesh-list
139188893|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
139188894|NCT03426592|Vitamins|vitamins|mesh-ancestor
139188895|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
139188896|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188897|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139188898|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139188899|NCT01567657|Midazolam|midazolam|mesh-list
139188900|NCT01567657|Meperidine|meperidine|mesh-list
139188901|NCT01567657|Propofol|propofol|mesh-list
139188902|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139188903|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188904|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188905|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139188906|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
139188907|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
139188908|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139188909|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139188910|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139188911|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139188912|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
139188913|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
139188914|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970773|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
138905180|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188915|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188916|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139188917|NCT01567657|Narcotics|narcotics|mesh-ancestor
139188918|NCT01567657|Analgesics|analgesics|mesh-ancestor
139188919|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
139188920|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188921|NCT03416062|Niacinamide|niacinamide|mesh-list
139188922|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
139188923|NCT03416062|Vitamins|vitamins|mesh-ancestor
139188924|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
139188925|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188926|NCT03761485|Fluorides|fluorides|mesh-list
139188927|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
139188928|NCT03761485|Protective Agents|protective agents|mesh-ancestor
139188929|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188930|NCT03766867|Vortioxetine|vortioxetine|mesh-list
139188931|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
139188932|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139188933|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139188934|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139188935|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188936|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188937|NCT03766867|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139188938|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139188939|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139188940|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188941|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188942|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
139188943|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139188944|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139188945|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139188946|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139188947|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
139188948|NCT02061293|Promethazine|promethazine|mesh-list
139188949|NCT02061293|Psilocybin|psilocybin|mesh-list
139188950|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139188951|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139188952|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188953|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188954|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
138786353|NCT00920829|Naltrexone|naltrexone|mesh-list
139188955|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
139188956|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
139188957|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188958|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
139188959|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
139188960|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139188961|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139188962|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
139188963|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
139188964|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188965|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188966|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139188967|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
139188968|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
139188969|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
139188970|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139188971|NCT03761329|Lidocaine|lidocaine|mesh-list
139188972|NCT03761329|Anesthetics|anesthetics|mesh-list
139188973|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
139188974|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139188975|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188976|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
139188977|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188978|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139188979|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139188980|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139188981|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139188982|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188983|NCT03415906|Valsartan|valsartan|mesh-list
139188984|NCT03415906|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139188985|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139188986|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139188987|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139188988|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188989|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
139188990|NCT03415750|Everolimus|everolimus|mesh-list
139188991|NCT03415750|Tacrolimus|tacrolimus|mesh-list
139188992|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139188993|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
139188994|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139188995|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139188996|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139188997|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139188998|NCT03415750|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139188999|NCT03415750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139189000|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189001|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139189002|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139189003|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
139189004|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139189005|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189006|NCT01239719|Clemastine|clemastine|mesh-list
139189007|NCT01239719|Dexamethasone|dexamethasone|mesh-list
139189008|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
139189009|NCT01239719|BB 1101|bb 1101|mesh-list
139189010|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139189011|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
139189012|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
139189013|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189014|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189015|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139189016|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
139189017|NCT01239719|Hormones|hormones|mesh-ancestor
139189018|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139189019|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139189020|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189021|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
139189022|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189023|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189024|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
139189025|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
139189026|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139189027|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
139189028|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
139189029|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189030|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139189031|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
138970812|NCT00811460|Hormones|hormones|mesh-ancestor
139189032|NCT03916679|Fludarabine|fludarabine|mesh-list
139189033|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139189034|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
139189035|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189036|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189037|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139189038|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
139189039|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189040|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189041|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139189042|NCT03421990|Anesthetics|anesthetics|mesh-list
139189043|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189044|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189046|NCT02913612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139189047|NCT02913612|Maleic acid|maleic acid|mesh-list
139189048|NCT02913612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905258|NCT00761020|Mefloquine|mefloquine|mesh-list
139189049|NCT02913612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189050|NCT02913612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139189051|NCT02913612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138939557|NCT02183129|Analgesics|analgesics|mesh-ancestor
139189052|NCT02913612|Adrenergic Agents|adrenergic agents|mesh-ancestor
139189053|NCT02913612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189054|NCT02913612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189055|NCT02913612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139189056|NCT02913612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139189057|NCT03426202|Modafinil|modafinil|mesh-list
139189058|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139189059|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189060|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139189061|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139189062|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139189063|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189064|NCT01248299|Cisplatin|cisplatin|mesh-list
139189065|NCT01248299|Docetaxel|docetaxel|mesh-list
139189066|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
139189067|NCT01248299|Fluorouracil|fluorouracil|mesh-list
139189068|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189069|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
139189070|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
139189071|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
139189072|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189073|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
139189074|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139189075|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139189076|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
139189077|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189078|NCT01239875|Vaccines|vaccines|mesh-list
139189079|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139189080|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
139189081|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189082|NCT03415594|Glucagon|glucagon|mesh-list
139189083|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139189084|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139189085|NCT03415594|Hormones|hormones|mesh-ancestor
139189086|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139189087|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189088|NCT03415594|Incretins|incretins|mesh-ancestor
139189089|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
139189090|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
139189091|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139189092|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139189093|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189094|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189095|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189096|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189097|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
139189098|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
139189099|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139189100|NCT03620838|Progesterone|progesterone|mesh-list
139189101|NCT03620838|Progestins|progestins|mesh-ancestor
139189102|NCT03620838|Hormones|hormones|mesh-ancestor
139189103|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139189104|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189105|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139189106|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139189107|NCT01239953|Paclitaxel|paclitaxel|mesh-list
139189108|NCT01239953|Everolimus|everolimus|mesh-list
139189109|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139189110|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189111|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
139189112|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
139189113|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
139189114|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189115|NCT01239953|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139189116|NCT01239953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139189117|NCT01239953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189118|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139189119|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
139189120|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189121|NCT01322191|Morphine|morphine|mesh-list
139189122|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139189123|NCT01322191|Narcotics|narcotics|mesh-ancestor
139189124|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189125|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189126|NCT01322191|Analgesics|analgesics|mesh-ancestor
139189127|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
139189128|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189130|NCT03620760|Ticagrelor|ticagrelor|mesh-list
139189131|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139189132|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189133|NCT03620760|Analgesics|analgesics|mesh-ancestor
139189134|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
139189135|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189136|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189137|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139189138|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189139|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139189140|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139189141|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189142|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139189143|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139189144|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189145|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
139189146|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139189147|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139189148|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139189149|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
139189150|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189151|NCT03765931|Amoxicillin|amoxicillin|mesh-list
139189152|NCT03765931|Doxycycline|doxycycline|mesh-list
139189153|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139189154|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189155|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
139189156|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139189157|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139189158|NCT01240265|Vitamin D|vitamin d|mesh-list
139189159|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
139189160|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
139189161|NCT01240265|Vitamins|vitamins|mesh-list
139189162|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
139189163|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189164|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139189165|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139189166|NCT03638076|Ritonavir|ritonavir|mesh-list
139189167|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139189168|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139189169|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
139189170|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189171|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189172|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139189173|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139189174|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
139189175|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189176|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139189177|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139189178|NCT01329731|Olaflur|olaflur|mesh-list
139189179|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
139189180|NCT01329731|Protective Agents|protective agents|mesh-ancestor
139189181|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189182|NCT03765697|Lidocaine|lidocaine|mesh-list
139189183|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
139189184|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
139189185|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189186|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189187|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
139189188|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189189|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139189190|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139189191|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139189192|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139189193|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189194|NCT03311841|Rifampin|rifampin|mesh-list
139189195|NCT03311841|Midazolam|midazolam|mesh-list
139189196|NCT03311841|Dabigatran|dabigatran|mesh-list
139189197|NCT03311841|Atorvastatin|atorvastatin|mesh-list
139189198|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139189199|NCT03311841|Pitavastatin|pitavastatin|mesh-list
139189200|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139189201|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139189202|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139189203|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189204|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189205|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139189206|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139189207|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139189208|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139189209|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
139189210|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
139189211|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
139189212|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
139189213|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970845|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139189214|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189215|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139189216|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139189218|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139189219|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139189220|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189221|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
139189222|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139189223|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
139189224|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
139189225|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139189226|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
139189227|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139189228|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189229|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
139189230|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139189231|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139189232|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139189233|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139189234|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139189235|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138786367|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139189236|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139189237|NCT01249937|Triamcinolone|triamcinolone|mesh-list
139189238|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139189239|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139189240|NCT01249937|Ranibizumab|ranibizumab|mesh-list
139189241|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139189242|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139189243|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139189244|NCT01249937|Growth Substances|growth substances|mesh-ancestor
139189245|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189246|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
139189247|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189248|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139189249|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
139189250|NCT01249937|Hormones|hormones|mesh-ancestor
139189251|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139189252|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139189253|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
139189254|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189255|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189256|NCT02528201|Celecoxib|celecoxib|mesh-list
139189257|NCT02528201|Diclofenac|diclofenac|mesh-list
139189258|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139189259|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189260|NCT02528201|Analgesics|analgesics|mesh-ancestor
139189261|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
139189262|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189263|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189264|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139189265|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189266|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139189267|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139189268|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189269|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189270|NCT03758677|Gemcitabine|gemcitabine|mesh-list
139189271|NCT03758677|Docetaxel|docetaxel|mesh-list
139189272|NCT03758677|Pemetrexed|pemetrexed|mesh-list
139189273|NCT03758677|Apatinib|apatinib|mesh-list
139189274|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139189275|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
139189276|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939784|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189278|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
139189279|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
139189280|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
139189281|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189282|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139189283|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139189284|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139189285|NCT03764683|Suvorexant|suvorexant|mesh-list
139189286|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139189287|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139189288|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189289|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189290|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139189291|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189292|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189293|NCT03414892|Globalagliatin|globalagliatin|mesh-list
139189294|NCT03414892|Enzyme Activators|enzyme activators|mesh-ancestor
139189295|NCT03414892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786381|NCT02878265|Zinc|zinc|mesh-list
139189296|NCT01242605|Gemcitabine|gemcitabine|mesh-list
139189297|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189298|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139189299|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
139189300|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189301|NCT03414814|Osimertinib|osimertinib|mesh-list
139189302|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189303|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139189304|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189305|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189306|NCT03421366|Posaconazole|posaconazole|mesh-list
139189307|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
139189308|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189309|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139189310|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139189311|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138905458|NCT00763204|Hormones|hormones|mesh-ancestor
139189312|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139189313|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139189314|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189315|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189316|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139189318|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139189319|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189320|NCT03764605|Metformin|metformin|mesh-list
139189321|NCT03764605|Tolvaptan|tolvaptan|mesh-list
139189322|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138970873|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189323|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189324|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139189325|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189326|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
139189328|NCT03764527|Lumefantrine|lumefantrine|mesh-list
139189329|NCT03764527|Artemether|artemether|mesh-list
139189330|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139189331|NCT03764527|Amodiaquine|amodiaquine|mesh-list
139189332|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
139189333|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139189334|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139189335|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189336|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189337|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
139189338|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
139189339|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139189340|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
139189341|NCT01321801|Pregabalin|pregabalin|mesh-list
139189342|NCT01321801|Analgesics|analgesics|mesh-ancestor
139189343|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
139189344|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189345|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189346|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
139189347|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139189348|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139189349|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189350|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139189351|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139189352|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139189353|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189354|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139189355|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
139189356|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139189357|NCT01155375|Hematinics|hematinics|mesh-ancestor
139189358|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139189359|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139189360|NCT01155375|Trace Elements|trace elements|mesh-ancestor
139189361|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
139189362|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189364|NCT03759301|Hormones|hormones|mesh-list
139189365|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139189366|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189367|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139189368|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
139189369|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139189370|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
139189371|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
139189372|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139189373|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189374|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
139189375|NCT02260102|Temocillin|temocillin|mesh-list
139189376|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139189377|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189378|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
139189379|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139189380|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189381|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189382|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189383|NCT03425734|Analgesics|analgesics|mesh-ancestor
139189384|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
139189385|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189386|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139189387|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139189388|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139189389|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
139189390|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189391|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189392|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
139189393|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139189394|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
139189395|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
139189396|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189397|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189398|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189399|NCT03420586|Analgesics|analgesics|mesh-ancestor
139189400|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
139189401|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189402|NCT03759067|Clopidogrel|clopidogrel|mesh-list
139189403|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139189404|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139189405|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139189406|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139189407|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
139189408|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189409|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189410|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189411|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
139189412|NCT03425656|Docetaxel|docetaxel|mesh-list
139189413|NCT03425656|Doxorubicin|doxorubicin|mesh-list
139189414|NCT03425656|Trastuzumab|trastuzumab|mesh-list
139189415|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139189416|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
139189417|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786475|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139189418|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189419|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139189420|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
139189421|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189422|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189423|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139189424|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
139189425|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
139189426|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
139189427|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139189428|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139189429|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139189430|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189431|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139189432|NCT03413722|Everolimus|everolimus|mesh-list
139189433|NCT03413722|Tacrolimus|tacrolimus|mesh-list
139189434|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139189435|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
139189436|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189437|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139189438|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189439|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189440|NCT03413722|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139189441|NCT03413722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139189442|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189443|NCT04843462|Esketamine|esketamine|mesh-list
139189444|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
139189445|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139189446|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
139189447|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139189448|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189449|NCT03413410|Metoprolol|metoprolol|mesh-list
139189450|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139189451|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139189452|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
139189453|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
139189454|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189455|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189456|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139189457|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139189458|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139189459|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
139189460|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189461|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189462|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139189463|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139189464|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
139189465|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189466|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139189467|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139189468|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
139189469|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
139189470|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189471|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189472|NCT03424876|Sunitinib|sunitinib|mesh-list
139189473|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
139189474|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189475|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139189476|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139189477|NCT03424876|Growth Substances|growth substances|mesh-ancestor
139189478|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189479|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
139189480|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139189481|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905527|NCT00672958|Vortioxetine|vortioxetine|mesh-list
139189482|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189483|NCT03476577|Ibuprofen|ibuprofen|mesh-list
139189484|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139189485|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189486|NCT03476577|Analgesics|analgesics|mesh-ancestor
139189487|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
139189488|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189489|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189490|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139189491|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189492|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139189493|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189494|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189495|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139189496|NCT03419650|Hormones|hormones|mesh-ancestor
139189497|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139189498|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189499|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
138940021|NCT05157412|Hormones|hormones|mesh-ancestor
139189501|NCT04893915|Interleukin-2|interleukin-2|mesh-list
139189502|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139189503|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
139189504|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189505|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189506|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139189507|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
139189508|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189509|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189510|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139189511|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189512|NCT04893915|Analgesics|analgesics|mesh-ancestor
139189513|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
139189514|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189515|NCT03419494|Doxorubicin|doxorubicin|mesh-list
139189516|NCT03419494|Daunorubicin|daunorubicin|mesh-list
139189517|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139189518|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139189519|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189520|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139189521|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139189522|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189523|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189524|NCT03413020|Amoxicillin|amoxicillin|mesh-list
139189525|NCT03413020|Metronidazole|metronidazole|mesh-list
139189526|NCT03413020|Clarithromycin|clarithromycin|mesh-list
139189527|NCT03413020|Levofloxacin|levofloxacin|mesh-list
139189528|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
139189529|NCT03413020|Esomeprazole|esomeprazole|mesh-list
139189530|NCT03413020|Bismuth|bismuth|mesh-list
139189531|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189532|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139189533|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189534|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139189535|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139189536|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139189537|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139189538|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139189539|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189540|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139189541|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139189542|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139189543|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139189544|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139189545|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139189546|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905538|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189547|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139189549|NCT03413020|Diuretics|diuretics|mesh-ancestor
139189550|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
139189551|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189552|NCT03413020|Expectorants|expectorants|mesh-ancestor
139189553|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
139189554|NCT03424408|Aspirin|aspirin|mesh-list
139189555|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139189556|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189557|NCT03424408|Analgesics|analgesics|mesh-ancestor
139189558|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
139189559|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189560|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189561|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139189562|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189563|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139189564|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139189565|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189566|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139189567|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139189568|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189569|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
139189570|NCT03305055|Fentanyl|fentanyl|mesh-list
139189571|NCT03305055|Ketamine|ketamine|mesh-list
139189572|NCT03305055|Analgesics|analgesics|mesh-ancestor
139189573|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
139189574|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189575|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189576|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139189577|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139189579|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
139189580|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189581|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139189582|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139189583|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189584|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189585|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139189586|NCT03305055|Narcotics|narcotics|mesh-ancestor
139189587|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139189588|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
139189589|NCT03412552|Analgesics|analgesics|mesh-ancestor
139189590|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
139189591|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189592|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189593|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
139189594|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189595|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139189596|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
139189597|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138786527|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
139189598|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139189599|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189600|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139189602|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139189603|NCT03412474|Acetaminophen|acetaminophen|mesh-list
139189604|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
139189605|NCT03412474|Bupivacaine|bupivacaine|mesh-list
139189606|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
139189607|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
139189608|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189609|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189610|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
139189611|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189612|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139189613|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189614|NCT03412474|Analgesics|analgesics|mesh-ancestor
139189615|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139189616|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139189617|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139189618|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
139189619|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189620|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189621|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
139189622|NCT03273387|Trimetazidine|trimetazidine|mesh-list
139189623|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
139189624|NCT04447612|Gemcitabine|gemcitabine|mesh-list
139189625|NCT04447612|Durvalumab|durvalumab|mesh-list
139189626|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189627|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139189628|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
139189629|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189630|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139189631|NCT03418558|Trastuzumab|trastuzumab|mesh-list
139189632|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139189633|NCT03418558|Maytansine|maytansine|mesh-list
138970954|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139189634|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139189635|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189636|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139189637|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
139189638|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
139189639|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
139189640|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189641|NCT03418558|Immunotoxins|immunotoxins|mesh-ancestor
139189642|NCT03418558|Immunoconjugates|immunoconjugates|mesh-ancestor
139189643|NCT03418558|Immunologic Factors|immunologic factors|mesh-ancestor
139189644|NCT03418558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189645|NCT03412006|Fulacimstat|fulacimstat|mesh-list
139189646|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189647|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189648|NCT03418246|Calcium|calcium|mesh-list
139189649|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139189650|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189652|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139189653|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189654|NCT03411850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139189655|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189656|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139189657|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
139189658|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189659|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189660|NCT05170594|Bevacizumab|bevacizumab|mesh-list
139189661|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
139189662|NCT05170594|Fluzoparib|fluzoparib|mesh-list
139189663|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139189664|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189665|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139189666|NCT05170594|Growth Substances|growth substances|mesh-ancestor
139189667|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189668|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
139189669|NCT05170594|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139189670|NCT05170594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189671|NCT05170594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189672|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
139189673|NCT03273153|Atezolizumab|atezolizumab|mesh-list
139189674|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139189675|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189676|NCT03273153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139189677|NCT03273153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189679|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139189680|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
139189681|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
139189682|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189683|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189684|NCT02520934|Miglustat|miglustat|mesh-list
139189685|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189686|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189687|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139189688|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139189689|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
139189690|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189691|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139189692|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139189693|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189694|NCT02749968|Bupivacaine|bupivacaine|mesh-list
139189695|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
139189696|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
139189697|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189698|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189699|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
139189700|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189701|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139189702|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139189703|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189704|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
139189705|NCT03417700|Vitamin D|vitamin d|mesh-list
139189706|NCT03417700|Vitamins|vitamins|mesh-ancestor
139189707|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
139189708|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189709|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139189710|NCT03410524|Simethicone|simethicone|mesh-list
139189711|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
139189712|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189713|NCT03410524|Emollients|emollients|mesh-ancestor
139189714|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
139189715|NCT02713776|Pasireotide|pasireotide|mesh-list
139189716|NCT02713776|Somatostatin|somatostatin|mesh-list
139189717|NCT02713776|Hormones|hormones|mesh-ancestor
139189718|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139189719|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189720|NCT05215990|Metformin|metformin|mesh-list
139189721|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139189722|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189723|NCT03268941|Metoclopramide|metoclopramide|mesh-list
139189724|NCT03268941|Maleic acid|maleic acid|mesh-list
139189725|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189726|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189727|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
139189728|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
138786547|NCT04213924|Bupivacaine|bupivacaine|mesh-list
139189729|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189730|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189731|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139189732|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139189733|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139189734|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
139189735|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189736|NCT05215834|Remifentanil|remifentanil|mesh-list
139189737|NCT05215834|Propofol|propofol|mesh-list
139189738|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139189739|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189740|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189741|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139189742|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
139189743|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
139189744|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139189745|NCT05215834|Narcotics|narcotics|mesh-ancestor
139189746|NCT05215834|Analgesics|analgesics|mesh-ancestor
139189747|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
139189748|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189749|NCT03394144|Durvalumab|durvalumab|mesh-list
139189750|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139189751|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189752|NCT05011149|Ibuprofen|ibuprofen|mesh-list
139189753|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139189754|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189755|NCT05011149|Analgesics|analgesics|mesh-ancestor
139189756|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
139189757|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189758|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189759|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139189760|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189761|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139189762|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189763|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189764|NCT03393988|Fentanyl|fentanyl|mesh-list
139189765|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
139189766|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
139189767|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139189768|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189769|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189770|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189771|NCT03393988|Analgesics|analgesics|mesh-ancestor
139189772|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
139189773|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189774|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139189775|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139189776|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139189777|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
139189778|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189779|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189780|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139189781|NCT03393988|Narcotics|narcotics|mesh-ancestor
139189782|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139189783|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139189784|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
139189785|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
139189786|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
139189787|NCT03410212|Ketorolac|ketorolac|mesh-list
139189788|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139189789|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139189790|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189791|NCT03410212|Analgesics|analgesics|mesh-ancestor
139189792|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
139189793|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189794|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189795|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139189796|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189797|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139189798|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189799|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189800|NCT03397264|Aflibercept|aflibercept|mesh-list
139189801|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139189802|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138971006|NCT02594423|Bevacizumab|bevacizumab|mesh-list
139189803|NCT03397264|Growth Substances|growth substances|mesh-ancestor
139189804|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189805|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
139189806|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189807|NCT03397186|Trabectedin|trabectedin|mesh-list
139189808|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139189809|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
139189810|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189811|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189812|NCT03393364|Ketorolac|ketorolac|mesh-list
139189813|NCT03393364|Oxycodone|oxycodone|mesh-list
139189814|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139189815|NCT03393364|Narcotics|narcotics|mesh-ancestor
139189816|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189817|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189818|NCT03393364|Analgesics|analgesics|mesh-ancestor
139189819|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
139189820|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189821|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139189822|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189823|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139189824|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189825|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139189826|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189827|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189828|NCT04632706|Ivermectin|ivermectin|mesh-list
139189829|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139189830|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189831|NCT03405454|Durvalumab|durvalumab|mesh-list
139189832|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139189833|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189834|NCT05168176|Dolutegravir|dolutegravir|mesh-list
139189835|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139189836|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139189837|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189838|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189839|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139189840|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139189841|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
139189842|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189843|NCT04539730|Bupivacaine|bupivacaine|mesh-list
139189844|NCT04539730|Ropivacaine|ropivacaine|mesh-list
139189845|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
139189846|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
139189847|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189848|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189849|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
139189850|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189851|NCT03396484|Methyldopa|methyldopa|mesh-list
138786566|NCT00616720|Interferons|interferons|mesh-list
139189852|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139189853|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
139189854|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
139189855|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189856|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189857|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139189858|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139189859|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139189860|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
139189861|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189862|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189863|NCT03321396|Calcium|calcium|mesh-list
139189864|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139189865|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189866|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
139189867|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
139189868|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139189869|NCT03321006|Escitalopram|escitalopram|mesh-list
139189870|NCT03321006|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138971019|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
139189871|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139189872|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139189873|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189874|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189875|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
139189876|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189877|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189878|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
139189879|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139189880|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139189882|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
139189883|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
139189884|NCT01974609|Acetaminophen|acetaminophen|mesh-list
139189885|NCT01974609|Ibuprofen|ibuprofen|mesh-list
139189886|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139189887|NCT01974609|Hydrocodone|hydrocodone|mesh-list
139189888|NCT01974609|Narcotics|narcotics|mesh-list
139189889|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189890|NCT01974609|Analgesics|analgesics|mesh-ancestor
139189891|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
139189892|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189893|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189894|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
139189895|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139189896|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139189897|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189898|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139189899|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189900|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189901|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139189902|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189903|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
139189904|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
139189905|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
139189906|NCT02593123|Molgramostim|molgramostim|mesh-list
139189907|NCT02593123|Lenograstim|lenograstim|mesh-list
139189908|NCT02593123|Sargramostim|sargramostim|mesh-list
139189909|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139189910|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
139189911|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189912|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139189913|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189914|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139189915|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
139189916|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139189917|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139189918|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189919|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189920|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
139189921|NCT03396250|Promethazine|promethazine|mesh-list
139189922|NCT03396250|Naproxen|naproxen|mesh-list
139189923|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139189924|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189925|NCT03396250|Analgesics|analgesics|mesh-ancestor
139189926|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
139189927|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189928|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189929|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139189930|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189931|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
139189932|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139189933|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189934|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189935|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139189936|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139189937|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139189938|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
139189939|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
139189940|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
139189941|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
139189942|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139189943|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139189944|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
139189945|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
139189946|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139189947|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139189948|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
139189949|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
139189950|NCT03302559|Vitamin A|vitamin a|mesh-list
139189951|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
139189952|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
139189953|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139189954|NCT03302559|Protective Agents|protective agents|mesh-ancestor
139189955|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189956|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
139189957|NCT03302559|Vitamins|vitamins|mesh-ancestor
139189958|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
139189959|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
139189960|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189961|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139189962|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189963|NCT03763669|Folic Acid|folic acid|mesh-list
139189964|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
139189965|NCT03763669|Inositol|inositol|mesh-list
139189966|NCT03763669|Hematinics|hematinics|mesh-ancestor
139189967|NCT03763669|Vitamins|vitamins|mesh-ancestor
139189968|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
139189969|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189970|NCT03302247|Gemcitabine|gemcitabine|mesh-list
139189971|NCT03302247|Nivolumab|nivolumab|mesh-list
139189972|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139189973|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
139189974|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189975|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139189976|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139189977|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139189978|NCT04363840|Aspirin|aspirin|mesh-list
139189979|NCT04363840|Vitamin D|vitamin d|mesh-list
139189980|NCT04363840|Vitamins|vitamins|mesh-ancestor
139189981|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
139189982|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189983|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139189984|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139189985|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139189986|NCT04363840|Analgesics|analgesics|mesh-ancestor
139189987|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
139189988|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139189989|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139189990|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139189991|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139189992|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139189993|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139189994|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139189995|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139189996|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139189998|NCT04981665|Tislelizumab|tislelizumab|mesh-list
139189999|NCT04981665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139190000|NCT04981665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190001|NCT03392740|Lisinopril|lisinopril|mesh-list
139190002|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139190003|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
139190004|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190005|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190006|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139190007|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139190008|NCT03392740|Protective Agents|protective agents|mesh-ancestor
139190009|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190010|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
139190011|NCT02818023|Vemurafenib|vemurafenib|mesh-list
139190012|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139190013|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190014|NCT02818023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139190015|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190016|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139190017|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190018|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139190019|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139190020|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190021|NCT04631536|Folic Acid|folic acid|mesh-list
139190022|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
139190023|NCT04631536|Nicorandil|nicorandil|mesh-list
139190024|NCT04631536|Nebivolol|nebivolol|mesh-list
139190025|NCT04631536|Atorvastatin|atorvastatin|mesh-list
139190026|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138940572|NCT00879892|Xenon|xenon|mesh-list
139190027|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139190028|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
139190029|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190030|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139190031|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139190032|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190034|NCT04631536|Vitamins|vitamins|mesh-ancestor
139190035|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
139190036|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190037|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139190038|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
139190039|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139190040|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139190041|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139190042|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
139190043|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190044|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139190045|NCT03262233|Nicotine|nicotine|mesh-list
139190046|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139190047|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
139190048|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190049|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190050|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139190051|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139190052|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
139190053|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190054|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190055|NCT05166538|Clopidogrel|clopidogrel|mesh-list
139190056|NCT05166538|Ticagrelor|ticagrelor|mesh-list
139190057|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139190058|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139190059|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139190060|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139190061|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
139190062|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190063|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190064|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190065|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139190066|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139190067|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190068|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139190069|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139190070|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139190071|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190072|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
139190073|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190074|NCT04666441|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
139190075|NCT04666441|Antiviral Agents|antiviral agents|mesh-ancestor
139190076|NCT04666441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139190077|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
139190078|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139190079|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139190080|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139190081|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138971092|NCT00236899|Paclitaxel|paclitaxel|mesh-list
139190082|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190083|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
139190084|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190085|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190086|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139190087|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190089|NCT04447378|Fondaparinux|fondaparinux|mesh-list
139190090|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139190091|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
139190092|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139190093|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
139190094|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190095|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190096|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
139190097|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139190098|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139190099|NCT03125980|Capecitabine|capecitabine|mesh-list
139190100|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
138940613|NCT04039126|Iodine|iodine|mesh-list
139190101|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139190102|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
139190103|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190104|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190105|NCT03399604|Treprostinil|treprostinil|mesh-list
139190106|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139190107|NCT03399526|Calcitriol|calcitriol|mesh-list
139190108|NCT03399526|Betamethasone|betamethasone|mesh-list
139190109|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
139190110|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139190111|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
139190112|NCT03399526|Clobetasol|clobetasol|mesh-list
139190113|NCT03399526|Prednicarbate|prednicarbate|mesh-list
139190114|NCT03399526|Calcipotriene|calcipotriene|mesh-list
139190115|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139190116|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139190117|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
139190118|NCT03399526|Hormones|hormones|mesh-ancestor
139190119|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139190120|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190121|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139190122|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
139190123|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
139190124|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139190125|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139190126|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139190127|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190128|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139190129|NCT03399526|Vitamins|vitamins|mesh-ancestor
139190130|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
139190131|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139190132|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139190133|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
139190134|NCT03392272|Coagulants|coagulants|mesh-ancestor
139190135|NCT03905902|Vaccines|vaccines|mesh-list
139190136|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
139190137|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190138|NCT03638310|Gentamicins|gentamicins|mesh-list
139190139|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139190140|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139190141|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139190142|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190143|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190144|NCT04656691|Bamlanivimab|bamlanivimab|mesh-list
139190145|NCT04656691|Antiviral Agents|antiviral agents|mesh-ancestor
139190146|NCT04656691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139190147|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
139190148|NCT03399448|Fludarabine|fludarabine|mesh-list
139190149|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139190150|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
139190151|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190152|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139190153|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139190154|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
139190155|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190156|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190157|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139190159|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
139190160|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190161|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139190162|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139190163|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139190164|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139190165|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
139190166|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190167|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139190168|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139190169|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190170|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
139190171|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
139190172|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190173|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190174|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940685|NCT00736866|Antidotes|antidotes|mesh-ancestor
139190175|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
139190176|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
139190177|NCT01610700|Nabiximols|nabiximols|mesh-list
139190178|NCT01610700|Analgesics|analgesics|mesh-ancestor
139190179|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
139190180|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190181|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190182|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
139190183|NCT04632459|Ramucirumab|ramucirumab|mesh-list
139190184|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139190185|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190186|NCT04632459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139190187|NCT04632459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190188|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139190189|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139190190|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
139190191|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139190192|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190193|NCT03316872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139190194|NCT03316872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190196|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139190197|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
139190198|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190199|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190200|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139190201|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
139190202|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
139190203|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139190204|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139190205|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139190206|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139190207|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
139190208|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190209|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190210|NCT04623684|Phenylephrine|phenylephrine|mesh-list
139190211|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
139190212|NCT04623684|Tropicamide|tropicamide|mesh-list
139190213|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139190214|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
139190215|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
139190216|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190217|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190218|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
139190219|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139190220|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
139190221|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
139190222|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139190223|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139190224|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139190225|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
139190226|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190227|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190228|NCT04623684|Protective Agents|protective agents|mesh-ancestor
139190229|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139190230|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139190231|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
139190232|NCT03297021|Ondansetron|ondansetron|mesh-list
139190233|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
139190234|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
139190235|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190236|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190237|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139190238|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
139190239|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
139190240|NCT03297021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138786702|NCT02497300|Diuretics|diuretics|mesh-ancestor
139190241|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139190242|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
139190243|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190244|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190245|NCT03752749|Prednisolone|prednisolone|mesh-list
139190246|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139190247|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
139190248|NCT03752749|Hormones|hormones|mesh-ancestor
139190249|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139190250|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190251|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139190252|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190253|NCT01988571|Atorvastatin|atorvastatin|mesh-list
139190254|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139190255|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138971158|NCT00236197|Rabeprazole|rabeprazole|mesh-list
139190256|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
139190257|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190258|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139190259|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139190260|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190261|NCT03755557|Budesonide|budesonide|mesh-list
139190262|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139190263|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139190264|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
139190265|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190266|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190267|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139190268|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
139190269|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
139190270|NCT03755557|Hormones|hormones|mesh-ancestor
139190271|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139190272|NCT03511599|Cycloserine|cycloserine|mesh-list
139190273|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139190274|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139190275|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139190276|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
139190277|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139190278|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
139190279|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190280|NCT01140867|Zonisamide|zonisamide|mesh-list
139190281|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
139190282|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139190283|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139190284|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190285|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139190286|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190287|NCT04572997|Apremilast|apremilast|mesh-list
139190288|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139190289|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139190290|NCT04572997|Analgesics|analgesics|mesh-ancestor
139190291|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
139190292|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190293|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190294|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139190295|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139190296|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139190297|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139190298|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190299|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190300|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139190301|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139190302|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190304|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190305|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139190306|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
139190307|NCT02891070|Coagulants|coagulants|mesh-ancestor
139190308|NCT00381381|Donepezil|donepezil|mesh-list
139190309|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139190310|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190311|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190312|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
139190313|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190314|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190315|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
139190316|NCT03637335|Carboplatin|carboplatin|mesh-list
139190317|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190318|NCT02939937|Phenytoin|phenytoin|mesh-list
139190319|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
139190320|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139190321|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138940834|NCT01608451|Vitamin D|vitamin d|mesh-list
139190322|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139190323|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190324|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139190325|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139190326|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139190327|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139190328|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190329|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139190330|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
139190331|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190332|NCT02774265|Aspirin|aspirin|mesh-list
139190333|NCT02774265|Heparin|heparin|mesh-list
139190334|NCT02774265|Enoxaparin|enoxaparin|mesh-list
139190335|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139190336|NCT02774265|Tinzaparin|tinzaparin|mesh-list
139190337|NCT02774265|Dalteparin|dalteparin|mesh-list
139190338|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139190339|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139190340|NCT02774265|Analgesics|analgesics|mesh-ancestor
138905786|NCT00766246|Growth Substances|growth substances|mesh-ancestor
139190341|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
139190342|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190343|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190344|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139190345|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139190346|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139190347|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139190348|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190349|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139190350|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139190351|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190352|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
139190353|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
139190354|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139190355|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139190356|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139190357|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190358|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190359|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139190360|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139190361|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190362|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
139190363|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190365|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139190366|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190367|NCT05239390|Dronabinol|dronabinol|mesh-list
139190368|NCT05239390|Hallucinogens|hallucinogens|mesh-ancestor
139190369|NCT05239390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190370|NCT05239390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139190371|NCT05239390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139190372|NCT05239390|Analgesics|analgesics|mesh-ancestor
139190373|NCT05239390|Sensory System Agents|sensory system agents|mesh-ancestor
139190374|NCT05239390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190375|NCT05239390|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139190376|NCT05239390|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139190377|NCT05239390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190378|NCT05239390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190380|NCT05239390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139190381|NCT03752437|Heparin|heparin|mesh-list
139190382|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
139190383|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139190384|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139190385|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190386|NCT05239312|Anti-Infective Agents|anti-infective agents|mesh-list
139190387|NCT05239312|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139190388|NCT04748341|Benzocaine|benzocaine|mesh-list
139190389|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
139190390|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
139190391|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139190392|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190393|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
139190394|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190395|NCT01328002|Milnacipran|milnacipran|mesh-list
139190396|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
139190397|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139190398|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139190399|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139190400|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190401|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190402|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190403|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139190404|NCT01328002|Analgesics|analgesics|mesh-ancestor
139190405|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
139190406|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190407|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
139190408|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139190409|NCT05239078|Anesthetics|anesthetics|mesh-list
139190410|NCT05239078|Anesthetics, Local|anesthetics, local|mesh-list
139190411|NCT05239078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139190412|NCT05239078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190413|NCT05239078|Sensory System Agents|sensory system agents|mesh-ancestor
138786748|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190414|NCT05239078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190415|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139190416|NCT02579265|SMOFlipid|smoflipid|mesh-list
139190417|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
139190418|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139190419|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139190420|NCT05238220|Valganciclovir|valganciclovir|mesh-list
139190421|NCT05238220|Antiviral Agents|antiviral agents|mesh-ancestor
139190422|NCT05238220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139190423|NCT04446598|Tadalafil|tadalafil|mesh-list
139190424|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
139190425|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139190426|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139190427|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190428|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190429|NCT04446598|Urological Agents|urological agents|mesh-ancestor
139190430|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
139190431|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139190432|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190433|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190434|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139190435|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139190436|NCT03391570|Analgesics|analgesics|mesh-ancestor
139190437|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
139190438|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190439|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190440|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139190441|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139190442|NCT03755089|Lidocaine|lidocaine|mesh-list
139190443|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
139190444|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
139190445|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139190446|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190447|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
138905838|NCT00772174|Metformin|metformin|mesh-list
139190448|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190449|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139190450|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139190451|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139190452|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139190453|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190454|NCT03757117|Hormones|hormones|mesh-list
139190455|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139190456|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190457|NCT03752125|Caffeine|caffeine|mesh-list
139190458|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139190459|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190460|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139190461|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190462|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190463|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139190464|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139190465|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
139190466|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190467|NCT03289533|Avelumab|avelumab|mesh-list
139190468|NCT03289533|Axitinib|axitinib|mesh-list
139190469|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139190470|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190471|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139190472|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190473|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190474|NCT03395002|Fluticasone|fluticasone|mesh-list
139190476|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
139190477|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139190478|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138786761|NCT04209478|Morphine|morphine|mesh-list
139190479|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139190480|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
139190481|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190482|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190483|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139190484|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
139190485|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
139190486|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139190487|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
139190489|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
139190490|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190491|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190492|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139190493|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139190494|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139190495|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
139190496|NCT05238064|Cyclophosphamide|cyclophosphamide|mesh-list
139190497|NCT05238064|Doxorubicin|doxorubicin|mesh-list
139190498|NCT05238064|Vincristine|vincristine|mesh-list
139190499|NCT05238064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139190500|NCT05238064|Immunologic Factors|immunologic factors|mesh-ancestor
139190501|NCT05238064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190502|NCT05238064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139190503|NCT05238064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139190504|NCT05238064|Alkylating Agents|alkylating agents|mesh-ancestor
139190505|NCT05238064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190506|NCT05238064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190507|NCT05238064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139190508|NCT05238064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139190509|NCT05238064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139190510|NCT05238064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139190511|NCT05238064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190512|NCT05238064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139190513|NCT05238064|Tubulin Modulators|tubulin modulators|mesh-ancestor
139190514|NCT05238064|Antimitotic Agents|antimitotic agents|mesh-ancestor
139190515|NCT05238064|Mitosis Modulators|mitosis modulators|mesh-ancestor
139190516|NCT03390790|Lidocaine|lidocaine|mesh-list
139190517|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
139190518|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
139190519|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139190520|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190521|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
139190522|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190523|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139190524|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139190525|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139190526|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139190527|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190528|NCT03697993|Levofloxacin|levofloxacin|mesh-list
139190529|NCT03697993|Fosfomycin|fosfomycin|mesh-list
139190530|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139190531|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139190532|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139190533|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139190534|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138786767|NCT04209478|Analgesics|analgesics|mesh-ancestor
139190535|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190536|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190537|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190538|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139190539|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139190540|NCT05393245|Tiotropium Bromide|tiotropium bromide|mesh-list
139190542|NCT05393245|Cholinergic Agents|cholinergic agents|mesh-list
139190543|NCT05393245|Muscarinic Antagonists|muscarinic antagonists|mesh-list
139190544|NCT05393245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139190545|NCT05393245|Autonomic Agents|autonomic agents|mesh-ancestor
139190546|NCT05393245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190547|NCT05393245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971225|NCT00278395|Vorinostat|vorinostat|mesh-list
139190548|NCT05393245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139190549|NCT05393245|Respiratory System Agents|respiratory system agents|mesh-ancestor
139190550|NCT05393245|Parasympatholytics|parasympatholytics|mesh-ancestor
139190551|NCT05393245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139190552|NCT05393245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190553|NCT05393245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190554|NCT03390712|Risperidone|risperidone|mesh-list
139190555|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139190556|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
139190557|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139190558|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
139190559|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190560|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190561|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190562|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139190563|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139190564|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139190565|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139190566|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
139190567|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139190568|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139190569|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
139190570|NCT03756727|Vitamins|vitamins|mesh-ancestor
139190571|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
139190572|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190573|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
139190574|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190575|NCT03756727|Protective Agents|protective agents|mesh-ancestor
139190576|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139190577|NCT03398434|Apixaban|apixaban|mesh-list
139190578|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139190579|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
139190580|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139190581|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
139190582|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190583|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190584|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
139190585|NCT03398122|Apatinib|apatinib|mesh-list
139190586|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190587|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139190588|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190589|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190590|NCT05459857|Menthol|menthol|mesh-list
139190591|NCT05459857|Antipruritics|antipruritics|mesh-ancestor
139190592|NCT05459857|Dermatologic Agents|dermatologic agents|mesh-ancestor
139190593|NCT03394222|Budesonide|budesonide|mesh-list
139190594|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139190595|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139190596|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
139190597|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190598|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190599|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139190600|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
139190601|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
139190602|NCT03394222|Hormones|hormones|mesh-ancestor
139190603|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139190604|NCT03398044|Dexamethasone|dexamethasone|mesh-list
139190605|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139190606|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
139190607|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
139190608|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190609|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190610|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139190611|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
139190612|NCT03398044|Hormones|hormones|mesh-ancestor
139190613|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139190614|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139190615|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190616|NCT03389776|Anesthetics|anesthetics|mesh-list
138941125|NCT05728632|Adrenergic Agents|adrenergic agents|mesh-ancestor
139190617|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139190618|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190619|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
139190620|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139190621|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139190622|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
139190623|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190624|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190625|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139190626|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
139190627|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
139190628|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139190629|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
139190630|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190631|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190632|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
139190634|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139190635|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
139190636|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139190637|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139190638|NCT03750721|Rifampin|rifampin|mesh-list
139190639|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139190640|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
139190641|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139190642|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139190643|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
139190644|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139190645|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190646|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190647|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139190648|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139190649|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139190650|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139190651|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139190652|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139190653|NCT01481272|Leucovorin|leucovorin|mesh-list
139190654|NCT01481272|Cytarabine|cytarabine|mesh-list
139190655|NCT01481272|Methotrexate|methotrexate|mesh-list
139190656|NCT01481272|Etoposide|etoposide|mesh-list
139190657|NCT01481272|Ofatumumab|ofatumumab|mesh-list
139190658|NCT01481272|Lenograstim|lenograstim|mesh-list
139190659|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139190660|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
139190661|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138971246|NCT00886002|Analgesics|analgesics|mesh-ancestor
139190662|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190663|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139190664|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
139190665|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905908|NCT04047940|Metformin|metformin|mesh-list
139190666|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190668|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190669|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139190670|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139190671|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
139190672|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139190673|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139190674|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139190675|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139190676|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139190677|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
139190678|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139190680|NCT01481272|Protective Agents|protective agents|mesh-ancestor
139190681|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
139190682|NCT01481272|Vitamins|vitamins|mesh-ancestor
139190683|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
139190684|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139190685|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
139190686|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139190687|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190688|NCT04478695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139190689|NCT04478695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190690|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
139190691|NCT02687386|Analgesics|analgesics|mesh-ancestor
139190692|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
139190693|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190694|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190695|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190696|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139190697|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139190698|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190699|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190700|NCT04531813|Butenafine|butenafine|mesh-list
139190701|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
139190702|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139190703|NCT01380028|Prednisone|prednisone|mesh-list
139190704|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139190705|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
139190706|NCT01380028|Hormones|hormones|mesh-ancestor
139190707|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139190708|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190709|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139190710|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190711|NCT01305460|Azacitidine|azacitidine|mesh-list
139190712|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139190713|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
139190714|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190715|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190716|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190717|NCT03754543|Iron|iron|mesh-list
139190718|NCT03754543|Trace Elements|trace elements|mesh-ancestor
139190719|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
139190720|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190721|NCT01199302|Brodalumab|brodalumab|mesh-list
139190722|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
139190723|NCT03754387|Ceftazidime|ceftazidime|mesh-list
139190724|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139190725|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139190727|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139190728|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139190729|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139190730|NCT03171480|Diuretics|diuretics|mesh-ancestor
139190731|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
139190732|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190733|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
139190734|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139190735|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190736|NCT04465357|Erenumab|erenumab|mesh-list
139190737|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139190738|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190739|NCT04465357|Analgesics|analgesics|mesh-ancestor
139190740|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
139190741|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190742|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190743|NCT05396690|Sevoflurane|sevoflurane|mesh-list
139190744|NCT05396690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139190745|NCT05396690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139190746|NCT05396690|Anesthetics, General|anesthetics, general|mesh-ancestor
139190747|NCT05396690|Anesthetics|anesthetics|mesh-ancestor
139190748|NCT05396690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139190749|NCT05396690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190750|NCT01384058|Simvastatin|simvastatin|mesh-list
139190751|NCT01384058|Ezetimibe|ezetimibe|mesh-list
139190752|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139190753|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139190754|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
139190755|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190756|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139190757|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139190758|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190759|NCT04401384|Pyridoxine|pyridoxine|mesh-list
139190760|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
139190761|NCT04401384|Doxylamine|doxylamine|mesh-list
139190762|NCT04401384|Dicyclomine|dicyclomine|mesh-list
139190763|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
139190764|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
139190765|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941283|NCT00613366|Antacids|antacids|mesh-ancestor
139190766|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190767|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139190768|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139190769|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
139190770|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
139190771|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190772|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190773|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
139190774|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139190775|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139190776|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
139190777|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
139190779|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
139190780|NCT03312114|Avelumab|avelumab|mesh-list
138786825|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
139190781|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139190782|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190783|NCT04239222|Ibuprofen|ibuprofen|mesh-list
139190784|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139190785|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139190786|NCT04239222|Analgesics|analgesics|mesh-ancestor
139190787|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
139190788|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190789|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190790|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139190791|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139190792|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139190793|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190794|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190796|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139190797|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190798|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190799|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190800|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
139190801|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139190802|NCT03084536|Acetaminophen|acetaminophen|mesh-list
139190803|NCT03084536|Celecoxib|celecoxib|mesh-list
139190804|NCT03084536|Midazolam|midazolam|mesh-list
139190805|NCT03084536|Fentanyl|fentanyl|mesh-list
139190806|NCT03084536|Gabapentin|gabapentin|mesh-list
139190807|NCT03084536|Bupivacaine|bupivacaine|mesh-list
139190808|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
139190809|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
139190810|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139190811|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190812|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
139190813|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190814|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139190815|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139190816|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139190817|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139190818|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139190819|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139190820|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
139190821|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
139190822|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
139190823|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190824|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190825|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139190826|NCT03084536|Narcotics|narcotics|mesh-ancestor
139190827|NCT03084536|Analgesics|analgesics|mesh-ancestor
139190828|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139190829|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
139190830|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139190831|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139190832|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139190833|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139190834|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139190835|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190836|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
139190837|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139190838|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139190839|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
138941351|NCT04037878|Narcotics|narcotics|mesh-ancestor
139190840|NCT03311724|Tirzepatide|tirzepatide|mesh-list
139190841|NCT03311724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139190842|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190843|NCT03311724|Incretins|incretins|mesh-ancestor
139190844|NCT03311724|Hormones|hormones|mesh-ancestor
139190845|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139190846|NCT05213312|Paclitaxel|paclitaxel|mesh-list
139190847|NCT05213312|Fluorouracil|fluorouracil|mesh-list
139190848|NCT05213312|Nivolumab|nivolumab|mesh-list
139190849|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139190850|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190851|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
139190852|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
139190853|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
139190854|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190855|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
139190856|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139190857|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139190858|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
139190859|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190860|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139190861|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139190862|NCT03311646|Nicotine|nicotine|mesh-list
139190863|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139190864|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
139190865|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190866|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190867|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139190868|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139190869|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
139190870|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190871|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190872|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
139190873|NCT03680274|Vitamins|vitamins|mesh-ancestor
139190874|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
139190875|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190876|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
139190877|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190878|NCT03680274|Protective Agents|protective agents|mesh-ancestor
139190879|NCT03288987|Leucovorin|leucovorin|mesh-list
139190880|NCT03288987|Bevacizumab|bevacizumab|mesh-list
139190881|NCT03288987|Fluorouracil|fluorouracil|mesh-list
139190882|NCT03288987|Irinotecan|irinotecan|mesh-list
139190883|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139190884|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190885|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138786853|NCT00617968|Docetaxel|docetaxel|mesh-list
139190886|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139190887|NCT03288987|Growth Substances|growth substances|mesh-ancestor
139190888|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190889|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
139190890|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
139190891|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190892|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139190893|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139190894|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
139190895|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139190896|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139190897|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190898|NCT03288987|Antidotes|antidotes|mesh-ancestor
139190899|NCT03288987|Protective Agents|protective agents|mesh-ancestor
139190900|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
139190901|NCT03288987|Vitamins|vitamins|mesh-ancestor
139190902|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
139190903|NCT01379846|Vaccines|vaccines|mesh-list
139190904|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
139190905|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190906|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
139190907|NCT01379300|Dabigatran|dabigatran|mesh-list
139190908|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139190909|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
139190910|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139190911|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
139190912|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190913|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190914|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
139190915|NCT03682224|Epinephrine|epinephrine|mesh-list
139190916|NCT03682224|Bupivacaine|bupivacaine|mesh-list
139190917|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
139190918|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
138941431|NCT00810381|Isosorbide|isosorbide|mesh-list
139190919|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139190920|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190921|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
139190922|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190923|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139190924|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139190925|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
139190926|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190927|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190928|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139190929|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139190930|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
139190931|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139190932|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
139190933|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
139190934|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
139190935|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139190936|NCT01383044|Carvedilol|carvedilol|mesh-list
139190937|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139190938|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139190939|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
139190940|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190941|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190942|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190943|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139190944|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
139190945|NCT01383044|Protective Agents|protective agents|mesh-ancestor
139190946|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139190947|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139190948|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139190949|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
139190950|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139190951|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139190952|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
139190953|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139190954|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
139190955|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139190956|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190957|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139190958|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
139190959|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139190960|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139190961|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139190962|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
139190963|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190964|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190965|NCT03083990|Bevacizumab|bevacizumab|mesh-list
139190966|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139190967|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190968|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139190969|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139190970|NCT03083990|Growth Substances|growth substances|mesh-ancestor
139190971|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190972|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
139190973|NCT03252015|Lasmiditan|lasmiditan|mesh-list
139190974|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139190975|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
139190976|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139190977|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190978|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190979|NCT01314027|Gemcitabine|gemcitabine|mesh-list
139190980|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
139190981|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139190982|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
139190983|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190984|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190985|NCT03708003|Venetoclax|venetoclax|mesh-list
139190986|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139190987|NCT03083132|Modafinil|modafinil|mesh-list
139190988|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139190989|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190990|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139190991|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139190992|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139190993|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190994|NCT04121468|Metformin|metformin|mesh-list
139190995|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139190996|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190997|NCT03648489|Paclitaxel|paclitaxel|mesh-list
139190998|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139190999|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191000|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
139191001|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
139191002|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
139191003|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191004|NCT01382888|Heparin|heparin|mesh-list
139191005|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
139191006|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139191007|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139191008|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191009|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139191010|NCT03249909|Laxatives|laxatives|mesh-ancestor
139191011|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139191012|NCT04809116|Pimavanserin|pimavanserin|mesh-list
139191013|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139191014|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139191015|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139191016|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139191017|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191018|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191019|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139191020|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139191021|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139191022|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
139191023|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971341|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191024|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191026|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
139191027|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191028|NCT01382732|Oxytocin|oxytocin|mesh-list
139191029|NCT01382732|Carbetocin|carbetocin|mesh-list
139191030|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
139191031|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139191032|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191033|NCT02183870|Crizotinib|crizotinib|mesh-list
139191034|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191035|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139191036|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191037|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191038|NCT03076970|Sumatriptan|sumatriptan|mesh-list
139191039|NCT03076970|Lasmiditan|lasmiditan|mesh-list
139191040|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139191041|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139191042|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139191043|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
139191044|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191045|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191046|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191047|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
139191048|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
139191049|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139191050|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139191051|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191052|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191053|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191054|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191055|NCT04897880|Panobinostat|panobinostat|mesh-list
139191056|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191057|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139191058|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191059|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191060|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
139191062|NCT02890992|Niacinamide|niacinamide|mesh-list
139191063|NCT02890992|Ezetimibe|ezetimibe|mesh-list
139191064|NCT02890992|Alirocumab|alirocumab|mesh-list
139191065|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
139191066|NCT02890992|Fenofibrate|fenofibrate|mesh-list
139191067|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138941585|NCT00422383|Rituximab|rituximab|mesh-list
139191068|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139191069|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
139191070|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191071|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139191072|NCT02890992|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139191073|NCT02890992|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139191074|NCT02890992|Protease Inhibitors|protease inhibitors|mesh-ancestor
139191075|NCT02890992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191076|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
139191077|NCT02890992|Vitamins|vitamins|mesh-ancestor
139191078|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
139191079|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191080|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
139191081|NCT03603912|Metformin|metformin|mesh-list
139191082|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139191083|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191084|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139191085|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139191086|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139191087|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191088|NCT05274984|Lidocaine|lidocaine|mesh-list
139191089|NCT05274984|Anesthetics, Local|anesthetics, local|mesh-ancestor
139191090|NCT05274984|Anesthetics|anesthetics|mesh-ancestor
139191091|NCT05274984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191092|NCT05274984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191093|NCT05274984|Sensory System Agents|sensory system agents|mesh-ancestor
139191094|NCT05274984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191095|NCT05274984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139191096|NCT05274984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139191097|NCT05274984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139191098|NCT05274984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139191099|NCT05274984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191100|NCT05274672|Ciprofloxacin|ciprofloxacin|mesh-list
139191101|NCT05274672|Cephalexin|cephalexin|mesh-list
139191102|NCT05274672|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139191103|NCT05274672|Nitrofurantoin|nitrofurantoin|mesh-list
139191104|NCT05274672|Trimethoprim|trimethoprim|mesh-list
139191105|NCT05274672|Sulfamethoxazole|sulfamethoxazole|mesh-list
139191106|NCT05274672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139191107|NCT05274672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191108|NCT05274672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139191109|NCT05274672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139191110|NCT05274672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191111|NCT05274672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191112|NCT05274672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191113|NCT05274672|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139191114|NCT05274672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139191115|NCT05274672|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139191116|NCT05274672|Antimalarials|antimalarials|mesh-ancestor
139191117|NCT05274672|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139191118|NCT05274672|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139191119|NCT05274672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139191120|NCT05274672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139191121|NCT05274672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139191122|NCT01379144|Latanoprost|latanoprost|mesh-list
139191123|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139191124|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139191125|NCT01376882|Caffeine|caffeine|mesh-list
139191126|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139191127|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191128|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139191129|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191130|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191131|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138906037|NCT02628587|Clopidogrel|clopidogrel|mesh-list
139191132|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139191133|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
139191134|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191136|NCT04656002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139191137|NCT04656002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191138|NCT04656002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191139|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
139191140|NCT01382498|Calcium|calcium|mesh-list
139191141|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139191142|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191144|NCT01382498|Coagulants|coagulants|mesh-ancestor
139191145|NCT03476538|Gabapentin|gabapentin|mesh-list
139191146|NCT03476538|Analgesics|analgesics|mesh-ancestor
139191147|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
139191148|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191149|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191150|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
139191151|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139191152|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139191153|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191154|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139191155|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139191156|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139191157|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191158|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191159|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
139191160|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
139191161|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139191162|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139191163|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139191164|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139191165|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191166|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
139191167|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191168|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191169|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139191170|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191171|NCT00000116|Vitamin A|vitamin a|mesh-list
139191172|NCT00000116|Vitamins|vitamins|mesh-ancestor
139191173|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
139191174|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191175|NCT05232396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139191176|NCT05232396|Antibodies|antibodies|mesh-list
139191177|NCT05232396|Immunoglobulins|immunoglobulins|mesh-list
139191178|NCT05232396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139191179|NCT05232396|Immunologic Factors|immunologic factors|mesh-ancestor
139191180|NCT05232396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191181|NCT05232396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191182|NCT05222724|Ibuprofen|ibuprofen|mesh-list
139191183|NCT05222724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139191184|NCT05222724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139191185|NCT05222724|Analgesics|analgesics|mesh-ancestor
139191186|NCT05222724|Sensory System Agents|sensory system agents|mesh-ancestor
139191187|NCT05222724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191188|NCT05222724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191189|NCT05222724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191190|NCT05222724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138391753|NCT01506557|Vitamin D|vitamin d|mesh-list
139191191|NCT05222724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139191192|NCT05222724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191193|NCT05222724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191194|NCT01382342|Rasagiline|rasagiline|mesh-list
139191195|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139191196|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191197|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191198|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139191199|NCT01382342|Protective Agents|protective agents|mesh-ancestor
139191200|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191201|NCT03471728|Linaclotide|linaclotide|mesh-list
139191202|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139191203|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
139191204|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191205|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139191206|NCT03630614|Nicotine|nicotine|mesh-list
139191207|NCT03630614|Varenicline|varenicline|mesh-list
139191208|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139191209|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
139191210|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191211|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191212|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139191213|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139191214|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
139191215|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941728|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
139191216|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191217|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139191218|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191220|NCT01378754|Propofol|propofol|mesh-list
139191221|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139191222|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191223|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191224|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139191225|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
139191226|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
139191227|NCT05764304|Sinomenine|sinomenine|mesh-list
139191228|NCT05764304|Glucocorticoids|glucocorticoids|mesh-list
139191229|NCT05764304|Hormones|hormones|mesh-ancestor
139191230|NCT05764304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191231|NCT05764304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191232|NCT05764304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191234|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139191235|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191236|NCT05764226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139191237|NCT02826512|Niraparib|niraparib|mesh-list
139191238|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139191239|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191240|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191241|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191242|NCT02731352|Apatinib|apatinib|mesh-list
139191243|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191244|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139191245|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191246|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191247|NCT05132660|Levodopa|levodopa|mesh-list
139191248|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139191249|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139191250|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139191251|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
139191252|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191253|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906066|NCT00675779|Dacuronium|dacuronium|mesh-list
139191254|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191255|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139191256|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
139191257|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
139191258|NCT05762744|Exenatide|exenatide|mesh-list
139191259|NCT05762744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139191260|NCT05762744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191261|NCT05762744|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139191262|NCT05762744|Incretins|incretins|mesh-ancestor
139191263|NCT05762744|Hormones|hormones|mesh-ancestor
139191264|NCT05762744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191265|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
139191266|NCT02257424|Trametinib|trametinib|mesh-list
139191267|NCT02257424|Dabrafenib|dabrafenib|mesh-list
139191268|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
139191269|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139191270|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139191271|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191272|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191273|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191274|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191275|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191276|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139191277|NCT01858922|Cytarabine|cytarabine|mesh-list
139191278|NCT01858922|Dexamethasone|dexamethasone|mesh-list
139191279|NCT01858922|Prednisone|prednisone|mesh-list
139191280|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
139191281|NCT01858922|Cisplatin|cisplatin|mesh-list
139191282|NCT01858922|Doxorubicin|doxorubicin|mesh-list
139191283|NCT01858922|Etoposide|etoposide|mesh-list
139191284|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
139191285|NCT01858922|Vincristine|vincristine|mesh-list
139191286|NCT01858922|Bleomycin|bleomycin|mesh-list
139191287|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139191288|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
139191289|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191290|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138941804|NCT00610714|Paclitaxel|paclitaxel|mesh-list
139191291|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139191292|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
139191293|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191294|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191295|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139191296|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191298|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
139191299|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191300|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139191301|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
139191302|NCT01858922|Hormones|hormones|mesh-ancestor
139191303|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191304|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138971448|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
139191305|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191306|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139191307|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139191308|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139191309|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139191310|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139191311|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
139191312|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
139191313|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191314|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
139191315|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
139191316|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
139191319|NCT01378286|Amodiaquine|amodiaquine|mesh-list
139191320|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
139191321|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139191322|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139191323|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191324|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191325|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
139191326|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
139191327|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139191328|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
139191329|NCT01378286|Amebicides|amebicides|mesh-ancestor
139191330|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191331|NCT01377974|Miltefosine|miltefosine|mesh-list
139191332|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
139191333|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
139191334|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191335|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191336|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139191337|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139191338|NCT03071276|Cytarabine|cytarabine|mesh-list
139191339|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
139191340|NCT03071276|Methotrexate|methotrexate|mesh-list
139191341|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
139191342|NCT03071276|Fludarabine|fludarabine|mesh-list
139191343|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139191344|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
139191345|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139191346|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191347|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139191348|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
139191349|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191350|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191351|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
139191352|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191353|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139191354|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139191355|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
139191356|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191357|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139191358|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
139191359|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191360|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191361|NCT03629600|Indomethacin|indomethacin|mesh-list
139191362|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139191363|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139191364|NCT03629600|Analgesics|analgesics|mesh-ancestor
139191365|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
139191366|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191367|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191368|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138971465|NCT02541396|Ketamine|ketamine|mesh-list
139191371|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
139191372|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139191373|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139191374|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191375|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191376|NCT03074162|Diclofenac|diclofenac|mesh-list
139191377|NCT03074162|Capsaicin|capsaicin|mesh-list
138786985|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191378|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139191379|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139191380|NCT03074162|Analgesics|analgesics|mesh-ancestor
138787004|NCT02299414|Nifedipine|nifedipine|mesh-list
139191381|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
139191382|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191383|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191384|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191385|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191386|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139191387|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191388|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191389|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
139191390|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
139191391|NCT05069012|Morphine|morphine|mesh-list
139191392|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139191393|NCT05069012|Narcotics|narcotics|mesh-ancestor
139191394|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191395|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191396|NCT05069012|Analgesics|analgesics|mesh-ancestor
139191397|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
139191398|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191399|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
139191400|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139191401|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191402|NCT02888106|Tenofovir|tenofovir|mesh-list
139191403|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139191404|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
139191405|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
139191406|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191407|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139191408|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139191409|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191410|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191411|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139191412|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139191413|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191414|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
139191415|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139191416|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
139191417|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139191418|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
139191419|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191420|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191421|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
139191422|NCT03304626|Prednisone|prednisone|mesh-list
139191423|NCT03304626|Budesonide|budesonide|mesh-list
139191424|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191425|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
139191426|NCT03304626|Hormones|hormones|mesh-ancestor
139191427|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191428|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191429|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139191430|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191431|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139191432|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
139191433|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191435|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
139191436|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
139191437|NCT05121714|Caffeine|caffeine|mesh-list
139191438|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139191439|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191440|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139191441|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191442|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191443|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138941954|NCT00642369|Haloperidol|haloperidol|mesh-list
139191444|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139191445|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
139191446|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191447|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139191448|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139191449|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191450|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139191451|NCT05121714|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139191452|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139191453|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139191454|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
139191455|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139191456|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
139191457|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139191458|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139191459|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139191460|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
139191461|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139191462|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191463|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191464|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139191465|NCT02958150|Analgesics|analgesics|mesh-ancestor
139191466|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
139191467|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191468|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139191469|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139191470|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139191471|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
139191472|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191473|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191474|NCT04250142|Methamphetamine|methamphetamine|mesh-list
139191475|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139191476|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191477|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
139191478|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
139191479|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191480|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
139191481|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191482|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191483|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
139191484|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139191485|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139191486|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139191487|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139191488|NCT02714322|Adalimumab|adalimumab|mesh-list
138971481|NCT02541396|Narcotics|narcotics|mesh-ancestor
139191489|NCT02714322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139191490|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191491|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191492|NCT03267576|Metformin|metformin|mesh-list
139191493|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139191494|NCT03267576|Canagliflozin|canagliflozin|mesh-list
139191495|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139191496|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191497|NCT03267576|Incretins|incretins|mesh-ancestor
139191498|NCT03267576|Hormones|hormones|mesh-ancestor
139191499|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191500|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139191501|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
139191502|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191503|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191504|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139191505|NCT02472912|Adalimumab|adalimumab|mesh-list
139191506|NCT02472912|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139191507|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191508|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191509|NCT02356458|Bortezomib|bortezomib|mesh-list
139191510|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191511|NCT03243630|Menthol|menthol|mesh-list
139191512|NCT03243630|Nicotine|nicotine|mesh-list
139191513|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139191514|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
139191515|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191516|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191517|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139191518|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139191519|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
139191520|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191521|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191522|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
139191523|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
139191524|NCT03753685|Ensartinib|ensartinib|mesh-list
139191525|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191526|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139191527|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191528|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191529|NCT02787044|Vaccines|vaccines|mesh-list
139191530|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
139191531|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191532|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
139191533|NCT01345019|Denosumab|denosumab|mesh-list
139191534|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139191535|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191536|NCT03629522|Ondansetron|ondansetron|mesh-list
139191537|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
139191538|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
139191539|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191540|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191541|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139191542|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
139191543|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
139191544|NCT03629522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139191545|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139191546|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
139191547|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191548|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191549|NCT03751111|Naloxone|naloxone|mesh-list
139191550|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139191551|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191552|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
139191553|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191554|NCT05167370|Amifostine|amifostine|mesh-list
139191555|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139191556|NCT05167370|Protective Agents|protective agents|mesh-ancestor
139191557|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191558|NCT01265537|Tacrolimus|tacrolimus|mesh-list
139191559|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139191560|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
139191561|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191562|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139191563|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191564|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191565|NCT05763836|Ibuprofen|ibuprofen|mesh-list
139191566|NCT05763836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139191567|NCT05763836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139191568|NCT05763836|Analgesics|analgesics|mesh-ancestor
139191569|NCT05763836|Sensory System Agents|sensory system agents|mesh-ancestor
139191570|NCT05763836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191571|NCT05763836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191572|NCT05763836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191573|NCT05763836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191574|NCT05763836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139191575|NCT05763836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191576|NCT05763836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191577|NCT01237535|Progesterone|progesterone|mesh-list
139191578|NCT01237535|Estrogens|estrogens|mesh-list
139191579|NCT01237535|Progestins|progestins|mesh-ancestor
139191580|NCT01237535|Hormones|hormones|mesh-ancestor
139191581|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191582|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191583|NCT04396639|Factor VIII|factor viii|mesh-list
139191584|NCT04396639|Coagulants|coagulants|mesh-ancestor
139191585|NCT01146431|Anesthetics|anesthetics|mesh-list
139191586|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191587|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191588|NCT01250249|Vaccines|vaccines|mesh-list
139191589|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
139191590|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
139191591|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942096|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191592|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139191593|NCT03747679|Mannitol|mannitol|mesh-list
139191594|NCT03747679|Sorbitol|sorbitol|mesh-list
139191595|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139191596|NCT03747679|Diuretics|diuretics|mesh-ancestor
139191597|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
139191598|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191599|NCT03747679|Cathartics|cathartics|mesh-ancestor
139191600|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139191601|NCT01243385|Metformin|metformin|mesh-list
139191602|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139191603|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191604|NCT01147133|Clopidogrel|clopidogrel|mesh-list
139191605|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139191606|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139191607|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139191608|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139191610|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191611|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191612|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191613|NCT04167085|Doxycycline|doxycycline|mesh-list
139191614|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139191615|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191616|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
139191617|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139191618|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139191619|NCT01147289|Meloxicam|meloxicam|mesh-list
139191620|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139191621|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139191622|NCT01147289|Analgesics|analgesics|mesh-ancestor
139191623|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
139191624|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191625|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191626|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191627|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191628|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139191629|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139191630|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191631|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191632|NCT01237769|Vitamin D|vitamin d|mesh-list
139191633|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
139191634|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
139191635|NCT01237769|Vitamins|vitamins|mesh-list
139191636|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
139191637|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191638|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139191639|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139191640|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139191641|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
139191642|NCT03914963|Coagulants|coagulants|mesh-ancestor
139191643|NCT04162795|Loratadine|loratadine|mesh-list
139191644|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
139191645|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
139191646|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139191647|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139191648|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139191649|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
139191650|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
139191651|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191652|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191653|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191654|NCT01250951|Deferasirox|deferasirox|mesh-list
139191655|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139191656|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
139191657|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
139191658|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191659|NCT03069482|Nicotine|nicotine|mesh-list
139191660|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139191661|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
139191662|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191663|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191664|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138942169|NCT01038895|Ramipril|ramipril|mesh-list
139191665|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139191666|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
139191667|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191668|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191670|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139191671|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191672|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139191673|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
139191674|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191675|NCT05083910|Misoprostol|misoprostol|mesh-list
139191676|NCT05083910|Oxytocin|oxytocin|mesh-list
139191677|NCT05083910|Carbetocin|carbetocin|mesh-list
139191678|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
139191679|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138787125|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191680|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191681|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139191682|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
139191683|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139191684|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139191685|NCT01250561|Valacyclovir|valacyclovir|mesh-list
139191687|NCT01250561|Analgesics|analgesics|mesh-ancestor
139191688|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
139191689|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191690|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191691|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
139191692|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139191693|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139191694|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191695|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139191696|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139191697|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139191698|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191699|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191700|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
139191701|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
139191702|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191703|NCT05055908|Atezolizumab|atezolizumab|mesh-list
139191704|NCT05055908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139191705|NCT05055908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191706|NCT05055908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139191707|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191708|NCT01147523|Vitamin E|vitamin e|mesh-list
139191709|NCT01147523|Spironolactone|spironolactone|mesh-list
139191710|NCT01147523|Vitamins|vitamins|mesh-ancestor
139191711|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
139191712|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191713|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
139191714|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191715|NCT01147523|Protective Agents|protective agents|mesh-ancestor
139191716|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139191717|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
139191718|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191719|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139191720|NCT01147523|Diuretics|diuretics|mesh-ancestor
139191721|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
139191722|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
138971634|NCT00812396|Testosterone|testosterone|mesh-list
139191724|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
139191725|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191726|NCT01251029|Expectorants|expectorants|mesh-ancestor
139191727|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
139191728|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139191729|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
139191730|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191731|NCT01251029|Protective Agents|protective agents|mesh-ancestor
139191732|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191733|NCT01251029|Antidotes|antidotes|mesh-ancestor
139191734|NCT01251107|Prednisone|prednisone|mesh-list
139191735|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
139191736|NCT01251107|Dacarbazine|dacarbazine|mesh-list
139191737|NCT01251107|Doxorubicin|doxorubicin|mesh-list
139191738|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139191739|NCT01251107|Etoposide|etoposide|mesh-list
138906194|NCT00818766|Cefazolin|cefazolin|mesh-list
139191740|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
139191741|NCT01251107|Vincristine|vincristine|mesh-list
139191742|NCT01251107|Bleomycin|bleomycin|mesh-list
139191743|NCT01251107|Vinblastine|vinblastine|mesh-list
139191744|NCT01251107|Procarbazine|procarbazine|mesh-list
139191745|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139191746|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
139191747|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191748|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191749|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139191750|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
139191751|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191752|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191753|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139191754|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139191755|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139191756|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139191757|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191758|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191759|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
139191760|NCT01251107|Hormones|hormones|mesh-ancestor
139191761|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191762|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139191763|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139191764|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
139191765|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
139191766|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
139191767|NCT01125176|Thalidomide|thalidomide|mesh-list
139191768|NCT01125176|Rituximab|rituximab|mesh-list
139191769|NCT01125176|Lenalidomide|lenalidomide|mesh-list
139191770|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139191771|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191772|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
139191773|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191774|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191775|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139191776|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139191777|NCT01125176|Growth Substances|growth substances|mesh-ancestor
139191778|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
139191779|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139191780|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
139191781|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139191782|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191784|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139191785|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191786|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139191787|NCT00882050|Incretins|incretins|mesh-ancestor
139191788|NCT00882050|Hormones|hormones|mesh-ancestor
139191789|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191790|NCT03912857|Apatinib|apatinib|mesh-list
139191791|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191792|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139191793|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191794|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191795|NCT04892420|Dexamethasone|dexamethasone|mesh-list
139191796|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
139191797|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
139191798|NCT04892420|Bupivacaine|bupivacaine|mesh-list
139191799|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191800|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
139191801|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
139191802|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191803|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191804|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139191805|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
139191807|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191808|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139191809|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191810|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
139191811|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
139191812|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191813|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
139191814|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139191815|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139191816|NCT04892420|Analgesics|analgesics|mesh-ancestor
139191817|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139191818|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139191819|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139191820|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
139191821|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191822|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191823|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139191824|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
139191825|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139191826|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139191827|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139191828|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
139191829|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139191830|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139191831|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139191832|NCT01251263|Estradiol|estradiol|mesh-list
139191833|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139191834|NCT01251263|Estrogens|estrogens|mesh-ancestor
139191835|NCT01251263|Hormones|hormones|mesh-ancestor
139191836|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191837|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191838|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139191839|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
139191840|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139191841|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139191842|NCT04707534|Dexamethasone|dexamethasone|mesh-list
139191843|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191844|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
139191845|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
139191846|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191847|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191848|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139191849|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
139191851|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191852|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139191853|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191854|NCT05761730|Dexamethasone|dexamethasone|mesh-list
139191855|NCT05761730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191856|NCT05761730|Antiemetics|antiemetics|mesh-ancestor
139191857|NCT05761730|Autonomic Agents|autonomic agents|mesh-ancestor
139191858|NCT05761730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191859|NCT05761730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191860|NCT05761730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139191861|NCT05761730|Glucocorticoids|glucocorticoids|mesh-ancestor
139191863|NCT05761730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191864|NCT05761730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139191865|NCT05761730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191866|NCT04353817|Ivacaftor|ivacaftor|mesh-list
139191867|NCT04353817|Elexacaftor|elexacaftor|mesh-list
139191868|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139191869|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139191870|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191871|NCT00159588|Angiotensin II|angiotensin ii|mesh-list
139191872|NCT00159588|Gabapentin|gabapentin|mesh-list
139191873|NCT00159588|Valproic Acid|valproic acid|mesh-list
139191874|NCT00159588|Antidepressive Agents|antidepressive agents|mesh-list
139191875|NCT00159588|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
139191876|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139191877|NCT00159588|Analgesics|analgesics|mesh-ancestor
139191878|NCT00159588|Sensory System Agents|sensory system agents|mesh-ancestor
139191879|NCT00159588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191880|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191881|NCT00159588|Anticonvulsants|anticonvulsants|mesh-ancestor
139191882|NCT00159588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139191883|NCT00159588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139191884|NCT00159588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191885|NCT00159588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139191886|NCT00159588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139191887|NCT00159588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139191888|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191889|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191890|NCT00159588|Antimanic Agents|antimanic agents|mesh-ancestor
139191891|NCT00159588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191892|NCT00159588|GABA Agents|gaba agents|mesh-ancestor
139191893|NCT00159588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139191894|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139191895|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
139191896|NCT04166942|Belumosudil|belumosudil|mesh-list
139191897|NCT04166942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139191898|NCT04166942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787187|NCT00626015|Temozolomide|temozolomide|mesh-list
139191899|NCT04166942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191900|NCT04349917|Methylphenidate|methylphenidate|mesh-list
139191901|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139191902|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191903|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139191904|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139191905|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138971669|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
139191906|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191907|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
139191908|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191909|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139191910|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139191911|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139191912|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
139191913|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191914|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139191915|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139191916|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191917|NCT04691856|Acetaminophen|acetaminophen|mesh-list
139191918|NCT04691856|Ibuprofen|ibuprofen|mesh-list
139191919|NCT04691856|Morphine|morphine|mesh-list
139191920|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139191921|NCT04691856|Narcotics|narcotics|mesh-ancestor
139191922|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191923|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191924|NCT04691856|Analgesics|analgesics|mesh-ancestor
139191925|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
139191926|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191927|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139191928|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139191929|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191930|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139191931|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139191932|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191933|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191934|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
139191935|NCT01254929|Frovatriptan|frovatriptan|mesh-list
139191936|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139191937|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
139191938|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191939|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191940|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191941|NCT03300570|Dolcanatide|dolcanatide|mesh-list
139191942|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139191943|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
139191944|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191945|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139191946|NCT03853694|Morphine|morphine|mesh-list
139191947|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139191948|NCT03853694|Narcotics|narcotics|mesh-ancestor
139191949|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139191950|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191952|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
139191953|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191954|NCT04154293|Isotretinoin|isotretinoin|mesh-list
139191955|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
139191957|NCT01148147|Analgesics|analgesics|mesh-ancestor
139191958|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
139191959|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191960|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191961|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139191962|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
139191963|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139191964|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
139191965|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
139191966|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139191967|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191968|NCT03902249|Dexamethasone|dexamethasone|mesh-list
139191969|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139191970|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
139191971|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
139191972|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139191973|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191974|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139191975|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
139191976|NCT03902249|Hormones|hormones|mesh-ancestor
139191977|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139191978|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139191979|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191980|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
139191981|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
139191982|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139191983|NCT03908489|Protective Agents|protective agents|mesh-ancestor
139191984|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191985|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139191986|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139191987|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139191988|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139191989|NCT04342897|Zansecimab|zansecimab|mesh-list
139191990|NCT04342897|Antiviral Agents|antiviral agents|mesh-ancestor
139191991|NCT04342897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191992|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
139191993|NCT03263767|Fludarabine|fludarabine|mesh-list
139191994|NCT03263767|Clofarabine|clofarabine|mesh-list
139191995|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
139191996|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139191997|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
139191998|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139191999|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139192000|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139192001|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
139192002|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192003|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192004|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139192005|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139192006|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
139192007|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139192008|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139192009|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
139192010|NCT03908333|Paclitaxel|paclitaxel|mesh-list
139192011|NCT03908333|Gemcitabine|gemcitabine|mesh-list
139192012|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139192013|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138787312|NCT02697058|Calcium|calcium|mesh-list
139192014|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192015|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
139192016|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
139192017|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
139192018|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192020|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
139192021|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192022|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139192023|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
139192024|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
139192025|NCT03908333|Protective Agents|protective agents|mesh-ancestor
139192026|NCT04340557|Losartan|losartan|mesh-list
139192027|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139192028|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139192029|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139192030|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139192031|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192032|NCT04549376|Iodine|iodine|mesh-list
139192033|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
139192034|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
139192035|NCT04549376|Povidone|povidone|mesh-list
139192036|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139192037|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192038|NCT04549376|Trace Elements|trace elements|mesh-ancestor
139192039|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
139192040|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192041|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
139192042|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
139192043|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
139192044|NCT01149395|Lansoprazole|lansoprazole|mesh-list
139192045|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139192046|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139192047|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139192048|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192049|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192051|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139192052|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139192053|NCT02527733|Growth Substances|growth substances|mesh-ancestor
139192054|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192055|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
139192056|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192057|NCT04135495|Ivacaftor|ivacaftor|mesh-list
139192058|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139192059|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139192060|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192061|NCT01148303|Etoricoxib|etoricoxib|mesh-list
139192062|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139192063|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139192064|NCT01148303|Analgesics|analgesics|mesh-ancestor
139192065|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
138971723|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192066|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192067|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192068|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192069|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139192070|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139192071|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139192072|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192073|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192074|NCT03066830|Metformin|metformin|mesh-list
139192075|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139192076|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139192077|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192078|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139192079|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192080|NCT05205200|Paclitaxel|paclitaxel|mesh-list
139192081|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139192083|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
139192084|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
139192085|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
139192086|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192087|NCT01149629|Droxidopa|droxidopa|mesh-list
139192088|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139192089|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139192090|NCT05205122|Mitomycins|mitomycins|mesh-list
139192091|NCT05205122|Mitomycin|mitomycin|mesh-list
139192092|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139192093|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192094|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
138906284|NCT04150757|Ketamine|ketamine|mesh-list
139192095|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192096|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139192097|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192098|NCT03907163|Dronabinol|dronabinol|mesh-list
139192099|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
139192100|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192101|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139192102|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139192103|NCT03907163|Analgesics|analgesics|mesh-ancestor
139192104|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
139192105|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192106|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139192107|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139192108|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139192109|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192110|NCT03907163|Hormones|hormones|mesh-ancestor
139192111|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192112|NCT01253681|Paclitaxel|paclitaxel|mesh-list
139192113|NCT01253681|Carboplatin|carboplatin|mesh-list
139192114|NCT01253681|Trebananib|trebananib|mesh-list
139192115|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139192116|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192117|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
139192118|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
139192119|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
139192120|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192121|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139192122|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139192123|NCT01253681|Growth Substances|growth substances|mesh-ancestor
139192124|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192125|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
139192126|NCT01149941|Ibuprofen|ibuprofen|mesh-list
139192127|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139192128|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139192129|NCT01149941|Analgesics|analgesics|mesh-ancestor
139192130|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
139192131|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192132|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192133|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192134|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139192135|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139192136|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192137|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192138|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
139192139|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192140|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
139192141|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
139192142|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192143|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192144|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139192145|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
139192146|NCT01589549|Hormones|hormones|mesh-ancestor
139192147|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192148|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139192149|NCT01589549|Protective Agents|protective agents|mesh-ancestor
139192150|NCT03899675|Caffeine|caffeine|mesh-list
139192151|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139192152|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192153|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139192154|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192155|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192156|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139192157|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139192158|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
139192159|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139192160|NCT01562197|Axitinib|axitinib|mesh-list
139192161|NCT01562197|Lomustine|lomustine|mesh-list
139192162|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192163|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139192164|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192165|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192166|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139192167|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
139192168|NCT03905837|Lidocaine|lidocaine|mesh-list
139192169|NCT03905837|Piperidine|piperidine|mesh-list
139192170|NCT03905837|Remifentanil|remifentanil|mesh-list
139192171|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
139192172|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
139192173|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139192174|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192175|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
139192176|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192177|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139192178|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139192179|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139192180|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139192181|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192182|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139192183|NCT03905837|Narcotics|narcotics|mesh-ancestor
139192184|NCT03905837|Analgesics|analgesics|mesh-ancestor
139192185|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139192186|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139192187|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
139192188|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
139192189|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139192190|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139192191|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192192|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192193|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192194|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139192196|NCT01148615|Aflibercept|aflibercept|mesh-list
139192197|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192198|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
139192199|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
139192200|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
139192201|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192202|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139192203|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139192204|NCT01148615|Growth Substances|growth substances|mesh-ancestor
139192205|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192206|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
139192207|NCT03905759|Colchicine|colchicine|mesh-list
139192208|NCT03905759|Amiodarone|amiodarone|mesh-list
139192209|NCT03905759|Dronedarone|dronedarone|mesh-list
139192210|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
139192211|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139192212|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
139192213|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
139192214|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
139192215|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192216|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192217|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139192218|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
139192219|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139192220|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139192221|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139192222|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139192223|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139192224|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192225|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139192226|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139192227|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139192229|NCT01255475|Hydralazine|hydralazine|mesh-list
139192230|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139192231|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139192232|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139192233|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192234|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139192235|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192236|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
139192237|NCT05208398|Warfarin|warfarin|mesh-list
139192238|NCT05208398|Apixaban|apixaban|mesh-list
139192239|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
139192240|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139192241|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
139192242|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139192243|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
139192244|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192245|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192246|NCT05593601|Neomycin|neomycin|mesh-list
139192247|NCT05593601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139192248|NCT05593601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192249|NCT05593601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139192250|NCT05593601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192251|NCT05593601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192252|NCT03629210|Dexamethasone|dexamethasone|mesh-list
139192253|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192254|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
139192255|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
139192256|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192257|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192258|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139192259|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
139192260|NCT03629210|Hormones|hormones|mesh-ancestor
139192261|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192262|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139192263|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192264|NCT03899285|Citalopram|citalopram|mesh-list
139192265|NCT03899285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139192266|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139192267|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139192268|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192269|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139192270|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
139192271|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192272|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139192273|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
139192274|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139192276|NCT01254071|Dutasteride|dutasteride|mesh-list
139192277|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139192278|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139192279|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139192280|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
139192281|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139192282|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192283|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192284|NCT01254071|Urological Agents|urological agents|mesh-ancestor
139192285|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139192286|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139192287|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192288|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
139192289|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192290|NCT05761418|Misoprostol|misoprostol|mesh-list
139192291|NCT05761418|Dinoprostone|dinoprostone|mesh-list
139192292|NCT05761418|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139192293|NCT05761418|Abortifacient Agents|abortifacient agents|mesh-ancestor
139192294|NCT05761418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139192295|NCT05761418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192296|NCT05761418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139192297|NCT05761418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139192298|NCT05761418|Oxytocics|oxytocics|mesh-ancestor
139192299|NCT05207774|Oxytocin|oxytocin|mesh-list
139192300|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
139192301|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139192302|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192303|NCT02528123|Tobramycin|tobramycin|mesh-list
139192304|NCT02528123|Ofloxacin|ofloxacin|mesh-list
139192305|NCT02528123|Dexamethasone|dexamethasone|mesh-list
139192306|NCT02528123|Benoxinate|benoxinate|mesh-list
139192307|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
139192308|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192309|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
139192310|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
139192311|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192312|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192313|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139192314|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
139192315|NCT02528123|Hormones|hormones|mesh-ancestor
139192316|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192317|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139192318|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192319|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139192320|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192321|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139192322|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139192323|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139192324|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192325|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192326|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139192327|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139192328|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
139192329|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
139192330|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139192331|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
139192332|NCT02527811|Urinastatin|urinastatin|mesh-list
139192333|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
139192334|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139192335|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
139192336|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192337|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192338|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139192339|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138942837|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192340|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192341|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
139192342|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
139192343|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139192344|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139192345|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192346|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192347|NCT01254383|Urological Agents|urological agents|mesh-ancestor
139192348|NCT03700970|Bupivacaine|bupivacaine|mesh-list
139192349|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
139192350|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
139192351|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139192352|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192353|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
139192354|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192355|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
139192356|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139192357|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139192358|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139192359|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139192360|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192361|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
139192362|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139192363|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192364|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139192365|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192366|NCT04320745|Testosterone|testosterone|mesh-list
139192367|NCT04320745|Androgens|androgens|mesh-ancestor
139192368|NCT04320745|Hormones|hormones|mesh-ancestor
139192369|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192370|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192371|NCT01254461|Pravastatin|pravastatin|mesh-list
139192372|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139192373|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139192374|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
139192375|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192376|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139192377|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139192378|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192379|NCT03747523|Vitamin D|vitamin d|mesh-list
139192380|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
139192381|NCT03747523|Vitamins|vitamins|mesh-ancestor
139192382|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
139192383|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192384|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139192385|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139192386|NCT05293171|Moxifloxacin|moxifloxacin|mesh-list
139192387|NCT05293171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139192388|NCT05293171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192389|NCT05293171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139192390|NCT05293171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139192391|NCT05293171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192392|NCT05293171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192393|NCT05293171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192394|NCT03063086|Fluticasone|fluticasone|mesh-list
139192395|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139192396|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192397|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139192398|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
139192399|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906352|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
139192400|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192401|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139192402|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
139192403|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
139192404|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139192405|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139192406|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139192407|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139192408|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
139192409|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139192410|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192411|NCT03904745|Atosiban|atosiban|mesh-list
139192412|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
139192413|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192414|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192415|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
139192416|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139192417|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
139192418|NCT05187338|Ipilimumab|ipilimumab|mesh-list
139192419|NCT05187338|Durvalumab|durvalumab|mesh-list
139192420|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139192421|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192422|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139192423|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192424|NCT03898583|Calcitriol|calcitriol|mesh-list
139192425|NCT03898583|Betamethasone|betamethasone|mesh-list
139192426|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
139192427|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138787355|NCT02870478|Atropine|atropine|mesh-list
139192428|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
139192429|NCT03898583|Calcipotriene|calcipotriene|mesh-list
139192430|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139192431|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192432|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
139192433|NCT03898583|Hormones|hormones|mesh-ancestor
139192434|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192435|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192436|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139192437|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
139192438|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
139192439|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139192440|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139192441|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139192442|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192443|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139192444|NCT03898583|Vitamins|vitamins|mesh-ancestor
139192445|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
139192446|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139192447|NCT03898193|Montelukast|montelukast|mesh-list
139192448|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139192449|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
139192450|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139192451|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
139192452|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192453|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192454|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139192455|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139192456|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192457|NCT03321188|Paclitaxel|paclitaxel|mesh-list
139192458|NCT03321188|Carboplatin|carboplatin|mesh-list
139192459|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139192460|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192461|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
139192462|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
139192463|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
139192464|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192465|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139192466|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139192467|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192468|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139192469|NCT01254617|Cetuximab|cetuximab|mesh-list
139192470|NCT01254617|Lenalidomide|lenalidomide|mesh-list
139192471|NCT01254617|Antibodies|antibodies|mesh-list
139192472|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
139192473|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139192474|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
139192475|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192476|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192477|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139192478|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139192479|NCT01254617|Growth Substances|growth substances|mesh-ancestor
139192480|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
139192481|NCT01150331|Levetiracetam|levetiracetam|mesh-list
139192482|NCT01150331|Clonazepam|clonazepam|mesh-list
139192483|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
139192484|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
139192485|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
139192486|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
139192487|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139192488|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192489|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192490|NCT01256489|Infliximab|infliximab|mesh-list
139192491|NCT01256489|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139192492|NCT01256489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192493|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
139192494|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139192495|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139192496|NCT03746119|Nicotine|nicotine|mesh-list
139192497|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139192498|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
138787366|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
139192499|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192500|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192501|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139192502|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139192503|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
139192504|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139192505|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192507|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139192509|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
139192510|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
139192511|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139192512|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192513|NCT03903887|Antibodies|antibodies|mesh-list
139192514|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
139192515|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192516|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139192517|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139192518|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192519|NCT05122130|Melatonin|melatonin|mesh-list
139192520|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
139192521|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192522|NCT05122130|Protective Agents|protective agents|mesh-ancestor
139192523|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192524|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139192525|NCT02898506|Liraglutide|liraglutide|mesh-list
139192526|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139192527|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192528|NCT02898506|Incretins|incretins|mesh-ancestor
139192529|NCT02898506|Hormones|hormones|mesh-ancestor
139192530|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192531|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
139192532|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139192533|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
139192534|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192535|NCT04123405|Expectorants|expectorants|mesh-ancestor
139192536|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
139192537|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139192538|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
138971912|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139192539|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192540|NCT04123405|Protective Agents|protective agents|mesh-ancestor
139192541|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192542|NCT04123405|Antidotes|antidotes|mesh-ancestor
139192543|NCT02611232|Liraglutide|liraglutide|mesh-list
139192544|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139192545|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192546|NCT02611232|Incretins|incretins|mesh-ancestor
139192547|NCT02611232|Hormones|hormones|mesh-ancestor
139192548|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192549|NCT01150877|Vitamin D|vitamin d|mesh-list
139192550|NCT01150877|Vitamins|vitamins|mesh-ancestor
139192551|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
139192552|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192553|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139192554|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139192555|NCT03893591|Dalteparin|dalteparin|mesh-list
139192556|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
139192557|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139192558|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139192559|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192560|NCT01256801|Interleukin-2|interleukin-2|mesh-list
139192561|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192562|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139192563|NCT01256801|Analgesics|analgesics|mesh-ancestor
139192564|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
139192565|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192566|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192567|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
139192568|NCT02519738|Triamcinolone|triamcinolone|mesh-list
139192569|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139192570|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192571|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
139192572|NCT02519738|Hormones|hormones|mesh-ancestor
139192573|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192574|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192575|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139192576|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
138906404|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
139192577|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139192578|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192579|NCT03893747|Vaccines|vaccines|mesh-list
139192580|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
139192581|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192582|NCT02343224|Interferons|interferons|mesh-list
139192583|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
139192584|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
139192585|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139192586|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192587|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
139192588|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192589|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
139192590|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192591|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
139192592|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139192593|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192594|NCT04314037|Praziquantel|praziquantel|mesh-list
139192595|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
139192596|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139192597|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192598|NCT05737862|Folic Acid|folic acid|mesh-list
139192599|NCT05737862|Hematinics|hematinics|mesh-ancestor
139192600|NCT05737862|Vitamin B Complex|vitamin b complex|mesh-ancestor
139192601|NCT05737862|Vitamins|vitamins|mesh-ancestor
139192602|NCT05737862|Micronutrients|micronutrients|mesh-ancestor
139192603|NCT05737862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192604|NCT02097680|Letrozole|letrozole|mesh-list
139192605|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192606|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139192607|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139192608|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192609|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192610|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139192611|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
139192612|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192613|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192614|NCT01150955|Resveratrol|resveratrol|mesh-list
139192615|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
139192616|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192617|NCT01150955|Protective Agents|protective agents|mesh-ancestor
139192618|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192619|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192620|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139192621|NCT03897413|Antacids|antacids|mesh-list
139192622|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
139192623|NCT03897413|Calcium|calcium|mesh-list
139192624|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139192625|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192626|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192627|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139192628|NCT01258439|Ritonavir|ritonavir|mesh-list
139192629|NCT01258439|Darunavir|darunavir|mesh-list
139192630|NCT01258439|Tenofovir|tenofovir|mesh-list
139192631|NCT01258439|Emtricitabine|emtricitabine|mesh-list
139192632|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
139192633|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139192634|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139192635|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139192636|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
139192637|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192638|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192639|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138906414|NCT00818454|Albuterol|albuterol|mesh-list
139192640|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139192641|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
139192642|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192643|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139192644|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139192645|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139192646|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139192647|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139192648|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139192649|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
139192650|NCT01560572|Prednisolone|prednisolone|mesh-list
139192651|NCT01560572|Tacrolimus|tacrolimus|mesh-list
139192652|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139192653|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
139192654|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192655|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139192656|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192657|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192658|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192659|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
139192660|NCT01560572|Hormones|hormones|mesh-ancestor
139192661|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192662|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139192663|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192664|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139192665|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139192666|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
139192667|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139192668|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192669|NCT05209256|Pemetrexed|pemetrexed|mesh-list
139192670|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192671|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192672|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192673|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139192674|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139192675|NCT03896321|Anticoagulants|anticoagulants|mesh-list
139192676|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139192677|NCT05211050|Cromakalim|cromakalim|mesh-list
139192678|NCT05211050|Sumatriptan|sumatriptan|mesh-list
139192679|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139192680|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139192681|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139192682|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
139192683|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139192684|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192685|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192686|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139192687|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139192688|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
139192689|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192690|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139192691|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
139192692|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
139192693|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
139192694|NCT03892499|Itraconazole|itraconazole|mesh-list
139192695|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
139192696|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192697|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139192698|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139192699|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192700|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192701|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139192702|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
139192703|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192704|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192705|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139192707|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
139192708|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139192709|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192710|NCT01151267|Anesthetics|anesthetics|mesh-list
139192711|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943208|NCT00712712|Morphine|morphine|mesh-list
139192712|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192713|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
139192714|NCT01259141|Azithromycin|azithromycin|mesh-list
139192715|NCT01259141|Cephalosporins|cephalosporins|mesh-list
139192716|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139192717|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192718|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139192719|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139192720|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192721|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192722|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192724|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
139192725|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
139192726|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139192727|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192728|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
139192729|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192730|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139192731|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139192732|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139192733|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139192734|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192735|NCT01152203|Bevacizumab|bevacizumab|mesh-list
139192736|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139192737|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139192738|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192739|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139192740|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139192741|NCT01152203|Growth Substances|growth substances|mesh-ancestor
139192742|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192743|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
139192744|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139192745|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
139192746|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192747|NCT01257815|Ranibizumab|ranibizumab|mesh-list
139192748|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139192749|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139192750|NCT01257815|Growth Substances|growth substances|mesh-ancestor
139192751|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192752|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
139192753|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192754|NCT03892421|Cytarabine|cytarabine|mesh-list
139192755|NCT03892421|Dexamethasone|dexamethasone|mesh-list
139192756|NCT03892421|Rituximab|rituximab|mesh-list
139192757|NCT03892421|Carboplatin|carboplatin|mesh-list
139192758|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192759|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
139192760|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
139192761|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192762|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192763|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139192764|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
139192765|NCT03892421|Hormones|hormones|mesh-ancestor
139192766|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138906440|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192767|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139192768|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192769|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139192770|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
139192771|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139192772|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139192773|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
139192774|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192775|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
139192776|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192777|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139192778|NCT05546567|Niacinamide|niacinamide|mesh-list
139192779|NCT05546567|Niacin|niacin|mesh-list
139192780|NCT05546567|Nicotinic Acids|nicotinic acids|mesh-list
139192781|NCT05546567|Vitamin B Complex|vitamin b complex|mesh-ancestor
139192782|NCT05546567|Vitamins|vitamins|mesh-ancestor
139192783|NCT05546567|Micronutrients|micronutrients|mesh-ancestor
139192784|NCT05546567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192785|NCT05546567|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139192786|NCT05546567|Antimetabolites|antimetabolites|mesh-ancestor
139192787|NCT05546567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192788|NCT05546567|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139192789|NCT05546567|Vasodilator Agents|vasodilator agents|mesh-ancestor
139192791|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139192792|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192793|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139192794|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192795|NCT01257893|Aspirin|aspirin|mesh-list
139192796|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139192797|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139192798|NCT01257893|Analgesics|analgesics|mesh-ancestor
139192799|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
139192800|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192801|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192802|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192803|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139192804|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139192805|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139192806|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192807|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139192808|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139192809|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192810|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
139192811|NCT01152593|Mupirocin|mupirocin|mesh-list
139192812|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139192813|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192814|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139192815|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192816|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192817|NCT01259219|Rifabutin|rifabutin|mesh-list
139192818|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139192819|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192820|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139192821|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
139192822|NCT03891095|Oxytocin|oxytocin|mesh-list
139192823|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
139192824|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139192825|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192826|NCT05667077|Amantadine|amantadine|mesh-list
139192827|NCT05667077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139192828|NCT05667077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139192829|NCT05667077|Antiviral Agents|antiviral agents|mesh-ancestor
139192830|NCT05667077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192831|NCT05667077|Dopamine Agents|dopamine agents|mesh-ancestor
139192832|NCT05667077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139192833|NCT05667077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192834|NCT05667077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192835|NCT05667077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139192836|NCT05667077|Analgesics|analgesics|mesh-ancestor
139192837|NCT05667077|Sensory System Agents|sensory system agents|mesh-ancestor
139192838|NCT05667077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192839|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
139192840|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139192841|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139192842|NCT03894839|Glutaral|glutaral|mesh-list
139192844|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139192845|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192846|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
139192847|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
139192848|NCT01152749|Nicotine|nicotine|mesh-list
138787385|NCT00619996|Docetaxel|docetaxel|mesh-list
139192849|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139192850|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
139192851|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192852|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192853|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139192854|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139192855|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
139192856|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139192857|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192858|NCT03894683|Melatonin|melatonin|mesh-list
139192859|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
139192860|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192861|NCT03894683|Protective Agents|protective agents|mesh-ancestor
139192862|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943357|NCT00921128|Muscimol|muscimol|mesh-list
139192863|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139192865|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139192866|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139192867|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139192868|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
139192869|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139192870|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192871|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192872|NCT01259531|Urological Agents|urological agents|mesh-ancestor
139192873|NCT01151735|Complement C1s|complement c1s|mesh-list
139192874|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
139192875|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192876|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139192877|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139192878|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192879|NCT03061214|Incretins|incretins|mesh-ancestor
139192880|NCT03061214|Hormones|hormones|mesh-ancestor
139192881|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139192882|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139192883|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
139192884|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192885|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192886|NCT01152827|Everolimus|everolimus|mesh-list
139192887|NCT01152827|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139192888|NCT01152827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139192889|NCT01152827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192890|NCT01152827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192891|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139192892|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
139192893|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192894|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192895|NCT01153373|Ethanol|ethanol|mesh-list
139192896|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139192897|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192898|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139192899|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192900|NCT03889145|Amlodipine|amlodipine|mesh-list
139192901|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139192902|NCT03889145|Telmisartan|telmisartan|mesh-list
139192903|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139192904|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139192905|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139192906|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192907|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139192908|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192909|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
139192910|NCT03889145|Diuretics|diuretics|mesh-ancestor
139192911|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
139192912|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139192913|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139192914|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139192915|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
139192916|NCT03888677|Epirubicin|epirubicin|mesh-list
139192917|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139192918|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
139192919|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192920|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139192921|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139192922|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
139192923|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192924|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192925|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139192926|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139192927|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139192928|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139192929|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192930|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
139192931|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139192932|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192933|NCT01260233|Nicotine|nicotine|mesh-list
139192934|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139192935|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
138906492|NCT04139915|Dactolisib|dactolisib|mesh-list
139192936|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192937|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192938|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139192939|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139192940|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
139192941|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139192942|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192943|NCT04435964|Immunomodulating Agents|immunomodulating agents|mesh-list
139192944|NCT04435964|Immunologic Factors|immunologic factors|mesh-ancestor
139192945|NCT04435964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192946|NCT01153919|Interferons|interferons|mesh-list
139192947|NCT01153919|Ribavirin|ribavirin|mesh-list
139192948|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
139192949|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
139192950|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139192951|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192952|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
139192953|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192954|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
139192955|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192956|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
139192957|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192958|NCT03912389|Carboplatin|carboplatin|mesh-list
139192959|NCT03912389|Pemetrexed|pemetrexed|mesh-list
139192960|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192961|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192962|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192963|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139192964|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139192965|NCT01147757|Remifentanil|remifentanil|mesh-list
139192966|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139192967|NCT01147757|Narcotics|narcotics|mesh-ancestor
139192968|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139192969|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192970|NCT01147757|Analgesics|analgesics|mesh-ancestor
139192971|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
139192972|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192973|NCT01251809|Pegaspargase|pegaspargase|mesh-list
139192974|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192975|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
139192976|NCT01154387|Tacrolimus|tacrolimus|mesh-list
139192977|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
139192978|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139192979|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139192980|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
139192981|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139192982|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139192983|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139192984|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139192985|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139192986|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192987|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139192988|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
139192989|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139192990|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192991|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
139192992|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139192993|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192994|NCT01260623|Prednisone|prednisone|mesh-list
139192995|NCT01260623|Prednisolone|prednisolone|mesh-list
139192996|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139192997|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
139192998|NCT01260623|Hormones|hormones|mesh-ancestor
139192999|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193000|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193001|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139193002|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193003|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139193004|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
139193005|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139193006|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
139193007|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139193008|NCT01260857|Diuretics|diuretics|mesh-ancestor
139193009|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
139193010|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193011|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139193012|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139193013|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193015|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139193016|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193017|NCT01153217|Tenofovir|tenofovir|mesh-list
139193018|NCT01153217|Abacavir|abacavir|mesh-list
139193019|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
139193020|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193021|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139193022|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139193023|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193024|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193025|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139193026|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139193027|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
139193028|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139193029|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193030|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139193031|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
139193032|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139193033|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193034|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193035|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193036|NCT03889379|Albuterol|albuterol|mesh-list
139193037|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139193038|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
139193039|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193040|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193041|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139193042|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
139193043|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
139193044|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139193045|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139193046|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139193047|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139193048|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
139193049|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193050|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193051|NCT01586507|Tramadol|tramadol|mesh-list
139193052|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139193053|NCT01586507|Narcotics|narcotics|mesh-ancestor
139193054|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139193055|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193056|NCT01586507|Analgesics|analgesics|mesh-ancestor
139193057|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
139193058|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193059|NCT03910361|Pioglitazone|pioglitazone|mesh-list
139193060|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139193061|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193062|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138787404|NCT00622570|Thiopental|thiopental|mesh-list
139193063|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
139193064|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139193065|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139193066|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139193067|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
139193068|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139193069|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193070|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139193071|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139193072|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139193073|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139193074|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193075|NCT03885947|Fludarabine|fludarabine|mesh-list
139193076|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
139193077|NCT03885947|Thiotepa|thiotepa|mesh-list
139193078|NCT03885947|Valproic Acid|valproic acid|mesh-list
138972158|NCT01072045|Prednisone|prednisone|mesh-list
139193079|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193080|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193081|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139193082|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
139193083|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193084|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943585|NCT01035619|Moxidectin|moxidectin|mesh-list
139193085|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139193086|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
139193087|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139193088|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
139193089|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193090|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
139193091|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193092|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
139193093|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139193094|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139193095|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139193096|NCT01261481|Tolvaptan|tolvaptan|mesh-list
139193097|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139193098|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193099|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
139193100|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193101|NCT01261637|Ropivacaine|ropivacaine|mesh-list
139193102|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
139193103|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
139193104|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139193105|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193106|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
139193107|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193108|NCT01262183|Panitumumab|panitumumab|mesh-list
139193109|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139193110|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193111|NCT01154933|Exenatide|exenatide|mesh-list
139193112|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139193113|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193114|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139193115|NCT01154933|Incretins|incretins|mesh-ancestor
139193116|NCT01154933|Hormones|hormones|mesh-ancestor
139193117|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193118|NCT01155635|Carvedilol|carvedilol|mesh-list
139193119|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139193120|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139193121|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
139193122|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193123|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193124|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193125|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139193126|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
139193127|NCT01155635|Protective Agents|protective agents|mesh-ancestor
139193128|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139193129|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139193130|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139193131|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
138787406|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139193132|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139193133|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139193134|NCT01155089|Anastrozole|anastrozole|mesh-list
139193135|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139193136|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193137|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139193138|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139193139|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592905|NCT00168012|Antibodies|antibodies|mesh-list
139193140|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193141|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139193142|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
139193143|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193144|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193145|NCT01155245|Teriparatide|teriparatide|mesh-list
139193146|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139193147|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193148|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139193149|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
139193150|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139193151|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
139193152|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193153|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
139193154|NCT01262417|Protective Agents|protective agents|mesh-ancestor
139193155|NCT01155791|Prednisone|prednisone|mesh-list
139193156|NCT01155791|Docetaxel|docetaxel|mesh-list
139193157|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193158|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
139193159|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
139193160|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
139193161|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193162|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139193163|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
139193164|NCT01155791|Hormones|hormones|mesh-ancestor
139193165|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193166|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193167|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139193168|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139193169|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139193170|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139193171|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193172|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193173|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139193174|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139193175|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193176|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
139193177|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193178|NCT03881423|Bromides|bromides|mesh-list
139193179|NCT03881423|Rocuronium|rocuronium|mesh-list
139193180|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
139193181|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
139193182|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138972175|NCT01073059|Ertapenem|ertapenem|mesh-list
139193183|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139193184|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193185|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193187|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139193188|NCT01155947|Anastrozole|anastrozole|mesh-list
139193189|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139193190|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193191|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139193192|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139193193|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193194|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193195|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139193196|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
139193197|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193198|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193199|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139193200|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139193201|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139193202|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139193203|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193204|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139193205|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139193206|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139193207|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
139193208|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193209|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193210|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139193211|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139193212|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
139193213|NCT01264133|Adefovir|adefovir|mesh-list
139193214|NCT01264133|Clevudine|clevudine|mesh-list
139193215|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
139193216|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193217|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139193218|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139193219|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193220|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193221|NCT02527577|Ropivacaine|ropivacaine|mesh-list
139193222|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
139193223|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
139193224|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139193225|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193226|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
139193227|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193228|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139193229|NCT03883841|Hematinics|hematinics|mesh-ancestor
139193230|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
139193231|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193232|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139193233|NCT03881111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139193234|NCT03881111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193235|NCT01264211|Diacerein|diacerein|mesh-list
139193236|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139193237|NCT03880877|Leucovorin|leucovorin|mesh-list
139193238|NCT03880877|Antidotes|antidotes|mesh-ancestor
139193239|NCT03880877|Protective Agents|protective agents|mesh-ancestor
139193240|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193241|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
139193242|NCT03880877|Vitamins|vitamins|mesh-ancestor
139193243|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
139193244|NCT05666999|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139193245|NCT05666999|Laxatives|laxatives|mesh-ancestor
139193246|NCT05666999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139193248|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139193249|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
139193250|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
139193251|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139193252|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193253|NCT01264289|Finasteride|finasteride|mesh-list
139193254|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139193255|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139193256|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193257|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193258|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
139193259|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193260|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193261|NCT01264289|Urological Agents|urological agents|mesh-ancestor
139193262|NCT03880487|Oxycodone|oxycodone|mesh-list
139193263|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139193264|NCT03880487|Narcotics|narcotics|mesh-ancestor
139193265|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139193266|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193267|NCT03880487|Analgesics|analgesics|mesh-ancestor
139193268|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
138787417|NCT00890266|Riboflavin|riboflavin|mesh-list
139193269|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193271|NCT03880409|Epinephrine|epinephrine|mesh-list
139193272|NCT03880409|Racepinephrine|racepinephrine|mesh-list
139193273|NCT03880409|Carticaine|carticaine|mesh-list
139193274|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
139193275|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
139193276|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
139193277|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139193278|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193279|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
139193280|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193281|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139193282|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139193283|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139193284|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139193285|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193286|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139193287|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139193288|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
139193289|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193290|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139193291|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139193292|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
139193293|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138972230|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
139193294|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
139193296|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
139193297|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139193298|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
139193299|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139193300|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193301|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139193302|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139193303|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193304|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943804|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
139193305|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193306|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139193307|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139193308|NCT01264367|Interferons|interferons|mesh-list
139193309|NCT01264367|Clevudine|clevudine|mesh-list
139193310|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193311|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
139193312|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193313|NCT01262963|Dabrafenib|dabrafenib|mesh-list
139193314|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193315|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139193316|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193317|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193318|NCT01264445|Vaccines|vaccines|mesh-list
139193319|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
139193320|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193321|NCT01157975|Pioglitazone|pioglitazone|mesh-list
139193322|NCT01157975|Prednisone|prednisone|mesh-list
139193323|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139193324|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
139193325|NCT01157975|Hormones|hormones|mesh-ancestor
139193326|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193327|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193328|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139193329|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193330|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139193331|NCT03060512|Naloxegol|naloxegol|mesh-list
139193332|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139193333|NCT03060512|Laxatives|laxatives|mesh-ancestor
139193334|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139193335|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139193336|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193337|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
139193338|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193339|NCT01263353|Everolimus|everolimus|mesh-list
139193340|NCT01263353|Pasireotide|pasireotide|mesh-list
139193341|NCT01263353|Somatostatin|somatostatin|mesh-list
139193342|NCT01263353|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139193343|NCT01263353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139193344|NCT01263353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193345|NCT01263353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193346|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139193347|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
138972247|NCT00211081|Spironolactone|spironolactone|mesh-list
139193348|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193349|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193350|NCT01263353|Hormones|hormones|mesh-ancestor
139193351|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193352|NCT01158287|Sorafenib|sorafenib|mesh-list
139193353|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193354|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139193355|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193356|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193357|NCT01158365|Glycerol|glycerol|mesh-list
139193358|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139193359|NCT01158365|Protective Agents|protective agents|mesh-ancestor
139193360|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193361|NCT01156649|Acetaminophen|acetaminophen|mesh-list
139193362|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139193363|NCT01156649|Analgesics|analgesics|mesh-ancestor
139193364|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
139193365|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193366|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193367|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
139193368|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
139193369|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139193370|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193371|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139193372|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139193373|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193374|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193375|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193376|NCT03879707|Melatonin|melatonin|mesh-list
139193377|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
139193378|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193379|NCT03879707|Protective Agents|protective agents|mesh-ancestor
139193380|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193381|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943880|NCT00882076|Etoposide|etoposide|mesh-list
139193382|NCT01265147|Nedaplatin|nedaplatin|mesh-list
139193383|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193384|NCT01159145|Omeprazole|omeprazole|mesh-list
139193385|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139193386|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139193387|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139193388|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193389|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193390|NCT01156883|Cytarabine|cytarabine|mesh-list
139193391|NCT01156883|Dexamethasone|dexamethasone|mesh-list
139193392|NCT01156883|Prednisone|prednisone|mesh-list
139193393|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
139193394|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
139193395|NCT01156883|Ifosfamide|ifosfamide|mesh-list
139193396|NCT01156883|Doxorubicin|doxorubicin|mesh-list
139193397|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139193398|NCT01156883|Methotrexate|methotrexate|mesh-list
139193399|NCT01156883|Vincristine|vincristine|mesh-list
139193400|NCT01156883|Daunorubicin|daunorubicin|mesh-list
139193401|NCT01156883|Asparaginase|asparaginase|mesh-list
139193402|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
139193403|NCT01156883|Thioguanine|thioguanine|mesh-list
139193404|NCT01156883|Vindesine|vindesine|mesh-list
139193405|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139193406|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
139193407|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193408|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138972263|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
139193409|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139193410|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
139193411|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193412|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787426|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
139193413|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139193414|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139193415|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
139193416|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
139193417|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193418|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139193419|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
139193420|NCT01156883|Hormones|hormones|mesh-ancestor
139193421|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193422|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139193423|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139193424|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139193425|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139193426|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193427|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139193428|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
139193429|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139193430|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139193431|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
139193432|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
139193433|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139193434|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139193435|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
139193436|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193437|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139193438|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
139193439|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
139193440|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
139193441|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139193442|NCT01156883|Protective Agents|protective agents|mesh-ancestor
139193443|NCT01156961|Paclitaxel|paclitaxel|mesh-list
139193444|NCT01156961|Bevacizumab|bevacizumab|mesh-list
139193445|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139193446|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193447|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
139193448|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
139193449|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
139193450|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193451|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139193452|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139193453|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139193454|NCT01156961|Growth Substances|growth substances|mesh-ancestor
138943953|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139193455|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193456|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
139193457|NCT01159301|Sorafenib|sorafenib|mesh-list
139193458|NCT01159301|Entinostat|entinostat|mesh-list
139193459|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139193460|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193461|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139193462|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193463|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193464|NCT01159379|Ertapenem|ertapenem|mesh-list
139193465|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139193466|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193467|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139193468|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138906630|NCT02626481|Dexamethasone|dexamethasone|mesh-list
139193469|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193470|NCT01159847|Incretins|incretins|mesh-ancestor
139193471|NCT01159847|Hormones|hormones|mesh-ancestor
139193472|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193473|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139193474|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
139193475|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193476|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193477|NCT02539160|Ticagrelor|ticagrelor|mesh-list
139193478|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139193479|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139193480|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139193481|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139193482|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
139193483|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193484|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193485|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193486|NCT01265927|Trastuzumab|trastuzumab|mesh-list
139193487|NCT01265927|Imetelstat|imetelstat|mesh-list
139193488|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139193489|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193490|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193491|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193492|NCT01266005|Entecavir|entecavir|mesh-list
139193493|NCT01266005|Clevudine|clevudine|mesh-list
139193494|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
139193495|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193496|NCT04292899|Remdesivir|remdesivir|mesh-list
139193497|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
139193498|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193499|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
139193500|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193501|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
139193502|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139193503|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139193504|NCT03876899|Analgesics|analgesics|mesh-ancestor
139193505|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
139193506|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193507|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193508|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139193509|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139193510|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139193511|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
139193512|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193513|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139193514|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
139193515|NCT03241173|Nivolumab|nivolumab|mesh-list
139193516|NCT03241173|Ipilimumab|ipilimumab|mesh-list
139193517|NCT03241173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139193518|NCT03241173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906644|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
139193519|NCT03241173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139193520|NCT03241173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193521|NCT03264066|Atezolizumab|atezolizumab|mesh-list
139193522|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139193523|NCT03264066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139193524|NCT03264066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972291|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
139193525|NCT03264066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139193526|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193527|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
139193528|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193529|NCT03759041|Vancomycin|vancomycin|mesh-list
139193530|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139193531|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193532|NCT04110145|Linaclotide|linaclotide|mesh-list
139193533|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139193534|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
139193535|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193536|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139193537|NCT02477618|Brexanolone|brexanolone|mesh-list
139193538|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
139193539|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193540|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193541|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193542|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
139193543|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
139193544|NCT01268033|Rituximab|rituximab|mesh-list
139193545|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139193546|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193547|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
139193548|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193549|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139193550|NCT01162031|Bortezomib|bortezomib|mesh-list
139193551|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193552|NCT02879162|Durvalumab|durvalumab|mesh-list
139193553|NCT02879162|Tremelimumab|tremelimumab|mesh-list
139193554|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139193555|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193556|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
139193557|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193558|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193559|NCT02285504|Brexanolone|brexanolone|mesh-list
139193560|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
139193561|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193562|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193563|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193564|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
139193565|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
139193566|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139193567|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139193568|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
139193569|NCT05158491|Irinotecan|irinotecan|mesh-list
139193570|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139193571|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139193572|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193573|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906672|NCT00777322|Riboflavin|riboflavin|mesh-list
139193574|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193575|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
139193576|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139193577|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193578|NCT03876587|Docetaxel|docetaxel|mesh-list
139193579|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193580|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
139193581|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
139193582|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
139193583|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193584|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139193585|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
139193586|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193587|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
139193588|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193589|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139193590|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
139193591|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
139193592|NCT03282357|Protective Agents|protective agents|mesh-ancestor
139193593|NCT01162967|Posaconazole|posaconazole|mesh-list
139193594|NCT01162967|Benzonidazole|benzonidazole|mesh-list
139193595|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
139193596|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193597|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139193598|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139193599|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139193600|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139193601|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139193602|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193603|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193604|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139193605|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
139193606|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193607|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193608|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139193609|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
139193610|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139193611|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
139193612|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139193613|NCT04272775|Dexamethasone|dexamethasone|mesh-list
139193614|NCT04272775|Lenalidomide|lenalidomide|mesh-list
139193616|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139193617|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
139193618|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
139193619|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193620|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193621|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139193622|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
139193623|NCT04272775|Hormones|hormones|mesh-ancestor
139193624|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193625|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139193626|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193627|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
138972329|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
139193628|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139193629|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139193630|NCT04272775|Growth Substances|growth substances|mesh-ancestor
139193631|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
139193632|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
139193633|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193634|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193635|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
139193636|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139193637|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193638|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
139193639|NCT01163201|Fludarabine|fludarabine|mesh-list
139193640|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139193641|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
139193642|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193643|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139193644|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139193645|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
139193646|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193647|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193648|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139193649|NCT03876041|Dexamethasone|dexamethasone|mesh-list
139193650|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
139193651|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
139193652|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139193653|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139193654|NCT03876041|BB 1101|bb 1101|mesh-list
139193655|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139193656|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
139193657|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
139193658|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193659|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193660|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139193661|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
139193662|NCT03876041|Hormones|hormones|mesh-ancestor
139193663|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193664|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139193665|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193666|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
139193667|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193668|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193669|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139193670|NCT03876041|Protective Agents|protective agents|mesh-ancestor
139193671|NCT04102345|Zolpidem|zolpidem|mesh-list
139193672|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139193673|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139193674|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139193675|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193676|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139193677|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
139193678|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
139193679|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193680|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193681|NCT01163435|Clarithromycin|clarithromycin|mesh-list
139193683|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138944189|NCT00827307|Tamoxifen|tamoxifen|mesh-list
139193685|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139193686|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193687|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193688|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139193689|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139193690|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139193691|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139193692|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139193693|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193694|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139193695|NCT03299244|Cinacalcet|cinacalcet|mesh-list
139193696|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139193697|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193698|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139193699|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
139193700|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193702|NCT03757715|Bupivacaine|bupivacaine|mesh-list
139193703|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139193704|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
139193705|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
139193706|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193707|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193708|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139193709|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
139193710|NCT03757715|Hormones|hormones|mesh-ancestor
139193711|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193712|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139193713|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193714|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
139193715|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
139193716|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139193717|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
139193718|NCT01163825|Mitogens|mitogens|mesh-list
139193719|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
139193720|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193721|NCT01163903|Doxorubicin|doxorubicin|mesh-list
139193722|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139193723|NCT01163903|Pantoprazole|pantoprazole|mesh-list
139193724|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139193725|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193726|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139193727|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139193728|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193729|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193730|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139193731|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139193732|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139193733|NCT03745807|Nivolumab|nivolumab|mesh-list
139193734|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138972383|NCT02550782|Analgesics|analgesics|mesh-ancestor
139193735|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193736|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139193737|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193738|NCT01164059|Haloperidol|haloperidol|mesh-list
139193739|NCT01164059|Olanzapine|olanzapine|mesh-list
139193740|NCT01164059|Aripiprazole|aripiprazole|mesh-list
139193741|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139193742|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
139193743|NCT01164059|Flupenthixol|flupenthixol|mesh-list
139193744|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
139193745|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
139193746|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
139193747|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193748|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193749|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139193750|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139193751|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139193752|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139193753|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139193754|NCT01164059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139193755|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139193756|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139193757|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193759|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
139193760|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
139193761|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
139193762|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
139193763|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139193764|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139193765|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139193766|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139193767|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139193768|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139193769|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139193770|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
139193772|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193773|NCT03878771|Clobetasol|clobetasol|mesh-list
139193774|NCT03878771|Benzocaine|benzocaine|mesh-list
139193775|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139193776|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
139193777|NCT03878771|Hormones|hormones|mesh-ancestor
139193778|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193779|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193780|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
139193781|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
139193782|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139193783|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
139193784|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193785|NCT02959918|Sirolimus|sirolimus|mesh-list
139193786|NCT02959918|Temsirolimus|temsirolimus|mesh-list
139193787|NCT02959918|MTOR Inhibitors|mtor inhibitors|mesh-list
139193788|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139193789|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193790|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139193791|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193792|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
139193793|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139193794|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
139193795|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193796|NCT02959918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139193797|NCT02959918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193798|NCT02959918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193799|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
139193800|NCT01266707|Vaccines|vaccines|mesh-list
139193801|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
139193802|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193803|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139193804|NCT01266707|Growth Substances|growth substances|mesh-ancestor
139193805|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
139193806|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193807|NCT03263442|Thiamine|thiamine|mesh-list
139193808|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
139193809|NCT03263442|Vitamins|vitamins|mesh-ancestor
139193810|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
139193811|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193812|NCT01164215|Leucovorin|leucovorin|mesh-list
139193813|NCT01164215|Fluorouracil|fluorouracil|mesh-list
139193814|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
139193815|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
139193816|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193817|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
139193818|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193819|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139193820|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193821|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139193822|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
139193823|NCT01164215|Antidotes|antidotes|mesh-ancestor
139193824|NCT01164215|Protective Agents|protective agents|mesh-ancestor
139193825|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
139193826|NCT01164215|Vitamins|vitamins|mesh-ancestor
139193827|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
139193828|NCT04245709|Clenbuterol|clenbuterol|mesh-list
139193829|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139193830|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139193831|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
139193832|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193833|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193834|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193835|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139193836|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
139193837|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193838|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139193839|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
139193840|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
139193841|NCT03878693|Fomepizole|fomepizole|mesh-list
139193842|NCT03878693|Antidotes|antidotes|mesh-ancestor
139193843|NCT03878693|Protective Agents|protective agents|mesh-ancestor
139193844|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193845|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193846|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193847|NCT05305495|Empagliflozin|empagliflozin|mesh-list
139193848|NCT05305495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138972420|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
139193849|NCT05305495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193850|NCT05305495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139193851|NCT05305495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193852|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
139193853|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139193854|NCT02527109|Nifedipine|nifedipine|mesh-list
139193855|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139193856|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139193857|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193858|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139193859|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193860|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
139193861|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
139193862|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139193863|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
139193864|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
139193865|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139193866|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
139193867|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139193868|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193869|NCT02940522|Progestins|progestins|mesh-ancestor
139193870|NCT02940522|Hormones|hormones|mesh-ancestor
139193871|NCT01266785|Infliximab|infliximab|mesh-list
139193872|NCT01266785|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139193873|NCT01266785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139193874|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
139193875|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139193876|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139193877|NCT03262038|Ondansetron|ondansetron|mesh-list
139193878|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
139193879|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
139193880|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193881|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193882|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139193883|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
139193884|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
139193885|NCT03262038|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139193886|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139193887|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
139193888|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193889|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193890|NCT03746821|Biotin|biotin|mesh-list
139193891|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
139193892|NCT03746821|Vitamins|vitamins|mesh-ancestor
139193893|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
139193894|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193895|NCT02472964|Paclitaxel|paclitaxel|mesh-list
139193896|NCT02472964|Docetaxel|docetaxel|mesh-list
139193897|NCT02472964|Trastuzumab|trastuzumab|mesh-list
139193898|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139193899|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193900|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
139193901|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
139193902|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
139193903|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193904|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139193905|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139193906|NCT01160315|Norethindrone|norethindrone|mesh-list
139193907|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
139193908|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
139193909|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139193910|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
139193911|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139193912|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193913|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139193914|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139193915|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193916|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139193917|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139193918|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139193919|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
139193920|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
139193921|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193922|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
139193923|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193924|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193925|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
139193926|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139193927|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139193928|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
139193929|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193930|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139193931|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139193932|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193933|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193934|NCT03380728|Ibogaine|ibogaine|mesh-list
139193935|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
139193936|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193937|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139193938|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139193939|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139193940|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139193941|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193942|NCT01104922|Cetuximab|cetuximab|mesh-list
139193943|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139193944|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193945|NCT01164761|Ramipril|ramipril|mesh-list
139193946|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139193947|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
139193948|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193949|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193950|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139193951|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
139193952|NCT03385096|Melphalan|melphalan|mesh-list
139193953|NCT03385096|Busulfan|busulfan|mesh-list
139193954|NCT03385096|Etoposide|etoposide|mesh-list
139193955|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139193956|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
139193957|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193958|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139193959|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139193960|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
139193961|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193962|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139193963|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139193964|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139193965|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139193966|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139193967|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193968|NCT02526875|Amlodipine|amlodipine|mesh-list
139193969|NCT02526875|Telmisartan|telmisartan|mesh-list
139193970|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139193971|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139193972|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139193973|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193974|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139193975|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193976|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
139193977|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139193978|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139193980|NCT04222699|Mupirocin|mupirocin|mesh-list
139193981|NCT04222699|Calcium|calcium|mesh-list
139193982|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139193983|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193984|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139193985|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139193986|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
139193987|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139193988|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139193989|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139193990|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139193991|NCT01269203|Curcumin|curcumin|mesh-list
139193992|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139193993|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139193994|NCT01269203|Analgesics|analgesics|mesh-ancestor
139193995|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
139193996|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139193997|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193998|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139193999|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139194000|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194001|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194002|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194003|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
139194004|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139194005|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
139194006|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139194007|NCT01160627|Expectorants|expectorants|mesh-ancestor
139194008|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
139194009|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139194010|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
139194011|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194012|NCT01160627|Protective Agents|protective agents|mesh-ancestor
139194013|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194014|NCT01160627|Antidotes|antidotes|mesh-ancestor
139194015|NCT04075513|Insulin|insulin|mesh-list
139194016|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139194017|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
139194018|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
139194019|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139194020|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194021|NCT03877679|Triamcinolone|triamcinolone|mesh-list
139194022|NCT03877679|Curcumin|curcumin|mesh-list
139194023|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139194024|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
139194025|NCT03877679|Hormones|hormones|mesh-ancestor
139194026|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139194027|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194028|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194029|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194030|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139194031|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139194033|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
139194034|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194035|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139194036|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194038|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194039|NCT04652206|Paclitaxel|paclitaxel|mesh-list
139194040|NCT04652206|Gemcitabine|gemcitabine|mesh-list
139194041|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139194042|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194043|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
139194044|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
139194045|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
139194046|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194047|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139194048|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
139194049|NCT01269281|Sumatriptan|sumatriptan|mesh-list
139194050|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139194051|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139194052|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139194053|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
139194054|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194055|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194056|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194057|NCT02778204|Maraviroc|maraviroc|mesh-list
139194058|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139194059|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138906784|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139194060|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194061|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139194062|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139194063|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
139194064|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139194065|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139194066|NCT01160705|Docetaxel|docetaxel|mesh-list
139194067|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194068|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
139194069|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
139194070|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
139194071|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194072|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139194073|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
139194074|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139194075|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
139194076|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139194077|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194078|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139194079|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139194080|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194081|NCT03261336|Vitamin D|vitamin d|mesh-list
139194082|NCT03261336|Calcitriol|calcitriol|mesh-list
139194083|NCT03261336|Ketoconazole|ketoconazole|mesh-list
139194084|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
139194085|NCT03261336|Vitamins|vitamins|mesh-ancestor
139194086|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
139194087|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194088|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139194089|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139194090|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139194091|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
139194092|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972479|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194093|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139194094|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139194095|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194096|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194097|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139194098|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
139194099|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139194100|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139194101|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139194102|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139194103|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139194104|NCT03384862|Folic Acid|folic acid|mesh-list
139194105|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
139194106|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
139194107|NCT03384862|Vitamins|vitamins|mesh-ancestor
139194108|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
139194109|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194110|NCT03384862|Hematinics|hematinics|mesh-ancestor
139194111|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
139194112|NCT01269437|Budesonide|budesonide|mesh-list
139194113|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139194114|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139194115|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
139194116|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194117|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194118|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139194119|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
139194120|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
139194121|NCT01269437|Hormones|hormones|mesh-ancestor
139194122|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139194123|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
139194124|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
139194125|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194126|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
139194127|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194128|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194129|NCT00462748|Atorvastatin|atorvastatin|mesh-list
139194130|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139194131|NCT00462748|Simvastatin|simvastatin|mesh-list
139194132|NCT00462748|Ezetimibe|ezetimibe|mesh-list
139194133|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139194134|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139194135|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
139194136|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194137|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139194138|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139194139|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194140|NCT01161017|Topiramate|topiramate|mesh-list
139194141|NCT01161017|Amitriptyline|amitriptyline|mesh-list
139194143|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139194144|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194145|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139194146|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
139194147|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139194148|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139194149|NCT01161017|Analgesics|analgesics|mesh-ancestor
139194150|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
139194151|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194152|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139194153|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139194154|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139194155|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194156|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
139194157|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194158|NCT03935685|Mirtazapine|mirtazapine|mesh-list
139194159|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
139194160|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139194161|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139194162|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
139194163|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
139194164|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194165|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194166|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194167|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139194168|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139194169|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139194170|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139194171|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139194173|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
139194174|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139194175|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139194176|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
139194177|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139194178|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139194179|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
139194180|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194181|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139194182|NCT03238911|Hematinics|hematinics|mesh-ancestor
139194183|NCT01269515|Etoricoxib|etoricoxib|mesh-list
139194184|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139194185|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139194186|NCT01269515|Analgesics|analgesics|mesh-ancestor
139194187|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
139194188|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906813|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
139194189|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194190|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139194191|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139194192|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139194193|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139194194|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194195|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194196|NCT00418834|Atorvastatin|atorvastatin|mesh-list
139194197|NCT00418834|Ezetimibe|ezetimibe|mesh-list
139194198|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139194199|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139194200|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
139194201|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194202|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139194203|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139194204|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194205|NCT01269671|Peppermint oil|peppermint oil|mesh-list
138944697|NCT00931450|Sunitinib|sunitinib|mesh-list
139194206|NCT01269671|Melatonin|melatonin|mesh-list
139194207|NCT01269671|Simethicone|simethicone|mesh-list
139194208|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
139194209|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194210|NCT01269671|Protective Agents|protective agents|mesh-ancestor
139194211|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194212|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139194213|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
139194214|NCT01269671|Emollients|emollients|mesh-ancestor
139194215|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
139194216|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
139194217|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
139194218|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194219|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139194220|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
139194221|NCT04407286|Vitamin D|vitamin d|mesh-list
139194222|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
139194223|NCT04407286|Vitamins|vitamins|mesh-ancestor
139194224|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
139194225|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194226|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139194227|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139194228|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139194229|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
139194230|NCT03276975|Coagulants|coagulants|mesh-ancestor
139194231|NCT03125746|Exemestane|exemestane|mesh-list
139194232|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194233|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139194234|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139194235|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194236|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194237|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139194238|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
139194239|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139194240|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194241|NCT03877601|Bevacizumab|bevacizumab|mesh-list
139194242|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138564246|NCT00319267|Bosentan|bosentan|mesh-list
139194243|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194244|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139194245|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139194246|NCT03877601|Growth Substances|growth substances|mesh-ancestor
139194247|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194248|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
139194249|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
139194250|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
139194251|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139194252|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
139194253|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138972546|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
139194254|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194255|NCT03297216|Progestins|progestins|mesh-ancestor
139194256|NCT03297216|Hormones|hormones|mesh-ancestor
139194257|NCT03260868|Insulin|insulin|mesh-list
139194258|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139194259|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
139194260|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
139194261|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
139194262|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139194263|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194264|NCT01165385|Cisplatin|cisplatin|mesh-list
139194265|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194266|NCT01267487|Heparin|heparin|mesh-list
139194267|NCT01267487|Calcium heparin|calcium heparin|mesh-list
139194268|NCT01267487|Protamines|protamines|mesh-list
139194269|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
139194270|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139194271|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139194272|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194273|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
139194274|NCT01267487|Coagulants|coagulants|mesh-ancestor
139194275|NCT01267643|Alefacept|alefacept|mesh-list
139194276|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
139194277|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
139194278|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194279|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
139194280|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139194281|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194282|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194283|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139194284|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139194285|NCT01269827|Protective Agents|protective agents|mesh-ancestor
139194286|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194287|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
139194288|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139194289|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
139194290|NCT03388372|Temozolomide|temozolomide|mesh-list
139194291|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
139194292|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139194293|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
139194294|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194295|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194296|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139194297|NCT05173246|Paclitaxel|paclitaxel|mesh-list
139194298|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139194299|NCT05173246|Cisplatin|cisplatin|mesh-list
139194300|NCT05173246|Carboplatin|carboplatin|mesh-list
139194301|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139194302|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194303|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
139194304|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
139194305|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
139194306|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194307|NCT01167101|Pantoprazole|pantoprazole|mesh-list
139194308|NCT01167101|Rebamipide|rebamipide|mesh-list
139194309|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139194310|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139194311|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139194312|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194313|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194314|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
139194315|NCT01167101|Protective Agents|protective agents|mesh-ancestor
139194316|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194317|NCT05173090|Ropivacaine|ropivacaine|mesh-list
139194318|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
139194319|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
139194320|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139194321|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194322|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
139194323|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194324|NCT02526953|Paclitaxel|paclitaxel|mesh-list
139194326|NCT02526953|Mitomycins|mitomycins|mesh-list
139194327|NCT02526953|Mitomycin|mitomycin|mesh-list
139194328|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139194329|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194330|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
139194331|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
139194332|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
139194333|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194334|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139194335|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
139194336|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139194337|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
139194338|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139194339|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194340|NCT03258762|Leucovorin|leucovorin|mesh-list
139194341|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
139194342|NCT03258762|Calcium|calcium|mesh-list
139194343|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
139194344|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139194345|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194346|NCT03258762|Antidotes|antidotes|mesh-ancestor
139194347|NCT03258762|Protective Agents|protective agents|mesh-ancestor
139194348|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
139194349|NCT03258762|Vitamins|vitamins|mesh-ancestor
139194350|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
139194351|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
139194352|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139194353|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139194354|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139194355|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138944843|NCT00567268|Gabapentin|gabapentin|mesh-list
139194356|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194357|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194358|NCT05427669|Leucovorin|leucovorin|mesh-list
139194359|NCT05427669|Fluorouracil|fluorouracil|mesh-list
139194360|NCT05427669|Oxaliplatin|oxaliplatin|mesh-list
139194361|NCT05427669|Irinotecan|irinotecan|mesh-list
139194362|NCT05427669|Levoleucovorin|levoleucovorin|mesh-list
139194363|NCT05427669|Antimetabolites|antimetabolites|mesh-ancestor
139194364|NCT05427669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194365|NCT05427669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139194366|NCT05427669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194367|NCT05427669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139194368|NCT05427669|Immunologic Factors|immunologic factors|mesh-ancestor
139194369|NCT05427669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194370|NCT05427669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139194371|NCT05427669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139194372|NCT05427669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194373|NCT05427669|Antidotes|antidotes|mesh-ancestor
139194374|NCT05427669|Protective Agents|protective agents|mesh-ancestor
139194375|NCT05427669|Vitamin B Complex|vitamin b complex|mesh-ancestor
139194376|NCT05427669|Vitamins|vitamins|mesh-ancestor
139194377|NCT05427669|Micronutrients|micronutrients|mesh-ancestor
139194378|NCT01270373|Docetaxel|docetaxel|mesh-list
139194379|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194380|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
139194381|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
139194382|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
139194383|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194384|NCT03713086|Vaccines|vaccines|mesh-list
138972565|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
139194386|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194387|NCT01271231|Azithromycin|azithromycin|mesh-list
139194388|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139194389|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139194390|NCT03379558|Alirocumab|alirocumab|mesh-list
139194391|NCT03379558|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139194392|NCT03379558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139194393|NCT03379558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139194394|NCT03379558|Antimetabolites|antimetabolites|mesh-ancestor
139194395|NCT03379558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194396|NCT03379558|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139194397|NCT03379558|Protease Inhibitors|protease inhibitors|mesh-ancestor
139194398|NCT03379558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194399|NCT03379558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139194400|NCT01169909|Ranibizumab|ranibizumab|mesh-list
139194401|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139194402|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139194403|NCT01169909|Growth Substances|growth substances|mesh-ancestor
139194404|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194405|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
139194406|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194407|NCT04502589|Disulfiram|disulfiram|mesh-list
139194408|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139194409|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139194410|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194411|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194412|NCT03387904|Irinotecan|irinotecan|mesh-list
139194413|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139194414|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139194415|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194416|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194417|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194418|NCT03291288|Tolbutamide|tolbutamide|mesh-list
139194419|NCT03291288|Midazolam|midazolam|mesh-list
139194420|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139194421|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139194422|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139194423|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194424|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139194425|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139194426|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139194427|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139194428|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
139194429|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
139194430|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
139194431|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
139194432|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194433|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194434|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139194435|NCT05172310|FAPI-46|fapi-46|mesh-list
139194436|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139194437|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194438|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139194439|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139194440|NCT04084626|Lenalidomide|lenalidomide|mesh-list
139194441|NCT04084626|Antibodies|antibodies|mesh-list
139194442|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
139194443|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787510|NCT01008618|Fentanyl|fentanyl|mesh-list
139194444|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138972592|NCT00893256|Citalopram|citalopram|mesh-list
139194445|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139194446|NCT04084626|Growth Substances|growth substances|mesh-ancestor
139194447|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
139194448|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194450|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139194451|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139194452|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139194453|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139194454|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139194455|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
139194456|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194457|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194458|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194459|NCT03871517|Aspirin|aspirin|mesh-list
139194460|NCT03871517|Indobufen|indobufen|mesh-list
139194461|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139194462|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139194463|NCT03871517|Analgesics|analgesics|mesh-ancestor
139194464|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
139194465|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194466|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194467|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139194468|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139194469|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139194470|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139194471|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194472|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139194473|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139194474|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194475|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
139194476|NCT03387592|Leucovorin|leucovorin|mesh-list
139194477|NCT03387592|Capecitabine|capecitabine|mesh-list
139194478|NCT03387592|Fluorouracil|fluorouracil|mesh-list
139194479|NCT03387592|Temozolomide|temozolomide|mesh-list
139194480|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
139194481|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139194482|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
139194483|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194484|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194485|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139194486|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
139194487|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194488|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139194489|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
139194490|NCT03387592|Antidotes|antidotes|mesh-ancestor
139194491|NCT03387592|Protective Agents|protective agents|mesh-ancestor
139194492|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
139194493|NCT03387592|Vitamins|vitamins|mesh-ancestor
139194494|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
139194495|NCT04445506|Dexamethasone|dexamethasone|mesh-list
139194496|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139194497|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
139194498|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
139194499|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194500|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194501|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139194502|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
139194503|NCT04445506|Hormones|hormones|mesh-ancestor
139194504|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139194505|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139194506|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194507|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
139194508|NCT03379012|Sunitinib|sunitinib|mesh-list
139194509|NCT03379012|Testosterone|testosterone|mesh-list
139194510|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
139194511|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
139194512|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139194513|NCT03379012|Androgens|androgens|mesh-ancestor
139194514|NCT03379012|Hormones|hormones|mesh-ancestor
139194515|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139194516|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564517|NCT00327184|PENTA|penta|mesh-list
139194517|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139194518|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194519|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
139194520|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139194521|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139194522|NCT03379012|Growth Substances|growth substances|mesh-ancestor
139194523|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
139194524|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139194525|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194526|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194527|NCT03383302|Nivolumab|nivolumab|mesh-list
139194528|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139194529|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194530|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139194531|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194532|NCT03493126|Estradiol|estradiol|mesh-list
139194533|NCT03493126|Estrogens|estrogens|mesh-ancestor
139194534|NCT03493126|Hormones|hormones|mesh-ancestor
139194535|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139194536|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194537|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139194538|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139194539|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194540|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139194541|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
139194542|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194543|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
139194544|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138972617|NCT00901368|Hormones|hormones|mesh-ancestor
139194545|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139194546|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194547|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
139194548|NCT03386656|Coagulants|coagulants|mesh-ancestor
139194549|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139194550|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139194551|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139194552|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139194553|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194554|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139194555|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139194556|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139194557|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
139194558|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194559|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194560|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139194561|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139194562|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
139194564|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139194565|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
139194566|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139194567|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194568|NCT01170143|Trastuzumab|trastuzumab|mesh-list
139194569|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139194570|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194571|NCT05171530|Lenvatinib|lenvatinib|mesh-list
139194573|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194574|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139194575|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194576|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194577|NCT02936037|Biotin|biotin|mesh-list
139194578|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
139194579|NCT02936037|Vitamins|vitamins|mesh-ancestor
139194580|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
139194581|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194582|NCT01283789|Everolimus|everolimus|mesh-list
139194583|NCT01283789|Lapatinib|lapatinib|mesh-list
139194584|NCT01283789|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139194585|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139194586|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194587|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194588|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139194589|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
139194590|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194591|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194593|NCT03383068|Exenatide|exenatide|mesh-list
139194594|NCT03383068|Acarbose|acarbose|mesh-list
139194595|NCT03383068|Orlistat|orlistat|mesh-list
139194596|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139194597|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194598|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139194599|NCT03383068|Incretins|incretins|mesh-ancestor
139194600|NCT03383068|Hormones|hormones|mesh-ancestor
139194601|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139194602|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139194603|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194604|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194605|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139194606|NCT03378310|Linrodostat|linrodostat|mesh-list
139194607|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194608|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194609|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
139194610|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139194611|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194612|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139194613|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
139194614|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139194615|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139194616|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194617|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194618|NCT04194151|Propofol|propofol|mesh-list
139194619|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139194620|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139194621|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194622|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139194623|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
139194624|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
139194625|NCT01281761|Irinotecan|irinotecan|mesh-list
139194626|NCT01281761|Cetuximab|cetuximab|mesh-list
139194627|NCT01281761|Simvastatin|simvastatin|mesh-list
139194628|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139194629|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139194630|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194631|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194632|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194633|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139194634|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139194635|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139194636|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
139194637|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139194638|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139194639|NCT04280328|Daratumumab|daratumumab|mesh-list
139194640|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194641|NCT03748147|Misoprostol|misoprostol|mesh-list
139194642|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139194643|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
139194644|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139194645|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194646|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139194647|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139194648|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
139194649|NCT01580813|Acipimox|acipimox|mesh-list
139194650|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139194651|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
139194652|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194653|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139194654|NCT04446364|Disinfectants|disinfectants|mesh-list
139194655|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139194656|NCT01588535|Benzocaine|benzocaine|mesh-list
139194657|NCT01588535|Anesthetics, Local|anesthetics, local|mesh-ancestor
139194658|NCT01588535|Anesthetics|anesthetics|mesh-ancestor
139194659|NCT01588535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139194660|NCT01588535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194661|NCT01588535|Sensory System Agents|sensory system agents|mesh-ancestor
139194662|NCT01588535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194663|NCT01165931|Riociguat|riociguat|mesh-list
139194664|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
139194665|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194666|NCT01274273|Interferons|interferons|mesh-list
139194667|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
139194668|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
139194669|NCT01274273|Aldesleukin|aldesleukin|mesh-list
139194670|NCT01274273|Bevacizumab|bevacizumab|mesh-list
139194671|NCT01274273|Interleukin-2|interleukin-2|mesh-list
139194672|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139194673|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194674|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139194675|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139194676|NCT01274273|Growth Substances|growth substances|mesh-ancestor
139194677|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194678|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
139194679|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
139194680|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139194681|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
139194682|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139194683|NCT01274273|Analgesics|analgesics|mesh-ancestor
139194684|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
139194685|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194686|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139194687|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139194688|NCT04058353|Ivacaftor|ivacaftor|mesh-list
139194689|NCT04058353|Elexacaftor|elexacaftor|mesh-list
139194690|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139194691|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139194692|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194693|NCT01167725|Leucovorin|leucovorin|mesh-list
139194694|NCT01167725|Bevacizumab|bevacizumab|mesh-list
139194695|NCT01167725|Cetuximab|cetuximab|mesh-list
139194696|NCT01167725|Capecitabine|capecitabine|mesh-list
139194697|NCT01167725|Fluorouracil|fluorouracil|mesh-list
139194698|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
139194699|NCT01167725|Irinotecan|irinotecan|mesh-list
139194700|NCT01167725|Mitomycins|mitomycins|mesh-list
139194701|NCT01167725|Mitomycin|mitomycin|mesh-list
139194702|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
139194703|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139194704|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194705|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139194706|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139194707|NCT01167725|Growth Substances|growth substances|mesh-ancestor
139194708|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194709|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
139194710|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139194711|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
139194712|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194713|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139194714|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
139194715|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139194716|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139194717|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194718|NCT01167725|Antidotes|antidotes|mesh-ancestor
139194719|NCT01167725|Protective Agents|protective agents|mesh-ancestor
139194720|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
139194721|NCT01167725|Vitamins|vitamins|mesh-ancestor
139194722|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
139194723|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139194724|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
139194725|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139194726|NCT04446130|Decitabine|decitabine|mesh-list
138972688|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
139194727|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139194728|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
139194729|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194730|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194731|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194732|NCT03226275|Amlodipine|amlodipine|mesh-list
139194733|NCT03226275|Bisoprolol|bisoprolol|mesh-list
138906938|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139194734|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138564757|NCT00086528|XL647|xl647|mesh-list
139194735|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139194736|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139194737|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194738|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139194739|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194740|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
139194741|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
139194742|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
139194743|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194744|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139194745|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139194746|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139194747|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
139194748|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194750|NCT03382756|Atorvastatin|atorvastatin|mesh-list
139194751|NCT03382756|Fenofibrate|fenofibrate|mesh-list
139194752|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139194753|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139194754|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
139194755|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194756|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139194757|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139194758|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194759|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
139194760|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139194761|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
139194762|NCT01166087|Fluoxetine|fluoxetine|mesh-list
139194763|NCT01166087|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139194764|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139194765|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139194766|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194767|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194768|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
139194769|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194770|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139194771|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
139194772|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139194773|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139194774|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139194775|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194776|NCT01170767|Bevacizumab|bevacizumab|mesh-list
139194777|NCT01170767|Ranibizumab|ranibizumab|mesh-list
139194778|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139194779|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194780|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139194781|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139194782|NCT01170767|Growth Substances|growth substances|mesh-ancestor
139194783|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194784|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
139194786|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139194787|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
139194788|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194789|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194790|NCT01150890|Brodalumab|brodalumab|mesh-list
139194791|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
139194792|NCT01167803|Desflurane|desflurane|mesh-list
139194793|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138906968|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
139194794|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
139194795|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
139194796|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139194797|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194798|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139194799|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139194800|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194801|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194802|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139194803|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139194804|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194805|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
139194806|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194807|NCT01275911|Remifentanil|remifentanil|mesh-list
139194809|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139194810|NCT01275911|Narcotics|narcotics|mesh-ancestor
139194811|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139194812|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194813|NCT01275911|Analgesics|analgesics|mesh-ancestor
139194814|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
139194815|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194816|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139194817|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139194818|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139194819|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
139194820|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194821|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194822|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
139194823|NCT01166165|Vitamin D|vitamin d|mesh-list
139194824|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139194825|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194826|NCT01166165|Vitamins|vitamins|mesh-ancestor
139194827|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
139194828|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139194829|NCT03286218|Alprazolam|alprazolam|mesh-list
139194830|NCT03286218|Lasmiditan|lasmiditan|mesh-list
139194831|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139194832|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139194834|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139194835|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139194836|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139194837|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
139194838|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
139194839|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194840|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194841|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139194842|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
139194843|NCT03745261|Fluticasone|fluticasone|mesh-list
139194844|NCT03745261|Xhance|xhance|mesh-list
139194845|NCT03745261|Bromides|bromides|mesh-list
139194846|NCT03745261|Albuterol|albuterol|mesh-list
139194847|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
139194848|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139194849|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139194850|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139194851|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139194852|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
139194853|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194854|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194855|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138906985|NCT04141319|Ketorolac|ketorolac|mesh-list
139194856|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
139194857|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
139194858|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139194859|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
139194860|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139194861|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
139194862|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194863|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194864|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139194865|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139194866|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139194867|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
139194868|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
139194869|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
139194870|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139194871|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
139194872|NCT03745261|Hormones|hormones|mesh-ancestor
139194873|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139194874|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
139194875|NCT03744949|Remifentanil|remifentanil|mesh-list
139194876|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139194877|NCT03744949|Narcotics|narcotics|mesh-ancestor
139194878|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139194879|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194880|NCT03744949|Analgesics|analgesics|mesh-ancestor
139194881|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
139194882|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194884|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
139194885|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139194886|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139194887|NCT04016779|Viloxazine|viloxazine|mesh-list
139194888|NCT04016779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139194889|NCT04016779|Antidepressive Agents|antidepressive agents|mesh-ancestor
139194890|NCT04016779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139194891|NCT04016779|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139194892|NCT04016779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139194893|NCT04016779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139194894|NCT04016779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194895|NCT04016779|Adrenergic Agents|adrenergic agents|mesh-ancestor
139194896|NCT04016779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194897|NCT04016779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194898|NCT03870503|Misoprostol|misoprostol|mesh-list
139194899|NCT03870503|Oxytocin|oxytocin|mesh-list
139194900|NCT03870503|Carbetocin|carbetocin|mesh-list
139194901|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
139194902|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139194903|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194904|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139194905|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
139194906|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139194907|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139194908|NCT02857426|Nivolumab|nivolumab|mesh-list
139194909|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139194910|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194911|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139194912|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194913|NCT05181033|Letrozole|letrozole|mesh-list
139194914|NCT05181033|Lenvatinib|lenvatinib|mesh-list
139194915|NCT05181033|Fulvestrant|fulvestrant|mesh-list
138906995|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139194916|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194917|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139194918|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139194919|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194920|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194921|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139194922|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
139194923|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139194924|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194925|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139194926|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139194927|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139194928|NCT05666765|Isotretinoin|isotretinoin|mesh-list
139194929|NCT05666765|Silymarin|silymarin|mesh-list
139194930|NCT05666765|Dermatologic Agents|dermatologic agents|mesh-ancestor
139194931|NCT05666765|Antioxidants|antioxidants|mesh-ancestor
139194932|NCT05666765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194933|NCT05666765|Protective Agents|protective agents|mesh-ancestor
139194934|NCT05666765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194935|NCT01127256|Carbamazepine|carbamazepine|mesh-list
139194936|NCT01127256|Zonisamide|zonisamide|mesh-list
139194937|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
139194938|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
139194939|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139194940|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139194941|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194942|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139194943|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139194944|NCT01127256|Analgesics|analgesics|mesh-ancestor
139194945|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
139194946|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139194947|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139194948|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139194949|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194950|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139194951|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139194952|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138972752|NCT03455556|Maytansine|maytansine|mesh-list
139194953|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139194954|NCT03377842|Leucovorin|leucovorin|mesh-list
139194955|NCT03377842|Apatinib|apatinib|mesh-list
139194956|NCT03377842|Fluorouracil|fluorouracil|mesh-list
139194957|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
139194958|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194959|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139194960|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194961|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194962|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
139194963|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139194964|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139194965|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
139194966|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194967|NCT03377842|Antidotes|antidotes|mesh-ancestor
139194968|NCT03377842|Protective Agents|protective agents|mesh-ancestor
139194969|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
138945446|NCT00936676|Rasagiline|rasagiline|mesh-list
139194970|NCT03377842|Vitamins|vitamins|mesh-ancestor
139194971|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
139194972|NCT01277705|Vaccines|vaccines|mesh-list
139194973|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
139194974|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194975|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
139194976|NCT04757337|Doxorubicin|doxorubicin|mesh-list
139194977|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138907014|NCT00683891|Clozapine|clozapine|mesh-list
139194978|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
139194979|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139194980|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139194981|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139194982|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
139194983|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194984|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194985|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139194986|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139194987|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139194988|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139194989|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139194990|NCT03946527|Lanreotide|lanreotide|mesh-list
139194991|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194992|NCT03377608|Tenofovir|tenofovir|mesh-list
139194993|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139194994|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
139194995|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
139194996|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139194997|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139194998|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139194999|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195000|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195001|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139195002|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139195003|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139195004|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
139195005|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139195006|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195007|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139195008|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139195009|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139195010|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195011|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139195012|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139195013|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139195014|NCT01282073|Cyclosporine|cyclosporine|mesh-list
139195015|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
139195016|NCT01282073|Cyclosporins|cyclosporins|mesh-list
139195017|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195018|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195019|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139195020|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
139195021|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195022|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
139195023|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195024|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
139195025|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139195026|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139195027|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139195028|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195029|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139195030|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
139195031|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139195032|NCT01166477|Ritonavir|ritonavir|mesh-list
139195033|NCT01166477|Lopinavir|lopinavir|mesh-list
139195034|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139195035|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139195036|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
139195037|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195038|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195039|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139195040|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139195041|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
139195042|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195043|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139195044|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139195045|NCT01282151|Cisplatin|cisplatin|mesh-list
139195046|NCT01282151|Pemetrexed|pemetrexed|mesh-list
139195047|NCT01282151|Docetaxel|docetaxel|mesh-list
139195048|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195049|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195050|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195051|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139195052|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139195053|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
139195054|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
139195055|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
139195056|NCT03377218|Iodine|iodine|mesh-list
139195057|NCT03377218|Selenium|selenium|mesh-list
139195058|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
139195059|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139195060|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195061|NCT03377218|Trace Elements|trace elements|mesh-ancestor
139195062|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
139195063|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195064|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
139195065|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195066|NCT03377218|Protective Agents|protective agents|mesh-ancestor
139195067|NCT01168505|Teferrol|teferrol|mesh-list
139195068|NCT01168505|Hematinics|hematinics|mesh-ancestor
139195069|NCT04013191|Padsevonil|padsevonil|mesh-list
139195070|NCT04013191|Anticonvulsants|anticonvulsants|mesh-ancestor
139195071|NCT03867929|Vitamin D|vitamin d|mesh-list
139195072|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139195073|NCT03867929|Calcifediol|calcifediol|mesh-list
139195074|NCT03867929|Vitamins|vitamins|mesh-ancestor
139195075|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
139195076|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195077|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139195078|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
139195079|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139195080|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139195081|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195082|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139195083|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195084|NCT01171469|Imiquimod|imiquimod|mesh-list
139195085|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139195086|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
139195087|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195088|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195089|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
139195090|NCT02695992|Metoprolol|metoprolol|mesh-list
139195091|NCT02695992|Diltiazem|diltiazem|mesh-list
139195092|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139195093|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139195094|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
139195095|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
139195096|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195097|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195098|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139195099|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139195100|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139195101|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
139195102|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195103|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195104|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139195105|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139195106|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139195107|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
139195108|NCT04050865|Dexamethasone|dexamethasone|mesh-list
139195109|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139195110|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
139195111|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
139195112|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195113|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195114|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139195115|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
139195116|NCT04050865|Hormones|hormones|mesh-ancestor
139195117|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139195118|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139195119|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195120|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
139195122|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139195123|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139195124|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907061|NCT00781300|Dexamethasone|dexamethasone|mesh-list
139195125|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195126|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195127|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139195129|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139195130|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195131|NCT04048681|Cocaine|cocaine|mesh-list
139195132|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
139195133|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
139195134|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195135|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195136|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
139195137|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195138|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139195139|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139195140|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139195141|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139195142|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195143|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
139195144|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195145|NCT01282385|Simvastatin|simvastatin|mesh-list
139195146|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139195147|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139195148|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
139195149|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195150|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139195151|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139195152|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195153|NCT01166711|Chromium|chromium|mesh-list
139195154|NCT01166711|Paclitaxel|paclitaxel|mesh-list
139195155|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139195156|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139195157|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195158|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
139195159|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
139195160|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
139195161|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195162|NCT01166711|Trace Elements|trace elements|mesh-ancestor
139195163|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
139195164|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195165|NCT01168739|Quercetin|quercetin|mesh-list
139195166|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
139195167|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195169|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195170|NCT01171781|Cisplatin|cisplatin|mesh-list
139195171|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195172|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
139195173|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
139195174|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195175|NCT01171859|Doxycycline|doxycycline|mesh-list
139195176|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
139195177|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139195178|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195179|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
139195180|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139195181|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139195182|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
139195183|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138972828|NCT04035876|Apatinib|apatinib|mesh-list
139195184|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139195185|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
139195186|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
139195187|NCT02652468|Rituximab|rituximab|mesh-list
139195188|NCT02652468|Fludarabine|fludarabine|mesh-list
139195189|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
139195190|NCT02652468|Tacrolimus|tacrolimus|mesh-list
139195191|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139195192|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
139195193|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195194|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139195195|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139195196|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
139195197|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195198|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195199|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139195200|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139195201|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139195203|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139195204|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195205|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139195206|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139195207|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
139195208|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139195209|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195210|NCT04673877|Vancomycin|vancomycin|mesh-list
139195211|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139195212|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195213|NCT01166789|Lubiprostone|lubiprostone|mesh-list
139195214|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139195215|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139195216|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195217|NCT01314339|Desloratadine|desloratadine|mesh-list
139195218|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139195219|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
139195220|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195221|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195222|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195223|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139195224|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139195225|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
139195226|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
139195227|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139195228|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
139195229|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139195230|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139195231|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195232|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195233|NCT01168817|Urological Agents|urological agents|mesh-ancestor
139195234|NCT01279811|Dopamine|dopamine|mesh-list
139195235|NCT01279811|Norepinephrine|norepinephrine|mesh-list
139195236|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139195237|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139195238|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139195239|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
139195240|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195241|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195242|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195243|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
139195244|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
139195245|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195246|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139195247|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
138972839|NCT00635492|Insulin|insulin|mesh-list
139195248|NCT01279811|Protective Agents|protective agents|mesh-ancestor
139195249|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
139195250|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139195251|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195252|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139195253|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139195254|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195255|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195256|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195257|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139195258|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139195259|NCT03745105|Dexamethasone|dexamethasone|mesh-list
139195260|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
139195262|NCT03745105|Mepivacaine|mepivacaine|mesh-list
139195263|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139195264|NCT03745105|BB 1101|bb 1101|mesh-list
139195265|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139195266|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
139195267|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
139195268|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945740|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139195269|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195270|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139195271|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
139195272|NCT03745105|Hormones|hormones|mesh-ancestor
139195273|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139195274|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139195275|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195276|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
139195277|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
139195278|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195279|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
139195280|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
139195281|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195282|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195283|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139195284|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139195285|NCT03745105|Analgesics|analgesics|mesh-ancestor
139195286|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139195287|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139195288|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
139195289|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139195290|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139195291|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139195292|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139195293|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195294|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
139195295|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195296|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195297|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139195298|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195299|NCT03744247|Lenvatinib|lenvatinib|mesh-list
139195301|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
139195302|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
139195303|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195304|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195305|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139195306|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195307|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195308|NCT01282619|Huperzine A|huperzine a|mesh-list
139195309|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139195310|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195311|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195312|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
138787556|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195313|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195314|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195315|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139195316|NCT01282619|Protective Agents|protective agents|mesh-ancestor
139195317|NCT01282697|Sirolimus|sirolimus|mesh-list
139195318|NCT01282697|Irinotecan|irinotecan|mesh-list
139195319|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139195320|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139195321|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195322|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195323|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195324|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139195325|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195326|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139195327|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
139195328|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139195329|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
139195330|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195331|NCT01169597|Prednisone|prednisone|mesh-list
139195332|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139195333|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
139195334|NCT01169597|Hormones|hormones|mesh-ancestor
139195335|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139195336|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195337|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139195338|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195339|NCT02527798|Furosemide|furosemide|mesh-list
139195340|NCT02527798|Diuretics|diuretics|mesh-ancestor
139195341|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
139195342|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195343|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139195344|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139195345|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195346|NCT05331911|Propofol|propofol|mesh-list
139195347|NCT05331911|Sevoflurane|sevoflurane|mesh-list
139195348|NCT05331911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139195349|NCT05331911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195350|NCT05331911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195351|NCT05331911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139195352|NCT05331911|Anesthetics, General|anesthetics, general|mesh-ancestor
139195353|NCT05331911|Anesthetics|anesthetics|mesh-ancestor
139195354|NCT05331911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139195355|NCT05331911|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139195356|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139195357|NCT03857542|Pilocarpine|pilocarpine|mesh-list
139195358|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139195359|NCT03857542|Miotics|miotics|mesh-ancestor
139195360|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
139195361|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195362|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195363|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139195364|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139195365|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
139195366|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195367|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195368|NCT01172717|Panitumumab|panitumumab|mesh-list
139195369|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139195370|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195371|NCT03209973|Tislelizumab|tislelizumab|mesh-list
139195372|NCT03209973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139195373|NCT03209973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195374|NCT03751631|Phenylephrine|phenylephrine|mesh-list
139195375|NCT03751631|Oxymetazoline|oxymetazoline|mesh-list
139195376|NCT03751631|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139195377|NCT03751631|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139195378|NCT03751631|Tropicamide|tropicamide|mesh-list
139195379|NCT03751631|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139195380|NCT03751631|Mydriatics|mydriatics|mesh-ancestor
139195381|NCT03751631|Autonomic Agents|autonomic agents|mesh-ancestor
139195382|NCT03751631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195383|NCT03751631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195384|NCT03751631|Sympathomimetics|sympathomimetics|mesh-ancestor
139195385|NCT03751631|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139195386|NCT03751631|Nasal Decongestants|nasal decongestants|mesh-ancestor
139195387|NCT03751631|Respiratory System Agents|respiratory system agents|mesh-ancestor
139195388|NCT03751631|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139195389|NCT03751631|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139195390|NCT03751631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139195391|NCT03751631|Adrenergic Agents|adrenergic agents|mesh-ancestor
139195392|NCT03751631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195393|NCT03751631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195394|NCT03751631|Protective Agents|protective agents|mesh-ancestor
139195395|NCT03751631|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139195396|NCT03751631|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139195397|NCT03751631|Cholinergic Agents|cholinergic agents|mesh-ancestor
139195398|NCT03866681|Sirolimus|sirolimus|mesh-list
139195399|NCT03866681|Warfarin|warfarin|mesh-list
139195400|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139195401|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195402|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139195403|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195404|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
139195405|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139195406|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
139195407|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195408|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
138810882|NCT02752113|Hormones|hormones|mesh-ancestor
139195409|NCT03736369|Esomeprazole|esomeprazole|mesh-list
139195410|NCT03736369|Fexuprazan|fexuprazan|mesh-list
139195411|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139195412|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139195413|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139195414|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195415|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195416|NCT03867695|Ropivacaine|ropivacaine|mesh-list
139195417|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
139195418|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
139195419|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195420|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195421|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
139195422|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195424|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
139195425|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195426|NCT01172171|Protective Agents|protective agents|mesh-ancestor
139195427|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195428|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195429|NCT03655717|Ethanol|ethanol|mesh-list
139195430|NCT03655717|Dronabinol|dronabinol|mesh-list
139195431|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139195432|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195433|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195434|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195435|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
139195436|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139195437|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139195438|NCT03655717|Analgesics|analgesics|mesh-ancestor
139195439|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
139195440|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195441|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139195442|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139195443|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195444|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195445|NCT03655717|Hormones|hormones|mesh-ancestor
139195446|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139195447|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
139195448|NCT03867071|Hematinics|hematinics|mesh-ancestor
139195449|NCT01284413|Cisplatin|cisplatin|mesh-list
139195450|NCT01284413|Gemcitabine|gemcitabine|mesh-list
139195451|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195452|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139195453|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
139195454|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195455|NCT05152017|Vaccines|vaccines|mesh-list
139195456|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
139195457|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195458|NCT03866993|Paclitaxel|paclitaxel|mesh-list
139195459|NCT03866993|Carboplatin|carboplatin|mesh-list
139195460|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139195461|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195462|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
139195463|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
139195464|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
139195465|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195466|NCT01172405|Ibuprofen|ibuprofen|mesh-list
139195467|NCT01172405|Caffeine|caffeine|mesh-list
139195468|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139195469|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139195470|NCT01172405|Analgesics|analgesics|mesh-ancestor
139195471|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
139195472|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195473|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195474|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139195475|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139195476|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139195477|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195478|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195479|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139195480|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139195481|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139195482|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139195483|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
139195484|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195485|NCT04000165|Mitapivat|mitapivat|mesh-list
139195486|NCT04000165|Enzyme Activators|enzyme activators|mesh-ancestor
139195487|NCT04000165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195488|NCT03375424|Vedolizumab|vedolizumab|mesh-list
139195489|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139195490|NCT03187197|Dabigatran|dabigatran|mesh-list
139195491|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
139195492|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139195493|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
139195494|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945965|NCT00843453|Hematinics|hematinics|mesh-ancestor
139195495|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195496|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
139195497|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
139195498|NCT01284647|Sucralfate|sucralfate|mesh-list
139195499|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139195500|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139195501|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195502|NCT04000009|Pimavanserin|pimavanserin|mesh-list
139195503|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139195504|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139195505|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139195506|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139195507|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195508|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195509|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139195510|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139195511|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139195512|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
139195513|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195514|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195515|NCT03282240|Vaccines|vaccines|mesh-list
139195516|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
139195517|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195518|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
139195519|NCT01284725|Azathioprine|azathioprine|mesh-list
139195520|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139195521|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139195522|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195523|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139195524|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
139195525|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139195526|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195527|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787566|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139195528|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195530|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139195531|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
139195532|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195533|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139195534|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
139195535|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139195536|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139195537|NCT01173107|Colchicine|colchicine|mesh-list
139195538|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
139195539|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139195540|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
139195541|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
139195542|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
139195543|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195544|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195545|NCT03744091|Dronabinol|dronabinol|mesh-list
139195546|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
139195547|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195548|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139195549|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139195550|NCT03744091|Analgesics|analgesics|mesh-ancestor
139195551|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
139195552|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195553|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139195554|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139195555|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195556|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195557|NCT03744091|Hormones|hormones|mesh-ancestor
139195558|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139195559|NCT03376594|Loratadine|loratadine|mesh-list
139195560|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
139195561|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
139195562|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139195563|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139195564|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139195565|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
139195566|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
139195567|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195568|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195569|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195571|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
139195572|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
139195573|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
139195574|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139195575|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139195576|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195577|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195578|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195579|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139195580|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139195581|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
139195582|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139195583|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
139195584|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139195585|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139195586|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195587|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195588|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139195589|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139195590|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
139195591|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139195592|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139195593|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139195594|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139195595|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139195596|NCT04060758|Latanoprost|latanoprost|mesh-list
139195597|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139195598|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139195599|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139195600|NCT03863405|Metformin|metformin|mesh-list
139195601|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139195602|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195604|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139195605|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195606|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139195607|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139195608|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195609|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195610|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195611|NCT04024891|Phentolamine|phentolamine|mesh-list
139195612|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139195613|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139195614|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139195615|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139195616|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
139195617|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195618|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195619|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195620|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139195621|NCT01178021|Chloroquine|chloroquine|mesh-list
139195622|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139195623|NCT01178021|Primaquine|primaquine|mesh-list
139195624|NCT01178021|Amebicides|amebicides|mesh-ancestor
139195625|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139195626|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139195627|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195628|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
139195629|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139195630|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139195631|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139195632|NCT01178021|Analgesics|analgesics|mesh-ancestor
139195633|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
138907238|NCT00778726|Benazepril|benazepril|mesh-list
139195634|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195635|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195636|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139195637|NCT01178021|Filaricides|filaricides|mesh-ancestor
139195638|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
139195639|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
139195640|NCT03250182|Budesonide|budesonide|mesh-list
139195641|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
139195642|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
139195643|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139195644|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139195645|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
139195646|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195647|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195648|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139195649|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
139195650|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
139195651|NCT03250182|Hormones|hormones|mesh-ancestor
139195652|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139195653|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139195654|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139195655|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139195656|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
139195657|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195658|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195659|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139195660|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139195661|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139195662|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
139195663|NCT01173263|Propofol|propofol|mesh-list
139195664|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139195665|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195666|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195667|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139195668|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
139195669|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
139195670|NCT03381430|Gefitinib|gefitinib|mesh-list
139195671|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195672|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139195673|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195674|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195675|NCT01288157|Golimumab|golimumab|mesh-list
139195676|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139195677|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139195678|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139195679|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139195680|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
139195681|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195682|NCT03993379|Ipilimumab|ipilimumab|mesh-list
139195683|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139195684|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195685|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139195686|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195687|NCT03866447|Vitamin D|vitamin d|mesh-list
139195688|NCT03866447|Adapalene|adapalene|mesh-list
139195689|NCT03866447|Vitamins|vitamins|mesh-ancestor
139195690|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
139195691|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195692|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139195693|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139195694|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139195695|NCT03866447|Analgesics|analgesics|mesh-ancestor
139195696|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
139195697|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195698|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139195699|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139195700|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
139195701|NCT03370120|Padsevonil|padsevonil|mesh-list
139195702|NCT03370120|Anticonvulsants|anticonvulsants|mesh-ancestor
139195703|NCT01175291|Leucovorin|leucovorin|mesh-list
139195704|NCT01175291|Bevacizumab|bevacizumab|mesh-list
139195705|NCT01175291|Fluorouracil|fluorouracil|mesh-list
139195706|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
139195707|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
139195708|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139195709|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195710|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139195711|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139195712|NCT01175291|Growth Substances|growth substances|mesh-ancestor
139195713|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195714|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
139195716|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195717|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139195718|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139195719|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
139195720|NCT01175291|Antidotes|antidotes|mesh-ancestor
139195721|NCT01175291|Protective Agents|protective agents|mesh-ancestor
139195722|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
139195723|NCT01175291|Vitamins|vitamins|mesh-ancestor
139195724|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
139195725|NCT03230266|Insulin|insulin|mesh-list
139195726|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139195727|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195728|NCT03732469|Acetaminophen|acetaminophen|mesh-list
139195729|NCT03732469|Fentanyl|fentanyl|mesh-list
139195730|NCT03732469|Propofol|propofol|mesh-list
139195731|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139195732|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195733|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195734|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139195735|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
139195736|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
139195737|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139195738|NCT03732469|Narcotics|narcotics|mesh-ancestor
139195739|NCT03732469|Analgesics|analgesics|mesh-ancestor
139195740|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
139195741|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195742|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139195743|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138787579|NCT00603538|Paclitaxel|paclitaxel|mesh-list
139195744|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
139195745|NCT03381352|Capecitabine|capecitabine|mesh-list
139195746|NCT03381352|Mitomycins|mitomycins|mesh-list
139195747|NCT03381352|Mitomycin|mitomycin|mesh-list
139195748|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139195749|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
139195750|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195751|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195752|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139195753|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
139195754|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139195755|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195756|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
139195757|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
139195758|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
139195759|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195760|NCT01175525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139195761|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139195762|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139195763|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
139195764|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139195765|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195766|NCT03381118|Cytarabine|cytarabine|mesh-list
139195767|NCT03381118|Nivolumab|nivolumab|mesh-list
139195768|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139195769|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195770|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139195771|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195772|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139195773|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
139195774|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
139195775|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195776|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139195777|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
139195778|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195779|NCT02954575|Factor VIII|factor viii|mesh-list
139195780|NCT02954575|Coagulants|coagulants|mesh-ancestor
139195781|NCT02997358|Doxorubicin|doxorubicin|mesh-list
139195782|NCT02997358|Trabectedin|trabectedin|mesh-list
139195783|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139195784|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195785|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139195786|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139195787|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195788|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195789|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139195790|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
139195792|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
139195793|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
139195794|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
139195795|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195796|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195797|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195798|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
139195799|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139195801|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195802|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
139195803|NCT03381040|Protective Agents|protective agents|mesh-ancestor
139195804|NCT03376048|Ropivacaine|ropivacaine|mesh-list
139195805|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
139195806|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
139195807|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195808|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195809|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
139195810|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195811|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
139195812|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
139195813|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139195814|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195815|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139195816|NCT01285037|Gemcitabine|gemcitabine|mesh-list
139195817|NCT01285037|Cetuximab|cetuximab|mesh-list
139195818|NCT01285037|Ramucirumab|ramucirumab|mesh-list
139195819|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195820|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139195821|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
139195822|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195823|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139195824|NCT03732391|Carboplatin|carboplatin|mesh-list
139195825|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
139195826|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195827|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139195828|NCT03732391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139195829|NCT03732391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195830|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
139195831|NCT03374722|Narcotics|narcotics|mesh-ancestor
139195832|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195833|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195834|NCT03374722|Analgesics|analgesics|mesh-ancestor
139195835|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
139195836|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195837|NCT03207243|Fluticasone|fluticasone|mesh-list
139195838|NCT03207243|Xhance|xhance|mesh-list
139195839|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139195840|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139195841|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139195842|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
139195843|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195844|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195845|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139195846|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
139195847|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
139195848|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139195849|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139195850|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139195851|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139195852|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
139195853|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195854|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195855|NCT01285271|Sevoflurane|sevoflurane|mesh-list
139195856|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139195857|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139195858|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
139195859|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
139195860|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195861|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195862|NCT03982069|Vaccines|vaccines|mesh-list
139195863|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
139195864|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195865|NCT03219723|Amoxicillin|amoxicillin|mesh-list
139195866|NCT03219723|Metronidazole|metronidazole|mesh-list
139195867|NCT03219723|Clarithromycin|clarithromycin|mesh-list
139195868|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139195869|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195870|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139195871|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139195872|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139195873|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195874|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195875|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139195876|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139195877|NCT03628417|Bleomycin|bleomycin|mesh-list
139195878|NCT03628417|Calcium|calcium|mesh-list
139195879|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139195880|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195881|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139195882|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195883|NCT03369964|Atezolizumab|atezolizumab|mesh-list
139195884|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
139195885|NCT03369964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139195886|NCT03369964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195887|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139195888|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195889|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
139195890|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139195891|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195892|NCT01173809|Amiodarone|amiodarone|mesh-list
139195893|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139195894|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
138973015|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
139195895|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139195896|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139195897|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195898|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139195899|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139195900|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139195901|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195902|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139195903|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139195904|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139195905|NCT03375580|Metformin|metformin|mesh-list
139195906|NCT03375580|Simvastatin|simvastatin|mesh-list
139195907|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139195908|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195909|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139195910|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139195911|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
139195912|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195913|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139195914|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139195915|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195916|NCT01286909|Lycopene|lycopene|mesh-list
139195917|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139195918|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
139195919|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195920|NCT01286909|Protective Agents|protective agents|mesh-ancestor
139195921|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195922|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139195923|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139195924|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195925|NCT02954887|Cannabidiol|cannabidiol|mesh-list
139195926|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
139195927|NCT03860129|Sevoflurane|sevoflurane|mesh-list
139195928|NCT03860129|Desflurane|desflurane|mesh-list
139195929|NCT03860129|Isoflurane|isoflurane|mesh-list
139195930|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139195931|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139195932|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
139195933|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
139195934|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139195935|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195936|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139195937|NCT03369808|Vaccines|vaccines|mesh-list
139195938|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
139195939|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195940|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139195941|NCT03369808|Antacids|antacids|mesh-ancestor
139195942|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195943|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139195944|NCT02525237|Apatinib|apatinib|mesh-list
139195945|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195946|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139195947|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195948|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195950|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139195951|NCT03369574|Reslizumab|reslizumab|mesh-list
139195952|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139195953|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
139195954|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139195955|NCT02651740|Rifaximin|rifaximin|mesh-list
139195956|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139195957|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139195958|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139195959|NCT03862391|Analgesics|analgesics|mesh-list
139195960|NCT03862391|Antiemetics|antiemetics|mesh-list
139195961|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
139195962|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195963|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195965|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139195966|NCT03859583|Capsaicin|capsaicin|mesh-list
139195967|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
139195968|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
139195969|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
139195970|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195971|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195972|NCT03369262|Atosiban|atosiban|mesh-list
139195973|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
139195974|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139195975|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195976|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
139195977|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139195978|NCT03276078|Bromides|bromides|mesh-list
139195979|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
139195980|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139195981|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
139195982|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139195983|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195984|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139195985|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
139195986|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139195987|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139195988|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139195989|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
139195990|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195991|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139195992|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
139195993|NCT01288547|Theobromine|theobromine|mesh-list
139195994|NCT01288547|Caffeine|caffeine|mesh-list
139195995|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139195996|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139195997|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139195998|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139195999|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196000|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139196001|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139196002|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
139196003|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196004|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139196005|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
139196006|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196007|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139196008|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
139196009|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
139196010|NCT03373864|Anesthetics|anesthetics|mesh-list
139196011|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196012|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196014|NCT04597320|Fentanyl|fentanyl|mesh-list
139196015|NCT04597320|Esketamine|esketamine|mesh-list
139196016|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139196017|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139196018|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196019|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196020|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139196021|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139196022|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139196023|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138946485|NCT00562588|Dipyridamole|dipyridamole|mesh-list
139196024|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
139196026|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
139196027|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
139196028|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196029|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196030|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139196031|NCT04597320|Narcotics|narcotics|mesh-ancestor
139196032|NCT04597320|Analgesics|analgesics|mesh-ancestor
139196033|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
139196034|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787591|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
139196035|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
139196036|NCT03373708|Tamoxifen|tamoxifen|mesh-list
139196037|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
139196038|NCT03373708|Docetaxel|docetaxel|mesh-list
139196039|NCT03373708|Letrozole|letrozole|mesh-list
139196040|NCT03373708|Epirubicin|epirubicin|mesh-list
139196041|NCT03373708|Goserelin|goserelin|mesh-list
139196042|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139196043|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
139196044|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196045|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196046|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139196047|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
139196048|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196049|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196050|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139196051|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
139196052|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
139196053|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
139196054|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139196055|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139196056|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196057|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139196058|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
139196059|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139196060|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139196061|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139196062|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139196063|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139196064|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139196065|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139196066|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139196068|NCT03123952|Immunoconjugates|immunoconjugates|mesh-ancestor
139196069|NCT03123952|Immunologic Factors|immunologic factors|mesh-ancestor
139196070|NCT03123952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196071|NCT02519608|Aspirin|aspirin|mesh-list
139196072|NCT02519608|Clopidogrel|clopidogrel|mesh-list
139196073|NCT02519608|Ticagrelor|ticagrelor|mesh-list
139196074|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139196075|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139196076|NCT02519608|Analgesics|analgesics|mesh-ancestor
139196077|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
139196078|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196079|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196080|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139196081|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196082|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139196083|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139196084|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196085|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139196086|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139196087|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196088|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
139196089|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139196090|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139196091|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139196092|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
139196093|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196094|NCT05181852|Pregabalin|pregabalin|mesh-list
139196095|NCT05181852|Analgesics|analgesics|mesh-ancestor
139196096|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
138946561|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139196097|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196098|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196099|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
139196100|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139196101|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139196102|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196103|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139196104|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139196105|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139196106|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196107|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139196109|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139196110|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
139196111|NCT04584684|Povidone|povidone|mesh-list
139196112|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139196113|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196114|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196115|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196116|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
139196117|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
139196118|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
139196119|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139196120|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139196121|NCT03124420|Amoxicillin|amoxicillin|mesh-list
139196122|NCT03124420|Clarithromycin|clarithromycin|mesh-list
139196123|NCT03124420|Lansoprazole|lansoprazole|mesh-list
139196124|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
139196125|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139196126|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196127|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139196128|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196129|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196130|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138907439|NCT02555800|Growth Substances|growth substances|mesh-ancestor
139196131|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139196132|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139196133|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139196134|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139196135|NCT03231228|Cefazolin|cefazolin|mesh-list
139196136|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139196137|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196138|NCT01178645|Cytarabine|cytarabine|mesh-list
139196139|NCT01178645|Etoposide|etoposide|mesh-list
139196140|NCT01178645|Melphalan|melphalan|mesh-list
139196141|NCT01178645|Busulfan|busulfan|mesh-list
139196142|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139196143|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196144|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139196145|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139196146|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196147|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196148|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139196149|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
139196150|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
139196151|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196152|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139196153|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
139196154|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196155|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139196156|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
139196157|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139196158|NCT01285505|Alprazolam|alprazolam|mesh-list
139196159|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139196160|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196161|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196162|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139196163|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139196164|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139196165|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
139196166|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
139196167|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196168|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196169|NCT03372850|Esomeprazole|esomeprazole|mesh-list
139196170|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139196171|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139196172|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139196173|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196174|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196175|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
139196176|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139196177|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
139196178|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196179|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
139196180|NCT04525066|Protective Agents|protective agents|mesh-ancestor
139196181|NCT03362788|Vitamin K|vitamin k|mesh-list
139196182|NCT03362788|Anticoagulants|anticoagulants|mesh-list
139196183|NCT03362788|Vitamins|vitamins|mesh-ancestor
139196184|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
139196185|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196186|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139196187|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139196188|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196189|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
139196190|NCT03362788|Coagulants|coagulants|mesh-ancestor
139196191|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
139196192|NCT03368794|Narcotics|narcotics|mesh-ancestor
139196193|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196194|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196195|NCT03368794|Analgesics|analgesics|mesh-ancestor
139196196|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
139196197|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196198|NCT03862079|Tazobactam|tazobactam|mesh-list
139196199|NCT03862079|Piperacillin|piperacillin|mesh-list
139196200|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139196201|NCT03862079|Nystatin|nystatin|mesh-list
139196202|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139196203|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196204|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139196205|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196206|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196207|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
139196208|NCT03862079|Ionophores|ionophores|mesh-ancestor
139196209|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139196210|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139196211|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196212|NCT01179269|Paclitaxel|paclitaxel|mesh-list
139196213|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139196214|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196215|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
139196216|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
139196217|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
139196218|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196219|NCT00165724|Donepezil|donepezil|mesh-list
139196220|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139196221|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196222|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196223|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
139196224|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196225|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196226|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
139196227|NCT01287455|Vitamin D|vitamin d|mesh-list
139196228|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
139196229|NCT01287455|Vitamins|vitamins|mesh-ancestor
139196230|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
139196231|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196232|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139196233|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139196234|NCT03865511|Osimertinib|osimertinib|mesh-list
139196235|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196236|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139196237|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196238|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196239|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
139196240|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139196241|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196242|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139196243|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139196244|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
139196245|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139196246|NCT01287689|Antibodies|antibodies|mesh-list
139196247|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
139196248|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
139196249|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196250|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
139196251|NCT01179503|Vitamin D|vitamin d|mesh-list
139196252|NCT01179503|Calcium|calcium|mesh-list
139196254|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
139196255|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196256|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139196257|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139196258|NCT03372304|Ropivacaine|ropivacaine|mesh-list
139196259|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
139196260|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
139196261|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196262|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196263|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
139196264|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196265|NCT02525081|Ramipril|ramipril|mesh-list
139196266|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139196267|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
139196268|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196269|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196270|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139196271|NCT05566548|Bilirubin|bilirubin|mesh-list
139196272|NCT05566548|Antioxidants|antioxidants|mesh-ancestor
139196273|NCT05566548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196274|NCT05566548|Protective Agents|protective agents|mesh-ancestor
139196275|NCT05566548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196276|NCT02525003|Vitamin D|vitamin d|mesh-list
139196277|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
139196278|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
139196279|NCT02525003|Vitamins|vitamins|mesh-list
139196280|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
139196281|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196282|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139196283|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139196284|NCT03464448|Teriflunomide|teriflunomide|mesh-list
139196285|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139196286|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139196287|NCT03464448|Analgesics|analgesics|mesh-ancestor
139196288|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
139196289|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196290|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196291|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139196292|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196293|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139196294|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
139196295|NCT03362008|Varenicline|varenicline|mesh-list
139196296|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139196297|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139196298|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
139196299|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196300|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196301|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196302|NCT03123406|Cinacalcet|cinacalcet|mesh-list
139196303|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139196304|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196305|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139196306|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
139196307|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139196308|NCT01179659|Pantoprazole|pantoprazole|mesh-list
139196309|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139196310|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139196311|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139196312|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196313|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196314|NCT03361774|Fluorides|fluorides|mesh-list
139196315|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
139196316|NCT03361774|Protective Agents|protective agents|mesh-ancestor
139196317|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196318|NCT04523740|Acetaminophen|acetaminophen|mesh-list
139196319|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139196320|NCT04523740|Analgesics|analgesics|mesh-ancestor
139196321|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
139196322|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196323|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196324|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
139196325|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
139196326|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139196327|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
139196328|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139196329|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
139196330|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196331|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196332|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
139196333|NCT04523662|Apatinib|apatinib|mesh-list
139196334|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196335|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139196336|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196337|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196338|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
139196339|NCT03371992|Nivolumab|nivolumab|mesh-list
139196340|NCT03371992|Atezolizumab|atezolizumab|mesh-list
139196341|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139196342|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196343|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139196344|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196345|NCT03682705|Upadacitinib|upadacitinib|mesh-list
139196346|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139196347|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139196348|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196349|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196350|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196351|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
139196352|NCT03361618|Astringents|astringents|mesh-ancestor
139196353|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196354|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
139196355|NCT01314495|Abatacept|abatacept|mesh-list
139196357|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196358|NCT01314495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139196359|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196360|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139196361|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
139196362|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196363|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196364|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139196365|NCT03123484|Gefitinib|gefitinib|mesh-list
139196366|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196367|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139196368|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196369|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196370|NCT03179787|Aripiprazole|aripiprazole|mesh-list
139196371|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
139196372|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139196373|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139196374|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139196375|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196376|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196377|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
139196378|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
139196379|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196380|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196381|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139196382|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139196383|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
139196384|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139196385|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139196386|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139196387|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139196388|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
139196389|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
139196390|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
139196391|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196392|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
139196393|NCT02956057|Protective Agents|protective agents|mesh-ancestor
139196394|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196395|NCT02956057|Vitamins|vitamins|mesh-ancestor
139196396|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
139196397|NCT02956057|Cathartics|cathartics|mesh-ancestor
139196398|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139196399|NCT04526470|Paclitaxel|paclitaxel|mesh-list
139196400|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139196401|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196402|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
139196403|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
139196404|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
139196405|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196407|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139196408|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196409|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
139196410|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139196411|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139196412|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139196413|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
139196414|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196415|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196416|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196417|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
139196418|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139196419|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139196420|NCT01179971|Analgesics|analgesics|mesh-ancestor
139196421|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
139196422|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196423|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196424|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139196425|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196426|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139196427|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
139196428|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196429|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139196430|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
139196431|NCT04237584|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139196432|NCT04237584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196433|NCT03681691|Estradiol|estradiol|mesh-list
139196434|NCT03681691|Estrogens|estrogens|mesh-ancestor
139196435|NCT03681691|Hormones|hormones|mesh-ancestor
139196436|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139196437|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196438|NCT03360760|Doxorubicin|doxorubicin|mesh-list
139196439|NCT03360760|Methotrexate|methotrexate|mesh-list
139196440|NCT03360760|Ifosfamide|ifosfamide|mesh-list
139196441|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
139196442|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196443|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139196444|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139196445|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139196446|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196447|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196448|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139196449|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
139196450|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139196451|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196452|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139196453|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
139196454|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
139196455|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139196456|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139196457|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
139196458|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196459|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139196460|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139196461|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
139196462|NCT01285661|Vitamin K|vitamin k|mesh-list
139196463|NCT01285661|Warfarin|warfarin|mesh-list
139196464|NCT01285661|Anticoagulants|anticoagulants|mesh-list
139196465|NCT01285661|Vitamins|vitamins|mesh-ancestor
139196466|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
139196467|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196468|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139196469|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139196470|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196471|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
139196472|NCT01285661|Coagulants|coagulants|mesh-ancestor
139196473|NCT03360682|Tenofovir|tenofovir|mesh-list
139196474|NCT03360682|Lamivudine|lamivudine|mesh-list
139196475|NCT03360682|Emtricitabine|emtricitabine|mesh-list
139196476|NCT03360682|Dolutegravir|dolutegravir|mesh-list
139196477|NCT03360682|Abacavir|abacavir|mesh-list
139196478|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
139196479|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196480|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139196481|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139196482|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196483|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196484|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139196485|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139196486|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139196487|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139196488|NCT01180205|Amlodipine|amlodipine|mesh-list
139196489|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139196490|NCT01180205|Telmisartan|telmisartan|mesh-list
139196491|NCT01180205|Olmesartan|olmesartan|mesh-list
139196492|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139196493|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139196494|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139196495|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139196496|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196497|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139196498|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196499|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
139196500|NCT01180205|Diuretics|diuretics|mesh-ancestor
139196501|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
139196502|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139196503|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139196504|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139196505|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
139196506|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139196507|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139196508|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196509|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
139196510|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196511|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196512|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
139196513|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139196514|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196515|NCT03867084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139196516|NCT03867084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196517|NCT03860831|Midazolam|midazolam|mesh-list
139196518|NCT03860831|Ketamine|ketamine|mesh-list
139196519|NCT03860831|Analgesics|analgesics|mesh-ancestor
139196520|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
139196521|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973218|NCT00905814|Axitinib|axitinib|mesh-list
139196522|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196523|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139196524|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139196525|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
139196526|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
139196527|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196528|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139196529|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139196530|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196531|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196532|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139196533|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139196534|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139196535|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139196536|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139196537|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
139196538|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
139196539|NCT03667326|Aspirin|aspirin|mesh-list
139196540|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139196541|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139196542|NCT03667326|Analgesics|analgesics|mesh-ancestor
139196543|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
139196544|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196545|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196546|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139196547|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196548|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139196549|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139196550|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196551|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139196552|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139196553|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196554|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
139196555|NCT04525300|Liraglutide|liraglutide|mesh-list
139196556|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139196557|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196558|NCT04525300|Incretins|incretins|mesh-ancestor
139196559|NCT04525300|Hormones|hormones|mesh-ancestor
139196560|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139196561|NCT03865121|Nicotine|nicotine|mesh-list
139196562|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139196563|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
139196564|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196565|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973246|NCT00906048|Rifampin|rifampin|mesh-list
139196566|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139196567|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139196568|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
139196569|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196570|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196571|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
139196572|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139196573|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
139196574|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196575|NCT03680911|Expectorants|expectorants|mesh-ancestor
139196576|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
139196577|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139196578|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
139196579|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196580|NCT03680911|Protective Agents|protective agents|mesh-ancestor
139196581|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196582|NCT03680911|Antidotes|antidotes|mesh-ancestor
139196583|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
139196584|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139196585|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196586|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196587|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139196588|NCT03370588|Analgesics|analgesics|mesh-ancestor
139196589|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
139196590|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196591|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139196592|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139196593|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139196594|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
139196595|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196596|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196597|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
139196598|NCT05156814|Progestins|progestins|mesh-ancestor
139196599|NCT05156814|Hormones|hormones|mesh-ancestor
139196600|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139196601|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196602|NCT01289483|Fospropofol|fospropofol|mesh-list
139196603|NCT01289483|Propofol|propofol|mesh-list
139196604|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139196605|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196606|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196607|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139196608|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
139196609|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
139196610|NCT01289327|Midazolam|midazolam|mesh-list
139196612|NCT01289327|Propofol|propofol|mesh-list
139196613|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139196614|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196615|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196616|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139196617|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
139196619|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139196620|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139196621|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139196622|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139196623|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
139196624|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
139196625|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196626|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196627|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139196628|NCT01289327|Narcotics|narcotics|mesh-ancestor
138947086|NCT01049815|Sevelamer|sevelamer|mesh-list
139196630|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
139196631|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196632|NCT01181063|Budesonide|budesonide|mesh-list
139196633|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
139196634|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139196635|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139196636|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
139196637|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196638|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196639|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139196640|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
139196641|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
139196642|NCT01181063|Hormones|hormones|mesh-ancestor
139196643|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138907576|NCT00460603|Axitinib|axitinib|mesh-list
139196644|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139196645|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139196646|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139196647|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
139196648|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196649|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196650|NCT02596997|Brincidofovir|brincidofovir|mesh-list
139196651|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
139196652|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196653|NCT03649477|Carbetocin|carbetocin|mesh-list
139196654|NCT03649477|Oxytocin|oxytocin|mesh-list
139196655|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
139196656|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139196657|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196658|NCT03359746|Grazoprevir|grazoprevir|mesh-list
139196659|NCT03359746|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139196660|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
139196661|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196662|NCT01310101|Dexamethasone|dexamethasone|mesh-list
139196663|NCT01310101|Ofatumumab|ofatumumab|mesh-list
139196664|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139196665|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
139196666|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
139196667|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196668|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196669|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139196670|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
139196671|NCT01310101|Hormones|hormones|mesh-ancestor
139196672|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139196673|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139196674|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196675|NCT03639727|Mannitol|mannitol|mesh-list
139196676|NCT03639727|Citric Acid|citric acid|mesh-list
139196677|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
139196678|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139196679|NCT03639727|Diuretics|diuretics|mesh-ancestor
139196680|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
139196681|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196682|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
139196683|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139196684|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
139196685|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
139196686|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196687|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139196688|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139196689|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196690|NCT04523272|Sunitinib|sunitinib|mesh-list
139196691|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196692|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139196693|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139196694|NCT04523272|Growth Substances|growth substances|mesh-ancestor
139196695|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196696|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
139196697|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139196698|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196699|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196700|NCT01289561|Ethanol|ethanol|mesh-list
139196701|NCT01289561|Quinine|quinine|mesh-list
139196702|NCT01289561|Caffeine|caffeine|mesh-list
139196703|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139196704|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947164|NCT00852579|Azithromycin|azithromycin|mesh-list
139196705|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196706|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196707|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139196708|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139196709|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196710|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196711|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139196712|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139196713|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
139196714|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196715|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
139196716|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139196717|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139196718|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139196719|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139196720|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196721|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139196722|NCT01289561|Analgesics|analgesics|mesh-ancestor
139196723|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
139196724|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
139196725|NCT03855527|Fluorides|fluorides|mesh-list
139196726|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
139196727|NCT03855527|Protective Agents|protective agents|mesh-ancestor
139196728|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196729|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139196730|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196731|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
139196732|NCT03366064|Pemetrexed|pemetrexed|mesh-list
139196733|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196734|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196735|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196736|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139196737|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139196738|NCT03677401|Serlopitant|serlopitant|mesh-list
139196739|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139196740|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196741|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196742|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196743|NCT03357874|Clopidogrel|clopidogrel|mesh-list
139196744|NCT03357874|Ticagrelor|ticagrelor|mesh-list
139196745|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139196746|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139196747|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139196748|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139196749|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
139196750|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196751|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196752|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196753|NCT01286051|Ganirelix|ganirelix|mesh-list
139196754|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
138787624|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196755|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139196756|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196757|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139196758|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139196759|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139196760|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139196761|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196762|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196763|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196764|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
139196765|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139196766|NCT02359513|Fluoxetine|fluoxetine|mesh-list
139196767|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
139196768|NCT02359513|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139196769|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139196770|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139196771|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196772|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196773|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
139196774|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196775|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139196776|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139196777|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139196778|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139196779|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196780|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
139196781|NCT01184495|Hematinics|hematinics|mesh-ancestor
139196782|NCT03864575|Celecoxib|celecoxib|mesh-list
139196783|NCT03864575|Nivolumab|nivolumab|mesh-list
139196784|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139196785|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196786|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139196787|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196788|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139196789|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139196790|NCT03864575|Analgesics|analgesics|mesh-ancestor
139196791|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
139196792|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196793|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196794|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139196795|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196796|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139196797|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139196798|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196799|NCT03357718|Midazolam|midazolam|mesh-list
139196800|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
139196801|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139196802|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196803|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196804|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139196805|NCT03357718|Analgesics|analgesics|mesh-ancestor
139196806|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
139196807|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196808|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139196809|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139196810|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139196811|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
139196812|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196813|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196814|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139196815|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139196816|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139196817|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139196818|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139196819|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
139196820|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
139196821|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
139196822|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
139196823|NCT04521400|Interferons|interferons|mesh-list
139196824|NCT04521400|Ritonavir|ritonavir|mesh-list
139196825|NCT04521400|Lopinavir|lopinavir|mesh-list
139196826|NCT04521400|Interferon-beta|interferon-beta|mesh-list
139196827|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
139196828|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196829|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
139196830|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196831|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139196832|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139196833|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
139196834|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196835|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196836|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139196837|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139196838|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139196839|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139196840|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
138973342|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
139196841|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196842|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139196843|NCT03864185|Rituximab|rituximab|mesh-list
139196844|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139196845|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196846|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
139196847|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196848|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139196849|NCT01185119|Glucagon|glucagon|mesh-list
139196850|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139196851|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139196852|NCT01185119|Hormones|hormones|mesh-ancestor
139196853|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139196854|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196855|NCT01185119|Incretins|incretins|mesh-ancestor
139196856|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
139196857|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
139196858|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139196859|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139196860|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196861|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139196862|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
139196863|NCT01185197|Prednisolone|prednisolone|mesh-list
139196864|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139196865|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139196866|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139196867|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
139196868|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139196869|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139196870|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139196871|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196872|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139196873|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
139196874|NCT01185197|Hormones|hormones|mesh-ancestor
138907652|NCT01022983|Simendan|simendan|mesh-list
139196875|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139196876|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196877|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139196878|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139196879|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
139196880|NCT03733873|Coagulants|coagulants|mesh-ancestor
139196881|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139196882|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
139196883|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196884|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139196885|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
139196886|NCT03733639|Coagulants|coagulants|mesh-ancestor
139196888|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
139196889|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
139196890|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139196891|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139196892|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139196893|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
139196894|NCT03358888|Narcotics|narcotics|mesh-ancestor
139196895|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138787629|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139002739|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139002740|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
139002741|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139002742|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139002743|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139002744|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139002745|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139002746|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
139002782|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139002783|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139002784|NCT00776633|Analgesics|analgesics|mesh-ancestor
139002785|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
139003180|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139003181|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139003182|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
139003183|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003184|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003185|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139003186|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
139003187|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
139003188|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139003189|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139003190|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139003191|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139003192|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
139003193|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003297|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139003298|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
139003299|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004276|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139004277|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004278|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004279|NCT02530879|Esomeprazole|esomeprazole|mesh-list
139004280|NCT02530879|Omeprazole|omeprazole|mesh-list
139004281|NCT02530879|Lansoprazole|lansoprazole|mesh-list
139004282|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
139004283|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139004284|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138508641|NCT05669417|Analgesics|analgesics|mesh-ancestor
139004329|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004330|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139004331|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139004332|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139004333|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139004334|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
139004335|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
139004336|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
139004337|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
139004338|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004339|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004341|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139004342|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139004343|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
139004344|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004345|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004346|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004347|NCT00072475|Vatalanib|vatalanib|mesh-list
139004348|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139004349|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004350|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004351|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
139004352|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139004353|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139004354|NCT00066469|Prednisone|prednisone|mesh-list
139004355|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
139004356|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139004357|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139004358|NCT00066469|Prednisolone|prednisolone|mesh-list
139004359|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
139004360|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
139004361|NCT00066469|Rituximab|rituximab|mesh-list
139004362|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139004363|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
139004364|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139004365|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
139004647|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139004648|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139004649|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
139004650|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139004651|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004652|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139004653|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139004654|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004655|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004656|NCT00791531|Methotrexate|methotrexate|mesh-list
139004657|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139004658|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
139004659|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139004660|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004661|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139004662|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
139004663|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004664|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004665|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
139004666|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004667|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139005149|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005150|NCT00803699|Trace Elements|trace elements|mesh-ancestor
139005151|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
139005152|NCT00798785|Rituximab|rituximab|mesh-list
139005153|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139005731|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139005732|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139005733|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
139005734|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005736|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139005737|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139005738|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139005739|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005740|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005741|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139005742|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
139005743|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005744|NCT00817739|Leuprolide|leuprolide|mesh-list
139005745|NCT00817739|Flutamide|flutamide|mesh-list
139005746|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139005747|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
139006131|NCT00022633|Gemcitabine|gemcitabine|mesh-list
139006132|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139006133|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006134|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
139006135|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
138514646|NCT03079427|Cisplatin|cisplatin|mesh-list
139006165|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139006166|NCT01020279|Analgesics|analgesics|mesh-ancestor
139006167|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
139006168|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006169|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006170|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139006171|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139006172|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139006173|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139006174|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006175|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006176|NCT01020357|Caffeine|caffeine|mesh-list
139006177|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
139006178|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006179|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139006180|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006181|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139006216|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
139006217|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139006218|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
139006219|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
139006220|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139006221|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139006244|NCT00480441|Hormones|hormones|mesh-ancestor
139006245|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139006246|NCT01022463|Atenolol|atenolol|mesh-list
139006247|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139006248|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139006249|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
139006250|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
139006251|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006252|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006253|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139006254|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139006255|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139006256|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
139006257|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006258|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006259|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139006260|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139006261|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139006262|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139006263|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006264|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138757026|NCT01061151|Ritonavir|ritonavir|mesh-list
139006266|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139006267|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
139006268|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006269|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006270|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139006271|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139006272|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
139006273|NCT01018251|Alovudine|alovudine|mesh-list
139006634|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139006635|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006636|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
139006637|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139006638|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
139006639|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006640|NCT00364156|Nicotine|nicotine|mesh-list
139006641|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139006862|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139006863|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006865|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006866|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139006973|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139007008|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139007009|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139007010|NCT00457743|Growth Substances|growth substances|mesh-ancestor
139007011|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007012|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
139007013|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139007014|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516551|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
139007248|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139007249|NCT00449787|Analgesics|analgesics|mesh-ancestor
139007250|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
138517218|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007286|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
139007287|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139007288|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139007289|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517267|NCT00017576|Carboplatin|carboplatin|mesh-list
139007389|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139007390|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139007391|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007392|NCT00446199|Drospirenone|drospirenone|mesh-list
139007393|NCT00446199|Estradiol|estradiol|mesh-list
139007394|NCT00446199|Estrogens|estrogens|mesh-ancestor
139007395|NCT00446199|Hormones|hormones|mesh-ancestor
139007396|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139007397|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758143|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
139007398|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139007399|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
139007400|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139007401|NCT00446199|Diuretics|diuretics|mesh-ancestor
139007402|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
139007403|NCT01027689|Alprazolam|alprazolam|mesh-list
139007404|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139007405|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138517439|NCT04734353|Ticagrelor|ticagrelor|mesh-list
139007541|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
139007542|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007543|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139007544|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139007545|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139007546|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139007547|NCT00381706|Leucovorin|leucovorin|mesh-list
139007548|NCT00381706|Cisplatin|cisplatin|mesh-list
139007549|NCT00381706|Fluorouracil|fluorouracil|mesh-list
138758287|NCT02797717|Prednisone|prednisone|mesh-list
139007551|NCT00381706|Irinotecan|irinotecan|mesh-list
139007552|NCT00381706|Cetuximab|cetuximab|mesh-list
139007553|NCT00381706|Epirubicin|epirubicin|mesh-list
139007554|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007555|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
139007556|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007557|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139008194|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008195|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139008196|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
139008197|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
139008198|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
139008199|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139008200|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139008201|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139008202|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008622|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008624|NCT00361504|Tapentadol|tapentadol|mesh-list
139008625|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139008626|NCT00361504|Narcotics|narcotics|mesh-ancestor
139008627|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139008782|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
139008783|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139008784|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008785|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139008786|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139008787|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139008788|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139008789|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008790|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139008791|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139008792|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139008793|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
139008794|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008795|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008796|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139008797|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139009040|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139009042|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139009043|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009044|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139009045|NCT02549651|Durvalumab|durvalumab|mesh-list
139009046|NCT02549651|Tremelimumab|tremelimumab|mesh-list
139009047|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009048|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009050|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139009051|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
139009052|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009053|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
139009054|NCT03999372|Protective Agents|protective agents|mesh-ancestor
139009055|NCT05733468|Calcium, Dietary|calcium, dietary|mesh-list
139009056|NCT05733468|Calcium|calcium|mesh-list
139009109|NCT05427630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139009110|NCT05427630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139009112|NCT05427630|Sensory System Agents|sensory system agents|mesh-ancestor
139009113|NCT05427630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139009114|NCT05427630|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139009115|NCT05427630|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139009116|NCT05427630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009117|NCT05427630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009118|NCT05427630|Hormones|hormones|mesh-ancestor
139009119|NCT05427630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139009120|NCT01050556|Folic Acid|folic acid|mesh-list
139009121|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
139009122|NCT01050556|Hematinics|hematinics|mesh-ancestor
139009123|NCT01050556|Vitamins|vitamins|mesh-ancestor
139009124|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
139009125|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009126|NCT05889871|Apatinib|apatinib|mesh-list
139009127|NCT05889871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009128|NCT05889871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139009129|NCT05889871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009130|NCT05889871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009131|NCT05889455|Sildenafil Citrate|sildenafil citrate|mesh-list
139009132|NCT05889455|Vasodilator Agents|vasodilator agents|mesh-ancestor
139009133|NCT05889455|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139009134|NCT05889455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139009135|NCT05889455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009136|NCT05889455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009137|NCT05889455|Urological Agents|urological agents|mesh-ancestor
139009138|NCT05889442|Cromakalim|cromakalim|mesh-list
139009139|NCT05889442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139009140|NCT05889442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138522355|NCT05568940|Tibolone|tibolone|mesh-list
139009161|NCT05889390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139009162|NCT05889390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139009163|NCT05889390|Alkylating Agents|alkylating agents|mesh-ancestor
139009164|NCT05889390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139009165|NCT05889390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139009166|NCT05889390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139009167|NCT05889390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139009168|NCT05889390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009169|NCT05889338|Adalimumab|adalimumab|mesh-list
139009170|NCT05889338|Methotrexate|methotrexate|mesh-list
139009171|NCT05889338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139009172|NCT05889338|Abortifacient Agents|abortifacient agents|mesh-ancestor
139009173|NCT05889338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139009174|NCT05889338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009175|NCT05889338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139009176|NCT05889338|Antimetabolites|antimetabolites|mesh-ancestor
139009177|NCT05889338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009178|NCT05889338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009179|NCT05889338|Dermatologic Agents|dermatologic agents|mesh-ancestor
139009180|NCT05889338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009181|NCT05889338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139009182|NCT05889338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139009183|NCT05889338|Immunologic Factors|immunologic factors|mesh-ancestor
139009184|NCT05889338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907785|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139009185|NCT05889338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139009186|NCT05889338|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139009187|NCT05889338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139009188|NCT05889143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139009189|NCT05889143|Ezetimibe|ezetimibe|mesh-list
139009190|NCT05889143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139009191|NCT05889143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139009192|NCT05889143|Antimetabolites|antimetabolites|mesh-ancestor
139009193|NCT05889143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009194|NCT05889143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139009195|NCT05889143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139009232|NCT05887908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139009233|NCT05887908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009234|NCT05887908|Protease Inhibitors|protease inhibitors|mesh-ancestor
139009293|NCT05597085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139009295|NCT05597085|Immunoconjugates|immunoconjugates|mesh-ancestor
139009296|NCT05597085|Immunologic Factors|immunologic factors|mesh-ancestor
139009297|NCT05597085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009298|NCT05577481|Antidepressive Agents|antidepressive agents|mesh-list
139009299|NCT05577481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139009300|NCT05465135|Artenimol|artenimol|mesh-list
139009393|NCT04685421|Bupivacaine|bupivacaine|mesh-list
139009394|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
139009395|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
139009396|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139009397|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009398|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
139009399|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139009400|NCT04680975|Belumosudil|belumosudil|mesh-list
139009401|NCT04680975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139009402|NCT04680975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009403|NCT04680975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009404|NCT04673786|Ustekinumab|ustekinumab|mesh-list
139009405|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
139009406|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139009408|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009409|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009410|NCT04597671|Durvalumab|durvalumab|mesh-list
139009411|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009412|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009413|NCT04583969|Remdesivir|remdesivir|mesh-list
139009414|NCT04583969|Lenzilumab|lenzilumab|mesh-list
139009415|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
139009416|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009417|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
139009418|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009419|NCT04583969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139009420|NCT04575857|Atorvastatin|atorvastatin|mesh-list
139009421|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139009422|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139009993|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139009994|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139009995|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139009996|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139009997|NCT02255357|Oxytocin|oxytocin|mesh-list
139009998|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
139009999|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139010000|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010001|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139010002|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139010061|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139010062|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139010063|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
139010064|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139010065|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010066|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139010105|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139010106|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139010107|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139010109|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010110|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010111|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010112|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139010113|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010114|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139010115|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
139010116|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
139010117|NCT00823433|Penicillins|penicillins|mesh-list
139010118|NCT00823433|Penicillin V|penicillin v|mesh-list
139010119|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139010120|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010121|NCT00423657|Vancomycin|vancomycin|mesh-list
139010122|NCT00423657|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139010123|NCT00423657|Aztreonam|aztreonam|mesh-list
139010124|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139010125|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010126|NCT00831155|Nicotine|nicotine|mesh-list
139010127|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139010128|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
139010129|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010130|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010131|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139010132|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139010133|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
139010134|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010135|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010136|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
139010137|NCT00827021|Hematinics|hematinics|mesh-list
139010138|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
139010139|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
139010140|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010261|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
139010395|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
139010397|NCT00832481|Metformin|metformin|mesh-list
139010398|NCT00832481|Repaglinide|repaglinide|mesh-list
139010399|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139010400|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010401|NCT04044287|Misoprostol|misoprostol|mesh-list
139010402|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139010403|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
139010404|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139010405|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010406|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139010452|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
139010453|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139010454|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
139010455|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010456|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139010457|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139010458|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
139010459|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010460|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010461|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139010462|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139010463|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139010464|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139010465|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010466|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139010467|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
139010468|NCT00825149|Hormones|hormones|mesh-ancestor
139010469|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139010470|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138524603|NCT00020657|Ondansetron|ondansetron|mesh-list
139010497|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010498|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138907876|NCT02621255|Bupivacaine|bupivacaine|mesh-list
139010499|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139010500|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139010501|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139010502|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010503|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139010504|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
139010505|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139010506|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
139010507|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010508|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010509|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139010510|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
139010511|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
139010512|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139010513|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
139010514|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010515|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010517|NCT02549963|Anticoagulants|anticoagulants|mesh-list
139010581|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139010582|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
139010583|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
139010584|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010585|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010586|NCT01051102|Insulin|insulin|mesh-list
139010587|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139010588|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
139010589|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
139010590|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139010591|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
139010592|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139010593|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139010594|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010595|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139010596|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
139010694|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139010695|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010696|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
139010697|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
139010698|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010699|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010700|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139010701|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139010702|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
139010703|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139010704|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139010705|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139010706|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139010707|NCT01055938|Valproic Acid|valproic acid|mesh-list
139010708|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
139010709|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010710|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010711|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
139010712|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010713|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010714|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
139010715|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139010716|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139010751|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010752|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973571|NCT00820352|Bosentan|bosentan|mesh-list
139010754|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139010755|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139010756|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010757|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139010875|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139010877|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139010878|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
139010879|NCT05416476|Anisodine|anisodine|mesh-list
139010880|NCT05416476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139010881|NCT05416476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139010882|NCT05416476|Analgesics|analgesics|mesh-ancestor
139010883|NCT05416476|Sensory System Agents|sensory system agents|mesh-ancestor
139010921|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011019|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
139011020|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011021|NCT00529542|Atorvastatin|atorvastatin|mesh-list
139011022|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139011023|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139011024|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
139011057|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
139011058|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011059|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139011060|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011061|NCT00830531|Bumetanide|bumetanide|mesh-list
139011062|NCT00830531|Diuretics|diuretics|mesh-ancestor
139011063|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
139011064|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011065|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138525029|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
139011097|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139011098|NCT02546531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139011099|NCT05205720|Ropivacaine|ropivacaine|mesh-list
139011100|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
139011101|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
139011102|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139011103|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011104|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
139011105|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011106|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
139011107|NCT00841061|Trace Elements|trace elements|mesh-ancestor
139011108|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
139011109|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011110|NCT04042805|Lenvatinib|lenvatinib|mesh-list
139011111|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011375|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011376|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011377|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139011378|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139011379|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139011380|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011381|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011382|NCT00527904|Naproxen|naproxen|mesh-list
139011383|NCT00527904|Esomeprazole|esomeprazole|mesh-list
139011384|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139011385|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139011386|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139011387|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011388|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011389|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139011390|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139011391|NCT00527904|Analgesics|analgesics|mesh-ancestor
139011392|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
139011393|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011896|NCT00526110|Docetaxel|docetaxel|mesh-list
139011897|NCT00526110|Fluorouracil|fluorouracil|mesh-list
139011898|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
139011899|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011900|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
139011901|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
139011902|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
139011903|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762583|NCT04300881|Eplerenone|eplerenone|mesh-list
139011904|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
139011905|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139011906|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139011907|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
139011908|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011909|NCT00859079|Insulin|insulin|mesh-list
139011910|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139011911|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139011912|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139011913|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011914|NCT00859079|Incretins|incretins|mesh-ancestor
139011915|NCT00859079|Hormones|hormones|mesh-ancestor
139011916|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139011917|NCT02544425|Dexamethasone|dexamethasone|mesh-list
139011918|NCT02544425|Etoposide|etoposide|mesh-list
139011919|NCT02544425|Melphalan|melphalan|mesh-list
139011920|NCT02544425|Busulfan|busulfan|mesh-list
139011921|NCT02544425|Asparaginase|asparaginase|mesh-list
139011939|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139011940|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
139011941|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139011942|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139011943|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
139011944|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
139011945|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139011946|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139011947|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011948|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
139011949|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
139011950|NCT04523688|Temozolomide|temozolomide|mesh-list
139011951|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139011952|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
139011953|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011954|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011955|NCT00511836|Naltrexone|naltrexone|mesh-list
139011956|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139011957|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139011958|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011959|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
139011960|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011961|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
139011962|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139011963|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139011964|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011965|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139011966|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011967|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139011968|NCT03998436|Esmolol|esmolol|mesh-list
139011969|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139011970|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139011971|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139011972|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
139011973|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139011974|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011975|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011976|NCT00855101|Voriconazole|voriconazole|mesh-list
138973603|NCT00227539|Pemetrexed|pemetrexed|mesh-list
138526937|NCT00028691|Chlorambucil|chlorambucil|mesh-list
139012183|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012184|NCT00860639|Immunotoxins|immunotoxins|mesh-ancestor
139012185|NCT00860639|Immunoconjugates|immunoconjugates|mesh-ancestor
139012186|NCT00860639|Immunologic Factors|immunologic factors|mesh-ancestor
139012187|NCT00860639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012188|NCT00863291|Buprenorphine|buprenorphine|mesh-list
139012189|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139012190|NCT00863291|Narcotics|narcotics|mesh-ancestor
139012191|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012192|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012223|NCT00861107|Vaccines|vaccines|mesh-list
139012224|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
139012225|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012226|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
139012227|NCT00510510|Bromides|bromides|mesh-list
139012228|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
139012229|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139012230|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139012231|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139012232|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
139012233|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012234|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012235|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012236|NCT04685694|Misoprostol|misoprostol|mesh-list
138527278|NCT00030368|Paclitaxel|paclitaxel|mesh-list
139012272|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012273|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139012275|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139012360|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139012361|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139012362|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139012363|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012364|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012365|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
139012366|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139012367|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139012368|NCT00617591|Growth Substances|growth substances|mesh-ancestor
139012369|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
139012370|NCT00864305|Gabapentin|gabapentin|mesh-list
139012467|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012797|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012798|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012799|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139012800|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139012801|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139012802|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139012803|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
139012804|NCT00617123|Vorapaxar|vorapaxar|mesh-list
139012805|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139012806|NCT00877955|Alprazolam|alprazolam|mesh-list
139012807|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138528111|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
139012836|NCT00434109|Sunitinib|sunitinib|mesh-list
139012837|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012838|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139012839|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139012840|NCT00434109|Growth Substances|growth substances|mesh-ancestor
139012841|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012842|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
139012843|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139012844|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012845|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012846|NCT00875069|Ethanol|ethanol|mesh-list
139012847|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139012848|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012849|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012850|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012851|NCT01029639|Insulin|insulin|mesh-list
139012852|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139012907|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
139012908|NCT03726671|Choline|choline|mesh-list
139012909|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
139012939|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012940|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
138763634|NCT01006707|Ondansetron|ondansetron|mesh-list
139012941|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139012942|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
139012943|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012944|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139012945|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139012946|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012948|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012949|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139012950|NCT00875927|Zinc|zinc|mesh-list
139012951|NCT00875927|Propolis|propolis|mesh-list
139012952|NCT00875927|Trace Elements|trace elements|mesh-ancestor
139012953|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
139012954|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012955|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012956|NCT00878657|Gemcitabine|gemcitabine|mesh-list
139013083|NCT01005758|Doxorubicin|doxorubicin|mesh-list
139013084|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139013085|NCT01005758|Methotrexate|methotrexate|mesh-list
139013086|NCT01005758|Etoposide|etoposide|mesh-list
139013087|NCT01005758|Vincristine|vincristine|mesh-list
139013088|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
139013089|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
139013090|NCT01005758|Pegaspargase|pegaspargase|mesh-list
139013091|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
139013092|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139013093|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
139013094|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013096|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139013097|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
139013098|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013135|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013172|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013174|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139013175|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139013176|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
139013350|NCT05881187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039573|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013413|NCT05880186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013414|NCT05880186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013415|NCT05880186|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139013416|NCT05880186|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139013417|NCT05880186|Purinergic Agents|purinergic agents|mesh-ancestor
139013418|NCT05880186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139013419|NCT05880082|Cisplatin|cisplatin|mesh-list
139013420|NCT05880082|Carboplatin|carboplatin|mesh-list
139013421|NCT05880082|Tislelizumab|tislelizumab|mesh-list
139013422|NCT05880082|Nedaplatin|nedaplatin|mesh-list
139013423|NCT05880082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013462|NCT05879536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013463|NCT05879536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013597|NCT05846906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013599|NCT05846906|Fertility Agents|fertility agents|mesh-ancestor
139013600|NCT05846906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139013601|NCT05846906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139013602|NCT05846906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139013662|NCT05764395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013663|NCT05764395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139013664|NCT05764395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013665|NCT05727371|Hylan|hylan|mesh-list
139013666|NCT05727371|Viscosupplements|viscosupplements|mesh-ancestor
139013667|NCT05727371|Protective Agents|protective agents|mesh-ancestor
139013668|NCT05727371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013669|NCT05714306|Cyclophosphamide|cyclophosphamide|mesh-list
139013670|NCT05714306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139013671|NCT05714306|Immunologic Factors|immunologic factors|mesh-ancestor
139013672|NCT05714306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013673|NCT05714306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138908079|NCT00790816|Lapatinib|lapatinib|mesh-list
139013674|NCT05714306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139013675|NCT05714306|Alkylating Agents|alkylating agents|mesh-ancestor
139013676|NCT05714306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013677|NCT05714306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013678|NCT05714306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139013679|NCT05706259|Vitamin D|vitamin d|mesh-list
139013680|NCT05706259|Ergocalciferols|ergocalciferols|mesh-list
139013710|NCT05704166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013712|NCT05680558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139013713|NCT05680558|Dermatologic Agents|dermatologic agents|mesh-ancestor
139013714|NCT05667324|Dexamethasone|dexamethasone|mesh-list
139013715|NCT05667324|Ropivacaine|ropivacaine|mesh-list
139013716|NCT05667324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139013717|NCT05667324|Antiemetics|antiemetics|mesh-ancestor
139013718|NCT05667324|Autonomic Agents|autonomic agents|mesh-ancestor
139013719|NCT05667324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013720|NCT05667324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013721|NCT05667324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139013722|NCT05667324|Glucocorticoids|glucocorticoids|mesh-ancestor
139013723|NCT05667324|Hormones|hormones|mesh-ancestor
139039574|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139013761|NCT05644041|Antimetabolites|antimetabolites|mesh-ancestor
139013870|NCT05490134|Naloxone|naloxone|mesh-list
139013871|NCT05490134|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139013872|NCT05490134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013873|NCT05490134|Sensory System Agents|sensory system agents|mesh-ancestor
139013874|NCT05490134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013875|NCT05475613|Immunomodulating Agents|immunomodulating agents|mesh-list
139013876|NCT05475613|Immunologic Factors|immunologic factors|mesh-ancestor
139013877|NCT05475613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013878|NCT05440201|Enoxaparin|enoxaparin|mesh-list
139013879|NCT05440201|Anticoagulants|anticoagulants|mesh-list
139013880|NCT05440201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139013881|NCT05440201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139013882|NCT05440201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013983|NCT06013735|Sodium Fluoride|sodium fluoride|mesh-list
139013984|NCT06013735|Cariostatic Agents|cariostatic agents|mesh-ancestor
139013985|NCT06013735|Protective Agents|protective agents|mesh-ancestor
139013986|NCT06013735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013987|NCT06013735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139013988|NCT06013735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013989|NCT06013540|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138764683|NCT04294953|Analgesics|analgesics|mesh-ancestor
139013990|NCT06013540|Tretinoin|tretinoin|mesh-list
139013991|NCT06013540|Hydroquinone|hydroquinone|mesh-list
139014430|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139014431|NCT03198351|Teriflunomide|teriflunomide|mesh-list
139014432|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139014433|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139014434|NCT03198351|Analgesics|analgesics|mesh-ancestor
139014435|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
139014436|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014437|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014438|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139014439|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139014440|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139014441|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
139014442|NCT03160040|Minocycline|minocycline|mesh-list
139014443|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139014444|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139014445|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
139014446|NCT03107182|Promethazine|promethazine|mesh-list
138908115|NCT02623127|Sunitinib|sunitinib|mesh-list
139014447|NCT03107182|Dexamethasone|dexamethasone|mesh-list
139014448|NCT03107182|Paclitaxel|paclitaxel|mesh-list
139014449|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139014450|NCT03107182|Carboplatin|carboplatin|mesh-list
139014451|NCT03107182|Nivolumab|nivolumab|mesh-list
139014452|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
139014453|NCT03107182|Famotidine|famotidine|mesh-list
139014454|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139014455|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014456|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
139014457|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
139014458|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
139014459|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014460|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139014461|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
139014462|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
139014463|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014464|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014465|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139014466|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
139014467|NCT03107182|Hormones|hormones|mesh-ancestor
139014468|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139014469|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139014470|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014471|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139014472|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
139014473|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014474|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139014475|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139014477|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139014478|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
139014479|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
139014480|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
139014481|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139014482|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
139014483|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
139014484|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014485|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139014486|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
139014487|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
139014488|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139014489|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139014490|NCT02879318|Paclitaxel|paclitaxel|mesh-list
139014491|NCT02879318|Gemcitabine|gemcitabine|mesh-list
139014492|NCT02879318|Durvalumab|durvalumab|mesh-list
139014493|NCT02879318|Tremelimumab|tremelimumab|mesh-list
139014494|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139014495|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014496|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
139014497|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
139014498|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
139014499|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014500|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139014501|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
139014502|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014503|NCT02833701|Vitamins|vitamins|mesh-list
139014504|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
139014505|NCT02833701|Bevacizumab|bevacizumab|mesh-list
139014506|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139014507|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
139014509|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
139014510|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139014511|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
138765203|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014512|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014513|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138908125|NCT05263492|Pembrolizumab|pembrolizumab|mesh-list
139014514|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139014515|NCT02833701|Growth Substances|growth substances|mesh-ancestor
139014516|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014517|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
139014518|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
139014519|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
139014520|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
139014521|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014522|NCT02833701|Protective Agents|protective agents|mesh-ancestor
139014523|NCT02767999|Fluoxetine|fluoxetine|mesh-list
139014524|NCT02767999|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138973698|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
139014525|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139014526|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139014527|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014528|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014529|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
139014530|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014531|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139014532|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
139014533|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139014534|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139014535|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139014536|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014537|NCT02675465|Miglustat|miglustat|mesh-list
139014538|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014539|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014540|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139014541|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139014542|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
139014543|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139014544|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139014545|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139014546|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014547|NCT02670707|Cytarabine|cytarabine|mesh-list
139014548|NCT02670707|Prednisone|prednisone|mesh-list
138530512|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139014550|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139014551|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
139014552|NCT02670707|Hormones|hormones|mesh-ancestor
139014553|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139014554|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014555|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139014556|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014557|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139014558|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
139014559|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014560|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
139014561|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139014562|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139014563|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
139014564|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139014565|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
139014566|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
139014567|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
139014568|NCT02658890|Nivolumab|nivolumab|mesh-list
139014569|NCT02658890|Ipilimumab|ipilimumab|mesh-list
139014570|NCT02658890|Linrodostat|linrodostat|mesh-list
139014571|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014572|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014573|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139014574|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014575|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014576|NCT02597062|Dexamethasone|dexamethasone|mesh-list
139014577|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
139014578|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139014579|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
139014580|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014581|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139014582|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139014583|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
139014584|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014585|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973715|NCT00987441|Dsuvia|dsuvia|mesh-list
139014586|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138530538|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
139014587|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139014588|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
139014589|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
139014590|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014591|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139014592|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
139014594|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139014595|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139014596|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139014597|NCT02458014|Blinatumomab|blinatumomab|mesh-list
139014598|NCT02458014|Antibodies|antibodies|mesh-list
139014599|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
139014600|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139014601|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
139014602|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139014603|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
139014604|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014605|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014606|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139014607|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
139014608|NCT02451982|Nivolumab|nivolumab|mesh-list
139014609|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
139014610|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014611|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139014612|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139014613|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139014614|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
139014615|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014616|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014617|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139014618|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014619|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139014620|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
139014621|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014622|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530574|NCT00206089|Ximelagatran|ximelagatran|mesh-list
139014623|NCT02444741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139014624|NCT02444741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014625|NCT02122185|Metformin|metformin|mesh-list
139014626|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139014627|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014628|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
139014629|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139014630|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139014631|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139014632|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
139014633|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
139014634|NCT01248585|Dexamethasone|dexamethasone|mesh-list
139014635|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139014636|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
139014637|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
139014638|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014639|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014640|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139014641|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
139014642|NCT01248585|Hormones|hormones|mesh-ancestor
139014643|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139014644|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139014645|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014646|NCT00993655|Paclitaxel|paclitaxel|mesh-list
139014647|NCT00993655|Carboplatin|carboplatin|mesh-list
139014648|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139014649|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014650|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
139014651|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
139014652|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
139014653|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014654|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139014655|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
139014656|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139014657|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
139014658|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014659|NCT05316493|Megestrol|megestrol|mesh-list
139014660|NCT05316493|Megestrol Acetate|megestrol acetate|mesh-list
139014661|NCT05316493|Contraceptive Agents|contraceptive agents|mesh-list
139014662|NCT05316493|Levonorgestrel|levonorgestrel|mesh-list
139014663|NCT05316493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139014664|NCT05316493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014665|NCT05316493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138765353|NCT02684305|Oxytocin|oxytocin|mesh-list
139014666|NCT05316493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139014667|NCT05316493|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139014668|NCT05316493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139014669|NCT05316493|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138530610|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139014670|NCT05316493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139014671|NCT05316493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014672|NCT05316493|Appetite Stimulants|appetite stimulants|mesh-ancestor
139014673|NCT05316493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139014674|NCT05316467|Megestrol|megestrol|mesh-list
139014675|NCT05316467|Megestrol Acetate|megestrol acetate|mesh-list
139014676|NCT05316467|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139014677|NCT05316467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139014678|NCT05316467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139014679|NCT05316467|Contraceptive Agents|contraceptive agents|mesh-ancestor
139014680|NCT05316467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139014681|NCT05316467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014682|NCT05316467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139014683|NCT05316467|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139014684|NCT05316467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139014685|NCT05316467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014686|NCT05316467|Appetite Stimulants|appetite stimulants|mesh-ancestor
139014687|NCT05316467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139014688|NCT05304949|Ranibizumab|ranibizumab|mesh-list
139014689|NCT05304949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139014690|NCT05304949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139014691|NCT05304949|Growth Substances|growth substances|mesh-ancestor
139014692|NCT05304949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014693|NCT05304949|Growth Inhibitors|growth inhibitors|mesh-ancestor
139014694|NCT05304949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014695|NCT05294341|Norethindrone|norethindrone|mesh-list
139014696|NCT05294341|Norethindrone Acetate|norethindrone acetate|mesh-list
139014697|NCT05294341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139014698|NCT05294341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139014699|NCT05294341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139014700|NCT05294341|Contraceptive Agents|contraceptive agents|mesh-ancestor
139014701|NCT05294341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139014702|NCT05294341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014703|NCT05294341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139014704|NCT05294341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139014705|NCT05293964|Everolimus|everolimus|mesh-list
139014706|NCT05293964|Palbociclib|palbociclib|mesh-list
139014707|NCT05293964|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139014708|NCT05293964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139014709|NCT05293964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014710|NCT05293964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014711|NCT05293964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139014712|NCT05293964|Immunologic Factors|immunologic factors|mesh-ancestor
139014713|NCT05293964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014714|NCT05293964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014716|NCT05290207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014717|NCT05271240|Bevacizumab|bevacizumab|mesh-list
139014718|NCT05271240|Temozolomide|temozolomide|mesh-list
139014719|NCT05271240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014720|NCT05271240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014721|NCT05271240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139014722|NCT05271240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139014723|NCT05271240|Growth Substances|growth substances|mesh-ancestor
139014724|NCT05271240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014725|NCT05271240|Growth Inhibitors|growth inhibitors|mesh-ancestor
139014726|NCT05271240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139014727|NCT05271240|Alkylating Agents|alkylating agents|mesh-ancestor
139014728|NCT05271240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014729|NCT05264883|Azacitidine|azacitidine|mesh-list
139014730|NCT05264883|Decitabine|decitabine|mesh-list
139014731|NCT05264883|Venetoclax|venetoclax|mesh-list
139014732|NCT05264883|Aclarubicin|aclarubicin|mesh-list
139014733|NCT05264883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139014734|NCT05264883|Antimetabolites|antimetabolites|mesh-ancestor
139014735|NCT05264883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014736|NCT05264883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014737|NCT05264883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014738|NCT05264883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139014739|NCT05264883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139014740|NCT05264883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139014741|NCT05263453|Vemurafenib|vemurafenib|mesh-list
139014742|NCT05263453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014743|NCT05263453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139014744|NCT05263453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014745|NCT05263453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014746|NCT05257629|Nicotine|nicotine|mesh-list
139014747|NCT05257629|Varenicline|varenicline|mesh-list
139014748|NCT05257629|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139014749|NCT05257629|Autonomic Agents|autonomic agents|mesh-ancestor
139014750|NCT05257629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014751|NCT05257629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014752|NCT05257629|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139014753|NCT05257629|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139014754|NCT05257629|Cholinergic Agents|cholinergic agents|mesh-ancestor
139014755|NCT05257629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014756|NCT05257629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014757|NCT05245669|Denosumab|denosumab|mesh-list
139014758|NCT05245669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139014759|NCT05245669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014760|NCT05233332|Vemurafenib|vemurafenib|mesh-list
139014761|NCT05233332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014762|NCT05233332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139014763|NCT05233332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014764|NCT05233332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014765|NCT05232084|Fentanyl|fentanyl|mesh-list
139014766|NCT05232084|Bupivacaine|bupivacaine|mesh-list
139014767|NCT05232084|Anesthetics, Local|anesthetics, local|mesh-ancestor
139014768|NCT05232084|Anesthetics|anesthetics|mesh-ancestor
139014769|NCT05232084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139014770|NCT05232084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014771|NCT05232084|Sensory System Agents|sensory system agents|mesh-ancestor
139014772|NCT05232084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014773|NCT05232084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139014774|NCT05232084|Narcotics|narcotics|mesh-ancestor
139014775|NCT05232084|Analgesics|analgesics|mesh-ancestor
139014776|NCT05232084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139014777|NCT05232084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139014778|NCT05232084|Anesthetics, General|anesthetics, general|mesh-ancestor
139014779|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
139014780|NCT05195619|Vaccines|vaccines|mesh-list
139014781|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
139014782|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014783|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139014784|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139014785|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139014786|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
139014787|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014788|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014789|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139014790|NCT05158517|Vedolizumab|vedolizumab|mesh-list
139014791|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139014793|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139014794|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014795|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139014796|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014797|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139014798|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139014799|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139014800|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014801|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014802|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139014803|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139014804|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014805|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
139014806|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014807|NCT05132231|Brodalumab|brodalumab|mesh-list
139014808|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
139014809|NCT05099107|Albuterol|albuterol|mesh-list
139014810|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139014811|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
139014812|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014813|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765507|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
139014814|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139014815|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
139014816|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
139014817|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139014818|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139014819|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139014820|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139014821|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
139014822|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014823|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014824|NCT04998786|Dexamethasone|dexamethasone|mesh-list
139014825|NCT04998786|Ixazomib|ixazomib|mesh-list
139014826|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139014827|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
139014828|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
139014829|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014830|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014831|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139014832|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
139014833|NCT04998786|Hormones|hormones|mesh-ancestor
139014834|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139014835|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139014836|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014837|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
139014838|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014839|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014840|NCT04998500|Hormones|hormones|mesh-list
139014841|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139014842|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014843|NCT04992624|Dronabinol|dronabinol|mesh-list
139014844|NCT04992624|Cannabidiol|cannabidiol|mesh-list
139014845|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
139014846|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
139014847|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973815|NCT04388319|Zonisamide|zonisamide|mesh-list
139014848|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139014849|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139014850|NCT04992624|Analgesics|analgesics|mesh-ancestor
139014851|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
139014852|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014853|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139014854|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139014855|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014856|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014858|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139014859|NCT04964089|Aflibercept|aflibercept|mesh-list
139014860|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139014861|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139014862|NCT04964089|Growth Substances|growth substances|mesh-ancestor
139014863|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014864|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
139014865|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014866|NCT04931355|Cetrorelix|cetrorelix|mesh-list
139014867|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139014868|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014869|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139014870|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
139014871|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139014872|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
139014873|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
139014874|NCT04924374|Atezolizumab|atezolizumab|mesh-list
139014875|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139014876|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014877|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014878|NCT04924374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138530895|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014879|NCT04924374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014880|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
139014881|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014882|NCT04918147|Acetaminophen|acetaminophen|mesh-list
139014883|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
139014884|NCT04918147|Promethazine|promethazine|mesh-list
139014885|NCT04918147|Prednisone|prednisone|mesh-list
139014886|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
139014887|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139014888|NCT04918147|Elotuzumab|elotuzumab|mesh-list
139014889|NCT04918147|Famotidine|famotidine|mesh-list
139014890|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139014891|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
139014892|NCT04918147|Hormones|hormones|mesh-ancestor
139014893|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139014894|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014895|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139014896|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014897|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139014898|NCT04918147|Analgesics|analgesics|mesh-ancestor
139014899|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
139014900|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014901|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
139014902|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
139014903|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
139014904|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139014905|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139014906|NCT04918147|Protective Agents|protective agents|mesh-ancestor
139014907|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139014908|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139014909|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139014910|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
139014911|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
139014912|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139014919|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
139014920|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139014921|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139014931|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139014932|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139014933|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014934|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
139014935|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014936|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139014937|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
139014938|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139014939|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139014940|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139014941|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139014942|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014943|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
139014944|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014945|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139014946|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139014947|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014948|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
139014949|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014951|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139014952|NCT04848792|Protective Agents|protective agents|mesh-ancestor
139014953|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014954|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014955|NCT04805775|Desflurane|desflurane|mesh-list
139014956|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139014957|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
139014958|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
139014959|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139014960|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014961|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
139014962|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139014963|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139014965|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014966|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014967|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139014968|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
139014969|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139014970|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
139014971|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014972|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014973|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139014974|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
139014975|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
139014976|NCT04755647|Protective Agents|protective agents|mesh-ancestor
139014977|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
139014978|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014979|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014980|NCT04699123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139014981|NCT04699123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014982|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
139014983|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139014984|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
139014985|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014986|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139014987|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139014988|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
139014989|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014990|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014991|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139014992|NCT04648020|Clonidine|clonidine|mesh-list
139014993|NCT04648020|Analgesics|analgesics|mesh-ancestor
139014994|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
139014995|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014996|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014997|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139014998|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
139014999|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
139015000|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139015001|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139015002|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139015003|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
139015004|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139015005|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015006|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
139015007|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
139015008|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139015009|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015010|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015011|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
139015012|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138531081|NCT00208312|Adenosine|adenosine|mesh-list
139015013|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015014|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015015|NCT04614194|Letrozole|letrozole|mesh-list
139015016|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015017|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139015018|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139015019|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015020|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015021|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139015022|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
139015023|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015024|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015025|NCT04593654|Dalteparin|dalteparin|mesh-list
139015026|NCT04593654|Tinzaparin|tinzaparin|mesh-list
139015027|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139015028|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
139015029|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139015030|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139015031|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015032|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
139015033|NCT04591210|Giapreza|giapreza|mesh-list
139015034|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139015035|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
139015036|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139015037|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139015038|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015039|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139015040|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139015043|NCT04585893|Etoposide|etoposide|mesh-list
139015044|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139015045|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015046|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
139015047|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015048|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139015049|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139015050|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139015051|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139015052|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015053|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015054|NCT04547946|Trametinib|trametinib|mesh-list
139015055|NCT04547946|Dabrafenib|dabrafenib|mesh-list
139015056|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015057|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139015058|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015059|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015060|NCT04535700|Pioglitazone|pioglitazone|mesh-list
139015061|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139015062|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015063|NCT04437225|Glycolic acid|glycolic acid|mesh-list
139015064|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
139015065|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
139015066|NCT04429555|Ibudilast|ibudilast|mesh-list
139015067|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139015068|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
139015069|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015070|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015071|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139015072|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
139015073|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139015074|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015075|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015076|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139015077|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
139015078|NCT04400474|Atezolizumab|atezolizumab|mesh-list
139015079|NCT04400474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139015080|NCT04400474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015081|NCT04400474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139015082|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015083|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139015085|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139015086|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015087|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139015088|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139015089|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
139015090|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015091|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139015092|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139015093|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015094|NCT04305496|Fulvestrant|fulvestrant|mesh-list
139015095|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138908343|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
139015096|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015097|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139015098|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139015099|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
139015100|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015101|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015102|NCT04301934|Estradiol|estradiol|mesh-list
139015103|NCT04301934|Estrogens|estrogens|mesh-list
139015104|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139015105|NCT04301934|Hormones|hormones|mesh-ancestor
138973876|NCT01075789|Lidocaine|lidocaine|mesh-list
139015106|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015107|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015108|NCT04281017|Anesthetics|anesthetics|mesh-list
139015109|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015110|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015111|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
139015112|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
139015113|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015114|NCT04261036|Protective Agents|protective agents|mesh-ancestor
139015115|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015116|NCT04261036|Vitamins|vitamins|mesh-ancestor
139015117|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
139015118|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139015119|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
139015120|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139015121|NCT04095832|Anesthetics|anesthetics|mesh-list
139015122|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015123|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015124|NCT04083365|Capecitabine|capecitabine|mesh-list
139015125|NCT04083365|Durvalumab|durvalumab|mesh-list
139015126|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139015127|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
139015128|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015129|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015130|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139015131|NCT04072068|Edoxaban|edoxaban|mesh-list
139015132|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139015133|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
139015134|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139015135|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
139015136|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015137|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015138|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
139015139|NCT04019327|Temozolomide|temozolomide|mesh-list
139015140|NCT04019327|Talazoparib|talazoparib|mesh-list
139015141|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139015142|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
139015143|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015144|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015145|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139015146|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015147|NCT03970655|Dexamethasone|dexamethasone|mesh-list
139015148|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
139015149|NCT03970655|Epinephrine|epinephrine|mesh-list
139015150|NCT03970655|Racepinephrine|racepinephrine|mesh-list
139015151|NCT03970655|Bupivacaine|bupivacaine|mesh-list
139015152|NCT03970655|Ropivacaine|ropivacaine|mesh-list
139015153|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
139015154|NCT03970655|BB 1101|bb 1101|mesh-list
139015155|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015156|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
139015157|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
139015158|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015159|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015160|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139015161|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
139015162|NCT03970655|Hormones|hormones|mesh-ancestor
139015163|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015164|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139015165|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015166|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
139015167|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015168|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015169|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
139015170|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
139015171|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015172|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
139015173|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139015174|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139015175|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
139015176|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139015177|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139015178|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139015179|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139015180|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
139015181|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
139015182|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
139015183|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139015184|NCT03916627|Cemiplimab|cemiplimab|mesh-list
138765881|NCT01192295|Analgesics|analgesics|mesh-ancestor
139015185|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139015186|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015187|NCT03912064|Ipilimumab|ipilimumab|mesh-list
139015188|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139015189|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015190|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139015191|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015192|NCT03911453|Rucaparib|rucaparib|mesh-list
139015193|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139015194|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015195|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015196|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015197|NCT03865290|Ondansetron|ondansetron|mesh-list
139015198|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
139015199|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
139015200|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015201|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015202|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139015203|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
139015204|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
139015205|NCT03865290|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139015206|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139015207|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
139015208|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139015209|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015210|NCT03840291|Edoxaban|edoxaban|mesh-list
139015211|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139015212|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
139015213|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139015214|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
139015215|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015216|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015217|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
139015218|NCT03837626|Amiloride|amiloride|mesh-list
139015219|NCT03837626|Diuretics|diuretics|mesh-ancestor
139015220|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
139015221|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015222|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139015223|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139015224|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139015225|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015226|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139015227|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139015228|NCT03781219|Vemurafenib|vemurafenib|mesh-list
139015229|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015230|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139015231|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015232|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015233|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139015234|NCT03773237|SMOFlipid|smoflipid|mesh-list
139015235|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139015236|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139015237|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139015238|NCT03694808|Vaccines|vaccines|mesh-list
139015239|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
139015240|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015241|NCT03659539|Propofol|propofol|mesh-list
139015242|NCT03659539|Desflurane|desflurane|mesh-list
139015243|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139015244|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015245|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015246|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139015247|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
139015248|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
139015249|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139015250|NCT03659136|Everolimus|everolimus|mesh-list
139015251|NCT03659136|Exemestane|exemestane|mesh-list
139015252|NCT03659136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139015253|NCT03659136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139015254|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015255|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015256|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139015257|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
139015258|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015259|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015260|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139015261|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139015262|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139015263|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
139015264|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015265|NCT03629418|Phenylephrine|phenylephrine|mesh-list
139015266|NCT03629418|Norepinephrine|norepinephrine|mesh-list
139015267|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139015268|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
139015269|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
139015270|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015271|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015272|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
139015273|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139015274|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
139015275|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
139015276|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139015277|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139015278|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138814085|NCT02717871|Ofloxacin|ofloxacin|mesh-list
139015279|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
139015280|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139015281|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015283|NCT03606213|Vaccines|vaccines|mesh-list
139015284|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
139015285|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015286|NCT03514108|Metformin|metformin|mesh-list
139015287|NCT03514108|Hydralazine|hydralazine|mesh-list
139015288|NCT03514108|Isosorbide|isosorbide|mesh-list
139015289|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139015290|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139015291|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139015292|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015293|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139015294|NCT03514108|Diuretics|diuretics|mesh-ancestor
139015295|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
139015296|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
139015297|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139015298|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015299|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139015300|NCT03390036|Triamcinolone|triamcinolone|mesh-list
138531679|NCT00210847|Analgesics|analgesics|mesh-ancestor
139015301|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139015302|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139015303|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139015304|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015305|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
139015306|NCT03390036|Hormones|hormones|mesh-ancestor
139015307|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015308|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015309|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139015310|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
139015311|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015312|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015313|NCT03379506|Grazoprevir|grazoprevir|mesh-list
139015314|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
139015315|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139015316|NCT03375788|Hormones|hormones|mesh-list
139015317|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
139015318|NCT03375788|Tesamorelin|tesamorelin|mesh-list
139015319|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015320|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015321|NCT03375788|Growth Substances|growth substances|mesh-ancestor
139015322|NCT03341936|Nivolumab|nivolumab|mesh-list
139015323|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139015324|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015325|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139015326|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015327|NCT03306446|Adalimumab|adalimumab|mesh-list
139015328|NCT03306446|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139015329|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015330|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139015331|NCT03292133|Gefitinib|gefitinib|mesh-list
139015332|NCT03292133|Nazartinib|nazartinib|mesh-list
139015333|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015334|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139015335|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015336|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015338|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139015339|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
139015340|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
138531738|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139015341|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015342|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973933|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
139015343|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139015344|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139015345|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139015346|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
139015347|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139015348|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015349|NCT03289728|Protective Agents|protective agents|mesh-ancestor
139015350|NCT03275415|Budesonide|budesonide|mesh-list
139015351|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015352|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139015353|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
139015354|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015355|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015356|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139015357|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
139015358|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
139015359|NCT03275415|Hormones|hormones|mesh-ancestor
139015360|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015361|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
139015362|NCT03233724|Decitabine|decitabine|mesh-list
139015363|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
139015364|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139015365|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015366|NCT03233724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139015367|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015368|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139015369|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
139015370|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015371|NCT03230734|Docetaxel|docetaxel|mesh-list
139015372|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015373|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
139015374|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
139015375|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
139015376|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015377|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139015378|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139015379|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139015380|NCT03229408|Analgesics|analgesics|mesh-ancestor
139015381|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
138908458|NCT00786448|Darifenacin|darifenacin|mesh-list
139015382|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015383|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015384|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015385|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139015395|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015396|NCT03077451|Nelfinavir|nelfinavir|mesh-list
139015397|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139015398|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139015399|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
139015400|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015401|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015402|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139015403|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139015404|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
139015405|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139015406|NCT02998268|Paclitaxel|paclitaxel|mesh-list
139015407|NCT02998268|Carboplatin|carboplatin|mesh-list
139015408|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
139015409|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139015410|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015411|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
139015412|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
139015413|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
139015414|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015415|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139015416|NCT02998268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138531819|NCT00212173|Sibutramine|sibutramine|mesh-list
139015448|NCT02813135|Cytarabine|cytarabine|mesh-list
139015450|NCT02813135|Cyclophosphamide|cyclophosphamide|mesh-list
139015451|NCT02813135|Temozolomide|temozolomide|mesh-list
139015452|NCT02813135|Carboplatin|carboplatin|mesh-list
139015453|NCT02813135|Nivolumab|nivolumab|mesh-list
139015454|NCT02813135|Irinotecan|irinotecan|mesh-list
139015455|NCT02813135|Everolimus|everolimus|mesh-list
139015456|NCT02813135|Topotecan|topotecan|mesh-list
139015457|NCT02813135|Olaparib|olaparib|mesh-list
139015458|NCT02813135|Futibatinib|futibatinib|mesh-list
139015459|NCT02813135|Adavosertib|adavosertib|mesh-list
139015460|NCT02813135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139015461|NCT02813135|Immunologic Factors|immunologic factors|mesh-ancestor
139015462|NCT02813135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015463|NCT02813135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139015464|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139015465|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
139015466|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015467|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015468|NCT02813135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139015469|NCT02813135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015470|NCT02813135|Antiemetics|antiemetics|mesh-ancestor
139015471|NCT02813135|Autonomic Agents|autonomic agents|mesh-ancestor
139015472|NCT02813135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974010|NCT04004871|Cisplatin|cisplatin|mesh-list
139015474|NCT02813135|Glucocorticoids|glucocorticoids|mesh-ancestor
139015475|NCT02813135|Hormones|hormones|mesh-ancestor
139015476|NCT02813135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015478|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139015479|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139015480|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139015481|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139015482|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015483|NCT02813135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139015484|NCT02813135|Antimetabolites|antimetabolites|mesh-ancestor
139015485|NCT02813135|Antiviral Agents|antiviral agents|mesh-ancestor
139015486|NCT02813135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139015487|NCT02813135|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139015488|NCT02813135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139015489|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139015490|NCT02732288|Melatonin|melatonin|mesh-list
139015491|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
139015492|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015493|NCT02732288|Protective Agents|protective agents|mesh-ancestor
139015494|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015495|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015496|NCT02687958|Everolimus|everolimus|mesh-list
139015497|NCT02687958|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139015498|NCT02687958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139015499|NCT02687958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015500|NCT02687958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015501|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139015502|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
139015503|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015504|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015505|NCT02478710|Vancomycin|vancomycin|mesh-list
139015506|NCT02478710|Tobramycin|tobramycin|mesh-list
139015507|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139015508|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139015509|NCT02476279|Indomethacin|indomethacin|mesh-list
139015510|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139015511|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139015512|NCT02476279|Analgesics|analgesics|mesh-ancestor
139015513|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
139015514|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015515|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015516|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015517|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139015518|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
139015519|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
139015520|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139015521|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139015522|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015523|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015524|NCT02425865|Golimumab|golimumab|mesh-list
139015525|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139015526|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015527|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139015528|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
139015529|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015530|NCT02425852|Prednisolone|prednisolone|mesh-list
139015531|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
139015532|NCT02425852|Infliximab|infliximab|mesh-list
139015533|NCT02425852|Azathioprine|azathioprine|mesh-list
139015534|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015535|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
139015536|NCT02425852|Hormones|hormones|mesh-ancestor
139015537|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015538|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015539|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139015540|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015541|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139015542|NCT02425852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139015543|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
139015544|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139015545|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
139015546|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015547|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139015548|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139015549|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
139015550|NCT02333188|Leucovorin|leucovorin|mesh-list
139015551|NCT02333188|Paclitaxel|paclitaxel|mesh-list
139015552|NCT02333188|Fluorouracil|fluorouracil|mesh-list
139015553|NCT02333188|Irinotecan|irinotecan|mesh-list
139015554|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139015555|NCT02333188|Calcium|calcium|mesh-list
139015556|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
139015557|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139015558|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015559|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
139015560|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
139015561|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
139015562|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015563|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138766283|NCT04315194|Naproxen|naproxen|mesh-list
139015564|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015565|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
139015566|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139015567|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139015568|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
139015569|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139015570|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139015571|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015572|NCT02333188|Antidotes|antidotes|mesh-ancestor
139015573|NCT02333188|Protective Agents|protective agents|mesh-ancestor
139015574|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
139015575|NCT02333188|Vitamins|vitamins|mesh-ancestor
138974059|NCT00224029|Oxybutynin|oxybutynin|mesh-list
139015577|NCT02282358|Mocetinostat|mocetinostat|mesh-list
139015578|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139015579|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015580|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015581|NCT02177578|Temozolomide|temozolomide|mesh-list
139015582|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139015583|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
139015584|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015585|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015586|NCT01892709|Hydromorphone|hydromorphone|mesh-list
139015587|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139015588|NCT01892709|Narcotics|narcotics|mesh-ancestor
139015589|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015590|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015591|NCT01892709|Analgesics|analgesics|mesh-ancestor
139015592|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
139015593|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015594|NCT01806571|Cytarabine|cytarabine|mesh-list
139015595|NCT01806571|Daunorubicin|daunorubicin|mesh-list
139015596|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139015597|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
139015598|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015599|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015600|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
139015601|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139015602|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139015603|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
139015604|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015605|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139015606|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139015608|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015609|NCT01633177|Vitamin D|vitamin d|mesh-list
139015610|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
139015611|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
139015612|NCT01633177|Vitamins|vitamins|mesh-list
139015613|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
139015614|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015615|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139015616|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139015617|NCT01517451|Androgens|androgens|mesh-list
139015618|NCT01517451|Hormones|hormones|mesh-ancestor
139015619|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015620|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015621|NCT01204216|Biotin|biotin|mesh-list
139015622|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
139015623|NCT01204216|Vitamins|vitamins|mesh-ancestor
139015624|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
139015625|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015626|NCT01104350|Gemcitabine|gemcitabine|mesh-list
139015627|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139015628|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
138532253|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
139015629|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015630|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015631|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
139015632|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139015633|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015634|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
139015637|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139015638|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
139015639|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015640|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139015641|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139015642|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
139015643|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015645|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139015646|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139015647|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139015648|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139015649|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015650|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139015651|NCT00999037|Sevelamer|sevelamer|mesh-list
139015652|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
139015653|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
139015654|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015655|NCT00921856|Acetylcholine|acetylcholine|mesh-list
139015656|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
139015657|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138208567|NCT00290654|Tamoxifen|tamoxifen|mesh-list
139015658|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
139015659|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139015660|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015661|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015662|NCT00833664|Terbinafine|terbinafine|mesh-list
139015663|NCT00833664|Antifungal Agents|antifungal agents|mesh-ancestor
139015664|NCT00833664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139015665|NCT00833664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015666|NCT00833664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015668|NCT00696111|Progesterone|progesterone|mesh-list
139015669|NCT00696111|Estrogens|estrogens|mesh-list
139015670|NCT00696111|Progestins|progestins|mesh-ancestor
139015671|NCT00696111|Hormones|hormones|mesh-ancestor
139015672|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015673|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015674|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139015675|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
139015676|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139015677|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139015678|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015679|NCT00224393|Etanercept|etanercept|mesh-list
139015680|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139015681|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139015682|NCT00224393|Analgesics|analgesics|mesh-ancestor
139015683|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
139015684|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015685|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015686|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015687|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139015688|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139015689|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139015690|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
139015691|NCT00199862|Antibodies|antibodies|mesh-list
139015692|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
139015693|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015694|NCT00128310|Gemcitabine|gemcitabine|mesh-list
139015695|NCT00128310|Vinorelbine|vinorelbine|mesh-list
139015696|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138974114|NCT00719849|Cyclosporine|cyclosporine|mesh-list
139015697|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
139015698|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015699|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015700|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139015701|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
139015702|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
139015703|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
139015704|NCT00885443|Propofol|propofol|mesh-list
139015705|NCT00885443|Sevoflurane|sevoflurane|mesh-list
139015706|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139015707|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015708|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015709|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139015710|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
139015711|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
139015712|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139015713|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139015714|NCT00882869|Sorafenib|sorafenib|mesh-list
139015715|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015716|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139015717|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015718|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015719|NCT00882947|Iloprost|iloprost|mesh-list
139015720|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139015721|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
139015722|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139015723|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139015724|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
139015725|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015726|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015727|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139015728|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
139015729|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139015730|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139015731|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139015732|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
139015733|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139015734|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015735|NCT00530348|Interferons|interferons|mesh-list
139015736|NCT00530348|Interferon-beta|interferon-beta|mesh-list
139015737|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
139015738|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
138908602|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015739|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015740|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
139015741|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139015742|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139015743|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
139015744|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015745|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139015746|NCT01007864|Pramipexole|pramipexole|mesh-list
139015747|NCT01007864|Ropinirole|ropinirole|mesh-list
139015748|NCT01007864|Piribedil|piribedil|mesh-list
139015749|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
139015750|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015751|NCT01007864|Protective Agents|protective agents|mesh-ancestor
139015752|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015753|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139015754|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139015755|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
139015756|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
139015757|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139015758|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139015759|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
139015760|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015761|NCT01008020|Protective Agents|protective agents|mesh-ancestor
139015762|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015763|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139015764|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139015765|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015766|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139015767|NCT01008098|Escitalopram|escitalopram|mesh-list
139015768|NCT01008098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139015769|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139015770|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139015771|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015772|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139015773|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
139015774|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015775|NCT00530270|Dexamethasone|dexamethasone|mesh-list
139015776|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015777|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
139015778|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
139015779|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015780|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015781|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139015782|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
139015784|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015785|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139015786|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015787|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139015788|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139015789|NCT01001624|Hydroquinone|hydroquinone|mesh-list
139015790|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
139015791|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015792|NCT01001624|Protective Agents|protective agents|mesh-ancestor
139015793|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015794|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139015795|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
139015797|NCT01001780|Pentostatin|pentostatin|mesh-list
139015798|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139015799|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
139015800|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015801|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139015802|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139015803|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
139015804|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015805|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015806|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139015807|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139015808|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139015809|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015810|NCT01008566|Sorafenib|sorafenib|mesh-list
139015811|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138974145|NCT00822536|Analgesics|analgesics|mesh-ancestor
139015812|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015813|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139015814|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015815|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015816|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
139015817|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015818|NCT03885596|Acetaminophen|acetaminophen|mesh-list
139015819|NCT03885596|Celecoxib|celecoxib|mesh-list
139015820|NCT03885596|Ketorolac|ketorolac|mesh-list
139015821|NCT03885596|Lidocaine|lidocaine|mesh-list
139015822|NCT03885596|Fentanyl|fentanyl|mesh-list
139015823|NCT03885596|Bupivacaine|bupivacaine|mesh-list
139015824|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
139015825|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
139015826|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015827|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015828|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
139015829|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015830|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139015831|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139015832|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139015833|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139015834|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015835|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139015836|NCT03885596|Narcotics|narcotics|mesh-ancestor
139015837|NCT03885596|Analgesics|analgesics|mesh-ancestor
139015838|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139015839|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139015840|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
139015841|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139015842|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
139015843|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139015844|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138532570|NCT00042068|Analgesics|analgesics|mesh-ancestor
139015845|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139015846|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139015847|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139015848|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015849|NCT01002092|Endostar protein|endostar protein|mesh-list
139015850|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139015851|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139015852|NCT01002092|Growth Substances|growth substances|mesh-ancestor
139015853|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015854|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
139015855|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015856|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
139015857|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
139015858|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
139015860|NCT00529100|Pemetrexed|pemetrexed|mesh-list
139015861|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015862|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015863|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015864|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139015865|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139015866|NCT00529802|Everolimus|everolimus|mesh-list
139015867|NCT00529802|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139015868|NCT00529802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139015869|NCT00529802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015870|NCT00529802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015871|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139015872|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
139015873|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015874|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015876|NCT00528866|Bicalutamide|bicalutamide|mesh-list
139015877|NCT00528866|Flutamide|flutamide|mesh-list
139015878|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015879|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
139015880|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
139015881|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
139015882|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015883|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
139015884|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
139015885|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015886|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015887|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139015889|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015890|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139015891|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
138908657|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139015892|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015893|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015894|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139015895|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
139015896|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
139015897|NCT03999008|Hormones|hormones|mesh-ancestor
139015898|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015899|NCT05140148|Amantadine|amantadine|mesh-list
139015900|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139015901|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139015902|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
139015903|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139015904|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
139015905|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139015906|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015907|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015908|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139015909|NCT05140148|Analgesics|analgesics|mesh-ancestor
139015910|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
139015911|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015912|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
139015913|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139015914|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015915|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015916|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139015917|NCT04932746|Analgesics|analgesics|mesh-ancestor
139015918|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
139015919|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015920|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139015921|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139015922|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139015923|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
139015924|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139015925|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015927|NCT00614393|Cetuximab|cetuximab|mesh-list
139015928|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139015929|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139015930|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139015931|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015932|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015933|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015934|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139015935|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
139015936|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015937|NCT00880529|Morphine|morphine|mesh-list
139015938|NCT00880529|Bupivacaine|bupivacaine|mesh-list
139015939|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
139015941|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015942|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015943|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
139015944|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015945|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139015947|NCT00880529|Analgesics|analgesics|mesh-ancestor
139015948|NCT00880841|Buprenorphine|buprenorphine|mesh-list
139015949|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139015950|NCT00880841|Naloxone|naloxone|mesh-list
139015951|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139015952|NCT00880841|Narcotics|narcotics|mesh-ancestor
139015953|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015954|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015955|NCT00880841|Analgesics|analgesics|mesh-ancestor
139015956|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
139015957|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015958|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139015959|NCT00883259|Metformin|metformin|mesh-list
139015960|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139015961|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015962|NCT00885599|Listerine|listerine|mesh-list
139015963|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139015964|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139015965|NCT04366115|Dexamethasone|dexamethasone|mesh-list
139015966|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
139015967|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139015968|NCT04366115|BB 1101|bb 1101|mesh-list
139015969|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015970|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
139015971|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
139015972|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015973|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015974|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139015975|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
139015976|NCT04366115|Hormones|hormones|mesh-ancestor
139015977|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015978|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139015979|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015980|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
139015981|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139015982|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015983|NCT04038125|Dexamethasone|dexamethasone|mesh-list
139015984|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139015985|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
139015986|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
139015987|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139015988|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015989|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139015990|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
139015991|NCT04038125|Hormones|hormones|mesh-ancestor
139015992|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139015993|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139015994|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139015995|NCT00881153|Cefprozil|cefprozil|mesh-list
139015996|NCT00881153|Cephalosporins|cephalosporins|mesh-list
139015997|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139015998|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139015999|NCT00885833|Fludarabine|fludarabine|mesh-list
139016000|NCT00885833|Busulfan|busulfan|mesh-list
139016001|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
139016002|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016003|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016004|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139016005|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
139016006|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016007|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
139016008|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139016009|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139016011|NCT00612677|Pemetrexed|pemetrexed|mesh-list
139016012|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016013|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016014|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016015|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139016016|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139016017|NCT04038749|Cabergoline|cabergoline|mesh-list
139016018|NCT04038749|Bromocriptine|bromocriptine|mesh-list
139016019|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139016020|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139016021|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
139016022|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
139016023|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016024|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016025|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016026|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
139016027|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139016028|NCT00881231|Cilostazol|cilostazol|mesh-list
139016029|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139016030|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
139016031|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016032|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016033|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139016034|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
139016035|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139016036|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139016037|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016038|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139016039|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
139016040|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139016041|NCT00881231|Protective Agents|protective agents|mesh-ancestor
139016042|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139016043|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139016044|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016045|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
139016046|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139016047|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139016048|NCT00881387|Rituximab|rituximab|mesh-list
139016049|NCT00881387|Gemcitabine|gemcitabine|mesh-list
139016050|NCT00881387|Vinorelbine|vinorelbine|mesh-list
139016051|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139016052|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016053|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
139016054|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016055|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016056|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139016057|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
139016058|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016059|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139016060|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
139016061|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
139016062|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
139016063|NCT00883883|Cefdinir|cefdinir|mesh-list
139016064|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139016065|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016066|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139016067|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139016068|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139016069|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016070|NCT00881543|Incretins|incretins|mesh-ancestor
139016071|NCT00881543|Hormones|hormones|mesh-ancestor
139016072|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139016073|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
139016074|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016075|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016077|NCT00881855|Cephalosporins|cephalosporins|mesh-list
139016078|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139016079|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016080|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
139016081|NCT04015115|Narcotics|narcotics|mesh-ancestor
139016082|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016083|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016084|NCT04015115|Analgesics|analgesics|mesh-ancestor
139016085|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
139016086|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016087|NCT02543645|Atezolizumab|atezolizumab|mesh-list
139016088|NCT02543645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139016089|NCT02543645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016090|NCT02543645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139016091|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016092|NCT02543411|Lidocaine|lidocaine|mesh-list
139016093|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
139016094|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
139016095|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016096|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016097|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
139016098|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016099|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139016100|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139016101|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139016102|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139016103|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016104|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
139016106|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
139016107|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139016108|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
139016109|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016110|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016111|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139016112|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
139016113|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016114|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016115|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139016116|NCT00882401|Vitamin D|vitamin d|mesh-list
139016117|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
139016118|NCT00882401|Vitamins|vitamins|mesh-ancestor
139016119|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
139016120|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016121|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139016122|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139016123|NCT00886457|Interferons|interferons|mesh-list
139016124|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
139016125|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
139016126|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139016127|NCT00886457|Decitabine|decitabine|mesh-list
139016128|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016129|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
139016130|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016131|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
139016132|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016133|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139016134|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
139016135|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016136|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016137|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
139016138|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139016139|NCT04038671|Charcoal|charcoal|mesh-list
139016140|NCT04038671|Antidotes|antidotes|mesh-ancestor
139016141|NCT04038671|Protective Agents|protective agents|mesh-ancestor
139016142|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016143|NCT02543099|Policosanol|policosanol|mesh-list
139016144|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139016145|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139016146|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
139016147|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016148|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139016149|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139016150|NCT00882635|Heparin|heparin|mesh-list
139016151|NCT00882635|Enoxaparin|enoxaparin|mesh-list
139016152|NCT00882635|Calcium heparin|calcium heparin|mesh-list
139016153|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
139016154|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139016155|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139016156|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016157|NCT00609869|Rituximab|rituximab|mesh-list
139016158|NCT00609869|Lenalidomide|lenalidomide|mesh-list
139016159|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139016160|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016161|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
139016162|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016163|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016164|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139016165|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139016166|NCT00609869|Growth Substances|growth substances|mesh-ancestor
139016168|NCT00888797|Etodolac|etodolac|mesh-list
139016169|NCT00888797|Propranolol|propranolol|mesh-list
139016170|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139016171|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139016172|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
139016173|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016174|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016175|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016176|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139016177|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139016178|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
139016179|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139016180|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139016181|NCT00888797|Analgesics|analgesics|mesh-ancestor
139016182|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
139016183|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016184|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139016185|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016186|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139016187|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139016188|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016189|NCT00884663|Propranolol|propranolol|mesh-list
139016190|NCT00884663|Candesartan|candesartan|mesh-list
139016191|NCT00884663|Candesartan cilexetil|candesartan cilexetil|mesh-list
139016192|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139016193|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139016194|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
139016195|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016196|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016197|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016198|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139016199|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139016200|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
139016201|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139016202|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139016204|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139016205|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139016206|NCT00887003|Prednisolone|prednisolone|mesh-list
139016207|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
139016208|NCT00887003|Bupivacaine|bupivacaine|mesh-list
139016209|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139016210|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
139016211|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
139016212|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
139016213|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016214|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016215|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
139016216|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016217|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139016218|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
139016219|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
139016220|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139016221|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
139016222|NCT00887003|Hormones|hormones|mesh-ancestor
139016223|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139016224|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139016225|NCT00887003|Protective Agents|protective agents|mesh-ancestor
139016226|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139016227|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016228|NCT00887081|Ribavirin|ribavirin|mesh-list
139016229|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
139016230|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
139016231|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139016232|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139016233|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139016234|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
139016235|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016236|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
139016237|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016238|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
139016239|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016240|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016241|NCT03998696|Cisplatin|cisplatin|mesh-list
139016242|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016243|NCT00611975|Bupropion|bupropion|mesh-list
139016244|NCT00611975|Fluoxetine|fluoxetine|mesh-list
139016245|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139016246|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
139016247|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139016248|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139016249|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139016250|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139016251|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016252|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
139016253|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016254|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016255|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139016256|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138974235|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
139016257|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016258|NCT00611975|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139016259|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
139016261|NCT05695352|Levonorgestrel|levonorgestrel|mesh-list
139016262|NCT05695352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139016263|NCT05695352|Contraceptive Agents|contraceptive agents|mesh-ancestor
139016264|NCT05695352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139016265|NCT05695352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016266|NCT05695352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139016267|NCT05695352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139016268|NCT05695352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139016269|NCT05695352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139016270|NCT05695352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139016271|NCT05695352|Analgesics|analgesics|mesh-ancestor
139016272|NCT05695352|Sensory System Agents|sensory system agents|mesh-ancestor
139016273|NCT05695352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016274|NCT05695352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139016275|NCT05695352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016276|NCT05695352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139016277|NCT05695352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139016278|NCT05695352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016279|NCT05695352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016280|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
139016281|NCT04895306|Testosterone|testosterone|mesh-list
139016282|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
139016283|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
139016284|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139016285|NCT04895306|Androgens|androgens|mesh-ancestor
139016286|NCT04895306|Hormones|hormones|mesh-ancestor
138532899|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139016287|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139016288|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016289|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139016290|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016291|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
139016292|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139016294|NCT00889343|Fluorouracil|fluorouracil|mesh-list
139016295|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
139016296|NCT00889343|Irinotecan|irinotecan|mesh-list
139016297|NCT00889343|Sorafenib|sorafenib|mesh-list
139016298|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
139016299|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016300|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139016301|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016302|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139016303|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
139016304|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016305|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139016306|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139016307|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016308|NCT00889343|Antidotes|antidotes|mesh-ancestor
139016309|NCT00889343|Protective Agents|protective agents|mesh-ancestor
139016310|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
139016311|NCT00889343|Vitamins|vitamins|mesh-ancestor
139016312|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
139016313|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139016314|NCT00884819|Fenofibrate|fenofibrate|mesh-list
139016315|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139016316|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
139016317|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016318|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139016319|NCT00573131|Paclitaxel|paclitaxel|mesh-list
139016320|NCT00573131|Cisplatin|cisplatin|mesh-list
139016321|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139016322|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016323|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
139016324|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
139016325|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
139016326|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016327|NCT01565018|Rotigotine|rotigotine|mesh-list
139016329|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
139016330|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016331|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016332|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016333|NCT01565096|Metformin|metformin|mesh-list
139016334|NCT01565096|Glimepiride|glimepiride|mesh-list
139016335|NCT01565096|Vildagliptin|vildagliptin|mesh-list
139016336|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139016337|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016338|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139016339|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139016340|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
139016341|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139016342|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
139016343|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016344|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016345|NCT00889499|Tropisetron|tropisetron|mesh-list
139016346|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
139016347|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
139016348|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016349|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016350|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139016351|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139016352|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139016353|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
139016354|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016355|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016356|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139016357|NCT00889655|Laxatives|laxatives|mesh-ancestor
139016358|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139016359|NCT05002946|Naltrexone|naltrexone|mesh-list
139016360|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139016361|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139016362|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016363|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
139016364|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016365|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
138974275|NCT00926640|Etoposide|etoposide|mesh-list
139016366|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139016367|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016368|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016369|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139016370|NCT04635098|Analgesics|analgesics|mesh-ancestor
139016371|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
139016372|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016373|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139016374|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139016375|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139016376|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
139016377|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016378|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016379|NCT00521144|Topotecan|topotecan|mesh-list
139016380|NCT00521144|Obatoclax|obatoclax|mesh-list
139016381|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139016382|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139016383|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016384|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016385|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016386|NCT00520676|Carboplatin|carboplatin|mesh-list
139016387|NCT00520676|Docetaxel|docetaxel|mesh-list
139016388|NCT00520676|Pemetrexed|pemetrexed|mesh-list
139016389|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016390|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
139016391|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
139016392|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
139016393|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016394|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016395|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139016396|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139016397|NCT00889733|Cisplatin|cisplatin|mesh-list
139016398|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016399|NCT00887627|Conivaptan|conivaptan|mesh-list
139016400|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139016401|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533010|NCT00122824|Analgesics|analgesics|mesh-ancestor
139016402|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
139016403|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016404|NCT00885287|Lumefantrine|lumefantrine|mesh-list
139016405|NCT00885287|Artemether|artemether|mesh-list
139016406|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139016407|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
139016408|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139016409|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139016410|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016411|NCT02542007|Sirolimus|sirolimus|mesh-list
139016412|NCT02542007|Temsirolimus|temsirolimus|mesh-list
139016413|NCT02542007|MTOR Inhibitors|mtor inhibitors|mesh-list
139016414|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139016415|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016416|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139016417|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016418|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
139016419|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139016420|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
139016421|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974293|NCT00827216|Erythromycin|erythromycin|mesh-list
139016422|NCT02542007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139016423|NCT02542007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016424|NCT02542007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016425|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138533037|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
139016426|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139016427|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139016428|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016429|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016430|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139016431|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139016432|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139016433|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
139016434|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016435|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016436|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139016437|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139016438|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
139016439|NCT00890279|Imidapril|imidapril|mesh-list
139016440|NCT00890279|Cilnidipine|cilnidipine|mesh-list
139016441|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139016442|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139016443|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016444|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139016445|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016446|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139016447|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
139016448|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016449|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139016450|NCT00608543|Aripiprazole|aripiprazole|mesh-list
139016451|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
138533086|NCT00123175|Hormones|hormones|mesh-ancestor
139016452|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139016453|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139016454|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139016455|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016456|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016457|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
139016458|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
139016459|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016460|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016461|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139016462|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139016463|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
139016464|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139016465|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139016466|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139016467|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139016468|NCT02541383|Thalidomide|thalidomide|mesh-list
139016469|NCT02541383|Dexamethasone|dexamethasone|mesh-list
138767165|NCT05907499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016470|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
139016471|NCT02541383|Bortezomib|bortezomib|mesh-list
139016472|NCT02541383|Daratumumab|daratumumab|mesh-list
139016474|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139016475|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139016476|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
139016477|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
139016478|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016479|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016480|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139016481|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
139016482|NCT02541383|Hormones|hormones|mesh-ancestor
139016483|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139016484|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139016485|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016486|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
139016487|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016488|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533252|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139016489|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139016490|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
139016491|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
139016492|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139016493|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016494|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139016495|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139016496|NCT02541383|Growth Substances|growth substances|mesh-ancestor
139016497|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
139016498|NCT04036487|Propofol|propofol|mesh-list
139016499|NCT04036487|Desflurane|desflurane|mesh-list
139016500|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139016501|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016502|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016503|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139016504|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
139016505|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
139016506|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139016507|NCT05278793|Ferrous fumarate|ferrous fumarate|mesh-list
139016508|NCT05278793|Trace Elements|trace elements|mesh-ancestor
139016509|NCT05278793|Micronutrients|micronutrients|mesh-ancestor
139016510|NCT05278793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016511|NCT04037657|Propofol|propofol|mesh-list
139016512|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139016513|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016514|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016515|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139016516|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
139016518|NCT00893009|Theophylline|theophylline|mesh-list
139016519|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139016520|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
139016521|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016522|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016523|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139016524|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
139016525|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139016526|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016527|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016528|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
139016529|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139016530|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139016531|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
139016532|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016533|NCT00890747|Sunitinib|sunitinib|mesh-list
139016534|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016535|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139016536|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139016537|NCT00890747|Growth Substances|growth substances|mesh-ancestor
139016538|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016539|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
139016540|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139016542|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016543|NCT04017845|Tribenoside|tribenoside|mesh-list
139016544|NCT04017845|Lidocaine|lidocaine|mesh-list
139016545|NCT04017845|Diltiazem|diltiazem|mesh-list
138767245|NCT05901961|Protective Agents|protective agents|mesh-ancestor
139016546|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
139016547|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
139016548|NCT04017845|Bisacodyl|bisacodyl|mesh-list
139016549|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
139016550|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
139016551|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016552|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016553|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
139016554|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016555|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139016556|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139016557|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139016558|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139016559|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016560|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139016561|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
139016562|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139016563|NCT04017845|Cathartics|cathartics|mesh-ancestor
139016564|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139016565|NCT04017845|Laxatives|laxatives|mesh-ancestor
139016566|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139016567|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139016568|NCT04017845|Analgesics|analgesics|mesh-ancestor
139016569|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139016570|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016571|NCT00520130|Cytarabine|cytarabine|mesh-list
139016572|NCT00520130|Cyclosporine|cyclosporine|mesh-list
139016573|NCT00520130|Rituximab|rituximab|mesh-list
139016574|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
139016575|NCT00520130|Fludarabine|fludarabine|mesh-list
139016576|NCT00520130|Cyclosporins|cyclosporins|mesh-list
139016577|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139016578|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016579|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
139016580|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016581|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016582|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139016583|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
139016584|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016585|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139016586|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
139016587|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016588|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016589|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
139016590|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
139016591|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139016592|NCT00519896|Sunitinib|sunitinib|mesh-list
139016593|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016594|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139016595|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139016596|NCT00519896|Growth Substances|growth substances|mesh-ancestor
139016597|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016598|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
139016599|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139016600|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016601|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016603|NCT00527618|Acyclovir|acyclovir|mesh-list
139016604|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
139016605|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016606|NCT00527072|Infliximab|infliximab|mesh-list
139016607|NCT00527072|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139016608|NCT00527072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139016609|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
139016610|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139016611|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016612|NCT00519428|Dexetimide|dexetimide|mesh-list
139016613|NCT00519428|Citalopram|citalopram|mesh-list
139016614|NCT00519428|Bupropion|bupropion|mesh-list
139016615|NCT00519428|Escitalopram|escitalopram|mesh-list
139016616|NCT00519428|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139016617|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139016618|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139016619|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016620|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016621|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
139016622|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016624|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139016625|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
139016626|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
139016627|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016628|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139016629|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139016630|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
139016631|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139016632|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
139016633|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139016634|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139016635|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
139016636|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139016637|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139016638|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016639|NCT00431847|Anesthetics|anesthetics|mesh-list
139016640|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016641|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016642|NCT00431067|Afatinib|afatinib|mesh-list
139016643|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016644|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139016645|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016646|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016647|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
138533635|NCT00043589|Donepezil|donepezil|mesh-list
139016648|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139016649|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
139016651|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016652|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016653|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139016654|NCT00430989|Analgesics|analgesics|mesh-ancestor
139016655|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
139016656|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016657|NCT00518882|Liraglutide|liraglutide|mesh-list
139016658|NCT00518882|Exenatide|exenatide|mesh-list
139016659|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139016660|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016661|NCT00518882|Incretins|incretins|mesh-ancestor
139016662|NCT00518882|Hormones|hormones|mesh-ancestor
139016663|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139016664|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139016665|NCT00518180|Lactitol|lactitol|mesh-list
139016666|NCT00518180|Vaccines|vaccines|mesh-list
139016667|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
139016668|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016669|NCT00518180|Cathartics|cathartics|mesh-ancestor
139016670|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139016671|NCT00525902|Adalimumab|adalimumab|mesh-list
139016672|NCT00525902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139016673|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139016674|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016675|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139016676|NCT00525824|Simvastatin|simvastatin|mesh-list
139016677|NCT00525824|Ezetimibe|ezetimibe|mesh-list
139016678|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139016679|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139016680|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
139016681|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016682|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139016683|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139016684|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016685|NCT00525590|Carmustine|carmustine|mesh-list
139016686|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139016687|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
139016688|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016689|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016690|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
139016691|NCT00430677|Prednisone|prednisone|mesh-list
139016692|NCT00430677|Prednisolone|prednisolone|mesh-list
139016693|NCT00430677|Abatacept|abatacept|mesh-list
139016694|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139016695|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
139016696|NCT00430677|Hormones|hormones|mesh-ancestor
139016697|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139016698|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016699|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139016701|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139016702|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139016703|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
139016704|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139016705|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016706|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016707|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016708|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139016709|NCT00430677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139016710|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139016711|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
139016712|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016713|NCT02631759|Levetiracetam|levetiracetam|mesh-list
139016714|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
139016715|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
139016716|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
139016717|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139016718|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016719|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
139016720|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139016721|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
139016722|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016723|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016724|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139016725|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
139016726|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
138533787|NCT00126646|Antibodies|antibodies|mesh-list
139016727|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139016728|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
139016729|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016730|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016731|NCT04501406|Pioglitazone|pioglitazone|mesh-list
139016732|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139016733|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016734|NCT03656666|Thalidomide|thalidomide|mesh-list
139016735|NCT03656666|Apremilast|apremilast|mesh-list
139016736|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139016737|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139016738|NCT03656666|Analgesics|analgesics|mesh-ancestor
139016739|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
139016740|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016741|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016742|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139016743|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016744|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139016745|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139016746|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016747|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016748|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139016749|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
139016750|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
139016751|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139016752|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016753|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139016754|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139016755|NCT03656666|Growth Substances|growth substances|mesh-ancestor
139016756|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
139016757|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016758|NCT00430521|Vaccines|vaccines|mesh-list
139016759|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
139016760|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016761|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139016762|NCT01036035|Pilocarpine|pilocarpine|mesh-list
139016763|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139016764|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139016765|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
139016766|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016767|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016768|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767470|NCT04624178|Nivolumab|nivolumab|mesh-list
138767471|NCT04624178|Rucaparib|rucaparib|mesh-list
139016769|NCT01036035|Urological Agents|urological agents|mesh-ancestor
139016770|NCT01036035|Miotics|miotics|mesh-ancestor
139016771|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
139016772|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016773|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139016774|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139016775|NCT01036659|Ecallantide|ecallantide|mesh-list
139016776|NCT01036659|Bradykinin|bradykinin|mesh-list
139016777|NCT01036659|Kallikreins|kallikreins|mesh-list
139016778|NCT01036659|Kininogens|kininogens|mesh-list
139016779|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
139016780|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139016781|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
139016782|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016783|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016784|NCT01036659|Analgesics|analgesics|mesh-ancestor
139016785|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
139016786|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016787|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016788|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139016789|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139016790|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139016791|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016792|NCT01036659|Coagulants|coagulants|mesh-ancestor
139016793|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
139016794|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
139016795|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139016796|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
139016797|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139016798|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
139016799|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016800|NCT01033149|Expectorants|expectorants|mesh-ancestor
139016801|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
139016802|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139016803|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
139016804|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016805|NCT01033149|Protective Agents|protective agents|mesh-ancestor
139016806|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016807|NCT01033149|Antidotes|antidotes|mesh-ancestor
139016808|NCT06051344|Zoledronic Acid|zoledronic acid|mesh-list
139016809|NCT06051344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139016810|NCT06051344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016811|NCT06051240|Lithium Carbonate|lithium carbonate|mesh-list
139016812|NCT06051240|Antidepressive Agents|antidepressive agents|mesh-ancestor
139016813|NCT06051240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139016814|NCT06051240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016815|NCT06051240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016816|NCT06051240|Antimanic Agents|antimanic agents|mesh-ancestor
139016817|NCT06051240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139016818|NCT06051240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016819|NCT06051240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016820|NCT06050941|Cytarabine|cytarabine|mesh-list
139016821|NCT06050941|Idarubicin|idarubicin|mesh-list
139016822|NCT06050941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139016823|NCT06050941|Antimetabolites|antimetabolites|mesh-ancestor
139016824|NCT06050941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016825|NCT06050941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016826|NCT06050941|Antiviral Agents|antiviral agents|mesh-ancestor
139016827|NCT06050941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016828|NCT06050941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139016829|NCT06050941|Immunologic Factors|immunologic factors|mesh-ancestor
139016830|NCT06050941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016831|NCT06050941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139016832|NCT06050941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139016833|NCT06050941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139016834|NCT06050941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016835|NCT06050863|Chlorhexidine|chlorhexidine|mesh-list
139016836|NCT06050863|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139016837|NCT06050863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139016838|NCT06050863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016839|NCT06050863|Disinfectants|disinfectants|mesh-ancestor
139016840|NCT06050863|Dermatologic Agents|dermatologic agents|mesh-ancestor
139016841|NCT06050785|Vancomycin|vancomycin|mesh-list
139016842|NCT06050785|Gentamicins|gentamicins|mesh-list
139016843|NCT06050785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139016844|NCT06050785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016845|NCT06050785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139016846|NCT06050785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016847|NCT06050785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016849|NCT06180759|Analgesics|analgesics|mesh-ancestor
139016850|NCT06180759|Sensory System Agents|sensory system agents|mesh-ancestor
139016851|NCT06180759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016852|NCT06180759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016853|NCT06180759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139016854|NCT06180759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139016855|NCT06180759|Anesthetics, General|anesthetics, general|mesh-ancestor
139016856|NCT06180759|Anesthetics|anesthetics|mesh-ancestor
139016857|NCT06180759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016858|NCT06180759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139016859|NCT06180759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139016860|NCT06180759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016861|NCT06180759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016862|NCT06180733|Pembrolizumab|pembrolizumab|mesh-list
139016863|NCT06180733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139016864|NCT06180733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139016865|NCT06180733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139016866|NCT06180733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016868|NCT06180720|Carbidopa|carbidopa|mesh-list
139016869|NCT06180720|Entacapone|entacapone|mesh-list
139016870|NCT06180720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139016871|NCT06180720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139016872|NCT06180720|Dopamine Agents|dopamine agents|mesh-ancestor
139016873|NCT06180720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016874|NCT06180720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016875|NCT06180720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016876|NCT06180720|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139016877|NCT06180720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016878|NCT06180720|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139016879|NCT06180707|Listerine|listerine|mesh-list
138534024|NCT00043940|Bivalirudin|bivalirudin|mesh-list
139016880|NCT06180707|Pregabalin|pregabalin|mesh-list
139016881|NCT06180707|Fluorides|fluorides|mesh-list
139016882|NCT06180707|Sodium Fluoride|sodium fluoride|mesh-list
139016883|NCT06180707|Cariostatic Agents|cariostatic agents|mesh-ancestor
139016884|NCT06180707|Protective Agents|protective agents|mesh-ancestor
139016885|NCT06180707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016886|NCT06180707|Analgesics|analgesics|mesh-ancestor
139016887|NCT06180707|Sensory System Agents|sensory system agents|mesh-ancestor
139016888|NCT06180707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016889|NCT06180707|Anticonvulsants|anticonvulsants|mesh-ancestor
139016890|NCT06180707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139016891|NCT06180707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139016892|NCT06180707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016893|NCT06180707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139016894|NCT06180707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139016895|NCT06180707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139016896|NCT06180707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016897|NCT06180707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138534056|NCT00078195|Omalizumab|omalizumab|mesh-list
139016898|NCT06180707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139016899|NCT06180707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016901|NCT06180590|Velpatasvir|velpatasvir|mesh-list
139016902|NCT06180590|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139016903|NCT06180590|Antiviral Agents|antiviral agents|mesh-ancestor
139016904|NCT06180590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016905|NCT06180447|Vaccines|vaccines|mesh-list
139016906|NCT06180447|Immunologic Factors|immunologic factors|mesh-ancestor
139016907|NCT06180447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016908|NCT06180382|Adalimumab|adalimumab|mesh-list
139016909|NCT06180382|Vedolizumab|vedolizumab|mesh-list
139016910|NCT06180382|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139016911|NCT06180382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139016912|NCT06180382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016913|NCT06180382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139016914|NCT06180226|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139016915|NCT06180226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139016916|NCT06180226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016917|NCT06180200|Analgesics, Opioid|analgesics, opioid|mesh-list
139016918|NCT06180200|Narcotics|narcotics|mesh-ancestor
139016919|NCT06180200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016920|NCT06180200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016921|NCT06180200|Analgesics|analgesics|mesh-ancestor
138767616|NCT03641456|Bortezomib|bortezomib|mesh-list
139016922|NCT06180200|Sensory System Agents|sensory system agents|mesh-ancestor
139016923|NCT06180200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016924|NCT06180109|Empagliflozin|empagliflozin|mesh-list
139016925|NCT06180109|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139016926|NCT06180109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016927|NCT06180109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139016928|NCT06180109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016929|NCT06180070|Acetaminophen|acetaminophen|mesh-list
139016931|NCT06180070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139016932|NCT06180070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139016933|NCT06180070|Analgesics|analgesics|mesh-ancestor
139016934|NCT06180070|Sensory System Agents|sensory system agents|mesh-ancestor
139016935|NCT06180070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016936|NCT06180070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016937|NCT06180070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139016938|NCT06180070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139016939|NCT06180070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139016940|NCT06180070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016941|NCT06180070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016942|NCT06180070|Antipyretics|antipyretics|mesh-ancestor
139016943|NCT06180031|Magnesium Sulfate|magnesium sulfate|mesh-list
139016944|NCT06180031|Bupivacaine|bupivacaine|mesh-list
139016945|NCT06180031|Anesthetics, Local|anesthetics, local|mesh-ancestor
139016946|NCT06180031|Anesthetics|anesthetics|mesh-ancestor
139016947|NCT06180031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016948|NCT06180031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016949|NCT06180031|Sensory System Agents|sensory system agents|mesh-ancestor
138974587|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
139016950|NCT06180031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016951|NCT06180031|Analgesics|analgesics|mesh-ancestor
139016952|NCT06180031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139016953|NCT06180031|Anticonvulsants|anticonvulsants|mesh-ancestor
139016954|NCT06180031|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139016955|NCT06180031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139016956|NCT06180031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016957|NCT06180031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139016958|NCT06180031|Tocolytic Agents|tocolytic agents|mesh-ancestor
139016959|NCT06180031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139016960|NCT06179719|Propofol|propofol|mesh-list
139016961|NCT06179719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139016962|NCT06179719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016963|NCT06179719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016964|NCT06179719|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139016965|NCT06179719|Anesthetics, General|anesthetics, general|mesh-ancestor
139016966|NCT06179719|Anesthetics|anesthetics|mesh-ancestor
139016967|NCT06179706|Choline|choline|mesh-list
139016968|NCT06179706|Lipotropic Agents|lipotropic agents|mesh-ancestor
139016969|NCT06179706|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139016970|NCT06179706|Antimetabolites|antimetabolites|mesh-ancestor
139016971|NCT06179706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016972|NCT06179706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139016973|NCT06179706|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139016974|NCT06179706|Nootropic Agents|nootropic agents|mesh-ancestor
139016975|NCT06179485|Ketamine|ketamine|mesh-list
139016976|NCT06179485|Etomidate|etomidate|mesh-list
139016977|NCT06179485|Analgesics|analgesics|mesh-ancestor
139016978|NCT06179485|Sensory System Agents|sensory system agents|mesh-ancestor
139016979|NCT06179485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139016980|NCT06179485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016981|NCT06179485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139016982|NCT06179485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139016983|NCT06179485|Anesthetics, General|anesthetics, general|mesh-ancestor
139016984|NCT06179485|Anesthetics|anesthetics|mesh-ancestor
139016985|NCT06179485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139016986|NCT06179485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139016987|NCT06179485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139016988|NCT06179485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139016989|NCT06179485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016990|NCT06179485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139016991|NCT06175494|Vaccines|vaccines|mesh-list
139016992|NCT06175494|Immunologic Factors|immunologic factors|mesh-ancestor
139016993|NCT06175494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016994|NCT06173219|Immunomodulating Agents|immunomodulating agents|mesh-list
139016995|NCT06173219|Immunologic Factors|immunologic factors|mesh-ancestor
139016996|NCT06173219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016997|NCT06169280|Acetylcysteine|acetylcysteine|mesh-list
139016998|NCT06169280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139016999|NCT06169280|Antiviral Agents|antiviral agents|mesh-ancestor
139017000|NCT06169280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139017001|NCT06169280|Expectorants|expectorants|mesh-ancestor
139017002|NCT06169280|Respiratory System Agents|respiratory system agents|mesh-ancestor
139017003|NCT06169280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139017004|NCT06169280|Antioxidants|antioxidants|mesh-ancestor
139017005|NCT06169280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017006|NCT06169280|Protective Agents|protective agents|mesh-ancestor
139017007|NCT06169280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017008|NCT06169280|Antidotes|antidotes|mesh-ancestor
139017009|NCT06164821|Luspatercept|luspatercept|mesh-list
139017010|NCT06164821|Hematinics|hematinics|mesh-ancestor
139017011|NCT06162806|Magnesium Sulfate|magnesium sulfate|mesh-list
139017013|NCT06162806|Bupivacaine|bupivacaine|mesh-list
139017014|NCT06162806|Anesthetics, Local|anesthetics, local|mesh-ancestor
139017015|NCT06162806|Anesthetics|anesthetics|mesh-ancestor
139017016|NCT06162806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139017017|NCT06162806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017018|NCT06162806|Sensory System Agents|sensory system agents|mesh-ancestor
139017019|NCT06162806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017020|NCT06162806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139017021|NCT06162806|Narcotics|narcotics|mesh-ancestor
139017022|NCT06162806|Analgesics|analgesics|mesh-ancestor
139017023|NCT06162806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139017024|NCT06162806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139017025|NCT06162806|Anesthetics, General|anesthetics, general|mesh-ancestor
139017026|NCT06162806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139017027|NCT06162806|Anticonvulsants|anticonvulsants|mesh-ancestor
139017028|NCT06162806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139017029|NCT06162806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139017030|NCT06162806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534306|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
139017031|NCT06162806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139017033|NCT06162806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139017034|NCT06158841|Dexamethasone|dexamethasone|mesh-list
139017036|NCT06158841|Pomalidomide|pomalidomide|mesh-list
139017037|NCT06158841|Elotuzumab|elotuzumab|mesh-list
139017038|NCT06158841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139017039|NCT06158841|Antiemetics|antiemetics|mesh-ancestor
139017040|NCT06158841|Autonomic Agents|autonomic agents|mesh-ancestor
139017041|NCT06158841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017042|NCT06158841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017043|NCT06158841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139017044|NCT06158841|Glucocorticoids|glucocorticoids|mesh-ancestor
139017045|NCT06158841|Hormones|hormones|mesh-ancestor
139017046|NCT06158841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139017047|NCT06158841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139017048|NCT06158841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017049|NCT06158841|Immunologic Factors|immunologic factors|mesh-ancestor
139017050|NCT06158841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017051|NCT06158841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139017052|NCT06158841|Growth Substances|growth substances|mesh-ancestor
139017053|NCT06158841|Growth Inhibitors|growth inhibitors|mesh-ancestor
139017054|NCT06158620|Diclofenac|diclofenac|mesh-list
139017055|NCT06158620|Ketorolac|ketorolac|mesh-list
139017056|NCT06158620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139017057|NCT06158620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139017058|NCT06158620|Analgesics|analgesics|mesh-ancestor
139017059|NCT06158620|Sensory System Agents|sensory system agents|mesh-ancestor
139017060|NCT06158620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017061|NCT06158620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017062|NCT06158620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139017063|NCT06158620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139017064|NCT06158620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139017065|NCT06158620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017066|NCT06158620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017067|NCT06143670|Listerine|listerine|mesh-list
139017068|NCT06143670|Fluorides|fluorides|mesh-list
139017069|NCT06143670|Sodium Fluoride|sodium fluoride|mesh-list
139017070|NCT06143670|Tin Fluorides|tin fluorides|mesh-list
139017071|NCT06143670|Cariostatic Agents|cariostatic agents|mesh-ancestor
139017072|NCT06143670|Protective Agents|protective agents|mesh-ancestor
139017073|NCT06143670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017074|NCT06143670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138767767|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
139017075|NCT06143670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139017076|NCT06131593|Dexamethasone|dexamethasone|mesh-list
139017077|NCT06131593|Methylprednisolone|methylprednisolone|mesh-list
139017078|NCT06131593|Anesthetics|anesthetics|mesh-list
139017079|NCT06131593|Anesthetics, Local|anesthetics, local|mesh-list
139017080|NCT06131593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139017081|NCT06131593|Antiemetics|antiemetics|mesh-ancestor
139017082|NCT06131593|Autonomic Agents|autonomic agents|mesh-ancestor
139017083|NCT06131593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017084|NCT06131593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600158|NCT00158834|Xhance|xhance|mesh-list
139017085|NCT06131593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139017086|NCT06131593|Glucocorticoids|glucocorticoids|mesh-ancestor
139017087|NCT06131593|Hormones|hormones|mesh-ancestor
139017088|NCT06131593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139017089|NCT06131593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139017090|NCT06131593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017091|NCT06131593|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139017092|NCT06131593|Protective Agents|protective agents|mesh-ancestor
139017093|NCT06131593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139017094|NCT06131593|Sensory System Agents|sensory system agents|mesh-ancestor
139017095|NCT06107738|Daratumumab|daratumumab|mesh-list
139017096|NCT06107738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139017097|NCT06107738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017098|NCT06107738|Immunologic Factors|immunologic factors|mesh-ancestor
139017099|NCT06107738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017100|NCT06098144|Nicotine|nicotine|mesh-list
139017101|NCT06098144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139017102|NCT06098144|Autonomic Agents|autonomic agents|mesh-ancestor
139017103|NCT06098144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017104|NCT06098144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017105|NCT06098144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139017106|NCT06098144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139017107|NCT06098144|Cholinergic Agents|cholinergic agents|mesh-ancestor
139017108|NCT06098144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139017109|NCT06098144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017110|NCT06096714|Nicotine|nicotine|mesh-list
139017111|NCT06096714|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139017112|NCT06096714|Autonomic Agents|autonomic agents|mesh-ancestor
139017113|NCT06096714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017114|NCT06096714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017115|NCT06096714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139017116|NCT06096714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139017117|NCT06096714|Cholinergic Agents|cholinergic agents|mesh-ancestor
139017118|NCT06096714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139017119|NCT06096714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017120|NCT06095973|Ropivacaine|ropivacaine|mesh-list
139017121|NCT06095973|Anesthetics, Local|anesthetics, local|mesh-ancestor
139017122|NCT06095973|Anesthetics|anesthetics|mesh-ancestor
139017123|NCT06095973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139017124|NCT06095973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017125|NCT06095973|Sensory System Agents|sensory system agents|mesh-ancestor
139017126|NCT06095973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017127|NCT06083571|Diphenhydramine|diphenhydramine|mesh-list
139017128|NCT06083571|Promethazine|promethazine|mesh-list
139017129|NCT06083571|Ketorolac|ketorolac|mesh-list
139017130|NCT06083571|Prochlorperazine|prochlorperazine|mesh-list
139017131|NCT06083571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139017132|NCT06083571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139017133|NCT06083571|Analgesics|analgesics|mesh-ancestor
139017134|NCT06083571|Sensory System Agents|sensory system agents|mesh-ancestor
139017135|NCT06083571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017136|NCT06083571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017137|NCT06083571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139017138|NCT06083571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139017139|NCT06083571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139017140|NCT06083571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974698|NCT00938730|Warfarin|warfarin|mesh-list
139017141|NCT06083571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017142|NCT06083571|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139017143|NCT06083571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139017144|NCT06083571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139017145|NCT06083571|Anesthetics, Local|anesthetics, local|mesh-ancestor
139017148|NCT06083571|Autonomic Agents|autonomic agents|mesh-ancestor
139017149|NCT06083571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139017150|NCT06083571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139017151|NCT06083571|Histamine Antagonists|histamine antagonists|mesh-ancestor
139017152|NCT06083571|Histamine Agents|histamine agents|mesh-ancestor
139017153|NCT06083571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139017154|NCT06083571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139017155|NCT06083571|Antipruritics|antipruritics|mesh-ancestor
139017156|NCT06083571|Dermatologic Agents|dermatologic agents|mesh-ancestor
139017157|NCT06083571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139017158|NCT06083571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139017159|NCT06083571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139017160|NCT06083571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139017161|NCT06083571|Dopamine Agents|dopamine agents|mesh-ancestor
139017162|NCT06061536|Lamivudine|lamivudine|mesh-list
139017163|NCT06061536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139017164|NCT06061536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139017165|NCT06061536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017166|NCT06061536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017167|NCT06061536|Antiviral Agents|antiviral agents|mesh-ancestor
139017168|NCT06061536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139017169|NCT06061536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139017170|NCT06061536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139017171|NCT06060587|Docetaxel|docetaxel|mesh-list
139017173|NCT06060587|Tubulin Modulators|tubulin modulators|mesh-ancestor
139017174|NCT06060587|Antimitotic Agents|antimitotic agents|mesh-ancestor
139017175|NCT06060587|Mitosis Modulators|mitosis modulators|mesh-ancestor
139017176|NCT06060587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017177|NCT06055075|Daratumumab|daratumumab|mesh-list
139017178|NCT06055075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017179|NCT06027229|Vaccines|vaccines|mesh-list
139017180|NCT06027229|Immunologic Factors|immunologic factors|mesh-ancestor
139017181|NCT06027229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017182|NCT06026033|Desflurane|desflurane|mesh-list
139017183|NCT06026033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139017184|NCT06026033|Anesthetics, General|anesthetics, general|mesh-ancestor
139017185|NCT06026033|Anesthetics|anesthetics|mesh-ancestor
139017186|NCT06026033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139017187|NCT06026033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017188|NCT06017297|Gemcitabine|gemcitabine|mesh-list
139017189|NCT06017297|Durvalumab|durvalumab|mesh-list
139017190|NCT06017297|Tremelimumab|tremelimumab|mesh-list
139017191|NCT06017297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017192|NCT06017297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139017194|NCT06017297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017195|NCT06017297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017196|NCT05976230|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139017197|NCT05976230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139017198|NCT05976230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017199|NCT05969223|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139017200|NCT05969223|Immunologic Factors|immunologic factors|mesh-ancestor
139017201|NCT05969223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017202|NCT05968326|Atezolizumab|atezolizumab|mesh-list
139017203|NCT05968326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017204|NCT05968326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017205|NCT05968326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017206|NCT05968326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017207|NCT05966584|Fulvestrant|fulvestrant|mesh-list
139017208|NCT05966584|Benralizumab|benralizumab|mesh-list
139017209|NCT05966584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139017210|NCT05966584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017211|NCT05966584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139017212|NCT05966584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139017213|NCT05966584|Hormone Antagonists|hormone antagonists|mesh-ancestor
139017214|NCT05966584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139017215|NCT05966584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017216|NCT05966584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139017217|NCT05966584|Respiratory System Agents|respiratory system agents|mesh-ancestor
139017218|NCT05964868|Epinephrine|epinephrine|mesh-list
139017219|NCT05964868|Bupivacaine|bupivacaine|mesh-list
139017220|NCT05964868|Anesthetics, Local|anesthetics, local|mesh-ancestor
139017221|NCT05964868|Anesthetics|anesthetics|mesh-ancestor
139017222|NCT05964868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139017223|NCT05964868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017224|NCT05964868|Sensory System Agents|sensory system agents|mesh-ancestor
139017225|NCT05964868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017226|NCT05964868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139017227|NCT05964868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139017228|NCT05964868|Adrenergic Agents|adrenergic agents|mesh-ancestor
139017229|NCT05964868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139017230|NCT05964868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017231|NCT05964868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139017232|NCT05964868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139017233|NCT05964868|Autonomic Agents|autonomic agents|mesh-ancestor
139017234|NCT05964868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139017235|NCT05964868|Respiratory System Agents|respiratory system agents|mesh-ancestor
139017236|NCT05964868|Mydriatics|mydriatics|mesh-ancestor
139017237|NCT05964868|Sympathomimetics|sympathomimetics|mesh-ancestor
139017238|NCT05964868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139017239|NCT05954143|Pertuzumab|pertuzumab|mesh-list
139017240|NCT05954143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017241|NCT05954143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017242|NCT05945615|Phenylephrine|phenylephrine|mesh-list
139017243|NCT05945615|Oxymetazoline|oxymetazoline|mesh-list
139017244|NCT05945615|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139017245|NCT05945615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139017246|NCT05945615|Adrenergic Agents|adrenergic agents|mesh-ancestor
139017247|NCT05945615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139017248|NCT05945615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017249|NCT05945615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017250|NCT05945615|Sympathomimetics|sympathomimetics|mesh-ancestor
139017251|NCT05945615|Autonomic Agents|autonomic agents|mesh-ancestor
139017252|NCT05945615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017253|NCT05945615|Nasal Decongestants|nasal decongestants|mesh-ancestor
139017254|NCT05945615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139017255|NCT05945615|Respiratory System Agents|respiratory system agents|mesh-ancestor
139017256|NCT05945615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139017257|NCT05945615|Mydriatics|mydriatics|mesh-ancestor
139017258|NCT05945615|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139017259|NCT05945615|Protective Agents|protective agents|mesh-ancestor
139017260|NCT05926960|Pembrolizumab|pembrolizumab|mesh-list
139017261|NCT05926960|Nivolumab|nivolumab|mesh-list
139017262|NCT05926960|Ipilimumab|ipilimumab|mesh-list
139017263|NCT05926960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017264|NCT05926960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017265|NCT05926960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017266|NCT05926960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017267|NCT05908786|Bevacizumab|bevacizumab|mesh-list
139017269|NCT05908786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017270|NCT05908786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017271|NCT05908786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017272|NCT05908786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139017273|NCT05908786|Growth Substances|growth substances|mesh-ancestor
139017274|NCT05908786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017275|NCT05908786|Growth Inhibitors|growth inhibitors|mesh-ancestor
139017276|NCT05908786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017277|NCT05908786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017278|NCT05904886|Bevacizumab|bevacizumab|mesh-list
139017279|NCT05904886|Atezolizumab|atezolizumab|mesh-list
139017280|NCT05904886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017281|NCT05904886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017282|NCT05904886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017283|NCT05904886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139017284|NCT05904886|Growth Substances|growth substances|mesh-ancestor
139017285|NCT05904886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017286|NCT05904886|Growth Inhibitors|growth inhibitors|mesh-ancestor
139017287|NCT05904886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017288|NCT05904886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017289|NCT05896748|Rilpivirine|rilpivirine|mesh-list
139017290|NCT05896748|Cabotegravir|cabotegravir|mesh-list
139017291|NCT05896748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139017292|NCT05896748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139017293|NCT05896748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974768|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139017294|NCT05896748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017295|NCT05896748|Antiviral Agents|antiviral agents|mesh-ancestor
139017296|NCT05896748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139017297|NCT05896748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139017298|NCT05896748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139017299|NCT05896748|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139017300|NCT05896748|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139017302|NCT05888532|Trace Elements|trace elements|mesh-ancestor
139017303|NCT05888532|Micronutrients|micronutrients|mesh-ancestor
139017304|NCT05888532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017305|NCT05868525|Aspirin|aspirin|mesh-list
139017306|NCT05868525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139017307|NCT05868525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139017308|NCT05868525|Analgesics|analgesics|mesh-ancestor
139017309|NCT05868525|Sensory System Agents|sensory system agents|mesh-ancestor
139017310|NCT05868525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017311|NCT05868525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017312|NCT05868525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139017313|NCT05868525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139017314|NCT05868525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139017315|NCT05868525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139017316|NCT05868525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017317|NCT05868525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139017318|NCT05868525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139017319|NCT05868525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017320|NCT05868525|Antipyretics|antipyretics|mesh-ancestor
139017321|NCT05864534|Doxorubicin|doxorubicin|mesh-list
139017322|NCT05864534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139017323|NCT05864534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139017324|NCT05864534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017325|NCT05864534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139017326|NCT05864534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139017327|NCT05864534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017328|NCT05864534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017329|NCT05856695|Paclitaxel|paclitaxel|mesh-list
139017330|NCT05856695|Carboplatin|carboplatin|mesh-list
139017331|NCT05856695|Durvalumab|durvalumab|mesh-list
139017332|NCT05856695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139017333|NCT05856695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017334|NCT05856695|Tubulin Modulators|tubulin modulators|mesh-ancestor
139017335|NCT05856695|Antimitotic Agents|antimitotic agents|mesh-ancestor
139017336|NCT05856695|Mitosis Modulators|mitosis modulators|mesh-ancestor
139017337|NCT05856695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017338|NCT05856695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017339|NCT05844982|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139017340|NCT05844982|Faricimab|faricimab|mesh-list
139017341|NCT05844982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139017342|NCT05844982|Glucocorticoids|glucocorticoids|mesh-ancestor
139017343|NCT05844982|Hormones|hormones|mesh-ancestor
139017344|NCT05844982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139017345|NCT05844982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017346|NCT05844982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017347|NCT05844982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139017348|NCT05844982|Growth Substances|growth substances|mesh-ancestor
139017349|NCT05844982|Growth Inhibitors|growth inhibitors|mesh-ancestor
139017350|NCT05844982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017351|NCT05817656|Sucralfate|sucralfate|mesh-list
139017352|NCT05817656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139017380|NCT05763875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139017381|NCT05763875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139017382|NCT05763875|Antimetabolites|antimetabolites|mesh-ancestor
139017383|NCT05763875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017384|NCT05763875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139017385|NCT05752201|Vaccines|vaccines|mesh-list
139017386|NCT05752201|Immunologic Factors|immunologic factors|mesh-ancestor
139017387|NCT05752201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017388|NCT05749393|Heparin|heparin|mesh-list
139017389|NCT05749393|Calcium heparin|calcium heparin|mesh-list
139017390|NCT05749393|Anticoagulants|anticoagulants|mesh-ancestor
139017391|NCT05749393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139017392|NCT05749393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139017393|NCT05749393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017394|NCT05722015|Paclitaxel|paclitaxel|mesh-list
139017395|NCT05722015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139017396|NCT05722015|Carboplatin|carboplatin|mesh-list
139017397|NCT05722015|Pembrolizumab|pembrolizumab|mesh-list
139017398|NCT05722015|Pemetrexed|pemetrexed|mesh-list
139017399|NCT05722015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139017400|NCT05722015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017401|NCT05722015|Tubulin Modulators|tubulin modulators|mesh-ancestor
139017402|NCT05722015|Antimitotic Agents|antimitotic agents|mesh-ancestor
139017403|NCT05722015|Mitosis Modulators|mitosis modulators|mesh-ancestor
139017404|NCT05722015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017405|NCT05722015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017406|NCT05722015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017407|NCT05722015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017408|NCT05722015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139017409|NCT05722015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139017410|NCT05717738|Bevacizumab|bevacizumab|mesh-list
139017411|NCT05717738|Atezolizumab|atezolizumab|mesh-list
139017412|NCT05717738|Sorafenib|sorafenib|mesh-list
139017413|NCT05717738|Apatinib|apatinib|mesh-list
139017414|NCT05717738|Lenvatinib|lenvatinib|mesh-list
139017415|NCT05717738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139017416|NCT05717738|Antibodies|antibodies|mesh-list
139017417|NCT05717738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139017418|NCT05717738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017419|NCT05717738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017420|NCT05717738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017421|NCT05717738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139017422|NCT05717738|Growth Substances|growth substances|mesh-ancestor
139017423|NCT05717738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017424|NCT05717738|Growth Inhibitors|growth inhibitors|mesh-ancestor
139017425|NCT05717738|Immunologic Factors|immunologic factors|mesh-ancestor
138534962|NCT00131404|Hormones|hormones|mesh-ancestor
139017426|NCT05717738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139017427|NCT05717738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017428|NCT05717738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017430|NCT05713994|Atezolizumab|atezolizumab|mesh-list
139017431|NCT05713994|Sorafenib|sorafenib|mesh-list
139017432|NCT05713994|Apatinib|apatinib|mesh-list
139017433|NCT05713994|Lenvatinib|lenvatinib|mesh-list
139017434|NCT05713994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139017435|NCT05713994|Antibodies|antibodies|mesh-list
139017436|NCT05713994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139017437|NCT05713994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017438|NCT05713994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017439|NCT05713994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017440|NCT05713994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139017441|NCT05713994|Growth Substances|growth substances|mesh-ancestor
139017442|NCT05713994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017443|NCT05713994|Growth Inhibitors|growth inhibitors|mesh-ancestor
139017444|NCT05713994|Immunologic Factors|immunologic factors|mesh-ancestor
139017445|NCT05713994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139017446|NCT05713994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017447|NCT05713994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017449|NCT05695573|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139017450|NCT05695573|Protease Inhibitors|protease inhibitors|mesh-ancestor
139017451|NCT05695573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017452|NCT05695573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017453|NCT05683977|Durvalumab|durvalumab|mesh-list
139017454|NCT05683977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017455|NCT05683977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017456|NCT05674487|Misoprostol|misoprostol|mesh-list
139017457|NCT05674487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139017458|NCT05674487|Abortifacient Agents|abortifacient agents|mesh-ancestor
139017459|NCT05674487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139017460|NCT05674487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017461|NCT05674487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139017462|NCT05674487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139017463|NCT05674487|Oxytocics|oxytocics|mesh-ancestor
139017464|NCT05656508|Vaccines|vaccines|mesh-list
139017465|NCT05656508|Immunologic Factors|immunologic factors|mesh-ancestor
139017466|NCT05656508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017467|NCT05651594|Leucovorin|leucovorin|mesh-list
139017468|NCT05651594|Pembrolizumab|pembrolizumab|mesh-list
139017469|NCT05651594|Fluorouracil|fluorouracil|mesh-list
139017470|NCT05651594|Oxaliplatin|oxaliplatin|mesh-list
139017471|NCT05651594|Propranolol|propranolol|mesh-list
139017472|NCT05651594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017473|NCT05651594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017474|NCT05651594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017475|NCT05651594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017476|NCT05651594|Antimetabolites|antimetabolites|mesh-ancestor
139017477|NCT05651594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139017478|NCT05651594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139017479|NCT05651594|Immunologic Factors|immunologic factors|mesh-ancestor
139017480|NCT05651594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017481|NCT05651594|Antidotes|antidotes|mesh-ancestor
139017482|NCT05651594|Protective Agents|protective agents|mesh-ancestor
139017483|NCT05651594|Vitamin B Complex|vitamin b complex|mesh-ancestor
139017484|NCT05651594|Vitamins|vitamins|mesh-ancestor
139017485|NCT05651594|Micronutrients|micronutrients|mesh-ancestor
139017486|NCT05651594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139017487|NCT05651594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139017488|NCT05651594|Adrenergic Agents|adrenergic agents|mesh-ancestor
139017489|NCT05651594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139017490|NCT05651594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139017491|NCT05651594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139017492|NCT05651594|Vasodilator Agents|vasodilator agents|mesh-ancestor
139017493|NCT05649748|Treprostinil|treprostinil|mesh-list
139017494|NCT05649748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139017495|NCT05645432|Pregnanolone|pregnanolone|mesh-list
139017496|NCT05645432|Brexanolone|brexanolone|mesh-list
139017497|NCT05645432|Anesthetics|anesthetics|mesh-ancestor
139017498|NCT05645432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139017499|NCT05645432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017500|NCT05645432|Neurosteroids|neurosteroids|mesh-ancestor
139017503|NCT05645432|GABA Modulators|gaba modulators|mesh-ancestor
139017504|NCT05645432|GABA Agents|gaba agents|mesh-ancestor
139017505|NCT05641324|Dexamethasone|dexamethasone|mesh-list
139017506|NCT05641324|Lenalidomide|lenalidomide|mesh-list
139017507|NCT05641324|Daratumumab|daratumumab|mesh-list
139017508|NCT05641324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139017509|NCT05641324|Antiemetics|antiemetics|mesh-ancestor
139017510|NCT05641324|Autonomic Agents|autonomic agents|mesh-ancestor
139017511|NCT05641324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017512|NCT05641324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017513|NCT05641324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139017514|NCT05641324|Glucocorticoids|glucocorticoids|mesh-ancestor
139017515|NCT05641324|Hormones|hormones|mesh-ancestor
139017516|NCT05641324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139017517|NCT05641324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138535107|NCT00080340|Gefitinib|gefitinib|mesh-list
139017518|NCT05641324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017519|NCT05641324|Immunologic Factors|immunologic factors|mesh-ancestor
139017520|NCT05641324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017521|NCT05641324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139017522|NCT05641324|Growth Substances|growth substances|mesh-ancestor
139017523|NCT05641324|Growth Inhibitors|growth inhibitors|mesh-ancestor
139017524|NCT05631041|Silymarin|silymarin|mesh-list
139017525|NCT05631041|Antioxidants|antioxidants|mesh-ancestor
139017526|NCT05631041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017527|NCT05631041|Protective Agents|protective agents|mesh-ancestor
138768222|NCT00976677|Antibodies|antibodies|mesh-list
139017528|NCT05631041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017529|NCT05612490|Furosemide|furosemide|mesh-list
139017530|NCT05612490|Diuretics|diuretics|mesh-ancestor
139017531|NCT05612490|Natriuretic Agents|natriuretic agents|mesh-ancestor
139017532|NCT05612490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017533|NCT05612490|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139017534|NCT05612490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139017535|NCT05612490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017537|NCT05610735|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139017538|NCT05610735|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139017539|NCT05610735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017540|NCT05610735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139017541|NCT05610735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139017542|NCT05610735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017543|NCT05610735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017544|NCT05597917|Trabectedin|trabectedin|mesh-list
139017545|NCT05597917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139017546|NCT05597917|Alkylating Agents|alkylating agents|mesh-ancestor
139017547|NCT05597917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017548|NCT05597917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017549|NCT05583227|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139017550|NCT05583227|Immunologic Factors|immunologic factors|mesh-ancestor
139017551|NCT05583227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017552|NCT05578872|Pembrolizumab|pembrolizumab|mesh-list
139017553|NCT05578872|Ipilimumab|ipilimumab|mesh-list
139017554|NCT05578872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017555|NCT05578872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017556|NCT05578872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017557|NCT05578872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017558|NCT05566756|Ofatumumab|ofatumumab|mesh-list
139017559|NCT05566756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974842|NCT00823940|Glucagon|glucagon|mesh-list
139017586|NCT05493566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017587|NCT05493566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017588|NCT05493566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139017589|NCT05493566|Analgesics|analgesics|mesh-ancestor
139017590|NCT05493566|Sensory System Agents|sensory system agents|mesh-ancestor
139017591|NCT05493566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017592|NCT05493566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017593|NCT05493566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139017594|NCT05493566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139017595|NCT05493566|Antiviral Agents|antiviral agents|mesh-ancestor
139017596|NCT05493566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139017598|NCT05488678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139017599|NCT05488678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139017600|NCT05468359|Cyclophosphamide|cyclophosphamide|mesh-list
139017601|NCT05468359|Bevacizumab|bevacizumab|mesh-list
139017602|NCT05468359|Sorafenib|sorafenib|mesh-list
139017603|NCT05468359|Atezolizumab|atezolizumab|mesh-list
139017604|NCT05468359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138768296|NCT00644137|Pregabalin|pregabalin|mesh-list
139017605|NCT05468359|Immunologic Factors|immunologic factors|mesh-ancestor
139017606|NCT05468359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017607|NCT05468359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139017608|NCT05468359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139017609|NCT05468359|Alkylating Agents|alkylating agents|mesh-ancestor
139017610|NCT05468359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017611|NCT05468359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017612|NCT05468359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139017613|NCT05468359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017614|NCT05468359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017615|NCT05468359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139017616|NCT05468359|Growth Substances|growth substances|mesh-ancestor
139017617|NCT05468359|Growth Inhibitors|growth inhibitors|mesh-ancestor
139017618|NCT05468359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139017619|NCT05468359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017620|NCT05468359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017635|NCT05462613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017636|NCT05462613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017637|NCT05462613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139017638|NCT05462613|Growth Substances|growth substances|mesh-ancestor
139017639|NCT05462613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017640|NCT05462613|Growth Inhibitors|growth inhibitors|mesh-ancestor
139017641|NCT05462613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139017642|NCT05462613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139017643|NCT05462613|Analgesics|analgesics|mesh-ancestor
139017644|NCT05462613|Sensory System Agents|sensory system agents|mesh-ancestor
139017645|NCT05462613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017646|NCT05462613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139017647|NCT05462613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139017648|NCT05462613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139017649|NCT05462613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139017650|NCT05462613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535265|NCT00133315|Adalimumab|adalimumab|mesh-list
139017651|NCT05462613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139017652|NCT05462613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139017653|NCT05462613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017654|NCT05462613|Antipyretics|antipyretics|mesh-ancestor
139017655|NCT05402293|Lidocaine|lidocaine|mesh-list
139017656|NCT05402293|Anesthetics, Local|anesthetics, local|mesh-ancestor
139017657|NCT05402293|Anesthetics|anesthetics|mesh-ancestor
139017658|NCT05402293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139017659|NCT05402293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017660|NCT05402293|Sensory System Agents|sensory system agents|mesh-ancestor
139017661|NCT05402293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017662|NCT05402293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138535310|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
139017663|NCT05402293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139017664|NCT05402293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139017665|NCT05402293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139017666|NCT05402293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017667|NCT05392946|Dexamethasone|dexamethasone|mesh-list
139017668|NCT05392946|Dexamethasone acetate|dexamethasone acetate|mesh-list
139017669|NCT05392946|Bortezomib|bortezomib|mesh-list
139017670|NCT05392946|Daratumumab|daratumumab|mesh-list
139017671|NCT05392946|Ichthammol|ichthammol|mesh-list
139017672|NCT05392946|BB 1101|bb 1101|mesh-list
139017673|NCT05392946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139017674|NCT05392946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139017675|NCT05392946|Antiemetics|antiemetics|mesh-ancestor
139017676|NCT05392946|Autonomic Agents|autonomic agents|mesh-ancestor
139017677|NCT05392946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017678|NCT05392946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017679|NCT05392946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139017680|NCT05392946|Glucocorticoids|glucocorticoids|mesh-ancestor
139017681|NCT05392946|Hormones|hormones|mesh-ancestor
139017682|NCT05392946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139017683|NCT05392946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139017684|NCT05392946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017685|NCT05392946|Protease Inhibitors|protease inhibitors|mesh-ancestor
139017686|NCT05392946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017687|NCT05392946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017688|NCT05392946|Immunologic Factors|immunologic factors|mesh-ancestor
139017689|NCT05392946|Dermatologic Agents|dermatologic agents|mesh-ancestor
139017690|NCT05382299|Paclitaxel|paclitaxel|mesh-list
139017691|NCT05382299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139017692|NCT05382299|Carboplatin|carboplatin|mesh-list
139017693|NCT05382299|Gemcitabine|gemcitabine|mesh-list
139017694|NCT05382299|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139017695|NCT05382299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139017697|NCT05382299|Tubulin Modulators|tubulin modulators|mesh-ancestor
139017698|NCT05382299|Antimitotic Agents|antimitotic agents|mesh-ancestor
139017699|NCT05382299|Mitosis Modulators|mitosis modulators|mesh-ancestor
139017700|NCT05382299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017701|NCT05382299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139017702|NCT05382299|Antimetabolites|antimetabolites|mesh-ancestor
139017703|NCT05382299|Immunoconjugates|immunoconjugates|mesh-ancestor
139017704|NCT05382299|Immunologic Factors|immunologic factors|mesh-ancestor
139017705|NCT05382299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017706|NCT05378737|Exatecan|exatecan|mesh-list
139017707|NCT05378737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139017708|NCT05378737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139017709|NCT05378737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017710|NCT05378737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017711|NCT05378737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017712|NCT05344469|Interferons|interferons|mesh-list
139017713|NCT05344469|Interferon-beta|interferon-beta|mesh-list
139017714|NCT05344469|Ofatumumab|ofatumumab|mesh-list
139017715|NCT05344469|Glatiramer Acetate|glatiramer acetate|mesh-list
139017716|NCT05344469|(T,G)-A-L|(t,g)-a-l|mesh-list
139017717|NCT05344469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017718|NCT05344469|Antiviral Agents|antiviral agents|mesh-ancestor
139017719|NCT05344469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139017720|NCT05344469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139017721|NCT05344469|Immunologic Factors|immunologic factors|mesh-ancestor
139017722|NCT05344469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017723|NCT05344469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139017724|NCT05344469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139017725|NCT05314400|Liver Extracts|liver extracts|mesh-list
139017726|NCT05314400|Hematinics|hematinics|mesh-ancestor
139017727|NCT05309655|Adenosine|adenosine|mesh-list
139017728|NCT05309655|Analgesics|analgesics|mesh-ancestor
139017729|NCT05309655|Sensory System Agents|sensory system agents|mesh-ancestor
139017730|NCT05309655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017731|NCT05309655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017732|NCT05309655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139017733|NCT05309655|Vasodilator Agents|vasodilator agents|mesh-ancestor
139017735|NCT05309655|Purinergic Agonists|purinergic agonists|mesh-ancestor
139017736|NCT05309655|Purinergic Agents|purinergic agents|mesh-ancestor
139017737|NCT05309655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139017738|NCT05309655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017739|NCT05305794|Insulin|insulin|mesh-list
139017740|NCT05305794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139017741|NCT05305794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139017742|NCT05305794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017743|NCT05300152|Antibodies|antibodies|mesh-list
139017744|NCT05300152|Immunoglobulins|immunoglobulins|mesh-list
139017745|NCT05300152|Immunologic Factors|immunologic factors|mesh-ancestor
139017746|NCT05300152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017748|NCT05285891|Immunologic Factors|immunologic factors|mesh-ancestor
139017749|NCT05285891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017750|NCT05281601|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139017751|NCT05281601|Antiviral Agents|antiviral agents|mesh-ancestor
139017752|NCT05281601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139017753|NCT05280548|Venglustat|venglustat|mesh-list
139017754|NCT05280548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017755|NCT05280548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017756|NCT05265546|Psilocybin|psilocybin|mesh-list
139017757|NCT05265546|Hallucinogens|hallucinogens|mesh-ancestor
139017758|NCT05265546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017759|NCT05265546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139017760|NCT05232929|Risdiplam|risdiplam|mesh-list
139017761|NCT05232929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139017762|NCT05232929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017763|NCT05232929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017764|NCT05203510|Treprostinil|treprostinil|mesh-list
139017765|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139017766|NCT05151744|Ranibizumab|ranibizumab|mesh-list
139017767|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017768|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139017769|NCT05151744|Growth Substances|growth substances|mesh-ancestor
139017770|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017771|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
139017772|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017773|NCT05151731|Ranibizumab|ranibizumab|mesh-list
139017774|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017775|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139017776|NCT05151731|Growth Substances|growth substances|mesh-ancestor
139017777|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017778|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
139017779|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017780|NCT05141721|Leucovorin|leucovorin|mesh-list
139017781|NCT05141721|Bevacizumab|bevacizumab|mesh-list
139017782|NCT05141721|Ipilimumab|ipilimumab|mesh-list
139017784|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017785|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017786|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017787|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139017788|NCT05141721|Growth Substances|growth substances|mesh-ancestor
139017789|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017790|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
139017791|NCT05141721|Antidotes|antidotes|mesh-ancestor
139017792|NCT05141721|Protective Agents|protective agents|mesh-ancestor
139017793|NCT05141721|Vitamin B Complex|vitamin b complex|mesh-ancestor
139017794|NCT05141721|Vitamins|vitamins|mesh-ancestor
139017795|NCT05141721|Micronutrients|micronutrients|mesh-ancestor
139017796|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017797|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017798|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139017799|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
139017800|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017801|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139017802|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
139017803|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139017804|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017805|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139017806|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139017807|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139017808|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
139017809|NCT05126901|Ferric maltol|ferric maltol|mesh-list
139017810|NCT05126901|Hematinics|hematinics|mesh-ancestor
139017811|NCT05096728|Nifedipine|nifedipine|mesh-list
139017812|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139017813|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139017814|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017815|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139017816|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017817|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
139017818|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
139017819|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139017820|NCT05094154|Penicillins|penicillins|mesh-list
139017821|NCT05094154|Cephalosporins|cephalosporins|mesh-list
139017822|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139017823|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139017824|NCT05076149|Ivacaftor|ivacaftor|mesh-list
139017825|NCT05076149|Elexacaftor|elexacaftor|mesh-list
139017826|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139017827|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139017828|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017829|NCT05059522|Pemetrexed|pemetrexed|mesh-list
139017830|NCT05059522|Avelumab|avelumab|mesh-list
138768524|NCT04175587|Tretinoin|tretinoin|mesh-list
139017831|NCT05059522|Axitinib|axitinib|mesh-list
139017832|NCT05059522|Talazoparib|talazoparib|mesh-list
138535765|NCT00134992|Hormones|hormones|mesh-ancestor
139017833|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017834|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017835|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017836|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139017837|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139017838|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017839|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139017840|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139017841|NCT05030766|Nicotine|nicotine|mesh-list
139017842|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139017843|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
139017844|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017845|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017846|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138535819|NCT00145210|Atenolol|atenolol|mesh-list
139017847|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139017848|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
139017849|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139017850|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017851|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
139017852|NCT04989803|Fludarabine|fludarabine|mesh-list
139017853|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139017854|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
139017855|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017856|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139017857|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139017858|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
139017859|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017860|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017861|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139017862|NCT04975555|Siltuximab|siltuximab|mesh-list
139017863|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017864|NCT04933227|Capecitabine|capecitabine|mesh-list
139017865|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
139017866|NCT04933227|Atezolizumab|atezolizumab|mesh-list
139017867|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139017868|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
139017869|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017870|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017871|NCT04933227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017872|NCT04933227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017873|NCT04931342|Maytansine|maytansine|mesh-list
139017874|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139017875|NCT04931342|Cyclophosphamide|cyclophosphamide|mesh-list
139017876|NCT04931342|Bevacizumab|bevacizumab|mesh-list
139017877|NCT04931342|Trastuzumab|trastuzumab|mesh-list
139017878|NCT04931342|Atezolizumab|atezolizumab|mesh-list
139017879|NCT04931342|Letrozole|letrozole|mesh-list
139017880|NCT04931342|Olaparib|olaparib|mesh-list
139017881|NCT04931342|Palbociclib|palbociclib|mesh-list
139017882|NCT04931342|Ipatasertib|ipatasertib|mesh-list
139017883|NCT04931342|Hormones|hormones|mesh-list
139017884|NCT04931342|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139017885|NCT04931342|Inavolisib|inavolisib|mesh-list
139017886|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139017887|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017888|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
139017889|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
139017890|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
139017891|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017892|NCT04931342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139017893|NCT04931342|Immunologic Factors|immunologic factors|mesh-ancestor
139017894|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017895|NCT04931342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139017896|NCT04931342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139017897|NCT04931342|Alkylating Agents|alkylating agents|mesh-ancestor
139017898|NCT04931342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139017899|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017900|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017901|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138535925|NCT00145990|Miotics|miotics|mesh-ancestor
139017913|NCT04931342|Immunotoxins|immunotoxins|mesh-ancestor
139017914|NCT04931342|Immunoconjugates|immunoconjugates|mesh-ancestor
139017915|NCT04931342|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139017916|NCT04925479|Niacinamide|niacinamide|mesh-list
139017917|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
139017919|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
139017920|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017921|NCT04915950|APD791|apd791|mesh-list
139017922|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139017923|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139017924|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
139017925|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139017926|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909200|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
139017927|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017940|NCT04895436|Venetoclax|venetoclax|mesh-list
139017941|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
139017942|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017943|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017944|NCT04882241|Leucovorin|leucovorin|mesh-list
139017945|NCT04882241|Docetaxel|docetaxel|mesh-list
139017946|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
139017947|NCT04882241|Capecitabine|capecitabine|mesh-list
139017948|NCT04882241|Fluorouracil|fluorouracil|mesh-list
139017949|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
139017950|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017951|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
139017952|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
139017953|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
139017954|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017956|NCT04882241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017957|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139017958|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
139017959|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139017960|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
139017961|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017962|NCT04882241|Antidotes|antidotes|mesh-ancestor
139017963|NCT04882241|Protective Agents|protective agents|mesh-ancestor
139017964|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
139017965|NCT04882241|Vitamins|vitamins|mesh-ancestor
139017966|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
139017967|NCT04871321|Paclitaxel|paclitaxel|mesh-list
139017968|NCT04871321|Gemcitabine|gemcitabine|mesh-list
139017969|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139017970|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017971|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
139017972|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
139017973|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
139017974|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017975|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139017976|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
139017977|NCT04870034|Palbociclib|palbociclib|mesh-list
139017978|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017979|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139017980|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536015|NCT00146497|Budesonide|budesonide|mesh-list
139017981|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017982|NCT04817241|Cytarabine|cytarabine|mesh-list
139017983|NCT04817241|Decitabine|decitabine|mesh-list
139017984|NCT04817241|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139017985|NCT04817241|Daunorubicin|daunorubicin|mesh-list
139017986|NCT04817241|Venetoclax|venetoclax|mesh-list
139017987|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139017988|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
139017989|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017990|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017991|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
139017992|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139017993|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139017994|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
139017995|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017996|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139017997|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138536045|NCT00146614|Sirolimus|sirolimus|mesh-list
139017998|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139017999|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018000|NCT04792385|Drospirenone|drospirenone|mesh-list
139018001|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
139018002|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
139018003|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139018004|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139018005|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018006|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139018007|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139018008|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
139018009|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139018010|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139018012|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
139018013|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
139018014|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139018015|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018016|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139018017|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139018018|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018019|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018020|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018021|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139018022|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139018023|NCT04762953|Leucovorin|leucovorin|mesh-list
139018024|NCT04762953|Paclitaxel|paclitaxel|mesh-list
139018025|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139018026|NCT04762953|Fluorouracil|fluorouracil|mesh-list
139018027|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139018028|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018029|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
139018030|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
139018031|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
139018032|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018033|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
139018034|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139018035|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139018036|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
139018037|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018038|NCT04762953|Antidotes|antidotes|mesh-ancestor
139018039|NCT04762953|Protective Agents|protective agents|mesh-ancestor
139018040|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
139018041|NCT04762953|Vitamins|vitamins|mesh-ancestor
139018042|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
139018043|NCT04735978|Nivolumab|nivolumab|mesh-list
139018044|NCT04735978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018045|NCT04735978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018046|NCT04735978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018047|NCT04735978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018048|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
139018049|NCT04700072|Lenvatinib|lenvatinib|mesh-list
139018050|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018051|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018052|NCT04700072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018053|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909266|NCT00849680|Vaccines|vaccines|mesh-list
139018054|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139018055|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018056|NCT04678154|Vancomycin|vancomycin|mesh-list
139018057|NCT04678154|Tobramycin|tobramycin|mesh-list
139018058|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139018059|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018060|NCT04665856|Carboplatin|carboplatin|mesh-list
139018061|NCT04665856|Etoposide|etoposide|mesh-list
139018062|NCT04665856|Atezolizumab|atezolizumab|mesh-list
139018063|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018064|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139018065|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139018066|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139018067|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018068|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018069|NCT04665856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018070|NCT04665856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018071|NCT04622228|Carboplatin|carboplatin|mesh-list
139018072|NCT04622228|Etoposide|etoposide|mesh-list
139018073|NCT04622228|Atezolizumab|atezolizumab|mesh-list
139018074|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018075|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139018076|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139018077|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139018078|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018079|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018080|NCT04622228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018081|NCT04622228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018082|NCT04586010|Teriflunomide|teriflunomide|mesh-list
139018083|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139018084|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139018085|NCT04586010|Analgesics|analgesics|mesh-ancestor
139018086|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
139018087|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018088|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018089|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139018090|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139018091|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139018092|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
139018093|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
139018094|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139018095|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
139018096|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139018097|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018098|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018099|NCT04550442|Azacitidine|azacitidine|mesh-list
139018100|NCT04550442|Venetoclax|venetoclax|mesh-list
139018101|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139018102|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
139018103|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018104|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018105|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018106|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
139018107|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
139018108|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
139018109|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139018110|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139018111|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
139018112|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
139018113|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018114|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018115|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139018116|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
139018117|NCT04548999|Hormones|hormones|mesh-ancestor
139018118|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139018119|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139018120|NCT04548999|Protective Agents|protective agents|mesh-ancestor
139018121|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
139018122|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
139018123|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536310|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139018124|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018126|NCT04547907|Docetaxel|docetaxel|mesh-list
139018127|NCT04547907|Carboplatin|carboplatin|mesh-list
139018128|NCT04547907|Trastuzumab|trastuzumab|mesh-list
139018129|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139018130|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018131|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
139018132|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
139018133|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
139018134|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018135|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018137|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
139018138|NCT04534218|Capecitabine|capecitabine|mesh-list
139018139|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139018140|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
139018141|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018142|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138536349|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139018143|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139018144|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
139018145|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018146|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018147|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139018148|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139018149|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
139018150|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139018151|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139018152|NCT04534218|Analgesics|analgesics|mesh-ancestor
139018153|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
139018154|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018155|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139018156|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139018157|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139018158|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139018159|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139018160|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018161|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
139018162|NCT04511078|Panitumumab|panitumumab|mesh-list
139018163|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018164|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018165|NCT04495452|Fentanyl|fentanyl|mesh-list
139018166|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139018167|NCT04495452|Narcotics|narcotics|mesh-ancestor
139018168|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139018169|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018170|NCT04495452|Analgesics|analgesics|mesh-ancestor
139018171|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
139018172|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018173|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139018174|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139018175|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
139018176|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
139018177|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139018178|NCT04476030|Citalopram|citalopram|mesh-list
139018179|NCT04476030|Sertraline|sertraline|mesh-list
139018180|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139018181|NCT04476030|Escitalopram|escitalopram|mesh-list
139018182|NCT04476030|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139018183|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139018184|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139018185|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018186|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139018187|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
139018188|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018189|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018190|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139018191|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
139018192|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139018193|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139018194|NCT04476030|Analgesics|analgesics|mesh-ancestor
139018195|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
139018196|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
139018197|NCT04458831|Dexamethasone|dexamethasone|mesh-list
139018198|NCT04458831|Pomalidomide|pomalidomide|mesh-list
139018199|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139018200|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
139018201|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
139018202|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018203|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018204|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139018205|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
139018206|NCT04458831|Hormones|hormones|mesh-ancestor
139018207|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139018208|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139018209|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768894|NCT02666209|Hormones|hormones|mesh-ancestor
139018210|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
139018211|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139018212|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139018213|NCT04458831|Growth Substances|growth substances|mesh-ancestor
139018214|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
139018215|NCT04450316|Naltrexone|naltrexone|mesh-list
139018216|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139018217|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139018218|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018219|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
139018220|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018221|NCT04443062|177Lu-PSMA-617|177lu-psma-617|mesh-list
139018222|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139018223|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018224|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
139018225|NCT04438213|Metolazone|metolazone|mesh-list
139018226|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139018227|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018228|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139018229|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018230|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139018231|NCT04438213|Diuretics|diuretics|mesh-ancestor
139018232|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
139018233|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139018234|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139018235|NCT04431453|Remdesivir|remdesivir|mesh-list
139018236|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
139018237|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018238|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
139018239|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018240|NCT04395989|Paclitaxel|paclitaxel|mesh-list
139018241|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139018242|NCT04395989|Capecitabine|capecitabine|mesh-list
139018243|NCT04395989|Everolimus|everolimus|mesh-list
138909298|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139018244|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139018245|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018246|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
139018247|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
139018248|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
139018249|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018250|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018251|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139018252|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
139018253|NCT04395989|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139018254|NCT04395989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139018255|NCT04395989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018256|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139018257|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
139018258|NCT04360941|Palbociclib|palbociclib|mesh-list
139018260|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018261|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139018262|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018263|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018264|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018265|NCT04303858|Atezolizumab|atezolizumab|mesh-list
139018266|NCT04303858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018267|NCT04303858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018268|NCT04303858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018269|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018270|NCT04294810|Atezolizumab|atezolizumab|mesh-list
139018271|NCT04294810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018272|NCT04294810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018273|NCT04294810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018274|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018275|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139018276|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018278|NCT04239794|Sevoflurane|sevoflurane|mesh-list
139018279|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139018280|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139018281|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018282|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139018283|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
138768970|NCT01130532|Urological Agents|urological agents|mesh-ancestor
139018284|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
139018285|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139018286|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139018287|NCT04200911|Sirolimus|sirolimus|mesh-list
139018288|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139018289|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018290|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139018291|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018292|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
138536722|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
139018293|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139018294|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
139018295|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018297|NCT04076059|Hormones|hormones|mesh-ancestor
139018298|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139018299|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018300|NCT04006457|Vaccines|vaccines|mesh-list
139018301|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
139018302|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018303|NCT04003636|Cisplatin|cisplatin|mesh-list
139018304|NCT04003636|Gemcitabine|gemcitabine|mesh-list
139018305|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
139018306|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018307|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139018308|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
139018309|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018310|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018311|NCT04003636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018312|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139018313|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139018314|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018315|NCT03958045|Nivolumab|nivolumab|mesh-list
139018316|NCT03958045|Rucaparib|rucaparib|mesh-list
139018317|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018318|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018319|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018320|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018321|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139018322|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018323|NCT03954067|Pembrolizumab|pembrolizumab|mesh-list
139018324|NCT03954067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018325|NCT03954067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018326|NCT03954067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018327|NCT03954067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018328|NCT03952065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139018329|NCT03952065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975141|NCT00838838|Hormones|hormones|mesh-ancestor
139018330|NCT03952065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018331|NCT03952065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018332|NCT03911271|Atropine|atropine|mesh-list
139018333|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139018334|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139018335|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139018336|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
139018337|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018338|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018339|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139018340|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
139018341|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
139018342|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
139018343|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139018345|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
139018346|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139018347|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018348|NCT03844048|Venetoclax|venetoclax|mesh-list
139018349|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018350|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
139018351|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018352|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018353|NCT03833167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018354|NCT03833167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018355|NCT03768440|Ropivacaine|ropivacaine|mesh-list
139018356|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
139018357|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
139018358|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139018359|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018361|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018362|NCT03768063|Bevacizumab|bevacizumab|mesh-list
139018363|NCT03768063|Pembrolizumab|pembrolizumab|mesh-list
139018364|NCT03768063|Pemetrexed|pemetrexed|mesh-list
139018365|NCT03768063|Atezolizumab|atezolizumab|mesh-list
139018366|NCT03768063|Sunitinib|sunitinib|mesh-list
139018367|NCT03768063|Venetoclax|venetoclax|mesh-list
139018368|NCT03768063|Niraparib|niraparib|mesh-list
139018369|NCT03768063|Vemurafenib|vemurafenib|mesh-list
139018370|NCT03768063|Rucaparib|rucaparib|mesh-list
139018371|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018372|NCT03768063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018373|NCT03768063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018374|NCT03768063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138536931|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018375|NCT03768063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139018376|NCT03768063|Growth Substances|growth substances|mesh-ancestor
139018377|NCT03768063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018378|NCT03768063|Growth Inhibitors|growth inhibitors|mesh-ancestor
139018379|NCT03768063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018380|NCT03768063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018381|NCT03768063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139018382|NCT03768063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139018383|NCT03768063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138975165|NCT05591001|Ketamine|ketamine|mesh-list
139018384|NCT03768063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139018385|NCT03759587|Niraparib|niraparib|mesh-list
139018386|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139018387|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018388|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018389|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018390|NCT03752684|Calcium|calcium|mesh-list
139018391|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139018392|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018393|NCT03748953|Ixazomib|ixazomib|mesh-list
139018394|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018395|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
139018396|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018397|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018398|NCT03735121|Atezolizumab|atezolizumab|mesh-list
139018399|NCT03735121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018400|NCT03735121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018401|NCT03735121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018402|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018404|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
139018405|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018406|NCT03730194|Protective Agents|protective agents|mesh-ancestor
139018407|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018408|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139018409|NCT03723551|Afabicin|afabicin|mesh-list
139018410|NCT03723551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138909333|NCT00837434|Etanercept|etanercept|mesh-list
139018411|NCT03723551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018412|NCT03689699|Nivolumab|nivolumab|mesh-list
139018413|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018414|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018415|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018416|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018417|NCT03653507|Capecitabine|capecitabine|mesh-list
139018418|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
139018419|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139018420|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
139018421|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018422|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018423|NCT03568890|Aspirin|aspirin|mesh-list
139018424|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
139018425|NCT03568890|Apixaban|apixaban|mesh-list
139018426|NCT03568890|Edoxaban|edoxaban|mesh-list
139018427|NCT03568890|Dabigatran|dabigatran|mesh-list
139018428|NCT03568890|Clopidogrel|clopidogrel|mesh-list
139018429|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138769121|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139018430|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139018431|NCT03568890|Analgesics|analgesics|mesh-ancestor
139018432|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
139018433|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018434|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018435|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139018436|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139018437|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139018438|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139018439|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018440|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139018441|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139018442|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018443|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
139018444|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139018445|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139018446|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139018447|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
139018448|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139018449|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139018450|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
139018451|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139018452|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
139018453|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
139018454|NCT03559400|Gentamicins|gentamicins|mesh-list
139018455|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139018456|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018457|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139018458|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018459|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018460|NCT03530683|Dexamethasone|dexamethasone|mesh-list
139018461|NCT03530683|Azacitidine|azacitidine|mesh-list
139018462|NCT03530683|Venetoclax|venetoclax|mesh-list
139018463|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139018464|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
139018465|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
139018466|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018467|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018468|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139018469|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
139018471|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139018472|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138537152|NCT00406042|Prednisolone|prednisolone|mesh-list
139018473|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018474|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139018476|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018477|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018478|NCT03513484|Azacitidine|azacitidine|mesh-list
139018479|NCT03513484|Nintedanib|nintedanib|mesh-list
139018480|NCT03513484|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139018481|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139018482|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
139018483|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018484|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018485|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018486|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139018487|NCT03483012|Atezolizumab|atezolizumab|mesh-list
139018488|NCT03483012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018489|NCT03483012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018490|NCT03483012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018491|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018492|NCT03424005|Bevacizumab|bevacizumab|mesh-list
139018493|NCT03424005|Carboplatin|carboplatin|mesh-list
139018494|NCT03424005|Gemcitabine|gemcitabine|mesh-list
139018495|NCT03424005|Capecitabine|capecitabine|mesh-list
139018496|NCT03424005|Trastuzumab|trastuzumab|mesh-list
139018497|NCT03424005|Atezolizumab|atezolizumab|mesh-list
139018498|NCT03424005|Fulvestrant|fulvestrant|mesh-list
139018499|NCT03424005|Ipatasertib|ipatasertib|mesh-list
139018500|NCT03424005|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139018501|NCT03424005|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139018503|NCT03424005|Inavolisib|inavolisib|mesh-list
139018504|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018505|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018506|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018507|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139018508|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139018509|NCT03424005|Growth Substances|growth substances|mesh-ancestor
139018510|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018511|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
139018512|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139018514|NCT03424005|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018515|NCT03424005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138537246|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
139018516|NCT03424005|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139018517|NCT03424005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139018518|NCT03424005|Hormone Antagonists|hormone antagonists|mesh-ancestor
139018519|NCT03424005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139018521|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
139018522|NCT03424005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139018523|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018524|NCT03424005|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139018525|NCT03363893|Fulvestrant|fulvestrant|mesh-list
139018526|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139018527|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018528|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139018529|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139018530|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
139018531|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139018532|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018533|NCT03339128|Eluxadoline|eluxadoline|mesh-list
139018534|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139018535|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
139018536|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
139018537|NCT03231709|Alogliptin|alogliptin|mesh-list
139018538|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139018539|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018540|NCT03231709|Incretins|incretins|mesh-ancestor
139018541|NCT03231709|Hormones|hormones|mesh-ancestor
139018542|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138909370|NCT00702416|Acetaminophen|acetaminophen|mesh-list
139018543|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139018544|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
139018545|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018546|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018547|NCT03180502|Temozolomide|temozolomide|mesh-list
139018548|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139018549|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
139018550|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018560|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018561|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138537420|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018562|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139018563|NCT03117972|Growth Substances|growth substances|mesh-ancestor
139018564|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018565|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
139018566|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139018567|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
139018568|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018569|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139018570|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
139018571|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139018572|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139018573|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018574|NCT03117972|Antidotes|antidotes|mesh-ancestor
139018575|NCT03117972|Protective Agents|protective agents|mesh-ancestor
139018576|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
139018577|NCT03117972|Vitamins|vitamins|mesh-ancestor
139018578|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
139018588|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018589|NCT03032172|Risdiplam|risdiplam|mesh-list
139018590|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139018591|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018592|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018593|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139018594|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
139018595|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018596|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018597|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139018598|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018600|NCT02937818|Durvalumab|durvalumab|mesh-list
139018601|NCT02937818|Olaparib|olaparib|mesh-list
139018602|NCT02937818|Tremelimumab|tremelimumab|mesh-list
139018603|NCT02937818|Adavosertib|adavosertib|mesh-list
139018604|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018605|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018606|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139018607|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018608|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018609|NCT02916511|Paclitaxel|paclitaxel|mesh-list
139018610|NCT02916511|Carboplatin|carboplatin|mesh-list
139018611|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139018612|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018613|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
139018614|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
139018615|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
139018616|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018617|NCT02864394|Docetaxel|docetaxel|mesh-list
139018618|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
139018619|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018620|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
139018621|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
139018622|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
139018623|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018624|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018625|NCT02864394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018626|NCT02684006|Sunitinib|sunitinib|mesh-list
139018627|NCT02684006|Avelumab|avelumab|mesh-list
139018628|NCT02684006|Axitinib|axitinib|mesh-list
139018629|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018630|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139018631|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139018632|NCT02684006|Growth Substances|growth substances|mesh-ancestor
139018633|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018634|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
139018635|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139018636|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018637|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018638|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018639|NCT02654990|Dexamethasone|dexamethasone|mesh-list
139018640|NCT02654990|Bortezomib|bortezomib|mesh-list
139018641|NCT02654990|Panobinostat|panobinostat|mesh-list
139018642|NCT02654990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139018643|NCT02654990|Antiemetics|antiemetics|mesh-ancestor
139018644|NCT02654990|Autonomic Agents|autonomic agents|mesh-ancestor
139018645|NCT02654990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018646|NCT02654990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018647|NCT02654990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139018648|NCT02654990|Glucocorticoids|glucocorticoids|mesh-ancestor
139018649|NCT02654990|Hormones|hormones|mesh-ancestor
138975346|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
139018650|NCT02654990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139018651|NCT02654990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139018652|NCT02654990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018653|NCT02654990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139018654|NCT02654990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018655|NCT02654990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769344|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
139018657|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139018658|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
139018659|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018660|NCT02583672|Expectorants|expectorants|mesh-ancestor
139018661|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
139018662|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139018663|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
139018664|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018665|NCT02583672|Protective Agents|protective agents|mesh-ancestor
139018666|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018668|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
139018669|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139018670|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139018671|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018672|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
139018673|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139018674|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018675|NCT02516241|Carboplatin|carboplatin|mesh-list
139018676|NCT02516241|Gemcitabine|gemcitabine|mesh-list
139018677|NCT02516241|Durvalumab|durvalumab|mesh-list
139018678|NCT02516241|Tremelimumab|tremelimumab|mesh-list
139018679|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018680|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139018681|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
139018682|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018683|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018684|NCT02491528|Insulin|insulin|mesh-list
139018685|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139018686|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
139018687|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
139018688|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139018689|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139018690|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018691|NCT02464878|Etanercept|etanercept|mesh-list
139018692|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
139018693|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139018694|NCT02464878|Basiliximab|basiliximab|mesh-list
139018695|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139018696|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
138975368|NCT01010152|Narcotics|narcotics|mesh-ancestor
139018697|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139018698|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139018699|NCT02464878|Analgesics|analgesics|mesh-ancestor
139018700|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
139018701|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018702|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018703|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139018704|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139018705|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139018706|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139018707|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
139018708|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139018709|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139018710|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
139018711|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018712|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018713|NCT02162810|Prednisolone|prednisolone|mesh-list
139018714|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139018715|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
139018716|NCT02162810|Hormones|hormones|mesh-ancestor
139018717|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139018718|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018719|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139018720|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018721|NCT02040857|Tamoxifen|tamoxifen|mesh-list
139018722|NCT02040857|Letrozole|letrozole|mesh-list
139018723|NCT02040857|Palbociclib|palbociclib|mesh-list
139018724|NCT02040857|Anastrozole|anastrozole|mesh-list
139018725|NCT02040857|Exemestane|exemestane|mesh-list
139018726|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139018727|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018728|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139018729|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018730|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018731|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139018732|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
139018733|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139018734|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018735|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139018736|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139018737|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139018738|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139018739|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139018740|NCT02000089|Secretin|secretin|mesh-list
139018741|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139018742|NCT02000089|Hormones|hormones|mesh-ancestor
139018743|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139018744|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018745|NCT01358877|Paclitaxel|paclitaxel|mesh-list
139018746|NCT01358877|Docetaxel|docetaxel|mesh-list
139018747|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
139018748|NCT01358877|Carboplatin|carboplatin|mesh-list
139018749|NCT01358877|Doxorubicin|doxorubicin|mesh-list
139018750|NCT01358877|Fluorouracil|fluorouracil|mesh-list
139018751|NCT01358877|Trastuzumab|trastuzumab|mesh-list
139018752|NCT01358877|Epirubicin|epirubicin|mesh-list
139018753|NCT01358877|Pertuzumab|pertuzumab|mesh-list
139018754|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139018755|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018756|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
139018757|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
139018758|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
139018759|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018760|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139018761|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
139018762|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018763|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139018764|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139018765|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
139018766|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139018767|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139018768|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139018769|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139018770|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018771|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
139018772|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139018773|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018774|NCT01149083|Carboplatin|carboplatin|mesh-list
139018775|NCT01149083|Veliparib|veliparib|mesh-list
139018776|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018777|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139018778|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018779|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018780|NCT00694850|Riociguat|riociguat|mesh-list
139018781|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
139018782|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018783|NCT00670358|Prednisone|prednisone|mesh-list
139018784|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
139018785|NCT00670358|Rituximab|rituximab|mesh-list
139018786|NCT00670358|Doxorubicin|doxorubicin|mesh-list
138975415|NCT00537303|Insulin|insulin|mesh-list
139018787|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139018788|NCT00670358|Vincristine|vincristine|mesh-list
139018789|NCT00670358|Lenalidomide|lenalidomide|mesh-list
139018790|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139018791|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
139018792|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018793|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139018794|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139018795|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
139018796|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018797|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018798|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139018799|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018800|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139018801|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139018802|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139018803|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018804|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139018805|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
139018806|NCT00670358|Hormones|hormones|mesh-ancestor
139018807|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139018808|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139018809|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139018810|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
139018811|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
139018812|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
139018813|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139018814|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139018815|NCT00670358|Growth Substances|growth substances|mesh-ancestor
139018816|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
139018818|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
139018819|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018820|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
139018821|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018822|NCT00176631|Docetaxel|docetaxel|mesh-list
139018823|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018824|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
139018825|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
139018826|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
139018827|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018828|NCT00002965|Interferons|interferons|mesh-list
139018829|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
139018830|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
139018831|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139018832|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018833|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
138537827|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139018834|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018835|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
139018836|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018837|NCT06050343|Insulin|insulin|mesh-list
139018838|NCT06050343|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139018839|NCT06050343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139018840|NCT06050343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018841|NCT06050200|Liver Extracts|liver extracts|mesh-list
139018842|NCT06050200|Hematinics|hematinics|mesh-ancestor
139018843|NCT06050122|Veratrum Alkaloids|veratrum alkaloids|mesh-list
139018844|NCT06050122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138975456|NCT00505414|Morphine|morphine|mesh-list
139018845|NCT06050044|Bupivacaine|bupivacaine|mesh-list
139018846|NCT06050044|Anesthetics, Local|anesthetics, local|mesh-ancestor
139018847|NCT06050044|Anesthetics|anesthetics|mesh-ancestor
139018848|NCT06050044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139018849|NCT06050044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018850|NCT06050044|Sensory System Agents|sensory system agents|mesh-ancestor
139018851|NCT06050044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018852|NCT06050031|Antioxidants|antioxidants|mesh-list
139018853|NCT06050031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018854|NCT06050031|Protective Agents|protective agents|mesh-ancestor
138537882|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139018855|NCT06050031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018856|NCT06049966|Carboplatin|carboplatin|mesh-list
139018857|NCT06049966|Etoposide|etoposide|mesh-list
139018858|NCT06049966|Atezolizumab|atezolizumab|mesh-list
139018859|NCT06049966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018860|NCT06049966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139018861|NCT06049966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139018862|NCT06049966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139018863|NCT06049966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018864|NCT06049966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018865|NCT06049966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139018866|NCT06049966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018867|NCT06049901|Nitazoxanide|nitazoxanide|mesh-list
139018868|NCT06049901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139018869|NCT06049901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018870|NCT06049758|Levofloxacin|levofloxacin|mesh-list
139018871|NCT06049758|Enoxaparin|enoxaparin|mesh-list
139018872|NCT06049758|Anticoagulants|anticoagulants|mesh-ancestor
139018873|NCT06049758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139018874|NCT06049758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138537934|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
139018875|NCT06049758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018876|NCT06049758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139018877|NCT06049758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018878|NCT06049758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139018879|NCT06049758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139018880|NCT06049758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139018881|NCT06049758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018882|NCT06049758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018883|NCT06049758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139018884|NCT06049758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139018885|NCT06049745|Misoprostol|misoprostol|mesh-list
139018886|NCT06049745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139018887|NCT06049745|Abortifacient Agents|abortifacient agents|mesh-ancestor
139018888|NCT06049745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139018889|NCT06049745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018890|NCT06049745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138975479|NCT01813227|Rituximab|rituximab|mesh-list
139018891|NCT06049745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139018892|NCT06049745|Oxytocics|oxytocics|mesh-ancestor
139018893|NCT06049680|SMOFlipid|smoflipid|mesh-list
139018894|NCT06049680|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139018895|NCT06049680|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139018896|NCT06049680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139018897|NCT06049589|Chlorhexidine|chlorhexidine|mesh-list
139018898|NCT06049589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139018899|NCT06049589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018900|NCT06049589|Disinfectants|disinfectants|mesh-ancestor
139018901|NCT06049186|Metformin|metformin|mesh-list
139018902|NCT06049186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139018903|NCT06049186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018904|NCT06048874|Ropivacaine|ropivacaine|mesh-list
139018905|NCT06048874|Anesthetics, Local|anesthetics, local|mesh-ancestor
139018906|NCT06048874|Anesthetics|anesthetics|mesh-ancestor
139018907|NCT06048874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139018908|NCT06048874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018909|NCT06048874|Sensory System Agents|sensory system agents|mesh-ancestor
139018910|NCT06048874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018911|NCT06048848|Ropivacaine|ropivacaine|mesh-list
139018912|NCT06048848|Anesthetics, Local|anesthetics, local|mesh-ancestor
139018913|NCT06048848|Anesthetics|anesthetics|mesh-ancestor
139018914|NCT06048848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139018915|NCT06048848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018916|NCT06048848|Sensory System Agents|sensory system agents|mesh-ancestor
139018917|NCT06048848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018918|NCT06048614|Glycerol|glycerol|mesh-list
139018919|NCT06048614|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139018920|NCT06048614|Protective Agents|protective agents|mesh-ancestor
139018921|NCT06048614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018922|NCT06048341|Ropivacaine|ropivacaine|mesh-list
139018923|NCT06048341|Anesthetics, Local|anesthetics, local|mesh-ancestor
139018924|NCT06048341|Anesthetics|anesthetics|mesh-ancestor
139018925|NCT06048341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139018926|NCT06048341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018927|NCT06048341|Sensory System Agents|sensory system agents|mesh-ancestor
139018928|NCT06048341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018929|NCT06045884|Ropivacaine|ropivacaine|mesh-list
139018930|NCT06045884|Anesthetics, Local|anesthetics, local|mesh-ancestor
139018931|NCT06045884|Anesthetics|anesthetics|mesh-ancestor
139018932|NCT06045884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139018933|NCT06045884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018934|NCT06045884|Sensory System Agents|sensory system agents|mesh-ancestor
139018935|NCT06045884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018936|NCT06044805|Chloroquine|chloroquine|mesh-list
139018937|NCT06044805|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139018938|NCT06044805|Primaquine|primaquine|mesh-list
139018939|NCT06044805|Amebicides|amebicides|mesh-ancestor
139018940|NCT06044805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139018941|NCT06044805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139018942|NCT06044805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018943|NCT06044805|Antimalarials|antimalarials|mesh-ancestor
139018944|NCT06044805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139018945|NCT06044805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139018946|NCT06044805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139018947|NCT06044805|Analgesics|analgesics|mesh-ancestor
139018948|NCT06044805|Sensory System Agents|sensory system agents|mesh-ancestor
139018949|NCT06044805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018950|NCT06044805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018951|NCT06044805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139018953|NCT06044805|Antinematodal Agents|antinematodal agents|mesh-ancestor
139018954|NCT06044805|Anthelmintics|anthelmintics|mesh-ancestor
139018955|NCT06044779|Bupivacaine|bupivacaine|mesh-list
139018956|NCT06044779|Anesthetics, Local|anesthetics, local|mesh-ancestor
139018957|NCT06044779|Anesthetics|anesthetics|mesh-ancestor
139018958|NCT06044779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139018959|NCT06044779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018960|NCT06044779|Sensory System Agents|sensory system agents|mesh-ancestor
139018961|NCT06044779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018962|NCT06043362|Nicotine|nicotine|mesh-list
139018963|NCT06043362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139018964|NCT06043362|Autonomic Agents|autonomic agents|mesh-ancestor
139018965|NCT06043362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018966|NCT06043362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018967|NCT06043362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139018968|NCT06043362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139018969|NCT06043362|Cholinergic Agents|cholinergic agents|mesh-ancestor
139018970|NCT06043362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139018971|NCT06043362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018972|NCT06040060|Ketamine|ketamine|mesh-list
139018973|NCT06040060|Analgesics|analgesics|mesh-ancestor
139018974|NCT06040060|Sensory System Agents|sensory system agents|mesh-ancestor
139018975|NCT06040060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018976|NCT06040060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018977|NCT06040060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139018978|NCT06040060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139018979|NCT06040060|Anesthetics, General|anesthetics, general|mesh-ancestor
139018980|NCT06040060|Anesthetics|anesthetics|mesh-ancestor
139018981|NCT06040060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139018982|NCT06040060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139018983|NCT06040060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139018984|NCT06040060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139018985|NCT06040060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018987|NCT06040034|Anesthetics, Local|anesthetics, local|mesh-ancestor
139018988|NCT06040034|Anesthetics|anesthetics|mesh-ancestor
139018989|NCT06040034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139018990|NCT06040034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018991|NCT06040034|Sensory System Agents|sensory system agents|mesh-ancestor
139018992|NCT06040034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139018993|NCT06040034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139018994|NCT06040034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139018995|NCT06040034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138975517|NCT02548052|Betamethasone|betamethasone|mesh-list
139018996|NCT06040034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139018997|NCT06040034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018999|NCT06038981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139019000|NCT06038981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139019001|NCT06038981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019002|NCT06038981|Hemostatics|hemostatics|mesh-ancestor
139019003|NCT06038981|Coagulants|coagulants|mesh-ancestor
139019004|NCT05990400|Minoxidil|minoxidil|mesh-list
139019005|NCT05990400|Finasteride|finasteride|mesh-list
139019006|NCT05990400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139019007|NCT05990400|Vasodilator Agents|vasodilator agents|mesh-ancestor
139019008|NCT05990400|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139019009|NCT05990400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139019010|NCT05990400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538182|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139019011|NCT05990400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019012|NCT05990400|Hormone Antagonists|hormone antagonists|mesh-ancestor
139019013|NCT05990400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139019014|NCT05990400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019015|NCT05990400|Urological Agents|urological agents|mesh-ancestor
139019016|NCT05983302|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139019017|NCT05983302|Hemostatics|hemostatics|mesh-ancestor
139019018|NCT05983302|Coagulants|coagulants|mesh-ancestor
139019019|NCT05970731|Beclomethasone|beclomethasone|mesh-list
139019020|NCT05970731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139019021|NCT05970731|Glucocorticoids|glucocorticoids|mesh-ancestor
139019023|NCT05970731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139019024|NCT05970731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019025|NCT05970731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139019026|NCT05970731|Respiratory System Agents|respiratory system agents|mesh-ancestor
139019027|NCT05941247|Hemay005|hemay005|mesh-list
139019028|NCT05941247|Dermatologic Agents|dermatologic agents|mesh-ancestor
139019029|NCT05941247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138538232|NCT00157066|Vitamin D|vitamin d|mesh-list
139019030|NCT05941247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139019031|NCT05941247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019032|NCT05941247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019033|NCT05926505|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139019034|NCT05926505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139019035|NCT05897658|Levetiracetam|levetiracetam|mesh-list
139019036|NCT05897658|Anticonvulsants|anticonvulsants|mesh-ancestor
139019037|NCT05897658|Nootropic Agents|nootropic agents|mesh-ancestor
139019039|NCT05855577|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139019040|NCT05855577|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139019041|NCT05855577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139019042|NCT05855577|Adrenergic Agents|adrenergic agents|mesh-ancestor
139019043|NCT05855577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019044|NCT05855577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019045|NCT05855577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019046|NCT05855577|Urological Agents|urological agents|mesh-ancestor
139019047|NCT05809453|Lidocaine|lidocaine|mesh-list
139019048|NCT05809453|Cocaine|cocaine|mesh-list
139019049|NCT05809453|Anesthetics, Local|anesthetics, local|mesh-ancestor
139019050|NCT05809453|Anesthetics|anesthetics|mesh-ancestor
139019051|NCT05809453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139019052|NCT05809453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019053|NCT05809453|Sensory System Agents|sensory system agents|mesh-ancestor
139019054|NCT05809453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019055|NCT05809453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139019056|NCT05809453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139019057|NCT05809453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139019058|NCT05809453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139019059|NCT05809453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019060|NCT05809453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139019061|NCT05809453|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139019062|NCT05809453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139019063|NCT05809453|Dopamine Agents|dopamine agents|mesh-ancestor
139019064|NCT05809453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019065|NCT05694819|Goserelin|goserelin|mesh-list
139019066|NCT05694819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139019067|NCT05694819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019068|NCT05668988|Carboplatin|carboplatin|mesh-list
139019069|NCT05668988|Pemetrexed|pemetrexed|mesh-list
139019070|NCT05668988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019071|NCT05668988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019072|NCT05668988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019073|NCT05668988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139019074|NCT05668988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139019075|NCT05644600|Nintedanib|nintedanib|mesh-list
139019076|NCT05644600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019077|NCT05644600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139019078|NCT05644600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019079|NCT05644600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019080|NCT05628883|Cyclophosphamide|cyclophosphamide|mesh-list
139019081|NCT05628883|Fludarabine|fludarabine|mesh-list
139019082|NCT05628883|Interleukin-2|interleukin-2|mesh-list
139019083|NCT05628883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139019084|NCT05628883|Immunologic Factors|immunologic factors|mesh-ancestor
139019085|NCT05628883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019086|NCT05628883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139019087|NCT05628883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139019088|NCT05628883|Alkylating Agents|alkylating agents|mesh-ancestor
139019089|NCT05628883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019090|NCT05628883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019091|NCT05628883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139019092|NCT05628883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139019093|NCT05628883|Analgesics|analgesics|mesh-ancestor
139019094|NCT05628883|Sensory System Agents|sensory system agents|mesh-ancestor
139019095|NCT05628883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019096|NCT05590455|Adalimumab|adalimumab|mesh-list
139019097|NCT05590455|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139019098|NCT05590455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139019099|NCT05590455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139019100|NCT05582876|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139019101|NCT05582876|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138909499|NCT00922844|Sevoflurane|sevoflurane|mesh-list
139019102|NCT05582876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019103|NCT05580003|Moxifloxacin|moxifloxacin|mesh-list
139019104|NCT05580003|Midazolam|midazolam|mesh-list
139019105|NCT05580003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139019106|NCT05580003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139019107|NCT05580003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139019108|NCT05580003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019109|NCT05580003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139019110|NCT05580003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139019111|NCT05580003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139019112|NCT05580003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139019113|NCT05580003|Anesthetics, General|anesthetics, general|mesh-ancestor
139019114|NCT05580003|Anesthetics|anesthetics|mesh-ancestor
138538333|NCT00157729|Vitamins|vitamins|mesh-ancestor
139019115|NCT05580003|GABA Modulators|gaba modulators|mesh-ancestor
139019116|NCT05580003|GABA Agents|gaba agents|mesh-ancestor
139019117|NCT05580003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975597|NCT02547116|Rifampin|rifampin|mesh-list
139019118|NCT05580003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019119|NCT05580003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139019120|NCT05580003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139019121|NCT05580003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139019122|NCT05580003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139019123|NCT05580003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019124|NCT05580003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019126|NCT05572229|Daratumumab|daratumumab|mesh-list
139019127|NCT05572229|Immunologic Factors|immunologic factors|mesh-ancestor
139019128|NCT05572229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019129|NCT05572229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139019130|NCT05572229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139019131|NCT05572229|Growth Substances|growth substances|mesh-ancestor
139019132|NCT05572229|Growth Inhibitors|growth inhibitors|mesh-ancestor
139019133|NCT05572229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019134|NCT05570825|Pembrolizumab|pembrolizumab|mesh-list
139019135|NCT05570825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139019136|NCT05570825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019137|NCT05570825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139019138|NCT05570825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019139|NCT05569408|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139019140|NCT05569408|Antiviral Agents|antiviral agents|mesh-ancestor
138538391|NCT00051623|Infliximab|infliximab|mesh-list
139019141|NCT05569408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139019142|NCT05558410|Acetaminophen|acetaminophen|mesh-list
139019143|NCT05558410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139019144|NCT05558410|Analgesics|analgesics|mesh-ancestor
139019145|NCT05558410|Sensory System Agents|sensory system agents|mesh-ancestor
139019146|NCT05558410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019147|NCT05558410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019148|NCT05558410|Antipyretics|antipyretics|mesh-ancestor
139019149|NCT05508152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139019150|NCT05508152|Amoxicillin|amoxicillin|mesh-list
139019151|NCT05508152|Clavulanic Acid|clavulanic acid|mesh-list
139019152|NCT05508152|Clavulanic Acids|clavulanic acids|mesh-list
139019153|NCT05508152|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138909515|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
139019154|NCT05508152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139019155|NCT05508152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139019156|NCT05508152|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139019157|NCT05508152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019158|NCT05508152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019159|NCT05492565|Tenofovir|tenofovir|mesh-list
139019160|NCT05492565|Emtricitabine|emtricitabine|mesh-list
139019161|NCT05492565|Antiviral Agents|antiviral agents|mesh-ancestor
139019162|NCT05492565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139019163|NCT05492565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138538433|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
139019164|NCT05492565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139019165|NCT05492565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019166|NCT05492565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019167|NCT05492565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139019168|NCT05492565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139019169|NCT05486104|Hemay005|hemay005|mesh-list
139019170|NCT05486104|Dermatologic Agents|dermatologic agents|mesh-ancestor
139019171|NCT05486104|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139019172|NCT05486104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138975646|NCT00841802|Prednisone|prednisone|mesh-list
139019173|NCT05486104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019174|NCT05486104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019175|NCT05452174|Mirtazapine|mirtazapine|mesh-list
139019176|NCT05452174|Antidepressive Agents|antidepressive agents|mesh-ancestor
139019177|NCT05452174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139019178|NCT05452174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139019179|NCT05452174|Histamine Antagonists|histamine antagonists|mesh-ancestor
139019180|NCT05452174|Histamine Agents|histamine agents|mesh-ancestor
139019181|NCT05452174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019182|NCT05452174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019183|NCT05452174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019184|NCT05452174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139019185|NCT05452174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139019186|NCT05452174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139019187|NCT05452174|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138769863|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019188|NCT05452174|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139019189|NCT05452174|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139019190|NCT05452174|Adrenergic Agents|adrenergic agents|mesh-ancestor
139019191|NCT05452174|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139019192|NCT05452174|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139019193|NCT05452174|Serotonin Agents|serotonin agents|mesh-ancestor
139019194|NCT05452174|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139019195|NCT05448547|Hormones|hormones|mesh-list
139019196|NCT05448547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139019197|NCT05448547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019198|NCT05446779|Hydrocortisone|hydrocortisone|mesh-list
139019199|NCT05446779|Epinephrine|epinephrine|mesh-list
139019200|NCT05446779|Racepinephrine|racepinephrine|mesh-list
139019201|NCT05446779|Epinephryl borate|epinephryl borate|mesh-list
139019202|NCT05446779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139019203|NCT05446779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139019204|NCT05446779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139019205|NCT05446779|Adrenergic Agents|adrenergic agents|mesh-ancestor
139019206|NCT05446779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019207|NCT05446779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019208|NCT05446779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019209|NCT05446779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139019210|NCT05446779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139019211|NCT05446779|Autonomic Agents|autonomic agents|mesh-ancestor
139019212|NCT05446779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019213|NCT05446779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139019214|NCT05446779|Respiratory System Agents|respiratory system agents|mesh-ancestor
139019215|NCT05446779|Mydriatics|mydriatics|mesh-ancestor
139019216|NCT05446779|Sympathomimetics|sympathomimetics|mesh-ancestor
139019217|NCT05446779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139019218|NCT05423197|Panitumumab|panitumumab|mesh-list
139019219|NCT05423197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139019220|NCT05423197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019221|NCT05411471|Vaccines|vaccines|mesh-list
139019222|NCT05411471|Immunologic Factors|immunologic factors|mesh-ancestor
139019223|NCT05411471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019224|NCT05399498|Psilocybin|psilocybin|mesh-list
139019225|NCT05399498|Hallucinogens|hallucinogens|mesh-ancestor
139019226|NCT05399498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019227|NCT05399498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139019228|NCT05323812|Edaravone|edaravone|mesh-list
139019229|NCT05323812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139019230|NCT05323812|Antioxidants|antioxidants|mesh-ancestor
139019231|NCT05323812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019232|NCT05323812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139019233|NCT05323812|Protective Agents|protective agents|mesh-ancestor
139019234|NCT05323812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019235|NCT05301062|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139019236|NCT05301062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019237|NCT05271630|Proteasome Inhibitors|proteasome inhibitors|mesh-list
139019238|NCT05271630|Immunomodulating Agents|immunomodulating agents|mesh-list
139019239|NCT05271630|Protease Inhibitors|protease inhibitors|mesh-ancestor
139019240|NCT05271630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019241|NCT05271630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019242|NCT05271630|Immunologic Factors|immunologic factors|mesh-ancestor
139019243|NCT05271630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019244|NCT05254236|Vaccines|vaccines|mesh-list
139019245|NCT05254236|Immunologic Factors|immunologic factors|mesh-ancestor
139019246|NCT05254236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019247|NCT05245071|Maytansine|maytansine|mesh-list
139019248|NCT05245071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139019249|NCT05245071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019250|NCT05245071|Tubulin Modulators|tubulin modulators|mesh-ancestor
139019251|NCT05245071|Antimitotic Agents|antimitotic agents|mesh-ancestor
139019252|NCT05245071|Mitosis Modulators|mitosis modulators|mesh-ancestor
139019253|NCT05245071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019254|NCT05189457|Docetaxel|docetaxel|mesh-list
139019255|NCT05189457|Tislelizumab|tislelizumab|mesh-list
139019256|NCT05189457|Leuprolide|leuprolide|mesh-list
139019257|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139019258|NCT05189457|Hormones|hormones|mesh-list
139019259|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139019260|NCT05189457|Relugolix|relugolix|mesh-list
139019261|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019262|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
139019263|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
139019264|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
139019265|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019266|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139019267|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019268|NCT05189457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139019269|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139019270|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
139019271|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139019272|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139019273|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
139019274|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139019275|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
139019276|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139019277|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
139019278|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
139019280|NCT05159245|Atezolizumab|atezolizumab|mesh-list
139019281|NCT05159245|Pertuzumab|pertuzumab|mesh-list
139019282|NCT05159245|Trametinib|trametinib|mesh-list
138909545|NCT00591006|Phenytoin|phenytoin|mesh-list
139019283|NCT05159245|Vemurafenib|vemurafenib|mesh-list
139019284|NCT05159245|Dabrafenib|dabrafenib|mesh-list
139019285|NCT05159245|Pralsetinib|pralsetinib|mesh-list
139019286|NCT05159245|Entrectinib|entrectinib|mesh-list
139019287|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139019288|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019289|NCT05159245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139019290|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019291|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139019293|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
139019294|NCT05116995|Ticagrelor|ticagrelor|mesh-list
139019295|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139019296|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
139019297|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139019298|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
139019299|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019300|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019301|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
139019302|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139019303|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139019304|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139019305|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139019306|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
139019307|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019308|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019310|NCT05116917|Ipilimumab|ipilimumab|mesh-list
139019311|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139019312|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019313|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139019314|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019315|NCT05095857|Ketamine|ketamine|mesh-list
139019316|NCT05095857|Esketamine|esketamine|mesh-list
139019317|NCT05095857|Analgesics|analgesics|mesh-ancestor
139019318|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
139019319|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019320|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019321|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139019322|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139019323|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
139019324|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
139019325|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138538717|NCT00160264|Vitamins|vitamins|mesh-ancestor
139019326|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139019327|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139019328|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019329|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019330|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
139019331|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139019332|NCT05041842|Trastuzumab|trastuzumab|mesh-list
139019333|NCT05041842|Pertuzumab|pertuzumab|mesh-list
139019334|NCT05041842|Tucatinib|tucatinib|mesh-list
139019335|NCT05041842|Hormones|hormones|mesh-list
139019336|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139019337|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019338|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138770020|NCT02661373|Cobicistat|cobicistat|mesh-list
138770247|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
139019339|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019340|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139019342|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019343|NCT05014412|Dexamethasone|dexamethasone|mesh-list
139019344|NCT05014412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139019345|NCT05014412|Antiemetics|antiemetics|mesh-ancestor
139019346|NCT05014412|Autonomic Agents|autonomic agents|mesh-ancestor
139019347|NCT05014412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019348|NCT05014412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019349|NCT05014412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139019350|NCT05014412|Glucocorticoids|glucocorticoids|mesh-ancestor
139019351|NCT05014412|Hormones|hormones|mesh-ancestor
139019352|NCT05014412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139019353|NCT05014412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139019354|NCT05014412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019355|NCT04996004|Doxorubicin|doxorubicin|mesh-list
139019356|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139019357|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019358|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139019359|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139019360|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019361|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019363|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
139019364|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019365|NCT04922034|Amoxicillin|amoxicillin|mesh-list
139019366|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139019367|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139019368|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
139019369|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139019370|NCT04843917|Antibodies|antibodies|mesh-list
139019371|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
139019372|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
139019373|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019374|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
139019375|NCT04798339|Hematinics|hematinics|mesh-ancestor
139019376|NCT04791514|Treprostinil|treprostinil|mesh-list
139019377|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139019378|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
139019379|NCT04789096|Trastuzumab|trastuzumab|mesh-list
139019380|NCT04789096|Capecitabine|capecitabine|mesh-list
139019381|NCT04789096|Tucatinib|tucatinib|mesh-list
139019382|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139019383|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019384|NCT04789096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139019385|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019386|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139019387|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
139019388|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139019389|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538824|NCT00052559|Bevacizumab|bevacizumab|mesh-list
139019390|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139019391|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
139019392|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019394|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139019395|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019396|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139019397|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019398|NCT04598451|Prednisone|prednisone|mesh-list
139019399|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139019400|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
139019401|NCT04598451|Hormones|hormones|mesh-ancestor
139019402|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139019403|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019404|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139019405|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019406|NCT04589611|Amobarbital|amobarbital|mesh-list
139019407|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
139019408|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139019409|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
139019410|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019411|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
139019412|NCT04589611|Protective Agents|protective agents|mesh-ancestor
139019413|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139019414|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139019415|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
139019416|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
139019417|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019418|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019419|NCT04561466|Bezafibrate|bezafibrate|mesh-list
139019420|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139019421|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
139019422|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019423|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139019424|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
139019425|NCT04553263|Naltrexone|naltrexone|mesh-list
139019426|NCT04553263|Bupropion|bupropion|mesh-list
139019427|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139019428|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139019429|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019430|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
139019431|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019432|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139019433|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
139019434|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139019435|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139019436|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139019437|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139019438|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019439|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
139019440|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019441|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139019442|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139019443|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019444|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139019446|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
139019447|NCT04503694|Nivolumab|nivolumab|mesh-list
138975793|NCT00509236|Glipizide|glipizide|mesh-list
139019448|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139019449|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019450|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139019451|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019453|NCT04493151|Relebactam|relebactam|mesh-list
139019454|NCT04493151|Cilastatin|cilastatin|mesh-list
139019455|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139019456|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139019457|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
139019458|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019459|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019460|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139019461|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139019462|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
139019463|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139019464|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
139019465|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019466|NCT04454476|Trametinib|trametinib|mesh-list
139019467|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019468|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139019469|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909583|NCT00793468|Nicotine|nicotine|mesh-list
139019470|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019471|NCT04452461|Leucovorin|leucovorin|mesh-list
139019472|NCT04452461|Paclitaxel|paclitaxel|mesh-list
139019473|NCT04452461|Gemcitabine|gemcitabine|mesh-list
139019474|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
139019475|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139019476|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019477|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
139019478|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
139019479|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
139019480|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538964|NCT00044538|Taxane|taxane|mesh-list
138975832|NCT05221593|Lithium Carbonate|lithium carbonate|mesh-list
139019481|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139019483|NCT04452461|Antidotes|antidotes|mesh-ancestor
139019484|NCT04452461|Protective Agents|protective agents|mesh-ancestor
139019485|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019486|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
139019487|NCT04452461|Vitamins|vitamins|mesh-ancestor
139019488|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
139019489|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139019490|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139019491|NCT04278404|Metformin|metformin|mesh-list
139019492|NCT04278404|Interferons|interferons|mesh-list
139019493|NCT04278404|Ritonavir|ritonavir|mesh-list
139019494|NCT04278404|Ribavirin|ribavirin|mesh-list
139019495|NCT04278404|Lopinavir|lopinavir|mesh-list
139019496|NCT04278404|Oseltamivir|oseltamivir|mesh-list
139019497|NCT04278404|Remdesivir|remdesivir|mesh-list
139019498|NCT04278404|Azithromycin|azithromycin|mesh-list
139019499|NCT04278404|Clindamycin|clindamycin|mesh-list
139019500|NCT04278404|Meropenem|meropenem|mesh-list
139019501|NCT04278404|Voriconazole|voriconazole|mesh-list
139019502|NCT04278404|Ceftazidime|ceftazidime|mesh-list
139019503|NCT04278404|Cefepime|cefepime|mesh-list
139019504|NCT04278404|Fosfomycin|fosfomycin|mesh-list
139019505|NCT04278404|Cefdinir|cefdinir|mesh-list
139019506|NCT04278404|Dexamethasone|dexamethasone|mesh-list
139019507|NCT04278404|Budesonide|budesonide|mesh-list
139019508|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
139019509|NCT04278404|Colchicine|colchicine|mesh-list
139019510|NCT04278404|Amiodarone|amiodarone|mesh-list
139019511|NCT04278404|Bosentan|bosentan|mesh-list
139019512|NCT04278404|Guanfacine|guanfacine|mesh-list
139019513|NCT04278404|Labetalol|labetalol|mesh-list
139019514|NCT04278404|Nicardipine|nicardipine|mesh-list
139019515|NCT04278404|Nifedipine|nifedipine|mesh-list
139019516|NCT04278404|Milrinone|milrinone|mesh-list
139019517|NCT04278404|Furosemide|furosemide|mesh-list
139019518|NCT04278404|Spironolactone|spironolactone|mesh-list
139019519|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
139019520|NCT04278404|Oxycodone|oxycodone|mesh-list
139019521|NCT04278404|Gabapentin|gabapentin|mesh-list
139019522|NCT04278404|Nalbuphine|nalbuphine|mesh-list
139019523|NCT04278404|Clobazam|clobazam|mesh-list
139019524|NCT04278404|Zolpidem|zolpidem|mesh-list
139019525|NCT04278404|Risperidone|risperidone|mesh-list
139019526|NCT04278404|Amphetamine|amphetamine|mesh-list
139019527|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
139019528|NCT04278404|Sertraline|sertraline|mesh-list
139019529|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
139019530|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
139019531|NCT04278404|Terbutaline|terbutaline|mesh-list
139019532|NCT04278404|Sevelamer|sevelamer|mesh-list
139019533|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139019534|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
139019535|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
139019536|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019537|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019538|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139019539|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
139019540|NCT04278404|Hormones|hormones|mesh-ancestor
139019541|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139019542|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139019543|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975872|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
139019544|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
139019545|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313235|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138970110|NCT00881166|Paclitaxel|paclitaxel|mesh-list
139313236|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139313237|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139313238|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139313239|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
139313240|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139313241|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313242|NCT03504072|Etanercept|etanercept|mesh-list
139313243|NCT03504072|Tofacitinib|tofacitinib|mesh-list
139313244|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139313245|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139313246|NCT03504072|Analgesics|analgesics|mesh-ancestor
139313247|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
139313248|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313249|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313250|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139313251|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139313252|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139313253|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139313254|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
139313255|NCT03504072|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139313256|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139313257|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313258|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313259|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139313260|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139313261|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
139313262|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139313263|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313264|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313265|NCT02308254|Lixisenatide|lixisenatide|mesh-list
139313266|NCT02308254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139313267|NCT02308254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313268|NCT03361124|Oxytocin|oxytocin|mesh-list
139313269|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
139313270|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139313271|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313272|NCT03364088|Oxycodone|oxycodone|mesh-list
139313273|NCT03364088|Anesthetics|anesthetics|mesh-list
139313274|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313275|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313276|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139313277|NCT03364088|Narcotics|narcotics|mesh-ancestor
139313278|NCT03364088|Analgesics|analgesics|mesh-ancestor
139313279|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
139313280|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313281|NCT02304198|Udenafil|udenafil|mesh-list
139313282|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139313283|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139313284|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313285|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313286|NCT02304276|Calcium|calcium|mesh-list
139313287|NCT02304276|Fluorides|fluorides|mesh-list
139313288|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139313289|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313290|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
139313291|NCT02304276|Protective Agents|protective agents|mesh-ancestor
139313292|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139313293|NCT02308332|Tenofovir|tenofovir|mesh-list
139313294|NCT02308332|Emtricitabine|emtricitabine|mesh-list
139313295|NCT02308332|Rilpivirine|rilpivirine|mesh-list
139313296|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
139313297|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313298|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139313299|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139313300|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313301|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313302|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139313303|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139313304|NCT03509298|Antibodies|antibodies|mesh-list
139313305|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139313306|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
139313307|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313308|NCT03503994|Beclomethasone|beclomethasone|mesh-list
139313309|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139313310|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
139313311|NCT03503994|Hormones|hormones|mesh-ancestor
139313312|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313313|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313314|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139313315|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
139313317|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139313318|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313319|NCT01796002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139313320|NCT01796002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313321|NCT01796002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313322|NCT03509142|Sirolimus|sirolimus|mesh-list
139313323|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139313324|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313325|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139313326|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313327|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
139313328|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139313329|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
139313330|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313331|NCT03356912|Prednisone|prednisone|mesh-list
139313332|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139313333|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
139313334|NCT03356912|Hormones|hormones|mesh-ancestor
139313335|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313336|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313337|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139313338|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313339|NCT00102687|Azacitidine|azacitidine|mesh-list
139313340|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139313341|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
139313342|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313343|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313344|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313345|NCT04509440|Triamcinolone|triamcinolone|mesh-list
139313346|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139313347|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139313348|NCT04509440|Anesthetics|anesthetics|mesh-list
139313349|NCT04509440|Mepivacaine|mepivacaine|mesh-list
139313350|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
139313351|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139313352|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313353|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313354|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139313355|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
139313356|NCT04509440|Hormones|hormones|mesh-ancestor
139313357|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313358|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139313359|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
139313360|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313361|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313362|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
139313363|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313364|NCT02312544|Timolol|timolol|mesh-list
139313365|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139313366|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139313367|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
139313368|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139313369|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313370|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313371|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139313372|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139313373|NCT03360734|Cetuximab|cetuximab|mesh-list
139313374|NCT03360734|Panitumumab|panitumumab|mesh-list
139313375|NCT03360734|Necitumumab|necitumumab|mesh-list
139313376|NCT03360734|Antibodies|antibodies|mesh-list
139313377|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
139313378|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313379|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139313380|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313381|NCT02308644|Bevacizumab|bevacizumab|mesh-list
139313382|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139313383|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313384|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138970259|NCT00805298|Hormones|hormones|mesh-ancestor
139313385|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139313387|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313388|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
139313389|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
139313390|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139313391|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139313392|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313393|NCT04510636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139313394|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313395|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139313396|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
139313397|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139313398|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139313399|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313400|NCT03540849|Immunotoxins|immunotoxins|mesh-ancestor
139313401|NCT03540849|Immunoconjugates|immunoconjugates|mesh-ancestor
139313402|NCT03540849|Immunologic Factors|immunologic factors|mesh-ancestor
139313403|NCT03540849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313404|NCT02304354|Rituximab|rituximab|mesh-list
139313405|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139313406|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313407|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
139313408|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313409|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139313410|NCT03356600|Apatinib|apatinib|mesh-list
139313411|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313412|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139313413|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313414|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313415|NCT00102531|Cisplatin|cisplatin|mesh-list
139313416|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313417|NCT05347654|Sulfadiazine|sulfadiazine|mesh-list
139313418|NCT05347654|Silver Sulfadiazine|silver sulfadiazine|mesh-list
139313419|NCT05347654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139313420|NCT05347654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313421|NCT05347654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139313422|NCT05347654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139313424|NCT05347654|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139313425|NCT03360266|Listerine|listerine|mesh-list
139313426|NCT03360266|Fluorides|fluorides|mesh-list
139313427|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
139313428|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
139313429|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
139313430|NCT03360266|Protective Agents|protective agents|mesh-ancestor
139313431|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313432|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138909616|NCT00826514|Tanezumab|tanezumab|mesh-list
139313433|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313434|NCT02154789|Polidocanol|polidocanol|mesh-list
139313435|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139313436|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139313437|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139313438|NCT03506256|Norfloxacin|norfloxacin|mesh-list
139313439|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139313440|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313441|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139313442|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139313443|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313444|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313445|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313446|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139313447|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139313448|NCT03356444|Docetaxel|docetaxel|mesh-list
139313449|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
139313450|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313451|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
139313452|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
139313453|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
139313454|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313455|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139313456|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313457|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
138970336|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139313458|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313459|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313460|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139313461|NCT03503604|Leucovorin|leucovorin|mesh-list
139313462|NCT03503604|Paclitaxel|paclitaxel|mesh-list
139313463|NCT03503604|Carboplatin|carboplatin|mesh-list
139313464|NCT03503604|Gemcitabine|gemcitabine|mesh-list
139313465|NCT03503604|Fluorouracil|fluorouracil|mesh-list
139313466|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
139313467|NCT03503604|Irinotecan|irinotecan|mesh-list
139313468|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139313469|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313470|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
139313471|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
139313472|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
139313473|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313474|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139313475|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
139313476|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139313477|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
139313478|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313479|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139313480|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139313481|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313482|NCT03503604|Antidotes|antidotes|mesh-ancestor
139313483|NCT03503604|Protective Agents|protective agents|mesh-ancestor
139313484|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
139313485|NCT03503604|Vitamins|vitamins|mesh-ancestor
139313486|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
139313487|NCT04508816|Cetuximab|cetuximab|mesh-list
139313488|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
139313489|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139313490|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313491|NCT03359876|Warfarin|warfarin|mesh-list
139313492|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
139313493|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
139313494|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139313495|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
139313496|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139313498|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313499|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313500|NCT05226832|Triamcinolone|triamcinolone|mesh-list
139313501|NCT05226832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139313502|NCT05226832|Glucocorticoids|glucocorticoids|mesh-ancestor
139313503|NCT05226832|Hormones|hormones|mesh-ancestor
139313504|NCT05226832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313505|NCT05226832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313506|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
139313507|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139313508|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
139313509|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313510|NCT03354572|Expectorants|expectorants|mesh-ancestor
139313511|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
139313512|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139313513|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
139313514|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313515|NCT03354572|Protective Agents|protective agents|mesh-ancestor
139313516|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313517|NCT03354572|Antidotes|antidotes|mesh-ancestor
139313518|NCT03359798|Narcotics|narcotics|mesh-list
139313519|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313520|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313521|NCT03359798|Analgesics|analgesics|mesh-ancestor
139313522|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
139313523|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313524|NCT02309346|Clindamycin|clindamycin|mesh-list
139313525|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
139313526|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
139313527|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139313528|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313529|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139313530|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970404|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139313531|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313532|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139313533|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139313534|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313535|NCT03356054|Immunotoxins|immunotoxins|mesh-ancestor
139313537|NCT03356054|Immunologic Factors|immunologic factors|mesh-ancestor
139313538|NCT03356054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313539|NCT03354494|Desogestrel|desogestrel|mesh-list
139313540|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139313541|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139313542|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139313543|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
139313544|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139313545|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313546|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139313547|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139313548|NCT03354494|Progestins|progestins|mesh-ancestor
139313549|NCT03354494|Hormones|hormones|mesh-ancestor
139313550|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313551|NCT03354338|Amoxicillin|amoxicillin|mesh-list
139313552|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139313553|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313554|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
139313555|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139313556|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313557|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139313558|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139313559|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313560|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313561|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313562|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139313563|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139313564|NCT02309424|Acetic Acid|acetic acid|mesh-list
139313565|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139313566|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313567|NCT03506178|Phenylephrine|phenylephrine|mesh-list
139313568|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
139313569|NCT03506178|Menthol|menthol|mesh-list
139313570|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
139313571|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
139313572|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139313573|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139313574|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
139313575|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139313576|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313577|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313578|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
139313579|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
139313580|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313581|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
139313582|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139313583|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
139313584|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139313585|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
139313586|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139313587|NCT03506178|Protective Agents|protective agents|mesh-ancestor
139313588|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
139313589|NCT02578186|Promethazine|promethazine|mesh-list
139313590|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139313591|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139313592|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313593|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313594|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
139313595|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
139313596|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
139313597|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313598|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
139313599|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
139313600|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139313601|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139313602|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
139313603|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
139313604|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139313605|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313606|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139313607|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
139313608|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
139313609|NCT04128436|Progesterone|progesterone|mesh-list
139313610|NCT04128436|Progestins|progestins|mesh-ancestor
139313611|NCT04128436|Hormones|hormones|mesh-ancestor
139313612|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313613|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313614|NCT02309658|Cisplatin|cisplatin|mesh-list
139313615|NCT02309658|Gemcitabine|gemcitabine|mesh-list
139313616|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313617|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139313618|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
139313619|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313620|NCT05532280|Etoricoxib|etoricoxib|mesh-list
139313621|NCT05532280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139313622|NCT05532280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139313623|NCT05532280|Analgesics|analgesics|mesh-ancestor
139313624|NCT05532280|Sensory System Agents|sensory system agents|mesh-ancestor
139313625|NCT05532280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313626|NCT05532280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313627|NCT05532280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139313628|NCT05532280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139313629|NCT05532280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139313630|NCT05532280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139313631|NCT05532280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313632|NCT05532280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313633|NCT04517162|Povidone|povidone|mesh-list
139313634|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
139313635|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
139313636|NCT02155023|Insulin|insulin|mesh-list
139313637|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139313638|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139313639|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313640|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
139313641|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139313642|NCT02163213|Antibodies|antibodies|mesh-list
139313643|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
139313644|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313645|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
139313646|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139313647|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139313648|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313649|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
139313650|NCT04443920|Coagulants|coagulants|mesh-ancestor
139313651|NCT03359018|Apatinib|apatinib|mesh-list
139313652|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313653|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139313654|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313655|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313656|NCT05530252|Minocycline|minocycline|mesh-list
139313657|NCT05530252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139313658|NCT05530252|Anti-Infective Agents|anti-infective agents|mesh-list
139313659|NCT02163291|Paclitaxel|paclitaxel|mesh-list
139313660|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139313661|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313662|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
139313663|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
139313664|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
139313665|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313666|NCT03505788|Acetazolamide|acetazolamide|mesh-list
139313667|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
139313668|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139313669|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313670|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313671|NCT03505788|Diuretics|diuretics|mesh-ancestor
139313672|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
139313673|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313674|NCT02309970|Aspirin|aspirin|mesh-list
139313675|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139313676|NCT02309970|Warfarin|warfarin|mesh-list
139313677|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
139313678|NCT02309970|Dabigatran|dabigatran|mesh-list
139313679|NCT02309970|Apixaban|apixaban|mesh-list
139313680|NCT02309970|Clopidogrel|clopidogrel|mesh-list
139313681|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139313682|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139313683|NCT02309970|Analgesics|analgesics|mesh-ancestor
139313684|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
139313685|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313686|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313687|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970559|NCT00652028|Midazolam|midazolam|mesh-list
139313689|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139313690|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139313691|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313692|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139313693|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139313694|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313695|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
139313696|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139313697|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139313698|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139313699|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
139313700|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139313701|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
139313702|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139313703|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
139313704|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139313705|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
139313706|NCT03353948|Metformin|metformin|mesh-list
139313707|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139313708|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313709|NCT02161653|Pyridoxine|pyridoxine|mesh-list
139313710|NCT02161653|Prednisone|prednisone|mesh-list
139313711|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
139313712|NCT02161653|Metadoxine|metadoxine|mesh-list
139313713|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139313714|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
139313715|NCT02161653|Hormones|hormones|mesh-ancestor
139313716|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313717|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313718|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139313719|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313720|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139313721|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313722|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313723|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139313724|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139313725|NCT02161653|Protective Agents|protective agents|mesh-ancestor
139313726|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
139313727|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139313728|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
139313729|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139313730|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
139313731|NCT02161653|Vitamins|vitamins|mesh-ancestor
139313732|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
139313733|NCT02576938|Triamcinolone|triamcinolone|mesh-list
139313734|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139313735|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
139313736|NCT02576938|Hormones|hormones|mesh-ancestor
139313737|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313738|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313739|NCT02305836|Donepezil|donepezil|mesh-list
139313740|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139313741|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313742|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313743|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
139313744|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139313745|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313746|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
139313747|NCT03503136|Cisplatin|cisplatin|mesh-list
139313748|NCT03503136|Docetaxel|docetaxel|mesh-list
139313749|NCT03503136|Capecitabine|capecitabine|mesh-list
139313750|NCT03503136|Fluorouracil|fluorouracil|mesh-list
139313751|NCT03503136|Nedaplatin|nedaplatin|mesh-list
139313752|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313753|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
139313754|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
139313755|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
139313756|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313757|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139313758|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
139313759|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139313760|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
139313761|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313762|NCT02305992|Bupivacaine|bupivacaine|mesh-list
139313763|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
139313764|NCT02305992|Anesthetics|anesthetics|mesh-list
139313765|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313766|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313767|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
139313768|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313770|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139313771|NCT03355352|Narcotics|narcotics|mesh-ancestor
139313772|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313773|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313774|NCT03355352|Analgesics|analgesics|mesh-ancestor
139313775|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
139313776|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313777|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139313778|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139313779|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
139313780|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
139313781|NCT05529940|Folfirinox|folfirinox|mesh-list
139313782|NCT05529940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313783|NCT04463784|Efavirenz|efavirenz|mesh-list
139313784|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139313785|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139313786|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313787|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313788|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
139313789|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313790|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139313791|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139313792|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139313793|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139313794|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139313795|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139313796|NCT02310360|Fallypride|fallypride|mesh-list
139313797|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139313798|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139313799|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
139313800|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139313801|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313802|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313803|NCT03353480|Azithromycin|azithromycin|mesh-list
139313804|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139313805|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313806|NCT02306070|Metformin|metformin|mesh-list
139313807|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139313808|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313809|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
139313810|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139313811|NCT03353324|Bevacizumab|bevacizumab|mesh-list
139313812|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139313813|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313814|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139313815|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139313816|NCT03353324|Growth Substances|growth substances|mesh-ancestor
139313817|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313818|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
139313819|NCT03354962|Nivolumab|nivolumab|mesh-list
139313820|NCT03354962|Ipilimumab|ipilimumab|mesh-list
139313821|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139313822|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313823|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139313824|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313825|NCT04511468|Copper|copper|mesh-list
139313826|NCT04511468|Chromium|chromium|mesh-list
139313827|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
139313828|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313829|NCT04511468|Trace Elements|trace elements|mesh-ancestor
139313830|NCT05531422|Fentanyl|fentanyl|mesh-list
139313831|NCT05531422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139313832|NCT05531422|Narcotics|narcotics|mesh-ancestor
139313833|NCT05531422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313834|NCT05531422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313835|NCT05531422|Analgesics|analgesics|mesh-ancestor
139313836|NCT05531422|Sensory System Agents|sensory system agents|mesh-ancestor
139313837|NCT05531422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313838|NCT05531422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139313839|NCT05531422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139313840|NCT05531422|Anesthetics, General|anesthetics, general|mesh-ancestor
139313841|NCT05531422|Anesthetics|anesthetics|mesh-ancestor
139313842|NCT03354806|Analgesics|analgesics|mesh-list
139313843|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
139313844|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313845|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313846|NCT05529082|Analgesics, Opioid|analgesics, opioid|mesh-list
139313847|NCT05529082|Narcotics|narcotics|mesh-ancestor
139313848|NCT05529082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313849|NCT05529082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313850|NCT05529082|Analgesics|analgesics|mesh-ancestor
139313851|NCT05529082|Sensory System Agents|sensory system agents|mesh-ancestor
139313852|NCT05529082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313853|NCT05285878|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139313854|NCT05285878|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139313855|NCT05285878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313856|NCT05285878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139313857|NCT05285878|Immunologic Factors|immunologic factors|mesh-ancestor
139313858|NCT05285878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313859|NCT02314182|Bevacizumab|bevacizumab|mesh-list
139313860|NCT02314182|Capecitabine|capecitabine|mesh-list
139313861|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
139313862|NCT02314182|Irinotecan|irinotecan|mesh-list
139313863|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139313864|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909717|NCT02614937|Ranibizumab|ranibizumab|mesh-list
139313865|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139313866|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139313867|NCT02314182|Growth Substances|growth substances|mesh-ancestor
139313868|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313870|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139313871|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
139313872|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313873|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139313874|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139313875|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313876|NCT05531344|Tamsulosin|tamsulosin|mesh-list
139313877|NCT05531344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139313878|NCT05531344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139313879|NCT05531344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139313880|NCT05531344|Adrenergic Agents|adrenergic agents|mesh-ancestor
139313881|NCT05531344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139313882|NCT05531344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313883|NCT05531344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313884|NCT05531344|Urological Agents|urological agents|mesh-ancestor
139313885|NCT05531266|Glucocorticoids|glucocorticoids|mesh-list
139313886|NCT05531266|Hormones|hormones|mesh-ancestor
139313887|NCT05531266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313888|NCT05531266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313889|NCT03349658|Anesthetics|anesthetics|mesh-list
139313890|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313891|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313892|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
139313893|NCT03353012|Etonogestrel|etonogestrel|mesh-list
139313894|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139313895|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
139313896|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139313897|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313898|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139313899|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139313900|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139313901|NCT04462614|Heparin|heparin|mesh-list
139313902|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
139313903|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139313904|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139313905|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313906|NCT03349424|Somatostatin|somatostatin|mesh-list
139313907|NCT03349424|Hormones|hormones|mesh-ancestor
139313908|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139313909|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313910|NCT03349346|Rituximab|rituximab|mesh-list
139313911|NCT03349346|Carboplatin|carboplatin|mesh-list
139313912|NCT03349346|Etoposide|etoposide|mesh-list
139313913|NCT03349346|Ifosfamide|ifosfamide|mesh-list
139313914|NCT03349346|Idelalisib|idelalisib|mesh-list
139313915|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139313916|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139313917|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
139313918|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313919|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139313920|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139313921|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139313922|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139313923|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313924|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313925|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139313926|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
139313927|NCT03502434|Petrolatum|petrolatum|mesh-list
139313928|NCT03502434|Emollients|emollients|mesh-ancestor
138909733|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
139313929|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
139313930|NCT03352700|Dyclonine|dyclonine|mesh-list
139313931|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
139313932|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
139313933|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313934|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313935|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
139313936|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313937|NCT05522998|Propofol|propofol|mesh-list
139313938|NCT05522998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139313939|NCT05522998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313940|NCT05522998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313941|NCT05522998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139313942|NCT05522998|Anesthetics, General|anesthetics, general|mesh-ancestor
139313943|NCT05522998|Anesthetics|anesthetics|mesh-ancestor
139313944|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
139313945|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139313946|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
139313947|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139313948|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313949|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139313950|NCT03498534|Isoniazid|isoniazid|mesh-list
139313951|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
139313952|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139313953|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313954|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139313955|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139313956|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
139313957|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313958|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139313959|NCT03502356|Azithromycin|azithromycin|mesh-list
139313960|NCT03502356|Cefazolin|cefazolin|mesh-list
139313961|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139313962|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313963|NCT03498456|Amoxicillin|amoxicillin|mesh-list
139313964|NCT03498456|Clarithromycin|clarithromycin|mesh-list
139313965|NCT03498456|Lansoprazole|lansoprazole|mesh-list
139313966|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
139313967|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139313968|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139313969|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139313970|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139313971|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139313972|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139313973|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139313974|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139313975|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139313976|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139313977|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
139313978|NCT02317146|Analgesics|analgesics|mesh-ancestor
139313979|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
139313980|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139313981|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139313982|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
139313983|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313984|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139313985|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
139313986|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139313987|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139313988|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970861|NCT00799838|Ketoprofen|ketoprofen|mesh-list
139313989|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139313990|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
139313991|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139313993|NCT05528146|Cathartics|cathartics|mesh-ancestor
139313994|NCT05528146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139313995|NCT03349112|Lidocaine|lidocaine|mesh-list
139313996|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
139313997|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
139313998|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139313999|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314000|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
139314001|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314002|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139314003|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139314004|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139314005|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139314006|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314007|NCT03498222|Carboplatin|carboplatin|mesh-list
139314008|NCT03498222|Pemetrexed|pemetrexed|mesh-list
139314009|NCT03498222|Atezolizumab|atezolizumab|mesh-list
139314010|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314011|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314012|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314013|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139314014|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139314015|NCT03498222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139314016|NCT03498222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139314017|NCT02518022|Insulin|insulin|mesh-list
139314018|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
139314019|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
139314020|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139314021|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314034|NCT03497988|Oxytocin|oxytocin|mesh-list
139314035|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
139314036|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139314037|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314038|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
139314039|NCT04610476|Prednisolone|prednisolone|mesh-list
139314040|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139314041|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
139314042|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139314043|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
139314044|NCT04610476|Adalimumab|adalimumab|mesh-list
139314045|NCT04610476|Infliximab|infliximab|mesh-list
139314046|NCT04610476|Etanercept|etanercept|mesh-list
139314047|NCT04610476|Apremilast|apremilast|mesh-list
139314048|NCT04610476|Golimumab|golimumab|mesh-list
139314049|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
139314050|NCT04610476|Methotrexate|methotrexate|mesh-list
139314051|NCT04610476|Abatacept|abatacept|mesh-list
139314052|NCT04610476|Ustekinumab|ustekinumab|mesh-list
139314053|NCT04610476|Ixekizumab|ixekizumab|mesh-list
139314054|NCT04610476|Tofacitinib|tofacitinib|mesh-list
139314055|NCT04610476|Leflunomide|leflunomide|mesh-list
139314056|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139314057|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
139314058|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139314059|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
139314060|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139314061|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314062|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819001|NCT05337540|Hylan|hylan|mesh-list
139314063|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
139314064|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314065|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314066|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
139314067|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314068|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139314069|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139314070|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
139314071|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139314072|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139314073|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139314074|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
139314075|NCT04610476|Hormones|hormones|mesh-ancestor
139314076|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139314077|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139314078|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
139314079|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
139314080|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314081|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139314082|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139314083|NCT04610476|Protective Agents|protective agents|mesh-ancestor
139314084|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139314085|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139314086|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139314087|NCT04610476|Analgesics|analgesics|mesh-ancestor
139314088|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
139314089|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139314090|NCT04610476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139314091|NCT04610476|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139314092|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139314093|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139314094|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139314095|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314096|NCT03348800|Anesthetics|anesthetics|mesh-list
139314097|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314098|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314099|NCT02314806|Clindamycin|clindamycin|mesh-list
139314100|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
139314101|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
139314102|NCT02314806|Gentamicins|gentamicins|mesh-list
139314103|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139314104|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139314105|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314106|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139314107|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314108|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314109|NCT00709202|Betahistine|betahistine|mesh-list
139314110|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
139314111|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
139314112|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
139314113|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314114|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314115|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314116|NCT05517538|Botulinum Toxins|botulinum toxins|mesh-list
139314117|NCT05517538|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139314118|NCT05517538|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139314119|NCT05517538|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139314120|NCT05517538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139314121|NCT05517538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314122|NCT05517538|Cholinergic Agents|cholinergic agents|mesh-ancestor
139314123|NCT05517538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314124|NCT05517538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314125|NCT05517538|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139314126|NCT05517538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314127|NCT02321280|Denosumab|denosumab|mesh-list
139314128|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139314129|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314130|NCT02315118|Rituximab|rituximab|mesh-list
139314131|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139314132|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314133|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
139314134|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314135|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139314136|NCT03122756|Dexamethasone|dexamethasone|mesh-list
139314137|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139314138|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
139314139|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
139314140|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314141|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314142|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139314143|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
139314144|NCT03122756|Hormones|hormones|mesh-ancestor
139314145|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139314146|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139314147|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314148|NCT03122678|Thiamine|thiamine|mesh-list
139314149|NCT03122678|Vitamins|vitamins|mesh-ancestor
139314150|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
139314151|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314152|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
139314153|NCT02317770|Lidocaine|lidocaine|mesh-list
139314154|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
139314155|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
139314156|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314157|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314158|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
139314159|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314160|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139314161|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139314162|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139314163|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139314164|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314166|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314167|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139314168|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314169|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314170|NCT05526898|Triamcinolone|triamcinolone|mesh-list
139314171|NCT05526898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139314172|NCT05526898|Glucocorticoids|glucocorticoids|mesh-ancestor
139314173|NCT05526898|Hormones|hormones|mesh-ancestor
139314174|NCT05526898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139314175|NCT05526898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314176|NCT05526820|Vaccines|vaccines|mesh-list
139314177|NCT05526820|Immunologic Factors|immunologic factors|mesh-ancestor
139314178|NCT05526820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314179|NCT03352076|Danazol|danazol|mesh-list
139314180|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139314181|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
139314182|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139314183|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909783|NCT00805194|Docetaxel|docetaxel|mesh-list
139314184|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139314185|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139314186|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139314187|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139314188|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139314189|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
139314190|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314191|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314192|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314193|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139314194|NCT02738580|Hormones|hormones|mesh-ancestor
139314195|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139314196|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314197|NCT03497364|Bupivacaine|bupivacaine|mesh-list
139314198|NCT03497364|Ropivacaine|ropivacaine|mesh-list
139314199|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
139314200|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
139314201|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314202|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314203|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
139314204|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314205|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139314206|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139314207|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314208|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
139314209|NCT05516446|Chromium|chromium|mesh-list
139314210|NCT05516446|Paclitaxel|paclitaxel|mesh-list
139314211|NCT05516446|Everolimus|everolimus|mesh-list
139314212|NCT05516446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139314213|NCT05516446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314214|NCT05516446|Tubulin Modulators|tubulin modulators|mesh-ancestor
139314215|NCT05516446|Antimitotic Agents|antimitotic agents|mesh-ancestor
139314216|NCT05516446|Mitosis Modulators|mitosis modulators|mesh-ancestor
139314217|NCT05516446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314218|NCT05516446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139314219|NCT05516446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139314220|NCT05516446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314221|NCT05516446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139314222|NCT05516446|Immunologic Factors|immunologic factors|mesh-ancestor
139314223|NCT05516446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314224|NCT05516446|Trace Elements|trace elements|mesh-ancestor
139314225|NCT05516446|Micronutrients|micronutrients|mesh-ancestor
139314226|NCT02318082|Aldesleukin|aldesleukin|mesh-list
139314227|NCT02318082|Interleukin-2|interleukin-2|mesh-list
139314228|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314229|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139314230|NCT02318082|Analgesics|analgesics|mesh-ancestor
139314231|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
139314232|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314233|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314234|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139314235|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139314236|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
139314237|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314238|NCT03348098|Paclitaxel|paclitaxel|mesh-list
139314239|NCT03348098|Apatinib|apatinib|mesh-list
139314240|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139314241|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314242|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
139314243|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
139314244|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
139314245|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314246|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139314247|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314248|NCT03351842|Cisplatin|cisplatin|mesh-list
139314249|NCT03351842|Carboplatin|carboplatin|mesh-list
139314250|NCT03351842|Pemetrexed|pemetrexed|mesh-list
139314251|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314252|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314253|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314254|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139314255|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139314256|NCT02447406|Docetaxel|docetaxel|mesh-list
139314257|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314258|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
139314259|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
139314260|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
139314261|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314262|NCT04505228|Atropine|atropine|mesh-list
139314263|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139314264|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139314265|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139314266|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
139314267|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314268|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314269|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139314270|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
139314271|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
139314272|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
139314273|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139314274|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139314275|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
139314276|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314277|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314278|NCT05584826|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139314279|NCT05584826|Hallucinogens|hallucinogens|mesh-ancestor
139314280|NCT05584826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314281|NCT05584826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139314282|NCT05584826|Serotonin Agents|serotonin agents|mesh-ancestor
139314283|NCT05584826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314284|NCT05584826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314285|NCT05584826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139314286|NCT05584826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139314287|NCT05584826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139314288|NCT05584826|Adrenergic Agents|adrenergic agents|mesh-ancestor
139314289|NCT02322372|Bupivacaine|bupivacaine|mesh-list
138971164|NCT02541708|Folic Acid|folic acid|mesh-list
139314291|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314292|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314293|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
139314294|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
139314295|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314296|NCT01376804|Valganciclovir|valganciclovir|mesh-list
139314297|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
139314298|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314299|NCT05526118|Tenofovir|tenofovir|mesh-list
139314300|NCT05526118|Emtricitabine|emtricitabine|mesh-list
139314301|NCT05526118|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139314302|NCT05526118|Antiviral Agents|antiviral agents|mesh-ancestor
139314303|NCT05526118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314304|NCT05526118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139314305|NCT05526118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139314306|NCT05526118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314307|NCT05526118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314308|NCT05526118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139314309|NCT05526118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139314310|NCT03122132|Ritonavir|ritonavir|mesh-list
139314311|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139314312|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139314313|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
139314314|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314315|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314316|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139314317|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139314318|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
139314319|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314320|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139314321|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139314322|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
139314323|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139314324|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139314325|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314326|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
139314327|NCT03351686|Coagulants|coagulants|mesh-ancestor
139314328|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
139314329|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139314330|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314331|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
139314332|NCT02319018|Leucovorin|leucovorin|mesh-list
139314333|NCT02319018|Folic Acid|folic acid|mesh-list
139314334|NCT02319018|Fluorouracil|fluorouracil|mesh-list
139314335|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
139314336|NCT02319018|Calcium|calcium|mesh-list
139314337|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
139314338|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139314339|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314340|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139314341|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
139314342|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314343|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139314344|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314345|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139314346|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
139314347|NCT02319018|Antidotes|antidotes|mesh-ancestor
139314348|NCT02319018|Protective Agents|protective agents|mesh-ancestor
139314349|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
139314350|NCT02319018|Vitamins|vitamins|mesh-ancestor
139314351|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
139314352|NCT02319018|Hematinics|hematinics|mesh-ancestor
139314353|NCT02574520|Bupivacaine|bupivacaine|mesh-list
139314354|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139314355|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
139314356|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
139314357|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314358|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314359|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
139314360|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314361|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
139314362|NCT04425226|Lenvatinib|lenvatinib|mesh-list
139314363|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139314364|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314365|NCT04425226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139314366|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314367|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139314368|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314369|NCT05520658|Fluorouracil|fluorouracil|mesh-list
139314370|NCT05520658|Digoxin|digoxin|mesh-list
139314371|NCT05520658|Furosemide|furosemide|mesh-list
139314372|NCT05520658|Antimetabolites|antimetabolites|mesh-ancestor
139314373|NCT05520658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314374|NCT05520658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139314375|NCT05520658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314376|NCT05520658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139314377|NCT05520658|Immunologic Factors|immunologic factors|mesh-ancestor
139314378|NCT05520658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314379|NCT05520658|Diuretics|diuretics|mesh-ancestor
139314380|NCT05520658|Natriuretic Agents|natriuretic agents|mesh-ancestor
139314381|NCT05520658|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139314382|NCT05520658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139314383|NCT05520658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139314384|NCT05520658|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139314385|NCT05520658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314386|NCT05520658|Protective Agents|protective agents|mesh-ancestor
139314387|NCT04462926|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139314388|NCT04462926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139314389|NCT04462926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314390|NCT03351062|Tamoxifen|tamoxifen|mesh-list
139314391|NCT03351062|Toremifene|toremifene|mesh-list
139314392|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139314393|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
139314394|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139314395|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314396|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139314397|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314398|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139314399|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139314400|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139314401|NCT03496740|Bupivacaine|bupivacaine|mesh-list
139314402|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
139314403|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
139314404|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314405|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314406|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
139314407|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314408|NCT05515822|Oxycodone|oxycodone|mesh-list
139314409|NCT05515822|Dezocine|dezocine|mesh-list
139314410|NCT05515822|Esketamine|esketamine|mesh-list
139314411|NCT05515822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139314412|NCT05515822|Narcotics|narcotics|mesh-ancestor
139314413|NCT05515822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314414|NCT05515822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314415|NCT05515822|Analgesics|analgesics|mesh-ancestor
139314416|NCT05515822|Sensory System Agents|sensory system agents|mesh-ancestor
139314417|NCT05515822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314418|NCT05515822|Antidepressive Agents|antidepressive agents|mesh-ancestor
139314419|NCT05515822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139314420|NCT04294654|Vortioxetine|vortioxetine|mesh-list
139314421|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
139314422|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139314423|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139314424|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139314425|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314426|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314427|NCT04294654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139314428|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139314429|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139314430|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314431|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314432|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
139314433|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139314434|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139314435|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139314436|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139314437|NCT03496506|Selexipag|selexipag|mesh-list
139314438|NCT03496506|Clopidogrel|clopidogrel|mesh-list
139314439|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139314440|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139314441|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139314442|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139314443|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
139314444|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314445|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314446|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314447|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139314448|NCT02325024|Nabiximols|nabiximols|mesh-list
139314449|NCT02325024|Analgesics|analgesics|mesh-ancestor
139176419|NCT03872011|Vitamins|vitamins|mesh-list
139314450|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
139314451|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314452|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314453|NCT02319564|Beclomethasone|beclomethasone|mesh-list
139314454|NCT02319564|Albuterol|albuterol|mesh-list
139314455|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139314456|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
139314457|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314458|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314459|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139314460|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
139314461|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
139314462|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139314463|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139314464|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139314465|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139314466|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
139314467|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314468|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314469|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139314470|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
139314471|NCT02319564|Hormones|hormones|mesh-ancestor
139314472|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139314473|NCT02325180|Lumefantrine|lumefantrine|mesh-list
139314474|NCT02325180|Artemether|artemether|mesh-list
139314475|NCT02325180|Piperaquine|piperaquine|mesh-list
139314476|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139314477|NCT02325180|Artenimol|artenimol|mesh-list
139314478|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
139314479|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139314480|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139314481|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314482|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
139314483|NCT00709592|Tacrolimus|tacrolimus|mesh-list
139314484|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
139314485|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139314486|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139314487|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
139314488|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314489|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139314490|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314491|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314492|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139314493|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314494|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139314495|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
139314496|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139314497|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314498|NCT05515354|Nicotine|nicotine|mesh-list
139314499|NCT05515354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139314500|NCT05515354|Autonomic Agents|autonomic agents|mesh-ancestor
139314501|NCT05515354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314502|NCT05515354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314503|NCT05515354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139314504|NCT05515354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139314505|NCT05515354|Cholinergic Agents|cholinergic agents|mesh-ancestor
139314506|NCT05515354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314507|NCT05515354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314508|NCT02437370|Gemcitabine|gemcitabine|mesh-list
139314509|NCT02437370|Docetaxel|docetaxel|mesh-list
139314510|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
139314511|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139314512|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
139314513|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971389|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139314514|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314515|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
139314516|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
139314517|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
139314518|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139314519|NCT02437370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139314521|NCT05515120|Vitamin K|vitamin k|mesh-list
139314522|NCT05515120|Rivaroxaban|rivaroxaban|mesh-list
139314523|NCT05515120|Acenocoumarol|acenocoumarol|mesh-list
139314524|NCT05515120|Vitamins|vitamins|mesh-ancestor
139314525|NCT05515120|Micronutrients|micronutrients|mesh-ancestor
139314526|NCT05515120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314527|NCT05515120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139314528|NCT05515120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139314529|NCT05515120|Analgesics|analgesics|mesh-ancestor
139314530|NCT05515120|Sensory System Agents|sensory system agents|mesh-ancestor
139314531|NCT05515120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314532|NCT05515120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139314533|NCT05515120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139314534|NCT05515120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139314535|NCT05515120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139314536|NCT05515120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314537|NCT05515120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139314538|NCT05515120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139314539|NCT05515120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314540|NCT05515120|Antipyretics|antipyretics|mesh-ancestor
139314541|NCT05515120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139314542|NCT05515120|Antithrombins|antithrombins|mesh-ancestor
139314543|NCT05515120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139314544|NCT05515120|Protease Inhibitors|protease inhibitors|mesh-ancestor
139314545|NCT05515120|Anticoagulants|anticoagulants|mesh-ancestor
139314546|NCT05515120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139314547|NCT05515120|Hemostatics|hemostatics|mesh-ancestor
139314548|NCT05515120|Coagulants|coagulants|mesh-ancestor
139314549|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
139314550|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139314551|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
139314552|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314553|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138909871|NCT00658606|Alefacept|alefacept|mesh-list
139314554|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139314555|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
139314556|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314557|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314558|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139314559|NCT03495804|Mannitol|mannitol|mesh-list
139314560|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139314561|NCT03495804|Diuretics|diuretics|mesh-ancestor
139314562|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
139314563|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314564|NCT05519410|Lenvatinib|lenvatinib|mesh-list
139314565|NCT05519410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314566|NCT05519410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139314567|NCT05519410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314568|NCT05519410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314569|NCT05578586|Meropenem|meropenem|mesh-list
139314570|NCT05578586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139314571|NCT05578586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314572|NCT02570074|Fosfomycin|fosfomycin|mesh-list
139314573|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139314574|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314575|NCT02569996|Rituximab|rituximab|mesh-list
139314576|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139314577|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314578|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
139314579|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314580|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139314581|NCT02325882|Fentanyl|fentanyl|mesh-list
139314582|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
139314583|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139314584|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314585|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314586|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139314587|NCT02325882|Analgesics|analgesics|mesh-ancestor
139314588|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
139314589|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314590|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139314591|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139314592|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139314593|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
139314594|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314595|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314596|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139314597|NCT02325882|Narcotics|narcotics|mesh-ancestor
139314598|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139314599|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139314600|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
139314601|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
139314602|NCT00708500|Interferons|interferons|mesh-list
139314603|NCT00708500|Ribavirin|ribavirin|mesh-list
139314604|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
139314605|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
139314606|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139314607|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314608|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
139314609|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314610|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
139314611|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314612|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
139314613|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314614|NCT05144100|Cisplatin|cisplatin|mesh-list
139314615|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314616|NCT02320032|Aripiprazole|aripiprazole|mesh-list
139314617|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
139314618|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
139314619|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139314620|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139314621|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139314622|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314623|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314624|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
139314625|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
139314626|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314627|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314628|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139314629|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139314630|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
139314631|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139314632|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139314633|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139314634|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139314635|NCT05514652|Analgesics, Opioid|analgesics, opioid|mesh-list
139314636|NCT05514652|Anesthetics|anesthetics|mesh-list
139314637|NCT05514652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314638|NCT05514652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314639|NCT05514652|Narcotics|narcotics|mesh-ancestor
139314640|NCT05514652|Analgesics|analgesics|mesh-ancestor
139314641|NCT05514652|Sensory System Agents|sensory system agents|mesh-ancestor
139314642|NCT05514652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314643|NCT00673244|Furosemide|furosemide|mesh-list
139314644|NCT00673244|Diuretics|diuretics|mesh-ancestor
139314645|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
139314646|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314647|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139314648|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139314649|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314650|NCT02517788|Interferons|interferons|mesh-list
139314651|NCT02517788|Interferon-beta|interferon-beta|mesh-list
139314652|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
139314653|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314654|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
139314655|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314656|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
139314657|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314658|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139314659|NCT04599790|Lenvatinib|lenvatinib|mesh-list
139314660|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314661|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139314662|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314663|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314664|NCT03132168|Anesthetics|anesthetics|mesh-list
139314665|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314666|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971539|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139314667|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139314668|NCT04937062|Glycerol|glycerol|mesh-list
139314669|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139314670|NCT04937062|Protective Agents|protective agents|mesh-ancestor
139314671|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314672|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314673|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139314674|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139314675|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314676|NCT02324010|Incretins|incretins|mesh-ancestor
139314677|NCT02324010|Hormones|hormones|mesh-ancestor
139314678|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139314679|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139314680|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
139314681|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314682|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314683|NCT02320734|Rocuronium|rocuronium|mesh-list
139314684|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139314685|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139314686|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139314687|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314688|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314689|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
139314690|NCT03346226|Propofol|propofol|mesh-list
139314691|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139314692|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314693|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314694|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139314695|NCT03346226|Analgesics|analgesics|mesh-ancestor
139314696|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
139314697|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314698|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139314699|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139314700|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139314701|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
139314702|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314703|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314704|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139314705|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
139314706|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
139314707|NCT03347240|Baclofen|baclofen|mesh-list
139314708|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139314709|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314710|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139314711|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314712|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139314713|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
139314714|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
139314715|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314716|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314717|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
139314718|NCT02324088|Docetaxel|docetaxel|mesh-list
139314719|NCT02324088|Epirubicin|epirubicin|mesh-list
139314720|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139314721|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
139314722|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314723|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139314724|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139314725|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
139314726|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314727|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314728|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139314729|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
139314730|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
139314731|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
139314732|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139314733|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139314734|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139314735|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314736|NCT02324166|Cefazolin|cefazolin|mesh-list
139314737|NCT02324166|Lidocaine|lidocaine|mesh-list
139314738|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
139314739|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
139314740|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314741|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314742|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
139314743|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314744|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139314745|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139314746|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139314747|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139314748|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314749|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139314750|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314752|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139314753|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
139314754|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314755|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139314756|NCT03346538|Protective Agents|protective agents|mesh-ancestor
139314757|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314758|NCT02513342|Docetaxel|docetaxel|mesh-list
139314759|NCT02513342|Endostar protein|endostar protein|mesh-list
139314760|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314761|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
139314762|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
139314763|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
139314764|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314765|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139314766|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139314767|NCT02513342|Growth Substances|growth substances|mesh-ancestor
139314768|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314769|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
139314770|NCT03495024|Varenicline|varenicline|mesh-list
139314771|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139314772|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139314773|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
139314774|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314775|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314776|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314777|NCT04188314|Desflurane|desflurane|mesh-list
139314778|NCT04188314|Isoflurane|isoflurane|mesh-list
139314779|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139314780|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
139314781|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
139314782|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314783|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314784|NCT05512780|Letrozole|letrozole|mesh-list
139314785|NCT05512780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314786|NCT05512780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139314787|NCT05512780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139314788|NCT05512780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314789|NCT05512780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909930|NCT00825812|Atropine|atropine|mesh-list
139314790|NCT05512780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139314791|NCT05512780|Hormone Antagonists|hormone antagonists|mesh-ancestor
139314792|NCT05512780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139314793|NCT05512780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314794|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139314795|NCT02517164|Calcifediol|calcifediol|mesh-list
139314796|NCT02517164|Vitamins|vitamins|mesh-ancestor
139314797|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
139314798|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314799|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139314800|NCT04834362|Insulin|insulin|mesh-list
139314801|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139314802|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
139314803|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
139314804|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139314805|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314806|NCT05512702|Heparin|heparin|mesh-list
139314807|NCT05512702|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139314808|NCT05512702|Plasminogen|plasminogen|mesh-list
139314809|NCT05512702|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139314810|NCT05512702|Tinzaparin|tinzaparin|mesh-list
139314811|NCT05512702|Dalteparin|dalteparin|mesh-list
139314812|NCT05512702|Anticoagulants|anticoagulants|mesh-ancestor
139314813|NCT05512702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139314814|NCT05512702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139314815|NCT05512702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971688|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
139314817|NCT05512546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139314819|NCT05512546|Analgesics|analgesics|mesh-ancestor
139314820|NCT05512546|Sensory System Agents|sensory system agents|mesh-ancestor
139314821|NCT05512546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314822|NCT05512546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314823|NCT05512546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139314824|NCT05512546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139314825|NCT05512546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139314826|NCT05512546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139314827|NCT05512546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314828|NCT05512546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139314829|NCT05512546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139314830|NCT05512546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314831|NCT05512546|Antipyretics|antipyretics|mesh-ancestor
139314832|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
139314833|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139314834|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314835|NCT03345134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139314836|NCT03345134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314837|NCT02512562|Simeprevir|simeprevir|mesh-list
139314838|NCT02512562|Odalasvir|odalasvir|mesh-list
139314839|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
139314840|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314841|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
139314842|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314843|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314844|NCT02516774|Adalimumab|adalimumab|mesh-list
139314845|NCT02516774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139314846|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139314847|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139314848|NCT05510986|Fentanyl|fentanyl|mesh-list
139314849|NCT05510986|Oxycodone|oxycodone|mesh-list
139314850|NCT05510986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139314851|NCT05510986|Narcotics|narcotics|mesh-ancestor
139314852|NCT05510986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314853|NCT05510986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314854|NCT05510986|Analgesics|analgesics|mesh-ancestor
139314855|NCT05510986|Sensory System Agents|sensory system agents|mesh-ancestor
139314856|NCT05510986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314857|NCT05510986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139314858|NCT05510986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139314859|NCT05510986|Anesthetics, General|anesthetics, general|mesh-ancestor
139314860|NCT05510986|Anesthetics|anesthetics|mesh-ancestor
139314861|NCT04872400|Vancomycin|vancomycin|mesh-list
139314862|NCT04872400|Tobramycin|tobramycin|mesh-list
139314863|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139314864|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314865|NCT00101907|Gemcitabine|gemcitabine|mesh-list
139314866|NCT00101907|Panitumumab|panitumumab|mesh-list
139314867|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
139314868|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314869|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139314870|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
139314871|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314872|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139314873|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139314874|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314875|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
139314876|NCT03491748|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
139314877|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139314878|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314879|NCT04769206|Galantamine|galantamine|mesh-list
139314880|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139314881|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314882|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314883|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
139314884|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314885|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314886|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139314887|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
139314889|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
139314890|NCT03492996|Delpazolid|delpazolid|mesh-list
139314891|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139314892|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314893|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139314894|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314895|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314896|NCT02161965|Warfarin|warfarin|mesh-list
139314897|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
139314898|NCT02161965|Fluindione|fluindione|mesh-list
139314899|NCT02161965|Phenindione|phenindione|mesh-list
139314900|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
139314901|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139314902|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
139314903|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139314904|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
139314905|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314906|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314907|NCT02050308|Nicotine|nicotine|mesh-list
139314908|NCT02050308|Varenicline|varenicline|mesh-list
139314909|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139314910|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
139314911|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314912|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314913|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139314914|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139314915|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
139314916|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314917|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314918|NCT02516618|Fasinumab|fasinumab|mesh-list
139314919|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139314920|NCT02516618|Analgesics|analgesics|mesh-ancestor
139314921|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
139314922|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314923|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314924|NCT05507554|Analgesics|analgesics|mesh-list
139314925|NCT05507554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
139314926|NCT05507554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909956|NCT00707876|Hematinics|hematinics|mesh-ancestor
139314927|NCT05507554|Sensory System Agents|sensory system agents|mesh-ancestor
139314928|NCT05507554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314929|NCT02516462|Hormones|hormones|mesh-list
139314930|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139314931|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139314932|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314933|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
139314934|NCT04501250|Insulin|insulin|mesh-list
139314935|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139314936|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139314937|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314938|NCT02761629|Interferons|interferons|mesh-list
139314939|NCT02761629|Ribavirin|ribavirin|mesh-list
139314940|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
139314941|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
139314942|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139314943|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314944|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
139314945|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314946|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
139314947|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314948|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
139314949|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314950|NCT03345992|Clarithromycin|clarithromycin|mesh-list
139314951|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139314952|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139314953|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139314954|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314955|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314956|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139314957|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139314958|NCT02162121|Ketorolac|ketorolac|mesh-list
139314959|NCT02162121|Buprenorphine|buprenorphine|mesh-list
139314960|NCT02162121|Anesthetics|anesthetics|mesh-list
139314961|NCT02162121|Ropivacaine|ropivacaine|mesh-list
139314962|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
139314963|NCT02162121|Mepivacaine|mepivacaine|mesh-list
139314965|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139314966|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314967|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
139314968|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314969|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139314970|NCT02162121|Narcotics|narcotics|mesh-ancestor
139314971|NCT02162121|Analgesics|analgesics|mesh-ancestor
139314972|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139314973|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139314974|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139314975|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139314976|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139314977|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139314978|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314979|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314981|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139314982|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
138909964|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
139314983|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139314984|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139314985|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139314986|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139314987|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
139314988|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139314989|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314990|NCT04500704|Carboplatin|carboplatin|mesh-list
139314991|NCT04500704|Pemetrexed|pemetrexed|mesh-list
139314992|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139314993|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139314994|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139314995|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139314996|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139314997|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
139314998|NCT02164773|Analgesics|analgesics|mesh-ancestor
139314999|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
139315000|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315001|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315002|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
139315003|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315004|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139315005|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
139315006|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139315007|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139315008|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315009|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139315010|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
139315011|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139315012|NCT00101439|Ezetimibe|ezetimibe|mesh-list
139315013|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139315014|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139315015|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
139315016|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315017|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139315018|NCT03344822|Choline|choline|mesh-list
139315019|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139315020|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139315021|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315022|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
139315023|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139315024|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
139315025|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139315026|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139315027|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
139315028|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139315029|NCT02506790|Toremifene|toremifene|mesh-list
139315030|NCT02506790|Metformin|metformin|mesh-list
139315031|NCT02506790|Melatonin|melatonin|mesh-list
139315032|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139315033|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315034|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
139315035|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315036|NCT02506790|Protective Agents|protective agents|mesh-ancestor
139315037|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315038|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139315039|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315040|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139315041|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139315042|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
139315043|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139315044|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139315045|NCT04500002|Isoniazid|isoniazid|mesh-list
139315046|NCT04500002|Misoprostol|misoprostol|mesh-list
139315047|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139315048|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
138909985|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
139315049|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139315050|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315051|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139315052|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139315053|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
139315054|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
139315055|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139315056|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315057|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139315058|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139315059|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
139315060|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315061|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139315062|NCT02515682|Equol|equol|mesh-list
139315063|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
139315064|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139315065|NCT02515682|Estrogens|estrogens|mesh-ancestor
139315066|NCT02515682|Hormones|hormones|mesh-ancestor
139315067|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139315068|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315069|NCT02515604|Misoprostol|misoprostol|mesh-list
139315070|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139315071|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
139315072|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139315073|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315074|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139315075|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139315076|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
139315077|NCT02510534|Menotropins|menotropins|mesh-list
139315078|NCT02510534|Progesterone|progesterone|mesh-list
139315079|NCT02510534|Progestins|progestins|mesh-ancestor
139315080|NCT02510534|Hormones|hormones|mesh-ancestor
139315081|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139315082|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315083|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139315084|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
139315085|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139315086|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
139315087|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139315088|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315089|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315090|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139315091|NCT02510612|Analgesics|analgesics|mesh-ancestor
139315092|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
139315093|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315094|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139315095|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139315096|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139315097|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
139315098|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315099|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315100|NCT03749616|Acetaminophen|acetaminophen|mesh-list
139315101|NCT03749616|Ibuprofen|ibuprofen|mesh-list
139315102|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139315103|NCT03749616|Analgesics|analgesics|mesh-ancestor
139315104|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
139315105|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315106|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315107|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
139315108|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139315109|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139315110|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139315111|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139315112|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909993|NCT00803374|Ipilimumab|ipilimumab|mesh-list
139315113|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315114|NCT04532502|Anesthetics|anesthetics|mesh-list
139315115|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
139315116|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315117|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971995|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139315118|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
139315119|NCT02515526|Tolbutamide|tolbutamide|mesh-list
139315120|NCT02515526|Ethanol|ethanol|mesh-list
139315121|NCT02515526|Digoxin|digoxin|mesh-list
139315122|NCT02515526|Midazolam|midazolam|mesh-list
139315123|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
139315124|NCT02515526|Caffeine|caffeine|mesh-list
139315125|NCT02515526|Omeprazole|omeprazole|mesh-list
139315126|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139315127|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139315128|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315129|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315130|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139315131|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139315132|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139315133|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139315134|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
139315135|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
139315136|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
139315137|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
139315138|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315139|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315140|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139315141|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139315142|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315143|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139315144|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139315145|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
139315146|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139315147|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139315148|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139315149|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139315150|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315151|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139315152|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139315153|NCT02515526|Protective Agents|protective agents|mesh-ancestor
139315154|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
139315155|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
139315156|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139315157|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139315158|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139315159|NCT02515448|Gentamicins|gentamicins|mesh-list
139315160|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139315161|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315162|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139315163|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315164|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315165|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
139315166|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139315167|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
139315168|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315169|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
139315170|NCT02170857|Protective Agents|protective agents|mesh-ancestor
139315171|NCT04460820|Doxorubicin|doxorubicin|mesh-list
139315172|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139315173|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139315174|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315175|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139315176|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139315177|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315178|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315179|NCT02170935|Dabigatran|dabigatran|mesh-list
139315180|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
139315181|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139315182|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
139315183|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315184|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315185|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
139315186|NCT03488316|Calcium|calcium|mesh-list
139315187|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139315188|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315189|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
139315190|NCT02510222|Analgesics|analgesics|mesh-ancestor
139315191|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
139315192|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315193|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315194|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
139315195|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315196|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139315197|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
139315198|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139315199|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139315200|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315201|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139315202|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
139315203|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139315204|NCT05100264|Acetic Acid|acetic acid|mesh-list
139315205|NCT05100264|Retinol acetate|retinol acetate|mesh-list
139315206|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139315207|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315208|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139315209|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
139315210|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315211|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139315212|NCT05100264|Protective Agents|protective agents|mesh-ancestor
139315213|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315214|NCT02505776|Bimatoprost|bimatoprost|mesh-list
139315215|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139315216|NCT02171013|Dabigatran|dabigatran|mesh-list
139315217|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
139315218|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139315219|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
139315220|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315221|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315222|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
139315223|NCT02167425|Methadone|methadone|mesh-list
139315224|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139315225|NCT02167425|Narcotics|narcotics|mesh-ancestor
139315226|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315227|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315228|NCT02167425|Analgesics|analgesics|mesh-ancestor
139315229|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
139315230|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315231|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
139315232|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
139315233|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
139315234|NCT03111732|Capecitabine|capecitabine|mesh-list
139315235|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
139315236|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139315237|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315238|NCT03111732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139315239|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315240|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139315241|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
139315242|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
139315243|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315244|NCT02505386|Ertapenem|ertapenem|mesh-list
139315245|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139315246|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315247|NCT05507086|Anti-Infective Agents|anti-infective agents|mesh-list
139315248|NCT05507086|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139315249|NCT02514980|Ketamine|ketamine|mesh-list
139315250|NCT02514980|Bupivacaine|bupivacaine|mesh-list
139315251|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
139315252|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
139315253|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315254|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315255|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
139315256|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315257|NCT02514980|Analgesics|analgesics|mesh-ancestor
139176442|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
139315258|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139315259|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139315260|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
139315261|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139315262|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139315263|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315264|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315265|NCT02165475|Loperamide|loperamide|mesh-list
139315266|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
139315267|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139315268|NCT04862338|Niacinamide|niacinamide|mesh-list
139315269|NCT04862338|Niacin|niacin|mesh-list
139315270|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
139315271|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
139315272|NCT04862338|Vitamins|vitamins|mesh-ancestor
139315273|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
139315274|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315275|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139315276|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
139315277|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315278|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139315279|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
139315280|NCT02171325|Irinotecan|irinotecan|mesh-list
139315281|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139315282|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139315283|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315284|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315285|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315286|NCT02509286|Leucovorin|leucovorin|mesh-list
139315287|NCT02509286|Paclitaxel|paclitaxel|mesh-list
139315288|NCT02509286|Docetaxel|docetaxel|mesh-list
139315289|NCT02509286|Carboplatin|carboplatin|mesh-list
139315290|NCT02509286|Fluorouracil|fluorouracil|mesh-list
139315291|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
139315292|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139315293|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315294|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
139315295|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
139315296|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
139315297|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315298|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
139315299|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139315300|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139315301|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
139315302|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315303|NCT02509286|Antidotes|antidotes|mesh-ancestor
139315304|NCT02509286|Protective Agents|protective agents|mesh-ancestor
139315305|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
139315306|NCT02509286|Vitamins|vitamins|mesh-ancestor
139315307|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
139315308|NCT03065244|Infliximab|infliximab|mesh-list
139315309|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
139315310|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139315311|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
139315312|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139315313|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
139315314|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315315|NCT03065244|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139315316|NCT03065244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139315317|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
139315318|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139315319|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139315320|NCT02171481|Dabigatran|dabigatran|mesh-list
139315321|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
139315322|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139315323|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
139315324|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315325|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315326|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
139315327|NCT02171559|Enoxaparin|enoxaparin|mesh-list
139315328|NCT02171559|Dabigatran|dabigatran|mesh-list
139315329|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
139315330|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139315331|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139315332|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176446|NCT00073307|Sorafenib|sorafenib|mesh-list
139315333|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
139315334|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139315335|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
139315336|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315337|NCT04901754|Apatinib|apatinib|mesh-list
139315338|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315339|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139315340|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315341|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315342|NCT02509208|Hemostatics|hemostatics|mesh-list
139315343|NCT02509208|Coagulants|coagulants|mesh-ancestor
139315344|NCT02504996|Acetaminophen|acetaminophen|mesh-list
139315345|NCT02504996|Morphine|morphine|mesh-list
139315346|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138972228|NCT01073683|Docetaxel|docetaxel|mesh-list
139315347|NCT02504996|Narcotics|narcotics|mesh-ancestor
139315348|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315349|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315350|NCT02504996|Analgesics|analgesics|mesh-ancestor
139315351|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
139315352|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315353|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139315355|NCT00100815|Bevacizumab|bevacizumab|mesh-list
139315356|NCT00100815|Gemcitabine|gemcitabine|mesh-list
139315357|NCT00100815|Capecitabine|capecitabine|mesh-list
139315358|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139315359|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315360|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139315361|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139315362|NCT00100815|Growth Substances|growth substances|mesh-ancestor
139315363|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315364|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
139315365|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139315366|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
139315367|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315368|NCT00708422|Travoprost|travoprost|mesh-list
139315369|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139315370|NCT00708422|Latanoprost|latanoprost|mesh-list
139315371|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139315372|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139315373|NCT02514200|Riboflavin|riboflavin|mesh-list
138910042|NCT00856583|Risperidone|risperidone|mesh-list
139315374|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
139315375|NCT02514200|Vitamins|vitamins|mesh-ancestor
139315376|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
139315377|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315378|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139315379|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
139315380|NCT02504450|Haloperidol|haloperidol|mesh-list
139315381|NCT02504450|Ziprasidone|ziprasidone|mesh-list
139315382|NCT02504450|Loxapine|loxapine|mesh-list
139315383|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
139315384|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
139315385|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315386|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315387|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139315388|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139315389|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139315390|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315391|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139315392|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139315393|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
139315394|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315395|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315396|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139315397|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139315398|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
139315399|NCT02171637|Afatinib|afatinib|mesh-list
139315400|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315401|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139315402|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315403|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315404|NCT02171715|Afatinib|afatinib|mesh-list
139315405|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315406|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139315407|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315408|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315409|NCT02760069|Ondansetron|ondansetron|mesh-list
139315410|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
139315411|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
139315412|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315413|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315414|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139315415|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
139315416|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
139315417|NCT02760069|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139315418|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139315419|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
139315420|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315421|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315422|NCT02504138|Anesthetics|anesthetics|mesh-list
139315423|NCT02504138|Propofol|propofol|mesh-list
139315424|NCT02504138|Desflurane|desflurane|mesh-list
139315425|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315426|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315427|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139315428|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139315429|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
139315430|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139315431|NCT02508584|Antibodies|antibodies|mesh-list
139315432|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
139315433|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315434|NCT02171793|Olodaterol|olodaterol|mesh-list
139315435|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139315436|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
139315437|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315438|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315439|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139315440|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
139315441|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
139315442|NCT02508350|Daptomycin|daptomycin|mesh-list
139315443|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139315444|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315445|NCT02503826|Midazolam|midazolam|mesh-list
139315446|NCT02503826|Sufentanil|sufentanil|mesh-list
139315447|NCT02503826|Dsuvia|dsuvia|mesh-list
139315448|NCT02503826|Propofol|propofol|mesh-list
139315449|NCT02503826|Cisatracurium|cisatracurium|mesh-list
139315450|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139315451|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315452|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315453|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139315454|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
139315455|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
139315456|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139315457|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139315458|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139315459|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139315460|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
139315461|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
139315462|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315463|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315464|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139315465|NCT02503826|Narcotics|narcotics|mesh-ancestor
139315466|NCT02503826|Analgesics|analgesics|mesh-ancestor
139315467|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
139315468|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315469|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139315470|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139315471|NCT03121664|Itraconazole|itraconazole|mesh-list
139315472|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
139315473|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315474|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139315475|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139315476|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315477|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315478|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139315479|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
139315480|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139315481|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315482|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139315483|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139315484|NCT02503904|Metronidazole|metronidazole|mesh-list
139315485|NCT02503904|Lidocaine|lidocaine|mesh-list
139315486|NCT02503904|Epinephrine|epinephrine|mesh-list
139315487|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
139315488|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
139315489|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315490|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315491|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
139315492|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315493|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139315494|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139315495|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139315496|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139315497|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315498|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315499|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139315500|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139315501|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
139315502|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315503|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139315504|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139315505|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
139315506|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139315507|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
139315508|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
139315509|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
139315510|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139315511|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139315512|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139315513|NCT02172105|Olodaterol|olodaterol|mesh-list
139315514|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139315515|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
139315516|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315517|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315518|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139315519|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
139315520|NCT02513654|Lamotrigine|lamotrigine|mesh-list
139315521|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
139315522|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139315523|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139315524|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315525|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139315526|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315527|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139315528|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139315529|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315530|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139315531|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139315532|NCT02513888|Vitamin D|vitamin d|mesh-list
139315533|NCT02513888|Vitamins|vitamins|mesh-ancestor
139315534|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
139315535|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315536|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139315537|NCT00101595|Dasatinib|dasatinib|mesh-list
139315538|NCT00101595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315539|NCT00101595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139315540|NCT00101595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315541|NCT00101595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315542|NCT02174757|Doxycycline|doxycycline|mesh-list
139315543|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139315544|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315545|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
139315546|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139315547|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139315548|NCT02168127|Methylphenidate|methylphenidate|mesh-list
139315549|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139315550|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315551|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139315552|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139315553|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139315554|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315555|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
139315557|NCT02255955|Acetaminophen|acetaminophen|mesh-list
139315558|NCT02255955|Naproxen|naproxen|mesh-list
139315559|NCT02255955|Codeine|codeine|mesh-list
139315560|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139315561|NCT02255955|Analgesics|analgesics|mesh-ancestor
139315562|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
139315563|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315564|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315565|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
139315566|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139315567|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139315568|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139315569|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
139315570|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139315571|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910069|NCT02611700|Paclitaxel|paclitaxel|mesh-list
139315572|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315573|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139315574|NCT02255955|Narcotics|narcotics|mesh-ancestor
139315575|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315576|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
139315577|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
139315578|NCT02172261|Glimepiride|glimepiride|mesh-list
139315579|NCT02172261|Empagliflozin|empagliflozin|mesh-list
139315580|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139315581|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139315582|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315583|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139315584|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
139315585|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139315586|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315587|NCT02501564|Naproxen|naproxen|mesh-list
139315588|NCT02501564|Codeine|codeine|mesh-list
139315589|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139315590|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139315591|NCT02501564|Analgesics|analgesics|mesh-ancestor
139315592|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
139315593|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315594|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315595|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139315596|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139315597|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
139315598|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139315599|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315600|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315601|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139315602|NCT02501564|Narcotics|narcotics|mesh-ancestor
139315603|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315604|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
139315605|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
139315606|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
139315607|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139315608|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
139315609|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315610|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315611|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139315612|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
139315613|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
139315614|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139315615|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
139315616|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315617|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315618|NCT02172417|Ranitidine|ranitidine|mesh-list
139315619|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139315620|NCT02172417|Cimetidine|cimetidine|mesh-list
139315621|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
139315622|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139315623|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
139315624|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315625|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315626|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139315627|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
139315628|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
139315629|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139315630|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
139315631|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315632|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315633|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139315634|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139315635|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138910081|NCT00708344|Irbesartan|irbesartan|mesh-list
139315636|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
139315637|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
139315638|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139315639|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139315640|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315641|NCT02168205|Pomalidomide|pomalidomide|mesh-list
139315642|NCT02168205|Caffeine|caffeine|mesh-list
139315643|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139315644|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315645|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139315646|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315647|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315648|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139315649|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139315650|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
139315651|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315652|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
139315653|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139315654|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139315655|NCT02168205|Growth Substances|growth substances|mesh-ancestor
139315656|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
139315657|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315658|NCT03343652|Nivolumab|nivolumab|mesh-list
139315659|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139315660|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139315661|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315662|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139315663|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315664|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139315665|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
139315666|NCT02175069|Ropivacaine|ropivacaine|mesh-list
139315667|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
139315668|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
139315669|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315670|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315671|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
139315672|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315673|NCT04498520|Fulvestrant|fulvestrant|mesh-list
139315674|NCT04498520|Palbociclib|palbociclib|mesh-list
139315675|NCT04498520|Abexinostat|abexinostat|mesh-list
139315676|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139315677|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315678|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139315679|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139315680|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
139315681|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139315682|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315683|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139315684|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315685|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315686|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139315687|NCT02172495|Bromides|bromides|mesh-list
139315688|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
139315689|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139315690|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
139315691|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315692|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315693|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139315694|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
139315695|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
139315696|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139315697|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
139315698|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315699|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315700|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
139315701|NCT02172573|Pramipexole|pramipexole|mesh-list
139315702|NCT02172573|Bromocriptine|bromocriptine|mesh-list
139315703|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
138910091|NCT00866333|Entinostat|entinostat|mesh-list
139315704|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315705|NCT02172573|Protective Agents|protective agents|mesh-ancestor
139315706|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315707|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139315708|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139315709|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
139315710|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
139315711|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315712|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
139315713|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139315714|NCT02175381|Carboplatin|carboplatin|mesh-list
139315715|NCT02175381|Gemcitabine|gemcitabine|mesh-list
139315716|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315717|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139315718|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
139315719|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315720|NCT03540225|Progesterone|progesterone|mesh-list
139315721|NCT03540225|Progestins|progestins|mesh-ancestor
139315722|NCT03540225|Hormones|hormones|mesh-ancestor
139315723|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139315724|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315725|NCT02507648|Oseltamivir|oseltamivir|mesh-list
139315726|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
139315727|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315728|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315729|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315730|NCT02172729|Lidocaine|lidocaine|mesh-list
139315731|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
139315732|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
139315733|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315734|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315735|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
139315736|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315737|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139315738|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139315739|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139315740|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139315741|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315742|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
139315743|NCT02172807|Oxitropium|oxitropium|mesh-list
139315744|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139315745|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
139315746|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315747|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315748|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139315749|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
139315750|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
139315751|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139315752|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
139315753|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315754|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315755|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139315756|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
139315757|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315758|NCT02502968|Cytarabine|cytarabine|mesh-list
139315759|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139315760|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
139315761|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315762|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315763|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
139315764|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315765|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139315766|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
139315767|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315768|NCT02168751|Propofol|propofol|mesh-list
139315769|NCT02168751|Sevoflurane|sevoflurane|mesh-list
139315770|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139315771|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315772|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315773|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139315774|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
139315775|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
139315776|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139315778|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139315779|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315780|NCT03344042|Fentanyl|fentanyl|mesh-list
139315781|NCT03344042|Sufentanil|sufentanil|mesh-list
139315782|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139315783|NCT03344042|Narcotics|narcotics|mesh-ancestor
139315784|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139315785|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315786|NCT03344042|Analgesics|analgesics|mesh-ancestor
139315787|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
139315788|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315789|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139315790|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139315791|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
139315792|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
139315793|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139315794|NCT02175927|Amoxicillin|amoxicillin|mesh-list
139315795|NCT02175927|Metronidazole|metronidazole|mesh-list
139315796|NCT02175927|Tetracycline|tetracycline|mesh-list
139315797|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139315798|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
139315799|NCT02175927|Lansoprazole|lansoprazole|mesh-list
139315800|NCT02175927|Bismuth|bismuth|mesh-list
139315801|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139315802|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091548|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139315803|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315804|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
139315805|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139315806|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139315807|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139315808|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139315809|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315810|NCT02175927|Antacids|antacids|mesh-ancestor
139315811|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139315812|NCT02175927|Diuretics|diuretics|mesh-ancestor
139315813|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
139315814|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315815|NCT02175927|Expectorants|expectorants|mesh-ancestor
139315816|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
139315817|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139315818|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
139315819|NCT00707486|Coagulants|coagulants|mesh-ancestor
139315820|NCT02496182|Pirfenidone|pirfenidone|mesh-list
139315821|NCT02496182|Analgesics|analgesics|mesh-ancestor
139315822|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
139315823|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315824|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315825|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139315826|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139315827|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139315828|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139315829|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315830|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
139315831|NCT02168907|Rituximab|rituximab|mesh-list
139315832|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139315833|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138910106|NCT04118699|Rifaximin|rifaximin|mesh-list
139315834|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315835|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
139315836|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315837|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139315838|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139315839|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
139315840|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315841|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
139315842|NCT02168907|Protective Agents|protective agents|mesh-ancestor
139315843|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
139315844|NCT02168907|Vitamins|vitamins|mesh-ancestor
139315845|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
139315846|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
139315847|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139315848|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
139315849|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315850|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315851|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139315852|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
139315853|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139315854|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139315855|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139315856|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
139315857|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315858|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315859|NCT02500940|Leucovorin|leucovorin|mesh-list
139315860|NCT02500940|Fluorouracil|fluorouracil|mesh-list
139315861|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315862|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315863|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
139315864|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315865|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139315866|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139315867|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
139315868|NCT02500940|Antidotes|antidotes|mesh-ancestor
139315869|NCT02500940|Protective Agents|protective agents|mesh-ancestor
139315870|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
139315871|NCT02500940|Vitamins|vitamins|mesh-ancestor
139315872|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
139315873|NCT02495636|Atezolizumab|atezolizumab|mesh-list
139315874|NCT02495636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139315875|NCT02495636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315876|NCT02495636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139315877|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315878|NCT02169063|Listerine|listerine|mesh-list
139315879|NCT02169063|Fluorides|fluorides|mesh-list
139315880|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
139315881|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
139315882|NCT02169063|Protective Agents|protective agents|mesh-ancestor
139315883|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315884|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139315885|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315886|NCT04496882|Tenofovir|tenofovir|mesh-list
139315887|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
139315888|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139315889|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139315890|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139315891|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315892|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315893|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139315894|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139315895|NCT02502500|Celecoxib|celecoxib|mesh-list
139315896|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139315897|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139315898|NCT02502500|Analgesics|analgesics|mesh-ancestor
139315899|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
139315900|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315901|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315902|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139315903|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139315904|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139315905|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139315906|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315907|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315908|NCT02173665|Linagliptin|linagliptin|mesh-list
139315909|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139315910|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315911|NCT02173665|Incretins|incretins|mesh-ancestor
139315912|NCT02173665|Hormones|hormones|mesh-ancestor
139315913|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139315914|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139315915|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
139315916|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315917|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315918|NCT02495324|Valsartan|valsartan|mesh-list
139315919|NCT02495324|Olmesartan|olmesartan|mesh-list
139315920|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139315921|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139315922|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139315923|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139315924|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315925|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
139315926|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
139315927|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315928|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
139315929|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315930|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315932|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
139315933|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139315934|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139315935|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
139315936|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139315937|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315938|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315939|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139315940|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139315941|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139315942|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
139315943|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315944|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139315945|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139315946|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315947|NCT02502344|Metformin|metformin|mesh-list
139315948|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139315949|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315950|NCT02174211|Ranibizumab|ranibizumab|mesh-list
139315951|NCT02174211|Aflibercept|aflibercept|mesh-list
139315952|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139315953|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139315954|NCT02174211|Growth Substances|growth substances|mesh-ancestor
139315955|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315956|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
139315957|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315958|NCT04496492|Tocotrienols|tocotrienols|mesh-list
139315959|NCT04496492|Vitamin E|vitamin e|mesh-list
139315960|NCT04496492|Tocopherols|tocopherols|mesh-list
139315961|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
139315962|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315963|NCT04496492|Protective Agents|protective agents|mesh-ancestor
139315964|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315965|NCT04496492|Vitamins|vitamins|mesh-ancestor
139315966|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
139315967|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139315968|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139315969|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315970|NCT02502032|Cisatracurium|cisatracurium|mesh-list
139315971|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139315972|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139315973|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315974|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315975|NCT02494856|Naproxen|naproxen|mesh-list
139315976|NCT02494856|Esomeprazole|esomeprazole|mesh-list
139315977|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139315978|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139315979|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139315980|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139315981|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315982|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139315983|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139315984|NCT02494856|Analgesics|analgesics|mesh-ancestor
139315985|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
139315986|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139315987|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139315988|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139315989|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139315990|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
139315991|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139315992|NCT04495010|Nivolumab|nivolumab|mesh-list
139315993|NCT04495010|Ipilimumab|ipilimumab|mesh-list
139315994|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139315995|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139315996|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139315997|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139315998|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139315999|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
139316000|NCT03343418|Coagulants|coagulants|mesh-ancestor
139316001|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139316002|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
139316003|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316004|NCT02501798|Methylphenidate|methylphenidate|mesh-list
139316005|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139316006|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316007|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139316008|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139316009|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139316010|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316011|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
139316012|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316013|NCT02169609|Interleukin-2|interleukin-2|mesh-list
139316014|NCT02169609|Dinutuximab|dinutuximab|mesh-list
139316015|NCT02169609|Isotretinoin|isotretinoin|mesh-list
139316016|NCT02169609|Sargramostim|sargramostim|mesh-list
139316017|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
139316018|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316019|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316020|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139316021|NCT02169609|Analgesics|analgesics|mesh-ancestor
139316022|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
139316023|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316024|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
139316025|NCT02499614|Crizotinib|crizotinib|mesh-list
139316026|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316027|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139316028|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316029|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316030|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
139316031|NCT02169843|Sevoflurane|sevoflurane|mesh-list
139316032|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139316033|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316034|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316035|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139316036|NCT02169843|Analgesics|analgesics|mesh-ancestor
139316037|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
139316038|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316039|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139316040|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139316041|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139316042|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
139316043|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316044|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316045|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139316046|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139316047|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
139316048|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
139316049|NCT03341390|Aspirin|aspirin|mesh-list
139316050|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139316051|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139316052|NCT03341390|Analgesics|analgesics|mesh-ancestor
139316053|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
139316054|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316055|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316056|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139316057|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139316058|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139316059|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139316060|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316061|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139316062|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139316063|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316064|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
139316065|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
139316066|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316067|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139316068|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316069|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316070|NCT00707174|Imiquimod|imiquimod|mesh-list
139316071|NCT00707174|Tazarotene|tazarotene|mesh-list
139316072|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139316073|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
139316074|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316075|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316076|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
139316077|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
139316078|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
139316079|NCT03341234|Bupivacaine|bupivacaine|mesh-list
139316080|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
139316081|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
139316082|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316083|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316084|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
139316085|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316086|NCT02499224|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
139316087|NCT02499224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316088|NCT03120494|Tenofovir|tenofovir|mesh-list
139316089|NCT03120494|Emtricitabine|emtricitabine|mesh-list
139316090|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
139316091|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316092|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139316093|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139316094|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316095|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316096|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139316097|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139316098|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
139316099|NCT03537573|Narcotics|narcotics|mesh-ancestor
139316100|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316101|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316102|NCT03537573|Analgesics|analgesics|mesh-ancestor
139316103|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
139316104|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316105|NCT03120962|Famciclovir|famciclovir|mesh-list
139316106|NCT03120962|Oxycodone|oxycodone|mesh-list
139316107|NCT03120962|Gabapentin|gabapentin|mesh-list
139316108|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139316109|NCT03120962|Narcotics|narcotics|mesh-ancestor
139316110|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316111|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316112|NCT03120962|Analgesics|analgesics|mesh-ancestor
139316113|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
139316114|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316115|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
139316116|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139316117|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139316118|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139316119|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139316120|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139316121|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316122|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316123|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
139316124|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
139316125|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316126|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139316127|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316128|NCT02178813|Minocycline|minocycline|mesh-list
139316129|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139316130|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316131|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
139316132|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
139316133|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316134|NCT02177253|Bromides|bromides|mesh-list
139316135|NCT02177253|Albuterol|albuterol|mesh-list
139316136|NCT02177253|Ipratropium|ipratropium|mesh-list
139316137|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
139316138|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139316139|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
139316140|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316141|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316142|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139316144|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
139316145|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139316146|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139316147|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139316148|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139316149|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
139316150|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316151|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316152|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139316153|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
139316154|NCT02177331|Lacidipine|lacidipine|mesh-list
139316155|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139316156|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139316157|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139316158|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316159|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139316160|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316161|NCT02177409|Amlodipine|amlodipine|mesh-list
139316162|NCT02177409|Telmisartan|telmisartan|mesh-list
139316163|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139316164|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139316165|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139316166|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316167|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139316168|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316169|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
139316170|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139316171|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139316172|NCT02170623|Pantoprazole|pantoprazole|mesh-list
139316173|NCT02170623|Dabigatran|dabigatran|mesh-list
139316174|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139316175|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139316176|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139316177|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316178|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316180|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139316181|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
139316182|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
139316183|NCT02170701|Dabigatran|dabigatran|mesh-list
139316184|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
139316185|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139316186|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
139316187|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316188|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316189|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
139316190|NCT02498756|Ipilimumab|ipilimumab|mesh-list
139316191|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139316192|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316193|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139316194|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316195|NCT03336632|Cyclosporine|cyclosporine|mesh-list
139316196|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
139316197|NCT03336632|Cyclosporins|cyclosporins|mesh-list
139316198|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139316199|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
139316200|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316201|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139316202|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139316203|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
139316204|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316205|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316206|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139316207|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316208|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
139316209|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316210|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
139316211|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139316212|NCT02498288|Isotretinoin|isotretinoin|mesh-list
139316213|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
139316214|NCT02756403|Azithromycin|azithromycin|mesh-list
139316215|NCT02756403|Metronidazole|metronidazole|mesh-list
139316216|NCT02756403|Doxycycline|doxycycline|mesh-list
139316217|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139316218|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316219|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139316220|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139316221|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
139316222|NCT02494466|Montelukast|montelukast|mesh-list
139316223|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139316224|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
139316225|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139316226|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
139316227|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139316228|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316229|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139316230|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139316231|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316232|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139316233|NCT02177487|Telmisartan|telmisartan|mesh-list
139316234|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
139316235|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139316236|NCT02177487|Diuretics|diuretics|mesh-ancestor
139316237|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
139316238|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316239|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139316240|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139316241|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316242|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139316243|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139316244|NCT02177643|Diacerein|diacerein|mesh-list
139316245|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139316246|NCT03340376|Doxorubicin|doxorubicin|mesh-list
139316247|NCT03340376|Atezolizumab|atezolizumab|mesh-list
139316248|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139316249|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316250|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139316251|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139316252|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316253|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316254|NCT03340376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139316255|NCT03340376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139316256|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
139316257|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139316258|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
139316259|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316260|NCT02182167|Expectorants|expectorants|mesh-ancestor
139316261|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
139316262|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139316263|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
139316264|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316265|NCT02182167|Protective Agents|protective agents|mesh-ancestor
139316266|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316267|NCT02182167|Antidotes|antidotes|mesh-ancestor
139316268|NCT02182245|Paclitaxel|paclitaxel|mesh-list
139316269|NCT02182245|Carboplatin|carboplatin|mesh-list
139316270|NCT02182245|Nintedanib|nintedanib|mesh-list
139316271|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139316272|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316274|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
139316275|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
139316276|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316277|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139316278|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316279|NCT05233124|Aspirin|aspirin|mesh-list
139316280|NCT05233124|Rivaroxaban|rivaroxaban|mesh-list
139316281|NCT05233124|Clopidogrel|clopidogrel|mesh-list
139316282|NCT05233124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139316283|NCT05233124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139316284|NCT05233124|Analgesics|analgesics|mesh-ancestor
139316285|NCT05233124|Sensory System Agents|sensory system agents|mesh-ancestor
139316286|NCT05233124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316287|NCT05233124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316288|NCT05233124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139316289|NCT05233124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139316290|NCT05233124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139316291|NCT05233124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139316292|NCT05233124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316293|NCT05233124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139316294|NCT05233124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139316295|NCT05233124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316296|NCT05233124|Antipyretics|antipyretics|mesh-ancestor
139316297|NCT05233124|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139316298|NCT05233124|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139316299|NCT05233124|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139316300|NCT05233124|Purinergic Agents|purinergic agents|mesh-ancestor
139316301|NCT05233124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316302|NCT05233124|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139316303|NCT05233124|Antithrombins|antithrombins|mesh-ancestor
139316304|NCT05233124|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139316305|NCT05233124|Protease Inhibitors|protease inhibitors|mesh-ancestor
139316306|NCT05233124|Anticoagulants|anticoagulants|mesh-ancestor
139316307|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
139316308|NCT03339362|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139316309|NCT03339362|Bupivacaine|bupivacaine|mesh-list
139316310|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
139316311|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
139316312|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316313|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316314|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
139316315|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316316|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139316317|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
139316318|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
139316319|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139316320|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
139316321|NCT03339362|Hormones|hormones|mesh-ancestor
139316322|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139316323|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139316324|NCT03339362|Protective Agents|protective agents|mesh-ancestor
139316325|NCT02497820|Aspirin|aspirin|mesh-list
138973192|NCT02540070|Analgesics|analgesics|mesh-ancestor
139316326|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139316327|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139316328|NCT02497820|Analgesics|analgesics|mesh-ancestor
139316329|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
139316330|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316331|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316332|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139316333|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139316334|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139316335|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139316336|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316337|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139316338|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139316339|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316340|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
139316341|NCT02497508|Nivolumab|nivolumab|mesh-list
139316342|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139316343|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316344|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139176485|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316345|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316347|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139316348|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139316349|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
139316350|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316351|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139316352|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139316353|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316354|NCT03338348|Azacitidine|azacitidine|mesh-list
139316355|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139316356|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
139316357|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316358|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316359|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316360|NCT03334838|Nifurtimox|nifurtimox|mesh-list
139316361|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139316362|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139316363|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139316364|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316365|NCT02497118|Vinorelbine|vinorelbine|mesh-list
139316366|NCT02497118|Endostatins|endostatins|mesh-list
139316367|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316368|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139316369|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
139316370|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
139316371|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
139316372|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316373|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139316374|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139316375|NCT02497118|Growth Substances|growth substances|mesh-ancestor
139316376|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316377|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
139316378|NCT02496962|Atorvastatin|atorvastatin|mesh-list
139316379|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139316380|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139316381|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
139316382|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316383|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139316384|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139316385|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316386|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139316387|NCT03334136|Calcifediol|calcifediol|mesh-list
139316388|NCT03334136|Vitamins|vitamins|mesh-ancestor
139316389|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
139316390|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316391|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139316392|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139316393|NCT03120728|Etonogestrel|etonogestrel|mesh-list
139316394|NCT03120728|NuvaRing|nuvaring|mesh-list
139316395|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
139316396|NCT03120728|Estradiol|estradiol|mesh-list
139316397|NCT03120728|Estrogens|estrogens|mesh-ancestor
139316398|NCT03120728|Hormones|hormones|mesh-ancestor
139316399|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139316400|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316401|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139091549|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316402|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139316403|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139316404|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139316405|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139316406|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
139316407|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139316408|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316409|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316410|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139316411|NCT02496650|Analgesics|analgesics|mesh-ancestor
139316412|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
139316413|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316414|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139316415|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139316416|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139316417|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
139316418|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316419|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316420|NCT02492438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139316421|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
139316422|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316423|NCT03342170|Thrombin|thrombin|mesh-list
139316424|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
139316425|NCT03342170|Coagulants|coagulants|mesh-ancestor
139316426|NCT03333824|Midazolam|midazolam|mesh-list
139316427|NCT03333824|Granisetron|granisetron|mesh-list
139316428|NCT03333824|Caffeine|caffeine|mesh-list
139316429|NCT03333824|Omeprazole|omeprazole|mesh-list
139316430|NCT03333824|Adavosertib|adavosertib|mesh-list
139316431|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139316432|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139316433|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316434|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316435|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139316436|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139316437|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139316438|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139316439|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
139316440|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
139316441|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
139316442|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
139316443|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316444|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316445|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139316446|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139316447|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316448|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139316449|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139316450|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
139316451|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139316452|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139316453|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139316454|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
139316455|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
139316456|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316457|NCT03333824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139316458|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139316459|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
139316460|NCT02496494|Tacrolimus|tacrolimus|mesh-list
139316461|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139316462|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
139316463|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316464|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139316465|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316466|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316467|NCT03333278|Vitamins|vitamins|mesh-list
139316468|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
139316469|NCT03333278|Thiamine|thiamine|mesh-list
139316470|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
139316471|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139316472|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
139316473|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316474|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139316475|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
139316476|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910202|NCT04118777|Ropivacaine|ropivacaine|mesh-list
139316477|NCT03333278|Protective Agents|protective agents|mesh-ancestor
138973339|NCT00630812|Mannitol|mannitol|mesh-list
139316478|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
139316479|NCT04847596|Ofatumumab|ofatumumab|mesh-list
139316480|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316481|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139316482|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139316483|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139316484|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
139316485|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316486|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139316487|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139316488|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316489|NCT00706628|Nintedanib|nintedanib|mesh-list
139316490|NCT00706628|Afatinib|afatinib|mesh-list
139316491|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316492|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139316493|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316494|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316495|NCT05463614|Propranolol|propranolol|mesh-list
139316496|NCT05463614|Propafenone|propafenone|mesh-list
139316497|NCT05463614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139316498|NCT05463614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139316499|NCT05463614|Adrenergic Agents|adrenergic agents|mesh-ancestor
139316500|NCT05463614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316501|NCT05463614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316502|NCT05463614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316503|NCT05463614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139316504|NCT05463614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139316505|NCT05463614|Vasodilator Agents|vasodilator agents|mesh-ancestor
139316506|NCT05463614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139316507|NCT05463614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139316508|NCT05463614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139316510|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139316511|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316512|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
139316513|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316514|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139316515|NCT03332732|Metronidazole|metronidazole|mesh-list
139316516|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316517|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139316518|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139316519|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139316520|NCT02492360|Cisplatin|cisplatin|mesh-list
139316521|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316522|NCT02492282|Remifentanil|remifentanil|mesh-list
139316523|NCT02492282|Propofol|propofol|mesh-list
139316524|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139316525|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316526|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316527|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139316528|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
139316529|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
139316530|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139316531|NCT02492282|Narcotics|narcotics|mesh-ancestor
139316532|NCT02492282|Analgesics|analgesics|mesh-ancestor
139316533|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
139316534|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316535|NCT02492126|Citric Acid|citric acid|mesh-list
139316536|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
139316537|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
139316538|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139316539|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
139316540|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
139316541|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316542|NCT05464862|Lidocaine|lidocaine|mesh-list
139316543|NCT05464862|Anesthetics, Local|anesthetics, local|mesh-ancestor
139316544|NCT05464862|Anesthetics|anesthetics|mesh-ancestor
139316545|NCT05464862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316546|NCT05464862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316547|NCT05464862|Sensory System Agents|sensory system agents|mesh-ancestor
139316548|NCT05464862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316549|NCT05464862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139316550|NCT05464862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139316551|NCT05464862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139316552|NCT05464862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139316553|NCT05464862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316554|NCT03324776|Insulin|insulin|mesh-list
139316555|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139316556|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139316557|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316558|NCT02561806|Ustekinumab|ustekinumab|mesh-list
139316559|NCT02561806|Ixekizumab|ixekizumab|mesh-list
139316560|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
139316561|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
139316562|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139316563|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
139316564|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316565|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139316566|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139316567|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
139316568|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316569|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316570|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139316571|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139316572|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139316573|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
139316574|NCT03330860|Hormones|hormones|mesh-ancestor
139316575|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139316576|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316577|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316578|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316579|NCT03324542|Ranibizumab|ranibizumab|mesh-list
139316580|NCT03324542|Aflibercept|aflibercept|mesh-list
139316581|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316582|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139316583|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139316584|NCT03324542|Growth Substances|growth substances|mesh-ancestor
139316585|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316586|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
139316587|NCT03330782|Remifentanil|remifentanil|mesh-list
139316588|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139316589|NCT03330782|Narcotics|narcotics|mesh-ancestor
139316590|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316591|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316592|NCT03330782|Analgesics|analgesics|mesh-ancestor
139316593|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
139316594|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316595|NCT05506462|Ketamine|ketamine|mesh-list
139316596|NCT05506462|Analgesics|analgesics|mesh-ancestor
139316597|NCT05506462|Sensory System Agents|sensory system agents|mesh-ancestor
139316598|NCT05506462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316599|NCT05506462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316600|NCT05506462|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139316601|NCT05506462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139316602|NCT05506462|Anesthetics, General|anesthetics, general|mesh-ancestor
139316603|NCT05506462|Anesthetics|anesthetics|mesh-ancestor
139316604|NCT05506462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316605|NCT05506462|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139316606|NCT05506462|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139316607|NCT05506462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316608|NCT05506462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316609|NCT05505994|Dapagliflozin|dapagliflozin|mesh-list
139316610|NCT05505994|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139316611|NCT05505994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316612|NCT05505994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139316613|NCT05505994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316614|NCT02491268|Cilostazol|cilostazol|mesh-list
139316615|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139316616|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
139316617|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316618|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316619|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139316620|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
139316621|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139316622|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139316623|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316624|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139316625|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
139316626|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138973492|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
139316627|NCT02491268|Protective Agents|protective agents|mesh-ancestor
139316628|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139316629|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139316630|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316631|NCT03323684|Acetaminophen|acetaminophen|mesh-list
139316632|NCT03323684|Ketorolac|ketorolac|mesh-list
139316633|NCT03323684|Fentanyl|fentanyl|mesh-list
139316634|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139316635|NCT03323684|Narcotics|narcotics|mesh-ancestor
139316636|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316637|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316638|NCT03323684|Analgesics|analgesics|mesh-ancestor
139316639|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
139316640|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316641|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139316642|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139316643|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
139316644|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
139316645|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139316646|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
139316647|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139316648|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139316649|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139316650|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139316651|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316652|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316653|NCT02182401|Tolbutamide|tolbutamide|mesh-list
139316654|NCT02182401|Midazolam|midazolam|mesh-list
139316655|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139316656|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139316657|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316658|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316659|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139316660|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139316661|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139316662|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139316663|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
139316664|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
139316665|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
139316666|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
139316667|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316668|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316669|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139316670|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139316671|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
139316672|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139316673|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
139316674|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316675|NCT02177955|Midazolam|midazolam|mesh-list
139316676|NCT02177955|Diazepam|diazepam|mesh-list
139316677|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139316678|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139316679|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316680|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316681|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139316682|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139316683|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139316684|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139316685|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
139316686|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
139316687|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
139316688|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
139316689|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316690|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316691|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
139316692|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
139316693|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
139316694|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316695|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139316696|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139316697|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139316698|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
139316699|NCT03323528|Benzocaine|benzocaine|mesh-list
139316700|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
138973567|NCT00604188|Analgesics|analgesics|mesh-ancestor
139316701|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
139316702|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316703|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316704|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
139316705|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316706|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139316707|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316708|NCT05501158|Tamoxifen|tamoxifen|mesh-list
139316709|NCT05501158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139316710|NCT05501158|Hormone Antagonists|hormone antagonists|mesh-ancestor
139316711|NCT05501158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139316712|NCT05501158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316713|NCT05501158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139316714|NCT05501158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316715|NCT05501158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139316716|NCT05501158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139316717|NCT05501158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139316719|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
139316720|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139316721|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139316722|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316723|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316724|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316725|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139316726|NCT03537807|Protective Agents|protective agents|mesh-ancestor
139316727|NCT02182479|Fenoterol|fenoterol|mesh-list
138910260|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139316728|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139316729|NCT02182479|Ipratropium|ipratropium|mesh-list
139316730|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139316731|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
139316732|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316733|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316734|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139316735|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
139316736|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
139316737|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
139316738|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139316739|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139316740|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139316741|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139316742|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
139316743|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316744|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316745|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139316746|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
139316747|NCT02560558|Abatacept|abatacept|mesh-list
139316748|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139316749|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316750|NCT02560558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139316751|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316752|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139316753|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
139316754|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316755|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139316756|NCT03329456|Ropivacaine|ropivacaine|mesh-list
139316757|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
139316758|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
139316759|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139316760|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316761|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
139316762|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316763|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139316764|NCT02491736|Ketoprofen|ketoprofen|mesh-list
139316765|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139316766|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139316767|NCT02491736|Analgesics|analgesics|mesh-ancestor
139316768|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
139316769|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316770|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316771|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139316772|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139316773|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139316774|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316775|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973644|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
139316776|NCT05501080|Spironolactone|spironolactone|mesh-list
139316777|NCT05501080|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139316778|NCT05501080|Hormone Antagonists|hormone antagonists|mesh-ancestor
139316779|NCT05501080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139316780|NCT05501080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316781|NCT05501080|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139316782|NCT05501080|Diuretics|diuretics|mesh-ancestor
139316783|NCT05501080|Natriuretic Agents|natriuretic agents|mesh-ancestor
139316784|NCT02491970|Fluticasone|fluticasone|mesh-list
139316786|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
139316787|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139316788|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139316789|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139316790|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139316791|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
139316792|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316793|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316794|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139316795|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
139316796|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
139316797|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139316798|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139316799|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139316800|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139316801|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
139316802|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316803|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316804|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
139316805|NCT02491970|Hormones|hormones|mesh-ancestor
139316806|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139316807|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
139316808|NCT02182557|Ketotifen|ketotifen|mesh-list
139316809|NCT02182557|Epinastine|epinastine|mesh-list
139316810|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
139316811|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
139316812|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139316813|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
139316814|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
139316815|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316816|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316817|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316818|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139316819|NCT02182635|Oxitropium|oxitropium|mesh-list
139316820|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
139316821|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
139316822|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316823|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316824|NCT02182713|Bromides|bromides|mesh-list
139316825|NCT02182713|Albuterol|albuterol|mesh-list
139316826|NCT02182713|Ipratropium|ipratropium|mesh-list
139316827|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
139316828|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139316829|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
139316830|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316831|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316832|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139316833|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
139316834|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
139316835|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139316836|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139316837|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139316838|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139316839|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
139316840|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316841|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316842|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139316843|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
139316844|NCT03323372|Listerine|listerine|mesh-list
139316845|NCT03323372|Fluorides|fluorides|mesh-list
139316846|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
139316847|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
139316848|NCT03323372|Protective Agents|protective agents|mesh-ancestor
139316849|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316850|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139316851|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316852|NCT02180529|Methylphenidate|methylphenidate|mesh-list
139316853|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139316854|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316855|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139316856|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139316857|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139316858|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316859|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
139316860|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316861|NCT02182791|Nevirapine|nevirapine|mesh-list
139316862|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139316863|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139316864|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316865|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316866|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
139316867|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316868|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139316869|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139316870|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139316871|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139316872|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139316873|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
139316874|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316875|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139316876|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139316877|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316878|NCT02488538|Fluoxetine|fluoxetine|mesh-list
139316879|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
139316880|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
139316881|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139316882|NCT02488538|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138910316|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
139316883|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139316884|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139316885|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316886|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316887|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
139316888|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316889|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139316890|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
139316891|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139316892|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139316893|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139316894|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316895|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139316896|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139316897|NCT02568046|Leucovorin|leucovorin|mesh-list
139316898|NCT02568046|Fluorouracil|fluorouracil|mesh-list
139316899|NCT02568046|Irinotecan|irinotecan|mesh-list
139316900|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
139316901|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316902|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139316903|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316904|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139316905|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
139316906|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316907|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139316908|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139316909|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316910|NCT02568046|Antidotes|antidotes|mesh-ancestor
139316911|NCT02568046|Protective Agents|protective agents|mesh-ancestor
139316912|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
139316913|NCT02568046|Vitamins|vitamins|mesh-ancestor
139316914|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
139316915|NCT03536481|Ensartinib|ensartinib|mesh-list
139316916|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316917|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139316918|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316919|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316920|NCT02488616|Insulin|insulin|mesh-list
139316921|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138973791|NCT00225277|Glimepiride|glimepiride|mesh-list
139316922|NCT02488616|Hormones|hormones|mesh-list
139316923|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139316924|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316925|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139316927|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139316928|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139316929|NCT02256423|Analgesics|analgesics|mesh-ancestor
139316930|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
139316931|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139316932|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316933|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139316934|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139316935|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139316936|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316937|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316938|NCT03320486|Ketoconazole|ketoconazole|mesh-list
139316939|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
139316940|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316941|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139316942|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139316943|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316944|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316945|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139316946|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
139316947|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139316948|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316949|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139316950|NCT02567656|Tenalisib|tenalisib|mesh-list
139316951|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139316952|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316953|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316954|NCT02185833|Dirithromycin|dirithromycin|mesh-list
139316955|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139316956|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316957|NCT02180997|Tamsulosin|tamsulosin|mesh-list
139316958|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
139316959|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139316960|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139316961|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139316962|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
139316963|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139316964|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316965|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316966|NCT02180997|Urological Agents|urological agents|mesh-ancestor
139316967|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139316968|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139316969|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
139316970|NCT02560012|Sirolimus|sirolimus|mesh-list
139316971|NCT02560012|Everolimus|everolimus|mesh-list
139316972|NCT02560012|Temsirolimus|temsirolimus|mesh-list
139316973|NCT02560012|MTOR Inhibitors|mtor inhibitors|mesh-list
139316974|NCT02560012|Sorafenib|sorafenib|mesh-list
139316975|NCT02560012|Sunitinib|sunitinib|mesh-list
139316976|NCT02560012|Axitinib|axitinib|mesh-list
139316977|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139316978|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139316979|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139316980|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139316981|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
139316982|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139316983|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316984|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139316985|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139316986|NCT02560012|Growth Substances|growth substances|mesh-ancestor
139316987|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
139316988|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139316989|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316990|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139316991|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
139316992|NCT03320174|Tafenoquine|tafenoquine|mesh-list
139316993|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
139316994|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139316995|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139316996|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139316997|NCT03328364|Docetaxel|docetaxel|mesh-list
138723181|NCT01645410|Calcium|calcium|mesh-list
139316998|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139316999|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
139317000|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
139317001|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
139317002|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317003|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
139317004|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139317005|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
139317006|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139317007|NCT04514302|Antibodies|antibodies|mesh-list
139317008|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
139317009|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317010|NCT03319784|Triamcinolone|triamcinolone|mesh-list
139317011|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139317012|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139317013|NCT03319784|Ketorolac|ketorolac|mesh-list
139317014|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139317015|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139317016|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
139317017|NCT03319784|Hormones|hormones|mesh-ancestor
139317018|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139317019|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317020|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139317021|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
139317022|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317023|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317024|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139317025|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139317026|NCT03319784|Analgesics|analgesics|mesh-ancestor
139317027|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
139317028|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317029|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139317030|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139317031|NCT03319706|Olmesartan|olmesartan|mesh-list
139317032|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139317033|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139317034|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139317035|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139317036|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317037|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
139317038|NCT05045170|Propofol|propofol|mesh-list
139317039|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
139317040|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317041|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317042|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139317043|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139317044|NCT05045170|Analgesics|analgesics|mesh-ancestor
139317045|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
139317046|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317047|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139317048|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139317049|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139317050|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
139317051|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317052|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317053|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139317054|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
139317055|NCT03322124|Octenidine|octenidine|mesh-list
139317056|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139317057|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139317058|NCT04442984|Leucovorin|leucovorin|mesh-list
139317059|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
139317060|NCT04442984|Irinotecan|irinotecan|mesh-list
139317061|NCT04442984|Fluorouracil|fluorouracil|mesh-list
139317062|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317063|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139317064|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139317065|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317066|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317067|NCT04442984|Antidotes|antidotes|mesh-ancestor
139317068|NCT04442984|Protective Agents|protective agents|mesh-ancestor
139317069|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317070|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
139317071|NCT04442984|Vitamins|vitamins|mesh-ancestor
139317072|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
139317073|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
139317074|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139317075|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139317076|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
139317077|NCT03327506|Alprazolam|alprazolam|mesh-list
139317078|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139317079|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317080|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317081|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139317082|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139317083|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139317084|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
139317085|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
139317086|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317087|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317088|NCT02487914|Lidocaine|lidocaine|mesh-list
139317089|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
139317090|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
139317091|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317092|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317093|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
139317094|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317095|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139317096|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139317097|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139317098|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139317099|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317100|NCT02487680|Chromium|chromium|mesh-list
139317101|NCT02487680|Picolinic acid|picolinic acid|mesh-list
139317102|NCT02487680|Trace Elements|trace elements|mesh-ancestor
139317103|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
139317104|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317105|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139317106|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
139317107|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
139317108|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317109|NCT03319550|Caseins|caseins|mesh-list
139317110|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
139317111|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
139317112|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317113|NCT04442906|Fentanyl|fentanyl|mesh-list
139317114|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
139317115|NCT04442906|Bupivacaine|bupivacaine|mesh-list
139317116|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
139317117|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
139317118|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317119|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317120|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
139317121|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317122|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139317123|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139317124|NCT04442906|Analgesics|analgesics|mesh-ancestor
139317125|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139317126|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139317127|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139317128|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
139317129|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138910379|NCT00839306|Rabeprazole|rabeprazole|mesh-list
139317130|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317131|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139317132|NCT04442906|Narcotics|narcotics|mesh-ancestor
139317133|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139317134|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139317135|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
139317136|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
139317137|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
139317138|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317139|NCT03327350|Anticoagulants|anticoagulants|mesh-list
139317140|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
139317141|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139317142|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139317143|NCT03327272|Prednisolone|prednisolone|mesh-list
139317144|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
139317145|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139317146|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
139317147|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139317148|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
139317149|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
139317150|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317151|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317152|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139317153|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
139317154|NCT03327272|Hormones|hormones|mesh-ancestor
139317155|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139317156|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139317157|NCT03327272|Protective Agents|protective agents|mesh-ancestor
139317158|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139317159|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317160|NCT05508178|Vaccines|vaccines|mesh-list
139317161|NCT05508178|Immunologic Factors|immunologic factors|mesh-ancestor
139317162|NCT05508178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317163|NCT03327116|Methotrexate|methotrexate|mesh-list
139317164|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139317165|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
139317166|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139317167|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317168|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139317169|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
139317170|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317171|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317172|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
139317173|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317174|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139317175|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139317176|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
139317177|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139317178|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139317179|NCT06036095|Anesthetics|anesthetics|mesh-list
139317180|NCT06036095|Propofol|propofol|mesh-list
139317181|NCT06036095|Sevoflurane|sevoflurane|mesh-list
139317182|NCT06036095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317183|NCT06036095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317184|NCT06036095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139317185|NCT06036095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139317186|NCT06036095|Anesthetics, General|anesthetics, general|mesh-ancestor
139317187|NCT06036095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139317188|NCT06036095|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139317189|NCT06036043|Botulinum Toxins|botulinum toxins|mesh-list
139317190|NCT06036043|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139317191|NCT06036043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139317192|NCT06036043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139317193|NCT06036043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139317194|NCT06036043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317195|NCT06036043|Cholinergic Agents|cholinergic agents|mesh-ancestor
139317196|NCT06036043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317197|NCT06036043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317198|NCT06036043|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139317199|NCT06036043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317200|NCT06036030|Piperaquine|piperaquine|mesh-list
139317201|NCT06036030|Primaquine|primaquine|mesh-list
139317202|NCT06036030|Artenimol|artenimol|mesh-list
139317203|NCT06036030|Antimalarials|antimalarials|mesh-ancestor
139317204|NCT06036030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139317205|NCT06036030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139317206|NCT06036030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139317207|NCT06035978|Metoprolol|metoprolol|mesh-list
139317208|NCT06035978|Valsartan|valsartan|mesh-list
139317209|NCT06035978|Carvedilol|carvedilol|mesh-list
139317210|NCT06035978|Nebivolol|nebivolol|mesh-list
139317211|NCT06035978|Bisoprolol|bisoprolol|mesh-list
139317212|NCT06035978|Spironolactone|spironolactone|mesh-list
139317213|NCT06035978|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139317214|NCT06035978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139317215|NCT06035978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139317216|NCT06035978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139317217|NCT06035978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317218|NCT06035978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139317219|NCT06035978|Sympatholytics|sympatholytics|mesh-ancestor
139317220|NCT06035978|Autonomic Agents|autonomic agents|mesh-ancestor
139317221|NCT06035978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317222|NCT06035978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317223|NCT06035978|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139317224|NCT06035978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139317225|NCT06035978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139317226|NCT06035978|Adrenergic Agents|adrenergic agents|mesh-ancestor
139317227|NCT06035978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317228|NCT06035978|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139317229|NCT06035978|Hormone Antagonists|hormone antagonists|mesh-ancestor
139317230|NCT06035978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139317231|NCT06035978|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139317232|NCT06035978|Diuretics|diuretics|mesh-ancestor
139317233|NCT06035978|Natriuretic Agents|natriuretic agents|mesh-ancestor
139317234|NCT06035978|Antioxidants|antioxidants|mesh-ancestor
139317235|NCT06035978|Protective Agents|protective agents|mesh-ancestor
139317236|NCT06035978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139317237|NCT06035978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139317238|NCT06035978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139317239|NCT06035978|Vasodilator Agents|vasodilator agents|mesh-ancestor
139317240|NCT06035978|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139317241|NCT06035978|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139317242|NCT06035978|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139317243|NCT06035978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139317244|NCT06035978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139317245|NCT06035900|Psilocin|psilocin|mesh-list
139317246|NCT06035900|Hallucinogens|hallucinogens|mesh-ancestor
139317247|NCT06035900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317248|NCT06035900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139317249|NCT06035757|Neostigmine|neostigmine|mesh-list
139317250|NCT06035757|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139317251|NCT06035757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317252|NCT06035757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317253|NCT06035757|Cholinergic Agents|cholinergic agents|mesh-ancestor
139317254|NCT06035757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317255|NCT06035757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317256|NCT06035757|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139317257|NCT06035757|Autonomic Agents|autonomic agents|mesh-ancestor
139317258|NCT06035757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317259|NCT06035679|Trastuzumab|trastuzumab|mesh-list
139317260|NCT06035679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317261|NCT06035679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317262|NCT06035614|Tacrolimus|tacrolimus|mesh-list
139317263|NCT06035614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139317264|NCT06035614|Immunologic Factors|immunologic factors|mesh-ancestor
139317265|NCT06035614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317266|NCT06035614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139317267|NCT06035614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317268|NCT06035614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317281|NCT06035315|Micronutrients|micronutrients|mesh-list
139317282|NCT06035315|Trace Elements|trace elements|mesh-list
139317283|NCT06035315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317284|NCT06035224|Lenvatinib|lenvatinib|mesh-list
139317285|NCT06035224|Antibodies|antibodies|mesh-list
139317286|NCT06035224|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139317287|NCT06035224|Immunologic Factors|immunologic factors|mesh-ancestor
139317288|NCT06035224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317289|NCT06035224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317290|NCT06035224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139317291|NCT06035224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317292|NCT06035224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317293|NCT06035133|Bevacizumab|bevacizumab|mesh-list
139317294|NCT06035133|Cetuximab|cetuximab|mesh-list
139317295|NCT06035133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317296|NCT06035133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317297|NCT06035133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139317298|NCT06035133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139317299|NCT06035133|Growth Substances|growth substances|mesh-ancestor
139317300|NCT06035133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317301|NCT06035133|Growth Inhibitors|growth inhibitors|mesh-ancestor
139317302|NCT06035055|Tazobactam|tazobactam|mesh-list
139317303|NCT06035055|Ceftolozane|ceftolozane|mesh-list
139317304|NCT06035055|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
139317305|NCT06035055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139317306|NCT06035055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139317307|NCT06035055|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138910444|NCT00838682|Rabeprazole|rabeprazole|mesh-list
139317308|NCT06035055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317309|NCT06035055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317310|NCT06035055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139317311|NCT06035016|Capecitabine|capecitabine|mesh-list
139317312|NCT06035016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139317313|NCT06035016|Antimetabolites|antimetabolites|mesh-ancestor
139317314|NCT06035016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317315|NCT06035016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317316|NCT06034964|Tislelizumab|tislelizumab|mesh-list
139317317|NCT06034964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317318|NCT06034964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317319|NCT06034938|Tenofovir|tenofovir|mesh-list
139317320|NCT06034938|Lamivudine|lamivudine|mesh-list
139317321|NCT06034938|Antiviral Agents|antiviral agents|mesh-ancestor
139317322|NCT06034938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139317323|NCT06034938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139317324|NCT06034938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139317325|NCT06034938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317326|NCT06034938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317327|NCT06034938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139317328|NCT06034938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139317329|NCT06034860|Nivolumab|nivolumab|mesh-list
139317330|NCT06034860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317331|NCT06034860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317332|NCT06034860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139317333|NCT06034860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317334|NCT06034691|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139317335|NCT06034691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139317336|NCT06034691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139317337|NCT06034691|Antimetabolites|antimetabolites|mesh-ancestor
139317338|NCT06034691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317339|NCT06034691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139317340|NCT06034691|Protease Inhibitors|protease inhibitors|mesh-ancestor
139317341|NCT06034691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317342|NCT06034691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139317343|NCT06034626|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139317344|NCT06034626|Hyaluronic Acid|hyaluronic acid|mesh-list
139317345|NCT06034626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139317346|NCT06034626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139317347|NCT06034626|Immunologic Factors|immunologic factors|mesh-ancestor
139317348|NCT06034626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317349|NCT06034626|Viscosupplements|viscosupplements|mesh-ancestor
139317350|NCT06034626|Protective Agents|protective agents|mesh-ancestor
139317351|NCT06034561|Dexamethasone|dexamethasone|mesh-list
139317352|NCT06034561|Doxorubicin|doxorubicin|mesh-list
139317353|NCT06034561|Methotrexate|methotrexate|mesh-list
139317354|NCT06034561|Vincristine|vincristine|mesh-list
139317355|NCT06034561|Bortezomib|bortezomib|mesh-list
139317356|NCT06034561|Asparaginase|asparaginase|mesh-list
139317357|NCT06034561|Pegaspargase|pegaspargase|mesh-list
139317358|NCT06034561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139317359|NCT06034561|Antiemetics|antiemetics|mesh-ancestor
139317360|NCT06034561|Autonomic Agents|autonomic agents|mesh-ancestor
139317361|NCT06034561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317362|NCT06034561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317363|NCT06034561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139317364|NCT06034561|Glucocorticoids|glucocorticoids|mesh-ancestor
139317365|NCT06034561|Hormones|hormones|mesh-ancestor
139176512|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139317366|NCT06034561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139317367|NCT06034561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139317368|NCT06034561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317369|NCT06034561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317370|NCT06034561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317371|NCT06034561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139317372|NCT06034561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139317373|NCT06034561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139317374|NCT06034561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138974239|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
139317375|NCT06034561|Abortifacient Agents|abortifacient agents|mesh-ancestor
139317376|NCT06034561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139317377|NCT06034561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139317378|NCT06034561|Antimetabolites|antimetabolites|mesh-ancestor
139317379|NCT06034561|Dermatologic Agents|dermatologic agents|mesh-ancestor
139317380|NCT06034561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139317381|NCT06034561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139317382|NCT06034561|Immunologic Factors|immunologic factors|mesh-ancestor
139317383|NCT06034561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139317384|NCT06034561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139317385|NCT06034561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139317386|NCT06034561|Tubulin Modulators|tubulin modulators|mesh-ancestor
139317387|NCT06034561|Antimitotic Agents|antimitotic agents|mesh-ancestor
139317388|NCT06034561|Mitosis Modulators|mitosis modulators|mesh-ancestor
139317389|NCT06034418|Betamethasone|betamethasone|mesh-list
139317390|NCT06034418|Lidocaine|lidocaine|mesh-list
139317391|NCT06034418|Anesthetics, Local|anesthetics, local|mesh-ancestor
139317392|NCT06034418|Anesthetics|anesthetics|mesh-ancestor
139317393|NCT06034418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317394|NCT06034418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317395|NCT06034418|Sensory System Agents|sensory system agents|mesh-ancestor
139317396|NCT06034418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317397|NCT06034418|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139317398|NCT06034418|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139317399|NCT06034418|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139317400|NCT06034418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139317401|NCT06034418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317402|NCT06034418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139317403|NCT06034418|Glucocorticoids|glucocorticoids|mesh-ancestor
139317404|NCT06034418|Hormones|hormones|mesh-ancestor
139317405|NCT06034418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139317406|NCT06034418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139317407|NCT06034418|Respiratory System Agents|respiratory system agents|mesh-ancestor
139317408|NCT06030713|Cefazolin|cefazolin|mesh-list
139317409|NCT06030713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139317410|NCT06030713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139317411|NCT06021379|Trastuzumab|trastuzumab|mesh-list
139317412|NCT06021379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317413|NCT06021379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317414|NCT06003933|Lidocaine|lidocaine|mesh-list
139317415|NCT06003933|Bupivacaine|bupivacaine|mesh-list
139317416|NCT06003933|Anesthetics, Local|anesthetics, local|mesh-ancestor
139317417|NCT06003933|Anesthetics|anesthetics|mesh-ancestor
139317418|NCT06003933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317419|NCT06003933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317420|NCT06003933|Sensory System Agents|sensory system agents|mesh-ancestor
139317421|NCT06003933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317422|NCT06003933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139317423|NCT06003933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139317424|NCT06003933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139317425|NCT06003933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139317426|NCT06003933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317427|NCT05994807|Itraconazole|itraconazole|mesh-list
139317428|NCT05994807|Carbamazepine|carbamazepine|mesh-list
139317429|NCT05994807|Antifungal Agents|antifungal agents|mesh-ancestor
139317430|NCT05994807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139317431|NCT05994807|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139317432|NCT05994807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139317433|NCT05994807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176516|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139317434|NCT05994807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317435|NCT05994807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139317436|NCT05994807|Hormone Antagonists|hormone antagonists|mesh-ancestor
139317437|NCT05994807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139317438|NCT05994807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317439|NCT05994807|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139317440|NCT05994807|Anticonvulsants|anticonvulsants|mesh-ancestor
139317441|NCT05994807|Antimanic Agents|antimanic agents|mesh-ancestor
139317442|NCT05994807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139317443|NCT05994807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317444|NCT05994807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139317445|NCT05994807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139317446|NCT05994807|Analgesics|analgesics|mesh-ancestor
139317447|NCT05994807|Sensory System Agents|sensory system agents|mesh-ancestor
139317448|NCT05994807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317449|NCT05994807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139317450|NCT05994807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139317451|NCT05994807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139317452|NCT05994807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139317453|NCT05957926|Hyaluronic Acid|hyaluronic acid|mesh-list
139317454|NCT05957926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139317455|NCT05957926|Immunologic Factors|immunologic factors|mesh-ancestor
139317456|NCT05957926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317457|NCT05957926|Viscosupplements|viscosupplements|mesh-ancestor
139317458|NCT05957926|Protective Agents|protective agents|mesh-ancestor
139317460|NCT05946902|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139317461|NCT05946902|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139317462|NCT05946902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139317463|NCT05946902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139317464|NCT05946902|Adrenergic Agents|adrenergic agents|mesh-ancestor
139317465|NCT05946902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317466|NCT05946902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317467|NCT05946902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317468|NCT05946902|Urological Agents|urological agents|mesh-ancestor
139317469|NCT05946902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139317470|NCT05946902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139317471|NCT05946902|Cholinergic Agents|cholinergic agents|mesh-ancestor
139317472|NCT05919277|Antibodies|antibodies|mesh-list
139317473|NCT05919277|Immunoglobulins|immunoglobulins|mesh-list
139317474|NCT05919277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139317475|NCT05919277|Immunoglobulin G|immunoglobulin g|mesh-list
139317476|NCT05919277|Immunologic Factors|immunologic factors|mesh-ancestor
139317477|NCT05919277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317478|NCT05898763|Pembrolizumab|pembrolizumab|mesh-list
139317479|NCT05898763|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139317480|NCT05898763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317481|NCT05898763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317482|NCT05898763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139317483|NCT05898763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317484|NCT05898763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139317485|NCT05898763|Immunologic Factors|immunologic factors|mesh-ancestor
139317486|NCT05898763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317487|NCT05884242|Adalimumab|adalimumab|mesh-list
139317488|NCT05884242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139317489|NCT05884242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139317490|NCT05884242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139317491|NCT05868837|Rituximab|rituximab|mesh-list
139317492|NCT05868837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317493|NCT05868837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317494|NCT05868837|Immunologic Factors|immunologic factors|mesh-ancestor
139317495|NCT05868837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317496|NCT05868837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139317497|NCT05866627|Famotidine|famotidine|mesh-list
139317498|NCT05866627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139317499|NCT05866627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139317500|NCT05866627|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139317501|NCT05866627|Histamine Antagonists|histamine antagonists|mesh-ancestor
139317502|NCT05866627|Histamine Agents|histamine agents|mesh-ancestor
139317503|NCT05866627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317504|NCT05866627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317505|NCT05866627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317506|NCT05835284|Silicon|silicon|mesh-list
139317507|NCT05835284|Trace Elements|trace elements|mesh-ancestor
139317508|NCT05835284|Micronutrients|micronutrients|mesh-ancestor
139317509|NCT05835284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317510|NCT05786066|Ketamine|ketamine|mesh-list
139317511|NCT05786066|Analgesics|analgesics|mesh-ancestor
139317512|NCT05786066|Sensory System Agents|sensory system agents|mesh-ancestor
139317513|NCT05786066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317514|NCT05786066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317515|NCT05786066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139317516|NCT05786066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139317517|NCT05786066|Anesthetics, General|anesthetics, general|mesh-ancestor
139317518|NCT05786066|Anesthetics|anesthetics|mesh-ancestor
139317519|NCT05786066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317520|NCT05786066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139317521|NCT05786066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139317522|NCT05786066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317523|NCT05786066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317525|NCT05776888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317526|NCT05744648|Titanium dioxide|titanium dioxide|mesh-list
139317527|NCT05744648|Sunscreening Agents|sunscreening agents|mesh-ancestor
139317528|NCT05744648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139317529|NCT05744648|Protective Agents|protective agents|mesh-ancestor
139317530|NCT05744648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317531|NCT05744648|Dermatologic Agents|dermatologic agents|mesh-ancestor
139317532|NCT05744648|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139317533|NCT05708053|Metformin|metformin|mesh-list
139317534|NCT05708053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139317535|NCT05708053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317536|NCT05661188|Atezolizumab|atezolizumab|mesh-list
139317537|NCT05661188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139317538|NCT05661188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317539|NCT05661188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317540|NCT05661188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317541|NCT05640674|Acetaminophen|acetaminophen|mesh-list
139317542|NCT05640674|Ibuprofen|ibuprofen|mesh-list
139317543|NCT05640674|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139317544|NCT05640674|Hydrocodone|hydrocodone|mesh-list
139317545|NCT05640674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139317546|NCT05640674|Analgesics|analgesics|mesh-ancestor
139317547|NCT05640674|Sensory System Agents|sensory system agents|mesh-ancestor
139317548|NCT05640674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317549|NCT05640674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317550|NCT05640674|Antipyretics|antipyretics|mesh-ancestor
139317551|NCT05640674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139317552|NCT05640674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139317553|NCT05640674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139317554|NCT05640674|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139317555|NCT05640674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317556|NCT05640674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317557|NCT05640674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139317558|NCT05640674|Narcotics|narcotics|mesh-ancestor
139317559|NCT05640674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317560|NCT05640674|Antitussive Agents|antitussive agents|mesh-ancestor
139317561|NCT05640674|Respiratory System Agents|respiratory system agents|mesh-ancestor
139317562|NCT05620784|Furosemide|furosemide|mesh-list
139317563|NCT05620784|Diuretics|diuretics|mesh-list
139317564|NCT05620784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
139317565|NCT05620784|Natriuretic Agents|natriuretic agents|mesh-ancestor
139317566|NCT05620784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317567|NCT05620784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139317568|NCT05620784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317569|NCT05586477|Diphenhydramine|diphenhydramine|mesh-list
139317570|NCT05586477|Promethazine|promethazine|mesh-list
139317571|NCT05586477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139317572|NCT05586477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139317573|NCT05586477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317574|NCT05586477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317575|NCT05586477|Anesthetics, Local|anesthetics, local|mesh-ancestor
139317576|NCT05586477|Anesthetics|anesthetics|mesh-ancestor
139317577|NCT05586477|Sensory System Agents|sensory system agents|mesh-ancestor
139317578|NCT05586477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317579|NCT05586477|Antiemetics|antiemetics|mesh-ancestor
139317580|NCT05586477|Autonomic Agents|autonomic agents|mesh-ancestor
139317581|NCT05586477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139317582|NCT05586477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139317583|NCT05586477|Histamine Antagonists|histamine antagonists|mesh-ancestor
139317584|NCT05586477|Histamine Agents|histamine agents|mesh-ancestor
139317585|NCT05586477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317586|NCT05586477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317587|NCT05586477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139317588|NCT05586477|Antipruritics|antipruritics|mesh-ancestor
139317589|NCT05586477|Dermatologic Agents|dermatologic agents|mesh-ancestor
139317590|NCT05564598|Valganciclovir|valganciclovir|mesh-list
139317591|NCT05564598|Ganciclovir|ganciclovir|mesh-list
139317592|NCT05564598|Antiviral Agents|antiviral agents|mesh-list
139317593|NCT05564598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139317594|NCT05535023|Cemiplimab|cemiplimab|mesh-list
139317595|NCT05535023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317596|NCT05535023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317597|NCT05455658|Vaccines|vaccines|mesh-list
139317598|NCT05455658|Sargramostim|sargramostim|mesh-list
139317599|NCT05455658|Immunologic Factors|immunologic factors|mesh-ancestor
139317600|NCT05455658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317601|NCT05449366|Paclitaxel|paclitaxel|mesh-list
139317602|NCT05449366|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139317603|NCT05449366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139317604|NCT05449366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317605|NCT05449366|Tubulin Modulators|tubulin modulators|mesh-ancestor
139317606|NCT05449366|Antimitotic Agents|antimitotic agents|mesh-ancestor
139317607|NCT05449366|Mitosis Modulators|mitosis modulators|mesh-ancestor
139317608|NCT05449366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317609|NCT05415462|Vaccines|vaccines|mesh-list
139317610|NCT05415462|Immunologic Factors|immunologic factors|mesh-ancestor
139317611|NCT05415462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317612|NCT05395494|Cycloserine|cycloserine|mesh-list
139317613|NCT05395494|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139317614|NCT05395494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139317615|NCT05395494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139317616|NCT05395494|Antitubercular Agents|antitubercular agents|mesh-ancestor
139317617|NCT05395494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139317618|NCT05395494|Antimetabolites|antimetabolites|mesh-ancestor
139317619|NCT05395494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317620|NCT05389995|Potassium Citrate|potassium citrate|mesh-list
139317621|NCT05389995|Methamphetamine|methamphetamine|mesh-list
139317622|NCT05389995|Citric Acid|citric acid|mesh-list
139317623|NCT05389995|Sodium Citrate|sodium citrate|mesh-list
139317624|NCT05389995|Anticoagulants|anticoagulants|mesh-ancestor
139317625|NCT05389995|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139317626|NCT05389995|Chelating Agents|chelating agents|mesh-ancestor
139317627|NCT05389995|Sequestering Agents|sequestering agents|mesh-ancestor
139317628|NCT05389995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317629|NCT05389995|Diuretics|diuretics|mesh-ancestor
139317630|NCT05389995|Natriuretic Agents|natriuretic agents|mesh-ancestor
139317631|NCT05389995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317632|NCT05389995|Expectorants|expectorants|mesh-ancestor
139317633|NCT05389995|Respiratory System Agents|respiratory system agents|mesh-ancestor
139317634|NCT05389995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139317635|NCT05389995|Sympathomimetics|sympathomimetics|mesh-ancestor
139317636|NCT05389995|Autonomic Agents|autonomic agents|mesh-ancestor
139317637|NCT05389995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317638|NCT05389995|Dopamine Agents|dopamine agents|mesh-ancestor
139317639|NCT05389995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317640|NCT05389995|Adrenergic Agents|adrenergic agents|mesh-ancestor
139317641|NCT05389995|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139317642|NCT05389995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139317643|NCT05389995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139317644|NCT05389995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139317645|NCT05334433|Anesthetics|anesthetics|mesh-list
139317646|NCT05334433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317647|NCT05334433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317648|NCT05327309|Bleomycin|bleomycin|mesh-list
139317649|NCT05327309|Propranolol|propranolol|mesh-list
139317650|NCT05327309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139317651|NCT05327309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139317652|NCT05327309|Adrenergic Agents|adrenergic agents|mesh-ancestor
139317653|NCT05327309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317654|NCT05327309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317655|NCT05327309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317656|NCT05327309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139317657|NCT05327309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139317658|NCT05327309|Vasodilator Agents|vasodilator agents|mesh-ancestor
139317659|NCT05327309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139317660|NCT05327309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317661|NCT05318794|Doxorubicin|doxorubicin|mesh-list
139317662|NCT05318794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317663|NCT05318794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139317664|NCT05318794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139317665|NCT05318794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139317666|NCT05318794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317667|NCT05318794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317668|NCT05312593|Chlorhexidine|chlorhexidine|mesh-list
139317669|NCT05312593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139317670|NCT05312593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139317671|NCT05312593|Disinfectants|disinfectants|mesh-ancestor
139317672|NCT05266937|Paclitaxel|paclitaxel|mesh-list
139317673|NCT05266937|Carboplatin|carboplatin|mesh-list
139317674|NCT05266937|Atezolizumab|atezolizumab|mesh-list
139317675|NCT05266937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139317676|NCT05266937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317677|NCT05266937|Tubulin Modulators|tubulin modulators|mesh-ancestor
139317678|NCT05266937|Antimitotic Agents|antimitotic agents|mesh-ancestor
139317679|NCT05266937|Mitosis Modulators|mitosis modulators|mesh-ancestor
139317680|NCT05266937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317681|NCT05266937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139317682|NCT05266937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317683|NCT05256901|Glycopyrrolate|glycopyrrolate|mesh-list
139317684|NCT05256901|Neostigmine|neostigmine|mesh-list
139317685|NCT05256901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139317686|NCT05256901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317687|NCT05256901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317688|NCT05256901|Cholinergic Agents|cholinergic agents|mesh-ancestor
139317689|NCT05256901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317690|NCT05256901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317691|NCT05256901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139317692|NCT05256901|Autonomic Agents|autonomic agents|mesh-ancestor
139317693|NCT05256901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317694|NCT05256901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139317695|NCT05256901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139317696|NCT05256901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139317697|NCT05243524|Cyclophosphamide|cyclophosphamide|mesh-list
139317698|NCT05243524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139317699|NCT05243524|Immunologic Factors|immunologic factors|mesh-ancestor
139317700|NCT05243524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317701|NCT05243524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139317702|NCT05243524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139317703|NCT05243524|Alkylating Agents|alkylating agents|mesh-ancestor
139317704|NCT05243524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317705|NCT05243524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317706|NCT05243524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139317707|NCT05226455|Azacitidine|azacitidine|mesh-list
139317708|NCT05226455|Venetoclax|venetoclax|mesh-list
139317709|NCT05226455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139317710|NCT05226455|Antimetabolites|antimetabolites|mesh-ancestor
139317711|NCT05226455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317712|NCT05226455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317713|NCT05226455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317714|NCT05215418|Topiramate|topiramate|mesh-list
139317715|NCT05215418|Phentermine|phentermine|mesh-list
139317716|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
139317717|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139317718|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317719|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139317720|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
139317721|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139317722|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
139317723|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
139317724|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317725|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
139317726|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317727|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317728|NCT05209425|Vitamin D|vitamin d|mesh-list
139317729|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
139317730|NCT05209425|Vitamins|vitamins|mesh-ancestor
139317731|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
139317732|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317733|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139317734|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139317735|NCT05177601|Cycloserine|cycloserine|mesh-list
139317736|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139317737|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139317738|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139317739|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
139317740|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139317741|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
139317742|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317743|NCT05155709|Azacitidine|azacitidine|mesh-list
139317744|NCT05155709|Venetoclax|venetoclax|mesh-list
139317745|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138974612|NCT00831350|Ranibizumab|ranibizumab|mesh-list
139317746|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
139317747|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317748|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317749|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317750|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
139317751|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
139317752|NCT05132504|Folfirinox|folfirinox|mesh-list
139317753|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317754|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317755|NCT05132504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139317756|NCT05132504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317757|NCT05053750|Paclitaxel|paclitaxel|mesh-list
139317758|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139317759|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139317760|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317761|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
139317762|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
139317763|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
139317764|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317765|NCT05039281|Atezolizumab|atezolizumab|mesh-list
139317766|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139317767|NCT05039281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139317768|NCT05039281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317769|NCT05039281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317770|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317771|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
139317772|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317773|NCT05031494|Paclitaxel|paclitaxel|mesh-list
139317774|NCT05031494|Gemcitabine|gemcitabine|mesh-list
139317775|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139317776|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317777|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
139317778|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
139317779|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
139317780|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317781|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139317782|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
139317783|NCT05019703|Atezolizumab|atezolizumab|mesh-list
139317784|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139317785|NCT05019703|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139317786|NCT05019703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317787|NCT05019703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317788|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317789|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
139317790|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317791|NCT05010681|Lenvatinib|lenvatinib|mesh-list
139317792|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317793|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139317794|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317795|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317796|NCT05010668|Lenvatinib|lenvatinib|mesh-list
139317797|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317798|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139317799|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317800|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317802|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139317803|NCT04979377|Hormones|hormones|mesh-list
139317804|NCT04979377|Testosterone|testosterone|mesh-list
139317805|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139317806|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139317807|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317808|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139317809|NCT04979377|Androgens|androgens|mesh-ancestor
139317810|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139317811|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
139317812|NCT04965181|Nicotine|nicotine|mesh-list
139317813|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139317814|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
139317815|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317816|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317817|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139317818|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139317819|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
139317820|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317821|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317822|NCT04964128|Insulin|insulin|mesh-list
139317823|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138974685|NCT00933582|Naproxen|naproxen|mesh-list
139317824|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317825|NCT04943341|Triamcinolone|triamcinolone|mesh-list
139317826|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139317827|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139317828|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139317829|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139317830|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
139317831|NCT04943341|Hormones|hormones|mesh-ancestor
139317832|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139317833|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317834|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139317835|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
139317836|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317837|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317838|NCT04857645|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139317839|NCT04857645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139317840|NCT04857645|Antimetabolites|antimetabolites|mesh-ancestor
139317841|NCT04857645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910587|NCT03537924|Acetazolamide|acetazolamide|mesh-list
139317842|NCT04857645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317843|NCT04848974|Cytarabine|cytarabine|mesh-list
139317844|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
139317845|NCT04848974|Cladribine|cladribine|mesh-list
139317846|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139317847|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
139317848|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317849|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317850|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
139317851|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139317852|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139317853|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
139317854|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317855|NCT04844099|Piperaquine|piperaquine|mesh-list
139317856|NCT04844099|Artenimol|artenimol|mesh-list
139317857|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
139317858|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139317859|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139317860|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139317861|NCT04837014|Acetaminophen|acetaminophen|mesh-list
139317862|NCT04837014|Naproxen|naproxen|mesh-list
139317863|NCT04837014|Hydromorphone|hydromorphone|mesh-list
139317864|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139317865|NCT04837014|Analgesics|analgesics|mesh-ancestor
139317866|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
139317867|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317868|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317869|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
139317870|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139317871|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139317872|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139317873|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
139317874|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139317875|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317876|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317877|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139317878|NCT04837014|Narcotics|narcotics|mesh-ancestor
139317879|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317880|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
139317881|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317882|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317883|NCT04834349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139317884|NCT04834349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317885|NCT04774393|Decitabine|decitabine|mesh-list
139317886|NCT04774393|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139317887|NCT04774393|Venetoclax|venetoclax|mesh-list
139317888|NCT04774393|Ivosidenib|ivosidenib|mesh-list
139317889|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139317890|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
139317891|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317892|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317893|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317894|NCT04762069|Lomustine|lomustine|mesh-list
139317895|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139317896|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
139317897|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317898|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317900|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
139317901|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
139317902|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139317903|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317904|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
139317905|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317906|NCT04722575|Atezolizumab|atezolizumab|mesh-list
139317907|NCT04722575|Vemurafenib|vemurafenib|mesh-list
139317908|NCT04722575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139317909|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317910|NCT04722575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139317911|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317912|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139317913|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317914|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139317915|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139317916|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139317917|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
139317918|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
139317919|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139317920|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139317921|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139317922|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139317923|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317924|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
139317925|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139317926|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317927|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139317928|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317929|NCT04685577|Nefopam|nefopam|mesh-list
139317930|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139317931|NCT04685577|Analgesics|analgesics|mesh-ancestor
139317932|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
139317933|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139317934|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317935|NCT04671810|Eculizumab|eculizumab|mesh-list
139317936|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139317937|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139317938|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
139317939|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317940|NCT04667039|Ranibizumab|ranibizumab|mesh-list
139317941|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139317942|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139317943|NCT04667039|Growth Substances|growth substances|mesh-ancestor
139317944|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317945|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
139317946|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317948|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139317949|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139317950|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317951|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317952|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317953|NCT04628988|Prednisone|prednisone|mesh-list
139317954|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
139317955|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139317956|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
139317957|NCT04628988|Hormones|hormones|mesh-ancestor
138910607|NCT00590538|Hormones|hormones|mesh-ancestor
139317958|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139317959|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317960|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139317961|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317962|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317963|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317964|NCT04621435|Copper|copper|mesh-list
139317965|NCT04621435|Trace Elements|trace elements|mesh-ancestor
139317966|NCT04621435|Micronutrients|micronutrients|mesh-ancestor
139317967|NCT04621435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317968|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
139317969|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317970|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139317971|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974838|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139317972|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317974|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317975|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139317976|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317977|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317978|NCT04507919|Dabrafenib|dabrafenib|mesh-list
139317979|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317980|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139317981|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139317982|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317983|NCT04503551|Ranibizumab|ranibizumab|mesh-list
139317984|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139317985|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139317986|NCT04503551|Growth Substances|growth substances|mesh-ancestor
139317987|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139317988|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
139317989|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139317990|NCT04485195|Procainamide|procainamide|mesh-list
139317991|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139317992|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139317993|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139317994|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139317995|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139317996|NCT04485130|Disulfiram|disulfiram|mesh-list
139317997|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139317998|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139317999|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318000|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318001|NCT04469491|Interferons|interferons|mesh-list
139318002|NCT04469491|Interferon Type I|interferon type i|mesh-list
139318003|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318004|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
139318005|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318006|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
139318007|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318008|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318009|NCT04458948|Azithromycin|azithromycin|mesh-list
139318010|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
139318011|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139318012|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318013|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
139318014|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139318015|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139318016|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318017|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318018|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318019|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
139318020|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318021|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910632|NCT04110873|Ubiquinone|ubiquinone|mesh-list
139318022|NCT04432857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318023|NCT04432857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318024|NCT04386746|Gemcitabine|gemcitabine|mesh-list
139318025|NCT04386746|Docetaxel|docetaxel|mesh-list
139318026|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139318027|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
139318028|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318029|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318030|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
139318031|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
139318032|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
139318033|NCT04383119|Gemcitabine|gemcitabine|mesh-list
139318034|NCT04383119|Trabectedin|trabectedin|mesh-list
139318035|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139318036|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
139318037|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318038|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318039|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139318040|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
139318041|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
139318042|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318043|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318044|NCT04381650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318045|NCT04381650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318046|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139318047|NCT04350502|Amoxicillin|amoxicillin|mesh-list
139318048|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
139318049|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
139318050|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139318051|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318052|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318053|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318054|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139318055|NCT04339101|Sirolimus|sirolimus|mesh-list
139318056|NCT04339101|Fludarabine|fludarabine|mesh-list
139318057|NCT04339101|Melphalan|melphalan|mesh-list
139318058|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
139318059|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139318060|NCT04339101|Tacrolimus|tacrolimus|mesh-list
139318061|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318062|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318063|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139318064|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
139318065|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318066|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139318067|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318068|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139318069|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318070|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139318071|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
139318072|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139318073|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
139318074|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139318075|NCT04305548|Trabectedin|trabectedin|mesh-list
138910635|NCT02604615|Capecitabine|capecitabine|mesh-list
139318076|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139318077|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
139318078|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318079|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318080|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
139318081|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139318082|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
139318083|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139318084|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318085|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318086|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
139318087|NCT04246177|Lenvatinib|lenvatinib|mesh-list
139318088|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318089|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318090|NCT04246177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318091|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318092|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139318093|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318094|NCT04222010|Anesthetics|anesthetics|mesh-list
139318095|NCT04222010|Ropivacaine|ropivacaine|mesh-list
139318096|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139318097|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318098|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
139318099|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
139318100|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318101|NCT04205409|Nivolumab|nivolumab|mesh-list
139318102|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318103|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318104|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318105|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318106|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
139318107|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
139318108|NCT04179500|Bedaquiline|bedaquiline|mesh-list
139318109|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139318110|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318111|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139318112|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139318113|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318114|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318115|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318116|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
139318117|NCT04145700|Gemcitabine|gemcitabine|mesh-list
138974982|NCT00830492|Enclomiphene|enclomiphene|mesh-list
139318118|NCT04145700|Docetaxel|docetaxel|mesh-list
139318119|NCT04145700|Ramucirumab|ramucirumab|mesh-list
139318120|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139318121|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
139318122|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318123|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318124|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
139318125|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
139318126|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
139318127|NCT04128683|Bromocriptine|bromocriptine|mesh-list
139318128|NCT04128683|Amisulpride|amisulpride|mesh-list
139318129|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139318130|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139318131|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139318132|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318133|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139318134|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139318135|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
139318136|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139318137|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318138|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139318139|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
139318140|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139318141|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139318142|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
139318143|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318144|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
139318145|NCT04108156|Ranibizumab|ranibizumab|mesh-list
139318146|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139318147|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139318148|NCT04108156|Growth Substances|growth substances|mesh-ancestor
139318149|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318150|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
139318151|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318152|NCT04079738|Ixazomib|ixazomib|mesh-list
139318153|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318154|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
139318155|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318156|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318157|NCT04054635|Fluorides|fluorides|mesh-list
139176536|NCT03403374|Evolocumab|evolocumab|mesh-list
139318159|NCT04054635|Protective Agents|protective agents|mesh-ancestor
139318160|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318161|NCT04017247|Oxytocin|oxytocin|mesh-list
139318162|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
139318163|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139318164|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318165|NCT03953235|Nivolumab|nivolumab|mesh-list
139318166|NCT03953235|Ipilimumab|ipilimumab|mesh-list
139318167|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318168|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318169|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138910688|NCT05297292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139318170|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318171|NCT03897998|Naloxone|naloxone|mesh-list
139318172|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139318173|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318174|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
139318175|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318176|NCT03891706|Interleukin-2|interleukin-2|mesh-list
139318177|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318178|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139318179|NCT03891706|Analgesics|analgesics|mesh-ancestor
139318180|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
139318181|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318182|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318183|NCT03852992|Minoxidil|minoxidil|mesh-list
139318184|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139318185|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
139318186|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
139318187|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318188|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318189|NCT03832569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318190|NCT03832569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318191|NCT03820726|Nintedanib|nintedanib|mesh-list
139318192|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318193|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139318194|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318195|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318196|NCT03774446|Roscovitine|roscovitine|mesh-list
139318197|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318198|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
139318199|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318200|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139318201|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318202|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318203|NCT03754634|Diacerein|diacerein|mesh-list
139318204|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139318205|NCT03745404|Lidocaine|lidocaine|mesh-list
139318206|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
139318207|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
139318208|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139318209|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318210|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
139318211|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318212|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139318213|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139318214|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139318215|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139318216|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318217|NCT03737123|Carboplatin|carboplatin|mesh-list
139318218|NCT03737123|Gemcitabine|gemcitabine|mesh-list
139318219|NCT03737123|Docetaxel|docetaxel|mesh-list
139318220|NCT03737123|Atezolizumab|atezolizumab|mesh-list
139318221|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318222|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139318223|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
139318224|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318225|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
139318226|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
139318227|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
139318228|NCT03737123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318229|NCT03737123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318230|NCT03639714|Nivolumab|nivolumab|mesh-list
139318231|NCT03639714|Ipilimumab|ipilimumab|mesh-list
139318232|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318233|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318234|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318235|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318236|NCT03567876|Venetoclax|venetoclax|mesh-list
139318237|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318238|NCT03518801|Cannabidiol|cannabidiol|mesh-list
139318239|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
139318240|NCT03480334|Nivolumab|nivolumab|mesh-list
139318241|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318242|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318243|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318244|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318245|NCT03467750|Ketorolac|ketorolac|mesh-list
139318246|NCT03467750|Morphine|morphine|mesh-list
139318247|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139318248|NCT03467750|Narcotics|narcotics|mesh-ancestor
139318249|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139318250|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318251|NCT03467750|Analgesics|analgesics|mesh-ancestor
139318252|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
139318253|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318254|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139318255|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139318256|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139318257|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318258|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139318259|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318260|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318261|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
139318262|NCT03432741|Rituximab|rituximab|mesh-list
139318263|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139318264|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
139318265|NCT03432741|Nivolumab|nivolumab|mesh-list
139318266|NCT03432741|Trastuzumab|trastuzumab|mesh-list
139318267|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
139318268|NCT03432741|Gemcitabine|gemcitabine|mesh-list
139318269|NCT03432741|Daratumumab|daratumumab|mesh-list
139318270|NCT03432741|Romidepsin|romidepsin|mesh-list
139318271|NCT03432741|Belinostat|belinostat|mesh-list
139318272|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139318273|NCT03432741|Antibodies|antibodies|mesh-list
139318274|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
139318275|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139318276|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139318277|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
139318278|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318279|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318280|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318281|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139318282|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
139318283|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318284|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318285|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318286|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139318287|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139318288|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139318289|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318290|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
139318291|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
139318292|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318293|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318294|NCT03425006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318295|NCT03425006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318296|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
139318297|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139318298|NCT03401073|Antibodies|antibodies|mesh-list
139318299|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
138910719|NCT00588237|Paclitaxel|paclitaxel|mesh-list
139318300|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139318301|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
139318302|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318303|NCT03227419|Abatacept|abatacept|mesh-list
139318304|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318305|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724494|NCT02216409|Magrolimab|magrolimab|mesh-list
139318306|NCT03227419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318307|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318308|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139318309|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
139318310|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318311|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318312|NCT03173560|Everolimus|everolimus|mesh-list
139318313|NCT03173560|Lenvatinib|lenvatinib|mesh-list
139318314|NCT03173560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139318315|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139318316|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318317|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318318|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139318319|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
139318320|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318321|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318322|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
139318323|NCT03127774|Antidotes|antidotes|mesh-ancestor
139318324|NCT03127774|Protective Agents|protective agents|mesh-ancestor
139318325|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318326|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
139318327|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318328|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
139318329|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139318330|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318331|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
139318332|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
139318333|NCT03116529|Immunomodulating Agents|immunomodulating agents|mesh-list
139318334|NCT03116529|Immunologic Factors|immunologic factors|mesh-ancestor
139318335|NCT03116529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318336|NCT03023124|Doxorubicin|doxorubicin|mesh-list
139318337|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139318338|NCT03023124|Dacarbazine|dacarbazine|mesh-list
139318339|NCT03023124|Trabectedin|trabectedin|mesh-list
139318340|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139318341|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318342|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139318343|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139318344|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975216|NCT00839462|Vitamins|vitamins|mesh-ancestor
139318345|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318346|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139318347|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
139318348|NCT03004833|Nivolumab|nivolumab|mesh-list
139318349|NCT03004833|Doxorubicin|doxorubicin|mesh-list
139318350|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139318351|NCT03004833|Dacarbazine|dacarbazine|mesh-list
139318352|NCT03004833|Vinblastine|vinblastine|mesh-list
139318353|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318354|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318355|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318356|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318357|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139318358|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139318359|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139318360|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318361|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139318362|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
139318363|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139318364|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
139318365|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
139318366|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
139318367|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
139318368|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
139318369|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318370|NCT02825160|Iloprost|iloprost|mesh-list
139318371|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139318372|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
139318373|NCT02730923|Anastrozole|anastrozole|mesh-list
139318374|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139318375|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318376|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139318377|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139318378|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318379|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318380|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139318381|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
139318382|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318383|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318384|NCT02631447|Nivolumab|nivolumab|mesh-list
139318385|NCT02631447|Ipilimumab|ipilimumab|mesh-list
139318386|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318387|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318388|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318389|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318390|NCT02542852|Ritonavir|ritonavir|mesh-list
139318391|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139318392|NCT02542852|Dolutegravir|dolutegravir|mesh-list
139318393|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139318394|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139318395|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
139318396|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318397|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318398|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139318399|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139318400|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
139318401|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318402|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139318403|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139318404|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139318405|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139318406|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
139318407|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318408|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139318409|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139318410|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318411|NCT02390869|Rituximab|rituximab|mesh-list
139318412|NCT02390869|Lenalidomide|lenalidomide|mesh-list
139318413|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318414|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318415|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
139318416|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318417|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318418|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139318419|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139318420|NCT02390869|Growth Substances|growth substances|mesh-ancestor
139318421|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
139318422|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
139318423|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318424|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318425|NCT02343952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318426|NCT02343952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318427|NCT02250937|Fludarabine|fludarabine|mesh-list
139318428|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
139318429|NCT02250937|Busulfan|busulfan|mesh-list
139318430|NCT02250937|Venetoclax|venetoclax|mesh-list
139318431|NCT02250937|Cladribine|cladribine|mesh-list
139318432|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
139318433|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318434|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139318435|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
139318436|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318437|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139318438|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
139318439|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318440|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
139318441|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139318442|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139318443|NCT02223208|Prednisone|prednisone|mesh-list
139318444|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
139318445|NCT02223208|Doxorubicin|doxorubicin|mesh-list
139318446|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139318447|NCT02223208|Etoposide|etoposide|mesh-list
139318448|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
139318449|NCT02223208|Romidepsin|romidepsin|mesh-list
139318450|NCT02223208|Vincristine|vincristine|mesh-list
139318451|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139176546|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
139318452|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
139318453|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318454|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318455|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139318456|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
139318457|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318458|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318459|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139318460|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139318461|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139318462|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139318463|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318464|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139318465|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
139318466|NCT02223208|Hormones|hormones|mesh-ancestor
139318467|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318468|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139318469|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139318470|NCT02223208|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139318471|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
139318472|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
139318473|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
139318474|NCT01710176|Gemcitabine|gemcitabine|mesh-list
139318475|NCT01710176|Docetaxel|docetaxel|mesh-list
139318476|NCT01710176|Etoposide|etoposide|mesh-list
139318477|NCT01710176|Epirubicin|epirubicin|mesh-list
139318478|NCT01710176|Ifosfamide|ifosfamide|mesh-list
139318479|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
139318480|NCT01710176|Dacarbazine|dacarbazine|mesh-list
139318481|NCT01710176|Trabectedin|trabectedin|mesh-list
139318482|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139318483|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
139318484|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318485|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318486|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
139318487|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
139318488|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
139318489|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139318490|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139318491|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139318492|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318493|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139318494|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138975362|NCT01010152|Codeine|codeine|mesh-list
139318495|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
139318496|NCT01660971|Gemcitabine|gemcitabine|mesh-list
139318497|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139318499|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139318500|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
139318501|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318502|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318503|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139318504|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318505|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
139318506|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318507|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318508|NCT01592370|Dexamethasone|dexamethasone|mesh-list
139318509|NCT01592370|Nivolumab|nivolumab|mesh-list
139318510|NCT01592370|Ipilimumab|ipilimumab|mesh-list
139318511|NCT01592370|Daratumumab|daratumumab|mesh-list
139318512|NCT01592370|Pomalidomide|pomalidomide|mesh-list
139318513|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139318514|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
139318515|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
139318516|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318517|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318518|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139318519|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
139318520|NCT01592370|Hormones|hormones|mesh-ancestor
139318521|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318522|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139318523|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318524|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139176547|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139318525|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318526|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318527|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
139318528|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139318529|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139318530|NCT01592370|Growth Substances|growth substances|mesh-ancestor
139318531|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
139318533|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
139318534|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318535|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139318536|NCT01437709|Ofatumumab|ofatumumab|mesh-list
139318537|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139318538|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139318539|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
139318540|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318541|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318542|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
139318543|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318544|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
139318545|NCT01093183|Lenalidomide|lenalidomide|mesh-list
139318546|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139318547|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
139318548|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318549|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318550|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139318551|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
139318552|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318553|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318554|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139318555|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139318556|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139318557|NCT01093183|Growth Substances|growth substances|mesh-ancestor
139318558|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
139318559|NCT00777036|Dasatinib|dasatinib|mesh-list
139318560|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910753|NCT05563467|Pembrolizumab|pembrolizumab|mesh-list
139318561|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139318562|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318563|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318564|NCT00365157|Halichondrin B|halichondrin b|mesh-list
139318565|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
139318566|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
139318567|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
139318568|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318569|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318570|NCT00176644|Estradiol|estradiol|mesh-list
139318571|NCT00176644|Estrogens|estrogens|mesh-ancestor
139318572|NCT00176644|Hormones|hormones|mesh-ancestor
139318573|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318574|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318575|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139318576|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
139318577|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318578|NCT00045201|Irinotecan|irinotecan|mesh-list
139318579|NCT00045201|Camptothecin|camptothecin|mesh-list
139318580|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139318581|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139318582|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139318583|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318584|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318585|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318586|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139318587|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139318588|NCT03326960|Propofol|propofol|mesh-list
139318589|NCT03326960|Sevoflurane|sevoflurane|mesh-list
139318590|NCT03326960|Desflurane|desflurane|mesh-list
139318591|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139318592|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139318593|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318594|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139318595|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
139318596|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
139318597|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139318598|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139318599|NCT03319238|Ketamine|ketamine|mesh-list
139318600|NCT03319238|Analgesics|analgesics|mesh-ancestor
139318601|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
139318602|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318603|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318604|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139318605|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139318606|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
139318607|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
139318608|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139318609|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139318610|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139318611|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139318612|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318613|NCT03321890|Prednisone|prednisone|mesh-list
139318614|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
139318615|NCT03321890|Methotrexate|methotrexate|mesh-list
139318616|NCT03321890|Etoposide|etoposide|mesh-list
139318617|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139318618|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
139318619|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318620|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318621|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139318622|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
139318623|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318624|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318625|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139318626|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139318627|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
139318628|NCT03321890|Hormones|hormones|mesh-ancestor
139318629|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318630|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139318631|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139318632|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
139318633|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139318634|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139318635|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
139318636|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
139318637|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318638|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139318639|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139318640|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139318641|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139318642|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139318643|NCT05464394|Tranexamic Acid|tranexamic acid|mesh-list
139318644|NCT05464394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139318645|NCT05464394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139318646|NCT05464394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318648|NCT05464394|Coagulants|coagulants|mesh-ancestor
139318649|NCT05499598|Vitamin A|vitamin a|mesh-list
139318650|NCT05499598|Vitamins|vitamins|mesh-ancestor
139318651|NCT05499598|Micronutrients|micronutrients|mesh-ancestor
139318652|NCT05499598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318653|NCT04442750|Bupivacaine|bupivacaine|mesh-list
139318654|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
139318655|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
139318656|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139318657|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318658|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
139318659|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318660|NCT03326258|Nivolumab|nivolumab|mesh-list
139318661|NCT03326258|Ipilimumab|ipilimumab|mesh-list
139318662|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
139318663|NCT03326258|Antibodies|antibodies|mesh-list
139318664|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
139318665|NCT03326258|Immunotoxins|immunotoxins|mesh-list
139318666|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139318667|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
139318668|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
139318669|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318670|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139318671|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318672|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139318673|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318675|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139318676|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139318677|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318678|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
139318679|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
139318680|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
139318681|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318682|NCT02487212|Clobetasol|clobetasol|mesh-list
139318683|NCT02487212|Petrolatum|petrolatum|mesh-list
139318684|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139318685|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
139318686|NCT02487212|Hormones|hormones|mesh-ancestor
139318687|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318688|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318689|NCT02487212|Emollients|emollients|mesh-ancestor
139318690|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
139318691|NCT03318536|Granisetron|granisetron|mesh-list
139318692|NCT03318536|Serotonin|serotonin|mesh-list
139318693|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
139318694|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
139318695|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318696|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318697|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139318698|NCT03318536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139318699|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139318700|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
139318701|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139318702|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318703|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139318704|NCT03537027|Vitamin D|vitamin d|mesh-list
139318705|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
139318706|NCT03537027|Vitamins|vitamins|mesh-ancestor
139318707|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
139318708|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318709|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139318710|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139318711|NCT02183025|Meloxicam|meloxicam|mesh-list
139318712|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
139318713|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139318714|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139318715|NCT02183025|Analgesics|analgesics|mesh-ancestor
139318716|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
139318717|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318718|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318719|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139318720|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318721|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139318722|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139318723|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318724|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318725|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
139318726|NCT04282174|Melphalan|melphalan|mesh-list
139318727|NCT04282174|Busulfan|busulfan|mesh-list
139318728|NCT04282174|Thiotepa|thiotepa|mesh-list
139318729|NCT04282174|Fludarabine|fludarabine|mesh-list
139318730|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139318731|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
139318732|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318733|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318734|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139318735|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
139318736|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318737|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318738|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139318739|NCT02181309|Meloxicam|meloxicam|mesh-list
139318740|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139318741|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139318742|NCT02181309|Analgesics|analgesics|mesh-ancestor
139318743|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
139318744|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318745|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318746|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139318747|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318748|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139318749|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139318750|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318751|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318753|NCT02186145|Nystatin|nystatin|mesh-list
139318754|NCT02186145|Dexamethasone|dexamethasone|mesh-list
139318755|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139318756|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
139318757|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
139318758|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318759|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318760|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139318761|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
139318762|NCT02186145|Hormones|hormones|mesh-ancestor
139318763|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318764|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139318765|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318766|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318767|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139318768|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139318769|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139318770|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
139318771|NCT02186145|Ionophores|ionophores|mesh-ancestor
139318772|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139318773|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318774|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
139318775|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139318776|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
139318777|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139318778|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318779|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139318780|NCT02183103|Meloxicam|meloxicam|mesh-list
139318781|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139318782|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139318783|NCT02183103|Analgesics|analgesics|mesh-ancestor
139318784|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
139318785|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318786|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318787|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139318788|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318789|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139318790|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139318791|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318792|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318793|NCT03325790|Ebselen|ebselen|mesh-list
139318794|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139318795|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139318796|NCT03325790|Analgesics|analgesics|mesh-ancestor
139318797|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
139318798|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318799|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318800|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139318801|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318802|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139318803|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138910811|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318805|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318806|NCT03325790|Protective Agents|protective agents|mesh-ancestor
139318807|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139318808|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318809|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139318810|NCT02181543|Clonidine|clonidine|mesh-list
139318811|NCT02181543|Analgesics|analgesics|mesh-ancestor
139318812|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
139318813|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318814|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318815|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139318816|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
139318817|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
139318818|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139318819|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139318820|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139318821|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
139318822|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139318823|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318824|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
139318825|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139318826|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318827|NCT02490176|Liraglutide|liraglutide|mesh-list
139318828|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139318829|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318830|NCT02490176|Incretins|incretins|mesh-ancestor
139318831|NCT02490176|Hormones|hormones|mesh-ancestor
139318832|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318833|NCT02183181|Meloxicam|meloxicam|mesh-list
139318834|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139318835|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139318836|NCT02183181|Analgesics|analgesics|mesh-ancestor
139318837|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
139318838|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318839|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318840|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139318841|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139318842|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139318843|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139318844|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318845|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318846|NCT02490098|Insulin|insulin|mesh-list
139318847|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139318848|NCT02490098|Glucagon|glucagon|mesh-list
139318849|NCT02490098|Hormones|hormones|mesh-list
139318850|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139318851|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318852|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318853|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139318854|NCT02486822|Oxytocin|oxytocin|mesh-list
139318855|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
139318856|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139318857|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318858|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139318859|NCT02186457|Polymyxins|polymyxins|mesh-list
139318860|NCT02186457|Polymyxin B|polymyxin b|mesh-list
139318861|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318862|NCT02186535|Vitamin D|vitamin d|mesh-list
139318863|NCT02186535|Calcium|calcium|mesh-list
139318864|NCT02186535|Vitamins|vitamins|mesh-ancestor
139318865|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
139318866|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318867|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139318868|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139318869|NCT03325400|Fluorides|fluorides|mesh-list
139318870|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
139318871|NCT03325400|Protective Agents|protective agents|mesh-ancestor
139318872|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318873|NCT02181933|Lamivudine|lamivudine|mesh-list
139318874|NCT02181933|Zidovudine|zidovudine|mesh-list
139318875|NCT02181933|Nevirapine|nevirapine|mesh-list
139318876|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139318877|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139318878|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318879|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318880|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
139318881|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318882|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139318883|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139318884|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
139318885|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139318886|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139318887|NCT02183337|Pioglitazone|pioglitazone|mesh-list
139318888|NCT02183337|Linagliptin|linagliptin|mesh-list
139318889|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139318890|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318891|NCT02183337|Incretins|incretins|mesh-ancestor
139318892|NCT02183337|Hormones|hormones|mesh-ancestor
139318893|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318894|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139318895|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
139318896|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318897|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318898|NCT02489786|Digoxin|digoxin|mesh-list
139318899|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139318900|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139318901|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318902|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318903|NCT02489786|Protective Agents|protective agents|mesh-ancestor
139318904|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318905|NCT02489864|Terlipressin|terlipressin|mesh-list
139318906|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139318907|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139318908|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139318909|NCT02182011|Tenecteplase|tenecteplase|mesh-list
139318910|NCT02182011|Streptokinase|streptokinase|mesh-list
139318911|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139318912|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139318913|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318914|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139318915|NCT02486744|Hormones|hormones|mesh-ancestor
139318916|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318917|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318918|NCT02186769|Risperidone|risperidone|mesh-list
139318919|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139318920|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
139318921|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139318922|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318923|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318924|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139318925|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139318926|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139318927|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139318928|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139318929|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
139318930|NCT02486432|Levodopa|levodopa|mesh-list
139318931|NCT02486432|Carbidopa|carbidopa|mesh-list
139318932|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139318933|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139318934|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139318935|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
139318936|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139318937|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318938|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318939|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139318940|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318941|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139318942|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
139318943|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
139318944|NCT02489240|Vitamin D|vitamin d|mesh-list
139318945|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
139318946|NCT02489240|Vitamins|vitamins|mesh-ancestor
139318947|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
139318948|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318949|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138975803|NCT00842894|Insulin|insulin|mesh-list
139318950|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139318951|NCT02183415|Linagliptin|linagliptin|mesh-list
139318952|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139176566|NCT03756883|Xhance|xhance|mesh-list
139318953|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318955|NCT02183415|Hormones|hormones|mesh-ancestor
139318956|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318957|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139318958|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
139318959|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318960|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318961|NCT02486510|Maraviroc|maraviroc|mesh-list
139318962|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139318963|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139318964|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318965|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139318966|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139318967|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
139318968|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139318969|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139318970|NCT04493528|Lidocaine|lidocaine|mesh-list
139318971|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
139318972|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
139318973|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139318974|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318975|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
139318976|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139318977|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139318978|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139318979|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139318980|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139318981|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318982|NCT02183493|Linagliptin|linagliptin|mesh-list
139318983|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139318984|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139318985|NCT02183493|Incretins|incretins|mesh-ancestor
139318986|NCT02183493|Hormones|hormones|mesh-ancestor
139318987|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139318988|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139318989|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
139318990|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318991|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318992|NCT02187081|Sorafenib|sorafenib|mesh-list
139318993|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139318994|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139318995|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139318996|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139318997|NCT02485106|Rifaximin|rifaximin|mesh-list
139318998|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
139318999|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139319000|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319001|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139319002|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139319003|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319004|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319005|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139319006|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139319007|NCT02485106|Protective Agents|protective agents|mesh-ancestor
139319008|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319009|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
139319010|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139319011|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
139319012|NCT02485028|Mirodenafil|mirodenafil|mesh-list
139319013|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139319014|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139319015|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319016|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319017|NCT02183571|Metformin|metformin|mesh-list
139319018|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139319019|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319020|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139319021|NCT03318146|Latanoprost|latanoprost|mesh-list
139319022|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139319023|NCT02183649|Carbetapentane|carbetapentane|mesh-list
139319024|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
139319025|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
139319026|NCT02187315|Cisplatin|cisplatin|mesh-list
139319027|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319028|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
139319029|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
139319030|NCT02256735|Ritobegron|ritobegron|mesh-list
139319031|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139319032|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319033|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139319034|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139319035|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319036|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319037|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319038|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319039|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
139319040|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
139319041|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319042|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
139319043|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139319044|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139319045|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139319046|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
139319047|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319048|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
139319049|NCT02183805|Carboplatin|carboplatin|mesh-list
139319050|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139319051|NCT02183805|Paclitaxel|paclitaxel|mesh-list
139319052|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139319053|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
139319054|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319055|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139319056|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139319057|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
139319058|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319059|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319060|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139319061|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139319062|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
139319063|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
139319064|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
139319065|NCT03316352|Bupivacaine|bupivacaine|mesh-list
139319066|NCT03316352|Anesthetics|anesthetics|mesh-list
139319067|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
139319068|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139319069|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319070|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
139319071|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319072|NCT02187705|Telmisartan|telmisartan|mesh-list
139319073|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139319074|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139319075|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139319076|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319077|NCT03317912|Lidocaine|lidocaine|mesh-list
139319078|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
139319079|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
139319080|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139319081|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319082|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
138910896|NCT00450619|Sargramostim|sargramostim|mesh-list
139319083|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319084|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139319085|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139319086|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139319087|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139319088|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319089|NCT03321110|Ubiquinone|ubiquinone|mesh-list
139319090|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
139319091|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
139319092|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319094|NCT03317600|Lidocaine|lidocaine|mesh-list
139319095|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
139319096|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
139319097|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139319098|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319099|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
139319100|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319101|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139319102|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139319103|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139319104|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139319105|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319106|NCT02184117|Adenosine|adenosine|mesh-list
139319107|NCT02184117|Analgesics|analgesics|mesh-ancestor
139319108|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
139319109|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319110|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319111|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139319112|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
139319113|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139319114|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
139319115|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
139319116|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319117|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319118|NCT02184273|Dipyrone|dipyrone|mesh-list
139319119|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139319120|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139319121|NCT02184273|Analgesics|analgesics|mesh-ancestor
139319122|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
139319123|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319124|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319125|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139319126|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139319127|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
139319128|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
139319129|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319130|NCT02188173|Dexamethasone|dexamethasone|mesh-list
139319131|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139319132|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
139319133|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
139319134|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319135|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319136|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139319137|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
139319138|NCT02188173|Hormones|hormones|mesh-ancestor
139319139|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139319140|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139319141|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319142|NCT02184351|Clotrimazole|clotrimazole|mesh-list
139319143|NCT02184351|Miconazole|miconazole|mesh-list
139319144|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139319145|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319146|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
139319147|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139319148|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139319149|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319150|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319151|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139319152|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
139319153|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139319154|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319155|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139319156|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139319157|NCT02184429|PF-06669571|pf-06669571|mesh-list
139319158|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
139319159|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
139319160|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319161|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319162|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319163|NCT02484170|Mannitol|mannitol|mesh-list
139319164|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139319165|NCT02484170|Diuretics|diuretics|mesh-ancestor
139319166|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
139319167|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319168|NCT02188407|Propofol|propofol|mesh-list
139319169|NCT02188407|Sevoflurane|sevoflurane|mesh-list
139319170|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139319171|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139319172|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319173|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139319174|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
139319175|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
139319176|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139319177|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139319178|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
139319179|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139319180|NCT03317210|Hematinics|hematinics|mesh-ancestor
139319181|NCT02488694|Pemetrexed|pemetrexed|mesh-list
139319182|NCT02488694|Afatinib|afatinib|mesh-list
139319183|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319184|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319185|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319186|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139319187|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139319188|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139319189|NCT03316898|Memantine|memantine|mesh-list
139319190|NCT03316898|Donepezil|donepezil|mesh-list
139319191|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139319192|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319193|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319194|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
139319195|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319196|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319197|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
139319198|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139319199|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139319200|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
139319201|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139319202|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139319203|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
139319204|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
139319205|NCT02188953|Calcium|calcium|mesh-list
139319206|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139319207|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319208|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139319209|NCT02188953|Antacids|antacids|mesh-ancestor
138910939|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
139319210|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319211|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139319212|NCT02184819|Riboflavin|riboflavin|mesh-list
139319213|NCT02184819|Simendan|simendan|mesh-list
139319214|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
139319215|NCT02184819|Vitamins|vitamins|mesh-ancestor
139319216|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
139319217|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319218|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139319219|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
139319220|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139319221|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
139319222|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139319223|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139319224|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319225|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319226|NCT02184819|Protective Agents|protective agents|mesh-ancestor
139319227|NCT02256813|Vitamin K|vitamin k|mesh-list
139319228|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
139319229|NCT02256813|Midazolam|midazolam|mesh-list
139319230|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
139319231|NCT02256813|Caffeine|caffeine|mesh-list
139319232|NCT02256813|Omeprazole|omeprazole|mesh-list
139319233|NCT02256813|Warfarin|warfarin|mesh-list
139319234|NCT02256813|Vitamins|vitamins|mesh-ancestor
139319235|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
139319236|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319238|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139319239|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139319240|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139319241|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139319242|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139319243|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139319244|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
139319245|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
139319246|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
139319247|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
139319248|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319249|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319250|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
139319251|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139319252|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139319253|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319254|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139319255|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139319256|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
139319257|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139319258|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139319259|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139319260|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139319261|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139319262|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
139319263|NCT02256813|Coagulants|coagulants|mesh-ancestor
139319264|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
139319265|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
138910942|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139319266|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139319267|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139319268|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
139319269|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
139319270|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139319271|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139319272|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
139319273|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
139319274|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139319275|NCT02483624|Protective Agents|protective agents|mesh-ancestor
139319276|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319277|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319278|NCT02184897|Lenograstim|lenograstim|mesh-list
139319279|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139319280|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
139319281|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319282|NCT02184975|Hemostatics|hemostatics|mesh-list
139319283|NCT02184975|Coagulants|coagulants|mesh-ancestor
139319284|NCT02189343|Thalidomide|thalidomide|mesh-list
139319285|NCT02189343|Dexamethasone|dexamethasone|mesh-list
139319286|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
139319287|NCT02189343|Pomalidomide|pomalidomide|mesh-list
139319288|NCT02189343|Ricolinostat|ricolinostat|mesh-list
139319289|NCT02189343|BB 1101|bb 1101|mesh-list
139319290|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139319291|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
139319292|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
139319293|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319294|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319295|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139319296|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
139319297|NCT02189343|Hormones|hormones|mesh-ancestor
139319298|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139319299|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139319300|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319301|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
139319302|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319303|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319304|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
139319305|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139319306|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139319307|NCT02189343|Growth Substances|growth substances|mesh-ancestor
139319308|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
139319309|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139319310|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
139319311|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138725493|NCT06044480|Hormones|hormones|mesh-ancestor
139319312|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319313|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139319314|NCT03535701|Paclitaxel|paclitaxel|mesh-list
139319315|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139319316|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139319317|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319318|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
139319319|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
139319320|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
139319321|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319322|NCT02486276|Cilostazol|cilostazol|mesh-list
139319323|NCT02486276|Sumatriptan|sumatriptan|mesh-list
139319324|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139319325|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
138976181|NCT02773485|Cisplatin|cisplatin|mesh-list
139319326|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319327|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319328|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139319329|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
139319330|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139319331|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139319332|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319333|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139319334|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
139319335|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139319336|NCT02486276|Protective Agents|protective agents|mesh-ancestor
139319337|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139319338|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139319339|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319340|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139319341|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139319342|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139319343|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
139319344|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319345|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
139319346|NCT02189577|Bromides|bromides|mesh-list
139319347|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
139319348|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139319349|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139319350|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139319351|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
139319352|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319353|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319354|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319355|NCT02189655|Bupivacaine|bupivacaine|mesh-list
139319356|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
139319357|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
139319358|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139319359|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319360|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
139319361|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319362|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
139319363|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139319364|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139319365|NCT02193633|Paclitaxel|paclitaxel|mesh-list
139319366|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139319367|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139319368|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319369|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
139319370|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
139319371|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
139319372|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319373|NCT03315338|Prednisone|prednisone|mesh-list
139319374|NCT03315338|Cortisone|cortisone|mesh-list
139319375|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139319376|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
139319377|NCT03315338|Hormones|hormones|mesh-ancestor
139319378|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139319379|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319380|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139319381|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319382|NCT02483156|Ribavirin|ribavirin|mesh-list
139319383|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
139319384|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
139319385|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319386|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
139319387|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319389|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139319390|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139319391|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319392|NCT02485340|Isosorbide|isosorbide|mesh-list
139319393|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139319394|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139319395|NCT02485340|Sumatriptan|sumatriptan|mesh-list
139319396|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139319397|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139319398|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139319399|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
139319400|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319401|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319402|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319403|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139319404|NCT02485340|Diuretics|diuretics|mesh-ancestor
139319405|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
139319406|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
139319407|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139319408|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
139319409|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139319410|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
139319411|NCT02485262|Simeprevir|simeprevir|mesh-list
139319412|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
139319413|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319414|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
139319415|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319416|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319417|NCT02479490|Prednisone|prednisone|mesh-list
139319418|NCT02479490|Everolimus|everolimus|mesh-list
139319419|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139319420|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
139319421|NCT02479490|Hormones|hormones|mesh-ancestor
139319422|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139319423|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319424|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139319425|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319426|NCT02479490|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139319427|NCT02479490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139319428|NCT02479490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319429|NCT02479490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319430|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139319431|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
139319432|NCT02479256|Tamoxifen|tamoxifen|mesh-list
139319433|NCT02479256|Citric Acid|citric acid|mesh-list
139319434|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
139319435|NCT02479256|Clomiphene|clomiphene|mesh-list
139319436|NCT02479256|Enclomiphene|enclomiphene|mesh-list
139319437|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
139319438|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
139319439|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139319440|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
139319441|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
139319442|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319443|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139319444|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
139319445|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139319446|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319447|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139319448|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319449|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139319450|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139319451|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139319452|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139319453|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
139319454|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139319455|NCT02482766|Poractant alfa|poractant alfa|mesh-list
139319456|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139319457|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
139319458|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
139319459|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
139319460|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139319461|NCT02479178|Docetaxel|docetaxel|mesh-list
139319462|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319463|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
139319464|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
139319465|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
139319466|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319467|NCT03314792|Oxycodone|oxycodone|mesh-list
139319468|NCT03314792|Tapentadol|tapentadol|mesh-list
139319469|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139319470|NCT03314792|Narcotics|narcotics|mesh-ancestor
139319471|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139319472|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319473|NCT03314792|Analgesics|analgesics|mesh-ancestor
139319474|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
139319475|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319476|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139319477|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139319478|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139319479|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319480|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
139319481|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319482|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
139319483|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139319484|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
139319485|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319486|NCT02476526|Expectorants|expectorants|mesh-ancestor
139319487|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
139319488|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139319489|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
139319490|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319491|NCT02476526|Protective Agents|protective agents|mesh-ancestor
139319492|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319493|NCT02476526|Antidotes|antidotes|mesh-ancestor
139319494|NCT02479022|Insulin|insulin|mesh-list
139319495|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139319496|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
139319497|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139319498|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319499|NCT02476760|Insulin|insulin|mesh-list
139319500|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139319501|NCT02476760|Metformin|metformin|mesh-list
139319502|NCT02476760|Pioglitazone|pioglitazone|mesh-list
139319503|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139319504|NCT02476760|Liraglutide|liraglutide|mesh-list
139319505|NCT02476760|Exenatide|exenatide|mesh-list
139319506|NCT02476760|Glimepiride|glimepiride|mesh-list
139319507|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
139319508|NCT02476760|Vildagliptin|vildagliptin|mesh-list
139319509|NCT02476760|Saxagliptin|saxagliptin|mesh-list
139319510|NCT02476760|Acarbose|acarbose|mesh-list
139319511|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139319512|NCT02476760|Repaglinide|repaglinide|mesh-list
139319513|NCT02476760|Gliclazide|gliclazide|mesh-list
139319514|NCT02476760|Glipizide|glipizide|mesh-list
139319515|NCT02476760|Biguanides|biguanides|mesh-list
139319516|NCT02476760|Tolbutamide|tolbutamide|mesh-list
139319517|NCT02476760|Voglibose|voglibose|mesh-list
139319518|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
139319519|NCT02476760|Nateglinide|nateglinide|mesh-list
139319520|NCT02476760|Miglitol|miglitol|mesh-list
139319521|NCT02476760|Troglitazone|troglitazone|mesh-list
139319522|NCT02476760|Meglitinide|meglitinide|mesh-list
139319523|NCT02476760|Acetohexamide|acetohexamide|mesh-list
139319524|NCT02476760|Buformin|buformin|mesh-list
139319525|NCT02476760|Phenformin|phenformin|mesh-list
139319526|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
139319527|NCT02476760|Glibornuride|glibornuride|mesh-list
139319528|NCT02476760|Tolazamide|tolazamide|mesh-list
139319529|NCT02476760|Carbutamide|carbutamide|mesh-list
139319530|NCT02476760|Gliquidone|gliquidone|mesh-list
139319531|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139319532|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
139319533|NCT02476760|Incretins|incretins|mesh-list
139319534|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319535|NCT02476760|Hormones|hormones|mesh-ancestor
139319536|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139319537|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
139319538|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319539|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319540|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139319541|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139319542|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139319543|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
139319544|NCT05460338|Cholecalciferol|cholecalciferol|mesh-list
139319545|NCT05460338|Vitamin D|vitamin d|mesh-list
139319546|NCT05460338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139319547|NCT05460338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319548|NCT05460338|Vitamins|vitamins|mesh-ancestor
139319549|NCT05460338|Micronutrients|micronutrients|mesh-ancestor
139319550|NCT05460338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139319551|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139319552|NCT02476136|Fluoxetine|fluoxetine|mesh-list
139319553|NCT02476136|Paroxetine|paroxetine|mesh-list
139319554|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139319555|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139319556|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139319557|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139319558|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319559|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319560|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319561|NCT02476136|Analgesics|analgesics|mesh-ancestor
139319562|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
139319563|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319564|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
139319565|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139319566|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
139319567|NCT02476136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139319568|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
139319569|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138911029|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
139319570|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139319571|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139319572|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319573|NCT05437094|Itraconazole|itraconazole|mesh-list
139319574|NCT05437094|Antifungal Agents|antifungal agents|mesh-ancestor
139319575|NCT05437094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319576|NCT05437094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139319577|NCT05437094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139319578|NCT05437094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319579|NCT05437094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319580|NCT05437094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139319581|NCT05437094|Hormone Antagonists|hormone antagonists|mesh-ancestor
139319582|NCT05437094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139319583|NCT05437094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319584|NCT05437094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139319585|NCT05413772|Temocillin|temocillin|mesh-list
139319586|NCT05413772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139319587|NCT05413772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319588|NCT05713292|Pirfenidone|pirfenidone|mesh-list
139319589|NCT05713292|Analgesics|analgesics|mesh-ancestor
139319590|NCT05713292|Sensory System Agents|sensory system agents|mesh-ancestor
139319591|NCT05713292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319592|NCT05713292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319593|NCT05713292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139319594|NCT05713292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139319595|NCT05713292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139319596|NCT05713292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139319597|NCT05713292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319598|NCT02475824|Midazolam|midazolam|mesh-list
139319599|NCT02475824|Meperidine|meperidine|mesh-list
139319600|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
139319601|NCT02475824|Propofol|propofol|mesh-list
139319602|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139319603|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139319604|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319605|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139319606|NCT02475824|Analgesics|analgesics|mesh-ancestor
139319607|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
139319608|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319609|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139319610|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139319611|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139319612|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
139319613|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319614|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319615|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139319616|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
139319617|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
139319618|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139319619|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139319620|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139319621|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139319622|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
139319623|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
139319624|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139319625|NCT02475824|Narcotics|narcotics|mesh-ancestor
139319626|NCT02478242|Nafamostat|nafamostat|mesh-list
139319627|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139319628|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139319629|NCT02478242|Analgesics|analgesics|mesh-ancestor
139319630|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
139319631|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319632|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319633|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139319634|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139319635|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
139319636|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
139319637|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319638|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319639|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139319640|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139319641|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139319642|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139319643|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
139319644|NCT02475746|Itraconazole|itraconazole|mesh-list
139319645|NCT02475746|PF-06372865|pf-06372865|mesh-list
139319646|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
139319647|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319648|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139319649|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139319650|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319651|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319652|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139319653|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
139319654|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139319655|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319656|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139319657|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
139319658|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
139319659|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319660|NCT05715164|Nicotine|nicotine|mesh-list
139319661|NCT05715164|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139319662|NCT05715164|Autonomic Agents|autonomic agents|mesh-ancestor
139319663|NCT05715164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319664|NCT05715164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319665|NCT05715164|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139319666|NCT05715164|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139319667|NCT05715164|Cholinergic Agents|cholinergic agents|mesh-ancestor
139319668|NCT05715164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319669|NCT05715164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319670|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
139319671|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139319672|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
139319673|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139319674|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319675|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139319676|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139319677|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139319678|NCT02480894|Maraviroc|maraviroc|mesh-list
139319679|NCT02480894|Fostemsavir|fostemsavir|mesh-list
139319680|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139319681|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139319682|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319683|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139319684|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139319685|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
139319686|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319687|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139319688|NCT02474654|Ketorolac|ketorolac|mesh-list
139319689|NCT02474654|Epinephrine|epinephrine|mesh-list
139319690|NCT02474654|Racepinephrine|racepinephrine|mesh-list
139319691|NCT02474654|Fentanyl|fentanyl|mesh-list
139319692|NCT02474654|Bupivacaine|bupivacaine|mesh-list
139319693|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
139319694|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
139319695|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
139319696|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139319697|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319698|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
139319699|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319700|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139319701|NCT02474654|Narcotics|narcotics|mesh-ancestor
139319702|NCT02474654|Analgesics|analgesics|mesh-ancestor
139319703|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139319704|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139319705|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
139319706|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139319707|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139319708|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
139319709|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319710|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319711|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139319712|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139319713|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
138976556|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
139319714|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139319715|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
139319716|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
139319717|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
139319718|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139319719|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139319720|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139319721|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139319722|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139319723|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139319724|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319725|NCT02477852|Rifampin|rifampin|mesh-list
139319726|NCT02477852|Isoniazid|isoniazid|mesh-list
139319727|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
139319728|NCT02477852|Ethambutol|ethambutol|mesh-list
139319729|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139319730|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
139319731|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139319732|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319733|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
139319734|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139319735|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319736|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319737|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139319738|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139319739|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139319740|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139319741|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139319742|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139319743|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139319744|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139319745|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
139319746|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139319747|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139319748|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139319749|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139319750|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319751|NCT02725268|Paclitaxel|paclitaxel|mesh-list
139319752|NCT02725268|Serabelisib|serabelisib|mesh-list
139319753|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139319754|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319755|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
139319757|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
139319758|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319759|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319760|NCT00705536|Insulin|insulin|mesh-list
139319761|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139319762|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
139319763|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139319764|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319765|NCT02474420|Amlodipine|amlodipine|mesh-list
139319766|NCT02474420|Deferasirox|deferasirox|mesh-list
139319767|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139319768|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139319769|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139319770|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319771|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139319772|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319773|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
139319774|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139319775|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
139319776|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
139319777|NCT02474186|Paclitaxel|paclitaxel|mesh-list
139319778|NCT02474186|Docetaxel|docetaxel|mesh-list
139319779|NCT02474186|Capecitabine|capecitabine|mesh-list
139319780|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139319781|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319782|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
139319783|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
139319784|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
139319785|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319786|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139319787|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
139319788|NCT02477306|Rabeprazole|rabeprazole|mesh-list
138976637|NCT00861926|Hormones|hormones|mesh-ancestor
139319789|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139319790|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139319791|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139319792|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319793|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319794|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
139319795|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139319796|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319797|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139319798|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
139319799|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139319800|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319801|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319802|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319803|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
139319804|NCT02472626|Cytarabine|cytarabine|mesh-list
139319805|NCT02472626|Daunorubicin|daunorubicin|mesh-list
139319806|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139319807|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
139319808|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319809|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319810|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
138911095|NCT00830804|Ritonavir|ritonavir|mesh-list
139319811|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319812|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139319813|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
139319814|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319815|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139319816|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139319817|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139319818|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319819|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
139319820|NCT02472626|Protective Agents|protective agents|mesh-ancestor
139319821|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
139319822|NCT02472626|Vitamins|vitamins|mesh-ancestor
139319823|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
139319824|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
139319825|NCT02472392|Melphalan|melphalan|mesh-list
139319826|NCT02472392|Busulfan|busulfan|mesh-list
139319827|NCT02472392|Fludarabine|fludarabine|mesh-list
139319828|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
139319829|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139319830|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139319831|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
139319832|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319833|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139319834|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139319835|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
139319836|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319837|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319838|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139319839|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
139319840|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139319841|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319842|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
139319843|NCT02472080|Gemcitabine|gemcitabine|mesh-list
139319844|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
139319845|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139319846|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
139319847|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319848|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319849|NCT02473562|Varenicline|varenicline|mesh-list
139319850|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139319851|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139319852|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
139319853|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319854|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319855|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319856|NCT02724020|Everolimus|everolimus|mesh-list
139319857|NCT02724020|Serabelisib|serabelisib|mesh-list
139319858|NCT02724020|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139319859|NCT02724020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139319860|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319861|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319862|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139319863|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
139319864|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319865|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319866|NCT02660034|Tislelizumab|tislelizumab|mesh-list
139319868|NCT02660034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139319869|NCT02660034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319870|NCT02660034|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139319871|NCT02660034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319872|NCT02660034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319873|NCT02816736|Valsartan|valsartan|mesh-list
139319874|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139319875|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139319876|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139319877|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139319878|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319879|NCT02477072|Heparin|heparin|mesh-list
139319880|NCT02477072|Calcium heparin|calcium heparin|mesh-list
139319881|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
139319882|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139319883|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139319884|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319885|NCT05103410|Aripiprazole|aripiprazole|mesh-list
139319886|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
139319887|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139319888|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139319889|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139319890|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139319891|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319892|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
139319893|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
139319894|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319895|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319896|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139319897|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139319898|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
139319899|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139319900|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139319901|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139319902|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139319903|NCT02472236|Digoxin|digoxin|mesh-list
139319904|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139319905|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139319906|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319907|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319908|NCT02472236|Protective Agents|protective agents|mesh-ancestor
139319909|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319910|NCT03108872|Anticoagulants|anticoagulants|mesh-list
139319911|NCT02194491|AS2471907|as2471907|mesh-list
139319912|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139319913|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319914|NCT03487770|Aripiprazole|aripiprazole|mesh-list
139319915|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139319916|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
139319917|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139319918|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139319919|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139319920|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139319921|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319922|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
139319923|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
139319924|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139319925|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319926|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138911126|NCT01024075|Hormones|hormones|mesh-ancestor
139319927|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139319928|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
139319929|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139319930|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139319931|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139319932|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139319933|NCT02473328|Ritonavir|ritonavir|mesh-list
139319934|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139319935|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139319936|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139319937|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
138976784|NCT00502996|Rituximab|rituximab|mesh-list
139319939|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319940|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139319941|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139319942|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
139319943|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139319944|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139319945|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139319946|NCT02473406|Thymalfasin|thymalfasin|mesh-list
139319947|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139319948|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
139319949|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319950|NCT02473094|Metformin|metformin|mesh-list
139319951|NCT02473094|Capecitabine|capecitabine|mesh-list
139319952|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139319953|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319954|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139319955|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
139319956|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319957|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319958|NCT03492138|Dexamethasone|dexamethasone|mesh-list
139319959|NCT03492138|Ixazomib|ixazomib|mesh-list
139319960|NCT03492138|TIC10 compound|tic10 compound|mesh-list
139319961|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139319962|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
139319963|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
139319964|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139319965|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319966|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139319967|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
139319968|NCT03492138|Hormones|hormones|mesh-ancestor
139319969|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139319970|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139319971|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319972|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
139319973|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139319974|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319975|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139319976|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
139319977|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139319978|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
139319979|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319980|NCT03131700|Bevacizumab|bevacizumab|mesh-list
139319981|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139319982|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319983|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138911139|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
139319984|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139319985|NCT03131700|Growth Substances|growth substances|mesh-ancestor
139319986|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319987|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
139319988|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
139319989|NCT04706936|Fludarabine|fludarabine|mesh-list
139319990|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139319991|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
139319992|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139319993|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139319994|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139319995|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
139319996|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139319997|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139319998|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139319999|NCT02194881|Ivacaftor|ivacaftor|mesh-list
139320000|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139320001|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139320002|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320003|NCT02194179|Nevirapine|nevirapine|mesh-list
139320004|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139320005|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139320006|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320007|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320008|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
139320009|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320010|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138976857|NCT00864812|Fluticasone|fluticasone|mesh-list
139320011|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139320012|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139320013|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139320014|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139320015|NCT02194257|Ambroxol|ambroxol|mesh-list
139320016|NCT02194257|Expectorants|expectorants|mesh-ancestor
139320017|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
139320018|NCT02195115|Amitriptyline|amitriptyline|mesh-list
139320019|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139320020|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
139320021|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139320022|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139320023|NCT02195115|Analgesics|analgesics|mesh-ancestor
139320024|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
139320025|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320026|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320027|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139320028|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139320029|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139176620|NCT01280929|Ranibizumab|ranibizumab|mesh-list
139320030|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320032|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139320033|NCT02194335|Olcegepant|olcegepant|mesh-list
139320034|NCT02194335|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139320035|NCT02194335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320036|NCT02194335|Analgesics|analgesics|mesh-ancestor
139320037|NCT02194335|Sensory System Agents|sensory system agents|mesh-ancestor
139320038|NCT02194335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320039|NCT02194335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320040|NCT02195973|Paclitaxel|paclitaxel|mesh-list
139320041|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139320042|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320043|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
139320044|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
139320045|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
139320046|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320047|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139320048|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
139320049|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320050|NCT02195271|Melatonin|melatonin|mesh-list
139320051|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
139320052|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320053|NCT02195271|Protective Agents|protective agents|mesh-ancestor
139320054|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320055|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320056|NCT02196285|Vaccines|vaccines|mesh-list
139320057|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
139320058|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320059|NCT04229979|Cytarabine|cytarabine|mesh-list
139320060|NCT04229979|Azacitidine|azacitidine|mesh-list
139320061|NCT04229979|Decitabine|decitabine|mesh-list
139320062|NCT04229979|Venetoclax|venetoclax|mesh-list
139320063|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139320064|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
139320065|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320066|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320067|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
139320068|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320069|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139320070|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
139320071|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320072|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320073|NCT02196441|Bupivacaine|bupivacaine|mesh-list
139320074|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
139320075|NCT02196441|Tetracaine|tetracaine|mesh-list
139320076|NCT02196441|Anesthetics|anesthetics|mesh-list
139320077|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320078|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320079|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
139320080|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320081|NCT02195661|Melatonin|melatonin|mesh-list
139320082|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
139320083|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
139320084|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320085|NCT02195661|Protective Agents|protective agents|mesh-ancestor
139320086|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320087|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320088|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139320090|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139320091|NCT02195817|Nalmefene|nalmefene|mesh-list
139320092|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139320093|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320094|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
139320095|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320096|NCT03534063|Analgesics, Opioid|analgesics, opioid|mesh-list
139320097|NCT03534063|Narcotics|narcotics|mesh-ancestor
139320098|NCT03534063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320099|NCT03534063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320100|NCT03534063|Analgesics|analgesics|mesh-ancestor
139320101|NCT03534063|Sensory System Agents|sensory system agents|mesh-ancestor
139320102|NCT03534063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320103|NCT02197143|Esomeprazole|esomeprazole|mesh-list
139320104|NCT02197143|Ranitidine|ranitidine|mesh-list
139320105|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139320106|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139320107|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139320108|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139320109|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320110|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320111|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139320112|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
139320113|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
139320114|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139320115|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320116|NCT02096874|Bevacizumab|bevacizumab|mesh-list
139320117|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139320118|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320119|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139320120|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139320121|NCT02096874|Growth Substances|growth substances|mesh-ancestor
139320122|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320123|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
139320124|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
139320125|NCT02198547|Ropivacaine|ropivacaine|mesh-list
139320126|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
139320127|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
139320128|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320129|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320130|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
139320131|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320132|NCT02198547|Analgesics|analgesics|mesh-ancestor
139320133|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139320134|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
139320135|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139320136|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139320137|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320138|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139320139|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
139320140|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139320141|NCT01024608|Beclomethasone|beclomethasone|mesh-list
139320142|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139320143|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
139320144|NCT01024608|Hormones|hormones|mesh-ancestor
139320145|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139320146|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320147|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139320148|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
139320149|NCT03489798|Alprostadil|alprostadil|mesh-list
139320150|NCT03489798|Misoprostol|misoprostol|mesh-list
139320151|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139320152|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
139320153|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139320154|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320155|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139320156|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139320157|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
139320158|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139320159|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
138977007|NCT04615624|Furosemide|furosemide|mesh-list
139320160|NCT03489798|Urological Agents|urological agents|mesh-ancestor
139320161|NCT02031081|Prucalopride|prucalopride|mesh-list
139320162|NCT02031081|Laxatives|laxatives|mesh-ancestor
139320163|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139320164|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139320165|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139320166|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
139320167|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139320168|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320169|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320170|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
139320171|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
139320172|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139320173|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320174|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320175|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
139320176|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139320177|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320178|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320179|NCT02199171|Carboplatin|carboplatin|mesh-list
139320180|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320181|NCT00910650|Aldesleukin|aldesleukin|mesh-list
139320182|NCT00910650|Interleukin-2|interleukin-2|mesh-list
139320183|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320184|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139320185|NCT00910650|Analgesics|analgesics|mesh-ancestor
139320186|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
139320187|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320188|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320189|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139320190|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139320191|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
139320192|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320193|NCT02199327|Interferons|interferons|mesh-list
139320194|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
139320195|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
139320196|NCT02199327|Mitomycins|mitomycins|mesh-list
139320197|NCT02199327|Mitomycin|mitomycin|mesh-list
139320198|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320199|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
139320200|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320201|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
139320202|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320203|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139320204|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
139320205|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320206|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139320207|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320208|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
139320209|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
139320210|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139320211|NCT02198001|Amoxicillin|amoxicillin|mesh-list
139320212|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
139320213|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
139320214|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139320215|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320216|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139320217|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320218|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320219|NCT05116800|Gemcitabine|gemcitabine|mesh-list
139320220|NCT05116800|Docetaxel|docetaxel|mesh-list
139320221|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139320222|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
139320223|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320224|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320225|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
139320226|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
139320227|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
139320228|NCT04078737|Aspirin|aspirin|mesh-list
139320229|NCT04078737|Clopidogrel|clopidogrel|mesh-list
139320230|NCT04078737|Ticagrelor|ticagrelor|mesh-list
139320231|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139320232|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139320233|NCT04078737|Analgesics|analgesics|mesh-ancestor
139320234|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
139320235|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320236|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320237|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139320238|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139320239|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139320240|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139320241|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320242|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139320243|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139320244|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320245|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
139320246|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139320247|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139320248|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139320249|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
139320250|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139320251|NCT03491904|Fasinumab|fasinumab|mesh-list
139320252|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139320253|NCT03491904|Analgesics|analgesics|mesh-ancestor
139320254|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
139320255|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320256|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320257|NCT02199951|Piperaquine|piperaquine|mesh-list
139320258|NCT02199951|Artenimol|artenimol|mesh-list
139320259|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
139320260|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139320261|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139320262|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320263|NCT03533361|Lenvatinib|lenvatinib|mesh-list
139320264|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320265|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139320266|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320267|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320268|NCT01433328|Lidocaine|lidocaine|mesh-list
139320269|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
139320270|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
139320271|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320272|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320273|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
139320274|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320275|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139320276|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139320277|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139320278|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139320279|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320280|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139320281|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139320282|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
139320283|NCT02200185|Morphine|morphine|mesh-list
139320284|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139320285|NCT02200185|Narcotics|narcotics|mesh-ancestor
139320286|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320287|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320288|NCT02200185|Analgesics|analgesics|mesh-ancestor
139320289|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
139320290|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320291|NCT02201043|Thalidomide|thalidomide|mesh-list
139320292|NCT02201043|Tolnaftate|tolnaftate|mesh-list
139320293|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139320294|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
139320295|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320296|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
139320297|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139320298|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911208|NCT00789321|Amlodipine|amlodipine|mesh-list
139320299|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139320300|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139320301|NCT02201043|Growth Substances|growth substances|mesh-ancestor
139320302|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
139320303|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320304|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
139320305|NCT02201121|Phenylephrine|phenylephrine|mesh-list
139320306|NCT02201121|Dopamine|dopamine|mesh-list
139320307|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
139320308|NCT02201121|Ephedrine|ephedrine|mesh-list
139320309|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139320310|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
139320311|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
139320312|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320313|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320314|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
139320315|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139320316|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
139320317|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
139320318|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139320319|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139320320|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139320321|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
139320322|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139320323|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320324|NCT02201121|Protective Agents|protective agents|mesh-ancestor
139320325|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139320326|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
139320327|NCT02200575|Telmisartan|telmisartan|mesh-list
139320328|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139320329|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139320330|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139320331|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320332|NCT02201199|Insulin|insulin|mesh-list
139320333|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139320334|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
139320335|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139320336|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320337|NCT02200653|Losartan|losartan|mesh-list
139320338|NCT02200653|Telmisartan|telmisartan|mesh-list
139320339|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139320340|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139320341|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139320342|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139320343|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320344|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139320345|NCT03999411|Nicotine|nicotine|mesh-list
139320346|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
139320347|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320348|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139320349|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
139320350|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320351|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320352|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139320353|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139320354|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
139320355|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139320356|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320357|NCT05261997|Metformin|metformin|mesh-list
139320358|NCT05261997|Acarbose|acarbose|mesh-list
139320359|NCT05261997|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139320360|NCT05261997|Pancreatin|pancreatin|mesh-list
139320361|NCT05261997|Pancrelipase|pancrelipase|mesh-list
139320362|NCT05261997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320363|NCT05261997|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139320364|NCT05261997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320365|NCT05261997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320366|NCT05261997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139320367|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
139320368|NCT02206425|Dexamethasone|dexamethasone|mesh-list
139320369|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
139320370|NCT02206425|Prednisone|prednisone|mesh-list
139320371|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
139320372|NCT02206425|Melphalan|melphalan|mesh-list
139320373|NCT02206425|Doxorubicin|doxorubicin|mesh-list
139320374|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139320375|NCT02206425|Lenalidomide|lenalidomide|mesh-list
139320376|NCT02206425|Pomalidomide|pomalidomide|mesh-list
139320377|NCT02206425|BB 1101|bb 1101|mesh-list
139320378|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139320379|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
139320380|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320381|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139320382|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139320383|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
139320384|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320385|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320386|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139320387|NCT02206425|Vitamins|vitamins|mesh-ancestor
139320388|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
139320389|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139320390|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
139320391|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
139320392|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320393|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139320394|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
139320395|NCT02206425|Hormones|hormones|mesh-ancestor
139320396|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139320397|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139320398|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
139320399|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320400|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139320401|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139320402|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139320403|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139320404|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139320405|NCT02206425|Growth Substances|growth substances|mesh-ancestor
139320406|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
139320407|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
139320408|NCT02206425|Protective Agents|protective agents|mesh-ancestor
139320409|NCT02201667|Aspirin|aspirin|mesh-list
139320410|NCT02201667|Clopidogrel|clopidogrel|mesh-list
139320411|NCT02201667|Ticagrelor|ticagrelor|mesh-list
139320412|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139320413|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139320414|NCT02201667|Analgesics|analgesics|mesh-ancestor
139320415|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
139320416|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320417|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320418|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139320419|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139320420|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139320421|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139320422|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320423|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139320424|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139320425|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320426|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
139320427|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139320428|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139320429|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139320430|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
139320431|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139320432|NCT02206503|Dexamethasone|dexamethasone|mesh-list
139320433|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
139320434|NCT02206503|Lenalidomide|lenalidomide|mesh-list
139320435|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139320436|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
139320437|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320438|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139320439|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139320440|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
139320441|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320442|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320443|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139320444|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139320445|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
139320446|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
139320447|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320448|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139320449|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
139320450|NCT02206503|Hormones|hormones|mesh-ancestor
139320451|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139320452|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139320453|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139320454|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139320455|NCT02206503|Growth Substances|growth substances|mesh-ancestor
139320456|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
139320457|NCT02206659|Telmisartan|telmisartan|mesh-list
139320458|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139320459|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139320460|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139320461|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320462|NCT02206737|Nicotine|nicotine|mesh-list
139320463|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139320464|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
139320465|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320466|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320467|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139320468|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139320469|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
139320470|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139320471|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320472|NCT03533127|Bevacizumab|bevacizumab|mesh-list
139176637|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139320473|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139320474|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320475|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139320476|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139320477|NCT03533127|Growth Substances|growth substances|mesh-ancestor
139320478|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320479|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
139320480|NCT02207361|Paclitaxel|paclitaxel|mesh-list
139320481|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139320482|NCT02207361|Carboplatin|carboplatin|mesh-list
139320483|NCT02207361|Epirubicin|epirubicin|mesh-list
139320484|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139320485|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320486|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
139320487|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
139320488|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
139320489|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320490|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139320491|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139320492|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139320493|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320494|NCT02202525|Telmisartan|telmisartan|mesh-list
139320495|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139320496|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139320497|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139320498|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320499|NCT02202603|Teriparatide|teriparatide|mesh-list
139320500|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139320501|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320502|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139320503|NCT02202993|Mibefradil|mibefradil|mesh-list
139320504|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139320505|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139320506|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139320507|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320508|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139320509|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320510|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
139320511|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139320512|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139320513|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320514|NCT02190357|Rifaximin|rifaximin|mesh-list
139320515|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139320516|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320517|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139320518|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
139320519|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
139320520|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139320521|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
139320522|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139320523|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320524|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139320525|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139320526|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139320527|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139320528|NCT02257671|Estrogens|estrogens|mesh-ancestor
139320529|NCT02257671|Hormones|hormones|mesh-ancestor
139320530|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139320531|NCT01460160|Dasatinib|dasatinib|mesh-list
139320532|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320533|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139320534|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320535|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320536|NCT02203227|Turmeric extract|turmeric extract|mesh-list
139320537|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
139320538|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320539|NCT02203227|Protective Agents|protective agents|mesh-ancestor
139320540|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320541|NCT01170702|Ropivacaine|ropivacaine|mesh-list
139320542|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
139320543|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
139320544|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320545|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320546|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
139320547|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320548|NCT02203461|Ritonavir|ritonavir|mesh-list
139320549|NCT02203461|Lopinavir|lopinavir|mesh-list
139320550|NCT02203461|Darunavir|darunavir|mesh-list
139320551|NCT02203461|Tenofovir|tenofovir|mesh-list
139320552|NCT02203461|Emtricitabine|emtricitabine|mesh-list
139320553|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139320554|NCT02203461|Cobicistat|cobicistat|mesh-list
139320555|NCT02203461|Elvitegravir|elvitegravir|mesh-list
139320556|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139320557|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139320558|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
139320559|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320560|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320561|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139320562|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139320563|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
139320564|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320565|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139320566|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139320567|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139320568|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139320569|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139320570|NCT02191059|Docetaxel|docetaxel|mesh-list
139320571|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320572|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
139320573|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
139320574|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
139320575|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320576|NCT02191215|Nevirapine|nevirapine|mesh-list
139320577|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138911304|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139320578|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139320579|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320580|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320581|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
139320582|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320583|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139320584|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139320585|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139320586|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139320587|NCT02209155|Verapamil|verapamil|mesh-list
139320588|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139320589|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139320590|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139320591|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320592|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139320593|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320594|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
139320595|NCT03485118|Rituximab|rituximab|mesh-list
139320596|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139320597|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320598|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
139320599|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320600|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139320601|NCT02191293|Nevirapine|nevirapine|mesh-list
139320602|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139320603|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139320604|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320605|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320606|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
139320607|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320608|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139320609|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139320610|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139320611|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139320612|NCT02880540|Fentanyl|fentanyl|mesh-list
139320613|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
139320615|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139320616|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320617|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320619|NCT02880540|Analgesics|analgesics|mesh-ancestor
139320620|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
139320621|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320622|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139320623|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139320624|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139320625|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
139320626|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139320627|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320628|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139320629|NCT02880540|Narcotics|narcotics|mesh-ancestor
139320630|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139320631|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139320632|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
139320633|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
139320634|NCT02191371|Propofol|propofol|mesh-list
139320635|NCT02191371|Desflurane|desflurane|mesh-list
139320636|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139320637|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320638|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320639|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139320640|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
139320641|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
139320642|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139320643|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
139320644|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139320645|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320646|NCT03532737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139320647|NCT03532737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320648|NCT02741388|Cytarabine|cytarabine|mesh-list
139320649|NCT02741388|Dexamethasone|dexamethasone|mesh-list
139320650|NCT02741388|Rituximab|rituximab|mesh-list
139320651|NCT02741388|Gemcitabine|gemcitabine|mesh-list
139320652|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
139320653|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139320654|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
139320655|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
139320656|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320657|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320658|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139320659|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
139320660|NCT02741388|Hormones|hormones|mesh-ancestor
139320661|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139320662|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139320663|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320664|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139320665|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
139320666|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139320667|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139320668|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
139320669|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320670|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
139320671|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320672|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139320673|NCT02191527|Chrysarobin|chrysarobin|mesh-list
139320674|NCT02191527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139320675|NCT02191527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139320676|NCT02191527|Analgesics|analgesics|mesh-ancestor
139320677|NCT02191527|Sensory System Agents|sensory system agents|mesh-ancestor
139320678|NCT02191527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320679|NCT02191527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320680|NCT02191527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139320681|NCT02191527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139320682|NCT03484962|Antibodies|antibodies|mesh-list
139320683|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139320684|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
139320685|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977542|NCT00532935|Hormones|hormones|mesh-ancestor
139320686|NCT01331616|Bevacizumab|bevacizumab|mesh-list
139320687|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139320688|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320689|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139320690|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139320691|NCT01331616|Growth Substances|growth substances|mesh-ancestor
139320692|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320693|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
139320695|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139320696|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320697|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139320698|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
139320699|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139320700|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139320701|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
139320702|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320703|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320704|NCT02204397|Ustekinumab|ustekinumab|mesh-list
139320705|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
139320707|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
139320708|NCT02192229|Vitamins|vitamins|mesh-ancestor
139320709|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
139320710|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320711|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139320712|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139320713|NCT02192463|Nevirapine|nevirapine|mesh-list
139320714|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139320715|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139320716|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320717|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320718|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
139320719|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320720|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139320721|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139320722|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139320723|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139320724|NCT02204475|Interferons|interferons|mesh-list
139320725|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139320726|NCT02204475|Grazoprevir|grazoprevir|mesh-list
139320727|NCT02204475|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139320728|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320729|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
139320730|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320731|NCT02210169|Vancomycin|vancomycin|mesh-list
139320732|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139320733|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320734|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
139320735|NCT02210949|Hematinics|hematinics|mesh-ancestor
139320736|NCT02204553|Panobinostat|panobinostat|mesh-list
139320737|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320738|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139320739|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320740|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320741|NCT01109004|Dexamethasone|dexamethasone|mesh-list
139320742|NCT01109004|Lenalidomide|lenalidomide|mesh-list
139320743|NCT01109004|Bortezomib|bortezomib|mesh-list
139320744|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139320745|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
139320746|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
139320747|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320748|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320749|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139320750|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
139320751|NCT01109004|Hormones|hormones|mesh-ancestor
139320752|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139320753|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139320754|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320755|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
139320756|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139320757|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139320758|NCT01109004|Growth Substances|growth substances|mesh-ancestor
139320759|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
139320760|NCT02211729|Azithromycin|azithromycin|mesh-list
138977615|NCT03016312|Atezolizumab|atezolizumab|mesh-list
139320761|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
139320762|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
139320763|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139320764|NCT02211729|Amodiaquine|amodiaquine|mesh-list
138726934|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
139320765|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139320766|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320767|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
139320768|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139320769|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139320770|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139320771|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320772|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320773|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139320774|NCT05151510|Lidocaine|lidocaine|mesh-list
139320775|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
139320776|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
139320777|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320778|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320779|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
139320780|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320781|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139320782|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139320783|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139320784|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139320785|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320786|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
139320787|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139320788|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139320789|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320790|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
139320791|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139320792|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320793|NCT03484650|Lidocaine|lidocaine|mesh-list
139320794|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
139320795|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
139320796|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320797|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320798|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
139320799|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320800|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139320801|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139320802|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139320803|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139320804|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320805|NCT02192697|Naquotinib|naquotinib|mesh-list
139320806|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320807|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139320808|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320809|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320810|NCT05153928|Norethindrone|norethindrone|mesh-list
139320811|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
139320812|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139320813|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139320814|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139320815|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
139320816|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139320817|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320818|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139320819|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139320820|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
139320821|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139320822|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320823|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139176648|NCT01268995|Cyclosporine|cyclosporine|mesh-list
139320824|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139320825|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320826|NCT02192853|Incretins|incretins|mesh-ancestor
139320827|NCT02192853|Hormones|hormones|mesh-ancestor
139320828|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139176659|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
139320829|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139320831|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320832|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320833|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
139320834|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320835|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
139320836|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
139320837|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
139320838|NCT04574154|Anesthetics|anesthetics|mesh-list
139320839|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320840|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320841|NCT03484416|Vitamin D|vitamin d|mesh-list
139320842|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
139320843|NCT03484416|Calcium|calcium|mesh-list
139320844|NCT03484416|Vitamins|vitamins|mesh-ancestor
139320845|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
139320846|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320847|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139320848|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139320849|NCT03484416|Antacids|antacids|mesh-ancestor
139320850|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320851|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139320852|NCT02205255|Azithromycin|azithromycin|mesh-list
139320853|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139320854|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320855|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
139320856|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139320857|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
139320858|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320859|NCT03476772|Nalbuphine|nalbuphine|mesh-list
139320860|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139320861|NCT03476772|Narcotics|narcotics|mesh-ancestor
139320862|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320863|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320864|NCT03476772|Analgesics|analgesics|mesh-ancestor
139320865|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
139320866|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320867|NCT03535233|Triamcinolone|triamcinolone|mesh-list
139320868|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139320869|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139320870|NCT03535233|Clobetasol|clobetasol|mesh-list
139320871|NCT03535233|Minoxidil|minoxidil|mesh-list
139320872|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139320873|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139320874|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
139320875|NCT03535233|Hormones|hormones|mesh-ancestor
139320876|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139320877|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320878|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139320879|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
139320880|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320881|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320882|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139320883|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
139320884|NCT02205489|Cetirizine|cetirizine|mesh-list
139320885|NCT02205489|Acyclovir|acyclovir|mesh-list
139320886|NCT02205489|Ibuprofen|ibuprofen|mesh-list
139320887|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
139320888|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139320889|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139320890|NCT02205489|Prednisolone|prednisolone|mesh-list
139320891|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
139320892|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
139320893|NCT02205489|Esomeprazole|esomeprazole|mesh-list
139320894|NCT02205489|Ranitidine|ranitidine|mesh-list
139320895|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139320896|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
139320897|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139320898|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139320899|NCT02205489|Analgesics|analgesics|mesh-ancestor
139320900|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
139320901|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320902|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320903|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139320904|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139320905|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139320906|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320907|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320908|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
139176965|NCT03868969|Fosfomycin|fosfomycin|mesh-list
139320909|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
139320910|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139320911|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
139320912|NCT02205489|Hormones|hormones|mesh-ancestor
139320913|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139320914|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139320916|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139320917|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320918|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139320919|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139320920|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139320921|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
139320922|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139320923|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139320924|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139320925|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139320926|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
139320927|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
139320928|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139320929|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139320930|NCT02523846|Morphine|morphine|mesh-list
139320931|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139320932|NCT02523846|Narcotics|narcotics|mesh-ancestor
139320933|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139320934|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320935|NCT02523846|Analgesics|analgesics|mesh-ancestor
139320936|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
139320937|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320938|NCT03484260|Testosterone|testosterone|mesh-list
139320939|NCT03484260|Androgens|androgens|mesh-ancestor
139320940|NCT03484260|Hormones|hormones|mesh-ancestor
139320941|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139320942|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320943|NCT05195775|Tadalafil|tadalafil|mesh-list
139320944|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
139320945|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139320946|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139320947|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320948|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320949|NCT05195775|Urological Agents|urological agents|mesh-ancestor
139320950|NCT03480906|Latanoprost|latanoprost|mesh-list
139320951|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139320952|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139320953|NCT05262465|Azacitidine|azacitidine|mesh-list
139320954|NCT05262465|Venetoclax|venetoclax|mesh-list
139320955|NCT05262465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139320956|NCT05262465|Antimetabolites|antimetabolites|mesh-ancestor
139320957|NCT05262465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320958|NCT05262465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320959|NCT05262465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320960|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
139320961|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139320962|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
139320963|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320964|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
139320965|NCT02220621|Protective Agents|protective agents|mesh-ancestor
139320966|NCT04370418|Fluorouracil|fluorouracil|mesh-list
139320967|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
139320968|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320969|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139320970|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139320971|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139320972|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
139320973|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320974|NCT02220777|Omeprazole|omeprazole|mesh-list
139320975|NCT02220777|ASP8477|asp8477|mesh-list
139320976|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139320977|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139320978|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139320979|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139320980|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320981|NCT03476616|Valsartan|valsartan|mesh-list
139320982|NCT03476616|Eplerenone|eplerenone|mesh-list
139320983|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139320984|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139320985|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139320986|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139320987|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138977849|NCT00868010|Donepezil|donepezil|mesh-list
139320988|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
139320989|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139320990|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320991|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139320992|NCT03476616|Diuretics|diuretics|mesh-ancestor
139320993|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
139320995|NCT02205879|Analgesics|analgesics|mesh-ancestor
139320996|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
139320997|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139320998|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139320999|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
139321000|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139321001|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139177252|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139321002|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321003|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139321004|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139321005|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139321006|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321007|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139321008|NCT03483948|Azacitidine|azacitidine|mesh-list
138911401|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
139321009|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139321010|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
139321011|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321012|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321013|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321014|NCT03483870|Morphine|morphine|mesh-list
139321015|NCT03483870|Granisetron|granisetron|mesh-list
139321016|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139321017|NCT03483870|Narcotics|narcotics|mesh-ancestor
139321018|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321019|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321020|NCT03483870|Analgesics|analgesics|mesh-ancestor
139321021|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
139321022|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321023|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
139321024|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
139321025|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139321026|NCT03483870|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139321027|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139321028|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
139321029|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321030|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321031|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
139321032|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139321033|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321034|NCT03480516|Fluorides|fluorides|mesh-list
139321035|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
139321036|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
139321037|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
139321038|NCT03480516|Protective Agents|protective agents|mesh-ancestor
139321039|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321040|NCT02221401|Metformin|metformin|mesh-list
139321041|NCT02221401|Linagliptin|linagliptin|mesh-list
139321042|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139321043|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321044|NCT02221401|Incretins|incretins|mesh-ancestor
139321045|NCT02221401|Hormones|hormones|mesh-ancestor
139321046|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139321047|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139321048|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
139321049|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321050|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321051|NCT03483636|Lemborexant|lemborexant|mesh-list
139321052|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139321053|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321054|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321055|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139321056|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139321057|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321058|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321059|NCT02221479|Plerixafor|plerixafor|mesh-list
139321060|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139321061|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139321062|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
139321063|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139177496|NCT01284907|Vitamin D|vitamin d|mesh-list
139321064|NCT02221635|Risperidone|risperidone|mesh-list
139321065|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139321066|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
139321067|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321068|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321069|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321070|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138911414|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
139321071|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139321072|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321073|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139321074|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139321075|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
139321076|NCT02723864|Veliparib|veliparib|mesh-list
139321077|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321078|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139321079|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321080|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321081|NCT02225067|Calcium|calcium|mesh-list
139321082|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139321083|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321084|NCT03475758|Goserelin|goserelin|mesh-list
139321085|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139321086|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321087|NCT02231385|Acetic Acid|acetic acid|mesh-list
139321088|NCT02231385|Retinol acetate|retinol acetate|mesh-list
139321089|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139321090|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321091|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139321092|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
139321093|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321094|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139321095|NCT02231385|Protective Agents|protective agents|mesh-ancestor
139321096|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321097|NCT02523768|Basiliximab|basiliximab|mesh-list
139321098|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139321099|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
139321100|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321101|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139321102|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
139321103|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139321104|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321105|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
139321106|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139321107|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321108|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321110|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321111|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139321112|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321113|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321114|NCT03475680|Gentamicins|gentamicins|mesh-list
139321115|NCT03475680|Ornidazole|ornidazole|mesh-list
139321116|NCT03475680|Sennosides|sennosides|mesh-list
139321117|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139321118|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321119|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139321120|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321121|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321122|NCT03475680|Laxatives|laxatives|mesh-ancestor
139321123|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139321124|NCT03475680|Amebicides|amebicides|mesh-ancestor
139321125|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139321126|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139321127|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139321128|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139321129|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139321130|NCT03475524|Metformin|metformin|mesh-list
139321131|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139321132|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321133|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
139321134|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139321135|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139321136|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139321137|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139321138|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321139|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
139321140|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321141|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321142|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139177743|NCT01174927|Analgesics|analgesics|mesh-ancestor
139321143|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321144|NCT02471846|Atezolizumab|atezolizumab|mesh-list
139321145|NCT02471846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139321146|NCT02471846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321147|NCT02471846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139321148|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321149|NCT02472782|Teriparatide|teriparatide|mesh-list
139321150|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139321151|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321152|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139321153|NCT02258607|Trametinib|trametinib|mesh-list
139321154|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
139321155|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321156|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139321157|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321158|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321159|NCT03792750|Nivolumab|nivolumab|mesh-list
139321160|NCT03792750|Linrodostat|linrodostat|mesh-list
139321161|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139321162|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321163|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139321164|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321165|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321166|NCT02258763|Amoxicillin|amoxicillin|mesh-list
139321167|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
139321168|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
139321169|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139321170|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139321171|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321172|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139321173|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321174|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321175|NCT02469974|Busulfan|busulfan|mesh-list
139321176|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
139321177|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321178|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
139321179|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321180|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139321181|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139321182|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321183|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139321184|NCT03131622|Coal Tar|coal tar|mesh-list
139321185|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
139321186|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
139321187|NCT03482544|Pregabalin|pregabalin|mesh-list
139177843|NCT01179529|Omalizumab|omalizumab|mesh-list
139321189|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
139321190|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321191|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321192|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
139321193|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139321194|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139321195|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321196|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139321197|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139321198|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139321199|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321200|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139321201|NCT02750709|Nitisinone|nitisinone|mesh-list
139321202|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321203|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321204|NCT02222649|Vitamin D|vitamin d|mesh-list
139321205|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
139321206|NCT02222649|Vitamins|vitamins|mesh-ancestor
139321207|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
139321208|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321209|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139321210|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139321211|NCT02222727|Donepezil|donepezil|mesh-list
138978064|NCT00485134|Vaccines|vaccines|mesh-list
139321212|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139321213|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321214|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321215|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
139321216|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321217|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321218|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
139321219|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
139321220|NCT02723786|Azathioprine|azathioprine|mesh-list
139321221|NCT02723786|Tacrolimus|tacrolimus|mesh-list
139321222|NCT02723786|Basiliximab|basiliximab|mesh-list
139321223|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139321224|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
139321225|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321226|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139321227|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321228|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321229|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139321230|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321231|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139321232|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
139321233|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139321234|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321235|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
139321236|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139321237|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139321238|NCT03310736|Hepcidins|hepcidins|mesh-list
139321239|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321240|NCT02226783|Omeprazole|omeprazole|mesh-list
139321241|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139321242|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139321243|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139321244|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321245|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321246|NCT03482232|Acetaminophen|acetaminophen|mesh-list
139321247|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139321248|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139321249|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
139321250|NCT03482232|Ibuprofen|ibuprofen|mesh-list
139321251|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139321252|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139321253|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
139321254|NCT03482232|Expectorants|expectorants|mesh-list
139321255|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
139321256|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139321257|NCT03482232|Analgesics|analgesics|mesh-ancestor
139321258|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
139321259|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321260|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321261|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139321262|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139321263|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321264|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321265|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
139321266|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
139321267|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139321268|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
139321269|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139321271|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
139321272|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321273|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
139321274|NCT02227173|Digoxin|digoxin|mesh-list
139321275|NCT02227173|Montelukast|montelukast|mesh-list
139321276|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139321277|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
139321278|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139321279|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
139321280|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139321281|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321282|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139321283|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139321284|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321285|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139321286|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139321287|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321288|NCT02227173|Protective Agents|protective agents|mesh-ancestor
139321290|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
139321291|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321292|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139321293|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139321294|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139321295|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139321296|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139321297|NCT02469740|Clopidogrel|clopidogrel|mesh-list
139321298|NCT02469740|Ticagrelor|ticagrelor|mesh-list
139321299|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139321300|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139321301|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139321302|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139321303|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
139321304|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321305|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321306|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321307|NCT04432220|Apixaban|apixaban|mesh-list
139321308|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139321309|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
139321310|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139321311|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
139321312|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321313|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321314|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
139321315|NCT04405622|Gemcitabine|gemcitabine|mesh-list
139321316|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139321317|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
139321318|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321319|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321321|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
139321322|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
139321323|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321324|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
139321325|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321326|NCT02750943|Fluorides|fluorides|mesh-list
139321327|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
139321328|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
139321329|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
139321330|NCT02750943|Protective Agents|protective agents|mesh-ancestor
139321331|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321332|NCT03481920|Avelumab|avelumab|mesh-list
139321333|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139321334|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321335|NCT02227797|Voriconazole|voriconazole|mesh-list
139321336|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
139321337|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321338|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139321339|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139321340|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321341|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321342|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139321343|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
139321344|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139321345|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321346|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139321347|NCT05783778|Testosterone|testosterone|mesh-list
139321348|NCT05783778|Androgens|androgens|mesh-ancestor
139321349|NCT05783778|Hormones|hormones|mesh-ancestor
139321350|NCT05783778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139321351|NCT05783778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321352|NCT05783557|Clevidipine|clevidipine|mesh-list
139321353|NCT05783557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139321354|NCT05783557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139321355|NCT05783557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321356|NCT05783557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139321357|NCT05783557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321358|NCT05783518|Propofol|propofol|mesh-list
139321359|NCT05783518|Desflurane|desflurane|mesh-list
139321360|NCT05783518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138978209|NCT00996177|Fentanyl|fentanyl|mesh-list
139321361|NCT05783518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321362|NCT05783518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321363|NCT05783518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139321364|NCT05783518|Anesthetics, General|anesthetics, general|mesh-ancestor
139321365|NCT05783518|Anesthetics|anesthetics|mesh-ancestor
139321366|NCT05783518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139321367|NCT05783492|Ketamine|ketamine|mesh-list
139321368|NCT05783492|Analgesics|analgesics|mesh-ancestor
139321369|NCT05783492|Sensory System Agents|sensory system agents|mesh-ancestor
139321370|NCT05783492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321371|NCT05783492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321372|NCT05783492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139321373|NCT05783492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139321374|NCT05783492|Anesthetics, General|anesthetics, general|mesh-ancestor
139321375|NCT05783492|Anesthetics|anesthetics|mesh-ancestor
139321376|NCT05783492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321377|NCT05783492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139321378|NCT05783492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138911469|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
139321379|NCT05783492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321380|NCT05783492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321382|NCT05783479|Hyaluronic Acid|hyaluronic acid|mesh-list
139321383|NCT05783479|Estrogens|estrogens|mesh-ancestor
139321384|NCT05783479|Hormones|hormones|mesh-ancestor
139321385|NCT05783479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139321386|NCT05783479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321387|NCT05783479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139321388|NCT05783479|Immunologic Factors|immunologic factors|mesh-ancestor
139321389|NCT05783479|Viscosupplements|viscosupplements|mesh-ancestor
139321390|NCT05783479|Protective Agents|protective agents|mesh-ancestor
139321391|NCT05783453|Emollients|emollients|mesh-list
139321392|NCT05783453|Dermatologic Agents|dermatologic agents|mesh-ancestor
139321393|NCT05782933|Rituximab|rituximab|mesh-list
139321394|NCT05782933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139321395|NCT05782933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321396|NCT05782933|Immunologic Factors|immunologic factors|mesh-ancestor
139321397|NCT05782933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321398|NCT05782933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139321399|NCT05782920|Hyaluronic Acid|hyaluronic acid|mesh-list
139321400|NCT05782920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139321401|NCT05782920|Immunologic Factors|immunologic factors|mesh-ancestor
139321402|NCT05782920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321403|NCT05782920|Viscosupplements|viscosupplements|mesh-ancestor
139321404|NCT05782920|Protective Agents|protective agents|mesh-ancestor
139321405|NCT05782777|Ezetimibe|ezetimibe|mesh-list
139321406|NCT05782777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139321407|NCT05782777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139321408|NCT05782777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139321409|NCT05782777|Antimetabolites|antimetabolites|mesh-ancestor
139321410|NCT05782777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321411|NCT05782777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139321412|NCT05782777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321413|NCT05782764|Endostar protein|endostar protein|mesh-list
139321414|NCT05782764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139321415|NCT05782764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139321416|NCT05782764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139321417|NCT05782764|Growth Substances|growth substances|mesh-ancestor
139321418|NCT05782764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321419|NCT05782764|Growth Inhibitors|growth inhibitors|mesh-ancestor
139321420|NCT05782764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321421|NCT05782764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321422|NCT05782764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139321423|NCT05782751|Mitogens|mitogens|mesh-list
139321424|NCT05782751|Mitosis Modulators|mitosis modulators|mesh-ancestor
139321425|NCT05782751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321426|NCT05781074|Lenvatinib|lenvatinib|mesh-list
139321427|NCT05781074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321428|NCT05781074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139321429|NCT05781074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321430|NCT05781074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321431|NCT05780541|Remdesivir|remdesivir|mesh-list
139321432|NCT05780541|Antimetabolites|antimetabolites|mesh-ancestor
139321433|NCT05780541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321434|NCT05780541|Antiviral Agents|antiviral agents|mesh-ancestor
139321435|NCT05780541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321436|NCT05780463|Remdesivir|remdesivir|mesh-list
139321437|NCT05780463|Antimetabolites|antimetabolites|mesh-ancestor
139321438|NCT05780463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321439|NCT05780463|Antiviral Agents|antiviral agents|mesh-ancestor
139321440|NCT05780463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321441|NCT05779657|Midazolam|midazolam|mesh-list
139321442|NCT05779657|Ketamine|ketamine|mesh-list
139321443|NCT05779657|Analgesics|analgesics|mesh-ancestor
139321444|NCT05779657|Sensory System Agents|sensory system agents|mesh-ancestor
139321445|NCT05779657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321446|NCT05779657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321447|NCT05779657|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139321448|NCT05779657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139321449|NCT05779657|Anesthetics, General|anesthetics, general|mesh-ancestor
139321450|NCT05779657|Anesthetics|anesthetics|mesh-ancestor
139321451|NCT05779657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321452|NCT05779657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139321453|NCT05779657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139321454|NCT05779657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321455|NCT05779657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321456|NCT05779657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139321457|NCT05779657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139321458|NCT05779657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139321459|NCT05779657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139321460|NCT05779657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139321461|NCT05779657|GABA Modulators|gaba modulators|mesh-ancestor
139321462|NCT05779657|GABA Agents|gaba agents|mesh-ancestor
139321463|NCT05774054|Norepinephrine|norepinephrine|mesh-list
139321464|NCT05774054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139321465|NCT05774054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139321466|NCT05774054|Adrenergic Agents|adrenergic agents|mesh-ancestor
139321467|NCT05774054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321468|NCT05774054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321469|NCT05774054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321470|NCT05774054|Sympathomimetics|sympathomimetics|mesh-ancestor
139321471|NCT05774054|Autonomic Agents|autonomic agents|mesh-ancestor
139321472|NCT05774054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321473|NCT05774054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139321474|NCT05751148|Bupivacaine|bupivacaine|mesh-list
139321475|NCT05751148|Prilocaine|prilocaine|mesh-list
139321476|NCT05751148|Anesthetics, Local|anesthetics, local|mesh-ancestor
139321477|NCT05751148|Anesthetics|anesthetics|mesh-ancestor
139321478|NCT05751148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321479|NCT05751148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321480|NCT05751148|Sensory System Agents|sensory system agents|mesh-ancestor
139321481|NCT05751148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321482|NCT05711199|Nitroglycerin|nitroglycerin|mesh-list
139321483|NCT05711199|Vasodilator Agents|vasodilator agents|mesh-ancestor
139321484|NCT05703971|Atezolizumab|atezolizumab|mesh-list
139321485|NCT05703971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139321486|NCT05703971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321487|NCT05703971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139321488|NCT05703971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321489|NCT05703074|Niacinamide|niacinamide|mesh-list
139321490|NCT05703074|Niacin|niacin|mesh-list
139321491|NCT05703074|Nicotinic Acids|nicotinic acids|mesh-list
139321492|NCT05703074|Vitamin B Complex|vitamin b complex|mesh-ancestor
139321493|NCT05703074|Vitamins|vitamins|mesh-ancestor
139321494|NCT05703074|Micronutrients|micronutrients|mesh-ancestor
139321495|NCT05703074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321496|NCT05703074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139321497|NCT05703074|Antimetabolites|antimetabolites|mesh-ancestor
139321498|NCT05703074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321499|NCT05703074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139321500|NCT05703074|Vasodilator Agents|vasodilator agents|mesh-ancestor
139321501|NCT05701865|Ethanol|ethanol|mesh-list
139321502|NCT05701865|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139321503|NCT05701865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321504|NCT05701865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321505|NCT05701865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321506|NCT05701345|Antidepressive Agents|antidepressive agents|mesh-list
139321507|NCT05701345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139321508|NCT05674721|Ibuprofen|ibuprofen|mesh-list
139321509|NCT05674721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138978356|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
139321510|NCT05674721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139321511|NCT05674721|Analgesics|analgesics|mesh-ancestor
139321512|NCT05674721|Sensory System Agents|sensory system agents|mesh-ancestor
139321513|NCT05674721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321514|NCT05674721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321515|NCT05674721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139321516|NCT05674721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139321517|NCT05674721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139321518|NCT05674721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321519|NCT05674721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321520|NCT05664464|Sulfasalazine|sulfasalazine|mesh-list
139321521|NCT05664464|Temozolomide|temozolomide|mesh-list
139321522|NCT05664464|Gabapentin|gabapentin|mesh-list
139321523|NCT05664464|Memantine|memantine|mesh-list
139321524|NCT05664464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139321525|NCT05664464|Alkylating Agents|alkylating agents|mesh-ancestor
139321526|NCT05664464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321527|NCT05664464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321528|NCT05664464|Analgesics|analgesics|mesh-ancestor
139321529|NCT05664464|Sensory System Agents|sensory system agents|mesh-ancestor
139321530|NCT05664464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321531|NCT05664464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321532|NCT05664464|Anticonvulsants|anticonvulsants|mesh-ancestor
139321533|NCT05664464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139321534|NCT05664464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139321535|NCT05664464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321536|NCT05664464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139321537|NCT05664464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139321538|NCT05664464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139321539|NCT05664464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321540|NCT05664464|Antimanic Agents|antimanic agents|mesh-ancestor
139321541|NCT05664464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139321542|NCT05664464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139321543|NCT05664464|Dopamine Agents|dopamine agents|mesh-ancestor
139321544|NCT05664464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321545|NCT05664464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139321546|NCT05664464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139321547|NCT05664464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139321548|NCT05664464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139321549|NCT05664464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139321550|NCT05657457|Tenecteplase|tenecteplase|mesh-list
139321551|NCT05657457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139321552|NCT05657457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139321553|NCT05657457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321554|NCT05630989|Hydroxychloroquine|hydroxychloroquine|mesh-list
139321555|NCT05630989|Mitogens|mitogens|mesh-list
139321556|NCT05630989|Antimalarials|antimalarials|mesh-ancestor
139321557|NCT05630989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139321558|NCT05630989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139321559|NCT05630989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321560|NCT05630989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321561|NCT05630989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321562|NCT05630989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139321563|NCT05630989|Mitosis Modulators|mitosis modulators|mesh-ancestor
139321564|NCT05626530|Letermovir|letermovir|mesh-list
139321565|NCT05626530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139321566|NCT05626530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321567|NCT05626530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321568|NCT05626530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321569|NCT05626530|Antiviral Agents|antiviral agents|mesh-ancestor
139321570|NCT05626530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321571|NCT05601674|Anesthetics|anesthetics|mesh-list
139321572|NCT05601674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321573|NCT05601674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321574|NCT05527314|Fentanyl|fentanyl|mesh-list
139321575|NCT05527314|Remifentanil|remifentanil|mesh-list
139321576|NCT05527314|Sevoflurane|sevoflurane|mesh-list
139321577|NCT05527314|Cisatracurium|cisatracurium|mesh-list
139321578|NCT05527314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139321579|NCT05527314|Narcotics|narcotics|mesh-ancestor
139321580|NCT05527314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321581|NCT05527314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321582|NCT05527314|Analgesics|analgesics|mesh-ancestor
139321583|NCT05527314|Sensory System Agents|sensory system agents|mesh-ancestor
139321584|NCT05527314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321585|NCT05527314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139321586|NCT05527314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139321587|NCT05527314|Anesthetics, General|anesthetics, general|mesh-ancestor
139321589|NCT05527314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139321590|NCT05527314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139321591|NCT05527314|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139321592|NCT05527314|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139321593|NCT05484505|Nicotine|nicotine|mesh-list
139321594|NCT05484505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139321595|NCT05484505|Autonomic Agents|autonomic agents|mesh-ancestor
139321596|NCT05484505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321597|NCT05484505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321598|NCT05484505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139321599|NCT05484505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139321600|NCT05484505|Cholinergic Agents|cholinergic agents|mesh-ancestor
139321601|NCT05484505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321602|NCT05484505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321603|NCT05478161|Fexofenadine|fexofenadine|mesh-list
139321604|NCT05478161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139321605|NCT05478161|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139321606|NCT05478161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139321607|NCT05478161|Histamine Antagonists|histamine antagonists|mesh-ancestor
139321608|NCT05478161|Histamine Agents|histamine agents|mesh-ancestor
139321609|NCT05478161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321610|NCT05478161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321611|NCT05478161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321612|NCT05476822|Antibodies|antibodies|mesh-list
139321613|NCT05476822|Immunologic Factors|immunologic factors|mesh-ancestor
139321614|NCT05476822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321615|NCT05473364|Acetazolamide|acetazolamide|mesh-list
139321616|NCT05473364|Anticonvulsants|anticonvulsants|mesh-ancestor
139321617|NCT05473364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139321618|NCT05473364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321619|NCT05473364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321620|NCT05473364|Diuretics|diuretics|mesh-ancestor
139321621|NCT05473364|Natriuretic Agents|natriuretic agents|mesh-ancestor
139321622|NCT05473364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321623|NCT05413811|Fluorouracil|fluorouracil|mesh-list
139321624|NCT05413811|Antimetabolites|antimetabolites|mesh-ancestor
139321625|NCT05413811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321626|NCT05413811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139321627|NCT05413811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321628|NCT05413811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139321629|NCT05413811|Immunologic Factors|immunologic factors|mesh-ancestor
139321630|NCT05413811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321631|NCT05393804|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
139321632|NCT05393804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139321633|NCT05393804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321634|NCT05382494|Mometasone Furoate|mometasone furoate|mesh-list
139321635|NCT05382494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139321636|NCT05382494|Dermatologic Agents|dermatologic agents|mesh-ancestor
139321637|NCT05382494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139321638|NCT05351346|Prednisone|prednisone|mesh-list
139321639|NCT05351346|Cyclophosphamide|cyclophosphamide|mesh-list
139321640|NCT05351346|Rituximab|rituximab|mesh-list
139321641|NCT05351346|Doxorubicin|doxorubicin|mesh-list
139321642|NCT05351346|Vincristine|vincristine|mesh-list
139321643|NCT05351346|Lenalidomide|lenalidomide|mesh-list
139321644|NCT05351346|Decitabine|decitabine|mesh-list
139321645|NCT05351346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139321646|NCT05351346|Immunologic Factors|immunologic factors|mesh-ancestor
139321647|NCT05351346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321648|NCT05351346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139321649|NCT05351346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139321650|NCT05351346|Alkylating Agents|alkylating agents|mesh-ancestor
139321651|NCT05351346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321652|NCT05351346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321653|NCT05351346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139321654|NCT05351346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139321655|NCT05351346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139321656|NCT05351346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139321657|NCT05351346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139321658|NCT05351346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321659|NCT05351346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139321660|NCT05351346|Glucocorticoids|glucocorticoids|mesh-ancestor
139321661|NCT05351346|Hormones|hormones|mesh-ancestor
139321662|NCT05351346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139321663|NCT05351346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139321664|NCT05351346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139321665|NCT05351346|Tubulin Modulators|tubulin modulators|mesh-ancestor
139321666|NCT05351346|Antimitotic Agents|antimitotic agents|mesh-ancestor
139321667|NCT05351346|Mitosis Modulators|mitosis modulators|mesh-ancestor
139321668|NCT05351346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139321669|NCT05351346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139321670|NCT05351346|Growth Substances|growth substances|mesh-ancestor
139321671|NCT05351346|Growth Inhibitors|growth inhibitors|mesh-ancestor
139321672|NCT05351346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139321673|NCT05351346|Antimetabolites|antimetabolites|mesh-ancestor
139321674|NCT05323019|Ketamine|ketamine|mesh-list
139321675|NCT05323019|Esketamine|esketamine|mesh-list
139321676|NCT05323019|Analgesics|analgesics|mesh-ancestor
139321677|NCT05323019|Sensory System Agents|sensory system agents|mesh-ancestor
139321678|NCT05323019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321679|NCT05323019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321680|NCT05323019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139321681|NCT05323019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139321682|NCT05323019|Anesthetics, General|anesthetics, general|mesh-ancestor
139321683|NCT05323019|Anesthetics|anesthetics|mesh-ancestor
139321684|NCT05323019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321685|NCT05323019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139321686|NCT05323019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139321687|NCT05323019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321688|NCT05323019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321689|NCT05323019|Antidepressive Agents|antidepressive agents|mesh-ancestor
139321690|NCT05323019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139321691|NCT05276258|Bupivacaine|bupivacaine|mesh-list
139321692|NCT05276258|Anesthetics, Local|anesthetics, local|mesh-ancestor
139321693|NCT05276258|Anesthetics|anesthetics|mesh-ancestor
139321694|NCT05276258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139321695|NCT05276258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321696|NCT05276258|Sensory System Agents|sensory system agents|mesh-ancestor
139321697|NCT05276258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321698|NCT06145126|Prednisolone|prednisolone|mesh-list
139321699|NCT06145126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139321700|NCT06145126|Glucocorticoids|glucocorticoids|mesh-ancestor
139321701|NCT06145126|Hormones|hormones|mesh-ancestor
139321702|NCT06145126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139321703|NCT06145126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321704|NCT06145126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139321705|NCT06145126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321706|NCT06145074|Propranolol|propranolol|mesh-list
139321707|NCT06145074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139321708|NCT06145074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139321709|NCT06145074|Adrenergic Agents|adrenergic agents|mesh-ancestor
139321710|NCT06145074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321711|NCT06145074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321712|NCT06145074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321713|NCT06145074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139321714|NCT06145074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139321715|NCT06145074|Vasodilator Agents|vasodilator agents|mesh-ancestor
139321716|NCT06144983|Chlorhexidine|chlorhexidine|mesh-list
139321717|NCT06144983|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139321718|NCT06144983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139321719|NCT06144983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321720|NCT06144983|Disinfectants|disinfectants|mesh-ancestor
139321721|NCT06144983|Dermatologic Agents|dermatologic agents|mesh-ancestor
139321722|NCT06144814|Hyaluronic Acid|hyaluronic acid|mesh-list
139321723|NCT06144814|Estrogens|estrogens|mesh-list
139321724|NCT06144814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139321725|NCT06144814|Immunologic Factors|immunologic factors|mesh-ancestor
139321726|NCT06144814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321727|NCT06144814|Viscosupplements|viscosupplements|mesh-ancestor
139321728|NCT06144814|Protective Agents|protective agents|mesh-ancestor
139321729|NCT06144814|Hormones|hormones|mesh-ancestor
139321730|NCT06144814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139321731|NCT06144788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139321732|NCT06144788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321733|NCT06144788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139321734|NCT06144788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321735|NCT06144736|Etoposide|etoposide|mesh-list
139321736|NCT06144736|Bleomycin|bleomycin|mesh-list
139321737|NCT06144736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321738|NCT06144736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139321739|NCT06144736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139321740|NCT06144736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139321741|NCT06144736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321742|NCT06144736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321743|NCT06144736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139321744|NCT06144697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139321745|NCT06144697|Famotidine|famotidine|mesh-list
139321746|NCT06144697|Antiviral Agents|antiviral agents|mesh-ancestor
139321747|NCT06144697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321748|NCT06144697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139321749|NCT06144697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139321750|NCT06144697|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139321751|NCT06144697|Histamine Antagonists|histamine antagonists|mesh-ancestor
139321752|NCT06144697|Histamine Agents|histamine agents|mesh-ancestor
139321753|NCT06144697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321754|NCT06144697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321755|NCT06144697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321756|NCT06144125|Thrombin|thrombin|mesh-list
139321757|NCT06144125|Hemostatics|hemostatics|mesh-ancestor
139321758|NCT06144125|Coagulants|coagulants|mesh-ancestor
139321759|NCT06144112|Thrombin|thrombin|mesh-list
139321760|NCT06144112|Hemostatics|hemostatics|mesh-ancestor
139321761|NCT06144112|Coagulants|coagulants|mesh-ancestor
139321762|NCT06144060|Imipenem|imipenem|mesh-list
139321763|NCT06144060|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
139321764|NCT06144060|Cilastatin|cilastatin|mesh-list
139321765|NCT06144060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139321766|NCT06144060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321767|NCT06144060|Protease Inhibitors|protease inhibitors|mesh-ancestor
139321768|NCT06144060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321769|NCT06144060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321770|NCT06144034|Erythritol|erythritol|mesh-list
139321771|NCT06144034|Vasodilator Agents|vasodilator agents|mesh-ancestor
139321772|NCT06143904|Eliglustat|eliglustat|mesh-list
139321773|NCT06143904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321774|NCT06143904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321775|NCT06143787|Tranexamic Acid|tranexamic acid|mesh-list
139321776|NCT06143787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139321777|NCT06143787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139321778|NCT06143787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321779|NCT06143787|Hemostatics|hemostatics|mesh-ancestor
139321780|NCT06143787|Coagulants|coagulants|mesh-ancestor
139321781|NCT06143761|Paclitaxel|paclitaxel|mesh-list
139321782|NCT06143761|Carboplatin|carboplatin|mesh-list
139321783|NCT06143761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139321784|NCT06143761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139321785|NCT06143761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139321786|NCT06143761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321787|NCT06143761|Tubulin Modulators|tubulin modulators|mesh-ancestor
139321788|NCT06143761|Antimitotic Agents|antimitotic agents|mesh-ancestor
139321789|NCT06143761|Mitosis Modulators|mitosis modulators|mesh-ancestor
139321790|NCT06143761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321791|NCT06143761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139321792|NCT06143748|Paclitaxel|paclitaxel|mesh-list
139321793|NCT06143748|Cisplatin|cisplatin|mesh-list
139321794|NCT06143748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139321795|NCT06143748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321796|NCT06143748|Tubulin Modulators|tubulin modulators|mesh-ancestor
139321797|NCT06143748|Antimitotic Agents|antimitotic agents|mesh-ancestor
139321798|NCT06143748|Mitosis Modulators|mitosis modulators|mesh-ancestor
139321799|NCT06143748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321800|NCT06143631|Letrozole|letrozole|mesh-list
139321801|NCT06143631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321802|NCT06143631|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139321803|NCT06143631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139321804|NCT06143631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321805|NCT06143631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321806|NCT06143631|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139321807|NCT06143631|Hormone Antagonists|hormone antagonists|mesh-ancestor
139321808|NCT06143631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139321809|NCT06143631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321810|NCT06143579|Lenvatinib|lenvatinib|mesh-list
139321811|NCT06143579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321812|NCT06143579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139321813|NCT06143579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321814|NCT06143579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321815|NCT06143553|Paclitaxel|paclitaxel|mesh-list
139321816|NCT06143553|Vinorelbine|vinorelbine|mesh-list
139321817|NCT06143553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139321818|NCT06143553|Gemcitabine|gemcitabine|mesh-list
139321819|NCT06143553|Capecitabine|capecitabine|mesh-list
139321820|NCT06143553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139321821|NCT06143553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321822|NCT06143553|Tubulin Modulators|tubulin modulators|mesh-ancestor
139321823|NCT06143553|Antimitotic Agents|antimitotic agents|mesh-ancestor
139321824|NCT06143553|Mitosis Modulators|mitosis modulators|mesh-ancestor
139321825|NCT06143553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321826|NCT06143553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139321827|NCT06143553|Antimetabolites|antimetabolites|mesh-ancestor
139321828|NCT06143241|Anticonvulsants|anticonvulsants|mesh-list
138911555|NCT00805012|Docetaxel|docetaxel|mesh-list
139321829|NCT06143124|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
139321830|NCT06143124|Bismuth|bismuth|mesh-list
139321831|NCT06143124|Antacids|antacids|mesh-ancestor
139321832|NCT06143124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321833|NCT06143124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139321834|NCT06143124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321835|NCT06143124|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139321836|NCT06140485|Metformin|metformin|mesh-list
139321837|NCT06140485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139321838|NCT06140485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321839|NCT06136546|Infliximab|infliximab|mesh-list
139321840|NCT06136546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139321841|NCT06136546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139321842|NCT06136546|Dermatologic Agents|dermatologic agents|mesh-ancestor
139321843|NCT06136546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139321844|NCT06136546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139321845|NCT06132477|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139321846|NCT06132477|Incretins|incretins|mesh-ancestor
139321847|NCT06132477|Hormones|hormones|mesh-ancestor
139321848|NCT06132477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139321849|NCT06132477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321850|NCT06124937|Empagliflozin|empagliflozin|mesh-list
139321851|NCT06124937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139321852|NCT06124937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321853|NCT06124937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139321854|NCT06124937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321855|NCT06107114|Docetaxel|docetaxel|mesh-list
139321856|NCT06107114|Cetuximab|cetuximab|mesh-list
139321857|NCT06107114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321858|NCT06107114|Tubulin Modulators|tubulin modulators|mesh-ancestor
139321859|NCT06107114|Antimitotic Agents|antimitotic agents|mesh-ancestor
139321860|NCT06107114|Mitosis Modulators|mitosis modulators|mesh-ancestor
139321861|NCT06107114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321862|NCT06107114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139321863|NCT06095596|Upadacitinib|upadacitinib|mesh-list
139321864|NCT06095596|Vedolizumab|vedolizumab|mesh-list
139321865|NCT06095596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139177945|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
139321866|NCT06095596|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139321867|NCT06095596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139321868|NCT06095596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321869|NCT06095596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321870|NCT06095596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139321871|NCT06094842|Cyclophosphamide|cyclophosphamide|mesh-list
139321872|NCT06094842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139321874|NCT06094842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139321875|NCT06094842|Immunologic Factors|immunologic factors|mesh-ancestor
139321876|NCT06094842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321877|NCT06094842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139321878|NCT06094842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139321879|NCT06094842|Alkylating Agents|alkylating agents|mesh-ancestor
139321880|NCT06094842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321881|NCT06094842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321882|NCT06094842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139321883|NCT06080555|Ferric Compounds|ferric compounds|mesh-list
139321884|NCT06080555|Hematinics|hematinics|mesh-ancestor
139321885|NCT06076681|Amoxicillin|amoxicillin|mesh-list
139321886|NCT06076681|Rabeprazole|rabeprazole|mesh-list
139321887|NCT06076681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139321888|NCT06076681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321889|NCT06076681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139321890|NCT06076681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139321891|NCT06076681|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139321892|NCT06076681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321893|NCT06076681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321894|NCT06063109|Dapagliflozin|dapagliflozin|mesh-list
139321895|NCT06063109|Telmisartan|telmisartan|mesh-list
139321896|NCT06063109|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139321897|NCT06063109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321898|NCT06063109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139321899|NCT06063109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321900|NCT06063109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139321901|NCT06063109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139321902|NCT06063109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139321903|NCT06029309|Zanubrutinib|zanubrutinib|mesh-list
139321904|NCT06029309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321905|NCT06029309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139321906|NCT06029309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321907|NCT06029309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321908|NCT06025344|Probenecid|probenecid|mesh-list
139321909|NCT06025344|Uricosuric Agents|uricosuric agents|mesh-ancestor
139321910|NCT06025344|Gout Suppressants|gout suppressants|mesh-ancestor
139321911|NCT06025344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139321912|NCT06016556|Ritonavir|ritonavir|mesh-list
139321913|NCT06016556|Nirmatrelvir|nirmatrelvir|mesh-list
139321914|NCT06016556|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139321915|NCT06016556|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139321916|NCT06016556|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139321917|NCT06016556|Protease Inhibitors|protease inhibitors|mesh-ancestor
139321918|NCT06016556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321919|NCT06016556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321920|NCT06016556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139321921|NCT06016556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139321922|NCT06016556|Antiviral Agents|antiviral agents|mesh-ancestor
139321923|NCT06016556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321924|NCT06016556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139321925|NCT06016556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139321926|NCT05998941|Paclitaxel|paclitaxel|mesh-list
139321927|NCT05998941|Bevacizumab|bevacizumab|mesh-list
139321928|NCT05998941|Carboplatin|carboplatin|mesh-list
139321929|NCT05998941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139321930|NCT05998941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321931|NCT05998941|Tubulin Modulators|tubulin modulators|mesh-ancestor
139321932|NCT05998941|Antimitotic Agents|antimitotic agents|mesh-ancestor
139321933|NCT05998941|Mitosis Modulators|mitosis modulators|mesh-ancestor
139321934|NCT05998941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321935|NCT05998941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139321936|NCT05998941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139321937|NCT05998941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139321938|NCT05998941|Growth Substances|growth substances|mesh-ancestor
139321939|NCT05998941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321940|NCT05998941|Growth Inhibitors|growth inhibitors|mesh-ancestor
139321941|NCT05988463|Artesunate|artesunate|mesh-list
139321942|NCT05988463|Antimalarials|antimalarials|mesh-ancestor
139321943|NCT05988463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139321944|NCT05988463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139321945|NCT05988463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139321946|NCT05988463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321947|NCT05988463|Antiviral Agents|antiviral agents|mesh-ancestor
139321948|NCT05988463|Schistosomicides|schistosomicides|mesh-ancestor
139321949|NCT05988463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139321950|NCT05988463|Anthelmintics|anthelmintics|mesh-ancestor
139321951|NCT05973903|Pembrolizumab|pembrolizumab|mesh-list
139321952|NCT05973903|Lenvatinib|lenvatinib|mesh-list
139321953|NCT05973903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139321954|NCT05973903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321955|NCT05973903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139321956|NCT05973903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321957|NCT05973903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139321958|NCT05973903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321959|NCT05962229|Nicotine|nicotine|mesh-list
139321960|NCT05962229|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139321961|NCT05962229|Autonomic Agents|autonomic agents|mesh-ancestor
139321962|NCT05962229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321963|NCT05962229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321964|NCT05962229|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139321965|NCT05962229|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139321966|NCT05962229|Cholinergic Agents|cholinergic agents|mesh-ancestor
139321967|NCT05962229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139321968|NCT05962229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321969|NCT05961124|Niraparib|niraparib|mesh-list
139321970|NCT05961124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139321971|NCT05961124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321972|NCT05961124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321973|NCT05961124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321974|NCT05960864|Celecoxib|celecoxib|mesh-list
139321975|NCT05960864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139321976|NCT05960864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139321977|NCT05960864|Analgesics|analgesics|mesh-ancestor
139321978|NCT05960864|Sensory System Agents|sensory system agents|mesh-ancestor
139321979|NCT05960864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139321980|NCT05960864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321981|NCT05960864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139321982|NCT05960864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139321983|NCT05960864|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139321984|NCT05960864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139321985|NCT05960864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139321986|NCT05960864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139321987|NCT05956821|Bevacizumab|bevacizumab|mesh-list
139321988|NCT05956821|Cetuximab|cetuximab|mesh-list
139321989|NCT05956821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139321990|NCT05956821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139321991|NCT05956821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139321992|NCT05956821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139321993|NCT05956821|Growth Substances|growth substances|mesh-ancestor
139321994|NCT05956821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139321995|NCT05956821|Growth Inhibitors|growth inhibitors|mesh-ancestor
139321996|NCT05946642|Ivermectin|ivermectin|mesh-list
139321997|NCT05946642|Pyrimethamine|pyrimethamine|mesh-list
139321998|NCT05946642|Piperaquine|piperaquine|mesh-list
139321999|NCT05946642|Sulfadoxine|sulfadoxine|mesh-list
139322000|NCT05946642|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139322001|NCT05946642|Amodiaquine|amodiaquine|mesh-list
139322002|NCT05946642|Artenimol|artenimol|mesh-list
139322003|NCT05946642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139322004|NCT05946642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139322005|NCT05946642|Antimalarials|antimalarials|mesh-ancestor
139322006|NCT05946642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139322007|NCT05946642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139322008|NCT05946642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322009|NCT05946642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322010|NCT05946642|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139322011|NCT05945147|Midazolam|midazolam|mesh-list
139322012|NCT05945147|Ketamine|ketamine|mesh-list
139322013|NCT05945147|Analgesics|analgesics|mesh-ancestor
139322014|NCT05945147|Sensory System Agents|sensory system agents|mesh-ancestor
139322015|NCT05945147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322016|NCT05945147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322017|NCT05945147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139322018|NCT05945147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139322019|NCT05945147|Anesthetics, General|anesthetics, general|mesh-ancestor
139322020|NCT05945147|Anesthetics|anesthetics|mesh-ancestor
139322021|NCT05945147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322022|NCT05945147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139322023|NCT05945147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139322024|NCT05945147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322025|NCT05945147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322026|NCT05945147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139322027|NCT05945147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139322028|NCT05945147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139322029|NCT05945147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139322030|NCT05945147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139322031|NCT05945147|GABA Modulators|gaba modulators|mesh-ancestor
139322032|NCT05945147|GABA Agents|gaba agents|mesh-ancestor
139322033|NCT05936710|Dialysis Solutions|dialysis solutions|mesh-list
139322034|NCT05936710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139322035|NCT05934669|Midazolam|midazolam|mesh-list
139322036|NCT05934669|Dexmedetomidine|dexmedetomidine|mesh-list
139322037|NCT05934669|Ketamine|ketamine|mesh-list
139322038|NCT05934669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139322039|NCT05934669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322040|NCT05934669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322041|NCT05934669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139322042|NCT05934669|Analgesics|analgesics|mesh-ancestor
139322043|NCT05934669|Sensory System Agents|sensory system agents|mesh-ancestor
139322044|NCT05934669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322045|NCT05934669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139322046|NCT05934669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139322047|NCT05934669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139322048|NCT05934669|Adrenergic Agents|adrenergic agents|mesh-ancestor
139322049|NCT05934669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322050|NCT05934669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322051|NCT05934669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139322052|NCT05934669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139322053|NCT05934669|Anesthetics, General|anesthetics, general|mesh-ancestor
139322054|NCT05934669|Anesthetics|anesthetics|mesh-ancestor
139322055|NCT05934669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139322056|NCT05934669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139322057|NCT05934669|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139322058|NCT05934669|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139322059|NCT05934669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139322060|NCT05934669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139322061|NCT05934669|GABA Modulators|gaba modulators|mesh-ancestor
139322062|NCT05934669|GABA Agents|gaba agents|mesh-ancestor
139322063|NCT05921604|Gabapentin|gabapentin|mesh-list
139322064|NCT05921604|Baclofen|baclofen|mesh-list
139322065|NCT05921604|Analgesics|analgesics|mesh-ancestor
139322066|NCT05921604|Sensory System Agents|sensory system agents|mesh-ancestor
139322067|NCT05921604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322068|NCT05921604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322069|NCT05921604|Anticonvulsants|anticonvulsants|mesh-ancestor
139322070|NCT05921604|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139322071|NCT05921604|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139322072|NCT05921604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322073|NCT05921604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139322074|NCT05921604|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139322075|NCT05921604|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139322076|NCT05921604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322077|NCT05921604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322078|NCT05921604|Antimanic Agents|antimanic agents|mesh-ancestor
139322079|NCT05921604|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139322080|NCT05921604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139322081|NCT05921604|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139322082|NCT05921604|GABA Agonists|gaba agonists|mesh-ancestor
139322083|NCT05921604|GABA Agents|gaba agents|mesh-ancestor
139322084|NCT05893069|Oxandrolone|oxandrolone|mesh-list
139322085|NCT05893069|Androgens|androgens|mesh-ancestor
139322086|NCT05893069|Hormones|hormones|mesh-ancestor
139322087|NCT05893069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139322088|NCT05893069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322089|NCT05893069|Anabolic Agents|anabolic agents|mesh-ancestor
139322090|NCT05887479|Botulinum Toxins|botulinum toxins|mesh-list
139322091|NCT05887479|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139322092|NCT05887479|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139322093|NCT05887479|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139322094|NCT05887479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139322095|NCT05887479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322096|NCT05887479|Cholinergic Agents|cholinergic agents|mesh-ancestor
139322097|NCT05887479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322098|NCT05887479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322099|NCT05887479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139322100|NCT05887479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322101|NCT05882643|Iodine|iodine|mesh-list
139322102|NCT05882643|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139322103|NCT05882643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139322104|NCT05882643|Trace Elements|trace elements|mesh-ancestor
139322105|NCT05882643|Micronutrients|micronutrients|mesh-ancestor
139322106|NCT05882643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322107|NCT05879120|Pembrolizumab|pembrolizumab|mesh-list
139322108|NCT05879120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139322109|NCT05879120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322110|NCT05879120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139322111|NCT05879120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322112|NCT05857631|Cisplatin|cisplatin|mesh-list
139322113|NCT05857631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322114|NCT05856305|Copper|copper|mesh-list
139322115|NCT05856305|Chlorophyllin|chlorophyllin|mesh-list
139322116|NCT05856305|Trace Elements|trace elements|mesh-ancestor
139322117|NCT05856305|Micronutrients|micronutrients|mesh-ancestor
139322118|NCT05856305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322119|NCT05856305|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139322120|NCT05856305|Protective Agents|protective agents|mesh-ancestor
139322121|NCT05839366|Remifentanil|remifentanil|mesh-list
139322122|NCT05839366|Propofol|propofol|mesh-list
139322123|NCT05839366|Esketamine|esketamine|mesh-list
139322124|NCT05839366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139322125|NCT05839366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322126|NCT05839366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322127|NCT05839366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139322128|NCT05839366|Anesthetics, General|anesthetics, general|mesh-ancestor
139322129|NCT05839366|Anesthetics|anesthetics|mesh-ancestor
139322130|NCT05839366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139322131|NCT05839366|Narcotics|narcotics|mesh-ancestor
139322132|NCT05839366|Analgesics|analgesics|mesh-ancestor
139322133|NCT05839366|Sensory System Agents|sensory system agents|mesh-ancestor
139322134|NCT05839366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322135|NCT05839366|Antidepressive Agents|antidepressive agents|mesh-ancestor
139322136|NCT05839366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139322137|NCT05838716|Vitamin D|vitamin d|mesh-list
139322138|NCT05838716|Ergocalciferols|ergocalciferols|mesh-list
139322139|NCT05838716|Cholecalciferol|cholecalciferol|mesh-list
139322140|NCT05838716|Vitamins|vitamins|mesh-list
139322141|NCT05838716|Micronutrients|micronutrients|mesh-ancestor
139322142|NCT05838716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322143|NCT05838716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139322144|NCT05838716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139322145|NCT05810792|Interleukin-2|interleukin-2|mesh-list
139322146|NCT05810792|Histamine|histamine|mesh-list
139322147|NCT05810792|Histamine phosphate|histamine phosphate|mesh-list
139322148|NCT05810792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322149|NCT05810792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139322150|NCT05810792|Analgesics|analgesics|mesh-ancestor
139322151|NCT05810792|Sensory System Agents|sensory system agents|mesh-ancestor
139322152|NCT05810792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322153|NCT05810792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322154|NCT05810792|Histamine Agonists|histamine agonists|mesh-ancestor
139322155|NCT05810792|Histamine Agents|histamine agents|mesh-ancestor
139322156|NCT05810792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139177965|NCT01287715|Etanercept|etanercept|mesh-list
139322163|NCT05796167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322164|NCT05796167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322165|NCT05796167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139322166|NCT05796167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139322167|NCT05796167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139322168|NCT05796167|Serotonin Agents|serotonin agents|mesh-ancestor
139322169|NCT05796167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322170|NCT05796167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322171|NCT05774067|Terlipressin|terlipressin|mesh-list
139322172|NCT05774067|Vasopressins|vasopressins|mesh-list
139322173|NCT05774067|Norepinephrine|norepinephrine|mesh-list
139322174|NCT05774067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139322175|NCT05774067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139322176|NCT05774067|Adrenergic Agents|adrenergic agents|mesh-ancestor
139322177|NCT05774067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322178|NCT05774067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322179|NCT05774067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322180|NCT05774067|Sympathomimetics|sympathomimetics|mesh-ancestor
139322181|NCT05774067|Autonomic Agents|autonomic agents|mesh-ancestor
139322182|NCT05774067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322183|NCT05774067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139322184|NCT05774067|Hemostatics|hemostatics|mesh-ancestor
139322185|NCT05774067|Coagulants|coagulants|mesh-ancestor
139322186|NCT05774067|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139322187|NCT05774067|Natriuretic Agents|natriuretic agents|mesh-ancestor
139322188|NCT05774067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139322189|NCT05774015|Magnesium Oxide|magnesium oxide|mesh-list
139322190|NCT05774015|Antacids|antacids|mesh-ancestor
139322191|NCT05774015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322192|NCT05774015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139322200|NCT05709171|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139322201|NCT05709171|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139322202|NCT05709171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322203|NCT05686044|Phenserine|phenserine|mesh-list
139322204|NCT05686044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139322205|NCT05686044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322206|NCT05686044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322207|NCT05686044|Cholinergic Agents|cholinergic agents|mesh-ancestor
139322208|NCT05686044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322209|NCT05686044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322210|NCT05681572|Midazolam|midazolam|mesh-list
139322211|NCT05681572|Dexmedetomidine|dexmedetomidine|mesh-list
139322212|NCT05681572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139322213|NCT05681572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322214|NCT05681572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322215|NCT05681572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139322216|NCT05681572|Analgesics|analgesics|mesh-ancestor
139322217|NCT05681572|Sensory System Agents|sensory system agents|mesh-ancestor
139322218|NCT05681572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322219|NCT05681572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139322220|NCT05681572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139322221|NCT05681572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139322222|NCT05681572|Adrenergic Agents|adrenergic agents|mesh-ancestor
139177968|NCT01287715|Analgesics|analgesics|mesh-ancestor
139322223|NCT05681572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322224|NCT05681572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911622|NCT00651118|Azelastine|azelastine|mesh-list
139322225|NCT05681572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139322226|NCT05681572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139322227|NCT05681572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139322228|NCT05681572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139322229|NCT05681572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139322230|NCT05681572|Anesthetics, General|anesthetics, general|mesh-ancestor
139322231|NCT05681572|Anesthetics|anesthetics|mesh-ancestor
139322232|NCT05681572|GABA Modulators|gaba modulators|mesh-ancestor
139322233|NCT05681572|GABA Agents|gaba agents|mesh-ancestor
139322234|NCT05676034|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139322235|NCT05676034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322236|NCT05669560|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139322237|NCT05669560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139322238|NCT05669560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139322239|NCT05647564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139322240|NCT05647564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139322241|NCT05647564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322242|NCT05639218|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139322243|NCT05639218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139322244|NCT05639218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139322245|NCT05639218|Antimetabolites|antimetabolites|mesh-ancestor
139322246|NCT05639218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322247|NCT05639218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139322248|NCT05639218|Protease Inhibitors|protease inhibitors|mesh-ancestor
139322249|NCT05639218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322250|NCT05639218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139322251|NCT05630976|Isavuconazole|isavuconazole|mesh-list
139322252|NCT05630976|Antifungal Agents|antifungal agents|mesh-ancestor
139322253|NCT05630976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139322254|NCT05625087|Fulvestrant|fulvestrant|mesh-list
139322255|NCT05625087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139322256|NCT05625087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322257|NCT05625087|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139322258|NCT05625087|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139322259|NCT05625087|Hormone Antagonists|hormone antagonists|mesh-ancestor
139322260|NCT05625087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139322261|NCT05625087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322262|NCT05624359|Ropivacaine|ropivacaine|mesh-list
139322263|NCT05624359|Anesthetics, Local|anesthetics, local|mesh-ancestor
139322264|NCT05624359|Anesthetics|anesthetics|mesh-ancestor
139322265|NCT05624359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322266|NCT05624359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322267|NCT05624359|Sensory System Agents|sensory system agents|mesh-ancestor
138979110|NCT05232357|Chelating Agents|chelating agents|mesh-ancestor
139322268|NCT05624359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322269|NCT05620641|Gabapentin|gabapentin|mesh-list
139322270|NCT05620641|Ondansetron|ondansetron|mesh-list
139322271|NCT05620641|Analgesics|analgesics|mesh-ancestor
139322272|NCT05620641|Sensory System Agents|sensory system agents|mesh-ancestor
139322273|NCT05620641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322274|NCT05620641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322275|NCT05620641|Anticonvulsants|anticonvulsants|mesh-ancestor
139322276|NCT05620641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139322277|NCT05620641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139322278|NCT05620641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322279|NCT05620641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139322280|NCT05620641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139322281|NCT05620641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139322282|NCT05620641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322283|NCT05620641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322284|NCT05620641|Antimanic Agents|antimanic agents|mesh-ancestor
139322285|NCT05620641|Antiemetics|antiemetics|mesh-ancestor
139322286|NCT05620641|Autonomic Agents|autonomic agents|mesh-ancestor
139322287|NCT05620641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139322288|NCT05620641|Antipruritics|antipruritics|mesh-ancestor
139322289|NCT05620641|Dermatologic Agents|dermatologic agents|mesh-ancestor
139322290|NCT05620641|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139322291|NCT05620641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139322292|NCT05620641|Serotonin Agents|serotonin agents|mesh-ancestor
139322293|NCT05605080|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139322294|NCT05605080|Hemostatics|hemostatics|mesh-ancestor
139322295|NCT05605080|Coagulants|coagulants|mesh-ancestor
139322296|NCT05599347|Azithromycin|azithromycin|mesh-list
139322297|NCT05599347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139322298|NCT05599347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139322299|NCT05588609|Abiraterone Acetate|abiraterone acetate|mesh-list
139322300|NCT05588609|Afatinib|afatinib|mesh-list
139322301|NCT05588609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322302|NCT05588609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139322303|NCT05588609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322304|NCT05588609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322305|NCT05588609|Hormone Antagonists|hormone antagonists|mesh-ancestor
139322306|NCT05588609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139322307|NCT05588609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322308|NCT05588609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139322309|NCT05588609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139322310|NCT05580445|Gemcitabine|gemcitabine|mesh-list
139322311|NCT05580445|Conteltinib|conteltinib|mesh-list
139322312|NCT05580445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139322313|NCT05580445|Antimetabolites|antimetabolites|mesh-ancestor
139322314|NCT05580445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322315|NCT05580445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322316|NCT05580445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139322317|NCT05580445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322318|NCT05569954|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139322319|NCT05569954|Immunologic Factors|immunologic factors|mesh-ancestor
139322320|NCT05569954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322321|NCT05519059|Paclitaxel|paclitaxel|mesh-list
139322322|NCT05519059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139322323|NCT05519059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322324|NCT05519059|Tubulin Modulators|tubulin modulators|mesh-ancestor
139322325|NCT05519059|Antimitotic Agents|antimitotic agents|mesh-ancestor
139322326|NCT05519059|Mitosis Modulators|mitosis modulators|mesh-ancestor
139322327|NCT05519059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322328|NCT05516953|Baclofen|baclofen|mesh-list
139322329|NCT05516953|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138911647|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139322330|NCT05516953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322331|NCT05516953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139322332|NCT05516953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322333|NCT05516953|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139322334|NCT05516953|GABA Agonists|gaba agonists|mesh-ancestor
139322335|NCT05516953|GABA Agents|gaba agents|mesh-ancestor
139322336|NCT05516953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322337|NCT05516953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322338|NCT05502900|Melatonin|melatonin|mesh-list
139322339|NCT05502900|Antioxidants|antioxidants|mesh-ancestor
139322340|NCT05502900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322341|NCT05502900|Protective Agents|protective agents|mesh-ancestor
138979184|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139322342|NCT05502900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322343|NCT05502900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322344|NCT05436652|Prednisolone|prednisolone|mesh-list
139322345|NCT05436652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139322346|NCT05436652|Methylprednisolone|methylprednisolone|mesh-list
139322347|NCT05436652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139322348|NCT05436652|Prednisolone acetate|prednisolone acetate|mesh-list
139322349|NCT05436652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139322350|NCT05436652|Prednisolone phosphate|prednisolone phosphate|mesh-list
139322351|NCT05436652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139322352|NCT05436652|Glucocorticoids|glucocorticoids|mesh-ancestor
139322353|NCT05436652|Hormones|hormones|mesh-ancestor
139322354|NCT05436652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139322355|NCT05436652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322356|NCT05436652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139322357|NCT05436652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322358|NCT05436652|Antiemetics|antiemetics|mesh-ancestor
139322359|NCT05436652|Autonomic Agents|autonomic agents|mesh-ancestor
139322360|NCT05436652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322361|NCT05436652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139322362|NCT05436652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139322363|NCT05436652|Protective Agents|protective agents|mesh-ancestor
139322364|NCT05423951|Sufentanil|sufentanil|mesh-list
139322365|NCT05423951|Propofol|propofol|mesh-list
139322367|NCT05423951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139322368|NCT05423951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322369|NCT05423951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322370|NCT05423951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139322371|NCT05423951|Anesthetics, General|anesthetics, general|mesh-ancestor
139322372|NCT05423951|Anesthetics|anesthetics|mesh-ancestor
139322373|NCT05423951|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139322374|NCT05423951|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139322375|NCT05423951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139322376|NCT05423951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322377|NCT05423951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139322378|NCT05423951|Narcotics|narcotics|mesh-ancestor
139322379|NCT05423951|Analgesics|analgesics|mesh-ancestor
139322380|NCT05423951|Sensory System Agents|sensory system agents|mesh-ancestor
139322381|NCT05423951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139322382|NCT05421065|Ketamine|ketamine|mesh-list
139322383|NCT05421065|Psilocybin|psilocybin|mesh-list
139322384|NCT05421065|Analgesics|analgesics|mesh-ancestor
139322385|NCT05421065|Sensory System Agents|sensory system agents|mesh-ancestor
138911670|NCT00457639|Cholic Acids|cholic acids|mesh-list
139322386|NCT05421065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322387|NCT05421065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322388|NCT05421065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139322389|NCT05421065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139322390|NCT05421065|Anesthetics, General|anesthetics, general|mesh-ancestor
139322391|NCT05421065|Anesthetics|anesthetics|mesh-ancestor
139322392|NCT05421065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322393|NCT05421065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139322394|NCT05421065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139322395|NCT05421065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322396|NCT05421065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322397|NCT05421065|Hallucinogens|hallucinogens|mesh-ancestor
139322398|NCT05421065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139322399|NCT05397886|Propofol|propofol|mesh-list
139322400|NCT05397886|Flumazenil|flumazenil|mesh-list
139322401|NCT05397886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139322402|NCT05397886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322403|NCT05397886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322404|NCT05397886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139322405|NCT05397886|Anesthetics, General|anesthetics, general|mesh-ancestor
139322406|NCT05397886|Anesthetics|anesthetics|mesh-ancestor
139322407|NCT05397886|Antidotes|antidotes|mesh-ancestor
139322408|NCT05397886|Protective Agents|protective agents|mesh-ancestor
139322409|NCT05397886|GABA Modulators|gaba modulators|mesh-ancestor
139322410|NCT05397886|GABA Agents|gaba agents|mesh-ancestor
139322411|NCT05397886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322412|NCT05397886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322413|NCT05396118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139322414|NCT05396118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139322415|NCT05396118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322416|NCT05370495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139322417|NCT05370495|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139322418|NCT05369793|Thioctic Acid|thioctic acid|mesh-list
139322419|NCT05369793|Antioxidants|antioxidants|mesh-ancestor
139322420|NCT05369793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322421|NCT05369793|Protective Agents|protective agents|mesh-ancestor
139322422|NCT05369793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322423|NCT05369793|Vitamin B Complex|vitamin b complex|mesh-ancestor
139322424|NCT05369793|Vitamins|vitamins|mesh-ancestor
139322425|NCT05369793|Micronutrients|micronutrients|mesh-ancestor
139322426|NCT05357859|Vitamin D|vitamin d|mesh-list
139322427|NCT05357859|Cholecalciferol|cholecalciferol|mesh-list
139322428|NCT05357859|Vitamins|vitamins|mesh-ancestor
139322429|NCT05357859|Micronutrients|micronutrients|mesh-ancestor
139322430|NCT05357859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322431|NCT05357859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139322432|NCT05357859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139322433|NCT05348356|Nirogacestat|nirogacestat|mesh-list
139322434|NCT05348356|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139322435|NCT05348356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322436|NCT05348356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322437|NCT05338866|Capecitabine|capecitabine|mesh-list
139177980|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
139322438|NCT05338866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139322439|NCT05338866|Antimetabolites|antimetabolites|mesh-ancestor
139322440|NCT05338866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322441|NCT05338866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322442|NCT05327023|Mycophenolic Acid|mycophenolic acid|mesh-list
139322443|NCT05327023|Sirolimus|sirolimus|mesh-list
139322444|NCT05327023|Cyclophosphamide|cyclophosphamide|mesh-list
139322445|NCT05327023|Busulfan|busulfan|mesh-list
139322446|NCT05327023|Fludarabine|fludarabine|mesh-list
139322447|NCT05327023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139322448|NCT05327023|Immunologic Factors|immunologic factors|mesh-ancestor
139322449|NCT05327023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322450|NCT05327023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139322451|NCT05327023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139322452|NCT05327023|Alkylating Agents|alkylating agents|mesh-ancestor
139322453|NCT05327023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322454|NCT05327023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322455|NCT05327023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139322456|NCT05327023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139322457|NCT05327023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139322458|NCT05327023|Antitubercular Agents|antitubercular agents|mesh-ancestor
139322459|NCT05327023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139322460|NCT05327023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139322461|NCT05327023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322462|NCT05327023|Antifungal Agents|antifungal agents|mesh-ancestor
139322463|NCT05303064|Olanzapine|olanzapine|mesh-list
139322464|NCT05303064|Antiemetics|antiemetics|mesh-ancestor
139322465|NCT05303064|Autonomic Agents|autonomic agents|mesh-ancestor
139322466|NCT05303064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322467|NCT05303064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322468|NCT05303064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139322469|NCT05303064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139322470|NCT05303064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139322471|NCT05303064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322472|NCT05303064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139322473|NCT05303064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139322474|NCT05303064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139322475|NCT05303064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139322476|NCT05303064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322477|NCT05303064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322478|NCT05303064|Serotonin Agents|serotonin agents|mesh-ancestor
139322479|NCT05258773|Azasetron|azasetron|mesh-list
139322480|NCT05258773|Antiemetics|antiemetics|mesh-ancestor
139322481|NCT05258773|Autonomic Agents|autonomic agents|mesh-ancestor
139322482|NCT05258773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322483|NCT05258773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322484|NCT05258773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139322485|NCT05258773|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139322486|NCT05258773|Serotonin Agents|serotonin agents|mesh-ancestor
139322487|NCT05258773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322488|NCT05258773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322489|NCT05253118|Pemetrexed|pemetrexed|mesh-list
139322490|NCT05253118|Tislelizumab|tislelizumab|mesh-list
139322491|NCT05253118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322492|NCT05253118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322493|NCT05253118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322494|NCT05253118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139322495|NCT05253118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139322496|NCT05253118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139322497|NCT05251974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139322498|NCT05251974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139322499|NCT05251974|Adrenergic Agents|adrenergic agents|mesh-ancestor
139322500|NCT05251974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322501|NCT05251974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322502|NCT05251974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322503|NCT05251714|Fulvestrant|fulvestrant|mesh-list
139322504|NCT05251714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139322505|NCT05251714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322506|NCT05251714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139322507|NCT05251714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139322508|NCT05251714|Hormone Antagonists|hormone antagonists|mesh-ancestor
139322509|NCT05251714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139322510|NCT05251714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322511|NCT05251493|Iron|iron|mesh-list
139322512|NCT05251493|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139322513|NCT05251493|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139322514|NCT05251493|Trace Elements|trace elements|mesh-ancestor
139322515|NCT05251493|Micronutrients|micronutrients|mesh-ancestor
139322516|NCT05251493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322517|NCT05251493|Hematinics|hematinics|mesh-ancestor
139322518|NCT05227456|Etonogestrel|etonogestrel|mesh-list
139322519|NCT05227456|Desogestrel|desogestrel|mesh-list
139322520|NCT05227456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139322521|NCT05227456|Contraceptive Agents|contraceptive agents|mesh-ancestor
139322522|NCT05227456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139322523|NCT05227456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322524|NCT05227456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139322525|NCT05227456|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139322526|NCT05227456|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139322527|NCT05227456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139322528|NCT05227456|Progestins|progestins|mesh-ancestor
139322529|NCT05227456|Hormones|hormones|mesh-ancestor
139322530|NCT05227456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139322531|NCT05209074|Ivosidenib|ivosidenib|mesh-list
139322532|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322533|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322534|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322535|NCT05208619|Anesthetics|anesthetics|mesh-list
139322536|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322537|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322538|NCT05195645|Abatacept|abatacept|mesh-list
139322539|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139322540|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322541|NCT05195645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139322542|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322543|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139322544|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
139322545|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322546|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139322547|NCT05195060|Sotrovimab|sotrovimab|mesh-list
139322548|NCT05195060|Molnupiravir|molnupiravir|mesh-list
139322549|NCT05195060|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
139322550|NCT05195060|Antiviral Agents|antiviral agents|mesh-ancestor
139322551|NCT05195060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139322552|NCT05178849|Anesthetics|anesthetics|mesh-list
139322553|NCT05178849|Anesthetics, Local|anesthetics, local|mesh-list
139322554|NCT05178849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322555|NCT05178849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322556|NCT05178849|Sensory System Agents|sensory system agents|mesh-ancestor
139322557|NCT05178849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322558|NCT05164367|Atropine|atropine|mesh-list
139322559|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139322560|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139322561|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139322562|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
139322563|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322564|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178000|NCT03393000|Protective Agents|protective agents|mesh-ancestor
139322565|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139322566|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
139322567|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
139322568|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
139322569|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139322570|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139322571|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
139322572|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322573|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322574|NCT05125055|Paclitaxel|paclitaxel|mesh-list
139322575|NCT05125055|Docetaxel|docetaxel|mesh-list
139322576|NCT05125055|Fluorouracil|fluorouracil|mesh-list
139322577|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139322578|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322579|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
139322580|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
139322581|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
139322582|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322583|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
139322584|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139322585|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139322586|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
139322587|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322588|NCT05107921|Bromfenac|bromfenac|mesh-list
139322589|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139322590|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139322591|NCT05107921|Analgesics|analgesics|mesh-ancestor
139322592|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
139322593|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322594|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322595|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139322596|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139322597|NCT05098041|Rifampin|rifampin|mesh-list
139322598|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139322599|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
139322600|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139322601|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139322602|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
139322603|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139322604|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322605|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322606|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139322607|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139322608|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139322609|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139322610|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139322611|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139322612|NCT05088356|Plerixafor|plerixafor|mesh-list
139322613|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
139322614|NCT05088356|Melphalan|melphalan|mesh-list
139322615|NCT05088356|Fludarabine|fludarabine|mesh-list
139322616|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
139322617|NCT05088356|Tacrolimus|tacrolimus|mesh-list
139322618|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
139322619|NCT05088356|Lenograstim|lenograstim|mesh-list
139322620|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139322621|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
139322622|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322623|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139322624|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139322625|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322626|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322627|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139322628|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139322629|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
139322630|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
139322631|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139322632|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139322633|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139322634|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322635|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139322636|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139322637|NCT05076838|Diazepam|diazepam|mesh-list
139178004|NCT03393000|Vitamins|vitamins|mesh-ancestor
139322638|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139322639|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
139322640|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
139322641|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
139322642|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322643|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322644|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139322645|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139322646|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322647|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139322648|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139322649|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139322650|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139322651|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139322652|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139322653|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
139322655|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
139322656|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
139322657|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322658|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322659|NCT05076760|Nivolumab|nivolumab|mesh-list
139322660|NCT05076760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139322661|NCT05076760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322662|NCT05076760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139322663|NCT05076760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322664|NCT05069857|Apatinib|apatinib|mesh-list
139322665|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139322666|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322667|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139322668|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322669|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322670|NCT05069857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139322671|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
139322672|NCT05049863|Irinotecan|irinotecan|mesh-list
139322673|NCT05049863|Allopurinol|allopurinol|mesh-list
139322674|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139322675|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139322676|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322677|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322678|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322679|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139322680|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139322681|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
139322682|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139322683|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139322684|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
139322685|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
139322686|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139322687|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139322688|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
139322689|NCT05049863|Protective Agents|protective agents|mesh-ancestor
139322690|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322691|NCT04981067|Ropivacaine|ropivacaine|mesh-list
139322692|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
139322693|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
139322694|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322695|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322696|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
139322697|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322698|NCT04965597|Methotrexate|methotrexate|mesh-list
139322699|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
139322700|NCT04965597|Fludarabine|fludarabine|mesh-list
139322701|NCT04965597|Treosulfan|treosulfan|mesh-list
139322702|NCT04965597|Busulfan|busulfan|mesh-list
139322703|NCT04965597|Tacrolimus|tacrolimus|mesh-list
139322704|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
139322705|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139322706|NCT04965597|Immunoglobulins|immunoglobulins|mesh-list
139322707|NCT04965597|Antibodies|antibodies|mesh-list
139322708|NCT04965597|gamma-Globulins|gamma-globulins|mesh-list
139322709|NCT04965597|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139322710|NCT04965597|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139322712|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
139322713|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139322714|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322715|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139322716|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
139322717|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322718|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322719|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
139322720|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322721|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139322722|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139322723|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
139322724|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139322725|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139322726|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139322727|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139322728|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
139322729|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139322735|NCT04905810|Azacitidine|azacitidine|mesh-list
139322736|NCT04905810|Decitabine|decitabine|mesh-list
139322737|NCT04905810|Venetoclax|venetoclax|mesh-list
139322738|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139322739|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
139322740|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322741|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322742|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322743|NCT04891809|Dexamethasone|dexamethasone|mesh-list
139322744|NCT04891809|Lenalidomide|lenalidomide|mesh-list
139322745|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139322746|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
139322747|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
139322748|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322749|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322750|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139322751|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
139322752|NCT04891809|Hormones|hormones|mesh-ancestor
139322753|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139322754|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139322755|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322756|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
139322757|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139322758|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139322759|NCT04891809|Growth Substances|growth substances|mesh-ancestor
139322760|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
139322761|NCT04883242|Thalidomide|thalidomide|mesh-list
139322762|NCT04883242|Dexamethasone|dexamethasone|mesh-list
139322763|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
139322764|NCT04883242|Pomalidomide|pomalidomide|mesh-list
139322765|NCT04883242|Ichthammol|ichthammol|mesh-list
139322766|NCT04883242|BB 1101|bb 1101|mesh-list
139322767|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139322768|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139322769|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
139322770|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
139322771|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322772|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322773|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139322774|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
139322775|NCT04883242|Hormones|hormones|mesh-ancestor
139322776|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139322777|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139322778|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322779|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
139322780|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322781|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322782|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
139322783|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139322784|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139322785|NCT04883242|Growth Substances|growth substances|mesh-ancestor
139322786|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
139322787|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
139322788|NCT04883242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139322789|NCT04883242|Leprostatic Agents|leprostatic agents|mesh-ancestor
139322790|NCT04883242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139322791|NCT04883242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139322792|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
139322793|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139322794|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322795|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322796|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139322797|NCT04871308|Analgesics|analgesics|mesh-ancestor
139322798|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
139322799|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322800|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139322801|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139322802|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139322803|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
139322804|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322805|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322807|NCT04864067|Capecitabine|capecitabine|mesh-list
139322808|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
139322809|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139322810|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
139322811|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322812|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322813|NCT04864067|Antidotes|antidotes|mesh-ancestor
139322814|NCT04864067|Protective Agents|protective agents|mesh-ancestor
139322815|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322816|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
139322817|NCT04864067|Vitamins|vitamins|mesh-ancestor
139322818|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
139322819|NCT04856176|Paclitaxel|paclitaxel|mesh-list
139322820|NCT04856176|Carboplatin|carboplatin|mesh-list
139322821|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
139322822|NCT04856176|Pemetrexed|pemetrexed|mesh-list
139322823|NCT04856176|Molgramostim|molgramostim|mesh-list
139322824|NCT04856176|Sargramostim|sargramostim|mesh-list
139322825|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139322826|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322827|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
139322828|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
139322829|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
139322830|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322831|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139322832|NCT04856176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139322833|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322834|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139322835|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139322836|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
139322837|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322838|NCT04814355|Celecoxib|celecoxib|mesh-list
139322839|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139322840|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139322841|NCT04814355|Analgesics|analgesics|mesh-ancestor
139322842|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
139322843|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322844|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322845|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139322846|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139322847|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139322848|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139322849|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178017|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139322850|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322851|NCT04759274|Diuretics|diuretics|mesh-list
139322852|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
139322853|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322854|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
139322855|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139322856|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
139322857|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139322858|NCT04732000|Expectorants|expectorants|mesh-ancestor
139322859|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
139322860|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139322861|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
139322862|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322863|NCT04732000|Protective Agents|protective agents|mesh-ancestor
139322864|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322865|NCT04732000|Antidotes|antidotes|mesh-ancestor
139322866|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139322867|NCT04720157|177Lu-PSMA-617|177lu-psma-617|mesh-list
139322868|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139322869|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979712|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
139322870|NCT04710498|Atezolizumab|atezolizumab|mesh-list
139322871|NCT04710498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139322872|NCT04710498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322873|NCT04710498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139322874|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322875|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139322876|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139322877|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322878|NCT04682158|Paclitaxel|paclitaxel|mesh-list
139322879|NCT04682158|Carboplatin|carboplatin|mesh-list
139322880|NCT04682158|Propranolol|propranolol|mesh-list
139322881|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139322882|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322883|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
139322884|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
139322885|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
139322886|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322887|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139322888|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139322889|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
139322890|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322891|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322892|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139322893|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139322894|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
139322895|NCT04658160|Imidacloprid|imidacloprid|mesh-list
139322896|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
139322897|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322898|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322899|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322900|NCT04648241|Vaccines|vaccines|mesh-list
139322901|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
139322902|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322903|NCT04642469|Durvalumab|durvalumab|mesh-list
139322904|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139322905|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322906|NCT04630730|Gemcitabine|gemcitabine|mesh-list
139322907|NCT04630730|Atezolizumab|atezolizumab|mesh-list
139322908|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
139322909|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322910|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139322911|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
139322912|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322913|NCT04630730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139322914|NCT04630730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139322915|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139322916|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
139322917|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322918|NCT04614584|Mirtazapine|mirtazapine|mesh-list
139322919|NCT04614584|Methamphetamine|methamphetamine|mesh-list
139322920|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
138729095|NCT03833921|Hormones|hormones|mesh-ancestor
139322921|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139322922|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139322923|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
139322925|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322926|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322927|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322928|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139322929|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139322930|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322931|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139322932|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139322933|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139322934|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
139322935|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139322936|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139322937|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
139322938|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139322939|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139322940|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
139322941|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
138979784|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
139322942|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322944|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139322945|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139322946|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139322947|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139322948|NCT04606264|Dexamethasone|dexamethasone|mesh-list
139322949|NCT04606264|Morphine|morphine|mesh-list
139322950|NCT04606264|Hydromorphone|hydromorphone|mesh-list
139322951|NCT04606264|Ondansetron|ondansetron|mesh-list
139322952|NCT04606264|Aprepitant|aprepitant|mesh-list
139322953|NCT04606264|Dimenhydrinate|dimenhydrinate|mesh-list
139322954|NCT04606264|Perphenazine|perphenazine|mesh-list
139322955|NCT04606264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139322956|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
139322957|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
139322958|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139322959|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322960|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139322961|NCT04606264|Glucocorticoids|glucocorticoids|mesh-ancestor
139322962|NCT04606264|Hormones|hormones|mesh-ancestor
139322963|NCT04606264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139322964|NCT04606264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139322965|NCT04606264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322966|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139322967|NCT04606264|Narcotics|narcotics|mesh-ancestor
139322968|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139322969|NCT04606264|Analgesics|analgesics|mesh-ancestor
139322970|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
139322971|NCT04606264|Antipruritics|antipruritics|mesh-ancestor
139322972|NCT04606264|Dermatologic Agents|dermatologic agents|mesh-ancestor
139322973|NCT04606264|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139322974|NCT04606264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139322975|NCT04606264|Serotonin Agents|serotonin agents|mesh-ancestor
139322976|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322977|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322978|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139322979|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139322980|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139322981|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139322982|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139322983|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
139322984|NCT04606264|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139322985|NCT04606264|Histamine Antagonists|histamine antagonists|mesh-ancestor
139322986|NCT04606264|Histamine Agents|histamine agents|mesh-ancestor
139322987|NCT04604782|Regadenoson|regadenoson|mesh-list
139322988|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139322989|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139322990|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
139322991|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
139322992|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139322993|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139322994|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139322995|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
139322996|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139322997|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139322998|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139322999|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323000|NCT04589832|Entrectinib|entrectinib|mesh-list
139323001|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139323002|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323003|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323004|NCT04573192|Lomustine|lomustine|mesh-list
139323005|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139323006|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
139323007|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323008|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323009|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
139323010|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
139323011|NCT04518124|Propranolol|propranolol|mesh-list
139323012|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139323013|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139323014|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
139323015|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139323016|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979866|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
139323017|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323018|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139323019|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139323020|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
139323021|NCT04487834|Simethicone|simethicone|mesh-list
139323022|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
139323023|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323024|NCT04487834|Emollients|emollients|mesh-ancestor
139323025|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
139323026|NCT04474353|Temozolomide|temozolomide|mesh-list
139323027|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139323028|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
139323029|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323030|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323031|NCT04473716|Paclitaxel|paclitaxel|mesh-list
139323032|NCT04473716|Cisplatin|cisplatin|mesh-list
139323033|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139323034|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323035|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
139323036|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
139323037|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
139323038|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323039|NCT04458259|Axitinib|axitinib|mesh-list
139323040|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323041|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139323042|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323043|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323044|NCT04432623|Benserazide|benserazide|mesh-list
139323045|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139323046|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139323047|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323048|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323049|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
139323050|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139323051|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323052|NCT04431258|Folfirinox|folfirinox|mesh-list
139323053|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323055|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
139323056|NCT04426591|Vitamins|vitamins|mesh-ancestor
139323057|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
139323058|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323059|NCT04417257|Fenretinide|fenretinide|mesh-list
139323060|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139178028|NCT01180075|Emtricitabine|emtricitabine|mesh-list
139323061|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139323062|NCT04417257|Protective Agents|protective agents|mesh-ancestor
139323063|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323064|NCT04396587|Sufentanil|sufentanil|mesh-list
139323065|NCT04396587|Oxycodone|oxycodone|mesh-list
139323066|NCT04396587|Hydromorphone|hydromorphone|mesh-list
139323067|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139323068|NCT04396587|Narcotics|narcotics|mesh-ancestor
139323069|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139323070|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323071|NCT04396587|Analgesics|analgesics|mesh-ancestor
139323072|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
139323073|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323074|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139323075|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139323076|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
139323077|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
139323078|NCT04393506|Apatinib|apatinib|mesh-list
139323079|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139323080|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323081|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139323082|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323083|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323084|NCT04393506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323085|NCT04366726|Abaloparatide|abaloparatide|mesh-list
139323086|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139323087|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323088|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
139323089|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323090|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323091|NCT04318717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139323092|NCT04318717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323093|NCT04291885|Avelumab|avelumab|mesh-list
139323094|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323095|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323096|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139323097|NCT04270682|Cathartics|cathartics|mesh-ancestor
139323098|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139323099|NCT04261855|Avelumab|avelumab|mesh-list
139323100|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139323101|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323102|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323103|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139323104|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323105|NCT04259398|Propofol|propofol|mesh-list
139323106|NCT04259398|Sevoflurane|sevoflurane|mesh-list
139323107|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139323108|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139323109|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323110|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139323111|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
139323112|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
139323113|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139323114|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139323115|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
139323116|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323117|NCT04250064|Bevacizumab|bevacizumab|mesh-list
139323118|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323119|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323120|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139323121|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139323123|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323124|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
139323125|NCT04245514|Durvalumab|durvalumab|mesh-list
139323126|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323127|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323128|NCT04184999|Dexamethasone|dexamethasone|mesh-list
139323129|NCT04184999|Prednisolone|prednisolone|mesh-list
139323130|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139323131|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
139323132|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139323133|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
139323134|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139323135|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
139323136|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139323137|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
139323138|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
139323139|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323140|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323141|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139323142|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
139323143|NCT04184999|Hormones|hormones|mesh-ancestor
139323144|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139323145|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139323146|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323147|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139323148|NCT04184999|Protective Agents|protective agents|mesh-ancestor
139323149|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
139323150|NCT04173416|Narcotics|narcotics|mesh-ancestor
139323151|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139323152|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323153|NCT04173416|Analgesics|analgesics|mesh-ancestor
139323154|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
139323155|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323156|NCT04167163|Abaloparatide|abaloparatide|mesh-list
139323157|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139323158|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323159|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
139323160|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
139323161|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139323162|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139323163|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139323164|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323165|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323166|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980005|NCT00613574|Bromides|bromides|mesh-list
139323167|NCT04131829|Fluoxetine|fluoxetine|mesh-list
139323168|NCT04131829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139323169|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139323171|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323172|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139323173|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
139323174|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323175|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139323176|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
139323177|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139323178|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139323179|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139323180|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323181|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
139323182|NCT04088864|Fludarabine|fludarabine|mesh-list
139323183|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139323184|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
139323185|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323186|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139323187|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139323188|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
139323189|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323190|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323191|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139323192|NCT04058990|Paclitaxel|paclitaxel|mesh-list
139323193|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139323194|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139323195|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323196|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
139323197|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
139323198|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
139323199|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323200|NCT04028466|Omeprazole|omeprazole|mesh-list
139323201|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139323202|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139323203|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139323204|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323205|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323206|NCT04007393|Topiramate|topiramate|mesh-list
139323207|NCT04007393|Phentermine|phentermine|mesh-list
139323208|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
139323209|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139323210|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323211|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139323212|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
139323213|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139323214|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
139323215|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
139323216|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323217|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
139323218|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139323219|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323220|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
139323221|NCT03999203|Citric Acid|citric acid|mesh-list
139323222|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
139323223|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139323224|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
139323225|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323226|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323227|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139323228|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
139323229|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139323230|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
139323231|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323232|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139323233|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139323234|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
139323235|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
139323236|NCT03999203|Protective Agents|protective agents|mesh-ancestor
139323237|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
139323238|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139323239|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
139323240|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
139323241|NCT03996265|Bupropion|bupropion|mesh-list
138980091|NCT00141037|Prednisone|prednisone|mesh-list
139323242|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139323243|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
139323244|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139323245|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139323246|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138911881|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
139323247|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139323248|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323249|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
139323250|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139323251|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323252|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139323253|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139323254|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323255|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139323256|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
139323257|NCT03989466|Antibodies|antibodies|mesh-list
139323258|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
139323259|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139323260|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
139323261|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323262|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323263|NCT03984214|Dronabinol|dronabinol|mesh-list
139323264|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
139323265|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323266|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139323267|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139323268|NCT03984214|Analgesics|analgesics|mesh-ancestor
139323269|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
139323270|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323271|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139323272|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139323273|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139323274|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323275|NCT03984214|Hormones|hormones|mesh-ancestor
139323276|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139323277|NCT03982381|Metformin|metformin|mesh-list
139323278|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
139323279|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139323280|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323281|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139323282|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323283|NCT03979365|Tacrolimus|tacrolimus|mesh-list
139323284|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139323285|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
139323286|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323287|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139323288|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323289|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323290|NCT03969823|Osimertinib|osimertinib|mesh-list
139323291|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323292|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139323293|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323294|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323295|NCT03917940|Glimepiride|glimepiride|mesh-list
139323296|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139323297|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139323298|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323299|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139323300|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
139323302|NCT03906669|Letrozole|letrozole|mesh-list
139323303|NCT03906669|Progesterone|progesterone|mesh-list
139323304|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323305|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139323306|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139323307|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323308|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323309|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139323310|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
139323311|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139323312|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323313|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138980158|NCT00888602|Cathartics|cathartics|mesh-ancestor
139323314|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139323315|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139323316|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139323318|NCT03906669|Hormones|hormones|mesh-ancestor
139323319|NCT03889912|Cemiplimab|cemiplimab|mesh-list
139323320|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323321|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323322|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
139323323|NCT03882060|Hematinics|hematinics|mesh-ancestor
139323324|NCT03831295|Antibodies|antibodies|mesh-list
139323325|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
139323326|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323327|NCT03818191|Acamprosate|acamprosate|mesh-list
139323328|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139323329|NCT03800134|Paclitaxel|paclitaxel|mesh-list
139323330|NCT03800134|Cisplatin|cisplatin|mesh-list
139323331|NCT03800134|Carboplatin|carboplatin|mesh-list
139323332|NCT03800134|Gemcitabine|gemcitabine|mesh-list
139323333|NCT03800134|Pemetrexed|pemetrexed|mesh-list
139323334|NCT03800134|Durvalumab|durvalumab|mesh-list
139323335|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139323336|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323337|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
139323338|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
139323339|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
139323340|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323341|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139323342|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
139323343|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323344|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139323345|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139323346|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323347|NCT03792763|Denosumab|denosumab|mesh-list
139323348|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139323349|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139323350|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323351|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
139323352|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323353|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323354|NCT03792347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139323355|NCT03792347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323356|NCT03771651|Aspirin|aspirin|mesh-list
139323357|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139323358|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139323359|NCT03771651|Analgesics|analgesics|mesh-ancestor
139323360|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
139323361|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323362|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323363|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139323364|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139323365|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139323366|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139323367|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323368|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139323369|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139323370|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323371|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
139323372|NCT03738696|Bupivacaine|bupivacaine|mesh-list
139323373|NCT03738696|Ropivacaine|ropivacaine|mesh-list
139323374|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
139323375|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
139323376|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139323377|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323378|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
139323379|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323380|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
139323381|NCT03709680|Temozolomide|temozolomide|mesh-list
139323382|NCT03709680|Irinotecan|irinotecan|mesh-list
139323383|NCT03709680|Topotecan|topotecan|mesh-list
139323384|NCT03709680|Palbociclib|palbociclib|mesh-list
139323385|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139323386|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
139323387|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323388|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139323389|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139323390|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
139323391|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323392|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323393|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139323394|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139323395|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139323396|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323397|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139323398|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
139323399|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
139323400|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139323401|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139323402|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323403|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323404|NCT03686306|Urological Agents|urological agents|mesh-ancestor
139323405|NCT03681652|Azathioprine|azathioprine|mesh-list
139323406|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139323407|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
139323408|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323409|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139323410|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323411|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139323412|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
139323413|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323414|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139323415|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323416|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323417|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139323418|NCT03677596|Immunotoxins|immunotoxins|mesh-ancestor
139323419|NCT03677596|Immunoconjugates|immunoconjugates|mesh-ancestor
139323420|NCT03677596|Immunologic Factors|immunologic factors|mesh-ancestor
139323421|NCT03677596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323422|NCT03614741|Tinzaparin|tinzaparin|mesh-list
139323423|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139323424|NCT03614741|Dalteparin|dalteparin|mesh-list
139323425|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
139323426|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139323427|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139323428|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323429|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139323430|NCT03548454|Desipramine|desipramine|mesh-list
139323431|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139323432|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139323433|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139323434|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323435|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139323436|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323438|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
139323439|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323440|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
139323441|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139323442|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
139323443|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139323444|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323445|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139323446|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
139323447|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
139323448|NCT03513211|Itraconazole|itraconazole|mesh-list
139323449|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
139323450|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139323451|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139323452|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139323453|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323454|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323455|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139323456|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
139323457|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139323458|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139323459|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139323460|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
139323461|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139323462|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323463|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139323464|NCT03458429|Lenograstim|lenograstim|mesh-list
139323465|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139323466|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
139323467|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323468|NCT03448718|Olaparib|olaparib|mesh-list
139323469|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139323470|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323471|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323472|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323473|NCT03403621|Pentamidine|pentamidine|mesh-list
139323474|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
139323475|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139323476|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139323477|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139323478|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139323479|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139323480|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139323481|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323482|NCT03361735|Leuprolide|leuprolide|mesh-list
139323483|NCT03361735|Goserelin|goserelin|mesh-list
139323484|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139323485|NCT03361735|Hormones|hormones|mesh-list
139323486|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139178106|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
139323487|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323488|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139323489|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
139323490|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139323491|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139323492|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323493|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
139323494|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139323495|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
139323496|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139323497|NCT03306979|Expectorants|expectorants|mesh-ancestor
139323498|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
139323499|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139323500|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
139323501|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323502|NCT03306979|Protective Agents|protective agents|mesh-ancestor
139323503|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323504|NCT03306979|Antidotes|antidotes|mesh-ancestor
139323505|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
139323506|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323507|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323508|NCT03217071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139323509|NCT03217071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323510|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
139323511|NCT03199053|Saxagliptin|saxagliptin|mesh-list
139323512|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139323513|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323514|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139323515|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323516|NCT03199053|Incretins|incretins|mesh-ancestor
139323518|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139323519|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139323520|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
139323521|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323522|NCT03176173|Immunomodulating Agents|immunomodulating agents|mesh-list
139323523|NCT03176173|Immunologic Factors|immunologic factors|mesh-ancestor
139323524|NCT03176173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323525|NCT03168880|Paclitaxel|paclitaxel|mesh-list
139323526|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139323527|NCT03168880|Carboplatin|carboplatin|mesh-list
139323528|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139323529|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323530|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
139323531|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
139323532|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
139323533|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323534|NCT03149575|Carboplatin|carboplatin|mesh-list
139323535|NCT03149575|Temozolomide|temozolomide|mesh-list
139323536|NCT03149575|Lomustine|lomustine|mesh-list
139323537|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
139323538|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323539|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139323540|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
139323541|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323542|NCT03063749|Sirolimus|sirolimus|mesh-list
139323543|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139323544|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139323545|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139323546|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323547|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
139323548|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139323549|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
139323550|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323551|NCT03042936|Insulin|insulin|mesh-list
139323552|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139323553|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323554|NCT03027388|LB100|lb100|mesh-list
139323555|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323556|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323557|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323558|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
139323559|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139323560|NCT03007589|Protective Agents|protective agents|mesh-ancestor
139323561|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323562|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
139323563|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139323564|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139323565|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139323566|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
139323567|NCT02993029|Celecoxib|celecoxib|mesh-list
139323568|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139323569|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139323570|NCT02993029|Analgesics|analgesics|mesh-ancestor
139323571|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
139323572|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323573|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323574|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139323575|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139323576|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139323577|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139323578|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323579|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323580|NCT02992964|Nivolumab|nivolumab|mesh-list
139323581|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323582|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323583|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139323584|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323585|NCT02934282|HBOC 201|hboc 201|mesh-list
139323586|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
139323587|NCT02900976|Rituximab|rituximab|mesh-list
139323588|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139323589|NCT02900976|Antibodies|antibodies|mesh-list
139323590|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
139323591|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139323592|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
139323593|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323594|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323595|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139323596|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
139323597|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
139323598|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139323599|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323600|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323601|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
139323602|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139323603|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139323604|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323605|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
139323606|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139323607|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
139323608|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323609|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323610|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
139323611|NCT02693535|Nivolumab|nivolumab|mesh-list
139323612|NCT02693535|Trastuzumab|trastuzumab|mesh-list
139323613|NCT02693535|Ipilimumab|ipilimumab|mesh-list
139323614|NCT02693535|Atezolizumab|atezolizumab|mesh-list
139323615|NCT02693535|Pertuzumab|pertuzumab|mesh-list
139323616|NCT02693535|Sunitinib|sunitinib|mesh-list
139323617|NCT02693535|Olaparib|olaparib|mesh-list
139323618|NCT02693535|Palbociclib|palbociclib|mesh-list
139323619|NCT02693535|Temsirolimus|temsirolimus|mesh-list
139323620|NCT02693535|Vemurafenib|vemurafenib|mesh-list
139323621|NCT02693535|Talazoparib|talazoparib|mesh-list
139323622|NCT02693535|Tucatinib|tucatinib|mesh-list
139323623|NCT02693535|Futibatinib|futibatinib|mesh-list
139323624|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139323625|NCT02693535|Entrectinib|entrectinib|mesh-list
139323626|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323627|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323628|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139323629|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323630|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
139323631|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323632|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139323633|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139323634|NCT02693535|Growth Substances|growth substances|mesh-ancestor
139323635|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
139323636|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139323637|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323638|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139323639|NCT02693535|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139323640|NCT02693535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139323641|NCT02672917|Paclitaxel|paclitaxel|mesh-list
139323642|NCT02672917|Gemcitabine|gemcitabine|mesh-list
139323643|NCT02672917|Folfirinox|folfirinox|mesh-list
139323644|NCT02672917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139323645|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323646|NCT02672917|Tubulin Modulators|tubulin modulators|mesh-ancestor
139323647|NCT02672917|Antimitotic Agents|antimitotic agents|mesh-ancestor
139323648|NCT02672917|Mitosis Modulators|mitosis modulators|mesh-ancestor
139323649|NCT02672917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323650|NCT02672917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139323651|NCT02672917|Antimetabolites|antimetabolites|mesh-ancestor
139323652|NCT02672475|Paclitaxel|paclitaxel|mesh-list
139323653|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139323654|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139323655|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323656|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
139323657|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
139323658|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
139323659|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323660|NCT02572843|Durvalumab|durvalumab|mesh-list
139323661|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323662|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323663|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
139323664|NCT02546583|Furosemide|furosemide|mesh-list
139323665|NCT02546583|Bumetanide|bumetanide|mesh-list
139323666|NCT02546583|Diuretics|diuretics|mesh-list
139323667|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
139323668|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
139323669|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323670|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139323671|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323672|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139323673|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139323674|NCT02542696|Apomorphine|apomorphine|mesh-list
139323675|NCT02542696|Emetics|emetics|mesh-ancestor
139323676|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323677|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
139323678|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323679|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139323680|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
139323681|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
139323682|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139323683|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323684|NCT02503722|Osimertinib|osimertinib|mesh-list
139323685|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323686|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139323687|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323688|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323689|NCT02346253|Leuprolide|leuprolide|mesh-list
138980544|NCT02542592|Hormones|hormones|mesh-ancestor
139323690|NCT02346253|Goserelin|goserelin|mesh-list
139323691|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139323692|NCT02346253|Bicalutamide|bicalutamide|mesh-list
139323693|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139323694|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
139323695|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139323696|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323697|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139323698|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323699|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
139323700|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
139323701|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139323702|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
139323703|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139323704|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
139323705|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139323706|NCT02339740|Vitamins|vitamins|mesh-list
139323707|NCT02339740|Vitamin A|vitamin a|mesh-list
139323708|NCT02339740|Cytarabine|cytarabine|mesh-list
139323709|NCT02339740|Dexamethasone|dexamethasone|mesh-list
139323710|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
139323711|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
139323712|NCT02339740|Idarubicin|idarubicin|mesh-list
139323713|NCT02339740|Tretinoin|tretinoin|mesh-list
139323714|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
139323715|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
139323716|NCT02339740|BB 1101|bb 1101|mesh-list
139323717|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
139323718|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323719|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139323720|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
139323721|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
139323722|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323723|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139323724|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
139323725|NCT02339740|Hormones|hormones|mesh-ancestor
139323726|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139323727|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139323728|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323729|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
139323730|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323731|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323732|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139323733|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
139323734|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
139323735|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139323736|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139323737|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
139323738|NCT02339740|Analgesics|analgesics|mesh-ancestor
139323739|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
139323740|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139323741|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139323742|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139323743|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
139323744|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
139323745|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
139323746|NCT02339740|Protective Agents|protective agents|mesh-ancestor
139323747|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139323748|NCT02311179|Cimetidine|cimetidine|mesh-list
139323749|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139323750|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139323751|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139323752|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
139323753|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
139323754|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139323755|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323756|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323757|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139323758|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139323759|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323760|NCT01916317|Lidocaine|lidocaine|mesh-list
139323761|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
139323762|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
139323763|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139323764|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323765|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
139323766|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323767|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139323768|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139323769|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139323770|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139323771|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323772|NCT01785420|Trastuzumab|trastuzumab|mesh-list
139323773|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323774|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323775|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
139323776|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139323777|NCT01682941|Estrogens|estrogens|mesh-ancestor
139323778|NCT01682941|Hormones|hormones|mesh-ancestor
139323779|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139323780|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323781|NCT01631292|Vitamin D|vitamin d|mesh-list
139323782|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
139323783|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
139323784|NCT01631292|Vitamins|vitamins|mesh-list
139323785|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
139323786|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323787|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139323788|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139323789|NCT01589302|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139323790|NCT01589302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139323791|NCT01589302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323792|NCT01589302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323793|NCT01397552|Dexamethasone|dexamethasone|mesh-list
139323794|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
139323795|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139323796|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139323797|NCT01397552|Prednisolone|prednisolone|mesh-list
139323798|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
139323799|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139323800|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
139323801|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139323802|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
139323803|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
139323804|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323805|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323806|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139323807|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
139323809|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139323810|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139323811|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323812|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138911994|NCT00446563|Diuretics|diuretics|mesh-ancestor
139323813|NCT01397552|Protective Agents|protective agents|mesh-ancestor
139323814|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
139323815|NCT01096368|Cisplatin|cisplatin|mesh-list
139323816|NCT01096368|Carboplatin|carboplatin|mesh-list
139323817|NCT01096368|Etoposide|etoposide|mesh-list
139323818|NCT01096368|Vincristine|vincristine|mesh-list
139323819|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
139323820|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
139323821|NCT01096368|Lenograstim|lenograstim|mesh-list
139323822|NCT01096368|Mesna|mesna|mesh-list
139323823|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139323824|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
139323825|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323826|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139323827|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139323828|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
139323829|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323830|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323831|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139323832|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139323833|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139323834|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139323835|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323836|NCT01096368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139323837|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
139323838|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
139323839|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
139323840|NCT01096368|Protective Agents|protective agents|mesh-ancestor
139323841|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
139323842|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
139323843|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139323844|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139323845|NCT01020903|Aprepitant|aprepitant|mesh-list
139323846|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
139323848|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139323849|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323850|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139323851|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139323852|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139323853|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323854|NCT00938587|Prednisone|prednisone|mesh-list
139323855|NCT00938587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139323856|NCT00938587|Glucocorticoids|glucocorticoids|mesh-ancestor
139323857|NCT00938587|Hormones|hormones|mesh-ancestor
139323858|NCT00938587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139323859|NCT00938587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323860|NCT00938587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139323861|NCT00938587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323862|NCT00810693|Riociguat|riociguat|mesh-list
139323863|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
139323864|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323865|NCT00679120|Cimetidine|cimetidine|mesh-list
139323866|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139323867|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139323868|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139323869|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
139323870|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
139323871|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139323872|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323873|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323874|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139323875|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139323876|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323877|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
139323878|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139323879|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323880|NCT00381641|Sunitinib|sunitinib|mesh-list
139323881|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323882|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139323883|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139323884|NCT00381641|Growth Substances|growth substances|mesh-ancestor
139323885|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323886|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
139323887|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139323888|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323889|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323890|NCT00334815|Bevacizumab|bevacizumab|mesh-list
139323891|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139323892|NCT00334815|Cisplatin|cisplatin|mesh-list
139323893|NCT00334815|Docetaxel|docetaxel|mesh-list
139323894|NCT00334815|Etoposide|etoposide|mesh-list
139323895|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
139323896|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
139323897|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
139323898|NCT00334815|Antibodies|antibodies|mesh-list
139323899|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
139323900|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139323901|NCT00334815|Lenograstim|lenograstim|mesh-list
139323902|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
139323903|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323904|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139323905|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139323906|NCT00334815|Growth Substances|growth substances|mesh-ancestor
139323907|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323908|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
139323909|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
139323910|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
139323911|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
139323912|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
139323913|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323914|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139323915|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139323916|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139323917|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323918|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139323919|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
139323920|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
139323921|NCT05233982|Olaparib|olaparib|mesh-list
139323922|NCT05233982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139323923|NCT05233982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323924|NCT05233982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323925|NCT05233982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323926|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
139323927|NCT05199493|Giapreza|giapreza|mesh-list
139323928|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
139323929|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139323930|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139323931|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
139323932|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323933|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323934|NCT05112536|Paclitaxel|paclitaxel|mesh-list
139323935|NCT05112536|Carboplatin|carboplatin|mesh-list
139323936|NCT05112536|Doxorubicin|doxorubicin|mesh-list
139323937|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
139323938|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139323939|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323940|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
139323941|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
139323942|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
139323943|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323944|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139323945|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139323946|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139323947|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323948|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323949|NCT05112536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139323950|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
139323951|NCT05109455|Procyanidin|procyanidin|mesh-list
139323952|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
139323953|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323954|NCT05109455|Protective Agents|protective agents|mesh-ancestor
139323955|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323956|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139323957|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139323958|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139323959|NCT05079360|Everolimus|everolimus|mesh-list
139323960|NCT05079360|Exemestane|exemestane|mesh-list
139323961|NCT05079360|Estrogens|estrogens|mesh-list
139323962|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
139323963|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
139323964|NCT05079360|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139323965|NCT05079360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139323966|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139323967|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323968|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139323969|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
139323970|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323971|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323972|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139323973|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139323974|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139323975|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
139323976|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139323977|NCT05079360|Hormones|hormones|mesh-ancestor
139323978|NCT05078060|Vaccines|vaccines|mesh-list
139323979|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
139323980|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139323981|NCT05063786|Capecitabine|capecitabine|mesh-list
139323982|NCT05063786|Trastuzumab|trastuzumab|mesh-list
139323983|NCT05063786|Vinorelbine|vinorelbine|mesh-list
139323984|NCT05063786|Fulvestrant|fulvestrant|mesh-list
139323985|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139323986|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
139323987|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139323988|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139323989|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139323990|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139323991|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
139323992|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
139323993|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
139323994|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139323995|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138980841|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
139323996|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139323997|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
139323998|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139323999|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324000|NCT05012787|Vaccines|vaccines|mesh-list
139324001|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
139324002|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
139324003|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324004|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139324005|NCT04990167|Bromides|bromides|mesh-list
139324006|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
139324007|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139324008|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
139324009|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324010|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324011|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139324012|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
139324013|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
139324014|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139324015|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
139324016|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324017|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324018|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
139324019|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
139324020|NCT04918927|Favipiravir|favipiravir|mesh-list
139324021|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139324022|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324023|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
139324024|NCT04907084|Fenofibrate|fenofibrate|mesh-list
139324025|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139324026|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
139324027|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324028|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139324029|NCT04857983|Memantine|memantine|mesh-list
139324030|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139324031|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139324032|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
139324033|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324034|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324035|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324036|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139324037|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139324038|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
139324039|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324040|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324041|NCT04777708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139324042|NCT04777708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324043|NCT04763512|Caseins|caseins|mesh-list
139324044|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
139324045|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
139324046|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324047|NCT04730349|Nivolumab|nivolumab|mesh-list
139324048|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324049|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324050|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138912055|NCT00650104|Ropinirole|ropinirole|mesh-list
139324051|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324052|NCT04517396|Fenofibrate|fenofibrate|mesh-list
139324053|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
139324054|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139324055|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
139324056|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324057|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139324058|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139324059|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139324060|NCT04382352|Trastuzumab|trastuzumab|mesh-list
139324061|NCT04382352|Antibodies|antibodies|mesh-list
139324062|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
139324063|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139324064|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
139324065|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324066|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324067|NCT04311424|Tirzepatide|tirzepatide|mesh-list
139324068|NCT04311424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139324069|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980918|NCT01077661|Nebivolol|nebivolol|mesh-list
139324070|NCT04311424|Incretins|incretins|mesh-ancestor
139324072|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324074|NCT04301765|Androgens|androgens|mesh-ancestor
139324075|NCT04301765|Hormones|hormones|mesh-ancestor
139324076|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324077|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324078|NCT04291456|Minocycline|minocycline|mesh-list
139324079|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139324080|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324081|NCT04266977|Dexamethasone|dexamethasone|mesh-list
139324082|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139324083|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
139324084|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
139324085|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324086|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324087|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139324088|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
139324089|NCT04266977|Hormones|hormones|mesh-ancestor
139324090|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324091|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139324092|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324093|NCT04172922|Sirolimus|sirolimus|mesh-list
139324094|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139324095|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324096|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139324097|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324098|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
139324099|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139324100|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
139324101|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324102|NCT04139772|Docetaxel|docetaxel|mesh-list
139324103|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
139324104|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324105|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
139324106|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324107|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324108|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324109|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139324110|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324111|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
139324112|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324113|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324114|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139324115|NCT04091204|Olaparib|olaparib|mesh-list
139324116|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139324117|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324118|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324119|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324120|NCT04028245|Spartalizumab|spartalizumab|mesh-list
139324121|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139324122|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324123|NCT04028245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324124|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324125|NCT03975114|Durvalumab|durvalumab|mesh-list
139324126|NCT03975114|Tremelimumab|tremelimumab|mesh-list
139324127|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324128|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324129|NCT03955783|Venetoclax|venetoclax|mesh-list
139324130|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324131|NCT03942120|Ustekinumab|ustekinumab|mesh-list
139324132|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
139324133|NCT03940742|Tirzepatide|tirzepatide|mesh-list
139324134|NCT03940742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139324135|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324136|NCT03940742|Incretins|incretins|mesh-ancestor
139324137|NCT03940742|Hormones|hormones|mesh-ancestor
139324138|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324139|NCT03893240|Antibodies|antibodies|mesh-list
139324140|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
139324141|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
139324142|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324143|NCT03875274|Morphine|morphine|mesh-list
139324144|NCT03875274|Ropivacaine|ropivacaine|mesh-list
139324145|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139324146|NCT03875274|Narcotics|narcotics|mesh-ancestor
139324147|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139324148|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324149|NCT03875274|Analgesics|analgesics|mesh-ancestor
139324150|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
139324151|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324152|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
139324153|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
139324154|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
139324155|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324156|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324157|NCT03775850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139324158|NCT03775850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324159|NCT03762109|Dantrolene|dantrolene|mesh-list
139324160|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139324161|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324162|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139324163|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324164|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
139324165|NCT03732664|Nivolumab|nivolumab|mesh-list
139324166|NCT03732664|Durvalumab|durvalumab|mesh-list
139324167|NCT03732664|Tislelizumab|tislelizumab|mesh-list
139324168|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324169|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324170|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139324171|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324172|NCT03410784|Paclitaxel|paclitaxel|mesh-list
139324173|NCT03410784|Carboplatin|carboplatin|mesh-list
139324174|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
139324175|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139324176|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324177|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
139324178|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324179|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324180|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324181|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324182|NCT03410784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139324183|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
139324184|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
139324185|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324186|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
139324187|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139324188|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139324189|NCT03355482|Prednisolone|prednisolone|mesh-list
139324190|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
139324191|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139324192|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
139324193|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139324194|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
139324195|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
139324196|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324197|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324198|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139324199|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
139324200|NCT03355482|Hormones|hormones|mesh-ancestor
139324201|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324202|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139324203|NCT03355482|Protective Agents|protective agents|mesh-ancestor
139324204|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139324205|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324206|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139324207|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324208|NCT03310619|Nivolumab|nivolumab|mesh-list
139324209|NCT03310619|Durvalumab|durvalumab|mesh-list
139324210|NCT03310619|Relatlimab|relatlimab|mesh-list
139324211|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324212|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324213|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139324214|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324215|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
139324216|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
139324217|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324218|NCT03093064|Natalizumab|natalizumab|mesh-list
139324219|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
139324220|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981074|NCT00893048|Prednisone|prednisone|mesh-list
139324221|NCT03060577|Evolocumab|evolocumab|mesh-list
139324222|NCT03060577|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139324223|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139324224|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139324225|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
139324226|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324227|NCT03060577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139324228|NCT03060577|Protease Inhibitors|protease inhibitors|mesh-ancestor
139324229|NCT03060577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324230|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139324231|NCT02797275|Albuterol|albuterol|mesh-list
138912090|NCT00814762|Vaccines|vaccines|mesh-list
139324232|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139324233|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
139324234|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324235|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324236|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139324237|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
139324238|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
139324239|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139324240|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139324241|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139324242|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139324243|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
139324244|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324245|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324246|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
139324247|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324248|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324249|NCT02787005|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139324250|NCT02787005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324251|NCT02734290|Paclitaxel|paclitaxel|mesh-list
139324252|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
139324253|NCT02734290|Capecitabine|capecitabine|mesh-list
139324254|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139324255|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324256|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
139324257|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324258|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324259|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324260|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324261|NCT02734290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139324262|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139324263|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
139324264|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
139324265|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324266|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324267|NCT02673333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139324268|NCT02673333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324269|NCT02633189|Bevacizumab|bevacizumab|mesh-list
139324270|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139324271|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324272|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324273|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139324274|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139324275|NCT02633189|Growth Substances|growth substances|mesh-ancestor
139324276|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324277|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
139324278|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139324279|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324280|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324281|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139324282|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139324283|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139324284|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324285|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324286|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
139324287|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324288|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139324289|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139324290|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
139324291|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139324292|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324293|NCT02514083|Fludarabine|fludarabine|mesh-list
139324294|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324295|NCT02500576|Aldesleukin|aldesleukin|mesh-list
139324296|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
139324297|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
139324298|NCT02500576|Fludarabine|fludarabine|mesh-list
139324299|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
139324300|NCT02500576|Interleukin-2|interleukin-2|mesh-list
139324301|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139324302|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
139324303|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324304|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139324305|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139324306|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
139324307|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324308|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324309|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139324310|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324311|NCT02500576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139324312|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139324313|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
139324314|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139324315|NCT02500576|Analgesics|analgesics|mesh-ancestor
139324316|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
139324317|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324318|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139324319|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139324320|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
139324321|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324322|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
139324323|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139324324|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324326|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
139324327|NCT02214381|Doxorubicin|doxorubicin|mesh-list
139324328|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139324329|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324330|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
139324331|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324332|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324333|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324334|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139324335|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
139324336|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324337|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139324338|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139324339|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
139324340|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139324341|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139324342|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139324343|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139324344|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324346|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139324347|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
139324348|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324349|NCT02061761|Nivolumab|nivolumab|mesh-list
139324350|NCT02061761|Relatlimab|relatlimab|mesh-list
139324351|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324352|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324353|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139324354|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324355|NCT01927068|Paclitaxel|paclitaxel|mesh-list
138912121|NCT02605356|Bortezomib|bortezomib|mesh-list
139324356|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139324357|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324358|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
139324359|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324360|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324361|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324362|NCT01898104|Capecitabine|capecitabine|mesh-list
139324363|NCT01898104|Valproic Acid|valproic acid|mesh-list
139324364|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139324365|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
139324366|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324367|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981215|NCT00127933|Capecitabine|capecitabine|mesh-list
139324368|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
139324369|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324370|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
139324371|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324372|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324373|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
139324374|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139324375|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139324376|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139324377|NCT01817452|Paclitaxel|paclitaxel|mesh-list
139324378|NCT01817452|Trastuzumab|trastuzumab|mesh-list
139324379|NCT01817452|Pertuzumab|pertuzumab|mesh-list
139324380|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139324381|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324382|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
139324383|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324384|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324385|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324386|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324387|NCT01815242|Paclitaxel|paclitaxel|mesh-list
139324388|NCT01815242|Carboplatin|carboplatin|mesh-list
139324389|NCT01815242|Gemcitabine|gemcitabine|mesh-list
139324390|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139324391|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324392|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
139324393|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324394|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324395|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324396|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139324397|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
139324398|NCT01802749|Paclitaxel|paclitaxel|mesh-list
139324399|NCT01802749|Bevacizumab|bevacizumab|mesh-list
139324400|NCT01802749|Carboplatin|carboplatin|mesh-list
139324402|NCT01802749|Doxorubicin|doxorubicin|mesh-list
139324403|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139324404|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139324405|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324406|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
139324407|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324408|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324409|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324410|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324411|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139324412|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139324413|NCT01802749|Growth Substances|growth substances|mesh-ancestor
139324414|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324415|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
139324416|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139324417|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
139324418|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139324419|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139324420|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139324421|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324422|NCT01801904|Panitumumab|panitumumab|mesh-list
139324423|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324424|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324425|NCT01779206|Paclitaxel|paclitaxel|mesh-list
139324426|NCT01779206|Docetaxel|docetaxel|mesh-list
139324427|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
139324428|NCT01779206|Epirubicin|epirubicin|mesh-list
139324429|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139324430|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324431|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
139324432|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324433|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324434|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324435|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139324436|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
139324437|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324438|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139324439|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139324440|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
139324441|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139324442|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139324443|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139324444|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139324445|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324446|NCT01745965|Trastuzumab|trastuzumab|mesh-list
139324448|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324449|NCT01706120|Paclitaxel|paclitaxel|mesh-list
139324450|NCT01706120|Bevacizumab|bevacizumab|mesh-list
139324451|NCT01706120|Carboplatin|carboplatin|mesh-list
139324452|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139324453|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324454|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
139324455|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324456|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324457|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324458|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324459|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139324460|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139324461|NCT01706120|Growth Substances|growth substances|mesh-ancestor
139324462|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324463|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
139324464|NCT01656551|Gemcitabine|gemcitabine|mesh-list
139324465|NCT01656551|Pemetrexed|pemetrexed|mesh-list
139324466|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324467|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139324468|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
139324469|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324470|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324471|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139324472|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139324473|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
139324474|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
139324475|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139324476|NCT01649674|Cathartics|cathartics|mesh-ancestor
139324477|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139324478|NCT01628211|Leucovorin|leucovorin|mesh-list
139324479|NCT01628211|Folic Acid|folic acid|mesh-list
139324480|NCT01628211|Fluorouracil|fluorouracil|mesh-list
139324481|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
139324482|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
139324483|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
139324484|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324485|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139324486|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324487|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139324488|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
139324489|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324490|NCT01628211|Antidotes|antidotes|mesh-ancestor
139324491|NCT01628211|Protective Agents|protective agents|mesh-ancestor
139324492|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
139324493|NCT01628211|Vitamins|vitamins|mesh-ancestor
139324494|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
139324495|NCT01628211|Hematinics|hematinics|mesh-ancestor
139324496|NCT01593488|Cytarabine|cytarabine|mesh-list
139324497|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139324498|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
139324499|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324500|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324501|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
139324502|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324503|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139324504|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
139324505|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324506|NCT01405586|Gemcitabine|gemcitabine|mesh-list
139324507|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324508|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139324509|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
139324510|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324511|NCT01309230|Immunomodulating Agents|immunomodulating agents|mesh-list
139324512|NCT01309230|Immunologic Factors|immunologic factors|mesh-ancestor
139324513|NCT01309230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324514|NCT01238692|Rituximab|rituximab|mesh-list
139324515|NCT01238692|Panobinostat|panobinostat|mesh-list
139324516|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324517|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324518|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
139324519|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324520|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139324521|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139324522|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324523|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324524|NCT00996983|Ziconotide|ziconotide|mesh-list
139324525|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139324526|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139324527|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324528|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139324529|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324530|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139324531|NCT00996983|Protective Agents|protective agents|mesh-ancestor
139324532|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139324533|NCT00996983|Analgesics|analgesics|mesh-ancestor
139324534|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
139324535|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324536|NCT00660842|Paclitaxel|paclitaxel|mesh-list
139324537|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139324538|NCT00660842|Carboplatin|carboplatin|mesh-list
139324539|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139324540|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324541|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
139324542|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324543|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324544|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324545|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
139324546|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139324547|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138730739|NCT04781673|Ketamine|ketamine|mesh-list
139324548|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139324549|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324550|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
139324551|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324552|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324553|NCT00526396|Cisplatin|cisplatin|mesh-list
139324554|NCT00526396|Etoposide|etoposide|mesh-list
139324555|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
139324556|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324557|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139324558|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139324559|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139324560|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324561|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324562|NCT00431704|Carboplatin|carboplatin|mesh-list
139324563|NCT00431704|Trastuzumab|trastuzumab|mesh-list
139324564|NCT00431704|Vinorelbine|vinorelbine|mesh-list
139324565|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324566|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139324567|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139324568|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
139324569|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324570|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324571|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324572|NCT00412022|Tamoxifen|tamoxifen|mesh-list
139324573|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
139324574|NCT00412022|Letrozole|letrozole|mesh-list
139324575|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139324576|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324577|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139324578|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139324579|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324580|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324581|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139324582|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
139324583|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324584|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324585|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139324586|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139324587|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139324588|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139324589|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
139324590|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139324591|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
139324592|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139324593|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139324594|NCT03474510|Bupivacaine|bupivacaine|mesh-list
139324595|NCT03474510|Ropivacaine|ropivacaine|mesh-list
139324596|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
139324597|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
139324598|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139324599|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324600|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
139324601|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324602|NCT02470832|Itraconazole|itraconazole|mesh-list
139324603|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
139324604|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324605|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139324606|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139324607|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324608|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324609|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139324610|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
139324611|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324612|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324613|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139324614|NCT05258682|Acetylcysteine|acetylcysteine|mesh-list
139324615|NCT05258682|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139324616|NCT05258682|Antiviral Agents|antiviral agents|mesh-ancestor
139324617|NCT05258682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324618|NCT05258682|Expectorants|expectorants|mesh-ancestor
139324619|NCT05258682|Respiratory System Agents|respiratory system agents|mesh-ancestor
139324620|NCT05258682|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139324621|NCT05258682|Antioxidants|antioxidants|mesh-ancestor
139324622|NCT05258682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324623|NCT05258682|Protective Agents|protective agents|mesh-ancestor
139324624|NCT05258682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324625|NCT05258682|Antidotes|antidotes|mesh-ancestor
139324626|NCT02228031|Oxytocin|oxytocin|mesh-list
139324627|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
139324628|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139324629|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324630|NCT02232399|Simendan|simendan|mesh-list
139324631|NCT02232399|Milrinone|milrinone|mesh-list
139324632|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139324633|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
139324634|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139324635|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139324636|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324637|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324638|NCT02232399|Protective Agents|protective agents|mesh-ancestor
139324639|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324640|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139324641|NCT00704522|Ribavirin|ribavirin|mesh-list
139324642|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139324643|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
139324644|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324645|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
139324646|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324647|NCT04458558|Mifepristone|mifepristone|mesh-list
139324648|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139324649|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
139324650|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139324651|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324652|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139324653|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139324654|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139324655|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
139324656|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139324657|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139324658|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
139324659|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324660|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
139324661|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139324662|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139324663|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
139324664|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
139324665|NCT03930498|Antibodies|antibodies|mesh-list
139324666|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
139324667|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
139324668|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324669|NCT03817554|Dopamine|dopamine|mesh-list
139324670|NCT03817554|Pramipexole|pramipexole|mesh-list
139324671|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
139324672|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
139324673|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324674|NCT03817554|Protective Agents|protective agents|mesh-ancestor
139324675|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324676|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139324677|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139324678|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
139324679|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324680|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139324681|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
139324682|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
139324683|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324684|NCT02723630|Lenvatinib|lenvatinib|mesh-list
139324685|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324686|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139324687|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324688|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324689|NCT02866227|TOL-463|tol-463|mesh-list
139324690|NCT02866227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324691|NCT05258136|Antibodies|antibodies|mesh-list
139324692|NCT05258136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139324693|NCT05258136|Immunologic Factors|immunologic factors|mesh-ancestor
139324694|NCT05258136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324695|NCT02224131|Aspirin|aspirin|mesh-list
139324696|NCT02224131|Clopidogrel|clopidogrel|mesh-list
139324697|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139324698|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139324699|NCT02224131|Analgesics|analgesics|mesh-ancestor
139324700|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
139324701|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324702|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324703|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139324704|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139324705|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139324706|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139324707|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324708|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139324709|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139324710|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324711|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
139324712|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139324713|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139324714|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139324715|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
139324716|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324717|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139324718|NCT03473964|Hormones|hormones|mesh-ancestor
138912207|NCT00812578|Vitamin D|vitamin d|mesh-list
139324719|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324720|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324721|NCT03309644|Iodine|iodine|mesh-list
139324722|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139324723|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324724|NCT03309644|Trace Elements|trace elements|mesh-ancestor
139324725|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
139324726|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324727|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
139324728|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
139324729|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139324730|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139324731|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324732|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139324733|NCT02008292|Physostigmine|physostigmine|mesh-list
139324734|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139324735|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324736|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324737|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
139324738|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324739|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324740|NCT02008292|Miotics|miotics|mesh-ancestor
139324741|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
139324742|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324743|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138981599|NCT05941494|Mydriatics|mydriatics|mesh-ancestor
139324744|NCT03477864|Ipilimumab|ipilimumab|mesh-list
139324745|NCT03477864|Cemiplimab|cemiplimab|mesh-list
139324746|NCT03477864|Antibodies|antibodies|mesh-list
139324747|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
139324748|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139324749|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
139324750|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324751|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324752|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139324753|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324754|NCT02229045|Paclitaxel|paclitaxel|mesh-list
139324755|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139324756|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139324757|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324758|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
139324759|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
139324760|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
139324761|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324762|NCT02229123|Levetiracetam|levetiracetam|mesh-list
139324763|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
139324764|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
139324765|NCT02229201|Propofol|propofol|mesh-list
139324766|NCT02229201|Sevoflurane|sevoflurane|mesh-list
139324767|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139324768|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139324769|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324770|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139324771|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
139324772|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
139324773|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139324774|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139324775|NCT02224443|Midazolam|midazolam|mesh-list
139324776|NCT02224443|Fentanyl|fentanyl|mesh-list
139324777|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
139324778|NCT02224443|Remifentanil|remifentanil|mesh-list
139324779|NCT02224443|Propofol|propofol|mesh-list
139324780|NCT02224443|Etomidate|etomidate|mesh-list
139324781|NCT02224443|Sevoflurane|sevoflurane|mesh-list
139324782|NCT02224443|Atracurium|atracurium|mesh-list
139324783|NCT02224443|Cisatracurium|cisatracurium|mesh-list
139324784|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139324785|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139324786|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324787|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139324788|NCT02224443|Analgesics|analgesics|mesh-ancestor
139324789|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
139324790|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324791|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139324792|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139324793|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139324794|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
139324795|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324796|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324797|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139324798|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
139324799|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
139324800|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139324801|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139324802|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139324803|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139324804|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
139324805|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
139324806|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139324807|NCT02224443|Narcotics|narcotics|mesh-ancestor
139324808|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139324809|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139324810|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139324811|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139324812|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138731023|NCT04079218|Estradiol|estradiol|mesh-list
139324813|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139324814|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139324815|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
139324816|NCT01944800|Ticagrelor|ticagrelor|mesh-list
139324817|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139324818|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139324819|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139324820|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139324821|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139324822|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
139324823|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324824|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324825|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324826|NCT03617367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139324827|NCT03617367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139324828|NCT03617367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139324829|NCT03617367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324830|NCT03617367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324831|NCT03617367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139324832|NCT03617367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139324833|NCT03617367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324834|NCT03617367|Cholinergic Agents|cholinergic agents|mesh-ancestor
139324835|NCT03617367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324836|NCT02470676|Progesterone|progesterone|mesh-list
139324837|NCT02470676|Progestins|progestins|mesh-ancestor
139324838|NCT02470676|Hormones|hormones|mesh-ancestor
139324839|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324840|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324841|NCT01933724|Prednisone|prednisone|mesh-list
139324842|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
139324843|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139324844|NCT01933724|Hormones|hormones|mesh-ancestor
139324845|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324846|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324847|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139324848|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139324849|NCT02229747|Diclofenac|diclofenac|mesh-list
139324850|NCT02229747|Meloxicam|meloxicam|mesh-list
139324851|NCT02229747|Nimesulide|nimesulide|mesh-list
139324852|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139324853|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139324854|NCT02229747|Analgesics|analgesics|mesh-ancestor
139324855|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
139324856|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324857|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324858|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139324859|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139324860|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139324861|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324862|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324863|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139324864|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139324865|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
139324866|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324867|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139324868|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
139324869|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324870|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324871|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139324872|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139324873|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139324874|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
139324875|NCT03030222|Empagliflozin|empagliflozin|mesh-list
139324876|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139324877|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324878|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139324879|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324880|NCT02232945|Oseltamivir|oseltamivir|mesh-list
139324881|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
139324882|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324883|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324884|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324885|NCT02546622|Factor VIII|factor viii|mesh-list
139324886|NCT02546622|Coagulants|coagulants|mesh-ancestor
139324887|NCT03309566|Tenofovir|tenofovir|mesh-list
139324888|NCT03309566|Emtricitabine|emtricitabine|mesh-list
139324889|NCT03309566|Efavirenz|efavirenz|mesh-list
139324890|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
139324891|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324892|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139324893|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139324894|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324895|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324896|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139324897|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139324898|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139324899|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139324900|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139324901|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139324902|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139324903|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139324905|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139324906|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139324907|NCT00735657|Trace Elements|trace elements|mesh-ancestor
139324908|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
139324909|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324910|NCT02470442|Sevoflurane|sevoflurane|mesh-list
139324911|NCT02470442|Desflurane|desflurane|mesh-list
139324912|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139324913|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139324914|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
139324915|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
139324916|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139324917|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324918|NCT01329939|Montelukast|montelukast|mesh-list
139324919|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139324920|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
139324921|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139324922|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
139324923|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324924|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324925|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139324926|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139324927|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324928|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
139324929|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
139324930|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139324931|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
139324932|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324933|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139324934|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139324935|NCT02230371|Granisetron|granisetron|mesh-list
139324936|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
139324937|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
139324938|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324939|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324940|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139324941|NCT02230371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139324942|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139324943|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
139324944|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324945|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324946|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
139324947|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139324948|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
139324949|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324950|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
139324951|NCT03313934|Protective Agents|protective agents|mesh-ancestor
139324952|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
139324954|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324955|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139324956|NCT05137626|Digoxin|digoxin|mesh-list
139324957|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139324958|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139324959|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139324960|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324961|NCT05137626|Protective Agents|protective agents|mesh-ancestor
139324962|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324963|NCT02233023|Dopamine|dopamine|mesh-list
139324964|NCT02233023|Pramipexole|pramipexole|mesh-list
139324965|NCT02233023|Bromocriptine|bromocriptine|mesh-list
139324966|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
139324967|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
139324968|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981820|NCT05531591|Dopamine Agents|dopamine agents|mesh-ancestor
139324969|NCT02233023|Protective Agents|protective agents|mesh-ancestor
139324970|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324971|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139324972|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139324973|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
139324974|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324975|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139324976|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
139324977|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
139324978|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139324979|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
139324980|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139324981|NCT03710642|Prazosin|prazosin|mesh-list
139324982|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139324983|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139324984|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139324985|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139324986|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
139324987|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139324988|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139324989|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324990|NCT02259309|Misoprostol|misoprostol|mesh-list
139324991|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139324992|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
139324993|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139324994|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139324995|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139324996|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139324997|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
139324998|NCT04459026|Ropivacaine|ropivacaine|mesh-list
139324999|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
139325000|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
139325001|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139325002|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325003|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
139325004|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325005|NCT03473418|Ketoconazole|ketoconazole|mesh-list
139325006|NCT03473418|Terconazole|terconazole|mesh-list
139325007|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
139325008|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325009|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139325010|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139325011|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325012|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325013|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139325014|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
139325015|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325016|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325017|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139325018|NCT04282278|Apatinib|apatinib|mesh-list
139325019|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325020|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139325021|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325022|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325023|NCT00705224|Interferons|interferons|mesh-list
139325024|NCT00705224|Ribavirin|ribavirin|mesh-list
139325025|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325026|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
139325027|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325028|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
139325029|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325030|NCT02457156|Octreotide|octreotide|mesh-list
139325031|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139325032|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139325033|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325034|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
139325035|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
139325036|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139325037|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
139325038|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
139325039|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325040|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325041|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139325042|NCT02523300|Hormones|hormones|mesh-ancestor
139325043|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325044|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139325045|NCT02523300|Protective Agents|protective agents|mesh-ancestor
139325046|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
139325047|NCT02325960|Exenatide|exenatide|mesh-list
139325048|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139325049|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325050|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139325051|NCT02325960|Incretins|incretins|mesh-ancestor
139325052|NCT02325960|Hormones|hormones|mesh-ancestor
139325053|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325054|NCT05265650|Nivolumab|nivolumab|mesh-list
139325055|NCT05265650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139325056|NCT05265650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325057|NCT05265650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139325058|NCT05265650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325059|NCT02234349|Pancrelipase|pancrelipase|mesh-list
139325060|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139325061|NCT04458636|Prednisolone|prednisolone|mesh-list
139325062|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139325063|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
139325064|NCT04458636|Hormones|hormones|mesh-ancestor
139325065|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325066|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325067|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139325068|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325069|NCT03304652|Zaleplon|zaleplon|mesh-list
139325070|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
139325071|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139325072|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139325073|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325074|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
139325075|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
139325076|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325077|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325078|NCT03162783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139325079|NCT03162783|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139325080|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
139325081|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
139325082|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139325083|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139325084|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325085|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139325086|NCT02523144|Analgesics|analgesics|mesh-ancestor
139325087|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
139325088|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325089|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139325090|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139325091|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139325092|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
139325093|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325094|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325095|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139325096|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139325097|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325098|NCT00704132|Incretins|incretins|mesh-ancestor
139325099|NCT00704132|Hormones|hormones|mesh-ancestor
139325100|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325101|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139325102|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
139325103|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325104|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325105|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
139325106|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139325107|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
139325108|NCT03527238|Tacrolimus|tacrolimus|mesh-list
139325109|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139325110|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
139325111|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325112|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139325113|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325114|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325115|NCT03832179|Dexamethasone|dexamethasone|mesh-list
139325116|NCT03832179|Bevacizumab|bevacizumab|mesh-list
139325117|NCT03832179|Ranibizumab|ranibizumab|mesh-list
139325118|NCT03832179|Aflibercept|aflibercept|mesh-list
139325119|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139325120|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325121|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139325122|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139325123|NCT03832179|Growth Substances|growth substances|mesh-ancestor
139325124|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325125|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
139325126|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139325127|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
139325128|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
139325129|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325130|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139325131|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
139325132|NCT03832179|Hormones|hormones|mesh-ancestor
139325133|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325134|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139325135|NCT05154396|Loperamide|loperamide|mesh-list
139325136|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
139325137|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139325138|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139325139|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
139325140|NCT04740645|Coagulants|coagulants|mesh-ancestor
139325141|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139325142|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
139325143|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325144|NCT02802813|Piperaquine|piperaquine|mesh-list
139325145|NCT02802813|Primaquine|primaquine|mesh-list
139325146|NCT02802813|Artenimol|artenimol|mesh-list
139325147|NCT02802813|Artemisinins|artemisinins|mesh-list
139325148|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
139325149|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139325150|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139325151|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325152|NCT05134584|Lactulose|lactulose|mesh-list
139325153|NCT05134584|Linaclotide|linaclotide|mesh-list
139325154|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139325155|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139325156|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
139325157|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325158|NCT05633277|Polidocanol|polidocanol|mesh-list
139325159|NCT05633277|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139325160|NCT05633277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139325161|NCT03312140|Choline|choline|mesh-list
139325162|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
139325163|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139325164|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
139325165|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325166|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139325167|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139325168|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
139325169|NCT02233179|Calpastatin|calpastatin|mesh-list
139325170|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139325171|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
139325172|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325173|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325174|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139325175|NCT03311984|Dalteparin|dalteparin|mesh-list
139325176|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
139325177|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139325178|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139325179|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325180|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
139325181|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139325182|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
139325183|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325184|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
139325185|NCT03311906|Protective Agents|protective agents|mesh-ancestor
139325186|NCT03311750|Panitumumab|panitumumab|mesh-list
139325187|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139325188|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325189|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
139325190|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139325191|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325192|NCT03311672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139325193|NCT03311672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325194|NCT03311516|Insulin|insulin|mesh-list
139325195|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139325196|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139325197|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325198|NCT02811939|Dronabinol|dronabinol|mesh-list
139325199|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
139325200|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325201|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139325202|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139325203|NCT02811939|Analgesics|analgesics|mesh-ancestor
139325204|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
139325205|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325206|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139325207|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139325208|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325209|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325210|NCT02811939|Hormones|hormones|mesh-ancestor
139325211|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325212|NCT01329549|Carboplatin|carboplatin|mesh-list
139325213|NCT01329549|Nintedanib|nintedanib|mesh-list
139325214|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325215|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139325216|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325217|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325218|NCT02234739|Voriconazole|voriconazole|mesh-list
139325219|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
139325220|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325221|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139325222|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139325223|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325224|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325225|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139325226|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
139325227|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139178333|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
139325228|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325229|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139325231|NCT02736474|Bupropion|bupropion|mesh-list
139325232|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139325233|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139325234|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325235|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
139325236|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325237|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139325238|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
139325239|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139325240|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139325241|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139325242|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139325243|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325244|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
139325245|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325246|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139325247|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139325248|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325249|NCT03302390|Lidocaine|lidocaine|mesh-list
139325250|NCT03302390|Epinephrine|epinephrine|mesh-list
139325251|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
139325252|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
139325253|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139325254|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325255|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
139325256|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325257|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139325258|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139325259|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139325260|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139325261|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325262|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139325263|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139325264|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
139325265|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325266|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139325267|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139325268|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
139325269|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139325270|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
139325272|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
139325273|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139325274|NCT03712371|Chitosan|chitosan|mesh-list
139325275|NCT03712371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139325276|NCT03712371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139325277|NCT03712371|Antimetabolites|antimetabolites|mesh-ancestor
139325278|NCT03712371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325279|NCT03712371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138912330|NCT00795600|Insulin|insulin|mesh-list
139325280|NCT03712371|Chelating Agents|chelating agents|mesh-ancestor
139325281|NCT03712371|Sequestering Agents|sequestering agents|mesh-ancestor
139325282|NCT03712371|Hemostatics|hemostatics|mesh-ancestor
139325283|NCT03712371|Coagulants|coagulants|mesh-ancestor
139325284|NCT03472950|Ranolazine|ranolazine|mesh-list
139325285|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139325286|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139325287|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325288|NCT03706521|Lorecivivint|lorecivivint|mesh-list
139325289|NCT03706521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139325290|NCT02259543|Tetracycline|tetracycline|mesh-list
139325291|NCT02259543|Citric Acid|citric acid|mesh-list
139325292|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
139325293|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139325294|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325295|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139325296|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325297|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325298|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
139325299|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139325301|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
139325302|NCT03301454|Paclitaxel|paclitaxel|mesh-list
139325303|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139325304|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325305|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
139325306|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
139325307|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
139325308|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325309|NCT05727410|Docetaxel|docetaxel|mesh-list
139325310|NCT05727410|Nivolumab|nivolumab|mesh-list
139325311|NCT05727410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325312|NCT05727410|Tubulin Modulators|tubulin modulators|mesh-ancestor
139325313|NCT05727410|Antimitotic Agents|antimitotic agents|mesh-ancestor
139325314|NCT05727410|Mitosis Modulators|mitosis modulators|mesh-ancestor
139325315|NCT05727410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325316|NCT05727410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139325317|NCT05727410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139325318|NCT02467010|Dexamethasone|dexamethasone|mesh-list
139325319|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
139325320|NCT02467010|Bortezomib|bortezomib|mesh-list
139325321|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139325322|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
139325323|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325324|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139325325|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139325326|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
139325327|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325328|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325329|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139325330|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139325331|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
139325332|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
139325333|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325334|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139325335|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
139325336|NCT02467010|Hormones|hormones|mesh-ancestor
139325337|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325338|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139325339|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139325340|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139325341|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139325342|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139325343|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325344|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325345|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325346|NCT02232555|Analgesics|analgesics|mesh-ancestor
139325347|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
139325348|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325349|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
139325350|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139325351|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
139325352|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139325353|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139325354|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139325355|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325356|NCT00702650|Testosterone|testosterone|mesh-list
139325357|NCT00702650|Androgens|androgens|mesh-ancestor
139325359|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325360|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325361|NCT03230916|Relebactam|relebactam|mesh-list
139325362|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139325363|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325364|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325365|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139325366|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325368|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
139325369|NCT01337115|Anesthetics|anesthetics|mesh-list
139325370|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139325371|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325372|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
139325373|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325374|NCT03761784|Tretinoin|tretinoin|mesh-list
139325375|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139325376|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
139325377|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325378|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
139325379|NCT03300440|Vitamins|vitamins|mesh-list
139325380|NCT03300440|Biotin|biotin|mesh-list
139325381|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
139325382|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
139325383|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325384|NCT02236065|Lenograstim|lenograstim|mesh-list
139325385|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139325386|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
139325387|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325388|NCT02467556|Morphine|morphine|mesh-list
139325389|NCT02467556|Memantine|memantine|mesh-list
139325390|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139325391|NCT02467556|Narcotics|narcotics|mesh-ancestor
139325392|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139325393|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325394|NCT02467556|Analgesics|analgesics|mesh-ancestor
139325395|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
139325396|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325397|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139325398|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139325399|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
139325400|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325401|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325402|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139325403|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139325404|NCT02262585|Telmisartan|telmisartan|mesh-list
139325405|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139325406|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139325407|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139325408|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325409|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139325410|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
139325411|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139325412|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139325413|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139325414|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
139325415|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139325416|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325417|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138982274|NCT03897673|Iron|iron|mesh-list
139325418|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139325419|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139325420|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139325421|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325422|NCT02602353|Loxoprofen|loxoprofen|mesh-list
139325423|NCT02602353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139325424|NCT02602353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139325425|NCT02602353|Analgesics|analgesics|mesh-ancestor
139325426|NCT02602353|Sensory System Agents|sensory system agents|mesh-ancestor
139325427|NCT02602353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325428|NCT02602353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325429|NCT02602353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139325430|NCT02602353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139325431|NCT04983498|Ondansetron|ondansetron|mesh-list
139325432|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
139325433|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
139178351|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
139325434|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325435|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325436|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139325437|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
139325438|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
139325439|NCT04983498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139325440|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139325441|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
139325442|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325443|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325444|NCT03300362|Vaccines|vaccines|mesh-list
139325445|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
139325446|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325447|NCT02467400|Propranolol|propranolol|mesh-list
139325448|NCT02467400|Atenolol|atenolol|mesh-list
139325449|NCT02467400|Nebivolol|nebivolol|mesh-list
139325450|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139325451|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139325452|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
139325453|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325454|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325455|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325456|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139325457|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139325458|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
139325459|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
139325460|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
139325461|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325462|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139325463|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139325464|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139325465|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139325466|NCT03308708|Norepinephrine|norepinephrine|mesh-list
139325467|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139325468|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139325469|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
139325470|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325471|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912350|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325472|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325473|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
139325474|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
139325475|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325476|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139325477|NCT02262741|Durvalumab|durvalumab|mesh-list
139325478|NCT02262741|Tremelimumab|tremelimumab|mesh-list
139325479|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139325480|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325481|NCT00250341|Beclomethasone|beclomethasone|mesh-list
139325482|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139325483|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139325484|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
139325485|NCT00250341|Hormones|hormones|mesh-ancestor
139325486|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325487|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325488|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139325489|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
139325490|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138982345|NCT03698552|Epratuzumab|epratuzumab|mesh-list
139325491|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
139325492|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325493|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
139325494|NCT05156970|Carboplatin|carboplatin|mesh-list
139325495|NCT05156970|Docetaxel|docetaxel|mesh-list
139325496|NCT05156970|Apatinib|apatinib|mesh-list
139325497|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325498|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
139325499|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
139325500|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
139325501|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325502|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139325503|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325504|NCT02233881|Ipratropium|ipratropium|mesh-list
139325505|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139325506|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
139325507|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325508|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325509|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139325510|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
139325511|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139325512|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
139325513|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325514|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325515|NCT02234037|Decitabine|decitabine|mesh-list
139325516|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139325517|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
139325518|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325519|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325520|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325521|NCT02234193|Lidocaine|lidocaine|mesh-list
139325522|NCT02234193|Epinephrine|epinephrine|mesh-list
139325523|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
139325524|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
139325525|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139325526|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325527|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
139325528|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325529|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139325530|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139325531|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139325532|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139325533|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325534|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139325535|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139325536|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
139325537|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325538|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139325539|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139325540|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
139325541|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139325542|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
139325543|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
139325544|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
139325545|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139325546|NCT04476459|Apatinib|apatinib|mesh-list
139325547|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325548|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139325549|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325550|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325551|NCT02262897|Paclitaxel|paclitaxel|mesh-list
139325552|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139325553|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139325554|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325555|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
139325556|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
139325557|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
139325558|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325560|NCT02723006|Ipilimumab|ipilimumab|mesh-list
139325561|NCT02723006|Vedolizumab|vedolizumab|mesh-list
139325562|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139325563|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325564|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139325565|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091709|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325566|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139325567|NCT03308552|Paclitaxel|paclitaxel|mesh-list
139325568|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139325569|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139325570|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325571|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
139325572|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
139325573|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
139325574|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325575|NCT03308084|Dexamethasone|dexamethasone|mesh-list
139325576|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
139325577|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139325578|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139325579|NCT03308084|Prednisolone|prednisolone|mesh-list
139325580|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
139325581|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139325582|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
139325583|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139325584|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
139325585|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
139325586|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325587|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325588|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139325589|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
139325590|NCT03308084|Hormones|hormones|mesh-ancestor
139325591|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325592|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139325593|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325594|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139325595|NCT03308084|Protective Agents|protective agents|mesh-ancestor
139325596|NCT00702962|Carboplatin|carboplatin|mesh-list
139325597|NCT00702962|Etoposide|etoposide|mesh-list
139325598|NCT00702962|Vorinostat|vorinostat|mesh-list
139325599|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325600|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139325601|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139325602|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139325603|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325604|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325605|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139325606|NCT01379508|Tenofovir|tenofovir|mesh-list
139325607|NCT01379508|Telbivudine|telbivudine|mesh-list
139325608|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
139325609|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325610|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139325611|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139325612|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325613|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325614|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139325615|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139325616|NCT05162430|Propofol|propofol|mesh-list
139325617|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139178383|NCT03709056|Propofol|propofol|mesh-list
139325618|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139325619|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325620|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139325621|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
139325622|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
139325623|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
139325624|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139325625|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139325626|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325627|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139325628|NCT05031026|Analgesics|analgesics|mesh-ancestor
139325629|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
139325630|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325631|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139325632|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139325633|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139325634|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
139325635|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325636|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325637|NCT02264769|Carbetocin|carbetocin|mesh-list
139325638|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
139325639|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139325640|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325641|NCT02264847|Clomiphene|clomiphene|mesh-list
139325643|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
139325644|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139325645|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139325646|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
139325647|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325648|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325649|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139325650|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
139325651|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139325652|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139325653|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139325654|NCT03469128|Sertraline|sertraline|mesh-list
139325655|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
139325656|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139325657|NCT03469128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139325658|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139325659|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139325660|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325661|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325662|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
139325663|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325664|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
139325665|NCT05161572|Tegafur|tegafur|mesh-list
139325666|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325667|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139325668|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
139325669|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325670|NCT03472170|Lactoferrin|lactoferrin|mesh-list
139325671|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325672|NCT04156698|Docetaxel|docetaxel|mesh-list
139325673|NCT04156698|Capecitabine|capecitabine|mesh-list
139325674|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325675|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
139325676|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
139325677|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
139325678|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325679|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139325680|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
139325681|NCT03108326|Infliximab|infliximab|mesh-list
139325682|NCT03108326|Ustekinumab|ustekinumab|mesh-list
139325683|NCT03108326|Vedolizumab|vedolizumab|mesh-list
139325684|NCT03108326|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139325685|NCT03108326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139325687|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
139325688|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139325689|NCT04964024|Antibodies|antibodies|mesh-list
139325690|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
139325691|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325692|NCT02466542|Esmolol|esmolol|mesh-list
139325693|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139325694|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139325695|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139325696|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
139325697|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325698|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325699|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325700|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
139325701|NCT05067270|Treprostinil|treprostinil|mesh-list
139325702|NCT05067270|Citric Acid|citric acid|mesh-list
139325703|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
139325704|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
139325705|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139325706|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
139325707|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
139325708|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325709|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139325710|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325711|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139325712|NCT01437735|Montelukast|montelukast|mesh-list
139325713|NCT01437735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139325714|NCT01437735|Respiratory System Agents|respiratory system agents|mesh-ancestor
139325715|NCT01437735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139325716|NCT01437735|Hormone Antagonists|hormone antagonists|mesh-ancestor
139325717|NCT01437735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325718|NCT01437735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325719|NCT01437735|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139325720|NCT01437735|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139325721|NCT01437735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325722|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
139325723|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139325724|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325725|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325726|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139325727|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139325728|NCT03470610|Estradiol|estradiol|mesh-list
139325729|NCT03470610|Progesterone|progesterone|mesh-list
139325730|NCT03470610|Estrogens|estrogens|mesh-ancestor
139325731|NCT03470610|Hormones|hormones|mesh-ancestor
139325732|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325733|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325734|NCT03470610|Progestins|progestins|mesh-ancestor
139325735|NCT02509845|Anti-Infective Agents|anti-infective agents|mesh-list
139325736|NCT02509845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139325737|NCT03307148|Paclitaxel|paclitaxel|mesh-list
139325738|NCT03307148|Gemcitabine|gemcitabine|mesh-list
139325739|NCT03307148|Tretinoin|tretinoin|mesh-list
139325740|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139325741|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325742|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
139325743|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
139325744|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
139325745|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325746|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139325747|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
139325748|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
139325749|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
139325750|NCT03984591|Eplerenone|eplerenone|mesh-list
139325751|NCT03984591|Spironolactone|spironolactone|mesh-list
139325752|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139325753|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
139325754|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325755|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325756|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139325757|NCT03984591|Diuretics|diuretics|mesh-ancestor
139325758|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
139325759|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139325760|NCT02503137|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139325761|NCT03470532|Epinephrine|epinephrine|mesh-list
139325762|NCT03470532|Racepinephrine|racepinephrine|mesh-list
139325763|NCT03470532|Carticaine|carticaine|mesh-list
139325764|NCT03470532|Mepivacaine|mepivacaine|mesh-list
139325765|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
139325766|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139325767|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139325768|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
139325769|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325770|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325771|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325772|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139325773|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139325774|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
139325775|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325776|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139325777|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
139325778|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
139325779|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
139325780|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139325781|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
139325782|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
139325783|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139325784|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
139325785|NCT02502669|Finasteride|finasteride|mesh-list
139325786|NCT02502669|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139325787|NCT02502669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139325788|NCT02502669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325789|NCT02502669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325790|NCT02502669|Hormone Antagonists|hormone antagonists|mesh-ancestor
139325791|NCT02502669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325792|NCT02502669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325793|NCT02502669|Urological Agents|urological agents|mesh-ancestor
139325794|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
139325795|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
139325796|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
139325797|NCT03306836|Heparin|heparin|mesh-list
139325798|NCT03306836|Calcium heparin|calcium heparin|mesh-list
139325799|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
139325800|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139325801|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139325802|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325803|NCT04487145|Piperaquine|piperaquine|mesh-list
139325804|NCT04487145|Artenimol|artenimol|mesh-list
139325805|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
139325806|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139325807|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139325808|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325809|NCT00709956|Iloprost|iloprost|mesh-list
139325810|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139325811|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
139325812|NCT02268201|Tacrolimus|tacrolimus|mesh-list
139325813|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139325814|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
139325815|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325816|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139325817|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325818|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325819|NCT03306602|Z 350|z 350|mesh-list
139325820|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139325821|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139325822|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325823|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325824|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
139325825|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325826|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325827|NCT02268279|Solithromycin|solithromycin|mesh-list
139325828|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139325829|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325830|NCT02268357|Propranolol|propranolol|mesh-list
139325831|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139325832|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139325833|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
139325834|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325835|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325836|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325837|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139325838|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139325839|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
139325840|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
139325841|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325842|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139325843|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325844|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325845|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
139325846|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
139325847|NCT02466464|Coagulants|coagulants|mesh-ancestor
139325848|NCT01423149|Fosbretabulin|fosbretabulin|mesh-list
139325849|NCT01423149|Combretastatin|combretastatin|mesh-list
139325850|NCT01423149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139325851|NCT01423149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325852|NCT01423149|Tubulin Modulators|tubulin modulators|mesh-ancestor
139325853|NCT01423149|Antimitotic Agents|antimitotic agents|mesh-ancestor
139325854|NCT01423149|Mitosis Modulators|mitosis modulators|mesh-ancestor
139325855|NCT01423149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325856|NCT03470454|Linagliptin|linagliptin|mesh-list
139325857|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139325858|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325859|NCT03470454|Incretins|incretins|mesh-ancestor
139325860|NCT03470454|Hormones|hormones|mesh-ancestor
139325861|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139325862|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139325863|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
139325864|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325865|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325866|NCT03130842|Midazolam|midazolam|mesh-list
139325868|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139325869|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139325870|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139325871|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325872|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139325873|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139325874|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139325875|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139325876|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
139325877|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
139325878|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
139325879|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
139325880|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325881|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325882|NCT03130764|Durvalumab|durvalumab|mesh-list
139325883|NCT03130764|Tremelimumab|tremelimumab|mesh-list
139325884|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139325885|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325886|NCT01234779|Olanzapine|olanzapine|mesh-list
139325887|NCT01234779|Antiemetics|antiemetics|mesh-ancestor
139325888|NCT01234779|Autonomic Agents|autonomic agents|mesh-ancestor
139325889|NCT01234779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325890|NCT01234779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325891|NCT01234779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139325892|NCT01234779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139325893|NCT01234779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139325894|NCT01234779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139325895|NCT01234779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139325896|NCT01234779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139325897|NCT01234779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139325898|NCT01234779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139325899|NCT01234779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325900|NCT01234779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139325901|NCT01234779|Serotonin Agents|serotonin agents|mesh-ancestor
139325902|NCT03223350|Capsaicin|capsaicin|mesh-list
139325903|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
139325904|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
139325905|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
139325906|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325907|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325908|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
139325909|NCT03306368|Narcotics|narcotics|mesh-ancestor
139325910|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139325911|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325912|NCT03306368|Analgesics|analgesics|mesh-ancestor
139325913|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
139325914|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325915|NCT02840136|Meropenem|meropenem|mesh-list
139325916|NCT02840136|Tazobactam|tazobactam|mesh-list
139325917|NCT02840136|Piperacillin|piperacillin|mesh-list
139325918|NCT02840136|Ceftazidime|ceftazidime|mesh-list
139325919|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139325920|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139325921|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325922|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139325923|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325924|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325925|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139325926|NCT03306290|Cefoxitin|cefoxitin|mesh-list
139325927|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325928|NCT01616199|Vemurafenib|vemurafenib|mesh-list
139325929|NCT01616199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325930|NCT01616199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139325931|NCT01616199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139325932|NCT01616199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325933|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
139325934|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139325935|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139325936|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139325937|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139325938|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325940|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091710|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139325941|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325942|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139325943|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139325944|NCT04506138|Paclitaxel|paclitaxel|mesh-list
139325945|NCT04506138|Carboplatin|carboplatin|mesh-list
139325946|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139325947|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325948|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
139325949|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
139325950|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
139325951|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325952|NCT01407003|Licogliflozin|licogliflozin|mesh-list
139325953|NCT01407003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139325954|NCT01407003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325955|NCT01407003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139325956|NCT01407003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325957|NCT05346302|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139325958|NCT05346302|Immunologic Factors|immunologic factors|mesh-ancestor
139325959|NCT05346302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325960|NCT01232595|Vancomycin|vancomycin|mesh-list
139325961|NCT01232595|LFF571|lff571|mesh-list
139325962|NCT01232595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139325963|NCT01232595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325964|NCT01231347|Gemcitabine|gemcitabine|mesh-list
139325965|NCT01231347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139325966|NCT01231347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139325967|NCT01231347|Antimetabolites|antimetabolites|mesh-ancestor
139325968|NCT01231347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325969|NCT01231347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139325970|NCT01231347|Immunologic Factors|immunologic factors|mesh-ancestor
139325971|NCT01231347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325972|NCT01230957|Vaccines|vaccines|mesh-list
139325973|NCT01230957|Immunologic Factors|immunologic factors|mesh-ancestor
139325974|NCT01230957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325975|NCT01228383|Vaccines|vaccines|mesh-list
139325976|NCT01228383|Antibodies|antibodies|mesh-list
139325977|NCT01228383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139325978|NCT01228383|Immunoglobulins|immunoglobulins|mesh-list
139325979|NCT01228383|gamma-Globulins|gamma-globulins|mesh-list
139325980|NCT01228383|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139325981|NCT01228383|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139325982|NCT01228383|Immunologic Factors|immunologic factors|mesh-ancestor
139325983|NCT01228383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325984|NCT03305978|Ivermectin|ivermectin|mesh-list
139325985|NCT03305978|Selamectin|selamectin|mesh-list
139325986|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139325987|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139325988|NCT01594983|Fenofibrate|fenofibrate|mesh-list
139325989|NCT01594983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139325990|NCT01594983|Antimetabolites|antimetabolites|mesh-ancestor
139325991|NCT01594983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139325992|NCT01594983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139325993|NCT03305510|Vitamin D|vitamin d|mesh-list
139325994|NCT03305510|Vitamins|vitamins|mesh-ancestor
139325995|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
139325996|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139325997|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139325998|NCT01224795|Peramivir|peramivir|mesh-list
139325999|NCT01224795|Antiviral Agents|antiviral agents|mesh-ancestor
139326000|NCT01224795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326001|NCT01224795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326002|NCT01224795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326003|NCT01402401|Trastuzumab|trastuzumab|mesh-list
139326004|NCT01402401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139326005|NCT01402401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326006|NCT02720510|Dexamethasone|dexamethasone|mesh-list
139326007|NCT02720510|Lenalidomide|lenalidomide|mesh-list
139326008|NCT02720510|Bortezomib|bortezomib|mesh-list
139326009|NCT02720510|Panobinostat|panobinostat|mesh-list
139326010|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139326012|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
139326013|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326014|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326015|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139326016|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
139326017|NCT02720510|Hormones|hormones|mesh-ancestor
139326018|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139326019|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139326020|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326021|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
139326022|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139326023|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139326024|NCT02720510|Growth Substances|growth substances|mesh-ancestor
139326025|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
139326026|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139326027|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326028|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326029|NCT01220271|Temozolomide|temozolomide|mesh-list
139326030|NCT01220271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139326031|NCT01220271|Alkylating Agents|alkylating agents|mesh-ancestor
139326032|NCT01220271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326033|NCT01220271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326034|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
139326035|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139326036|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
139326037|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139326038|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
139326039|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326040|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326041|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
139326042|NCT01204749|Paclitaxel|paclitaxel|mesh-list
139326043|NCT01204749|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139326044|NCT01204749|Trebananib|trebananib|mesh-list
139326045|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
139326046|NCT01204749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139326047|NCT01204749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326048|NCT01204749|Tubulin Modulators|tubulin modulators|mesh-ancestor
139326049|NCT01204749|Antimitotic Agents|antimitotic agents|mesh-ancestor
139326050|NCT01204749|Mitosis Modulators|mitosis modulators|mesh-ancestor
139326051|NCT01204749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326052|NCT01204749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139326053|NCT01204749|Growth Substances|growth substances|mesh-ancestor
139326054|NCT01204749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326055|NCT01204749|Growth Inhibitors|growth inhibitors|mesh-ancestor
139326056|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139326057|NCT02466698|Metronidazole|metronidazole|mesh-list
139326058|NCT02466698|Vancomycin|vancomycin|mesh-list
139326059|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139326060|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139326061|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326062|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
139326063|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139326064|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139326065|NCT02466698|Laxatives|laxatives|mesh-ancestor
139326066|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139326067|NCT02720198|Milnacipran|milnacipran|mesh-list
139326068|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139326069|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
139326070|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
139326071|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139326072|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139326073|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139326074|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139326075|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326076|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139326077|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139326078|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139326079|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326080|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326081|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139326082|NCT02720198|Analgesics|analgesics|mesh-ancestor
139326083|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
139326084|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326085|NCT01193361|Interferons|interferons|mesh-list
139326086|NCT01193361|Ribavirin|ribavirin|mesh-list
139326087|NCT01193361|Interferon-alpha|interferon-alpha|mesh-list
139326088|NCT01193361|Interferon alpha-2|interferon alpha-2|mesh-list
139326089|NCT01193361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139326090|NCT01193361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326091|NCT01193361|Antiviral Agents|antiviral agents|mesh-ancestor
138982934|NCT01326325|Analgesics|analgesics|mesh-ancestor
139326092|NCT01193361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326093|NCT01193361|Antimetabolites|antimetabolites|mesh-ancestor
139326094|NCT01193361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326095|NCT01193361|Immunologic Factors|immunologic factors|mesh-ancestor
139326096|NCT01193361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326097|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139326098|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139326099|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326100|NCT02263677|Incretins|incretins|mesh-ancestor
139326101|NCT02263677|Hormones|hormones|mesh-ancestor
139326102|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139326103|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139326104|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
139326105|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326106|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326107|NCT01390545|Veltuzumab|veltuzumab|mesh-list
139326108|NCT01390545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326109|NCT01591473|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
139326110|NCT01591473|Poly I-C|poly i-c|mesh-list
139326111|NCT01591473|Antiviral Agents|antiviral agents|mesh-ancestor
139326112|NCT01591473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326113|NCT01591473|Interferon Inducers|interferon inducers|mesh-ancestor
139326114|NCT01591473|Immunologic Factors|immunologic factors|mesh-ancestor
139326115|NCT01591473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326116|NCT01192035|Ritonavir|ritonavir|mesh-list
139326117|NCT01192035|Lopinavir|lopinavir|mesh-list
139326118|NCT01192035|Nevirapine|nevirapine|mesh-list
139326119|NCT01192035|Efavirenz|efavirenz|mesh-list
139326120|NCT01192035|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139326121|NCT01192035|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139326122|NCT01192035|Protease Inhibitors|protease inhibitors|mesh-ancestor
139326123|NCT01192035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326124|NCT01192035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326125|NCT01192035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139326126|NCT01192035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139326127|NCT01192035|Antiviral Agents|antiviral agents|mesh-ancestor
139326128|NCT01192035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326129|NCT01192035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139326130|NCT01192035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139326131|NCT01192035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139326132|NCT01192035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139326133|NCT01192035|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139326134|NCT01192035|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139326135|NCT01192035|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139326136|NCT01192035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139326137|NCT01192035|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139326138|NCT01384383|Ledipasvir|ledipasvir|mesh-list
139326139|NCT01384383|Antiviral Agents|antiviral agents|mesh-ancestor
139326140|NCT01384383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326141|NCT01557777|Navitoclax|navitoclax|mesh-list
139326142|NCT01557777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326143|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
139326144|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139326145|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326146|NCT02268825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139326147|NCT02268825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326148|NCT01381731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139326149|NCT01381731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139326150|NCT02268903|Furosemide|furosemide|mesh-list
139326151|NCT02268903|Diuretics|diuretics|mesh-list
139326152|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
139326153|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326154|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139326155|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139326156|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326157|NCT01369095|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139326158|NCT01369095|Escitalopram|escitalopram|mesh-list
139326159|NCT01369095|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139326160|NCT01369095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139326161|NCT01369095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139326162|NCT01369095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326163|NCT01369095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326164|NCT01369095|Serotonin Agents|serotonin agents|mesh-ancestor
139326165|NCT01369095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326166|NCT01369095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326167|NCT01369095|Antidepressive Agents|antidepressive agents|mesh-ancestor
139326168|NCT01369095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139326169|NCT01369095|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139326170|NCT01369095|Analgesics|analgesics|mesh-ancestor
139326171|NCT01369095|Sensory System Agents|sensory system agents|mesh-ancestor
139326172|NCT01369095|Dopamine Agents|dopamine agents|mesh-ancestor
139326173|NCT02266173|Pertuzumab|pertuzumab|mesh-list
139326174|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139326175|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326176|NCT01168713|Levofloxacin|levofloxacin|mesh-list
139326177|NCT01168713|Solithromycin|solithromycin|mesh-list
139326178|NCT01168713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139326179|NCT01168713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326180|NCT01168713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139326181|NCT01168713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139326182|NCT01168713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139326183|NCT01168713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326184|NCT01168713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326185|NCT01168713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326186|NCT01168713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139326187|NCT01168713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139326188|NCT02269293|Paclitaxel|paclitaxel|mesh-list
139326189|NCT02269293|Carboplatin|carboplatin|mesh-list
139326190|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139326191|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326192|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
139326193|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
139326194|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
139326195|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326196|NCT01545453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139326197|NCT01545453|Immunologic Factors|immunologic factors|mesh-ancestor
139326198|NCT01545453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326199|NCT01366131|Paclitaxel|paclitaxel|mesh-list
139326200|NCT01366131|Bevacizumab|bevacizumab|mesh-list
139326201|NCT01366131|Carboplatin|carboplatin|mesh-list
139326202|NCT01366131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139326203|NCT01366131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326204|NCT01366131|Tubulin Modulators|tubulin modulators|mesh-ancestor
139326205|NCT01366131|Antimitotic Agents|antimitotic agents|mesh-ancestor
139326206|NCT01366131|Mitosis Modulators|mitosis modulators|mesh-ancestor
139326207|NCT01366131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326208|NCT01366131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139326209|NCT01366131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139326210|NCT01366131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139326211|NCT01366131|Growth Substances|growth substances|mesh-ancestor
139326212|NCT01366131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326213|NCT01366131|Growth Inhibitors|growth inhibitors|mesh-ancestor
139326214|NCT01365195|Ketamine|ketamine|mesh-list
139326215|NCT01365195|Analgesics|analgesics|mesh-ancestor
139326216|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
139178461|NCT03364608|Albuterol|albuterol|mesh-list
139326217|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326218|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326219|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139326220|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139326221|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
139326222|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
139326223|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139326224|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139326225|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139326226|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326227|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326228|NCT02269449|Hemostatics|hemostatics|mesh-list
139326229|NCT02269449|Coagulants|coagulants|mesh-ancestor
139326230|NCT01160601|Paclitaxel|paclitaxel|mesh-list
139326231|NCT01160601|Carboplatin|carboplatin|mesh-list
139326232|NCT01160601|Bavituximab|bavituximab|mesh-list
139326233|NCT01160601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139326234|NCT01160601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326235|NCT01160601|Tubulin Modulators|tubulin modulators|mesh-ancestor
139326236|NCT01160601|Antimitotic Agents|antimitotic agents|mesh-ancestor
139326237|NCT01160601|Mitosis Modulators|mitosis modulators|mesh-ancestor
139326238|NCT01160601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326239|NCT01160601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139326240|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
139326241|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139326242|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
139326243|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326244|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326245|NCT01356849|Atrasentan|atrasentan|mesh-list
139326246|NCT01356849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326247|NCT01356849|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139326248|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139326249|NCT01356849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326250|NCT02266485|Pravastatin|pravastatin|mesh-list
139326251|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139326252|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139326253|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
139326254|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326255|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139326256|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139326257|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326258|NCT02263989|Telmisartan|telmisartan|mesh-list
139326259|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139326260|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139326261|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139326262|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326263|NCT01516203|Rifampin|rifampin|mesh-list
139326264|NCT01516203|Isoniazid|isoniazid|mesh-list
139326265|NCT01516203|Pyrazinamide|pyrazinamide|mesh-list
139326266|NCT01516203|Ethambutol|ethambutol|mesh-list
139326267|NCT01516203|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139326268|NCT01516203|Antitubercular Agents|antitubercular agents|mesh-ancestor
139326269|NCT01516203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139326270|NCT01516203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326271|NCT01516203|Leprostatic Agents|leprostatic agents|mesh-ancestor
139326272|NCT01516203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139326273|NCT01516203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326274|NCT01516203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326275|NCT01516203|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139326276|NCT01516203|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139326277|NCT01516203|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139326278|NCT01516203|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139326279|NCT01516203|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139326280|NCT01516203|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139326281|NCT01516203|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139326282|NCT01516203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139326283|NCT01516203|Antimetabolites|antimetabolites|mesh-ancestor
139326284|NCT01516203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139326285|NCT01321359|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
139326286|NCT01321359|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
139326287|NCT01321359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326288|NCT01321359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326289|NCT00703118|Ribavirin|ribavirin|mesh-list
139326290|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
139326291|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139326292|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
139326293|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326294|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
139326295|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326296|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326297|NCT01510119|Hydroxychloroquine|hydroxychloroquine|mesh-list
139326298|NCT01510119|Everolimus|everolimus|mesh-list
139326299|NCT01510119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139326300|NCT01510119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139326301|NCT01510119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326302|NCT01510119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326303|NCT01510119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139326304|NCT01510119|Immunologic Factors|immunologic factors|mesh-ancestor
139326305|NCT01510119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326306|NCT01510119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326307|NCT01510119|Antimalarials|antimalarials|mesh-ancestor
139326308|NCT01510119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139326309|NCT01510119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139326310|NCT01510119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326311|NCT01510119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139326312|NCT01150695|Vaccines|vaccines|mesh-list
139326313|NCT01150695|Immunologic Factors|immunologic factors|mesh-ancestor
139326314|NCT01150695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326315|NCT01302249|Timolol|timolol|mesh-list
139326316|NCT01302249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139326317|NCT01302249|Latanoprost|latanoprost|mesh-list
138912553|NCT00455923|Hormones|hormones|mesh-ancestor
139326318|NCT01302249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139326319|NCT01302249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326320|NCT01302249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139326321|NCT01302249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139326322|NCT01302249|Adrenergic Agents|adrenergic agents|mesh-ancestor
139326323|NCT01302249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326324|NCT01302249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326325|NCT01302249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139326326|NCT01302249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139326327|NCT02261636|Mesalamine|mesalamine|mesh-list
139326328|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139326329|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139326330|NCT02261636|Analgesics|analgesics|mesh-ancestor
139326331|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
139326332|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326333|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326334|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139326335|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139326336|NCT05191706|Dexamethasone|dexamethasone|mesh-list
139326337|NCT05191706|Prednisolone|prednisolone|mesh-list
139326338|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139326339|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
139326340|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139326341|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
139326342|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139326343|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
139326344|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139326345|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
139326346|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
139326347|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326348|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326349|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139326350|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
139326351|NCT05191706|Hormones|hormones|mesh-ancestor
139326352|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139326353|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139326354|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326355|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139326356|NCT05191706|Protective Agents|protective agents|mesh-ancestor
139326358|NCT01493505|Carboplatin|carboplatin|mesh-list
139326359|NCT01493505|Trebananib|trebananib|mesh-list
139326360|NCT01493505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139326361|NCT01493505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326362|NCT01493505|Tubulin Modulators|tubulin modulators|mesh-ancestor
139326363|NCT01493505|Antimitotic Agents|antimitotic agents|mesh-ancestor
139326364|NCT01493505|Mitosis Modulators|mitosis modulators|mesh-ancestor
139326365|NCT01493505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326366|NCT01493505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139326367|NCT01493505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139326368|NCT01493505|Growth Substances|growth substances|mesh-ancestor
139326369|NCT01493505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326370|NCT01493505|Growth Inhibitors|growth inhibitors|mesh-ancestor
139326371|NCT01301157|Calcipotriene|calcipotriene|mesh-list
139326372|NCT01301157|Dermatologic Agents|dermatologic agents|mesh-ancestor
139326373|NCT02264145|Norflurane|norflurane|mesh-list
139326374|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139326375|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
139326376|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139326377|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326378|NCT02264301|Puerarin|puerarin|mesh-list
139326379|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
139326380|NCT02267109|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139326381|NCT02267109|Antiviral Agents|antiviral agents|mesh-ancestor
139326382|NCT02267109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326383|NCT04476069|Ibuprofen|ibuprofen|mesh-list
139326384|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139326385|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139326386|NCT04476069|Analgesics|analgesics|mesh-ancestor
139326387|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
139326388|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326389|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983242|NCT03868059|Testosterone|testosterone|mesh-list
139326390|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139326391|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139326392|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139326393|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326394|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326395|NCT01480479|Temozolomide|temozolomide|mesh-list
139326396|NCT01480479|Molgramostim|molgramostim|mesh-list
139326397|NCT01480479|Rindopepimut|rindopepimut|mesh-list
139326398|NCT01480479|Sargramostim|sargramostim|mesh-list
139326399|NCT01480479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139326400|NCT01480479|Alkylating Agents|alkylating agents|mesh-ancestor
139326401|NCT01480479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326402|NCT01480479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326403|NCT01480479|Immunologic Factors|immunologic factors|mesh-ancestor
139326404|NCT01480479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326405|NCT01480479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139326406|NCT01116141|Folic Acid|folic acid|mesh-list
139326407|NCT01116141|Methotrexate|methotrexate|mesh-list
139326408|NCT01116141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139326409|NCT01116141|Abortifacient Agents|abortifacient agents|mesh-ancestor
139326410|NCT01116141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139326411|NCT01116141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326412|NCT01116141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139326413|NCT01116141|Antimetabolites|antimetabolites|mesh-ancestor
139326414|NCT01116141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326415|NCT01116141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326416|NCT01116141|Dermatologic Agents|dermatologic agents|mesh-ancestor
139326417|NCT01116141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326418|NCT01116141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139326419|NCT01116141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139326420|NCT01116141|Immunologic Factors|immunologic factors|mesh-ancestor
139326421|NCT01116141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139326422|NCT01116141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139326423|NCT01116141|Hematinics|hematinics|mesh-ancestor
139326424|NCT01116141|Vitamin B Complex|vitamin b complex|mesh-ancestor
139326425|NCT01116141|Vitamins|vitamins|mesh-ancestor
139326426|NCT01116141|Micronutrients|micronutrients|mesh-ancestor
139326428|NCT01280565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139326429|NCT01280565|Alkylating Agents|alkylating agents|mesh-ancestor
139326430|NCT01280565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326431|NCT01280565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326432|NCT01113957|Doxorubicin|doxorubicin|mesh-list
139326433|NCT01113957|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139326434|NCT01113957|Temozolomide|temozolomide|mesh-list
139326435|NCT01113957|Veliparib|veliparib|mesh-list
139326436|NCT01113957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139326437|NCT01113957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326438|NCT01113957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139326439|NCT01113957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139326440|NCT01113957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326441|NCT01113957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326442|NCT01113957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139326443|NCT01113957|Alkylating Agents|alkylating agents|mesh-ancestor
139326444|NCT01113957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139326445|NCT01111773|Lidocaine|lidocaine|mesh-list
139326446|NCT01111773|Tetracaine|tetracaine|mesh-list
139326447|NCT01111773|Anesthetics, Local|anesthetics, local|mesh-ancestor
139326448|NCT01111773|Anesthetics|anesthetics|mesh-ancestor
139326449|NCT01111773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139326450|NCT01111773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326451|NCT01111773|Sensory System Agents|sensory system agents|mesh-ancestor
139326452|NCT01111773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326453|NCT01111773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139326454|NCT01111773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139326455|NCT01111773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139326456|NCT01111773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139326457|NCT01111773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326458|NCT01280331|Morphine|morphine|mesh-list
139326459|NCT01280331|Oxycodone|oxycodone|mesh-list
139326460|NCT01280331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139326461|NCT01280331|Narcotics|narcotics|mesh-ancestor
139326462|NCT01280331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139326463|NCT01280331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326464|NCT01280331|Analgesics|analgesics|mesh-ancestor
139326465|NCT01280331|Sensory System Agents|sensory system agents|mesh-ancestor
139326466|NCT01280331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326467|NCT01266525|Donepezil|donepezil|mesh-list
139326468|NCT01266525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139326469|NCT01266525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326470|NCT01266525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326471|NCT01266525|Cholinergic Agents|cholinergic agents|mesh-ancestor
139326472|NCT01266525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326473|NCT01266525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326474|NCT01266525|Nootropic Agents|nootropic agents|mesh-ancestor
139326475|NCT01265901|Cyclophosphamide|cyclophosphamide|mesh-list
139326476|NCT01265901|Sunitinib|sunitinib|mesh-list
139326477|NCT01265901|Molgramostim|molgramostim|mesh-list
139326478|NCT01265901|Sargramostim|sargramostim|mesh-list
139326479|NCT01265901|Immunologic Factors|immunologic factors|mesh-ancestor
139326480|NCT01265901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326481|NCT01265901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139326482|NCT01265901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139326483|NCT01265901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139326484|NCT01265901|Alkylating Agents|alkylating agents|mesh-ancestor
139326485|NCT01265901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326486|NCT01265901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326487|NCT01265901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139326488|NCT01265901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139326489|NCT01265901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139326491|NCT01265901|Growth Inhibitors|growth inhibitors|mesh-ancestor
139326492|NCT01265901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139326493|NCT01265901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326494|NCT05231382|Leucovorin|leucovorin|mesh-list
139326495|NCT05231382|Fluorouracil|fluorouracil|mesh-list
139326496|NCT05231382|Raltitrexed|raltitrexed|mesh-list
139326497|NCT05231382|Oxaliplatin|oxaliplatin|mesh-list
139326498|NCT05231382|Antimetabolites|antimetabolites|mesh-ancestor
139326499|NCT05231382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326500|NCT05231382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139326501|NCT05231382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326502|NCT05231382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139326503|NCT05231382|Immunologic Factors|immunologic factors|mesh-ancestor
139326504|NCT05231382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326505|NCT05231382|Antidotes|antidotes|mesh-ancestor
139326506|NCT05231382|Protective Agents|protective agents|mesh-ancestor
139326507|NCT05231382|Vitamin B Complex|vitamin b complex|mesh-ancestor
139326508|NCT05231382|Vitamins|vitamins|mesh-ancestor
139326509|NCT05231382|Micronutrients|micronutrients|mesh-ancestor
139326510|NCT05231382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139326511|NCT05231382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326512|NCT01262235|TKM-080301|tkm-080301|mesh-list
139326513|NCT01262235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139326514|NCT01262235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326515|NCT01262235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326516|NCT01262001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139326517|NCT01262001|Immunologic Factors|immunologic factors|mesh-ancestor
139326518|NCT01262001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326519|NCT01460511|Epinephrine|epinephrine|mesh-list
139326520|NCT01460511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139326521|NCT01460511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139326522|NCT01460511|Adrenergic Agents|adrenergic agents|mesh-ancestor
139326523|NCT01460511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326524|NCT01460511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326525|NCT01460511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326526|NCT01460511|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139326527|NCT01460511|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139326528|NCT01460511|Autonomic Agents|autonomic agents|mesh-ancestor
139326529|NCT01460511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326530|NCT01460511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139326531|NCT01460511|Respiratory System Agents|respiratory system agents|mesh-ancestor
139326532|NCT01460511|Mydriatics|mydriatics|mesh-ancestor
139326533|NCT01460511|Sympathomimetics|sympathomimetics|mesh-ancestor
139326534|NCT01460511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139326535|NCT03135171|Trastuzumab|trastuzumab|mesh-list
139326536|NCT03135171|Pertuzumab|pertuzumab|mesh-list
139326537|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139326538|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326539|NCT01449591|Metronidazole|metronidazole|mesh-list
139326540|NCT01449591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326541|NCT01449591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139326542|NCT01449591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139326543|NCT01449591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139326544|NCT00909753|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139326545|NCT00909753|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139326546|NCT00909753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139326547|NCT01444365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139326548|NCT01444365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139326549|NCT01444365|Analgesics|analgesics|mesh-ancestor
139326550|NCT01444365|Sensory System Agents|sensory system agents|mesh-ancestor
139326551|NCT01444365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326552|NCT01444365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326553|NCT01444365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139326554|NCT01444365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139326556|NCT01098435|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139326557|NCT01098435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326558|NCT01098435|Sensory System Agents|sensory system agents|mesh-ancestor
139326559|NCT01098435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326560|NCT00909597|Pioglitazone|pioglitazone|mesh-list
139326573|NCT05379855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139326574|NCT05379855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139326575|NCT05379855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139326576|NCT05379855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138912620|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
139326578|NCT05379855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326579|NCT05379855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326580|NCT05379855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139326581|NCT05379855|Respiratory System Agents|respiratory system agents|mesh-ancestor
139326582|NCT05379855|Mydriatics|mydriatics|mesh-ancestor
139326583|NCT05379855|Parasympatholytics|parasympatholytics|mesh-ancestor
139326584|NCT05379855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139326585|NCT05379855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139326586|NCT05379855|Cholinergic Agents|cholinergic agents|mesh-ancestor
139326587|NCT05379855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326588|NCT05379855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326589|NCT02718326|Aflibercept|aflibercept|mesh-list
139326590|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139326591|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139326592|NCT02718326|Growth Substances|growth substances|mesh-ancestor
139326593|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326594|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
139326595|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326596|NCT03691584|Dimercaprol|dimercaprol|mesh-list
139326597|NCT03691584|Chelating Agents|chelating agents|mesh-ancestor
139326598|NCT03691584|Sequestering Agents|sequestering agents|mesh-ancestor
139326599|NCT03691584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326612|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139326613|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
139326614|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326615|NCT03600714|Interferons|interferons|mesh-list
139326616|NCT03600714|Ritonavir|ritonavir|mesh-list
139326617|NCT03600714|Lonafarnib|lonafarnib|mesh-list
139326618|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326619|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
139326620|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326621|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139326622|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139326623|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
139326624|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326625|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326626|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139326627|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139326628|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139326629|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139326630|NCT04590326|Cemiplimab|cemiplimab|mesh-list
139326631|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139326632|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326633|NCT05163366|Ketamine|ketamine|mesh-list
139326634|NCT05163366|Morphine|morphine|mesh-list
139326635|NCT05163366|Analgesics|analgesics|mesh-ancestor
139326636|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
139326637|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326638|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326639|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139326640|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139326641|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
139326642|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
139326643|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139326644|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139326645|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139326646|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326647|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326648|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139326649|NCT05163366|Narcotics|narcotics|mesh-ancestor
139326650|NCT00900783|Valacyclovir|valacyclovir|mesh-list
139326651|NCT00900783|Antiviral Agents|antiviral agents|mesh-ancestor
139326652|NCT00900783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326653|NCT01035879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139326654|NCT01035879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139326655|NCT01035879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326656|NCT01035879|Incretins|incretins|mesh-ancestor
139326657|NCT01035879|Hormones|hormones|mesh-ancestor
139326658|NCT01035879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139326659|NCT01035879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139326660|NCT01035879|Protease Inhibitors|protease inhibitors|mesh-ancestor
139326661|NCT01035879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326662|NCT01035879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326663|NCT01029873|Cisplatin|cisplatin|mesh-list
139326664|NCT01029873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326665|NCT01024101|Paclitaxel|paclitaxel|mesh-list
139326666|NCT01024101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139326667|NCT01024101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326668|NCT01024101|Tubulin Modulators|tubulin modulators|mesh-ancestor
139326669|NCT01024101|Antimitotic Agents|antimitotic agents|mesh-ancestor
139326670|NCT01024101|Mitosis Modulators|mitosis modulators|mesh-ancestor
139326671|NCT01024101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326672|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
139326673|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326674|NCT00818571|Vildagliptin|vildagliptin|mesh-list
139326675|NCT00818571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139326676|NCT00818571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326677|NCT00818571|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139326678|NCT00818571|Protease Inhibitors|protease inhibitors|mesh-ancestor
139326679|NCT00818571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326680|NCT00818571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326681|NCT00818493|Acetaminophen|acetaminophen|mesh-list
139326682|NCT00818493|Morphine|morphine|mesh-list
139326683|NCT00818493|Oxycodone|oxycodone|mesh-list
139326684|NCT00818493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139326685|NCT00818493|Narcotics|narcotics|mesh-ancestor
139326686|NCT00818493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139326687|NCT00818493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326688|NCT00818493|Analgesics|analgesics|mesh-ancestor
139326689|NCT00818493|Sensory System Agents|sensory system agents|mesh-ancestor
139326690|NCT00818493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326691|NCT00818493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139326692|NCT00818493|Antipyretics|antipyretics|mesh-ancestor
139326693|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139326694|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139326695|NCT00893139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139326696|NCT00893139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139326697|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139326698|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326699|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139326700|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326701|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326702|NCT00892203|Sumatriptan|sumatriptan|mesh-list
139326703|NCT00892203|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139326704|NCT00892203|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139326705|NCT00892203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139326706|NCT00892203|Serotonin Agents|serotonin agents|mesh-ancestor
139326707|NCT00892203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326708|NCT00892203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326709|NCT00892203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326710|NCT00810147|BMS 708163|bms 708163|mesh-list
139326711|NCT00810147|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139326712|NCT00810147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326713|NCT00810147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326714|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
139326715|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139326716|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326717|NCT04375956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139326718|NCT04375956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326719|NCT04495478|Ramucirumab|ramucirumab|mesh-list
139326720|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139326721|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326722|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
139326723|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326724|NCT04487444|Thymalfasin|thymalfasin|mesh-list
139326725|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139326726|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
139326727|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326728|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
139326729|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139326730|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326731|NCT02717156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139326732|NCT02717156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326733|NCT00884715|Octreotide|octreotide|mesh-list
139326734|NCT00884715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139326735|NCT00884715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139326736|NCT00884715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326737|NCT03603080|Metformin|metformin|mesh-list
139326738|NCT03603080|Topiramate|topiramate|mesh-list
139326739|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
139326740|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139326741|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326742|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
139326743|NCT01019187|Modafinil|modafinil|mesh-list
139326744|NCT01019187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139326745|NCT01019187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326746|NCT01019187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139326747|NCT01019187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139326748|NCT01019187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139326749|NCT01019187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326751|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139326752|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
139326753|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326754|NCT01018875|Donepezil|donepezil|mesh-list
139326755|NCT01018875|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139326756|NCT01018875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326757|NCT01018875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326758|NCT01018875|Cholinergic Agents|cholinergic agents|mesh-ancestor
139326759|NCT01018875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326760|NCT01018875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326761|NCT01018875|Nootropic Agents|nootropic agents|mesh-ancestor
139326762|NCT00806403|Reteplase|reteplase|mesh-list
139326763|NCT00806403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138912653|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139326764|NCT00806403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139326765|NCT00806403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326766|NCT01007721|Fluticasone|fluticasone|mesh-list
139326767|NCT01007721|Xhance|xhance|mesh-list
139326768|NCT01007721|Montelukast|montelukast|mesh-list
139326769|NCT01007721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139326770|NCT01007721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139326771|NCT01007721|Autonomic Agents|autonomic agents|mesh-ancestor
139326772|NCT01007721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326773|NCT01007721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326774|NCT01007721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139326775|NCT01007721|Respiratory System Agents|respiratory system agents|mesh-ancestor
139326776|NCT01007721|Dermatologic Agents|dermatologic agents|mesh-ancestor
139326777|NCT01007721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139326778|NCT01007721|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139326779|NCT01007721|Hormone Antagonists|hormone antagonists|mesh-ancestor
139326780|NCT01007721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139326781|NCT01007721|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139326782|NCT01007721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139326783|NCT01007721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326784|NCT00701558|Gemcitabine|gemcitabine|mesh-list
139326785|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139326786|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139326787|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
139326788|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326789|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326790|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139326791|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326792|NCT03233828|Aldesleukin|aldesleukin|mesh-list
139326793|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326794|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139326795|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139326796|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
139326797|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326798|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
139326799|NCT03882177|Pyridoxal|pyridoxal|mesh-list
139326800|NCT03882177|Pyridoxine|pyridoxine|mesh-list
139326801|NCT03882177|Pravastatin|pravastatin|mesh-list
139326802|NCT03882177|Vitamins|vitamins|mesh-ancestor
139326803|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
139326804|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326805|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
139326806|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139326807|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139326808|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
139326809|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326810|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139326811|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139326812|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326814|NCT01007097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138912680|NCT00814580|Analgesics|analgesics|mesh-ancestor
139326815|NCT01007097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139326816|NCT01007097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326817|NCT01007097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139326818|NCT01007097|Immunologic Factors|immunologic factors|mesh-ancestor
139326819|NCT01663402|Alirocumab|alirocumab|mesh-list
139326820|NCT01663402|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139326821|NCT01663402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139326822|NCT01663402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139326823|NCT01663402|Antimetabolites|antimetabolites|mesh-ancestor
139326824|NCT01663402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326825|NCT01663402|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139326826|NCT01663402|Protease Inhibitors|protease inhibitors|mesh-ancestor
139326827|NCT01663402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326828|NCT01663402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139326829|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
139326830|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139326831|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139326832|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139326833|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139326834|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326835|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
139326836|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326837|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326838|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139326839|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326840|NCT00869661|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139326841|NCT00869661|Interferon-alpha|interferon-alpha|mesh-list
139326842|NCT00869661|Ribavirin|ribavirin|mesh-list
139326843|NCT00869661|Antiviral Agents|antiviral agents|mesh-ancestor
138983689|NCT05019885|Ketamine|ketamine|mesh-list
139326844|NCT00869661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326845|NCT00869661|Immunologic Factors|immunologic factors|mesh-ancestor
139326846|NCT00869661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326847|NCT00869661|Antimetabolites|antimetabolites|mesh-ancestor
139326848|NCT00869661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326849|NCT03192566|Acetaminophen|acetaminophen|mesh-list
139326850|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139326851|NCT03192566|Analgesics|analgesics|mesh-ancestor
139326852|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
139326853|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326854|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326855|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
139326856|NCT03296930|Ritonavir|ritonavir|mesh-list
139326857|NCT03296930|Ribavirin|ribavirin|mesh-list
139326858|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
139326859|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139326860|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139326861|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
139326862|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326863|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326864|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139326865|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139326866|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
139326867|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326868|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139326869|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139326870|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
139326871|NCT04607772|Rituximab|rituximab|mesh-list
139326872|NCT04607772|Gemcitabine|gemcitabine|mesh-list
139326873|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
139326874|NCT04607772|Lenalidomide|lenalidomide|mesh-list
139326875|NCT04607772|Venetoclax|venetoclax|mesh-list
139326876|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139326877|NCT04607772|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139326878|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139326879|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326880|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
139326881|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326882|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139326883|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139326884|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
139326885|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326886|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139326887|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139326888|NCT04607772|Growth Substances|growth substances|mesh-ancestor
139326889|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
139326890|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139326891|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
139326892|NCT04607772|Immunoconjugates|immunoconjugates|mesh-ancestor
139326893|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
139326894|NCT02464124|Lactulose|lactulose|mesh-list
139326895|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139326896|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139326897|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326898|NCT00859521|Levetiracetam|levetiracetam|mesh-list
139326899|NCT00859521|Anticonvulsants|anticonvulsants|mesh-ancestor
139326900|NCT00859521|Nootropic Agents|nootropic agents|mesh-ancestor
139326901|NCT05398770|Vitamin D|vitamin d|mesh-list
139326902|NCT05398770|Vitamins|vitamins|mesh-ancestor
139326903|NCT05398770|Micronutrients|micronutrients|mesh-ancestor
139326904|NCT05398770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326905|NCT05398770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139326906|NCT00843687|Risperidone|risperidone|mesh-list
139326907|NCT00843687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139326908|NCT00843687|Serotonin Agents|serotonin agents|mesh-ancestor
139326909|NCT00843687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326910|NCT00843687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326911|NCT00843687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326912|NCT00843687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139326913|NCT00843687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139326914|NCT00843687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139326915|NCT00843687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139326916|NCT00843687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139326917|NCT00843687|Dopamine Agents|dopamine agents|mesh-ancestor
139326918|NCT04642131|Caffeine|caffeine|mesh-list
139326919|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139326920|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326921|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139326922|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139326923|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326924|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139326925|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139326926|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
139326927|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326929|NCT01001715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139326930|NCT01001715|Analgesics|analgesics|mesh-ancestor
139326931|NCT01001715|Sensory System Agents|sensory system agents|mesh-ancestor
139326932|NCT01001715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139326933|NCT01001715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326934|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139326935|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139326936|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139326937|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139326938|NCT00789633|Gemcitabine|gemcitabine|mesh-list
139326939|NCT00789633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139326940|NCT00789633|Antimetabolites|antimetabolites|mesh-ancestor
139326941|NCT00789633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326942|NCT00789633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326943|NCT00788541|Hydrocortisone|hydrocortisone|mesh-list
139326944|NCT00788541|Anecortave|anecortave|mesh-list
139326945|NCT00788541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139326946|NCT00788541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139326947|NCT00788541|Growth Substances|growth substances|mesh-ancestor
139326948|NCT00788541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326949|NCT00788541|Growth Inhibitors|growth inhibitors|mesh-ancestor
139178562|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
139326951|NCT00788541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139326952|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139326953|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139326954|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139326955|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139326956|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139326957|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
139326958|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326959|NCT00786201|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139326960|NCT00786201|Immunologic Factors|immunologic factors|mesh-ancestor
139326961|NCT00786201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326962|NCT00841815|Amlodipine|amlodipine|mesh-list
139326963|NCT00841815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139326964|NCT00841815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139326965|NCT00841815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139326966|NCT00841815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326967|NCT00841815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139326968|NCT00841815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326969|NCT00841815|Vasodilator Agents|vasodilator agents|mesh-ancestor
139326970|NCT03296306|Cisplatin|cisplatin|mesh-list
139326971|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139326972|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
138912750|NCT00816712|Androgens|androgens|mesh-ancestor
139326973|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139326974|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139326975|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139326976|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
139326977|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139326978|NCT04440280|Expectorants|expectorants|mesh-ancestor
139326979|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
139326980|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139326981|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
139326982|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326983|NCT04440280|Protective Agents|protective agents|mesh-ancestor
139326984|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326985|NCT04440280|Antidotes|antidotes|mesh-ancestor
139326986|NCT00841659|Paroxetine|paroxetine|mesh-list
139326987|NCT00841659|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139326988|NCT00841659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139326989|NCT00841659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139326990|NCT00841659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139326991|NCT00841659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139326992|NCT00841659|Serotonin Agents|serotonin agents|mesh-ancestor
139326993|NCT00841659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139326994|NCT00841659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139326995|NCT00841659|Antidepressive Agents|antidepressive agents|mesh-ancestor
139326996|NCT00841659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139326997|NCT00841659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139326998|NCT00841659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139326999|NCT00841659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327001|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
139327002|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
139327003|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139327004|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327005|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139327006|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327007|NCT01001091|Dexamethasone|dexamethasone|mesh-list
139327008|NCT01001091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139327009|NCT01001091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139327010|NCT01001091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139327011|NCT01001091|Antiemetics|antiemetics|mesh-ancestor
139327012|NCT01001091|Autonomic Agents|autonomic agents|mesh-ancestor
139327013|NCT01001091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327014|NCT01001091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327015|NCT01001091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139327016|NCT01001091|Glucocorticoids|glucocorticoids|mesh-ancestor
139327017|NCT01001091|Hormones|hormones|mesh-ancestor
139327018|NCT01001091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139327019|NCT01001091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139327020|NCT01001091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327021|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
139327022|NCT05076682|Efavirenz|efavirenz|mesh-list
139327023|NCT05076682|Choline|choline|mesh-list
139327024|NCT05076682|Antibodies|antibodies|mesh-list
139327025|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
139327026|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327027|NCT05076682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139327028|NCT05076682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139327029|NCT05076682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327030|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327031|NCT05076682|Antiviral Agents|antiviral agents|mesh-ancestor
139327032|NCT05076682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327033|NCT05076682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139327034|NCT05076682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139327035|NCT05076682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139327036|NCT05076682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139327037|NCT05076682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139327038|NCT05076682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139327039|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
139327040|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139327041|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
139327042|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139327043|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139327044|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
139327045|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
139327046|NCT05076682|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139327047|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139327048|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139327049|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
139327050|NCT00840879|Meloxicam|meloxicam|mesh-list
139327051|NCT00840879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139327052|NCT00840879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139327053|NCT00840879|Analgesics|analgesics|mesh-ancestor
139327054|NCT00840879|Sensory System Agents|sensory system agents|mesh-ancestor
139327055|NCT00840879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327056|NCT00840879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327057|NCT00840879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139327058|NCT00840879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139327059|NCT00840879|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139327060|NCT00840879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139327061|NCT00840879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327062|NCT00840879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327063|NCT02163434|Gabapentin|gabapentin|mesh-list
139327064|NCT02163434|Metoclopramide|metoclopramide|mesh-list
139327065|NCT02163434|Analgesics|analgesics|mesh-ancestor
139327066|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
139327067|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327068|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327069|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
139327070|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139327071|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139327072|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139327073|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139327074|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139327075|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139327076|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327077|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327078|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
139327079|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
139327080|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
139327081|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139327082|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139327083|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139327084|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
139327085|NCT00840411|Clarithromycin|clarithromycin|mesh-list
139327086|NCT00840411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139327087|NCT00840411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327088|NCT00840411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139327089|NCT00840411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327090|NCT00840411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327091|NCT00840411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139327092|NCT00840411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139327093|NCT00840099|Amoxicillin|amoxicillin|mesh-list
139327094|NCT00840099|Clavulanic Acid|clavulanic acid|mesh-list
139327095|NCT00840099|Clavulanic Acids|clavulanic acids|mesh-list
139327096|NCT00840099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139327097|NCT00840099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139327098|NCT00840099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327099|NCT00840099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139327100|NCT00840099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327101|NCT00840099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327102|NCT03108248|Doxorubicin|doxorubicin|mesh-list
139327103|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
139327104|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
139327105|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138912783|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327106|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327107|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139327108|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139327109|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327110|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327111|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
139327112|NCT03108248|Coagulants|coagulants|mesh-ancestor
139327113|NCT00836901|Amoxicillin|amoxicillin|mesh-list
139327114|NCT00836901|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139327115|NCT00836901|Clavulanic Acids|clavulanic acids|mesh-list
139327116|NCT00836901|Clavulanic Acid|clavulanic acid|mesh-list
139327117|NCT00836901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139327118|NCT00836901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327119|NCT00836901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139327120|NCT00836901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327121|NCT00836901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327122|NCT04460560|Terlipressin|terlipressin|mesh-list
139327123|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139327124|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139327125|NCT04537689|Cyclosporine|cyclosporine|mesh-list
139327126|NCT04537689|Methotrexate|methotrexate|mesh-list
139327128|NCT04537689|Acitretin|acitretin|mesh-list
139327129|NCT04537689|Cyclosporins|cyclosporins|mesh-list
139327130|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139327131|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
139327132|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139327133|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327134|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139327135|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
139327136|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327137|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327138|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
139327139|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327140|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139327141|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139327142|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
139327143|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139327144|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139327145|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
139327146|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327147|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139327148|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
139327149|NCT03295760|Ubiquinone|ubiquinone|mesh-list
139327150|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
139327151|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
139327152|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327153|NCT03295760|Vitamins|vitamins|mesh-ancestor
139327154|NCT05563012|Capecitabine|capecitabine|mesh-list
139327155|NCT05563012|Oxaliplatin|oxaliplatin|mesh-list
139327156|NCT05563012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139327157|NCT05563012|Antimetabolites|antimetabolites|mesh-ancestor
139327158|NCT05563012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327159|NCT05563012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327160|NCT04501653|Methylphenidate|methylphenidate|mesh-list
139327161|NCT04501653|Psilocybin|psilocybin|mesh-list
139327162|NCT04501653|Psilocin|psilocin|mesh-list
139327163|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139327164|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327165|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139327166|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139327167|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139327168|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327169|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
139327170|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327171|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
139327172|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139327173|NCT04730206|Molnupiravir|molnupiravir|mesh-list
139327174|NCT04730206|Camostat|camostat|mesh-list
139327175|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
139327176|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327177|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327178|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139327179|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139327180|NCT04730206|Antiviral Agents|antiviral agents|mesh-ancestor
139327181|NCT04730206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327182|NCT00990327|Adenosine|adenosine|mesh-list
139327183|NCT00990327|Analgesics|analgesics|mesh-ancestor
139327184|NCT00990327|Sensory System Agents|sensory system agents|mesh-ancestor
139327185|NCT00990327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327186|NCT00990327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327187|NCT00990327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139327188|NCT00990327|Vasodilator Agents|vasodilator agents|mesh-ancestor
139327189|NCT00990327|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139327190|NCT00990327|Purinergic Agonists|purinergic agonists|mesh-ancestor
139327191|NCT00990327|Purinergic Agents|purinergic agents|mesh-ancestor
139327192|NCT00990327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327193|NCT00990327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327194|NCT03050814|Leucovorin|leucovorin|mesh-list
139327195|NCT03050814|Bevacizumab|bevacizumab|mesh-list
139327196|NCT03050814|Avelumab|avelumab|mesh-list
139327197|NCT03050814|Capecitabine|capecitabine|mesh-list
139327198|NCT03050814|Fluorouracil|fluorouracil|mesh-list
139327199|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
139327200|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139327201|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327202|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139327203|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139327204|NCT03050814|Growth Substances|growth substances|mesh-ancestor
139327205|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327206|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
139327207|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139327208|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
139327209|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327210|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139327211|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
139327212|NCT03050814|Antidotes|antidotes|mesh-ancestor
139327213|NCT03050814|Protective Agents|protective agents|mesh-ancestor
139327214|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
139327215|NCT03050814|Vitamins|vitamins|mesh-ancestor
139327216|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
139327217|NCT02462174|Ketamine|ketamine|mesh-list
139327218|NCT02462174|Bupivacaine|bupivacaine|mesh-list
139327219|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
139327220|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
139327221|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139327222|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327224|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327225|NCT02462174|Analgesics|analgesics|mesh-ancestor
139178584|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
139327226|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139327227|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139327228|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
139327229|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139327230|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139327231|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327232|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327233|NCT02564146|Paclitaxel|paclitaxel|mesh-list
139327234|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139327235|NCT02564146|Gemcitabine|gemcitabine|mesh-list
139327236|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139327237|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327238|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
139327239|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
139327240|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
139327241|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327242|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139327243|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
139327244|NCT00981357|Naproxen|naproxen|mesh-list
139327245|NCT00981357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139327246|NCT00981357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139327247|NCT00981357|Analgesics|analgesics|mesh-ancestor
139327248|NCT00981357|Sensory System Agents|sensory system agents|mesh-ancestor
139327249|NCT00981357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327250|NCT00981357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327251|NCT00981357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139327252|NCT00981357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139327253|NCT00981357|Gout Suppressants|gout suppressants|mesh-ancestor
139327254|NCT00981357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139327255|NCT00981357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327256|NCT00981357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327257|NCT02462252|Cyclosporine|cyclosporine|mesh-list
139327258|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
139327259|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139327260|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139327261|NCT02462252|Cyclosporins|cyclosporins|mesh-list
139327262|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139327263|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327264|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327265|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139327266|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
139327267|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327268|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
139327269|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327270|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
139327271|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139327272|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139327273|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139327274|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
139327275|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
139327276|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327277|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139327278|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
139327279|NCT02462252|Hormones|hormones|mesh-ancestor
139327280|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139327281|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139327282|NCT02462252|Protective Agents|protective agents|mesh-ancestor
139327283|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139327284|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327285|NCT03130452|Amoxicillin|amoxicillin|mesh-list
139327286|NCT03130452|Metronidazole|metronidazole|mesh-list
139327287|NCT03130452|Clarithromycin|clarithromycin|mesh-list
139327288|NCT03130452|Lansoprazole|lansoprazole|mesh-list
139327289|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
139327290|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139327291|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327292|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139327293|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139091711|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178589|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327294|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139327295|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327296|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327297|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139327298|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139327299|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139327300|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139327301|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139327302|NCT00979251|Oseltamivir|oseltamivir|mesh-list
139327304|NCT00979251|Antiviral Agents|antiviral agents|mesh-ancestor
139327305|NCT00979251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327306|NCT00979251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327307|NCT00979251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327308|NCT00979251|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139327309|NCT00979251|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139327310|NCT00979251|Dopamine Agents|dopamine agents|mesh-ancestor
139327311|NCT00979251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327312|NCT00979251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327313|NCT00979251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139327314|NCT00979251|Analgesics|analgesics|mesh-ancestor
139327315|NCT00979251|Sensory System Agents|sensory system agents|mesh-ancestor
139327316|NCT00979251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327317|NCT04551352|Adalimumab|adalimumab|mesh-list
139327318|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
139327319|NCT04551352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139327320|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139327321|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139327322|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139327323|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327324|NCT05398224|Rituximab|rituximab|mesh-list
139327325|NCT05398224|Methotrexate|methotrexate|mesh-list
139327326|NCT05398224|Zanubrutinib|zanubrutinib|mesh-list
139327327|NCT05398224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139327328|NCT05398224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327329|NCT05398224|Immunologic Factors|immunologic factors|mesh-ancestor
139327330|NCT05398224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327331|NCT05398224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139327332|NCT05398224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139327333|NCT05398224|Abortifacient Agents|abortifacient agents|mesh-ancestor
139327334|NCT05398224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139327335|NCT05398224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139327336|NCT05398224|Antimetabolites|antimetabolites|mesh-ancestor
139327337|NCT05398224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327338|NCT05398224|Dermatologic Agents|dermatologic agents|mesh-ancestor
139327339|NCT05398224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327340|NCT05398224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139327341|NCT05398224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139327342|NCT05398224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139327343|NCT05398224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139327344|NCT04542304|Metolazone|metolazone|mesh-list
139327345|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139327346|NCT04542304|Diuretics|diuretics|mesh-ancestor
139327347|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
139327348|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327349|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139327350|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139327351|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327352|NCT02463110|Sertraline|sertraline|mesh-list
139327353|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
139327354|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139327355|NCT02463110|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139327356|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139327357|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139327358|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327359|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327360|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
139327361|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327362|NCT05502952|Pentoxifylline|pentoxifylline|mesh-list
139327363|NCT05502952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139327364|NCT05502952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139178596|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
139327365|NCT05502952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327366|NCT05502952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139327367|NCT05502952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139327368|NCT05502952|Protective Agents|protective agents|mesh-ancestor
139327369|NCT05502952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327370|NCT05502952|Vasodilator Agents|vasodilator agents|mesh-ancestor
139327371|NCT05502952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139327372|NCT05502952|Antioxidants|antioxidants|mesh-ancestor
139327373|NCT00835575|Mirtazapine|mirtazapine|mesh-list
139327374|NCT00835575|Antidepressive Agents|antidepressive agents|mesh-ancestor
139327375|NCT00835575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139327376|NCT00835575|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139327377|NCT00835575|Histamine Antagonists|histamine antagonists|mesh-ancestor
139327378|NCT00835575|Histamine Agents|histamine agents|mesh-ancestor
139327379|NCT00835575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327380|NCT00835575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327381|NCT00835575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327382|NCT00835575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139327383|NCT00835575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139327384|NCT00835575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139327385|NCT00835575|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139327386|NCT00835575|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139327387|NCT00835575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139327388|NCT00835575|Adrenergic Agents|adrenergic agents|mesh-ancestor
139327389|NCT00835575|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139327390|NCT00835575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139327391|NCT00835575|Serotonin Agents|serotonin agents|mesh-ancestor
139327392|NCT00835575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139327393|NCT00777309|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139327394|NCT00777309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327395|NCT00777309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139327396|NCT00777309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327397|NCT00777309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327398|NCT03295214|Acetaminophen|acetaminophen|mesh-list
139327399|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139327400|NCT03295214|Analgesics|analgesics|mesh-ancestor
139327401|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
139327402|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327403|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327404|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
139327405|NCT04604704|Niacinamide|niacinamide|mesh-list
139327406|NCT04604704|Naltrexone|naltrexone|mesh-list
139327407|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139327408|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139327409|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327410|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
139327411|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327412|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
139327413|NCT04604704|Vitamins|vitamins|mesh-ancestor
139327414|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
139327415|NCT00776373|Cytarabine|cytarabine|mesh-list
139327416|NCT00776373|Sirolimus|sirolimus|mesh-list
139327417|NCT00776373|Etoposide|etoposide|mesh-list
139327418|NCT00776373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139327419|NCT00776373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327420|NCT00776373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139327421|NCT00776373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139327422|NCT00776373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327423|NCT00776373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327424|NCT00776373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139327425|NCT00776373|Antimetabolites|antimetabolites|mesh-ancestor
139327426|NCT00776373|Antiviral Agents|antiviral agents|mesh-ancestor
139327427|NCT00776373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327428|NCT00776373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139327429|NCT00776373|Immunologic Factors|immunologic factors|mesh-ancestor
139327430|NCT00776373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327431|NCT00776373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139327432|NCT00776373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139327433|NCT00776373|Antifungal Agents|antifungal agents|mesh-ancestor
139327434|NCT00772785|Buprenorphine|buprenorphine|mesh-list
139327435|NCT00772785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139327436|NCT00772785|Narcotics|narcotics|mesh-ancestor
139327437|NCT00772785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139327438|NCT00772785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327439|NCT00772785|Analgesics|analgesics|mesh-ancestor
139327440|NCT00772785|Sensory System Agents|sensory system agents|mesh-ancestor
139327441|NCT00772785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327442|NCT00772785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139327443|NCT02461706|Cannabidiol|cannabidiol|mesh-list
138984285|NCT02873338|Cytarabine|cytarabine|mesh-list
139327444|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
139327446|NCT05497570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139327447|NCT05497570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139327448|NCT05497570|Analgesics|analgesics|mesh-ancestor
139327449|NCT05497570|Sensory System Agents|sensory system agents|mesh-ancestor
139327450|NCT05497570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327451|NCT05497570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327452|NCT05497570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139327453|NCT05497570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139327454|NCT05497570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139327455|NCT05497570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327456|NCT05497570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327457|NCT00963885|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139327459|NCT00963885|Antiviral Agents|antiviral agents|mesh-ancestor
139327460|NCT00963885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327461|NCT00963885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139327462|NCT00835497|Metformin|metformin|mesh-list
139327463|NCT00835497|Glipizide|glipizide|mesh-list
139327464|NCT00835497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139327465|NCT00835497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327466|NCT00763503|Calcitriol|calcitriol|mesh-list
139327467|NCT00763503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139327468|NCT00763503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327469|NCT00763503|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139327470|NCT00763503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139327471|NCT00763503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327472|NCT00763503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139327473|NCT00763503|Vitamins|vitamins|mesh-ancestor
139327474|NCT00763503|Micronutrients|micronutrients|mesh-ancestor
139327475|NCT00763503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139327476|NCT00761709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139327477|NCT00761709|Latanoprost|latanoprost|mesh-list
139327478|NCT00761709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139327479|NCT00760539|Timolol|timolol|mesh-list
139327480|NCT00760539|Travoprost|travoprost|mesh-list
139327481|NCT00760539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139327482|NCT00760539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139327483|NCT00760539|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139327484|NCT00760539|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139327485|NCT00760539|Adrenergic Agents|adrenergic agents|mesh-ancestor
139327486|NCT00760539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327487|NCT00760539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327488|NCT00760539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327489|NCT00760539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139327490|NCT00760539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139327491|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139327492|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139327493|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
139327494|NCT00759135|Finasteride|finasteride|mesh-list
139327495|NCT00759135|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139327496|NCT00759135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139327497|NCT00759135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327498|NCT00759135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327499|NCT00759135|Hormone Antagonists|hormone antagonists|mesh-ancestor
139327500|NCT00759135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139178610|NCT01185769|Vitamins|vitamins|mesh-ancestor
139327501|NCT00759135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327502|NCT00759135|Urological Agents|urological agents|mesh-ancestor
139327503|NCT00835263|Lamotrigine|lamotrigine|mesh-list
139327504|NCT00835263|Anticonvulsants|anticonvulsants|mesh-ancestor
139327505|NCT00835263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139327506|NCT00835263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139327507|NCT00835263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327508|NCT00835263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139327509|NCT00835263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327510|NCT00835263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139327511|NCT00835263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139327512|NCT00835263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139327513|NCT00835263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139327514|NCT00835263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139327515|NCT02639910|Venetoclax|venetoclax|mesh-list
139327516|NCT02639910|Idelalisib|idelalisib|mesh-list
139327517|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327518|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327519|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327520|NCT04454580|Azacitidine|azacitidine|mesh-list
139327521|NCT04454580|Decitabine|decitabine|mesh-list
139327522|NCT04454580|Venetoclax|venetoclax|mesh-list
139327523|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139327524|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
139327525|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327526|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327527|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327528|NCT00948909|Donepezil|donepezil|mesh-list
139327529|NCT00948909|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139327530|NCT00948909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327531|NCT00948909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327532|NCT00948909|Cholinergic Agents|cholinergic agents|mesh-ancestor
139327533|NCT00948909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327534|NCT00948909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327535|NCT00948909|Nootropic Agents|nootropic agents|mesh-ancestor
139327536|NCT02522910|Docetaxel|docetaxel|mesh-list
139327537|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327538|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
139327539|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
139327540|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
139327541|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327542|NCT00948753|Maraviroc|maraviroc|mesh-list
139327543|NCT00948753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327544|NCT00948753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139327545|NCT00948753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139327546|NCT00948753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327547|NCT00948753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139327548|NCT00948753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139327549|NCT00948753|Antiviral Agents|antiviral agents|mesh-ancestor
139327550|NCT00948753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139327551|NCT05397834|Fluticasone|fluticasone|mesh-list
139327552|NCT05397834|Xhance|xhance|mesh-list
139327553|NCT05397834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139327554|NCT05397834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139327555|NCT05397834|Autonomic Agents|autonomic agents|mesh-ancestor
139327556|NCT05397834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327557|NCT05397834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327558|NCT05397834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139327559|NCT05397834|Respiratory System Agents|respiratory system agents|mesh-ancestor
139327560|NCT05397834|Dermatologic Agents|dermatologic agents|mesh-ancestor
139327561|NCT05397834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139327562|NCT03134547|Sevoflurane|sevoflurane|mesh-list
139327563|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139327564|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139327565|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
139327566|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
139327567|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139327568|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327569|NCT01963208|Ganaxolone|ganaxolone|mesh-list
139327570|NCT01963208|Neurosteroids|neurosteroids|mesh-ancestor
139327571|NCT01963208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178614|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327572|NCT01963208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327573|NCT01963208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327574|NCT01963208|GABA Modulators|gaba modulators|mesh-ancestor
139327576|NCT00834873|Carvedilol|carvedilol|mesh-list
139327577|NCT00834873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139327578|NCT00834873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139327579|NCT00834873|Adrenergic Agents|adrenergic agents|mesh-ancestor
139327580|NCT00834873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327581|NCT00834873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327582|NCT00834873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327583|NCT00834873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139327584|NCT00834873|Antioxidants|antioxidants|mesh-ancestor
139327585|NCT00834873|Protective Agents|protective agents|mesh-ancestor
139327586|NCT00834873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139327587|NCT00834873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139327588|NCT00834873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139327589|NCT00834873|Vasodilator Agents|vasodilator agents|mesh-ancestor
139327590|NCT00834873|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139327591|NCT00834873|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139327592|NCT01377480|Posaconazole|posaconazole|mesh-list
139327593|NCT01377480|Benzonidazole|benzonidazole|mesh-list
139327594|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
139327596|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139327597|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139327598|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139327599|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139327600|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139327601|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327602|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327603|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139327604|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
139327605|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139327606|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327607|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139327608|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
139327609|NCT04263909|Sufentanil|sufentanil|mesh-list
139327610|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139327611|NCT04263909|Narcotics|narcotics|mesh-ancestor
139327612|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139327613|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327614|NCT04263909|Analgesics|analgesics|mesh-ancestor
139327615|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
139327616|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327617|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139327618|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139327619|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
139327620|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
139327621|NCT01421264|Gabapentin|gabapentin|mesh-list
139327622|NCT01421264|Analgesics|analgesics|mesh-ancestor
139327623|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
139327624|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327625|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327626|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
139327627|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139327628|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139327629|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139327630|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139327631|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139327632|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139327633|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327634|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327635|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
139327636|NCT04415840|Acetic Acid|acetic acid|mesh-list
139327637|NCT04415840|Retinol acetate|retinol acetate|mesh-list
139327638|NCT04415840|Lugol's solution|lugol's solution|mesh-list
139327639|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139327640|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327641|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139327642|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
139327643|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327644|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139327645|NCT04415840|Protective Agents|protective agents|mesh-ancestor
139327646|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327647|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
139327648|NCT04415840|Coagulants|coagulants|mesh-ancestor
139327649|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
139327650|NCT04488614|Estrogens|estrogens|mesh-list
139327651|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139327652|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327653|NCT04488614|Hormones|hormones|mesh-ancestor
139327654|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139327655|NCT00834795|Carvedilol|carvedilol|mesh-list
139327656|NCT00834795|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139327657|NCT00834795|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139327658|NCT00834795|Adrenergic Agents|adrenergic agents|mesh-ancestor
139327659|NCT00834795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327660|NCT00834795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327661|NCT00834795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327662|NCT00834795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139327663|NCT00834795|Antioxidants|antioxidants|mesh-ancestor
139327664|NCT00834795|Protective Agents|protective agents|mesh-ancestor
139327665|NCT00834795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139327666|NCT00834795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139327667|NCT00834795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139327668|NCT00834795|Vasodilator Agents|vasodilator agents|mesh-ancestor
138912968|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139327669|NCT00834795|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139327670|NCT00834795|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139327671|NCT00834717|Granisetron|granisetron|mesh-list
139327672|NCT00834717|Antiemetics|antiemetics|mesh-ancestor
139327673|NCT00834717|Autonomic Agents|autonomic agents|mesh-ancestor
139327674|NCT00834717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327675|NCT00834717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327676|NCT00834717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139327677|NCT00834717|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139327678|NCT00834717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139327679|NCT00834717|Serotonin Agents|serotonin agents|mesh-ancestor
139327680|NCT00834717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327681|NCT00834717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327682|NCT00834639|Valproic Acid|valproic acid|mesh-list
139327683|NCT00834639|Anticonvulsants|anticonvulsants|mesh-ancestor
139327684|NCT00834639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327685|NCT00834639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327686|NCT00834639|GABA Agents|gaba agents|mesh-ancestor
139327687|NCT00834639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327688|NCT00834639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327689|NCT00834639|Antimanic Agents|antimanic agents|mesh-ancestor
139327690|NCT00834639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139327691|NCT00834639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139327692|NCT00834639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139327693|NCT00834561|Lamotrigine|lamotrigine|mesh-list
139327694|NCT00834561|Anticonvulsants|anticonvulsants|mesh-ancestor
139327695|NCT00834561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139327696|NCT00834561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139327697|NCT00834561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327698|NCT00834561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139327699|NCT00834561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327700|NCT00834561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139327701|NCT00834561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139327702|NCT00834561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139327703|NCT00834561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139327704|NCT00834561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139327705|NCT00754221|Reboxetine|reboxetine|mesh-list
139327706|NCT00754221|Antidepressive Agents|antidepressive agents|mesh-ancestor
139327707|NCT00754221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139327708|NCT00754221|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139327709|NCT00754221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139327710|NCT00754221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139327711|NCT00754221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327712|NCT00754221|Adrenergic Agents|adrenergic agents|mesh-ancestor
139327713|NCT00754221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327714|NCT00754221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327715|NCT00834405|Leflunomide|leflunomide|mesh-list
139327716|NCT00834405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327717|NCT00834405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327718|NCT00834405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139327719|NCT00834405|Immunologic Factors|immunologic factors|mesh-ancestor
139327720|NCT00834405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327721|NCT00834249|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139327722|NCT00834249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139327723|NCT00834249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139327724|NCT00834249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139327725|NCT00834249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327726|NCT00834249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327727|NCT00834249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327728|NCT00834249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139327729|NCT00834249|Antidepressive Agents|antidepressive agents|mesh-ancestor
139327730|NCT00834249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139327731|NCT00751803|Eletriptan|eletriptan|mesh-list
139327732|NCT00751803|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139327733|NCT00751803|Serotonin Agents|serotonin agents|mesh-ancestor
139327734|NCT00751803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327735|NCT00751803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327736|NCT00751803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327737|NCT05420961|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139327738|NCT05420961|Immunologic Factors|immunologic factors|mesh-ancestor
138984590|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
139327739|NCT05420961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327740|NCT05402397|Losartan|losartan|mesh-list
139327741|NCT05402397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139327742|NCT05402397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139327743|NCT05402397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139327744|NCT05402397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139327745|NCT05402397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327746|NCT00833937|Zolpidem|zolpidem|mesh-list
139327747|NCT00833937|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139327748|NCT00833937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139327749|NCT00833937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139327750|NCT00833937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327751|NCT00833937|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139327752|NCT00833937|GABA Agonists|gaba agonists|mesh-ancestor
139327753|NCT00833937|GABA Agents|gaba agents|mesh-ancestor
139327754|NCT00833937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327755|NCT00833937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327756|NCT00831051|Morphine|morphine|mesh-list
139327757|NCT00831051|Oxycodone|oxycodone|mesh-list
139327758|NCT00831051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139327759|NCT00831051|Narcotics|narcotics|mesh-ancestor
139327760|NCT00831051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139327761|NCT00831051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327762|NCT00831051|Analgesics|analgesics|mesh-ancestor
139327763|NCT00831051|Sensory System Agents|sensory system agents|mesh-ancestor
139327764|NCT00831051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327765|NCT00750633|Moxifloxacin|moxifloxacin|mesh-list
139327766|NCT00750633|Dexamethasone|dexamethasone|mesh-list
139327767|NCT00750633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139327768|NCT00750633|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139327769|NCT00750633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139327770|NCT00750633|Antiemetics|antiemetics|mesh-ancestor
139327771|NCT00750633|Autonomic Agents|autonomic agents|mesh-ancestor
139327772|NCT00750633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327773|NCT00750633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139178633|NCT01183663|Leucovorin|leucovorin|mesh-list
139327774|NCT00750633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139327775|NCT00750633|Glucocorticoids|glucocorticoids|mesh-ancestor
139327776|NCT00750633|Hormones|hormones|mesh-ancestor
139327777|NCT00750633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139327778|NCT00750633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139327779|NCT00750633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327780|NCT00750633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138912998|NCT04110288|Paclitaxel|paclitaxel|mesh-list
139327781|NCT00750633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327782|NCT00750633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139327783|NCT00750633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139327784|NCT00750633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327785|NCT00750633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327786|NCT00750243|Naproxen|naproxen|mesh-list
139327787|NCT00750243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139327788|NCT00750243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139327789|NCT00750243|Analgesics|analgesics|mesh-ancestor
139327790|NCT00750243|Sensory System Agents|sensory system agents|mesh-ancestor
139327791|NCT00750243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327792|NCT00750243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327793|NCT00750243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139327794|NCT00750243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139327795|NCT00750243|Gout Suppressants|gout suppressants|mesh-ancestor
139327796|NCT00750243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139327797|NCT00750243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327798|NCT00750243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327799|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
139327800|NCT00924170|Fludarabine|fludarabine|mesh-list
139327801|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139327802|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
139327803|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327804|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139327805|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139327806|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
139327807|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327808|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327809|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139327810|NCT04809285|Insulin|insulin|mesh-list
139327811|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139327812|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327813|NCT00920985|Contraceptive Agents|contraceptive agents|mesh-list
139327814|NCT00920985|Gestodene|gestodene|mesh-list
139327815|NCT00920985|Contraceptives, Oral|contraceptives, oral|mesh-list
139327816|NCT00920985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139327817|NCT00920985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327818|NCT00920985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139327819|NCT00920985|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139327820|NCT00920985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139327821|NCT00920985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139327822|NCT00920985|Progestins|progestins|mesh-ancestor
139327823|NCT00920985|Hormones|hormones|mesh-ancestor
139327824|NCT00920985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139327825|NCT05388747|Cefuroxime|cefuroxime|mesh-list
139327826|NCT05388747|Cefuroxime axetil|cefuroxime axetil|mesh-list
139327827|NCT05388747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139327828|NCT05388747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327829|NCT00828321|Ramipril|ramipril|mesh-list
139327830|NCT00828321|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139327831|NCT00828321|Protease Inhibitors|protease inhibitors|mesh-ancestor
139327832|NCT00828321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327833|NCT00828321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327834|NCT00828321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139327835|NCT01352715|Ritonavir|ritonavir|mesh-list
139327836|NCT01352715|Lopinavir|lopinavir|mesh-list
139327837|NCT01352715|Tenofovir|tenofovir|mesh-list
139327838|NCT01352715|Lamivudine|lamivudine|mesh-list
139327839|NCT01352715|Emtricitabine|emtricitabine|mesh-list
139327840|NCT01352715|Zidovudine|zidovudine|mesh-list
139327841|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
139327842|NCT01352715|Abacavir|abacavir|mesh-list
139327843|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139327844|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
139327845|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139327846|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139327847|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
139327848|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327849|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327850|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139327851|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139327852|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
139327853|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327854|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139327855|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139327856|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139327857|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139327858|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
139327859|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139327860|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139327861|NCT00743925|Atorvastatin|atorvastatin|mesh-list
139327862|NCT00743925|Varespladib methyl|varespladib methyl|mesh-list
139327863|NCT00743925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139327864|NCT00743925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139327865|NCT00743925|Antimetabolites|antimetabolites|mesh-ancestor
139327866|NCT00743925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327867|NCT00743925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139327868|NCT00743925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139327869|NCT00743925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327870|NCT00743925|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
139327871|NCT00738387|Docetaxel|docetaxel|mesh-list
139327872|NCT00738387|Vadimezan|vadimezan|mesh-list
139327873|NCT00738387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327874|NCT00738387|Tubulin Modulators|tubulin modulators|mesh-ancestor
139327875|NCT00738387|Antimitotic Agents|antimitotic agents|mesh-ancestor
139327876|NCT00738387|Mitosis Modulators|mitosis modulators|mesh-ancestor
139327877|NCT00738387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327878|NCT00645177|Paclitaxel|paclitaxel|mesh-list
139327879|NCT00645177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139327880|NCT00645177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327881|NCT00645177|Tubulin Modulators|tubulin modulators|mesh-ancestor
139327882|NCT00645177|Antimitotic Agents|antimitotic agents|mesh-ancestor
139327883|NCT00645177|Mitosis Modulators|mitosis modulators|mesh-ancestor
139327884|NCT00645177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327885|NCT00643383|Acetaminophen|acetaminophen|mesh-list
139327886|NCT00643383|Tramadol|tramadol|mesh-list
139327887|NCT00643383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139327888|NCT00643383|Analgesics|analgesics|mesh-ancestor
139327889|NCT00643383|Sensory System Agents|sensory system agents|mesh-ancestor
139327890|NCT00643383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327891|NCT00643383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327892|NCT00643383|Antipyretics|antipyretics|mesh-ancestor
139327893|NCT00643383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139327894|NCT00643383|Narcotics|narcotics|mesh-ancestor
139327895|NCT00643383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139327896|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139327897|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
139327898|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327899|NCT04285450|Vitamin K|vitamin k|mesh-list
139327900|NCT04285450|Vitamins|vitamins|mesh-ancestor
139327901|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
139327902|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327903|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139327904|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139327905|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327906|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
139327907|NCT04285450|Coagulants|coagulants|mesh-ancestor
139327908|NCT05497102|Lenalidomide|lenalidomide|mesh-list
139327909|NCT05497102|Immunologic Factors|immunologic factors|mesh-ancestor
139327910|NCT05497102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327911|NCT05497102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139327912|NCT05497102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139327913|NCT05497102|Growth Substances|growth substances|mesh-ancestor
139327914|NCT05497102|Growth Inhibitors|growth inhibitors|mesh-ancestor
139327915|NCT05497102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327916|NCT05490160|Tranexamic Acid|tranexamic acid|mesh-list
139327917|NCT05490160|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139327918|NCT05490160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139327919|NCT05490160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327920|NCT05490160|Hemostatics|hemostatics|mesh-ancestor
139327921|NCT05490160|Coagulants|coagulants|mesh-ancestor
139327922|NCT05495620|Dexamethasone|dexamethasone|mesh-list
139327923|NCT05495620|Lenalidomide|lenalidomide|mesh-list
139327924|NCT05495620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139327925|NCT05495620|Antiemetics|antiemetics|mesh-ancestor
139327926|NCT05495620|Autonomic Agents|autonomic agents|mesh-ancestor
139327927|NCT05495620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327928|NCT05495620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327929|NCT05495620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139327930|NCT05495620|Glucocorticoids|glucocorticoids|mesh-ancestor
139327931|NCT05495620|Hormones|hormones|mesh-ancestor
139327932|NCT05495620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139327933|NCT05495620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139327934|NCT05495620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327935|NCT05495620|Immunologic Factors|immunologic factors|mesh-ancestor
139327936|NCT05495620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139327937|NCT05495620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139327938|NCT05495620|Growth Substances|growth substances|mesh-ancestor
139327939|NCT05495620|Growth Inhibitors|growth inhibitors|mesh-ancestor
139327940|NCT05490082|Mirabegron|mirabegron|mesh-list
139327941|NCT05490082|Solifenacin Succinate|solifenacin succinate|mesh-list
139327942|NCT05490082|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139327943|NCT05490082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139327944|NCT05490082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139327945|NCT05490082|Adrenergic Agents|adrenergic agents|mesh-ancestor
139327946|NCT05490082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139327947|NCT05490082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327948|NCT05490082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327949|NCT05490082|Urological Agents|urological agents|mesh-ancestor
139327950|NCT05490082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139327951|NCT05490082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139327952|NCT05490082|Cholinergic Agents|cholinergic agents|mesh-ancestor
139327953|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
139327954|NCT02559310|Linezolid|linezolid|mesh-list
139327955|NCT02559310|Lefamulin|lefamulin|mesh-list
139327956|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139327957|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139327958|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139327959|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139327960|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139327961|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327962|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327963|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139327964|NCT05489848|Paclitaxel|paclitaxel|mesh-list
139327965|NCT05489848|Carboplatin|carboplatin|mesh-list
139327966|NCT05489848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139327967|NCT05489848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327968|NCT05489848|Tubulin Modulators|tubulin modulators|mesh-ancestor
139327969|NCT05489848|Antimitotic Agents|antimitotic agents|mesh-ancestor
139327970|NCT05489848|Mitosis Modulators|mitosis modulators|mesh-ancestor
139327971|NCT05489848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327972|NCT05489692|Leucovorin|leucovorin|mesh-list
139327973|NCT05489692|Fluorouracil|fluorouracil|mesh-list
139327974|NCT05489692|Oxaliplatin|oxaliplatin|mesh-list
139327975|NCT05489692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139327976|NCT05489692|Antimetabolites|antimetabolites|mesh-ancestor
139327977|NCT05489692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139327978|NCT05489692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139327979|NCT05489692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139327980|NCT05489692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139327981|NCT05489692|Immunologic Factors|immunologic factors|mesh-ancestor
139327982|NCT05489692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327983|NCT05489692|Antidotes|antidotes|mesh-ancestor
139327984|NCT05489692|Protective Agents|protective agents|mesh-ancestor
139327985|NCT05489692|Vitamin B Complex|vitamin b complex|mesh-ancestor
139327986|NCT05489692|Vitamins|vitamins|mesh-ancestor
139327987|NCT05489692|Micronutrients|micronutrients|mesh-ancestor
139327988|NCT05489692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139327989|NCT00721695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139327990|NCT00721695|Mydriatics|mydriatics|mesh-list
139327991|NCT00721695|Autonomic Agents|autonomic agents|mesh-ancestor
139327992|NCT00721695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139327993|NCT00721695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139327994|NCT00625833|Reboxetine|reboxetine|mesh-list
139327995|NCT00625833|Antidepressive Agents|antidepressive agents|mesh-ancestor
139327996|NCT00625833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139327997|NCT00625833|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139327998|NCT00625833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139327999|NCT00625833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139328000|NCT00625833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328001|NCT00625833|Adrenergic Agents|adrenergic agents|mesh-ancestor
139328002|NCT00625833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328003|NCT00625833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328004|NCT03299036|Doxorubicin|doxorubicin|mesh-list
139328005|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139328006|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328007|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139328008|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139328009|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328010|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328011|NCT03290846|Secretin|secretin|mesh-list
139328012|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139328013|NCT03290846|Hormones|hormones|mesh-ancestor
139328014|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328015|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328016|NCT03298958|Sirolimus|sirolimus|mesh-list
139328017|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139328018|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139328019|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139328020|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328021|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
139328022|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139328023|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
139328024|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328025|NCT03290456|Prednisone|prednisone|mesh-list
139328026|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328027|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
139328028|NCT03290456|Hormones|hormones|mesh-ancestor
139328029|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328030|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328031|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139328032|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328033|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
139328034|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139328035|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
139328036|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139178670|NCT03344172|Gemcitabine|gemcitabine|mesh-list
139328037|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
139328038|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328039|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328040|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
139328041|NCT03298646|Diclofenac|diclofenac|mesh-list
139328042|NCT03298646|Lidocaine|lidocaine|mesh-list
139328044|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
139328045|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328046|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328047|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
139328048|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328049|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139328050|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139328051|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139328052|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139328053|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328054|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139328055|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139328056|NCT03298646|Analgesics|analgesics|mesh-ancestor
139328057|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328058|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139328059|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139328060|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328061|NCT05488990|Calcitriol|calcitriol|mesh-list
139328062|NCT05488990|Calcipotriene|calcipotriene|mesh-list
139328063|NCT05488990|Dermatologic Agents|dermatologic agents|mesh-ancestor
139328064|NCT05488990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139328065|NCT05488990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328066|NCT05488990|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139328067|NCT05488990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139328068|NCT05488990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328069|NCT05488990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139328070|NCT05488990|Vitamins|vitamins|mesh-ancestor
139328071|NCT05488990|Micronutrients|micronutrients|mesh-ancestor
139328072|NCT05488990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139328073|NCT03289520|Clopidogrel|clopidogrel|mesh-list
139328074|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139328075|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139328076|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139328077|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139328078|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
139328079|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328080|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328081|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328082|NCT03293108|Vitamin D|vitamin d|mesh-list
139328083|NCT03293108|Denosumab|denosumab|mesh-list
139328084|NCT03293108|Calcium|calcium|mesh-list
139328085|NCT03293108|Vitamins|vitamins|mesh-ancestor
139328086|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
139328087|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328088|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139328089|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139328090|NCT03292796|Bimatoprost|bimatoprost|mesh-list
139328091|NCT03292796|Latanoprost|latanoprost|mesh-list
139328092|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139328093|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139328094|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139328095|NCT03288896|Ethanol|ethanol|mesh-list
139328096|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139328097|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139328098|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328099|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328100|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
139328101|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
139328102|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328103|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139328104|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328105|NCT03292172|Atezolizumab|atezolizumab|mesh-list
139328106|NCT03292172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139328107|NCT03292172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328108|NCT03292172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139328109|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328111|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139328112|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139328113|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
139328114|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984966|NCT00485758|Niacin|niacin|mesh-list
139328115|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139328116|NCT03288428|Morphine|morphine|mesh-list
139328117|NCT03288428|Nalbuphine|nalbuphine|mesh-list
139328118|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139328119|NCT03288428|Narcotics|narcotics|mesh-ancestor
139328120|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328121|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328122|NCT03288428|Analgesics|analgesics|mesh-ancestor
139328123|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
139328124|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328125|NCT03288350|Avelumab|avelumab|mesh-list
139328126|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139328127|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328128|NCT00003224|Vaccines|vaccines|mesh-list
139328129|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
139328130|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
139328131|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328132|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139328133|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139328134|NCT03288038|Ezetimibe|ezetimibe|mesh-list
139328135|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139328136|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139328137|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
139328138|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328139|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139328140|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139328141|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328142|NCT03287882|Micronutrients|micronutrients|mesh-list
139328143|NCT03287882|Trace Elements|trace elements|mesh-list
139328144|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328145|NCT03291314|Avelumab|avelumab|mesh-list
139328146|NCT03291314|Axitinib|axitinib|mesh-list
139328147|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139328148|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328149|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139328150|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328151|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328152|NCT03283202|Prednisone|prednisone|mesh-list
139328153|NCT03283202|Prednisolone|prednisolone|mesh-list
139328154|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
139328155|NCT03283202|Rituximab|rituximab|mesh-list
139328156|NCT03283202|Vincristine|vincristine|mesh-list
139328157|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139328158|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
139328159|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328160|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139328161|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139328162|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
139328163|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328164|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328165|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139328166|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139328167|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328168|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
139328169|NCT03283202|Hormones|hormones|mesh-ancestor
139328170|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328171|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139328172|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139328173|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
139328174|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
139328175|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
139178687|NCT01188733|Octreotide|octreotide|mesh-list
139328176|NCT03283046|Dexamethasone|dexamethasone|mesh-list
139328177|NCT03283046|Nivolumab|nivolumab|mesh-list
139328178|NCT03283046|Lenalidomide|lenalidomide|mesh-list
139328179|NCT03283046|Ipilimumab|ipilimumab|mesh-list
139328180|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328181|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
139328182|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
139328183|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328184|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328185|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139328186|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
139328187|NCT03283046|Hormones|hormones|mesh-ancestor
139328188|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328189|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139328190|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328191|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139328192|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139328193|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328194|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
139328195|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139328196|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139328197|NCT03283046|Growth Substances|growth substances|mesh-ancestor
139328198|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
139328199|NCT03287180|Buprenorphine|buprenorphine|mesh-list
139328200|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139328202|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139328203|NCT03287180|Narcotics|narcotics|mesh-ancestor
139328204|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328205|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328206|NCT03287180|Analgesics|analgesics|mesh-ancestor
139328207|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
139328208|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328209|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139328210|NCT02460146|CXA-10|cxa-10|mesh-list
139328211|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328212|NCT02460302|Progesterone|progesterone|mesh-list
139328213|NCT02460302|Progestins|progestins|mesh-ancestor
139328214|NCT02460302|Hormones|hormones|mesh-ancestor
139328215|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328216|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328217|NCT03282188|Sargramostim|sargramostim|mesh-list
139328218|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
139328219|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328220|NCT03384212|Cytarabine|cytarabine|mesh-list
139328221|NCT03384212|Fludarabine|fludarabine|mesh-list
139328222|NCT03384212|Busulfan|busulfan|mesh-list
139328223|NCT03384212|Cladribine|cladribine|mesh-list
139328224|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328225|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139328226|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
139328227|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328228|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139328229|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
139328230|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328231|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
139328232|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139328233|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
139328234|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139328235|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139328236|NCT02460068|Nivolumab|nivolumab|mesh-list
139328237|NCT02460068|Ipilimumab|ipilimumab|mesh-list
139328238|NCT02460068|Fotemustine|fotemustine|mesh-list
139328239|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139328240|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328241|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139328242|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328243|NCT03286244|Paclitaxel|paclitaxel|mesh-list
139328244|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139328245|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328246|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
139328247|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
139328248|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
139178692|NCT01101659|Analgesics|analgesics|mesh-ancestor
139328249|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328251|NCT03282110|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139328252|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139328253|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139328254|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328255|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328256|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
139328257|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328258|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139328259|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
139328260|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139328261|NCT03269786|Bilirubin|bilirubin|mesh-list
139328262|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
139328263|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328264|NCT03269786|Protective Agents|protective agents|mesh-ancestor
139328265|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985120|NCT00464620|Dasatinib|dasatinib|mesh-list
139328266|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
139328267|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
139328268|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
139328269|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328270|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328271|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
139328272|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139328273|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139328274|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
139328275|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328276|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328277|NCT03269318|Theophylline|theophylline|mesh-list
139328278|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139328279|NCT03269318|Montelukast|montelukast|mesh-list
139328280|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139328281|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
139328282|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328283|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328284|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139328285|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
139328286|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139328287|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139328288|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139328289|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
139328290|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328291|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328292|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139328293|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
139328294|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328295|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139328296|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139328297|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139328298|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328299|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
139328300|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139328301|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139328302|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
139328303|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
139328304|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139328305|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
139328306|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139328307|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
139328308|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328309|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328310|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
139328311|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139328312|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139328313|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139328314|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328315|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328316|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139328317|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139328318|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328319|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
138913116|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
139328320|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328321|NCT03107858|Dopamine|dopamine|mesh-list
139328322|NCT03107858|Norepinephrine|norepinephrine|mesh-list
139328323|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139328324|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139328325|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
139328326|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328327|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328328|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328329|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
139328330|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
139328331|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328332|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139328333|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139328334|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
139328335|NCT03107858|Protective Agents|protective agents|mesh-ancestor
139328336|NCT03269162|Docetaxel|docetaxel|mesh-list
139328337|NCT03269162|Pemetrexed|pemetrexed|mesh-list
139328338|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328339|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
139328340|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
139328341|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
139328342|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328343|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328344|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139328345|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139328346|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
139328347|NCT03284294|Vitamin D|vitamin d|mesh-list
139328348|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139328349|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328350|NCT03284294|Vitamins|vitamins|mesh-ancestor
139328351|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
139328352|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139328353|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
139328354|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139328355|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328356|NCT03268226|Beclomethasone|beclomethasone|mesh-list
139328357|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
139328358|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
139328359|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139328360|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
139328361|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328362|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328363|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139328364|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
139328365|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139328366|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139328367|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139328368|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
139328369|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328370|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328371|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139328372|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139328373|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139328374|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
139328375|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328376|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
139328377|NCT03268226|Hormones|hormones|mesh-ancestor
139328378|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328379|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
139328380|NCT02737475|Nivolumab|nivolumab|mesh-list
139328381|NCT02737475|Ipilimumab|ipilimumab|mesh-list
139328382|NCT02737475|Vaccines|vaccines|mesh-list
139328383|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
139328384|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328385|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139328386|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139328387|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139178699|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
139328388|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
139328389|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328390|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328391|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139328392|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139328393|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139328394|NCT02457806|Phenylephrine|phenylephrine|mesh-list
139328395|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
139328396|NCT02457806|Tetracaine|tetracaine|mesh-list
139328397|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
139328398|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
139328399|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328400|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328401|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
139328402|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328403|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139328404|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139328405|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
139328406|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328407|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328408|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
139328409|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
139328410|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
139328411|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139328412|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
139328413|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139328414|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
139328415|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139328416|NCT02457806|Protective Agents|protective agents|mesh-ancestor
139328417|NCT02459756|Citric Acid|citric acid|mesh-list
139328418|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
139328419|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328420|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
139328421|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139328422|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
139328423|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
139328424|NCT02557672|Thrombin|thrombin|mesh-list
139328425|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
139328426|NCT02557672|Coagulants|coagulants|mesh-ancestor
139328427|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
139328428|NCT02458196|Prednisone|prednisone|mesh-list
139328429|NCT02458196|Prednisolone|prednisolone|mesh-list
139328430|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328431|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
139328432|NCT02458196|Hormones|hormones|mesh-ancestor
139328433|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328434|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328435|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139328436|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328437|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139328438|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139328439|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
139328440|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139328441|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139328442|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328443|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328444|NCT05207735|Capecitabine|capecitabine|mesh-list
139328445|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139328446|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
139328447|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328448|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328449|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
139328450|NCT03264638|Cyproterone|cyproterone|mesh-list
139328451|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
139328452|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
139328453|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
139328454|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328455|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328456|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328457|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139328458|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
139178705|NCT03855865|Vortioxetine|vortioxetine|mesh-list
139328459|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139328460|NCT03264794|Gefitinib|gefitinib|mesh-list
139328461|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328462|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139328463|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328464|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328465|NCT02925923|Clopidogrel|clopidogrel|mesh-list
139328466|NCT02925923|Ticagrelor|ticagrelor|mesh-list
139328467|NCT02925923|Eptifibatide|eptifibatide|mesh-list
139328468|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139328469|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139328470|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139328471|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139328472|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
139328473|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328474|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328475|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328476|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139328477|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
139328478|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139328479|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139328480|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139328481|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139328482|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328483|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
139328484|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328485|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328486|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139328487|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328488|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139328489|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139328490|NCT03280316|Urological Agents|urological agents|mesh-ancestor
139328491|NCT02410343|Hormones|hormones|mesh-list
139328492|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328493|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328494|NCT05234840|Triamcinolone|triamcinolone|mesh-list
139328495|NCT05234840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328496|NCT05234840|Glucocorticoids|glucocorticoids|mesh-ancestor
139328497|NCT05234840|Hormones|hormones|mesh-ancestor
139328498|NCT05234840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328499|NCT05234840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328500|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
139328501|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139328502|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139328503|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139328504|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139328505|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139328506|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328507|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328508|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328509|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139328510|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
139328511|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139328512|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328513|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139328514|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139328515|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139328516|NCT02459288|Clopidogrel|clopidogrel|mesh-list
139328517|NCT02459288|Ticagrelor|ticagrelor|mesh-list
139328518|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139328519|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139328520|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139328521|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139328522|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
139328523|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328524|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328525|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328526|NCT00734253|Pyridoxamine|pyridoxamine|mesh-list
139328527|NCT00734253|Vitamin B Complex|vitamin b complex|mesh-ancestor
139328529|NCT00734253|Micronutrients|micronutrients|mesh-ancestor
139328530|NCT00734253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328531|NCT00730665|Esomeprazole|esomeprazole|mesh-list
139328532|NCT00730665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139328533|NCT00730665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139328534|NCT00730665|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139328535|NCT00730665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328536|NCT00730665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328537|NCT00714597|Enoxaparin|enoxaparin|mesh-list
139328538|NCT00714597|Semuloparin|semuloparin|mesh-list
139328539|NCT00714597|Enoxaparin sodium|enoxaparin sodium|mesh-list
139328540|NCT00714597|Anticoagulants|anticoagulants|mesh-ancestor
139328541|NCT00714597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139328542|NCT00714597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139328543|NCT00714597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328544|NCT03265886|Bupivacaine|bupivacaine|mesh-list
139328545|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
139328546|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
139328547|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328548|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328549|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
139328550|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328551|NCT00728091|Satavaptan|satavaptan|mesh-list
139328552|NCT00728091|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139328553|NCT00728091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328554|NCT00728091|Natriuretic Agents|natriuretic agents|mesh-ancestor
139328555|NCT00728091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328556|NCT03275090|SMOFlipid|smoflipid|mesh-list
139328557|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139328558|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139328559|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139328560|NCT03382821|Dexamethasone|dexamethasone|mesh-list
139328561|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
139328562|NCT03382821|Triamcinolone|triamcinolone|mesh-list
139328563|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138985428|NCT00467896|Iloprost|iloprost|mesh-list
139328564|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139328565|NCT03382821|Lidocaine|lidocaine|mesh-list
139328566|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139328567|NCT03382821|BB 1101|bb 1101|mesh-list
139328568|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139328569|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328570|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
139328571|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
139328572|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328573|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328574|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139328575|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
139328576|NCT03382821|Hormones|hormones|mesh-ancestor
139328577|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328578|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139328579|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328580|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
139328581|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328582|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328583|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
139328584|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
139328585|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328586|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
139328587|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139328588|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139328589|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139328590|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139328591|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139328592|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
139328593|NCT03263624|Tazarotene|tazarotene|mesh-list
139328594|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
139328595|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
139328596|NCT00711555|Dexamethasone|dexamethasone|mesh-list
139328597|NCT00711555|Ondansetron|ondansetron|mesh-list
139328598|NCT00711555|Aprepitant|aprepitant|mesh-list
139328599|NCT00711555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328600|NCT00711555|Antiemetics|antiemetics|mesh-ancestor
139328601|NCT00711555|Autonomic Agents|autonomic agents|mesh-ancestor
139328602|NCT00711555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328603|NCT00711555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328604|NCT00711555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139328605|NCT00711555|Glucocorticoids|glucocorticoids|mesh-ancestor
139328606|NCT00711555|Hormones|hormones|mesh-ancestor
139328607|NCT00711555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138913208|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
139328608|NCT00711555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139328609|NCT00711555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328610|NCT00711555|Antipruritics|antipruritics|mesh-ancestor
139328611|NCT00711555|Dermatologic Agents|dermatologic agents|mesh-ancestor
139328612|NCT00711555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139328613|NCT00711555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139328614|NCT00711555|Serotonin Agents|serotonin agents|mesh-ancestor
139328615|NCT00711555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328616|NCT00711555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328617|NCT00711555|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139328618|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
139328619|NCT02280993|Dexamethasone|dexamethasone|mesh-list
139328620|NCT02280993|Cisplatin|cisplatin|mesh-list
139328621|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139328622|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328623|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
139328624|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
139328625|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328626|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328627|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139328628|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
139328629|NCT02280993|Hormones|hormones|mesh-ancestor
139328630|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328631|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139328632|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328633|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139328634|NCT02280993|Immunotoxins|immunotoxins|mesh-ancestor
139328635|NCT02280993|Immunoconjugates|immunoconjugates|mesh-ancestor
139328636|NCT02280993|Immunologic Factors|immunologic factors|mesh-ancestor
139328637|NCT05492968|Phenylephrine|phenylephrine|mesh-list
139328638|NCT05492968|Epinephrine|epinephrine|mesh-list
139328639|NCT05492968|Oxymetazoline|oxymetazoline|mesh-list
139328640|NCT05492968|Norepinephrine|norepinephrine|mesh-list
139328641|NCT05492968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139328642|NCT05492968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139328643|NCT05492968|Adrenergic Agents|adrenergic agents|mesh-ancestor
139328644|NCT05492968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328645|NCT05492968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328646|NCT05492968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328647|NCT05492968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139328648|NCT05492968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139328649|NCT05492968|Autonomic Agents|autonomic agents|mesh-ancestor
139328650|NCT05492968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328651|NCT05492968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139328652|NCT05492968|Respiratory System Agents|respiratory system agents|mesh-ancestor
139328653|NCT05492968|Mydriatics|mydriatics|mesh-ancestor
139328654|NCT05492968|Sympathomimetics|sympathomimetics|mesh-ancestor
139328655|NCT05492968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139328656|NCT05492968|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139328657|NCT05492968|Nasal Decongestants|nasal decongestants|mesh-ancestor
139328658|NCT05492968|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139328659|NCT05492968|Protective Agents|protective agents|mesh-ancestor
139328660|NCT02457026|Triamcinolone|triamcinolone|mesh-list
139328661|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139328662|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139328663|NCT02457026|Aflibercept|aflibercept|mesh-list
139328664|NCT02457026|Verteporfin|verteporfin|mesh-list
139328665|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139328666|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328667|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
139328668|NCT02457026|Hormones|hormones|mesh-ancestor
139328669|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328670|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328671|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139328672|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
139328673|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328674|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328675|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139328676|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139328677|NCT02457026|Growth Substances|growth substances|mesh-ancestor
139328678|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
139328679|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328680|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139328681|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
139328682|NCT05492812|Melatonin|melatonin|mesh-list
139328683|NCT05492812|Chloral Hydrate|chloral hydrate|mesh-list
139328684|NCT05492812|Hydroxyzine|hydroxyzine|mesh-list
139328685|NCT05492812|Antioxidants|antioxidants|mesh-ancestor
139328686|NCT05492812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328687|NCT05492812|Protective Agents|protective agents|mesh-ancestor
139328688|NCT05492812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328689|NCT05492812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328690|NCT05492812|Antipruritics|antipruritics|mesh-ancestor
139328691|NCT05492812|Dermatologic Agents|dermatologic agents|mesh-ancestor
139328692|NCT05492812|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139328693|NCT05492812|Histamine Antagonists|histamine antagonists|mesh-ancestor
139328694|NCT05492812|Histamine Agents|histamine agents|mesh-ancestor
139328695|NCT05492812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328696|NCT05492812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139328697|NCT02458118|Secretin|secretin|mesh-list
139328698|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139328699|NCT02458118|Hormones|hormones|mesh-ancestor
139328700|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328701|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328702|NCT05487742|Dexmedetomidine|dexmedetomidine|mesh-list
139328703|NCT05487742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139328704|NCT05487742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328705|NCT05487742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328706|NCT05487742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139328707|NCT05487742|Analgesics|analgesics|mesh-ancestor
139328708|NCT05487742|Sensory System Agents|sensory system agents|mesh-ancestor
139328709|NCT05487742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328710|NCT05487742|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139328711|NCT05487742|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139328712|NCT05487742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139328713|NCT05487742|Adrenergic Agents|adrenergic agents|mesh-ancestor
139328714|NCT05487742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328715|NCT05487742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328716|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
139328717|NCT02457650|Fludarabine|fludarabine|mesh-list
139328718|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139328719|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
139328720|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328721|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139328722|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139328723|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
139328724|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328725|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328726|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139328727|NCT02456948|Minocycline|minocycline|mesh-list
139328728|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139328729|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139328730|NCT05487508|Dexamethasone|dexamethasone|mesh-list
139328731|NCT05487508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139328732|NCT05487508|Antiemetics|antiemetics|mesh-ancestor
139328733|NCT05487508|Autonomic Agents|autonomic agents|mesh-ancestor
139328734|NCT05487508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328735|NCT05487508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328736|NCT05487508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139328737|NCT05487508|Glucocorticoids|glucocorticoids|mesh-ancestor
139328738|NCT05487508|Hormones|hormones|mesh-ancestor
139328739|NCT05487508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139328740|NCT05487508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139328741|NCT05487508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328742|NCT02713490|Bupivacaine|bupivacaine|mesh-list
139328743|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
139328744|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
139328745|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328746|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328747|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
139328748|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328749|NCT05387954|Anticoagulants|anticoagulants|mesh-list
139328750|NCT05387954|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
139328751|NCT05387954|Antithrombins|antithrombins|mesh-ancestor
139328752|NCT05387954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139328753|NCT05387954|Protease Inhibitors|protease inhibitors|mesh-ancestor
139328754|NCT05387954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328755|NCT05387954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328756|NCT03262688|Bupivacaine|bupivacaine|mesh-list
139328757|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
139328758|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
139328759|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328760|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328761|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
139328762|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328763|NCT05486884|Benzocaine|benzocaine|mesh-list
139328764|NCT05486884|Anesthetics, Local|anesthetics, local|mesh-ancestor
139328765|NCT05486884|Anesthetics|anesthetics|mesh-ancestor
139328766|NCT05486884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328767|NCT05486884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328768|NCT05486884|Sensory System Agents|sensory system agents|mesh-ancestor
139328769|NCT05486884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328770|NCT05485792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139328771|NCT05485792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139328772|NCT05485792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328773|NCT05485402|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
139328774|NCT05485402|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
139328775|NCT05485402|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
139328776|NCT05485402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139328777|NCT05485402|Antioxidants|antioxidants|mesh-ancestor
139328778|NCT05485402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328779|NCT05485402|Protective Agents|protective agents|mesh-ancestor
139328780|NCT05485402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328781|NCT05485402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139328782|NCT05485402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139328783|NCT05485402|Disinfectants|disinfectants|mesh-ancestor
139328784|NCT05485402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139328785|NCT03797924|Ropivacaine|ropivacaine|mesh-list
139328786|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
139328787|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
139328788|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138985636|NCT00956748|Hormones|hormones|mesh-ancestor
139328789|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328790|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
139328791|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328792|NCT05486650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139328793|NCT05486650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328794|NCT05486650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139328795|NCT05486650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328796|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
139328797|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139328798|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139328799|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139328800|NCT02458742|Morphine|morphine|mesh-list
139328801|NCT02458742|Bupivacaine|bupivacaine|mesh-list
139328802|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
139328803|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
139328804|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328805|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328806|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
139328807|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328808|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139328809|NCT02458742|Narcotics|narcotics|mesh-ancestor
139328810|NCT02458742|Analgesics|analgesics|mesh-ancestor
139328811|NCT02403310|Cytarabine|cytarabine|mesh-list
139328812|NCT02403310|Daunorubicin|daunorubicin|mesh-list
139328813|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139328814|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
139328815|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328816|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328817|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
139328818|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139328819|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139328820|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
139328821|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328822|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139328823|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139328824|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139328825|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328826|NCT01665274|Capecitabine|capecitabine|mesh-list
139328827|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
139328828|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139328829|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
139328830|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328831|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328832|NCT05387876|Vitamin D|vitamin d|mesh-list
139328833|NCT05387876|Vitamins|vitamins|mesh-ancestor
139328834|NCT05387876|Micronutrients|micronutrients|mesh-ancestor
139328835|NCT05387876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328836|NCT05387876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139328837|NCT04560166|Irinotecan|irinotecan|mesh-list
139328838|NCT04560166|Temozolomide|temozolomide|mesh-list
139328839|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139328840|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139328841|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328842|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328843|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328844|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139328845|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
139328846|NCT03262376|Vitamins|vitamins|mesh-list
139328847|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
139328848|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328849|NCT02456714|Folfirinox|folfirinox|mesh-list
139328850|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328851|NCT03258866|Rituximab|rituximab|mesh-list
139328852|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139328853|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328854|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
139328855|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328856|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139328857|NCT03258476|Guanfacine|guanfacine|mesh-list
139328858|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139328859|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139328860|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139328861|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139328862|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
139328863|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328864|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328865|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328866|NCT03258398|Avelumab|avelumab|mesh-list
139328867|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139328868|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328869|NCT03261596|Mebendazole|mebendazole|mesh-list
139328870|NCT03261596|Piperazine|piperazine|mesh-list
139328871|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
139328872|NCT03261596|DMP 777|dmp 777|mesh-list
139328873|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
139328874|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
139328875|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139328876|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139328877|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
139328878|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
139328879|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
139328880|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328881|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328882|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328883|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139328884|NCT03825874|Amikacin|amikacin|mesh-list
139328885|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139328886|NCT03772574|Nicotine|nicotine|mesh-list
139328887|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139328888|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
139328889|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328890|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328891|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139328892|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139328893|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
139328894|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328895|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328896|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139328897|NCT02456558|Deferiprone|deferiprone|mesh-list
139328898|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139328899|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
139328900|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
139328901|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328902|NCT03798080|Insulin|insulin|mesh-list
139328903|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139328904|NCT03798080|Metformin|metformin|mesh-list
139328905|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
139328906|NCT03798080|Lixisenatide|lixisenatide|mesh-list
139328907|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139328908|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328909|NCT03257930|Ethanol|ethanol|mesh-list
139328910|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139328911|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139328912|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328913|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328914|NCT03257852|Methotrexate|methotrexate|mesh-list
139328915|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139328916|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
139328917|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139328918|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328919|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139328920|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
139328921|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328922|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328923|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
139328924|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328925|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139328926|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139328927|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
139328928|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139328929|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139328930|NCT05498896|Paclitaxel|paclitaxel|mesh-list
139328931|NCT05498896|Cyclophosphamide|cyclophosphamide|mesh-list
139328932|NCT05498896|Doxorubicin|doxorubicin|mesh-list
139328933|NCT05498896|Atezolizumab|atezolizumab|mesh-list
139328934|NCT05498896|Ipatasertib|ipatasertib|mesh-list
139328935|NCT05498896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139328936|NCT05498896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328937|NCT05498896|Tubulin Modulators|tubulin modulators|mesh-ancestor
139328938|NCT05498896|Antimitotic Agents|antimitotic agents|mesh-ancestor
139328939|NCT05498896|Mitosis Modulators|mitosis modulators|mesh-ancestor
139328940|NCT05498896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328941|NCT05498896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139328942|NCT05498896|Immunologic Factors|immunologic factors|mesh-ancestor
139328943|NCT05498896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328944|NCT05498896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139328945|NCT05498896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139328946|NCT05498896|Alkylating Agents|alkylating agents|mesh-ancestor
139328947|NCT05498896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139328948|NCT05498896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139328949|NCT05498896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139328950|NCT05498896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139328951|NCT05498896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139328952|NCT05498896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139328953|NCT05498896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139328954|NCT05498896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139328955|NCT02743221|Trifluridine|trifluridine|mesh-list
139328956|NCT02743221|Bevacizumab|bevacizumab|mesh-list
139328957|NCT02743221|Capecitabine|capecitabine|mesh-list
139178726|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
139328958|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139328959|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139328960|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139328961|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139328962|NCT02743221|Growth Substances|growth substances|mesh-ancestor
139328963|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328964|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
139328965|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139328966|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
139328967|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328968|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
138913373|NCT00790842|Dexamethasone|dexamethasone|mesh-list
139328969|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139328970|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
139328971|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
139328972|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
139328973|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139328974|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328975|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
139328976|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139328977|NCT03370263|Belimumab|belimumab|mesh-list
139328978|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139328979|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
139328980|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328981|NCT00692445|Mecamylamine|mecamylamine|mesh-list
139328982|NCT00692445|Dexetimide|dexetimide|mesh-list
139328983|NCT00692445|Citalopram|citalopram|mesh-list
139328984|NCT00692445|Escitalopram|escitalopram|mesh-list
139328985|NCT00692445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139328986|NCT00692445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139328987|NCT00692445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139328988|NCT00692445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139328989|NCT00692445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139328990|NCT00692445|Serotonin Agents|serotonin agents|mesh-ancestor
139328991|NCT00692445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139328992|NCT00692445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139328993|NCT00692445|Antidepressive Agents|antidepressive agents|mesh-ancestor
139328994|NCT00692445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139328995|NCT00692445|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139328996|NCT00692445|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139328997|NCT00692445|Parasympatholytics|parasympatholytics|mesh-ancestor
139328998|NCT00692445|Autonomic Agents|autonomic agents|mesh-ancestor
139328999|NCT00692445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329000|NCT00692445|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139329001|NCT00692445|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139329002|NCT00692445|Cholinergic Agents|cholinergic agents|mesh-ancestor
139329003|NCT00692445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139329004|NCT00692445|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
139329005|NCT00692445|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139329006|NCT03256292|Testosterone|testosterone|mesh-list
139329007|NCT03256292|Androgens|androgens|mesh-ancestor
139329008|NCT03256292|Hormones|hormones|mesh-ancestor
139329009|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329010|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329011|NCT04473261|Iodine|iodine|mesh-list
139329012|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
139329013|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139329014|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329015|NCT04473261|Trace Elements|trace elements|mesh-ancestor
139329016|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
139329017|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329018|NCT01358968|Gemcitabine|gemcitabine|mesh-list
139329019|NCT01358968|Pemetrexed|pemetrexed|mesh-list
139329020|NCT01358968|Desipramine|desipramine|mesh-list
139329021|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139329022|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
139329023|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329024|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329025|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329026|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139329027|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139329028|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139329029|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
139329030|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138735220|NCT00591617|Narcotics|narcotics|mesh-ancestor
139329031|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139329032|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139329033|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139329034|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
139329035|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329036|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329038|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
139329039|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139329040|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
139329041|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
139329042|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
139329043|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329044|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329046|NCT00624351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139329047|NCT00624351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329048|NCT03251690|Tenofovir|tenofovir|mesh-list
139329049|NCT03251690|Emtricitabine|emtricitabine|mesh-list
139329050|NCT03251690|Efavirenz|efavirenz|mesh-list
139329051|NCT03251690|Rilpivirine|rilpivirine|mesh-list
139329052|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
139329053|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329054|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139329055|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139329056|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329057|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329058|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139329059|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139329060|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139329061|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139329062|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139329063|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139329064|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139329065|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139329066|NCT03251768|Lenograstim|lenograstim|mesh-list
139329067|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139329068|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
139329069|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329070|NCT00687687|Paclitaxel|paclitaxel|mesh-list
139329071|NCT00687687|Carboplatin|carboplatin|mesh-list
139329072|NCT00687687|Iniparib|iniparib|mesh-list
139329073|NCT00687687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139329074|NCT00687687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329075|NCT00687687|Tubulin Modulators|tubulin modulators|mesh-ancestor
139329076|NCT00687687|Antimitotic Agents|antimitotic agents|mesh-ancestor
139329077|NCT00687687|Mitosis Modulators|mitosis modulators|mesh-ancestor
139329078|NCT00687687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329079|NCT00687687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139329080|NCT00687687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329081|NCT00701090|Metformin|metformin|mesh-list
139329082|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139329083|NCT00701090|Glimepiride|glimepiride|mesh-list
139329084|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139329085|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329086|NCT00701090|Incretins|incretins|mesh-ancestor
139329087|NCT00701090|Hormones|hormones|mesh-ancestor
139329088|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329089|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139329090|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
139329091|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985938|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139329092|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329093|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139329094|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139329096|NCT00614601|Vaccines|vaccines|mesh-list
139329097|NCT00614601|Immunologic Factors|immunologic factors|mesh-ancestor
139329098|NCT00614601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329099|NCT02283489|Paclitaxel|paclitaxel|mesh-list
139329100|NCT02283489|Endostatins|endostatins|mesh-list
139178732|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329101|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139329102|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329103|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
139329104|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
139329105|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
139329106|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329107|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139329108|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139329109|NCT02283489|Growth Substances|growth substances|mesh-ancestor
139329110|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329111|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
139329112|NCT02455232|Lidocaine|lidocaine|mesh-list
139329113|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
139329114|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
139329115|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329116|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329117|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
139329118|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329119|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139329120|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139329121|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139329122|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139329123|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329124|NCT03259958|Donepezil|donepezil|mesh-list
139329125|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139329126|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329127|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329128|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
139329129|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329130|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329131|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
139329132|NCT00679731|Methotrexate|methotrexate|mesh-list
139329133|NCT00679731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139329134|NCT00679731|Abortifacient Agents|abortifacient agents|mesh-ancestor
139329135|NCT00679731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139329136|NCT00679731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329137|NCT00679731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139329138|NCT00679731|Antimetabolites|antimetabolites|mesh-ancestor
139329139|NCT00679731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329140|NCT00679731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329141|NCT00679731|Dermatologic Agents|dermatologic agents|mesh-ancestor
139329142|NCT00679731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329143|NCT00679731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139329144|NCT00679731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139329145|NCT00679731|Immunologic Factors|immunologic factors|mesh-ancestor
139329146|NCT00679731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139329147|NCT00679731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139329148|NCT02455856|Itraconazole|itraconazole|mesh-list
139329149|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
139329150|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329151|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139329152|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139329153|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329154|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329155|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139329156|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
139329157|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329158|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329159|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139329160|NCT02283645|Minoxidil|minoxidil|mesh-list
139329161|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139329162|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
139329163|NCT00602745|Fluorouracil|fluorouracil|mesh-list
139329164|NCT00602745|Antimetabolites|antimetabolites|mesh-ancestor
138986012|NCT00897884|Metformin|metformin|mesh-list
139178735|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139329165|NCT00602745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329166|NCT00602745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139329167|NCT00602745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329168|NCT00602745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139329169|NCT00602745|Immunologic Factors|immunologic factors|mesh-ancestor
139329170|NCT00602745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329171|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
139329172|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139329173|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329174|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329175|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139329176|NCT03251222|Analgesics|analgesics|mesh-ancestor
139329177|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
139329178|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329179|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139329180|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139329181|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139329182|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
139329183|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329184|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329185|NCT03250910|Ribavirin|ribavirin|mesh-list
139329186|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
139329187|NCT03250910|Velpatasvir|velpatasvir|mesh-list
139329188|NCT03250910|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139329189|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
139329190|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329191|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
139329192|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329193|NCT02283801|Lamotrigine|lamotrigine|mesh-list
139329194|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139329195|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
139329196|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139329197|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139329198|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329199|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139329200|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329201|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139329202|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139329203|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329204|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139329205|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139329206|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139329207|NCT02455154|Letrozole|letrozole|mesh-list
139329208|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329209|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139329210|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139329211|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329212|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329213|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139329214|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
139329215|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329216|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329217|NCT03254810|Adalimumab|adalimumab|mesh-list
139329218|NCT03254810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139329219|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139329220|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139329221|NCT03255044|Atorvastatin|atorvastatin|mesh-list
139329222|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139329223|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139329224|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139329225|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
139329226|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329227|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139329228|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139329229|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329230|NCT00677079|Iniparib|iniparib|mesh-list
139329231|NCT00677079|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139329232|NCT00677079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329233|NCT00677079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329235|NCT03245996|Atenolol|atenolol|mesh-list
139329236|NCT03245996|Nebivolol|nebivolol|mesh-list
138986088|NCT00948402|Metformin|metformin|mesh-list
139329237|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139329238|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139329239|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
139329240|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
139329241|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329242|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329243|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139329244|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139329245|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139329246|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
139329247|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329248|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329249|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
139329250|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139329251|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139329252|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139329253|NCT02281929|Amoxicillin|amoxicillin|mesh-list
139329254|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
139329255|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
139329256|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139329257|NCT02281929|Prednisolone|prednisolone|mesh-list
139329258|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139329259|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329260|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139329261|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
139329262|NCT02281929|Hormones|hormones|mesh-ancestor
139329263|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329264|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329265|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139329266|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329267|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329268|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139178747|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139329269|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139329270|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139329271|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139329272|NCT05478772|Fluconazole|fluconazole|mesh-list
139329273|NCT05478772|Antifungal Agents|antifungal agents|mesh-ancestor
139329274|NCT05478772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329275|NCT05478772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139329276|NCT05478772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139329277|NCT05478772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329278|NCT05478772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329279|NCT05478772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139329280|NCT05478772|Hormone Antagonists|hormone antagonists|mesh-ancestor
139329281|NCT05478772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329282|NCT05478772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329283|NCT05478772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139329284|NCT05478772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139329285|NCT02945852|Apatinib|apatinib|mesh-list
139329286|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329287|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139329288|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329289|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329290|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
139329291|NCT03245528|Giapreza|giapreza|mesh-list
139329292|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139329293|NCT00495885|Volinanserin|volinanserin|mesh-list
139329294|NCT00495885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139329295|NCT00495885|Serotonin Agents|serotonin agents|mesh-ancestor
139329296|NCT00495885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329297|NCT00495885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329298|NCT00495885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329299|NCT03254186|Propranolol|propranolol|mesh-list
139329300|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139329301|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139329302|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
139329303|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329304|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329305|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329306|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139329307|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139329308|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
139329309|NCT03250598|Mitapivat|mitapivat|mesh-list
139329310|NCT03250598|Enzyme Activators|enzyme activators|mesh-ancestor
138913483|NCT00626392|Vitamins|vitamins|mesh-ancestor
139329311|NCT03250598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329312|NCT02282085|Olanzapine|olanzapine|mesh-list
139329313|NCT02282085|Risperidone|risperidone|mesh-list
139329314|NCT02282085|Aripiprazole|aripiprazole|mesh-list
139329315|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139329316|NCT02282085|Ziprasidone|ziprasidone|mesh-list
139329317|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
139329318|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139329319|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139329320|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
139329321|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329322|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329323|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329324|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139329325|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329326|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139329327|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139329328|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
139329329|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
139329330|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
139329331|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329332|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139329333|NCT02282085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139329334|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139329335|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139329336|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
139329337|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
139329338|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139329339|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139329340|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139329341|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139329342|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139329343|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139329344|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139329345|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
139329346|NCT03244592|Minocycline|minocycline|mesh-list
139329347|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139329348|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329349|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
139329350|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139329351|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
139329352|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329353|NCT03253328|Expectorants|expectorants|mesh-ancestor
139329354|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
139329355|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139329356|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
139329357|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329358|NCT03253328|Protective Agents|protective agents|mesh-ancestor
139329359|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329360|NCT03253328|Antidotes|antidotes|mesh-ancestor
139329361|NCT03253250|Tenofovir|tenofovir|mesh-list
139329362|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139329363|NCT03253250|Entecavir|entecavir|mesh-list
139329364|NCT03253250|Adefovir|adefovir|mesh-list
139329365|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
139329366|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329367|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139329368|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139329369|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329370|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329371|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139329372|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139329373|NCT03253562|Metformin|metformin|mesh-list
139329374|NCT03253562|Vildagliptin|vildagliptin|mesh-list
139329375|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139329376|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329377|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139329378|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
139329379|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329380|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329381|NCT03250052|Linagliptin|linagliptin|mesh-list
139329382|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139329383|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329384|NCT03250052|Incretins|incretins|mesh-ancestor
139329385|NCT03250052|Hormones|hormones|mesh-ancestor
139329386|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329387|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139329388|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
139329389|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329390|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329391|NCT05478382|Pregabalin|pregabalin|mesh-list
139329392|NCT05478382|Analgesics|analgesics|mesh-ancestor
139329393|NCT05478382|Sensory System Agents|sensory system agents|mesh-ancestor
139329394|NCT05478382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329395|NCT05478382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329396|NCT05478382|Anticonvulsants|anticonvulsants|mesh-ancestor
139329397|NCT05478382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139329398|NCT05478382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139329399|NCT05478382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329400|NCT05478382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139329401|NCT05478382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139329402|NCT05478382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139329403|NCT05478382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329404|NCT05478382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139329405|NCT03244358|Epalrestat|epalrestat|mesh-list
139329406|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329407|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329408|NCT03249740|Sunitinib|sunitinib|mesh-list
139329409|NCT03249740|Aflibercept|aflibercept|mesh-list
139329410|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329411|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139329412|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139329413|NCT03249740|Growth Substances|growth substances|mesh-ancestor
139329414|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329415|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
139329416|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139329417|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329418|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329419|NCT03057977|Empagliflozin|empagliflozin|mesh-list
139329420|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139329421|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329422|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139329423|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329424|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
139329425|NCT03249506|Empagliflozin|empagliflozin|mesh-list
139329426|NCT03249506|Canagliflozin|canagliflozin|mesh-list
139329427|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
139329428|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139329429|NCT03249506|Glucagon|glucagon|mesh-list
139329430|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139329431|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139329432|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329433|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139329434|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329435|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139329436|NCT03249506|Hormones|hormones|mesh-ancestor
139329437|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329438|NCT03249506|Incretins|incretins|mesh-ancestor
139329439|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
139329440|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329441|NCT03249662|Bupivacaine|bupivacaine|mesh-list
139329442|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
139329443|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
139329444|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329445|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329446|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
139329447|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329448|NCT03249428|Nicotine|nicotine|mesh-list
139329449|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139329450|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
139329451|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329452|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329453|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139329454|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139329455|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
139329456|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329457|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329459|NCT03243500|Bupivacaine|bupivacaine|mesh-list
139329460|NCT03243500|Atracurium|atracurium|mesh-list
139329461|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
139329462|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
139329463|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329464|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329465|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
139329466|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329467|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139329468|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139329469|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139329470|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139329471|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329472|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139329473|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139329474|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139329475|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139329476|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139329477|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
139329478|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329479|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
139329480|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139329481|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139329482|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139329483|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139329484|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329485|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
139329486|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329487|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329488|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139329489|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329490|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139329491|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139329492|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
138834357|NCT04259606|Antacids|antacids|mesh-ancestor
139329493|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329494|NCT04486508|Heparin|heparin|mesh-list
139329495|NCT04486508|Calcium heparin|calcium heparin|mesh-list
139329496|NCT04486508|Enoxaparin|enoxaparin|mesh-list
139329497|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
139329498|NCT04486508|Atorvastatin|atorvastatin|mesh-list
139329499|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139329500|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139329501|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139329502|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
139329503|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329504|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139329505|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329506|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
139329507|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139329508|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139329509|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
139329510|NCT02552212|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139329511|NCT02552212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139329512|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139329513|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
139329514|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329515|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139329516|NCT02454764|Interferons|interferons|mesh-list
139329517|NCT02454764|Tenofovir|tenofovir|mesh-list
139329518|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
139329519|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
139329520|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329521|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
139329522|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329523|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139329524|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139329525|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329526|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329527|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139329528|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139329529|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
139329530|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329531|NCT00685919|Carbidopa|carbidopa|mesh-list
138986403|NCT00115063|Orlistat|orlistat|mesh-list
139329532|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139329533|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139329535|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329536|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329537|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329538|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139329539|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329540|NCT03243344|Surgiflo|surgiflo|mesh-list
139329541|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
139329542|NCT03243344|Coagulants|coagulants|mesh-ancestor
139329543|NCT03243032|Ibuprofen|ibuprofen|mesh-list
139329544|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139329545|NCT03243032|Anesthetics|anesthetics|mesh-list
139329546|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
139178800|NCT01107431|Chromium|chromium|mesh-list
139329547|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329548|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329549|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139329550|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139329551|NCT03243032|Analgesics|analgesics|mesh-ancestor
139329552|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
139329553|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329554|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139329555|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139329556|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329557|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329558|NCT03249038|Chrysarobin|chrysarobin|mesh-list
139329559|NCT03249038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139329560|NCT03249038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139329561|NCT03249038|Analgesics|analgesics|mesh-ancestor
139329562|NCT03249038|Sensory System Agents|sensory system agents|mesh-ancestor
139329563|NCT03249038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329564|NCT03249038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329565|NCT03249038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139329566|NCT03249038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139329567|NCT03061331|Ivacaftor|ivacaftor|mesh-list
139329568|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139329569|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139329570|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329571|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139329572|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139329573|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329574|NCT05213585|Ivermectin|ivermectin|mesh-list
139329575|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139329576|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329577|NCT05482282|Vaccines|vaccines|mesh-list
139329578|NCT05482282|Immunologic Factors|immunologic factors|mesh-ancestor
139329579|NCT05482282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329580|NCT05209529|Durvalumab|durvalumab|mesh-list
139329581|NCT05209529|Olaparib|olaparib|mesh-list
139329582|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139329583|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329584|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139329585|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329586|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329587|NCT04424134|Spironolactone|spironolactone|mesh-list
139329588|NCT04424134|Bromhexine|bromhexine|mesh-list
139329589|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139329590|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
139329591|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329592|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329593|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139329594|NCT04424134|Diuretics|diuretics|mesh-ancestor
139329595|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
139329596|NCT04424134|Expectorants|expectorants|mesh-ancestor
139329597|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
139329598|NCT04486430|Salicylates|salicylates|mesh-list
139329599|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139329600|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139329601|NCT04486430|Analgesics|analgesics|mesh-ancestor
139329602|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
139329603|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329604|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329605|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139329606|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139329607|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139329608|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329609|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329610|NCT03248726|Bisacodyl|bisacodyl|mesh-list
139329611|NCT03248726|Cathartics|cathartics|mesh-ancestor
139329612|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139329613|NCT03248726|Laxatives|laxatives|mesh-ancestor
139329614|NCT05208827|Vitamin D|vitamin d|mesh-list
139329615|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
139329616|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
139329617|NCT05208827|Vitamins|vitamins|mesh-list
139329618|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
139329619|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329620|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139329621|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139329623|NCT04947059|Epirubicin|epirubicin|mesh-list
139329624|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139329625|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
139329626|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329627|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329628|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139329629|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139329630|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139329631|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329632|NCT05481970|Dexamethasone|dexamethasone|mesh-list
139329633|NCT05481970|Lidocaine|lidocaine|mesh-list
139329634|NCT05481970|Fentanyl|fentanyl|mesh-list
139329635|NCT05481970|Dexmedetomidine|dexmedetomidine|mesh-list
139329636|NCT05481970|Ketamine|ketamine|mesh-list
139329637|NCT05481970|Propofol|propofol|mesh-list
139329638|NCT05481970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139329639|NCT05481970|Antiemetics|antiemetics|mesh-ancestor
139329640|NCT05481970|Autonomic Agents|autonomic agents|mesh-ancestor
139329641|NCT05481970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329642|NCT05481970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329643|NCT05481970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139329644|NCT05481970|Glucocorticoids|glucocorticoids|mesh-ancestor
139329645|NCT05481970|Hormones|hormones|mesh-ancestor
139329646|NCT05481970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329647|NCT05481970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139329648|NCT05481970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329649|NCT05481970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329650|NCT05481970|Anesthetics, Local|anesthetics, local|mesh-ancestor
139329651|NCT05481970|Anesthetics|anesthetics|mesh-ancestor
139329652|NCT05481970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329653|NCT05481970|Sensory System Agents|sensory system agents|mesh-ancestor
139329654|NCT05481970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139329655|NCT05481970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139329656|NCT05481970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138913584|NCT00828958|Risperidone|risperidone|mesh-list
139329657|NCT05481970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139329658|NCT05481970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139329659|NCT05481970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139329660|NCT05481970|Analgesics|analgesics|mesh-ancestor
139329661|NCT05481970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139329662|NCT05481970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139329663|NCT05481970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139329664|NCT05481970|Adrenergic Agents|adrenergic agents|mesh-ancestor
139329665|NCT05481970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329666|NCT05481970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139329667|NCT05481970|Anesthetics, General|anesthetics, general|mesh-ancestor
139329668|NCT05481970|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139329669|NCT05481970|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139329670|NCT05481970|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139329671|NCT05481970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139329672|NCT05481970|Narcotics|narcotics|mesh-ancestor
139329673|NCT05481970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139329674|NCT03248648|Ketamine|ketamine|mesh-list
139329675|NCT03248648|Neostigmine|neostigmine|mesh-list
139329676|NCT03248648|Analgesics|analgesics|mesh-ancestor
139329677|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
139329678|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329679|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329680|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139329681|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138986534|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
139329682|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
139329684|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329685|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139329686|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139329687|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329688|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329689|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139329690|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329691|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
139329692|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139329693|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
139329694|NCT03241784|Interleukin-2|interleukin-2|mesh-list
139329695|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329696|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139329697|NCT03241784|Analgesics|analgesics|mesh-ancestor
139329698|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
139329699|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329700|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329701|NCT03242096|Sirolimus|sirolimus|mesh-list
139329702|NCT03242096|Paclitaxel|paclitaxel|mesh-list
139329703|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139329704|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329705|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
139329706|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
139329707|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
139329708|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329709|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139329710|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329711|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139329712|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
139329713|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139329714|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
139329715|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329716|NCT03241472|Letrozole|letrozole|mesh-list
139329717|NCT03241472|Clomiphene|clomiphene|mesh-list
139329718|NCT03241472|Enclomiphene|enclomiphene|mesh-list
139329719|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
139329720|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329721|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329722|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139329723|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139329724|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329725|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139329726|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
139329727|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329728|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329729|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139329730|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
139329731|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139329732|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139329733|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139329734|NCT04313075|Leronlimab|leronlimab|mesh-list
139329735|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139329736|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139329737|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329738|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139329739|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139329740|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
139329741|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329742|NCT03241550|Isavuconazole|isavuconazole|mesh-list
139329743|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
139329744|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329745|NCT03241706|Glucagon|glucagon|mesh-list
139329746|NCT03241706|Somatostatin|somatostatin|mesh-list
139329747|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329748|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139329749|NCT03241706|Hormones|hormones|mesh-ancestor
139329750|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329751|NCT03237416|Midazolam|midazolam|mesh-list
139329752|NCT03237416|Dabigatran|dabigatran|mesh-list
139329753|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139329754|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139329755|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329756|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329757|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139329758|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139329759|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139329760|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139329761|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
139329762|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
139329763|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
139329764|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
139329765|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329766|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329767|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
139329768|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139329769|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
139329770|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329771|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
139329772|NCT05211011|Fosfomycin|fosfomycin|mesh-list
139329773|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139329774|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329775|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
139329776|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139329777|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139329778|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329779|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
139329780|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329781|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329782|NCT04094519|Digoxin|digoxin|mesh-list
139329783|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139329784|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139329785|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139329786|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
139329787|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329788|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139329789|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139329790|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329791|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139329792|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139329793|NCT04094519|Protective Agents|protective agents|mesh-ancestor
139329794|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329795|NCT02189798|Imidacloprid|imidacloprid|mesh-list
139329796|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
139329797|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329798|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329799|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329800|NCT03107702|Melatonin|melatonin|mesh-list
139329801|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
139329802|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329803|NCT03107702|Protective Agents|protective agents|mesh-ancestor
139329804|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329805|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329806|NCT02554318|Rifampin|rifampin|mesh-list
139329807|NCT02554318|Isoniazid|isoniazid|mesh-list
139329808|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
139329809|NCT02554318|Ethambutol|ethambutol|mesh-list
139329810|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139329811|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
139329812|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139329813|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329814|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
139329815|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139329816|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329817|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329818|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139329819|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139329820|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139329821|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139329822|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139329823|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139329824|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139329825|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139329826|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
139329827|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139329828|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
139329829|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139329830|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
139329831|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329832|NCT03976973|Expectorants|expectorants|mesh-ancestor
139329833|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
139329834|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139329835|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
139329836|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329837|NCT03976973|Protective Agents|protective agents|mesh-ancestor
139329838|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329839|NCT03976973|Antidotes|antidotes|mesh-ancestor
139329840|NCT04066751|Ivacaftor|ivacaftor|mesh-list
139329841|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139329842|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139329843|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329844|NCT02550106|Omalizumab|omalizumab|mesh-list
139329845|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139329846|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139329847|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
139329848|NCT03237260|Vedolizumab|vedolizumab|mesh-list
139329849|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139329850|NCT03247400|Atorvastatin|atorvastatin|mesh-list
139329851|NCT03247400|Simvastatin|simvastatin|mesh-list
139329852|NCT03247400|Calcium|calcium|mesh-list
139329853|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139329854|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329855|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139329856|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139329857|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
139329858|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329859|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139329860|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139329861|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329862|NCT02453516|Epinephrine|epinephrine|mesh-list
139329863|NCT02453516|Ropivacaine|ropivacaine|mesh-list
139329864|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
139329865|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
139329866|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329867|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329868|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
139329869|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329870|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139329871|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139329872|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
139329873|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329874|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329875|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139329876|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139329877|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
139329878|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139329879|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
139329880|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
139329881|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
139329882|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139329883|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
139329884|NCT03716609|Citric Acid|citric acid|mesh-list
139329885|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
139329886|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
139329887|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139329888|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
139329889|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
139329890|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329891|NCT03716609|Cathartics|cathartics|mesh-ancestor
139329892|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139329893|NCT03709355|Clarithromycin|clarithromycin|mesh-list
139329894|NCT03709355|Rifampin|rifampin|mesh-list
139329895|NCT03709355|Rifabutin|rifabutin|mesh-list
139329896|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
139329897|NCT03709355|Omeprazole|omeprazole|mesh-list
139329898|NCT03709355|Atorvastatin|atorvastatin|mesh-list
139329899|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
139329900|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139329901|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139329902|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139329903|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139329904|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
139329905|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329906|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139329907|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139329908|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329909|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139329910|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139329911|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139329912|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139329913|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139329914|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139329915|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139329916|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139329917|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139329918|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
139329919|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139329920|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329921|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139329922|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139329923|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139329924|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139329925|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
139329926|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
139329927|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139329928|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139329929|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139329930|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138913662|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139329931|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139329932|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139329933|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139329934|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139329935|NCT03709355|Estrogens|estrogens|mesh-ancestor
139329937|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329938|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139329939|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139329940|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
139329941|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139329942|NCT05209217|Ketamine|ketamine|mesh-list
139329943|NCT05209217|Analgesics|analgesics|mesh-ancestor
139329944|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
139329945|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139329946|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329947|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139329948|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139329949|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
139329950|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
139329951|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329952|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139329953|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139329954|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329955|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329956|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139329957|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139329958|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139329959|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139329960|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329961|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139329962|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139329963|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139329964|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
139329965|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139178827|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139329966|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329967|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139329968|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139329969|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
139329970|NCT00700622|Insulin|insulin|mesh-list
139329971|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139329972|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
139329973|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
139329974|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139329975|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329976|NCT03628625|Letrozole|letrozole|mesh-list
139329977|NCT03628625|Misoprostol|misoprostol|mesh-list
139329978|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139329979|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139329980|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139329981|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139329982|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329983|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139329984|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
139329985|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139329986|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139329987|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139329988|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
139329989|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139329990|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139329991|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139329992|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
139329993|NCT02553928|Memantine|memantine|mesh-list
139329994|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139329995|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139329996|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
139329997|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139329998|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139329999|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330000|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139330001|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139330002|NCT03908255|Vitamins|vitamins|mesh-list
139330003|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
139330004|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330005|NCT03246776|Triclosan|triclosan|mesh-list
139330006|NCT03246776|Halometasone|halometasone|mesh-list
139330007|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139330008|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330009|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139330010|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139330011|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
139330012|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330013|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139330014|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139330015|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
139330016|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
139330017|NCT03246776|Hormones|hormones|mesh-ancestor
139330018|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139330019|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330020|NCT03246386|Posaconazole|posaconazole|mesh-list
139330021|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
139330022|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330023|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139330024|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139330025|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139330026|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139330027|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138913728|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
139330028|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330029|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330030|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139330031|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
139178832|NCT01104935|Trastuzumab|trastuzumab|mesh-list
139330032|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139330033|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330034|NCT03851081|Vincristine|vincristine|mesh-list
139330035|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139330036|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139330037|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330038|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
139330039|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
139330040|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
139330041|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330042|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139330043|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139330044|NCT03851081|Immunotoxins|immunotoxins|mesh-ancestor
139330045|NCT03851081|Immunoconjugates|immunoconjugates|mesh-ancestor
139330046|NCT03851081|Immunologic Factors|immunologic factors|mesh-ancestor
139330047|NCT03851081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330048|NCT03239600|Methotrexate|methotrexate|mesh-list
139330049|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139330050|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
139330051|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139330052|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330053|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139330054|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
139330055|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330056|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330057|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
139330058|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330059|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139330060|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139330061|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
139330062|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139330063|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138913775|NCT00824200|Tamsulosin|tamsulosin|mesh-list
139330065|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330066|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139330067|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330068|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330069|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
139330070|NCT03229616|Busulfan|busulfan|mesh-list
139330071|NCT03229616|Etoposide|etoposide|mesh-list
139330072|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139330073|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
139330074|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330075|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139330076|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139330077|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
139330078|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330079|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330080|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139330081|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139330082|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139330083|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139330084|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330085|NCT03234764|Immunomodulating Agents|immunomodulating agents|mesh-list
139330086|NCT03234764|Immunologic Factors|immunologic factors|mesh-ancestor
139330087|NCT03234764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330089|NCT03234842|Carboplatin|carboplatin|mesh-list
139330090|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139330091|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330092|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
139330093|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
139330094|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
139330095|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330096|NCT03229148|Anesthetics|anesthetics|mesh-list
139330097|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330098|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330099|NCT03228992|Ibuprofen|ibuprofen|mesh-list
139330100|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139330101|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139330102|NCT03228992|Analgesics|analgesics|mesh-ancestor
139330103|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
139330104|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330105|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330106|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139330107|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139330108|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139330109|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330110|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330111|NCT02452502|Atorvastatin|atorvastatin|mesh-list
139330112|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139330113|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139330114|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
139330115|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330116|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139330117|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139330118|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330119|NCT03234296|Metronidazole|metronidazole|mesh-list
139330120|NCT03234296|Levofloxacin|levofloxacin|mesh-list
139330121|NCT03234296|Ertapenem|ertapenem|mesh-list
139330122|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330123|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139330124|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139330125|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139178873|NCT03851731|Naltrexone|naltrexone|mesh-list
139330126|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139330127|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139330128|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139330129|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330130|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330131|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330132|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139330133|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139330134|NCT03228368|Atezolizumab|atezolizumab|mesh-list
139330135|NCT03228368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139330136|NCT03228368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330137|NCT03228368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139330138|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330139|NCT03665129|Avdoralimab|avdoralimab|mesh-list
139330140|NCT03665129|Durvalumab|durvalumab|mesh-list
139330141|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139330142|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330143|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139330144|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
139330145|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330146|NCT03235700|Nicorandil|nicorandil|mesh-list
139330147|NCT03235700|Adenosine|adenosine|mesh-list
139330148|NCT03235700|Analgesics|analgesics|mesh-ancestor
139330149|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
139330150|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330151|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330152|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139330153|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
139330154|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139330155|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
139330156|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
139330157|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330158|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330159|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139330160|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
139330161|NCT03235700|Vitamins|vitamins|mesh-ancestor
139330162|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
139330163|NCT03234062|Choline|choline|mesh-list
139330164|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
139330165|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139330166|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
139330167|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330168|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139330169|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139330170|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
139330171|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
139330172|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139330173|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139330174|NCT03235778|Analgesics|analgesics|mesh-ancestor
139330175|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
139330176|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330177|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330178|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139330179|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139330180|NCT04439513|Hemostatics|hemostatics|mesh-list
139330181|NCT04439513|Coagulants|coagulants|mesh-ancestor
139330182|NCT02452970|Gemcitabine|gemcitabine|mesh-list
139330183|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330184|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139330186|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330187|NCT03227900|Lidocaine|lidocaine|mesh-list
139330188|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
139330189|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
139330190|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330191|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330192|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
139330193|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330194|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139330195|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139330196|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139330197|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139330198|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330199|NCT03120182|Aspirin|aspirin|mesh-list
139330200|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139330201|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139330202|NCT03120182|Analgesics|analgesics|mesh-ancestor
139330203|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
139330204|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330205|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330207|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139330208|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139330209|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139330210|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330211|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139330212|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139330213|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330214|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
139330215|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
139330216|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139330217|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139330218|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330219|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
139330220|NCT02074436|Coagulants|coagulants|mesh-ancestor
139330221|NCT03227432|Dexamethasone|dexamethasone|mesh-list
139330222|NCT03227432|Nivolumab|nivolumab|mesh-list
139330223|NCT03227432|Pomalidomide|pomalidomide|mesh-list
139330224|NCT03227432|Elotuzumab|elotuzumab|mesh-list
139330225|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139330226|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
139330227|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
139330228|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330229|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330230|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139330231|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
139330232|NCT03227432|Hormones|hormones|mesh-ancestor
139330233|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139330234|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139330235|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330236|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139330237|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139330238|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330239|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
139330240|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139330241|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139330242|NCT03227432|Growth Substances|growth substances|mesh-ancestor
139330243|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
139330244|NCT03222518|Acetaminophen|acetaminophen|mesh-list
139330245|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139330246|NCT03222518|Piroxicam|piroxicam|mesh-list
139330247|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139330248|NCT03222518|Analgesics|analgesics|mesh-ancestor
139330249|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
139330250|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330251|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330252|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
139330253|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139330254|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139330255|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139330256|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330257|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330258|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139330259|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139330260|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139330261|NCT03222206|Analgesics|analgesics|mesh-ancestor
139330262|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
139330263|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330264|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330265|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139330266|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139330268|NCT03221816|Pyridoxine|pyridoxine|mesh-list
139330269|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
139330270|NCT03221816|Hematinics|hematinics|mesh-ancestor
139330271|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
139330272|NCT03221816|Vitamins|vitamins|mesh-ancestor
139330273|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
139330274|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330275|NCT03119636|Levodopa|levodopa|mesh-list
139330276|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139330277|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139330278|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
139330279|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330280|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330281|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330283|NCT03226340|Amlodipine|amlodipine|mesh-list
139330284|NCT03226340|Telmisartan|telmisartan|mesh-list
139330285|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
139330286|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139330287|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139330288|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139330289|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330290|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139330291|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330292|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
139330293|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139330294|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139330295|NCT03226340|Diuretics|diuretics|mesh-ancestor
139330296|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
139330297|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139330298|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139330299|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
139330300|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139330301|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
139330302|NCT03226340|Vitamins|vitamins|mesh-ancestor
139330303|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
139330304|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
139330305|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139330306|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139330307|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
139330308|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330309|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330310|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330311|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
139330312|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
139330313|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330314|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
139330315|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139330316|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
139330317|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139330318|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
139330319|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330321|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139330322|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330323|NCT03225950|Antibodies|antibodies|mesh-list
139330324|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
139330325|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330326|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
139330327|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139330328|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139330329|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330330|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
139330331|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330332|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330333|NCT03232112|Exenatide|exenatide|mesh-list
139330334|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139330335|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330336|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139330337|NCT03232112|Incretins|incretins|mesh-ancestor
139330338|NCT03232112|Hormones|hormones|mesh-ancestor
139330339|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139330340|NCT02554786|Fluticasone|fluticasone|mesh-list
139330341|NCT02554786|Xhance|xhance|mesh-list
139330342|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
139330343|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139330344|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139330345|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139330346|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
139330347|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330348|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330349|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139330350|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
139330351|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
139330352|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139330353|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138987214|NCT00908336|Docetaxel|docetaxel|mesh-list
139330354|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139330355|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139330356|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
139330357|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330358|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330359|NCT05202314|Immunomodulating Agents|immunomodulating agents|mesh-list
139330360|NCT05202314|Immunologic Factors|immunologic factors|mesh-ancestor
139330361|NCT05202314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330363|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
139330364|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
139330365|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330366|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330367|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
139330368|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330370|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139330371|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330372|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330373|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139330374|NCT03220880|Analgesics|analgesics|mesh-ancestor
139330375|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
139330376|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330377|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139330378|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139330379|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139330380|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
139330381|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330382|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330383|NCT02929589|Ibuprofen|ibuprofen|mesh-list
139330384|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
139330385|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139330386|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139330387|NCT02929589|Analgesics|analgesics|mesh-ancestor
139330388|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
139330389|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330390|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330391|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139330392|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139330393|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139330394|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330395|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330396|NCT02929589|Narcotics|narcotics|mesh-ancestor
139330397|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330398|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
139330399|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139330400|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330401|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139330402|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139330403|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330404|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330405|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330406|NCT02614547|Brexanolone|brexanolone|mesh-list
139330407|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
139330408|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330409|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330410|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330411|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
139330412|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
139330413|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
139330414|NCT04472481|Vitamin D|vitamin d|mesh-list
139330415|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139330416|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330417|NCT04472481|Vitamins|vitamins|mesh-ancestor
139330418|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
139330419|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139330420|NCT01233297|Azithromycin|azithromycin|mesh-list
139330421|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139330422|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330423|NCT04681079|Albuterol|albuterol|mesh-list
139330424|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139330425|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
139330426|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330427|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330428|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139330429|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
139330430|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
139330431|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139330432|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139330433|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139330434|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139330435|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
139330436|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913927|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
139330437|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330438|NCT00580125|Aripiprazole|aripiprazole|mesh-list
139330439|NCT00580125|Antidepressive Agents|antidepressive agents|mesh-ancestor
139330440|NCT00580125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139330441|NCT00580125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139330442|NCT00580125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139330443|NCT00580125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330444|NCT00580125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330445|NCT00580125|Dopamine Agonists|dopamine agonists|mesh-ancestor
139330446|NCT00580125|Dopamine Agents|dopamine agents|mesh-ancestor
139330447|NCT00580125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330448|NCT00580125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330449|NCT00580125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139330450|NCT00580125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139330451|NCT00580125|Serotonin Agents|serotonin agents|mesh-ancestor
139330452|NCT00580125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139330453|NCT00580125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139330454|NCT00580125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139330455|NCT00580125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139330456|NCT00579189|Moxifloxacin|moxifloxacin|mesh-list
139330457|NCT00579189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139330458|NCT00579189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139330459|NCT00579189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330460|NCT00579189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139330461|NCT00579189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139330462|NCT00579189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330463|NCT00579189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330464|NCT00579189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330465|NCT00667953|Temozolomide|temozolomide|mesh-list
139330466|NCT00667953|Imatinib Mesylate|imatinib mesylate|mesh-list
139330467|NCT00667953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139330468|NCT00667953|Alkylating Agents|alkylating agents|mesh-ancestor
139330469|NCT00667953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330470|NCT00667953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330471|NCT00667953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139330472|NCT00667953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330473|NCT00578955|Azithromycin|azithromycin|mesh-list
139330474|NCT00578955|Dexamethasone|dexamethasone|mesh-list
139330475|NCT00578955|Dexamethasone acetate|dexamethasone acetate|mesh-list
139330476|NCT00578955|BB 1101|bb 1101|mesh-list
139330477|NCT00578955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139330478|NCT00578955|Antiemetics|antiemetics|mesh-ancestor
139330479|NCT00578955|Autonomic Agents|autonomic agents|mesh-ancestor
139330480|NCT00578955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330481|NCT00578955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330482|NCT00578955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139330483|NCT00578955|Glucocorticoids|glucocorticoids|mesh-ancestor
139330484|NCT00578955|Hormones|hormones|mesh-ancestor
139330485|NCT00578955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139330486|NCT00578955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139330487|NCT00578955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330488|NCT00578955|Protease Inhibitors|protease inhibitors|mesh-ancestor
139330489|NCT00578955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330490|NCT00578955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330491|NCT00578955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139330492|NCT00578955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330493|NCT00576537|Immunomodulating Agents|immunomodulating agents|mesh-list
139330494|NCT00576537|Immunologic Factors|immunologic factors|mesh-ancestor
139330495|NCT00576537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330496|NCT02282241|Melatonin|melatonin|mesh-list
139330497|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
138929430|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330498|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330499|NCT02282241|Protective Agents|protective agents|mesh-ancestor
139330500|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330501|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330503|NCT02424851|Dexamethasone|dexamethasone|mesh-list
139330504|NCT02424851|Bortezomib|bortezomib|mesh-list
139330505|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139330506|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139330507|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
139330508|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
139330509|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330510|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330511|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139330512|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
139330513|NCT02424851|Hormones|hormones|mesh-ancestor
139330514|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139330515|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139330516|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330517|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139330518|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
139330519|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330520|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138913971|NCT00781326|Nimodipine|nimodipine|mesh-list
139330521|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
139330522|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
139330523|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139330524|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330525|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139330526|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139330527|NCT02424851|Growth Substances|growth substances|mesh-ancestor
139330528|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
139330529|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
139330530|NCT02284035|Lamivudine|lamivudine|mesh-list
139330531|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139330532|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139330533|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
139330534|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330535|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139330536|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139330537|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330538|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330539|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139330540|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139330541|NCT00484419|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139330542|NCT00484419|Rosiglitazone|rosiglitazone|mesh-list
139330543|NCT00484419|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139330544|NCT00484419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139330545|NCT00484419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330546|NCT00484419|Incretins|incretins|mesh-ancestor
139330547|NCT00484419|Hormones|hormones|mesh-ancestor
139330548|NCT00484419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139330549|NCT00484419|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139330550|NCT00484419|Protease Inhibitors|protease inhibitors|mesh-ancestor
139330551|NCT00484419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330552|NCT00484419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330553|NCT00484419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139330554|NCT00484419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139330555|NCT00484419|Antimetabolites|antimetabolites|mesh-ancestor
139330556|NCT00484419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139330557|NCT02273895|Scopolamine|scopolamine|mesh-list
139330558|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139330559|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139330560|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
139330561|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
139330562|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330563|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330564|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139330565|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
139330567|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
139330568|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330569|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330570|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139330571|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
139330572|NCT00480831|Paclitaxel|paclitaxel|mesh-list
139330573|NCT00480831|Bevacizumab|bevacizumab|mesh-list
139330574|NCT00480831|Carboplatin|carboplatin|mesh-list
139330575|NCT00480831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139330576|NCT00480831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330577|NCT00480831|Tubulin Modulators|tubulin modulators|mesh-ancestor
138914004|NCT02602002|Analgesics|analgesics|mesh-ancestor
139330578|NCT00480831|Antimitotic Agents|antimitotic agents|mesh-ancestor
139330579|NCT00480831|Mitosis Modulators|mitosis modulators|mesh-ancestor
139330580|NCT00480831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330581|NCT00480831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139330582|NCT00480831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139330583|NCT00480831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139330584|NCT00480831|Growth Substances|growth substances|mesh-ancestor
139330585|NCT00480831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330586|NCT00480831|Growth Inhibitors|growth inhibitors|mesh-ancestor
139330587|NCT03220256|Lamotrigine|lamotrigine|mesh-list
139330588|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
139330589|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139330590|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139330591|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330592|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139330593|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330594|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139330595|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139330596|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330597|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139330598|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139330599|NCT03220490|Timolol|timolol|mesh-list
139330600|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139330601|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139330602|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139330603|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
139330604|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330605|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330606|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330607|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139330608|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139330609|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139330610|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139330611|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139330612|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139330613|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139330614|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139330615|NCT02553772|Laxatives|laxatives|mesh-ancestor
139330616|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139330617|NCT03119714|Pemirolast|pemirolast|mesh-list
139330618|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
139330619|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
139330620|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330621|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330622|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330623|NCT00562887|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139330624|NCT00562887|Immunologic Factors|immunologic factors|mesh-ancestor
139330626|NCT05468554|Metformin|metformin|mesh-list
139330627|NCT05468554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139330628|NCT05468554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330629|NCT04617821|Paclitaxel|paclitaxel|mesh-list
139330630|NCT04617821|Gemcitabine|gemcitabine|mesh-list
139330631|NCT04617821|Folfirinox|folfirinox|mesh-list
139330632|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139330633|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330634|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
139330635|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
139330636|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
139330637|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330638|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139330639|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
139330640|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
139330641|NCT03219008|Mirtazapine|mirtazapine|mesh-list
139330642|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
139330643|NCT03219008|Fluoxetine|fluoxetine|mesh-list
139330644|NCT03219008|Bupropion|bupropion|mesh-list
139330645|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
139330646|NCT03219008|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139330647|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139330648|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139330649|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330650|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330651|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
139330652|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330653|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139330654|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
139330655|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139330656|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139330657|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139330658|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330659|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
139330660|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139330661|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330662|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139330663|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
139330664|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
139330665|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139330666|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139330667|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139330668|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139330669|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
139330670|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139330671|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139330672|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139330673|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139330674|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139330675|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139330676|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
139330677|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139330678|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139330679|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330680|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
139330681|NCT00562497|Remestemcel-l|remestemcel-l|mesh-list
139330682|NCT00562497|Prednisone|prednisone|mesh-list
139330683|NCT00562497|Methylprednisolone|methylprednisolone|mesh-list
139330684|NCT00562497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139330685|NCT00562497|Glucocorticoids|glucocorticoids|mesh-ancestor
139330686|NCT00562497|Hormones|hormones|mesh-ancestor
138188952|NCT04341883|Paclitaxel|paclitaxel|mesh-list
139330687|NCT00562497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139330688|NCT00562497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330689|NCT00562497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139330690|NCT00562497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330691|NCT00562497|Antiemetics|antiemetics|mesh-ancestor
139330692|NCT00562497|Autonomic Agents|autonomic agents|mesh-ancestor
139330693|NCT00562497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330694|NCT00562497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139330695|NCT00562497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139330696|NCT00562497|Protective Agents|protective agents|mesh-ancestor
139330697|NCT00562497|Antiviral Agents|antiviral agents|mesh-ancestor
139330698|NCT00562497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330699|NCT00468975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139330700|NCT00468975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139330701|NCT00468975|Autonomic Agents|autonomic agents|mesh-ancestor
139330702|NCT00468975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330703|NCT00468975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330704|NCT00468975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139330705|NCT00468975|Respiratory System Agents|respiratory system agents|mesh-ancestor
139330706|NCT00468975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139330707|NCT00468975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139330708|NCT00468975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139330709|NCT00468975|Adrenergic Agents|adrenergic agents|mesh-ancestor
139330710|NCT00468975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330711|NCT00468975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330712|NCT01503515|Fluconazole|fluconazole|mesh-list
139330713|NCT01503515|Voriconazole|voriconazole|mesh-list
139330714|NCT01503515|Caspofungin|caspofungin|mesh-list
139330715|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
139330716|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330717|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139330718|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139330719|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330720|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330721|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139330722|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
139330723|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139330724|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330725|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139330726|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139330727|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139330728|NCT00468273|Immunoglobulins|immunoglobulins|mesh-list
139330729|NCT00468273|Antibodies|antibodies|mesh-list
139330730|NCT00468273|gamma-Globulins|gamma-globulins|mesh-list
139330731|NCT00468273|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139330732|NCT00468273|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139330733|NCT00468273|Immunologic Factors|immunologic factors|mesh-ancestor
139330734|NCT00468273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330735|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
139330736|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139330737|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
139330738|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330739|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139330740|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330741|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
139330742|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139330743|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
139330744|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139330745|NCT03217916|Protective Agents|protective agents|mesh-ancestor
139330746|NCT00468117|Etanercept|etanercept|mesh-list
139330747|NCT00468117|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139330748|NCT00468117|Basiliximab|basiliximab|mesh-list
139330749|NCT00468117|Daclizumab|daclizumab|mesh-list
139330750|NCT00468117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139330751|NCT00468117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139330753|NCT00468117|Sensory System Agents|sensory system agents|mesh-ancestor
139330754|NCT00468117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330755|NCT00468117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330756|NCT00468117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139330757|NCT00468117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139330758|NCT00468117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139330759|NCT00468117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139330760|NCT00468117|Immunologic Factors|immunologic factors|mesh-ancestor
139330761|NCT00468039|Metformin|metformin|mesh-list
139330762|NCT00468039|Vildagliptin|vildagliptin|mesh-list
139330763|NCT00468039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139330764|NCT00468039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330765|NCT00468039|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139330766|NCT00468039|Protease Inhibitors|protease inhibitors|mesh-ancestor
139330767|NCT00468039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330768|NCT00468039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330769|NCT02742519|Ivacaftor|ivacaftor|mesh-list
139330770|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139330771|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139330772|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330773|NCT01375010|Vitamin D|vitamin d|mesh-list
139330774|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
139330775|NCT01375010|Vitamins|vitamins|mesh-list
139330776|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
139330777|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330778|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139330779|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139330780|NCT03231176|Capecitabine|capecitabine|mesh-list
139330781|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139330782|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
139330783|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330784|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330785|NCT00467025|Sorafenib|sorafenib|mesh-list
139330786|NCT00467025|Trebananib|trebananib|mesh-list
139330787|NCT00467025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330788|NCT00467025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139330789|NCT00467025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330790|NCT00467025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330791|NCT00467025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139330792|NCT00467025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139330793|NCT00467025|Growth Substances|growth substances|mesh-ancestor
139330794|NCT00467025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330795|NCT00467025|Growth Inhibitors|growth inhibitors|mesh-ancestor
139330796|NCT03230786|Metformin|metformin|mesh-list
139330797|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139330798|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330799|NCT02451098|Atorvastatin|atorvastatin|mesh-list
138987666|NCT02430077|Cathartics|cathartics|mesh-ancestor
139330801|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139330802|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139330803|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
139179019|NCT01328015|Oxybutynin|oxybutynin|mesh-list
139330804|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330805|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139330806|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139330807|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330808|NCT00546273|Vaccines|vaccines|mesh-list
139330809|NCT00546273|Immunologic Factors|immunologic factors|mesh-ancestor
139330810|NCT00546273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330811|NCT02452112|Lidocaine|lidocaine|mesh-list
139330812|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
139330813|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
139330814|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330815|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330816|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
139330817|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330818|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139330819|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139330820|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139330821|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139330822|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330823|NCT00659061|Micronutrients|micronutrients|mesh-list
139330824|NCT00659061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330825|NCT02451956|Paclitaxel|paclitaxel|mesh-list
139330826|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139330827|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330828|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
139330829|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
139330830|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
139330831|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330832|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
139330833|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139330834|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
139330835|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330836|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330837|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139330838|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
139330839|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139330840|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
139330841|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330842|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330843|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139330844|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
139330845|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
139330846|NCT02725372|Protective Agents|protective agents|mesh-ancestor
139330847|NCT02450786|Donepezil|donepezil|mesh-list
139330848|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139330849|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330850|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330851|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
139330852|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330853|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330854|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
139330855|NCT00539721|Ondansetron|ondansetron|mesh-list
139330856|NCT00539721|Rolapitant|rolapitant|mesh-list
139330857|NCT00539721|Antiemetics|antiemetics|mesh-ancestor
139330858|NCT00539721|Autonomic Agents|autonomic agents|mesh-ancestor
138914155|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330859|NCT00539721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330860|NCT00539721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330861|NCT00539721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139330862|NCT00539721|Antipruritics|antipruritics|mesh-ancestor
139330863|NCT00539721|Dermatologic Agents|dermatologic agents|mesh-ancestor
139330864|NCT00539721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139330865|NCT00539721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139330866|NCT00539721|Serotonin Agents|serotonin agents|mesh-ancestor
139330867|NCT00539721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330868|NCT00539721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330869|NCT00539721|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139330870|NCT00464061|Volinanserin|volinanserin|mesh-list
139330871|NCT00464061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139330872|NCT00464061|Serotonin Agents|serotonin agents|mesh-ancestor
138987743|NCT00731627|Simvastatin|simvastatin|mesh-list
139330873|NCT00464061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330874|NCT00464061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330875|NCT00464061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330876|NCT03230630|Melatonin|melatonin|mesh-list
139330877|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
139330878|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330879|NCT03230630|Protective Agents|protective agents|mesh-ancestor
139330880|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330881|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330882|NCT00460941|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139330883|NCT00460941|Incretins|incretins|mesh-ancestor
139330884|NCT00460941|Hormones|hormones|mesh-ancestor
139330885|NCT00460941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139330886|NCT00460941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330887|NCT00460317|Paclitaxel|paclitaxel|mesh-list
139330888|NCT00460317|Carboplatin|carboplatin|mesh-list
139330889|NCT00460317|Motesanib diphosphate|motesanib diphosphate|mesh-list
139330890|NCT00460317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139330891|NCT00460317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330892|NCT00460317|Tubulin Modulators|tubulin modulators|mesh-ancestor
139330893|NCT00460317|Antimitotic Agents|antimitotic agents|mesh-ancestor
139330894|NCT00460317|Mitosis Modulators|mitosis modulators|mesh-ancestor
139330895|NCT00460317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330896|NCT00460317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139330897|NCT00460317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330898|NCT03213548|Daminozide|daminozide|mesh-list
139330899|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
139330900|NCT03213548|Growth Substances|growth substances|mesh-ancestor
139330901|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330902|NCT00534027|Conatumumab|conatumumab|mesh-list
139330903|NCT00534027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139330904|NCT00534027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330905|NCT02548078|Vaccines|vaccines|mesh-list
139330906|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
139330907|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330908|NCT00532311|Atorvastatin|atorvastatin|mesh-list
139330909|NCT00532311|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139330910|NCT00532311|Simvastatin|simvastatin|mesh-list
139330911|NCT00532311|Pravastatin|pravastatin|mesh-list
139330912|NCT00532311|Lovastatin|lovastatin|mesh-list
139330913|NCT00532311|L 647318|l 647318|mesh-list
139330914|NCT00532311|Dihydromevinolin|dihydromevinolin|mesh-list
138914193|NCT02601924|Anesthetics|anesthetics|mesh-list
139330915|NCT00532311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139330916|NCT00532311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139330917|NCT00532311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139330918|NCT00532311|Antimetabolites|antimetabolites|mesh-ancestor
139330919|NCT00532311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330920|NCT00532311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139330921|NCT00532311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330922|NCT03230474|Morphine|morphine|mesh-list
139330923|NCT03230474|Naloxone|naloxone|mesh-list
139330924|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139330925|NCT03230474|Narcotics|narcotics|mesh-ancestor
139330926|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330927|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330928|NCT03230474|Analgesics|analgesics|mesh-ancestor
139330929|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
139330930|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330931|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139330932|NCT00529503|Rituximab|rituximab|mesh-list
139330933|NCT00529503|Dacetuzumab|dacetuzumab|mesh-list
139330934|NCT00529503|Carboplatin|carboplatin|mesh-list
139330935|NCT00529503|Etoposide|etoposide|mesh-list
139330936|NCT00529503|Ifosfamide|ifosfamide|mesh-list
139330937|NCT00529503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139330938|NCT00529503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139330939|NCT00529503|Immunologic Factors|immunologic factors|mesh-ancestor
139330940|NCT00529503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330941|NCT00529503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139330942|NCT00529503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139330943|NCT00529503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139330944|NCT00529503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139330945|NCT00529503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330946|NCT00529503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987817|NCT00904904|Ketorolac|ketorolac|mesh-list
139330947|NCT00529503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139330948|NCT00529503|Alkylating Agents|alkylating agents|mesh-ancestor
139330949|NCT05459194|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139330950|NCT05459194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139330951|NCT05459194|Autonomic Agents|autonomic agents|mesh-ancestor
139330952|NCT05459194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330953|NCT05459194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330954|NCT05459194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139330955|NCT05459194|Respiratory System Agents|respiratory system agents|mesh-ancestor
139330956|NCT05459194|Glucocorticoids|glucocorticoids|mesh-ancestor
139330958|NCT05459194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139330959|NCT05459194|Sympathomimetics|sympathomimetics|mesh-ancestor
139330960|NCT05476198|Anesthetics|anesthetics|mesh-list
139330961|NCT05476198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330962|NCT05476198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330963|NCT02280057|Metformin|metformin|mesh-list
139330964|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139330965|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330966|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139330967|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
139330968|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330969|NCT02282709|Asunaprevir|asunaprevir|mesh-list
139330970|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
139330971|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139330972|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330973|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
139330974|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139330975|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139330976|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330977|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139330978|NCT02282787|Analgesics|analgesics|mesh-ancestor
139330979|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
139330980|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139330981|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139330982|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139330983|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139330984|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
139330985|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330986|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330987|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
139330988|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139330989|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139330990|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139330991|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139330992|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139330993|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139330994|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
139330995|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139330996|NCT00458601|Temozolomide|temozolomide|mesh-list
139330997|NCT00458601|Molgramostim|molgramostim|mesh-list
139330998|NCT00458601|Rindopepimut|rindopepimut|mesh-list
139330999|NCT00458601|Sargramostim|sargramostim|mesh-list
139331000|NCT00458601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139331001|NCT00458601|Alkylating Agents|alkylating agents|mesh-ancestor
139331002|NCT00458601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331003|NCT00458601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331004|NCT00458601|Immunologic Factors|immunologic factors|mesh-ancestor
139331005|NCT00458601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331006|NCT00458601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139331007|NCT00658047|Methotrexate|methotrexate|mesh-list
139331008|NCT00658047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139331009|NCT00658047|Abortifacient Agents|abortifacient agents|mesh-ancestor
139331010|NCT00658047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139331011|NCT00658047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331012|NCT00658047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139331013|NCT00658047|Antimetabolites|antimetabolites|mesh-ancestor
139331014|NCT00658047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331015|NCT00658047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331016|NCT00658047|Dermatologic Agents|dermatologic agents|mesh-ancestor
139331017|NCT00658047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331018|NCT00658047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139331019|NCT00658047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138987897|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
139331021|NCT00658047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331022|NCT00658047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139331023|NCT03230162|Heparin|heparin|mesh-list
139331024|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139331025|NCT03230162|Tinzaparin|tinzaparin|mesh-list
139331026|NCT03230162|Dalteparin|dalteparin|mesh-list
139331027|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
139331028|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
139331029|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139331030|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139331031|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331032|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
139331033|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139331034|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139331035|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331036|NCT03230162|Urological Agents|urological agents|mesh-ancestor
139331037|NCT00455559|Imatinib Mesylate|imatinib mesylate|mesh-list
139331038|NCT00455559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331039|NCT00455559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139331040|NCT00455559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331041|NCT00455559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331042|NCT02916433|Octreotide|octreotide|mesh-list
139331043|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139331044|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139331045|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331046|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139331047|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331048|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139331049|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331050|NCT04059523|Tretinoin|tretinoin|mesh-list
139331051|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331052|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
139331053|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
139331054|NCT00657501|Testosterone|testosterone|mesh-list
139331055|NCT00657501|Androgens|androgens|mesh-ancestor
139331056|NCT00657501|Hormones|hormones|mesh-ancestor
139331057|NCT00657501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139331058|NCT00657501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331059|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
139331060|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
139331061|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139331062|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331063|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
139331064|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139331065|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139331066|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139331067|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331068|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331069|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331070|NCT03229694|Bosentan|bosentan|mesh-list
139331071|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
139331072|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139331073|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331074|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139331075|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139331076|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331077|NCT03209648|Itraconazole|itraconazole|mesh-list
139331078|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
139331079|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331080|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139331081|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139331082|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331083|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331084|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139331085|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
139331086|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139331087|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331088|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139331089|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
139331090|NCT04058899|Nalbuphine|nalbuphine|mesh-list
139331091|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139331092|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139331093|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331094|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139331095|NCT04058899|Analgesics|analgesics|mesh-ancestor
139331096|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
139331097|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139331098|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139331099|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139331100|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139331101|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
139331102|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139331103|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331104|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139331105|NCT04058899|Narcotics|narcotics|mesh-ancestor
139331106|NCT00657189|Sifalimumab|sifalimumab|mesh-list
139331107|NCT00657189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139331108|NCT00657189|Immunologic Factors|immunologic factors|mesh-ancestor
139331109|NCT00657189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331110|NCT03209180|Carvedilol|carvedilol|mesh-list
139331111|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139331112|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139331113|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
139331114|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139331115|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331116|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331117|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139331118|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
139331119|NCT03209180|Protective Agents|protective agents|mesh-ancestor
139331120|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139331121|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139331122|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139331123|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
139331124|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139331125|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139331126|NCT03215017|Loperamide|loperamide|mesh-list
139331127|NCT03215017|Sorbitol|sorbitol|mesh-list
139331128|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
139331129|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139331130|NCT03215017|Cathartics|cathartics|mesh-ancestor
139331131|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
139331132|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139331133|NCT02280447|Vaccines|vaccines|mesh-list
139331134|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
139331135|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331136|NCT00528333|Cytarabine|cytarabine|mesh-list
139331137|NCT00528333|Lintuzumab|lintuzumab|mesh-list
139331138|NCT00528333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139331139|NCT00528333|Antimetabolites|antimetabolites|mesh-ancestor
139331140|NCT00528333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331141|NCT00528333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331142|NCT00528333|Antiviral Agents|antiviral agents|mesh-ancestor
139331143|NCT00528333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331144|NCT00528333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331145|NCT00528333|Immunologic Factors|immunologic factors|mesh-ancestor
139331146|NCT00528333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331147|NCT00528333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139331148|NCT00526227|Clotrimazole|clotrimazole|mesh-list
139331149|NCT00526227|Miconazole|miconazole|mesh-list
139331150|NCT00526227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139331151|NCT00526227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331152|NCT00526227|Antifungal Agents|antifungal agents|mesh-ancestor
139331153|NCT00526227|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139331154|NCT00526227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139331155|NCT00526227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331156|NCT00526227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331157|NCT00526227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139331158|NCT00526227|Hormone Antagonists|hormone antagonists|mesh-ancestor
139331159|NCT00526227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139331160|NCT00526227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331161|NCT00526227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139331162|NCT00526227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139331163|NCT02280603|Minoxidil|minoxidil|mesh-list
139331164|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139331165|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
138988034|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139331166|NCT00524277|Molgramostim|molgramostim|mesh-list
139331167|NCT00524277|Vaccines|vaccines|mesh-list
139331168|NCT00524277|Sargramostim|sargramostim|mesh-list
139331169|NCT00524277|Immunologic Factors|immunologic factors|mesh-ancestor
139331170|NCT00524277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331171|NCT00524277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331172|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139331173|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139331174|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139331175|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
139331176|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331177|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139331178|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139331179|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331180|NCT00650949|Carboplatin|carboplatin|mesh-list
139331181|NCT00650949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331182|NCT00520923|Olanzapine|olanzapine|mesh-list
139331183|NCT00520923|Antiemetics|antiemetics|mesh-ancestor
139331184|NCT00520923|Autonomic Agents|autonomic agents|mesh-ancestor
139331185|NCT00520923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139331186|NCT00520923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331187|NCT00520923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139331188|NCT00520923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139331189|NCT00520923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139331190|NCT00520923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139331191|NCT00520923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139331192|NCT00520923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139331193|NCT00520923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139331194|NCT00520923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139331195|NCT00520923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331197|NCT00520923|Serotonin Agents|serotonin agents|mesh-ancestor
139331198|NCT02283177|Cytarabine|cytarabine|mesh-list
139331199|NCT02283177|Daunorubicin|daunorubicin|mesh-list
139331200|NCT02283177|Idarubicin|idarubicin|mesh-list
139331201|NCT02283177|Crenolanib|crenolanib|mesh-list
139331202|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139331203|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
139331204|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331205|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331206|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
139331207|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331208|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331209|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
139331210|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331211|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139331212|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139331213|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139331214|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331215|NCT00514371|Bortezomib|bortezomib|mesh-list
139331216|NCT00514371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331217|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139331218|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331219|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139331220|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139331221|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331222|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139331223|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
139331224|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139331225|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139331226|NCT02286453|Diclofenac|diclofenac|mesh-list
139331227|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139331228|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139331229|NCT02286453|Analgesics|analgesics|mesh-ancestor
139331230|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
139331231|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139331232|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331233|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139331234|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331235|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139331236|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331237|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331238|NCT00385515|Meclocycline|meclocycline|mesh-list
139331239|NCT00385515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139331240|NCT00385515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331241|NCT02286609|Deflazacort|deflazacort|mesh-list
139331243|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331244|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
139331245|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331246|NCT00508989|Niacin|niacin|mesh-list
139331247|NCT00508989|Acetylcholine|acetylcholine|mesh-list
139331248|NCT00508989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139331249|NCT00508989|Antimetabolites|antimetabolites|mesh-ancestor
139331250|NCT00508989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331251|NCT00508989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139331252|NCT00508989|Vasodilator Agents|vasodilator agents|mesh-ancestor
139331253|NCT00508989|Vitamin B Complex|vitamin b complex|mesh-ancestor
139331254|NCT00508989|Vitamins|vitamins|mesh-ancestor
139331255|NCT00508989|Micronutrients|micronutrients|mesh-ancestor
139331256|NCT00508989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331257|NCT00508989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139331258|NCT00508989|Cholinergic Agents|cholinergic agents|mesh-ancestor
139331259|NCT00508989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139331260|NCT03104842|Dexamethasone|dexamethasone|mesh-list
139331261|NCT03104842|Lenalidomide|lenalidomide|mesh-list
139331262|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139331263|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
139331264|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
139331265|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139331266|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331267|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139331268|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
139331269|NCT03104842|Hormones|hormones|mesh-ancestor
139331270|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139331271|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139331272|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331273|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
139331274|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139331275|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139331276|NCT03104842|Growth Substances|growth substances|mesh-ancestor
139331277|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
139331278|NCT00436683|Sevelamer|sevelamer|mesh-list
139331279|NCT00436683|Chelating Agents|chelating agents|mesh-ancestor
139331280|NCT00436683|Sequestering Agents|sequestering agents|mesh-ancestor
139331281|NCT00436683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331282|NCT00434811|Sirolimus|sirolimus|mesh-list
139331283|NCT00434811|Etanercept|etanercept|mesh-list
139331284|NCT00434811|Tacrolimus|tacrolimus|mesh-list
139331285|NCT00434811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139331286|NCT00434811|Basiliximab|basiliximab|mesh-list
139331287|NCT00434811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331288|NCT00434811|Immunologic Factors|immunologic factors|mesh-ancestor
139331289|NCT00434811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331290|NCT00434811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139331291|NCT00434811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331292|NCT00434811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331293|NCT00434811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139331294|NCT00434811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331295|NCT00434811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139331296|NCT00434811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331297|NCT00434811|Antifungal Agents|antifungal agents|mesh-ancestor
138914332|NCT00772668|Rituximab|rituximab|mesh-list
139331298|NCT00434811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139331299|NCT00434811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139331300|NCT00434811|Analgesics|analgesics|mesh-ancestor
139331301|NCT00434811|Sensory System Agents|sensory system agents|mesh-ancestor
139331302|NCT00434811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139331303|NCT00434811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139331304|NCT00434811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331305|NCT00434811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139331306|NCT03133845|Midazolam|midazolam|mesh-list
139331307|NCT03133845|Fentanyl|fentanyl|mesh-list
139331308|NCT03133845|Morphine|morphine|mesh-list
139331309|NCT03133845|Anesthetics|anesthetics|mesh-list
139331310|NCT03133845|Propofol|propofol|mesh-list
139331311|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139331312|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331313|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139331314|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139331315|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
139331316|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139331317|NCT03133845|Narcotics|narcotics|mesh-ancestor
139331318|NCT03133845|Analgesics|analgesics|mesh-ancestor
139331319|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
139331320|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139331321|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139331322|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139331323|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139331324|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139331325|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
139331326|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
139331327|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139331328|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331329|NCT00120393|Ritonavir|ritonavir|mesh-list
139331330|NCT00120393|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139331331|NCT00120393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139331332|NCT00120393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139331333|NCT00120393|Protease Inhibitors|protease inhibitors|mesh-ancestor
139331334|NCT00120393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331335|NCT00120393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331336|NCT00120393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139331337|NCT00120393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139331338|NCT00120393|Antiviral Agents|antiviral agents|mesh-ancestor
139331339|NCT00120393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331340|NCT00120393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139331341|NCT00120393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139331342|NCT05726019|Colchicine|colchicine|mesh-list
139331343|NCT05726019|Gout Suppressants|gout suppressants|mesh-ancestor
139331344|NCT05726019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331345|NCT05726019|Tubulin Modulators|tubulin modulators|mesh-ancestor
139331346|NCT05726019|Antimitotic Agents|antimitotic agents|mesh-ancestor
139331347|NCT05726019|Mitosis Modulators|mitosis modulators|mesh-ancestor
139331348|NCT05726019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331349|NCT05726019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331350|NCT00116415|Lamivudine|lamivudine|mesh-list
139331351|NCT00116415|Efavirenz|efavirenz|mesh-list
139331352|NCT00116415|Didanosine|didanosine|mesh-list
139331353|NCT00116415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139331354|NCT00116415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139331355|NCT00116415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331356|NCT00116415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331357|NCT00116415|Antiviral Agents|antiviral agents|mesh-ancestor
139331358|NCT00116415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331359|NCT00116415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139331360|NCT00116415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139331361|NCT00116415|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139331362|NCT00116415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139331363|NCT00116415|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139331364|NCT00116415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139331365|NCT00116415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139331366|NCT00116415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139331367|NCT00116415|Antimetabolites|antimetabolites|mesh-ancestor
139331368|NCT03207698|Metformin|metformin|mesh-list
139331369|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139331370|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331371|NCT03208712|Atezolizumab|atezolizumab|mesh-list
139331372|NCT03208712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139331373|NCT03208712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331374|NCT03208712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139331375|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331376|NCT03201380|Choline|choline|mesh-list
139331377|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
139331378|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139331379|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
139331380|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331381|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139331382|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139331383|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
139331384|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
139331385|NCT03208556|Fludarabine|fludarabine|mesh-list
139331386|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331387|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
139331388|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331389|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331390|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139331391|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
139331392|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331393|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331394|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139331396|NCT00429429|Immunologic Factors|immunologic factors|mesh-ancestor
139331397|NCT00429429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331398|NCT03201146|Cisplatin|cisplatin|mesh-list
139331399|NCT03201146|Carboplatin|carboplatin|mesh-list
139331400|NCT03201146|Pemetrexed|pemetrexed|mesh-list
139331401|NCT03201146|Apatinib|apatinib|mesh-list
139331402|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331403|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331404|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331405|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139331406|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139331407|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139331408|NCT00370383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139331409|NCT00370383|Satraplatin|satraplatin|mesh-list
139331410|NCT00370383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331411|NCT00370383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139331412|NCT00370383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331413|NCT00370383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331414|NCT00367887|Ribavirin|ribavirin|mesh-list
139331415|NCT00367887|Interferon alpha-2|interferon alpha-2|mesh-list
139331416|NCT00367887|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139331417|NCT00367887|Interferon-alpha|interferon-alpha|mesh-list
139331418|NCT00367887|Antimetabolites|antimetabolites|mesh-ancestor
138914356|NCT00784875|Zolpidem|zolpidem|mesh-list
139331419|NCT00367887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331420|NCT00367887|Antiviral Agents|antiviral agents|mesh-ancestor
139331421|NCT00367887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331422|NCT00367887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331423|NCT00367887|Immunologic Factors|immunologic factors|mesh-ancestor
139331424|NCT00367887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331425|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139331426|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139331427|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331428|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
139331429|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331430|NCT03207308|Vitamin A|vitamin a|mesh-list
139331431|NCT03207308|Vitamins|vitamins|mesh-ancestor
139331432|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
139331433|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331434|NCT00366795|Satavaptan|satavaptan|mesh-list
139331435|NCT00366795|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139331436|NCT00366795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331437|NCT00366795|Natriuretic Agents|natriuretic agents|mesh-ancestor
139331438|NCT00366795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331439|NCT00422019|Rilotumumab|rilotumumab|mesh-list
139331440|NCT00422019|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139331441|NCT00422019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139331442|NCT00422019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331443|NCT00422019|Immunologic Factors|immunologic factors|mesh-ancestor
139331444|NCT00422019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331446|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331447|NCT00360867|Motesanib diphosphate|motesanib diphosphate|mesh-list
139331448|NCT00360867|Imetelstat|imetelstat|mesh-list
139331449|NCT00360867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139331450|NCT00360867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331451|NCT00360867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331452|NCT02287389|Mitomycins|mitomycins|mesh-list
139331453|NCT02287389|Mitomycin|mitomycin|mesh-list
139331454|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139331455|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331456|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
139331457|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331458|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139331459|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331460|NCT00057993|Trastuzumab|trastuzumab|mesh-list
139331461|NCT00057993|Exemestane|exemestane|mesh-list
139331462|NCT00057993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139331463|NCT00057993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331464|NCT00057993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139331465|NCT00057993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139331466|NCT00057993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331467|NCT00057993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331468|NCT00057993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139331469|NCT00057993|Hormone Antagonists|hormone antagonists|mesh-ancestor
139331470|NCT00057993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139331471|NCT00057993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331472|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
139331473|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
139331474|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139331475|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139331476|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331477|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331478|NCT02284737|Urological Agents|urological agents|mesh-ancestor
139331479|NCT02448290|Docetaxel|docetaxel|mesh-list
139331480|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331481|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
139331482|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
139331483|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
139331484|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331485|NCT00357279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139331486|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139331487|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139331488|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139331489|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331490|NCT00055575|Scopolamine|scopolamine|mesh-list
139331491|NCT00055575|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139331492|NCT00055575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139331493|NCT00055575|Antiemetics|antiemetics|mesh-ancestor
139331494|NCT00055575|Autonomic Agents|autonomic agents|mesh-ancestor
139331495|NCT00055575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139331496|NCT00055575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331497|NCT00055575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139331498|NCT00055575|Mydriatics|mydriatics|mesh-ancestor
139331499|NCT00055575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139331500|NCT00055575|Cholinergic Agents|cholinergic agents|mesh-ancestor
139331501|NCT00055575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139331502|NCT00055575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331503|NCT00055575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139331504|NCT00055575|Parasympatholytics|parasympatholytics|mesh-ancestor
139331505|NCT00051129|Hydrocortisone|hydrocortisone|mesh-list
139331506|NCT00051129|Anecortave|anecortave|mesh-list
139331507|NCT00051129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139331508|NCT00051129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139331509|NCT00051129|Growth Substances|growth substances|mesh-ancestor
139331510|NCT00051129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331511|NCT00051129|Growth Inhibitors|growth inhibitors|mesh-ancestor
139331512|NCT00051129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331513|NCT00051129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139331514|NCT03200600|Dexamethasone|dexamethasone|mesh-list
139331515|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
139331516|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
139331517|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
139331518|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139331519|NCT03200600|BB 1101|bb 1101|mesh-list
139331520|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139331521|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
139331522|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
139331523|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139331524|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914411|NCT00853073|Growth Substances|growth substances|mesh-ancestor
139331525|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139331526|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
139331527|NCT03200600|Hormones|hormones|mesh-ancestor
139331528|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139331529|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139331530|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331531|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
139331532|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331533|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331534|NCT03200600|Analgesics|analgesics|mesh-ancestor
139331535|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
139331536|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139331537|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139331538|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331539|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139331540|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
139331541|NCT02547454|Hematinics|hematinics|mesh-ancestor
139331542|NCT00049959|Verteporfin|verteporfin|mesh-list
139331543|NCT00049959|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138988410|NCT00504075|Antibodies|antibodies|mesh-list
139331544|NCT00049959|Dermatologic Agents|dermatologic agents|mesh-ancestor
139331545|NCT03119324|Nimesulide|nimesulide|mesh-list
139331546|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139331547|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139331548|NCT03119324|Analgesics|analgesics|mesh-ancestor
139331549|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
139331550|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139331551|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331552|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139331553|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331554|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139331555|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331556|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331557|NCT00415623|Amlodipine|amlodipine|mesh-list
139331558|NCT00415623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139331559|NCT00415623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139331560|NCT00415623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139331561|NCT00415623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331562|NCT00415623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139331563|NCT00415623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331564|NCT00415623|Vasodilator Agents|vasodilator agents|mesh-ancestor
139331565|NCT03134001|Analgesics|analgesics|mesh-list
139331566|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
139331567|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139331568|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331569|NCT01969409|Rituximab|rituximab|mesh-list
139331570|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139331571|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331572|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
139331573|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331574|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331575|NCT05218577|Selenium|selenium|mesh-list
139331576|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
139331577|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331578|NCT05218577|Protective Agents|protective agents|mesh-ancestor
139331579|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331580|NCT05218577|Trace Elements|trace elements|mesh-ancestor
139331581|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
139331582|NCT00150813|Levetiracetam|levetiracetam|mesh-list
139331583|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
139331584|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
139331586|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139331587|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139331588|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
139331589|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139331590|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139331591|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331592|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331593|NCT02712788|Protective Agents|protective agents|mesh-ancestor
139331594|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331595|NCT00035529|Abatacept|abatacept|mesh-list
139331596|NCT00035529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139331597|NCT00035529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331598|NCT00035529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139331599|NCT00035529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331600|NCT00035529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331601|NCT00035529|Immunologic Factors|immunologic factors|mesh-ancestor
139331602|NCT00035529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331603|NCT00035529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331604|NCT00356109|Insulin|insulin|mesh-list
139331605|NCT00356109|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139331606|NCT00356109|Insulin Glargine|insulin glargine|mesh-list
139331607|NCT00356109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139331608|NCT00356109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331609|NCT03206138|Imiquimod|imiquimod|mesh-list
139331610|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139331611|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
139331612|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331613|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331614|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
139331615|NCT00006225|Flt3 ligand protein|flt3 ligand protein|mesh-list
139331616|NCT00006225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139331617|NCT00006225|Immunologic Factors|immunologic factors|mesh-ancestor
139331618|NCT00006225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331619|NCT00006225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139331620|NCT00006225|Protective Agents|protective agents|mesh-ancestor
139331621|NCT00005595|Arsenic Trioxide|arsenic trioxide|mesh-list
139331622|NCT00005595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331623|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
139331624|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
139331625|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331626|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331627|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
139331628|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139331629|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139331630|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
139331631|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139331632|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331633|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331634|NCT04477265|Urological Agents|urological agents|mesh-ancestor
139331635|NCT00353457|Capecitabine|capecitabine|mesh-list
139331636|NCT00353457|Oxaliplatin|oxaliplatin|mesh-list
139331637|NCT00353457|Cetuximab|cetuximab|mesh-list
139331638|NCT00353457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139331639|NCT00353457|Antimetabolites|antimetabolites|mesh-ancestor
139331640|NCT00353457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331641|NCT00353457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331642|NCT00353457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139331643|NCT00411099|Agomelatine|agomelatine|mesh-list
139331644|NCT00411099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139331645|NCT00411099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139331646|NCT00411099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331647|NCT03195530|Propofol|propofol|mesh-list
139331648|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139331649|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139331650|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331651|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139331652|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
139331653|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
139179160|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
139331654|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
139331655|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139331656|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139331657|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139331658|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
139331659|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331660|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139331661|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139331662|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331663|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331664|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139331666|NCT00406809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331667|NCT03200210|Febuxostat|febuxostat|mesh-list
139331668|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
139331669|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331670|NCT00004899|Etoposide|etoposide|mesh-list
139331671|NCT00004899|Busulfan|busulfan|mesh-list
139331672|NCT00004899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139331673|NCT00004899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331674|NCT00004899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139331675|NCT00004899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139331676|NCT00004899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331677|NCT00004899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331678|NCT00004899|Immunologic Factors|immunologic factors|mesh-ancestor
139331679|NCT00004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331680|NCT00004899|Alkylating Agents|alkylating agents|mesh-ancestor
139331681|NCT00004899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331682|NCT00004899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139331683|NCT00004899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139331684|NCT03199976|Fluticasone|fluticasone|mesh-list
139331685|NCT03199976|Xhance|xhance|mesh-list
139331686|NCT03199976|Bromides|bromides|mesh-list
139331687|NCT03199976|Albuterol|albuterol|mesh-list
139331688|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
139331689|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139331690|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139331691|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
139331692|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139331693|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331694|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139331695|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
138988561|NCT00905528|Ramipril|ramipril|mesh-list
139331696|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
139331697|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139331698|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
139331699|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139331700|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
139331701|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139331702|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331703|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
139331704|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
138914449|NCT00862121|Analgesics|analgesics|mesh-ancestor
139331705|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139331706|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139331707|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139331708|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139331709|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
139331710|NCT00369317|Cytarabine|cytarabine|mesh-list
139331711|NCT00369317|Etoposide|etoposide|mesh-list
139331712|NCT00369317|Daunorubicin|daunorubicin|mesh-list
139331713|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
139331714|NCT00369317|Asparaginase|asparaginase|mesh-list
139331715|NCT00369317|Thioguanine|thioguanine|mesh-list
139331716|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139331717|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331718|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139331719|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139331720|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331721|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331722|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139331723|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
139331724|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
139331725|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331726|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331727|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
139331728|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331729|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139331730|NCT02447666|Azacitidine|azacitidine|mesh-list
139331731|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139331732|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
139331733|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331734|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331735|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331736|NCT04469829|Methotrexate|methotrexate|mesh-list
139331737|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139331738|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
139331739|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139331740|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331741|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139331742|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
139331743|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331744|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331745|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
139331746|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331747|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139331748|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331749|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
139331750|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331751|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139331752|NCT00405951|Docetaxel|docetaxel|mesh-list
139331753|NCT00405951|Obatoclax|obatoclax|mesh-list
139331754|NCT00405951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331755|NCT00405951|Tubulin Modulators|tubulin modulators|mesh-ancestor
139331756|NCT00405951|Antimitotic Agents|antimitotic agents|mesh-ancestor
139331757|NCT00405951|Mitosis Modulators|mitosis modulators|mesh-ancestor
139331758|NCT00405951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331759|NCT00405951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331760|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139331761|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139331762|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331763|NCT03669757|Betamethasone|betamethasone|mesh-list
139331764|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
139331765|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139331766|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
139331767|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139331768|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139331769|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
139331770|NCT03669757|Hormones|hormones|mesh-ancestor
139331771|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139331772|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331773|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139331774|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
139331776|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
139331777|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
139331778|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139331779|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331780|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
139331781|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139331782|NCT00330369|Darusentan|darusentan|mesh-list
139331783|NCT00330369|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139331784|NCT00330369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331785|NCT03199664|Tacrolimus|tacrolimus|mesh-list
139331786|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331787|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
139331788|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331789|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139331790|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331791|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331792|NCT02447510|Mitogens|mitogens|mesh-list
139331793|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
139331794|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331795|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
139331797|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
139331798|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331799|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331800|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139331801|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
139331802|NCT05216237|Apatinib|apatinib|mesh-list
139331803|NCT05216237|Tegafur|tegafur|mesh-list
139331804|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331805|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139331806|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331807|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331808|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139331809|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
139331810|NCT00322257|Insulin|insulin|mesh-list
139331811|NCT00322257|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139331812|NCT00322257|Insulin Aspart|insulin aspart|mesh-list
139331813|NCT00322257|Insulin Detemir|insulin detemir|mesh-list
139331814|NCT00322257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139331815|NCT00322257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331816|NCT00312975|Tremelimumab|tremelimumab|mesh-list
139331817|NCT00312975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331818|NCT03199820|Dinoprostone|dinoprostone|mesh-list
139331819|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
139331820|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139331821|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331822|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139331823|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
139331824|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331825|NCT03199430|Protective Agents|protective agents|mesh-ancestor
139331826|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331827|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139331828|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139331829|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331830|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139331831|NCT02287857|Tenofovir|tenofovir|mesh-list
139331832|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
139331833|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331834|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139331835|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139331836|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331837|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331838|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139331839|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139331840|NCT01318499|Nepafenac|nepafenac|mesh-list
139331841|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139331842|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139331843|NCT01318499|Analgesics|analgesics|mesh-ancestor
139331844|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
139331845|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988714|NCT06137924|Dexamethasone|dexamethasone|mesh-list
139331846|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139179172|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139331847|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139331848|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331849|NCT00397293|Topotecan|topotecan|mesh-list
139331850|NCT00397293|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139331851|NCT00397293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139331852|NCT00397293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331853|NCT00397293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331854|NCT00397293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331855|NCT03628079|Mebendazole|mebendazole|mesh-list
139331856|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
139331857|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
139331858|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139331859|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331860|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
139331861|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
139331862|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
139331863|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331864|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331865|NCT03204734|Capecitabine|capecitabine|mesh-list
139331866|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139331867|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
139331868|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331869|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331870|NCT00396357|Metformin|metformin|mesh-list
139331871|NCT00396357|Vildagliptin|vildagliptin|mesh-list
139331872|NCT00396357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139331873|NCT00396357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331874|NCT00396357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139331875|NCT00396357|Protease Inhibitors|protease inhibitors|mesh-ancestor
139331876|NCT00396357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331877|NCT00396357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331878|NCT00394563|Tanezumab|tanezumab|mesh-list
139331879|NCT00394563|Analgesics|analgesics|mesh-ancestor
139331880|NCT00394563|Sensory System Agents|sensory system agents|mesh-ancestor
139331881|NCT00394563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139331882|NCT00394563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331883|NCT02449538|Everolimus|everolimus|mesh-list
139331884|NCT02449538|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139331885|NCT02449538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139331886|NCT02449538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331887|NCT02449538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331888|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331889|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
139331890|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331891|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331892|NCT02446652|Paclitaxel|paclitaxel|mesh-list
139331893|NCT02446652|Carboplatin|carboplatin|mesh-list
139331894|NCT02446652|Hydralazine|hydralazine|mesh-list
139331895|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139331896|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331897|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
139331898|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
139331899|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
138914482|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
139331900|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331901|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139331902|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
139331903|NCT00299715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139331904|NCT00299715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139331905|NCT00299715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139331906|NCT00299715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139331907|NCT00299715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331908|NCT00299715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139331909|NCT00299715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139331910|NCT00299715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139331911|NCT00299715|Serotonin Agents|serotonin agents|mesh-ancestor
139331912|NCT00299715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139331913|NCT00299715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331914|NCT00299715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139331915|NCT00299715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139331916|NCT00299715|Dopamine Agents|dopamine agents|mesh-ancestor
139331917|NCT00299325|Rimonabant|rimonabant|mesh-list
139331918|NCT00299325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139331919|NCT00299325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
139331920|NCT00299325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139331922|NCT00299325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331923|NCT00299325|Hormones|hormones|mesh-ancestor
139331924|NCT00299325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139331925|NCT00299325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331926|NCT00391209|Insulin|insulin|mesh-list
139331927|NCT00391209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139331928|NCT00391209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139331929|NCT00391209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331930|NCT02446574|Paclitaxel|paclitaxel|mesh-list
139331931|NCT02446574|Cisplatin|cisplatin|mesh-list
139331932|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139331933|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331934|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
139331935|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
139331936|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
139331937|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331938|NCT01775813|Metformin|metformin|mesh-list
139331939|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139331940|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331941|NCT00287547|Abatacept|abatacept|mesh-list
139331942|NCT00287547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139331943|NCT00287547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331944|NCT00287547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139331945|NCT00287547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331946|NCT00287547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331947|NCT00287547|Immunologic Factors|immunologic factors|mesh-ancestor
139331948|NCT00287547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331949|NCT00287547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139331950|NCT03204578|Midazolam|midazolam|mesh-list
139331951|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139331952|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139331953|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139331954|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331955|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139331956|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139331957|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139331958|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139331959|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
139331960|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
139331961|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
139331962|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
139331963|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139331964|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331965|NCT01694069|Tazobactam|tazobactam|mesh-list
139331966|NCT01694069|Piperacillin|piperacillin|mesh-list
139331967|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139331968|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139331969|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331970|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139331971|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139331972|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331973|NCT03204032|Thalidomide|thalidomide|mesh-list
139331974|NCT03204032|Temozolomide|temozolomide|mesh-list
139331975|NCT03204032|Tegafur|tegafur|mesh-list
139331976|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139331977|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
139331978|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139331979|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139331980|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139331981|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
139331982|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139331983|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
139331984|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139331985|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139331986|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139331987|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139331988|NCT03204032|Growth Substances|growth substances|mesh-ancestor
139331989|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
139331990|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139331991|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
139331993|NCT02285751|Clopidogrel|clopidogrel|mesh-list
139331994|NCT02285751|Ticagrelor|ticagrelor|mesh-list
139331995|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139331996|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139331997|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139331998|NCT02285751|Analgesics|analgesics|mesh-ancestor
139331999|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
139332000|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332001|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332002|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139332003|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139332004|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139332005|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139332006|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332007|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139332008|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139332009|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332010|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
139332011|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139332012|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139332013|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139332014|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
139332015|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332016|NCT02446730|Clopidogrel|clopidogrel|mesh-list
138914513|NCT00851903|Incretins|incretins|mesh-ancestor
139332017|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139332018|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139332019|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139332020|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139332021|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
139332022|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332023|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332024|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332026|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332027|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
139332028|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
139332029|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
139332030|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332031|NCT03532035|Brincidofovir|brincidofovir|mesh-list
139332032|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
139332033|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332034|NCT00282867|Insulin|insulin|mesh-list
139332035|NCT00282867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139332036|NCT00282867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332037|NCT03198338|Bupivacaine|bupivacaine|mesh-list
139332038|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
139332039|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
139332040|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332041|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332042|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
139332043|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332044|NCT05222633|Ranibizumab|ranibizumab|mesh-list
139332045|NCT05222633|Aflibercept|aflibercept|mesh-list
139332046|NCT05222633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139332047|NCT05222633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139332048|NCT05222633|Growth Substances|growth substances|mesh-ancestor
139332049|NCT05222633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332050|NCT05222633|Growth Inhibitors|growth inhibitors|mesh-ancestor
139332051|NCT05222633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332052|NCT05222243|Calcium|calcium|mesh-list
139332053|NCT05222243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139332054|NCT05222243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332055|NCT04469283|Caffeine|caffeine|mesh-list
139332056|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139332057|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332058|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139332059|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332060|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332061|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139332062|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139332063|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
139332064|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332065|NCT02285829|Bromides|bromides|mesh-list
139332066|NCT02285829|Rocuronium|rocuronium|mesh-list
139332067|NCT02285829|Cisatracurium|cisatracurium|mesh-list
138988942|NCT06133881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332068|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
139332069|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139332070|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139332071|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139179257|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332072|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332073|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332074|NCT03203408|Hylan|hylan|mesh-list
139332075|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
139332076|NCT03203408|Protective Agents|protective agents|mesh-ancestor
139332077|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332078|NCT02285985|Saxagliptin|saxagliptin|mesh-list
139332079|NCT02285985|Incretins|incretins|mesh-ancestor
139332080|NCT02285985|Hormones|hormones|mesh-ancestor
139332081|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332082|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332083|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139332084|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
139332085|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332086|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332087|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139332088|NCT02445872|Dexamethasone|dexamethasone|mesh-list
139332089|NCT02445872|Aprepitant|aprepitant|mesh-list
139332090|NCT02445872|Palonosetron|palonosetron|mesh-list
139332091|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139332092|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
139332093|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
139332094|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332095|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332096|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139332097|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
139332098|NCT02445872|Hormones|hormones|mesh-ancestor
139332099|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332100|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139332101|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332102|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139332103|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332104|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332105|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139332106|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139332107|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
139332108|NCT05221775|Lenvatinib|lenvatinib|mesh-list
139332109|NCT05221775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332110|NCT05221775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139332111|NCT05221775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332112|NCT05221775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332113|NCT04700423|Ivermectin|ivermectin|mesh-list
139332114|NCT04700423|Albendazole|albendazole|mesh-list
139332115|NCT04700423|Moxidectin|moxidectin|mesh-list
139332116|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139332117|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332118|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
139332119|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
139332120|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139332121|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139332122|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
139332123|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
139332124|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
139332125|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332126|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332127|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
139332128|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
139332129|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
139332130|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
139332131|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332132|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
139332133|NCT02445716|Testosterone|testosterone|mesh-list
139332134|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
139332135|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
139332136|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139332137|NCT02445716|Androgens|androgens|mesh-ancestor
139332138|NCT02445716|Hormones|hormones|mesh-ancestor
139332139|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332140|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332141|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139179270|NCT01108289|Oxytocin|oxytocin|mesh-list
139332142|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332143|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
139332144|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
139332145|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139332146|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332147|NCT03197636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139332148|NCT03197636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332150|NCT05724381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139332151|NCT05724381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332152|NCT05724381|Disinfectants|disinfectants|mesh-ancestor
139332153|NCT05724381|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139332154|NCT05724381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139332155|NCT03194594|Dexamethasone|dexamethasone|mesh-list
139332156|NCT03194594|Ketamine|ketamine|mesh-list
139332157|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139332158|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
139332159|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
139332160|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332161|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332162|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139332163|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
139332164|NCT03194594|Hormones|hormones|mesh-ancestor
139332165|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332166|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139332167|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332168|NCT03194594|Analgesics|analgesics|mesh-ancestor
139332169|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
139332170|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139332171|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139332172|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
139332173|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
139332174|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332175|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139332176|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139332177|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332178|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332179|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
139332180|NCT04407377|Tolperisone|tolperisone|mesh-list
139332181|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139332182|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
139332183|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139332184|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139332185|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332186|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139332187|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332188|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139332189|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332190|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
139332191|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139332192|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139332193|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139332194|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139332195|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332196|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
139332197|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332198|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332199|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139332200|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332201|NCT00257205|Temozolomide|temozolomide|mesh-list
139332202|NCT00257205|Dacarbazine|dacarbazine|mesh-list
139332203|NCT00257205|Tremelimumab|tremelimumab|mesh-list
139332204|NCT00257205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139332205|NCT00257205|Alkylating Agents|alkylating agents|mesh-ancestor
139332206|NCT00257205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332207|NCT00257205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332208|NCT03194204|Doxycycline|doxycycline|mesh-list
139332209|NCT03194204|Uric Acid|uric acid|mesh-list
139332210|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
139332211|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139332212|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332213|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
139332214|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139332215|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139332216|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
139332217|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332218|NCT03194204|Protective Agents|protective agents|mesh-ancestor
138989097|NCT06078241|Lidocaine|lidocaine|mesh-list
139332219|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332220|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
139332221|NCT03197480|Aflibercept|aflibercept|mesh-list
139332222|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139332223|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139332224|NCT03197480|Growth Substances|growth substances|mesh-ancestor
139332225|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332226|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
139332227|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332228|NCT00151281|Thalidomide|thalidomide|mesh-list
139332229|NCT00151281|Prednisone|prednisone|mesh-list
139332230|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
139332231|NCT00151281|Rituximab|rituximab|mesh-list
139332232|NCT00151281|Etoposide|etoposide|mesh-list
139332233|NCT00151281|Procarbazine|procarbazine|mesh-list
139332234|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139332235|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
139332236|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332237|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139332238|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139332239|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
139332240|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332241|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332242|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139332243|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139332244|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139332245|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
139332246|NCT00151281|Hormones|hormones|mesh-ancestor
139332247|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332248|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139332249|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139332250|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139332251|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139332252|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332253|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
139332254|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139332255|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332256|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139332257|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139332258|NCT00151281|Growth Substances|growth substances|mesh-ancestor
139332259|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
139332260|NCT03202862|Fulvestrant|fulvestrant|mesh-list
139332261|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139332262|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332263|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139332264|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139332265|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
139332266|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332267|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332268|NCT00255099|Etravirine|etravirine|mesh-list
139332269|NCT00255099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139332270|NCT00255099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139332271|NCT00255099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332272|NCT00255099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332273|NCT00255099|Antiviral Agents|antiviral agents|mesh-ancestor
139332274|NCT00255099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332275|NCT00231153|Povidone-Iodine|povidone-iodine|mesh-list
139332276|NCT00231153|Povidone|povidone|mesh-list
139332277|NCT00231153|Plasma Substitutes|plasma substitutes|mesh-ancestor
139332278|NCT00231153|Blood Substitutes|blood substitutes|mesh-ancestor
138914552|NCT00851591|Psyllium|psyllium|mesh-list
139332279|NCT00231153|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139332280|NCT00231153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332281|NCT03202784|Berotralstat|berotralstat|mesh-list
139332282|NCT03202784|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139332283|NCT03202784|Protease Inhibitors|protease inhibitors|mesh-ancestor
139332284|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332285|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332286|NCT05220527|Triamcinolone|triamcinolone|mesh-list
139332287|NCT05220527|Hyaluronic Acid|hyaluronic acid|mesh-list
139332288|NCT05220527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139332289|NCT05220527|Glucocorticoids|glucocorticoids|mesh-ancestor
139332290|NCT05220527|Hormones|hormones|mesh-ancestor
139332291|NCT05220527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332292|NCT05220527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332293|NCT05220527|Immunologic Factors|immunologic factors|mesh-ancestor
139332294|NCT05220527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139332295|NCT05220527|Viscosupplements|viscosupplements|mesh-ancestor
139332296|NCT05220527|Protective Agents|protective agents|mesh-ancestor
139332297|NCT03197402|Caseins|caseins|mesh-list
139332298|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
139332299|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
139332300|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332301|NCT05723991|Gemcitabine|gemcitabine|mesh-list
139332302|NCT05723991|Disitamab vedotin|disitamab vedotin|mesh-list
139332303|NCT05723991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139332304|NCT05723991|Antimetabolites|antimetabolites|mesh-ancestor
139332305|NCT05723991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332306|NCT05723991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332307|NCT05723991|Immunoconjugates|immunoconjugates|mesh-ancestor
139332308|NCT05723991|Immunologic Factors|immunologic factors|mesh-ancestor
139332309|NCT05723991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332310|NCT01318109|Metformin|metformin|mesh-list
139332311|NCT01318109|Alogliptin|alogliptin|mesh-list
139332312|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139332313|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332314|NCT01318109|Incretins|incretins|mesh-ancestor
139332315|NCT01318109|Hormones|hormones|mesh-ancestor
139332316|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332317|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139332318|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
139332319|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332320|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332321|NCT05720871|Capsaicin|capsaicin|mesh-list
139332322|NCT05720871|Antipruritics|antipruritics|mesh-ancestor
139332323|NCT05720871|Dermatologic Agents|dermatologic agents|mesh-ancestor
139332324|NCT05720871|Sensory System Agents|sensory system agents|mesh-ancestor
139332325|NCT05720871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332326|NCT05720871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332327|NCT05636267|Carboplatin|carboplatin|mesh-list
139332328|NCT05636267|Pemetrexed|pemetrexed|mesh-list
139332329|NCT05636267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332330|NCT05636267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332331|NCT05636267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332332|NCT05636267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139332333|NCT05636267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139332334|NCT03873311|Cytarabine|cytarabine|mesh-list
139332335|NCT03873311|Azacitidine|azacitidine|mesh-list
139332336|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139332337|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
139332338|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332339|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332340|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
139332341|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332342|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139332343|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
139332344|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332345|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332346|NCT00162279|Abatacept|abatacept|mesh-list
139332347|NCT00162279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139332348|NCT00162279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332349|NCT00162279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139332350|NCT00162279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332351|NCT00162279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139332352|NCT00162279|Immunologic Factors|immunologic factors|mesh-ancestor
139332353|NCT00162279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332354|NCT00162279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139332355|NCT00145431|Atorvastatin|atorvastatin|mesh-list
139332356|NCT00145431|Torcetrapib|torcetrapib|mesh-list
139332357|NCT00145431|Fenofibrate|fenofibrate|mesh-list
139332358|NCT00145431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139332359|NCT00145431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139332360|NCT00145431|Antimetabolites|antimetabolites|mesh-ancestor
139332361|NCT00145431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332362|NCT00145431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139332363|NCT00145431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139332364|NCT00145431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332365|NCT00135369|Lamivudine|lamivudine|mesh-list
139332366|NCT00135369|Efavirenz|efavirenz|mesh-list
139332367|NCT00135369|Stavudine|stavudine|mesh-list
139332368|NCT00135369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139332369|NCT00135369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139332370|NCT00135369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332371|NCT00135369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332372|NCT00135369|Antiviral Agents|antiviral agents|mesh-ancestor
139332373|NCT00135369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332374|NCT00135369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139332375|NCT00135369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139332376|NCT00135369|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139332377|NCT00135369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139332378|NCT00135369|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139332379|NCT00135369|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139332380|NCT00135369|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139332381|NCT00135369|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139332382|NCT00135369|Antimetabolites|antimetabolites|mesh-ancestor
139332383|NCT03530319|Azithromycin|azithromycin|mesh-list
139332384|NCT03530319|Doxycycline|doxycycline|mesh-list
139332385|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139332386|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332387|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
139332388|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139332389|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139332390|NCT05726253|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139332391|NCT05726253|Amoxicillin|amoxicillin|mesh-list
139332392|NCT05726253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332393|NCT02445404|Dexamethasone|dexamethasone|mesh-list
139332394|NCT02445404|Prednisone|prednisone|mesh-list
139332395|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
139332396|NCT02445404|Ifosfamide|ifosfamide|mesh-list
139332397|NCT02445404|Carboplatin|carboplatin|mesh-list
139332398|NCT02445404|Etoposide|etoposide|mesh-list
139332399|NCT02445404|Vincristine|vincristine|mesh-list
139332400|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139332401|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
139332402|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332403|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139332404|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139332405|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
139332406|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332407|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332408|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139332409|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139332410|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
139332411|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
139179289|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139332412|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332413|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139332414|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
139332416|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332417|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139332418|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332419|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139332420|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139332421|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139332422|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
139332423|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
139332424|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
139332425|NCT05726175|Disitamab vedotin|disitamab vedotin|mesh-list
139332426|NCT05726175|Immunoconjugates|immunoconjugates|mesh-ancestor
139332427|NCT05726175|Immunologic Factors|immunologic factors|mesh-ancestor
139332428|NCT05726175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332429|NCT03530085|Fludarabine|fludarabine|mesh-list
139332430|NCT03530085|Busulfan|busulfan|mesh-list
139332431|NCT03530085|Decitabine|decitabine|mesh-list
139332432|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332433|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139332434|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
139332435|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332436|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139332437|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
139332438|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332439|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
139332440|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139332441|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139332442|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332443|NCT03196934|Cannabidiol|cannabidiol|mesh-list
139332444|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
139332445|NCT03197012|Octreotide|octreotide|mesh-list
139332446|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
139332447|NCT03197012|Edotreotide|edotreotide|mesh-list
139332448|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
139332449|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
139332450|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332451|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139332452|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139332453|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139332454|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332455|NCT03530007|Ondansetron|ondansetron|mesh-list
139332456|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
139332457|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
139332458|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332459|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332460|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139332461|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
139332462|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
139332463|NCT03530007|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139332464|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139332465|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
139332466|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332467|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332468|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
139332469|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139332470|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139332471|NCT03529929|Prednisolone|prednisolone|mesh-list
139332472|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
139332473|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139332474|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
139332475|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139332476|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
139332477|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
139332478|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332479|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332480|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139332481|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
139332482|NCT03529929|Hormones|hormones|mesh-ancestor
139332483|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332484|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139332485|NCT03529929|Protective Agents|protective agents|mesh-ancestor
139332486|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139332487|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332488|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
139332489|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139332490|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
139332491|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332492|NCT03525561|Acetazolamide|acetazolamide|mesh-list
139332493|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
139332494|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139332495|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332496|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332497|NCT03525561|Diuretics|diuretics|mesh-ancestor
139332498|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
139332499|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332500|NCT05696691|Ketamine|ketamine|mesh-list
139332501|NCT05696691|Analgesics|analgesics|mesh-ancestor
139332502|NCT05696691|Sensory System Agents|sensory system agents|mesh-ancestor
139332503|NCT05696691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332504|NCT05696691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332505|NCT05696691|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139332506|NCT05696691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139332507|NCT05696691|Anesthetics, General|anesthetics, general|mesh-ancestor
139332508|NCT05696691|Anesthetics|anesthetics|mesh-ancestor
139332509|NCT05696691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332510|NCT05696691|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139332511|NCT05696691|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139332512|NCT05696691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332513|NCT05696691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332514|NCT03527355|Vaccines|vaccines|mesh-list
139332515|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
139332516|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332517|NCT05707169|Lidocaine|lidocaine|mesh-list
139332518|NCT05707169|Epinephrine|epinephrine|mesh-list
138989395|NCT05884320|Immunologic Factors|immunologic factors|mesh-ancestor
138914596|NCT00766467|Modafinil|modafinil|mesh-list
139332519|NCT05707169|Racepinephrine|racepinephrine|mesh-list
139332520|NCT05707169|Levobupivacaine|levobupivacaine|mesh-list
139332521|NCT05707169|Epinephryl borate|epinephryl borate|mesh-list
139332522|NCT05707169|Anesthetics, Local|anesthetics, local|mesh-ancestor
139332524|NCT05707169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332525|NCT05707169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332526|NCT05707169|Sensory System Agents|sensory system agents|mesh-ancestor
139332527|NCT05707169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332528|NCT05707169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139332529|NCT05707169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139332530|NCT05707169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139332531|NCT05707169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139332532|NCT05707169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332533|NCT05707169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139332534|NCT05707169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139332535|NCT05707169|Adrenergic Agents|adrenergic agents|mesh-ancestor
139332536|NCT05707169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332537|NCT05707169|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139332538|NCT05707169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139332539|NCT05707169|Autonomic Agents|autonomic agents|mesh-ancestor
139332540|NCT05707169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139332541|NCT05707169|Respiratory System Agents|respiratory system agents|mesh-ancestor
139332542|NCT05707169|Mydriatics|mydriatics|mesh-ancestor
139332543|NCT05707169|Sympathomimetics|sympathomimetics|mesh-ancestor
139332544|NCT05707169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139332545|NCT02712008|Aflibercept|aflibercept|mesh-list
139332546|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139332547|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139332548|NCT02712008|Growth Substances|growth substances|mesh-ancestor
139332549|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332550|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
139332551|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332552|NCT05130515|Niraparib|niraparib|mesh-list
139332553|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139332554|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332555|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332556|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332557|NCT02450084|Fentanyl|fentanyl|mesh-list
139332558|NCT02450084|Ropivacaine|ropivacaine|mesh-list
139332559|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
139332560|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
139332561|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332562|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332563|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
139332564|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914620|NCT00844805|Analgesics|analgesics|mesh-ancestor
139332565|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139332566|NCT02450084|Narcotics|narcotics|mesh-ancestor
139332567|NCT02450084|Analgesics|analgesics|mesh-ancestor
139332568|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139332569|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139332570|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
139332571|NCT03201770|Artesunate|artesunate|mesh-list
139332572|NCT03201770|Pyronaridine|pyronaridine|mesh-list
139332573|NCT03201770|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139332574|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
139332575|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139332576|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139332577|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332578|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332579|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
139332580|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
139332581|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139332582|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
139332583|NCT04188405|Decitabine|decitabine|mesh-list
139332584|NCT04188405|Venetoclax|venetoclax|mesh-list
139332585|NCT04188405|Ponatinib|ponatinib|mesh-list
139332586|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139332587|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
139332588|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332589|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332590|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332591|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139332592|NCT04176393|Ivosidenib|ivosidenib|mesh-list
139332593|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332594|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332595|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332596|NCT02449070|Nicorandil|nicorandil|mesh-list
139332597|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139332598|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139332599|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
139332600|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
139332601|NCT02449070|Vitamins|vitamins|mesh-ancestor
139332602|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
139332603|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332604|NCT03529149|Diltiazem|diltiazem|mesh-list
139332605|NCT03529149|Urapidil|urapidil|mesh-list
139332606|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139332607|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139332608|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139332609|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332610|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139332611|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332612|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
139332613|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139332614|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
139332615|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332616|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139332617|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139332618|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139332619|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
139332620|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
139332621|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139332622|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
139332623|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139332624|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
139332625|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914648|NCT00764751|Calcipotriene|calcipotriene|mesh-list
139332626|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332627|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
139332628|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
139332629|NCT02711306|Cathartics|cathartics|mesh-ancestor
139332630|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139332631|NCT03193112|Agomelatine|agomelatine|mesh-list
139332632|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139332633|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332634|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332636|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139332637|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332638|NCT03193424|Docetaxel|docetaxel|mesh-list
139332639|NCT03193424|Apatinib|apatinib|mesh-list
139332640|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332641|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
139332642|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
139332643|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
139332644|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332645|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139332646|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332647|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
139332648|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139332649|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139332650|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139332651|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139332652|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332653|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
139332654|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332655|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332656|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139332657|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332658|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
139332659|NCT03118076|Ropivacaine|ropivacaine|mesh-list
139332660|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139332661|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332662|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332663|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139332664|NCT03118076|Analgesics|analgesics|mesh-ancestor
139332665|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
139332666|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332667|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139332668|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139332669|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139332670|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
139332671|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332672|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332673|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
139332675|NCT03528915|Rifamycins|rifamycins|mesh-list
139332676|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
139332677|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139332678|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332679|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139332680|NCT03192878|Infliximab|infliximab|mesh-list
139332681|NCT03192878|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139332682|NCT03192878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139332683|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
139332684|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139332685|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139332687|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139332688|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
139332689|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332690|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332691|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
139332692|NCT03526575|Zaleplon|zaleplon|mesh-list
139332693|NCT03526575|Zolpidem|zolpidem|mesh-list
139332694|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139332695|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139332696|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332697|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332698|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139332699|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
139332700|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
139332701|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332702|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332703|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
139332704|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
139332705|NCT00189254|Imiquimod|imiquimod|mesh-list
139332706|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139332707|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
139332708|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332709|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332710|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
139332711|NCT03526419|Bupivacaine|bupivacaine|mesh-list
139332712|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
139332713|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
139332714|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332715|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332716|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
139332717|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332718|NCT03192644|Leucovorin|leucovorin|mesh-list
139332719|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
139332720|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
139332721|NCT03192644|Epirubicin|epirubicin|mesh-list
139332722|NCT03192644|Calcium|calcium|mesh-list
139332723|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
139332724|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332725|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139332726|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332727|NCT03192644|Antidotes|antidotes|mesh-ancestor
139332728|NCT03192644|Protective Agents|protective agents|mesh-ancestor
139332729|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
139332730|NCT03192644|Vitamins|vitamins|mesh-ancestor
139332731|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
139332732|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139332733|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139332734|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139332735|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332736|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332737|NCT03110055|Grazoprevir|grazoprevir|mesh-list
139332738|NCT03110055|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139332739|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
139332740|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332741|NCT01190852|Fluticasone|fluticasone|mesh-list
139332742|NCT01190852|Azelastine|azelastine|mesh-list
139332743|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139332744|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139332745|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
138989621|NCT05700903|Fertility Agents|fertility agents|mesh-ancestor
139179411|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139332746|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332747|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332748|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139332749|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
139332750|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
139332751|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139332752|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139332753|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332754|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332755|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139332756|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139332757|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
139332758|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
139332759|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332760|NCT02710214|Estrogens|estrogens|mesh-list
139332761|NCT02710214|Hormones|hormones|mesh-ancestor
139332762|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332763|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332764|NCT05561205|Methylphenidate|methylphenidate|mesh-list
139332765|NCT05561205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139332766|NCT05561205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332767|NCT05561205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139332768|NCT05561205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139332769|NCT05561205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139332770|NCT05561205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332771|NCT05561205|Dopamine Agents|dopamine agents|mesh-ancestor
139332772|NCT05561205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332773|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
139332774|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
139332775|NCT03052517|Growth Substances|growth substances|mesh-ancestor
139332776|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332777|NCT02443844|Tamsulosin|tamsulosin|mesh-list
139332778|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139332779|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139332780|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139332781|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
139332782|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332783|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332784|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332785|NCT02443844|Urological Agents|urological agents|mesh-ancestor
139332786|NCT02440100|Midazolam|midazolam|mesh-list
138914704|NCT00763035|Dobutamine|dobutamine|mesh-list
139332787|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139332788|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139332789|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332790|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332791|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139332792|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139332793|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139332794|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139332795|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
139332796|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
139332797|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
139332798|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
139332799|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332800|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332801|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
139332802|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
139332803|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332804|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
139332805|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332806|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332807|NCT02439944|Nicotine|nicotine|mesh-list
139332808|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139332809|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
139332810|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332811|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332812|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139332813|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139332814|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
139332815|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332816|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332817|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
139332818|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332819|NCT03190616|Apatinib|apatinib|mesh-list
139332820|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332821|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139332822|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332823|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989699|NCT05615974|Rituximab|rituximab|mesh-list
139332824|NCT02443922|Metformin|metformin|mesh-list
139332825|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139332826|NCT02443922|Glimepiride|glimepiride|mesh-list
139332827|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139332828|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332829|NCT02443922|Incretins|incretins|mesh-ancestor
139332830|NCT02443922|Hormones|hormones|mesh-ancestor
139332831|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332832|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139332833|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
139332834|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332835|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332836|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139332837|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139332838|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
139332839|NCT04799847|Catumaxomab|catumaxomab|mesh-list
139332840|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139332841|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
139332842|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139332843|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139332844|NCT02439866|Prednisolone|prednisolone|mesh-list
139332845|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
139332846|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139332847|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
139332848|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139332849|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
139332850|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
139332851|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332852|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332853|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139332854|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
139332855|NCT02439866|Hormones|hormones|mesh-ancestor
139332856|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332857|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139332858|NCT02439866|Protective Agents|protective agents|mesh-ancestor
139332859|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139332860|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332861|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
139332862|NCT02439788|Fludarabine|fludarabine|mesh-list
139332863|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139332864|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
139332865|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332866|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139332867|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139332868|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
139332869|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332870|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332871|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139332872|NCT03188198|Prednisone|prednisone|mesh-list
139332873|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
139332874|NCT03188198|Rituximab|rituximab|mesh-list
139332875|NCT03188198|Doxorubicin|doxorubicin|mesh-list
139332876|NCT03188198|Etoposide|etoposide|mesh-list
139332877|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
139332878|NCT03188198|Vincristine|vincristine|mesh-list
139332879|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139332880|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
139332881|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332882|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139332883|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139332884|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
139332885|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332886|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332887|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139332888|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139332889|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139332890|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139332891|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139332892|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332893|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139332894|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
139332895|NCT03188198|Hormones|hormones|mesh-ancestor
139332896|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332897|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139332898|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139332899|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
139332901|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
139332902|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
139332903|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139332904|NCT03188276|Ledipasvir|ledipasvir|mesh-list
139332905|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
139332906|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332907|NCT03190304|Enalapril|enalapril|mesh-list
139332908|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139332909|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139332910|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
139332911|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332912|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139332913|NCT02439632|Levofloxacin|levofloxacin|mesh-list
139332914|NCT02439632|Ofloxacin|ofloxacin|mesh-list
139332915|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
139332916|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
139332917|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139332918|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332919|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139332920|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139332921|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139332922|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332923|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332924|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332925|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139332926|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139332927|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139332928|NCT02443064|Vancomycin|vancomycin|mesh-list
139332929|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139332930|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139332931|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
139332932|NCT02741271|Prednisone|prednisone|mesh-list
139332933|NCT02741271|Prednisolone|prednisolone|mesh-list
139332934|NCT02741271|Albuterol|albuterol|mesh-list
139332935|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139332936|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
139332937|NCT02741271|Hormones|hormones|mesh-ancestor
139332938|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139332939|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332940|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139332941|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139332942|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
139332943|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332944|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139332945|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139332946|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
139332947|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
139332948|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139332949|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139332950|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139332951|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139332952|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
139332953|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139332954|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332955|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
139332956|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139332957|NCT02443142|Acetaminophen|acetaminophen|mesh-list
139332958|NCT02443142|Ibuprofen|ibuprofen|mesh-list
139332959|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139332960|NCT02443142|Analgesics|analgesics|mesh-ancestor
139332961|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
139332962|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332963|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332964|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
139332965|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139332966|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139332967|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139332968|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139332969|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332970|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332971|NCT03524079|Ajmaline|ajmaline|mesh-list
139332972|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139332973|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139332974|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139332975|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139332976|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332978|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
139332979|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
139332980|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139332981|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332982|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
139332983|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139332984|NCT02442674|Tolvaptan|tolvaptan|mesh-list
139332985|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139332986|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332987|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
139332988|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139332989|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
139332990|NCT02442752|Lansoprazole|lansoprazole|mesh-list
139332991|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139332992|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139332993|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139332994|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139332995|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139332996|NCT02442362|Paclitaxel|paclitaxel|mesh-list
139332997|NCT02442362|Fluorouracil|fluorouracil|mesh-list
139332998|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
139332999|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139333000|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333001|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
139333002|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
139333003|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
139333004|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333005|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
139333006|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139333007|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139333008|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
139333009|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333010|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
139333011|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139333012|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333013|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333014|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139333015|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139333016|NCT02433860|Nicotine|nicotine|mesh-list
139333017|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139333018|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
139333019|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333020|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333021|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139333022|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139333023|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
139333024|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333025|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333026|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
139333027|NCT03523455|Hematinics|hematinics|mesh-ancestor
139333028|NCT03189836|Rituximab|rituximab|mesh-list
139333029|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139333030|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333031|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
139333032|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333033|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139333034|NCT04466943|Rocuronium|rocuronium|mesh-list
139333035|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139333036|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139333037|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139333038|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333039|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333040|NCT03212469|Durvalumab|durvalumab|mesh-list
139333041|NCT03212469|Tremelimumab|tremelimumab|mesh-list
139333042|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139333043|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333044|NCT02442440|Anisodamine|anisodamine|mesh-list
139333045|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139333046|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139333047|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
139333048|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333049|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333051|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139333052|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139333053|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139333054|NCT02442440|Analgesics|analgesics|mesh-ancestor
139333055|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
139333056|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333058|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139333059|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139333060|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139333061|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
139333062|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
139333063|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
139333064|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139333065|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
139333066|NCT02442440|Protective Agents|protective agents|mesh-ancestor
139333067|NCT03187496|Midazolam|midazolam|mesh-list
139333068|NCT03187496|Caffeine|caffeine|mesh-list
139333069|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139333070|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139333071|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139333072|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333073|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333074|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139333075|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139333076|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139333077|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139333078|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
139333079|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
139333080|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
139333081|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
138914802|NCT00842153|Clobetasol|clobetasol|mesh-list
139333082|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333083|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333084|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139333085|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139333086|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
139333087|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139333088|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139333089|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333090|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139333091|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139333092|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139333093|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139333094|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
139333095|NCT02438072|Fexofenadine|fexofenadine|mesh-list
139333096|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
139333097|NCT02438072|Midazolam|midazolam|mesh-list
139333098|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
139333099|NCT02438072|Caffeine|caffeine|mesh-list
139333100|NCT02438072|Bupropion|bupropion|mesh-list
139333101|NCT02438072|Omeprazole|omeprazole|mesh-list
139333102|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139333103|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139333104|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333105|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333106|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139333107|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139333108|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139333109|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139333110|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
139333111|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
139333112|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
139333113|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
139333114|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333115|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333116|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139333117|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139333118|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333119|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139333120|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139333121|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
139333122|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139333123|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139179490|NCT01295047|Atenolol|atenolol|mesh-list
139333124|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139333125|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139333126|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
139333127|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139333128|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139333129|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139333130|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
139333131|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139333132|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139333133|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
139333134|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
139333135|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139333136|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139333137|NCT02438072|Analgesics|analgesics|mesh-ancestor
139333138|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
139333139|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333140|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139333141|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139333142|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139333143|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139333144|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139333145|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139333146|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139333147|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139333148|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
139333149|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
139333150|NCT03522987|Escitalopram|escitalopram|mesh-list
139333151|NCT03522987|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139333152|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139333153|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139333154|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333155|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333156|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
139333157|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333158|NCT02433626|Cisplatin|cisplatin|mesh-list
139333159|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333160|NCT02442128|Fentanyl|fentanyl|mesh-list
139333161|NCT02442128|Propofol|propofol|mesh-list
139333162|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139333163|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333164|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333165|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139333166|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
139333167|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
139333168|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139333169|NCT02442128|Narcotics|narcotics|mesh-ancestor
139333170|NCT02442128|Analgesics|analgesics|mesh-ancestor
139333171|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
139333172|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333173|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139333174|NCT04465773|Remifentanil|remifentanil|mesh-list
139333175|NCT04465773|Propofol|propofol|mesh-list
139333176|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
139333177|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333178|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333179|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139333180|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139333181|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
139333182|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139333183|NCT04465773|Narcotics|narcotics|mesh-ancestor
139333184|NCT04465773|Analgesics|analgesics|mesh-ancestor
139333185|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
139333186|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333187|NCT02709746|Vortioxetine|vortioxetine|mesh-list
139333188|NCT02709746|Fluoxetine|fluoxetine|mesh-list
139333189|NCT02709746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139333190|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139333191|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139333192|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333193|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333194|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
139333195|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333196|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139333197|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
139333198|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139333199|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139333200|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139333201|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333202|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139333203|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139333204|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333205|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139333206|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139333207|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139333208|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139333209|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
139333210|NCT02441894|Promethazine|promethazine|mesh-list
139333211|NCT02441894|Dexamethasone|dexamethasone|mesh-list
139333212|NCT02441894|Prednisolone|prednisolone|mesh-list
139333213|NCT02441894|Ondansetron|ondansetron|mesh-list
139333214|NCT02441894|Metoclopramide|metoclopramide|mesh-list
138914812|NCT00841763|Vaccines|vaccines|mesh-list
139333215|NCT02441894|Granisetron|granisetron|mesh-list
139333216|NCT02441894|Ranitidine|ranitidine|mesh-list
139333217|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
139333218|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139333219|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
139333220|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
139333221|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333222|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333223|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139333224|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
139333225|NCT02441894|Hormones|hormones|mesh-ancestor
139333226|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139333227|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139333228|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333229|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
139333230|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
139333231|NCT02441894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139333232|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139333233|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
139333234|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333235|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333236|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139333237|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139333238|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333239|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
139333240|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
139333241|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
139333242|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139333243|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
139333244|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
139333245|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139333246|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139333247|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139333248|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
139333249|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139333250|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139333251|NCT02433704|Cefazolin|cefazolin|mesh-list
139333252|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139333253|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333254|NCT05453825|Paclitaxel|paclitaxel|mesh-list
139333255|NCT05453825|Irinotecan|irinotecan|mesh-list
139333256|NCT05453825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139333257|NCT05453825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333258|NCT05453825|Tubulin Modulators|tubulin modulators|mesh-ancestor
139333259|NCT05453825|Antimitotic Agents|antimitotic agents|mesh-ancestor
139333260|NCT05453825|Mitosis Modulators|mitosis modulators|mesh-ancestor
139333261|NCT05453825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333262|NCT05453825|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139333263|NCT05453825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139333264|NCT05453825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333265|NCT02441816|Aflibercept|aflibercept|mesh-list
139333266|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139333267|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139333268|NCT02441816|Growth Substances|growth substances|mesh-ancestor
139333269|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333270|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
139333271|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333272|NCT02433314|Brexanolone|brexanolone|mesh-list
139333273|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
139333274|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333275|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333276|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333277|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
139333278|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
139333279|NCT02290431|Dexamethasone|dexamethasone|mesh-list
139333280|NCT02290431|Bortezomib|bortezomib|mesh-list
139333281|NCT02290431|Panobinostat|panobinostat|mesh-list
139333282|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139333283|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
139333284|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
139333285|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333286|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333287|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139333288|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
139333289|NCT02290431|Hormones|hormones|mesh-ancestor
139333290|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139333291|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139333292|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333293|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139333294|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333295|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333296|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
139333297|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139333298|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
139333299|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333300|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139333301|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139333302|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
139333303|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333304|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333305|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139333306|NCT02436980|Midazolam|midazolam|mesh-list
139333307|NCT02436980|Tramadol|tramadol|mesh-list
139333308|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139333309|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139333310|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333311|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333312|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139333313|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139333314|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139333315|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139333316|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
139333317|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
139333318|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
139333319|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
139333320|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139179512|NCT03472846|Teriparatide|teriparatide|mesh-list
139333321|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333322|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139333323|NCT02436980|Narcotics|narcotics|mesh-ancestor
139333324|NCT02436980|Analgesics|analgesics|mesh-ancestor
139333325|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
139333326|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333327|NCT02436902|Sorafenib|sorafenib|mesh-list
139333328|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
139333329|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333330|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139333331|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333332|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333333|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139333334|NCT02436902|Estrogens|estrogens|mesh-ancestor
139333335|NCT02436902|Hormones|hormones|mesh-ancestor
139333336|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139333337|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333338|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139333339|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
139333340|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139333341|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
139333342|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333343|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333344|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139333345|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
139333346|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139333347|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
139333348|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333349|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333350|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139333351|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
139333352|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
139333353|NCT02436512|Protective Agents|protective agents|mesh-ancestor
139333355|NCT04466241|Lopinavir|lopinavir|mesh-list
139333356|NCT04466241|Telmisartan|telmisartan|mesh-list
139333357|NCT04466241|Atorvastatin|atorvastatin|mesh-list
139333358|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139333359|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139333360|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
139333361|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333362|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139333363|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139333364|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333365|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139333366|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139333367|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
139333368|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139333369|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139333370|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
139333371|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333372|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139333373|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139333374|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139333375|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139333376|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139333377|NCT02440880|Dexamethasone|dexamethasone|mesh-list
139333378|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
139333379|NCT02440880|BB 1101|bb 1101|mesh-list
139333380|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139333381|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
139333382|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
139333383|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333384|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333385|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139333386|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
139333387|NCT02440880|Hormones|hormones|mesh-ancestor
139333388|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139333389|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139333390|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333391|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
139333392|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333393|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333394|NCT03186482|Rifampin|rifampin|mesh-list
139333395|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139333396|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139333397|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
139333398|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139333399|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333400|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
139333401|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139333402|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333403|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333404|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139333405|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139333406|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139333407|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139333408|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139333409|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139333410|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
139333411|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139333412|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139333413|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139333414|NCT03522207|Trazodone|trazodone|mesh-list
139333415|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139333416|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139333417|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333418|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333419|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139333420|NCT03522207|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139333421|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139333422|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139333423|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333424|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333425|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
139333426|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139333427|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
139333428|NCT03528057|Hemostatics|hemostatics|mesh-list
139333429|NCT03528057|Coagulants|coagulants|mesh-ancestor
139333430|NCT02707952|Ritonavir|ritonavir|mesh-list
139333431|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139333432|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139333433|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
139333434|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333435|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333436|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139333437|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139333438|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
139333439|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333440|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139333441|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139333442|NCT02291211|Cisplatin|cisplatin|mesh-list
139333443|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333444|NCT05392101|Deferasirox|deferasirox|mesh-list
139333445|NCT05392101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139333446|NCT05392101|Chelating Agents|chelating agents|mesh-ancestor
139333447|NCT05392101|Sequestering Agents|sequestering agents|mesh-ancestor
139333448|NCT05392101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333449|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139333450|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139333451|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139333452|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139333453|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333454|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333455|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333456|NCT02291367|Analgesics|analgesics|mesh-ancestor
139333457|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
139333458|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333459|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
139333460|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139333461|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
139333462|NCT02440958|Folfirinox|folfirinox|mesh-list
139333463|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333464|NCT02432534|Atorvastatin|atorvastatin|mesh-list
139333465|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139333466|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139333467|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
139333468|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333469|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139333470|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139333471|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333472|NCT02432612|Nabiximols|nabiximols|mesh-list
139333473|NCT02432612|Analgesics|analgesics|mesh-ancestor
139333474|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
139333475|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333476|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333477|NCT05705843|Vancomycin|vancomycin|mesh-list
139333478|NCT05705843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139333479|NCT05705843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333480|NCT02436044|Leucovorin|leucovorin|mesh-list
139333481|NCT02436044|Fluorouracil|fluorouracil|mesh-list
139333482|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
139333483|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
139333484|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
139333485|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333486|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139333487|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333488|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139333489|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
139333490|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333491|NCT02436044|Antidotes|antidotes|mesh-ancestor
139333492|NCT02436044|Protective Agents|protective agents|mesh-ancestor
139333493|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
139333494|NCT02436044|Vitamins|vitamins|mesh-ancestor
139333495|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
139333496|NCT02435732|Heparin|heparin|mesh-list
139333497|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
139333498|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139333499|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139333500|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333502|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
139333503|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
139333504|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333505|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333506|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139333507|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139333508|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139333509|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333510|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139333511|NCT02435654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139333512|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139333513|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139333514|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333515|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333516|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
139333517|NCT05571527|Hyaluronic Acid|hyaluronic acid|mesh-list
139333518|NCT05571527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139333519|NCT05571527|Immunologic Factors|immunologic factors|mesh-ancestor
139333520|NCT05571527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333521|NCT05571527|Viscosupplements|viscosupplements|mesh-ancestor
139333522|NCT05571527|Protective Agents|protective agents|mesh-ancestor
139333523|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
139333524|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139333525|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139333526|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
139333527|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333528|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333529|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333530|NCT05233514|Metformin|metformin|mesh-list
139333531|NCT05233514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139333532|NCT05233514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333533|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139333534|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139333535|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333536|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139333537|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333538|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333539|NCT02435186|Paclitaxel|paclitaxel|mesh-list
139333540|NCT02435186|Cisplatin|cisplatin|mesh-list
139333541|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139333542|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333543|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
139333544|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
139333545|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
139333546|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333547|NCT02435108|Crizotinib|crizotinib|mesh-list
139333548|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333549|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139333550|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333551|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333552|NCT02434952|Piperaquine|piperaquine|mesh-list
139333553|NCT02434952|Primaquine|primaquine|mesh-list
139333554|NCT02434952|Artenimol|artenimol|mesh-list
139333555|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
139333556|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139333557|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139333558|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333559|NCT03626753|Acetaminophen|acetaminophen|mesh-list
139333560|NCT03626753|Piroxicam|piroxicam|mesh-list
139333561|NCT03626753|Nefopam|nefopam|mesh-list
139333562|NCT03626753|Proroxan|proroxan|mesh-list
139333563|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139333564|NCT03626753|Analgesics|analgesics|mesh-ancestor
139333565|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
139333566|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333567|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333568|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
139333569|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139333570|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139333571|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139333572|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139333573|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333574|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333575|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139333576|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139333577|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
139333578|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333579|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139333580|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
139333581|NCT02440256|Narcotics|narcotics|mesh-ancestor
139333582|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333583|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333584|NCT02440256|Analgesics|analgesics|mesh-ancestor
139333585|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
139333586|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333587|NCT03185624|Rifaximin|rifaximin|mesh-list
139333588|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139333589|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333590|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139333591|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
139333592|NCT02707640|Pirfenidone|pirfenidone|mesh-list
139333593|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139333594|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
139333595|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333596|NCT02707640|Expectorants|expectorants|mesh-ancestor
139333597|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
139333598|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139333599|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
139333600|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333601|NCT02707640|Protective Agents|protective agents|mesh-ancestor
139333602|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333603|NCT02707640|Antidotes|antidotes|mesh-ancestor
139333604|NCT02707640|Analgesics|analgesics|mesh-ancestor
139333605|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
139333606|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333607|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139333608|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139333609|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139333610|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139333611|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333612|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
139333613|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139333614|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333615|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139333616|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333617|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
139333618|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139333619|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139333620|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139333621|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
139333622|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333623|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333624|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333625|NCT03188978|Atorvastatin|atorvastatin|mesh-list
139333626|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139333627|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139333628|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
139333629|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333630|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139333631|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139333632|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333633|NCT02431286|Dexamethasone|dexamethasone|mesh-list
139333634|NCT02431286|Aprepitant|aprepitant|mesh-list
139333635|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139333636|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
139333637|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
139333638|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333639|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333640|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139333641|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
139333642|NCT02431286|Hormones|hormones|mesh-ancestor
139333643|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139333644|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139333645|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333646|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139333647|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138990524|NCT04716933|Pemetrexed|pemetrexed|mesh-list
139333648|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333649|NCT02431208|Dexamethasone|dexamethasone|mesh-list
139333650|NCT02431208|Lenalidomide|lenalidomide|mesh-list
139333651|NCT02431208|Atezolizumab|atezolizumab|mesh-list
139333652|NCT02431208|Daratumumab|daratumumab|mesh-list
139333653|NCT02431208|Pomalidomide|pomalidomide|mesh-list
139333654|NCT02431208|Antibodies|antibodies|mesh-list
139333655|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139333656|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
139333657|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333658|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139333659|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
139333660|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
139333661|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333662|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139333663|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
139333664|NCT02431208|Hormones|hormones|mesh-ancestor
139333665|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139333666|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139333667|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333668|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139333669|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139333670|NCT02431208|Growth Substances|growth substances|mesh-ancestor
139333671|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
139333672|NCT02431208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139333673|NCT02431208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333674|NCT02431208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139333675|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
139333676|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
139333677|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139333678|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
139333679|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
139333680|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333681|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333682|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139333683|NCT03107078|Hormones|hormones|mesh-ancestor
138914929|NCT00859469|Gemcitabine|gemcitabine|mesh-list
139333684|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139333685|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139333686|NCT03107078|Protective Agents|protective agents|mesh-ancestor
139333687|NCT02430350|Edaravone|edaravone|mesh-list
139333688|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139333689|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
139333690|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333691|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139333692|NCT02430350|Protective Agents|protective agents|mesh-ancestor
139333693|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333694|NCT02429960|Remifentanil|remifentanil|mesh-list
139333695|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139333696|NCT02429960|Narcotics|narcotics|mesh-ancestor
139333697|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333698|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333699|NCT02429960|Analgesics|analgesics|mesh-ancestor
139333700|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
139333701|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333702|NCT02429804|Listerine|listerine|mesh-list
139333703|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
139333704|NCT02429804|Fluorides|fluorides|mesh-list
139333705|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
139333706|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139333707|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
139333708|NCT02429804|Protective Agents|protective agents|mesh-ancestor
139333709|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333710|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139333711|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333712|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139333713|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333714|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
139333715|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
139333716|NCT03185156|Propofol|propofol|mesh-list
139333717|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139333718|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333719|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333720|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139333721|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
138990600|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333722|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
139333723|NCT02429726|Cisplatin|cisplatin|mesh-list
139333724|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333725|NCT02429882|Brodalumab|brodalumab|mesh-list
139333726|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
139333727|NCT02430896|Methylphenidate|methylphenidate|mesh-list
139333728|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139333729|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139333730|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333731|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139333732|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138914962|NCT00859313|Sufentanil|sufentanil|mesh-list
139333733|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139333734|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333735|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
139333736|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333737|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139333738|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
139333739|NCT03184844|Thalidomide|thalidomide|mesh-list
139333740|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139333741|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
139333742|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333743|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
139333744|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139333745|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333746|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139333747|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139333748|NCT03184844|Growth Substances|growth substances|mesh-ancestor
139333749|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
139333750|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333751|NCT02425202|Ketamine|ketamine|mesh-list
139333752|NCT02425202|Analgesics|analgesics|mesh-ancestor
139333753|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
139333754|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333755|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333756|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139333757|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139333758|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
139333759|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
139333760|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333761|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139333762|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139333763|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333764|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333765|NCT03182504|Meropenem|meropenem|mesh-list
139333766|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139333767|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333768|NCT02428946|Bromocriptine|bromocriptine|mesh-list
139333769|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139333770|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139333771|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
139333772|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139333773|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333774|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
139333775|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
139333776|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333777|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333778|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
139333779|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139333780|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139333781|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333782|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
139333783|NCT02428868|Coagulants|coagulants|mesh-ancestor
139333784|NCT03181880|Bromides|bromides|mesh-list
139333785|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
139333786|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139333787|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
139333788|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333789|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333790|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139333791|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
139333792|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139333793|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139333794|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139333795|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
139333796|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333797|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333798|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
139333799|NCT03178994|Ketoconazole|ketoconazole|mesh-list
139333800|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
139333801|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333802|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139333803|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139333804|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333805|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333806|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139333807|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
139333808|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139333809|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333810|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139333811|NCT03182114|Bupivacaine|bupivacaine|mesh-list
139333812|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
139333813|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
139333814|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333815|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333816|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
139333817|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333819|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
139333820|NCT02428322|Vitamins|vitamins|mesh-ancestor
139333821|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
139333822|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333823|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139333824|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139333825|NCT03053063|Selonsertib|selonsertib|mesh-list
139333826|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139333827|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333828|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333829|NCT00702338|Hormones|hormones|mesh-list
139333830|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139333831|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139333832|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333833|NCT02427932|Gentamicins|gentamicins|mesh-list
139333834|NCT02427932|Ampicillin|ampicillin|mesh-list
139333835|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139333836|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333837|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139333838|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333839|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333840|NCT03626519|Menthol|menthol|mesh-list
139333841|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
139333842|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
139333843|NCT03184766|Ibuprofen|ibuprofen|mesh-list
139333844|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
139333845|NCT03184766|Ephedrine|ephedrine|mesh-list
139333846|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139333847|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139333848|NCT03184766|Analgesics|analgesics|mesh-ancestor
139333849|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
139333850|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333851|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333852|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139333853|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139333854|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139333855|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333856|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333857|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139333858|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
139333859|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139333860|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
139333861|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
139333862|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139333863|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139333864|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
139333865|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
139333866|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333867|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139333868|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
139333869|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139333870|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139333871|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139333872|NCT02420834|Laxatives|laxatives|mesh-ancestor
139333873|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139333874|NCT02423954|Sirolimus|sirolimus|mesh-list
139333875|NCT02423954|Capecitabine|capecitabine|mesh-list
139333876|NCT02423954|Nivolumab|nivolumab|mesh-list
139333877|NCT02423954|Irinotecan|irinotecan|mesh-list
139333878|NCT02423954|Temsirolimus|temsirolimus|mesh-list
139333879|NCT02423954|MTOR Inhibitors|mtor inhibitors|mesh-list
139333880|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139333881|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
139333882|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333883|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333884|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139333885|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139333886|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139333887|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139333888|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333889|NCT02423954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139333890|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139333891|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
139333892|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333893|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139333894|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333895|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139333896|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
139333897|NCT04221503|Niraparib|niraparib|mesh-list
139333898|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139333899|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333900|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333901|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333902|NCT02427308|Miltefosine|miltefosine|mesh-list
139333903|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
139333904|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333905|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333906|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139333907|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139333908|NCT03178292|Levofloxacin|levofloxacin|mesh-list
139333909|NCT03178292|Ofloxacin|ofloxacin|mesh-list
139333910|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139333911|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333912|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139333913|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139333914|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139333915|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333916|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333917|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333918|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139333919|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139333920|NCT02427386|Estradiol|estradiol|mesh-list
139333921|NCT02427386|Estrogens|estrogens|mesh-list
139333922|NCT02427386|Hormones|hormones|mesh-ancestor
139333923|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139333924|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333925|NCT03181178|Micronutrients|micronutrients|mesh-list
139333926|NCT03181178|Trace Elements|trace elements|mesh-list
139333927|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333928|NCT05478551|Botulinum Toxins|botulinum toxins|mesh-list
139333929|NCT05478551|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139333930|NCT05478551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139333931|NCT05478551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139333932|NCT05478551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333933|NCT05478551|Cholinergic Agents|cholinergic agents|mesh-ancestor
139333934|NCT05478551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333935|NCT05478551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333936|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
139333937|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
139333938|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333939|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139333940|NCT03180944|Lugol's solution|lugol's solution|mesh-list
139333941|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139333942|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
139333943|NCT03180944|Coagulants|coagulants|mesh-ancestor
138990827|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
139333944|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
139333945|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139333946|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333947|NCT04322669|Pidotimod|pidotimod|mesh-list
139333948|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139333949|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
139333950|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333952|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333953|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139333954|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139333955|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333956|NCT03180632|Lorazepam|lorazepam|mesh-list
139333957|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
139333958|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
139333959|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
139333960|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139333961|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333962|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139333963|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139333964|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139333965|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139333966|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139333967|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139333968|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
139333969|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
139333970|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139333971|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139333972|NCT02420132|Ranibizumab|ranibizumab|mesh-list
139333973|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139333974|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139333975|NCT02420132|Growth Substances|growth substances|mesh-ancestor
139333976|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333977|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
139333978|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139333979|NCT03183752|Metformin|metformin|mesh-list
139333980|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139333981|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333982|NCT03183674|Oxytocin|oxytocin|mesh-list
139333983|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
139333984|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139333985|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333986|NCT03117530|Minocycline|minocycline|mesh-list
139333987|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139333988|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139333989|NCT03889925|Hyaluronic Acid|hyaluronic acid|mesh-list
139333990|NCT03889925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139333991|NCT03889925|Immunologic Factors|immunologic factors|mesh-ancestor
139333992|NCT03889925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139333993|NCT03889925|Viscosupplements|viscosupplements|mesh-ancestor
139333994|NCT03889925|Protective Agents|protective agents|mesh-ancestor
139333995|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139333996|NCT05103254|Ezetimibe|ezetimibe|mesh-list
139333997|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139333998|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139333999|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
139334000|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334001|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139334002|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334003|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139334004|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334005|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
139334006|NCT02426840|Vitamin D|vitamin d|mesh-list
139334007|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
139334008|NCT02426840|Cholecalciferol|cholecalciferol|mesh-list
139334009|NCT02426840|Vitamins|vitamins|mesh-list
139334010|NCT02426840|Calcium|calcium|mesh-list
139334011|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
139334012|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334013|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139334014|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139334015|NCT03178526|Lovastatin|lovastatin|mesh-list
139334016|NCT03178526|L 647318|l 647318|mesh-list
139334017|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
139334018|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139334019|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139334020|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
139334021|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334022|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139334023|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139334024|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334026|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
139334027|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334028|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139334029|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139334030|NCT03180242|Trastuzumab|trastuzumab|mesh-list
139334031|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139334032|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334033|NCT00709904|Semuloparin|semuloparin|mesh-list
139334034|NCT00709904|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139334035|NCT00709904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139334036|NCT00709904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139334037|NCT00709904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334038|NCT00709904|Anticoagulants|anticoagulants|mesh-ancestor
139334039|NCT03183596|Dexamethasone|dexamethasone|mesh-list
139334040|NCT03183596|Bupivacaine|bupivacaine|mesh-list
139334041|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334042|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
139334043|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
139334044|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334045|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334046|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139334047|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
139334048|NCT03183596|Hormones|hormones|mesh-ancestor
139334049|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139334050|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139334051|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334052|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
139334053|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
139334054|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139334055|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
139334056|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
139334057|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139334058|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
139334059|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
139334060|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
139334061|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
139334062|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
139334063|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139334064|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139334065|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334066|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334067|NCT04325243|Urological Agents|urological agents|mesh-ancestor
139334068|NCT02419820|Aspirin|aspirin|mesh-list
139334069|NCT02419820|Clopidogrel|clopidogrel|mesh-list
139334071|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139334072|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139334073|NCT02419820|Analgesics|analgesics|mesh-ancestor
139334074|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
139334075|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334076|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334077|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334078|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334079|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139334080|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139334081|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334082|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139334083|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139334084|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334085|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
139179650|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334086|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139334087|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139334088|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139334089|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
139334090|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139334091|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139334092|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139334093|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
139334094|NCT05692739|Cyclosporine|cyclosporine|mesh-list
139334095|NCT05692739|Lubricant Eye Drops|lubricant eye drops|mesh-list
139334096|NCT05692739|Cyclosporins|cyclosporins|mesh-list
139334097|NCT05692739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334098|NCT05692739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334099|NCT05692739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334100|NCT05692739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139334101|NCT05692739|Immunologic Factors|immunologic factors|mesh-ancestor
139334102|NCT05692739|Antifungal Agents|antifungal agents|mesh-ancestor
139334103|NCT05692739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139334104|NCT05692739|Dermatologic Agents|dermatologic agents|mesh-ancestor
139334105|NCT05692739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334106|NCT05692739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139334107|NCT05692739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139334108|NCT05692739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139334109|NCT02419352|Atropine|atropine|mesh-list
139334110|NCT02419352|Neostigmine|neostigmine|mesh-list
139334111|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139334112|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139334113|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139334114|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
139334115|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334116|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334117|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139334118|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
139334119|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
139334120|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
139334121|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139334122|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139334123|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
139334124|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139334125|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334126|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139334127|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334128|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139334129|NCT03365687|Vitamin D|vitamin d|mesh-list
139334130|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
139334131|NCT03365687|Vitamins|vitamins|mesh-ancestor
139334132|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
139334133|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334134|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139334135|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139334136|NCT02419118|Dexamethasone|dexamethasone|mesh-list
139334137|NCT02419118|Lenalidomide|lenalidomide|mesh-list
139334138|NCT02419118|Daratumumab|daratumumab|mesh-list
139334139|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334140|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
139334141|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
139334142|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334143|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334144|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139334145|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
139334146|NCT02419118|Hormones|hormones|mesh-ancestor
139334147|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139334148|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139334149|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334150|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
139334151|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139179745|NCT01194115|Metronidazole|metronidazole|mesh-list
139334152|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139334153|NCT02419118|Growth Substances|growth substances|mesh-ancestor
139334154|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
139334155|NCT02426294|Pioglitazone|pioglitazone|mesh-list
139334156|NCT02426294|Glimepiride|glimepiride|mesh-list
139334157|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139334158|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334159|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139334160|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139334161|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
139334162|NCT02426450|Leucovorin|leucovorin|mesh-list
139334163|NCT02426450|Fluorouracil|fluorouracil|mesh-list
139334164|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
139334165|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
139334166|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915125|NCT00766506|Morphine|morphine|mesh-list
139334167|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139334168|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334169|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139334170|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
139334171|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334172|NCT02426450|Antidotes|antidotes|mesh-ancestor
139334173|NCT02426450|Protective Agents|protective agents|mesh-ancestor
139334174|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
139334175|NCT02426450|Vitamins|vitamins|mesh-ancestor
139334176|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
139334177|NCT02426060|Warfarin|warfarin|mesh-list
139334178|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
139334179|NCT02422784|Vitamin D|vitamin d|mesh-list
139334180|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
139334181|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
139334182|NCT02422784|Vitamins|vitamins|mesh-list
139334183|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
139334184|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334185|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139334186|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139334187|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
139334188|NCT03740009|Estrogens|estrogens|mesh-list
139334189|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139334190|NCT03740009|Hormones|hormones|mesh-ancestor
139334191|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139334192|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334193|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139334194|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139334195|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
139334196|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139334197|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
139334198|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139334199|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
139334200|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
139334201|NCT03182894|Azacitidine|azacitidine|mesh-list
139334202|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139334203|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334204|NCT03182894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139334205|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334206|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139334207|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
139334208|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334209|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139334210|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139334211|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139334212|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
139334213|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334214|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139334215|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139334216|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334217|NCT02423096|Haloperidol|haloperidol|mesh-list
139334219|NCT02423096|Risperidone|risperidone|mesh-list
139334220|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139334221|NCT02423096|Sulpiride|sulpiride|mesh-list
139334222|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139334223|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
139334224|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139334225|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334226|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334227|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139334228|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139334229|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139334230|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139334231|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139334232|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
139334233|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
139334234|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
139334235|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334236|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139334237|NCT02423096|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139334238|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139334239|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139334240|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
139334241|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139334242|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139334243|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
139334244|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139334245|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139334246|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334247|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139334248|NCT02423018|Pregabalin|pregabalin|mesh-list
139334249|NCT02423018|Analgesics|analgesics|mesh-ancestor
139334250|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
139334251|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334252|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334253|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
139334254|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139334255|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139334256|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334257|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139334258|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139334259|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139334260|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139334261|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139334263|NCT05691959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139334264|NCT05691959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334265|NCT02422706|Metronidazole|metronidazole|mesh-list
139334266|NCT02422706|Clarithromycin|clarithromycin|mesh-list
139334267|NCT02422706|Levofloxacin|levofloxacin|mesh-list
139334268|NCT02422706|Ofloxacin|ofloxacin|mesh-list
139334269|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
139334270|NCT02422706|Doxycycline|doxycycline|mesh-list
139334271|NCT02422706|Omeprazole|omeprazole|mesh-list
139334272|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139334273|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139334274|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139334275|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139334276|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139334277|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139334278|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139334279|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334280|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334281|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139334282|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139334283|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139334284|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139334285|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139334286|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139334287|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334288|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139334289|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
139334290|NCT03058757|Mitomycins|mitomycins|mesh-list
139334291|NCT03058757|Mitomycin|mitomycin|mesh-list
139334292|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139334293|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334294|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
139334295|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334296|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139334297|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334298|NCT03138889|Paclitaxel|paclitaxel|mesh-list
139334299|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139334300|NCT03138889|Carboplatin|carboplatin|mesh-list
139334301|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
139334302|NCT03138889|Pemetrexed|pemetrexed|mesh-list
139334303|NCT03138889|Atezolizumab|atezolizumab|mesh-list
139334304|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139334305|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334306|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
139334307|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
139334308|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
139334309|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334310|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139334311|NCT03138889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139334312|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334313|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139334314|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139334315|NCT01881763|Ketamine|ketamine|mesh-list
139334316|NCT01881763|Methohexital|methohexital|mesh-list
139334317|NCT01881763|Analgesics|analgesics|mesh-ancestor
139334318|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
139334319|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334320|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334321|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139334322|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139334323|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
139334324|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
139334325|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139334326|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139334327|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139334328|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139334329|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334331|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139334332|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
139334333|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334334|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334335|NCT02416388|Cytarabine|cytarabine|mesh-list
139334336|NCT02416388|Cyclosporine|cyclosporine|mesh-list
139334337|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
139334338|NCT02416388|Dexamethasone|dexamethasone|mesh-list
139334339|NCT02416388|Methotrexate|methotrexate|mesh-list
139334340|NCT02416388|Daunorubicin|daunorubicin|mesh-list
139334341|NCT02416388|Venetoclax|venetoclax|mesh-list
139334342|NCT02416388|Idarubicin|idarubicin|mesh-list
139334343|NCT02416388|Cyclosporins|cyclosporins|mesh-list
139334344|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334345|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
139334346|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
139334347|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334348|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334349|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139334350|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
139334351|NCT02416388|Hormones|hormones|mesh-ancestor
139334352|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139334353|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139334354|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334355|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139334356|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
139334357|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139334358|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139334359|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
139334360|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334361|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
139334362|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334363|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139334364|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139334365|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
139334366|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334367|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139334368|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
139334369|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139334370|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
139334371|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139334372|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139334373|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139334374|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139334375|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139334376|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
139334377|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139334378|NCT02886065|Lenalidomide|lenalidomide|mesh-list
139334379|NCT02886065|Poly ICLC|poly iclc|mesh-list
139334380|NCT02886065|Citarinostat|citarinostat|mesh-list
139334381|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
139334382|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334383|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139334384|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139334385|NCT02886065|Growth Substances|growth substances|mesh-ancestor
139334386|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
139334387|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334388|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
139334389|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139334390|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334391|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334392|NCT03392441|Insulin|insulin|mesh-list
139334393|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139334394|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334395|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
139334396|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334397|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
139334398|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139334399|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139334400|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334401|NCT03177824|Urological Agents|urological agents|mesh-ancestor
139334402|NCT02416232|Trametinib|trametinib|mesh-list
139334403|NCT02416232|Dabrafenib|dabrafenib|mesh-list
139334404|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334405|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139334406|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334407|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334408|NCT04482842|Warfarin|warfarin|mesh-list
139334409|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
139334410|NCT02767661|Capecitabine|capecitabine|mesh-list
139334411|NCT02767661|Letrozole|letrozole|mesh-list
139334412|NCT02767661|Anastrozole|anastrozole|mesh-list
139334413|NCT02767661|Exemestane|exemestane|mesh-list
139334414|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139334415|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139334416|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
139334417|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334418|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334419|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139334420|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334421|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139334422|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
139334423|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139334424|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334425|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139334427|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
139334428|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139334429|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334430|NCT03389243|Acetaminophen|acetaminophen|mesh-list
139334431|NCT03389243|Dipyrone|dipyrone|mesh-list
139334432|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139334433|NCT03389243|Analgesics|analgesics|mesh-ancestor
139334434|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
139334435|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334436|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334437|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
139334438|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139334439|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334440|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334441|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
139334442|NCT02421926|Dasatinib|dasatinib|mesh-list
139334443|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334444|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139334445|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334446|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334447|NCT02410460|Lidocaine|lidocaine|mesh-list
139334448|NCT02410460|Clonidine|clonidine|mesh-list
139334449|NCT02410460|Midazolam|midazolam|mesh-list
139334450|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
139334451|NCT02410460|Scopolamine|scopolamine|mesh-list
139334452|NCT02410460|Ketamine|ketamine|mesh-list
139334453|NCT02410460|Ondansetron|ondansetron|mesh-list
139334454|NCT02410460|Metoclopramide|metoclopramide|mesh-list
139334455|NCT02410460|Bupivacaine|bupivacaine|mesh-list
139334456|NCT02410460|Propofol|propofol|mesh-list
139334457|NCT02410460|Sevoflurane|sevoflurane|mesh-list
139334458|NCT02410460|Desflurane|desflurane|mesh-list
139334459|NCT02410460|Famotidine|famotidine|mesh-list
139334460|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139334461|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
139334462|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
139334463|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139334464|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334465|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
139334466|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334467|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139334468|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139334469|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139334470|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139334471|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334472|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139334473|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139334474|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
139334475|NCT02410460|Analgesics|analgesics|mesh-ancestor
139334476|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139334477|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139334478|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139334479|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139334480|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139334481|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139334482|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139334483|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139334484|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
139334485|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
139334486|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139334487|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139334488|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
139334489|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
139334490|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139334491|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
139334492|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
139334493|NCT02410460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139334494|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139334495|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
139334496|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139334497|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
139334498|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139334499|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139334500|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139334501|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
139334502|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139334503|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139334504|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
139334505|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139334506|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139334507|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
139334508|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139334509|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139334510|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
139334511|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
139334512|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
139334513|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
139334514|NCT02410226|Anesthetics|anesthetics|mesh-list
139334515|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139334516|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334517|NCT03116672|Diclofenac|diclofenac|mesh-list
139334518|NCT03116672|Ketorolac|ketorolac|mesh-list
139334519|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139334520|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139334521|NCT03116672|Analgesics|analgesics|mesh-ancestor
139334522|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
139334523|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334524|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334525|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334526|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334527|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139334528|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915220|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334529|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334530|NCT03174860|Diclofenac|diclofenac|mesh-list
139334531|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139334532|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139334533|NCT03174860|Analgesics|analgesics|mesh-ancestor
139334534|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
139334535|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334536|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334537|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334538|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334539|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139334540|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334541|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334542|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139334543|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139334544|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334545|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139334546|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334547|NCT02417090|Metformin|metformin|mesh-list
139334548|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139334549|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334550|NCT00703820|Cytarabine|cytarabine|mesh-list
139334551|NCT00703820|Etoposide|etoposide|mesh-list
139334552|NCT00703820|Daunorubicin|daunorubicin|mesh-list
139334553|NCT00703820|Clofarabine|clofarabine|mesh-list
139334554|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139334555|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334556|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139334557|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139334558|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334559|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334560|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139334561|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
139334562|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
139334563|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139334564|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139334565|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
139334566|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334567|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139334568|NCT03177980|Clonidine|clonidine|mesh-list
139334569|NCT03177980|Fentanyl|fentanyl|mesh-list
139334570|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139334571|NCT03177980|Narcotics|narcotics|mesh-ancestor
139334572|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139334573|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334574|NCT03177980|Analgesics|analgesics|mesh-ancestor
139334575|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
139334576|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334577|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139334578|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139334579|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
139334580|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
139334581|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139334582|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
139334583|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
139334584|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139334585|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139334586|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139334587|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
139334588|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139334589|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334590|NCT03177434|Lactulose|lactulose|mesh-list
139334591|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139334592|NCT02587325|Sirolimus|sirolimus|mesh-list
139334593|NCT02587325|Temsirolimus|temsirolimus|mesh-list
139334594|NCT02587325|MTOR Inhibitors|mtor inhibitors|mesh-list
139334595|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139334596|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139334597|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139334598|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334599|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
139334600|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139334601|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
139334602|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334603|NCT02587325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139334604|NCT02587325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334605|NCT02587325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334606|NCT02414984|Golimumab|golimumab|mesh-list
139334607|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139334608|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334609|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139334610|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
139334611|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334612|NCT02415062|Donepezil|donepezil|mesh-list
139334613|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139334614|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334615|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334616|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
139334617|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139334618|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334619|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
139334620|NCT02408978|Naproxen|naproxen|mesh-list
139334621|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139334622|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139334623|NCT02408978|Analgesics|analgesics|mesh-ancestor
139334624|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
139334625|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334626|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334627|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334628|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334629|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
139334630|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139180099|NCT01109927|Insulin|insulin|mesh-list
139334631|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334632|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334633|NCT02408744|Pirfenidone|pirfenidone|mesh-list
139334634|NCT02408744|Analgesics|analgesics|mesh-ancestor
139334635|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
139334636|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334637|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334638|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139334639|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139334640|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334641|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334642|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334643|NCT03174080|Fluorides|fluorides|mesh-list
139334644|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
139334645|NCT03174080|Protective Agents|protective agents|mesh-ancestor
139334646|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334647|NCT03116516|Amlodipine|amlodipine|mesh-list
139334648|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139334649|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139334650|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139334651|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139334652|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334653|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139334654|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334655|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
139334656|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138915250|NCT04100226|Vitamins|vitamins|mesh-ancestor
139334657|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139334658|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
139334659|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139334660|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139334661|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334662|NCT01564537|Dexamethasone|dexamethasone|mesh-list
139334663|NCT01564537|Lenalidomide|lenalidomide|mesh-list
139334664|NCT01564537|Ixazomib|ixazomib|mesh-list
139334665|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334666|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
139334667|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
139334668|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334669|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334670|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139334671|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
139334672|NCT01564537|Hormones|hormones|mesh-ancestor
139334673|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139334674|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139334675|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334676|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
139334677|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139334678|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139334679|NCT01564537|Growth Substances|growth substances|mesh-ancestor
139334680|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
139334681|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
139334682|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334683|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334684|NCT03174236|Metronidazole|metronidazole|mesh-list
139334685|NCT03174236|Gentamicins|gentamicins|mesh-list
139334686|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
139334687|NCT03174236|Penicillins|penicillins|mesh-list
139334688|NCT03174236|Penicillin G|penicillin g|mesh-list
139334689|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139334690|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
139334691|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139334692|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139334693|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139334694|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139334695|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139334696|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334697|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334698|NCT03172052|Streptokinase|streptokinase|mesh-list
139334700|NCT03172052|Protective Agents|protective agents|mesh-ancestor
139334701|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334702|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139334703|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139334704|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334705|NCT02408354|Glycerol|glycerol|mesh-list
139334706|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139334707|NCT02408354|Protective Agents|protective agents|mesh-ancestor
139334708|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334709|NCT03176264|Bevacizumab|bevacizumab|mesh-list
139334710|NCT03176264|Spartalizumab|spartalizumab|mesh-list
139334711|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139334712|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334713|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138915261|NCT00818519|Drospirenone|drospirenone|mesh-list
139334714|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139334715|NCT03176264|Growth Substances|growth substances|mesh-ancestor
139334716|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334717|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
139334718|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139334719|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334720|NCT02406170|Paclitaxel|paclitaxel|mesh-list
139334721|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139334722|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334723|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
139334724|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
139334725|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
139334726|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334727|NCT02413658|Phenytoin|phenytoin|mesh-list
139334728|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
139334729|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139334730|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139334731|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139334732|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334733|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139334734|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139334735|NCT02406014|Diclofenac|diclofenac|mesh-list
139334736|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139334737|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139334738|NCT02406014|Analgesics|analgesics|mesh-ancestor
139334739|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
139334740|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334741|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334742|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334743|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334744|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139334745|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334746|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334747|NCT02406092|Prednisone|prednisone|mesh-list
139334748|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
139334749|NCT02406092|Rituximab|rituximab|mesh-list
139334750|NCT02406092|Doxorubicin|doxorubicin|mesh-list
139334751|NCT02406092|Fludarabine|fludarabine|mesh-list
139334752|NCT02406092|Vincristine|vincristine|mesh-list
139334753|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139334754|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
139334755|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334756|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334757|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139334758|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
139334759|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334760|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334761|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139334762|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139334763|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139334764|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139334765|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139334766|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334767|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334768|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
139334769|NCT02406092|Hormones|hormones|mesh-ancestor
139334770|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139334771|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139334772|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139334773|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
139334774|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
139334775|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
139334776|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
139334777|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
139334778|NCT02405858|Prednisolone|prednisolone|mesh-list
139334779|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
139334780|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334781|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
139334782|NCT02405858|Hormones|hormones|mesh-ancestor
139334783|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139334784|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334785|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139334786|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334787|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139334788|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334789|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334790|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
139334791|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139334792|NCT03171740|Midazolam|midazolam|mesh-list
139334793|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
139334794|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139334795|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139334796|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139334797|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334798|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139334799|NCT03171740|Analgesics|analgesics|mesh-ancestor
139334800|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
139334801|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334802|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139334803|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139334804|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139334805|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
139334806|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139334807|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334808|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139334809|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139334810|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139334811|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139334812|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139334813|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
139334814|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
139334815|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
139334816|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
139334817|NCT03176186|Xenon|xenon|mesh-list
139334818|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139334819|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
139334820|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
139334821|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139334822|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334823|NCT04482764|Valproic Acid|valproic acid|mesh-list
139334824|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
139334825|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334826|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334827|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
139334828|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139334829|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334830|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
139334831|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139334832|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139334833|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139334834|NCT02408042|Rituximab|rituximab|mesh-list
139334835|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
139334836|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139334837|NCT02408042|Carboplatin|carboplatin|mesh-list
139334838|NCT02408042|Etoposide|etoposide|mesh-list
139334839|NCT02408042|Ifosfamide|ifosfamide|mesh-list
139334840|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139334841|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334842|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
138915293|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334843|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334844|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334845|NCT02408042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139180109|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334846|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334847|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139334848|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139334849|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139334850|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334851|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139334852|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
139334853|NCT02408042|Immunotoxins|immunotoxins|mesh-ancestor
139334854|NCT02408042|Immunoconjugates|immunoconjugates|mesh-ancestor
139334855|NCT03172988|Dexamethasone|dexamethasone|mesh-list
139334856|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
139334857|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
139334858|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
139334859|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139334860|NCT03172988|BB 1101|bb 1101|mesh-list
139334861|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334862|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
139334863|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
139334864|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334865|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334866|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139334867|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
139334868|NCT03172988|Hormones|hormones|mesh-ancestor
139334869|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139334870|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139334871|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334872|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
139334873|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334874|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334875|NCT03172988|Analgesics|analgesics|mesh-ancestor
139334876|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
139334877|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139334878|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139334879|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334880|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139334881|NCT03042611|Apatinib|apatinib|mesh-list
139334882|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334883|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139334884|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334885|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334886|NCT03171584|Itraconazole|itraconazole|mesh-list
139334887|NCT03171584|Fluconazole|fluconazole|mesh-list
139334888|NCT03171584|Terbinafine|terbinafine|mesh-list
139334889|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
139334890|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139334891|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139334892|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139334893|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334894|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334895|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139334896|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
139334897|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139334898|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334899|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138915302|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139334900|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139334901|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139334928|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
139334929|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139334930|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
139334931|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139334932|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334933|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139334934|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139334935|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139334936|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139334937|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139334938|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139334939|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
139334940|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139334941|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334942|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334943|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
139334944|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334945|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
139334946|NCT02407340|Oxytocin|oxytocin|mesh-list
139334947|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
139334948|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139334949|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334950|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139334951|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139334952|NCT02405156|Letrozole|letrozole|mesh-list
139334953|NCT02405156|Misoprostol|misoprostol|mesh-list
139180149|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139334954|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139334955|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139334956|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139334957|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334958|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334959|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139334960|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
139334961|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139334962|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334963|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139334964|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
139334965|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139334966|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139334967|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139334968|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
139334969|NCT02411942|Adapalene|adapalene|mesh-list
139334970|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139334971|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139334972|NCT02411942|Analgesics|analgesics|mesh-ancestor
139334973|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
139334974|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139334975|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334976|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139334977|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139334978|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
139334979|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139334980|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139334981|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334982|NCT02406950|Incretins|incretins|mesh-ancestor
139334983|NCT02406950|Hormones|hormones|mesh-ancestor
139334984|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139334985|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139334986|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
139334987|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139334988|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139334989|NCT02406872|Propofol|propofol|mesh-list
139334990|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139334991|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139334992|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139334993|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139334994|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
139334995|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
139334996|NCT03172676|Amoxicillin|amoxicillin|mesh-list
139334997|NCT03172676|Clarithromycin|clarithromycin|mesh-list
139334998|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139334999|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139335000|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335001|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139335002|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335003|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335004|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139335005|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139335006|NCT02404844|Tamoxifen|tamoxifen|mesh-list
139335007|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139335008|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
139335009|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139335010|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335011|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139335012|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915349|NCT00764322|Tamoxifen|tamoxifen|mesh-list
139335013|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139335014|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139335015|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139335016|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
139335017|NCT04482296|Astringents|astringents|mesh-ancestor
139335018|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335019|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
139335021|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139335022|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335023|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139335024|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335025|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
139335026|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139335027|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
139335028|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335029|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
139335030|NCT02404454|Protective Agents|protective agents|mesh-ancestor
139335031|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
139335032|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139335033|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335034|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
139335035|NCT02411786|Molgramostim|molgramostim|mesh-list
139335036|NCT02411786|Sargramostim|sargramostim|mesh-list
139335037|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
139335038|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335039|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335040|NCT02404376|Exenatide|exenatide|mesh-list
139335041|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139335042|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335043|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139335044|NCT02404376|Incretins|incretins|mesh-ancestor
139335045|NCT02404376|Hormones|hormones|mesh-ancestor
139335046|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139335047|NCT04466085|Vaccines|vaccines|mesh-list
139335048|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
139335049|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335050|NCT03517995|Sulforaphane|sulforaphane|mesh-list
139335051|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139335052|NCT03517995|Protective Agents|protective agents|mesh-ancestor
139335053|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335054|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335055|NCT02411630|Tenofovir|tenofovir|mesh-list
139335056|NCT02411630|Emtricitabine|emtricitabine|mesh-list
139335057|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
139335058|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335059|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139335060|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139335061|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335062|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335063|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139335064|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139335065|NCT02411318|Ethanol|ethanol|mesh-list
139335066|NCT02411318|Caffeine|caffeine|mesh-list
139335067|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139335068|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335069|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139335070|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335071|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335072|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139335073|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139335074|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
139335075|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335076|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139335077|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335078|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139335079|NCT03133299|Vitamin D|vitamin d|mesh-list
139335080|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
139335081|NCT03133299|Vitamins|vitamins|mesh-ancestor
139335082|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
139335083|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335084|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139335086|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139335087|NCT04465695|Interferons|interferons|mesh-list
139335088|NCT04465695|Interferon-beta|interferon-beta|mesh-list
139335089|NCT04465695|Clofazimine|clofazimine|mesh-list
139335090|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
139335091|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335092|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
139335093|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335094|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
139335095|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335096|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139335097|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139335098|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
139335099|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139335100|NCT03115736|Tenofovir|tenofovir|mesh-list
139335101|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
139335102|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335103|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139335104|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139335105|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335106|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335107|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139335108|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139335109|NCT04465851|Curcumin|curcumin|mesh-list
139335110|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139335111|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139335112|NCT04465851|Analgesics|analgesics|mesh-ancestor
139335113|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
139335114|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335115|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335116|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139335117|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139335118|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335119|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335120|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335121|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
139335122|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
139335123|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139335124|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
139335125|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
139335126|NCT02404142|Atracurium|atracurium|mesh-list
139335127|NCT02404142|Curare|curare|mesh-list
139335128|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139335129|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139335130|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139335131|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335132|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335133|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139335134|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139335135|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
139335136|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335137|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335138|NCT03522051|Calcium|calcium|mesh-list
139335139|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139335140|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335141|NCT03171974|Dexamethasone|dexamethasone|mesh-list
139335142|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139335143|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
139335144|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
139335145|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335146|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335147|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139335148|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
139335149|NCT03171974|Hormones|hormones|mesh-ancestor
139335150|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139335151|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139335152|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335153|NCT02292069|Amlodipine|amlodipine|mesh-list
139335154|NCT02292069|Atorvastatin|atorvastatin|mesh-list
139335155|NCT02292069|Calcium|calcium|mesh-list
139335156|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139335157|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335158|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139335159|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139335160|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
139335161|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335162|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139335163|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139335164|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335165|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139335166|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139335167|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139335168|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
139335169|NCT02404064|Metronidazole|metronidazole|mesh-list
139335170|NCT02404064|Cefotaxime|cefotaxime|mesh-list
139335171|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335172|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139335173|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139335174|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139335175|NCT02294643|Aspirin|aspirin|mesh-list
139335176|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
139335177|NCT02294643|Clopidogrel|clopidogrel|mesh-list
139335178|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139335179|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139335180|NCT02294643|Analgesics|analgesics|mesh-ancestor
139335181|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
139335182|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335183|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335184|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139335185|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139335186|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139335187|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139335188|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335189|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139335190|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139335191|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335192|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
138915409|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
139335193|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139335194|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139335195|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139335196|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
139335197|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335198|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139335199|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
139335200|NCT02410694|Thalidomide|thalidomide|mesh-list
139335201|NCT02410694|Dexamethasone|dexamethasone|mesh-list
139335202|NCT02410694|Ixazomib|ixazomib|mesh-list
139335203|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139335204|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
139335205|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
139335206|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335207|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335208|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139335209|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
139335210|NCT02410694|Hormones|hormones|mesh-ancestor
139335211|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139335212|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139335213|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335214|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139335215|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
139335216|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
139335217|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139335218|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335219|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139335220|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139335221|NCT02410694|Growth Substances|growth substances|mesh-ancestor
139335222|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
139335223|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
139335224|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335225|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335226|NCT03521895|Aflibercept|aflibercept|mesh-list
139335227|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139335228|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139335229|NCT03521895|Growth Substances|growth substances|mesh-ancestor
139335230|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335231|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
139335232|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335233|NCT02401880|Empagliflozin|empagliflozin|mesh-list
139335234|NCT02401880|Linagliptin|linagliptin|mesh-list
139335235|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139335236|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335237|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139335238|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335240|NCT02401880|Hormones|hormones|mesh-ancestor
139335241|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139335242|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139335243|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
139335244|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335245|NCT03170726|Ibuprofen|ibuprofen|mesh-list
139335246|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139335247|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139335248|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139335249|NCT03170726|Analgesics|analgesics|mesh-ancestor
139335250|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
139335251|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335252|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335253|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139335254|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139335255|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139335256|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335257|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335258|NCT03175016|Irinotecan|irinotecan|mesh-list
139335259|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139335260|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139335261|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335262|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335263|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335264|NCT03520257|Apatinib|apatinib|mesh-list
139335265|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335266|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139335267|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335268|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335269|NCT02292303|Zinc|zinc|mesh-list
139335270|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
139335271|NCT02292303|Trace Elements|trace elements|mesh-ancestor
139335272|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
139335273|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335274|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
139335275|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
139335276|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139335277|NCT02292303|Protective Agents|protective agents|mesh-ancestor
139335278|NCT02294955|Amiodarone|amiodarone|mesh-list
139335279|NCT02294955|Flecainide|flecainide|mesh-list
139335280|NCT02294955|Sotalol|sotalol|mesh-list
139335281|NCT02294955|Dronedarone|dronedarone|mesh-list
139335282|NCT02294955|Propafenone|propafenone|mesh-list
139335283|NCT02294955|Disopyramide|disopyramide|mesh-list
139335284|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139335285|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
139335286|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139335287|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139335288|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335289|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139335290|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139335291|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139335292|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335293|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139335294|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139335295|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139335296|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139335297|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139335298|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139335299|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
139335300|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335301|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335302|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
139335303|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
139335304|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335305|NCT02396888|Insulin|insulin|mesh-list
139335306|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139335307|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335308|NCT03517683|Methamphetamine|methamphetamine|mesh-list
139335309|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139335310|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335311|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
139335312|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
139335313|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335314|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
139335315|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335316|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335317|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
139335318|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139335319|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139335320|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139335321|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139335322|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
139335323|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139335324|NCT02164643|Flutemetamol|flutemetamol|mesh-list
139335325|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139335326|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335327|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139335328|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139335329|NCT02292459|Laxatives|laxatives|mesh-ancestor
139335330|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139335331|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139335332|NCT03170336|Amiloride|amiloride|mesh-list
139335333|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139335334|NCT03170336|Diuretics|diuretics|mesh-ancestor
139335335|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
139335336|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335337|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139335338|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139335339|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335340|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139335341|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139335342|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139335343|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139335344|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139335345|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139335346|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139335347|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335348|NCT02295189|Triamcinolone|triamcinolone|mesh-list
139335349|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139335350|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139335351|NCT02295189|Ketorolac|ketorolac|mesh-list
139335352|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139335353|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139335354|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139335355|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
139335356|NCT02295189|Hormones|hormones|mesh-ancestor
139335357|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139335358|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335359|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139335360|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
139335361|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335362|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335363|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139335364|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139335365|NCT02295189|Analgesics|analgesics|mesh-ancestor
139335366|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
139335367|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335368|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139335369|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139335370|NCT03519633|Neostigmine|neostigmine|mesh-list
138915447|NCT00704951|Posaconazole|posaconazole|mesh-list
139335371|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139335372|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335373|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335374|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
139335375|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335376|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335377|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139335378|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
139335379|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335380|NCT02289027|Vaccines|vaccines|mesh-list
139335381|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
138992258|NCT00938600|Vitamins|vitamins|mesh-list
139335382|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335383|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
139335384|NCT02396030|Analgesics|analgesics|mesh-ancestor
139335385|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
139335386|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335387|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335388|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
139335389|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139335390|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139335391|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
139335392|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139335393|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139335394|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335395|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139335396|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
139335397|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139335398|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
139335399|NCT02289261|Morphine|morphine|mesh-list
139335400|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139335401|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139335402|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335403|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139335404|NCT02289261|Analgesics|analgesics|mesh-ancestor
139335405|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
139335406|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335407|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139335408|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139335409|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139335410|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
139335411|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335412|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335413|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139335414|NCT02289261|Narcotics|narcotics|mesh-ancestor
139335415|NCT03168074|Lenvatinib|lenvatinib|mesh-list
139335416|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335417|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139335418|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335419|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335420|NCT02396108|Paclitaxel|paclitaxel|mesh-list
139335421|NCT02396108|Carboplatin|carboplatin|mesh-list
139335422|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139335423|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335424|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
139335425|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
139335426|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
139335427|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335428|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
139335429|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139335430|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139335431|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335432|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
139335433|NCT02403596|Coagulants|coagulants|mesh-ancestor
139335434|NCT02289495|Ritonavir|ritonavir|mesh-list
139335435|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
139335436|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139335437|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139335438|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
139335439|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335440|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335441|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139335442|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139335443|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
139335444|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335445|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139335446|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139335447|NCT01774721|Gefitinib|gefitinib|mesh-list
139335448|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335449|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139335450|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335451|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335452|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139335453|NCT02395952|Laxatives|laxatives|mesh-ancestor
139335454|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139335455|NCT03516903|Folic Acid|folic acid|mesh-list
138992331|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335457|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139335458|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
139335459|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139335460|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335461|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139335462|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
139335463|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335464|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335465|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
139335466|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335467|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139335468|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139335469|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
139335470|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139335471|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139335472|NCT03516903|Hematinics|hematinics|mesh-ancestor
139335473|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
139335474|NCT03516903|Vitamins|vitamins|mesh-ancestor
139335475|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
139335476|NCT03516747|Hormones|hormones|mesh-list
139335477|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
139335478|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139335479|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335480|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139335481|NCT03516669|Amoxicillin|amoxicillin|mesh-list
139335482|NCT03516669|Clarithromycin|clarithromycin|mesh-list
139335483|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139335484|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335485|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139335486|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335487|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335488|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139335489|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139335490|NCT02289807|Cisplatin|cisplatin|mesh-list
139335491|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335492|NCT02298153|Atezolizumab|atezolizumab|mesh-list
139335493|NCT02298153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139335494|NCT02298153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335495|NCT02298153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139335496|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335497|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139335498|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
139335499|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335500|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
139335501|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139335502|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335503|NCT02296047|Bromides|bromides|mesh-list
139335504|NCT02296047|Albuterol|albuterol|mesh-list
139335505|NCT02296047|Ipratropium|ipratropium|mesh-list
139335506|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
139335507|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139335508|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
139335509|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335510|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335511|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139335512|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
139335513|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
139335514|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139335515|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139335516|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139335517|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139335518|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
139335519|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335520|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335521|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139335522|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
139335523|NCT02293785|Oxycodone|oxycodone|mesh-list
139335524|NCT02293785|Naloxone|naloxone|mesh-list
139335525|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139335526|NCT02293785|Narcotics|narcotics|mesh-ancestor
139335527|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139335528|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335529|NCT02293785|Analgesics|analgesics|mesh-ancestor
139335530|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
139335531|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335532|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139335534|NCT01162109|Astringents|astringents|mesh-ancestor
139335535|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335536|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
139335537|NCT02296203|Irinotecan|irinotecan|mesh-list
139335538|NCT02296203|Cetuximab|cetuximab|mesh-list
139335539|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139335540|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139335541|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335542|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335543|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335544|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139335545|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
139335546|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139335547|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335548|NCT02296281|Pirfenidone|pirfenidone|mesh-list
139335549|NCT02296281|Analgesics|analgesics|mesh-ancestor
139335550|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
139335551|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335552|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915501|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335553|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139335554|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139335555|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139335556|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139335557|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335558|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139335559|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139335560|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139335561|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
139335562|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335563|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139335564|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139335565|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335566|NCT03513549|Loxapine|loxapine|mesh-list
139335567|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139335568|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139335569|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139335570|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335571|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139335572|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139335573|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
139335574|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335575|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335576|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139335577|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139335578|NCT03513393|Velpatasvir|velpatasvir|mesh-list
139335579|NCT03513393|Omeprazole|omeprazole|mesh-list
139335580|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139335581|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139335582|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139335583|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335584|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335585|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
139335586|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335587|NCT02299401|Misoprostol|misoprostol|mesh-list
139335588|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139335589|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
139335590|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139335591|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335592|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139335593|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139335594|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
139335595|NCT02699450|Ranibizumab|ranibizumab|mesh-list
139335596|NCT02699450|Faricimab|faricimab|mesh-list
139335597|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139335598|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139335599|NCT02699450|Growth Substances|growth substances|mesh-ancestor
139335600|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335601|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
139335602|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139180246|NCT03715881|Hormones|hormones|mesh-ancestor
139335603|NCT02299557|Phenylephrine|phenylephrine|mesh-list
139335604|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
139335605|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139335606|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139335607|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
139335608|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335609|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335610|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335611|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
139335612|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
139335613|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335614|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
139335615|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139335616|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
139335617|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139335618|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
139335619|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139335620|NCT02299557|Protective Agents|protective agents|mesh-ancestor
139335621|NCT02302989|Ranibizumab|ranibizumab|mesh-list
139335622|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139335623|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139335624|NCT02302989|Growth Substances|growth substances|mesh-ancestor
139335625|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335626|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
139335627|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335628|NCT02296671|Leucovorin|leucovorin|mesh-list
139335629|NCT02296671|Fluorouracil|fluorouracil|mesh-list
139335630|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
139335631|NCT02296671|Pemetrexed|pemetrexed|mesh-list
139335632|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
139335633|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335634|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139335635|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335636|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139335637|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
139335638|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335639|NCT02296671|Antidotes|antidotes|mesh-ancestor
139335640|NCT02296671|Protective Agents|protective agents|mesh-ancestor
139335641|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
139335642|NCT02296671|Vitamins|vitamins|mesh-ancestor
139335643|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
139335644|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335645|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139335646|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139335647|NCT02296749|Sirolimus|sirolimus|mesh-list
139335648|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139335649|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335650|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139335651|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335652|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
139335653|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139335654|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
139335655|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335656|NCT04481750|Edaravone|edaravone|mesh-list
139335657|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139335658|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
139335659|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335660|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139335661|NCT04481750|Protective Agents|protective agents|mesh-ancestor
139335662|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335663|NCT02303223|Propofol|propofol|mesh-list
138915522|NCT00833261|Cetuximab|cetuximab|mesh-list
139335664|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139335665|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139335666|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335667|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139335668|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
139335669|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
139335670|NCT03168698|Oxytocin|oxytocin|mesh-list
139335671|NCT03168698|Carbetocin|carbetocin|mesh-list
139335672|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
139335673|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139335674|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180252|NCT01197781|Verapamil|verapamil|mesh-list
139335675|NCT04464135|Acetic Acid|acetic acid|mesh-list
139335676|NCT04464135|Retinol acetate|retinol acetate|mesh-list
139335677|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139335678|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335679|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139335680|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
139335681|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335682|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138992558|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
139335683|NCT04464135|Protective Agents|protective agents|mesh-ancestor
139335684|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335685|NCT03510351|Tazobactam|tazobactam|mesh-list
139335686|NCT03510351|Ceftolozane|ceftolozane|mesh-list
139335687|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
139335688|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139335689|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335690|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139335691|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335692|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335693|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139335694|NCT02403284|Liraglutide|liraglutide|mesh-list
139335695|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139335696|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335697|NCT02403284|Incretins|incretins|mesh-ancestor
139335698|NCT02403284|Hormones|hormones|mesh-ancestor
139335699|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139335700|NCT02400866|Olanzapine|olanzapine|mesh-list
139335701|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
139335702|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
139335703|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335704|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335705|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139335706|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139335707|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139335708|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139335709|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139335710|NCT02400866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139335711|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139335712|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139335713|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335714|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335715|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
139335716|NCT02400788|Sorafenib|sorafenib|mesh-list
139335717|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335718|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139335719|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335720|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335721|NCT02403128|Aflibercept|aflibercept|mesh-list
139335722|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139335723|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139335724|NCT02403128|Growth Substances|growth substances|mesh-ancestor
139335725|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335726|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
139335727|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335728|NCT02297217|Paclitaxel|paclitaxel|mesh-list
139335729|NCT02297217|Carboplatin|carboplatin|mesh-list
139335730|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139335731|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335732|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
139335733|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
139335734|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
139335735|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335736|NCT03515577|Edetic Acid|edetic acid|mesh-list
139335737|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139335738|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
139335739|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
139335740|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335741|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
139335742|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139335743|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139335744|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
139335745|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139335746|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139335747|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335748|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139335749|NCT02300649|Analgesics|analgesics|mesh-ancestor
139335750|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
139335751|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335752|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139335753|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139335754|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139335755|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
139335756|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138992646|NCT00940238|Dexetimide|dexetimide|mesh-list
139335757|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335758|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139335759|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139335760|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
139335761|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139335762|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335763|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139335764|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139335765|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139335766|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335767|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139335768|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139335769|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335771|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139335772|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139335773|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139335774|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
139335775|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335776|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335777|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335778|NCT02303769|Urological Agents|urological agents|mesh-ancestor
139335779|NCT02303847|Ketamine|ketamine|mesh-list
139335780|NCT02303847|Analgesics|analgesics|mesh-ancestor
139335781|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
139335782|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335783|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335784|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139335785|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139335786|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
139335787|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
139335788|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139335789|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139335790|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139335791|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335792|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335793|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139335794|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
139335795|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139335796|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139335797|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139335798|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139335799|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335800|NCT03511833|Ketamine|ketamine|mesh-list
139335801|NCT03511833|Morphine|morphine|mesh-list
139335802|NCT03511833|Analgesics|analgesics|mesh-ancestor
139335803|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
139335804|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335805|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335806|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139335807|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139335808|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
139335809|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
139335810|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139335811|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139335812|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139335813|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335814|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335815|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139335816|NCT03511833|Narcotics|narcotics|mesh-ancestor
139335817|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
139335818|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335819|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335820|NCT02696798|Ixekizumab|ixekizumab|mesh-list
139335821|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
139335822|NCT02304081|Saxagliptin|saxagliptin|mesh-list
139335823|NCT02304081|Incretins|incretins|mesh-ancestor
139335824|NCT02304081|Hormones|hormones|mesh-ancestor
139335825|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139335826|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335827|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139335828|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
139335829|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335830|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335831|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139335832|NCT02304237|Progesterone|progesterone|mesh-list
139335833|NCT02304237|Progestins|progestins|mesh-ancestor
139335835|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139335836|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335837|NCT03515187|Bromides|bromides|mesh-list
139335838|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139335839|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139335840|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
139335841|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
139335842|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139335843|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
139335844|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335845|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
139335846|NCT03515187|Protective Agents|protective agents|mesh-ancestor
139335847|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
139335848|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139335849|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139335850|NCT02395016|Gemcitabine|gemcitabine|mesh-list
139335851|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
139335852|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139335853|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
139335854|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335855|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915568|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
139335856|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139335857|NCT04480268|Paclitaxel|paclitaxel|mesh-list
139335858|NCT04480268|Gemcitabine|gemcitabine|mesh-list
139335859|NCT04480268|Capecitabine|capecitabine|mesh-list
139335860|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139335861|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335862|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
139335863|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
139335864|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
139335865|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335866|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139335867|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
139335868|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139335869|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
139335870|NCT03510975|Coagulants|coagulants|mesh-ancestor
139335871|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139335872|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
139335873|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335874|NCT03169790|Leucovorin|leucovorin|mesh-list
139335875|NCT03169790|Paclitaxel|paclitaxel|mesh-list
139335876|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
139335877|NCT03169790|Bevacizumab|bevacizumab|mesh-list
139335878|NCT03169790|Rituximab|rituximab|mesh-list
139335879|NCT03169790|Capecitabine|capecitabine|mesh-list
139335880|NCT03169790|Fluorouracil|fluorouracil|mesh-list
139335881|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
139335882|NCT03169790|Avelumab|avelumab|mesh-list
139335883|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139335884|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335885|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
139335886|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
139335887|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
139180263|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139335888|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335890|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
139335891|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335892|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139335893|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139335894|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
139335895|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139335896|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139335897|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139335898|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139335899|NCT03169790|Growth Substances|growth substances|mesh-ancestor
139335900|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
139335901|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139335902|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
139335903|NCT03169790|Antidotes|antidotes|mesh-ancestor
139335904|NCT03169790|Protective Agents|protective agents|mesh-ancestor
139335905|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
139335906|NCT03169790|Vitamins|vitamins|mesh-ancestor
139335907|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
139335908|NCT02304393|Atezolizumab|atezolizumab|mesh-list
139335909|NCT02304393|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139335910|NCT02304393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335911|NCT02304393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139335912|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335913|NCT02402972|Leucovorin|leucovorin|mesh-list
139335914|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
139335915|NCT02402972|Floxuridine|floxuridine|mesh-list
139335916|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
139335917|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335918|NCT02402972|Antidotes|antidotes|mesh-ancestor
139335919|NCT02402972|Protective Agents|protective agents|mesh-ancestor
139335920|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335921|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
139335922|NCT02402972|Vitamins|vitamins|mesh-ancestor
139335923|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
139335924|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139335925|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
139335926|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335927|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
139335928|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335929|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139335930|NCT02394470|Protective Agents|protective agents|mesh-ancestor
139335931|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335932|NCT02304627|Insulin|insulin|mesh-list
139335933|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139335934|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335935|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
139335936|NCT02394158|Metformin|metformin|mesh-list
139335937|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139335938|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335939|NCT03508635|Prednisone|prednisone|mesh-list
139335940|NCT03508635|Cortisone|cortisone|mesh-list
139335941|NCT03508635|Mifepristone|mifepristone|mesh-list
139335942|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139335943|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
139335944|NCT03508635|Hormones|hormones|mesh-ancestor
139335945|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139335946|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335947|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139335948|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335949|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139335950|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
139335951|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139335952|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139335953|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139335954|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139335955|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
139335956|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139335957|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139335958|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
139335959|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
139335960|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139335961|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139335962|NCT04481282|Terbutaline|terbutaline|mesh-list
139335963|NCT04481282|Danazol|danazol|mesh-list
139335964|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139335965|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
139335966|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335967|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335968|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139335969|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
139335970|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
139335971|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
139335972|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139335973|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139335974|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139335975|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139335976|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
139335977|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139335978|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335979|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139335980|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
139335981|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139335982|NCT02541604|Atezolizumab|atezolizumab|mesh-list
139335983|NCT02541604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139335984|NCT02541604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335985|NCT02541604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139335986|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139335987|NCT02393846|Ketoprofen|ketoprofen|mesh-list
139335988|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139335989|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139335990|NCT02393846|Analgesics|analgesics|mesh-ancestor
139335991|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
139335992|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139335993|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139335994|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139335995|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139335996|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139335997|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139335998|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139335999|NCT02302209|Oxytocin|oxytocin|mesh-list
139336000|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
139336001|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139336002|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336003|NCT02394002|Propofol|propofol|mesh-list
139336004|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139336005|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336006|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336007|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139336008|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
139336009|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
139336010|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139336011|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139336012|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139336013|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
139336014|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139336015|NCT02402348|Metformin|metformin|mesh-list
139336016|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139336017|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336018|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139336019|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139336020|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
139336021|NCT02399462|Hormones|hormones|mesh-ancestor
139336022|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336023|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336024|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336025|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336026|NCT03505047|Copper|copper|mesh-list
139336027|NCT03505047|Trace Elements|trace elements|mesh-ancestor
139336028|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
139336029|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336030|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
139336031|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139336033|NCT02305485|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139336034|NCT02305485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139336035|NCT02305485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336036|NCT02305485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336037|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139336038|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
139336039|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336040|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336041|NCT02311569|Mirabegron|mirabegron|mesh-list
139336042|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139336043|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139336044|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139336045|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
139336046|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336047|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336048|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336049|NCT02311569|Urological Agents|urological agents|mesh-ancestor
139336050|NCT02393456|Oxytocin|oxytocin|mesh-list
139336051|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
139336052|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139336053|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336054|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
139336055|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139336056|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139336057|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336058|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139336059|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139336060|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
139336061|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336062|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336064|NCT02306733|Ergonovine|ergonovine|mesh-list
139336065|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
139336066|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139336067|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336068|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139336069|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
139336070|NCT03507465|Capecitabine|capecitabine|mesh-list
139336071|NCT03507465|Letrozole|letrozole|mesh-list
139336072|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139336073|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
139336074|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336075|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336076|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139336077|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139336078|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336079|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139336080|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
139336081|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336082|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336083|NCT05476042|Epoetin Alfa|epoetin alfa|mesh-list
139336084|NCT05476042|Hematinics|hematinics|mesh-ancestor
139336085|NCT03507387|Phenylephrine|phenylephrine|mesh-list
139336086|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
139336087|NCT03507387|Bupivacaine|bupivacaine|mesh-list
139336088|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
139336089|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
139336090|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336091|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336092|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
139336093|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139180277|NCT03940469|Hormones|hormones|mesh-ancestor
139336094|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139336095|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
139336096|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
139336097|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
139336098|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139336099|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
139336100|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
139336101|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139336102|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139336103|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139336104|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
139336105|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336106|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336107|NCT03507387|Protective Agents|protective agents|mesh-ancestor
139336108|NCT02694536|Gemcitabine|gemcitabine|mesh-list
139336109|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139336110|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139336111|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
139336112|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336113|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336114|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139336115|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336116|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
139336117|NCT02312037|Antibodies|antibodies|mesh-list
139336118|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
139336119|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
139336120|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336121|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139336122|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336123|NCT02312037|Immunotoxins|immunotoxins|mesh-ancestor
139336124|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
139336125|NCT03167918|Metformin|metformin|mesh-list
139336126|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
139336127|NCT03167918|Calcium|calcium|mesh-list
139336128|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139336129|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336130|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139336131|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138993011|NCT05324891|Fentanyl|fentanyl|mesh-list
139336132|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
139336133|NCT03167918|Coagulants|coagulants|mesh-ancestor
139336134|NCT05745818|Colchicine|colchicine|mesh-list
139336135|NCT05745818|Gout Suppressants|gout suppressants|mesh-ancestor
139336136|NCT05745818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139336137|NCT05745818|Tubulin Modulators|tubulin modulators|mesh-ancestor
139336138|NCT05745818|Antimitotic Agents|antimitotic agents|mesh-ancestor
139336139|NCT05745818|Mitosis Modulators|mitosis modulators|mesh-ancestor
139336140|NCT05745818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336141|NCT05745818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336142|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
139336143|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139336144|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139336145|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336146|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
139336147|NCT02393300|Coagulants|coagulants|mesh-ancestor
139336148|NCT03106610|Nivolumab|nivolumab|mesh-list
139336149|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139336150|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336151|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139336152|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336153|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139336154|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139336155|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336156|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
139336157|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139336158|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139336159|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
139336160|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336161|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139336162|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139336163|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139336164|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139336165|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139180288|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139336166|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336167|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139336168|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336169|NCT05475886|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
139336170|NCT05475886|Plasma Substitutes|plasma substitutes|mesh-ancestor
139336171|NCT05475886|Blood Substitutes|blood substitutes|mesh-ancestor
139336172|NCT02312115|Furosemide|furosemide|mesh-list
139336173|NCT02312115|Diuretics|diuretics|mesh-ancestor
139336174|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
139336175|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336176|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139336177|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139336178|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915619|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
139336179|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139336180|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139336181|NCT03026140|Celecoxib|celecoxib|mesh-list
139336182|NCT03026140|Nivolumab|nivolumab|mesh-list
139336183|NCT03026140|Ipilimumab|ipilimumab|mesh-list
139336184|NCT03026140|Relatlimab|relatlimab|mesh-list
139336185|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139336186|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336187|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139336188|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336189|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139336190|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139336191|NCT03026140|Analgesics|analgesics|mesh-ancestor
139336192|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
139336193|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336194|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336195|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139336196|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139336197|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139336198|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139336199|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336200|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
139336201|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
139336202|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139336203|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
139336204|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139336205|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139336206|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
139336207|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
139336208|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336209|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336210|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139336211|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
139336212|NCT02398994|Hormones|hormones|mesh-ancestor
139336213|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336214|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139336215|NCT02398994|Protective Agents|protective agents|mesh-ancestor
139336216|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
139336217|NCT02306889|Fenofibrate|fenofibrate|mesh-list
139336218|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139336219|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
139336220|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336221|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139336222|NCT02393144|Meperidine|meperidine|mesh-list
139336223|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
139336224|NCT02393144|Analgesics|analgesics|mesh-list
139336225|NCT02393144|Oxytocin|oxytocin|mesh-list
139336226|NCT02393144|Dinoprostone|dinoprostone|mesh-list
139336227|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
139336228|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139336229|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336230|NCT02393144|Narcotics|narcotics|mesh-ancestor
139336231|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336232|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
139336233|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336234|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139336235|NCT02306031|Diclofenac|diclofenac|mesh-list
139336236|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
139336237|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139336238|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139336239|NCT02306031|Analgesics|analgesics|mesh-ancestor
139336240|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
139336241|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336242|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336243|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139336244|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139336245|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139336246|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336247|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336248|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139336249|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139336250|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139336251|NCT02392910|Hematinics|hematinics|mesh-ancestor
139336252|NCT02307045|Nicotine|nicotine|mesh-list
139336253|NCT02307045|Varenicline|varenicline|mesh-list
139336254|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139336255|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
139336256|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336257|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336258|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139336259|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139336260|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
139336261|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336262|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336263|NCT03167372|Imidacloprid|imidacloprid|mesh-list
139336264|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
139336265|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336266|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336267|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336268|NCT03504345|Progesterone|progesterone|mesh-list
139336269|NCT03504345|Progestins|progestins|mesh-ancestor
139336270|NCT03504345|Hormones|hormones|mesh-ancestor
139336271|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336272|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336273|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
139336274|NCT02307201|Analgesics|analgesics|mesh-ancestor
139336275|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
139336276|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336277|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336278|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
139336279|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336280|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139336281|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
139336282|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139336283|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139336284|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336285|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139336286|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
139336287|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139336288|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
139336289|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139336290|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336291|NCT03167216|Cetirizine|cetirizine|mesh-list
139336292|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
139336293|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139336294|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139336295|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139336296|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
139336297|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
139336298|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336299|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336300|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336301|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
139336302|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
139336303|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139336304|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139336305|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
139336307|NCT02393066|Propofol|propofol|mesh-list
139336308|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139336309|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336310|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336311|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139336312|NCT02393066|Analgesics|analgesics|mesh-ancestor
139336313|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
139336314|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336315|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139336316|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139336317|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139336318|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
139336319|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336320|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336321|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139336322|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
139336323|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
139336324|NCT02398838|Misoprostol|misoprostol|mesh-list
139336325|NCT02398838|Mifepristone|mifepristone|mesh-list
139336326|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139336327|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
139336328|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139336329|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336330|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139336331|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139336332|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
139336333|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139336334|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139336335|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139336336|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139336337|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
139336338|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139336339|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139336340|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
139336341|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336342|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
139336343|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139336344|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139336345|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
139336346|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
139336347|NCT02398682|Protective Agents|protective agents|mesh-ancestor
139336348|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336349|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139336350|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
139336351|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336352|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336353|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139336354|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336355|NCT03504033|Desflurane|desflurane|mesh-list
139336356|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139336357|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
139336358|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
139336359|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336360|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336361|NCT03132519|Remifentanil|remifentanil|mesh-list
139336362|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139336363|NCT03132519|Narcotics|narcotics|mesh-ancestor
139336364|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336365|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336366|NCT03132519|Analgesics|analgesics|mesh-ancestor
139336367|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
139336368|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336369|NCT02398448|Allopurinol|allopurinol|mesh-list
139336370|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
139336371|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336372|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336373|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
139336374|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139336375|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139336376|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
139336377|NCT02398448|Protective Agents|protective agents|mesh-ancestor
139336378|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336379|NCT02392520|Cetrorelix|cetrorelix|mesh-list
139336380|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139336381|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
139336382|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139336383|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336384|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
139336385|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336386|NCT02316249|Estradiol|estradiol|mesh-list
139336387|NCT02316249|Hormones|hormones|mesh-ancestor
139336388|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336389|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336390|NCT02316249|Estrogens|estrogens|mesh-ancestor
139336391|NCT02696096|Buprenorphine|buprenorphine|mesh-list
139336392|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139336393|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139336394|NCT02696096|Narcotics|narcotics|mesh-ancestor
139336395|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336396|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336397|NCT02696096|Analgesics|analgesics|mesh-ancestor
139336398|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
139336399|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336400|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139336401|NCT02316327|Bevacizumab|bevacizumab|mesh-list
139336402|NCT02316327|Gemcitabine|gemcitabine|mesh-list
139336403|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139336404|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336405|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139336406|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139336407|NCT02316327|Growth Substances|growth substances|mesh-ancestor
139336408|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336409|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
139336410|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139336411|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
139336412|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336413|NCT02695628|Misonidazole|misonidazole|mesh-list
138915684|NCT00761280|Temozolomide|temozolomide|mesh-list
139336414|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336415|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139336416|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139336417|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139336418|NCT02392364|Aflibercept|aflibercept|mesh-list
139336419|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139336420|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139336421|NCT02392364|Growth Substances|growth substances|mesh-ancestor
139336422|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336423|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
139336424|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336425|NCT02392676|Olaparib|olaparib|mesh-list
139336426|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139336427|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336428|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993309|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139336429|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336430|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139336431|NCT03106298|Hematinics|hematinics|mesh-ancestor
139336432|NCT02307591|Amiodarone|amiodarone|mesh-list
139336433|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139336434|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
139336435|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139336436|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139336437|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336438|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139336439|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139336440|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139336441|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336442|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139336443|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139336444|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139336445|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
139336446|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139336447|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336448|NCT03506997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139336449|NCT03506997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336450|NCT02398136|Midazolam|midazolam|mesh-list
139336451|NCT02398136|Ketamine|ketamine|mesh-list
139336452|NCT02398136|Analgesics|analgesics|mesh-ancestor
139336453|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
139336454|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336455|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336456|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139336457|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139336458|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
139336459|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
139336460|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336461|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139336462|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139336463|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336464|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336465|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139336466|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139336467|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139336468|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139336469|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139336470|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
139336471|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
139336472|NCT05745584|Mirabegron|mirabegron|mesh-list
139336473|NCT05745584|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139336474|NCT05745584|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139336475|NCT05745584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139336476|NCT05745584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139336477|NCT05745584|Adrenergic Agents|adrenergic agents|mesh-ancestor
139336478|NCT05745584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336479|NCT05745584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336480|NCT05745584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336481|NCT05745584|Urological Agents|urological agents|mesh-ancestor
139336482|NCT05745584|Cholinergic Agents|cholinergic agents|mesh-ancestor
139336483|NCT02312661|Metformin|metformin|mesh-list
139336484|NCT02312661|Paclitaxel|paclitaxel|mesh-list
139336485|NCT02312661|Carboplatin|carboplatin|mesh-list
139336486|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139336487|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336488|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
139336489|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
139336490|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
139336491|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336492|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139336493|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336494|NCT02398058|Olaparib|olaparib|mesh-list
139336495|NCT02398058|Trabectedin|trabectedin|mesh-list
139336496|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139336497|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336498|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336499|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336500|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139336501|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
139336502|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
139336503|NCT03501615|Immunotoxins|immunotoxins|mesh-ancestor
139336505|NCT03501615|Immunologic Factors|immunologic factors|mesh-ancestor
139336506|NCT03501615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336507|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336508|NCT03506919|Allopurinol|allopurinol|mesh-list
139336509|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
139336510|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336511|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336512|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
139336513|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139336514|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139336515|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
139336516|NCT03506919|Protective Agents|protective agents|mesh-ancestor
139336517|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336518|NCT02545504|Leucovorin|leucovorin|mesh-list
139336519|NCT02545504|Fluorouracil|fluorouracil|mesh-list
139336520|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
139336521|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
139336522|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336523|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139336524|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336525|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139336526|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
139336527|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336528|NCT02545504|Antidotes|antidotes|mesh-ancestor
139336529|NCT02545504|Protective Agents|protective agents|mesh-ancestor
139336530|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
139336531|NCT02545504|Vitamins|vitamins|mesh-ancestor
139336532|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
139336533|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
139336534|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139336535|NCT03506841|Protective Agents|protective agents|mesh-ancestor
139336536|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336537|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
139336538|NCT02397512|Lactulose|lactulose|mesh-list
139336539|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139336540|NCT02313051|Everolimus|everolimus|mesh-list
139336541|NCT02313051|Letrozole|letrozole|mesh-list
139336542|NCT02313051|Goserelin|goserelin|mesh-list
139336543|NCT02313051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139336544|NCT02313051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139336545|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336546|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336547|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139336548|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
139336549|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336550|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336551|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139336552|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139336553|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139336554|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
139336555|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336556|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139336557|NCT02397590|Atorvastatin|atorvastatin|mesh-list
139336558|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139336559|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139336560|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
139336561|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336562|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139336563|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139336564|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336565|NCT02397356|Ketamine|ketamine|mesh-list
139336566|NCT02397356|Analgesics|analgesics|mesh-ancestor
139336567|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
139336568|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336569|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336570|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139336571|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139336572|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
139336573|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
139336574|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336575|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139336576|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139336577|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336578|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336580|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139336581|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139336582|NCT02540668|Warfarin|warfarin|mesh-list
139336583|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
139336584|NCT03506763|Diclofenac|diclofenac|mesh-list
139336585|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139336586|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139336587|NCT03506763|Analgesics|analgesics|mesh-ancestor
139336588|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
139336589|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336590|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336591|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139336592|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139336593|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139336594|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336595|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336596|NCT02441439|Iron|iron|mesh-list
139336597|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139336598|NCT02441439|Trace Elements|trace elements|mesh-ancestor
139336599|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
139336600|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336601|NCT02441439|Hematinics|hematinics|mesh-ancestor
139336602|NCT02308137|Domperidone|domperidone|mesh-list
139336603|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336604|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
139336605|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
139336606|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336607|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336608|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139336609|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139336610|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
139336611|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336612|NCT03501459|Rituximab|rituximab|mesh-list
139336613|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139336614|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336615|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
139336616|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336617|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139336618|NCT02317263|Testosterone|testosterone|mesh-list
139336619|NCT02317263|Androgens|androgens|mesh-ancestor
139336620|NCT02317263|Hormones|hormones|mesh-ancestor
139336621|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336622|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336623|NCT02317341|Midazolam|midazolam|mesh-list
139336624|NCT02317341|Ketamine|ketamine|mesh-list
139336625|NCT02317341|Analgesics|analgesics|mesh-ancestor
139336626|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
139336627|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336628|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336629|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139336630|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139336631|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
139336632|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
139336633|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336634|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139336635|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139336636|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336637|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336638|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139336639|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139336640|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139336641|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139336642|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139336643|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
139336644|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
139336645|NCT02317419|Paclitaxel|paclitaxel|mesh-list
139336646|NCT02317419|Gemcitabine|gemcitabine|mesh-list
139336647|NCT02317419|LMB-100|lmb-100|mesh-list
139336648|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139336649|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336650|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
139336651|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
139336652|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
139336653|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336654|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139336655|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
139336656|NCT02317419|Immunoconjugates|immunoconjugates|mesh-ancestor
139336657|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
139336658|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336659|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139336661|NCT03943888|Neostigmine|neostigmine|mesh-list
139336662|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139336663|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139336664|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139336665|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
139336666|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336667|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336668|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139336669|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
139336670|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
139336671|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
139336672|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139336673|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139336674|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
139336675|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336676|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336677|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139336678|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336679|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139336680|NCT03502551|Ketamine|ketamine|mesh-list
139336681|NCT03502551|Analgesics|analgesics|mesh-ancestor
139336682|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
139336683|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336684|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336685|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139336686|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139336687|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
139336688|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
139336689|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336690|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139336691|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139336692|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336693|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336694|NCT02314377|Bevacizumab|bevacizumab|mesh-list
139336695|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139336696|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336697|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139336698|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139336699|NCT02314377|Growth Substances|growth substances|mesh-ancestor
139336700|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336701|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
139336702|NCT02942290|Azacitidine|azacitidine|mesh-list
139336703|NCT02942290|Venetoclax|venetoclax|mesh-list
139336704|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139336705|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
139336706|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336707|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336708|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336709|NCT02540356|Antibodies|antibodies|mesh-list
139336710|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
139336711|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
139336712|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336713|NCT05463094|Metformin|metformin|mesh-list
139336714|NCT05463094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139336715|NCT05463094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336716|NCT05431348|Hydrocortisone|hydrocortisone|mesh-list
139336717|NCT05431348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139336718|NCT02392130|Clobetasol|clobetasol|mesh-list
139336719|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139336720|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
139336721|NCT02392130|Hormones|hormones|mesh-ancestor
139336722|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336723|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336725|NCT05356091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139336726|NCT05356091|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139336727|NCT05356091|Anesthetics, General|anesthetics, general|mesh-ancestor
139336728|NCT05356091|Anesthetics|anesthetics|mesh-ancestor
139336729|NCT05356091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336730|NCT05356091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336731|NCT05351021|Metformin|metformin|mesh-list
139336732|NCT05351021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139336733|NCT05351021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336734|NCT02688764|Calcium|calcium|mesh-list
139336735|NCT02688764|Calcium acetate|calcium acetate|mesh-list
139336736|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139336737|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336738|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
139336739|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
139336740|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336741|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
139336742|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139336743|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336744|NCT02688608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139336745|NCT02688608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336746|NCT02688530|Dexamethasone|dexamethasone|mesh-list
139336747|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
139336748|NCT02688530|BB 1101|bb 1101|mesh-list
139336749|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139336750|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
139336751|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
139336752|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336753|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336754|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139336755|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
139336756|NCT02688530|Hormones|hormones|mesh-ancestor
139336757|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336758|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139336759|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336760|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
139336761|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336762|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336763|NCT05744804|Aspirin|aspirin|mesh-list
139336764|NCT05744804|Rivaroxaban|rivaroxaban|mesh-list
139336765|NCT05744804|Clopidogrel|clopidogrel|mesh-list
139336766|NCT05744804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139336767|NCT05744804|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139336768|NCT05744804|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139336769|NCT05744804|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139336770|NCT05744804|Purinergic Agents|purinergic agents|mesh-ancestor
139336771|NCT05744804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336772|NCT05744804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336773|NCT05744804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336774|NCT05744804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139336775|NCT05744804|Antithrombins|antithrombins|mesh-ancestor
139336776|NCT05744804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139336777|NCT05744804|Protease Inhibitors|protease inhibitors|mesh-ancestor
139336778|NCT05744804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336779|NCT05744804|Anticoagulants|anticoagulants|mesh-ancestor
139336780|NCT05744804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139336781|NCT05744804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139336782|NCT05744804|Analgesics|analgesics|mesh-ancestor
139336783|NCT05744804|Sensory System Agents|sensory system agents|mesh-ancestor
139336784|NCT05744804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336785|NCT05744804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139336786|NCT05744804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139336787|NCT05744804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139336788|NCT05744804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139336789|NCT05744804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139336790|NCT05744804|Antipyretics|antipyretics|mesh-ancestor
139336791|NCT05744726|Bone wax|bone wax|mesh-list
139336792|NCT05744726|Hemostatics|hemostatics|mesh-ancestor
139336793|NCT05744726|Coagulants|coagulants|mesh-ancestor
139336794|NCT02467270|Ponatinib|ponatinib|mesh-list
139336795|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336796|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139336797|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336798|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336799|NCT05150795|Pregabalin|pregabalin|mesh-list
139336800|NCT05150795|Fentanyl|fentanyl|mesh-list
139336801|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139336802|NCT05150795|Narcotics|narcotics|mesh-ancestor
139336803|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336804|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336805|NCT05150795|Analgesics|analgesics|mesh-ancestor
139336806|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
139336807|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336808|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139336809|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139336810|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
139336811|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
139336812|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
139336813|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139336814|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139336815|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336816|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139336817|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139336818|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139336819|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139336820|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
139336821|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
139336822|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139336823|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139336824|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139336825|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139336826|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336827|NCT02533570|Immunotoxins|immunotoxins|mesh-ancestor
139336828|NCT02533570|Immunoconjugates|immunoconjugates|mesh-ancestor
139336829|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
139336830|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336831|NCT02268448|Clonidine|clonidine|mesh-list
139336832|NCT02268448|Naltrexone|naltrexone|mesh-list
139336833|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139336834|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139336835|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336836|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
139336837|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336838|NCT02268448|Analgesics|analgesics|mesh-ancestor
139336839|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139336840|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
139336841|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
139336842|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139336843|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139336844|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139336845|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
139336846|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336847|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336848|NCT05744570|Anesthetics|anesthetics|mesh-list
139336849|NCT05744570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139336850|NCT05744570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336851|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
139336852|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139336853|NCT03036839|Ledipasvir|ledipasvir|mesh-list
139336854|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
139336855|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139336856|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139336857|NCT04977791|Antibodies|antibodies|mesh-list
139336858|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139336859|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
139336860|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336861|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336862|NCT04977791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139180331|NCT01213433|Artesunate|artesunate|mesh-list
139336863|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336864|NCT03625739|Amoxicillin|amoxicillin|mesh-list
139336865|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
139336866|NCT03625739|Levofloxacin|levofloxacin|mesh-list
139336867|NCT03625739|Isoniazid|isoniazid|mesh-list
139336868|NCT03625739|Cycloserine|cycloserine|mesh-list
139336869|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
139336870|NCT03625739|Imipenem|imipenem|mesh-list
139336871|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
139336872|NCT03625739|Amikacin|amikacin|mesh-list
139336873|NCT03625739|Ethambutol|ethambutol|mesh-list
139336874|NCT03625739|Bedaquiline|bedaquiline|mesh-list
139336875|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139336876|NCT03625739|Clofazimine|clofazimine|mesh-list
139336877|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
139336878|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
139336879|NCT03625739|Streptomycin|streptomycin|mesh-list
139336880|NCT03625739|Kanamycin|kanamycin|mesh-list
139336881|NCT03625739|Ethionamide|ethionamide|mesh-list
139336882|NCT03625739|Capreomycin|capreomycin|mesh-list
139336883|NCT03625739|Thioacetazone|thioacetazone|mesh-list
139336884|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
139336885|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139336886|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139336887|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139336888|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139336889|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336890|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336891|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336892|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139336893|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139336894|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139336895|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139336896|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
139336897|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139336898|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139336899|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
139336900|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139336901|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139336902|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139336903|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139336904|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139336905|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139336907|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139336908|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139336909|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336910|NCT03902951|Leuprolide|leuprolide|mesh-list
139336911|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
139336912|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139336913|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
139336914|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139336915|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336916|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139336917|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336918|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139336919|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139336920|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336921|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
139336922|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336923|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139336924|NCT01286207|Rizatriptan|rizatriptan|mesh-list
139336925|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139336926|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
139336927|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139336928|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336929|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336930|NCT05408026|Dexamethasone|dexamethasone|mesh-list
139336931|NCT05408026|Bortezomib|bortezomib|mesh-list
139336932|NCT05408026|Daratumumab|daratumumab|mesh-list
139336933|NCT05408026|Pomalidomide|pomalidomide|mesh-list
139336934|NCT05408026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139336935|NCT05408026|Antiemetics|antiemetics|mesh-ancestor
139336936|NCT05408026|Autonomic Agents|autonomic agents|mesh-ancestor
139336937|NCT05408026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139336938|NCT05408026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336939|NCT05408026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139336940|NCT05408026|Glucocorticoids|glucocorticoids|mesh-ancestor
139336941|NCT05408026|Hormones|hormones|mesh-ancestor
139336942|NCT05408026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336943|NCT05408026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139336944|NCT05408026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139336945|NCT05408026|Immunologic Factors|immunologic factors|mesh-ancestor
139336946|NCT05408026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139336947|NCT05408026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139336948|NCT05408026|Growth Substances|growth substances|mesh-ancestor
139336949|NCT05408026|Growth Inhibitors|growth inhibitors|mesh-ancestor
139336950|NCT04423510|Phenol|phenol|mesh-list
139336951|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139336952|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139336953|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
139336954|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139336955|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139336956|NCT00968201|Montelukast|montelukast|mesh-list
139336957|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139336958|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
139336959|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139336960|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
139336961|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138993850|NCT00946946|Mesalamine|mesalamine|mesh-list
139336962|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336963|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139336964|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139336965|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336966|NCT00943397|Montelukast|montelukast|mesh-list
139336967|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139336968|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
139336969|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139336970|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
139336971|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336972|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336973|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139336974|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139336975|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139336976|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
139336977|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139336978|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
139336979|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139336980|NCT00702845|Hormones|hormones|mesh-list
139336981|NCT00702845|Progesterone|progesterone|mesh-list
139336982|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139336983|NCT00702845|Ganirelix|ganirelix|mesh-list
139336984|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139336985|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336986|NCT00702845|Progestins|progestins|mesh-ancestor
139336987|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
139336988|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139336990|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139336991|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139336992|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139336993|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
139336994|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139336995|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139336996|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139336997|NCT00647933|Estrogens|estrogens|mesh-ancestor
139336998|NCT00647933|Hormones|hormones|mesh-ancestor
138915849|NCT00759564|Lactams|lactams|mesh-list
139336999|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337000|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139337001|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
139337002|NCT00641771|Vitamin D|vitamin d|mesh-list
139337003|NCT00641771|Alendronate|alendronate|mesh-list
139337004|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139337005|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337006|NCT00641771|Vitamins|vitamins|mesh-ancestor
139337007|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
139337008|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139337009|NCT00519857|Tibolone|tibolone|mesh-list
139337010|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
139337011|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
139337012|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337013|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337014|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139337015|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139337016|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337017|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139337018|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
139337019|NCT00519857|Hormones|hormones|mesh-ancestor
139337020|NCT00431093|Tibolone|tibolone|mesh-list
139337021|NCT00431093|Estradiol|estradiol|mesh-list
139337022|NCT00431093|Estrogens|estrogens|mesh-ancestor
139337023|NCT00431093|Hormones|hormones|mesh-ancestor
139337024|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337025|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337026|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
139337027|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
139337028|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139337029|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139337030|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337031|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139337032|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
139337033|NCT00092963|Rizatriptan|rizatriptan|mesh-list
139337034|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337035|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337036|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337037|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139337038|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
139337039|NCT00092885|Montelukast|montelukast|mesh-list
139337040|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139337041|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
139337042|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139337043|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
139337044|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337045|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337046|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139337047|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139337048|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337049|NCT03673735|Durvalumab|durvalumab|mesh-list
139337050|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337051|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139337052|NCT00092105|Montelukast|montelukast|mesh-list
139337053|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139337054|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
139337055|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139337056|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
139180363|NCT06107803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139337057|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337058|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337059|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139337060|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139337061|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337062|NCT00092027|Alendronate|alendronate|mesh-list
139337063|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337064|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139337065|NCT00076973|Montelukast|montelukast|mesh-list
139337066|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139337067|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
139337068|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139337069|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
139337070|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337071|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337072|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139337073|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139337074|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337075|NCT02314533|Fenofibrate|fenofibrate|mesh-list
139337076|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139337077|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
139337078|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337079|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139337080|NCT03502395|Lidocaine|lidocaine|mesh-list
139337081|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
139337082|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
139337083|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139337084|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337085|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
139337086|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337087|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139337088|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139337089|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139337090|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139337091|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337092|NCT02318043|Fluticasone|fluticasone|mesh-list
139337093|NCT02318043|Budesonide|budesonide|mesh-list
139337094|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139337095|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139337096|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139337097|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139337098|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
139337099|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337100|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337101|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139337102|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
139337103|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
139337104|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139337105|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
139337106|NCT02318043|Hormones|hormones|mesh-ancestor
139337107|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337108|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139337109|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139337110|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139337111|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
139337112|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337113|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337114|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
139337115|NCT03433313|Trastuzumab|trastuzumab|mesh-list
139337116|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139337117|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337118|NCT02318121|Oxytocin|oxytocin|mesh-list
139337119|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
139337120|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139337121|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337122|NCT02318199|Anesthetics|anesthetics|mesh-list
139337123|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139337124|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337125|NCT05225597|Carbachol|carbachol|mesh-list
139337126|NCT05225597|Epinephrine|epinephrine|mesh-list
139337127|NCT05225597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139337128|NCT05225597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139337129|NCT05225597|Adrenergic Agents|adrenergic agents|mesh-ancestor
139337130|NCT05225597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337131|NCT05225597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337132|NCT05225597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337133|NCT05225597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139337134|NCT05225597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139337135|NCT05225597|Autonomic Agents|autonomic agents|mesh-ancestor
139337136|NCT05225597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337137|NCT05225597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139337138|NCT05225597|Respiratory System Agents|respiratory system agents|mesh-ancestor
139337139|NCT05225597|Mydriatics|mydriatics|mesh-ancestor
139337140|NCT05225597|Sympathomimetics|sympathomimetics|mesh-ancestor
139337141|NCT05225597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139337142|NCT05225597|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139337143|NCT05225597|Miotics|miotics|mesh-ancestor
139337144|NCT05225597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139337145|NCT05225597|Cholinergic Agents|cholinergic agents|mesh-ancestor
139337146|NCT05225597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139337147|NCT05225597|Analgesics|analgesics|mesh-ancestor
139337148|NCT05225597|Sensory System Agents|sensory system agents|mesh-ancestor
139337149|NCT05225597|Protective Agents|protective agents|mesh-ancestor
139337150|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
139337151|NCT03070327|Lenalidomide|lenalidomide|mesh-list
139337152|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139337153|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
139337154|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337155|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139337156|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139337157|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
139337158|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337159|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337160|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139337161|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139337162|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139337163|NCT03070327|Growth Substances|growth substances|mesh-ancestor
139337164|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
139337165|NCT00543127|Fulvestrant|fulvestrant|mesh-list
139337166|NCT00543127|Anastrozole|anastrozole|mesh-list
139337167|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139337168|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337169|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139337170|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139337171|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
139337172|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337173|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337174|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139337175|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139337176|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337177|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337178|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139337179|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139337180|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994080|NCT01083589|Docetaxel|docetaxel|mesh-list
139337181|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337182|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
139337183|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337184|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337185|NCT02309385|Dexamethasone|dexamethasone|mesh-list
139337186|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
139337187|NCT02309385|Prednisolone|prednisolone|mesh-list
139337188|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139337189|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
139337190|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139337191|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
139337192|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139337193|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
139337194|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139337195|NCT02309385|BB 1101|bb 1101|mesh-list
139337196|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139337197|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
139337198|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
139337199|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337200|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337201|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139337202|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
139337203|NCT02309385|Hormones|hormones|mesh-ancestor
139337204|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337205|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139337206|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337207|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
139337208|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337209|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337210|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139337211|NCT02309385|Protective Agents|protective agents|mesh-ancestor
139337212|NCT02315001|Liraglutide|liraglutide|mesh-list
139337213|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139337214|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337215|NCT02315001|Incretins|incretins|mesh-ancestor
139337216|NCT02315001|Hormones|hormones|mesh-ancestor
139337217|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337218|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139337219|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139337220|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
139337221|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337222|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337223|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
139337224|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337225|NCT03500367|Sirolimus|sirolimus|mesh-list
139337226|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139337227|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139337228|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139337229|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337230|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
139337231|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139337232|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
139337233|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337234|NCT02318433|Dexamethasone|dexamethasone|mesh-list
139337235|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139337236|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
139337237|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
139337238|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337239|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337240|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139337241|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
139337242|NCT02318433|Hormones|hormones|mesh-ancestor
139337243|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337244|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139337245|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337246|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
139337247|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139337248|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
139337249|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337250|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
139337251|NCT02318511|Protective Agents|protective agents|mesh-ancestor
139337252|NCT02315391|Glycine|glycine|mesh-list
139337253|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
139337254|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337255|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337256|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337257|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
139337258|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139337259|NCT03022981|Velpatasvir|velpatasvir|mesh-list
139337260|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
139337261|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139337262|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
139337263|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
139337264|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337265|NCT03502005|Tenofovir|tenofovir|mesh-list
139337266|NCT03502005|Emtricitabine|emtricitabine|mesh-list
139337267|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139337268|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
139337269|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139337270|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139337271|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139337272|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337273|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337274|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139337275|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139337276|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139337277|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139337278|NCT03669445|Dexamethasone|dexamethasone|mesh-list
139337279|NCT03669445|Lenalidomide|lenalidomide|mesh-list
139337280|NCT03669445|Daratumumab|daratumumab|mesh-list
139337281|NCT03669445|Ixazomib|ixazomib|mesh-list
139337282|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139337283|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
139337284|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
139337285|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337286|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337287|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139337288|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
139337289|NCT03669445|Hormones|hormones|mesh-ancestor
139337290|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337291|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139337292|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337293|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
139337294|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139337295|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139337296|NCT03669445|Growth Substances|growth substances|mesh-ancestor
139337297|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
139337298|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
139337299|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337300|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337301|NCT03500133|Cytarabine|cytarabine|mesh-list
139337302|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
139337303|NCT03500133|Cisplatin|cisplatin|mesh-list
139337304|NCT03500133|Etoposide|etoposide|mesh-list
139337305|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337306|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139337307|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
139337308|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337309|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
139337310|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139337311|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139337312|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
139337313|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337314|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139337315|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139337316|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139337317|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337318|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139337319|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
139337320|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
139337321|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337322|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139337323|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
139337324|NCT03500133|Hormones|hormones|mesh-ancestor
139337325|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337326|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139337327|NCT03500133|Protective Agents|protective agents|mesh-ancestor
139337328|NCT04462809|Talazoparib|talazoparib|mesh-list
139337329|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139337330|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337331|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337332|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337333|NCT02320773|Mirabegron|mirabegron|mesh-list
139337334|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139337335|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139337336|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139337337|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
139337338|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337339|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337340|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337341|NCT02320773|Urological Agents|urological agents|mesh-ancestor
139337342|NCT03377699|Insulin|insulin|mesh-list
139337343|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139337344|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
139337345|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
139337346|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139337347|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337348|NCT04463901|Mitomycins|mitomycins|mesh-list
139337349|NCT04463901|Mitomycin|mitomycin|mesh-list
139337350|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139337351|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337352|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
139337353|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337354|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139337355|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337356|NCT01314443|Vitamin E|vitamin e|mesh-list
139337357|NCT01314443|Tocopherols|tocopherols|mesh-list
139337358|NCT01314443|Tocotrienols|tocotrienols|mesh-list
139337359|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
139337360|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
139337361|NCT01314443|Nicotine|nicotine|mesh-list
139337362|NCT01314443|Vitamins|vitamins|mesh-ancestor
139337363|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
139337364|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337365|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139337366|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
139337367|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337368|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139337369|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139337370|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
139337371|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337372|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337373|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
139337374|NCT01314443|Protective Agents|protective agents|mesh-ancestor
139337375|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139337376|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139337377|NCT03498417|Antibodies|antibodies|mesh-list
139337378|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
139337379|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337380|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
139337381|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139337382|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337383|NCT03212651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139337384|NCT03212651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337385|NCT02319135|Cytarabine|cytarabine|mesh-list
139337386|NCT02319135|Fludarabine|fludarabine|mesh-list
139337387|NCT02319135|Lenograstim|lenograstim|mesh-list
139337388|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337389|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139337390|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
139337391|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337392|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139337393|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
139337394|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337395|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
139337396|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139337397|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139337398|NCT03499743|Celecoxib|celecoxib|mesh-list
139337399|NCT03499743|Scopolamine|scopolamine|mesh-list
139337400|NCT03499743|Bromides|bromides|mesh-list
139337401|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139337402|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139337403|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139337404|NCT03499743|Analgesics|analgesics|mesh-ancestor
139337405|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
139337406|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337407|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337408|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139337409|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139337410|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139337411|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139337412|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337413|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337414|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
139337415|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139337416|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
139337417|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
139337418|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139337419|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
139337420|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139337421|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
139337422|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337423|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138916023|NCT05693090|Osimertinib|osimertinib|mesh-list
139337424|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
139337425|NCT02310087|Vitamin E|vitamin e|mesh-list
139337426|NCT02310087|Vitamins|vitamins|mesh-ancestor
139337427|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
139337428|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337429|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
139337430|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337431|NCT02310087|Protective Agents|protective agents|mesh-ancestor
139337432|NCT02923921|Leucovorin|leucovorin|mesh-list
139337433|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
139337434|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337435|NCT02923921|Antidotes|antidotes|mesh-ancestor
139337436|NCT02923921|Protective Agents|protective agents|mesh-ancestor
139337437|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337438|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
139337439|NCT02923921|Vitamins|vitamins|mesh-ancestor
139337440|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
139337441|NCT02310243|Palbociclib|palbociclib|mesh-list
139337442|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337443|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139337444|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337445|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337446|NCT03497715|Ibuprofen|ibuprofen|mesh-list
139337447|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139337448|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139337449|NCT03497715|Analgesics|analgesics|mesh-ancestor
139337450|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
139337451|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337452|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337453|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139337454|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139337455|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139337456|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337457|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337458|NCT02321241|Aflibercept|aflibercept|mesh-list
139337459|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139337460|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139337461|NCT02321241|Growth Substances|growth substances|mesh-ancestor
139337462|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337463|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
139337464|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337465|NCT03583307|Sirolimus|sirolimus|mesh-list
139337466|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139337467|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139337468|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139337469|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337470|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
139337471|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139337472|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
139337473|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337474|NCT03039023|Choline|choline|mesh-list
139337475|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
139337476|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139337477|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
139337478|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337479|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139337480|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139337481|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
139337482|NCT02321397|Oxycodone|oxycodone|mesh-list
139337483|NCT02321397|Naloxone|naloxone|mesh-list
139337484|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139337485|NCT02321397|Narcotics|narcotics|mesh-ancestor
139337486|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139337487|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337488|NCT02321397|Analgesics|analgesics|mesh-ancestor
139337489|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
139337490|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337491|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139337492|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
139337493|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139337494|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139337495|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337496|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
139337497|NCT02319915|Coagulants|coagulants|mesh-ancestor
139337498|NCT04898309|Complement C1s|complement c1s|mesh-list
139337499|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139337500|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
139337501|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
139337502|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337503|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139337504|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139337505|NCT03498963|Dimercaprol|dimercaprol|mesh-list
139337506|NCT03498963|Chelating Agents|chelating agents|mesh-ancestor
139337507|NCT03498963|Sequestering Agents|sequestering agents|mesh-ancestor
139337508|NCT03498963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337509|NCT02311101|Mitomycins|mitomycins|mesh-list
139337510|NCT02311101|Mitomycin|mitomycin|mesh-list
139337511|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139337512|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337513|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
139337514|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337515|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139337516|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337517|NCT04620187|Cisplatin|cisplatin|mesh-list
139337518|NCT04620187|Carboplatin|carboplatin|mesh-list
139337519|NCT04620187|Trastuzumab|trastuzumab|mesh-list
139337520|NCT04620187|Maytansine|maytansine|mesh-list
139337521|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337522|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139337523|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139337524|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
139337525|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
139337526|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
139337527|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337528|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
139337529|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139337530|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
139337531|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337532|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
139337533|NCT03668665|Protective Agents|protective agents|mesh-ancestor
139337534|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139337535|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
139337536|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139337537|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
139337538|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337539|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337540|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139337541|NCT03704909|Epinephrine|epinephrine|mesh-list
139337542|NCT03704909|Racepinephrine|racepinephrine|mesh-list
139337543|NCT03704909|Ephedrine|ephedrine|mesh-list
139337544|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
139337545|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139337546|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139337547|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
139337548|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337549|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337550|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337551|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139337552|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139337553|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
139337554|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337555|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139337556|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
139337557|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
139337558|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
139337559|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139337560|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139337561|NCT03704831|Anesthetics|anesthetics|mesh-list
139337562|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
139337563|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139337564|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337565|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
139337566|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337567|NCT03704675|Vactosertib|vactosertib|mesh-list
139337568|NCT03704675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139337569|NCT03704675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337570|NCT03704675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337571|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
139337572|NCT03494517|Analgesics|analgesics|mesh-ancestor
139337573|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
139337574|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337575|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337576|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
139337577|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139337578|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139337579|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
139337580|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139337581|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139337582|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337583|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139337584|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
139337585|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139337586|NCT04912427|Dexamethasone|dexamethasone|mesh-list
139337587|NCT04912427|Bortezomib|bortezomib|mesh-list
139337588|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139337589|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
139337590|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
139337591|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337592|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337593|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139337594|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
139337595|NCT04912427|Hormones|hormones|mesh-ancestor
139337596|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337597|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139337598|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337599|NCT02322645|Eszopiclone|eszopiclone|mesh-list
139337600|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139337601|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139337602|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337603|NCT04050761|Nivolumab|nivolumab|mesh-list
139337604|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139337605|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337606|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139337607|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337608|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139337609|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139337610|NCT03496389|Acetaminophen|acetaminophen|mesh-list
139337611|NCT03496389|Gabapentin|gabapentin|mesh-list
139337612|NCT03496389|Tramadol|tramadol|mesh-list
139337613|NCT03496389|Analgesics|analgesics|mesh-ancestor
139337614|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
139337615|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337616|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337617|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
139337618|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139337619|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139337620|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139337621|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139337622|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139337623|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139337624|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337625|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337627|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139337628|NCT03496389|Narcotics|narcotics|mesh-ancestor
139337629|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139337630|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
139337631|NCT03491709|Cetuximab|cetuximab|mesh-list
139337632|NCT03491709|Antibodies|antibodies|mesh-list
139337633|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139337634|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
139337635|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994511|NCT03952650|Analgesics|analgesics|mesh-ancestor
139337636|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139337637|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337639|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139337640|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139337641|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337642|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
139337643|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337644|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337645|NCT02323191|Atezolizumab|atezolizumab|mesh-list
139337646|NCT02323191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139337647|NCT02323191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337648|NCT02323191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139337649|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337650|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139337651|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
139337652|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139337653|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
139337654|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337655|NCT02323347|Progesterone|progesterone|mesh-list
139337656|NCT02323347|Progestins|progestins|mesh-ancestor
139337657|NCT02323347|Hormones|hormones|mesh-ancestor
139337658|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337659|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337660|NCT03495765|Ranibizumab|ranibizumab|mesh-list
139337661|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139337662|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139337663|NCT03495765|Growth Substances|growth substances|mesh-ancestor
139337664|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337665|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
139337666|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337667|NCT03491475|Ajmaline|ajmaline|mesh-list
139337668|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139337669|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139337670|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139337671|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139337672|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337673|NCT03499119|Erenumab|erenumab|mesh-list
139337674|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139337675|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337676|NCT03499119|Analgesics|analgesics|mesh-ancestor
139337677|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
139337678|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337679|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337680|NCT03328845|Insulin|insulin|mesh-list
139337681|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139337682|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
139337683|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
139337684|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139337685|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337686|NCT02323737|Cisplatin|cisplatin|mesh-list
139337687|NCT02323737|Irinotecan|irinotecan|mesh-list
139337688|NCT02323737|Etoposide|etoposide|mesh-list
139337689|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337690|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139337691|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139337692|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337693|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337694|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139337695|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139337696|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
139337697|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
139337698|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337699|NCT03491085|Amoxicillin|amoxicillin|mesh-list
139337700|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
139337701|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
139337702|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139337703|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139337704|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139337705|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139337706|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337707|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337708|NCT02323971|Ticagrelor|ticagrelor|mesh-list
139337709|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139337710|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139337711|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139337712|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139337713|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
139337714|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337715|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337716|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337718|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
138916106|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
139337719|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139337720|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337721|NCT03495063|Caffeine|caffeine|mesh-list
139337722|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139337723|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337724|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139337725|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337726|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337727|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139337728|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139337729|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
139337730|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337731|NCT03490617|Misoprostol|misoprostol|mesh-list
139337732|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139337733|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
139337734|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139337735|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337736|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139337737|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139337738|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
139337739|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
139337740|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139337741|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139337742|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139337743|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139337744|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139337745|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337746|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337747|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337748|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139337749|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
139337750|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139337751|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337752|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139337753|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139337754|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139337755|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
139337756|NCT03490539|Azathioprine|azathioprine|mesh-list
139337757|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139337758|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337759|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139337760|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
139337761|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139337762|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139337763|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337764|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337765|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
139337766|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139337767|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139337768|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
139337769|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337770|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139337771|NCT03493503|Albuterol|albuterol|mesh-list
139337772|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139337773|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
139337774|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337775|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337776|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139337777|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
139337778|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
139337779|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139337780|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139337781|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139337782|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138994693|NCT00744107|Cobalt|cobalt|mesh-list
139337783|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
139337784|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337785|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337787|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139337788|NCT03489837|Dipropizine|dipropizine|mesh-list
139337789|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
139337790|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
139337791|NCT03625505|Venetoclax|venetoclax|mesh-list
139337792|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337793|NCT03493269|Midazolam|midazolam|mesh-list
139337794|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139337795|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139337796|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139337797|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337798|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139337799|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139337800|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139337801|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139337802|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
139337803|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
139337804|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
139337805|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
139337806|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337807|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337808|NCT04257682|Bupivacaine|bupivacaine|mesh-list
139337809|NCT04257682|Ropivacaine|ropivacaine|mesh-list
139337810|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
139337811|NCT04257682|Mepivacaine|mepivacaine|mesh-list
139337812|NCT04257682|Anesthetics|anesthetics|mesh-list
139337813|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139337814|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337815|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
139337816|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337817|NCT05404906|Azacitidine|azacitidine|mesh-list
139337818|NCT05404906|Venetoclax|venetoclax|mesh-list
139337819|NCT05404906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139337820|NCT05404906|Antimetabolites|antimetabolites|mesh-ancestor
139337821|NCT05404906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337822|NCT05404906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337823|NCT05404906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337824|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139337825|NCT03020407|Dopamine|dopamine|mesh-list
139337826|NCT03020407|Epinephrine|epinephrine|mesh-list
139337827|NCT03020407|Norepinephrine|norepinephrine|mesh-list
139337828|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139337829|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139337830|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139337831|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139337832|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
139337833|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337834|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337835|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337836|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139337837|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139337838|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
139337839|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337840|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139337841|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
139337842|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
139337843|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
139337844|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139337845|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
139337846|NCT03020407|Protective Agents|protective agents|mesh-ancestor
139337847|NCT03624959|Itraconazole|itraconazole|mesh-list
139337848|NCT03624959|Rifampin|rifampin|mesh-list
139337849|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
139337850|NCT03624959|Ozanimod|ozanimod|mesh-list
139337851|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
139337852|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916124|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139337853|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139337854|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139337855|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337856|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337857|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139337858|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
139337859|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139337860|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337861|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139337862|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139337863|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
139337864|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139337865|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
139337866|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139337867|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139337868|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139337869|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139337870|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139337871|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139337872|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139337873|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139337874|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139337875|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
139337876|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139337877|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
139337878|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139337879|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139337880|NCT02536846|Olanzapine|olanzapine|mesh-list
139337881|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
139337882|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
139337883|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337884|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337885|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139337886|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139337887|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139337888|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139337889|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139337890|NCT02536846|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139337891|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139337892|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139337893|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337894|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337895|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
139337896|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139337897|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337898|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139337899|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139337900|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337901|NCT05439460|Phenylephrine|phenylephrine|mesh-list
139337902|NCT05439460|Vasopressins|vasopressins|mesh-list
139337903|NCT05439460|Arginine Vasopressin|arginine vasopressin|mesh-list
139337904|NCT05439460|Epinephrine|epinephrine|mesh-list
139337905|NCT05439460|Racepinephrine|racepinephrine|mesh-list
139337906|NCT05439460|Oxymetazoline|oxymetazoline|mesh-list
139337907|NCT05439460|Epinephryl borate|epinephryl borate|mesh-list
139337908|NCT05439460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139337909|NCT05439460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139337910|NCT05439460|Adrenergic Agents|adrenergic agents|mesh-ancestor
139337911|NCT05439460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337912|NCT05439460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337913|NCT05439460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337914|NCT05439460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139337915|NCT05439460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139337916|NCT05439460|Autonomic Agents|autonomic agents|mesh-ancestor
139337917|NCT05439460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337918|NCT05439460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139337919|NCT05439460|Respiratory System Agents|respiratory system agents|mesh-ancestor
139337920|NCT05439460|Mydriatics|mydriatics|mesh-ancestor
139337921|NCT05439460|Sympathomimetics|sympathomimetics|mesh-ancestor
139337922|NCT05439460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139337923|NCT05439460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139337924|NCT05439460|Nasal Decongestants|nasal decongestants|mesh-ancestor
139337925|NCT05439460|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139337926|NCT05439460|Protective Agents|protective agents|mesh-ancestor
139337927|NCT05439460|Hemostatics|hemostatics|mesh-ancestor
139337928|NCT05439460|Coagulants|coagulants|mesh-ancestor
139337929|NCT05439460|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139337930|NCT05439460|Natriuretic Agents|natriuretic agents|mesh-ancestor
139337931|NCT01661140|Methotrexate|methotrexate|mesh-list
139337932|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139337933|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
139337934|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139337935|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337936|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139337937|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
139337938|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337939|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337940|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
139337941|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337942|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139337943|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139337944|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
139337945|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139337946|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139337947|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139337948|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139337949|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139337950|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
139337951|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337952|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139337953|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139337954|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337956|NCT05436886|Analgesics|analgesics|mesh-ancestor
139337957|NCT05436886|Sensory System Agents|sensory system agents|mesh-ancestor
139337958|NCT05436886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139337959|NCT05436886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337960|NCT05436886|Anticonvulsants|anticonvulsants|mesh-ancestor
139337961|NCT05436886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139337962|NCT05436886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139337963|NCT05436886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139337964|NCT05436886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139337965|NCT05436886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139337966|NCT05436886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139337967|NCT05436886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139337968|NCT05436886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337969|NCT05436886|Antimanic Agents|antimanic agents|mesh-ancestor
139337970|NCT01373151|Adalimumab|adalimumab|mesh-list
139337971|NCT01373151|Methotrexate|methotrexate|mesh-list
138916152|NCT04092309|Valsartan|valsartan|mesh-list
139337972|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139337973|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
139337974|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139337975|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337976|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139337977|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
139337978|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337979|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337980|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
139337981|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337982|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139337983|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139337984|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
139337985|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139337986|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139337987|NCT01373151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139337988|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139337989|NCT01660906|Dasatinib|dasatinib|mesh-list
139337990|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337991|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139337992|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139337993|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139337994|NCT05435014|Ethiodized Oil|ethiodized oil|mesh-list
139337995|NCT05435014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139337996|NCT03666949|Anesthetics|anesthetics|mesh-list
139337997|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139337998|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139337999|NCT00886691|Bevacizumab|bevacizumab|mesh-list
139338000|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139338001|NCT00886691|Everolimus|everolimus|mesh-list
139338002|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
139338003|NCT00886691|Antibodies|antibodies|mesh-list
139338004|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
139338005|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139338006|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
139338007|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338008|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139338009|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139338010|NCT00886691|Growth Substances|growth substances|mesh-ancestor
139338011|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338012|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
139338013|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
139338014|NCT00886691|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139338015|NCT00886691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139338016|NCT00886691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338017|NCT00886691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338018|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139338019|NCT00960297|Paclitaxel|paclitaxel|mesh-list
139338020|NCT00960297|Bevacizumab|bevacizumab|mesh-list
139338021|NCT00960297|Carboplatin|carboplatin|mesh-list
139338022|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139338023|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338024|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
139338025|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
139338026|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
139338027|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338028|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139338029|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139338030|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139338031|NCT00960297|Growth Substances|growth substances|mesh-ancestor
139338032|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338033|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
139338034|NCT05112861|Bevacizumab|bevacizumab|mesh-list
139338035|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139180426|NCT06106932|Leuprolide|leuprolide|mesh-list
139338036|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338037|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139338038|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139338040|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338041|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
139338042|NCT03012061|Fluticasone|fluticasone|mesh-list
139338043|NCT03012061|Xhance|xhance|mesh-list
139338044|NCT03012061|Albuterol|albuterol|mesh-list
139338045|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139338046|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139338047|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
139338048|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338049|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338050|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139338051|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
139338052|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
139338053|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139338054|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
139338055|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139338056|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139338057|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139338058|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139338059|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
139338060|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338061|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338062|NCT00408863|Tibolone|tibolone|mesh-list
139338063|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
139338064|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
139338065|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139338066|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338067|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139338068|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139338069|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338070|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139338071|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
139338072|NCT00408863|Hormones|hormones|mesh-ancestor
139338073|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
139338074|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139338075|NCT05085327|Protective Agents|protective agents|mesh-ancestor
139338076|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338077|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
139338078|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139338079|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
139338080|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139338081|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338082|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338083|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139338084|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139338085|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139338086|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
139338087|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338088|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338089|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139338090|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139338091|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
139338093|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
139338094|NCT03131973|Methotrexate|methotrexate|mesh-list
139338095|NCT03131973|Digoxin|digoxin|mesh-list
139338096|NCT03131973|Midazolam|midazolam|mesh-list
139338097|NCT03131973|Caffeine|caffeine|mesh-list
139338098|NCT03131973|Omeprazole|omeprazole|mesh-list
139338099|NCT03131973|Pravastatin|pravastatin|mesh-list
139338100|NCT03131973|Montelukast|montelukast|mesh-list
139338101|NCT03131973|Branebrutinib|branebrutinib|mesh-list
139338102|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139338103|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
139338104|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138916174|NCT03977142|Chrysarobin|chrysarobin|mesh-list
139338105|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338106|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139338107|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
139180436|NCT06106802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338108|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338109|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338110|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
139338111|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338112|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139338113|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139338114|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
139338115|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139338116|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139338117|NCT03131973|Antidotes|antidotes|mesh-ancestor
139338118|NCT03131973|Protective Agents|protective agents|mesh-ancestor
139338119|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
139338120|NCT03131973|Vitamins|vitamins|mesh-ancestor
139338121|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
139338122|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139338123|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139338124|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338125|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139338126|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139338127|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139338128|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139338129|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
139338130|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
139338131|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
139338132|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
139338133|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338134|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139338135|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139338136|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139338137|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139338138|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
139338139|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139338140|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139338141|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139338142|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139338143|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
139338144|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139338145|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
139338146|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139338147|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139338148|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139338149|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139338150|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139338151|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139338152|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139338153|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139338154|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139338155|NCT03131973|Analgesics|analgesics|mesh-ancestor
139338156|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
139338157|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338158|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139338159|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139338160|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139338161|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139338162|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139338163|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
139338164|NCT05078931|Lenvatinib|lenvatinib|mesh-list
139338165|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139338166|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338167|NCT05078931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138916176|NCT03977142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139338168|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338169|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139338170|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338171|NCT04825197|Poractant alfa|poractant alfa|mesh-list
139338172|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139338173|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
139338174|NCT04703361|Niacin|niacin|mesh-list
139338175|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139338176|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
139338177|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338178|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139338179|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
139338180|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
139338182|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
139338183|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338184|NCT03010423|Nicorandil|nicorandil|mesh-list
139338185|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139338186|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139338187|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
139338188|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
139338189|NCT03010423|Vitamins|vitamins|mesh-ancestor
139338190|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
139338191|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338192|NCT05576597|Butyric Acid|butyric acid|mesh-list
139338193|NCT05576597|Histamine Antagonists|histamine antagonists|mesh-ancestor
139338194|NCT05576597|Histamine Agents|histamine agents|mesh-ancestor
139338195|NCT05576597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338196|NCT05576597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338197|NCT05576597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338198|NCT03665779|Pyridoxine|pyridoxine|mesh-list
139338199|NCT03665779|Isosorbide|isosorbide|mesh-list
139338200|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139338201|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139338202|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139338203|NCT03665779|Diuretics|diuretics|mesh-ancestor
139338204|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
139338205|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338206|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
139338207|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139338208|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338209|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
139338210|NCT03665779|Vitamins|vitamins|mesh-ancestor
139338211|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
139338212|NCT03703505|Mitapivat|mitapivat|mesh-list
139338213|NCT03703505|Enzyme Activators|enzyme activators|mesh-ancestor
139338214|NCT03703505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338215|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139338216|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139338217|NCT04944017|Ketamine|ketamine|mesh-list
139338218|NCT04944017|Analgesics|analgesics|mesh-ancestor
139338219|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
139338220|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338221|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338222|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139338223|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139338224|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
139338225|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
139338226|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338227|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139338228|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139338229|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338230|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338231|NCT03703427|Capecitabine|capecitabine|mesh-list
139338232|NCT03703427|Vinorelbine|vinorelbine|mesh-list
139338233|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139338234|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
139338235|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338236|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338237|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139338239|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
139338240|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
139338241|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
139338242|NCT03703349|Analgesics|analgesics|mesh-ancestor
139338243|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
139338244|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338245|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338246|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
139338247|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338248|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139338250|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139338251|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139338252|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338253|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139338254|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
139338255|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139338256|NCT03008005|Dronabinol|dronabinol|mesh-list
139338257|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
139338258|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338259|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139338260|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139338261|NCT03008005|Analgesics|analgesics|mesh-ancestor
139338262|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
139338263|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338264|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139338265|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139338266|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338267|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338268|NCT03008005|Hormones|hormones|mesh-ancestor
139338269|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139338270|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
139338271|NCT03666325|Cetuximab|cetuximab|mesh-list
139338272|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139338273|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338274|NCT03666325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139338275|NCT03666325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338276|NCT02440425|Paclitaxel|paclitaxel|mesh-list
139338277|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
139338278|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139338279|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338280|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
139338281|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
139338282|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
139338283|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338284|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139338285|NCT02440425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139338286|NCT04182321|Metformin|metformin|mesh-list
139338287|NCT04182321|Entecavir|entecavir|mesh-list
139338288|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139338289|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338290|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
139338291|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139338292|NCT03702959|Betamethasone|betamethasone|mesh-list
139338293|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139338294|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
139338295|NCT03702959|Hormones|hormones|mesh-ancestor
139338296|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139338297|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338298|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139338299|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
139338300|NCT03001219|Methotrexate|methotrexate|mesh-list
139338301|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139338302|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
139338303|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139338304|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338305|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139338306|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
139338307|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995190|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338308|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338309|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
139338310|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338311|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139338312|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139338313|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
139338314|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139338315|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139338316|NCT03702803|Alprazolam|alprazolam|mesh-list
139338317|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139338318|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338319|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338320|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139338321|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139338322|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139338323|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
139338324|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
139338325|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338326|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338327|NCT03702647|Ropivacaine|ropivacaine|mesh-list
139338328|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
139338329|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
139338330|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338331|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338332|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
139338333|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338334|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
139338335|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139338336|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338338|NCT03000673|Enoxaparin|enoxaparin|mesh-list
139338339|NCT03000673|Calcium heparin|calcium heparin|mesh-list
139338340|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
139338341|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139338342|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139338343|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338344|NCT05423249|Ascorbic Acid|ascorbic acid|mesh-list
139338345|NCT05423249|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
139338346|NCT05423249|Antioxidants|antioxidants|mesh-ancestor
139338347|NCT05423249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338348|NCT05423249|Protective Agents|protective agents|mesh-ancestor
139338349|NCT05423249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338350|NCT05423249|Vitamins|vitamins|mesh-ancestor
139338351|NCT05423249|Micronutrients|micronutrients|mesh-ancestor
139338352|NCT05423249|Antidiarrheals|antidiarrheals|mesh-ancestor
139338353|NCT05423249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139338354|NCT02912455|Canagliflozin|canagliflozin|mesh-list
139338355|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139338356|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338357|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139338358|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338359|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
139338360|NCT03702491|Apatinib|apatinib|mesh-list
139338361|NCT03702491|Tegafur|tegafur|mesh-list
139338362|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338363|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139338364|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338365|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338366|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139338367|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
139338368|NCT03663751|Decitabine|decitabine|mesh-list
139338369|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139338370|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
139338371|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338372|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338373|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338374|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
139338375|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139338376|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139338377|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338378|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
139338379|NCT04054687|Coagulants|coagulants|mesh-ancestor
139338380|NCT03492489|Cemiplimab|cemiplimab|mesh-list
139338381|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139338382|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995259|NCT00749567|Growth Substances|growth substances|mesh-ancestor
139338383|NCT02531698|Vaccines|vaccines|mesh-list
139338384|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
139338385|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338386|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
139338387|NCT04308837|Promethazine|promethazine|mesh-list
139338388|NCT04308837|Dexamethasone|dexamethasone|mesh-list
139338389|NCT04308837|Paclitaxel|paclitaxel|mesh-list
139338390|NCT04308837|Carboplatin|carboplatin|mesh-list
139338392|NCT04308837|Famotidine|famotidine|mesh-list
139338393|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139338394|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338395|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
139338396|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
139338397|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
139338398|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338399|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139338400|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
139338401|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
139338402|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338403|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338404|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139338405|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
139338406|NCT04308837|Hormones|hormones|mesh-ancestor
139338407|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139338408|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139338409|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139338410|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139338411|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338412|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
139338413|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
139338414|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
139338415|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139338416|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
139338417|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
139338418|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338419|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139338420|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
139338421|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
139338422|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139338423|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139338424|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
139338425|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139338426|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139338427|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
139338428|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139338429|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139338430|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139338431|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139338432|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338433|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
139338434|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338435|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338436|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139338437|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338438|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
139338439|NCT00403793|Etonogestrel|etonogestrel|mesh-list
139338440|NCT00403793|Testosterone|testosterone|mesh-list
139338441|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
139338442|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
139338443|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139338444|NCT00403793|Androgens|androgens|mesh-ancestor
139338445|NCT00403793|Hormones|hormones|mesh-ancestor
139338446|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139338447|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338448|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139338449|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338450|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
139338451|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139338452|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
139338453|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139338454|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139338455|NCT03034577|Neostigmine|neostigmine|mesh-list
139338456|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139338457|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338458|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338459|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
139338460|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338461|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338462|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139338463|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
139338464|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338465|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139338466|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139338467|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139338468|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139338469|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139338470|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338471|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338472|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338473|NCT04364997|Analgesics|analgesics|mesh-ancestor
139338474|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
139338475|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338476|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
139338477|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139338478|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
139338479|NCT05417386|Leucovorin|leucovorin|mesh-list
139338480|NCT05417386|Capecitabine|capecitabine|mesh-list
139338481|NCT05417386|Fluorouracil|fluorouracil|mesh-list
139338482|NCT05417386|Oxaliplatin|oxaliplatin|mesh-list
139338483|NCT05417386|Irinotecan|irinotecan|mesh-list
139338484|NCT05417386|Folfirinox|folfirinox|mesh-list
139338485|NCT05417386|Camptothecin|camptothecin|mesh-list
139338486|NCT05417386|Levoleucovorin|levoleucovorin|mesh-list
139338487|NCT05417386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338488|NCT05417386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139338489|NCT05417386|Antimetabolites|antimetabolites|mesh-ancestor
139338490|NCT05417386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338491|NCT05417386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338492|NCT05417386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139338493|NCT05417386|Immunologic Factors|immunologic factors|mesh-ancestor
139338494|NCT05417386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139338495|NCT05417386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139338496|NCT05417386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338497|NCT05417386|Antidotes|antidotes|mesh-ancestor
139338498|NCT05417386|Protective Agents|protective agents|mesh-ancestor
139338499|NCT05417386|Vitamin B Complex|vitamin b complex|mesh-ancestor
139338500|NCT05417386|Vitamins|vitamins|mesh-ancestor
139338501|NCT05417386|Micronutrients|micronutrients|mesh-ancestor
139338502|NCT05417386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139338503|NCT04005729|Cangrelor|cangrelor|mesh-list
139338504|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139338505|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139338506|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139338507|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139338508|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
139338509|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338510|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338511|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338512|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
139338513|NCT03487107|Yimitasvir|yimitasvir|mesh-list
139338514|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
139338515|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139338516|NCT02997163|Talazoparib|talazoparib|mesh-list
139338517|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139338518|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338519|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338520|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338521|NCT03705065|Bupivacaine|bupivacaine|mesh-list
139338522|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
139338523|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
139338524|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338525|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338526|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
139338527|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338528|NCT03702023|Acetaminophen|acetaminophen|mesh-list
139338529|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139338530|NCT03702023|Analgesics|analgesics|mesh-ancestor
139338531|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
139180459|NCT06106529|Urological Agents|urological agents|mesh-ancestor
139338532|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338533|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338534|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
139338535|NCT03698513|Aspirin|aspirin|mesh-list
139338536|NCT03698513|Clopidogrel|clopidogrel|mesh-list
139338537|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139338538|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139338539|NCT03698513|Analgesics|analgesics|mesh-ancestor
139338540|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
139338541|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338542|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338543|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139338544|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139338545|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139338546|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139338547|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338548|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139338549|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139338550|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338551|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
138916247|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139338552|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139338553|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139338554|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139338555|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
139338556|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338557|NCT03698435|Valganciclovir|valganciclovir|mesh-list
139338558|NCT03698435|Ganciclovir|ganciclovir|mesh-list
139338559|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139338560|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
139338561|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139338562|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139338563|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338564|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338565|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139338566|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139338567|NCT03697889|Naproxen|naproxen|mesh-list
139338568|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139338569|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139338570|NCT03697889|Analgesics|analgesics|mesh-ancestor
139338571|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
139338572|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338573|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338574|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139338575|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139338576|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
139338577|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139338578|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338579|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338580|NCT03692819|Amoxicillin|amoxicillin|mesh-list
139338581|NCT03692819|Metronidazole|metronidazole|mesh-list
139338582|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139338583|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139338584|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139338585|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139338586|NCT00458536|Molgramostim|molgramostim|mesh-list
139338587|NCT00458536|Sargramostim|sargramostim|mesh-list
139338588|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
139338589|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338590|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338591|NCT03697655|Daratumumab|daratumumab|mesh-list
139338592|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338593|NCT02526550|Vaccines|vaccines|mesh-list
139338594|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
139338595|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338596|NCT05565352|Ketamine|ketamine|mesh-list
139338597|NCT05565352|Analgesics|analgesics|mesh-ancestor
139338598|NCT05565352|Sensory System Agents|sensory system agents|mesh-ancestor
139338599|NCT05565352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338600|NCT05565352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338601|NCT05565352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139338602|NCT05565352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139338603|NCT05565352|Anesthetics, General|anesthetics, general|mesh-ancestor
139338604|NCT05565352|Anesthetics|anesthetics|mesh-ancestor
139338605|NCT05565352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338606|NCT05565352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139338607|NCT05565352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139338608|NCT05565352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338609|NCT05565352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995492|NCT00106639|Tacrolimus|tacrolimus|mesh-list
139338610|NCT04423276|Donepezil|donepezil|mesh-list
139338611|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139338612|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338613|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338614|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
139338615|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338616|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338617|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
139338618|NCT03701087|Vitamin D|vitamin d|mesh-list
139338619|NCT03701087|Vitamins|vitamins|mesh-ancestor
139338620|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
139338621|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338622|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139338623|NCT03697265|Pregnanolone|pregnanolone|mesh-list
139338624|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
139338625|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338626|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338627|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139338628|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139338629|NCT04336943|Durvalumab|durvalumab|mesh-list
139338630|NCT04336943|Olaparib|olaparib|mesh-list
139338631|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139338632|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
139338633|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139338634|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
139338635|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139338636|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338637|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
139338638|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338639|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338640|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338641|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
139338642|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139338643|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139338644|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139338645|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
139338646|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
139338647|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
139338648|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
139338649|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139338650|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338651|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338652|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
139338653|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139338654|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338655|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338656|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
139338657|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139338658|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139338659|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139338660|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338661|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
139338662|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338663|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338664|NCT03696095|Ropivacaine|ropivacaine|mesh-list
139338665|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
139338666|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
139338667|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338668|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338669|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
139338670|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338671|NCT03700229|Rituximab|rituximab|mesh-list
139338672|NCT03700229|Bortezomib|bortezomib|mesh-list
139338673|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139338674|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338675|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
139338676|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338677|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139338678|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139338679|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139338680|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338681|NCT03695705|Rifaximin|rifaximin|mesh-list
139338682|NCT03695705|Norfloxacin|norfloxacin|mesh-list
139338683|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139338684|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139338685|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139338686|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139338687|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139338688|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338689|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338690|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338691|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139338692|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139338694|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
139338695|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338696|NCT04050215|Edetic Acid|edetic acid|mesh-list
139338697|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139338698|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
139338699|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
139338700|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338701|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
139338702|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139338703|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139338704|NCT03699449|Paclitaxel|paclitaxel|mesh-list
139338705|NCT03699449|Durvalumab|durvalumab|mesh-list
139338706|NCT03699449|Olaparib|olaparib|mesh-list
139338707|NCT03699449|Tremelimumab|tremelimumab|mesh-list
139338708|NCT03699449|Cediranib|cediranib|mesh-list
139338709|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139338710|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139338711|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338712|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
139338713|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
139338714|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
139338715|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338716|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139338717|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
139338718|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338719|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139338720|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338721|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139338722|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
139338723|NCT04475939|Niraparib|niraparib|mesh-list
139338724|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139338725|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338726|NCT04475939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139338727|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338728|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139338729|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338730|NCT03699293|Aspirin|aspirin|mesh-list
139338731|NCT03699293|Celecoxib|celecoxib|mesh-list
139338732|NCT03699293|Naproxen|naproxen|mesh-list
139338733|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139338734|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139338735|NCT03699293|Analgesics|analgesics|mesh-ancestor
139338736|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
139338737|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338738|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338739|NCT03699293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139338740|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139338741|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139338742|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139338743|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338744|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139338745|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139338746|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338747|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
139338748|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139338749|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
139338750|NCT03029819|Nicotine|nicotine|mesh-list
139338751|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139338752|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
139338753|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338754|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338755|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139338756|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139338757|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
139338758|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338759|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338760|NCT03105830|Acetaminophen|acetaminophen|mesh-list
139338761|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139338762|NCT03105830|Analgesics|analgesics|mesh-ancestor
139338763|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
139338764|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338765|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338766|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
139338767|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
139338768|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139338769|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139338770|NCT03699215|Simendan|simendan|mesh-list
139338771|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139338772|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
139338773|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139338774|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139338775|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338776|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338777|NCT03699215|Protective Agents|protective agents|mesh-ancestor
139338778|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338779|NCT03694535|Mitomycins|mitomycins|mesh-list
139338780|NCT03694535|Mitomycin|mitomycin|mesh-list
139338781|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139338782|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338783|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
139338784|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338785|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139338786|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338787|NCT03115034|Melatonin|melatonin|mesh-list
139338788|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
139338789|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338790|NCT03115034|Protective Agents|protective agents|mesh-ancestor
139338791|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338792|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338793|NCT03027557|Denosumab|denosumab|mesh-list
139338794|NCT03027557|Cinacalcet|cinacalcet|mesh-list
139338795|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139338796|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338797|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139338798|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139338799|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
139338800|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139338801|NCT03698825|Vactosertib|vactosertib|mesh-list
139338802|NCT03698825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139338803|NCT03698825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338804|NCT03698825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338805|NCT02691572|Acetaminophen|acetaminophen|mesh-list
139338806|NCT02691572|Ketorolac|ketorolac|mesh-list
139338807|NCT02691572|Fentanyl|fentanyl|mesh-list
139338808|NCT02691572|Bupivacaine|bupivacaine|mesh-list
139338809|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
139338810|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
139338811|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338812|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338813|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
139338814|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338815|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139338816|NCT02691572|Narcotics|narcotics|mesh-ancestor
139338817|NCT02691572|Analgesics|analgesics|mesh-ancestor
139338818|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139338819|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139338820|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
139338821|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139338822|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
139338823|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139338824|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139338825|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139338826|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139338827|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338828|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338829|NCT05320172|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139338830|NCT05320172|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139338831|NCT03693833|Cannabidiol|cannabidiol|mesh-list
139338832|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
139338833|NCT03693599|Carbetocin|carbetocin|mesh-list
139338834|NCT03693599|Syntometrine|syntometrine|mesh-list
139338835|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
138995709|NCT00967850|Verteporfin|verteporfin|mesh-list
139338836|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139338837|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338838|NCT04277663|Interferons|interferons|mesh-list
139338839|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338840|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
139338841|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139338842|NCT04270643|Vitamin D|vitamin d|mesh-list
139338843|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
139338844|NCT04270643|Vitamins|vitamins|mesh-ancestor
139338845|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
139338846|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338847|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139338848|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139338849|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139338850|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139338851|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139338852|NCT02677844|Loperamide|loperamide|mesh-list
139338853|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
139338854|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139338855|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
139338856|NCT03687905|Chloroquine|chloroquine|mesh-list
139338857|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
139338858|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139338859|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139338860|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139338861|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338862|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338863|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139338864|NCT03687905|Amebicides|amebicides|mesh-ancestor
139338865|NCT03687515|Prednisone|prednisone|mesh-list
139338866|NCT03687515|Budesonide|budesonide|mesh-list
139338867|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139338868|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
139338869|NCT03687515|Hormones|hormones|mesh-ancestor
139338870|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139338871|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338872|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139338873|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338874|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139338876|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338877|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139338878|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
139338879|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139338880|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139338881|NCT02691494|Norethindrone|norethindrone|mesh-list
139338882|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
139338883|NCT02691494|Estradiol|estradiol|mesh-list
139338884|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139338885|NCT02691494|Estrogens|estrogens|mesh-ancestor
139338886|NCT02691494|Hormones|hormones|mesh-ancestor
139338887|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139338888|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338889|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139338890|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
139338891|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139338892|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139338893|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139338894|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139338895|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139338896|NCT02682602|Tacrine|tacrine|mesh-list
139338897|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139338898|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338899|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338900|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
139338901|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338902|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338903|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139338904|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
139338905|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338906|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
139338907|NCT03691337|Bupivacaine|bupivacaine|mesh-list
139338908|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139338909|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
139338910|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
139338911|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338912|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995784|NCT01013805|Antidotes|antidotes|mesh-ancestor
139338913|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
139338914|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338916|NCT02681510|Varenicline|varenicline|mesh-list
139338917|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139338918|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
139338919|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338920|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338921|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139338922|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139338923|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
139338924|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338925|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338926|NCT03690323|Paclitaxel|paclitaxel|mesh-list
139338927|NCT03690323|Gemcitabine|gemcitabine|mesh-list
139338928|NCT03690323|Folfirinox|folfirinox|mesh-list
139338929|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139338930|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139338931|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
139338932|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
139338933|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
139338934|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338935|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139338936|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
139338937|NCT03682211|Fentanyl|fentanyl|mesh-list
139338938|NCT03682211|Morphine|morphine|mesh-list
139338939|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139338940|NCT03682211|Narcotics|narcotics|mesh-ancestor
139338941|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338942|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338943|NCT03682211|Analgesics|analgesics|mesh-ancestor
139338944|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
139338945|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338946|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139338947|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139338948|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
139338949|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
139338950|NCT02690714|Plasminogen|plasminogen|mesh-list
139338951|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139338952|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139338953|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338954|NCT03690167|Mitogens|mitogens|mesh-list
139338955|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
139338956|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338957|NCT03165890|Acetazolamide|acetazolamide|mesh-list
139338958|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
139338959|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139338960|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338961|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338962|NCT03165890|Diuretics|diuretics|mesh-ancestor
139338963|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
139338964|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338965|NCT03681509|Pramipexole|pramipexole|mesh-list
139338966|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
139338967|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338968|NCT03681509|Protective Agents|protective agents|mesh-ancestor
139338969|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338970|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139338971|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139338972|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
139338973|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
139338974|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139338975|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
139338976|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
139338977|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139338978|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139338979|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338980|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
139338981|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139338982|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338983|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338984|NCT03161210|Anesthetics|anesthetics|mesh-list
139338985|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338986|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338987|NCT03164096|Bupivacaine|bupivacaine|mesh-list
139338988|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
139338989|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
139338990|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139338991|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139338992|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
139338993|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139338994|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
139338995|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139338996|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139338997|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139338998|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139338999|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139339000|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339001|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
139339002|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
139339003|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139339004|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339005|NCT03681197|Metformin|metformin|mesh-list
139339006|NCT03681197|Clomiphene|clomiphene|mesh-list
139339007|NCT03681197|Enclomiphene|enclomiphene|mesh-list
139339008|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
139339009|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139339010|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339011|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139339012|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
139339013|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139339014|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139339015|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
139339016|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139339017|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139339018|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139339019|NCT03485703|Azithromycin|azithromycin|mesh-list
139339020|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139339021|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339022|NCT03165344|Prednisone|prednisone|mesh-list
139339023|NCT03165344|Triamcinolone|triamcinolone|mesh-list
139339024|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139339025|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139339026|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
139339027|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139339028|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139339029|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139339030|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
139339031|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139339032|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139339033|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
139339034|NCT03165344|Hormones|hormones|mesh-ancestor
139339035|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139339036|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339037|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139339038|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339039|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139339040|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
139339041|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339042|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339043|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139339044|NCT03165344|Antacids|antacids|mesh-ancestor
139339045|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139339046|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
139339047|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139339048|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139339049|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
139339050|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339051|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339052|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339053|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
139339054|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
139339055|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339056|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
139339057|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139339058|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
139339059|NCT03689465|Cyclosporine|cyclosporine|mesh-list
139339060|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
139339061|NCT03689465|Methotrexate|methotrexate|mesh-list
139339062|NCT03689465|Cyclosporins|cyclosporins|mesh-list
139339063|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139339064|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
139339065|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139339066|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339067|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139339068|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
139339069|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339070|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339071|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
139339072|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339073|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139339074|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139339075|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
138916401|NCT00749190|Hormones|hormones|mesh-ancestor
139339076|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139339077|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139339078|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
139339079|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339080|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139339081|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139339082|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139339083|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
139339084|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139339086|NCT03485625|Ketorolac|ketorolac|mesh-list
139339087|NCT03485625|Lidocaine|lidocaine|mesh-list
139339088|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
139339089|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
139339090|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339091|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339092|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
139339093|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339094|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139339095|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139339096|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139339097|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139339098|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339099|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139339100|NCT03485625|Analgesics|analgesics|mesh-ancestor
139339101|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
139339102|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139339103|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139339104|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139339105|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139339106|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339107|NCT03680885|Lidocaine|lidocaine|mesh-list
139339108|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
139339109|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
139339110|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339111|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339112|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
139339113|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339114|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139339115|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139339116|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139180550|NCT06102395|Paclitaxel|paclitaxel|mesh-list
139339117|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139339118|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339119|NCT03033069|Sertraline|sertraline|mesh-list
139339120|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
139339121|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
139339122|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139339123|NCT03033069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139339124|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139339125|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139339126|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339127|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339128|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
139339129|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339130|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
139339131|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
139339132|NCT03685409|Metformin|metformin|mesh-list
139339133|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139339134|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339135|NCT03165500|Midazolam|midazolam|mesh-list
139339136|NCT03165500|Diazepam|diazepam|mesh-list
139339137|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
139339138|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139339139|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139339140|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916410|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
139339141|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339143|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139339144|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139339145|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139339146|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
139339147|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
139339148|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
139339149|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
139339150|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339151|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339152|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139339153|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139339154|NCT03165500|Analgesics|analgesics|mesh-ancestor
139339155|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
139339156|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339157|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
139339158|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
139339159|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
139339160|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139339161|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139339162|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139339163|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
139339164|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139339165|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339166|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339167|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139339168|NCT03163238|Analgesics|analgesics|mesh-ancestor
139339169|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
139339170|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339171|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139339172|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139339173|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139339174|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
139339175|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339176|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339177|NCT03486561|Ranolazine|ranolazine|mesh-list
139339178|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139339179|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139339180|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339181|NCT03680573|Allopurinol|allopurinol|mesh-list
139339182|NCT03680573|Nitroprusside|nitroprusside|mesh-list
139339183|NCT03680573|Nitroarginine|nitroarginine|mesh-list
139339184|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
139339185|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
139339186|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339187|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339188|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
139339189|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139339190|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139339191|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
139339192|NCT03680573|Protective Agents|protective agents|mesh-ancestor
139339193|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339194|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139339195|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
139339196|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139339197|NCT03689075|Tacrolimus|tacrolimus|mesh-list
139339198|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139339199|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
139339200|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339201|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139339202|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916420|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
139339203|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339204|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
139339205|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139339206|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139339207|NCT03680495|Prednisolone|prednisolone|mesh-list
139339208|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
139339209|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139339210|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
139339211|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139339212|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
138996079|NCT00972426|Carteolol|carteolol|mesh-list
139339213|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
139339214|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339215|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339216|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139339217|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
139339218|NCT03680495|Hormones|hormones|mesh-ancestor
139339219|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139339220|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139339221|NCT03680495|Protective Agents|protective agents|mesh-ancestor
139339222|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139339223|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339224|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
139339225|NCT03492255|Prednisone|prednisone|mesh-list
139339226|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
139339227|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
139339228|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139339229|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
139339230|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339231|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139339232|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139339233|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
139339234|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339235|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339236|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139339237|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139339238|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
139339239|NCT03492255|Hormones|hormones|mesh-ancestor
139339240|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139339241|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139339242|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139339243|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139339244|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
139339245|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139339246|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339247|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339248|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
139339249|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
139339250|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339251|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139339252|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139339253|NCT03492255|Protective Agents|protective agents|mesh-ancestor
139339254|NCT03684863|Capecitabine|capecitabine|mesh-list
139339255|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139339256|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
139339257|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339258|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339260|NCT03680339|Oxytocin|oxytocin|mesh-list
139339261|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
139339262|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139339263|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339264|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139339265|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
139339266|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139339267|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139339268|NCT03680183|Entecavir|entecavir|mesh-list
139339269|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
139339270|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339271|NCT02136069|Infliximab|infliximab|mesh-list
139339272|NCT02136069|Etrolizumab|etrolizumab|mesh-list
139339273|NCT02136069|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139339274|NCT02136069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139339275|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
139339276|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139339277|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139339278|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
139339279|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339280|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139339281|NCT02917031|Saxagliptin|saxagliptin|mesh-list
139339282|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139339283|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339284|NCT02917031|Incretins|incretins|mesh-ancestor
139339285|NCT02917031|Hormones|hormones|mesh-ancestor
139339286|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139339287|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139339288|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
139339289|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339290|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339291|NCT04460547|Interferons|interferons|mesh-list
139339292|NCT04460547|Interferon-beta|interferon-beta|mesh-list
139339293|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
139339294|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
139339296|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339297|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
139339298|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339299|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
139339300|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139339301|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139339302|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339303|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339304|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139339305|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
139339306|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339307|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139339308|NCT03132051|Triamcinolone|triamcinolone|mesh-list
139339309|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139339310|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139339311|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139339312|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139339313|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
139339314|NCT03132051|Hormones|hormones|mesh-ancestor
139339315|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139339316|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339317|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139339318|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
139339319|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339320|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339321|NCT03684707|Metformin|metformin|mesh-list
139339322|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139339323|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339324|NCT01018563|Farletuzumab|farletuzumab|mesh-list
139339325|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339326|NCT02528188|Tanezumab|tanezumab|mesh-list
139339327|NCT02528188|Analgesics|analgesics|mesh-ancestor
139339328|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
139339329|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339330|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339331|NCT03684395|Warfarin|warfarin|mesh-list
139339332|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
139339333|NCT03684395|Dabigatran|dabigatran|mesh-list
139339334|NCT03684395|Apixaban|apixaban|mesh-list
139339335|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
139339336|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139339337|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
138916447|NCT00814307|Tofacitinib|tofacitinib|mesh-list
139339338|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139339339|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
139339340|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339341|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339342|NCT04460001|Triamcinolone|triamcinolone|mesh-list
139339343|NCT04460001|Ranibizumab|ranibizumab|mesh-list
139339344|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139339345|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139339346|NCT04460001|Growth Substances|growth substances|mesh-ancestor
139339347|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339348|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
139339349|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339350|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139339351|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
139339352|NCT04460001|Hormones|hormones|mesh-ancestor
139339353|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139339354|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
139339355|NCT03484845|Lactoferrin|lactoferrin|mesh-list
139339356|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339357|NCT03484845|Trace Elements|trace elements|mesh-ancestor
139339358|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
139339359|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339360|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
139339361|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139339362|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139339363|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339364|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
139339365|NCT03679481|Coagulants|coagulants|mesh-ancestor
139339366|NCT04461249|Travoprost|travoprost|mesh-list
139339367|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139339368|NCT04461249|Latanoprost|latanoprost|mesh-list
139339369|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139339370|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139339371|NCT05151549|Carboplatin|carboplatin|mesh-list
139339372|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339373|NCT05151393|Vitamin D|vitamin d|mesh-list
139339374|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
139339375|NCT05151393|Vitamins|vitamins|mesh-ancestor
139339376|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
139339377|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339378|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139339379|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139339380|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139339381|NCT03484611|Cetrorelix|cetrorelix|mesh-list
139339382|NCT03484611|Menotropins|menotropins|mesh-list
139339383|NCT03484611|Progesterone|progesterone|mesh-list
139339384|NCT03484611|Progestins|progestins|mesh-ancestor
139339385|NCT03484611|Hormones|hormones|mesh-ancestor
139339386|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139339387|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339388|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139339389|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139339390|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
139339391|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
139339392|NCT03679325|Vitamin D|vitamin d|mesh-list
139339393|NCT03679325|Vitamins|vitamins|mesh-ancestor
139339394|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
139339395|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339396|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139339397|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
139339398|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139339399|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339400|NCT03878927|Immunotoxins|immunotoxins|mesh-ancestor
139339401|NCT03878927|Immunoconjugates|immunoconjugates|mesh-ancestor
139339402|NCT03878927|Immunologic Factors|immunologic factors|mesh-ancestor
139339403|NCT03878927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339404|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
139339405|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139180570|NCT06102382|Norepinephrine|norepinephrine|mesh-list
139339406|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139339407|NCT03623711|Bupropion|bupropion|mesh-list
139339408|NCT03623711|Escitalopram|escitalopram|mesh-list
139339409|NCT03623711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139339410|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139339411|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139339412|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339413|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339414|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
139339415|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339416|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339417|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139339418|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
139339419|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139339420|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139339421|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
139339422|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139339423|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139339424|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339425|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139339426|NCT03623711|Analgesics|analgesics|mesh-ancestor
139339427|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
139339428|NCT05382442|Leucovorin|leucovorin|mesh-list
139339429|NCT05382442|Bevacizumab|bevacizumab|mesh-list
139339430|NCT05382442|Capecitabine|capecitabine|mesh-list
139339431|NCT05382442|Fluorouracil|fluorouracil|mesh-list
139339432|NCT05382442|Oxaliplatin|oxaliplatin|mesh-list
139339433|NCT05382442|Irinotecan|irinotecan|mesh-list
139339434|NCT05382442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139339435|NCT05382442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339436|NCT05382442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139339437|NCT05382442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139339438|NCT05382442|Growth Substances|growth substances|mesh-ancestor
139339439|NCT05382442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339440|NCT05382442|Growth Inhibitors|growth inhibitors|mesh-ancestor
139339441|NCT05382442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139339442|NCT05382442|Antimetabolites|antimetabolites|mesh-ancestor
139339443|NCT05382442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339444|NCT05382442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139339445|NCT05382442|Immunologic Factors|immunologic factors|mesh-ancestor
139339446|NCT05382442|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139339447|NCT05382442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139339448|NCT05382442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339449|NCT05382442|Antidotes|antidotes|mesh-ancestor
139339450|NCT05382442|Protective Agents|protective agents|mesh-ancestor
139339451|NCT05382442|Vitamin B Complex|vitamin b complex|mesh-ancestor
139339452|NCT05382442|Vitamins|vitamins|mesh-ancestor
139339453|NCT05382442|Micronutrients|micronutrients|mesh-ancestor
139339454|NCT05362474|Montelukast|montelukast|mesh-list
139339455|NCT05362474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139339456|NCT05362474|Respiratory System Agents|respiratory system agents|mesh-ancestor
139339457|NCT05362474|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139339458|NCT05362474|Hormone Antagonists|hormone antagonists|mesh-ancestor
139339459|NCT05362474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139339460|NCT05362474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339461|NCT05362474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139339462|NCT05362474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139339463|NCT05362474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339464|NCT05542342|Tislelizumab|tislelizumab|mesh-list
139339465|NCT05542342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139339466|NCT05542342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339467|NCT05599516|Vaccines|vaccines|mesh-list
139339468|NCT05599516|Immunologic Factors|immunologic factors|mesh-ancestor
139339469|NCT05599516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339470|NCT05380024|Ensartinib|ensartinib|mesh-list
139339471|NCT05380024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339472|NCT05380024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139339473|NCT05380024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339474|NCT05380024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339475|NCT05342194|Gemcitabine|gemcitabine|mesh-list
139339476|NCT05342194|Oxaliplatin|oxaliplatin|mesh-list
139339477|NCT05342194|Lenvatinib|lenvatinib|mesh-list
139339478|NCT05342194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339479|NCT05342194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139339480|NCT05342194|Antimetabolites|antimetabolites|mesh-ancestor
139339481|NCT05342194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339482|NCT05342194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139339483|NCT05342194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339484|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
139339485|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
139339486|NCT03623789|Hemostatics|hemostatics|mesh-list
139339487|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139339488|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139339489|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339490|NCT03623789|Coagulants|coagulants|mesh-ancestor
139339491|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
139339492|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139339493|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139339494|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339495|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139339496|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139339497|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339498|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339499|NCT05306470|Lidocaine|lidocaine|mesh-list
139339500|NCT05306470|Ethyl Chloride|ethyl chloride|mesh-list
139339501|NCT05306470|Anesthetics, Local|anesthetics, local|mesh-ancestor
139339502|NCT05306470|Anesthetics|anesthetics|mesh-ancestor
139339503|NCT05306470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339504|NCT05306470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339505|NCT05306470|Sensory System Agents|sensory system agents|mesh-ancestor
139339506|NCT05306470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339507|NCT05306470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139339508|NCT05306470|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139339509|NCT05306470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139339510|NCT05306470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139339511|NCT05306470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339512|NCT05340010|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139339513|NCT05340010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139339514|NCT05340010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339515|NCT05339386|Xenon|xenon|mesh-list
139339516|NCT05339386|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139339517|NCT05339386|Anesthetics, General|anesthetics, general|mesh-ancestor
138996379|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139339518|NCT05339386|Anesthetics|anesthetics|mesh-ancestor
139339519|NCT05339386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339520|NCT05339386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339521|NCT05339074|Ketamine|ketamine|mesh-list
139339522|NCT05339074|Analgesics|analgesics|mesh-ancestor
139339523|NCT05339074|Sensory System Agents|sensory system agents|mesh-ancestor
139339524|NCT05339074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339525|NCT05339074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191402|NCT03620890|Coagulants|coagulants|mesh-ancestor
139339526|NCT05339074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139339527|NCT05339074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139339528|NCT05339074|Anesthetics, General|anesthetics, general|mesh-ancestor
139339529|NCT05339074|Anesthetics|anesthetics|mesh-ancestor
139339530|NCT05339074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339531|NCT05339074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139339532|NCT05339074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139339533|NCT05339074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339534|NCT05339074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339535|NCT05560282|Fenfluramine|fenfluramine|mesh-list
139339536|NCT05560282|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139339537|NCT05560282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139339538|NCT05560282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139339539|NCT05560282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339540|NCT05560282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339541|NCT05560282|Serotonin Agents|serotonin agents|mesh-ancestor
139339542|NCT05560282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339543|NCT05338450|Clemastine|clemastine|mesh-list
139339545|NCT05338450|Dermatologic Agents|dermatologic agents|mesh-ancestor
139339546|NCT05338450|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139339547|NCT05338450|Histamine Antagonists|histamine antagonists|mesh-ancestor
139339548|NCT05338450|Histamine Agents|histamine agents|mesh-ancestor
139339549|NCT05338450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339550|NCT05338450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339551|NCT05338450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339552|NCT05338450|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139339553|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139339554|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139339555|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139339556|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
139339557|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339558|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139339559|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139339560|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339561|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139339562|NCT03676985|Antibodies|antibodies|mesh-list
139339563|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
139339564|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139339565|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
139339566|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339567|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339568|NCT05348824|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139339569|NCT05348824|Eusol|eusol|mesh-list
139339570|NCT05348824|Disinfectants|disinfectants|mesh-ancestor
139339571|NCT05348824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339572|NCT02988401|Insulin|insulin|mesh-list
139339573|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139339574|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339575|NCT05266456|Vaccines|vaccines|mesh-list
139339576|NCT05266456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139339577|NCT05266456|Immunologic Factors|immunologic factors|mesh-ancestor
139339578|NCT05266456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339579|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139339580|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
139339581|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339582|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339583|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139339584|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139339585|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139339586|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
139339587|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339588|NCT03484221|Capecitabine|capecitabine|mesh-list
139339589|NCT03484221|Fluorouracil|fluorouracil|mesh-list
139339590|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
139339591|NCT03484221|Irinotecan|irinotecan|mesh-list
139339592|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138996455|NCT00975312|Tretinoin|tretinoin|mesh-list
139339593|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
139339594|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339595|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339596|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139339597|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
139339598|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339599|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139339600|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139339601|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339602|NCT03857139|Nicotine|nicotine|mesh-list
139339603|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139339604|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
139339605|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339606|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339607|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139339608|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139339609|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
139339610|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339611|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339612|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
139339613|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139339614|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339615|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139339616|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139339617|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339618|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339619|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339621|NCT05255770|Anesthetics, Local|anesthetics, local|mesh-ancestor
139339622|NCT05255770|Anesthetics|anesthetics|mesh-ancestor
139339623|NCT05255770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339624|NCT05255770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339625|NCT05255770|Sensory System Agents|sensory system agents|mesh-ancestor
139339626|NCT05255770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339627|NCT05322538|Vitamin D|vitamin d|mesh-list
139339628|NCT05322538|Ergocalciferols|ergocalciferols|mesh-list
139339629|NCT05322538|Cholecalciferol|cholecalciferol|mesh-list
139339630|NCT05322538|Vitamins|vitamins|mesh-list
139339631|NCT05322538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139339632|NCT05322538|Micronutrients|micronutrients|mesh-ancestor
139339633|NCT05322538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339634|NCT05322538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139339635|NCT05322538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139339636|NCT04965220|Trametinib|trametinib|mesh-list
139339637|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339638|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139339639|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339640|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339641|NCT03389477|Cisplatin|cisplatin|mesh-list
139339642|NCT03389477|Cetuximab|cetuximab|mesh-list
139339643|NCT03389477|Palbociclib|palbociclib|mesh-list
139339644|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339645|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139339646|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139339647|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339648|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339649|NCT02680574|Darbepoetin alfa|darbepoetin alfa|mesh-list
139339650|NCT02680574|Hematinics|hematinics|mesh-ancestor
139339651|NCT03672149|Cefazolin|cefazolin|mesh-list
139339652|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139339653|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339654|NCT03672071|Ephedrine|ephedrine|mesh-list
139339655|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
139339656|NCT03672071|Norepinephrine|norepinephrine|mesh-list
139339657|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139339658|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339659|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
139339660|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
139339661|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339662|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139339663|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
139339664|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339665|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339666|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139339667|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139339668|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
139339669|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
139339670|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139339671|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139339672|NCT03480945|Nitroprusside|nitroprusside|mesh-list
139339673|NCT03480945|Serotonin|serotonin|mesh-list
139339674|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139339675|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
139339676|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339677|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339678|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339679|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139339680|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
139339681|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139339682|NCT03483207|Heparin|heparin|mesh-list
139339683|NCT03483207|Warfarin|warfarin|mesh-list
139339684|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
139339685|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139339686|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139339687|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339688|NCT05132985|Carboplatin|carboplatin|mesh-list
139339689|NCT05132985|Pemetrexed|pemetrexed|mesh-list
139180586|NCT06086197|Gemcitabine|gemcitabine|mesh-list
139339690|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339691|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339692|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339693|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139339694|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139339695|NCT03739593|Dexamethasone|dexamethasone|mesh-list
139339696|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
139339697|NCT03739593|BB 1101|bb 1101|mesh-list
139339698|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139339699|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
139339700|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
139339701|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339702|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339703|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139339704|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
139339705|NCT03739593|Hormones|hormones|mesh-ancestor
139339706|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139339707|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139339708|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339709|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
139339710|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339711|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339712|NCT03480867|Temozolomide|temozolomide|mesh-list
139339713|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139339714|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
139339715|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339716|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339717|NCT05254912|Sunscreening Agents|sunscreening agents|mesh-list
139339718|NCT05254912|Petrolatum|petrolatum|mesh-list
139339719|NCT05254912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139339720|NCT05254912|Protective Agents|protective agents|mesh-ancestor
139339721|NCT05254912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339722|NCT05254912|Dermatologic Agents|dermatologic agents|mesh-ancestor
139339723|NCT05254912|Emollients|emollients|mesh-ancestor
139339724|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
139339725|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139339726|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339727|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339728|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139339729|NCT03480789|Analgesics|analgesics|mesh-ancestor
139339730|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
139339731|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339732|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139339733|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139339734|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139339735|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
139339736|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339737|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339738|NCT03475407|Dexamethasone|dexamethasone|mesh-list
139339739|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
139339740|NCT03475407|BB 1101|bb 1101|mesh-list
139339741|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139339742|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
139339743|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
139339744|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339745|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339746|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139339747|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
139339749|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138916549|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
139339750|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139339751|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339752|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
139339753|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339754|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339755|NCT03655197|Doxycycline|doxycycline|mesh-list
139339756|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139339757|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339758|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
139339759|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139339760|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139339761|NCT05317624|Methylprednisolone|methylprednisolone|mesh-list
139339762|NCT05317624|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139339763|NCT05317624|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139339764|NCT05317624|Prednisolone|prednisolone|mesh-list
139339765|NCT05317624|Prednisolone acetate|prednisolone acetate|mesh-list
139339766|NCT05317624|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139339767|NCT05317624|Prednisolone phosphate|prednisolone phosphate|mesh-list
139339768|NCT05317624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139339769|NCT05317624|Antiemetics|antiemetics|mesh-ancestor
139339770|NCT05317624|Autonomic Agents|autonomic agents|mesh-ancestor
139339771|NCT05317624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339772|NCT05317624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339773|NCT05317624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139339774|NCT05317624|Glucocorticoids|glucocorticoids|mesh-ancestor
139339776|NCT05317624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139339777|NCT05317624|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139339778|NCT05317624|Protective Agents|protective agents|mesh-ancestor
139339779|NCT05317624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139339780|NCT05317624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339781|NCT03475017|Curcumin|curcumin|mesh-list
139339782|NCT03475017|Piperine|piperine|mesh-list
139339783|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139339784|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139339785|NCT03475017|Analgesics|analgesics|mesh-ancestor
139339786|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
139339787|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339788|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339789|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139339790|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139339791|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339792|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339793|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339794|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139339795|NCT02674568|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
139339796|NCT02674568|Immunoconjugates|immunoconjugates|mesh-ancestor
139339797|NCT02674568|Immunologic Factors|immunologic factors|mesh-ancestor
139339798|NCT02674568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339799|NCT03474939|Midazolam|midazolam|mesh-list
139339800|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139339801|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139339802|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339803|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339804|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139339805|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139339806|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139339807|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139339808|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
139339809|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
139339810|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
139339811|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
139339812|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339813|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339814|NCT03131583|Colchicine|colchicine|mesh-list
139339815|NCT03131583|Febuxostat|febuxostat|mesh-list
139339816|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
139339817|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139339818|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
139339819|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
139339820|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
138916563|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339821|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339822|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339824|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139339825|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339826|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
139339827|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
139339828|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
139339829|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339831|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139339832|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
139339833|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339834|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339835|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139339836|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
139339837|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139339838|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139339839|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339840|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139339841|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
139339842|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139339843|NCT03480321|Protective Agents|protective agents|mesh-ancestor
139339844|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139339845|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139339846|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339847|NCT04928950|Charcoal|charcoal|mesh-list
139339848|NCT04928950|Antidotes|antidotes|mesh-ancestor
139339849|NCT04928950|Protective Agents|protective agents|mesh-ancestor
139339850|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339851|NCT02986269|Anesthetics|anesthetics|mesh-list
139339852|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339853|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339854|NCT03474237|Hormones|hormones|mesh-list
139339855|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139339856|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339857|NCT03480165|Parecoxib|parecoxib|mesh-list
139339858|NCT03480165|Ropivacaine|ropivacaine|mesh-list
139339859|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
139339860|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
139339861|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339862|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339863|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
139339864|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339865|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139339866|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139339867|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339868|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339869|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139339870|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139339871|NCT03480165|Analgesics|analgesics|mesh-ancestor
139339872|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139339873|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139339874|NCT05311852|Palmidrol|palmidrol|mesh-list
139339875|NCT05311852|Antioxidants|antioxidants|mesh-list
139339876|NCT05311852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339877|NCT05311852|Protective Agents|protective agents|mesh-ancestor
139339878|NCT05311852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339879|NCT05311852|Analgesics|analgesics|mesh-ancestor
139339880|NCT05311852|Sensory System Agents|sensory system agents|mesh-ancestor
139339881|NCT05311852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339882|NCT05311852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139339883|NCT05311852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139339884|NCT05311852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139339885|NCT05311852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139339886|NCT05311852|Antiviral Agents|antiviral agents|mesh-ancestor
139339887|NCT05311852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339888|NCT05311852|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139339889|NCT05311852|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139339890|NCT05311852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339891|NCT05311852|Hormones|hormones|mesh-ancestor
139339892|NCT05311852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996764|NCT00982566|Navitoclax|navitoclax|mesh-list
139339893|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139339894|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139339895|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139339896|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139339897|NCT03671915|Insulin|insulin|mesh-list
139339898|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139339899|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339900|NCT03302195|Heparin|heparin|mesh-list
139339901|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
139339902|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139339903|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139339904|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339905|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139339906|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
139339907|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139339908|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
139339909|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339910|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
139339911|NCT03114020|Protective Agents|protective agents|mesh-ancestor
139339912|NCT04460079|Lenograstim|lenograstim|mesh-list
139339913|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139339914|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
139339915|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339916|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
139339917|NCT03473691|Immunoconjugates|immunoconjugates|mesh-ancestor
139339918|NCT03473691|Immunologic Factors|immunologic factors|mesh-ancestor
139339919|NCT03473691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339920|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139339921|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339922|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139339923|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
139339924|NCT03676361|Coagulants|coagulants|mesh-ancestor
139339925|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139339926|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
139339927|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339928|NCT01712763|Goserelin|goserelin|mesh-list
139339929|NCT01712763|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139339930|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139339931|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339932|NCT01712763|Luteolytic Agents|luteolytic agents|mesh-ancestor
139339933|NCT01712763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139339934|NCT01712763|Contraceptive Agents|contraceptive agents|mesh-ancestor
139339935|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139339936|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339937|NCT01712763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139339938|NCT05218486|Isotretinoin|isotretinoin|mesh-list
139339939|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
139339940|NCT05216770|Bupivacaine|bupivacaine|mesh-list
139339941|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
139339942|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
139339943|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339944|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339945|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
139339946|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139339947|NCT05236036|Mycophenolic Acid|mycophenolic acid|mesh-list
139339948|NCT05236036|Temozolomide|temozolomide|mesh-list
139339949|NCT05236036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139339950|NCT05236036|Alkylating Agents|alkylating agents|mesh-ancestor
138568625|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139339951|NCT05236036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339952|NCT05236036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339953|NCT05236036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139339954|NCT05236036|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139339955|NCT05236036|Antitubercular Agents|antitubercular agents|mesh-ancestor
139339956|NCT05236036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139339957|NCT05236036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139339958|NCT05236036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339959|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139339960|NCT02781779|Laxatives|laxatives|mesh-ancestor
139339961|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139339962|NCT05270200|Azacitidine|azacitidine|mesh-list
139339963|NCT05270200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139339964|NCT05270200|Antimetabolites|antimetabolites|mesh-ancestor
139339965|NCT05270200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339966|NCT05270200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339967|NCT05270200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339968|NCT03671057|Midazolam|midazolam|mesh-list
139339969|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139339970|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139339971|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139339972|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339973|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139339974|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139339975|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139339976|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139339977|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
139339978|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
139339979|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
139339980|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
139339981|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139339982|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339983|NCT03670901|Rituximab|rituximab|mesh-list
139339984|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139339985|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339986|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
139339987|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339988|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139339989|NCT05166616|Osimertinib|osimertinib|mesh-list
139339990|NCT05166616|Triptolide|triptolide|mesh-list
139339991|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139339992|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139339993|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139339994|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139339995|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139339996|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
139339997|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
139339998|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139339999|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139340000|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
139340001|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139340002|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139340003|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
139340004|NCT05213728|Vaccines|vaccines|mesh-list
139340005|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
139340006|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340007|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
139340008|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139340009|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139340010|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340011|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139340012|NCT05165836|Analgesics|analgesics|mesh-ancestor
139340013|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
139340014|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340015|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139340016|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139340017|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139340018|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
139340019|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340020|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340021|NCT04238416|Lactulose|lactulose|mesh-list
139340022|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139340023|NCT05162014|Empagliflozin|empagliflozin|mesh-list
139340024|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139340025|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139340026|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340027|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340028|NCT05226754|Diacerein|diacerein|mesh-list
139340029|NCT05226754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139340030|NCT01657162|Alendronate|alendronate|mesh-list
139340031|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139340032|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340033|NCT05209906|Fentanyl|fentanyl|mesh-list
139340034|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139340035|NCT05209906|Narcotics|narcotics|mesh-ancestor
139340036|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139340037|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340038|NCT05209906|Analgesics|analgesics|mesh-ancestor
139340039|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
139340040|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340041|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139340042|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139340043|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
139340044|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
139340045|NCT05633810|Aspirin|aspirin|mesh-list
139340046|NCT05633810|Colchicine|colchicine|mesh-list
139340047|NCT05633810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139340048|NCT05633810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139340049|NCT05633810|Analgesics|analgesics|mesh-ancestor
139340050|NCT05633810|Sensory System Agents|sensory system agents|mesh-ancestor
139340051|NCT05633810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340052|NCT05633810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340053|NCT05633810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139340054|NCT05633810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340055|NCT05633810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139340056|NCT05633810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139340057|NCT05633810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340058|NCT05633810|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139340059|NCT05633810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139340060|NCT05633810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340061|NCT05633810|Antipyretics|antipyretics|mesh-ancestor
139340062|NCT05633810|Gout Suppressants|gout suppressants|mesh-ancestor
139340063|NCT05633810|Tubulin Modulators|tubulin modulators|mesh-ancestor
139340064|NCT05633810|Antimitotic Agents|antimitotic agents|mesh-ancestor
139340065|NCT05633810|Mitosis Modulators|mitosis modulators|mesh-ancestor
139340066|NCT05633810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340067|NCT05203822|Itraconazole|itraconazole|mesh-list
139340068|NCT05203822|Tepotinib|tepotinib|mesh-list
139340069|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
139340070|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340071|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139340072|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139340073|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340074|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340075|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139340076|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
139340077|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139340078|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340079|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139340080|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340081|NCT01373294|Lenalidomide|lenalidomide|mesh-list
139340082|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
139340083|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
139340084|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340085|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139340086|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139340087|NCT01373294|Growth Substances|growth substances|mesh-ancestor
139340088|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
139340089|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340090|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139340091|NCT04422028|Desogestrel|desogestrel|mesh-list
139340092|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139340093|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139340094|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139340095|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
139340096|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139340097|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340098|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139340099|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139340100|NCT04422028|Progestins|progestins|mesh-ancestor
139340101|NCT04422028|Hormones|hormones|mesh-ancestor
139340102|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139340103|NCT01656304|Bevacizumab|bevacizumab|mesh-list
139340104|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139340105|NCT01656304|Antibodies|antibodies|mesh-list
139340106|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
139340107|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139340108|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340109|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139180614|NCT06071260|Atropine|atropine|mesh-list
139340110|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139340111|NCT01656304|Growth Substances|growth substances|mesh-ancestor
139340112|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340113|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
139340114|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
139340115|NCT04421872|Anesthetics|anesthetics|mesh-list
139340116|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139340117|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340118|NCT04227028|Bevacizumab|bevacizumab|mesh-list
139340119|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139340120|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
139340121|NCT04227028|Antibodies|antibodies|mesh-list
139340122|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
139340123|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139340124|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
139340125|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340126|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139340127|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139340128|NCT04227028|Growth Substances|growth substances|mesh-ancestor
139340129|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340130|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
139340131|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
139340132|NCT03023423|Atezolizumab|atezolizumab|mesh-list
139340133|NCT03023423|Daratumumab|daratumumab|mesh-list
139340134|NCT03023423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139340135|NCT03023423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340136|NCT03023423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139340137|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340138|NCT03675191|Orlistat|orlistat|mesh-list
139340139|NCT03675191|Phentermine|phentermine|mesh-list
139340140|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340141|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340142|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139340143|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139340144|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139340145|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340146|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
139340147|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
139340148|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
139340149|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340150|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
139340151|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340152|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139340153|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139340154|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340155|NCT03198689|Immunotoxins|immunotoxins|mesh-ancestor
139340156|NCT03198689|Immunoconjugates|immunoconjugates|mesh-ancestor
139340157|NCT03198689|Immunologic Factors|immunologic factors|mesh-ancestor
139340158|NCT03198689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340159|NCT04421716|Ursolic acid|ursolic acid|mesh-list
139340160|NCT04421716|Curcumin|curcumin|mesh-list
139340161|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139340162|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139340163|NCT04421716|Analgesics|analgesics|mesh-ancestor
139340164|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
139340165|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340166|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340167|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139340168|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340169|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340170|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340171|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340172|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340173|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139340174|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139340175|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
139340176|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139340177|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340178|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
139340179|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
139340180|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139340181|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
139340182|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139340183|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139340184|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340185|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139340186|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340187|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340188|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139340189|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139340190|NCT01126749|Gemcitabine|gemcitabine|mesh-list
138997064|NCT01033318|Losartan|losartan|mesh-list
139340191|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340192|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139340193|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
139340194|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340219|NCT03674333|Folic Acid|folic acid|mesh-list
139340220|NCT03674333|Hematinics|hematinics|mesh-ancestor
139340221|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
139340222|NCT03674333|Vitamins|vitamins|mesh-ancestor
139340223|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
139340224|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340225|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
139340226|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139340227|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139340228|NCT03674099|Prednisolone|prednisolone|mesh-list
139340229|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
139340230|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
139340231|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139340232|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
139340233|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139340234|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
139340235|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
139340236|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340237|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340238|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139340239|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
139340240|NCT03674099|Hormones|hormones|mesh-ancestor
139340241|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139340242|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139340243|NCT03674099|Protective Agents|protective agents|mesh-ancestor
139340244|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139340245|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340246|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139340247|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340248|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340249|NCT05124340|Vaccines|vaccines|mesh-list
139340250|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
139340251|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340252|NCT05084404|Guanabenz|guanabenz|mesh-list
139340253|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139340254|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139340255|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139340256|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139340257|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
139340258|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340259|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340260|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340261|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
139340263|NCT03473613|Calcium|calcium|mesh-list
139340264|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139340265|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340266|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139340267|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139340268|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139340269|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
139340270|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
139340271|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340272|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340274|NCT03670043|Psyllium|psyllium|mesh-list
139340275|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139340276|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340277|NCT03670043|Cathartics|cathartics|mesh-ancestor
139340278|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139340279|NCT05561660|Aspirin|aspirin|mesh-list
139340280|NCT05561660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139340281|NCT05561660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139340282|NCT05561660|Analgesics|analgesics|mesh-ancestor
139340283|NCT05561660|Sensory System Agents|sensory system agents|mesh-ancestor
139340284|NCT05561660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340285|NCT05561660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340286|NCT05561660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139340287|NCT05561660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340288|NCT05561660|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139340289|NCT05561660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139340290|NCT05561660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340291|NCT05561660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139340292|NCT05561660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139340293|NCT05561660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340294|NCT05561660|Antipyretics|antipyretics|mesh-ancestor
139340295|NCT03042819|Doxorubicin|doxorubicin|mesh-list
139340296|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139340297|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340298|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139340299|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139340300|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340301|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340302|NCT02832687|Acetaminophen|acetaminophen|mesh-list
139340303|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139340304|NCT02832687|Analgesics|analgesics|mesh-ancestor
139340305|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
139340306|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340307|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340308|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
139340309|NCT04372017|Vitamin D|vitamin d|mesh-list
139340310|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
139340311|NCT04372017|Vitamins|vitamins|mesh-ancestor
139340312|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
139340313|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340314|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139340315|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
139340316|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139340317|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138916746|NCT00918177|Levodopa|levodopa|mesh-list
139340318|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340319|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340320|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340321|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340322|NCT05233358|Pembrolizumab|pembrolizumab|mesh-list
139340323|NCT05233358|Nivolumab|nivolumab|mesh-list
139340324|NCT05233358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139340325|NCT05233358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139340326|NCT05233358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340327|NCT05233358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340328|NCT02387918|Dexamethasone|dexamethasone|mesh-list
139340329|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139340330|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
139340331|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
139340332|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340333|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340334|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139340335|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
139340336|NCT02387918|Hormones|hormones|mesh-ancestor
139340337|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139340338|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139340339|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340340|NCT04312971|Norepinephrine|norepinephrine|mesh-list
139340341|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139340342|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139340343|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
139340344|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340345|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340346|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340347|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
139340348|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
139340349|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340350|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139340351|NCT05231330|Fluorides|fluorides|mesh-list
139340352|NCT05231330|Cariostatic Agents|cariostatic agents|mesh-ancestor
139340353|NCT05231330|Protective Agents|protective agents|mesh-ancestor
139340354|NCT05231330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340355|NCT03179475|Oxycodone|oxycodone|mesh-list
139340356|NCT03179475|Naloxone|naloxone|mesh-list
139340357|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139340358|NCT03179475|Narcotics|narcotics|mesh-ancestor
139340359|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139340360|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340361|NCT03179475|Analgesics|analgesics|mesh-ancestor
139340362|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
139340363|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340364|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139340365|NCT03105986|Probenecid|probenecid|mesh-list
139340366|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
139340367|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
139340368|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340369|NCT02391662|Paclitaxel|paclitaxel|mesh-list
139340370|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139340371|NCT02391662|Gemcitabine|gemcitabine|mesh-list
139340372|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139340373|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340374|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
139340375|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
139340376|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
139340377|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340378|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139340379|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
139340380|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
139340381|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139340382|NCT05258955|Chlorhexidine|chlorhexidine|mesh-list
139340383|NCT05258955|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139340384|NCT05258955|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139340385|NCT05258955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340386|NCT05258955|Disinfectants|disinfectants|mesh-ancestor
139340387|NCT05258955|Dermatologic Agents|dermatologic agents|mesh-ancestor
139340388|NCT05173324|Vaccines|vaccines|mesh-list
139340389|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
139340390|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340391|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
139340392|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139340393|NCT04223518|Antibodies|antibodies|mesh-list
139340394|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
139340395|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340396|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
139180632|NCT06062979|Rilpivirine|rilpivirine|mesh-list
139340397|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
139340398|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139340399|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139340400|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340401|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340402|NCT02387450|Urological Agents|urological agents|mesh-ancestor
139340404|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139340405|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139340406|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139340407|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
139340408|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340409|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340410|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340411|NCT02390882|Urological Agents|urological agents|mesh-ancestor
139340412|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
139340413|NCT02387138|Irinotecan|irinotecan|mesh-list
139340414|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340415|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139340416|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139340417|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340418|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340419|NCT02387060|Fentanyl|fentanyl|mesh-list
139340420|NCT02387060|Bupivacaine|bupivacaine|mesh-list
139340421|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
139340422|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
139340423|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139340424|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340425|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
139340426|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340427|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139340428|NCT02387060|Narcotics|narcotics|mesh-ancestor
139340429|NCT02387060|Analgesics|analgesics|mesh-ancestor
139340430|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139340431|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139340432|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
139340433|NCT01365052|Naproxen|naproxen|mesh-list
139340434|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139340435|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139340436|NCT01365052|Analgesics|analgesics|mesh-ancestor
139340437|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
139340438|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340439|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340440|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139340441|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340442|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
139340443|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139340444|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340445|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340446|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
139340447|NCT05155215|Fludarabine|fludarabine|mesh-list
139340448|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139340449|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
139340450|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340451|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340452|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139340453|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
139340454|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340455|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340456|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139340457|NCT03471585|Dronabinol|dronabinol|mesh-list
139340458|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
139340459|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340460|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139340461|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139340462|NCT03471585|Analgesics|analgesics|mesh-ancestor
139340463|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
139340464|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340465|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139340466|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139340467|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340468|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340469|NCT03471585|Hormones|hormones|mesh-ancestor
139340470|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139340471|NCT05072782|Infliximab|infliximab|mesh-list
139340472|NCT05072782|Methotrexate|methotrexate|mesh-list
139340473|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139340474|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
139340475|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139340476|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340477|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139340478|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
139340479|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340480|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340481|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
139340482|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340483|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139340484|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139340485|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
139340486|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340487|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139340488|NCT05072782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139340489|NCT05072782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139340490|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139340491|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139340492|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
139340493|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
139340494|NCT03379389|Methenamine|methenamine|mesh-list
139340495|NCT03379389|Acriflavine|acriflavine|mesh-list
139340496|NCT03379389|Methylene Blue|methylene blue|mesh-list
139340497|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997350|NCT05919121|Hydrocortisone|hydrocortisone|mesh-list
139340498|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340499|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340500|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139340501|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139340503|NCT05170438|Lenvatinib|lenvatinib|mesh-list
139340504|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139340505|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340506|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
139340507|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
139340508|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
139340509|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340510|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139340511|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340512|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
139340513|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139340514|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340515|NCT03478605|Dexamethasone|dexamethasone|mesh-list
139340516|NCT03478605|Ondansetron|ondansetron|mesh-list
139340517|NCT03478605|Olanzapine|olanzapine|mesh-list
139340518|NCT03478605|Aprepitant|aprepitant|mesh-list
139340519|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139340520|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
139340521|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
139340522|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340523|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340524|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139340525|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
139340526|NCT03478605|Hormones|hormones|mesh-ancestor
139340527|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139340528|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139340529|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340530|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
139340531|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
139340532|NCT03478605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139340533|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139340534|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
139340535|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340536|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340537|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139340538|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139340539|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139340540|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139340541|NCT03478605|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139340542|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139340543|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139340544|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139340545|NCT05258799|Cytarabine|cytarabine|mesh-list
139340546|NCT05258799|Decitabine|decitabine|mesh-list
139340547|NCT05258799|Aclarubicin|aclarubicin|mesh-list
139340548|NCT05258799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139340549|NCT05258799|Antimetabolites|antimetabolites|mesh-ancestor
139340550|NCT05258799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340551|NCT05258799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340552|NCT05258799|Antiviral Agents|antiviral agents|mesh-ancestor
139340553|NCT05258799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340554|NCT05258799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139340555|NCT05258799|Immunologic Factors|immunologic factors|mesh-ancestor
139340556|NCT05258799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340557|NCT05258799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340558|NCT05258799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139340559|NCT05258799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139340560|NCT05258799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139340561|NCT04233892|Estrogens|estrogens|mesh-list
139340562|NCT04233892|Hormones|hormones|mesh-ancestor
139340563|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139340564|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340565|NCT02386358|Benzonidazole|benzonidazole|mesh-list
139340566|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139340567|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
139340568|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340569|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139340570|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139340571|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138997435|NCT05882812|Diclofenac|diclofenac|mesh-list
139340572|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340573|NCT03283371|Natalizumab|natalizumab|mesh-list
139340574|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
139340575|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340576|NCT05069350|Bupivacaine|bupivacaine|mesh-list
139340577|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
139340578|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
139340579|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139340580|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340581|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
139340582|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340583|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
139340584|NCT03471351|Tenalisib|tenalisib|mesh-list
139340585|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139340586|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340587|NCT03471351|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139340588|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340589|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139340590|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340591|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
139340592|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139340593|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139340594|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340595|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
139340596|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
139340598|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139340599|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139340600|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340601|NCT03891446|Bimatoprost|bimatoprost|mesh-list
139340602|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139340603|NCT03059511|Nalbuphine|nalbuphine|mesh-list
139340604|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139340605|NCT03059511|Narcotics|narcotics|mesh-ancestor
139340606|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180643|NCT06062979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139340607|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340609|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
139340610|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340611|NCT04439786|Lidocaine|lidocaine|mesh-list
139340612|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
139340613|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
139340614|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139340615|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340616|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
139340617|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340618|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139340619|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139340620|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139340621|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139340622|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340623|NCT02665286|Naproxen|naproxen|mesh-list
139340624|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139340625|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139340626|NCT02665286|Orphenadrine|orphenadrine|mesh-list
139340627|NCT02665286|Methocarbamol|methocarbamol|mesh-list
139340628|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139340629|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139340630|NCT02665286|Analgesics|analgesics|mesh-ancestor
139340631|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
139340632|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340633|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340634|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340635|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
139340636|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139340637|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340638|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340639|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
139340640|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340641|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139340642|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139340643|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139340644|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139340645|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
139340646|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
139340647|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139340648|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
139340649|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139340651|NCT02390102|Hematinics|hematinics|mesh-ancestor
139340652|NCT03663673|Decanoic acid|decanoic acid|mesh-list
139340653|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
139340654|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340655|NCT03664063|Azithromycin|azithromycin|mesh-list
139340656|NCT03664063|Ivermectin|ivermectin|mesh-list
139340657|NCT03664063|Albendazole|albendazole|mesh-list
139340658|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
139340659|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139340660|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340661|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139340662|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
139340663|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
139340664|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139340665|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139340666|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
139340667|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
139340668|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
139340669|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340670|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340671|NCT03664063|Filaricides|filaricides|mesh-ancestor
139340672|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
139340673|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139340674|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340675|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
139340676|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139340677|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
139340678|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340679|NCT02911285|Expectorants|expectorants|mesh-ancestor
139340680|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
139340682|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
139340683|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340684|NCT02911285|Protective Agents|protective agents|mesh-ancestor
139340685|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340686|NCT02911285|Antidotes|antidotes|mesh-ancestor
139340687|NCT04997902|Tipifarnib|tipifarnib|mesh-list
139340688|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340689|NCT01061515|Bevacizumab|bevacizumab|mesh-list
139340690|NCT01061515|Capecitabine|capecitabine|mesh-list
139340691|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
139340692|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139340693|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340694|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139340695|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139340696|NCT01061515|Growth Substances|growth substances|mesh-ancestor
139340697|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340698|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
139340699|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139340700|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
139340701|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340702|NCT01069939|Esomeprazole|esomeprazole|mesh-list
139340703|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139340704|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139340705|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139340706|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340707|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340708|NCT01069705|Tobramycin|tobramycin|mesh-list
139340709|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139340710|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340711|NCT01069627|Bevacizumab|bevacizumab|mesh-list
139340712|NCT01069627|Fotemustine|fotemustine|mesh-list
139340713|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139340714|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340715|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139340716|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139340717|NCT01069627|Growth Substances|growth substances|mesh-ancestor
139340718|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340719|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
139340720|NCT04057261|Liraglutide|liraglutide|mesh-list
139340721|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139340722|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340723|NCT04057261|Incretins|incretins|mesh-ancestor
139340724|NCT04057261|Hormones|hormones|mesh-ancestor
139340725|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139340726|NCT01064245|Mannitol|mannitol|mesh-list
139340727|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
139340728|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139340729|NCT01064245|Diuretics|diuretics|mesh-ancestor
139340730|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
139340731|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340732|NCT01064245|Miotics|miotics|mesh-ancestor
139340733|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
139340734|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340735|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139340736|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139340737|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
139340738|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139340739|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139340740|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
139340741|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340742|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340743|NCT04056949|Paclitaxel|paclitaxel|mesh-list
139340744|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139340745|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139340746|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340747|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
139340748|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
139340750|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340751|NCT03662425|Oxytocin|oxytocin|mesh-list
139340752|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
139340753|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139340754|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340755|NCT03673163|Lidocaine|lidocaine|mesh-list
139340756|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
139340757|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
139340758|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139340759|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340760|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
139340761|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340762|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139340763|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139340764|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139340765|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139340766|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340767|NCT03662269|Indomethacin|indomethacin|mesh-list
139340768|NCT03662269|Omeprazole|omeprazole|mesh-list
139340769|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139340770|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139340771|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139340772|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340773|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340774|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139340775|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139340776|NCT03662269|Analgesics|analgesics|mesh-ancestor
139340777|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
139340778|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340779|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340780|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139340781|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340782|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
139340783|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
139340784|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139340785|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139340786|NCT04056325|Ivermectin|ivermectin|mesh-list
139340787|NCT04056325|Moxidectin|moxidectin|mesh-list
139340788|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139340789|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340790|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
139340791|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
139340792|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139340793|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139340794|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
139340795|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139340796|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
139340797|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340798|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997648|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340799|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340800|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139340801|NCT01585025|Cathartics|cathartics|mesh-ancestor
139340802|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139340803|NCT00328653|Cyclosporine|cyclosporine|mesh-list
139340804|NCT00328653|Cyclosporins|cyclosporins|mesh-list
139340805|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340806|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340807|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139340808|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
139340809|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340810|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
139340811|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340812|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
139340813|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340814|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139340815|NCT03662113|Domperidone|domperidone|mesh-list
139340816|NCT03662113|Simethicone|simethicone|mesh-list
139340817|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
139340818|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
139340819|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340820|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340821|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139340822|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139340823|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
139340824|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340825|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340826|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
139340827|NCT03662113|Emollients|emollients|mesh-ancestor
139340828|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
139340829|NCT03662035|Apatinib|apatinib|mesh-list
139340830|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340831|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139340832|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340833|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340834|NCT05798546|Cyclophosphamide|cyclophosphamide|mesh-list
139340835|NCT05798546|Fludarabine|fludarabine|mesh-list
139340836|NCT05798546|Interleukin-2|interleukin-2|mesh-list
139340837|NCT05798546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139340838|NCT05798546|Immunologic Factors|immunologic factors|mesh-ancestor
139340839|NCT05798546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340840|NCT05798546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340841|NCT05798546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139340842|NCT05798546|Alkylating Agents|alkylating agents|mesh-ancestor
139340843|NCT05798546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340844|NCT05798546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340845|NCT05798546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139340846|NCT05798546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139340847|NCT05798546|Analgesics|analgesics|mesh-ancestor
139340848|NCT05798546|Sensory System Agents|sensory system agents|mesh-ancestor
139340849|NCT05798546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340850|NCT05798195|Dexamethasone|dexamethasone|mesh-list
139340851|NCT05798195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139340852|NCT05798195|Antiemetics|antiemetics|mesh-ancestor
139340853|NCT05798195|Autonomic Agents|autonomic agents|mesh-ancestor
139340854|NCT05798195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340855|NCT05798195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340856|NCT05798195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139340857|NCT05798195|Glucocorticoids|glucocorticoids|mesh-ancestor
139340858|NCT05798195|Hormones|hormones|mesh-ancestor
139340859|NCT05798195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139340860|NCT05798195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139340861|NCT05798195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340862|NCT05797948|Cyclophosphamide|cyclophosphamide|mesh-list
139340863|NCT05797948|Fludarabine|fludarabine|mesh-list
139340864|NCT05797948|Lenalidomide|lenalidomide|mesh-list
139340865|NCT05797948|Azacitidine|azacitidine|mesh-list
139340866|NCT05797948|Obinutuzumab|obinutuzumab|mesh-list
139340867|NCT05797948|Zanubrutinib|zanubrutinib|mesh-list
139340868|NCT05797948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139340869|NCT05797948|Immunologic Factors|immunologic factors|mesh-ancestor
139340870|NCT05797948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340871|NCT05797948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340872|NCT05797948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139340873|NCT05797948|Alkylating Agents|alkylating agents|mesh-ancestor
139340874|NCT05797948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340875|NCT05797948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340876|NCT05797948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139340877|NCT05797948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139340878|NCT05797948|Antimetabolites|antimetabolites|mesh-ancestor
139340879|NCT05797948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139340880|NCT05797948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139340881|NCT05797948|Growth Substances|growth substances|mesh-ancestor
139340882|NCT05797948|Growth Inhibitors|growth inhibitors|mesh-ancestor
139340883|NCT05797948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340884|NCT05797948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139340885|NCT05797948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139340886|NCT05797818|Chlorhexidine|chlorhexidine|mesh-list
139340887|NCT05797818|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139340888|NCT05797818|Methylene Blue|methylene blue|mesh-list
139340889|NCT05797818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139340890|NCT05797818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340891|NCT05797818|Disinfectants|disinfectants|mesh-ancestor
139340892|NCT05797818|Dermatologic Agents|dermatologic agents|mesh-ancestor
139340893|NCT05797818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340894|NCT05797818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340895|NCT05797792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139340896|NCT05797792|Plasminogen|plasminogen|mesh-list
139340897|NCT05797792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139340898|NCT05797792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139340899|NCT05797792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340900|NCT05797753|Itraconazole|itraconazole|mesh-list
139340901|NCT05797753|Erythromycin|erythromycin|mesh-list
139340902|NCT05797753|Erythromycin Estolate|erythromycin estolate|mesh-list
139340903|NCT05797753|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139340904|NCT05797753|Erythromycin stearate|erythromycin stearate|mesh-list
139340905|NCT05797753|Antifungal Agents|antifungal agents|mesh-ancestor
139340906|NCT05797753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340907|NCT05797753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139340908|NCT05797753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139340909|NCT05797753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340910|NCT05797753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340911|NCT05797753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139340912|NCT05797753|Hormone Antagonists|hormone antagonists|mesh-ancestor
139340913|NCT05797753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139340914|NCT05797753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340915|NCT05797753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139340916|NCT05797753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139340917|NCT05797753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139340918|NCT05797753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139340919|NCT05797714|Tenofovir|tenofovir|mesh-list
139340920|NCT05797714|Antiviral Agents|antiviral agents|mesh-ancestor
139340921|NCT05797714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139340922|NCT05797714|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139340923|NCT05797714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139340924|NCT05797714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917191|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139340925|NCT05797714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340926|NCT05797714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139340927|NCT05797714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139340928|NCT05797584|Dobutamine|dobutamine|mesh-list
139340929|NCT05797584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139340930|NCT05797584|Sympathomimetics|sympathomimetics|mesh-ancestor
139340931|NCT05797584|Autonomic Agents|autonomic agents|mesh-ancestor
139340932|NCT05797584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340933|NCT05797584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340934|NCT05797584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139340935|NCT05797584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139340936|NCT05797584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139340937|NCT05797584|Adrenergic Agents|adrenergic agents|mesh-ancestor
139340938|NCT05797584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340939|NCT05797584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340940|NCT05797584|Protective Agents|protective agents|mesh-ancestor
139340941|NCT05797493|Atezolizumab|atezolizumab|mesh-list
139340942|NCT05797493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139340943|NCT05797493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340944|NCT05797493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139340945|NCT05797493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340946|NCT05797220|Diltiazem|diltiazem|mesh-list
139340947|NCT05797220|Botulinum Toxins|botulinum toxins|mesh-list
139340948|NCT05797220|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139340949|NCT05797220|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139340950|NCT05797220|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139340951|NCT05797220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139340952|NCT05797220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340953|NCT05797220|Cholinergic Agents|cholinergic agents|mesh-ancestor
139340954|NCT05797220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139340955|NCT05797220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340956|NCT05797220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139340957|NCT05797220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139340958|NCT05797220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139340959|NCT05797220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139340960|NCT05797220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139340961|NCT05797220|Vasodilator Agents|vasodilator agents|mesh-ancestor
139340962|NCT05797077|Capecitabine|capecitabine|mesh-list
139340963|NCT05797077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139340964|NCT05797077|Antimetabolites|antimetabolites|mesh-ancestor
139340965|NCT05797077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340966|NCT05797077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340967|NCT05797038|Tacrolimus|tacrolimus|mesh-list
139340968|NCT05797038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139340969|NCT05797038|Immunologic Factors|immunologic factors|mesh-ancestor
139340970|NCT05797038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340971|NCT05797038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139340972|NCT05797038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139340973|NCT05797038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340974|NCT05795933|Vitamin D|vitamin d|mesh-list
139340975|NCT05795933|Cholecalciferol|cholecalciferol|mesh-list
139340976|NCT05795933|Vitamins|vitamins|mesh-ancestor
139340977|NCT05795933|Micronutrients|micronutrients|mesh-ancestor
139340978|NCT05795933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340979|NCT05795933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139340980|NCT05795933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139340981|NCT05703854|Cyclophosphamide|cyclophosphamide|mesh-list
139340982|NCT05703854|Fludarabine|fludarabine|mesh-list
139340983|NCT05703854|Fludarabine phosphate|fludarabine phosphate|mesh-list
139340984|NCT05703854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139340985|NCT05703854|Immunologic Factors|immunologic factors|mesh-ancestor
139340986|NCT05703854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139340987|NCT05703854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139340988|NCT05703854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139340989|NCT05703854|Alkylating Agents|alkylating agents|mesh-ancestor
139340990|NCT05703854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139340991|NCT05703854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340992|NCT05703854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139340993|NCT05703854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139340994|NCT05703854|Antimetabolites|antimetabolites|mesh-ancestor
139340995|NCT05692999|Pembrolizumab|pembrolizumab|mesh-list
139340996|NCT05692999|Pemetrexed|pemetrexed|mesh-list
139340997|NCT05692999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139340998|NCT05692999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139340999|NCT05692999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139341000|NCT05692999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341001|NCT05692999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341002|NCT05692999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139341003|NCT05692999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139341004|NCT05661591|Fluconazole|fluconazole|mesh-list
139341005|NCT05661591|Antifungal Agents|antifungal agents|mesh-ancestor
139341006|NCT05661591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139341007|NCT05661591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139341008|NCT05661591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139341009|NCT05661591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917254|NCT04111328|Dsuvia|dsuvia|mesh-list
139341010|NCT05661591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341011|NCT05661591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139341012|NCT05661591|Hormone Antagonists|hormone antagonists|mesh-ancestor
139341013|NCT05661591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139341014|NCT05661591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341015|NCT05661591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139341016|NCT05661591|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139341017|NCT05661201|Doxorubicin|doxorubicin|mesh-list
139341018|NCT05661201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139341019|NCT05661201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341020|NCT05661201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139341021|NCT05661201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139341022|NCT05661201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341023|NCT05661201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341024|NCT05634148|Dexmedetomidine|dexmedetomidine|mesh-list
139341025|NCT05634148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139341026|NCT05634148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139341027|NCT05634148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341028|NCT05634148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139341029|NCT05634148|Analgesics|analgesics|mesh-ancestor
139341030|NCT05634148|Sensory System Agents|sensory system agents|mesh-ancestor
139341031|NCT05634148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341032|NCT05634148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139341033|NCT05634148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139341034|NCT05634148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139341035|NCT05634148|Adrenergic Agents|adrenergic agents|mesh-ancestor
139341036|NCT05634148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139341037|NCT05634148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341039|NCT05622123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139341040|NCT05622123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341041|NCT05622123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139341042|NCT05622123|Incretins|incretins|mesh-ancestor
139341043|NCT05622123|Hormones|hormones|mesh-ancestor
139341044|NCT05622123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139341045|NCT05594082|Trastuzumab|trastuzumab|mesh-list
139341046|NCT05594082|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139341047|NCT05594082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139341048|NCT05594082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341049|NCT05594082|Immunoconjugates|immunoconjugates|mesh-ancestor
139341050|NCT05594082|Immunologic Factors|immunologic factors|mesh-ancestor
139341051|NCT05594082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341052|NCT05574374|Fexuprazan|fexuprazan|mesh-list
139341053|NCT05574374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139341054|NCT05506787|Esketamine|esketamine|mesh-list
139341055|NCT05506787|Antidepressive Agents|antidepressive agents|mesh-ancestor
139341056|NCT05506787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139341057|NCT05503511|Bumetanide|bumetanide|mesh-list
139341058|NCT05503511|Diuretics|diuretics|mesh-ancestor
139341059|NCT05503511|Natriuretic Agents|natriuretic agents|mesh-ancestor
139341060|NCT05503511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341061|NCT05503511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139341062|NCT05503511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139341063|NCT05503511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341064|NCT05503355|Venetoclax|venetoclax|mesh-list
139341065|NCT05503355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341066|NCT05453851|Pancrelipase|pancrelipase|mesh-list
139341067|NCT05453851|Pancreatin|pancreatin|mesh-list
139341068|NCT05453851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139341069|NCT05445024|Sufentanil|sufentanil|mesh-list
139341070|NCT05445024|Nalbuphine|nalbuphine|mesh-list
139341071|NCT05445024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139341072|NCT05445024|Narcotics|narcotics|mesh-ancestor
139341073|NCT05445024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139341074|NCT05445024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341075|NCT05445024|Analgesics|analgesics|mesh-ancestor
139341076|NCT05445024|Sensory System Agents|sensory system agents|mesh-ancestor
139341077|NCT05445024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341078|NCT05445024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139341079|NCT05445024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139341080|NCT05445024|Anesthetics, General|anesthetics, general|mesh-ancestor
139341081|NCT05445024|Anesthetics|anesthetics|mesh-ancestor
139341082|NCT05429814|Menthol|menthol|mesh-list
139341083|NCT05429814|Antipruritics|antipruritics|mesh-ancestor
139341084|NCT05429814|Dermatologic Agents|dermatologic agents|mesh-ancestor
139341085|NCT05420337|Morphine|morphine|mesh-list
139341086|NCT05420337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139341087|NCT05420337|Narcotics|narcotics|mesh-ancestor
139341088|NCT05420337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139341089|NCT05420337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341090|NCT05420337|Analgesics|analgesics|mesh-ancestor
139341091|NCT05420337|Sensory System Agents|sensory system agents|mesh-ancestor
139341092|NCT05420337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341093|NCT05390905|Tramadol|tramadol|mesh-list
139341094|NCT05390905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139341095|NCT05390905|Narcotics|narcotics|mesh-ancestor
138997954|NCT03635164|Durvalumab|durvalumab|mesh-list
139341096|NCT05390905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139341097|NCT05390905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341099|NCT05390905|Sensory System Agents|sensory system agents|mesh-ancestor
139341100|NCT05390905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341101|NCT05366621|Denosumab|denosumab|mesh-list
139341102|NCT05366621|Diphosphonates|diphosphonates|mesh-list
139341103|NCT05366621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341104|NCT05366621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139341105|NCT05359146|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
139341106|NCT05359146|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139341107|NCT05359146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341108|NCT05335252|Dronabinol|dronabinol|mesh-list
139341109|NCT05335252|Hallucinogens|hallucinogens|mesh-ancestor
139341110|NCT05335252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341111|NCT05335252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139341112|NCT05335252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139341113|NCT05335252|Analgesics|analgesics|mesh-ancestor
139341114|NCT05335252|Sensory System Agents|sensory system agents|mesh-ancestor
139341115|NCT05335252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341116|NCT05335252|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139341117|NCT05335252|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139341118|NCT05335252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139341119|NCT05335252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341120|NCT05335252|Hormones|hormones|mesh-ancestor
139341121|NCT05335252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139341122|NCT05325775|SR 142801|sr 142801|mesh-list
139341123|NCT05325775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139341124|NCT05325775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139341125|NCT05325775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139341126|NCT05325775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341127|NCT05325775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139341128|NCT05284084|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
139341129|NCT05284084|Histamine Antagonists|histamine antagonists|mesh-ancestor
139341130|NCT05284084|Histamine Agents|histamine agents|mesh-ancestor
139341131|NCT05284084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139341132|NCT05284084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341133|NCT05284084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341134|NCT05226351|Dronabinol|dronabinol|mesh-list
139341135|NCT05226351|Hallucinogens|hallucinogens|mesh-ancestor
139341136|NCT05226351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341137|NCT05226351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139341138|NCT05226351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139341139|NCT05226351|Analgesics|analgesics|mesh-ancestor
139341140|NCT05226351|Sensory System Agents|sensory system agents|mesh-ancestor
139341141|NCT05226351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341142|NCT05226351|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139341143|NCT05226351|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139341144|NCT05226351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139341145|NCT05226351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341146|NCT05226351|Hormones|hormones|mesh-ancestor
139341147|NCT05226351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139341148|NCT05215548|Afatinib|afatinib|mesh-list
139341149|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341150|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139341151|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917334|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139341152|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341153|NCT05209555|Pilocarpine|pilocarpine|mesh-list
139341154|NCT05209555|Miotics|miotics|mesh-ancestor
139341155|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
139341156|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341157|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341158|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139341159|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139341160|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
139341161|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139341162|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341163|NCT05202145|Cyclosporine|cyclosporine|mesh-list
139341164|NCT05202145|Tacrolimus|tacrolimus|mesh-list
139341165|NCT05202145|Cyclosporins|cyclosporins|mesh-list
139341166|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139341167|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
139341168|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341169|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139341170|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341171|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341172|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
139341173|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139341174|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
139341175|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139341176|NCT05142904|Iodine|iodine|mesh-list
139341177|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
139341178|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139341179|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139341180|NCT05142904|Trace Elements|trace elements|mesh-ancestor
139341181|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
139341182|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341183|NCT05042648|Buprenorphine|buprenorphine|mesh-list
139341184|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139341185|NCT05042648|Narcotics|narcotics|mesh-ancestor
139341186|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139341187|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341188|NCT05042648|Analgesics|analgesics|mesh-ancestor
139341189|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
139341190|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917364|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
139341191|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139341192|NCT05036317|Empagliflozin|empagliflozin|mesh-list
139341193|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139341194|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341195|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139341196|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341197|NCT04990388|Acetaminophen|acetaminophen|mesh-list
139341198|NCT04990388|Antipyretics|antipyretics|mesh-list
139341199|NCT04990388|Cetirizine|cetirizine|mesh-list
139341200|NCT04990388|Ibuprofen|ibuprofen|mesh-list
139341201|NCT04990388|Famotidine|famotidine|mesh-list
139341202|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139341203|NCT04990388|Analgesics|analgesics|mesh-ancestor
139341204|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
139341205|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341206|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341207|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139341208|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139341209|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139341210|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139341211|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341212|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341213|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139341214|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139341215|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139341216|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
139341217|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
139341218|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139341219|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139341220|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139341221|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139341222|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
139341223|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139341224|NCT04871269|Dronabinol|dronabinol|mesh-list
139180700|NCT05922605|Ketamine|ketamine|mesh-list
139341225|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
139341226|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341227|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139341228|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139341229|NCT04871269|Analgesics|analgesics|mesh-ancestor
139341230|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
139341231|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341232|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139341233|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139341234|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139341235|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341236|NCT04871269|Hormones|hormones|mesh-ancestor
139341237|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139341238|NCT04837131|Ixazomib|ixazomib|mesh-list
139341239|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341240|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
139341241|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341242|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341243|NCT04764214|Osimertinib|osimertinib|mesh-list
139341244|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341245|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139341246|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341247|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341248|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
139341249|NCT04653818|Velpatasvir|velpatasvir|mesh-list
139341250|NCT04653818|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139341251|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
139341252|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139341253|NCT04578652|Metformin|metformin|mesh-list
139341254|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139341255|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341256|NCT04570631|Dexamethasone|dexamethasone|mesh-list
139341257|NCT04570631|Bortezomib|bortezomib|mesh-list
139341258|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139341259|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
139341260|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
139341261|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341262|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341263|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139341264|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
139341265|NCT04570631|Hormones|hormones|mesh-ancestor
139341266|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139341267|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139341268|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341269|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
139341270|NCT04550832|Bedaquiline|bedaquiline|mesh-list
139341271|NCT04550832|Delpazolid|delpazolid|mesh-list
139341272|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139341273|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139341274|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139341275|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138917437|NCT00799058|Dapivirine|dapivirine|mesh-list
139341276|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341277|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341278|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341279|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
139341280|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139341281|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
139341282|NCT04477629|Abatacept|abatacept|mesh-list
139341283|NCT04477629|Tacrolimus|tacrolimus|mesh-list
139341284|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139341285|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
139341286|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341287|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139341288|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341289|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341290|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139341291|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341292|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139341293|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
139341294|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139341295|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139180708|NCT05922605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139341296|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139341297|NCT04477629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139341298|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139341300|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
139341301|NCT04476277|Vitamins|vitamins|mesh-ancestor
139341302|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
139341303|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341304|NCT04430517|Niacinamide|niacinamide|mesh-list
139341305|NCT04430517|Niacin|niacin|mesh-list
139341306|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
139341307|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
139341308|NCT04430517|Vitamins|vitamins|mesh-ancestor
139341309|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
139341310|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341311|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139341312|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
139341313|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341314|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139341315|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
139341316|NCT04414943|Ketamine|ketamine|mesh-list
139341317|NCT04414943|Esketamine|esketamine|mesh-list
139341318|NCT04414943|Analgesics|analgesics|mesh-ancestor
139341319|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
139341320|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341321|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341322|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139341323|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139341324|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
139341325|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
139341326|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139341327|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139341328|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139341329|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139341330|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341331|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
139341332|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139341334|NCT04354025|Fludarabine|fludarabine|mesh-list
139341335|NCT04354025|Interleukin-2|interleukin-2|mesh-list
139341336|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341337|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139341338|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
139341339|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341340|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139341341|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
139341342|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341343|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
139341344|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139341345|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139341346|NCT04354025|Analgesics|analgesics|mesh-ancestor
139341347|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
139341348|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341349|NCT04347720|Acetaminophen|acetaminophen|mesh-list
139341350|NCT04347720|Ibuprofen|ibuprofen|mesh-list
139341351|NCT04347720|Indomethacin|indomethacin|mesh-list
139341352|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139341353|NCT04347720|Analgesics|analgesics|mesh-ancestor
139341354|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
139341355|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341356|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341357|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
139341358|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139341359|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139341360|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139341361|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139341362|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341363|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341364|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
139341365|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
139341366|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139341367|NCT04325802|Naltrexone|naltrexone|mesh-list
139341368|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139341369|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139341370|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341371|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
139341372|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341374|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
139341375|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139341376|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341377|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341378|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
139341379|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
139341380|NCT04241562|Mitogens|mitogens|mesh-list
139341381|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
139341382|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341383|NCT04209192|Amikacin|amikacin|mesh-list
139341384|NCT04209192|Fosfomycin|fosfomycin|mesh-list
139341385|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139341386|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139341387|NCT04199468|Ketamine|ketamine|mesh-list
139341388|NCT04199468|Dronabinol|dronabinol|mesh-list
139341389|NCT04199468|Analgesics|analgesics|mesh-ancestor
139341390|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
139341391|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341392|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341393|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139341394|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139341395|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
139341396|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
139341397|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139341398|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139341399|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139341400|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998252|NCT01081717|Golimumab|golimumab|mesh-list
139341401|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341402|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
139341403|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139341404|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139341405|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139341406|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139341407|NCT04199468|Hormones|hormones|mesh-ancestor
139341408|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139341409|NCT04178148|Amikacin|amikacin|mesh-list
139341410|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139341411|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139341412|NCT04126681|Interferons|interferons|mesh-list
139341413|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
139341414|NCT04126681|Dasatinib|dasatinib|mesh-list
139341415|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
139341416|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
139341417|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341418|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
139341419|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139341420|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139341421|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341422|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341423|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
139341424|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139341425|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139341426|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139341427|NCT04118855|Axitinib|axitinib|mesh-list
139341428|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341429|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139341430|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341431|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341432|NCT04011150|Fentanyl|fentanyl|mesh-list
139341433|NCT04011150|Ropivacaine|ropivacaine|mesh-list
139341434|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
139341435|NCT04011150|Anesthetics|anesthetics|mesh-list
139341436|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139341437|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341438|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
139341439|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341440|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139341441|NCT04011150|Narcotics|narcotics|mesh-ancestor
139341442|NCT04011150|Analgesics|analgesics|mesh-ancestor
139341443|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139341444|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139341445|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
139341446|NCT03927378|Ketamine|ketamine|mesh-list
139341447|NCT03927378|Esketamine|esketamine|mesh-list
139341448|NCT03927378|Analgesics|analgesics|mesh-ancestor
139341449|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
139341450|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341451|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341452|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139341453|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139341454|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
139341455|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
139341456|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139341457|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139341458|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139341459|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139341460|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341461|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
139341462|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139341463|NCT03875391|Oxytocin|oxytocin|mesh-list
139341464|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
139341465|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139341466|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341467|NCT03836066|Bevacizumab|bevacizumab|mesh-list
139341468|NCT03836066|Atezolizumab|atezolizumab|mesh-list
139341469|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139341470|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341471|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139341472|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139341473|NCT03836066|Growth Substances|growth substances|mesh-ancestor
139341474|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341475|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
139341476|NCT03836066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139341477|NCT03836066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341478|NCT03778242|Tranexamic Acid|tranexamic acid|mesh-list
139341479|NCT03778242|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139341480|NCT03778242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139341481|NCT03778242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341482|NCT03778242|Hemostatics|hemostatics|mesh-ancestor
139341483|NCT03778242|Coagulants|coagulants|mesh-ancestor
139341484|NCT03772613|Heparin|heparin|mesh-list
139341485|NCT03772613|Calcium heparin|calcium heparin|mesh-list
139341486|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
139341487|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139341488|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139341489|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341490|NCT03698461|Leucovorin|leucovorin|mesh-list
139341491|NCT03698461|Bevacizumab|bevacizumab|mesh-list
139341492|NCT03698461|Atezolizumab|atezolizumab|mesh-list
139341493|NCT03698461|Fluorouracil|fluorouracil|mesh-list
139341494|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
139341495|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
139341496|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139341497|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341498|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139341499|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139341500|NCT03698461|Growth Substances|growth substances|mesh-ancestor
139341501|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341502|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
139341503|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
139341504|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341505|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139341506|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139341507|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
139341508|NCT03698461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139341509|NCT03698461|Antidotes|antidotes|mesh-ancestor
139341510|NCT03698461|Protective Agents|protective agents|mesh-ancestor
139341511|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
139341512|NCT03698461|Vitamins|vitamins|mesh-ancestor
139341513|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
139341514|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
139341515|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
139341516|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139341517|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139341518|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139341519|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341520|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341521|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139341522|NCT03261102|Adalimumab|adalimumab|mesh-list
139341523|NCT03261102|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139341524|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139341525|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139341526|NCT02848131|Dasatinib|dasatinib|mesh-list
139341527|NCT02848131|Quercetin|quercetin|mesh-list
139341528|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341529|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139341530|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341531|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341532|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
139341533|NCT02848131|Protective Agents|protective agents|mesh-ancestor
139341534|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341535|NCT02846376|Nivolumab|nivolumab|mesh-list
139341536|NCT02846376|Ipilimumab|ipilimumab|mesh-list
139341537|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139341538|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341539|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139341540|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341541|NCT02590601|Bromocriptine|bromocriptine|mesh-list
139341542|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139341543|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139341544|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
139341545|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139341546|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341547|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
139341548|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
139341549|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139341550|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341551|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139341552|NCT02240498|Methylene Blue|methylene blue|mesh-list
139341553|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341554|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341555|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139341556|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139341557|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139341558|NCT02178098|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139341559|NCT02178098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139341561|NCT02178098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341562|NCT02178098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139341563|NCT02178098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341564|NCT02178098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139341565|NCT02178098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341566|NCT01885689|Sirolimus|sirolimus|mesh-list
139341567|NCT01885689|Melphalan|melphalan|mesh-list
139341568|NCT01885689|Clofarabine|clofarabine|mesh-list
139341569|NCT01885689|Tacrolimus|tacrolimus|mesh-list
139341570|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139341571|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
139341572|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341573|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139341574|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917680|NCT00734994|Mitomycin|mitomycin|mesh-list
139341575|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341576|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139341577|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139341578|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139341579|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341580|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
139341581|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139341582|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
139341583|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139341584|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139341585|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
139341586|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
139341587|NCT01798004|Melphalan|melphalan|mesh-list
139341588|NCT01798004|Busulfan|busulfan|mesh-list
139341589|NCT01798004|Mechlorethamine|mechlorethamine|mesh-list
139341590|NCT01798004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139341591|NCT01798004|Cisplatin|cisplatin|mesh-list
139341592|NCT01798004|Doxorubicin|doxorubicin|mesh-list
139341593|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139341594|NCT01798004|Etoposide|etoposide|mesh-list
139341595|NCT01798004|Vincristine|vincristine|mesh-list
139341596|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
139341597|NCT01798004|Topotecan|topotecan|mesh-list
139341598|NCT01798004|Podophyllotoxin|podophyllotoxin|mesh-list
139341599|NCT01798004|Lenograstim|lenograstim|mesh-list
139341600|NCT01798004|Mesna|mesna|mesh-list
139341601|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139341602|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
139341603|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341604|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139341605|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139341606|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
139341607|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341608|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341609|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139341610|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139341611|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139341612|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139341613|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341614|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139341615|NCT01798004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139341616|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
139341617|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
139341618|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
139341619|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139341620|NCT01798004|Protective Agents|protective agents|mesh-ancestor
139341621|NCT01798004|Keratolytic Agents|keratolytic agents|mesh-ancestor
139341622|NCT01798004|Dermatologic Agents|dermatologic agents|mesh-ancestor
139341623|NCT01693380|Vaccines|vaccines|mesh-list
139341624|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
139341625|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341626|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139341627|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139341628|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138917699|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139341629|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341630|NCT01542879|Hematinics|hematinics|mesh-ancestor
139341631|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139341632|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139341633|NCT01492972|Leuprolide|leuprolide|mesh-list
139341634|NCT01492972|Goserelin|goserelin|mesh-list
139341635|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139341636|NCT01492972|Buserelin|buserelin|mesh-list
139341637|NCT01492972|Androgens|androgens|mesh-list
139341638|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139341639|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
139341640|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139341641|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341642|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139341643|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341644|NCT01492972|Hormones|hormones|mesh-ancestor
139341645|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139341646|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
139341647|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139341648|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
139341649|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139341650|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
139341651|NCT01256398|Leucovorin|leucovorin|mesh-list
139341652|NCT01256398|Folic Acid|folic acid|mesh-list
139341653|NCT01256398|Cytarabine|cytarabine|mesh-list
139341654|NCT01256398|Dexamethasone|dexamethasone|mesh-list
139341655|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
139341656|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
139341658|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
139341659|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139341660|NCT01256398|Methotrexate|methotrexate|mesh-list
139341661|NCT01256398|Fludarabine|fludarabine|mesh-list
139341662|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
139341663|NCT01256398|Etoposide|etoposide|mesh-list
139341664|NCT01256398|Vincristine|vincristine|mesh-list
139341665|NCT01256398|Daunorubicin|daunorubicin|mesh-list
139341666|NCT01256398|Dasatinib|dasatinib|mesh-list
139341667|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
139341668|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
139341669|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
139341670|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139341671|NCT01256398|Tacrolimus|tacrolimus|mesh-list
139341672|NCT01256398|Antibodies|antibodies|mesh-list
139341673|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
139341674|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139341675|NCT01256398|Lenograstim|lenograstim|mesh-list
139341676|NCT01256398|BB 1101|bb 1101|mesh-list
139341677|NCT01256398|Calcium|calcium|mesh-list
139341678|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
139341679|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139341680|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
139341681|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341682|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139341683|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139341684|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
138917720|NCT00798434|Urological Agents|urological agents|mesh-ancestor
139341685|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341686|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341687|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139341688|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139341689|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
139341690|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
139341691|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341692|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139341693|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
139341694|NCT01256398|Hormones|hormones|mesh-ancestor
139341695|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139341696|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139341697|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
139341698|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341699|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139341700|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139341701|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139341702|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
139341703|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139341704|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139341705|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
139341706|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
139341707|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139341708|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139341709|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139341710|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139341711|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139341712|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
139341713|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139341714|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139341715|NCT01256398|Antidotes|antidotes|mesh-ancestor
139341716|NCT01256398|Protective Agents|protective agents|mesh-ancestor
139341717|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
139341718|NCT01256398|Vitamins|vitamins|mesh-ancestor
139341719|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
139341720|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139341721|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
139341722|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
139341723|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
139341724|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139341725|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139341726|NCT01256398|Hematinics|hematinics|mesh-ancestor
139341727|NCT01020383|Abciximab|abciximab|mesh-list
139341728|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
139341729|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139341730|NCT00889876|Metformin|metformin|mesh-list
139341731|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139341732|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341733|NCT00587067|Floxuridine|floxuridine|mesh-list
139341734|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139341735|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
139341736|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341737|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341738|NCT00453154|Cisplatin|cisplatin|mesh-list
139341739|NCT00453154|Carboplatin|carboplatin|mesh-list
139341740|NCT00453154|Etoposide|etoposide|mesh-list
139341741|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
139341742|NCT00453154|Sunitinib|sunitinib|mesh-list
139341743|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
139341744|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341745|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139341746|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139341747|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139341748|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341749|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341750|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139341751|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139341752|NCT00453154|Growth Substances|growth substances|mesh-ancestor
139341753|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341754|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
139341755|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139341756|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
139341757|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
139341758|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
139341759|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
139341760|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
139341761|NCT00309257|Valsartan|valsartan|mesh-list
139341762|NCT00309257|Benazepril|benazepril|mesh-list
139341763|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139341764|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139341765|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139341766|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341767|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139341768|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
139341769|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341770|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
139341771|NCT00258960|Doxorubicin|doxorubicin|mesh-list
139341772|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139341773|NCT00258960|Trastuzumab|trastuzumab|mesh-list
139341774|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139341775|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
139341776|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341777|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139341778|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139341779|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
139341780|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341781|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341782|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139341783|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139341784|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139341785|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139341786|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341787|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139341788|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
139341790|NCT00121992|Doxorubicin|doxorubicin|mesh-list
139341791|NCT00121992|Fluorouracil|fluorouracil|mesh-list
139341792|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139341793|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
139341794|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341795|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139341796|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139341797|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
139341798|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341799|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341800|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139341801|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
139341802|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
139341803|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
139341804|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139341805|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139341806|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139341807|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341808|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
139341809|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139341811|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
139341812|NCT00070564|Doxorubicin|doxorubicin|mesh-list
139341813|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139341814|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139341815|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341816|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
139341817|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
139341818|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
139341819|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341820|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139341821|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
139341822|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341823|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139341824|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139341825|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
139341826|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139341827|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139341828|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139341829|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139341830|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341831|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
139341832|NCT05158647|Analgesics|analgesics|mesh-ancestor
139341833|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
139341834|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341835|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341836|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
139341837|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139341838|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139341839|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
139341840|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139341841|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139341842|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341843|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139341844|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
139341845|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139341846|NCT02738151|Insulin|insulin|mesh-list
139341847|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139341848|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
139341849|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139341850|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341851|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
139341852|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
139341853|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139341854|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139341855|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341856|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139341857|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
139341858|NCT03471039|Growth Substances|growth substances|mesh-ancestor
139341859|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341860|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
139341861|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998703|NCT03853551|Osimertinib|osimertinib|mesh-list
139341862|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341863|NCT03472677|Capsaicin|capsaicin|mesh-list
139341864|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
139180745|NCT05729932|Analgesics|analgesics|mesh-ancestor
139341865|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
139341866|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
139341867|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341868|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341869|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139341871|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
139341872|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139341873|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
139341874|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341875|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341876|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139341877|NCT00702195|Hormones|hormones|mesh-ancestor
139341878|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139341879|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341880|NCT02915159|Abatacept|abatacept|mesh-list
139341881|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139341882|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341883|NCT02915159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139341884|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341885|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139341886|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
139341887|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341888|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139341889|NCT03669263|Fentanyl|fentanyl|mesh-list
139341890|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139341891|NCT03669263|Narcotics|narcotics|mesh-ancestor
139341892|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139341893|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341894|NCT03669263|Analgesics|analgesics|mesh-ancestor
139341895|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
139341896|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341897|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139341898|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139341899|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
139341900|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
139341901|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139341902|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139341903|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341904|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
139341905|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139341906|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341907|NCT02521870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139341908|NCT02521870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341909|NCT02385656|Modafinil|modafinil|mesh-list
139341910|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139341911|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341912|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139341913|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139341914|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139341915|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341916|NCT02389868|Lovastatin|lovastatin|mesh-list
139341917|NCT02389868|L 647318|l 647318|mesh-list
139341918|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
139341919|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139341920|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139341921|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
139341922|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341923|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139341924|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139341925|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341926|NCT03623087|Dexamethasone|dexamethasone|mesh-list
139341927|NCT03623087|Gemcitabine|gemcitabine|mesh-list
139341928|NCT03623087|Etoposide|etoposide|mesh-list
139341929|NCT03623087|Asparaginase|asparaginase|mesh-list
139341930|NCT03623087|Ifosfamide|ifosfamide|mesh-list
139341931|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139341932|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
139341933|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
139341934|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341935|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341936|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139341937|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
139341939|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139341940|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139341941|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341942|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139341943|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
139341944|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341945|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139341946|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139341947|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139341948|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341949|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139341950|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
139341951|NCT03113396|Baclofen|baclofen|mesh-list
139341952|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139341953|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341954|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139341955|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139341956|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139341957|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
139341958|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
139341959|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139341960|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341961|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
139341962|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341963|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
139341964|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139341965|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341966|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139341967|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
139341968|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139341969|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
139341970|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341971|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139341972|NCT03693170|Cetuximab|cetuximab|mesh-list
139341973|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139341974|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341975|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
139341976|NCT05062954|Procyanidin|procyanidin|mesh-list
139341977|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
139341978|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341979|NCT05062954|Protective Agents|protective agents|mesh-ancestor
139341980|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341981|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139341982|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139341983|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139341984|NCT05048524|Leucovorin|leucovorin|mesh-list
139341985|NCT05048524|Gemcitabine|gemcitabine|mesh-list
139341986|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
139341987|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139341988|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
139341989|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139341990|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139341991|NCT05048524|Antidotes|antidotes|mesh-ancestor
139341992|NCT05048524|Protective Agents|protective agents|mesh-ancestor
139341993|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139341994|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
139341995|NCT05048524|Vitamins|vitamins|mesh-ancestor
139341996|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
139341997|NCT02389400|Methotrexate|methotrexate|mesh-list
138917935|NCT00807599|Growth Substances|growth substances|mesh-ancestor
139341998|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139341999|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
139342000|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139342001|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342002|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139342003|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
139342004|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342005|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342006|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
139342007|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342008|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139342009|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139342010|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
139342011|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139342012|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139342013|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
139342014|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139342015|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
139342016|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342017|NCT03669029|Golimumab|golimumab|mesh-list
139342018|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139342019|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139342020|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342021|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139342022|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
139342023|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342024|NCT03668015|Sorbitol|sorbitol|mesh-list
139342025|NCT03668015|Cathartics|cathartics|mesh-ancestor
139342026|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139342027|NCT02385734|Mitogens|mitogens|mesh-list
139342028|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
139342029|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342030|NCT02385500|Fesoterodine|fesoterodine|mesh-list
139342031|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139342032|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139342033|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
139342034|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342035|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342036|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342037|NCT02385500|Urological Agents|urological agents|mesh-ancestor
139342038|NCT02385422|Propranolol|propranolol|mesh-list
139342039|NCT02385422|Carvedilol|carvedilol|mesh-list
139342040|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139342041|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139342042|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
139342043|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342044|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342045|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342046|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139342047|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139342048|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
139342049|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
139342050|NCT02385422|Protective Agents|protective agents|mesh-ancestor
139342051|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139342052|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139342053|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139342054|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139342055|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139342056|NCT02520388|Methylphenidate|methylphenidate|mesh-list
139342057|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139342058|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342059|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139342060|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139342061|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139342062|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342063|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
139342064|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342065|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139342066|NCT03667937|Laxatives|laxatives|mesh-ancestor
139342067|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139342068|NCT03667235|Glutaral|glutaral|mesh-list
139342069|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
139342070|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139342071|NCT02668640|Adalimumab|adalimumab|mesh-list
139342072|NCT02668640|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139342073|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342074|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139342075|NCT05043766|Naltrexone|naltrexone|mesh-list
139342076|NCT05043766|Oxycodone|oxycodone|mesh-list
139342077|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139342078|NCT05043766|Narcotics|narcotics|mesh-ancestor
139342079|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342080|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342081|NCT05043766|Analgesics|analgesics|mesh-ancestor
139342082|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
139342083|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342084|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139342085|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139342086|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
139342087|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139342088|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
139342089|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139342090|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342091|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139342092|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342093|NCT03011333|Epinephrine|epinephrine|mesh-list
139342094|NCT03011333|Bupivacaine|bupivacaine|mesh-list
139342095|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
139342096|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
139342097|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342098|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342099|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
139342100|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342101|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139342102|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139342103|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
139342104|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342105|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342106|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139342107|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139342108|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
139342109|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139342110|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
139342111|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
139342112|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
139342113|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139342114|NCT04570397|Ravulizumab|ravulizumab|mesh-list
139342115|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139342116|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139342117|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
139342118|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342119|NCT02385188|Acetaminophen|acetaminophen|mesh-list
139342120|NCT02385188|Imiquimod|imiquimod|mesh-list
139342121|NCT02385188|Lidocaine|lidocaine|mesh-list
139342122|NCT02385188|Petrolatum|petrolatum|mesh-list
139342123|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
139342124|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
139342125|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342126|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342127|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
139342128|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342129|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139342130|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139342131|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139342132|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139342133|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342134|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139342135|NCT02385188|Analgesics|analgesics|mesh-ancestor
139342136|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
139342137|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139342138|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
139342139|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342140|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
139342141|NCT02385188|Emollients|emollients|mesh-ancestor
139342142|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
139342143|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139342144|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139342145|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139342146|NCT02384954|Rituximab|rituximab|mesh-list
139342147|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139342148|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342149|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
139342150|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342151|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139342152|NCT02384876|Ephedrine|ephedrine|mesh-list
139342153|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
139342154|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139342155|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139342156|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342157|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
139342158|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
139342159|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342160|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139342161|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
139342162|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342163|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342164|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139342165|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139342166|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
139342167|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
139342168|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
139342169|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
139342170|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139342171|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342172|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139342173|NCT02377388|Saxagliptin|saxagliptin|mesh-list
139342174|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139342175|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342176|NCT02377388|Incretins|incretins|mesh-ancestor
139342177|NCT02377388|Hormones|hormones|mesh-ancestor
139342178|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918048|NCT04030091|Insulin|insulin|mesh-list
139342179|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139342180|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
139342181|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342182|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342183|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
139342184|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
139342185|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
139342186|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342187|NCT02382146|Dexamethasone|dexamethasone|mesh-list
139342188|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
139342189|NCT02382146|Ondansetron|ondansetron|mesh-list
139342190|NCT02382146|BB 1101|bb 1101|mesh-list
139342191|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342192|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
139342193|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
139342194|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342195|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342196|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139342197|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
139342198|NCT02382146|Hormones|hormones|mesh-ancestor
139342199|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139342200|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139342201|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342202|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
139342203|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342204|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342205|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
139342206|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
139342207|NCT02382146|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139342208|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139342209|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
139342210|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342211|NCT02382068|Dexamethasone|dexamethasone|mesh-list
139342212|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342213|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
139342215|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342216|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342217|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139342218|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
139342219|NCT02382068|Hormones|hormones|mesh-ancestor
139342220|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139342221|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139342222|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342223|NCT04731272|Dulaglutide|dulaglutide|mesh-list
139342224|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139342225|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342226|NCT02381600|Vitamin D|vitamin d|mesh-list
139342227|NCT02381600|Vitamins|vitamins|mesh-ancestor
139342228|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
139342229|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342230|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139342231|NCT03113084|Heparin|heparin|mesh-list
139342232|NCT03113084|Calcium heparin|calcium heparin|mesh-list
139342233|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
139342234|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139342235|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139342236|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342237|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
139342239|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139342240|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342241|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139342242|NCT04439474|Vitamin D|vitamin d|mesh-list
139342243|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
139342244|NCT04439474|Vitamins|vitamins|mesh-ancestor
139342245|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
139342246|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342247|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139342248|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139342249|NCT02662556|Sufentanil|sufentanil|mesh-list
139342250|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139342251|NCT02662556|Narcotics|narcotics|mesh-ancestor
139342252|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342253|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342254|NCT02662556|Analgesics|analgesics|mesh-ancestor
139342255|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
139342256|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342257|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139342258|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139342259|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
139342260|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
139342261|NCT02376452|Leucovorin|leucovorin|mesh-list
139342262|NCT02376452|Fluorouracil|fluorouracil|mesh-list
139342263|NCT02376452|Raltitrexed|raltitrexed|mesh-list
139342264|NCT02376452|Irinotecan|irinotecan|mesh-list
139342265|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
139342266|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342267|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139342268|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342269|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139342270|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
139342271|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342272|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139342273|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139342274|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342275|NCT02376452|Antidotes|antidotes|mesh-ancestor
139342276|NCT02376452|Protective Agents|protective agents|mesh-ancestor
139342277|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
139342278|NCT02376452|Vitamins|vitamins|mesh-ancestor
139342279|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
139342280|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139342281|NCT02516098|Scopolamine|scopolamine|mesh-list
139342282|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139342283|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139342284|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
139342285|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
139342286|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342287|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342288|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139342289|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
139342290|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139342291|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
139342292|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342293|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342294|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139342295|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
139342297|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139342298|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342299|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
139342300|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342301|NCT03105674|Anesthetics|anesthetics|mesh-list
139342302|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
139342303|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342304|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342305|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
139342306|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342307|NCT02380898|Ketorolac|ketorolac|mesh-list
139342308|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139342309|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139342310|NCT02380898|Analgesics|analgesics|mesh-ancestor
138999153|NCT00482001|Donepezil|donepezil|mesh-list
139342311|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
139342312|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342313|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342314|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342315|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139342316|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139342317|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342318|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342319|NCT02376296|Docetaxel|docetaxel|mesh-list
139342320|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342321|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
139342322|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
139342323|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
139342324|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342325|NCT01364428|Insulin|insulin|mesh-list
139342326|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139342327|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
139342328|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139342329|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342330|NCT02380586|Anesthetics|anesthetics|mesh-list
139342331|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342332|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342333|NCT02375828|Glyburide|glyburide|mesh-list
139342334|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139342335|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342336|NCT02371226|Insulin|insulin|mesh-list
139342337|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139342338|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139342339|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342340|NCT02371304|Capecitabine|capecitabine|mesh-list
139342341|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139342342|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
139342343|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342344|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342345|NCT02380352|Amoxicillin|amoxicillin|mesh-list
139342346|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139342347|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139342348|NCT02380118|Midazolam|midazolam|mesh-list
139342349|NCT02380118|Haloperidol|haloperidol|mesh-list
139342350|NCT02380118|Olanzapine|olanzapine|mesh-list
139342351|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
139342352|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139342353|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139342354|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342355|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342356|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139180782|NCT05618236|Atropine|atropine|mesh-list
139342357|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139342358|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139342359|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139342360|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
139342361|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
139342362|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
139342363|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
139342364|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342365|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342366|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
139342367|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
139342368|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918166|NCT00733902|Tanezumab|tanezumab|mesh-list
139342369|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139342370|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139342371|NCT02380118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139342372|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139342373|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139342374|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
139342375|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139342376|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
139342377|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139342378|NCT03113708|Heparin|heparin|mesh-list
139342379|NCT03113708|Calcium heparin|calcium heparin|mesh-list
139342380|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
139342381|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139342382|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139342383|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342384|NCT02371148|Rituximab|rituximab|mesh-list
139342385|NCT02371148|Bortezomib|bortezomib|mesh-list
139342386|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139342387|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139342388|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342389|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
139342390|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342391|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139342392|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139342393|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
139342394|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342395|NCT02375360|Immunomodulating Agents|immunomodulating agents|mesh-list
139342396|NCT02375360|Immunologic Factors|immunologic factors|mesh-ancestor
139342397|NCT02375360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342398|NCT02370680|Aspirin|aspirin|mesh-list
139342399|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139342400|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139342401|NCT02370680|Analgesics|analgesics|mesh-ancestor
139342402|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
139342403|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342404|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342405|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342406|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139342407|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139342408|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139342409|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342410|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139342411|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139342412|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342413|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
139342414|NCT02370758|Valganciclovir|valganciclovir|mesh-list
139342415|NCT02370758|Ganciclovir|ganciclovir|mesh-list
139342416|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139342417|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
139342418|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139342419|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139342420|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342421|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342422|NCT02379026|Vitamin D|vitamin d|mesh-list
139342423|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
139342424|NCT02379026|Vitamins|vitamins|mesh-ancestor
139342425|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
139342426|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342427|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139342428|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139342429|NCT02991859|Fluticasone|fluticasone|mesh-list
139342430|NCT02991859|Xhance|xhance|mesh-list
139342431|NCT02991859|Budesonide|budesonide|mesh-list
139342432|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342433|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139342434|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
139342435|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342436|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342437|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139342438|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
139342439|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
139342440|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139342441|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
139342442|NCT02991859|Hormones|hormones|mesh-ancestor
139342443|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139342444|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
139342445|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139342446|NCT02374736|Antibodies|antibodies|mesh-list
139342447|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
139342448|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
139342449|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342450|NCT02369978|Benzonidazole|benzonidazole|mesh-list
139342451|NCT02369978|Nifurtimox|nifurtimox|mesh-list
139342452|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139342453|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
139342454|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342455|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139342456|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139342457|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139342458|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139342459|NCT03661489|Propofol|propofol|mesh-list
139342460|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139342461|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342462|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342463|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139342464|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
138999294|NCT00420238|Analgesics|analgesics|mesh-ancestor
139342465|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
139342466|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139342467|NCT04056169|Ezetimibe|ezetimibe|mesh-list
139342468|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139342469|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139342470|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
139342471|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342472|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139342473|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139342474|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342475|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139342476|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139342477|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
139342478|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342479|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139342480|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342481|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139342482|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342483|NCT03008915|Aspirin|aspirin|mesh-list
139342484|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139342485|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
139342486|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139342487|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139342488|NCT03008915|Analgesics|analgesics|mesh-ancestor
139342489|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
139342490|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342491|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342492|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342493|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139342494|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139342495|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139342496|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342497|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139342498|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139342499|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342500|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
139342501|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139342502|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139342503|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
139342504|NCT03622489|Acetaminophen|acetaminophen|mesh-list
139342505|NCT03622489|Dipyrone|dipyrone|mesh-list
139342506|NCT03622489|Ibuprofen|ibuprofen|mesh-list
139342507|NCT03622489|Morphine|morphine|mesh-list
139342508|NCT03622489|Tramadol|tramadol|mesh-list
139342509|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139342510|NCT03622489|Narcotics|narcotics|mesh-ancestor
139342511|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342512|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342513|NCT03622489|Analgesics|analgesics|mesh-ancestor
139342514|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
139342515|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342516|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139342517|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
139342518|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139342519|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342520|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139342521|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139342522|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342523|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342524|NCT03667001|Lidocaine|lidocaine|mesh-list
139342525|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
139342526|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
139342527|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342528|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342529|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
139342530|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342531|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139342532|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139342533|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139342534|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139342535|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342536|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
139342537|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
139342538|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139342539|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138999370|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
139342540|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139342542|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342543|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139342544|NCT03666299|Lidocaine|lidocaine|mesh-list
139342545|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
139342546|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
139342547|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342548|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342549|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
139342550|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342551|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138918278|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342552|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139342553|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139342554|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139342555|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342556|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
139342557|NCT03591380|Belimumab|belimumab|mesh-list
139342558|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139342559|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
139342560|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342561|NCT04057469|Tulobuterol|tulobuterol|mesh-list
139342562|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139342563|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139342564|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
139342565|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342566|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342567|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342568|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139342569|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
139342570|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342571|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139342572|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
139342573|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
139342574|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139342575|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342576|NCT03658291|Levofloxacin|levofloxacin|mesh-list
139342577|NCT03658291|Ofloxacin|ofloxacin|mesh-list
139342578|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139342579|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139342580|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139342581|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139342582|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139342583|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342584|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342585|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342586|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139342587|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139342588|NCT03658213|Goserelin|goserelin|mesh-list
139342589|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139342590|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342591|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
139342592|NCT03006887|Lenvatinib|lenvatinib|mesh-list
139342593|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139342594|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342595|NCT03006887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139342596|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342597|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139342598|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342599|NCT02377856|Interferons|interferons|mesh-list
139342600|NCT02377856|Ribavirin|ribavirin|mesh-list
139342601|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
139342602|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
139342603|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139342604|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342605|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
139342606|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139342607|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
139342608|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342609|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
139342610|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342611|NCT02377778|Thiopental|thiopental|mesh-list
139342612|NCT02377778|Propofol|propofol|mesh-list
139342613|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138999441|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
139342614|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342615|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342616|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139342617|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
139342618|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
139342619|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
139342620|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
139342621|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
139342622|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342623|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342624|NCT02514772|Rituximab|rituximab|mesh-list
139342625|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139342626|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342627|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
139342628|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342629|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139342630|NCT03658057|Rocuronium|rocuronium|mesh-list
139342631|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139342632|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139342634|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342635|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342636|NCT03657979|Ropivacaine|ropivacaine|mesh-list
139342637|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
139342638|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
139342639|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342640|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342641|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
139342642|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342643|NCT03659851|Simendan|simendan|mesh-list
139342644|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139342645|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
139342646|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139342647|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139342648|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342649|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342650|NCT03659851|Protective Agents|protective agents|mesh-ancestor
139342651|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342652|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139342653|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342654|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139342655|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
139342656|NCT02368730|Coagulants|coagulants|mesh-ancestor
139342657|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139342658|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
139342659|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342660|NCT03659305|Bevacizumab|bevacizumab|mesh-list
139342661|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139342662|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342663|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139342664|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139342665|NCT03659305|Growth Substances|growth substances|mesh-ancestor
139342666|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342667|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
139342668|NCT02788981|Paclitaxel|paclitaxel|mesh-list
139342669|NCT02788981|Mifepristone|mifepristone|mesh-list
139342670|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139342671|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342672|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
139342673|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
139342674|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
139342675|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342676|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139342677|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
139342678|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139342679|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342680|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139342681|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139342682|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139342683|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
139342684|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139342685|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139342686|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
139342687|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139342688|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
139342689|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139342690|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139342691|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139342692|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139342693|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
139342694|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139342695|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
139342696|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139342697|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342698|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139342699|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139342700|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342702|NCT02373722|Mineral Oil|mineral oil|mesh-list
139342703|NCT02373722|Emollients|emollients|mesh-ancestor
139342704|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
139342705|NCT03000179|Avelumab|avelumab|mesh-list
139342706|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139342707|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342708|NCT03658993|Rifaximin|rifaximin|mesh-list
139342709|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139342710|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139342711|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139342712|NCT02373410|Bupivacaine|bupivacaine|mesh-list
139342713|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
139342714|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
139342715|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342716|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342717|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
139342718|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342719|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139342720|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342721|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
139342722|NCT02920177|Hormones|hormones|mesh-ancestor
139342723|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139342724|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342725|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139342726|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
139342727|NCT03006341|Telmisartan|telmisartan|mesh-list
139342728|NCT03006341|Warfarin|warfarin|mesh-list
139342729|NCT03006341|Dabigatran|dabigatran|mesh-list
139342730|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
139342731|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139342732|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139342733|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139342734|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342735|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
139342736|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139342737|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
139342738|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342739|NCT05022784|Nintedanib|nintedanib|mesh-list
139342740|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342741|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139342742|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342743|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342744|NCT03665753|Ketorolac|ketorolac|mesh-list
139342745|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139342746|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139342747|NCT03665753|Analgesics|analgesics|mesh-ancestor
139342748|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
139342749|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342750|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342751|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342752|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139342753|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139342754|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342755|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342756|NCT02512042|Brinzolamide|brinzolamide|mesh-list
139342757|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139342758|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342759|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342760|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139342761|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138999591|NCT00969566|Hormones|hormones|mesh-ancestor
139342762|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139342763|NCT01066897|Pramipexole|pramipexole|mesh-list
139342764|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
139342765|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342766|NCT01066897|Protective Agents|protective agents|mesh-ancestor
139342767|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342768|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139342769|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139342770|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
139342771|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
139342772|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342773|NCT02373254|Acetaminophen|acetaminophen|mesh-list
139342774|NCT02373254|Ibuprofen|ibuprofen|mesh-list
139342775|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139342776|NCT02373254|Hydrocodone|hydrocodone|mesh-list
139342777|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139342778|NCT02373254|Analgesics|analgesics|mesh-ancestor
139342779|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
139342780|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342781|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342782|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
139342783|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139342784|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342785|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139342786|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139342787|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342788|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342789|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139342790|NCT02373254|Narcotics|narcotics|mesh-ancestor
139342791|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342792|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
139342793|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
139342794|NCT03657355|Zolpidem|zolpidem|mesh-list
139342795|NCT03657355|Suvorexant|suvorexant|mesh-list
139342796|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139342797|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139342798|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342799|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342800|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139342801|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
139342802|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
139342803|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342804|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342805|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139342806|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
139342807|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139342808|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
139342809|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139342810|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342811|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139342812|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139342813|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139342814|NCT02365532|Dofetilide|dofetilide|mesh-list
139342815|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139342816|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139342817|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139342818|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342819|NCT03113162|Cytarabine|cytarabine|mesh-list
139342820|NCT03113162|Etoposide|etoposide|mesh-list
139342821|NCT03113162|Melphalan|melphalan|mesh-list
139342822|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139342823|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342824|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139342825|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138918396|NCT00590135|Atorvastatin|atorvastatin|mesh-list
139342826|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342827|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342828|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139342829|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
139342830|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
139342831|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139342832|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139342833|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
139342834|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139180821|NCT05598255|Sensory System Agents|sensory system agents|mesh-ancestor
139342835|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139342838|NCT02356705|Lidocaine|lidocaine|mesh-list
139342839|NCT02356705|Midazolam|midazolam|mesh-list
139342840|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139342841|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139342842|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139342843|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342844|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139342845|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139342846|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139342847|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139342848|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
139342849|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
139342850|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
139342851|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
139342852|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342853|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342854|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
139342855|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
139342856|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342857|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139342858|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139342859|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139342860|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139342861|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
139342862|NCT02511184|Crizotinib|crizotinib|mesh-list
139342863|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139342864|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342865|NCT02511184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139342866|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342867|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139342868|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342869|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
138918430|NCT00737100|Bromides|bromides|mesh-list
139342870|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139342871|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139342872|NCT02367560|Prednisolone|prednisolone|mesh-list
139342873|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
139342874|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139342875|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
139342876|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342877|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
139342878|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
139342879|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342880|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342881|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139342882|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
139342883|NCT02367560|Hormones|hormones|mesh-ancestor
139342884|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139342885|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139342886|NCT02367560|Protective Agents|protective agents|mesh-ancestor
139342887|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139342888|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342889|NCT02372942|Progesterone|progesterone|mesh-list
139342890|NCT02372942|Progestins|progestins|mesh-ancestor
139342891|NCT02372942|Hormones|hormones|mesh-ancestor
139342892|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139342893|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342894|NCT02364986|Interferons|interferons|mesh-list
139342895|NCT02364986|Interferon-beta|interferon-beta|mesh-list
139342896|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
139342897|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342898|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
139342899|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139342900|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
139342901|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342902|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139342903|NCT02372786|Lidocaine|lidocaine|mesh-list
139342904|NCT02372786|Tetracaine|tetracaine|mesh-list
139342905|NCT02372786|Prilocaine|prilocaine|mesh-list
139342906|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
139342907|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
139342908|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139180832|NCT05587894|Antiviral Agents|antiviral agents|mesh-ancestor
139342909|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342910|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
139342911|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342912|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139342913|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139342914|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139342915|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139342916|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342917|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139342918|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139342919|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139342920|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139342921|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342922|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139342923|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342924|NCT02367404|Analgesics|analgesics|mesh-ancestor
139342925|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
139342926|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342927|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
139342928|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139342929|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
139342930|NCT02367248|Deferoxamine|deferoxamine|mesh-list
139342931|NCT02367248|Siderophores|siderophores|mesh-ancestor
139342932|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139342933|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
139342934|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
139342935|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342936|NCT03656965|Acyclovir|acyclovir|mesh-list
139342937|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
139342938|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139342939|NCT02384239|Tamoxifen|tamoxifen|mesh-list
139342940|NCT02384239|Fulvestrant|fulvestrant|mesh-list
139342941|NCT02384239|Palbociclib|palbociclib|mesh-list
139342942|NCT02384239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138918481|NCT00790400|Everolimus|everolimus|mesh-list
139342943|NCT02384239|Hormone Antagonists|hormone antagonists|mesh-ancestor
139342944|NCT02384239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139342945|NCT02384239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342946|NCT02384239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139342947|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342948|NCT02384239|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139342949|NCT02384239|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139342950|NCT02384239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139342951|NCT02384239|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139342952|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139342953|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342954|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342955|NCT02364752|Diuretics|diuretics|mesh-list
139342956|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
139342957|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
139342958|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342959|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139342960|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342961|NCT02372240|Dexamethasone|dexamethasone|mesh-list
139342962|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139342963|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
139342964|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
139342965|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139342966|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342967|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139342968|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
139342969|NCT02372240|Hormones|hormones|mesh-ancestor
139342970|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139342971|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139342972|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342973|NCT02364206|Temozolomide|temozolomide|mesh-list
139342974|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139342975|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
139180835|NCT05587894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139342976|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342977|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342978|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
139342979|NCT02366546|Fludarabine|fludarabine|mesh-list
139342980|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139342981|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
139342982|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139342983|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139342984|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139342985|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
139342986|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342987|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342988|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139342989|NCT02364362|Docetaxel|docetaxel|mesh-list
139342990|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139342991|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
139342992|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
139342993|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
139342994|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139342995|NCT03004469|Finasteride|finasteride|mesh-list
139342996|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139342997|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139342998|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139342999|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343000|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
139343001|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139343002|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343003|NCT03004469|Urological Agents|urological agents|mesh-ancestor
139343004|NCT02358824|Amlodipine|amlodipine|mesh-list
139343005|NCT02358824|Telmisartan|telmisartan|mesh-list
139343006|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139343007|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139343008|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139343009|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343010|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139343011|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343012|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
139343013|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139343014|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139343015|NCT02359136|Epinephrine|epinephrine|mesh-list
139343016|NCT02359136|Analgesics|analgesics|mesh-list
139343017|NCT02359136|Anesthetics|anesthetics|mesh-list
139343018|NCT02359136|Ropivacaine|ropivacaine|mesh-list
139343019|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343020|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343021|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
139343022|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
139343023|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343024|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139343025|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139343026|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
139343027|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343028|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343029|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139343030|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139343031|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
139343032|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139343033|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
139343034|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
139343035|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
139343036|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139343037|NCT02998151|Minocycline|minocycline|mesh-list
139343038|NCT02998151|Acamprosate|acamprosate|mesh-list
139343039|NCT02998151|Baclofen|baclofen|mesh-list
139343040|NCT02998151|Lovastatin|lovastatin|mesh-list
139343041|NCT02998151|L 647318|l 647318|mesh-list
139343042|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
139343043|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139180841|NCT05580861|Analgesics|analgesics|mesh-ancestor
139343044|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343045|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139343046|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343047|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139343048|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343049|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139343050|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
139343051|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
139343052|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343053|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343054|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139343055|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139343056|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
139343057|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139343058|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139343059|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343060|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139343061|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139343062|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139343063|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
139343064|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343065|NCT04057937|Apremilast|apremilast|mesh-list
139343066|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139343067|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139343068|NCT04057937|Analgesics|analgesics|mesh-ancestor
139343069|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
139343070|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343071|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343072|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139343073|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139343074|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139343075|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139343076|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343077|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343078|NCT01069523|Guanfacine|guanfacine|mesh-list
139343079|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139343080|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139343081|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139343082|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139343083|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
139343084|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343085|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343086|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343087|NCT01069289|Budesonide|budesonide|mesh-list
139343088|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
139343089|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139343090|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139343091|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139343092|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
139343093|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343094|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343095|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139343096|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
139343097|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
139343098|NCT01069289|Hormones|hormones|mesh-ancestor
139343099|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139343100|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139343101|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139343102|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139343103|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
139343104|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343105|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343106|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
139343107|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139343108|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343109|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139343110|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
139343111|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139180846|NCT05580861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139343112|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343113|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343114|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343116|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139343117|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139343118|NCT02510794|Growth Substances|growth substances|mesh-ancestor
139343119|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343120|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
139343121|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343122|NCT04056923|Methylene Blue|methylene blue|mesh-list
139343123|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343124|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343125|NCT03664115|Itraconazole|itraconazole|mesh-list
139343126|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
139343127|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343128|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139343129|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139343130|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343131|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999980|NCT00975572|Vaccines|vaccines|mesh-list
139343132|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139343133|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
139343134|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139343135|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343136|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139343137|NCT04056845|Acetaminophen|acetaminophen|mesh-list
139343138|NCT04056845|Diclofenac|diclofenac|mesh-list
139343139|NCT04056845|Analgesics|analgesics|mesh-list
139343140|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139343141|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139343142|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
139343143|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343144|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343145|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139343146|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139343147|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139343148|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343149|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343150|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
139343151|NCT02510014|Buprenorphine|buprenorphine|mesh-list
139343152|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139343153|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139343154|NCT02510014|Narcotics|narcotics|mesh-ancestor
139343155|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343156|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343157|NCT02510014|Analgesics|analgesics|mesh-ancestor
139343158|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
139343159|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343160|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139343161|NCT02509312|Ketorolac|ketorolac|mesh-list
139343162|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139343163|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139343164|NCT02509312|Analgesics|analgesics|mesh-ancestor
139343165|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
139343166|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343167|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343168|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139343169|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139343170|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139343171|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343172|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343173|NCT02362958|Capecitabine|capecitabine|mesh-list
139343174|NCT02362958|Vinorelbine|vinorelbine|mesh-list
139343175|NCT02362958|Lapatinib|lapatinib|mesh-list
139343176|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139343177|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
139343178|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180850|NCT05572476|Durvalumab|durvalumab|mesh-list
139343180|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139343181|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
139343182|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
139343183|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
139343184|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139343185|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343186|NCT04973800|Simvastatin|simvastatin|mesh-list
139343187|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139343188|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139343189|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
139343190|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343191|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138918671|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343192|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139343193|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343194|NCT02519842|Dexamethasone|dexamethasone|mesh-list
139343195|NCT02519842|Ondansetron|ondansetron|mesh-list
139343196|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
139343197|NCT02519842|Aprepitant|aprepitant|mesh-list
139343198|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
139343199|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139343200|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
139343201|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
139343202|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343203|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343204|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139343205|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
139343206|NCT02519842|Hormones|hormones|mesh-ancestor
139343207|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139343208|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139343209|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343210|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
139343211|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
139343212|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139343213|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
139343214|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343215|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343216|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139343217|NCT02509078|Cisatracurium|cisatracurium|mesh-list
139343218|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139343219|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139343220|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343221|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343222|NCT02993783|Vedolizumab|vedolizumab|mesh-list
139343223|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139343224|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
139343225|NCT03661775|Analgesics|analgesics|mesh-ancestor
139343226|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
139343227|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343228|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343229|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
139343230|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343231|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139343232|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
139343233|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139343234|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139343235|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343236|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139343237|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
139343238|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139343239|NCT03660761|Apatinib|apatinib|mesh-list
139343240|NCT03660761|Temozolomide|temozolomide|mesh-list
139343241|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343242|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139343243|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343244|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343245|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139343246|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
139343247|NCT02993471|Vitamin K|vitamin k|mesh-list
139343248|NCT02993471|Midazolam|midazolam|mesh-list
139343249|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
139343250|NCT02993471|Caffeine|caffeine|mesh-list
139343251|NCT02993471|Ixekizumab|ixekizumab|mesh-list
139343252|NCT02993471|Omeprazole|omeprazole|mesh-list
139343253|NCT02993471|Warfarin|warfarin|mesh-list
139343254|NCT02993471|Vitamins|vitamins|mesh-ancestor
139343255|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
139343256|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343257|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139343258|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139343259|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343260|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139343261|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139343262|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139343263|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139343264|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
139343265|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
139343266|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
139343267|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
139343268|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343269|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343270|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
139343271|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139343272|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139343273|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343274|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139343275|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139343276|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
139343277|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139343278|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139343279|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139343280|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139343281|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139343282|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
139343283|NCT02993471|Coagulants|coagulants|mesh-ancestor
139343284|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
139343285|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
139343286|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139343287|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139343288|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
139343289|NCT01068743|Metformin|metformin|mesh-list
139343290|NCT01068743|Saxagliptin|saxagliptin|mesh-list
139343291|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139343292|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343293|NCT01068743|Incretins|incretins|mesh-ancestor
139343294|NCT01068743|Hormones|hormones|mesh-ancestor
139343295|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139343296|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139343297|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
139343298|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343299|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343300|NCT03622541|Sorafenib|sorafenib|mesh-list
139343301|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343302|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139343303|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343304|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343305|NCT03658733|Amoxicillin|amoxicillin|mesh-list
139343306|NCT03658733|Tetracycline|tetracycline|mesh-list
139343307|NCT03658733|Furazolidone|furazolidone|mesh-list
139343308|NCT03658733|Esomeprazole|esomeprazole|mesh-list
139343309|NCT03658733|Rabeprazole|rabeprazole|mesh-list
139343310|NCT03658733|Bismuth|bismuth|mesh-list
139343311|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139343312|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343313|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139343314|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139343315|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139343316|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343317|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343318|NCT03658733|Antacids|antacids|mesh-ancestor
139343319|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139343320|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139343321|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139343322|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139343323|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139343324|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139343325|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139343326|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
139343327|NCT04056143|Apixaban|apixaban|mesh-list
139343328|NCT04056143|Edoxaban|edoxaban|mesh-list
139343329|NCT04056143|Dabigatran|dabigatran|mesh-list
139343330|NCT04056143|Thromboplastin|thromboplastin|mesh-list
139343331|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139343332|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
139343333|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139343334|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
139343335|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343336|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343337|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
139343338|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
139343339|NCT04056143|Coagulants|coagulants|mesh-ancestor
139343340|NCT03661463|Aspirin|aspirin|mesh-list
139343341|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139343342|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139343343|NCT03661463|Analgesics|analgesics|mesh-ancestor
138918760|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139343344|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
139343345|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343346|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343347|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139343348|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139343349|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139343350|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139343351|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343352|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139343353|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139343354|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343355|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
139343356|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
139343357|NCT03658421|Morphine|morphine|mesh-list
139343358|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139343359|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343360|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343361|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139343362|NCT03658421|Analgesics|analgesics|mesh-ancestor
139343363|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
139343364|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343365|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139343366|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139343367|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139343368|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
139343369|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343370|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343371|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139343372|NCT03658421|Narcotics|narcotics|mesh-ancestor
139343373|NCT03660293|Captopril|captopril|mesh-list
139343374|NCT03660293|Atorvastatin|atorvastatin|mesh-list
139343375|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139343376|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139343377|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
139343378|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343379|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139343380|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139343381|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343382|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139343383|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
139343384|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139343385|NCT02986139|Etanercept|etanercept|mesh-list
139343386|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139343387|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139343388|NCT02986139|Analgesics|analgesics|mesh-ancestor
139343389|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
138918836|NCT00729612|Paclitaxel|paclitaxel|mesh-list
139343390|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343391|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343392|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139343393|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139343394|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139343395|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139343396|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
139343398|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139343399|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
139343400|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
139343401|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
139343402|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139343403|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139343404|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343405|NCT01066585|Ivermectin|ivermectin|mesh-list
139343406|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139343407|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343408|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
139343409|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139343410|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
139343411|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343412|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139343413|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139343414|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
139343415|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343416|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343417|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139343418|NCT02980783|Lidocaine|lidocaine|mesh-list
139343419|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
139343420|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
139343421|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343422|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343423|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
139343424|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343425|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139343426|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139343427|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139343428|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139343429|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343430|NCT02989649|Metformin|metformin|mesh-list
139343431|NCT02989649|Pioglitazone|pioglitazone|mesh-list
139343432|NCT02989649|Alogliptin|alogliptin|mesh-list
139343433|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139343434|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343435|NCT02989649|Incretins|incretins|mesh-ancestor
139343437|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139343438|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139343439|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
139343440|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343441|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343442|NCT03659435|Rivastigmine|rivastigmine|mesh-list
139343443|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139343444|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343445|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343446|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
139343447|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343448|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343449|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139343450|NCT03659435|Protective Agents|protective agents|mesh-ancestor
139343451|NCT01067339|Darapladib|darapladib|mesh-list
139343452|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
139343453|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343454|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343455|NCT04484675|Milrinone|milrinone|mesh-list
139343456|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139343457|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139343458|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
139180871|NCT05485012|Analgesics|analgesics|mesh-ancestor
139343459|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139343460|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139343461|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343462|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343463|NCT04484675|Protective Agents|protective agents|mesh-ancestor
139343464|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343465|NCT03658109|Lidocaine|lidocaine|mesh-list
139343466|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
139343467|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
139343468|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343469|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343470|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
139343471|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343472|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139343473|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139343474|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139343475|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139343476|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343477|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
139343478|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139343479|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343480|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138918926|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
139343481|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343482|NCT03660917|Riluzole|riluzole|mesh-list
139343483|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
139343484|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139343485|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139343486|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343487|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343488|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343489|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139343490|NCT03660917|Protective Agents|protective agents|mesh-ancestor
139343491|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
139343492|NCT02977507|Hydroquinone|hydroquinone|mesh-list
139343493|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139343494|NCT02977507|Protective Agents|protective agents|mesh-ancestor
139343495|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343496|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
139343497|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
139343498|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343499|NCT04471415|Atezolizumab|atezolizumab|mesh-list
139343500|NCT04471415|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139343501|NCT04471415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343502|NCT04471415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139343503|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343504|NCT02976103|Analgesics|analgesics|mesh-list
139343505|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
139343506|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343507|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343509|NCT03653845|Racepinephrine|racepinephrine|mesh-list
139343510|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
139343511|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139343512|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139343513|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
139343514|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343515|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343516|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343517|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139343518|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139343519|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
139343520|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343521|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139343522|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
139343523|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
139343524|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
139343525|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139343526|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139343527|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
139343528|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343529|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139343530|NCT01066039|Bisoprolol|bisoprolol|mesh-list
139343531|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139343532|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
139343533|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
139343534|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343535|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343536|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139343537|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139343538|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139343539|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
139343540|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343541|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343542|NCT04217967|Lenalidomide|lenalidomide|mesh-list
139343543|NCT04217967|Ixazomib|ixazomib|mesh-list
139343544|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
139343545|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343546|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139343547|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139343548|NCT04217967|Growth Substances|growth substances|mesh-ancestor
139343549|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
139343550|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343551|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
139343552|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343553|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343554|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139343555|NCT02919761|Hormones|hormones|mesh-ancestor
139343556|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139343557|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343558|NCT02910167|Acetaminophen|acetaminophen|mesh-list
139343559|NCT02910167|Scopolamine|scopolamine|mesh-list
139343560|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139343561|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139343562|NCT02910167|Analgesics|analgesics|mesh-ancestor
139343563|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
139343564|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343565|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343566|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
139343567|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139343568|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
139343569|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
139343570|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139343571|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
139343572|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139343573|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
139343574|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343575|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343576|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139343577|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
139343578|NCT04458285|Valsartan|valsartan|mesh-list
139343579|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139343580|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139000416|NCT00976976|Cisplatin|cisplatin|mesh-list
139343582|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139343583|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343584|NCT05156541|Interferons|interferons|mesh-list
139343585|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
139343586|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343587|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
139343588|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343589|NCT01067105|Ciclesonide|ciclesonide|mesh-list
139343590|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
139343591|NCT01067105|Hormones|hormones|mesh-ancestor
139343592|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139343593|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343595|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
139343596|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139343597|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139343598|NCT03470649|Hematinics|hematinics|mesh-ancestor
139343599|NCT02910011|Doxycycline|doxycycline|mesh-list
139343600|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139343601|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343602|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
139343603|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139343604|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139343605|NCT04456803|Sevelamer|sevelamer|mesh-list
139343606|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
139343607|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
139343608|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343609|NCT02908529|Oxybutynin|oxybutynin|mesh-list
139343610|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139343611|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139343612|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139343613|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139343614|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343615|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
139343616|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343617|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343618|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
139343619|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
139343620|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343621|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139343622|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139343623|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
139343624|NCT02908529|Urological Agents|urological agents|mesh-ancestor
139343625|NCT03469557|Capecitabine|capecitabine|mesh-list
139343626|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
139343627|NCT03469557|Tislelizumab|tislelizumab|mesh-list
139343628|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343629|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139343630|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
139343631|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343632|NCT03469557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139343633|NCT02643381|Ketamine|ketamine|mesh-list
139343634|NCT02643381|Etomidate|etomidate|mesh-list
139343635|NCT02643381|Analgesics|analgesics|mesh-ancestor
139343636|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
139343637|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343638|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343639|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139343640|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139343641|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
139343642|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
139343643|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343644|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139343645|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139343646|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343647|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343648|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139343649|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
139343650|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
139343651|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
139343652|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139343653|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139343654|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343655|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343656|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343657|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139343658|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
139343659|NCT04328961|Protective Agents|protective agents|mesh-ancestor
139343660|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343661|NCT04328961|Vitamins|vitamins|mesh-ancestor
139343662|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
139343663|NCT00455403|Chloroquine|chloroquine|mesh-list
139343664|NCT00455403|Amebicides|amebicides|mesh-ancestor
139343665|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139343666|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139343667|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343668|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
139343669|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139343670|NCT03470337|Wobenzym|wobenzym|mesh-list
139343671|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139343672|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
138919027|NCT04083807|Thrombin|thrombin|mesh-list
139343673|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343674|NCT03576261|Polygeline|polygeline|mesh-list
139343675|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
139343676|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
139343677|NCT03469323|Succinylcholine|succinylcholine|mesh-list
139343678|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139343679|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139343680|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139343681|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343682|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343683|NCT05160285|Nivolumab|nivolumab|mesh-list
139343684|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139343685|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343686|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139343687|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343688|NCT05160051|FAPI-46|fapi-46|mesh-list
139343689|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139343690|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343691|NCT03471819|Serotonin|serotonin|mesh-list
139343692|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139343693|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
139343694|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343695|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343696|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343697|NCT03618693|Anesthetics|anesthetics|mesh-list
139343698|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343699|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343700|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
139343701|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139343702|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139343703|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343704|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
139343705|NCT01064167|Coagulants|coagulants|mesh-ancestor
139343706|NCT04205305|Labetalol|labetalol|mesh-list
139343707|NCT04205305|Nicardipine|nicardipine|mesh-list
139343708|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139343709|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139343710|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
139343711|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343712|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343713|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343714|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139343715|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
139343716|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
139343717|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343718|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139343719|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139343720|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139343721|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139343722|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139343723|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
139343724|NCT03470103|Aflibercept|aflibercept|mesh-list
139343725|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139343726|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139343727|NCT03470103|Growth Substances|growth substances|mesh-ancestor
139343728|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343729|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
139343730|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343731|NCT01064947|Retapamulin|retapamulin|mesh-list
139343732|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139343733|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343734|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
139343735|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139343736|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139343737|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343738|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
139343739|NCT03469947|Coagulants|coagulants|mesh-ancestor
139343740|NCT05157087|Omalizumab|omalizumab|mesh-list
139343741|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139343743|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
139343744|NCT04054063|Etomidate|etomidate|mesh-list
139343745|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139343746|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343747|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343748|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139343749|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
139343750|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
139343751|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139343752|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139343753|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343754|NCT03652441|Immunotoxins|immunotoxins|mesh-ancestor
139343755|NCT03652441|Immunoconjugates|immunoconjugates|mesh-ancestor
139343756|NCT03652441|Immunologic Factors|immunologic factors|mesh-ancestor
139343757|NCT03652441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343758|NCT02918071|Benralizumab|benralizumab|mesh-list
139343759|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139343760|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
139343761|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
139343762|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
139343763|NCT05162625|Cefazolin|cefazolin|mesh-list
139343764|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139343765|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139343766|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139343767|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343768|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139343769|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139343770|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343771|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343772|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343773|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139343774|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139343775|NCT02506816|Olaparib|olaparib|mesh-list
139343776|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139343777|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343778|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343779|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343780|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
139343781|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
139343782|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343783|NCT05009901|Protective Agents|protective agents|mesh-ancestor
139343784|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343785|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
139343786|NCT05009901|Vitamins|vitamins|mesh-ancestor
139343787|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
139343788|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
139343789|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139343790|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343791|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343792|NCT05162001|Disulfiram|disulfiram|mesh-list
139343793|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139343794|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138919134|NCT02593968|Interferons|interferons|mesh-list
139343795|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343796|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343797|NCT03469167|Epinephrine|epinephrine|mesh-list
139343798|NCT03469167|CEGP-003|cegp-003|mesh-list
139343799|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139343800|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139343801|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
139000647|NCT00983450|Hormones|hormones|mesh-ancestor
139343802|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343803|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343804|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343805|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139343806|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139343807|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
139343808|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343809|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139343810|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
139343811|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
139343812|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
139343813|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139343815|NCT03469167|Coagulants|coagulants|mesh-ancestor
139343816|NCT01063153|Methylphenidate|methylphenidate|mesh-list
139343817|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139343818|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343819|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139343820|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139343821|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139343822|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343823|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
139343824|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343825|NCT05161221|Acetaminophen|acetaminophen|mesh-list
139343826|NCT05161221|Naproxen|naproxen|mesh-list
139343827|NCT05161221|Oxycodone|oxycodone|mesh-list
139343828|NCT05161221|Bupivacaine|bupivacaine|mesh-list
139343829|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
139343830|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
139343831|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343832|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343833|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
139343834|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343835|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139343836|NCT05161221|Narcotics|narcotics|mesh-ancestor
139343837|NCT05161221|Analgesics|analgesics|mesh-ancestor
139343838|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139343839|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139343840|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139343841|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138919179|NCT01020643|Propofol|propofol|mesh-list
139343842|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
139343843|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139343844|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343845|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343846|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
139343847|NCT02505334|Liraglutide|liraglutide|mesh-list
139343848|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139343849|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343850|NCT02505334|Incretins|incretins|mesh-ancestor
139343851|NCT02505334|Hormones|hormones|mesh-ancestor
139343852|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139343853|NCT03469089|Ketamine|ketamine|mesh-list
139343854|NCT03469089|Modafinil|modafinil|mesh-list
139343855|NCT03469089|Analgesics|analgesics|mesh-ancestor
139343856|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
139343857|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343858|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343859|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139343860|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139343861|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
139343862|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
139343863|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343864|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139343865|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139343866|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343867|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343868|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139343869|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139343870|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139343871|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139343872|NCT04969510|Pramoxine|pramoxine|mesh-list
139343873|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
139343874|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
139343875|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343876|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343877|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
139343878|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343879|NCT02504320|Febuxostat|febuxostat|mesh-list
139343880|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
139343881|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139343882|NCT05014516|Xenon|xenon|mesh-list
139343883|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139343884|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
139343885|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
139343886|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139343887|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343888|NCT01061671|Simvastatin|simvastatin|mesh-list
139343889|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139343890|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139343891|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
139343892|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343893|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139343894|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139343895|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343896|NCT04969120|Metoclopramide|metoclopramide|mesh-list
139343897|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
139343898|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
139343899|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343900|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343901|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139343902|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139343903|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139343904|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
139343905|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343906|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343907|NCT00709995|Sunitinib|sunitinib|mesh-list
139343908|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343909|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139343910|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139343911|NCT00709995|Growth Substances|growth substances|mesh-ancestor
139343912|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343913|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
139343914|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139343915|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919239|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139343916|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343917|NCT02503540|Aflibercept|aflibercept|mesh-list
139343918|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139343919|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139343920|NCT02503540|Growth Substances|growth substances|mesh-ancestor
139343921|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343922|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
139343923|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343924|NCT04053985|Lenvatinib|lenvatinib|mesh-list
139343925|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343926|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139343927|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343928|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343929|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
139343930|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139343931|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
139343932|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343933|NCT04455243|Expectorants|expectorants|mesh-ancestor
139343934|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
139343935|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139343936|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
139343937|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343938|NCT04455243|Protective Agents|protective agents|mesh-ancestor
139343939|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343940|NCT04455243|Antidotes|antidotes|mesh-ancestor
139343941|NCT04454775|Protein C|protein c|mesh-list
139343942|NCT04454775|Antithrombins|antithrombins|mesh-list
139343943|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
139343944|NCT04454775|Protein S|protein s|mesh-list
139343945|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139343946|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
139343947|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139343948|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343949|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
139343950|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139343951|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139343952|NCT03651661|Insulin|insulin|mesh-list
139343953|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139343954|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139343955|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343956|NCT01060111|Topiramate|topiramate|mesh-list
139343957|NCT01060111|Propranolol|propranolol|mesh-list
139343958|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139343959|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139343960|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
139343961|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139343962|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343963|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343964|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139343965|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139343966|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
139343967|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
139343968|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139343969|NCT02969863|Pancrelipase|pancrelipase|mesh-list
139343970|NCT02969863|Pancreatin|pancreatin|mesh-list
139343971|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139343972|NCT03651427|Estradiol|estradiol|mesh-list
139343973|NCT03651427|Estrogens|estrogens|mesh-ancestor
139343974|NCT03651427|Hormones|hormones|mesh-ancestor
139343975|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139343976|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343977|NCT05285293|Vitamin A|vitamin a|mesh-list
139343978|NCT05285293|Vitamins|vitamins|mesh-ancestor
139343979|NCT05285293|Micronutrients|micronutrients|mesh-ancestor
139343980|NCT05285293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343981|NCT03650257|Temozolomide|temozolomide|mesh-list
139343982|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139343983|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
139343984|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139343985|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139343986|NCT03649243|Propolis|propolis|mesh-list
139343987|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139343988|NCT03649165|Acetaminophen|acetaminophen|mesh-list
139343989|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139343990|NCT03649165|Analgesics|analgesics|mesh-ancestor
139343991|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
139343992|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139343993|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139343994|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
139343995|NCT03649009|Thiamine|thiamine|mesh-list
139343996|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
139343997|NCT03649009|Metoclopramide|metoclopramide|mesh-list
139343998|NCT03649009|Vitamins|vitamins|mesh-ancestor
139343999|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
139344000|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344001|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139344002|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
139344003|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
139344004|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
139344005|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344006|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139344007|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139344008|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139344009|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
139344010|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344011|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344012|NCT03650023|Chitosan|chitosan|mesh-list
139344013|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139344014|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139344015|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
139344016|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344017|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139344018|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
139344019|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
139344020|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
139344021|NCT03650023|Coagulants|coagulants|mesh-ancestor
139344022|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
139344023|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
139344024|NCT04054999|Methylene Blue|methylene blue|mesh-list
139344025|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344026|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344027|NCT04054999|Hematinics|hematinics|mesh-ancestor
139344028|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
139344029|NCT04054999|Vitamins|vitamins|mesh-ancestor
139344030|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
139344031|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344032|NCT03649945|Docetaxel|docetaxel|mesh-list
139344033|NCT03649945|Endostar protein|endostar protein|mesh-list
139344034|NCT03649945|Nedaplatin|nedaplatin|mesh-list
139344035|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344036|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
139344037|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
139344038|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
139344039|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344040|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139344041|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139344042|NCT03649945|Growth Substances|growth substances|mesh-ancestor
139344043|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344044|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
139344046|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139344047|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
139344048|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139344049|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139344050|NCT03650881|Analgesics|analgesics|mesh-ancestor
139344051|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
139344052|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344053|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344054|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139344055|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139344056|NCT02904265|Acetazolamide|acetazolamide|mesh-list
139344057|NCT02904265|Diazepam|diazepam|mesh-list
139344058|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
139344059|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139344060|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344061|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344062|NCT02904265|Diuretics|diuretics|mesh-ancestor
139344063|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
139344064|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344065|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139344066|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
139344067|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
138919329|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
139344068|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344069|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139344070|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139344071|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139344072|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139344073|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139344074|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139344075|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139344076|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139344077|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139344078|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
139344079|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
139344080|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
139344081|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
139344082|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344083|NCT03648229|Timolol|timolol|mesh-list
139344084|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139344085|NCT03648229|Latanoprost|latanoprost|mesh-list
139344086|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139344087|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139344088|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139344089|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
139344090|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344091|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344092|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344093|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139344094|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139344095|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
139344096|NCT03648697|Fludarabine|fludarabine|mesh-list
139344097|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139344098|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
139344099|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344100|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139344101|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139344102|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
139344103|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344104|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344105|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139344106|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139344107|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
139344108|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344109|NCT02967679|Biotin|biotin|mesh-list
139344110|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
139344111|NCT02967679|Vitamins|vitamins|mesh-ancestor
139344112|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
139344113|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344114|NCT04447053|Belimumab|belimumab|mesh-list
139344115|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139344116|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
139344117|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344118|NCT04361799|Insulin|insulin|mesh-list
139344119|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139344120|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344121|NCT05390073|Hormones|hormones|mesh-list
139344122|NCT05390073|Mitogens|mitogens|mesh-list
139344123|NCT05390073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344124|NCT05390073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139344125|NCT05390073|Mitosis Modulators|mitosis modulators|mesh-ancestor
139344126|NCT05390073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344127|NCT03647839|Nivolumab|nivolumab|mesh-list
139344128|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139344129|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344130|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139344131|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344132|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139344133|NCT04454307|Tramadol|tramadol|mesh-list
139344134|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139344135|NCT04454307|Narcotics|narcotics|mesh-ancestor
139344136|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139344137|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344138|NCT04454307|Analgesics|analgesics|mesh-ancestor
139344139|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
139344140|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344141|NCT05388123|Rituximab|rituximab|mesh-list
139344142|NCT05388123|Vemurafenib|vemurafenib|mesh-list
139344143|NCT05388123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139344144|NCT05388123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344145|NCT05388123|Immunologic Factors|immunologic factors|mesh-ancestor
139344146|NCT05388123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344147|NCT05388123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139344148|NCT05388123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139344149|NCT05388123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344150|NCT05388123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344151|NCT04455711|Lidocaine|lidocaine|mesh-list
139344152|NCT04455711|Remifentanil|remifentanil|mesh-list
139344153|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
139344154|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
139344155|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139344156|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344157|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
139344158|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344159|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139344160|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139344161|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139344162|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139344163|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344164|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139344165|NCT04455711|Narcotics|narcotics|mesh-ancestor
139344166|NCT04455711|Analgesics|analgesics|mesh-ancestor
139344167|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
139344168|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139344169|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139344170|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139344171|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139180915|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139344172|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344173|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
139344174|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344175|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344176|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139344177|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344178|NCT04062669|Vaccines|vaccines|mesh-list
139344179|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
139344180|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344181|NCT05387967|Valsartan|valsartan|mesh-list
139344182|NCT05387967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139344183|NCT05387967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139344184|NCT05387967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139344185|NCT05387967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139344186|NCT05387967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344187|NCT03856359|Rifaximin|rifaximin|mesh-list
139344188|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139344189|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344190|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139344191|NCT04052659|Azacitidine|azacitidine|mesh-list
139344192|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139344193|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
139344194|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344195|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344196|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344197|NCT02964247|Liraglutide|liraglutide|mesh-list
139344198|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139344199|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344200|NCT02964247|Incretins|incretins|mesh-ancestor
139344201|NCT02964247|Hormones|hormones|mesh-ancestor
139344202|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139344203|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
139344204|NCT03654729|Edetic Acid|edetic acid|mesh-list
139344205|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
139344206|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139344207|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
139344208|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
139344209|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344210|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
139344211|NCT03654729|Vitamins|vitamins|mesh-ancestor
139344212|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
139344213|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344214|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
139344215|NCT04052269|Tadalafil|tadalafil|mesh-list
139344216|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
139344217|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139344218|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139344219|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919396|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
139344220|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344221|NCT04052269|Urological Agents|urological agents|mesh-ancestor
139344222|NCT01377987|Acetazolamide|acetazolamide|mesh-list
139344223|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
139344224|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139344225|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344226|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344227|NCT01377987|Diuretics|diuretics|mesh-ancestor
139344228|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
139344229|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344230|NCT03645187|Celecoxib|celecoxib|mesh-list
139344231|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139344232|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139344233|NCT03645187|Analgesics|analgesics|mesh-ancestor
139344234|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
139180918|NCT05065866|Azacitidine|azacitidine|mesh-list
139344235|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344236|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344237|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139344238|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139344239|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139344240|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139344241|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344242|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344244|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
139344245|NCT03645109|Vitamins|vitamins|mesh-ancestor
139344246|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
139344247|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344248|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139344249|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139344250|NCT04455555|Rotigotine|rotigotine|mesh-list
139344251|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
139344252|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
139344253|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344254|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344255|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344256|NCT02898259|Rituximab|rituximab|mesh-list
139344257|NCT02898259|Lenalidomide|lenalidomide|mesh-list
139344258|NCT02898259|Ixazomib|ixazomib|mesh-list
139344259|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139344260|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344261|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
139344262|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344263|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139344264|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139344265|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139344266|NCT02898259|Growth Substances|growth substances|mesh-ancestor
139344267|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
139344268|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
139344269|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344270|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344271|NCT02963935|Liraglutide|liraglutide|mesh-list
139344272|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139344273|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344274|NCT02963935|Incretins|incretins|mesh-ancestor
139344275|NCT02963935|Hormones|hormones|mesh-ancestor
139344276|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139344277|NCT03644641|Propofol|propofol|mesh-list
139344278|NCT03644641|Desflurane|desflurane|mesh-list
139344279|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139344280|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139344281|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344282|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139344283|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
139344284|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
139344285|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139344286|NCT05283421|Estrogens|estrogens|mesh-list
139344287|NCT05283421|Hormones|hormones|mesh-ancestor
139344288|NCT05283421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139344289|NCT05283421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344290|NCT02963701|Ibuprofen|ibuprofen|mesh-list
139344291|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
139344292|NCT02963701|Ephedrine|ephedrine|mesh-list
139344293|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139344294|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139344295|NCT02963701|Analgesics|analgesics|mesh-ancestor
139344296|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
139344297|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344298|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344299|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139344300|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139344301|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139344302|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344303|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344304|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139344305|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
139344306|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139344307|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
138919455|NCT00782210|Olodaterol|olodaterol|mesh-list
139344309|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139344310|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139344311|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
139344312|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
139344313|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344314|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
139344315|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139344316|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344317|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139344318|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139344319|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344320|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344321|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344322|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139344323|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139344324|NCT03643549|Temozolomide|temozolomide|mesh-list
139344325|NCT03643549|Bortezomib|bortezomib|mesh-list
139344326|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139344327|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
139344328|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344329|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344330|NCT05262205|Anesthetics|anesthetics|mesh-list
139344331|NCT05262205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139344332|NCT05262205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344333|NCT03641053|Iodine|iodine|mesh-list
139344334|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
139344335|NCT03641053|Povidone|povidone|mesh-list
139344336|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139344337|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344338|NCT03641053|Trace Elements|trace elements|mesh-ancestor
139344339|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
139344340|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344341|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
139344342|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
139344343|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139344344|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
139344345|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344346|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139344347|NCT03468777|Lansoprazole|lansoprazole|mesh-list
139344348|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
139344349|NCT03468777|Ranitidine|ranitidine|mesh-list
139344350|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139344351|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139344352|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139344353|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139344354|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344355|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344356|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139344357|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
139344358|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
139344359|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344360|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344361|NCT03640377|Praziquantel|praziquantel|mesh-list
139344362|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
139344363|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139344364|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344365|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139344366|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
139344367|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344368|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
139344369|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
139344370|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139344371|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344372|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344373|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
139344374|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139344375|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139344376|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344377|NCT03632187|Abatacept|abatacept|mesh-list
139344378|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139344379|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344380|NCT03632187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139344381|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344382|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139344383|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
139344384|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344385|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139344386|NCT05110209|Bevacizumab|bevacizumab|mesh-list
139344387|NCT05110209|Ranibizumab|ranibizumab|mesh-list
139344388|NCT05110209|Aflibercept|aflibercept|mesh-list
139344389|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139344390|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344391|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139344392|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139344393|NCT05110209|Growth Substances|growth substances|mesh-ancestor
139344394|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344395|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
139344396|NCT04454151|Azithromycin|azithromycin|mesh-list
139344397|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139344398|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344399|NCT05272683|Itraconazole|itraconazole|mesh-list
139344400|NCT05272683|Antifungal Agents|antifungal agents|mesh-ancestor
139344401|NCT05272683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344402|NCT05272683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139344403|NCT05272683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139344404|NCT05272683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344405|NCT05272683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344406|NCT05272683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139344407|NCT05272683|Hormone Antagonists|hormone antagonists|mesh-ancestor
139344408|NCT05272683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139344409|NCT05272683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344410|NCT05272683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139344411|NCT03934671|Antioxidants|antioxidants|mesh-list
139344412|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001247|NCT00987116|Prednisone|prednisone|mesh-list
139344414|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344415|NCT03130179|Nicotine|nicotine|mesh-list
139344416|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139344417|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
139344418|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344419|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344420|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139344421|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139344422|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
139344423|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344424|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344425|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139344426|NCT03466983|Hematinics|hematinics|mesh-ancestor
139344427|NCT05439213|Epinephrine|epinephrine|mesh-list
139344428|NCT05439213|Racepinephrine|racepinephrine|mesh-list
139344429|NCT05439213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139344430|NCT05439213|Epinephryl borate|epinephryl borate|mesh-list
139344431|NCT05439213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139344432|NCT05439213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139344433|NCT05439213|Adrenergic Agents|adrenergic agents|mesh-ancestor
139344434|NCT05439213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344435|NCT05439213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344436|NCT05439213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344437|NCT05439213|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139344438|NCT05439213|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139344439|NCT05439213|Autonomic Agents|autonomic agents|mesh-ancestor
139344440|NCT05439213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344441|NCT05439213|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139344442|NCT05439213|Respiratory System Agents|respiratory system agents|mesh-ancestor
139344443|NCT05439213|Mydriatics|mydriatics|mesh-ancestor
139344444|NCT05439213|Sympathomimetics|sympathomimetics|mesh-ancestor
139344445|NCT05439213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139344446|NCT03466749|Paclitaxel|paclitaxel|mesh-list
139344447|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139344448|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344449|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
139344450|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
139344451|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
139344452|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344453|NCT03466437|Methamphetamine|methamphetamine|mesh-list
139344454|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139344455|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344456|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
139344457|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
139344458|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344459|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
139344460|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344461|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344462|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
139344463|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139344464|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139344465|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138919608|NCT04101578|Protective Agents|protective agents|mesh-ancestor
139344466|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139344467|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
139344468|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344469|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344470|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139344471|NCT01909245|Gastrins|gastrins|mesh-list
139344472|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
139344473|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344474|NCT01909245|Hormones|hormones|mesh-ancestor
139344475|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139344476|NCT03465969|Tacrolimus|tacrolimus|mesh-list
139344477|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139344478|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
139344479|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344480|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139344481|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344482|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344483|NCT05397795|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139344484|NCT05397795|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139344485|NCT05397795|Luteolytic Agents|luteolytic agents|mesh-ancestor
139001312|NCT01088659|Tenofovir|tenofovir|mesh-list
139344486|NCT05397795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139344487|NCT05397795|Contraceptive Agents|contraceptive agents|mesh-ancestor
139344488|NCT05397795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139344489|NCT05397795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344490|NCT05397795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139344491|NCT05397795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139344492|NCT05397795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344493|NCT03130101|Insulin|insulin|mesh-list
139344494|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139344495|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344496|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
139344497|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
139344498|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139344499|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
139344500|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344501|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139344502|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139344503|NCT02735577|Disulfiram|disulfiram|mesh-list
139344504|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139344505|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139344506|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344507|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344508|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139344509|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139344510|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
139344511|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139344512|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139344513|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344514|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
139344515|NCT01068613|Tiotropium Bromide|tiotropium bromide|mesh-list
139344516|NCT01068613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139344517|NCT01068613|Autonomic Agents|autonomic agents|mesh-ancestor
139344518|NCT01068613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344519|NCT01068613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344520|NCT01068613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139344521|NCT01068613|Respiratory System Agents|respiratory system agents|mesh-ancestor
139344522|NCT01068613|Parasympatholytics|parasympatholytics|mesh-ancestor
139344523|NCT01068613|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139344524|NCT01068613|Cholinergic Agents|cholinergic agents|mesh-ancestor
139344525|NCT01068613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344526|NCT01068613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344527|NCT05396937|Bevacizumab|bevacizumab|mesh-list
139344528|NCT05396937|Atezolizumab|atezolizumab|mesh-list
139344529|NCT05396937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139344530|NCT05396937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344531|NCT05396937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139344532|NCT05396937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139344533|NCT05396937|Growth Substances|growth substances|mesh-ancestor
139344534|NCT05396937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344535|NCT05396937|Growth Inhibitors|growth inhibitors|mesh-ancestor
139344536|NCT05396937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139344537|NCT05396937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344538|NCT03642145|Deflazacort|deflazacort|mesh-list
139344539|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139344540|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139344541|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
139344542|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344543|NCT01064791|Mycophenolic Acid|mycophenolic acid|mesh-list
139344544|NCT01064791|Tacrolimus|tacrolimus|mesh-list
139344545|NCT01064791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139344546|NCT01064791|Immunologic Factors|immunologic factors|mesh-ancestor
139344547|NCT01064791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344548|NCT01064791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139344549|NCT01064791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344550|NCT01064791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344551|NCT01064791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139344552|NCT01064791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344553|NCT01064791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139344554|NCT01064791|Antitubercular Agents|antitubercular agents|mesh-ancestor
139344555|NCT01064791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139344556|NCT01064791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344557|NCT03465423|Propofol|propofol|mesh-list
139344558|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
139344559|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139001388|NCT03519074|Cisplatin|cisplatin|mesh-list
139344560|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344561|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139344562|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139344563|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
139344564|NCT05161351|Vitamin D|vitamin d|mesh-list
139344565|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
139344566|NCT05161351|Baclofen|baclofen|mesh-list
139344567|NCT05161351|Vitamins|vitamins|mesh-ancestor
139344568|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
139344569|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344570|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139344571|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139344572|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139344573|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139344574|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344575|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139344576|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
139344577|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
139344578|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344579|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344580|NCT03465345|Metformin|metformin|mesh-list
139344581|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
139344582|NCT03465345|Procyanidin|procyanidin|mesh-list
139344583|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139344584|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344585|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
139344586|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344587|NCT03465345|Protective Agents|protective agents|mesh-ancestor
139344588|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139344589|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139344590|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344591|NCT02983799|Olaparib|olaparib|mesh-list
139344592|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139344593|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344594|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344595|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344596|NCT05385705|Cyclophosphamide|cyclophosphamide|mesh-list
139344597|NCT05385705|Trastuzumab|trastuzumab|mesh-list
139344598|NCT05385705|Interleukin-2|interleukin-2|mesh-list
139344599|NCT05385705|Pertuzumab|pertuzumab|mesh-list
139344600|NCT05385705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139344601|NCT05385705|Immunologic Factors|immunologic factors|mesh-ancestor
139344602|NCT05385705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344603|NCT05385705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139344604|NCT05385705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139344605|NCT05385705|Alkylating Agents|alkylating agents|mesh-ancestor
139344606|NCT05385705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344607|NCT05385705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344608|NCT05385705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139344609|NCT05385705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139344610|NCT05385705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139344611|NCT05385705|Analgesics|analgesics|mesh-ancestor
139344612|NCT05385705|Sensory System Agents|sensory system agents|mesh-ancestor
139344613|NCT05385705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344614|NCT02186847|Metformin|metformin|mesh-list
139344615|NCT02186847|Paclitaxel|paclitaxel|mesh-list
139344616|NCT02186847|Carboplatin|carboplatin|mesh-list
139344617|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138919737|NCT04079517|Tamoxifen|tamoxifen|mesh-list
139344618|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344619|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
139344620|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
139344621|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
139344622|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344623|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139344624|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344625|NCT05274789|Dexmedetomidine|dexmedetomidine|mesh-list
139344626|NCT05274789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139344627|NCT05274789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139344628|NCT05274789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344629|NCT05274789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139344630|NCT05274789|Analgesics|analgesics|mesh-ancestor
139344631|NCT05274789|Sensory System Agents|sensory system agents|mesh-ancestor
139344632|NCT05274789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344633|NCT05274789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139344634|NCT05274789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139001461|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
139344635|NCT05274789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139344636|NCT05274789|Adrenergic Agents|adrenergic agents|mesh-ancestor
139344637|NCT05274789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344638|NCT05274789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344639|NCT02353247|Norethindrone|norethindrone|mesh-list
139344640|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
139344641|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139344642|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139344643|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139344644|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
139344645|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139344646|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344647|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139344648|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139344650|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138919778|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
139344651|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139344652|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139180953|NCT05037500|Decitabine|decitabine|mesh-list
139344654|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139344655|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
139344656|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344657|NCT03343431|Tenofovir|tenofovir|mesh-list
139344658|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
139344659|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344660|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139344661|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139344662|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344663|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344664|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139344665|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139344666|NCT05226897|Metformin|metformin|mesh-list
139344667|NCT05226897|Dapagliflozin|dapagliflozin|mesh-list
139344668|NCT05226897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139344669|NCT05226897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344670|NCT05226897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139344671|NCT05226897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344672|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
139344673|NCT04453761|Vitamins|vitamins|mesh-ancestor
139344674|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
139344675|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344676|NCT03463317|Aspirin|aspirin|mesh-list
139344677|NCT03463317|Warfarin|warfarin|mesh-list
139344678|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
139344679|NCT03463317|Dabigatran|dabigatran|mesh-list
139344680|NCT03463317|Apixaban|apixaban|mesh-list
139344681|NCT03463317|Edoxaban|edoxaban|mesh-list
139344682|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
139344683|NCT03463317|Clopidogrel|clopidogrel|mesh-list
139344684|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139344685|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139344686|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139344687|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139344688|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
139344689|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344690|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344691|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344692|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
139344693|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139344694|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
139344695|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139344696|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
139344697|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344698|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139344699|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139344700|NCT03463317|Analgesics|analgesics|mesh-ancestor
139344701|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
139344702|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344703|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139344704|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139344705|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139344706|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139344707|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139344708|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
139344709|NCT02906579|Praliciguat|praliciguat|mesh-list
139344710|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139344711|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
139344712|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344713|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139344714|NCT04975347|Naloxone|naloxone|mesh-list
139344715|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344716|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139344717|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
139344718|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344719|NCT03463083|Fentanyl|fentanyl|mesh-list
139344720|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
139344721|NCT03463083|Bupivacaine|bupivacaine|mesh-list
139344722|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
139344723|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
139344724|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139344725|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344726|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
139344727|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344728|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139344729|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139344730|NCT03463083|Analgesics|analgesics|mesh-ancestor
139344731|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139344732|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139344733|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138919846|NCT02596269|Nefopam|nefopam|mesh-list
139344734|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
139344735|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344736|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344737|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139344738|NCT03463083|Narcotics|narcotics|mesh-ancestor
139344739|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139344740|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139344741|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
139344742|NCT04971837|Cannabidiol|cannabidiol|mesh-list
139344743|NCT04971837|Sorbitol|sorbitol|mesh-list
139344744|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
139344745|NCT04971837|Cathartics|cathartics|mesh-ancestor
139344746|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139344747|NCT01328535|Temozolomide|temozolomide|mesh-list
139344748|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139344749|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
139344750|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344751|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344752|NCT03463005|Propolis|propolis|mesh-list
139344753|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344754|NCT02522169|Infliximab|infliximab|mesh-list
139344755|NCT02522169|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139344756|NCT02522169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139344757|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
139344758|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139344759|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139344760|NCT03656393|Carboplatin|carboplatin|mesh-list
139344761|NCT03656393|Vinorelbine|vinorelbine|mesh-list
139344762|NCT03656393|Gefitinib|gefitinib|mesh-list
139344763|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344764|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139344765|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
139344766|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
139344767|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
139344768|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344769|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139344770|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344771|NCT02979197|Celecoxib|celecoxib|mesh-list
139344772|NCT02979197|Amlodipine|amlodipine|mesh-list
139344773|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139344774|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139344775|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139344776|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344777|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139344778|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344779|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
139344780|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139344781|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139344782|NCT02979197|Analgesics|analgesics|mesh-ancestor
139344783|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
139344784|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344785|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139344786|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139344787|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139344788|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139344789|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344791|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139344792|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344793|NCT03654365|Caffeine|caffeine|mesh-list
139344794|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139344795|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344796|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139344797|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344798|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344799|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139344800|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139344801|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
139344802|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344803|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
139344804|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139344805|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139344806|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344807|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139344808|NCT03655847|Analgesics|analgesics|mesh-ancestor
138919929|NCT04078425|Diuretics|diuretics|mesh-ancestor
139344809|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
139344810|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344811|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139344812|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139344813|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139344814|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
139344815|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344816|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344817|NCT03655457|Poractant alfa|poractant alfa|mesh-list
139344818|NCT03655457|Beractant|beractant|mesh-list
139344819|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139344820|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
139344821|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139344822|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139344823|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
139344824|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344825|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139344826|NCT04453371|Plasminogen|plasminogen|mesh-list
139344827|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139344828|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139344829|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344830|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
139344831|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
139344832|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
139344833|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139344834|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
139344835|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139344836|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139344837|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344838|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139344839|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139344840|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344841|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344842|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344843|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344844|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139344845|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
139344846|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
139344847|NCT02980523|Protective Agents|protective agents|mesh-ancestor
139344848|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
139344849|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
139344850|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139344851|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139344852|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
139344853|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139180968|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
138919964|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139344854|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344855|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344857|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
139344858|NCT03460743|Vaccines|vaccines|mesh-list
139344859|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
139344860|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344861|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
139344862|NCT03460743|Coagulants|coagulants|mesh-ancestor
139344864|NCT02980133|Xhance|xhance|mesh-list
139344865|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139344866|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139344867|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139344868|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
139344869|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344870|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344871|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139344872|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
139344873|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
139344874|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139344875|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139344876|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139344877|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139344878|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
139344879|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344880|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344881|NCT03653663|Simvastatin|simvastatin|mesh-list
139344882|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139344883|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139344884|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
139344885|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344886|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139344887|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139344888|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344889|NCT02979431|Gontivimab|gontivimab|mesh-list
139344890|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
139344891|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344892|NCT03460275|Osimertinib|osimertinib|mesh-list
139344893|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344894|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139344895|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344896|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344897|NCT03468231|Leucovorin|leucovorin|mesh-list
139344898|NCT03468231|Fluorouracil|fluorouracil|mesh-list
139344899|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
139344900|NCT03468231|Sorafenib|sorafenib|mesh-list
139344901|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
139344902|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344903|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139344904|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344905|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139344906|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
139344907|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344908|NCT03468231|Antidotes|antidotes|mesh-ancestor
139344909|NCT03468231|Protective Agents|protective agents|mesh-ancestor
139344910|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
139344911|NCT03468231|Vitamins|vitamins|mesh-ancestor
139344912|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
139344913|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139344914|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344915|NCT03468153|Immunomodulating Agents|immunomodulating agents|mesh-list
139344916|NCT03468153|Immunologic Factors|immunologic factors|mesh-ancestor
139344917|NCT03468153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344918|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
139344919|NCT03460041|Bupivacaine|bupivacaine|mesh-list
139344920|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
139344921|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
139344922|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139344923|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344924|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
139344925|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344926|NCT03460041|Analgesics|analgesics|mesh-ancestor
139344927|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139344928|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
139344929|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139344930|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139344931|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344932|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139344933|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
139344934|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139344935|NCT02522013|Aminophylline|aminophylline|mesh-list
139344936|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139001770|NCT04048577|Natalizumab|natalizumab|mesh-list
139344937|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
139344938|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344939|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344940|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139344941|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
139344942|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139344943|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139344944|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344945|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344946|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139344947|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139344948|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
139344949|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139344950|NCT02522013|Protective Agents|protective agents|mesh-ancestor
139344951|NCT02978417|Naltrexone|naltrexone|mesh-list
139344952|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139344953|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139344954|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344955|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
139344956|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139344957|NCT03458559|Etidronic Acid|etidronic acid|mesh-list
139344958|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139344959|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344960|NCT03458559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139344961|NCT03458559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139344962|NCT03457467|Apatinib|apatinib|mesh-list
139344963|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139344964|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139344965|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344966|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344967|NCT05191875|Doxycycline|doxycycline|mesh-list
139344968|NCT05191875|Furazolidone|furazolidone|mesh-list
139344969|NCT05191875|Bismuth|bismuth|mesh-list
139344970|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139344971|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344972|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
139344973|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139344974|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139344975|NCT05191875|Antacids|antacids|mesh-ancestor
139344976|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344977|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139344978|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139344979|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139344980|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139344981|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139344982|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139344983|NCT04370145|Meropenem|meropenem|mesh-list
139344984|NCT04370145|Tinidazole|tinidazole|mesh-list
139344985|NCT04370145|Teicoplanin|teicoplanin|mesh-list
139344986|NCT04370145|Sulperazone|sulperazone|mesh-list
139344987|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139344988|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139344989|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
139344990|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139344991|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139344992|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139344993|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139344994|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139344995|NCT03453723|Lidocaine|lidocaine|mesh-list
139344996|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
139344997|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
139344998|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139344999|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345000|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
139345001|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345002|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139345003|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139345004|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139345005|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139345006|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345007|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
139345008|NCT04774965|Promethazine|promethazine|mesh-list
139345009|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139345010|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139345011|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345012|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345013|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
139345014|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
139345015|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
139345016|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345017|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
139345018|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
139345019|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139345020|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139345021|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
139345022|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
139345023|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345024|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345025|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139345026|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
139345027|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
139345028|NCT03452553|Doxorubicin|doxorubicin|mesh-list
139345029|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139345030|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345031|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139345032|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139345033|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345034|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345035|NCT03452475|Lumefantrine|lumefantrine|mesh-list
139345036|NCT03452475|Artemether|artemether|mesh-list
139345037|NCT03452475|Piperaquine|piperaquine|mesh-list
139345038|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139345039|NCT03452475|Mefloquine|mefloquine|mesh-list
139345040|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
139345041|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139345042|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139345043|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345044|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
139345045|NCT03451227|Remifentanil|remifentanil|mesh-list
139345046|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139345047|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345048|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345049|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139345050|NCT03451227|Analgesics|analgesics|mesh-ancestor
139345051|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
139345052|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345053|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139345054|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139345055|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139345056|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
139345057|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345058|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345059|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139345060|NCT03451227|Narcotics|narcotics|mesh-ancestor
139345061|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
139345062|NCT02529813|Fludarabine|fludarabine|mesh-list
139345063|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
139345064|NCT02529813|Tisagenlecleucel|tisagenlecleucel|mesh-list
139345065|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139345066|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
139345067|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345068|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139345069|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139345070|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
139345071|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345072|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345073|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139345074|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139345075|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
139345076|NCT02529813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139345077|NCT05321511|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139345078|NCT05321511|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139345079|NCT05321511|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139345080|NCT05321511|Hormones|hormones|mesh-ancestor
139345081|NCT05321511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345082|NCT05321511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345083|NCT05321511|Luteolytic Agents|luteolytic agents|mesh-ancestor
139345084|NCT05321511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139345085|NCT05321511|Contraceptive Agents|contraceptive agents|mesh-ancestor
139001918|NCT00403234|Buprenorphine|buprenorphine|mesh-list
139345086|NCT05321511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139345087|NCT05321511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139345088|NCT05321511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139345089|NCT05321511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345091|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139345092|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345093|NCT02417103|Incretins|incretins|mesh-ancestor
139345094|NCT02417103|Hormones|hormones|mesh-ancestor
139345095|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345096|NCT02097225|Trametinib|trametinib|mesh-list
139345097|NCT02097225|Dabrafenib|dabrafenib|mesh-list
139345098|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345099|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139345100|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345101|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345102|NCT02958865|PF-06700841|pf-06700841|mesh-list
139345103|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139345104|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345105|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345106|NCT02501902|Paclitaxel|paclitaxel|mesh-list
139345107|NCT02501902|Palbociclib|palbociclib|mesh-list
139345108|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139345109|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345110|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
139345111|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
139345112|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
139345113|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345114|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139345115|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345116|NCT05320575|Zanubrutinib|zanubrutinib|mesh-list
139345117|NCT05320575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345118|NCT05320575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139345119|NCT05320575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345120|NCT05320575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345121|NCT03448731|Doxycycline|doxycycline|mesh-list
139345122|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139345123|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345124|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
139345125|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139345126|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139345127|NCT04452669|Epoprostenol|epoprostenol|mesh-list
139345128|NCT04452669|Tezosentan|tezosentan|mesh-list
139345129|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139345130|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139345131|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
139345132|NCT03719001|Clevidipine|clevidipine|mesh-list
139345133|NCT03719001|Phenylephrine|phenylephrine|mesh-list
139345134|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
139345135|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
139345136|NCT03719001|Calcium|calcium|mesh-list
139345137|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139345138|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345139|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139345140|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345141|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138920199|NCT00798161|Metformin|metformin|mesh-list
139345143|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
139345144|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345145|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139345146|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139345147|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139345148|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
139345149|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345150|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345151|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139345152|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
139345153|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
139345154|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
139345155|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139345156|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
139345157|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
139345158|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139345159|NCT03719001|Protective Agents|protective agents|mesh-ancestor
139345160|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139345161|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139001986|NCT00767975|Rifampin|rifampin|mesh-list
139345162|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139345163|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139345164|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139345165|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139345166|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345167|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
139345168|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345169|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345170|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
139345171|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139345172|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345173|NCT02499952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139345174|NCT02499952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345175|NCT02498392|JNJ-42165279|jnj-42165279|mesh-list
139345176|NCT02498392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345177|NCT02498392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345178|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
139345179|NCT03205605|Oxybutynin|oxybutynin|mesh-list
139345180|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
139345181|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
139345182|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345183|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345184|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139345185|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139345186|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
139345187|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345188|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345189|NCT03205605|Urological Agents|urological agents|mesh-ancestor
139345190|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139345191|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345192|NCT05006638|Atropine|atropine|mesh-list
139345193|NCT05006638|Ondansetron|ondansetron|mesh-list
139345194|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
139345195|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
139345196|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
139345197|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
139345198|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345199|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345200|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139345201|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
139345202|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
139345203|NCT05006638|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139345204|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139345205|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
139345206|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345207|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345208|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139345209|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139345210|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139345211|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139345212|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
139345213|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
139345214|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
139345215|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139345216|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139345217|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
139345218|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139345219|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139345220|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
139345221|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
139345222|NCT02498236|Oxytocin|oxytocin|mesh-list
139345223|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
139345224|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139345225|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345226|NCT01283997|Minocycline|minocycline|mesh-list
139345227|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139345228|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345229|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
139345230|NCT02496676|Analgesics|analgesics|mesh-ancestor
139345231|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
139345232|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345233|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345234|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
139345235|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345236|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139345237|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
139345238|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139345239|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139345240|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345241|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139345242|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
139345243|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139345244|NCT01160211|Trastuzumab|trastuzumab|mesh-list
139345245|NCT01160211|Lapatinib|lapatinib|mesh-list
139345246|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139345247|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139345248|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345249|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139345250|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345251|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345252|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139345253|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139345254|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
139345255|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345256|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345257|NCT03443271|Bupivacaine|bupivacaine|mesh-list
139345258|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
139345259|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
139345260|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345261|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345262|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
139345263|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345264|NCT01064687|Metformin|metformin|mesh-list
139345265|NCT01064687|Pioglitazone|pioglitazone|mesh-list
139345266|NCT01064687|Exenatide|exenatide|mesh-list
139345267|NCT01064687|Dulaglutide|dulaglutide|mesh-list
139345268|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139345269|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345270|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139345271|NCT01064687|Incretins|incretins|mesh-ancestor
139345272|NCT01064687|Hormones|hormones|mesh-ancestor
139345273|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345274|NCT03447873|Lamivudine|lamivudine|mesh-list
139345275|NCT03447873|Cobicistat|cobicistat|mesh-list
139345276|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139345277|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139345278|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345279|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345280|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
139345281|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345282|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139345283|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139345284|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139345285|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139345286|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
139345287|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139345288|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139345289|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139345290|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139345291|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345292|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
139345293|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345294|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345295|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139345296|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345297|NCT03621995|Catalase|catalase|mesh-list
139345298|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
139345299|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345300|NCT03621995|Protective Agents|protective agents|mesh-ancestor
139345301|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345302|NCT03443037|Amantadine|amantadine|mesh-list
139345303|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139345304|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139345305|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
139345306|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345307|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
139345308|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345309|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345310|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345311|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139345313|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
139345314|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345315|NCT03442491|Hemostatics|hemostatics|mesh-list
139345316|NCT03442491|Coagulants|coagulants|mesh-ancestor
139345317|NCT02918279|Liraglutide|liraglutide|mesh-list
139345318|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139345319|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345320|NCT02918279|Incretins|incretins|mesh-ancestor
139345321|NCT02918279|Hormones|hormones|mesh-ancestor
139345322|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345323|NCT02956837|Vaccines|vaccines|mesh-list
139345324|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
139345325|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345326|NCT03447093|Methimazole|methimazole|mesh-list
139345327|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
139345328|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
139345329|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
139345330|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345331|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345332|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
139345333|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345334|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139345335|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139345336|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
139345337|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139345338|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
139345339|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345340|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
139345341|NCT03640351|Protective Agents|protective agents|mesh-ancestor
139345342|NCT03640273|Loratadine|loratadine|mesh-list
139345343|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
139345344|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
139345345|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139345346|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139345347|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139345348|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
139345349|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
139345350|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345351|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345352|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345353|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
139345354|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139345355|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139345356|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345357|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
139345358|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
139345359|NCT01063283|Bevacizumab|bevacizumab|mesh-list
139345360|NCT01063283|Carboplatin|carboplatin|mesh-list
139345361|NCT01063283|Pemetrexed|pemetrexed|mesh-list
139345362|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139345363|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345364|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139345365|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139345366|NCT01063283|Growth Substances|growth substances|mesh-ancestor
139345367|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345368|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
139345369|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345370|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345371|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139345372|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139345373|NCT01062971|Timolol|timolol|mesh-list
139345374|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139345375|NCT01062971|Dorzolamide|dorzolamide|mesh-list
139345376|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139345377|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139345378|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
139345379|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345380|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345381|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345382|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139345383|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139345384|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139345385|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139345386|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139345387|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139345388|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345389|NCT03446937|Dexamethasone|dexamethasone|mesh-list
139345390|NCT03446937|Betamethasone|betamethasone|mesh-list
139345391|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
139345392|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139345393|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
139345394|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
139345395|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139345396|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139345397|NCT03446937|BB 1101|bb 1101|mesh-list
139345398|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139345399|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
139345400|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
139345401|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345402|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345403|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139345404|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
139345405|NCT03446937|Hormones|hormones|mesh-ancestor
139345406|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345407|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139345408|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345409|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139345410|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
139345411|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
139345412|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345413|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345414|NCT03652493|Carboplatin|carboplatin|mesh-list
139345415|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345416|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
139345417|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139345418|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139345419|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139345420|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139345421|NCT02493868|Sertraline|sertraline|mesh-list
139345422|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
139345423|NCT02493868|Esketamine|esketamine|mesh-list
139345424|NCT02493868|Escitalopram|escitalopram|mesh-list
139345425|NCT02493868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139345426|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139345427|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139345428|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345429|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345430|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
139345431|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345432|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345433|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139345434|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139345435|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139345436|NCT02493868|Analgesics|analgesics|mesh-ancestor
139345437|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
139345438|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
139345439|NCT03619057|Anesthetics|anesthetics|mesh-list
139345440|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345441|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345442|NCT04451655|Insulin|insulin|mesh-list
139345443|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139345444|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345445|NCT03446625|Resveratrol|resveratrol|mesh-list
139345446|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
139345447|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345448|NCT03446625|Protective Agents|protective agents|mesh-ancestor
139345449|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345450|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345451|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139345452|NCT02516410|Ivacaftor|ivacaftor|mesh-list
139345453|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139345454|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139345455|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345456|NCT02493712|Mesalamine|mesalamine|mesh-list
139345457|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139345458|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139345459|NCT02493712|Analgesics|analgesics|mesh-ancestor
139345460|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
139002288|NCT01324258|Gemcitabine|gemcitabine|mesh-list
139345461|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345462|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345464|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139345465|NCT03446547|Durvalumab|durvalumab|mesh-list
139345466|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139345467|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345468|NCT02516332|Escitalopram|escitalopram|mesh-list
139345469|NCT02516332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139345470|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139345471|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139345472|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345473|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345474|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
139345475|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345476|NCT03437655|Eugenol|eugenol|mesh-list
139345477|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
139345478|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
139345479|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
139345480|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139345481|NCT03437655|Protective Agents|protective agents|mesh-ancestor
139345482|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345483|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345484|NCT01062425|Temozolomide|temozolomide|mesh-list
139345485|NCT01062425|Cediranib|cediranib|mesh-list
139345486|NCT01062425|Maleic acid|maleic acid|mesh-list
139345487|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139345488|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
139345489|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345490|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345491|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345492|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139345493|NCT03437187|Analgesics|analgesics|mesh-list
139345494|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345495|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
139345496|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345497|NCT02491684|Interferons|interferons|mesh-list
139345498|NCT02491684|Interferon-beta|interferon-beta|mesh-list
139345499|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
139345500|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345501|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
139345502|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345503|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
139345504|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345505|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139345506|NCT03445611|Lidocaine|lidocaine|mesh-list
139345507|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139345508|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
139345509|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
139345510|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345511|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345512|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
139345513|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345514|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139345515|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139345516|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139345517|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139345518|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345519|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
139345520|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139345521|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139345522|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345523|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
139345524|NCT04360629|Coagulants|coagulants|mesh-ancestor
139345525|NCT04727229|Bupivacaine|bupivacaine|mesh-list
139345526|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
139345527|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
139345528|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345529|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345530|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
139345531|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345532|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139345533|NCT03436719|Metronidazole|metronidazole|mesh-list
139345534|NCT03436719|Erythromycin|erythromycin|mesh-list
139345535|NCT03436719|Cefoperazone|cefoperazone|mesh-list
139345536|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139345537|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345538|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
139345539|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139345540|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139345541|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139345542|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139345543|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345544|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345545|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
139345546|NCT01061333|Nedocromil|nedocromil|mesh-list
139345547|NCT01061333|Montelukast|montelukast|mesh-list
139345548|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139345549|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
139345550|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139345551|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
139345552|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345553|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345554|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139345555|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139345556|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345557|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139345558|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
139345559|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139345560|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
139181017|NCT04934800|Cladribine|cladribine|mesh-list
139345561|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
139345562|NCT02489968|Empagliflozin|empagliflozin|mesh-list
139345563|NCT02489968|Linagliptin|linagliptin|mesh-list
139345564|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139345565|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345566|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139345567|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345568|NCT02489968|Incretins|incretins|mesh-ancestor
139345569|NCT02489968|Hormones|hormones|mesh-ancestor
139345570|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345571|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139345572|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
139345573|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345574|NCT03436173|Fluoxetine|fluoxetine|mesh-list
139345575|NCT03436173|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139345576|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138920540|NCT00770588|Gefitinib|gefitinib|mesh-list
139345577|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139345578|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345579|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345580|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
139345581|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345582|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139345583|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
139345584|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139345585|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139345586|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139345587|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345588|NCT03444831|Buspirone|buspirone|mesh-list
139345589|NCT03444831|Omeprazole|omeprazole|mesh-list
139345590|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139345591|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139345592|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139345593|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345594|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345595|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139345596|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139345597|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345598|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345599|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139345600|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139345601|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
139345602|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345603|NCT02481934|Lenalidomide|lenalidomide|mesh-list
139345604|NCT02481934|Bortezomib|bortezomib|mesh-list
139345605|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
139345606|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345607|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139345608|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139345609|NCT02481934|Growth Substances|growth substances|mesh-ancestor
139345610|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
139345611|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345613|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139345614|NCT03444519|Diuretics|diuretics|mesh-ancestor
139345615|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
139345616|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345617|NCT03129009|Anesthetics|anesthetics|mesh-list
139345618|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345619|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345620|NCT02489500|Bortezomib|bortezomib|mesh-list
139345621|NCT02489500|Melphalan|melphalan|mesh-list
139345622|NCT02489500|Lenograstim|lenograstim|mesh-list
139345623|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345624|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139345625|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
139345626|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345627|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139345628|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139345629|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
139345630|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345631|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139345632|NCT04053959|Insulin|insulin|mesh-list
139345633|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139345634|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139345635|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345636|NCT03652571|Nortriptyline|nortriptyline|mesh-list
139345637|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139345638|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
139345639|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139345640|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139345641|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139345642|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139345643|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345644|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
139345645|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345646|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345647|NCT03652103|Bupivacaine|bupivacaine|mesh-list
139345648|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
139345649|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
139345650|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345651|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345652|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
139345653|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345654|NCT03651947|Denosumab|denosumab|mesh-list
139345655|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139345656|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345657|NCT03651557|Salicylates|salicylates|mesh-list
139345658|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139345659|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139345660|NCT03651557|Analgesics|analgesics|mesh-ancestor
139345661|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
139345662|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345663|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345664|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139345665|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139345666|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139345667|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345668|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345669|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
139345670|NCT03432975|Povidone|povidone|mesh-list
139345671|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
139345672|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
138920597|NCT03904563|Bevacizumab|bevacizumab|mesh-list
139345673|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139345674|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345675|NCT02488330|Bevacizumab|bevacizumab|mesh-list
139345676|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139345677|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139345678|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345679|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139345680|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139345681|NCT02488330|Growth Substances|growth substances|mesh-ancestor
139002513|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
139345682|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345684|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139345685|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345686|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345687|NCT03432663|Amiodarone|amiodarone|mesh-list
139345688|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139345689|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
139345690|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139345691|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139345692|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345693|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139345694|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139345695|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139345696|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345697|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139345698|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139345699|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139345701|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139345702|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
139345703|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345704|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345705|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139345706|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139345707|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
139345708|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345709|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345710|NCT02481310|Cytarabine|cytarabine|mesh-list
139345711|NCT02481310|Prednisone|prednisone|mesh-list
139345712|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
139345713|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139345714|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139345715|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139345716|NCT02481310|Cortisone|cortisone|mesh-list
139345717|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
139345718|NCT02481310|Rituximab|rituximab|mesh-list
139345719|NCT02481310|Doxorubicin|doxorubicin|mesh-list
139345720|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139345721|NCT02481310|Methotrexate|methotrexate|mesh-list
139345722|NCT02481310|Etoposide|etoposide|mesh-list
139345723|NCT02481310|Vincristine|vincristine|mesh-list
139345724|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
139345725|NCT02481310|Ixazomib|ixazomib|mesh-list
139345726|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
139345727|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139345728|NCT02481310|Antibodies|antibodies|mesh-list
139345729|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
139345730|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139345731|NCT02481310|Glycine|glycine|mesh-list
139345732|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139345733|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
139345734|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345735|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139345736|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139345737|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
139345738|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345739|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345740|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139345741|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139345742|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139345743|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139345744|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345745|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139345746|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
139345747|NCT02481310|Hormones|hormones|mesh-ancestor
139345748|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345749|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139345750|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139345751|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
139345752|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139345753|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139345754|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
139345755|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
139345756|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139345757|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139345758|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139345759|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
139345760|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345761|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
139345762|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
139345763|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
139345764|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
139345765|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
139345766|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
139181036|NCT04893356|Dacarbazine|dacarbazine|mesh-list
139345767|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345768|NCT03432195|Donepezil|donepezil|mesh-list
139345769|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139345770|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345771|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345772|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
139345773|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345774|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345775|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
139345776|NCT03431961|Triamcinolone|triamcinolone|mesh-list
139345777|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139345778|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139345779|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139345780|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139345781|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
139345782|NCT03431961|Hormones|hormones|mesh-ancestor
139345783|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345784|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345785|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139345786|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
139345787|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345788|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345789|NCT02480764|Valsartan|valsartan|mesh-list
139345790|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139345791|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139345792|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139345793|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139345794|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345795|NCT03434691|Remifentanil|remifentanil|mesh-list
139345796|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139345797|NCT03434691|Narcotics|narcotics|mesh-ancestor
139345798|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345799|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345800|NCT03434691|Analgesics|analgesics|mesh-ancestor
139345801|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
139345802|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139345803|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139345804|NCT03434613|Ezetimibe|ezetimibe|mesh-list
139345805|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139345806|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139345807|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
139345808|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345809|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139345810|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139345811|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345812|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
139345813|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345814|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139345815|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345816|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345817|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
139345818|NCT03428685|Progestins|progestins|mesh-ancestor
139345819|NCT03428685|Hormones|hormones|mesh-ancestor
139345820|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345821|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345822|NCT05665647|Ritonavir|ritonavir|mesh-list
139345823|NCT05665647|Itraconazole|itraconazole|mesh-list
139345824|NCT05665647|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139345825|NCT05665647|Rifampin|rifampin|mesh-list
139345826|NCT05665647|Midazolam|midazolam|mesh-list
139345827|NCT05665647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139345828|NCT05665647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139345829|NCT05665647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345830|NCT05665647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345831|NCT05665647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139345832|NCT05665647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139345833|NCT05665647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139345834|NCT05665647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139345835|NCT05665647|Anesthetics, General|anesthetics, general|mesh-ancestor
139345836|NCT05665647|Anesthetics|anesthetics|mesh-ancestor
139345837|NCT05665647|GABA Modulators|gaba modulators|mesh-ancestor
139345838|NCT05665647|GABA Agents|gaba agents|mesh-ancestor
139345839|NCT05665647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345840|NCT05665647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345841|NCT05665647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139345842|NCT05665647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139345843|NCT05665647|Protease Inhibitors|protease inhibitors|mesh-ancestor
139345844|NCT05665647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345845|NCT05665647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139345846|NCT05665647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139345847|NCT05665647|Antiviral Agents|antiviral agents|mesh-ancestor
139345848|NCT05665647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345849|NCT05665647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139345850|NCT05665647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139345851|NCT05665647|Antifungal Agents|antifungal agents|mesh-ancestor
139345852|NCT05665647|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139345853|NCT05665647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139345854|NCT05665647|Hormone Antagonists|hormone antagonists|mesh-ancestor
139345855|NCT05665647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345856|NCT05665647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139345857|NCT05665647|Antitubercular Agents|antitubercular agents|mesh-ancestor
139345858|NCT05665647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139345859|NCT05665647|Leprostatic Agents|leprostatic agents|mesh-ancestor
139345860|NCT05665647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139345861|NCT05665647|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139345862|NCT05665647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139345863|NCT05665647|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139345864|NCT05665647|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139345865|NCT05665647|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139345866|NCT05665647|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139345868|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139345869|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139345870|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139345871|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139345872|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
139345873|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345874|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345875|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345876|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
139345877|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139345878|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139345879|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345880|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
139345881|NCT03431805|Coagulants|coagulants|mesh-ancestor
139345882|NCT03428607|Olaparib|olaparib|mesh-list
139345883|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139345884|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345885|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345886|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345887|NCT02521233|Losartan|losartan|mesh-list
139345888|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139345889|NCT02521233|Candesartan|candesartan|mesh-list
139345890|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
139345891|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
139345892|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139345893|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139345894|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139345895|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139345896|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345897|NCT02521233|Diuretics|diuretics|mesh-ancestor
139345898|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
139345899|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345900|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139345901|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139345902|NCT03428529|Capecitabine|capecitabine|mesh-list
139345903|NCT03428529|Fluorouracil|fluorouracil|mesh-list
139345904|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139345905|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
139345906|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345907|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345908|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139345910|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345911|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
139345912|NCT03431649|Beraprost|beraprost|mesh-list
139345913|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345914|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
139345915|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139345916|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139345917|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345918|NCT03431649|Urological Agents|urological agents|mesh-ancestor
139345919|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139345920|NCT04450095|Ambrisentan|ambrisentan|mesh-list
139345921|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139345922|NCT03101475|Durvalumab|durvalumab|mesh-list
139345923|NCT03101475|Tremelimumab|tremelimumab|mesh-list
139345924|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139345925|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345926|NCT01060007|Leucovorin|leucovorin|mesh-list
139345927|NCT01060007|Capecitabine|capecitabine|mesh-list
139345928|NCT01060007|Fluorouracil|fluorouracil|mesh-list
139345929|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
139345930|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139345931|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
139345932|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345933|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139345934|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139345935|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
139345936|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345937|NCT01060007|Antidotes|antidotes|mesh-ancestor
139345938|NCT01060007|Protective Agents|protective agents|mesh-ancestor
139345939|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
139345940|NCT01060007|Vitamins|vitamins|mesh-ancestor
139345941|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
139345942|NCT04175925|Famotidine|famotidine|mesh-list
139345943|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139345944|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138920712|NCT00721578|Voriconazole|voriconazole|mesh-list
139345945|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139345946|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
139345947|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
139345948|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139345949|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345950|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345951|NCT02971007|Fluconazole|fluconazole|mesh-list
139345952|NCT02971007|Amphotericin B|amphotericin b|mesh-list
139345953|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139345954|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
139345955|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345956|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139345957|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139345958|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345959|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345960|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139345961|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
139345962|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139345963|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345964|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139345965|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139345966|NCT02971007|Amebicides|amebicides|mesh-ancestor
139345967|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139345968|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139345969|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139345970|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
139345971|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
139181050|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345972|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345973|NCT03428139|Protective Agents|protective agents|mesh-ancestor
139345974|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139345975|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
139345976|NCT03428139|Vitamins|vitamins|mesh-ancestor
139345977|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
139345978|NCT03650543|Amoxicillin|amoxicillin|mesh-list
139345979|NCT03650543|Clarithromycin|clarithromycin|mesh-list
139345980|NCT03650543|Omeprazole|omeprazole|mesh-list
139002809|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
139345981|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139345982|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139345983|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139345984|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139345985|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139345986|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139345987|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139345988|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139345989|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139345990|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139345992|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
139345993|NCT02970305|Pimavanserin|pimavanserin|mesh-list
139345994|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139345995|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139345996|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139345997|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139345998|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139345999|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346000|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139346001|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139346002|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139346003|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
139346004|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139346005|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346006|NCT03649763|Lidocaine|lidocaine|mesh-list
139346007|NCT03649763|Bupivacaine|bupivacaine|mesh-list
139346008|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
139346009|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
139346010|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346011|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346012|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
139346013|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346014|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139346015|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139346016|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139346017|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139346018|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346019|NCT03427437|Epinephrine|epinephrine|mesh-list
139346020|NCT03427437|Racepinephrine|racepinephrine|mesh-list
139346021|NCT03427437|Bupivacaine|bupivacaine|mesh-list
139346022|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
139346023|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
139346024|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
139346025|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346026|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346027|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
139346028|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346029|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139346030|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139346031|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
139346032|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139346033|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346034|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139346035|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139346036|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
139346037|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139346038|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
139346039|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
139346040|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
139346041|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139346042|NCT03427359|Capecitabine|capecitabine|mesh-list
139346043|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346044|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139346045|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
139346046|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346047|NCT05053659|Venetoclax|venetoclax|mesh-list
139346048|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139346049|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346050|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139346051|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139346052|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139346053|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346054|NCT03649139|Immunomodulating Agents|immunomodulating agents|mesh-list
139346055|NCT03649139|Immunologic Factors|immunologic factors|mesh-ancestor
139346056|NCT03649139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346058|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346059|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
139346060|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
139346061|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
139346062|NCT03423225|Tacrolimus|tacrolimus|mesh-list
139346063|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139346064|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
139346065|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920742|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
139346066|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139346067|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346068|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346069|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
139346070|NCT02521077|Vitamins|vitamins|mesh-ancestor
139346071|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
139346072|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346073|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
139346074|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346075|NCT02521077|Protective Agents|protective agents|mesh-ancestor
139346076|NCT03429621|Simethicone|simethicone|mesh-list
139346077|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
139346078|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346079|NCT03429621|Emollients|emollients|mesh-ancestor
139346080|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
139346081|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
139346082|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
139346083|NCT03426969|Melphalan|melphalan|mesh-list
139346084|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
139346085|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139346086|NCT03426969|Fludarabine|fludarabine|mesh-list
139346087|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
139346088|NCT03426969|Tacrolimus|tacrolimus|mesh-list
139346089|NCT03426969|Lenograstim|lenograstim|mesh-list
139346090|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139346091|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
139346092|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346093|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139346094|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139346095|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
139346096|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346097|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346098|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139346099|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139346100|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
139346101|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139346102|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139346103|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346104|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139346105|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139346106|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
139346107|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139346108|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346110|NCT03422445|Apatinib|apatinib|mesh-list
139346111|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139346112|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
139346113|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346114|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346115|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139346116|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346117|NCT03429309|Propofol|propofol|mesh-list
139346118|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139346119|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346120|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346121|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139346122|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
139346123|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
139346124|NCT03429075|Psilocybin|psilocybin|mesh-list
139346125|NCT03429075|Escitalopram|escitalopram|mesh-list
139346126|NCT03429075|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139346127|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139346128|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139346129|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002961|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139346130|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139346131|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
139346132|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346133|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139346134|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
139346135|NCT03422289|Folic Acid|folic acid|mesh-list
139346136|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
139346137|NCT03422289|Inositol|inositol|mesh-list
139346138|NCT03422289|Hematinics|hematinics|mesh-ancestor
139346139|NCT03422289|Vitamins|vitamins|mesh-ancestor
139346140|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
139346141|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346142|NCT03422055|Fucoidan|fucoidan|mesh-list
139346143|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139346144|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139346145|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
139346146|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346147|NCT04449471|Naproxen|naproxen|mesh-list
139346148|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139346149|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139346150|NCT04449471|Analgesics|analgesics|mesh-ancestor
139346151|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
139346152|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346153|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346154|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139346155|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139346156|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
139346157|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139346158|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346159|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346160|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
139346161|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139346162|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
139346163|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
139346164|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346165|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346166|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139346167|NCT03127371|Analgesics|analgesics|mesh-ancestor
139346168|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
139346169|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346170|NCT03421821|Ropivacaine|ropivacaine|mesh-list
139346171|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
139346172|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
139346173|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346174|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346175|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
139346176|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346177|NCT03421743|Molgramostim|molgramostim|mesh-list
139346178|NCT03421743|Sargramostim|sargramostim|mesh-list
139346179|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346180|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
139346181|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346182|NCT01103349|Montelukast|montelukast|mesh-list
139346183|NCT01103349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139346184|NCT01103349|Respiratory System Agents|respiratory system agents|mesh-ancestor
139346185|NCT01103349|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139346186|NCT01103349|Hormone Antagonists|hormone antagonists|mesh-ancestor
139346187|NCT01103349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139346188|NCT01103349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346189|NCT01103349|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139346190|NCT01103349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139346191|NCT01103349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346192|NCT03421275|Fentanyl|fentanyl|mesh-list
139346193|NCT03421275|Esketamine|esketamine|mesh-list
139346194|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139346195|NCT03421275|Narcotics|narcotics|mesh-ancestor
139346196|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346197|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346198|NCT03421275|Analgesics|analgesics|mesh-ancestor
139346199|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
139346200|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346201|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139346202|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139346203|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
139346204|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
139346205|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
139346206|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139346208|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139346209|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139346210|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346211|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346212|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346213|NCT03421119|Insulin|insulin|mesh-list
139346214|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139346215|NCT03421119|Metformin|metformin|mesh-list
139346216|NCT03421119|Liraglutide|liraglutide|mesh-list
139346217|NCT03421119|Secretagogues|secretagogues|mesh-list
139346218|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139346219|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346220|NCT03421119|Incretins|incretins|mesh-ancestor
139346221|NCT03421119|Hormones|hormones|mesh-ancestor
139346222|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139346223|NCT03426033|Warfarin|warfarin|mesh-list
139346224|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
139346225|NCT02432547|Aflibercept|aflibercept|mesh-list
139346226|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139346227|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139346228|NCT02432547|Growth Substances|growth substances|mesh-ancestor
139346229|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346230|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
139346231|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346232|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139346233|NCT02345733|Amoxicillin|amoxicillin|mesh-list
139346234|NCT02345733|Metronidazole|metronidazole|mesh-list
139346235|NCT02345733|Doxycycline|doxycycline|mesh-list
139346236|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346237|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139346238|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139346239|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
139346240|NCT03415269|Ambroxol|ambroxol|mesh-list
139346241|NCT03415269|Expectorants|expectorants|mesh-ancestor
139346242|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
139346243|NCT03618589|Pregabalin|pregabalin|mesh-list
139346244|NCT03618589|Analgesics|analgesics|mesh-ancestor
139346245|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
139346246|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346247|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346248|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
139346249|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139346250|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139346251|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346252|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139346253|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139346254|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139346255|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346256|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139346257|NCT03127449|Aflutinib|aflutinib|mesh-list
139346258|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139346259|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346260|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346261|NCT02521155|Fenbendazole|fenbendazole|mesh-list
139346262|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
139346263|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
139346264|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139346265|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346266|NCT03415191|Ketamine|ketamine|mesh-list
139346267|NCT03415191|Analgesics|analgesics|mesh-ancestor
139346268|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
139346269|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346270|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346271|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139346272|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139346273|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
139346274|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
139346275|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346276|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139346277|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139346278|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139346279|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346280|NCT03419949|Pregabalin|pregabalin|mesh-list
139346281|NCT03419949|Lamotrigine|lamotrigine|mesh-list
139346282|NCT03419949|Analgesics|analgesics|mesh-ancestor
139346283|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
139346284|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346285|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346286|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
139346287|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139346288|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139346289|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346290|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139346291|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139346292|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139346293|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346294|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139346295|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139346296|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139346297|NCT03414879|Lidocaine|lidocaine|mesh-list
139346298|NCT03414879|Ketamine|ketamine|mesh-list
139346299|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
139346300|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
139346301|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346302|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346303|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
139346304|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346305|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139346306|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139346307|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139346308|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139346309|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346310|NCT03414879|Analgesics|analgesics|mesh-ancestor
139346311|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139346312|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139346313|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
139346314|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139346315|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139346316|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139346317|NCT03419715|Bimatoprost|bimatoprost|mesh-list
139346318|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139346319|NCT03618355|Sirolimus|sirolimus|mesh-list
139346320|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139346321|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346322|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139346323|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346324|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
139346325|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139346326|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
139346327|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346328|NCT04448457|Sufentanil|sufentanil|mesh-list
139346329|NCT04448457|Oxycodone|oxycodone|mesh-list
139346330|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139346331|NCT04448457|Narcotics|narcotics|mesh-ancestor
139346332|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346333|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346334|NCT04448457|Analgesics|analgesics|mesh-ancestor
139346335|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
139346336|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346337|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139346338|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139346339|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
139346340|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
139346341|NCT05384743|Rituximab|rituximab|mesh-list
139346342|NCT05384743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139346343|NCT05384743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346344|NCT05384743|Immunologic Factors|immunologic factors|mesh-ancestor
139346345|NCT05384743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346346|NCT05384743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139346347|NCT03414333|Hormones|hormones|mesh-list
139346348|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139346349|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346350|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
139346351|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346352|NCT03616639|Morphine|morphine|mesh-list
139346353|NCT03616639|Oxycodone|oxycodone|mesh-list
139346354|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139346355|NCT03616639|Narcotics|narcotics|mesh-ancestor
139346356|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346357|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346358|NCT03616639|Analgesics|analgesics|mesh-ancestor
139346359|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
139346360|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346361|NCT03616561|Apremilast|apremilast|mesh-list
139346362|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139346363|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139346364|NCT03616561|Analgesics|analgesics|mesh-ancestor
139346365|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
139346366|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346367|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346368|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139346369|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139346370|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139181112|NCT04639986|Gemcitabine|gemcitabine|mesh-list
139346371|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139346372|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346373|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346374|NCT03615313|Antibodies|antibodies|mesh-list
139346375|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
139346376|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346377|NCT03617575|Lactoferrin|lactoferrin|mesh-list
139346378|NCT03617575|Fesoterodine|fesoterodine|mesh-list
139346379|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346380|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139346381|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139346382|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
139346383|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139346384|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346385|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346386|NCT03617575|Urological Agents|urological agents|mesh-ancestor
139346387|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
139346388|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139346389|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346390|NCT03616405|Amoxicillin|amoxicillin|mesh-list
139346391|NCT03616405|Tetracycline|tetracycline|mesh-list
139346392|NCT03616405|Furazolidone|furazolidone|mesh-list
139346393|NCT03616405|Rabeprazole|rabeprazole|mesh-list
139346394|NCT03616405|Bismuth|bismuth|mesh-list
139346395|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139346396|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346397|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139346398|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139346399|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139346400|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346401|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346402|NCT03616405|Antacids|antacids|mesh-ancestor
139346403|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139346404|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139346405|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139346406|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139346407|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139346408|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139346409|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139346410|NCT03419559|Durvalumab|durvalumab|mesh-list
139346411|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139346412|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346413|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
139346414|NCT02873689|Lansoprazole|lansoprazole|mesh-list
139346415|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139346416|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139346417|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139346418|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346419|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346420|NCT02873377|Nicotine|nicotine|mesh-list
139346421|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139346422|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
139346423|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346424|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346425|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139346426|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139346427|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
139346428|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139346429|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346430|NCT03647579|Midazolam|midazolam|mesh-list
139346431|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
139346432|NCT03647579|Ketamine|ketamine|mesh-list
139346433|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139346434|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346435|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346436|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139346437|NCT03647579|Analgesics|analgesics|mesh-ancestor
139346438|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
139346439|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920819|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
139346440|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139346441|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139181114|NCT04639986|Vinorelbine|vinorelbine|mesh-list
139346442|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139346443|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
139346444|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139346445|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346446|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139346447|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139346448|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
139346449|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
139346450|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139346451|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139346452|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139346453|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139346454|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139346455|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139346456|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
139346457|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
139346458|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
139346459|NCT04046861|Vitamins|vitamins|mesh-ancestor
139346460|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
139346461|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346462|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
139346463|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346464|NCT04046861|Protective Agents|protective agents|mesh-ancestor
139346465|NCT02236741|Pramipexole|pramipexole|mesh-list
139346466|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
139346467|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346468|NCT02236741|Protective Agents|protective agents|mesh-ancestor
139346469|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346470|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139346471|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139346472|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
139346473|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
139346474|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139346475|NCT03648671|Rasagiline|rasagiline|mesh-list
139346476|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139346477|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346478|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346479|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139346480|NCT03648671|Protective Agents|protective agents|mesh-ancestor
139346481|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346482|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
139346483|NCT03647423|Cetuximab|cetuximab|mesh-list
139346484|NCT03647423|Avelumab|avelumab|mesh-list
139346485|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139346486|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
139346487|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346488|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139346489|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139346490|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
139346491|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346492|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346493|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139346494|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139346495|NCT04052711|Minocycline|minocycline|mesh-list
139346496|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138920835|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139346497|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346498|NCT03621683|Antioxidants|antioxidants|mesh-list
139346499|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346500|NCT03621683|Protective Agents|protective agents|mesh-ancestor
139346501|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346502|NCT03614065|Endostar protein|endostar protein|mesh-list
139346503|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
139346504|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139346505|NCT03614065|Growth Substances|growth substances|mesh-ancestor
139346506|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346507|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
139346508|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346509|NCT03621527|Remifentanil|remifentanil|mesh-list
139346510|NCT03621527|Anesthetics|anesthetics|mesh-list
139346511|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346512|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346513|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139346515|NCT03621527|Analgesics|analgesics|mesh-ancestor
139346516|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
139346517|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346518|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139346519|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139346520|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346521|NCT03646721|Incretins|incretins|mesh-ancestor
139346522|NCT03646721|Hormones|hormones|mesh-ancestor
139346523|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139346524|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139346525|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
139346526|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346527|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346528|NCT03613753|Irinotecan|irinotecan|mesh-list
139346529|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139346530|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139346531|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346532|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346533|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346534|NCT04051853|Sorafenib|sorafenib|mesh-list
139346535|NCT04051853|Midazolam|midazolam|mesh-list
139346536|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139346537|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139346538|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346539|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346540|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139346541|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139346542|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139346543|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139346544|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
139346545|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
139346546|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
139346547|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
139346548|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139346549|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346550|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346551|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139346552|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346553|NCT03643757|Bupivacaine|bupivacaine|mesh-list
139346554|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
139346555|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
139346556|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346557|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346558|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
139346559|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346560|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
139346561|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139346562|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
139346563|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346564|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346565|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139346566|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
139346567|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139346568|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
139346569|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346570|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139346571|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139346572|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
139346573|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
139346574|NCT03718793|Protective Agents|protective agents|mesh-ancestor
139346575|NCT02962739|Tenofovir|tenofovir|mesh-list
139346576|NCT02962739|Emtricitabine|emtricitabine|mesh-list
139346577|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
139346578|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346579|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139346580|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139346581|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346582|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346583|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139346584|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139346585|NCT01344629|Telmisartan|telmisartan|mesh-list
139346586|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139346587|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139346588|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138752697|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
139346589|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346591|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139346592|NCT03642665|Estradiol|estradiol|mesh-list
139346593|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139346594|NCT03642665|Progesterone|progesterone|mesh-list
139346595|NCT03642665|Estrogens|estrogens|mesh-ancestor
139346596|NCT03642665|Hormones|hormones|mesh-ancestor
139346597|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139346598|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346599|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139346600|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
139346601|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139346602|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139346603|NCT03642665|Progestins|progestins|mesh-ancestor
139346604|NCT03642353|Listerine|listerine|mesh-list
139346605|NCT03642353|Triclosan|triclosan|mesh-list
139346606|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
139346607|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
139346608|NCT03642353|Protective Agents|protective agents|mesh-ancestor
139346609|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346610|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139346611|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346612|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139346613|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139346614|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
139346615|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346616|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139346617|NCT03424707|Eperisone|eperisone|mesh-list
139346618|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
139346619|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139346620|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139346621|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346622|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139346623|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346624|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139346625|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139346626|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346627|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
139346628|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
139346629|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
139346630|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139346631|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139346632|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
139346633|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139346634|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346635|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346636|NCT03418935|Niacinamide|niacinamide|mesh-list
139346637|NCT03418935|Niacin|niacin|mesh-list
139346638|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
139346639|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
139346640|NCT03418935|Vitamins|vitamins|mesh-ancestor
139346641|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
139346642|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346643|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139346644|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
139346645|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346646|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139346647|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
139346648|NCT03413319|Tilavonemab|tilavonemab|mesh-list
139346649|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
139346650|NCT03424629|Methotrexate|methotrexate|mesh-list
139346651|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139346652|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
139346653|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139346654|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346655|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139346656|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
139346657|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346658|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346659|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
139346660|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346661|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139346662|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139346663|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
139346664|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139346665|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139346666|NCT03424473|Tucatinib|tucatinib|mesh-list
139346667|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346668|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139346669|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346670|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346671|NCT04448379|Osimertinib|osimertinib|mesh-list
139346672|NCT04448379|Afatinib|afatinib|mesh-list
139346673|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346674|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139346675|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346676|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346677|NCT04448223|Latanoprost|latanoprost|mesh-list
139346678|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139346679|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139346680|NCT03644147|Acetaminophen|acetaminophen|mesh-list
139346681|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139346682|NCT03644147|Analgesics|analgesics|mesh-ancestor
139346683|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
139346684|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346685|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346686|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
139346687|NCT02743923|Paclitaxel|paclitaxel|mesh-list
139346688|NCT02743923|Bevacizumab|bevacizumab|mesh-list
139346689|NCT02743923|Carboplatin|carboplatin|mesh-list
139346690|NCT02743923|Pemetrexed|pemetrexed|mesh-list
139346691|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139346692|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346693|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
139346694|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
139346695|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
139346696|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346697|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139346698|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139346699|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139346700|NCT02743923|Growth Substances|growth substances|mesh-ancestor
139346701|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346702|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
139346703|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346704|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139346705|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139346706|NCT01065779|Alendronate|alendronate|mesh-list
139346707|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139346708|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346709|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139346710|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346711|NCT03570359|Interferons|interferons|mesh-list
139346712|NCT03570359|Interferon-beta|interferon-beta|mesh-list
139346713|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
139346714|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346715|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
139346716|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346717|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
139346718|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346719|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139346720|NCT02358200|Paclitaxel|paclitaxel|mesh-list
139346721|NCT02358200|Carboplatin|carboplatin|mesh-list
139346722|NCT02358200|Talazoparib|talazoparib|mesh-list
139346723|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138920918|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
139346724|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346725|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
139346726|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
139346727|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
139346728|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346729|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139346730|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346731|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
139346732|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
139346733|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346734|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139346735|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139346736|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346737|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139346738|NCT03127605|Immunotoxins|immunotoxins|mesh-ancestor
139346739|NCT03127605|Immunoconjugates|immunoconjugates|mesh-ancestor
139346740|NCT03127605|Immunologic Factors|immunologic factors|mesh-ancestor
139346741|NCT03127605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346742|NCT03112538|Insulin|insulin|mesh-list
139346743|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139346744|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139346745|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346746|NCT05283551|Famciclovir|famciclovir|mesh-list
139346747|NCT05283551|Antiviral Agents|antiviral agents|mesh-ancestor
139346748|NCT05283551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346749|NCT05283551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139346750|NCT05283551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346751|NCT05283551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346752|NCT02357732|Nivolumab|nivolumab|mesh-list
139346753|NCT02357732|Trametinib|trametinib|mesh-list
139346754|NCT02357732|Dabrafenib|dabrafenib|mesh-list
139346755|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139346756|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346757|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139346758|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346759|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139346760|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346761|NCT03112148|Tofacitinib|tofacitinib|mesh-list
139346762|NCT03112148|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139346763|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139346764|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346765|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346766|NCT03423849|Gemcitabine|gemcitabine|mesh-list
139346767|NCT03423849|Capecitabine|capecitabine|mesh-list
139346768|NCT03423849|Vinorelbine|vinorelbine|mesh-list
139346769|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346770|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139346771|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
139346772|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346773|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139346774|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
139346775|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
139346776|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
139346777|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139346778|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
139346779|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346780|NCT02362256|Clonidine|clonidine|mesh-list
139346781|NCT02362256|Naltrexone|naltrexone|mesh-list
139346782|NCT02362256|Lorazepam|lorazepam|mesh-list
139346783|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139346784|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139346785|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346786|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
139346787|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346788|NCT02362256|Analgesics|analgesics|mesh-ancestor
139346789|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139346790|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
139346791|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
139346792|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139346793|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139346794|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139346795|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
139346796|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139346797|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346798|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
139346799|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
139346800|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139181132|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
139346801|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139346802|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346803|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139346804|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139346805|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139346806|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
139346807|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
139346808|NCT03412305|Amoxicillin|amoxicillin|mesh-list
139346809|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139346810|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346811|NCT02109081|Dexamethasone|dexamethasone|mesh-list
139346812|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139346813|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
139346814|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
139346815|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346816|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346817|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139346818|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
139346819|NCT02109081|Hormones|hormones|mesh-ancestor
139346820|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139346821|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139346822|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346823|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139346824|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139346825|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139346826|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
139346827|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
139346828|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
139346829|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139346830|NCT03397875|Protective Agents|protective agents|mesh-ancestor
139346831|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346832|NCT02362022|Morphine|morphine|mesh-list
139346833|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139346834|NCT02362022|Narcotics|narcotics|mesh-ancestor
139346835|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346836|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346837|NCT02362022|Analgesics|analgesics|mesh-ancestor
139346838|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
139346839|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346840|NCT03412071|Metronidazole|metronidazole|mesh-list
139346841|NCT03412071|Clindamycin|clindamycin|mesh-list
139346842|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
139346843|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
139346844|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139346845|NCT03412071|Tinidazole|tinidazole|mesh-list
139346846|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346847|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139346848|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139346849|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139346850|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139346851|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346852|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346853|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139346854|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
139346855|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139346856|NCT03397797|Rocuronium|rocuronium|mesh-list
139346857|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139346858|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139346859|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139346860|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346861|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346862|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139181137|NCT04493138|Azacitidine|azacitidine|mesh-list
139346863|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346864|NCT05170581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139346865|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346866|NCT02351882|Nabilone|nabilone|mesh-list
139346867|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
139346868|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
139346869|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346870|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346871|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139346872|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139346873|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139346874|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346875|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139346876|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
139346877|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
139346878|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
139346879|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346880|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346881|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
139346882|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346883|NCT05169801|Paclitaxel|paclitaxel|mesh-list
139346884|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139346885|NCT05169801|Carboplatin|carboplatin|mesh-list
139346886|NCT05169801|Bevacizumab|bevacizumab|mesh-list
139346887|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139346888|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346889|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
139346890|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
139346891|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
139346892|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346893|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139346894|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139346895|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139346897|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346898|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
139346899|NCT04447443|Loperamide|loperamide|mesh-list
139346900|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
139346901|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139346902|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139346903|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139346904|NCT01345253|Belimumab|belimumab|mesh-list
139346905|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139346906|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
139346907|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346908|NCT03397329|Mitapivat|mitapivat|mesh-list
139346909|NCT03397329|Enzyme Activators|enzyme activators|mesh-ancestor
139346910|NCT03397329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346911|NCT03150134|Cyclosporine|cyclosporine|mesh-list
139346912|NCT03150134|Cyclosporins|cyclosporins|mesh-list
139346913|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139346914|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346915|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346916|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
139346917|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346918|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
139346919|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346920|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
139346921|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139346922|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139346923|NCT03411369|Vitamins|vitamins|mesh-list
139346924|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
139346925|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346926|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139346927|NCT02351804|Dexamethasone|dexamethasone|mesh-list
139346928|NCT02351804|Ropivacaine|ropivacaine|mesh-list
139346929|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139346930|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
139346931|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
139346932|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346933|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346934|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139181151|NCT04323956|Rituximab|rituximab|mesh-list
139346935|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
139346936|NCT02351804|Hormones|hormones|mesh-ancestor
139346937|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139346938|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139346939|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346940|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
139346941|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
139346942|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346943|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
139346944|NCT03640403|Artesunate|artesunate|mesh-list
139346945|NCT03640403|Piperaquine|piperaquine|mesh-list
139346946|NCT03640403|Amodiaquine|amodiaquine|mesh-list
139346947|NCT03640403|Artenimol|artenimol|mesh-list
139346948|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
139346949|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139346950|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139346951|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346952|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346953|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
139346954|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
139346955|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139346956|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
139346957|NCT02355938|Vancomycin|vancomycin|mesh-list
139346958|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
139346959|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139346960|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139346961|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
139346962|NCT03397173|Azacitidine|azacitidine|mesh-list
139346963|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139346964|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
139346965|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346966|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139346967|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346968|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
139346969|NCT03397173|Protective Agents|protective agents|mesh-ancestor
139346970|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346971|NCT03397173|Vitamins|vitamins|mesh-ancestor
139346972|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
139346973|NCT03640247|Acetaminophen|acetaminophen|mesh-list
139346974|NCT03640247|Ibuprofen|ibuprofen|mesh-list
139346975|NCT03640247|Oxycodone|oxycodone|mesh-list
139346976|NCT03640247|Tramadol|tramadol|mesh-list
139346977|NCT03640247|Hydrocodone|hydrocodone|mesh-list
139346978|NCT03640247|Narcotics|narcotics|mesh-list
139346979|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139346980|NCT03640247|Analgesics|analgesics|mesh-ancestor
139346981|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
139346982|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139346983|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346984|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
139346985|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139346986|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139346987|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139346988|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139346989|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139346990|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139346991|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139346992|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139346993|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
139346994|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
139346995|NCT03394131|Insulin|insulin|mesh-list
139346996|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139346997|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139346998|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139346999|NCT02360618|Metformin|metformin|mesh-list
139347000|NCT02360618|Simvastatin|simvastatin|mesh-list
139347001|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139347002|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347003|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139347004|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139347005|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
139347006|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347007|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139347008|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139347009|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347010|NCT05214183|Rituximab|rituximab|mesh-list
139347011|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
139347012|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139347013|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347014|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
139347015|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347016|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139347017|NCT01344161|Vitamin D|vitamin d|mesh-list
139347018|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
139347019|NCT01344161|Vitamins|vitamins|mesh-ancestor
139347020|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
139347021|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347022|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139347023|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139347024|NCT02451358|Vaccines|vaccines|mesh-list
139347025|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
139347026|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347027|NCT02360384|Linaclotide|linaclotide|mesh-list
139347028|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139347029|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
139347030|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347031|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139347032|NCT03396861|Aflibercept|aflibercept|mesh-list
139347033|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139347034|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139347035|NCT03396861|Growth Substances|growth substances|mesh-ancestor
139347036|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347037|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
139347038|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347039|NCT02749721|Vortioxetine|vortioxetine|mesh-list
139347040|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
139347041|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139347042|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139347043|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139347044|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347045|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347046|NCT02749721|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139347047|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139347048|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139347049|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347050|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347051|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
139347052|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139347053|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139347054|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139347055|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139347056|NCT02351102|Valacyclovir|valacyclovir|mesh-list
139347057|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
139347058|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347059|NCT02351024|Naproxen|naproxen|mesh-list
139347060|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139347061|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139347062|NCT02351024|Analgesics|analgesics|mesh-ancestor
139347063|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
139347064|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347065|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347066|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139347067|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139347068|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
139347069|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139347070|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347071|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347072|NCT02355704|Atorvastatin|atorvastatin|mesh-list
139347073|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139347074|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139347075|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
139347076|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347077|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139347078|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139347079|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347080|NCT03396393|Artenimol|artenimol|mesh-list
139347081|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
139347082|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139347083|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139347084|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347085|NCT03393819|Ethanol|ethanol|mesh-list
139347086|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
139347087|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139347088|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347089|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347090|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347091|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
139347092|NCT03393507|Apatinib|apatinib|mesh-list
139347093|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347094|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139347095|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347096|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347097|NCT01348139|AZD-3199|azd-3199|mesh-list
139347098|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139347099|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139347100|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139347101|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
139347102|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347103|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347104|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347105|NCT02355236|Celecoxib|celecoxib|mesh-list
139347106|NCT02355236|Naproxen|naproxen|mesh-list
139347107|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139347108|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139347109|NCT02355236|Analgesics|analgesics|mesh-ancestor
139347110|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
139347111|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347112|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347113|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139347114|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139347115|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139347116|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139347117|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347118|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347119|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
139347120|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139347121|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347122|NCT02359604|Esomeprazole|esomeprazole|mesh-list
139347123|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139347124|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139347125|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139347126|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347127|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347128|NCT03410511|Nicotine|nicotine|mesh-list
139347129|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139347130|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
139347131|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347132|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347133|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138753234|NCT01111851|Aprepitant|aprepitant|mesh-list
139347134|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139347135|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
139347136|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347137|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347138|NCT05169021|Folic Acid|folic acid|mesh-list
139347139|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
139347140|NCT05169021|Amlodipine|amlodipine|mesh-list
139347141|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
139347142|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139347143|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139347144|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347145|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139347146|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347147|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
139347148|NCT05169021|Hematinics|hematinics|mesh-ancestor
139347149|NCT05169021|Vitamins|vitamins|mesh-ancestor
139347150|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
139347151|NCT02359292|Charcoal|charcoal|mesh-list
139347152|NCT02359292|Antidotes|antidotes|mesh-ancestor
139347153|NCT02359292|Protective Agents|protective agents|mesh-ancestor
139347154|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347155|NCT05168787|Valsartan|valsartan|mesh-list
139347156|NCT05168787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139347157|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138921006|NCT04110587|Analgesics|analgesics|mesh-list
139347158|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139347159|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139347160|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347161|NCT02359214|Vitamin D|vitamin d|mesh-list
139347162|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
139347163|NCT02359214|Vitamins|vitamins|mesh-ancestor
139347164|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
139347165|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347166|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139347167|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139347168|NCT02359370|Lidocaine|lidocaine|mesh-list
139347169|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
139347170|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
139347171|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
139347172|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347173|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347174|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
139347175|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347176|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139347177|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139347178|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139347179|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139347180|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347181|NCT02359370|Analgesics|analgesics|mesh-ancestor
139347182|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
139347183|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139347184|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139347185|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
139347186|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139347187|NCT02359448|Melatonin|melatonin|mesh-list
139347188|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
139347189|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347190|NCT02359448|Protective Agents|protective agents|mesh-ancestor
139347191|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347192|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347193|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139347194|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139004020|NCT05254808|Fosfomycin|fosfomycin|mesh-list
139347195|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
139347196|NCT02359526|Hormones|hormones|mesh-ancestor
139347197|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139347198|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347199|NCT03618953|Atezolizumab|atezolizumab|mesh-list
139347200|NCT03618953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139347201|NCT03618953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139181185|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
139347202|NCT03618953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139347203|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347205|NCT02354768|Loperamide|loperamide|mesh-list
139347206|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
139347207|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347208|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139347209|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
139347210|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139347211|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139347212|NCT02354612|Bevacizumab|bevacizumab|mesh-list
139347213|NCT02354612|Capecitabine|capecitabine|mesh-list
139347214|NCT02354612|Axitinib|axitinib|mesh-list
138921021|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
139347215|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139347216|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347217|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139347218|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139347219|NCT02354612|Growth Substances|growth substances|mesh-ancestor
139347220|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347221|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
139347222|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139347223|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
139347224|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347225|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139347226|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347227|NCT02348450|Irinotecan|irinotecan|mesh-list
139347228|NCT02348450|Etoposide|etoposide|mesh-list
139347229|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347230|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139347231|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139347232|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347233|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347234|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139347235|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139347236|NCT03393273|Elotuzumab|elotuzumab|mesh-list
139347237|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347238|NCT03613597|Etoposide|etoposide|mesh-list
139347239|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
139347240|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347241|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139347242|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139347243|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139347244|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347245|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347246|NCT02348372|Glycine|glycine|mesh-list
139347247|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
139347248|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347249|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347250|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347251|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139347252|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
139347253|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347254|NCT03614533|Vaccines|vaccines|mesh-list
139347255|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
139347256|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347257|NCT03147404|Avelumab|avelumab|mesh-list
139347258|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139347259|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347260|NCT03614455|Itraconazole|itraconazole|mesh-list
139347261|NCT03614455|Posaconazole|posaconazole|mesh-list
139347262|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
139347263|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
139347264|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347265|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139347266|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139347267|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347268|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347269|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139347270|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
139181189|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347271|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139347272|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347273|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139347274|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139347275|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139347277|NCT03393117|Bupivacaine|bupivacaine|mesh-list
139347278|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
139347279|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
139347280|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347281|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347282|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
139347283|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347284|NCT03393117|Analgesics|analgesics|mesh-ancestor
139347285|NCT02032303|Ticagrelor|ticagrelor|mesh-list
139347286|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139347287|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139347288|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139347289|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139347290|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139347291|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
139347292|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347293|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347294|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347295|NCT04297293|Ramosetron|ramosetron|mesh-list
139347296|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
139347297|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
139347298|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347299|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347300|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139347301|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139347302|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
139347303|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347304|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347305|NCT03392961|Insulin|insulin|mesh-list
139347306|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139347307|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347308|NCT02350946|Oxytocin|oxytocin|mesh-list
139347309|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
139347310|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139347311|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347312|NCT00000371|Cycloserine|cycloserine|mesh-list
139347313|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139347314|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347315|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139347316|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
139347317|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139347318|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
139347319|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347320|NCT02350712|Carboplatin|carboplatin|mesh-list
139347321|NCT02350712|Cetuximab|cetuximab|mesh-list
139347322|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347323|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139347324|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139347325|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139347326|NCT03618797|Fenofibrate|fenofibrate|mesh-list
139347327|NCT03618797|Pitavastatin|pitavastatin|mesh-list
139347328|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139347329|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
139347330|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347331|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139347332|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139347333|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139347334|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347335|NCT03149432|Gabapentin|gabapentin|mesh-list
139347336|NCT03149432|Analgesics|analgesics|mesh-ancestor
139347337|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
139347338|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347339|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347340|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
139347341|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139347342|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139347343|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347344|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139347345|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139347346|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139347347|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347348|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347349|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
139347350|NCT05384483|Cariprazine|cariprazine|mesh-list
139347351|NCT05384483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139347352|NCT05384483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139347353|NCT05384483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347354|NCT05384483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347355|NCT05384483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139347356|NCT05061563|Esomeprazole|esomeprazole|mesh-list
139347357|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139347358|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139347359|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139347360|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347361|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347363|NCT03147092|Atenolol|atenolol|mesh-list
139347364|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139347365|NCT03147092|Clonidine|clonidine|mesh-list
139347366|NCT03147092|Captopril|captopril|mesh-list
139347367|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139347368|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139347369|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139347370|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139347371|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347372|NCT03147092|Diuretics|diuretics|mesh-ancestor
139347373|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
139347374|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347375|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139347376|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139347377|NCT03147092|Analgesics|analgesics|mesh-ancestor
139347378|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
139347379|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347380|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
139347381|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
139347382|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139347383|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139347384|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139347385|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
139347386|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347387|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139347388|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139347389|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139347390|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139347391|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
139347392|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347393|NCT03149588|Propofol|propofol|mesh-list
139347394|NCT03149588|Sevoflurane|sevoflurane|mesh-list
139347395|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139347396|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347397|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347398|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139347399|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
139347400|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
139347401|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139347402|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139347403|NCT03613207|Lidocaine|lidocaine|mesh-list
139347404|NCT03613207|Prilocaine|prilocaine|mesh-list
139347405|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
139347406|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
139347407|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347408|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347409|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
139347410|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347411|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139347412|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139347413|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139347414|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139347415|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347417|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139004235|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
139347418|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
139347419|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347420|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347421|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347422|NCT02350400|Irinotecan|irinotecan|mesh-list
139347423|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139347424|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139347425|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347426|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347427|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347428|NCT03612817|Timolol|timolol|mesh-list
139347429|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139347430|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139347431|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
139347432|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347433|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347434|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347435|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139347436|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139347437|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
139347438|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347439|NCT03612349|Menthol|menthol|mesh-list
139347440|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
139347441|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
139347442|NCT03146858|Enoxaparin|enoxaparin|mesh-list
139347443|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
139347444|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139347445|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139347446|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347447|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139347448|NCT03408405|Hormones|hormones|mesh-ancestor
139347449|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139347450|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347451|NCT03408093|Interferons|interferons|mesh-list
139347452|NCT03408093|Interferon-beta|interferon-beta|mesh-list
139347453|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
139347454|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347455|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
139347456|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347457|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
139347458|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347459|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139347460|NCT04679623|Midazolam|midazolam|mesh-list
139347461|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139347462|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139347463|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347464|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347465|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139347466|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139347467|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139347468|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139347469|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
139347470|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
139347471|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
139347472|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
139347473|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347474|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347475|NCT02353988|Bicalutamide|bicalutamide|mesh-list
139347476|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
139347477|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
139347478|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139347479|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347480|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347481|NCT03392571|Paclitaxel|paclitaxel|mesh-list
139347482|NCT03392571|Cisplatin|cisplatin|mesh-list
139347483|NCT03392571|Gemcitabine|gemcitabine|mesh-list
139347484|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139347485|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347486|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
139347487|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
139347488|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
139347489|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347490|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139347491|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
139347492|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
139347493|NCT04656067|Ethamsylate|ethamsylate|mesh-list
139347494|NCT04656067|Oxytocin|oxytocin|mesh-list
139347495|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
139347496|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139347497|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347498|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139347499|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139347500|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347501|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
139347502|NCT04656067|Coagulants|coagulants|mesh-ancestor
139347503|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
139347504|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
139347505|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347506|NCT03612037|Protective Agents|protective agents|mesh-ancestor
139347507|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347508|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
139347509|NCT03612037|Vitamins|vitamins|mesh-ancestor
139347510|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
139347511|NCT04447209|Chrysarobin|chrysarobin|mesh-list
139347512|NCT04447209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139347513|NCT04447209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139347514|NCT04447209|Analgesics|analgesics|mesh-ancestor
139347515|NCT04447209|Sensory System Agents|sensory system agents|mesh-ancestor
139347516|NCT04447209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347517|NCT04447209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347518|NCT04447209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139347519|NCT04447209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139347520|NCT04199624|Omeprazole|omeprazole|mesh-list
139347521|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347522|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139347523|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139347524|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139347525|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347526|NCT03611491|Lidocaine|lidocaine|mesh-list
139347527|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
139347528|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
139347529|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347530|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347531|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
139347532|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347533|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139347534|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139347535|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139347536|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139347537|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347538|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139347539|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
139347540|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347541|NCT03611179|Bevacizumab|bevacizumab|mesh-list
139347542|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139347543|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347544|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139347545|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139347546|NCT03611179|Growth Substances|growth substances|mesh-ancestor
139347547|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347548|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
139347549|NCT03126123|Acetic Acid|acetic acid|mesh-list
139347550|NCT03126123|Retinol acetate|retinol acetate|mesh-list
139347551|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139347552|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347553|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139181210|NCT04212650|Losartan|losartan|mesh-list
139347554|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
139347555|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347556|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139347557|NCT03126123|Protective Agents|protective agents|mesh-ancestor
139347558|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347559|NCT02353676|Bupivacaine|bupivacaine|mesh-list
139347560|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
139347561|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
139347562|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347563|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347564|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
139347565|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347566|NCT05168007|Cariprazine|cariprazine|mesh-list
139347567|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139347568|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139347569|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347570|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347571|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139347572|NCT02032927|Acetaminophen|acetaminophen|mesh-list
139347574|NCT02032927|Codeine|codeine|mesh-list
139347575|NCT02032927|Naloxone|naloxone|mesh-list
139347576|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139347577|NCT02032927|Analgesics|analgesics|mesh-ancestor
139347578|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
139347579|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347580|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347581|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
139347582|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139347583|NCT02032927|Narcotics|narcotics|mesh-ancestor
139347584|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347585|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139347586|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
139347587|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
139347588|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139347589|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
139347590|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347591|NCT03392103|Raltitrexed|raltitrexed|mesh-list
139347592|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139347593|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
139347594|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347595|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347596|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139347597|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347598|NCT03610945|Fluconazole|fluconazole|mesh-list
139347599|NCT03610945|Quinidine|quinidine|mesh-list
139347600|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
139347601|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347602|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139347603|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139347604|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347605|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347606|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139347607|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
139347608|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139347609|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347610|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139347611|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139347612|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139347613|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139347614|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
139347615|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347616|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139347617|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
139347618|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139347619|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139347620|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139347621|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139347622|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
139347623|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139347624|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139347625|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139347626|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139347627|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
139347628|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139347629|NCT05167851|Lazertinib|lazertinib|mesh-list
139347630|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139347631|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347632|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347633|NCT02236715|Ipratropium|ipratropium|mesh-list
139347634|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139347635|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
139347636|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347637|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347638|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139347639|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
139347640|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139347641|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
139347642|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347643|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347644|NCT03823365|Blinatumomab|blinatumomab|mesh-list
139347645|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347646|NCT03616691|Bevacizumab|bevacizumab|mesh-list
139347647|NCT03616691|Atezolizumab|atezolizumab|mesh-list
139347648|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139347649|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139347650|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347651|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139347652|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139347653|NCT03616691|Growth Substances|growth substances|mesh-ancestor
139347654|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347655|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
139347656|NCT03616691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139347657|NCT03616691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347658|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
139347659|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
139347660|NCT03158168|Astringents|astringents|mesh-ancestor
139347661|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347662|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
139347663|NCT02865499|Acarbose|acarbose|mesh-list
139347664|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139347665|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347666|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347667|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139347668|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347669|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
139347670|NCT03156062|Salicylates|salicylates|mesh-list
139347671|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347672|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
139347673|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
139347674|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
139347675|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139347676|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139347677|NCT03156062|Analgesics|analgesics|mesh-ancestor
139347678|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
139347679|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347680|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347681|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139347682|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139347683|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139347684|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181226|NCT04172220|Midazolam|midazolam|mesh-list
139347685|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347686|NCT03404739|Ceftazidime|ceftazidime|mesh-list
139347687|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139347688|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347689|NCT02031965|Dexamethasone|dexamethasone|mesh-list
139347690|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139347691|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
139347692|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
139347693|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347694|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347695|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139347696|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
139347698|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139347699|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139347700|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347701|NCT03149120|Nivolumab|nivolumab|mesh-list
139347702|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139347703|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347704|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139347705|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347706|NCT04849325|Sirolimus|sirolimus|mesh-list
139347707|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139347708|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347709|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139347710|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347711|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
139347712|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139347713|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
139347714|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347715|NCT03403023|Cyclosporine|cyclosporine|mesh-list
139347716|NCT03403023|Cyclosporins|cyclosporins|mesh-list
139347717|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347718|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347719|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139347720|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
139347721|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347722|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
139347723|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347724|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
139347725|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139347726|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139347727|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
139347728|NCT02864407|Olodaterol|olodaterol|mesh-list
139347729|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139347730|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
139347731|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347732|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347733|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139347734|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
139347735|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
139347736|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139347737|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
139347738|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347739|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347740|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139347741|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139347742|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347743|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139347744|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347745|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347746|NCT03394989|Fluticasone|fluticasone|mesh-list
139347747|NCT03394989|Xhance|xhance|mesh-list
139347748|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139347749|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139347750|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139347751|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139347752|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
139347753|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139181230|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139347754|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347755|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139347756|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
139347757|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
139347758|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139347759|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139347760|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139347761|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139347762|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
139347763|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347764|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347765|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
139347766|NCT03394989|Hormones|hormones|mesh-ancestor
139347767|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139347768|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
139347769|NCT02033239|Insulin|insulin|mesh-list
139347770|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139347771|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
139347772|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
139347773|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139347774|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139347775|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347776|NCT02486302|Etanercept|etanercept|mesh-list
139347777|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139347778|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139347779|NCT02486302|Analgesics|analgesics|mesh-ancestor
139347780|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
139347781|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347782|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347783|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139347784|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139347785|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139347786|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139347787|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
139347788|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139347789|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347790|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139347791|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347792|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347793|NCT03615833|Vitamin D|vitamin d|mesh-list
139347794|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
139347795|NCT03615833|Vitamins|vitamins|mesh-ancestor
139347796|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
139347797|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347798|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139347799|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139347800|NCT02747875|Fentanyl|fentanyl|mesh-list
139347801|NCT02747875|Methadone|methadone|mesh-list
139347802|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139347803|NCT02747875|Narcotics|narcotics|mesh-ancestor
139347804|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139347805|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347806|NCT02747875|Analgesics|analgesics|mesh-ancestor
139347807|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
139347808|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347809|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139347810|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139347811|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
139347812|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
139347813|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
139347814|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
139347815|NCT03394833|Polygeline|polygeline|mesh-list
139347816|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
139347817|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
139347818|NCT02347358|Plasminogen|plasminogen|mesh-list
139347819|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139347820|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139347821|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139347822|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347823|NCT03610321|Gefarnate|gefarnate|mesh-list
139347824|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139347825|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139347826|NCT02236793|Becaplermin|becaplermin|mesh-list
139347827|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
139347828|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
139347829|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139347830|NCT02236793|Growth Substances|growth substances|mesh-ancestor
139347831|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347832|NCT02347046|Dotinurad|dotinurad|mesh-list
139347833|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
139347834|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
139347835|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139347836|NCT03391245|Vitamin D|vitamin d|mesh-list
139347837|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139347838|NCT03391245|Calcifediol|calcifediol|mesh-list
139347839|NCT03391245|Vitamins|vitamins|mesh-ancestor
139347840|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
139347841|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347842|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139347843|NCT03401619|Vitamin D|vitamin d|mesh-list
139347844|NCT03401619|Calcitonin|calcitonin|mesh-list
139347845|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
139347846|NCT03401619|Diphosphonates|diphosphonates|mesh-list
139347847|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139347848|NCT03401619|Katacalcin|katacalcin|mesh-list
139347849|NCT03401619|Vitamins|vitamins|mesh-ancestor
139347850|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
139347851|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347852|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139347853|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139347854|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
139347855|NCT03399903|Mesalamine|mesalamine|mesh-list
139347856|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139347857|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139347858|NCT03399903|Analgesics|analgesics|mesh-ancestor
139347859|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
139347860|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347861|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347862|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139347863|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139347864|NCT03146468|Nivolumab|nivolumab|mesh-list
139347865|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139347866|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347867|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138921204|NCT01816971|Hormones|hormones|mesh-ancestor
139347868|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347869|NCT02353130|Memantine|memantine|mesh-list
139347870|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139347871|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139347872|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
139347873|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139347874|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347875|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347876|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139347877|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139347878|NCT02033551|Paclitaxel|paclitaxel|mesh-list
139347879|NCT02033551|Carboplatin|carboplatin|mesh-list
139347880|NCT02033551|Veliparib|veliparib|mesh-list
139347881|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139347882|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347883|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
139347884|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
139347885|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
139347886|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347887|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139347888|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347889|NCT02450578|Atovaquone|atovaquone|mesh-list
139347890|NCT02450578|Proguanil|proguanil|mesh-list
139347891|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
139347892|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347893|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
139347894|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139347895|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139181242|NCT04161248|Rituximab|rituximab|mesh-list
139347896|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347897|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347898|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
139347900|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
139347901|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
139347902|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347903|NCT03146390|Listerine|listerine|mesh-list
139347904|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
139347905|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139347906|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139347907|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
139347908|NCT03146390|Protective Agents|protective agents|mesh-ancestor
139347909|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347910|NCT02859415|Plicamycin|plicamycin|mesh-list
139347911|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139347912|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347913|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139347914|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347915|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139347916|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347917|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347918|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139347919|NCT02871791|Everolimus|everolimus|mesh-list
139347920|NCT02871791|Palbociclib|palbociclib|mesh-list
139347921|NCT02871791|Exemestane|exemestane|mesh-list
139347922|NCT02871791|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139347923|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139347924|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347925|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347926|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139347927|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
139347928|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347929|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347930|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139347931|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139347932|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139347933|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
139347934|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139347935|NCT02346578|Flutamide|flutamide|mesh-list
139347936|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
139347937|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
139347938|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139347939|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347940|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139347941|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347942|NCT03112382|Vitamins|vitamins|mesh-list
139347943|NCT03112382|Vitamin A|vitamin a|mesh-list
139347944|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
139004760|NCT00049543|Gefitinib|gefitinib|mesh-list
139347946|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347947|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
139347948|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347949|NCT03112382|Protective Agents|protective agents|mesh-ancestor
139347950|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139347951|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347952|NCT03399669|Gefitinib|gefitinib|mesh-list
139347953|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347954|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139347955|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347956|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347957|NCT03148574|Misoprostol|misoprostol|mesh-list
139347958|NCT03148574|Oxytocin|oxytocin|mesh-list
139347959|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
139347960|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139347961|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347962|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139347963|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
139347964|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139347965|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139347966|NCT02343536|Prednisone|prednisone|mesh-list
139347967|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
139347968|NCT02343536|Rituximab|rituximab|mesh-list
139347969|NCT02343536|Vincristine|vincristine|mesh-list
139347970|NCT02343536|Azacitidine|azacitidine|mesh-list
139347971|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139347972|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
139347973|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139347974|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139347975|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139347976|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
139347977|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139347978|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139347979|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139347980|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139347981|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139347982|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
139347983|NCT02343536|Hormones|hormones|mesh-ancestor
139347984|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139347985|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139347986|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139347987|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
139347988|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
139347989|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
139347990|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139347991|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
139347992|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139347993|NCT02343614|Celecoxib|celecoxib|mesh-list
139347994|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139347995|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139347996|NCT02343614|Analgesics|analgesics|mesh-ancestor
139347997|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
139347998|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139347999|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348000|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139348001|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139348002|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139348003|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139348004|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348005|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348006|NCT02871635|Adalimumab|adalimumab|mesh-list
139348007|NCT02871635|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139348008|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139348009|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139348010|NCT03390465|Amlodipine|amlodipine|mesh-list
139348011|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139348012|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139348013|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139348014|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139348015|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348016|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139348017|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004836|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348018|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
139348019|NCT03390465|Diuretics|diuretics|mesh-ancestor
139348020|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
139348021|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139348022|NCT03390387|Dexamethasone|dexamethasone|mesh-list
139348023|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
139348024|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
139348025|NCT03390387|Bortezomib|bortezomib|mesh-list
139348026|NCT03390387|Daunorubicin|daunorubicin|mesh-list
139348027|NCT03390387|Idarubicin|idarubicin|mesh-list
139348028|NCT03390387|BB 1101|bb 1101|mesh-list
139348029|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139348030|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
139348031|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
139348032|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348033|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348034|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139348035|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
139348036|NCT03390387|Hormones|hormones|mesh-ancestor
139348037|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348038|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139348039|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348040|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
139348041|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348042|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348043|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139348044|NCT03390387|Protective Agents|protective agents|mesh-ancestor
139348045|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139348046|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139348047|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139348048|NCT03146000|Meloxicam|meloxicam|mesh-list
139348049|NCT03146000|Lidocaine|lidocaine|mesh-list
139348050|NCT03146000|Prilocaine|prilocaine|mesh-list
139348051|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139348052|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
139348053|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
139348054|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348055|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348056|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
139348057|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348058|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139348059|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139348060|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139348061|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139348062|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348063|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139348064|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139348065|NCT03146000|Analgesics|analgesics|mesh-ancestor
139348066|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139348067|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139348068|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139348069|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139348070|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348071|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139348072|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
139348073|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
139348074|NCT02346188|Trace Elements|trace elements|mesh-ancestor
139348075|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
139348076|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348077|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
139348078|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
139348079|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139348080|NCT02346188|Protective Agents|protective agents|mesh-ancestor
139348081|NCT02477332|Omalizumab|omalizumab|mesh-list
139348082|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139348083|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139348084|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
139348085|NCT02346110|Dexamethasone|dexamethasone|mesh-list
139348086|NCT02346110|Epinephrine|epinephrine|mesh-list
139348087|NCT02346110|Racepinephrine|racepinephrine|mesh-list
139348088|NCT02346110|Bupivacaine|bupivacaine|mesh-list
139348089|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
139348090|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139348091|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
139348092|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
139348093|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348094|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348095|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139348096|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
139348097|NCT02346110|Hormones|hormones|mesh-ancestor
139348098|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348099|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139348100|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348101|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
139348102|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
139348103|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348104|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
139348105|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139348106|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139348107|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
139348108|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348109|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348110|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139348111|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139348112|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139348113|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
139348114|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
139348115|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
139348116|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139348117|NCT02348528|Dexamethasone|dexamethasone|mesh-list
139348118|NCT02348528|Lenalidomide|lenalidomide|mesh-list
139348119|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139348120|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
139348121|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
139348122|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348123|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348124|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139348125|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
139348127|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348128|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139348129|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348130|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
139348131|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139348132|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139348133|NCT02348528|Growth Substances|growth substances|mesh-ancestor
139348134|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
139348135|NCT02342600|Trametinib|trametinib|mesh-list
139348136|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348137|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139348138|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348139|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348140|NCT03147638|Warfarin|warfarin|mesh-list
139348141|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
139348142|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
139348143|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139348144|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139348145|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
139348146|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
139348147|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348148|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348149|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
139348150|NCT02862535|Nivolumab|nivolumab|mesh-list
139348151|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348152|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139348153|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139348154|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348155|NCT02033707|Scopolamine|scopolamine|mesh-list
139348156|NCT02033707|Hallucinogens|hallucinogens|mesh-list
139348157|NCT02033707|Nicotine|nicotine|mesh-list
139348158|NCT02033707|Histamine Antagonists|histamine antagonists|mesh-list
139348159|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139348160|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
139348161|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348162|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348163|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139348164|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139348165|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
139348166|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348167|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348168|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139348169|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
139348170|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139348171|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
139005003|NCT00802139|Iron|iron|mesh-list
139348172|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139348173|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139348174|NCT02033707|Histamine Agents|histamine agents|mesh-ancestor
139348175|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139348176|NCT02039336|Docetaxel|docetaxel|mesh-list
139348177|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348178|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
139348179|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
139348180|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
139348181|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348182|NCT04935476|Dapsone|dapsone|mesh-list
139348183|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139348184|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
139348185|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139348186|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139348187|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139348188|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348189|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348190|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
139348191|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139348192|NCT02476006|Atorvastatin|atorvastatin|mesh-list
139348193|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139348194|NCT02476006|Simvastatin|simvastatin|mesh-list
139348195|NCT02476006|Ezetimibe|ezetimibe|mesh-list
139348196|NCT02476006|Alirocumab|alirocumab|mesh-list
139348197|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139348198|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139348199|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
139348200|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348201|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139348202|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139348203|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348204|NCT02476006|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139348205|NCT02476006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139348206|NCT02476006|Protease Inhibitors|protease inhibitors|mesh-ancestor
139348207|NCT02344940|Tamoxifen|tamoxifen|mesh-list
139348208|NCT02344940|Toremifene|toremifene|mesh-list
139348209|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139348210|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
139348211|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348212|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348213|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139348214|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348215|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139348216|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139348217|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139348218|NCT03615677|Esomeprazole|esomeprazole|mesh-list
139348219|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139348220|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139348221|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139348222|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348223|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348224|NCT02344862|Dotinurad|dotinurad|mesh-list
139348225|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
139348226|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
139348227|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139348228|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
139348229|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139348230|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139348231|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
139348232|NCT03614273|Epinephrine|epinephrine|mesh-list
139348233|NCT03614273|Racepinephrine|racepinephrine|mesh-list
139348234|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
139348235|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139348236|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139348237|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
139348238|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348239|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348240|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348241|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139348242|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139348243|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
139348244|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348245|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139348246|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
139348247|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
139348248|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
139348249|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139348250|NCT02336984|Trastuzumab|trastuzumab|mesh-list
139348251|NCT02336984|Pertuzumab|pertuzumab|mesh-list
139348252|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139348253|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348254|NCT03145610|Triclosan|triclosan|mesh-list
139348255|NCT03145610|Fluorides|fluorides|mesh-list
139348256|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
139348257|NCT03145610|Protective Agents|protective agents|mesh-ancestor
139348258|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348259|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139348260|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139348261|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139348262|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139348263|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
139348264|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348265|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139348266|NCT02341586|Iron|iron|mesh-list
139348267|NCT02341586|Trace Elements|trace elements|mesh-ancestor
139348268|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
139348269|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348270|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139348271|NCT02336906|Laxatives|laxatives|mesh-ancestor
139348272|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139348273|NCT03613961|Anesthetics|anesthetics|mesh-list
139348274|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348275|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348276|NCT02341352|Fluorides|fluorides|mesh-list
139348277|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
139348278|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
139348279|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139348280|NCT02341352|Antibodies|antibodies|mesh-list
139348281|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
139348282|NCT02341352|Protective Agents|protective agents|mesh-ancestor
139348283|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348284|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
139348285|NCT02344550|Everolimus|everolimus|mesh-list
139348286|NCT02344550|Letrozole|letrozole|mesh-list
139348287|NCT02344550|Leuprolide|leuprolide|mesh-list
139348288|NCT02344550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139348289|NCT02344550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139348290|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348291|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348292|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139348293|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
139348294|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348295|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348296|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139348297|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139348298|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139348299|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
139348300|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348301|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139348302|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
139348303|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139348304|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139348305|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
139348306|NCT02419612|Glimepiride|glimepiride|mesh-list
139348307|NCT02419612|Saxagliptin|saxagliptin|mesh-list
139348308|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139348309|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348310|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139348311|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348312|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139348313|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139348314|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
139348315|NCT02419612|Incretins|incretins|mesh-ancestor
139348316|NCT02419612|Hormones|hormones|mesh-ancestor
139348317|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348318|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139348319|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
139348320|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348321|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
139348322|NCT03612947|Bupivacaine|bupivacaine|mesh-list
139348323|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
139348324|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
139348325|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139005145|NCT00803699|Selenium|selenium|mesh-list
139348326|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348327|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
139348328|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348329|NCT03612947|Analgesics|analgesics|mesh-ancestor
139348330|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139348331|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
138921347|NCT00442117|Budesonide|budesonide|mesh-list
139348332|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139348333|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139348334|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348335|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139348336|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
139348337|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139348338|NCT02344784|Methylphenidate|methylphenidate|mesh-list
139348339|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139348340|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348341|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139348342|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139348343|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139348344|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348345|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
139348346|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348347|NCT02447848|Sufentanil|sufentanil|mesh-list
139348348|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139348349|NCT02447848|Narcotics|narcotics|mesh-ancestor
139348350|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348351|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348352|NCT02447848|Analgesics|analgesics|mesh-ancestor
139348353|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
139348354|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348355|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139348356|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139348357|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
139348358|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
139348359|NCT02336516|Azithromycin|azithromycin|mesh-list
139348360|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139348361|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139348362|NCT05254652|Pregabalin|pregabalin|mesh-list
139348363|NCT05254652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139348364|NCT05254652|Analgesics|analgesics|mesh-ancestor
139348365|NCT05254652|Sensory System Agents|sensory system agents|mesh-ancestor
139348366|NCT05254652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348367|NCT05254652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348368|NCT05254652|Anticonvulsants|anticonvulsants|mesh-ancestor
139348369|NCT05254652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139348370|NCT05254652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139348371|NCT05254652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348372|NCT05254652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139348373|NCT05254652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139348374|NCT05254652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139348375|NCT05254652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348376|NCT05254652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139348377|NCT05254652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139348378|NCT05254652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139348379|NCT05254652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348380|NCT05254652|Antidepressive Agents|antidepressive agents|mesh-ancestor
139348381|NCT05254652|Dopamine Agents|dopamine agents|mesh-ancestor
139348382|NCT02343926|Metformin|metformin|mesh-list
139348383|NCT02343926|Vildagliptin|vildagliptin|mesh-list
139348384|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139348385|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348386|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139348387|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
139348388|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348389|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348390|NCT03112226|Estradiol|estradiol|mesh-list
139348391|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
139348392|NCT03112226|Estrogens|estrogens|mesh-ancestor
139348393|NCT03112226|Hormones|hormones|mesh-ancestor
139348394|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348395|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348396|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
139348397|NCT02343692|Pancrelipase|pancrelipase|mesh-list
139348398|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139348399|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
139348400|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139348401|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139348402|NCT02332616|Prednisolone|prednisolone|mesh-list
139348403|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
139348404|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139348405|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
139348406|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139348407|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
139348408|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
139348409|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348410|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348411|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139348412|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
139348413|NCT02332616|Hormones|hormones|mesh-ancestor
139348414|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348415|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139348416|NCT02332616|Protective Agents|protective agents|mesh-ancestor
139348417|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139348418|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348419|NCT03345173|Ketamine|ketamine|mesh-list
139348420|NCT03345173|Analgesics|analgesics|mesh-ancestor
139348421|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
139348422|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348423|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348424|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139348425|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139348426|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
139348427|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
139348428|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348429|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139348430|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139348431|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348432|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348433|NCT03618173|Dexamethasone|dexamethasone|mesh-list
139348434|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
139348435|NCT03618173|BB 1101|bb 1101|mesh-list
139348436|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139348437|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
139348438|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
139348439|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348440|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348441|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139348442|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
139348443|NCT03618173|Hormones|hormones|mesh-ancestor
139348444|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348445|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139348446|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348447|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
139348448|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348449|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348450|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
139348451|NCT02336048|Chlorambucil|chlorambucil|mesh-list
139348452|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139348453|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348454|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139348455|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
139348456|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348457|NCT03612401|Mirabegron|mirabegron|mesh-list
139348458|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139348459|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139348460|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139348461|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
139348462|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348463|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348464|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348465|NCT03612401|Urological Agents|urological agents|mesh-ancestor
139348466|NCT03612323|Piroxicam|piroxicam|mesh-list
139348467|NCT03612323|Carticaine|carticaine|mesh-list
139348468|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
139348469|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
139348470|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348471|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005288|NCT00806663|Sunitinib|sunitinib|mesh-list
139348472|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
139348473|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348474|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139348475|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139348476|NCT03612323|Analgesics|analgesics|mesh-ancestor
139348477|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139348478|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139348479|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139348480|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348481|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348482|NCT02994719|Amantadine|amantadine|mesh-list
139348483|NCT02994719|Levodopa|levodopa|mesh-list
139348484|NCT02994719|Carbidopa|carbidopa|mesh-list
139348485|NCT02994719|Pramipexole|pramipexole|mesh-list
139348486|NCT02994719|Ropinirole|ropinirole|mesh-list
139348487|NCT02994719|Entacapone|entacapone|mesh-list
139348488|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139348489|NCT02994719|Tolcapone|tolcapone|mesh-list
139348490|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139348491|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139348492|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
139348493|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348494|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348495|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348496|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139348497|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348498|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
138921386|NCT00770120|Everolimus|everolimus|mesh-list
139348499|NCT02994719|Protective Agents|protective agents|mesh-ancestor
139348500|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
139348501|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
139348502|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139348503|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139348504|NCT02994719|Analgesics|analgesics|mesh-ancestor
139348505|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
139348506|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348507|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139348508|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139348509|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
139348510|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
139348511|NCT04346108|Antibodies|antibodies|mesh-list
139348512|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
139348513|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139348514|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139348515|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
139348516|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
139348517|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348518|NCT02335736|Cetrorelix|cetrorelix|mesh-list
139348519|NCT02335736|Hormones|hormones|mesh-list
139181285|NCT03992196|Rotigotine|rotigotine|mesh-list
139348520|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
139348521|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348522|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348523|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139348524|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
139348525|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139348526|NCT03613259|Alovudine|alovudine|mesh-list
139348527|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
139348528|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139348529|NCT02032355|Anesthetics|anesthetics|mesh-list
139348530|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348531|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348532|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
139348533|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139348534|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
139348535|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348536|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348537|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139348538|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
139348539|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
139348540|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139348541|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
139348542|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348543|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348544|NCT03612557|Penicillins|penicillins|mesh-list
139005363|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139348545|NCT03612557|Penicillin G|penicillin g|mesh-list
139348546|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139348547|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
139348548|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139348549|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139348550|NCT03067844|Alirocumab|alirocumab|mesh-list
139348551|NCT03067844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139348552|NCT03067844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139348553|NCT03067844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139348554|NCT03067844|Antimetabolites|antimetabolites|mesh-ancestor
139348555|NCT03067844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348556|NCT03067844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139348557|NCT03067844|Protease Inhibitors|protease inhibitors|mesh-ancestor
139348558|NCT03067844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348559|NCT03067844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139348560|NCT02340182|Metronidazole|metronidazole|mesh-list
139348561|NCT02340182|Vancomycin|vancomycin|mesh-list
139348562|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
139348563|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139348564|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139348565|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139348566|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139348567|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139348568|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139348569|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348570|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348571|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348572|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139348573|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139348574|NCT02339714|Loratadine|loratadine|mesh-list
139348575|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
139348576|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
139348577|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139348578|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139348579|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139348580|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
139348581|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
139348582|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348583|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348584|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348585|NCT02335190|Lidocaine|lidocaine|mesh-list
139348586|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
139348587|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
139348588|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348589|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348590|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
139348591|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348592|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139348593|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139348594|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139348595|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139348596|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348597|NCT02339324|Interferons|interferons|mesh-list
139348598|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
139348599|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
139348600|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
139348601|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139348602|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348603|NCT02339324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139348604|NCT02339324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348605|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
139348606|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139348607|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
139348608|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348609|NCT02418754|Aflibercept|aflibercept|mesh-list
139348610|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139348611|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139348612|NCT02418754|Growth Substances|growth substances|mesh-ancestor
139348613|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348614|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
139348615|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348616|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
139348617|NCT02334488|Everolimus|everolimus|mesh-list
139348618|NCT02334488|Tacrolimus|tacrolimus|mesh-list
139348619|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139348620|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
139348621|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348622|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139005440|NCT00807521|Hormones|hormones|mesh-ancestor
139348623|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348624|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348626|NCT02334488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139348627|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348628|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139348629|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139348630|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
139348631|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139348632|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139348633|NCT02862457|Paclitaxel|paclitaxel|mesh-list
139348634|NCT02862457|Cisplatin|cisplatin|mesh-list
139348635|NCT02862457|Carboplatin|carboplatin|mesh-list
139348636|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
139348637|NCT02862457|Pemetrexed|pemetrexed|mesh-list
139348638|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139348639|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348640|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
139348641|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
139348642|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
139348643|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348644|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139348645|NCT02862457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139348646|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348647|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139348648|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139348649|NCT02334254|Warfarin|warfarin|mesh-list
139348650|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
139348651|NCT02334254|Clopidogrel|clopidogrel|mesh-list
139348652|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139348653|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139348654|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139181311|NCT03595059|Paclitaxel|paclitaxel|mesh-list
139348655|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139348656|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
139348657|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348658|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348659|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348660|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
139348661|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139348662|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
139348663|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139348664|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
139348665|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348666|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
139348667|NCT02331602|Dabigatran|dabigatran|mesh-list
139348668|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139348669|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
139348670|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139348671|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
139348672|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348673|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348674|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
139348675|NCT02338934|Vitamin D|vitamin d|mesh-list
139348676|NCT02338934|Cinacalcet|cinacalcet|mesh-list
139348677|NCT02338934|Vitamins|vitamins|mesh-ancestor
139348678|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
139348679|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348680|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139348681|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139348682|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139348683|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
139348684|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348685|NCT03861039|Tirzepatide|tirzepatide|mesh-list
139348686|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139348687|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348688|NCT03861039|Incretins|incretins|mesh-ancestor
139348689|NCT03861039|Hormones|hormones|mesh-ancestor
139348690|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348691|NCT02334176|Lidocaine|lidocaine|mesh-list
139348692|NCT02334176|Epinephrine|epinephrine|mesh-list
139348693|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
139348694|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
139348695|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348696|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348697|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
139005513|NCT00813527|Fenofibrate|fenofibrate|mesh-list
139348698|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348699|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139348700|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139348701|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139348702|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139348703|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348704|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139348705|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139348706|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
139348707|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348708|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139348709|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139348710|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
139348711|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139348712|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
139348713|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
139348714|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
139348715|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139348716|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
139348717|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139348718|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139348719|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139348720|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348721|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348722|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
139348723|NCT03609307|Bevacizumab|bevacizumab|mesh-list
139348724|NCT03609307|Propranolol|propranolol|mesh-list
139348725|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139348726|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348727|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139348728|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139348729|NCT03609307|Growth Substances|growth substances|mesh-ancestor
139348730|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348731|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
139348732|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139348733|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139348734|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
139348735|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348736|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348737|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139348738|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139348739|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
139348740|NCT03399435|Epinephrine|epinephrine|mesh-list
139348741|NCT03399435|Racepinephrine|racepinephrine|mesh-list
139348742|NCT03399435|Bupivacaine|bupivacaine|mesh-list
139348743|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
139348744|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
139348745|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
139348746|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
139348747|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348748|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348749|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
139348750|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348751|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139348752|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139348753|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
139348754|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348755|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348756|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139348757|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139348758|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
139348759|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139348760|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
139348761|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
139348762|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
139348763|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139348764|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139348765|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139348766|NCT01936688|Etanercept|etanercept|mesh-list
139348767|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139348768|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139348769|NCT01936688|Analgesics|analgesics|mesh-ancestor
139348770|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
139348771|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005590|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
139348772|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348773|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139348774|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139348775|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139348776|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139348777|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
139348778|NCT02338544|Adapalene|adapalene|mesh-list
139348779|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139348780|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
139348781|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139348782|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139348783|NCT02338544|Analgesics|analgesics|mesh-ancestor
139348784|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
139348785|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348786|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348787|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139348788|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139348789|NCT04446663|Paclitaxel|paclitaxel|mesh-list
139348790|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139348791|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139348792|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348793|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
139348794|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
139348795|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
139181315|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
139348796|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348797|NCT01861496|Cisplatin|cisplatin|mesh-list
139348798|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348799|NCT02520219|Endostar protein|endostar protein|mesh-list
139348800|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139348801|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139348802|NCT02520219|Growth Substances|growth substances|mesh-ancestor
139348803|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348804|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
139348805|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348806|NCT03394287|Apatinib|apatinib|mesh-list
139348807|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348808|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139348809|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348810|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348811|NCT02338622|Olaparib|olaparib|mesh-list
139348812|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139348813|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348814|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348815|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348816|NCT02338466|Tenecteplase|tenecteplase|mesh-list
139348817|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139348818|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139348819|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348820|NCT03394209|Oseltamivir|oseltamivir|mesh-list
139348821|NCT03394209|Favipiravir|favipiravir|mesh-list
139348822|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
139348823|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139348824|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348825|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348826|NCT03399201|Anesthetics|anesthetics|mesh-list
139348827|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348828|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348829|NCT02520453|Durvalumab|durvalumab|mesh-list
139348830|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139348831|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348832|NCT03389763|Remifentanil|remifentanil|mesh-list
139348833|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139348834|NCT03389763|Narcotics|narcotics|mesh-ancestor
139348835|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348836|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348837|NCT03389763|Analgesics|analgesics|mesh-ancestor
139348838|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
139348839|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348840|NCT02866175|Vitamin K|vitamin k|mesh-list
139348841|NCT02866175|Edoxaban|edoxaban|mesh-list
139348842|NCT02866175|Clopidogrel|clopidogrel|mesh-list
139348843|NCT02866175|Ticagrelor|ticagrelor|mesh-list
139348844|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139348845|NCT02866175|Vitamins|vitamins|mesh-ancestor
139348846|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
139005669|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348847|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348848|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139348849|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139348850|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139348851|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139348852|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
139348853|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348854|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348855|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139348856|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139348857|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
139348858|NCT02866175|Coagulants|coagulants|mesh-ancestor
139348859|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138921474|NCT00468559|Esomeprazole|esomeprazole|mesh-list
139348860|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
139348861|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139348862|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
139348863|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348864|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
139348865|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
139181321|NCT03564678|Vitamins|vitamins|mesh-ancestor
139348866|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139348867|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
139348868|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348869|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
139348870|NCT02330822|Protective Agents|protective agents|mesh-ancestor
139348871|NCT02338310|Letrozole|letrozole|mesh-list
139348872|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139348873|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348874|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139348875|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348876|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348877|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139348878|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
139348879|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348880|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348881|NCT03389607|Anesthetics|anesthetics|mesh-list
139348882|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348883|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348884|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
139348885|NCT02817789|Clopidogrel|clopidogrel|mesh-list
139348886|NCT02817789|Ticagrelor|ticagrelor|mesh-list
139348887|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139348888|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139348889|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139348890|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139348891|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
139348892|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348893|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348894|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348895|NCT02817789|Analgesics|analgesics|mesh-ancestor
139348896|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
139348897|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348898|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139348899|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139348900|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139348901|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139348902|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139348903|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348904|NCT05383625|Vaccines|vaccines|mesh-list
139348905|NCT05383625|Immunologic Factors|immunologic factors|mesh-ancestor
139348906|NCT05383625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348907|NCT03389451|Edetic Acid|edetic acid|mesh-list
139348908|NCT03389451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139348909|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
139348910|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
139348911|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348912|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
139348913|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139348914|NCT03389451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139348915|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139348916|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139348917|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139348918|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
139348919|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139348920|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348921|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
139348922|NCT02330120|Propofol|propofol|mesh-list
139348923|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139348924|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139348925|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181333|NCT03263650|Prednisone|prednisone|mesh-list
139348926|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139348927|NCT02330120|Analgesics|analgesics|mesh-ancestor
139348928|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
139348929|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348930|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139348931|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139348932|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139348933|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
139348934|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139348935|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348936|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139348937|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
139348938|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
139348939|NCT03389295|Cisplatin|cisplatin|mesh-list
139348940|NCT03389295|Docetaxel|docetaxel|mesh-list
139348941|NCT03389295|Fluorouracil|fluorouracil|mesh-list
139348942|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348943|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
139348944|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
139348945|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
139348946|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139348947|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
139348948|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139348949|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139348950|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
139348951|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348952|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139348953|NCT03398811|Etonogestrel|etonogestrel|mesh-list
139348954|NCT03398811|Desogestrel|desogestrel|mesh-list
139348955|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
139348956|NCT03398811|Progesterone|progesterone|mesh-list
139348957|NCT03398811|Progestins|progestins|mesh-ancestor
139348958|NCT03398811|Hormones|hormones|mesh-ancestor
139348959|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348960|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348961|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139348962|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
139348963|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139348964|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139348965|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139348966|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139348967|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139348968|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139348969|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139348970|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348971|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
139348972|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139348973|NCT01300143|Estrogens|estrogens|mesh-ancestor
139348974|NCT01300143|Hormones|hormones|mesh-ancestor
139348975|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348976|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348977|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139348978|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348979|NCT01336205|Naloxegol|naloxegol|mesh-list
139348980|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139348981|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348982|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
139348983|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348984|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
139348985|NCT03610685|Prednisolone|prednisolone|mesh-list
139348986|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139348987|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
139348988|NCT03610685|Hormones|hormones|mesh-ancestor
139348989|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139348990|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139348991|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139348992|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139348993|NCT02327234|Ibuprofen|ibuprofen|mesh-list
139348994|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139348995|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139348997|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
139348998|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139348999|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349000|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139349001|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139349002|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139349003|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349004|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349005|NCT01123707|Aripiprazole|aripiprazole|mesh-list
139349006|NCT01123707|Escitalopram|escitalopram|mesh-list
139349007|NCT01123707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139349008|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139349009|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139349010|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349011|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349012|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
139349013|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349014|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
139349015|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139349016|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139349017|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139349018|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349019|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
139349020|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
139349021|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139349022|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139349023|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139349024|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139349025|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139349026|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139349027|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
139349028|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
139349029|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139349030|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
139349031|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349032|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349033|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139349034|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
139349035|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139349036|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139349037|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139349038|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
139349039|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921520|NCT00586508|Bevacizumab|bevacizumab|mesh-list
139349040|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349041|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139349042|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
139349043|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139349044|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
139349045|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139349046|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349047|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349048|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139349049|NCT02327156|Analgesics|analgesics|mesh-ancestor
139349050|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
139349051|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349052|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139349053|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139349054|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139349055|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
139349056|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349057|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349058|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139349059|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
139349060|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139349061|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
139349062|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349064|NCT02039804|Protective Agents|protective agents|mesh-ancestor
139349065|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139349066|NCT03385161|Ethanol|ethanol|mesh-list
139349067|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
139349068|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139349069|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139349070|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139349071|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139349072|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349074|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349075|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349076|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139349077|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349078|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349079|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139349080|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349081|NCT02327000|Pregabalin|pregabalin|mesh-list
139349082|NCT02327000|Analgesics|analgesics|mesh-ancestor
139349083|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
139349084|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349085|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349086|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
139349087|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139349088|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139349089|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349090|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139349091|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139349092|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139349093|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349094|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139349095|NCT02033603|Ropivacaine|ropivacaine|mesh-list
139349096|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
139349097|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
139349098|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349099|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349100|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
139349101|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349102|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
139349103|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139349104|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
139349105|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139349106|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349107|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139349108|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139349109|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139349110|NCT00862251|Atorvastatin|atorvastatin|mesh-list
139349111|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139349112|NCT00862251|Simvastatin|simvastatin|mesh-list
139349113|NCT00862251|Ezetimibe|ezetimibe|mesh-list
139349114|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139349115|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139349116|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
139349117|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349118|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139349119|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139349120|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349121|NCT00885963|Sapacitabine|sapacitabine|mesh-list
139349122|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349123|NCT00725127|Aspirin|aspirin|mesh-list
139349124|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139349125|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139349126|NCT00725127|Analgesics|analgesics|mesh-ancestor
139349127|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
139349128|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349129|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349130|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139349131|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139349132|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139349133|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139349134|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349135|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139349136|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139349137|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349138|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
139349139|NCT02328950|Cytarabine|cytarabine|mesh-list
139349140|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
139349141|NCT02328950|Busulfan|busulfan|mesh-list
139349142|NCT02328950|Fludarabine|fludarabine|mesh-list
139349143|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139349144|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
139349145|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349146|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139349147|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139349148|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
139349149|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349150|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349151|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139349152|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139349154|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
138921552|NCT00916760|Antacids|antacids|mesh-ancestor
139349155|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349156|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
139349157|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139349158|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349159|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139349160|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349161|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
139349162|NCT03389061|Velpatasvir|velpatasvir|mesh-list
139349163|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139349164|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
139349165|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349166|NCT02038868|Tamsulosin|tamsulosin|mesh-list
139349167|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139349168|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139349169|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139349170|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
139349171|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349172|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349173|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349174|NCT02038868|Urological Agents|urological agents|mesh-ancestor
139349175|NCT02328794|Varenicline|varenicline|mesh-list
139349176|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139349177|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139349178|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
139349179|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349180|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349181|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349182|NCT03388827|Misoprostol|misoprostol|mesh-list
139349183|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139349184|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
139349185|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139349186|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349187|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139349188|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139349189|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
139349190|NCT02328716|Cisplatin|cisplatin|mesh-list
139349191|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349192|NCT00445107|Montelukast|montelukast|mesh-list
139349193|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139349194|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
139349195|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139349196|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
139349197|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139349198|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349199|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139349200|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139349201|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349202|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
139349203|NCT05077592|Povidone|povidone|mesh-list
139349204|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
139349205|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
139349206|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139349207|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349208|NCT00038727|Metformin|metformin|mesh-list
138921567|NCT02599532|Apixaban|apixaban|mesh-list
139349209|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139349210|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349211|NCT02864381|Nivolumab|nivolumab|mesh-list
139349212|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139349213|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349214|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139349215|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349216|NCT05230472|Simvastatin|simvastatin|mesh-list
139006043|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
139349217|NCT05230472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139349218|NCT05230472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139349219|NCT05230472|Antimetabolites|antimetabolites|mesh-ancestor
139349220|NCT05230472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349221|NCT05230472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139349222|NCT05230472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139349223|NCT05230472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349224|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
139349225|NCT03398031|Antacids|antacids|mesh-ancestor
139349226|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349227|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139349228|NCT02039960|Bupropion|bupropion|mesh-list
139349229|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139349230|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
139349231|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139349232|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139349233|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139349234|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139349235|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349236|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
139349237|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349238|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349239|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139349240|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139349241|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349242|NCT05383313|Midazolam|midazolam|mesh-list
139349243|NCT05383313|Ketamine|ketamine|mesh-list
139349244|NCT05383313|Psilocybin|psilocybin|mesh-list
139349245|NCT05383313|Analgesics|analgesics|mesh-ancestor
139349246|NCT05383313|Sensory System Agents|sensory system agents|mesh-ancestor
139349247|NCT05383313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349248|NCT05383313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349249|NCT05383313|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139349250|NCT05383313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139349251|NCT05383313|Anesthetics, General|anesthetics, general|mesh-ancestor
139349252|NCT05383313|Anesthetics|anesthetics|mesh-ancestor
139349253|NCT05383313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349254|NCT05383313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139349255|NCT05383313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139349256|NCT05383313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349257|NCT05383313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349258|NCT05383313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139349259|NCT05383313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139349260|NCT05383313|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139349261|NCT05383313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139349262|NCT05383313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139349263|NCT05383313|GABA Modulators|gaba modulators|mesh-ancestor
139349264|NCT05383313|GABA Agents|gaba agents|mesh-ancestor
139349265|NCT05383313|Hallucinogens|hallucinogens|mesh-ancestor
139349266|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139349267|NCT03144128|Vitamin D|vitamin d|mesh-list
139349268|NCT03144128|Vitamins|vitamins|mesh-ancestor
139181362|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
139349269|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
139349270|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349271|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139349273|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139349274|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349275|NCT00409773|Atorvastatin|atorvastatin|mesh-list
139349276|NCT00409773|Simvastatin|simvastatin|mesh-list
139349277|NCT00409773|Ezetimibe|ezetimibe|mesh-list
139349278|NCT00409773|Calcium|calcium|mesh-list
139349279|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139349280|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349281|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139349282|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139349283|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
139349284|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349285|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139349286|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139349287|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349288|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139349289|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139349290|NCT02034422|Antioxidants|antioxidants|mesh-list
139349291|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349292|NCT02034422|Protective Agents|protective agents|mesh-ancestor
139349293|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349294|NCT02325986|Fluorouracil|fluorouracil|mesh-list
139349295|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349296|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
139349297|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349298|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139349299|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139349300|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
139349301|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349302|NCT00398151|Montelukast|montelukast|mesh-list
139349303|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139349304|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
139349305|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139349306|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
139349307|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139349308|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349309|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139349310|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139349311|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349312|NCT03610139|Vitamin D|vitamin d|mesh-list
139349313|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
139349314|NCT03610139|Vitamins|vitamins|mesh-ancestor
139349315|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
139349316|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349317|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139349318|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139349319|NCT02327624|Clopidogrel|clopidogrel|mesh-list
139349320|NCT02327624|Ticagrelor|ticagrelor|mesh-list
139349321|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139349322|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139349323|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139349324|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139349325|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
139349326|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349327|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349328|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349329|NCT03388671|Bupivacaine|bupivacaine|mesh-list
139349330|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
139349331|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
139349332|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349333|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349334|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
139349335|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349336|NCT02327936|Fesoterodine|fesoterodine|mesh-list
139349337|NCT02327936|Oxybutynin|oxybutynin|mesh-list
139349338|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139349339|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139349340|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
139349341|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349342|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349343|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349344|NCT02327936|Urological Agents|urological agents|mesh-ancestor
139349345|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
139349346|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
139349347|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349348|NCT03609827|Melphalan|melphalan|mesh-list
139349349|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139349350|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
139349351|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349352|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349353|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139349354|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139349355|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
139349356|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349357|NCT02858401|Vesatolimod|vesatolimod|mesh-list
139349358|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
139349359|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349360|NCT03144596|Tamsulosin|tamsulosin|mesh-list
139349361|NCT03144596|Alfuzosin|alfuzosin|mesh-list
139349362|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139349363|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139349364|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139349365|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
139349366|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349367|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349368|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349369|NCT03144596|Urological Agents|urological agents|mesh-ancestor
139349370|NCT00127647|Montelukast|montelukast|mesh-list
139349371|NCT00127647|Pranlukast|pranlukast|mesh-list
139349372|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139349373|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
139349374|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139349375|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
139349376|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139349377|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349378|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139349379|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139349380|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349381|NCT03111446|Anesthetics|anesthetics|mesh-list
139349382|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349383|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349384|NCT02034071|Diazoxide|diazoxide|mesh-list
139349385|NCT02034071|Choline|choline|mesh-list
139349386|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
139349387|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139349388|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
139349389|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349390|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139349391|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139349392|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
139349393|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138573620|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
139349394|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
139349395|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
139349396|NCT03609359|Lenvatinib|lenvatinib|mesh-list
139349397|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139349398|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349399|NCT03609359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139349400|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349401|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139349402|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349403|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139349404|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139349405|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139349406|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
139349407|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349408|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139349409|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139349410|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349411|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
139349412|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139349413|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139349414|NCT04822376|Ansuvimab|ansuvimab|mesh-list
139349415|NCT04822376|Antiviral Agents|antiviral agents|mesh-ancestor
139349416|NCT04822376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349417|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
139349418|NCT05173545|Analgesics|analgesics|mesh-ancestor
139349419|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
139349420|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349421|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349422|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349423|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139349424|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139349425|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349426|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349427|NCT05383183|Choline|choline|mesh-list
139349428|NCT05383183|Lipotropic Agents|lipotropic agents|mesh-ancestor
139349429|NCT05383183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139349430|NCT05383183|Antimetabolites|antimetabolites|mesh-ancestor
139349431|NCT05383183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349432|NCT05383183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139349433|NCT05383183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139349434|NCT05383183|Nootropic Agents|nootropic agents|mesh-ancestor
139349435|NCT02327702|Emtricitabine|emtricitabine|mesh-list
139349436|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
139006265|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139349437|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349438|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139349439|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139349440|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349441|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349442|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139349443|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139349444|NCT03609775|Ethanol|ethanol|mesh-list
139349445|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139349446|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349447|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349448|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349449|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
139349450|NCT03690765|Progestins|progestins|mesh-ancestor
139349451|NCT03690765|Hormones|hormones|mesh-ancestor
139349452|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139349453|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349454|NCT02033941|Phenol|phenol|mesh-list
139349455|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139349456|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349457|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
139349458|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139349459|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139349460|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
139349461|NCT03143972|Remifentanil|remifentanil|mesh-list
139349462|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139349463|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349464|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349465|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139349466|NCT03143972|Analgesics|analgesics|mesh-ancestor
139349467|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
139349468|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349469|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139349470|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139349471|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139349472|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
139349473|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349474|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349475|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139349476|NCT03143972|Narcotics|narcotics|mesh-ancestor
139349477|NCT02237027|Tenofovir|tenofovir|mesh-list
139349478|NCT02237027|Emtricitabine|emtricitabine|mesh-list
139349479|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139349480|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
139349481|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349482|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139349483|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139349484|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349485|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349486|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139349487|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139349488|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139349489|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139349490|NCT03143738|Anesthetics|anesthetics|mesh-list
139349491|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349492|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349493|NCT04393753|Avelumab|avelumab|mesh-list
139349494|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139349495|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349496|NCT04647903|Amphetamine|amphetamine|mesh-list
139349497|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
139349498|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139349499|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349500|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
139349501|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
139349502|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349503|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
139349504|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921641|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139349505|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349506|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
139349507|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139349508|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139349509|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139349510|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139349511|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139349512|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139349513|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139349514|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349515|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349516|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
139349517|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349518|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139349519|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139349520|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
139349521|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139349522|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349523|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139349524|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139349525|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349526|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349527|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139181391|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
139349528|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139349529|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139349530|NCT03380325|Iloprost|iloprost|mesh-list
139349531|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139349532|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
139349533|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139349534|NCT02237053|Octreotide|octreotide|mesh-list
139349535|NCT02237053|Glucagon|glucagon|mesh-list
139349536|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349537|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139349538|NCT02237053|Hormones|hormones|mesh-ancestor
139349539|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139349540|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139349541|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349542|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
139349543|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
139349544|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139349545|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139349546|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349547|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139349548|NCT04997174|Celecoxib|celecoxib|mesh-list
139349549|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139349550|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139349551|NCT04997174|Analgesics|analgesics|mesh-ancestor
139349552|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
139349553|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349554|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349555|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139349556|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139349557|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139349558|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139349559|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349560|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349561|NCT02237209|Vaccines|vaccines|mesh-list
139349562|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
139349563|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349564|NCT03387111|Leucovorin|leucovorin|mesh-list
139349565|NCT03387111|Paclitaxel|paclitaxel|mesh-list
139349566|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
139349567|NCT03387111|Bevacizumab|bevacizumab|mesh-list
139349568|NCT03387111|Capecitabine|capecitabine|mesh-list
139349569|NCT03387111|Fluorouracil|fluorouracil|mesh-list
139349570|NCT03387111|Cetuximab|cetuximab|mesh-list
139349571|NCT03387111|Avelumab|avelumab|mesh-list
139349572|NCT03387111|Necitumumab|necitumumab|mesh-list
139349573|NCT03387111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139349574|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349575|NCT03387111|Tubulin Modulators|tubulin modulators|mesh-ancestor
139349576|NCT03387111|Antimitotic Agents|antimitotic agents|mesh-ancestor
139349577|NCT03387111|Mitosis Modulators|mitosis modulators|mesh-ancestor
139349578|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349579|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139349580|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
139349581|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349582|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139349583|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139349584|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
139006428|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
139349585|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139349586|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139349587|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139349588|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139349589|NCT03387111|Growth Substances|growth substances|mesh-ancestor
139349590|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
139349591|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139349592|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
139349593|NCT03387111|Antidotes|antidotes|mesh-ancestor
139349594|NCT03387111|Protective Agents|protective agents|mesh-ancestor
139349595|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
139349596|NCT03387111|Vitamins|vitamins|mesh-ancestor
139349597|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
139349598|NCT03608293|Dimercaprol|dimercaprol|mesh-list
139349599|NCT03608293|Chelating Agents|chelating agents|mesh-ancestor
139349600|NCT03608293|Sequestering Agents|sequestering agents|mesh-ancestor
139349601|NCT03608293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349603|NCT03608501|Dexamethasone|dexamethasone|mesh-list
139349604|NCT03608501|Ixazomib|ixazomib|mesh-list
139349605|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139349606|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
139349607|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
139349608|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349609|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349610|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139349611|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
139349612|NCT03608501|Hormones|hormones|mesh-ancestor
139349613|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139349614|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139349615|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349616|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349617|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139349618|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
139349619|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
139349620|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139349621|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349622|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139349623|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139349624|NCT03608501|Growth Substances|growth substances|mesh-ancestor
139349625|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
139349626|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
139349627|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349628|NCT03608761|Rebamipide|rebamipide|mesh-list
139349629|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139349630|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139349631|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
139349632|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349633|NCT03608761|Protective Agents|protective agents|mesh-ancestor
139349634|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349635|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349636|NCT04554836|Cetuximab|cetuximab|mesh-list
139349637|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139349638|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349639|NCT04536272|Heparin|heparin|mesh-list
139349640|NCT04536272|Calcium heparin|calcium heparin|mesh-list
139349641|NCT04536272|Enoxaparin|enoxaparin|mesh-list
139349642|NCT04536272|Nadroparin|nadroparin|mesh-list
139349643|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
139349644|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139349645|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139349646|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349647|NCT02731131|Ribavirin|ribavirin|mesh-list
139349648|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139349649|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
139349650|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349651|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
139349652|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349653|NCT04585724|Palbociclib|palbociclib|mesh-list
139349654|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349655|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139349656|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349657|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349658|NCT02237261|Prednisone|prednisone|mesh-list
139349659|NCT02237261|Bortezomib|bortezomib|mesh-list
139349660|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139349661|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139349662|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
139349663|NCT02237261|Hormones|hormones|mesh-ancestor
139349664|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139349665|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921700|NCT00753896|Exenatide|exenatide|mesh-list
139349666|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139349667|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349668|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139349669|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
139349670|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349672|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139349673|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
139349674|NCT03386643|Hormones|hormones|mesh-ancestor
139349675|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139349676|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349677|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
139349678|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139349679|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349680|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349681|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139349682|NCT05171985|Analgesics|analgesics|mesh-ancestor
139349683|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
139349684|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349685|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139349686|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139349687|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139349688|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
139349689|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349690|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349691|NCT02237365|Aspirin|aspirin|mesh-list
139349692|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139349693|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139349694|NCT02237365|Analgesics|analgesics|mesh-ancestor
139349695|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
139349696|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349697|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349698|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139349699|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139349700|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139349701|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139349702|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349703|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139349704|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139349705|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349706|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
139349707|NCT03383367|TEMPO|tempo|mesh-list
139349708|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
139349709|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349710|NCT03383367|Protective Agents|protective agents|mesh-ancestor
139349711|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349712|NCT02856113|Alogliptin|alogliptin|mesh-list
139349713|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139349714|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349715|NCT02856113|Incretins|incretins|mesh-ancestor
139349716|NCT02856113|Hormones|hormones|mesh-ancestor
139349717|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139349718|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139349719|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
139349720|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349721|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349722|NCT03386565|Lidocaine|lidocaine|mesh-list
139349723|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139349724|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
139349725|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
139349726|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349727|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349728|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
139349729|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349730|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139349731|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139349732|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139349733|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139349734|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349735|NCT02237339|Allopurinol|allopurinol|mesh-list
139349736|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
139349737|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349738|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349739|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
139349740|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139349741|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139349743|NCT02237339|Protective Agents|protective agents|mesh-ancestor
139349744|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349745|NCT05171751|Octreotide|octreotide|mesh-list
139349746|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139349747|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139349748|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349749|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
139349750|NCT03971084|Caseins|caseins|mesh-list
139349751|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139349752|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
139349753|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349754|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349755|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349756|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
139349757|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
139349758|NCT03379779|Dimercaprol|dimercaprol|mesh-list
139349759|NCT03379779|Chelating Agents|chelating agents|mesh-ancestor
138921738|NCT01760655|Tacrolimus|tacrolimus|mesh-list
139349760|NCT03379779|Sequestering Agents|sequestering agents|mesh-ancestor
139349761|NCT03379779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349762|NCT04083014|Bortezomib|bortezomib|mesh-list
139349763|NCT04083014|Antibodies|antibodies|mesh-list
139349764|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
139349765|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349766|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349767|NCT03563066|Benralizumab|benralizumab|mesh-list
139349768|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139349769|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
139349770|NCT03140384|Misoprostol|misoprostol|mesh-list
139349771|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139349772|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
139349773|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139349774|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349775|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139349776|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139349777|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
139349778|NCT05117307|Bupivacaine|bupivacaine|mesh-list
139349779|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
139349780|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
139349781|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349782|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349783|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
139349784|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349785|NCT03739268|Sevelamer|sevelamer|mesh-list
139349786|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
139349787|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
139349788|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349789|NCT02787590|Simvastatin|simvastatin|mesh-list
139349790|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139349791|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139349792|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
139349793|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349794|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139349795|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139349796|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349797|NCT03382743|Lidocaine|lidocaine|mesh-list
139349798|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
139349799|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
139349800|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349801|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349802|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
139349803|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349804|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139349805|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139349806|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139349807|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139349808|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349809|NCT02854631|Prednisolone|prednisolone|mesh-list
139349810|NCT02854631|Selonsertib|selonsertib|mesh-list
139349811|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139349812|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
139349814|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139349815|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349816|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139349817|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349818|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139349819|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349820|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349821|NCT03607643|Leucovorin|leucovorin|mesh-list
139349822|NCT03607643|Bevacizumab|bevacizumab|mesh-list
139349823|NCT03607643|Gemcitabine|gemcitabine|mesh-list
139349824|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
139349825|NCT03607643|Irinotecan|irinotecan|mesh-list
139349826|NCT03607643|Temozolomide|temozolomide|mesh-list
139349827|NCT03607643|Bortezomib|bortezomib|mesh-list
139349828|NCT03607643|Cannabidiol|cannabidiol|mesh-list
139349829|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139349830|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349831|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139349832|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139349833|NCT03607643|Growth Substances|growth substances|mesh-ancestor
139349834|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349835|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
139349836|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139349837|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
139349838|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349839|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139349840|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139349841|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349842|NCT03607643|Antidotes|antidotes|mesh-ancestor
139349843|NCT03607643|Protective Agents|protective agents|mesh-ancestor
139349844|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
139349845|NCT03607643|Vitamins|vitamins|mesh-ancestor
139349846|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
139349847|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139349848|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
139349849|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
139349850|NCT02855359|Prednisone|prednisone|mesh-list
139349851|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
139349852|NCT02855359|Rituximab|rituximab|mesh-list
139349853|NCT02855359|Doxorubicin|doxorubicin|mesh-list
139349854|NCT02855359|Vincristine|vincristine|mesh-list
139349855|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139349856|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
139349857|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349858|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139349859|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139349860|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
139349861|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349862|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349863|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139349864|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139349865|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139349866|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139349867|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139349868|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349869|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139349870|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
139349871|NCT02855359|Hormones|hormones|mesh-ancestor
139349872|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139349873|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139349874|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139349875|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
139349876|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
139349877|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
139349878|NCT05084456|Docetaxel|docetaxel|mesh-list
139349879|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139349880|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
139349881|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
139349882|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
139349883|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349884|NCT03607903|Adalimumab|adalimumab|mesh-list
139349885|NCT03607903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139349886|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139349887|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139349888|NCT04438850|Ivermectin|ivermectin|mesh-list
139349889|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139349890|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349891|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139349892|NCT03385863|Poractant alfa|poractant alfa|mesh-list
139349893|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
139349894|NCT03382431|PC-786|pc-786|mesh-list
139349895|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
139349896|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139349897|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349898|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349899|NCT03141632|Dulaglutide|dulaglutide|mesh-list
139349900|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139349901|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349902|NCT04282239|Lidocaine|lidocaine|mesh-list
139349903|NCT04282239|Epinephrine|epinephrine|mesh-list
139349904|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
139349905|NCT04282239|Ropivacaine|ropivacaine|mesh-list
139349906|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
139349907|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
139349908|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139349909|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349910|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
139349911|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349912|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139349913|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139349914|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139349915|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139349916|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349917|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139349918|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139349919|NCT04282239|Analgesics|analgesics|mesh-ancestor
139349920|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139349921|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139349922|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139349923|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
139349924|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349925|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139349926|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139349927|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
139349928|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139349929|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
139349930|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
139349931|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
139349932|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139349933|NCT03605173|Vitamin D|vitamin d|mesh-list
139349934|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
139349935|NCT03605173|Cholecalciferol|cholecalciferol|mesh-list
139349936|NCT03605173|Vitamins|vitamins|mesh-list
139349937|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
139349938|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349939|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139349940|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139349941|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
139349942|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
139349943|NCT03382275|Iron|iron|mesh-list
139349944|NCT03382275|Ferric maltol|ferric maltol|mesh-list
139349945|NCT03382275|Trace Elements|trace elements|mesh-ancestor
139349946|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
139349947|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349948|NCT03382275|Hematinics|hematinics|mesh-ancestor
139349949|NCT05080478|Clopidogrel|clopidogrel|mesh-list
139349950|NCT05080478|Ticagrelor|ticagrelor|mesh-list
139349951|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139349952|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139349953|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139349954|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139349955|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
139349956|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349957|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349958|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349959|NCT05082974|Varenicline|varenicline|mesh-list
139349960|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139349961|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139349962|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
139006801|NCT01026129|Lidocaine|lidocaine|mesh-list
139349963|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349964|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349965|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349967|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139349968|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139349969|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
139349970|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349971|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139349972|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139349973|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139349974|NCT02237443|Bromides|bromides|mesh-list
139349975|NCT02237443|Rocuronium|rocuronium|mesh-list
139349976|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
139349977|NCT02237443|Succinylcholine|succinylcholine|mesh-list
139349978|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
139349979|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139349980|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139349981|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139349982|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139349983|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139349984|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139349985|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139349986|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139349987|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
139349988|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139349989|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139349990|NCT03141398|Pancrelipase|pancrelipase|mesh-list
139349991|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139349992|NCT03733418|Vitamin D|vitamin d|mesh-list
139349993|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
139349994|NCT03733418|Vitamins|vitamins|mesh-ancestor
139349995|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
139349996|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921823|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
139349997|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139349998|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139349999|NCT03607331|Citalopram|citalopram|mesh-list
139350000|NCT03607331|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139350001|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139350002|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350003|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350004|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350005|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
139350006|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350007|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139350008|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
139350009|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139350010|NCT05082896|Anesthetics|anesthetics|mesh-list
139350011|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350012|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350013|NCT03607955|Paclitaxel|paclitaxel|mesh-list
139350014|NCT03607955|Carboplatin|carboplatin|mesh-list
139350015|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139350016|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350017|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
139350018|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
139350019|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
139350020|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350021|NCT02067975|Tryptophan|tryptophan|mesh-list
139350022|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139350023|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
139350024|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139350025|NCT03143036|Thalidomide|thalidomide|mesh-list
139350026|NCT03143036|Dexamethasone|dexamethasone|mesh-list
139350027|NCT03143036|Daratumumab|daratumumab|mesh-list
139350028|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139350029|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
139350030|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
139350031|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350032|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350033|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139350034|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
139350035|NCT03143036|Hormones|hormones|mesh-ancestor
139350036|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139350037|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139350038|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350039|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139350041|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
139350042|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139350043|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139350044|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139350045|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139350046|NCT03143036|Growth Substances|growth substances|mesh-ancestor
139350047|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
139350048|NCT05080010|Carboplatin|carboplatin|mesh-list
139350049|NCT05080010|Etoposide|etoposide|mesh-list
139350050|NCT05080010|Vincristine|vincristine|mesh-list
139350051|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350052|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139350053|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139350054|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139350055|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350056|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350057|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
139350058|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
139350059|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
139350060|NCT03385551|Estradiol|estradiol|mesh-list
139350061|NCT03385551|Estrogens|estrogens|mesh-ancestor
139350062|NCT03385551|Hormones|hormones|mesh-ancestor
139350063|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139350064|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350065|NCT03606473|Amphetamine|amphetamine|mesh-list
139350066|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
139350067|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139350068|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350069|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
139350070|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
139350071|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350072|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
139350073|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350074|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350075|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
139350076|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139350077|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139350078|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350079|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139350080|NCT03316274|Nivolumab|nivolumab|mesh-list
139350081|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139350082|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350083|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139350084|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350086|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139350087|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
139350088|NCT03252626|Urological Agents|urological agents|mesh-ancestor
139350089|NCT05072054|Atorvastatin|atorvastatin|mesh-list
139350090|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139350091|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139350092|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139350093|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
139350094|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350095|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139350096|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139350097|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350098|NCT03142880|Ropivacaine|ropivacaine|mesh-list
139350099|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
139350100|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
139350101|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350102|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350103|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
139350104|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350105|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
139350106|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139350107|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
139350108|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139350109|NCT03381495|Sufentanil|sufentanil|mesh-list
139350110|NCT03381495|Ropivacaine|ropivacaine|mesh-list
139350111|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
139350112|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
139350113|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350114|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350115|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
139350116|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350117|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139350118|NCT03381495|Narcotics|narcotics|mesh-ancestor
139350119|NCT03381495|Analgesics|analgesics|mesh-ancestor
139350120|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139350121|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139350122|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
139350123|NCT03059498|Bupivacaine|bupivacaine|mesh-list
139350124|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
139350125|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
139350126|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350127|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350128|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
139350129|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350130|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
139350131|NCT03142646|Fludarabine|fludarabine|mesh-list
139350132|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139350133|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
139350134|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350135|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139350136|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139350137|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
139350138|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350139|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350140|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139350141|NCT03541083|Blinatumomab|blinatumomab|mesh-list
139350142|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350143|NCT03602027|Gefitinib|gefitinib|mesh-list
139350144|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350145|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139350146|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350147|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350148|NCT03141476|Cefuroxime|cefuroxime|mesh-list
139350149|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
139350150|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139350151|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139350152|NCT03601871|Thalidomide|thalidomide|mesh-list
139350153|NCT03601871|Dexamethasone|dexamethasone|mesh-list
139350154|NCT03601871|Palonosetron|palonosetron|mesh-list
139350155|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
139350156|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139350157|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
139350158|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
139350159|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350160|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350161|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139350162|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
139350163|NCT03601871|Hormones|hormones|mesh-ancestor
139350164|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139350165|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139350166|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350167|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139350168|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
139350169|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
139350170|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139350171|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139350172|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139350173|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139350174|NCT03601871|Growth Substances|growth substances|mesh-ancestor
139350175|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
139350176|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139350177|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
139350178|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350179|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350180|NCT03380949|Remifentanil|remifentanil|mesh-list
139350181|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
139350182|NCT03380949|Narcotics|narcotics|mesh-ancestor
139350183|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350184|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350185|NCT03380949|Analgesics|analgesics|mesh-ancestor
139350186|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
139350187|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350188|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139350189|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139007030|NCT00815399|Metformin|metformin|mesh-list
139350190|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350191|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139350192|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139350193|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
139350194|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350195|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350196|NCT05078372|Midazolam|midazolam|mesh-list
139350197|NCT05078372|Ropivacaine|ropivacaine|mesh-list
139350198|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
139350199|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
139350200|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350201|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350202|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
139350203|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350204|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139350205|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139350206|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139350207|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139350208|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139350209|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139350210|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
139350211|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
139350212|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
139350213|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350214|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350215|NCT03380871|Carboplatin|carboplatin|mesh-list
139350216|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
139350217|NCT03380871|Pemetrexed|pemetrexed|mesh-list
139350218|NCT03380871|Poly ICLC|poly iclc|mesh-list
139350219|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350220|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139350221|NCT03380871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139350222|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350223|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350224|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139350225|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139350226|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
139350227|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
139350228|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350229|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
139350230|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139350231|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350232|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350233|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139350235|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
139350236|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350237|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139350238|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139350239|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139350240|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
139350241|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350242|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350243|NCT02486666|Enoxaparin|enoxaparin|mesh-list
139350244|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
139350245|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
139350246|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139350247|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139350248|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350249|NCT02237807|Dirithromycin|dirithromycin|mesh-list
139350250|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139350251|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139350252|NCT03125187|Heparin|heparin|mesh-list
139350253|NCT03125187|Calcium heparin|calcium heparin|mesh-list
139350254|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
139350255|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139350256|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139350257|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350258|NCT02038946|Nivolumab|nivolumab|mesh-list
139350259|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139350260|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350261|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139350262|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350263|NCT03377907|Lidocaine|lidocaine|mesh-list
139007107|NCT00647699|Riboflavin|riboflavin|mesh-list
139350264|NCT03377907|Ketamine|ketamine|mesh-list
139350265|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
139350266|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
139350267|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350268|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350269|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
139350270|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350271|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139350272|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139350273|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139350274|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350275|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350276|NCT03377907|Analgesics|analgesics|mesh-ancestor
139350277|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139350278|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139350279|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
139350280|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139350281|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139350282|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350283|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
139350284|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
139350285|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139350286|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139350287|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
139350288|NCT03369795|Methotrexate|methotrexate|mesh-list
139350289|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139350290|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
139350291|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139350292|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350293|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139350295|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350296|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350297|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
139350298|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350299|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139350300|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139350301|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
139350302|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139350303|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139350304|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
139350305|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
139350306|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139350307|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139350308|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350309|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350310|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139350311|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139350312|NCT05393414|Acetaminophen|acetaminophen|mesh-list
139350313|NCT05393414|Ketorolac|ketorolac|mesh-list
139350314|NCT05393414|Morphine|morphine|mesh-list
139350315|NCT05393414|Analgesics, Opioid|analgesics, opioid|mesh-list
139350316|NCT05393414|Narcotics|narcotics|mesh-ancestor
139350317|NCT05393414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350318|NCT05393414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350319|NCT05393414|Analgesics|analgesics|mesh-ancestor
139350320|NCT05393414|Sensory System Agents|sensory system agents|mesh-ancestor
139350321|NCT05393414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350322|NCT05393414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139350323|NCT05393414|Antipyretics|antipyretics|mesh-ancestor
139350324|NCT05393414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139350325|NCT05393414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139350326|NCT05393414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139350327|NCT05393414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139350328|NCT05393414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350329|NCT05393414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350330|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
139350331|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
139350332|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139350333|NCT02034500|Vaccines|vaccines|mesh-list
139350334|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
139350335|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350336|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139350337|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
139350338|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
139350339|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350340|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139350341|NCT03955640|Olaparib|olaparib|mesh-list
139350342|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139350343|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350344|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350345|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350346|NCT03369093|Amoxicillin|amoxicillin|mesh-list
139350347|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139350348|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139350349|NCT03369015|Amphetamine|amphetamine|mesh-list
139350350|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
139350351|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139350352|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350353|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
139350354|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
139350355|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350356|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
139350357|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350358|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350359|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
139350360|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139350361|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139350362|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350363|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139350364|NCT03890744|Docetaxel|docetaxel|mesh-list
139350365|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350366|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
139350367|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
139350368|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
139350369|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350370|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139350371|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139350372|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139350373|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139350374|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139350375|NCT03374007|Antibodies|antibodies|mesh-list
139350376|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
139350377|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139350378|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
139350379|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350380|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350381|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
139350382|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139350383|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139350384|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
139350385|NCT05392166|Calcium|calcium|mesh-list
139350386|NCT05392166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139350387|NCT05392166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350388|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
139350389|NCT02853331|Sunitinib|sunitinib|mesh-list
139350390|NCT02853331|Axitinib|axitinib|mesh-list
139350391|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139350392|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350393|NCT02853331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139350394|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350395|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139350396|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139350397|NCT02853331|Growth Substances|growth substances|mesh-ancestor
139350398|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350399|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
139350400|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139350401|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350402|NCT03136640|Docetaxel|docetaxel|mesh-list
139350403|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350404|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
139350405|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
139350406|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
139350407|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350408|NCT02675439|Ipilimumab|ipilimumab|mesh-list
139350409|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139350410|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350411|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139350412|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350414|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139350415|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139350416|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139350417|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139350418|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350419|NCT03368391|Lidocaine|lidocaine|mesh-list
139350420|NCT03368391|Phenylephrine|phenylephrine|mesh-list
139350421|NCT03368391|Epinephrine|epinephrine|mesh-list
139350422|NCT03368391|Racepinephrine|racepinephrine|mesh-list
139350423|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
139350424|NCT03368391|Tetracaine|tetracaine|mesh-list
139350425|NCT03368391|Mepivacaine|mepivacaine|mesh-list
139350426|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
139350427|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
139350428|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
138921923|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
139350429|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350430|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350431|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
139350432|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350433|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139350434|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139350435|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139350436|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350437|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350438|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139350439|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139350440|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
139350441|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350442|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139350443|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139350445|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139350446|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
139350447|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
139350448|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
139350449|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139350450|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
139350451|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139350452|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139350453|NCT03368391|Protective Agents|protective agents|mesh-ancestor
139350454|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139350455|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139350456|NCT03373305|Lenalidomide|lenalidomide|mesh-list
139350457|NCT03373305|Piperidine|piperidine|mesh-list
139350458|NCT03373305|Antibodies|antibodies|mesh-list
139350459|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
139350460|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139350461|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
139350462|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
139350463|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350464|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350465|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139350466|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139350467|NCT03373305|Growth Substances|growth substances|mesh-ancestor
139350468|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
139350469|NCT03373305|Immunotoxins|immunotoxins|mesh-ancestor
139350470|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139350471|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350472|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350473|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139350474|NCT03376737|Pemetrexed|pemetrexed|mesh-list
139350475|NCT03376737|Apatinib|apatinib|mesh-list
139350476|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350477|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350478|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350479|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139350480|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139350481|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139350482|NCT03373227|Tacrolimus|tacrolimus|mesh-list
139350483|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139007328|NCT00447603|Losartan|losartan|mesh-list
139350484|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
139350485|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350486|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139350487|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350488|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350489|NCT02484716|Timolol|timolol|mesh-list
139350490|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139350491|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139350492|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
139350493|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350494|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350495|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350496|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139350497|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139350498|NCT03373149|Hormones|hormones|mesh-list
139350499|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139350500|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139350501|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350502|NCT05386784|Cholecalciferol|cholecalciferol|mesh-list
139350503|NCT05386784|Vitamin D|vitamin d|mesh-list
139350504|NCT05386784|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139350505|NCT05386784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139350506|NCT05386784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350507|NCT05386784|Vitamins|vitamins|mesh-ancestor
139350508|NCT05386784|Micronutrients|micronutrients|mesh-ancestor
139350509|NCT05386784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139350510|NCT05386784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139350511|NCT05386784|Hormone Antagonists|hormone antagonists|mesh-ancestor
139350512|NCT05386784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139350513|NCT05386784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139350514|NCT05386784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139350515|NCT03602287|Lidocaine|lidocaine|mesh-list
139350516|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
139350517|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
139350518|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350519|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350520|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
139350521|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350522|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139350523|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139350524|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139350525|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350526|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350527|NCT03137498|Ketorolac|ketorolac|mesh-list
139350528|NCT03137498|Lidocaine|lidocaine|mesh-list
139350529|NCT03137498|Prilocaine|prilocaine|mesh-list
139350530|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
139350531|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
139350532|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350533|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350534|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
139350535|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350536|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139350537|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139350538|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139350539|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350540|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350541|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139350542|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139350543|NCT03137498|Analgesics|analgesics|mesh-ancestor
139350544|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139350545|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139350546|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139350547|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350548|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139350549|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139350550|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
139350551|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139350552|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350553|NCT03602131|Gemcitabine|gemcitabine|mesh-list
139350554|NCT03602131|Busulfan|busulfan|mesh-list
139350555|NCT03602131|Cladribine|cladribine|mesh-list
139350556|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139350557|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
139350558|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350559|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350560|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
139350561|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139350562|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
139350563|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350564|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139350565|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139350566|NCT05851391|Anesthetics|anesthetics|mesh-list
139350567|NCT05851391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350568|NCT05851391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350569|NCT05851352|Antibodies|antibodies|mesh-list
139350570|NCT05851352|Immunologic Factors|immunologic factors|mesh-ancestor
139350571|NCT05851352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350572|NCT05851014|Letrozole|letrozole|mesh-list
139350573|NCT05851014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350574|NCT05851014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139350575|NCT05851014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139350576|NCT05851014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350577|NCT05851014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350578|NCT05851014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139350579|NCT05851014|Hormone Antagonists|hormone antagonists|mesh-ancestor
139350580|NCT05851014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139350581|NCT05851014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350582|NCT05850936|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139350583|NCT05850936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139350584|NCT05850871|Aztreonam|aztreonam|mesh-list
139350585|NCT05850871|Avibactam|avibactam|mesh-list
139350586|NCT05850871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139350587|NCT05850871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139350588|NCT05850871|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139350589|NCT05850871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350590|NCT05850871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350591|NCT05850832|Magnesium Sulfate|magnesium sulfate|mesh-list
139350592|NCT05850832|Esmolol|esmolol|mesh-list
139350593|NCT05850832|Analgesics|analgesics|mesh-ancestor
139350594|NCT05850832|Sensory System Agents|sensory system agents|mesh-ancestor
139350595|NCT05850832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350596|NCT05850832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350597|NCT05850832|Anesthetics|anesthetics|mesh-ancestor
139350598|NCT05850832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350599|NCT05850832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139350600|NCT05850832|Anticonvulsants|anticonvulsants|mesh-ancestor
139350601|NCT05850832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139350602|NCT05850832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350603|NCT05850832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350604|NCT05850832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139350605|NCT05850832|Tocolytic Agents|tocolytic agents|mesh-ancestor
139350606|NCT05850832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139350607|NCT05850832|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139350608|NCT05850832|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139350609|NCT05850832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139350610|NCT05850832|Adrenergic Agents|adrenergic agents|mesh-ancestor
139350611|NCT05850832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350612|NCT05850702|Lidocaine|lidocaine|mesh-list
139350613|NCT05850702|Anesthetics, Local|anesthetics, local|mesh-ancestor
139350614|NCT05850702|Anesthetics|anesthetics|mesh-ancestor
139350615|NCT05850702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350616|NCT05850702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350617|NCT05850702|Sensory System Agents|sensory system agents|mesh-ancestor
139350618|NCT05850702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350619|NCT05850702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139350620|NCT05850702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139350621|NCT05850702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139350622|NCT05850702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350623|NCT05850702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350624|NCT05850559|Mitogens|mitogens|mesh-list
139350625|NCT05850559|Mitosis Modulators|mitosis modulators|mesh-ancestor
139350626|NCT05850559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350627|NCT05850507|Vaccines|vaccines|mesh-list
139350628|NCT05850507|Immunologic Factors|immunologic factors|mesh-ancestor
139350629|NCT05850507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350630|NCT05850468|Lidocaine|lidocaine|mesh-list
139350631|NCT05850468|Fentanyl|fentanyl|mesh-list
139350632|NCT05850468|Anesthetics|anesthetics|mesh-list
139350633|NCT05850468|Anesthetics, Local|anesthetics, local|mesh-ancestor
139350634|NCT05850468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350635|NCT05850468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350636|NCT05850468|Sensory System Agents|sensory system agents|mesh-ancestor
139350637|NCT05850468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350638|NCT05850468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139350639|NCT05850468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139350640|NCT05850468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139350641|NCT05850468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350642|NCT05850468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350643|NCT05850468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139350644|NCT05850468|Narcotics|narcotics|mesh-ancestor
139350645|NCT05850468|Analgesics|analgesics|mesh-ancestor
139350646|NCT05850468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139350647|NCT05850468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139350648|NCT05850468|Anesthetics, General|anesthetics, general|mesh-ancestor
139350649|NCT05850377|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139350650|NCT05850377|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139350651|NCT05850377|Dermatologic Agents|dermatologic agents|mesh-ancestor
139350652|NCT06042426|Acetaminophen|acetaminophen|mesh-list
139350653|NCT06042426|Dexamethasone|dexamethasone|mesh-list
139350655|NCT06042426|Oxycodone|oxycodone|mesh-list
139350656|NCT06042426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139350657|NCT06042426|Antiemetics|antiemetics|mesh-ancestor
139350658|NCT06042426|Autonomic Agents|autonomic agents|mesh-ancestor
139350659|NCT06042426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350660|NCT06042426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350661|NCT06042426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139350662|NCT06042426|Glucocorticoids|glucocorticoids|mesh-ancestor
139350663|NCT06042426|Hormones|hormones|mesh-ancestor
139350664|NCT06042426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139350665|NCT06042426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139350666|NCT06042426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350667|NCT06042426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139350668|NCT06042426|Narcotics|narcotics|mesh-ancestor
139350669|NCT06042426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350670|NCT06042426|Analgesics|analgesics|mesh-ancestor
139350671|NCT06042426|Sensory System Agents|sensory system agents|mesh-ancestor
139350672|NCT06042426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139350673|NCT06042426|Antipyretics|antipyretics|mesh-ancestor
139350674|NCT06042309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139350675|NCT06042010|Triamcinolone|triamcinolone|mesh-list
139350676|NCT06042010|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139350677|NCT06042010|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139350678|NCT06042010|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139350679|NCT06042010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139350680|NCT06042010|Glucocorticoids|glucocorticoids|mesh-ancestor
139350681|NCT06042010|Hormones|hormones|mesh-ancestor
139350682|NCT06042010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139350683|NCT06042010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350684|NCT06042010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139350685|NCT06042010|Immunologic Factors|immunologic factors|mesh-ancestor
139350686|NCT06042010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350687|NCT06042010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350688|NCT06041984|Glycopyrrolate|glycopyrrolate|mesh-list
139350689|NCT06041984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139350690|NCT06041984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139350691|NCT06041984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139350692|NCT06041984|Cholinergic Agents|cholinergic agents|mesh-ancestor
139350693|NCT06041984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350694|NCT06041984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350695|NCT06041984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350696|NCT06041750|Anesthetics|anesthetics|mesh-list
139350697|NCT06041750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350698|NCT06041750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350699|NCT06041724|Endostatins|endostatins|mesh-list
139350700|NCT06041724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350701|NCT06041724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139350702|NCT06041724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139350703|NCT06041724|Growth Substances|growth substances|mesh-ancestor
139181492|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
139350704|NCT06041724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350705|NCT06041724|Growth Inhibitors|growth inhibitors|mesh-ancestor
139350707|NCT06041711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350708|NCT06041711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350709|NCT06041529|Amlodipine|amlodipine|mesh-list
139007550|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
139350711|NCT06041529|Telmisartan|telmisartan|mesh-list
139350712|NCT06041529|Chlorthalidone|chlorthalidone|mesh-list
139350713|NCT06041529|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139350714|NCT06041529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139350715|NCT06041529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139350716|NCT06041529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350717|NCT06041529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350718|NCT06041529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139350719|NCT06041529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350720|NCT06041529|Vasodilator Agents|vasodilator agents|mesh-ancestor
139350721|NCT06041529|Diuretics|diuretics|mesh-ancestor
139350722|NCT06041529|Natriuretic Agents|natriuretic agents|mesh-ancestor
139350723|NCT06041529|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139350724|NCT06041529|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139350725|NCT06041529|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139350726|NCT06041490|Bevacizumab|bevacizumab|mesh-list
139350727|NCT06041490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139350728|NCT06041490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350729|NCT06041490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139350730|NCT06041490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139350731|NCT06041490|Growth Substances|growth substances|mesh-ancestor
139350732|NCT06041490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350733|NCT06041490|Growth Inhibitors|growth inhibitors|mesh-ancestor
139350734|NCT06041477|Leucovorin|leucovorin|mesh-list
139350735|NCT06041477|Folic Acid|folic acid|mesh-list
139350736|NCT06041477|Oxaliplatin|oxaliplatin|mesh-list
139350737|NCT06041477|Lenvatinib|lenvatinib|mesh-list
139350738|NCT06041477|Antibodies|antibodies|mesh-list
139350739|NCT06041477|Immunoglobulins|immunoglobulins|mesh-list
139350740|NCT06041477|Immunologic Factors|immunologic factors|mesh-list
139350741|NCT06041477|Immunomodulating Agents|immunomodulating agents|mesh-list
139350742|NCT06041477|Levoleucovorin|levoleucovorin|mesh-list
139350743|NCT06041477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350744|NCT06041477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350745|NCT06041477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139350746|NCT06041477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350747|NCT06041477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350748|NCT06041477|Antidotes|antidotes|mesh-ancestor
139350749|NCT06041477|Protective Agents|protective agents|mesh-ancestor
139350750|NCT06041477|Vitamin B Complex|vitamin b complex|mesh-ancestor
139350751|NCT06041477|Vitamins|vitamins|mesh-ancestor
139350752|NCT06041477|Micronutrients|micronutrients|mesh-ancestor
139350753|NCT06041477|Hematinics|hematinics|mesh-ancestor
139350754|NCT06041451|Methylprednisolone|methylprednisolone|mesh-list
139350755|NCT06041451|Immunoglobulins|immunoglobulins|mesh-list
139350756|NCT06041451|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139350757|NCT06041451|gamma-Globulins|gamma-globulins|mesh-list
139350758|NCT06041451|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139350759|NCT06041451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139350760|NCT06041451|Antiemetics|antiemetics|mesh-ancestor
139350761|NCT06041451|Autonomic Agents|autonomic agents|mesh-ancestor
139350762|NCT06041451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350763|NCT06041451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350764|NCT06041451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139350765|NCT06041451|Glucocorticoids|glucocorticoids|mesh-ancestor
139350766|NCT06041451|Hormones|hormones|mesh-ancestor
139350767|NCT06041451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139350768|NCT06041451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139350769|NCT06041451|Protective Agents|protective agents|mesh-ancestor
139350770|NCT06041451|Immunologic Factors|immunologic factors|mesh-ancestor
139350771|NCT06041425|Sufentanil|sufentanil|mesh-list
139350772|NCT06041425|Oxycodone|oxycodone|mesh-list
139350773|NCT06041425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139350774|NCT06041425|Narcotics|narcotics|mesh-ancestor
139350775|NCT06041425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350776|NCT06041425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350777|NCT06041425|Analgesics|analgesics|mesh-ancestor
139350778|NCT06041425|Sensory System Agents|sensory system agents|mesh-ancestor
139350779|NCT06041425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350780|NCT06041425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139350781|NCT06041425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139350782|NCT06041425|Anesthetics, General|anesthetics, general|mesh-ancestor
139007637|NCT04285866|Durvalumab|durvalumab|mesh-list
139350783|NCT06041425|Anesthetics|anesthetics|mesh-ancestor
139350784|NCT06041399|Metformin|metformin|mesh-list
139350785|NCT06041399|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139350786|NCT06041399|Hypolipidemic Agents|hypolipidemic agents|mesh-list
139350787|NCT06041399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350788|NCT06041399|Antimetabolites|antimetabolites|mesh-ancestor
139350789|NCT06041399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350790|NCT06041399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139350791|NCT06041178|Flurbiprofen|flurbiprofen|mesh-list
139350792|NCT06041178|Analgesics|analgesics|mesh-ancestor
139350793|NCT06041178|Sensory System Agents|sensory system agents|mesh-ancestor
139350794|NCT06041178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350795|NCT06041178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350796|NCT06041178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139350797|NCT06041178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139350798|NCT06041178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139350799|NCT06041178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139350800|NCT06041178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138922004|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
139350801|NCT06041178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350802|NCT06041178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350803|NCT06041152|Psilocybin|psilocybin|mesh-list
139350804|NCT06041152|Hallucinogens|hallucinogens|mesh-ancestor
139350805|NCT06041152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350806|NCT06041152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139350807|NCT06041035|Paclitaxel|paclitaxel|mesh-list
139350808|NCT06041035|Gemcitabine|gemcitabine|mesh-list
139350809|NCT06041035|Capecitabine|capecitabine|mesh-list
139350810|NCT06041035|Oxaliplatin|oxaliplatin|mesh-list
139350811|NCT06041035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139350812|NCT06041035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350813|NCT06041035|Tubulin Modulators|tubulin modulators|mesh-ancestor
139350814|NCT06041035|Antimitotic Agents|antimitotic agents|mesh-ancestor
139350815|NCT06041035|Mitosis Modulators|mitosis modulators|mesh-ancestor
139350816|NCT06041035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350817|NCT06041035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139350818|NCT06041035|Antimetabolites|antimetabolites|mesh-ancestor
139350819|NCT06040970|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139350820|NCT06040970|Immunoconjugates|immunoconjugates|mesh-ancestor
139350821|NCT06040970|Immunologic Factors|immunologic factors|mesh-ancestor
139350822|NCT06040970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350823|NCT06040944|Antipsychotic Agents|antipsychotic agents|mesh-list
139350824|NCT06040944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139350825|NCT06040944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350826|NCT06040944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350827|NCT06040944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139350828|NCT06040905|Ubiquinone|ubiquinone|mesh-list
139350829|NCT06040905|Coenzyme Q10|coenzyme q10|mesh-list
139350830|NCT06040905|Micronutrients|micronutrients|mesh-ancestor
139350831|NCT06040905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350832|NCT06040905|Vitamins|vitamins|mesh-ancestor
139350833|NCT06040853|Tranexamic Acid|tranexamic acid|mesh-list
139350834|NCT06040853|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139350835|NCT06040853|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139350836|NCT06040853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350837|NCT06040853|Hemostatics|hemostatics|mesh-ancestor
139350838|NCT06040853|Coagulants|coagulants|mesh-ancestor
139350839|NCT06032052|Immunomodulating Agents|immunomodulating agents|mesh-list
139350840|NCT06032052|Immunologic Factors|immunologic factors|mesh-list
139350841|NCT06032052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350842|NCT06017323|Paclitaxel|paclitaxel|mesh-list
139350843|NCT06017323|Gemcitabine|gemcitabine|mesh-list
139350844|NCT06017323|Proglumide|proglumide|mesh-list
139350845|NCT06017323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139350846|NCT06017323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350847|NCT06017323|Tubulin Modulators|tubulin modulators|mesh-ancestor
139350848|NCT06017323|Antimitotic Agents|antimitotic agents|mesh-ancestor
139350849|NCT06017323|Mitosis Modulators|mitosis modulators|mesh-ancestor
139350850|NCT06017323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350851|NCT06017323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139350852|NCT06017323|Antimetabolites|antimetabolites|mesh-ancestor
139350853|NCT06017323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139350854|NCT06017323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139350855|NCT06000501|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
139350856|NCT06000501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139350857|NCT06000501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350858|NCT06000501|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139350859|NCT06000501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139350860|NCT06000501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350861|NCT06000501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350863|NCT06000501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350864|NCT05987371|Albuterol|albuterol|mesh-list
139350865|NCT05987371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139350866|NCT05987371|Autonomic Agents|autonomic agents|mesh-ancestor
139350867|NCT05987371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350868|NCT05987371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350869|NCT05987371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139350870|NCT05987371|Respiratory System Agents|respiratory system agents|mesh-ancestor
139350871|NCT05987371|Tocolytic Agents|tocolytic agents|mesh-ancestor
139350872|NCT05987371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139350873|NCT05987371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139350874|NCT05987371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139350875|NCT05987371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139350876|NCT05987371|Adrenergic Agents|adrenergic agents|mesh-ancestor
139350877|NCT05987371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350878|NCT05987371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350879|NCT05944887|Lidocaine|lidocaine|mesh-list
139350880|NCT05944887|Propofol|propofol|mesh-list
139350881|NCT05944887|Anesthetics, Local|anesthetics, local|mesh-ancestor
139350882|NCT05944887|Anesthetics|anesthetics|mesh-ancestor
139350883|NCT05944887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350884|NCT05944887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350885|NCT05944887|Sensory System Agents|sensory system agents|mesh-ancestor
139350886|NCT05944887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350887|NCT05944887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139350888|NCT05944887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139350889|NCT05944887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139350890|NCT05944887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350891|NCT05944887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350892|NCT05944887|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139350893|NCT05944887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139350894|NCT05944887|Anesthetics, General|anesthetics, general|mesh-ancestor
139350895|NCT05914077|Secretin|secretin|mesh-list
139350896|NCT05914077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139350897|NCT05914077|Hormones|hormones|mesh-ancestor
139350898|NCT05914077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139350899|NCT05914077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350900|NCT05896761|Rilpivirine|rilpivirine|mesh-list
139350901|NCT05896761|Cabotegravir|cabotegravir|mesh-list
139350902|NCT05896761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139350903|NCT05896761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139350904|NCT05896761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350905|NCT05896761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350906|NCT05896761|Antiviral Agents|antiviral agents|mesh-ancestor
139350907|NCT05896761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139350908|NCT05896761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139350909|NCT05896761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139350910|NCT05896761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139350911|NCT05896761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139350912|NCT05892770|Zinc|zinc|mesh-list
139350913|NCT05892770|Botulinum Toxins|botulinum toxins|mesh-list
139350914|NCT05892770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139350915|NCT05892770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139350916|NCT05892770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139350917|NCT05892770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139350918|NCT05892770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350919|NCT05892770|Cholinergic Agents|cholinergic agents|mesh-ancestor
139350920|NCT05892770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350921|NCT05892770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350922|NCT05892770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139350923|NCT05892770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350924|NCT05892770|Trace Elements|trace elements|mesh-ancestor
139350925|NCT05892770|Micronutrients|micronutrients|mesh-ancestor
139350926|NCT05838664|Rivaroxaban|rivaroxaban|mesh-list
139350927|NCT05838664|Apixaban|apixaban|mesh-list
139350928|NCT05838664|Dabigatran|dabigatran|mesh-list
139350929|NCT05838664|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139350930|NCT05838664|Antithrombins|antithrombins|mesh-ancestor
139350931|NCT05838664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139350932|NCT05838664|Protease Inhibitors|protease inhibitors|mesh-ancestor
139350933|NCT05838664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139350934|NCT05838664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350935|NCT05838664|Anticoagulants|anticoagulants|mesh-ancestor
139350936|NCT05831124|Vaccines|vaccines|mesh-list
139350937|NCT05831124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139350938|NCT05831124|Immunologic Factors|immunologic factors|mesh-ancestor
139350939|NCT05831124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350940|NCT05827159|Naltrexone|naltrexone|mesh-list
139350941|NCT05827159|Gabapentin|gabapentin|mesh-list
139350942|NCT05827159|Analgesics|analgesics|mesh-ancestor
139350943|NCT05827159|Sensory System Agents|sensory system agents|mesh-ancestor
139350944|NCT05827159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350945|NCT05827159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350946|NCT05827159|Anticonvulsants|anticonvulsants|mesh-ancestor
139350947|NCT05827159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139350948|NCT05827159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139350949|NCT05827159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350950|NCT05827159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139350951|NCT05827159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139350952|NCT05827159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139350953|NCT05827159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350954|NCT05827159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350955|NCT05827159|Antimanic Agents|antimanic agents|mesh-ancestor
139350956|NCT05827159|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139350957|NCT05827159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139350958|NCT05735379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139350959|NCT05735379|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139350960|NCT05735379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350961|NCT05735379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350962|NCT05735379|Cholinergic Agents|cholinergic agents|mesh-ancestor
139350963|NCT05735379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139350964|NCT05735379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139350965|NCT05708638|Anesthetics|anesthetics|mesh-list
138922054|NCT00579501|Dexamethasone|dexamethasone|mesh-list
139350966|NCT05708638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350967|NCT05708638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350968|NCT05695781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139350969|NCT05695781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139181532|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757107|NCT01239992|Niacin|niacin|mesh-list
139350970|NCT05639712|Fentanyl|fentanyl|mesh-list
139350971|NCT05639712|Morphine|morphine|mesh-list
139350972|NCT05639712|Oxycodone|oxycodone|mesh-list
139350973|NCT05639712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139350974|NCT05639712|Narcotics|narcotics|mesh-ancestor
139350975|NCT05639712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139350976|NCT05639712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139350977|NCT05639712|Analgesics|analgesics|mesh-ancestor
139350978|NCT05639712|Sensory System Agents|sensory system agents|mesh-ancestor
139350979|NCT05639712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139350980|NCT05639712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139350981|NCT05639712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139350982|NCT05639712|Anesthetics, General|anesthetics, general|mesh-ancestor
139350983|NCT05639712|Anesthetics|anesthetics|mesh-ancestor
139350984|NCT05619172|Cetuximab|cetuximab|mesh-list
139350985|NCT05619172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139350986|NCT05619172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139350987|NCT05611242|Salicylic Acid|salicylic acid|mesh-list
139350988|NCT05611242|Salicylates|salicylates|mesh-list
139350989|NCT05611242|Tirofiban|tirofiban|mesh-list
139350990|NCT05611242|Abciximab|abciximab|mesh-list
139350991|NCT05611242|Clopidogrel|clopidogrel|mesh-list
139350992|NCT05611242|Cangrelor|cangrelor|mesh-list
139350993|NCT05611242|Eptifibatide|eptifibatide|mesh-list
139350994|NCT05611242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139350995|NCT05611242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139350996|NCT05611242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139350997|NCT05611242|Analgesics|analgesics|mesh-ancestor
139350998|NCT05611242|Sensory System Agents|sensory system agents|mesh-ancestor
139350999|NCT05611242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351000|NCT05611242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351001|NCT05611242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139351002|NCT05611242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139351003|NCT05611242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139351004|NCT05611242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139351005|NCT05611242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351006|NCT05611242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139351007|NCT05611242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351008|NCT05611242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139351009|NCT05611242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139351010|NCT05611242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139351011|NCT05611242|Purinergic Agents|purinergic agents|mesh-ancestor
139351012|NCT05611242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139351013|NCT05611242|Anticoagulants|anticoagulants|mesh-ancestor
139351014|NCT05611242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351015|NCT05611242|Antifungal Agents|antifungal agents|mesh-ancestor
139351016|NCT05611242|Keratolytic Agents|keratolytic agents|mesh-ancestor
139351017|NCT05611242|Dermatologic Agents|dermatologic agents|mesh-ancestor
139351018|NCT05582694|UB-421|ub-421|mesh-list
139351019|NCT05582694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139351020|NCT05582694|Antiviral Agents|antiviral agents|mesh-ancestor
139351021|NCT05582694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351022|NCT05567094|Dexamethasone|dexamethasone|mesh-list
139351023|NCT05567094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139351024|NCT05567094|Antiemetics|antiemetics|mesh-ancestor
139351025|NCT05567094|Autonomic Agents|autonomic agents|mesh-ancestor
139351026|NCT05567094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922073|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
139351027|NCT05567094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351028|NCT05567094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139351029|NCT05567094|Glucocorticoids|glucocorticoids|mesh-ancestor
139351030|NCT05567094|Hormones|hormones|mesh-ancestor
139351031|NCT05567094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139351032|NCT05567094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139351033|NCT05567094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351034|NCT05555888|Capecitabine|capecitabine|mesh-list
139351035|NCT05555888|Oxaliplatin|oxaliplatin|mesh-list
139351036|NCT05555888|Antibodies|antibodies|mesh-list
139351037|NCT05555888|Immunologic Factors|immunologic factors|mesh-ancestor
139351038|NCT05555888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351039|NCT05555888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139351040|NCT05555888|Antimetabolites|antimetabolites|mesh-ancestor
139351041|NCT05555888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351042|NCT05555888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351043|NCT05554211|Tranexamic Acid|tranexamic acid|mesh-list
139351044|NCT05554211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139351045|NCT05554211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139351046|NCT05554211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351047|NCT05554211|Hemostatics|hemostatics|mesh-ancestor
139351048|NCT05554211|Coagulants|coagulants|mesh-ancestor
139351049|NCT05442554|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139351050|NCT05442554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351051|NCT05442554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351052|NCT05442554|Immunotoxins|immunotoxins|mesh-ancestor
139351053|NCT05442554|Immunoconjugates|immunoconjugates|mesh-ancestor
139351054|NCT05442554|Immunologic Factors|immunologic factors|mesh-ancestor
139351055|NCT05442554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351056|NCT05439876|Melatonin|melatonin|mesh-list
139351057|NCT05439876|Antioxidants|antioxidants|mesh-ancestor
139351058|NCT05439876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351059|NCT05439876|Protective Agents|protective agents|mesh-ancestor
139351060|NCT05439876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351061|NCT05439876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139351062|NCT05412394|Prednisolone|prednisolone|mesh-list
139351063|NCT05412394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139351064|NCT05412394|Glucocorticoids|glucocorticoids|mesh-ancestor
139351065|NCT05412394|Hormones|hormones|mesh-ancestor
139351066|NCT05412394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139351067|NCT05412394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351068|NCT05412394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139351069|NCT05412394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351070|NCT05408559|Sulforaphane|sulforaphane|mesh-list
139351071|NCT05408559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139351072|NCT05408559|Protective Agents|protective agents|mesh-ancestor
139351073|NCT05408559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351075|NCT05408091|Antibodies|antibodies|mesh-list
139351076|NCT05408091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139351077|NCT05408091|Immunologic Factors|immunologic factors|mesh-ancestor
139351078|NCT05408091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351079|NCT05390307|Dapagliflozin|dapagliflozin|mesh-list
139351080|NCT05390307|Liraglutide|liraglutide|mesh-list
139351081|NCT05390307|Glucagon|glucagon|mesh-list
139351082|NCT05390307|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139351083|NCT05390307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139007926|NCT05354700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351084|NCT05390307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351085|NCT05390307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139351086|NCT05390307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351087|NCT05390307|Incretins|incretins|mesh-ancestor
139351088|NCT05390307|Hormones|hormones|mesh-ancestor
139351089|NCT05390307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139351090|NCT05390307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139351091|NCT05319639|Leucovorin|leucovorin|mesh-list
139351092|NCT05319639|Paclitaxel|paclitaxel|mesh-list
139351093|NCT05319639|Fluorouracil|fluorouracil|mesh-list
139351094|NCT05319639|Oxaliplatin|oxaliplatin|mesh-list
139351095|NCT05319639|Irinotecan|irinotecan|mesh-list
139351096|NCT05319639|Tislelizumab|tislelizumab|mesh-list
139351097|NCT05319639|Levoleucovorin|levoleucovorin|mesh-list
139351098|NCT05319639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139351099|NCT05319639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351100|NCT05319639|Tubulin Modulators|tubulin modulators|mesh-ancestor
139351101|NCT05319639|Antimitotic Agents|antimitotic agents|mesh-ancestor
139351102|NCT05319639|Mitosis Modulators|mitosis modulators|mesh-ancestor
139351103|NCT05319639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351104|NCT05319639|Antimetabolites|antimetabolites|mesh-ancestor
139351105|NCT05319639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139351106|NCT05319639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139351107|NCT05319639|Immunologic Factors|immunologic factors|mesh-ancestor
139351108|NCT05319639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351109|NCT05319639|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139351110|NCT05319639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139351111|NCT05319639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351112|NCT05319639|Antidotes|antidotes|mesh-ancestor
139351113|NCT05319639|Protective Agents|protective agents|mesh-ancestor
139351114|NCT05319639|Vitamin B Complex|vitamin b complex|mesh-ancestor
139351115|NCT05319639|Vitamins|vitamins|mesh-ancestor
139351116|NCT05319639|Micronutrients|micronutrients|mesh-ancestor
139351117|NCT05319639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351118|NCT05260684|Trametinib|trametinib|mesh-list
139351119|NCT05260684|Vemurafenib|vemurafenib|mesh-list
139351120|NCT05260684|Dabrafenib|dabrafenib|mesh-list
139351121|NCT05260684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351122|NCT05260684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139351123|NCT05260684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351124|NCT05260684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351125|NCT05228925|Vitamin D|vitamin d|mesh-list
139351126|NCT05228925|Vitamins|vitamins|mesh-ancestor
139351127|NCT05228925|Micronutrients|micronutrients|mesh-ancestor
139351128|NCT05228925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351129|NCT05228925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139351130|NCT05133531|Eculizumab|eculizumab|mesh-list
139351131|NCT05133531|Ravulizumab|ravulizumab|mesh-list
139351132|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139351133|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139351134|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
139351135|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351136|NCT05102721|Avelumab|avelumab|mesh-list
139351137|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351138|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351139|NCT05048784|Sotorasib|sotorasib|mesh-list
139351140|NCT05048784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139351141|NCT05048784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351142|NCT05048784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351143|NCT05048784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351144|NCT05038228|Vitamin K|vitamin k|mesh-list
139351145|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
139351146|NCT05038228|Apixaban|apixaban|mesh-list
139351147|NCT05038228|Dabigatran|dabigatran|mesh-list
139351148|NCT05038228|Vitamins|vitamins|mesh-ancestor
139351149|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
139351150|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351151|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139351152|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
138922110|NCT02598830|Vitamins|vitamins|mesh-ancestor
139351153|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139351154|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
139351155|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351156|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351157|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
139351158|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139351159|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139351160|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
139351161|NCT05038228|Coagulants|coagulants|mesh-ancestor
139351162|NCT05002569|Nivolumab|nivolumab|mesh-list
139351163|NCT05002569|Relatlimab|relatlimab|mesh-list
139351164|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351165|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351166|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139351167|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351168|NCT04894123|Trifluridine|trifluridine|mesh-list
139351169|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
139351170|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351171|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
139351172|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351173|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
139351174|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351175|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139351176|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
139351177|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139351178|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139351179|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139351180|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
139351181|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139351182|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351183|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139351184|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139351185|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139351186|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139351187|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351189|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139351190|NCT04892953|Carboplatin|carboplatin|mesh-list
139351191|NCT04892953|Gemcitabine|gemcitabine|mesh-list
139351192|NCT04892953|Pemetrexed|pemetrexed|mesh-list
139351193|NCT04892953|Durvalumab|durvalumab|mesh-list
139351194|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
139351195|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139351196|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
139351197|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139351198|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351199|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
139351200|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
139351201|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
139351202|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351203|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139351204|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
139351205|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351206|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139351207|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139351208|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351209|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
139351210|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351211|NCT04884282|Docetaxel|docetaxel|mesh-list
139351212|NCT04884282|Nivolumab|nivolumab|mesh-list
139351213|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351214|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
139351215|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
139351216|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
139351217|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351218|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351219|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139351220|NCT04876781|Tofacitinib|tofacitinib|mesh-list
139351221|NCT04876781|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139351222|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139351223|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351224|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351225|NCT04856904|Trifarotene|trifarotene|mesh-list
139351226|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
139351227|NCT04849845|Insulin|insulin|mesh-list
139351228|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139351229|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139351230|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351231|NCT04803877|Nivolumab|nivolumab|mesh-list
139351232|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351233|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351234|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139351235|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351236|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
139351237|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139351238|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351239|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139351240|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139351241|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351242|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351243|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351244|NCT04758871|Progesterone|progesterone|mesh-list
139351245|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
139351246|NCT04758871|Progestins|progestins|mesh-ancestor
139351247|NCT04758871|Hormones|hormones|mesh-ancestor
139351248|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139351249|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351250|NCT04737603|Buprenorphine|buprenorphine|mesh-list
139351251|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139351252|NCT04737603|Naloxone|naloxone|mesh-list
139351253|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139351254|NCT04737603|Narcotics|narcotics|mesh-ancestor
139351255|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139351256|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351257|NCT04737603|Analgesics|analgesics|mesh-ancestor
139351258|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
139351259|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351260|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139351261|NCT04713787|Albendazole|albendazole|mesh-list
139351262|NCT04713787|Oxfendazole|oxfendazole|mesh-list
139351263|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
139351264|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139351265|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351266|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
139351267|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139351268|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139351269|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
139351270|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
139351271|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
138922135|NCT05285358|Mitosis Modulators|mitosis modulators|mesh-ancestor
139351272|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351273|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351274|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
139351275|NCT04626128|Aflibercept|aflibercept|mesh-list
139351276|NCT04626128|Axitinib|axitinib|mesh-list
139351277|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139351278|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139351279|NCT04626128|Growth Substances|growth substances|mesh-ancestor
139351280|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351281|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
139351282|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351283|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139351284|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351285|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351286|NCT04582435|Insulin|insulin|mesh-list
139351287|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139351288|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351289|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
139351290|NCT04581824|Dostarlimab|dostarlimab|mesh-list
139351291|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351292|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351293|NCT04581824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139351294|NCT04581824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351295|NCT04536298|Vitamin D|vitamin d|mesh-list
139351296|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
139351297|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
139351298|NCT04536298|Vitamins|vitamins|mesh-list
139351299|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
139351300|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351301|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139351302|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139351303|NCT04424303|Tofacitinib|tofacitinib|mesh-list
139351304|NCT04424303|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139351305|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139351306|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351307|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351308|NCT04421820|Leucovorin|leucovorin|mesh-list
139351309|NCT04421820|Fluorouracil|fluorouracil|mesh-list
139351310|NCT04421820|Oxaliplatin|oxaliplatin|mesh-list
139351311|NCT04421820|Antimetabolites|antimetabolites|mesh-ancestor
139351312|NCT04421820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351313|NCT04421820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139351314|NCT04421820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351315|NCT04421820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139351316|NCT04421820|Immunologic Factors|immunologic factors|mesh-ancestor
139351317|NCT04421820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351318|NCT04421820|Antidotes|antidotes|mesh-ancestor
139351319|NCT04421820|Protective Agents|protective agents|mesh-ancestor
139351321|NCT04421820|Vitamins|vitamins|mesh-ancestor
139351322|NCT04421820|Micronutrients|micronutrients|mesh-ancestor
139351323|NCT04411654|Sirolimus|sirolimus|mesh-list
139351324|NCT04411654|Prednisone|prednisone|mesh-list
139351325|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
139351326|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139351327|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139351328|NCT04411654|Prednisolone|prednisolone|mesh-list
139351329|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
139351330|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139351331|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
139351332|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139351333|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
139351334|NCT04411654|Hormones|hormones|mesh-ancestor
138922156|NCT02590224|Glycine|glycine|mesh-list
139351335|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139351336|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351337|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139351338|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351339|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139351340|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351341|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139351342|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
139351343|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139351344|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
139351345|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
139351346|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
139351347|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351348|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139351349|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139351350|NCT04411654|Protective Agents|protective agents|mesh-ancestor
139351351|NCT04367090|Docetaxel|docetaxel|mesh-list
139351352|NCT04367090|Trastuzumab|trastuzumab|mesh-list
139351353|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351354|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
139351355|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
139351356|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
139351357|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351358|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351359|NCT04337450|Lamivudine|lamivudine|mesh-list
139351360|NCT04337450|Dolutegravir|dolutegravir|mesh-list
139351361|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139351362|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139351363|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351364|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351365|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
139351366|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351367|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139351368|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139351369|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139351370|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139351371|NCT04321993|Antiviral Agents|antiviral agents|mesh-list
139351372|NCT04321993|Remdesivir|remdesivir|mesh-list
139351373|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139351374|NCT04321993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351375|NCT04321993|Antimetabolites|antimetabolites|mesh-ancestor
139351376|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351377|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139351378|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351379|NCT04296305|Hydromorphone|hydromorphone|mesh-list
139351380|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139351381|NCT04296305|Narcotics|narcotics|mesh-ancestor
139351382|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139351383|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351384|NCT04296305|Analgesics|analgesics|mesh-ancestor
139351385|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
139351386|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351387|NCT04233567|Infigratinib|infigratinib|mesh-list
139351388|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351389|NCT04095689|Docetaxel|docetaxel|mesh-list
139351390|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
139351391|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351392|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
139351393|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
139351394|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
139351395|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351396|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351397|NCT04095689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139351398|NCT03978988|Aspirin|aspirin|mesh-list
139351399|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139351400|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139351401|NCT03978988|Analgesics|analgesics|mesh-ancestor
139351402|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
139351403|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351404|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351405|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139351406|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139351407|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139351408|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139351409|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351410|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139351411|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139351412|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351413|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
139351414|NCT03950427|Bupropion|bupropion|mesh-list
139351415|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139351416|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
139351417|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139351418|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139351419|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139351420|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139351421|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351422|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
139351423|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139351424|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351425|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139351426|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139351427|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351428|NCT03911505|Miglustat|miglustat|mesh-list
139351429|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351430|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351431|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139351432|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139351433|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
139351434|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351435|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139351436|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139351437|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351438|NCT03885089|Infliximab|infliximab|mesh-list
139351439|NCT03885089|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139351440|NCT03885089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139351441|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
139351442|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139351443|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139351444|NCT03851588|Dolutegravir|dolutegravir|mesh-list
139351445|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139351446|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139351447|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351448|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351449|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139351450|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139351451|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
139351452|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351453|NCT03850444|Paclitaxel|paclitaxel|mesh-list
139351454|NCT03850444|Carboplatin|carboplatin|mesh-list
139351455|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
139351456|NCT03850444|Pemetrexed|pemetrexed|mesh-list
139351457|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139351458|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351459|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
139351460|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
139351461|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
139351462|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351463|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351464|NCT03850444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139351465|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351466|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139351467|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139351468|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
139351469|NCT03850379|Levofloxacin|levofloxacin|mesh-list
139351470|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139351471|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351472|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139351473|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139351474|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351475|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351476|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351477|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139351478|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139351479|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139351480|NCT03824483|Venetoclax|venetoclax|mesh-list
139351481|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
139351482|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
139351483|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351484|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351485|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139351486|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351487|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351488|NCT03820141|Trastuzumab|trastuzumab|mesh-list
139351489|NCT03820141|Durvalumab|durvalumab|mesh-list
139351490|NCT03820141|Pertuzumab|pertuzumab|mesh-list
139351491|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351492|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351493|NCT03742245|Olaparib|olaparib|mesh-list
139351494|NCT03742245|Vorinostat|vorinostat|mesh-list
139351495|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139351496|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351497|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922218|NCT02574975|Miotics|miotics|mesh-ancestor
139351498|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351499|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139351500|NCT03732677|Gemcitabine|gemcitabine|mesh-list
139351501|NCT03732677|Durvalumab|durvalumab|mesh-list
139351502|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351503|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139351504|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
139351505|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351506|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351507|NCT03619551|Busulfan|busulfan|mesh-list
139351508|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
139351509|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351510|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139351511|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
139351512|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351513|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139351514|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351515|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139351516|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139351517|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139351518|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
139351519|NCT03522753|Hormones|hormones|mesh-ancestor
139351520|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139351521|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351522|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139351523|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351524|NCT03471507|Diclofenac|diclofenac|mesh-list
139351525|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139351526|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139351527|NCT03471507|Analgesics|analgesics|mesh-ancestor
139351528|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
139351529|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351530|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351531|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139351532|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139351533|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139351534|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351535|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351536|NCT03459222|Nivolumab|nivolumab|mesh-list
139351537|NCT03459222|Ipilimumab|ipilimumab|mesh-list
139351538|NCT03459222|Relatlimab|relatlimab|mesh-list
139351539|NCT03459222|Linrodostat|linrodostat|mesh-list
139351540|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351541|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351542|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139351543|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351544|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351545|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
139351546|NCT03366155|Irinotecan|irinotecan|mesh-list
139351547|NCT03366155|Cetuximab|cetuximab|mesh-list
139351548|NCT03366155|Panitumumab|panitumumab|mesh-list
139351549|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351550|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139351551|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139351552|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351553|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351554|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351555|NCT03321019|Capsaicin|capsaicin|mesh-list
139351556|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
139351557|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
139351558|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
139351559|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351560|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351561|NCT03137407|Botulinum Toxins|botulinum toxins|mesh-list
139351562|NCT03137407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139351563|NCT03137407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139351564|NCT03137407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139351565|NCT03137407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139351566|NCT03137407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351567|NCT03137407|Cholinergic Agents|cholinergic agents|mesh-ancestor
139351568|NCT03137407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139351569|NCT03137407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351570|NCT03137407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139351571|NCT03137407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351572|NCT02743494|Nivolumab|nivolumab|mesh-list
139351573|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351574|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351575|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139351576|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351577|NCT02722538|Gemcitabine|gemcitabine|mesh-list
139351578|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139351579|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
139351580|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351581|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351582|NCT02531126|Ozanimod|ozanimod|mesh-list
139351583|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139351584|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351585|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139351586|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
139351587|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351588|NCT02401503|Venetoclax|venetoclax|mesh-list
139351589|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139351590|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
139351591|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351592|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139351593|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
139351594|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351595|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351596|NCT02272998|Ponatinib|ponatinib|mesh-list
139351597|NCT02272998|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139351598|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139351599|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351600|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351601|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351602|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
139351603|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
139351604|NCT02272842|Vitamins|vitamins|mesh-ancestor
139351606|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351607|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
139351608|NCT02272842|Hematinics|hematinics|mesh-ancestor
139351609|NCT02258659|Paclitaxel|paclitaxel|mesh-list
139351610|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139351611|NCT02258659|Carboplatin|carboplatin|mesh-list
139351612|NCT02258659|Fluorouracil|fluorouracil|mesh-list
139351613|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
139351614|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139351615|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351616|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
139351617|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
139351618|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
139351619|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351620|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
139351621|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138922244|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351622|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139351623|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
139351624|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351625|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
139351626|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351627|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139351628|NCT02064673|Curcumin|curcumin|mesh-list
139351629|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139351630|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139351631|NCT02064673|Analgesics|analgesics|mesh-ancestor
139351632|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
139351633|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351634|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351635|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139351636|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139351637|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351638|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351639|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351640|NCT01990300|Pioglitazone|pioglitazone|mesh-list
139351641|NCT01990300|Alogliptin|alogliptin|mesh-list
139351642|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139351643|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351644|NCT01990300|Incretins|incretins|mesh-ancestor
139351645|NCT01990300|Hormones|hormones|mesh-ancestor
139351646|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139351647|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139351648|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
139351649|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351650|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351651|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139351652|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351653|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351654|NCT01909934|Immunotoxins|immunotoxins|mesh-ancestor
139351655|NCT01909934|Immunoconjugates|immunoconjugates|mesh-ancestor
139351656|NCT01909934|Immunologic Factors|immunologic factors|mesh-ancestor
139351657|NCT01909934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351658|NCT01740648|Fluorouracil|fluorouracil|mesh-list
139351659|NCT01740648|Trametinib|trametinib|mesh-list
139351660|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
139351661|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351662|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139351663|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351664|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139351665|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
139351666|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139181666|NCT01213667|Growth Substances|growth substances|mesh-ancestor
139351667|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139351668|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351669|NCT01697566|Metformin|metformin|mesh-list
139351670|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139351671|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351672|NCT01638442|Tosedostat|tosedostat|mesh-list
139351673|NCT01638442|Glycine|glycine|mesh-list
139351674|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351675|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351676|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
139351677|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139351678|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351679|NCT01318317|Plerixafor|plerixafor|mesh-list
139351680|NCT01318317|Rituximab|rituximab|mesh-list
139351681|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139351682|NCT01318317|Antibodies|antibodies|mesh-list
139351683|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
139351684|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139351685|NCT01318317|Lenograstim|lenograstim|mesh-list
139351686|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
139351687|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351688|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351689|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139351690|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139351691|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139351692|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139351693|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
139351694|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351695|NCT01076400|Topotecan|topotecan|mesh-list
139351696|NCT01076400|Adavosertib|adavosertib|mesh-list
139351697|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351698|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139351699|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139351700|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351701|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351702|NCT00934895|Paclitaxel|paclitaxel|mesh-list
139351703|NCT00934895|Everolimus|everolimus|mesh-list
139351704|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139351705|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139351706|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351707|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
139351708|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
139351709|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
139351710|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351711|NCT00934895|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139351712|NCT00934895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139351713|NCT00934895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351714|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139351715|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
139351716|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351717|NCT00913497|Insulin|insulin|mesh-list
139351718|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139351719|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
139351720|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
139351721|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139351722|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351723|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
139351724|NCT00556933|Sirolimus|sirolimus|mesh-list
139351725|NCT00556933|Tacrolimus|tacrolimus|mesh-list
139351726|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
139351727|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139351728|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139351729|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
139351730|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351731|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139351732|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351733|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351734|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139351735|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351736|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139351737|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
139351738|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139351739|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351740|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
139351741|NCT00503880|Cytarabine|cytarabine|mesh-list
139351742|NCT00503880|Clofarabine|clofarabine|mesh-list
139351743|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139351744|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
139351745|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351746|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351747|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
139351748|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351749|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139351750|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
138922271|NCT02573727|Terlipressin|terlipressin|mesh-list
139351751|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351752|NCT00378326|Tacrolimus|tacrolimus|mesh-list
139351753|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139351754|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
139351755|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351756|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139351757|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351758|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351759|NCT00106600|Pixantrone|pixantrone|mesh-list
139351760|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139351761|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139351762|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351763|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351764|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351765|NCT00006478|Sargramostim|sargramostim|mesh-list
139351766|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
139351767|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
139351768|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351769|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139351770|NCT05850143|Dexamethasone|dexamethasone|mesh-list
139351771|NCT05850143|Prednisolone|prednisolone|mesh-list
139351772|NCT05850143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139351773|NCT05850143|Antiemetics|antiemetics|mesh-ancestor
139351774|NCT05850143|Autonomic Agents|autonomic agents|mesh-ancestor
139351775|NCT05850143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351776|NCT05850143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351777|NCT05850143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139351778|NCT05850143|Glucocorticoids|glucocorticoids|mesh-ancestor
139351779|NCT05850143|Hormones|hormones|mesh-ancestor
139351780|NCT05850143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139351781|NCT05850143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139351782|NCT05850143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351783|NCT05850117|Amoxicillin|amoxicillin|mesh-list
139351784|NCT05850117|Metronidazole|metronidazole|mesh-list
139351785|NCT05850117|Levofloxacin|levofloxacin|mesh-list
139351786|NCT05850117|Ofloxacin|ofloxacin|mesh-list
139351787|NCT05850117|Tetracycline|tetracycline|mesh-list
139351788|NCT05850117|Esomeprazole|esomeprazole|mesh-list
139351789|NCT05850117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139351790|NCT05850117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351791|NCT05850117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139351792|NCT05850117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139351793|NCT05850117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139351794|NCT05850117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139351795|NCT05850117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139351796|NCT05850117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351797|NCT05850117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351798|NCT05850117|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139351799|NCT05850117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139351800|NCT05850117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139351801|NCT05850117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351802|NCT05850117|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139351803|NCT05850117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139351804|NCT05850117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139351805|NCT05849883|Omeprazole|omeprazole|mesh-list
139351806|NCT05849883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139351807|NCT05849883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139351808|NCT05849883|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139351809|NCT05849883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351810|NCT05849883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351811|NCT05849766|Dapagliflozin|dapagliflozin|mesh-list
139351812|NCT05849766|Carvedilol|carvedilol|mesh-list
139351813|NCT05849766|Ramipril|ramipril|mesh-list
139351814|NCT05849766|Spironolactone|spironolactone|mesh-list
139351815|NCT05849766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139351816|NCT05849766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351817|NCT05849766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139351818|NCT05849766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351819|NCT05849766|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139351820|NCT05849766|Hormone Antagonists|hormone antagonists|mesh-ancestor
138922277|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139351821|NCT05849766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139351822|NCT05849766|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139351823|NCT05849766|Diuretics|diuretics|mesh-ancestor
139351824|NCT05849766|Natriuretic Agents|natriuretic agents|mesh-ancestor
139351825|NCT05849766|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139351826|NCT05849766|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139351827|NCT05849766|Adrenergic Agents|adrenergic agents|mesh-ancestor
139351828|NCT05849766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139351829|NCT05849766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139351830|NCT05849766|Antioxidants|antioxidants|mesh-ancestor
139351831|NCT05849766|Protective Agents|protective agents|mesh-ancestor
139351832|NCT05849766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139351833|NCT05849766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139351834|NCT05849766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139351835|NCT05849766|Vasodilator Agents|vasodilator agents|mesh-ancestor
139351836|NCT05849766|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139351837|NCT05849766|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139351838|NCT05849766|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139351839|NCT05849766|Protease Inhibitors|protease inhibitors|mesh-ancestor
139351840|NCT05849766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351841|NCT05849662|Cytarabine|cytarabine|mesh-list
139351842|NCT05849662|Fludarabine|fludarabine|mesh-list
139351843|NCT05849662|Azacitidine|azacitidine|mesh-list
139351844|NCT05849662|Trametinib|trametinib|mesh-list
139351845|NCT05849662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351846|NCT05849662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139351847|NCT05849662|Antimetabolites|antimetabolites|mesh-ancestor
139351848|NCT05849662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351849|NCT05849662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139351850|NCT05849662|Immunologic Factors|immunologic factors|mesh-ancestor
139351851|NCT05849662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351852|NCT05849662|Antiviral Agents|antiviral agents|mesh-ancestor
139351853|NCT05849662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351854|NCT05849662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351855|NCT05849662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139351856|NCT05849597|Dexmedetomidine|dexmedetomidine|mesh-list
139351858|NCT05849597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139351859|NCT05849597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139351860|NCT05849597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351861|NCT05849597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139351862|NCT05849597|Analgesics|analgesics|mesh-ancestor
139351863|NCT05849597|Sensory System Agents|sensory system agents|mesh-ancestor
139351864|NCT05849597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351865|NCT05849597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139351866|NCT05849597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139351867|NCT05849597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139351868|NCT05849597|Adrenergic Agents|adrenergic agents|mesh-ancestor
139351869|NCT05849597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139351870|NCT05849597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351871|NCT05849597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139351872|NCT05849597|Anesthetics, General|anesthetics, general|mesh-ancestor
139351873|NCT05849597|Anesthetics|anesthetics|mesh-ancestor
139351874|NCT05847283|Dydrogesterone|dydrogesterone|mesh-list
139351875|NCT05847283|Progestins|progestins|mesh-ancestor
139351876|NCT05847283|Hormones|hormones|mesh-ancestor
139351877|NCT05847283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139351878|NCT05847283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351879|NCT05845580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139351880|NCT05845580|Red yeast rice|red yeast rice|mesh-list
139181684|NCT03845179|Hormones|hormones|mesh-ancestor
139351881|NCT05845580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139351882|NCT05845580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139351883|NCT05845580|Antimetabolites|antimetabolites|mesh-ancestor
139351884|NCT05845580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351885|NCT05845580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351886|NCT05845580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139351887|NCT05843968|Mycophenolic Acid|mycophenolic acid|mesh-list
139351888|NCT05843968|Rituximab|rituximab|mesh-list
139351889|NCT05843968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351890|NCT05843968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351891|NCT05843968|Immunologic Factors|immunologic factors|mesh-ancestor
139351892|NCT05843968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351893|NCT05843968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139351894|NCT05843968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139351895|NCT05843968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139351896|NCT05843968|Antitubercular Agents|antitubercular agents|mesh-ancestor
139351897|NCT05843968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139351898|NCT05843968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139351899|NCT05843968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351900|NCT05843968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351901|NCT05841134|Capecitabine|capecitabine|mesh-list
139351902|NCT05841134|Oxaliplatin|oxaliplatin|mesh-list
139351903|NCT05841134|Tislelizumab|tislelizumab|mesh-list
139351904|NCT05841134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139351905|NCT05841134|Antimetabolites|antimetabolites|mesh-ancestor
139351906|NCT05841134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351907|NCT05841134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351908|NCT05841134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351909|NCT05831878|Disitamab vedotin|disitamab vedotin|mesh-list
139351910|NCT05831878|Immunoconjugates|immunoconjugates|mesh-ancestor
139351911|NCT05831878|Immunologic Factors|immunologic factors|mesh-ancestor
139351912|NCT05831878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351913|NCT05827705|Ephedrine|ephedrine|mesh-list
139351914|NCT05827705|Pseudoephedrine|pseudoephedrine|mesh-list
139351915|NCT05827705|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139351916|NCT05827705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351917|NCT05827705|Sympathomimetics|sympathomimetics|mesh-ancestor
139351918|NCT05827705|Autonomic Agents|autonomic agents|mesh-ancestor
139351919|NCT05827705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351920|NCT05827705|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139351921|NCT05827705|Adrenergic Agents|adrenergic agents|mesh-ancestor
139351922|NCT05827705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008747|NCT01052896|Gabapentin|gabapentin|mesh-list
139351923|NCT05827705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351924|NCT05827705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139351925|NCT05827705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139351926|NCT05827705|Respiratory System Agents|respiratory system agents|mesh-ancestor
139351927|NCT05827705|Nasal Decongestants|nasal decongestants|mesh-ancestor
139351928|NCT05816746|Decitabine|decitabine|mesh-list
139351929|NCT05816746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139351930|NCT05816746|Antimetabolites|antimetabolites|mesh-ancestor
139351931|NCT05816746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351932|NCT05816746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351933|NCT05816746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351934|NCT05949229|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139351935|NCT05949229|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139351936|NCT05949229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139351937|NCT05949229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139351938|NCT05949229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351939|NCT05949229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139351940|NCT05949229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351941|NCT05949229|Analgesics|analgesics|mesh-ancestor
139351942|NCT05949229|Sensory System Agents|sensory system agents|mesh-ancestor
139351943|NCT05949229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351944|NCT05949229|Antidepressive Agents|antidepressive agents|mesh-ancestor
139351945|NCT05949229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139351946|NCT05949229|Dopamine Agents|dopamine agents|mesh-ancestor
139351947|NCT05948891|Beclomethasone|beclomethasone|mesh-list
139351948|NCT05948891|Glycopyrrolate|glycopyrrolate|mesh-list
139351949|NCT05948891|Formoterol Fumarate|formoterol fumarate|mesh-list
139351950|NCT05948891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139351951|NCT05948891|Autonomic Agents|autonomic agents|mesh-ancestor
139351952|NCT05948891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139351953|NCT05948891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351954|NCT05948891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139351955|NCT05948891|Respiratory System Agents|respiratory system agents|mesh-ancestor
139351956|NCT05948891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139351957|NCT05948891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139351958|NCT05948891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139351959|NCT05948891|Adrenergic Agents|adrenergic agents|mesh-ancestor
139351960|NCT05948891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139351961|NCT05948891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351962|NCT05948891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139351963|NCT05948891|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139351964|NCT05948891|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139351965|NCT05948891|Cholinergic Agents|cholinergic agents|mesh-ancestor
139351966|NCT05948891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139351967|NCT05948891|Glucocorticoids|glucocorticoids|mesh-ancestor
139351968|NCT05948891|Hormones|hormones|mesh-ancestor
139351969|NCT05948891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139351970|NCT05948449|Oxaliplatin|oxaliplatin|mesh-list
139351971|NCT05948449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351972|NCT05948228|Fluorides|fluorides|mesh-list
139351973|NCT05948228|Cariostatic Agents|cariostatic agents|mesh-ancestor
139351974|NCT05948228|Protective Agents|protective agents|mesh-ancestor
139351975|NCT05948228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351976|NCT05948072|Cetuximab|cetuximab|mesh-list
138922341|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351977|NCT05948072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139351978|NCT05948072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351979|NCT05947825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139351980|NCT05947825|Paclitaxel|paclitaxel|mesh-list
139351981|NCT05947825|Gemcitabine|gemcitabine|mesh-list
139351982|NCT05947825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139351983|NCT05947825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139351984|NCT05947825|Tubulin Modulators|tubulin modulators|mesh-ancestor
139351985|NCT05947825|Antimitotic Agents|antimitotic agents|mesh-ancestor
139351986|NCT05947825|Mitosis Modulators|mitosis modulators|mesh-ancestor
139351987|NCT05947825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139351988|NCT05947825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139351989|NCT05947825|Antimetabolites|antimetabolites|mesh-ancestor
139351990|NCT05947825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139351991|NCT05947825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139351992|NCT05947825|Incretins|incretins|mesh-ancestor
139351993|NCT05947825|Hormones|hormones|mesh-ancestor
139351994|NCT05947825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139351995|NCT05947825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139008821|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
139351996|NCT05947825|Protease Inhibitors|protease inhibitors|mesh-ancestor
139351997|NCT05947825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139351998|NCT05947812|Tafenoquine|tafenoquine|mesh-list
139351999|NCT05947812|Antimalarials|antimalarials|mesh-ancestor
139352000|NCT05947812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139352001|NCT05947812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139352002|NCT05947812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139352003|NCT05947708|Dialysis Solutions|dialysis solutions|mesh-list
139352004|NCT05947708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139352005|NCT05947669|Methylprednisolone|methylprednisolone|mesh-list
139352006|NCT05947669|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139352007|NCT05947669|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139352008|NCT05947669|Prednisolone|prednisolone|mesh-list
139352009|NCT05947669|Prednisolone acetate|prednisolone acetate|mesh-list
139352010|NCT05947669|Infliximab|infliximab|mesh-list
139352011|NCT05947669|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139352012|NCT05947669|Prednisolone phosphate|prednisolone phosphate|mesh-list
139352013|NCT05947669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139352014|NCT05947669|Antiemetics|antiemetics|mesh-ancestor
139352015|NCT05947669|Autonomic Agents|autonomic agents|mesh-ancestor
139352016|NCT05947669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352017|NCT05947669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352018|NCT05947669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139352019|NCT05947669|Glucocorticoids|glucocorticoids|mesh-ancestor
139352020|NCT05947669|Hormones|hormones|mesh-ancestor
139352021|NCT05947669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139352022|NCT05947669|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139352023|NCT05947669|Protective Agents|protective agents|mesh-ancestor
139352024|NCT05947669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139352025|NCT05947669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352026|NCT05947669|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139352027|NCT05947669|Dermatologic Agents|dermatologic agents|mesh-ancestor
139352028|NCT05947669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352029|NCT05947643|Theophylline|theophylline|mesh-list
139352030|NCT05947643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139352031|NCT05947643|Autonomic Agents|autonomic agents|mesh-ancestor
139352032|NCT05947643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352033|NCT05947643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352034|NCT05947643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139352035|NCT05947643|Respiratory System Agents|respiratory system agents|mesh-ancestor
139352036|NCT05947643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139352037|NCT05947643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352038|NCT05947643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352039|NCT05947643|Vasodilator Agents|vasodilator agents|mesh-ancestor
139352040|NCT05947643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139352041|NCT05947643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139352042|NCT05947643|Purinergic Agents|purinergic agents|mesh-ancestor
139352043|NCT05947643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352044|NCT05947604|Midazolam|midazolam|mesh-list
139352045|NCT05947604|Dextromethorphan|dextromethorphan|mesh-list
139352046|NCT05947604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139352047|NCT05947604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139352048|NCT05947604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352049|NCT05947604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352050|NCT05947604|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139352051|NCT05947604|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139352052|NCT05947604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139352053|NCT05947604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139352054|NCT05947604|Anesthetics, General|anesthetics, general|mesh-ancestor
139352055|NCT05947604|Anesthetics|anesthetics|mesh-ancestor
139352056|NCT05947604|GABA Modulators|gaba modulators|mesh-ancestor
139352057|NCT05947604|GABA Agents|gaba agents|mesh-ancestor
139352058|NCT05947604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352059|NCT05947604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352060|NCT05947604|Antitussive Agents|antitussive agents|mesh-ancestor
139352061|NCT05947604|Respiratory System Agents|respiratory system agents|mesh-ancestor
139352062|NCT05947604|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139352063|NCT05947604|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139352064|NCT05947513|Curcumin|curcumin|mesh-list
139352065|NCT05947513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139352066|NCT05947513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139352067|NCT05947513|Analgesics|analgesics|mesh-ancestor
139352068|NCT05947513|Sensory System Agents|sensory system agents|mesh-ancestor
139352069|NCT05947513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352070|NCT05947513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352071|NCT05947513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139352072|NCT05947513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352073|NCT05947513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352074|NCT05947513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352075|NCT05947513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352076|NCT05947461|Diclofenac|diclofenac|mesh-list
139352077|NCT05947461|Indomethacin|indomethacin|mesh-list
139352078|NCT05947461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139352079|NCT05947461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139352080|NCT05947461|Analgesics|analgesics|mesh-ancestor
139352081|NCT05947461|Sensory System Agents|sensory system agents|mesh-ancestor
139352082|NCT05947461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352083|NCT05947461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352084|NCT05947461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139352085|NCT05947461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139181703|NCT01196455|Mitomycin|mitomycin|mesh-list
139352086|NCT05947461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139352087|NCT05947461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352088|NCT05947461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352089|NCT05947461|Gout Suppressants|gout suppressants|mesh-ancestor
139352090|NCT05947461|Tocolytic Agents|tocolytic agents|mesh-ancestor
139352091|NCT05947461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139352092|NCT05947383|Psilocybin|psilocybin|mesh-list
139352093|NCT05947383|Hallucinogens|hallucinogens|mesh-ancestor
139352094|NCT05947383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352095|NCT05947383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139352096|NCT05944445|Linezolid|linezolid|mesh-list
139352097|NCT05944445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139352098|NCT05944445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139352099|NCT05944445|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139352100|NCT05944445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352101|NCT05944445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352102|NCT05944055|Vitamin D|vitamin d|mesh-list
139352103|NCT05944055|Vitamins|vitamins|mesh-ancestor
139352104|NCT05944055|Micronutrients|micronutrients|mesh-ancestor
139352105|NCT05944055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352106|NCT05944055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139352107|NCT05933057|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
139352108|NCT05933057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139352109|NCT05933057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352110|NCT05933057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352111|NCT05925049|Natalizumab|natalizumab|mesh-list
139352112|NCT05925049|Immunologic Factors|immunologic factors|mesh-ancestor
139352113|NCT05925049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352114|NCT05906459|Antibodies|antibodies|mesh-list
139352115|NCT05906459|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
139352116|NCT05906459|Immunologic Factors|immunologic factors|mesh-ancestor
139352117|NCT05906459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352118|NCT05862168|Paclitaxel|paclitaxel|mesh-list
139352119|NCT05862168|Fluorouracil|fluorouracil|mesh-list
139352120|NCT05862168|Tislelizumab|tislelizumab|mesh-list
139352121|NCT05862168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139352122|NCT05862168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352123|NCT05862168|Tubulin Modulators|tubulin modulators|mesh-ancestor
139352124|NCT05862168|Antimitotic Agents|antimitotic agents|mesh-ancestor
139352125|NCT05862168|Mitosis Modulators|mitosis modulators|mesh-ancestor
139352126|NCT05862168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352127|NCT05862168|Antimetabolites|antimetabolites|mesh-ancestor
139352128|NCT05862168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139352129|NCT05862168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139352130|NCT05862168|Immunologic Factors|immunologic factors|mesh-ancestor
139352131|NCT05862168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352132|NCT05862168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352133|NCT05855876|Ketamine|ketamine|mesh-list
139352134|NCT05855876|Analgesics|analgesics|mesh-ancestor
139352135|NCT05855876|Sensory System Agents|sensory system agents|mesh-ancestor
139352136|NCT05855876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352137|NCT05855876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352138|NCT05855876|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139352139|NCT05855876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139352140|NCT05855876|Anesthetics, General|anesthetics, general|mesh-ancestor
139352141|NCT05855876|Anesthetics|anesthetics|mesh-ancestor
139352142|NCT05855876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352143|NCT05855876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139352144|NCT05855876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139352145|NCT05855876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352146|NCT05855876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352147|NCT05838287|Pioglitazone|pioglitazone|mesh-list
139352148|NCT05838287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139352149|NCT05838287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352150|NCT05825066|Paclitaxel|paclitaxel|mesh-list
139352151|NCT05825066|Gemcitabine|gemcitabine|mesh-list
139352152|NCT05825066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139352153|NCT05825066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352154|NCT05825066|Tubulin Modulators|tubulin modulators|mesh-ancestor
139352155|NCT05825066|Antimitotic Agents|antimitotic agents|mesh-ancestor
139352156|NCT05825066|Mitosis Modulators|mitosis modulators|mesh-ancestor
139352157|NCT05825066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352158|NCT05825066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139352159|NCT05825066|Antimetabolites|antimetabolites|mesh-ancestor
139352160|NCT05808010|Hydrotalcite|hydrotalcite|mesh-list
139352161|NCT05808010|Antacids|antacids|mesh-ancestor
138922380|NCT00435487|Calcium heparin|calcium heparin|mesh-list
139352162|NCT05808010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352163|NCT05808010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139352164|NCT05799378|Hydroxychloroquine|hydroxychloroquine|mesh-list
139352165|NCT05799378|Antimalarials|antimalarials|mesh-ancestor
139352166|NCT05799378|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139352167|NCT05799378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139352168|NCT05799378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139352169|NCT05799378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352170|NCT05799378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352171|NCT05799378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352172|NCT05794958|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139352173|NCT05794958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352174|NCT05794958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352175|NCT05754203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139352176|NCT05754203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352177|NCT05754203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352178|NCT05754203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352179|NCT05724329|Dasatinib|dasatinib|mesh-list
139352180|NCT05724329|Tislelizumab|tislelizumab|mesh-list
139352181|NCT05724329|Quercetin|quercetin|mesh-list
139352182|NCT05724329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352183|NCT05724329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139352184|NCT05724329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352185|NCT05724329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352186|NCT05724329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352187|NCT05724329|Antioxidants|antioxidants|mesh-ancestor
139352188|NCT05724329|Protective Agents|protective agents|mesh-ancestor
139352189|NCT05724329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352190|NCT05718466|Bevacizumab|bevacizumab|mesh-list
139352191|NCT05718466|Carboplatin|carboplatin|mesh-list
139352192|NCT05718466|Irinotecan|irinotecan|mesh-list
139352193|NCT05718466|Etoposide|etoposide|mesh-list
139352194|NCT05718466|Temozolomide|temozolomide|mesh-list
139352195|NCT05718466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352196|NCT05718466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352197|NCT05718466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139352198|NCT05718466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139352199|NCT05718466|Growth Substances|growth substances|mesh-ancestor
139352200|NCT05718466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352201|NCT05718466|Growth Inhibitors|growth inhibitors|mesh-ancestor
139352202|NCT05718466|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139352203|NCT05718466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139352204|NCT05718466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352205|NCT05718466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352206|NCT05718466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139352207|NCT05718466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139352208|NCT05718466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139352209|NCT05718466|Alkylating Agents|alkylating agents|mesh-ancestor
139352210|NCT05680129|Metformin|metformin|mesh-list
139352211|NCT05680129|Dulaglutide|dulaglutide|mesh-list
139352212|NCT05680129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139352213|NCT05680129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352214|NCT05640934|Melatonin|melatonin|mesh-list
139352215|NCT05640934|Antioxidants|antioxidants|mesh-ancestor
139352216|NCT05640934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352217|NCT05640934|Protective Agents|protective agents|mesh-ancestor
139352218|NCT05640934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352219|NCT05640934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352220|NCT05508009|Cyclophosphamide|cyclophosphamide|mesh-list
139352221|NCT05508009|Melphalan|melphalan|mesh-list
139352222|NCT05508009|Rituximab|rituximab|mesh-list
139352223|NCT05508009|Fludarabine|fludarabine|mesh-list
139352224|NCT05508009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139352225|NCT05508009|Immunologic Factors|immunologic factors|mesh-ancestor
139352226|NCT05508009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352227|NCT05508009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139181774|NCT05479591|Incretins|incretins|mesh-ancestor
139352228|NCT05508009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139352229|NCT05508009|Alkylating Agents|alkylating agents|mesh-ancestor
139352230|NCT05508009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352231|NCT05508009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352232|NCT05508009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139352233|NCT05508009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352234|NCT05459298|Vitamin D|vitamin d|mesh-list
139352235|NCT05459298|Cholecalciferol|cholecalciferol|mesh-list
139352236|NCT05459298|Vitamins|vitamins|mesh-ancestor
139352237|NCT05459298|Micronutrients|micronutrients|mesh-ancestor
139352238|NCT05459298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352239|NCT05459298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139352240|NCT05459298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139352241|NCT05400577|Sotorasib|sotorasib|mesh-list
139352242|NCT05400577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139352243|NCT05400577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352244|NCT05400577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352245|NCT05400577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352246|NCT05288777|Capecitabine|capecitabine|mesh-list
139352247|NCT05288777|Trastuzumab|trastuzumab|mesh-list
139352248|NCT05288777|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139352249|NCT05288777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139352250|NCT05288777|Antimetabolites|antimetabolites|mesh-ancestor
139352251|NCT05288777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352252|NCT05288777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352253|NCT05288777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352254|NCT05288777|Tubulin Modulators|tubulin modulators|mesh-ancestor
139352255|NCT05288777|Antimitotic Agents|antimitotic agents|mesh-ancestor
139352256|NCT05288777|Mitosis Modulators|mitosis modulators|mesh-ancestor
139352257|NCT05288777|Immunotoxins|immunotoxins|mesh-ancestor
139352258|NCT05288777|Immunoconjugates|immunoconjugates|mesh-ancestor
139352259|NCT05288777|Immunologic Factors|immunologic factors|mesh-ancestor
139352260|NCT05288777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352261|NCT05156281|Teriflunomide|teriflunomide|mesh-list
139352262|NCT05156281|Remibrutinib|remibrutinib|mesh-list
139352263|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139352264|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139352265|NCT05156281|Analgesics|analgesics|mesh-ancestor
139352266|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
139352267|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352268|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352269|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139352270|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352271|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139352272|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
139352273|NCT05156281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139352274|NCT05156281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352275|NCT05156281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352276|NCT05153174|Sulforaphane|sulforaphane|mesh-list
139352277|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139352278|NCT05153174|Protective Agents|protective agents|mesh-ancestor
139352279|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352280|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352281|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
139352282|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139352283|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
139352284|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352285|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352286|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139352287|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
139352288|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139352289|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
139352290|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352291|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139181791|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352292|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139352293|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
139352294|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
139352295|NCT05101746|Protective Agents|protective agents|mesh-ancestor
139352296|NCT04938453|Nintedanib|nintedanib|mesh-list
139352297|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352298|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139352299|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352300|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352301|NCT04778982|Fulvestrant|fulvestrant|mesh-list
139352302|NCT04778982|Palbociclib|palbociclib|mesh-list
139352303|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139352304|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352305|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139352306|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139352307|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
139352308|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139352309|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352310|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139352311|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352312|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352313|NCT04772781|Ibuprofen|ibuprofen|mesh-list
139352314|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139352315|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139352316|NCT04772781|Analgesics|analgesics|mesh-ancestor
139352317|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
139352318|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352319|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352320|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139352321|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352322|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139352323|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352324|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352325|NCT04699591|Domperidone|domperidone|mesh-list
139352326|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
139352327|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
139352328|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352329|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352330|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139352331|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139352332|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
139352333|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352334|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352335|NCT04679948|Midazolam|midazolam|mesh-list
139352336|NCT04679948|Caffeine|caffeine|mesh-list
139352337|NCT04679948|Omeprazole|omeprazole|mesh-list
139352338|NCT04679948|Warfarin|warfarin|mesh-list
139352339|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139352340|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139352341|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352342|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352343|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139352344|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139352345|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139352346|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139352347|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
139352348|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
139352349|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
139352350|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
139352351|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352352|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352353|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
139352354|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139352355|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139352356|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352357|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139352358|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139352359|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
139352360|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139181802|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139352361|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139352362|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139352363|NCT04647435|Tramadol|tramadol|mesh-list
139352364|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139352365|NCT04647435|Narcotics|narcotics|mesh-ancestor
139352366|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352367|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352368|NCT04647435|Analgesics|analgesics|mesh-ancestor
139352369|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
139352370|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352371|NCT04637529|Ibuprofen|ibuprofen|mesh-list
139352372|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139352373|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139352374|NCT04637529|Analgesics|analgesics|mesh-ancestor
139352375|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
139352376|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352377|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352378|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139352379|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352380|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139352381|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352382|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352383|NCT04625803|Apatinib|apatinib|mesh-list
139352384|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352385|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139352386|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352387|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352388|NCT04491084|Antibodies|antibodies|mesh-list
139352389|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
139352390|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
139352391|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352392|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139352393|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139352394|NCT04491084|Protective Agents|protective agents|mesh-ancestor
139352395|NCT04446117|Prednisone|prednisone|mesh-list
139352396|NCT04446117|Atezolizumab|atezolizumab|mesh-list
139352397|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
139352398|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139352399|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
139352400|NCT04446117|Hormones|hormones|mesh-ancestor
139352401|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139352402|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352403|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139352404|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352405|NCT04446117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139352406|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352407|NCT04446117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352408|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139352409|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352410|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
139352411|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139352412|NCT04397003|Durvalumab|durvalumab|mesh-list
139352413|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922416|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
139352414|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352415|NCT04326257|Nivolumab|nivolumab|mesh-list
139352416|NCT04326257|Ipilimumab|ipilimumab|mesh-list
139352417|NCT04326257|Relatlimab|relatlimab|mesh-list
139352418|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352419|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352420|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139352421|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352422|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
139352423|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139352424|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139352425|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139352426|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139352427|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139181806|NCT01119599|Temozolomide|temozolomide|mesh-list
139352428|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352429|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352430|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139352431|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139352432|NCT04114136|Metformin|metformin|mesh-list
139352433|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
139352434|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
139352435|NCT04114136|Nivolumab|nivolumab|mesh-list
139352436|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139352437|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352438|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352439|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352440|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139352441|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352442|NCT04112043|Niacinamide|niacinamide|mesh-list
139352444|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
139352445|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
139352446|NCT04112043|Vitamins|vitamins|mesh-ancestor
139352447|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
139352448|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352450|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
139352451|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352452|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139352453|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
139352454|NCT03997968|Rituximab|rituximab|mesh-list
139352455|NCT03997968|Gemcitabine|gemcitabine|mesh-list
139352456|NCT03997968|Capecitabine|capecitabine|mesh-list
139352457|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139352458|NCT03997968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352459|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352460|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
139352461|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352462|NCT03997968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352463|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139352464|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
138922430|NCT02588196|BB 1101|bb 1101|mesh-list
139352465|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352466|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139352467|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
139352468|NCT03995706|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139352469|NCT03995706|Immunoconjugates|immunoconjugates|mesh-ancestor
139352470|NCT03995706|Immunologic Factors|immunologic factors|mesh-ancestor
139352471|NCT03995706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352472|NCT03984097|Dexamethasone|dexamethasone|mesh-list
139352473|NCT03984097|Lenalidomide|lenalidomide|mesh-list
139352474|NCT03984097|Bortezomib|bortezomib|mesh-list
139352475|NCT03984097|Pomalidomide|pomalidomide|mesh-list
139352476|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139352477|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
139352478|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
139352479|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352480|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352481|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139352482|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
139352483|NCT03984097|Hormones|hormones|mesh-ancestor
139352484|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139352485|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139352486|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352487|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
139352488|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139352489|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139352490|NCT03984097|Growth Substances|growth substances|mesh-ancestor
139352491|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
139352492|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
139352493|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139352494|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139352495|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139352496|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352497|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
139352498|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352499|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352500|NCT03741478|Insulin|insulin|mesh-list
139352501|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139352502|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
139352503|NCT03741478|Olanzapine|olanzapine|mesh-list
139352504|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139352505|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352506|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
139352507|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
139352508|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352509|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139352510|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139352511|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139352512|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352513|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139352514|NCT03741478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139352515|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139352516|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139352517|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352518|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352519|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
139352520|NCT03669367|Abatacept|abatacept|mesh-list
139352521|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139009349|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
139352522|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352523|NCT03669367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352524|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352525|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139352526|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
139352527|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352528|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352529|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
139352530|NCT03630081|Meropenem|meropenem|mesh-list
139352531|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139352532|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139352533|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139352534|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139352535|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352536|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352537|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352538|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139352539|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139352540|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
139352541|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139352542|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352543|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352544|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139352545|NCT03522688|Analgesics|analgesics|mesh-ancestor
139352546|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
139352547|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352548|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139352549|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139352550|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139352551|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
139352552|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352553|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352554|NCT03493919|Vaccines|vaccines|mesh-list
139352555|NCT03493919|Immunologic Factors|immunologic factors|mesh-ancestor
139352556|NCT03493919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352557|NCT03326128|Bupropion|bupropion|mesh-list
139352558|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139352559|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
139352560|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139352561|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139352562|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139352563|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139352564|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352565|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
139352566|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352567|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352568|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139352569|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139352570|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352572|NCT03277924|Nivolumab|nivolumab|mesh-list
139352573|NCT03277924|Methotrexate|methotrexate|mesh-list
139352574|NCT03277924|Sunitinib|sunitinib|mesh-list
139352575|NCT03277924|Epirubicin|epirubicin|mesh-list
139352576|NCT03277924|Ifosfamide|ifosfamide|mesh-list
139352577|NCT03277924|Dacarbazine|dacarbazine|mesh-list
139352578|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352579|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139352580|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139352581|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139352582|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352583|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352584|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352585|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139352586|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139352587|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
139352588|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139352589|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352590|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139352591|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
139352592|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
139352593|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139352594|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139352595|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
139352596|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352597|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139352598|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139352599|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139352600|NCT03277924|Growth Substances|growth substances|mesh-ancestor
139352601|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
139352602|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139352603|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139352604|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
139352605|NCT03176134|Tedizolid|tedizolid|mesh-list
139352606|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
139352607|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139352608|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139352609|NCT03152786|Propranolol|propranolol|mesh-list
139352610|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139352611|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139352612|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
139352613|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352614|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352615|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352616|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139352617|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139352618|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
139352619|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
139352620|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139352621|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139352622|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
139352623|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352624|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352625|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139352626|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
139352627|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352628|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352629|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139352630|NCT02538484|Letrozole|letrozole|mesh-list
139352631|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352632|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139352633|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139352634|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352635|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352636|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139352637|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
139352638|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139352639|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352640|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
139352641|NCT02484391|Cytarabine|cytarabine|mesh-list
139352642|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
139352643|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139352644|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
139352645|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352646|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352647|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
139352648|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139352649|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139352650|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
139352651|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352652|NCT02484391|Analgesics|analgesics|mesh-ancestor
139352653|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
139352654|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352655|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139352656|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139352658|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
139352659|NCT02484391|Protective Agents|protective agents|mesh-ancestor
139352660|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
139352661|NCT02484391|Vitamins|vitamins|mesh-ancestor
139352662|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
139352663|NCT02478320|Ilorasertib|ilorasertib|mesh-list
139352664|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352665|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139352666|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352667|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352668|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139352669|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352670|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352671|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139352672|NCT02311998|Immunotoxins|immunotoxins|mesh-ancestor
139352673|NCT02311998|Immunoconjugates|immunoconjugates|mesh-ancestor
139352674|NCT02311998|Immunologic Factors|immunologic factors|mesh-ancestor
139352675|NCT02311998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352676|NCT02252042|Docetaxel|docetaxel|mesh-list
139352677|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
139352678|NCT02252042|Methotrexate|methotrexate|mesh-list
139352679|NCT02252042|Cetuximab|cetuximab|mesh-list
139352680|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352681|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
139352682|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
139352683|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
139352684|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352685|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352686|NCT02252042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139352687|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139352688|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
139352689|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139352690|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352691|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139352692|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
139352693|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
139352694|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352695|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139352696|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139352697|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
139352698|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352699|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139352700|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
139352701|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352702|NCT02099058|Nivolumab|nivolumab|mesh-list
138922505|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139352703|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139352704|NCT02099058|Osimertinib|osimertinib|mesh-list
139352705|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139352706|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352707|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352708|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139352709|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352710|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139352711|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352712|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
139352713|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352714|NCT01900847|Ketamine|ketamine|mesh-list
139352715|NCT01900847|Morphine|morphine|mesh-list
139352716|NCT01900847|Analgesics|analgesics|mesh-ancestor
139352717|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
139352718|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352719|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352720|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139352721|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139352722|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
139352723|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
139352724|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352725|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139352726|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139352727|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352728|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352729|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139352730|NCT01900847|Narcotics|narcotics|mesh-ancestor
139352731|NCT01710007|Atorvastatin|atorvastatin|mesh-list
139352732|NCT01710007|Pitavastatin|pitavastatin|mesh-list
139352733|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139352734|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139352735|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
139352736|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352737|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139352738|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139352739|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352740|NCT01357772|Tamoxifen|tamoxifen|mesh-list
139352741|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139352742|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
139009604|NCT03891667|Disulfiram|disulfiram|mesh-list
139352743|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139352744|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352745|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139352746|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352747|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139352748|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139352749|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139352750|NCT00378482|Tremelimumab|tremelimumab|mesh-list
139352751|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352752|NCT05813860|Infliximab|infliximab|mesh-list
139352753|NCT05813860|Azathioprine|azathioprine|mesh-list
139352754|NCT05813860|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139352755|NCT05813860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139352756|NCT05813860|Dermatologic Agents|dermatologic agents|mesh-ancestor
139352757|NCT05813860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139352758|NCT05813860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352759|NCT05813860|Antimetabolites|antimetabolites|mesh-ancestor
139352760|NCT05813860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352761|NCT05813860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139352762|NCT05813860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352763|NCT05813860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139352764|NCT05813860|Immunologic Factors|immunologic factors|mesh-ancestor
139352765|NCT05813860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352766|NCT05788276|Dapagliflozin|dapagliflozin|mesh-list
139352767|NCT05788276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139352768|NCT05788276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352769|NCT05788276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139352770|NCT05788276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352771|NCT05759572|Apatinib|apatinib|mesh-list
139352772|NCT05759572|Fulvestrant|fulvestrant|mesh-list
139352773|NCT05759572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352774|NCT05759572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139352775|NCT05759572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352776|NCT05759572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352777|NCT05759572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139352778|NCT05759572|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139352779|NCT05759572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139352780|NCT05759572|Hormone Antagonists|hormone antagonists|mesh-ancestor
139352781|NCT05759572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139352782|NCT05759572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352783|NCT05738694|Axitinib|axitinib|mesh-list
139352784|NCT05738694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352785|NCT05738694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139352786|NCT05738694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352787|NCT05738694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352788|NCT05731986|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
139352789|NCT05731986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139352790|NCT05731986|Immunologic Factors|immunologic factors|mesh-ancestor
139352791|NCT05731986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352792|NCT05725499|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
139352793|NCT05725499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139352794|NCT05725499|Immunologic Factors|immunologic factors|mesh-ancestor
139352795|NCT05725499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352797|NCT05708521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139352798|NCT05708521|Narcotics|narcotics|mesh-ancestor
139352799|NCT05708521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352800|NCT05708521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352801|NCT05708521|Analgesics|analgesics|mesh-ancestor
139352802|NCT05708521|Sensory System Agents|sensory system agents|mesh-ancestor
139352803|NCT05708521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352804|NCT05707234|Midazolam|midazolam|mesh-list
139352805|NCT05707234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139352806|NCT05707234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139352807|NCT05707234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352808|NCT05707234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352809|NCT05707234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139352810|NCT05707234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139352811|NCT05707234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139352812|NCT05707234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139352813|NCT05707234|Anesthetics, General|anesthetics, general|mesh-ancestor
139352814|NCT05707234|Anesthetics|anesthetics|mesh-ancestor
139352815|NCT05707234|GABA Modulators|gaba modulators|mesh-ancestor
139352816|NCT05707234|GABA Agents|gaba agents|mesh-ancestor
139352817|NCT05707234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009673|NCT03685773|Niacin|niacin|mesh-list
138922538|NCT00719121|Analgesics|analgesics|mesh-ancestor
139352818|NCT05707234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352819|NCT05702359|Vitamin D|vitamin d|mesh-list
139352820|NCT05702359|Ergocalciferols|ergocalciferols|mesh-list
139352821|NCT05702359|Cholecalciferol|cholecalciferol|mesh-list
139352822|NCT05702359|Vitamins|vitamins|mesh-list
139352823|NCT05702359|Micronutrients|micronutrients|mesh-ancestor
139352824|NCT05702359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352825|NCT05702359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139352826|NCT05702359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139352827|NCT05702073|Insulin Glargine|insulin glargine|mesh-list
139352828|NCT05702073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139352829|NCT05702073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352830|NCT05690282|Acetaminophen|acetaminophen|mesh-list
139352831|NCT05690282|Ibuprofen|ibuprofen|mesh-list
139352832|NCT05690282|Gabapentin|gabapentin|mesh-list
139352833|NCT05690282|Bupivacaine|bupivacaine|mesh-list
139352834|NCT05690282|Anesthetics, Local|anesthetics, local|mesh-ancestor
139352835|NCT05690282|Anesthetics|anesthetics|mesh-ancestor
139352836|NCT05690282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352837|NCT05690282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352838|NCT05690282|Sensory System Agents|sensory system agents|mesh-ancestor
139352839|NCT05690282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352840|NCT05690282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139352841|NCT05690282|Analgesics|analgesics|mesh-ancestor
139352842|NCT05690282|Antipyretics|antipyretics|mesh-ancestor
139352843|NCT05690282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139352844|NCT05690282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139352845|NCT05690282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352846|NCT05690282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139352847|NCT05690282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352848|NCT05690282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352849|NCT05690282|Anticonvulsants|anticonvulsants|mesh-ancestor
139352850|NCT05690282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139352851|NCT05690282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139352852|NCT05690282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139352853|NCT05690282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139352854|NCT05690282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139352855|NCT05690282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352856|NCT05690282|Antimanic Agents|antimanic agents|mesh-ancestor
139352857|NCT05677334|Insulin|insulin|mesh-list
139352858|NCT05677334|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139352859|NCT05677334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139352860|NCT05677334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352861|NCT05676645|Lumefantrine|lumefantrine|mesh-list
139352862|NCT05676645|Artemether|artemether|mesh-list
139352863|NCT05676645|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139352864|NCT05676645|Antimalarials|antimalarials|mesh-ancestor
139352865|NCT05676645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139352866|NCT05676645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139352867|NCT05676645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922548|NCT00719199|Cetuximab|cetuximab|mesh-list
139352868|NCT05591651|Hyaluronic Acid|hyaluronic acid|mesh-list
139352869|NCT05591651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139352870|NCT05591651|Immunologic Factors|immunologic factors|mesh-ancestor
139352871|NCT05591651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352872|NCT05591651|Viscosupplements|viscosupplements|mesh-ancestor
139352873|NCT05591651|Protective Agents|protective agents|mesh-ancestor
139352874|NCT05574504|Avelumab|avelumab|mesh-list
139352875|NCT05574504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139352876|NCT05574504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139352877|NCT05574504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352878|NCT05574504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352879|NCT05545670|Allopurinol|allopurinol|mesh-list
139352880|NCT05545670|Antimetabolites|antimetabolites|mesh-ancestor
139352881|NCT05545670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352882|NCT05545670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352883|NCT05545670|Gout Suppressants|gout suppressants|mesh-ancestor
139352884|NCT05545670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139352885|NCT05545670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139352886|NCT05545670|Antioxidants|antioxidants|mesh-ancestor
139352887|NCT05545670|Protective Agents|protective agents|mesh-ancestor
139352888|NCT05545670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352889|NCT05514106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139352890|NCT05514106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352891|NCT05514106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352892|NCT05514106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352893|NCT05514106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139352894|NCT05487794|Methyltestosterone|methyltestosterone|mesh-list
139352896|NCT05487794|Testosterone undecanoate|testosterone undecanoate|mesh-list
139352897|NCT05487794|Testosterone enanthate|testosterone enanthate|mesh-list
139352898|NCT05487794|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139352899|NCT05487794|Androgens|androgens|mesh-ancestor
139352900|NCT05487794|Hormones|hormones|mesh-ancestor
139352901|NCT05487794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139352902|NCT05487794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352903|NCT05487794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139352904|NCT05487794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352905|NCT05487794|Anabolic Agents|anabolic agents|mesh-ancestor
139352906|NCT05481528|Moxifloxacin|moxifloxacin|mesh-list
139352907|NCT05481528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139352908|NCT05481528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139352909|NCT05481528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139352910|NCT05481528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139352911|NCT05481528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352912|NCT05481528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352913|NCT05481528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352914|NCT05461131|Azithromycin|azithromycin|mesh-list
139352915|NCT05461131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139352916|NCT05461131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139352917|NCT05413863|Insulin|insulin|mesh-list
139352918|NCT05413863|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139352919|NCT05413863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139352920|NCT05413863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352921|NCT05374499|Epinephrine|epinephrine|mesh-list
139352922|NCT05374499|Bupivacaine|bupivacaine|mesh-list
139352923|NCT05374499|Anesthetics, Local|anesthetics, local|mesh-ancestor
139352924|NCT05374499|Anesthetics|anesthetics|mesh-ancestor
139352925|NCT05374499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352926|NCT05374499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352927|NCT05374499|Sensory System Agents|sensory system agents|mesh-ancestor
139352928|NCT05374499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352929|NCT05374499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139352930|NCT05374499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139352931|NCT05374499|Adrenergic Agents|adrenergic agents|mesh-ancestor
139352932|NCT05374499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352933|NCT05374499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352934|NCT05374499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139352935|NCT05374499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139352936|NCT05374499|Autonomic Agents|autonomic agents|mesh-ancestor
139352937|NCT05374499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139352938|NCT05374499|Respiratory System Agents|respiratory system agents|mesh-ancestor
139352939|NCT05374499|Mydriatics|mydriatics|mesh-ancestor
139352940|NCT05374499|Sympathomimetics|sympathomimetics|mesh-ancestor
139352941|NCT05374499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139352942|NCT05367492|Varenicline|varenicline|mesh-list
139352943|NCT05367492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139352944|NCT05367492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139352945|NCT05367492|Cholinergic Agents|cholinergic agents|mesh-ancestor
139352946|NCT05367492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352947|NCT05367492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352948|NCT05367492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352949|NCT05357690|Bupivacaine|bupivacaine|mesh-list
139352950|NCT05357690|Anesthetics, Local|anesthetics, local|mesh-ancestor
139352951|NCT05357690|Anesthetics|anesthetics|mesh-ancestor
139352952|NCT05357690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352953|NCT05357690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352954|NCT05357690|Sensory System Agents|sensory system agents|mesh-ancestor
139352955|NCT05357690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352956|NCT05341154|Dexmedetomidine|dexmedetomidine|mesh-list
139352957|NCT05341154|Ketamine|ketamine|mesh-list
139352958|NCT05341154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139352959|NCT05341154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139352960|NCT05341154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352961|NCT05341154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139352962|NCT05341154|Analgesics|analgesics|mesh-ancestor
139352963|NCT05341154|Sensory System Agents|sensory system agents|mesh-ancestor
139352964|NCT05341154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352965|NCT05341154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139352966|NCT05341154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139352967|NCT05341154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139352968|NCT05341154|Adrenergic Agents|adrenergic agents|mesh-ancestor
139352969|NCT05341154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139352970|NCT05341154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352971|NCT05341154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139352972|NCT05341154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139352973|NCT05341154|Anesthetics, General|anesthetics, general|mesh-ancestor
139352974|NCT05341154|Anesthetics|anesthetics|mesh-ancestor
139352975|NCT05341154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139352976|NCT05341154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139352977|NCT05330858|Rabeprazole|rabeprazole|mesh-list
139352978|NCT05330858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139352979|NCT05330858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139352980|NCT05330858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139352981|NCT05330858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139352982|NCT05330858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139352983|NCT05328102|Lenalidomide|lenalidomide|mesh-list
139352984|NCT05328102|Immunologic Factors|immunologic factors|mesh-ancestor
139352985|NCT05328102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352986|NCT05328102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139352987|NCT05328102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139352988|NCT05328102|Growth Substances|growth substances|mesh-ancestor
139352989|NCT05328102|Growth Inhibitors|growth inhibitors|mesh-ancestor
139352990|NCT05328102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139352991|NCT05317676|Palmidrol|palmidrol|mesh-list
139352992|NCT05317676|Analgesics|analgesics|mesh-ancestor
139352993|NCT05317676|Sensory System Agents|sensory system agents|mesh-ancestor
139352994|NCT05317676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139352995|NCT05317676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139352996|NCT05317676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139352997|NCT05317676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139352998|NCT05317676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139352999|NCT05317676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139353000|NCT05317676|Antiviral Agents|antiviral agents|mesh-ancestor
139353001|NCT05317676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139353002|NCT05317676|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139353003|NCT05317676|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139353004|NCT05317676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353005|NCT05317676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353006|NCT05317676|Hormones|hormones|mesh-ancestor
139353007|NCT05317676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139353008|NCT05312268|Rasburicase|rasburicase|mesh-list
139353009|NCT05312268|Gout Suppressants|gout suppressants|mesh-ancestor
139353010|NCT05312268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139353011|NCT05295927|Prednisone|prednisone|mesh-list
139353012|NCT05295927|Prednisolone|prednisolone|mesh-list
139353013|NCT05295927|Abiraterone Acetate|abiraterone acetate|mesh-list
139353014|NCT05295927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139353015|NCT05295927|Glucocorticoids|glucocorticoids|mesh-ancestor
139353016|NCT05295927|Hormones|hormones|mesh-ancestor
139353017|NCT05295927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139353018|NCT05295927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353019|NCT05295927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139353020|NCT05295927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353021|NCT05295927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139353022|NCT05295927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353023|NCT05295927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353024|NCT05295927|Hormone Antagonists|hormone antagonists|mesh-ancestor
139353025|NCT05295927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139353026|NCT05288673|Ravulizumab|ravulizumab|mesh-list
139353027|NCT05288673|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139353028|NCT05288673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139353029|NCT05288673|Immunologic Factors|immunologic factors|mesh-ancestor
139353030|NCT05288673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353031|NCT05288660|Ravulizumab|ravulizumab|mesh-list
139353032|NCT05288660|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139353033|NCT05288660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139353034|NCT05288660|Immunologic Factors|immunologic factors|mesh-ancestor
139353035|NCT05288660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353036|NCT05257460|Insulin|insulin|mesh-list
139353037|NCT05257460|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139353038|NCT05257460|Insulin Lispro|insulin lispro|mesh-list
139353039|NCT05257460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139353040|NCT05257460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353041|NCT05254626|Pioglitazone|pioglitazone|mesh-list
139353042|NCT05254626|Dapagliflozin|dapagliflozin|mesh-list
139353043|NCT05254626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139009933|NCT02516696|Hormones|hormones|mesh-ancestor
139353044|NCT05254626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353045|NCT05254626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139353046|NCT05254626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353047|NCT05246085|Hydrocortisone|hydrocortisone|mesh-list
139353048|NCT05246085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139353049|NCT05223335|Clopidogrel|clopidogrel|mesh-list
139353050|NCT05223335|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139353051|NCT05223335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139353052|NCT05223335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139353053|NCT05223335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139353054|NCT05223335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139353055|NCT05223335|Purinergic Agents|purinergic agents|mesh-ancestor
139353056|NCT05223335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353057|NCT05223335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353058|NCT05223335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353059|NCT05216653|Capecitabine|capecitabine|mesh-list
139353060|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
139353061|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139353062|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
139353063|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353064|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353065|NCT05211791|Anesthetics|anesthetics|mesh-list
139353066|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139353067|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353068|NCT05150587|Rifaximin|rifaximin|mesh-list
139353069|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139353070|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139353071|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139353072|NCT05143229|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139353073|NCT05143229|Immunoconjugates|immunoconjugates|mesh-ancestor
139353074|NCT05143229|Immunologic Factors|immunologic factors|mesh-ancestor
139353075|NCT05143229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353076|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
139353077|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353078|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353079|NCT05120596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139353080|NCT05120596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353081|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
139353082|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139353083|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182026|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139353084|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353085|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139353086|NCT05099055|Analgesics|analgesics|mesh-ancestor
139353087|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
139353088|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353089|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139353090|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139353091|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139353092|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
139353093|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353094|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353095|NCT05024344|Dexamethasone|dexamethasone|mesh-list
139353096|NCT05024344|Ropivacaine|ropivacaine|mesh-list
139353097|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139353098|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
139353099|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
139353100|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353101|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353102|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139353103|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
139353104|NCT05024344|Hormones|hormones|mesh-ancestor
139353105|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139353106|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139353107|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353108|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
139353109|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
139353110|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139353111|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
139353112|NCT04997304|Albuterol|albuterol|mesh-list
139353113|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139353114|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
139353115|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353116|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353117|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139353118|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
139353119|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139353120|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139353121|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139353122|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
139353123|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353124|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353125|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
139353126|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139353127|NCT04993027|Vancomycin|vancomycin|mesh-list
139353128|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139353129|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139353130|NCT04991324|Vitamin D|vitamin d|mesh-list
139353131|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
139353132|NCT04991324|Vitamins|vitamins|mesh-ancestor
139353133|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
139353134|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353135|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139353136|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139353137|NCT04984616|Atorvastatin|atorvastatin|mesh-list
139182055|NCT01585415|Aldesleukin|aldesleukin|mesh-list
139353138|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139353139|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139353140|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
139353141|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353142|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139353143|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139353144|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353145|NCT04966481|Cetuximab|cetuximab|mesh-list
139353146|NCT04966481|Palbociclib|palbociclib|mesh-list
139353147|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353148|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353149|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139353150|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353151|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353152|NCT04871412|Vitamin D|vitamin d|mesh-list
139353153|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
139353154|NCT04871412|Cholecalciferol|cholecalciferol|mesh-list
139353155|NCT04871412|Vitamins|vitamins|mesh-list
139353156|NCT04871412|Curcumin|curcumin|mesh-list
139353157|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
139353158|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353159|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139353160|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139353161|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139353162|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139353163|NCT04871412|Analgesics|analgesics|mesh-ancestor
139353164|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
139353165|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353166|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139353167|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139353168|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353169|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353170|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353172|NCT04868877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353173|NCT04868877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139353174|NCT04868877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353175|NCT04868877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353176|NCT04818086|Buprenorphine|buprenorphine|mesh-list
139353177|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139353178|NCT04818086|Lemborexant|lemborexant|mesh-list
139353179|NCT04818086|Naloxone|naloxone|mesh-list
139353180|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139353181|NCT04818086|Narcotics|narcotics|mesh-ancestor
139353182|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139353183|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353184|NCT04818086|Analgesics|analgesics|mesh-ancestor
139353185|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
139353186|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353187|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139353188|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139353189|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353190|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353191|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139353192|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139353193|NCT04799431|Poly I-C|poly i-c|mesh-list
139353194|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139353195|NCT04799431|Poly ICLC|poly iclc|mesh-list
139353196|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
139353197|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
139353198|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353199|NCT04799431|Laxatives|laxatives|mesh-ancestor
139353200|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139353201|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
139353202|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139353203|NCT04724668|Melatonin|melatonin|mesh-list
139353204|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
139353205|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353206|NCT04724668|Protective Agents|protective agents|mesh-ancestor
139353207|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353208|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139353209|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
139353210|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139353211|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139353212|NCT04685772|Prednisolone|prednisolone|mesh-list
139353213|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
139353214|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139353215|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
139353216|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139353217|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
139353218|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
139353219|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353220|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353221|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139353222|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
139353223|NCT04685772|Hormones|hormones|mesh-ancestor
139353224|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139353225|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139353226|NCT04685772|Protective Agents|protective agents|mesh-ancestor
139182122|NCT03843229|Bufanolides|bufanolides|mesh-list
139353228|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353229|NCT04609189|Vitamin D|vitamin d|mesh-list
139353230|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
139353231|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
139353232|NCT04609189|Calcium|calcium|mesh-list
139353233|NCT04609189|Vitamins|vitamins|mesh-ancestor
139353234|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
139353235|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353236|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139353237|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139353238|NCT04609189|Antacids|antacids|mesh-ancestor
139353239|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353240|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139353241|NCT04604795|Itraconazole|itraconazole|mesh-list
139353242|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
139353243|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139353244|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139353245|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139353246|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353247|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353248|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139353249|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
139353250|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139353251|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353252|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139353253|NCT04587128|Irinotecan|irinotecan|mesh-list
139353254|NCT04587128|Cetuximab|cetuximab|mesh-list
139353255|NCT04587128|Panitumumab|panitumumab|mesh-list
139353256|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139353257|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139353258|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353259|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353260|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353261|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353262|NCT04563273|Vaccines|vaccines|mesh-list
139353263|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
139353264|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
139353265|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353266|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139010108|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
139353267|NCT04552782|Ethanol|ethanol|mesh-list
139353268|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139353269|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139353270|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139353271|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353272|NCT04539977|Carboplatin|carboplatin|mesh-list
139353273|NCT04539977|Etoposide|etoposide|mesh-list
139353274|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
139353275|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353276|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139353277|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139353278|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139353279|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353280|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353281|NCT04535141|Olanzapine|olanzapine|mesh-list
139353282|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
139353283|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
139353284|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353285|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353286|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139353287|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139353288|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139353289|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139353290|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139353291|NCT04535141|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139353292|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139353293|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139182137|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353294|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353295|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353296|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
139353297|NCT04534023|Idebenone|idebenone|mesh-list
139353298|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
139353299|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353300|NCT04534023|Protective Agents|protective agents|mesh-ancestor
139353301|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353302|NCT04480918|Ketamine|ketamine|mesh-list
139353303|NCT04480918|Esketamine|esketamine|mesh-list
139353304|NCT04480918|Analgesics|analgesics|mesh-ancestor
139353305|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
139353306|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353307|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353308|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139353309|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139353310|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
139353311|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
139353312|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139353313|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139353314|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139353315|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353316|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353317|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
139353318|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139353319|NCT04374500|Verapamil|verapamil|mesh-list
139353320|NCT04374500|Nitroprusside|nitroprusside|mesh-list
139353321|NCT04374500|Acetylcholine|acetylcholine|mesh-list
139353322|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
139353323|NCT04374500|Bradykinin|bradykinin|mesh-list
139353324|NCT04374500|Substance P|substance p|mesh-list
139353325|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139353326|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139353327|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139353328|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353329|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139353330|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353331|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139353332|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139353333|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139353334|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
139353335|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353336|NCT04326283|Trametinib|trametinib|mesh-list
139353337|NCT04326283|Riluzole|riluzole|mesh-list
139353338|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353339|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139353340|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353341|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353342|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
139353343|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139353344|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139353345|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353346|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353347|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139182141|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139353348|NCT04326283|Protective Agents|protective agents|mesh-ancestor
139353349|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139353350|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
139353351|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139353352|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139353353|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139353354|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139353355|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353356|NCT04266353|Resveratrol|resveratrol|mesh-list
139353357|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
139353358|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353359|NCT04266353|Protective Agents|protective agents|mesh-ancestor
139353360|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353361|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353362|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139353363|NCT04231643|Dronabinol|dronabinol|mesh-list
139353364|NCT04231643|Cannabidiol|cannabidiol|mesh-list
139353365|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
139353366|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353367|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139353368|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139353369|NCT04231643|Analgesics|analgesics|mesh-ancestor
139353370|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
139353371|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353372|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139353373|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139353374|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353375|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353376|NCT04231643|Hormones|hormones|mesh-ancestor
139353377|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139353378|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
139353379|NCT04174196|Lenalidomide|lenalidomide|mesh-list
139353381|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
139353382|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353383|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139353384|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139353385|NCT04174196|Growth Substances|growth substances|mesh-ancestor
139353386|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
139353387|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353388|NCT04171167|Fluticasone|fluticasone|mesh-list
139353389|NCT04171167|Xhance|xhance|mesh-list
139353390|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139353391|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139353392|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
139353393|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353394|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353395|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139353396|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
139353397|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
139353398|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139353399|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
139353400|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139353401|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353402|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353403|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353404|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
139353405|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139353406|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
139353407|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353408|NCT04119284|Protective Agents|protective agents|mesh-ancestor
139353409|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353410|NCT04117763|Empagliflozin|empagliflozin|mesh-list
139353411|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139353412|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353413|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139353414|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353415|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
139353416|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
139353417|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353419|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353420|NCT04078880|Vitamins|vitamins|mesh-ancestor
139353421|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
139353422|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139353423|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139353424|NCT04071574|Cetrorelix|cetrorelix|mesh-list
139353425|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139353426|NCT04071574|Hormones|hormones|mesh-ancestor
139353427|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139353428|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353429|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
139353430|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139353431|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
139353432|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139353433|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139353434|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139353435|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353436|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139353437|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
139353438|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
139353439|NCT04002362|Triamcinolone|triamcinolone|mesh-list
139353440|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139353441|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139353442|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139353443|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139353444|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
139353445|NCT04002362|Hormones|hormones|mesh-ancestor
139353446|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139353447|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353448|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139353449|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
139353450|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353451|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353452|NCT03982186|JNJ-56136379|jnj-56136379|mesh-list
139353453|NCT03982186|Antiviral Agents|antiviral agents|mesh-ancestor
139353454|NCT03982186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139353455|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
139353456|NCT03970252|Leucovorin|leucovorin|mesh-list
139353457|NCT03970252|Folic Acid|folic acid|mesh-list
139353458|NCT03970252|Fluorouracil|fluorouracil|mesh-list
139353459|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
139353460|NCT03970252|Nivolumab|nivolumab|mesh-list
139353461|NCT03970252|Irinotecan|irinotecan|mesh-list
139353462|NCT03970252|Camptothecin|camptothecin|mesh-list
139353463|NCT03970252|Calcium|calcium|mesh-list
139353465|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139353466|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353467|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139353468|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
139353469|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353470|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139353471|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353472|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139353473|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
139353474|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353475|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139353476|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139353477|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139353478|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353479|NCT03970252|Antidotes|antidotes|mesh-ancestor
139353480|NCT03970252|Protective Agents|protective agents|mesh-ancestor
139353481|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
139353482|NCT03970252|Vitamins|vitamins|mesh-ancestor
139353483|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
139353484|NCT03970252|Hematinics|hematinics|mesh-ancestor
139353485|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139353486|NCT03932409|Paclitaxel|paclitaxel|mesh-list
139353487|NCT03932409|Carboplatin|carboplatin|mesh-list
139353488|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
139353489|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139353490|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353491|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
139353492|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
139353493|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
139353494|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353495|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353496|NCT03932409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139353498|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139353499|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139353500|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353501|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
139353502|NCT03907852|Nivolumab|nivolumab|mesh-list
139353503|NCT03907852|Fludarabine|fludarabine|mesh-list
139353504|NCT03907852|Ipilimumab|ipilimumab|mesh-list
139353505|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139353506|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
139353507|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353508|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139353509|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139353510|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
139353511|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353512|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353513|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139353514|NCT03907852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353515|NCT03907852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139353516|NCT03896633|Brinzolamide|brinzolamide|mesh-list
139353517|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139353518|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353519|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353520|NCT03890731|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139353521|NCT03890731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139353522|NCT03890731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353523|NCT03890731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353524|NCT03872180|Venetoclax|venetoclax|mesh-list
139353525|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139353526|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
139353527|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353528|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139353529|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
139353530|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353531|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353532|NCT03847649|Prednisone|prednisone|mesh-list
139353533|NCT03847649|Durvalumab|durvalumab|mesh-list
139353534|NCT03847649|Tremelimumab|tremelimumab|mesh-list
139353535|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139353536|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
139353537|NCT03847649|Hormones|hormones|mesh-ancestor
139353538|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139353539|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353540|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139353541|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353542|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353543|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
139353544|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139353545|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139353546|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139353547|NCT03847311|Analgesics|analgesics|mesh-ancestor
139353548|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
139353549|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353550|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353551|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139353552|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139353553|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139353554|NCT03845543|Paclitaxel|paclitaxel|mesh-list
139353555|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139353556|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353557|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
139353558|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
139353559|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
139353560|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353561|NCT03827889|Fluorides|fluorides|mesh-list
139353562|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
139353563|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
139353564|NCT03827889|Protective Agents|protective agents|mesh-ancestor
139353565|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353566|NCT03826563|Melatonin|melatonin|mesh-list
139353567|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
139353568|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353569|NCT03826563|Protective Agents|protective agents|mesh-ancestor
139353570|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353571|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139353572|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
139353573|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353574|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353575|NCT03823131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139353576|NCT03823131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353577|NCT03822091|Terlipressin|terlipressin|mesh-list
139353578|NCT03822091|Norepinephrine|norepinephrine|mesh-list
139353579|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139353580|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139353581|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139353582|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139353583|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
139353584|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353585|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922812|NCT02572089|Naloxone|naloxone|mesh-list
139353586|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353587|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
139353588|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
139353589|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353590|NCT03739619|Gemcitabine|gemcitabine|mesh-list
139353591|NCT03739619|Nivolumab|nivolumab|mesh-list
139353592|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139353593|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139353594|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
139353595|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353596|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353597|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353598|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139353599|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139353600|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
139353601|NCT03664544|Edaravone|edaravone|mesh-list
139353602|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139353603|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
139353604|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353605|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139353606|NCT03664544|Protective Agents|protective agents|mesh-ancestor
139353607|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353608|NCT03521570|Nivolumab|nivolumab|mesh-list
139353609|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353610|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353611|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139353612|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353613|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
139353614|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353615|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353616|NCT03468218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139353617|NCT03468218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353618|NCT03408574|Mecamylamine|mecamylamine|mesh-list
139353619|NCT03408574|Nicotine|nicotine|mesh-list
139353620|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139353621|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
139353622|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353623|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353624|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139353625|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139353626|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
139353627|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353628|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353629|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139353630|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
139353631|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139353632|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139353633|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
139353634|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353635|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353636|NCT03222570|Serotonin|serotonin|mesh-list
138922832|NCT04936854|Prednisolone|prednisolone|mesh-list
139353637|NCT03222570|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139353638|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139353639|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
139353640|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353641|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353642|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353643|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139353644|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139353645|NCT03136328|Edotreotide|edotreotide|mesh-list
139353646|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139353647|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353648|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
139353649|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139353650|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353651|NCT02966782|Azacitidine|azacitidine|mesh-list
139353652|NCT02966782|Venetoclax|venetoclax|mesh-list
139353653|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139353654|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
139353655|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353656|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353657|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353658|NCT02925650|Phenserine|phenserine|mesh-list
139353659|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139353660|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353661|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353662|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
139353663|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353664|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353665|NCT02914938|Rituximab|rituximab|mesh-list
139353666|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
139353667|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139353668|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353669|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
139353670|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353671|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139353672|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139353673|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353674|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353675|NCT02849457|Vigabatrin|vigabatrin|mesh-list
139353676|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
139353677|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353678|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353679|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
139353680|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353681|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353682|NCT02802631|Minocycline|minocycline|mesh-list
139353683|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139353684|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139353685|NCT02757898|Biotin|biotin|mesh-list
139353686|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
139353687|NCT02757898|Vitamins|vitamins|mesh-ancestor
139353688|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
139353689|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353690|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
139353691|NCT02730546|Leucovorin|leucovorin|mesh-list
139353692|NCT02730546|Folic Acid|folic acid|mesh-list
139353693|NCT02730546|Paclitaxel|paclitaxel|mesh-list
139353694|NCT02730546|Carboplatin|carboplatin|mesh-list
139353695|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
139353696|NCT02730546|Fluorouracil|fluorouracil|mesh-list
139353697|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
139353698|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139353699|NCT02730546|Calcium|calcium|mesh-list
139353700|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
139353701|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139353702|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353703|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
139353704|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
139353705|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
138584753|NCT04517188|Iodine|iodine|mesh-list
139353719|NCT02730546|Vitamins|vitamins|mesh-ancestor
139353720|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
139353721|NCT02730546|Hematinics|hematinics|mesh-ancestor
139353722|NCT02672098|Carboplatin|carboplatin|mesh-list
139353723|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353724|NCT02649335|Propranolol|propranolol|mesh-list
139353725|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139353726|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139353727|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
139353728|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353729|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353730|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353731|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139353732|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139353733|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
139353773|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
139353774|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353775|NCT02133872|Minocycline|minocycline|mesh-list
139353776|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139353777|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139353778|NCT01820858|Paclitaxel|paclitaxel|mesh-list
139353779|NCT01820858|Carboplatin|carboplatin|mesh-list
139353780|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139353781|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353782|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
139353783|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
139353784|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
139353785|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353786|NCT01755897|Paclitaxel|paclitaxel|mesh-list
139353787|NCT01755897|Cisplatin|cisplatin|mesh-list
139353788|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139353789|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353790|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
139353791|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
139010650|NCT00837317|Phenol|phenol|mesh-list
139353792|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
139353793|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353794|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139353796|NCT01738607|Laxatives|laxatives|mesh-ancestor
139353797|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139353798|NCT01738607|Cathartics|cathartics|mesh-ancestor
139353799|NCT01728259|Dexamethasone|dexamethasone|mesh-list
139353800|NCT01728259|Bortezomib|bortezomib|mesh-list
139353801|NCT01728259|Pomalidomide|pomalidomide|mesh-list
139353802|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139353803|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
139353804|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
139353805|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353806|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353807|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139353808|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
139353809|NCT01728259|Hormones|hormones|mesh-ancestor
139353810|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139353811|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139353812|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353813|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
139353814|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139353815|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139353816|NCT01728259|Growth Substances|growth substances|mesh-ancestor
139353817|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
139353818|NCT01722604|Brinzolamide|brinzolamide|mesh-list
139353819|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139353820|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353821|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353822|NCT01305499|Azacitidine|azacitidine|mesh-list
139353823|NCT01305499|Entinostat|entinostat|mesh-list
139353824|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139353825|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
139353826|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353827|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353828|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353829|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139353830|NCT01202994|Flutemetamol|flutemetamol|mesh-list
139353831|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139353832|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353833|NCT00930943|Oxymorphone|oxymorphone|mesh-list
139353834|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139353835|NCT00930943|Narcotics|narcotics|mesh-ancestor
139353836|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139353837|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353838|NCT00930943|Analgesics|analgesics|mesh-ancestor
139353839|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
139353840|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353841|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139353842|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
139353843|NCT00670670|Caseins|caseins|mesh-list
139353844|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139353845|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
139353846|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353847|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922918|NCT00720915|Anticoagulants|anticoagulants|mesh-list
139353848|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353849|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
139353850|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
139353851|NCT00670618|Fluorides|fluorides|mesh-list
139353852|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
139353853|NCT00670618|Protective Agents|protective agents|mesh-ancestor
139353854|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353855|NCT00620425|Sumatriptan|sumatriptan|mesh-list
139353856|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139353857|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139353858|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139353859|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
139353860|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353861|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353862|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353863|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
139353864|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139353865|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
139353866|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353867|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353868|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139353869|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
139353870|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139353871|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
139353872|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353873|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353874|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139353875|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
139353876|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
139353877|NCT00515281|Protective Agents|protective agents|mesh-ancestor
139353878|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139353879|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
139353880|NCT00504582|Coagulants|coagulants|mesh-ancestor
139353881|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139353882|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
139353883|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353884|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139353885|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
139353886|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139353887|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353888|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139353889|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139353890|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139353891|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
139353892|NCT00335114|Cyclosporine|cyclosporine|mesh-list
139353893|NCT00335114|Cyclosporins|cyclosporins|mesh-list
139353894|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353895|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353896|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139353897|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
139353898|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353899|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
139353900|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139353901|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
139353902|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139353903|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139353904|NCT03606577|Dexamethasone|dexamethasone|mesh-list
139353905|NCT03606577|Lenalidomide|lenalidomide|mesh-list
139353906|NCT03606577|Daratumumab|daratumumab|mesh-list
139353907|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139353908|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
139353909|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
139353910|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353911|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353912|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139353913|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
139353914|NCT03606577|Hormones|hormones|mesh-ancestor
139353915|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139353916|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139353917|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353918|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
139353919|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139353920|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139353921|NCT03606577|Growth Substances|growth substances|mesh-ancestor
139353922|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
139353923|NCT03601975|Gemcitabine|gemcitabine|mesh-list
139353924|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353925|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139353926|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
139353927|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353928|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139353929|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139353930|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353931|NCT03137186|Metformin|metformin|mesh-list
139353932|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139353933|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353934|NCT03137030|Acetaminophen|acetaminophen|mesh-list
139353935|NCT03137030|Hydrocodone|hydrocodone|mesh-list
139353936|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139353937|NCT03137030|Analgesics|analgesics|mesh-ancestor
139353938|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
139353939|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139353940|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353941|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
139353942|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139353943|NCT03137030|Narcotics|narcotics|mesh-ancestor
139353944|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139353945|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
139353946|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
139353947|NCT03596749|Sevelamer|sevelamer|mesh-list
139353948|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
139353949|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
139353950|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353951|NCT01595061|Cisplatin|cisplatin|mesh-list
139353952|NCT01595061|Gemcitabine|gemcitabine|mesh-list
139353953|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353954|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139353955|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
139353956|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353957|NCT03367143|Carboplatin|carboplatin|mesh-list
139353958|NCT03367143|Etoposide|etoposide|mesh-list
139353959|NCT03367143|Lenalidomide|lenalidomide|mesh-list
139353960|NCT03367143|Ifosfamide|ifosfamide|mesh-list
139353961|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353962|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139353963|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139353964|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139353965|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353966|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353967|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
139353968|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353969|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139353970|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139353971|NCT03367143|Growth Substances|growth substances|mesh-ancestor
139353972|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
139353973|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139353974|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
139353975|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
139353976|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139353977|NCT04762316|Pyridoxal|pyridoxal|mesh-list
139353978|NCT04762316|Pyridoxine|pyridoxine|mesh-list
139353979|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
139353980|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
139353981|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
139353982|NCT04762316|Vitamins|vitamins|mesh-ancestor
139353983|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
139353984|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353985|NCT03372447|Thiamine|thiamine|mesh-list
139353986|NCT03372447|Pyridoxine|pyridoxine|mesh-list
139353987|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
139353988|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
139353989|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
139353990|NCT03372447|Vitamins|vitamins|mesh-ancestor
139353991|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
139353992|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139353993|NCT03372447|Hematinics|hematinics|mesh-ancestor
139353994|NCT03376191|Apatinib|apatinib|mesh-list
139353995|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139353996|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139353997|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139353998|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139353999|NCT03366597|Sevoflurane|sevoflurane|mesh-list
139354000|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139354001|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139354002|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
139354003|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
139354004|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354005|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354006|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
139354007|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139354008|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
139354009|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
139354010|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354011|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354012|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
139354013|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354014|NCT03109886|Maleic acid|maleic acid|mesh-list
139354015|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354016|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354017|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
139354018|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139354019|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139354020|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139354021|NCT03110198|Mesalamine|mesalamine|mesh-list
139354022|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139354023|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139354024|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139354025|NCT03110198|Analgesics|analgesics|mesh-ancestor
139354026|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
139354027|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354028|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354029|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139354030|NCT04460781|Vaccines|vaccines|mesh-list
139354031|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
139354032|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354033|NCT03371589|Dexamethasone|dexamethasone|mesh-list
139354034|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139354035|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
139354036|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
139354037|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354038|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354039|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139354040|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
139354041|NCT03371589|Hormones|hormones|mesh-ancestor
139354042|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139354043|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139354044|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354045|NCT03365817|Fentanyl|fentanyl|mesh-list
139354046|NCT03365817|Morphine|morphine|mesh-list
139354047|NCT03365817|Oxycodone|oxycodone|mesh-list
139354048|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
139354049|NCT03365817|Tramadol|tramadol|mesh-list
139354050|NCT03365817|Methadone|methadone|mesh-list
139354051|NCT03365817|Narcotics|narcotics|mesh-ancestor
139354052|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354053|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354054|NCT03365817|Analgesics|analgesics|mesh-ancestor
139354055|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
139354056|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354057|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139354058|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139354059|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
139354060|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
139354061|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
139354062|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
139354063|NCT02852005|Vaccines|vaccines|mesh-list
139354064|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
139354065|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354066|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
139354067|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139354068|NCT03365115|Fentanyl|fentanyl|mesh-list
139354069|NCT03365115|Morphine|morphine|mesh-list
139354070|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139354071|NCT03365115|Narcotics|narcotics|mesh-ancestor
139354072|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354073|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354074|NCT03365115|Analgesics|analgesics|mesh-ancestor
139354075|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
139354076|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354077|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139354078|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139354079|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
139354080|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
139354081|NCT02237755|Citric Acid|citric acid|mesh-list
139354082|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
139354083|NCT02237755|Clomiphene|clomiphene|mesh-list
139354084|NCT02237755|Enclomiphene|enclomiphene|mesh-list
139354085|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
139354086|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
139354087|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139354088|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
139354089|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
139354090|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354091|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139354092|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
139354093|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139354094|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010926|NCT00347776|Azithromycin|azithromycin|mesh-list
139354095|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139354096|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
139354097|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139354098|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139354099|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139354101|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139354102|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139354103|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139354104|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139354105|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
139354106|NCT04524897|Hormones|hormones|mesh-ancestor
139354107|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139354108|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354109|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139354110|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
139354111|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354112|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354113|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
139354114|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139354115|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139354116|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354117|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
139354118|NCT03364569|Coagulants|coagulants|mesh-ancestor
139354119|NCT03363477|Enoxaparin|enoxaparin|mesh-list
139354120|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
139354121|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
139354122|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139354123|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139354124|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354126|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139354127|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354128|NCT03592537|Midazolam|midazolam|mesh-list
139354129|NCT03592537|Fentanyl|fentanyl|mesh-list
139354130|NCT03592537|Bupivacaine|bupivacaine|mesh-list
139354131|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
139354132|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
139354133|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354134|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354135|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
139354136|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354137|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139354138|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139354139|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139354140|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139354141|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139354142|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139354143|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
139354144|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
139354145|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
139354146|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922973|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139354147|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354148|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139354149|NCT03592537|Narcotics|narcotics|mesh-ancestor
139354150|NCT03592537|Analgesics|analgesics|mesh-ancestor
139354151|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
139354152|NCT03362853|Nemonoxacin|nemonoxacin|mesh-list
139354153|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139354154|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139354155|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139354156|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139354157|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354158|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354159|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354160|NCT02849743|Oxytocin|oxytocin|mesh-list
139354161|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
139354162|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139354163|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354164|NCT05063006|Methamphetamine|methamphetamine|mesh-list
139354165|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139354166|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354167|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
139354168|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
139354169|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354170|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
139354171|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354172|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354173|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
139354174|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139354175|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139354176|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139354177|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139354178|NCT03587077|Isosorbide|isosorbide|mesh-list
139354179|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139354180|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139354181|NCT03587077|Misoprostol|misoprostol|mesh-list
139354182|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139354183|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
139354184|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139354185|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354186|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139354187|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139354188|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
139354189|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139354190|NCT03587077|Diuretics|diuretics|mesh-ancestor
139354191|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
139354192|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
139354193|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139354194|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354195|NCT02238457|Losartan|losartan|mesh-list
139354196|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139354197|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139354198|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139354199|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139354200|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354201|NCT02238535|Iloprost|iloprost|mesh-list
139354202|NCT02238535|Warfarin|warfarin|mesh-list
139354203|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
139354204|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139354205|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
139354206|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139354207|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139354208|NCT03909074|Vaccines|vaccines|mesh-list
139354209|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
139354210|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354211|NCT03138668|Ropivacaine|ropivacaine|mesh-list
139354212|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
139354213|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
139354214|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354215|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354216|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
139354217|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354218|NCT03371043|Analgesics|analgesics|mesh-list
139354219|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
139354220|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354221|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354222|NCT03600961|Sirolimus|sirolimus|mesh-list
139354223|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139354224|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139354225|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139354226|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354227|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
139354228|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139354229|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
139354230|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354231|NCT05013242|Goserelin|goserelin|mesh-list
139354232|NCT05013242|Dienogest|dienogest|mesh-list
139354233|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139354234|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354235|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139354236|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
139354237|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139354238|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354239|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139354240|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139354241|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139354242|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139354243|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
139354244|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139354245|NCT03590275|Folfirinox|folfirinox|mesh-list
139354246|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354247|NCT05089448|Amlodipine|amlodipine|mesh-list
139354248|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139354249|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139011073|NCT04926324|Dostarlimab|dostarlimab|mesh-list
139354250|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139354251|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354252|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139354253|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354254|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
139354255|NCT02849509|Vitamin K|vitamin k|mesh-list
139354256|NCT02849509|Dabigatran|dabigatran|mesh-list
139354257|NCT02849509|Vitamins|vitamins|mesh-ancestor
139354258|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
139354259|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354260|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
139354261|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139354262|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
139354263|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354264|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354265|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
139354266|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139354267|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139354268|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
139354269|NCT02849509|Coagulants|coagulants|mesh-ancestor
139354270|NCT00151424|Olanzapine|olanzapine|mesh-list
139354271|NCT00151424|Asenapine|asenapine|mesh-list
139354272|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
139354273|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
139354274|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354275|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354276|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139354277|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139354278|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139354279|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354280|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139354281|NCT00151424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139354282|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139354283|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139354284|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354285|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354286|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
139354287|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
139354288|NCT03600727|Propofol|propofol|mesh-list
139354289|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139354290|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354291|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354292|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139354293|NCT03600727|Analgesics|analgesics|mesh-ancestor
139354294|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
139354295|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354296|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139354297|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139354298|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139354299|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
139354300|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354301|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354302|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139354303|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
139354304|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
139354305|NCT03584893|Dehydrocholesterols|dehydrocholesterols|mesh-list
139354306|NCT03584893|Provitamins|provitamins|mesh-ancestor
139354307|NCT03584893|Vitamins|vitamins|mesh-ancestor
139354308|NCT03584893|Micronutrients|micronutrients|mesh-ancestor
139354309|NCT03584893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354310|NCT03362073|Ketamine|ketamine|mesh-list
139354311|NCT03362073|Analgesics|analgesics|mesh-ancestor
139354312|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
139354313|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354314|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354315|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139354316|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139354317|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
139354319|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354320|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139354321|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139354322|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354323|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354324|NCT03582865|Tamoxifen|tamoxifen|mesh-list
139354325|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139354326|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
139354327|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139354329|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139354330|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354331|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139354332|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139354333|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139354334|NCT03136406|Leucovorin|leucovorin|mesh-list
139354335|NCT03136406|Paclitaxel|paclitaxel|mesh-list
139354336|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
139354337|NCT03136406|Bevacizumab|bevacizumab|mesh-list
139354338|NCT03136406|Capecitabine|capecitabine|mesh-list
139354339|NCT03136406|Fluorouracil|fluorouracil|mesh-list
139354340|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
139354341|NCT03136406|Avelumab|avelumab|mesh-list
139354342|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139354343|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354344|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
139354345|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
139354346|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
139354347|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354348|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139354349|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
139354350|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354351|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139354352|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139354353|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
139354354|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139354355|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139354356|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139354357|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139354358|NCT03136406|Growth Substances|growth substances|mesh-ancestor
139354359|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
139354360|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139354361|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
139354362|NCT03136406|Antidotes|antidotes|mesh-ancestor
139354363|NCT03136406|Protective Agents|protective agents|mesh-ancestor
139354364|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
139354365|NCT03136406|Vitamins|vitamins|mesh-ancestor
139354366|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
139354367|NCT03590197|Melatonin|melatonin|mesh-list
139354368|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
139354369|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354370|NCT03590197|Protective Agents|protective agents|mesh-ancestor
139354371|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354372|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354373|NCT03357315|Immunomodulating Agents|immunomodulating agents|mesh-list
139354374|NCT03357315|Immunologic Factors|immunologic factors|mesh-ancestor
139354375|NCT03357315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354376|NCT05057468|Cyclosporine|cyclosporine|mesh-list
139354377|NCT05057468|Rituximab|rituximab|mesh-list
139354378|NCT05057468|Cyclosporins|cyclosporins|mesh-list
139354379|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139354380|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354381|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
139354382|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354383|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139354384|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354385|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354386|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139354387|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
139354388|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139354389|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
139354390|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139354392|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139354393|NCT02518503|Simvastatin|simvastatin|mesh-list
139354394|NCT02518503|Pravastatin|pravastatin|mesh-list
139354395|NCT02518503|Lovastatin|lovastatin|mesh-list
139354396|NCT02518503|L 647318|l 647318|mesh-list
139354397|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
139354398|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139354399|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139354400|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
139354401|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354402|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139354403|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139354404|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354406|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
139354407|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
139354408|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
139354409|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354410|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354411|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
139354412|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354413|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139354414|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139354415|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139354416|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139354417|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354418|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139354419|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139354420|NCT03600493|Analgesics|analgesics|mesh-ancestor
139354421|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139354422|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139354423|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139354424|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
139354425|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354426|NCT03138356|Metformin|metformin|mesh-list
139354427|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
139354428|NCT03138356|Saxagliptin|saxagliptin|mesh-list
139354429|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139354430|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354431|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139354432|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354433|NCT03138356|Incretins|incretins|mesh-ancestor
139354434|NCT03138356|Hormones|hormones|mesh-ancestor
139354435|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139354436|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139354437|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
139354438|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354439|NCT03137966|Deferoxamine|deferoxamine|mesh-list
139354440|NCT03137966|Siderophores|siderophores|mesh-ancestor
139354441|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139354442|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
139354443|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
139354444|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354445|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
139354446|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139354447|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
139354448|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354449|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
139354450|NCT04521387|Protective Agents|protective agents|mesh-ancestor
139354451|NCT03579979|Methylene Blue|methylene blue|mesh-list
139354452|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354453|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354454|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
139354455|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139354456|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139354457|NCT04509219|Prednisolone|prednisolone|mesh-list
139354458|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
139354459|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139354460|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
139354461|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139354462|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
139354463|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
139354464|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354465|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354466|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139354467|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
139354468|NCT04509219|Hormones|hormones|mesh-ancestor
139354469|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139354470|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139354471|NCT04509219|Protective Agents|protective agents|mesh-ancestor
139354472|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139354473|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354474|NCT04444635|Fentanyl|fentanyl|mesh-list
139354475|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139354476|NCT04444635|Narcotics|narcotics|mesh-ancestor
139011306|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
139354477|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354478|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354479|NCT04444635|Analgesics|analgesics|mesh-ancestor
139354480|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
139354481|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354482|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139354483|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139354484|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
139354485|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
139354486|NCT03579823|Adalimumab|adalimumab|mesh-list
139354487|NCT03579823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139354488|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139354489|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139354490|NCT04444011|Amoxicillin|amoxicillin|mesh-list
139354491|NCT04444011|Clarithromycin|clarithromycin|mesh-list
139354492|NCT04444011|Bismuth|bismuth|mesh-list
139354493|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139354494|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139354495|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139354496|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354497|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354498|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139354499|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139354500|NCT04444011|Antacids|antacids|mesh-ancestor
139354501|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139354502|NCT04443387|Vitamin D|vitamin d|mesh-list
139354503|NCT04443387|Vitamins|vitamins|mesh-ancestor
139354504|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
139354505|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354506|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139354507|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
139354508|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139354509|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354510|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354511|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139354512|NCT02316236|Analgesics|analgesics|mesh-ancestor
139354513|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
139354514|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354515|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139354516|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139354517|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139354518|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
139354519|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354520|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354521|NCT04521075|Nivolumab|nivolumab|mesh-list
139354522|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139354523|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354524|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139354525|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354526|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
139354527|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139354529|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
139354530|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139354531|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354532|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354533|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139354534|NCT03601091|Analgesics|analgesics|mesh-ancestor
139354535|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
139354536|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354537|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139354538|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139354539|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139354540|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
139354541|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354542|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354543|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139354544|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139354545|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139354546|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139354547|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139354548|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
139354549|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
139354550|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
139354551|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
139354552|NCT04508829|Antibodies|antibodies|mesh-list
139354553|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139354554|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
139354555|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354556|NCT04521309|Antibodies|antibodies|mesh-list
139354557|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
139354558|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354559|NCT04521153|Apatinib|apatinib|mesh-list
139354560|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354561|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139354562|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354563|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354564|NCT04362566|Bupivacaine|bupivacaine|mesh-list
139354565|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
139354566|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
139354567|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354568|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354569|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
139354570|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354571|NCT03579589|Neostigmine|neostigmine|mesh-list
139354572|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139354573|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354574|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354575|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
139354576|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354577|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354578|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139354579|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
139354580|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354581|NCT03600623|Paclitaxel|paclitaxel|mesh-list
139354582|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139354583|NCT03600623|Gemcitabine|gemcitabine|mesh-list
139354584|NCT03600623|Fluorouracil|fluorouracil|mesh-list
139354585|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
139354586|NCT03600623|Irinotecan|irinotecan|mesh-list
139354587|NCT03600623|Folfirinox|folfirinox|mesh-list
139354588|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139354589|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354590|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
139354591|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
139354592|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
138923153|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
139354593|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354594|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139354595|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
139354596|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139354597|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
139354598|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354599|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139354600|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139354601|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354602|NCT02848729|Acetaminophen|acetaminophen|mesh-list
139354603|NCT02848729|Morphine|morphine|mesh-list
139354604|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139354605|NCT02848729|Narcotics|narcotics|mesh-ancestor
139354606|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354607|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354608|NCT02848729|Analgesics|analgesics|mesh-ancestor
139354609|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
139354610|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354611|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139354612|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
139354613|NCT03600467|Seviteronel|seviteronel|mesh-list
139354614|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354615|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139354616|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354617|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354618|NCT04520919|Anesthetics|anesthetics|mesh-list
139354619|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354620|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354621|NCT03600311|Vitamin D|vitamin d|mesh-list
139354622|NCT03600311|Calcium|calcium|mesh-list
139354623|NCT03600311|Vitamins|vitamins|mesh-ancestor
139354624|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
139354625|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354626|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139354627|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139011452|NCT00527826|Fluticasone|fluticasone|mesh-list
139354628|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
139354629|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139354630|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
139354631|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
139354632|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139354633|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139354634|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354635|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354636|NCT03603119|Dexamethasone|dexamethasone|mesh-list
139354637|NCT03603119|Midazolam|midazolam|mesh-list
139354638|NCT03603119|Ondansetron|ondansetron|mesh-list
139354639|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139354640|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
139354641|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
139354642|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354643|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354644|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139354645|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
139354646|NCT03603119|Hormones|hormones|mesh-ancestor
139354647|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139354648|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139354649|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354650|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139354651|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139354652|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354653|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139354654|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139354655|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139354656|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139354657|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
139354658|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
139354659|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
139354660|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
139354661|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354662|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354664|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
139354665|NCT03603119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139354666|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139354667|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
139354668|NCT03356769|Aspirin|aspirin|mesh-list
139354669|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
139354670|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139354671|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139354672|NCT03356769|Analgesics|analgesics|mesh-ancestor
139354673|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
139354674|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354675|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354676|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139354677|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139354678|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139354679|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139354680|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354681|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139354682|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139354683|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354684|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
139354685|NCT04508439|Heparin|heparin|mesh-list
139354686|NCT04508439|Enoxaparin|enoxaparin|mesh-list
139354687|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139354688|NCT04508439|Tinzaparin|tinzaparin|mesh-list
139354689|NCT04508439|Dalteparin|dalteparin|mesh-list
139354690|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
139354691|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139354692|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139354693|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354694|NCT02237651|Anesthetics|anesthetics|mesh-list
139354695|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354696|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354697|NCT02237729|Adalimumab|adalimumab|mesh-list
139354698|NCT02237729|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139354699|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139354700|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139354701|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
139354702|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
139354703|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139354704|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
139354705|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354706|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354707|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139354708|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
138516748|NCT00016133|Antidotes|antidotes|mesh-ancestor
139354709|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139354710|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139354711|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139354712|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
139354713|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354714|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354715|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
139354716|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139354717|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
139354718|NCT03354117|Meloxicam|meloxicam|mesh-list
139354719|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
139354720|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139354721|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139354722|NCT03354117|Analgesics|analgesics|mesh-ancestor
139354723|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
139354724|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354725|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354726|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139354727|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139354728|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139354729|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139354730|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354731|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354732|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139354733|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
139354734|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139354735|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139354736|NCT03360981|Incretins|incretins|mesh-list
139354737|NCT03360981|Hormones|hormones|mesh-ancestor
139354738|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139354739|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354740|NCT03597815|Aflibercept|aflibercept|mesh-list
139354741|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139354742|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139354743|NCT03597815|Growth Substances|growth substances|mesh-ancestor
139354744|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354745|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
139354746|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354747|NCT03595085|Streptokinase|streptokinase|mesh-list
139354748|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139354749|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139354750|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354751|NCT00158756|Vaccines|vaccines|mesh-list
139354752|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
139354753|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354754|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139354755|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
139354756|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139354757|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
139354758|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139354759|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354760|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139354761|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139354762|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354763|NCT04519125|Tenofovir|tenofovir|mesh-list
139354764|NCT04519125|Emtricitabine|emtricitabine|mesh-list
139354765|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
139354766|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139354767|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139354768|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139354769|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354770|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354771|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139354772|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139354773|NCT02730195|Pioglitazone|pioglitazone|mesh-list
139354774|NCT02730195|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139354775|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139354776|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354777|NCT02730195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139354778|NCT02730195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011604|NCT00520572|Etanercept|etanercept|mesh-list
139354779|NCT02730195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354780|NCT03360279|Paclitaxel|paclitaxel|mesh-list
139354781|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139354782|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354783|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
139354784|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
139354785|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
139354786|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354787|NCT03353103|Listerine|listerine|mesh-list
139354788|NCT03353103|Fluorides|fluorides|mesh-list
139354789|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
139354790|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
139354791|NCT03353103|Protective Agents|protective agents|mesh-ancestor
139354792|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354793|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139354794|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139354795|NCT03360123|Midazolam|midazolam|mesh-list
139354796|NCT03360123|Triazolam|triazolam|mesh-list
139354797|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139354798|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139354799|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354800|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354801|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139354802|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139354803|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139354804|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139354805|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
139354806|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
139354807|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
139354808|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
139354809|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354810|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354811|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
139354812|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
139354813|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139354814|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139354815|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354816|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
139354817|NCT03360045|Coagulants|coagulants|mesh-ancestor
139354818|NCT03353025|Dopamine|dopamine|mesh-list
139354819|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
139354820|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138519148|NCT00392561|Vitamin E|vitamin e|mesh-list
139354821|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
139354822|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
139354823|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354824|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354825|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
139354826|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354827|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354828|NCT03353025|Protective Agents|protective agents|mesh-ancestor
139354829|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139354830|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139354831|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354832|NCT04506957|Chrysarobin|chrysarobin|mesh-list
139354833|NCT04506957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139354834|NCT04506957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139354835|NCT04506957|Analgesics|analgesics|mesh-ancestor
139354836|NCT04506957|Sensory System Agents|sensory system agents|mesh-ancestor
139354837|NCT04506957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354838|NCT04506957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354839|NCT04506957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139354840|NCT04506957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139354841|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139354842|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139354843|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139354844|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
139354845|NCT03352947|Trametinib|trametinib|mesh-list
139354846|NCT03352947|Dabrafenib|dabrafenib|mesh-list
139354847|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354848|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139354849|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354850|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354851|NCT02730351|Fluticasone|fluticasone|mesh-list
139354852|NCT02730351|Xhance|xhance|mesh-list
139354853|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139354854|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139354855|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
139354856|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354857|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354858|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139354859|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
139354860|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
139354861|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139354862|NCT03359655|Scopolamine|scopolamine|mesh-list
139354863|NCT03359655|Bromides|bromides|mesh-list
139354864|NCT03359655|Misoprostol|misoprostol|mesh-list
139354865|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139354866|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139354867|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
139354868|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139354869|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354870|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139354871|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139354872|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
139354873|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
139354874|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139354875|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
139354876|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
139354877|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354878|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
139354879|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139354880|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
139354881|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354882|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923223|NCT04067505|Nadroparin|nadroparin|mesh-list
139354883|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139354884|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
139354885|NCT03352869|Metformin|metformin|mesh-list
139354886|NCT03352869|Exenatide|exenatide|mesh-list
139354887|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139354888|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354889|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139354890|NCT03352869|Incretins|incretins|mesh-ancestor
139354891|NCT03352869|Hormones|hormones|mesh-ancestor
139354892|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139354893|NCT03359499|Trimebutine|trimebutine|mesh-list
139354894|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139354895|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
139354896|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
139354897|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354898|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354899|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
139354900|NCT03352479|Narcotics|narcotics|mesh-ancestor
139354901|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354902|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354903|NCT03352479|Analgesics|analgesics|mesh-ancestor
139354904|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
139354905|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354906|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
139354907|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139354908|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139354909|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354910|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139354911|NCT03355053|Analgesics|analgesics|mesh-ancestor
139354912|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
139354913|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354914|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139354915|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139354916|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139354917|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
139354918|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354919|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354920|NCT03358953|Nicotine|nicotine|mesh-list
139354921|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139354922|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
139354923|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139354924|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354925|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139354926|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139354927|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
139354928|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139354929|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354930|NCT04509999|Bicalutamide|bicalutamide|mesh-list
139354931|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
139354932|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
139354933|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139354934|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354935|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354937|NCT04505943|Misoprostol|misoprostol|mesh-list
139354938|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139354939|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
139354940|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139354941|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354942|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139354943|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139354944|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
139354945|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
139354946|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139354947|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139354948|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139354949|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139354950|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
139354951|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354952|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139354953|NCT03358719|Poly I-C|poly i-c|mesh-list
139354954|NCT03358719|Nivolumab|nivolumab|mesh-list
139354955|NCT03358719|Decitabine|decitabine|mesh-list
139354956|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139354957|NCT03358719|Poly ICLC|poly iclc|mesh-list
139354958|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139354959|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354960|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139354961|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354962|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139354963|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
139354964|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354965|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
139354966|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
139354967|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354968|NCT03358719|Laxatives|laxatives|mesh-ancestor
139354969|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139354970|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
139354971|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139354972|NCT04505475|Hemostatics|hemostatics|mesh-list
139354973|NCT04505475|Coagulants|coagulants|mesh-ancestor
139354974|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139354975|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139354976|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
139354977|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354978|NCT03350373|Dotinurad|dotinurad|mesh-list
139354979|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
139354980|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
139354981|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139354982|NCT03350295|Nifurtimox|nifurtimox|mesh-list
139354983|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139354984|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139354985|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139354986|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139354987|NCT03349983|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139354988|NCT03349983|Antiviral Agents|antiviral agents|mesh-ancestor
139354989|NCT03349983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139354990|NCT03349827|Apatinib|apatinib|mesh-list
139354991|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139354992|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139354993|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139354994|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139354995|NCT04503915|Estrogens|estrogens|mesh-list
139354996|NCT04503915|Hormones|hormones|mesh-ancestor
139354997|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138923240|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139354998|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139354999|NCT04504851|Rifampin|rifampin|mesh-list
139355000|NCT04504851|Isoniazid|isoniazid|mesh-list
139355001|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
139355002|NCT04504851|Ethambutol|ethambutol|mesh-list
139355003|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139355004|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139355005|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139355006|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
139355007|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355008|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139355009|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139355010|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355011|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139355012|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
139355013|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139355014|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355015|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
139355016|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139355017|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139355018|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139355019|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139355020|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139355021|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139355022|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139355023|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139355024|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139355025|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
139355026|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355027|NCT03030261|Dexamethasone|dexamethasone|mesh-list
139355028|NCT03030261|Pomalidomide|pomalidomide|mesh-list
139355029|NCT03030261|Elotuzumab|elotuzumab|mesh-list
139355030|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139355031|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
139355032|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
139355033|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355034|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355035|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139355036|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
139355037|NCT03030261|Hormones|hormones|mesh-ancestor
139355038|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139355039|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139355040|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355041|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
139355042|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139355043|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139355044|NCT03030261|Growth Substances|growth substances|mesh-ancestor
139355045|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
139355046|NCT02176161|Metformin|metformin|mesh-list
139355047|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139355048|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355049|NCT03348735|Lidocaine|lidocaine|mesh-list
139355050|NCT03348735|Pregabalin|pregabalin|mesh-list
139355051|NCT03348735|Capsaicin|capsaicin|mesh-list
139355052|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
139355053|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
139355054|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139355055|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355056|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
139355057|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355058|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139355059|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139355060|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139355061|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138522618|NCT04742699|Lemborexant|lemborexant|mesh-list
139355062|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355063|NCT03348735|Analgesics|analgesics|mesh-ancestor
139355064|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
139355065|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139355066|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139355067|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139355068|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139355069|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139355070|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
139355071|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
139355072|NCT01700673|Azacitidine|azacitidine|mesh-list
139355073|NCT01700673|Sargramostim|sargramostim|mesh-list
139355074|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139355075|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
139355076|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355077|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355078|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355079|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
139355080|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355081|NCT03898154|Dexamethasone|dexamethasone|mesh-list
139355082|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
139355083|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139355084|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139355085|NCT03898154|Prednisolone|prednisolone|mesh-list
139355086|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
139355087|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139355088|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
139355089|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139355090|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
139355091|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
139355092|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355093|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355094|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139355095|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
139355096|NCT03898154|Hormones|hormones|mesh-ancestor
139355097|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139355098|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139355099|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355100|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139355101|NCT03898154|Protective Agents|protective agents|mesh-ancestor
139355102|NCT02517957|Loperamide|loperamide|mesh-list
139355103|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
139355104|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139355105|NCT03348267|Caseins|caseins|mesh-list
139355106|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
139355107|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
139355108|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355109|NCT03136796|Meropenem|meropenem|mesh-list
139355110|NCT03136796|Piperacillin|piperacillin|mesh-list
139355111|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139355112|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355113|NCT05243745|Fluorides|fluorides|mesh-list
139355114|NCT05243745|Cariostatic Agents|cariostatic agents|mesh-ancestor
139355115|NCT05243745|Protective Agents|protective agents|mesh-ancestor
139355116|NCT05243745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355117|NCT04500717|Carboplatin|carboplatin|mesh-list
139355118|NCT04500717|Pemetrexed|pemetrexed|mesh-list
139355119|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355120|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355121|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355122|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139355123|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139355124|NCT01680458|Fluconazole|fluconazole|mesh-list
139355125|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
139355126|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355127|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139355128|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139355129|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355130|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355131|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139355132|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
139355133|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139355134|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355135|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139355136|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139355137|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139355138|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139355139|NCT03346317|Estradiol|estradiol|mesh-list
139355140|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139355141|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
139355142|NCT03346317|Estrogens|estrogens|mesh-ancestor
139355143|NCT03346317|Hormones|hormones|mesh-ancestor
139355144|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139355145|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355146|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139355147|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
139355148|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139355149|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139355150|NCT03346317|Progestins|progestins|mesh-ancestor
139355151|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
139355152|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139355153|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
139355154|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355155|NCT01550432|Expectorants|expectorants|mesh-ancestor
139355156|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
139355157|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139355158|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
139355159|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355160|NCT01550432|Protective Agents|protective agents|mesh-ancestor
139355161|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355162|NCT01550432|Antidotes|antidotes|mesh-ancestor
139355163|NCT04502277|Fluconazole|fluconazole|mesh-list
139355164|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
139355165|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355166|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139355167|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139355168|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355169|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355170|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139355171|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
139355172|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139355173|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355174|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139355175|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139355176|NCT05730608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139355177|NCT05730608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139355178|NCT05730608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355179|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
139355180|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139355181|NCT04850144|Bromides|bromides|mesh-list
139355182|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
139355183|NCT04850144|Charcoal|charcoal|mesh-list
139355184|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139355185|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
139355186|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355187|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355188|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139355189|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
139355190|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
139355191|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139355192|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
139355193|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355194|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355195|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
139355196|NCT04850144|Antidotes|antidotes|mesh-ancestor
139355197|NCT04850144|Protective Agents|protective agents|mesh-ancestor
139355198|NCT04590794|Plasminogen|plasminogen|mesh-list
139355199|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139355200|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139355201|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355202|NCT00709761|Paclitaxel|paclitaxel|mesh-list
139355203|NCT00709761|Lapatinib|lapatinib|mesh-list
139355204|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139355205|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355206|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
139355207|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
139355208|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
139355209|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355210|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139355211|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355212|NCT05584683|Amoxicillin|amoxicillin|mesh-list
139355213|NCT05584683|Clavulanic Acid|clavulanic acid|mesh-list
139355214|NCT05584683|Clavulanic Acids|clavulanic acids|mesh-list
139355215|NCT05584683|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139355216|NCT05584683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139355217|NCT05584683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355218|NCT05584683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139355219|NCT05584683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355220|NCT05584683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355221|NCT02516631|Misoprostol|misoprostol|mesh-list
139355222|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139355223|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
139355224|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139355225|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355226|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139355227|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139355228|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
139355229|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
139355230|NCT02516475|Astringents|astringents|mesh-ancestor
139355231|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355232|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
139355233|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139355235|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139355236|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355237|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355238|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139355239|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139355240|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355241|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
139355242|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355243|NCT03423680|Aripiprazole|aripiprazole|mesh-list
139355244|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
139355245|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139355246|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139355247|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139355248|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139355249|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355250|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
139355251|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
139355252|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355253|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355254|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139355255|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139355256|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
139355257|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139355258|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139355259|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139355260|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139355261|NCT04443543|Capecitabine|capecitabine|mesh-list
139355262|NCT04443543|Fluorouracil|fluorouracil|mesh-list
139355263|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
139355264|NCT04443543|Irinotecan|irinotecan|mesh-list
139355265|NCT04443543|Tislelizumab|tislelizumab|mesh-list
139355266|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139355267|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
139355268|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355269|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355270|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139355271|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
139355272|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355273|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139355274|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139355275|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355276|NCT04443543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139355277|NCT02516085|Metformin|metformin|mesh-list
139355278|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139355279|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355281|NCT02515929|Procyanidin|procyanidin|mesh-list
139355282|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
139355283|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355284|NCT02515929|Protective Agents|protective agents|mesh-ancestor
139355285|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355286|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139355287|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139355288|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355289|NCT03347721|Lidocaine|lidocaine|mesh-list
139355290|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
139355291|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
139355292|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139355293|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355294|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
139355295|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355296|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139355297|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139355298|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139355299|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139355300|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355301|NCT02848651|Atezolizumab|atezolizumab|mesh-list
139355302|NCT02848651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139355303|NCT02848651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355304|NCT02848651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139012129|NCT00523848|Doxorubicin|doxorubicin|mesh-list
139355305|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355307|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139355308|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
139355309|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
139355310|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355311|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
139355312|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355313|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
139355314|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355315|NCT04500561|Gemcitabine|gemcitabine|mesh-list
139355316|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
139355317|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139355318|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
139355319|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355320|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355321|NCT04507256|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139355322|NCT04507256|Antiviral Agents|antiviral agents|mesh-ancestor
139355323|NCT04507256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355324|NCT05094596|Montelukast|montelukast|mesh-list
139355325|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139355326|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
139355327|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139355328|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
139355329|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139355330|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355331|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139355332|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139355333|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355334|NCT01678820|Metformin|metformin|mesh-list
139355335|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139355336|NCT01678820|Glimepiride|glimepiride|mesh-list
139355337|NCT01678820|Simvastatin|simvastatin|mesh-list
139355338|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139355339|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355340|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139355341|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139355342|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
139355343|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355344|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139355345|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139355346|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355347|NCT01678820|Incretins|incretins|mesh-ancestor
139355348|NCT01678820|Hormones|hormones|mesh-ancestor
139355349|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139355350|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139355351|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
139355352|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139355353|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139355354|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
139355355|NCT02515695|Interferons|interferons|mesh-list
139355356|NCT02515695|Interferon-beta|interferon-beta|mesh-list
139355357|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
139355358|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355359|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
139355360|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355361|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
139355362|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355363|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139355364|NCT03346629|Misoprostol|misoprostol|mesh-list
139355365|NCT03346629|Mifepristone|mifepristone|mesh-list
139355366|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139355367|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
139355368|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139355369|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355370|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139355371|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139355372|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
139355373|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139355374|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139355375|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139355376|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139355377|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
139355378|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139355379|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139355380|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
139355381|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139355382|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
139355383|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139355384|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139355385|NCT04501965|Azithromycin|azithromycin|mesh-list
139355386|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
139355387|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139355388|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355389|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
139355390|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139355391|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139355392|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355393|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355394|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139355395|NCT04437836|Rifampin|rifampin|mesh-list
139355396|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139355397|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
139355398|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139355399|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355400|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
139355401|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139355402|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355403|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355404|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139355405|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139355406|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139355407|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139355408|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139355409|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139355410|NCT03122067|Oxytocin|oxytocin|mesh-list
139355411|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
139355412|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139355413|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355414|NCT04536194|Dopamine|dopamine|mesh-list
139355415|NCT04536194|Norepinephrine|norepinephrine|mesh-list
139355416|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139355417|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139355418|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
139355419|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355420|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355421|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355422|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
139355423|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
139355424|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355425|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139355426|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139355427|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
139355428|NCT04536194|Protective Agents|protective agents|mesh-ancestor
139355429|NCT03122769|Metformin|metformin|mesh-list
139355430|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139355431|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355432|NCT03121833|Endostar protein|endostar protein|mesh-list
139355433|NCT03121833|Endostatins|endostatins|mesh-list
139355434|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139355435|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139355436|NCT03121833|Growth Substances|growth substances|mesh-ancestor
139355437|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355438|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
139355439|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355440|NCT03121521|Melatonin|melatonin|mesh-list
139355441|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
139355442|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355443|NCT03121521|Protective Agents|protective agents|mesh-ancestor
139355444|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355445|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139355446|NCT05590923|Dexamethasone|dexamethasone|mesh-list
139355447|NCT05590923|Olanzapine|olanzapine|mesh-list
139355448|NCT05590923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139355449|NCT05590923|Antiemetics|antiemetics|mesh-ancestor
139355450|NCT05590923|Autonomic Agents|autonomic agents|mesh-ancestor
139355451|NCT05590923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355452|NCT05590923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355453|NCT05590923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139355454|NCT05590923|Glucocorticoids|glucocorticoids|mesh-ancestor
139355455|NCT05590923|Hormones|hormones|mesh-ancestor
139355456|NCT05590923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139355457|NCT05590923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139355458|NCT05590923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355459|NCT05590923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139355460|NCT05590923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139355461|NCT05590923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139355462|NCT05590923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139355463|NCT05590923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139355464|NCT05590923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139355465|NCT05590923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139355466|NCT05590923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355467|NCT05590923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355468|NCT05590923|Serotonin Agents|serotonin agents|mesh-ancestor
139355469|NCT02643056|Panitumumab|panitumumab|mesh-list
139355470|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139355471|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355472|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
139355473|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139355474|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355475|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139355476|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139355477|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355478|NCT02238145|Ipratropium|ipratropium|mesh-list
139355479|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139355480|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
139355481|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355482|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355483|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139355484|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
139355485|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139355486|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
139355487|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355488|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355489|NCT04550637|Apixaban|apixaban|mesh-list
139355490|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138923417|NCT03907605|Hormones|hormones|mesh-list
139355491|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
139355492|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139355493|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
139355494|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355495|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355496|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
139355497|NCT03345303|Bortezomib|bortezomib|mesh-list
139355498|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355499|NCT03574909|Aspirin|aspirin|mesh-list
139355500|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139355501|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139355502|NCT03574909|Analgesics|analgesics|mesh-ancestor
139355503|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
139355504|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355505|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355506|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139355507|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139355508|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139355509|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139355510|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355511|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139355512|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139355513|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355514|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
139355515|NCT03579043|Cocaine|cocaine|mesh-list
139355516|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
139355517|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
139355518|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139355519|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355520|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
139355521|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355522|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139355523|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139355524|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139355525|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139355526|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355527|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
139355528|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355529|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
139355530|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
139355531|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139355532|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139355533|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139355534|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139355535|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355536|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
139355537|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355538|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355539|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139355540|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355541|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
139355542|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
139355543|NCT02660138|Coagulants|coagulants|mesh-ancestor
139355544|NCT03576469|Complement C1s|complement c1s|mesh-list
139355545|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139355546|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
139355547|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
139355548|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355549|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139355550|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139355551|NCT05097950|Acetaminophen|acetaminophen|mesh-list
139355552|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139355553|NCT05097950|Analgesics|analgesics|mesh-ancestor
139355554|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
139355555|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355556|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355557|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
139355558|NCT05097248|Doxorubicin|doxorubicin|mesh-list
139355559|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139355560|NCT05097248|Losartan|losartan|mesh-list
139355561|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139355562|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355563|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139355564|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139355565|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355566|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355567|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139355568|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139355569|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139355570|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139355571|NCT01603394|Pregabalin|pregabalin|mesh-list
139355572|NCT01603394|Analgesics|analgesics|mesh-ancestor
139355573|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
139355574|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355575|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355576|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
139355577|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139355578|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139355579|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355580|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139355581|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139355582|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139355583|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139355584|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139355585|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
139355586|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139355587|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139355588|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139355589|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139355590|NCT02729025|Evolocumab|evolocumab|mesh-list
139355591|NCT02729025|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139355592|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139355593|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139355594|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
139355595|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355596|NCT02729025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139355597|NCT02729025|Protease Inhibitors|protease inhibitors|mesh-ancestor
139355598|NCT02729025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012427|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
139355599|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139355600|NCT05599971|Fluorouracil|fluorouracil|mesh-list
139355602|NCT05599971|Furosemide|furosemide|mesh-list
139355603|NCT05599971|Antimetabolites|antimetabolites|mesh-ancestor
139355604|NCT05599971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355605|NCT05599971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139355606|NCT05599971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355607|NCT05599971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139355608|NCT05599971|Immunologic Factors|immunologic factors|mesh-ancestor
139355609|NCT05599971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355610|NCT05599971|Diuretics|diuretics|mesh-ancestor
139355611|NCT05599971|Natriuretic Agents|natriuretic agents|mesh-ancestor
138923452|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355612|NCT05599971|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139355613|NCT05599971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139355614|NCT05599971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139355615|NCT05599971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139355616|NCT05599971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355617|NCT05599971|Protective Agents|protective agents|mesh-ancestor
139355618|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
139355619|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139355620|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355621|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355622|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355623|NCT02511795|Olaparib|olaparib|mesh-list
139355624|NCT02511795|Adavosertib|adavosertib|mesh-list
139355625|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139355626|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355627|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355628|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355629|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
139355630|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
139355631|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355632|NCT04796636|Protective Agents|protective agents|mesh-ancestor
139355633|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355634|NCT04796636|Vitamins|vitamins|mesh-ancestor
139355635|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
139355636|NCT04501809|Misoprostol|misoprostol|mesh-list
139355637|NCT04501809|Oxytocin|oxytocin|mesh-list
139355638|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
139355639|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139355640|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355641|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139355642|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
139355643|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139355644|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139355645|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
139355646|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
139355647|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139355648|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
139355649|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139355650|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355651|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139355652|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139355653|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139355654|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139355655|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355656|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139355657|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139355658|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355659|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355660|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355661|NCT02514681|Paclitaxel|paclitaxel|mesh-list
139355662|NCT02514681|Vinorelbine|vinorelbine|mesh-list
139355663|NCT02514681|Docetaxel|docetaxel|mesh-list
139355664|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139355665|NCT02514681|Gemcitabine|gemcitabine|mesh-list
139355666|NCT02514681|Capecitabine|capecitabine|mesh-list
139355667|NCT02514681|Trastuzumab|trastuzumab|mesh-list
139355668|NCT02514681|Pertuzumab|pertuzumab|mesh-list
139355669|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139355670|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355671|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
139355672|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
139355673|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
139355674|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012514|NCT00866645|Sulpiride|sulpiride|mesh-list
139355675|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139355676|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
139355677|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139355678|NCT02511639|Everolimus|everolimus|mesh-list
139355679|NCT02511639|Letrozole|letrozole|mesh-list
139355680|NCT02511639|Anastrozole|anastrozole|mesh-list
139355681|NCT02511639|Exemestane|exemestane|mesh-list
139355682|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139355683|NCT02511639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139355684|NCT02511639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139355685|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355686|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355687|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139355688|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
139355689|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355690|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355691|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139355693|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
139355694|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139355695|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139355696|NCT02514603|Prexasertib|prexasertib|mesh-list
139355697|NCT02514603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139355698|NCT02514603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355699|NCT02514603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355700|NCT02511483|Propranolol|propranolol|mesh-list
139355701|NCT02511483|Morphine|morphine|mesh-list
139355702|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139355703|NCT02511483|Narcotics|narcotics|mesh-ancestor
139355704|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139355705|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355706|NCT02511483|Analgesics|analgesics|mesh-ancestor
139355707|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
139355708|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355709|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139355710|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139355711|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
139355712|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355713|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355714|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139355715|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139355716|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
139355717|NCT04429802|Prucalopride|prucalopride|mesh-list
139355718|NCT04429802|Laxatives|laxatives|mesh-ancestor
139355719|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139355720|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139355721|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139355722|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
139355723|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355724|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355725|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355726|NCT02511405|Bevacizumab|bevacizumab|mesh-list
139355727|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139355728|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355729|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139355730|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139355731|NCT02511405|Growth Substances|growth substances|mesh-ancestor
139355732|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355733|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
139355734|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
139355735|NCT04387760|Favipiravir|favipiravir|mesh-list
139355736|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
139355737|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139355738|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139355739|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355740|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355741|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355742|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139355743|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
139355744|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
139355745|NCT05091086|Denosumab|denosumab|mesh-list
139355746|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139012575|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139355747|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355748|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
139355749|NCT05091008|Ledipasvir|ledipasvir|mesh-list
139355750|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139355751|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
139355752|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355753|NCT02918084|Letrozole|letrozole|mesh-list
139355754|NCT02918084|Anastrozole|anastrozole|mesh-list
139355755|NCT02918084|Exemestane|exemestane|mesh-list
139355756|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355757|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139355758|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139355759|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355760|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355761|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139355762|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
139355763|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139355764|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355765|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139355766|NCT01603082|Clopidogrel|clopidogrel|mesh-list
139355767|NCT01603082|Ticagrelor|ticagrelor|mesh-list
139355768|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139355769|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139355770|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139355771|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139355772|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
139355773|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355774|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355775|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355776|NCT04499313|Dexamethasone|dexamethasone|mesh-list
139355777|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
139355778|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139355779|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139355780|NCT04499313|Prednisolone|prednisolone|mesh-list
139355781|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
139355782|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139355783|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
139355784|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139355785|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
139355786|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
139355787|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923497|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
139355788|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355789|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139355790|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
139355791|NCT04499313|Hormones|hormones|mesh-ancestor
139355792|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139355793|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139355794|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355795|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139355796|NCT04499313|Protective Agents|protective agents|mesh-ancestor
139355797|NCT04331756|Anesthetics|anesthetics|mesh-list
139355798|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139355799|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355800|NCT02510781|Carboplatin|carboplatin|mesh-list
139355801|NCT02510781|Docetaxel|docetaxel|mesh-list
139355802|NCT02510781|Trastuzumab|trastuzumab|mesh-list
139355803|NCT02510781|Epirubicin|epirubicin|mesh-list
139355804|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355805|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
139355806|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
139355807|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
139355808|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355809|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139355810|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139355811|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139355812|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139355813|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355814|NCT03121599|Alovudine|alovudine|mesh-list
139355815|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
139355816|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355817|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
139355818|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355819|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
139355820|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
139182756|NCT01298401|Capecitabine|capecitabine|mesh-list
139355821|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
139355822|NCT02510469|Apatinib|apatinib|mesh-list
139355823|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355824|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139355825|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355826|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355827|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
139355828|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139355829|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
139355830|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355831|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
139355832|NCT02510235|Protective Agents|protective agents|mesh-ancestor
139355833|NCT05081336|Alirocumab|alirocumab|mesh-list
139355834|NCT05081336|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139355835|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139355836|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139355837|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
139355838|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355839|NCT05081336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139355840|NCT05081336|Protease Inhibitors|protease inhibitors|mesh-ancestor
139355841|NCT05081336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355842|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139355843|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139355844|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139355845|NCT03710876|Celecoxib|celecoxib|mesh-list
139355846|NCT03710876|Gemcitabine|gemcitabine|mesh-list
139355847|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139355848|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
139355849|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355850|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355851|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139355852|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139355853|NCT03710876|Analgesics|analgesics|mesh-ancestor
139355854|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
139355855|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355856|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355857|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139355858|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139355859|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139355860|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139355861|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355862|NCT02513433|Bupivacaine|bupivacaine|mesh-list
139355863|NCT02513433|Ropivacaine|ropivacaine|mesh-list
139355864|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
139355865|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
139355866|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
139355867|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139355868|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355869|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
139355870|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355871|NCT02510157|Dexamethasone|dexamethasone|mesh-list
139355872|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139355873|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
139355874|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
139355875|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355876|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355877|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139355878|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
139355879|NCT02510157|Hormones|hormones|mesh-ancestor
139355880|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139355881|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139355882|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355883|NCT03345147|Vitamins|vitamins|mesh-list
139355884|NCT03345147|Vitamin A|vitamin a|mesh-list
139355885|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
139355886|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
139355887|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355888|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
139355889|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355890|NCT03345147|Protective Agents|protective agents|mesh-ancestor
139355891|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139355892|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355893|NCT03662919|Adalimumab|adalimumab|mesh-list
139355894|NCT03662919|Infliximab|infliximab|mesh-list
139355895|NCT03662919|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139355896|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139012721|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
139355897|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139355898|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
139355899|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139355900|NCT05375240|Ceftriaxone|ceftriaxone|mesh-list
139355901|NCT05375240|Propranolol|propranolol|mesh-list
139355902|NCT05375240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139355903|NCT05375240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139355904|NCT05375240|Adrenergic Agents|adrenergic agents|mesh-ancestor
139355905|NCT05375240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355906|NCT05375240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355907|NCT05375240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355908|NCT05375240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139355909|NCT05375240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139355910|NCT05375240|Vasodilator Agents|vasodilator agents|mesh-ancestor
139355911|NCT05375240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139355912|NCT05375240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355914|NCT00406393|Methotrexate|methotrexate|mesh-list
139355915|NCT00406393|Tacrolimus|tacrolimus|mesh-list
139355916|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139355917|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
139355918|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139355919|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355920|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139355921|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
139355922|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355923|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355924|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
139355925|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355926|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139355927|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139355928|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
139355929|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139355930|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139355931|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139355932|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139355933|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139355934|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139355935|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
139355936|NCT02513355|Cisplatin|cisplatin|mesh-list
139355937|NCT02513355|Endostar protein|endostar protein|mesh-list
139355938|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139355939|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139355940|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139355941|NCT02513355|Growth Substances|growth substances|mesh-ancestor
139355942|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355943|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
139355944|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
139355945|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139355946|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139355947|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923545|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
139355948|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139355949|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139355950|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
139355951|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355952|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355953|NCT02509923|Rabeprazole|rabeprazole|mesh-list
139355954|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139355955|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139355956|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139355957|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355958|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355959|NCT03578263|Oxytocin|oxytocin|mesh-list
139355960|NCT03578263|Carbetocin|carbetocin|mesh-list
139355961|NCT03578263|Ergonovine|ergonovine|mesh-list
139355962|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
139355963|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139355965|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139355966|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
139355967|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139355968|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139355969|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139355970|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139355971|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355972|NCT02845375|Neostigmine|neostigmine|mesh-list
139355973|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139355974|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139355975|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012794|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139355976|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
139355977|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355978|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355979|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139355980|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
139355981|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355982|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
139355983|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139355984|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139355985|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
139355986|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139355987|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139355988|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139355989|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
139355990|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
139355991|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139355992|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
139355993|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139355994|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
139355995|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
139355996|NCT03344679|Adenosine|adenosine|mesh-list
139355997|NCT03344679|Bupivacaine|bupivacaine|mesh-list
139355998|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
139355999|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
139356000|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356001|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356002|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
139356003|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356004|NCT03344679|Analgesics|analgesics|mesh-ancestor
139356005|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139356006|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
139356007|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139356008|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139356009|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356010|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139356011|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
139356012|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139356013|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
139356014|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139356015|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
139356016|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
139356017|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356018|NCT02259829|Amlodipine|amlodipine|mesh-list
139356019|NCT02259829|Telmisartan|telmisartan|mesh-list
139356020|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139356021|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139356022|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139356023|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139356024|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356025|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139356026|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356027|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
139356028|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139356029|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139356030|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
139356031|NCT03344523|Hematinics|hematinics|mesh-ancestor
139356032|NCT02658734|Trastuzumab|trastuzumab|mesh-list
139356033|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139356034|NCT02658734|Maytansine|maytansine|mesh-list
139356035|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139356036|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356037|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139356038|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
139356039|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
139356040|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
139356041|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356042|NCT02658734|Immunotoxins|immunotoxins|mesh-ancestor
139356043|NCT02658734|Immunoconjugates|immunoconjugates|mesh-ancestor
139356044|NCT02658734|Immunologic Factors|immunologic factors|mesh-ancestor
139356045|NCT02658734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356046|NCT03344445|Anesthetics|anesthetics|mesh-list
138923617|NCT04620291|UB-421|ub-421|mesh-list
139356047|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356048|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356049|NCT04501107|Insulin|insulin|mesh-list
139356050|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139356051|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
139356052|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139356053|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356054|NCT03143985|Pomalidomide|pomalidomide|mesh-list
139356055|NCT03143985|Vactosertib|vactosertib|mesh-list
139356056|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
139356057|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356058|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139356059|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139356060|NCT03143985|Growth Substances|growth substances|mesh-ancestor
139356061|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
139356062|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356063|NCT03143985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139356064|NCT03143985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356065|NCT03143985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356066|NCT02605148|Vitamin D|vitamin d|mesh-list
139356067|NCT02605148|Vitamins|vitamins|mesh-ancestor
139356068|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
139356069|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356070|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139356071|NCT02395640|Capecitabine|capecitabine|mesh-list
139356072|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
139356073|NCT02395640|Epirubicin|epirubicin|mesh-list
139356074|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139356075|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
139356076|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356077|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356078|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139356079|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139356080|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139356081|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356082|NCT02509143|Ramosetron|ramosetron|mesh-list
139356083|NCT02509143|Antiemetics|antiemetics|mesh-list
139356084|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
139356085|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356086|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356087|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139356088|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139356089|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
139356090|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356091|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356092|NCT05100446|Amoxicillin|amoxicillin|mesh-list
139356093|NCT05100446|Esomeprazole|esomeprazole|mesh-list
139356094|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139356095|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356096|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139356097|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139356098|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139182792|NCT01125683|Donepezil|donepezil|mesh-list
139356099|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356100|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356101|NCT02506803|Paclitaxel|paclitaxel|mesh-list
139356102|NCT02506803|Gemcitabine|gemcitabine|mesh-list
139356103|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139356104|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356105|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
139356106|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
139356107|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
139356108|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356109|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139356110|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
139356111|NCT02844439|XL647|xl647|mesh-list
139356112|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356113|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139356114|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356115|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356116|NCT04531592|Valproic Acid|valproic acid|mesh-list
139356117|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
139356118|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356119|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356120|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
139356121|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356122|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356123|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
139356124|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139356125|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012947|NCT00875849|Cetuximab|cetuximab|mesh-list
139356126|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139356127|NCT03571711|Meropenem|meropenem|mesh-list
139356128|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139356129|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356130|NCT03570541|Acetaminophen|acetaminophen|mesh-list
139356131|NCT03570541|Morphine|morphine|mesh-list
139356132|NCT03570541|Ropivacaine|ropivacaine|mesh-list
139356133|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139356134|NCT03570541|Narcotics|narcotics|mesh-ancestor
139356135|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356136|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356137|NCT03570541|Analgesics|analgesics|mesh-ancestor
139356138|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
139356139|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356140|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
139356141|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
139356142|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139356143|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
139356144|NCT00708435|Protein C|protein c|mesh-list
139356146|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
139356147|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139356148|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139356149|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356150|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
139356151|NCT02508753|Tazobactam|tazobactam|mesh-list
139356152|NCT02508753|Ceftolozane|ceftolozane|mesh-list
139356153|NCT02508753|Cephalosporins|cephalosporins|mesh-list
139356154|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139356155|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356156|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139356157|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139356158|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356159|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356160|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356161|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139356162|NCT02506647|Insulin|insulin|mesh-list
139356163|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139356164|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
139356165|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139356166|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356167|NCT02571530|Trastuzumab|trastuzumab|mesh-list
139356168|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139356169|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356170|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
139356171|NCT04379024|Estrogens|estrogens|mesh-list
139356172|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139356173|NCT04379024|Hormones|hormones|mesh-ancestor
139356174|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139356175|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356176|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139356177|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139356178|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
139356179|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139356180|NCT04497831|Morphine|morphine|mesh-list
139356181|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139356182|NCT04497831|Narcotics|narcotics|mesh-ancestor
139356183|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356184|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356185|NCT04497831|Analgesics|analgesics|mesh-ancestor
139356186|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
139356187|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356188|NCT04498689|Paclitaxel|paclitaxel|mesh-list
139356189|NCT04498689|Gemcitabine|gemcitabine|mesh-list
139356190|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139356191|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356192|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
139356193|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
139356194|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
139356195|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356196|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139356197|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
139356198|NCT05103098|Misoprostol|misoprostol|mesh-list
139356199|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139356200|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
139356201|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139356202|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356203|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139356204|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139356206|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139356207|NCT04272008|Estradiol|estradiol|mesh-list
139356208|NCT04272008|Estrogens|estrogens|mesh-ancestor
139356209|NCT04272008|Hormones|hormones|mesh-ancestor
139356210|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139356211|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356212|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139356213|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
139356214|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139356215|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139356216|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139356217|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139356218|NCT05103020|Bevacizumab|bevacizumab|mesh-list
139356219|NCT05103020|Cetuximab|cetuximab|mesh-list
139356220|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
139356221|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139356222|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356223|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139356224|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139356225|NCT05103020|Growth Substances|growth substances|mesh-ancestor
139356226|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356227|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
139356228|NCT02501109|Aripiprazole|aripiprazole|mesh-list
139356229|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
139356230|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139356231|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139356232|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139356233|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356234|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356235|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
139356236|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
139356237|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356238|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356239|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139356240|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139356241|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
139356242|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139356243|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139356244|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139356245|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139356246|NCT05060666|Ivermectin|ivermectin|mesh-list
139356247|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139356248|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356249|NCT02506335|Cholic Acids|cholic acids|mesh-list
139356250|NCT02506335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139356251|NCT01353859|Methotrexate|methotrexate|mesh-list
139356252|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139356253|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
139356254|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139356255|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356256|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139356257|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
139356258|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356259|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356260|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
139356261|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356262|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139356263|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139356264|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
139356265|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139356266|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139356267|NCT02238197|Ipratropium|ipratropium|mesh-list
139356268|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139356269|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
139356270|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356271|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356272|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139356273|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
139356274|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139356275|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
139356276|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356277|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356278|NCT03592199|Sunitinib|sunitinib|mesh-list
139356279|NCT03592199|Axitinib|axitinib|mesh-list
139356280|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356281|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139356282|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139356283|NCT03592199|Growth Substances|growth substances|mesh-ancestor
139356284|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356285|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
139356286|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139356287|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356288|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356289|NCT02245867|Antibodies|antibodies|mesh-list
139356290|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139356291|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
139356292|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356293|NCT02507583|Insulin|insulin|mesh-list
139356294|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139356295|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356296|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139356297|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
139356298|NCT02506023|Coagulants|coagulants|mesh-ancestor
139356299|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139356300|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
139356301|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356302|NCT02246179|Lidocaine|lidocaine|mesh-list
139356303|NCT02246179|Epinephrine|epinephrine|mesh-list
139356304|NCT02246179|Prilocaine|prilocaine|mesh-list
139356305|NCT02246179|Carticaine|carticaine|mesh-list
139356306|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139356307|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
139356308|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
139356309|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356310|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356311|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
139356312|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356313|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139356314|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139356315|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139356316|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139356317|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356318|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139356319|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139356320|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
139356321|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356322|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139356323|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139356324|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
139356325|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139356326|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
139356327|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
139356328|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
139356329|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139356330|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139356331|NCT02238275|Telmisartan|telmisartan|mesh-list
139356332|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139356333|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139356334|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139356335|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356336|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
139356337|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139356338|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356339|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356340|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139356341|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139356342|NCT04394117|Losartan|losartan|mesh-list
139356343|NCT04394117|Valsartan|valsartan|mesh-list
139356344|NCT04394117|Telmisartan|telmisartan|mesh-list
139356345|NCT04394117|Candesartan|candesartan|mesh-list
139356346|NCT04394117|Olmesartan|olmesartan|mesh-list
139356347|NCT04394117|Irbesartan|irbesartan|mesh-list
139356348|NCT04394117|Eprosartan|eprosartan|mesh-list
139356349|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139356350|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139356351|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139356352|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356353|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139356354|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
139356355|NCT02500563|Caseins|caseins|mesh-list
139182837|NCT03724981|Dulaglutide|dulaglutide|mesh-list
139356357|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
139356358|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356360|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139356361|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356362|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356363|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139356364|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356365|NCT02243137|Aspirin|aspirin|mesh-list
139356366|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
139356367|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139356368|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139356369|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139356370|NCT02243137|Analgesics|analgesics|mesh-ancestor
139356371|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
139356372|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356373|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356374|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139356375|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139356376|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139356377|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139356378|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356379|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139356380|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139356381|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356382|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
139356383|NCT03343977|Docetaxel|docetaxel|mesh-list
139356384|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356385|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
139356386|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
139356387|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
139356388|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356389|NCT02850965|Adalimumab|adalimumab|mesh-list
139356390|NCT02850965|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139356391|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139356392|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139356393|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139356394|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139356395|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139356396|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
139356397|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356398|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139356399|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139356400|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356401|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
139356402|NCT01375959|Resveratrol|resveratrol|mesh-list
139356403|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
139356404|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356405|NCT01375959|Protective Agents|protective agents|mesh-ancestor
139356406|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356407|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356408|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139356409|NCT02238353|Fluticasone|fluticasone|mesh-list
139356410|NCT02238353|Azelastine|azelastine|mesh-list
139356411|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139356412|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139356413|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
139356414|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356415|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356416|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139356417|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
139356418|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
139356419|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139356420|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139356421|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356422|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356423|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139356424|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139356425|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
139356426|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
139182840|NCT01123031|Esomeprazole|esomeprazole|mesh-list
139356427|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139013242|NCT05883384|Chelating Agents|chelating agents|mesh-ancestor
139356430|NCT04482686|Vitamins|vitamins|mesh-list
139356431|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
139356432|NCT04482686|Zinc|zinc|mesh-list
139356433|NCT04482686|Doxycycline|doxycycline|mesh-list
139356434|NCT04482686|Ivermectin|ivermectin|mesh-list
139356435|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
139356436|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
139356437|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356438|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139356439|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139356440|NCT04482686|Trace Elements|trace elements|mesh-ancestor
139356441|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
139356442|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356443|NCT04482686|Protective Agents|protective agents|mesh-ancestor
139356444|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139356445|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356446|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
139356447|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139356448|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139356449|NCT04482686|Astringents|astringents|mesh-ancestor
139356450|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
139356451|NCT03580889|Atropine|atropine|mesh-list
139356452|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
139356453|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139356454|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139356455|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139356456|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
139356457|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356458|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356459|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139356460|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
139356461|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
139356462|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
139356463|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139356464|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139356465|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
139356466|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356467|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356468|NCT02500017|Melatonin|melatonin|mesh-list
139356469|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
139356470|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356471|NCT02500017|Protective Agents|protective agents|mesh-ancestor
139356472|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356473|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356474|NCT02505633|Lidocaine|lidocaine|mesh-list
139356475|NCT02505633|Epinephrine|epinephrine|mesh-list
139356476|NCT02505633|Racepinephrine|racepinephrine|mesh-list
139356477|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
139356478|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
139356479|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
139356480|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356481|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356482|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
139356483|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356484|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139356485|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139356486|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139356487|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139356488|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356489|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139356490|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139356491|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
139356492|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356493|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139356494|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139356495|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
139356496|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139356497|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
139356498|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
139356499|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
139356500|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139356501|NCT03587441|Neostigmine|neostigmine|mesh-list
139013318|NCT05881746|Liver Extracts|liver extracts|mesh-list
139356502|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139356503|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356504|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356505|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
139356506|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356507|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356508|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139356509|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
139356510|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356511|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
139356512|NCT05102396|Oxybutynin|oxybutynin|mesh-list
139356513|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
139356514|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
139356515|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356516|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356517|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139356518|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139356519|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
139356520|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356521|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356522|NCT05102396|Urological Agents|urological agents|mesh-ancestor
139356523|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139356524|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356525|NCT01165645|Ritonavir|ritonavir|mesh-list
139356526|NCT01165645|Lopinavir|lopinavir|mesh-list
139356527|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139356528|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139356529|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
139356530|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356531|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356532|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139356533|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139356534|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
139356535|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356536|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139356537|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139356538|NCT03569995|Cytarabine|cytarabine|mesh-list
139356539|NCT03569995|Rituximab|rituximab|mesh-list
139356540|NCT03569995|Methotrexate|methotrexate|mesh-list
139356541|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139356542|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356543|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
139356544|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356545|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139356546|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139356547|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
139356548|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139356549|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139356550|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
139356551|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356552|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
139356553|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356554|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139356555|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139356556|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139356557|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
139356558|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356559|NCT02238431|Leuprolide|leuprolide|mesh-list
139356560|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139356561|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
139356562|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139356563|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356564|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139356565|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139182854|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
139356566|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
139356567|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356568|NCT02238509|Trastuzumab|trastuzumab|mesh-list
139356569|NCT02238509|Lapatinib|lapatinib|mesh-list
139356570|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139356571|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356572|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139356573|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356574|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356575|NCT03579914|Metoprolol|metoprolol|mesh-list
139356576|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139356577|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139356578|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
139356579|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
139013389|NCT05880693|Anticonvulsants|anticonvulsants|mesh-ancestor
139356580|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356581|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356582|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139356583|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139356584|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139356585|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
139356586|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356587|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356588|NCT03573037|Anticoagulants|anticoagulants|mesh-list
139356589|NCT05354635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139356590|NCT05354635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356591|NCT03585413|Micronutrients|micronutrients|mesh-list
139356592|NCT03585413|Trace Elements|trace elements|mesh-list
139356593|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356594|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
139356595|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139356596|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
139356597|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356598|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
139356599|NCT03569683|Protective Agents|protective agents|mesh-ancestor
139356600|NCT00708201|Alvimopan|alvimopan|mesh-list
139356601|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139356602|NCT03572959|Triamcinolone|triamcinolone|mesh-list
139356603|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139356604|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139356605|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139356606|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139356607|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
139356608|NCT03572959|Hormones|hormones|mesh-ancestor
139356609|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139356610|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356611|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139356612|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
139356613|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356614|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356615|NCT02500251|Rituximab|rituximab|mesh-list
139356616|NCT02500251|Bortezomib|bortezomib|mesh-list
139356617|NCT02500251|Belimumab|belimumab|mesh-list
139356618|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139356619|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356620|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
139356621|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356622|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139356623|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139356624|NCT03568513|Curcumin|curcumin|mesh-list
139356625|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139356626|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139356627|NCT03568513|Analgesics|analgesics|mesh-ancestor
139356628|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
139356629|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356630|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356631|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139356632|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139356633|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356634|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139182859|NCT01217879|Telmisartan|telmisartan|mesh-list
139356635|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356637|NCT02982668|Mosapride|mosapride|mesh-list
139356638|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
139356639|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
139356640|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356641|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356642|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139356643|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139356644|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139356645|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
139356646|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356647|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356648|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139356649|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
139356650|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139356651|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356652|NCT05354479|Acetaminophen|acetaminophen|mesh-list
139356653|NCT05354479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139356654|NCT05354479|Analgesics|analgesics|mesh-ancestor
139356655|NCT05354479|Sensory System Agents|sensory system agents|mesh-ancestor
139356656|NCT05354479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356657|NCT05354479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356658|NCT05354479|Antipyretics|antipyretics|mesh-ancestor
139356659|NCT02505399|Clopidogrel|clopidogrel|mesh-list
139356660|NCT02505399|Ticagrelor|ticagrelor|mesh-list
139356661|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139356662|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139356663|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139356664|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139356665|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
139356666|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356667|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356668|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356669|NCT02728089|Tazobactam|tazobactam|mesh-list
139356670|NCT02728089|Ceftolozane|ceftolozane|mesh-list
139356671|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139356672|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356673|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139356674|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356675|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356676|NCT05110118|Bevacizumab|bevacizumab|mesh-list
139356677|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
139356678|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139356679|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356680|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139356681|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139356682|NCT05110118|Growth Substances|growth substances|mesh-ancestor
139356683|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356684|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
139356685|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
139356686|NCT03572647|Hematinics|hematinics|mesh-ancestor
139356687|NCT02495181|Aflibercept|aflibercept|mesh-list
139356688|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139356689|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139356690|NCT02495181|Growth Substances|growth substances|mesh-ancestor
139356691|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356692|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
139356693|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356694|NCT02499861|Decitabine|decitabine|mesh-list
139356695|NCT02499861|Genistein|genistein|mesh-list
139356696|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139356697|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
139356698|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356699|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356700|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356701|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139356702|NCT02499861|Protective Agents|protective agents|mesh-ancestor
139356703|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356704|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139356705|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
138762736|NCT02709265|Fosfomycin|fosfomycin|mesh-list
139356706|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139356707|NCT02499861|Estrogens|estrogens|mesh-ancestor
139356708|NCT02499861|Hormones|hormones|mesh-ancestor
139356709|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139356710|NCT05505435|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139356711|NCT05505435|Medroxyprogesterone|medroxyprogesterone|mesh-list
139356712|NCT05505435|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139356713|NCT05505435|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139356714|NCT05505435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139356715|NCT05505435|Contraceptive Agents|contraceptive agents|mesh-ancestor
139356716|NCT05505435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139356717|NCT05505435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356718|NCT05505435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139356719|NCT05505435|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139356720|NCT05505435|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139356721|NCT05505435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139356722|NCT05505435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356723|NCT02840461|Ivermectin|ivermectin|mesh-list
139356724|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139356725|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356726|NCT05108714|Lidocaine|lidocaine|mesh-list
139356727|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
139356728|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
139356729|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356730|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356731|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
139356732|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356733|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139356734|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139356735|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139356736|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139356737|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356738|NCT02495415|Fenretinide|fenretinide|mesh-list
139356739|NCT02495415|Retinamide|retinamide|mesh-list
139356740|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356741|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139356742|NCT02495415|Protective Agents|protective agents|mesh-ancestor
139356743|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356744|NCT02505009|Tenofovir|tenofovir|mesh-list
139356745|NCT02505009|Entecavir|entecavir|mesh-list
139356746|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
139356747|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356748|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139356749|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139356750|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356751|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356752|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139356753|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139356754|NCT05353543|Antidepressive Agents|antidepressive agents|mesh-list
139356755|NCT05353543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139356756|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139356757|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139356758|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139356759|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
139356760|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356761|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356762|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139356763|NCT02499627|Immunotoxins|immunotoxins|mesh-ancestor
139356764|NCT02499627|Immunoconjugates|immunoconjugates|mesh-ancestor
139356765|NCT02499627|Immunologic Factors|immunologic factors|mesh-ancestor
139356766|NCT02499627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356767|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139356768|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139356769|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
139356770|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139356771|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356772|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139356773|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139356774|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139356775|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356776|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
139182864|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
139356777|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139356778|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
139356779|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356780|NCT02505087|Expectorants|expectorants|mesh-ancestor
139356781|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
139356782|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139356783|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
139356784|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356785|NCT02505087|Protective Agents|protective agents|mesh-ancestor
139356786|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356787|NCT02505087|Antidotes|antidotes|mesh-ancestor
139356788|NCT02839681|Maytansine|maytansine|mesh-list
139356789|NCT02839681|Anetumab ravtansine|anetumab ravtansine|mesh-list
139356790|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139356791|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356792|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
139356793|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
139356794|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
139356795|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356796|NCT02839681|Immunoconjugates|immunoconjugates|mesh-ancestor
139356797|NCT02839681|Immunologic Factors|immunologic factors|mesh-ancestor
139356798|NCT02839681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356799|NCT02504463|Naltrexone|naltrexone|mesh-list
139356800|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139356801|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139356802|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356803|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
139356804|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013619|NCT05826327|Sufentanil|sufentanil|mesh-list
139356805|NCT03566329|Lidocaine|lidocaine|mesh-list
139356806|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
139356807|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
139356808|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
139356809|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356810|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356811|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
139356812|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356813|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139356814|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139356815|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139356816|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139356817|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356818|NCT03566329|Analgesics|analgesics|mesh-ancestor
139356819|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
139356820|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139356821|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139356822|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
139356823|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139356824|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
139356825|NCT02499237|Denosumab|denosumab|mesh-list
139356826|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139356827|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356828|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
139356829|NCT02499393|Analgesics|analgesics|mesh-ancestor
139356830|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
139356831|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356832|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356833|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
139356834|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356835|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139356836|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
139356837|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139356838|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139356839|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356840|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139356841|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
139356842|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139356843|NCT02504307|Sirolimus|sirolimus|mesh-list
139356844|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139356845|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356846|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139356847|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356848|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
139356849|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139356850|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
139356851|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356852|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
139356853|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356854|NCT03567343|Melatonin|melatonin|mesh-list
139356855|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
139356856|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356857|NCT03567343|Protective Agents|protective agents|mesh-ancestor
139356858|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356859|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356860|NCT04595864|Leucovorin|leucovorin|mesh-list
139356861|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
139356862|NCT04595864|Calcium|calcium|mesh-list
139356863|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
139356864|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139356865|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356866|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356867|NCT04595864|Antidotes|antidotes|mesh-ancestor
139356868|NCT04595864|Protective Agents|protective agents|mesh-ancestor
139356869|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
139356870|NCT04595864|Vitamins|vitamins|mesh-ancestor
139356871|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
139356872|NCT04583462|Metformin|metformin|mesh-list
139356873|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139356874|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356875|NCT04456322|Cisplatin|cisplatin|mesh-list
139356876|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
139356877|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356878|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139356879|NCT02503761|Meropenem|meropenem|mesh-list
139356880|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139356881|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356882|NCT04097912|Aspirin|aspirin|mesh-list
139356883|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139356884|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139356885|NCT04097912|Analgesics|analgesics|mesh-ancestor
139356886|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
139356887|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356888|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356889|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139356890|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139356891|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139356892|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139356893|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356894|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139356895|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139356896|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139356897|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
139356898|NCT04966676|Nivolumab|nivolumab|mesh-list
139356899|NCT04966676|Ipilimumab|ipilimumab|mesh-list
139356900|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139356901|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356902|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139356903|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356904|NCT03340779|Dobutamine|dobutamine|mesh-list
139356905|NCT03340779|Norepinephrine|norepinephrine|mesh-list
139356906|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139356907|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139356908|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
139356909|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356910|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356911|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356912|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
139356913|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
139356914|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356915|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139356916|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139356917|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139356918|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139356919|NCT03340779|Protective Agents|protective agents|mesh-ancestor
139356920|NCT04040738|Anesthetics|anesthetics|mesh-list
139356921|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356922|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356923|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
139356924|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139356925|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356926|NCT05087732|Lidocaine|lidocaine|mesh-list
139356927|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
139356928|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
139356929|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356930|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356931|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
139356932|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356933|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139356934|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139356935|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139356936|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139356937|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356938|NCT03340701|Progesterone|progesterone|mesh-list
139356939|NCT03340701|Progestins|progestins|mesh-ancestor
139356940|NCT03340701|Hormones|hormones|mesh-ancestor
139356941|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139356942|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356943|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
139356944|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139356945|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
139356946|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139356947|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356948|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139356949|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
139356950|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139356951|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
139356952|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356953|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356954|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139356955|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
139356956|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
139356957|NCT02498535|Protective Agents|protective agents|mesh-ancestor
139356958|NCT04727138|Midazolam|midazolam|mesh-list
139356959|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139356960|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139356961|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139356962|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356963|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139356964|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139356965|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139356966|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139356967|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
139356968|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
139356969|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
139356970|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
139356971|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139356972|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356973|NCT02498457|Calcium|calcium|mesh-list
139356974|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139356975|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356976|NCT02498301|Rifaximin|rifaximin|mesh-list
139356977|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139356978|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139356979|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139356980|NCT03343665|Nivolumab|nivolumab|mesh-list
139356981|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139356982|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139356983|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139356984|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356986|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139356987|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139356988|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
139356989|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356990|NCT03342807|Insulin|insulin|mesh-list
139356991|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139356992|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356993|NCT02570672|Metformin|metformin|mesh-list
139356994|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139356995|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139356996|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
139356997|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139356998|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139356999|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357000|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
139357001|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357002|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357003|NCT04593914|Protective Agents|protective agents|mesh-list
139357004|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357005|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
139357006|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139357007|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357008|NCT03342651|Vitamin D|vitamin d|mesh-list
139357009|NCT03342651|Vitamins|vitamins|mesh-ancestor
139357010|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
139357011|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357012|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139357013|NCT04819568|Terlipressin|terlipressin|mesh-list
139357014|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139357015|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139357016|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
139357017|NCT02502981|Spironolactone|spironolactone|mesh-list
139357018|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139357019|NCT02502981|Diuretics|diuretics|mesh-list
139357020|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
139357021|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
139357022|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
139357023|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139357024|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357025|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139357026|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
139357027|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139357028|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139357029|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357030|NCT02502981|Hormones|hormones|mesh-ancestor
139357031|NCT04230746|Trimethoprim|trimethoprim|mesh-list
139357032|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139357033|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
139357034|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139357035|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357036|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
139357037|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139357038|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139357039|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139357040|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357041|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357042|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139357043|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139357044|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139357045|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139357046|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
139357047|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139357048|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
139357049|NCT05111444|Paclitaxel|paclitaxel|mesh-list
139357050|NCT05111444|Capecitabine|capecitabine|mesh-list
139357051|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
139357052|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139357053|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357054|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
139357055|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
139357056|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
139357057|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357058|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139357059|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
139357060|NCT03769688|Metronidazole|metronidazole|mesh-list
139357061|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357062|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139357063|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139357064|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139357065|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
139357066|NCT02502825|Miotics|miotics|mesh-ancestor
139357067|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
139357068|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357069|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357070|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139357071|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139357072|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
139357073|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139357074|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139357075|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
139357076|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357077|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357078|NCT02498145|Nicotine|nicotine|mesh-list
139357079|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139357080|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
139357081|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357082|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357083|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139357084|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139357085|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
139357086|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357087|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357088|NCT02497911|Bupivacaine|bupivacaine|mesh-list
139357089|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
139357090|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
139357091|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357092|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357093|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
139357094|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357095|NCT02497833|Tretinoin|tretinoin|mesh-list
139357096|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357097|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
139357098|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
139357099|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
139357100|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139357101|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
139357102|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
139357103|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357104|NCT02493933|Expectorants|expectorants|mesh-ancestor
139357105|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
139357106|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139357107|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
139357108|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357109|NCT02493933|Protective Agents|protective agents|mesh-ancestor
139357110|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357111|NCT02493933|Antidotes|antidotes|mesh-ancestor
139357112|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139357113|NCT02493933|Estrogens|estrogens|mesh-ancestor
139357114|NCT02493933|Hormones|hormones|mesh-ancestor
139357115|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139357116|NCT04153604|Doxycycline|doxycycline|mesh-list
139357117|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139357118|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357119|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
139357120|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139357121|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139357122|NCT03338205|Ketamine|ketamine|mesh-list
139357123|NCT03338205|Analgesics|analgesics|mesh-ancestor
139357124|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
139357125|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139182886|NCT05665075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357126|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357127|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139357128|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139357129|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
139357130|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
139357131|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357132|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139357133|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139357134|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357135|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357136|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
139357137|NCT04314050|Tramadol|tramadol|mesh-list
139357138|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139357139|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357140|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357141|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139357142|NCT04314050|Analgesics|analgesics|mesh-ancestor
139357143|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
139357144|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357145|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139357146|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139357147|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139357148|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
139357149|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357150|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357151|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139357152|NCT04314050|Narcotics|narcotics|mesh-ancestor
139357153|NCT03343509|Metronidazole|metronidazole|mesh-list
139357154|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357155|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139357156|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139357157|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139357158|NCT04516148|Clindamycin|clindamycin|mesh-list
139357159|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
139357160|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
139357161|NCT04516148|Cefazolin|cefazolin|mesh-list
139357162|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139357163|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357164|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139357165|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357166|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357167|NCT02497053|Pemetrexed|pemetrexed|mesh-list
139357168|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357169|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357170|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357171|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139357172|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139357173|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139357174|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357175|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
139357176|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139357177|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357178|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357179|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139357180|NCT03337581|Analgesics|analgesics|mesh-ancestor
139357181|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
139013993|NCT06013540|Antioxidants|antioxidants|mesh-ancestor
139357182|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357183|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139357184|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139357185|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139357186|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
139357187|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357188|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357189|NCT02496975|Cyclosporine|cyclosporine|mesh-list
139357190|NCT02496975|Cyclosporins|cyclosporins|mesh-list
139357191|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357192|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357193|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139357194|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
139357195|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357196|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
139357197|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357198|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
139357199|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357200|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139357201|NCT03337503|Dronabinol|dronabinol|mesh-list
139357202|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
139357203|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357204|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139357205|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139357206|NCT03337503|Analgesics|analgesics|mesh-ancestor
139357207|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
139357208|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357209|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139357210|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139357211|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357212|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357213|NCT03337503|Hormones|hormones|mesh-ancestor
139357214|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139357215|NCT01675622|Morphine|morphine|mesh-list
139357216|NCT01675622|Oxycodone|oxycodone|mesh-list
139357217|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139357218|NCT01675622|Narcotics|narcotics|mesh-ancestor
139357219|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357220|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357221|NCT01675622|Analgesics|analgesics|mesh-ancestor
139357222|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
138923989|NCT00735813|Heparin|heparin|mesh-list
139357223|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357224|NCT02496741|Metformin|metformin|mesh-list
139357225|NCT02496741|Chloroquine|chloroquine|mesh-list
139357226|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139357227|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357228|NCT02496741|Amebicides|amebicides|mesh-ancestor
139357229|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139357230|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139357231|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357232|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
139357233|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357234|NCT04496037|Rituximab|rituximab|mesh-list
139357235|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139357236|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357237|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
139357238|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357239|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357240|NCT02493465|Everolimus|everolimus|mesh-list
139357241|NCT02493465|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139357242|NCT02493465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139357243|NCT02493465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357244|NCT02493465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357245|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139357246|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
139357247|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357248|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357249|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
139357250|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357251|NCT04495569|Antibodies|antibodies|mesh-list
139357252|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139357253|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
139357254|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357255|NCT03337191|Morphine|morphine|mesh-list
139357256|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
139357257|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139357258|NCT03337191|Narcotics|narcotics|mesh-ancestor
139357259|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357260|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357261|NCT03337191|Analgesics|analgesics|mesh-ancestor
139357262|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
139357263|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357264|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
139357265|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
139357266|NCT04494243|Rabeprazole|rabeprazole|mesh-list
139182897|NCT03714165|Defensins|defensins|mesh-list
139357268|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139357269|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139357270|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357271|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357272|NCT03337035|Oxytocin|oxytocin|mesh-list
139357273|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
139357274|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139357275|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357276|NCT03330717|Anesthetics|anesthetics|mesh-list
139357277|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357278|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357279|NCT02655224|Relugolix|relugolix|mesh-list
139357280|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
139357281|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
139357282|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139357283|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357284|NCT04494321|Budesonide|budesonide|mesh-list
139357285|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
139357286|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139357287|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139357288|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
139357289|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357290|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357291|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139357292|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
139357293|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
139357294|NCT04494321|Hormones|hormones|mesh-ancestor
139357295|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139357296|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139357297|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139357298|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139357299|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
139357300|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357301|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357302|NCT03330171|Vaccines|vaccines|mesh-list
139357303|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
139357304|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357305|NCT05118542|Methimazole|methimazole|mesh-list
139357306|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
139357307|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
139357308|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
139357309|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139357310|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357311|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
139357312|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357313|NCT03336801|Propofol|propofol|mesh-list
139357314|NCT03336801|Sevoflurane|sevoflurane|mesh-list
139357315|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139357316|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357317|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357318|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139357319|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
139357320|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
139357321|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139357322|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139357323|NCT05115578|Midazolam|midazolam|mesh-list
139357324|NCT05115578|Remifentanil|remifentanil|mesh-list
139357325|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139357326|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139357327|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357328|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357329|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139357330|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139357331|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139357332|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139357333|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
139357335|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
139357337|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357338|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357339|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139357340|NCT05115578|Narcotics|narcotics|mesh-ancestor
139357341|NCT05115578|Analgesics|analgesics|mesh-ancestor
139357342|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
139357343|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357344|NCT02636036|Nivolumab|nivolumab|mesh-list
139357345|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139357346|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357347|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139357348|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357349|NCT03329781|Curcumin|curcumin|mesh-list
139357350|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139357351|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139357352|NCT03329781|Analgesics|analgesics|mesh-ancestor
139357353|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
139357354|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357355|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357356|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139357357|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357358|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357359|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357360|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357361|NCT02437604|Fluticasone|fluticasone|mesh-list
139357362|NCT02437604|Xhance|xhance|mesh-list
139357363|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139357364|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139357365|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139357366|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139357367|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
139357368|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357369|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357370|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139357371|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
139357372|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
139357373|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139357374|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139357375|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139357376|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139357377|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
139357378|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357379|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357380|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
139357381|NCT02437604|Hormones|hormones|mesh-ancestor
139357382|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139357383|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
139357384|NCT03329547|Cefixime|cefixime|mesh-list
139357385|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139357386|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357387|NCT05463627|Metformin|metformin|mesh-list
139357388|NCT05463627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139357389|NCT05463627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357390|NCT01975298|Interferons|interferons|mesh-list
139357391|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
139357392|NCT01975298|Interferon-beta|interferon-beta|mesh-list
139357393|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357394|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
139357395|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357396|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139357397|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
139357398|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357399|NCT03324867|Insulin|insulin|mesh-list
139357400|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139357401|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139357402|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357403|NCT05084534|Midodrine|midodrine|mesh-list
139357404|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
139357405|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
139357406|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014218|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139357407|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357408|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139357409|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139357410|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139357411|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139357412|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
139357413|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357414|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357415|NCT04645316|Propofol|propofol|mesh-list
139357416|NCT04645316|Sevoflurane|sevoflurane|mesh-list
139357417|NCT04645316|Desflurane|desflurane|mesh-list
139357418|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139357419|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357420|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357421|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139357422|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
139357423|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
139357424|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139357425|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139357426|NCT02491515|Denosumab|denosumab|mesh-list
139357427|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139357428|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357429|NCT05113628|Methylene Blue|methylene blue|mesh-list
139357430|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357431|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357432|NCT04247750|Sirolimus|sirolimus|mesh-list
139357433|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139357434|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357435|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139357436|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357437|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
139357438|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139357439|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
139357440|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357441|NCT02493231|Ketamine|ketamine|mesh-list
139357442|NCT02493231|Nefopam|nefopam|mesh-list
139357443|NCT02493231|Analgesics|analgesics|mesh-ancestor
139357444|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
139357445|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357446|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357447|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139357448|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139357449|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
139357450|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
139357451|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357452|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139357453|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139357454|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357455|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357456|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139357457|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139357458|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139357459|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139357460|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139357461|NCT05112692|Cetrorelix|cetrorelix|mesh-list
139357462|NCT05112692|Menotropins|menotropins|mesh-list
139357463|NCT05112692|Estradiol|estradiol|mesh-list
139357464|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139357465|NCT05112692|Progesterone|progesterone|mesh-list
139357466|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
139357467|NCT05112692|Estrogens|estrogens|mesh-ancestor
139357468|NCT05112692|Hormones|hormones|mesh-ancestor
139357469|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139357470|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357471|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139357472|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
139357473|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139357474|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139357475|NCT05112692|Progestins|progestins|mesh-ancestor
139357476|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
139357477|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139357478|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357479|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139357480|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
139357481|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
139357482|NCT03328533|Phenylephrine|phenylephrine|mesh-list
139357483|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
139357484|NCT03328533|Norepinephrine|norepinephrine|mesh-list
139014290|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
139357485|NCT03328533|Bupivacaine|bupivacaine|mesh-list
139357486|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
139357487|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
139357488|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357489|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357490|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
139357491|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357492|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139357493|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
139357494|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
139357495|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
139357496|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139357497|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
139357498|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
139357499|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139357500|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139357501|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139357502|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
139357503|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357504|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357505|NCT03328533|Protective Agents|protective agents|mesh-ancestor
139357506|NCT05117372|Immunomodulating Agents|immunomodulating agents|mesh-list
139357507|NCT05117372|Immunologic Factors|immunologic factors|mesh-ancestor
139357508|NCT05117372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357509|NCT03324243|Cytarabine|cytarabine|mesh-list
139357510|NCT03324243|Fludarabine|fludarabine|mesh-list
139357511|NCT03324243|Crenolanib|crenolanib|mesh-list
139357512|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357513|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139357514|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
139357515|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357516|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139357517|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
139357518|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357519|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
139357520|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357521|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
139357522|NCT03328299|Bupivacaine|bupivacaine|mesh-list
139357523|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
139357524|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
139357525|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357526|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357527|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
139357528|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357529|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139357530|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139357531|NCT03328299|Analgesics|analgesics|mesh-ancestor
139357532|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138924073|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
139357533|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139357534|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139357535|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
139357536|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357537|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357538|NCT03564301|Metronidazole|metronidazole|mesh-list
139357539|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357540|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139357541|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139357542|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139357543|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
139357544|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139357545|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357546|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139182916|NCT01220219|Analgesics|analgesics|mesh-ancestor
139357547|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139357548|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357549|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357550|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357552|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
139357553|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357554|NCT03335241|Doxorubicin|doxorubicin|mesh-list
139357555|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139357556|NCT03335241|Fludarabine|fludarabine|mesh-list
139357557|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139357558|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357559|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139357560|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139357561|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357562|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357563|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139357564|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139357565|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
139357566|NCT03120663|Amoxicillin|amoxicillin|mesh-list
139357567|NCT03120663|Clindamycin|clindamycin|mesh-list
139357568|NCT03120663|Meropenem|meropenem|mesh-list
139357569|NCT03120663|Tazobactam|tazobactam|mesh-list
139357570|NCT03120663|Piperacillin|piperacillin|mesh-list
139357571|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
139357572|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
139357573|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139357574|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139357575|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139357576|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357577|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138924082|NCT00736905|Rilpivirine|rilpivirine|mesh-list
139357578|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357579|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357580|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139357581|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
139357582|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139357583|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139357584|NCT02578394|Prednisolone|prednisolone|mesh-list
139357585|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
139357586|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139357587|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139357588|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
139357589|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139357590|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
139357591|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
139357592|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357593|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357594|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139357595|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
139357596|NCT02578394|Hormones|hormones|mesh-ancestor
139357597|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139357598|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139357599|NCT02578394|Protective Agents|protective agents|mesh-ancestor
139357600|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139357601|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357602|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357603|NCT04493229|Oxytocin|oxytocin|mesh-list
139357604|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
139357605|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139357606|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357607|NCT03120273|Lansoprazole|lansoprazole|mesh-list
139357608|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
139357609|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139357610|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139357611|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139357612|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357613|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357614|NCT02122718|Allopurinol|allopurinol|mesh-list
139357615|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
139357616|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357617|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357618|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
139357619|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357620|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139357621|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
139357622|NCT02122718|Protective Agents|protective agents|mesh-ancestor
139357623|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357624|NCT04513652|Carticaine|carticaine|mesh-list
139357625|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
139357626|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
139357627|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357628|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357629|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
139357630|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357631|NCT00706797|Etanercept|etanercept|mesh-list
139357632|NCT00706797|Methotrexate|methotrexate|mesh-list
139357633|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139357634|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
139357635|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139357636|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357637|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139357638|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
139357639|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357640|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357641|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
139357642|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357643|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139357644|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139357645|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
139357646|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357647|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139357648|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139357649|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139357650|NCT00706797|Analgesics|analgesics|mesh-ancestor
139357651|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
139357652|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357653|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139357654|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139357655|NCT03323697|Escitalopram|escitalopram|mesh-list
139357656|NCT03323697|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139357657|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139357658|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139357659|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357660|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357661|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
139357662|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357663|NCT00706641|Dasatinib|dasatinib|mesh-list
139357664|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357665|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139357666|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357667|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357668|NCT03335085|Oxytocin|oxytocin|mesh-list
139357669|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
139357670|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139357671|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357672|NCT03323619|Anesthetics|anesthetics|mesh-list
139357673|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357674|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357675|NCT03323541|Lenograstim|lenograstim|mesh-list
139357676|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139357677|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
139357678|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357679|NCT03335007|Aceclofenac|aceclofenac|mesh-list
139357680|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139357681|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139357682|NCT03335007|Analgesics|analgesics|mesh-ancestor
139357683|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
139357684|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357685|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357686|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139357687|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357688|NCT01362530|Ondansetron|ondansetron|mesh-list
139357690|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
139357691|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
139357692|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
139357693|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357694|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357695|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139357696|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
139357697|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
139357698|NCT01362530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139357699|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139357700|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
139357701|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357702|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357703|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139357704|NCT04494399|Interferons|interferons|mesh-list
139357705|NCT04494399|Ribavirin|ribavirin|mesh-list
139357706|NCT04494399|Interferon-beta|interferon-beta|mesh-list
139357707|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
139357708|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357709|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
139357710|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357711|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
139357712|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357714|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357715|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139357716|NCT01758614|Aspirin|aspirin|mesh-list
139357717|NCT01758614|Clopidogrel|clopidogrel|mesh-list
139357718|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139357719|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139357720|NCT01758614|Analgesics|analgesics|mesh-ancestor
139357721|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
139357722|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357723|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357724|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139357725|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357726|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139357727|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139357728|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357729|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139357730|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139357731|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357732|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
139357733|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139357734|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139357735|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139357736|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
139357737|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357738|NCT02490657|Iloprost|iloprost|mesh-list
139357739|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139357740|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
139357741|NCT04323566|Rituximab|rituximab|mesh-list
139357742|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139357743|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357744|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
139357745|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357746|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357747|NCT03109119|Propofol|propofol|mesh-list
139357748|NCT03109119|Sevoflurane|sevoflurane|mesh-list
139357749|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139357750|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357751|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357752|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139357753|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
139357754|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
139357755|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139357756|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139357757|NCT03326661|Clindamycin|clindamycin|mesh-list
139357758|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
139182937|NCT03441789|Hormones|hormones|mesh-ancestor
139357759|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
139357760|NCT03326661|Penicillins|penicillins|mesh-list
139357761|NCT03326661|Metronidazole|metronidazole|mesh-list
139357762|NCT03326661|Penicillin V|penicillin v|mesh-list
139357763|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139357764|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357765|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139357766|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357767|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357768|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139357769|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139357770|NCT03333915|Pamiparib|pamiparib|mesh-list
139357771|NCT03333915|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139357772|NCT03333915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357773|NCT03333915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357774|NCT03333915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357775|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139357776|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139357777|NCT02654054|Norethindrone|norethindrone|mesh-list
139357778|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
139357779|NCT02654054|Estradiol|estradiol|mesh-list
139357780|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139357781|NCT02654054|Estrogens|estrogens|mesh-ancestor
139357782|NCT02654054|Hormones|hormones|mesh-ancestor
139357783|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139357784|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357785|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139357786|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
139357787|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139357788|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139357789|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139357790|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139357791|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139357792|NCT03186404|Atorvastatin|atorvastatin|mesh-list
139357793|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139357794|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139357795|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
139357796|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357797|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139357798|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139357799|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357800|NCT02492373|Clobetasol|clobetasol|mesh-list
139357801|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139357802|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
139357803|NCT02492373|Hormones|hormones|mesh-ancestor
139357804|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139357805|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357806|NCT03073070|Biotin|biotin|mesh-list
139357807|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
139357808|NCT03073070|Vitamins|vitamins|mesh-ancestor
139357809|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
139357810|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357811|NCT02905214|Sirolimus|sirolimus|mesh-list
139357812|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138924174|NCT00737685|Fludarabine|fludarabine|mesh-list
139357813|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357814|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139357815|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357816|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
139357817|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139357818|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
139357819|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357820|NCT03333603|Esomeprazole|esomeprazole|mesh-list
139357821|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139357822|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139357823|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139357824|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357825|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357826|NCT03333525|Insulin|insulin|mesh-list
139357827|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139357828|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357829|NCT03333369|Levodopa|levodopa|mesh-list
139357830|NCT03333369|Benserazide|benserazide|mesh-list
139357831|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139357832|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139357833|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
139357834|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357835|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357836|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357837|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357838|NCT03325803|Lidocaine|lidocaine|mesh-list
139357839|NCT03325803|Prilocaine|prilocaine|mesh-list
139357840|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139357841|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
139357842|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
139357843|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357844|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357845|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
139357846|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357847|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139357848|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139357849|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139357850|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139357851|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357852|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139357853|NCT05465343|Aflutinib|aflutinib|mesh-list
139357854|NCT05465343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139357855|NCT05465343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924179|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357856|NCT05465343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357857|NCT03325491|Acipimox|acipimox|mesh-list
139357858|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139357859|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
139357860|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357861|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139357862|NCT04150562|Avelumab|avelumab|mesh-list
139357863|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139357864|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357865|NCT03325413|Anesthetics|anesthetics|mesh-list
139357866|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357867|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357868|NCT03325335|Midazolam|midazolam|mesh-list
139357869|NCT03325335|Remifentanil|remifentanil|mesh-list
139357870|NCT03325335|Propofol|propofol|mesh-list
139357871|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139357872|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357873|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357874|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139357875|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
139357876|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
139357877|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139357878|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139357879|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139357880|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139357881|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
139357882|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
139357883|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139357884|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357885|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139357886|NCT03325335|Narcotics|narcotics|mesh-ancestor
139357887|NCT03325335|Analgesics|analgesics|mesh-ancestor
139357888|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
139357889|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357890|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139357891|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
139357892|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
139357893|NCT05114720|Docetaxel|docetaxel|mesh-list
139357894|NCT05114720|Doxorubicin|doxorubicin|mesh-list
139357895|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139357896|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139357897|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139357898|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
139182943|NCT03359005|Vincristine|vincristine|mesh-list
139357899|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357900|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357901|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139357902|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
139357903|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357904|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357905|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139357906|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
139357907|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
139357908|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
139357909|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139357910|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139357911|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139357912|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357913|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357914|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139357915|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
139357916|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139357917|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139357918|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139357919|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139357920|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
139357921|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139357922|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139357923|NCT04493463|Prednisolone|prednisolone|mesh-list
139357924|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
139357925|NCT04493463|Ropivacaine|ropivacaine|mesh-list
139357926|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139357927|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
139357928|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
139357929|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
139357930|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139357931|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357932|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
139357933|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357934|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139357935|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
139357936|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
139357937|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139357938|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
139357939|NCT04493463|Hormones|hormones|mesh-ancestor
139357940|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139357941|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139357942|NCT04493463|Protective Agents|protective agents|mesh-ancestor
139357943|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139357944|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357945|NCT04493073|Mitomycins|mitomycins|mesh-list
139357946|NCT04493073|Mitomycin|mitomycin|mesh-list
139357947|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139357948|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357949|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
139357950|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357951|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139357952|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139357953|NCT00748904|Rifaximin|rifaximin|mesh-list
139357954|NCT00748904|Lactulose|lactulose|mesh-list
139357955|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139357956|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139357957|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139357958|NCT03321903|Charcoal|charcoal|mesh-list
139357959|NCT03321903|Antidotes|antidotes|mesh-ancestor
139357960|NCT03321903|Protective Agents|protective agents|mesh-ancestor
139357961|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357962|NCT04411550|Pertuzumab|pertuzumab|mesh-list
139357963|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139357964|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357965|NCT03321825|Lidocaine|lidocaine|mesh-list
139357966|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
139357967|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
139357968|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
139357969|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139182952|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
139357970|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357971|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
139357972|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139357973|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139357974|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139357975|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139357976|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139357977|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139357978|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139357979|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
139357980|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
139357981|NCT03321825|Protective Agents|protective agents|mesh-ancestor
139357982|NCT02492217|Adalimumab|adalimumab|mesh-list
139357983|NCT02492217|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139357984|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139357985|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139357986|NCT05229536|Vaccines|vaccines|mesh-list
139357987|NCT05229536|Immunologic Factors|immunologic factors|mesh-ancestor
139357988|NCT05229536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357989|NCT04810910|Molgramostim|molgramostim|mesh-list
139357990|NCT04810910|Sargramostim|sargramostim|mesh-list
139357991|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
139357992|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139357993|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139357994|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
139357995|NCT03320187|Dinoprostone|dinoprostone|mesh-list
139357996|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
139357997|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
139357998|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139357999|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358000|NCT03320109|Vitamin D|vitamin d|mesh-list
139358001|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
139358002|NCT03320109|Cholecalciferol|cholecalciferol|mesh-list
139358003|NCT03320109|Vitamins|vitamins|mesh-list
139358004|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
139358005|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358006|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139358007|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139358008|NCT04529876|Abatacept|abatacept|mesh-list
139358009|NCT04529876|Tofacitinib|tofacitinib|mesh-list
139358010|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139358011|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358012|NCT04529876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139358013|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358014|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139358015|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
139358016|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358017|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139358018|NCT04529876|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139358019|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139358020|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358022|NCT03320031|Linagliptin|linagliptin|mesh-list
139358023|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139358024|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358025|NCT03320031|Incretins|incretins|mesh-ancestor
139358026|NCT03320031|Hormones|hormones|mesh-ancestor
139358027|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139358028|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139358029|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
139358030|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358031|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358032|NCT04510922|Droxidopa|droxidopa|mesh-list
139358033|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139358034|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139358035|NCT05465031|Valsartan|valsartan|mesh-list
139358036|NCT05465031|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139358037|NCT05465031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139358038|NCT05465031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139358039|NCT05465031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139182955|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139358040|NCT05465031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358041|NCT04510844|Evolocumab|evolocumab|mesh-list
139358042|NCT04510844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139358043|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139358044|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139358045|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
139358046|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358047|NCT04510844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139358048|NCT04510844|Protease Inhibitors|protease inhibitors|mesh-ancestor
139358049|NCT04510844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358050|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139358051|NCT05464953|Triamcinolone|triamcinolone|mesh-list
139358052|NCT05464953|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139358053|NCT05464953|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139358054|NCT05464953|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139358055|NCT05464953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139358056|NCT05464953|Glucocorticoids|glucocorticoids|mesh-ancestor
139358057|NCT05464953|Hormones|hormones|mesh-ancestor
139358058|NCT05464953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139358059|NCT05464953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358060|NCT05464953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139358061|NCT05464953|Immunologic Factors|immunologic factors|mesh-ancestor
139358062|NCT05464953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358063|NCT05464953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358064|NCT02491749|Anesthetics|anesthetics|mesh-list
139358065|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358066|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358067|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
139358068|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139358069|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358070|NCT04408898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139358071|NCT04408898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358072|NCT02490345|Gabapentin|gabapentin|mesh-list
139358073|NCT02490345|Analgesics|analgesics|mesh-ancestor
139358074|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
139358075|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358076|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358077|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
139358078|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139358079|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139358080|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358081|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139358082|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139358083|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139358084|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358085|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358086|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
139358087|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
139358088|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139358089|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139358090|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358091|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
139358092|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
139358093|NCT03319563|Epinephrine|epinephrine|mesh-list
139358094|NCT03319563|Anesthetics|anesthetics|mesh-list
139358095|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
139358096|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358097|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358098|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139358099|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139358100|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
139358101|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358102|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358103|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139358104|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139358105|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
138924249|NCT00733083|Morphine|morphine|mesh-list
139358106|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358107|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139358108|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
139358109|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
139358110|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
139358111|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139358112|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
139358113|NCT02485119|Anetumab ravtansine|anetumab ravtansine|mesh-list
139358114|NCT02485119|Immunoconjugates|immunoconjugates|mesh-ancestor
139358115|NCT02485119|Immunologic Factors|immunologic factors|mesh-ancestor
139358116|NCT02485119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358117|NCT02484573|Propranolol|propranolol|mesh-list
139358118|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139358119|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139358120|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
139358121|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358122|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358123|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358124|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139358125|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139358126|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
139358128|NCT02489955|Amikacin|amikacin|mesh-list
139358129|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139358130|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358131|NCT03734744|Vitamin D|vitamin d|mesh-list
139358132|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
139358133|NCT03734744|Vitamins|vitamins|mesh-ancestor
139358134|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
139358135|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358136|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139358137|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139358138|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139358139|NCT03576716|Calcifediol|calcifediol|mesh-list
139358140|NCT03576716|Vitamins|vitamins|mesh-ancestor
139358141|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
139358142|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358143|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139358144|NCT02487381|Dronabinol|dronabinol|mesh-list
139358145|NCT02487381|Cannabidiol|cannabidiol|mesh-list
139358146|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
139358147|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
139358148|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358149|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139358150|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139358151|NCT02487381|Analgesics|analgesics|mesh-ancestor
139358152|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
139358153|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358154|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139358155|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139358156|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358157|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358158|NCT02487381|Hormones|hormones|mesh-ancestor
139358159|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139358160|NCT02487849|Carboplatin|carboplatin|mesh-list
139014964|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
139358161|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358162|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139358163|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358164|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
139358165|NCT04021550|Telmisartan|telmisartan|mesh-list
139358166|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139358167|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139358168|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139358169|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358170|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
139358171|NCT04021550|Protective Agents|protective agents|mesh-ancestor
139358172|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358173|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
139358174|NCT04021550|Vitamins|vitamins|mesh-ancestor
139358175|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
139358176|NCT02489487|Ritonavir|ritonavir|mesh-list
139358177|NCT02489487|Darunavir|darunavir|mesh-list
139358178|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
139358179|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139358180|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139358181|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
139358182|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358183|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358184|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139358185|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139358186|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
139358187|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358188|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139358189|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139358190|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139358191|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139358192|NCT02096354|Irinotecan|irinotecan|mesh-list
139358193|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358194|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139358195|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139358196|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358197|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358198|NCT03177746|Tadalafil|tadalafil|mesh-list
139358199|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
139358200|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139358201|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139358202|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358203|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358204|NCT03177746|Urological Agents|urological agents|mesh-ancestor
139358205|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139358206|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139358207|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139358208|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
139358209|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358210|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139358211|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139358212|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358213|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139358214|NCT02483715|Amoxicillin|amoxicillin|mesh-list
139358215|NCT02483715|Metronidazole|metronidazole|mesh-list
139358216|NCT02483715|Tetracycline|tetracycline|mesh-list
139358217|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139358218|NCT02483715|Rabeprazole|rabeprazole|mesh-list
139358219|NCT02483715|Bismuth|bismuth|mesh-list
139358220|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139358221|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358222|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
139358223|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139358224|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139358225|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139358226|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139358227|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358228|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358229|NCT02483715|Antacids|antacids|mesh-ancestor
138933468|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
139358230|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139358231|NCT02483793|Tamsulosin|tamsulosin|mesh-list
139358232|NCT02483793|Oxybutynin|oxybutynin|mesh-list
139358233|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139358234|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139358235|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139358236|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
139358237|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358238|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358239|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358240|NCT02483793|Urological Agents|urological agents|mesh-ancestor
139358241|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
139358242|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
139358243|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358244|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139358245|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139358246|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
139358247|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
139358248|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139358249|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
139358250|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358251|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
139358252|NCT03200288|Protective Agents|protective agents|mesh-ancestor
139358253|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
139358254|NCT03318471|Analgesics|analgesics|mesh-ancestor
139358255|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
139358256|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358257|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358258|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
139358259|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358260|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139358261|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
139358262|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139358263|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139358264|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358265|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139358266|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
139358267|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139358268|NCT02489409|Gemcitabine|gemcitabine|mesh-list
139358269|NCT02489409|Vinorelbine|vinorelbine|mesh-list
139358270|NCT02489409|Endostatins|endostatins|mesh-list
139358271|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139358272|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
139358273|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358274|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358275|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139358276|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
139358277|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
139358278|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
139358279|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139358280|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139358281|NCT02489409|Growth Substances|growth substances|mesh-ancestor
139358282|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358283|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
139358284|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
139358285|NCT03930602|Deucravacitinib|deucravacitinib|mesh-list
139358286|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139358287|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139358288|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358289|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358290|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139358291|NCT03930602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139358292|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139358293|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139358294|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358295|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358296|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
139358297|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139358298|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
139358299|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139358300|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139358301|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358302|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139358303|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
139358304|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139358305|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139358306|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139358307|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139358308|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
139358309|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358310|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139358311|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139358312|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358314|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139358315|NCT02489019|Narcotics|narcotics|mesh-ancestor
139358316|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358317|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358318|NCT02489019|Analgesics|analgesics|mesh-ancestor
139358319|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
139358320|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358321|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139358322|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139358323|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
139358324|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
139358325|NCT02604446|Oxycodone|oxycodone|mesh-list
139358326|NCT02604446|Tapentadol|tapentadol|mesh-list
139358327|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139358328|NCT02604446|Narcotics|narcotics|mesh-ancestor
139358329|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358330|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358331|NCT02604446|Analgesics|analgesics|mesh-ancestor
139358332|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
139358333|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358334|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139358335|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139358336|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139358337|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358338|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
139358339|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358340|NCT02847637|Factor VIII|factor viii|mesh-list
139358341|NCT02847637|Coagulants|coagulants|mesh-ancestor
139358342|NCT00584246|Pregabalin|pregabalin|mesh-list
139358343|NCT00584246|Analgesics|analgesics|mesh-ancestor
139358344|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
139358345|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358346|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358347|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
139358348|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139358349|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139358350|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358351|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139183012|NCT03832621|Nivolumab|nivolumab|mesh-list
139358352|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139358353|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139358354|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358355|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139358356|NCT05124314|Misoprostol|misoprostol|mesh-list
139358357|NCT05124314|Mifepristone|mifepristone|mesh-list
139358358|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139358359|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
139358360|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139358361|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358362|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139358363|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139358364|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
139358365|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139358366|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139358367|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139358368|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139358369|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
139358370|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139358371|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139358372|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
139358373|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139358374|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
139358375|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139358376|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139358377|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
139358378|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
139358379|NCT03320967|Coagulants|coagulants|mesh-ancestor
139358380|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139358381|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139358382|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
139358383|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358384|NCT02483325|Fludarabine|fludarabine|mesh-list
139358385|NCT02483325|Busulfan|busulfan|mesh-list
139358386|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
139358387|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358388|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358389|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139358390|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
139358391|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358392|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
139358393|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139358394|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139358395|NCT04211090|Carboplatin|carboplatin|mesh-list
139358396|NCT04211090|Pemetrexed|pemetrexed|mesh-list
139358397|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358398|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358399|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358400|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139358401|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139358402|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
139358403|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139358404|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
139358405|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139358406|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
139358407|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358408|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358409|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
139358410|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
139358411|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139358412|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358413|NCT04538534|Nicardipine|nicardipine|mesh-list
139358414|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139358415|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139358416|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139358417|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358418|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139358419|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358420|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
139358421|NCT03318159|Posaconazole|posaconazole|mesh-list
139358422|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
139183021|NCT01220375|Plerixafor|plerixafor|mesh-list
139358423|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358424|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139358425|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139358426|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139358427|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139358428|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139358429|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358430|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358431|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139358432|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
139358433|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139358434|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358435|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
139358436|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
139358437|NCT02724410|Amoxicillin|amoxicillin|mesh-list
139358438|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
139358439|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
139358440|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139358441|NCT02724410|Ertapenem|ertapenem|mesh-list
139358442|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139358443|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358444|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139358445|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358446|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358447|NCT02486601|Paclitaxel|paclitaxel|mesh-list
139358448|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139358449|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358450|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
139358451|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
139358452|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
139358453|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358454|NCT02487069|Cyclosporine|cyclosporine|mesh-list
139358455|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
139358456|NCT02487069|Methotrexate|methotrexate|mesh-list
139358457|NCT02487069|Cyclosporins|cyclosporins|mesh-list
139358458|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139358459|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139358460|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
139358461|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139358462|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358463|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139358464|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
139358465|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358466|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358467|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
139358468|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358469|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139358470|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139358471|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
139358472|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139358473|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139358474|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
139358475|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358476|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139358477|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139358478|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139358479|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
139358480|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139358481|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
139358482|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358483|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358484|NCT03317847|Dexamethasone|dexamethasone|mesh-list
139358485|NCT03317847|Bromfenac|bromfenac|mesh-list
139358486|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139358487|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139358488|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
139358489|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
139358490|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358491|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358492|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139358493|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
139358495|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139358496|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139358497|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358498|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139358499|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139358500|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139358501|NCT03317847|Analgesics|analgesics|mesh-ancestor
139358502|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
139358503|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139358504|NCT01342081|Timolol|timolol|mesh-list
139358505|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139358506|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139358507|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139358508|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139358509|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
139358510|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358511|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358512|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358513|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139358514|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139358515|NCT03563833|Anesthetics|anesthetics|mesh-list
139358516|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358517|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358518|NCT02483169|Aspirin|aspirin|mesh-list
139358519|NCT02483169|Cilostazol|cilostazol|mesh-list
139358520|NCT02483169|Probucol|probucol|mesh-list
139358521|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139358522|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139358523|NCT02483169|Analgesics|analgesics|mesh-ancestor
139358524|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
139358525|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358526|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358527|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139358528|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139358529|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139358530|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139358531|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358532|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139358533|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139358534|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358535|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
139358536|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139015337|NCT03289728|Dobutamine|dobutamine|mesh-list
139358537|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
139358538|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139358539|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
139358540|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
139358541|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139358542|NCT02483169|Protective Agents|protective agents|mesh-ancestor
139358543|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139358544|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139358545|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139358546|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139358547|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
139358548|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139358549|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
139358550|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
139358551|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139358552|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
139358553|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
139358554|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358555|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358556|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139358557|NCT02489097|Analgesics|analgesics|mesh-ancestor
139358558|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
139358559|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358560|NCT02203682|Doxycycline|doxycycline|mesh-list
139358561|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139358562|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358563|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
139358564|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139358565|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139358566|NCT02256800|Leucovorin|leucovorin|mesh-list
139358567|NCT02256800|Bevacizumab|bevacizumab|mesh-list
139358568|NCT02256800|Irinotecan|irinotecan|mesh-list
139358569|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139358570|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358571|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139358572|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139358573|NCT02256800|Growth Substances|growth substances|mesh-ancestor
139358574|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358575|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
139358576|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139358577|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139358578|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358579|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358580|NCT02256800|Antidotes|antidotes|mesh-ancestor
139358581|NCT02256800|Protective Agents|protective agents|mesh-ancestor
139358582|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
139358583|NCT02256800|Vitamins|vitamins|mesh-ancestor
139358584|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
139358585|NCT01341457|Gemcitabine|gemcitabine|mesh-list
139358586|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139358587|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
139358588|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358589|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358590|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
139358591|NCT02488473|Ropivacaine|ropivacaine|mesh-list
139358592|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139358593|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358594|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358595|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139358596|NCT02488473|Analgesics|analgesics|mesh-ancestor
139358597|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
139358598|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358599|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139358600|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139358601|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139358602|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
139358603|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358604|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358605|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
139358606|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
139358607|NCT05128292|Selenium|selenium|mesh-list
139358608|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
139358609|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358610|NCT05128292|Protective Agents|protective agents|mesh-ancestor
139358611|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358612|NCT05128292|Trace Elements|trace elements|mesh-ancestor
139358613|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
139358614|NCT03971708|Lidocaine|lidocaine|mesh-list
139358615|NCT03971708|Ropivacaine|ropivacaine|mesh-list
139358616|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
139358617|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
139358618|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358619|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358620|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
139358621|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358622|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139358623|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139358624|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139358625|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139358626|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358627|NCT02832037|BI 425809|bi 425809|mesh-list
139358628|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
139358629|NCT02482857|Aspirin|aspirin|mesh-list
139358630|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139358631|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139358632|NCT02482857|Analgesics|analgesics|mesh-ancestor
139358633|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
139358634|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358635|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358636|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139358637|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139358638|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139358639|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139358640|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358641|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139358642|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139358643|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358644|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
139358645|NCT02480049|Montelukast|montelukast|mesh-list
139358646|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139358647|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
139358648|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139358649|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
139358650|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139358651|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358652|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139358653|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139358654|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358655|NCT02479971|Clindamycin|clindamycin|mesh-list
139358656|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
139358657|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
139358658|NCT02479971|Gentamicins|gentamicins|mesh-list
139358659|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139358660|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358661|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139358662|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358663|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358664|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
139358665|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
139358666|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358667|NCT02486055|Vitamins|vitamins|mesh-ancestor
139358668|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
139358669|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
139358670|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
139358671|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358672|NCT02485821|Misoprostol|misoprostol|mesh-list
139358673|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139358674|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139358675|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139358676|NCT02485821|Estradiol|estradiol|mesh-list
139358677|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139358678|NCT02485821|Estrogens|estrogens|mesh-ancestor
139358679|NCT02485821|Hormones|hormones|mesh-ancestor
139358680|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139358681|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358682|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139358683|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
139358684|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139358685|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139358686|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139358687|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
139358688|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139358689|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139358691|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139358692|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139358693|NCT02479815|Micronutrients|micronutrients|mesh-list
139358694|NCT02479815|Trace Elements|trace elements|mesh-list
139358695|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358696|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
139358697|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
139358698|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139358699|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358700|NCT04119830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139358701|NCT04119830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358702|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
139358703|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358704|NCT04049786|Metoprolol|metoprolol|mesh-list
139358705|NCT04049786|Carvedilol|carvedilol|mesh-list
139358706|NCT04049786|Midazolam|midazolam|mesh-list
139358707|NCT04049786|Simvastatin|simvastatin|mesh-list
139358708|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139358709|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139358710|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358711|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358712|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139358713|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139358714|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139358715|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139358716|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
139358717|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
139358718|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
139358719|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
139358720|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358721|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358722|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139358723|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139358724|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
139358725|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139358726|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139358727|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358728|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139358729|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139358730|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
139358731|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
139358732|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358733|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139358734|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139358735|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139358736|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
139358737|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
139358738|NCT04049786|Protective Agents|protective agents|mesh-ancestor
139358739|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139358740|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139358741|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139358742|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
139358743|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139358744|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139358745|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
139358746|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
139358747|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358748|NCT03316599|Paclitaxel|paclitaxel|mesh-list
139358749|NCT03316599|Gemcitabine|gemcitabine|mesh-list
139358750|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139358751|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358752|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
139358753|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
139358754|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
139358755|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358756|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139358757|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
139358758|NCT02482155|Ibuprofen|ibuprofen|mesh-list
139358759|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139358760|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139358761|NCT02482155|Analgesics|analgesics|mesh-ancestor
139358762|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
139358763|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358764|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358765|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139358766|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139358767|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139358768|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358769|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358770|NCT01675154|Orlistat|orlistat|mesh-list
139358771|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358772|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358773|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139358774|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139358775|NCT02485431|Deflazacort|deflazacort|mesh-list
139358776|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139183043|NCT01126073|Niacin|niacin|mesh-list
138924398|NCT02568735|Analgesics|analgesics|mesh-ancestor
139358777|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139358778|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
139358779|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358780|NCT02744755|Adalimumab|adalimumab|mesh-list
139358781|NCT02744755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139358782|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139358783|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139358784|NCT03314493|Spironolactone|spironolactone|mesh-list
139358785|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139358786|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
139358787|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139358788|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358789|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139358790|NCT03314493|Diuretics|diuretics|mesh-ancestor
139358791|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
139358792|NCT03912350|Balovaptan|balovaptan|mesh-list
139358793|NCT03912350|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139358794|NCT03912350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358795|NCT03912350|Natriuretic Agents|natriuretic agents|mesh-ancestor
139358796|NCT03912350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358797|NCT03801200|Apatinib|apatinib|mesh-list
139358798|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358799|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139358800|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358801|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358802|NCT02485041|Mirodenafil|mirodenafil|mesh-list
139358803|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139358804|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139358805|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358806|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358807|NCT02484963|Zolpidem|zolpidem|mesh-list
139358808|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139358809|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139358810|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358811|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358812|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139358813|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
139358814|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
139358815|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358816|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358817|NCT05713773|Caffeine|caffeine|mesh-list
139358818|NCT05713773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139358819|NCT05713773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358820|NCT05713773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139358821|NCT05713773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358822|NCT05713773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358823|NCT05713773|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139358824|NCT05713773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139358825|NCT05713773|Purinergic Agents|purinergic agents|mesh-ancestor
139358826|NCT05713773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358827|NCT02829775|Interferons|interferons|mesh-list
139358828|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
139358829|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
139358830|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139358831|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358832|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
139358833|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358834|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
139358835|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139015644|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358836|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138924417|NCT00733473|Hormones|hormones|mesh-ancestor
139358837|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139358838|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
139358839|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358840|NCT02476773|Antacids|antacids|mesh-ancestor
139358841|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358842|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139358843|NCT04500860|Tadalafil|tadalafil|mesh-list
139358844|NCT04500860|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139358845|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
139358846|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139358847|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139358848|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358849|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358850|NCT04500860|Urological Agents|urological agents|mesh-ancestor
139358851|NCT04500860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139358852|NCT04500860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139358853|NCT04500860|Cholinergic Agents|cholinergic agents|mesh-ancestor
139358854|NCT04500860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358855|NCT04500860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358856|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139358857|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358858|NCT02479581|Floxacillin|floxacillin|mesh-list
139358859|NCT02479581|Dexamethasone|dexamethasone|mesh-list
139358860|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
139358861|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139358862|NCT02479581|Scopolamine|scopolamine|mesh-list
139358863|NCT02479581|Morphine|morphine|mesh-list
139358864|NCT02479581|Anesthetics|anesthetics|mesh-list
139358865|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139358866|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
139358867|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
139358868|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358869|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358870|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139358871|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
139358872|NCT02479581|Hormones|hormones|mesh-ancestor
139358873|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139358874|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139358875|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358876|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358877|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139358878|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139358879|NCT02479581|Narcotics|narcotics|mesh-ancestor
139358880|NCT02479581|Analgesics|analgesics|mesh-ancestor
139358881|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
139358882|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139358883|NCT02479581|Protective Agents|protective agents|mesh-ancestor
139358884|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139358885|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
139358886|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139358887|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
139358888|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358889|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139358890|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139358891|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358892|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
139358893|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
139358894|NCT02479347|Povidone|povidone|mesh-list
139358895|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139358896|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358897|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
139358898|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
139358899|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
139358900|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
139358901|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139358902|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
139358903|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139358904|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
139358905|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358906|NCT02481609|Expectorants|expectorants|mesh-ancestor
139358907|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
139358908|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139358909|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
139358910|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358911|NCT02481609|Protective Agents|protective agents|mesh-ancestor
139358912|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358913|NCT02481609|Antidotes|antidotes|mesh-ancestor
139358914|NCT05373225|Acetic Acid|acetic acid|mesh-list
139358915|NCT05373225|Retinol acetate|retinol acetate|mesh-list
139358916|NCT05373225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139358917|NCT05373225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358918|NCT05373225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139358919|NCT05373225|Immunologic Factors|immunologic factors|mesh-ancestor
139358920|NCT05373225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358921|NCT05373225|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139358922|NCT05373225|Protective Agents|protective agents|mesh-ancestor
139358923|NCT05373225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358924|NCT01355575|Rifaximin|rifaximin|mesh-list
139358925|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139358926|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358927|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139358928|NCT05125640|Progesterone|progesterone|mesh-list
139358929|NCT05125640|Progestins|progestins|mesh-ancestor
139358930|NCT05125640|Hormones|hormones|mesh-ancestor
139358931|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139358932|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358933|NCT03314259|Tamsulosin|tamsulosin|mesh-list
139358934|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139358935|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139358936|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139358937|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
139358938|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139358939|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358940|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358941|NCT03314259|Urological Agents|urological agents|mesh-ancestor
139358942|NCT02481453|Sirolimus|sirolimus|mesh-list
139358943|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139358944|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358945|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139358946|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139358947|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
139358949|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
139358950|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358951|NCT02825251|Insulin|insulin|mesh-list
139358952|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139358953|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
139358954|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
139358955|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139358956|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139358957|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358958|NCT03563365|Adapalene|adapalene|mesh-list
139358959|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139358960|NCT03563365|Resveratrol|resveratrol|mesh-list
139358961|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
139358962|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358963|NCT03563365|Protective Agents|protective agents|mesh-ancestor
139358964|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139358965|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358966|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139358967|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
139358968|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139358969|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139358970|NCT03563365|Analgesics|analgesics|mesh-ancestor
139358971|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
139358972|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139358973|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139358974|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139358975|NCT02475915|Tenofovir|tenofovir|mesh-list
139358976|NCT02475915|Emtricitabine|emtricitabine|mesh-list
139358977|NCT02475915|Efavirenz|efavirenz|mesh-list
139358978|NCT02475915|Maraviroc|maraviroc|mesh-list
139358979|NCT02475915|Darunavir|darunavir|mesh-list
139358980|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
139358981|NCT02475915|Vorinostat|vorinostat|mesh-list
139358982|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
139358983|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139358984|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139358985|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139358986|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139358987|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139358988|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139358989|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139015796|NCT01001780|Rituximab|rituximab|mesh-list
139358990|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
139358991|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139358992|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139358993|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139358994|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139358995|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139358996|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139358997|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139358998|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139358999|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139359000|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359001|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139359002|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139359003|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139359004|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139359005|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139359006|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139359007|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
139359008|NCT03833323|Treprostinil|treprostinil|mesh-list
139359009|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139359010|NCT03110575|Cyclobenzaprine|cyclobenzaprine|mesh-list
139359011|NCT03110575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139359012|NCT03110575|Antidepressive Agents|antidepressive agents|mesh-ancestor
139359013|NCT03110575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139359014|NCT03110575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139359015|NCT03110575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359016|NCT03110575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139359017|NCT03110575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359018|NCT03110575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139359019|NCT03110575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359020|NCT05384847|Hormones|hormones|mesh-list
139359021|NCT05384847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359022|NCT05384847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359023|NCT02478879|Teriparatide|teriparatide|mesh-list
139359024|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
139359025|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359026|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139359027|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139359028|NCT02478645|Ramosetron|ramosetron|mesh-list
139359029|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
139359030|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
139359031|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359032|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359033|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139359034|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139359035|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
139359036|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139359037|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359038|NCT05871957|Vitamin D|vitamin d|mesh-list
139359039|NCT05871957|Ergocalciferols|ergocalciferols|mesh-list
139359040|NCT05871957|Cholecalciferol|cholecalciferol|mesh-list
139359041|NCT05871957|Vitamins|vitamins|mesh-list
139359042|NCT05871957|Micronutrients|micronutrients|mesh-ancestor
139359043|NCT05871957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359044|NCT05871957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139359045|NCT05871957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139359046|NCT05871073|Dexamethasone|dexamethasone|mesh-list
139359047|NCT05871073|Ropivacaine|ropivacaine|mesh-list
139359048|NCT05871073|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139359049|NCT05871073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139359050|NCT05871073|Antiemetics|antiemetics|mesh-ancestor
139359051|NCT05871073|Autonomic Agents|autonomic agents|mesh-ancestor
139359052|NCT05871073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359053|NCT05871073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359054|NCT05871073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139359055|NCT05871073|Glucocorticoids|glucocorticoids|mesh-ancestor
139359056|NCT05871073|Hormones|hormones|mesh-ancestor
139359057|NCT05871073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359058|NCT05871073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139359059|NCT05871073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359060|NCT05871073|Anesthetics, Local|anesthetics, local|mesh-ancestor
139359061|NCT05871073|Anesthetics|anesthetics|mesh-ancestor
139359062|NCT05871073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359063|NCT05871073|Sensory System Agents|sensory system agents|mesh-ancestor
139015875|NCT00528866|Docetaxel|docetaxel|mesh-list
139359064|NCT05871021|Bevacizumab|bevacizumab|mesh-list
139359065|NCT05871021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139359066|NCT05871021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359067|NCT05871021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139359068|NCT05871021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139359069|NCT05871021|Growth Substances|growth substances|mesh-ancestor
139359070|NCT05871021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359071|NCT05871021|Growth Inhibitors|growth inhibitors|mesh-ancestor
139359072|NCT05870969|Liver Extracts|liver extracts|mesh-list
139359073|NCT05870969|Hematinics|hematinics|mesh-ancestor
139359074|NCT05870917|Dexamethasone|dexamethasone|mesh-list
139359075|NCT05870917|Lenalidomide|lenalidomide|mesh-list
139359076|NCT05870917|Bortezomib|bortezomib|mesh-list
139359077|NCT05870917|Venetoclax|venetoclax|mesh-list
139359078|NCT05870917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139359079|NCT05870917|Antiemetics|antiemetics|mesh-ancestor
139359080|NCT05870917|Autonomic Agents|autonomic agents|mesh-ancestor
139359081|NCT05870917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359082|NCT05870917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359083|NCT05870917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139359084|NCT05870917|Glucocorticoids|glucocorticoids|mesh-ancestor
139359085|NCT05870917|Hormones|hormones|mesh-ancestor
139359086|NCT05870917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359087|NCT05870917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139359088|NCT05870917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359089|NCT05870917|Immunologic Factors|immunologic factors|mesh-ancestor
139359090|NCT05870917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139359091|NCT05870917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139359092|NCT05870917|Growth Substances|growth substances|mesh-ancestor
139359093|NCT05870917|Growth Inhibitors|growth inhibitors|mesh-ancestor
139359094|NCT05870553|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139359095|NCT05870553|Laxatives|laxatives|mesh-ancestor
139359096|NCT05870553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139359097|NCT05870501|Midazolam|midazolam|mesh-list
139359098|NCT05870501|Ketamine|ketamine|mesh-list
139359099|NCT05870501|Analgesics|analgesics|mesh-ancestor
139359100|NCT05870501|Sensory System Agents|sensory system agents|mesh-ancestor
139359101|NCT05870501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359102|NCT05870501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359103|NCT05870501|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139359104|NCT05870501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139359105|NCT05870501|Anesthetics, General|anesthetics, general|mesh-ancestor
139359106|NCT05870501|Anesthetics|anesthetics|mesh-ancestor
139359107|NCT05870501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359108|NCT05870501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139359109|NCT05870501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139359110|NCT05870501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139359111|NCT05870501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359112|NCT05870501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139359113|NCT05870501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139359114|NCT05870501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139359115|NCT05870501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139359116|NCT05870501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139359117|NCT05870501|GABA Modulators|gaba modulators|mesh-ancestor
139359118|NCT05870501|GABA Agents|gaba agents|mesh-ancestor
139359119|NCT05870475|Interferons|interferons|mesh-list
139359120|NCT05870475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359121|NCT05870475|Antiviral Agents|antiviral agents|mesh-ancestor
139359122|NCT05870475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139359123|NCT05870436|Choline|choline|mesh-list
139359124|NCT05870436|Methacholine Chloride|methacholine chloride|mesh-list
139359125|NCT05870436|Lipotropic Agents|lipotropic agents|mesh-ancestor
139359126|NCT05870436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139359127|NCT05870436|Antimetabolites|antimetabolites|mesh-ancestor
139359128|NCT05870436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359129|NCT05870436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139359130|NCT05870436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139359131|NCT05870436|Nootropic Agents|nootropic agents|mesh-ancestor
139359132|NCT05870436|Miotics|miotics|mesh-ancestor
139359133|NCT05870436|Autonomic Agents|autonomic agents|mesh-ancestor
139359134|NCT05870436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359135|NCT05870436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359136|NCT05870436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139359137|NCT05870436|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139359138|NCT05870436|Respiratory System Agents|respiratory system agents|mesh-ancestor
139359139|NCT05870436|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139359140|NCT05870436|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139015946|NCT00880529|Narcotics|narcotics|mesh-ancestor
139359141|NCT05870436|Cholinergic Agents|cholinergic agents|mesh-ancestor
139359142|NCT05870436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139359143|NCT05870423|Olaparib|olaparib|mesh-list
139359144|NCT05870423|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139359145|NCT05870423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359146|NCT05870423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359147|NCT05870423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359148|NCT05870358|Melatonin|melatonin|mesh-list
139359149|NCT05870358|Antioxidants|antioxidants|mesh-ancestor
139359150|NCT05870358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359151|NCT05870358|Protective Agents|protective agents|mesh-ancestor
139359152|NCT05870358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359153|NCT05870358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359154|NCT05870111|Choline|choline|mesh-list
139359155|NCT05870111|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139359156|NCT05870111|Lipotropic Agents|lipotropic agents|mesh-ancestor
139359157|NCT05870111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139359158|NCT05870111|Antimetabolites|antimetabolites|mesh-ancestor
139359159|NCT05870111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359160|NCT05870111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139359161|NCT05870111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139359162|NCT05870111|Nootropic Agents|nootropic agents|mesh-ancestor
139359163|NCT05870059|Chlorhexidine|chlorhexidine|mesh-list
139359164|NCT05870059|Propolis|propolis|mesh-list
139359165|NCT05870059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139359166|NCT05870059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139359167|NCT05870059|Disinfectants|disinfectants|mesh-ancestor
139359168|NCT05870007|Atorvastatin|atorvastatin|mesh-list
139359169|NCT05870007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139359170|NCT05870007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139359171|NCT05870007|Antimetabolites|antimetabolites|mesh-ancestor
139359172|NCT05870007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359173|NCT05870007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139359174|NCT05870007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139359175|NCT05870007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359176|NCT05866653|Lidocaine|lidocaine|mesh-list
139359177|NCT05866653|Anesthetics, Local|anesthetics, local|mesh-ancestor
139359178|NCT05866653|Anesthetics|anesthetics|mesh-ancestor
139359179|NCT05866653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359180|NCT05866653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359181|NCT05866653|Sensory System Agents|sensory system agents|mesh-ancestor
139359182|NCT05866653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359183|NCT05866653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139359184|NCT05866653|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139359185|NCT05866653|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139359186|NCT05866653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139359187|NCT05866653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359188|NCT05790577|Niacinamide|niacinamide|mesh-list
139359189|NCT05790577|Niacin|niacin|mesh-list
139359190|NCT05790577|Nicotinic Acids|nicotinic acids|mesh-list
139359191|NCT05790577|Metformin|metformin|mesh-list
139359192|NCT05790577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139359193|NCT05790577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359194|NCT05790577|Vitamin B Complex|vitamin b complex|mesh-ancestor
139359195|NCT05790577|Vitamins|vitamins|mesh-ancestor
139359196|NCT05790577|Micronutrients|micronutrients|mesh-ancestor
139359197|NCT05790577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139359198|NCT05790577|Antimetabolites|antimetabolites|mesh-ancestor
139359199|NCT05790577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359200|NCT05790577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139359201|NCT05790577|Vasodilator Agents|vasodilator agents|mesh-ancestor
139359202|NCT05778838|Midodrine|midodrine|mesh-list
139359203|NCT05778838|Sympathomimetics|sympathomimetics|mesh-ancestor
139359204|NCT05778838|Autonomic Agents|autonomic agents|mesh-ancestor
139359205|NCT05778838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359206|NCT05778838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359207|NCT05778838|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139359208|NCT05778838|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139359209|NCT05778838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139359210|NCT05778838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139359211|NCT05778838|Adrenergic Agents|adrenergic agents|mesh-ancestor
139359212|NCT05778838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139359213|NCT05778838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359214|NCT05760248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139359215|NCT05757544|Ganaxolone|ganaxolone|mesh-list
139359216|NCT05757544|Neurosteroids|neurosteroids|mesh-ancestor
139359217|NCT05757544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139359218|NCT05757544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359219|NCT05757544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359220|NCT05757544|GABA Modulators|gaba modulators|mesh-ancestor
139359221|NCT05757544|GABA Agents|gaba agents|mesh-ancestor
139359222|NCT05688943|Anesthetics|anesthetics|mesh-list
139359223|NCT05688943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359224|NCT05688943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359225|NCT05638919|Antiviral Agents|antiviral agents|mesh-list
139359226|NCT05638919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139359227|NCT05631405|Dexamethasone|dexamethasone|mesh-list
139359228|NCT05631405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139359229|NCT05631405|Antiemetics|antiemetics|mesh-ancestor
139359230|NCT05631405|Autonomic Agents|autonomic agents|mesh-ancestor
139359231|NCT05631405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359232|NCT05631405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359233|NCT05631405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139359234|NCT05631405|Glucocorticoids|glucocorticoids|mesh-ancestor
139359235|NCT05631405|Hormones|hormones|mesh-ancestor
139359236|NCT05631405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359237|NCT05631405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139359238|NCT05631405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359239|NCT05621655|Vaccines|vaccines|mesh-list
139359240|NCT05621655|Immunologic Factors|immunologic factors|mesh-ancestor
139359241|NCT05621655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359242|NCT05586724|Norethindrone|norethindrone|mesh-list
139359243|NCT05586724|Norethindrone Acetate|norethindrone acetate|mesh-list
139359244|NCT05586724|Progesterone|progesterone|mesh-list
139359245|NCT05586724|Estrogens|estrogens|mesh-list
139359246|NCT05586724|Progestins|progestins|mesh-ancestor
139359247|NCT05586724|Hormones|hormones|mesh-ancestor
139359248|NCT05586724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359249|NCT05586724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359250|NCT05586724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139359251|NCT05586724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139359252|NCT05586724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139359253|NCT05586724|Contraceptive Agents|contraceptive agents|mesh-ancestor
139359254|NCT05586724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139359255|NCT05586724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139359256|NCT05586724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139359257|NCT05485558|Acetylcysteine|acetylcysteine|mesh-list
139359258|NCT05485558|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139359259|NCT05485558|Antiviral Agents|antiviral agents|mesh-ancestor
139359260|NCT05485558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139359261|NCT05485558|Expectorants|expectorants|mesh-ancestor
139359262|NCT05485558|Respiratory System Agents|respiratory system agents|mesh-ancestor
139359263|NCT05485558|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139359264|NCT05485558|Antioxidants|antioxidants|mesh-ancestor
139359265|NCT05485558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359266|NCT05485558|Protective Agents|protective agents|mesh-ancestor
139359267|NCT05485558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359268|NCT05485558|Antidotes|antidotes|mesh-ancestor
139359269|NCT05383196|Paclitaxel|paclitaxel|mesh-list
139359270|NCT05383196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139359271|NCT05383196|Onvansertib|onvansertib|mesh-list
139359272|NCT05383196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139359273|NCT05383196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359274|NCT05383196|Tubulin Modulators|tubulin modulators|mesh-ancestor
139359275|NCT05383196|Antimitotic Agents|antimitotic agents|mesh-ancestor
139359276|NCT05383196|Mitosis Modulators|mitosis modulators|mesh-ancestor
139359277|NCT05383196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359278|NCT05383196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139359279|NCT05383196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359280|NCT05340582|Acetaminophen|acetaminophen|mesh-list
139359281|NCT05340582|Ibuprofen|ibuprofen|mesh-list
139359282|NCT05340582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139359283|NCT05340582|Analgesics|analgesics|mesh-ancestor
139359284|NCT05340582|Sensory System Agents|sensory system agents|mesh-ancestor
139359285|NCT05340582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359286|NCT05340582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359287|NCT05340582|Antipyretics|antipyretics|mesh-ancestor
139359288|NCT05340582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139359289|NCT05340582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139359290|NCT05340582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139359291|NCT05340582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139359292|NCT05340582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139016105|NCT00882323|Fludarabine|fludarabine|mesh-list
139359293|NCT05340582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359294|NCT05285605|Ulipristal acetate|ulipristal acetate|mesh-list
139359295|NCT05285605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139359296|NCT05285605|Contraceptive Agents|contraceptive agents|mesh-ancestor
139359297|NCT05285605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139359298|NCT05285605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359299|NCT05285605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139359301|NCT05179733|Lenalidomide|lenalidomide|mesh-list
139359302|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
139359303|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139359304|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359305|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
139359306|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359307|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139359308|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139359309|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139359310|NCT05179733|Growth Substances|growth substances|mesh-ancestor
139359311|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
139359312|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139359313|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359314|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359315|NCT05083247|Paclitaxel|paclitaxel|mesh-list
139359316|NCT05083247|Gemcitabine|gemcitabine|mesh-list
139359317|NCT05083247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139359318|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359319|NCT05083247|Tubulin Modulators|tubulin modulators|mesh-ancestor
139359320|NCT05083247|Antimitotic Agents|antimitotic agents|mesh-ancestor
139359321|NCT05083247|Mitosis Modulators|mitosis modulators|mesh-ancestor
139359322|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359323|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139359324|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
139359325|NCT05076110|Acetaminophen|acetaminophen|mesh-list
139359326|NCT05076110|Ibuprofen|ibuprofen|mesh-list
139359327|NCT05076110|Oxycodone|oxycodone|mesh-list
139359328|NCT05076110|Gabapentin|gabapentin|mesh-list
139359329|NCT05076110|Methocarbamol|methocarbamol|mesh-list
139359330|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139359331|NCT05076110|Analgesics|analgesics|mesh-ancestor
139359332|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
139359333|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359334|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359335|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
139359336|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139359337|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139359338|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139359339|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139359340|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359341|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359342|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139359343|NCT05076110|Narcotics|narcotics|mesh-ancestor
139359344|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359345|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
139359346|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139359347|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139359348|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139359349|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139359350|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139359351|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139359352|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
139359353|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139359354|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139359355|NCT05063838|Anesthetics|anesthetics|mesh-list
139359356|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359357|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359358|NCT05174650|Atezolizumab|atezolizumab|mesh-list
139359359|NCT05174650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139359360|NCT05174650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359361|NCT05174650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139359362|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359363|NCT04986579|Trastuzumab|trastuzumab|mesh-list
139359364|NCT04986579|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139359365|NCT04986579|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139359366|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139359367|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359368|NCT04986579|Immunoconjugates|immunoconjugates|mesh-ancestor
139359369|NCT04986579|Immunologic Factors|immunologic factors|mesh-ancestor
139359370|NCT04986579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359371|NCT04939441|Tenofovir|tenofovir|mesh-list
139359372|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
139359373|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139359374|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139359375|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139359376|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359377|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359378|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139359379|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139359380|NCT04937738|Leucovorin|leucovorin|mesh-list
139359381|NCT04937738|Docetaxel|docetaxel|mesh-list
139359382|NCT04937738|Capecitabine|capecitabine|mesh-list
139359383|NCT04937738|Fluorouracil|fluorouracil|mesh-list
139359384|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
139359385|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359386|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
139359387|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
139359388|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
139359389|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359390|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139359391|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
139359392|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139359393|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
139359394|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359395|NCT04937738|Antidotes|antidotes|mesh-ancestor
139359396|NCT04937738|Protective Agents|protective agents|mesh-ancestor
139359397|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
139359398|NCT04937738|Vitamins|vitamins|mesh-ancestor
139359399|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
139359400|NCT04860505|Doxycycline|doxycycline|mesh-list
139359401|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139359402|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139359403|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
139359404|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139359405|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139359406|NCT04810559|Antibodies|antibodies|mesh-list
139359407|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
139359408|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359409|NCT04724018|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139359410|NCT04724018|Immunoconjugates|immunoconjugates|mesh-ancestor
139359411|NCT04724018|Immunologic Factors|immunologic factors|mesh-ancestor
139359412|NCT04724018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359413|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139359414|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
139359415|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359416|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
139359417|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359418|NCT04653831|Pirfenidone|pirfenidone|mesh-list
139359419|NCT04653831|Analgesics|analgesics|mesh-ancestor
139359420|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
139359421|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359422|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359423|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139359424|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139359425|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139359426|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139359427|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359428|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139359429|NCT04512638|Amoxicillin|amoxicillin|mesh-list
139359430|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
139359431|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139359432|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139359433|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139359434|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
139359435|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
139359436|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
139359437|NCT04510428|Antibodies|antibodies|mesh-list
139359438|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
139359439|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139359440|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139359441|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
139359442|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016260|NCT05695352|Meloxicam|meloxicam|mesh-list
139359443|NCT04437303|Anticoagulants|anticoagulants|mesh-list
139359444|NCT04436107|Lenalidomide|lenalidomide|mesh-list
139359445|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
139359446|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
139359447|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359448|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139359449|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139359450|NCT04436107|Growth Substances|growth substances|mesh-ancestor
139359451|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
138924625|NCT00740259|Flunarizine|flunarizine|mesh-list
139359452|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359453|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139359454|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359455|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359456|NCT04411693|Dexamethasone|dexamethasone|mesh-list
139359457|NCT04411693|Aflibercept|aflibercept|mesh-list
139359458|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139359459|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
139359460|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
139359461|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359462|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359463|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139359464|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
139359465|NCT04411693|Hormones|hormones|mesh-ancestor
139359466|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359467|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139359468|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359469|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139359470|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139359471|NCT04411693|Growth Substances|growth substances|mesh-ancestor
139359472|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
139359473|NCT04380740|Abatacept|abatacept|mesh-list
139359474|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139359475|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359476|NCT04380740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139359477|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359478|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139359479|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
139359480|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359481|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139359482|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
139359483|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139359484|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139359485|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359486|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
139359487|NCT04274335|Coagulants|coagulants|mesh-ancestor
139359488|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
139359489|NCT04267887|Prednisone|prednisone|mesh-list
139359490|NCT04267887|Cortisone|cortisone|mesh-list
139359491|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
139359492|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
139359493|NCT04267887|Hormones|hormones|mesh-list
139359494|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139359495|NCT04267887|Androgens|androgens|mesh-list
139359496|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
139359497|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139359498|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
139359499|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359500|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359501|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139359502|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359503|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139359504|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359505|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359506|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
139359507|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139359508|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
139359509|NCT04267887|Protective Agents|protective agents|mesh-ancestor
139359510|NCT04267887|Vitamins|vitamins|mesh-ancestor
139359511|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
139359512|NCT04267887|Estrogens|estrogens|mesh-ancestor
139359513|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
139359514|NCT04238767|Dolutegravir|dolutegravir|mesh-list
139359515|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139359516|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139359517|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359518|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359519|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139359520|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139359521|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
139359522|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139359523|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139359524|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
139359525|NCT04177355|MEDI9197|medi9197|mesh-list
139359526|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139359527|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
139359528|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359529|NCT04177355|Antacids|antacids|mesh-ancestor
139359530|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359531|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139359532|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
139359533|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139359534|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139359535|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
139359536|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139359537|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359538|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359539|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
139359540|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
139359541|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359542|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
139359543|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139359544|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
139359545|NCT04063865|Everolimus|everolimus|mesh-list
139359546|NCT04063865|Tacrolimus|tacrolimus|mesh-list
139359547|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139359548|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
139359549|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359550|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139359551|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359552|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359553|NCT04063865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139359554|NCT04063865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139359555|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359556|NCT04015700|Coal Tar|coal tar|mesh-list
139359557|NCT04015700|Vaccines|vaccines|mesh-list
139359558|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
139359559|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359560|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
139359561|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
139359562|NCT03994211|Itraconazole|itraconazole|mesh-list
139359563|NCT03994211|Rifampin|rifampin|mesh-list
139359564|NCT03994211|Pamiparib|pamiparib|mesh-list
139359565|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
139359566|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139359567|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139359568|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139359569|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359570|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359571|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139359572|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
139359573|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359574|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359575|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139359576|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139359577|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
139359578|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139359579|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
139359580|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139359581|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139359582|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139359583|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139359584|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139359585|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139359586|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139359587|NCT03994211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139359588|NCT03994211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359590|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
139359591|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139359592|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359593|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359594|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139359595|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
139359596|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139359597|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359598|NCT03910660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139359599|NCT03910660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359601|NCT03875378|Hormones|hormones|mesh-ancestor
139359602|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359603|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359604|NCT03818607|Eculizumab|eculizumab|mesh-list
139359605|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139359606|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139359607|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
139359608|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359609|NCT03796156|Aspirin|aspirin|mesh-list
139359610|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139359611|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139359612|NCT03796156|Analgesics|analgesics|mesh-ancestor
139359613|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
139359614|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359615|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359616|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139359617|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139359618|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139359619|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139359620|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359621|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139359622|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139359623|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359624|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
139359625|NCT03737292|Bupivacaine|bupivacaine|mesh-list
139359626|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
139359627|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
139359628|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359629|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359630|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
139359631|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359632|NCT03710460|Metformin|metformin|mesh-list
139359633|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
139359634|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139359635|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359636|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139359637|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359638|NCT03650894|Nivolumab|nivolumab|mesh-list
139359639|NCT03650894|Ipilimumab|ipilimumab|mesh-list
139359640|NCT03650894|Bicalutamide|bicalutamide|mesh-list
139359641|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139359642|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359643|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139359644|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359645|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
139359646|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
139359647|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359648|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359649|NCT03606694|Metformin|metformin|mesh-list
139359650|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139359651|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359652|NCT03544281|Dexamethasone|dexamethasone|mesh-list
139359653|NCT03544281|Lenalidomide|lenalidomide|mesh-list
139359654|NCT03544281|Bortezomib|bortezomib|mesh-list
139359655|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139359656|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
139359657|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
139359658|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359659|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359660|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139359661|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
139359662|NCT03544281|Hormones|hormones|mesh-ancestor
139359663|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359664|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139359665|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359666|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
139359667|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139359668|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139359669|NCT03544281|Growth Substances|growth substances|mesh-ancestor
139359670|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
139359671|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139359672|NCT03387579|SMOFlipid|smoflipid|mesh-list
139359673|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139359674|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139359675|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139359676|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
139359677|NCT03339635|Testosterone|testosterone|mesh-list
139359678|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
139359679|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
139359680|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139359681|NCT03339635|Androgens|androgens|mesh-ancestor
139359682|NCT03339635|Hormones|hormones|mesh-ancestor
139359683|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359684|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359685|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139359686|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359687|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
139359688|NCT03322215|Capecitabine|capecitabine|mesh-list
139359689|NCT03322215|Fulvestrant|fulvestrant|mesh-list
139359690|NCT03322215|Palbociclib|palbociclib|mesh-list
139359691|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139359692|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
139359693|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359694|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359695|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139359696|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139359697|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139359698|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
139359699|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359700|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359701|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139359702|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359703|NCT03094884|Paclitaxel|paclitaxel|mesh-list
139359704|NCT03094884|Carboplatin|carboplatin|mesh-list
139359705|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139359706|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359707|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
139359708|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
139359709|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
139359710|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359711|NCT03029390|Metformin|metformin|mesh-list
139359712|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139359713|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359714|NCT02822144|Lidocaine|lidocaine|mesh-list
139359715|NCT02822144|Remifentanil|remifentanil|mesh-list
139359716|NCT02822144|Propofol|propofol|mesh-list
139359717|NCT02822144|Etomidate|etomidate|mesh-list
139359718|NCT02822144|Succinylcholine|succinylcholine|mesh-list
139359719|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
139359720|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
139359721|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359722|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359723|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
139359724|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359725|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139359726|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139359727|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139359728|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139359729|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359730|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139359731|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139359732|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
139359733|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139359734|NCT02822144|Narcotics|narcotics|mesh-ancestor
139359735|NCT02822144|Analgesics|analgesics|mesh-ancestor
139359736|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139359737|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139359738|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139359739|NCT02725060|Phenylephrine|phenylephrine|mesh-list
139359740|NCT02725060|Isoproterenol|isoproterenol|mesh-list
139359741|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
139359742|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139359743|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
139359744|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
139359745|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359746|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359747|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
139359748|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139359749|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
139359750|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
139359751|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139359752|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139359753|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139359754|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
139359755|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139359756|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359757|NCT02725060|Protective Agents|protective agents|mesh-ancestor
139359758|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139359759|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139359760|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139359761|NCT02565680|Prednisone|prednisone|mesh-list
139359762|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139359763|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
139359764|NCT02565680|Hormones|hormones|mesh-ancestor
139359765|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359766|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359767|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139359768|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359769|NCT02422615|Fulvestrant|fulvestrant|mesh-list
139359770|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139359771|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359772|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139359773|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139359774|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
139359775|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359776|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359777|NCT02382406|Paclitaxel|paclitaxel|mesh-list
139359778|NCT02382406|Carboplatin|carboplatin|mesh-list
139359779|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
139359780|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139359781|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359782|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
139359783|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
139359784|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
139359785|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183163|NCT00890617|Hormones|hormones|mesh-ancestor
139359786|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139359787|NCT02382406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139359788|NCT02134327|Midazolam|midazolam|mesh-list
139359789|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
139359790|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139359791|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359792|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359793|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139359794|NCT02134327|Analgesics|analgesics|mesh-ancestor
139359795|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
139359796|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359797|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139359798|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139359799|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139359800|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
139359801|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139359802|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359803|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139359804|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139359805|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139359806|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139359807|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139359808|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
139359809|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
139359810|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
139359811|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
139359812|NCT02101268|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
139359813|NCT02101268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139359814|NCT02101268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359815|NCT02101268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359816|NCT01880515|Tetracycline|tetracycline|mesh-list
139359817|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139359818|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139016623|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139359819|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139359820|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359821|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359822|NCT01780883|Melatonin|melatonin|mesh-list
139359823|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
139359824|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359825|NCT01780883|Protective Agents|protective agents|mesh-ancestor
139359826|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359827|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359828|NCT01668719|Dexamethasone|dexamethasone|mesh-list
139359829|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
139359830|NCT01668719|Lenalidomide|lenalidomide|mesh-list
139359831|NCT01668719|Bortezomib|bortezomib|mesh-list
139359832|NCT01668719|Elotuzumab|elotuzumab|mesh-list
139359833|NCT01668719|Ichthammol|ichthammol|mesh-list
139359834|NCT01668719|BB 1101|bb 1101|mesh-list
139359835|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139359836|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
139359837|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
139359838|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359839|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359840|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139359841|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
139359842|NCT01668719|Hormones|hormones|mesh-ancestor
139359843|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359844|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139359845|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359846|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
139359847|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139359848|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139359849|NCT01668719|Growth Substances|growth substances|mesh-ancestor
139359850|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
139359851|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
139359852|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183168|NCT03468946|Caffeine|caffeine|mesh-list
139359853|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359854|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
139359855|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
139359856|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139359857|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359858|NCT01488045|Midazolam|midazolam|mesh-list
139359859|NCT01488045|Fentanyl|fentanyl|mesh-list
139359860|NCT01488045|Propofol|propofol|mesh-list
139359861|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139359862|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359863|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359864|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139359865|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
139359866|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
139359867|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139359868|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139359869|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139359870|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139359871|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
139359872|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
139359873|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139359874|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359875|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139359876|NCT01488045|Narcotics|narcotics|mesh-ancestor
139359877|NCT01488045|Analgesics|analgesics|mesh-ancestor
139359878|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
139359879|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359880|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
139359881|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139359882|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139359883|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
139359884|NCT00946712|Paclitaxel|paclitaxel|mesh-list
139359885|NCT00946712|Bevacizumab|bevacizumab|mesh-list
139359886|NCT00946712|Carboplatin|carboplatin|mesh-list
139359887|NCT00946712|Cetuximab|cetuximab|mesh-list
139359888|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139359889|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139359890|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
139359891|NCT00946712|Antibodies|antibodies|mesh-list
139359892|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
139359893|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139359894|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
139359895|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139016700|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359896|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359897|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
139359898|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
139359899|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
139359900|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359901|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139359902|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139359903|NCT00946712|Growth Substances|growth substances|mesh-ancestor
139359904|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359905|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
139359906|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
139359907|NCT00656669|Paclitaxel|paclitaxel|mesh-list
139359908|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
139359909|NCT00656669|Doxorubicin|doxorubicin|mesh-list
139359910|NCT00656669|Sunitinib|sunitinib|mesh-list
139359911|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139359912|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359913|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
139359914|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
139359915|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
139359916|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359917|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139359918|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
139359919|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359920|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139359921|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139359922|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
139359923|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139359924|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139359925|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139359926|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139359927|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359928|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139359929|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139359930|NCT00656669|Growth Substances|growth substances|mesh-ancestor
139359931|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
139359932|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139359933|NCT03829579|Esketamine|esketamine|mesh-list
139359934|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
139359935|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139359936|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139359937|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139359938|NCT01362296|Docetaxel|docetaxel|mesh-list
139359939|NCT01362296|Trametinib|trametinib|mesh-list
139359940|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359941|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
139359942|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
139359943|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
139359944|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924740|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
139359945|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139359946|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359947|NCT01338415|Bosentan|bosentan|mesh-list
139359948|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139359949|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139359950|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359951|NCT04353128|Melatonin|melatonin|mesh-list
139359952|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
139359953|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359954|NCT04353128|Protective Agents|protective agents|mesh-ancestor
139359955|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359956|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359957|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139359958|NCT04263350|Cobicistat|cobicistat|mesh-list
139359959|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139359960|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139359961|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
139359962|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139359963|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359964|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139359965|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139359966|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
139359967|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139359968|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139359969|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139359970|NCT03562585|Antibodies|antibodies|mesh-list
139359971|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139359972|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
139359973|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359975|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139359976|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359977|NCT02259985|Itasetron|itasetron|mesh-list
139359978|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
139359979|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
139359980|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139359981|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139359982|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139359983|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139359984|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139359985|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
139359986|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139359987|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139359988|NCT01371643|Octreotide|octreotide|mesh-list
139359989|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139359990|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139359991|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139359992|NCT03023462|Droperidol|droperidol|mesh-list
139359993|NCT03023462|Oxycodone|oxycodone|mesh-list
139359994|NCT03023462|Ondansetron|ondansetron|mesh-list
139359995|NCT03023462|Ropivacaine|ropivacaine|mesh-list
139183181|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
139359996|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
139359997|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
139359998|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139359999|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360000|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
139360001|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360002|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139360003|NCT03023462|Narcotics|narcotics|mesh-ancestor
139360004|NCT03023462|Analgesics|analgesics|mesh-ancestor
139360005|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
139360006|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
139360007|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139360008|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
139360009|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
139360010|NCT03023462|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139360011|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139360012|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
139360013|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360014|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360015|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139360016|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139360017|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139360018|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139360019|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139360020|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139360021|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
139360022|NCT02824952|Osimertinib|osimertinib|mesh-list
139360023|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360024|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139360025|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360026|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360027|NCT01371565|Mifepristone|mifepristone|mesh-list
139360028|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139360029|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
139360030|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139360031|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360032|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139360033|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139360034|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139360035|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
139360036|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139360037|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139360038|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
139360039|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360040|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
139360041|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139360042|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139360043|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139360044|NCT02821819|Hormones|hormones|mesh-ancestor
139360045|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139016867|NCT06180720|Levodopa|levodopa|mesh-list
139360046|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360048|NCT04500548|Ipilimumab|ipilimumab|mesh-list
139360049|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139360050|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360051|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139360052|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360053|NCT05707819|Antibodies|antibodies|mesh-list
139360054|NCT05707819|Immunologic Factors|immunologic factors|mesh-ancestor
139360055|NCT05707819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360056|NCT03034538|Zonisamide|zonisamide|mesh-list
139360057|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
139360058|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139360059|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139360060|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360061|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139360062|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360063|NCT02468180|Polidocanol|polidocanol|mesh-list
139360064|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139360065|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139360066|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
139183184|NCT01218425|Carbidopa|carbidopa|mesh-list
139360067|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139360068|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139360069|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360070|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139360071|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139360072|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
139360073|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139360074|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
139360075|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139360076|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360077|NCT05053880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139360078|NCT05053880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360079|NCT00094016|Beclomethasone|beclomethasone|mesh-list
139360080|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360081|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
139360082|NCT00094016|Hormones|hormones|mesh-ancestor
139360083|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360084|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360085|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139360086|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
139360087|NCT05134298|Meropenem|meropenem|mesh-list
139360088|NCT05134298|Tazobactam|tazobactam|mesh-list
139360089|NCT05134298|Piperacillin|piperacillin|mesh-list
139360090|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139360091|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139360092|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139360093|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139360094|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360095|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360096|NCT05134220|Calcium|calcium|mesh-list
139360097|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139360098|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360099|NCT03954379|Dexamethasone|dexamethasone|mesh-list
139360100|NCT03954379|Dexamethasone acetate|dexamethasone acetate|mesh-list
139360101|NCT03954379|Analgesics|analgesics|mesh-list
139360102|NCT03954379|Anesthetics|anesthetics|mesh-list
139360103|NCT03954379|Anesthetics, Local|anesthetics, local|mesh-list
139360104|NCT03954379|BB 1101|bb 1101|mesh-list
139360105|NCT03954379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360106|NCT03954379|Antiemetics|antiemetics|mesh-ancestor
139360107|NCT03954379|Autonomic Agents|autonomic agents|mesh-ancestor
139360108|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360109|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360110|NCT03954379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139360111|NCT03954379|Glucocorticoids|glucocorticoids|mesh-ancestor
139360112|NCT03954379|Hormones|hormones|mesh-ancestor
139360113|NCT03954379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360114|NCT03954379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139360115|NCT03954379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924773|NCT00740883|Warfarin|warfarin|mesh-list
139360116|NCT03954379|Protease Inhibitors|protease inhibitors|mesh-ancestor
139360117|NCT03954379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360118|NCT03954379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360119|NCT03954379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139360120|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
139360121|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
139360122|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139360123|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139360124|NCT02036125|Prednisolone|prednisolone|mesh-list
139360125|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
139360126|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139360127|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
139360128|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360129|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
139360130|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
139360131|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360132|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360133|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139360134|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
139360135|NCT02036125|Hormones|hormones|mesh-ancestor
139360136|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360137|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139360138|NCT02036125|Protective Agents|protective agents|mesh-ancestor
139360139|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139360140|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360141|NCT05133752|Nemonoxacin|nemonoxacin|mesh-list
139360142|NCT05133752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139360143|NCT05133752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139360144|NCT02818777|Cannabidiol|cannabidiol|mesh-list
139360145|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
139360146|NCT05128916|Terbinafine|terbinafine|mesh-list
139360147|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
139360148|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139360149|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360150|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360151|NCT05133050|Ramipril|ramipril|mesh-list
139360152|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139360153|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
139360154|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360155|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360156|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139360157|NCT02817841|Drospirenone|drospirenone|mesh-list
139360158|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139360159|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
139360160|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360161|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360162|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139360163|NCT02817841|Diuretics|diuretics|mesh-ancestor
139360164|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
139360165|NCT05132270|Thalidomide|thalidomide|mesh-list
139360166|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
139360167|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139360168|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
139360169|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360170|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
139360171|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139360172|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139360173|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139360174|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139360175|NCT05132270|Growth Substances|growth substances|mesh-ancestor
139360176|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
139360177|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360178|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
139360179|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360180|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360181|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139360182|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
139360183|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139360184|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
139360185|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139360186|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139360187|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360188|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139360189|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360190|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139360191|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139360192|NCT05121038|Leucovorin|leucovorin|mesh-list
139360193|NCT05121038|Fluorouracil|fluorouracil|mesh-list
139360194|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
139360195|NCT05121038|Irinotecan|irinotecan|mesh-list
139360196|NCT05121038|Panitumumab|panitumumab|mesh-list
139360197|NCT05121038|Folfirinox|folfirinox|mesh-list
139360198|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
139360199|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360200|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139360201|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360202|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139360203|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
139360204|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360205|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139360206|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139360207|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360208|NCT05121038|Antidotes|antidotes|mesh-ancestor
139360209|NCT05121038|Protective Agents|protective agents|mesh-ancestor
139360210|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
139360211|NCT05121038|Vitamins|vitamins|mesh-ancestor
139360212|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
139360213|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139360214|NCT05097794|Indapamide|indapamide|mesh-list
139360215|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139360216|NCT05097794|Diuretics|diuretics|mesh-ancestor
139360217|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
139360218|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360219|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139360220|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138924820|NCT00918086|Vitamin D|vitamin d|mesh-list
139360221|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360222|NCT02036281|Substance P|substance p|mesh-list
139360223|NCT02036281|Neurokinin A|neurokinin a|mesh-list
139360224|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360225|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360226|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360227|NCT02036359|Docetaxel|docetaxel|mesh-list
139360228|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139360229|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360230|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
139360231|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
139360232|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
139360233|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360234|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139360235|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360236|NCT02036437|Misoprostol|misoprostol|mesh-list
139360237|NCT02036437|Dinoprostone|dinoprostone|mesh-list
139360238|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139360239|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
139360240|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139360241|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360242|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139360243|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139360244|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
139360245|NCT05027360|Nitroprusside|nitroprusside|mesh-list
139360246|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139360247|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
139360248|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139360249|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360250|NCT02036983|Anesthetics|anesthetics|mesh-list
139360251|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
139360252|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139360253|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360254|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
139360255|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360256|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
139360257|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360258|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
139360259|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360260|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360261|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139360262|NCT05689177|Vaccines|vaccines|mesh-list
139360263|NCT05689177|Immunologic Factors|immunologic factors|mesh-ancestor
139360264|NCT05689177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360265|NCT04818320|Favipiravir|favipiravir|mesh-list
139360266|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
139360267|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139360268|NCT02475135|Tenofovir|tenofovir|mesh-list
139360269|NCT02475135|Emtricitabine|emtricitabine|mesh-list
139360270|NCT02475135|Darunavir|darunavir|mesh-list
139360271|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139360273|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139360274|NCT02475135|Elvitegravir|elvitegravir|mesh-list
139360275|NCT02475135|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139360276|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
139360277|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139360278|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139360279|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139360280|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360281|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360282|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139360283|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139360284|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139360285|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139360286|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
139360287|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139360288|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139360289|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139360290|NCT05118620|Bupivacaine|bupivacaine|mesh-list
139360291|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
139360292|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
139360293|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139360294|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360295|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
139360296|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360297|NCT02814643|Benralizumab|benralizumab|mesh-list
139360298|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139360299|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
139360300|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
139360301|NCT05080790|Interleukin-2|interleukin-2|mesh-list
139360302|NCT05080790|Dinutuximab|dinutuximab|mesh-list
139360303|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360304|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139360305|NCT05080790|Analgesics|analgesics|mesh-ancestor
139360306|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
139360307|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360308|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360309|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139360310|NCT02036827|Bromides|bromides|mesh-list
139360311|NCT02036827|Rocuronium|rocuronium|mesh-list
139360312|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
139360313|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139360314|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139360315|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139360316|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360317|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360318|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
139360319|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139360320|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360321|NCT02475213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139360322|NCT02475213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360323|NCT05256056|Bupivacaine|bupivacaine|mesh-list
139360324|NCT05256056|Anesthetics, Local|anesthetics, local|mesh-ancestor
139360325|NCT05256056|Anesthetics|anesthetics|mesh-ancestor
139360326|NCT05256056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139360327|NCT05256056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360328|NCT05256056|Sensory System Agents|sensory system agents|mesh-ancestor
139360329|NCT05256056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360330|NCT02724111|Rocuronium|rocuronium|mesh-list
139360331|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139360332|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139360333|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139360334|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360335|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360336|NCT02480751|Beraprost|beraprost|mesh-list
139360337|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139360338|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
139360339|NCT04227314|Apremilast|apremilast|mesh-list
138924864|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924865|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139360340|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139360341|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139360342|NCT04227314|Analgesics|analgesics|mesh-ancestor
139360343|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
139360344|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360345|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360347|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139360348|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139183203|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139360349|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139360350|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360351|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360353|NCT04223648|Ipilimumab|ipilimumab|mesh-list
139360354|NCT04223648|Durvalumab|durvalumab|mesh-list
139360355|NCT04223648|Tremelimumab|tremelimumab|mesh-list
139360356|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139360357|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360358|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139360359|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360360|NCT02814175|Adalimumab|adalimumab|mesh-list
139360361|NCT02814175|Methotrexate|methotrexate|mesh-list
139360362|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139360363|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
139360364|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139360365|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360366|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139360367|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
139360368|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360369|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360370|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
139360371|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360372|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139360373|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139360374|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
139360375|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139360376|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139360377|NCT02814175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139360378|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360379|NCT02475057|Hormones|hormones|mesh-list
139360380|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139360381|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360382|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360383|NCT02474667|Mitogens|mitogens|mesh-list
139360384|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
139360385|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360386|NCT03096080|XL647|xl647|mesh-list
139360387|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360388|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139360389|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360390|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360391|NCT01335997|Niacin|niacin|mesh-list
139360392|NCT01335997|Niacinamide|niacinamide|mesh-list
139360393|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
139360394|NCT01335997|Simvastatin|simvastatin|mesh-list
139360395|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139360396|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139360397|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
138924891|NCT00741117|Bilirubin|bilirubin|mesh-list
138924892|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
138924893|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924894|NCT00741117|Protective Agents|protective agents|mesh-ancestor
138924895|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594890|NCT00175617|Minoxidil|minoxidil|mesh-list
138594919|NCT00148031|Ribavirin|ribavirin|mesh-list
139360398|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360399|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139360400|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139360401|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360402|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
139360403|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
139360404|NCT01335997|Vitamins|vitamins|mesh-ancestor
139360405|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
139360406|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360407|NCT02048215|Ephedrine|ephedrine|mesh-list
139360408|NCT02048215|Caffeine|caffeine|mesh-list
139360409|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139360410|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360411|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139360412|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360413|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360414|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139360415|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139360416|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
139360417|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360418|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
139360419|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
139360420|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360421|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139360422|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
139360423|NCT04849832|Fesoterodine|fesoterodine|mesh-list
139360424|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139360425|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139360426|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
139360427|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360428|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360429|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360430|NCT04849832|Urological Agents|urological agents|mesh-ancestor
139360431|NCT02048293|Remifentanil|remifentanil|mesh-list
138924896|NCT00732992|Pemetrexed|pemetrexed|mesh-list
139360432|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139360433|NCT02048293|Narcotics|narcotics|mesh-ancestor
139360434|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139360435|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360436|NCT02048293|Analgesics|analgesics|mesh-ancestor
139360437|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
139360438|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360439|NCT02050009|Metformin|metformin|mesh-list
139360440|NCT02050009|Paclitaxel|paclitaxel|mesh-list
139360441|NCT02050009|Carboplatin|carboplatin|mesh-list
139360442|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139360443|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360444|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
139360445|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
139360446|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
139360447|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360448|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139360449|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360450|NCT04717154|Nivolumab|nivolumab|mesh-list
139360451|NCT04717154|Ipilimumab|ipilimumab|mesh-list
139360452|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139360453|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360454|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139360455|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360456|NCT02474511|Anesthetics|anesthetics|mesh-list
139360457|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139360458|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360459|NCT03108963|Metformin|metformin|mesh-list
139360460|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139360461|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360462|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
139360463|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
139360464|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139360465|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139360466|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139360467|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360468|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360469|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139360470|NCT02474433|Misoprostol|misoprostol|mesh-list
139360471|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139360472|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
139360473|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139360474|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360475|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139360476|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139360477|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
139360478|NCT04812002|Bevacizumab|bevacizumab|mesh-list
139360479|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139360480|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139360481|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360482|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139360483|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139360484|NCT04812002|Growth Substances|growth substances|mesh-ancestor
139360485|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360486|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
139360487|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360488|NCT03424460|Hemostatics|hemostatics|mesh-list
139360489|NCT03424460|Coagulants|coagulants|mesh-ancestor
139360490|NCT05712837|Salicylic Acid|salicylic acid|mesh-list
139360491|NCT05712837|Salicylates|salicylates|mesh-list
139360492|NCT05712837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139360493|NCT05712837|Antifungal Agents|antifungal agents|mesh-ancestor
139360494|NCT05712837|Keratolytic Agents|keratolytic agents|mesh-ancestor
139360495|NCT05712837|Dermatologic Agents|dermatologic agents|mesh-ancestor
139360496|NCT05712837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139360497|NCT05712837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139360498|NCT05712837|Analgesics|analgesics|mesh-ancestor
139360499|NCT05712837|Sensory System Agents|sensory system agents|mesh-ancestor
139360500|NCT05712837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360501|NCT05712837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360502|NCT05712837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360503|NCT05712837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139360504|NCT05712837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139360505|NCT05712837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360506|NCT05712837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360507|NCT02472249|Norepinephrine|norepinephrine|mesh-list
139360508|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139360509|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139360510|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
139360511|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360512|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360513|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360514|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
139360515|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
139360516|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360517|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139360518|NCT02313194|Buspirone|buspirone|mesh-list
139360519|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139360520|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139360521|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138924970|NCT05742243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360522|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360523|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139360524|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139360525|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
139360526|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360527|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360528|NCT04435652|Paclitaxel|paclitaxel|mesh-list
139360529|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139360530|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139360531|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360532|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
139360533|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
139360534|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
139360535|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360536|NCT02473887|Ondansetron|ondansetron|mesh-list
139360537|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
139360538|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
139360539|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360540|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360541|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139360542|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
139360543|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
139360544|NCT02473887|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139360545|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139360546|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
139360547|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360548|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360549|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
139360550|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360551|NCT00071552|Fluticasone|fluticasone|mesh-list
139360552|NCT00071552|Xhance|xhance|mesh-list
139360553|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360554|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139360555|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
139360556|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183216|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360557|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360558|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139360559|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
139360560|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
139360561|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139360562|NCT05164263|Empagliflozin|empagliflozin|mesh-list
139360563|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139360564|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360565|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139360566|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360567|NCT04767711|Prednisolone|prednisolone|mesh-list
139360568|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360569|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
139360570|NCT04767711|Hormones|hormones|mesh-ancestor
139360571|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360572|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360573|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139360574|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360575|NCT02473809|Liraglutide|liraglutide|mesh-list
139360576|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139360577|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360578|NCT02473809|Incretins|incretins|mesh-ancestor
139360579|NCT02473809|Hormones|hormones|mesh-ancestor
139360580|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360581|NCT03976934|Tamsulosin|tamsulosin|mesh-list
139360582|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139360583|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139360584|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139360585|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
139360586|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360587|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360588|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360589|NCT03976934|Urological Agents|urological agents|mesh-ancestor
139360590|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139360591|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139360592|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
139360593|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360594|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360595|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139360596|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
139360597|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
139360598|NCT02416180|Hormones|hormones|mesh-ancestor
139360599|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360600|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
139360601|NCT02473575|Caffeine|caffeine|mesh-list
139360602|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139360603|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360604|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139360605|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360606|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360607|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139360608|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139360609|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
139360610|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360611|NCT03770546|Betamethasone|betamethasone|mesh-list
139360612|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360613|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
139360614|NCT03770546|Hormones|hormones|mesh-ancestor
139360615|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360616|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360617|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139360618|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
139360619|NCT05341323|Ketamine|ketamine|mesh-list
139360620|NCT05341323|Bupivacaine|bupivacaine|mesh-list
139360621|NCT05341323|Anesthetics, Local|anesthetics, local|mesh-ancestor
139360622|NCT05341323|Anesthetics|anesthetics|mesh-ancestor
139360623|NCT05341323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139360624|NCT05341323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360625|NCT05341323|Sensory System Agents|sensory system agents|mesh-ancestor
139360626|NCT05341323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360627|NCT05341323|Analgesics|analgesics|mesh-ancestor
139360628|NCT05341323|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139360629|NCT05341323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139360630|NCT05341323|Anesthetics, General|anesthetics, general|mesh-ancestor
139360631|NCT05341323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139360632|NCT05341323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139360633|NCT05341323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360634|NCT05341323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360636|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
139360637|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360638|NCT04622865|Protective Agents|protective agents|mesh-ancestor
139360639|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360640|NCT02473185|Methylphenidate|methylphenidate|mesh-list
139360641|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139360642|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360643|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139360644|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139360645|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139360646|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360647|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
139360648|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360649|NCT02445586|Docetaxel|docetaxel|mesh-list
139360650|NCT02445586|Trastuzumab|trastuzumab|mesh-list
139360651|NCT02445586|Pertuzumab|pertuzumab|mesh-list
139360652|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360653|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
139360654|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
139360655|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
139360656|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360657|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139360658|NCT02471547|Mitomycins|mitomycins|mesh-list
139360659|NCT02471547|Mitomycin|mitomycin|mesh-list
139360660|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139360661|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360662|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
139360663|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360664|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139360665|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360666|NCT02477631|Deferiprone|deferiprone|mesh-list
139360667|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139360668|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
139360669|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
139360670|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139017536|NCT05610735|Doxorubicin|doxorubicin|mesh-list
139360671|NCT01674062|Trastuzumab|trastuzumab|mesh-list
139360672|NCT01674062|Pertuzumab|pertuzumab|mesh-list
139360673|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139360674|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360675|NCT02472873|Ethanol|ethanol|mesh-list
139360676|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139360677|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139360678|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139360679|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360680|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
139360681|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139360682|NCT02472886|Ledipasvir|ledipasvir|mesh-list
139360683|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
139360684|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139360685|NCT04570839|Nivolumab|nivolumab|mesh-list
139360686|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139360687|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360688|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139360689|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360690|NCT05283356|Ticagrelor|ticagrelor|mesh-list
139360691|NCT05283356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139360692|NCT05283356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139360693|NCT05283356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139360694|NCT05283356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139360695|NCT05283356|Purinergic Agents|purinergic agents|mesh-ancestor
139360697|NCT05283356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360698|NCT05283356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360699|NCT02472652|Aripiprazole|aripiprazole|mesh-list
139360700|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
139360701|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139360702|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139360703|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139360704|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139360705|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360706|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
139360707|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
139360708|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360709|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360710|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139360711|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139360712|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
139360713|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139360714|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139360715|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139360716|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139360717|NCT05243186|Methylphenidate|methylphenidate|mesh-list
139360718|NCT05243186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139360719|NCT05243186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360720|NCT05243186|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139360721|NCT05243186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139360722|NCT05243186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139360723|NCT05243186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360724|NCT05243186|Dopamine Agents|dopamine agents|mesh-ancestor
139360725|NCT05243186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360726|NCT02808182|Niacin|niacin|mesh-list
139360727|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
139360728|NCT02808182|Niacinamide|niacinamide|mesh-list
139360729|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139360730|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
139360731|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360732|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139360733|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
139360734|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
139360735|NCT02808182|Vitamins|vitamins|mesh-ancestor
139360736|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
139360737|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360738|NCT04695704|Montelukast|montelukast|mesh-list
139360739|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139360740|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139360741|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
139360742|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
139360743|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360744|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360745|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139360746|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139360747|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360749|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139360750|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
139360751|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139360752|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139360753|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
139360754|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139360755|NCT05217758|Mifepristone|mifepristone|mesh-list
139360756|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139360757|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
139360758|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139360759|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360760|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139360761|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139360762|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139360763|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
139360764|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139360765|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139360766|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
139360767|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360768|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
139360769|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139360770|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139360771|NCT02051023|Fluorometholone|fluorometholone|mesh-list
139360772|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
139360773|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139360774|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139360775|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360776|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
139360777|NCT02051023|Hormones|hormones|mesh-ancestor
139360778|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360779|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360780|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139360781|NCT02415556|Insulin|insulin|mesh-list
138925099|NCT02581176|Apixaban|apixaban|mesh-list
139360782|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139360783|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139360784|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360785|NCT05192798|Paclitaxel|paclitaxel|mesh-list
139360786|NCT05192798|Bevacizumab|bevacizumab|mesh-list
139360787|NCT05192798|Apatinib|apatinib|mesh-list
139360788|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139360789|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139360790|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360791|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
139360792|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
139360793|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
139360794|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360795|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139360796|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139360797|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139360798|NCT05192798|Growth Substances|growth substances|mesh-ancestor
139360799|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360800|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
139360801|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139360802|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360803|NCT02048683|Sevoflurane|sevoflurane|mesh-list
139360804|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139360805|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139360806|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
139360807|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
139360808|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139360809|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360810|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
139360811|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139360812|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139360813|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360814|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
139360815|NCT03108807|Coagulants|coagulants|mesh-ancestor
139360816|NCT02048761|Metformin|metformin|mesh-list
139360817|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139360818|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360819|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139360820|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
139360821|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139360822|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139360823|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139360824|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360825|NCT02048917|Bupropion|bupropion|mesh-list
139360826|NCT02048917|Varenicline|varenicline|mesh-list
139360827|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139360828|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
139360829|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139360830|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139360831|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139360832|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139360833|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360834|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
139360835|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360836|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360837|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139360838|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139360839|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360840|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139360841|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139360842|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
139360843|NCT02472717|Liraglutide|liraglutide|mesh-list
139360844|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139360845|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360846|NCT02472717|Incretins|incretins|mesh-ancestor
139360847|NCT02472717|Hormones|hormones|mesh-ancestor
139360848|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360849|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
139360850|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139360851|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139360852|NCT02049073|Prednisolone|prednisolone|mesh-list
139360853|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
139360854|NCT02049073|Zonisamide|zonisamide|mesh-list
139360855|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139360856|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
139360857|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360858|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
139360859|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
139360860|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360861|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360862|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139360863|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
139360864|NCT02049073|Hormones|hormones|mesh-ancestor
139360865|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360866|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139360867|NCT02049073|Protective Agents|protective agents|mesh-ancestor
139360868|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139360869|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360870|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
139360871|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139360872|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139360873|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360874|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139360875|NCT04518345|Azacitidine|azacitidine|mesh-list
139360876|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139360877|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
139360878|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360879|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360880|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360881|NCT02260063|Epinastine|epinastine|mesh-list
139360882|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139360883|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
139360884|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
139360885|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360886|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360887|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360888|NCT04398914|Paclitaxel|paclitaxel|mesh-list
139360889|NCT04398914|Trastuzumab|trastuzumab|mesh-list
139360890|NCT04398914|Pertuzumab|pertuzumab|mesh-list
139360891|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139360892|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360893|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
139360894|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
139360895|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
139360896|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360897|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139360898|NCT03561649|Adalimumab|adalimumab|mesh-list
139360899|NCT03561649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139360900|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360901|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139360902|NCT02807623|Ibuprofen|ibuprofen|mesh-list
139360903|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139360904|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139360905|NCT02807623|Analgesics|analgesics|mesh-ancestor
139360906|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
139360907|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360908|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360909|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360910|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139360911|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139360912|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360913|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360915|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139360916|NCT05137964|Vitamins|vitamins|mesh-ancestor
139360917|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
139360918|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360919|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139360920|NCT04374578|Dulaglutide|dulaglutide|mesh-list
139360921|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139360922|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360923|NCT02470923|Nicotine|nicotine|mesh-list
139360924|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139360925|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
139360926|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360927|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360928|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139360929|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139360930|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
139360931|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360932|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360933|NCT02049229|Everolimus|everolimus|mesh-list
139360934|NCT02049229|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139360935|NCT02049229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139360936|NCT02049229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139360937|NCT02049229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360938|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139360939|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
139360940|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360941|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360942|NCT02805907|Calcifediol|calcifediol|mesh-list
139360943|NCT02805907|Vitamins|vitamins|mesh-ancestor
139360944|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
139360945|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360946|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139360947|NCT02477397|Fluticasone|fluticasone|mesh-list
139360949|NCT02477397|Budesonide|budesonide|mesh-list
139360950|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
139360951|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139360952|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139360953|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139360954|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139360955|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139360956|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
139360957|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139360958|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360959|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139360960|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
139360961|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
139360962|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139360963|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
139360964|NCT02477397|Hormones|hormones|mesh-ancestor
139360965|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139360966|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139360967|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139360968|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139360969|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
139360970|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360971|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360972|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
139360973|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139360974|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139183236|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139360975|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139360976|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139360977|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139360978|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139360979|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360980|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139360981|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
139360982|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139360983|NCT02470767|Anticoagulants|anticoagulants|mesh-list
139360984|NCT02049541|Rituximab|rituximab|mesh-list
139360985|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139360986|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139360987|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
139360988|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360989|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139360990|NCT02470611|Alendronate|alendronate|mesh-list
139360991|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139360992|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360993|NCT05305898|Metformin|metformin|mesh-list
139360994|NCT05305898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139360995|NCT05305898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139360996|NCT02469831|Rocuronium|rocuronium|mesh-list
139360997|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139360998|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139360999|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139361000|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361001|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361002|NCT02995005|Tenofovir|tenofovir|mesh-list
139361003|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
139361004|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361005|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139361006|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139361007|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361008|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361009|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139361010|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139361011|NCT03561415|Posaconazole|posaconazole|mesh-list
139361012|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
139361013|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361014|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139361015|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139361016|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139361017|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139361018|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139361019|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361020|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361021|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139361022|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
139361023|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139361024|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361025|NCT02477007|Acetaminophen|acetaminophen|mesh-list
139361026|NCT02477007|Ibuprofen|ibuprofen|mesh-list
139361027|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139361028|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139361029|NCT02477007|Analgesics|analgesics|mesh-ancestor
139361030|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
139361031|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361032|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361033|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138925143|NCT04062045|Ropivacaine|ropivacaine|mesh-list
139361034|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139361035|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139361036|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361037|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361038|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
139361039|NCT02052973|Propolis|propolis|mesh-list
139361040|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361041|NCT02053519|Vitamin D|vitamin d|mesh-list
139361042|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
139361043|NCT02053519|Vitamins|vitamins|mesh-ancestor
139361044|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
139361045|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361046|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139183244|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
139361047|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139361048|NCT02053597|Paclitaxel|paclitaxel|mesh-list
139361049|NCT02053597|Doxorubicin|doxorubicin|mesh-list
139361050|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139361051|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361052|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
139361053|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
139361054|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
139361055|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361056|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139361057|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139361058|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139361059|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361060|NCT02801617|Latanoprost|latanoprost|mesh-list
139361061|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139361062|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139361063|NCT02056249|Norepinephrine|norepinephrine|mesh-list
139361064|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139361065|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139361066|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
139361067|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361068|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361069|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361070|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
139361071|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
139361072|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361073|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139361074|NCT04140968|Progesterone|progesterone|mesh-list
139361075|NCT04140968|Progestins|progestins|mesh-ancestor
139361076|NCT04140968|Hormones|hormones|mesh-ancestor
139361077|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139361078|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361079|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
139361080|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139361081|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361082|NCT04383938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139361083|NCT04383938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361084|NCT01334515|Isotretinoin|isotretinoin|mesh-list
139361085|NCT01334515|Sargramostim|sargramostim|mesh-list
139361086|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361087|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
139361088|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
139361089|NCT02415400|Aspirin|aspirin|mesh-list
139361090|NCT02415400|Vitamin K|vitamin k|mesh-list
139361091|NCT02415400|Apixaban|apixaban|mesh-list
139361092|NCT02415400|Vitamins|vitamins|mesh-ancestor
139361093|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
139361094|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361095|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139361096|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139361097|NCT02415400|Analgesics|analgesics|mesh-ancestor
139361098|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
139361099|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361100|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139361101|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139361102|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139361103|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139361104|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925154|NCT04137354|Vitamin A|vitamin a|mesh-list
139361105|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139361106|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139361107|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361108|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
139361109|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139361110|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
139361111|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139361112|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
139361113|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
139361114|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139361115|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
139361116|NCT02415400|Coagulants|coagulants|mesh-ancestor
139361117|NCT02053675|Vasopressins|vasopressins|mesh-list
139361118|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
139361119|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
139361120|NCT02053675|Coagulants|coagulants|mesh-ancestor
139361121|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139361122|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139361123|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
139361124|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361125|NCT02037997|Docetaxel|docetaxel|mesh-list
139361126|NCT02037997|Pemetrexed|pemetrexed|mesh-list
139361127|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139361128|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361129|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
139361130|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
139361131|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
139361132|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361133|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361134|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139361135|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139361136|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139361137|NCT02056405|Mosapride|mosapride|mesh-list
139361138|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139361139|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139361140|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
139361141|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361142|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361143|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361144|NCT02056717|Dexamethasone|dexamethasone|mesh-list
139361145|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139361146|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
139361147|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
139361148|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361149|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361150|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139361151|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
139361152|NCT02056717|Hormones|hormones|mesh-ancestor
139361153|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139361154|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139361155|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361156|NCT04194801|Fisogatinib|fisogatinib|mesh-list
139361157|NCT04194801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361158|NCT02802865|Letrozole|letrozole|mesh-list
139361159|NCT02802865|Clomiphene|clomiphene|mesh-list
139361160|NCT02802865|Enclomiphene|enclomiphene|mesh-list
139361161|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
139361162|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361163|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361164|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139361165|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139361166|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361167|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139361168|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
139361169|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139361170|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361171|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139361172|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
139361173|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139361174|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139361175|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139361176|NCT02414932|Midazolam|midazolam|mesh-list
139361177|NCT02414932|Ketamine|ketamine|mesh-list
139361178|NCT02414932|Analgesics|analgesics|mesh-ancestor
139361179|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
139361180|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361181|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361182|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139361183|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139361184|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
139361185|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
139361186|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361187|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139361188|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139361189|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361190|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361191|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139361192|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139361193|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139361194|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139361195|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139361196|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
139361197|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
139361198|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
139361199|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139361200|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
139361201|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
139361202|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361203|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361204|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139361205|NCT02476929|Analgesics|analgesics|mesh-ancestor
139361206|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
139361207|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361208|NCT02054143|Sevoflurane|sevoflurane|mesh-list
139361209|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139361210|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139361211|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
139361212|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
139361213|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361214|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361215|NCT02058667|Paclitaxel|paclitaxel|mesh-list
139361216|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139361217|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361218|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
139361219|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
139361220|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
139361221|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361222|NCT02470455|Atorvastatin|atorvastatin|mesh-list
139361223|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139361224|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139361225|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
139361226|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361227|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139361228|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139361229|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361230|NCT02057263|Alendronate|alendronate|mesh-list
139361231|NCT02057263|Diphosphonates|diphosphonates|mesh-list
139361232|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139361233|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361234|NCT05550909|Artesunate|artesunate|mesh-list
139361235|NCT05550909|Lumefantrine|lumefantrine|mesh-list
139361236|NCT05550909|Artemether|artemether|mesh-list
139361237|NCT05550909|Primaquine|primaquine|mesh-list
139361238|NCT05550909|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139361239|NCT05550909|Amodiaquine|amodiaquine|mesh-list
139361240|NCT05550909|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
139361241|NCT05550909|Antimalarials|antimalarials|mesh-ancestor
139361242|NCT05550909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139361243|NCT05550909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139361244|NCT05550909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361245|NCT05550909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361246|NCT05550909|Antiviral Agents|antiviral agents|mesh-ancestor
139361247|NCT05550909|Schistosomicides|schistosomicides|mesh-ancestor
139361248|NCT05550909|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139361249|NCT05550909|Anthelmintics|anthelmintics|mesh-ancestor
139361250|NCT02054299|Thiamine|thiamine|mesh-list
139361251|NCT02054299|Proguanil|proguanil|mesh-list
139361252|NCT02054299|Sumatriptan|sumatriptan|mesh-list
139361253|NCT02054299|Amitriptyline|amitriptyline|mesh-list
139361254|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139361255|NCT02054299|Fenoterol|fenoterol|mesh-list
139361256|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139361257|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139361258|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139361259|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
139361260|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361261|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361262|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361263|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139361264|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
139361265|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139361266|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139018136|NCT04534218|Aspirin|aspirin|mesh-list
139361267|NCT02054299|Analgesics|analgesics|mesh-ancestor
139361268|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
139361269|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361270|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139361271|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139361272|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139361273|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
139361274|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
139361275|NCT02054299|Vitamins|vitamins|mesh-ancestor
139361276|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
139361277|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139361278|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
139361279|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139361280|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139361281|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361282|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
139361283|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139361284|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
139361285|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139361286|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
139361287|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
139361288|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
139361289|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139361290|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139361291|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139361292|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139361293|NCT02058823|Amlodipine|amlodipine|mesh-list
139361294|NCT02058823|Valsartan|valsartan|mesh-list
139361295|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139361296|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139361297|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139361298|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361299|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139361300|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361301|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
139361302|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139361303|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139361304|NCT00704535|Ezetimibe|ezetimibe|mesh-list
139361305|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139361306|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139361307|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
139361308|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361309|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139361310|NCT02058901|Sunitinib|sunitinib|mesh-list
139361311|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361312|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139361313|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139361314|NCT02058901|Growth Substances|growth substances|mesh-ancestor
139361315|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361316|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
139361317|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139361318|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361319|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361320|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139361321|NCT02058979|Cefazolin|cefazolin|mesh-list
139361322|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361323|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139361324|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
139361325|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361326|NCT03893955|Paclitaxel|paclitaxel|mesh-list
139361327|NCT03893955|Carboplatin|carboplatin|mesh-list
139361328|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139361329|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361330|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
139361331|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
139361332|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
139361333|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361334|NCT02648204|Dulaglutide|dulaglutide|mesh-list
139361335|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139361336|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361337|NCT03310749|Metformin|metformin|mesh-list
139361338|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139361339|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361340|NCT03310593|Cannabidiol|cannabidiol|mesh-list
139361341|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
139361342|NCT05304338|Chlorhexidine|chlorhexidine|mesh-list
139361343|NCT05304338|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139361344|NCT05304338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361345|NCT05304338|Disinfectants|disinfectants|mesh-ancestor
139361347|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139361348|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
139361349|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139361350|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
139361351|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361352|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361353|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
139361354|NCT02058277|Aprepitant|aprepitant|mesh-list
139361355|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
139361356|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
139361357|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361358|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361359|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139361360|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139361361|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361362|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361363|NCT04813562|Vaccines|vaccines|mesh-list
139361364|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
139361365|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361366|NCT03314025|Tamsulosin|tamsulosin|mesh-list
139361367|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139361368|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139361369|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139361370|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
139361371|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361372|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361373|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361374|NCT03314025|Urological Agents|urological agents|mesh-ancestor
139361375|NCT02055079|Sirolimus|sirolimus|mesh-list
139361376|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139361377|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361378|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139361379|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361380|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
139361381|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139361382|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
139361383|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361384|NCT02470065|Afatinib|afatinib|mesh-list
139361385|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361386|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139361387|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361388|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361389|NCT03313869|Vitamin E|vitamin e|mesh-list
139361390|NCT03313869|Selenium|selenium|mesh-list
139361391|NCT03313869|Vitamins|vitamins|mesh-ancestor
139361392|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
139361393|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361394|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
139361395|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361396|NCT03313869|Protective Agents|protective agents|mesh-ancestor
139361397|NCT03313869|Trace Elements|trace elements|mesh-ancestor
139361398|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139361399|NCT00705159|Tobramycin|tobramycin|mesh-list
139361400|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139361401|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361402|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139361403|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139361404|NCT01673984|Goserelin|goserelin|mesh-list
139361405|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
139361407|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
139361408|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139361409|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361410|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139361411|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139361412|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361413|NCT03313791|Caseins|caseins|mesh-list
139361414|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
139361415|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
139361416|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361417|NCT03310047|Lidocaine|lidocaine|mesh-list
139361418|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
139361419|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
139361420|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361421|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361422|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
139361423|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361424|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139361425|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139361426|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139361427|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139361428|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361430|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361431|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361432|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
139361433|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139361434|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361435|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361436|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139361437|NCT03313479|Analgesics|analgesics|mesh-ancestor
139361438|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
139361439|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361440|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139361441|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139361442|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139361443|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
139361444|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361445|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361446|NCT03313401|Aflibercept|aflibercept|mesh-list
139361447|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139361448|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139361449|NCT03313401|Growth Substances|growth substances|mesh-ancestor
139361450|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361451|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
139361452|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361453|NCT03313323|Ipilimumab|ipilimumab|mesh-list
139361454|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139361455|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361456|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139361457|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361458|NCT05302232|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139361459|NCT05302232|Methylprednisolone|methylprednisolone|mesh-list
139361460|NCT05302232|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139361461|NCT05302232|Prednisolone|prednisolone|mesh-list
139361462|NCT05302232|Prednisolone acetate|prednisolone acetate|mesh-list
139361463|NCT05302232|Lidocaine|lidocaine|mesh-list
139361464|NCT05302232|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139361465|NCT05302232|Prednisolone phosphate|prednisolone phosphate|mesh-list
139361466|NCT05302232|Anesthetics, Local|anesthetics, local|mesh-ancestor
139361467|NCT05302232|Anesthetics|anesthetics|mesh-ancestor
139361468|NCT05302232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361469|NCT05302232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361470|NCT05302232|Sensory System Agents|sensory system agents|mesh-ancestor
139361471|NCT05302232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361472|NCT05302232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139361473|NCT05302232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139361474|NCT05302232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139361475|NCT05302232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139361476|NCT05302232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361477|NCT05302232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139361478|NCT05302232|Antiemetics|antiemetics|mesh-ancestor
139361479|NCT05302232|Autonomic Agents|autonomic agents|mesh-ancestor
139361480|NCT05302232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139361481|NCT05302232|Glucocorticoids|glucocorticoids|mesh-ancestor
139361482|NCT05302232|Hormones|hormones|mesh-ancestor
139361483|NCT05302232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139361484|NCT05302232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139361485|NCT05302232|Protective Agents|protective agents|mesh-ancestor
139361486|NCT05302232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139361487|NCT05302232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361488|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139361489|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361490|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139361491|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925217|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139361492|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361493|NCT03304431|Lidocaine|lidocaine|mesh-list
139361494|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
139361495|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
139361496|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361497|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361498|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
139361499|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361500|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139361501|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139361502|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139361503|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139361504|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361505|NCT04741334|Anticoagulants|anticoagulants|mesh-list
139361506|NCT04741334|Dicumarol|dicumarol|mesh-list
139361507|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139361508|NCT04741334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361509|NCT04741334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361510|NCT04741334|Uncoupling Agents|uncoupling agents|mesh-ancestor
139361511|NCT03309735|Progesterone|progesterone|mesh-list
139361512|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
139361513|NCT03309735|Progestins|progestins|mesh-ancestor
139361514|NCT03309735|Hormones|hormones|mesh-ancestor
139361515|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139361516|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361517|NCT02926586|Cytarabine|cytarabine|mesh-list
139361518|NCT02926586|Fludarabine|fludarabine|mesh-list
139361519|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361520|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139361521|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
139361522|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361523|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139361524|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
139361525|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361526|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
139361527|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361528|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
139361529|NCT04490967|Salicylates|salicylates|mesh-list
139361530|NCT04490967|Silybin|silybin|mesh-list
139361531|NCT04490967|Silymarin|silymarin|mesh-list
139361532|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
139361533|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361534|NCT04490967|Protective Agents|protective agents|mesh-ancestor
139361535|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361536|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361537|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
139361538|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
139361539|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
139361540|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139361541|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139361542|NCT04490967|Analgesics|analgesics|mesh-ancestor
139361543|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
139361544|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361545|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139361546|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139361547|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139361548|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361549|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139361550|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361551|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
139361552|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
139361553|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361554|NCT03312777|Tramadol|tramadol|mesh-list
139361555|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139361556|NCT03312777|Narcotics|narcotics|mesh-ancestor
139361557|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361558|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361559|NCT03312777|Analgesics|analgesics|mesh-ancestor
139361560|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
139361561|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361562|NCT02332928|Melatonin|melatonin|mesh-list
139361563|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
139361564|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361565|NCT02332928|Protective Agents|protective agents|mesh-ancestor
139361566|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361567|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361568|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139361569|NCT03738878|Valsartan|valsartan|mesh-list
139361570|NCT03738878|Bradykinin|bradykinin|mesh-list
139361571|NCT03738878|Kininogens|kininogens|mesh-list
139361572|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139361573|NCT03738878|Substance P|substance p|mesh-list
139361574|NCT03738878|Neurokinin A|neurokinin a|mesh-list
139361575|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139361576|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361577|NCT03738878|Incretins|incretins|mesh-ancestor
139361578|NCT03738878|Hormones|hormones|mesh-ancestor
139361579|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139361580|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139361581|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
139361582|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361583|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361584|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139361585|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139361586|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139361587|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
139361588|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139361589|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361590|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
139361591|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
139361592|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139361593|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361594|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361595|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
139361596|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139361597|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361598|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361599|NCT01506986|Metronidazole|metronidazole|mesh-list
139361600|NCT01506986|Clarithromycin|clarithromycin|mesh-list
139361601|NCT01506986|Lansoprazole|lansoprazole|mesh-list
139361602|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
139361603|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361604|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139361605|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139361606|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139361607|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139361608|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361609|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361610|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139361611|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139361612|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139361613|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139361614|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139361615|NCT02714894|Clozapine|clozapine|mesh-list
139361616|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139361617|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
139361618|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361619|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361620|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361621|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139361622|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139361623|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361624|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139361625|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
139361626|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
139361627|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
139361628|NCT03303651|Narcotics|narcotics|mesh-ancestor
139361629|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361630|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361631|NCT03303651|Analgesics|analgesics|mesh-ancestor
139361632|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
139361633|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361634|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139361635|NCT03312153|Eusol|eusol|mesh-list
139361636|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
139361637|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361638|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
139361639|NCT03303573|Hematinics|hematinics|mesh-ancestor
139361640|NCT03303495|Leucovorin|leucovorin|mesh-list
139361641|NCT03303495|Bevacizumab|bevacizumab|mesh-list
139361642|NCT03303495|Fluorouracil|fluorouracil|mesh-list
139361643|NCT03303495|Irinotecan|irinotecan|mesh-list
139018513|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
139361644|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139361645|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361646|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139361647|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139361648|NCT03303495|Growth Substances|growth substances|mesh-ancestor
139361649|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361650|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
139361651|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
139361652|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361653|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139361654|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139361655|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
139361656|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139361657|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139361658|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361659|NCT03303495|Antidotes|antidotes|mesh-ancestor
139361660|NCT03303495|Protective Agents|protective agents|mesh-ancestor
139361661|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
139361662|NCT03303495|Vitamins|vitamins|mesh-ancestor
139361663|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
139361664|NCT03308955|Tramadol|tramadol|mesh-list
139361665|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139361666|NCT03308955|Narcotics|narcotics|mesh-ancestor
139361667|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361668|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361669|NCT03308955|Analgesics|analgesics|mesh-ancestor
139361670|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
139361671|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361672|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139361673|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
139361674|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361675|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139361676|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139361677|NCT03308643|Oxytocin|oxytocin|mesh-list
139361678|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
139361679|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139361680|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361681|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
139361682|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139361683|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139361684|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139361685|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139361686|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361687|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
139361688|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361689|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361690|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139361691|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925319|NCT02566707|Lamivudine|lamivudine|mesh-list
139361692|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
139361693|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139361694|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361696|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
139361697|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
139361698|NCT03308487|Vitamins|vitamins|mesh-list
139361699|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
139361700|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361701|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139361702|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139361703|NCT03308331|Nicotine|nicotine|mesh-list
139361704|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139361705|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
139361706|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361707|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361708|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139361709|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139361710|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
139361711|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361712|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361713|NCT02414854|Albuterol|albuterol|mesh-list
139361714|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139361715|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
139361716|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361717|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361718|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139361719|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
139361720|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
139361721|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139361722|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139361723|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139361724|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139361725|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
139361726|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361727|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361728|NCT03308253|Vancomycin|vancomycin|mesh-list
139361729|NCT03308253|Tobramycin|tobramycin|mesh-list
139361730|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139361731|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361732|NCT02467023|Lidocaine|lidocaine|mesh-list
139361733|NCT02467023|Fentanyl|fentanyl|mesh-list
139361734|NCT02467023|Midazolam|midazolam|mesh-list
139361735|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
139361736|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
139361737|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361738|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361739|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
139361740|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361741|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139361742|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139361743|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139361744|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139361745|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361746|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139361747|NCT02467023|Narcotics|narcotics|mesh-ancestor
139361748|NCT02467023|Analgesics|analgesics|mesh-ancestor
139361749|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139361750|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139361751|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
138925324|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361752|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139361753|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139361754|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139361755|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139361756|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
139361757|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
139361758|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361759|NCT02055703|Itraconazole|itraconazole|mesh-list
139361760|NCT02055703|Rifampin|rifampin|mesh-list
139361761|NCT02055703|Digoxin|digoxin|mesh-list
139361762|NCT02055703|Donepezil|donepezil|mesh-list
139361763|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
139361764|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361765|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139361766|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139361767|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361768|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361769|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139361770|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
139361771|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139361772|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361773|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139361774|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139361775|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
139361776|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361777|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
139361778|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139361779|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
139361780|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139361781|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
139361782|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139361783|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139361784|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139361785|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139361786|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139361787|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139361788|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139361789|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139361790|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139361791|NCT02055703|Protective Agents|protective agents|mesh-ancestor
139361792|NCT02058433|Paclitaxel|paclitaxel|mesh-list
139361793|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139361794|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139361795|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361796|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
139361797|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
139361798|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
139361799|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361800|NCT03561181|Vaccines|vaccines|mesh-list
139361801|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
139361802|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361803|NCT02060149|Minocycline|minocycline|mesh-list
139361804|NCT02060149|Sulbactam|sulbactam|mesh-list
139361805|NCT02060149|Cefoperazone|cefoperazone|mesh-list
139361806|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139361807|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139361808|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361809|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139361810|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361811|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361812|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
139361813|NCT03302403|Fludarabine|fludarabine|mesh-list
139361814|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139361815|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
139361816|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361817|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139361818|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139361819|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
139361820|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361821|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361822|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139361823|NCT02038621|Paclitaxel|paclitaxel|mesh-list
139361824|NCT02038621|Capecitabine|capecitabine|mesh-list
139361825|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
139183290|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139361826|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139361828|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
139361829|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
139361830|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
139361831|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361832|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139361833|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
139361834|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
139361835|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139361836|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361837|NCT03332498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139361838|NCT03332498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361839|NCT05727969|Dexmedetomidine|dexmedetomidine|mesh-list
139361840|NCT05727969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139361841|NCT05727969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361842|NCT05727969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361843|NCT05727969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139361844|NCT05727969|Analgesics|analgesics|mesh-ancestor
139361845|NCT05727969|Sensory System Agents|sensory system agents|mesh-ancestor
139361846|NCT05727969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361847|NCT05727969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139361848|NCT05727969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139361849|NCT05727969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139361850|NCT05727969|Adrenergic Agents|adrenergic agents|mesh-ancestor
139361851|NCT05727969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361852|NCT05727969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361853|NCT01334125|Metformin|metformin|mesh-list
139361854|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139361855|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361856|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139361857|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139361858|NCT01333501|Interferons|interferons|mesh-list
139361859|NCT01333501|Interferon-beta|interferon-beta|mesh-list
139361860|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139361861|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
139361862|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361863|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
139361864|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361865|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
139361866|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361867|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139361868|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361869|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139361870|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139361871|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
139361872|NCT01362140|Hematinics|hematinics|mesh-ancestor
139361873|NCT03307941|Fluorouracil|fluorouracil|mesh-list
139361874|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
139361875|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
139361876|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361877|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139361878|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361879|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139361880|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
139361881|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361882|NCT03307863|Topiramate|topiramate|mesh-list
139361883|NCT03307863|Carbamazepine|carbamazepine|mesh-list
139361884|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
139361885|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139361886|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361887|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
139361888|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139361889|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361890|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139361891|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139361892|NCT03307863|Analgesics|analgesics|mesh-ancestor
139361893|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
139361894|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138767949|NCT00003601|Tretinoin|tretinoin|mesh-list
139361895|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139361896|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139361897|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361898|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139361899|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139361900|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
139361901|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139361902|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361903|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361904|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139361905|NCT04656470|Analgesics|analgesics|mesh-ancestor
139361906|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
139361907|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361908|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139361909|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139361910|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139361911|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
139361912|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139361913|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361914|NCT05391074|Vitamins|vitamins|mesh-list
139361915|NCT05391074|Micronutrients|micronutrients|mesh-ancestor
139361916|NCT05391074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361917|NCT02467647|Thalidomide|thalidomide|mesh-list
139361918|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139361919|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
139361920|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361921|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
139361922|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139361923|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361924|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139361925|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139361926|NCT02467647|Growth Substances|growth substances|mesh-ancestor
139361927|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
139361928|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361929|NCT03263936|Cytarabine|cytarabine|mesh-list
139361930|NCT03263936|Fludarabine|fludarabine|mesh-list
139361931|NCT03263936|Decitabine|decitabine|mesh-list
139361932|NCT03263936|Vorinostat|vorinostat|mesh-list
139361933|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361934|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139361935|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
139361936|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361937|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139361938|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
139361939|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361940|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
139361941|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361942|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361943|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139361944|NCT03307551|Propofol|propofol|mesh-list
139361945|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139361946|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139361947|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361948|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139361949|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
139361950|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
139361951|NCT02060305|Bevacizumab|bevacizumab|mesh-list
139361952|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139361953|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361954|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139361955|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139361956|NCT02060305|Growth Substances|growth substances|mesh-ancestor
139361957|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361958|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
139361959|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139361960|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139361961|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361962|NCT02059759|Aldesleukin|aldesleukin|mesh-list
139361963|NCT02059759|Interleukin-2|interleukin-2|mesh-list
139361964|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139361965|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139361967|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
139361968|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361969|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361970|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139361971|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139361972|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
139361973|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361974|NCT03103022|Acetaminophen|acetaminophen|mesh-list
139361975|NCT03103022|Ibuprofen|ibuprofen|mesh-list
139361976|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139361977|NCT03103022|Analgesics|analgesics|mesh-ancestor
139361978|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
139361979|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139361980|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139361981|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
139361982|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139361983|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139361984|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139361985|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139361986|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361987|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361988|NCT00702507|Miconazole|miconazole|mesh-list
139361989|NCT00702507|Clotrimazole|clotrimazole|mesh-list
139361990|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
139361991|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139361992|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139361993|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139361994|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139361995|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139361996|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139361997|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
139361998|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139361999|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362000|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139362001|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139362002|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139362003|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
139362004|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139362005|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139362006|NCT03301233|Estradiol|estradiol|mesh-list
139362007|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139362008|NCT03301233|Estrogens|estrogens|mesh-ancestor
139362009|NCT03301233|Hormones|hormones|mesh-ancestor
139362010|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139362011|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362012|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139362013|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
139362014|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139362015|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139362016|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
139362017|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139362018|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139362019|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362020|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362021|NCT03301233|Urological Agents|urological agents|mesh-ancestor
139362022|NCT02581748|Trastuzumab|trastuzumab|mesh-list
139362023|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139362024|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362025|NCT03113942|Thalidomide|thalidomide|mesh-list
139362026|NCT03113942|Pomalidomide|pomalidomide|mesh-list
139362027|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
139362028|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362029|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139362030|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139362031|NCT03113942|Growth Substances|growth substances|mesh-ancestor
139183309|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
139362032|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
139362033|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362034|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139362035|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
139362036|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139362037|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362038|NCT03104270|Dexamethasone|dexamethasone|mesh-list
139362039|NCT03104270|Pomalidomide|pomalidomide|mesh-list
139362040|NCT03104270|Elotuzumab|elotuzumab|mesh-list
139362041|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139362042|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
139362043|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
139362044|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362045|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362046|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139362047|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
139362048|NCT03104270|Hormones|hormones|mesh-ancestor
139362049|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139362050|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139362051|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362052|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
139362053|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139362054|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139362055|NCT03104270|Growth Substances|growth substances|mesh-ancestor
139362056|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
139362057|NCT03300765|Apatinib|apatinib|mesh-list
139362058|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362059|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139362060|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362061|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362062|NCT04064918|Timolol|timolol|mesh-list
139362063|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362064|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139362065|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139362066|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
139362067|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362068|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362069|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139362070|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139362071|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139362072|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139362073|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139362074|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
139362075|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362076|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362077|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139362078|NCT02467946|Immunotoxins|immunotoxins|mesh-ancestor
139362079|NCT02467946|Immunoconjugates|immunoconjugates|mesh-ancestor
139362080|NCT02467946|Immunologic Factors|immunologic factors|mesh-ancestor
139362081|NCT02467946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362082|NCT04688294|Valsartan|valsartan|mesh-list
139362083|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139362084|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139362085|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139362086|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139362087|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362088|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
139362089|NCT03300609|Leucovorin|leucovorin|mesh-list
139362090|NCT03300609|Folic Acid|folic acid|mesh-list
139362091|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
139362092|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
139362093|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139362094|NCT03300609|Panitumumab|panitumumab|mesh-list
139362095|NCT03300609|Capecitabine|capecitabine|mesh-list
139362096|NCT03300609|Fluorouracil|fluorouracil|mesh-list
139362097|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
139362098|NCT03300609|Antibodies|antibodies|mesh-list
139362099|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
139362101|NCT03300609|Calcium|calcium|mesh-list
139362102|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
139362103|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
139362104|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362105|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362106|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139362107|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139362108|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139362109|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
139362110|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362111|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139362112|NCT03300609|Antidotes|antidotes|mesh-ancestor
139362113|NCT03300609|Protective Agents|protective agents|mesh-ancestor
139362114|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
139362115|NCT03300609|Vitamins|vitamins|mesh-ancestor
139362116|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
139362117|NCT03300609|Hematinics|hematinics|mesh-ancestor
139362118|NCT00583778|Ipratropium|ipratropium|mesh-list
139362119|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139362120|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
139362121|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362122|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362123|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139362124|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
139362125|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139362126|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
139362127|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362128|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362129|NCT03300531|Betamethasone|betamethasone|mesh-list
139362130|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139362131|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
139362132|NCT03300531|Hormones|hormones|mesh-ancestor
139362133|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139362134|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362135|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139362136|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
139362137|NCT02467335|Fostemsavir|fostemsavir|mesh-list
139362138|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139362139|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139362140|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
139362141|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362142|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139362143|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139362144|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362145|NCT02809820|Metoprolol|metoprolol|mesh-list
139362146|NCT02809820|Carvedilol|carvedilol|mesh-list
139362147|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139362148|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139362149|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139362150|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
139362151|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
139362152|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362153|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362154|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139362155|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139362156|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
139362157|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362158|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362159|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
139362160|NCT02809820|Protective Agents|protective agents|mesh-ancestor
139362161|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139362162|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139362163|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139362164|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
139362165|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139362166|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139362167|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
139362168|NCT04491357|Calcium|calcium|mesh-list
139362169|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139362170|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362171|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139362173|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139362174|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139362175|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362176|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
139362177|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362179|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
139362180|NCT02786498|Vitamins|vitamins|mesh-ancestor
139362181|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
139362182|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362183|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139362184|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139362185|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139362186|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139362187|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362188|NCT02597660|Hormones|hormones|mesh-list
139362189|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139362190|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362191|NCT02419664|Edotreotide|edotreotide|mesh-list
139362192|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139362193|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362194|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
139362195|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139362196|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362197|NCT04435574|Lactoferrin|lactoferrin|mesh-list
139362198|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362199|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
139362200|NCT03104426|Hematinics|hematinics|mesh-ancestor
139362201|NCT02163356|Ketoconazole|ketoconazole|mesh-list
139362202|NCT02163356|Vincristine|vincristine|mesh-list
139362203|NCT02163356|Fenretinide|fenretinide|mesh-list
139362204|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139362205|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362206|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
139362207|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
139362208|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
139362209|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362210|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
139362211|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362212|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139362213|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139362214|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362215|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139362216|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
139362217|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139362218|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362219|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139362220|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139362221|NCT02163356|Protective Agents|protective agents|mesh-ancestor
139362222|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
139362223|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139362224|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
139362225|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
139362226|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362227|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362228|NCT03867110|Atorvastatin|atorvastatin|mesh-list
139362229|NCT03867110|Ezetimibe|ezetimibe|mesh-list
139362230|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139362231|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139362232|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
139362233|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362234|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139362235|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139362236|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362237|NCT03865082|Nivolumab|nivolumab|mesh-list
139362238|NCT03865082|Ipilimumab|ipilimumab|mesh-list
139362239|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139362240|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362241|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139362242|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362243|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139362244|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
139362245|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139362246|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139362247|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362248|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362249|NCT03102398|Urological Agents|urological agents|mesh-ancestor
139362250|NCT01187810|Cytarabine|cytarabine|mesh-list
139362251|NCT01187810|Methotrexate|methotrexate|mesh-list
139362252|NCT01187810|Fenretinide|fenretinide|mesh-list
139362253|NCT01187810|Retinamide|retinamide|mesh-list
139362254|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139362255|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
139362256|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139362257|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362258|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139362259|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
139362260|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362261|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362262|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
139362263|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362264|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139362265|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139362266|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
139362267|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139362268|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139362269|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
139362270|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362271|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139362272|NCT01187810|Protective Agents|protective agents|mesh-ancestor
139362273|NCT03104036|Mesalamine|mesalamine|mesh-list
139362274|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139362275|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139362276|NCT03104036|Analgesics|analgesics|mesh-ancestor
139362277|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
139362278|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362279|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362280|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139362281|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139362282|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
139362283|NCT03449888|Calcium|calcium|mesh-list
139362284|NCT03449888|Regadenoson|regadenoson|mesh-list
139362285|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139362286|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362287|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139362288|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139362289|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139362290|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
139362291|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
139362292|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362293|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362294|NCT03308396|Durvalumab|durvalumab|mesh-list
139362295|NCT03308396|Guadecitabine|guadecitabine|mesh-list
139362296|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139362297|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362298|NCT02720523|Upadacitinib|upadacitinib|mesh-list
139362299|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139362300|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139362301|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362302|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362303|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139362304|NCT02646332|Amoxicillin|amoxicillin|mesh-list
139362305|NCT02646332|Metronidazole|metronidazole|mesh-list
139362306|NCT02646332|Clarithromycin|clarithromycin|mesh-list
139362307|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
139362308|NCT02646332|Lansoprazole|lansoprazole|mesh-list
139362309|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139362310|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362311|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139362313|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139362314|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362315|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362316|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139362317|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139362318|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139362319|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139362320|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139362321|NCT00015002|Betamethasone|betamethasone|mesh-list
139362322|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139362323|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
139362324|NCT00015002|Hormones|hormones|mesh-ancestor
139362325|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139362326|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362327|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139362328|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
139362329|NCT03103412|Tofacitinib|tofacitinib|mesh-list
139362330|NCT03103412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139362331|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139362332|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362333|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362334|NCT02061007|Misonidazole|misonidazole|mesh-list
139362335|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362336|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139362337|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139362338|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362339|NCT02086604|Lenalidomide|lenalidomide|mesh-list
139362340|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139362341|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
139362342|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362343|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139362344|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139362345|NCT02086604|Growth Substances|growth substances|mesh-ancestor
139362346|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
139362347|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362348|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139362349|NCT02086604|Immunotoxins|immunotoxins|mesh-ancestor
139362350|NCT02086604|Immunoconjugates|immunoconjugates|mesh-ancestor
139362351|NCT03103568|Tolbutamide|tolbutamide|mesh-list
139362352|NCT03103568|Metoprolol|metoprolol|mesh-list
139362353|NCT03103568|Furosemide|furosemide|mesh-list
139362354|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
139362355|NCT03103568|Nitisinone|nitisinone|mesh-list
139362356|NCT03103568|Diuretics|diuretics|mesh-ancestor
139362357|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
138925536|NCT04061655|Hematinics|hematinics|mesh-ancestor
139362358|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362359|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139362360|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139362361|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362362|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139362363|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139362364|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
139362365|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
139362366|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362367|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139362368|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139362369|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139362370|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
139362371|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362372|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139362373|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362374|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139362375|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139362376|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139362377|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139362378|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362379|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
139362380|NCT03103646|Itraconazole|itraconazole|mesh-list
139362381|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139362382|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
139362383|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362384|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138768432|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362385|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139362386|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362387|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362388|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139362389|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
139362390|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139362391|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362392|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139362393|NCT01554410|Gemcitabine|gemcitabine|mesh-list
139362394|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362395|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139362396|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
139362397|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362398|NCT03299829|Trientine|trientine|mesh-list
139362399|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
139362400|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
139362401|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362402|NCT04968158|Acetaminophen|acetaminophen|mesh-list
139362403|NCT04968158|Etoricoxib|etoricoxib|mesh-list
139362404|NCT04968158|Tramadol|tramadol|mesh-list
139362405|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139362406|NCT04968158|Analgesics|analgesics|mesh-ancestor
139362407|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
139362408|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362409|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362410|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
139362411|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139362412|NCT04968158|Narcotics|narcotics|mesh-ancestor
139362413|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362414|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139362415|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139362416|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139362417|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139362418|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139362419|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362420|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362421|NCT02059915|Oxycodone|oxycodone|mesh-list
139362422|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139362423|NCT02059915|Narcotics|narcotics|mesh-ancestor
139362424|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362425|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362426|NCT02059915|Analgesics|analgesics|mesh-ancestor
139362427|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
139362428|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362429|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
139362430|NCT02471404|Glimepiride|glimepiride|mesh-list
139362431|NCT02471404|Saxagliptin|saxagliptin|mesh-list
139362432|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139362433|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362434|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139362435|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362436|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139362437|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139362438|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
139362439|NCT02471404|Incretins|incretins|mesh-ancestor
139362440|NCT02471404|Hormones|hormones|mesh-ancestor
139362441|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139362442|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139362443|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
139362444|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362445|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
139362446|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139362447|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
139362448|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139362449|NCT02061475|Lidocaine|lidocaine|mesh-list
139362450|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
139362451|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
139362452|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362453|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362454|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
139362455|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362456|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139362457|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139362458|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139362459|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139362460|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362461|NCT03100994|Bupivacaine|bupivacaine|mesh-list
139362462|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
139362463|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
139362464|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362465|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362466|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
139362467|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362468|NCT04160936|Bupivacaine|bupivacaine|mesh-list
139019341|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362469|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
139362470|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
139362471|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362472|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362473|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
139362474|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362475|NCT03103334|Methotrexate|methotrexate|mesh-list
139362476|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139362477|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
139362478|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139362479|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362480|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139362481|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
139362482|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362483|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362484|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
139362485|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362486|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139362487|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139362488|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
139362489|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139362490|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139362491|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139362492|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
138925633|NCT00721214|Azacitidine|azacitidine|mesh-list
139362493|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362494|NCT00795158|Desloratadine|desloratadine|mesh-list
139362495|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139362496|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
139362497|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362498|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362499|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362500|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139362501|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139362502|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
139362503|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
139362504|NCT02063269|Rivastigmine|rivastigmine|mesh-list
139362505|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139362506|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362507|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362508|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
139362509|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362510|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362511|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139362512|NCT02063269|Protective Agents|protective agents|mesh-ancestor
139362513|NCT00794846|Cetirizine|cetirizine|mesh-list
139362514|NCT00794846|Desloratadine|desloratadine|mesh-list
139362515|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139362516|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139362517|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139362518|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
139362519|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
139183343|NCT01205347|Simvastatin|simvastatin|mesh-list
139362520|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362521|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362522|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362523|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139362524|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
139362525|NCT00794768|Fexofenadine|fexofenadine|mesh-list
139362526|NCT00794768|Desloratadine|desloratadine|mesh-list
139362527|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139362528|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
139362529|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362530|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362531|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362532|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139362533|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139362534|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
139362535|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
139362536|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139362537|NCT02060851|Iron|iron|mesh-list
139362538|NCT02060851|Trace Elements|trace elements|mesh-ancestor
139362539|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
139362540|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362541|NCT00779636|Desloratadine|desloratadine|mesh-list
139362542|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139362543|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
139362544|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362545|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362546|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362547|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138925643|NCT02592278|Listerine|listerine|mesh-list
139362548|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139362549|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
139362550|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
139362551|NCT02060929|Esketamine|esketamine|mesh-list
139362552|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
139362553|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139362554|NCT00757562|Desloratadine|desloratadine|mesh-list
139362555|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139362556|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
139362557|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362558|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362559|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362560|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139362561|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139362562|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
139362563|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
139362564|NCT03299517|Lidocaine|lidocaine|mesh-list
139362565|NCT03299517|Amiodarone|amiodarone|mesh-list
139362566|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139362567|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
139362568|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
139362569|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362570|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362571|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
139362572|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362573|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139362574|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139362575|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139362576|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362577|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
139362578|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139362579|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139362580|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139362581|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362582|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139362583|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139362584|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139362585|NCT00651404|Ezetimibe|ezetimibe|mesh-list
139362586|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139362587|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139362588|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
139362589|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362590|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139362591|NCT00651014|Ezetimibe|ezetimibe|mesh-list
139362592|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139362593|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139362594|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
139362595|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362596|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139362597|NCT04435418|Apixaban|apixaban|mesh-list
139362598|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139362599|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
139362600|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139362601|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
139362602|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362603|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362604|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
139362605|NCT02062255|Aspirin|aspirin|mesh-list
139362606|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139362607|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139362608|NCT02062255|Analgesics|analgesics|mesh-ancestor
139362609|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
139362610|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362611|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362612|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139362613|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139362614|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139362615|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139362616|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362617|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139362618|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139362619|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362620|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
139362621|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139362622|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
139362623|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139362624|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
139362625|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362626|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
139362627|NCT05547243|Vaccines|vaccines|mesh-list
139362628|NCT05547243|Immunologic Factors|immunologic factors|mesh-ancestor
139362629|NCT05547243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362630|NCT03100604|Sevoflurane|sevoflurane|mesh-list
139362631|NCT03100604|Desflurane|desflurane|mesh-list
139362632|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139362633|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139362634|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
139362635|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
139362636|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362637|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362638|NCT00398294|Simvastatin|simvastatin|mesh-list
139362639|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139362640|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139362641|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
139362642|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362643|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139362644|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139362645|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362646|NCT04823403|Nivolumab|nivolumab|mesh-list
139362647|NCT04823403|Ipilimumab|ipilimumab|mesh-list
139362648|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139362649|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362650|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139362651|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362652|NCT03493646|Azacitidine|azacitidine|mesh-list
139362653|NCT03493646|Cc-486|cc-486|mesh-list
139362654|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139362655|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
139362656|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362657|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362658|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362659|NCT05519865|Tislelizumab|tislelizumab|mesh-list
139362660|NCT05519865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139362661|NCT05519865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362662|NCT05244200|Insulin|insulin|mesh-list
139362663|NCT05244200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139362664|NCT05244200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362665|NCT03991832|Durvalumab|durvalumab|mesh-list
139362666|NCT03991832|Olaparib|olaparib|mesh-list
139362667|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139362668|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362669|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139362670|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362671|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362672|NCT01361594|Insulin|insulin|mesh-list
139362673|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139362674|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139362675|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362676|NCT04435028|Ketotifen|ketotifen|mesh-list
139362677|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
139362678|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
139362679|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139362680|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
139362681|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
139362682|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362683|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362684|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362685|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139362686|NCT05060198|Lumefantrine|lumefantrine|mesh-list
139362687|NCT05060198|Artemether|artemether|mesh-list
139362688|NCT05060198|Piperaquine|piperaquine|mesh-list
139362689|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139362690|NCT05060198|Artenimol|artenimol|mesh-list
139362691|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
139362692|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139362693|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139362694|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362696|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
139362697|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139362698|NCT04478084|Antibodies|antibodies|mesh-list
139362699|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
139362700|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362701|NCT03098888|Dimercaprol|dimercaprol|mesh-list
139362702|NCT03098888|Chelating Agents|chelating agents|mesh-ancestor
139362703|NCT03098888|Sequestering Agents|sequestering agents|mesh-ancestor
139362704|NCT03098888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362705|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
139362706|NCT03098810|Astringents|astringents|mesh-ancestor
139362707|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362708|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
139362709|NCT02464761|Verteporfin|verteporfin|mesh-list
139362710|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139362711|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
139362712|NCT02462889|Aflibercept|aflibercept|mesh-list
139362713|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139362714|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139362715|NCT02462889|Growth Substances|growth substances|mesh-ancestor
139362716|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362717|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
139362718|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362719|NCT02462577|Morphine|morphine|mesh-list
139362720|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139362721|NCT02462577|Narcotics|narcotics|mesh-ancestor
139362722|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362723|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362724|NCT02462577|Analgesics|analgesics|mesh-ancestor
139362725|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
139362726|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362727|NCT02462499|Eplerenone|eplerenone|mesh-list
139362728|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139362729|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
139362730|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139362731|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362732|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139362733|NCT02462499|Diuretics|diuretics|mesh-ancestor
139362734|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
139362735|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139362736|NCT02464683|Vitamin D|vitamin d|mesh-list
139362737|NCT02464683|Vitamins|vitamins|mesh-ancestor
139362738|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
139362739|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362740|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139362741|NCT02061631|Dexamethasone|dexamethasone|mesh-list
139362742|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
139362743|NCT02061631|Docetaxel|docetaxel|mesh-list
139362744|NCT02061631|BB 1101|bb 1101|mesh-list
139362745|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139362746|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
139362747|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
139362748|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362749|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362750|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139362751|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
139362752|NCT02061631|Hormones|hormones|mesh-ancestor
139362753|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139362754|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139362755|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362756|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
139362757|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362758|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362759|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
139362760|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
139362761|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
139362762|NCT03098342|Amorolfine|amorolfine|mesh-list
139362763|NCT03098342|Methylene Blue|methylene blue|mesh-list
139362764|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362765|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362766|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
139362767|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362768|NCT05059418|Clonazepam|clonazepam|mesh-list
139362769|NCT05059418|Capsaicin|capsaicin|mesh-list
139362770|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
139362771|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
139362772|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
139362773|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362774|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362775|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
139362776|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
139362777|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
139362778|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362779|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362780|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
139362781|NCT02062333|Esmolol|esmolol|mesh-list
139362782|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139362783|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362784|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362785|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139362786|NCT02062333|Analgesics|analgesics|mesh-ancestor
139362787|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
139362788|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362789|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139362790|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139362791|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139362792|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
139362793|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362794|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362795|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139362796|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139362798|NCT02063425|Fluoxetine|fluoxetine|mesh-list
139362799|NCT02063425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139362800|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139362801|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139362802|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362803|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362804|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
139362805|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362806|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139362807|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
139362808|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139362809|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139362810|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139362811|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362812|NCT05071118|Pregabalin|pregabalin|mesh-list
139362813|NCT05071118|Analgesics|analgesics|mesh-ancestor
139362814|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
139362815|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362816|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362817|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
139362818|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139362819|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139362820|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362821|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139362822|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139362823|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139362824|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362825|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139362826|NCT03464019|Etripamil|etripamil|mesh-list
139362827|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139362828|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139362829|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362830|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139362831|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362832|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
139362833|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
139362834|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139362835|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362836|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362837|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
139362838|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139362839|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362840|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362841|NCT05069870|Itraconazole|itraconazole|mesh-list
139362842|NCT05069870|Rifampin|rifampin|mesh-list
139362843|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
139362844|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
139362845|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362846|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139362847|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139362848|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362849|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362850|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139362851|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
139183374|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139362852|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139362853|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362854|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139362855|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139362856|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
139362857|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139362858|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
139362859|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139362860|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139362861|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139362862|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139362863|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139362864|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139362865|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139362866|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139362867|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
139362868|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139362869|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139362870|NCT05275491|Calcium|calcium|mesh-list
139362871|NCT05275491|Parathyroid Hormone|parathyroid hormone|mesh-list
139362872|NCT05275491|Hormones|hormones|mesh-list
139362873|NCT05275491|Mitogens|mitogens|mesh-list
139362874|NCT05275491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139362875|NCT05275491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362876|NCT05275491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139362877|NCT05275491|Mitosis Modulators|mitosis modulators|mesh-ancestor
139362878|NCT05275491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362879|NCT02976753|Factor VIII|factor viii|mesh-list
139362880|NCT02976753|Coagulants|coagulants|mesh-ancestor
139362881|NCT04559529|Levetiracetam|levetiracetam|mesh-list
139362882|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
139362883|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
139362884|NCT04490421|Etoposide|etoposide|mesh-list
139362885|NCT04490421|Apatinib|apatinib|mesh-list
139362886|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362887|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139362888|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139362889|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139362890|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362891|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362892|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139362893|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
139362894|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139362895|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362896|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139362897|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362898|NCT02462109|Lorazepam|lorazepam|mesh-list
139362899|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
139362900|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
139362901|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
139362902|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362903|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362904|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139362905|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139362906|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362907|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139362908|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139362909|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139362910|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
139362911|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
139362912|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925794|NCT00720122|Mecasermin|mecasermin|mesh-list
139362913|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362914|NCT02063581|Ipatasertib|ipatasertib|mesh-list
139362915|NCT02063581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362916|NCT02063581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139362917|NCT02063581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362918|NCT02063581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362920|NCT02056899|Analgesics|analgesics|mesh-ancestor
139362921|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
138768982|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
139362922|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362923|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362924|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
139362925|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139362926|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139362927|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139362928|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139362929|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139362930|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139362931|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362932|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362933|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
139362934|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
139362935|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
139362936|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362937|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362938|NCT02462265|Analgesics|analgesics|mesh-ancestor
139362939|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
139362940|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362941|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139362942|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139362943|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362944|NCT02461875|Cabergoline|cabergoline|mesh-list
139362945|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139362946|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139362947|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
139362948|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
139362949|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362950|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362951|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362952|NCT02461719|Cyclosporine|cyclosporine|mesh-list
139362953|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139362954|NCT02461719|Cyclosporins|cyclosporins|mesh-list
139362955|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139362956|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362957|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139362958|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
139362959|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362960|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
139362961|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362962|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
139362963|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139362964|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139362965|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139362967|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139362968|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
139362969|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139362970|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362971|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139362972|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139362973|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
139362974|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139362975|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362976|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
139362977|NCT02064049|Velpatasvir|velpatasvir|mesh-list
139362978|NCT02064049|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139362979|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
139362980|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139362981|NCT02064829|Paclitaxel|paclitaxel|mesh-list
139362982|NCT02064829|genexol-PM|genexol-pm|mesh-list
139362983|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139362984|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139362985|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139362986|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
139362987|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
139362988|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
139362989|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362990|NCT02064517|Calcium|calcium|mesh-list
139362991|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139362992|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139362993|NCT02067949|Simvastatin|simvastatin|mesh-list
139362994|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139362995|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139362996|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
139362997|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139362998|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139362999|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139363000|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363001|NCT02068339|Oltipraz|oltipraz|mesh-list
139363002|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
139363003|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363004|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
139363005|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139363006|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
139363007|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139363008|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139363009|NCT02068339|Protective Agents|protective agents|mesh-ancestor
139363010|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363011|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363012|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139363013|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139363014|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363015|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363016|NCT02065843|Midazolam|midazolam|mesh-list
139363017|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139363018|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139363019|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363020|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363021|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139363022|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139363023|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139363024|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139363025|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
139363026|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
139363027|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
139363028|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
139363029|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363030|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363031|NCT02066077|Propofol|propofol|mesh-list
139363032|NCT02066077|Etomidate|etomidate|mesh-list
139363033|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139363034|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363035|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363036|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139363037|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
139363038|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
139363039|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139363040|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
139363041|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363042|NCT02065063|Palbociclib|palbociclib|mesh-list
139363043|NCT02065063|Trametinib|trametinib|mesh-list
139363044|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363045|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139363046|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363047|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363048|NCT02069197|Orlistat|orlistat|mesh-list
139363049|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363050|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363051|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139363052|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139363053|NCT02069431|Oxytocin|oxytocin|mesh-list
139363054|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
139363055|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139363056|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363057|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
139363058|NCT01652872|Hematinics|hematinics|mesh-ancestor
139363059|NCT02065219|Bupivacaine|bupivacaine|mesh-list
139363060|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
139363061|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
139363062|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363063|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363064|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
139363065|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363066|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
139363067|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139363068|NCT03560011|Antibodies|antibodies|mesh-list
139363069|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
139363070|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363071|NCT02069665|Ribavirin|ribavirin|mesh-list
139363072|NCT02069665|Ibuprofen|ibuprofen|mesh-list
139363073|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
139363074|NCT02069665|Albuterol|albuterol|mesh-list
139363075|NCT02069665|Guaifenesin|guaifenesin|mesh-list
139363076|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139363077|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
139363078|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363079|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
139363080|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363081|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139363082|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139363083|NCT02069665|Analgesics|analgesics|mesh-ancestor
139363084|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
139363085|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363086|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363087|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139363088|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139363089|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139363090|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363091|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139363092|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
139363093|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139363094|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
139363095|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
139363096|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139363097|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139363098|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139363099|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139363100|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
139363101|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363102|NCT02069665|Expectorants|expectorants|mesh-ancestor
139363103|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139363104|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
139363105|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139363106|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
139363107|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
139363108|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139363109|NCT04938856|Lamotrigine|lamotrigine|mesh-list
139363110|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
139363111|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139363112|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139363113|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363114|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139363115|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363116|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139363117|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139363118|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363119|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139363120|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139363121|NCT02461329|Polygeline|polygeline|mesh-list
139363122|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
139363123|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
139363124|NCT02463825|Pimozide|pimozide|mesh-list
139363125|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139363126|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139363127|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363128|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363129|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139363130|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139363131|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
139363132|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363133|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363134|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139363135|NCT02069977|Aripiprazole|aripiprazole|mesh-list
139363136|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
139363137|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139363138|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139363139|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139363140|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363141|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363142|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
139363144|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363145|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363146|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139363147|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139363148|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
139363149|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139363150|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139363151|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139363152|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139363153|NCT04490031|Ketamine|ketamine|mesh-list
139363154|NCT04490031|Analgesics|analgesics|mesh-ancestor
139363155|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
139363156|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363157|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363158|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139363159|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139363160|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
139363161|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
139363162|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363163|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139363164|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139363165|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363166|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363167|NCT02443402|Insulin|insulin|mesh-list
139363168|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139363169|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
139363170|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139363171|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
139363172|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
139363173|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139363174|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363175|NCT02443402|Incretins|incretins|mesh-ancestor
139363176|NCT02443402|Hormones|hormones|mesh-ancestor
139363177|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139363178|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139363179|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
139363180|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363181|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363182|NCT02067013|Ranibizumab|ranibizumab|mesh-list
139363183|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139363184|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139363185|NCT02067013|Growth Substances|growth substances|mesh-ancestor
139363186|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363187|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
139363188|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363189|NCT03298581|Clobetasol|clobetasol|mesh-list
139363190|NCT03298581|Halobetasol|halobetasol|mesh-list
139363191|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139363192|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139363193|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
139363194|NCT03298581|Hormones|hormones|mesh-ancestor
139363195|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139363196|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363197|NCT01370005|Empagliflozin|empagliflozin|mesh-list
139363198|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139363199|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363200|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139363201|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363202|NCT02070133|Simvastatin|simvastatin|mesh-list
139363203|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139363204|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139363205|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
139363206|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363207|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139363208|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139363209|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363210|NCT02070289|PF-06372865|pf-06372865|mesh-list
139363211|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
139363212|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
139363213|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363214|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020103|NCT05753670|Urological Agents|urological agents|mesh-ancestor
139363215|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363216|NCT02071927|Azacitidine|azacitidine|mesh-list
139363217|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139363218|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
139363219|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363220|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363221|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363222|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
139363223|NCT02072083|Ketamine|ketamine|mesh-list
139363224|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139363225|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363226|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363227|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139363228|NCT02072083|Analgesics|analgesics|mesh-ancestor
139363229|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
139363230|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363231|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139363232|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139363233|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139363234|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
139363235|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363236|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363237|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139363238|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139363239|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
139363240|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
139363241|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139363242|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139363243|NCT02070679|Vitamin E|vitamin e|mesh-list
139363244|NCT02070679|Tocopherols|tocopherols|mesh-list
139363245|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
139363246|NCT02070679|Vitamins|vitamins|mesh-ancestor
139363247|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
139363248|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363249|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
139363250|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363251|NCT02070679|Protective Agents|protective agents|mesh-ancestor
139363252|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139363253|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
139363254|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139363255|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139363256|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139363257|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
139363258|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139363259|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363260|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139363261|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139363262|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139363263|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139363264|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363265|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139363266|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139363267|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363268|NCT02072317|Raltitrexed|raltitrexed|mesh-list
139363269|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139363270|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
139363271|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363272|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363273|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139363274|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363275|NCT01651000|Calcifediol|calcifediol|mesh-list
139363276|NCT01651000|Vitamins|vitamins|mesh-ancestor
139363277|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
139363278|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363279|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139363280|NCT02469610|Bupivacaine|bupivacaine|mesh-list
139363281|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
139363282|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
139363283|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363284|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363285|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
139363286|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363287|NCT02071069|Fluorouracil|fluorouracil|mesh-list
139020182|NCT05614544|Propofol|propofol|mesh-list
139363288|NCT02071069|Irinotecan|irinotecan|mesh-list
139363289|NCT02071069|Cetuximab|cetuximab|mesh-list
139363290|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
139363291|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363292|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139363293|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363294|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139363295|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
139363296|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363297|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139363298|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139363299|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363300|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139363301|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
139363302|NCT02076373|Hematinics|hematinics|mesh-ancestor
139363303|NCT02072785|Vincristine|vincristine|mesh-list
139363304|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139363305|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363306|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
139363307|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
139363308|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
139363309|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363310|NCT02469298|Oseltamivir|oseltamivir|mesh-list
139363311|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
139363312|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363313|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363314|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363315|NCT02076451|DS-8273a|ds-8273a|mesh-list
139363316|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139363317|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363318|NCT02071303|Celecoxib|celecoxib|mesh-list
139363319|NCT02071303|Tramadol|tramadol|mesh-list
139363320|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139363321|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139363322|NCT02071303|Analgesics|analgesics|mesh-ancestor
139363323|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
139363324|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363325|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926060|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363326|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139363327|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139363328|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139363329|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139363330|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363331|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363332|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139363333|NCT02071303|Narcotics|narcotics|mesh-ancestor
139363334|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363335|NCT02076529|Ramosetron|ramosetron|mesh-list
139363336|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
139363337|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
139363338|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183416|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
139363339|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363340|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139363341|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139363342|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
139363343|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363344|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363345|NCT02411578|Glucagon|glucagon|mesh-list
139363346|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139363347|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139363348|NCT02411578|Hormones|hormones|mesh-ancestor
139363349|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139363350|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363351|NCT02411578|Incretins|incretins|mesh-ancestor
139363352|NCT02076685|Isoniazid|isoniazid|mesh-list
139363353|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
139363354|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139363355|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363356|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139363357|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139363358|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
139363359|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363360|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139363361|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
139363362|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
139363363|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
139363364|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363365|NCT05077917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139363366|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139363367|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139363368|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
139363369|NCT02071459|Droxidopa|droxidopa|mesh-list
139363370|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139363371|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139363372|NCT02463747|Vancomycin|vancomycin|mesh-list
139363373|NCT02463747|Meropenem|meropenem|mesh-list
139363374|NCT02463747|Tazobactam|tazobactam|mesh-list
139363375|NCT02463747|Piperacillin|piperacillin|mesh-list
139363376|NCT02463747|Ceftazidime|ceftazidime|mesh-list
139363377|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139363378|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139363379|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363380|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139363381|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363382|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363383|NCT02071537|Chloroquine|chloroquine|mesh-list
139363384|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139363385|NCT02071537|Carboplatin|carboplatin|mesh-list
139363386|NCT02071537|Gemcitabine|gemcitabine|mesh-list
139363387|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363388|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139363389|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
139363390|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363391|NCT02071537|Amebicides|amebicides|mesh-ancestor
139363392|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139363393|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139363394|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363395|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
139363396|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139363397|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139363398|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139363399|NCT02071537|Analgesics|analgesics|mesh-ancestor
139363400|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
139363401|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363402|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363403|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139363404|NCT02071537|Filaricides|filaricides|mesh-ancestor
139363405|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
139363406|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
139363407|NCT02076841|Interferons|interferons|mesh-list
139363408|NCT02076841|Interferon-beta|interferon-beta|mesh-list
139363409|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
139363410|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363411|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
139363412|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363413|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
139363414|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363415|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139363416|NCT02442310|Deferiprone|deferiprone|mesh-list
139363417|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139363418|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
139363419|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
139363420|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363421|NCT02071615|Caffeine|caffeine|mesh-list
139363422|NCT02071615|Methylphenidate|methylphenidate|mesh-list
139363423|NCT02071615|Modafinil|modafinil|mesh-list
139363424|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139363425|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363426|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139363427|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363428|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363429|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139363430|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139363431|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
139363432|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363433|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139363434|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139363435|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139363436|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
139363437|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138926117|NCT00747279|Insulin|insulin|mesh-list
139020328|NCT05274048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363438|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139363439|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139363440|NCT02077231|Vitamins|vitamins|mesh-list
139363441|NCT02077231|Vitamin A|vitamin a|mesh-list
139363442|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
139363443|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
139363444|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363445|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
139363446|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363447|NCT02077231|Protective Agents|protective agents|mesh-ancestor
139363448|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139363449|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363450|NCT02077309|Linagliptin|linagliptin|mesh-list
139363451|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139363452|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363453|NCT02077309|Incretins|incretins|mesh-ancestor
139363454|NCT02077309|Hormones|hormones|mesh-ancestor
139363455|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139363456|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139363457|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
139363458|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363459|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363460|NCT01369849|Rituximab|rituximab|mesh-list
139363461|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139363462|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139363463|NCT01369849|Antibodies|antibodies|mesh-list
139363464|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
139363465|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139363466|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
139363467|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363468|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363469|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139363470|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139363471|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
139363472|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363473|NCT02716779|Interferons|interferons|mesh-list
139363474|NCT02716779|Ribavirin|ribavirin|mesh-list
139363475|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363476|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
139363477|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363478|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
139363479|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363480|NCT02074189|Gemcitabine|gemcitabine|mesh-list
139363481|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363482|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139363483|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
139363484|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363485|NCT02463591|Thrombin|thrombin|mesh-list
139363486|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
139363487|NCT02463591|Coagulants|coagulants|mesh-ancestor
139363488|NCT02079961|Micronutrients|micronutrients|mesh-list
139363489|NCT02079961|Trace Elements|trace elements|mesh-list
139363490|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363491|NCT03298347|Caffeine|caffeine|mesh-list
139363492|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139363493|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363494|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139363495|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363496|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363497|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139363498|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138926121|NCT00742287|Procyanidin|procyanidin|mesh-list
139363499|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
139363500|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363501|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
139363502|NCT02077777|Mesalamine|mesalamine|mesh-list
139363503|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139363504|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139363505|NCT02077777|Analgesics|analgesics|mesh-ancestor
139363506|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
139363507|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363508|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363509|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139363510|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139363511|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
139363512|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139363513|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363514|NCT05036421|Empagliflozin|empagliflozin|mesh-list
139363515|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139020407|NCT04885998|AMG 757|amg 757|mesh-list
139363516|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363517|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139363518|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363519|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
139363520|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
139363522|NCT03298191|Calcium|calcium|mesh-list
139363523|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139363524|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363525|NCT03298191|Analgesics|analgesics|mesh-ancestor
139363526|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
139363527|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363528|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
139363529|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363530|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139363531|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
139363532|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139363533|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363534|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
139363535|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139363536|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
139363537|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
139363538|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139363539|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139363540|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139363541|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
139363542|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363543|NCT01369615|Oxycodone|oxycodone|mesh-list
139363544|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139363545|NCT01369615|Narcotics|narcotics|mesh-ancestor
139363546|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363547|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363548|NCT01369615|Analgesics|analgesics|mesh-ancestor
139363549|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
139363550|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363551|NCT02077933|Everolimus|everolimus|mesh-list
139363552|NCT02077933|Exemestane|exemestane|mesh-list
139363553|NCT02077933|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139363554|NCT02077933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139363555|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363556|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363557|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139363558|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
139363559|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363560|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363561|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139363562|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139363563|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139363564|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
139363565|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139363566|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
139363567|NCT02078089|Morphine|morphine|mesh-list
139363568|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139363569|NCT02078089|Narcotics|narcotics|mesh-ancestor
139363570|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363571|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363572|NCT02078089|Analgesics|analgesics|mesh-ancestor
139363573|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
139363574|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363575|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
139363576|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139363577|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139363578|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139363579|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363580|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139363581|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139363582|NCT02074891|Tenofovir|tenofovir|mesh-list
139363583|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
139363584|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363585|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139363586|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139363587|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363588|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363589|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139363591|NCT02078167|Policosanol|policosanol|mesh-list
139363592|NCT02078167|Red yeast rice|red yeast rice|mesh-list
139363593|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139363594|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139363595|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139363596|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
139363597|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363598|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363599|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139363600|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139363601|NCT02078323|Linaclotide|linaclotide|mesh-list
139363602|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139363603|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
139363604|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363605|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139363606|NCT02075749|Triamcinolone|triamcinolone|mesh-list
139363607|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139363608|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139363609|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139363610|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139363611|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
139363612|NCT02075749|Hormones|hormones|mesh-ancestor
139363613|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139363614|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363615|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139363616|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
139363617|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363618|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363619|NCT02081287|Inositol|inositol|mesh-list
138926150|NCT00719264|Everolimus|everolimus|mesh-list
139363620|NCT02081287|Lamotrigine|lamotrigine|mesh-list
139363621|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
139363622|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139363623|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139363624|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363625|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139363626|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363627|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139363628|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139363629|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363630|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139363631|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139363632|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
139363633|NCT02081287|Vitamins|vitamins|mesh-ancestor
139363634|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
139363635|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139363636|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139363637|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139363638|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363639|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363640|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139363641|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139363642|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363643|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
139363644|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363645|NCT04918069|Capsaicin|capsaicin|mesh-list
139363646|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
139363647|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
139363648|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
139363649|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363650|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363651|NCT02083315|Morphine|morphine|mesh-list
139363652|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139363653|NCT02083315|Narcotics|narcotics|mesh-ancestor
139363654|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363655|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363656|NCT02083315|Analgesics|analgesics|mesh-ancestor
139363657|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
139363658|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363659|NCT03559387|Lenograstim|lenograstim|mesh-list
139363660|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139363661|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
139363662|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363663|NCT02079337|Rocuronium|rocuronium|mesh-list
139363664|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139363665|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139363666|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139363667|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363668|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363670|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139363671|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139363672|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139363673|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
139363674|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363675|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139363676|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139363677|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363678|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139363679|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363680|NCT02079727|Celecoxib|celecoxib|mesh-list
139363681|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139363682|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139363683|NCT02079727|Analgesics|analgesics|mesh-ancestor
139363684|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
139363685|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139183446|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
139363686|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363687|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139363688|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139363689|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139363690|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139363691|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363692|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363693|NCT02082067|Ketorolac|ketorolac|mesh-list
139363694|NCT02082067|Morphine|morphine|mesh-list
139363695|NCT02082067|Anesthetics|anesthetics|mesh-list
139363696|NCT02082067|Ropivacaine|ropivacaine|mesh-list
139363697|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
139363698|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
139363699|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363700|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363701|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139363702|NCT02082067|Narcotics|narcotics|mesh-ancestor
139363703|NCT02082067|Analgesics|analgesics|mesh-ancestor
139363704|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
139363705|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363706|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139363707|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139363708|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139363709|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139363710|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139363711|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363712|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363713|NCT06131918|Thioctic Acid|thioctic acid|mesh-list
139363714|NCT06131918|Resveratrol|resveratrol|mesh-list
139363715|NCT06131918|Superoxide Dismutase|superoxide dismutase|mesh-list
139363716|NCT06131918|Antioxidants|antioxidants|mesh-ancestor
139363717|NCT06131918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363718|NCT06131918|Protective Agents|protective agents|mesh-ancestor
139363719|NCT06131918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363720|NCT06131918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363721|NCT06131918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139363722|NCT06131918|Vitamin B Complex|vitamin b complex|mesh-ancestor
139363723|NCT06131918|Vitamins|vitamins|mesh-ancestor
139363724|NCT06131918|Micronutrients|micronutrients|mesh-ancestor
139363725|NCT06131918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139363726|NCT06131554|Vaccines|vaccines|mesh-list
139363727|NCT06131554|Immunologic Factors|immunologic factors|mesh-ancestor
139363728|NCT06131554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363729|NCT06131476|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139363730|NCT06131476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139363731|NCT06131398|Pembrolizumab|pembrolizumab|mesh-list
139363732|NCT06131398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139363733|NCT06131398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363734|NCT06131398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139363735|NCT06131398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363736|NCT06131294|Fluorides|fluorides|mesh-list
139363737|NCT06131294|Cariostatic Agents|cariostatic agents|mesh-ancestor
139363738|NCT06131294|Protective Agents|protective agents|mesh-ancestor
139363739|NCT06131294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363740|NCT06131268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139363741|NCT06131268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139363742|NCT06131268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139363743|NCT06131268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139363744|NCT06131268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363745|NCT06131268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363746|NCT06131268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363747|NCT06131268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139363748|NCT06131268|Antidepressive Agents|antidepressive agents|mesh-ancestor
139363749|NCT06131268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139363750|NCT06131255|Citalopram|citalopram|mesh-list
139363751|NCT06131255|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139363752|NCT06131255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139183451|NCT03817411|Capecitabine|capecitabine|mesh-list
139363753|NCT06131255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139363754|NCT06131255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363755|NCT06131255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363756|NCT06131255|Serotonin Agents|serotonin agents|mesh-ancestor
139363757|NCT06131255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363758|NCT06131255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139363759|NCT06131255|Antidepressive Agents|antidepressive agents|mesh-ancestor
139363760|NCT06131255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139363761|NCT06131021|Amoxicillin|amoxicillin|mesh-list
139363762|NCT06131021|Metronidazole|metronidazole|mesh-list
139363763|NCT06131021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139363764|NCT06131021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363765|NCT06131021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139363766|NCT06131021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139363767|NCT06130995|Relugolix|relugolix|mesh-list
139363768|NCT06130995|Androgen Antagonists|androgen antagonists|mesh-ancestor
139363769|NCT06130995|Hormone Antagonists|hormone antagonists|mesh-ancestor
139363770|NCT06130995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138524550|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
139363771|NCT06130995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363772|NCT06130826|Immunomodulating Agents|immunomodulating agents|mesh-list
139363773|NCT06130826|Immunologic Factors|immunologic factors|mesh-ancestor
139363774|NCT06130826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363775|NCT06130618|Lidocaine|lidocaine|mesh-list
139363776|NCT06130618|Anesthetics, Local|anesthetics, local|mesh-ancestor
139363777|NCT06130618|Anesthetics|anesthetics|mesh-ancestor
139363778|NCT06130618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363779|NCT06130618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363780|NCT06130618|Sensory System Agents|sensory system agents|mesh-ancestor
139363781|NCT06130618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363782|NCT06130618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139363783|NCT06130618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139363784|NCT06130618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139363785|NCT06130618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139363786|NCT06130618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363787|NCT06130449|Methyltestosterone|methyltestosterone|mesh-list
139363788|NCT06130449|Testosterone|testosterone|mesh-list
139363789|NCT06130449|Testosterone undecanoate|testosterone undecanoate|mesh-list
139363790|NCT06130449|Testosterone enanthate|testosterone enanthate|mesh-list
139363791|NCT06130449|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139363792|NCT06130449|Androgens|androgens|mesh-ancestor
139363793|NCT06130449|Hormones|hormones|mesh-ancestor
139363794|NCT06130449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139363795|NCT06130449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363796|NCT06130449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139363797|NCT06130449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363798|NCT06130449|Anabolic Agents|anabolic agents|mesh-ancestor
139363799|NCT06130384|Bromfenac|bromfenac|mesh-list
139363800|NCT06130384|Lubricant Eye Drops|lubricant eye drops|mesh-list
139363801|NCT06130384|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139363802|NCT06130384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139363803|NCT06130384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139363804|NCT06130384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139363805|NCT06130384|Analgesics|analgesics|mesh-ancestor
139363806|NCT06130384|Sensory System Agents|sensory system agents|mesh-ancestor
139363807|NCT06130384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363808|NCT06130384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363809|NCT06130384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139020706|NCT03565913|Cathartics|cathartics|mesh-ancestor
139363810|NCT06130384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139363811|NCT06130345|Vaccines|vaccines|mesh-list
139363812|NCT06130345|Immunologic Factors|immunologic factors|mesh-ancestor
139363813|NCT06130345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363814|NCT06129032|Anesthetics|anesthetics|mesh-list
139363815|NCT06129032|Anesthetics, Local|anesthetics, local|mesh-list
139363816|NCT06129032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363817|NCT06129032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363818|NCT06129032|Sensory System Agents|sensory system agents|mesh-ancestor
139363819|NCT06129032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363820|NCT06127940|Sotorasib|sotorasib|mesh-list
139363821|NCT06127940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139363822|NCT06127940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363823|NCT06127940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139363824|NCT06127940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363825|NCT06127901|Anesthetics|anesthetics|mesh-list
139363826|NCT06127901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363827|NCT06127901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363828|NCT06127693|Vaccines|vaccines|mesh-list
139363829|NCT06127693|Immunologic Factors|immunologic factors|mesh-ancestor
139363830|NCT06127693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363831|NCT06127628|Ropivacaine|ropivacaine|mesh-list
139363832|NCT06127628|Anesthetics, Local|anesthetics, local|mesh-ancestor
139363833|NCT06127628|Anesthetics|anesthetics|mesh-ancestor
139363834|NCT06127628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363835|NCT06127628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363836|NCT06127628|Sensory System Agents|sensory system agents|mesh-ancestor
139363837|NCT06127628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363838|NCT06127589|Nicotine|nicotine|mesh-list
139363839|NCT06127589|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139363840|NCT06127589|Autonomic Agents|autonomic agents|mesh-ancestor
139363841|NCT06127589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363842|NCT06127589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363843|NCT06127589|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139363844|NCT06127589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139363845|NCT06127589|Cholinergic Agents|cholinergic agents|mesh-ancestor
139363846|NCT06127589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363847|NCT06127589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363848|NCT06127498|Antibodies|antibodies|mesh-list
139363849|NCT06127498|Immunoglobulins|immunoglobulins|mesh-list
139363850|NCT06127498|Immunologic Factors|immunologic factors|mesh-ancestor
139363851|NCT06127498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363852|NCT06127433|Insulin|insulin|mesh-list
139363853|NCT06127433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139363854|NCT06127433|Metformin|metformin|mesh-list
139363855|NCT06127433|Insulin Glargine|insulin glargine|mesh-list
139363856|NCT06127433|Dapagliflozin|dapagliflozin|mesh-list
139363857|NCT06127433|Insulin Aspart|insulin aspart|mesh-list
139363858|NCT06127433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139363859|NCT06127433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363860|NCT06127433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139363861|NCT06127433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363862|NCT06127407|Ivosidenib|ivosidenib|mesh-list
139363863|NCT06127407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363864|NCT06127407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363865|NCT06127407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363866|NCT06127381|Glycolic acid|glycolic acid|mesh-list
139363867|NCT06127381|Keratolytic Agents|keratolytic agents|mesh-ancestor
139363868|NCT06127381|Dermatologic Agents|dermatologic agents|mesh-ancestor
139363869|NCT06127355|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139363870|NCT06127355|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139363871|NCT06127355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139363872|NCT06127303|Immunomodulating Agents|immunomodulating agents|mesh-list
139363873|NCT06127303|Immunologic Factors|immunologic factors|mesh-ancestor
139363874|NCT06127303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363875|NCT06127264|Carbon Fiber|carbon fiber|mesh-list
139363876|NCT06127264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139363877|NCT06127264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363878|NCT06127212|Dapagliflozin|dapagliflozin|mesh-list
139363879|NCT06127212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139363880|NCT06127212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363881|NCT06127212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139363882|NCT06127212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363883|NCT06127160|Cephalexin|cephalexin|mesh-list
139363884|NCT06127160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139020782|NCT03074513|Antibodies|antibodies|mesh-list
139363885|NCT06127160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363887|NCT06126991|Midazolam|midazolam|mesh-list
139363888|NCT06126991|Fentanyl|fentanyl|mesh-list
139363889|NCT06126991|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139363890|NCT06126991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139183464|NCT01218893|Proguanil|proguanil|mesh-list
139363891|NCT06126991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139363892|NCT06126991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363893|NCT06126991|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139363894|NCT06126991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139363895|NCT06126991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139363896|NCT06126991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139363897|NCT06126991|Anesthetics, General|anesthetics, general|mesh-ancestor
139363898|NCT06126991|Anesthetics|anesthetics|mesh-ancestor
139363899|NCT06126991|GABA Modulators|gaba modulators|mesh-ancestor
139363900|NCT06126991|GABA Agents|gaba agents|mesh-ancestor
139363901|NCT06126991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363902|NCT06126991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363903|NCT06126991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139363904|NCT06126991|Narcotics|narcotics|mesh-ancestor
139363905|NCT06126991|Analgesics|analgesics|mesh-ancestor
139363906|NCT06126991|Sensory System Agents|sensory system agents|mesh-ancestor
139363907|NCT06126991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363908|NCT06126991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139363909|NCT06126991|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139363910|NCT06126991|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139363911|NCT06126991|Histamine Antagonists|histamine antagonists|mesh-ancestor
139363912|NCT06126991|Histamine Agents|histamine agents|mesh-ancestor
139363913|NCT06126952|Mometasone Furoate|mometasone furoate|mesh-list
139363914|NCT06126952|Azelastine|azelastine|mesh-list
139363915|NCT06126952|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139363916|NCT06126952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139363917|NCT06126952|Dermatologic Agents|dermatologic agents|mesh-ancestor
139363918|NCT06126952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139363919|NCT06126952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139363920|NCT06126952|Autonomic Agents|autonomic agents|mesh-ancestor
139363921|NCT06126952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139363922|NCT06126952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363923|NCT06126952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139363924|NCT06126952|Respiratory System Agents|respiratory system agents|mesh-ancestor
139363925|NCT06126952|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139363926|NCT06126952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363927|NCT06126952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363928|NCT06126952|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139363929|NCT06126952|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139363930|NCT06126952|Histamine Antagonists|histamine antagonists|mesh-ancestor
139363931|NCT06126952|Histamine Agents|histamine agents|mesh-ancestor
139363932|NCT06126952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139363933|NCT06126952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139363934|NCT06126952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139363935|NCT06126952|Analgesics|analgesics|mesh-ancestor
139363936|NCT06126952|Sensory System Agents|sensory system agents|mesh-ancestor
139363937|NCT06126952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139363938|NCT06126913|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139363939|NCT06126913|Antiviral Agents|antiviral agents|mesh-ancestor
139363940|NCT06126913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363941|NCT06126835|Ozanimod|ozanimod|mesh-list
139363942|NCT06126835|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139363943|NCT06126835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363944|NCT06126835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139363945|NCT06126835|Immunologic Factors|immunologic factors|mesh-ancestor
139363946|NCT06126835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363947|NCT06126731|Amoxicillin|amoxicillin|mesh-list
139363948|NCT06126731|Metronidazole|metronidazole|mesh-list
139363949|NCT06126731|Vancomycin|vancomycin|mesh-list
139363950|NCT06126731|Ciprofloxacin|ciprofloxacin|mesh-list
139363951|NCT06126731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139363952|NCT06126731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139363953|NCT06126731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139363954|NCT06126731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139363955|NCT06126731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139363956|NCT06126731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139363957|NCT06126731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363958|NCT06126731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363959|NCT06126731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363960|NCT06126731|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139363961|NCT06126731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139363962|NCT06126705|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139363963|NCT06126705|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139363964|NCT06126705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363966|NCT06126640|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139363967|NCT06126640|Maytansine|maytansine|mesh-list
139363968|NCT06126640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139363969|NCT06126640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363970|NCT06126640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139363971|NCT06126640|Tubulin Modulators|tubulin modulators|mesh-ancestor
139363972|NCT06126640|Antimitotic Agents|antimitotic agents|mesh-ancestor
139363973|NCT06126640|Mitosis Modulators|mitosis modulators|mesh-ancestor
139363974|NCT06126640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363975|NCT06126640|Immunotoxins|immunotoxins|mesh-ancestor
139363976|NCT06126640|Immunoconjugates|immunoconjugates|mesh-ancestor
139363977|NCT06126640|Immunologic Factors|immunologic factors|mesh-ancestor
139363978|NCT06126640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363979|NCT06126588|Everolimus|everolimus|mesh-list
139363980|NCT06126588|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139363981|NCT06126588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139363982|NCT06126588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363983|NCT06126588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363984|NCT06126588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139363985|NCT06126588|Immunologic Factors|immunologic factors|mesh-ancestor
139363986|NCT06126588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363987|NCT06126588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139363988|NCT06126380|Tacrolimus|tacrolimus|mesh-list
139363989|NCT06126380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139363990|NCT06126380|Immunologic Factors|immunologic factors|mesh-ancestor
139363991|NCT06126380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139363992|NCT06126380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139363993|NCT06126380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139363994|NCT06126380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139363995|NCT06126354|Insulin|insulin|mesh-list
139363996|NCT06126354|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139363997|NCT06126354|Dexamethasone|dexamethasone|mesh-list
139363998|NCT06126354|Dexamethasone acetate|dexamethasone acetate|mesh-list
139363999|NCT06126354|Octreotide|octreotide|mesh-list
139364000|NCT06126354|Glucagon|glucagon|mesh-list
139364001|NCT06126354|Hormones|hormones|mesh-list
139364002|NCT06126354|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139364003|NCT06126354|BB 1101|bb 1101|mesh-list
139364004|NCT06126354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139364005|NCT06126354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364006|NCT06126354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139364007|NCT06126354|Antiemetics|antiemetics|mesh-ancestor
139364008|NCT06126354|Autonomic Agents|autonomic agents|mesh-ancestor
139364009|NCT06126354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364010|NCT06126354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139364011|NCT06126354|Glucocorticoids|glucocorticoids|mesh-ancestor
139364012|NCT06126354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139364013|NCT06126354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139364014|NCT06126354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364015|NCT06126354|Protease Inhibitors|protease inhibitors|mesh-ancestor
139364016|NCT06126354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364017|NCT06126354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364018|NCT06126354|Incretins|incretins|mesh-ancestor
139364019|NCT06126263|Clindamycin|clindamycin|mesh-list
139364020|NCT06126263|Clindamycin palmitate|clindamycin palmitate|mesh-list
139364021|NCT06126263|Clindamycin phosphate|clindamycin phosphate|mesh-list
139364022|NCT06126263|Linezolid|linezolid|mesh-list
139364023|NCT06126263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139364024|NCT06126263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139364025|NCT06126263|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139364026|NCT06126263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364027|NCT06126263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364028|NCT06126042|Abatacept|abatacept|mesh-list
139364029|NCT06126042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139364030|NCT06126042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364031|NCT06126042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139364032|NCT06126042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364033|NCT06126042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139364034|NCT06126042|Immunologic Factors|immunologic factors|mesh-ancestor
139364035|NCT06126042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139183474|NCT03824119|Ibuprofen|ibuprofen|mesh-list
139364036|NCT06126042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139364037|NCT06126029|Metformin|metformin|mesh-list
139364038|NCT06126029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139364039|NCT06126029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364040|NCT06125665|Aminophylline|aminophylline|mesh-list
139364041|NCT06125665|Dexmedetomidine|dexmedetomidine|mesh-list
139364042|NCT06125665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139364043|NCT06125665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364044|NCT06125665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364045|NCT06125665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139364046|NCT06125665|Analgesics|analgesics|mesh-ancestor
139364047|NCT06125665|Sensory System Agents|sensory system agents|mesh-ancestor
139364048|NCT06125665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364049|NCT06125665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139364050|NCT06125665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139364051|NCT06125665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139364052|NCT06125665|Adrenergic Agents|adrenergic agents|mesh-ancestor
139364053|NCT06125665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364054|NCT06125665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364055|NCT06125665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139364056|NCT06125665|Autonomic Agents|autonomic agents|mesh-ancestor
139364057|NCT06125665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139364058|NCT06125665|Respiratory System Agents|respiratory system agents|mesh-ancestor
139364059|NCT06125665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139364060|NCT06125665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139364061|NCT06125665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364062|NCT06125665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139364063|NCT06125665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139364064|NCT06125665|Purinergic Agents|purinergic agents|mesh-ancestor
139364065|NCT06125665|Protective Agents|protective agents|mesh-ancestor
139364066|NCT06125340|Amoxicillin|amoxicillin|mesh-list
139364067|NCT06125340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139364068|NCT06125340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139364069|NCT06124703|Prednisone|prednisone|mesh-list
139364070|NCT06124703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139364071|NCT06124703|Glucocorticoids|glucocorticoids|mesh-ancestor
139364072|NCT06124703|Hormones|hormones|mesh-ancestor
139364073|NCT06124703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139364074|NCT06124703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364075|NCT06124703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139364076|NCT06124703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364077|NCT06124066|Tamsulosin|tamsulosin|mesh-list
139364078|NCT06124066|Mirabegron|mirabegron|mesh-list
139364079|NCT06124066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139364080|NCT06124066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139364081|NCT06124066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139364082|NCT06124066|Adrenergic Agents|adrenergic agents|mesh-ancestor
139364083|NCT06124066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364084|NCT06124066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364085|NCT06124066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364086|NCT06124066|Urological Agents|urological agents|mesh-ancestor
139364087|NCT06124066|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139364088|NCT06124066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139364089|NCT06124066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139364090|NCT06121544|Flutemetamol|flutemetamol|mesh-list
139364091|NCT06121544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139364092|NCT06121544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364093|NCT06120842|Timolol|timolol|mesh-list
139364094|NCT06120842|Bimatoprost|bimatoprost|mesh-list
139364095|NCT06120842|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139364096|NCT06120842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139364097|NCT06120842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364098|NCT06120842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139364099|NCT06120842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139364100|NCT06120842|Adrenergic Agents|adrenergic agents|mesh-ancestor
139364101|NCT06120842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364102|NCT06120842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364103|NCT06120842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139364104|NCT06120842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139364105|NCT06118957|Enoxaparin|enoxaparin|mesh-list
139364106|NCT06118957|Anticoagulants|anticoagulants|mesh-ancestor
139364107|NCT06118957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139364108|NCT06118957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139364109|NCT06118957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364110|NCT06116955|Midazolam|midazolam|mesh-list
139364111|NCT06116955|Sufentanil|sufentanil|mesh-list
139364112|NCT06116955|Dsuvia|dsuvia|mesh-list
139364114|NCT06116955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139364115|NCT06116955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364116|NCT06116955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364117|NCT06116955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139364118|NCT06116955|Anesthetics, General|anesthetics, general|mesh-ancestor
139364119|NCT06116955|Anesthetics|anesthetics|mesh-ancestor
139364120|NCT06116955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139364121|NCT06116955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139364122|NCT06116955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139364123|NCT06116955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139364124|NCT06116955|GABA Modulators|gaba modulators|mesh-ancestor
139364125|NCT06116955|GABA Agents|gaba agents|mesh-ancestor
139364126|NCT06116955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364127|NCT06116955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364128|NCT06116955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139364129|NCT06116955|Narcotics|narcotics|mesh-ancestor
139364130|NCT06116955|Analgesics|analgesics|mesh-ancestor
139364131|NCT06116955|Sensory System Agents|sensory system agents|mesh-ancestor
139364132|NCT06116955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364133|NCT06116578|Pembrolizumab|pembrolizumab|mesh-list
139364134|NCT06116578|Olaparib|olaparib|mesh-list
139364135|NCT06116578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139364136|NCT06116578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364137|NCT06116578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139364138|NCT06116578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364139|NCT06116578|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139364140|NCT06116578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364141|NCT06105476|Vitamin A|vitamin a|mesh-list
139364142|NCT06105476|Ethanol|ethanol|mesh-list
139364143|NCT06105476|Retinol palmitate|retinol palmitate|mesh-list
139364144|NCT06105476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139364145|NCT06105476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139364146|NCT06105476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364147|NCT06105476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364148|NCT06105476|Vitamins|vitamins|mesh-ancestor
139364149|NCT06105476|Micronutrients|micronutrients|mesh-ancestor
139364150|NCT06105476|Antioxidants|antioxidants|mesh-ancestor
139364151|NCT06105476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364152|NCT06105476|Protective Agents|protective agents|mesh-ancestor
139364153|NCT06105476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139364154|NCT06105476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364155|NCT06091956|Deucravacitinib|deucravacitinib|mesh-list
139364156|NCT06091956|Dermatologic Agents|dermatologic agents|mesh-ancestor
139364157|NCT06091956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139364158|NCT06091956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364159|NCT06091956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364160|NCT06088147|Triamcinolone|triamcinolone|mesh-list
139364161|NCT06088147|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139364162|NCT06088147|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139364163|NCT06088147|Methotrexate|methotrexate|mesh-list
139364164|NCT06088147|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139364165|NCT06088147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139364166|NCT06088147|Abortifacient Agents|abortifacient agents|mesh-ancestor
139364167|NCT06088147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139364168|NCT06088147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364169|NCT06088147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139364170|NCT06088147|Antimetabolites|antimetabolites|mesh-ancestor
139364171|NCT06088147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364172|NCT06088147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364173|NCT06088147|Dermatologic Agents|dermatologic agents|mesh-ancestor
139364174|NCT06088147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364175|NCT06088147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139364176|NCT06088147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139364177|NCT06088147|Immunologic Factors|immunologic factors|mesh-ancestor
139364179|NCT06088147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139364180|NCT06088147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139364181|NCT06088147|Glucocorticoids|glucocorticoids|mesh-ancestor
139364182|NCT06088147|Hormones|hormones|mesh-ancestor
139364183|NCT06088147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139364184|NCT06081114|Micronutrients|micronutrients|mesh-list
139364185|NCT06081114|Trace Elements|trace elements|mesh-list
139364186|NCT06081114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364187|NCT06077240|Menthol|menthol|mesh-list
139364188|NCT06077240|Nicotine|nicotine|mesh-list
139364189|NCT06077240|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139364190|NCT06077240|Autonomic Agents|autonomic agents|mesh-ancestor
139364191|NCT06077240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364192|NCT06077240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364193|NCT06077240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139364194|NCT06077240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139364195|NCT06077240|Cholinergic Agents|cholinergic agents|mesh-ancestor
139364196|NCT06077240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364197|NCT06077240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364198|NCT06077240|Antipruritics|antipruritics|mesh-ancestor
139364199|NCT06077240|Dermatologic Agents|dermatologic agents|mesh-ancestor
139364200|NCT06069414|Anesthetics|anesthetics|mesh-list
139364201|NCT06069414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364202|NCT06069414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364203|NCT06067399|Chrysarobin|chrysarobin|mesh-list
139364204|NCT06067399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139364205|NCT06067399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139364206|NCT06067399|Analgesics|analgesics|mesh-ancestor
139364207|NCT06067399|Sensory System Agents|sensory system agents|mesh-ancestor
139364208|NCT06067399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364209|NCT06067399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364210|NCT06067399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139364211|NCT06067399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139364212|NCT06058962|Suramin|suramin|mesh-list
139364213|NCT06058962|Antinematodal Agents|antinematodal agents|mesh-ancestor
139364214|NCT06058962|Anthelmintics|anthelmintics|mesh-ancestor
139364215|NCT06058962|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139364216|NCT06058962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139364217|NCT06058962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364218|NCT06058962|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139364219|NCT06058962|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139364220|NCT06056310|Cisplatin|cisplatin|mesh-list
139364221|NCT06056310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364222|NCT06049953|Antipsychotic Agents|antipsychotic agents|mesh-list
139364223|NCT06049953|Antidepressive Agents|antidepressive agents|mesh-list
139364224|NCT06049953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139364225|NCT06049953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139364226|NCT06049953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138926371|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139364227|NCT06049953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364228|NCT06046417|Insulin|insulin|mesh-list
139364229|NCT06046417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139364230|NCT06046417|Insulin Aspart|insulin aspart|mesh-list
139364231|NCT06046417|Insulin Lispro|insulin lispro|mesh-list
139364232|NCT06046417|Pramlintide|pramlintide|mesh-list
139364233|NCT06046417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139364234|NCT06046417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364235|NCT06022757|Pembrolizumab|pembrolizumab|mesh-list
139364236|NCT06022757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139364237|NCT06022757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364238|NCT06022757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139364239|NCT06022757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364240|NCT06016452|Chlorophyllin|chlorophyllin|mesh-list
139364241|NCT06016452|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139364242|NCT06016452|Protective Agents|protective agents|mesh-ancestor
139364243|NCT06016452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364244|NCT06014658|Antibodies|antibodies|mesh-list
139364245|NCT06014658|Immunoconjugates|immunoconjugates|mesh-list
139364246|NCT06014658|Immunologic Factors|immunologic factors|mesh-ancestor
139364247|NCT06014658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364248|NCT06011889|Etanercept|etanercept|mesh-list
139364249|NCT06011889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139364250|NCT06011889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139364251|NCT06011889|Analgesics|analgesics|mesh-ancestor
139364252|NCT06011889|Sensory System Agents|sensory system agents|mesh-ancestor
139364253|NCT06011889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364254|NCT06011889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364255|NCT06011889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139364256|NCT06011889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139364257|NCT06011889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139364258|NCT06011889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139364259|NCT06011889|Immunologic Factors|immunologic factors|mesh-ancestor
139364260|NCT06006026|Ropivacaine|ropivacaine|mesh-list
139364261|NCT06006026|Anesthetics, Local|anesthetics, local|mesh-ancestor
139364262|NCT06006026|Anesthetics|anesthetics|mesh-ancestor
139364263|NCT06006026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364264|NCT06006026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364265|NCT06006026|Sensory System Agents|sensory system agents|mesh-ancestor
139364266|NCT06006026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364267|NCT06002152|Bupivacaine|bupivacaine|mesh-list
139364268|NCT06002152|Anesthetics, Local|anesthetics, local|mesh-ancestor
139364269|NCT06002152|Anesthetics|anesthetics|mesh-ancestor
139364270|NCT06002152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364271|NCT06002152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364272|NCT06002152|Sensory System Agents|sensory system agents|mesh-ancestor
139364273|NCT06002152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364274|NCT05997277|Deucravacitinib|deucravacitinib|mesh-list
139364275|NCT05997277|Dermatologic Agents|dermatologic agents|mesh-ancestor
139364276|NCT05997277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139364277|NCT05997277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364278|NCT05997277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364279|NCT05996523|Pembrolizumab|pembrolizumab|mesh-list
139364280|NCT05996523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139364281|NCT05996523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364282|NCT05996523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139364283|NCT05996523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364284|NCT05995769|Psilocybin|psilocybin|mesh-list
139364285|NCT05995769|Hallucinogens|hallucinogens|mesh-ancestor
139364286|NCT05995769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364287|NCT05995769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138926383|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
139364288|NCT05978206|Nandrolone Decanoate|nandrolone decanoate|mesh-list
139364289|NCT05978206|Nandrolone|nandrolone|mesh-list
139364290|NCT05978206|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
139364291|NCT05978206|Androgens|androgens|mesh-ancestor
139364292|NCT05978206|Hormones|hormones|mesh-ancestor
139364293|NCT05978206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139364294|NCT05978206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364295|NCT05978206|Anabolic Agents|anabolic agents|mesh-ancestor
139364296|NCT05978206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139364297|NCT05973006|Vaccines|vaccines|mesh-list
139364298|NCT05973006|Immunologic Factors|immunologic factors|mesh-ancestor
139364299|NCT05973006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364300|NCT05970354|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139364301|NCT05970354|Anesthetics, Local|anesthetics, local|mesh-ancestor
139364302|NCT05970354|Anesthetics|anesthetics|mesh-ancestor
139364303|NCT05970354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364304|NCT05970354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364305|NCT05970354|Sensory System Agents|sensory system agents|mesh-ancestor
139364306|NCT05970354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364307|NCT05970354|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139364308|NCT05967052|Pregabalin|pregabalin|mesh-list
139364309|NCT05967052|Analgesics|analgesics|mesh-ancestor
139364310|NCT05967052|Sensory System Agents|sensory system agents|mesh-ancestor
139364311|NCT05967052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364312|NCT05967052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364313|NCT05967052|Anticonvulsants|anticonvulsants|mesh-ancestor
139364314|NCT05967052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139364315|NCT05967052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139364316|NCT05967052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364317|NCT05967052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139364318|NCT05967052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139364319|NCT05967052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139364320|NCT05967052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364321|NCT05967052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139364322|NCT05966090|Vaccines|vaccines|mesh-list
139364323|NCT05966090|Immunologic Factors|immunologic factors|mesh-ancestor
139364324|NCT05966090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364325|NCT05964920|Methyltestosterone|methyltestosterone|mesh-list
139364326|NCT05964920|Testosterone|testosterone|mesh-list
139364327|NCT05964920|Testosterone undecanoate|testosterone undecanoate|mesh-list
139364328|NCT05964920|Testosterone enanthate|testosterone enanthate|mesh-list
139364329|NCT05964920|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139364330|NCT05964920|Androgens|androgens|mesh-ancestor
139364331|NCT05964920|Hormones|hormones|mesh-ancestor
139364332|NCT05964920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139364333|NCT05964920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364334|NCT05964920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139364335|NCT05964920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364336|NCT05964920|Anabolic Agents|anabolic agents|mesh-ancestor
139364337|NCT05950724|Etanercept|etanercept|mesh-list
139364338|NCT05950724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139364339|NCT05950724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139364340|NCT05950724|Analgesics|analgesics|mesh-ancestor
139364341|NCT05950724|Sensory System Agents|sensory system agents|mesh-ancestor
139364342|NCT05950724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364343|NCT05950724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926409|NCT00748371|Aspirin|aspirin|mesh-list
139364344|NCT05950724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139364345|NCT05950724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139364346|NCT05950724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139364347|NCT05950724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139364348|NCT05950724|Immunologic Factors|immunologic factors|mesh-ancestor
139364349|NCT05932693|Menthol|menthol|mesh-list
139364350|NCT05932693|Antipruritics|antipruritics|mesh-ancestor
139364351|NCT05932693|Dermatologic Agents|dermatologic agents|mesh-ancestor
139364352|NCT05929716|Rituximab|rituximab|mesh-list
139364353|NCT05929716|Magrolimab|magrolimab|mesh-list
139364354|NCT05929716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139364355|NCT05929716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364356|NCT05929716|Immunologic Factors|immunologic factors|mesh-ancestor
139364357|NCT05929716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364358|NCT05929716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139364359|NCT05914194|Mazindol|mazindol|mesh-list
139364360|NCT05914194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139364361|NCT05914194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364362|NCT05914194|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139364363|NCT05914194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139364364|NCT05914194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139364365|NCT05914194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364366|NCT05914194|Adrenergic Agents|adrenergic agents|mesh-ancestor
139364367|NCT05914194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364368|NCT05914194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139364369|NCT05914194|Dopamine Agents|dopamine agents|mesh-ancestor
139364370|NCT05909150|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139364371|NCT05908526|Suvorexant|suvorexant|mesh-list
139364372|NCT05908526|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139364373|NCT05908526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139364374|NCT05908526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364375|NCT05908526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364376|NCT05908526|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139364377|NCT05908526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364378|NCT05908526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364379|NCT05900284|Metformin|metformin|mesh-list
139364380|NCT05900284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139364381|NCT05900284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364382|NCT05900258|Tirbanibulin|tirbanibulin|mesh-list
139364383|NCT05900258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364384|NCT05900258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364385|NCT05893030|Anesthetics|anesthetics|mesh-list
139364386|NCT05893030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364387|NCT05893030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364388|NCT05862688|Anti-Infective Agents|anti-infective agents|mesh-list
139364389|NCT05862688|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139364390|NCT05862545|Budesonide|budesonide|mesh-list
139364391|NCT05862545|Glycopyrrolate|glycopyrrolate|mesh-list
139364392|NCT05862545|Formoterol Fumarate|formoterol fumarate|mesh-list
139364393|NCT05862545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139364394|NCT05862545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139364395|NCT05862545|Autonomic Agents|autonomic agents|mesh-ancestor
139364396|NCT05862545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364397|NCT05862545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364398|NCT05862545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139364399|NCT05862545|Respiratory System Agents|respiratory system agents|mesh-ancestor
139364400|NCT05862545|Glucocorticoids|glucocorticoids|mesh-ancestor
139364401|NCT05862545|Hormones|hormones|mesh-ancestor
139364402|NCT05862545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139364403|NCT05862545|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139364404|NCT05862545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139364405|NCT05862545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139364406|NCT05862545|Adrenergic Agents|adrenergic agents|mesh-ancestor
139364407|NCT05862545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364408|NCT05862545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364409|NCT05862545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139364410|NCT05862545|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139364411|NCT05862545|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139364412|NCT05862545|Cholinergic Agents|cholinergic agents|mesh-ancestor
139364413|NCT05833867|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139364414|NCT05833867|Immunoconjugates|immunoconjugates|mesh-ancestor
139364415|NCT05833867|Immunologic Factors|immunologic factors|mesh-ancestor
139364416|NCT05833867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364417|NCT05824338|Bupivacaine|bupivacaine|mesh-list
139364418|NCT05824338|Ropivacaine|ropivacaine|mesh-list
139364419|NCT05824338|Anesthetics|anesthetics|mesh-list
139364420|NCT05824338|Anesthetics, Local|anesthetics, local|mesh-ancestor
139364421|NCT05824338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364422|NCT05824338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364423|NCT05824338|Sensory System Agents|sensory system agents|mesh-ancestor
139364424|NCT05824338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364425|NCT05821309|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139364426|NCT05821309|Glycerol|glycerol|mesh-list
139364427|NCT05821309|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139364428|NCT05821309|Protective Agents|protective agents|mesh-ancestor
139364429|NCT05821309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364430|NCT05821309|Laxatives|laxatives|mesh-ancestor
139364431|NCT05821309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139364432|NCT05815680|Metformin|metformin|mesh-list
139364433|NCT05815680|Digoxin|digoxin|mesh-list
139364434|NCT05815680|Warfarin|warfarin|mesh-list
139364435|NCT05815680|Atorvastatin|atorvastatin|mesh-list
139364436|NCT05815680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139364437|NCT05815680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364438|NCT05815680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139364439|NCT05815680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139364440|NCT05815680|Antimetabolites|antimetabolites|mesh-ancestor
138926437|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364441|NCT05815680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364442|NCT05815680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139364443|NCT05815680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139364444|NCT05815680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364445|NCT05815680|Anticoagulants|anticoagulants|mesh-ancestor
139364446|NCT05815680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139364447|NCT05815680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139364448|NCT05815680|Protective Agents|protective agents|mesh-ancestor
139364449|NCT05813288|Pramipexole|pramipexole|mesh-list
139364450|NCT05813288|Antioxidants|antioxidants|mesh-ancestor
139364451|NCT05813288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364452|NCT05813288|Protective Agents|protective agents|mesh-ancestor
139364453|NCT05813288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364454|NCT05813288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139364455|NCT05813288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139364456|NCT05813288|Dopamine Agonists|dopamine agonists|mesh-ancestor
139364457|NCT05813288|Dopamine Agents|dopamine agents|mesh-ancestor
139364458|NCT05813288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364459|NCT05803551|Ketamine|ketamine|mesh-list
139364460|NCT05803551|Analgesics|analgesics|mesh-ancestor
139364461|NCT05803551|Sensory System Agents|sensory system agents|mesh-ancestor
139364462|NCT05803551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364463|NCT05803551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364464|NCT05803551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139364465|NCT05803551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139364466|NCT05803551|Anesthetics, General|anesthetics, general|mesh-ancestor
139364467|NCT05803551|Anesthetics|anesthetics|mesh-ancestor
139364468|NCT05803551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364469|NCT05803551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139364470|NCT05803551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139364471|NCT05803551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364472|NCT05803551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364473|NCT05800860|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
139364474|NCT05800860|Hallucinogens|hallucinogens|mesh-ancestor
139364475|NCT05800860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364476|NCT05800860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139364477|NCT05800860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139364478|NCT05800860|Serotonin Agents|serotonin agents|mesh-ancestor
139364479|NCT05800860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364480|NCT05800860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364481|NCT05800860|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139364482|NCT05797246|Bevacizumab|bevacizumab|mesh-list
139364483|NCT05797246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139364484|NCT05797246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364485|NCT05797246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139364486|NCT05797246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139364487|NCT05797246|Growth Substances|growth substances|mesh-ancestor
139364488|NCT05797246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364489|NCT05797246|Growth Inhibitors|growth inhibitors|mesh-ancestor
139364490|NCT05789342|Itraconazole|itraconazole|mesh-list
139364491|NCT05789342|Oseltamivir|oseltamivir|mesh-list
139364492|NCT05789342|Digoxin|digoxin|mesh-list
139364493|NCT05789342|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139364494|NCT05789342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139364495|NCT05789342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139364496|NCT05789342|Antimetabolites|antimetabolites|mesh-ancestor
139364497|NCT05789342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364498|NCT05789342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139364499|NCT05789342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139364500|NCT05789342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364501|NCT05789342|Antifungal Agents|antifungal agents|mesh-ancestor
139364502|NCT05789342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139364503|NCT05789342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139364504|NCT05789342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139364505|NCT05789342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139364506|NCT05789342|Hormone Antagonists|hormone antagonists|mesh-ancestor
139364507|NCT05789342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139364508|NCT05789342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364509|NCT05789342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139364510|NCT05789342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139364511|NCT05789342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139364512|NCT05789342|Protective Agents|protective agents|mesh-ancestor
139364513|NCT05789342|Antiviral Agents|antiviral agents|mesh-ancestor
139364514|NCT05786443|Empagliflozin|empagliflozin|mesh-list
139364515|NCT05786443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139364516|NCT05786443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364517|NCT05786443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139364518|NCT05786443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364522|NCT05776823|Naloxone|naloxone|mesh-list
139364523|NCT05776823|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139364524|NCT05776823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364525|NCT05776823|Sensory System Agents|sensory system agents|mesh-ancestor
139364526|NCT05776823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364527|NCT05770531|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139364528|NCT05770531|Immunoconjugates|immunoconjugates|mesh-ancestor
139364529|NCT05770531|Immunologic Factors|immunologic factors|mesh-ancestor
139364530|NCT05770531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364531|NCT05748600|Pramipexole|pramipexole|mesh-list
139364532|NCT05748600|Antioxidants|antioxidants|mesh-ancestor
139364533|NCT05748600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364534|NCT05748600|Protective Agents|protective agents|mesh-ancestor
139364535|NCT05748600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364536|NCT05748600|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139364537|NCT05748600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139364538|NCT05748600|Dopamine Agonists|dopamine agonists|mesh-ancestor
139364539|NCT05748600|Dopamine Agents|dopamine agents|mesh-ancestor
139364540|NCT05748600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364541|NCT05742568|Amoxicillin|amoxicillin|mesh-list
139364542|NCT05742568|Clarithromycin|clarithromycin|mesh-list
139364543|NCT05742568|Esomeprazole|esomeprazole|mesh-list
139364544|NCT05742568|Bismuth|bismuth|mesh-list
139364545|NCT05742568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139364546|NCT05742568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139364547|NCT05742568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139364548|NCT05742568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139364549|NCT05742568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139364550|NCT05742568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364551|NCT05742568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364552|NCT05742568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139364553|NCT05742568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139364554|NCT05742568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139364555|NCT05742568|Antacids|antacids|mesh-ancestor
139364556|NCT05739136|Norethindrone|norethindrone|mesh-list
139364557|NCT05739136|Norethindrone Acetate|norethindrone acetate|mesh-list
139364558|NCT05739136|Estradiol|estradiol|mesh-list
139364559|NCT05739136|Relugolix|relugolix|mesh-list
139364560|NCT05739136|Estrogens|estrogens|mesh-ancestor
139364561|NCT05739136|Hormones|hormones|mesh-ancestor
139364562|NCT05739136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139364563|NCT05739136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364564|NCT05739136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139364565|NCT05739136|Contraceptive Agents|contraceptive agents|mesh-ancestor
139364566|NCT05739136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139364567|NCT05739136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139364568|NCT05739136|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139364569|NCT05739136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139364570|NCT05739136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139364571|NCT05739136|Androgen Antagonists|androgen antagonists|mesh-ancestor
139364572|NCT05739136|Hormone Antagonists|hormone antagonists|mesh-ancestor
139364573|NCT05739123|Relugolix|relugolix|mesh-list
139364574|NCT05739123|Androgen Antagonists|androgen antagonists|mesh-ancestor
139364575|NCT05739123|Hormone Antagonists|hormone antagonists|mesh-ancestor
139364576|NCT05739123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139364577|NCT05739123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364578|NCT05729594|Bimatoprost|bimatoprost|mesh-list
139364579|NCT05729594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139364580|NCT05727527|Anesthetics|anesthetics|mesh-list
139364581|NCT05727527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364582|NCT05727527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364583|NCT05727475|Fluorides|fluorides|mesh-list
139364584|NCT05727475|Cariostatic Agents|cariostatic agents|mesh-ancestor
139364585|NCT05727475|Protective Agents|protective agents|mesh-ancestor
139364586|NCT05727475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364587|NCT05722782|Acetaminophen|acetaminophen|mesh-list
139364588|NCT05722782|Piroxicam|piroxicam|mesh-list
139364589|NCT05722782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139364590|NCT05722782|Analgesics|analgesics|mesh-ancestor
139364591|NCT05722782|Sensory System Agents|sensory system agents|mesh-ancestor
139364592|NCT05722782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364593|NCT05722782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364594|NCT05722782|Antipyretics|antipyretics|mesh-ancestor
139364595|NCT05722782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139364596|NCT05722782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139364597|NCT05722782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139364598|NCT05722782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139364599|NCT05722782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364600|NCT05722782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364601|NCT05722327|Irinotecan|irinotecan|mesh-list
139364602|NCT05722327|Cetuximab|cetuximab|mesh-list
139364603|NCT05722327|Adagrasib|adagrasib|mesh-list
139364604|NCT05722327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139364605|NCT05722327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139364606|NCT05722327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364607|NCT05722327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364608|NCT05722327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364609|NCT05722327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139364610|NCT05708755|Valganciclovir|valganciclovir|mesh-list
139364611|NCT05708755|Antiviral Agents|antiviral agents|mesh-ancestor
139364612|NCT05708755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139364613|NCT05685394|Dapagliflozin|dapagliflozin|mesh-list
139364614|NCT05685394|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139364615|NCT05685394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364616|NCT05685394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139364617|NCT05685394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364618|NCT05677633|Sargramostim|sargramostim|mesh-list
139364619|NCT05677633|Immunologic Factors|immunologic factors|mesh-ancestor
139364620|NCT05677633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364621|NCT05676476|Antihypertensive Agents|antihypertensive agents|mesh-list
139364622|NCT05670106|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139364623|NCT05670106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139364624|NCT05670106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364625|NCT05668091|Ritonavir|ritonavir|mesh-list
139364626|NCT05668091|Nirmatrelvir|nirmatrelvir|mesh-list
139364627|NCT05668091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139364628|NCT05668091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139364629|NCT05668091|Protease Inhibitors|protease inhibitors|mesh-ancestor
139364630|NCT05668091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364631|NCT05668091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364632|NCT05668091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139364633|NCT05668091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139364634|NCT05668091|Antiviral Agents|antiviral agents|mesh-ancestor
139364635|NCT05668091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139364636|NCT05668091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139364637|NCT05668091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139364638|NCT05667727|Epinephrine|epinephrine|mesh-list
139364639|NCT05667727|Albuterol|albuterol|mesh-list
139364640|NCT05667727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139364641|NCT05667727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139364642|NCT05667727|Adrenergic Agents|adrenergic agents|mesh-ancestor
139364643|NCT05667727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364644|NCT05667727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364645|NCT05667727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364646|NCT05667727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139364647|NCT05667727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139364648|NCT05667727|Autonomic Agents|autonomic agents|mesh-ancestor
139364649|NCT05667727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364650|NCT05667727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139364651|NCT05667727|Respiratory System Agents|respiratory system agents|mesh-ancestor
139183533|NCT01297855|Rifampin|rifampin|mesh-list
139364652|NCT05667727|Mydriatics|mydriatics|mesh-ancestor
139364653|NCT05667727|Sympathomimetics|sympathomimetics|mesh-ancestor
139364654|NCT05667727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139364655|NCT05667727|Tocolytic Agents|tocolytic agents|mesh-ancestor
139364656|NCT05667727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139364657|NCT05667727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139364658|NCT05649085|Cobalt|cobalt|mesh-list
139364659|NCT05649085|Chromium|chromium|mesh-list
139364660|NCT05649085|Trace Elements|trace elements|mesh-ancestor
139364661|NCT05649085|Micronutrients|micronutrients|mesh-ancestor
139364662|NCT05649085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364663|NCT05637567|Aspirin|aspirin|mesh-list
139364664|NCT05637567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139364665|NCT05637567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139364666|NCT05637567|Analgesics|analgesics|mesh-ancestor
139364667|NCT05637567|Sensory System Agents|sensory system agents|mesh-ancestor
139364668|NCT05637567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364669|NCT05637567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364670|NCT05637567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139364671|NCT05637567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139364672|NCT05637567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139364673|NCT05637567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139364674|NCT05637567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364675|NCT05637567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139364676|NCT05637567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139364677|NCT05637567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364678|NCT05637567|Antipyretics|antipyretics|mesh-ancestor
139364679|NCT05630638|Dolutegravir|dolutegravir|mesh-list
139364680|NCT05630638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139364681|NCT05630638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139364682|NCT05630638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364683|NCT05630638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364684|NCT05630638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139364685|NCT05630638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139364686|NCT05630638|Antiviral Agents|antiviral agents|mesh-ancestor
139364687|NCT05630638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139364688|NCT05618002|Clonidine|clonidine|mesh-list
139364689|NCT05618002|Lemborexant|lemborexant|mesh-list
139364690|NCT05618002|Zopiclone|zopiclone|mesh-list
139364691|NCT05618002|Analgesics|analgesics|mesh-ancestor
139364692|NCT05618002|Sensory System Agents|sensory system agents|mesh-ancestor
139364693|NCT05618002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364694|NCT05618002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364695|NCT05618002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139364696|NCT05618002|Sympatholytics|sympatholytics|mesh-ancestor
139364697|NCT05618002|Autonomic Agents|autonomic agents|mesh-ancestor
139364698|NCT05618002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139364699|NCT05618002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139364700|NCT05618002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139364701|NCT05618002|Adrenergic Agents|adrenergic agents|mesh-ancestor
139364702|NCT05618002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364703|NCT05618002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364704|NCT05618002|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139364705|NCT05618002|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139364706|NCT05618002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139364707|NCT05618002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364708|NCT05585034|Pembrolizumab|pembrolizumab|mesh-list
139364709|NCT05585034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139364710|NCT05585034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364711|NCT05585034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139364712|NCT05585034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364713|NCT05579769|Cyclosporine|cyclosporine|mesh-list
139364714|NCT05579769|Cyclophosphamide|cyclophosphamide|mesh-list
139364715|NCT05579769|Busulfan|busulfan|mesh-list
139364716|NCT05579769|Thiotepa|thiotepa|mesh-list
139364717|NCT05579769|Methotrexate|methotrexate|mesh-list
139364718|NCT05579769|Fludarabine|fludarabine|mesh-list
139364719|NCT05579769|Cyclosporins|cyclosporins|mesh-list
139364720|NCT05579769|Thymoglobulin|thymoglobulin|mesh-list
139364721|NCT05579769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139364722|NCT05579769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139364723|NCT05579769|Immunologic Factors|immunologic factors|mesh-ancestor
139364724|NCT05579769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364725|NCT05579769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139364726|NCT05579769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139364727|NCT05579769|Alkylating Agents|alkylating agents|mesh-ancestor
139364728|NCT05579769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364729|NCT05579769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364730|NCT05579769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139364731|NCT05579769|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139364732|NCT05579769|Abortifacient Agents|abortifacient agents|mesh-ancestor
139364733|NCT05579769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139364734|NCT05579769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139364735|NCT05579769|Antimetabolites|antimetabolites|mesh-ancestor
138926539|NCT00755859|Hormones|hormones|mesh-ancestor
139364736|NCT05579769|Dermatologic Agents|dermatologic agents|mesh-ancestor
139364737|NCT05579769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364738|NCT05579769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139364739|NCT05579769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139364740|NCT05579769|Antifungal Agents|antifungal agents|mesh-ancestor
139364741|NCT05579769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139364742|NCT05579769|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139364743|NCT05562999|Bromides|bromides|mesh-list
139364744|NCT05562999|Rocuronium|rocuronium|mesh-list
139364745|NCT05562999|Anticonvulsants|anticonvulsants|mesh-ancestor
139364746|NCT05562999|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139364747|NCT05562999|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139364748|NCT05562999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139364749|NCT05562999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364750|NCT05562999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364751|NCT05515874|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139364752|NCT05515874|Hematinics|hematinics|mesh-ancestor
139364753|NCT05515874|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139364754|NCT05515874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139364755|NCT05507658|Capecitabine|capecitabine|mesh-list
139364756|NCT05507658|Oxaliplatin|oxaliplatin|mesh-list
139364757|NCT05507658|Tislelizumab|tislelizumab|mesh-list
139364758|NCT05507658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139364759|NCT05507658|Antimetabolites|antimetabolites|mesh-ancestor
139364760|NCT05507658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364761|NCT05507658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364762|NCT05507658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139364763|NCT05478720|Diazooxonorleucine|diazooxonorleucine|mesh-list
139364764|NCT05478720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139364765|NCT05478720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364766|NCT05478720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139364767|NCT05478720|Antimetabolites|antimetabolites|mesh-ancestor
139364768|NCT05478720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364769|NCT05472792|Tamoxifen|tamoxifen|mesh-list
139364770|NCT05472792|Toremifene|toremifene|mesh-list
139364771|NCT05472792|Letrozole|letrozole|mesh-list
139364772|NCT05472792|Fulvestrant|fulvestrant|mesh-list
139364773|NCT05472792|Anastrozole|anastrozole|mesh-list
139364774|NCT05472792|Exemestane|exemestane|mesh-list
139364775|NCT05472792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364776|NCT05472792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139364777|NCT05472792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139364778|NCT05472792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364779|NCT05472792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364780|NCT05472792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139364781|NCT05472792|Hormone Antagonists|hormone antagonists|mesh-ancestor
139364782|NCT05472792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139364783|NCT05472792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364784|NCT05472792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139364785|NCT05472792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139364786|NCT05472792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139364787|NCT05472792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139364788|NCT05472792|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139364789|NCT05463783|Tenofovir|tenofovir|mesh-list
139364790|NCT05463783|Emtricitabine|emtricitabine|mesh-list
139364791|NCT05463783|Darunavir|darunavir|mesh-list
139364792|NCT05463783|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139364793|NCT05463783|Cobicistat|cobicistat|mesh-list
139364794|NCT05463783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139364795|NCT05463783|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139364796|NCT05463783|Antiviral Agents|antiviral agents|mesh-ancestor
139364797|NCT05463783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139364798|NCT05463783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139364799|NCT05463783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139364800|NCT05463783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364801|NCT05463783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364802|NCT05463783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139364803|NCT05463783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139364804|NCT05463783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139364805|NCT05463783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139364806|NCT05463783|Protease Inhibitors|protease inhibitors|mesh-ancestor
139364807|NCT05463783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139364808|NCT05463783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139364809|NCT05463224|Lazertinib|lazertinib|mesh-list
139364810|NCT05463224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139364811|NCT05463224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364812|NCT05463224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364813|NCT05461794|Docetaxel|docetaxel|mesh-list
139364814|NCT05461794|Irinotecan|irinotecan|mesh-list
139364815|NCT05461794|Tislelizumab|tislelizumab|mesh-list
139364816|NCT05461794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364817|NCT05461794|Tubulin Modulators|tubulin modulators|mesh-ancestor
139364818|NCT05461794|Antimitotic Agents|antimitotic agents|mesh-ancestor
139364819|NCT05461794|Mitosis Modulators|mitosis modulators|mesh-ancestor
139364820|NCT05461794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364821|NCT05461794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139364822|NCT05461794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139364823|NCT05461794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364824|NCT05461794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139364825|NCT05429762|Maytansine|maytansine|mesh-list
139364826|NCT05429762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139364827|NCT05429762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364828|NCT05429762|Tubulin Modulators|tubulin modulators|mesh-ancestor
139364829|NCT05429762|Antimitotic Agents|antimitotic agents|mesh-ancestor
139364830|NCT05429762|Mitosis Modulators|mitosis modulators|mesh-ancestor
139364831|NCT05429762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364832|NCT05427981|Buprenorphine|buprenorphine|mesh-list
139364833|NCT05427981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139364834|NCT05427981|Narcotics|narcotics|mesh-ancestor
139364835|NCT05427981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364836|NCT05427981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364837|NCT05427981|Analgesics|analgesics|mesh-ancestor
139364838|NCT05427981|Sensory System Agents|sensory system agents|mesh-ancestor
139364839|NCT05427981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364840|NCT05427981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139364841|NCT05424315|Dapagliflozin|dapagliflozin|mesh-list
139364842|NCT05424315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139364843|NCT05424315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364844|NCT05424315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139364845|NCT05424315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364850|NCT05419466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364851|NCT05419466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139364852|NCT05400915|Paclitaxel|paclitaxel|mesh-list
139364853|NCT05400915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139364854|NCT05400915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364855|NCT05400915|Tubulin Modulators|tubulin modulators|mesh-ancestor
139364856|NCT05400915|Antimitotic Agents|antimitotic agents|mesh-ancestor
139364857|NCT05400915|Mitosis Modulators|mitosis modulators|mesh-ancestor
139364858|NCT05400915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364859|NCT05391230|Permethrin|permethrin|mesh-list
139364860|NCT05391230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364861|NCT05391230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364862|NCT05386706|Metformin|metformin|mesh-list
139364863|NCT05386706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139364864|NCT05386706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364865|NCT05376319|Rituximab|rituximab|mesh-list
139364866|NCT05376319|Obinutuzumab|obinutuzumab|mesh-list
139364867|NCT05376319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021765|NCT03742258|Hormones|hormones|mesh-ancestor
139364868|NCT05376319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364869|NCT05376319|Immunologic Factors|immunologic factors|mesh-ancestor
139364870|NCT05376319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364871|NCT05376319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139364878|NCT05367271|Dexamethasone|dexamethasone|mesh-list
139364879|NCT05367271|Cortisone|cortisone|mesh-list
139364880|NCT05367271|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139364881|NCT05367271|Botulinum Toxins|botulinum toxins|mesh-list
139364882|NCT05367271|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139364883|NCT05367271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139364884|NCT05367271|Antiemetics|antiemetics|mesh-ancestor
139364885|NCT05367271|Autonomic Agents|autonomic agents|mesh-ancestor
139364886|NCT05367271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364887|NCT05367271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364888|NCT05367271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139364889|NCT05367271|Glucocorticoids|glucocorticoids|mesh-ancestor
139364890|NCT05367271|Hormones|hormones|mesh-ancestor
139364891|NCT05367271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139364892|NCT05367271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139364893|NCT05367271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364894|NCT05367271|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139364895|NCT05367271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139364896|NCT05367271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364897|NCT05367271|Cholinergic Agents|cholinergic agents|mesh-ancestor
139364898|NCT05367271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364899|NCT05367271|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139364900|NCT05322473|Adalimumab|adalimumab|mesh-list
139364901|NCT05322473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139364902|NCT05322473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139364903|NCT05322473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139364904|NCT05316220|Mesalamine|mesalamine|mesh-list
139364905|NCT05316220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139364906|NCT05316220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139364907|NCT05316220|Analgesics|analgesics|mesh-ancestor
139364908|NCT05316220|Sensory System Agents|sensory system agents|mesh-ancestor
139364909|NCT05316220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364910|NCT05316220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364911|NCT05316220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139364912|NCT05316220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139364913|NCT05311085|Nicotine|nicotine|mesh-list
139183569|NCT01221935|Serotonin Agents|serotonin agents|mesh-ancestor
139364914|NCT05311085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139364916|NCT05311085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364917|NCT05311085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364918|NCT05311085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139364919|NCT05311085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139364920|NCT05311085|Cholinergic Agents|cholinergic agents|mesh-ancestor
139364921|NCT05311085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364922|NCT05311085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364923|NCT05304390|Carbon Monoxide|carbon monoxide|mesh-list
139364924|NCT05304390|Antimetabolites|antimetabolites|mesh-ancestor
139364925|NCT05304390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364926|NCT05304390|Gasotransmitters|gasotransmitters|mesh-ancestor
139364927|NCT05304390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364928|NCT05304390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364929|NCT05289908|Folic Acid|folic acid|mesh-list
139364930|NCT05289908|Vitamin B 12|vitamin b 12|mesh-list
139364931|NCT05289908|Dexamethasone|dexamethasone|mesh-list
139364932|NCT05289908|Pemetrexed|pemetrexed|mesh-list
139364933|NCT05289908|Vitamins|vitamins|mesh-ancestor
139364934|NCT05289908|Micronutrients|micronutrients|mesh-ancestor
139364935|NCT05289908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364936|NCT05289908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139364937|NCT05289908|Antiemetics|antiemetics|mesh-ancestor
139364938|NCT05289908|Autonomic Agents|autonomic agents|mesh-ancestor
139364939|NCT05289908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139364940|NCT05289908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139364941|NCT05289908|Glucocorticoids|glucocorticoids|mesh-ancestor
139364942|NCT05289908|Hormones|hormones|mesh-ancestor
139364943|NCT05289908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139364944|NCT05289908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139364945|NCT05289908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364946|NCT05289908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364947|NCT05289908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364948|NCT05289908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139364949|NCT05289908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139364951|NCT05289908|Vitamin B Complex|vitamin b complex|mesh-ancestor
139364952|NCT05272384|Nivolumab|nivolumab|mesh-list
139364953|NCT05272384|Decitabine|decitabine|mesh-list
139364954|NCT05272384|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139364955|NCT05272384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139364956|NCT05272384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364957|NCT05272384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139364958|NCT05272384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364959|NCT05272384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139364960|NCT05272384|Antimetabolites|antimetabolites|mesh-ancestor
139364961|NCT05272384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364962|NCT05267054|Rituximab|rituximab|mesh-list
139364963|NCT05267054|Tislelizumab|tislelizumab|mesh-list
139364964|NCT05267054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139364965|NCT05267054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364966|NCT05267054|Immunologic Factors|immunologic factors|mesh-ancestor
139364967|NCT05267054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364968|NCT05267054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139364969|NCT05265208|Capecitabine|capecitabine|mesh-list
139364970|NCT05265208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139364971|NCT05265208|Antimetabolites|antimetabolites|mesh-ancestor
139364972|NCT05265208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364973|NCT05265208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364974|NCT05264025|Fexofenadine|fexofenadine|mesh-list
139364975|NCT05264025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139364976|NCT05264025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139364977|NCT05264025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139364978|NCT05264025|Histamine Antagonists|histamine antagonists|mesh-ancestor
139364979|NCT05264025|Histamine Agents|histamine agents|mesh-ancestor
139364980|NCT05264025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139364981|NCT05264025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926608|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
139364982|NCT05264025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139364983|NCT05219877|Levofloxacin|levofloxacin|mesh-list
139364984|NCT05219877|Ofloxacin|ofloxacin|mesh-list
139364985|NCT05219877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139364986|NCT05219877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139364987|NCT05219877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139364988|NCT05219877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139364989|NCT05219877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139364990|NCT05219877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139364991|NCT05219877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139364992|NCT05219877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139364993|NCT05219877|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139364994|NCT05219877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139364995|NCT05199051|Cytarabine|cytarabine|mesh-list
139364996|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
139364997|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139364998|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
139364999|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365000|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365001|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
139365002|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139365003|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139365004|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
139365005|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365006|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365007|NCT05199051|Immunotoxins|immunotoxins|mesh-ancestor
139365008|NCT05199051|Immunoconjugates|immunoconjugates|mesh-ancestor
139365009|NCT05188053|Ketorolac|ketorolac|mesh-list
139365010|NCT05188053|Epinephrine|epinephrine|mesh-list
139365011|NCT05188053|Ropivacaine|ropivacaine|mesh-list
139365012|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
139365013|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
139365014|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139365015|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365016|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
139365017|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365018|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139365019|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139365020|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
139365021|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365022|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365023|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139365024|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139365025|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
139365026|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139365027|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
139365028|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
139365029|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
139365030|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139365031|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139365032|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139365033|NCT05188053|Analgesics|analgesics|mesh-ancestor
139365034|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139365035|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139365036|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139365037|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365038|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
138926624|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
139365039|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365040|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365041|NCT05141357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365042|NCT05141357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365043|NCT05141149|Gemcitabine|gemcitabine|mesh-list
139365044|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139365045|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
139365046|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365047|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365059|NCT05137184|Fentanyl|fentanyl|mesh-list
139365060|NCT05137184|Morphine|morphine|mesh-list
139365061|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
139365062|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139365063|NCT05137184|Narcotics|narcotics|mesh-ancestor
139365064|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139365065|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365066|NCT05137184|Analgesics|analgesics|mesh-ancestor
139365067|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
139365068|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365069|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139365070|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139365071|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
139365072|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
139365073|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139365074|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
139365075|NCT05059626|Simvastatin|simvastatin|mesh-list
139365076|NCT05059626|Estrogens|estrogens|mesh-list
139365077|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139365078|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139365079|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
139365080|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365081|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139365082|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139365083|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365084|NCT05059626|Hormones|hormones|mesh-ancestor
139365085|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139365086|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365087|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139365088|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139365089|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
139365090|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139365091|NCT05052827|Caseins|caseins|mesh-list
139365092|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
139365093|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
139365094|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365096|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
139365097|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365098|NCT05034627|Asparaginase|asparaginase|mesh-list
139365099|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365100|NCT05033041|Metoclopramide|metoclopramide|mesh-list
139365101|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
139365102|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
139365103|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365104|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365105|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139365106|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139365107|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139365108|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
139365109|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365110|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365111|NCT05031780|Mitapivat|mitapivat|mesh-list
139365112|NCT05031780|Enzyme Activators|enzyme activators|mesh-ancestor
139365113|NCT05031780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365114|NCT04976816|Triamcinolone|triamcinolone|mesh-list
139365115|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139365116|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139365117|NCT04976816|Betamethasone|betamethasone|mesh-list
139365118|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
139365119|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139365120|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
139365121|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139365122|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139365123|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139365124|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
139365125|NCT04976816|Hormones|hormones|mesh-ancestor
139365126|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139365127|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365128|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139365129|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
139365130|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365131|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365132|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139365133|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
139365134|NCT04971356|Aspirin|aspirin|mesh-list
139365135|NCT04971356|Ticagrelor|ticagrelor|mesh-list
139365136|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139365137|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139365138|NCT04971356|Analgesics|analgesics|mesh-ancestor
139365139|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
139365140|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365141|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365142|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139365143|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139365144|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139365145|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139365146|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365147|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139365148|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139365149|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365150|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
139365151|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139365152|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139365153|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139365154|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
139365155|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365156|NCT04965701|Osimertinib|osimertinib|mesh-list
139365157|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365158|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139365159|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365160|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365161|NCT04961593|Caspofungin|caspofungin|mesh-list
139365162|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
139365163|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139365164|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365165|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365166|NCT04961580|Ceftazidime|ceftazidime|mesh-list
139022062|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
139365167|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139365168|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139365170|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139365171|NCT04961190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139365172|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139365173|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139365174|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365175|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365176|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
139365177|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365178|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139365179|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
139365180|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139365181|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139365182|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139365183|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365184|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139365185|NCT04952597|Tislelizumab|tislelizumab|mesh-list
139365186|NCT04952597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365187|NCT04952597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365188|NCT04952129|Selenium|selenium|mesh-list
139365189|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
139365190|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
139365191|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365192|NCT04952129|Protective Agents|protective agents|mesh-ancestor
139365193|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365194|NCT04952129|Trace Elements|trace elements|mesh-ancestor
139365195|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
139365196|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139365197|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365199|NCT04947085|Analgesics|analgesics|mesh-ancestor
139365200|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
139365201|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365202|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365203|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139365204|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139365205|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
139365206|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
139365207|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139365208|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139365209|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139365210|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365211|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365212|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
139365213|NCT04941703|Cathartics|cathartics|mesh-ancestor
138926674|NCT00715676|Vitamins|vitamins|mesh-ancestor
139365214|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139365215|NCT04903002|Oxytocin|oxytocin|mesh-list
139365216|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
139365217|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139365218|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365219|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
139365220|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139365221|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
139365222|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139365228|NCT04850222|Fluoxetine|fluoxetine|mesh-list
139365229|NCT04850222|Calcium|calcium|mesh-list
139365230|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139365231|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365232|NCT04850222|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139365233|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139365234|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139365235|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365236|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365237|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
139365238|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139365239|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
139365240|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139365241|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139365242|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139365243|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365244|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
139365245|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139365246|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
139365247|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139365248|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139365249|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139365250|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
139365251|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365252|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365253|NCT04811027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365254|NCT04811027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365255|NCT04762888|Edetic Acid|edetic acid|mesh-list
139365256|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139365257|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
139365258|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
139365259|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365260|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
139365261|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139365262|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139365263|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
139365264|NCT04740814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139365265|NCT04740814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139365266|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139365267|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
139365268|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365269|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139365270|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
139365271|NCT04740307|Lenvatinib|lenvatinib|mesh-list
139365272|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365273|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365274|NCT04740307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365275|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365276|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139365277|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365278|NCT04735549|Hormones|hormones|mesh-list
139365279|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139365280|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365281|NCT04732286|Bevacizumab|bevacizumab|mesh-list
139365282|NCT04732286|Atezolizumab|atezolizumab|mesh-list
139365283|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365284|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365285|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139365286|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139365287|NCT04732286|Growth Substances|growth substances|mesh-ancestor
139365288|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365289|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
139365290|NCT04732286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365291|NCT04732286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365292|NCT04728230|Carboplatin|carboplatin|mesh-list
139365293|NCT04728230|Etoposide|etoposide|mesh-list
139365294|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
139365295|NCT04728230|Durvalumab|durvalumab|mesh-list
139365296|NCT04728230|Olaparib|olaparib|mesh-list
139365297|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
139365298|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
139365299|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139365300|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
139365301|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365302|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139365303|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139365304|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139365305|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365306|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365307|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365308|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
139365309|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365310|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139365311|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
139365312|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
139365313|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
139365314|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
139365315|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
139365316|NCT04727424|Budesonide|budesonide|mesh-list
139365317|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
139365318|NCT04727424|Fluoxetine|fluoxetine|mesh-list
139365319|NCT04727424|Maleic acid|maleic acid|mesh-list
139365320|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139365321|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139365322|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
139365323|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365324|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365325|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139365326|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
139365327|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
139365328|NCT04727424|Hormones|hormones|mesh-ancestor
139365329|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139365330|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365331|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365332|NCT04727424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139365333|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139365334|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139365335|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365337|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139365338|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
139365339|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139365340|NCT04727424|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139365341|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139365342|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139365343|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139365344|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139365345|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139365346|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139365347|NCT04725656|Nicotine|nicotine|mesh-list
139365348|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139365349|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
139365350|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365351|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365352|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139365353|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139365354|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
139365355|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365356|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365357|NCT04718415|Paclitaxel|paclitaxel|mesh-list
139365358|NCT04718415|Carboplatin|carboplatin|mesh-list
139365359|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139365360|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365361|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
139365362|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
139365363|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
139365364|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365365|NCT04711252|Palbociclib|palbociclib|mesh-list
139365366|NCT04711252|Anastrozole|anastrozole|mesh-list
139365367|NCT04711252|Hormones|hormones|mesh-list
139365368|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139365369|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139365370|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365371|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365372|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139365373|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365374|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365375|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139365376|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139365377|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139365378|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139365379|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
139365380|NCT04697602|Colchicine|colchicine|mesh-list
139365381|NCT04697602|Febuxostat|febuxostat|mesh-list
139365382|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
139365383|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139365384|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
139365385|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
139365386|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
139365387|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365388|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365389|NCT04688151|Rituximab|rituximab|mesh-list
139365390|NCT04688151|Durvalumab|durvalumab|mesh-list
139365391|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
139365392|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365393|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365394|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
139365395|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365396|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139365397|NCT04638686|Lamivudine|lamivudine|mesh-list
139365398|NCT04638686|Dolutegravir|dolutegravir|mesh-list
139365399|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139365400|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139365401|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365402|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365403|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
139365404|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139365405|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139365406|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139365407|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139365408|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139365409|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139365410|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139365411|NCT04590404|Nicotine|nicotine|mesh-list
139365412|NCT04590404|Varenicline|varenicline|mesh-list
139365413|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139365414|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
139365415|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365416|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365417|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139365418|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139365419|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
139365420|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365421|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365422|NCT04577755|Thalidomide|thalidomide|mesh-list
139365423|NCT04577755|Pomalidomide|pomalidomide|mesh-list
139365424|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
139365425|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365426|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139365427|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139365428|NCT04577755|Growth Substances|growth substances|mesh-ancestor
139365429|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
139365430|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365431|NCT04577755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139365432|NCT04577755|Leprostatic Agents|leprostatic agents|mesh-ancestor
139365433|NCT04577755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139365434|NCT04577755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139365435|NCT04571619|Buprenorphine|buprenorphine|mesh-list
139365436|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139365437|NCT04571619|Narcotics|narcotics|mesh-ancestor
139365438|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139365439|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365440|NCT04571619|Analgesics|analgesics|mesh-ancestor
139365441|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
139365442|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365443|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139365444|NCT04561362|Pembrolizumab|pembrolizumab|mesh-list
139365445|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365446|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365447|NCT04561362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365448|NCT04561362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365449|NCT04544683|Dexamethasone|dexamethasone|mesh-list
139365450|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
139365451|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139365452|NCT04544683|BB 1101|bb 1101|mesh-list
139365453|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139365454|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
138926747|NCT04056039|Colchicine|colchicine|mesh-list
139365455|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
139365456|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365457|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365458|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139365459|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
139365460|NCT04544683|Hormones|hormones|mesh-ancestor
139365461|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139365462|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139365463|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365464|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
139365465|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365466|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365467|NCT04519164|Eplerenone|eplerenone|mesh-list
139365468|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
139365469|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139365470|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
139365471|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139365472|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365473|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139365474|NCT04519164|Diuretics|diuretics|mesh-ancestor
139365475|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
139365476|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139365477|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139365478|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139365479|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365480|NCT04509674|Empagliflozin|empagliflozin|mesh-list
139365481|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139365482|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365483|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139365484|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365485|NCT04486716|Ofatumumab|ofatumumab|mesh-list
139365486|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365487|NCT04447352|Leucovorin|leucovorin|mesh-list
139365488|NCT04447352|Docetaxel|docetaxel|mesh-list
139365489|NCT04447352|Fluorouracil|fluorouracil|mesh-list
139365490|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
139365491|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365492|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
139365493|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
139365494|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
139365495|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365496|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
139365497|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139365498|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139365499|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
139365500|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365501|NCT04447352|Antidotes|antidotes|mesh-ancestor
139365502|NCT04447352|Protective Agents|protective agents|mesh-ancestor
139365503|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
139365504|NCT04447352|Vitamins|vitamins|mesh-ancestor
139365505|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
139365506|NCT04435600|Ustekinumab|ustekinumab|mesh-list
139365507|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
139365508|NCT04420351|Aspirin|aspirin|mesh-list
139365509|NCT04420351|Clopidogrel|clopidogrel|mesh-list
139365510|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139365511|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139365512|NCT04420351|Analgesics|analgesics|mesh-ancestor
139365513|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
139365514|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365515|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365516|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139365517|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139365518|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139365519|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139365520|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365521|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139365522|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139365523|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365524|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
139365525|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139365526|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139365527|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139365528|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
139365529|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365530|NCT04396496|Daratumumab|daratumumab|mesh-list
139365531|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365532|NCT04375267|Olaparib|olaparib|mesh-list
139365533|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139365534|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139365535|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365536|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365537|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365538|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139022449|NCT00609167|Hormones|hormones|mesh-ancestor
139365539|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
139365540|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365541|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365542|NCT04332653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365543|NCT04332653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365544|NCT04329806|Amlodipine|amlodipine|mesh-list
139365545|NCT04329806|Moxonidine|moxonidine|mesh-list
139365546|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139365547|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139365548|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139365549|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365550|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139365551|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365552|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
139365553|NCT04325217|Nintedanib|nintedanib|mesh-list
139365554|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365555|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139365556|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365557|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365558|NCT04324840|Temozolomide|temozolomide|mesh-list
139365559|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139365560|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
139365561|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365562|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365563|NCT04314895|Paclitaxel|paclitaxel|mesh-list
139365564|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139365565|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139365566|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365567|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
139365568|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
139365569|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
139365570|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365571|NCT04310176|Bevacizumab|bevacizumab|mesh-list
139365572|NCT04310176|Capecitabine|capecitabine|mesh-list
139365573|NCT04310176|Fluorouracil|fluorouracil|mesh-list
139365574|NCT04310176|Valproic Acid|valproic acid|mesh-list
139365575|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365576|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365577|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139365578|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139365579|NCT04310176|Growth Substances|growth substances|mesh-ancestor
139365580|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365581|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
139365582|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139365583|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
139365584|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365585|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139365586|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
139365587|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
139365588|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365589|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
139365590|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365591|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
139365592|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139365593|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139365594|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139365595|NCT04296175|Paclitaxel|paclitaxel|mesh-list
139365596|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139365597|NCT04296175|Carboplatin|carboplatin|mesh-list
139365598|NCT04296175|Epirubicin|epirubicin|mesh-list
139365599|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139365600|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365601|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
139365602|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
139365603|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
139365604|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365605|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139365606|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139365607|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139365608|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365609|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
139365611|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139365612|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
139365613|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139365614|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365615|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139365617|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139365618|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139365619|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365620|NCT04260854|Bupivacaine|bupivacaine|mesh-list
139365621|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
139365622|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
138926786|NCT00919178|Vaccines|vaccines|mesh-list
139365623|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139365624|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365625|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
139365626|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365627|NCT04246086|Lenalidomide|lenalidomide|mesh-list
139365628|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
139365629|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365630|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139365631|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139365632|NCT04246086|Growth Substances|growth substances|mesh-ancestor
139365633|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
139365634|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365635|NCT04226248|Rivastigmine|rivastigmine|mesh-list
139365636|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139365637|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365638|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365639|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
139365640|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365641|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365642|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139365643|NCT04226248|Protective Agents|protective agents|mesh-ancestor
139365644|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
139365645|NCT04208347|Apatinib|apatinib|mesh-list
139365646|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365647|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139365648|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365649|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365650|NCT04194203|Paclitaxel|paclitaxel|mesh-list
139365651|NCT04194203|Bevacizumab|bevacizumab|mesh-list
139365652|NCT04194203|Carboplatin|carboplatin|mesh-list
139365653|NCT04194203|Pemetrexed|pemetrexed|mesh-list
139365654|NCT04194203|Atezolizumab|atezolizumab|mesh-list
139365655|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139365656|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365657|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
139365658|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
139365659|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
139365660|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365661|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365662|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139365663|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139365664|NCT04194203|Growth Substances|growth substances|mesh-ancestor
139365665|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365666|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
139365667|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365668|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139365669|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139365670|NCT04194203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365671|NCT04179019|Amlodipine|amlodipine|mesh-list
139365672|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139365673|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139365674|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139365675|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926831|NCT02590016|Insulin|insulin|mesh-list
139365676|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139365677|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365678|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
139365679|NCT04165070|Paclitaxel|paclitaxel|mesh-list
139365680|NCT04165070|Carboplatin|carboplatin|mesh-list
138446089|NCT01842230|Niacin|niacin|mesh-list
139365681|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
139365682|NCT04165070|Pemetrexed|pemetrexed|mesh-list
139365683|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139365684|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365685|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
139365686|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
139365687|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
139022593|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
139365688|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365689|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365690|NCT04165070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365691|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365692|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139365693|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139365694|NCT04153136|Valsartan|valsartan|mesh-list
139365695|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139365696|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139365697|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139365698|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139365699|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365700|NCT04103489|Eculizumab|eculizumab|mesh-list
139365701|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139365702|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139365703|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
139365704|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365705|NCT04099355|Dronabinol|dronabinol|mesh-list
139365706|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
139365707|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365708|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139365709|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139365710|NCT04099355|Analgesics|analgesics|mesh-ancestor
139365711|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
139365712|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365713|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139365714|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139365715|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365716|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365717|NCT04099355|Hormones|hormones|mesh-ancestor
139365718|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139365719|NCT04099251|Nivolumab|nivolumab|mesh-list
139365720|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365721|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365722|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365723|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365724|NCT04070573|Aspirin|aspirin|mesh-list
139365725|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139365726|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139365727|NCT04070573|Analgesics|analgesics|mesh-ancestor
139365728|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
139365729|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365730|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365731|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139365732|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139365733|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139365734|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139365735|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365736|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139365737|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139365738|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365739|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
139365740|NCT04068753|Niraparib|niraparib|mesh-list
139365741|NCT04068753|Dostarlimab|dostarlimab|mesh-list
139365742|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139365743|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365744|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365745|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365746|NCT04066491|Gemcitabine|gemcitabine|mesh-list
139365747|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365748|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139365749|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
139365750|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365751|NCT04062266|Azacitidine|azacitidine|mesh-list
139365753|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139365754|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
139365755|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365756|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365757|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365758|NCT04045665|Anticoagulants|anticoagulants|mesh-list
139365759|NCT04034459|Leucovorin|leucovorin|mesh-list
139365760|NCT04034459|Folic Acid|folic acid|mesh-list
139365761|NCT04034459|Bevacizumab|bevacizumab|mesh-list
139365762|NCT04034459|Cetuximab|cetuximab|mesh-list
139365763|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
139365764|NCT04034459|Irinotecan|irinotecan|mesh-list
139365765|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
139365766|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365767|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365768|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139365769|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139365770|NCT04034459|Growth Substances|growth substances|mesh-ancestor
139365771|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365772|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
139365773|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139365774|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139365775|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365776|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365777|NCT04034459|Antidotes|antidotes|mesh-ancestor
139365778|NCT04034459|Protective Agents|protective agents|mesh-ancestor
139365779|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
139365780|NCT04034459|Vitamins|vitamins|mesh-ancestor
139365781|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
139365782|NCT04034459|Hematinics|hematinics|mesh-ancestor
139365783|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139365784|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
139365785|NCT04023227|Valsartan|valsartan|mesh-list
139365786|NCT04023227|Enalapril|enalapril|mesh-list
139365787|NCT04023227|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139365788|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139365789|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139365790|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139365791|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365792|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139365793|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
139365794|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365795|NCT03999749|Nivolumab|nivolumab|mesh-list
139365796|NCT03999749|Ipilimumab|ipilimumab|mesh-list
139365797|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365798|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365799|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365800|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365801|NCT03945513|Dienogest|dienogest|mesh-list
139365802|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139365803|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139365804|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139365805|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139365806|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
139365807|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139365808|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365809|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139365810|NCT03945513|Estrogens|estrogens|mesh-ancestor
139365811|NCT03945513|Hormones|hormones|mesh-ancestor
139365812|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139365813|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139365814|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
139365815|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139365816|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365817|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
139365818|NCT03941262|Avelumab|avelumab|mesh-list
139365819|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365820|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365821|NCT03941262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365822|NCT03941262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365824|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365825|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
139365826|NCT03926091|Docetaxel|docetaxel|mesh-list
139365827|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139365828|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
139365829|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365830|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139365831|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139365832|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
139365833|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365834|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365835|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139365836|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
139365837|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
139365838|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
139365840|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
139365841|NCT03913559|Promethazine|promethazine|mesh-list
139365842|NCT03913559|Cytarabine|cytarabine|mesh-list
139365843|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
139365844|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139365845|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
139365846|NCT03913559|Methotrexate|methotrexate|mesh-list
139365847|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139365848|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139365849|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
139365850|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139365851|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365852|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139365853|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
139365854|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365855|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365856|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
139365857|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365858|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139365859|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139365860|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
139365861|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139365862|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139365863|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
139365864|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139365865|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139365866|NCT03913559|Analgesics|analgesics|mesh-ancestor
139365867|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
139365868|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365869|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
139365870|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139365871|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
139365872|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
139365873|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139365874|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
139365875|NCT03913559|Hormones|hormones|mesh-ancestor
139365876|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139365877|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139365878|NCT03913559|Protective Agents|protective agents|mesh-ancestor
139365879|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139365880|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139365881|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139365882|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139365883|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
139365884|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
139365885|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139365886|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
139365887|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
139365888|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365889|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139365890|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
139365891|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365892|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139365893|NCT03913559|Immunotoxins|immunotoxins|mesh-ancestor
139365894|NCT03913559|Immunoconjugates|immunoconjugates|mesh-ancestor
139365895|NCT03892642|Avelumab|avelumab|mesh-list
139365896|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365897|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365899|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139365900|NCT03883828|Mupirocin|mupirocin|mesh-list
139365901|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139365902|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139365903|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
139365904|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
139365905|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139365906|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139365907|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365908|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365909|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
139365910|NCT03835819|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139365911|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365912|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365913|NCT03835819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365914|NCT03835819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365915|NCT03835819|Immunoconjugates|immunoconjugates|mesh-ancestor
139365916|NCT03835819|Immunologic Factors|immunologic factors|mesh-ancestor
139365917|NCT03835819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365918|NCT03832361|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139365919|NCT03832361|Immunoconjugates|immunoconjugates|mesh-ancestor
139365920|NCT03832361|Immunologic Factors|immunologic factors|mesh-ancestor
139365921|NCT03832361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365922|NCT03828292|Dexamethasone|dexamethasone|mesh-list
139365923|NCT03828292|Bortezomib|bortezomib|mesh-list
139365924|NCT03828292|Pomalidomide|pomalidomide|mesh-list
139365925|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139365926|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
139365927|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
139365928|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365929|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365930|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139365931|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
139365932|NCT03828292|Hormones|hormones|mesh-ancestor
139365933|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139365934|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139365935|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365936|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
139365937|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139365938|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139365939|NCT03828292|Growth Substances|growth substances|mesh-ancestor
139365940|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
139365941|NCT03825250|Valproic Acid|valproic acid|mesh-list
139365942|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
139365943|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139365944|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365945|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
139365946|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365947|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365948|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
139365949|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139365950|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139365951|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139365952|NCT03805100|Ranibizumab|ranibizumab|mesh-list
139365953|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139365954|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139365955|NCT03805100|Growth Substances|growth substances|mesh-ancestor
139365956|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365957|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
139365958|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365959|NCT03794999|Benralizumab|benralizumab|mesh-list
139365960|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139365961|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
139365962|NCT03777917|Hyaluronic Acid|hyaluronic acid|mesh-list
139365963|NCT03777917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139365964|NCT03777917|Immunologic Factors|immunologic factors|mesh-ancestor
139365965|NCT03777917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365966|NCT03777917|Viscosupplements|viscosupplements|mesh-ancestor
139365967|NCT03777917|Protective Agents|protective agents|mesh-ancestor
139365968|NCT03698851|Methamphetamine|methamphetamine|mesh-list
139365969|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139365970|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139365971|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
139365972|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
139365973|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139365974|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
139365975|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139365976|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365977|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
139365978|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139365979|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139365980|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139365981|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139365982|NCT03697850|Atezolizumab|atezolizumab|mesh-list
139365983|NCT03697850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365984|NCT03697850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365985|NCT03697850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365986|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365987|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
139365989|NCT03693014|Ipilimumab|ipilimumab|mesh-list
139365990|NCT03693014|Atezolizumab|atezolizumab|mesh-list
139365991|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139365992|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139365993|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139365994|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139365995|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
139365996|NCT03602235|Melphalan|melphalan|mesh-list
139365997|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139365998|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
139365999|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366000|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366001|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139366002|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366003|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
139366004|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366005|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
139366006|NCT03602235|Protective Agents|protective agents|mesh-ancestor
139366007|NCT03602235|Vitamins|vitamins|mesh-ancestor
139366008|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
139366009|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
139366010|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
139366011|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139366012|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366013|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366014|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
139366015|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
139366016|NCT03583359|Lidocaine|lidocaine|mesh-list
139366017|NCT03583359|Anesthetics, Local|anesthetics, local|mesh-ancestor
139366018|NCT03583359|Anesthetics|anesthetics|mesh-ancestor
139366019|NCT03583359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139366020|NCT03583359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366021|NCT03583359|Sensory System Agents|sensory system agents|mesh-ancestor
139366022|NCT03583359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366023|NCT03583359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139366024|NCT03583359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139366025|NCT03583359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139366026|NCT03583359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139366027|NCT03583359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366028|NCT03575013|Docetaxel|docetaxel|mesh-list
139366029|NCT03575013|Avelumab|avelumab|mesh-list
139366030|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366031|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
139366032|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
139366033|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
139366034|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366035|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366037|NCT03548428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139366038|NCT03548428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366039|NCT03548428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366040|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366041|NCT03537651|Ivacaftor|ivacaftor|mesh-list
139366042|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139366043|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138926910|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366044|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366045|NCT03503786|Paclitaxel|paclitaxel|mesh-list
139366046|NCT03503786|Carboplatin|carboplatin|mesh-list
139366047|NCT03503786|Avelumab|avelumab|mesh-list
139366048|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139366049|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366050|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
139366051|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
139366052|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
139366053|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366054|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366055|NCT03493542|Vaccines|vaccines|mesh-list
139366056|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
139366057|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366058|NCT03476798|Bevacizumab|bevacizumab|mesh-list
139366059|NCT03476798|Rucaparib|rucaparib|mesh-list
139366060|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366061|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366062|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139366063|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139366064|NCT03476798|Growth Substances|growth substances|mesh-ancestor
139366065|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366066|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
139366067|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139366068|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366069|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366070|NCT03457142|Dexamethasone|dexamethasone|mesh-list
139366071|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
139366072|NCT03457142|Abatacept|abatacept|mesh-list
139366073|NCT03457142|Ixazomib|ixazomib|mesh-list
139366074|NCT03457142|Ichthammol|ichthammol|mesh-list
139366075|NCT03457142|BB 1101|bb 1101|mesh-list
139366076|NCT03457142|Glycine|glycine|mesh-list
139366077|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139366078|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
139366079|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
139366080|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366081|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366082|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139366083|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
139366084|NCT03457142|Hormones|hormones|mesh-ancestor
139366085|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366086|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139366087|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366088|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366089|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
139366090|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366091|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139366092|NCT03457142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366093|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366094|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
139366095|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139366096|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
139366097|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
139366098|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139366099|NCT03434262|Gemcitabine|gemcitabine|mesh-list
139366100|NCT03434262|Trametinib|trametinib|mesh-list
139366101|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139366102|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
139366103|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366104|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366105|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139366106|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366107|NCT03425643|Gemcitabine|gemcitabine|mesh-list
139366108|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
139366109|NCT03425643|Pemetrexed|pemetrexed|mesh-list
139366110|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366111|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139366112|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
139366113|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366114|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366115|NCT03425643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139366116|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366117|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139366118|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139366119|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
139366120|NCT03342079|Anesthetics|anesthetics|mesh-list
139366121|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
139366122|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139366123|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366124|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
139366125|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366126|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139366127|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
139366128|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139366129|NCT03342079|Analgesics|analgesics|mesh-ancestor
139366130|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
139366131|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
139366132|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366133|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366134|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139366135|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366136|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366137|NCT03277170|Montelukast|montelukast|mesh-list
139366138|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139366139|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
139366140|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139366141|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
139366142|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366143|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366144|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139366145|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139366146|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366147|NCT03199300|Trastuzumab|trastuzumab|mesh-list
139366148|NCT03199300|Bleomycin|bleomycin|mesh-list
139366149|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366150|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366151|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139366152|NCT03173092|Dexamethasone|dexamethasone|mesh-list
139366153|NCT03173092|Lenalidomide|lenalidomide|mesh-list
139366154|NCT03173092|Ixazomib|ixazomib|mesh-list
139366155|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139366156|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
139366157|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
139366158|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366159|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366160|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139366161|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
139366162|NCT03173092|Hormones|hormones|mesh-ancestor
139366163|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366164|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139366165|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366166|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
139366167|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139366168|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139366169|NCT03173092|Growth Substances|growth substances|mesh-ancestor
139366170|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
139366171|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
139366172|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366173|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366174|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139366175|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139366176|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366178|NCT03104400|Upadacitinib|upadacitinib|mesh-list
139366179|NCT03104400|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139366180|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139366181|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139366182|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139366183|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139366184|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366185|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366186|NCT03092674|Cytarabine|cytarabine|mesh-list
139366187|NCT03092674|Nivolumab|nivolumab|mesh-list
139366188|NCT03092674|Azacitidine|azacitidine|mesh-list
139366189|NCT03092674|Decitabine|decitabine|mesh-list
139366190|NCT03092674|Midostaurin|midostaurin|mesh-list
139366191|NCT03092674|Staurosporine|staurosporine|mesh-list
139366192|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366193|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366194|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139366195|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366196|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139366197|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
139366198|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
139366199|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139366200|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366201|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
139366202|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366203|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366204|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139366205|NCT02974725|Trametinib|trametinib|mesh-list
139366206|NCT02974725|Naporafenib|naporafenib|mesh-list
139366207|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366208|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139366209|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366210|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366211|NCT02966756|Venetoclax|venetoclax|mesh-list
139023136|NCT00908531|Letrozole|letrozole|mesh-list
139366212|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366213|NCT02938923|Testosterone|testosterone|mesh-list
139366214|NCT02938923|Androgens|androgens|mesh-ancestor
139366215|NCT02938923|Hormones|hormones|mesh-ancestor
139366216|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366217|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366218|NCT02932618|Factor VIII|factor viii|mesh-list
139366219|NCT02932618|Coagulants|coagulants|mesh-ancestor
139366220|NCT02922764|Carboplatin|carboplatin|mesh-list
139366221|NCT02922764|Docetaxel|docetaxel|mesh-list
139366222|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
139366223|NCT02922764|Pemetrexed|pemetrexed|mesh-list
139366224|NCT02922764|Ipilimumab|ipilimumab|mesh-list
139366225|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366226|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
139366227|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
139366228|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
139366229|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366230|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366231|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139366232|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366233|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139366234|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139366235|NCT02878798|Topiramate|topiramate|mesh-list
139366236|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
139366237|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139366238|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366239|NCT02854436|Niraparib|niraparib|mesh-list
139366240|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139366241|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366242|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366243|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366244|NCT02845323|Nivolumab|nivolumab|mesh-list
139366245|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366246|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366247|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139366248|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366249|NCT02826434|Durvalumab|durvalumab|mesh-list
139366250|NCT02826434|Poly ICLC|poly iclc|mesh-list
139366251|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366252|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366253|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
139366254|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
139366255|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366256|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
139366257|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139366258|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139366259|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366260|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139366261|NCT02819141|Analgesics|analgesics|mesh-ancestor
139366262|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
139366263|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366264|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139366265|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139366266|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139366267|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
139366268|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139366269|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366270|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139366271|NCT02725177|Hormones|hormones|mesh-ancestor
139366272|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366273|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366274|NCT02624596|Midazolam|midazolam|mesh-list
139366275|NCT02624596|Ketamine|ketamine|mesh-list
139366276|NCT02624596|Analgesics|analgesics|mesh-ancestor
139366277|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
139366278|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366279|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366280|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139366281|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139366282|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
139366283|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
139366284|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139366285|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139366286|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139366287|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023204|NCT00909077|Rituximab|rituximab|mesh-list
139366288|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366289|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139366290|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139366291|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139366292|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139366293|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139366294|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
139366295|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
139366296|NCT02624128|Cetuximab|cetuximab|mesh-list
139366297|NCT02624128|Valproic Acid|valproic acid|mesh-list
139366298|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366299|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366300|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
139366301|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366302|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366303|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
139366304|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139366305|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366306|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
139366307|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139366308|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139366309|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139366310|NCT02621151|Gemcitabine|gemcitabine|mesh-list
139366311|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
139366312|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139366313|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
139366314|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366315|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366316|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366317|NCT02621151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139366319|NCT02578368|Docetaxel|docetaxel|mesh-list
139366320|NCT02578368|Fluorouracil|fluorouracil|mesh-list
139366321|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
139366322|NCT02578368|Trastuzumab|trastuzumab|mesh-list
139366323|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
139366324|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366325|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
139366326|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
139366327|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
139366328|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366329|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366330|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
139366331|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139366332|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366333|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
139366334|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366335|NCT02578368|Antidotes|antidotes|mesh-ancestor
139366336|NCT02578368|Protective Agents|protective agents|mesh-ancestor
139366337|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
139366338|NCT02578368|Vitamins|vitamins|mesh-ancestor
139366339|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
139366340|NCT02570542|Cytarabine|cytarabine|mesh-list
139366341|NCT02570542|Plerixafor|plerixafor|mesh-list
139366342|NCT02570542|Etoposide|etoposide|mesh-list
139366343|NCT02570542|Melphalan|melphalan|mesh-list
139366344|NCT02570542|Carmustine|carmustine|mesh-list
139366345|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139366346|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366347|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139366348|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139366349|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366350|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366351|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139366352|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
139366353|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
139366354|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139366355|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366356|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
139366357|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366358|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139366359|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
139023272|NCT03986008|Liraglutide|liraglutide|mesh-list
139366360|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139366361|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139366362|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139366363|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139366364|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139366365|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139366366|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139366367|NCT02488759|Nivolumab|nivolumab|mesh-list
139366368|NCT02488759|Ipilimumab|ipilimumab|mesh-list
139366369|NCT02488759|Relatlimab|relatlimab|mesh-list
139366370|NCT02488759|Daratumumab|daratumumab|mesh-list
139366371|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366372|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366373|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139366374|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366375|NCT02483247|Paclitaxel|paclitaxel|mesh-list
139366376|NCT02483247|Doxorubicin|doxorubicin|mesh-list
139366377|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
139366378|NCT02483247|Capecitabine|capecitabine|mesh-list
139366379|NCT02483247|Nivolumab|nivolumab|mesh-list
139366380|NCT02483247|Sunitinib|sunitinib|mesh-list
139366381|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139366382|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366383|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
138927012|NCT02559921|Vaccines|vaccines|mesh-list
139366384|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
139366385|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
139366386|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366388|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139366389|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139366390|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366391|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366392|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139366393|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139366394|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
139366395|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139366396|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139366397|NCT02483247|Growth Substances|growth substances|mesh-ancestor
139366398|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366399|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
139366400|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139366401|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
139366402|NCT02467361|Nivolumab|nivolumab|mesh-list
139366403|NCT02467361|Ipilimumab|ipilimumab|mesh-list
139366404|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366405|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366406|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139366407|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366408|NCT02368301|Dexamethasone|dexamethasone|mesh-list
139366409|NCT02368301|Lenalidomide|lenalidomide|mesh-list
139366410|NCT02368301|Elotuzumab|elotuzumab|mesh-list
139366411|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139366412|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
139366413|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
139366414|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366415|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366416|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139366417|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
139366418|NCT02368301|Hormones|hormones|mesh-ancestor
139366419|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366420|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139366421|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366422|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
139366423|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139366424|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139366425|NCT02368301|Growth Substances|growth substances|mesh-ancestor
139366426|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
139366427|NCT02352558|Dexamethasone|dexamethasone|mesh-list
139366428|NCT02352558|Bortezomib|bortezomib|mesh-list
139366429|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
139366430|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139366431|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
139366432|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
139366433|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366434|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366435|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139366436|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
139366437|NCT02352558|Hormones|hormones|mesh-ancestor
139366438|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366439|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139366440|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366441|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139366443|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366444|NCT02320435|Trastuzumab|trastuzumab|mesh-list
139366445|NCT02320435|Pertuzumab|pertuzumab|mesh-list
139366446|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366447|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366448|NCT02264665|Everolimus|everolimus|mesh-list
139366449|NCT02264665|Sunitinib|sunitinib|mesh-list
139366450|NCT02264665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139366451|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139366452|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366453|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366454|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366455|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
139366456|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366457|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366458|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139366459|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139366460|NCT02264665|Growth Substances|growth substances|mesh-ancestor
139366461|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
139366462|NCT02180711|Rituximab|rituximab|mesh-list
139366463|NCT02180711|Lenalidomide|lenalidomide|mesh-list
139366464|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
139366465|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366466|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366467|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
139366468|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366469|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139366470|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139366471|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139366472|NCT02180711|Growth Substances|growth substances|mesh-ancestor
139366473|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
139366474|NCT02047474|Leucovorin|leucovorin|mesh-list
139366475|NCT02047474|Fluorouracil|fluorouracil|mesh-list
139366476|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
139366477|NCT02047474|Irinotecan|irinotecan|mesh-list
139366478|NCT02047474|Calcium|calcium|mesh-list
139366479|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
139366480|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139366481|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366482|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
139366483|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366484|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139366485|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366486|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366487|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
139366488|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139366489|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139366490|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366491|NCT02047474|Antidotes|antidotes|mesh-ancestor
139366492|NCT02047474|Protective Agents|protective agents|mesh-ancestor
139366493|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
139366494|NCT02047474|Vitamins|vitamins|mesh-ancestor
139366495|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
139366496|NCT01972217|Prednisone|prednisone|mesh-list
139366497|NCT01972217|Prednisolone|prednisolone|mesh-list
139366498|NCT01972217|Olaparib|olaparib|mesh-list
139366499|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139366500|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
139366501|NCT01972217|Hormones|hormones|mesh-ancestor
138927059|NCT00682929|Analgesics|analgesics|mesh-ancestor
139366502|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366503|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366504|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139366505|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366506|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139366507|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366508|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366509|NCT01934452|Sunitinib|sunitinib|mesh-list
139366510|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366511|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139366512|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139366513|NCT01934452|Growth Substances|growth substances|mesh-ancestor
139366514|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366515|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
139023415|NCT00931697|Mefloquine|mefloquine|mesh-list
139366516|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139366517|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366518|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366519|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
139366520|NCT01864109|Temozolomide|temozolomide|mesh-list
139366522|NCT01864109|Doxorubicin|doxorubicin|mesh-list
139366523|NCT01864109|Irinotecan|irinotecan|mesh-list
139366524|NCT01864109|Etoposide|etoposide|mesh-list
139366525|NCT01864109|Vincristine|vincristine|mesh-list
139366526|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
139366527|NCT01864109|Razoxane|razoxane|mesh-list
139366528|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366529|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
138772573|NCT00902668|Lovastatin|lovastatin|mesh-list
139366530|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366532|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139366533|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
139366534|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366535|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366536|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139366537|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139366538|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139366539|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139366540|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366541|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139366542|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139366543|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
139366544|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
139366545|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
139366546|NCT01864109|Protective Agents|protective agents|mesh-ancestor
139366547|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139366548|NCT01809691|Bicalutamide|bicalutamide|mesh-list
139366549|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
139366550|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
139366551|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366552|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366553|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366554|NCT01786265|Prednisone|prednisone|mesh-list
139366555|NCT01786265|Cortisone|cortisone|mesh-list
139366556|NCT01786265|Leuprolide|leuprolide|mesh-list
139366557|NCT01786265|Goserelin|goserelin|mesh-list
139366558|NCT01786265|Flutamide|flutamide|mesh-list
139366559|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
139366560|NCT01786265|Bicalutamide|bicalutamide|mesh-list
139366561|NCT01786265|Nilutamide|nilutamide|mesh-list
139366562|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139366563|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
139366564|NCT01786265|Hormones|hormones|mesh-ancestor
139366565|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366566|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366567|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139366568|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366569|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139366570|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
139366571|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139366572|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139366573|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366574|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366575|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
139366576|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139366577|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
139366578|NCT01772472|Trastuzumab|trastuzumab|mesh-list
139366579|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139366580|NCT01772472|Maytansine|maytansine|mesh-list
139366581|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366582|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366583|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139366584|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
139366585|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
139366586|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
139366587|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366588|NCT01772472|Immunotoxins|immunotoxins|mesh-ancestor
139366589|NCT01772472|Immunoconjugates|immunoconjugates|mesh-ancestor
139366590|NCT01772472|Immunologic Factors|immunologic factors|mesh-ancestor
139366591|NCT01772472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366592|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139366593|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139366594|NCT01619176|Methotrexate|methotrexate|mesh-list
139366595|NCT01619176|Leflunomide|leflunomide|mesh-list
139366596|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139366597|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
139366598|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139366599|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366600|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139366601|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
139366602|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366603|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366604|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
139366605|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366606|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139366607|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366608|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
139366609|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138927097|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139366610|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139366611|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139366612|NCT01619176|Analgesics|analgesics|mesh-ancestor
139366613|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
139366614|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366615|NCT01481974|Treprostinil|treprostinil|mesh-list
139366616|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139366617|NCT01413516|Varenicline|varenicline|mesh-list
139366618|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139366619|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139366620|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
139366621|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139366622|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366623|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366625|NCT01106534|Everolimus|everolimus|mesh-list
139366626|NCT01106534|Clopidogrel|clopidogrel|mesh-list
139366627|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139366628|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139366629|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139366630|NCT01106534|Analgesics|analgesics|mesh-ancestor
139366631|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
139366632|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366633|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366634|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139366635|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139366636|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139366637|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139366638|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366639|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139366640|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139366641|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366642|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
139366643|NCT01106534|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139366644|NCT01106534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139366645|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366646|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
139366647|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366648|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139366649|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139366650|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139366651|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
139366652|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139366653|NCT01098955|Varenicline|varenicline|mesh-list
139366654|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139366655|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139366656|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
139366657|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139366658|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366659|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366660|NCT01009788|Temozolomide|temozolomide|mesh-list
139366661|NCT01009788|Veliparib|veliparib|mesh-list
139366662|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139366663|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
139366664|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366665|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366666|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139366667|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366668|NCT00997009|Paclitaxel|paclitaxel|mesh-list
139366669|NCT00997009|Carboplatin|carboplatin|mesh-list
139366670|NCT00997009|Cetuximab|cetuximab|mesh-list
139366671|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139366672|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366673|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
139366674|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
139366675|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
139366676|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366677|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366678|NCT00657878|Paclitaxel|paclitaxel|mesh-list
139366679|NCT00657878|Carboplatin|carboplatin|mesh-list
139366680|NCT00657878|Gemcitabine|gemcitabine|mesh-list
139366681|NCT00657878|Doxorubicin|doxorubicin|mesh-list
139366682|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139366683|NCT00657878|Topotecan|topotecan|mesh-list
139366684|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139366685|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366686|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
139366687|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
139366688|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
139366689|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366690|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139366691|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
139366692|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139366693|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139366694|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139366695|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366696|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139366697|NCT00513526|Vaccines|vaccines|mesh-list
139366698|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
139366699|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366700|NCT00412594|Rituximab|rituximab|mesh-list
139366701|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139366702|NCT00412594|Cladribine|cladribine|mesh-list
139366703|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
139366704|NCT00412594|Antibodies|antibodies|mesh-list
139366705|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
139366706|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139366707|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
139366708|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366709|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366710|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139366711|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366712|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139366713|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
139366714|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366715|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
139366716|NCT00321555|Immunotoxins|immunotoxins|mesh-list
139366717|NCT00321555|Immunoconjugates|immunoconjugates|mesh-ancestor
139366718|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
139366719|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366720|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
139366721|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139366722|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
139366723|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139366724|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366725|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139366726|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139366727|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139366728|NCT00099437|Fulvestrant|fulvestrant|mesh-list
139366729|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139366730|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366731|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139366732|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139366733|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
139366734|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366735|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366736|NCT00047060|Cyclosporine|cyclosporine|mesh-list
139366737|NCT00047060|Fludarabine|fludarabine|mesh-list
139366738|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
139366739|NCT00047060|Cyclosporins|cyclosporins|mesh-list
139366740|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366741|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366742|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366743|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
139183689|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
139366744|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366745|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366746|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
139366747|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139366748|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
139366749|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139366750|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139366751|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366753|NCT02084563|Decitabine|decitabine|mesh-list
139366754|NCT02084563|Daunorubicin|daunorubicin|mesh-list
139366755|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139366756|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
139366757|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366758|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366759|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
139366760|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139366761|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366762|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
139366763|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366764|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139366765|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139366766|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139366767|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366768|NCT02084719|Antibodies|antibodies|mesh-list
139366769|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
139366770|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366771|NCT02084875|Tofacitinib|tofacitinib|mesh-list
139366772|NCT02084875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139366773|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139366774|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366775|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366776|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
139366777|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139366778|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366779|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
139366780|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139366781|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139366782|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139366783|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139366784|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366785|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366786|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366787|NCT02082613|Polidocanol|polidocanol|mesh-list
139366788|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139366789|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139366790|NCT02085109|Theobromine|theobromine|mesh-list
139366791|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139366792|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
139366793|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366794|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366795|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139366796|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
139366797|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
139366798|NCT03557983|Fenofibrate|fenofibrate|mesh-list
139366799|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139366800|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
139366801|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366802|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139366803|NCT03558919|Mirabegron|mirabegron|mesh-list
139366804|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
139366805|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139366806|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139366807|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139366808|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
139366809|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139366810|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366811|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366812|NCT03558919|Urological Agents|urological agents|mesh-ancestor
139366813|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139366814|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139366815|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
139366816|NCT02085577|Acetaminophen|acetaminophen|mesh-list
139366817|NCT02085577|Sufentanil|sufentanil|mesh-list
139023713|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
139366818|NCT02085577|Ketamine|ketamine|mesh-list
139366819|NCT02085577|Morphine|morphine|mesh-list
139366820|NCT02085577|Dsuvia|dsuvia|mesh-list
139366821|NCT02085577|Ondansetron|ondansetron|mesh-list
139366822|NCT02085577|Analgesics|analgesics|mesh-ancestor
139366823|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
139366824|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366825|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366826|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139366827|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139366828|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
139366829|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
139366830|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139366831|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139366832|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139366833|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139366834|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366835|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139366836|NCT02085577|Narcotics|narcotics|mesh-ancestor
139366837|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139366838|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
139366839|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
139366840|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
139366841|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139366842|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
139366843|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
139366844|NCT02085577|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139366845|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139366846|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
139366847|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139366848|NCT02085655|Thalidomide|thalidomide|mesh-list
139366849|NCT02085655|Dexamethasone|dexamethasone|mesh-list
139366850|NCT02085655|Gemcitabine|gemcitabine|mesh-list
139366851|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
139366852|NCT02085655|Methotrexate|methotrexate|mesh-list
139366853|NCT02085655|Pegaspargase|pegaspargase|mesh-list
139366854|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139366855|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
139366856|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
139366857|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366858|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366859|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139366860|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
139366861|NCT02085655|Hormones|hormones|mesh-ancestor
139366862|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366863|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139366864|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366865|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139366866|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
139366867|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366868|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139366869|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
139366870|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139366871|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
139366872|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366873|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139366874|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366875|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
139366876|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139366877|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139366878|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
139366879|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139366880|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139366881|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139366882|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139366883|NCT02085655|Growth Substances|growth substances|mesh-ancestor
139366884|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
139366885|NCT02085967|Itraconazole|itraconazole|mesh-list
139366886|NCT02085967|Rifampin|rifampin|mesh-list
139366887|NCT02085967|Midazolam|midazolam|mesh-list
139366889|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139366890|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139366891|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139366892|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366893|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139366894|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139366895|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139023784|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139366896|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139366897|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
139366898|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
139366899|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
139366900|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
139366901|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139366902|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366903|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139366904|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
139366905|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139366906|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139366907|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139366908|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
139366909|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139366910|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139366911|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366912|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
139366913|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139366914|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139366915|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139366916|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
139366917|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366918|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139366919|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139366920|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
139366921|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139366922|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
139366923|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139366924|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139366925|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139366926|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139366927|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139366928|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139366929|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139366930|NCT02091505|Ranibizumab|ranibizumab|mesh-list
139366931|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139366932|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139366933|NCT02091505|Growth Substances|growth substances|mesh-ancestor
139366934|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366935|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
139366936|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366937|NCT02091817|Oxytocin|oxytocin|mesh-list
139366938|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
139366939|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139366940|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366941|NCT02086279|Hormones|hormones|mesh-list
139366942|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139366943|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366944|NCT02091973|Everolimus|everolimus|mesh-list
139366945|NCT02091973|Tacrolimus|tacrolimus|mesh-list
139366946|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139366947|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
139366948|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366949|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139366950|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366951|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366952|NCT02091973|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139366953|NCT02091973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139366954|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366955|NCT03558295|Anticoagulants|anticoagulants|mesh-list
139366956|NCT02089399|Olmesartan|olmesartan|mesh-list
139366957|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139366958|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139366959|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139366960|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
139366961|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366962|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139366963|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139366964|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366965|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139366966|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139366967|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139366968|NCT03557437|Amoxicillin|amoxicillin|mesh-list
139366969|NCT03557437|Metronidazole|metronidazole|mesh-list
139366970|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
139366971|NCT03557437|Esomeprazole|esomeprazole|mesh-list
139366972|NCT03557437|Bismuth|bismuth|mesh-list
139366973|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139366974|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139366975|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139366976|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139366977|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139366978|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139366979|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139366980|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139366981|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139366982|NCT03557437|Antacids|antacids|mesh-ancestor
139366983|NCT03557437|Diuretics|diuretics|mesh-ancestor
139366984|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
139366985|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366986|NCT03557437|Expectorants|expectorants|mesh-ancestor
139366987|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
139366988|NCT02089633|BCT-100|bct-100|mesh-list
139366989|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139366990|NCT02086747|Acetaminophen|acetaminophen|mesh-list
139366991|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139366992|NCT02086747|Analgesics|analgesics|mesh-ancestor
139366993|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
139366994|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139366995|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139366996|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
139366997|NCT02086825|Rifaximin|rifaximin|mesh-list
139366998|NCT02086825|Lactulose|lactulose|mesh-list
139366999|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139367000|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367001|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367002|NCT02086903|Clopidogrel|clopidogrel|mesh-list
139367003|NCT02086903|Ticagrelor|ticagrelor|mesh-list
139367004|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139367005|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139367006|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139367007|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139367008|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
139367009|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367010|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367011|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367012|NCT02087215|Boron|boron|mesh-list
139367013|NCT02087215|Trace Elements|trace elements|mesh-ancestor
139367014|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
139367015|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367016|NCT02087527|Dexamethasone|dexamethasone|mesh-list
139367017|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139367018|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
139367019|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
139367020|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367021|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367022|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367023|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
139367024|NCT02087527|Hormones|hormones|mesh-ancestor
139183712|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139367025|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367026|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139367027|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367028|NCT02087683|Vitamin D|vitamin d|mesh-list
139367029|NCT02087683|Vitamins|vitamins|mesh-ancestor
139367030|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
139367031|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367032|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139367033|NCT02092363|Paclitaxel|paclitaxel|mesh-list
139367034|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139367035|NCT02092363|Carboplatin|carboplatin|mesh-list
139367036|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
139367037|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139367038|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367039|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
139367040|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
139367041|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
139367042|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367043|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
139367044|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367045|NCT03558139|Avelumab|avelumab|mesh-list
139367046|NCT03558139|Magrolimab|magrolimab|mesh-list
139367047|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139367048|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367049|NCT02089867|Ezetimibe|ezetimibe|mesh-list
139367050|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139367051|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139367052|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
139367053|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367054|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139367055|NCT02092597|Exenatide|exenatide|mesh-list
139367056|NCT02092597|Linagliptin|linagliptin|mesh-list
139367057|NCT02092597|Gliclazide|gliclazide|mesh-list
139367058|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139367059|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367060|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139367061|NCT02092597|Incretins|incretins|mesh-ancestor
139367062|NCT02092597|Hormones|hormones|mesh-ancestor
139367063|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367064|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139367065|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
139367066|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367067|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367068|NCT02093143|Remifentanil|remifentanil|mesh-list
139367069|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139367070|NCT02093143|Narcotics|narcotics|mesh-ancestor
139367071|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139367072|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367073|NCT02093143|Analgesics|analgesics|mesh-ancestor
139367074|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
139367075|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367076|NCT02093299|Clopidogrel|clopidogrel|mesh-list
139367077|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139367078|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139367079|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139367080|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139367081|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
139367082|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367083|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367084|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367085|NCT00454753|Dasatinib|dasatinib|mesh-list
139367086|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367087|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139367088|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367089|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367090|NCT02093533|Eculizumab|eculizumab|mesh-list
139367091|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139367092|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139367093|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
139367094|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367095|NCT03297879|Metformin|metformin|mesh-list
139367096|NCT03297879|Exenatide|exenatide|mesh-list
139367097|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139367098|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367099|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139367100|NCT03297879|Incretins|incretins|mesh-ancestor
139367101|NCT03297879|Hormones|hormones|mesh-ancestor
139367102|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367103|NCT02093845|Everolimus|everolimus|mesh-list
139367104|NCT02093845|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139367105|NCT02093845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139367106|NCT02093845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367107|NCT02093845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367108|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139367109|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
139367110|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367111|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367112|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
139367113|NCT04489797|Rabeprazole|rabeprazole|mesh-list
139367114|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139367115|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367116|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139367117|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367118|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367119|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367120|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139367121|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139367122|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367123|NCT02096419|Clopidogrel|clopidogrel|mesh-list
139367124|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139367125|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139367126|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139367127|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139367129|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367130|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367131|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367132|NCT02094157|Heparin|heparin|mesh-list
139367133|NCT02094157|Calcium heparin|calcium heparin|mesh-list
139367134|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139367135|NCT02094157|Tinzaparin|tinzaparin|mesh-list
139367136|NCT02094157|Dalteparin|dalteparin|mesh-list
139367137|NCT02094157|Warfarin|warfarin|mesh-list
139367138|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
139367139|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139367140|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139367141|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367142|NCT02094313|Atorvastatin|atorvastatin|mesh-list
139367143|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
139367144|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139367145|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
139367146|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367147|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139367148|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139367149|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367150|NCT02094391|Ipilimumab|ipilimumab|mesh-list
139367151|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139367152|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367153|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139367154|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367155|NCT02094469|Cilostazol|cilostazol|mesh-list
139367156|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139367157|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
139367158|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367159|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367160|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139367161|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
139367162|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139367163|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139367164|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367165|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139367166|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
139367167|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139367168|NCT02094469|Protective Agents|protective agents|mesh-ancestor
139367169|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139367170|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139367171|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367172|NCT02094703|Levofloxacin|levofloxacin|mesh-list
139367173|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
139367174|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139367175|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367176|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139367177|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139367178|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139367179|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367180|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367181|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367182|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139367183|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139367184|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139367185|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139367186|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
139367187|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367188|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367189|NCT02094703|Urological Agents|urological agents|mesh-ancestor
139367190|NCT02098837|Dolutegravir|dolutegravir|mesh-list
139367191|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139367192|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139367193|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367194|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367195|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139367196|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139367197|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
139367198|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367199|NCT02098915|Metoclopramide|metoclopramide|mesh-list
139367200|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
139367201|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
139367202|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367203|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367204|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367205|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139367206|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139367207|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
139367208|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367209|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367210|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
139367211|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139367212|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367213|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139367214|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367215|NCT05046860|Dalbavancin|dalbavancin|mesh-list
139367216|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139367217|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367218|NCT02095405|Caffeine|caffeine|mesh-list
139367219|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139367220|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367221|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139367222|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367223|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367224|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139367225|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139367226|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
139367227|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367228|NCT02096965|Tolvaptan|tolvaptan|mesh-list
139367229|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139367230|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367231|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
139367232|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367233|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
139367234|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139367235|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367236|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
139367237|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139367238|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367239|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
139367240|NCT02095717|Curcumin|curcumin|mesh-list
139367241|NCT02095717|Docetaxel|docetaxel|mesh-list
139367242|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367243|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
139367244|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
139367245|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
139367246|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367247|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139367248|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139367249|NCT02095717|Analgesics|analgesics|mesh-ancestor
139367250|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
139367251|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367252|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367253|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139367254|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139367255|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367256|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
139367257|NCT03099824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139367258|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
139367259|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367260|NCT03099824|Protective Agents|protective agents|mesh-ancestor
139367261|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367262|NCT02718417|Paclitaxel|paclitaxel|mesh-list
139367263|NCT02718417|Carboplatin|carboplatin|mesh-list
139367264|NCT02718417|Avelumab|avelumab|mesh-list
139367265|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139367266|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139367267|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367268|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
139367269|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
139024163|NCT00936689|Doxorubicin|doxorubicin|mesh-list
139367270|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
139367271|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367272|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139367273|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
139367274|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367275|NCT05067530|Paclitaxel|paclitaxel|mesh-list
139367276|NCT05067530|Carboplatin|carboplatin|mesh-list
139367277|NCT05067530|Palbociclib|palbociclib|mesh-list
139367278|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139367279|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367280|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
139367281|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
139367282|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
139367283|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367284|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139367285|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367286|NCT02640404|Vaccines|vaccines|mesh-list
139367287|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
139367288|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367289|NCT03097406|Imidacloprid|imidacloprid|mesh-list
139367290|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
139367291|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367292|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367293|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367294|NCT03099590|Puerarin|puerarin|mesh-list
139367295|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
139367296|NCT05054426|Methotrexate|methotrexate|mesh-list
139367297|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139367298|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
139367299|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139367300|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367301|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139367302|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
139367303|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367304|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367305|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
139367306|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367307|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139367308|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139367309|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
139367310|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139367311|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139367312|NCT00701727|Ezetimibe|ezetimibe|mesh-list
139367313|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139367314|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139367315|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
139367316|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367317|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139367318|NCT02463513|Vitamins|vitamins|mesh-list
139367319|NCT02463513|Riboflavin|riboflavin|mesh-list
139367320|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
139367321|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
139367322|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367323|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139367324|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
139367325|NCT04155008|Dexamethasone|dexamethasone|mesh-list
139367326|NCT04155008|Dronabinol|dronabinol|mesh-list
139183784|NCT05390710|Paclitaxel|paclitaxel|mesh-list
139367327|NCT04155008|Mirtazapine|mirtazapine|mesh-list
139367328|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139367329|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
139367330|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
139367331|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367332|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367333|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367334|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
139367335|NCT04155008|Hormones|hormones|mesh-ancestor
139367336|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367337|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139367338|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367339|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
139367340|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139367341|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139367342|NCT04155008|Analgesics|analgesics|mesh-ancestor
139367343|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
139367344|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139367345|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139367346|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367347|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367348|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
139367349|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139367350|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
139367351|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
139367352|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139367353|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139367354|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139367355|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139367356|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139367357|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139367358|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
139367359|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139367360|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139367361|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
139367362|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139367363|NCT05044364|Clevidipine|clevidipine|mesh-list
139367364|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139367365|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139367366|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367367|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139367368|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367369|NCT03993717|Vaccines|vaccines|mesh-list
139367370|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
139367371|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367372|NCT05054114|Interferons|interferons|mesh-list
139367373|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
139367374|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367375|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
139367376|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367377|NCT04665531|Ropivacaine|ropivacaine|mesh-list
139367378|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
139367379|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
139367380|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138927384|NCT02559141|Norepinephrine|norepinephrine|mesh-list
139367381|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367382|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
139183788|NCT05390710|Tubulin Modulators|tubulin modulators|mesh-ancestor
139367383|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367384|NCT01369069|Insulin|insulin|mesh-list
139367385|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139367386|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139367387|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367388|NCT02097511|Metoprolol|metoprolol|mesh-list
139367389|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
139367390|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139367391|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139367392|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
139367393|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
139367394|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367395|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367396|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139367397|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139367398|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139367399|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
139367400|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367401|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367402|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139367403|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139367404|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139367405|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139367406|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
139367407|NCT03957681|Brodalumab|brodalumab|mesh-list
139367408|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
139367409|NCT05043740|Evolocumab|evolocumab|mesh-list
139367410|NCT05043740|Alirocumab|alirocumab|mesh-list
139367411|NCT05043740|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139367412|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139367413|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139367414|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
139367415|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367416|NCT05043740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139367417|NCT05043740|Protease Inhibitors|protease inhibitors|mesh-ancestor
139367418|NCT05043740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367419|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139024307|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139367420|NCT03928275|Aldesleukin|aldesleukin|mesh-list
139367421|NCT03928275|Interleukin-2|interleukin-2|mesh-list
139367423|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367424|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139367425|NCT03928275|Analgesics|analgesics|mesh-ancestor
139367426|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
139367427|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367428|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367429|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139367430|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139367431|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
139367432|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367433|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139367434|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
139367435|NCT05043896|Tadalafil|tadalafil|mesh-list
139367436|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
139367437|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139367438|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139367439|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367440|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367441|NCT05043896|Urological Agents|urological agents|mesh-ancestor
139367442|NCT03096704|Vitamin D|vitamin d|mesh-list
139367443|NCT03096704|Vitamins|vitamins|mesh-ancestor
139367444|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
139367445|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367446|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139367447|NCT02099695|Oxybutynin|oxybutynin|mesh-list
139367448|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
139367449|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
139367450|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367451|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367452|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139367453|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139367454|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
139367455|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367456|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367457|NCT02099695|Urological Agents|urological agents|mesh-ancestor
139367458|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
139367459|NCT05066516|Linagliptin|linagliptin|mesh-list
139367460|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139367461|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367462|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139367463|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367464|NCT05066516|Incretins|incretins|mesh-ancestor
139367465|NCT05066516|Hormones|hormones|mesh-ancestor
139367466|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367467|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139367468|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
139367469|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367470|NCT02097589|Atorvastatin|atorvastatin|mesh-list
139367471|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139367472|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
139367473|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367474|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139367475|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139367476|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
139367477|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367478|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139367479|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139367480|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367481|NCT03836001|Serlopitant|serlopitant|mesh-list
139367482|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139367483|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367484|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367485|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367486|NCT02465866|Promethazine|promethazine|mesh-list
139367487|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
139367488|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
139367489|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139367490|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
139367491|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
139367492|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367493|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367494|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024382|NCT02991365|Insulin|insulin|mesh-list
139367495|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139367496|NCT05052008|Erenumab|erenumab|mesh-list
139367497|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139367498|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367499|NCT05052008|Analgesics|analgesics|mesh-ancestor
139367500|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
139367501|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367502|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367503|NCT05066360|Hormones|hormones|mesh-list
139367504|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367505|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367506|NCT02439970|Valganciclovir|valganciclovir|mesh-list
139367507|NCT02439970|Brincidofovir|brincidofovir|mesh-list
139367508|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
139367509|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367510|NCT03290859|Propofol|propofol|mesh-list
139367511|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139367512|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139367513|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367514|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139367515|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
139367516|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
139367517|NCT05065658|Posaconazole|posaconazole|mesh-list
139367518|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
139367519|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367520|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139367521|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139367522|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139367523|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139367524|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139367525|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367526|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367527|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139367528|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
139367529|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367530|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367531|NCT02102815|Dexamethasone|dexamethasone|mesh-list
139367532|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139367533|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
139367534|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
139367535|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367536|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367537|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367538|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
139367539|NCT02102815|Hormones|hormones|mesh-ancestor
139367540|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367541|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139367542|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367543|NCT04935112|Pantoprazole|pantoprazole|mesh-list
139367544|NCT04935112|Famotidine|famotidine|mesh-list
139367545|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139367546|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367547|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139367548|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367549|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367550|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139367551|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
139367552|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
139367553|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367554|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367555|NCT02102971|Liver Extracts|liver extracts|mesh-list
139367556|NCT02102971|Hematinics|hematinics|mesh-ancestor
139367557|NCT03555487|Choline|choline|mesh-list
139367558|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
139367559|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139367560|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
139367561|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367562|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367563|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139367564|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
139367565|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139367566|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139367567|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367568|NCT02103049|Ezetimibe|ezetimibe|mesh-list
139367569|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139367570|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139367572|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367573|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139367574|NCT03099278|Ezetimibe|ezetimibe|mesh-list
139367575|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139367576|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139367577|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
139367578|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367579|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139367580|NCT02103205|Iron|iron|mesh-list
139367581|NCT02103205|Lactoferrin|lactoferrin|mesh-list
139367582|NCT02103205|Trace Elements|trace elements|mesh-ancestor
139367583|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
139367584|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367585|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367586|NCT03290703|Rabeprazole|rabeprazole|mesh-list
139367587|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139367588|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367589|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139367590|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139183816|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139367591|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367592|NCT02408068|Dexamethasone|dexamethasone|mesh-list
139367593|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
139367594|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139367595|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139367596|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139367597|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139367598|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
139367599|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
139367600|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367601|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367602|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367603|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
139367604|NCT02408068|Hormones|hormones|mesh-ancestor
139367605|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367606|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139367607|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367608|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
139367609|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139367610|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
139367611|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367612|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
139367613|NCT02465853|Protective Agents|protective agents|mesh-ancestor
139367614|NCT02465385|Linaclotide|linaclotide|mesh-list
139367615|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139367616|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
139367617|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367618|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367619|NCT05050604|Choline|choline|mesh-list
139367620|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
139367621|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139367622|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
138927442|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
139367623|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367624|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367625|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139367626|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
139367627|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
139367628|NCT03290625|Ketamine|ketamine|mesh-list
139367629|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139367630|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139367631|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367632|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139367633|NCT03290625|Analgesics|analgesics|mesh-ancestor
139367634|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
139367635|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367636|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139367637|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139367638|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139367639|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
139367640|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367641|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367642|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139367643|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139024529|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139367644|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
139367646|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139367647|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139367648|NCT02250781|TIC10 compound|tic10 compound|mesh-list
139367649|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367650|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
139367651|NCT03099122|Prednisone|prednisone|mesh-list
139367652|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
139367653|NCT03099122|Tacrolimus|tacrolimus|mesh-list
139367654|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
139367655|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139367656|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
139367657|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139367658|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
139367659|NCT03099122|Hormones|hormones|mesh-ancestor
139367660|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367661|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367662|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139367663|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367664|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139367665|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
139367666|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139367667|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367668|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367669|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139367670|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139367671|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
139367672|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139367673|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367674|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
139367675|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
139367676|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367677|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367678|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139367679|NCT03099122|Protective Agents|protective agents|mesh-ancestor
139367680|NCT04335201|Defibrotide|defibrotide|mesh-list
139367681|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139367682|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139367683|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367684|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139367685|NCT03295851|Iron|iron|mesh-list
139367686|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
139367687|NCT03295851|Trace Elements|trace elements|mesh-ancestor
139367688|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
139367689|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367690|NCT03096470|Anesthetics|anesthetics|mesh-list
139367691|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139367692|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367693|NCT02100553|Itraconazole|itraconazole|mesh-list
139367694|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139367695|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
139367696|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367697|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139367698|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139367699|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367700|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367701|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139367702|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
139367703|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367704|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367705|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139367706|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139367707|NCT02100787|Laxatives|laxatives|mesh-ancestor
139367708|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367709|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139367710|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139367711|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367712|NCT04718805|Darunavir|darunavir|mesh-list
139367713|NCT04718805|Cobicistat|cobicistat|mesh-list
139367714|NCT04718805|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139367715|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139367716|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139367717|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
139024605|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
139367718|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367719|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367720|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139367721|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139367722|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
139367723|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367724|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139367725|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139367726|NCT05042336|Lenvatinib|lenvatinib|mesh-list
139367727|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367728|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139367729|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367730|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367731|NCT03096392|Insulin|insulin|mesh-list
139367732|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139367733|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
139367734|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138927472|NCT00761241|Docetaxel|docetaxel|mesh-list
139367735|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367736|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
139367737|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
139367738|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139367739|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367740|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367741|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367742|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139367743|NCT02460393|Antibodies|antibodies|mesh-list
139367744|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
139367745|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139367746|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
139367747|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367748|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367749|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139367750|NCT02250859|Minocycline|minocycline|mesh-list
139367751|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367752|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
139367753|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139367754|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367755|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
139367756|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
139367757|NCT03295383|Rituximab|rituximab|mesh-list
139367758|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139367759|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
139367760|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367761|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139367762|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139367763|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
139367764|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367765|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367766|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139367767|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139367768|NCT02101255|Fluorides|fluorides|mesh-list
139367769|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
139367770|NCT02101255|Protective Agents|protective agents|mesh-ancestor
139367771|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367772|NCT05063318|Itraconazole|itraconazole|mesh-list
139367773|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
139367774|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367775|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139367776|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139367777|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367778|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367779|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139367780|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
139367781|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367782|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367783|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139367784|NCT02104297|Remifentanil|remifentanil|mesh-list
139367785|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139367786|NCT02104297|Narcotics|narcotics|mesh-ancestor
139367787|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139367788|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367789|NCT02104297|Analgesics|analgesics|mesh-ancestor
139367790|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
139367791|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367792|NCT02106481|Ropivacaine|ropivacaine|mesh-list
139367793|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
139367794|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
139367795|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139367796|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367797|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
139367798|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367799|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
139367800|NCT02106559|Trioxsalen|trioxsalen|mesh-list
139367801|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367802|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
139367803|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139367804|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
139367805|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139367806|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139367807|NCT05047874|Prednisolone|prednisolone|mesh-list
139367808|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
139367809|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139367810|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
139367811|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139367812|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
139367813|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
139367814|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367815|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367816|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367817|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
139367818|NCT05047874|Hormones|hormones|mesh-ancestor
139367819|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139367820|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139367821|NCT05047874|Protective Agents|protective agents|mesh-ancestor
139367822|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139367823|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367824|NCT04488705|Albuterol|albuterol|mesh-list
139367825|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139367826|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
139367827|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367828|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367829|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139367830|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
139367831|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
139367832|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139367833|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139367834|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139367835|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139367836|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
139367837|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367838|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367839|NCT02106637|Varenicline|varenicline|mesh-list
139367840|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139367841|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139367842|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
139367843|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367844|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367845|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367846|NCT05047328|Inolimomab|inolimomab|mesh-list
139367847|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139367848|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
139367849|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367850|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
139367851|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139367852|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
139367853|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139367854|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367855|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139367856|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139367857|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139367858|NCT02106793|Mitomycins|mitomycins|mesh-list
139367859|NCT02106793|Mitomycin|mitomycin|mesh-list
139367860|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139367861|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367862|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
139367863|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367864|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139367865|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024755|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
139367866|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139367867|NCT02104843|Asunaprevir|asunaprevir|mesh-list
139367868|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139367869|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139367870|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
139367871|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367872|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139367873|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139367874|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367875|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
139367876|NCT05041790|Choline|choline|mesh-list
139367877|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
139367878|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139367879|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
139367880|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367881|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367882|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139367883|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
139367884|NCT02105077|Anesthetics|anesthetics|mesh-list
139367886|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139367887|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367888|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139367889|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
139367890|NCT02101567|Oxytocin|oxytocin|mesh-list
139367891|NCT02101567|Carbetocin|carbetocin|mesh-list
139367892|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
139367893|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139367894|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367895|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
139367896|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
139367897|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139367898|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139367899|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367900|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367901|NCT02106871|Urological Agents|urological agents|mesh-ancestor
139367902|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
139367903|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367904|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
139367905|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
139367906|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
139367907|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139367908|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139367909|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367910|NCT02407990|Tislelizumab|tislelizumab|mesh-list
139367911|NCT02407990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139367912|NCT02407990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367913|NCT02105155|Tacrolimus|tacrolimus|mesh-list
139367914|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139367915|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
139367916|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927516|NCT00920660|Hormones|hormones|mesh-ancestor
139367917|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139367918|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367919|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367920|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139367921|NCT03294525|Mirtazapine|mirtazapine|mesh-list
139367922|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
139367923|NCT03294525|Escitalopram|escitalopram|mesh-list
139367924|NCT03294525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139367925|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139367926|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139367927|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367928|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367929|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
139367930|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367931|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367932|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139367933|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139367934|NCT03294525|Analgesics|analgesics|mesh-ancestor
139367935|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
139367936|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
139367937|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139024830|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139367938|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
139367939|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
139367940|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139367941|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139367942|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139367943|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139367944|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139367945|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139367946|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
139367947|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139367948|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139367949|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139367950|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
139367951|NCT05036174|Promethazine|promethazine|mesh-list
139367952|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139367953|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139367954|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139367955|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367956|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
139367957|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
139367958|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
139367959|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139367960|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
139367961|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
139367962|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139367963|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139367964|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
139367965|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
139367966|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367967|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367968|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139367969|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
139367970|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
139367971|NCT03283059|Donepezil|donepezil|mesh-list
139367972|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139367973|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139367974|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367975|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
139367976|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139367977|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367978|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
139367979|NCT05060588|Valsartan|valsartan|mesh-list
139367980|NCT05060588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139367981|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139367982|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139367983|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139367984|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139367985|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
139367986|NCT02105311|Travoprost|travoprost|mesh-list
139367987|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139367988|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139367989|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139367990|NCT03554395|Antibodies|antibodies|mesh-list
139367991|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139367992|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
139367993|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139367994|NCT03282825|Paclitaxel|paclitaxel|mesh-list
139367995|NCT03282825|Decitabine|decitabine|mesh-list
139367996|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139367997|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139367998|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
139367999|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
139368000|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
139368001|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368002|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139368003|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
139368004|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368005|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139368006|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139368007|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139368008|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
139368009|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368010|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139368011|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139368012|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024904|NCT01009892|Codeine|codeine|mesh-list
139368014|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368015|NCT03288051|Dobutamine|dobutamine|mesh-list
139368016|NCT03288051|Norepinephrine|norepinephrine|mesh-list
139368017|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139368018|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139368019|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
139368020|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368021|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368022|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368023|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
139368024|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
139368025|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368026|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139368027|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139368028|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139368029|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139368030|NCT03288051|Protective Agents|protective agents|mesh-ancestor
139368031|NCT05035472|Phenylephrine|phenylephrine|mesh-list
139368032|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
139368033|NCT05035472|Norepinephrine|norepinephrine|mesh-list
139368034|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139368035|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139368036|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
139368037|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
139368038|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368039|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368040|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
139368041|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
139368042|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
139368043|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139368044|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139368045|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138927546|NCT02677545|Aspirin|aspirin|mesh-list
139368046|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
139368047|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368048|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368049|NCT05035472|Protective Agents|protective agents|mesh-ancestor
139368050|NCT02460627|Lidocaine|lidocaine|mesh-list
139368051|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
139368052|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
139368053|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139368054|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368055|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
139368056|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368057|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139368058|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139368059|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139368060|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139368061|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368062|NCT02107729|Lidocaine|lidocaine|mesh-list
139368063|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
139368064|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
139368065|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139368066|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368067|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
139368068|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368069|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139368070|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139368071|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139368072|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139368073|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368074|NCT03282513|Ivosidenib|ivosidenib|mesh-list
139368075|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368076|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368077|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368078|NCT02107807|Lactitol|lactitol|mesh-list
139368079|NCT02107807|Vaccines|vaccines|mesh-list
139368080|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
139368081|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368082|NCT02107807|Cathartics|cathartics|mesh-ancestor
139368083|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139368084|NCT01673282|Lacosamide|lacosamide|mesh-list
139368085|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
139368086|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139368087|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139368088|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139368089|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368090|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139368091|NCT02113735|Hormones|hormones|mesh-ancestor
139368092|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368093|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368094|NCT02113813|Naquotinib|naquotinib|mesh-list
139368095|NCT02113813|Midazolam|midazolam|mesh-list
139368096|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139368097|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139368098|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139368099|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368100|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139368101|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139368102|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139368103|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139368104|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
139368105|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
139368106|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
139368107|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
139368108|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368109|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368110|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927551|NCT02677545|Analgesics|analgesics|mesh-ancestor
139368111|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139368112|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368113|NCT03095144|Anesthetics|anesthetics|mesh-list
139368114|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139368115|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368116|NCT03095222|Ketamine|ketamine|mesh-list
139368117|NCT03095222|Analgesics|analgesics|mesh-ancestor
139368118|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
139368119|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368120|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368121|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139368122|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139368123|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
139368124|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
139368125|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139368126|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139368127|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139368128|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368129|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368131|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139368132|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139368133|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
139368134|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368135|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
139368136|NCT03095378|Tetracycline|tetracycline|mesh-list
139368137|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139368138|NCT03095378|Citric Acid|citric acid|mesh-list
139368139|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
139368140|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139368141|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368142|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368143|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
139368144|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139368145|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
139368146|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
139368147|NCT05025098|Azacitidine|azacitidine|mesh-list
139368148|NCT05025098|Venetoclax|venetoclax|mesh-list
139368149|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139368150|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
139368151|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368152|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368153|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368154|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
139368155|NCT05038202|Bromides|bromides|mesh-list
139368156|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
139368157|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368158|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
139368159|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139368160|NCT02114359|Cisplatin|cisplatin|mesh-list
139368161|NCT02114359|Capecitabine|capecitabine|mesh-list
139368162|NCT02114359|Fluorouracil|fluorouracil|mesh-list
139368163|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
139368164|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368165|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138927563|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
139368166|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
139368167|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368168|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139368169|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
139368170|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368172|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139368173|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139368174|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139368175|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139368176|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
139368177|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368178|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368179|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368180|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
139368181|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139368182|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
139368183|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368184|NCT02108353|Melatonin|melatonin|mesh-list
139368185|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
139368186|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368187|NCT02108353|Protective Agents|protective agents|mesh-ancestor
139368188|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368189|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139368190|NCT04157751|Empagliflozin|empagliflozin|mesh-list
139368191|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139368192|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368193|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139368194|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368195|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
139368196|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139368197|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368198|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139368199|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139368200|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368201|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368202|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368203|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139368204|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139368205|NCT02110459|Murepavadin|murepavadin|mesh-list
139368206|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139368207|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368208|NCT03287505|Aripiprazole|aripiprazole|mesh-list
139368209|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
139368210|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139368211|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139368212|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139368213|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139368214|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368215|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
139368216|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
139368217|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368218|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368219|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139368220|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139368221|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
139368222|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139368223|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139368224|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139368225|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139368226|NCT03090698|Triamcinolone|triamcinolone|mesh-list
139368227|NCT03090698|Hylan|hylan|mesh-list
139368228|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368229|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
139368230|NCT03090698|Hormones|hormones|mesh-ancestor
139368231|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368232|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368233|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
139368234|NCT03090698|Protective Agents|protective agents|mesh-ancestor
139368235|NCT03293511|Oxytocin|oxytocin|mesh-list
139368236|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
139025130|NCT01015352|Hematinics|hematinics|mesh-ancestor
139368237|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139368238|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368239|NCT02251171|Ritonavir|ritonavir|mesh-list
139368240|NCT02251171|Tipranavir|tipranavir|mesh-list
139368241|NCT02251171|Rifabutin|rifabutin|mesh-list
139368242|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139368243|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139368244|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
139368245|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368246|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368247|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139368248|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139368249|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
139368250|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368251|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139368252|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139368253|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139368254|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139368255|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
139368256|NCT02110537|Flecainide|flecainide|mesh-list
139368257|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139368258|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139368259|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139368260|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139368261|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368262|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
139368263|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139368264|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139368265|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368266|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139368267|NCT03293277|Analgesics|analgesics|mesh-ancestor
139368268|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
139368269|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368270|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139368271|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139368272|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139368273|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
139368274|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368275|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368276|NCT02108743|Albuterol|albuterol|mesh-list
139368277|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139368278|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
139368279|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368280|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368281|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139368282|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
139368283|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
139368284|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139368285|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139368286|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139368287|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139368288|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
139368289|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368290|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368291|NCT03292965|Neostigmine|neostigmine|mesh-list
139368292|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139368293|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927586|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
139368294|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368295|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
139368296|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368297|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368298|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139368299|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
139368300|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368301|NCT05024084|Anesthetics|anesthetics|mesh-list
139368302|NCT05024084|Sevoflurane|sevoflurane|mesh-list
139368303|NCT05024084|Desflurane|desflurane|mesh-list
139368304|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139368305|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368306|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139368307|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139368308|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
139368309|NCT02109289|Etanercept|etanercept|mesh-list
139368310|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139368311|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139368312|NCT02109289|Analgesics|analgesics|mesh-ancestor
139368313|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
139368314|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368315|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368316|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368317|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139368318|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139368319|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139368320|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
139368322|NCT03553303|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139368323|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139368324|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139368325|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139368326|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368327|NCT03286959|Calcium|calcium|mesh-list
139368328|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139368329|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368330|NCT03292575|Anticoagulants|anticoagulants|mesh-list
139368331|NCT02115529|Nabilone|nabilone|mesh-list
139368332|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
139368333|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
139368334|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368335|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368336|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139368337|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139368338|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139368339|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139368340|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139368341|NCT01652716|Exenatide|exenatide|mesh-list
139368342|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139368343|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368344|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139368345|NCT01652716|Incretins|incretins|mesh-ancestor
139368346|NCT01652716|Hormones|hormones|mesh-ancestor
139368347|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368348|NCT02459613|Annexin A5|annexin a5|mesh-list
139368349|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368350|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368351|NCT02251249|Acetaminophen|acetaminophen|mesh-list
139368352|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139368353|NCT02251249|Analgesics|analgesics|mesh-ancestor
139368354|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
139368355|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368356|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368357|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
139368358|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
139368359|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139368360|NCT03292263|Nivolumab|nivolumab|mesh-list
139368361|NCT03292263|Melphalan|melphalan|mesh-list
139368362|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139368363|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368364|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139368365|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368366|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139368367|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
139368368|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139368369|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139368370|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
139368371|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368372|NCT02115763|Caffeine|caffeine|mesh-list
139368373|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139368374|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368375|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139368376|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368377|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139183911|NCT03923231|Ritonavir|ritonavir|mesh-list
139368378|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139368379|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139368380|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
139368381|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368382|NCT03286803|Vaccines|vaccines|mesh-list
139368383|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
139368384|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368385|NCT03292185|Insulin|insulin|mesh-list
139368386|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139368387|NCT03292185|Liraglutide|liraglutide|mesh-list
139368388|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
139368389|NCT03292185|Xultophy|xultophy|mesh-list
139368390|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139368391|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368392|NCT03292185|Incretins|incretins|mesh-ancestor
139368393|NCT03292185|Hormones|hormones|mesh-ancestor
139368394|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368395|NCT02109679|Metformin|metformin|mesh-list
139368396|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139368397|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368398|NCT05023304|Prednisolone|prednisolone|mesh-list
139368399|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368400|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
139368401|NCT05023304|Hormones|hormones|mesh-ancestor
139368402|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368403|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368404|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139368405|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368406|NCT02109913|Everolimus|everolimus|mesh-list
139368407|NCT02109913|Exemestane|exemestane|mesh-list
139368408|NCT02109913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139368409|NCT02109913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139368410|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368411|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368412|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139368413|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
139368414|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368415|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368416|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139368417|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139368418|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139368419|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
139368420|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368421|NCT02116231|Cisplatin|cisplatin|mesh-list
139368422|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368423|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
139368424|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139368425|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
139368426|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
139368427|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139368428|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
139368429|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368430|NCT02116465|Levodopa|levodopa|mesh-list
139368431|NCT02116465|Carbidopa|carbidopa|mesh-list
139368432|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139368433|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139368434|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139368435|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
139368436|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368437|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368438|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368439|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139368440|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368441|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139368442|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
139368443|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
139368444|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139368445|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139368446|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
139368447|NCT02119117|Vitamins|vitamins|mesh-ancestor
139368448|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
139368449|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368451|NCT05016128|Esketamine|esketamine|mesh-list
139368452|NCT05016128|Analgesics|analgesics|mesh-ancestor
139368453|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
139368454|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368455|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368456|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139368457|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139368458|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
139368459|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
139368460|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139368461|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139368462|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139368463|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368464|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368465|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
139368466|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139368468|NCT02111317|Peficitinib|peficitinib|mesh-list
139368469|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139368470|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139368471|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139368472|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368473|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139368474|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368475|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
139368476|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368477|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139368478|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
139368479|NCT03553615|Ivermectin|ivermectin|mesh-list
139368480|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139368481|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368482|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
139368483|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139368484|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139368485|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368486|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139368487|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139368488|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368489|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368490|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368491|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139368492|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
139368493|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139368494|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368495|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139368496|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139368497|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139368498|NCT02111473|Testosterone|testosterone|mesh-list
139368499|NCT02111473|Androgens|androgens|mesh-ancestor
139368500|NCT02111473|Hormones|hormones|mesh-ancestor
139368501|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368502|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368503|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
139368504|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139368505|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139368506|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
139368507|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368508|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368509|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368510|NCT02119273|Prednisone|prednisone|mesh-list
139368511|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368512|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
139368513|NCT02119273|Hormones|hormones|mesh-ancestor
139368514|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368515|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368516|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139368517|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368518|NCT05029076|Liraglutide|liraglutide|mesh-list
139368519|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139368520|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368521|NCT05029076|Incretins|incretins|mesh-ancestor
139368522|NCT05029076|Hormones|hormones|mesh-ancestor
139368523|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368524|NCT05016440|Lisinopril|lisinopril|mesh-list
139368525|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139368526|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
139368527|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368528|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368529|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139368530|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139368531|NCT05016440|Protective Agents|protective agents|mesh-ancestor
139368532|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368533|NCT02111629|Fluconazole|fluconazole|mesh-list
139368534|NCT02111629|Secnidazole|secnidazole|mesh-list
139025436|NCT01013558|Remifentanil|remifentanil|mesh-list
139368535|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
139368536|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368537|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139368538|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139368539|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368540|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368541|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139368542|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
139368543|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368544|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368545|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139368546|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139368547|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139368548|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139368549|NCT02111707|Indomethacin|indomethacin|mesh-list
139368550|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139368551|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139368552|NCT02111707|Analgesics|analgesics|mesh-ancestor
139368553|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
139368554|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368555|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368556|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368557|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139368558|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
139368559|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
139368560|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139368561|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139368562|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368563|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368564|NCT03552601|Methamphetamine|methamphetamine|mesh-list
139368565|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139368566|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368567|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
139368568|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
139368569|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368570|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
139368571|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368572|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368573|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
139368574|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139368575|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139368576|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139368577|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139368578|NCT05021588|Anticoagulants|anticoagulants|mesh-list
139368579|NCT03087890|Trimethoprim|trimethoprim|mesh-list
139368580|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139368581|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
139368582|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139368583|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368584|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
139368585|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139368586|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139368587|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139368588|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368589|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368590|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139368591|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139368592|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139368593|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139368594|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
139368595|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368596|NCT02117401|Midazolam|midazolam|mesh-list
139368597|NCT02117401|Ketamine|ketamine|mesh-list
139368598|NCT02117401|Remifentanil|remifentanil|mesh-list
139368599|NCT02117401|Propofol|propofol|mesh-list
139368600|NCT02117401|Mivacurium|mivacurium|mesh-list
139368601|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139368602|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139368603|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368604|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139368605|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
139368606|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
139368607|NCT02117401|Analgesics|analgesics|mesh-ancestor
139368608|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
139368609|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368610|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139368611|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139368612|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139368613|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368614|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368615|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139368616|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139368617|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139368618|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139368619|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
139368620|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
139368621|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139368622|NCT02117401|Narcotics|narcotics|mesh-ancestor
139368623|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139368624|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139368625|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139368626|NCT04434404|Silymarin|silymarin|mesh-list
139368627|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
139368628|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368629|NCT04434404|Protective Agents|protective agents|mesh-ancestor
139368630|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368631|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
139368632|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139368633|NCT02251483|Antibodies|antibodies|mesh-list
139368634|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
139368635|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368636|NCT02117869|Furocoumarins|furocoumarins|mesh-list
139368637|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
139368638|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139368639|NCT02120599|Folic Acid|folic acid|mesh-list
139368640|NCT02120599|Hematinics|hematinics|mesh-ancestor
139368641|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
139368642|NCT02120599|Vitamins|vitamins|mesh-ancestor
139368643|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
139368644|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368645|NCT02112097|Etanercept|etanercept|mesh-list
139368646|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139368647|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139368648|NCT02112097|Analgesics|analgesics|mesh-ancestor
139368649|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
139368650|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368651|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368652|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368653|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139368654|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139368655|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139368656|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
139368657|NCT02112175|Lenalidomide|lenalidomide|mesh-list
139368658|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
139368659|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368660|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139368661|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139368662|NCT02112175|Growth Substances|growth substances|mesh-ancestor
139368663|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
139368664|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368665|NCT03553537|Prednisone|prednisone|mesh-list
139368666|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
139368667|NCT03553537|Doxorubicin|doxorubicin|mesh-list
139368668|NCT03553537|Vincristine|vincristine|mesh-list
139368669|NCT03553537|Decitabine|decitabine|mesh-list
139368670|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139368671|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
139368672|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368673|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139368674|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139368675|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
139368676|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368677|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368678|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139368679|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139368680|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139368681|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139368682|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368683|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368684|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
139025587|NCT00488826|Vaccines|vaccines|mesh-list
139368685|NCT03553537|Hormones|hormones|mesh-ancestor
139368686|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368687|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139368688|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139368689|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
139368690|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
139368691|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
139368692|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139368693|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
139368694|NCT04434170|Valsartan|valsartan|mesh-list
139368695|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139368696|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139368697|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139368698|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139368699|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368700|NCT03086174|Antibodies|antibodies|mesh-list
139368701|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139368702|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
139368703|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368704|NCT03085784|Aflibercept|aflibercept|mesh-list
139368705|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139368706|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139368707|NCT03085784|Growth Substances|growth substances|mesh-ancestor
139368708|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368709|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
139368710|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368711|NCT05021276|Basiliximab|basiliximab|mesh-list
139368712|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139368713|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
139368714|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368715|NCT05014490|Etoricoxib|etoricoxib|mesh-list
139368716|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139368717|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139368718|NCT05014490|Analgesics|analgesics|mesh-ancestor
139368719|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
139368720|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368721|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368722|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368723|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139368724|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139368725|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139368726|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368727|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368728|NCT05020964|Trastuzumab|trastuzumab|mesh-list
139368729|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139368730|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368731|NCT05014100|Lenalidomide|lenalidomide|mesh-list
139368732|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
139368733|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368734|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139368735|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139368736|NCT05014100|Growth Substances|growth substances|mesh-ancestor
139368737|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
139368738|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368739|NCT05027126|Folic Acid|folic acid|mesh-list
139368740|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
139368741|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139368742|NCT05027126|Vitamins|vitamins|mesh-ancestor
139368743|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
139368744|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368745|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139368746|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139368747|NCT05027126|Analgesics|analgesics|mesh-ancestor
139368748|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
139368749|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368750|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368751|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139368752|NCT05027126|Hematinics|hematinics|mesh-ancestor
139368753|NCT02120677|Itraconazole|itraconazole|mesh-list
139368754|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
139368755|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368756|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139368757|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139368758|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368759|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368760|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139368761|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
139368762|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368763|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368764|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139368765|NCT02120911|Trastuzumab|trastuzumab|mesh-list
139368766|NCT02120911|Pertuzumab|pertuzumab|mesh-list
139368767|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139368768|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368769|NCT02112487|Macitentan|macitentan|mesh-list
139368770|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139368771|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139368772|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368773|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139368774|NCT03094442|Dexamethasone|dexamethasone|mesh-list
139368775|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368776|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
139368777|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
139368778|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368779|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368780|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139368781|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
139368782|NCT03094442|Hormones|hormones|mesh-ancestor
139368783|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368784|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139368785|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368786|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
139368787|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138927687|NCT02582996|Acetaminophen|acetaminophen|mesh-list
139368788|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368789|NCT02112643|Selenium|selenium|mesh-list
139368790|NCT02112643|Selenic Acid|selenic acid|mesh-list
139368791|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
139368792|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368793|NCT02112643|Protective Agents|protective agents|mesh-ancestor
139368794|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368795|NCT02112643|Trace Elements|trace elements|mesh-ancestor
139368796|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
139368797|NCT02112721|Vitamin D|vitamin d|mesh-list
139368798|NCT02112721|Vitamins|vitamins|mesh-ancestor
139368799|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
139368800|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368801|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139368802|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139368803|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
139368804|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368805|NCT02122939|Escitalopram|escitalopram|mesh-list
139368806|NCT02122939|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139368807|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139368808|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139368809|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368810|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368811|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
139368812|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368813|NCT04434248|Ritonavir|ritonavir|mesh-list
139368814|NCT04434248|Lopinavir|lopinavir|mesh-list
139368815|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
139368816|NCT04434248|Chloroquine|chloroquine|mesh-list
139368817|NCT04434248|Favipiravir|favipiravir|mesh-list
139368818|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139368819|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139368820|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
139368821|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368822|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368823|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139368824|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139368825|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
139368826|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368827|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139368828|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139368829|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
139368830|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139368831|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139368832|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139368833|NCT04434248|Amebicides|amebicides|mesh-ancestor
139368834|NCT02121457|Selenium|selenium|mesh-list
139368835|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
139368836|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368837|NCT02121457|Protective Agents|protective agents|mesh-ancestor
139368838|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368839|NCT02121457|Trace Elements|trace elements|mesh-ancestor
139368840|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
139368841|NCT02251795|Aspirin|aspirin|mesh-list
139368842|NCT02251795|Ritonavir|ritonavir|mesh-list
139368843|NCT02251795|Darunavir|darunavir|mesh-list
139368844|NCT02251795|Tipranavir|tipranavir|mesh-list
139368845|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138927703|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
139368846|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139368847|NCT02251795|Analgesics|analgesics|mesh-ancestor
139368848|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
139368849|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368850|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368851|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368852|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139368853|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139368854|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139368855|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368856|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139368857|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139368858|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368859|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
139368860|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139368861|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139368862|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
139368863|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139368864|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139368865|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
139368866|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368867|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139368868|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139368869|NCT05013164|Leucovorin|leucovorin|mesh-list
139368870|NCT05013164|Folic Acid|folic acid|mesh-list
139368871|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
139368872|NCT05013164|Antidotes|antidotes|mesh-ancestor
139368873|NCT05013164|Protective Agents|protective agents|mesh-ancestor
139368874|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368875|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
139368876|NCT05013164|Vitamins|vitamins|mesh-ancestor
139368877|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
139368878|NCT05013164|Hematinics|hematinics|mesh-ancestor
139368879|NCT02251951|Paclitaxel|paclitaxel|mesh-list
139368880|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139368881|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368882|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
139368883|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
139368884|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
139368885|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368886|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139368887|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139368888|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
139368889|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368890|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139368891|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139368892|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
139368893|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
139368894|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368895|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368896|NCT02121613|Tamsulosin|tamsulosin|mesh-list
139368897|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
139368898|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139368899|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139368900|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139368901|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
139368902|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368903|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368904|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368905|NCT02121613|Urological Agents|urological agents|mesh-ancestor
139368906|NCT03091712|Insulin|insulin|mesh-list
139368907|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139368908|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368910|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
139368911|NCT03552211|Vitamins|vitamins|mesh-ancestor
139368912|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
139368913|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368914|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
139368915|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368916|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
139368917|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139368918|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
139368919|NCT03281187|Testosterone|testosterone|mesh-list
139368920|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
139368921|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
139368922|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139368923|NCT03281187|Androgens|androgens|mesh-ancestor
139368924|NCT03281187|Hormones|hormones|mesh-ancestor
139368925|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139368926|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368927|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139368928|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368929|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
139368930|NCT03291249|Omeprazole|omeprazole|mesh-list
139368931|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139368932|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139368933|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139368934|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368935|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368936|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
139368937|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
139368938|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139368939|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139368940|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368941|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139368942|NCT05013320|Analgesics|analgesics|mesh-ancestor
139368943|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
139368944|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139368945|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139368946|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139368947|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139368948|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
139368949|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368950|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368951|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139368952|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139368953|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139368954|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
139368955|NCT02437162|Golimumab|golimumab|mesh-list
139368956|NCT02437162|Ustekinumab|ustekinumab|mesh-list
139368957|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
139368958|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139368959|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139368960|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139368961|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
139368962|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139368963|NCT03291093|Flutemetamol|flutemetamol|mesh-list
139368964|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139368965|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368966|NCT02123563|Listerine|listerine|mesh-list
139368967|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139368968|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368969|NCT02122003|Sorafenib|sorafenib|mesh-list
139368970|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368971|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139368972|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368973|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139368974|NCT03079388|Azithromycin|azithromycin|mesh-list
139368975|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
139368976|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
139368977|NCT03079388|Albendazole|albendazole|mesh-list
139368978|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139368979|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139368980|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139368981|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
139368982|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139368983|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139368984|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139368985|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139368986|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025888|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139368987|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139368989|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
139368990|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139368991|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
139368992|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
139368993|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
139368994|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368995|NCT03079544|Asparaginase|asparaginase|mesh-list
139368996|NCT03079544|Pegaspargase|pegaspargase|mesh-list
139368997|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139368998|NCT03286101|Ivermectin|ivermectin|mesh-list
139368999|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139369000|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369001|NCT02437084|Atorvastatin|atorvastatin|mesh-list
139369002|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139369003|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139369004|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
139369005|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369006|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139369007|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139369008|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369009|NCT05009498|Vitamin D|vitamin d|mesh-list
139369010|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
139369011|NCT05009498|Vitamins|vitamins|mesh-ancestor
139369012|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
139369013|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369014|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139369015|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139369016|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139369017|NCT02406586|Carvedilol|carvedilol|mesh-list
139369018|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139369019|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139369020|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139369021|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
139369022|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369023|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369024|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369025|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139369026|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
139369027|NCT02406586|Protective Agents|protective agents|mesh-ancestor
139369028|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139369029|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139369030|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139369031|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
139369032|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139369033|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139369034|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139369035|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139369036|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139369037|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139369038|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139369039|NCT02406586|Analgesics|analgesics|mesh-ancestor
139369040|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
139369041|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369042|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139369043|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139369044|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
139369045|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139369046|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369047|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369048|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139369049|NCT03091166|Analgesics|analgesics|mesh-ancestor
139369050|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
139369051|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369052|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139369053|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139369054|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139369055|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
139369056|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369057|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369058|NCT02122393|Sertraline|sertraline|mesh-list
139369059|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
139369060|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139369061|NCT02122393|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139369062|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139369063|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139369064|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369065|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369066|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
139369067|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369068|NCT03821883|Aspirin|aspirin|mesh-list
139369069|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139369070|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139369071|NCT03821883|Analgesics|analgesics|mesh-ancestor
139369072|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
139369073|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369074|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369075|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139369076|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139369077|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139369078|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139369079|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369080|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139369081|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139369082|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369084|NCT03080480|Pioglitazone|pioglitazone|mesh-list
139369085|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139369086|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369087|NCT02126761|Vaccines|vaccines|mesh-list
139369088|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
139369089|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369090|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139369091|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139369092|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139369093|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139369094|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369095|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
139369096|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369097|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369098|NCT03280641|Warfarin|warfarin|mesh-list
139369099|NCT03280641|Dabigatran|dabigatran|mesh-list
139369100|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
139369101|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
139369102|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139369103|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
139369104|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369105|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369106|NCT03285165|Propofol|propofol|mesh-list
139369107|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139369108|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369109|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369110|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139369111|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
139369112|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
139369113|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
139369114|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139369115|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369116|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369117|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139369118|NCT03285087|Analgesics|analgesics|mesh-ancestor
139369119|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
139369120|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369121|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139369122|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139369123|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139369124|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
139369125|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369126|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369127|NCT02122627|Vitamin D|vitamin d|mesh-list
139369128|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
139369129|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
139369130|NCT02122627|Vitamins|vitamins|mesh-list
139369131|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
139369132|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369133|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139369134|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139369135|NCT02122705|Remifentanil|remifentanil|mesh-list
139369136|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139369137|NCT02122705|Narcotics|narcotics|mesh-ancestor
139369138|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369139|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369140|NCT02122705|Analgesics|analgesics|mesh-ancestor
139369141|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
139369142|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369143|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139369144|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139369145|NCT03384225|Cytarabine|cytarabine|mesh-list
139369146|NCT03384225|Fludarabine|fludarabine|mesh-list
139369147|NCT03384225|Busulfan|busulfan|mesh-list
139369148|NCT03384225|Cladribine|cladribine|mesh-list
139369149|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369150|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139369151|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
139369152|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369153|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139369154|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
139369155|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369156|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
139369157|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369158|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
139369159|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139369160|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139369161|NCT05019326|Andrographolide|andrographolide|mesh-list
139369162|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139369163|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139369164|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139369165|NCT05019326|Analgesics|analgesics|mesh-ancestor
139369166|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
139369167|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369168|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369169|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139369170|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139369171|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139369172|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369173|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
139369174|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139369175|NCT05008250|Metoprolol|metoprolol|mesh-list
139369176|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139369177|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139369178|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
139369179|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
139369180|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369181|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369182|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139369183|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139369184|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139369185|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
139369186|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369187|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369188|NCT03079076|Bupivacaine|bupivacaine|mesh-list
139369189|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
139369190|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
139369191|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369192|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369193|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
139369194|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369195|NCT03271749|Anesthetics|anesthetics|mesh-list
139369196|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369197|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369198|NCT03280407|Leucovorin|leucovorin|mesh-list
139369199|NCT03280407|Capecitabine|capecitabine|mesh-list
139369200|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
139369201|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
139369202|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139369203|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
139369204|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369205|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369206|NCT03280407|Antidotes|antidotes|mesh-ancestor
139369207|NCT03280407|Protective Agents|protective agents|mesh-ancestor
139026119|NCT00496470|Hormones|hormones|mesh-ancestor
139369208|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369209|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
139369210|NCT03280407|Vitamins|vitamins|mesh-ancestor
139369211|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
139369212|NCT03078842|Zinc|zinc|mesh-list
139369213|NCT03078842|Trace Elements|trace elements|mesh-ancestor
139369214|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
139369215|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369216|NCT05007860|Vaccines|vaccines|mesh-list
139369217|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
139369218|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369219|NCT03270033|Dexamethasone|dexamethasone|mesh-list
139369220|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
139369221|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
139369222|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139369223|NCT03270033|BB 1101|bb 1101|mesh-list
139369224|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139369225|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
139369226|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
139369227|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369228|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369229|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139369230|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
139369232|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369233|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139369234|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369235|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
139369236|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369237|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369238|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139369239|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369240|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139369241|NCT03270033|Analgesics|analgesics|mesh-ancestor
139369242|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
139369243|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139369244|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139369245|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139369246|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
139369247|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369248|NCT03280095|Acetaminophen|acetaminophen|mesh-list
139369249|NCT03280095|Codeine|codeine|mesh-list
139369250|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139369251|NCT03280095|Analgesics|analgesics|mesh-ancestor
139369252|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
139369253|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369254|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369255|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
139369256|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139369257|NCT03280095|Narcotics|narcotics|mesh-ancestor
139369258|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369259|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
139369260|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
139369261|NCT04463030|Vitamins|vitamins|mesh-list
139369262|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
139369263|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
139369264|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369265|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
139369266|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369267|NCT04463030|Protective Agents|protective agents|mesh-ancestor
139369268|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
139369269|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
139369270|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369271|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
139369272|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369273|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369274|NCT05010356|Insulin|insulin|mesh-list
139369275|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139369276|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369277|NCT03269955|Thrombin|thrombin|mesh-list
139369278|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
139369279|NCT03269955|Coagulants|coagulants|mesh-ancestor
139369280|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
139369281|NCT05006846|Narcotics|narcotics|mesh-ancestor
139369282|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369283|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369284|NCT05006846|Analgesics|analgesics|mesh-ancestor
139369285|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
139369286|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026185|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139369287|NCT02457520|Isotretinoin|isotretinoin|mesh-list
139369288|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
139369289|NCT02457585|Infliximab|infliximab|mesh-list
139369290|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139369292|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
139369293|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139369294|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139369295|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
139369296|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
139369297|NCT02457507|Vitamins|vitamins|mesh-ancestor
139369298|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
139369299|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369300|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
139369301|NCT02457507|Hematinics|hematinics|mesh-ancestor
139369302|NCT03265197|Lidocaine|lidocaine|mesh-list
139369303|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
139369304|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
139369305|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369306|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369307|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
139369308|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369309|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138927821|NCT00762255|Bevacizumab|bevacizumab|mesh-list
139369310|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139369311|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139369312|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139369313|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369314|NCT03078374|Warfarin|warfarin|mesh-list
139369315|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
139369316|NCT02788279|Atezolizumab|atezolizumab|mesh-list
139369317|NCT02788279|Antibodies|antibodies|mesh-list
139369318|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
139369319|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369320|NCT02788279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139369321|NCT02788279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369322|NCT02788279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139369323|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369324|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139369325|NCT03264651|Anastrozole|anastrozole|mesh-list
139369326|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139369327|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369328|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139369329|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139369330|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369331|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369332|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139369333|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
139369334|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369335|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369336|NCT03078062|Dexamethasone|dexamethasone|mesh-list
139369337|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139369338|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
139369339|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
139369340|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369341|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369342|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139369343|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
139369344|NCT03078062|Hormones|hormones|mesh-ancestor
139369345|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369346|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139369347|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369348|NCT02435992|Ozanimod|ozanimod|mesh-list
139369349|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139369350|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369351|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139369352|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
139369353|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369354|NCT02457351|Itraconazole|itraconazole|mesh-list
139183994|NCT03740243|Buprenorphine|buprenorphine|mesh-list
139369355|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
139369356|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369357|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139369358|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138927868|NCT04340882|Docetaxel|docetaxel|mesh-list
139369359|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369360|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369361|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139369362|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
139369363|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369364|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369365|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139369366|NCT02788513|BI 425809|bi 425809|mesh-list
139369367|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
139369368|NCT03077828|Carboplatin|carboplatin|mesh-list
139369369|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
139369370|NCT03077828|Etoposide|etoposide|mesh-list
139369371|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
139369372|NCT03077828|Ifosfamide|ifosfamide|mesh-list
139369373|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
139369374|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
139369375|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369376|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139369377|NCT03077828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139369378|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369379|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139369380|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139369381|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139369382|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369383|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139369384|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
139369385|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
139369386|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
139369387|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
139369388|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
139369389|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
139369390|NCT02126995|Metadoxine|metadoxine|mesh-list
139369391|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139369392|NCT05257291|Melatonin|melatonin|mesh-list
139369393|NCT05257291|Antioxidants|antioxidants|mesh-ancestor
139369394|NCT05257291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369395|NCT05257291|Protective Agents|protective agents|mesh-ancestor
139369396|NCT05257291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369397|NCT05257291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369398|NCT04930900|Epinephrine|epinephrine|mesh-list
139369399|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139369400|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139369401|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
139369402|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369403|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369404|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369405|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139369406|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139369407|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
139369408|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369409|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139369410|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
139369411|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
139369412|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
139369413|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139369414|NCT02458209|Bococizumab|bococizumab|mesh-list
139369415|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139369416|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139369417|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
139369418|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369419|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139369420|NCT02127151|Talazoparib|talazoparib|mesh-list
139369421|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139369422|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369423|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184001|NCT03740243|Analgesics|analgesics|mesh-ancestor
139369424|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369425|NCT03077516|Meloxicam|meloxicam|mesh-list
139369426|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139369427|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139369428|NCT03077516|Analgesics|analgesics|mesh-ancestor
139369429|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
139369430|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369431|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369432|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139369433|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139369434|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139369435|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139369436|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026335|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
139369437|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369438|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139369439|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139369441|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139369442|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369443|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
139369444|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
139369445|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
139369446|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369447|NCT03072992|Curcumin|curcumin|mesh-list
139369448|NCT03072992|Paclitaxel|paclitaxel|mesh-list
139369449|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139369450|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369451|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
139369452|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
139369453|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
139369454|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369455|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139369456|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139369457|NCT03072992|Analgesics|analgesics|mesh-ancestor
139369458|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
139369459|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369460|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369461|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139369462|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139369463|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369464|NCT03267771|Progesterone|progesterone|mesh-list
139369465|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
139369466|NCT03267771|Progestins|progestins|mesh-ancestor
139369467|NCT03267771|Hormones|hormones|mesh-ancestor
138927902|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369468|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369469|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369470|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
139369471|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139369472|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139369473|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369474|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
139369475|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
139369476|NCT02456961|Riboflavin|riboflavin|mesh-list
139369477|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
139369478|NCT02456961|Vitamins|vitamins|mesh-ancestor
139369479|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
139369480|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369481|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139369482|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
139369483|NCT03551197|Budesonide|budesonide|mesh-list
139369484|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
139369485|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139369486|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139369487|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
139369488|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369489|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369490|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139369491|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
139369492|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
139369493|NCT03551197|Hormones|hormones|mesh-ancestor
139369494|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369495|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139369496|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139369497|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139369498|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
139369499|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369500|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369501|NCT02435836|Aripiprazole|aripiprazole|mesh-list
139369502|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
139369503|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139369504|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139369505|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139369506|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369507|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369508|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
139369509|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
139369510|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369511|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369512|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139369513|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139369514|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
139369515|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139369516|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139369517|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139369518|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139369519|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139369520|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139369521|NCT05075265|Methadone|methadone|mesh-list
139369522|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139369523|NCT05075265|Narcotics|narcotics|mesh-ancestor
139369524|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369525|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369526|NCT05075265|Analgesics|analgesics|mesh-ancestor
139369527|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
139369528|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369529|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
139369530|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
139369531|NCT02127541|Exenatide|exenatide|mesh-list
139369532|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139369533|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369534|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139369535|NCT02127541|Incretins|incretins|mesh-ancestor
139369536|NCT02127541|Hormones|hormones|mesh-ancestor
139369537|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369538|NCT03263871|Micronutrients|micronutrients|mesh-list
139369539|NCT03263871|Trace Elements|trace elements|mesh-list
139369540|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369541|NCT04992182|Vaccines|vaccines|mesh-list
139369542|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
139369543|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369544|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
139369545|NCT02124655|Listerine|listerine|mesh-list
139369546|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139369547|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369548|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
139369549|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
139369550|NCT03263715|Hormones|hormones|mesh-ancestor
139369551|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369552|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369553|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
139369554|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139369555|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
139369556|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369557|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139369558|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139369559|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
139369560|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369561|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369562|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139369564|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139369565|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369566|NCT02456740|Analgesics|analgesics|mesh-ancestor
139369567|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
139369568|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369569|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369570|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139369571|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139369572|NCT03266601|Interferons|interferons|mesh-list
139369573|NCT03266601|Ribavirin|ribavirin|mesh-list
139369574|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369575|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
139369576|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369577|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
139369578|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369579|NCT02458755|Atorvastatin|atorvastatin|mesh-list
139369580|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139369581|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139369582|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139369583|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
139369584|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369585|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139369586|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139369587|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369588|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
139369589|NCT04462406|Nivolumab|nivolumab|mesh-list
139369590|NCT04462406|Ipilimumab|ipilimumab|mesh-list
138927941|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369591|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139369592|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369593|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139369594|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369595|NCT02400580|Acetaminophen|acetaminophen|mesh-list
139369596|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139369597|NCT02400580|Analgesics|analgesics|mesh-ancestor
139369598|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
139369599|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369600|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369601|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
139369602|NCT03262857|Lidocaine|lidocaine|mesh-list
139369603|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
139369604|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
139369605|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
139369606|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369607|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369608|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
139369609|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369610|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139369611|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139369612|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139369613|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139369614|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369615|NCT03262857|Analgesics|analgesics|mesh-ancestor
139369616|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
139369617|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139369618|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139369619|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
139369620|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139369621|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
139369622|NCT02127697|Albuterol|albuterol|mesh-list
139369623|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139369624|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
139369625|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369626|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369627|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139369628|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
139369629|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
139369630|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139369631|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139369632|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139369633|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139369634|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
139369635|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369636|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369637|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139369638|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139369639|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139369640|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
139369641|NCT02127775|Lesinurad|lesinurad|mesh-list
139369642|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
139369643|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139369644|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
139369645|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
139369646|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139369647|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
139369648|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369649|NCT02252341|Expectorants|expectorants|mesh-ancestor
138927968|NCT02558205|Liver Extracts|liver extracts|mesh-list
139369650|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
139369651|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139369652|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
139369653|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369654|NCT02252341|Protective Agents|protective agents|mesh-ancestor
139369655|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369656|NCT02252341|Antidotes|antidotes|mesh-ancestor
139369657|NCT02127853|Gabapentin|gabapentin|mesh-list
139369658|NCT02127853|Analgesics|analgesics|mesh-ancestor
139369659|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
139369660|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369661|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369662|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
139369663|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139369664|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139369665|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369666|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139369667|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139369668|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139369669|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369670|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369671|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
139369673|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139369674|NCT03266445|Naloxone|naloxone|mesh-list
139369675|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139369676|NCT03266445|Narcotics|narcotics|mesh-ancestor
139369677|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369678|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369679|NCT03266445|Analgesics|analgesics|mesh-ancestor
139369680|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
139369681|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369682|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139369683|NCT01367119|Ketamine|ketamine|mesh-list
139369684|NCT01367119|Methohexital|methohexital|mesh-list
139369685|NCT01367119|Analgesics|analgesics|mesh-ancestor
139369686|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
139369687|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369688|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369689|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139369690|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139369691|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
139369692|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
139369693|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369694|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139369695|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139369696|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369697|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369698|NCT02252107|Decitabine|decitabine|mesh-list
139369699|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139369700|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
139369701|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369702|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369703|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369704|NCT03262545|Apatinib|apatinib|mesh-list
139369705|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369706|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139369707|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369708|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369709|NCT03262077|Methylene Blue|methylene blue|mesh-list
139369710|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369711|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369712|NCT03265899|Lactitol|lactitol|mesh-list
139369713|NCT03265899|Oxytocin|oxytocin|mesh-list
139369714|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
139369715|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139369716|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369717|NCT03265899|Cathartics|cathartics|mesh-ancestor
139369718|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139369719|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
139369720|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
139369721|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369722|NCT02125201|Fentanyl|fentanyl|mesh-list
139369723|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139369724|NCT02125201|Narcotics|narcotics|mesh-ancestor
139369725|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369726|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369727|NCT02125201|Analgesics|analgesics|mesh-ancestor
139369728|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
139369729|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369730|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139369731|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139369732|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
139369733|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
139369734|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
139369735|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369736|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139369737|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369738|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369739|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
139369740|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369741|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369742|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139369743|NCT03074942|Reslizumab|reslizumab|mesh-list
139369744|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139369745|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
139369746|NCT02125435|ASP2408|asp2408|mesh-list
139369747|NCT02125435|Immunoconjugates|immunoconjugates|mesh-ancestor
139369748|NCT02125435|Immunologic Factors|immunologic factors|mesh-ancestor
139369749|NCT02125435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369750|NCT02458911|Paclitaxel|paclitaxel|mesh-list
139369751|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139369752|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369753|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
138775777|NCT04240834|Aspirin|aspirin|mesh-list
139369754|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
139369755|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
139369756|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369757|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
139369758|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
139369759|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369760|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
139369761|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369762|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369764|NCT02128243|Cisplatin|cisplatin|mesh-list
139369765|NCT02128243|Docetaxel|docetaxel|mesh-list
139369766|NCT02128243|Capecitabine|capecitabine|mesh-list
139369767|NCT02128243|Fluorouracil|fluorouracil|mesh-list
139369768|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
139369769|NCT02128243|Epirubicin|epirubicin|mesh-list
139369770|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
139369771|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369772|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
139369773|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
139369774|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
139369775|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369776|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139369777|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
139369778|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139369779|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
139369780|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369781|NCT02128243|Antidotes|antidotes|mesh-ancestor
139369782|NCT02128243|Protective Agents|protective agents|mesh-ancestor
139369783|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
139369784|NCT02128243|Vitamins|vitamins|mesh-ancestor
139369785|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
139369786|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139369787|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139369788|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139369789|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369790|NCT03072290|Triamcinolone|triamcinolone|mesh-list
139369791|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139369792|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139369793|NCT03072290|Lidocaine|lidocaine|mesh-list
139369794|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139369795|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
139369796|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
139369797|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369798|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369799|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
139369800|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369801|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139369802|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139369803|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139369804|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139369805|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369806|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139369807|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
139369808|NCT03072290|Hormones|hormones|mesh-ancestor
139369809|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369810|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139026718|NCT00466440|Hormones|hormones|mesh-ancestor
139369811|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
139369812|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369813|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139369814|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
139369816|NCT02132689|Calcium heparin|calcium heparin|mesh-list
139369817|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139369818|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369819|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
139369820|NCT02128321|Repaglinide|repaglinide|mesh-list
139369821|NCT02128321|Isavuconazole|isavuconazole|mesh-list
139369822|NCT02128321|Caffeine|caffeine|mesh-list
139369823|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139369824|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369825|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139369826|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369827|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369828|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139369829|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139369830|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
139369831|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369832|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139369833|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
139369834|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369835|NCT02457975|Ranibizumab|ranibizumab|mesh-list
139369836|NCT02457975|Aflibercept|aflibercept|mesh-list
139369837|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369838|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139369839|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139369840|NCT02457975|Growth Substances|growth substances|mesh-ancestor
139369841|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369842|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
139369843|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139369844|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369845|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139369846|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369847|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369848|NCT02125903|Ropivacaine|ropivacaine|mesh-list
139369849|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
139369850|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
139369851|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369852|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369853|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
139369854|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369855|NCT04997564|Tenofovir|tenofovir|mesh-list
139369856|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
139369857|NCT04997564|Velpatasvir|velpatasvir|mesh-list
139369858|NCT04997564|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139369859|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
139369860|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369861|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139369862|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139369863|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928043|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
139369864|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369865|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139369866|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139369867|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
139369868|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139369869|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139369870|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369871|NCT03842943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139369872|NCT03842943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369873|NCT02126137|Ezetimibe|ezetimibe|mesh-list
139369874|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139369875|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139369876|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
139369877|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369878|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139369879|NCT02126293|Zinc|zinc|mesh-list
139369880|NCT02126293|Trace Elements|trace elements|mesh-ancestor
139369881|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
139369882|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369883|NCT03261921|Dexamethasone|dexamethasone|mesh-list
139369884|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
139369885|NCT03261921|Bupivacaine|bupivacaine|mesh-list
139369886|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139369887|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
139026820|NCT00508742|Vaccines|vaccines|mesh-list
139369888|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
139369889|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369890|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369891|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139369892|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
139369893|NCT03261921|Hormones|hormones|mesh-ancestor
139369894|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369895|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139369896|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369897|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
139369898|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
139369899|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139369900|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
139369901|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139369902|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139369903|NCT03261921|Analgesics|analgesics|mesh-ancestor
139369904|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139369905|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139369906|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139369907|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
139369908|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139369909|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369910|NCT02635724|Peramivir|peramivir|mesh-list
139369911|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
139369912|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369913|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369914|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369915|NCT02133469|Vaccines|vaccines|mesh-list
139369916|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139369917|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
139369918|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369919|NCT02126527|Sirolimus|sirolimus|mesh-list
139369920|NCT02126527|Auranofin|auranofin|mesh-list
139369921|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139369922|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369923|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139369924|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369925|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
139369926|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139369927|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
139369928|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369929|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139369930|NCT02133625|Pioglitazone|pioglitazone|mesh-list
139369931|NCT02133625|Carboplatin|carboplatin|mesh-list
139369932|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369933|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139369934|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369935|NCT02260687|Aflibercept|aflibercept|mesh-list
139369936|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139369937|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139369938|NCT02260687|Growth Substances|growth substances|mesh-ancestor
139369939|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369940|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
139369941|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369942|NCT03071822|Dexamethasone|dexamethasone|mesh-list
139369943|NCT03071822|Gemcitabine|gemcitabine|mesh-list
139369944|NCT03071822|Etoposide|etoposide|mesh-list
139369945|NCT03071822|Asparaginase|asparaginase|mesh-list
139369946|NCT03071822|Ifosfamide|ifosfamide|mesh-list
139369947|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139369948|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
139369949|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
139369950|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139369951|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369952|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139369953|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
139369954|NCT03071822|Hormones|hormones|mesh-ancestor
139369955|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369956|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139369957|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139369958|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139369959|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
139184059|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
139369960|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369961|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139369962|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139369963|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139369964|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369965|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139369966|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
139369968|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139369969|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139369970|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139369971|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139369973|NCT04991012|Hormones|hormones|mesh-ancestor
139369974|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139369975|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369976|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139369977|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
139369978|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369979|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369980|NCT02252731|Warfarin|warfarin|mesh-list
139369981|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
139369982|NCT02128633|Listerine|listerine|mesh-list
139369983|NCT02128633|Fluorides|fluorides|mesh-list
139369984|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
139369985|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
139369986|NCT02128633|Protective Agents|protective agents|mesh-ancestor
139369987|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139369988|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139369989|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369990|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
139369991|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
139369992|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139369993|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139369994|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139369995|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139369996|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139369997|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139369998|NCT03252561|Anesthetics|anesthetics|mesh-list
139369999|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
139370000|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370001|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604451|NCT00177567|Lamotrigine|lamotrigine|mesh-list
139370002|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
139370003|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370004|NCT02252263|Elotuzumab|elotuzumab|mesh-list
139370005|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370006|NCT04996550|Metoprolol|metoprolol|mesh-list
139370007|NCT04996550|Carvedilol|carvedilol|mesh-list
139370008|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139370009|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139370010|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
139370011|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
139370012|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370013|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370014|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139370015|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139370016|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139370017|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
139370018|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139370019|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370020|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
139370021|NCT04996550|Protective Agents|protective agents|mesh-ancestor
139370022|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139370023|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139370024|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139370025|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
139370026|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139370027|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139370028|NCT03252171|Immunomodulating Agents|immunomodulating agents|mesh-list
139370029|NCT03252171|Immunologic Factors|immunologic factors|mesh-ancestor
139184075|NCT03922373|Benzonatate|benzonatate|mesh-list
139370030|NCT03252171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370031|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139370032|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
139370033|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370034|NCT02135965|Caffeine|caffeine|mesh-list
139370035|NCT02135965|Albuterol|albuterol|mesh-list
139370036|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139370037|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370038|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139370039|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370040|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370041|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139370043|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
139370044|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139370045|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139370046|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
139370047|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370048|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139370049|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
139370050|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
139370051|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139370052|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139370053|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139370054|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139370055|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
139370056|NCT02455401|Remifentanil|remifentanil|mesh-list
139370057|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139370058|NCT02455401|Narcotics|narcotics|mesh-ancestor
139370059|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370060|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370061|NCT02455401|Analgesics|analgesics|mesh-ancestor
139370062|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
139370063|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370064|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
139370065|NCT03260829|Vitamins|vitamins|mesh-ancestor
139370066|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
139370067|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370068|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
139370069|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370070|NCT03260829|Protective Agents|protective agents|mesh-ancestor
139370071|NCT02134093|Midazolam|midazolam|mesh-list
139370072|NCT02134093|Sufentanil|sufentanil|mesh-list
139370073|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
139370074|NCT02134093|Remifentanil|remifentanil|mesh-list
139370075|NCT02134093|Anesthetics|anesthetics|mesh-list
139370076|NCT02134093|Propofol|propofol|mesh-list
139370077|NCT02134093|Etomidate|etomidate|mesh-list
139370078|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
139370079|NCT02134093|Rocuronium|rocuronium|mesh-list
139370080|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370081|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370082|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139370083|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139370084|NCT02134093|Analgesics|analgesics|mesh-ancestor
139370085|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
139370086|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370087|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139370088|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139370089|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139370090|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
139370091|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139370092|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370093|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139370094|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
139370095|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139370096|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139370097|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139370098|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139370099|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
139370100|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
139370101|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139370102|NCT02134093|Narcotics|narcotics|mesh-ancestor
138776121|NCT01107444|Docetaxel|docetaxel|mesh-list
139370103|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139370104|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139370105|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139370106|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139370107|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139370108|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
139370110|NCT03074786|Emtricitabine|emtricitabine|mesh-list
139370111|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139370112|NCT03074786|Dapivirine|dapivirine|mesh-list
139370113|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
139370114|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370115|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139370116|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139370117|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370118|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370119|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139370120|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139370121|NCT03070028|Phenol|phenol|mesh-list
139370122|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139370123|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370124|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
139370125|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139370126|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139370127|NCT03260439|Tramadol|tramadol|mesh-list
139370128|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139370129|NCT03260439|Narcotics|narcotics|mesh-ancestor
139370130|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370131|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370132|NCT03260439|Analgesics|analgesics|mesh-ancestor
139370133|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
139370134|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370135|NCT02634788|Buprenorphine|buprenorphine|mesh-list
139370136|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139370137|NCT02634788|Narcotics|narcotics|mesh-ancestor
139370138|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370139|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370140|NCT02634788|Analgesics|analgesics|mesh-ancestor
139370141|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
139370142|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370143|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139370144|NCT03260283|Fentanyl|fentanyl|mesh-list
139370145|NCT03260283|Meperidine|meperidine|mesh-list
139370146|NCT03260283|Ropivacaine|ropivacaine|mesh-list
139370147|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
139370148|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
139370149|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370150|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370151|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
139370152|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370153|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139370154|NCT03260283|Narcotics|narcotics|mesh-ancestor
139370155|NCT03260283|Analgesics|analgesics|mesh-ancestor
139370156|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139370157|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139370158|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
139370159|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
139370160|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139370161|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139370162|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370163|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
139370164|NCT03251469|Coagulants|coagulants|mesh-ancestor
139370165|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
139370166|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139370167|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
139370168|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370169|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
139370170|NCT04986644|Protective Agents|protective agents|mesh-ancestor
139370171|NCT02785939|Docetaxel|docetaxel|mesh-list
139370172|NCT02785939|Palbociclib|palbociclib|mesh-list
139370173|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370174|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
139370175|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
139370176|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
139370177|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370178|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139370179|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370180|NCT03583229|Aspirin|aspirin|mesh-list
139370181|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139370182|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139370183|NCT03583229|Analgesics|analgesics|mesh-ancestor
139370184|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
139370185|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370186|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370187|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139370188|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139370189|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139370190|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139370191|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370192|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139370193|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139370194|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370195|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
139370196|NCT02259803|Amlodipine|amlodipine|mesh-list
139370197|NCT02259803|Telmisartan|telmisartan|mesh-list
139370198|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139370199|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139370200|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139370201|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139370202|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370203|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139370204|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370205|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
139370206|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139370207|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139370208|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
139370209|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370210|NCT03069950|Leucovorin|leucovorin|mesh-list
139370211|NCT03069950|Dexamethasone|dexamethasone|mesh-list
139370212|NCT03069950|Fluorouracil|fluorouracil|mesh-list
139370213|NCT03069950|Irinotecan|irinotecan|mesh-list
139370214|NCT03069950|Panitumumab|panitumumab|mesh-list
139370215|NCT03069950|Floxuridine|floxuridine|mesh-list
139370216|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139370217|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
139370218|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
139370219|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370220|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370221|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139370222|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
139370223|NCT03069950|Hormones|hormones|mesh-ancestor
139370224|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139370225|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139370226|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370227|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
139370228|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370229|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139370230|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139370231|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
139370232|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139370233|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139370234|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370235|NCT03069950|Antidotes|antidotes|mesh-ancestor
139370236|NCT03069950|Protective Agents|protective agents|mesh-ancestor
139370237|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
139370238|NCT03069950|Vitamins|vitamins|mesh-ancestor
139370239|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
139370240|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139370241|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139370242|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370243|NCT03577457|Oxytocin|oxytocin|mesh-list
139370244|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
139370245|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139370246|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370247|NCT02455245|Carboplatin|carboplatin|mesh-list
139370248|NCT02455245|Vincristine|vincristine|mesh-list
139370249|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604695|NCT00167960|Tazobactam|tazobactam|mesh-list
139370250|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139370251|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
139370252|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
139370253|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
139370254|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370255|NCT03537599|Daratumumab|daratumumab|mesh-list
139370256|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370257|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139370258|NCT04986254|Meropenem|meropenem|mesh-list
139370259|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
139370260|NCT04986254|Tazobactam|tazobactam|mesh-list
139370261|NCT04986254|Piperacillin|piperacillin|mesh-list
139370262|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139370263|NCT04986254|Penicillin G|penicillin g|mesh-list
139370264|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139370265|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
139370266|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370267|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139370268|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370269|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370270|NCT03257943|Ivermectin|ivermectin|mesh-list
139027160|NCT00385827|Prednisone|prednisone|mesh-list
139370271|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139370272|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370273|NCT04986098|Paclitaxel|paclitaxel|mesh-list
139370274|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139370275|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370276|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
139370277|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
139370278|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
139370279|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370280|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
139370281|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
139370282|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139370283|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370284|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370285|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139370286|NCT02239445|Analgesics|analgesics|mesh-ancestor
139370287|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
139370288|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370289|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139370290|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139370291|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139370292|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
139370293|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139370294|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370295|NCT03071042|Docetaxel|docetaxel|mesh-list
139370296|NCT03071042|Apatinib|apatinib|mesh-list
139370297|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370298|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
139370299|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
139370300|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
139370301|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370302|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139370303|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370304|NCT03582605|Amoxicillin|amoxicillin|mesh-list
139370305|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139370306|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370307|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
139370308|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
139370309|NCT04989140|Dexamethasone|dexamethasone|mesh-list
139370310|NCT04989140|Pomalidomide|pomalidomide|mesh-list
139370311|NCT04989140|Ixazomib|ixazomib|mesh-list
139370312|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138928135|NCT00768183|Morphine|morphine|mesh-list
139370313|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
139370314|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
139370315|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370316|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370317|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139370319|NCT04989140|Hormones|hormones|mesh-ancestor
139370320|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139370321|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139370322|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370323|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
139370324|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139370325|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139370326|NCT04989140|Growth Substances|growth substances|mesh-ancestor
139370327|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
139370328|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
139370329|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370330|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370331|NCT03246009|Lenograstim|lenograstim|mesh-list
139370332|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139370333|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
139370334|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370335|NCT03246399|Lorecivivint|lorecivivint|mesh-list
139370336|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139370337|NCT02134249|Cabergoline|cabergoline|mesh-list
139370338|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139370339|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139370340|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
139370341|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
139370342|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139370343|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370344|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370345|NCT03245853|Riboflavin|riboflavin|mesh-list
139370346|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
139370347|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
139370348|NCT03245853|Vitamins|vitamins|mesh-ancestor
139370349|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
139370350|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370351|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139370352|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
139370353|NCT03574649|Paclitaxel|paclitaxel|mesh-list
139370354|NCT03574649|Docetaxel|docetaxel|mesh-list
139370355|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
139370356|NCT03574649|Carboplatin|carboplatin|mesh-list
139370357|NCT03574649|Fluorouracil|fluorouracil|mesh-list
139370358|NCT03574649|Avelumab|avelumab|mesh-list
139370359|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139370360|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370361|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
139370362|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
139370363|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
139370364|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370365|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139370366|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
139370367|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370368|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139370369|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139370370|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
139370371|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139370372|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
139370373|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139370374|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139370375|NCT02128945|Fludarabine|fludarabine|mesh-list
139370376|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370377|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139370378|NCT03073928|Ropivacaine|ropivacaine|mesh-list
139370379|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
139370380|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
139370381|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370382|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370383|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
139370384|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370385|NCT02134405|Esomeprazole|esomeprazole|mesh-list
139370386|NCT02134405|Rebamipide|rebamipide|mesh-list
139370387|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139370388|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139370389|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139370390|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370391|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370392|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
139370393|NCT02134405|Protective Agents|protective agents|mesh-ancestor
139370394|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370395|NCT03574415|Fexuprazan|fexuprazan|mesh-list
139370396|NCT03574415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139370397|NCT02456025|Tacrolimus|tacrolimus|mesh-list
139370398|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139370399|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
139370400|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370401|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139370402|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370403|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370404|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
139370405|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139370406|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370407|NCT02136511|Rituximab|rituximab|mesh-list
139370408|NCT02136511|Idelalisib|idelalisib|mesh-list
139370409|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139370410|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370411|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
139370412|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370413|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139370414|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370415|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370416|NCT02136589|Diclofenac|diclofenac|mesh-list
139370417|NCT02136589|Travoprost|travoprost|mesh-list
139370418|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139370419|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139370420|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139027306|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
139370421|NCT02136589|Analgesics|analgesics|mesh-ancestor
139370422|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
139370423|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370424|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370425|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139370426|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139370427|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139370428|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370429|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370431|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139370432|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370433|NCT02129101|Azacitidine|azacitidine|mesh-list
139370434|NCT02129101|Decitabine|decitabine|mesh-list
139370435|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139370436|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
139370437|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370438|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370439|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370440|NCT02134717|Maraviroc|maraviroc|mesh-list
139370441|NCT02134717|Dimercaprol|dimercaprol|mesh-list
139370442|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139370443|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139370444|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370445|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139370446|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139370447|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
139370448|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370449|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139370450|NCT02134717|Chelating Agents|chelating agents|mesh-ancestor
139370451|NCT02134717|Sequestering Agents|sequestering agents|mesh-ancestor
139370452|NCT03245385|Halobetasol|halobetasol|mesh-list
139370453|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139370454|NCT02136823|Isradipine|isradipine|mesh-list
139370455|NCT02136823|Riluzole|riluzole|mesh-list
139370456|NCT02136823|Memantine|memantine|mesh-list
139370457|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139370458|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139370459|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
139370460|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139370461|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370462|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370463|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139370464|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139370465|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
139370466|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139370467|NCT02136823|Protective Agents|protective agents|mesh-ancestor
139370468|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139370469|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139370470|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139370471|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139370472|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
139370473|NCT03250143|Cyclosporine|cyclosporine|mesh-list
139370474|NCT03250143|Azathioprine|azathioprine|mesh-list
139370475|NCT03250143|Cyclosporins|cyclosporins|mesh-list
139370476|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370477|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370478|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139370479|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
139370480|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370481|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
139370482|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370483|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
139370484|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139370485|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139370486|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
139370487|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139370488|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370489|NCT03073850|Anticoagulants|anticoagulants|mesh-list
139370490|NCT03073850|Edoxaban|edoxaban|mesh-list
139370491|NCT03073850|Clopidogrel|clopidogrel|mesh-list
139370492|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370493|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370494|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139370495|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370496|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139370497|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139370498|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139370499|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
139370500|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139370501|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139370502|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
139370503|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139370504|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
139370505|NCT03257319|Morphine|morphine|mesh-list
139370506|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139370507|NCT03257319|Narcotics|narcotics|mesh-ancestor
139370508|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370509|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370510|NCT03257319|Analgesics|analgesics|mesh-ancestor
139370511|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
139370512|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370513|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
139370514|NCT03070574|Mesalamine|mesalamine|mesh-list
139370515|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139370516|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139370517|NCT03070574|Analgesics|analgesics|mesh-ancestor
139370518|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
139370519|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370520|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370521|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139370522|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139370523|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
139370524|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139370525|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370526|NCT03257241|Cytarabine|cytarabine|mesh-list
139370527|NCT03257241|Fludarabine|fludarabine|mesh-list
139370528|NCT03257241|Daunorubicin|daunorubicin|mesh-list
139370529|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
139370530|NCT03257241|Idarubicin|idarubicin|mesh-list
139370531|NCT03257241|Cladribine|cladribine|mesh-list
139370532|NCT03257241|Lenograstim|lenograstim|mesh-list
139370533|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370534|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139370535|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
139370536|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370537|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139370538|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
139370539|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370540|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
139370541|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370542|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139370543|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139370544|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139370545|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139370546|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370547|NCT03257241|Analgesics|analgesics|mesh-ancestor
139370548|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
139370549|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370550|NCT02129179|Glucagon|glucagon|mesh-list
139370551|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139370552|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139370553|NCT02129179|Hormones|hormones|mesh-ancestor
139370554|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139370555|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370556|NCT02129179|Incretins|incretins|mesh-ancestor
139370557|NCT02129257|Leucovorin|leucovorin|mesh-list
139370558|NCT02129257|Folic Acid|folic acid|mesh-list
139370559|NCT02129257|Fluorouracil|fluorouracil|mesh-list
139370560|NCT02129257|Irinotecan|irinotecan|mesh-list
139370561|NCT02129257|Aflibercept|aflibercept|mesh-list
139370562|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
139370563|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
138928190|NCT02558595|Niacin|niacin|mesh-list
139370564|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370565|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139370566|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370567|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139370568|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
139370569|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370570|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139370571|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139370572|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027454|NCT00494780|Hormones|hormones|mesh-ancestor
139370573|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139370574|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139370575|NCT02129257|Growth Substances|growth substances|mesh-ancestor
139370576|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
139370577|NCT02129257|Antidotes|antidotes|mesh-ancestor
139370578|NCT02129257|Protective Agents|protective agents|mesh-ancestor
139370579|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
139370580|NCT02129257|Vitamins|vitamins|mesh-ancestor
139370581|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
139370582|NCT02129257|Hematinics|hematinics|mesh-ancestor
139370583|NCT03245307|Apatinib|apatinib|mesh-list
139370584|NCT03245307|Nifedipine|nifedipine|mesh-list
139370585|NCT03245307|Warfarin|warfarin|mesh-list
139370586|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
139370587|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370588|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139370589|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370590|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370591|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139370592|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139370593|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139370594|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370595|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
139370596|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
139370597|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139370598|NCT02136979|Propofol|propofol|mesh-list
139370599|NCT02136979|Sevoflurane|sevoflurane|mesh-list
139370600|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139370601|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370602|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370603|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139370604|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
139370605|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
139370606|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139370607|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139370608|NCT02455011|Volagidemab|volagidemab|mesh-list
139370609|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139370610|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370611|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139370612|NCT03249285|Perindopril|perindopril|mesh-list
139370613|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139370614|NCT03249285|Diuretics|diuretics|mesh-ancestor
139370615|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
139370616|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370617|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139370618|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139370619|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370620|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139370621|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
139370622|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370623|NCT03249519|Cisplatin|cisplatin|mesh-list
139370624|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370625|NCT04983524|Propolis|propolis|mesh-list
139370626|NCT04983524|Calcium|calcium|mesh-list
139370627|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139370628|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370629|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370630|NCT03576911|Ubiquinone|ubiquinone|mesh-list
139370631|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
139370632|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
139370633|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370634|NCT03576911|Vitamins|vitamins|mesh-ancestor
139370635|NCT02634320|Aripiprazole|aripiprazole|mesh-list
139370636|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
139370637|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
139370638|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139370639|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139370640|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139370641|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370642|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370643|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
139370644|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
139370645|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139370646|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370647|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139370648|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139370649|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
139370650|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139370651|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139370652|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139370653|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139370654|NCT02435680|Carboplatin|carboplatin|mesh-list
139370655|NCT02435680|Gemcitabine|gemcitabine|mesh-list
139370656|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370657|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139370658|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
139370659|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370660|NCT04988048|Vaccines|vaccines|mesh-list
139370661|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
139370662|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370663|NCT04982900|Aflutinib|aflutinib|mesh-list
139370664|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139370665|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184127|NCT05389150|Sensory System Agents|sensory system agents|mesh-ancestor
139370666|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370667|NCT03256071|Decitabine|decitabine|mesh-list
139370668|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139370669|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
139370670|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370671|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370672|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370673|NCT03248817|Phenylephrine|phenylephrine|mesh-list
139370674|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
139370675|NCT03248817|Bupivacaine|bupivacaine|mesh-list
139370676|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
139370677|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
139370678|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370679|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370680|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
139370681|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370682|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139370683|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
139370684|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
139370685|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
139370686|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139370687|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
139370688|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
139370689|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139370690|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139370691|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139370692|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
139370693|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139370694|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370695|NCT03248817|Protective Agents|protective agents|mesh-ancestor
139370696|NCT03647774|Naltrexone|naltrexone|mesh-list
139370697|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139370698|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139370699|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370700|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
139370701|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370702|NCT03248973|Ampicillin|ampicillin|mesh-list
139370703|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139370704|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370705|NCT02832531|Aspirin|aspirin|mesh-list
139370706|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
139370707|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139370708|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139370709|NCT02832531|Analgesics|analgesics|mesh-ancestor
139370710|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
139370711|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370712|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370713|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139370714|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139370715|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139370716|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139370717|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370718|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139370719|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139370720|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370721|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
139370722|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139370723|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
139370724|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139370725|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
139370726|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
139370727|NCT03248427|Paclitaxel|paclitaxel|mesh-list
139027615|NCT00942617|Aspirin|aspirin|mesh-list
139370728|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
139370729|NCT03248427|Doxorubicin|doxorubicin|mesh-list
139370730|NCT03248427|Letrozole|letrozole|mesh-list
139370731|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139370732|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139370733|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
139370734|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
139370735|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
139370736|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370737|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139370739|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370740|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139370741|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139370742|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
139370743|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139370744|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139370745|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139370746|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139370747|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370748|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139370749|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139370750|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139370751|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
139370752|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139370753|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139370754|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370755|NCT03243903|Insulin|insulin|mesh-list
139370756|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139370757|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139370758|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370759|NCT03576677|Simendan|simendan|mesh-list
139370760|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139370761|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
139370762|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139370763|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139370764|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370765|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370766|NCT03576677|Protective Agents|protective agents|mesh-ancestor
139370767|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370768|NCT03247257|Lidocaine|lidocaine|mesh-list
139370769|NCT03247257|Anesthetics|anesthetics|mesh-list
139370770|NCT03247257|Propofol|propofol|mesh-list
139370771|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
139370772|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370773|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370774|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
139370775|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370776|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139370777|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139370778|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139370779|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139370780|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370781|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139370782|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139370783|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
139370784|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
139370785|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139370786|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370787|NCT02239835|Ritonavir|ritonavir|mesh-list
139370788|NCT02239835|Saquinavir|saquinavir|mesh-list
139370789|NCT02239835|Tipranavir|tipranavir|mesh-list
139370790|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138928267|NCT00770445|Insulin|insulin|mesh-list
139370791|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139370792|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
139370793|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370794|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370795|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139370796|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139370797|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
139370798|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370799|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139370800|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139370801|NCT02239913|Topiramate|topiramate|mesh-list
139370802|NCT02239913|Phentermine|phentermine|mesh-list
139370803|NCT02239913|Cocaine|cocaine|mesh-list
139370804|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
139370805|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139370806|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370807|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
139370808|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
139370809|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370810|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
139370811|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370812|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139370813|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139370814|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139370815|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139370816|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370818|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139370819|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139370820|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
139370821|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139370822|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
139370823|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
139370824|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
139370825|NCT03576287|Apremilast|apremilast|mesh-list
139370826|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139370827|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139370828|NCT03576287|Analgesics|analgesics|mesh-ancestor
139370829|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
139370830|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370831|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370832|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139370833|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139370834|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139370835|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139370836|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370837|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370838|NCT02455869|Alendronate|alendronate|mesh-list
139370839|NCT02455869|Atorvastatin|atorvastatin|mesh-list
139370840|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139370841|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139370842|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
139370843|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370844|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139370845|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139370846|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370847|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139370848|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370849|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139370850|NCT03246555|Perindopril|perindopril|mesh-list
139370851|NCT03246555|Indapamide|indapamide|mesh-list
139370852|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139370853|NCT03246555|Diuretics|diuretics|mesh-ancestor
139370854|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
139370855|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370856|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139370857|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139370858|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370859|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139370860|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
139370861|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370862|NCT03576053|Lidocaine|lidocaine|mesh-list
139370863|NCT03576053|Serotonin|serotonin|mesh-list
139370864|NCT03576053|Histamine|histamine|mesh-list
139370865|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
139370866|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
139370867|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370868|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370869|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
139370870|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370871|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139370872|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139370873|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139370874|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139370875|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370876|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139370877|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
139370878|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139370879|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
139370881|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
139370882|NCT03242967|Hematinics|hematinics|mesh-ancestor
139370883|NCT03239457|Mitogens|mitogens|mesh-list
139370884|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
139370885|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370886|NCT00075803|Fluconazole|fluconazole|mesh-list
139370887|NCT00075803|Voriconazole|voriconazole|mesh-list
139370888|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
139370889|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370890|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139370891|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139370892|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370893|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370894|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139370895|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
139370896|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139370897|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370898|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139370899|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139370900|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139370901|NCT03242499|Lovastatin|lovastatin|mesh-list
139370902|NCT03242499|L 647318|l 647318|mesh-list
139370903|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
139370904|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139370905|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139370906|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
139370907|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370908|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139370909|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139370910|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370911|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
139370912|NCT02523911|Simethicone|simethicone|mesh-list
139370913|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
139370914|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139370915|NCT02523911|Analgesics|analgesics|mesh-ancestor
139370916|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
139370917|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370918|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370919|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
139370920|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139370921|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139370922|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
139370923|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139370924|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139370925|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370926|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139370927|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
139370928|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139370929|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
139370930|NCT02523911|Emollients|emollients|mesh-ancestor
139370931|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
139370932|NCT02523911|Cathartics|cathartics|mesh-ancestor
139370933|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139370934|NCT03572231|Mirabegron|mirabegron|mesh-list
139370935|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
139370936|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139370937|NCT03572231|Fesoterodine|fesoterodine|mesh-list
139370938|NCT03572231|Oxybutynin|oxybutynin|mesh-list
139370939|NCT03572231|Darifenacin|darifenacin|mesh-list
139370940|NCT03572231|Propiverine|propiverine|mesh-list
139370941|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139370942|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139370943|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139370944|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
139370945|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139184140|NCT05389150|Narcotics|narcotics|mesh-ancestor
139370946|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370947|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370948|NCT03572231|Urological Agents|urological agents|mesh-ancestor
139370949|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139370950|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139370951|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
139370952|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
139370953|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
139370954|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139370956|NCT02135029|Bococizumab|bococizumab|mesh-list
139370957|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139370958|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139370959|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
139370960|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370961|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139370962|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139370963|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370964|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
139370965|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139370966|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139370967|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370968|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
139370969|NCT03573245|Coagulants|coagulants|mesh-ancestor
139370970|NCT02241161|Bacteriocins|bacteriocins|mesh-list
139370971|NCT02241161|Antioxidants|antioxidants|mesh-list
139370972|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370973|NCT02241161|Protective Agents|protective agents|mesh-ancestor
139370974|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370975|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139370976|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139370977|NCT02135263|Enalapril|enalapril|mesh-list
139370978|NCT02135263|Methylphenidate|methylphenidate|mesh-list
139370979|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139370980|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139370981|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139370982|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139370983|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139370984|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370985|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
139370986|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139370987|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139370988|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
139370989|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139370990|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139370991|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
139370992|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139370993|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139370994|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139370995|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139370996|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139370997|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139370998|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
139370999|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371000|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371001|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139371002|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371003|NCT02239523|Denosumab|denosumab|mesh-list
139371004|NCT02239523|Teriparatide|teriparatide|mesh-list
139371005|NCT02239523|Diphosphonates|diphosphonates|mesh-list
139371006|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139371007|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371008|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139371009|NCT02137213|Naloxone|naloxone|mesh-list
139371010|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139371011|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371012|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
139371013|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371014|NCT03571919|Lidocaine|lidocaine|mesh-list
139371015|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
139371016|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
139371017|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371018|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371019|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
139371020|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371021|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139371022|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139371023|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139371024|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139371025|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371026|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
139371027|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139371028|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139371029|NCT02252809|Prednisolone|prednisolone|mesh-list
139371030|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
139371031|NCT02252809|Adalimumab|adalimumab|mesh-list
139371032|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139371033|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
139371034|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139371035|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
139371036|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
139371037|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371038|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371039|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139371040|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
139371041|NCT02252809|Hormones|hormones|mesh-ancestor
139371042|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139371043|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139371044|NCT02252809|Protective Agents|protective agents|mesh-ancestor
138928302|NCT00763893|Losartan|losartan|mesh-list
139371045|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139371046|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371047|NCT02252809|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139371048|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139371049|NCT02137525|Fentanyl|fentanyl|mesh-list
139371050|NCT02137525|Morphine|morphine|mesh-list
139371051|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139371052|NCT02137525|Narcotics|narcotics|mesh-ancestor
139371053|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371054|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371055|NCT02137525|Analgesics|analgesics|mesh-ancestor
139371056|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
139371057|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371058|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139371059|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139371060|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
139371061|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
139371062|NCT02137681|Rituximab|rituximab|mesh-list
139371063|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139371064|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371065|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
139371066|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371067|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139371068|NCT02842073|Naltrexone|naltrexone|mesh-list
139371069|NCT02842073|Bupropion|bupropion|mesh-list
139371070|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139371071|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139371072|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371073|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
139371074|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371075|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139371076|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
139371077|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139371078|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139371079|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139371080|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139184158|NCT01132235|Etanercept|etanercept|mesh-list
139371081|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371082|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
139371083|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371084|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139371085|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139371086|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371087|NCT02135887|Leucovorin|leucovorin|mesh-list
139371088|NCT02135887|Folic Acid|folic acid|mesh-list
139371089|NCT02135887|Fluorouracil|fluorouracil|mesh-list
139371090|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
139371091|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
139371092|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
139371093|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371094|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139371095|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371096|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139371097|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
139371098|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371099|NCT02135887|Antidotes|antidotes|mesh-ancestor
139371100|NCT02135887|Protective Agents|protective agents|mesh-ancestor
139371101|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
139371102|NCT02135887|Vitamins|vitamins|mesh-ancestor
139371103|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
139371104|NCT02135887|Hematinics|hematinics|mesh-ancestor
139371105|NCT02137993|Olanzapine|olanzapine|mesh-list
139371106|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
139371107|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
139371108|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371109|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371110|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139371111|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139371112|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139371113|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371114|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139371115|NCT02137993|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139371116|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139371117|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139371118|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371119|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371120|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
139371121|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139371122|NCT02245841|Hormones|hormones|mesh-ancestor
139371123|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139371124|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371125|NCT05709041|Anesthetics|anesthetics|mesh-list
139371126|NCT05709041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371127|NCT05709041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371128|NCT03570281|Enoxaparin|enoxaparin|mesh-list
139371129|NCT03570281|Edoxaban|edoxaban|mesh-list
139371130|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
139371131|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139371132|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139371133|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371134|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139371135|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
139371136|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139371137|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
139371138|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371139|NCT02242799|Artesunate|artesunate|mesh-list
139371140|NCT02242799|Lumefantrine|lumefantrine|mesh-list
139371141|NCT02242799|Artemether|artemether|mesh-list
139371142|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139371143|NCT02242799|Amodiaquine|amodiaquine|mesh-list
139371144|NCT02242799|Dolutegravir|dolutegravir|mesh-list
139371145|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
139371146|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139371147|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139371148|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139371149|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371150|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
139371152|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139371153|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
139371154|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139371155|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139371156|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371157|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371158|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139371159|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139371160|NCT02138383|Paclitaxel|paclitaxel|mesh-list
139371161|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139371162|NCT02138383|Gemcitabine|gemcitabine|mesh-list
139371163|NCT02138383|Androgens|androgens|mesh-list
139371164|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139371165|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371166|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
139371167|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
139371168|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
139371169|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371170|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139371171|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
139371172|NCT02138383|Hormones|hormones|mesh-ancestor
139371173|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139371174|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371175|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
139371176|NCT02243735|Trace Elements|trace elements|mesh-ancestor
139371177|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
139371178|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371179|NCT02138539|Hydroquinone|hydroquinone|mesh-list
139371180|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
139371181|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371182|NCT02138539|Protective Agents|protective agents|mesh-ancestor
139371183|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371184|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139371185|NCT02252419|Acetaminophen|acetaminophen|mesh-list
139371186|NCT02252419|Dexamethasone|dexamethasone|mesh-list
139371187|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139371188|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
139371189|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
139371190|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371191|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371192|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139371193|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
139371194|NCT02252419|Hormones|hormones|mesh-ancestor
139371195|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139371196|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139371197|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371198|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139371199|NCT02252419|Analgesics|analgesics|mesh-ancestor
139371200|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
139371201|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
139371202|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
139371203|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139371204|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139371205|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371206|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
139371207|NCT02252497|Coagulants|coagulants|mesh-ancestor
139371208|NCT02138773|Tamsulosin|tamsulosin|mesh-list
139371209|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139371210|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139371211|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139371212|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
139371213|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371214|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371215|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371216|NCT02138773|Urological Agents|urological agents|mesh-ancestor
139371217|NCT01367275|Irinotecan|irinotecan|mesh-list
139371218|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139371219|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139371220|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371221|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371222|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371224|NCT02138929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139371225|NCT02138929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138928354|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
139371226|NCT02138929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371227|NCT02138929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371228|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139371229|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
139371230|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371231|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371232|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
139371233|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139371234|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371235|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371236|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139371237|NCT02253199|Analgesics|analgesics|mesh-ancestor
139371238|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
139371239|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371240|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139371241|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139371242|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139371243|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
139371244|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371245|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371246|NCT02842853|Vaccines|vaccines|mesh-list
139371247|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
139371248|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371249|NCT02139241|Ramosetron|ramosetron|mesh-list
139371250|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
139371251|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
139371252|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371253|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371254|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139371255|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139028123|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
139371256|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
139371257|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371258|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371259|NCT03569579|Memantine|memantine|mesh-list
139371260|NCT03569579|Donepezil|donepezil|mesh-list
139371261|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139371262|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371263|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371264|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
139371265|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371266|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371267|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
139371268|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139371269|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139371270|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
139371271|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139371272|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139371273|NCT02130661|Itraconazole|itraconazole|mesh-list
139371274|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
139371275|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139371276|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139371277|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139371278|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371279|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371280|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139371281|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
139371282|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139371283|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371284|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139371285|NCT02130739|Fentanyl|fentanyl|mesh-list
139371286|NCT02130739|Propofol|propofol|mesh-list
139371287|NCT02130739|Ropivacaine|ropivacaine|mesh-list
139371288|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
139371289|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371290|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184173|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371291|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139371292|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139371293|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
139371294|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
139371295|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
139371296|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371297|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139371298|NCT02130739|Narcotics|narcotics|mesh-ancestor
139371299|NCT02130739|Analgesics|analgesics|mesh-ancestor
139371300|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139371301|NCT02248493|Acetaminophen|acetaminophen|mesh-list
139371302|NCT02248493|Ketoprofen|ketoprofen|mesh-list
139371303|NCT02248493|Morphine|morphine|mesh-list
139371304|NCT02248493|Tramadol|tramadol|mesh-list
139371305|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139371306|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139371307|NCT02248493|Narcotics|narcotics|mesh-ancestor
139371308|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371309|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371310|NCT02248493|Analgesics|analgesics|mesh-ancestor
139371311|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
139371312|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371313|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139371314|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
139371315|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139371316|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139371317|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139371318|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139371319|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371320|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371321|NCT05577871|Dexmedetomidine|dexmedetomidine|mesh-list
139371322|NCT05577871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139371323|NCT05577871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371324|NCT05577871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371325|NCT05577871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139371326|NCT05577871|Analgesics|analgesics|mesh-ancestor
139371327|NCT05577871|Sensory System Agents|sensory system agents|mesh-ancestor
139371328|NCT05577871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371329|NCT05577871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139371330|NCT05577871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139371331|NCT05577871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139371332|NCT05577871|Adrenergic Agents|adrenergic agents|mesh-ancestor
139371333|NCT05577871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371334|NCT05577871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371335|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
139371336|NCT02130817|Dexamethasone|dexamethasone|mesh-list
139371337|NCT02130817|Prednisone|prednisone|mesh-list
139371338|NCT02130817|Abatacept|abatacept|mesh-list
139371339|NCT02130817|Tacrolimus|tacrolimus|mesh-list
139371340|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
139371341|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139371342|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
139371343|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139371344|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
139371345|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
139371346|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139371347|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139371348|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
139371349|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
139371350|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371351|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371352|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139371353|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
139371354|NCT02130817|Hormones|hormones|mesh-ancestor
139371355|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139371356|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139371357|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371358|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371359|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371360|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139371361|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
139184182|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
139371362|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139371363|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139371364|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139371365|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
139371366|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139371367|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139371368|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139371369|NCT02130817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139371370|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139371371|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
139371372|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
139371373|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371374|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371375|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371376|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
139371377|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
139371378|NCT02130973|Denosumab|denosumab|mesh-list
139371379|NCT02130973|Teriparatide|teriparatide|mesh-list
139371380|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139371381|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371382|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139371383|NCT02456662|Ondansetron|ondansetron|mesh-list
139371384|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
139371385|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
139371386|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371387|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371388|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139371389|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
139371390|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
139371391|NCT02456662|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139371392|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139371393|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
139371394|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371395|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371396|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
139371397|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
139371398|NCT03548311|Vitamins|vitamins|mesh-ancestor
139371399|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
139371400|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371401|NCT01653262|Brivaracetam|brivaracetam|mesh-list
139371402|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
139371403|NCT02455336|Fenofibrate|fenofibrate|mesh-list
139371404|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139371405|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
139371406|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028285|NCT00953459|Sunitinib|sunitinib|mesh-list
139371408|NCT02253121|Insulin|insulin|mesh-list
139371409|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139371410|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
139371411|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139371423|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
139371424|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371425|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371426|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
139371427|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139371428|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139371429|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139371430|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139371431|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371432|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371433|NCT05354375|Immunomodulating Agents|immunomodulating agents|mesh-list
139371434|NCT05354375|Immunologic Factors|immunologic factors|mesh-ancestor
139371435|NCT05354375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371436|NCT03566303|Vitamin K|vitamin k|mesh-list
139371437|NCT03566303|Warfarin|warfarin|mesh-list
139371438|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
139371439|NCT03566303|Vitamins|vitamins|mesh-ancestor
139371440|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
139371441|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371442|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
139371443|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139371444|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
139371445|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139371446|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
139371447|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371448|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371449|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139371450|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139371451|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
139371452|NCT03566303|Coagulants|coagulants|mesh-ancestor
139371453|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139371454|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371455|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139371456|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371457|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371458|NCT05936528|Lactoferrin|lactoferrin|mesh-list
139371459|NCT05936528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139371460|NCT05936216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
139371461|NCT05936216|Immunologic Factors|immunologic factors|mesh-ancestor
139371462|NCT05936216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184210|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139371475|NCT05936060|Plasma-lyte 148|plasma-lyte 148|mesh-list
139371476|NCT05936060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139371477|NCT05936060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139371478|NCT05936021|Darbepoetin alfa|darbepoetin alfa|mesh-list
139371479|NCT05936021|Hematinics|hematinics|mesh-ancestor
139371480|NCT05935449|Lidocaine|lidocaine|mesh-list
139371481|NCT05935449|Anesthetics, Local|anesthetics, local|mesh-ancestor
139371482|NCT05935449|Anesthetics|anesthetics|mesh-ancestor
139371483|NCT05935449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371484|NCT05935449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371485|NCT05935449|Sensory System Agents|sensory system agents|mesh-ancestor
139371486|NCT05935449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371487|NCT05935449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139371488|NCT05935449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139371489|NCT05935449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139371490|NCT05935449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139371491|NCT05935449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371493|NCT05935293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139371494|NCT05935293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371495|NCT05935293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371496|NCT05935293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139371497|NCT05935293|Analgesics|analgesics|mesh-ancestor
139371498|NCT05935293|Sensory System Agents|sensory system agents|mesh-ancestor
139371499|NCT05935293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371500|NCT05935293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139371501|NCT05935293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139371502|NCT05935293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139371503|NCT05935293|Adrenergic Agents|adrenergic agents|mesh-ancestor
139371504|NCT05935293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371505|NCT05935293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371506|NCT05935280|Lidocaine|lidocaine|mesh-list
139371507|NCT05935280|Sodium Channel Blockers|sodium channel blockers|mesh-list
139371508|NCT05935280|Anesthetics, Local|anesthetics, local|mesh-ancestor
139371509|NCT05935280|Anesthetics|anesthetics|mesh-ancestor
139371510|NCT05935280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371511|NCT05935280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371512|NCT05935280|Sensory System Agents|sensory system agents|mesh-ancestor
139371513|NCT05935280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371514|NCT05935280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139371515|NCT05935280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139371516|NCT05935280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139371517|NCT05935280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371518|NCT05934812|Oxytocin|oxytocin|mesh-list
139371519|NCT05934812|Oxytocics|oxytocics|mesh-ancestor
139371520|NCT05934812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139371521|NCT05934812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371522|NCT05934799|Clopidogrel|clopidogrel|mesh-list
139371523|NCT05934799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139371524|NCT05934799|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139371525|NCT05934799|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139371526|NCT05934799|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139371527|NCT05934799|Purinergic Agents|purinergic agents|mesh-ancestor
139371528|NCT05934799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371529|NCT05934799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371530|NCT05934799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371531|NCT05934552|Lactulose|lactulose|mesh-list
139371532|NCT05934552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139371533|NCT05933538|Cariprazine|cariprazine|mesh-list
139371534|NCT05933538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139371535|NCT05933538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139371536|NCT05933538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371537|NCT05933538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371538|NCT05933538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139371539|NCT05916053|Vitamin D|vitamin d|mesh-list
139371540|NCT05916053|Vitamins|vitamins|mesh-ancestor
139371541|NCT05916053|Micronutrients|micronutrients|mesh-ancestor
139371542|NCT05916053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371543|NCT05916053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139371544|NCT05892393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139371545|NCT05892393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138928423|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
139371546|NCT05892393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371547|NCT05879419|Benzocaine|benzocaine|mesh-list
139371548|NCT05879419|Anesthetics, Local|anesthetics, local|mesh-ancestor
139371549|NCT05879419|Anesthetics|anesthetics|mesh-ancestor
139371550|NCT05879419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371551|NCT05879419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371552|NCT05879419|Sensory System Agents|sensory system agents|mesh-ancestor
139371553|NCT05879419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371554|NCT05820594|BCG Vaccine|bcg vaccine|mesh-list
139371556|NCT05820594|Immunologic Factors|immunologic factors|mesh-ancestor
139371557|NCT05820594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371558|NCT05790499|Atorvastatin|atorvastatin|mesh-list
139371559|NCT05790499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139371560|NCT05790499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139371561|NCT05790499|Antimetabolites|antimetabolites|mesh-ancestor
139371562|NCT05790499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371563|NCT05790499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139371564|NCT05790499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139371565|NCT05790499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371566|NCT05643170|Xanomeline|xanomeline|mesh-list
139371567|NCT05643170|Trospium chloride|trospium chloride|mesh-list
139371568|NCT05643170|Parasympatholytics|parasympatholytics|mesh-ancestor
139371569|NCT05643170|Autonomic Agents|autonomic agents|mesh-ancestor
139371570|NCT05643170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371571|NCT05643170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371572|NCT05643170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139371573|NCT05643170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139371574|NCT05643170|Cholinergic Agents|cholinergic agents|mesh-ancestor
139371575|NCT05643170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371576|NCT05643170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371577|NCT05643170|Urological Agents|urological agents|mesh-ancestor
139371578|NCT05643170|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139371579|NCT05643170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139371580|NCT05643170|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139371581|NCT05643170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139371582|NCT05635916|Bupivacaine|bupivacaine|mesh-list
139371583|NCT05635916|Anesthetics, Local|anesthetics, local|mesh-ancestor
139371584|NCT05635916|Anesthetics|anesthetics|mesh-ancestor
139371585|NCT05635916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371586|NCT05635916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371587|NCT05635916|Sensory System Agents|sensory system agents|mesh-ancestor
139371588|NCT05635916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371589|NCT05633771|Adalimumab|adalimumab|mesh-list
139371590|NCT05633771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139371591|NCT05633771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139371592|NCT05633771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139371593|NCT05613062|Oren gedoku to|oren gedoku to|mesh-list
139371594|NCT05613062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139371595|NCT05613062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139371596|NCT05613062|Analgesics|analgesics|mesh-ancestor
139371597|NCT05613062|Sensory System Agents|sensory system agents|mesh-ancestor
139371598|NCT05613062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371599|NCT05613062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371600|NCT05613062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139371601|NCT05613062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139371602|NCT05511415|Dexmedetomidine|dexmedetomidine|mesh-list
139371603|NCT05511415|Oxytocin|oxytocin|mesh-list
139371604|NCT05511415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139371605|NCT05511415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371606|NCT05511415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371607|NCT05511415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139371608|NCT05511415|Analgesics|analgesics|mesh-ancestor
139371609|NCT05511415|Sensory System Agents|sensory system agents|mesh-ancestor
139371610|NCT05511415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371611|NCT05511415|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139371612|NCT05511415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139371613|NCT05511415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139371614|NCT05511415|Adrenergic Agents|adrenergic agents|mesh-ancestor
139371615|NCT05511415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371616|NCT05511415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371617|NCT05511415|Oxytocics|oxytocics|mesh-ancestor
139371618|NCT05511415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139371619|NCT05350215|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139371620|NCT05350215|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139371621|NCT05350215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139371622|NCT05350215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139371623|NCT05350215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371624|NCT05350215|Adrenergic Agents|adrenergic agents|mesh-ancestor
139371625|NCT05350215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371626|NCT05350215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028517|NCT00459342|Dasatinib|dasatinib|mesh-list
139371627|NCT05258747|Olaparib|olaparib|mesh-list
139371628|NCT05258747|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139371629|NCT05258747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371630|NCT05258747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371631|NCT05258747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371632|NCT05127395|Acyclovir|acyclovir|mesh-list
139371633|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
139371634|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139371635|NCT05022342|Fulvestrant|fulvestrant|mesh-list
139371636|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139371637|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371638|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139371639|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139371640|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
139371641|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139371642|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371643|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
139371644|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
139371645|NCT04950270|Coagulants|coagulants|mesh-ancestor
139371646|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139371647|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139371648|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
139371649|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371650|NCT04802876|Tislelizumab|tislelizumab|mesh-list
139371651|NCT04802876|Spartalizumab|spartalizumab|mesh-list
139371652|NCT04802876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139371653|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371654|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139371655|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371656|NCT04789928|Gentamicins|gentamicins|mesh-list
139371657|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139371658|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139371659|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139371660|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371661|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371662|NCT04762992|Enoxaparin|enoxaparin|mesh-list
139371663|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
139371664|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139371665|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139371666|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371667|NCT04738123|Xanomeline|xanomeline|mesh-list
139371668|NCT04738123|Trospium chloride|trospium chloride|mesh-list
139371669|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
139184234|NCT03380091|Vitamin D|vitamin d|mesh-list
139371670|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
139371671|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371672|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371673|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139371674|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139371675|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
139371676|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371677|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371678|NCT04738123|Urological Agents|urological agents|mesh-ancestor
139371679|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139371680|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139371681|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139371682|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139371683|NCT04704453|Amitriptyline|amitriptyline|mesh-list
139371684|NCT04704453|Capsaicin|capsaicin|mesh-list
139371685|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
139371686|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
139371687|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
139371688|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371689|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371690|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139371691|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
139371692|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139371693|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139371694|NCT04704453|Analgesics|analgesics|mesh-ancestor
139371695|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139371696|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139371697|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139371698|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371699|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
139028582|NCT01026714|Rifampin|rifampin|mesh-list
139371700|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371701|NCT04695847|Antibodies|antibodies|mesh-list
139371702|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
139371703|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139371704|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
139371705|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
139371706|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371707|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139371708|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
139371709|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139371710|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
139371711|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139371712|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371713|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139371714|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139371715|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139371716|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371717|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139371718|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139371719|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139371720|NCT04675333|Carboplatin|carboplatin|mesh-list
139371721|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
139371722|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371723|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139371724|NCT04675333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138928471|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139371725|NCT04675333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371726|NCT04665050|Vaccines|vaccines|mesh-list
139371727|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139371728|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
139371729|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371730|NCT04581395|Rocuronium|rocuronium|mesh-list
139371731|NCT04581395|Succinylcholine|succinylcholine|mesh-list
139371732|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139371733|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139371734|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139371735|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371736|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371737|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139371738|NCT04572100|Paclitaxel|paclitaxel|mesh-list
139371739|NCT04572100|Carboplatin|carboplatin|mesh-list
139184247|NCT03919253|Maleic acid|maleic acid|mesh-list
139371740|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139371742|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
139371743|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
139371744|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
139371745|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371746|NCT04564625|Vitamin D|vitamin d|mesh-list
139371747|NCT04564625|Vitamins|vitamins|mesh-ancestor
139371748|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
139371749|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371750|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139371751|NCT04560322|Venetoclax|venetoclax|mesh-list
139371752|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
139371753|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
139371754|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371755|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139371756|NCT04504734|Bucillamine|bucillamine|mesh-list
139371757|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139371758|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139371759|NCT04504734|Analgesics|analgesics|mesh-ancestor
139371760|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
139371761|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371762|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371763|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139371764|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139371765|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
139371766|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371767|NCT04504734|Protective Agents|protective agents|mesh-ancestor
139371768|NCT04388774|Ketamine|ketamine|mesh-list
139371769|NCT04388774|Analgesics|analgesics|mesh-ancestor
139371770|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
139371771|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371772|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371773|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139371774|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139371775|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
139371776|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
139371777|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139371778|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139371779|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139371780|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371781|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371782|NCT04267614|Etanercept|etanercept|mesh-list
139371783|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139371784|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139371785|NCT04267614|Analgesics|analgesics|mesh-ancestor
139371786|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
139371787|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371788|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371789|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139371790|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139371791|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139371792|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139371793|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
139371794|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
139371795|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
139371796|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139371797|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139371798|NCT04164212|Vaccines|vaccines|mesh-list
139371799|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
139371800|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371801|NCT04112199|Terlipressin|terlipressin|mesh-list
139371802|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139371803|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139371804|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
139371805|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139371806|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371807|NCT04089904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139371808|NCT04089904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371809|NCT04055428|Valsartan|valsartan|mesh-list
139371810|NCT04055428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139371811|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139371812|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139371813|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139371814|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371815|NCT03998488|Psyllium|psyllium|mesh-list
139371816|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
139371817|NCT03998488|Cathartics|cathartics|mesh-ancestor
139371818|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139371819|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
139371820|NCT03861702|Irinotecan|irinotecan|mesh-list
139371821|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139371822|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139371823|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371824|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371825|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371826|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139371827|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
139371828|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371829|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139371830|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139371831|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
139371832|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139371833|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371834|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139371835|NCT03653338|Rituximab|rituximab|mesh-list
139371836|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
139371837|NCT03653338|Fludarabine|fludarabine|mesh-list
139371838|NCT03653338|Thiotepa|thiotepa|mesh-list
139371839|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
139371840|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139371841|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371842|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
139371843|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371844|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139371845|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371846|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139371847|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139371848|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
139371849|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139371850|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
139371852|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139371853|NCT03610724|Tisagenlecleucel|tisagenlecleucel|mesh-list
139371854|NCT03610724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139371855|NCT03610724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371856|NCT03576755|Spironolactone|spironolactone|mesh-list
139371857|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139371858|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
139371859|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139371860|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371861|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139371862|NCT03576755|Diuretics|diuretics|mesh-ancestor
139371863|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
139371864|NCT03572049|Itraconazole|itraconazole|mesh-list
139371865|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139371866|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
139371867|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139371868|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139371869|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139371870|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371871|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371872|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139371873|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
139371874|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139371875|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371876|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139371877|NCT03556332|Dexamethasone|dexamethasone|mesh-list
139371878|NCT03556332|Lenalidomide|lenalidomide|mesh-list
139371879|NCT03556332|Daratumumab|daratumumab|mesh-list
139371880|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139371881|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
139371882|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
139371883|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139371884|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371885|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139371886|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
139371887|NCT03556332|Hormones|hormones|mesh-ancestor
139371888|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139371889|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139371890|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371891|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
139371892|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139371893|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139371894|NCT03556332|Growth Substances|growth substances|mesh-ancestor
139371895|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
139371896|NCT03555877|Letrozole|letrozole|mesh-list
139371897|NCT03555877|Fulvestrant|fulvestrant|mesh-list
139371898|NCT03555877|Anastrozole|anastrozole|mesh-list
139371899|NCT03555877|Exemestane|exemestane|mesh-list
139371900|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371901|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139371902|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139371903|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371904|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371905|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139371906|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
139371907|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139371908|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371909|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139371910|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139371911|NCT03481972|Doxycycline|doxycycline|mesh-list
139371912|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
139371913|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139371914|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139371915|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
139371916|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139371917|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139371918|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
139371919|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139371920|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139371921|NCT03472560|Avelumab|avelumab|mesh-list
139371922|NCT03472560|Axitinib|axitinib|mesh-list
139371923|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139371924|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371925|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139371926|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371927|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371929|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139371930|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139371931|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
139371932|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139371933|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139371934|NCT03336216|Leucovorin|leucovorin|mesh-list
139371935|NCT03336216|Paclitaxel|paclitaxel|mesh-list
139371936|NCT03336216|Gemcitabine|gemcitabine|mesh-list
139371937|NCT03336216|Fluorouracil|fluorouracil|mesh-list
139371938|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
139371939|NCT03336216|Nivolumab|nivolumab|mesh-list
139371940|NCT03336216|Irinotecan|irinotecan|mesh-list
139371941|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139371942|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371943|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
139371944|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
139371945|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
139371946|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371947|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139371948|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
139371949|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139371950|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
139371951|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371952|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139371953|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139371954|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139371955|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139371956|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371957|NCT03336216|Antidotes|antidotes|mesh-ancestor
139371958|NCT03336216|Protective Agents|protective agents|mesh-ancestor
139371959|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
139371960|NCT03336216|Vitamins|vitamins|mesh-ancestor
139371961|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
139371962|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139371963|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139371964|NCT03269994|Tazobactam|tazobactam|mesh-list
139371965|NCT03269994|Piperacillin|piperacillin|mesh-list
139371966|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139371967|NCT03269994|Cefoxitin|cefoxitin|mesh-list
139371968|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139371969|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139371970|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139371971|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139371972|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371973|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
139371974|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139371975|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
139371976|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139371977|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371978|NCT03062358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139371979|NCT03062358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139371980|NCT02903537|Vitamin D|vitamin d|mesh-list
139371981|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
139371982|NCT02903537|Interferons|interferons|mesh-list
139371983|NCT02903537|Interferon-beta|interferon-beta|mesh-list
139371984|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139371985|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
139371986|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139371987|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
139371988|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371989|NCT02903537|Vitamins|vitamins|mesh-ancestor
139371990|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
139371991|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139371992|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139371993|NCT02706873|Methotrexate|methotrexate|mesh-list
139371994|NCT02706873|Upadacitinib|upadacitinib|mesh-list
139371995|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139371996|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
139371997|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139028878|NCT03867383|Calcium|calcium|mesh-list
139371998|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139371999|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139372000|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
139372001|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372002|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372004|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372005|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139372006|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139372007|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
139372008|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139372009|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139372010|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139372011|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139372012|NCT02677038|Olaparib|olaparib|mesh-list
139372013|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139372014|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372015|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372016|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372017|NCT02584634|Avelumab|avelumab|mesh-list
139372018|NCT02584634|Crizotinib|crizotinib|mesh-list
139372019|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139372020|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372021|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139372022|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184263|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372023|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372024|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
139372025|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372026|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139372027|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372028|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372029|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
139372030|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139372031|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
139372032|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372033|NCT02124941|Expectorants|expectorants|mesh-ancestor
139372034|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
139372035|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139372036|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
139372037|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372038|NCT02124941|Protective Agents|protective agents|mesh-ancestor
139372039|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372040|NCT02124941|Antidotes|antidotes|mesh-ancestor
139372041|NCT01868451|Doxorubicin|doxorubicin|mesh-list
139372042|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139372043|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139372044|NCT01868451|Dacarbazine|dacarbazine|mesh-list
139372045|NCT01868451|Vinblastine|vinblastine|mesh-list
139372046|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139372047|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372048|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139372049|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139372050|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372051|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372052|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139372053|NCT01868451|Immunotoxins|immunotoxins|mesh-ancestor
139372054|NCT01868451|Immunoconjugates|immunoconjugates|mesh-ancestor
139372055|NCT01868451|Immunologic Factors|immunologic factors|mesh-ancestor
139372056|NCT01868451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372057|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139372058|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
139372059|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139372060|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
139372061|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
139372062|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
139372063|NCT01767675|Carboplatin|carboplatin|mesh-list
139372064|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372065|NCT01275729|Furosemide|furosemide|mesh-list
139372066|NCT01275729|Diuretics|diuretics|mesh-ancestor
139372067|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
139372068|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372069|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139372070|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139372071|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372072|NCT01107626|Paclitaxel|paclitaxel|mesh-list
139372073|NCT01107626|Bevacizumab|bevacizumab|mesh-list
139372074|NCT01107626|Carboplatin|carboplatin|mesh-list
139372075|NCT01107626|Pemetrexed|pemetrexed|mesh-list
139372076|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139372077|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372078|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
139372079|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
139372080|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
139372081|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928552|NCT02580344|Analgesics|analgesics|mesh-ancestor
139372082|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139372083|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139372084|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139372085|NCT01107626|Growth Substances|growth substances|mesh-ancestor
139372086|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372087|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
139372088|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372089|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139372090|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139184268|NCT03919175|Rituximab|rituximab|mesh-list
139372091|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
139372092|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372093|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139372094|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
139372095|NCT00828009|Paclitaxel|paclitaxel|mesh-list
139372096|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
139372097|NCT00828009|Bevacizumab|bevacizumab|mesh-list
139372098|NCT00828009|Carboplatin|carboplatin|mesh-list
139372099|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139372100|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372101|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
139372102|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
139372103|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
139372104|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372105|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139372106|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
139372107|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372108|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139372109|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139372110|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
139372111|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139372112|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139372113|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139372114|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139372115|NCT00828009|Growth Substances|growth substances|mesh-ancestor
139372116|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
139372117|NCT00578721|Aspirin|aspirin|mesh-list
139372118|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139372119|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139372120|NCT00578721|Analgesics|analgesics|mesh-ancestor
139372121|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
139372122|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372123|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372124|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139372125|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139372126|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139372127|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139372128|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372129|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139372130|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139372131|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372132|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
139372133|NCT00357890|Insulin|insulin|mesh-list
139372134|NCT00357890|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139372135|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
139372136|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139372137|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372138|NCT00068393|Gemcitabine|gemcitabine|mesh-list
139372139|NCT00068393|Doxorubicin|doxorubicin|mesh-list
139372140|NCT00068393|Lenograstim|lenograstim|mesh-list
139372141|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139372142|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
139372143|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372144|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372145|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139372146|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139372147|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139372148|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372149|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139372150|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
139372151|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372152|NCT00062010|Interferons|interferons|mesh-list
139372153|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
139372154|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
139372155|NCT00062010|Paclitaxel|paclitaxel|mesh-list
139372156|NCT00062010|Tretinoin|tretinoin|mesh-list
139372157|NCT00062010|Isotretinoin|isotretinoin|mesh-list
139372158|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139372159|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372160|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
139372161|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
139372162|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
139184273|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139372163|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372165|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372166|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
139372167|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372168|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
139372169|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
139372170|NCT00061568|Sirolimus|sirolimus|mesh-list
139372171|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
139372172|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139372173|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372174|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139372175|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372176|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
139372177|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139372178|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
139372179|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372180|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139372181|NCT00047008|Cisplatin|cisplatin|mesh-list
139372182|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372183|NCT03567941|Acetaminophen|acetaminophen|mesh-list
139372184|NCT03567941|Hydrocodone|hydrocodone|mesh-list
139372185|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139372186|NCT03567941|Analgesics|analgesics|mesh-ancestor
139372187|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
139372188|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372189|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372190|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
139372191|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139372192|NCT03567941|Narcotics|narcotics|mesh-ancestor
139372193|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139372194|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
139372195|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
139372196|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139372197|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139372198|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139372199|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
139372200|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372201|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139372202|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139372203|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372204|NCT03566225|Metformin|metformin|mesh-list
139372205|NCT03566225|Pioglitazone|pioglitazone|mesh-list
139372206|NCT03566225|Clomiphene|clomiphene|mesh-list
139372207|NCT03566225|Enclomiphene|enclomiphene|mesh-list
139372208|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
139372209|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139372210|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372211|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139372212|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
139372213|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139372214|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139372215|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
139372216|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139372217|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139372218|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139372219|NCT02397694|Dolutegravir|dolutegravir|mesh-list
139372220|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139372221|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139372222|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372223|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372224|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139372225|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139372226|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
139372227|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372228|NCT03566069|Oxytocin|oxytocin|mesh-list
139372230|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139372231|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372232|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
139372233|NCT03567629|Leucovorin|leucovorin|mesh-list
139372234|NCT03567629|Bevacizumab|bevacizumab|mesh-list
139372235|NCT03567629|Cetuximab|cetuximab|mesh-list
139372236|NCT03567629|Capecitabine|capecitabine|mesh-list
139372237|NCT03567629|Fluorouracil|fluorouracil|mesh-list
139372238|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
139372239|NCT03567629|Irinotecan|irinotecan|mesh-list
139372240|NCT03567629|Calcium|calcium|mesh-list
139372241|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
139372242|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139372243|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372244|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139372245|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139372246|NCT03567629|Growth Substances|growth substances|mesh-ancestor
139372247|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372248|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
139372249|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139372250|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139372251|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139372253|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372254|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139372255|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
139372256|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139372257|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139372258|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372259|NCT03567629|Antidotes|antidotes|mesh-ancestor
139372260|NCT03567629|Protective Agents|protective agents|mesh-ancestor
139372261|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
139372262|NCT03567629|Vitamins|vitamins|mesh-ancestor
139372263|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
139372264|NCT02783599|Doxorubicin|doxorubicin|mesh-list
139372265|NCT02783599|Olaratumab|olaratumab|mesh-list
139372266|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139372267|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372268|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139372269|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139372270|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372271|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372272|NCT03567395|Melatonin|melatonin|mesh-list
139372273|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
139372274|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372275|NCT03567395|Protective Agents|protective agents|mesh-ancestor
139372276|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372277|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139372278|NCT03565133|Quinine|quinine|mesh-list
139372279|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
139372280|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139372281|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139372282|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372283|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139372284|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372285|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139372286|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372287|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139372288|NCT03565133|Analgesics|analgesics|mesh-ancestor
139372289|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
139372290|NCT05353673|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139372291|NCT05353673|Danazol|danazol|mesh-list
139372292|NCT05353673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139372293|NCT05353673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372294|NCT05353673|Incretins|incretins|mesh-ancestor
139372295|NCT05353673|Hormones|hormones|mesh-ancestor
139372296|NCT05353673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139372297|NCT05353673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139372298|NCT05353673|Protease Inhibitors|protease inhibitors|mesh-ancestor
139372299|NCT05353673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372300|NCT05353673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372301|NCT05353673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139372302|NCT05353673|Hormone Antagonists|hormone antagonists|mesh-ancestor
139372303|NCT05353205|Flumatinib|flumatinib|mesh-list
139372304|NCT05353205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139372305|NCT05353205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372306|NCT05353205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372308|NCT03068234|Analgesics|analgesics|mesh-ancestor
139372309|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
139372310|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372312|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139372313|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139372314|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139372315|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139372316|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372317|NCT05339399|Oxytocin|oxytocin|mesh-list
139372318|NCT05339399|Oxytocics|oxytocics|mesh-ancestor
139372319|NCT05339399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139372320|NCT05339399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372321|NCT05634824|Immunoglobulins|immunoglobulins|mesh-list
139372322|NCT05634824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139372323|NCT05634824|Antibodies|antibodies|mesh-list
139372324|NCT05634824|gamma-Globulins|gamma-globulins|mesh-list
139372325|NCT05634824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139372326|NCT05634824|Immunologic Factors|immunologic factors|mesh-ancestor
139372327|NCT05634824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372328|NCT02454478|Everolimus|everolimus|mesh-list
139372329|NCT02454478|Lenvatinib|lenvatinib|mesh-list
139372330|NCT02454478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139372331|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139372332|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372333|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372334|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139372335|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
139372336|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372337|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372338|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139372339|NCT02359097|Hematinics|hematinics|mesh-ancestor
139372340|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139372341|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139372342|NCT03563963|Lidocaine|lidocaine|mesh-list
139372343|NCT03563963|Ropivacaine|ropivacaine|mesh-list
139372344|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139372345|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
139372346|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
139372347|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139372348|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372349|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
139372350|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372351|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139372352|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139372353|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139372354|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139372355|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372356|NCT03066518|Melatonin|melatonin|mesh-list
139372357|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
139372358|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372359|NCT03066518|Protective Agents|protective agents|mesh-ancestor
139372360|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372361|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139372362|NCT03069248|Interferons|interferons|mesh-list
139372363|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
139372364|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139372365|NCT03069248|Rituximab|rituximab|mesh-list
139372366|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139372367|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372368|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
139372369|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372370|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139372371|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
139372372|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372373|NCT05730062|Oxycodone|oxycodone|mesh-list
138928636|NCT00667251|Docetaxel|docetaxel|mesh-list
139372374|NCT05730062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139372375|NCT05730062|Narcotics|narcotics|mesh-ancestor
139372376|NCT05730062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139372377|NCT05730062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372378|NCT05730062|Analgesics|analgesics|mesh-ancestor
139372379|NCT05730062|Sensory System Agents|sensory system agents|mesh-ancestor
139372380|NCT05730062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372381|NCT03068936|Cisplatin|cisplatin|mesh-list
139372382|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372384|NCT05017610|Methimazole|methimazole|mesh-list
139372385|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139372386|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
139372387|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372388|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372389|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
139372390|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
139372391|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139372392|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372393|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
139372394|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139372395|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
139372396|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372397|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372398|NCT02452762|Vitamin D|vitamin d|mesh-list
139372399|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
139372400|NCT02452762|Vitamins|vitamins|mesh-ancestor
139372401|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
139372402|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372403|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139372404|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139372405|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
139372406|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139372407|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372408|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
139372409|NCT05633420|Artesunate|artesunate|mesh-list
139372410|NCT05633420|Pyronaridine|pyronaridine|mesh-list
139372411|NCT05633420|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139372412|NCT05633420|Antimalarials|antimalarials|mesh-ancestor
139372413|NCT05633420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139372414|NCT05633420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139372415|NCT05633420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372416|NCT05633420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372417|NCT05633420|Antiviral Agents|antiviral agents|mesh-ancestor
139372418|NCT05633420|Schistosomicides|schistosomicides|mesh-ancestor
139372419|NCT05633420|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139372420|NCT05633420|Anthelmintics|anthelmintics|mesh-ancestor
139372421|NCT04699058|Antibodies|antibodies|mesh-list
139372422|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
139372423|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372424|NCT05487092|Letrozole|letrozole|mesh-list
139372425|NCT05487092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372426|NCT05487092|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139372427|NCT05487092|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139372428|NCT05487092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372429|NCT05487092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372430|NCT05487092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139372431|NCT05487092|Hormone Antagonists|hormone antagonists|mesh-ancestor
139372432|NCT05487092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139372433|NCT05487092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372434|NCT05728892|Melatonin|melatonin|mesh-list
139372435|NCT05728892|Antioxidants|antioxidants|mesh-ancestor
139372436|NCT05728892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372437|NCT05728892|Protective Agents|protective agents|mesh-ancestor
139372438|NCT05728892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372439|NCT05728892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139372440|NCT03067688|Amlodipine|amlodipine|mesh-list
139184287|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
139372441|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139372442|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139372443|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139372444|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139372445|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139372446|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372447|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139372448|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372449|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
139372450|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139372451|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139372452|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
139372453|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139372454|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139029324|NCT00384033|Analgesics|analgesics|mesh-ancestor
139372455|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372456|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139372457|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139372458|NCT02396758|Plasminogen|plasminogen|mesh-list
139372459|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139372460|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139372461|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139372462|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372463|NCT05728424|Amoxicillin|amoxicillin|mesh-list
139372464|NCT05728424|Levofloxacin|levofloxacin|mesh-list
139372465|NCT05728424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139372466|NCT05728424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372467|NCT05728424|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139372468|NCT05728424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139372469|NCT05728424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139372470|NCT05728424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372471|NCT05728424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372472|NCT05728424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372473|NCT05728424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139372474|NCT05728424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139372475|NCT05728268|Paclitaxel|paclitaxel|mesh-list
139372476|NCT05728268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139372477|NCT05728268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372478|NCT05728268|Tubulin Modulators|tubulin modulators|mesh-ancestor
139372479|NCT05728268|Antimitotic Agents|antimitotic agents|mesh-ancestor
139372480|NCT05728268|Mitosis Modulators|mitosis modulators|mesh-ancestor
139372481|NCT05728268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372482|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
139372483|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138928675|NCT00776763|Bevacizumab|bevacizumab|mesh-list
139372484|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372485|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139372486|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372487|NCT04926844|Midazolam|midazolam|mesh-list
139372488|NCT04926844|Levetiracetam|levetiracetam|mesh-list
139372489|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139372490|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139372491|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139372492|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372493|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139372494|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139372495|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139372496|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139372497|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
139372498|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
139372499|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
139372500|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
139372501|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139372502|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372503|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
139372504|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
139372505|NCT05482256|Listerine|listerine|mesh-list
139372506|NCT05482256|Sodium Fluoride|sodium fluoride|mesh-list
139372507|NCT05482256|Cariostatic Agents|cariostatic agents|mesh-ancestor
139372508|NCT05482256|Protective Agents|protective agents|mesh-ancestor
139372509|NCT05482256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372510|NCT05482256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139372511|NCT05482256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372512|NCT01651936|Methotrexate|methotrexate|mesh-list
139372513|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139372514|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
139372515|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139372516|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372517|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139372518|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
139372519|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372520|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372521|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
139372522|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372523|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139372524|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139372525|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
139372526|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139372527|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139372528|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139372529|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
139372530|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372531|NCT03065504|Turmeric extract|turmeric extract|mesh-list
139372532|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
139372533|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372534|NCT03065504|Protective Agents|protective agents|mesh-ancestor
139372535|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372536|NCT02630966|Vedolizumab|vedolizumab|mesh-list
139372537|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139372538|NCT05724212|Interferons|interferons|mesh-list
139372539|NCT05724212|Interferon-gamma|interferon-gamma|mesh-list
139372540|NCT05724212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372541|NCT05724212|Antiviral Agents|antiviral agents|mesh-ancestor
139372542|NCT05724212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372544|NCT01651780|Calcium heparin|calcium heparin|mesh-list
139372545|NCT01651780|Bivalirudin|bivalirudin|mesh-list
139372546|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
139372547|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139372548|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139372549|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372550|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
139372551|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139372552|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
139372553|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372554|NCT02394730|Vorapaxar|vorapaxar|mesh-list
139372555|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139372556|NCT05376878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139372557|NCT05376878|Trastuzumab|trastuzumab|mesh-list
139372558|NCT05376878|Camptothecin|camptothecin|mesh-list
139372559|NCT05376878|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139372560|NCT05376878|Antibodies|antibodies|mesh-list
139372561|NCT05376878|Immunoglobulins|immunoglobulins|mesh-list
139372562|NCT05376878|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139372563|NCT05376878|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139372564|NCT05376878|Immunoconjugates|immunoconjugates|mesh-list
139372565|NCT05376878|Immunologic Factors|immunologic factors|mesh-ancestor
139372566|NCT05376878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372567|NCT05376878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372568|NCT05376878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372569|NCT05376878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139372570|NCT05376878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139372571|NCT05376878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139372572|NCT05376878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372573|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139372574|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
139372575|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139372576|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
139372577|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372578|NCT05357612|Pimavanserin|pimavanserin|mesh-list
139372579|NCT05357612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139372580|NCT05357612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139372581|NCT05357612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139372583|NCT05357612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139372584|NCT05357612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372585|NCT05357612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139372586|NCT05357612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139372587|NCT05357612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139372588|NCT05357612|Serotonin Agents|serotonin agents|mesh-ancestor
139372589|NCT05357612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139372590|NCT05357612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372591|NCT02394340|Luliconazole|luliconazole|mesh-list
139372592|NCT02394340|Omeprazole|omeprazole|mesh-list
139372593|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139372594|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139372595|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139372596|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372597|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372598|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
139372599|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372600|NCT01672736|Dexamethasone|dexamethasone|mesh-list
139372601|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
139372602|NCT01672736|Bortezomib|bortezomib|mesh-list
139029471|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372603|NCT01672736|BB 1101|bb 1101|mesh-list
139372604|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139372605|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
139372606|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
139372607|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372608|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372609|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139372610|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
139372611|NCT01672736|Hormones|hormones|mesh-ancestor
139372612|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139372613|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139372614|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372615|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
139372616|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372617|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372618|NCT03065660|Mifepristone|mifepristone|mesh-list
139372619|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139372620|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
139372621|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139372622|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372623|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139372624|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139372625|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139372626|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
139372627|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139372628|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139372629|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
139372630|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139372631|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
139372632|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139372633|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139372634|NCT03893630|Aspirin|aspirin|mesh-list
139372635|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139372636|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139372637|NCT03893630|Analgesics|analgesics|mesh-ancestor
139372638|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
139372639|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372640|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372641|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139372642|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139372643|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139372644|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139372645|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372646|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139372647|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139372648|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372650|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
139372651|NCT03065816|Antacids|antacids|mesh-ancestor
139372652|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372653|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139372654|NCT05619848|Midazolam|midazolam|mesh-list
139372655|NCT05619848|Remifentanil|remifentanil|mesh-list
139372656|NCT05619848|Bromides|bromides|mesh-list
139372657|NCT05619848|Propofol|propofol|mesh-list
139372658|NCT05619848|Etomidate|etomidate|mesh-list
139372659|NCT05619848|Rocuronium|rocuronium|mesh-list
139372660|NCT05619848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139372661|NCT05619848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139372662|NCT05619848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372663|NCT05619848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139372664|NCT05619848|Anesthetics, General|anesthetics, general|mesh-ancestor
139372665|NCT05619848|Anesthetics|anesthetics|mesh-ancestor
139372666|NCT05619848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139372667|NCT05619848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139372668|NCT05619848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139372669|NCT05619848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139372670|NCT05619848|GABA Modulators|gaba modulators|mesh-ancestor
139372671|NCT05619848|GABA Agents|gaba agents|mesh-ancestor
139372672|NCT05619848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139372673|NCT05619848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372674|NCT05619848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139372675|NCT05619848|Narcotics|narcotics|mesh-ancestor
139372676|NCT05619848|Analgesics|analgesics|mesh-ancestor
139372677|NCT05619848|Sensory System Agents|sensory system agents|mesh-ancestor
139372678|NCT05619848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372679|NCT05619848|Anticonvulsants|anticonvulsants|mesh-ancestor
139372680|NCT05619848|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139372681|NCT05619848|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139372682|NCT05619848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139372683|NCT01560637|Treprostinil|treprostinil|mesh-list
139372684|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139372685|NCT04157036|Ibuprofen|ibuprofen|mesh-list
139372686|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
139372687|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139372688|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139372689|NCT04157036|Prednisolone|prednisolone|mesh-list
139372690|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
139372691|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139372692|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
139372693|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139372694|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139372695|NCT04157036|Analgesics|analgesics|mesh-ancestor
139372696|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
139372697|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372698|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372699|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139372700|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139372701|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139372702|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372703|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372704|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
139372705|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
139372706|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139372707|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
139372708|NCT04157036|Hormones|hormones|mesh-ancestor
139372709|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139372710|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139372711|NCT04157036|Protective Agents|protective agents|mesh-ancestor
139372712|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139372713|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372714|NCT03547375|Apatinib|apatinib|mesh-list
139372715|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372716|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139372717|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372718|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372719|NCT01353911|Interferons|interferons|mesh-list
139372720|NCT01353911|Ribavirin|ribavirin|mesh-list
139184322|NCT01302613|Vitamins|vitamins|mesh-ancestor
139372721|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
139372722|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
139372723|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139372724|NCT01353911|Grazoprevir|grazoprevir|mesh-list
139372725|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372726|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
139372727|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372728|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
139372729|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372730|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
139372731|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372732|NCT05575297|Rifampin|rifampin|mesh-list
139372733|NCT05575297|Methotrexate|methotrexate|mesh-list
139372734|NCT05575297|Febuxostat|febuxostat|mesh-list
139372735|NCT05575297|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139372736|NCT05575297|Abortifacient Agents|abortifacient agents|mesh-ancestor
139372737|NCT05575297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139372738|NCT05575297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372739|NCT05575297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139372740|NCT05575297|Antimetabolites|antimetabolites|mesh-ancestor
139372741|NCT05575297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372742|NCT05575297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372743|NCT05575297|Dermatologic Agents|dermatologic agents|mesh-ancestor
139372744|NCT05575297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372745|NCT05575297|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139372746|NCT05575297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139372747|NCT05575297|Immunologic Factors|immunologic factors|mesh-ancestor
139372748|NCT05575297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139372749|NCT05575297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139372750|NCT05575297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139372751|NCT05575297|Antitubercular Agents|antitubercular agents|mesh-ancestor
139372752|NCT05575297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139029623|NCT00967031|Capecitabine|capecitabine|mesh-list
139372753|NCT05575297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372754|NCT05575297|Leprostatic Agents|leprostatic agents|mesh-ancestor
139372755|NCT05575297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139372756|NCT05575297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139372757|NCT05575297|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139372758|NCT05575297|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139372759|NCT05575297|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139372760|NCT05575297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139372761|NCT05575297|Gout Suppressants|gout suppressants|mesh-ancestor
139372762|NCT01671488|Mitomycins|mitomycins|mesh-list
139372763|NCT01671488|Mitomycin|mitomycin|mesh-list
139372764|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139372765|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372766|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
139372767|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372768|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139372769|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372770|NCT05400889|Tofacitinib|tofacitinib|mesh-list
139372771|NCT05400889|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139372772|NCT05400889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139372773|NCT05400889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372774|NCT05400889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372775|NCT05325229|Bevacizumab|bevacizumab|mesh-list
139372776|NCT05325229|Docetaxel|docetaxel|mesh-list
139372777|NCT05325229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139372778|NCT05325229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372779|NCT05325229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139372780|NCT05325229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139372781|NCT05325229|Growth Substances|growth substances|mesh-ancestor
139372782|NCT05325229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372783|NCT05325229|Growth Inhibitors|growth inhibitors|mesh-ancestor
139372784|NCT05325229|Tubulin Modulators|tubulin modulators|mesh-ancestor
139372785|NCT05325229|Antimitotic Agents|antimitotic agents|mesh-ancestor
139372786|NCT05325229|Mitosis Modulators|mitosis modulators|mesh-ancestor
139372787|NCT05325229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139184324|NCT03803371|Acetaminophen|acetaminophen|mesh-list
139372788|NCT05573581|Botulinum Toxins|botulinum toxins|mesh-list
139372789|NCT05573581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139372790|NCT05573581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139372791|NCT05573581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139372792|NCT05573581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139372793|NCT05573581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372794|NCT05573581|Cholinergic Agents|cholinergic agents|mesh-ancestor
139372795|NCT05573581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139372796|NCT05573581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372797|NCT05573581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139372798|NCT05573581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372799|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139372800|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139372801|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139372802|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139372803|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372804|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139372805|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139372806|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139372807|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139372808|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
139372809|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139372810|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372811|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139372812|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139372813|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
139372814|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139372815|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139372816|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
139372817|NCT05573425|Tazarotene|tazarotene|mesh-list
139372818|NCT05573425|Dermatologic Agents|dermatologic agents|mesh-ancestor
139372819|NCT05573425|Keratolytic Agents|keratolytic agents|mesh-ancestor
139372820|NCT02253901|Ritonavir|ritonavir|mesh-list
139372821|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139372822|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139372823|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139372824|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
139372825|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372826|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372827|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139372828|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139372829|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
139372830|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372831|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139372832|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139372833|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139372834|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139372835|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
139372836|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139372837|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139372838|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372839|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372840|NCT03546283|Protective Agents|protective agents|mesh-ancestor
139372841|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372842|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139372843|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139372844|NCT03547219|Escitalopram|escitalopram|mesh-list
138928768|NCT00467779|Midazolam|midazolam|mesh-list
139372845|NCT03547219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139372846|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139372847|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139372848|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372849|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139372850|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
139372851|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372852|NCT04069819|Cilostazol|cilostazol|mesh-list
139372853|NCT04069819|Escitalopram|escitalopram|mesh-list
139184330|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372854|NCT04069819|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139372855|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139372856|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139372857|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372858|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139372859|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
139372860|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372861|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
139372862|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372863|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139372864|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139372865|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
139372866|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139372867|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139372868|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139372869|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
139372870|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139372871|NCT04069819|Protective Agents|protective agents|mesh-ancestor
139372872|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139372873|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139372874|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372875|NCT04084496|Folfirinox|folfirinox|mesh-list
139372876|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372877|NCT02831855|Methotrexate|methotrexate|mesh-list
139372878|NCT02831855|Tofacitinib|tofacitinib|mesh-list
139372879|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139372880|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
139372881|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139372882|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372883|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139372884|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
139372885|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372886|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372887|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
139372888|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372889|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139372890|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139372891|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
139372892|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139372893|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139372894|NCT02831855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139372895|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139372896|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
139372897|NCT01356407|Cathartics|cathartics|mesh-ancestor
139372898|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139372899|NCT00109837|Leucovorin|leucovorin|mesh-list
139372900|NCT00109837|Cytarabine|cytarabine|mesh-list
139372901|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139372902|NCT00109837|Dexamethasone|dexamethasone|mesh-list
139372903|NCT00109837|Prednisone|prednisone|mesh-list
139372904|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
139372905|NCT00109837|Doxorubicin|doxorubicin|mesh-list
139372906|NCT00109837|Methotrexate|methotrexate|mesh-list
139372907|NCT00109837|Vincristine|vincristine|mesh-list
139372908|NCT00109837|Daunorubicin|daunorubicin|mesh-list
139372909|NCT00109837|Asparaginase|asparaginase|mesh-list
139372910|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
139372911|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
139372912|NCT00109837|Thioguanine|thioguanine|mesh-list
139372913|NCT00109837|Allopurinol|allopurinol|mesh-list
139372914|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139372915|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
139372916|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372917|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139372918|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139372919|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
139372920|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372921|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372922|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139372923|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139372924|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
139372925|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
139372926|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139372927|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139372929|NCT00109837|Hormones|hormones|mesh-ancestor
139372930|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139372931|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139372932|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139372933|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139372934|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139372935|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139372936|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139372937|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
139372938|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139372939|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139372940|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
139372941|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
139372942|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139372943|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139372944|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
139372945|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372946|NCT00109837|Antidotes|antidotes|mesh-ancestor
139372947|NCT00109837|Protective Agents|protective agents|mesh-ancestor
139372948|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
139372949|NCT00109837|Vitamins|vitamins|mesh-ancestor
139372950|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
139372951|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139372952|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
139372953|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
139372954|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
139372955|NCT00109837|Analgesics|analgesics|mesh-ancestor
139372956|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
139372957|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
139372958|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139372959|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
139372960|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139372961|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139372962|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
139372963|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139372964|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139372965|NCT05229445|Insulin|insulin|mesh-list
139372966|NCT05229445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139372967|NCT05229445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372968|NCT01671332|Suramin|suramin|mesh-list
139372969|NCT01671332|Docetaxel|docetaxel|mesh-list
139372970|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372971|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
139372972|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
139372973|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
139372974|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372975|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
139372976|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
139372977|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139372978|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139372979|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139372980|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139372982|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
139372983|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372984|NCT03897062|Suvorexant|suvorexant|mesh-list
139372985|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139372986|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139372987|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139372988|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139372989|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139372990|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139372991|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372992|NCT00100802|Temozolomide|temozolomide|mesh-list
139372993|NCT00100802|Lomustine|lomustine|mesh-list
139372994|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139372995|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
139372996|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139372997|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139372998|NCT01355159|Folic Acid|folic acid|mesh-list
139372999|NCT01355159|Hematinics|hematinics|mesh-ancestor
139373000|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
139373001|NCT01355159|Vitamins|vitamins|mesh-ancestor
139373002|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
139373003|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373004|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
139373005|NCT04661852|Topotecan|topotecan|mesh-list
139373006|NCT04661852|Mitogens|mitogens|mesh-list
139373007|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139373008|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
139373009|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373010|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139373011|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139373012|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
139373013|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373014|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373015|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139373016|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139373017|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139373018|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373019|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
139373020|NCT02630186|Atezolizumab|atezolizumab|mesh-list
139373021|NCT02630186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139373022|NCT02630186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373023|NCT02630186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139373024|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373025|NCT00002462|Cobalt|cobalt|mesh-list
139373026|NCT00002462|Prednisone|prednisone|mesh-list
139373027|NCT00002462|Doxorubicin|doxorubicin|mesh-list
139373028|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139373029|NCT00002462|Bleomycin|bleomycin|mesh-list
139373030|NCT00002462|Vincristine|vincristine|mesh-list
139373031|NCT00002462|Vinblastine|vinblastine|mesh-list
139373032|NCT00002462|Procarbazine|procarbazine|mesh-list
139373033|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
139373034|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139373035|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373036|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139373037|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139373038|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373039|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373040|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139373041|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
139373042|NCT00002462|Hormones|hormones|mesh-ancestor
139373043|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373044|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373045|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139373046|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139373047|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
139373048|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
139373049|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
139373050|NCT00002462|Trace Elements|trace elements|mesh-ancestor
139373051|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
139373052|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
139029918|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139373053|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139373054|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
139373055|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
139373057|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139373058|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139373059|NCT01669928|Renin Inhibitors|renin inhibitors|mesh-list
139373060|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139373061|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373062|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373063|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
139373064|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373065|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139373066|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139373067|NCT04440176|Vaccines|vaccines|mesh-list
139373068|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
139373069|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373070|NCT03595592|Paclitaxel|paclitaxel|mesh-list
139373071|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139373072|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
139373073|NCT03595592|Carboplatin|carboplatin|mesh-list
139373074|NCT03595592|Doxorubicin|doxorubicin|mesh-list
139373075|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139373076|NCT03595592|Trastuzumab|trastuzumab|mesh-list
139373077|NCT03595592|Atezolizumab|atezolizumab|mesh-list
139373078|NCT03595592|Pertuzumab|pertuzumab|mesh-list
139373079|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139373080|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373081|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
139373082|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
139373083|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
139373084|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373085|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139373086|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
139373087|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373088|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139373089|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139373090|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
139373091|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139373092|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139373093|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139373094|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139373095|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373096|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139373097|NCT03595592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139373098|NCT01355081|Vortioxetine|vortioxetine|mesh-list
138928814|NCT00777543|Ferulic acid|ferulic acid|mesh-list
139373099|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
139373100|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139373101|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139373102|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139373103|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139373104|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373105|NCT01355081|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139373106|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139373107|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139373108|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373109|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373110|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
139373111|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139373112|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139373113|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139373114|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139373115|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139373116|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
139373117|NCT02259959|Olodaterol|olodaterol|mesh-list
139373118|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139373119|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
139373120|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373121|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373122|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139373123|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
139373124|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
139373125|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139373126|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
139373127|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030003|NCT00973037|Tamoxifen|tamoxifen|mesh-list
139373128|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373129|NCT03062462|Clopidogrel|clopidogrel|mesh-list
139373130|NCT03062462|Ticagrelor|ticagrelor|mesh-list
139373131|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139373132|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139373133|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139373134|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139373135|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
139373136|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373137|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373138|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373139|NCT04433078|Doxycycline|doxycycline|mesh-list
139373140|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139373141|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139373142|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
139373143|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139373144|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139373145|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
139373146|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373147|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139373148|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373149|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373150|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
139373151|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373152|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373153|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139373154|NCT04368533|Fluorides|fluorides|mesh-list
139373155|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
139373156|NCT04368533|Protective Agents|protective agents|mesh-ancestor
139373157|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373158|NCT02627144|Interferons|interferons|mesh-list
139373159|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
139373160|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
139373161|NCT02627144|Bevacizumab|bevacizumab|mesh-list
139373162|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139373163|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928830|NCT00777543|Protective Agents|protective agents|mesh-ancestor
139373164|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139373165|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139373166|NCT02627144|Growth Substances|growth substances|mesh-ancestor
139373167|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373168|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
139373169|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
139373170|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139373171|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
139373172|NCT04586335|Olaparib|olaparib|mesh-list
139373173|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139373174|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373175|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373176|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373177|NCT04981886|Bimatoprost|bimatoprost|mesh-list
139373178|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139373179|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139373180|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
139373181|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373182|NCT04548440|Paclitaxel|paclitaxel|mesh-list
139373183|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139373184|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139373185|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373186|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
139373187|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
139373188|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
139373189|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373190|NCT02626520|Paclitaxel|paclitaxel|mesh-list
139373191|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139373192|NCT02626520|Gemcitabine|gemcitabine|mesh-list
139373193|NCT02626520|Fluorouracil|fluorouracil|mesh-list
139373194|NCT02626520|Irinotecan|irinotecan|mesh-list
139373195|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139373196|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373197|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
139373198|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
139373199|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
139373200|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373201|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139373202|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
139373203|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139373204|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
139373205|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373206|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139373207|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139373208|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373209|NCT03063710|Olaparib|olaparib|mesh-list
139373210|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139373211|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373212|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373213|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373214|NCT05084521|Famotidine|famotidine|mesh-list
139373215|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139373216|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139373217|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139373218|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
139373219|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
139373220|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373221|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373222|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373223|NCT05063851|Memantine|memantine|mesh-list
139373224|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139373225|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139373226|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
139373227|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373228|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373229|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373230|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139373231|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139373232|NCT03359161|Furosemide|furosemide|mesh-list
139373233|NCT03359161|Diuretics|diuretics|mesh-ancestor
139373234|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
139373235|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373236|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139373237|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139373238|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373239|NCT03277339|Paroxetine|paroxetine|mesh-list
139373240|NCT03277339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139373241|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139373242|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139373243|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373244|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373245|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
139373246|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373247|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139373248|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
139373249|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139373250|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139373251|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139373252|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373253|NCT03145675|Enoxaparin|enoxaparin|mesh-list
139373254|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
139373255|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
139373256|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139373257|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139373258|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373259|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
139373260|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139373261|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139373262|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373263|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139373264|NCT04042727|Analgesics|analgesics|mesh-ancestor
139373265|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
139373266|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373267|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139373268|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139373269|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139373270|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
139373271|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373272|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373273|NCT02035943|Insulin|insulin|mesh-list
139373274|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139373275|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139373276|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373278|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
139373279|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
139373280|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373281|NCT02394028|Etrolizumab|etrolizumab|mesh-list
139373282|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139373283|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
139373284|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373285|NCT02819297|Laxatives|laxatives|mesh-list
139373286|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139373287|NCT03063788|Copper|copper|mesh-list
139373288|NCT03063788|Trace Elements|trace elements|mesh-ancestor
139373289|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
139373290|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373291|NCT02821715|Flecainide|flecainide|mesh-list
139373292|NCT02821715|Modafinil|modafinil|mesh-list
139373293|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139373294|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373295|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139373296|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139373297|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139373298|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373299|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139373300|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139373301|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139373302|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139373303|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
139373304|NCT03545347|Nandrolone|nandrolone|mesh-list
139373305|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
139373306|NCT03545347|Androgens|androgens|mesh-ancestor
139373307|NCT03545347|Hormones|hormones|mesh-ancestor
139373308|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373309|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373310|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
139373311|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139373312|NCT02815397|Metformin|metformin|mesh-list
139373313|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139373314|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373315|NCT02427958|Leuprolide|leuprolide|mesh-list
139373316|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139373317|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
139373318|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139373319|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373320|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139373321|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373322|NCT03715127|Psilocybin|psilocybin|mesh-list
139373323|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
139373324|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373325|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139373326|NCT02260037|Epinastine|epinastine|mesh-list
139373327|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139373328|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
139373329|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
139373330|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373331|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373332|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373333|NCT02036489|Prednisone|prednisone|mesh-list
139373334|NCT02036489|Vincristine|vincristine|mesh-list
139373335|NCT02036489|Daunorubicin|daunorubicin|mesh-list
139373336|NCT02036489|Asparaginase|asparaginase|mesh-list
139373337|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
139373338|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139373339|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
139373340|NCT02036489|Hormones|hormones|mesh-ancestor
139373341|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373342|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373343|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139373344|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373345|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139373346|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
139373347|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
139373348|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
139373349|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373351|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139373352|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139373353|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373354|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
139373355|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139373356|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139373357|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
139373358|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139373359|NCT02392624|Omalizumab|omalizumab|mesh-list
139373360|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139373361|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139373362|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
139373363|NCT02047565|Edoxaban|edoxaban|mesh-list
139373364|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139373365|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
139373366|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139373367|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
139373368|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373369|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373370|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
139373371|NCT03063866|Midazolam|midazolam|mesh-list
139373372|NCT03063866|Fentanyl|fentanyl|mesh-list
139373373|NCT03063866|Propofol|propofol|mesh-list
139373374|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139373375|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139373376|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373377|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139373378|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
139373379|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
139373380|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139373381|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139373382|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139373383|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139373384|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
139373385|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
139373386|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373387|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373388|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139373389|NCT03063866|Narcotics|narcotics|mesh-ancestor
139373390|NCT03063866|Analgesics|analgesics|mesh-ancestor
139373391|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
139373392|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373393|NCT02037191|Methotrexate|methotrexate|mesh-list
139373394|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139373395|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
139373396|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139373397|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373398|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139373399|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
139373400|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373401|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373402|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
139373403|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373404|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139373405|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139373406|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
139373407|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139373408|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139373409|NCT04980170|Amoxicillin|amoxicillin|mesh-list
139373410|NCT04980170|Clindamycin|clindamycin|mesh-list
139373411|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
139373412|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
139373413|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139373414|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
139373415|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
139373416|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139373417|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139373418|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139373419|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373420|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373421|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139373422|NCT02387164|Vitamin D|vitamin d|mesh-list
139373423|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
139373424|NCT02387164|Vitamins|vitamins|mesh-ancestor
139373425|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
139373426|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373427|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139373428|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139373429|NCT02047799|Calcitriol|calcitriol|mesh-list
139373430|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139373431|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373432|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139373433|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139373434|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373435|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139373436|NCT02047799|Vitamins|vitamins|mesh-ancestor
139373437|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
139373438|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139373439|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
139373440|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139373441|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373442|NCT02392234|Ivacaftor|ivacaftor|mesh-list
139373443|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139373444|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139373445|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373446|NCT02036723|Bevacizumab|bevacizumab|mesh-list
139373447|NCT02036723|Ranibizumab|ranibizumab|mesh-list
139373448|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139373449|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373450|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139373451|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139373452|NCT02036723|Growth Substances|growth substances|mesh-ancestor
139373453|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373454|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
139373455|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139373456|NCT02036879|Norethindrone|norethindrone|mesh-list
139373457|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
139373458|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
139373459|NCT02036879|Estradiol|estradiol|mesh-list
139373460|NCT02036879|Estrogens|estrogens|mesh-ancestor
139373461|NCT02036879|Hormones|hormones|mesh-ancestor
139373462|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373463|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373464|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139373465|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
139373466|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139373467|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139373468|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139373469|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139373470|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139373471|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139373472|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
139373473|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139373474|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
139373475|NCT02963090|Topotecan|topotecan|mesh-list
139373476|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139373477|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373478|NCT02963090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139373479|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373480|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139373481|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139373482|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373483|NCT02048423|Ketamine|ketamine|mesh-list
139373484|NCT02048423|Analgesics|analgesics|mesh-ancestor
139373485|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
139373486|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373487|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373488|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139373489|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139373490|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
139373491|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
139373492|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139373493|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139373494|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139373495|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373496|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373497|NCT02037035|Ketamine|ketamine|mesh-list
139373498|NCT02037035|Analgesics|analgesics|mesh-ancestor
139373499|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
139373500|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373501|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373502|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139373503|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139373504|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
139373505|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
139373506|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139373507|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139373508|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139373509|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373510|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373511|NCT04979468|Lamivudine|lamivudine|mesh-list
139373512|NCT04979468|Dolutegravir|dolutegravir|mesh-list
139373513|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139373514|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139373515|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373516|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373517|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
139373518|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139373519|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139373520|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139373521|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139373522|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139373523|NCT03562169|Thalidomide|thalidomide|mesh-list
139373524|NCT03562169|Dexamethasone|dexamethasone|mesh-list
139373525|NCT03562169|Ixazomib|ixazomib|mesh-list
139373526|NCT03562169|Glycine|glycine|mesh-list
139373527|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139373528|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
139373529|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
139373530|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373531|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373532|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139373533|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
139373534|NCT03562169|Hormones|hormones|mesh-ancestor
139373535|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373536|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139373537|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373538|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139373539|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
139373540|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
139373541|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139373542|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139373543|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139373544|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139373545|NCT03562169|Growth Substances|growth substances|mesh-ancestor
139373546|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
139373547|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
139373548|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373549|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373550|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
139373551|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373552|NCT02427802|Gentamicins|gentamicins|mesh-list
139373553|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139373554|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139373555|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139373556|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373557|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373558|NCT02050529|Labetalol|labetalol|mesh-list
139373559|NCT02050529|Hydralazine|hydralazine|mesh-list
139373560|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139373561|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139373562|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
139373563|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373564|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373565|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373566|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139373567|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
139373568|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
139373569|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373570|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139373571|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139373572|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
139373573|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139373574|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139373575|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
139373576|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139373577|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139373578|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373579|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373580|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139373581|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139373582|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373583|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
139373584|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373585|NCT02048969|Flumazenil|flumazenil|mesh-list
139373586|NCT02048969|Antidotes|antidotes|mesh-ancestor
139373587|NCT02048969|Protective Agents|protective agents|mesh-ancestor
139373588|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373589|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
139373590|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
139373591|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373592|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373593|NCT03561935|Propafenone|propafenone|mesh-list
139373594|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139373595|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139373596|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139373597|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139373598|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373599|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
139373600|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139373601|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
139373602|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139373603|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373604|NCT02808143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138928914|NCT00433537|Dexamethasone|dexamethasone|mesh-list
139373605|NCT02808143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373606|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139373607|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
139373608|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373609|NCT02620280|Paclitaxel|paclitaxel|mesh-list
139373610|NCT02620280|Carboplatin|carboplatin|mesh-list
139373611|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139373612|NCT02620280|Atezolizumab|atezolizumab|mesh-list
139373613|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139373614|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373615|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
139373616|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
139373617|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
139373618|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373619|NCT02620280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139373620|NCT02620280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139373621|NCT02806973|Glucagon|glucagon|mesh-list
139373622|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139373623|NCT02806973|Hormones|hormones|mesh-ancestor
139373624|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373625|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139184381|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
139373626|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
139373627|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
139373628|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373629|NCT02037737|Abatacept|abatacept|mesh-list
139373630|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139373631|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373632|NCT02037737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139373633|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373634|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139373635|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
139373636|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373637|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139373638|NCT02037503|Ketamine|ketamine|mesh-list
139373639|NCT02037503|Analgesics|analgesics|mesh-ancestor
139373640|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
139373641|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373642|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373643|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139373644|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139373645|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
139030518|NCT00364533|Tapentadol|tapentadol|mesh-list
139373647|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139373648|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139373649|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139373650|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373651|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373652|NCT02049671|Hormones|hormones|mesh-list
139373653|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373654|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373655|NCT02037815|Mannitol|mannitol|mesh-list
139373656|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139373657|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139373658|NCT02037815|Diuretics|diuretics|mesh-ancestor
139373659|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
139373660|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373661|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139373662|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139373663|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
139373664|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139373665|NCT02053727|Abatacept|abatacept|mesh-list
139373666|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139373667|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373668|NCT02053727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139373669|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373670|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139373671|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
139373672|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373673|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139373674|NCT02051153|Modafinil|modafinil|mesh-list
139373675|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139373676|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373677|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139373678|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139373679|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139373680|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373681|NCT02807363|Leuprolide|leuprolide|mesh-list
139373682|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139373683|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
139373684|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139373685|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373686|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139373687|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373688|NCT02051231|Oxytocin|oxytocin|mesh-list
139373689|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
139184383|NCT03497767|Osimertinib|osimertinib|mesh-list
139373690|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139373691|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373692|NCT02051387|Cannabidiol|cannabidiol|mesh-list
139373693|NCT02051387|Olanzapine|olanzapine|mesh-list
139373694|NCT02051387|Risperidone|risperidone|mesh-list
139373695|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139373696|NCT02051387|Amisulpride|amisulpride|mesh-list
139373697|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139373698|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
139373699|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373700|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373701|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373702|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139373703|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139373704|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139373705|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139373706|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139373707|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
139373708|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
139373709|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
139373710|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373711|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139373712|NCT02051387|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139373713|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139373714|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139373715|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
139373716|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
139373717|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139373718|NCT02052167|Methotrexate|methotrexate|mesh-list
139030595|NCT00983177|Colchicine|colchicine|mesh-list
139373719|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139373720|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
139373721|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139373722|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373723|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139373724|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
139373725|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373726|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373727|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
139373728|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373729|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139373730|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139373731|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
139373732|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139373733|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139373734|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
139373735|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139373736|NCT03524417|Antibodies|antibodies|mesh-list
139373737|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
139373738|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373739|NCT03806543|Vancomycin|vancomycin|mesh-list
139373740|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139373741|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139373742|NCT02052323|Artesunate|artesunate|mesh-list
139373743|NCT02052323|Mefloquine|mefloquine|mesh-list
139373744|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
139373745|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139373746|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139373747|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139373748|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373749|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
139373750|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
139373751|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139373752|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
139373753|NCT02056223|Acetaminophen|acetaminophen|mesh-list
139373754|NCT02056223|Ibuprofen|ibuprofen|mesh-list
139373755|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139373756|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139373757|NCT02056223|Analgesics|analgesics|mesh-ancestor
139373758|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
139373759|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373760|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373761|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139373762|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139373763|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139373764|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373765|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373766|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
139373767|NCT02056379|Dexamethasone|dexamethasone|mesh-list
139373768|NCT02056379|Budesonide|budesonide|mesh-list
139373769|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139373770|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
139373771|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
139373772|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373773|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373774|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139373775|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
139373776|NCT02056379|Hormones|hormones|mesh-ancestor
139373777|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373778|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139373779|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373780|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139373781|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139373782|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
139373783|NCT02383966|Carboplatin|carboplatin|mesh-list
139373784|NCT02383966|Fluorouracil|fluorouracil|mesh-list
139373785|NCT02383966|Cetuximab|cetuximab|mesh-list
139373786|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373787|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
139373788|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373789|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139373790|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139373791|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
139030666|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
139373792|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373793|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139373794|NCT02054663|Clopidogrel|clopidogrel|mesh-list
139373795|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139373796|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139373797|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139373799|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
139373800|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373801|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373802|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373803|NCT02054975|Vitamin D|vitamin d|mesh-list
139373804|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
139373805|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
139373806|NCT02054975|Vitamins|vitamins|mesh-list
139373807|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
139373808|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373809|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139373810|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139373811|NCT02055131|Aspirin|aspirin|mesh-list
139373812|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139373813|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139373814|NCT02055131|Analgesics|analgesics|mesh-ancestor
139373815|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
139373816|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139373817|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373818|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139373819|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139373820|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139373821|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139373822|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373823|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139373824|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139373825|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373826|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
139373827|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
139373828|NCT02056847|Pitavastatin|pitavastatin|mesh-list
139373829|NCT02056847|Calcium|calcium|mesh-list
139373830|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139373831|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373832|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139373833|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139373834|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139373835|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139373836|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
139373837|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373838|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373839|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139373840|NCT02052713|Tamsulosin|tamsulosin|mesh-list
139373841|NCT02052713|Dutasteride|dutasteride|mesh-list
139373842|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139373843|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139373844|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139373845|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
139373846|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373847|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373848|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373849|NCT02052713|Urological Agents|urological agents|mesh-ancestor
139373850|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139373851|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139373852|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373853|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
139373854|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373855|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
139373856|NCT02057003|Grazoprevir|grazoprevir|mesh-list
139373857|NCT02057003|Ledipasvir|ledipasvir|mesh-list
139373858|NCT02057003|Velpatasvir|velpatasvir|mesh-list
139373859|NCT02057003|Simeprevir|simeprevir|mesh-list
139373860|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
139373861|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139373862|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
139373863|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373864|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373865|NCT02426086|Niacinamide|niacinamide|mesh-list
139373866|NCT02426086|Imetelstat|imetelstat|mesh-list
139373867|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
139373868|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373869|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373870|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139373871|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
139373873|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
139373874|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373875|NCT02055911|Ranibizumab|ranibizumab|mesh-list
139373876|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139373877|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139373878|NCT02055911|Growth Substances|growth substances|mesh-ancestor
139373879|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373880|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
139373881|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373882|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139373883|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
139373884|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373885|NCT02390362|Rituximab|rituximab|mesh-list
139373886|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139373887|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373888|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
139373889|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373890|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139373891|NCT02389816|Vortioxetine|vortioxetine|mesh-list
139373892|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
139373893|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139373894|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139373895|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139373896|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139373897|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373898|NCT02389816|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139373899|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139373900|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139373901|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373902|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373904|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139373905|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139373906|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139373907|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139373908|NCT02388724|Lansoprazole|lansoprazole|mesh-list
139373909|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
139373910|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139373911|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139373912|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139373913|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373914|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373915|NCT02382640|Febuxostat|febuxostat|mesh-list
139373916|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
139373917|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139373918|NCT02801669|Edoxaban|edoxaban|mesh-list
139373919|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139373920|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
139373921|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139373922|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
139373923|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373924|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373925|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
139373926|NCT02804399|Rifampin|rifampin|mesh-list
139373927|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139373928|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
139373929|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139373930|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139373931|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
139373932|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139373933|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373934|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373935|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139373936|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139373937|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139373938|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139373939|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139373940|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139373941|NCT05614037|Felodipine|felodipine|mesh-list
139373942|NCT05614037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139373943|NCT05614037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139373944|NCT05614037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139373945|NCT05614037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139373946|NCT05614037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373947|NCT05614037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139373948|NCT05614037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373949|NCT05614037|Vasodilator Agents|vasodilator agents|mesh-ancestor
139373950|NCT02058875|Cyclosporine|cyclosporine|mesh-list
139373951|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
139373952|NCT02058875|Prednisone|prednisone|mesh-list
139373953|NCT02058875|Cyclosporins|cyclosporins|mesh-list
139373954|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139373955|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
139373956|NCT02058875|Hormones|hormones|mesh-ancestor
139373957|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373958|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373959|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139373960|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139373961|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373962|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373963|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139373964|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
139373965|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
139373966|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139184412|NCT04308304|Donepezil|donepezil|mesh-list
139373967|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
139373968|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139373969|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139373970|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139373971|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139373972|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
139373973|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139373974|NCT02059031|Cabotegravir|cabotegravir|mesh-list
139373975|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139373976|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139373977|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139373978|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373979|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139373980|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139373981|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
139373982|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139373983|NCT01333865|Memantine|memantine|mesh-list
139373984|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139373985|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139373986|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
139373987|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139373988|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139373989|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373990|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139373991|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139373992|NCT04978688|Relugolix|relugolix|mesh-list
139373993|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
139373994|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
139373995|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139373996|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139373997|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
139373998|NCT04434326|Vorolanib|vorolanib|mesh-list
139373999|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139374000|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374001|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374002|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
139374003|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139374004|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139374005|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139374006|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139374007|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374008|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
139374009|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374010|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374011|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139374012|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374013|NCT02172872|Decitabine|decitabine|mesh-list
139374014|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139374015|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
139374016|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374017|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374018|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374019|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
139374020|NCT02059655|Bimatoprost|bimatoprost|mesh-list
139374021|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139374022|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139374023|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139374024|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139374025|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374026|NCT05636501|Prednisolone|prednisolone|mesh-list
139374027|NCT05636501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139374028|NCT05636501|Glucocorticoids|glucocorticoids|mesh-ancestor
139374029|NCT05636501|Hormones|hormones|mesh-ancestor
139374030|NCT05636501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139374031|NCT05636501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374032|NCT05636501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139374033|NCT05636501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374034|NCT02058173|Chloroquine|chloroquine|mesh-list
139374035|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139374037|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139374038|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139374039|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374040|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
139374041|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139374042|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139374043|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139374044|NCT02058173|Analgesics|analgesics|mesh-ancestor
139374045|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
139374046|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374047|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374048|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139374049|NCT02058173|Filaricides|filaricides|mesh-ancestor
138928981|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
139374050|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
139374051|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
139374052|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
139374053|NCT02060201|Saxagliptin|saxagliptin|mesh-list
139374054|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139374055|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374056|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139374057|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374058|NCT02060201|Incretins|incretins|mesh-ancestor
139374059|NCT02060201|Hormones|hormones|mesh-ancestor
139374060|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139374061|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139374062|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
139374063|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374064|NCT03561233|Omeprazole|omeprazole|mesh-list
139374065|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139374066|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139374067|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139374068|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374069|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374070|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139374071|NCT02058485|Midazolam|midazolam|mesh-list
139374072|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
139374073|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139374074|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139374075|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374076|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139374077|NCT02058485|Analgesics|analgesics|mesh-ancestor
139374078|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
139374079|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374080|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139374081|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139374082|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139374083|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
139374084|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374085|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374086|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139374087|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139374088|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139374089|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139374090|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139374091|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
139374092|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
139374093|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
139374094|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
139374095|NCT02060279|Carotenoids|carotenoids|mesh-list
139374096|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
139374097|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374098|NCT02060279|Protective Agents|protective agents|mesh-ancestor
139374099|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374100|NCT02058641|Darapladib|darapladib|mesh-list
139374101|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
139374102|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374103|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374104|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
139374105|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139374106|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139374107|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374108|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
139374109|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
139374110|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374111|NCT02059967|Paclitaxel|paclitaxel|mesh-list
139374112|NCT02059967|Carboplatin|carboplatin|mesh-list
139374113|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139374114|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374115|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
139374116|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
139374117|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
138928989|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374118|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374119|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139374120|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139374121|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374122|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139374123|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
139374124|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374125|NCT02061449|Romidepsin|romidepsin|mesh-list
139374126|NCT02061449|Poly ICLC|poly iclc|mesh-list
139374127|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
139374128|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
139374129|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374130|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139374131|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374132|NCT02061449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139374133|NCT02061449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374134|NCT02061449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374135|NCT02060591|Bupivacaine|bupivacaine|mesh-list
139374136|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
139374137|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
139374138|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139374139|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374140|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
139374141|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374142|NCT02060669|Capecitabine|capecitabine|mesh-list
139374143|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139374144|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
139374145|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374146|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374147|NCT04428008|Thymalfasin|thymalfasin|mesh-list
139374148|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139374149|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
139374150|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374151|NCT02046590|Propofol|propofol|mesh-list
139374152|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
139374153|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139374154|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374155|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139374156|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139374157|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
139374158|NCT02796755|Riluzole|riluzole|mesh-list
139374159|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
139374160|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139374161|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139374162|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374163|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374164|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374165|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139374166|NCT02796755|Protective Agents|protective agents|mesh-ancestor
139374167|NCT02061917|Lobeline|lobeline|mesh-list
139374168|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139374169|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
139374170|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374171|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374172|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139374173|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139374174|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
139374175|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374176|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374177|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
138928996|NCT00773331|Hematinics|hematinics|mesh-ancestor
139374179|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139374180|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374181|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139374182|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374183|NCT02382016|Macitentan|macitentan|mesh-list
139374184|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139374185|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139374186|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374187|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139374188|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139374189|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139374190|NCT02422186|Sertraline|sertraline|mesh-list
139374191|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
139374192|NCT02422186|Esketamine|esketamine|mesh-list
139374193|NCT02422186|Escitalopram|escitalopram|mesh-list
139374194|NCT02422186|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139374195|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139374196|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139374197|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374198|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374199|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
139374200|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374201|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374202|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139374203|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139374204|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139374205|NCT02422186|Analgesics|analgesics|mesh-ancestor
139374206|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
139374207|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
139374208|NCT02796677|Bromides|bromides|mesh-list
139374209|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
139374210|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
139374211|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139374212|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
139374213|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374214|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374215|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139374216|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
139374217|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139374218|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139374219|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139374220|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
139374221|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374222|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374223|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
139374224|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139374225|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
139374226|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
139374227|NCT04973462|Oseltamivir|oseltamivir|mesh-list
139374228|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
139374229|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374230|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929012|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139374231|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374232|NCT02378506|Etanercept|etanercept|mesh-list
139374233|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139374234|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139374235|NCT02378506|Analgesics|analgesics|mesh-ancestor
139374236|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
139374237|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374238|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374239|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139374240|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139374241|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139374242|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139374243|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
139374245|NCT02794883|Ipilimumab|ipilimumab|mesh-list
139374246|NCT02794883|Tremelimumab|tremelimumab|mesh-list
139374247|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
139374248|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139374249|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
139374250|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139374251|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374252|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
139374253|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374254|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139374255|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374256|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
139374257|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139374258|NCT02063789|Antibodies|antibodies|mesh-list
139374259|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
139374260|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374261|NCT02063945|Risperidone|risperidone|mesh-list
139374262|NCT02063945|Methylphenidate|methylphenidate|mesh-list
139374263|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139374264|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
139374265|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374266|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374267|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374268|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139374269|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139374270|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139374271|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139374272|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139374273|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
139374274|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139374275|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139374276|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139374277|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139374278|NCT02064023|Insulin|insulin|mesh-list
139374279|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139374280|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139374281|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374282|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
139374283|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
139374284|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
139374285|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374286|NCT01370603|Atorvastatin|atorvastatin|mesh-list
139374287|NCT01370603|Ezetimibe|ezetimibe|mesh-list
139374288|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139374289|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139374290|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
139374291|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374292|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139374293|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139374294|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374295|NCT02659397|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139374296|NCT02659397|Atorvastatin|atorvastatin|mesh-list
139374297|NCT02659397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139374298|NCT02659397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139374299|NCT02659397|Antimetabolites|antimetabolites|mesh-ancestor
139374300|NCT02659397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374301|NCT02659397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139374302|NCT02659397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139374303|NCT02659397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374304|NCT02659397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139374305|NCT02659397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374306|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
139374307|NCT02347072|Bromides|bromides|mesh-list
139374308|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
139374309|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
139374310|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139374311|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
139374312|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031192|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
139374313|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374314|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139374315|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
139374316|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139374317|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139374318|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139374319|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
139374320|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374321|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374322|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
139374323|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139374324|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
139374325|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
139374326|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139374327|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139374329|NCT02064491|Docetaxel|docetaxel|mesh-list
139374330|NCT02064491|Cisplatin|cisplatin|mesh-list
139374331|NCT02064491|Carboplatin|carboplatin|mesh-list
139374332|NCT02064491|Pemetrexed|pemetrexed|mesh-list
139374333|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139374334|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139374335|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374336|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
139374337|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
139374338|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
139374339|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374340|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374341|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139374342|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139374343|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139374344|NCT02064881|Metformin|metformin|mesh-list
139374345|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139374346|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374347|NCT02346370|Docetaxel|docetaxel|mesh-list
139374348|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374349|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
139374350|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
139374351|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
139374352|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374353|NCT02065739|Itraconazole|itraconazole|mesh-list
139374354|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
139374355|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
139374356|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374357|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139374358|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139374359|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374360|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374361|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139374362|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
139374363|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139374364|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374365|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139374366|NCT02068079|Vemurafenib|vemurafenib|mesh-list
139374367|NCT02068079|Trientine|trientine|mesh-list
139374368|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374369|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139374370|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374371|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374372|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
139374373|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
139374374|NCT02793947|Epinephrine|epinephrine|mesh-list
139374375|NCT02793947|Morphine|morphine|mesh-list
139374376|NCT02793947|Ropivacaine|ropivacaine|mesh-list
139374377|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139374378|NCT02793947|Narcotics|narcotics|mesh-ancestor
139374379|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139374380|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374381|NCT02793947|Analgesics|analgesics|mesh-ancestor
139374382|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
139374383|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374385|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
139374386|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139374387|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139374388|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
139374389|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374390|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374391|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139374392|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139374393|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
139374394|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139374395|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
139374396|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
139374397|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
139374398|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139374399|NCT02068235|Ponesimod|ponesimod|mesh-list
139374400|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139374401|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374402|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139374403|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
139374404|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374405|NCT01370213|Interleukin-2|interleukin-2|mesh-list
139374406|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139374407|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374408|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139374409|NCT01370213|Analgesics|analgesics|mesh-ancestor
139374410|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
139374411|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374412|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374413|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
139374414|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139374415|NCT02066207|Atorvastatin|atorvastatin|mesh-list
139374416|NCT02066207|Fenofibrate|fenofibrate|mesh-list
139374417|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139374418|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139374419|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
139374420|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374421|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139374422|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139374423|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374424|NCT01370525|Esomeprazole|esomeprazole|mesh-list
139374425|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139374426|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139374427|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139374428|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139184446|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139374429|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374431|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374432|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374433|NCT02068625|Rasagiline|rasagiline|mesh-list
139374434|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139374435|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374436|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374437|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139374438|NCT02068625|Protective Agents|protective agents|mesh-ancestor
139374439|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374440|NCT02068859|Diclofenac|diclofenac|mesh-list
139374441|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139374442|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139374443|NCT02068859|Analgesics|analgesics|mesh-ancestor
139374444|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
139374445|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374446|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374447|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139374448|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139374449|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139374450|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374451|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374452|NCT02068937|Furosemide|furosemide|mesh-list
139374453|NCT02068937|Diuretics|diuretics|mesh-ancestor
139374454|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
139374455|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374456|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139374457|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139374458|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374459|NCT02066675|Trabectedin|trabectedin|mesh-list
139374460|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139374461|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
139031356|NCT01017458|Hormones|hormones|mesh-ancestor
139374462|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374463|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374464|NCT02072135|Bupivacaine|bupivacaine|mesh-list
139374465|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
139374466|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
139374467|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139374468|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374469|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
139374470|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374471|NCT02067065|Propofol|propofol|mesh-list
139374472|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139374473|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139374474|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374475|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139374476|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
139374477|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
139374478|NCT02067143|Cytarabine|cytarabine|mesh-list
139374479|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139374480|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
139374481|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374482|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374483|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
139374484|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374485|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139374486|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
139374487|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374488|NCT02072213|Tamsulosin|tamsulosin|mesh-list
139374489|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139374490|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138929129|NCT00778791|Metformin|metformin|mesh-list
139374491|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139374492|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
139374493|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374494|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374495|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374496|NCT02072213|Urological Agents|urological agents|mesh-ancestor
139374497|NCT02072291|Nifedipine|nifedipine|mesh-list
139374498|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139374499|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139374500|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374501|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139374502|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374503|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
139374504|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
139374505|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139374506|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139374507|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
139374508|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374509|NCT03059888|Abatacept|abatacept|mesh-list
139374510|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139374511|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374512|NCT03059888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139374513|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374514|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139374515|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
139374516|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374517|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139374518|NCT03061838|Rituximab|rituximab|mesh-list
139374519|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139374520|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374521|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
139374522|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374523|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139374524|NCT04964180|Indomethacin|indomethacin|mesh-list
139374525|NCT04964180|Lidocaine|lidocaine|mesh-list
139374526|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
139374527|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
139374528|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139374529|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374530|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
139374531|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374532|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139374533|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139374534|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139374535|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139374536|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374537|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139374538|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139374539|NCT04964180|Analgesics|analgesics|mesh-ancestor
139374540|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139374541|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139374542|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
139374543|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
139374544|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139374545|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139374546|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374547|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
139374548|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139374549|NCT02067377|Antibodies|antibodies|mesh-list
139374550|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
139374551|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374552|NCT02073149|Iron|iron|mesh-list
139374553|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
139374554|NCT02073149|Trace Elements|trace elements|mesh-ancestor
139374555|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
139374556|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374557|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139374558|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
139374559|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
139374560|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374562|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139374563|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139374564|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139374565|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374566|NCT02067767|Lamivudine|lamivudine|mesh-list
139374567|NCT02067767|Abacavir|abacavir|mesh-list
139374568|NCT02067767|Dolutegravir|dolutegravir|mesh-list
139374569|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139374570|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139374571|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374572|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374573|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
139374574|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374575|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139374576|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139374577|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139374578|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139374579|NCT02073227|Metformin|metformin|mesh-list
139374580|NCT02073227|Canagliflozin|canagliflozin|mesh-list
139374581|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139374582|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374583|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139374584|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374585|NCT03060044|Fluticasone|fluticasone|mesh-list
139374586|NCT03060044|Xhance|xhance|mesh-list
139374587|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139374588|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139374589|NCT03060044|Charcoal|charcoal|mesh-list
139374590|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139374591|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139374592|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
139374593|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374594|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374595|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139374596|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
139374597|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
139374598|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139374599|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139374600|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139374601|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139374602|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
139374603|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374604|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374605|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
139374606|NCT03060044|Hormones|hormones|mesh-ancestor
139374607|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139374608|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
139374609|NCT03060044|Antidotes|antidotes|mesh-ancestor
139374610|NCT03060044|Protective Agents|protective agents|mesh-ancestor
139374611|NCT02070653|Ticagrelor|ticagrelor|mesh-list
139374612|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139374613|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139374614|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139374615|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139374616|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
139374617|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139184485|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139374618|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374619|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374620|NCT04831892|Isosorbide|isosorbide|mesh-list
139374621|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139374622|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139374623|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139374624|NCT04831892|Diuretics|diuretics|mesh-ancestor
139374625|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
139374626|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374627|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
139374628|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139374629|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374630|NCT02073773|Levodopa|levodopa|mesh-list
139374631|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139374632|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139374633|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
139374634|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374635|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374636|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374637|NCT03062150|Cycloserine|cycloserine|mesh-list
139374638|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
139374639|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139374640|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374641|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139374642|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
139374643|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139374644|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
139374645|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374646|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139374647|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
139374648|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139374649|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139374650|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374651|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
139374652|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
139374653|NCT02076659|Methotrexate|methotrexate|mesh-list
139374654|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139374655|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
139374656|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139374657|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374658|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139374659|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
139374660|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374661|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374662|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
139374663|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374664|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139374665|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139374666|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
139374667|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139374668|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139374669|NCT02076815|Anagrelide|anagrelide|mesh-list
139374670|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139374671|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139374672|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374673|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139374674|NCT02071043|Capecitabine|capecitabine|mesh-list
139374675|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
139374676|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139374677|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
139374678|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374679|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374680|NCT02076893|Ibuprofen|ibuprofen|mesh-list
139374681|NCT02076893|Gabapentin|gabapentin|mesh-list
139374682|NCT02076893|Tramadol|tramadol|mesh-list
139374683|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139374684|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139374686|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
139374687|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374688|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374689|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139374691|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139374692|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374693|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374694|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
139374695|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139374696|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139374697|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139374698|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139374699|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139374700|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139374701|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374702|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
139374703|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139374704|NCT02076893|Narcotics|narcotics|mesh-ancestor
139374705|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139374706|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139374707|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139374708|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374709|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374710|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139374711|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139374712|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374713|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
139374714|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374715|NCT04963088|Capecitabine|capecitabine|mesh-list
139374716|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
139374717|NCT04963088|Tislelizumab|tislelizumab|mesh-list
139374718|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139374719|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
138929200|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
139374720|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374721|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374722|NCT04963088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139374723|NCT02074319|Methotrexate|methotrexate|mesh-list
139374724|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139374725|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
139374726|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139374727|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374728|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139374729|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
139374730|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374731|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374732|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
139374733|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374734|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139374735|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139374736|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
139374737|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139374738|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139374739|NCT04975022|Insulin|insulin|mesh-list
139374740|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139374741|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374742|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139374743|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
139374744|NCT03061604|Octreotide|octreotide|mesh-list
139374745|NCT03061604|Hemostatics|hemostatics|mesh-list
139374746|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374747|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139374748|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139374749|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374750|NCT03061604|Coagulants|coagulants|mesh-ancestor
139374751|NCT04974944|Paclitaxel|paclitaxel|mesh-list
139374752|NCT04974944|Bevacizumab|bevacizumab|mesh-list
139374753|NCT04974944|Carboplatin|carboplatin|mesh-list
139374754|NCT04974944|Apatinib|apatinib|mesh-list
139374755|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139374756|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374757|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
139374758|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
139374759|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
139374760|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374761|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139374762|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139374763|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139374765|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374766|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
139374767|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139374768|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374769|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139374770|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139374771|NCT04962386|Hormones|hormones|mesh-list
139374772|NCT04962386|Estradiol|estradiol|mesh-list
139374773|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139374774|NCT04962386|Progesterone|progesterone|mesh-list
139374775|NCT04962386|Estrogens|estrogens|mesh-list
139374776|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139374777|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374778|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139374779|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
139374780|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139374781|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139374782|NCT04962386|Progestins|progestins|mesh-ancestor
139374783|NCT02071355|Simeprevir|simeprevir|mesh-list
139374784|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
139374785|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374786|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
139374787|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374788|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374789|NCT02071433|Iodine|iodine|mesh-list
139374790|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139374791|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374792|NCT02071433|Trace Elements|trace elements|mesh-ancestor
139374793|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
139374794|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374795|NCT04962308|Vaccines|vaccines|mesh-list
139374796|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
139374797|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374798|NCT02071589|Nifedipine|nifedipine|mesh-list
139374799|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139374800|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139374801|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374802|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139374803|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374804|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
139374805|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
139374806|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139374807|NCT02077751|Biotin|biotin|mesh-list
139374808|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
139374809|NCT02077751|Vitamins|vitamins|mesh-ancestor
139374810|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
139374811|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374812|NCT04961684|Amorolfine|amorolfine|mesh-list
139374813|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
139374814|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374815|NCT03061058|Docetaxel|docetaxel|mesh-list
139374816|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
139374817|NCT03061058|Irinotecan|irinotecan|mesh-list
139374818|NCT03061058|Pemetrexed|pemetrexed|mesh-list
139374819|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374820|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
139374821|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
139374822|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
139374823|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374824|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139374825|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139374826|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374827|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139374828|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139374829|NCT04961918|Durvalumab|durvalumab|mesh-list
139374830|NCT04961918|Lenvatinib|lenvatinib|mesh-list
139374831|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139374832|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374833|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139374834|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374835|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374836|NCT04954040|Azithromycin|azithromycin|mesh-list
139374837|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
139374838|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139374839|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139374840|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
139374841|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139374842|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139374843|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374844|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374845|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139374846|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
139374848|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
138929232|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
139374849|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
139374850|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139374851|NCT04424654|Androgens|androgens|mesh-ancestor
139374852|NCT04424654|Hormones|hormones|mesh-ancestor
139374853|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139374854|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374855|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139374856|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374857|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
139374858|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
139374859|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
139374860|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139374861|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139374862|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374863|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139374864|NCT04968392|Analgesics|analgesics|mesh-ancestor
139374865|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
139374866|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374867|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139374868|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139374869|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139374870|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
139374871|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374872|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374873|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
139374874|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
139374875|NCT02792699|Rituximab|rituximab|mesh-list
139374876|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139374877|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374878|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
139374879|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374880|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139374881|NCT04968002|Apatinib|apatinib|mesh-list
139374882|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374883|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139374884|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374885|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374886|NCT04961138|Lenvatinib|lenvatinib|mesh-list
139374887|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374888|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139374889|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374890|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374891|NCT03061136|Clonazepam|clonazepam|mesh-list
139374892|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
139374893|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
139374894|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
138929247|NCT00789945|Insulin|insulin|mesh-list
139374895|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374896|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374897|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374898|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139374900|NCT02080169|Fentanyl|fentanyl|mesh-list
139374901|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
139374902|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139374903|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139374904|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374905|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139374906|NCT02080169|Analgesics|analgesics|mesh-ancestor
139374907|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
139374908|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374909|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139374910|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139374911|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139374912|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
139374913|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374914|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374915|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139374916|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139374917|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139374918|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139374919|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139374920|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
139374921|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
139374922|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
139374923|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
139374924|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139374925|NCT02080169|Narcotics|narcotics|mesh-ancestor
139374926|NCT02078063|Mepivacaine|mepivacaine|mesh-list
139374927|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
139374928|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
139374929|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139374930|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374931|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
139374932|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374933|NCT04951856|Evolocumab|evolocumab|mesh-list
139374934|NCT04951856|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139374935|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139374936|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139374937|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
139374938|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374939|NCT04951856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139374940|NCT04951856|Protease Inhibitors|protease inhibitors|mesh-ancestor
139374941|NCT04951856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374942|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139374943|NCT04951232|Cinepazide|cinepazide|mesh-list
139374944|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
139374945|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
139374946|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
139374947|NCT04959578|Hematinics|hematinics|mesh-ancestor
139374948|NCT04959500|Temozolomide|temozolomide|mesh-list
139374949|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139374950|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
139374951|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374952|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374953|NCT02076191|Decitabine|decitabine|mesh-list
139374954|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139374955|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
139374956|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374957|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374958|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374959|NCT02080715|Tolcapone|tolcapone|mesh-list
139374960|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139374961|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139374962|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139374963|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374964|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374965|NCT04965662|Tenofovir|tenofovir|mesh-list
139374966|NCT04965662|Emtricitabine|emtricitabine|mesh-list
139374967|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139374968|NCT04965662|Maraviroc|maraviroc|mesh-list
139374969|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
139374970|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139184524|NCT03799315|Nicotine|nicotine|mesh-list
139374971|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139374972|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139374973|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374974|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374976|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139374977|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139374978|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139374979|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139374980|NCT02078609|Midostaurin|midostaurin|mesh-list
139374981|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139374982|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139374983|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139374984|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374985|NCT04957940|SMOFlipid|smoflipid|mesh-list
139374986|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139374987|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139374988|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139374989|NCT03060278|Nicotine|nicotine|mesh-list
139374990|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139374991|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
139374992|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139374993|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139374994|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139374995|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139374996|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
139374997|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139374998|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139374999|NCT02083991|Prednisolone|prednisolone|mesh-list
139375000|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
139375001|NCT02083991|Basiliximab|basiliximab|mesh-list
139375002|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139375003|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
139375004|NCT02083991|Hormones|hormones|mesh-ancestor
139375005|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139375006|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375007|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139375008|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375009|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
139375010|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139375011|NCT02081027|Riluzole|riluzole|mesh-list
139375012|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
139375013|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139375014|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139375015|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375016|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929289|NCT00785421|Antidotes|antidotes|mesh-ancestor
139375017|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375018|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139375019|NCT02081027|Protective Agents|protective agents|mesh-ancestor
139375020|NCT04948034|Tislelizumab|tislelizumab|mesh-list
139375021|NCT04948034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139375022|NCT04948034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375023|NCT04947956|Apatinib|apatinib|mesh-list
139375024|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375025|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139375026|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375027|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375028|NCT03254511|Enoxaparin|enoxaparin|mesh-list
139375029|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
139375030|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
139375031|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139375032|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139375033|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375034|NCT04947566|Ibuprofen|ibuprofen|mesh-list
139375035|NCT04947566|Naproxen|naproxen|mesh-list
139375036|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139375037|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139375038|NCT04947566|Analgesics|analgesics|mesh-ancestor
139184529|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139375039|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
139375040|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375041|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375042|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139375043|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139375044|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139375045|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375046|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375047|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
139375049|NCT03241875|Gabapentin|gabapentin|mesh-list
139375050|NCT03241875|Analgesics|analgesics|mesh-ancestor
139375051|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
139375052|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375053|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375054|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
139375055|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139375056|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375057|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375058|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139375059|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139375060|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139375061|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139375062|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139375063|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139375064|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139375065|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375066|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
139375067|NCT03058094|Pemetrexed|pemetrexed|mesh-list
139375068|NCT03058094|Abivertinib|abivertinib|mesh-list
139375069|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375070|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375071|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375072|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139375073|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139375074|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139375075|NCT04944524|Methotrexate|methotrexate|mesh-list
139375076|NCT04944524|Tofacitinib|tofacitinib|mesh-list
139375077|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139375078|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
139375079|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139375080|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375081|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139375082|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
139375083|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375084|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375085|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
139375086|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375087|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139375088|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139375089|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
139375090|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139375091|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139375092|NCT04944524|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139375093|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139375094|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139375095|NCT04412876|Imipramine|imipramine|mesh-list
139375096|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139375097|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139375098|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375099|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375100|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375101|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375102|NCT04412876|Analgesics|analgesics|mesh-ancestor
139375103|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
139375104|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375105|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
139375106|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139375107|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
139184534|NCT05387200|Alendronate|alendronate|mesh-list
139375108|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139375109|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139375110|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
139375111|NCT03241563|Triamcinolone|triamcinolone|mesh-list
139375112|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
139375113|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139375114|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
139375115|NCT03241563|Hormones|hormones|mesh-ancestor
139375116|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139375117|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375118|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139375119|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139375120|NCT03241641|Tenofovir|tenofovir|mesh-list
139375121|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
139375122|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375123|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139375124|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139375125|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375126|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375127|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139375128|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139375129|NCT04486521|Siltuximab|siltuximab|mesh-list
139375130|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375131|NCT04955834|Insulin|insulin|mesh-list
139375132|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139375133|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375134|NCT03241407|Triclosan|triclosan|mesh-list
139375135|NCT03241407|Fluorides|fluorides|mesh-list
139375136|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
139032029|NCT01050387|Vitamin D|vitamin d|mesh-list
139375137|NCT03241407|Protective Agents|protective agents|mesh-ancestor
139375138|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375139|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139375140|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375141|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139375142|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139375143|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
139375144|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375145|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139375146|NCT03238131|Ivermectin|ivermectin|mesh-list
139375147|NCT03238131|Albendazole|albendazole|mesh-list
139375148|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139375149|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375150|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
139375151|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
139375152|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139375153|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139375154|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
139375155|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
139375156|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
139375157|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375158|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375159|NCT01369433|Sirolimus|sirolimus|mesh-list
139375160|NCT01369433|Paclitaxel|paclitaxel|mesh-list
139375161|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139375162|NCT01369433|Capecitabine|capecitabine|mesh-list
139375163|NCT01369433|Temsirolimus|temsirolimus|mesh-list
139375164|NCT01369433|MTOR Inhibitors|mtor inhibitors|mesh-list
139375165|NCT01369433|Tivozanib|tivozanib|mesh-list
139375166|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139375167|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375168|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
139375169|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
139375170|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
139375171|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375172|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139375173|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
139375174|NCT01369433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139375175|NCT01369433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375176|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139375177|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
139375178|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375179|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139375180|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139184537|NCT03442972|Teduglutide|teduglutide|mesh-list
139375181|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139375182|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
139375183|NCT04946162|Tadalafil|tadalafil|mesh-list
139375184|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
139375185|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139375186|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139375187|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375188|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375189|NCT04946162|Urological Agents|urological agents|mesh-ancestor
139375190|NCT02084225|Lidocaine|lidocaine|mesh-list
139375191|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
139375192|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
139375193|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139375194|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375195|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
139375196|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375197|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139375198|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139375199|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139375200|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375201|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375202|NCT04945694|Fentanyl|fentanyl|mesh-list
139375203|NCT04945694|Propofol|propofol|mesh-list
139375204|NCT04945694|Sevoflurane|sevoflurane|mesh-list
139375205|NCT04945694|Atracurium|atracurium|mesh-list
139375206|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139375207|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139375208|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375209|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139375210|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
139032124|NCT04573673|Emodin|emodin|mesh-list
139375211|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
139375212|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139375213|NCT04945694|Narcotics|narcotics|mesh-ancestor
139375214|NCT04945694|Analgesics|analgesics|mesh-ancestor
139375215|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
139375216|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375217|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139375218|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139375219|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139375220|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139375221|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139375222|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139375223|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139375224|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139375225|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
139375226|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375227|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375228|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139375229|NCT02084303|Hematinics|hematinics|mesh-ancestor
139375230|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139375231|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139375232|NCT02420847|Gemcitabine|gemcitabine|mesh-list
139375233|NCT02420847|Doxorubicin|doxorubicin|mesh-list
139375234|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139375235|NCT02420847|Ixazomib|ixazomib|mesh-list
139375236|NCT02420847|Glycine|glycine|mesh-list
139375237|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139375238|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
139375239|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375240|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375241|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139375242|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139375243|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139375244|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375245|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
139375246|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
139375247|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375248|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375249|NCT03253887|Ethanol|ethanol|mesh-list
139375250|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139375251|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375252|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139375253|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375255|NCT02453607|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139375256|NCT02453607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139375257|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
139375258|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139375259|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139375260|NCT02453529|Nafithromycin|nafithromycin|mesh-list
139375261|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929329|NCT00440947|Lamivudine|lamivudine|mesh-list
139375262|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375263|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139375264|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375265|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375266|NCT03241017|Durvalumab|durvalumab|mesh-list
139375267|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139375268|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375269|NCT03237741|Rabeprazole|rabeprazole|mesh-list
139375270|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139375271|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139375272|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139375273|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375274|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375275|NCT03240939|Tadalafil|tadalafil|mesh-list
139375276|NCT03240939|Dutasteride|dutasteride|mesh-list
139375277|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
139375278|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139375279|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139375280|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375281|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375282|NCT03240939|Urological Agents|urological agents|mesh-ancestor
139375283|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139375284|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139375285|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
139375286|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139375287|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375288|NCT02624492|Rituximab|rituximab|mesh-list
139375289|NCT02624492|BI 836826|bi 836826|mesh-list
139375290|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139375291|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375292|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
139375293|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375294|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139375295|NCT03240783|Dexamethasone|dexamethasone|mesh-list
139375296|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
139375297|NCT03240783|Betamethasone|betamethasone|mesh-list
139375298|NCT03240783|BB 1101|bb 1101|mesh-list
139375299|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139375300|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
139375301|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
139375302|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375303|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375304|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139375305|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
139375306|NCT03240783|Hormones|hormones|mesh-ancestor
139375307|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139375308|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139375309|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375310|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
139375311|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375312|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375313|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139375314|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
139375315|NCT03237507|Paclitaxel|paclitaxel|mesh-list
139375316|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
139375317|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139375318|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375319|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
138929353|NCT01029769|Olanzapine|olanzapine|mesh-list
139375320|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
139375321|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
139375322|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375323|NCT04945226|Finasteride|finasteride|mesh-list
139375324|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139375325|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139375326|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375327|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375328|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
139375329|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139375330|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375331|NCT04945226|Urological Agents|urological agents|mesh-ancestor
139375332|NCT01975831|Durvalumab|durvalumab|mesh-list
139375333|NCT01975831|Tremelimumab|tremelimumab|mesh-list
139375334|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139375335|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375336|NCT04945070|Insulin|insulin|mesh-list
139375337|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139375338|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375339|NCT03240471|Calpastatin|calpastatin|mesh-list
139375340|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139375341|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
139375342|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375343|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375344|NCT04942652|Itraconazole|itraconazole|mesh-list
139375345|NCT04942652|Esomeprazole|esomeprazole|mesh-list
139375346|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139375347|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139375348|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139375349|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375350|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375351|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
139375352|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375353|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139375354|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139375355|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139375356|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
139375357|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139375358|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375359|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139375360|NCT03240549|Bevacizumab|bevacizumab|mesh-list
139375361|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139375362|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375363|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139375364|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139375366|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375367|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
139375368|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
139375369|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
139375370|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139375371|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139375372|NCT04933292|Prednisolone|prednisolone|mesh-list
139375373|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
139375374|NCT04933292|Azathioprine|azathioprine|mesh-list
139375375|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139375376|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
139375377|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139375378|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375379|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139375380|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
139375381|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139375382|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375383|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375384|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375385|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139375386|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
139375387|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
139375388|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375389|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375390|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139375391|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
139375392|NCT04933292|Hormones|hormones|mesh-ancestor
139375393|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139375394|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139375395|NCT04933292|Protective Agents|protective agents|mesh-ancestor
139375396|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139375397|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
139375398|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139375399|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139375400|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
139375401|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139375402|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
139375403|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139375404|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139375405|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375406|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
139375407|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
139375408|NCT03237117|Hormones|hormones|mesh-list
139375409|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139375410|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375411|NCT03239691|ACT-709478|act-709478|mesh-list
139375412|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139375413|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375414|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375415|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139375416|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375417|NCT04944602|Omalizumab|omalizumab|mesh-list
139375418|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139375419|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139375420|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
139375421|NCT03253107|Trastuzumab|trastuzumab|mesh-list
139375422|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139375423|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375424|NCT03236883|Gemcitabine|gemcitabine|mesh-list
139375425|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139375426|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
139375427|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375428|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375429|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
139375430|NCT03236961|Metronidazole|metronidazole|mesh-list
139375431|NCT03236961|Levofloxacin|levofloxacin|mesh-list
139375432|NCT03236961|Ertapenem|ertapenem|mesh-list
139375433|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139375434|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375435|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139375436|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139375437|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375438|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375439|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375440|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139375441|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139375442|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139375443|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139375444|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139375445|NCT05234619|Ketorolac|ketorolac|mesh-list
139375446|NCT05234619|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139375447|NCT05234619|Lidocaine|lidocaine|mesh-list
139375448|NCT05234619|Anesthetics, Local|anesthetics, local|mesh-ancestor
139375449|NCT05234619|Anesthetics|anesthetics|mesh-ancestor
139375450|NCT05234619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139375451|NCT05234619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375452|NCT05234619|Sensory System Agents|sensory system agents|mesh-ancestor
139375453|NCT05234619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375454|NCT05234619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139375455|NCT05234619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139375456|NCT05234619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139375457|NCT05234619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375458|NCT05234619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375459|NCT05234619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139375460|NCT05234619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139375462|NCT05234619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139375463|NCT05234619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139375464|NCT05234619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139375465|NCT05234619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375466|NCT04921904|Ramucirumab|ramucirumab|mesh-list
139375467|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375468|NCT02622386|Riboflavin|riboflavin|mesh-list
139375469|NCT02622386|Vitamins|vitamins|mesh-ancestor
139375470|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
139375471|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375472|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
139375473|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139375474|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
139375475|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
139375476|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139375477|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139375478|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375479|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
139375480|NCT04427618|Coagulants|coagulants|mesh-ancestor
139375481|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
139375482|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139375483|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139375484|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375485|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139375486|NCT03236727|Analgesics|analgesics|mesh-ancestor
139375487|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
139375488|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375489|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139375490|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139375491|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139375492|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
139375493|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375494|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375495|NCT03236493|PF-06700841|pf-06700841|mesh-list
139375496|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139375497|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375498|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375499|NCT04921124|Teriparatide|teriparatide|mesh-list
139375500|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139375501|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375502|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139375503|NCT04921046|Lidocaine|lidocaine|mesh-list
139375504|NCT04921046|Midazolam|midazolam|mesh-list
139375505|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139375506|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139375507|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139375508|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375509|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139375510|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139375511|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139375512|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139375513|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
139375514|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
139375515|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
139375516|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
139375517|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375518|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375519|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
139375520|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
139375521|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375522|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139375523|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139375524|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139375525|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375526|NCT02792231|Teriflunomide|teriflunomide|mesh-list
139375528|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139375529|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375530|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
139375531|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375532|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139375533|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139375534|NCT02792231|Analgesics|analgesics|mesh-ancestor
139375535|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
139375536|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375537|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139375538|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139375539|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139375540|NCT04930952|Ethanol|ethanol|mesh-list
139375541|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139375542|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375543|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139375544|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375545|NCT04920968|Rituximab|rituximab|mesh-list
139375546|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
139375547|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138929422|NCT02555943|Tenofovir|tenofovir|mesh-list
139375548|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375549|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
139375550|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375551|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139375552|NCT00700401|Ribavirin|ribavirin|mesh-list
139375553|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139375554|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
139375555|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375556|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
139375557|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375558|NCT04931108|Atenolol|atenolol|mesh-list
139375559|NCT04931108|Nitrendipine|nitrendipine|mesh-list
139375560|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139375561|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139375562|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
139375563|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
139375564|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375565|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375566|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139375567|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139375568|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139375569|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
139375570|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375571|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375572|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139375573|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375574|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139375575|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
139375576|NCT04920500|Cytarabine|cytarabine|mesh-list
139375577|NCT04920500|Daunorubicin|daunorubicin|mesh-list
139375578|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139375579|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
139375580|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375581|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375582|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
139375583|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375584|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139375585|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
139375586|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375587|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139375588|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139375589|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139375590|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375591|NCT02084615|Aspirin|aspirin|mesh-list
139375592|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139375593|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139375594|NCT02084615|Analgesics|analgesics|mesh-ancestor
139375595|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
139375596|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375597|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375598|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139375599|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139375600|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139375601|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139375602|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375603|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139375604|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139375605|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375606|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
139375607|NCT03559751|Nicotine|nicotine|mesh-list
139375608|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139375609|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
139375610|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138929440|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
139375611|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375612|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139375613|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139375614|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
139375615|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375616|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375617|NCT03234699|Midazolam|midazolam|mesh-list
139375618|NCT03234699|Cenobamate|cenobamate|mesh-list
139375619|NCT03234699|Bupropion|bupropion|mesh-list
139375620|NCT03234699|Omeprazole|omeprazole|mesh-list
139375621|NCT03234699|Warfarin|warfarin|mesh-list
139375622|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139375623|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139375624|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139375625|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375626|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139375627|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139375628|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139375629|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139375630|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
139375631|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
139375632|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
139375633|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
139375634|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375635|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375636|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
139375637|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139375638|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139375639|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139375640|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375641|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139375642|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
139375643|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139375644|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139375645|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375646|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
139375647|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139375648|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139375649|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
139375650|NCT03228771|Atorvastatin|atorvastatin|mesh-list
139375651|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139375652|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139375653|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
139375654|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375655|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139375656|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139375657|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375658|NCT02081339|Ranibizumab|ranibizumab|mesh-list
139375659|NCT02081339|Aflibercept|aflibercept|mesh-list
139375660|NCT02081339|Verteporfin|verteporfin|mesh-list
139375661|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139375662|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139375663|NCT02081339|Growth Substances|growth substances|mesh-ancestor
139375664|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375665|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
139375666|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375667|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139375668|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
139375670|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139375671|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375672|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139375673|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
139375674|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375675|NCT03559673|Lacosamide|lacosamide|mesh-list
139375676|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
139375677|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139375678|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139375679|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375680|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375681|NCT03234387|Acetylcholine|acetylcholine|mesh-list
139375682|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375683|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
139375684|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139375685|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
139375686|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375687|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375688|NCT03235947|Trimethoprim|trimethoprim|mesh-list
139375689|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
139375690|NCT03235947|Fosfomycin|fosfomycin|mesh-list
139375691|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139375692|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375693|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
139375694|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139375695|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139375696|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139375697|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375698|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375699|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139375700|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139375701|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139375702|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139375703|NCT03057470|Insulin|insulin|mesh-list
139375704|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139375705|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139375706|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375707|NCT02871401|Valganciclovir|valganciclovir|mesh-list
139375708|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
139375709|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375710|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
139375711|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375712|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139375713|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375714|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375715|NCT02085005|Capecitabine|capecitabine|mesh-list
139375716|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
139375717|NCT02085005|Aflibercept|aflibercept|mesh-list
139375718|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139375719|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
139375720|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375721|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375722|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139375723|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139375724|NCT02085005|Growth Substances|growth substances|mesh-ancestor
139375725|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375726|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
139375727|NCT03235869|Durvalumab|durvalumab|mesh-list
139184587|NCT01229189|Vitamin D|vitamin d|mesh-list
139375728|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139375729|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375730|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139375731|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
139375732|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375733|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
139375734|NCT03057314|Calcium|calcium|mesh-list
139375735|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139375736|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375737|NCT03057314|Antacids|antacids|mesh-ancestor
139375738|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375739|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139375740|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139375741|NCT02081495|Doxorubicin|doxorubicin|mesh-list
139375742|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139375743|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375744|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139375745|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139375746|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375747|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375748|NCT03056846|Sulfalene|sulfalene|mesh-list
139375749|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375750|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139375751|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
139375752|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139375753|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139375754|NCT03227679|Bupropion|bupropion|mesh-list
139375755|NCT03227679|Nicotine|nicotine|mesh-list
139375756|NCT03227679|Varenicline|varenicline|mesh-list
139375757|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139375758|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
139375759|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375760|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375761|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139375762|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139375763|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
139375764|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375765|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375766|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139375767|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
139375768|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139375769|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139375770|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139375771|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375772|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
139375773|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139375774|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139375775|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375776|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139375777|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139375778|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139375779|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375780|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375781|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
139375782|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375783|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375784|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139375785|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375786|NCT04937894|Tigecycline|tigecycline|mesh-list
139375787|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139375788|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375789|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139375790|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375791|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375792|NCT04919252|Vedolizumab|vedolizumab|mesh-list
139375793|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139375794|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
139375795|NCT04919174|Remifentanil|remifentanil|mesh-list
139375796|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139375797|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139375798|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375799|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139375800|NCT04919174|Analgesics|analgesics|mesh-ancestor
139375801|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
139375802|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375803|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139375804|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139375805|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139375806|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
139375807|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375808|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375809|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139375810|NCT04919174|Narcotics|narcotics|mesh-ancestor
139375811|NCT02085239|Lidocaine|lidocaine|mesh-list
139375812|NCT02085239|Ropivacaine|ropivacaine|mesh-list
139375813|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
139375814|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
139375815|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139375816|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375817|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
139375818|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375819|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139375820|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139375821|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139375822|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375823|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375824|NCT05143489|Lidocaine|lidocaine|mesh-list
139375825|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
139375826|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
139375827|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139375828|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375829|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
139375830|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375831|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139375832|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139375833|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139375834|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375835|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375836|NCT02085317|Nitroprusside|nitroprusside|mesh-list
139375837|NCT02085317|Acetylcholine|acetylcholine|mesh-list
139375838|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139375839|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
139375840|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139375841|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375842|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139375843|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
139375844|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375845|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375846|NCT03234153|Durvalumab|durvalumab|mesh-list
139375847|NCT03234153|Tremelimumab|tremelimumab|mesh-list
139375848|NCT03234153|Immunomodulating Agents|immunomodulating agents|mesh-list
139375849|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
139375850|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139375851|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375852|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375853|NCT03056924|Vaccines|vaccines|mesh-list
139375854|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
139375855|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375856|NCT05523401|Psilocybin|psilocybin|mesh-list
139375857|NCT05523401|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138610312|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
139375858|NCT05523401|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|mesh-list
139375859|NCT05523401|Hallucinogens|hallucinogens|mesh-ancestor
139375860|NCT05523401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375861|NCT05523401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139375862|NCT05523401|Serotonin Agents|serotonin agents|mesh-ancestor
139375863|NCT05523401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375864|NCT05523401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375865|NCT05523401|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139375866|NCT05523401|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139375867|NCT05523401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139375868|NCT05523401|Adrenergic Agents|adrenergic agents|mesh-ancestor
139375869|NCT05523401|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139375870|NCT05523401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139375871|NCT05523401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139375872|NCT05523401|Serotonin 5-HT2 Receptor Agonists|serotonin 5-ht2 receptor agonists|mesh-ancestor
139375873|NCT05523401|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139375874|NCT04918862|Granisetron|granisetron|mesh-list
139375875|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
139375876|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
139375877|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375878|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375879|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139375880|NCT04918862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139375881|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139375882|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
139375883|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375884|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375885|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
139375886|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139375887|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139375888|NCT02452281|Ipilimumab|ipilimumab|mesh-list
139375889|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139375890|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375891|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139375892|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375893|NCT02452125|Nicotine|nicotine|mesh-list
139375894|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139375895|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
139375896|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139375897|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375898|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139375899|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139375900|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
139375901|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375902|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375903|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139375904|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
139375905|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139375906|NCT02619812|Antibodies|antibodies|mesh-list
139375907|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
139375908|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375909|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139375910|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139375911|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
139375912|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375913|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139375914|NCT03222765|Metformin|metformin|mesh-list
139375915|NCT03222765|Linagliptin|linagliptin|mesh-list
139375916|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139375917|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375918|NCT03222765|Incretins|incretins|mesh-ancestor
139375919|NCT03222765|Hormones|hormones|mesh-ancestor
139375920|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139375921|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139375922|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
139375923|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375924|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375925|NCT04485585|Tamsulosin|tamsulosin|mesh-list
139375926|NCT04485585|Mirabegron|mirabegron|mesh-list
139184611|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
139375927|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139375928|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139375929|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139375931|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375932|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375933|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375934|NCT04485585|Urological Agents|urological agents|mesh-ancestor
139375935|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139375936|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139375937|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139375938|NCT03222687|Prednisone|prednisone|mesh-list
139375939|NCT03222687|Tacrolimus|tacrolimus|mesh-list
139375940|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139375941|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
139375942|NCT03222687|Hormones|hormones|mesh-ancestor
139375943|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139375944|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375945|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139375946|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375947|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139375948|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
139375949|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139375950|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139375951|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375952|NCT03055442|Inositol|inositol|mesh-list
139375953|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
139375954|NCT03055442|Vitamins|vitamins|mesh-ancestor
139375955|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
139375956|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375957|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
139032858|NCT01055925|Laxatives|laxatives|mesh-ancestor
139375958|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
139375959|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375960|NCT03226431|Protective Agents|protective agents|mesh-ancestor
139375961|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375962|NCT03226431|Vitamins|vitamins|mesh-ancestor
139375963|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
139375964|NCT02451579|Cetirizine|cetirizine|mesh-list
139375965|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
139375966|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139375967|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139375968|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139375969|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
139375970|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139375971|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375972|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375973|NCT04935788|Caseins|caseins|mesh-list
139375974|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
139375975|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
139375976|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375977|NCT03233295|Vitamin D|vitamin d|mesh-list
139375978|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
139375979|NCT03233295|Vitamins|vitamins|mesh-ancestor
139375980|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
139375981|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375982|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139375983|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139375984|NCT04917458|Vitamin D|vitamin d|mesh-list
139375985|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
139375986|NCT04917458|Vitamins|vitamins|mesh-ancestor
139375987|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
139375988|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139375989|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139375990|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139375991|NCT03225963|Temozolomide|temozolomide|mesh-list
139375992|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139184617|NCT05401721|Hemostatics|hemostatics|mesh-ancestor
139375993|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
139375994|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139375995|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139375996|NCT03221907|Pregabalin|pregabalin|mesh-list
139375997|NCT03221907|Analgesics|analgesics|mesh-ancestor
139375998|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
139375999|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376000|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376001|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
139376002|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139376003|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139376004|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376005|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139376006|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139376007|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139376008|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376009|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139376010|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139376011|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
139376012|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139376013|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
139376014|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376015|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376016|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139376017|NCT03107481|Acetaminophen|acetaminophen|mesh-list
139376018|NCT03107481|Hydromorphone|hydromorphone|mesh-list
139376019|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139376020|NCT03107481|Analgesics|analgesics|mesh-ancestor
139376021|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
139376022|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376023|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376024|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
139376025|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139376026|NCT03107481|Narcotics|narcotics|mesh-ancestor
139376027|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376028|NCT04934852|Ephedrine|ephedrine|mesh-list
139376029|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
139376030|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139376031|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032945|NCT01030614|Hormones|hormones|mesh-ancestor
139376032|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
139376033|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
139376034|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376035|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139376036|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
139376037|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376038|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376039|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139376040|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139376041|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
139376042|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
139376043|NCT04934618|Irinotecan|irinotecan|mesh-list
139376044|NCT04934618|Apatinib|apatinib|mesh-list
139376045|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139376046|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139184623|NCT01560481|Metformin|metformin|mesh-list
139376047|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376048|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376049|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376050|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139376051|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139376052|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139376053|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376054|NCT04916522|Colchicine|colchicine|mesh-list
139376055|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
139376056|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139376057|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
139376058|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
139376059|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
139376060|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376061|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376062|NCT04407650|Metformin|metformin|mesh-list
139376063|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139376064|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139376065|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376066|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139376067|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139376068|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
139376069|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139376070|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139376071|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
139376072|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139376073|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139376074|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139376075|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376076|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376077|NCT03220815|Methamphetamine|methamphetamine|mesh-list
139376078|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139376079|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376080|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
139376081|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
139376082|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376083|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
139376084|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376085|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376086|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
139376087|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139376088|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138929543|NCT00427999|Hormones|hormones|mesh-ancestor
139376089|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139376090|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139376091|NCT04913402|Sufentanil|sufentanil|mesh-list
139376093|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139376094|NCT04913402|Narcotics|narcotics|mesh-ancestor
139376095|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376096|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376097|NCT04913402|Analgesics|analgesics|mesh-ancestor
139376098|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
139376099|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376100|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139376101|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139376102|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
139376103|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
139376104|NCT04912934|Insulin|insulin|mesh-list
139376105|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139376106|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376107|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139376108|NCT04915586|Plasminogen|plasminogen|mesh-list
139376109|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139376110|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139184644|NCT03368859|Fluorouracil|fluorouracil|mesh-list
139376111|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376112|NCT03232125|Ramosetron|ramosetron|mesh-list
139376113|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
139376114|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
139376115|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376116|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376117|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139376118|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139376119|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
139376120|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376121|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376122|NCT03224637|Acetaminophen|acetaminophen|mesh-list
139376123|NCT03224637|Ketorolac|ketorolac|mesh-list
139376124|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139376125|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139376126|NCT03224637|Analgesics|analgesics|mesh-ancestor
139376127|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
139376128|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376129|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376130|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
139376131|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139376132|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139376133|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139376134|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139376135|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376136|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376137|NCT04912700|Vaccines|vaccines|mesh-list
139376138|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
139376139|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376140|NCT03224871|Aldesleukin|aldesleukin|mesh-list
139376141|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
139376142|NCT03224871|Nivolumab|nivolumab|mesh-list
139376143|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139376144|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376145|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139376146|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376147|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139376148|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139376149|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
139376150|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139376151|NCT03220425|Insulin|insulin|mesh-list
139376152|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138676697|NCT05642689|Iron|iron|mesh-list
139376153|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
139376154|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
139376155|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
139376156|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
139376157|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139376158|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376159|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139376160|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139376161|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139376162|NCT03220191|Palbociclib|palbociclib|mesh-list
139376163|NCT03220191|Rabeprazole|rabeprazole|mesh-list
139376164|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376165|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139376166|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376167|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376168|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139376169|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139376170|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139376171|NCT03220113|Thiamine|thiamine|mesh-list
139376172|NCT03220113|Dexamethasone|dexamethasone|mesh-list
139376173|NCT03220113|Lidocaine|lidocaine|mesh-list
139376174|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139376175|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
139376176|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
139376177|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376178|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376179|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139033086|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139376180|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
139376181|NCT03220113|Hormones|hormones|mesh-ancestor
139376182|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139376183|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139376184|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376185|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
139376186|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
139376187|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376188|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
139376189|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139376190|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139376191|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139376192|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139376193|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376194|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
139376195|NCT03220113|Vitamins|vitamins|mesh-ancestor
139376196|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
139376197|NCT02254525|Ibuprofen|ibuprofen|mesh-list
139376198|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139376199|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139376200|NCT02254525|Analgesics|analgesics|mesh-ancestor
139376201|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
139376202|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376203|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376204|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139376205|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139376206|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139376207|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376208|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376209|NCT03231813|Emollients|emollients|mesh-list
139376210|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
139376211|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
139376212|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
139376213|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139376214|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376215|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376216|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
139376217|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139376218|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376219|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376220|NCT02143531|Haloperidol|haloperidol|mesh-list
139376221|NCT02143531|Ondansetron|ondansetron|mesh-list
139376222|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
139376223|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
139376224|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
139376225|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376226|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376227|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139376228|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
139376229|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
139376230|NCT02143531|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139376231|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139376232|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
139376233|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376234|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376235|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139376236|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139376237|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376238|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139376239|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139376240|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
139376241|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139376242|NCT04485117|Anesthetics|anesthetics|mesh-list
139376243|NCT04485117|Propofol|propofol|mesh-list
139376244|NCT04485117|Sevoflurane|sevoflurane|mesh-list
139376245|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376246|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376247|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139376248|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139376249|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
139376250|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139376251|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139376252|NCT00803569|Sargramostim|sargramostim|mesh-list
139376253|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
139376254|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376255|NCT02143687|Sevoflurane|sevoflurane|mesh-list
139376256|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139376257|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139376258|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
139033157|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
139376259|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
139376260|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376261|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376262|NCT02143765|Acarbose|acarbose|mesh-list
139376263|NCT02143765|Mitiglinide|mitiglinide|mesh-list
139376264|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139376265|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376266|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376267|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139376268|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376269|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
139376270|NCT02148367|Hematinics|hematinics|mesh-ancestor
139376271|NCT00482833|Methotrexate|methotrexate|mesh-list
139376272|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
139376273|NCT00482833|Idarubicin|idarubicin|mesh-list
139376274|NCT00482833|Tretinoin|tretinoin|mesh-list
139376275|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
139376276|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139376277|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
139376278|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139376279|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376280|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139376281|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
139376282|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929584|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
139376283|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376284|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
139376285|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376286|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139376287|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139376288|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
139376289|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139376290|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139376291|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139376292|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139376293|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139376294|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
139376295|NCT02451033|Hormones|hormones|mesh-list
139376296|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139376297|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376298|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
139376299|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139376300|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139376301|NCT04485429|Prednisolone|prednisolone|mesh-list
139376302|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
139376303|NCT04485429|Heparin|heparin|mesh-list
139376304|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139376305|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
139376306|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139376307|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
139376308|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
139376309|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376310|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376311|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139376312|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
139376313|NCT04485429|Hormones|hormones|mesh-ancestor
139376314|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139376315|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139376316|NCT04485429|Protective Agents|protective agents|mesh-ancestor
139376317|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139376318|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376319|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
139376320|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139376321|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139376322|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376323|NCT00112957|Vaccines|vaccines|mesh-list
139184664|NCT03368859|Vitamins|vitamins|mesh-ancestor
139376324|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
139376325|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376326|NCT02140801|Clopidogrel|clopidogrel|mesh-list
139376328|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139376329|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139376330|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139376331|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139376332|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
139033238|NCT01052259|Gusperimus|gusperimus|mesh-list
139376333|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376334|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376335|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376336|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139376337|NCT02148601|Vancomycin|vancomycin|mesh-list
139376338|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139376339|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
139376340|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
139376341|NCT02141035|Vitamins|vitamins|mesh-ancestor
139376342|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
139376343|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376344|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
139376345|NCT03214653|Propofol|propofol|mesh-list
139376346|NCT03214653|Sevoflurane|sevoflurane|mesh-list
139376347|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138929592|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
139376348|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376349|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376350|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139376351|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
139376352|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
139376353|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139376354|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139376355|NCT02450877|Azacitidine|azacitidine|mesh-list
139376356|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139376357|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
139376358|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376359|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376360|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376361|NCT02141113|Guanfacine|guanfacine|mesh-list
139376362|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139376363|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139376364|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139376365|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139376366|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
139376367|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376368|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376369|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376370|NCT03213639|Esomeprazole|esomeprazole|mesh-list
139376371|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139376372|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139376373|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139376374|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376375|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376376|NCT03231033|Pioglitazone|pioglitazone|mesh-list
139376377|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139376378|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376379|NCT02141347|Durvalumab|durvalumab|mesh-list
139376380|NCT02141347|Tremelimumab|tremelimumab|mesh-list
139376381|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139376382|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376383|NCT02254759|Midazolam|midazolam|mesh-list
139376384|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139376385|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139376386|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376387|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376388|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139376389|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139376390|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139376391|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139376392|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
139376393|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
139376394|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
139376395|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
139376396|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376397|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376398|NCT03208257|Esmolol|esmolol|mesh-list
139376399|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138929613|NCT02576288|Hormones|hormones|mesh-ancestor
139376400|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139376401|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139376402|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
139376403|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376404|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376405|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376406|NCT02141425|Peficitinib|peficitinib|mesh-list
139033305|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376407|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376408|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376409|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139376410|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
139376411|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376413|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139376414|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139376415|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
139376416|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376417|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376418|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139376419|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139376420|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
139376421|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376422|NCT03208101|Vaccines|vaccines|mesh-list
139376423|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
139376424|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376425|NCT02149225|Poly I-C|poly i-c|mesh-list
139376426|NCT02149225|Molgramostim|molgramostim|mesh-list
139376427|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139376428|NCT02149225|Vaccines|vaccines|mesh-list
139376429|NCT02149225|Sargramostim|sargramostim|mesh-list
139376430|NCT02149225|Poly ICLC|poly iclc|mesh-list
139376431|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
139376432|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376433|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376434|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
139376435|NCT02149225|Laxatives|laxatives|mesh-ancestor
139376436|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139376437|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
139376438|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139376439|NCT03208335|Endostatins|endostatins|mesh-list
139376440|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376441|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139376442|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139376443|NCT03208335|Growth Substances|growth substances|mesh-ancestor
139376444|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376445|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
139376446|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
139376447|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139376448|NCT03211065|Antibodies|antibodies|mesh-list
139376449|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
139376450|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376451|NCT02149459|Metformin|metformin|mesh-list
139376452|NCT02149459|Biguanides|biguanides|mesh-list
139376453|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139376454|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376455|NCT02376790|Etanercept|etanercept|mesh-list
139376456|NCT02376790|Methotrexate|methotrexate|mesh-list
139376457|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139376458|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
139376459|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139376460|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376461|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139376462|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
139376463|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376464|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376465|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
139376466|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376467|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139376468|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139376469|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
139376470|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139376471|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139376472|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139376473|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139376474|NCT02376790|Analgesics|analgesics|mesh-ancestor
139376475|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
139376476|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376477|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139376478|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139376479|NCT02141737|Lidocaine|lidocaine|mesh-list
139376480|NCT02141737|Midazolam|midazolam|mesh-list
139376481|NCT02141737|Fentanyl|fentanyl|mesh-list
139376482|NCT02141737|Etomidate|etomidate|mesh-list
139376483|NCT02141737|Rocuronium|rocuronium|mesh-list
139376484|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
139376485|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
139376486|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376487|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376488|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
139376489|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376490|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139376491|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139376492|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139376493|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139376494|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376495|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139376496|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139376497|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139376498|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139376499|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139376500|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139376501|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
139376502|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
139376503|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
139376504|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376505|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139376506|NCT02141737|Narcotics|narcotics|mesh-ancestor
139376507|NCT02141737|Analgesics|analgesics|mesh-ancestor
139376508|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138929651|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
139376509|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139376510|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139376511|NCT02254447|Candesartan|candesartan|mesh-list
139376512|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
139376513|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139376514|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139376515|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139376516|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376517|NCT02376166|Metformin|metformin|mesh-list
139376518|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139376519|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376520|NCT03207165|Dobutamine|dobutamine|mesh-list
139376521|NCT03207165|Milrinone|milrinone|mesh-list
139376522|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
139376523|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139376524|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
139376525|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
139376526|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376527|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376528|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139376529|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139376530|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139376531|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
139376532|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376533|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376534|NCT03207165|Protective Agents|protective agents|mesh-ancestor
139376535|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139376536|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
139376537|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139376538|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376539|NCT02142205|Natalizumab|natalizumab|mesh-list
139376540|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
139376541|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376542|NCT03209427|Morphine|morphine|mesh-list
139376543|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139376544|NCT03209427|Narcotics|narcotics|mesh-ancestor
139376545|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376546|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376547|NCT03209427|Analgesics|analgesics|mesh-ancestor
139376548|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
139376549|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376550|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
139376551|NCT03544723|Nivolumab|nivolumab|mesh-list
139376552|NCT03544723|Atezolizumab|atezolizumab|mesh-list
139376553|NCT03544723|Durvalumab|durvalumab|mesh-list
139376554|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139376555|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376556|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139376557|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376558|NCT03209661|Menthol|menthol|mesh-list
139376559|NCT03209661|Nicotine|nicotine|mesh-list
139376560|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139033456|NCT00335829|Bevacizumab|bevacizumab|mesh-list
139376561|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
139376562|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376563|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376564|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139376565|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139376566|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
139376567|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376568|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376569|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
139376570|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
139376571|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139376572|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
139376573|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139376574|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
139376575|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
139376576|NCT03209115|Calcium|calcium|mesh-list
139376577|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139376578|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376579|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139376580|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139376581|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139376582|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
139376583|NCT03209193|Sevoflurane|sevoflurane|mesh-list
139376584|NCT03209193|Desflurane|desflurane|mesh-list
139376585|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139376586|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139376587|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
139376588|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
139376589|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376590|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376591|NCT02142595|Midazolam|midazolam|mesh-list
139376592|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
139376593|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139376594|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376595|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376596|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139376597|NCT02142595|Analgesics|analgesics|mesh-ancestor
139376598|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
139376599|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376600|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139376601|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139376602|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139376603|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
139376604|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376605|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376606|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139376607|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139376608|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139376609|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139376610|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139376611|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
139376612|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
139376613|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
139376614|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
139376615|NCT04898374|Cisplatin|cisplatin|mesh-list
139376616|NCT04898374|Gemcitabine|gemcitabine|mesh-list
139376617|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376618|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139376619|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
139376620|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376621|NCT03207477|Mydriatics|mydriatics|mesh-list
139376622|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
139376623|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376624|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376625|NCT02452515|Fulacimstat|fulacimstat|mesh-list
139376626|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376627|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376628|NCT03206931|Selitrectinib|selitrectinib|mesh-list
139376629|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376630|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376631|NCT02344342|Diuretics|diuretics|mesh-list
139376632|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
139376633|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376634|NCT02452437|Oxycodone|oxycodone|mesh-list
139376635|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139376636|NCT02452437|Narcotics|narcotics|mesh-ancestor
139376637|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376638|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376639|NCT02452437|Analgesics|analgesics|mesh-ancestor
139376640|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
139376641|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376642|NCT03208413|Thalidomide|thalidomide|mesh-list
139376643|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139376644|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
139376645|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376646|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
139376647|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139376648|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139376649|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139376650|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139376651|NCT03208413|Growth Substances|growth substances|mesh-ancestor
139376652|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
139376653|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376654|NCT03201159|Pentamidine|pentamidine|mesh-list
139376655|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
139376656|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139376657|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139376658|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139376659|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139376660|NCT02149927|Sevoflurane|sevoflurane|mesh-list
139376661|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139376662|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139376663|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
139376664|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
139376665|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376666|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376668|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
139376669|NCT02142751|Fosfomycin|fosfomycin|mesh-list
139376670|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139376671|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139376672|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139376673|NCT02142829|Bupivacaine|bupivacaine|mesh-list
139376674|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
139376675|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
139376676|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376677|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376678|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
139376679|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376680|NCT03200691|Antibodies|antibodies|mesh-list
139376681|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
139376682|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376683|NCT02150161|Lidocaine|lidocaine|mesh-list
139376684|NCT02150161|Fentanyl|fentanyl|mesh-list
139376685|NCT02150161|Ketamine|ketamine|mesh-list
139376686|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
139376687|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
139376688|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376689|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376690|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
139376691|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376692|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139376693|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139376694|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139376695|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139376696|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376697|NCT02150161|Analgesics|analgesics|mesh-ancestor
139376698|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139376699|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139376700|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
139376701|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139376702|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139376703|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376704|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139376705|NCT02150161|Narcotics|narcotics|mesh-ancestor
139376706|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139376707|NCT03200613|Heparin|heparin|mesh-list
139376708|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139376709|NCT03200613|Tinzaparin|tinzaparin|mesh-list
139376710|NCT03200613|Dalteparin|dalteparin|mesh-list
139376711|NCT03200613|Apixaban|apixaban|mesh-list
139033609|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376712|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
139376713|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139376714|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139376715|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376716|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139376717|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
139376718|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139376719|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
139376720|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376721|NCT02150317|Sorafenib|sorafenib|mesh-list
139376722|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
139376723|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376724|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139376725|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376726|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376727|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139376728|NCT02150317|Estrogens|estrogens|mesh-ancestor
139376729|NCT02150317|Hormones|hormones|mesh-ancestor
139376730|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139376731|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376732|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139376733|NCT02310568|PF-06372865|pf-06372865|mesh-list
139376734|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
139376735|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
139376736|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376737|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376738|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376739|NCT02448069|Argatroban|argatroban|mesh-list
139376740|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
139376741|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139376742|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
139376743|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376744|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376745|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
139376746|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139376747|NCT02449941|Rabeprazole|rabeprazole|mesh-list
139376748|NCT02449941|Pantoprazole|pantoprazole|mesh-list
139376749|NCT02449941|Lansoprazole|lansoprazole|mesh-list
139376750|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
139376751|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139376752|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139376753|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139376754|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376755|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376756|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
139376757|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139376758|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
139376759|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139376760|NCT03199989|Capecitabine|capecitabine|mesh-list
139376761|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
139376762|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139376763|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
139376764|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376765|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376766|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
139376767|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139376768|NCT03195543|Thrombin|thrombin|mesh-list
139376769|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
139376770|NCT03195543|Coagulants|coagulants|mesh-ancestor
139376771|NCT03204669|Trace Elements|trace elements|mesh-list
139376772|NCT03204669|Micronutrients|micronutrients|mesh-list
139376773|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376774|NCT03199677|Apatinib|apatinib|mesh-list
139376775|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376776|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139376777|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376778|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376779|NCT02780167|Abrocitinib|abrocitinib|mesh-list
139376780|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139376781|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376782|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376783|NCT02447757|Remifentanil|remifentanil|mesh-list
139376784|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139376785|NCT02447757|Narcotics|narcotics|mesh-ancestor
139376786|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376787|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376788|NCT02447757|Analgesics|analgesics|mesh-ancestor
139376789|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
139376790|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376791|NCT02447835|Olanzapine|olanzapine|mesh-list
139376792|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
139376793|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
139376794|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376795|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376796|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139376797|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139376798|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139376799|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376800|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139376801|NCT02447835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139376802|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139376803|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139376804|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376805|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376806|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
139376807|NCT02447679|Tegafur|tegafur|mesh-list
139376808|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139376809|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
139376810|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376811|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376812|NCT03203967|Morphine|morphine|mesh-list
139376813|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139376814|NCT03203967|Narcotics|narcotics|mesh-ancestor
139376815|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376816|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376817|NCT03203967|Analgesics|analgesics|mesh-ancestor
139376818|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
139376819|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376820|NCT03204045|Fentanyl|fentanyl|mesh-list
139376821|NCT03204045|Oxycodone|oxycodone|mesh-list
139376822|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139376823|NCT03204045|Narcotics|narcotics|mesh-ancestor
139376824|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376825|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376826|NCT03204045|Analgesics|analgesics|mesh-ancestor
139376827|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
139376828|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376829|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139376830|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139376831|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
139376832|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
139376833|NCT03199521|Thrombin|thrombin|mesh-list
139376834|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
139376835|NCT03199521|Coagulants|coagulants|mesh-ancestor
139376836|NCT03195153|Allopurinol|allopurinol|mesh-list
139376837|NCT03195153|Atorvastatin|atorvastatin|mesh-list
139376838|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139376839|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139376840|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
139376841|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376842|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139376843|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139376844|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376845|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
139376846|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139376847|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139376848|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
139376849|NCT03195153|Protective Agents|protective agents|mesh-ancestor
139376850|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376851|NCT03195309|Fentanyl|fentanyl|mesh-list
139376852|NCT03195309|Ropivacaine|ropivacaine|mesh-list
139376853|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
139376854|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
139376855|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376856|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376857|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
139376858|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376859|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139376860|NCT03195309|Narcotics|narcotics|mesh-ancestor
139376861|NCT03195309|Analgesics|analgesics|mesh-ancestor
139376862|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139376863|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139376864|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
139376865|NCT03198819|Cefotaxime|cefotaxime|mesh-list
139376866|NCT03198819|Cefoxitin|cefoxitin|mesh-list
139376867|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139376868|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139376869|NCT02447601|Simvastatin|simvastatin|mesh-list
139376870|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139376871|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139376872|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
139376873|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376874|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139376875|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139376876|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376878|NCT03118713|Glimepiride|glimepiride|mesh-list
139376879|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
139376880|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139184720|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
139376881|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376882|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139376883|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139376884|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
139376885|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139376886|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376887|NCT03198585|Empagliflozin|empagliflozin|mesh-list
139376888|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139376889|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376890|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139376891|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376892|NCT02447289|Midazolam|midazolam|mesh-list
139376893|NCT02447289|Ketamine|ketamine|mesh-list
139376894|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139376895|NCT02447289|Analgesics|analgesics|mesh-ancestor
139376896|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
139376897|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139376898|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376899|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139376900|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139376901|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
139376902|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
139376903|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376904|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139376905|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139376906|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376907|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376908|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139376909|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139376910|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139376911|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139376912|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139376913|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
139376914|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
139376915|NCT02447211|Doxepin|doxepin|mesh-list
139376916|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139376917|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139376918|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376919|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376920|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139376921|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
139376922|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139376923|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
139376924|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
139376925|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139376926|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376927|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
139376928|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139376929|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
139376930|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376931|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139376932|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139376933|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
139376934|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376935|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376936|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139376937|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
139376938|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
139376939|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139376940|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
139376941|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376942|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376943|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
139376944|NCT03203031|Anesthetics|anesthetics|mesh-list
139376945|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139376946|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376947|NCT03118479|Anastrozole|anastrozole|mesh-list
139376948|NCT03118479|Testosterone|testosterone|mesh-list
139376949|NCT03118479|Androgens|androgens|mesh-ancestor
139376950|NCT03118479|Hormones|hormones|mesh-ancestor
139376951|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139376952|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376953|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139376954|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376955|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139376956|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139376957|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376958|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376959|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139376960|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
139376961|NCT03197961|Tenofovir|tenofovir|mesh-list
139376962|NCT03197961|Emtricitabine|emtricitabine|mesh-list
139376963|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139376964|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
139376965|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
139376966|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139376967|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139376968|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139376969|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139376970|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139376971|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139376972|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139376973|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139376974|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139376975|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139376976|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
139376977|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139376978|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376979|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139376980|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139376981|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139376982|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139376983|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139376984|NCT03202875|Insulin|insulin|mesh-list
139376985|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139376986|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
139376987|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
139376988|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139376989|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139376990|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139376991|NCT03197571|Leucovorin|leucovorin|mesh-list
139376992|NCT03197571|Paclitaxel|paclitaxel|mesh-list
139376993|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
139376994|NCT03197571|Bevacizumab|bevacizumab|mesh-list
139376995|NCT03197571|Capecitabine|capecitabine|mesh-list
139376996|NCT03197571|Fluorouracil|fluorouracil|mesh-list
139376997|NCT03197571|Fulvestrant|fulvestrant|mesh-list
139376998|NCT03197571|Avelumab|avelumab|mesh-list
139376999|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139377000|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377001|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
139377002|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
139377003|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
139377004|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377005|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139377006|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
139377007|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377008|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139377009|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139377010|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
139377011|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139377012|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139377013|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139377014|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139377015|NCT03197571|Growth Substances|growth substances|mesh-ancestor
139377016|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
139377017|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139184731|NCT01232075|Letrozole|letrozole|mesh-list
139377019|NCT03197571|Antidotes|antidotes|mesh-ancestor
139377020|NCT03197571|Protective Agents|protective agents|mesh-ancestor
139377021|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
139377022|NCT03197571|Vitamins|vitamins|mesh-ancestor
139377023|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
139377024|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139377025|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139377026|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139377027|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
139377028|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139377029|NCT02446977|Riboflavin|riboflavin|mesh-list
139377030|NCT02446977|Vitamins|vitamins|mesh-ancestor
139377031|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
139377032|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377033|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
139377034|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139377035|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
139377036|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
139377037|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
139377038|NCT02447055|Melphalan|melphalan|mesh-list
139377039|NCT02447055|Fludarabine|fludarabine|mesh-list
139377040|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
139377041|NCT02447055|Tacrolimus|tacrolimus|mesh-list
139377042|NCT02447055|Lenograstim|lenograstim|mesh-list
139377043|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139377044|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
139377045|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377046|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139377047|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139377048|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
139377049|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377050|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377051|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139377052|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139377053|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
139377054|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139377055|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139377056|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377057|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139377058|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139377059|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
139377060|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139377061|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377062|NCT03202563|Metformin|metformin|mesh-list
139377063|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
139377064|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139377065|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377066|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139377067|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377068|NCT03197493|Levodopa|levodopa|mesh-list
139377069|NCT03197493|Carbidopa|carbidopa|mesh-list
139377070|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139377071|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139377072|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139377073|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
139377074|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377075|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377076|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377077|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139377078|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377079|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139377080|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
139377081|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
139377082|NCT02450175|Everolimus|everolimus|mesh-list
139377083|NCT02450175|Letrozole|letrozole|mesh-list
139377084|NCT02450175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139377085|NCT02450175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139377086|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377087|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377088|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139377089|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
139377090|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377091|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377092|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139377093|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139377094|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139377095|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
139377096|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139377098|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
139377099|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377100|NCT03202407|Calcium|calcium|mesh-list
139377101|NCT03202407|Sevelamer|sevelamer|mesh-list
139377102|NCT03202407|Calcium acetate|calcium acetate|mesh-list
139377103|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139377104|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377105|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
139377106|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
139377107|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377108|NCT02261077|Scopolamine|scopolamine|mesh-list
139377109|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139377110|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139377111|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
139377112|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
139377113|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377114|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377115|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139377116|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
139377117|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139377118|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
139377119|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377120|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377121|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139377122|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
139377123|NCT03196869|Cisplatin|cisplatin|mesh-list
139377124|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377125|NCT02150473|Adalimumab|adalimumab|mesh-list
139377126|NCT02150473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139377127|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139377128|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139377129|NCT02446431|Sirolimus|sirolimus|mesh-list
139377130|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
139377131|NCT02446431|Bevacizumab|bevacizumab|mesh-list
139377132|NCT02446431|Temsirolimus|temsirolimus|mesh-list
139377133|NCT02446431|MTOR Inhibitors|mtor inhibitors|mesh-list
139377134|NCT02446431|Valproic Acid|valproic acid|mesh-list
139377135|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139377136|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
139377137|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377138|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139377139|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139377140|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
139377141|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377142|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377143|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139377144|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139377145|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139377146|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139377147|NCT02446431|Growth Substances|growth substances|mesh-ancestor
139377148|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
139377149|NCT02446431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139377150|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377151|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139377152|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377153|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139377154|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
139377155|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
139377156|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
139377157|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377158|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
139377159|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139377160|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139377161|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139377162|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
139377163|NCT02446353|Megestrol|megestrol|mesh-list
139377164|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139377165|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377166|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
139377167|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139377168|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377169|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139377170|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139377171|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139377172|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
139377173|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139377174|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139377175|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139377176|NCT02144389|Praziquantel|praziquantel|mesh-list
139377177|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
139377178|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139377179|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377180|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
139377181|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139377182|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
139377183|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377184|NCT03197103|Expectorants|expectorants|mesh-ancestor
139377185|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
139377186|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139377187|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
139377188|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377189|NCT03197103|Protective Agents|protective agents|mesh-ancestor
139377190|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377191|NCT03197103|Antidotes|antidotes|mesh-ancestor
139377192|NCT02144623|Valproic Acid|valproic acid|mesh-list
139377193|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
139377194|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377195|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377196|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
139377197|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377198|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377199|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
139377200|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139377201|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139377202|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139377203|NCT03201861|Paclitaxel|paclitaxel|mesh-list
139377204|NCT03201861|Docetaxel|docetaxel|mesh-list
139377205|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138929790|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377206|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139377207|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377208|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
139377209|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
139377210|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
139377211|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377212|NCT03194685|FF-10101|ff-10101|mesh-list
139377213|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139377214|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377215|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377216|NCT00105079|Ritonavir|ritonavir|mesh-list
139377217|NCT00105079|Lopinavir|lopinavir|mesh-list
139377218|NCT00105079|Saquinavir|saquinavir|mesh-list
139377219|NCT00105079|Tenofovir|tenofovir|mesh-list
139377220|NCT00105079|Emtricitabine|emtricitabine|mesh-list
139377221|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139377222|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139377223|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139377224|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
139377225|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377226|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377227|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139377228|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139377229|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
139377230|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377231|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139377232|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139377233|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139377234|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139377235|NCT03196401|Durvalumab|durvalumab|mesh-list
139377236|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139377237|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377238|NCT02150707|Liraglutide|liraglutide|mesh-list
139377239|NCT02150707|Exenatide|exenatide|mesh-list
139377240|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139377241|NCT02150707|Glucagon|glucagon|mesh-list
139377242|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139377243|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139034132|NCT00352365|Lenalidomide|lenalidomide|mesh-list
139377244|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377245|NCT02150707|Incretins|incretins|mesh-ancestor
139377246|NCT02150707|Hormones|hormones|mesh-ancestor
139377247|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139377248|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139377249|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139377250|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
139377251|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377252|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377254|NCT03196479|Propofol|propofol|mesh-list
139377255|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139377256|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139377257|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377258|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139377259|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
139377260|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
139377261|NCT03196479|Analgesics|analgesics|mesh-ancestor
139377262|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
139377263|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377264|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139377265|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139377266|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139377267|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377268|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377269|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
139377270|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
139377271|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139377272|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377273|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377274|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
139377275|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139377276|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139377277|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377278|NCT02151721|Gefitinib|gefitinib|mesh-list
139377279|NCT02151721|Vorinostat|vorinostat|mesh-list
139377280|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377281|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139377282|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377283|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377284|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139377285|NCT03201393|Acetaminophen|acetaminophen|mesh-list
139377286|NCT03201393|Naltrexone|naltrexone|mesh-list
139377287|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139377288|NCT03201393|Analgesics|analgesics|mesh-ancestor
139377289|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
139377290|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377291|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377292|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
139377293|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139377294|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139377295|NCT03192969|Abatacept|abatacept|mesh-list
139377296|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
139377297|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139377298|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377299|NCT03192969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139377300|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377301|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139377302|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
139377303|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377304|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139377305|NCT03192969|Hormones|hormones|mesh-ancestor
139377306|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139377307|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
139377308|NCT03194139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139377309|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
139377310|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377311|NCT03194139|Protective Agents|protective agents|mesh-ancestor
139377312|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377313|NCT03118167|Antioxidants|antioxidants|mesh-list
139377314|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377315|NCT03118167|Protective Agents|protective agents|mesh-ancestor
139377316|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377317|NCT00189267|Imiquimod|imiquimod|mesh-list
139377318|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139377319|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
139377320|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377321|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377322|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
139377324|NCT02444949|Endostar protein|endostar protein|mesh-list
139377325|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377326|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139377327|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139377328|NCT02444949|Growth Substances|growth substances|mesh-ancestor
139377329|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377330|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
139377331|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139377332|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139377333|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139377334|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
139377335|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377336|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139377337|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139377338|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377339|NCT03192657|Basiliximab|basiliximab|mesh-list
139377340|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139377341|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139377342|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
139377343|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377344|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377345|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377346|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
139377347|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139377348|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
139377349|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377350|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
139377351|NCT02444169|Protective Agents|protective agents|mesh-ancestor
139377352|NCT03194061|Cisplatin|cisplatin|mesh-list
139377353|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377354|NCT02343406|Temozolomide|temozolomide|mesh-list
139377355|NCT02343406|Lomustine|lomustine|mesh-list
139377356|NCT02343406|ABT-414|abt-414|mesh-list
139377357|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139377358|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
139377359|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377360|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377361|NCT02343406|Immunoconjugates|immunoconjugates|mesh-ancestor
139377362|NCT02343406|Immunologic Factors|immunologic factors|mesh-ancestor
139377363|NCT02343406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377364|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
139377365|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139377366|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
139377367|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377368|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139377369|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139377370|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
139377371|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377372|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377373|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139377374|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
139377375|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139377376|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
139377377|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377378|NCT03193749|Amiodarone|amiodarone|mesh-list
139377379|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139377380|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
139377381|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139377382|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139377383|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377384|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139377385|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139377386|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139377387|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377388|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139377389|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139377390|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139377391|NCT02444013|Folic Acid|folic acid|mesh-list
139377392|NCT02444013|Uric Acid|uric acid|mesh-list
139377393|NCT02444013|Hematinics|hematinics|mesh-ancestor
139377394|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
139377395|NCT02444013|Vitamins|vitamins|mesh-ancestor
139377396|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
139377397|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377398|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
139377399|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377400|NCT02444013|Protective Agents|protective agents|mesh-ancestor
139377401|NCT02444637|Rivastigmine|rivastigmine|mesh-list
139377402|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139377403|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377404|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377405|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
139377406|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377407|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377408|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139377409|NCT02444637|Protective Agents|protective agents|mesh-ancestor
139377410|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
139377411|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139377412|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
139377413|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139377414|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377415|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139377416|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139377417|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139377418|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139377419|NCT02710071|Nebivolol|nebivolol|mesh-list
139377420|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139377421|NCT02710071|Diuretics|diuretics|mesh-ancestor
139377422|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
139377423|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377424|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139377425|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139377426|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377427|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
139377428|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139377429|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139377430|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139377431|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
139377432|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377433|NCT02439489|Carboplatin|carboplatin|mesh-list
139377434|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377435|NCT02444481|Polymyxins|polymyxins|mesh-list
139377436|NCT02444481|Neomycin|neomycin|mesh-list
139377437|NCT02444481|Nystatin|nystatin|mesh-list
139377438|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139377439|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377440|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139377441|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377442|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377443|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
139377444|NCT02444481|Ionophores|ionophores|mesh-ancestor
139377445|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139377446|NCT02444559|Clonidine|clonidine|mesh-list
139377447|NCT02444559|Ropivacaine|ropivacaine|mesh-list
139377448|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
139377449|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
139377450|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139377451|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377452|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
139377453|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377454|NCT02444559|Analgesics|analgesics|mesh-ancestor
139377455|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139377456|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
139377457|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
139377458|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139377459|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139377460|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139377461|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
139377462|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377463|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377464|NCT03190239|Pemetrexed|pemetrexed|mesh-list
139377465|NCT03190239|Apatinib|apatinib|mesh-list
139377466|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377467|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377468|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377469|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139034351|NCT01005641|Exemestane|exemestane|mesh-list
139034408|NCT03882047|Xhance|xhance|mesh-list
139377470|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139377471|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139377472|NCT02439411|Trametinib|trametinib|mesh-list
139377473|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377474|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139377475|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377476|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377477|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
139377478|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377479|NCT02443311|Betamethasone|betamethasone|mesh-list
139377480|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
139377481|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139377482|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
139377483|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
139377484|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139377485|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139377486|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
139377487|NCT02443311|Hormones|hormones|mesh-ancestor
139377488|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139377489|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377490|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139377491|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
139377492|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139377493|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139377494|NCT02443311|Analgesics|analgesics|mesh-ancestor
139377495|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
139377496|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377497|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139377498|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
139377499|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139377500|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
139377501|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139377502|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377503|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377504|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
139377505|NCT02373202|Mizoribine|mizoribine|mesh-list
139377506|NCT02373202|Bucillamine|bucillamine|mesh-list
139377507|NCT02373202|Tacrolimus|tacrolimus|mesh-list
139377508|NCT02373202|Leflunomide|leflunomide|mesh-list
139377509|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139377510|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
139377511|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377512|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139377513|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377514|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377515|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377516|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139377517|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139377518|NCT02373202|Analgesics|analgesics|mesh-ancestor
139377519|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
139377520|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377521|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139377522|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139377523|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139377524|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139377525|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139377526|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377527|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
139377528|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139377529|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139377530|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
139377531|NCT02373202|Protective Agents|protective agents|mesh-ancestor
139377532|NCT03192111|Entinostat|entinostat|mesh-list
139377533|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377534|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138929848|NCT00791739|Pregabalin|pregabalin|mesh-list
139377535|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377536|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377537|NCT02622074|Paclitaxel|paclitaxel|mesh-list
139377538|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139377539|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
139377540|NCT02622074|Carboplatin|carboplatin|mesh-list
139377541|NCT02622074|Doxorubicin|doxorubicin|mesh-list
139377542|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
139377543|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139034426|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377544|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377545|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
139377546|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
139377547|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
139377548|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377549|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139377550|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
139377551|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377552|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139184795|NCT01230983|Leucovorin|leucovorin|mesh-list
139377553|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139377555|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139377556|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139377557|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139377558|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139377559|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377560|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139377561|NCT02622074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139377562|NCT02438709|Etoricoxib|etoricoxib|mesh-list
139377563|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
139377564|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139377565|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139377566|NCT02438709|Analgesics|analgesics|mesh-ancestor
139377567|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
139377568|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377569|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377570|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139377571|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139377572|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139377573|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377574|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377575|NCT05438758|Ketamine|ketamine|mesh-list
139377576|NCT05438758|Esketamine|esketamine|mesh-list
139377577|NCT05438758|Analgesics|analgesics|mesh-ancestor
139377578|NCT05438758|Sensory System Agents|sensory system agents|mesh-ancestor
139377579|NCT05438758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377580|NCT05438758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377581|NCT05438758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139377582|NCT05438758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139377583|NCT05438758|Anesthetics, General|anesthetics, general|mesh-ancestor
139377584|NCT05438758|Anesthetics|anesthetics|mesh-ancestor
139377585|NCT05438758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139377586|NCT05438758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139377587|NCT05438758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139377588|NCT05438758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377589|NCT05438758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377590|NCT05438758|Antidepressive Agents|antidepressive agents|mesh-ancestor
139377591|NCT05438758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139377592|NCT02442921|Colchicine|colchicine|mesh-list
139377593|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
139377594|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139377595|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
139377596|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
139377597|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
139377598|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377599|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377600|NCT02438865|Epirubicin|epirubicin|mesh-list
139377601|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139377602|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377603|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139377604|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139377605|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377606|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377607|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
139377608|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
139377609|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377610|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
139377611|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
139377612|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
139377613|NCT02342704|Natalizumab|natalizumab|mesh-list
139377614|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139377615|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
139377616|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377617|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139377618|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377619|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139377620|NCT02442453|Turmeric extract|turmeric extract|mesh-list
139377621|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
139377622|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377623|NCT02442453|Protective Agents|protective agents|mesh-ancestor
139377624|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377626|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139377627|NCT02438397|Metformin|metformin|mesh-list
139377628|NCT02438397|Acarbose|acarbose|mesh-list
139377629|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139377630|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377631|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139377632|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377633|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377634|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
139377635|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139377636|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139377637|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139377638|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139377639|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377640|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
139377641|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377642|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377643|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139377644|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377645|NCT02442531|Docetaxel|docetaxel|mesh-list
139377646|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377647|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
139377648|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
139377649|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
139377650|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377651|NCT03193203|Etanercept|etanercept|mesh-list
139377652|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139377653|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139377654|NCT03193203|Analgesics|analgesics|mesh-ancestor
139377655|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
139377656|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377657|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377658|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139377659|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139377660|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139377661|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139377662|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
139377663|NCT02442063|Paclitaxel|paclitaxel|mesh-list
139377664|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139377665|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139377666|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377667|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
139377668|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
139377669|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
139377670|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377671|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139377672|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139377673|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139377674|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
139377675|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377676|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377677|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139377678|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
139377679|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139377680|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
139377681|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139377682|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377683|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377684|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139377685|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377686|NCT03054662|Hemostatics|hemostatics|mesh-list
139377687|NCT03054662|Coagulants|coagulants|mesh-ancestor
139377688|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
139377689|NCT04922996|Calcium|calcium|mesh-list
139377690|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139377691|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377693|NCT04922996|Coagulants|coagulants|mesh-ancestor
139377694|NCT04913480|Durvalumab|durvalumab|mesh-list
139377695|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139377696|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377697|NCT02441907|Aflibercept|aflibercept|mesh-list
139377698|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139377699|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139377700|NCT02441907|Growth Substances|growth substances|mesh-ancestor
139377701|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377702|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
139377703|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377704|NCT02437461|Triamcinolone|triamcinolone|mesh-list
139377705|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139377706|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139377707|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139377708|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139377709|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
139377710|NCT02437461|Hormones|hormones|mesh-ancestor
139377711|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139377712|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377713|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139377714|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
139377715|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377716|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377717|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
139377718|NCT04910594|Hematinics|hematinics|mesh-ancestor
139377719|NCT02441673|Ephedrine|ephedrine|mesh-list
139377720|NCT02441673|Meperidine|meperidine|mesh-list
139377721|NCT02441673|Tramadol|tramadol|mesh-list
139377722|NCT02441673|Nefopam|nefopam|mesh-list
139377723|NCT02441673|Metoclopramide|metoclopramide|mesh-list
139377724|NCT02441673|Ranitidine|ranitidine|mesh-list
139377725|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139377726|NCT02441673|Oxytocin|oxytocin|mesh-list
139377727|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
139377728|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139377729|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377730|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139377731|NCT02441673|Narcotics|narcotics|mesh-ancestor
139377732|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139377733|NCT02441673|Analgesics|analgesics|mesh-ancestor
139377734|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
139377735|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377736|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
139377737|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
139377738|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139377739|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139377740|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139377741|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
139377742|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377743|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377744|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139377745|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
139377746|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139377747|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
139377748|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139377749|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139377750|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
139377751|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
139377752|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139377753|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139377754|NCT04910126|Doxorubicin|doxorubicin|mesh-list
139377755|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139377756|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139377757|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377758|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139377759|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139377760|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377761|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377762|NCT04922450|Paclitaxel|paclitaxel|mesh-list
138929913|NCT00792363|Panitumumab|panitumumab|mesh-list
139377763|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139377764|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139377765|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377766|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
139377767|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
139377768|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
139377769|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377770|NCT04922450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139377771|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
139377772|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
139377773|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377774|NCT04903808|Protective Agents|protective agents|mesh-ancestor
139377775|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377776|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139377777|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377778|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139377779|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377780|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
139377781|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
139377782|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377783|NCT04893980|Aldesleukin|aldesleukin|mesh-list
139377784|NCT04893980|Interleukin-2|interleukin-2|mesh-list
139377785|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377786|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139377787|NCT04893980|Analgesics|analgesics|mesh-ancestor
139377788|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
139377789|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377790|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377791|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139377792|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139377793|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
139377794|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377795|NCT04149470|Omeprazole|omeprazole|mesh-list
139377796|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139377797|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139377798|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139377799|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377800|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377801|NCT04902638|Dexamethasone|dexamethasone|mesh-list
139377802|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139377803|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
139377804|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
139377805|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377806|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377807|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139377808|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
139377809|NCT04902638|Hormones|hormones|mesh-ancestor
139377810|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139377811|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139377812|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377813|NCT02617628|Naltrexone|naltrexone|mesh-list
139377814|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139377815|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139377816|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377817|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
139377818|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377819|NCT03053414|Vitamin D|vitamin d|mesh-list
139377820|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
139377821|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
139377822|NCT03053414|Vitamins|vitamins|mesh-ancestor
139377823|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
139377824|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377825|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139377826|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139377827|NCT02308540|Vaccines|vaccines|mesh-list
139377828|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139377829|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
138929923|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139377830|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377831|NCT02308228|Metformin|metformin|mesh-list
139377832|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139377833|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377834|NCT03051932|Acetaminophen|acetaminophen|mesh-list
139377835|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139377836|NCT03051932|Analgesics|analgesics|mesh-ancestor
139377837|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
139377838|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377839|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377840|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
139377841|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
139377842|NCT04900766|Analgesics|analgesics|mesh-ancestor
139377843|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
139377844|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377845|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377846|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377847|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139377848|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139377849|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377850|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377852|NCT04908566|Antibodies|antibodies|mesh-list
139377853|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
139377854|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
139377855|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377856|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377857|NCT04892654|Dolutegravir|dolutegravir|mesh-list
139377858|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139377859|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139377860|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377861|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377862|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139377863|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139377864|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
139377865|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377866|NCT04899674|Bupropion|bupropion|mesh-list
139377867|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139377868|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
139377869|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139377870|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139377871|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139377872|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139377873|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377874|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
139377875|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377876|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377877|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139377878|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139377879|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377880|NCT04907708|Metformin|metformin|mesh-list
139377881|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139377882|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377883|NCT04890626|Tenofovir|tenofovir|mesh-list
139377884|NCT04890626|Emtricitabine|emtricitabine|mesh-list
139377885|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139377886|NCT04890626|Dexamethasone|dexamethasone|mesh-list
139377887|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
139377888|NCT04890626|BB 1101|bb 1101|mesh-list
139377889|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139377890|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
139377891|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
139377892|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377893|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377894|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139377895|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
139377896|NCT04890626|Hormones|hormones|mesh-ancestor
139377897|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139377898|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139377899|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377900|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
139377901|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377902|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377903|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
139377904|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377905|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139377906|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139377907|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139377908|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139377909|NCT04907864|Ibuprofen|ibuprofen|mesh-list
139377910|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139377911|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139377912|NCT04907864|Analgesics|analgesics|mesh-ancestor
139377913|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
139377914|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377915|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377916|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139377917|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139184889|NCT01133873|Analgesics|analgesics|mesh-ancestor
139377918|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139377919|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377920|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377921|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139377922|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139377923|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377925|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
139377926|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139377927|NCT04907474|Tropicamide|tropicamide|mesh-list
139377928|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139377929|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139377930|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
139377931|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
139377932|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377933|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377934|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
139377935|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139377936|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
139377937|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
139377938|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139377939|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139377940|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139377941|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
139377942|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377943|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377944|NCT04907474|Protective Agents|protective agents|mesh-ancestor
139377945|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139377946|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139377947|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
139377948|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
139377949|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139377950|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377951|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
139377952|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
139377953|NCT04890392|Tislelizumab|tislelizumab|mesh-list
139377954|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139377955|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139377956|NCT04890392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139377957|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377958|NCT02616614|Clindamycin|clindamycin|mesh-list
139377959|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
139377960|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
139377961|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139377962|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139377963|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139377964|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139377965|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139377966|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377967|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
139377968|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
139377969|NCT04906772|Ketamine|ketamine|mesh-list
139377970|NCT04906772|Propofol|propofol|mesh-list
139377971|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139377972|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139377973|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377974|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139377975|NCT04906772|Analgesics|analgesics|mesh-ancestor
139377976|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
139377977|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139377978|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139377979|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139377980|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139377981|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
139377982|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139377983|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139377984|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139377985|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
139377986|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
139377987|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139377988|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139377989|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139377990|NCT04889768|Antibodies|antibodies|mesh-list
139377991|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
139377992|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377993|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
139377994|NCT04898270|Flupenthixol|flupenthixol|mesh-list
139377995|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
139377996|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139377997|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139377998|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139377999|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139378000|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139378001|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
139378002|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378003|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378004|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
139378005|NCT04906304|Cyclosporine|cyclosporine|mesh-list
139378006|NCT04906304|Everolimus|everolimus|mesh-list
139378007|NCT04906304|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139378008|NCT04906304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139378009|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378010|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378011|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139378012|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
139378013|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378014|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378015|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139378016|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139378017|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
139378018|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139378019|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378020|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
139378021|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
139378022|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139378023|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139378024|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139378025|NCT03051698|Metronidazole|metronidazole|mesh-list
139378026|NCT03051698|Vancomycin|vancomycin|mesh-list
139378027|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
139378028|NCT03051698|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139378029|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378030|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139378031|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139378032|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139378033|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139378034|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378035|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378036|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378037|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139378038|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139378039|NCT03051698|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139378040|NCT03051698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139378041|NCT03051698|Immunologic Factors|immunologic factors|mesh-ancestor
139378042|NCT03051698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378043|NCT04887818|Lidocaine|lidocaine|mesh-list
139378044|NCT04887818|Diltiazem|diltiazem|mesh-list
139378045|NCT04887818|Nifedipine|nifedipine|mesh-list
139378046|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
139378047|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
139378048|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378049|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378050|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
139378051|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378052|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139378053|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139378054|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139378055|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139378056|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378057|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139378058|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139378059|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
139378060|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
139378061|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139378062|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139378063|NCT04883996|Pilocarpine|pilocarpine|mesh-list
139378064|NCT04883996|Miotics|miotics|mesh-ancestor
139378065|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
139378066|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378067|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378068|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139378069|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139378070|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
139378071|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378072|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378073|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
139378074|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139378075|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
139378076|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139378077|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378078|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
139378079|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
139378080|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139378081|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
139378082|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378083|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
139378084|NCT04884464|Protective Agents|protective agents|mesh-ancestor
139378085|NCT05028608|Carbamazepine|carbamazepine|mesh-list
139378086|NCT05028608|Midazolam|midazolam|mesh-list
139378087|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139378088|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139378089|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378090|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378091|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139378092|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139378093|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139378094|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139378095|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
139378096|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
139378097|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
139378098|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
139378099|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378100|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378101|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
139378102|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
139378103|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139378104|NCT05028608|Analgesics|analgesics|mesh-ancestor
139378105|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
139378106|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378107|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139378108|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139378109|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139378110|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139378111|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
139378112|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
139378113|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139378114|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139378115|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378116|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378117|NCT04882826|Urological Agents|urological agents|mesh-ancestor
139378118|NCT04309916|Esomeprazole|esomeprazole|mesh-list
139378119|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139378120|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139378121|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139378122|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378123|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378124|NCT01596062|Cyclosporine|cyclosporine|mesh-list
139378125|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
139378126|NCT01596062|Everolimus|everolimus|mesh-list
139378127|NCT01596062|Cyclosporins|cyclosporins|mesh-list
139378128|NCT01596062|Basiliximab|basiliximab|mesh-list
139378129|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378130|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378131|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139378132|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
139378133|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378134|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
139378135|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378136|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
139378137|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139378138|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139378139|NCT01596062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139378140|NCT01596062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138929983|NCT00495716|Acyclovir|acyclovir|mesh-list
139378141|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378142|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139378143|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139378144|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
139378145|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139378146|NCT02614898|Eculizumab|eculizumab|mesh-list
139378147|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139378148|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139378149|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
139378150|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378152|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
139378153|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
139378154|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378155|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139378156|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139378157|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
139378158|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378159|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378160|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139378161|NCT03352934|Avelumab|avelumab|mesh-list
139378162|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139378163|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378164|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
139378165|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
139378166|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139378167|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378168|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139378169|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
139378170|NCT04881110|Liraglutide|liraglutide|mesh-list
139378171|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139378172|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378173|NCT04881110|Incretins|incretins|mesh-ancestor
139378174|NCT04881110|Hormones|hormones|mesh-ancestor
139378175|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139378176|NCT02152423|Enoxaparin|enoxaparin|mesh-list
139378177|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
139378178|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139378179|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139378180|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378181|NCT02145559|Metformin|metformin|mesh-list
139378182|NCT02145559|Sirolimus|sirolimus|mesh-list
139378183|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139378184|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378185|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139378186|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378187|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139378188|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378189|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
139378190|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139378191|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
139378193|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378194|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139378195|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378196|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378197|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
139378198|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139378199|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
139378200|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378201|NCT03154580|Expectorants|expectorants|mesh-ancestor
139378202|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
139378203|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139378204|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
139378205|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378206|NCT03154580|Protective Agents|protective agents|mesh-ancestor
139378207|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378208|NCT03154580|Antidotes|antidotes|mesh-ancestor
139378209|NCT02145715|Thalidomide|thalidomide|mesh-list
139378210|NCT02145715|Dexamethasone|dexamethasone|mesh-list
139378211|NCT02145715|Bortezomib|bortezomib|mesh-list
139378212|NCT02145715|Panobinostat|panobinostat|mesh-list
139378213|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139378214|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
139378215|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
139378216|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378217|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378218|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139378219|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
139378220|NCT02145715|Hormones|hormones|mesh-ancestor
139378221|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139378222|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139378223|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378224|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139378225|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
139378227|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139378228|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378229|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139378230|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139378231|NCT02145715|Growth Substances|growth substances|mesh-ancestor
139378232|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
139378233|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139378234|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378235|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378236|NCT04871750|Caseins|caseins|mesh-list
139378237|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
139378238|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
139378239|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378240|NCT02152579|Isosorbide|isosorbide|mesh-list
139378241|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139378242|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139378243|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139378244|NCT02152579|Diuretics|diuretics|mesh-ancestor
139378245|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
139378246|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378247|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
139378248|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139378249|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378250|NCT02155777|Norinyl|norinyl|mesh-list
139378251|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139378252|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139378253|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139378254|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
139378255|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139378256|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378257|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139378258|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139378259|NCT02145949|Tryptophan|tryptophan|mesh-list
139378260|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139378261|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
139378262|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139378263|NCT00806390|Metoprolol|metoprolol|mesh-list
139378264|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139378265|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139378266|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
139378267|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
138930013|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139378268|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378269|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378270|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139378271|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139378272|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139378273|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
139378274|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378275|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378276|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
139378277|NCT00566618|Dasatinib|dasatinib|mesh-list
139378278|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378279|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139378280|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378281|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378282|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139378283|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378284|NCT02769481|Glimepiride|glimepiride|mesh-list
139378285|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
139378286|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139378287|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139378288|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378289|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139378290|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
139378291|NCT04877210|Insulin|insulin|mesh-list
139378292|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139378293|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139378294|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378295|NCT02152969|Amlodipine|amlodipine|mesh-list
139378296|NCT02152969|Telmisartan|telmisartan|mesh-list
139378297|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
139378298|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139378299|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139378300|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139378301|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378302|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139378303|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378304|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
139378305|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139378306|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139378307|NCT02152969|Diuretics|diuretics|mesh-ancestor
139378308|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
139378309|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139378310|NCT04879004|Ropivacaine|ropivacaine|mesh-list
139378311|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
139378312|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
139378313|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378314|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378315|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
139378316|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378318|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139378319|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
139378320|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139378321|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378322|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139378323|NCT02153125|Diuretics|diuretics|mesh-ancestor
138930035|NCT00788463|Beclomethasone|beclomethasone|mesh-list
139378324|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
139378325|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139378326|NCT04878926|Midazolam|midazolam|mesh-list
139378327|NCT04878926|Propofol|propofol|mesh-list
139378328|NCT04878926|Anesthetics|anesthetics|mesh-list
139378329|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
139378330|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139378331|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378332|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378333|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139378334|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
139378335|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139378336|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139378337|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139378338|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139378339|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
139378340|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
139378341|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378342|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378343|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
139378344|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378345|NCT04862767|Aldesleukin|aldesleukin|mesh-list
139378346|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378347|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139378348|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139378349|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
139378350|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378351|NCT02146261|Quetmolimab|quetmolimab|mesh-list
139378352|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139378353|NCT02153281|Phenelzine|phenelzine|mesh-list
139378354|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
139378355|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139378356|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139378357|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378358|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378359|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
139378360|NCT03542851|Convulsants|convulsants|mesh-ancestor
139378361|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139378362|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378363|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
139378364|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
139378365|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378366|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378367|NCT02769247|Naproxen|naproxen|mesh-list
139378368|NCT02769247|Lidocaine|lidocaine|mesh-list
139378369|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
139378370|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
139378371|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378372|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378373|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
139378374|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378375|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139378376|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139378377|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139378378|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139378379|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378380|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139378381|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139378382|NCT02769247|Analgesics|analgesics|mesh-ancestor
139378383|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139378384|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139378385|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
139378386|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139378387|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378388|NCT02146651|Insulin|insulin|mesh-list
138930043|NCT00579254|Amlodipine|amlodipine|mesh-list
139378389|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139378390|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
139378391|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139378392|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378393|NCT03542149|Tocopherols|tocopherols|mesh-list
139378394|NCT03542149|Vitamin E|vitamin e|mesh-list
139378395|NCT03542149|Tocotrienols|tocotrienols|mesh-list
139378396|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
139378397|NCT03542149|Piperaquine|piperaquine|mesh-list
139378398|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
139378399|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139378400|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139378401|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378402|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
139378403|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378404|NCT03542149|Protective Agents|protective agents|mesh-ancestor
139378405|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378406|NCT03542149|Vitamins|vitamins|mesh-ancestor
139378407|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
139378408|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
139378409|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139378410|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139378411|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139378412|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378413|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
139378414|NCT02153593|Coagulants|coagulants|mesh-ancestor
139378415|NCT02154217|Timolol|timolol|mesh-list
139378416|NCT02154217|Bimatoprost|bimatoprost|mesh-list
139378417|NCT02154217|Latanoprost|latanoprost|mesh-list
139378418|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139378419|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139378420|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
139378421|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378422|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378423|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378424|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139378425|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139378426|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139378427|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139378428|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139378429|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
139378430|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378431|NCT02147041|Protective Agents|protective agents|mesh-ancestor
139378432|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378433|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139378434|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139378435|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378436|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139378437|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
139378438|NCT02767765|Hematinics|hematinics|mesh-ancestor
139378439|NCT00103207|Cetuximab|cetuximab|mesh-list
139378440|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139378441|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378442|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
139378443|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139378444|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
139378445|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378446|NCT02157181|Rituximab|rituximab|mesh-list
139378447|NCT02157181|Cladribine|cladribine|mesh-list
139378448|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139035325|NCT01032798|Mepivacaine|mepivacaine|mesh-list
139378449|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378450|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
139378451|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378452|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139378453|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139378454|NCT02159287|Heparin|heparin|mesh-list
139378455|NCT02159287|Calcium heparin|calcium heparin|mesh-list
139378456|NCT02159287|Enoxaparin|enoxaparin|mesh-list
139378457|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
139378458|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
139378459|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139378460|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139378461|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378462|NCT05005273|Nivolumab|nivolumab|mesh-list
139378463|NCT05005273|Ipilimumab|ipilimumab|mesh-list
139378464|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139378465|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378466|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139378467|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378468|NCT02157337|Atorvastatin|atorvastatin|mesh-list
139378469|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139378470|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139378471|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
139378472|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378473|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139378474|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139378475|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378476|NCT02159599|Ritonavir|ritonavir|mesh-list
139378477|NCT02159599|Darunavir|darunavir|mesh-list
139378478|NCT02159599|Tenofovir|tenofovir|mesh-list
139378479|NCT02159599|Lamivudine|lamivudine|mesh-list
139378480|NCT02159599|Emtricitabine|emtricitabine|mesh-list
139378481|NCT02159599|Abacavir|abacavir|mesh-list
139378482|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139378483|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139378484|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
139378485|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378486|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378487|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139378488|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139378489|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
139378490|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378491|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139378492|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139378493|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139378494|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139378495|NCT03541681|Anesthetics|anesthetics|mesh-list
139378496|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
139378497|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378498|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378499|NCT03541681|Hormones|hormones|mesh-ancestor
139378500|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139378501|NCT02157415|Polihexanide|polihexanide|mesh-list
139378502|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
139378503|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378504|NCT02157571|Levofloxacin|levofloxacin|mesh-list
139378505|NCT02157571|Ofloxacin|ofloxacin|mesh-list
139378506|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
139378507|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
139378508|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139378509|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378510|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139378511|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139378512|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139378513|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378514|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378515|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378516|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139378517|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139378518|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139378519|NCT01369355|Ustekinumab|ustekinumab|mesh-list
139378520|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
139378521|NCT03541993|Resveratrol|resveratrol|mesh-list
139378522|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
139378523|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378524|NCT03541993|Protective Agents|protective agents|mesh-ancestor
139378525|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378526|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378527|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139378528|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
139378529|NCT02157649|Codeine|codeine|mesh-list
139378530|NCT02157649|Guaifenesin|guaifenesin|mesh-list
139378531|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139378532|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139378533|NCT02157649|Narcotics|narcotics|mesh-ancestor
139378534|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378535|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378536|NCT02157649|Analgesics|analgesics|mesh-ancestor
139378537|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
139378538|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378539|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
139378540|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
139378541|NCT02157649|Expectorants|expectorants|mesh-ancestor
139378542|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139378543|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139378544|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
139378545|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378546|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378547|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
139378548|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139378549|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
139378550|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
139378551|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
139378552|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139378553|NCT02159911|Misoprostol|misoprostol|mesh-list
139378554|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139378555|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
139378556|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139378557|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378558|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139378559|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139378560|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
139378561|NCT03542617|Dexamethasone|dexamethasone|mesh-list
139378562|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139378563|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
139378564|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
139378565|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378566|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378567|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139378568|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
139378569|NCT03542617|Hormones|hormones|mesh-ancestor
139378570|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139378571|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139378572|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378573|NCT04878770|Cyclosporine|cyclosporine|mesh-list
139378574|NCT04878770|Cyclosporins|cyclosporins|mesh-list
139378575|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378576|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378577|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139378578|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
139378579|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378580|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
139378581|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378582|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
139378583|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139378584|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139378585|NCT02086019|Ramipril|ramipril|mesh-list
139378586|NCT02086019|Bisoprolol|bisoprolol|mesh-list
139378587|NCT02086019|Heparin|heparin|mesh-list
139378588|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139378589|NCT02086019|Tinzaparin|tinzaparin|mesh-list
139378590|NCT02086019|Dalteparin|dalteparin|mesh-list
139378591|NCT02086019|Clopidogrel|clopidogrel|mesh-list
139378592|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139378593|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378594|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378595|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139378596|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139378597|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378598|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139378599|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378600|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139378601|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139378602|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139378603|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
139378604|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378605|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
139378606|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
139378607|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139378608|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139378609|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139378610|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
139378611|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
139378612|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
139378613|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139378615|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139378616|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139378617|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139378618|NCT02086097|Analgesics|analgesics|mesh-ancestor
139378619|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
139378620|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378621|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378622|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139378623|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139378624|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139378625|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378626|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378627|NCT02307682|Aflibercept|aflibercept|mesh-list
139378628|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139378629|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139378630|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139378631|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139378632|NCT02307682|Growth Substances|growth substances|mesh-ancestor
139378633|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378634|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
139378635|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378636|NCT02088515|Docetaxel|docetaxel|mesh-list
139378637|NCT02088515|Nedaplatin|nedaplatin|mesh-list
139378638|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378639|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
139378640|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
139378641|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
139378642|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378644|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139378645|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139378646|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378647|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139378648|NCT04870502|Clomiphene|clomiphene|mesh-list
139378649|NCT04870502|Enclomiphene|enclomiphene|mesh-list
139378650|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
139378651|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139378652|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
139378653|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139378654|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378655|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139378656|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
139378657|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139378658|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139378659|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139378660|NCT02088671|Propofol|propofol|mesh-list
139378661|NCT02088671|Desflurane|desflurane|mesh-list
139378662|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139378663|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378664|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378665|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139378666|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
139378667|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
139378668|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139378669|NCT04870190|Osimertinib|osimertinib|mesh-list
139378670|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378671|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139378672|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378673|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378674|NCT03049046|Caffeic acid|caffeic acid|mesh-list
139378675|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
139378676|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378677|NCT03049046|Protective Agents|protective agents|mesh-ancestor
139035541|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
139378678|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378679|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
139378680|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
139378681|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
139184961|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139378682|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378683|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378684|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
139378685|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378686|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139378687|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378688|NCT03048110|Itraconazole|itraconazole|mesh-list
139378689|NCT03048110|Rifampin|rifampin|mesh-list
139378690|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
139378691|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378692|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139378693|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139378694|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378695|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378696|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139378697|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
139378698|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139378699|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378700|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139378701|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139378702|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
139378703|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139378704|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
139378705|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139378706|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139378707|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139378708|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139378709|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139378710|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139378711|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139378712|NCT05256758|Fenofibrate|fenofibrate|mesh-list
139378713|NCT05256758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139378714|NCT05256758|Antimetabolites|antimetabolites|mesh-ancestor
139378715|NCT05256758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378716|NCT05256758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139378717|NCT02791763|Glycine|glycine|mesh-list
139378718|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
139378719|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378720|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378721|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378722|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
139091550|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091551|NCT04542733|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139091552|NCT04542733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139091553|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091554|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
139091555|NCT04520126|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
139091556|NCT04520126|Oleuropein|oleuropein|mesh-list
139091557|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091558|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
139091559|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091560|NCT04520126|Protective Agents|protective agents|mesh-ancestor
139091561|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091562|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139091563|NCT04520126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139091564|NCT04520126|Disinfectants|disinfectants|mesh-ancestor
139091565|NCT04520126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139091566|NCT04520126|Vasodilator Agents|vasodilator agents|mesh-ancestor
139091567|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
139091568|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091569|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139091570|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091571|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091572|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
139091573|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139091574|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091575|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139091576|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139091577|NCT04428866|Glucagon|glucagon|mesh-list
139378723|NCT02086409|Vitamin D|vitamin d|mesh-list
139378724|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
139378725|NCT02086409|Cholecalciferol|cholecalciferol|mesh-list
139378726|NCT02086409|Vitamins|vitamins|mesh-list
139378727|NCT02086409|Calcium|calcium|mesh-list
139378728|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
139378729|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378730|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139378731|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139378732|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
139378733|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
139378734|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378735|NCT02613572|Protective Agents|protective agents|mesh-ancestor
139378736|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378737|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
139378738|NCT02613572|Vitamins|vitamins|mesh-ancestor
139378739|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
139378740|NCT02088983|Choline|choline|mesh-list
139378741|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139378742|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
139378743|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139378744|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
139378745|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378746|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139378747|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139378748|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
139378749|NCT02089061|Atorvastatin|atorvastatin|mesh-list
139378750|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139378751|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139378752|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139378753|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
139378754|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378755|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139378756|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139378757|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378758|NCT02082665|Dabrafenib|dabrafenib|mesh-list
139378759|NCT02082665|Midazolam|midazolam|mesh-list
139378760|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139378761|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139378762|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139378763|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378764|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378765|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139378766|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139378767|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139378768|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139378769|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
139378770|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
139378771|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
139378772|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
139378773|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378774|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378775|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139378776|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139378777|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
139378778|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139378779|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139378780|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378781|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378782|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139378783|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
139378784|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139378785|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
139378786|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378787|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
139378788|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139378789|NCT02341456|Paclitaxel|paclitaxel|mesh-list
139378790|NCT02341456|Carboplatin|carboplatin|mesh-list
139378791|NCT02341456|Adavosertib|adavosertib|mesh-list
139378792|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139378793|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378794|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
139378795|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
139378796|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
139378797|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378798|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378799|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
139378800|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
139378801|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139378802|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378803|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378804|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139378805|NCT02083055|Analgesics|analgesics|mesh-ancestor
139378806|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
139378807|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378808|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139378809|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139378810|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139378811|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
139378812|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378813|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378814|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
139378815|NCT02089295|Oxycodone|oxycodone|mesh-list
139378816|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139378817|NCT02089295|Narcotics|narcotics|mesh-ancestor
139378818|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378819|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378820|NCT02089295|Analgesics|analgesics|mesh-ancestor
139378821|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
139378822|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378823|NCT02370784|Atorvastatin|atorvastatin|mesh-list
139378824|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139378825|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139378826|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
139378827|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378828|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139378829|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139378830|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378831|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
139378832|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139378833|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378834|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
139378835|NCT01595438|Ceftazidime|ceftazidime|mesh-list
139378836|NCT01595438|Avibactam|avibactam|mesh-list
139378837|NCT01595438|Doripenem|doripenem|mesh-list
139378838|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139378839|NCT01595438|Trimethoprim|trimethoprim|mesh-list
139378840|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
139378841|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139378842|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378843|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139378844|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139378845|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378846|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378847|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378848|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139378849|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139378850|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139378851|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
139378852|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139378853|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139378854|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139378855|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139378856|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139378857|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139378858|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
139378859|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139378860|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378861|NCT02340520|Theophylline|theophylline|mesh-list
139378862|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139378863|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
138930140|NCT00710216|Lamivudine|lamivudine|mesh-list
139378864|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378865|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378866|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139378867|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
139378868|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139378869|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378870|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378871|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
139378872|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139378873|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139378874|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
139378875|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378876|NCT02087579|Olanzapine|olanzapine|mesh-list
139378877|NCT02087579|Risperidone|risperidone|mesh-list
139378878|NCT02087579|Aripiprazole|aripiprazole|mesh-list
139378879|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139378880|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139378881|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139378882|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
139378883|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378884|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378885|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378886|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139378887|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139378888|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378889|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139378890|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139378891|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
139378892|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
139378893|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
139378894|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378895|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139378896|NCT02087579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139378897|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139378898|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139378899|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
139378900|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
139378901|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139378902|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139378903|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139378904|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139378905|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139378906|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139378907|NCT02339584|Brinzolamide|brinzolamide|mesh-list
139378908|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139378909|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139378910|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139378911|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139378912|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139378913|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
139378914|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378915|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378916|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378917|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139378918|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378919|NCT02339506|Cosyntropin|cosyntropin|mesh-list
139378920|NCT02339506|Hormones|hormones|mesh-ancestor
139378921|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139378922|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378923|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
139378924|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139378925|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
139378926|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139378927|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
139378928|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139378929|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
139378930|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
139378931|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378932|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378933|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139378935|NCT02087813|Hormones|hormones|mesh-ancestor
139378936|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139378937|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139378938|NCT02087813|Protective Agents|protective agents|mesh-ancestor
139378939|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139378940|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378941|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378942|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378943|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139378944|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139378945|NCT02089529|Ibuprofen|ibuprofen|mesh-list
139378946|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139378947|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139378948|NCT02089529|Analgesics|analgesics|mesh-ancestor
139378949|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
139378950|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378951|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378952|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139378953|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139378954|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139378955|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378956|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378957|NCT02090933|Celecoxib|celecoxib|mesh-list
139378958|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139378959|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139378960|NCT02090933|Analgesics|analgesics|mesh-ancestor
139378961|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
139378962|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378963|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378964|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139378965|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139378966|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139378967|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139378968|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139378969|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378970|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
139378971|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139184984|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139378972|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139378973|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139378974|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139378976|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
139378977|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139378978|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139378979|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139378980|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139378981|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
139378982|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139378983|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139378984|NCT02089763|BCT-100|bct-100|mesh-list
139378985|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139378986|NCT02089841|Lumefantrine|lumefantrine|mesh-list
139378987|NCT02089841|Artemether|artemether|mesh-list
139378988|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139378989|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
139378990|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139378991|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139378992|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139378993|NCT03045770|Leucovorin|leucovorin|mesh-list
139378994|NCT03045770|Paclitaxel|paclitaxel|mesh-list
139378995|NCT03045770|Fluorouracil|fluorouracil|mesh-list
139378996|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
139378997|NCT03045770|Irinotecan|irinotecan|mesh-list
139378998|NCT03045770|Calcium|calcium|mesh-list
139378999|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
139379000|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139379001|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379002|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
139379003|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
139379004|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
139379005|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379006|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139379007|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379008|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
139379009|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139379010|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139379011|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
139379012|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139379013|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139379014|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379015|NCT03045770|Antidotes|antidotes|mesh-ancestor
139379016|NCT03045770|Protective Agents|protective agents|mesh-ancestor
139379017|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
139379018|NCT03045770|Vitamins|vitamins|mesh-ancestor
139379019|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
139379020|NCT02095847|Proflavine|proflavine|mesh-list
139379021|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139379022|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139379023|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
139379024|NCT02091401|Analgesics|analgesics|mesh-ancestor
139035888|NCT00428844|Oxacillin|oxacillin|mesh-list
139379025|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
139379026|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379027|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379028|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
139379029|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379030|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139379031|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
139379032|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139379033|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139379034|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379035|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139379036|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
139379037|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139379038|NCT01594970|Bimatoprost|bimatoprost|mesh-list
139379039|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139379040|NCT04869176|Caffeine|caffeine|mesh-list
139379041|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
139379042|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379043|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139379044|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379045|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139379046|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379047|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139379048|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139379049|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
139379050|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379051|NCT03557255|Simendan|simendan|mesh-list
139379052|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139379053|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
139379054|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139379055|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139379056|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379057|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379058|NCT03557255|Protective Agents|protective agents|mesh-ancestor
139379059|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379060|NCT04868552|Naloxone|naloxone|mesh-list
139379061|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139379062|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379063|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
139379064|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379065|NCT02090153|Leucovorin|leucovorin|mesh-list
139379066|NCT02090153|Tegafur|tegafur|mesh-list
139379067|NCT02090153|Antidotes|antidotes|mesh-ancestor
139379068|NCT02090153|Protective Agents|protective agents|mesh-ancestor
139379069|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379070|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
139379071|NCT02090153|Vitamins|vitamins|mesh-ancestor
139379072|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
139379073|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139379074|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
139379075|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379076|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379077|NCT00358163|Paclitaxel|paclitaxel|mesh-list
139379078|NCT00358163|Vatalanib|vatalanib|mesh-list
139379079|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139379080|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379081|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
139379082|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
139379083|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
139379084|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379085|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139379086|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379087|NCT02096315|Murepavadin|murepavadin|mesh-list
139379088|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139379089|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139379090|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
139379091|NCT02337946|Leucovorin|leucovorin|mesh-list
139379092|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
139379093|NCT02337946|Fluorouracil|fluorouracil|mesh-list
139379094|NCT02337946|Panitumumab|panitumumab|mesh-list
139379095|NCT02337946|Calcium|calcium|mesh-list
139379096|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
139379097|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139379098|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035965|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379099|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139379100|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379101|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
139185029|NCT03451396|Lifitegrast|lifitegrast|mesh-list
139379102|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379103|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139379104|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139379105|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
139379106|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139379107|NCT02337946|Antidotes|antidotes|mesh-ancestor
139379108|NCT02337946|Protective Agents|protective agents|mesh-ancestor
139379109|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
139379110|NCT02337946|Vitamins|vitamins|mesh-ancestor
139379111|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
139379112|NCT04865510|Heparin|heparin|mesh-list
139379113|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
139379114|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379115|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139379116|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139379117|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
139379118|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139379119|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
139379120|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139379121|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
139379122|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379123|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
139379124|NCT03047096|Protective Agents|protective agents|mesh-ancestor
139379125|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
139379126|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
139379127|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139379128|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
139379129|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139379130|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
139379131|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379132|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379133|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
139379134|NCT02093195|Bosentan|bosentan|mesh-list
139379135|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139379136|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139379137|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
139379138|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139379139|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139379140|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379141|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
139379142|NCT03555617|Itraconazole|itraconazole|mesh-list
139379143|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
139379144|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139379145|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139379146|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139379147|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379148|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379149|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139379150|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
139379151|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139379152|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379153|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139379154|NCT02098889|Scopolamine|scopolamine|mesh-list
139379155|NCT02098889|Bromides|bromides|mesh-list
139379156|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139379157|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
139379158|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139379159|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
139379160|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
139379161|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379162|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379163|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139379164|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
139379165|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139379166|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
139379167|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139185037|NCT02528825|Analgesics|analgesics|mesh-ancestor
139379168|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379169|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139379170|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
139379171|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139379172|NCT01369199|Entecavir|entecavir|mesh-list
139379173|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
139379174|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139379175|NCT02097173|Methotrexate|methotrexate|mesh-list
139379176|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139379177|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
139379178|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139379179|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379180|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139379181|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
139379182|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379183|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379184|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
139379185|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379186|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139379187|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139379188|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
139379189|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139379190|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139379191|NCT02097329|Palbociclib|palbociclib|mesh-list
139379192|NCT02097329|Rabeprazole|rabeprazole|mesh-list
139379193|NCT02097329|Famotidine|famotidine|mesh-list
139379194|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
139379195|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
139379196|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139379197|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139379198|NCT02097329|Antacids|antacids|mesh-list
139379199|NCT02097329|TEMPO|tempo|mesh-list
139379200|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379201|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139379202|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379203|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379204|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139379205|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139379206|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139379207|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
139379208|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
139379209|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379210|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379211|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
139379212|NCT02097329|Protective Agents|protective agents|mesh-ancestor
139379213|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139379214|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
139379215|NCT02093585|Tenofovir|tenofovir|mesh-list
139379216|NCT02093585|Abacavir|abacavir|mesh-list
139379217|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
139379218|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139379219|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139379220|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139379221|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379222|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379223|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139379224|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139379225|NCT02099357|Vitamin D|vitamin d|mesh-list
139379226|NCT02099357|Vitamins|vitamins|mesh-ancestor
139379227|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
139379228|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379229|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139379230|NCT02093741|Factor VIII|factor viii|mesh-list
139379231|NCT02093741|Coagulants|coagulants|mesh-ancestor
139379232|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
139379233|NCT02097407|Propofol|propofol|mesh-list
139379234|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139379235|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379236|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379237|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139379238|NCT02097407|Analgesics|analgesics|mesh-ancestor
139379239|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
139379240|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379241|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139379242|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139379243|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139379244|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
139379245|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379246|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379247|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139379248|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
139379249|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
139379250|NCT02250599|Paclitaxel|paclitaxel|mesh-list
139379251|NCT02250599|Bevacizumab|bevacizumab|mesh-list
139379252|NCT02250599|Carboplatin|carboplatin|mesh-list
139379253|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139379255|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
139379256|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
139379257|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
139379258|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379259|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139379260|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139379261|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139379262|NCT02250599|Growth Substances|growth substances|mesh-ancestor
138930194|NCT00711620|Thymalfasin|thymalfasin|mesh-list
139379263|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379264|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
139379265|NCT02094053|Donepezil|donepezil|mesh-list
139379266|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139379267|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379268|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379269|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
139379270|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379271|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379272|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
139379273|NCT03555929|Dexamethasone|dexamethasone|mesh-list
139379274|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139379275|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
139379276|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
139379277|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379278|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379279|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139379280|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
139379281|NCT03555929|Hormones|hormones|mesh-ancestor
139379282|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139379283|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139379284|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379285|NCT02099981|Pimagedine|pimagedine|mesh-list
139379286|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379287|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379288|NCT02250209|Capecitabine|capecitabine|mesh-list
139379289|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
139379290|NCT02250209|Trastuzumab|trastuzumab|mesh-list
139379291|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139379292|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
139379293|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379294|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379295|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139379296|NCT02097953|Rifampin|rifampin|mesh-list
139379297|NCT02097953|Daptomycin|daptomycin|mesh-list
139379298|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139379299|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
139379300|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139379301|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139379302|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
139379303|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139379304|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379305|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379306|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139379307|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139379309|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139379310|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139379311|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139379312|NCT02094287|Dimethindene|dimethindene|mesh-list
139379313|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
139379314|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
139379315|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139379316|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
139379317|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
139379318|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379319|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379320|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379321|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139379322|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
139379323|NCT02100293|Analgesics|analgesics|mesh-ancestor
139379324|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
139379325|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379326|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379327|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
139379328|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138930210|NCT00767039|Beractant|beractant|mesh-list
139379329|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139379330|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
139379331|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139379332|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139379333|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379334|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139379335|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
139379336|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139379337|NCT02094599|Dronabinol|dronabinol|mesh-list
139379338|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
139379339|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379340|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139379341|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139379342|NCT02094599|Analgesics|analgesics|mesh-ancestor
139379343|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
139379344|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379345|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139379346|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139379347|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379348|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379349|NCT02094599|Hormones|hormones|mesh-ancestor
139379350|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139379351|NCT02094833|Vaccines|vaccines|mesh-list
139379352|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
139379353|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379354|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
139379355|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
139379356|NCT02100605|Ephedrine|ephedrine|mesh-list
139379357|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139379358|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
139379359|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139379360|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379361|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
139379362|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
139379363|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379364|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
139379365|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379366|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379367|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139379368|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139379369|NCT02100761|Voriconazole|voriconazole|mesh-list
139379370|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
139379371|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139379372|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139379373|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139379374|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139185057|NCT03361605|Propofol|propofol|mesh-list
139379375|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379376|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139379377|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
139379378|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139379379|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379380|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139379381|NCT02100917|Trastuzumab|trastuzumab|mesh-list
139379382|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139379383|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379384|NCT02098421|Oxytocin|oxytocin|mesh-list
139379385|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
138930211|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139379386|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139379387|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379388|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
139379389|NCT02098499|Promethazine|promethazine|mesh-list
139379390|NCT02098499|Haloperidol|haloperidol|mesh-list
139379391|NCT02098499|Metoclopramide|metoclopramide|mesh-list
139379392|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
139379393|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139379394|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139379395|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379396|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379397|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
139036268|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
139379398|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
139379399|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
139379400|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379401|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
139379402|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
139379403|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139379404|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139379405|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
139379406|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
139379407|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379408|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379409|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139379410|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
139379411|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
139379412|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139379413|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139379414|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139379415|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139379416|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
139379417|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139379418|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139379419|NCT02097017|Lidocaine|lidocaine|mesh-list
139379420|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
139379421|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
139379422|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379423|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379424|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
139379425|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379426|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139379427|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139379428|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139379429|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139379430|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379431|NCT03555383|Hemostatics|hemostatics|mesh-list
139379432|NCT03555383|Coagulants|coagulants|mesh-ancestor
139379433|NCT02101151|Vitamin D|vitamin d|mesh-list
139379434|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
139379435|NCT02101151|Vitamins|vitamins|mesh-ancestor
139379436|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
139379437|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379438|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139379439|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139379440|NCT02101229|Insulin|insulin|mesh-list
139379441|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139379442|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139379443|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379444|NCT02102555|Acetaminophen|acetaminophen|mesh-list
139379445|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139379446|NCT02102555|Analgesics|analgesics|mesh-ancestor
139379447|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
139379448|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379449|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379450|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
139379452|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
139379453|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139379454|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
139379455|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379456|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379457|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
139379458|NCT02102711|Vitamin A|vitamin a|mesh-list
139379459|NCT02102711|Vitamins|vitamins|mesh-ancestor
139379460|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
139379461|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379462|NCT02106767|Rifampin|rifampin|mesh-list
139379463|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139379464|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139379465|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139379466|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
139379467|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379468|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139379469|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139379470|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379471|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139379472|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
139379473|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139036345|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
139379474|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139379476|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139379477|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139379478|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139379479|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139379480|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139379481|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139379482|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139379483|NCT02103023|Imiquimod|imiquimod|mesh-list
139379484|NCT02103023|Vaccines|vaccines|mesh-list
139379485|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
139379486|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379487|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139379488|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379489|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
139379490|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139379491|NCT02101931|Levulinic acid|levulinic acid|mesh-list
139379492|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139379493|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
139379494|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379495|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379496|NCT02106845|Digoxin|digoxin|mesh-list
139379497|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139379498|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139379499|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139379500|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
139379501|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379502|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139379503|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139379504|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379505|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139379506|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139379507|NCT02106845|Protective Agents|protective agents|mesh-ancestor
138930237|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139379508|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379509|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
139379510|NCT03554447|Dexetimide|dexetimide|mesh-list
139379511|NCT03554447|Citalopram|citalopram|mesh-list
139379512|NCT03554447|Escitalopram|escitalopram|mesh-list
139379513|NCT03554447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139379514|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139379515|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139185068|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139379516|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379517|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379518|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
139379519|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379520|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139379521|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139379522|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
139379523|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
139379524|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379525|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139379526|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139379527|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
139379528|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139379529|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
139379530|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139379531|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139379532|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379533|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139379534|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139379535|NCT03554447|Protective Agents|protective agents|mesh-ancestor
139379536|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
139379537|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139379539|NCT02103335|Dexamethasone|dexamethasone|mesh-list
139379540|NCT02103335|Pomalidomide|pomalidomide|mesh-list
139379541|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139379542|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
139379543|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
139379544|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379545|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379546|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139379547|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
139379548|NCT02103335|Hormones|hormones|mesh-ancestor
139379549|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139379550|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139379551|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379552|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
139379553|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139379554|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139379555|NCT02103335|Growth Substances|growth substances|mesh-ancestor
139379556|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
139379557|NCT02610140|Vinorelbine|vinorelbine|mesh-list
139379558|NCT02610140|Maytansine|maytansine|mesh-list
139379559|NCT02610140|Anetumab ravtansine|anetumab ravtansine|mesh-list
139379560|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139379561|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379562|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
139379563|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
139379564|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
139379565|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379566|NCT02610140|Immunoconjugates|immunoconjugates|mesh-ancestor
139379567|NCT02610140|Immunologic Factors|immunologic factors|mesh-ancestor
139379568|NCT02610140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379569|NCT02102321|Albendazole|albendazole|mesh-list
139379570|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
139379571|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139379572|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139379573|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
138930254|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
139379574|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139379575|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139379576|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
139379577|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
139379578|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
139379579|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379580|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379581|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139379582|NCT02103569|Norethindrone|norethindrone|mesh-list
139379583|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
139379584|NCT02103569|Estradiol|estradiol|mesh-list
139379585|NCT02103569|Asunaprevir|asunaprevir|mesh-list
139379586|NCT02103569|Estrogens|estrogens|mesh-ancestor
139379587|NCT02103569|Hormones|hormones|mesh-ancestor
139379588|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139379589|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379590|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139379591|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
139379592|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139379593|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139379594|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139379595|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139379596|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139379597|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
139379598|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379599|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379600|NCT02103647|Pregabalin|pregabalin|mesh-list
139379601|NCT02103647|Analgesics|analgesics|mesh-ancestor
139379602|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
139379603|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379604|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379605|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
139379606|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139379607|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139379608|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379609|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139379610|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139379611|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139379612|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379613|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139379614|NCT02109965|Midazolam|midazolam|mesh-list
139379615|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
139379616|NCT02109965|Propofol|propofol|mesh-list
139379617|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139379618|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379619|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379620|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139379621|NCT02109965|Analgesics|analgesics|mesh-ancestor
139379622|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
139379623|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379624|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139379625|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139379626|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139379627|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
139379628|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379629|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379630|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139379631|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
138930272|NCT00795171|Docetaxel|docetaxel|mesh-list
139379632|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
139379633|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139379634|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139379635|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139379636|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139379637|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
139379638|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
139379639|NCT02789657|Paclitaxel|paclitaxel|mesh-list
139379640|NCT02789657|Carboplatin|carboplatin|mesh-list
139379641|NCT02789657|Trastuzumab|trastuzumab|mesh-list
139379642|NCT02789657|Pertuzumab|pertuzumab|mesh-list
139379643|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139379644|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379645|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
139379646|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
139379647|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
139379648|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379649|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139379650|NCT03555071|Vaccines|vaccines|mesh-list
139379651|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
139379652|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379653|NCT02609984|Atezolizumab|atezolizumab|mesh-list
139379654|NCT02609984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139379655|NCT02609984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379656|NCT02609984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139379657|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379658|NCT02107079|Melatonin|melatonin|mesh-list
139379660|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379661|NCT02107079|Protective Agents|protective agents|mesh-ancestor
139379662|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379663|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379664|NCT02107235|ON 01910|on 01910|mesh-list
139379665|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379666|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139379667|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379668|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379669|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
139379670|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139379671|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139379672|NCT02103725|Analgesics|analgesics|mesh-ancestor
139379673|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
139379674|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379675|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379676|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139379677|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139379678|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
139379679|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139379680|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
139379681|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139379682|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379683|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379684|NCT03042260|Trimethoprim|trimethoprim|mesh-list
139379685|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139379686|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
139379687|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139379688|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139379689|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
139379690|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139379691|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139379692|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139379693|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379694|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379695|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139379696|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139379697|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139379698|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139379699|NCT02110355|Trametinib|trametinib|mesh-list
139379700|NCT02110355|Dabrafenib|dabrafenib|mesh-list
139379701|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379702|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139379703|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379704|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379705|NCT02107391|Leuprolide|leuprolide|mesh-list
139379706|NCT02107391|Goserelin|goserelin|mesh-list
139379707|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139379708|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
139379709|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139379710|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379711|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139379712|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379713|NCT02103881|Ketamine|ketamine|mesh-list
139379714|NCT02103881|Haloperidol|haloperidol|mesh-list
139379715|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
139379716|NCT02103881|Analgesics|analgesics|mesh-ancestor
139379717|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
139379718|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379719|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379720|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139379721|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139379722|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
139379723|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
139379724|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379725|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139379726|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139379727|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379728|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379729|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
139379730|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
139379731|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139379732|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139379733|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139379734|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139379735|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139379736|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
139379737|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139379738|NCT03554915|Midazolam|midazolam|mesh-list
139379739|NCT03554915|Ketamine|ketamine|mesh-list
139379740|NCT03554915|Analgesics|analgesics|mesh-ancestor
139379741|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
139379742|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379743|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379744|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139379745|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139379746|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
139379747|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
139379748|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379749|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139379750|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139379751|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379752|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379753|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139379754|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139379755|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139379756|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139379757|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139379758|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
139379759|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
139379760|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
139379761|NCT03044522|Narcotics|narcotics|mesh-ancestor
139379762|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379763|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379764|NCT03044522|Analgesics|analgesics|mesh-ancestor
139379765|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
139379766|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379767|NCT03044366|Anesthetics|anesthetics|mesh-list
139379768|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379769|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379770|NCT02250833|Amlodipine|amlodipine|mesh-list
139379771|NCT02250833|Telmisartan|telmisartan|mesh-list
139379772|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139379773|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139379774|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139379775|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379776|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139379777|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379778|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
139379779|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139379780|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139379782|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139379783|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379784|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379785|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139379786|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
139379787|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
139379788|NCT03041948|Acetaminophen|acetaminophen|mesh-list
139379789|NCT03041948|Dexamethasone|dexamethasone|mesh-list
139379790|NCT03041948|Ketorolac|ketorolac|mesh-list
139379791|NCT03041948|Morphine|morphine|mesh-list
139379792|NCT03041948|Remifentanil|remifentanil|mesh-list
139379793|NCT03041948|Ondansetron|ondansetron|mesh-list
139379794|NCT03041948|Propofol|propofol|mesh-list
139379795|NCT03041948|Sevoflurane|sevoflurane|mesh-list
139379796|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139379797|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
139379798|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
139379799|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379800|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379801|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139379802|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
139379803|NCT03041948|Hormones|hormones|mesh-ancestor
139185080|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379804|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139379805|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139379806|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379807|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139379808|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379809|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139379810|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
139379811|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
139379812|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139379813|NCT03041948|Narcotics|narcotics|mesh-ancestor
139379814|NCT03041948|Analgesics|analgesics|mesh-ancestor
139379815|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
139379816|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139379817|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
139379818|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139379819|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139379820|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
139379821|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
138930308|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139379822|NCT03041948|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139379823|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139379824|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
139379825|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379826|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379827|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139379828|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139379829|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139379830|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379831|NCT02104193|Simvastatin|simvastatin|mesh-list
139379832|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139379833|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139379834|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
139379835|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379836|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139379837|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139379838|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379839|NCT03042182|Vaccines|vaccines|mesh-list
139379840|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
139379841|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379842|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
139379843|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
139379844|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139379845|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139379846|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139379847|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379848|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139036724|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
139379849|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139379850|NCT02611778|Ranibizumab|ranibizumab|mesh-list
139379851|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139379852|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139379853|NCT02611778|Growth Substances|growth substances|mesh-ancestor
139379854|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379855|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
139379856|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379858|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
139379859|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139379860|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
139379861|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
139379862|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
139379863|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379864|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379866|NCT04856852|Temozolomide|temozolomide|mesh-list
139379867|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139379868|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
139185328|NCT05624671|Anesthetics, General|anesthetics, general|mesh-ancestor
139379869|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379871|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139379872|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139379873|NCT04856852|Trace Elements|trace elements|mesh-ancestor
139379874|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
139379875|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379876|NCT01453179|Diclofenac|diclofenac|mesh-list
139379877|NCT01453179|Imiquimod|imiquimod|mesh-list
139379878|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138930317|NCT00712400|Latanoprost|latanoprost|mesh-list
139379879|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139379880|NCT01453179|Analgesics|analgesics|mesh-ancestor
139379881|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
139379882|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139185463|NCT05682807|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139185536|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139379883|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379884|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139379885|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139379886|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139379887|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379888|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379889|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139379890|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
139379891|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379892|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
139379893|NCT03192033|Hemostatics|hemostatics|mesh-list
139379894|NCT03192033|Coagulants|coagulants|mesh-ancestor
139379895|NCT06100796|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139379896|NCT06100796|Pembrolizumab|pembrolizumab|mesh-list
139379897|NCT06100796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139379898|NCT06100796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379899|NCT06100796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139379900|NCT06100796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379901|NCT06100796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379902|NCT06100783|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139379903|NCT06100783|Contraceptive Agents|contraceptive agents|mesh-list
139379904|NCT06100783|Medroxyprogesterone|medroxyprogesterone|mesh-list
139379905|NCT06100783|Progesterone|progesterone|mesh-list
139379906|NCT06100783|Progestins|progestins|mesh-ancestor
139379907|NCT06100783|Hormones|hormones|mesh-ancestor
139379908|NCT06100783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139379909|NCT06100783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379910|NCT06100783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139379911|NCT06100783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139379912|NCT06100783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139379913|NCT06100783|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139379914|NCT06100783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139379915|NCT06100783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379916|NCT06100783|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139379917|NCT06100783|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139379918|NCT06100783|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139379919|NCT06100510|Aspirin|aspirin|mesh-list
139185815|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
139379920|NCT06100510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139036798|NCT00276484|Ezetimibe|ezetimibe|mesh-list
139379921|NCT06100510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139379922|NCT06100510|Analgesics|analgesics|mesh-ancestor
139379923|NCT06100510|Sensory System Agents|sensory system agents|mesh-ancestor
139379924|NCT06100510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379925|NCT06100510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379926|NCT06100510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139379927|NCT06100510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139379928|NCT06100510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139379929|NCT06100510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139185939|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139379930|NCT06100510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379931|NCT06100510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139379932|NCT06100510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139379933|NCT06100510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379934|NCT06100510|Antipyretics|antipyretics|mesh-ancestor
139379935|NCT06100315|Nalbuphine|nalbuphine|mesh-list
139379936|NCT06100315|Bupivacaine|bupivacaine|mesh-list
139379937|NCT06100315|Anesthetics, Local|anesthetics, local|mesh-ancestor
139379938|NCT06100315|Anesthetics|anesthetics|mesh-ancestor
139379939|NCT06100315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379940|NCT06100315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379941|NCT06100315|Sensory System Agents|sensory system agents|mesh-ancestor
139379942|NCT06100315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379943|NCT06100315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139379944|NCT06100315|Narcotics|narcotics|mesh-ancestor
139379945|NCT06100315|Analgesics|analgesics|mesh-ancestor
139379946|NCT06099990|Prednisone|prednisone|mesh-list
139379947|NCT06099990|Abiraterone Acetate|abiraterone acetate|mesh-list
139379948|NCT06099990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139379949|NCT06099990|Glucocorticoids|glucocorticoids|mesh-ancestor
139379950|NCT06099990|Hormones|hormones|mesh-ancestor
139379951|NCT06099990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139379952|NCT06099990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379953|NCT06099990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139379954|NCT06099990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379955|NCT06099990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139379956|NCT06099990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139379957|NCT06099990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379958|NCT06099990|Hormone Antagonists|hormone antagonists|mesh-ancestor
139379959|NCT06099990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139379960|NCT06099938|Sufentanil|sufentanil|mesh-list
139379961|NCT06099938|Ropivacaine|ropivacaine|mesh-list
139379962|NCT06099938|Anesthetics, Local|anesthetics, local|mesh-ancestor
139379963|NCT06099938|Anesthetics|anesthetics|mesh-ancestor
139379964|NCT06099938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139379965|NCT06099938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379966|NCT06099938|Sensory System Agents|sensory system agents|mesh-ancestor
139379967|NCT06099938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379968|NCT06099938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139379969|NCT06099938|Narcotics|narcotics|mesh-ancestor
139379970|NCT06099938|Analgesics|analgesics|mesh-ancestor
139379971|NCT06099938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139379972|NCT06099938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139379973|NCT06099938|Anesthetics, General|anesthetics, general|mesh-ancestor
139379974|NCT06099418|Atezolizumab|atezolizumab|mesh-list
139379975|NCT06099418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139379976|NCT06099418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379977|NCT06099418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139379978|NCT06099418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139379979|NCT06099379|Dronabinol|dronabinol|mesh-list
139379980|NCT06099379|Cannabidiol|cannabidiol|mesh-list
139379981|NCT06099379|Anticonvulsants|anticonvulsants|mesh-ancestor
139379982|NCT06099379|Hallucinogens|hallucinogens|mesh-ancestor
139379983|NCT06099379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139379984|NCT06099379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139379985|NCT06099379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139379986|NCT06099379|Analgesics|analgesics|mesh-ancestor
139186137|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
139379987|NCT06099379|Sensory System Agents|sensory system agents|mesh-ancestor
139379988|NCT06099379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139379989|NCT06099379|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139379990|NCT06099379|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139379991|NCT06099379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139379992|NCT06099379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139379993|NCT06099379|Hormones|hormones|mesh-ancestor
139379994|NCT06099379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139379995|NCT06099366|Cytarabine|cytarabine|mesh-list
139379996|NCT06099366|Dexamethasone|dexamethasone|mesh-list
139379997|NCT06099366|Dexamethasone acetate|dexamethasone acetate|mesh-list
139379998|NCT06099366|Cyclophosphamide|cyclophosphamide|mesh-list
139379999|NCT06099366|Doxorubicin|doxorubicin|mesh-list
139380000|NCT06099366|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139380001|NCT06099366|Methotrexate|methotrexate|mesh-list
139380002|NCT06099366|Vincristine|vincristine|mesh-list
139380003|NCT06099366|Asparaginase|asparaginase|mesh-list
139380004|NCT06099366|Mercaptopurine|mercaptopurine|mesh-list
139380005|NCT06099366|BB 1101|bb 1101|mesh-list
139380006|NCT06099366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139380007|NCT06099366|Immunologic Factors|immunologic factors|mesh-ancestor
139380008|NCT06099366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186183|NCT02861950|Bupivacaine|bupivacaine|mesh-list
139380009|NCT06099366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139380010|NCT06099366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139380011|NCT06099366|Alkylating Agents|alkylating agents|mesh-ancestor
139380012|NCT06099366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380013|NCT06099366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380014|NCT06099366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139380015|NCT06099366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139380017|NCT06099366|Autonomic Agents|autonomic agents|mesh-ancestor
139380018|NCT06099366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380019|NCT06099366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139380020|NCT06099366|Glucocorticoids|glucocorticoids|mesh-ancestor
139380021|NCT06099366|Hormones|hormones|mesh-ancestor
139380022|NCT06099366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139380023|NCT06099366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139380024|NCT06099366|Protease Inhibitors|protease inhibitors|mesh-ancestor
139380025|NCT06099366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380026|NCT06099366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139380027|NCT06099366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139380028|NCT06099366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139380029|NCT06099366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139380030|NCT06099366|Abortifacient Agents|abortifacient agents|mesh-ancestor
139380031|NCT06099366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139380032|NCT06099366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139380033|NCT06099366|Antimetabolites|antimetabolites|mesh-ancestor
139380034|NCT06099366|Dermatologic Agents|dermatologic agents|mesh-ancestor
139380035|NCT06099366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139380036|NCT06099366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139380037|NCT06099366|Antiviral Agents|antiviral agents|mesh-ancestor
139380038|NCT06099366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139380039|NCT06099366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139380040|NCT06099366|Tubulin Modulators|tubulin modulators|mesh-ancestor
139380041|NCT06099366|Antimitotic Agents|antimitotic agents|mesh-ancestor
139380042|NCT06099366|Mitosis Modulators|mitosis modulators|mesh-ancestor
139380043|NCT06099314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139186288|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380044|NCT06099314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380045|NCT06099314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380046|NCT06099314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380047|NCT06099119|Pancrelipase|pancrelipase|mesh-list
139380048|NCT06099119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139380049|NCT06099067|Liraglutide|liraglutide|mesh-list
139380050|NCT06099067|Canagliflozin|canagliflozin|mesh-list
139380051|NCT06099067|Saxagliptin|saxagliptin|mesh-list
139380052|NCT06099067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139380053|NCT06099067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139380054|NCT06099067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380055|NCT06099067|Incretins|incretins|mesh-ancestor
139380056|NCT06099067|Hormones|hormones|mesh-ancestor
139380057|NCT06099067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139380058|NCT06099067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139380059|NCT06099067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380060|NCT06099067|Protease Inhibitors|protease inhibitors|mesh-ancestor
139380061|NCT06099067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380062|NCT06098898|Trastuzumab|trastuzumab|mesh-list
139380063|NCT06098898|Atezolizumab|atezolizumab|mesh-list
139380064|NCT06098898|Tislelizumab|tislelizumab|mesh-list
139380065|NCT06098898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380066|NCT06098898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380067|NCT06098898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139380068|NCT06098898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380069|NCT06098833|Sildenafil Citrate|sildenafil citrate|mesh-list
139380070|NCT06098833|Vasodilator Agents|vasodilator agents|mesh-ancestor
139380071|NCT06098833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139380072|NCT06098833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139380073|NCT06098833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380074|NCT06098833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380075|NCT06098833|Urological Agents|urological agents|mesh-ancestor
139380076|NCT06098820|Vitamin D|vitamin d|mesh-list
139380077|NCT06098820|Vitamins|vitamins|mesh-ancestor
139380078|NCT06098820|Micronutrients|micronutrients|mesh-ancestor
139380079|NCT06098820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380080|NCT06098820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139380081|NCT06098209|Dexmedetomidine|dexmedetomidine|mesh-list
139380082|NCT06098209|Propofol|propofol|mesh-list
139380083|NCT06098209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139380084|NCT06098209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139380085|NCT06098209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139186540|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380086|NCT06098209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139380087|NCT06098209|Analgesics|analgesics|mesh-ancestor
139380088|NCT06098209|Sensory System Agents|sensory system agents|mesh-ancestor
139380089|NCT06098209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380090|NCT06098209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139380091|NCT06098209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139380092|NCT06098209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139380093|NCT06098209|Adrenergic Agents|adrenergic agents|mesh-ancestor
139380094|NCT06098209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139380095|NCT06098209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380096|NCT06098209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139380097|NCT06098209|Anesthetics, General|anesthetics, general|mesh-ancestor
139380098|NCT06098209|Anesthetics|anesthetics|mesh-ancestor
139380099|NCT06098105|Bupivacaine|bupivacaine|mesh-list
139380100|NCT06098105|Anesthetics, Local|anesthetics, local|mesh-ancestor
139380101|NCT06098105|Anesthetics|anesthetics|mesh-ancestor
139380102|NCT06098105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139380103|NCT06098105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380104|NCT06098105|Sensory System Agents|sensory system agents|mesh-ancestor
139380105|NCT06098105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380106|NCT06097962|Atezolizumab|atezolizumab|mesh-list
139380107|NCT06097962|Tislelizumab|tislelizumab|mesh-list
139380108|NCT06097962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139380109|NCT06097962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380110|NCT06097962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380111|NCT06097962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380112|NCT06096298|Vitamin B 12|vitamin b 12|mesh-list
139380113|NCT06096298|Hydroxocobalamin|hydroxocobalamin|mesh-list
139380114|NCT06096298|Vitamins|vitamins|mesh-ancestor
139380115|NCT06096298|Micronutrients|micronutrients|mesh-ancestor
139380116|NCT06096298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380117|NCT06096298|Vitamin B Complex|vitamin b complex|mesh-ancestor
139380118|NCT06096298|Hematinics|hematinics|mesh-ancestor
139380119|NCT06096103|Iron|iron|mesh-list
139380120|NCT06096103|Micronutrients|micronutrients|mesh-ancestor
139380121|NCT06096103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380122|NCT06096103|Trace Elements|trace elements|mesh-ancestor
139380123|NCT06093841|Cyclophosphamide|cyclophosphamide|mesh-list
139380124|NCT06093841|Fludarabine|fludarabine|mesh-list
139380125|NCT06093841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139380126|NCT06093841|Immunologic Factors|immunologic factors|mesh-ancestor
139380127|NCT06093841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380128|NCT06093841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139380129|NCT06093841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139380130|NCT06093841|Alkylating Agents|alkylating agents|mesh-ancestor
139380131|NCT06093841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380132|NCT06093841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380133|NCT06093841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139380134|NCT06091917|Betaine|betaine|mesh-list
139380135|NCT06091917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139380136|NCT06091917|Lipotropic Agents|lipotropic agents|mesh-ancestor
139380137|NCT06091917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139380138|NCT06091917|Antimetabolites|antimetabolites|mesh-ancestor
139380139|NCT06091917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380140|NCT06091917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139380141|NCT06077344|Anesthetics|anesthetics|mesh-list
139380142|NCT06077344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139380143|NCT06077344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380144|NCT06073600|Metformin|metformin|mesh-list
139380145|NCT06073600|Vildagliptin|vildagliptin|mesh-list
139380146|NCT06073600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139380147|NCT06073600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380148|NCT06073600|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139380149|NCT06073600|Protease Inhibitors|protease inhibitors|mesh-ancestor
139380150|NCT06073600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380151|NCT06073600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380152|NCT06069843|Ketamine|ketamine|mesh-list
139380153|NCT06069843|Analgesics|analgesics|mesh-ancestor
139380154|NCT06069843|Sensory System Agents|sensory system agents|mesh-ancestor
139380155|NCT06069843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380156|NCT06069843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380157|NCT06069843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139380158|NCT06069843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139380159|NCT06069843|Anesthetics, General|anesthetics, general|mesh-ancestor
139380160|NCT06069843|Anesthetics|anesthetics|mesh-ancestor
139380161|NCT06069843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139380162|NCT06069843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139187079|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380163|NCT06069843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139380164|NCT06069843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139380165|NCT06069843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380166|NCT06059222|Zoledronic Acid|zoledronic acid|mesh-list
139380167|NCT06059222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139380168|NCT06059222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139380169|NCT06059222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380170|NCT06059222|Immunologic Factors|immunologic factors|mesh-ancestor
139380172|NCT05994378|Hormone Antagonists|hormone antagonists|mesh-ancestor
139380173|NCT05994378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139380174|NCT05994378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380175|NCT05986422|Methylprednisolone|methylprednisolone|mesh-list
139380177|NCT05986422|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139380178|NCT05986422|Prednisolone|prednisolone|mesh-list
139380179|NCT05986422|Prednisolone acetate|prednisolone acetate|mesh-list
139380180|NCT05986422|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139380181|NCT05986422|Prednisolone phosphate|prednisolone phosphate|mesh-list
139380182|NCT05986422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139380183|NCT05986422|Antiemetics|antiemetics|mesh-ancestor
139380184|NCT05986422|Autonomic Agents|autonomic agents|mesh-ancestor
139380185|NCT05986422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380186|NCT05986422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380187|NCT05986422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139380188|NCT05986422|Glucocorticoids|glucocorticoids|mesh-ancestor
139380189|NCT05986422|Hormones|hormones|mesh-ancestor
139380190|NCT05986422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139380191|NCT05986422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139380192|NCT05986422|Protective Agents|protective agents|mesh-ancestor
139380193|NCT05986422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139380194|NCT05986422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380195|NCT05980689|Capecitabine|capecitabine|mesh-list
139380196|NCT05980689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139380197|NCT05980689|Antimetabolites|antimetabolites|mesh-ancestor
139380198|NCT05980689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380199|NCT05980689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380200|NCT05929768|Paclitaxel|paclitaxel|mesh-list
139380201|NCT05929768|Docetaxel|docetaxel|mesh-list
139380202|NCT05929768|Cyclophosphamide|cyclophosphamide|mesh-list
139380203|NCT05929768|Carboplatin|carboplatin|mesh-list
139380204|NCT05929768|Doxorubicin|doxorubicin|mesh-list
139380205|NCT05929768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139380206|NCT05929768|Pembrolizumab|pembrolizumab|mesh-list
139380207|NCT05929768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139380208|NCT05929768|Daunorubicin|daunorubicin|mesh-list
139380209|NCT05929768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139380210|NCT05929768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380211|NCT05929768|Tubulin Modulators|tubulin modulators|mesh-ancestor
139380212|NCT05929768|Antimitotic Agents|antimitotic agents|mesh-ancestor
139380213|NCT05929768|Mitosis Modulators|mitosis modulators|mesh-ancestor
139380214|NCT05929768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380215|NCT05929768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139380216|NCT05929768|Immunologic Factors|immunologic factors|mesh-ancestor
139380217|NCT05929768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380218|NCT05929768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139380219|NCT05929768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139380220|NCT05929768|Alkylating Agents|alkylating agents|mesh-ancestor
139380221|NCT05929768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139380222|NCT05929768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139380223|NCT05929768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139380224|NCT05929768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139380225|NCT05929768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380226|NCT05929768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139187848|NCT01313689|Ofatumumab|ofatumumab|mesh-list
139380227|NCT05929768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139380230|NCT05928741|Vitamins|vitamins|mesh-ancestor
139380231|NCT05928741|Micronutrients|micronutrients|mesh-ancestor
139380232|NCT05928741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380233|NCT05928741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139380234|NCT05928741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139380235|NCT05887492|Pembrolizumab|pembrolizumab|mesh-list
139380236|NCT05887492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380237|NCT05887492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139187973|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380238|NCT05887492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139380239|NCT05887492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380240|NCT05881135|Choline|choline|mesh-list
139380241|NCT05881135|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139380242|NCT05881135|Lipotropic Agents|lipotropic agents|mesh-ancestor
139380243|NCT05881135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139380244|NCT05881135|Antimetabolites|antimetabolites|mesh-ancestor
139380245|NCT05881135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380246|NCT05881135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139380247|NCT05881135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139380248|NCT05881135|Nootropic Agents|nootropic agents|mesh-ancestor
139380249|NCT05786716|Trastuzumab|trastuzumab|mesh-list
139380250|NCT05786716|Pertuzumab|pertuzumab|mesh-list
139188182|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
139380251|NCT05786716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380252|NCT05786716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380253|NCT05781035|Dexmedetomidine|dexmedetomidine|mesh-list
139380254|NCT05781035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139380255|NCT05781035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380256|NCT05781035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139380257|NCT05781035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139380258|NCT05781035|Analgesics|analgesics|mesh-ancestor
139380259|NCT05781035|Sensory System Agents|sensory system agents|mesh-ancestor
139188326|NCT03434782|Listerine|listerine|mesh-list
139380260|NCT05781035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139188395|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380261|NCT05781035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139380262|NCT05781035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139380263|NCT05781035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139380264|NCT05781035|Adrenergic Agents|adrenergic agents|mesh-ancestor
139380265|NCT05781035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139188540|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139380266|NCT05781035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380267|NCT05770544|Entrectinib|entrectinib|mesh-list
139380268|NCT05770544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139380269|NCT05770544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380270|NCT05770544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380271|NCT05768178|Vemurafenib|vemurafenib|mesh-list
139380272|NCT05768178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380273|NCT05768178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139380274|NCT05768178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380275|NCT05768178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380276|NCT05722886|Trastuzumab|trastuzumab|mesh-list
139380277|NCT05722886|Atezolizumab|atezolizumab|mesh-list
139380279|NCT05722886|Vemurafenib|vemurafenib|mesh-list
139380280|NCT05722886|Entrectinib|entrectinib|mesh-list
139380281|NCT05722886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380282|NCT05722886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380283|NCT05722886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139380284|NCT05722886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380285|NCT05722886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139380286|NCT05722886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380287|NCT05666310|Zoledronic Acid|zoledronic acid|mesh-list
139380288|NCT05666310|Denosumab|denosumab|mesh-list
139380289|NCT05666310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139380290|NCT05666310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380291|NCT05618912|Petrolatum|petrolatum|mesh-list
139380292|NCT05618912|Emollients|emollients|mesh-ancestor
139380293|NCT05618912|Dermatologic Agents|dermatologic agents|mesh-ancestor
139380294|NCT05618587|Lithium Carbonate|lithium carbonate|mesh-list
139380295|NCT05618587|Antidepressive Agents|antidepressive agents|mesh-ancestor
139380296|NCT05618587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139380297|NCT05618587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380298|NCT05618587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380299|NCT05618587|Antimanic Agents|antimanic agents|mesh-ancestor
139380300|NCT05618587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139380301|NCT05618587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139380302|NCT05618587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380303|NCT05565625|Sunscreening Agents|sunscreening agents|mesh-list
139380304|NCT05565625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139380305|NCT05565625|Protective Agents|protective agents|mesh-ancestor
139188884|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139380306|NCT05565625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380308|NCT05561387|Dexamethasone|dexamethasone|mesh-list
139380309|NCT05561387|Dexamethasone acetate|dexamethasone acetate|mesh-list
139380310|NCT05561387|Lenalidomide|lenalidomide|mesh-list
139380311|NCT05561387|Bortezomib|bortezomib|mesh-list
139380312|NCT05561387|Daratumumab|daratumumab|mesh-list
139380313|NCT05561387|Ichthammol|ichthammol|mesh-list
139380314|NCT05561387|BB 1101|bb 1101|mesh-list
139380315|NCT05561387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139380316|NCT05561387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139380317|NCT05561387|Antiemetics|antiemetics|mesh-ancestor
139380318|NCT05561387|Autonomic Agents|autonomic agents|mesh-ancestor
139380319|NCT05561387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380320|NCT05561387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380321|NCT05561387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139380323|NCT05561387|Hormones|hormones|mesh-ancestor
139380324|NCT05561387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139380325|NCT05561387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139380326|NCT05561387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380327|NCT05561387|Protease Inhibitors|protease inhibitors|mesh-ancestor
139380328|NCT05561387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380329|NCT05561387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380330|NCT05561387|Immunologic Factors|immunologic factors|mesh-ancestor
139380331|NCT05561387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139380332|NCT05561387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139380333|NCT05561387|Growth Substances|growth substances|mesh-ancestor
139380334|NCT05561387|Growth Inhibitors|growth inhibitors|mesh-ancestor
139380335|NCT05561387|Dermatologic Agents|dermatologic agents|mesh-ancestor
139380337|NCT05511948|Antioxidants|antioxidants|mesh-ancestor
139380338|NCT05511948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380339|NCT05511948|Protective Agents|protective agents|mesh-ancestor
139380340|NCT05511948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380341|NCT05511948|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139380343|NCT05461092|Analgesics, Opioid|analgesics, opioid|mesh-list
139380344|NCT05461092|Bupivacaine|bupivacaine|mesh-list
139380345|NCT05461092|Anesthetics, Local|anesthetics, local|mesh-ancestor
139380346|NCT05461092|Anesthetics|anesthetics|mesh-ancestor
139380347|NCT05461092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139380348|NCT05461092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380349|NCT05461092|Sensory System Agents|sensory system agents|mesh-ancestor
139380350|NCT05461092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380351|NCT05461092|Narcotics|narcotics|mesh-ancestor
139380352|NCT05461092|Analgesics|analgesics|mesh-ancestor
139380353|NCT05420935|Immunoglobulin G|immunoglobulin g|mesh-list
139380354|NCT05420935|Immunoglobulin E|immunoglobulin e|mesh-list
139380355|NCT05420935|Immunologic Factors|immunologic factors|mesh-ancestor
139380356|NCT05420935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380357|NCT05371288|Thioctic Acid|thioctic acid|mesh-list
139380358|NCT05371288|Acetylcysteine|acetylcysteine|mesh-list
139380359|NCT05371288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139380360|NCT05371288|Antioxidants|antioxidants|mesh-ancestor
139380361|NCT05371288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380362|NCT05371288|Protective Agents|protective agents|mesh-ancestor
139380363|NCT05371288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380364|NCT05371288|Vitamin B Complex|vitamin b complex|mesh-ancestor
139380365|NCT05371288|Vitamins|vitamins|mesh-ancestor
139380366|NCT05371288|Micronutrients|micronutrients|mesh-ancestor
139380367|NCT05371288|Antiviral Agents|antiviral agents|mesh-ancestor
139380368|NCT05371288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139380369|NCT05371288|Expectorants|expectorants|mesh-ancestor
139380370|NCT05371288|Respiratory System Agents|respiratory system agents|mesh-ancestor
139380371|NCT05371288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139380372|NCT05371288|Antidotes|antidotes|mesh-ancestor
139380373|NCT05325853|Proxymetacaine|proxymetacaine|mesh-list
139380374|NCT05325853|Propoxycaine|propoxycaine|mesh-list
139380375|NCT05325853|Anesthetics, Local|anesthetics, local|mesh-ancestor
139380376|NCT05325853|Anesthetics|anesthetics|mesh-ancestor
139380377|NCT05325853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139380378|NCT05325853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380379|NCT05325853|Sensory System Agents|sensory system agents|mesh-ancestor
139380380|NCT05325853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380381|NCT05312255|Propranolol|propranolol|mesh-list
139380382|NCT05312255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139380383|NCT05312255|Adrenergic Agents|adrenergic agents|mesh-list
139380384|NCT05312255|Adrenergic Antagonists|adrenergic antagonists|mesh-list
139380385|NCT05312255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139380386|NCT05312255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380387|NCT05312255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380388|NCT05312255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139380389|NCT05312255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139380390|NCT05312255|Vasodilator Agents|vasodilator agents|mesh-ancestor
139380391|NCT05276219|Furosemide|furosemide|mesh-list
139380392|NCT05276219|Isosorbide|isosorbide|mesh-list
139380393|NCT05276219|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139380394|NCT05276219|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139380395|NCT05276219|Diuretics|diuretics|mesh-ancestor
139380396|NCT05276219|Natriuretic Agents|natriuretic agents|mesh-ancestor
139380397|NCT05276219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380398|NCT05276219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139380399|NCT05276219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139380400|NCT05276219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380401|NCT05276219|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139380402|NCT05276219|Vasodilator Agents|vasodilator agents|mesh-ancestor
139380403|NCT05276219|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139380404|NCT05265052|Oxycodone|oxycodone|mesh-list
139380405|NCT05265052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139380406|NCT05265052|Narcotics|narcotics|mesh-ancestor
139380407|NCT05265052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139380408|NCT05265052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380409|NCT05265052|Analgesics|analgesics|mesh-ancestor
139380410|NCT05265052|Sensory System Agents|sensory system agents|mesh-ancestor
139380411|NCT05265052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380412|NCT05255484|Antibodies|antibodies|mesh-list
139380413|NCT05255484|Immunologic Factors|immunologic factors|mesh-ancestor
139380414|NCT05255484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380415|NCT05223816|Nivolumab|nivolumab|mesh-list
139380416|NCT05223816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380417|NCT05223816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380418|NCT05223816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139380419|NCT05223816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380420|NCT05199714|Pramlintide|pramlintide|mesh-list
139380421|NCT05199714|Pancrelipase|pancrelipase|mesh-list
139380422|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139380423|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139380424|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380425|NCT05121974|Azithromycin|azithromycin|mesh-list
139380426|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
139380427|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139380428|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139380429|NCT05074940|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
139189317|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
139380433|NCT05041257|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139380434|NCT05041257|Immunoconjugates|immunoconjugates|mesh-ancestor
139380435|NCT05041257|Immunologic Factors|immunologic factors|mesh-ancestor
139380436|NCT05041257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380437|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139380438|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380439|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
139380440|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
139380441|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
139380442|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380484|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
139380485|NCT04942067|Lenalidomide|lenalidomide|mesh-list
139380486|NCT04942067|Daratumumab|daratumumab|mesh-list
139380487|NCT04942067|Pomalidomide|pomalidomide|mesh-list
139380488|NCT04942067|BB 1101|bb 1101|mesh-list
139380489|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139380490|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
139380491|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
139380492|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380493|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139189548|NCT03413020|Antacids|antacids|mesh-ancestor
139380494|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139380495|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
139380496|NCT04942067|Hormones|hormones|mesh-ancestor
139380497|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139380498|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139380499|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380500|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
139380501|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380502|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380503|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
139189601|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
139380504|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139380505|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139380506|NCT04942067|Growth Substances|growth substances|mesh-ancestor
139380507|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
139380508|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139380509|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
139380510|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139380511|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
139189678|NCT03418090|Xenon|xenon|mesh-list
139380512|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380513|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139380514|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
139380515|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139380516|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
139380517|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380518|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139380519|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
139380520|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139380521|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
139380522|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380523|NCT04887298|Annamycin|annamycin|mesh-list
139380524|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139380525|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380526|NCT04843579|Clarithromycin|clarithromycin|mesh-list
139380527|NCT04843579|Dexamethasone|dexamethasone|mesh-list
139380528|NCT04843579|Pomalidomide|pomalidomide|mesh-list
139380529|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139037390|NCT03972982|Insulin|insulin|mesh-list
139380530|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
139380531|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
139380532|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380533|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380534|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139380535|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
139380536|NCT04843579|Hormones|hormones|mesh-ancestor
139380537|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139380538|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139380539|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380540|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139380541|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139380542|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139380543|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380544|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380545|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139380546|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139380547|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
139380548|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139380549|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139380550|NCT04843579|Growth Substances|growth substances|mesh-ancestor
139380551|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
139380553|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139380554|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380555|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
139380556|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
139380557|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380558|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
139380559|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139380560|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380561|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
139380562|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139380563|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139380564|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139380565|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139380566|NCT04723147|Levodopa|levodopa|mesh-list
139380567|NCT04723147|Carbidopa|carbidopa|mesh-list
139380568|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139380569|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139380570|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139380571|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
139380572|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139380573|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380574|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380575|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139380576|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380577|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139380578|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
139380579|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
139380580|NCT04669158|Idebenone|idebenone|mesh-list
139380581|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
139380582|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380583|NCT04669158|Protective Agents|protective agents|mesh-ancestor
139380584|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380585|NCT04606316|Nivolumab|nivolumab|mesh-list
139380586|NCT04606316|Ipilimumab|ipilimumab|mesh-list
139380587|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380588|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380589|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139380590|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380591|NCT04565431|Natalizumab|natalizumab|mesh-list
139380592|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
139380593|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380594|NCT04484740|Gepotidacin|gepotidacin|mesh-list
139380595|NCT04484740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139380596|NCT04484740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380597|NCT04484740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380598|NCT04484740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380599|NCT04469530|Sirolimus|sirolimus|mesh-list
139380600|NCT04469530|Celecoxib|celecoxib|mesh-list
139380601|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
139380602|NCT04469530|Etoposide|etoposide|mesh-list
139380603|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139380604|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
139380605|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380606|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139380607|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139380608|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
139380609|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380610|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380611|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139380612|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139380613|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139380614|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139380615|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380616|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139380617|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139380618|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139380619|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
139380620|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139380621|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139380623|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
139380624|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380625|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139380626|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139380627|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139380628|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
139380629|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
139380630|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380631|NCT04401761|Aspirin|aspirin|mesh-list
139380632|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
139380633|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139380634|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139380635|NCT04401761|Analgesics|analgesics|mesh-ancestor
139380636|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
139380637|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380638|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380639|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139380640|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139380641|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139380642|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139380643|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380644|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139380645|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139380646|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380647|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
139380648|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139380649|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
139380650|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139380651|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
139380652|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
139380653|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139380654|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
139380655|NCT04329975|Coagulants|coagulants|mesh-ancestor
139380656|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139380657|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
139380658|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380659|NCT04313634|Dasatinib|dasatinib|mesh-list
139380660|NCT04313634|Quercetin|quercetin|mesh-list
139380661|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380662|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139380663|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380664|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380665|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
139380666|NCT04313634|Protective Agents|protective agents|mesh-ancestor
139380667|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380668|NCT04248569|Nivolumab|nivolumab|mesh-list
139380669|NCT04248569|Ipilimumab|ipilimumab|mesh-list
139380670|NCT04248569|Poly ICLC|poly iclc|mesh-list
139380671|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380672|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380673|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139380674|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380675|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
139380676|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
139380677|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380678|NCT04238663|Bevacizumab|bevacizumab|mesh-list
139380679|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380680|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380681|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139380682|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139380683|NCT04238663|Growth Substances|growth substances|mesh-ancestor
139380684|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380685|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
139380687|NCT04102020|Venetoclax|venetoclax|mesh-list
139380688|NCT04102020|Cc-486|cc-486|mesh-list
139380689|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139380690|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
139380691|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380692|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380693|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380694|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
139380695|NCT04060017|Leucovorin|leucovorin|mesh-list
139380696|NCT04060017|Calcium|calcium|mesh-list
139380697|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
139380698|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139380699|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380700|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139380701|NCT04060017|Antidotes|antidotes|mesh-ancestor
139380702|NCT04060017|Protective Agents|protective agents|mesh-ancestor
139380703|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
139380704|NCT04060017|Vitamins|vitamins|mesh-ancestor
139380705|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
139380706|NCT04052698|Factor VIII|factor viii|mesh-list
139380707|NCT04052698|Coagulants|coagulants|mesh-ancestor
139380708|NCT03980483|Tofacitinib|tofacitinib|mesh-list
139380709|NCT03980483|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139380710|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139380711|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139190303|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139380712|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380714|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139380715|NCT03862716|Metformin|metformin|mesh-list
139380716|NCT03862716|Liraglutide|liraglutide|mesh-list
139380717|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
139380718|NCT03862716|Xultophy|xultophy|mesh-list
139380719|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139380720|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380721|NCT03862716|Incretins|incretins|mesh-ancestor
139380722|NCT03862716|Hormones|hormones|mesh-ancestor
139380723|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139190364|NCT03755479|Insulin|insulin|mesh-list
139380724|NCT03840239|Capecitabine|capecitabine|mesh-list
139380725|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
139380726|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139380727|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
139380728|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380729|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380730|NCT03824808|Lidocaine|lidocaine|mesh-list
139380731|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
139380732|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
139380733|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139380734|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380735|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
139380736|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380737|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139380738|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139380739|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139380740|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139380741|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380742|NCT03798691|Vaccines|vaccines|mesh-list
139380743|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
139380744|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380745|NCT03768492|Caffeine|caffeine|mesh-list
139380746|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139380747|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380748|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139380749|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380750|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380751|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139380752|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139380753|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
139380754|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139380755|NCT03733691|Lenalidomide|lenalidomide|mesh-list
139380756|NCT03733691|Ixazomib|ixazomib|mesh-list
139380757|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
138930532|NCT00789711|Insulin|insulin|mesh-list
139380758|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139190541|NCT05393245|Olodaterol|olodaterol|mesh-list
139380759|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139380760|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139380761|NCT03733691|Growth Substances|growth substances|mesh-ancestor
139380762|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
139380763|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380764|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
139380765|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380766|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380767|NCT03686124|Nivolumab|nivolumab|mesh-list
139380768|NCT03686124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380769|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380770|NCT03686124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139380771|NCT03686124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380772|NCT03600883|Sotorasib|sotorasib|mesh-list
139380773|NCT03600883|Midazolam|midazolam|mesh-list
139380774|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139380775|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139380776|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139380777|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380778|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139380779|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139380780|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139380781|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139380782|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
139380783|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
139380784|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
139380785|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
139380786|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139380787|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139190667|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
139380788|NCT03600883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139380789|NCT03600883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380790|NCT03600883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380791|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
139380792|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
139380793|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139380794|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380795|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380796|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139380797|NCT03510468|Pyridoxine|pyridoxine|mesh-list
139380798|NCT03510468|Vitamin B 6|vitamin b 6|mesh-list
139380799|NCT03510468|Tenofovir|tenofovir|mesh-list
139380800|NCT03510468|Isoniazid|isoniazid|mesh-list
139380801|NCT03510468|Rifapentine|rifapentine|mesh-list
139380803|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
139380804|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380805|NCT03510468|Antiviral Agents|antiviral agents|mesh-ancestor
139380806|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139380807|NCT03510468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139380808|NCT03510468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139380809|NCT03510468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380810|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380811|NCT03510468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139380812|NCT03510468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139380813|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
139380814|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
139380815|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139380816|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139380817|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139380818|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
139380819|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139380820|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139380821|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
139380822|NCT03355560|Nivolumab|nivolumab|mesh-list
139380823|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380824|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380825|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139380826|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380827|NCT03218826|Docetaxel|docetaxel|mesh-list
139380828|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380829|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
139380830|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
139380831|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
139380832|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380833|NCT03192501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139380834|NCT03192501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380835|NCT03192501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139380836|NCT03192501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380837|NCT03192501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380838|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
139380839|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139380840|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139380841|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
139380842|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139380843|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380844|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380845|NCT03149809|Urological Agents|urological agents|mesh-ancestor
139380846|NCT03063632|Interferons|interferons|mesh-list
139380847|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
139380849|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139380850|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380851|NCT03063632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139380852|NCT03063632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380853|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
139380854|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139380873|NCT02891603|Tacrolimus|tacrolimus|mesh-list
139380874|NCT02891603|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139380875|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139380876|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
139380877|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380878|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139380879|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380880|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380881|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139380882|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139380883|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139380884|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380885|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
139380886|NCT02891603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139380887|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
139380888|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139380889|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139380891|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139380892|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
139380893|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
139380894|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139380895|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380896|NCT02839915|Leucovorin|leucovorin|mesh-list
139191061|NCT02890992|Niacin|niacin|mesh-list
139380898|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
139380899|NCT02839915|Antidotes|antidotes|mesh-ancestor
139380900|NCT02839915|Protective Agents|protective agents|mesh-ancestor
139380901|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380902|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
139380903|NCT02839915|Vitamins|vitamins|mesh-ancestor
139380904|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
139380905|NCT02839915|Hematinics|hematinics|mesh-ancestor
139380906|NCT02792257|Dronabinol|dronabinol|mesh-list
139380907|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
139380908|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380910|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139380912|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
139380913|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380914|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139380915|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139380916|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139380917|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380918|NCT02792257|Hormones|hormones|mesh-ancestor
139380919|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139380920|NCT02756962|Cytarabine|cytarabine|mesh-list
139380921|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139380922|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
139380923|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380924|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380925|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
139380926|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139191135|NCT04656002|Vactosertib|vactosertib|mesh-list
139380927|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139380928|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
139380929|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380930|NCT02711826|Acetaminophen|acetaminophen|mesh-list
139380931|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
139380932|NCT02711826|Promethazine|promethazine|mesh-list
139380933|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
139380934|NCT02711826|Everolimus|everolimus|mesh-list
139380935|NCT02711826|Tacrolimus|tacrolimus|mesh-list
139380936|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139380937|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
139380938|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380939|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139380940|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139380941|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380942|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139380943|NCT02711826|Analgesics|analgesics|mesh-ancestor
139380944|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
139380945|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139380946|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
139380947|NCT02711826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139380948|NCT02711826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139380949|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380950|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139380951|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139380952|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
139380953|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139380954|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139380955|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139380956|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139380957|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139380958|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
139380959|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
139380960|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
139380961|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
139380962|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139380963|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139380964|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
139380965|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
139191317|NCT01378286|Artesunate|artesunate|mesh-list
139380966|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139380967|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139380968|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
139380969|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
139380970|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
139380971|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
139380972|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139380973|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139380974|NCT02665117|Diuretics|diuretics|mesh-ancestor
139380975|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
139380976|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380977|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139380978|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139380979|NCT02665117|Cathartics|cathartics|mesh-ancestor
139380980|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139380981|NCT02659254|Sirolimus|sirolimus|mesh-list
139380982|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139380983|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037838|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
139380984|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139380985|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139380986|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
139380987|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139380988|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
139380989|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380990|NCT02617485|Prednisone|prednisone|mesh-list
139380991|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
139380992|NCT02617485|Rituximab|rituximab|mesh-list
139380993|NCT02617485|Doxorubicin|doxorubicin|mesh-list
139380994|NCT02617485|Vincristine|vincristine|mesh-list
139380995|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139380996|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
139380997|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139380998|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139380999|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139381000|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
139381001|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381002|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381003|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139381004|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139381005|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139381006|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139381007|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139381008|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381009|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139381010|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
139381011|NCT02617485|Hormones|hormones|mesh-ancestor
139381012|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139381013|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139381014|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139381015|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
139381016|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
139381017|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
139381018|NCT02514278|Capecitabine|capecitabine|mesh-list
139381019|NCT02514278|Folfirinox|folfirinox|mesh-list
139381020|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139381021|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
139381022|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381023|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381024|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
139381025|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139381026|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381027|NCT02337686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139381028|NCT02337686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381029|NCT02138357|Buprenorphine|buprenorphine|mesh-list
139381030|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139381031|NCT02138357|Narcotics|narcotics|mesh-ancestor
139381032|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381033|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381034|NCT02138357|Analgesics|analgesics|mesh-ancestor
139381035|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
139381036|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381038|NCT02115295|Cytarabine|cytarabine|mesh-list
139381039|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
139381040|NCT02115295|Venetoclax|venetoclax|mesh-list
139381041|NCT02115295|Idarubicin|idarubicin|mesh-list
139381042|NCT02115295|Cladribine|cladribine|mesh-list
139381043|NCT02115295|Midostaurin|midostaurin|mesh-list
139381044|NCT02115295|Staurosporine|staurosporine|mesh-list
139381045|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139381046|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
139381047|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381048|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381049|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
139381050|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381051|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139381052|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
139381053|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381054|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139381055|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139381056|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139381057|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381059|NCT02109614|Niacin|niacin|mesh-list
139037915|NCT01069965|BGP 15|bgp 15|mesh-list
139381060|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139381061|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
139381062|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381063|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139381064|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
139381065|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
139381066|NCT02109614|Vitamins|vitamins|mesh-ancestor
139381067|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
139381068|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381069|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
139381070|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
139381071|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139381072|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139381073|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381074|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381075|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381076|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139381077|NCT01006798|Vaccines|vaccines|mesh-list
139381078|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
139381079|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381080|NCT00877656|Zanolimumab|zanolimumab|mesh-list
139381081|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139381082|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381083|NCT00113360|Everolimus|everolimus|mesh-list
139381084|NCT00113360|Octreotide|octreotide|mesh-list
139381085|NCT00113360|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139381086|NCT00113360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139381087|NCT00113360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381088|NCT00113360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381089|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139381090|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
139381091|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381092|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381093|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139381094|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139381095|NCT00087685|Everolimus|everolimus|mesh-list
139381096|NCT00087685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139381097|NCT00087685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139381098|NCT00087685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381099|NCT00087685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381100|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139381101|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
139381102|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381103|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381104|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
139381105|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
139381106|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139381107|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
139381108|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381109|NCT03188445|Protective Agents|protective agents|mesh-ancestor
139381110|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381111|NCT03188445|Vitamins|vitamins|mesh-ancestor
139381112|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
139381113|NCT03188445|Trace Elements|trace elements|mesh-ancestor
139381114|NCT03188445|Hematinics|hematinics|mesh-ancestor
139381115|NCT04483635|Vitamin D|vitamin d|mesh-list
139381116|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
139381117|NCT04483635|Vitamins|vitamins|mesh-ancestor
139381118|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
139381119|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381120|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139381121|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139381122|NCT04865900|Antibodies|antibodies|mesh-list
139381123|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
139381124|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381125|NCT03191721|Triclosan|triclosan|mesh-list
139381126|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
139381127|NCT03191721|Fluorides|fluorides|mesh-list
139381128|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
139381129|NCT03191721|Protective Agents|protective agents|mesh-ancestor
139381130|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381131|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139381132|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139381133|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139381134|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
139381135|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381136|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139381137|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
139191686|NCT01250561|Gabapentin|gabapentin|mesh-list
139381138|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139381139|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
139381140|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381141|NCT04864496|Expectorants|expectorants|mesh-ancestor
139381142|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
139381143|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139381144|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
139381145|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381146|NCT04864496|Protective Agents|protective agents|mesh-ancestor
139381147|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381148|NCT04864496|Antidotes|antidotes|mesh-ancestor
139381149|NCT03188289|Chitosan|chitosan|mesh-list
139381150|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
139381151|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139381152|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
139381153|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381154|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
139381155|NCT03188289|Protective Agents|protective agents|mesh-ancestor
139381156|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139381157|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139381158|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
139381159|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381160|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139191806|NCT04892420|Hormones|hormones|mesh-ancestor
139381161|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
139381162|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
139381163|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
139381164|NCT03188289|Coagulants|coagulants|mesh-ancestor
139381165|NCT03044912|Mirabegron|mirabegron|mesh-list
139381166|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139381167|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139381168|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139381169|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
139381170|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139381171|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381172|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381173|NCT03044912|Urological Agents|urological agents|mesh-ancestor
139381174|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139381175|NCT03041012|Romidepsin|romidepsin|mesh-list
139381176|NCT03041012|Antibodies, Blocking|antibodies, blocking|mesh-list
139381177|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
139381178|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381179|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139381180|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381181|NCT03041012|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139381182|NCT03041012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381183|NCT03041012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381184|NCT03041012|Immunologic Factors|immunologic factors|mesh-ancestor
139381185|NCT03041012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381186|NCT03187899|Ropivacaine|ropivacaine|mesh-list
139381187|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
139381188|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
139381189|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381190|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381191|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
139381192|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381193|NCT01648582|Metformin|metformin|mesh-list
139381194|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
138930799|NCT00772109|Vaccines|vaccines|mesh-list
139381195|NCT01648582|Dulaglutide|dulaglutide|mesh-list
139381196|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139381197|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381198|NCT02440347|Anesthetics|anesthetics|mesh-list
139191862|NCT05761730|Hormones|hormones|mesh-ancestor
139381199|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381200|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381201|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139381202|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139381203|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
139381204|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139381205|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381206|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139381207|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139381208|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139381209|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
139381210|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
139381211|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381212|NCT03189069|Warfarin|warfarin|mesh-list
139381213|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
139381214|NCT03189069|Dabigatran|dabigatran|mesh-list
139381215|NCT03189069|Apixaban|apixaban|mesh-list
139381216|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
139381217|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139381218|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
139381219|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139381220|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
139381221|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381222|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381224|NCT03040934|Everolimus|everolimus|mesh-list
139381225|NCT03040934|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139381226|NCT03040934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139381227|NCT03040934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381228|NCT03040934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381229|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139381230|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
139381231|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381232|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381233|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139381234|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381235|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139381236|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
139381237|NCT04861142|Denosumab|denosumab|mesh-list
139381238|NCT04861142|Alendronate|alendronate|mesh-list
139381239|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139381240|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381241|NCT03117855|Capecitabine|capecitabine|mesh-list
139381242|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139381243|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
139381244|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381245|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381246|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
139381247|NCT02607800|Velpatasvir|velpatasvir|mesh-list
139381248|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
139381249|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381250|NCT02304484|Evolocumab|evolocumab|mesh-list
139381251|NCT02304484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139381252|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139381253|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139381254|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
139381255|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381256|NCT02304484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139381257|NCT02304484|Protease Inhibitors|protease inhibitors|mesh-ancestor
139381258|NCT02304484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381259|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139381260|NCT02434029|Budesonide|budesonide|mesh-list
139381261|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139381262|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139381263|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
139381264|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381265|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381266|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139381267|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
139381268|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
139381269|NCT02434029|Hormones|hormones|mesh-ancestor
139381270|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139381271|NCT02708355|Esomeprazole|esomeprazole|mesh-list
139381272|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139381273|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139381274|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139381275|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381276|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381277|NCT04854044|TIC10 compound|tic10 compound|mesh-list
139381278|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381279|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
139381280|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139381281|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381282|NCT02337478|Vincristine|vincristine|mesh-list
139381283|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139381284|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381285|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
139191951|NCT03853694|Analgesics|analgesics|mesh-ancestor
139381286|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
139038135|NCT01046058|Simeprevir|simeprevir|mesh-list
139381287|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
139381288|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381289|NCT02434653|Chrysarobin|chrysarobin|mesh-list
139381290|NCT02434653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139381291|NCT02434653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139381292|NCT02434653|Analgesics|analgesics|mesh-ancestor
139381293|NCT02434653|Sensory System Agents|sensory system agents|mesh-ancestor
139381294|NCT02434653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381295|NCT02434653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381296|NCT02434653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139381297|NCT02434653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139381298|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139381299|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139381300|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139381301|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
139381302|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381303|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139381304|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139381305|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381307|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139381308|NCT03188835|Protective Agents|protective agents|mesh-ancestor
139381309|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381310|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139381312|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139381313|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139192019|NCT03908333|Vitamins|vitamins|mesh-ancestor
139381314|NCT04847024|Analgesics|analgesics|mesh-ancestor
139381315|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
139381316|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139192082|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381318|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138930887|NCT00794859|Sorafenib|sorafenib|mesh-list
139381319|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139381320|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139381321|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139381322|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381323|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381324|NCT04860674|Carboplatin|carboplatin|mesh-list
139381325|NCT04860674|Etoposide|etoposide|mesh-list
139192228|NCT01255475|Amlodipine|amlodipine|mesh-list
139381326|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139381327|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381328|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139381329|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139381330|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139381331|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381332|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381333|NCT04860674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139381334|NCT04853342|Aflutinib|aflutinib|mesh-list
139381335|NCT04853342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139381336|NCT04853342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381337|NCT04853342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381339|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139381340|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381341|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
139381342|NCT02430363|Ipatasertib|ipatasertib|mesh-list
139381344|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139381345|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139192506|NCT01149005|Insulin|insulin|mesh-list
139381346|NCT02430363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139381347|NCT02430363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381348|NCT02430363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139381349|NCT02430363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381350|NCT02429973|Sirolimus|sirolimus|mesh-list
139381351|NCT02429973|Gemcitabine|gemcitabine|mesh-list
139381352|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139381353|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
139381354|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381355|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381356|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139381357|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138930935|NCT02575508|Irinotecan|irinotecan|mesh-list
139381358|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139381359|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
139381360|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139381361|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
139381362|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381363|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
139038208|NCT01234532|Anastrozole|anastrozole|mesh-list
139381364|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
139381365|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139381366|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139381367|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139192790|NCT03895229|Empagliflozin|empagliflozin|mesh-list
139381368|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381369|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381370|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139381371|NCT04846634|Paclitaxel|paclitaxel|mesh-list
139381372|NCT04846634|Docetaxel|docetaxel|mesh-list
139381373|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139381374|NCT04846634|Cisplatin|cisplatin|mesh-list
139381375|NCT04846634|Carboplatin|carboplatin|mesh-list
139381376|NCT04846634|Gemcitabine|gemcitabine|mesh-list
139381377|NCT04846634|Pemetrexed|pemetrexed|mesh-list
139381378|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139381379|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381380|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
139381381|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
139381382|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
139381383|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381384|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139381385|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
139381386|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381387|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139381388|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139381389|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139381390|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139381391|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139381392|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381393|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381394|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139381395|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139381396|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139193270|NCT03880409|Lidocaine|lidocaine|mesh-list
139381398|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930944|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381399|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381400|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139381401|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139381402|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
139381403|NCT02429817|Edetic Acid|edetic acid|mesh-list
139381404|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
139381405|NCT02429817|Antidotes|antidotes|mesh-ancestor
139381406|NCT02429817|Protective Agents|protective agents|mesh-ancestor
139381407|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381408|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
139381409|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
139381410|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381411|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139381412|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
139381413|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139381414|NCT04851860|Immunomodulating Agents|immunomodulating agents|mesh-list
139381415|NCT04851860|Immunologic Factors|immunologic factors|mesh-ancestor
139381416|NCT04851860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139193701|NCT03757715|Dexamethasone|dexamethasone|mesh-list
139381417|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
139381418|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139381419|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
139193771|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139381446|NCT04851392|Cannabidiol|cannabidiol|mesh-list
139381447|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
139381448|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
139381449|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381450|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139381451|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139381452|NCT04851392|Analgesics|analgesics|mesh-ancestor
139381453|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
138930983|NCT04042948|Acetaminophen|acetaminophen|mesh-list
139381454|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381455|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139381456|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139381457|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139381458|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381459|NCT04851392|Hormones|hormones|mesh-ancestor
139381460|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139381461|NCT02429193|Prednisone|prednisone|mesh-list
139381462|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
139194032|NCT03877679|Analgesics|analgesics|mesh-ancestor
139381463|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139381464|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
139381466|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139194172|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139381467|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381468|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139381469|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381470|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139381471|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139381472|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381473|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
139381474|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139381475|NCT04859738|Lidocaine|lidocaine|mesh-list
139381476|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
139381477|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
139381478|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139381479|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381480|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
139381481|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381482|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139381483|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139381484|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139381485|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139381486|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381487|NCT02429271|Clopidogrel|clopidogrel|mesh-list
139381488|NCT02429271|Ticagrelor|ticagrelor|mesh-list
139381489|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139381490|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139381491|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139381492|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139381493|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
139381494|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139194385|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
139381495|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381496|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381498|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
139194572|NCT05171530|Taxane|taxane|mesh-list
139381499|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381500|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381502|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139381503|NCT04851002|Mitogens|mitogens|mesh-list
139381504|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
139381505|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381506|NCT04844996|Ezetimibe|ezetimibe|mesh-list
139381507|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139381508|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139381509|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
139381510|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139194749|NCT03382756|Choline|choline|mesh-list
139381511|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139194808|NCT01275911|Esmolol|esmolol|mesh-list
139381512|NCT02425137|Gemcitabine|gemcitabine|mesh-list
139381513|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139381514|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
139381515|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381516|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139194883|NCT03870581|Warfarin|warfarin|mesh-list
139381517|NCT03182595|Acetaminophen|acetaminophen|mesh-list
139381518|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139381519|NCT03182595|Analgesics|analgesics|mesh-ancestor
139381520|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
139381521|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381522|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381524|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
139381525|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
139381528|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
139195168|NCT01168739|Protective Agents|protective agents|mesh-ancestor
139381529|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139381530|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139381531|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139381532|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139381533|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139381534|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381535|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381536|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139381537|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139381538|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381539|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
139381540|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139381541|NCT04833218|Propranolol|propranolol|mesh-list
139381542|NCT04833218|Clonidine|clonidine|mesh-list
139381543|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139381544|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139381545|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
139381546|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139195529|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
139381547|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381548|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381549|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139381550|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139381551|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
139381552|NCT04833218|Analgesics|analgesics|mesh-ancestor
139381553|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
139381554|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381556|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
139381557|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139381558|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139381560|NCT04833374|Prednisone|prednisone|mesh-list
139381561|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
139381562|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139381563|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139381564|NCT04833374|Prednisolone|prednisolone|mesh-list
139381565|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
139381566|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139381567|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
139381568|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139381569|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
139381570|NCT04833374|Hormones|hormones|mesh-ancestor
139381571|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139381572|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381573|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139381574|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139381575|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
139381576|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
139381577|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139196108|NCT04584684|Ethanol|ethanol|mesh-list
139381578|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139381579|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139381580|NCT04833374|Protective Agents|protective agents|mesh-ancestor
139381581|NCT02707965|Topiramate|topiramate|mesh-list
139381582|NCT02707965|Lamotrigine|lamotrigine|mesh-list
139381583|NCT02707965|Zonisamide|zonisamide|mesh-list
139038429|NCT00386100|Metformin|metformin|mesh-list
139381584|NCT02707965|Carbamazepine|carbamazepine|mesh-list
139381585|NCT02707965|Phenytoin|phenytoin|mesh-list
139381587|NCT02707965|Levetiracetam|levetiracetam|mesh-list
139381588|NCT02707965|Valproic Acid|valproic acid|mesh-list
139381589|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
139381590|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139381591|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139381592|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
139381593|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139381594|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138931081|NCT00764699|Mecasermin|mecasermin|mesh-list
139381595|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139381596|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139381598|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139381599|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139196611|NCT01289327|Alfentanil|alfentanil|mesh-list
139381600|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139381601|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139381602|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
139381603|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139381604|NCT02707965|Analgesics|analgesics|mesh-ancestor
139381605|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
139381606|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139381607|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139381608|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139002192|NCT01037140|Vitamins|vitamins|mesh-ancestor
139002193|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
139002194|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002195|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139002196|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139002197|NCT05357456|Epinephrine|epinephrine|mesh-list
139002198|NCT05357456|Racepinephrine|racepinephrine|mesh-list
139002199|NCT05357456|Epinephryl borate|epinephryl borate|mesh-list
139002200|NCT05357456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139002201|NCT05357456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139002202|NCT05357456|Adrenergic Agents|adrenergic agents|mesh-ancestor
139002203|NCT05357456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002204|NCT05357456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752983|NCT03817502|Cariprazine|cariprazine|mesh-list
139002205|NCT05357456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002206|NCT05357456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139002207|NCT05357456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138968527|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968528|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
138968529|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138968530|NCT00860496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138968531|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138968532|NCT00864162|Ramipril|ramipril|mesh-list
138968533|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138968534|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
138968535|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968536|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968537|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138719358|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138968539|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
138968540|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968542|NCT00795314|Butorphanol|butorphanol|mesh-list
138968543|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138968544|NCT00795314|Narcotics|narcotics|mesh-ancestor
138968545|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138968546|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968547|NCT00795314|Analgesics|analgesics|mesh-ancestor
138968548|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
138968549|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968550|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138968551|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138968552|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
138968553|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
138968554|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
138968555|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
138968556|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138968557|NCT03926169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138583353|NCT00136526|Estrogens|estrogens|mesh-ancestor
138968558|NCT03926169|Immunologic Factors|immunologic factors|mesh-ancestor
138968559|NCT03926169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968560|NCT00864240|Clobetasol|clobetasol|mesh-list
138968561|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138968562|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
138968563|NCT00864240|Hormones|hormones|mesh-ancestor
138968564|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968565|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968566|NCT00979641|Docetaxel|docetaxel|mesh-list
138968567|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968568|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
139002208|NCT05357456|Autonomic Agents|autonomic agents|mesh-ancestor
139002209|NCT05357456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002210|NCT05357456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139002211|NCT05357456|Respiratory System Agents|respiratory system agents|mesh-ancestor
139002212|NCT05357456|Mydriatics|mydriatics|mesh-ancestor
139002213|NCT05357456|Sympathomimetics|sympathomimetics|mesh-ancestor
139002214|NCT05357456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139002215|NCT00069121|Leucovorin|leucovorin|mesh-list
139002216|NCT00069121|Capecitabine|capecitabine|mesh-list
139002217|NCT00069121|Fluorouracil|fluorouracil|mesh-list
139002218|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
138968569|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
138968570|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
138968571|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968572|NCT00864318|Paclitaxel|paclitaxel|mesh-list
138968573|NCT00864318|Etoposide|etoposide|mesh-list
138968574|NCT00864318|Ifosfamide|ifosfamide|mesh-list
138968575|NCT00864318|Carboplatin|carboplatin|mesh-list
138968576|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138968577|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968578|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
138968579|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
138968580|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
138968581|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968582|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138968583|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138968584|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968585|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138968586|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
138968587|NCT00788060|Everolimus|everolimus|mesh-list
138968588|NCT00788060|Sunitinib|sunitinib|mesh-list
138968589|NCT00788060|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138968590|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138968591|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968592|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968593|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968594|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
138968595|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968596|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968597|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138968598|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138968599|NCT00788060|Growth Substances|growth substances|mesh-ancestor
138968600|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
138968602|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
138968603|NCT00788138|Vitamins|vitamins|mesh-ancestor
138968604|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
138968605|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968606|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138968607|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138968608|NCT00864396|Lansoprazole|lansoprazole|mesh-list
138968609|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138968610|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138968611|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138968612|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968613|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968614|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
138968615|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138968616|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138968617|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138968618|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
138968619|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968620|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138968621|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138968622|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968623|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968624|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139002219|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139002220|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
139002221|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002222|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002223|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139002224|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
139002225|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002226|NCT00069121|Antidotes|antidotes|mesh-ancestor
139002227|NCT00069121|Protective Agents|protective agents|mesh-ancestor
139002228|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
139002229|NCT00069121|Vitamins|vitamins|mesh-ancestor
139002230|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
139002231|NCT00768911|Temozolomide|temozolomide|mesh-list
138968625|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138968627|NCT00961467|Prednisone|prednisone|mesh-list
138968628|NCT00961467|Melphalan|melphalan|mesh-list
138968629|NCT00961467|Lenalidomide|lenalidomide|mesh-list
138968630|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138968631|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
138968632|NCT00961467|Hormones|hormones|mesh-ancestor
138968633|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968634|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931197|NCT00841438|Abciximab|abciximab|mesh-list
138968635|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138968636|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968637|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138968638|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
138968639|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968640|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138968641|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968642|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
138968643|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138968644|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138968645|NCT00961467|Growth Substances|growth substances|mesh-ancestor
138968646|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
138968647|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
138968648|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138968649|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968650|NCT00980031|Eplerenone|eplerenone|mesh-list
138968651|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138968652|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
138968653|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968654|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968655|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138968656|NCT00980031|Diuretics|diuretics|mesh-ancestor
138968657|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
138968658|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138968659|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
138968660|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138968661|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968662|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138968663|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968665|NCT00980109|Zanamivir|zanamivir|mesh-list
138968666|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
138968667|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968668|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968669|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968670|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138968671|NCT00980187|Indapamide|indapamide|mesh-list
138968672|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138968673|NCT00980187|Diuretics|diuretics|mesh-ancestor
138968674|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
138968675|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002232|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139002233|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
139002234|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002235|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002236|NCT00769145|Ranibizumab|ranibizumab|mesh-list
139002237|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139002238|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139002239|NCT00769145|Growth Substances|growth substances|mesh-ancestor
139002240|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002241|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
139002242|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968676|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138968677|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138968678|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968679|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
138968680|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138968681|NCT00284089|Ranibizumab|ranibizumab|mesh-list
138968682|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138968683|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138968684|NCT00284089|Growth Substances|growth substances|mesh-ancestor
138968685|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968686|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
138968687|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719508|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
138968689|NCT00984633|Propofol|propofol|mesh-list
138968691|NCT00984633|Rocuronium|rocuronium|mesh-list
138968692|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138968693|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138968694|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968695|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138968696|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
138968697|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
138968698|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138968699|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138968700|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
138968701|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138968702|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138968703|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138968704|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968705|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138968706|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968707|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968708|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968709|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138968710|NCT00976755|Everolimus|everolimus|mesh-list
138968711|NCT00976755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138968712|NCT00976755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138968713|NCT00976755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968714|NCT00976755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968715|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968716|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
138968717|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968718|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968719|NCT00864474|Maraviroc|maraviroc|mesh-list
138968720|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138968721|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138968722|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968723|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138968724|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138968725|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
138968726|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968727|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138968728|NCT00283387|Betaine|betaine|mesh-list
139002243|NCT00763997|Acetaminophen|acetaminophen|mesh-list
139002244|NCT00763997|Dipyrone|dipyrone|mesh-list
139002245|NCT00763997|Ibuprofen|ibuprofen|mesh-list
139002246|NCT00763997|Parecoxib|parecoxib|mesh-list
139002247|NCT00763997|Valdecoxib|valdecoxib|mesh-list
139002248|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139002249|NCT00763997|Analgesics|analgesics|mesh-ancestor
139002250|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
139002251|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002252|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501451|NCT00030784|Ifosfamide|ifosfamide|mesh-list
138968729|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138583648|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
138968730|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
138968731|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138968732|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
138968733|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968734|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138968735|NCT00788294|Tanezumab|tanezumab|mesh-list
138968736|NCT00788294|Analgesics|analgesics|mesh-ancestor
138968737|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
138968738|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968739|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968740|NCT00795548|Azacitidine|azacitidine|mesh-list
138968741|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138968742|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
138968743|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968744|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968745|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968746|NCT00282919|Azithromycin|azithromycin|mesh-list
138968747|NCT00282919|Chloroquine|chloroquine|mesh-list
138968748|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138968749|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968750|NCT00282919|Amebicides|amebicides|mesh-ancestor
138968751|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138968752|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138968753|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
138968754|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138968755|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138968756|NCT00984789|Gestodene|gestodene|mesh-list
138968757|NCT00984789|Norelgestromin|norelgestromin|mesh-list
138968758|NCT00984789|Femovan|femovan|mesh-list
138968759|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138968760|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138968761|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138968762|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
138719594|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
138968763|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138968764|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968765|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138968766|NCT00984789|Estrogens|estrogens|mesh-ancestor
138968767|NCT00984789|Hormones|hormones|mesh-ancestor
138968768|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968769|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138968770|NCT00984789|Progestins|progestins|mesh-ancestor
138968771|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138968772|NCT00864552|Factor VIII|factor viii|mesh-list
138968773|NCT00864552|Coagulants|coagulants|mesh-ancestor
138968774|NCT04046822|Liraglutide|liraglutide|mesh-list
138968775|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138968776|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968777|NCT04046822|Incretins|incretins|mesh-ancestor
138968778|NCT04046822|Hormones|hormones|mesh-ancestor
138968779|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968780|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138968781|NCT04007835|Gefitinib|gefitinib|mesh-list
138968782|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968783|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138968784|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002253|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
139002254|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139002255|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139002256|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139002257|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139002258|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002259|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002260|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138931338|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139002262|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138968785|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968786|NCT00800930|Butyric Acid|butyric acid|mesh-list
138968787|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
138968788|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
138968789|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968790|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968791|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968792|NCT00868062|Polygeline|polygeline|mesh-list
138968793|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
138968794|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
138968795|NCT00742781|Vitamin D|vitamin d|mesh-list
138968796|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
138968797|NCT00742781|Vitamins|vitamins|mesh-ancestor
138968798|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
138968799|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968800|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138968801|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138968802|NCT00280735|Carboplatin|carboplatin|mesh-list
138968803|NCT00280735|Docetaxel|docetaxel|mesh-list
138968804|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968805|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
138968806|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
138968807|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
138968808|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968809|NCT03975283|Bupivacaine|bupivacaine|mesh-list
138968810|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
138968811|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
138968812|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138968813|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968814|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
138968815|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968817|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138968818|NCT00801086|Ethanol|ethanol|mesh-list
138968819|NCT00801086|Tempol|tempol|mesh-list
138968820|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138968821|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968822|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138968823|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968824|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
138968825|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968826|NCT00801086|Protective Agents|protective agents|mesh-ancestor
138968827|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138968828|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968829|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138968830|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138968831|NCT00788606|Bevacizumab|bevacizumab|mesh-list
138968832|NCT00788606|Rituximab|rituximab|mesh-list
138968833|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138968834|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968835|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138968836|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138968837|NCT00788606|Growth Substances|growth substances|mesh-ancestor
138968838|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968839|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
138968840|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
139002263|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139002264|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139002265|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
139002266|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002267|NCT00399568|Acetaminophen|acetaminophen|mesh-list
139002268|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139002269|NCT00399568|Analgesics|analgesics|mesh-ancestor
139002270|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
139002271|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002272|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002273|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
139002274|NCT01039558|Ecabet|ecabet|mesh-list
139002275|NCT01039558|Lansoprazole|lansoprazole|mesh-list
139002276|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
139002277|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139002278|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139002279|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139002280|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968841|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138968842|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
138968843|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
138968844|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138968845|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138968846|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968847|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968848|NCT00795938|Urological Agents|urological agents|mesh-ancestor
138968849|NCT00260065|Decitabine|decitabine|mesh-list
138968850|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138968851|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
138968852|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968853|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968854|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968855|NCT01071655|Fluorouracil|fluorouracil|mesh-list
138968856|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
138968857|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968858|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138968859|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968860|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968861|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
138968862|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968863|NCT02531581|Furosemide|furosemide|mesh-list
138968864|NCT02531581|Diuretics|diuretics|mesh-list
138968865|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
138968866|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968867|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138968868|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138968869|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968870|NCT04046510|Oxytocin|oxytocin|mesh-list
138968871|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
138968872|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138968873|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968874|NCT00506350|Vaccines|vaccines|mesh-list
138968875|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
138968876|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968877|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
138968878|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
138968879|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
138968880|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138968881|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002281|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002283|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
139002284|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139002285|NCT01039558|Protective Agents|protective agents|mesh-ancestor
139002286|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002287|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002289|NCT01324258|Trametinib|trametinib|mesh-list
138501639|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
138968882|NCT00742625|Cytarabine|cytarabine|mesh-list
138968883|NCT00742625|Bortezomib|bortezomib|mesh-list
138968884|NCT00742625|Daunorubicin|daunorubicin|mesh-list
138968885|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138968886|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
138968887|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968888|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968889|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
138968890|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968891|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968892|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
138968893|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968894|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138968895|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138968896|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138968897|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968898|NCT00801788|Oxycodone|oxycodone|mesh-list
138968899|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138968900|NCT00801788|Narcotics|narcotics|mesh-ancestor
138968901|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138968902|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968903|NCT00801788|Analgesics|analgesics|mesh-ancestor
138968904|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
138968905|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968906|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138968907|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968908|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
138968909|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138968910|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138968911|NCT00796250|Prednisolone|prednisolone|mesh-list
138968912|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138968913|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
138968914|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138968915|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
138968916|NCT00796250|Infliximab|infliximab|mesh-list
138968917|NCT00796250|Azathioprine|azathioprine|mesh-list
138968918|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138968919|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
138968920|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138968921|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
138968922|NCT00796250|Hormones|hormones|mesh-ancestor
138968923|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968924|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968925|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138968926|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968927|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
138968928|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
138968929|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968930|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138968931|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138968932|NCT00796250|Protective Agents|protective agents|mesh-ancestor
138968933|NCT00796250|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138968934|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
138968935|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138968936|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
138968937|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931470|NCT04045821|Plerixafor|plerixafor|mesh-list
138968938|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138583866|NCT01243177|Lacosamide|lacosamide|mesh-list
139002290|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139002291|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
139002292|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002293|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002294|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139002295|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002297|NCT00068419|Sulindac|sulindac|mesh-list
139002298|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002299|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138968939|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968940|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
138968941|NCT00788918|Interferons|interferons|mesh-list
138968942|NCT00788918|Ribavirin|ribavirin|mesh-list
138968943|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968944|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
138968945|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968946|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
138968947|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968948|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
138968949|NCT02596373|Analgesics|analgesics|mesh-ancestor
138968950|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
138968951|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968952|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968953|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968954|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138968955|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138968956|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968957|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968958|NCT00801866|Bevacizumab|bevacizumab|mesh-list
138968959|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138968960|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968961|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138968962|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138968963|NCT00801866|Growth Substances|growth substances|mesh-ancestor
138968964|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968965|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
138968966|NCT03973879|Atezolizumab|atezolizumab|mesh-list
138968967|NCT03973879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138968968|NCT03973879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968969|NCT03973879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138968970|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968971|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138968972|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138968973|NCT00860964|Estradiol|estradiol|mesh-list
138968974|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138968975|NCT00860964|Estrogens|estrogens|mesh-ancestor
138968976|NCT00860964|Hormones|hormones|mesh-ancestor
138968977|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968978|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968979|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138968980|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
138968981|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138968995|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968996|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138968997|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138968998|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583947|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968999|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969000|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138969001|NCT00740051|Glimepiride|glimepiride|mesh-list
138969002|NCT00740051|Linagliptin|linagliptin|mesh-list
138969003|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138969004|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139002300|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
139002301|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139002302|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002303|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139002304|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002305|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139002306|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139002307|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139002308|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139002309|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138969005|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969006|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138969007|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
138969008|NCT00740051|Incretins|incretins|mesh-ancestor
138969009|NCT00740051|Hormones|hormones|mesh-ancestor
138969010|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138969011|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138969012|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
138969013|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969014|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969015|NCT00864864|Sunitinib|sunitinib|mesh-list
138969016|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969017|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138969018|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138969019|NCT00864864|Growth Substances|growth substances|mesh-ancestor
138969020|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969021|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
138969022|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138969023|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969024|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969025|NCT00868764|Granisetron|granisetron|mesh-list
138969026|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
138969027|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
138969028|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969029|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969030|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138969031|NCT00868764|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138969032|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138969033|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
138969034|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969035|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969036|NCT00518986|Modafinil|modafinil|mesh-list
138969037|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138969038|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969039|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138969040|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138969041|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138969042|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969043|NCT00864942|Lenalidomide|lenalidomide|mesh-list
138969044|NCT00864942|Rituximab|rituximab|mesh-list
138969045|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138969046|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
138969047|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969048|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138969049|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138969050|NCT00864942|Growth Substances|growth substances|mesh-ancestor
138969051|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
138931552|NCT00842998|Trastuzumab|trastuzumab|mesh-list
138969052|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002311|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
139002312|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002313|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139002314|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139002315|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139002316|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002317|NCT02557373|Vitamins|vitamins|mesh-list
139002318|NCT02557373|Vitamin A|vitamin a|mesh-list
139002319|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
139002320|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
138969053|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138969054|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138969055|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138969056|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
138969057|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969058|NCT00870402|Spironolactone|spironolactone|mesh-list
138969059|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138969060|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
138969061|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138969062|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969063|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138969064|NCT00870402|Diuretics|diuretics|mesh-ancestor
138969065|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
138969066|NCT00742235|Vitamin D|vitamin d|mesh-list
138969067|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
138969068|NCT00742235|Vitamins|vitamins|mesh-ancestor
138969069|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
138969070|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969071|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138969072|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138969073|NCT00742079|Cycloserine|cycloserine|mesh-list
138969074|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138969075|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969076|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138969077|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
138969078|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138969079|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
138969080|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969081|NCT04730362|Propofol|propofol|mesh-list
138969082|NCT04730362|Sevoflurane|sevoflurane|mesh-list
138969084|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138969085|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969086|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138969087|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138969088|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
138969089|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138969090|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138969091|NCT00662792|Tiotropium Bromide|tiotropium bromide|mesh-list
138969092|NCT00662792|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138969093|NCT00662792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138969094|NCT00662792|Autonomic Agents|autonomic agents|mesh-ancestor
138969095|NCT00662792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969096|NCT00662792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969097|NCT00662792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138969098|NCT00662792|Respiratory System Agents|respiratory system agents|mesh-ancestor
138969099|NCT00662792|Parasympatholytics|parasympatholytics|mesh-ancestor
138969100|NCT00662792|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138969101|NCT00662792|Cholinergic Agents|cholinergic agents|mesh-ancestor
138969102|NCT00662792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969103|NCT00662792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969104|NCT00662792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138969105|NCT00662792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138969106|NCT00662792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138969107|NCT00662792|Adrenergic Agents|adrenergic agents|mesh-ancestor
138969108|NCT00870480|Finasteride|finasteride|mesh-list
139002321|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002322|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
139002323|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002324|NCT02557373|Protective Agents|protective agents|mesh-ancestor
139002325|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139002326|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002327|NCT01757626|Molgramostim|molgramostim|mesh-list
139002328|NCT01757626|Sargramostim|sargramostim|mesh-list
138969109|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138584220|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
138969110|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138969112|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969113|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
138969114|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138969115|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969116|NCT00870480|Urological Agents|urological agents|mesh-ancestor
138969117|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
138969118|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969119|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138969120|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138969121|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138584269|NCT00154791|Gemcitabine|gemcitabine|mesh-list
138969122|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138969123|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
138969124|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138969125|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969126|NCT00616902|Vitamins|vitamins|mesh-ancestor
138969127|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
138969128|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138969129|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
138969130|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138969131|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138969132|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
138969133|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969134|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719959|NCT01089647|Hormones|hormones|mesh-ancestor
138969135|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969136|NCT00801944|Urological Agents|urological agents|mesh-ancestor
138969137|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138969138|NCT00870714|Ketoconazole|ketoconazole|mesh-list
138969139|NCT00870714|Docetaxel|docetaxel|mesh-list
138969140|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969141|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
138969142|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
138969143|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
138969144|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969145|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
138969146|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969147|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138969148|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138969149|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969150|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138969151|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
138969152|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138969153|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969154|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138969155|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138969156|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
138969157|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969158|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
138969159|NCT02598011|Flucytosine|flucytosine|mesh-list
138969160|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
138931643|NCT00429793|Sirolimus|sirolimus|mesh-list
138969161|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969162|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
138969163|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969164|NCT00869310|Dexamethasone|dexamethasone|mesh-list
139002329|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
139002330|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002331|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002332|NCT04048811|Propofol|propofol|mesh-list
139002333|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139002334|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139002335|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002336|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139002337|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
139002338|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
139002339|NCT01086631|Rituximab|rituximab|mesh-list
138501973|NCT00000620|Diuretics|diuretics|mesh-ancestor
138969165|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
138969166|NCT00869310|Aprepitant|aprepitant|mesh-list
138969167|NCT00869310|Metoclopramide|metoclopramide|mesh-list
138969168|NCT00869310|BB 1101|bb 1101|mesh-list
138969169|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138969170|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
138969171|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
138969172|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969173|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969174|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138969175|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
138969176|NCT00869310|Hormones|hormones|mesh-ancestor
138969177|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138969178|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138969179|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969180|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
138969181|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969182|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969183|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138969184|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969185|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138584495|NCT00141401|Pregabalin|pregabalin|mesh-list
138969186|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138969187|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
138969188|NCT00662558|Celecoxib|celecoxib|mesh-list
138969189|NCT00662558|Tramadol|tramadol|mesh-list
138969190|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138969191|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138969192|NCT00662558|Analgesics|analgesics|mesh-ancestor
138969193|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
138969194|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969195|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969196|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138969197|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138969198|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138969199|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138969200|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969201|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969202|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138969203|NCT00662558|Narcotics|narcotics|mesh-ancestor
138969204|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138969205|NCT00869700|Lumefantrine|lumefantrine|mesh-list
138969206|NCT00869700|Artemether|artemether|mesh-list
138969207|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138969208|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
138969209|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138969210|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138969211|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969212|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
138969213|NCT00869856|Hematinics|hematinics|mesh-ancestor
138969214|NCT00876486|genexol-PM|genexol-pm|mesh-list
138969215|NCT00876486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969216|NCT00876486|Tubulin Modulators|tubulin modulators|mesh-ancestor
138969217|NCT00876486|Antimitotic Agents|antimitotic agents|mesh-ancestor
139002340|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139002341|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002342|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
139002343|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002344|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139002345|NCT00399490|Tanezumab|tanezumab|mesh-list
139002346|NCT00399490|Analgesics|analgesics|mesh-ancestor
139002347|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
139002348|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002349|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002350|NCT00398866|Triamcinolone|triamcinolone|mesh-list
138969218|NCT00876486|Mitosis Modulators|mitosis modulators|mesh-ancestor
138969219|NCT00876486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969220|NCT00802334|Ritonavir|ritonavir|mesh-list
138969221|NCT00802334|Lopinavir|lopinavir|mesh-list
138969222|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138969223|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138969224|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
138969225|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969226|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969227|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138969228|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138969229|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
138969230|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969231|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138969232|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138969233|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138969234|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138969235|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138969236|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138969237|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969238|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138969239|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138584621|NCT00155376|Analgesics|analgesics|mesh-ancestor
138969240|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138969241|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
138969242|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969243|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969244|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138969245|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138969246|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
138969248|NCT00796796|Temsirolimus|temsirolimus|mesh-list
138969249|NCT00796796|MTOR Inhibitors|mtor inhibitors|mesh-list
138969250|NCT00796796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138969251|NCT00796796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969252|NCT00796796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969253|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138969254|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
138969255|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969256|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969257|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138969258|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969259|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138969260|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
138969261|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
138969262|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
138969263|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
138969264|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969265|NCT03794076|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138969266|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138969267|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138969268|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
138969269|NCT00739973|Amlodipine|amlodipine|mesh-list
138969270|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139002351|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139002352|NCT00398866|Bupivacaine|bupivacaine|mesh-list
139002353|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
139002355|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
139002356|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
139002357|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139002358|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002359|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
139002360|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002361|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139002362|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
139002363|NCT00398866|Hormones|hormones|mesh-ancestor
139039557|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138969271|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138969272|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138969273|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969274|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138969275|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969277|NCT00802568|Fludarabine|fludarabine|mesh-list
138969278|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
138969279|NCT00802568|Busulfan|busulfan|mesh-list
138969280|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138969281|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969282|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138969283|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
138969284|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969285|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138969286|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
138969287|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969288|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
138969289|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138969290|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138969292|NCT00802802|Rifampin|rifampin|mesh-list
138969293|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138969294|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138969295|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969296|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969297|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
138969298|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969299|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138969300|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138969301|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138969302|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138969303|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138969304|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138969305|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138969306|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
138969307|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138969308|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
138969309|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138969310|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138969311|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138969312|NCT00802958|Clobetasol|clobetasol|mesh-list
138969313|NCT00802958|Halobetasol|halobetasol|mesh-list
138969314|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138969315|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138969316|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
138969317|NCT00802958|Hormones|hormones|mesh-ancestor
138969318|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139002364|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139002365|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139002366|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
138931753|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
139002367|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139002368|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
139002369|NCT00398866|Protective Agents|protective agents|mesh-ancestor
139002370|NCT00771563|Cisplatin|cisplatin|mesh-list
139002371|NCT00771563|Docetaxel|docetaxel|mesh-list
139002372|NCT00771563|Enoxaparin|enoxaparin|mesh-list
139002373|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002374|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
139002375|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
139002376|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
139002377|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002378|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
139002379|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138969319|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584885|NCT00141908|Hormones|hormones|mesh-ancestor
138969320|NCT01565512|Bupivacaine|bupivacaine|mesh-list
138969321|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
138969322|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
138969323|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138969324|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969325|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
138969326|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969327|NCT04895930|Aflutinib|aflutinib|mesh-list
138969328|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138969329|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969330|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969331|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138969332|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138969333|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
138969334|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969335|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969336|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138969337|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
138969338|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138969339|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138969340|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138969341|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
138969342|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969343|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969344|NCT00789308|Cyclosporine|cyclosporine|mesh-list
138969345|NCT00789308|Sirolimus|sirolimus|mesh-list
138969346|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
138969347|NCT00789308|Etanercept|etanercept|mesh-list
138969348|NCT00789308|Heparin|heparin|mesh-list
138969349|NCT00789308|Dextrans|dextrans|mesh-list
138969350|NCT00789308|Tacrolimus|tacrolimus|mesh-list
138969351|NCT00789308|Cyclosporins|cyclosporins|mesh-list
138969352|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
138969353|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138969354|NCT00789308|Basiliximab|basiliximab|mesh-list
138969355|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138969356|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
138969357|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969358|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138720193|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
138969359|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969360|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969361|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
138969362|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139002381|NCT00775073|Bevacizumab|bevacizumab|mesh-list
139002382|NCT00775073|Everolimus|everolimus|mesh-list
139002383|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139002384|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002385|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139002386|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139002387|NCT00775073|Growth Substances|growth substances|mesh-ancestor
139002388|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002389|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
139002390|NCT00775073|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139002391|NCT00775073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139002392|NCT00775073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002393|NCT00775073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002394|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139002395|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
139002396|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139002397|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138969363|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
138969364|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138969365|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138969366|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969367|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138969368|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
138969369|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138969370|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
138969371|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138585064|NCT04511923|Heparin|heparin|mesh-list
138969372|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138969373|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138931810|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
138969374|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138969375|NCT00789308|Analgesics|analgesics|mesh-ancestor
138969376|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
138969377|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969378|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138969379|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138969380|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
138969381|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
138969383|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138969384|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138969385|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969386|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
138969387|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
138969388|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
138969389|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969390|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
138969391|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138969392|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969393|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138969394|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138969395|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969396|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969397|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969398|NCT00871104|Vancomycin|vancomycin|mesh-list
138969399|NCT00871104|Imipenem|imipenem|mesh-list
138969400|NCT00871104|Fosfomycin|fosfomycin|mesh-list
138969401|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139002398|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139002399|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139002400|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002401|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002402|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002404|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
139002405|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002406|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
139002407|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139002408|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
139002409|NCT01589146|Heparin|heparin|mesh-list
139002410|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139002411|NCT01589146|Tinzaparin|tinzaparin|mesh-list
139002412|NCT01589146|Dalteparin|dalteparin|mesh-list
139002413|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
139002414|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139002415|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138931839|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002416|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002417|NCT00775151|Amlodipine|amlodipine|mesh-list
139002418|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139002419|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138969402|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969403|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
138969404|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138969405|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969406|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
138969408|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
138969409|NCT00727415|Lenalidomide|lenalidomide|mesh-list
138969410|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138969411|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
138969412|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969413|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138969414|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138969415|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
138969416|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969417|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969418|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138969419|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138969420|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
138969421|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138969422|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138969423|NCT00727415|Growth Substances|growth substances|mesh-ancestor
138969424|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
138969425|NCT00803192|Famotidine|famotidine|mesh-list
138969426|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138969427|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138969428|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138969429|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
138969430|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
138969431|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969432|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931872|NCT01344252|Lidocaine|lidocaine|mesh-list
138969433|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720258|NCT00179010|Adenosine|adenosine|mesh-list
139002420|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139002421|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002422|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139002423|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002424|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
139002425|NCT04694300|Acetaminophen|acetaminophen|mesh-list
139002426|NCT04694300|Naproxen|naproxen|mesh-list
139002427|NCT04694300|Tramadol|tramadol|mesh-list
139002428|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139002429|NCT04694300|Analgesics|analgesics|mesh-ancestor
139002430|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
138969435|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138969436|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138969437|NCT00544557|Analgesics|analgesics|mesh-ancestor
138969438|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
138969439|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969440|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969441|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138969442|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138969443|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138585439|NCT00143975|Analgesics|analgesics|mesh-ancestor
138969444|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138969445|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
138969446|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
138969447|NCT00877110|Vincristine|vincristine|mesh-list
138969448|NCT00877110|Topotecan|topotecan|mesh-list
138969449|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138969450|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
138969451|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969452|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138969453|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138969454|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
138969455|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969456|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969457|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138969458|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138969459|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
138969460|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
138969461|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
138969462|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138969463|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138969464|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969465|NCT00727259|Ribavirin|ribavirin|mesh-list
138969466|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138969467|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
138969468|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969469|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
138969470|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969472|NCT00789386|Remifentanil|remifentanil|mesh-list
138969473|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138969474|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138969475|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138969476|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969477|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138969478|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138969479|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138969480|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138969481|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
138969482|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
138969483|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
138969484|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
138969485|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969486|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969487|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138969488|NCT00789386|Narcotics|narcotics|mesh-ancestor
139002431|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753204|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
139002432|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002433|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
139002434|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139002435|NCT04694300|Narcotics|narcotics|mesh-ancestor
139002436|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139002437|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139002438|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139002439|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139002440|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
139002441|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139002442|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002443|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002445|NCT00771641|Trace Elements|trace elements|mesh-ancestor
139002446|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
139002447|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002448|NCT05408000|Propofol|propofol|mesh-list
139002449|NCT05408000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139002450|NCT05408000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139002451|NCT05408000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002452|NCT05408000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139002453|NCT05408000|Anesthetics, General|anesthetics, general|mesh-ancestor
139002454|NCT05408000|Anesthetics|anesthetics|mesh-ancestor
138969489|NCT00789386|Analgesics|analgesics|mesh-ancestor
138969490|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
138969491|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969492|NCT00789464|Trimethoprim|trimethoprim|mesh-list
138969493|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
138969494|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138969495|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969496|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
138969497|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138969498|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138969499|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138969500|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969501|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969502|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138969503|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138969504|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138969505|NCT00797030|Cyclosporine|cyclosporine|mesh-list
138969506|NCT00797030|Cyclosporins|cyclosporins|mesh-list
138969507|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969508|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969509|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138969510|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
138969511|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969512|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
138969513|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969514|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
138969515|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139002455|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
139002456|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
139002457|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139002458|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139002459|NCT00673361|Temozolomide|temozolomide|mesh-list
139002460|NCT00673361|Sorafenib|sorafenib|mesh-list
139002461|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139002462|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
139002463|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002464|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002465|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138502450|NCT00000686|Stavudine|stavudine|mesh-list
138969516|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138969517|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
138969518|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
138969519|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969520|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
138969521|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
138969522|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138969523|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138585594|NCT00507091|Antidotes|antidotes|mesh-ancestor
138969524|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138969525|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969526|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138969527|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138969528|NCT00877266|Mepivacaine|mepivacaine|mesh-list
138969529|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
138969530|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
138969531|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138969532|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969533|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
138969534|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969535|NCT02553824|Topiramate|topiramate|mesh-list
138969536|NCT02553824|Phentermine|phentermine|mesh-list
138969537|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
138969538|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138969539|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969540|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138969541|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
138969542|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138969543|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
138969544|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
138969545|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969546|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
138969547|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969548|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969549|NCT04039854|Propofol|propofol|mesh-list
138969550|NCT04039854|Sevoflurane|sevoflurane|mesh-list
138969551|NCT04039854|Desflurane|desflurane|mesh-list
138969552|NCT04039854|Isoflurane|isoflurane|mesh-list
138969553|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138969554|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138969555|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969556|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138969557|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
138969558|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
138969559|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138969560|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138969561|NCT04045730|Paclitaxel|paclitaxel|mesh-list
138969562|NCT04045730|Gemcitabine|gemcitabine|mesh-list
138969563|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
138969564|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138969565|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969566|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
138969567|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
138969568|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
139002466|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002467|NCT00393718|Liraglutide|liraglutide|mesh-list
139002468|NCT00393718|Glyburide|glyburide|mesh-list
139002469|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139002470|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002471|NCT00393718|Incretins|incretins|mesh-ancestor
139002472|NCT00393718|Hormones|hormones|mesh-ancestor
139002473|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139002474|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139002475|NCT00669071|Tretinoin|tretinoin|mesh-list
139002476|NCT00669071|Hydroquinone|hydroquinone|mesh-list
139002477|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002478|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
139002479|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
139002480|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139002481|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
138969569|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969570|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138969572|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138969573|NCT04045730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138969574|NCT00977223|Aprepitant|aprepitant|mesh-list
138969575|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
138969576|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
138969577|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
138969578|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969579|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969580|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138969581|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138969582|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720405|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
138969583|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969584|NCT00977301|Ritonavir|ritonavir|mesh-list
138969585|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
138969586|NCT00977301|Olanzapine|olanzapine|mesh-list
138969587|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138969588|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138969589|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
138969590|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969591|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969592|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138969593|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138969594|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
138969595|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969596|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138969597|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138969598|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
138969599|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
138969600|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969601|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969602|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138969603|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138969604|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138969605|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138969606|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138969607|NCT00977301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138969608|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138969609|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138969610|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969611|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
138969612|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139002482|NCT00669071|Hormones|hormones|mesh-ancestor
139002483|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139002484|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002485|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
139002486|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002487|NCT00669071|Protective Agents|protective agents|mesh-ancestor
139002488|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139002489|NCT00398320|Bevacizumab|bevacizumab|mesh-list
139002490|NCT00398320|Capecitabine|capecitabine|mesh-list
139002491|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
139002492|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139002493|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002494|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139002495|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139002496|NCT00398320|Growth Substances|growth substances|mesh-ancestor
139002497|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002498|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
139002499|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139002500|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
139002501|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002502|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
139002503|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139002504|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002505|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002506|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139002507|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139002508|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
139002509|NCT04003688|Analgesics|analgesics|mesh-ancestor
139002510|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
139002511|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002512|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502587|NCT00000716|Zidovudine|zidovudine|mesh-list
138969613|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138969614|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969615|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138969616|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138969617|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138969618|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969619|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
138969620|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969621|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
139002514|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139002515|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139002516|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
139002517|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139002518|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139002519|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002520|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138932042|NCT00709644|Estradiol|estradiol|mesh-list
139002521|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
139002522|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139002523|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
138969622|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138969623|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
138969624|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969625|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138969626|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138969627|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
138969628|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969629|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969630|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138969631|NCT00984945|Vaccines|vaccines|mesh-list
138969632|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
138969633|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969634|NCT00879918|Nicotine|nicotine|mesh-list
138969635|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138969636|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
138969637|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969638|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969639|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138969641|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
138969642|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969643|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969644|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
138969645|NCT01565590|Propofol|propofol|mesh-list
138969646|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138969647|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138969648|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969649|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138969650|NCT01565590|Analgesics|analgesics|mesh-ancestor
138969651|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
138969652|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969653|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138969654|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138969655|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138969656|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
138969657|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887227|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969658|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969659|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138969660|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
138969662|NCT00877422|Vitamin D|vitamin d|mesh-list
138969663|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
138969664|NCT00877422|Vitamins|vitamins|mesh-ancestor
138969665|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
138585981|NCT00508456|Temozolomide|temozolomide|mesh-list
138969666|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932070|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138969667|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138969668|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138969669|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
138969670|NCT04039698|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138969671|NCT04039698|Velpatasvir|velpatasvir|mesh-list
138969672|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
138969673|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969674|NCT04006821|Apatinib|apatinib|mesh-list
138969675|NCT04006821|Antibodies|antibodies|mesh-list
138586053|NCT00148824|Vaccines|vaccines|mesh-list
139002525|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139002526|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
139002527|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002528|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139002529|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139002530|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
139002531|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002532|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002533|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139002534|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139002535|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139002536|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139002537|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002538|NCT00772187|Fentanyl|fentanyl|mesh-list
139002539|NCT00772187|Morphine|morphine|mesh-list
139002540|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
139002541|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139002542|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969677|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969678|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969679|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138969680|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969681|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969682|NCT00803816|Everolimus|everolimus|mesh-list
138969683|NCT00803816|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138969684|NCT00803816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138969685|NCT00803816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969686|NCT00803816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969687|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138969688|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
138969689|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969690|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969691|NCT00797264|Ketamine|ketamine|mesh-list
138969692|NCT00797264|Morphine|morphine|mesh-list
138969693|NCT00797264|Analgesics|analgesics|mesh-ancestor
138969694|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
138969695|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969696|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969697|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138969698|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138969699|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
138969700|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
138969701|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138969702|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138969703|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138969704|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969705|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969706|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138969707|NCT00797264|Narcotics|narcotics|mesh-ancestor
138969708|NCT00981201|Celecoxib|celecoxib|mesh-list
138586110|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
138969709|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138969710|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138969712|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
138969713|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002543|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139002544|NCT00772187|Narcotics|narcotics|mesh-ancestor
139002545|NCT00772187|Analgesics|analgesics|mesh-ancestor
139002546|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
139002547|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002548|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139002549|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139002550|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
139002551|NCT00772265|Insulin|insulin|mesh-list
139002552|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
139002553|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139002554|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002555|NCT00779441|Zolpidem|zolpidem|mesh-list
139002556|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139002557|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139002558|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139002559|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002560|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139002561|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
139002562|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
139002563|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002564|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002565|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
139002566|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138969714|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969715|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138969716|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138969717|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138969718|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138969719|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969720|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969721|NCT05279391|Dexamethasone|dexamethasone|mesh-list
138969722|NCT05279391|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138969723|NCT05279391|Heparin|heparin|mesh-list
138969724|NCT05279391|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138969725|NCT05279391|Tinzaparin|tinzaparin|mesh-list
138969726|NCT05279391|Dalteparin|dalteparin|mesh-list
138969727|NCT05279391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138969728|NCT05279391|Antiemetics|antiemetics|mesh-ancestor
138969729|NCT05279391|Autonomic Agents|autonomic agents|mesh-ancestor
138969730|NCT05279391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969731|NCT05279391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969732|NCT05279391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138720575|NCT00479856|Paclitaxel|paclitaxel|mesh-list
138969733|NCT05279391|Glucocorticoids|glucocorticoids|mesh-ancestor
138969734|NCT05279391|Hormones|hormones|mesh-ancestor
138969735|NCT05279391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138969736|NCT05279391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138969737|NCT05279391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969738|NCT05279391|Anticoagulants|anticoagulants|mesh-ancestor
138969739|NCT05279391|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138969740|NCT05279391|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139002567|NCT02556437|Antibodies|antibodies|mesh-list
139002568|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
139002569|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002570|NCT04946006|Oxytocin|oxytocin|mesh-list
139002571|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
139002572|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139002573|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002574|NCT00775619|Carvedilol|carvedilol|mesh-list
139002575|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139002576|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139002577|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
139002578|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002579|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002580|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969741|NCT05279391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969742|NCT05279391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138969743|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138969744|NCT00789620|Lidocaine|lidocaine|mesh-list
138969745|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
138969746|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
138969747|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138969748|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969749|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
138969750|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969751|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138969752|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138969753|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138969754|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138969755|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969756|NCT03970265|Meropenem|meropenem|mesh-list
138969757|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138969758|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969759|NCT00803894|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
138969760|NCT00803894|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138969761|NCT00803894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969762|NCT00803894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969763|NCT05371925|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
138969764|NCT05371925|Anticoagulants|anticoagulants|mesh-ancestor
138969765|NCT05371925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138969766|NCT05371925|Antimetabolites|antimetabolites|mesh-ancestor
138969767|NCT05371925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969768|NCT05371925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138969769|NCT05371925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138969770|NCT05371925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138969771|NCT05371925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138969772|NCT05371925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969773|NCT00797420|Fluconazole|fluconazole|mesh-list
138969774|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
138969775|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969776|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138969777|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138969778|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969779|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969780|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138969781|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
138969782|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138969783|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002581|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139002582|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
139002583|NCT00775619|Protective Agents|protective agents|mesh-ancestor
139002584|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139002585|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139002586|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139002587|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
139002588|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139002589|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139002590|NCT00775697|Montelukast|montelukast|mesh-list
139002591|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
139002592|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139002593|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
139002594|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
138969784|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138969785|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138969786|NCT00981513|Vaccines|vaccines|mesh-list
138969787|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
138969788|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969789|NCT00872274|Sumatriptan|sumatriptan|mesh-list
138969790|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138969791|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138969792|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138969793|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
138969794|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969795|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969796|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586248|NCT00468364|Insulin|insulin|mesh-list
138969797|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138969799|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138969800|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138969801|NCT00872586|Diuretics|diuretics|mesh-ancestor
138969802|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
138969803|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969804|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138969805|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138969806|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969807|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138969808|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138969809|NCT00726557|Interferons|interferons|mesh-list
138969810|NCT00726557|Ribavirin|ribavirin|mesh-list
138969811|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
138969812|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
138969813|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138932222|NCT05809804|Esketamine|esketamine|mesh-list
138969814|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969815|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
138969816|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969817|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
138969818|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969819|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
138969820|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969821|NCT00803972|Insulin|insulin|mesh-list
138969822|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138969823|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
138969824|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138969825|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969826|NCT00880386|Losartan|losartan|mesh-list
138969827|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138969828|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138969829|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139002595|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139002596|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002597|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139002598|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139002599|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002600|NCT05357066|Nitrous Oxide|nitrous oxide|mesh-list
139002601|NCT05357066|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139002602|NCT05357066|Anesthetics, General|anesthetics, general|mesh-ancestor
139002603|NCT05357066|Anesthetics|anesthetics|mesh-ancestor
139002604|NCT05357066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138969830|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138969831|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969832|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138969833|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138969834|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
138969835|NCT00804050|Vitamins|vitamins|mesh-list
138969836|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
138969837|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969838|NCT00877734|Baclofen|baclofen|mesh-list
138969839|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138969840|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969841|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138969842|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969843|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138969844|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
138969845|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
138969846|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969847|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969848|NCT00981591|Iloprost|iloprost|mesh-list
138969849|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138932253|NCT05809024|Letrozole|letrozole|mesh-list
138969850|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
138969851|NCT00978159|Esomeprazole|esomeprazole|mesh-list
138969852|NCT00978159|Famotidine|famotidine|mesh-list
138969853|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138969854|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138969855|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138969856|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969857|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969858|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138969859|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
138969860|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
138969861|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969862|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586404|NCT06183008|Antibodies|antibodies|mesh-list
138969863|NCT00804206|Bevacizumab|bevacizumab|mesh-list
138969864|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138969865|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969866|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138969867|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138969868|NCT00804206|Growth Substances|growth substances|mesh-ancestor
138969869|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969870|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
138969871|NCT00877812|Glycine|glycine|mesh-list
138969872|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
138969873|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969874|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586451|NCT06182735|Alkylating Agents|alkylating agents|mesh-ancestor
138969875|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969876|NCT00981903|Tinzaparin|tinzaparin|mesh-list
138969877|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138720711|NCT00478023|Morphine|morphine|mesh-list
138969878|NCT00981903|Dalteparin|dalteparin|mesh-list
138969879|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
138969880|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139002605|NCT05357066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002606|NCT05357066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139002607|NCT05357066|Analgesics|analgesics|mesh-ancestor
139002608|NCT05357066|Sensory System Agents|sensory system agents|mesh-ancestor
138932278|NCT05764876|Linezolid|linezolid|mesh-list
139002609|NCT05357066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002610|NCT02556905|Dexamethasone|dexamethasone|mesh-list
139002611|NCT02556905|Lenalidomide|lenalidomide|mesh-list
139002612|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139002613|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
139002614|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
139002615|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002616|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002617|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139002618|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
139002619|NCT02556905|Hormones|hormones|mesh-ancestor
138502984|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138969881|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138969882|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969883|NCT00738881|Pemetrexed|pemetrexed|mesh-list
138969884|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138969885|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969886|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969887|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969888|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138586549|NCT06181695|Dsuvia|dsuvia|mesh-list
138969889|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138969890|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138969891|NCT00657020|Nicotine|nicotine|mesh-list
138969892|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138969893|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
138969894|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969895|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969896|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138969897|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138969898|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
138969899|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969900|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969901|NCT03921723|Dolutegravir|dolutegravir|mesh-list
138969902|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138969903|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138969904|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969905|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969906|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138969907|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138969908|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
138969909|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138969910|NCT00872664|Carotenoids|carotenoids|mesh-list
138969911|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
138969912|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969913|NCT00872664|Protective Agents|protective agents|mesh-ancestor
138969914|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969915|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
138969916|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138969917|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138969918|NCT00878124|Ubiquinone|ubiquinone|mesh-list
138969919|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
138969920|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
138969921|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969922|NCT00878124|Vitamins|vitamins|mesh-ancestor
138969923|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
138969924|NCT00978315|Vitamin D|vitamin d|mesh-list
138969925|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139002620|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139002621|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139002622|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002623|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
139002624|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139002625|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139002626|NCT02556905|Growth Substances|growth substances|mesh-ancestor
139002627|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
139002628|NCT00539006|Fluticasone|fluticasone|mesh-list
139002630|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139002631|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139002632|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
139002633|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002634|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002635|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139002636|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
139002637|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
139002638|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139002639|NCT04047329|Anesthetics|anesthetics|mesh-list
138969926|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969927|NCT00978315|Vitamins|vitamins|mesh-ancestor
138969928|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
138969929|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138969930|NCT00978393|Liraglutide|liraglutide|mesh-list
138969931|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138969932|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969933|NCT00978393|Incretins|incretins|mesh-ancestor
138969934|NCT00978393|Hormones|hormones|mesh-ancestor
138969935|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138969936|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
138969937|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138969938|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969939|NCT04740996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138969940|NCT04740996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969941|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138969942|NCT00872976|Dasatinib|dasatinib|mesh-list
138586633|NCT06181188|Analgesics|analgesics|mesh-ancestor
138969943|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138969944|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
138932356|NCT05610800|Hormones|hormones|mesh-ancestor
138969945|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969946|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969947|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138969948|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969949|NCT00544167|Paclitaxel|paclitaxel|mesh-list
138969950|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
138969951|NCT00544167|Doxorubicin|doxorubicin|mesh-list
138969952|NCT00544167|Sorafenib|sorafenib|mesh-list
138969953|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138969954|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969956|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
138969957|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
138969958|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969959|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138969960|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
139002640|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139002641|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002642|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
139002643|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139002644|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139002645|NCT00537056|Sunitinib|sunitinib|mesh-list
139002646|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139002647|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002648|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139002649|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139002650|NCT00537056|Growth Substances|growth substances|mesh-ancestor
139002651|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002652|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
139002653|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138969961|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969962|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138969963|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138969964|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
138969965|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138969966|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138969967|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138969968|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138969969|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969970|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138969971|NCT00659438|Bicalutamide|bicalutamide|mesh-list
138969972|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
138969973|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
138969974|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138969975|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969976|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969977|NCT05225844|Apatinib|apatinib|mesh-list
138969978|NCT05225844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138969979|NCT05225844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138969980|NCT05225844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138969981|NCT05225844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969982|NCT00878514|Alprazolam|alprazolam|mesh-list
138969983|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138969984|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138969985|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138969986|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138969987|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138969988|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138969989|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
138969990|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
138969991|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138969992|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138969993|NCT00804440|Ibuprofen|ibuprofen|mesh-list
138969994|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138969995|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138969996|NCT00804440|Analgesics|analgesics|mesh-ancestor
138969997|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
138969998|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138969999|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970000|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970001|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138970002|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138970003|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970004|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970005|NCT00880854|Tremelimumab|tremelimumab|mesh-list
139002654|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002655|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002656|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139002657|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
139002658|NCT00779831|Ephedrine|ephedrine|mesh-list
139002659|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138586783|NCT06175390|FAPI-46|fapi-46|mesh-list
138970006|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970007|NCT00543855|Donepezil|donepezil|mesh-list
138970008|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138970009|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970010|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970011|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
138970012|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586835|NCT06161454|Antiviral Agents|antiviral agents|mesh-ancestor
138970013|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970014|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
138970015|NCT00797810|Cytarabine|cytarabine|mesh-list
138970016|NCT00797810|Dexamethasone|dexamethasone|mesh-list
138970017|NCT00797810|Prednisone|prednisone|mesh-list
138970018|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
138970019|NCT00797810|Ifosfamide|ifosfamide|mesh-list
138970020|NCT00797810|Rituximab|rituximab|mesh-list
138970021|NCT00797810|Vincristine|vincristine|mesh-list
138970022|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138970023|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
138970024|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970025|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138970026|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138970027|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
138970028|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970029|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970030|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138970031|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970032|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
138970033|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
138970034|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970035|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138970036|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
138970037|NCT00797810|Hormones|hormones|mesh-ancestor
138970038|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138970039|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138970040|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138970041|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138970042|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
138970043|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
138970044|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970045|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138970046|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
138970047|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
138970048|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
138970049|NCT00873210|Sunitinib|sunitinib|mesh-list
138970050|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970051|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138970052|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138970053|NCT00873210|Growth Substances|growth substances|mesh-ancestor
138970054|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970055|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
138970056|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138970057|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970058|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970059|NCT00978471|Thiotepa|thiotepa|mesh-list
138970060|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138970061|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
138970062|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970063|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970064|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138970065|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138970066|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
138970067|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002661|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002662|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002663|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139002664|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
139002665|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
139002666|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139002667|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139002668|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
139002669|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
139002670|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002671|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002672|NCT00535262|Selegiline|selegiline|mesh-list
138970068|NCT00804674|Bupivacaine|bupivacaine|mesh-list
138970069|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
138970070|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
138970071|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138970072|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970073|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
138970074|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970076|NCT00881088|Nadroparin|nadroparin|mesh-list
138970077|NCT00881088|Fondaparinux|fondaparinux|mesh-list
138970078|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138970080|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138970081|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
138970082|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970083|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970084|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
138970085|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138970086|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138970087|NCT00978549|Docetaxel|docetaxel|mesh-list
138970088|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970089|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
138970090|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
138970091|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
138970092|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970093|NCT00656084|Rituximab|rituximab|mesh-list
138970094|NCT00656084|Gemcitabine|gemcitabine|mesh-list
138970095|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
138970096|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138970097|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970098|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
138970099|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970100|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138932456|NCT05222932|Avelumab|avelumab|mesh-list
138970101|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138970102|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
138970103|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970104|NCT00656084|Analgesics|analgesics|mesh-ancestor
138970105|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
138970106|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970107|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138970108|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138970109|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970111|NCT00881166|Etoposide|etoposide|mesh-list
138970113|NCT00881166|Carboplatin|carboplatin|mesh-list
138970114|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138970115|NCT00881166|Topotecan|topotecan|mesh-list
138970116|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138970117|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970118|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
138970119|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
138970120|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
138970121|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002673|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
139002674|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139002675|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139002676|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139002677|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139002678|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002679|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002680|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139002681|NCT00535262|Protective Agents|protective agents|mesh-ancestor
139002682|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002683|NCT00772499|Atenolol|atenolol|mesh-list
139002684|NCT00772499|Amlodipine|amlodipine|mesh-list
139002685|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139002686|NCT00772499|Olmesartan|olmesartan|mesh-list
139002687|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138970122|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138970123|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138970124|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970125|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138970126|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138970127|NCT00804752|Vitamin D|vitamin d|mesh-list
138970128|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
138970129|NCT00804752|Cholecalciferol|cholecalciferol|mesh-list
138970130|NCT00804752|Vitamins|vitamins|mesh-list
138970131|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
138970132|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970133|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138970134|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138970135|NCT05225766|Bupivacaine|bupivacaine|mesh-list
138970136|NCT05225766|Anesthetics, Local|anesthetics, local|mesh-ancestor
138970137|NCT05225766|Anesthetics|anesthetics|mesh-ancestor
138970138|NCT05225766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138970139|NCT05225766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970140|NCT05225766|Sensory System Agents|sensory system agents|mesh-ancestor
138970141|NCT05225766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970142|NCT00804830|Bevacizumab|bevacizumab|mesh-list
138970143|NCT00804830|Doxorubicin|doxorubicin|mesh-list
138970144|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138970145|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970146|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138970147|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138970148|NCT00804830|Growth Substances|growth substances|mesh-ancestor
138970149|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970150|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
138970151|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138970152|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138970153|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138970154|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970155|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970156|NCT00982215|Acetaminophen|acetaminophen|mesh-list
138970157|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138970158|NCT00982215|Analgesics|analgesics|mesh-ancestor
138970159|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
138970160|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970161|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970162|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
138970163|NCT00613938|Oxycodone|oxycodone|mesh-list
138970164|NCT00613938|Tapentadol|tapentadol|mesh-list
138970165|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138970166|NCT00613938|Narcotics|narcotics|mesh-ancestor
138970167|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138970168|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002688|NCT00772499|Hydralazine|hydralazine|mesh-list
139002689|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139002690|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138970169|NCT00613938|Analgesics|analgesics|mesh-ancestor
138970170|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
138970171|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970172|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138970173|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138970174|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138970175|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970176|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
138970177|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970178|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138970179|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138970180|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970181|NCT00805064|Triamcinolone|triamcinolone|mesh-list
138970182|NCT00805064|Bevacizumab|bevacizumab|mesh-list
138970183|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138970184|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970185|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138970186|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138970187|NCT00805064|Growth Substances|growth substances|mesh-ancestor
138970188|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970189|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
138970190|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970191|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
138970192|NCT00805064|Hormones|hormones|mesh-ancestor
138970193|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138970194|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
138970195|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138970196|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
138970197|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970198|NCT00655928|Expectorants|expectorants|mesh-ancestor
138970199|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
138970200|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138970201|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
138970202|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970203|NCT00655928|Protective Agents|protective agents|mesh-ancestor
138970204|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970205|NCT00655928|Antidotes|antidotes|mesh-ancestor
138970206|NCT00873756|Bevacizumab|bevacizumab|mesh-list
138970207|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138970208|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970209|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138970210|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138970211|NCT00873756|Growth Substances|growth substances|mesh-ancestor
138970212|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970213|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
138970214|NCT00873834|Fluoxetine|fluoxetine|mesh-list
138970215|NCT00873834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138970216|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138970217|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138970218|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970219|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970220|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
138970221|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970222|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138970223|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
138970224|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138970225|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138970226|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138970227|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970228|NCT00655850|Paclitaxel|paclitaxel|mesh-list
138970229|NCT00655850|Gemcitabine|gemcitabine|mesh-list
138970230|NCT00655850|Bevacizumab|bevacizumab|mesh-list
138970231|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138970232|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970233|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
138970234|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
138970235|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
138970236|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002691|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139002692|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002693|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139002694|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002695|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
139002696|NCT00772499|Diuretics|diuretics|mesh-ancestor
139002697|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
139002698|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139002699|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139002700|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139002701|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139002702|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
139002703|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
138970237|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138970238|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
138970239|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138970240|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138970241|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138970242|NCT00655850|Growth Substances|growth substances|mesh-ancestor
138970243|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970244|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
138970245|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
138970246|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970247|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970248|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
138970249|NCT00805298|Epinephrine|epinephrine|mesh-list
138970250|NCT00805298|Racepinephrine|racepinephrine|mesh-list
138970251|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
138970252|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970254|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
138970255|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721081|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
138970256|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970257|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138970258|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
138970260|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138970261|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138970262|NCT00805298|Protective Agents|protective agents|mesh-ancestor
138970263|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138970264|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138970265|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
138970266|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970267|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970268|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138970269|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138970270|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138970271|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
138970272|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
138970273|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
138970274|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138970275|NCT00881400|Cefprozil|cefprozil|mesh-list
138970276|NCT00881400|Cephalosporins|cephalosporins|mesh-list
138970277|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138970278|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970279|NCT00246571|Sunitinib|sunitinib|mesh-list
138970280|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970281|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138970282|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138970283|NCT00246571|Growth Substances|growth substances|mesh-ancestor
138970284|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587350|NCT05548582|Acetaminophen|acetaminophen|mesh-list
139002704|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002705|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139002706|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139002707|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139002708|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
139002709|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002710|NCT00989690|Docetaxel|docetaxel|mesh-list
139002711|NCT00989690|Pemetrexed|pemetrexed|mesh-list
139002712|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139002713|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002714|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
139002715|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
139002716|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
139002717|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002718|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002719|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139002720|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139002721|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139002722|NCT00074581|Ritonavir|ritonavir|mesh-list
139002723|NCT00074581|Lopinavir|lopinavir|mesh-list
139002724|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139002725|NCT00074581|Tenofovir|tenofovir|mesh-list
139002726|NCT00074581|Lamivudine|lamivudine|mesh-list
139002727|NCT00074581|Emtricitabine|emtricitabine|mesh-list
139002728|NCT00074581|Zidovudine|zidovudine|mesh-list
139002729|NCT00074581|Nevirapine|nevirapine|mesh-list
138753500|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
139002730|NCT00074581|Didanosine|didanosine|mesh-list
139002731|NCT00074581|Stavudine|stavudine|mesh-list
139002732|NCT00074581|Efavirenz|efavirenz|mesh-list
139002733|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139002734|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139002735|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
139002736|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002737|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002738|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139002747|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139002748|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139002749|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139002750|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139002751|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139002752|NCT00776477|Aspirin|aspirin|mesh-list
139002753|NCT00776477|Clopidogrel|clopidogrel|mesh-list
139002754|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139002755|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139002756|NCT00776477|Analgesics|analgesics|mesh-ancestor
139002757|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
139002758|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002759|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002760|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139002761|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139002762|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139002763|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139002764|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002765|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139002766|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139002767|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002768|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
139002769|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139002770|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139002771|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139002772|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
139002773|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002774|NCT00772655|Rituximab|rituximab|mesh-list
139002775|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139002776|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002777|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
139002778|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002779|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139002780|NCT00776633|Aspirin|aspirin|mesh-list
139002781|NCT00776633|Clopidogrel|clopidogrel|mesh-list
139002786|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002787|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002788|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139002789|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139002790|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139002791|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139002792|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002793|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139002794|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139002795|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002796|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
138970285|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
138970286|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138970287|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970288|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970290|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
138970291|NCT02553044|Vitamins|vitamins|mesh-ancestor
138970292|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
138970293|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970294|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138970295|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138970296|NCT00545103|Mesalamine|mesalamine|mesh-list
138970297|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138970298|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138970299|NCT00545103|Analgesics|analgesics|mesh-ancestor
138970300|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
138970301|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970302|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970303|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970304|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138970305|NCT00586157|Methylphenidate|methylphenidate|mesh-list
138970306|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138970307|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970308|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138970309|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138970310|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138970311|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970312|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
138970313|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970314|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
138970315|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970316|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
138970318|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138970319|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970320|NCT00809744|Vitamins|vitamins|mesh-ancestor
138970321|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
138970322|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138970323|NCT00246337|Rizatriptan|rizatriptan|mesh-list
138970324|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138970325|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
138970326|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970327|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970328|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970329|NCT01581853|Ritonavir|ritonavir|mesh-list
138970330|NCT01581853|Lopinavir|lopinavir|mesh-list
138970331|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138970332|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138970333|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
138970334|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970335|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970337|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138970338|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
139002797|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139002798|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139002799|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139002800|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
139002801|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002802|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139002803|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139002804|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970339|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970340|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138970341|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138970342|NCT01070641|Carvedilol|carvedilol|mesh-list
138970343|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138970344|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138970345|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
138970346|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970347|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970348|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970349|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138970350|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
138970351|NCT01070641|Protective Agents|protective agents|mesh-ancestor
138970352|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138970353|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138970354|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138970355|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
138970356|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138970357|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138970358|NCT00982449|Fialuridine|fialuridine|mesh-list
138970359|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
138587560|NCT05302388|Methylprednisolone|methylprednisolone|mesh-list
138970361|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138970362|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970363|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970364|NCT02593721|Ibuprofen|ibuprofen|mesh-list
138970365|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138970366|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138970367|NCT02593721|Analgesics|analgesics|mesh-ancestor
138970368|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
138970369|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970370|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970371|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970372|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138970373|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138970374|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970375|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970376|NCT00985647|Lamivudine|lamivudine|mesh-list
138970377|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138970378|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138970379|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970380|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970381|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
138970382|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970383|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138970384|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138970385|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138970386|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
138970387|NCT00806468|Coagulants|coagulants|mesh-ancestor
138970388|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138970389|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
138970390|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970391|NCT00982527|Fenoldopam|fenoldopam|mesh-list
138970392|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138970393|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
138970394|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
138970395|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
139002805|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139002806|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139002807|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139002808|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002811|NCT03961087|Ubiquinone|ubiquinone|mesh-list
139002812|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
139002813|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
139002814|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
139002815|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002816|NCT03961087|Vitamins|vitamins|mesh-ancestor
138970396|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970397|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970398|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970399|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
138970400|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138970401|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
138970402|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138970403|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970405|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138970406|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138970407|NCT00725621|Infliximab|infliximab|mesh-list
138970408|NCT00725621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138970409|NCT00725621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970410|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
138970411|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138970412|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138970413|NCT00613626|Etoposide|etoposide|mesh-list
138970414|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970415|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138970416|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138970417|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138970418|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970419|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970420|NCT00725543|Infliximab|infliximab|mesh-list
138970421|NCT00725543|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138970422|NCT00725543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970423|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
138970424|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138970425|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138970426|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
138970427|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138970428|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970429|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138970430|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
138970431|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138970432|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970433|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970434|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970435|NCT00616434|Interferons|interferons|mesh-list
138970436|NCT00616434|Interferon-beta|interferon-beta|mesh-list
138970437|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
138970438|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970439|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
138970440|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970441|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
138970442|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970443|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138970444|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138970445|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970446|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138970447|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970448|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970449|NCT00257725|Methylphenidate|methylphenidate|mesh-list
139002817|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139002818|NCT03961087|Protective Agents|protective agents|mesh-ancestor
139002819|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
139002820|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
139002821|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139002822|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139002823|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002824|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139002825|NCT03960775|Analgesics|analgesics|mesh-ancestor
139002826|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
138503762|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
138970450|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138970451|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970452|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138970453|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138970454|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138970455|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970456|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
138970457|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970458|NCT00544869|Tolvaptan|tolvaptan|mesh-list
138970459|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138970460|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970461|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
138970462|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970463|NCT02593643|Midazolam|midazolam|mesh-list
138970464|NCT02593643|Ketamine|ketamine|mesh-list
138970465|NCT02593643|Analgesics|analgesics|mesh-ancestor
138970466|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
138970467|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970468|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970469|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138970470|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138970471|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
138970472|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
138970473|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138970474|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138970475|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138970476|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138932690|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138970477|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970478|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138970479|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138970480|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138970481|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138970482|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138970483|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
138970484|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
138970485|NCT00881556|Fludarabine|fludarabine|mesh-list
138970486|NCT00881556|Busulfan|busulfan|mesh-list
138970487|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
138970488|NCT00881556|Lorazepam|lorazepam|mesh-list
138970489|NCT00881556|Tacrolimus|tacrolimus|mesh-list
138970490|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970491|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970492|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138970493|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
138970494|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970495|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138970496|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970497|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
138970498|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138970499|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138970500|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138970502|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
138970503|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
138932716|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002827|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002828|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139002829|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139002830|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139002831|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
139002832|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002833|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002834|NCT00536978|Cytarabine|cytarabine|mesh-list
139002835|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
139002836|NCT00536978|Melphalan|melphalan|mesh-list
139002837|NCT00536978|Carmustine|carmustine|mesh-list
139002838|NCT00536978|Rituximab|rituximab|mesh-list
139002839|NCT00536978|Methotrexate|methotrexate|mesh-list
139002840|NCT00536978|Fludarabine|fludarabine|mesh-list
139002841|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
139002842|NCT00536978|Etoposide|etoposide|mesh-list
139002843|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
139002844|NCT00536978|Tacrolimus|tacrolimus|mesh-list
139002845|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139002846|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
139002847|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970504|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970505|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138970506|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138970507|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138970508|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138970509|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138970510|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138970511|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
138970512|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
138970513|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970514|NCT00881634|Cetirizine|cetirizine|mesh-list
138970515|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
138970516|NCT00881634|Ephedrine|ephedrine|mesh-list
138970517|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138970518|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138970519|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138970520|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
138970521|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
138588027|NCT04466618|Heparin|heparin|mesh-list
138970522|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970523|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970524|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970525|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138970526|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
138970527|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970528|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138970529|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
138970530|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
138970531|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138970532|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138970533|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
138970534|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
138970535|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
138970536|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138970537|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138970538|NCT00878670|Analgesics|analgesics|mesh-ancestor
138970539|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
139002848|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138932766|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138932767|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
138932768|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932769|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
138932770|NCT04202692|Protective Agents|protective agents|mesh-ancestor
138932771|NCT04202692|Antacids|antacids|mesh-ancestor
138932774|NCT04177758|Vitamin D|vitamin d|mesh-list
139002849|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139002850|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
139002851|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002852|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002853|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139002854|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139002855|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139002856|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
139002857|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139002858|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139002859|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
139002860|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
138970540|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970541|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970542|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138588056|NCT04401059|Gefitinib|gefitinib|mesh-list
138970543|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138970544|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138970545|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
138970546|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970547|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138970548|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
138970549|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138970550|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138970551|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138721386|NCT01125046|Bevacizumab|bevacizumab|mesh-list
138970552|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138970553|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970554|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970555|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970556|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138970557|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
138970558|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138970560|NCT00652028|Fentanyl|fentanyl|mesh-list
138970561|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
138970562|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138970563|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138970564|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970565|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138970567|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
138970568|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970569|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138970570|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138970571|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138970572|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
138970573|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970574|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970575|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138970576|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138970577|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138970578|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138970579|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138970580|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
138970581|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
138584738|NCT04517227|Durvalumab|durvalumab|mesh-list
138932800|NCT04150458|Choline|choline|mesh-list
138932801|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
138932802|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138932803|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
138970582|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
138970583|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
138970584|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138970585|NCT00652028|Narcotics|narcotics|mesh-ancestor
138970586|NCT00799136|Prednisone|prednisone|mesh-list
139002861|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002862|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139002863|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139002864|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
139002865|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139002866|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139002867|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139002868|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139002869|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139002870|NCT03809611|Choline|choline|mesh-list
139002871|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
139002872|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139002873|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
139002874|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002875|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139002876|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139002877|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
139002878|NCT05360342|Vitamins|vitamins|mesh-list
139002879|NCT05360342|Vitamin K|vitamin k|mesh-list
138970587|NCT00799136|Vincristine|vincristine|mesh-list
138970588|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970589|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
138970590|NCT00799136|Hormones|hormones|mesh-ancestor
138970591|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138970592|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970593|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138970594|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588164|NCT04234048|Protective Agents|protective agents|mesh-ancestor
138970595|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138970597|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
138970598|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
138970599|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970600|NCT02592395|Folfirinox|folfirinox|mesh-list
138970601|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970602|NCT00799214|Metronidazole|metronidazole|mesh-list
138970603|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970604|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138970605|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138970606|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138970607|NCT00733421|Etoricoxib|etoricoxib|mesh-list
138970608|NCT00733421|Tramadol|tramadol|mesh-list
138970609|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138970610|NCT00733421|Narcotics|narcotics|mesh-ancestor
138970611|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138970612|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970613|NCT00733421|Analgesics|analgesics|mesh-ancestor
138970614|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
138970615|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970616|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138970617|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138970618|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138932808|NCT04147208|Ritonavir|ritonavir|mesh-list
138970619|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138970620|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138970621|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138970622|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970623|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970624|NCT00613080|Leucovorin|leucovorin|mesh-list
138970625|NCT00613080|Capecitabine|capecitabine|mesh-list
139002880|NCT05360342|Vitamin K 1|vitamin k 1|mesh-list
139002881|NCT05360342|Micronutrients|micronutrients|mesh-ancestor
139002882|NCT05360342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002883|NCT05360342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139002884|NCT05360342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139002885|NCT05360342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002886|NCT05360342|Hemostatics|hemostatics|mesh-ancestor
139002887|NCT05360342|Coagulants|coagulants|mesh-ancestor
139002888|NCT05290220|Lenvatinib|lenvatinib|mesh-list
139002889|NCT05290220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002890|NCT05290220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139002891|NCT05290220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002892|NCT05290220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002893|NCT04026230|Atorvastatin|atorvastatin|mesh-list
139002894|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139002895|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139002896|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
139002897|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002898|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139002899|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139002900|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002901|NCT00536510|Niacin|niacin|mesh-list
139002902|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139002903|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
138504003|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138970626|NCT00613080|Fluorouracil|fluorouracil|mesh-list
138970627|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
138970628|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138970629|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
138970630|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970631|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970632|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138970633|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
138970634|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970635|NCT00613080|Antidotes|antidotes|mesh-ancestor
138970636|NCT00613080|Protective Agents|protective agents|mesh-ancestor
138970637|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
138970638|NCT00613080|Vitamins|vitamins|mesh-ancestor
138970639|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
138970640|NCT00917891|Dapivirine|dapivirine|mesh-list
138970641|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138970642|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138970643|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
138970644|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970645|NCT00732875|Infliximab|infliximab|mesh-list
138970646|NCT00732875|Methotrexate|methotrexate|mesh-list
138970647|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138970648|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
138970649|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138970650|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970651|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138970652|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
139002904|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002905|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139002906|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
139002907|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
139002908|NCT00536510|Vitamins|vitamins|mesh-ancestor
139002909|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
139002910|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002911|NCT04424264|Tenofovir|tenofovir|mesh-list
139002912|NCT04424264|Lamivudine|lamivudine|mesh-list
139002913|NCT04424264|Emtricitabine|emtricitabine|mesh-list
139002914|NCT04424264|Efavirenz|efavirenz|mesh-list
139039558|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039546|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138970653|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970654|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970656|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970657|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138970658|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138970659|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
138970660|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138970661|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138970662|NCT00732875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138970663|NCT00732875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970664|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138970665|NCT00881790|Fluorides|fluorides|mesh-list
138970666|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
138970667|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
138970668|NCT00881790|Protective Agents|protective agents|mesh-ancestor
138970669|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970670|NCT00810446|Rifabutin|rifabutin|mesh-list
138970671|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138970672|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970673|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138970674|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
138970675|NCT00810524|Lamivudine|lamivudine|mesh-list
138970676|NCT00810524|Adefovir|adefovir|mesh-list
138970677|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138970678|NCT00810524|Telbivudine|telbivudine|mesh-list
138970679|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138970680|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138970681|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970682|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970683|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
138970684|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970685|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138970686|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138970687|NCT00810680|Valproic Acid|valproic acid|mesh-list
138970688|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
138970689|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970690|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970691|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
138970692|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970693|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970694|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
138970695|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138970696|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138970697|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138970698|NCT00799448|Insulin|insulin|mesh-list
138970699|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138970700|NCT00799448|Repaglinide|repaglinide|mesh-list
138970701|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
138970702|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
138970703|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
138970704|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138970705|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970706|NCT00806936|Insulin|insulin|mesh-list
139002915|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139002916|NCT04424264|Rifampin|rifampin|mesh-list
139002917|NCT04424264|Isoniazid|isoniazid|mesh-list
139002918|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
139002919|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139002920|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139002921|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139002922|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002923|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002924|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139002925|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139002926|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139002927|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139002928|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138970707|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138970708|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138970709|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970710|NCT00799682|Travoprost|travoprost|mesh-list
138970711|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138970712|NCT00799682|Latanoprost|latanoprost|mesh-list
138970713|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138970714|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138970715|NCT03829020|Metformin|metformin|mesh-list
138970716|NCT03829020|Nelfinavir|nelfinavir|mesh-list
138970717|NCT03829020|Bortezomib|bortezomib|mesh-list
138970718|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138970719|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970720|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970721|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138970722|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138970723|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
138970724|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970725|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970726|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138970727|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138970728|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
138970729|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970730|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138970731|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
138970732|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138970733|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
138970734|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970735|NCT00874926|Factor VIII|factor viii|mesh-list
138970736|NCT00874926|Coagulants|coagulants|mesh-ancestor
138970737|NCT00810914|Bupivacaine|bupivacaine|mesh-list
138970738|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
138970739|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
138970740|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138970741|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970742|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
138970743|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970744|NCT00878904|Epirubicin|epirubicin|mesh-list
138970746|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138970747|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970748|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138970749|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138970750|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970751|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970752|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138970753|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
139002929|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139002930|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139002931|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139002932|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139002933|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
139002934|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139002935|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
138504185|NCT00001181|Testolactone|testolactone|mesh-list
138970754|NCT00737711|Hematinics|hematinics|mesh-ancestor
138970755|NCT00807326|Simethicone|simethicone|mesh-list
138970756|NCT00807326|Loperamide|loperamide|mesh-list
138970757|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
138588522|NCT03179904|Letrozole|letrozole|mesh-list
138970758|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138970759|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
138970760|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970761|NCT00807326|Emollients|emollients|mesh-ancestor
138970762|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
138970763|NCT00875082|Montelukast|montelukast|mesh-list
138970764|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138970765|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
138970766|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138970767|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
138970768|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138970769|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970770|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138970771|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138970772|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970774|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138970775|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138970776|NCT02552342|Prednisolone|prednisolone|mesh-list
138970777|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
138970778|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138970779|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
138970780|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970781|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
138970782|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
138970783|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970784|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970785|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138970786|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
138970787|NCT02552342|Hormones|hormones|mesh-ancestor
138970788|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138970789|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138970790|NCT02552342|Protective Agents|protective agents|mesh-ancestor
138970791|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138970792|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970793|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138970794|NCT00811226|Olmesartan|olmesartan|mesh-list
138970795|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138970796|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138970797|NCT00811226|Diuretics|diuretics|mesh-ancestor
138970798|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
138970799|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970800|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138932955|NCT06063473|Trifarotene|trifarotene|mesh-list
138970801|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138970802|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970803|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138970804|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138970805|NCT00238303|Vorinostat|vorinostat|mesh-list
138970806|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970807|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138970808|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970809|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588703|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
138970810|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139002936|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139002937|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139002938|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139002939|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139002940|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139002941|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
139002942|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139002943|NCT00398086|Paclitaxel|paclitaxel|mesh-list
139002944|NCT00398086|Gemcitabine|gemcitabine|mesh-list
139002945|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139002946|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139002947|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002948|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
139002949|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
139002950|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
139002951|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002952|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139002953|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
138970811|NCT00811460|Incretins|incretins|mesh-ancestor
138970813|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138970814|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970815|NCT00875238|Doxorubicin|doxorubicin|mesh-list
138970816|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138970817|NCT00875238|Trastuzumab|trastuzumab|mesh-list
138970818|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138588764|NCT02225405|Cisplatin|cisplatin|mesh-list
138970819|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970820|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138970821|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138970822|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970823|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970824|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138970825|NCT00732251|Allopurinol|allopurinol|mesh-list
138970826|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
138970827|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970828|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970829|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
138970830|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138970831|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138970832|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
138970833|NCT00732251|Protective Agents|protective agents|mesh-ancestor
138970834|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970835|NCT00882024|Tranilast|tranilast|mesh-list
138970836|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138970837|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138970838|NCT00882024|Analgesics|analgesics|mesh-ancestor
138970839|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
138970840|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970841|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970842|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970843|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138970844|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138588884|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138970846|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970847|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138970848|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139002954|NCT04364360|Sulforaphane|sulforaphane|mesh-list
139002955|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139002956|NCT04364360|Protective Agents|protective agents|mesh-ancestor
139002957|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002958|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002959|NCT00536198|Sertraline|sertraline|mesh-list
139002960|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
139002962|NCT00536198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139002963|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139002964|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139002965|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970849|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
138970850|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
138970851|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970852|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138970853|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138970854|NCT00799760|Oseltamivir|oseltamivir|mesh-list
138970855|NCT00799760|Zanamivir|zanamivir|mesh-list
138970856|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
138970857|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970858|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970859|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970860|NCT00799838|Amoxicillin|amoxicillin|mesh-list
138588952|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
138970862|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138970863|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970864|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138970865|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138970866|NCT00799838|Analgesics|analgesics|mesh-ancestor
138970867|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
138970868|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970869|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970870|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138970871|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138970872|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138970874|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970875|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
138970876|NCT00737477|Hematinics|hematinics|mesh-ancestor
138970877|NCT00800150|Fludarabine|fludarabine|mesh-list
138970878|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
138970879|NCT00800150|Melphalan|melphalan|mesh-list
138970880|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970881|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138970882|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
138970883|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970884|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138970885|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
138970886|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970887|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138970888|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
138970889|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138970890|NCT00800306|Simendan|simendan|mesh-list
138970891|NCT00800306|Dobutamine|dobutamine|mesh-list
138970892|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138970893|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
138970894|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138970895|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138970896|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970897|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970898|NCT00800306|Protective Agents|protective agents|mesh-ancestor
138970899|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970900|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
138970901|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
139002967|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
139002968|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002969|NCT00393484|Lamivudine|lamivudine|mesh-list
139002970|NCT00393484|Entecavir|entecavir|mesh-list
139002971|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139002972|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139002973|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002974|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002975|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
139002976|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139002977|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139002978|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139002979|NCT00667823|Macitentan|macitentan|mesh-list
139002980|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139002981|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139002982|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002983|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139002984|NCT00536120|Natalizumab|natalizumab|mesh-list
139002985|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
139002986|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
139002987|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002988|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139002989|NCT00057811|Leucovorin|leucovorin|mesh-list
139002990|NCT00057811|Cytarabine|cytarabine|mesh-list
138970902|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970903|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138970904|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138970905|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138970906|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
138970907|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970908|NCT01581775|Valproic Acid|valproic acid|mesh-list
138970909|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
138970910|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970911|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970912|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
138970913|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138970914|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970915|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
138970916|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138970917|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138970918|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138970919|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138970920|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970921|NCT01072747|Heparin|heparin|mesh-list
138970922|NCT01072747|Calcium heparin|calcium heparin|mesh-list
138970923|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
138970924|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138970925|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138970926|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970927|NCT00879372|Tianeptine|tianeptine|mesh-list
139002991|NCT00057811|Prednisone|prednisone|mesh-list
139002992|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
139002993|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139002994|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139002995|NCT00057811|Prednisolone|prednisolone|mesh-list
139002996|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
139002997|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
139002998|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139002999|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139003000|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139003001|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
139003002|NCT00057811|Rituximab|rituximab|mesh-list
139003003|NCT00057811|Doxorubicin|doxorubicin|mesh-list
139003004|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139003005|NCT00057811|Methotrexate|methotrexate|mesh-list
139003006|NCT00057811|Etoposide|etoposide|mesh-list
139003007|NCT00057811|Vincristine|vincristine|mesh-list
139003008|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
139003009|NCT00057811|Rasburicase|rasburicase|mesh-list
139003010|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139003011|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
139003012|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
138970928|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138970929|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
138970930|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138970931|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
138970932|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138970933|NCT00731783|Mupirocin|mupirocin|mesh-list
138970934|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138970935|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970936|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
138970937|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
138970938|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138970939|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138970940|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970941|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970942|NCT02592083|Tamoxifen|tamoxifen|mesh-list
138970943|NCT02592083|Goserelin|goserelin|mesh-list
138970944|NCT02592083|Palbociclib|palbociclib|mesh-list
138970945|NCT02592083|Exemestane|exemestane|mesh-list
138970946|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138970947|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138970948|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
138970949|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138970950|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970951|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138970952|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138970953|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138970955|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138970956|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138970957|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970958|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970959|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138970960|NCT04589676|Naloxone|naloxone|mesh-list
138970961|NCT04589676|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138970962|NCT04589676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970963|NCT04589676|Sensory System Agents|sensory system agents|mesh-ancestor
138589378|NCT00471640|Dexamethasone|dexamethasone|mesh-list
139003013|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139003014|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
139003015|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003016|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139003017|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139003018|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
139003019|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003020|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003021|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139003022|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139003023|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139003024|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139003025|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139003026|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003027|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139003028|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
139003029|NCT00057811|Hormones|hormones|mesh-ancestor
139003030|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139003031|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139003032|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139003033|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
138970964|NCT04589676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138970965|NCT00724451|Ribavirin|ribavirin|mesh-list
138970966|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138970967|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138970968|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
138970969|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970970|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
138970971|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970972|NCT00724373|Ribavirin|ribavirin|mesh-list
138970973|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138970974|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
138970975|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970976|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
138970977|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970978|NCT02594579|Vitamin D|vitamin d|mesh-list
138970979|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
138970980|NCT02594579|Vitamins|vitamins|mesh-ancestor
138970981|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
138970982|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138970983|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138970984|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138970985|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138970986|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138970987|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138970988|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138970989|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138970990|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
138970991|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138970992|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138970993|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139003034|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139003035|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139003036|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
139003037|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
139003038|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139003039|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139003040|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139003041|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
139003042|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003043|NCT00057811|Antidotes|antidotes|mesh-ancestor
139003044|NCT00057811|Protective Agents|protective agents|mesh-ancestor
139003045|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
139003047|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
139003048|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
139003049|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
139003050|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
139003051|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
139003052|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
139003053|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003054|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139003055|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139003056|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
139003057|NCT03502148|Cisplatin|cisplatin|mesh-list
138970994|NCT00724061|Interferons|interferons|mesh-list
138970995|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
138970996|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
138970997|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138970998|NCT00724061|Furocoumarins|furocoumarins|mesh-list
138970999|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971000|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
138971001|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589494|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
138971002|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
138971003|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971004|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
138971005|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138971007|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138887228|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138971008|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971009|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138971010|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138971011|NCT02594423|Growth Substances|growth substances|mesh-ancestor
138971012|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971013|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
138971014|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
138971015|NCT00882414|Hematinics|hematinics|mesh-ancestor
138971016|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138971017|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138971018|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138589550|NCT00149877|Tegaserod|tegaserod|mesh-list
138971020|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971021|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138971022|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138971023|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003058|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003059|NCT02530801|Bevacizumab|bevacizumab|mesh-list
139003060|NCT02530801|Fluorouracil|fluorouracil|mesh-list
139003061|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139003062|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003063|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139003064|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139003065|NCT02530801|Growth Substances|growth substances|mesh-ancestor
139003066|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003067|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
139003068|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
139003069|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003070|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139003071|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139003072|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
139003073|NCT01091077|Naringenin|naringenin|mesh-list
138504594|NCT00001343|Hormones|hormones|mesh-ancestor
138971024|NCT00875784|Sumatriptan|sumatriptan|mesh-list
138971025|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138971026|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138971027|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138971028|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
138971029|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971030|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971031|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971032|NCT00731549|Aripiprazole|aripiprazole|mesh-list
138971033|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
138971034|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138971035|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138971036|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138971037|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971038|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971039|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
138971040|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
138971041|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971042|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971043|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138971044|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138971045|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
138971046|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138971047|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138971048|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138971049|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138971050|NCT00882570|Cefdinir|cefdinir|mesh-list
138971051|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138971052|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138971053|NCT00882882|Metformin|metformin|mesh-list
138971054|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138589735|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
138971055|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971056|NCT00882960|Fentanyl|fentanyl|mesh-list
138971057|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138971058|NCT00882960|Narcotics|narcotics|mesh-ancestor
138971059|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971060|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971061|NCT00882960|Analgesics|analgesics|mesh-ancestor
138971062|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
138971063|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971064|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139003074|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139003075|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139003076|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139003077|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
139003078|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139003079|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003080|NCT01094275|Omeprazole|omeprazole|mesh-list
139003081|NCT01094275|Clopidogrel|clopidogrel|mesh-list
139003082|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139003083|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139003084|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139003085|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139003086|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
138971065|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138971066|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
138971067|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
138971068|NCT00883194|Ropivacaine|ropivacaine|mesh-list
138971069|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
138971070|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
138971071|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971072|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971073|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
138971074|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971075|NCT00888732|Insulin|insulin|mesh-list
138971076|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138971077|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
138971078|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
138971079|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138971080|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138971081|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971082|NCT00730925|Paclitaxel|paclitaxel|mesh-list
138971083|NCT00730925|Afatinib|afatinib|mesh-list
138971084|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138971085|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971086|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
138971087|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
138971088|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
138971089|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971090|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138971091|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971093|NCT00236899|Docetaxel|docetaxel|mesh-list
138971094|NCT00236899|Gemcitabine|gemcitabine|mesh-list
138971095|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138971096|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971097|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
138971098|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
138971099|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
138971100|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971101|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138971102|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
138971103|NCT00611130|Vigabatrin|vigabatrin|mesh-list
138971104|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
138971105|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971106|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971107|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
138971108|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971109|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971110|NCT00885690|Olanzapine|olanzapine|mesh-list
138971111|NCT00885690|Sertindole|sertindole|mesh-list
138971112|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
138971113|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
138589841|NCT00509743|Analgesics|analgesics|mesh-ancestor
138971114|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003087|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003088|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003089|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003090|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139003091|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139003092|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139003093|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003094|NCT01089205|Metformin|metformin|mesh-list
139003095|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139003096|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003097|NCT02866682|Tacrolimus|tacrolimus|mesh-list
139003098|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139003099|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
139003100|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003101|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139003102|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003103|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003104|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
139003105|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139003106|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
139003107|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003108|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933277|NCT05204641|Levodopa|levodopa|mesh-list
139003109|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139003110|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
139003111|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139003112|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
139003113|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971115|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971116|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138971117|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138971118|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138971119|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971120|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138971121|NCT00885690|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138971122|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138971123|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138971124|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971125|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971126|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
138971127|NCT00888810|Topotecan|topotecan|mesh-list
138971128|NCT00888810|Lapatinib|lapatinib|mesh-list
138589896|NCT00338221|Glycine|glycine|mesh-list
138971129|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138971130|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138971131|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971132|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003114|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003115|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139003116|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
139003117|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
139003118|NCT01089439|Protective Agents|protective agents|mesh-ancestor
139003119|NCT00992030|Rituximab|rituximab|mesh-list
139003120|NCT00992030|Doxorubicin|doxorubicin|mesh-list
139003121|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139003122|NCT00992030|Dacarbazine|dacarbazine|mesh-list
139003123|NCT00992030|Bleomycin|bleomycin|mesh-list
139003124|NCT00992030|Vinblastine|vinblastine|mesh-list
139003125|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139003126|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003127|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
139003128|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003129|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139003130|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139003131|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139003132|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139003133|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003134|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003135|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139003136|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
139003137|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139003138|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
139003139|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
138971133|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971134|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138971135|NCT00256243|Paclitaxel|paclitaxel|mesh-list
138971136|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
138971137|NCT00256243|Carboplatin|carboplatin|mesh-list
138971138|NCT00256243|Doxorubicin|doxorubicin|mesh-list
138971139|NCT00256243|Trastuzumab|trastuzumab|mesh-list
138933307|NCT05117489|Cortisone|cortisone|mesh-list
138971140|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138971141|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971142|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
138971143|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
138971144|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
138971145|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971146|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138971147|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
138971148|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971149|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138589955|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971150|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138971151|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
138971152|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138971153|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138971154|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138971155|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139003140|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
139003141|NCT01976390|Sirolimus|sirolimus|mesh-list
139003142|NCT01976390|Everolimus|everolimus|mesh-list
139003143|NCT01976390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139003144|NCT01976390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139003145|NCT01976390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003146|NCT01976390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003147|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139003148|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
138971156|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971157|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138971159|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138971160|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138590010|NCT00150384|Amlodipine|amlodipine|mesh-list
138971161|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138971162|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971163|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971165|NCT02541708|Hematinics|hematinics|mesh-ancestor
138971166|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
138971167|NCT02541708|Vitamins|vitamins|mesh-ancestor
138971168|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
138971169|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971170|NCT03973567|Norepinephrine|norepinephrine|mesh-list
138971171|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
138971172|NCT03973567|Serotonin|serotonin|mesh-list
138971173|NCT03973567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138933331|NCT04976088|Diclofenac|diclofenac|mesh-list
138971174|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138971175|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138971176|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
138971177|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971178|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971179|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971180|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138971181|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138971182|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
138971183|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
138971184|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
138971185|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971186|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138971187|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138971188|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138971189|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138971190|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
138971191|NCT00885924|Coagulants|coagulants|mesh-ancestor
138971192|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138971193|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
138971194|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971195|NCT01071889|Flumazenil|flumazenil|mesh-list
138971196|NCT01071889|Antidotes|antidotes|mesh-ancestor
138971197|NCT01071889|Protective Agents|protective agents|mesh-ancestor
138971198|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971199|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
138971200|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
138971201|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039547|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971202|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971203|NCT03973411|Ondansetron|ondansetron|mesh-list
138971204|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
138971205|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
138971206|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971207|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971208|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138971209|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
138971210|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
138971211|NCT03973411|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138971212|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138971213|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
138971214|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003149|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003150|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003151|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139003152|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003153|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139003154|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
139003156|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139003157|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
139003158|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003159|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003160|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
139003161|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139003162|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139003163|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139003164|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003165|NCT00780377|Bradykinin|bradykinin|mesh-list
139003166|NCT00780377|Kininogens|kininogens|mesh-list
139003167|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
139003168|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139003169|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
139003170|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003171|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003172|NCT05219942|Insulin|insulin|mesh-list
139003173|NCT05219942|Insulin Glargine|insulin glargine|mesh-list
139003174|NCT05219942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139003175|NCT05219942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003176|NCT00669617|Fluticasone|fluticasone|mesh-list
139003178|NCT00669617|Albuterol|albuterol|mesh-list
139003179|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138753942|NCT01200342|Paclitaxel|paclitaxel|mesh-list
139003194|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003195|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
139003196|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139003197|NCT03979352|Empagliflozin|empagliflozin|mesh-list
139003198|NCT03979352|Pancrelipase|pancrelipase|mesh-list
139003199|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139003200|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003201|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139003202|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504904|NCT00001457|Lamivudine|lamivudine|mesh-list
138971215|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971216|NCT00883506|Lisinopril|lisinopril|mesh-list
138971217|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138971218|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
138971219|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971220|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971221|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138971222|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138971223|NCT00883506|Protective Agents|protective agents|mesh-ancestor
138971224|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971226|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971227|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138971228|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971229|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971230|NCT00889044|Clopidogrel|clopidogrel|mesh-list
138971231|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138971232|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138971233|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138590309|NCT00511225|Vitamins|vitamins|mesh-ancestor
138971234|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138971235|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
138971236|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971237|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971238|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971239|NCT00886002|Fentanyl|fentanyl|mesh-list
138971240|NCT00886002|Buprenorphine|buprenorphine|mesh-list
138971241|NCT00886002|Naloxone|naloxone|mesh-list
138971242|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138971243|NCT00886002|Narcotics|narcotics|mesh-ancestor
138971244|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971245|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971247|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
138971248|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971249|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138971250|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138971251|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
138971252|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
138971253|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138971254|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
138971255|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138971256|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
138971257|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138971258|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971259|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138971260|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138971261|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138971262|NCT00883818|Azithromycin|azithromycin|mesh-list
138971263|NCT00883818|Doxycycline|doxycycline|mesh-list
138971264|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138971265|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138971266|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
138971267|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138971268|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138971269|NCT00889356|Clindamycin|clindamycin|mesh-list
139003203|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139003204|NCT00773201|Sotalol|sotalol|mesh-list
139003205|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139003206|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139003207|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
139003208|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003209|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003210|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003211|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139003212|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
139003213|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
139003214|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971270|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
138971271|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
138971272|NCT00889356|Amphotericin B|amphotericin b|mesh-list
138971273|NCT00889356|Tetracycline|tetracycline|mesh-list
138971274|NCT00889356|Ketoconazole|ketoconazole|mesh-list
138971275|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138971276|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138971277|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138971278|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138971279|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971280|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971281|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
138971282|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138971283|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138590492|NCT00403949|Azelaic acid|azelaic acid|mesh-list
138971284|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138971285|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
138971286|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138971287|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971288|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138971289|NCT00889356|Amebicides|amebicides|mesh-ancestor
138971290|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138971291|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138971292|NCT00889434|Tocotrienols|tocotrienols|mesh-list
138971293|NCT00889434|Vitamin E|vitamin e|mesh-list
138971294|NCT00889434|Tocopherols|tocopherols|mesh-list
138971295|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
138971296|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971297|NCT00889434|Protective Agents|protective agents|mesh-ancestor
138971298|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971299|NCT00889434|Vitamins|vitamins|mesh-ancestor
138971300|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
138971301|NCT00612534|Sufentanil|sufentanil|mesh-list
138971302|NCT00612534|Dsuvia|dsuvia|mesh-list
138971303|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138971304|NCT00612534|Narcotics|narcotics|mesh-ancestor
138971305|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971306|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971307|NCT00612534|Analgesics|analgesics|mesh-ancestor
138590613|NCT00514891|Vitamin A|vitamin a|mesh-list
138971308|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
138971309|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971310|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138971311|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138971312|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
138971313|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
138971314|NCT02542254|Albuterol|albuterol|mesh-list
138971315|NCT02542254|Ipratropium|ipratropium|mesh-list
138971316|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138971317|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
138971318|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971319|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971320|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139003216|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139003217|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003218|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
139003219|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139003220|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003221|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139003222|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003223|NCT00992576|Hydromorphone|hydromorphone|mesh-list
138971321|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
138971322|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
138971323|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138971324|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138590673|NCT04620200|Nivolumab|nivolumab|mesh-list
138971325|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138971326|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138971327|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
138971328|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971329|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971330|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138971331|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
138971332|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
138971333|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138971334|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971335|NCT00736853|Acetaminophen|acetaminophen|mesh-list
138971336|NCT00736853|Tramadol|tramadol|mesh-list
138971337|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138971338|NCT00736853|Analgesics|analgesics|mesh-ancestor
138971339|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
138971340|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590784|NCT02950441|Niacin|niacin|mesh-list
138971342|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
138971343|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138971344|NCT00736853|Narcotics|narcotics|mesh-ancestor
138971345|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971346|NCT04037514|Acetaminophen|acetaminophen|mesh-list
138971347|NCT04037514|Ibuprofen|ibuprofen|mesh-list
138971348|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138971349|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138971350|NCT04037514|Analgesics|analgesics|mesh-ancestor
138971351|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
138971352|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971353|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971354|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138971355|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138971356|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138971357|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971358|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971359|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
138971360|NCT00730847|Vaccines|vaccines|mesh-list
138971361|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
138971362|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971363|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
138971364|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138971365|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971366|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971367|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138971368|NCT00573066|Analgesics|analgesics|mesh-ancestor
138971369|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
138971370|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971371|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138971372|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138971373|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138971374|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
138971375|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971376|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971377|NCT02541552|Ropivacaine|ropivacaine|mesh-list
139003224|NCT00992576|Naloxone|naloxone|mesh-list
139003225|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139003226|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003227|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
139003228|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003229|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139003230|NCT00992576|Narcotics|narcotics|mesh-ancestor
139003231|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139003232|NCT00992576|Analgesics|analgesics|mesh-ancestor
139003233|NCT00777569|Nicotine|nicotine|mesh-list
139003234|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139003235|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
139003236|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003237|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003238|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139003239|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139003240|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
139003241|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003242|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003243|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139003244|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971378|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
138971379|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
138971380|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971381|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971382|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
138971383|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971384|NCT00886314|Midazolam|midazolam|mesh-list
138971385|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138971386|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138722248|NCT00580931|Niacin|niacin|mesh-list
138971387|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971388|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971390|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138971391|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138971392|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138971393|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
138971394|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
138971395|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
138971396|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
138971397|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971398|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971399|NCT00890214|Epoprostenol|epoprostenol|mesh-list
138971400|NCT00890214|Heparin|heparin|mesh-list
138971401|NCT00890214|Calcium heparin|calcium heparin|mesh-list
138971402|NCT00890214|Tezosentan|tezosentan|mesh-list
138971403|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
138971404|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138971405|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138971406|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971407|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138971408|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138971409|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
138971410|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138971411|NCT00730691|Vortioxetine|vortioxetine|mesh-list
138971412|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139003245|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139003246|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003247|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003248|NCT00535730|Vaccines|vaccines|mesh-list
139003249|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139003250|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
139003251|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003252|NCT00992654|Maraviroc|maraviroc|mesh-list
139003253|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139003254|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139003255|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003256|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139003257|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139003258|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
139003259|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003260|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138971413|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138971414|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138971415|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971416|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971417|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971418|NCT00730691|Analgesics|analgesics|mesh-ancestor
138971419|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
138971420|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971421|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
138971422|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138971423|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
138971424|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138971425|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138971426|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971427|NCT00730691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138971428|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
138971429|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138971430|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138971431|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138971432|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138971433|NCT00886860|Misoprostol|misoprostol|mesh-list
138971434|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138971435|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
138971436|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138971437|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971438|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138971439|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138971440|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
138971441|NCT00884442|Nifedipine|nifedipine|mesh-list
138971442|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138971443|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138971444|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971445|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138971446|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971447|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
138971449|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138971450|NCT02543034|Petrolatum|petrolatum|mesh-list
138971451|NCT02543034|Emollients|emollients|mesh-ancestor
138971452|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
138971453|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
138971454|NCT00278161|Rituximab|rituximab|mesh-list
139003261|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139003262|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
139003263|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139003264|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139003265|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003266|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003267|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139003268|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139003269|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003270|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
139003271|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003272|NCT00995306|Capsaicin|capsaicin|mesh-list
139003273|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
139003274|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
139003275|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
139003276|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003277|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003278|NCT00666965|Rotigotine|rotigotine|mesh-list
139003279|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
139003280|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
139003281|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003282|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003283|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003284|NCT00781157|Phenylephrine|phenylephrine|mesh-list
139003285|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
139003286|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139003287|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
139003288|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
139003289|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003290|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003291|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
139003292|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139003293|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
139003294|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
139003295|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139003296|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139003300|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003301|NCT00781157|Protective Agents|protective agents|mesh-ancestor
139003302|NCT00777959|Sirolimus|sirolimus|mesh-list
139003303|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139003304|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003305|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139003306|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003307|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
139003308|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138971455|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138971456|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
138971457|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971458|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138971459|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138971460|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
138971461|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971462|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971463|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138971464|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138971466|NCT02541396|Oxycodone|oxycodone|mesh-list
138971467|NCT02541396|Analgesics|analgesics|mesh-ancestor
138971468|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
138971469|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971470|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971471|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138971472|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138971473|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
138971474|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
138971475|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971476|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138971477|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138971478|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138591218|NCT05190705|BB 1101|bb 1101|mesh-list
138971479|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971480|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138971482|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
138971483|NCT00255151|Lansoprazole|lansoprazole|mesh-list
138971484|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138971485|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138971486|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138971487|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971488|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971489|NCT03973957|Fentanyl|fentanyl|mesh-list
138971490|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138971491|NCT03973957|Narcotics|narcotics|mesh-ancestor
138971492|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971493|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591284|NCT04898231|Infliximab|infliximab|mesh-list
138971494|NCT03973957|Analgesics|analgesics|mesh-ancestor
138971495|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
138971496|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971497|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138971498|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138971499|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
138971500|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
138971501|NCT00658658|Panitumumab|panitumumab|mesh-list
138971502|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138971503|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971504|NCT00723203|Panobinostat|panobinostat|mesh-list
138971505|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971506|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138971507|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971508|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971509|NCT00891072|Acetic Acid|acetic acid|mesh-list
138971510|NCT00891072|Paclitaxel|paclitaxel|mesh-list
138971511|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
138971512|NCT00891072|Carboplatin|carboplatin|mesh-list
139003309|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
139003310|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003311|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
139003312|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139003313|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
139003314|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139003315|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139003316|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003317|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139003318|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003319|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139003320|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139003321|NCT00778115|Simethicone|simethicone|mesh-list
139003322|NCT00778115|Loperamide|loperamide|mesh-list
139003323|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
139003324|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139003325|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
139003326|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003327|NCT00778115|Emollients|emollients|mesh-ancestor
139003328|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
139003329|NCT00993122|Ribavirin|ribavirin|mesh-list
139003330|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
139003331|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003332|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
139003333|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003334|NCT00778193|Aspirin|aspirin|mesh-list
138754095|NCT02877537|Albuterol|albuterol|mesh-list
139003335|NCT00778193|Celecoxib|celecoxib|mesh-list
139003336|NCT00778193|Naproxen|naproxen|mesh-list
139003337|NCT00778193|Clopidogrel|clopidogrel|mesh-list
139003338|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139003339|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139003340|NCT00778193|Analgesics|analgesics|mesh-ancestor
139003341|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
138971513|NCT00891072|Retinol acetate|retinol acetate|mesh-list
138971514|NCT00891072|Gossypol|gossypol|mesh-list
138971515|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138971516|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971517|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
138971518|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
138971519|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
138971520|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971521|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138971522|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138971523|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139003342|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003343|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003344|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139003345|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139003346|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139003347|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139003348|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003349|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139003350|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139003351|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003352|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
139003353|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139003354|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138971524|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
138971525|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971526|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138971527|NCT00891072|Protective Agents|protective agents|mesh-ancestor
138971528|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138971529|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
138971530|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138971531|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138971532|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138971533|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138971534|NCT02591927|Insulin|insulin|mesh-list
138971535|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138971536|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971537|NCT00891150|Oxytocin|oxytocin|mesh-list
138971538|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
138971540|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971541|NCT00800462|Bromides|bromides|mesh-list
138971542|NCT00800462|Oxybutynin|oxybutynin|mesh-list
138971543|NCT00800462|Darifenacin|darifenacin|mesh-list
138971544|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
138971545|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
138971546|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
138971547|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971548|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971549|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138971550|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138971551|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
138971552|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971553|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971554|NCT00800462|Urological Agents|urological agents|mesh-ancestor
138971555|NCT00233389|Rebamipide|rebamipide|mesh-list
138971556|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138971557|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138971558|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
138971559|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971560|NCT00233389|Protective Agents|protective agents|mesh-ancestor
138971561|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971562|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971563|NCT00891306|Cyclosporine|cyclosporine|mesh-list
138971564|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
138971565|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
138971566|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138971567|NCT00891306|Cyclosporins|cyclosporins|mesh-list
138971568|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971569|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971570|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138971571|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
138971572|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971573|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
139003355|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139003356|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
139003357|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003358|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139003359|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
139003360|NCT00778271|Gabapentin|gabapentin|mesh-list
139003361|NCT00778271|Analgesics|analgesics|mesh-ancestor
139003362|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
139003363|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003364|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003365|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
139003366|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139003367|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139003368|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139003369|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139003370|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139003371|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138971574|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138971575|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
138971576|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138971577|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138971578|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138971579|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971580|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138971581|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
138971582|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138971583|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138971584|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
138971585|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
138971586|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971587|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138971588|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
138971589|NCT00891306|Hormones|hormones|mesh-ancestor
138971590|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138971591|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138971592|NCT00891306|Protective Agents|protective agents|mesh-ancestor
138971593|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138971594|NCT00807872|Antibodies|antibodies|mesh-list
138971595|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138971596|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
138971597|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971598|NCT00813722|Losartan|losartan|mesh-list
138971599|NCT00813722|Atenolol|atenolol|mesh-list
138971600|NCT00813722|Amlodipine|amlodipine|mesh-list
138971601|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138971602|NCT00813722|Calcium|calcium|mesh-list
138971603|NCT00813722|Diuretics|diuretics|mesh-list
138971604|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138971605|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138971606|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971607|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138971608|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138971609|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138971610|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971611|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
138722430|NCT02213159|Narcotics|narcotics|mesh-ancestor
138971612|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138971613|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138971614|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139003372|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003373|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003374|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
139003376|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139003377|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003378|NCT00995618|Tranilast|tranilast|mesh-list
139003379|NCT00995618|Febuxostat|febuxostat|mesh-list
139003380|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
139003381|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139003382|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139003383|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139003384|NCT00995618|Analgesics|analgesics|mesh-ancestor
139003385|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
139003386|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003387|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003388|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139003389|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139003390|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139003391|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003392|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138971615|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
138971616|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138971617|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138971618|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
138971619|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971620|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
138971621|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
138971622|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971623|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138971624|NCT00812318|Cabotegravir|cabotegravir|mesh-list
138971625|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138971626|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138971627|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971628|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971629|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138971630|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138971631|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
138971632|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138971633|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
138971635|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
138971636|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
138971637|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138971638|NCT00812396|Androgens|androgens|mesh-ancestor
138971639|NCT00812396|Hormones|hormones|mesh-ancestor
138591491|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
138971640|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138971641|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971642|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138971643|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971644|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
138971645|NCT00807950|Simvastatin|simvastatin|mesh-list
138971646|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139003393|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139003394|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
139003395|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
139003396|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138933522|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139003397|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139003398|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139003399|NCT00778427|Metformin|metformin|mesh-list
139003400|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139003401|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003402|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139003403|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139003404|NCT00667355|Adalimumab|adalimumab|mesh-list
139003405|NCT00667355|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139003406|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139003407|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139003408|NCT00778505|Remifentanil|remifentanil|mesh-list
139003409|NCT00778505|Propofol|propofol|mesh-list
139003410|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139003411|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139003412|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003413|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139003414|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
139003415|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
139003416|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138505528|NCT00018213|Naltrexone|naltrexone|mesh-list
138971647|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138971648|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
138971649|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971650|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138971651|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138971652|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971653|NCT00649220|Memantine|memantine|mesh-list
138971654|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138971655|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138971656|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
138971657|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971658|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971659|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971660|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138971661|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138971662|NCT00654368|Etanercept|etanercept|mesh-list
138971663|NCT00654368|Methotrexate|methotrexate|mesh-list
138971664|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138971665|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
138971666|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138971667|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591607|NCT03007238|Interleukin-2|interleukin-2|mesh-list
138971668|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138971670|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971671|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971672|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
138971673|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003417|NCT00778505|Narcotics|narcotics|mesh-ancestor
139003418|NCT00778505|Analgesics|analgesics|mesh-ancestor
139003419|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
139003420|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003421|NCT00532844|Vitamins|vitamins|mesh-list
139003422|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
139003423|NCT00532844|Verapamil|verapamil|mesh-list
139003424|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
139003425|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003426|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
139003427|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003428|NCT00532844|Protective Agents|protective agents|mesh-ancestor
138971674|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138971675|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138971676|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
138971677|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138971678|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138933559|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
138971679|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138971680|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138971681|NCT00654368|Analgesics|analgesics|mesh-ancestor
138971682|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
138971683|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971684|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138971685|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138971686|NCT00812864|Capecitabine|capecitabine|mesh-list
138971687|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138971689|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971690|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971691|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
138971692|NCT00808184|Midazolam|midazolam|mesh-list
138971693|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138971694|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138971695|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971696|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971697|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138971698|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138971699|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138971700|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138971701|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
138971702|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
138971703|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
138971704|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
138971705|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971706|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971707|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138971708|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138971709|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
138971710|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138971711|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138971712|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138971713|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971714|NCT00647426|Carboplatin|carboplatin|mesh-list
138971715|NCT00647426|Docetaxel|docetaxel|mesh-list
138971716|NCT00647426|Sorafenib|sorafenib|mesh-list
138971717|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971718|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
138971719|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
138971720|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
138971721|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971722|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138591783|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
138971724|NCT00647348|Simvastatin|simvastatin|mesh-list
138971725|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138971726|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138971727|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
138971728|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003429|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139003430|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139003431|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139003432|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139003433|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
139003434|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
138933570|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
139003435|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139003436|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003437|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139003438|NCT00778661|Amoxicillin|amoxicillin|mesh-list
139003439|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139003440|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003441|NCT00993356|Lanreotide|lanreotide|mesh-list
139003442|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003443|NCT00781547|Hormones|hormones|mesh-list
139003444|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139003445|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003446|NCT00778739|Cefprozil|cefprozil|mesh-list
139003447|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139003448|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003449|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
139003450|NCT00781625|Methenamine|methenamine|mesh-list
139003451|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
139003452|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139003453|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003454|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139003455|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
139003456|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139003457|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003458|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139003459|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
139003460|NCT00666263|Antibodies|antibodies|mesh-list
139003461|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
139003462|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139003463|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139003464|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
139003465|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971729|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138971730|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139003466|NCT00667277|Bevacizumab|bevacizumab|mesh-list
139003467|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139003468|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003469|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139003470|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139003471|NCT00667277|Growth Substances|growth substances|mesh-ancestor
139003472|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003473|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
139003474|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
139003475|NCT00774527|Fludarabine|fludarabine|mesh-list
139003476|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139003477|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139003478|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
139003479|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003480|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139003481|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139003482|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
138971731|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971732|NCT00647270|Adalimumab|adalimumab|mesh-list
138971733|NCT00647270|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138971734|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138971735|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138971736|NCT00645944|Eszopiclone|eszopiclone|mesh-list
138971737|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138971738|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971739|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971740|NCT00813332|Docetaxel|docetaxel|mesh-list
138971741|NCT00813332|Endostar protein|endostar protein|mesh-list
138971742|NCT00813332|Endostatins|endostatins|mesh-list
138971743|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971744|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
138971745|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
138971746|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
138971747|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971748|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138971749|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138971750|NCT00813332|Growth Substances|growth substances|mesh-ancestor
138971751|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971752|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
138971753|NCT04708496|Efavirenz|efavirenz|mesh-list
138971754|NCT04708496|Dolutegravir|dolutegravir|mesh-list
138971755|NCT04708496|Lumefantrine|lumefantrine|mesh-list
138971756|NCT04708496|Artemether|artemether|mesh-list
138971757|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138971758|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138971759|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138971760|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971761|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971762|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
138971763|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138971764|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138971765|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138971766|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138971767|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138971768|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138971769|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139003483|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003484|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003485|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139003486|NCT00778973|Sertraline|sertraline|mesh-list
139003487|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
139003488|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139003489|NCT00778973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139003490|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139003491|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139003492|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003493|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003494|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
139003495|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003496|NCT00774605|Varenicline|varenicline|mesh-list
139003497|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139003498|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139003499|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
139003500|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003501|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003502|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003503|NCT00779051|Zolpidem|zolpidem|mesh-list
139003504|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138971770|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138971771|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138971772|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138971773|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138971774|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
138971775|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138591891|NCT00518245|Enoxaparin|enoxaparin|mesh-list
138971776|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138971777|NCT00646958|Linezolid|linezolid|mesh-list
138971778|NCT00646958|Radezolid|radezolid|mesh-list
138971779|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
138971780|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138971781|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138971782|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138971783|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971784|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971785|NCT00813410|Insulin|insulin|mesh-list
138971786|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138971787|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971788|NCT00642746|Leucovorin|leucovorin|mesh-list
138971789|NCT00642746|Fluorouracil|fluorouracil|mesh-list
138971790|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
138971791|NCT00642746|Irinotecan|irinotecan|mesh-list
138971792|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138971793|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
138971794|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971795|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138971796|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971797|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138971798|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
139003505|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139003506|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139003507|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003508|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139003509|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
139003510|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
139003511|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003512|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003513|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
139003514|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139003515|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139003516|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
139003517|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003518|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139003519|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139003520|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003521|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003522|NCT00782093|Volociximab|volociximab|mesh-list
139003523|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139003524|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139003525|NCT00782093|Growth Substances|growth substances|mesh-ancestor
139003526|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003527|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
138971799|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971800|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138971801|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138971802|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971803|NCT00642746|Antidotes|antidotes|mesh-ancestor
138971804|NCT00642746|Protective Agents|protective agents|mesh-ancestor
138971805|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
138971806|NCT00642746|Vitamins|vitamins|mesh-ancestor
138971807|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
138971808|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138971809|NCT00814268|Aspirin|aspirin|mesh-list
138933619|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138971810|NCT00814268|Clopidogrel|clopidogrel|mesh-list
138971811|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138971812|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138971813|NCT00814268|Analgesics|analgesics|mesh-ancestor
138971814|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
138971815|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971816|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971817|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138971818|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138971819|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138971820|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138971821|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971822|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138971823|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138971824|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971825|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
138971826|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138971827|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139003528|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003529|NCT00784511|Vitamin D|vitamin d|mesh-list
139003530|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
139003531|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
139003532|NCT00784511|Vitamins|vitamins|mesh-list
139003533|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
139003534|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003535|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139003536|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139003537|NCT00784589|Rituximab|rituximab|mesh-list
139003538|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139003539|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003540|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
139003541|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971828|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138971829|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
138971830|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971831|NCT00817622|Vitamin E|vitamin e|mesh-list
138971832|NCT00817622|Vitamins|vitamins|mesh-ancestor
138971833|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
138971834|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971835|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
138971836|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971837|NCT00817622|Protective Agents|protective agents|mesh-ancestor
138971838|NCT00808418|Docetaxel|docetaxel|mesh-list
138971839|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971840|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
138971841|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
138971842|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
138971843|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971844|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
138971845|NCT00642668|Hematinics|hematinics|mesh-ancestor
138971846|NCT00817934|Bisacodyl|bisacodyl|mesh-list
138971847|NCT00817934|Cathartics|cathartics|mesh-ancestor
138971848|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138971849|NCT00817934|Laxatives|laxatives|mesh-ancestor
138971850|NCT00729833|Sunitinib|sunitinib|mesh-list
138971851|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971852|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138971853|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138971854|NCT00729833|Growth Substances|growth substances|mesh-ancestor
138971855|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971856|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
138971857|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138971858|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971859|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971860|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
138971861|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138971862|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138971863|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138971864|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138971865|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971866|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971867|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971868|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138971869|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138971870|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
138971871|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
138971872|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138971873|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138971874|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971875|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971876|NCT00814736|Urological Agents|urological agents|mesh-ancestor
139003542|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139003543|NCT00784667|Cetuximab|cetuximab|mesh-list
139003544|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139003545|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139003546|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003547|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139003548|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003549|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003550|NCT00784745|Dexamethasone|dexamethasone|mesh-list
139003551|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139003552|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
139003553|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
139003554|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003555|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003556|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139003557|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
139003558|NCT00784745|Hormones|hormones|mesh-ancestor
139039559|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138971877|NCT00818090|Paclitaxel|paclitaxel|mesh-list
138971878|NCT00818090|Cisplatin|cisplatin|mesh-list
138592155|NCT04457180|Repaglinide|repaglinide|mesh-list
138971879|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138971880|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971881|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
138971882|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
138971883|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
138971884|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971885|NCT00642356|Levodopa|levodopa|mesh-list
138971886|NCT00642356|Carbidopa|carbidopa|mesh-list
138971887|NCT00642356|Entacapone|entacapone|mesh-list
138971888|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138971889|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138971890|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138971891|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
138971892|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971893|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971894|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971895|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138971896|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971897|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138971898|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138971899|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
138971900|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
138971901|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138971902|NCT00642278|Canagliflozin|canagliflozin|mesh-list
138971903|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138971904|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971905|NCT00642278|Incretins|incretins|mesh-ancestor
138971906|NCT00642278|Hormones|hormones|mesh-ancestor
138971907|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138971908|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138971909|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
138971910|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971911|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592261|NCT00521092|Sunitinib|sunitinib|mesh-list
138971913|NCT00812786|Cyclosporine|cyclosporine|mesh-list
138971914|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
138971915|NCT00812786|Everolimus|everolimus|mesh-list
138971916|NCT00812786|Tacrolimus|tacrolimus|mesh-list
139003559|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139003560|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139003561|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003562|NCT00993512|Bleomycin|bleomycin|mesh-list
139003563|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139003564|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003565|NCT00662129|Paclitaxel|paclitaxel|mesh-list
139003566|NCT00662129|Bevacizumab|bevacizumab|mesh-list
139003567|NCT00662129|Gemcitabine|gemcitabine|mesh-list
139003568|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139003569|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138971917|NCT00812786|Cyclosporins|cyclosporins|mesh-list
138971918|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138971919|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
138971920|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971921|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138971922|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971923|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971924|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
138971925|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138971926|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
138971927|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138971928|NCT00812786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138971929|NCT00812786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138971930|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971931|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138971932|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138971933|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
138971934|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138971935|NCT00815048|Atropine|atropine|mesh-list
138971936|NCT00815048|Fentanyl|fentanyl|mesh-list
138971937|NCT00815048|Remifentanil|remifentanil|mesh-list
138971938|NCT00815048|Succinylcholine|succinylcholine|mesh-list
138971939|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138971940|NCT00815048|Narcotics|narcotics|mesh-ancestor
138971941|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138971942|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971943|NCT00815048|Analgesics|analgesics|mesh-ancestor
138971944|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
138971945|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971946|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138971947|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138971948|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
138971949|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
138971950|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138971951|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138971952|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
138971953|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138971954|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
138971955|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
138971956|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
138971957|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138971958|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138971959|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
138971960|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138971961|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971962|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138971963|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138971964|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138971965|NCT02551796|Levofloxacin|levofloxacin|mesh-list
138971966|NCT02551796|Ofloxacin|ofloxacin|mesh-list
138971967|NCT02551796|Tobramycin|tobramycin|mesh-list
138971968|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
138971969|NCT02551796|Dexamethasone|dexamethasone|mesh-list
138971970|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
138971971|NCT02551796|BB 1101|bb 1101|mesh-list
139003570|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003571|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
139003572|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
139003573|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
138506025|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138971972|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
138971973|NCT02551796|Dipivefrin|dipivefrin|mesh-list
138971974|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138971975|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
138971976|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
138971977|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138971978|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138971979|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138971980|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
138971981|NCT02551796|Hormones|hormones|mesh-ancestor
138971982|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138592367|NCT03458923|Analgesics|analgesics|mesh-ancestor
138971983|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138971984|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138971985|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
138971986|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138971987|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138971988|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138971989|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138971990|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138971991|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138971992|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138592409|NCT00152178|Tamoxifen|tamoxifen|mesh-list
138971993|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138971994|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138971996|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
138971997|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
138971998|NCT02551796|Protective Agents|protective agents|mesh-ancestor
138971999|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138972000|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
138972001|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972002|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138972003|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138972004|NCT00723125|Paclitaxel|paclitaxel|mesh-list
138972005|NCT00723125|Bevacizumab|bevacizumab|mesh-list
138972006|NCT00723125|Carboplatin|carboplatin|mesh-list
138972007|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138972008|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138972009|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972010|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
138972011|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
138972012|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
138972013|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972014|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138972015|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138972016|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138972017|NCT00723125|Growth Substances|growth substances|mesh-ancestor
138972018|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972019|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
138972020|NCT00640562|Risperidone|risperidone|mesh-list
138972021|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138972022|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138972023|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
138972024|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039548|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138972025|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972026|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972027|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138972028|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138972029|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972030|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138972031|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138972032|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
138972033|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
138972034|NCT00815204|Dexamethasone|dexamethasone|mesh-list
138972035|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139003574|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003575|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139003576|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139003577|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139003578|NCT00662129|Growth Substances|growth substances|mesh-ancestor
139003579|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003580|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
139003581|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139003582|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
139003583|NCT00993746|Lidocaine|lidocaine|mesh-list
139003584|NCT00993746|Bupivacaine|bupivacaine|mesh-list
139003585|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
139003586|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
139003587|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139003588|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003589|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
139003590|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003591|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139003592|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139003593|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139003594|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139003595|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003596|NCT00789971|Triamcinolone|triamcinolone|mesh-list
139003597|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139003598|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139003599|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139003600|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139003601|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
139003602|NCT00789971|Hormones|hormones|mesh-ancestor
139003603|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138972036|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
138972037|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
138972038|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972039|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972040|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138972041|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
138972042|NCT00815204|Hormones|hormones|mesh-ancestor
138972043|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138972044|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138972045|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972046|NCT00721955|Loxapine|loxapine|mesh-list
138972047|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138972048|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139003604|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003605|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139003606|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
139003607|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003608|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003609|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139003610|NCT00782405|Mirtazapine|mirtazapine|mesh-list
139003611|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
139003612|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139003613|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139003614|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139003615|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139003616|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003617|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139003618|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
139003619|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
139003620|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003621|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972049|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972050|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972051|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138972052|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138972053|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
138972054|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972055|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972056|NCT00585689|Carboplatin|carboplatin|mesh-list
138972057|NCT00585689|Gemcitabine|gemcitabine|mesh-list
138972058|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138972059|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972060|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138972061|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
138972062|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972063|NCT00815282|Vaccines|vaccines|mesh-list
138972064|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
138972065|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972066|NCT02593019|Adavosertib|adavosertib|mesh-list
138972067|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972068|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972069|NCT00729365|Ramipril|ramipril|mesh-list
138972070|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138972071|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
138972072|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972073|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972074|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138972075|NCT00818870|Omeprazole|omeprazole|mesh-list
138972076|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138972077|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138972078|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138972079|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972080|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972081|NCT00254293|Abatacept|abatacept|mesh-list
138972082|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138972083|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138972084|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972085|NCT00254293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139003622|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139003623|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139003624|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139003625|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139003626|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
139003627|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139003628|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139003630|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139003631|NCT05343260|Propofol|propofol|mesh-list
139003632|NCT05343260|Sevoflurane|sevoflurane|mesh-list
139003633|NCT05343260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138972086|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972087|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138972088|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
138972089|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972090|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138972091|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138972092|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
138972093|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972094|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138972095|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972096|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972097|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
138972098|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972099|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
138972100|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138972101|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972102|NCT00253747|Methylphenidate|methylphenidate|mesh-list
138972103|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138972104|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972105|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138972106|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138972107|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138972108|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972109|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
138972110|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972111|NCT00252733|Candesartan|candesartan|mesh-list
138972112|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
138972113|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138972114|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138972115|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138972116|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972117|NCT03974035|Ropivacaine|ropivacaine|mesh-list
138972118|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
138972119|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
138972120|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972121|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972122|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
138972123|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972124|NCT00275821|Ranibizumab|ranibizumab|mesh-list
138972125|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138972126|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138972127|NCT00275821|Growth Substances|growth substances|mesh-ancestor
138972128|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972129|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
138972130|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972131|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
138972132|NCT00275509|Dexamethasone|dexamethasone|mesh-list
138972133|NCT00275509|Prednisone|prednisone|mesh-list
138972134|NCT00275509|Tacrolimus|tacrolimus|mesh-list
138972135|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
138972136|NCT00275509|Daclizumab|daclizumab|mesh-list
139003634|NCT05343260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139003635|NCT05343260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003636|NCT05343260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139003637|NCT05343260|Anesthetics, General|anesthetics, general|mesh-ancestor
139003638|NCT05343260|Anesthetics|anesthetics|mesh-ancestor
139003639|NCT05343260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139003640|NCT05343260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139003641|NCT00664859|Atorvastatin|atorvastatin|mesh-list
139003642|NCT00664859|Fenofibrate|fenofibrate|mesh-list
139003643|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139003644|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139003645|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
138972137|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138972138|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
138972139|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
138972140|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972141|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972142|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138972143|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
138972144|NCT00275509|Hormones|hormones|mesh-ancestor
138972145|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138972146|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138972147|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972148|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138972149|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
138972150|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138972151|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972152|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972153|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138972154|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138972155|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
138972156|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138933903|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
138972157|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972159|NCT01072045|Propranolol|propranolol|mesh-list
138972160|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138972161|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
138972162|NCT01072045|Hormones|hormones|mesh-ancestor
138972163|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138972164|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972165|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138972166|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972167|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138972168|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138972169|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
138972170|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972171|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972172|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138972173|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138972174|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
138972176|NCT01073059|Valproic Acid|valproic acid|mesh-list
138972177|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
138972178|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972179|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972180|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
138972181|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972182|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972183|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
138972184|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138972185|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972186|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138972187|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138972188|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972189|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
139003646|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003648|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139003649|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003650|NCT00996788|Rebamipide|rebamipide|mesh-list
139003651|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139003652|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139003653|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
139003654|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003655|NCT00996788|Protective Agents|protective agents|mesh-ancestor
139003656|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506318|NCT05576181|Cyclophosphamide|cyclophosphamide|mesh-list
138972190|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
138972191|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138972192|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972193|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972194|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
138972195|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138972196|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972197|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972198|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
138972199|NCT00252499|Fenofibrate|fenofibrate|mesh-list
138972200|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138972201|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972202|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138972203|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
138972204|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972205|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138972206|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138972207|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
138972208|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972209|NCT00163657|Cyclosporine|cyclosporine|mesh-list
138972210|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
138972211|NCT00163657|Tacrolimus|tacrolimus|mesh-list
138972212|NCT00163657|Cyclosporins|cyclosporins|mesh-list
138972213|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138972214|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
138972215|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972216|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138972217|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972218|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972219|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
138972220|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972221|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
138972222|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138972223|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138972224|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972225|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138972226|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
138972227|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138972229|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972231|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
138972232|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
138972233|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972234|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138972235|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
138972236|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972237|NCT00230971|Metronidazole|metronidazole|mesh-list
138972238|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
138972239|NCT00230971|Tigecycline|tigecycline|mesh-list
138972240|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972241|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139003657|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003658|NCT01564550|Insulin|insulin|mesh-list
139003659|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139003660|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139003661|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003662|NCT00790439|Cyclosporine|cyclosporine|mesh-list
139003663|NCT00790439|Sirolimus|sirolimus|mesh-list
139003664|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
139003665|NCT00790439|Heparin|heparin|mesh-list
139003666|NCT00790439|Calcium heparin|calcium heparin|mesh-list
139003667|NCT00790439|Dextrans|dextrans|mesh-list
139003668|NCT00790439|Tacrolimus|tacrolimus|mesh-list
139003669|NCT00790439|Cyclosporins|cyclosporins|mesh-list
139003670|NCT00790439|Basiliximab|basiliximab|mesh-list
139003671|NCT00790439|Daclizumab|daclizumab|mesh-list
139003672|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139003673|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
139003674|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003675|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139003676|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003677|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003678|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
139003679|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003680|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
139003681|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139003682|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138593077|NCT02947243|Morphine|morphine|mesh-list
138972242|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138972243|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138972244|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138972245|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972246|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972248|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138972249|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
138972250|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138972251|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972252|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138972253|NCT00211081|Diuretics|diuretics|mesh-ancestor
138972254|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
138972255|NCT00884676|Sunitinib|sunitinib|mesh-list
138972256|NCT00884676|Epothilone B|epothilone b|mesh-list
138972257|NCT00884676|Epothilones|epothilones|mesh-list
138972258|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972259|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138972260|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138972261|NCT00884676|Growth Substances|growth substances|mesh-ancestor
138972262|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972264|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138972265|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972266|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972267|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
138972268|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
138972269|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
138972270|NCT00891384|Lenalidomide|lenalidomide|mesh-list
139003683|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003684|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139003685|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
139003686|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139003687|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
139003688|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139003689|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139003690|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
139003691|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
138972271|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
138972272|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972273|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138972274|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138972275|NCT00891384|Growth Substances|growth substances|mesh-ancestor
138972276|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
138972277|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972278|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138972279|NCT00887328|Plasminogen|plasminogen|mesh-list
138972280|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138972281|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138972282|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972283|NCT00609336|Gemcitabine|gemcitabine|mesh-list
138972284|NCT00609336|Capecitabine|capecitabine|mesh-list
138972285|NCT00609336|Docetaxel|docetaxel|mesh-list
138972286|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
138972287|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138972288|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
138972289|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972290|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972292|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
138972293|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
138972294|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
138972295|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138972296|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972297|NCT02541084|Aflibercept|aflibercept|mesh-list
138972298|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138972299|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138972300|NCT02541084|Growth Substances|growth substances|mesh-ancestor
138972301|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972302|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
138972303|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972304|NCT04397406|Fentanyl|fentanyl|mesh-list
138972305|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
138972306|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
138972307|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138972308|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972309|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972310|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138972311|NCT04397406|Analgesics|analgesics|mesh-ancestor
138972312|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
138972313|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972314|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138972315|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138972316|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138972317|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
138972318|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972319|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972320|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138972321|NCT04397406|Narcotics|narcotics|mesh-ancestor
138972322|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138972323|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138972324|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
138972325|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
138972326|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
138972327|NCT00891540|Ropivacaine|ropivacaine|mesh-list
138972328|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
138972330|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972331|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003693|NCT00785603|Paroxetine|paroxetine|mesh-list
139003694|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139003695|NCT00785603|Narcotics|narcotics|mesh-ancestor
139003696|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139003697|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003698|NCT00785603|Analgesics|analgesics|mesh-ancestor
139003699|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
139003700|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003701|NCT00785603|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139003702|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139003703|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139003704|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972332|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
138972333|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972334|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138972335|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
138972336|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972337|NCT00891696|Sirolimus|sirolimus|mesh-list
138972338|NCT00891696|Nitroprusside|nitroprusside|mesh-list
138972339|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138972340|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972341|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138972342|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972343|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
138972344|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138972345|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
138972346|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972347|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972348|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138972349|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
138972350|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138972351|NCT00640328|Ofatumumab|ofatumumab|mesh-list
138972352|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138972353|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972354|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
138972355|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972356|NCT04036890|Minocycline|minocycline|mesh-list
138972357|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138593426|NCT00527800|Lumefantrine|lumefantrine|mesh-list
138972358|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972359|NCT00162097|Efavirenz|efavirenz|mesh-list
138972360|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138972361|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138972362|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138972363|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972364|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972365|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
138972366|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972367|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138972368|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138972369|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138972370|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138972371|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138972372|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138972373|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
138972374|NCT02550782|Bupivacaine|bupivacaine|mesh-list
138972375|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
138972376|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
138972377|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972378|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003705|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003706|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
139003707|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139003708|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
139003709|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139003710|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139003711|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139003712|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003713|NCT00570401|Dasatinib|dasatinib|mesh-list
139003714|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003715|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139003716|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003717|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972379|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
138972380|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972381|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138972382|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138972384|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138972385|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138972386|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138972387|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
138972388|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972389|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972390|NCT05278728|Irinotecan|irinotecan|mesh-list
138972391|NCT05278728|Nimotuzumab|nimotuzumab|mesh-list
138972392|NCT05278728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138972393|NCT05278728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138972394|NCT05278728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972395|NCT05278728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972396|NCT05278728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972397|NCT05278728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138972398|NCT01073761|Ritonavir|ritonavir|mesh-list
138972399|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138972400|NCT01073761|Darunavir|darunavir|mesh-list
138972401|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138972402|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138972403|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
138972404|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972405|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972406|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138972407|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138972408|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
138972409|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972410|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138972411|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138972412|NCT00819104|Metoprolol|metoprolol|mesh-list
138972413|NCT00819104|Amlodipine|amlodipine|mesh-list
138934030|NCT01805804|Valsartan|valsartan|mesh-list
138972414|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138972415|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138972416|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138972417|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039549|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
138972418|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138972419|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972421|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138972422|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
138972423|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
138972424|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972425|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138972426|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139003718|NCT00532298|Vaccines|vaccines|mesh-list
139003719|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
139003720|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003721|NCT04047017|Apatinib|apatinib|mesh-list
139003722|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003723|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139003724|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003725|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003726|NCT00997022|Sorafenib|sorafenib|mesh-list
139003727|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972427|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138972428|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
138972429|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972430|NCT02542098|Hydrocodone|hydrocodone|mesh-list
138972431|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138972432|NCT02542098|Narcotics|narcotics|mesh-ancestor
138972433|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972434|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972435|NCT02542098|Analgesics|analgesics|mesh-ancestor
138972436|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
138972437|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972438|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
138972439|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
138972440|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138972441|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
138972442|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972443|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
138972444|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138972445|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972446|NCT00885066|Gemcitabine|gemcitabine|mesh-list
138972447|NCT00885066|Capecitabine|capecitabine|mesh-list
138972448|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138972449|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138972450|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
138972451|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972452|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972453|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138972454|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972455|NCT00888108|Docetaxel|docetaxel|mesh-list
138972456|NCT00888108|Navitoclax|navitoclax|mesh-list
138972457|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972458|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
138972459|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
138972460|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
138934059|NCT01718873|Hematinics|hematinics|mesh-ancestor
138972461|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972462|NCT00885300|Cloxacillin|cloxacillin|mesh-list
138972463|NCT00885300|Heparin|heparin|mesh-list
138972464|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
138972465|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138972466|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138972467|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972468|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138972469|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972470|NCT00888186|Levodopa|levodopa|mesh-list
138972471|NCT00888186|Carbidopa|carbidopa|mesh-list
138972472|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138972473|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138972474|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
138972475|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972476|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972477|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972478|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138972480|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138972481|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138972482|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138972483|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139003728|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139003730|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003731|NCT00786149|Varenicline|varenicline|mesh-list
139003732|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139003733|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139003734|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
139003735|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003736|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003737|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003738|NCT00410410|Abatacept|abatacept|mesh-list
139003739|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139003740|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003741|NCT00410410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139003742|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972484|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972485|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138972486|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138972487|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138972488|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
138972489|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972490|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972491|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138208912|NCT03418805|Ibuprofen|ibuprofen|mesh-list
138972492|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138972493|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
138972494|NCT00892398|Ranibizumab|ranibizumab|mesh-list
138972495|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138972496|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138972497|NCT00892398|Growth Substances|growth substances|mesh-ancestor
138972498|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972499|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
138972500|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972501|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
138972502|NCT00892476|Calcium|calcium|mesh-list
138972503|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138972504|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972505|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138972506|NCT02541786|Rabeprazole|rabeprazole|mesh-list
138972507|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
138972508|NCT02541786|Lansoprazole|lansoprazole|mesh-list
138972509|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138972510|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138972511|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138972512|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972513|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972514|NCT00888342|Ethanol|ethanol|mesh-list
138972515|NCT00888342|Zopiclone|zopiclone|mesh-list
138972516|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138972517|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972518|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593931|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972519|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972520|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138972521|NCT00608868|Gefitinib|gefitinib|mesh-list
138972522|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972523|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138972524|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972525|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003743|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139003744|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
139003745|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003746|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139003747|NCT00782951|Morphine|morphine|mesh-list
139003748|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138972526|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138972527|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
138972528|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972529|NCT04036500|Estradiol|estradiol|mesh-list
138972530|NCT04036500|Estrogens|estrogens|mesh-ancestor
138972531|NCT04036500|Hormones|hormones|mesh-ancestor
138972532|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138972533|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972534|NCT00895674|Sorafenib|sorafenib|mesh-list
138972535|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972536|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138972537|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934106|NCT00802646|Narcotics|narcotics|mesh-ancestor
138972538|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972539|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
138972540|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138972541|NCT04035330|Eusol|eusol|mesh-list
138972542|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
138972543|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972544|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138972545|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972547|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
138972548|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972549|NCT04035096|Protective Agents|protective agents|mesh-ancestor
138972550|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972551|NCT04035096|Vitamins|vitamins|mesh-ancestor
138972552|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
138972553|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
138972554|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138594032|NCT00169182|Niacin|niacin|mesh-list
138972555|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
138972556|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972557|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972558|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138972559|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
138972560|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138972561|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
138972562|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972563|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972564|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138972566|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
138972567|NCT00608322|Protective Agents|protective agents|mesh-ancestor
138972568|NCT00608244|Tacrolimus|tacrolimus|mesh-list
138972569|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138972570|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
138972571|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972572|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138972573|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972574|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972575|NCT00893100|Diltiazem|diltiazem|mesh-list
138972576|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138972577|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138972578|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138972579|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972580|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138972581|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972582|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
138972583|NCT00896376|Trastuzumab|trastuzumab|mesh-list
138972584|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138972585|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972586|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
138972587|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
138972588|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138972589|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003749|NCT00782951|Narcotics|narcotics|mesh-ancestor
139003750|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139003751|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003752|NCT00782951|Analgesics|analgesics|mesh-ancestor
139003753|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
139003754|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003755|NCT02555813|Paclitaxel|paclitaxel|mesh-list
139003756|NCT02555813|Gemcitabine|gemcitabine|mesh-list
139003757|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139003758|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139003759|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003760|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
139003761|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
139003762|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
139003763|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003764|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139003765|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
139003766|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
139003767|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139003768|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972590|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138972591|NCT00893256|Risperidone|risperidone|mesh-list
138972593|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138972594|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
138972595|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972596|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972597|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972598|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138972599|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138972600|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972601|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138972602|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138972603|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
138972604|NCT00893256|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138972605|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138972606|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138972607|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138972608|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
138972609|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138972610|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138972611|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
138972612|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972613|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972614|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138972615|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
138972616|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
138972618|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138972619|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
138972620|NCT00901524|Interferons|interferons|mesh-list
138972621|NCT00901524|Ribavirin|ribavirin|mesh-list
138972622|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
138972623|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
138972624|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138972625|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003769|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139003770|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
139003771|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139003772|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003773|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003774|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003775|NCT00783107|Cyclosporine|cyclosporine|mesh-list
139003776|NCT00783107|Cyclosporins|cyclosporins|mesh-list
139003777|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003778|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003779|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139003780|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
139003781|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003782|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
138972626|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
138972627|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972628|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
138972629|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972630|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
138972631|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972632|NCT00893412|Tramadol|tramadol|mesh-list
138972633|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138972634|NCT00893412|Narcotics|narcotics|mesh-ancestor
138972635|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972636|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972637|NCT00893412|Analgesics|analgesics|mesh-ancestor
138972638|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
138972639|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972640|NCT00893490|Mitomycins|mitomycins|mesh-list
138972641|NCT00893490|Mitomycin|mitomycin|mesh-list
138972642|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138972643|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972644|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
138972645|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972646|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138972647|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972648|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
138972649|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
138972650|NCT00638690|Prednisone|prednisone|mesh-list
138972651|NCT00638690|Prednisolone|prednisolone|mesh-list
138972652|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
138972653|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138972654|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
138972655|NCT00638690|Hormones|hormones|mesh-ancestor
138972656|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138972657|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972658|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138972659|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972660|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138972661|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972662|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972663|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
138972664|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138972665|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
138972666|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972667|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972668|NCT00893724|Tocopherols|tocopherols|mesh-list
138972669|NCT00893724|Vitamin E|vitamin e|mesh-list
138972670|NCT00893724|Tocotrienols|tocotrienols|mesh-list
138972671|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
139003783|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003784|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
139003785|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139003786|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139003787|NCT00534404|Nicotine|nicotine|mesh-list
139003788|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139003789|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
139003790|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003791|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003792|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139003793|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139003794|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
138972672|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
138972673|NCT00893724|Niacinamide|niacinamide|mesh-list
138972675|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
138972676|NCT00893724|Ubiquinone|ubiquinone|mesh-list
138972677|NCT00893724|Minocycline|minocycline|mesh-list
138972678|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
138972679|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138972680|NCT00893724|Vitamins|vitamins|mesh-ancestor
138972681|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
138972682|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972683|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
138972684|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972685|NCT00893724|Protective Agents|protective agents|mesh-ancestor
138972686|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138972687|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972689|NCT00893724|Expectorants|expectorants|mesh-ancestor
138972690|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
138972691|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138972692|NCT00893724|Antidotes|antidotes|mesh-ancestor
138972693|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
138972694|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138972695|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
138972696|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138972697|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
138972698|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
138972699|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138972700|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
138972701|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972702|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972703|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138972704|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
138972705|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138972706|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
138972707|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972708|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972709|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138972710|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
138972711|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
138972712|NCT00893880|Protective Agents|protective agents|mesh-ancestor
138972713|NCT00815594|Bevacizumab|bevacizumab|mesh-list
138594553|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
138972714|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138972715|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972716|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138972717|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138972718|NCT00815594|Growth Substances|growth substances|mesh-ancestor
138972719|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972720|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
138972721|NCT00897312|Interferons|interferons|mesh-list
138972722|NCT00897312|Ribavirin|ribavirin|mesh-list
138972723|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
138972724|NCT00897312|Infliximab|infliximab|mesh-list
138972725|NCT00897312|Tremelimumab|tremelimumab|mesh-list
138972726|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972727|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
139003795|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003796|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003797|NCT00393094|Bevacizumab|bevacizumab|mesh-list
139003798|NCT00393094|Irinotecan|irinotecan|mesh-list
139003799|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139003800|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003801|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139003802|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139003803|NCT00393094|Growth Substances|growth substances|mesh-ancestor
139003804|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972728|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972729|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
138972730|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972731|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
138972732|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972733|NCT00897312|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138972734|NCT00897312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138972735|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
138972736|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138972737|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138972738|NCT02540460|Delpazolid|delpazolid|mesh-list
138972739|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
138972740|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138972741|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972742|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138723563|NCT01681680|Metformin|metformin|mesh-list
138972743|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972744|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972745|NCT00543387|Docetaxel|docetaxel|mesh-list
138972746|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972747|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
138972748|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
138972749|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
138972750|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972751|NCT03455556|Atezolizumab|atezolizumab|mesh-list
138972753|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138972754|NCT03455556|Anetumab ravtansine|anetumab ravtansine|mesh-list
138972755|NCT03455556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138972756|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972757|NCT03455556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138972758|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972759|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
138972760|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972761|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138972762|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
138972763|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
138972764|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
138972765|NCT03455556|Immunoconjugates|immunoconjugates|mesh-ancestor
138972766|NCT04017624|Nicotine|nicotine|mesh-list
138972767|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138972768|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
138594719|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138972769|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972770|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972771|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138972772|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138972773|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
138972774|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972775|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972776|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
138972777|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972778|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
138972779|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972780|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003805|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
139003806|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139003807|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139003808|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003809|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003811|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003812|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139003813|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139003814|NCT00783653|Growth Substances|growth substances|mesh-ancestor
139003815|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003816|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
138972781|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138972782|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138972783|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
138972784|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972785|NCT00983151|Tramadol|tramadol|mesh-list
138972786|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138972787|NCT00983151|Narcotics|narcotics|mesh-ancestor
138972788|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972789|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972790|NCT00983151|Analgesics|analgesics|mesh-ancestor
138972791|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
138972792|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972793|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
138972794|NCT00635570|NuvaRing|nuvaring|mesh-list
138594779|NCT05273671|Analgesics|analgesics|mesh-ancestor
138972795|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138972796|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138972797|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
138972798|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138972799|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972800|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138972801|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138972802|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138972803|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138972804|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972805|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138972806|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138972807|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594827|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
138972808|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972809|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972810|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
138972811|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138972812|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972813|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138972814|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
138972815|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138972816|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972817|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972818|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972819|NCT00986115|Memantine|memantine|mesh-list
138972820|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138972821|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138972822|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
138972823|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972824|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972825|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972826|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138972827|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138972829|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003817|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139003818|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003819|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003820|NCT00786305|Amikacin|amikacin|mesh-list
139003821|NCT00786305|Ceftazidime|ceftazidime|mesh-list
139003822|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139003823|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003824|NCT01044004|Modafinil|modafinil|mesh-list
139003825|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139003826|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003827|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139003828|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139003829|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139003830|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003831|NCT00786383|Ramucirumab|ramucirumab|mesh-list
139003832|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003833|NCT00790595|Sunitinib|sunitinib|mesh-list
139003834|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003835|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139003836|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139003837|NCT00790595|Growth Substances|growth substances|mesh-ancestor
139003838|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972830|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138972831|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972832|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972833|NCT00902070|Rocuronium|rocuronium|mesh-list
138972834|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138972835|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138972836|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138972837|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972838|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972840|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138972841|NCT00635492|Exenatide|exenatide|mesh-list
138972842|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138972843|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972844|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138972845|NCT00635492|Incretins|incretins|mesh-ancestor
138972846|NCT00635492|Hormones|hormones|mesh-ancestor
138972847|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138972848|NCT00543309|Milrinone|milrinone|mesh-list
138972849|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138972850|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138972851|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138972852|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
138972853|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138972854|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138972855|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972856|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972857|NCT00543309|Protective Agents|protective agents|mesh-ancestor
138972858|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972859|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
138972860|NCT00569582|Mifepristone|mifepristone|mesh-list
139003839|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
139003840|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139003841|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003842|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003844|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139003845|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139003846|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139003847|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003848|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139003849|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139003850|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139003851|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139003852|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
139003853|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
139003854|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
139003855|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
139003856|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003857|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003858|NCT00409708|Methylphenidate|methylphenidate|mesh-list
139003859|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139003860|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003861|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139003862|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138972861|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138972862|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
138972863|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138972864|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972865|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138972866|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138972867|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138972868|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
138972869|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138972870|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138972871|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
138972872|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138972873|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
138972874|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138972875|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138972876|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
138972877|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138972878|NCT00988845|Protective Agents|protective agents|mesh-ancestor
138972879|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972880|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972881|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138972882|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138972883|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972884|NCT00902460|Midazolam|midazolam|mesh-list
138972885|NCT00902460|Tofacitinib|tofacitinib|mesh-list
139003863|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139003864|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003865|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
139003866|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003867|NCT00790985|Naproxen|naproxen|mesh-list
139003868|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139003869|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139003870|NCT00790985|Analgesics|analgesics|mesh-ancestor
139003871|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
139003872|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003873|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003874|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139003875|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139003876|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
139003877|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139003878|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003879|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003880|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
139003881|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
139003882|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003883|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139003884|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003885|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139003886|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
139003887|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003888|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139003889|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003890|NCT01324492|Everolimus|everolimus|mesh-list
139003891|NCT01324492|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139003892|NCT01324492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138972886|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138972887|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138972888|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972889|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972890|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138972891|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138972892|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138972893|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138972894|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
138972895|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
138972896|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
138972897|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
138972898|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003893|NCT01324492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003894|NCT01324492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003895|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139003896|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
139003897|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003898|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003899|NCT01039948|Gefitinib|gefitinib|mesh-list
139003900|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003901|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139003902|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003903|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003904|NCT00391846|Metoprolol|metoprolol|mesh-list
138934278|NCT02573064|Vancomycin|vancomycin|mesh-list
138972899|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972900|NCT00902460|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138972901|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138972902|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972903|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
138972904|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138972905|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972906|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138972907|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972908|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138972909|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
138972910|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138972911|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
138972912|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972913|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
138972914|NCT00809198|Protective Agents|protective agents|mesh-ancestor
138972915|NCT00809198|Laxatives|laxatives|mesh-ancestor
138972916|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138972917|NCT00986505|Lidocaine|lidocaine|mesh-list
138972918|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
138972919|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
138972920|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972921|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972922|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
138972923|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972924|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138972925|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138972926|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138972927|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138595315|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
138972928|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972929|NCT03667443|Inositol|inositol|mesh-list
138972930|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
138972931|NCT03667443|Vitamins|vitamins|mesh-ancestor
138972932|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
138972933|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972934|NCT00902772|Lorazepam|lorazepam|mesh-list
138972935|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
138972936|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
138972937|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
138972938|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972939|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972940|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138972941|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138972942|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138972943|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138972944|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138972945|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138972946|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
138972947|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
138972948|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003905|NCT00391846|Valsartan|valsartan|mesh-list
139003906|NCT00391846|Carvedilol|carvedilol|mesh-list
139003907|NCT00391846|Candesartan|candesartan|mesh-list
139003908|NCT00391846|Ramipril|ramipril|mesh-list
139003909|NCT00391846|Enalapril|enalapril|mesh-list
139003910|NCT00391846|Lisinopril|lisinopril|mesh-list
139003911|NCT00391846|Eplerenone|eplerenone|mesh-list
139003912|NCT00391846|Bisoprolol|bisoprolol|mesh-list
139003913|NCT00391846|Captopril|captopril|mesh-list
139003914|NCT00391846|Trandolapril|trandolapril|mesh-list
139003915|NCT00391846|Spironolactone|spironolactone|mesh-list
139003916|NCT00391846|Diuretics|diuretics|mesh-list
139003917|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139003918|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139003919|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139003920|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003921|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139003922|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
139003923|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
138972949|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972950|NCT00894660|Amodiaquine|amodiaquine|mesh-list
138972951|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
138972952|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138972953|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138972954|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972955|NCT00721409|Letrozole|letrozole|mesh-list
138972956|NCT00721409|Palbociclib|palbociclib|mesh-list
138972957|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138972958|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138972959|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138972960|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972961|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972962|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138972963|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
138723785|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
138972964|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138972965|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972966|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138972967|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
138972968|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138972969|NCT00542997|Antibodies|antibodies|mesh-list
138972970|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
138972971|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972972|NCT00903084|Tenofovir|tenofovir|mesh-list
138972973|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
138972974|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138972975|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138972976|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138972977|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138972978|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972979|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138972980|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138972981|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
138972982|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138972983|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
138972984|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138972985|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138972986|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138972987|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
138972988|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
138972989|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138972990|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
139003924|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139003925|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003926|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139003927|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139003928|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139003929|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
139003930|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003931|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139003932|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
139003933|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138972991|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138972992|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138972993|NCT02591771|Epinephrine|epinephrine|mesh-list
138972994|NCT02591771|Racepinephrine|racepinephrine|mesh-list
138972995|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
138972996|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138972997|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138972998|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
138972999|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973000|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973001|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973002|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138973003|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138973004|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
138973005|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973006|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138973007|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
138973008|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
138973009|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
138973010|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138973011|NCT00986817|Terlipressin|terlipressin|mesh-list
138973012|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138973013|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138973014|NCT00572832|Vaccines|vaccines|mesh-list
138973016|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973017|NCT02591849|Glucagon|glucagon|mesh-list
138973018|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138973019|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138973020|NCT02591849|Hormones|hormones|mesh-ancestor
138973021|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138973022|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973023|NCT02591849|Incretins|incretins|mesh-ancestor
138973024|NCT00898794|Bevacizumab|bevacizumab|mesh-list
138973025|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138973026|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973027|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138973028|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138973029|NCT00898794|Growth Substances|growth substances|mesh-ancestor
138595659|NCT05780437|Remdesivir|remdesivir|mesh-list
138973030|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973031|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
138973032|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
138973033|NCT04086719|Deucravacitinib|deucravacitinib|mesh-list
138973034|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
138973035|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138973036|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138973037|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973038|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138723861|NCT01201759|Analgesics|analgesics|mesh-ancestor
138973039|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973040|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973041|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
138973042|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138973043|NCT00898950|Aspirin|aspirin|mesh-list
139003934|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139003935|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
139003936|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
139003937|NCT00391846|Protective Agents|protective agents|mesh-ancestor
138934321|NCT00712062|Pemetrexed|pemetrexed|mesh-list
139003938|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139003939|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139003940|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139003941|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
139003942|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139003943|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139003944|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138507465|NCT05309304|Cefazolin|cefazolin|mesh-list
138973044|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
138973045|NCT00898950|Salicylates|salicylates|mesh-list
138973046|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138973047|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138973048|NCT00898950|Analgesics|analgesics|mesh-ancestor
138973049|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
138973050|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973051|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973052|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138973053|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138973054|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138973055|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138973056|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973057|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138973058|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138973059|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973060|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
138973061|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973062|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
138973063|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
138973064|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
138973065|NCT03622515|Anesthetics|anesthetics|mesh-list
138973066|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138973067|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973068|NCT05279235|Favipiravir|favipiravir|mesh-list
138973069|NCT05279235|Antiviral Agents|antiviral agents|mesh-ancestor
138973070|NCT05279235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973071|NCT00229723|Gefitinib|gefitinib|mesh-list
138973072|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973073|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138934344|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
138973074|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973075|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973076|NCT04035798|Memantine|memantine|mesh-list
138973077|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138973078|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138973079|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
138973080|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973081|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973082|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973083|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138973084|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138973085|NCT01075477|Rituximab|rituximab|mesh-list
138973086|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138973087|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973088|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
138973089|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973090|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138973091|NCT01075555|Sorafenib|sorafenib|mesh-list
138973092|NCT01075555|Pravastatin|pravastatin|mesh-list
138973093|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973094|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139003945|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
139003946|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003947|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139003948|NCT00391768|Oseltamivir|oseltamivir|mesh-list
139003949|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
139003950|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139003951|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003952|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003954|NCT00391222|Risperidone|risperidone|mesh-list
139003955|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139003956|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
139003957|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139003958|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003959|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973095|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973096|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973097|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138973098|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138973099|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
138973100|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138973101|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138973102|NCT00627926|Interferons|interferons|mesh-list
138973103|NCT00627926|Ribavirin|ribavirin|mesh-list
138973104|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
138973105|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
138973106|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138973107|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973108|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
138973109|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973110|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
138973111|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973112|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
138973113|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973114|NCT00228553|Modafinil|modafinil|mesh-list
138973115|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138973116|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973117|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138973118|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138973119|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138973120|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973121|NCT00922506|Doxazosin|doxazosin|mesh-list
138973122|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138973123|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138973124|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138973125|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
138973126|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973127|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973128|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973129|NCT00922506|Urological Agents|urological agents|mesh-ancestor
138973130|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138973131|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138973132|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138973133|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138973134|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
138973135|NCT00816140|Clarithromycin|clarithromycin|mesh-list
138973136|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138973137|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973138|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138973139|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934413|NCT00618982|Sorafenib|sorafenib|mesh-list
139003960|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139003961|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139003962|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139003963|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139003964|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139003965|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
139003966|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
139003967|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
139003968|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973140|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973141|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138973142|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138973143|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138973144|NCT00895128|Dasatinib|dasatinib|mesh-list
138973145|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973146|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138973147|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973148|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973149|NCT00903942|Paclitaxel|paclitaxel|mesh-list
138973150|NCT00903942|Carboplatin|carboplatin|mesh-list
138973151|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138973152|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138973153|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973154|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
138973155|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
138973156|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
138973157|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973158|NCT00895362|Cetuximab|cetuximab|mesh-list
138973159|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138973160|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138973161|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596060|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
138973162|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138973163|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973164|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973165|NCT00904098|Frovatriptan|frovatriptan|mesh-list
138973166|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138973167|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
138973168|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973169|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973170|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973171|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
138973172|NCT00904176|Digoxin|digoxin|mesh-list
138973173|NCT00904176|Warfarin|warfarin|mesh-list
138973174|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138973175|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973176|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138973177|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973178|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
138973179|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138973180|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138973181|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973182|NCT00904176|Protective Agents|protective agents|mesh-ancestor
138973183|NCT02540070|Ketorolac|ketorolac|mesh-list
138973184|NCT02540070|Epinephrine|epinephrine|mesh-list
138973185|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
138973186|NCT02540070|Morphine|morphine|mesh-list
138973187|NCT02540070|Ropivacaine|ropivacaine|mesh-list
138973188|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138973189|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138973190|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973191|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138973193|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
138973194|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973195|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138973196|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139003969|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139003970|NCT00391222|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139003971|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139003972|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139003973|NCT00409006|Pemetrexed|pemetrexed|mesh-list
139003974|NCT00409006|Gefitinib|gefitinib|mesh-list
139003975|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003976|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003977|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139003978|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139003979|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139003980|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139003981|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
139003982|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139003983|NCT00997880|Calcium|calcium|mesh-list
138973197|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138973198|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
138973199|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973200|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973201|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138973202|NCT02540070|Narcotics|narcotics|mesh-ancestor
138973203|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
138973204|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
138973205|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138973206|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138973207|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
138973208|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138973209|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
138973210|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
138973211|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
138973212|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138973213|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138973214|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138973215|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138973216|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138596230|NCT03283150|Remifentanil|remifentanil|mesh-list
138973217|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973219|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973220|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138973221|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973222|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973223|NCT00900510|Trimethoprim|trimethoprim|mesh-list
138973224|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138973225|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
138973226|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138973227|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973228|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
138973229|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138973230|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138973231|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138973232|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973233|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973234|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138973235|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138973236|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138973237|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138973238|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
138973239|NCT00160693|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138973240|NCT00160693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139003984|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139003985|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139003986|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139003987|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139003988|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139003990|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973241|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138973242|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
138973243|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973244|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138973245|NCT00906048|Levofloxacin|levofloxacin|mesh-list
138973247|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138973248|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973249|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138973250|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138973251|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138973252|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973253|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973254|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973255|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138973256|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138973257|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138973258|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
138973259|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
138973260|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138973261|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138973262|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138973263|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138973264|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138973265|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138973266|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138973267|NCT00906126|Misoprostol|misoprostol|mesh-list
138973268|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138973269|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
138973270|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138973271|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973272|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138973273|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138973274|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
138973275|NCT00900744|Tamoxifen|tamoxifen|mesh-list
138973276|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138973277|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
138973278|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138973279|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973280|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138973281|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973282|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138973283|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138973284|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138973285|NCT00643760|Pregabalin|pregabalin|mesh-list
138973286|NCT00643760|Gabapentin|gabapentin|mesh-list
138973287|NCT00643760|Analgesics|analgesics|mesh-ancestor
138596396|NCT00382070|Letrozole|letrozole|mesh-list
138973288|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
138973289|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973290|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973291|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
138973292|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138973293|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138973294|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973295|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138973296|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138973297|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139003992|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139003993|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139003994|NCT00408928|Bortezomib|bortezomib|mesh-list
139003995|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003996|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
139003997|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139003998|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139003999|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139004000|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
139004001|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139004002|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973298|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138973299|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138973300|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138973301|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138973302|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973303|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
138973304|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
138973305|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138973306|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138973307|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
138973308|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973309|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138973310|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138596438|NCT02915731|Vitamin A|vitamin a|mesh-list
138934512|NCT00848458|Azelaic acid|azelaic acid|mesh-list
138973311|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973312|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973313|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138973314|NCT00906360|Cetuximab|cetuximab|mesh-list
138973315|NCT00906360|Sunitinib|sunitinib|mesh-list
138973316|NCT00906360|Antibodies|antibodies|mesh-list
138973317|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
138973318|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138973319|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
138973320|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973321|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973322|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138973323|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138973324|NCT00906360|Growth Substances|growth substances|mesh-ancestor
138973325|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
138973326|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138973327|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973328|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973329|NCT00603798|Imiquimod|imiquimod|mesh-list
138973330|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138973331|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
138973332|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973333|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973334|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
138973335|NCT00819572|Antibodies|antibodies|mesh-list
138973336|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
138973337|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
138973338|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973340|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138973341|NCT00630812|Diuretics|diuretics|mesh-ancestor
138973343|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973344|NCT00906516|Bevacizumab|bevacizumab|mesh-list
138973345|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138973346|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973347|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138973348|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138973349|NCT00906516|Growth Substances|growth substances|mesh-ancestor
138973350|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004003|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004004|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004005|NCT00998036|Sirolimus|sirolimus|mesh-list
139004006|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139004007|NCT00998036|Temsirolimus|temsirolimus|mesh-list
139004008|NCT00998036|MTOR Inhibitors|mtor inhibitors|mesh-list
139004009|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754774|NCT01070979|Estradiol|estradiol|mesh-list
138973351|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
138973352|NCT00629798|Fludarabine|fludarabine|mesh-list
138973353|NCT00629798|Melphalan|melphalan|mesh-list
138973354|NCT00629798|Busulfan|busulfan|mesh-list
138973355|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138973356|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973357|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973358|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138973359|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
138973360|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973361|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138973362|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
138973363|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138973364|NCT00160615|Levetiracetam|levetiracetam|mesh-list
138973365|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
138973366|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
138973367|NCT00906594|Latanoprost|latanoprost|mesh-list
138973368|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138973369|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138973370|NCT03970759|Fluorides|fluorides|mesh-list
138973371|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
138973372|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
138973373|NCT03970759|Protective Agents|protective agents|mesh-ancestor
138973374|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973375|NCT00905190|Ondansetron|ondansetron|mesh-list
138973376|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
138973377|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
138973378|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973379|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973380|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138973381|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
138973382|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
138973383|NCT00905190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138973384|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138973385|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
138973386|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973387|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973388|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138973389|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
138973390|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
138973391|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138973392|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
138973393|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973394|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973395|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138973396|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
138973397|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138973398|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138973399|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138973400|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
138973401|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973402|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973403|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138973404|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
138973405|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138973406|NCT00627458|Vaccines|vaccines|mesh-list
138973407|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
138973408|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973409|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
138973410|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138973411|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973412|NCT00909168|Immunotoxins|immunotoxins|mesh-ancestor
139004010|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139004011|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004012|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004013|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139004014|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
139004015|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004016|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139004017|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139004018|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139004019|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
139004022|NCT05254808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138934546|NCT00717704|Dasatinib|dasatinib|mesh-list
139004023|NCT05254808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139004024|NCT05254808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139004025|NCT02275286|Trabectedin|trabectedin|mesh-list
139004026|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139004027|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
139004028|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004029|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004030|NCT00998192|Paclitaxel|paclitaxel|mesh-list
139004031|NCT00998192|Carboplatin|carboplatin|mesh-list
139004032|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139004033|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004034|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
139004035|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
139004036|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
139004037|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004038|NCT00994526|Vitamin E|vitamin e|mesh-list
139004039|NCT00994526|Calcium|calcium|mesh-list
139004040|NCT00994526|Vitamins|vitamins|mesh-ancestor
139004041|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
139004042|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004043|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138973413|NCT00909168|Immunoconjugates|immunoconjugates|mesh-ancestor
138973414|NCT00909168|Immunologic Factors|immunologic factors|mesh-ancestor
138973415|NCT00909168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973416|NCT00816218|Pioglitazone|pioglitazone|mesh-list
138973417|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138973418|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973419|NCT00819728|Docetaxel|docetaxel|mesh-list
138973420|NCT00819728|Irinotecan|irinotecan|mesh-list
138973421|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973422|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
139004044|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
139004045|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004046|NCT00994526|Protective Agents|protective agents|mesh-ancestor
139004047|NCT00998504|Resveratrol|resveratrol|mesh-list
139004048|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
139004049|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004050|NCT00998504|Protective Agents|protective agents|mesh-ancestor
139004051|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004052|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004053|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139004054|NCT00788684|Rituximab|rituximab|mesh-list
139004055|NCT00788684|Navitoclax|navitoclax|mesh-list
139004056|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139004057|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004058|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
139004059|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004060|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139004061|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
139004062|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139004063|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
139004064|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139004065|NCT00998972|Expectorants|expectorants|mesh-ancestor
138934560|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
139004066|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
139004067|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139004068|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
139039560|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973423|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
138973424|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
139039550|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138973425|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973426|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138973427|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138973428|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973429|NCT00906828|Levodopa|levodopa|mesh-list
138973430|NCT00906828|Carbidopa|carbidopa|mesh-list
138973431|NCT00906828|Entacapone|entacapone|mesh-list
138973432|NCT00906828|Tolcapone|tolcapone|mesh-list
138973433|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138973434|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138973435|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
138973436|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973437|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973438|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973439|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138973440|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973441|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138973442|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
138973443|NCT00819806|Vaccines|vaccines|mesh-list
138973444|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
138973445|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973446|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139004069|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004070|NCT00998972|Protective Agents|protective agents|mesh-ancestor
139004071|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004072|NCT00998972|Antidotes|antidotes|mesh-ancestor
139004073|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139004074|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
138973447|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138973448|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138973449|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
138973450|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973451|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973452|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138973453|NCT00909402|Capecitabine|capecitabine|mesh-list
138973454|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973455|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138973456|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
138973457|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973458|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
138973459|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138973460|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138973461|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973462|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
138973463|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
138973464|NCT00821444|Ziprasidone|ziprasidone|mesh-list
138973465|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138973466|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
138973467|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973468|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973469|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973470|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138973471|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138973472|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138973473|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138973474|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138973475|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
138973476|NCT00909558|Immunomodulating Agents|immunomodulating agents|mesh-list
138973477|NCT00909558|Immunologic Factors|immunologic factors|mesh-ancestor
138973478|NCT00909558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973479|NCT00819962|Bupivacaine|bupivacaine|mesh-list
138973480|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
138973481|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
138973482|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138973483|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973484|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
138973485|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973486|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138973487|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138973488|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138724307|NCT04536662|Dexamethasone|dexamethasone|mesh-list
138973489|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138973490|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973491|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973493|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973494|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138973495|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138973496|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138973497|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138973498|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
138973499|NCT00927498|Cytarabine|cytarabine|mesh-list
138973500|NCT00927498|Daunorubicin|daunorubicin|mesh-list
138973501|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
138973502|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138973503|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596991|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
138973504|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138973505|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138973506|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004075|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004076|NCT00998816|Pregabalin|pregabalin|mesh-list
139004077|NCT00998816|Analgesics|analgesics|mesh-ancestor
139004078|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
139004079|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004080|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004081|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
139004082|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139004083|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139004084|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004085|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139004086|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139004087|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139004088|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004089|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139004090|NCT00533702|Dacarbazine|dacarbazine|mesh-list
139004091|NCT00533702|Ramucirumab|ramucirumab|mesh-list
139004092|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139004093|NCT00533702|Imidazole|imidazole|mesh-list
139004094|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139004095|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
139039561|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138973507|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973508|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138973509|NCT00927498|Immunotoxins|immunotoxins|mesh-ancestor
138973510|NCT00927498|Immunoconjugates|immunoconjugates|mesh-ancestor
138973511|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
138973512|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973513|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138973514|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
138973515|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
138973516|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973517|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138973518|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
138973519|NCT00159913|Citric Acid|citric acid|mesh-list
138973520|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
138973521|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
138973522|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138973523|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
138973524|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
138973525|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973526|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
138973527|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138973528|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138973529|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973530|NCT00159913|Urological Agents|urological agents|mesh-ancestor
138973531|NCT05498259|Rituximab|rituximab|mesh-list
138973532|NCT05498259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138973533|NCT05498259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973534|NCT05498259|Immunologic Factors|immunologic factors|mesh-ancestor
138973535|NCT05498259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973536|NCT05498259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138973537|NCT00821600|Risperidone|risperidone|mesh-list
138973538|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139004096|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004097|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004098|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
139004099|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004100|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004101|NCT00408694|Bevacizumab|bevacizumab|mesh-list
139004102|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139004103|NCT00408694|Cisplatin|cisplatin|mesh-list
139004104|NCT00408694|Fluorouracil|fluorouracil|mesh-list
139004105|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
139004106|NCT00408694|Antibodies|antibodies|mesh-list
139004107|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
139004108|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139004109|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
139004110|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004111|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139004112|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139004113|NCT00408694|Growth Substances|growth substances|mesh-ancestor
139004114|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004115|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
139004116|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
139004117|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
139004118|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004119|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138973539|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
138973540|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973541|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973542|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973543|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138973544|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138973545|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934619|NCT04018768|Ibuprofen|ibuprofen|mesh-list
138973546|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138973547|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138973548|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
138973549|NCT00987207|Cyclosporine|cyclosporine|mesh-list
138973550|NCT00987207|Cyclosporins|cyclosporins|mesh-list
138973551|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973552|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973553|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138973554|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
138973555|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973556|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
138973557|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973558|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
138973559|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138973560|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138973561|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138973562|NCT00604188|Buprenorphine|buprenorphine|mesh-list
138973563|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138973564|NCT00604188|Narcotics|narcotics|mesh-ancestor
138973565|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004120|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139004121|NCT00999128|Rabeprazole|rabeprazole|mesh-list
139004122|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139004123|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139004124|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139004125|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004126|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004127|NCT00999206|Vaccines|vaccines|mesh-list
139004128|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
139004129|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004130|NCT01043224|Clobetasol|clobetasol|mesh-list
139004131|NCT01043224|Calcipotriene|calcipotriene|mesh-list
139004132|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139004133|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
139004134|NCT01043224|Hormones|hormones|mesh-ancestor
139004135|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139004136|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004137|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
139004138|NCT01044238|Methylphenidate|methylphenidate|mesh-list
139004139|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139004140|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004141|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139039562|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138973566|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973568|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
138973569|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973570|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138973572|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138973573|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138973574|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973575|NCT00927654|Iloprost|iloprost|mesh-list
138973576|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138973577|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
138973578|NCT00927732|Quinidine|quinidine|mesh-list
138973579|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
138973580|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138973581|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
138973582|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
138973583|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973584|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973585|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138973586|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138973587|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
138973588|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973589|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973590|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
138973591|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138973592|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138973593|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973594|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973595|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138973596|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139004142|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139004143|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139004144|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004145|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
139004146|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004147|NCT01043380|Atorvastatin|atorvastatin|mesh-list
139004148|NCT01043380|Ezetimibe|ezetimibe|mesh-list
139004149|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139004150|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139004151|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
139039563|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138973597|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
138973598|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138973599|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138973600|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138973601|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138973602|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138973604|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138973605|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973606|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973607|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973608|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138973609|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138973610|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138973611|NCT00927966|Everolimus|everolimus|mesh-list
138973612|NCT00927966|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138973613|NCT00927966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138973614|NCT00927966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973615|NCT00927966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973616|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138973617|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
138973618|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973619|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973620|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138973621|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
138973622|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138973623|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138973624|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138973625|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138973626|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973627|NCT00720941|Sunitinib|sunitinib|mesh-list
138973628|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973629|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138973630|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138973631|NCT00720941|Growth Substances|growth substances|mesh-ancestor
138973632|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973633|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
138973634|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138973635|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934641|NCT02573922|Naloxone|naloxone|mesh-list
138973636|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973637|NCT00924222|Propofol|propofol|mesh-list
138973638|NCT00924222|Sevoflurane|sevoflurane|mesh-list
138973639|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138973640|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138973641|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973642|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138973643|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
138973645|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138973646|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138973647|NCT01075711|Prednisone|prednisone|mesh-list
138973648|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138973649|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
138973650|NCT01075711|Hormones|hormones|mesh-ancestor
139004152|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004154|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139004155|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004156|NCT01044394|Bisacodyl|bisacodyl|mesh-list
139004157|NCT01044394|Cathartics|cathartics|mesh-ancestor
139004158|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138973651|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138973652|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973653|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138973654|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973655|NCT01073371|Prilocaine|prilocaine|mesh-list
138973656|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
138973657|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
138973658|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138973659|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973660|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
138973661|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973662|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
138973663|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138973664|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138973665|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973666|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
138973667|NCT03970213|Coagulants|coagulants|mesh-ancestor
138973668|NCT00821834|Ticlopidine|ticlopidine|mesh-list
138973669|NCT00821834|Clopidogrel|clopidogrel|mesh-list
138973670|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138973671|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138973672|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138973673|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138973674|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
138973675|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973676|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973677|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973678|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138973679|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138973680|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138973681|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138973682|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973683|NCT04005417|Fluorides|fluorides|mesh-list
138973684|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
138973685|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
138973686|NCT04005417|Protective Agents|protective agents|mesh-ancestor
138973687|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973688|NCT01073839|Gemcitabine|gemcitabine|mesh-list
138973689|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973690|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138973691|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
138973692|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973693|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138973694|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973695|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138973696|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597541|NCT00164892|Analgesics|analgesics|mesh-ancestor
138973697|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973699|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138973700|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
138973701|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973702|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973703|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138973704|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
138973705|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138973706|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138973707|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138973708|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
139004160|NCT03474094|Atezolizumab|atezolizumab|mesh-list
139004161|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139004162|NCT03474094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139004163|NCT03474094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004164|NCT03474094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139004165|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004166|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
139004167|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004168|NCT01043536|Temozolomide|temozolomide|mesh-list
139004169|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139004170|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
139039564|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138973709|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973710|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973711|NCT05420727|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138973712|NCT05420727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138973713|NCT05420727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973714|NCT00987441|Sufentanil|sufentanil|mesh-list
138973716|NCT00987441|Ropivacaine|ropivacaine|mesh-list
138973717|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
138973718|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
138973719|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138597664|NCT00425490|Incretins|incretins|mesh-ancestor
138973720|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973721|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
138973722|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973723|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138973724|NCT00987441|Narcotics|narcotics|mesh-ancestor
138973725|NCT00987441|Analgesics|analgesics|mesh-ancestor
138973726|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138973727|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138597727|NCT00152750|Clonidine|clonidine|mesh-list
138973728|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
138973729|NCT00584987|Fluticasone|fluticasone|mesh-list
138973730|NCT00584987|Xhance|xhance|mesh-list
138973731|NCT00584987|Phenylephrine|phenylephrine|mesh-list
138973732|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
138973733|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138973734|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138973735|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
138973736|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973737|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973738|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138973739|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
138973740|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
138973741|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138973742|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138973743|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138973744|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
138973745|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973746|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973747|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
138973748|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
138973749|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138973750|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138973751|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
138973752|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138973753|NCT00584987|Protective Agents|protective agents|mesh-ancestor
138973754|NCT00727961|Doxorubicin|doxorubicin|mesh-list
138973755|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138973756|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138973757|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973758|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139004171|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004172|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004173|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139004174|NCT00056407|Dutasteride|dutasteride|mesh-list
139004175|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139004176|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139004177|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004178|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004179|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
139004180|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139004181|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004182|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
139004183|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004184|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139004185|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
139004186|NCT00073021|Mesalamine|mesalamine|mesh-list
139004187|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139004188|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139004189|NCT00073021|Analgesics|analgesics|mesh-ancestor
139004190|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
139004191|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004192|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004193|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139004194|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139004195|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
138934696|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139004196|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139004197|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
139004198|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004199|NCT00395746|Liraglutide|liraglutide|mesh-list
138973759|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138973760|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973761|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973762|NCT00568958|Naltrexone|naltrexone|mesh-list
138973763|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138973764|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138973765|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973766|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
138973767|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973768|NCT00821912|Docetaxel|docetaxel|mesh-list
138973769|NCT00821912|Capecitabine|capecitabine|mesh-list
138973770|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973771|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
138973772|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
138973773|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
139004200|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139004201|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004202|NCT00395746|Incretins|incretins|mesh-ancestor
139004203|NCT00395746|Hormones|hormones|mesh-ancestor
139004204|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139004205|NCT01004900|Timolol|timolol|mesh-list
139004206|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139004207|NCT01004900|Travoprost|travoprost|mesh-list
139004208|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139004209|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139004210|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
139004211|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004212|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004213|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004214|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139004215|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139004216|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139004217|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139004218|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139004219|NCT04001348|Diazepam|diazepam|mesh-list
138973774|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973775|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138973776|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
138973777|NCT00727649|Loperamide|loperamide|mesh-list
138973778|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
138973779|NCT00727649|Psyllium|psyllium|mesh-list
138973780|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138973781|NCT00727649|Cathartics|cathartics|mesh-ancestor
138973782|NCT04006041|Paclitaxel|paclitaxel|mesh-list
138973783|NCT04006041|Cisplatin|cisplatin|mesh-list
138973784|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138973785|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973786|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
138973787|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
138973788|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
138973789|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973790|NCT00225277|Pioglitazone|pioglitazone|mesh-list
138973792|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138973793|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973794|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138973795|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138973796|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
138973797|NCT00821054|Lapatinib|lapatinib|mesh-list
138973798|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973799|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138973800|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973801|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973802|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138973803|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138973804|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
138973805|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973806|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973807|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138973808|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
138973809|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138973810|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139004220|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139004221|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
139004222|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
139004223|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
139004224|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004225|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004226|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139004227|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138508514|NCT05892276|Anticonvulsants|anticonvulsants|mesh-ancestor
138973811|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138973812|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
138973813|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973814|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973816|NCT04388319|Bupropion|bupropion|mesh-list
138973817|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138973818|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
138973819|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138973820|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138973821|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138973822|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138973823|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973824|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
138973825|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973826|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973827|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138973828|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138973829|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973830|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
138973831|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138973832|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138973833|NCT04085627|Amlodipine|amlodipine|mesh-list
138973834|NCT04085627|Valsartan|valsartan|mesh-list
138973835|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
138973836|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138973837|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138973838|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138973839|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973840|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138973841|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973842|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
138973843|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138973844|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138973845|NCT04085393|Granisetron|granisetron|mesh-list
138973846|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
138973847|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
138973848|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973849|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597983|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138973850|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138973851|NCT04085393|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138973852|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138973853|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
138973854|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973855|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973856|NCT00717275|Temozolomide|temozolomide|mesh-list
138973857|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138973858|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
138973859|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973860|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973861|NCT04006353|Rifampin|rifampin|mesh-list
138724702|NCT03113955|Epirubicin|epirubicin|mesh-list
138973862|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138973863|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
138973864|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139004228|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004229|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139004230|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139004231|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139004232|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139004233|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139004234|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139004236|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
139004237|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
139004238|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
139004239|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004240|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004241|NCT00395512|Pioglitazone|pioglitazone|mesh-list
139004242|NCT00395512|Alogliptin|alogliptin|mesh-list
138973865|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598044|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
138973866|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
138973867|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138973868|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973869|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973870|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138973871|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138973872|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138973873|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138973874|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138973875|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138973877|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
138973878|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
138973879|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138973880|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973881|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
138973882|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973883|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138973884|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138973885|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138973886|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138973887|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973888|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
138973889|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138973890|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
138973891|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973892|NCT00584909|Paclitaxel|paclitaxel|mesh-list
138973893|NCT00584909|Carboplatin|carboplatin|mesh-list
138973894|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138973895|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973896|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
138973897|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
138973898|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
138973899|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973900|NCT03947099|Ketamine|ketamine|mesh-list
138973901|NCT03947099|Analgesics|analgesics|mesh-ancestor
138973902|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
138973903|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973904|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973905|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138973906|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138973907|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
138973908|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
138973909|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138973910|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139004243|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139004244|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004245|NCT00395512|Incretins|incretins|mesh-ancestor
139004246|NCT00395512|Hormones|hormones|mesh-ancestor
139004247|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139004248|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139004249|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
139004250|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004251|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004252|NCT03956017|Ubiquinone|ubiquinone|mesh-list
139004253|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
139004254|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
139004255|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004256|NCT03956017|Vitamins|vitamins|mesh-ancestor
139004257|NCT00994916|Amifampridine|amifampridine|mesh-list
139004258|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139004259|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004260|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004261|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139004262|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139004263|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004264|NCT00999440|Methadone|methadone|mesh-list
139004265|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139004266|NCT00999440|Narcotics|narcotics|mesh-ancestor
139004267|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004268|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004269|NCT00999440|Analgesics|analgesics|mesh-ancestor
139004270|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
139004271|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004272|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
139004273|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
139004274|NCT00054691|Gefitinib|gefitinib|mesh-list
139004275|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004285|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139004286|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004287|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004288|NCT03957499|Dexamethasone|dexamethasone|mesh-list
139004289|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
139004290|NCT03957499|Bupivacaine|bupivacaine|mesh-list
139004291|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139004292|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
139004293|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
139004294|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004295|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004296|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139004297|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
139004298|NCT03957499|Hormones|hormones|mesh-ancestor
139004299|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139004300|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139004301|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004302|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
139004303|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
139004304|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004305|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
139004306|NCT03957499|Analgesics|analgesics|mesh-ancestor
139004307|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139004308|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
139004309|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138973911|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138973912|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973913|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973914|NCT05361915|Abivertinib|abivertinib|mesh-list
138973915|NCT05361915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138973916|NCT05361915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138973917|NCT05361915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973918|NCT00929058|Bevacizumab|bevacizumab|mesh-list
138973919|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138973920|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973921|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138973922|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138973923|NCT00929058|Growth Substances|growth substances|mesh-ancestor
138973924|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973925|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
138973926|NCT00907452|Thalidomide|thalidomide|mesh-list
138973927|NCT00907452|Dexamethasone|dexamethasone|mesh-list
138973928|NCT00907452|Prednisone|prednisone|mesh-list
138973929|NCT00907452|Lenalidomide|lenalidomide|mesh-list
138973930|NCT00907452|Melphalan|melphalan|mesh-list
138973931|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138973932|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
138973934|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973935|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973936|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138973937|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
138973938|NCT00907452|Hormones|hormones|mesh-ancestor
139004310|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139004311|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004312|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139004313|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
139004314|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139004315|NCT01040338|Nicotine|nicotine|mesh-list
139004316|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139004317|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
139004318|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004319|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004320|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139004321|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139004322|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
139004323|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004324|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004325|NCT03955939|Midazolam|midazolam|mesh-list
139004326|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139004327|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139004328|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004366|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004367|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139004368|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139004369|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
139004370|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004371|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004372|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139004373|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138973939|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138973940|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138973941|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973942|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
138973943|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138598405|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138973944|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138973945|NCT00907452|Growth Substances|growth substances|mesh-ancestor
138973946|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
138973947|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138973948|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
138973949|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973950|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138973951|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138973952|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
138973953|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138973954|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973955|NCT00717197|Capecitabine|capecitabine|mesh-list
138973956|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138973957|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
138973958|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973959|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138973960|NCT00925392|Doripenem|doripenem|mesh-list
138973961|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138973962|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138973963|NCT05315271|Ketamine|ketamine|mesh-list
138973964|NCT05315271|Bupivacaine|bupivacaine|mesh-list
138973965|NCT05315271|Anesthetics, Local|anesthetics, local|mesh-ancestor
138973966|NCT05315271|Anesthetics|anesthetics|mesh-ancestor
138973967|NCT05315271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138973968|NCT05315271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973969|NCT05315271|Sensory System Agents|sensory system agents|mesh-ancestor
138973970|NCT05315271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973971|NCT05315271|Analgesics|analgesics|mesh-ancestor
138973972|NCT05315271|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138973973|NCT05315271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138973974|NCT05315271|Anesthetics, General|anesthetics, general|mesh-ancestor
138598464|NCT02922283|Interleukin-2|interleukin-2|mesh-list
138973975|NCT05315271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138973976|NCT05315271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138973977|NCT05315271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138973978|NCT05315271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973979|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
138973980|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138973981|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138973982|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138973983|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138973984|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138973985|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
138973986|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973987|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138973988|NCT05313477|Ergocalciferols|ergocalciferols|mesh-list
138973989|NCT05313477|Vitamin D|vitamin d|mesh-list
138973990|NCT05313477|Calcium Carbonate|calcium carbonate|mesh-list
138973991|NCT05313477|Calcium|calcium|mesh-list
138973992|NCT05313477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138973993|NCT05313477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004374|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139004375|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
139004376|NCT00066469|Hormones|hormones|mesh-ancestor
139004377|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139004378|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139004379|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
139004380|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
139004381|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138973994|NCT05313477|Antacids|antacids|mesh-ancestor
138973995|NCT05313477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138973996|NCT05313477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138973997|NCT05313477|Vitamins|vitamins|mesh-ancestor
138973998|NCT05313477|Micronutrients|micronutrients|mesh-ancestor
138973999|NCT05313477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138974000|NCT00224107|Silodosin|silodosin|mesh-list
138974001|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138974002|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138974003|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138974004|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
138974005|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974006|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974007|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974008|NCT00224107|Urological Agents|urological agents|mesh-ancestor
138974009|NCT04004871|Paclitaxel|paclitaxel|mesh-list
138974011|NCT04004871|Fluorouracil|fluorouracil|mesh-list
138974012|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138974013|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974014|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
138974015|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
138974016|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
138974017|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974018|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
138974019|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138974020|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138974021|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
138974022|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974023|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138974024|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138974025|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138974026|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
138974027|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974028|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138974029|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138974030|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974031|NCT00987909|Immunomodulating Agents|immunomodulating agents|mesh-list
138974032|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
138974033|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974034|NCT00822380|Iron|iron|mesh-list
138974035|NCT00822380|Trace Elements|trace elements|mesh-list
138974036|NCT00822380|Folic Acid|folic acid|mesh-list
138974037|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
138974038|NCT00822380|Micronutrients|micronutrients|mesh-list
138974039|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974040|NCT00822380|Hematinics|hematinics|mesh-ancestor
138974041|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
138974042|NCT00822380|Vitamins|vitamins|mesh-ancestor
138598552|NCT02920801|Metformin|metformin|mesh-list
138974043|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
138974044|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974045|NCT00822380|Protective Agents|protective agents|mesh-ancestor
138974046|NCT00720083|Cisplatin|cisplatin|mesh-list
138974047|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974048|NCT00209131|Tamsulosin|tamsulosin|mesh-list
138974049|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138974050|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138974051|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138974052|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
138974053|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004382|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139004383|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139004384|NCT00066469|Protective Agents|protective agents|mesh-ancestor
139004385|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
139004386|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139004387|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139004388|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004389|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
139004390|NCT01094977|Coagulants|coagulants|mesh-ancestor
139004392|NCT01095133|Diuretics|diuretics|mesh-ancestor
139004393|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
139004394|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004395|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138508877|NCT05326464|Tofacitinib|tofacitinib|mesh-list
138974054|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974055|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974056|NCT00209131|Urological Agents|urological agents|mesh-ancestor
138974057|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
138974058|NCT00907608|Hematinics|hematinics|mesh-ancestor
138974060|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
138974061|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
138974062|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974063|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974064|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138974065|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138974066|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
138974067|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974068|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974069|NCT00224029|Urological Agents|urological agents|mesh-ancestor
138974070|NCT00929370|Glycine|glycine|mesh-list
138974071|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
138974072|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974073|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974074|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974075|NCT00907764|Regadenoson|regadenoson|mesh-list
138974076|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138974077|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138974078|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
138974079|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
138974080|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974081|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974082|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974083|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138974084|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
138974085|NCT02550314|Coagulants|coagulants|mesh-ancestor
138974086|NCT01073527|Adenosine|adenosine|mesh-list
138974087|NCT01073527|Albuterol|albuterol|mesh-list
138974088|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138974089|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
138974090|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974091|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974092|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138974093|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
138974094|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
138974095|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138974096|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138974097|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138974098|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138974099|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
138974100|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974101|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004396|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139004397|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139004398|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004399|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139004400|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139004401|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
139004402|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139004403|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
139004404|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004405|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004406|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139004407|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
139004408|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
139004409|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138974102|NCT01073527|Analgesics|analgesics|mesh-ancestor
138974103|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
138974104|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138974105|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
138974106|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138974107|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
138974108|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
138974109|NCT02538432|Gemcitabine|gemcitabine|mesh-list
138974110|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138974111|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
138598699|NCT02918812|Lidocaine|lidocaine|mesh-list
138974112|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974113|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974115|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
138974116|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
138974117|NCT00719849|Fludarabine|fludarabine|mesh-list
138974118|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
138974119|NCT00719849|Cyclosporins|cyclosporins|mesh-list
138974120|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138974121|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138974122|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
138974123|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974124|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138974125|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138974126|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
138974127|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974128|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974129|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138974130|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138974131|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
138974132|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974133|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
138974134|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974135|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
138974136|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138974137|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138974138|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138974139|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
138974140|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138974141|NCT00822536|Aspirin|aspirin|mesh-list
138974142|NCT00822536|Clopidogrel|clopidogrel|mesh-list
138974143|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138974144|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138974146|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
138974147|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974148|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004411|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004412|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004413|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
139004414|NCT01095211|Vitamins|vitamins|mesh-ancestor
139004415|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
139004416|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004417|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139004418|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139004419|NCT00053365|Irofulven|irofulven|mesh-list
139004420|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139004421|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
138509000|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
138974149|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138974150|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138974151|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138974152|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138974153|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974154|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138974155|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138974156|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974157|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
138974158|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138974159|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138974160|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138974161|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
138974162|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974163|NCT00826826|Amiodarone|amiodarone|mesh-list
138974164|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138974165|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
138974166|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138974167|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138974168|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974169|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138974170|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138974171|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138974172|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974173|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138974174|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138974175|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138974176|NCT02592941|Deflazacort|deflazacort|mesh-list
138974177|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138974178|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138974179|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
138974180|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974181|NCT00822614|Fentanyl|fentanyl|mesh-list
138974182|NCT00822614|Morphine|morphine|mesh-list
138974183|NCT00822614|Oxycodone|oxycodone|mesh-list
138974184|NCT00822614|Hydromorphone|hydromorphone|mesh-list
138974185|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138974186|NCT00822614|Narcotics|narcotics|mesh-ancestor
138974187|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138974188|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974189|NCT00822614|Analgesics|analgesics|mesh-ancestor
138974190|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
138974191|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974192|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138974193|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138974194|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
138974195|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
138974196|NCT04087967|Cytarabine|cytarabine|mesh-list
138974197|NCT04087967|Decitabine|decitabine|mesh-list
138974198|NCT04087967|Idarubicin|idarubicin|mesh-list
139004422|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004423|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004424|NCT00387010|Fentanyl|fentanyl|mesh-list
139004425|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139004426|NCT00387010|Narcotics|narcotics|mesh-ancestor
139004427|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004428|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004429|NCT00387010|Analgesics|analgesics|mesh-ancestor
138974199|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138974200|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
138974201|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974202|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974203|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
138974204|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974205|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138974206|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
138974207|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974208|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974209|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138974210|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138974211|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138974212|NCT00926016|Pioglitazone|pioglitazone|mesh-list
138974213|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138599119|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
138974214|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974215|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138974216|NCT04017104|Edotreotide|edotreotide|mesh-list
138974217|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138974218|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974219|NCT00827138|Rebastinib|rebastinib|mesh-list
138974220|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974221|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138974222|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974223|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974224|NCT00817466|Epinephrine|epinephrine|mesh-list
138974225|NCT00817466|Racepinephrine|racepinephrine|mesh-list
138974226|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
138974227|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138974228|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138974229|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
138974230|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974231|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974232|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974233|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138974234|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138974236|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974237|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138974238|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
138974240|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
138974241|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138974242|NCT00930072|Clonidine|clonidine|mesh-list
138974243|NCT00930072|Bupivacaine|bupivacaine|mesh-list
138974244|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
138974245|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
138974246|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138974247|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599308|NCT00189033|Psyllium|psyllium|mesh-list
138974248|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
138974249|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974250|NCT00930072|Analgesics|analgesics|mesh-ancestor
138974251|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138974252|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
138974253|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
138974254|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138974255|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138974256|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138974257|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
138974258|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004430|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
139004431|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004432|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139004433|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139004434|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
139004435|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
139004436|NCT01092091|BCT-100|bct-100|mesh-list
139004437|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004438|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
139004439|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139004440|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004441|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
139004442|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139004443|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139004444|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004445|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
139004446|NCT00386308|Coagulants|coagulants|mesh-ancestor
139004447|NCT00064987|Hormones|hormones|mesh-list
139004448|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139004449|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139004450|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004451|NCT00374140|Everolimus|everolimus|mesh-list
139004452|NCT00374140|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139004453|NCT00374140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139004454|NCT00374140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004455|NCT00374140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974259|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974260|NCT00626522|Bromides|bromides|mesh-list
138974261|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
138974262|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138974263|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
138974264|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974265|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974266|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138974267|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
138599375|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
138974268|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138974269|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138974270|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138974271|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
138974272|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974273|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974274|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
138974276|NCT00926640|Belinostat|belinostat|mesh-list
138974277|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974278|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138974279|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138974280|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138974281|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004456|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139004457|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
139004458|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004459|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004461|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139004462|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139004463|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139004464|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004465|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139004466|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
139004467|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139004468|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139004469|NCT03955705|Nefopam|nefopam|mesh-list
139004470|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139004471|NCT03955705|Analgesics|analgesics|mesh-ancestor
138974282|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974283|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138974284|NCT00931398|Methylphenidate|methylphenidate|mesh-list
138974285|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138974286|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974287|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138974288|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138974289|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138974290|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974291|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
138974292|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974294|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
138974295|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138974296|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
138974297|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138974298|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974299|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138974300|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138974301|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974302|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974303|NCT00822848|Sorafenib|sorafenib|mesh-list
138974304|NCT00822848|Epirubicin|epirubicin|mesh-list
138974305|NCT00822848|Ifosfamide|ifosfamide|mesh-list
138974306|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974307|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138974308|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974309|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974310|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138974311|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138974312|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138974313|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138974314|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
138974315|NCT00926718|Remifentanil|remifentanil|mesh-list
138934963|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138974316|NCT00926718|Rocuronium|rocuronium|mesh-list
138974317|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138974318|NCT00926718|Narcotics|narcotics|mesh-ancestor
138974319|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138974320|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974321|NCT00926718|Analgesics|analgesics|mesh-ancestor
138974322|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
138974323|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974324|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139004472|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
139004473|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004474|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004475|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
139004476|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139004477|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139004478|NCT00786695|Esomeprazole|esomeprazole|mesh-list
139004479|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139004480|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139004481|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139004482|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004483|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004484|NCT00786851|Lenalidomide|lenalidomide|mesh-list
138974325|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138974326|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138974327|NCT00823004|Letrozole|letrozole|mesh-list
138974328|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
138974329|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
138974330|NCT00823004|Buserelin|buserelin|mesh-list
138974331|NCT00823004|Ganirelix|ganirelix|mesh-list
138974332|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974333|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138974334|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138974335|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974336|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974337|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138974338|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
138974339|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138974340|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974341|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138974342|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138974343|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138974344|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
138974345|NCT00827450|Caffeine|caffeine|mesh-list
138974346|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138974347|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974348|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138974349|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974350|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974351|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138974352|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138974353|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
138974354|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974355|NCT00930306|Tolbutamide|tolbutamide|mesh-list
138974356|NCT00930306|Midazolam|midazolam|mesh-list
138974357|NCT00930306|Caffeine|caffeine|mesh-list
138974358|NCT00930306|Omeprazole|omeprazole|mesh-list
138974359|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138974360|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138974361|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138974362|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974363|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138974364|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138974365|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138974366|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138974367|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
138974368|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
138974369|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
138974370|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
138974371|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974372|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974373|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139004485|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
139004486|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004487|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139004488|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139004489|NCT00786851|Growth Substances|growth substances|mesh-ancestor
139004490|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
139004491|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004492|NCT00787007|Equol|equol|mesh-list
139004493|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
139004494|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139004495|NCT00787007|Estrogens|estrogens|mesh-ancestor
139004496|NCT00787007|Hormones|hormones|mesh-ancestor
139004497|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509307|NCT04557956|Trametinib|trametinib|mesh-list
138974374|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138974375|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974376|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138974377|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138974378|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
138974379|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138974380|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138974381|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138974382|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138974383|NCT00830882|Albuterol|albuterol|mesh-list
138974384|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138974385|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
138974386|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974387|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974388|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138974389|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
138974390|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
138974391|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138974392|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138974393|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138974394|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138974395|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
138974396|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974397|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974398|NCT00823238|Tobramycin|tobramycin|mesh-list
138974399|NCT00823238|Ceftazidime|ceftazidime|mesh-list
138974400|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138974401|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974402|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
138974403|NCT00827684|Sirolimus|sirolimus|mesh-list
138974404|NCT00827684|Irinotecan|irinotecan|mesh-list
138974405|NCT00827684|Temsirolimus|temsirolimus|mesh-list
138974406|NCT00827684|MTOR Inhibitors|mtor inhibitors|mesh-list
138974407|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138974408|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138974409|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974410|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974411|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974412|NCT00827684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138974413|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138974414|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
138974415|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974416|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138974417|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974418|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138974419|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
138974420|NCT00927030|Melatonin|melatonin|mesh-list
138974421|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
138974422|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004498|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004500|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139004501|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004502|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
139004503|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
139004504|NCT00386152|Hematinics|hematinics|mesh-ancestor
139004505|NCT00787553|Cefazolin|cefazolin|mesh-list
139004506|NCT00787553|Tinidazole|tinidazole|mesh-list
139004507|NCT00787553|Imidazole|imidazole|mesh-list
139004508|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139004509|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139004510|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974423|NCT00927030|Protective Agents|protective agents|mesh-ancestor
138974424|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974425|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138974426|NCT00931866|Diclofenac|diclofenac|mesh-list
138974427|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138974428|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138974429|NCT00931866|Analgesics|analgesics|mesh-ancestor
138974430|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
138974431|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974432|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974433|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138974434|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138974435|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138974436|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974437|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974438|NCT00827840|Risperidone|risperidone|mesh-list
138974439|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138974440|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138974441|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
138974442|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974443|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974444|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974445|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138974446|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138974447|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138974448|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138974449|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138974450|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
138974451|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138974452|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138974453|NCT00827996|Adalimumab|adalimumab|mesh-list
138974454|NCT00827996|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138974455|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138974456|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138974457|NCT00936780|Paclitaxel|paclitaxel|mesh-list
138974458|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138974459|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974460|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
138974461|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
138974462|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
138974463|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974464|NCT00823550|Lamivudine|lamivudine|mesh-list
138974465|NCT00823550|Entecavir|entecavir|mesh-list
138974466|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138974467|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138974468|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974469|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974470|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
138974471|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974472|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138974473|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138974474|NCT00932100|Heparin|heparin|mesh-list
139004511|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004512|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
139004513|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139004514|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139004515|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139004516|NCT00795353|Alefacept|alefacept|mesh-list
139004517|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
139004518|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
139004519|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004520|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
139004521|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139004522|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
139004523|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139004524|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004525|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139004526|NCT01045876|Dexamethasone|dexamethasone|mesh-list
138974475|NCT00932100|Calcium heparin|calcium heparin|mesh-list
138974476|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138974477|NCT00932100|Tinzaparin|tinzaparin|mesh-list
138974478|NCT00932100|Dalteparin|dalteparin|mesh-list
138974479|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
138974480|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138974481|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138974482|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974483|NCT00828230|Budesonide|budesonide|mesh-list
138974484|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138974485|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138974486|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
138974487|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974488|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974489|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138974490|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
138974491|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
138974492|NCT00828230|Hormones|hormones|mesh-ancestor
138935035|NCT05659290|Bevacizumab|bevacizumab|mesh-list
138974493|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138974494|NCT04469556|Leucovorin|leucovorin|mesh-list
138974495|NCT04469556|Paclitaxel|paclitaxel|mesh-list
138974496|NCT04469556|Gemcitabine|gemcitabine|mesh-list
138974497|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
138974498|NCT04469556|Irinotecan|irinotecan|mesh-list
138974499|NCT04469556|Folfirinox|folfirinox|mesh-list
138974500|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138974501|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974502|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
138974503|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
138974504|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
138974505|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974506|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138974507|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
138974508|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138974509|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138974510|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974511|NCT04469556|Antidotes|antidotes|mesh-ancestor
138974512|NCT04469556|Protective Agents|protective agents|mesh-ancestor
138974513|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974514|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
138974515|NCT04469556|Vitamins|vitamins|mesh-ancestor
138974516|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
138974517|NCT00937092|Dopamine|dopamine|mesh-list
138974518|NCT00937092|Furosemide|furosemide|mesh-list
138974519|NCT00937092|Diuretics|diuretics|mesh-ancestor
138974520|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
139004527|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139004529|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
139004530|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004531|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004532|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139004533|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
139004534|NCT01045876|Hormones|hormones|mesh-ancestor
139004535|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139004536|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139004537|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004538|NCT00385762|Paroxetine|paroxetine|mesh-list
139004539|NCT00385762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139004540|NCT00385762|Serotonin|serotonin|mesh-list
138974521|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974522|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138974523|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138974524|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974525|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138974526|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
138974527|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
138974528|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974529|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
138974530|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974531|NCT00937092|Protective Agents|protective agents|mesh-ancestor
138974532|NCT04124601|Nivolumab|nivolumab|mesh-list
138974533|NCT04124601|Ipilimumab|ipilimumab|mesh-list
138974534|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138974535|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725354|NCT06046105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138974536|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138974537|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974538|NCT05046639|Lidocaine|lidocaine|mesh-list
138974539|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
138974540|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
138974541|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138974542|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974543|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
138974544|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974545|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138974546|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138974547|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138974548|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138974549|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974550|NCT00931008|Docetaxel|docetaxel|mesh-list
138974551|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974552|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
138974553|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
138974554|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
138974555|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974556|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
138974557|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138974558|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138974559|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974560|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138974561|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138974562|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974563|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974564|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004541|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139004542|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139004543|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004544|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004545|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
139004546|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004547|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139004548|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
139004549|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139004550|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139004551|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139004552|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004553|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139004554|NCT00385684|Acetaminophen|acetaminophen|mesh-list
139004555|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139004556|NCT00385684|Hydrocodone|hydrocodone|mesh-list
138974565|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138974566|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
138974567|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138974568|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974569|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138974570|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138974571|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138974572|NCT00932880|Amlodipine|amlodipine|mesh-list
138974573|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138974574|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138974575|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138974576|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974577|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138974578|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974579|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
138974580|NCT00937482|Cediranib|cediranib|mesh-list
138974581|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974582|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974583|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974584|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138974585|NCT00931086|Belimumab|belimumab|mesh-list
138974586|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138974588|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974589|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
138974590|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138974591|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
138974592|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138974593|NCT04453839|Protective Agents|protective agents|mesh-ancestor
138974594|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974595|NCT03977454|Ropivacaine|ropivacaine|mesh-list
138974596|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
138974597|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
138974598|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138974599|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974600|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
138974601|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974602|NCT02549066|Milrinone|milrinone|mesh-list
138974603|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138974604|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139004557|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139004558|NCT00385684|Narcotics|narcotics|mesh-ancestor
139004559|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004560|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004561|NCT00385684|Analgesics|analgesics|mesh-ancestor
139004562|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
139004563|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004564|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
139004565|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
139004566|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139004567|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
139004568|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139004569|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139004570|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138974605|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
138974606|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138974607|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138974608|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039551|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974609|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974610|NCT02549066|Protective Agents|protective agents|mesh-ancestor
138974611|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974613|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138974614|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138974615|NCT00831350|Growth Substances|growth substances|mesh-ancestor
138974616|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974617|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
138974618|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974619|NCT00938184|Paroxetine|paroxetine|mesh-list
138974620|NCT00938184|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138974621|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138974622|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139039552|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974623|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974624|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974625|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
138974626|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974627|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138974628|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
138974629|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138974630|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138974631|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138974632|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974633|NCT00938262|Rifampin|rifampin|mesh-list
138974634|NCT00938262|Ketoconazole|ketoconazole|mesh-list
138974635|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138974636|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
138974637|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138974638|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974639|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
138974640|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138974641|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974642|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974643|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138974644|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138974645|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138974646|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138974647|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139004571|NCT00661661|Tofacitinib|tofacitinib|mesh-list
139004572|NCT00661661|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139004573|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139004574|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004575|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004576|NCT00038467|Tamoxifen|tamoxifen|mesh-list
139004577|NCT00038467|Exemestane|exemestane|mesh-list
139004578|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139004579|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
139004580|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138974648|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138974649|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
138974650|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138974651|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138974652|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138974653|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
138974654|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138974655|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974656|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138974657|NCT00933426|Paclitaxel|paclitaxel|mesh-list
138974658|NCT00933426|Lenalidomide|lenalidomide|mesh-list
138974659|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138974660|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974661|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
138974662|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
138974663|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
138974664|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974665|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
138974666|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974667|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138974668|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138974669|NCT00933426|Growth Substances|growth substances|mesh-ancestor
138974670|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
138974671|NCT04013958|Ketamine|ketamine|mesh-list
138974672|NCT04013958|Analgesics|analgesics|mesh-ancestor
138974673|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
138974674|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974675|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974676|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138974677|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138974678|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
138974679|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
138974680|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138974681|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138974682|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138974683|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974684|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974686|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138974687|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138974688|NCT00933582|Analgesics|analgesics|mesh-ancestor
138974689|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
138974690|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974691|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974692|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138974693|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138974694|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
138974695|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138974696|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974697|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974699|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
138974700|NCT00933816|Fluorouracil|fluorouracil|mesh-list
138974701|NCT00933816|Sorafenib|sorafenib|mesh-list
138974702|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004581|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004582|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139004583|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004584|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139004585|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139004586|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139004587|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139004588|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139004589|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004590|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004591|NCT01095445|Ribavirin|ribavirin|mesh-list
139004592|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139004593|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
139004594|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974703|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
138974704|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974705|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138974706|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138974707|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
138974708|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974709|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138974710|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974711|NCT00538785|Palivizumab|palivizumab|mesh-list
138974712|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
138974713|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974714|NCT01563939|Remifentanil|remifentanil|mesh-list
138974715|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138974716|NCT01563939|Narcotics|narcotics|mesh-ancestor
138974717|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138974718|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974719|NCT01563939|Analgesics|analgesics|mesh-ancestor
138974720|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
138974721|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974722|NCT03287271|Paclitaxel|paclitaxel|mesh-list
138974723|NCT03287271|Carboplatin|carboplatin|mesh-list
138974724|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138974725|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974726|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
138974727|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
138974728|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
138974729|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974730|NCT00990405|Amoxicillin|amoxicillin|mesh-list
138974731|NCT00990405|Clarithromycin|clarithromycin|mesh-list
138974732|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138974733|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974734|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138974735|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974736|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974737|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138974738|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138974739|NCT00990639|Candesartan|candesartan|mesh-list
138974740|NCT00990639|Candesartan cilexetil|candesartan cilexetil|mesh-list
138974741|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138974742|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138974743|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138974744|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974745|NCT03742947|Hemostatics|hemostatics|mesh-list
138974746|NCT03742947|Coagulants|coagulants|mesh-ancestor
138974747|NCT05359497|Liver Extracts|liver extracts|mesh-list
139004595|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
139004596|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139004598|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139004599|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139004600|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004601|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139004602|NCT00050167|Paclitaxel|paclitaxel|mesh-list
139004603|NCT00050167|Docetaxel|docetaxel|mesh-list
139004604|NCT00050167|Capecitabine|capecitabine|mesh-list
139004605|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139004606|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004607|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
139004608|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
139004609|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
138755358|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139004610|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004611|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139004612|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
139004613|NCT01096927|Amoxicillin|amoxicillin|mesh-list
139004614|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
139004615|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
139004616|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139004617|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935123|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139004618|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974748|NCT05359497|Hematinics|hematinics|mesh-ancestor
138974749|NCT00990795|Cyclosporine|cyclosporine|mesh-list
138974750|NCT00990795|Cyclosporins|cyclosporins|mesh-list
138974751|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974752|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974753|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138974754|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
138974755|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974756|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
138974757|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974758|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
138974759|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138974760|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138974761|NCT00622700|Teriflunomide|teriflunomide|mesh-list
138974762|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138974763|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138974764|NCT00622700|Analgesics|analgesics|mesh-ancestor
138974765|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
138974766|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974767|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974769|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138974770|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138974771|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
138974772|NCT00831506|Digoxin|digoxin|mesh-list
138974773|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138974774|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138974775|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004619|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004620|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139004622|NCT00660023|Hematinics|hematinics|mesh-ancestor
139004623|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
139004624|NCT02554955|Daclizumab|daclizumab|mesh-list
139004625|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139004626|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004627|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139004628|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
139004629|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139004630|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139004631|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004632|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004633|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139004634|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
139004635|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004636|NCT00062647|Vancomycin|vancomycin|mesh-list
139004637|NCT00062647|Cloxacillin|cloxacillin|mesh-list
139004638|NCT00062647|Oxacillin|oxacillin|mesh-list
139004639|NCT00062647|Telavancin|telavancin|mesh-list
139004640|NCT00062647|Nafcillin|nafcillin|mesh-list
139004641|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139004642|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139004643|NCT00570323|Fulvestrant|fulvestrant|mesh-list
139004644|NCT00570323|Anastrozole|anastrozole|mesh-list
139004645|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139004646|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004668|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139004669|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
139004670|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139004671|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139004672|NCT00788099|Gemcitabine|gemcitabine|mesh-list
139004673|NCT00788099|Sorafenib|sorafenib|mesh-list
139004674|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139004675|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
139004676|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004677|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004678|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139004679|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004680|NCT00795587|Mannitol|mannitol|mesh-list
139004681|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139004682|NCT00795587|Diuretics|diuretics|mesh-ancestor
139004683|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
139004684|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004685|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
139004686|NCT00661505|Hematinics|hematinics|mesh-ancestor
139004687|NCT00788333|Trastuzumab|trastuzumab|mesh-list
139004688|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139004689|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004690|NCT00795899|Paclitaxel|paclitaxel|mesh-list
139004691|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
139004692|NCT00795899|Trastuzumab|trastuzumab|mesh-list
139004693|NCT00795899|Epirubicin|epirubicin|mesh-list
139004694|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138509874|NCT03420521|Nivolumab|nivolumab|mesh-list
138974776|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974777|NCT00831506|Protective Agents|protective agents|mesh-ancestor
138974778|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974779|NCT02842359|Irbesartan|irbesartan|mesh-list
138974780|NCT02842359|Atorvastatin|atorvastatin|mesh-list
138974781|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138974782|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138974783|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
138974784|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974785|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138974786|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138974787|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974788|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138974789|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138974790|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138974791|NCT00828776|Heparin|heparin|mesh-list
138974792|NCT00828776|Calcium heparin|calcium heparin|mesh-list
138974793|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
138974794|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138974795|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138974796|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974797|NCT00622466|Paclitaxel|paclitaxel|mesh-list
138974798|NCT00622466|Sorafenib|sorafenib|mesh-list
139004695|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004696|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
139004697|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
139004698|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
139004699|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004700|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139004701|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
139004702|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004703|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139004704|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139004705|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
139004706|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139004707|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138974799|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138974800|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974801|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
138974802|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
138974803|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
138974804|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974805|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138974806|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974807|NCT04043858|Midodrine|midodrine|mesh-list
138974808|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
138974809|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
138974810|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974811|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974812|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138974813|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138974814|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138974815|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138974816|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
138974817|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974818|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974819|NCT05359419|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138974820|NCT05359419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138974821|NCT05359419|Dermatologic Agents|dermatologic agents|mesh-ancestor
138974822|NCT00823862|Ribavirin|ribavirin|mesh-list
138974823|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
138974824|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974825|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
138974826|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974827|NCT00537771|Tamoxifen|tamoxifen|mesh-list
138974828|NCT00537771|Anastrozole|anastrozole|mesh-list
138974829|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138974830|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
138974831|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138974832|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974833|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138974834|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600550|NCT00159380|Pimagedine|pimagedine|mesh-list
138974835|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138974836|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138974837|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138974839|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138974840|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974841|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974843|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138974844|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139004708|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139004709|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139004710|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139004711|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004712|NCT00795977|Picibanil|picibanil|mesh-list
139004713|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004714|NCT00796211|Nortriptyline|nortriptyline|mesh-list
139004715|NCT00796211|Calcipotriene|calcipotriene|mesh-list
139004716|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
139004717|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139004718|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
139004719|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139004720|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139004721|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139004722|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139004723|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004724|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
139004725|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004726|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004727|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
139004728|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139004729|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138509987|NCT03113422|Venetoclax|venetoclax|mesh-list
138974845|NCT00823940|Hormones|hormones|mesh-ancestor
138974846|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138974847|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974848|NCT00823940|Incretins|incretins|mesh-ancestor
138974849|NCT00829322|Modafinil|modafinil|mesh-list
138974850|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138974851|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974852|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138974853|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138974854|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138974855|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974856|NCT00623480|Factor VIII|factor viii|mesh-list
138974857|NCT00623480|Coagulants|coagulants|mesh-ancestor
138974858|NCT02513667|Ceritinib|ceritinib|mesh-list
138974859|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974860|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138974861|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974862|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974863|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
138974864|NCT03823911|Grazoprevir|grazoprevir|mesh-list
138974865|NCT03823911|Ledipasvir|ledipasvir|mesh-list
138974866|NCT03823911|Velpatasvir|velpatasvir|mesh-list
138974867|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138974868|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138974869|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
138974870|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974871|NCT00829634|Methamphetamine|methamphetamine|mesh-list
138974872|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138974873|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004730|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139004731|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
139004732|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139004733|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139004735|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004736|NCT00662909|Mirabegron|mirabegron|mesh-list
139004737|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139004738|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139004739|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139004740|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
139004741|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004742|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004743|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004744|NCT00662909|Urological Agents|urological agents|mesh-ancestor
139004745|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
139004746|NCT00050011|Letrozole|letrozole|mesh-list
139004747|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004748|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138974874|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
138974875|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
138974876|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974877|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
138974878|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974879|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974880|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
138974881|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138974882|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138974883|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138974884|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138974885|NCT04003467|Teriparatide|teriparatide|mesh-list
138974886|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138974887|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974888|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138974889|NCT00832208|Amphotericin B|amphotericin b|mesh-list
138974890|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138974891|NCT00832208|Amebicides|amebicides|mesh-ancestor
138974892|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138974893|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138974894|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974895|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138974896|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
138974897|NCT05361057|Cytarabine|cytarabine|mesh-list
138974898|NCT05361057|Azacitidine|azacitidine|mesh-list
138974899|NCT05361057|Daunorubicin|daunorubicin|mesh-list
138974900|NCT05361057|Venetoclax|venetoclax|mesh-list
138974901|NCT05361057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138974902|NCT05361057|Antimetabolites|antimetabolites|mesh-ancestor
138974903|NCT05361057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974904|NCT05361057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974905|NCT05361057|Antiviral Agents|antiviral agents|mesh-ancestor
138974906|NCT05361057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974907|NCT05361057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138974908|NCT05361057|Immunologic Factors|immunologic factors|mesh-ancestor
138974909|NCT05361057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974910|NCT05361057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004749|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139004750|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004751|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004752|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139004753|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
139004754|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139004755|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004756|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139004757|NCT00661427|Cetuximab|cetuximab|mesh-list
139004758|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139004759|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004761|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004762|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139004763|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004764|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004765|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
139004766|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139004767|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974911|NCT05361057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138974912|NCT05361057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138974913|NCT05361057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138974914|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
138974915|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138974916|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138974917|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138974918|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138974919|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974920|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974921|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974922|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138600816|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138935192|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
138974923|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138974924|NCT00832364|Etanercept|etanercept|mesh-list
138974925|NCT00832364|Acitretin|acitretin|mesh-list
138974926|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138974927|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138974928|NCT00832364|Analgesics|analgesics|mesh-ancestor
138974929|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
138974930|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974931|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974932|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138974933|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138600899|NCT00543049|Sunitinib|sunitinib|mesh-list
138974934|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138974935|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138974936|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
138974937|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
138974938|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
138974939|NCT00832442|Metoprolol|metoprolol|mesh-list
138974940|NCT00832442|Carvedilol|carvedilol|mesh-list
138974941|NCT00832442|Nebivolol|nebivolol|mesh-list
138974942|NCT00832442|Bisoprolol|bisoprolol|mesh-list
138974943|NCT00832442|Bucindolol|bucindolol|mesh-list
138974944|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138974945|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139004768|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
139004769|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004770|NCT00035815|Mitogens|mitogens|mesh-list
139004771|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
139004772|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004773|NCT00662831|Dalteparin|dalteparin|mesh-list
139004774|NCT00662831|Tinzaparin|tinzaparin|mesh-list
139004775|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139004776|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
139004777|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139004778|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139004779|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004780|NCT02555423|Anesthetics|anesthetics|mesh-list
138974946|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138974947|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
138974948|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
138974949|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138974950|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974951|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138974952|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138974953|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
138974954|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138974955|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138974956|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
138974957|NCT00832442|Protective Agents|protective agents|mesh-ancestor
138974958|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138974959|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138974960|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138974961|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
138974962|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138974963|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138974964|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138974965|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138974966|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138974967|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
138974968|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138974969|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
138974970|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138974971|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138974972|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138974973|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
138974974|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138974975|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974976|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138935201|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138974977|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138974978|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138974979|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138974980|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138974981|NCT00830492|Clomiphene|clomiphene|mesh-list
138974983|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
138974984|NCT00830492|Buserelin|buserelin|mesh-list
138974985|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138974986|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
138974987|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138974988|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138974989|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138974990|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
138974991|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138974992|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138974993|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138974994|NCT00830570|Warfarin|warfarin|mesh-list
138974995|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
139004781|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
139004782|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
139004783|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004784|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004785|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
139004786|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004788|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139004789|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004790|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004791|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139004792|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
139004793|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
139004794|NCT00662363|Lubiprostone|lubiprostone|mesh-list
139004795|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139004796|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139004797|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004798|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139004799|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138974996|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
138974997|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138974998|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138974999|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975000|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138975001|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975002|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138975003|NCT04043702|Topiramate|topiramate|mesh-list
138975004|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
138975005|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138975006|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975007|NCT02550080|Dapsone|dapsone|mesh-list
138975008|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975009|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
138975010|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138975011|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138975012|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138975013|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975014|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975015|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
138975016|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138975017|NCT02547350|Pirarubicin|pirarubicin|mesh-list
138975018|NCT02547350|Epirubicin|epirubicin|mesh-list
138975019|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975020|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138975021|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138975022|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138975023|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975024|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975025|NCT00838214|Prednisone|prednisone|mesh-list
138975026|NCT00838214|Budesonide|budesonide|mesh-list
138975027|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975028|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
138975029|NCT00838214|Hormones|hormones|mesh-ancestor
138975030|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975031|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004800|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139004801|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004802|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004803|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139004804|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139004805|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139004806|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
139004807|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004808|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004809|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139004810|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139004811|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
138510274|NCT01228331|Methotrexate|methotrexate|mesh-list
138975032|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138975033|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975034|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138975035|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
138975036|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975037|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138975038|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
138975039|NCT00621764|Vaccines|vaccines|mesh-list
138975040|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
138975041|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975042|NCT00838370|Capecitabine|capecitabine|mesh-list
138975043|NCT00838370|Fluorouracil|fluorouracil|mesh-list
138975044|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138975045|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
138975046|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975047|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975048|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138975049|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
138975050|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975051|NCT00537381|Prednisone|prednisone|mesh-list
138975052|NCT00537381|Docetaxel|docetaxel|mesh-list
138975053|NCT00537381|Intetumumab|intetumumab|mesh-list
138975054|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975055|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
138975056|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
138975057|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
138975058|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975059|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975060|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
138975061|NCT00537381|Hormones|hormones|mesh-ancestor
138975062|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975063|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601114|NCT00544570|Melphalan|melphalan|mesh-list
138975064|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138975065|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138975066|NCT00833300|Haloperidol|haloperidol|mesh-list
138975067|NCT00833300|Olanzapine|olanzapine|mesh-list
138975068|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
138975069|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
138975070|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
138975071|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975072|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975073|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138975074|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138975075|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138975076|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975077|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138975078|NCT00833300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138975079|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139004812|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
139004814|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
139004815|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004816|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139004817|NCT02554175|Propofol|propofol|mesh-list
139004818|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139004819|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004820|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004821|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139004822|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
138975080|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138975081|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975082|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975083|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
138975084|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138975085|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
138975086|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138975087|NCT00833378|Ritonavir|ritonavir|mesh-list
138975088|NCT00833378|Lopinavir|lopinavir|mesh-list
138975089|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138975090|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138601175|NCT00160277|Moxonidine|moxonidine|mesh-list
138975091|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
138975092|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975093|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975094|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138975095|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138975096|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
138975097|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975098|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138975099|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138975100|NCT05359341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138975101|NCT05359341|Empagliflozin|empagliflozin|mesh-list
138975102|NCT05359341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138975103|NCT05359341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138975104|NCT05359341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138975105|NCT05359341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975106|NCT05359341|Incretins|incretins|mesh-ancestor
138975107|NCT05359341|Hormones|hormones|mesh-ancestor
138975108|NCT05359341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975109|NCT05359341|Protease Inhibitors|protease inhibitors|mesh-ancestor
138975110|NCT05359341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975111|NCT05359341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975112|NCT05398731|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138975113|NCT05398731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138975114|NCT05398731|Adrenergic Agents|adrenergic agents|mesh-ancestor
138975115|NCT05398731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975116|NCT05398731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975117|NCT05398731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975118|NCT00838760|Darunavir|darunavir|mesh-list
138975119|NCT00838760|TMC-310911|tmc-310911|mesh-list
138975120|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138975121|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138975122|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
138975123|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975124|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975125|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138975126|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138975127|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
138975128|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975129|NCT03791398|Nivolumab|nivolumab|mesh-list
138975130|NCT03791398|TIC10 compound|tic10 compound|mesh-list
138975131|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139004823|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
139004824|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139004825|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139004826|NCT00789503|Vitamin D|vitamin d|mesh-list
139004827|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
139004828|NCT00789503|Calcium|calcium|mesh-list
139004829|NCT00789503|Vitamins|vitamins|mesh-ancestor
139004830|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
139004831|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004832|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139004833|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139004834|NCT00797303|Bevacizumab|bevacizumab|mesh-list
139004835|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139004837|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139004838|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139004839|NCT00797303|Growth Substances|growth substances|mesh-ancestor
138975132|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975133|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138975134|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975135|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
138975136|NCT00838838|Testosterone|testosterone|mesh-list
138975137|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
138975138|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
138975139|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138975140|NCT00838838|Androgens|androgens|mesh-ancestor
138975142|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975143|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975144|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138975145|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975146|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
138975147|NCT05360979|Endostatins|endostatins|mesh-list
138975148|NCT05360979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975149|NCT05360979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138975150|NCT05360979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138975151|NCT05360979|Growth Substances|growth substances|mesh-ancestor
138975152|NCT05360979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975153|NCT05360979|Growth Inhibitors|growth inhibitors|mesh-ancestor
138975154|NCT00833534|Rituximab|rituximab|mesh-list
138975155|NCT00833534|Lenalidomide|lenalidomide|mesh-list
138601344|NCT00546130|Cisplatin|cisplatin|mesh-list
138975156|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138975157|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975158|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
138975159|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975160|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138975161|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138975162|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138975163|NCT00833534|Growth Substances|growth substances|mesh-ancestor
138975164|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
138975166|NCT05591001|Propofol|propofol|mesh-list
138975167|NCT05591001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138975168|NCT05591001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975169|NCT05591001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975170|NCT05591001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138975171|NCT05591001|Anesthetics, General|anesthetics, general|mesh-ancestor
138975172|NCT05591001|Anesthetics|anesthetics|mesh-ancestor
138975173|NCT05591001|Analgesics|analgesics|mesh-ancestor
138975174|NCT05591001|Sensory System Agents|sensory system agents|mesh-ancestor
138975175|NCT05591001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975176|NCT05591001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138975177|NCT05591001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139004840|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004842|NCT00661193|Paclitaxel|paclitaxel|mesh-list
139004843|NCT00661193|Carboplatin|carboplatin|mesh-list
139004844|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139004845|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139004846|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004847|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
139004848|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
139004849|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
139004850|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004851|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139004852|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004853|NCT00801047|Remifentanil|remifentanil|mesh-list
139004854|NCT00801047|Bupivacaine|bupivacaine|mesh-list
139004855|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
139004856|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
138330820|NCT05256641|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138601389|NCT00546325|Rimonabant|rimonabant|mesh-list
138975178|NCT05591001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138975179|NCT05591001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975180|NCT05591001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975181|NCT00517192|Ritonavir|ritonavir|mesh-list
138975182|NCT00517192|Darunavir|darunavir|mesh-list
138975183|NCT00517192|Tipranavir|tipranavir|mesh-list
138975184|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138975185|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138975186|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
138975187|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975188|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975189|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138975190|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138975191|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
138975192|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975193|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138975194|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138975195|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
138975196|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138975197|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975198|NCT00833768|Sevelamer|sevelamer|mesh-list
138975199|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
138975200|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
138975201|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975202|NCT00510484|Pancrelipase|pancrelipase|mesh-list
138975203|NCT00510484|Pancreatin|pancreatin|mesh-list
138975204|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138975205|NCT00839228|Perhexiline|perhexiline|mesh-list
138975206|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138975207|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138975208|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975209|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138975210|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975211|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
138975212|NCT05408481|Hydrocortisone|hydrocortisone|mesh-list
138975213|NCT05408481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975214|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
138975215|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
138975217|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
138975218|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004857|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004858|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004859|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
139004860|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004861|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139004862|NCT00801047|Narcotics|narcotics|mesh-ancestor
139004863|NCT00801047|Analgesics|analgesics|mesh-ancestor
139004864|NCT00801125|Natalizumab|natalizumab|mesh-list
139004865|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
139004866|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004867|NCT00801281|Prednisone|prednisone|mesh-list
139004868|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
139004869|NCT00801281|Rituximab|rituximab|mesh-list
139004870|NCT00801281|Doxorubicin|doxorubicin|mesh-list
139004871|NCT00801281|Vincristine|vincristine|mesh-list
139004872|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139004873|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
139004874|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004875|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139004876|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139004877|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
139004878|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004879|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139004880|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139004881|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139004882|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139004883|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138975219|NCT05590143|Dapagliflozin|dapagliflozin|mesh-list
138975220|NCT05590143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138975221|NCT05590143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975222|NCT05590143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138975223|NCT05590143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975224|NCT00622388|Ofatumumab|ofatumumab|mesh-list
138975225|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975226|NCT01156389|Ritonavir|ritonavir|mesh-list
138975227|NCT01156389|Artesunate|artesunate|mesh-list
138975228|NCT01156389|Pyronaridine|pyronaridine|mesh-list
138975229|NCT01156389|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
138975230|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138975231|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138975232|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
138975233|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975234|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975235|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138975236|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138975237|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
138975238|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975239|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139004884|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139004885|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139004886|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139004887|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
139004888|NCT00801281|Hormones|hormones|mesh-ancestor
139004889|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139004890|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139004891|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139004892|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
139004893|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
139004894|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
139004895|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139004896|NCT00801515|Maraviroc|maraviroc|mesh-list
138188800|NCT03122847|Hormones|hormones|mesh-ancestor
138975240|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138975241|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
138975242|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138975243|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138975244|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975245|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
138975246|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138975247|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
138975248|NCT04043624|Lidocaine|lidocaine|mesh-list
138975249|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
138975250|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
138975251|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975252|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975253|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
138975254|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975255|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138975256|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138975257|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138975258|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138975259|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975260|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
138975261|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138975262|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138975263|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975264|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
138975265|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
138975266|NCT00625742|Ibuprofen|ibuprofen|mesh-list
138975267|NCT00625742|Atenolol|atenolol|mesh-list
138975268|NCT00625742|Melatonin|melatonin|mesh-list
138975269|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138975270|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138975271|NCT00625742|Analgesics|analgesics|mesh-ancestor
138975272|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
138975273|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975274|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975275|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975276|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138975277|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138975278|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975279|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975280|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
138975281|NCT00625742|Protective Agents|protective agents|mesh-ancestor
138726102|NCT05624996|Paclitaxel|paclitaxel|mesh-list
138975282|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975283|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138975284|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138975285|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
138975286|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
139004897|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139004898|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139004899|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004900|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139004901|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139004902|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
139004903|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139004904|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139004905|NCT00797693|Misoprostol|misoprostol|mesh-list
139004906|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139004907|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
139004908|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138755657|NCT01229111|Protective Agents|protective agents|mesh-ancestor
138194758|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
138975287|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138975288|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138975289|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138975290|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
138975291|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975292|NCT05589441|Insulin|insulin|mesh-list
138975293|NCT05589441|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138975294|NCT05589441|Albuterol|albuterol|mesh-list
138975295|NCT05589441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138975296|NCT05589441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975297|NCT05589441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138975298|NCT05589441|Autonomic Agents|autonomic agents|mesh-ancestor
138975299|NCT05589441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975300|NCT05589441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138975301|NCT05589441|Respiratory System Agents|respiratory system agents|mesh-ancestor
138975302|NCT05589441|Tocolytic Agents|tocolytic agents|mesh-ancestor
138975303|NCT05589441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138975304|NCT05589441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138975305|NCT05589441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138975306|NCT05589441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138975307|NCT05589441|Adrenergic Agents|adrenergic agents|mesh-ancestor
138975308|NCT05589441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975309|NCT05589441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975310|NCT00825188|Amlodipine|amlodipine|mesh-list
138975311|NCT00825188|Eplerenone|eplerenone|mesh-list
138975312|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138975313|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138975314|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138975315|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975316|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138975317|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975318|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
138975319|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138975320|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
138975321|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975322|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138975323|NCT00825188|Diuretics|diuretics|mesh-ancestor
138975324|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
138975325|NCT00834470|Atropine|atropine|mesh-list
138975326|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138975327|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138975328|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138975329|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
138975330|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975331|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975332|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139004909|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004910|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139004911|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139004912|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
139004913|NCT00797771|Insulin|insulin|mesh-list
139004914|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139004915|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004916|NCT00793559|Terlipressin|terlipressin|mesh-list
139004917|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138935300|NCT01005914|Cytarabine|cytarabine|mesh-list
139004918|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139004919|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139004920|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
138975333|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
138975334|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
138975335|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
138975336|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138975337|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138975338|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
138975339|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975340|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975341|NCT03997864|Prazosin|prazosin|mesh-list
138975342|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138975343|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138975344|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138975345|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138975347|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975348|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975349|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975350|NCT05407467|Curcumin|curcumin|mesh-list
138975351|NCT05407467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138975352|NCT05407467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138975353|NCT05407467|Analgesics|analgesics|mesh-ancestor
138975354|NCT05407467|Sensory System Agents|sensory system agents|mesh-ancestor
138975355|NCT05407467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975356|NCT05407467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975357|NCT05407467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975358|NCT05407467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138975359|NCT05407467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975360|NCT05407467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975361|NCT05407467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975363|NCT01010152|Analgesics|analgesics|mesh-ancestor
138975364|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
138975365|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975366|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975367|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138975369|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975370|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
138975371|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
138975372|NCT02549846|Atorvastatin|atorvastatin|mesh-list
138975373|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138975374|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138975375|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138975376|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
138975377|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975378|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138975379|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138975380|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975381|NCT05407155|Paclitaxel|paclitaxel|mesh-list
138975382|NCT05407155|Bevacizumab|bevacizumab|mesh-list
138975383|NCT05407155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138975384|NCT05407155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975385|NCT05407155|Tubulin Modulators|tubulin modulators|mesh-ancestor
138975386|NCT05407155|Antimitotic Agents|antimitotic agents|mesh-ancestor
139004921|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
139004922|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139004923|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139004924|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004925|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004926|NCT00798083|Lidocaine|lidocaine|mesh-list
139004927|NCT00798083|Ketamine|ketamine|mesh-list
139004928|NCT00798083|Amitriptyline|amitriptyline|mesh-list
139004929|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
139004930|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
139004931|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004932|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510688|NCT00064285|Alvocidib|alvocidib|mesh-list
138975387|NCT05407155|Mitosis Modulators|mitosis modulators|mesh-ancestor
138975388|NCT05407155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975389|NCT05407155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138975390|NCT05407155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138975391|NCT05407155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138975392|NCT05407155|Growth Substances|growth substances|mesh-ancestor
138975393|NCT05407155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975394|NCT05407155|Growth Inhibitors|growth inhibitors|mesh-ancestor
138975395|NCT00840242|Nicotine|nicotine|mesh-list
138975396|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138975397|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
138975398|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975399|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975400|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138975401|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138975402|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
138975403|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975404|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975405|NCT00840398|Buspirone|buspirone|mesh-list
138975406|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138975407|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138975408|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975409|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975410|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138975411|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138975412|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
138975413|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601769|NCT00184977|Xhance|xhance|mesh-list
138975414|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975416|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138975417|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
138975418|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
138975419|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138975420|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
138975421|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138975422|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975423|NCT02548286|Amlodipine|amlodipine|mesh-list
138975424|NCT02548286|Candesartan|candesartan|mesh-list
138975425|NCT02548286|Candesartan cilexetil|candesartan cilexetil|mesh-list
138975426|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138975427|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138975428|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138975429|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975430|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138975431|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975432|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
138975433|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138975434|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138975435|NCT05360433|Oxycodone|oxycodone|mesh-list
138975436|NCT05360433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139004933|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
139004934|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004935|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138935324|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
139004936|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139004937|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139004938|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139004939|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004940|NCT00798083|Analgesics|analgesics|mesh-ancestor
139004941|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139004942|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139004943|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
139004944|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139004945|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139004946|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004947|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139004948|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
139004949|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139004950|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139004951|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139004952|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139004953|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
139004954|NCT00798395|Zopiclone|zopiclone|mesh-list
138975437|NCT05360433|Narcotics|narcotics|mesh-ancestor
138975438|NCT05360433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975439|NCT05360433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975440|NCT05360433|Analgesics|analgesics|mesh-ancestor
138975441|NCT05360433|Sensory System Agents|sensory system agents|mesh-ancestor
138975442|NCT05360433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975443|NCT00834860|Ribavirin|ribavirin|mesh-list
138975444|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138975445|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
138975446|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975447|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
138975448|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975449|NCT00825422|Ropivacaine|ropivacaine|mesh-list
138975450|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
138975451|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
138975452|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975453|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975454|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
138975455|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975457|NCT00505414|Tapentadol|tapentadol|mesh-list
138975458|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138975459|NCT00505414|Narcotics|narcotics|mesh-ancestor
138975460|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975461|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975462|NCT00505414|Analgesics|analgesics|mesh-ancestor
138975463|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
138975464|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975465|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138975466|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139004955|NCT00798395|Mirtazapine|mirtazapine|mesh-list
139004956|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139004957|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004958|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004959|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
139004960|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139004961|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139004962|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
139004963|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
139004964|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004965|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004966|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138975467|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138601849|NCT00161564|Rituximab|rituximab|mesh-list
138975468|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975469|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
138975470|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975471|NCT02549924|Resveratrol|resveratrol|mesh-list
138975472|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
138975473|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975474|NCT02549924|Protective Agents|protective agents|mesh-ancestor
138975475|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975476|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975477|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138975478|NCT01813227|Dexamethasone|dexamethasone|mesh-list
138975480|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975481|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
138975482|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
138975483|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975484|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975485|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138975486|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
138975487|NCT01813227|Hormones|hormones|mesh-ancestor
138975488|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975489|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138975490|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975491|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138975492|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
138975493|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138975494|NCT01012882|Immunomodulating Agents|immunomodulating agents|mesh-list
138975495|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
138975496|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975497|NCT00989469|Irinotecan|irinotecan|mesh-list
138975498|NCT00989469|Sorafenib|sorafenib|mesh-list
138975499|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138975500|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138975501|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975502|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975503|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726331|NCT05408845|Immunotoxins|immunotoxins|mesh-ancestor
138975504|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138975505|NCT01010308|Nadolol|nadolol|mesh-list
138975506|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138975507|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138975508|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
138975509|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975510|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975511|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975512|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138975513|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138975514|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
138975515|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
139004968|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139004969|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139004970|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139004971|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
139004972|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139004973|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139004974|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
138975516|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975518|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
138975519|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138975520|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
138975521|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138975522|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975523|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
138975524|NCT02548052|Hormones|hormones|mesh-ancestor
138975525|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975526|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975527|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138975528|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
138975529|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
138975530|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138975531|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138975532|NCT04590417|Estradiol|estradiol|mesh-list
138975533|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138975534|NCT04590417|Cyproterone|cyproterone|mesh-list
138975535|NCT04590417|Estrogens|estrogens|mesh-ancestor
138975536|NCT04590417|Hormones|hormones|mesh-ancestor
138975537|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975538|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975539|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138975540|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
138975541|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138975542|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138975543|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
138975544|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
138975545|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975546|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138975547|NCT00825656|Capsaicin|capsaicin|mesh-list
138975548|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
138975549|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
138975550|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
138975551|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975552|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975553|NCT00989625|Naproxen|naproxen|mesh-list
138975554|NCT00989625|Sumatriptan|sumatriptan|mesh-list
138975555|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138975556|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138975557|NCT00989625|Analgesics|analgesics|mesh-ancestor
138975558|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
138975559|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975560|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975561|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975562|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138975563|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
138975564|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138975565|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975566|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975567|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138975568|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138975569|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138975570|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
138975571|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975572|NCT00841256|Glycerol|glycerol|mesh-list
138975573|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138975574|NCT00841256|Protective Agents|protective agents|mesh-ancestor
139004975|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139004976|NCT00801905|Nepafenac|nepafenac|mesh-list
139004977|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139004978|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139004979|NCT00801905|Analgesics|analgesics|mesh-ancestor
139004980|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
139004981|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139004982|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755738|NCT02839135|Scopolamine|scopolamine|mesh-list
139004983|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138625683|NCT00563446|Hematinics|hematinics|mesh-ancestor
139004984|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139004985|NCT00658541|Zolpidem|zolpidem|mesh-list
139004986|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139004987|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139004988|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139004989|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139004990|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139004991|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
139004992|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
139004993|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139004994|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139004995|NCT00048061|Vitamin D|vitamin d|mesh-list
139004996|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
139004997|NCT00048061|Calcium|calcium|mesh-list
139004998|NCT00048061|Vitamins|vitamins|mesh-ancestor
139004999|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
139005000|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005001|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139005002|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139005004|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139005005|NCT00802139|Trace Elements|trace elements|mesh-ancestor
139005006|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
139005007|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975575|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975576|NCT00989703|Methotrexate|methotrexate|mesh-list
138975577|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138975578|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
138975579|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138975580|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975581|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138975582|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
138602114|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
138975583|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005008|NCT00802139|Hematinics|hematinics|mesh-ancestor
139005009|NCT00802217|Capsaicin|capsaicin|mesh-list
139005010|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
139005011|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
139005012|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
139005013|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005014|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005015|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
139005016|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139005017|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139005018|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139005019|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
139005020|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139005021|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005022|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005023|NCT00802373|Urological Agents|urological agents|mesh-ancestor
139005024|NCT03957109|Anesthetics|anesthetics|mesh-list
138510978|NCT00065533|Pemetrexed|pemetrexed|mesh-list
138975584|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975585|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
138975586|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975587|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138975588|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138975589|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
138975590|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138975591|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138975592|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
138975593|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138975594|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975595|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
138975596|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975598|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138975599|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
138975600|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138975601|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975602|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
138975603|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138975604|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975605|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975606|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138975607|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138975608|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138975609|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138975610|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138975611|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138975612|NCT02549690|Testosterone|testosterone|mesh-list
138975613|NCT02549690|Androgens|androgens|mesh-ancestor
138975614|NCT02549690|Hormones|hormones|mesh-ancestor
138975615|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975616|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975617|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
138975618|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138975619|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975620|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975621|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138975622|NCT02549768|Analgesics|analgesics|mesh-ancestor
138975623|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
139005025|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139005026|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005027|NCT00802451|Mesalamine|mesalamine|mesh-list
139005028|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139005029|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139005030|NCT00802451|Analgesics|analgesics|mesh-ancestor
139005031|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
139005032|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005033|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005034|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005035|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139005036|NCT03956953|Deucravacitinib|deucravacitinib|mesh-list
139005037|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
139005038|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139005039|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005040|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005041|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
139005042|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139005043|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005044|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
139005045|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139005046|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975624|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975625|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138975626|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138935394|NCT00861250|Hormones|hormones|mesh-ancestor
138975627|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138975628|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
138975629|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975630|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975631|NCT00841724|Fludarabine|fludarabine|mesh-list
138975632|NCT00841724|Busulfan|busulfan|mesh-list
138975633|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
138975634|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975635|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975636|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138975637|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
138602165|NCT00162149|Nevirapine|nevirapine|mesh-list
138975638|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975639|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
138975640|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138975641|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138975642|NCT00843362|Dinoprostone|dinoprostone|mesh-list
138975643|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
138975644|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138975645|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975647|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
138975648|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975649|NCT00841802|Hormones|hormones|mesh-ancestor
138975650|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975651|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975652|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138975653|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005047|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139005049|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005050|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005051|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005052|NCT01097317|Carboplatin|carboplatin|mesh-list
139005053|NCT01097317|Vinorelbine|vinorelbine|mesh-list
139005054|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005055|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139005056|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
139005057|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
138755813|NCT00893737|Naproxen|naproxen|mesh-list
139005058|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
139005059|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005060|NCT01095679|Baclofen|baclofen|mesh-list
139005061|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139005062|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005063|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139005064|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005065|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139005066|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
139005067|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
139005068|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039565|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138975654|NCT00621140|Linagliptin|linagliptin|mesh-list
138975655|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138975656|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975657|NCT00621140|Incretins|incretins|mesh-ancestor
138975658|NCT00621140|Hormones|hormones|mesh-ancestor
138975659|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975660|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138975661|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
138975662|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975663|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975664|NCT00207727|Ustekinumab|ustekinumab|mesh-list
138975665|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
138975666|NCT00841880|Felodipine|felodipine|mesh-list
138975667|NCT00841880|Ramipril|ramipril|mesh-list
138975668|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138975669|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
138975670|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975671|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975672|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138975673|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138975674|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138975675|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138975676|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138975677|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975678|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
138975679|NCT00843440|Bevacizumab|bevacizumab|mesh-list
138975680|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139005069|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005070|NCT00794261|Lenograstim|lenograstim|mesh-list
139005071|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139005072|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
139005073|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005074|NCT03953287|Acetaminophen|acetaminophen|mesh-list
139005075|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139005076|NCT03953287|Analgesics|analgesics|mesh-ancestor
139005077|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
139005078|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005079|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005080|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
139005081|NCT01097551|Phenylephrine|phenylephrine|mesh-list
139005082|NCT01097551|Acetylcholine|acetylcholine|mesh-list
139005083|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
138975681|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975682|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138975683|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138975684|NCT00843440|Growth Substances|growth substances|mesh-ancestor
138975685|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602303|NCT00185445|Fludarabine|fludarabine|mesh-list
138975686|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
138975687|NCT00504556|Warfarin|warfarin|mesh-list
138975688|NCT00504556|Edoxaban|edoxaban|mesh-list
138975689|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
138975690|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138975691|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
138975692|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138975693|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
138975694|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975695|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975696|NCT00206323|Topiramate|topiramate|mesh-list
138975697|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
138975698|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138975699|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975700|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
138975701|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138975702|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975703|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
138975704|NCT00842114|Interferons|interferons|mesh-list
138975705|NCT00842114|Prednisone|prednisone|mesh-list
138975706|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
138975707|NCT00842114|Vincristine|vincristine|mesh-list
138975708|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138975709|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
138975710|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975711|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138975712|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138975713|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
138935423|NCT00861094|Vitamins|vitamins|mesh-ancestor
138975714|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975715|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975716|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138975717|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975718|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
138975719|NCT00842114|Hormones|hormones|mesh-ancestor
138975720|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975721|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138975722|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
138975723|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975724|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138975725|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
138975726|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
138975727|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
139005084|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
139005085|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139005086|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
139005087|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139005088|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005089|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005090|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139005091|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
139005092|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
139005093|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005094|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
139005095|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139005096|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
139005097|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
139005098|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139005099|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139005100|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138975728|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
138975729|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138975730|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975731|NCT00536991|Calcitriol|calcitriol|mesh-list
138975732|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138975733|NCT00536991|Ketoconazole|ketoconazole|mesh-list
138975734|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
138975735|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138975736|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138975737|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138975738|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975739|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
138975740|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975741|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138975742|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138975743|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975744|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975745|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138975746|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
138975747|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975748|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975749|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138975750|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138975751|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138975752|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138975753|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138975754|NCT00536991|Vitamins|vitamins|mesh-ancestor
138975755|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
138975756|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138975757|NCT00504166|Alendronate|alendronate|mesh-list
138975758|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138975759|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975760|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
138975761|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138975762|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138975763|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138975764|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
138975765|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975766|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139005101|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
139005102|NCT01097551|Protective Agents|protective agents|mesh-ancestor
139005103|NCT00803309|Interferons|interferons|mesh-list
139005105|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
139005106|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
139005107|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139005108|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005109|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
139005110|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005111|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
139039566|NCT00419744|Budesonide|budesonide|mesh-list
138975767|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138975768|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975769|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138975770|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138975771|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
138975772|NCT02546648|Coagulants|coagulants|mesh-ancestor
138975773|NCT00842504|Micafungin|micafungin|mesh-list
138975774|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
138975775|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975776|NCT00842582|Azacitidine|azacitidine|mesh-list
138975777|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138975778|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
138975779|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975780|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975781|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975782|NCT00843908|Imidacloprid|imidacloprid|mesh-list
138975783|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
138975784|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602457|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975785|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975786|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975787|NCT00842660|Gemcitabine|gemcitabine|mesh-list
138975788|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138975789|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
138975790|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975791|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975792|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138975794|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138975795|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975796|NCT00509236|Incretins|incretins|mesh-ancestor
138975797|NCT00509236|Hormones|hormones|mesh-ancestor
138975798|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138975799|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138975800|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
138975801|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975802|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975804|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138975805|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
138975806|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
138975807|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
138975808|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138975809|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138975810|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975811|NCT00508924|Heparin|heparin|mesh-list
138975812|NCT00508924|Argatroban|argatroban|mesh-list
138975813|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
138975814|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138975815|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138975816|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975817|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
138975818|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138975819|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
138975820|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975821|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139005112|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005113|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
139005114|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005115|NCT03953209|Spironolactone|spironolactone|mesh-list
139005116|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139005117|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
139005118|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005119|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005120|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139005121|NCT03953209|Diuretics|diuretics|mesh-ancestor
139005122|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
139005123|NCT01583959|Folic Acid|folic acid|mesh-list
139005124|NCT01583959|Hematinics|hematinics|mesh-ancestor
139005125|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
139005126|NCT01583959|Vitamins|vitamins|mesh-ancestor
139005127|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
139005128|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005129|NCT00803387|Travoprost|travoprost|mesh-list
139005130|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139005131|NCT02553551|Vitamins|vitamins|mesh-list
139005132|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
139005133|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005134|NCT00803465|Fluticasone|fluticasone|mesh-list
139005135|NCT00803465|Xhance|xhance|mesh-list
139005136|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005137|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139005138|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
139005139|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005140|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005141|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139005142|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
139005143|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
139005144|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139005146|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
139005147|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005148|NCT00803699|Protective Agents|protective agents|mesh-ancestor
139005154|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005155|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
139005156|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005157|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139005158|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139005159|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139005160|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005161|NCT01095991|Incretins|incretins|mesh-ancestor
139005162|NCT01095991|Hormones|hormones|mesh-ancestor
139005163|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005164|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139005165|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
138511358|NCT00071266|Niacin|niacin|mesh-list
138975822|NCT00836576|Benazepril|benazepril|mesh-list
138975823|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138975824|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
138975825|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975826|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975827|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138975828|NCT00836654|Catumaxomab|catumaxomab|mesh-list
138975829|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138975830|NCT00844064|Trabedersen|trabedersen|mesh-list
138975831|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975833|NCT05221593|Antidepressive Agents|antidepressive agents|mesh-ancestor
138975834|NCT05221593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138975835|NCT05221593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975836|NCT05221593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975837|NCT05221593|Antimanic Agents|antimanic agents|mesh-ancestor
138975838|NCT05221593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138975839|NCT05221593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975840|NCT05221593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975841|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
138975842|NCT00844142|Etanercept|etanercept|mesh-list
138975843|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138975844|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138975845|NCT00844142|Analgesics|analgesics|mesh-ancestor
138975846|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
138975847|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975848|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975849|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975850|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138975851|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138975852|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138975853|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
138975854|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975855|NCT00837044|Naproxen|naproxen|mesh-list
138975856|NCT00837044|Sumatriptan|sumatriptan|mesh-list
138975857|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138975858|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138975859|NCT00837044|Analgesics|analgesics|mesh-ancestor
138975860|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
138975861|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975862|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975863|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975864|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138975865|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
138975866|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138975867|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975868|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975869|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138975870|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138975871|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139005167|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005168|NCT00794807|Alefacept|alefacept|mesh-list
139005169|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
139005170|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
139005171|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005172|NCT00794885|Folic Acid|folic acid|mesh-list
139005173|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
139005174|NCT00794885|Enalapril|enalapril|mesh-list
139005175|NCT00794885|Enalaprilat|enalaprilat|mesh-list
139005176|NCT00794885|Maleic acid|maleic acid|mesh-list
138975873|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975874|NCT01013272|Lamivudine|lamivudine|mesh-list
138975875|NCT01013272|Entecavir|entecavir|mesh-list
138975876|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138975877|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138975878|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975879|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975880|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
138975881|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975882|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138975883|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138975884|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
138975885|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138975886|NCT01010698|Acyclovir|acyclovir|mesh-list
138975887|NCT01010698|Cimetidine|cimetidine|mesh-list
138975888|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
138975889|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975890|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138975891|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138975892|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138975893|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
138975894|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
138975895|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138975896|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975897|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975898|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138975899|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138975900|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975901|NCT03541486|Gemcitabine|gemcitabine|mesh-list
138975902|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138975903|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
138975904|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975905|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975906|NCT00620750|Naltrexone|naltrexone|mesh-list
138975907|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138975908|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138975909|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975910|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
138975911|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975912|NCT02547896|Diclofenac|diclofenac|mesh-list
138975913|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138975914|NCT02547896|Codeine|codeine|mesh-list
138975915|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138975916|NCT02547896|Analgesics|analgesics|mesh-ancestor
138975917|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
138975918|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975919|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975920|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138975921|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138975922|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138975923|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975924|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975925|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138975926|NCT02547896|Narcotics|narcotics|mesh-ancestor
138975927|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975928|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
139005177|NCT00794885|Hematinics|hematinics|mesh-ancestor
139005178|NCT00794885|Vitamins|vitamins|mesh-ancestor
139005179|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
139005180|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005181|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005182|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005183|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139005184|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
139005185|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139005186|NCT00803933|Pentamidine|pentamidine|mesh-list
139005187|NCT00803933|Pafuramidine|pafuramidine|mesh-list
139005188|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
139005189|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005190|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139005191|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139005192|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139005193|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
139005194|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139005195|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005196|NCT00799175|Ketorolac|ketorolac|mesh-list
139005197|NCT00799175|Epinephrine|epinephrine|mesh-list
139005198|NCT00799175|Ropivacaine|ropivacaine|mesh-list
139005199|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
139005200|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
139005201|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139005202|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005203|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
139005204|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005205|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139005206|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139005207|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
139005208|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139005209|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005210|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138755961|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
139005211|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139005212|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
139005213|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138511488|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
139005214|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
139005215|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
139005216|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
139005217|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139005218|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139005219|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139005220|NCT00799175|Analgesics|analgesics|mesh-ancestor
139005221|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005222|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139005223|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139005224|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005225|NCT00656513|Pilocarpine|pilocarpine|mesh-list
138975929|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
138975930|NCT01564251|Gemcitabine|gemcitabine|mesh-list
138975931|NCT01564251|GDC-0575|gdc-0575|mesh-list
138975932|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138975933|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
138975934|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975935|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975936|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138975937|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975938|NCT00508144|Pemetrexed|pemetrexed|mesh-list
138975939|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602595|NCT00163319|Ciclesonide|ciclesonide|mesh-list
138975940|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975941|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975942|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138975943|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138975944|NCT00844454|Ethanol|ethanol|mesh-list
138975945|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138975946|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975947|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975948|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975949|NCT02545712|Ethanol|ethanol|mesh-list
138975950|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
138975951|NCT02545712|Sorbitol|sorbitol|mesh-list
138975952|NCT02545712|Glycerol|glycerol|mesh-list
138975953|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138975954|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975955|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138975956|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975957|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138975958|NCT02545712|Protective Agents|protective agents|mesh-ancestor
138975959|NCT02545712|Cathartics|cathartics|mesh-ancestor
138975960|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138975961|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
138975962|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
138975963|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
138975964|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138975965|NCT01011010|Doxorubicin|doxorubicin|mesh-list
138975966|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138975967|NCT01011010|Mitomycins|mitomycins|mesh-list
138975968|NCT01011010|Mitomycin|mitomycin|mesh-list
138975969|NCT01011010|Sorafenib|sorafenib|mesh-list
138975970|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138975971|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138975972|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138975973|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138975974|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138975975|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975976|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138975977|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
138975978|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138975980|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138975981|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
138975982|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005227|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
139005228|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005229|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005230|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139005231|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139005232|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
139005233|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139005234|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005235|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139005236|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
139005237|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005238|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005239|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139005240|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975983|NCT00851708|Expectorants|expectorants|mesh-ancestor
138975984|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
138975985|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138975986|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
138975987|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975988|NCT00851708|Protective Agents|protective agents|mesh-ancestor
138975989|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138975990|NCT00851708|Antidotes|antidotes|mesh-ancestor
138975991|NCT01011166|Ribavirin|ribavirin|mesh-list
138975992|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138975993|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
138975994|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975995|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
138975996|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138975997|NCT00621842|Lamotrigine|lamotrigine|mesh-list
138975998|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
138975999|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138976000|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138976001|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976002|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138976003|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976004|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138976005|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138976006|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138976007|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138976008|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138976010|NCT04849455|Ropivacaine|ropivacaine|mesh-list
138976011|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
138976012|NCT04849455|Anesthetics|anesthetics|mesh-list
138976013|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138976014|NCT04849455|Narcotics|narcotics|mesh-ancestor
138976015|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138976016|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976017|NCT04849455|Analgesics|analgesics|mesh-ancestor
138976018|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
138976019|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976020|NCT02545010|Paclitaxel|paclitaxel|mesh-list
138976021|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138976022|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976023|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
138976024|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
138976025|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
138976026|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976027|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139005241|NCT00804245|Choline|choline|mesh-list
139005242|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
139005243|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139005244|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
139005245|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005246|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139005247|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139005248|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
139005249|NCT00804401|Naproxen|naproxen|mesh-list
139005250|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139005251|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139005252|NCT00804401|Analgesics|analgesics|mesh-ancestor
139005253|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
139005254|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005255|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005256|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005257|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139005258|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
139005259|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139005260|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005261|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005262|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139005263|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
139005264|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138976028|NCT01013506|Letrozole|letrozole|mesh-list
138976029|NCT01013506|Goserelin|goserelin|mesh-list
138976030|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976031|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138976032|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976033|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976034|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138976035|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138976036|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138976037|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
138976038|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976039|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976040|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138976041|NCT00844688|Gemcitabine|gemcitabine|mesh-list
138976042|NCT00844688|Sorafenib|sorafenib|mesh-list
138976043|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138976044|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
138976045|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976046|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976047|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138976048|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976049|NCT04541680|Nintedanib|nintedanib|mesh-list
138976050|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976051|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138976052|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976053|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976054|NCT00855530|Amibegron|amibegron|mesh-list
139005265|NCT02553083|Amoxicillin|amoxicillin|mesh-list
139005266|NCT02553083|Doxycycline|doxycycline|mesh-list
139005267|NCT02553083|Esomeprazole|esomeprazole|mesh-list
139005268|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139005269|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005270|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
139005271|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139005272|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139005273|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139005274|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139005275|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139005276|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005277|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005278|NCT00804947|Melphalan|melphalan|mesh-list
139005279|NCT00804947|Busulfan|busulfan|mesh-list
138976055|NCT00855530|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138976056|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138976057|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138976058|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
138976059|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976060|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976061|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976062|NCT00855530|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138976063|NCT00855608|Adalimumab|adalimumab|mesh-list
138976064|NCT00855608|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138976065|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138976066|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138976067|NCT00851864|Tinzaparin|tinzaparin|mesh-list
138976068|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138976069|NCT00851864|Dalteparin|dalteparin|mesh-list
138976070|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
138976071|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138976072|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138976073|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976074|NCT00851942|Cosyntropin|cosyntropin|mesh-list
138976075|NCT00851942|Hormones|hormones|mesh-ancestor
138976076|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976077|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976078|NCT00503776|Amifostine|amifostine|mesh-list
138976079|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138976080|NCT00503776|Protective Agents|protective agents|mesh-ancestor
138976081|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976082|NCT02545634|Sulfalene|sulfalene|mesh-list
138976083|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138976084|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138976085|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
138976086|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138976087|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138976088|NCT00855686|Memantine|memantine|mesh-list
138976089|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138976090|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138976091|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
138976092|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976093|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976094|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976095|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138976096|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138976097|NCT00619112|Temozolomide|temozolomide|mesh-list
138976098|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138976099|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
138976100|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976101|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005280|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139005282|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005283|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005284|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139005285|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139005286|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
139005287|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005289|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005290|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139005291|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138976102|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
138976103|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
138976104|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976105|NCT00845156|Protective Agents|protective agents|mesh-ancestor
138976106|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976107|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
138976109|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
138976110|NCT00852332|Curcumin|curcumin|mesh-list
138976111|NCT00852332|Docetaxel|docetaxel|mesh-list
138976112|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976113|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
138976114|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
138976115|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
138976116|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976117|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138976118|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138976119|NCT00852332|Analgesics|analgesics|mesh-ancestor
138976120|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
138976121|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976122|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976123|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138976124|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138976125|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976126|NCT00852410|Lidocaine|lidocaine|mesh-list
138976127|NCT00852410|Epinephrine|epinephrine|mesh-list
138976128|NCT00852410|Racepinephrine|racepinephrine|mesh-list
138976129|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
138976130|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
138976131|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
138976132|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138976133|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976134|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
138976135|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976136|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138976137|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138976138|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138976139|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138976140|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976141|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138976142|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138976143|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
138976144|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976145|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138976146|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138976147|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
138976149|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
138976150|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
138976151|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
138976152|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138976153|NCT00992121|Bevacizumab|bevacizumab|mesh-list
138976154|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138976155|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005292|NCT00806663|Growth Substances|growth substances|mesh-ancestor
139005293|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005294|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
139005295|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139005296|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005297|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005298|NCT00806741|Phenylephrine|phenylephrine|mesh-list
139005299|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
139005300|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138511825|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
138976156|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138976157|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138976158|NCT00992121|Growth Substances|growth substances|mesh-ancestor
138976159|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976160|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
138976161|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138976162|NCT04420299|Bemiparin|bemiparin|mesh-list
138976163|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
138976164|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138976165|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138935596|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138976166|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976167|NCT00992199|Fluorouracil|fluorouracil|mesh-list
138976168|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976169|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
138976170|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976171|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138976172|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138976173|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
138976174|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976175|NCT00856310|Fasinumab|fasinumab|mesh-list
138976176|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138976177|NCT00856310|Analgesics|analgesics|mesh-ancestor
138976178|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
138976179|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976180|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976182|NCT02773485|Gemcitabine|gemcitabine|mesh-list
138976183|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976184|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138976185|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
138976186|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976187|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
138976189|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976190|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976191|NCT00992355|Tobramycin|tobramycin|mesh-list
138976192|NCT00992355|Dexamethasone|dexamethasone|mesh-list
138976193|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
138976194|NCT00992355|Ketorolac|ketorolac|mesh-list
138976195|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138976196|NCT00992355|BB 1101|bb 1101|mesh-list
138976197|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138976198|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
138976199|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
138976200|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976201|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976202|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138976203|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
138976204|NCT00992355|Hormones|hormones|mesh-ancestor
138976205|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976206|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138976207|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976208|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
138976209|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976210|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976211|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138976212|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139005302|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
139005303|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
139005304|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005305|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005306|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
139005307|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139005308|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
139005309|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
139005310|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139005311|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139005312|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139005313|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
139005314|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139005315|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005316|NCT00806741|Protective Agents|protective agents|mesh-ancestor
139005317|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976213|NCT00992355|Analgesics|analgesics|mesh-ancestor
138976214|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
138976215|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138976216|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138976217|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138976218|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138976219|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
138976220|NCT00852566|Dasatinib|dasatinib|mesh-list
138976221|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976222|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138976223|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603137|NCT04472767|Nivolumab|nivolumab|mesh-list
138976224|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976225|NCT00856622|Timolol|timolol|mesh-list
138976226|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138976227|NCT00856622|Latanoprost|latanoprost|mesh-list
138976228|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138976229|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138976230|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138976231|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
138976232|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138603174|NCT04055909|Nangibotide|nangibotide|mesh-list
138976233|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976234|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976235|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138976236|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138976237|NCT00856700|Incretins|incretins|mesh-list
138976238|NCT00856700|Hormones|hormones|mesh-ancestor
138976239|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976240|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976241|NCT00618956|Milnacipran|milnacipran|mesh-list
138976242|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
138976243|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138976244|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138976245|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138976246|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976247|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976248|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976249|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138976250|NCT00618956|Analgesics|analgesics|mesh-ancestor
138976251|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
139005318|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
139005319|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139005320|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005321|NCT00805649|Dexamethasone|dexamethasone|mesh-list
139005322|NCT00805649|Bevacizumab|bevacizumab|mesh-list
139005323|NCT00805649|Temazepam|temazepam|mesh-list
139005324|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139005325|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005326|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139005327|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139005328|NCT00805649|Growth Substances|growth substances|mesh-ancestor
139005329|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005330|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
139005331|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005332|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
139005333|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
139005334|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005335|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139005336|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
139005337|NCT00805649|Hormones|hormones|mesh-ancestor
139005338|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976252|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976253|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
138976254|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138976255|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138976256|NCT00845546|Loratadine|loratadine|mesh-list
138976257|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
138976258|NCT00845546|Ephedrine|ephedrine|mesh-list
138976259|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
138976260|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
138976261|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138976262|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138976263|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138976264|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
138976265|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
138976266|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976267|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976268|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976269|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138976270|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
138976271|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976272|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138976273|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
138976274|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
138976275|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138976276|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138976277|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
138976278|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
138976279|NCT00852956|Betahistine|betahistine|mesh-list
138976280|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
138976281|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
138976282|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
138976283|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976284|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976285|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976286|NCT00716417|Afatinib|afatinib|mesh-list
139005339|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139005340|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139005341|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139005342|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139005343|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139005344|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139005345|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
139005346|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
139005347|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139005348|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005349|NCT00807053|Ciclesonide|ciclesonide|mesh-list
139005350|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
139005351|NCT00807053|Hormones|hormones|mesh-ancestor
139005352|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138512008|NCT00075673|Celecoxib|celecoxib|mesh-list
138976287|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976288|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138976289|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976290|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976291|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
138976292|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138976293|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976294|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976295|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138976296|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138976297|NCT02592863|Protective Agents|protective agents|mesh-ancestor
138976298|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976300|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138976301|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
138976302|NCT00719537|Aspirin|aspirin|mesh-list
138976303|NCT00719537|Progesterone|progesterone|mesh-list
138976304|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138976305|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138976306|NCT00719537|Analgesics|analgesics|mesh-ancestor
138976307|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
138976308|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976309|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976310|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138976311|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138976312|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138976313|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138935620|NCT00724802|Triacetin|triacetin|mesh-list
138976314|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976315|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138976316|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138976317|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976319|NCT00719537|Progestins|progestins|mesh-ancestor
138976320|NCT00719537|Hormones|hormones|mesh-ancestor
138976321|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976322|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
138976323|NCT00853190|Hydrocodone|hydrocodone|mesh-list
138976324|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976325|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138976326|NCT00853190|Narcotics|narcotics|mesh-ancestor
138976327|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138727157|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
138976328|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976329|NCT00853190|Analgesics|analgesics|mesh-ancestor
138976330|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
138976331|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005353|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005354|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139005355|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
139005356|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139005357|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139005358|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005359|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
139005360|NCT00809393|Coagulants|coagulants|mesh-ancestor
139005361|NCT00658775|Esomeprazole|esomeprazole|mesh-list
139005362|NCT00658775|Rabeprazole|rabeprazole|mesh-list
138756106|NCT04286152|Mirabegron|mirabegron|mesh-list
139005364|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139005365|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138976332|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
138976334|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
138976335|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
138976336|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138976337|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
138976338|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
138976339|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976340|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138976341|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
138976342|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
138976343|NCT00573794|Adalimumab|adalimumab|mesh-list
138976344|NCT00573794|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138976345|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138976346|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138976347|NCT00715793|Temozolomide|temozolomide|mesh-list
138976348|NCT00715793|Decitabine|decitabine|mesh-list
138976349|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138976350|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
138976351|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976352|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603509|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138976353|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138976354|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
138976355|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976356|NCT00924014|Furosemide|furosemide|mesh-list
138976357|NCT00924014|Conivaptan|conivaptan|mesh-list
138976358|NCT00924014|Diuretics|diuretics|mesh-ancestor
138976359|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
138976360|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976361|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138976362|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138976363|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976364|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138976365|NCT00853268|Oxycodone|oxycodone|mesh-list
138976366|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138976367|NCT00853268|Narcotics|narcotics|mesh-ancestor
138976368|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138976369|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976370|NCT00853268|Analgesics|analgesics|mesh-ancestor
138976371|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
138976372|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976373|NCT00845780|Amiodarone|amiodarone|mesh-list
138976374|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138976375|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
138976376|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138976377|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138976378|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976379|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138976380|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138976381|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138976382|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005367|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005368|NCT00488631|Golimumab|golimumab|mesh-list
139005369|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139005370|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139005371|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005372|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139005373|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
139005374|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005375|NCT00809549|Lenograstim|lenograstim|mesh-list
139005376|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138976383|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138976384|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138976385|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138976386|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
138976387|NCT00853502|Testosterone|testosterone|mesh-list
138976388|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
138976389|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
138976390|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138976391|NCT00853502|Androgens|androgens|mesh-ancestor
138976392|NCT00853502|Hormones|hormones|mesh-ancestor
138976393|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976394|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976395|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138976396|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976397|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
138976398|NCT00853736|Oxycodone|oxycodone|mesh-list
138976399|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138976400|NCT00853736|Narcotics|narcotics|mesh-ancestor
138976401|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138976402|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976403|NCT00853736|Analgesics|analgesics|mesh-ancestor
138976404|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
138976405|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976406|NCT00857168|Testosterone|testosterone|mesh-list
138976407|NCT00857168|Androgens|androgens|mesh-ancestor
138976408|NCT00857168|Hormones|hormones|mesh-ancestor
138976409|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976410|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976411|NCT00857324|Vorinostat|vorinostat|mesh-list
138976412|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976413|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138976414|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976415|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976416|NCT00853892|Oxycodone|oxycodone|mesh-list
138976417|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138976418|NCT00853892|Narcotics|narcotics|mesh-ancestor
138935642|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
138976419|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138976420|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976421|NCT00853892|Analgesics|analgesics|mesh-ancestor
138976422|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
138976423|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976424|NCT00857558|Saxagliptin|saxagliptin|mesh-list
138976425|NCT00857558|Incretins|incretins|mesh-ancestor
138976426|NCT00857558|Hormones|hormones|mesh-ancestor
138976427|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976428|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976429|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138976430|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
138976431|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976432|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976433|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138976434|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138976435|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
139005377|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
139005378|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005379|NCT00809627|Caffeine|caffeine|mesh-list
139005380|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139005381|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005382|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139005383|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005384|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005385|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139005386|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139005387|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
139005388|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139005389|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139005390|NCT00809705|Incretins|incretins|mesh-ancestor
139005391|NCT00809705|Hormones|hormones|mesh-ancestor
139005392|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005393|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005394|NCT00655499|Irinotecan|irinotecan|mesh-list
138976436|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976437|NCT00715559|Cysteamine|cysteamine|mesh-list
138976438|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138976439|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976440|NCT00620282|Liraglutide|liraglutide|mesh-list
138976441|NCT00620282|Glimepiride|glimepiride|mesh-list
138976442|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138976443|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976444|NCT00620282|Incretins|incretins|mesh-ancestor
138976445|NCT00620282|Hormones|hormones|mesh-ancestor
138976446|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976447|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138976448|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138976449|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
138976450|NCT05684861|Isotretinoin|isotretinoin|mesh-list
138976451|NCT05684861|Dermatologic Agents|dermatologic agents|mesh-ancestor
138976452|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
138976453|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138976454|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138976455|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976456|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
138976457|NCT04042688|Coagulants|coagulants|mesh-ancestor
138976458|NCT02590133|Fluorouracil|fluorouracil|mesh-list
138976459|NCT02590133|Endostar protein|endostar protein|mesh-list
138976460|NCT02590133|Endostatins|endostatins|mesh-list
138976461|NCT02590133|Nedaplatin|nedaplatin|mesh-list
138976462|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
138976463|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976464|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138976465|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976466|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138976467|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
138976468|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976470|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138976471|NCT02590133|Growth Substances|growth substances|mesh-ancestor
138976472|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
138976473|NCT00854204|Darunavir|darunavir|mesh-list
138976474|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138976475|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139005396|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139005397|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139005398|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005399|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005400|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005401|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139005402|NCT00800267|Timolol|timolol|mesh-list
139005403|NCT00800267|Latanoprost|latanoprost|mesh-list
139005404|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139005405|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139005406|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
139005407|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139005408|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005409|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005410|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139005411|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139005412|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139005413|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139005414|NCT00809939|Progesterone|progesterone|mesh-list
139005415|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
139005416|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
139005417|NCT00809939|Progestins|progestins|mesh-ancestor
139005418|NCT00809939|Hormones|hormones|mesh-ancestor
139005419|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005420|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005421|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138976476|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
138976477|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976478|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976479|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138976480|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138976481|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
138976482|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138976483|NCT00857870|Metformin|metformin|mesh-list
138976484|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
138976485|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138976486|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976487|NCT00848432|Risperidone|risperidone|mesh-list
138976488|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138976489|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
138976490|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976491|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976492|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976493|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138976494|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138603679|NCT00164216|Artesunate|artesunate|mesh-list
139005422|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
139005423|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
139005424|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139005425|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139005426|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
139005427|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005428|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139005429|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139005430|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935663|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
139005431|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005433|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005434|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
139005435|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
139005436|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976495|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138976496|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138976497|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138976498|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
138976499|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138976500|NCT00854750|Hormones|hormones|mesh-ancestor
138976501|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976502|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976503|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138976504|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
138976505|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138976506|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138976507|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
138976508|NCT00858338|Floxuridine|floxuridine|mesh-list
138976509|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138976510|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
138976511|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976512|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976513|NCT00515086|Everolimus|everolimus|mesh-list
138976514|NCT00515086|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138976515|NCT00515086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138976516|NCT00515086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976517|NCT00515086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976518|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138976519|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
138976520|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976521|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976522|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
138976523|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976524|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138976525|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976526|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976527|NCT00849368|Azathioprine|azathioprine|mesh-list
138976528|NCT00849368|Allopurinol|allopurinol|mesh-list
138976529|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
138976530|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976531|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976532|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
138976533|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138976534|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138976535|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
138976536|NCT00849368|Protective Agents|protective agents|mesh-ancestor
138976537|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976538|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138976539|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976540|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139005437|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005438|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139005439|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
139005441|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005442|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139005443|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005444|NCT00800423|Timolol|timolol|mesh-list
139005445|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139005446|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005447|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139005448|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139005449|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
139005450|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139005451|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976541|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
138976542|NCT02544932|Warfarin|warfarin|mesh-list
138976543|NCT02544932|Dabigatran|dabigatran|mesh-list
138976544|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
138976545|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
138976546|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138976547|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
138976548|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976549|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976550|NCT02544854|Propofol|propofol|mesh-list
138976551|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138976552|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138976553|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976554|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138976555|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
138976557|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
138976558|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
138976559|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976560|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138976561|NCT02544776|Amlodipine|amlodipine|mesh-list
138976562|NCT02544776|Clomiphene|clomiphene|mesh-list
138976563|NCT02544776|Enclomiphene|enclomiphene|mesh-list
138976564|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
138976565|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976566|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138976567|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138976568|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138976569|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138976570|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976571|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
138976572|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138976573|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
138976574|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976575|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138976576|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
138976577|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138976578|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138976579|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138976580|NCT00859118|Axitinib|axitinib|mesh-list
138976581|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976582|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138976583|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976584|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976585|NCT00849602|Chloroquine|chloroquine|mesh-list
138976586|NCT00849602|Amebicides|amebicides|mesh-ancestor
138976587|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139005452|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139005453|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139005454|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139005455|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139005456|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139005457|NCT00651755|Prednisone|prednisone|mesh-list
139005458|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
139005459|NCT00651755|Rituximab|rituximab|mesh-list
139005460|NCT00651755|Doxorubicin|doxorubicin|mesh-list
139005461|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139005462|NCT00651755|Vincristine|vincristine|mesh-list
139005463|NCT00651755|Ondansetron|ondansetron|mesh-list
139005464|NCT00651755|Aprepitant|aprepitant|mesh-list
139005465|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139005466|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
138976588|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138976589|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138976590|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
138976591|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138976592|NCT00859274|Budesonide|budesonide|mesh-list
138976593|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138976594|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138976595|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
138976596|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976597|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976598|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138976599|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
138976600|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
138976601|NCT00859274|Hormones|hormones|mesh-ancestor
138976602|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976603|NCT00859352|Midazolam|midazolam|mesh-list
138976604|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138976605|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138976606|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138976607|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976608|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138976609|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138976610|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138976611|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138976612|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
138976613|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
138976614|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
138976615|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
138976616|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976617|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976618|NCT00861926|Beclomethasone|beclomethasone|mesh-list
138976619|NCT00861926|Albuterol|albuterol|mesh-list
138976620|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
138976621|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138976622|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
138976623|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976624|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976625|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138976626|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
138976627|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138976628|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138727460|NCT04054375|Prednisone|prednisone|mesh-list
138976629|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138976630|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
138976631|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976632|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976633|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
138976634|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138976635|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005467|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005468|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139005469|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139005470|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
139005471|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005472|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005473|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139005474|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139005475|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139005476|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139005477|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138976636|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
138976638|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976639|NCT00849992|Imiquimod|imiquimod|mesh-list
138976640|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138976641|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
138976642|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976643|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976644|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
138976645|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
138976646|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138976647|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138976648|NCT02544698|Vaccines|vaccines|mesh-list
138976649|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
138976650|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976651|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
138976652|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138976653|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
138976654|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976655|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976656|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138976657|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
138976658|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138976659|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138976660|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138976661|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
138976662|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976663|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976664|NCT00862472|Timolol|timolol|mesh-list
138976665|NCT00862472|Cloprostenol|cloprostenol|mesh-list
138976666|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
138976667|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138976668|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
138976669|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138976670|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976671|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138976672|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138976673|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138976674|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
138976675|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976676|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976677|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138976678|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138976679|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
138976680|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976681|NCT00850382|Cytarabine|cytarabine|mesh-list
138976682|NCT00850382|Daunorubicin|daunorubicin|mesh-list
138976683|NCT00850382|Dasatinib|dasatinib|mesh-list
138976684|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138976685|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
138976686|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976687|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005478|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005479|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005480|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
139005481|NCT00651755|Hormones|hormones|mesh-ancestor
139005482|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005483|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139039567|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
138976688|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
138976689|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138976690|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138976691|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
138976692|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976693|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138976694|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138976695|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138976696|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976697|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138976698|NCT00860366|Uric Acid|uric acid|mesh-list
138976699|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
138976700|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976701|NCT00860366|Protective Agents|protective agents|mesh-ancestor
138976702|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976703|NCT00862628|Rebamipide|rebamipide|mesh-list
138976704|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138976705|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138976706|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
138976707|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976708|NCT00862628|Protective Agents|protective agents|mesh-ancestor
138976709|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976710|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976711|NCT00507442|Dexamethasone|dexamethasone|mesh-list
138976712|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
138976713|NCT00507442|Lenalidomide|lenalidomide|mesh-list
138976714|NCT00507442|Bortezomib|bortezomib|mesh-list
138976715|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138976716|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
138976717|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976718|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138976719|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138976720|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
138976721|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976722|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976723|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138976724|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138976725|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
138976726|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
138976727|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976728|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138976729|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
138976730|NCT00507442|Hormones|hormones|mesh-ancestor
138976731|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976732|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138976733|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138976734|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138976735|NCT00507442|Growth Substances|growth substances|mesh-ancestor
138976736|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
138976737|NCT00862706|Telbivudine|telbivudine|mesh-list
138976738|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
138976739|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138976740|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138976741|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976742|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976743|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138976745|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
138976746|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138976747|NCT00850850|Physostigmine|physostigmine|mesh-list
138976748|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138976749|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005484|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139005485|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
139005486|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
139005487|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
139005488|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
139005489|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
139005490|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005491|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139005492|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
139005493|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
139005494|NCT00651755|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139005495|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139005496|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
138512610|NCT00079963|Vitamins|vitamins|mesh-list
138976750|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976751|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
138976752|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976753|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976754|NCT00850850|Miotics|miotics|mesh-ancestor
138976755|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
138976756|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976757|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138976758|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
138976759|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138976760|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138976761|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138976762|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138976763|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976764|NCT00863096|Vaccines|vaccines|mesh-list
138976765|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
138976766|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976767|NCT00870272|Misoprostol|misoprostol|mesh-list
138976768|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138976769|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
138976770|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138976771|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976772|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138976773|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138976774|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
138976775|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
138976776|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138976777|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976778|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138976779|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
138976780|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138976781|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138976782|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976783|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976785|NCT00502996|Methotrexate|methotrexate|mesh-list
138976786|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138976787|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976788|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
138976789|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976790|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138976791|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138976792|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
138976793|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138976794|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138976795|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
138976796|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976797|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
138976798|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005497|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139005498|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139005500|NCT00807755|Etoposide|etoposide|mesh-list
139005501|NCT00807755|Everolimus|everolimus|mesh-list
139005502|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005503|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139005504|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139005505|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139005506|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976799|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138976800|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138976801|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138976802|NCT00865436|Metformin|metformin|mesh-list
138976803|NCT00865436|Glyburide|glyburide|mesh-list
138976804|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138976805|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976806|NCT00715403|Nintedanib|nintedanib|mesh-list
138976807|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976808|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138976809|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976810|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976811|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
138976812|NCT01013584|Vitamin D|vitamin d|mesh-list
138976813|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138976814|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976815|NCT01013584|Vitamins|vitamins|mesh-ancestor
138976816|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
138976817|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138976818|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
138976819|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138976820|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138976821|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976822|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
138976823|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
138976824|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138976825|NCT00864188|Beta Carotene|beta carotene|mesh-list
138976826|NCT00864188|Carotenoids|carotenoids|mesh-list
138976827|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
138976828|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603969|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
138976829|NCT00864188|Protective Agents|protective agents|mesh-ancestor
138976830|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976832|NCT00864188|Vitamins|vitamins|mesh-ancestor
138976833|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
138976834|NCT00865670|Azithromycin|azithromycin|mesh-list
138976835|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138976836|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138976837|NCT00864344|Sertraline|sertraline|mesh-list
138976838|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
138976839|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138976840|NCT00864344|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138976841|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138976842|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138976843|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976844|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976845|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
138976846|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976847|NCT00864500|Clobetasol|clobetasol|mesh-list
138976848|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138976849|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
138976850|NCT00864500|Hormones|hormones|mesh-ancestor
138976851|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976852|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976853|NCT00864734|Metformin|metformin|mesh-list
138976854|NCT00864734|Glyburide|glyburide|mesh-list
138727682|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138976855|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139005507|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005508|NCT00807755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139005509|NCT00807755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139005510|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139005511|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
139005512|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005514|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139005515|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
139005516|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005517|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139005518|NCT00810563|Bupivacaine|bupivacaine|mesh-list
139005519|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
139005520|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
139005521|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139005522|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512738|NCT00080431|Daclizumab|daclizumab|mesh-list
138976856|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976858|NCT00864812|Xhance|xhance|mesh-list
138976859|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
138976860|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138976861|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138976862|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138976863|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138976864|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
138976865|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976866|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976867|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138603995|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138976868|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
138976869|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
138976870|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138976871|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
138976872|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138976873|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
138976874|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976875|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976876|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138976877|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138976878|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138976879|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
138976880|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
138976882|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976883|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
138976884|NCT02590055|Gemcitabine|gemcitabine|mesh-list
138976885|NCT02590055|Docetaxel|docetaxel|mesh-list
138976886|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138976887|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
138976888|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976889|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976890|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
138976891|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
138976892|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
138976893|NCT00864890|Dexetimide|dexetimide|mesh-list
138976894|NCT00864890|Citalopram|citalopram|mesh-list
138976895|NCT00864890|Escitalopram|escitalopram|mesh-list
138976896|NCT00864890|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138976897|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138976898|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139005523|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
139005524|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005525|NCT00808145|Cisplatin|cisplatin|mesh-list
139005526|NCT00808145|Gemcitabine|gemcitabine|mesh-list
139005527|NCT00808145|Sorafenib|sorafenib|mesh-list
139005528|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005529|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139005530|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
139005531|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005532|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139005533|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005534|NCT02552459|Sufentanil|sufentanil|mesh-list
139005535|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
139005536|NCT02552459|Dsuvia|dsuvia|mesh-list
139005537|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139005538|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139005539|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005540|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139005541|NCT02552459|Analgesics|analgesics|mesh-ancestor
139005542|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
139005543|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005544|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139005545|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138512794|NCT00080782|Celecoxib|celecoxib|mesh-list
138976899|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976900|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976901|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
138976902|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976903|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138976904|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
138976905|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138976906|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138976907|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138976908|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
138976909|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
138976910|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976911|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138976912|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138976913|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
138976914|NCT00919295|Mirtazapine|mirtazapine|mesh-list
138976915|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
138976916|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138976917|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138976918|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
138976919|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
138976920|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976921|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976922|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976923|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138976924|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138976925|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138976926|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139005546|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139005547|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
139005548|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139005549|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005550|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139005551|NCT02552459|Narcotics|narcotics|mesh-ancestor
139005552|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139005553|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139005554|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
139005555|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
139005556|NCT00810953|Pentamidine|pentamidine|mesh-list
139005557|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
139005558|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005559|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139005560|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139005561|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139005563|NCT00811031|Docetaxel|docetaxel|mesh-list
139005564|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976927|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138976928|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138976929|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
138976930|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138976931|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138976932|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
138976933|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138976934|NCT00865748|Metformin|metformin|mesh-list
138976935|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138976936|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976937|NCT00865982|Docetaxel|docetaxel|mesh-list
138976938|NCT00865982|Capecitabine|capecitabine|mesh-list
138976939|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976940|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
138976941|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
138976942|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
138976943|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976944|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138976945|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
138976946|NCT00866060|Memantine|memantine|mesh-list
138976947|NCT00866060|Donepezil|donepezil|mesh-list
138976948|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138976949|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976950|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976951|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
138976952|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976953|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976954|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
138976955|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138976956|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138976957|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
138976958|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138976959|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138976960|NCT00871052|Vitamin D|vitamin d|mesh-list
138976961|NCT00871052|Calcipotriene|calcipotriene|mesh-list
138976962|NCT00871052|Vitamins|vitamins|mesh-ancestor
138976963|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
138976964|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976965|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138976966|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
138976967|NCT00502840|Rituximab|rituximab|mesh-list
139005565|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
139005566|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
139005567|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
139005568|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005569|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005570|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
139005571|NCT00811031|Hormones|hormones|mesh-ancestor
139005572|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005573|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005574|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139005575|NCT02552537|Mannitol|mannitol|mesh-list
139005576|NCT02552537|Omeprazole|omeprazole|mesh-list
138976968|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138976969|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976970|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
138976971|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976972|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138976973|NCT00514540|Carboplatin|carboplatin|mesh-list
138976974|NCT00514540|Docetaxel|docetaxel|mesh-list
138976975|NCT00514540|Etoposide|etoposide|mesh-list
138976976|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976977|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
138976978|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
138976979|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
138976980|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138976981|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138976982|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138976983|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138976985|NCT03121534|Dexamethasone|dexamethasone|mesh-list
138976986|NCT03121534|Nivolumab|nivolumab|mesh-list
138976987|NCT03121534|Blinatumomab|blinatumomab|mesh-list
138976988|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138976989|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
138976990|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
138976991|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138976992|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138976993|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138976994|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
138976995|NCT03121534|Hormones|hormones|mesh-ancestor
138976996|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138976997|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138976998|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976999|NCT03121534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138977000|NCT03121534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138977001|NCT03121534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977002|NCT01012102|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138977003|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
138977004|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138977005|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
138977006|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977008|NCT04615624|Diuretics|diuretics|mesh-ancestor
138977009|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
138977010|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977011|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138977012|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138977013|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977014|NCT00713609|Clindamycin|clindamycin|mesh-list
138977015|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
138977016|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
138977017|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138977018|NCT00713609|Tazarotene|tazarotene|mesh-list
138977019|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138977020|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005577|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139005578|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139005579|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139005580|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005581|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005582|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139005584|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
139005585|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005586|NCT00808223|Alefacept|alefacept|mesh-list
138977021|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138977022|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977023|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977024|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
138977025|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
138977026|NCT00513682|Pancrelipase|pancrelipase|mesh-list
138977027|NCT00513682|Pancreatin|pancreatin|mesh-list
138977028|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138977029|NCT00493012|Vitamin D|vitamin d|mesh-list
138977030|NCT00493012|Vitamins|vitamins|mesh-ancestor
138977031|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
138977032|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977033|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138977034|NCT00918593|Bleomycin|bleomycin|mesh-list
138977035|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138977036|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977037|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
138977038|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
138977039|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
138977040|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977041|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977042|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
138977043|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977044|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138977045|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138977046|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977047|NCT05238233|Proxymetacaine|proxymetacaine|mesh-list
138977048|NCT05238233|Pilocarpine|pilocarpine|mesh-list
138977049|NCT05238233|Tropicamide|tropicamide|mesh-list
138977050|NCT05238233|Miotics|miotics|mesh-ancestor
138977051|NCT05238233|Autonomic Agents|autonomic agents|mesh-ancestor
138977052|NCT05238233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977053|NCT05238233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977054|NCT05238233|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138977055|NCT05238233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138977056|NCT05238233|Cholinergic Agents|cholinergic agents|mesh-ancestor
138977057|NCT05238233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977058|NCT05238233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977059|NCT05238233|Mydriatics|mydriatics|mesh-ancestor
138977060|NCT05238233|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138977061|NCT05238233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138977062|NCT05238233|Anesthetics, Local|anesthetics, local|mesh-ancestor
138977063|NCT05238233|Anesthetics|anesthetics|mesh-ancestor
138977064|NCT05238233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977065|NCT05238233|Sensory System Agents|sensory system agents|mesh-ancestor
138977066|NCT00617708|Gemcitabine|gemcitabine|mesh-list
138977067|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138977068|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138977069|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138977070|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
138604163|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977071|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977072|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977073|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138977074|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977075|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
138977076|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005587|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
139005588|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
139005589|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005591|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
139005592|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139005593|NCT00811421|Mefloquine|mefloquine|mesh-list
139005594|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
139005595|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139005596|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139005597|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005598|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139005599|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005600|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005601|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139005602|NCT00569777|Ketotifen|ketotifen|mesh-list
139005603|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
139005604|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
139005605|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138935819|NCT00861952|Mineral Oil|mineral oil|mesh-list
139005606|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
139005607|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
139005608|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977077|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
138977078|NCT04083209|Narcotics|narcotics|mesh-ancestor
138977079|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977080|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977081|NCT04083209|Analgesics|analgesics|mesh-ancestor
138977082|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
138977083|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977084|NCT00864968|Nabumetone|nabumetone|mesh-list
138977085|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138977086|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138977087|NCT00864968|Analgesics|analgesics|mesh-ancestor
138977088|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
138977089|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977090|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977091|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138977092|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138977093|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138977094|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138977095|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977096|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977097|NCT00876044|Aflibercept|aflibercept|mesh-list
138977098|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138977099|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138977100|NCT00876044|Growth Substances|growth substances|mesh-ancestor
138977101|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977102|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
138977103|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977104|NCT00866216|Azithromycin|azithromycin|mesh-list
138977105|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138977106|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977107|NCT00871208|Retapamulin|retapamulin|mesh-list
138977108|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
138977109|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138977110|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139005609|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005610|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005611|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139005612|NCT00654095|Atorvastatin|atorvastatin|mesh-list
139005613|NCT00654095|Ezetimibe|ezetimibe|mesh-list
139005614|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139005615|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139005616|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
139005617|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977111|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138977112|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
138977113|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
138977114|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138977115|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138977116|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977117|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138977118|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138977119|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138977120|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138977121|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977122|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977123|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977124|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138977125|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
138977126|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138977127|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
138977128|NCT00866450|Calcium|calcium|mesh-list
138977129|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138935836|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138977130|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977131|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138977132|NCT03894969|Vaccines|vaccines|mesh-list
138977133|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
138977134|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977135|NCT00876434|Sirolimus|sirolimus|mesh-list
138977136|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138977137|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977138|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138977139|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977140|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
138977141|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138977142|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
138977143|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977144|NCT00871442|Fentanyl|fentanyl|mesh-list
138977145|NCT00871442|Bupivacaine|bupivacaine|mesh-list
138977146|NCT00871442|Anesthetics|anesthetics|mesh-list
138977147|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
138977148|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977149|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977150|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
138977151|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977152|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138977153|NCT00871442|Narcotics|narcotics|mesh-ancestor
138977154|NCT00871442|Analgesics|analgesics|mesh-ancestor
138977155|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138977156|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138977157|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
138977158|NCT05355597|Clonidine|clonidine|mesh-list
138977159|NCT05355597|Epinephrine|epinephrine|mesh-list
138977160|NCT05355597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138977161|NCT05355597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138977162|NCT05355597|Adrenergic Agents|adrenergic agents|mesh-ancestor
138977163|NCT05355597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977164|NCT05355597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977165|NCT05355597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977166|NCT05355597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139005618|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139005619|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139005620|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005621|NCT00811967|Ribavirin|ribavirin|mesh-list
139005622|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139005623|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
139005624|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
138513151|NCT05568082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138977167|NCT05355597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138977168|NCT05355597|Autonomic Agents|autonomic agents|mesh-ancestor
138977169|NCT05355597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977170|NCT05355597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138977171|NCT05355597|Respiratory System Agents|respiratory system agents|mesh-ancestor
138977172|NCT05355597|Mydriatics|mydriatics|mesh-ancestor
138977173|NCT05355597|Sympathomimetics|sympathomimetics|mesh-ancestor
138977174|NCT05355597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138977175|NCT05355597|Analgesics|analgesics|mesh-ancestor
138977176|NCT05355597|Sensory System Agents|sensory system agents|mesh-ancestor
138977177|NCT05355597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138977178|NCT05355597|Sympatholytics|sympatholytics|mesh-ancestor
138977179|NCT05355597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138977180|NCT00866528|Paclitaxel|paclitaxel|mesh-list
138977181|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138977182|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977183|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
138977184|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
138977185|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
138977186|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977187|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138639965|NCT00416325|Lycopene|lycopene|mesh-list
138977188|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
138977189|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977190|NCT00992667|Acetovanillone|acetovanillone|mesh-list
138977191|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138977192|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138977193|NCT00992667|Analgesics|analgesics|mesh-ancestor
138977194|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
138977195|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977196|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977197|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138977198|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138977199|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
138977200|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977201|NCT00992667|Protective Agents|protective agents|mesh-ancestor
138977202|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977203|NCT05171972|Ofatumumab|ofatumumab|mesh-list
138977204|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977205|NCT00992823|Iron|iron|mesh-list
138977206|NCT00992823|Trace Elements|trace elements|mesh-ancestor
138977207|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
138977208|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977209|NCT03894813|Metronidazole|metronidazole|mesh-list
138977210|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977211|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138977212|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138977213|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138977214|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
138977215|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138977216|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
138977217|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977218|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977219|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138977220|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
138977221|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
138977222|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138977223|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
138977224|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977225|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977226|NCT00876824|Amphotericin B|amphotericin b|mesh-list
138977227|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139005625|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005627|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005628|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
139005629|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005630|NCT04046159|Tamoxifen|tamoxifen|mesh-list
139005631|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139005632|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
139005633|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005634|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005635|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139005636|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005637|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138513220|NCT03151434|Analgesics|analgesics|mesh-ancestor
138977228|NCT00876824|Amebicides|amebicides|mesh-ancestor
138977229|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138977230|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138977231|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977232|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138977233|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
138977234|NCT00866684|Cyclosporine|cyclosporine|mesh-list
138977235|NCT00866684|Sirolimus|sirolimus|mesh-list
138977236|NCT00866684|Azathioprine|azathioprine|mesh-list
138977237|NCT00866684|Tacrolimus|tacrolimus|mesh-list
138977238|NCT00866684|Cyclosporins|cyclosporins|mesh-list
138977239|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138977240|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
138977241|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977242|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138977243|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977244|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977245|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
138977246|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977247|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
138977248|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138977249|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138977250|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977251|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138977252|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
138977253|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138977254|NCT00993057|Insulin|insulin|mesh-list
138977255|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138977256|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977257|NCT00866762|Vorinostat|vorinostat|mesh-list
138977258|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138977259|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977260|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977261|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977262|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
138977263|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138977264|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
138977265|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977266|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138977267|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977268|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
138977269|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977270|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
138977271|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138977272|NCT00876902|Protective Agents|protective agents|mesh-ancestor
138977273|NCT00993135|Methotrexate|methotrexate|mesh-list
138977274|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139005638|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139005639|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139005640|NCT00653939|Paclitaxel|paclitaxel|mesh-list
139005641|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
139005642|NCT00653939|Combretastatin|combretastatin|mesh-list
139005643|NCT00653939|Bevacizumab|bevacizumab|mesh-list
139005644|NCT00653939|Carboplatin|carboplatin|mesh-list
139005645|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139005646|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005647|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
139005648|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
138977275|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
138977276|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138977277|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977278|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138977279|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
138977280|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977281|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977282|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
138977283|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977284|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138977285|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138977286|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
138977287|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138977288|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138977289|NCT00866996|Methylphenidate|methylphenidate|mesh-list
138977290|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138977291|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138977292|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977293|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138977294|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138977295|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138977296|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977297|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
138977298|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977299|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138977300|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
138977301|NCT00871910|Dexamethasone|dexamethasone|mesh-list
138977302|NCT00871910|Ondansetron|ondansetron|mesh-list
138977303|NCT00871910|Aprepitant|aprepitant|mesh-list
138977304|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138977305|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
138977306|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
138977307|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977308|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977309|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138977311|NCT00871910|Hormones|hormones|mesh-ancestor
138977312|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138977313|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138977314|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977315|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
138977316|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
138977317|NCT00871910|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138977318|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138977319|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
138977320|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977321|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977322|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138977323|NCT05355441|Analgesics|analgesics|mesh-list
138977324|NCT05355441|Sensory System Agents|sensory system agents|mesh-ancestor
138977325|NCT05355441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977326|NCT05355441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977327|NCT01564329|Endostar protein|endostar protein|mesh-list
138977328|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139005649|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
139005650|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005651|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139005652|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139005653|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139005654|NCT00653939|Growth Substances|growth substances|mesh-ancestor
139005655|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005656|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
139005657|NCT00812123|Cyclosporine|cyclosporine|mesh-list
139005658|NCT00812123|Sirolimus|sirolimus|mesh-list
139005659|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
139005660|NCT00812123|Prednisone|prednisone|mesh-list
139005661|NCT00812123|Cyclosporins|cyclosporins|mesh-list
139005662|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005663|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
139005664|NCT00812123|Hormones|hormones|mesh-ancestor
138513349|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138977329|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138977330|NCT01564329|Growth Substances|growth substances|mesh-ancestor
138977331|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977332|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
138977333|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977334|NCT05213481|Tepotinib|tepotinib|mesh-list
138977335|NCT05213481|Carbamazepine|carbamazepine|mesh-list
138977336|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
138977337|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
138977338|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138977339|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977340|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977341|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138977342|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138977343|NCT05213481|Analgesics|analgesics|mesh-ancestor
138977344|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
138977345|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977346|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138977347|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138977348|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977349|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138977350|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138977351|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977352|NCT00993525|Ranibizumab|ranibizumab|mesh-list
138977353|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138977354|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138977355|NCT00993525|Growth Substances|growth substances|mesh-ancestor
138977356|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977357|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
138977358|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977359|NCT00993681|Vaccines|vaccines|mesh-list
138977360|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
138977361|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977362|NCT03892707|Folic Acid|folic acid|mesh-list
138977363|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
138977364|NCT03892707|Celecoxib|celecoxib|mesh-list
138977365|NCT03892707|Etoricoxib|etoricoxib|mesh-list
138977366|NCT03892707|Meloxicam|meloxicam|mesh-list
138977367|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138977368|NCT03892707|Nimesulide|nimesulide|mesh-list
138977369|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138977370|NCT03892707|Benphothiamine|benphothiamine|mesh-list
138977371|NCT03892707|Vitamins|vitamins|mesh-ancestor
138977372|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
138977373|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005665|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005666|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005667|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139005668|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005670|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005671|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139005672|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
139005673|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
139005674|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005675|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
139005676|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138513407|NCT00136981|Torcetrapib|torcetrapib|mesh-list
138977374|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138977375|NCT03892707|Analgesics|analgesics|mesh-ancestor
138977376|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
138977377|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977378|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138977379|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138977380|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138977381|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977382|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977383|NCT03892707|Hematinics|hematinics|mesh-ancestor
138977384|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138977385|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
138977386|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
138977387|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
138977388|NCT00513604|Aldesleukin|aldesleukin|mesh-list
138977389|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
138977390|NCT00513604|Fludarabine|fludarabine|mesh-list
138977391|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
138977392|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138977393|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
138977394|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977395|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138977396|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138977397|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
138977398|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977399|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977400|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138977401|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138977402|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
138977403|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138977404|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138977405|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
138977406|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977407|NCT00872144|Nabiximols|nabiximols|mesh-list
138977408|NCT00872144|Analgesics|analgesics|mesh-ancestor
138977409|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
138977410|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977411|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977412|NCT00867152|Ritonavir|ritonavir|mesh-list
138977413|NCT00867152|Lopinavir|lopinavir|mesh-list
138977414|NCT00867152|Darunavir|darunavir|mesh-list
138977415|NCT00867152|Dolutegravir|dolutegravir|mesh-list
138977416|NCT00867152|Etravirine|etravirine|mesh-list
138977417|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138977418|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138977419|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
138977420|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977421|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977422|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138977423|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138977424|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
138977425|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005677|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139005678|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139005679|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139005680|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
139005681|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139005682|NCT00646451|Pregabalin|pregabalin|mesh-list
139005683|NCT00646451|Analgesics|analgesics|mesh-ancestor
139005684|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
139005685|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005686|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977426|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138977427|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138977428|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138977429|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138977430|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138977431|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138977432|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138977433|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
138977434|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977435|NCT00872378|Exenatide|exenatide|mesh-list
138977436|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138604484|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977437|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977438|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138977439|NCT00872378|Incretins|incretins|mesh-ancestor
138977440|NCT00872378|Hormones|hormones|mesh-ancestor
138977441|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138977442|NCT00994071|Temozolomide|temozolomide|mesh-list
138977443|NCT00994071|Veliparib|veliparib|mesh-list
138977444|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138977445|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
138977446|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977447|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977448|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138977449|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977450|NCT00994149|Diazoxide|diazoxide|mesh-list
138977451|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138977452|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
138977453|NCT00573248|Nicotine|nicotine|mesh-list
138977454|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138977455|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
138977456|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977457|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977458|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138977459|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138977460|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
138977461|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977462|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977463|NCT04039880|Olorofim|olorofim|mesh-list
138977464|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
138977465|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977466|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
138977467|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138977468|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
138977469|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977470|NCT00994305|Expectorants|expectorants|mesh-ancestor
138977471|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
138977472|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138977473|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
138977474|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977475|NCT00994305|Protective Agents|protective agents|mesh-ancestor
138977476|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977477|NCT00994305|Antidotes|antidotes|mesh-ancestor
138977478|NCT00877760|Interferons|interferons|mesh-list
138977479|NCT00877760|Entecavir|entecavir|mesh-list
138977480|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005687|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
139005688|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139005689|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139005690|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005691|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139005692|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139005693|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139005694|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139005695|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139005696|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
139005697|NCT00809237|Gefitinib|gefitinib|mesh-list
139005698|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
139005699|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139005700|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138977481|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
138977482|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977483|NCT04083911|Cytarabine|cytarabine|mesh-list
138977484|NCT04083911|Decitabine|decitabine|mesh-list
138977485|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
138977486|NCT04083911|Aclarubicin|aclarubicin|mesh-list
138977487|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138977488|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
138977489|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977490|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977491|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
138977492|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977493|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138977494|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
138977495|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977496|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977497|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138977498|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138977499|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138977500|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138977501|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138935912|NCT00866944|Leucovorin|leucovorin|mesh-list
138977502|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
138977503|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138977504|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138977505|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
138977506|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977507|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138977508|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138977509|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977510|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977512|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138977513|NCT00994383|Narcotics|narcotics|mesh-ancestor
138977514|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977515|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977516|NCT00994383|Analgesics|analgesics|mesh-ancestor
138977517|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
138977518|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977519|NCT02588417|Dexamethasone|dexamethasone|mesh-list
138977520|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
138977521|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138977522|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
138977523|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
138977524|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977525|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977526|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138977527|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
138977528|NCT02588417|Hormones|hormones|mesh-ancestor
138977529|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005701|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005702|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005703|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005704|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139005705|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005706|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139005707|NCT00817583|Docetaxel|docetaxel|mesh-list
139005708|NCT00817583|Fluorouracil|fluorouracil|mesh-list
139005709|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005710|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
139005711|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
139005712|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
139005713|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005714|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
139005715|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139005716|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139005717|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
139005718|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005719|NCT00817661|Vitamin A|vitamin a|mesh-list
139005720|NCT00817661|Vitamins|vitamins|mesh-ancestor
139005721|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
139005722|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005723|NCT00642707|Leronlimab|leronlimab|mesh-list
139005724|NCT00642707|Antibodies|antibodies|mesh-list
139005725|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139005726|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
139005727|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005728|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139005729|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139005730|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005735|NCT02551523|Dolutegravir|dolutegravir|mesh-list
139005748|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139005749|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005750|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138935923|NCT00866944|Antidotes|antidotes|mesh-ancestor
139005751|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005752|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
139005753|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
139005754|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005755|NCT00817895|Cisplatin|cisplatin|mesh-list
139005756|NCT00817895|Fluorouracil|fluorouracil|mesh-list
139005757|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005758|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
139005759|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005760|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139005761|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139005762|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
139005763|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005764|NCT00814229|Vaccines|vaccines|mesh-list
139005765|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
139005766|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
139005767|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005768|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139005769|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139005770|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139005771|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139005772|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138513626|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
138977530|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138977531|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977532|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
138977533|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
138977534|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977535|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
138977537|NCT00532935|Pioglitazone|pioglitazone|mesh-list
138977538|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138977539|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138977540|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977541|NCT00532935|Incretins|incretins|mesh-ancestor
138977543|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138977544|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138977545|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
138977546|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977547|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977548|NCT00994539|Morphine|morphine|mesh-list
138977549|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138977550|NCT00994539|Narcotics|narcotics|mesh-ancestor
138977551|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977552|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005773|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005774|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
139005775|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139005776|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005777|NCT00061945|Leucovorin|leucovorin|mesh-list
139005778|NCT00061945|Cytarabine|cytarabine|mesh-list
139005779|NCT00061945|Acyclovir|acyclovir|mesh-list
139005780|NCT00061945|Trimethoprim|trimethoprim|mesh-list
139005781|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
139005782|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139005783|NCT00061945|Dexamethasone|dexamethasone|mesh-list
138935931|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138935932|NCT00577824|Incretins|incretins|mesh-ancestor
139005784|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
139005785|NCT00061945|Methotrexate|methotrexate|mesh-list
139005786|NCT00061945|Vincristine|vincristine|mesh-list
139005787|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
139005788|NCT00061945|Daunorubicin|daunorubicin|mesh-list
139005789|NCT00061945|Asparaginase|asparaginase|mesh-list
139005790|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
139005791|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
139005792|NCT00061945|Allopurinol|allopurinol|mesh-list
139005793|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
139005794|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139005795|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
138977553|NCT00994539|Analgesics|analgesics|mesh-ancestor
138977554|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
138977555|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977556|NCT00878306|Ritonavir|ritonavir|mesh-list
138977557|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138977558|NCT00878306|Efavirenz|efavirenz|mesh-list
138977559|NCT00878306|Disulfiram|disulfiram|mesh-list
138977560|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138977561|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138977562|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
138977563|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977564|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977565|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138977566|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138977567|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
138977568|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977569|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138977570|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138977571|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138977572|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138977573|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138977574|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138977575|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138977576|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138977577|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138977578|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138977579|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138977580|NCT00994617|Losartan|losartan|mesh-list
138977581|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138977582|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138977583|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138977584|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138977585|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139005796|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005797|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139005798|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139005799|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
139005800|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005801|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005802|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139005803|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005805|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
139005806|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005807|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139005808|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
139005809|NCT00061945|Hormones|hormones|mesh-ancestor
139005810|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005811|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139005812|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139005813|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
139005814|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138756566|NCT02827903|Metformin|metformin|mesh-list
139005815|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139005816|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
139005817|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
139005818|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005819|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139005820|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139005821|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
138977586|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977587|NCT00994617|Diuretics|diuretics|mesh-ancestor
138977588|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
138977589|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977590|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138977591|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138977592|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
138977593|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
138977594|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138977595|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
138977596|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
138977597|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977598|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977599|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977600|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
138977601|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
138977602|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138977603|NCT00919451|Cyclosporine|cyclosporine|mesh-list
138977604|NCT00919451|Cyclosporins|cyclosporins|mesh-list
138977605|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005822|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005823|NCT00061945|Antidotes|antidotes|mesh-ancestor
139005824|NCT00061945|Protective Agents|protective agents|mesh-ancestor
139005825|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
139005826|NCT00061945|Vitamins|vitamins|mesh-ancestor
139005827|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
139005828|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139005829|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
139005830|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
139005831|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
139005832|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139005833|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139005834|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139005835|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139005836|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139005837|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
139005838|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139005839|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
139005840|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139005841|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
139005842|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139005843|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139005844|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139005845|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139005846|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139005847|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139005848|NCT00817973|Caseins|caseins|mesh-list
139005849|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
139005850|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
138513785|NCT03837977|Antidotes|antidotes|mesh-ancestor
138977606|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977607|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138977608|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
138977609|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977610|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
138977611|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977612|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
138977613|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138977614|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138977616|NCT03016312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138935963|NCT00870298|Trimethoprim|trimethoprim|mesh-list
138935964|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
138935965|NCT00870298|Warfarin|warfarin|mesh-list
138935966|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
138935967|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138977617|NCT03016312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977618|NCT03016312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138977619|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977620|NCT05059223|Reboxetine|reboxetine|mesh-list
138977621|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
138977622|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138604599|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139005851|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005853|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
139005854|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005855|NCT00642473|Metronidazole|metronidazole|mesh-list
139005856|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139005857|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005858|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139005859|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005860|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005861|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005862|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139005863|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139005864|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139005865|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139005866|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139005867|NCT00366340|Vaccines|vaccines|mesh-list
139005868|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139005869|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
139005870|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005871|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
139005872|NCT03992326|Fludarabine|fludarabine|mesh-list
139005873|NCT03992326|Interleukin-2|interleukin-2|mesh-list
139005874|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139005875|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
139005876|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005877|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139005878|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139005879|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
139005880|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005881|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005882|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139005883|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138977623|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138977624|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138977625|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138977626|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977627|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
138977628|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977629|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977630|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139005884|NCT03992326|Analgesics|analgesics|mesh-ancestor
139005885|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
139005886|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005887|NCT01045954|Insulin|insulin|mesh-list
139005888|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
139005889|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
139005890|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139005891|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005892|NCT01046032|Metformin|metformin|mesh-list
139005893|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139005894|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977631|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
138977632|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138977633|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138977634|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138977635|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977636|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977637|NCT01014052|Retinol acetate|retinol acetate|mesh-list
138977638|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138977639|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
138977640|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977641|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138977642|NCT01014052|Protective Agents|protective agents|mesh-ancestor
138977643|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977644|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
138977645|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977646|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138977647|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977648|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977649|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
138977650|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138977651|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138977652|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138977653|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138977654|NCT01015300|Bevacizumab|bevacizumab|mesh-list
138977655|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138977656|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977657|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138977658|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138977659|NCT01015300|Growth Substances|growth substances|mesh-ancestor
138977660|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977661|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
138977662|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
138977663|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
138977664|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138977665|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
138977666|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977667|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138977668|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138604636|NCT00167765|Abciximab|abciximab|mesh-list
138977669|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
138977670|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977671|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977672|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138977673|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138977674|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138977675|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
138977676|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138977677|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977678|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977679|NCT02589041|Ropivacaine|ropivacaine|mesh-list
138977680|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
138977681|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
138977682|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977683|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005896|NCT00061633|Penicillins|penicillins|mesh-list
139005897|NCT00061633|Telavancin|telavancin|mesh-list
139005898|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139005899|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139005900|NCT00645593|Gemcitabine|gemcitabine|mesh-list
139005901|NCT00645593|Cetuximab|cetuximab|mesh-list
139005902|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005903|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139005904|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
139005905|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005906|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139005907|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
139005908|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
138513933|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138977684|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
138977685|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887229|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138977686|NCT00492232|Zolpidem|zolpidem|mesh-list
138977687|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138977688|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138977689|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977690|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977691|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138977692|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
138977693|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
138977694|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977695|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977696|NCT02587871|Cytarabine|cytarabine|mesh-list
138977697|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138977698|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
138977699|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977700|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977701|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
138977702|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977703|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138977704|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
138977705|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977706|NCT00919919|Progesterone|progesterone|mesh-list
138977707|NCT00919919|Progestins|progestins|mesh-ancestor
138977708|NCT00919919|Hormones|hormones|mesh-ancestor
138977709|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138977710|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977711|NCT00491764|Posaconazole|posaconazole|mesh-list
138977712|NCT00491764|Terbinafine|terbinafine|mesh-list
138977713|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
138977714|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604659|NCT02906176|Voriconazole|voriconazole|mesh-list
138977715|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138977716|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138977717|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138977718|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138977719|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138977720|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977721|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977722|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138977723|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
138977724|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138977725|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977726|NCT02586311|Amlodipine|amlodipine|mesh-list
138977727|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139005909|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005911|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139005912|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139005913|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139005914|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
139005915|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139005916|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005917|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139005918|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139005919|NCT02550977|Progestins|progestins|mesh-ancestor
139005920|NCT02550977|Hormones|hormones|mesh-ancestor
139005921|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005922|NCT01045018|Mesalamine|mesalamine|mesh-list
139005923|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139005924|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139005925|NCT01045018|Analgesics|analgesics|mesh-ancestor
139005926|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
138977728|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138977729|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138977730|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977731|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138977732|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977733|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
138977734|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138977735|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
138977736|NCT00615836|Coagulants|coagulants|mesh-ancestor
138977737|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138977738|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
138977739|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977740|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
138977741|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138977742|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977743|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977744|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138977745|NCT05139212|Analgesics|analgesics|mesh-ancestor
138977746|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
138977747|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977748|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138977749|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138977750|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138977751|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
138977752|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977753|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977754|NCT00872924|Sumatriptan|sumatriptan|mesh-list
138977755|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138977756|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138977757|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138977758|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
138977759|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977760|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977761|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977762|NCT00878540|Mirtazapine|mirtazapine|mesh-list
138977763|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
138977764|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139005927|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005928|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005929|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005930|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139005931|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
139005932|NCT01049464|Analgesics|analgesics|mesh-ancestor
139005933|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
139005934|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139005935|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005936|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
139005937|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139005938|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139005939|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
138514048|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138977765|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138977766|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
138977767|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
138977768|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977769|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977770|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977771|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138977772|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138977773|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977774|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138977775|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138977776|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138977777|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
138977778|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138977779|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138977780|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
138977781|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138977782|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
138977783|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138977784|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
138977785|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
138977786|NCT04018274|Estradiol|estradiol|mesh-list
138977787|NCT04018274|Estrogens|estrogens|mesh-ancestor
138977788|NCT04018274|Hormones|hormones|mesh-ancestor
138977789|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138977790|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977791|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138936044|NCT00862264|Beclomethasone|beclomethasone|mesh-list
138977792|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138977793|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138977794|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138977795|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138977796|NCT00873002|Sorafenib|sorafenib|mesh-list
138977797|NCT00873002|Panobinostat|panobinostat|mesh-list
138977798|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977799|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138977800|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977801|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977802|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138977803|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
138977804|NCT00491530|Atorvastatin|atorvastatin|mesh-list
138977805|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138977806|NCT00491530|Simvastatin|simvastatin|mesh-list
138977807|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
138977808|NCT00491530|Calcium|calcium|mesh-list
138977809|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138977810|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005940|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139005941|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139005942|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005943|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139005944|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
139005945|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139005946|NCT01046266|Cetuximab|cetuximab|mesh-list
139005947|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139005948|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005949|NCT00365794|Testosterone|testosterone|mesh-list
139005950|NCT00365794|Androgens|androgens|mesh-ancestor
139005951|NCT00365794|Hormones|hormones|mesh-ancestor
139005952|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139005953|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005954|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
139005955|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139005956|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138514132|NCT00142129|Bortezomib|bortezomib|mesh-list
138977811|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138604708|NCT00167999|Tazobactam|tazobactam|mesh-list
138977812|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138977813|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138977814|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
138977815|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977816|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138977817|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138977818|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977819|NCT00617240|Metformin|metformin|mesh-list
138977820|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138977821|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977822|NCT00615290|Tipranavir|tipranavir|mesh-list
138977823|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138977824|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138977825|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
138977826|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977827|NCT02587169|Doxorubicin|doxorubicin|mesh-list
138977828|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138977829|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138977830|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936074|NCT00870532|Vinorelbine|vinorelbine|mesh-list
138977831|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138977832|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138977833|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887230|NCT02713763|Growth Substances|growth substances|mesh-ancestor
138977834|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977835|NCT00873236|Interferons|interferons|mesh-list
138977836|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
138977837|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
138977838|NCT00873236|Bevacizumab|bevacizumab|mesh-list
138977839|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138977840|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977841|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138977842|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138977843|NCT00873236|Growth Substances|growth substances|mesh-ancestor
138977844|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977845|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
138977846|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
138977847|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977848|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
139005966|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
138756716|NCT00889603|Donepezil|donepezil|mesh-list
139005967|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005968|NCT01049542|Astressin|astressin|mesh-list
139005969|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138977850|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138977851|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977852|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977853|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
138977854|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977855|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977856|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
138977857|NCT05683301|Amlodipine|amlodipine|mesh-list
138977858|NCT05683301|Perindopril|perindopril|mesh-list
138977859|NCT05683301|Indapamide|indapamide|mesh-list
138977860|NCT05683301|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
138977861|NCT05683301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138977862|NCT05683301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138977863|NCT05683301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138977864|NCT05683301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977865|NCT05683301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138977866|NCT05683301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977867|NCT05683301|Vasodilator Agents|vasodilator agents|mesh-ancestor
138977868|NCT05683301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138977869|NCT05683301|Protease Inhibitors|protease inhibitors|mesh-ancestor
138977870|NCT05683301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977871|NCT05683301|Diuretics|diuretics|mesh-ancestor
138977872|NCT05683301|Natriuretic Agents|natriuretic agents|mesh-ancestor
138977873|NCT05683301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138977884|NCT00873392|Nicotine|nicotine|mesh-list
138977885|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138977886|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
138977887|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977888|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977889|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138977890|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138977891|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
138977892|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977893|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977894|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
138977895|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139005970|NCT01049542|Protective Agents|protective agents|mesh-ancestor
138936091|NCT01951274|Serlopitant|serlopitant|mesh-list
139005971|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005972|NCT01049620|Capecitabine|capecitabine|mesh-list
139005973|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
139005974|NCT01049620|Everolimus|everolimus|mesh-list
139005975|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139005976|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
139005977|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005978|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139005979|NCT01049620|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139005980|NCT01049620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139005981|NCT01049620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005982|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139005983|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
139005984|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139005985|NCT00059839|Prednisone|prednisone|mesh-list
139005986|NCT00059839|Doxorubicin|doxorubicin|mesh-list
139005987|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139005988|NCT00059839|Methotrexate|methotrexate|mesh-list
139005989|NCT00059839|Vincristine|vincristine|mesh-list
139005990|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
139005991|NCT00059839|Vinblastine|vinblastine|mesh-list
139005992|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139005993|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977896|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138977897|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138977898|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138977899|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138977900|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977901|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977902|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977903|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138977904|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
138977905|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138977906|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728745|NCT04902443|Nivolumab|nivolumab|mesh-list
138977907|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138977908|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138977909|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138977910|NCT00879164|Bupivacaine|bupivacaine|mesh-list
138977911|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
138977912|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
138977913|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977914|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977915|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
138977916|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977917|NCT04731155|Alirocumab|alirocumab|mesh-list
138977918|NCT04731155|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
138977919|NCT04731155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138977920|NCT04731155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138977921|NCT04731155|Antimetabolites|antimetabolites|mesh-ancestor
138977922|NCT04731155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977923|NCT04731155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138977924|NCT04731155|Protease Inhibitors|protease inhibitors|mesh-ancestor
139005994|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139005995|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139005996|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139005997|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139005998|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139005999|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
139006000|NCT00059839|Hormones|hormones|mesh-ancestor
139006001|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139006002|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006003|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139006004|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139006005|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
139006006|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139006007|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139006008|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
139006009|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
138977925|NCT04731155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977926|NCT04731155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138977927|NCT04729049|Morphine|morphine|mesh-list
138977928|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138977929|NCT04729049|Narcotics|narcotics|mesh-ancestor
138977930|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138977931|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977932|NCT04729049|Analgesics|analgesics|mesh-ancestor
138977933|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
138977934|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977935|NCT02585765|Pioglitazone|pioglitazone|mesh-list
138977936|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138977937|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977938|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
138977939|NCT04634669|Bupropion|bupropion|mesh-list
138977940|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138977941|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
138977942|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138977943|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138977944|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138977945|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138977946|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977947|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
138977948|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977949|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977950|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138977951|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138977952|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138977953|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
138977954|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
138977955|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138977956|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138977957|NCT02585531|Dexamethasone|dexamethasone|mesh-list
138977958|NCT02585531|Epinephrine|epinephrine|mesh-list
138977959|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138977960|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
138977961|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
138977962|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138977963|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977964|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138977965|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
139006010|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139006011|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139006012|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
139006013|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139006014|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139006015|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139006016|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
139006017|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
139006018|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
139006019|NCT00059215|Clopidogrel|clopidogrel|mesh-list
139006020|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139006021|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139006022|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139006023|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139006024|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139006025|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
139006026|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006027|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006028|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138977966|NCT02585531|Hormones|hormones|mesh-ancestor
138977967|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138977968|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138977969|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138977970|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138977971|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138977972|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
138977973|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138977974|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138977975|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138977976|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138977977|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138977978|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
138728813|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
138977979|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
138977980|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
138977981|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138977982|NCT00920153|Cytarabine|cytarabine|mesh-list
138977983|NCT00920153|Dexamethasone|dexamethasone|mesh-list
138977984|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
138977985|NCT00920153|Gemcitabine|gemcitabine|mesh-list
138977986|NCT00920153|Doxorubicin|doxorubicin|mesh-list
138977987|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138977988|NCT00920153|Etoposide|etoposide|mesh-list
138977989|NCT00920153|Vincristine|vincristine|mesh-list
138977990|NCT00920153|Melphalan|melphalan|mesh-list
138977991|NCT00920153|Vinorelbine|vinorelbine|mesh-list
138977992|NCT00920153|Ifosfamide|ifosfamide|mesh-list
138977993|NCT00920153|Dacarbazine|dacarbazine|mesh-list
138977994|NCT00920153|Carmustine|carmustine|mesh-list
138977995|NCT00920153|Bleomycin|bleomycin|mesh-list
138977996|NCT00920153|Vindesine|vindesine|mesh-list
138977997|NCT00920153|Mitoguazone|mitoguazone|mesh-list
138977998|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138977999|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
138978000|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
138978001|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978002|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978003|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139006030|NCT00058825|Fludarabine|fludarabine|mesh-list
139006031|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
139006032|NCT00058825|Tacrolimus|tacrolimus|mesh-list
139006033|NCT00058825|Cyclosporins|cyclosporins|mesh-list
139006034|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006035|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006036|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139006037|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
139006038|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006039|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139006040|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006041|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
139006042|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006044|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139006045|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139006046|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139006047|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
139006048|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006049|NCT03953989|Ranolazine|ranolazine|mesh-list
139006050|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139006051|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138514391|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138978004|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
138978005|NCT00920153|Hormones|hormones|mesh-ancestor
138978006|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138978007|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138978008|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978009|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138978010|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
138978011|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978012|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138978013|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138978014|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138978015|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978016|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138978017|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
138978018|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978019|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138978020|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
138978021|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
138978022|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
138978023|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
138978024|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138978025|NCT00920153|Protective Agents|protective agents|mesh-ancestor
138978026|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138978027|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
138978028|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138978029|NCT04080713|Budesonide|budesonide|mesh-list
138978030|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138978031|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138978032|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
138978033|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006052|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006053|NCT01096225|Vaccines|vaccines|mesh-list
139006054|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
139006055|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006056|NCT02535130|Amikacin|amikacin|mesh-list
139006057|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139006058|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006059|NCT01046500|Inositol|inositol|mesh-list
139006060|NCT01046500|Metformin|metformin|mesh-list
139006061|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139006062|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006063|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
139006064|NCT01046500|Vitamins|vitamins|mesh-ancestor
139006065|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
139006066|NCT01046578|Letrozole|letrozole|mesh-list
139006067|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138514467|NCT00404716|Cilostazol|cilostazol|mesh-list
138978034|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978035|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138978036|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
138978037|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
138978038|NCT04080713|Hormones|hormones|mesh-ancestor
138978039|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138978040|NCT05519189|Ropivacaine|ropivacaine|mesh-list
138978041|NCT05519189|Anesthetics, Local|anesthetics, local|mesh-ancestor
138978042|NCT05519189|Anesthetics|anesthetics|mesh-ancestor
138978043|NCT05519189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138978044|NCT05519189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978045|NCT05519189|Sensory System Agents|sensory system agents|mesh-ancestor
138978046|NCT05519189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978047|NCT04080323|Dinoprostone|dinoprostone|mesh-list
138978048|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
138978049|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138978050|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978051|NCT03930017|Vaccines|vaccines|mesh-list
138978052|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
138978053|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978054|NCT00533949|Paclitaxel|paclitaxel|mesh-list
138978055|NCT00533949|Carboplatin|carboplatin|mesh-list
138978056|NCT00533949|Cetuximab|cetuximab|mesh-list
138978057|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138728890|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
138978058|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978059|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
138978060|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
138978061|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
138978062|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978063|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138978065|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
138978066|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978067|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138978068|NCT02585141|Clindamycin|clindamycin|mesh-list
138978069|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
138978070|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
138978071|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978072|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138978073|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978074|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978075|NCT04079231|Aflibercept|aflibercept|mesh-list
138978076|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138978077|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138978078|NCT04079231|Growth Substances|growth substances|mesh-ancestor
139006068|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139006069|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139006070|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006071|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006072|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139006073|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
139006074|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139006075|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006076|NCT00372424|Docetaxel|docetaxel|mesh-list
139006077|NCT00372424|Trastuzumab|trastuzumab|mesh-list
138978079|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978080|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
138978081|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978082|NCT00994695|Vaccines|vaccines|mesh-list
138978083|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
138978084|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978085|NCT04521803|Rifampin|rifampin|mesh-list
138978086|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138978087|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
138978088|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138978089|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978090|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
138978091|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138978092|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978093|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978094|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138978095|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138978096|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138978097|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138978098|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138936157|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
138978099|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138978100|NCT00920465|Misoprostol|misoprostol|mesh-list
138978101|NCT00920465|Mifepristone|mifepristone|mesh-list
138978102|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138978103|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
138978104|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138978105|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978106|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138978107|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138978108|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
138978109|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138978110|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138978111|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138978112|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138978113|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
138978114|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138978115|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138978116|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
138978117|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138978118|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
138978119|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138978120|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138978121|NCT00994773|Tenofovir|tenofovir|mesh-list
138978122|NCT00994773|Entecavir|entecavir|mesh-list
138978123|NCT00994773|Simvastatin|simvastatin|mesh-list
138978124|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
138978125|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978126|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138978127|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138978128|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978129|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978130|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138978131|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139006078|NCT00372424|Sunitinib|sunitinib|mesh-list
139006079|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006080|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
139006081|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
139006082|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
139006083|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006084|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139006085|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139006086|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139006087|NCT00372424|Growth Substances|growth substances|mesh-ancestor
139006088|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006089|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
139006090|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139006091|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006092|NCT02530411|Fulvestrant|fulvestrant|mesh-list
139006093|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139006094|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006095|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138514577|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
138728963|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
138978132|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138978133|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138978134|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
138978135|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138978136|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138978137|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
138978138|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138978139|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
138978140|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138978141|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
138978142|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978143|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978144|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
138978145|NCT03084237|Docetaxel|docetaxel|mesh-list
138978146|NCT03084237|Trastuzumab|trastuzumab|mesh-list
138978147|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978148|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
138978149|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
138978150|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
138978151|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978152|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138978153|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
138978154|NCT00996021|Dolutegravir|dolutegravir|mesh-list
138978155|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138978156|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138978157|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978158|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138978159|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138978160|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978161|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978162|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978163|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138978164|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
138978165|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138978166|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006096|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139006097|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
139006098|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139006099|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006100|NCT01327027|Vasopressins|vasopressins|mesh-list
139006101|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
139006102|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
139006103|NCT01327027|Coagulants|coagulants|mesh-ancestor
139006104|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139006105|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139006106|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
139006107|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006108|NCT01093807|Enalapril|enalapril|mesh-list
139006109|NCT01093807|Enalaprilat|enalaprilat|mesh-list
139006110|NCT01093807|Lercanidipine|lercanidipine|mesh-list
139006111|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139006112|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
139006113|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006114|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006115|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139006116|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139006117|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139006118|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139006119|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006120|NCT00044083|Tolcapone|tolcapone|mesh-list
139006121|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139006122|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139006123|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139006124|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006125|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006126|NCT00058123|Poly ICLC|poly iclc|mesh-list
139006127|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
139006128|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
139006129|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006130|NCT00022633|Paclitaxel|paclitaxel|mesh-list
139006137|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006138|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139006139|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
139006140|NCT00021541|Tipifarnib|tipifarnib|mesh-list
139006141|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006142|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
139006143|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006144|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139006145|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006146|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006147|NCT02688790|Dalbavancin|dalbavancin|mesh-list
139006148|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139006149|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006150|NCT00488475|Etanercept|etanercept|mesh-list
139006151|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139006152|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139006153|NCT00488475|Analgesics|analgesics|mesh-ancestor
139006154|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
139006155|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006156|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006157|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139006158|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139006159|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139006160|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139006161|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
139006162|NCT01020279|Celecoxib|celecoxib|mesh-list
139006163|NCT01020279|Ketoprofen|ketoprofen|mesh-list
139006164|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139006182|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006183|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139006184|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139006185|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
139006186|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006187|NCT00042991|Gefitinib|gefitinib|mesh-list
139006188|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006189|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139006190|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006191|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006192|NCT00466167|Pramipexole|pramipexole|mesh-list
139006193|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
139006194|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006195|NCT00466167|Protective Agents|protective agents|mesh-ancestor
139006196|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006197|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139006198|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139006199|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
139006200|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
139006201|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006202|NCT01017939|Prednisone|prednisone|mesh-list
139006203|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
139006204|NCT01017939|Theophylline|theophylline|mesh-list
139006205|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
139006206|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139006207|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
139006208|NCT01017939|Hormones|hormones|mesh-ancestor
139006209|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139006210|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006211|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139006212|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006213|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139006214|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006215|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006222|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006223|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139006224|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
139006225|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006226|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139006227|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139006228|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
139006229|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139006230|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139006231|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
139006232|NCT00480441|Dronabinol|dronabinol|mesh-list
139006233|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
139006234|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006235|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139006236|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139006237|NCT00480441|Analgesics|analgesics|mesh-ancestor
139006238|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
139006239|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006240|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139006241|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139006242|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006243|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006274|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
139006275|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006277|NCT00463047|Oxycodone|oxycodone|mesh-list
139006278|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139006279|NCT00463047|Narcotics|narcotics|mesh-ancestor
139006280|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139006281|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006282|NCT00463047|Analgesics|analgesics|mesh-ancestor
139006283|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
139006284|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006285|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139006286|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139006287|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
139006288|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
139006289|NCT00487539|Golimumab|golimumab|mesh-list
139006290|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138978167|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138978168|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138978169|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138978170|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138978171|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138978172|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138978173|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138978174|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
138978175|NCT00996099|Insulin|insulin|mesh-list
138978176|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138978177|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138978178|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978179|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
138978180|NCT02584751|Omeprazole|omeprazole|mesh-list
138978181|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138978182|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138978183|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138978184|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978185|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978186|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138978187|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
138978188|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978189|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978190|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138978191|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
138978192|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138978193|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
138978194|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138978195|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138978196|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
138978197|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
138978198|NCT02584751|Protective Agents|protective agents|mesh-ancestor
138978199|NCT00999219|Zolpidem|zolpidem|mesh-list
138978200|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138978201|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138978202|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138978203|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978204|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138978205|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
138978206|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
138729070|NCT04026009|Vaccines|vaccines|mesh-list
138978207|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138978208|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978210|NCT00996177|Morphine|morphine|mesh-list
138978211|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139006291|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139006292|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139006293|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139006295|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006296|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
139006297|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139006298|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006299|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006300|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139006301|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139006302|NCT00486759|Bevacizumab|bevacizumab|mesh-list
139006303|NCT00486759|Rituximab|rituximab|mesh-list
139006304|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139006305|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006306|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139006307|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139006308|NCT00486759|Growth Substances|growth substances|mesh-ancestor
139006309|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006310|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
139006311|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
139006312|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139006313|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
139006314|NCT00486603|Temozolomide|temozolomide|mesh-list
139006315|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139006316|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
139006317|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006318|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006319|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
139006320|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139006321|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139006322|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006323|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978212|NCT00996177|Narcotics|narcotics|mesh-ancestor
138978213|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138978214|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978215|NCT00996177|Analgesics|analgesics|mesh-ancestor
138978216|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
138978217|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978218|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138978219|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138978220|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
139006324|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139006325|NCT00474045|Insulin|insulin|mesh-list
139006326|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139006327|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
139006328|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
139006329|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
139006330|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
139006331|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
139006332|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139006333|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006334|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139006335|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
139006336|NCT01020825|Coagulants|coagulants|mesh-ancestor
139006337|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
139006338|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139006339|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139006340|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139006341|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139006342|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006343|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
139006344|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006345|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006346|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139006347|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006348|NCT00462501|Leucovorin|leucovorin|mesh-list
139006349|NCT00462501|Bevacizumab|bevacizumab|mesh-list
139006350|NCT00462501|Fluorouracil|fluorouracil|mesh-list
139006351|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
139006352|NCT00462501|Calcium|calcium|mesh-list
139006353|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
139006354|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139006355|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006356|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139006357|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139006358|NCT00462501|Growth Substances|growth substances|mesh-ancestor
139006359|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006360|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
139006361|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139006362|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
138978221|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
139006363|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006364|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139006365|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139006366|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
139006367|NCT00462501|Antidotes|antidotes|mesh-ancestor
139006368|NCT00462501|Protective Agents|protective agents|mesh-ancestor
139006369|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
139006370|NCT00462501|Vitamins|vitamins|mesh-ancestor
139006371|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
139006372|NCT03996603|Estrogens|estrogens|mesh-list
139006373|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139006374|NCT03996603|Hormones|hormones|mesh-ancestor
139006375|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139006376|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006377|NCT00462345|Rituximab|rituximab|mesh-list
139006378|NCT00462345|Methotrexate|methotrexate|mesh-list
139006379|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139006380|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006381|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
139006382|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006383|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139006384|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138978222|NCT04079933|Nicotine|nicotine|mesh-list
138978223|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138978224|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
138978225|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978226|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936227|NCT00726960|Analgesics|analgesics|mesh-ancestor
138978227|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138978228|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138978229|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
138978230|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138978231|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978232|NCT00999297|Capsaicin|capsaicin|mesh-list
138978233|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
138978234|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
138978235|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
138978236|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978237|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978238|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
138978239|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978240|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138978241|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978242|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978243|NCT05371223|Gemcitabine|gemcitabine|mesh-list
138978244|NCT05371223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138978245|NCT05371223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138978246|NCT05371223|Antimetabolites|antimetabolites|mesh-ancestor
138978247|NCT05371223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978248|NCT05371223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978249|NCT00532779|Naltrexone|naltrexone|mesh-list
138978250|NCT00532779|Bupropion|bupropion|mesh-list
138978251|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138978252|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138978253|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006385|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
139006386|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139006387|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139006388|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
139006389|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006390|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
139006391|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006392|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139006393|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139006394|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139006395|NCT01022541|Bevacizumab|bevacizumab|mesh-list
139006396|NCT01022541|Capecitabine|capecitabine|mesh-list
139006397|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
139006398|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139006399|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006400|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139006401|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139006402|NCT01022541|Growth Substances|growth substances|mesh-ancestor
139006403|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006404|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
139006405|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139006406|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
139006407|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978254|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
138978255|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978256|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138978257|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
138978258|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138978259|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138978260|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138978261|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138978262|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978263|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
138978264|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138978265|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138978266|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138978267|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978268|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138978269|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
138978270|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978271|NCT00996411|Salvinorin A|salvinorin a|mesh-list
138978272|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
138978273|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978274|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138978275|NCT00996567|Cetuximab|cetuximab|mesh-list
138978276|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138978277|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978278|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
138978279|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139006409|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
139006410|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006411|NCT01049854|Vidarabine|vidarabine|mesh-list
139006412|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
139006413|NCT01049854|Thiotepa|thiotepa|mesh-list
139006414|NCT01049854|Busulfan|busulfan|mesh-list
139006415|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
139006416|NCT01049854|Fludarabine|fludarabine|mesh-list
139006417|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139006418|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139006419|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
139006420|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006421|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139006422|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139006423|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
139006424|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006425|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006426|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138515010|NCT01903421|Fentanyl|fentanyl|mesh-list
138978280|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978281|NCT02852655|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138978282|NCT02852655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978283|NCT00500110|Docetaxel|docetaxel|mesh-list
138978284|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
138978285|NCT00500110|Leuprolide|leuprolide|mesh-list
138978286|NCT00500110|Goserelin|goserelin|mesh-list
138978287|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978288|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
138978289|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
138978290|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
138978291|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605064|NCT05880459|Propofol|propofol|mesh-list
138978292|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138978293|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978294|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138978295|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
138978296|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138978297|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978298|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138978300|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138978301|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978302|NCT04358237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138978303|NCT04358237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978304|NCT05304533|Itraconazole|itraconazole|mesh-list
138978305|NCT05304533|Verapamil|verapamil|mesh-list
138978306|NCT05304533|Antifungal Agents|antifungal agents|mesh-ancestor
138978307|NCT05304533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978308|NCT05304533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138978309|NCT05304533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138978310|NCT05304533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978311|NCT05304533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978312|NCT05304533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138978313|NCT05304533|Hormone Antagonists|hormone antagonists|mesh-ancestor
138978314|NCT05304533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138978315|NCT05304533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006427|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139006429|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
139006430|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006431|NCT00453999|Oseltamivir|oseltamivir|mesh-list
139006432|NCT00453999|Peramivir|peramivir|mesh-list
139006433|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
139006434|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006435|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006436|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006437|NCT00453921|Methylphenidate|methylphenidate|mesh-list
139006438|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139006439|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006440|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139006441|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139006442|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139006443|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006444|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
138978316|NCT05304533|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138978317|NCT05304533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138978318|NCT05304533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138978319|NCT05304533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138978320|NCT05304533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138978321|NCT05304533|Vasodilator Agents|vasodilator agents|mesh-ancestor
138978322|NCT00534495|Rilonacept|rilonacept|mesh-list
138978323|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138978324|NCT04077827|Propofol|propofol|mesh-list
138978325|NCT04077827|Desflurane|desflurane|mesh-list
138978326|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138978327|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605080|NCT05880459|Tocolytic Agents|tocolytic agents|mesh-ancestor
138978328|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978329|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138978330|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
138978331|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
138978332|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138978334|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978335|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138978336|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978337|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978338|NCT05332587|Rituximab|rituximab|mesh-list
138978339|NCT05332587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138978340|NCT05332587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978341|NCT05332587|Immunologic Factors|immunologic factors|mesh-ancestor
138978342|NCT05332587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978343|NCT05332587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138978344|NCT00996879|Midazolam|midazolam|mesh-list
138978345|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138978346|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138978347|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138978348|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978349|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138978350|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138978351|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138978352|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138978353|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
138978354|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
138978355|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
139006445|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006446|NCT00382720|Docetaxel|docetaxel|mesh-list
139006447|NCT00382720|Capecitabine|capecitabine|mesh-list
139006448|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
139006449|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006450|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
139006451|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
139006452|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
139006453|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006454|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139006455|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
138978357|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138978358|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978359|NCT02582177|Ketoconazole|ketoconazole|mesh-list
138978360|NCT02582177|Clotrimazole|clotrimazole|mesh-list
138978361|NCT02582177|Miconazole|miconazole|mesh-list
138978362|NCT02582177|Dexamethasone|dexamethasone|mesh-list
138978363|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
138978364|NCT02582177|Betamethasone|betamethasone|mesh-list
138978365|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
138978366|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138978367|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
138978368|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138978369|NCT02582177|BB 1101|bb 1101|mesh-list
138978370|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138978371|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
138978372|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
138978373|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978374|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978375|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138978376|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
138978377|NCT02582177|Hormones|hormones|mesh-ancestor
138978378|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138978379|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138978380|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978381|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
138978382|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978383|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978384|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138978385|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
138978386|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
138978387|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978388|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138978389|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138978390|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138978391|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
138978392|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138978393|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138978394|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138978395|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
138978396|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
138978397|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138978398|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138978399|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138978400|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138978401|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978402|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
138978403|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138978404|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978405|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138978406|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978407|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138978408|NCT00997191|Triamcinolone|triamcinolone|mesh-list
138978409|NCT00997191|Bevacizumab|bevacizumab|mesh-list
138978410|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139006456|NCT01025349|Bevacizumab|bevacizumab|mesh-list
139006457|NCT01025349|Docetaxel|docetaxel|mesh-list
139006458|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139006459|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006460|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139006461|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139006462|NCT01025349|Growth Substances|growth substances|mesh-ancestor
139006463|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006464|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
139006465|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
139006466|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
139006467|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
139006468|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006469|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
139006470|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139006471|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
139006472|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139006473|NCT00371566|Lapatinib|lapatinib|mesh-list
139006474|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006475|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139006476|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978411|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978412|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138978413|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138978414|NCT00997191|Growth Substances|growth substances|mesh-ancestor
138978415|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978416|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
138978417|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138978418|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
138978419|NCT00997191|Hormones|hormones|mesh-ancestor
138978420|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138978421|NCT00997269|Ubiquinone|ubiquinone|mesh-list
138978422|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
138978423|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
138978424|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978425|NCT00997269|Vitamins|vitamins|mesh-ancestor
138978426|NCT02582099|Gentamicins|gentamicins|mesh-list
138978427|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138978428|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978429|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138978430|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978431|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978432|NCT00997347|Misoprostol|misoprostol|mesh-list
138978433|NCT00997347|Mifepristone|mifepristone|mesh-list
138978434|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138978435|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
138978436|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138978437|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978438|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138978439|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138978440|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
138978441|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138978442|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138978443|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138978444|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138978445|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
139006477|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006478|NCT00371254|Dasatinib|dasatinib|mesh-list
139006479|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006480|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139006481|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006482|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006483|NCT00452673|Capecitabine|capecitabine|mesh-list
139006484|NCT00452673|Dasatinib|dasatinib|mesh-list
139006485|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139006486|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
139006487|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006488|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006489|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139006490|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006491|NCT00461253|Copper|copper|mesh-list
139006492|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
138757235|NCT04238221|Doxofylline|doxofylline|mesh-list
139006493|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139006494|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
139006495|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139006496|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006497|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139006498|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139006499|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138978446|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138978447|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138978448|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
138978449|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138978450|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
138978451|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138978452|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138978453|NCT00997581|Apremilast|apremilast|mesh-list
138978454|NCT00997581|Indomethacin|indomethacin|mesh-list
138978455|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138978456|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138978457|NCT00997581|Analgesics|analgesics|mesh-ancestor
138978458|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
138978459|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978460|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978461|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138978462|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138978463|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138978464|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138978465|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978466|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978467|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
138978468|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
138978469|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138978470|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138978471|NCT05183139|Dexamethasone|dexamethasone|mesh-list
139006500|NCT00461253|Trace Elements|trace elements|mesh-ancestor
139006501|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
139006502|NCT00469833|Insulin|insulin|mesh-list
139006503|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139006504|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
139006505|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
139006506|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139006507|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006508|NCT00641537|Cladribine|cladribine|mesh-list
139006509|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006510|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139006511|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
139006512|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006513|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139006514|NCT00814541|Dexamethasone|dexamethasone|mesh-list
139006515|NCT00814541|Doxorubicin|doxorubicin|mesh-list
139006516|NCT00814541|Bortezomib|bortezomib|mesh-list
139006517|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139006518|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
139006519|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
138978472|NCT05183139|Lenalidomide|lenalidomide|mesh-list
138978473|NCT05183139|Pomalidomide|pomalidomide|mesh-list
138978474|NCT05183139|Ixazomib|ixazomib|mesh-list
138978475|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138978476|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
138978477|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
138978478|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978479|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978480|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138978481|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
138978482|NCT05183139|Hormones|hormones|mesh-ancestor
138978483|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138978484|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138978485|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978486|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
138978487|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138978488|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138978489|NCT05183139|Growth Substances|growth substances|mesh-ancestor
138978490|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
138978491|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
138978492|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605227|NCT05090085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978494|NCT00999843|Sorafenib|sorafenib|mesh-list
138978495|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978496|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138978497|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978498|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978499|NCT00997659|Chromium|chromium|mesh-list
138978500|NCT00997659|Picolinic acid|picolinic acid|mesh-list
138978501|NCT00997659|Trace Elements|trace elements|mesh-ancestor
138978502|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
138978503|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978504|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138978505|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
138978506|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
138978507|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978508|NCT03827213|Bupivacaine|bupivacaine|mesh-list
138978509|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
138978510|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
138978511|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138978512|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006520|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006521|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006522|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139006523|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
139006524|NCT00814541|Hormones|hormones|mesh-ancestor
139006525|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139006526|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139006527|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006528|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139006529|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139006530|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139006531|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006532|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006533|NCT00814619|Capecitabine|capecitabine|mesh-list
139006534|NCT00814619|Panitumumab|panitumumab|mesh-list
139006535|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139006536|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
139006537|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978513|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
138978514|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978515|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
138978516|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138978517|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138978518|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138978519|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138978520|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978521|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
138978522|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138978523|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978524|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138978525|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978526|NCT04077983|Paclitaxel|paclitaxel|mesh-list
138978527|NCT04077983|Gemcitabine|gemcitabine|mesh-list
138978528|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138978529|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978530|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
138978531|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
138978532|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
138978533|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978534|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138978535|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
138978536|NCT03822845|Edetic Acid|edetic acid|mesh-list
138978537|NCT03822845|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138978538|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
138978539|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
138978540|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978541|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
138978542|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138978543|NCT03822845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138978544|NCT01000233|Inositol|inositol|mesh-list
138978545|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
138978546|NCT01000233|Vitamins|vitamins|mesh-ancestor
138978547|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
138978548|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978549|NCT04075955|Olanzapine|olanzapine|mesh-list
138978550|NCT04075955|Aprepitant|aprepitant|mesh-list
139006538|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006539|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139006541|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139006542|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139006543|NCT00641147|Analgesics|analgesics|mesh-ancestor
139006544|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
139006545|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006546|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006547|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139006548|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139006549|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006550|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006551|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006552|NCT00460239|Morphine|morphine|mesh-list
139006553|NCT00460239|Buprenorphine|buprenorphine|mesh-list
139006554|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139006555|NCT00460239|Narcotics|narcotics|mesh-ancestor
139006556|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139006557|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006558|NCT00460239|Analgesics|analgesics|mesh-ancestor
138978551|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
138978552|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
138978553|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978554|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978555|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138978556|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138978557|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138978558|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138978559|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138978560|NCT04075955|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138978561|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138978562|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138978563|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978564|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138978565|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
138978566|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138978567|NCT00484198|Pioglitazone|pioglitazone|mesh-list
138978568|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138978569|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978570|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
138978571|NCT04077905|Doxorubicin|doxorubicin|mesh-list
138978572|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138978573|NCT04077905|Etoposide|etoposide|mesh-list
138978574|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138978575|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978576|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138978577|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138978578|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978579|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978580|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138978581|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138978582|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
138978583|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
139006559|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
139006560|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006561|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139006562|NCT00640835|Buprenorphine|buprenorphine|mesh-list
139006563|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139006564|NCT00640835|Naloxone|naloxone|mesh-list
138978584|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978585|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978586|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138978587|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
138978588|NCT04077905|Hormones|hormones|mesh-ancestor
138978589|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138978590|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138978591|NCT04077905|Protective Agents|protective agents|mesh-ancestor
138978592|NCT04471246|Cephalexin|cephalexin|mesh-list
138978593|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138978594|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978595|NCT04276259|Naltrexone|naltrexone|mesh-list
138978596|NCT04276259|Buprenorphine|buprenorphine|mesh-list
138978597|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138978598|NCT04276259|Narcotics|narcotics|mesh-ancestor
138978599|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138978600|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978601|NCT04276259|Analgesics|analgesics|mesh-ancestor
138978602|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
138978603|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978604|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138978605|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138978606|NCT00499486|Sirolimus|sirolimus|mesh-list
138978607|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138978608|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978609|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138936346|NCT00805311|Aspirin|aspirin|mesh-list
138978610|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978611|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
138978612|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138978613|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
138605337|NCT04692077|Emtricitabine|emtricitabine|mesh-list
138978614|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978615|NCT01019278|Cisplatin|cisplatin|mesh-list
138978616|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978617|NCT01014520|Gabapentin|gabapentin|mesh-list
138978618|NCT01014520|Amitriptyline|amitriptyline|mesh-list
138978619|NCT01014520|Analgesics|analgesics|mesh-ancestor
138978620|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
138978621|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978622|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978623|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
138978624|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138978625|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138978626|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138978627|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138978628|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138978629|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138978630|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138978631|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978632|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
138978633|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138978634|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
138978635|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138978636|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138978637|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138978638|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138978639|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
138978640|NCT01016002|Temoporfin|temoporfin|mesh-list
138978641|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978642|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138978643|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
138978644|NCT01019434|Sirolimus|sirolimus|mesh-list
138978645|NCT01019434|Temozolomide|temozolomide|mesh-list
138978646|NCT01019434|Temsirolimus|temsirolimus|mesh-list
138978647|NCT01019434|MTOR Inhibitors|mtor inhibitors|mesh-list
139006565|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139006566|NCT00640835|Narcotics|narcotics|mesh-ancestor
139006567|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139006568|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006569|NCT00640835|Analgesics|analgesics|mesh-ancestor
139006570|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
139006571|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006572|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139006573|NCT03839355|Warfarin|warfarin|mesh-list
139006574|NCT03839355|Apixaban|apixaban|mesh-list
139006575|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
139006576|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139006577|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
139006578|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139006579|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
139006580|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936359|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139006581|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006582|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139006583|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
139006584|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138978648|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138978649|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
138978650|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978651|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978652|NCT01019434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138605364|NCT04497961|Lenalidomide|lenalidomide|mesh-list
138978653|NCT01019434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978654|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138978655|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
138978656|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978657|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138978658|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978659|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138978660|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
138978661|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138978662|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138978663|NCT00499252|Paclitaxel|paclitaxel|mesh-list
138978664|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138978665|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138978666|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978667|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
138978668|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
138978669|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
138978670|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978671|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138978672|NCT01019590|Olmesartan|olmesartan|mesh-list
138978673|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138978674|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138978675|NCT01019590|Diuretics|diuretics|mesh-ancestor
138978676|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
138978677|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978678|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138978679|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138978680|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978681|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138978682|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139006585|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139006586|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139006587|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139006588|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006589|NCT02551133|Dexamethasone|dexamethasone|mesh-list
139006590|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139006591|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
139006592|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
139006593|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006594|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006595|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139006596|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
139006598|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138515590|NCT00847860|Aspirin|aspirin|mesh-list
138978683|NCT03775421|Macitentan|macitentan|mesh-list
138978684|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138978685|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138978686|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978687|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138978688|NCT00532155|Dexamethasone|dexamethasone|mesh-list
138978689|NCT00532155|Docetaxel|docetaxel|mesh-list
138978690|NCT00532155|Aflibercept|aflibercept|mesh-list
138978691|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138978692|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
138978693|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
138978694|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978695|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978696|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138978697|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
138978698|NCT00532155|Hormones|hormones|mesh-ancestor
138978699|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138978700|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138978701|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978702|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
138978703|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
138978704|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
138978705|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978706|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138978707|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138978708|NCT00532155|Growth Substances|growth substances|mesh-ancestor
138978709|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
138978710|NCT01019668|Verteporfin|verteporfin|mesh-list
138978711|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138978712|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
138978713|NCT01019746|Propofol|propofol|mesh-list
138978714|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138978715|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138978716|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978717|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138978718|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
138978719|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
138978720|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
138978721|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138978722|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138978723|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
138978724|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138978725|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978726|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138978727|NCT03762395|CXA-10|cxa-10|mesh-list
139006599|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139006600|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006601|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
139006602|NCT00452439|Vitamin D|vitamin d|mesh-list
139006603|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
139006604|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
139006605|NCT00452439|Calcium|calcium|mesh-list
139006606|NCT00452439|Vitamins|vitamins|mesh-ancestor
139006607|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
139006608|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006609|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139006610|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139006611|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139006612|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139006613|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006614|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139006615|NCT01023087|Colistin|colistin|mesh-list
139006616|NCT01023087|Polymyxins|polymyxins|mesh-list
139006617|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139006618|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936397|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006619|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
139006620|NCT00381940|Bortezomib|bortezomib|mesh-list
139006621|NCT00381940|Vinorelbine|vinorelbine|mesh-list
139006622|NCT00381940|Ifosfamide|ifosfamide|mesh-list
139006623|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006624|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139006625|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
139006626|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
139006627|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
139006628|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006629|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139006630|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
139006631|NCT00818675|Sirolimus|sirolimus|mesh-list
139006632|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139006633|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006642|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
139006643|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006644|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006645|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139006646|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139006647|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
139006648|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006649|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006650|NCT00452361|Cyclosporine|cyclosporine|mesh-list
139006651|NCT00452361|Sirolimus|sirolimus|mesh-list
139006652|NCT00452361|Tacrolimus|tacrolimus|mesh-list
139006653|NCT00452361|Cyclosporins|cyclosporins|mesh-list
139006654|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139006655|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139006656|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
139006657|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006658|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515685|NCT00011960|Paclitaxel|paclitaxel|mesh-list
138978728|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138978729|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
138605431|NCT04287062|Suvorexant|suvorexant|mesh-list
138978731|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
138978732|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138978733|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138978734|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978735|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
138978736|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
138978737|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978738|NCT01014832|Insulin|insulin|mesh-list
138978739|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138978740|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138978741|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978742|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
138978743|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138978744|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138978745|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978746|NCT03996473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138978747|NCT03996473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978748|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
138978749|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
138978750|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138978751|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
138978752|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978753|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138978754|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138978755|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138978756|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138978757|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978758|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138978759|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
138978760|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978761|NCT00483574|Vaccines|vaccines|mesh-list
138978762|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
138978763|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978764|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138978765|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138978766|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138978767|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139006659|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006661|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006662|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
139006663|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139006664|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139006665|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139006666|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006667|NCT03334318|Allopurinol|allopurinol|mesh-list
139006668|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
139006669|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006670|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006671|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
139006672|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139006673|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139006674|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
139006675|NCT03334318|Protective Agents|protective agents|mesh-ancestor
139006676|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006677|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
139006678|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139006679|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139006680|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006681|NCT01049932|Rilpivirine|rilpivirine|mesh-list
139006682|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138978768|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978769|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138978770|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978771|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138978772|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
138978773|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138978774|NCT00998439|Paclitaxel|paclitaxel|mesh-list
138978775|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138978776|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978777|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
138978778|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
138978779|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
138978780|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978781|NCT01000779|Propranolol|propranolol|mesh-list
138978782|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138978783|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138978784|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
138978785|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138978786|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978787|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978788|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138978789|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138978790|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
138978791|NCT01000857|Paroxetine|paroxetine|mesh-list
138978792|NCT01000857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139006683|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139006684|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006685|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006686|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
139006687|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006688|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139006689|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139006690|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
139006691|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139006692|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
139006693|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139006694|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139006695|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139006696|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139006697|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006698|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
139006699|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006700|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006701|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138515785|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138978793|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138978794|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138978795|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978796|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138978797|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
138978798|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978799|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138978800|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
138978801|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138978802|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138978803|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138978804|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978805|NCT01004445|Amikacin|amikacin|mesh-list
138978806|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138978807|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978808|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
138978809|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138978810|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
138978811|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978812|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
138978813|NCT02580695|Protective Agents|protective agents|mesh-ancestor
138978814|NCT02581553|Allopurinol|allopurinol|mesh-list
138978815|NCT02581553|Lesinurad|lesinurad|mesh-list
138978816|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
138978817|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978818|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978819|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
138978820|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138978821|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138978822|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
138978823|NCT02581553|Protective Agents|protective agents|mesh-ancestor
138978824|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978825|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
138978826|NCT03944915|Paclitaxel|paclitaxel|mesh-list
139006702|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006703|NCT01047748|Digoxin|digoxin|mesh-list
139006704|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139006705|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139006706|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936430|NCT00732524|Glipizide|glipizide|mesh-list
139006707|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006708|NCT01047748|Protective Agents|protective agents|mesh-ancestor
139006709|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006710|NCT00568451|Paclitaxel|paclitaxel|mesh-list
139006711|NCT00568451|Carboplatin|carboplatin|mesh-list
139006712|NCT00568451|Temozolomide|temozolomide|mesh-list
139006713|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139006714|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006715|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
139006716|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
139006717|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
139006718|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006719|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139006720|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
139006721|NCT00459537|Terbinafine|terbinafine|mesh-list
139006722|NCT00459537|Amorolfine|amorolfine|mesh-list
139006723|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
138515872|NCT00846690|Lidocaine|lidocaine|mesh-list
138978827|NCT03944915|Carboplatin|carboplatin|mesh-list
138978828|NCT03944915|Fluorouracil|fluorouracil|mesh-list
138978829|NCT03944915|Nivolumab|nivolumab|mesh-list
138978830|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
138978831|NCT03944915|Lenograstim|lenograstim|mesh-list
138978832|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138978833|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978834|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
138978835|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
138978836|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
138978837|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978838|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
138978839|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138978840|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138978841|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
138978842|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978843|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138978844|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138978845|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138978846|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
138978847|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978848|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138978849|NCT00482170|Etanercept|etanercept|mesh-list
138978850|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138978851|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138978852|NCT00482170|Analgesics|analgesics|mesh-ancestor
138978853|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
138978854|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978855|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978856|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138978857|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139006724|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006725|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006726|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006727|NCT03866421|Liver Extracts|liver extracts|mesh-list
139006728|NCT03866421|Hematinics|hematinics|mesh-ancestor
139006729|NCT00819377|Milrinone|milrinone|mesh-list
139006730|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139006731|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139006732|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
139006733|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139006734|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139006735|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006736|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006737|NCT00819377|Protective Agents|protective agents|mesh-ancestor
139006738|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006739|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
139006740|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
139006741|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139006742|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006743|NCT01023243|Aspirin|aspirin|mesh-list
139006744|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139006745|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139006746|NCT01023243|Analgesics|analgesics|mesh-ancestor
138515890|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
138978858|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138978859|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138978860|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
138978861|NCT05228249|Cytarabine|cytarabine|mesh-list
138978862|NCT05228249|Etoposide|etoposide|mesh-list
138978863|NCT05228249|Podophyllotoxin|podophyllotoxin|mesh-list
138978864|NCT05228249|Etoposide phosphate|etoposide phosphate|mesh-list
138978865|NCT05228249|Melphalan|melphalan|mesh-list
138978866|NCT05228249|Mechlorethamine|mechlorethamine|mesh-list
138978867|NCT05228249|Carmustine|carmustine|mesh-list
138978868|NCT05228249|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138978869|NCT05228249|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
138978870|NCT05228249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138978871|NCT05228249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978872|NCT05228249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138978873|NCT05228249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138978874|NCT05228249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978875|NCT05228249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978876|NCT05228249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138978877|NCT05228249|Antimetabolites|antimetabolites|mesh-ancestor
138978878|NCT05228249|Antiviral Agents|antiviral agents|mesh-ancestor
138978879|NCT05228249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978880|NCT05228249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138978881|NCT05228249|Immunologic Factors|immunologic factors|mesh-ancestor
138978882|NCT05228249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978883|NCT05228249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138978884|NCT05228249|Alkylating Agents|alkylating agents|mesh-ancestor
138978885|NCT05228249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138978886|NCT05228249|Keratolytic Agents|keratolytic agents|mesh-ancestor
139006747|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
139006748|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006749|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006750|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139006752|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139006753|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139006754|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006755|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139006756|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139006757|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006758|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
139006759|NCT03762915|Minocycline|minocycline|mesh-list
139006760|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138978887|NCT05228249|Dermatologic Agents|dermatologic agents|mesh-ancestor
138978888|NCT05228249|Tubulin Modulators|tubulin modulators|mesh-ancestor
138978889|NCT05228249|Antimitotic Agents|antimitotic agents|mesh-ancestor
138978890|NCT05228249|Mitosis Modulators|mitosis modulators|mesh-ancestor
138978891|NCT05228249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138978892|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
138978893|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138978894|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138978895|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978896|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
138978897|NCT02580227|Coagulants|coagulants|mesh-ancestor
138978898|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
138978899|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138978900|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978901|NCT01001013|Pioglitazone|pioglitazone|mesh-list
138978902|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138978904|NCT01004601|Docetaxel|docetaxel|mesh-list
138978905|NCT01004601|Pemetrexed|pemetrexed|mesh-list
138978906|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978907|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
138978908|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
138978909|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
138978910|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978911|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978912|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138978913|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138978914|NCT01001247|Rilpivirine|rilpivirine|mesh-list
138978915|NCT01001247|Omeprazole|omeprazole|mesh-list
138978916|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138978917|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138978918|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138978919|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138978920|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978921|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138978922|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138978923|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
138978924|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978925|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138978926|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138978927|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
138978928|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978929|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138978930|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138978931|NCT04205357|Analgesics|analgesics|mesh-ancestor
138978932|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
138978933|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138978934|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978935|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139006761|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006762|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
139006763|NCT00469209|Bortezomib|bortezomib|mesh-list
139006764|NCT00469209|Melphalan|melphalan|mesh-list
139006765|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
139006766|NCT00469209|Vitamins|vitamins|mesh-ancestor
139006767|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
139006768|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006769|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978936|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138978937|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138978938|NCT02580773|Tinzaparin|tinzaparin|mesh-list
138978939|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
138978940|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138978941|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138978942|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978943|NCT01008813|Vaccines|vaccines|mesh-list
138978944|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
138978945|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978946|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
138978947|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138978948|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138978949|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978950|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
138978951|NCT01005147|Coagulants|coagulants|mesh-ancestor
138978952|NCT01001871|Vitamins|vitamins|mesh-list
138978953|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
138978954|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978955|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
138729795|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
138978956|NCT01005381|Vitamin D|vitamin d|mesh-list
138978957|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
138978958|NCT01005381|Calcium|calcium|mesh-list
138978959|NCT01005381|Vitamins|vitamins|mesh-ancestor
138978960|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
138978961|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978962|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138978963|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138978964|NCT01005381|Antacids|antacids|mesh-ancestor
138978965|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978966|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138978967|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
138978968|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138978969|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978970|NCT05154279|Terlipressin|terlipressin|mesh-list
138978971|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138978972|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138978973|NCT01005537|Aldesleukin|aldesleukin|mesh-list
138978974|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
138978975|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138978976|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
138978977|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978978|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138978979|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138978980|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
138978981|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978982|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978983|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138978984|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138978985|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138978986|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
138978987|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138978988|NCT01005927|Calcium|calcium|mesh-list
138978989|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138978990|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138978992|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138978993|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
138978994|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
138978995|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
138978996|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978997|NCT01002729|Oseltamivir|oseltamivir|mesh-list
139006770|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139006771|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
139006772|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006773|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139006774|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139006775|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
139006776|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
139006777|NCT00469209|Protective Agents|protective agents|mesh-ancestor
139006778|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139006779|NCT00635219|Vortioxetine|vortioxetine|mesh-list
139006780|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139006781|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139006782|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139006783|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006784|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138978998|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
138978999|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979000|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979001|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979002|NCT01002807|Metformin|metformin|mesh-list
138979003|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
138979004|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138979005|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979006|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138979007|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979008|NCT05733117|Vitamin D|vitamin d|mesh-list
138979009|NCT05733117|Vitamins|vitamins|mesh-ancestor
138979010|NCT05733117|Micronutrients|micronutrients|mesh-ancestor
138979011|NCT05733117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979012|NCT05733117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138979013|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
138979014|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138979015|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979016|NCT00615056|Leucovorin|leucovorin|mesh-list
138979017|NCT00615056|Bevacizumab|bevacizumab|mesh-list
138979018|NCT00615056|Fluorouracil|fluorouracil|mesh-list
138979019|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
138979020|NCT00615056|Irinotecan|irinotecan|mesh-list
138979021|NCT00615056|Axitinib|axitinib|mesh-list
138979022|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
138979023|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138979024|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979025|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138979026|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138979027|NCT00615056|Growth Substances|growth substances|mesh-ancestor
138979028|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979029|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
138979030|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
138979031|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979032|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138979033|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138979034|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
138979035|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138605667|NCT02589600|Vitamin D|vitamin d|mesh-list
138979036|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138979037|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979038|NCT00615056|Antidotes|antidotes|mesh-ancestor
138979039|NCT00615056|Protective Agents|protective agents|mesh-ancestor
138979040|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
139006785|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006786|NCT00635219|Analgesics|analgesics|mesh-ancestor
139006787|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
139006788|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006789|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
139006790|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139006791|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
139006792|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139006793|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139006794|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139006795|NCT00635219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139006796|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
139006797|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139006798|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139006799|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139006800|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139006802|NCT01026129|Remifentanil|remifentanil|mesh-list
139006803|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
138979041|NCT00615056|Vitamins|vitamins|mesh-ancestor
138979042|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
138979043|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138979044|NCT01006551|Ziprasidone|ziprasidone|mesh-list
138979045|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138979046|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
138979047|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138979048|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979049|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630863|NCT00232037|Tegaserod|tegaserod|mesh-list
138979050|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138979051|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138979052|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138979053|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138979054|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138979055|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
138979056|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
138979057|NCT00873626|Levofloxacin|levofloxacin|mesh-list
138979058|NCT00873626|Ofloxacin|ofloxacin|mesh-list
138979059|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
138979060|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138979061|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979062|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138979063|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138979064|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979065|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979066|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979067|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138979068|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138979069|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138979070|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138979071|NCT00879242|Deferasirox|deferasirox|mesh-list
138979072|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138979073|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
138979074|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
138979075|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979076|NCT05732493|Capecitabine|capecitabine|mesh-list
138979077|NCT05732493|Oxaliplatin|oxaliplatin|mesh-list
138979078|NCT05732493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138979079|NCT05732493|Antimetabolites|antimetabolites|mesh-ancestor
139006804|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
139006805|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139006806|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006807|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
139006808|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006809|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139006810|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139006811|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139006812|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139006813|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006814|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139006815|NCT01026129|Narcotics|narcotics|mesh-ancestor
139006816|NCT01026129|Analgesics|analgesics|mesh-ancestor
139006817|NCT01026285|Risperidone|risperidone|mesh-list
139006818|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
139006819|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139006820|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
139006821|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006822|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006823|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006824|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139006825|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138979080|NCT05732493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979081|NCT05732493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979082|NCT00868634|Bevacizumab|bevacizumab|mesh-list
138979083|NCT00868634|Capecitabine|capecitabine|mesh-list
138979084|NCT00868634|Vinorelbine|vinorelbine|mesh-list
138979085|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138979086|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979087|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138979088|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138979089|NCT00868634|Growth Substances|growth substances|mesh-ancestor
138979090|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979091|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
138979092|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138979093|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
138979094|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979095|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138979096|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
138979097|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
138979098|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
138979099|NCT05232357|Sodium thiosulfate|sodium thiosulfate|mesh-list
138979100|NCT05232357|Methylene Blue|methylene blue|mesh-list
138979101|NCT05232357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979102|NCT05232357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979103|NCT05232357|Antidotes|antidotes|mesh-ancestor
138979104|NCT05232357|Protective Agents|protective agents|mesh-ancestor
138979105|NCT05232357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979106|NCT05232357|Antioxidants|antioxidants|mesh-ancestor
138979107|NCT05232357|Antitubercular Agents|antitubercular agents|mesh-ancestor
138979108|NCT05232357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139006826|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139006827|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139006828|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
139006829|NCT01026363|Vitamin D|vitamin d|mesh-list
139006830|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
139006831|NCT01026363|Cholecalciferol|cholecalciferol|mesh-list
139006832|NCT01026363|Calcitriol|calcitriol|mesh-list
139006833|NCT01026363|Vitamins|vitamins|mesh-list
139006834|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
139006835|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006836|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139006837|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139006838|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139006839|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139006840|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006841|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139006842|NCT01023399|Artesunate|artesunate|mesh-list
139006843|NCT01023399|Amodiaquine|amodiaquine|mesh-list
139006844|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
139006845|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139006846|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139006847|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006848|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006849|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
139006850|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
139006851|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139006852|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
139006853|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
139006854|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139006855|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139006856|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139006857|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139006858|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006859|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
139006860|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006861|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006864|NCT00451035|Panobinostat|panobinostat|mesh-list
139006867|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006868|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006869|NCT00468585|Bevacizumab|bevacizumab|mesh-list
139006870|NCT00468585|Capecitabine|capecitabine|mesh-list
139006871|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139006872|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006873|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139006874|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139006875|NCT00468585|Growth Substances|growth substances|mesh-ancestor
139006876|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006877|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
139006878|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139006879|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
139006880|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006881|NCT01026597|Alirocumab|alirocumab|mesh-list
139006882|NCT01026597|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139006883|NCT01026597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139006884|NCT01026597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139006885|NCT01026597|Antimetabolites|antimetabolites|mesh-ancestor
139006886|NCT01026597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006887|NCT01026597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139006888|NCT01026597|Protease Inhibitors|protease inhibitors|mesh-ancestor
139006889|NCT01026597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006890|NCT01026597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139006891|NCT00450801|Leucovorin|leucovorin|mesh-list
138979109|NCT05232357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979111|NCT05232357|Sequestering Agents|sequestering agents|mesh-ancestor
138979112|NCT00879476|Ramipril|ramipril|mesh-list
138979113|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138979114|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
138979115|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979116|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979117|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138979118|NCT00868946|Ribavirin|ribavirin|mesh-list
138979119|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
138979120|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979121|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
138979122|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979123|NCT00482014|Carboplatin|carboplatin|mesh-list
138979124|NCT00482014|Pemetrexed|pemetrexed|mesh-list
138979125|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979126|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979127|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979128|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138979129|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138979130|NCT00879788|Ramipril|ramipril|mesh-list
138979131|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138979132|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
138979133|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006893|NCT00450801|Thalidomide|thalidomide|mesh-list
139006894|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
139006895|NCT00450801|Ifosfamide|ifosfamide|mesh-list
139006896|NCT00450801|Rituximab|rituximab|mesh-list
139006897|NCT00450801|Doxorubicin|doxorubicin|mesh-list
139006898|NCT00450801|Methotrexate|methotrexate|mesh-list
139006899|NCT00450801|Etoposide|etoposide|mesh-list
138979134|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979135|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138979136|NCT03595553|Vancomycin|vancomycin|mesh-list
138979137|NCT03595553|Ridinilazole|ridinilazole|mesh-list
138979138|NCT03595553|Benzimidazole|benzimidazole|mesh-list
138979139|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138979140|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936609|NCT00652899|Analgesics|analgesics|mesh-ancestor
138979141|NCT03595553|Anthelmintics|anthelmintics|mesh-ancestor
138979142|NCT03595553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138979143|NCT00874172|Analgesics|analgesics|mesh-list
138979144|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
138979145|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138979146|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979147|NCT00614822|Bevacizumab|bevacizumab|mesh-list
138979148|NCT00614822|Carboplatin|carboplatin|mesh-list
138979149|NCT00614822|Pemetrexed|pemetrexed|mesh-list
138979150|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138979151|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979152|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138979153|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138979154|NCT00614822|Growth Substances|growth substances|mesh-ancestor
138979155|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979156|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
138979157|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979158|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979159|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138979160|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138979161|NCT04861298|Quercetin|quercetin|mesh-list
138979162|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
138979163|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979164|NCT04861298|Protective Agents|protective agents|mesh-ancestor
138979165|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979166|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
138979167|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138979168|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138979169|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979170|NCT03582917|Vitamins|vitamins|mesh-ancestor
138979171|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
138979172|NCT05226728|Pembrolizumab|pembrolizumab|mesh-list
138979173|NCT05226728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138979174|NCT05226728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979175|NCT05226728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138979176|NCT05226728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979177|NCT00869180|Diclofenac|diclofenac|mesh-list
138979178|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138979179|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138979180|NCT00869180|Analgesics|analgesics|mesh-ancestor
138979181|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
138979182|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138979183|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979185|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138979186|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138979187|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979188|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979189|NCT00874328|Irinotecan|irinotecan|mesh-list
138979190|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979191|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138979192|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138979193|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979194|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979195|NCT00874406|Leucovorin|leucovorin|mesh-list
138979196|NCT00874406|Fluorouracil|fluorouracil|mesh-list
138979197|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
138979198|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
139006900|NCT00450801|Vincristine|vincristine|mesh-list
139006901|NCT00450801|Granisetron|granisetron|mesh-list
139006902|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139006903|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
139006904|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006905|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139006906|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139006907|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
139006908|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006909|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006910|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139006911|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139006912|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139006913|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139006914|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139006915|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006916|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139006917|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
138979199|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979200|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138979201|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979202|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138979203|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
138979204|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979205|NCT00874406|Antidotes|antidotes|mesh-ancestor
138979206|NCT00874406|Protective Agents|protective agents|mesh-ancestor
138979207|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
138979208|NCT00874406|Vitamins|vitamins|mesh-ancestor
138979209|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
138979210|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
138979211|NCT00880178|Niacin|niacin|mesh-list
138979212|NCT00880178|Niacinamide|niacinamide|mesh-list
138979213|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
138979214|NCT00880178|Simvastatin|simvastatin|mesh-list
138979215|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138979216|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138979217|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
138979218|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979219|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138979220|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138979221|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979222|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
138979223|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
138979224|NCT00880178|Vitamins|vitamins|mesh-ancestor
138979225|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
138979226|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979227|NCT04077125|Rifaximin|rifaximin|mesh-list
138979228|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138979229|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979230|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138979231|NCT05172401|Triamcinolone|triamcinolone|mesh-list
138979232|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138979233|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138979234|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138979235|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138979236|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
138979237|NCT05172401|Hormones|hormones|mesh-ancestor
138936651|NCT00734318|Xhance|xhance|mesh-list
139006918|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139006919|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139006920|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
139006921|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
139006922|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139006923|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139006924|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139006925|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
139006926|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139006927|NCT00450801|Antidotes|antidotes|mesh-ancestor
139006928|NCT00450801|Protective Agents|protective agents|mesh-ancestor
139006929|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
139006930|NCT00450801|Vitamins|vitamins|mesh-ancestor
139006931|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
139006932|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
139006933|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
139006934|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
139006935|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
139006936|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
138979238|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138979239|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979240|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138979241|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
138979242|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979243|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979244|NCT00143455|Cisplatin|cisplatin|mesh-list
138979245|NCT00143455|Irinotecan|irinotecan|mesh-list
138979246|NCT00143455|Etoposide|etoposide|mesh-list
138979247|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979248|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138979249|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138979250|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979251|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979252|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138979253|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138979254|NCT01006863|Phenylephrine|phenylephrine|mesh-list
138979255|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
138979256|NCT01006863|Ephedrine|ephedrine|mesh-list
138979257|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138979258|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
138979259|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
138979260|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138979261|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979262|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
138979263|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138979264|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
138979265|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
138979266|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138979267|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138979268|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138979269|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
138979270|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138979271|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979272|NCT01006863|Protective Agents|protective agents|mesh-ancestor
138979273|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138979274|NCT03529955|Apremilast|apremilast|mesh-list
138979275|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138979276|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139006937|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139006938|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139006939|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
139006940|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139006941|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139006942|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139006943|NCT00450801|Growth Substances|growth substances|mesh-ancestor
139006944|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
139006945|NCT00450801|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139006946|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139006947|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
139006948|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006949|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
139006950|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139006951|NCT00458211|Ziprasidone|ziprasidone|mesh-list
139006952|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139006953|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
139006954|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006955|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006956|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006957|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139006958|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139006959|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139006960|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139006961|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139006962|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
139006963|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
139006964|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139006965|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006966|NCT00457821|Ivacaftor|ivacaftor|mesh-list
139006967|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139006968|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139006969|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006970|NCT00633893|Apixaban|apixaban|mesh-list
139006971|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139006972|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
139006974|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
139006975|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006976|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006977|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
139006978|NCT02550665|Donepezil|donepezil|mesh-list
139006979|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139006980|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139006981|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006982|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
139006983|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006984|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006985|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
139006986|NCT00819845|Carvedilol|carvedilol|mesh-list
139006987|NCT00819845|Ramipril|ramipril|mesh-list
138936687|NCT00728312|Aripiprazole|aripiprazole|mesh-list
139006988|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139006989|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139006990|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139006991|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
139006992|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139006993|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139006994|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139006995|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139006996|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
139006997|NCT00819845|Protective Agents|protective agents|mesh-ancestor
139006998|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139006999|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139007000|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139007001|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
139007002|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139007003|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139007004|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
139007005|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007006|NCT00457743|Sunitinib|sunitinib|mesh-list
139007007|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007015|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007017|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139007018|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007019|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007020|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
139007021|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007022|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007023|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
139007024|NCT00820469|Rituximab|rituximab|mesh-list
139007025|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138979277|NCT03529955|Analgesics|analgesics|mesh-ancestor
138979278|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
138979279|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138979280|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979281|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138979282|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138979283|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138979284|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138979285|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979286|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979287|NCT00142909|Lofexidine|lofexidine|mesh-list
138979288|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138979289|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138979290|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979291|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
138979292|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138979293|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138979294|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138979295|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138979296|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
138979297|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138979298|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979299|NCT01007019|Esomeprazole|esomeprazole|mesh-list
138979300|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138979301|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138979302|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138979303|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979304|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979305|NCT03508739|Valsartan|valsartan|mesh-list
138979306|NCT03508739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138979307|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138979308|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138979309|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138979310|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979311|NCT00205699|Olanzapine|olanzapine|mesh-list
138979312|NCT00205699|Risperidone|risperidone|mesh-list
138979313|NCT00205699|Aripiprazole|aripiprazole|mesh-list
138979314|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138979315|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
138979316|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138979317|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979318|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979319|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138979320|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138979321|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138979322|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138979323|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138979324|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
138979325|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
138979326|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
138979327|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007026|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007027|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
139007028|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007029|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139007032|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139007033|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007034|NCT00644969|Varenicline|varenicline|mesh-list
139007035|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139007036|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139007037|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
139007038|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007039|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007040|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007041|NCT00812435|Eptifibatide|eptifibatide|mesh-list
139007042|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139007043|NCT00812513|Becaplermin|becaplermin|mesh-list
139007044|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
139007045|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
138516650|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
138979328|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138979329|NCT00205699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138979330|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138979331|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138730183|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
138979332|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
138979333|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
138979334|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138979335|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138979336|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138979337|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138979338|NCT03503513|Gentamicins|gentamicins|mesh-list
138979339|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138979340|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979341|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138979342|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979343|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979344|NCT02580149|Clopidogrel|clopidogrel|mesh-list
138979345|NCT02580149|Ticagrelor|ticagrelor|mesh-list
138979346|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138979347|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138979348|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138979349|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138979350|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
138979351|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138979352|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979353|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979354|NCT04996017|Atezolizumab|atezolizumab|mesh-list
138979355|NCT04996017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138979356|NCT04996017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979357|NCT04996017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138979358|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979359|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
138979360|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139007046|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139007047|NCT00812513|Growth Substances|growth substances|mesh-ancestor
139007048|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007049|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
139007050|NCT00820547|Bevacizumab|bevacizumab|mesh-list
139007051|NCT00820547|Docetaxel|docetaxel|mesh-list
139007052|NCT00820547|Fluorouracil|fluorouracil|mesh-list
139007053|NCT00820547|Epirubicin|epirubicin|mesh-list
139007054|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139007055|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
139007056|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007057|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139007058|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139007059|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
139007060|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007061|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007062|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139007063|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139007064|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138516706|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
138979361|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
138979362|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138979363|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
138979364|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979365|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979366|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
138979367|NCT01007565|Anesthetics|anesthetics|mesh-list
138979368|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138979369|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979370|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
138979371|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138979372|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979373|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138979374|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
138979375|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138979376|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979377|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979378|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979379|NCT02798471|Heparin|heparin|mesh-list
138979380|NCT02798471|Enoxaparin|enoxaparin|mesh-list
138979381|NCT02798471|Warfarin|warfarin|mesh-list
138979382|NCT02798471|Edoxaban|edoxaban|mesh-list
138979383|NCT02798471|Fondaparinux|fondaparinux|mesh-list
138979384|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
138979385|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138979386|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138979387|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979388|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138979389|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
138979390|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138979391|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
138979392|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979393|NCT03443765|Vitamin D|vitamin d|mesh-list
138979394|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
138979395|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138979396|NCT03443765|Antibodies|antibodies|mesh-list
138979397|NCT03443765|Vitamins|vitamins|mesh-ancestor
138979398|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
139007065|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139007067|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
139007068|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
139007069|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
139007070|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
139007071|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
139007072|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139007073|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139007074|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139007075|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139007076|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007077|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
139007078|NCT00815867|Hematinics|hematinics|mesh-ancestor
138979399|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979400|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138936777|NCT02569866|Cephalexin|cephalexin|mesh-list
138979401|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
138979402|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
138979403|NCT03441893|Mesalamine|mesalamine|mesh-list
138979404|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138979405|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138979406|NCT03441893|Analgesics|analgesics|mesh-ancestor
138979407|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
138979408|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138979409|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979410|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138979411|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138979412|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138979413|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979415|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138979416|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
138979417|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979418|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979419|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138979420|NCT00489736|Amiodarone|amiodarone|mesh-list
138979421|NCT00489736|Dronedarone|dronedarone|mesh-list
138979422|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138979423|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
138979424|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138979425|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138979426|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979427|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138979428|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138979429|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138979430|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979431|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138979432|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138979433|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138979434|NCT00617084|Everolimus|everolimus|mesh-list
138979435|NCT00617084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138979436|NCT00617084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138979437|NCT00617084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979438|NCT00617084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979439|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138979440|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
138979441|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979442|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979443|NCT02758847|Paclitaxel|paclitaxel|mesh-list
138979444|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138979445|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138979446|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007080|NCT00815945|Doxorubicin|doxorubicin|mesh-list
139007081|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007082|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139007083|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139007084|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139007085|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007086|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007087|NCT00812825|Prednisolone|prednisolone|mesh-list
139007088|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139007089|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
139007090|NCT00812825|Hormones|hormones|mesh-ancestor
139007091|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139007092|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007093|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139007094|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007095|NCT00628355|Lidocaine|lidocaine|mesh-list
139007096|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
139007097|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
139007098|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139007099|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007100|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
138979447|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
138979448|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
138979449|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
138979450|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979451|NCT01016860|Irinotecan|irinotecan|mesh-list
138979452|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138979453|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138979454|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979455|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979456|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979457|NCT00874484|Enoxaparin|enoxaparin|mesh-list
138979458|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
138979459|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138979460|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138979461|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979462|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138979463|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
138979464|NCT00489424|Acetaminophen|acetaminophen|mesh-list
138979465|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138979466|NCT00489424|Analgesics|analgesics|mesh-ancestor
138979467|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
138979468|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138979469|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979470|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
138979471|NCT00869570|Capecitabine|capecitabine|mesh-list
138979472|NCT00869570|Sorafenib|sorafenib|mesh-list
138979473|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138979474|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
138979475|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979476|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979477|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139007101|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007102|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139007103|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139007104|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139007105|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139007106|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007108|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139007109|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138516890|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
138979478|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979479|NCT00880412|Etazolate|etazolate|mesh-list
138979480|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138979481|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979482|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979483|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138979484|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138979485|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138979486|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979487|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138979488|NCT01020136|Axitinib|axitinib|mesh-list
138979489|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979490|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138979491|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979492|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979493|NCT03412643|Paclitaxel|paclitaxel|mesh-list
138979494|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
138979495|NCT03412643|Doxorubicin|doxorubicin|mesh-list
138979496|NCT03412643|Trastuzumab|trastuzumab|mesh-list
138979497|NCT03412643|Pertuzumab|pertuzumab|mesh-list
138979498|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138979499|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979500|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
138979501|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
138979502|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
138979503|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936876|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
138979504|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138979505|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
138979506|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979507|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138979508|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138979509|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
138979510|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138979511|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138979512|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138979513|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138979514|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979515|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138979516|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138979517|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138979518|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979519|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138979520|NCT01020214|Olmesartan|olmesartan|mesh-list
138979521|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138979522|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138979523|NCT01020214|Diuretics|diuretics|mesh-ancestor
138979524|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
138979525|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979526|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138979527|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138979528|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979529|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138979530|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138979531|NCT03970824|Adalimumab|adalimumab|mesh-list
138979532|NCT03970824|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139007111|NCT00647699|Vitamins|vitamins|mesh-ancestor
139007112|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
139007113|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007114|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139007115|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
139007116|NCT00813059|Bevacizumab|bevacizumab|mesh-list
139007117|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139007118|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007119|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139007120|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139007121|NCT00813059|Growth Substances|growth substances|mesh-ancestor
139007122|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007123|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
139007124|NCT00467649|Insulin|insulin|mesh-list
139007125|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139007126|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
138979533|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138979534|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138979535|NCT00933894|Escitalopram|escitalopram|mesh-list
138979536|NCT00933894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138979537|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138979538|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138979539|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979540|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138979541|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
138979542|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979543|NCT00564486|Acetaminophen|acetaminophen|mesh-list
138979544|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138979545|NCT00564486|Analgesics|analgesics|mesh-ancestor
138979546|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
138979547|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138979548|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979549|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
138979550|NCT00481078|Paclitaxel|paclitaxel|mesh-list
138979551|NCT00481078|Carboplatin|carboplatin|mesh-list
138979552|NCT00481078|Vorinostat|vorinostat|mesh-list
138979553|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138979554|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979555|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
138730409|NCT05931965|Vitamins|vitamins|mesh-ancestor
138979556|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
138979557|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
138979558|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979559|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138979560|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979561|NCT00480532|Doxycycline|doxycycline|mesh-list
138979562|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
138979563|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138979564|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138979565|NCT00480532|Estradiol|estradiol|mesh-list
138979566|NCT00480532|Estrogens|estrogens|mesh-ancestor
138979567|NCT00480532|Hormones|hormones|mesh-ancestor
138979568|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138979569|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979570|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138979571|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
138979572|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138979573|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138979574|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139007127|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
139007128|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
139007129|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
139007130|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
139007131|NCT00467649|Pramlintide|pramlintide|mesh-list
139007132|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
139007133|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139007134|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007135|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
139007136|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139007137|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007138|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139007139|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007140|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
139007141|NCT00450333|Hematinics|hematinics|mesh-ancestor
139007142|NCT00643565|Bevacizumab|bevacizumab|mesh-list
138517003|NCT00016952|Vitamins|vitamins|mesh-ancestor
138979575|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979576|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
138979577|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138979578|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138979579|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138979580|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138979581|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138979582|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138979583|NCT04013880|Decitabine|decitabine|mesh-list
138979584|NCT04013880|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138979585|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138979586|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
138979587|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979588|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979589|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979590|NCT00934518|Cetuximab|cetuximab|mesh-list
138979591|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138979592|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979593|NCT00496366|Capecitabine|capecitabine|mesh-list
138979594|NCT00496366|Lapatinib|lapatinib|mesh-list
138979595|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138979596|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
138979597|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979598|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979599|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138979600|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979601|NCT00934752|Paclitaxel|paclitaxel|mesh-list
138979602|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138979603|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979604|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
138979605|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
138979606|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
138979607|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979609|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138979610|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138979611|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
138979612|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979613|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979614|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138979615|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138979616|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
138979617|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979618|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139007143|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139007144|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007145|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139007146|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139007147|NCT00643565|Growth Substances|growth substances|mesh-ancestor
139007148|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007149|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
139007150|NCT00450255|Aflibercept|aflibercept|mesh-list
139007151|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
139007152|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139007153|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139007154|NCT00450255|Growth Substances|growth substances|mesh-ancestor
139007155|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007156|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
138979619|NCT00934830|Amoxicillin|amoxicillin|mesh-list
138979620|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979621|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
138979622|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138979623|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979624|NCT02575404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138979625|NCT02575404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979626|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
138979627|NCT00564018|Protamines|protamines|mesh-list
138979628|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138979629|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979630|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
138979631|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979632|NCT00564018|Coagulants|coagulants|mesh-ancestor
138979633|NCT00935298|Tacrolimus|tacrolimus|mesh-list
138979634|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138979635|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
138979636|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979637|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138979638|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979639|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979640|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
138979641|NCT04014192|Empagliflozin|empagliflozin|mesh-list
138979642|NCT04014192|Canagliflozin|canagliflozin|mesh-list
138979643|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138979644|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979645|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138979646|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979647|NCT00935610|Caseins|caseins|mesh-list
138979648|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
138979649|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
138979650|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979651|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
138979652|NCT04013646|Hematinics|hematinics|mesh-ancestor
138979653|NCT04074473|Propranolol|propranolol|mesh-list
138979654|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138979655|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138979656|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
138979657|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138979658|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979659|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979660|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138979661|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138979662|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
138979663|NCT03093480|Factor VIII|factor viii|mesh-list
138979664|NCT03093480|Coagulants|coagulants|mesh-ancestor
138979665|NCT02578511|Ixazomib|ixazomib|mesh-list
139007157|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007158|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139007159|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139007160|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007161|NCT00813137|Endostar protein|endostar protein|mesh-list
139007162|NCT00813137|Endostatins|endostatins|mesh-list
139007163|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139007164|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139007165|NCT00813137|Growth Substances|growth substances|mesh-ancestor
139007166|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007167|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
139007168|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007169|NCT01024179|Sirolimus|sirolimus|mesh-list
139007170|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139007171|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007172|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139007173|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007174|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
139007175|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138517123|NCT00017225|Carboplatin|carboplatin|mesh-list
138979666|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979667|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
138979668|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979669|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979670|NCT00563784|Paclitaxel|paclitaxel|mesh-list
138979671|NCT00563784|Carboplatin|carboplatin|mesh-list
138979672|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138979673|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138979674|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979675|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
138979676|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
138979677|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
138979678|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979679|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138979680|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979681|NCT00203047|Prednisone|prednisone|mesh-list
138979682|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
138979683|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
138979684|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138979685|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
138979686|NCT00203047|Hormones|hormones|mesh-ancestor
138979687|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138979688|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979689|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138979690|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979691|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138979692|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
138979693|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138979694|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138979696|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138979697|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979698|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
138979699|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
138979700|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
138936979|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
138979701|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979702|NCT04074551|Losartan|losartan|mesh-list
139007176|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
139007177|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007179|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139007180|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
139007181|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007182|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007183|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007184|NCT02551367|Letrozole|letrozole|mesh-list
139007185|NCT02551367|Clomiphene|clomiphene|mesh-list
139007186|NCT02551367|Enclomiphene|enclomiphene|mesh-list
139007187|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
139007188|NCT02551367|Hormones|hormones|mesh-list
139007189|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007190|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139007191|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007192|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007193|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139007194|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139007195|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007196|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139007197|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
139007198|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139007199|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
139007200|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139007201|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139007202|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139007203|NCT00813449|Dacarbazine|dacarbazine|mesh-list
139007204|NCT00813449|Endostar protein|endostar protein|mesh-list
139007205|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139007206|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
139007207|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007208|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007209|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139007210|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139007211|NCT00813449|Growth Substances|growth substances|mesh-ancestor
138517180|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007212|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007213|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
139007214|NCT00822029|Alendronate|alendronate|mesh-list
139007215|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139007216|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007217|NCT00467259|Testosterone|testosterone|mesh-list
139007218|NCT00467259|Androgens|androgens|mesh-ancestor
139007219|NCT00467259|Hormones|hormones|mesh-ancestor
139007220|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139007221|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007222|NCT01022151|Aminophylline|aminophylline|mesh-list
139007223|NCT01022151|Doxapram|doxapram|mesh-list
139007224|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139007225|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
139007226|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007227|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007228|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139007229|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
139007230|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139007231|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139007232|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007233|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007234|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139007235|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139007236|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
139007237|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007238|NCT01022151|Protective Agents|protective agents|mesh-ancestor
139007239|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139007240|NCT01022229|Vitamins|vitamins|mesh-list
139007241|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
139007242|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
139007243|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007244|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
139007245|NCT00449787|Naproxen|naproxen|mesh-list
139007246|NCT00449787|Sumatriptan|sumatriptan|mesh-list
139007247|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139007251|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007252|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007253|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139007254|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139007255|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
139007256|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139007257|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007258|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007259|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139007260|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139007261|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139007262|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
139007263|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138937033|NCT00870220|Estrogens|estrogens|mesh-ancestor
139007264|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139007265|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139007266|NCT01566279|Everolimus|everolimus|mesh-list
139007267|NCT01566279|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139007268|NCT01566279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139007269|NCT01566279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007270|NCT01566279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007271|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139007272|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
139007273|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007274|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007275|NCT00449163|Leucovorin|leucovorin|mesh-list
139007276|NCT00449163|Bevacizumab|bevacizumab|mesh-list
139007277|NCT00449163|Irinotecan|irinotecan|mesh-list
139007278|NCT00449163|Floxuridine|floxuridine|mesh-list
139007279|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
139007280|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139007281|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007282|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139007283|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139007284|NCT00449163|Growth Substances|growth substances|mesh-ancestor
139007285|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007290|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007292|NCT00449163|Protective Agents|protective agents|mesh-ancestor
139007293|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
139007294|NCT00449163|Vitamins|vitamins|mesh-ancestor
139007295|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
139007296|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139007297|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
139007298|NCT01026987|Plerixafor|plerixafor|mesh-list
139007299|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139007300|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139007301|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
139007302|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007303|NCT00448539|Rufinamide|rufinamide|mesh-list
139007304|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
139007305|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139007306|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139007307|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139007308|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007309|NCT00457665|Efavirenz|efavirenz|mesh-list
139007310|NCT00457665|Nelfinavir|nelfinavir|mesh-list
139007311|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139007312|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139007313|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007314|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007315|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
139007316|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007317|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139007318|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138979703|NCT04074551|Amlodipine|amlodipine|mesh-list
138979704|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138979705|NCT04074551|Ezetimibe|ezetimibe|mesh-list
138979706|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138979707|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138979708|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138979709|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979710|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138979711|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937071|NCT00871156|Analgesics|analgesics|mesh-ancestor
138979713|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138979714|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138979715|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
138979716|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138979717|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138979718|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979719|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139007319|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139007320|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139007321|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139007322|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139007323|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139007324|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139007325|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
139007326|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139007327|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139007329|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139007330|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139007331|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139007332|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139007333|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139007334|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007335|NCT00447603|Diuretics|diuretics|mesh-ancestor
139007336|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
139007337|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007338|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139007339|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139007341|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138979720|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138979721|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138979722|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
138979723|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138979724|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979725|NCT02608385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138979726|NCT02608385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979727|NCT00142519|Morphine|morphine|mesh-list
138979728|NCT00142519|Methadone|methadone|mesh-list
138979729|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138979730|NCT00142519|Narcotics|narcotics|mesh-ancestor
138979731|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138979732|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979733|NCT00142519|Analgesics|analgesics|mesh-ancestor
138979734|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
138979735|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138979736|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
138979737|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
138979738|NCT00141817|Pantoprazole|pantoprazole|mesh-list
138979739|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138979740|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138979741|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138979742|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979743|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979744|NCT03967171|Oxytocin|oxytocin|mesh-list
138979745|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
138979746|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138979747|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979748|NCT03967327|Morphine|morphine|mesh-list
139007342|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007343|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007344|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007345|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138937087|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
139007346|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139007347|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139007348|NCT01027611|Lidocaine|lidocaine|mesh-list
139007349|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
139007350|NCT01027611|Propoxycaine|propoxycaine|mesh-list
139007351|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
139007352|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
139007353|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139007354|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007355|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
139007356|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007357|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139007358|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139007359|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139007360|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139007361|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979749|NCT03967327|Buprenorphine|buprenorphine|mesh-list
138979750|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138979751|NCT03967327|Narcotics|narcotics|mesh-ancestor
138979752|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138979753|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979754|NCT03967327|Analgesics|analgesics|mesh-ancestor
138979755|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
138979756|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138979757|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138979758|NCT01075945|Lumefantrine|lumefantrine|mesh-list
138979759|NCT01075945|Artemether|artemether|mesh-list
138979760|NCT01075945|Piperaquine|piperaquine|mesh-list
138979761|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138979762|NCT01075945|Artenimol|artenimol|mesh-list
138979763|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
138979764|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138979765|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138979766|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979767|NCT00874562|Sirolimus|sirolimus|mesh-list
138979768|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138979769|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979770|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138979771|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979772|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
138979773|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138979774|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
138979775|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979776|NCT00201643|Dexamethasone|dexamethasone|mesh-list
138979777|NCT00201643|Betamethasone|betamethasone|mesh-list
138979778|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138979779|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
138979780|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
138979781|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138979782|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730643|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
139007362|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139007363|NCT01024413|Gefitinib|gefitinib|mesh-list
139007364|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007365|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139007366|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007367|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007368|NCT00446511|Valsartan|valsartan|mesh-list
139007369|NCT00446511|Enalapril|enalapril|mesh-list
139007370|NCT00446511|Enalaprilat|enalaprilat|mesh-list
139007371|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139007372|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139007373|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139007374|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007375|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139007376|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
139007377|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007378|NCT01024491|Paroxetine|paroxetine|mesh-list
139007379|NCT01024491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139007380|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139007381|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139007382|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007383|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007384|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
139007385|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007386|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139007387|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
139007388|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139007406|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007407|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139007408|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139007409|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139007410|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
139007411|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
139007412|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007413|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007414|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
139007415|NCT01024647|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139007416|NCT01024647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139007417|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139007418|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
139007419|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007420|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139007421|NCT01027923|Cytarabine|cytarabine|mesh-list
138979783|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138979785|NCT00201643|Hormones|hormones|mesh-ancestor
138979786|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138979787|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138979788|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979789|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138979790|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
138979791|NCT03798314|Nivolumab|nivolumab|mesh-list
138979792|NCT03798314|Pomalidomide|pomalidomide|mesh-list
138979793|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138979794|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979795|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138979796|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979797|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
138979798|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979799|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138979800|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138979801|NCT03798314|Growth Substances|growth substances|mesh-ancestor
138979802|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
138979803|NCT01077427|Gemcitabine|gemcitabine|mesh-list
138979804|NCT01077427|Capecitabine|capecitabine|mesh-list
138979805|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979806|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138979807|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
138979808|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979809|NCT00883064|Lisinopril|lisinopril|mesh-list
138979810|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138979811|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
138979812|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979813|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979814|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138979815|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138979816|NCT00883064|Protective Agents|protective agents|mesh-ancestor
138979817|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979818|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
138979819|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
138979820|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
138979821|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
138979822|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138979823|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979824|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138979825|NCT01077505|Incretins|incretins|mesh-ancestor
139007422|NCT01027923|Plerixafor|plerixafor|mesh-list
139007423|NCT01027923|Etoposide|etoposide|mesh-list
139007424|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
139007425|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139007426|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007427|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139007428|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139007429|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007430|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517527|NCT00019227|Calcium|calcium|mesh-list
138979826|NCT01077505|Hormones|hormones|mesh-ancestor
138979827|NCT01077505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138979828|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138979829|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138979830|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138979831|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
138979832|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138979833|NCT01073995|Triamcinolone|triamcinolone|mesh-list
138979834|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138979835|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138979836|NCT01073995|Bupivacaine|bupivacaine|mesh-list
138979837|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138979838|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
138979839|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
138979840|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138979841|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979842|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
138979843|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138979844|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138979845|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
138979846|NCT01073995|Hormones|hormones|mesh-ancestor
138979847|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138979848|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138979849|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
138979850|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979851|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979852|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138979853|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138979854|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138979855|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138979856|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979857|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138979858|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138979859|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138979860|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138979861|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
138979862|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138979863|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979864|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138979865|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138979867|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138979868|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138979869|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
138979870|NCT00874874|Sorafenib|sorafenib|mesh-list
138979871|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979872|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138979873|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979874|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979875|NCT04489628|Vitamin D|vitamin d|mesh-list
138979876|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
138979877|NCT04489628|Vitamins|vitamins|mesh-ancestor
138979878|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
138937180|NCT06146842|Sensory System Agents|sensory system agents|mesh-ancestor
138979879|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979880|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139007431|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139007432|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
139007433|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
139007434|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007435|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139007436|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
139007437|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007438|NCT01027923|Analgesics|analgesics|mesh-ancestor
139007439|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
139007440|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007441|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139007442|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139007443|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
139007444|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
138979881|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138979882|NCT00130039|Cilostazol|cilostazol|mesh-list
138979883|NCT00130039|Clopidogrel|clopidogrel|mesh-list
138979884|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138979885|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138979886|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138979887|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138979888|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
138979889|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138979890|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979891|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979892|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138979893|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
138979894|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138979895|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138979896|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
138979897|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138979898|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138979899|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
138979900|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138979901|NCT00130039|Protective Agents|protective agents|mesh-ancestor
138979902|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138979903|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138979904|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979905|NCT00875030|Artesunate|artesunate|mesh-list
138979906|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
138979907|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138979908|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138979909|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979910|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979911|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
138979912|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
138979913|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138979914|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
138979915|NCT00883298|Bevacizumab|bevacizumab|mesh-list
138979916|NCT00883298|Temozolomide|temozolomide|mesh-list
138979917|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138979918|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979919|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138979920|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138979921|NCT00883298|Growth Substances|growth substances|mesh-ancestor
138979922|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979923|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
138979924|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138979925|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
138979926|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979927|NCT00881114|Cetuximab|cetuximab|mesh-list
138979928|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007445|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139007446|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139007447|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007448|NCT01027065|Tenofovir|tenofovir|mesh-list
139007449|NCT01027065|Entecavir|entecavir|mesh-list
139007450|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
139007451|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007452|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139007453|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139007454|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007455|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007456|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139007457|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138979929|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138979930|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138979931|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
138979932|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979933|NCT00141271|Ziprasidone|ziprasidone|mesh-list
138979934|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138979935|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
138979936|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138979937|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979938|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979939|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138979940|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138979941|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138979942|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138979943|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138979944|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
138979945|NCT01017640|Mitomycins|mitomycins|mesh-list
138979946|NCT01017640|Mitomycin|mitomycin|mesh-list
138979947|NCT01017640|Veliparib|veliparib|mesh-list
138979948|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138979949|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979950|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
138979951|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979952|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138979953|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979954|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138979955|NCT00614120|Metformin|metformin|mesh-list
138979956|NCT00614120|Liraglutide|liraglutide|mesh-list
138979957|NCT00614120|Glimepiride|glimepiride|mesh-list
138979958|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138979959|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979960|NCT00614120|Incretins|incretins|mesh-ancestor
138979961|NCT00614120|Hormones|hormones|mesh-ancestor
138979962|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138979963|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138979964|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138979965|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
138979966|NCT00496054|Vaccines|vaccines|mesh-list
138979967|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
138979968|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979969|NCT00495820|Methylphenidate|methylphenidate|mesh-list
138979970|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138979971|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138979972|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138979973|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138979974|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138979975|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007458|NCT00456495|Ranibizumab|ranibizumab|mesh-list
139007459|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139007460|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139007461|NCT00456495|Growth Substances|growth substances|mesh-ancestor
139007462|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007463|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
139007464|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007465|NCT00445341|Alvocidib|alvocidib|mesh-list
139007466|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007467|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
139007468|NCT00445341|Growth Substances|growth substances|mesh-ancestor
139007469|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007470|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138979976|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
138979977|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138979978|NCT04387240|Artesunate|artesunate|mesh-list
138979979|NCT04387240|Artemisinins|artemisinins|mesh-list
138979980|NCT04387240|Artemisinin|artemisinin|mesh-list
138979981|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
138979982|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138979983|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138979984|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979985|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138979986|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
138979987|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
138979988|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138979989|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
138979990|NCT00495586|Amoxicillin|amoxicillin|mesh-list
138979991|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
138979992|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
138979993|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138979994|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138979995|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138979996|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138979997|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138979998|NCT00613730|Gemcitabine|gemcitabine|mesh-list
138979999|NCT00613730|Panitumumab|panitumumab|mesh-list
138980000|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138980001|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
138980002|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980003|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980004|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138980006|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
138980007|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138980008|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
138980009|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980010|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980011|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138980012|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
138980013|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
138980014|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138980015|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
138980016|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138980017|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980018|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
138980019|NCT00881426|Cefprozil|cefprozil|mesh-list
138980020|NCT00881426|Cephalosporins|cephalosporins|mesh-list
138980021|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138980022|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980023|NCT00883532|Budesonide|budesonide|mesh-list
138980024|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138980025|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138980026|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138980027|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
138980028|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007471|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007472|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007473|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139007474|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139007475|NCT00444951|Vaccines|vaccines|mesh-list
139007476|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
139007477|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007478|NCT00444795|Sunitinib|sunitinib|mesh-list
139007479|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138517786|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980029|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980030|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138980031|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
138980032|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
138980033|NCT00883532|Hormones|hormones|mesh-ancestor
138980034|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138980035|NCT00881582|Interferons|interferons|mesh-list
138980036|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
138980037|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
138980038|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138980039|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980040|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
138980041|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980042|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
138980043|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980044|NCT00881738|Clarithromycin|clarithromycin|mesh-list
138980045|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138980046|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980047|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138980048|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980049|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980050|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138980051|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138980052|NCT00613106|Ibuprofen|ibuprofen|mesh-list
138980053|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138980054|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138980055|NCT00613106|Analgesics|analgesics|mesh-ancestor
138980056|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
138980057|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980058|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980059|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138980060|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980061|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138980062|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980063|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980064|NCT00881816|Paclitaxel|paclitaxel|mesh-list
138980065|NCT00881816|Capecitabine|capecitabine|mesh-list
138980066|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138980067|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980068|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
138980069|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
138980070|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
138980071|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980072|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138980073|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
138980074|NCT03712904|Aflibercept|aflibercept|mesh-list
138980075|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
138980076|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138980077|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138980078|NCT03712904|Growth Substances|growth substances|mesh-ancestor
138980079|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980080|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
138980081|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980082|NCT00875966|Azithromycin|azithromycin|mesh-list
138980083|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139007480|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139007481|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139007482|NCT00444795|Growth Substances|growth substances|mesh-ancestor
139007483|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007484|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
139007485|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139007486|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007487|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007488|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
139007489|NCT03846219|Calcium|calcium|mesh-list
139007490|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138517854|NCT05574218|Glycine|glycine|mesh-list
138980084|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980085|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
138980086|NCT00141037|Trimethoprim|trimethoprim|mesh-list
138980087|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
138980088|NCT00141037|Valganciclovir|valganciclovir|mesh-list
138980089|NCT00141037|Ganciclovir|ganciclovir|mesh-list
138980090|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138980092|NCT00141037|Tacrolimus|tacrolimus|mesh-list
138980093|NCT00141037|Daclizumab|daclizumab|mesh-list
138980094|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138980095|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
138980096|NCT00141037|Hormones|hormones|mesh-ancestor
138980097|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138980098|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980099|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138980100|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980101|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138980102|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
138980103|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138980104|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980105|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980106|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138980107|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138980108|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
138980109|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138980110|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980111|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138980112|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
138980113|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138980114|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138980115|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138980116|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138980117|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138980118|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138980119|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
138980120|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138980121|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
138980122|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138980123|NCT01582555|Antidotes|antidotes|mesh-ancestor
138980124|NCT01582555|Protective Agents|protective agents|mesh-ancestor
138980125|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980126|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
138980127|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980128|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
138980129|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980130|NCT01582555|Expectorants|expectorants|mesh-ancestor
138980131|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
138980132|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138980133|NCT00923390|Aldesleukin|aldesleukin|mesh-list
138980134|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
138980135|NCT00923390|Fludarabine|fludarabine|mesh-list
138980136|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139007491|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007492|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139007493|NCT00455325|Chloroquine|chloroquine|mesh-list
139007494|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139007495|NCT00455325|Amebicides|amebicides|mesh-ancestor
139007496|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139007497|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139007498|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007499|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
139007500|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139007501|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139007502|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139007503|NCT00455325|Analgesics|analgesics|mesh-ancestor
139007504|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
139007505|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007506|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007507|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139007508|NCT00455325|Filaricides|filaricides|mesh-ancestor
139007509|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
139007510|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
138980137|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
138980138|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980139|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980140|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138980141|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
138980142|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980143|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980144|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138980145|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138980146|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138980147|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
138980148|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980149|NCT00885794|Ranibizumab|ranibizumab|mesh-list
138980150|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138980151|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138980152|NCT00885794|Growth Substances|growth substances|mesh-ancestor
138980153|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980154|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
138980155|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980157|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
138980159|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138980160|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
138980161|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138980162|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138980163|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138980164|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
138980165|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980166|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138980167|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138980168|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980169|NCT00888758|Sirolimus|sirolimus|mesh-list
138980170|NCT00888758|Umirolimus|umirolimus|mesh-list
138980171|NCT00888758|Everolimus|everolimus|mesh-list
138980172|NCT00888758|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138980173|NCT00888758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138980174|NCT00888758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007511|NCT01028079|Aspirin|aspirin|mesh-list
139007512|NCT01028079|Ibuprofen|ibuprofen|mesh-list
139007513|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139007514|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139007515|NCT01028079|Analgesics|analgesics|mesh-ancestor
139007516|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
139007517|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007518|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007519|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139007520|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139007521|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139007522|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138937394|NCT06132698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139007523|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007524|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139007525|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139007526|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007527|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
139007528|NCT00443781|Anesthetics|anesthetics|mesh-list
139007529|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139007530|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007531|NCT00443703|Ritonavir|ritonavir|mesh-list
139007532|NCT00443703|Lopinavir|lopinavir|mesh-list
139007533|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
139007534|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139007535|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139007536|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
139007537|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007538|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007539|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139007540|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139007558|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139007559|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
139007560|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007561|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139007562|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139007563|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007564|NCT00381706|Antidotes|antidotes|mesh-ancestor
139007565|NCT00381706|Protective Agents|protective agents|mesh-ancestor
139007566|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
139007567|NCT00381706|Vitamins|vitamins|mesh-ancestor
139007568|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
139007569|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139007570|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139007571|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139007572|NCT01045642|Omeprazole|omeprazole|mesh-list
139007573|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139007574|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139007575|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139007576|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980175|NCT00888758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980176|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138980177|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
138980178|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980179|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980180|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138980181|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138980182|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980183|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138980184|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
138980185|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138980186|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980187|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
138980188|NCT04038320|Ledipasvir|ledipasvir|mesh-list
138980189|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
138980190|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980191|NCT00563706|Risperidone|risperidone|mesh-list
138980192|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138980193|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
138980194|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138980195|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980196|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980197|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138980198|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138606244|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
138980199|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138980200|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138980201|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138980202|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
138980203|NCT02543606|Esomeprazole|esomeprazole|mesh-list
138980204|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138980205|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138980206|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138980207|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980208|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980209|NCT00939588|Valsartan|valsartan|mesh-list
138980210|NCT00939588|Telmisartan|telmisartan|mesh-list
138980211|NCT00939588|Ramipril|ramipril|mesh-list
138980212|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138980213|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139007578|NCT05357430|Propofol|propofol|mesh-list
139007579|NCT05357430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139007580|NCT05357430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139007581|NCT05357430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007582|NCT05357430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139007583|NCT05357430|Anesthetics, General|anesthetics, general|mesh-ancestor
139007584|NCT05357430|Anesthetics|anesthetics|mesh-ancestor
139007585|NCT00370552|Paclitaxel|paclitaxel|mesh-list
139007586|NCT00370552|Epothilones|epothilones|mesh-list
139007587|NCT00370552|Bevacizumab|bevacizumab|mesh-list
139007588|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138937437|NCT06091904|Anesthetics, General|anesthetics, general|mesh-ancestor
138937438|NCT06091904|Anesthetics|anesthetics|mesh-ancestor
138937439|NCT06087757|Clemastine|clemastine|mesh-list
138937440|NCT06087757|Antipruritics|antipruritics|mesh-ancestor
138937441|NCT06087757|Dermatologic Agents|dermatologic agents|mesh-ancestor
138937442|NCT06087757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138937443|NCT06087757|Histamine Antagonists|histamine antagonists|mesh-ancestor
138937445|NCT06087757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138937446|NCT06087757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937447|NCT06087757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007589|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007590|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518066|NCT00022230|Aldesleukin|aldesleukin|mesh-list
138980214|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138980215|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980216|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138980217|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
138980218|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980219|NCT00889148|Gabapentin|gabapentin|mesh-list
138980220|NCT00889148|Analgesics|analgesics|mesh-ancestor
138980221|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
138980222|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980223|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980224|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
138980225|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138980226|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138980227|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138980228|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138980229|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138980230|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138980231|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138980232|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980233|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
138980234|NCT00936156|Carboplatin|carboplatin|mesh-list
138980235|NCT00936156|Etoposide|etoposide|mesh-list
138980236|NCT00936156|Thiotepa|thiotepa|mesh-list
138980237|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980238|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138980239|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138980240|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138980241|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980242|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980243|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138980244|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
138980245|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138606272|NCT02896582|Cytarabine|cytarabine|mesh-list
138980246|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138980247|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
138980248|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980249|NCT00129961|Cyclosporine|cyclosporine|mesh-list
138980250|NCT00129961|Sirolimus|sirolimus|mesh-list
138980251|NCT00129961|Tacrolimus|tacrolimus|mesh-list
138980252|NCT00129961|Cyclosporins|cyclosporins|mesh-list
138980253|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138980254|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
138980255|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980256|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138980257|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007591|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
139007592|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
139007593|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007594|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139007595|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139007596|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139007597|NCT00370552|Growth Substances|growth substances|mesh-ancestor
139007598|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007599|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
139007600|NCT00537030|Asparaginase|asparaginase|mesh-list
139007601|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007602|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
139007603|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138937482|NCT06017284|Thalidomide|thalidomide|mesh-list
139007604|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007605|NCT04928820|Edetic Acid|edetic acid|mesh-list
139007606|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139007607|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
139007608|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
139007609|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007610|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
139007611|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139007612|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138980258|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980259|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
138980260|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980261|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
138980262|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980263|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138980264|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138980265|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980266|NCT00528567|Bevacizumab|bevacizumab|mesh-list
138980267|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138980268|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980269|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138980270|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138980271|NCT00528567|Growth Substances|growth substances|mesh-ancestor
138980272|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980273|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
138980274|NCT00936234|Vildagliptin|vildagliptin|mesh-list
138980275|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138980276|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980277|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138980278|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
138980279|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980280|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980281|NCT00886028|Doxorubicin|doxorubicin|mesh-list
138980282|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138980283|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980284|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138980285|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138980286|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139007614|NCT04429152|Lamivudine|lamivudine|mesh-list
139007615|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
139007616|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007617|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139007618|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139007619|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007620|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007621|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138758362|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
139007622|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139007623|NCT04001400|Rabeprazole|rabeprazole|mesh-list
139007624|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139007625|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139007626|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139007627|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007628|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007629|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139007630|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138937494|NCT06017284|Immunologic Factors|immunologic factors|mesh-ancestor
138937495|NCT06017284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937496|NCT06017284|Leprostatic Agents|leprostatic agents|mesh-ancestor
138937497|NCT06017284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138937498|NCT06017284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632860|NCT00237224|Letrozole|letrozole|mesh-list
139007631|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139007632|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139007633|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980287|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980288|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980289|NCT00936546|Rituximab|rituximab|mesh-list
138980290|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138980291|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980292|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
138980293|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980294|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980295|NCT00936624|Montelukast|montelukast|mesh-list
138980296|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138980297|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
138980298|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138980299|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
138980300|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138980301|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980302|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138606305|NCT00196638|Interferons|interferons|mesh-list
138980303|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138980304|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980305|NCT00138151|Interferons|interferons|mesh-list
138980306|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
138980307|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
138937515|NCT05991453|Propofol|propofol|mesh-list
138937516|NCT05991453|Anesthetics|anesthetics|mesh-list
138937517|NCT05991453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138937518|NCT05991453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138980308|NCT00138151|Paclitaxel|paclitaxel|mesh-list
138980309|NCT00138151|Isotretinoin|isotretinoin|mesh-list
138980310|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138980311|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980312|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
138980313|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
138980314|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
138980315|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007634|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
139007635|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007636|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007638|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139007639|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007641|NCT01047982|Inositol|inositol|mesh-list
139007642|NCT01047982|Hematinics|hematinics|mesh-ancestor
139007643|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
139007644|NCT01047982|Vitamins|vitamins|mesh-ancestor
139007645|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
139007646|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007647|NCT00536874|Gemcitabine|gemcitabine|mesh-list
139007648|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
139007649|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139007650|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
139007651|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007652|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007653|NCT00991848|Lidocaine|lidocaine|mesh-list
139007654|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
139007655|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
139007656|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139007657|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007658|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
139007659|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007660|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139007661|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139007662|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139007663|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138937560|NCT05950646|Sensory System Agents|sensory system agents|mesh-ancestor
139007664|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007665|NCT05281068|Danazol|danazol|mesh-list
139007666|NCT05281068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139007667|NCT05281068|Hormone Antagonists|hormone antagonists|mesh-ancestor
139007668|NCT05281068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139007669|NCT05281068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007670|NCT00380068|Ambrisentan|ambrisentan|mesh-list
138518234|NCT05512754|Analgesics|analgesics|mesh-ancestor
138980316|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
138980317|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007671|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139007672|NCT00991926|Orlistat|orlistat|mesh-list
139007673|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007674|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007675|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139007676|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139007677|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
139007678|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139007679|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007680|NCT04230954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139007681|NCT04230954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138518300|NCT00023244|Sirolimus|sirolimus|mesh-list
138980318|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
138980319|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980320|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
138980321|NCT02543060|Fluorides|fluorides|mesh-list
138980322|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
138980323|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
138980324|NCT02543060|Protective Agents|protective agents|mesh-ancestor
138980325|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980327|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138980328|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
138980329|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980330|NCT00889616|Antacids|antacids|mesh-ancestor
138980331|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980332|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138980333|NCT02581631|Nivolumab|nivolumab|mesh-list
138980334|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138980335|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138980336|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980337|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138980338|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980339|NCT02581631|Immunotoxins|immunotoxins|mesh-ancestor
138980340|NCT02581631|Immunoconjugates|immunoconjugates|mesh-ancestor
138980341|NCT02581631|Immunologic Factors|immunologic factors|mesh-ancestor
138980342|NCT02581631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980343|NCT00884546|Dexamethasone|dexamethasone|mesh-list
138980344|NCT00884546|Lenalidomide|lenalidomide|mesh-list
138980345|NCT00884546|Bortezomib|bortezomib|mesh-list
138980346|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138980347|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
138980348|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
138980349|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980350|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980351|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138980352|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
138980353|NCT00884546|Hormones|hormones|mesh-ancestor
138980354|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138980355|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138980356|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980357|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
138980358|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138980359|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138980360|NCT00884546|Growth Substances|growth substances|mesh-ancestor
138980361|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
138980362|NCT00886106|Midazolam|midazolam|mesh-list
138980363|NCT00886106|Remifentanil|remifentanil|mesh-list
138980364|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138980365|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138980366|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138980367|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980368|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138980369|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138980370|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139007682|NCT00536484|Fesoterodine|fesoterodine|mesh-list
139007683|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139007684|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139007685|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
139007686|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007687|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007688|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007689|NCT00536484|Urological Agents|urological agents|mesh-ancestor
139007690|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139007691|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
139007692|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980371|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138980372|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
138980373|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
138980374|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
138980375|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
138980376|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138980377|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980378|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138980379|NCT00886106|Narcotics|narcotics|mesh-ancestor
138980380|NCT00886106|Analgesics|analgesics|mesh-ancestor
138980381|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
138980382|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980383|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
138980384|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980385|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138980386|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138980387|NCT00889694|Analgesics|analgesics|mesh-ancestor
138980388|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
138980389|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980390|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980391|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138980392|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980393|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138980394|NCT00529035|Interleukin-2|interleukin-2|mesh-list
138980395|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980396|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138980397|NCT00529035|Analgesics|analgesics|mesh-ancestor
138980398|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
138980399|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980400|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980401|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
138980402|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
138980403|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138980404|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138980405|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980406|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980407|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980408|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980409|NCT02578043|Clindamycin|clindamycin|mesh-list
138980410|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
138980411|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
138980412|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138980413|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138980414|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980415|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138980416|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980417|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980418|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
138980419|NCT00889850|Esomeprazole|esomeprazole|mesh-list
138980420|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138980421|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138980422|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138980423|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007693|NCT00992004|Turmeric extract|turmeric extract|mesh-list
139007694|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
139007695|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007696|NCT00992004|Protective Agents|protective agents|mesh-ancestor
139007697|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007698|NCT00992082|Ketorolac|ketorolac|mesh-list
139007699|NCT00992082|Epinephrine|epinephrine|mesh-list
139007700|NCT00992082|Morphine|morphine|mesh-list
139007701|NCT00992082|Ropivacaine|ropivacaine|mesh-list
139007702|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139007703|NCT00992082|Narcotics|narcotics|mesh-ancestor
139007704|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139007705|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007706|NCT00992082|Analgesics|analgesics|mesh-ancestor
139007707|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
139007708|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007709|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
139007710|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
138980424|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980425|NCT04074317|Insulin|insulin|mesh-list
138980426|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138980427|NCT04074317|Pramlintide|pramlintide|mesh-list
138980428|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138980429|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980430|NCT00941148|Insulin|insulin|mesh-list
138980431|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138980432|NCT00941148|Metformin|metformin|mesh-list
138980433|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
138980434|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
138980435|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
138980436|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
138980437|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138980438|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980439|NCT02541500|Minocycline|minocycline|mesh-list
138980440|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138980441|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980442|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
138980443|NCT04073849|Hematinics|hematinics|mesh-ancestor
138980444|NCT03263429|Irinotecan|irinotecan|mesh-list
138980445|NCT03263429|Panitumumab|panitumumab|mesh-list
138980446|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138980447|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138980448|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980449|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980450|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980451|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138980452|NCT00609674|Fluticasone|fluticasone|mesh-list
138980453|NCT00609674|Xhance|xhance|mesh-list
138980454|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138980455|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138980456|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
138980457|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731313|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138980458|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980459|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138980460|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
138980461|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
138980462|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138980463|NCT00941382|Metformin|metformin|mesh-list
138980464|NCT00941382|Sibutramine|sibutramine|mesh-list
138980465|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138980466|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007711|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139007712|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139007713|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
139007714|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007715|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007716|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139007717|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139007718|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
139007719|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139007720|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
139007721|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
139007722|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
139007723|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139007724|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139007725|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139007726|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139007727|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980467|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
138980468|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138980469|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
138980470|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138980471|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138980472|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980473|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138980474|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980475|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980476|NCT00941460|Temozolomide|temozolomide|mesh-list
138980477|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138980478|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
138980479|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980480|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980481|NCT00890318|Ketoconazole|ketoconazole|mesh-list
138980482|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
138980483|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980484|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138980485|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138980486|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980487|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980488|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138980489|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
138980490|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138980491|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980492|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138980493|NCT00563316|Irinotecan|irinotecan|mesh-list
138980494|NCT00563316|Panitumumab|panitumumab|mesh-list
138980495|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138980496|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138980497|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980498|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980499|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980500|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138980501|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
138980502|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138980503|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138980504|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007728|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139007729|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007730|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
139007731|NCT00455013|Sirolimus|sirolimus|mesh-list
139007732|NCT00455013|Abatacept|abatacept|mesh-list
139007733|NCT00455013|Tacrolimus|tacrolimus|mesh-list
139007734|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
139007735|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139007736|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
139007737|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007738|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139007739|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007740|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007741|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139007742|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007743|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139007744|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
139007745|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139007746|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007747|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
139007748|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139007749|NCT00455013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139007750|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139007751|NCT00363298|Caffeine|caffeine|mesh-list
139007752|NCT00363298|Amphetamine|amphetamine|mesh-list
139007753|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
139007754|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139007755|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007756|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139007757|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007758|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007759|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139007760|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139007761|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
139007762|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007763|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
139007764|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
138980505|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138980506|NCT04037774|Analgesics|analgesics|mesh-ancestor
139007765|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007766|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
139007767|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
139007768|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139007769|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139007770|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139007771|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139007772|NCT05254548|Flurbiprofen|flurbiprofen|mesh-list
139007773|NCT05254548|Midazolam|midazolam|mesh-list
139007774|NCT05254548|Omeprazole|omeprazole|mesh-list
139007775|NCT05254548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139007776|NCT05254548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139007777|NCT05254548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139007778|NCT05254548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007779|NCT05254548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139007780|NCT05254548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139007781|NCT05254548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139007782|NCT05254548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139007783|NCT05254548|Anesthetics, General|anesthetics, general|mesh-ancestor
139007784|NCT05254548|Anesthetics|anesthetics|mesh-ancestor
139007785|NCT05254548|GABA Modulators|gaba modulators|mesh-ancestor
138980507|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
138980508|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980509|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138980510|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138980511|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138980512|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
138980513|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138980514|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980515|NCT02542748|Norepinephrine|norepinephrine|mesh-list
138980516|NCT02542748|Ephedrine|ephedrine|mesh-list
138980517|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138980518|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138980519|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
138980520|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138980521|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980522|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980523|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
138980524|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
138980525|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980526|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138980527|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138980528|NCT00941616|Factor VIII|factor viii|mesh-list
138980529|NCT00941616|Coagulants|coagulants|mesh-ancestor
138980530|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
138980531|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138980532|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138980533|NCT02542592|Prednisolone|prednisolone|mesh-list
138980534|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
138980535|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138980536|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
138980537|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138980538|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
138980539|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
138980540|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007786|NCT05254548|GABA Agents|gaba agents|mesh-ancestor
139007787|NCT05254548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007788|NCT05254548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007789|NCT05254548|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139007790|NCT05254548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139007791|NCT05254548|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139007792|NCT05254548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007793|NCT05254548|Analgesics|analgesics|mesh-ancestor
139007794|NCT05254548|Sensory System Agents|sensory system agents|mesh-ancestor
139007795|NCT05254548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007796|NCT05254548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139007797|NCT05254548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139007798|NCT05254548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139007799|NCT05254548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139007800|NCT05254548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139007801|NCT00363142|Ritonavir|ritonavir|mesh-list
139007802|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
139007803|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139007804|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138980541|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980542|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138980543|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
138980545|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138980546|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138980547|NCT02542592|Protective Agents|protective agents|mesh-ancestor
138606554|NCT00170690|Treosulfan|treosulfan|mesh-list
138980548|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138980549|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980551|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138980552|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138980553|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980554|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980555|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980556|NCT04430036|Cisplatin|cisplatin|mesh-list
138980557|NCT04430036|Gemcitabine|gemcitabine|mesh-list
138980558|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980559|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138980560|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
138980561|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980562|NCT00528957|Tenofovir|tenofovir|mesh-list
138980563|NCT00528957|Zidovudine|zidovudine|mesh-list
138980564|NCT00528957|Stavudine|stavudine|mesh-list
138980565|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
138980566|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980567|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138980568|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138980569|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980570|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980571|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138980572|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138980573|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
138980574|NCT00890630|Oxytocin|oxytocin|mesh-list
138980575|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
138980576|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138980577|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980578|NCT00890708|Voriconazole|voriconazole|mesh-list
138980579|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
139007805|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
139007806|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007807|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007808|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139007809|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139007810|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
139007811|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007812|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139007813|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139007814|NCT05246982|Capecitabine|capecitabine|mesh-list
139007815|NCT05246982|Oxaliplatin|oxaliplatin|mesh-list
139007816|NCT05246982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139007817|NCT05246982|Antimetabolites|antimetabolites|mesh-ancestor
139007818|NCT05246982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007819|NCT05246982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007820|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
139007821|NCT04002024|Salicylates|salicylates|mesh-list
139007822|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007823|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
139007824|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
139007825|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
139007826|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139007827|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139007828|NCT04002024|Analgesics|analgesics|mesh-ancestor
139007829|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
139007830|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007831|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007832|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139007833|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139007834|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139007835|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007836|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007837|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
139007838|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138980580|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980581|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138980582|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138980583|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980584|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980585|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139007839|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139007840|NCT01028313|Prednisolone|prednisolone|mesh-list
139007841|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
139007842|NCT01028313|Panobinostat|panobinostat|mesh-list
139007843|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138980586|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
138980587|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138980588|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980589|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138980590|NCT00890786|Bevacizumab|bevacizumab|mesh-list
138980591|NCT00890786|Irinotecan|irinotecan|mesh-list
138980592|NCT00890786|Temozolomide|temozolomide|mesh-list
138980593|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138606609|NCT00170885|Everolimus|everolimus|mesh-list
138980594|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980595|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138980596|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138980597|NCT00890786|Growth Substances|growth substances|mesh-ancestor
138980598|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980599|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
138980600|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138980601|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138937723|NCT05703048|Esmolol|esmolol|mesh-list
138980602|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980603|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980604|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138980605|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
138980606|NCT00560508|Pramipexole|pramipexole|mesh-list
138980607|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
138980608|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980609|NCT00560508|Protective Agents|protective agents|mesh-ancestor
138980610|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980611|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138980612|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138980613|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
138980614|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
138980615|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138980616|NCT00890942|Naloxone|naloxone|mesh-list
138980617|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138980618|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980619|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
138980620|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980621|NCT00942006|Doxycycline|doxycycline|mesh-list
138980622|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
138980623|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138980624|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980625|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
138980626|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138980627|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138980628|NCT02542124|Interleukin-12|interleukin-12|mesh-list
138980629|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138980630|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
138980631|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980632|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138980633|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138980634|NCT02542124|Growth Substances|growth substances|mesh-ancestor
138980635|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
138980636|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980637|NCT00942318|Insulin|insulin|mesh-list
138980638|NCT00942318|Metformin|metformin|mesh-list
138980639|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
138980640|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138980641|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980642|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138606626|NCT02502253|Resveratrol|resveratrol|mesh-list
138980643|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138980644|NCT05280054|Probenecid|probenecid|mesh-list
138980645|NCT05280054|Uricosuric Agents|uricosuric agents|mesh-ancestor
138980646|NCT05280054|Gout Suppressants|gout suppressants|mesh-ancestor
138980647|NCT05280054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980648|NCT03999099|Suvorexant|suvorexant|mesh-list
138980649|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138980650|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138980651|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139007845|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139007846|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
139007847|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
138758587|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139007848|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007849|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007850|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139007851|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
139007852|NCT01028313|Hormones|hormones|mesh-ancestor
139007853|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139007854|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139007855|NCT01028313|Protective Agents|protective agents|mesh-ancestor
139007856|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139007857|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007858|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139007859|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007860|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007861|NCT04001712|Caffeine|caffeine|mesh-list
139007862|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
139007863|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007864|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139007865|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007866|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139007867|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007868|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138518781|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
138980652|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980653|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138980654|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138980655|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980656|NCT01007799|Vitamin D|vitamin d|mesh-list
138980657|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
138980658|NCT01007799|Cholecalciferol|cholecalciferol|mesh-list
138980659|NCT01007799|Vitamins|vitamins|mesh-list
138980660|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
138980661|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980662|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138980663|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138980664|NCT00609518|Folic Acid|folic acid|mesh-list
138980665|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
138980666|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
138980667|NCT00609518|Dexamethasone|dexamethasone|mesh-list
138980668|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
138980669|NCT00609518|Pemetrexed|pemetrexed|mesh-list
138980670|NCT00609518|BB 1101|bb 1101|mesh-list
138980671|NCT00609518|Vitamins|vitamins|mesh-ancestor
138980672|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
139007869|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139007870|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
139007871|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007872|NCT01027377|Factor VIII|factor viii|mesh-list
139007873|NCT01027377|Coagulants|coagulants|mesh-ancestor
139007874|NCT00992160|Vestipitant|vestipitant|mesh-list
139007875|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139007876|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007877|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007878|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007879|NCT00379912|Azacitidine|azacitidine|mesh-list
139007880|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
139007881|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139007882|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
139007883|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007884|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007885|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007886|NCT00379912|Hematinics|hematinics|mesh-ancestor
139007888|NCT00379834|Dorzolamide|dorzolamide|mesh-list
139007889|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139007890|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139007891|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
139007892|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007893|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007894|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007895|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139007896|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139007897|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139007898|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980673|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980674|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138980675|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
138980676|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
138980677|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980678|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138980679|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
138980680|NCT00609518|Hormones|hormones|mesh-ancestor
138980681|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138980682|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138980683|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980684|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
138980685|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980686|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980687|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139007899|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
139007900|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
139007901|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
139007902|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139007903|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007904|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139007905|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139007906|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139007907|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139007908|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139007909|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139007910|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
139007911|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007912|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007913|NCT03453840|Lumefantrine|lumefantrine|mesh-list
139007914|NCT03453840|Artemether|artemether|mesh-list
139007915|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138980688|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138980689|NCT00609518|Hematinics|hematinics|mesh-ancestor
138980690|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138980691|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138980692|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980693|NCT00886496|Lectins|lectins|mesh-list
138980694|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
138980695|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
138980696|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980697|NCT00886496|Coagulants|coagulants|mesh-ancestor
138980698|NCT00884858|Maraviroc|maraviroc|mesh-list
138980699|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138980700|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138980701|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980702|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138980703|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138980704|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
138980705|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980706|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138980707|NCT00891332|Leucovorin|leucovorin|mesh-list
138980708|NCT00891332|Antidotes|antidotes|mesh-ancestor
138980709|NCT00891332|Protective Agents|protective agents|mesh-ancestor
138980710|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980711|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
138980712|NCT00891332|Vitamins|vitamins|mesh-ancestor
138980713|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
138980714|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
138980715|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138980716|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980717|NCT00886574|Aspirin|aspirin|mesh-list
138980718|NCT00886574|Cilostazol|cilostazol|mesh-list
138980719|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138980720|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138980721|NCT00886574|Analgesics|analgesics|mesh-ancestor
138980722|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
138980723|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980724|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980725|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138980726|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980727|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138980728|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138980729|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980730|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139007917|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139007918|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139007919|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139007920|NCT05354700|Carboplatin|carboplatin|mesh-list
139007921|NCT05354700|Etoposide|etoposide|mesh-list
139007922|NCT05354700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007923|NCT05354700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139007924|NCT05354700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139007925|NCT05354700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139007927|NCT05354700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007928|NCT03339258|Doxazosin|doxazosin|mesh-list
139007929|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139007930|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139007931|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139007932|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139007933|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
139007934|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139007935|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007936|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007937|NCT00992706|Doxorubicin|doxorubicin|mesh-list
139007938|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139007939|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139007940|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007941|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139007942|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139007943|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980731|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138980732|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980733|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
138980734|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138980735|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
138980736|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138980737|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
138980738|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
138980739|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138980740|NCT00886574|Protective Agents|protective agents|mesh-ancestor
138980741|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138980742|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138980743|NCT00611858|Fluorouracil|fluorouracil|mesh-list
138980744|NCT00611858|Cetuximab|cetuximab|mesh-list
138980745|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
138980746|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980747|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138980748|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980749|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138980750|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
138980751|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007944|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007945|NCT00454779|Cisplatin|cisplatin|mesh-list
139007946|NCT00454779|Docetaxel|docetaxel|mesh-list
139007947|NCT00454779|Panitumumab|panitumumab|mesh-list
139007948|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007949|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
139007950|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
139007951|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
139007952|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007953|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139007954|NCT00992862|Moexipril|moexipril|mesh-list
138980752|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138980753|NCT00137449|Sunitinib|sunitinib|mesh-list
138980754|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980755|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138980756|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138980757|NCT00137449|Growth Substances|growth substances|mesh-ancestor
138980758|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980759|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
138980760|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138980761|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980762|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731617|NCT01602003|Hormones|hormones|mesh-ancestor
138980763|NCT00886886|Reboxetine|reboxetine|mesh-list
138980764|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
138980765|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138980766|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138980767|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138980768|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138980769|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980770|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
138980771|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138980772|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980773|NCT00887042|Fludarabine|fludarabine|mesh-list
138980774|NCT00887042|Busulfan|busulfan|mesh-list
138980775|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
138980776|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980777|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980778|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138980779|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
138980780|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980781|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
138980782|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138980783|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138980784|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
138980785|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
138980786|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138980787|NCT00892112|Antibodies|antibodies|mesh-list
138980788|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
138980789|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138980790|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
138980791|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980792|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
138980793|NCT00887120|Ritonavir|ritonavir|mesh-list
138980794|NCT00887120|Lopinavir|lopinavir|mesh-list
138980795|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138980796|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138980797|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
138980798|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980799|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980800|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138980801|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138980802|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
138980803|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937873|NCT05567406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138937874|NCT05567406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937875|NCT05567406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937876|NCT05555706|Paclitaxel|paclitaxel|mesh-list
138937877|NCT05555706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138937878|NCT05555706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937879|NCT05555706|Tubulin Modulators|tubulin modulators|mesh-ancestor
138980804|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139007955|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139007956|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
139007957|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007958|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007959|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139007960|NCT00993096|Insulin|insulin|mesh-list
139007961|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139007962|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
139007963|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
139007964|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139007965|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
139007966|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139007967|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
139007968|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138980805|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138980806|NCT00892190|Dasatinib|dasatinib|mesh-list
138980807|NCT00892190|Tretinoin|tretinoin|mesh-list
138980808|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980809|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138980810|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980811|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980812|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
138980813|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
138980814|NCT00887276|Amoxicillin|amoxicillin|mesh-list
138980815|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
138980816|NCT00887276|Ampicillin|ampicillin|mesh-list
138980817|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138980818|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980819|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138980820|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138980821|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980822|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980823|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980825|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
138980826|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138980827|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980828|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138980829|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980830|NCT00608894|Prednisone|prednisone|mesh-list
138980831|NCT00608894|Azathioprine|azathioprine|mesh-list
138980832|NCT00608894|Tacrolimus|tacrolimus|mesh-list
138980833|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138980834|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
138980835|NCT00608894|Hormones|hormones|mesh-ancestor
138980836|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138980837|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980838|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138980839|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980840|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138980842|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138980843|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980844|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980845|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
138980846|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138980847|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980848|NCT00892346|Thalidomide|thalidomide|mesh-list
138980849|NCT00892346|Melphalan|melphalan|mesh-list
138980850|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138980851|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
139007969|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139007970|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139007971|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007972|NCT03994107|Paclitaxel|paclitaxel|mesh-list
139007973|NCT03994107|Doxorubicin|doxorubicin|mesh-list
139007974|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139007975|NCT03994107|Trastuzumab|trastuzumab|mesh-list
138937891|NCT05545384|Rituximab|rituximab|mesh-list
138937892|NCT05545384|Azathioprine|azathioprine|mesh-list
139007976|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139007977|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139007978|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007979|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
139007980|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
139007981|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
138980852|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980853|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980854|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138980855|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138980856|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
138980857|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980858|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
138980859|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138980860|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980861|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138980862|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138980863|NCT00892346|Growth Substances|growth substances|mesh-ancestor
138980864|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
138980865|NCT00892424|Sorafenib|sorafenib|mesh-list
138980866|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980867|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138980868|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980869|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980870|NCT02541032|Minocycline|minocycline|mesh-list
138980871|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138980872|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138980873|NCT00892502|Bismuth|bismuth|mesh-list
138980874|NCT00892502|Antacids|antacids|mesh-ancestor
138980875|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980876|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138980877|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138980878|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
138980879|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138980880|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138980881|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138980882|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
138980883|NCT00191113|Estradiol|estradiol|mesh-list
138980884|NCT00191113|Hormones|hormones|mesh-ancestor
138980885|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138980886|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980887|NCT00191113|Estrogens|estrogens|mesh-ancestor
138980888|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138980889|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
138980890|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138980891|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138980892|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138980893|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138980894|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138980895|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138980896|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138980897|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980898|NCT03965052|Travoprost|travoprost|mesh-list
138980899|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138980900|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138980901|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138980902|NCT00892658|Sorafenib|sorafenib|mesh-list
139007982|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007983|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139007984|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139007985|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139007986|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139007987|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139007988|NCT03469713|Nivolumab|nivolumab|mesh-list
139007989|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139007990|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139007991|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139007992|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007993|NCT00427635|Esomeprazole|esomeprazole|mesh-list
139007994|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139007995|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138519178|NCT00028314|Ritonavir|ritonavir|mesh-list
138980903|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980904|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138980905|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980906|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980907|NCT00892736|Veliparib|veliparib|mesh-list
138980908|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138980909|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980910|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980911|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138980912|NCT03966235|Melatonin|melatonin|mesh-list
138980913|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
138731762|NCT01645826|Diltiazem|diltiazem|mesh-list
138980914|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980915|NCT03966235|Protective Agents|protective agents|mesh-ancestor
138980916|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980917|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138980919|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138980920|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
138980921|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138980922|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138980923|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138980924|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
138980925|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138980926|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980927|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980928|NCT00606320|Aripiprazole|aripiprazole|mesh-list
138980929|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
138980930|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138980931|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138980932|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138980933|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138980934|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980935|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
138980936|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
138606792|NCT00611572|Flumazenil|flumazenil|mesh-list
138980937|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138980938|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980939|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138980940|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138980941|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
138980942|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138980943|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139007996|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139007997|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758735|NCT02781493|Prucalopride|prucalopride|mesh-list
139007998|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139007999|NCT00993642|Panobinostat|panobinostat|mesh-list
139008000|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008001|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139008002|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008003|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008004|NCT01028547|Dexamethasone|dexamethasone|mesh-list
139008005|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139008006|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
139008007|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
139008008|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008009|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008010|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139008011|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
139008012|NCT01028547|Hormones|hormones|mesh-ancestor
139008013|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008014|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138519233|NCT00028587|Paclitaxel|paclitaxel|mesh-list
138980944|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138980945|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138980946|NCT03966079|Plasminogen|plasminogen|mesh-list
138980947|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138980948|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138980949|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138980950|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980951|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
138980952|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
138980953|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138980954|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980955|NCT03966859|Atorvastatin|atorvastatin|mesh-list
138980956|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138980957|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138980958|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
138980959|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980960|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138980961|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138980962|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980963|NCT00528411|Aspirin|aspirin|mesh-list
138980964|NCT00528411|Clopidogrel|clopidogrel|mesh-list
138980965|NCT00528411|Ticagrelor|ticagrelor|mesh-list
138980966|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138980967|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138980968|NCT00528411|Analgesics|analgesics|mesh-ancestor
138980969|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
138980970|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980971|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980972|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138980973|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138980974|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138980975|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139008015|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008016|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
139008017|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
138937930|NCT05443061|Nitroglycerin|nitroglycerin|mesh-list
139008018|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139008019|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139008020|NCT01031355|Calcium|calcium|mesh-list
139008021|NCT01031355|Estradiol|estradiol|mesh-list
139008022|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139008023|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138519296|NCT03959501|Hormones|hormones|mesh-ancestor
138980976|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138980977|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138980978|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138980979|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980980|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
138980981|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138980982|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138606807|NCT00171587|Vatalanib|vatalanib|mesh-list
138980983|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138980984|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
138980985|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138980986|NCT00895544|Vaccines|vaccines|mesh-list
138980987|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
138980988|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980989|NCT00895778|Rocuronium|rocuronium|mesh-list
138980990|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138980991|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138980992|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138980993|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138980994|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138980995|NCT00187135|Fentanyl|fentanyl|mesh-list
138980996|NCT00187135|Propofol|propofol|mesh-list
138980997|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138980998|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138980999|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981000|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138981001|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
138981002|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
138981003|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138981004|NCT00187135|Narcotics|narcotics|mesh-ancestor
138981005|NCT00187135|Analgesics|analgesics|mesh-ancestor
138981006|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
138981007|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981008|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138981009|NCT00896402|Iodine|iodine|mesh-list
138981010|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
138981011|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138981012|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
138981013|NCT00896402|Povidone|povidone|mesh-list
138981014|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138981015|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981016|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
138981017|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
138981018|NCT00896402|Trace Elements|trace elements|mesh-ancestor
138981019|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
138981020|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981021|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
138981022|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
138981023|NCT00560352|Dexamethasone|dexamethasone|mesh-list
138981024|NCT00560352|Bortezomib|bortezomib|mesh-list
138981025|NCT00560352|Dasatinib|dasatinib|mesh-list
138981026|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138981027|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
138981028|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
138981029|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981030|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981031|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138937953|NCT05421858|Fluconazole|fluconazole|mesh-list
138981032|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
138981033|NCT00560352|Hormones|hormones|mesh-ancestor
138981034|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008024|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008025|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139008026|NCT01031355|Estrogens|estrogens|mesh-ancestor
139008027|NCT01031355|Hormones|hormones|mesh-ancestor
139008028|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008029|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139008030|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
139008031|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139008032|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139008033|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
139008034|NCT01031355|Vitamins|vitamins|mesh-ancestor
139008035|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
139008036|NCT00993720|Liraglutide|liraglutide|mesh-list
139008037|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139008038|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008039|NCT00993720|Incretins|incretins|mesh-ancestor
139008040|NCT00993720|Hormones|hormones|mesh-ancestor
139008041|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008042|NCT03891264|Cannabidiol|cannabidiol|mesh-list
139008043|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
139008044|NCT00425607|Lonafarnib|lonafarnib|mesh-list
139008045|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008046|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008047|NCT00437073|Capecitabine|capecitabine|mesh-list
139008048|NCT00437073|Topotecan|topotecan|mesh-list
139008049|NCT00437073|Lapatinib|lapatinib|mesh-list
139008050|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139008051|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
138981035|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138981036|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981037|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138981038|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981039|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981040|NCT00892892|Nitrendipine|nitrendipine|mesh-list
138981041|NCT00892892|Rilmenidine|rilmenidine|mesh-list
138981042|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138981043|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138981044|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138981045|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981046|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138981047|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981048|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
138981049|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
138981050|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
138981051|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981052|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138981053|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138981054|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139008052|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008053|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008054|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139008055|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139008056|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008057|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139008058|NCT00425373|Amlodipine|amlodipine|mesh-list
139008059|NCT00425373|Valsartan|valsartan|mesh-list
139008060|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139008061|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139008062|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138519413|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
138981055|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
138981056|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981057|NCT00944814|Zinc|zinc|mesh-list
138981058|NCT00944814|Trace Elements|trace elements|mesh-ancestor
138981059|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
138981060|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981061|NCT00527787|Naproxen|naproxen|mesh-list
138981062|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138981063|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138981064|NCT00527787|Analgesics|analgesics|mesh-ancestor
138981065|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
138981066|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981067|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981068|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138981069|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138981070|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
138981071|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138981072|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981073|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981075|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138981076|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
138981077|NCT00893048|Hormones|hormones|mesh-ancestor
138606860|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138981078|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138981079|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981080|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138981081|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981082|NCT00942864|Ranibizumab|ranibizumab|mesh-list
138981083|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138981084|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138981085|NCT00942864|Growth Substances|growth substances|mesh-ancestor
138981086|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981087|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
138981088|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981090|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138981091|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138981092|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981093|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981094|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138981095|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138981096|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138981097|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138981098|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
138981099|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
138981100|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
138981101|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
138981102|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981103|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981104|NCT00943176|Modafinil|modafinil|mesh-list
138981105|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138981106|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008063|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008064|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139008065|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008066|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
139008067|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139008068|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139008069|NCT01031589|Rilpivirine|rilpivirine|mesh-list
139008070|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138758812|NCT05340985|Provitamins|provitamins|mesh-ancestor
139008071|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139008072|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008073|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008074|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
139008075|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139008076|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138981107|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138981108|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138981109|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138981110|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981112|NCT00129259|Trace Elements|trace elements|mesh-ancestor
138981113|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
138981114|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981115|NCT00896714|Anesthetics|anesthetics|mesh-list
138981116|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981117|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981118|NCT00940524|Cytarabine|cytarabine|mesh-list
138981119|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
138981120|NCT00940524|Methotrexate|methotrexate|mesh-list
138981121|NCT00940524|Etoposide|etoposide|mesh-list
138981122|NCT00940524|Asparaginase|asparaginase|mesh-list
138981123|NCT00940524|Dasatinib|dasatinib|mesh-list
138981124|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
138981125|NCT00940524|Pegaspargase|pegaspargase|mesh-list
138981126|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138981127|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
138981128|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981129|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138981130|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138981131|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
138981132|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981133|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981134|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138981135|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138981136|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
138981137|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138981138|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138731987|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
138981139|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
138981140|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
138981141|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981142|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138981143|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138981144|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138981145|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138981146|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138981147|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
138981148|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981149|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139008077|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139008078|NCT03894540|Paclitaxel|paclitaxel|mesh-list
139008079|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
139008080|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139008081|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008082|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
139008083|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
139008084|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
139008085|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008086|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139008087|NCT03894540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139008088|NCT00993876|Citalopram|citalopram|mesh-list
139008089|NCT00993876|Reboxetine|reboxetine|mesh-list
139008090|NCT00993876|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139008091|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139008092|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139008093|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008094|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981150|NCT00940524|Analgesics|analgesics|mesh-ancestor
138981151|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
138981152|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981153|NCT00186901|Vitamin D|vitamin d|mesh-list
138981154|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
138981155|NCT00186901|Calcium|calcium|mesh-list
138981156|NCT00186901|Vitamins|vitamins|mesh-ancestor
138981157|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
138981158|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981159|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138981160|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138981161|NCT00186901|Antacids|antacids|mesh-ancestor
138981162|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981163|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138981164|NCT00943410|Trastuzumab|trastuzumab|mesh-list
138981165|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981166|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981167|NCT00896948|Antibodies|antibodies|mesh-list
138981168|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
138981169|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981170|NCT00186121|Anastrozole|anastrozole|mesh-list
138981171|NCT00186121|Goserelin|goserelin|mesh-list
138981172|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138981173|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981174|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138981175|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138981176|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981177|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981178|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138981179|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
138981180|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138981181|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981182|NCT00897026|Paclitaxel|paclitaxel|mesh-list
138981183|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
138981184|NCT00897026|Doxorubicin|doxorubicin|mesh-list
138981185|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138981186|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138606982|NCT00197613|Lamivudine|lamivudine|mesh-list
138981187|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008095|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
139008096|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008097|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139008098|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
139008099|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139008100|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139008101|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
139008103|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139008104|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139008105|NCT01646814|Analgesics|analgesics|mesh-ancestor
139008106|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
139008107|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008108|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008109|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138981188|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
138981189|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
138981190|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
138981191|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981192|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138981193|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
138981194|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981195|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138981196|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138981197|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
138981198|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138981199|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138981200|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138981201|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138981202|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981203|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138981204|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
138981205|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138981206|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138981207|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138981208|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981209|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981210|NCT01076491|Mannitol|mannitol|mesh-list
138981211|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138981212|NCT01076491|Diuretics|diuretics|mesh-ancestor
138981213|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
138732067|NCT01608984|Sufentanil|sufentanil|mesh-list
138981214|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981216|NCT00127933|Docetaxel|docetaxel|mesh-list
138981217|NCT00127933|Trastuzumab|trastuzumab|mesh-list
138981218|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138981219|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
138981220|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981221|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981222|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
138981223|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
138981224|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
138981225|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981226|NCT03875313|Talazoparib|talazoparib|mesh-list
138938039|NCT05277896|Ketamine|ketamine|mesh-list
138981227|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138981228|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981229|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981230|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981231|NCT01008345|Ezetimibe|ezetimibe|mesh-list
138981232|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139008110|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139008111|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139008112|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139008113|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008114|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139008115|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139008116|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008117|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
139008118|NCT00994344|Ritonavir|ritonavir|mesh-list
139008119|NCT00994344|Lopinavir|lopinavir|mesh-list
139008120|NCT00994344|Darunavir|darunavir|mesh-list
139008121|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139008122|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139008123|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
139008124|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008125|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008126|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139008127|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139008128|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
139008129|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139008130|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139008131|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139008132|NCT00994500|Bortezomib|bortezomib|mesh-list
139008133|NCT00994500|Vorinostat|vorinostat|mesh-list
139008134|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008135|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139008136|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519643|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138981233|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138981234|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
138981235|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981236|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138981237|NCT06089811|Tryptophan|tryptophan|mesh-list
138981238|NCT06089811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138981239|NCT06089811|Antidepressive Agents|antidepressive agents|mesh-ancestor
138981240|NCT06089811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138981241|NCT06089733|Itraconazole|itraconazole|mesh-list
138981242|NCT06089733|Rifampin|rifampin|mesh-list
138981243|NCT06089733|Antifungal Agents|antifungal agents|mesh-ancestor
138981244|NCT06089733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981245|NCT06089733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138981246|NCT06089733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138981247|NCT06089733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981248|NCT06089733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981249|NCT06089733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138981250|NCT06089733|Hormone Antagonists|hormone antagonists|mesh-ancestor
138981251|NCT06089733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008137|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008138|NCT01416636|Treprostinil|treprostinil|mesh-list
139008139|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139008140|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
139008141|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139008142|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139008143|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139008144|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139008145|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008146|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
139008147|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008148|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008149|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139008150|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008151|NCT00999258|Sirolimus|sirolimus|mesh-list
139008152|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139008153|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139008154|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139008155|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008156|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
139008157|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139008158|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
139008159|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008160|NCT00994734|Mifepristone|mifepristone|mesh-list
138981252|NCT06089733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981253|NCT06089733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138981254|NCT06089733|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138981255|NCT06089733|Antitubercular Agents|antitubercular agents|mesh-ancestor
138981256|NCT06089733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138981257|NCT06089733|Leprostatic Agents|leprostatic agents|mesh-ancestor
138981258|NCT06089733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138981259|NCT06089733|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138981260|NCT06089733|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138981261|NCT06089733|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138981262|NCT06089733|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138981263|NCT06089733|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138981264|NCT06089733|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138981265|NCT06089720|Zinc Oxide|zinc oxide|mesh-list
138981266|NCT06089720|Dermatologic Agents|dermatologic agents|mesh-ancestor
138981267|NCT06089720|Sunscreening Agents|sunscreening agents|mesh-ancestor
138981268|NCT06089720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138981269|NCT06089720|Protective Agents|protective agents|mesh-ancestor
138981270|NCT06089720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981271|NCT06089707|Naloxone|naloxone|mesh-list
138981272|NCT06089707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138981273|NCT06089707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981274|NCT06089707|Sensory System Agents|sensory system agents|mesh-ancestor
138981275|NCT06089707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981276|NCT06089382|Lenvatinib|lenvatinib|mesh-list
139008161|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139008162|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
139008163|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139008164|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008165|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139008166|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139008167|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139008168|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
139008169|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139008170|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139008171|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
139008172|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008173|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
139008174|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139008175|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139008177|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
139008178|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139008179|NCT00994812|Metformin|metformin|mesh-list
139008180|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139008181|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938083|NCT05232825|Hormones|hormones|mesh-ancestor
139008182|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
139008183|NCT00994968|Docetaxel|docetaxel|mesh-list
139008184|NCT00994968|Doxorubicin|doxorubicin|mesh-list
139008185|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139008186|NCT00994968|Tegafur|tegafur|mesh-list
139008187|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139008188|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
139008189|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008190|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139008191|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139008192|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
139008193|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008203|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139008204|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
139008205|NCT03887442|Paclitaxel|paclitaxel|mesh-list
139008206|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139008207|NCT03887442|Cetuximab|cetuximab|mesh-list
139008208|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139008209|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008210|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
139008211|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
139008212|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
139008213|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008214|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139008215|NCT00996060|Hydralazine|hydralazine|mesh-list
139008216|NCT00996060|Valproic Acid|valproic acid|mesh-list
139008217|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
139008218|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758957|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139008219|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008220|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
139008221|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008222|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008223|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
139008224|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139008225|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139008226|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139008227|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139008228|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
139008229|NCT00995046|Factor VIII|factor viii|mesh-list
139008230|NCT00995046|Coagulants|coagulants|mesh-ancestor
139008231|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139039568|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138981277|NCT06089382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981278|NCT06089382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138981279|NCT06089382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981280|NCT06089382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981282|NCT06089356|Valproic Acid|valproic acid|mesh-list
138981283|NCT06089356|Anticonvulsants|anticonvulsants|mesh-ancestor
138981284|NCT06089356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138981285|NCT06089356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981286|NCT06089356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981287|NCT06089356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981288|NCT06089356|GABA Agents|gaba agents|mesh-ancestor
138981289|NCT06089356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981290|NCT06089356|Antimanic Agents|antimanic agents|mesh-ancestor
138981291|NCT06089356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139008232|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
139008233|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139008234|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
139008235|NCT04000932|Hormones|hormones|mesh-ancestor
139008236|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008237|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008238|NCT05170230|Terlipressin|terlipressin|mesh-list
139008239|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139008240|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139008241|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139008242|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
139008243|NCT01000116|Coagulants|coagulants|mesh-ancestor
139008244|NCT00996684|Plasminogen|plasminogen|mesh-list
139008245|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139008246|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139008247|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008248|NCT00996762|Lapatinib|lapatinib|mesh-list
139008249|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981292|NCT06089356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981293|NCT06089356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138981294|NCT06089330|Irinotecan|irinotecan|mesh-list
138981295|NCT06089330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138981296|NCT06089330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138981297|NCT06089330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981298|NCT06089330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981299|NCT06089330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981300|NCT06089317|Lubricant Eye Drops|lubricant eye drops|mesh-list
138981301|NCT06089317|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138981302|NCT06089317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138981303|NCT06089200|Morphine|morphine|mesh-list
138981304|NCT06089200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138981305|NCT06089200|Narcotics|narcotics|mesh-ancestor
138981306|NCT06089200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981307|NCT06089200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981308|NCT06089200|Analgesics|analgesics|mesh-ancestor
138981309|NCT06089200|Sensory System Agents|sensory system agents|mesh-ancestor
138981310|NCT06089200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981311|NCT06089122|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138981312|NCT06089122|Immunologic Factors|immunologic factors|mesh-ancestor
138981313|NCT06089122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981314|NCT06089044|Dalbavancin|dalbavancin|mesh-list
138981315|NCT06089044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138981316|NCT06089044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981317|NCT06088797|Metronidazole|metronidazole|mesh-list
138981318|NCT06088797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981319|NCT06088797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138981320|NCT06088797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138981321|NCT06088797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138981322|NCT06088771|Cemiplimab|cemiplimab|mesh-list
138981323|NCT06088771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981324|NCT06088771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981325|NCT06088745|Vaccines|vaccines|mesh-list
138981326|NCT06088745|Immunologic Factors|immunologic factors|mesh-ancestor
138981327|NCT06088745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981329|NCT06088433|Clopidogrel|clopidogrel|mesh-list
138981330|NCT06088433|Ticagrelor|ticagrelor|mesh-list
138981331|NCT06088433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138981332|NCT06088433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139008250|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139008251|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008252|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008254|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139008255|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008256|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008257|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008258|NCT00997074|Ibuprofen|ibuprofen|mesh-list
139008259|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139008260|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139008261|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139008262|NCT00997074|Analgesics|analgesics|mesh-ancestor
138981333|NCT06088433|Analgesics|analgesics|mesh-ancestor
138981334|NCT06088433|Sensory System Agents|sensory system agents|mesh-ancestor
138981335|NCT06088433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981336|NCT06088433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981337|NCT06088433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138981338|NCT06088433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138981339|NCT06088433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138981340|NCT06088433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138981341|NCT06088433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981342|NCT06088433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138981343|NCT06088433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138981344|NCT06088433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981345|NCT06088433|Antipyretics|antipyretics|mesh-ancestor
138938136|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
138981346|NCT06088433|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138981347|NCT06088433|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138981348|NCT06088433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138981349|NCT06088433|Purinergic Agents|purinergic agents|mesh-ancestor
138981350|NCT06088433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981351|NCT06088420|Morphine|morphine|mesh-list
138981352|NCT06088420|Bupivacaine|bupivacaine|mesh-list
138981353|NCT06088420|Anesthetics, Local|anesthetics, local|mesh-ancestor
138981354|NCT06088420|Anesthetics|anesthetics|mesh-ancestor
138981355|NCT06088420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981356|NCT06088420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981357|NCT06088420|Sensory System Agents|sensory system agents|mesh-ancestor
138981358|NCT06088420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981359|NCT06088420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138981360|NCT06088420|Narcotics|narcotics|mesh-ancestor
138981361|NCT06088420|Analgesics|analgesics|mesh-ancestor
138732221|NCT02279615|Tamsulosin|tamsulosin|mesh-list
138981362|NCT06088407|Tranexamic Acid|tranexamic acid|mesh-list
138981363|NCT06088407|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138981364|NCT06088407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138981365|NCT06088407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981366|NCT06088407|Hemostatics|hemostatics|mesh-ancestor
138981367|NCT06088407|Coagulants|coagulants|mesh-ancestor
138981368|NCT06088316|Amoxicillin|amoxicillin|mesh-list
138981369|NCT06088316|Levofloxacin|levofloxacin|mesh-list
138981370|NCT06088316|Esomeprazole|esomeprazole|mesh-list
138981371|NCT06088316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138981372|NCT06088316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981373|NCT06088316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138981374|NCT06088316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138981375|NCT06088316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138981376|NCT06088316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981377|NCT06088316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981378|NCT06088316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138981379|NCT06088316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138981380|NCT06088316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139008263|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
139008264|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008265|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008266|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139008267|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139008268|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008269|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008270|NCT05249712|Androgens|androgens|mesh-list
139008271|NCT05249712|Hormones|hormones|mesh-ancestor
139008272|NCT05249712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008273|NCT05249712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008274|NCT01000896|Paclitaxel|paclitaxel|mesh-list
139008275|NCT01000896|Carboplatin|carboplatin|mesh-list
139008276|NCT01000896|Saracatinib|saracatinib|mesh-list
139008277|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139008278|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008279|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
139008280|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
139008281|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
139008282|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008283|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008284|NCT00997542|Allopurinol|allopurinol|mesh-list
139008285|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
139008286|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981381|NCT06088316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981382|NCT06088316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138981383|NCT06088316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138981384|NCT06088082|Bupivacaine|bupivacaine|mesh-list
138981385|NCT06088082|Anesthetics, Local|anesthetics, local|mesh-ancestor
138981386|NCT06088082|Anesthetics|anesthetics|mesh-ancestor
138981387|NCT06088082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981388|NCT06088082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981389|NCT06088082|Sensory System Agents|sensory system agents|mesh-ancestor
138981390|NCT06088082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981391|NCT06087965|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138981392|NCT06087965|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138981393|NCT06087965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981394|NCT06087965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138981395|NCT06087965|Immunologic Factors|immunologic factors|mesh-ancestor
138981396|NCT06087965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981397|NCT06087952|Anticoagulants|anticoagulants|mesh-list
138981398|NCT06087796|Metformin|metformin|mesh-list
138981399|NCT06087796|Betamethasone|betamethasone|mesh-list
138981400|NCT06087796|Betamethasone Valerate|betamethasone valerate|mesh-list
138981401|NCT06087796|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138981402|NCT06087796|Betamethasone benzoate|betamethasone benzoate|mesh-list
138981403|NCT06087796|Pentoxifylline|pentoxifylline|mesh-list
138981404|NCT06087796|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138981405|NCT06087796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138981406|NCT06087796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008287|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008288|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
139008289|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139008290|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139008291|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
139008292|NCT00997542|Protective Agents|protective agents|mesh-ancestor
139008293|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008294|NCT01001130|Fluticasone|fluticasone|mesh-list
139008295|NCT01001130|Xhance|xhance|mesh-list
139008296|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139008297|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139008298|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
139008299|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008300|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008301|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139008302|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
138981407|NCT06087796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138981408|NCT06087796|Glucocorticoids|glucocorticoids|mesh-ancestor
138981409|NCT06087796|Hormones|hormones|mesh-ancestor
138981410|NCT06087796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138981411|NCT06087796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138981412|NCT06087796|Respiratory System Agents|respiratory system agents|mesh-ancestor
138981413|NCT06087796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138981414|NCT06087796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981415|NCT06087796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981416|NCT06087796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138981417|NCT06087796|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138981418|NCT06087796|Protective Agents|protective agents|mesh-ancestor
138981419|NCT06087796|Vasodilator Agents|vasodilator agents|mesh-ancestor
138981420|NCT06087796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138981421|NCT06087796|Antioxidants|antioxidants|mesh-ancestor
138981422|NCT06087705|Hyaluronic Acid|hyaluronic acid|mesh-list
138981423|NCT06087705|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138981424|NCT06087705|Immunologic Factors|immunologic factors|mesh-ancestor
138981425|NCT06087705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981426|NCT06087705|Viscosupplements|viscosupplements|mesh-ancestor
138981427|NCT06087705|Protective Agents|protective agents|mesh-ancestor
138981428|NCT06087653|Dexamethasone|dexamethasone|mesh-list
138981429|NCT06087653|Lenalidomide|lenalidomide|mesh-list
138981430|NCT06087653|Bortezomib|bortezomib|mesh-list
138981431|NCT06087653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138981432|NCT06087653|Antiemetics|antiemetics|mesh-ancestor
138981433|NCT06087653|Autonomic Agents|autonomic agents|mesh-ancestor
138981434|NCT06087653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981435|NCT06087653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981436|NCT06087653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138981437|NCT06087653|Glucocorticoids|glucocorticoids|mesh-ancestor
138981438|NCT06087653|Hormones|hormones|mesh-ancestor
138981439|NCT06087653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138981440|NCT06087653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138981441|NCT06087653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981442|NCT06087653|Immunologic Factors|immunologic factors|mesh-ancestor
138981443|NCT06087653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138981444|NCT06087653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138981445|NCT06087653|Growth Substances|growth substances|mesh-ancestor
138981446|NCT06087653|Growth Inhibitors|growth inhibitors|mesh-ancestor
138981447|NCT06087588|Ethanol|ethanol|mesh-list
138981448|NCT06087588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138981449|NCT06087588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981450|NCT06087588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981451|NCT06087588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008303|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
139008304|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139008305|NCT00424827|Gemcitabine|gemcitabine|mesh-list
139008306|NCT00424827|Fluorouracil|fluorouracil|mesh-list
139008307|NCT00424827|Cetuximab|cetuximab|mesh-list
139008308|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139008309|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
139008310|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008311|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008312|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139008313|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
139008314|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008315|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139008316|NCT01001364|Budesonide|budesonide|mesh-list
139008317|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
139008318|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139008319|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139008320|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
139008321|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138520045|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981452|NCT06087562|Ropivacaine|ropivacaine|mesh-list
138981453|NCT06087562|Anesthetics, Local|anesthetics, local|mesh-ancestor
138981454|NCT06087562|Anesthetics|anesthetics|mesh-ancestor
138981455|NCT06087562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981456|NCT06087562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981457|NCT06087562|Sensory System Agents|sensory system agents|mesh-ancestor
138981458|NCT06087562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981459|NCT06085729|Carboplatin|carboplatin|mesh-list
138981460|NCT06085729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981461|NCT06083922|Dexamethasone|dexamethasone|mesh-list
138981462|NCT06083922|Cyclophosphamide|cyclophosphamide|mesh-list
138981463|NCT06083922|Bortezomib|bortezomib|mesh-list
138981464|NCT06083922|Daratumumab|daratumumab|mesh-list
138981465|NCT06083922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138981466|NCT06083922|Immunologic Factors|immunologic factors|mesh-ancestor
138981467|NCT06083922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981468|NCT06083922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138981469|NCT06083922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138981470|NCT06083922|Alkylating Agents|alkylating agents|mesh-ancestor
138981471|NCT06083922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981472|NCT06083922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981473|NCT06083922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138981474|NCT06083922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138981475|NCT06083922|Antiemetics|antiemetics|mesh-ancestor
138981476|NCT06083922|Autonomic Agents|autonomic agents|mesh-ancestor
138981477|NCT06083922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938256|NCT05028725|Lugol's solution|lugol's solution|mesh-list
138981478|NCT06083922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138981479|NCT06083922|Glucocorticoids|glucocorticoids|mesh-ancestor
138981480|NCT06083922|Hormones|hormones|mesh-ancestor
138981481|NCT06083922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138981482|NCT06083922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138981483|NCT06080204|Octreotide|octreotide|mesh-list
138981484|NCT06080204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138981485|NCT06080204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138981486|NCT06080204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981487|NCT06072768|Prednisone|prednisone|mesh-list
138981488|NCT06072768|Prednisolone|prednisolone|mesh-list
139008322|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008323|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139008324|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
139008325|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
139008327|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008328|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139008329|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139008330|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139008331|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
139008332|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008333|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008334|NCT01031667|Cilostazol|cilostazol|mesh-list
139008335|NCT01031667|Probucol|probucol|mesh-list
139008336|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139008337|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
139008338|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008339|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008340|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139008341|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
139008342|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139008343|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139008344|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008345|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139008346|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
139008347|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138981489|NCT06072768|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138981490|NCT06072768|Methylprednisolone|methylprednisolone|mesh-list
138981491|NCT06072768|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138981492|NCT06072768|Prednisolone acetate|prednisolone acetate|mesh-list
138981493|NCT06072768|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138981494|NCT06072768|Prednisolone phosphate|prednisolone phosphate|mesh-list
138981495|NCT06072768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138981496|NCT06072768|Glucocorticoids|glucocorticoids|mesh-ancestor
138981497|NCT06072768|Hormones|hormones|mesh-ancestor
138981498|NCT06072768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138981499|NCT06072768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981500|NCT06072768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138981501|NCT06072768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981502|NCT06072768|Antiemetics|antiemetics|mesh-ancestor
138981503|NCT06072768|Autonomic Agents|autonomic agents|mesh-ancestor
138981504|NCT06072768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981505|NCT06072768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138981506|NCT06072768|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138981507|NCT06072768|Protective Agents|protective agents|mesh-ancestor
138981508|NCT06058130|Anticoagulants|anticoagulants|mesh-list
138981509|NCT06057467|Anticoagulants|anticoagulants|mesh-list
138981510|NCT06053021|Aspirin|aspirin|mesh-list
139008348|NCT01031667|Protective Agents|protective agents|mesh-ancestor
139008349|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139008350|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139008351|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008352|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139008353|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139008354|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
139008355|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139008356|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
139008357|NCT03995277|Biotin|biotin|mesh-list
139008358|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
139008359|NCT03995277|Vitamins|vitamins|mesh-ancestor
139008360|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
139008361|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732383|NCT01580202|Lamivudine|lamivudine|mesh-list
138981512|NCT06053021|Dipyridamole|dipyridamole|mesh-list
138981513|NCT06053021|Clopidogrel|clopidogrel|mesh-list
138981514|NCT06053021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138981515|NCT06053021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138981516|NCT06053021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138981517|NCT06053021|Analgesics|analgesics|mesh-ancestor
138981518|NCT06053021|Sensory System Agents|sensory system agents|mesh-ancestor
138981519|NCT06053021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981520|NCT06053021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981521|NCT06053021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138981522|NCT06053021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138981523|NCT06053021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138981524|NCT06053021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138981525|NCT06053021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981526|NCT06053021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138981527|NCT06053021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981528|NCT06053021|Antipyretics|antipyretics|mesh-ancestor
138981529|NCT06053021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138981530|NCT06053021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138981531|NCT06053021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138981532|NCT06053021|Purinergic Agents|purinergic agents|mesh-ancestor
138981533|NCT06053021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981534|NCT06053021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138981535|NCT06053021|Autonomic Agents|autonomic agents|mesh-ancestor
138938310|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
138981536|NCT06053021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138981537|NCT06053021|Respiratory System Agents|respiratory system agents|mesh-ancestor
138981538|NCT06053021|Vasodilator Agents|vasodilator agents|mesh-ancestor
138981539|NCT06053021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138981540|NCT06053021|Protective Agents|protective agents|mesh-ancestor
138981541|NCT06053021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138981542|NCT06053021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138981543|NCT06049940|Vaccines|vaccines|mesh-list
138981544|NCT06049940|Immunologic Factors|immunologic factors|mesh-ancestor
138981545|NCT06049940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981546|NCT06045819|Venetoclax|venetoclax|mesh-list
138981547|NCT06045819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981548|NCT06014775|Antibodies|antibodies|mesh-list
138981549|NCT06014775|Immunologic Factors|immunologic factors|mesh-ancestor
138981550|NCT06014775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981551|NCT06012669|Lactoferrin|lactoferrin|mesh-list
138981552|NCT06012669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981553|NCT05999994|Cyclophosphamide|cyclophosphamide|mesh-list
138981554|NCT05999994|Temozolomide|temozolomide|mesh-list
138981555|NCT05999994|Gemcitabine|gemcitabine|mesh-list
138981556|NCT05999994|Docetaxel|docetaxel|mesh-list
138981557|NCT05999994|Irinotecan|irinotecan|mesh-list
138981558|NCT05999994|Vinorelbine|vinorelbine|mesh-list
138981559|NCT05999994|Ramucirumab|ramucirumab|mesh-list
138981560|NCT05999994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138981561|NCT05999994|Immunologic Factors|immunologic factors|mesh-ancestor
138981562|NCT05999994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008362|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
139008363|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
139008364|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
139008365|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139008366|NCT04000386|Protective Agents|protective agents|mesh-ancestor
139008367|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008368|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
139008369|NCT00998088|Hematinics|hematinics|mesh-ancestor
139008370|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
139008371|NCT00377962|Everolimus|everolimus|mesh-list
138759107|NCT05157997|Antibodies|antibodies|mesh-list
139008372|NCT00377962|Azathioprine|azathioprine|mesh-list
139008373|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139008374|NCT00377962|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139008375|NCT00377962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139008376|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008377|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981563|NCT05999994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138981564|NCT05999994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138981565|NCT05999994|Alkylating Agents|alkylating agents|mesh-ancestor
138981566|NCT05999994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981567|NCT05999994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981568|NCT05999994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138981569|NCT05999994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138981570|NCT05999994|Antimetabolites|antimetabolites|mesh-ancestor
138981571|NCT05999994|Tubulin Modulators|tubulin modulators|mesh-ancestor
138981572|NCT05999994|Antimitotic Agents|antimitotic agents|mesh-ancestor
138981573|NCT05999994|Mitosis Modulators|mitosis modulators|mesh-ancestor
138981574|NCT05999994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138981575|NCT05999994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138981576|NCT05999994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981577|NCT05999994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138981578|NCT05966688|Azithromycin|azithromycin|mesh-list
138981580|NCT05966688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138981581|NCT05966688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981582|NCT05966688|Antitubercular Agents|antitubercular agents|mesh-ancestor
138981583|NCT05941494|Phenylephrine|phenylephrine|mesh-list
138981584|NCT05941494|Oxymetazoline|oxymetazoline|mesh-list
138981585|NCT05941494|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138981586|NCT05941494|Ephedrine|ephedrine|mesh-list
138981587|NCT05941494|Pseudoephedrine|pseudoephedrine|mesh-list
138981588|NCT05941494|Anesthetics|anesthetics|mesh-list
138981589|NCT05941494|Propofol|propofol|mesh-list
138981590|NCT05941494|Sevoflurane|sevoflurane|mesh-list
138981591|NCT05941494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938341|NCT04970576|Warfarin|warfarin|mesh-list
138981592|NCT05941494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981593|NCT05941494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138981594|NCT05941494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138981595|NCT05941494|Anesthetics, General|anesthetics, general|mesh-ancestor
138981596|NCT05941494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138981597|NCT05941494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138981598|NCT05941494|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138981600|NCT05941494|Autonomic Agents|autonomic agents|mesh-ancestor
138981601|NCT05941494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981602|NCT05941494|Sympathomimetics|sympathomimetics|mesh-ancestor
138981603|NCT05941494|Nasal Decongestants|nasal decongestants|mesh-ancestor
138981604|NCT05941494|Respiratory System Agents|respiratory system agents|mesh-ancestor
138981605|NCT05941494|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138981606|NCT05941494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138981607|NCT05941494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138981608|NCT05941494|Adrenergic Agents|adrenergic agents|mesh-ancestor
138981609|NCT05941494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008378|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139008379|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
139008380|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008381|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008382|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
139008383|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139008384|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139008385|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139008386|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138981610|NCT05941494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981611|NCT05941494|Protective Agents|protective agents|mesh-ancestor
138981612|NCT05941494|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138981613|NCT05941494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138981614|NCT05941494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138981615|NCT05932238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138981616|NCT05860439|Polidocanol|polidocanol|mesh-list
138981617|NCT05860439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138981618|NCT05860439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138981619|NCT05858710|Doxorubicin|doxorubicin|mesh-list
138981620|NCT05858710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138981621|NCT05858710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981622|NCT05858710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138981623|NCT05858710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138981624|NCT05858710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981625|NCT05858710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981626|NCT05852873|Ritonavir|ritonavir|mesh-list
138981627|NCT05852873|Nirmatrelvir|nirmatrelvir|mesh-list
138981628|NCT05852873|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
138981629|NCT05852873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138981630|NCT05852873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138981631|NCT05852873|Protease Inhibitors|protease inhibitors|mesh-ancestor
138981632|NCT05852873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981633|NCT05852873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981634|NCT05852873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138981635|NCT05852873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138981636|NCT05852873|Antiviral Agents|antiviral agents|mesh-ancestor
138981637|NCT05852873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981638|NCT05852873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138981639|NCT05852873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138981640|NCT05845359|Methadone|methadone|mesh-list
138981641|NCT05845359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138981642|NCT05845359|Narcotics|narcotics|mesh-ancestor
138981643|NCT05845359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981644|NCT05845359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981645|NCT05845359|Analgesics|analgesics|mesh-ancestor
138981646|NCT05845359|Sensory System Agents|sensory system agents|mesh-ancestor
138981647|NCT05845359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981648|NCT05845359|Antitussive Agents|antitussive agents|mesh-ancestor
138981649|NCT05845359|Respiratory System Agents|respiratory system agents|mesh-ancestor
138981651|NCT05816070|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138981652|NCT05816070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138981653|NCT05816070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138981654|NCT05816070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981655|NCT05816070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138981656|NCT05816070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138981657|NCT05816070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138981658|NCT05816070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981659|NCT05816070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981660|NCT05816070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981661|NCT05816070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138981662|NCT05816070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138981663|NCT05795413|Bupivacaine|bupivacaine|mesh-list
138981664|NCT05795413|Anesthetics, Local|anesthetics, local|mesh-ancestor
139008388|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139008389|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139008390|NCT00424749|Prednisone|prednisone|mesh-list
139008391|NCT00424749|Rituximab|rituximab|mesh-list
139008392|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139008393|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008394|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
139008395|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008396|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139008397|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139008398|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
139008399|NCT00424749|Hormones|hormones|mesh-ancestor
139008400|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008401|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138981665|NCT05795413|Anesthetics|anesthetics|mesh-ancestor
138981666|NCT05795413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981667|NCT05795413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981668|NCT05795413|Sensory System Agents|sensory system agents|mesh-ancestor
138981669|NCT05795413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981670|NCT05788081|Rituximab|rituximab|mesh-list
138981671|NCT05788081|Nivolumab|nivolumab|mesh-list
138981672|NCT05788081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981673|NCT05788081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981674|NCT05788081|Immunologic Factors|immunologic factors|mesh-ancestor
138981675|NCT05788081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981676|NCT05788081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138981677|NCT05788081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138981678|NCT05788081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981679|NCT05762536|Docetaxel|docetaxel|mesh-list
138981680|NCT05762536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981681|NCT05762536|Tubulin Modulators|tubulin modulators|mesh-ancestor
138981682|NCT05762536|Antimitotic Agents|antimitotic agents|mesh-ancestor
138981683|NCT05762536|Mitosis Modulators|mitosis modulators|mesh-ancestor
138981684|NCT05762536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981685|NCT05757219|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138607299|NCT00554827|Hematinics|hematinics|mesh-ancestor
138981686|NCT05757219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981687|NCT05757219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981688|NCT05754073|Oxytocin|oxytocin|mesh-list
138981689|NCT05754073|Oxytocics|oxytocics|mesh-ancestor
138981690|NCT05754073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138981691|NCT05754073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981692|NCT05718856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138981693|NCT05718856|Antibodies|antibodies|mesh-list
138981694|NCT05718856|Immunoglobulins|immunoglobulins|mesh-list
138981695|NCT05718856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138981696|NCT05718856|Immunologic Factors|immunologic factors|mesh-ancestor
138981697|NCT05718856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981698|NCT05718856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981699|NCT05693766|Capecitabine|capecitabine|mesh-list
138981700|NCT05693766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138981701|NCT05693766|Antimetabolites|antimetabolites|mesh-ancestor
138981702|NCT05693766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981703|NCT05693766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981704|NCT05681780|Cyclophosphamide|cyclophosphamide|mesh-list
138981705|NCT05681780|Nivolumab|nivolumab|mesh-list
138981706|NCT05681780|Fludarabine|fludarabine|mesh-list
138981707|NCT05681780|Interleukin-2|interleukin-2|mesh-list
138981708|NCT05681780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138981709|NCT05681780|Immunologic Factors|immunologic factors|mesh-ancestor
139008402|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139008403|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139008404|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139008405|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139008406|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008407|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008408|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008409|NCT00424593|Analgesics|analgesics|mesh-ancestor
139008410|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
139008411|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008412|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
138981710|NCT05681780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981711|NCT05681780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138981712|NCT05681780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138981713|NCT05681780|Alkylating Agents|alkylating agents|mesh-ancestor
138981714|NCT05681780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981715|NCT05681780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981716|NCT05681780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138981717|NCT05681780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981718|NCT05681780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138981719|NCT05681780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138981720|NCT05681780|Analgesics|analgesics|mesh-ancestor
138981721|NCT05681780|Sensory System Agents|sensory system agents|mesh-ancestor
138981722|NCT05681780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981723|NCT05945160|Thioctic Acid|thioctic acid|mesh-list
138981724|NCT05945160|Ubiquinone|ubiquinone|mesh-list
138981725|NCT05945160|Coenzyme Q10|coenzyme q10|mesh-list
138981726|NCT05945160|Antioxidants|antioxidants|mesh-ancestor
138981727|NCT05945160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981728|NCT05945160|Protective Agents|protective agents|mesh-ancestor
138981729|NCT05945160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981730|NCT05945160|Vitamin B Complex|vitamin b complex|mesh-ancestor
138981731|NCT05945160|Vitamins|vitamins|mesh-ancestor
138981732|NCT05945160|Micronutrients|micronutrients|mesh-ancestor
138981733|NCT05660525|Nicotine|nicotine|mesh-list
138981734|NCT05660525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138981735|NCT05660525|Autonomic Agents|autonomic agents|mesh-ancestor
138981736|NCT05660525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607335|NCT02072863|Prednisone|prednisone|mesh-list
138981738|NCT05660525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138981739|NCT05660525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138981740|NCT05660525|Cholinergic Agents|cholinergic agents|mesh-ancestor
138981741|NCT05660525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981742|NCT05660525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981743|NCT05659537|Dulaglutide|dulaglutide|mesh-list
138981744|NCT05659537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138981745|NCT05659537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981746|NCT05645146|Nicotine|nicotine|mesh-list
138981747|NCT05645146|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138981748|NCT05645146|Autonomic Agents|autonomic agents|mesh-ancestor
138981749|NCT05645146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981750|NCT05645146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981751|NCT05645146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138981752|NCT05645146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138981753|NCT05645146|Cholinergic Agents|cholinergic agents|mesh-ancestor
138981754|NCT05645146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981755|NCT05645146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981756|NCT05612074|Nitric Oxide|nitric oxide|mesh-list
138981757|NCT05612074|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138981758|NCT05612074|Autonomic Agents|autonomic agents|mesh-ancestor
138981759|NCT05612074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981760|NCT05612074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008413|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139008414|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
139008416|NCT00369382|Sirolimus|sirolimus|mesh-list
139008417|NCT00369382|Tacrolimus|tacrolimus|mesh-list
139008418|NCT00369382|Cyclosporins|cyclosporins|mesh-list
139008419|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139008420|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
139008421|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008422|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139008423|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008424|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008425|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
139008426|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139008427|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
139008428|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139008429|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138981761|NCT05612074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138981762|NCT05612074|Respiratory System Agents|respiratory system agents|mesh-ancestor
138981763|NCT05612074|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138981764|NCT05612074|Antioxidants|antioxidants|mesh-ancestor
138981765|NCT05612074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981766|NCT05612074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981767|NCT05612074|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138981768|NCT05612074|Vasodilator Agents|vasodilator agents|mesh-ancestor
138981769|NCT05612074|Gasotransmitters|gasotransmitters|mesh-ancestor
138981770|NCT05612074|Protective Agents|protective agents|mesh-ancestor
138981771|NCT05586971|Allopurinol|allopurinol|mesh-list
138981772|NCT05586971|Antimetabolites|antimetabolites|mesh-ancestor
138981773|NCT05586971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981774|NCT05586971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981775|NCT05586971|Gout Suppressants|gout suppressants|mesh-ancestor
138981776|NCT05586971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138981777|NCT05586971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138981779|NCT05586971|Protective Agents|protective agents|mesh-ancestor
138981780|NCT05586971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981781|NCT05578820|Ganciclovir|ganciclovir|mesh-list
138981782|NCT05578820|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138981783|NCT05578820|Antiviral Agents|antiviral agents|mesh-ancestor
138981784|NCT05578820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981785|NCT05578820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138981786|NCT05578820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981787|NCT05578820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981788|NCT05566834|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
138981789|NCT05566834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138981790|NCT05566834|Alkylating Agents|alkylating agents|mesh-ancestor
138981791|NCT05566834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981792|NCT05566834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981793|NCT05550246|Oxybutynin|oxybutynin|mesh-list
138981794|NCT05550246|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138981795|NCT05550246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138981796|NCT05550246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138981797|NCT05550246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138981798|NCT05550246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981799|NCT05550246|Adrenergic Agents|adrenergic agents|mesh-ancestor
138981800|NCT05550246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981801|NCT05550246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981802|NCT05550246|Parasympatholytics|parasympatholytics|mesh-ancestor
139008430|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139008431|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008432|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
139008433|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008434|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139008435|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008436|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008437|NCT00377260|Amoxicillin|amoxicillin|mesh-list
139008438|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
139008439|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
139008440|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139008441|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139008442|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981803|NCT05550246|Autonomic Agents|autonomic agents|mesh-ancestor
138981804|NCT05550246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981805|NCT05550246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138981806|NCT05550246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138981807|NCT05550246|Cholinergic Agents|cholinergic agents|mesh-ancestor
138981808|NCT05550246|Urological Agents|urological agents|mesh-ancestor
138981809|NCT05531591|Aripiprazole|aripiprazole|mesh-list
138981810|NCT05531591|Lithium Carbonate|lithium carbonate|mesh-list
138981811|NCT05531591|Bupropion|bupropion|mesh-list
138981812|NCT05531591|Nortriptyline|nortriptyline|mesh-list
138981813|NCT05531591|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138981814|NCT05531591|Antidepressive Agents|antidepressive agents|mesh-ancestor
138981815|NCT05531591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138981816|NCT05531591|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138981817|NCT05531591|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138981818|NCT05531591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138981819|NCT05531591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981821|NCT05531591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981822|NCT05531591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981823|NCT05531591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138938416|NCT04822064|Analgesics|analgesics|mesh-ancestor
138981824|NCT05531591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138981825|NCT05531591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981826|NCT05531591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138981827|NCT05531591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138981828|NCT05531591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981829|NCT05531591|Dopamine Agonists|dopamine agonists|mesh-ancestor
138981830|NCT05531591|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138981831|NCT05531591|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138981832|NCT05531591|Serotonin Agents|serotonin agents|mesh-ancestor
138981833|NCT05531591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138981834|NCT05531591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138981835|NCT05531591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138981836|NCT05531591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138981837|NCT05531591|Antimanic Agents|antimanic agents|mesh-ancestor
138981838|NCT05531591|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138981839|NCT05531591|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138981840|NCT05531591|Adrenergic Agents|adrenergic agents|mesh-ancestor
138981841|NCT05524935|Pembrolizumab|pembrolizumab|mesh-list
138981842|NCT05524935|Olaparib|olaparib|mesh-list
138981843|NCT05524935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981844|NCT05524935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981845|NCT05524935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138981846|NCT05524935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981847|NCT05524935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138981848|NCT05524935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981849|NCT05522036|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138981850|NCT05522036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139008443|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139008445|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008446|NCT00441441|Fluticasone|fluticasone|mesh-list
139008447|NCT00441441|Xhance|xhance|mesh-list
139008448|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139008449|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139008450|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139008451|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
139008452|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008453|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008454|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139008455|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
139008456|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
139008457|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139008458|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139008459|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139008460|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139008461|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
139008462|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008463|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981851|NCT05522036|Dermatologic Agents|dermatologic agents|mesh-ancestor
138981852|NCT05508594|Sufentanil|sufentanil|mesh-list
138981853|NCT05508594|Ketamine|ketamine|mesh-list
138981854|NCT05508594|Analgesics|analgesics|mesh-ancestor
138981855|NCT05508594|Sensory System Agents|sensory system agents|mesh-ancestor
138981856|NCT05508594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607435|NCT01989325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138981857|NCT05508594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981858|NCT05508594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138981859|NCT05508594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138981860|NCT05508594|Anesthetics, General|anesthetics, general|mesh-ancestor
138981862|NCT05508594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981863|NCT05508594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138981864|NCT05508594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138981865|NCT05508594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981866|NCT05508594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981867|NCT05508594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138981868|NCT05508594|Narcotics|narcotics|mesh-ancestor
138981869|NCT05508594|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138981870|NCT05505630|Midazolam|midazolam|mesh-list
138981871|NCT05505630|Dexmedetomidine|dexmedetomidine|mesh-list
138981872|NCT05505630|Ketamine|ketamine|mesh-list
138981873|NCT05505630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
138981874|NCT05505630|Anesthetics|anesthetics|mesh-list
138981875|NCT05505630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138981876|NCT05505630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981877|NCT05505630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981878|NCT05505630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138981879|NCT05505630|Analgesics|analgesics|mesh-ancestor
138981880|NCT05505630|Sensory System Agents|sensory system agents|mesh-ancestor
138981881|NCT05505630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981882|NCT05505630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138981883|NCT05505630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139008464|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
139008466|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008467|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139008468|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139008469|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008470|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008471|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139008472|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
139008473|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008474|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008475|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139008476|NCT00436605|Dasatinib|dasatinib|mesh-list
139008477|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138520631|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981884|NCT05505630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138981885|NCT05505630|Adrenergic Agents|adrenergic agents|mesh-ancestor
138981886|NCT05505630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981887|NCT05505630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981888|NCT05505630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138981889|NCT05505630|Anesthetics, General|anesthetics, general|mesh-ancestor
138981890|NCT05505630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138981891|NCT05505630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138981892|NCT05505630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138981893|NCT05505630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138981894|NCT05505630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138981895|NCT05505630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138981896|NCT05505630|GABA Modulators|gaba modulators|mesh-ancestor
138981897|NCT05505630|GABA Agents|gaba agents|mesh-ancestor
138981898|NCT05498441|Antipsychotic Agents|antipsychotic agents|mesh-list
138981899|NCT05498441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138981900|NCT05498441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138607466|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
138981901|NCT05498441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981902|NCT05498441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138981903|NCT05483062|Fluorides|fluorides|mesh-list
138981904|NCT05483062|Tin Fluorides|tin fluorides|mesh-list
138981905|NCT05483062|Cariostatic Agents|cariostatic agents|mesh-ancestor
138981906|NCT05483062|Protective Agents|protective agents|mesh-ancestor
138981907|NCT05483062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981908|NCT05458674|Trastuzumab|trastuzumab|mesh-list
138981909|NCT05458674|Tucatinib|tucatinib|mesh-list
138981910|NCT05458674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981911|NCT05458674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981912|NCT05458674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138981913|NCT05458674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981914|NCT05458674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981915|NCT05445414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138981916|NCT05445414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138981917|NCT05378464|Trastuzumab|trastuzumab|mesh-list
138981918|NCT05378464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981919|NCT05378464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981920|NCT05358522|Analgesics, Opioid|analgesics, opioid|mesh-list
138981921|NCT05358522|Narcotics|narcotics|mesh-ancestor
138981922|NCT05358522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981923|NCT05358522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981924|NCT05358522|Analgesics|analgesics|mesh-ancestor
138981925|NCT05358522|Sensory System Agents|sensory system agents|mesh-ancestor
138981926|NCT05358522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981927|NCT05260671|Cetuximab|cetuximab|mesh-list
139008478|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139008479|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008480|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008481|NCT01034787|Tremelimumab|tremelimumab|mesh-list
139008482|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008483|NCT01028781|Thalidomide|thalidomide|mesh-list
139008484|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139008485|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
139008486|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008487|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
139008488|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139008489|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139008490|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139008491|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138981928|NCT05260671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981929|NCT05260671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981930|NCT05180422|Sotorasib|sotorasib|mesh-list
138981931|NCT05180422|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138981932|NCT05180422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981933|NCT05180422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981934|NCT05180422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981935|NCT05161533|Cisplatin|cisplatin|mesh-list
138981936|NCT05161533|Carboplatin|carboplatin|mesh-list
138981937|NCT05161533|Etoposide|etoposide|mesh-list
138981938|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
138981939|NCT05161533|Durvalumab|durvalumab|mesh-list
138981940|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
138981941|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
138981942|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138981943|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
138981944|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981945|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138981946|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138981947|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138981948|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981949|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981950|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981951|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
138981952|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981953|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
138981954|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
138938463|NCT04738695|Antibodies|antibodies|mesh-list
138981955|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
138981956|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
138981957|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
138981958|NCT05156606|Testosterone|testosterone|mesh-list
138981959|NCT05156606|Androgens|androgens|mesh-ancestor
138981960|NCT05156606|Hormones|hormones|mesh-ancestor
138981961|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138981962|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732810|NCT01688024|Mitomycins|mitomycins|mesh-list
138981963|NCT05132439|Metformin|metformin|mesh-list
138981964|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138981965|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981966|NCT05086250|Ketamine|ketamine|mesh-list
138981967|NCT05086250|Analgesics|analgesics|mesh-ancestor
138981968|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
138981969|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138981970|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981971|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138981972|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138981973|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
138981974|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
139008493|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
139008494|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008495|NCT01031901|Sirolimus|sirolimus|mesh-list
139008496|NCT01031901|Temsirolimus|temsirolimus|mesh-list
139008497|NCT01031901|MTOR Inhibitors|mtor inhibitors|mesh-list
139008498|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139008499|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139008500|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139008501|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008502|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
139008503|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138981975|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138981976|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138981977|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138981978|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138981979|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981980|NCT05070403|Afatinib|afatinib|mesh-list
138981981|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981982|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138981983|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138981984|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981985|NCT05064085|Capecitabine|capecitabine|mesh-list
138981986|NCT05064085|Cemiplimab|cemiplimab|mesh-list
138981987|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138981988|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
138981989|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138981990|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981991|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981992|NCT05030493|Bevacizumab|bevacizumab|mesh-list
138981993|NCT05030493|Panitumumab|panitumumab|mesh-list
138981994|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138981995|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138981996|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138981997|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138981998|NCT05030493|Growth Substances|growth substances|mesh-ancestor
138981999|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982000|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
138982001|NCT05023382|Teduglutide|teduglutide|mesh-list
138982002|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138982003|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138982004|NCT05023382|Protective Agents|protective agents|mesh-ancestor
138982005|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982006|NCT05021991|Pramoxine|pramoxine|mesh-list
138982007|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
138982008|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
138982009|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138982010|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982011|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
138982012|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982013|NCT05014438|Branebrutinib|branebrutinib|mesh-list
138982014|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982015|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982016|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982017|NCT05014048|Vitamin D|vitamin d|mesh-list
138982018|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
138982019|NCT05014048|Vitamins|vitamins|mesh-ancestor
138982020|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
138982021|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982022|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138982023|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138982024|NCT05008783|Capecitabine|capecitabine|mesh-list
138982025|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
138982026|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139008504|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
139008505|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008506|NCT01031901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139008507|NCT01031901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008508|NCT01031901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008509|NCT00368992|Paclitaxel|paclitaxel|mesh-list
139008510|NCT00368992|Bevacizumab|bevacizumab|mesh-list
139008511|NCT00368992|Cetuximab|cetuximab|mesh-list
138982027|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
138982028|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982029|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982030|NCT04996823|Ipilimumab|ipilimumab|mesh-list
138982031|NCT04996823|Axitinib|axitinib|mesh-list
138982032|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982033|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982034|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138982035|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982036|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982037|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982038|NCT04982367|Sirolimus|sirolimus|mesh-list
138982039|NCT04982367|Paclitaxel|paclitaxel|mesh-list
138732879|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138982040|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138982041|NCT04982367|Temsirolimus|temsirolimus|mesh-list
138982042|NCT04982367|MTOR Inhibitors|mtor inhibitors|mesh-list
138982043|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138982044|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982045|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
138982046|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
138982047|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
138982048|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982049|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138982050|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138982051|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138982052|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
138982053|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982054|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
138982055|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982056|NCT04982367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982057|NCT04982367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982058|NCT04979442|Trabectedin|trabectedin|mesh-list
138982059|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138982060|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
138982061|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982062|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982063|NCT04969887|Nivolumab|nivolumab|mesh-list
138982064|NCT04969887|Ipilimumab|ipilimumab|mesh-list
138982065|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982066|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982067|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138982068|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982069|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
138982070|NCT04968132|Narcotics|narcotics|mesh-ancestor
138982071|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138982072|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982073|NCT04968132|Analgesics|analgesics|mesh-ancestor
138982074|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
138982075|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982076|NCT04968054|Propofol|propofol|mesh-list
138982077|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138982078|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138982079|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982080|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138982081|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
138982082|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
138982083|NCT04951804|Bupivacaine|bupivacaine|mesh-list
138982084|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
138982085|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
139008512|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139008513|NCT00368992|Antibodies|antibodies|mesh-list
139008514|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
139008515|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139008516|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139008517|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008518|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
139008519|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
139008520|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
139008521|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008522|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139008523|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139008524|NCT00368992|Growth Substances|growth substances|mesh-ancestor
139008525|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008526|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
139008527|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
139008528|NCT00376246|Ezetimibe|ezetimibe|mesh-list
139008529|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139008530|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139008531|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
139008532|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008533|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139008534|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138982086|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138607590|NCT01874626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138982087|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982088|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
138982089|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982091|NCT04940299|Ipilimumab|ipilimumab|mesh-list
138982092|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
138982093|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
138982094|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982095|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982096|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138982097|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982098|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
138982099|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982100|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
138982101|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138982102|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
138982103|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982104|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
138982105|NCT04936204|Protective Agents|protective agents|mesh-ancestor
138982106|NCT04868565|Caffeine|caffeine|mesh-list
138982107|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
138982108|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982109|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138982110|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982111|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138982112|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982113|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139008536|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139008537|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139008538|NCT00375934|Analgesics|analgesics|mesh-ancestor
139008539|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
139008540|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982114|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138982115|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
138982116|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138982117|NCT04858776|Dexamethasone|dexamethasone|mesh-list
138982118|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138982119|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
138982120|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
138982121|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982122|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982123|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138982124|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
138982125|NCT04858776|Hormones|hormones|mesh-ancestor
138982126|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138982127|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138982128|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982129|NCT04849416|Pirtobrutinib|pirtobrutinib|mesh-list
138607626|NCT01859962|Ribavirin|ribavirin|mesh-list
138982135|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138982136|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982137|NCT04786340|Pirenzepine|pirenzepine|mesh-list
138982138|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138982139|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138982140|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138982141|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138982142|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138982143|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
138982144|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138982145|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982146|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982148|NCT04763577|Kininogens|kininogens|mesh-list
138982149|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
138982150|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138982151|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
138982152|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982153|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982154|NCT04739358|Tepotinib|tepotinib|mesh-list
138982155|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982156|NCT04713735|Lactoferrin|lactoferrin|mesh-list
138982157|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138982158|NCT04591808|Perindopril|perindopril|mesh-list
138982159|NCT04591808|Atorvastatin|atorvastatin|mesh-list
138982160|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138982161|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138982162|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
138982163|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982164|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138982165|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138982166|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982167|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138982168|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
138982169|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138982170|NCT04588545|Trastuzumab|trastuzumab|mesh-list
138982171|NCT04588545|Pertuzumab|pertuzumab|mesh-list
138982172|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982173|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982178|NCT04544202|Trametinib|trametinib|mesh-list
138982179|NCT04544202|Dabrafenib|dabrafenib|mesh-list
138982180|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982181|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982182|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982183|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982188|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982189|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982190|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008541|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008542|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139008543|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139008544|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139008545|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008546|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008547|NCT01052584|Chloroquine|chloroquine|mesh-list
139008548|NCT01052584|Lumefantrine|lumefantrine|mesh-list
139008549|NCT01052584|Artemether|artemether|mesh-list
139008550|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138982191|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982192|NCT04481451|Ropivacaine|ropivacaine|mesh-list
138982193|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
138982194|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
138982195|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138982196|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982197|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
138982198|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982199|NCT04415333|Butyric Acid|butyric acid|mesh-list
138982200|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
138982201|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
138982202|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138982203|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982204|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982205|NCT04249622|Rifaximin|rifaximin|mesh-list
138982206|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138982207|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138982208|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138982209|NCT04249544|Pramipexole|pramipexole|mesh-list
138982210|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
138982211|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982212|NCT04249544|Protective Agents|protective agents|mesh-ancestor
138982213|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982214|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138982215|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138982216|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
138982217|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
138982218|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138982219|NCT04230980|Gabapentin|gabapentin|mesh-list
138982220|NCT04230980|Analgesics|analgesics|mesh-ancestor
138982221|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
138982222|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982223|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982224|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
138982225|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138982226|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138982227|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138982228|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138982229|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138982230|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138982231|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138982232|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982233|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
138982234|NCT04218968|Carvedilol|carvedilol|mesh-list
138982235|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138982236|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138982237|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
138982238|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138982239|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607662|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
138982240|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982241|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138982242|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
138982243|NCT04218968|Protective Agents|protective agents|mesh-ancestor
138982244|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139008551|NCT01052584|Amebicides|amebicides|mesh-ancestor
139008552|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139008553|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139008554|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139008555|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
139008556|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139008557|NCT02534506|Nivolumab|nivolumab|mesh-list
139008558|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139008559|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008560|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139008561|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008562|NCT01050322|Gemcitabine|gemcitabine|mesh-list
139008563|NCT01050322|Capecitabine|capecitabine|mesh-list
138982245|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138982246|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138982247|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
138982248|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138982249|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138982250|NCT04140448|Ranibizumab|ranibizumab|mesh-list
138982251|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138982252|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138982253|NCT04140448|Growth Substances|growth substances|mesh-ancestor
138982254|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982255|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
138982256|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982257|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
138982258|NCT04087096|Denosumab|denosumab|mesh-list
138982259|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138982260|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982261|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138982262|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
138982263|NCT04006769|Entacapone|entacapone|mesh-list
138733106|NCT01332318|Analgesics|analgesics|mesh-ancestor
138982264|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982265|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982266|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982267|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982268|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138982269|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138982270|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138982271|NCT03936998|Vancomycin|vancomycin|mesh-list
138982272|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138982273|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138982275|NCT03897673|Trace Elements|trace elements|mesh-ancestor
138982276|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
138982277|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982278|NCT03873805|Vidarabine|vidarabine|mesh-list
138982279|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
138982280|NCT03873805|Fludarabine|fludarabine|mesh-list
138982281|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
138982282|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982283|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
138982284|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982285|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138982286|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138982287|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
138982288|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982289|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982290|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138982291|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138982292|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
138982293|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
138982294|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138982295|NCT03792841|Etanercept|etanercept|mesh-list
139008565|NCT01050322|Lapatinib|lapatinib|mesh-list
139008566|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139008567|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
139008568|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008569|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008570|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139008571|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
139008572|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
139008573|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
139008574|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139008575|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008576|NCT00531960|Bevacizumab|bevacizumab|mesh-list
139008577|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139008578|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139008579|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008580|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139008581|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139008582|NCT00531960|Growth Substances|growth substances|mesh-ancestor
139008583|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008584|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
139008585|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139008586|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008587|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982296|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
138982297|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138982298|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982299|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982300|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982301|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138982302|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138982304|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
138982305|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982306|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982307|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138982308|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138982309|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138982310|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982311|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
138982312|NCT03727724|Cetuximab|cetuximab|mesh-list
138982313|NCT03727724|Afatinib|afatinib|mesh-list
138982314|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982315|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982316|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982317|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982318|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982319|NCT03714555|Copper|copper|mesh-list
138982320|NCT03714555|Paclitaxel|paclitaxel|mesh-list
138982321|NCT03714555|Gemcitabine|gemcitabine|mesh-list
138982322|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139008588|NCT01001676|Paclitaxel|paclitaxel|mesh-list
139008589|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139008590|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008591|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
139008592|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
139008593|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
139008594|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008595|NCT00816959|Bleomycin|bleomycin|mesh-list
139008596|NCT00816959|Dacarbazine|dacarbazine|mesh-list
138759334|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
139008597|NCT00816959|Vinblastine|vinblastine|mesh-list
139008598|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139008599|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008600|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008601|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139008602|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
139008603|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139008604|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
139008605|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
139008606|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
139008607|NCT01001754|Ribavirin|ribavirin|mesh-list
139008608|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139008609|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
139008610|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008611|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
139008612|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139008613|NCT00825851|Nicotine|nicotine|mesh-list
139008614|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139008615|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
139008616|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008617|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008618|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139008619|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139008620|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
139008621|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008623|NCT00361504|Oxycodone|oxycodone|mesh-list
139008628|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008629|NCT00361504|Analgesics|analgesics|mesh-ancestor
139008630|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
139008631|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008632|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139008633|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139008634|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139008635|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008636|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
139008637|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008638|NCT00361270|Complement Factor H|complement factor h|mesh-list
139008639|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139008640|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139008641|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
139008642|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008643|NCT00826163|Budesonide|budesonide|mesh-list
139008644|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139008645|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139008646|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
138982323|NCT03714555|Folfirinox|folfirinox|mesh-list
138982324|NCT03714555|Disulfiram|disulfiram|mesh-list
138982325|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138982326|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982327|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
138982328|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
138982329|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
138640661|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
138982330|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982331|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138982332|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
138982333|NCT03714555|Trace Elements|trace elements|mesh-ancestor
138982334|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
138982335|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982336|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138982337|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138982338|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982339|NCT03701295|Azacitidine|azacitidine|mesh-list
138982340|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138982341|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
138982342|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982343|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982344|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982346|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982347|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982349|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138982350|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138982351|NCT03697720|Analgesics|analgesics|mesh-ancestor
138982352|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
138982353|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982354|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982355|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138982356|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138982357|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
138982358|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138982359|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008647|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008648|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008649|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139008650|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
139008651|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
139008652|NCT00826163|Hormones|hormones|mesh-ancestor
139008653|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008654|NCT00998166|Bevacizumab|bevacizumab|mesh-list
139008655|NCT00998166|Pemetrexed|pemetrexed|mesh-list
139008656|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139008657|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008658|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139008659|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139008660|NCT00998166|Growth Substances|growth substances|mesh-ancestor
139008661|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008662|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
138982360|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982361|NCT03635983|Nivolumab|nivolumab|mesh-list
138982362|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982363|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982364|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138982365|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982366|NCT03610971|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138982367|NCT03610971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982368|NCT03610971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982369|NCT03610971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982370|NCT03596385|Metoprolol|metoprolol|mesh-list
138982371|NCT03596385|Atenolol|atenolol|mesh-list
138982372|NCT03596385|Carvedilol|carvedilol|mesh-list
138982373|NCT03596385|Bisoprolol|bisoprolol|mesh-list
138982374|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138982375|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138982376|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138982377|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
138982378|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
138982379|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982380|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982381|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138982382|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138982383|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
138982384|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138982385|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982386|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
138982387|NCT03596385|Protective Agents|protective agents|mesh-ancestor
138982388|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138982389|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138607730|NCT01807546|ON 01910|on 01910|mesh-list
138982390|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138982392|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138982393|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138982394|NCT03549000|Spartalizumab|spartalizumab|mesh-list
138982395|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138982396|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982397|NCT03549000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982398|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982399|NCT03517449|Paclitaxel|paclitaxel|mesh-list
138982400|NCT03517449|Doxorubicin|doxorubicin|mesh-list
139008663|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008664|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008665|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139008666|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139008667|NCT03990922|Morphine|morphine|mesh-list
139008668|NCT03990922|Ropivacaine|ropivacaine|mesh-list
139008669|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139008670|NCT03990922|Narcotics|narcotics|mesh-ancestor
138759411|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
139008671|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139008672|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008673|NCT03990922|Analgesics|analgesics|mesh-ancestor
139008674|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
139008675|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008676|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
138982401|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
138982402|NCT03517449|Lenvatinib|lenvatinib|mesh-list
138982403|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138982404|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982405|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
138982406|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
138982407|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
138982408|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982409|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138982410|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138982411|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138982412|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982413|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982414|NCT03517449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138982415|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982416|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
138982417|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
138982418|NCT03480360|Fludarabine|fludarabine|mesh-list
138982419|NCT03480360|Tacrolimus|tacrolimus|mesh-list
138982420|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982421|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
138982422|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982423|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138982424|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138982425|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
138982426|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607759|NCT01777555|Dopamine Agents|dopamine agents|mesh-ancestor
138982427|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982428|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138982429|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138982430|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982431|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138982432|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138982433|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
138982434|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138982435|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138982436|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138982437|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138982438|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138982439|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
138982440|NCT03410836|Lidocaine|lidocaine|mesh-list
138982441|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
138982442|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
138982443|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138982444|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982445|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
139008677|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
139008678|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
139008679|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139008680|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
139008681|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139008682|NCT00822263|Expectorants|expectorants|mesh-ancestor
139008683|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
138938661|NCT04347434|Ezetimibe|ezetimibe|mesh-list
139008684|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139008685|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
139008686|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008687|NCT00822263|Protective Agents|protective agents|mesh-ancestor
139008688|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008689|NCT00822263|Antidotes|antidotes|mesh-ancestor
139008690|NCT03992170|Daratumumab|daratumumab|mesh-list
139008691|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008692|NCT00817037|Nifedipine|nifedipine|mesh-list
139008693|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
139008694|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139008695|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139008696|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008697|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139008698|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008699|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
139008700|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
139008701|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139008702|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139008703|NCT00998322|Gemcitabine|gemcitabine|mesh-list
139008704|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139008705|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
139008706|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008707|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008708|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
139008709|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139008710|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982446|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982447|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138982448|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138982449|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138982450|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138982451|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982452|NCT03390595|Carboplatin|carboplatin|mesh-list
139008711|NCT01002300|Oxytocin|oxytocin|mesh-list
139008712|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
139008713|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139008714|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008715|NCT00822419|Lidocaine|lidocaine|mesh-list
139008716|NCT00822419|Ketamine|ketamine|mesh-list
139008717|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
139008718|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
139008719|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139008720|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008721|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
139008722|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008723|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139008724|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139008725|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139008726|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139008727|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008728|NCT00822419|Analgesics|analgesics|mesh-ancestor
139008729|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139008730|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139008731|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
138982453|NCT03390595|Gemcitabine|gemcitabine|mesh-list
138982454|NCT03390595|Avelumab|avelumab|mesh-list
138982455|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982456|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138982457|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
138982458|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982459|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982460|NCT03387761|Nivolumab|nivolumab|mesh-list
138982461|NCT03387761|Ipilimumab|ipilimumab|mesh-list
138982462|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982463|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982464|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138982465|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982466|NCT03367312|Xenon|xenon|mesh-list
138982467|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138982468|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
138982469|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
138982470|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138982471|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982472|NCT03288545|Carboplatin|carboplatin|mesh-list
138982473|NCT03288545|Gemcitabine|gemcitabine|mesh-list
138982474|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
138982475|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982476|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138982477|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
138982478|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982479|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982480|NCT03288545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138982481|NCT03274414|Cisplatin|cisplatin|mesh-list
138982482|NCT03274414|Etoposide|etoposide|mesh-list
138982483|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982484|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138982485|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139008732|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139008733|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139008734|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008735|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139008736|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
139008737|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139008738|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139008739|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008740|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008741|NCT01002534|Urological Agents|urological agents|mesh-ancestor
139008743|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139008744|NCT00817271|Hormones|hormones|mesh-ancestor
139008745|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008746|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008748|NCT01052896|Analgesics|analgesics|mesh-ancestor
139008749|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
139008750|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008751|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008752|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
138982486|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138982487|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982488|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982489|NCT03267316|Paclitaxel|paclitaxel|mesh-list
138982490|NCT03267316|Carboplatin|carboplatin|mesh-list
138982491|NCT03267316|Gemcitabine|gemcitabine|mesh-list
138982492|NCT03267316|Pemetrexed|pemetrexed|mesh-list
138982493|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138982494|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982495|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
138982496|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
138982497|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
138982498|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982499|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138982500|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
138982501|NCT03267316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982502|NCT03267316|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138982503|NCT03267316|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138982504|NCT03257631|Thalidomide|thalidomide|mesh-list
138982505|NCT03257631|Pomalidomide|pomalidomide|mesh-list
138982506|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
138982507|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938705|NCT04307511|Analgesics|analgesics|mesh-ancestor
138982508|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138982509|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138982510|NCT03257631|Growth Substances|growth substances|mesh-ancestor
138982511|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
138982512|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982513|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982514|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
138982515|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138982516|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138982517|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
138982518|NCT03152058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138982519|NCT03152058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139008753|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139008754|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139008755|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139008756|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139008757|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139008758|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139008759|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008760|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008761|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
139008763|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139008764|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139008765|NCT01002690|Analgesics|analgesics|mesh-ancestor
139008766|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
139008767|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008768|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008769|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139008770|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139008771|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139008772|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139008773|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008774|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008775|NCT01048684|Mannitol|mannitol|mesh-list
139008776|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139008777|NCT01048684|Diuretics|diuretics|mesh-ancestor
139008778|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
139008779|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008780|NCT01002768|Insulin|insulin|mesh-list
139008781|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139008799|NCT00998556|Bromocriptine|bromocriptine|mesh-list
139008800|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139008801|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139008802|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
139008803|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008804|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008805|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
139008806|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
139008807|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138524626|NCT00020696|Tirapazamine|tirapazamine|mesh-list
139008808|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008809|NCT01052974|Ropivacaine|ropivacaine|mesh-list
139008810|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
138982520|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982521|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
138982522|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982523|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138982524|NCT03122639|Atorvastatin|atorvastatin|mesh-list
138982525|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138982526|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138982527|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
138982528|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982529|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138982530|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138982531|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982532|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
138982533|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138982534|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
138982535|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982536|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982537|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138982538|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138982539|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138982540|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982541|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982542|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138982543|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138982544|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982545|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
138982546|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138982547|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
138982548|NCT02998567|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138982549|NCT02998567|Guadecitabine|guadecitabine|mesh-list
138982550|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982551|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982552|NCT02998567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138982553|NCT02998567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982554|NCT02998567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138982555|NCT02998567|Antimetabolites|antimetabolites|mesh-ancestor
138982557|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
138982558|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138982559|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982560|NCT02916979|Methotrexate|methotrexate|mesh-list
138982561|NCT02916979|Fludarabine|fludarabine|mesh-list
138982562|NCT02916979|Busulfan|busulfan|mesh-list
138982563|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
138982564|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138982565|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
138982566|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138982567|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008811|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
139008812|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139008813|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008814|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
139008815|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008816|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
139008817|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
139008818|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139008819|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008820|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008822|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139008823|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139008824|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008825|NCT01003002|Levodopa|levodopa|mesh-list
139008826|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139008827|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139008828|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
138982568|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138982569|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
138982570|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982571|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982572|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
138982573|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982574|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138982575|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982576|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
138982577|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138982578|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138982579|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
138982580|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138982581|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138982582|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
138982583|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982584|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982585|NCT02702414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138982586|NCT02702414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982587|NCT02548559|Cannabidiol|cannabidiol|mesh-list
138982588|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
138982589|NCT02491632|Dexamethasone|dexamethasone|mesh-list
138982590|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
138982591|NCT02491632|Ichthammol|ichthammol|mesh-list
138982592|NCT02491632|BB 1101|bb 1101|mesh-list
138982593|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138982594|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
138982596|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982597|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982598|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138982599|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
138982600|NCT02491632|Hormones|hormones|mesh-ancestor
138982601|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138982602|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138982603|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982604|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
138982605|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982606|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982607|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
138982608|NCT02086188|Mirabegron|mirabegron|mesh-list
139008829|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008830|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008831|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008832|NCT01003158|Paclitaxel|paclitaxel|mesh-list
139008833|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139008834|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008835|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
139008836|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
139008837|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
139008838|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008839|NCT03883386|Loratadine|loratadine|mesh-list
139008840|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
139008841|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
139008842|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138982609|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138982610|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138982611|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138982612|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
138982613|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138982614|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982615|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982616|NCT02086188|Urological Agents|urological agents|mesh-ancestor
138982617|NCT02022982|Palbociclib|palbociclib|mesh-list
138982618|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982619|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982620|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982621|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982622|NCT01361399|Aspirin|aspirin|mesh-list
138982623|NCT01361399|Lidocaine|lidocaine|mesh-list
138982624|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
138982625|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
138982626|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138982627|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982628|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
138982629|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982630|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138982631|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138982632|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138982633|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138982634|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733483|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
138982635|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138982636|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138982637|NCT01361399|Analgesics|analgesics|mesh-ancestor
138982638|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138982639|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138982640|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138982641|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138982642|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138982643|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138982644|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982645|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
138982646|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138982647|NCT01116622|Bexarotene|bexarotene|mesh-list
138982648|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982649|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982650|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982651|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982652|NCT01064479|Cisplatin|cisplatin|mesh-list
138982653|NCT01064479|Carboplatin|carboplatin|mesh-list
139008843|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139008844|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139008845|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
139008846|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
139008847|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008848|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008849|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982654|NCT01064479|Docetaxel|docetaxel|mesh-list
138982655|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138982656|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982657|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
138982658|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
138982659|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
138982660|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982661|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982662|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982663|NCT00640978|Everolimus|everolimus|mesh-list
138982664|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138982665|NCT00640978|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138982666|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982667|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982668|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982669|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982670|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
138982671|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982672|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982673|NCT00449748|Everolimus|everolimus|mesh-list
138982674|NCT00449748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138982675|NCT00449748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982676|NCT00449748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982677|NCT00449748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982678|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982679|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
138982680|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982681|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982682|NCT00241098|Valsartan|valsartan|mesh-list
138982683|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138982684|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138982685|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138982686|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982687|NCT00171015|Valsartan|valsartan|mesh-list
138982688|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138982689|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138982690|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138982691|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138982692|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982693|NCT00171015|Diuretics|diuretics|mesh-ancestor
138982694|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
138982695|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982696|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138982697|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138982698|NCT05225961|Aspirin|aspirin|mesh-list
138982699|NCT05225961|Tirofiban|tirofiban|mesh-list
138982700|NCT05225961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138982701|NCT05225961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138982702|NCT05225961|Analgesics|analgesics|mesh-ancestor
138982703|NCT05225961|Sensory System Agents|sensory system agents|mesh-ancestor
138982704|NCT05225961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982705|NCT05225961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982706|NCT05225961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138982707|NCT05225961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138982708|NCT05225961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138982709|NCT05225961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138938782|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
138982710|NCT05225961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982711|NCT05225961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139008851|NCT00530946|Atorvastatin|atorvastatin|mesh-list
139008852|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139008853|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139008854|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
139008855|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008856|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139008857|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139008858|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008859|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139008860|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139008861|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139008862|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139008863|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008864|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
139008865|NCT00424047|Dexamethasone|dexamethasone|mesh-list
139008866|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
139008867|NCT00424047|Lenalidomide|lenalidomide|mesh-list
139008868|NCT00424047|BB 1101|bb 1101|mesh-list
139008869|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139008870|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
139008871|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
139008872|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008873|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008874|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138982712|NCT05225961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138982713|NCT05225961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982714|NCT05225961|Antipyretics|antipyretics|mesh-ancestor
138982715|NCT00556998|Voriconazole|voriconazole|mesh-list
138982716|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
138982717|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138982718|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138982719|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138982720|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982721|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982722|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138982723|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
138982724|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138982725|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982726|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138982727|NCT00945360|Letrozole|letrozole|mesh-list
138982728|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138982729|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982730|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138982731|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982732|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982733|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138982734|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
138982735|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008875|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
139008876|NCT00424047|Hormones|hormones|mesh-ancestor
139008877|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008878|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139008879|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008880|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
139008881|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008882|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008883|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
139008884|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139008885|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139008886|NCT00424047|Growth Substances|growth substances|mesh-ancestor
139008887|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
139008888|NCT00530790|Ropinirole|ropinirole|mesh-list
139008889|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139008890|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139008891|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
139008892|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
139008893|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008894|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008895|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008896|NCT01032057|Gemcitabine|gemcitabine|mesh-list
139008897|NCT01032057|Capecitabine|capecitabine|mesh-list
139008898|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139008899|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
139008900|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008901|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008902|NCT01003314|Vaccines|vaccines|mesh-list
139008903|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
139008904|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982736|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982737|NCT00943566|Sufentanil|sufentanil|mesh-list
138982738|NCT00943566|Morphine|morphine|mesh-list
138982739|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138982740|NCT00943566|Narcotics|narcotics|mesh-ancestor
138982741|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138982742|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982743|NCT00943566|Analgesics|analgesics|mesh-ancestor
138982744|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
138982745|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982746|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138982747|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138982748|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
138982749|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
138982750|NCT00940680|Losartan|losartan|mesh-list
138982751|NCT00940680|Amlodipine|amlodipine|mesh-list
139008905|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
139008907|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008908|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
139008909|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139008910|NCT01006668|Propofol|propofol|mesh-list
139008911|NCT01006668|Sevoflurane|sevoflurane|mesh-list
139008912|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139008913|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139008914|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008915|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139008916|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
139008917|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
139008918|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139008919|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138982752|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138982753|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138982754|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138982755|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982756|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138982757|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982758|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
138982759|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138982760|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138982761|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138982762|NCT00945438|Vaccines|vaccines|mesh-list
138982763|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
138938818|NCT04120311|Dexamethasone|dexamethasone|mesh-list
138982764|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982765|NCT00527397|Insulin|insulin|mesh-list
138982766|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138982767|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982768|NCT00943956|Everolimus|everolimus|mesh-list
138982769|NCT00943956|Leuprolide|leuprolide|mesh-list
138982770|NCT00943956|Bicalutamide|bicalutamide|mesh-list
138982771|NCT00943956|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138982772|NCT00943956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982773|NCT00943956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982774|NCT00943956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982775|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982776|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
138982777|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982778|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982779|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138982780|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
138982781|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138982782|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138982783|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
138982784|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
138982785|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138982786|NCT00944346|Metformin|metformin|mesh-list
138982787|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138982788|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982789|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138982790|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
138982791|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982792|NCT00940836|Acetaminophen|acetaminophen|mesh-list
138982793|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
138982794|NCT00940836|Phenylephrine|phenylephrine|mesh-list
138982795|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138982796|NCT00940836|Analgesics|analgesics|mesh-ancestor
138982797|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
139008920|NCT00360568|Levodopa|levodopa|mesh-list
139008921|NCT00360568|Carbidopa|carbidopa|mesh-list
139008922|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139008923|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139008924|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139008925|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
139008926|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008927|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008928|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008929|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139008930|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008931|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139008932|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
139008933|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
139008934|NCT00436215|Bevacizumab|bevacizumab|mesh-list
139008935|NCT00436215|Sorafenib|sorafenib|mesh-list
139008936|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139008937|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008938|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139008939|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139008940|NCT00436215|Growth Substances|growth substances|mesh-ancestor
139008941|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008942|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
139008943|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139008944|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938826|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139008945|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982798|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982799|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982800|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
138982801|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138982802|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
138982803|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
138982804|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
138982805|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138982806|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
138982807|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
138982808|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138982809|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138982810|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138982811|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
138982812|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138982813|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982814|NCT00940836|Protective Agents|protective agents|mesh-ancestor
138982815|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
138982816|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
138982817|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138982818|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
138982819|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
138982820|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139008946|NCT05734248|Hyaluronic Acid|hyaluronic acid|mesh-list
139008947|NCT05734248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139008948|NCT05734248|Immunologic Factors|immunologic factors|mesh-ancestor
139008949|NCT05734248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008950|NCT05734248|Viscosupplements|viscosupplements|mesh-ancestor
139008951|NCT05734248|Protective Agents|protective agents|mesh-ancestor
139008952|NCT00441363|Bromocriptine|bromocriptine|mesh-list
139008953|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139008954|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139008955|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
139008956|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139008957|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008958|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
139008959|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
139008960|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008961|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008962|NCT00626795|Mupirocin|mupirocin|mesh-list
139008963|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138522041|NCT00129857|HU 211|hu 211|mesh-list
138608070|NCT00174551|Prazosin|prazosin|mesh-list
138982821|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
138982822|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138982823|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982824|NCT00944424|Vitamin D|vitamin d|mesh-list
138982825|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
138982826|NCT00944424|Cholecalciferol|cholecalciferol|mesh-list
138982827|NCT00944424|Vitamins|vitamins|mesh-list
138982828|NCT00944424|Docetaxel|docetaxel|mesh-list
138982829|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
138982830|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982831|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982832|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
138982833|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
138982834|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
138982835|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982836|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138982837|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138982838|NCT00944502|Dexamethasone|dexamethasone|mesh-list
138982839|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138982840|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
138982841|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
138982842|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982843|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982844|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138982845|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
138982846|NCT00944502|Hormones|hormones|mesh-ancestor
138982847|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138982848|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138982849|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982850|NCT00949962|Leuprolide|leuprolide|mesh-list
138982851|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
138982852|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138982853|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
138982854|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138982855|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982856|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138982857|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139008964|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139008965|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139008966|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008967|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759709|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139008968|NCT00826553|Midazolam|midazolam|mesh-list
139008969|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
139008970|NCT00826553|Lorazepam|lorazepam|mesh-list
139008971|NCT00826553|Propofol|propofol|mesh-list
139008972|NCT00826553|GABA Agonists|gaba agonists|mesh-list
139008973|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139008974|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139008975|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139008976|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139008977|NCT00826553|Analgesics|analgesics|mesh-ancestor
139008978|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
138522083|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138982858|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
138982859|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138982860|NCT00946374|Cyclosporine|cyclosporine|mesh-list
138982861|NCT00946374|Doxorubicin|doxorubicin|mesh-list
138982862|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138982863|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982864|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138982865|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138982866|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982867|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982868|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
138982869|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982870|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138982871|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982872|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
138982873|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138982874|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
138982875|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138982876|NCT00950196|Amantadine|amantadine|mesh-list
138982877|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138982878|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138982879|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
138982880|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138982881|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
138982882|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138982883|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982884|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982885|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138982886|NCT00950196|Analgesics|analgesics|mesh-ancestor
138982887|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
138982888|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982889|NCT01565109|Docetaxel|docetaxel|mesh-list
138982890|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982891|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
138982892|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
138982893|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
138982894|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982895|NCT00525915|Fluorouracil|fluorouracil|mesh-list
138982896|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
138982897|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
138982898|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982899|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139008979|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139008980|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139008981|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139008983|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
139008984|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008985|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139008986|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139008987|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
139008988|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
139008989|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139008990|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139008991|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139008992|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139008993|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
138982900|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982901|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982902|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
138982903|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982904|NCT00521001|Everolimus|everolimus|mesh-list
138982905|NCT00521001|Temozolomide|temozolomide|mesh-list
138982906|NCT00521001|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138982907|NCT00521001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982908|NCT00521001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982909|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982910|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982912|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982913|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982914|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138982915|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
138982916|NCT00134563|Teriflunomide|teriflunomide|mesh-list
138982917|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138982918|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138982919|NCT00134563|Analgesics|analgesics|mesh-ancestor
138982920|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
138982921|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982922|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982923|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138982924|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138982925|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138982926|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
138982927|NCT03966547|Anesthetics|anesthetics|mesh-list
138982928|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
138982929|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138982930|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982931|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
138982932|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982933|NCT01326325|Ketamine|ketamine|mesh-list
138982935|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
138982936|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982937|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982938|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138982939|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138982940|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
138982941|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
138982942|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138982943|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138982944|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138982945|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139008994|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
139008995|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
139008996|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
139008997|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
139008998|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139009000|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009001|NCT00626561|Paclitaxel|paclitaxel|mesh-list
139009002|NCT00626561|Bevacizumab|bevacizumab|mesh-list
139009003|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139009004|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009005|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
139009006|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
139009007|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
139009008|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009009|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138982946|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982947|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
138982948|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138982949|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138608140|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
138982950|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982951|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
138982952|NCT01326403|Coagulants|coagulants|mesh-ancestor
138982953|NCT00520845|Celecoxib|celecoxib|mesh-list
138982954|NCT00520845|Docetaxel|docetaxel|mesh-list
138982955|NCT00520845|Pemetrexed|pemetrexed|mesh-list
138982956|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982957|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
138982958|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
138982959|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
138982960|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982961|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982962|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138982963|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138982964|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138982965|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138982966|NCT00520845|Analgesics|analgesics|mesh-ancestor
138982967|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
138982968|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982969|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982970|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138982971|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138982972|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138982973|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138982974|NCT00185731|Atorvastatin|atorvastatin|mesh-list
138982975|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138982976|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138982977|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
138982978|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982979|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138982980|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138982981|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982982|NCT00582491|Modafinil|modafinil|mesh-list
138982983|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138982984|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982985|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138982986|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138982987|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138982988|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009010|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139009011|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139009012|NCT00626561|Growth Substances|growth substances|mesh-ancestor
139009013|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009014|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
139009016|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139009017|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139009018|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139009019|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
139009020|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009021|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009022|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009023|NCT00423891|Entecavir|entecavir|mesh-list
139009024|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
139009025|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009026|NCT00830609|Ribavirin|ribavirin|mesh-list
139009027|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139009028|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
139009029|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
139009030|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009031|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
139009032|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009033|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
139009034|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009035|NCT00822809|Prednisolone|prednisolone|mesh-list
139009036|NCT00822809|Catumaxomab|catumaxomab|mesh-list
139009037|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139009038|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
139009039|NCT00822809|Hormones|hormones|mesh-ancestor
139009041|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009057|NCT05733468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139009058|NCT05733468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009059|NCT05733468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139009061|NCT00830843|Isoflurane|isoflurane|mesh-list
139009062|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139009063|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139009064|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009065|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139009066|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
139009067|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
139009068|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139009069|NCT00826787|Levetiracetam|levetiracetam|mesh-list
139009070|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
139009071|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
139009072|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139009073|NCT00823121|Buserelin|buserelin|mesh-list
139009074|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139009075|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009076|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139009077|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
139009078|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139009079|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139009080|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009081|NCT00626405|Paclitaxel|paclitaxel|mesh-list
139009082|NCT00626405|Bevacizumab|bevacizumab|mesh-list
139009083|NCT00626405|Carboplatin|carboplatin|mesh-list
139009084|NCT00626405|Temozolomide|temozolomide|mesh-list
139009085|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139009086|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139009087|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138982989|NCT00520767|Dexamethasone|dexamethasone|mesh-list
138982990|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
138982991|NCT00520767|Bortezomib|bortezomib|mesh-list
138982992|NCT00520767|Melphalan|melphalan|mesh-list
138982993|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138982995|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138982996|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
138982997|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
138982998|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138982999|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983000|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138983001|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
138983002|NCT00520767|Hormones|hormones|mesh-ancestor
138983003|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983004|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138983005|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983006|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
139009088|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
139009089|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
139009090|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
139009091|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009092|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009093|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139009094|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139009095|NCT00626405|Growth Substances|growth substances|mesh-ancestor
139009096|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009097|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
139009098|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139009099|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
139009100|NCT00826865|Levetiracetam|levetiracetam|mesh-list
139009101|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
139009102|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
139009103|NCT00358150|Eliglustat|eliglustat|mesh-list
139009104|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009105|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009106|NCT05427630|Dronabinol|dronabinol|mesh-list
139009107|NCT05427630|Hallucinogens|hallucinogens|mesh-ancestor
139009108|NCT05427630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009111|NCT05427630|Analgesics|analgesics|mesh-ancestor
139009141|NCT05889442|Autonomic Agents|autonomic agents|mesh-ancestor
139009142|NCT05889442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139009143|NCT05889442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009144|NCT05889442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139009145|NCT05889442|Respiratory System Agents|respiratory system agents|mesh-ancestor
139009146|NCT05889442|Parasympatholytics|parasympatholytics|mesh-ancestor
139009147|NCT05889442|Vasodilator Agents|vasodilator agents|mesh-ancestor
139009148|NCT05889390|Paclitaxel|paclitaxel|mesh-list
139009149|NCT05889390|Cyclophosphamide|cyclophosphamide|mesh-list
139009150|NCT05889390|Carboplatin|carboplatin|mesh-list
139009151|NCT05889390|Doxorubicin|doxorubicin|mesh-list
139009152|NCT05889390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139009153|NCT05889390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009154|NCT05889390|Tubulin Modulators|tubulin modulators|mesh-ancestor
139009155|NCT05889390|Antimitotic Agents|antimitotic agents|mesh-ancestor
139009156|NCT05889390|Mitosis Modulators|mitosis modulators|mesh-ancestor
139009157|NCT05889390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009158|NCT05889390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139009159|NCT05889390|Immunologic Factors|immunologic factors|mesh-ancestor
139009160|NCT05889390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009196|NCT05889143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009197|NCT05889052|Pyrimethamine|pyrimethamine|mesh-list
138759924|NCT02755753|Lansoprazole|lansoprazole|mesh-list
139009198|NCT05889052|Sulfadoxine|sulfadoxine|mesh-list
139009199|NCT05889052|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139009200|NCT05889052|Antimalarials|antimalarials|mesh-ancestor
139009201|NCT05889052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139009202|NCT05889052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139009203|NCT05889052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009204|NCT05889052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139009205|NCT05889052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009206|NCT05889052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009207|NCT05889052|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139009208|NCT05889026|Botulinum Toxins|botulinum toxins|mesh-list
139009209|NCT05889026|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139009210|NCT05889026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139009211|NCT05889026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009212|NCT05889026|Cholinergic Agents|cholinergic agents|mesh-ancestor
139009213|NCT05889026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009214|NCT05889026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009215|NCT05888922|Minoxidil|minoxidil|mesh-list
139009216|NCT05888922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139009217|NCT05888922|Vasodilator Agents|vasodilator agents|mesh-ancestor
139009218|NCT05887947|Nicotine|nicotine|mesh-list
139009219|NCT05887947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139009220|NCT05887947|Autonomic Agents|autonomic agents|mesh-ancestor
139009221|NCT05887947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139009222|NCT05887947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009223|NCT05887947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139009224|NCT05887947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139009225|NCT05887947|Cholinergic Agents|cholinergic agents|mesh-ancestor
139009226|NCT05887947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009227|NCT05887947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009228|NCT05887908|Imipenem|imipenem|mesh-list
139009229|NCT05887908|Cefepime|cefepime|mesh-list
139009230|NCT05887908|Aztreonam|aztreonam|mesh-list
139009231|NCT05887908|Cilastatin|cilastatin|mesh-list
139009235|NCT05887908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009236|NCT05887908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009237|NCT05887778|Dexamethasone|dexamethasone|mesh-list
139009238|NCT05887778|Dexamethasone acetate|dexamethasone acetate|mesh-list
139009239|NCT05887778|BB 1101|bb 1101|mesh-list
139009240|NCT05887778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139009241|NCT05887778|Antiemetics|antiemetics|mesh-ancestor
139009242|NCT05887778|Autonomic Agents|autonomic agents|mesh-ancestor
139009243|NCT05887778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139009244|NCT05887778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009245|NCT05887778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139009246|NCT05887778|Glucocorticoids|glucocorticoids|mesh-ancestor
139009247|NCT05887778|Hormones|hormones|mesh-ancestor
139009248|NCT05887778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139009249|NCT05887778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139009250|NCT05887778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009251|NCT05887778|Protease Inhibitors|protease inhibitors|mesh-ancestor
139009252|NCT05887778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009253|NCT05887778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009254|NCT05881382|Lenograstim|lenograstim|mesh-list
139009255|NCT05881382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139009256|NCT05881382|Immunologic Factors|immunologic factors|mesh-ancestor
139009257|NCT05881382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009258|NCT05843708|Ciprofloxacin|ciprofloxacin|mesh-list
139009259|NCT05843708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138983007|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983008|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983009|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138983010|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
138983011|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138983012|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138983013|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
138983014|NCT03873987|Oritavancin|oritavancin|mesh-list
138983015|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138983016|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983017|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138983018|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
138983019|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138983020|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
138983021|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983022|NCT00528645|Saracatinib|saracatinib|mesh-list
138983023|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983024|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983025|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983026|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
138983027|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
138983028|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138983029|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
138983030|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983032|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
138983033|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139009260|NCT05843708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009261|NCT05843708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139009262|NCT05843708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139009263|NCT05843708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009264|NCT05843708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009265|NCT05843708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009266|NCT05843708|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139009267|NCT05843708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139009268|NCT05743946|Ivacaftor|ivacaftor|mesh-list
139009269|NCT05743946|Elexacaftor|elexacaftor|mesh-list
139009270|NCT05743946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139009271|NCT05743946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139009272|NCT05743946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009273|NCT05742789|Propofol|propofol|mesh-list
139009274|NCT05742789|Sevoflurane|sevoflurane|mesh-list
139009275|NCT05742789|Isoflurane|isoflurane|mesh-list
139009276|NCT05742789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139009277|NCT05742789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139009278|NCT05742789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009279|NCT05742789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139009280|NCT05742789|Anesthetics, General|anesthetics, general|mesh-ancestor
139009281|NCT05742789|Anesthetics|anesthetics|mesh-ancestor
139009282|NCT05742789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139009283|NCT05742789|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139009284|NCT05721846|Nivolumab|nivolumab|mesh-list
139009285|NCT05721846|Ipilimumab|ipilimumab|mesh-list
139009286|NCT05721846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009287|NCT05721846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009288|NCT05721846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139009289|NCT05721846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009290|NCT05597085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139009291|NCT05597085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009292|NCT05597085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009294|NCT05597085|Immunotoxins|immunotoxins|mesh-ancestor
139009301|NCT05465135|Antimalarials|antimalarials|mesh-ancestor
139009302|NCT05465135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139009303|NCT05465135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139009304|NCT05465135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009305|NCT05425732|Vaccines|vaccines|mesh-list
139009306|NCT05425732|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139009307|NCT05425732|Immunologic Factors|immunologic factors|mesh-ancestor
139009308|NCT05425732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009309|NCT05389514|Cyclophosphamide|cyclophosphamide|mesh-list
139009310|NCT05389514|Gemcitabine|gemcitabine|mesh-list
139009311|NCT05389514|Pembrolizumab|pembrolizumab|mesh-list
139009312|NCT05389514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139009313|NCT05389514|Immunologic Factors|immunologic factors|mesh-ancestor
139009314|NCT05389514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009315|NCT05389514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139009316|NCT05389514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139009317|NCT05389514|Alkylating Agents|alkylating agents|mesh-ancestor
139009318|NCT05389514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009319|NCT05389514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009320|NCT05389514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139009321|NCT05389514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139009322|NCT05389514|Antimetabolites|antimetabolites|mesh-ancestor
139009323|NCT05389514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009324|NCT05389514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139009325|NCT05327777|Oxycodone|oxycodone|mesh-list
139009326|NCT05327777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139009327|NCT05327777|Narcotics|narcotics|mesh-ancestor
139009328|NCT05327777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938973|NCT03786237|ON 01910|on 01910|mesh-list
139009329|NCT05327777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009330|NCT05327777|Analgesics|analgesics|mesh-ancestor
139009331|NCT05327777|Sensory System Agents|sensory system agents|mesh-ancestor
139009332|NCT05327777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983034|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
138983035|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983036|NCT01017796|Protective Agents|protective agents|mesh-ancestor
138983037|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983038|NCT01017796|Antidotes|antidotes|mesh-ancestor
138983039|NCT01017796|Vitamins|vitamins|mesh-ancestor
138983040|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
138983041|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
138983042|NCT01783535|Carboplatin|carboplatin|mesh-list
138983043|NCT01783535|Doxorubicin|doxorubicin|mesh-list
138983044|NCT01783535|Etoposide|etoposide|mesh-list
138983045|NCT01783535|Vincristine|vincristine|mesh-list
138983046|NCT01783535|Topotecan|topotecan|mesh-list
138983047|NCT01783535|Lenograstim|lenograstim|mesh-list
139009333|NCT05304546|Pembrolizumab|pembrolizumab|mesh-list
139009334|NCT05304546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009335|NCT05304546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009336|NCT05304546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139009337|NCT05304546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009338|NCT05234099|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139009339|NCT05234099|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139009340|NCT05234099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009341|NCT05180773|Bromocriptine|bromocriptine|mesh-list
139009342|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
139009343|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139009344|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
139009345|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139009346|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
139009347|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009348|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009350|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138522541|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138983048|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138983049|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
138983050|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983051|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138983052|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138983053|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
138983054|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983055|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983056|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138983057|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138983058|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138983059|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138983060|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983061|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138983062|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138983063|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
138983064|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
138983065|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
138983066|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138983067|NCT04073537|Paclitaxel|paclitaxel|mesh-list
138983068|NCT04073537|Carboplatin|carboplatin|mesh-list
138983069|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138983070|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983071|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
138983072|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
138983073|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
138983074|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983075|NCT01020994|Octenidine|octenidine|mesh-list
138983076|NCT01020994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983077|NCT01020994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138983078|NCT00494026|Carboplatin|carboplatin|mesh-list
138983079|NCT00494026|Pemetrexed|pemetrexed|mesh-list
138983080|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983081|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983082|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983083|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138983084|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138983085|NCT00524589|Calcitriol|calcitriol|mesh-list
139009351|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139009352|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
139009353|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139009354|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009355|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
139009356|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
139009357|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009358|NCT04957758|Varenicline|varenicline|mesh-list
139009359|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139009360|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139009361|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
139009362|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009363|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009364|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009365|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
139009366|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009367|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009368|NCT04920383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139009369|NCT04920383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522599|NCT04771520|Mebendazole|mebendazole|mesh-list
138983086|NCT00524589|Dexamethasone|dexamethasone|mesh-list
138983087|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138983088|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
138983089|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
138983090|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983091|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983092|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138983093|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
138983095|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983096|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138983097|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983098|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138983099|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138983100|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138983101|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983102|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138983103|NCT00524589|Vitamins|vitamins|mesh-ancestor
138983104|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
138983105|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138983106|NCT01015066|Naltrexone|naltrexone|mesh-list
138983107|NCT01015066|Buprenorphine|buprenorphine|mesh-list
138983108|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138983109|NCT01015066|Naloxone|naloxone|mesh-list
138983110|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138983111|NCT01015066|Narcotics|narcotics|mesh-ancestor
138983112|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983113|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983114|NCT01015066|Analgesics|analgesics|mesh-ancestor
138983115|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
138983116|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983117|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138983118|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138983119|NCT00472030|Omalizumab|omalizumab|mesh-list
139009370|NCT04827134|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
139009371|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139009372|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139009373|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
139009374|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009376|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139009377|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009378|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139009379|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009380|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
139009381|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139009382|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
139009383|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009384|NCT04725617|Varenicline|varenicline|mesh-list
139009385|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139009386|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139009387|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
139009388|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009389|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009390|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009391|NCT04702737|AMG 757|amg 757|mesh-list
139009392|NCT04702737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009407|NCT04602533|Durvalumab|durvalumab|mesh-list
139009423|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
139009424|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009425|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139009426|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139009427|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009428|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139009429|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
139009430|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009431|NCT04502706|Rituximab|rituximab|mesh-list
139009432|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009433|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009434|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
139009435|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009436|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139009437|NCT04486833|Cisplatin|cisplatin|mesh-list
139009438|NCT04486833|Carboplatin|carboplatin|mesh-list
139009439|NCT04486833|Osimertinib|osimertinib|mesh-list
139009440|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009441|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139009442|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009443|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009444|NCT04468776|Zolpidem|zolpidem|mesh-list
138983120|NCT00472030|Prednisone|prednisone|mesh-list
138983121|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138983122|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
138983123|NCT00472030|Hormones|hormones|mesh-ancestor
138983124|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983125|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983126|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138983127|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983128|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138983129|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138983130|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
138983131|NCT00127855|Vaccines|vaccines|mesh-list
138983132|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138983133|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
138983134|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983135|NCT00493636|Gemcitabine|gemcitabine|mesh-list
138983136|NCT00493636|Capecitabine|capecitabine|mesh-list
138983137|NCT00493636|Sorafenib|sorafenib|mesh-list
138983138|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138608337|NCT04675177|Polidocanol|polidocanol|mesh-list
138983139|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
138983140|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983141|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983142|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138983143|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983144|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138983145|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983146|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138983147|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983148|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983150|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139009446|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139009447|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139009448|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139009449|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009450|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139009451|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
139009452|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
139009453|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009454|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009455|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139009456|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139009457|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139009458|NCT04468776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139009459|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139009460|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139009461|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
139009462|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139009463|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
139009464|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
139009465|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
139009466|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009467|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009468|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009469|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139009470|NCT04416269|Insulin|insulin|mesh-list
139009471|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138983151|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983152|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138983153|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
138983154|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138983155|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138983156|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983157|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
138983158|NCT03965767|Coagulants|coagulants|mesh-ancestor
138983159|NCT00132769|MK 0873|mk 0873|mesh-list
138734007|NCT01608347|Folic Acid|folic acid|mesh-list
138983160|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138983161|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138983162|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983163|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983165|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138983166|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
138983167|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
138983168|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983169|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009472|NCT04416269|Metformin|metformin|mesh-list
139009473|NCT04416269|Pioglitazone|pioglitazone|mesh-list
139009474|NCT04416269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139009475|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139009476|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009477|NCT04416269|Protease Inhibitors|protease inhibitors|mesh-ancestor
139009478|NCT04416269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009479|NCT04416269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009480|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
139009481|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139009482|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
139009483|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009484|NCT04374461|Expectorants|expectorants|mesh-ancestor
139009485|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
139009486|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139009487|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
139009488|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009489|NCT04374461|Protective Agents|protective agents|mesh-ancestor
139009490|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009491|NCT04374461|Antidotes|antidotes|mesh-ancestor
139009492|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
139009493|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139009494|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139009495|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009496|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
139009497|NCT04344860|Coagulants|coagulants|mesh-ancestor
139009498|NCT04333420|Vilobelimab|vilobelimab|mesh-list
139009499|NCT04333420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139009500|NCT04333420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139009501|NCT04333420|Immunologic Factors|immunologic factors|mesh-ancestor
139009502|NCT04333420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009503|NCT04247165|Paclitaxel|paclitaxel|mesh-list
139009504|NCT04247165|Gemcitabine|gemcitabine|mesh-list
139009505|NCT04247165|Nivolumab|nivolumab|mesh-list
139009506|NCT04247165|Ipilimumab|ipilimumab|mesh-list
139009507|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139009508|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009509|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
139009510|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
138983170|NCT00132691|Cyclosporine|cyclosporine|mesh-list
139009511|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
139009512|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009513|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139009514|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
139009515|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009516|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139009517|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
139009518|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139009519|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009520|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139009521|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009522|NCT04219280|Methylphenidate|methylphenidate|mesh-list
139009523|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139009524|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009525|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139009526|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139009527|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139009528|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009529|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
139009530|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009531|NCT04177693|Letrozole|letrozole|mesh-list
139009532|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139009533|NCT04177693|Clomiphene|clomiphene|mesh-list
139009534|NCT04177693|Enclomiphene|enclomiphene|mesh-list
139009535|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
139009536|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983171|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
138983172|NCT00132691|Infliximab|infliximab|mesh-list
138983173|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138983174|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
138983175|NCT00132691|Chlorambucil|chlorambucil|mesh-list
138983176|NCT00132691|Methotrexate|methotrexate|mesh-list
138983177|NCT00132691|Azathioprine|azathioprine|mesh-list
138983178|NCT00132691|Tacrolimus|tacrolimus|mesh-list
138983179|NCT00132691|Cyclosporins|cyclosporins|mesh-list
138983180|NCT00132691|Daclizumab|daclizumab|mesh-list
138983181|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138983182|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
138983183|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
138983184|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983185|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138983186|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138983187|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983188|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983189|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138983190|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138983191|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
139009537|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009538|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139009539|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139009540|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009541|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139009542|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
139009543|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139009544|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009545|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139009546|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
139009547|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139009548|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139009549|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139009550|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
139009551|NCT04177693|Protective Agents|protective agents|mesh-ancestor
139009552|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139009553|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139009554|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139009555|NCT04118387|Acetazolamide|acetazolamide|mesh-list
139009556|NCT04118387|Zolpidem|zolpidem|mesh-list
138983192|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138983193|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138983194|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
138983195|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
138983196|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983197|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138983198|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138983199|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138983200|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
138983201|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983202|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138983203|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138983204|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
138983205|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138983206|NCT00132691|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138983207|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138983208|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138983209|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
138983210|NCT00132691|Hormones|hormones|mesh-ancestor
138983211|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983212|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138983213|NCT00125359|Bexarotene|bexarotene|mesh-list
138983214|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983215|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138983216|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983217|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983218|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138983219|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138983220|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138983221|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983222|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983223|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138983224|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138983225|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139009557|NCT04118387|Buspirone|buspirone|mesh-list
139009558|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
139009559|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139009560|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009561|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009562|NCT04118387|Diuretics|diuretics|mesh-ancestor
139009563|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
139009564|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009565|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139009566|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139009567|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139009568|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139009569|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
139009570|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
139009571|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009572|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139009573|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139009574|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139009575|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139009576|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
139009577|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
139009578|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138983226|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
138983227|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138983228|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983229|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138983230|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138983231|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
138983232|NCT01076803|Lanreotide|lanreotide|mesh-list
138983233|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983234|NCT00523419|Pemetrexed|pemetrexed|mesh-list
138983235|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983236|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983237|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983238|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138983239|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138983240|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
138983241|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138983243|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
138983244|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
138983245|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138983246|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983247|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
138983248|NCT03868059|Hormones|hormones|mesh-ancestor
138983249|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983250|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983251|NCT03868059|Androgens|androgens|mesh-ancestor
138983252|NCT04028115|Ixazomib|ixazomib|mesh-list
138983253|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983254|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
138983255|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983256|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983257|NCT06027970|Terlipressin|terlipressin|mesh-list
138983258|NCT06027970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139009579|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009580|NCT04105335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139009581|NCT04105335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009582|NCT04072952|Palbociclib|palbociclib|mesh-list
139009583|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009584|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139009585|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009586|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009587|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
139009588|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009589|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009590|NCT04032418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139009591|NCT04032418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009592|NCT04006522|Atezolizumab|atezolizumab|mesh-list
139009593|NCT04006522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139009594|NCT04006522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009595|NCT04006522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009596|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009597|NCT03922048|Bupivacaine|bupivacaine|mesh-list
139009598|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
139009599|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
139009600|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139009601|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009602|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
139009603|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139009605|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139009606|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139009607|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009608|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009609|NCT03866174|Niacin|niacin|mesh-list
138983259|NCT06027970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138983260|NCT06027151|Metronidazole|metronidazole|mesh-list
138983261|NCT06027151|Minocycline|minocycline|mesh-list
138983262|NCT06027151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983263|NCT06027151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138983264|NCT06027151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138983265|NCT06027151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138983266|NCT06027086|Durvalumab|durvalumab|mesh-list
138983267|NCT06027086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138983268|NCT06027086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983269|NCT06027073|Omalizumab|omalizumab|mesh-list
138983270|NCT06027073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139009610|NCT03866174|Psilocybin|psilocybin|mesh-list
139009611|NCT03866174|Vitamins|vitamins|mesh-ancestor
139009612|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
139009613|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009614|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
139009615|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139009616|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
139009617|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009618|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139009619|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
139009620|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
139009621|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139009622|NCT03859869|Pancrelipase|pancrelipase|mesh-list
139009623|NCT03859869|Pancreatin|pancreatin|mesh-list
139009624|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139009625|NCT03764098|Guanfacine|guanfacine|mesh-list
139009626|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139009627|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139009628|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139009629|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139009630|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
139009631|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009632|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009633|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009634|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139009635|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139009636|NCT03740204|Estradiol|estradiol|mesh-list
139009637|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139009638|NCT03740204|Progesterone|progesterone|mesh-list
138983271|NCT06027073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138983272|NCT06027073|Respiratory System Agents|respiratory system agents|mesh-ancestor
138983273|NCT06026878|Gemcitabine|gemcitabine|mesh-list
138983274|NCT06026878|Nimotuzumab|nimotuzumab|mesh-list
138983275|NCT06026878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983276|NCT06026878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138983277|NCT06026878|Antimetabolites|antimetabolites|mesh-ancestor
138983278|NCT06026878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983279|NCT06026878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138983280|NCT06026787|Dapagliflozin|dapagliflozin|mesh-list
138983281|NCT06026787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138983282|NCT06026787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983283|NCT06026787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138983284|NCT06026787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983285|NCT06026553|Ketorolac|ketorolac|mesh-list
138983286|NCT06026553|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138983287|NCT06026553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138983288|NCT06026553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138983289|NCT06026553|Analgesics|analgesics|mesh-ancestor
139009639|NCT03740204|Estrogens|estrogens|mesh-ancestor
139009640|NCT03740204|Hormones|hormones|mesh-ancestor
139009641|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139009642|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009643|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139009644|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
139009645|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139009646|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138760345|NCT01183104|Incretins|incretins|mesh-ancestor
139009647|NCT03740204|Progestins|progestins|mesh-ancestor
139009648|NCT03735563|Fentanyl|fentanyl|mesh-list
139009649|NCT03735563|Ketamine|ketamine|mesh-list
139009650|NCT03735563|Analgesics|analgesics|mesh-ancestor
139009651|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
139009652|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139009653|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009654|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139009655|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139009656|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
139009657|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
139009658|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139009659|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138983290|NCT06026553|Sensory System Agents|sensory system agents|mesh-ancestor
138983291|NCT06026553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983292|NCT06026553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983293|NCT06026553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138983294|NCT06026553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138983295|NCT06026553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138983296|NCT06026553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983297|NCT06026553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983298|NCT06026527|Magnesium Sulfate|magnesium sulfate|mesh-list
138983299|NCT06026527|Analgesics|analgesics|mesh-ancestor
138983300|NCT06026527|Sensory System Agents|sensory system agents|mesh-ancestor
138983301|NCT06026527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983302|NCT06026527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983303|NCT06026527|Anesthetics|anesthetics|mesh-ancestor
138983304|NCT06026527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983305|NCT06026527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138983306|NCT06026527|Anticonvulsants|anticonvulsants|mesh-ancestor
138983307|NCT06026527|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138983308|NCT06026527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138983309|NCT06026527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983310|NCT06026527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138983311|NCT06026527|Tocolytic Agents|tocolytic agents|mesh-ancestor
138983312|NCT06026527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138983313|NCT06022068|Sirolimus|sirolimus|mesh-list
138983314|NCT06022068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138983315|NCT06022068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983316|NCT06022068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138983317|NCT06022068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983318|NCT06022068|Antifungal Agents|antifungal agents|mesh-ancestor
138983319|NCT06022068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138983320|NCT06022068|Immunologic Factors|immunologic factors|mesh-ancestor
139009660|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139009661|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009662|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009663|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139009665|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139009666|NCT03715153|Bumetanide|bumetanide|mesh-list
139009667|NCT03715153|Diuretics|diuretics|mesh-ancestor
139009668|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
139009669|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983321|NCT06022068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983322|NCT05997199|Vitamin D|vitamin d|mesh-list
138983323|NCT05997199|Vitamins|vitamins|mesh-ancestor
138983324|NCT05997199|Micronutrients|micronutrients|mesh-ancestor
138983325|NCT05997199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983326|NCT05997199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138983327|NCT05980702|Paclitaxel|paclitaxel|mesh-list
138983328|NCT05980702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138983329|NCT05980702|Carboplatin|carboplatin|mesh-list
138983330|NCT05980702|Pembrolizumab|pembrolizumab|mesh-list
138983331|NCT05980702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138983332|NCT05980702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983333|NCT05980702|Tubulin Modulators|tubulin modulators|mesh-ancestor
138983334|NCT05980702|Antimitotic Agents|antimitotic agents|mesh-ancestor
138983335|NCT05980702|Mitosis Modulators|mitosis modulators|mesh-ancestor
138983336|NCT05980702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983337|NCT05980702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138983338|NCT05980702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138983339|NCT05974748|Propolis|propolis|mesh-list
138983340|NCT05974748|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138983341|NCT05974748|Eusol|eusol|mesh-list
138983342|NCT05974748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983343|NCT05974748|Disinfectants|disinfectants|mesh-ancestor
138983344|NCT05959850|Ambroxol|ambroxol|mesh-list
138983345|NCT05959850|Expectorants|expectorants|mesh-ancestor
138983346|NCT05959850|Respiratory System Agents|respiratory system agents|mesh-ancestor
138983347|NCT05955768|Lidocaine|lidocaine|mesh-list
138983348|NCT05955768|Anesthetics, Local|anesthetics, local|mesh-ancestor
138983349|NCT05955768|Anesthetics|anesthetics|mesh-ancestor
138983350|NCT05955768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983351|NCT05955768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983352|NCT05955768|Sensory System Agents|sensory system agents|mesh-ancestor
138983353|NCT05955768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983354|NCT05955768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138983355|NCT05955768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138983356|NCT05955768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138983357|NCT05955768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138983358|NCT05955768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983359|NCT05938699|Bimatoprost|bimatoprost|mesh-list
138983360|NCT05938699|Nitric Oxide|nitric oxide|mesh-list
138983361|NCT05938699|Lubricant Eye Drops|lubricant eye drops|mesh-list
138983362|NCT05938699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138983363|NCT05938699|Autonomic Agents|autonomic agents|mesh-ancestor
138983364|NCT05938699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983365|NCT05938699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983366|NCT05938699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138608491|NCT00204438|Progestins|progestins|mesh-ancestor
138983367|NCT05938699|Respiratory System Agents|respiratory system agents|mesh-ancestor
138983368|NCT05938699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138983369|NCT05938699|Antioxidants|antioxidants|mesh-ancestor
138983370|NCT05938699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983371|NCT05938699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138983372|NCT05938699|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138983373|NCT05938699|Vasodilator Agents|vasodilator agents|mesh-ancestor
138983374|NCT05938699|Gasotransmitters|gasotransmitters|mesh-ancestor
138983375|NCT05938699|Protective Agents|protective agents|mesh-ancestor
138983376|NCT05938699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139009670|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139009671|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139009672|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009674|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
139009675|NCT03685773|Niacinamide|niacinamide|mesh-list
139009676|NCT03685773|Diazoxide|diazoxide|mesh-list
139009677|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139009678|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
139009679|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009680|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139009681|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
139009682|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
139009683|NCT03685773|Vitamins|vitamins|mesh-ancestor
139009684|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
139009685|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009686|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139009687|NCT03683277|Dexamethasone|dexamethasone|mesh-list
139009688|NCT03683277|Pomalidomide|pomalidomide|mesh-list
139009689|NCT03683277|Ixazomib|ixazomib|mesh-list
139009690|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139009691|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
139009692|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
139009693|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139009694|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009695|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139009696|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
139009697|NCT03683277|Hormones|hormones|mesh-ancestor
139009698|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139009699|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139009700|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009701|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
139009702|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139009703|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139009704|NCT03683277|Growth Substances|growth substances|mesh-ancestor
139009705|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
139009706|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
139009707|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983377|NCT05938699|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138983378|NCT05938699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138983379|NCT05843838|Bupivacaine|bupivacaine|mesh-list
139009708|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009709|NCT03665207|Insulin|insulin|mesh-list
139009710|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139009711|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009712|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
139009713|NCT03660683|Saxagliptin|saxagliptin|mesh-list
139009714|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139009715|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009716|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139009717|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009718|NCT03660683|Incretins|incretins|mesh-ancestor
139009719|NCT03660683|Hormones|hormones|mesh-ancestor
138760417|NCT01227668|Aripiprazole|aripiprazole|mesh-list
139009720|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139009721|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139009722|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
139009723|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009724|NCT03569293|Upadacitinib|upadacitinib|mesh-list
139009725|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139009726|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139009727|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009728|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009729|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139009730|NCT03566511|Diazoxide|diazoxide|mesh-list
139009731|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139009732|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
139009733|NCT03464136|Adalimumab|adalimumab|mesh-list
139009734|NCT03464136|Ustekinumab|ustekinumab|mesh-list
139009735|NCT03464136|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139009736|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139009737|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139009738|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
139009739|NCT03397706|Valganciclovir|valganciclovir|mesh-list
138983380|NCT05843838|Anesthetics|anesthetics|mesh-list
138983381|NCT05843838|Anesthetics, Local|anesthetics, local|mesh-ancestor
138983382|NCT05843838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983383|NCT05843838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983384|NCT05843838|Sensory System Agents|sensory system agents|mesh-ancestor
138983385|NCT05843838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983386|NCT05828095|MEDI9197|medi9197|mesh-list
138983387|NCT05828095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138983388|NCT05828095|Immunologic Factors|immunologic factors|mesh-ancestor
138983389|NCT05828095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009741|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009742|NCT03382587|Aflibercept|aflibercept|mesh-list
139009743|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139009744|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139009745|NCT03382587|Growth Substances|growth substances|mesh-ancestor
139009746|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009747|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
139009748|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009749|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
139009750|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138983390|NCT05816356|Decitabine|decitabine|mesh-list
138983391|NCT05816356|Tetrahydrouridine|tetrahydrouridine|mesh-list
138983392|NCT05816356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138983393|NCT05816356|Antimetabolites|antimetabolites|mesh-ancestor
138983394|NCT05816356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983395|NCT05816356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983396|NCT05816356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983397|NCT05801757|Propofol|propofol|mesh-list
138983398|NCT05801757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138983399|NCT05801757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983400|NCT05801757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983401|NCT05801757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138983402|NCT05801757|Anesthetics, General|anesthetics, general|mesh-ancestor
138983403|NCT05801757|Anesthetics|anesthetics|mesh-ancestor
138983404|NCT05799755|Nintedanib|nintedanib|mesh-list
138983405|NCT05799755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983406|NCT05799755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138983408|NCT05799755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983409|NCT05796089|Carboplatin|carboplatin|mesh-list
138983410|NCT05796089|Etoposide|etoposide|mesh-list
138983411|NCT05796089|Etoposide phosphate|etoposide phosphate|mesh-list
138983412|NCT05796089|Durvalumab|durvalumab|mesh-list
138983413|NCT05796089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983414|NCT05796089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138983415|NCT05796089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138983416|NCT05796089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138983417|NCT05796089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983418|NCT05796089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983419|NCT05796089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138983420|NCT05774366|Desflurane|desflurane|mesh-list
138983421|NCT05774366|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138983422|NCT05774366|Anesthetics, General|anesthetics, general|mesh-ancestor
138983423|NCT05774366|Anesthetics|anesthetics|mesh-ancestor
138983424|NCT05774366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983425|NCT05774366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983426|NCT05759156|Tranexamic Acid|tranexamic acid|mesh-list
138983427|NCT05759156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138983428|NCT05759156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138983429|NCT05759156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983430|NCT05759156|Hemostatics|hemostatics|mesh-ancestor
138983431|NCT05759156|Coagulants|coagulants|mesh-ancestor
138983432|NCT05692167|Dexmedetomidine|dexmedetomidine|mesh-list
138983433|NCT05692167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138983434|NCT05692167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983435|NCT05692167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983436|NCT05692167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138983437|NCT05692167|Analgesics|analgesics|mesh-ancestor
138983438|NCT05692167|Sensory System Agents|sensory system agents|mesh-ancestor
138983439|NCT05692167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983440|NCT05692167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138983441|NCT05692167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138983442|NCT05692167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138983443|NCT05692167|Adrenergic Agents|adrenergic agents|mesh-ancestor
138983444|NCT05692167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009751|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139009752|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009753|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139009754|NCT03325972|Analgesics|analgesics|mesh-ancestor
139009755|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
139009756|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139009757|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139009758|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139009759|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139009760|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
139009761|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009762|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009763|NCT03247712|Nivolumab|nivolumab|mesh-list
139009764|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139009765|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009766|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139009767|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009768|NCT03048825|Colchicine|colchicine|mesh-list
139009769|NCT03048825|Spironolactone|spironolactone|mesh-list
139009770|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
139009771|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139009772|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
139009773|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
139009774|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
139009775|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983445|NCT05692167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983446|NCT05669846|Pembrolizumab|pembrolizumab|mesh-list
138983447|NCT05669846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138983448|NCT05669846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983449|NCT05669846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138983450|NCT05669846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983451|NCT05650775|Methylphenidate|methylphenidate|mesh-list
138983452|NCT05650775|Adderall|adderall|mesh-list
138983453|NCT05650775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138983454|NCT05650775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983455|NCT05650775|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138983456|NCT05650775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138608550|NCT04679506|Cytarabine|cytarabine|mesh-list
138983457|NCT05650775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138983458|NCT05650775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983459|NCT05650775|Dopamine Agents|dopamine agents|mesh-ancestor
138734320|NCT00594087|Eszopiclone|eszopiclone|mesh-list
138983460|NCT05650775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138983461|NCT05630222|Acetaminophen|acetaminophen|mesh-list
138983462|NCT05630222|Ibuprofen|ibuprofen|mesh-list
138983463|NCT05630222|Morphine|morphine|mesh-list
138983464|NCT05630222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138983465|NCT05630222|Narcotics|narcotics|mesh-ancestor
139009776|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009777|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139009778|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
139009779|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139009780|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009781|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139009782|NCT03048825|Diuretics|diuretics|mesh-ancestor
139009783|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
139009785|NCT03039413|Trace Elements|trace elements|mesh-ancestor
139009786|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
139009787|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009788|NCT03026790|Buprenorphine|buprenorphine|mesh-list
139009789|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139009790|NCT03026790|Naloxone|naloxone|mesh-list
139009791|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139009792|NCT03026790|Narcotics|narcotics|mesh-ancestor
139009793|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139009794|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009795|NCT03026790|Analgesics|analgesics|mesh-ancestor
139009796|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
139009797|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139009798|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139009799|NCT02735707|Aspirin|aspirin|mesh-list
139009800|NCT02735707|Vitamins|vitamins|mesh-list
138939178|NCT03215030|Hormones|hormones|mesh-ancestor
139009801|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
139009802|NCT02735707|Interferons|interferons|mesh-list
139009803|NCT02735707|Ritonavir|ritonavir|mesh-list
139009804|NCT02735707|Lopinavir|lopinavir|mesh-list
139009805|NCT02735707|Interferon-beta|interferon-beta|mesh-list
138983466|NCT05630222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983467|NCT05630222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983468|NCT05630222|Analgesics|analgesics|mesh-ancestor
138983469|NCT05630222|Sensory System Agents|sensory system agents|mesh-ancestor
138983470|NCT05630222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983471|NCT05630222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138983472|NCT05630222|Antipyretics|antipyretics|mesh-ancestor
138983473|NCT05630222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138983474|NCT05630222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138983475|NCT05630222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138983476|NCT05630222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138983477|NCT05630222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983478|NCT05630222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983479|NCT05618730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138983480|NCT05618730|Lubricant Eye Drops|lubricant eye drops|mesh-list
138983481|NCT05618730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138983482|NCT05598619|Ascorbic Acid|ascorbic acid|mesh-list
138983483|NCT05598619|Vitamins|vitamins|mesh-ancestor
138983484|NCT05598619|Micronutrients|micronutrients|mesh-ancestor
139009806|NCT02735707|Oseltamivir|oseltamivir|mesh-list
139009807|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
139009808|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
139009809|NCT02735707|Baloxavir|baloxavir|mesh-list
139009810|NCT02735707|Amoxicillin|amoxicillin|mesh-list
139009811|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
139009812|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
139009813|NCT02735707|Levofloxacin|levofloxacin|mesh-list
139009814|NCT02735707|Ivermectin|ivermectin|mesh-list
139009815|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
139009816|NCT02735707|Tazobactam|tazobactam|mesh-list
139009817|NCT02735707|Piperacillin|piperacillin|mesh-list
139009818|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
139009819|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139009820|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139009821|NCT02735707|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139009822|NCT02735707|Dexamethasone|dexamethasone|mesh-list
139009823|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
138983485|NCT05598619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983486|NCT05598619|Antioxidants|antioxidants|mesh-ancestor
138983487|NCT05598619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983488|NCT05598619|Protective Agents|protective agents|mesh-ancestor
138983489|NCT05546554|Suvorexant|suvorexant|mesh-list
138983490|NCT05546554|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138983491|NCT05546554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138983492|NCT05546554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983493|NCT05546554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983494|NCT05546554|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138983495|NCT05546554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138983496|NCT05546554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983497|NCT05540574|Zolpidem|zolpidem|mesh-list
138983498|NCT05540574|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138983499|NCT05540574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138983500|NCT05540574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983501|NCT05540574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983502|NCT05540574|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138983503|NCT05540574|GABA Agonists|gaba agonists|mesh-ancestor
138983504|NCT05540574|GABA Agents|gaba agents|mesh-ancestor
138983505|NCT05540574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138983506|NCT05540574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983507|NCT05523986|Vitamin D|vitamin d|mesh-list
138983508|NCT05523986|Vitamins|vitamins|mesh-ancestor
138983509|NCT05523986|Micronutrients|micronutrients|mesh-ancestor
138608572|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
138983510|NCT05523986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983511|NCT05523986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138983512|NCT05501678|Diphenhydramine|diphenhydramine|mesh-list
138983513|NCT05501678|Promethazine|promethazine|mesh-list
138983514|NCT05501678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138983515|NCT05501678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138983516|NCT05501678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983517|NCT05501678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983518|NCT05501678|Anesthetics, Local|anesthetics, local|mesh-ancestor
138983519|NCT05501678|Anesthetics|anesthetics|mesh-ancestor
138983520|NCT05501678|Sensory System Agents|sensory system agents|mesh-ancestor
138983521|NCT05501678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983522|NCT05501678|Antiemetics|antiemetics|mesh-ancestor
138983523|NCT05501678|Autonomic Agents|autonomic agents|mesh-ancestor
138983524|NCT05501678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138983525|NCT05501678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138983526|NCT05501678|Histamine Antagonists|histamine antagonists|mesh-ancestor
138983527|NCT05501678|Histamine Agents|histamine agents|mesh-ancestor
139009824|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139009825|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139009826|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139009827|NCT02735707|Apremilast|apremilast|mesh-list
139009828|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139009829|NCT02735707|Losartan|losartan|mesh-list
139009830|NCT02735707|Valsartan|valsartan|mesh-list
139009831|NCT02735707|Telmisartan|telmisartan|mesh-list
139009832|NCT02735707|Candesartan|candesartan|mesh-list
139009833|NCT02735707|Ramipril|ramipril|mesh-list
139009834|NCT02735707|Olmesartan|olmesartan|mesh-list
139009835|NCT02735707|Enalapril|enalapril|mesh-list
139009836|NCT02735707|Lisinopril|lisinopril|mesh-list
139009837|NCT02735707|Irbesartan|irbesartan|mesh-list
139009838|NCT02735707|Perindopril|perindopril|mesh-list
139009839|NCT02735707|Captopril|captopril|mesh-list
139009840|NCT02735707|Trandolapril|trandolapril|mesh-list
139009841|NCT02735707|Clopidogrel|clopidogrel|mesh-list
139009842|NCT02735707|Ticagrelor|ticagrelor|mesh-list
139009843|NCT02735707|Simvastatin|simvastatin|mesh-list
139009844|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139009845|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
138983528|NCT05501678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138983529|NCT05501678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983530|NCT05501678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138983531|NCT05501678|Antipruritics|antipruritics|mesh-ancestor
138983532|NCT05501678|Dermatologic Agents|dermatologic agents|mesh-ancestor
138983533|NCT05497596|Vitamin D|vitamin d|mesh-list
138983534|NCT05497596|Vitamins|vitamins|mesh-ancestor
138983535|NCT05497596|Micronutrients|micronutrients|mesh-ancestor
138983536|NCT05497596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983537|NCT05497596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138983538|NCT05495204|Ibalizumab|ibalizumab|mesh-list
138983539|NCT05495204|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138983540|NCT05495204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138983541|NCT05495204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138983542|NCT05495204|Antiviral Agents|antiviral agents|mesh-ancestor
138983543|NCT05495204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983544|NCT05495204|Immunologic Factors|immunologic factors|mesh-ancestor
138983545|NCT05495204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983546|NCT05488405|Mesalamine|mesalamine|mesh-list
138983547|NCT05488405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138983548|NCT05488405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138983549|NCT05488405|Analgesics|analgesics|mesh-ancestor
138983550|NCT05488405|Sensory System Agents|sensory system agents|mesh-ancestor
138983551|NCT05488405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983552|NCT05488405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983553|NCT05488405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138983554|NCT05488405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138983555|NCT05468697|Palbociclib|palbociclib|mesh-list
138983556|NCT05468697|Belzutifan|belzutifan|mesh-list
138983557|NCT05468697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983558|NCT05468697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138983559|NCT05468697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983560|NCT05468697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983561|NCT05430438|Dialysis Solutions|dialysis solutions|mesh-list
138983562|NCT05430438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138983563|NCT05320393|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138983564|NCT05320393|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138983565|NCT05320393|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138983566|NCT05320393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983567|NCT05320393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009846|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139009847|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139009849|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
139009850|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009851|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139009852|NCT02735707|Antiemetics|antiemetics|mesh-ancestor
139009853|NCT02735707|Autonomic Agents|autonomic agents|mesh-ancestor
139009854|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983568|NCT05320393|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138983569|NCT05320393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138983570|NCT05320393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983571|NCT05320393|Cholinergic Agents|cholinergic agents|mesh-ancestor
138983572|NCT05320393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138983573|NCT05283980|Bupivacaine|bupivacaine|mesh-list
138983574|NCT05283980|Anesthetics, Local|anesthetics, local|mesh-ancestor
138983575|NCT05283980|Anesthetics|anesthetics|mesh-ancestor
138983576|NCT05283980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983577|NCT05283980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983578|NCT05283980|Sensory System Agents|sensory system agents|mesh-ancestor
138983579|NCT05283980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983580|NCT05272254|Povidone-Iodine|povidone-iodine|mesh-list
138983581|NCT05272254|Povidone|povidone|mesh-list
138983582|NCT05272254|Plasma Substitutes|plasma substitutes|mesh-ancestor
138983583|NCT05272254|Blood Substitutes|blood substitutes|mesh-ancestor
138983584|NCT05272254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138983585|NCT05272254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983586|NCT05264896|Leucovorin|leucovorin|mesh-list
138983587|NCT05264896|Docetaxel|docetaxel|mesh-list
138983588|NCT05264896|Oxaliplatin|oxaliplatin|mesh-list
138983589|NCT05264896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983590|NCT05264896|Tubulin Modulators|tubulin modulators|mesh-ancestor
138983591|NCT05264896|Antimitotic Agents|antimitotic agents|mesh-ancestor
138983592|NCT05264896|Mitosis Modulators|mitosis modulators|mesh-ancestor
138983593|NCT05264896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983594|NCT05264896|Antidotes|antidotes|mesh-ancestor
138983595|NCT05264896|Protective Agents|protective agents|mesh-ancestor
138983596|NCT05264896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983645|NCT05176509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983646|NCT05176288|Palbociclib|palbociclib|mesh-list
138983647|NCT05176288|Avelumab|avelumab|mesh-list
138983648|NCT05176288|Axitinib|axitinib|mesh-list
138983649|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983650|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138983651|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983652|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983653|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138983654|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
138983655|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
138983656|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983657|NCT05098028|Rifaximin|rifaximin|mesh-list
138983658|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138983659|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983660|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138983661|NCT05082753|Ivermectin|ivermectin|mesh-list
138983662|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138983663|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983664|NCT05081986|Cycloserine|cycloserine|mesh-list
138983665|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138983666|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983667|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138983668|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
138983669|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138983670|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
138983671|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983672|NCT05053737|Atezolizumab|atezolizumab|mesh-list
138983673|NCT05053737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139009855|NCT02735707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139009856|NCT02735707|Glucocorticoids|glucocorticoids|mesh-ancestor
139009858|NCT02735707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139009859|NCT02735707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139009860|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009861|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009862|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139009863|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139009864|NCT02735707|Analgesics|analgesics|mesh-ancestor
139009865|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
139009866|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139009867|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139009868|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139009869|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983674|NCT05053737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983675|NCT05053737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138983676|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983677|NCT05038735|Fulvestrant|fulvestrant|mesh-list
138983678|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138983679|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983680|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138983681|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138983682|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
138983683|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983684|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983685|NCT05021484|Felzartamab|felzartamab|mesh-list
138983686|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983687|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
138734547|NCT00595140|Hormones|hormones|mesh-ancestor
138983688|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983690|NCT05019885|Analgesics|analgesics|mesh-ancestor
138983691|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
138983692|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983693|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608685|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983694|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138983695|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138983696|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
138983697|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
138983698|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983699|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138983700|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138939230|NCT03119012|Ticagrelor|ticagrelor|mesh-list
138983701|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138983702|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983703|NCT05002270|Cetuximab|cetuximab|mesh-list
138983704|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138983705|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983706|NCT04990323|Vidarabine|vidarabine|mesh-list
138983707|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
138983708|NCT04990323|Busulfan|busulfan|mesh-list
138983709|NCT04990323|Thiotepa|thiotepa|mesh-list
138983710|NCT04990323|Fludarabine|fludarabine|mesh-list
138983711|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
138983712|NCT04990323|Clofarabine|clofarabine|mesh-list
138983713|NCT04990323|Tacrolimus|tacrolimus|mesh-list
138983714|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138983715|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
138983716|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009871|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139009872|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
139009873|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139009874|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139009875|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
139009876|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139009877|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139009878|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139009879|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139009880|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138983717|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138983718|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138983719|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
138983720|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983721|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983722|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138983723|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138983724|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
138983725|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
138983726|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983727|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138983728|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983731|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
138983732|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983733|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983734|NCT04965064|Capecitabine|capecitabine|mesh-list
138983735|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138983736|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
138983737|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983738|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983739|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
138983740|NCT04938024|Vitamins|vitamins|mesh-ancestor
138983741|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
138983742|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983743|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
138983744|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983745|NCT04938024|Protective Agents|protective agents|mesh-ancestor
138983746|NCT04899778|Iron|iron|mesh-list
138983747|NCT04899778|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138983748|NCT04899778|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138983749|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
138983750|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
138983751|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138983752|NCT04899778|Estradiol|estradiol|mesh-list
138983753|NCT04899778|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138983754|NCT04899778|Trace Elements|trace elements|mesh-ancestor
138983756|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983757|NCT04899778|Estrogens|estrogens|mesh-ancestor
138983758|NCT04899778|Hormones|hormones|mesh-ancestor
138983759|NCT04899778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983760|NCT04899778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138983761|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138983762|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138983763|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
138983764|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138983765|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138983766|NCT04892706|Analgesics|analgesics|mesh-ancestor
138983767|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
139009881|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139009882|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139009883|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
139009884|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009885|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139009886|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139009887|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139009888|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
139009889|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139009890|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139009891|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138983768|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983769|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983770|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138983771|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138983772|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
138983773|NCT04843982|Esketamine|esketamine|mesh-list
138983774|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
138983775|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138983776|NCT04824599|Ropivacaine|ropivacaine|mesh-list
138983777|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
138983778|NCT04824599|Anesthetics|anesthetics|mesh-list
138983779|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983780|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983781|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
138983782|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983783|NCT04817800|Azelastine|azelastine|mesh-list
138983784|NCT04817800|Beclomethasone|beclomethasone|mesh-list
138983785|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138983786|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
138983787|NCT04817800|Hormones|hormones|mesh-ancestor
138983788|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983789|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983790|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138983791|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
138983792|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138983793|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
138608802|NCT00176774|Fluorouracil|fluorouracil|mesh-list
138983794|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983795|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138983796|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983797|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983798|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138983799|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138983800|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138983801|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
138983802|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
138983803|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138983804|NCT04802408|Listerine|listerine|mesh-list
138983805|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
138983806|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138983807|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983808|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
138983809|NCT04802408|Protective Agents|protective agents|mesh-ancestor
138983810|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983811|NCT04740593|Methamphetamine|methamphetamine|mesh-list
138983812|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138983813|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983814|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
138983815|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
138983816|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983817|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
138983818|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139009892|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139009893|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
139009894|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139009895|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139009896|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
139009897|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139009898|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139009899|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139009900|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
139009901|NCT02735707|Protective Agents|protective agents|mesh-ancestor
139009902|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139009903|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139009904|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139009905|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139009906|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139009907|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139009908|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139009909|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
139009910|NCT02637973|Empagliflozin|empagliflozin|mesh-list
139009911|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139009912|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009913|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139009914|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009915|NCT02546921|Immunoglobulin E|immunoglobulin e|mesh-list
139009916|NCT02546921|Immunologic Factors|immunologic factors|mesh-ancestor
138523802|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
138983819|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983820|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
138983821|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138983822|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138983823|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138983824|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138983825|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138983826|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
138983827|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
138983828|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983829|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983830|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
138983831|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983832|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138983833|NCT04675151|Phentolamine|phentolamine|mesh-list
138983834|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138983835|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138983836|NCT04675151|Pilocarpine|pilocarpine|mesh-list
138983837|NCT04675151|Miotics|miotics|mesh-ancestor
138983838|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
138983839|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983840|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009917|NCT02546921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009919|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
139009920|NCT02527681|Cephalosporins|cephalosporins|mesh-list
139009921|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139009922|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009923|NCT02516696|Clarithromycin|clarithromycin|mesh-list
139009924|NCT02516696|Dexamethasone|dexamethasone|mesh-list
139009925|NCT02516696|Lenalidomide|lenalidomide|mesh-list
139009926|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139009927|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
139009928|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
139009929|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139009930|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009931|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139009932|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
139009934|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139009935|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139009936|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009937|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
138983841|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138983842|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138983843|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
138983844|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138983845|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983846|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138983847|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138983848|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
138983849|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138983850|NCT04674670|Bromocriptine|bromocriptine|mesh-list
138983851|NCT04674670|Amisulpride|amisulpride|mesh-list
138983852|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138983853|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138983854|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983855|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983856|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138983857|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138983858|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
138983859|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138983860|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983861|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138983862|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
138983863|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138983864|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138983865|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
138983866|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983867|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
138983868|NCT04629547|Suvorexant|suvorexant|mesh-list
138983869|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138983870|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138983871|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983872|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983873|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138983874|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138983875|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009938|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139009939|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139009940|NCT02516696|Growth Substances|growth substances|mesh-ancestor
139009941|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
139009942|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139009943|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009944|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139009945|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009946|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009947|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139009948|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139009949|NCT02513329|Bupivacaine|bupivacaine|mesh-list
139009950|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
139009951|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
139009952|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139009953|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009954|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
139009955|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139009956|NCT02425826|Thalidomide|thalidomide|mesh-list
139009957|NCT02425826|Apremilast|apremilast|mesh-list
139009958|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139009959|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139009960|NCT02425826|Analgesics|analgesics|mesh-ancestor
138523934|NCT02250326|Cc-486|cc-486|mesh-list
138983876|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
138983877|NCT04598074|Narcotics|narcotics|mesh-ancestor
138983878|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138983879|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983880|NCT04598074|Analgesics|analgesics|mesh-ancestor
138983881|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
138983882|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983883|NCT04585750|Pembrolizumab|pembrolizumab|mesh-list
138608869|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
138983884|NCT04585750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138983885|NCT04585750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983886|NCT04585750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138983887|NCT04585750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983889|NCT04520451|Hormones|hormones|mesh-ancestor
138983890|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983891|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983892|NCT04507412|Dexamethasone|dexamethasone|mesh-list
138983893|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138983894|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
138983895|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
138983896|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983897|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983898|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138983899|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
138983900|NCT04507412|Hormones|hormones|mesh-ancestor
138983901|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139009961|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
139009962|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139009963|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139009964|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139009965|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139009966|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139009967|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139009968|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009969|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009970|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139009971|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
139009972|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
139009973|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139009974|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139009975|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139009976|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139009977|NCT02425826|Growth Substances|growth substances|mesh-ancestor
139009978|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
139009979|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009980|NCT02278120|Tamoxifen|tamoxifen|mesh-list
139009981|NCT02278120|Letrozole|letrozole|mesh-list
139009982|NCT02278120|Anastrozole|anastrozole|mesh-list
139009983|NCT02278120|Goserelin|goserelin|mesh-list
139009984|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139009985|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139009986|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139009987|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139009988|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139009989|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139009990|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
139009991|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139009992|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010003|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010004|NCT02155647|Avelumab|avelumab|mesh-list
139010005|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139010006|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010007|NCT02057107|Docetaxel|docetaxel|mesh-list
139010008|NCT02057107|Cetuximab|cetuximab|mesh-list
139010009|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010010|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
139010011|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
139010012|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
139010013|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010014|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139010015|NCT01479075|Insulin|insulin|mesh-list
139010016|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139010017|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139010018|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010019|NCT01082679|Buprenorphine|buprenorphine|mesh-list
139010020|NCT01082679|Methadone|methadone|mesh-list
139010021|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139010022|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139010023|NCT01082679|Narcotics|narcotics|mesh-ancestor
139010024|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139010025|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983902|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138983903|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983904|NCT04488926|Palmidrol|palmidrol|mesh-list
138983905|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138983906|NCT04488926|Analgesics|analgesics|mesh-ancestor
138983907|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
138983908|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983909|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983910|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138983911|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138983912|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138983913|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
138983914|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983915|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138983916|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138983917|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608902|NCT00204906|Vitamin D|vitamin d|mesh-list
138983918|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983920|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983921|NCT04483739|Dexamethasone|dexamethasone|mesh-list
138983922|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
138983923|NCT04483739|Lenalidomide|lenalidomide|mesh-list
138983924|NCT04483739|BB 1101|bb 1101|mesh-list
138983925|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138983926|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
138983927|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
138983928|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983929|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983930|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138983931|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
138983932|NCT04483739|Hormones|hormones|mesh-ancestor
139010026|NCT01082679|Analgesics|analgesics|mesh-ancestor
139010027|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
139010028|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010029|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139010030|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
139010031|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
139010032|NCT00976963|Fosfomycin|fosfomycin|mesh-list
139010033|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139010034|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010035|NCT00958633|Bupropion|bupropion|mesh-list
139010036|NCT00958633|Escitalopram|escitalopram|mesh-list
139010037|NCT00958633|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139010038|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139010039|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139010040|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010041|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010042|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
139010043|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010044|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139010045|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
139010046|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139010047|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139010048|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
139010049|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139010050|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139010051|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010052|NCT00393783|Trastuzumab|trastuzumab|mesh-list
139010053|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139010054|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010055|NCT00074269|Cyclosporine|cyclosporine|mesh-list
139010056|NCT00074269|Methotrexate|methotrexate|mesh-list
139010057|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
139010058|NCT00074269|Fludarabine|fludarabine|mesh-list
139010059|NCT00074269|Melphalan|melphalan|mesh-list
139010060|NCT00074269|Cyclosporins|cyclosporins|mesh-list
139010068|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010069|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010070|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
139010071|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010072|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139010073|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139010074|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
139010075|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139010076|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139010077|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
139010078|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010079|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139010080|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139010081|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
139010082|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139010083|NCT00423735|Dasatinib|dasatinib|mesh-list
139010084|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138524090|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
138983933|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983934|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138983935|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983936|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
138983937|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983938|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983939|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
138983940|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138983941|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138983942|NCT04483739|Growth Substances|growth substances|mesh-ancestor
138983943|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
138983944|NCT04461535|Hormones|hormones|mesh-list
138983945|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138983946|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138983947|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
138983948|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983949|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983950|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138983951|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983952|NCT04432012|Dexamethasone|dexamethasone|mesh-list
138983953|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
138983954|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138983955|NCT04432012|BB 1101|bb 1101|mesh-list
138983956|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138983957|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
138983958|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
138983959|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983960|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983961|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138983962|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
138983963|NCT04432012|Hormones|hormones|mesh-ancestor
138983964|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138983965|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138983966|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983967|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
138983968|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010085|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139010086|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010087|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010088|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
139010089|NCT01032213|Analgesics|analgesics|mesh-ancestor
139010090|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
139010091|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010092|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010093|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
139010094|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139010095|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139010096|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
139010097|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139010098|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139010099|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010100|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139010101|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
139010102|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139010104|NCT00357994|Carbidopa|carbidopa|mesh-list
139010141|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
139010142|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010143|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010145|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
139010146|NCT02550119|Aprepitant|aprepitant|mesh-list
139010147|NCT02550119|Dolasetron|dolasetron|mesh-list
139010148|NCT02550119|Ichthammol|ichthammol|mesh-list
139010149|NCT02550119|BB 1101|bb 1101|mesh-list
139010150|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139010151|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
139010152|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
139010153|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010154|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010155|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139010156|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
139010157|NCT02550119|Hormones|hormones|mesh-ancestor
139010158|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139010159|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139010160|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010161|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
139010162|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010163|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010164|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139010165|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010166|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
139010167|NCT02550119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139010168|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139010169|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
139010170|NCT02548403|Simethicone|simethicone|mesh-list
139010171|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
138983969|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983970|NCT04420598|Trastuzumab|trastuzumab|mesh-list
138983971|NCT04420598|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138983972|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138983973|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983974|NCT04420598|Immunoconjugates|immunoconjugates|mesh-ancestor
138983975|NCT04420598|Immunologic Factors|immunologic factors|mesh-ancestor
138983976|NCT04420598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983977|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
138983978|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983979|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138983980|NCT04369937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138983981|NCT04369937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983982|NCT04312360|Metronidazole|metronidazole|mesh-list
138983983|NCT04312360|Fosfomycin|fosfomycin|mesh-list
139010172|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010173|NCT02548403|Emollients|emollients|mesh-ancestor
139010174|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
139010175|NCT00367432|Levetiracetam|levetiracetam|mesh-list
139010176|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
139010177|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
139010178|NCT00623363|Piclozotan|piclozotan|mesh-list
139010179|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139010180|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139010181|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
139010182|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010183|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010184|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010185|NCT00827177|Sorafenib|sorafenib|mesh-list
139010186|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010187|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139010188|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010189|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010190|NCT00423267|Fluconazole|fluconazole|mesh-list
139010191|NCT00423267|Posaconazole|posaconazole|mesh-list
139010192|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
139010193|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010194|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139010195|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139010196|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010197|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010198|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139010199|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
138983984|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983985|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138983986|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138983987|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138983988|NCT04272372|Ketoprofen|ketoprofen|mesh-list
138983989|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138983990|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138983991|NCT04272372|Analgesics|analgesics|mesh-ancestor
138983992|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
138983993|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138983994|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983995|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138983996|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138983997|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138983998|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138983999|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984000|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138984001|NCT04256473|Saruplase|saruplase|mesh-list
139010200|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139010202|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139010203|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139010204|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139010205|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139010206|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139010207|NCT02549261|Etoposide|etoposide|mesh-list
139010208|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
139010209|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010210|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139010211|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139010212|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139010213|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010214|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010215|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139010216|NCT00357760|Aflibercept|aflibercept|mesh-list
139010217|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
139010218|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139010219|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139010220|NCT00357760|Growth Substances|growth substances|mesh-ancestor
139010221|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010222|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
138524253|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
138984002|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138984003|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138984004|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984005|NCT04198363|Amoxicillin|amoxicillin|mesh-list
138984006|NCT04198363|Clarithromycin|clarithromycin|mesh-list
138984007|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
138984008|NCT04198363|Esomeprazole|esomeprazole|mesh-list
138984009|NCT04198363|Bismuth|bismuth|mesh-list
138984010|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984011|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138984012|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138984013|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138984014|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138984015|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138984016|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984017|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138984018|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138984019|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138984020|NCT04198363|Antacids|antacids|mesh-ancestor
138984021|NCT04198363|Diuretics|diuretics|mesh-ancestor
138984022|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
138984023|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984024|NCT04198363|Expectorants|expectorants|mesh-ancestor
138984025|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
138984026|NCT04195828|Paclitaxel|paclitaxel|mesh-list
138984027|NCT04195828|Apatinib|apatinib|mesh-list
139010223|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010225|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139010226|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
139010227|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010228|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010229|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010230|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139010231|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139010232|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139010233|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139010234|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139010235|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
139010236|NCT03742336|Dabigatran|dabigatran|mesh-list
139010237|NCT03742336|Abrocitinib|abrocitinib|mesh-list
139010238|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
139010239|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139010240|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
139010241|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010242|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010243|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
139010244|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139010245|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139010246|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
139010247|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010248|NCT00824057|Midazolam|midazolam|mesh-list
139010249|NCT00824057|Caffeine|caffeine|mesh-list
139010250|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139010251|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139010252|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139010253|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010254|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138760929|NCT02750137|Tetracaine|tetracaine|mesh-list
139010255|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139010256|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139010257|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139010258|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
139010259|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
139010260|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
139010263|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010264|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139010265|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139010266|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010267|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139010268|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139010269|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
139010270|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
139010271|NCT01053208|Promethazine|promethazine|mesh-list
139010272|NCT01053208|Ibuprofen|ibuprofen|mesh-list
139010273|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010274|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139010275|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139010276|NCT01053208|Analgesics|analgesics|mesh-ancestor
139010277|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
139010278|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010279|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010280|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139010281|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139010282|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139010283|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984028|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138984029|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984030|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
138984031|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
138984032|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
138984033|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984034|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138984035|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984036|NCT04173247|Mineral Oil|mineral oil|mesh-list
138984037|NCT04173247|Emollients|emollients|mesh-ancestor
138984038|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
138984039|NCT04112823|Dexamethasone|dexamethasone|mesh-list
138984040|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
138984041|NCT04112823|BB 1101|bb 1101|mesh-list
138984042|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138984043|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
138984044|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
138984045|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984046|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984047|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138984048|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
138984049|NCT04112823|Hormones|hormones|mesh-ancestor
138984050|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984051|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138984052|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984053|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
138984054|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984055|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984056|NCT04093219|Acetaminophen|acetaminophen|mesh-list
138984057|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139010284|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139010285|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139010286|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139010287|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
139010288|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
139010289|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
139010290|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
139010291|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139010292|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139010293|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
139010294|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
139010295|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010296|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139010297|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
139010298|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
139010299|NCT00423189|Ranibizumab|ranibizumab|mesh-list
139010300|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139010301|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139010302|NCT00423189|Growth Substances|growth substances|mesh-ancestor
139010303|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010304|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
139010305|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010306|NCT00831545|Temozolomide|temozolomide|mesh-list
139010307|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139010308|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
139010309|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010310|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010311|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
139010312|NCT00824135|Rituximab|rituximab|mesh-list
139010313|NCT00824135|Melphalan|melphalan|mesh-list
139010314|NCT00824135|Thiotepa|thiotepa|mesh-list
139010315|NCT00824135|Clofarabine|clofarabine|mesh-list
139010316|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
139010317|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984058|NCT04093219|Analgesics|analgesics|mesh-ancestor
138734912|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
138984059|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
138984060|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984061|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984062|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
138984063|NCT04046107|Cemiplimab|cemiplimab|mesh-list
138984064|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984065|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984066|NCT03896737|Thalidomide|thalidomide|mesh-list
138984067|NCT03896737|Dexamethasone|dexamethasone|mesh-list
138984068|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
139010318|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010319|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
139010320|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010321|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139010322|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139010323|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139010324|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
139010325|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139010326|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010327|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010328|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010329|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139010330|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
139010331|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139010332|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139010333|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139010335|NCT00422799|Rituximab|rituximab|mesh-list
139010336|NCT00422799|Bortezomib|bortezomib|mesh-list
139010337|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139010338|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010339|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
139010340|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984069|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
138984070|NCT03896737|Bortezomib|bortezomib|mesh-list
138984071|NCT03896737|Daratumumab|daratumumab|mesh-list
138984072|NCT03896737|BB 1101|bb 1101|mesh-list
138984073|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138984074|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
138984075|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984076|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138984077|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138984078|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
138984079|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984080|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984081|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138939476|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
138984082|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138984083|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
138984084|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
138984085|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984086|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138984087|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
138984088|NCT03896737|Hormones|hormones|mesh-ancestor
138984089|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984090|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138984091|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
138984092|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984093|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
138984094|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138984095|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138984096|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138984097|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139010341|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139010342|NCT00827411|Aspirin|aspirin|mesh-list
139010343|NCT00827411|Clopidogrel|clopidogrel|mesh-list
139010344|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139010345|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139010346|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139010347|NCT00827411|Analgesics|analgesics|mesh-ancestor
139010348|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
139010349|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010350|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010351|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139010352|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139010353|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139010354|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139010355|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010356|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139010357|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139010358|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010359|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
139010360|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139010361|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139010362|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139010363|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
138984098|NCT03896737|Growth Substances|growth substances|mesh-ancestor
138984099|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
138984100|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138984101|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138984102|NCT03815929|Estradiol|estradiol|mesh-list
138984103|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138984104|NCT03815929|Estrogens|estrogens|mesh-ancestor
138984105|NCT03815929|Hormones|hormones|mesh-ancestor
138984106|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984107|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984108|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138984109|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
138984110|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138984111|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138984112|NCT03809988|Letrozole|letrozole|mesh-list
138984113|NCT03809988|Fulvestrant|fulvestrant|mesh-list
138984114|NCT03809988|Palbociclib|palbociclib|mesh-list
138984115|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984116|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138984117|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138984118|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984119|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984120|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138984121|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
138984122|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984123|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984124|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138984125|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139010364|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010365|NCT00435045|Atorvastatin|atorvastatin|mesh-list
139010366|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139010367|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139010368|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
139010369|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010370|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139010371|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139010372|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010373|NCT00441129|Insulin|insulin|mesh-list
139010374|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139010375|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010376|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
139010377|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139010378|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010379|NCT00831857|Bevacizumab|bevacizumab|mesh-list
139010380|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
139010381|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139010382|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010383|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139010384|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139010385|NCT00831857|Growth Substances|growth substances|mesh-ancestor
139010386|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010387|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
139010388|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139010389|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010390|NCT00832013|Propofol|propofol|mesh-list
139010391|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139010392|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139010393|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010394|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139010396|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
139010410|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139010411|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010412|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139010413|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010414|NCT00825071|Dexamethasone|dexamethasone|mesh-list
139010415|NCT00825071|Ondansetron|ondansetron|mesh-list
139010416|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139010417|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
139010418|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
139010419|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010420|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010421|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139010422|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
139010423|NCT00825071|Hormones|hormones|mesh-ancestor
139010424|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984126|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138984127|NCT03773107|Dexamethasone|dexamethasone|mesh-list
138984128|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138984129|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
138984130|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
138984131|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984132|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984133|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138984134|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
138984135|NCT03773107|Hormones|hormones|mesh-ancestor
138984136|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984137|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138984138|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984140|NCT03743766|Relatlimab|relatlimab|mesh-list
138984141|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984142|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984143|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138984144|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984145|NCT03716180|Paclitaxel|paclitaxel|mesh-list
138984146|NCT03716180|Trastuzumab|trastuzumab|mesh-list
138984147|NCT03716180|Pertuzumab|pertuzumab|mesh-list
138984148|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138984149|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984150|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
138984151|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
138984152|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
138984153|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984154|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984155|NCT03696199|Anesthetics|anesthetics|mesh-list
138984156|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138984157|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984161|NCT03566667|Metoprolol|metoprolol|mesh-list
138984162|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138984163|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138984164|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
138984165|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
139010425|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139010426|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010427|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
139010428|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
139010429|NCT00825071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139010430|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139010431|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
139010432|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010433|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010434|NCT00574847|Escitalopram|escitalopram|mesh-list
139010435|NCT00574847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139010436|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139010437|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139010438|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010439|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010440|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
139010441|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010442|NCT00348790|Vatalanib|vatalanib|mesh-list
139010443|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139010444|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010445|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010446|NCT00825149|Prednisone|prednisone|mesh-list
139010447|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
139010448|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139010449|NCT00825149|Doxorubicin|doxorubicin|mesh-list
139010450|NCT00825149|Fludarabine|fludarabine|mesh-list
139010451|NCT00825149|Vincristine|vincristine|mesh-list
139010471|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139010472|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
139010473|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
139010474|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
139010475|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139010476|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139010477|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
139010478|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
139010479|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139010480|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
139010481|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139010482|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010483|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139010484|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139010485|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139010486|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139010487|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139010488|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139010489|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010490|NCT02549105|Lidocaine|lidocaine|mesh-list
139010491|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139010492|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
139010493|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
139010494|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139010495|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010496|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
139010518|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139010519|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
139010520|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139010521|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
139010522|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010523|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010524|NCT00624065|Carvedilol|carvedilol|mesh-list
139010525|NCT00624065|Lisinopril|lisinopril|mesh-list
139010526|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139010527|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139010528|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
139010529|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010530|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010531|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010532|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139010533|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
139010534|NCT00624065|Protective Agents|protective agents|mesh-ancestor
139010535|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139010536|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139010537|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139010538|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
139010539|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139010540|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139010541|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139010542|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
139010543|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010544|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139010545|NCT00833339|Mifepristone|mifepristone|mesh-list
139010546|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139010547|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
139010548|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139010549|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010550|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139010551|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138984166|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984167|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984168|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138984169|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138984170|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139010552|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139010554|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139010555|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139010556|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
139010557|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139010558|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
139010559|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139010560|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139010561|NCT00825617|Hormones|hormones|mesh-list
139010562|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139010563|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010564|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
139010565|NCT00360334|Exenatide|exenatide|mesh-list
139010566|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139010567|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010568|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139010569|NCT00360334|Incretins|incretins|mesh-ancestor
139010570|NCT00360334|Hormones|hormones|mesh-ancestor
139010571|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139010572|NCT00422097|Epothilones|epothilones|mesh-list
139010573|NCT00422097|Famotidine|famotidine|mesh-list
139010574|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
139010575|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
139010576|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
139010577|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010578|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010579|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139010580|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139010597|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010598|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139010599|NCT00434967|Candesartan|candesartan|mesh-list
139010600|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
139010601|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139010602|NCT00434967|Diuretics|diuretics|mesh-ancestor
139010603|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
139010604|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010605|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139010606|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139010607|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010608|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139010609|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139010610|NCT00833729|Etanercept|etanercept|mesh-list
139010611|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139010612|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139010613|NCT00833729|Analgesics|analgesics|mesh-ancestor
139010614|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
139010615|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010616|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010617|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139010618|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139010619|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139010620|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139010621|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
139010622|NCT00837239|Gemcitabine|gemcitabine|mesh-list
139010623|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139010624|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
139010625|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010626|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010627|NCT00833807|Paclitaxel|paclitaxel|mesh-list
139010628|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139010629|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138609168|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
138984171|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
138984172|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984173|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984174|NCT03539614|Prazosin|prazosin|mesh-list
138984175|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138984176|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139010630|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010631|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
139010632|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
139010633|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
139010634|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010635|NCT00833963|Trastuzumab|trastuzumab|mesh-list
139010636|NCT00833963|Pertuzumab|pertuzumab|mesh-list
139010637|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139010638|NCT00833963|Maytansine|maytansine|mesh-list
139010639|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139010640|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010641|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139010642|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
139010643|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
139010644|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
139010645|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010646|NCT00833963|Immunotoxins|immunotoxins|mesh-ancestor
139010647|NCT00833963|Immunoconjugates|immunoconjugates|mesh-ancestor
139010648|NCT00833963|Immunologic Factors|immunologic factors|mesh-ancestor
139010649|NCT00833963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010651|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139010652|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010653|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
139010654|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139010655|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139010656|NCT04043897|Rifaximin|rifaximin|mesh-list
139010657|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139010658|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010659|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139010660|NCT00356590|Etanercept|etanercept|mesh-list
139010661|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139010662|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139010663|NCT00356590|Analgesics|analgesics|mesh-ancestor
139010664|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
139010665|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010666|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984177|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138984178|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138984179|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
138984180|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010667|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139010668|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139010669|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139010670|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139010671|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
139010672|NCT00828503|Valganciclovir|valganciclovir|mesh-list
139010673|NCT00828503|Everolimus|everolimus|mesh-list
139010674|NCT00828503|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139010675|NCT00828503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139010676|NCT00828503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010677|NCT00828503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010678|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139010679|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
139010680|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010681|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010682|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
139010683|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010684|NCT00834665|Molgramostim|molgramostim|mesh-list
139010685|NCT00834665|Sargramostim|sargramostim|mesh-list
139010686|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
139010687|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010688|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010689|NCT00837707|Aripiprazole|aripiprazole|mesh-list
139010690|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
139010691|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139010692|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139010693|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139010717|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139010718|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139010719|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
139010720|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139010721|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
139010722|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010723|NCT00356278|Cycloserine|cycloserine|mesh-list
139010724|NCT00356278|Alprazolam|alprazolam|mesh-list
139010725|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139010726|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010727|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139010728|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
139010729|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139010730|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
139010731|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010732|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139010733|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139010734|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010735|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139010736|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139010737|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139010738|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
139010739|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
139010740|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010741|NCT03991780|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139010742|NCT03991780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139010743|NCT03991780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010744|NCT03991780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010745|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
139010746|NCT00837941|Promethazine|promethazine|mesh-list
139010747|NCT00837941|Pregabalin|pregabalin|mesh-list
139010748|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139010749|NCT00837941|Analgesics|analgesics|mesh-ancestor
139010750|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
139010753|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
139010758|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139010759|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139010760|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139010761|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139010762|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139010763|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139010764|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010765|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
139010766|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
139010767|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139010768|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139010769|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
139010771|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
139010772|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
139010773|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139010774|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139010775|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
139010776|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
139010777|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139010778|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
139010779|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
139010780|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
139010781|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139010782|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
139010783|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
139010784|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010785|NCT00356200|Fluphenazine|fluphenazine|mesh-list
139010786|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
138224293|NCT01450319|Cetuximab|cetuximab|mesh-list
138984181|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984182|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984183|NCT03514589|Cosyntropin|cosyntropin|mesh-list
138984184|NCT03514589|Hormones|hormones|mesh-ancestor
138984185|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984186|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984187|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138984188|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138984189|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984190|NCT03475810|Midazolam|midazolam|mesh-list
138984191|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138984192|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138984193|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138984194|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984195|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138984196|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139010787|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
139010788|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139010789|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139010790|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139010791|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010792|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139010793|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139010794|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
139010795|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010796|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010797|NCT00356122|Bevacizumab|bevacizumab|mesh-list
139010798|NCT00356122|Docetaxel|docetaxel|mesh-list
139010799|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
139010800|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139010801|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010802|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139010803|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139010804|NCT00356122|Growth Substances|growth substances|mesh-ancestor
139010805|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010806|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
139010807|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
139010808|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
139010809|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
139010810|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010811|NCT00828815|Etravirine|etravirine|mesh-list
139010812|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139010813|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139010814|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010815|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010816|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
139010817|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010818|NCT01053520|Navitoclax|navitoclax|mesh-list
139010819|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010820|NCT00347932|Besifloxacin|besifloxacin|mesh-list
138984197|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138984198|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138984199|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
138984200|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
138984201|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
138984202|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
138984203|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984204|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010821|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139010822|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010823|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139010824|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139010825|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010826|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010827|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010828|NCT00828971|Amoxicillin|amoxicillin|mesh-list
139010829|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
139010830|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139010831|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139010832|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010833|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139010834|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139010835|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010836|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010837|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010838|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139010839|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
139010840|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139010841|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984205|NCT03443856|Nivolumab|nivolumab|mesh-list
138984206|NCT03443856|Ipilimumab|ipilimumab|mesh-list
138984207|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984208|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984209|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138887231|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984210|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984211|NCT03389750|Oxymorphone|oxymorphone|mesh-list
138984212|NCT03389750|Oxycodone|oxycodone|mesh-list
138984213|NCT03389750|Hydromorphone|hydromorphone|mesh-list
138984214|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138984215|NCT03389750|Narcotics|narcotics|mesh-ancestor
138984216|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138984217|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984218|NCT03389750|Analgesics|analgesics|mesh-ancestor
138984219|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
138984220|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984221|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138984222|NCT03328884|Irinotecan|irinotecan|mesh-list
138984223|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138984224|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138984225|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984226|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984227|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984228|NCT03282981|Timolol|timolol|mesh-list
138984229|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138984230|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138984231|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
138609311|NCT00200694|Valsartan|valsartan|mesh-list
138984246|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
138984247|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010842|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139010843|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139010844|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139010845|NCT00528996|Bromides|bromides|mesh-list
139010846|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
139010847|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139010848|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
139010849|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010850|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010851|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139010852|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
139010853|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
139010854|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139010855|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
139010856|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010857|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010858|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
139010859|NCT00359788|Albuterol|albuterol|mesh-list
139010860|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
139010861|NCT00359788|Ipratropium|ipratropium|mesh-list
139010862|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139010863|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
139010864|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010865|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010866|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139010867|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
139010868|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
139010869|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139010870|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
139010871|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138939647|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139010872|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010873|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
139010874|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139010876|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139010884|NCT05416476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139010885|NCT05416476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010886|NCT05416476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139010888|NCT05416476|Parasympatholytics|parasympatholytics|mesh-ancestor
139010889|NCT05416476|Autonomic Agents|autonomic agents|mesh-ancestor
139010890|NCT00623597|Ritonavir|ritonavir|mesh-list
139010891|NCT00623597|Saquinavir|saquinavir|mesh-list
139010892|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139010893|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139010894|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
139010895|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010896|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010897|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139010898|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139010899|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
139010900|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010901|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139010902|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139010903|NCT01056172|Ribavirin|ribavirin|mesh-list
139010904|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139010905|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
139010906|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
139010907|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010908|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
139010909|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010910|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
139010911|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010912|NCT00838955|Sirolimus|sirolimus|mesh-list
139010913|NCT00838955|Temsirolimus|temsirolimus|mesh-list
139010914|NCT00838955|MTOR Inhibitors|mtor inhibitors|mesh-list
139010915|NCT00838955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139010916|NCT00838955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010917|NCT00838955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010918|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139010919|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
139010920|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524867|NCT00021671|Erythromycin|erythromycin|mesh-list
139010922|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138761603|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
139010923|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010924|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139010925|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
139010927|NCT00347776|Tetracycline|tetracycline|mesh-list
139010928|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139010929|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010930|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139010931|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010932|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010933|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139010934|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139010935|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010936|NCT00829205|Rituximab|rituximab|mesh-list
139010937|NCT00829205|Carboplatin|carboplatin|mesh-list
139010938|NCT00829205|Etoposide|etoposide|mesh-list
139010939|NCT00829205|Ifosfamide|ifosfamide|mesh-list
139010940|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
139010941|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139010942|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010943|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
139010944|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010945|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139010946|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139010947|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139010948|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139010949|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010950|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984248|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984249|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138984250|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984251|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138984252|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138984253|NCT03156036|Capecitabine|capecitabine|mesh-list
138984254|NCT03156036|Temozolomide|temozolomide|mesh-list
138984255|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138984256|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
138984257|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984258|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984259|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138984260|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
138984290|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984291|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984292|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
139010951|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139010952|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
139010953|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139010954|NCT00829205|Protective Agents|protective agents|mesh-ancestor
139010955|NCT00839111|Irinotecan|irinotecan|mesh-list
139010956|NCT00839111|Sorafenib|sorafenib|mesh-list
139010957|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139010958|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139010959|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010960|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010961|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139010962|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139010963|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139010964|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139010965|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139010966|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
139010967|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139010968|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010969|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010970|NCT00836381|Urological Agents|urological agents|mesh-ancestor
139010971|NCT02533336|Abamectin|abamectin|mesh-list
139010972|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
139010973|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139010974|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139010975|NCT01053910|Ramipril|ramipril|mesh-list
139010976|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139010977|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
139010978|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139010979|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139010980|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139010981|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139010982|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
139010983|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010984|NCT01008384|Vitamin D|vitamin d|mesh-list
139010985|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
138984293|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138984294|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138984295|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
138984296|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984297|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
139010986|NCT01008384|Vitamins|vitamins|mesh-ancestor
139010987|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
139010988|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010989|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139010990|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139010991|NCT02547155|Anesthetics|anesthetics|mesh-list
139010992|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139010993|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139010994|NCT00836849|Sertraline|sertraline|mesh-list
139010995|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
139010996|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139010997|NCT00836849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139010998|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139010999|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139011000|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011001|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139011002|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
139011003|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011004|NCT00839345|Clopidogrel|clopidogrel|mesh-list
139011005|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139011006|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139011007|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139011008|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139011009|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
139011010|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139011011|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011012|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011013|NCT00839501|Acetazolamide|acetazolamide|mesh-list
139011014|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
139011015|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139011016|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011017|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011018|NCT00839501|Diuretics|diuretics|mesh-ancestor
139011025|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011026|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139011027|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139011029|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
139011030|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011031|NCT00621959|Levocetirizine|levocetirizine|mesh-list
139011032|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139011033|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139011034|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
139011035|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
139011036|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139011037|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011038|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011039|NCT00839657|Warfarin|warfarin|mesh-list
139011040|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
139011041|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
139011042|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
139011043|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
139011044|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
139011045|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139011046|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011047|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
139011048|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139011049|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011050|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139011051|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011052|NCT00840125|Docetaxel|docetaxel|mesh-list
139011053|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139011054|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011055|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
139011056|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
139011066|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139011067|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011068|NCT05014542|Analgesics|analgesics|mesh-list
139011069|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
139011070|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011071|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011072|NCT04926324|Niraparib|niraparib|mesh-list
139011074|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139011075|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011076|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011077|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011078|NCT00621257|Vitamin D|vitamin d|mesh-list
139011079|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
139011080|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
139011081|NCT00621257|Vitamins|vitamins|mesh-list
139011082|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
139011083|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011084|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139011085|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139011086|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
139011087|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139011088|NCT00840671|Protective Agents|protective agents|mesh-ancestor
139011089|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011090|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
139011091|NCT02546531|Gemcitabine|gemcitabine|mesh-list
139011092|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
139011093|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139011094|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
139011095|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011096|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011112|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139011113|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011114|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011115|NCT05643846|Bupivacaine|bupivacaine|mesh-list
139011116|NCT05643846|Anesthetics, Local|anesthetics, local|mesh-list
139011117|NCT05643846|Anesthetics|anesthetics|mesh-list
139011118|NCT05643846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139011119|NCT05643846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011120|NCT05643846|Sensory System Agents|sensory system agents|mesh-ancestor
139011121|NCT05643846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011122|NCT00841139|Perhexiline|perhexiline|mesh-list
139011123|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139011124|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139011125|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011126|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139011127|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011128|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
139011129|NCT00844337|Amoxicillin|amoxicillin|mesh-list
138984298|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138984299|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138984300|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138984301|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138984302|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138984303|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984304|NCT02864147|Imiquimod|imiquimod|mesh-list
138984305|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138984306|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
138984307|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984308|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984309|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
138984310|NCT02863055|Nintedanib|nintedanib|mesh-list
138984311|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984312|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138984313|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984314|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984315|NCT02809690|Clevudine|clevudine|mesh-list
138984316|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
138984317|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138984318|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
138984319|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984320|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984321|NCT02777385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138984322|NCT02777385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984323|NCT02725567|Ivacaftor|ivacaftor|mesh-list
138984324|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138984325|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138984326|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984327|NCT02639702|Clozapine|clozapine|mesh-list
138984328|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138984329|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
138984330|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984331|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984332|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984333|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138984334|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139011130|NCT00844337|Gentamicins|gentamicins|mesh-list
139011131|NCT00844337|Penicillins|penicillins|mesh-list
139011132|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139011133|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138939728|NCT01134614|Ipilimumab|ipilimumab|mesh-list
139011134|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139011135|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011136|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011137|NCT00841373|Ranibizumab|ranibizumab|mesh-list
139011138|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139011139|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139011140|NCT00841373|Growth Substances|growth substances|mesh-ancestor
139011141|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011142|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
138984335|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138984336|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138984337|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
138984338|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
138984339|NCT02592356|Lenvatinib|lenvatinib|mesh-list
138984340|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984341|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138984342|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984343|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984344|NCT02517684|Prednisolone|prednisolone|mesh-list
138984345|NCT02517684|Infliximab|infliximab|mesh-list
138984347|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138984348|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
138984349|NCT02517684|Hormones|hormones|mesh-ancestor
138984350|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984351|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984352|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138984353|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984354|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138984355|NCT02517684|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138984356|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
138984357|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138984358|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
138984359|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984360|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138984361|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138984362|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
138984363|NCT02209545|Pyridoxine|pyridoxine|mesh-list
138984364|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
138984365|NCT02209545|Misoprostol|misoprostol|mesh-list
138984366|NCT02209545|Vitamins|vitamins|mesh-ancestor
138984367|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
138984368|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609479|NCT00206154|Budesonide|budesonide|mesh-list
138984369|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138984370|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
138984371|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138984372|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138984373|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138984374|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
138984375|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
138984376|NCT02108964|Nazartinib|nazartinib|mesh-list
138984377|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984378|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138984379|NCT01976065|Metronidazole|metronidazole|mesh-list
138984380|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
138984381|NCT01976065|Minocycline|minocycline|mesh-list
138984382|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138984383|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138984384|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138984385|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138984386|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139011143|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011145|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
139011146|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
139011147|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139011148|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011149|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
139011150|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011151|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139011152|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139011153|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139011154|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139011155|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011156|NCT00841841|Acetaminophen|acetaminophen|mesh-list
138984387|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984388|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984389|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984390|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138984391|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138984392|NCT01921335|Trastuzumab|trastuzumab|mesh-list
138984393|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984394|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984395|NCT01915810|Nicotine|nicotine|mesh-list
138984396|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138984397|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
138984398|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984399|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984400|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138984401|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138984402|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
138984403|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984404|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984405|NCT01909453|Vemurafenib|vemurafenib|mesh-list
138984406|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984407|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138984408|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984409|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984410|NCT01797523|Metformin|metformin|mesh-list
138984411|NCT01797523|Everolimus|everolimus|mesh-list
138984412|NCT01797523|Letrozole|letrozole|mesh-list
138609535|NCT00559858|Pyridoxine|pyridoxine|mesh-list
138984413|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138984414|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984415|NCT01797523|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138984416|NCT01797523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138984417|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984418|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984419|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138984420|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
138984421|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984422|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138984423|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138984424|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138984425|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
138984426|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984427|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138984428|NCT01787500|Cetuximab|cetuximab|mesh-list
138984429|NCT01787500|Irinotecan|irinotecan|mesh-list
138984430|NCT01787500|Camptothecin|camptothecin|mesh-list
138984431|NCT01787500|Vemurafenib|vemurafenib|mesh-list
139011158|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139011159|NCT00841841|Analgesics|analgesics|mesh-ancestor
139011160|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
139011161|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011162|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011163|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
139011164|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139011165|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011166|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139011167|NCT02545751|Thymalfasin|thymalfasin|mesh-list
139011168|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139011169|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
139011170|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011171|NCT00841919|Insulin|insulin|mesh-list
139011172|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139011173|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
139011174|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
139011175|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
139011176|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
139011177|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
139011178|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139011179|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011180|NCT00852059|Methylphenidate|methylphenidate|mesh-list
139011181|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139011182|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011183|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139011184|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139011185|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138525274|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
138984432|NCT01787500|Antibodies|antibodies|mesh-list
138735277|NCT01346540|Nintedanib|nintedanib|mesh-list
138984433|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
138984434|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138984435|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
138984436|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984437|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984438|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138984439|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138984440|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984441|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984442|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138984443|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138984444|NCT01669824|Aspirin|aspirin|mesh-list
138984445|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138984446|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138984447|NCT01669824|Analgesics|analgesics|mesh-ancestor
139011186|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011187|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
139011188|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139011189|NCT00844727|Rofecoxib|rofecoxib|mesh-list
139011190|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139011191|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139011192|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011193|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011194|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139011195|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139011196|NCT00844727|Analgesics|analgesics|mesh-ancestor
139011197|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
139011198|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138525318|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
138984448|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
138984449|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984450|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984451|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138984452|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138984453|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138984454|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138984455|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984456|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138984457|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138984458|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609566|NCT04638439|Entecavir|entecavir|mesh-list
138984459|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
138984461|NCT01472562|Lenalidomide|lenalidomide|mesh-list
138984462|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984463|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984464|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
138984465|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984466|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138984467|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138984468|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138984469|NCT01472562|Growth Substances|growth substances|mesh-ancestor
138984470|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
138984471|NCT01196390|Paclitaxel|paclitaxel|mesh-list
138984472|NCT01196390|Carboplatin|carboplatin|mesh-list
138984473|NCT01196390|Trastuzumab|trastuzumab|mesh-list
138984474|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138984475|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
138984476|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138984477|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984478|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
138984479|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
138984480|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
138984481|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984482|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984483|NCT01164995|Carboplatin|carboplatin|mesh-list
138984484|NCT01164995|Adavosertib|adavosertib|mesh-list
138984485|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984486|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984487|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984488|NCT01156129|Bisacodyl|bisacodyl|mesh-list
138984489|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138984490|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138984491|NCT01156129|Cathartics|cathartics|mesh-ancestor
138984492|NCT01156129|Laxatives|laxatives|mesh-ancestor
138984493|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
138984494|NCT00956007|Cetuximab|cetuximab|mesh-list
139011199|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011200|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011201|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139011202|NCT00528528|Ribavirin|ribavirin|mesh-list
139011203|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
139011204|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
139011205|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139011206|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139011207|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139011208|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
139011209|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011210|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
139011211|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011212|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
139011213|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011214|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011215|NCT00620555|Gabapentin|gabapentin|mesh-list
139011216|NCT00620555|Analgesics|analgesics|mesh-ancestor
139011217|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
139011218|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011219|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011220|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
139011221|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139011222|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139011223|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139011224|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139011225|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139011226|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139011227|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138525380|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138984495|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984496|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984497|NCT00905515|Cyclosporine|cyclosporine|mesh-list
138984498|NCT00905515|Tacrolimus|tacrolimus|mesh-list
138984499|NCT00905515|Cyclosporins|cyclosporins|mesh-list
138984500|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138984501|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
138984502|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984503|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138984504|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984505|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984506|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
138984507|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735348|NCT01340768|Incretins|incretins|mesh-ancestor
138984508|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
138984509|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138984510|NCT00877500|Epothilones|epothilones|mesh-list
139011228|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011229|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
139011230|NCT00845351|Bexarotene|bexarotene|mesh-list
139011231|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011232|NCT02546141|Caseins|caseins|mesh-list
139011233|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
139011234|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
139011235|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011236|NCT00845819|Iodine|iodine|mesh-list
139011237|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
139011238|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139011239|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
139011240|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
139011241|NCT00845819|Nystatin|nystatin|mesh-list
139011242|NCT00845819|Povidone|povidone|mesh-list
139011243|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139011244|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011245|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
139011246|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
139011247|NCT00845819|Trace Elements|trace elements|mesh-ancestor
139011248|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
139011249|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011250|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
138525432|NCT00051090|Lamivudine|lamivudine|mesh-list
138984511|NCT00877500|Epothilone B|epothilone b|mesh-list
138984512|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
138984513|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
138984514|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
138984515|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984516|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984517|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138984518|NCT00659126|Hematinics|hematinics|mesh-ancestor
138984519|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138984520|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138984521|NCT00581139|Midazolam|midazolam|mesh-list
138984522|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
138939960|NCT04039828|Zinc|zinc|mesh-list
138984523|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138984524|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984525|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138984526|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138984527|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138984528|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138984529|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138984530|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138984531|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
138984532|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
138984533|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
138984534|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984535|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984536|NCT00572013|Rituximab|rituximab|mesh-list
138984537|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984538|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984539|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
138984540|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984541|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138984542|NCT00493831|Nicotine|nicotine|mesh-list
139011251|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
139011252|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139011253|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
139011254|NCT00845819|Ionophores|ionophores|mesh-ancestor
139011255|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139011256|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011258|NCT02546843|Atracurium|atracurium|mesh-list
139011259|NCT02546843|Cisatracurium|cisatracurium|mesh-list
139011260|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139011261|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139011262|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138984543|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138984544|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
138984545|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984546|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984547|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138984548|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138984549|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
138984550|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984551|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984552|NCT00482690|Nicotine|nicotine|mesh-list
138984553|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138984554|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
138984555|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984556|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984557|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138984558|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138984559|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
138984560|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984561|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984562|NCT00004197|Prednisone|prednisone|mesh-list
138984563|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
138984564|NCT00004197|Doxorubicin|doxorubicin|mesh-list
138984565|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138984566|NCT00004197|Vincristine|vincristine|mesh-list
138984567|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
138984568|NCT00004197|Sargramostim|sargramostim|mesh-list
138984569|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138984570|NCT00004197|Vaccines|vaccines|mesh-list
138984571|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138984572|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
138984573|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984574|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138984575|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138984576|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
138984577|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984578|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984579|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138984580|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138984581|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138984582|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138984583|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984584|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138735437|NCT01326546|Entecavir|entecavir|mesh-list
138984585|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
138984586|NCT00004197|Hormones|hormones|mesh-ancestor
138984587|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984588|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138984589|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138984591|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
138984592|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
138984593|NCT00004197|Analgesics|analgesics|mesh-ancestor
138984594|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
139011263|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011264|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011265|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139011266|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139011267|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
139011268|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139011269|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011270|NCT03998982|Dexamethasone|dexamethasone|mesh-list
139011271|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
139011272|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011273|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
138984595|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984596|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138984597|NCT03865407|Allopurinol|allopurinol|mesh-list
138984598|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
138984599|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984600|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984601|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
138984602|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138984603|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138984604|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
138984605|NCT03865407|Protective Agents|protective agents|mesh-ancestor
138984606|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984607|NCT00487942|Modafinil|modafinil|mesh-list
138984608|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138984609|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609714|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
138984610|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138984611|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138984612|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138984613|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984615|NCT00132301|Docetaxel|docetaxel|mesh-list
138984616|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984617|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
138984618|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
138984619|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
138984620|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984621|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138984622|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
138984623|NCT00132301|Hormones|hormones|mesh-ancestor
138984624|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984625|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984626|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138984627|NCT00519831|Cetuximab|cetuximab|mesh-list
138984628|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984629|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984630|NCT04303845|Erenumab|erenumab|mesh-list
138984631|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138984632|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984633|NCT04303845|Analgesics|analgesics|mesh-ancestor
138984634|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
138984635|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984636|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984637|NCT04187703|Azacitidine|azacitidine|mesh-list
138984638|NCT04187703|Decitabine|decitabine|mesh-list
138984639|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138984640|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
138984641|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984642|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984643|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984644|NCT00131911|Sorafenib|sorafenib|mesh-list
138984645|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984646|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139011274|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
139011275|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011276|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011277|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139011278|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
139011279|NCT03998982|Hormones|hormones|mesh-ancestor
139011280|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139011281|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139011282|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011283|NCT00620321|Cytarabine|cytarabine|mesh-list
139011284|NCT00620321|Idarubicin|idarubicin|mesh-list
139011285|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139011286|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
139011287|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011288|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011289|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
139011290|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011291|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139011292|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
139011293|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011294|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139011295|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139011296|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139011297|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011298|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
139011299|NCT00621023|Decitabine|decitabine|mesh-list
139011300|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
139011301|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139011302|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
139011303|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525609|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
138984647|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984648|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984650|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138984651|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
138984652|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984653|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984654|NCT01074619|Memantine|memantine|mesh-list
138984655|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138984656|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138984657|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
138984658|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984659|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011304|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011305|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011307|NCT00621023|Protective Agents|protective agents|mesh-ancestor
139011308|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011310|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
139011311|NCT00848861|Midazolam|midazolam|mesh-list
139011312|NCT00848861|Meperidine|meperidine|mesh-list
139011313|NCT00848861|Propofol|propofol|mesh-list
139011314|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139011315|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139011316|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011317|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139011318|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
139011319|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
139011320|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139011321|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139011322|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139011323|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139011324|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
139011325|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
139011326|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139011327|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011328|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139011329|NCT00848861|Narcotics|narcotics|mesh-ancestor
139011330|NCT00848861|Analgesics|analgesics|mesh-ancestor
139011331|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
138735494|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984660|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984661|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138984662|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138984663|NCT00183625|Olanzapine|olanzapine|mesh-list
138984664|NCT00183625|Risperidone|risperidone|mesh-list
138984665|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138984666|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
138984667|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984668|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984669|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984670|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138984671|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138984672|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138984673|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138984674|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138984675|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
138984676|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
138984677|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
138984678|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984679|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138984680|NCT00183625|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138984681|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138984682|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138984683|NCT00511875|Doxycycline|doxycycline|mesh-list
139011332|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011333|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
139011334|NCT00852371|Piperaquine|piperaquine|mesh-list
139011335|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
139011336|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139011337|NCT00852371|Amodiaquine|amodiaquine|mesh-list
139011339|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
139011340|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139011341|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138940026|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
139011342|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011343|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139011344|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011345|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011346|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139011347|NCT00528372|Metformin|metformin|mesh-list
138984684|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138984685|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138984686|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
138984687|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138984688|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138984689|NCT02576327|Dexamethasone|dexamethasone|mesh-list
138984690|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
138984691|NCT02576327|Aprepitant|aprepitant|mesh-list
138984692|NCT02576327|Tropisetron|tropisetron|mesh-list
138984693|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138984694|NCT02576327|BB 1101|bb 1101|mesh-list
138984695|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138984696|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
138984697|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
138984698|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984699|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984700|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138984701|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
138984702|NCT02576327|Hormones|hormones|mesh-ancestor
138984703|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984704|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138984705|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984706|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
138984707|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609821|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984708|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984709|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138984710|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984711|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138984712|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138984713|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
138984714|NCT00183391|Methylphenidate|methylphenidate|mesh-list
138984715|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138984716|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138984717|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984718|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138984719|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138984720|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138984721|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984722|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
138984723|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984724|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138984725|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
138984727|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139011348|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
139011349|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139011350|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011351|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139011352|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011353|NCT01564680|Acetaminophen|acetaminophen|mesh-list
139011354|NCT01564680|Lornoxicam|lornoxicam|mesh-list
139011355|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139011356|NCT01564680|Analgesics|analgesics|mesh-ancestor
139011357|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
139011358|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011359|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011360|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
139011361|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139011362|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011363|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139011364|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
139011365|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011366|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139011367|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011368|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011369|NCT00527982|Celecoxib|celecoxib|mesh-list
139011370|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139011371|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139011372|NCT00527982|Analgesics|analgesics|mesh-ancestor
139011373|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
139011374|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011394|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011395|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011396|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139011397|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
139011398|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139011399|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139011400|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139011401|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139011402|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139011403|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011404|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139011405|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011406|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
139011407|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139011409|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139011410|NCT00842933|Prednisone|prednisone|mesh-list
139011411|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
139011412|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
139011413|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139011414|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139011415|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139011416|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011417|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
139011418|NCT00842933|Hormones|hormones|mesh-ancestor
139039569|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138984728|NCT00493246|Analgesics|analgesics|mesh-ancestor
138984729|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
138984730|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984731|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984732|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
138984733|NCT01021150|Cisplatin|cisplatin|mesh-list
138984734|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984735|NCT03997006|Atropine|atropine|mesh-list
138984736|NCT03997006|Aminophylline|aminophylline|mesh-list
138984737|NCT03997006|Neostigmine|neostigmine|mesh-list
138984738|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138609862|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
138984739|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138984740|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138984741|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
138984742|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984743|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984744|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138984745|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
138984746|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
138984747|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
138984748|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138984749|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138984750|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
139011419|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139011420|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011421|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139011422|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011423|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
139011424|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
139011425|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011426|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139011427|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139011428|NCT00842933|Protective Agents|protective agents|mesh-ancestor
139011429|NCT00849095|Budesonide|budesonide|mesh-list
139011430|NCT00849095|Terbutaline|terbutaline|mesh-list
139011431|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
139011432|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139011433|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011434|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139011435|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
139011436|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011437|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011438|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139011439|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
139011440|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
139011441|NCT00849095|Hormones|hormones|mesh-ancestor
139011442|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139011443|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139011444|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138984751|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984752|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984753|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138984754|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984755|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138984756|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138984757|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138984758|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138984759|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138984760|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
138984761|NCT03997006|Protective Agents|protective agents|mesh-ancestor
138984762|NCT02281955|Cisplatin|cisplatin|mesh-list
138984763|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984764|NCT02272049|Xenon|xenon|mesh-list
138984765|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138984766|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
138984767|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
138984768|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138984769|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984770|NCT03996538|Metformin|metformin|mesh-list
138984771|NCT03996538|Vaccines|vaccines|mesh-list
138984772|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
139011445|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139011446|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
139011447|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139011448|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011449|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
139011450|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
139011451|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139011454|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139011455|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011456|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139011457|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
139011458|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011459|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011460|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139011461|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
139011462|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
139011463|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139011464|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138525888|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
138984773|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984774|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138984775|NCT02576015|Lidocaine|lidocaine|mesh-list
138984776|NCT02576015|Ropivacaine|ropivacaine|mesh-list
138984777|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
138984778|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
138984779|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138984780|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984781|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
138984782|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984783|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138984784|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138984785|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138984786|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138984787|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984788|NCT02577965|Everolimus|everolimus|mesh-list
138984789|NCT02577965|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138984790|NCT02577965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138984791|NCT02577965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984792|NCT02577965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984793|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138984794|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
138984795|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984796|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984797|NCT00182689|Sorafenib|sorafenib|mesh-list
138984798|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984799|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138984800|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984801|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984802|NCT02578121|Dexamethasone|dexamethasone|mesh-list
138984803|NCT02578121|Pomalidomide|pomalidomide|mesh-list
138984804|NCT02578121|Ixazomib|ixazomib|mesh-list
138984805|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138984806|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
138984807|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
138984808|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011465|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139011466|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139011467|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
139011468|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139011469|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011470|NCT00849329|Lapatinib|lapatinib|mesh-list
139011471|NCT00849329|Esomeprazole|esomeprazole|mesh-list
139011472|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139011473|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139011474|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139011475|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011476|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011477|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011478|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139011479|NCT00852683|Pregabalin|pregabalin|mesh-list
139011480|NCT00852683|Analgesics|analgesics|mesh-ancestor
139011481|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
139011482|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940138|NCT00617734|Cetuximab|cetuximab|mesh-list
139011483|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011484|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
139011485|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139011486|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139011487|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011488|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139011489|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139011490|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138984809|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984810|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138984811|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
138984812|NCT02578121|Hormones|hormones|mesh-ancestor
138984813|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984814|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138984815|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984816|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
138984817|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138984818|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138984819|NCT02578121|Growth Substances|growth substances|mesh-ancestor
138984820|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
138984821|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
138984822|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138984823|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984824|NCT00487240|Insulin|insulin|mesh-list
138984825|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138984826|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
138984827|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
138984828|NCT00487240|Protamines|protamines|mesh-list
138984829|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138984830|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011491|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139011492|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139011493|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
139011494|NCT00619307|Ibuprofen|ibuprofen|mesh-list
139011495|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139011496|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139011497|NCT00619307|Analgesics|analgesics|mesh-ancestor
139011498|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
139011499|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011500|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011501|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011502|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139011503|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139011504|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011505|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011506|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139011507|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
138940166|NCT00415519|Protective Agents|protective agents|mesh-ancestor
139011508|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011509|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
139011510|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011511|NCT00855881|Tegafur|tegafur|mesh-list
139011512|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139011513|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
139011514|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011515|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011516|NCT00619229|Alprostadil|alprostadil|mesh-list
138525996|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138984831|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
138984832|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984833|NCT00487240|Coagulants|coagulants|mesh-ancestor
138984834|NCT02577809|Indomethacin|indomethacin|mesh-list
138984835|NCT02577809|Fentanyl|fentanyl|mesh-list
138984836|NCT02577809|Morphine|morphine|mesh-list
138984837|NCT02577809|Bupivacaine|bupivacaine|mesh-list
138984838|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
138984839|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
138984840|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138984841|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984842|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
138984843|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984844|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138984845|NCT02577809|Narcotics|narcotics|mesh-ancestor
138984846|NCT02577809|Analgesics|analgesics|mesh-ancestor
138984847|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138984848|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138984849|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
138984850|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138984851|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138984852|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011517|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139011518|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
139011519|NCT00619229|Urological Agents|urological agents|mesh-ancestor
139011520|NCT02546297|Budesonide|budesonide|mesh-list
139011521|NCT02546297|Bromides|bromides|mesh-list
139011522|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
139011523|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
138940193|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011524|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139011525|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011526|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139011527|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
139011528|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011529|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011530|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139011531|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
139011532|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
139011533|NCT02546297|Hormones|hormones|mesh-ancestor
139011534|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139011535|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139011536|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139011537|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139011538|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
139011539|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139011540|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011541|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
139011542|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139011543|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
139011544|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
139011545|NCT00618995|Niacin|niacin|mesh-list
139011546|NCT00618995|Niacinamide|niacinamide|mesh-list
139011547|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
139011548|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139011549|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
139011550|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526045|NCT00025181|Ipilimumab|ipilimumab|mesh-list
138984853|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138984854|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
138984855|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
138984856|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138984857|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138984858|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011551|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139011552|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
139011553|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
139011554|NCT00618995|Vitamins|vitamins|mesh-ancestor
139011555|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
139011556|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011557|NCT03685344|Durvalumab|durvalumab|mesh-list
139011558|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139011559|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139011560|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139011561|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011562|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
139011563|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011564|NCT00856271|Losartan|losartan|mesh-list
139011565|NCT00856271|Olmesartan|olmesartan|mesh-list
139011566|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139011567|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139011568|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139011569|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139011570|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139011571|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011572|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
139011573|NCT00856505|Everolimus|everolimus|mesh-list
139011574|NCT00856505|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139011575|NCT00856505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139011576|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011577|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011578|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139011579|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
138984859|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984860|NCT02224391|Nicotine|nicotine|mesh-list
138984861|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138984862|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
138984863|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984864|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984865|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138984866|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138984867|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
138984868|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984869|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984870|NCT00487162|Insulin|insulin|mesh-list
138984871|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138984872|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984873|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
138984874|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984875|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984876|NCT03871959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139011580|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011582|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139011583|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139011584|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
139011585|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139011586|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011587|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
139011588|NCT02544893|Bupivacaine|bupivacaine|mesh-list
139011589|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
139011590|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
139011591|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139011592|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011593|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
139011594|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011595|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139011596|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139011597|NCT02544893|Analgesics|analgesics|mesh-ancestor
138526137|NCT00025337|Antidotes|antidotes|mesh-ancestor
138984877|NCT03871959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984878|NCT00487084|Lidocaine|lidocaine|mesh-list
138984879|NCT00487084|Morphine|morphine|mesh-list
138984880|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
138984881|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
138984882|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138984883|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984884|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
138984885|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984886|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138984887|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138984888|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138984889|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138984890|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984891|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138984892|NCT00487084|Narcotics|narcotics|mesh-ancestor
138984893|NCT00487084|Analgesics|analgesics|mesh-ancestor
138984894|NCT00466726|Sargramostim|sargramostim|mesh-list
138984895|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
138984896|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984897|NCT01721291|Albuterol|albuterol|mesh-list
138984898|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138984899|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
138984900|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984901|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984902|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138984903|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
138984904|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
138984905|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138984906|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138984907|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138984908|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138984909|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
138984910|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984911|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984912|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138984913|NCT01021540|Hormones|hormones|mesh-ancestor
139011598|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139011599|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139011600|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139011601|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
139011602|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139011603|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011605|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139011606|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139011607|NCT00520572|Analgesics|analgesics|mesh-ancestor
139011608|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
139011609|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011610|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011611|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011612|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139011613|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139011614|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138984914|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984915|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984917|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
138984918|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
138984919|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138984920|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984921|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
138984922|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984923|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138984924|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138984925|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138984926|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138984927|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984928|NCT02199665|Dexamethasone|dexamethasone|mesh-list
138984929|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138984930|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
138984931|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
138984932|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984933|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984934|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138984935|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
138984936|NCT02199665|Hormones|hormones|mesh-ancestor
138984937|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138984938|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138984939|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984940|NCT01021696|Acetaminophen|acetaminophen|mesh-list
138984941|NCT01021696|Pregabalin|pregabalin|mesh-list
138984942|NCT01021696|Morphine|morphine|mesh-list
138610095|NCT00180050|Hormones|hormones|mesh-ancestor
138984943|NCT01021696|Buprenorphine|buprenorphine|mesh-list
138984944|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138984945|NCT01021696|Narcotics|narcotics|mesh-ancestor
138984946|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138984947|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984948|NCT01021696|Analgesics|analgesics|mesh-ancestor
138984949|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
138984950|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984951|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
138984952|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138984953|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139011615|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
139011616|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
139011617|NCT00853697|Testosterone|testosterone|mesh-list
139011618|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
139011619|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
139011620|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139011621|NCT00853697|Dutasteride|dutasteride|mesh-list
139011622|NCT00853697|Androgens|androgens|mesh-ancestor
139011623|NCT00853697|Hormones|hormones|mesh-ancestor
139011624|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138526254|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
138984954|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984955|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138984956|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138984957|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138984959|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138984960|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
138984961|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138984962|NCT02577575|Oxytocin|oxytocin|mesh-list
138984963|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
138984964|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138984965|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984967|NCT00485758|Niacinamide|niacinamide|mesh-list
138984968|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
138984969|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138984970|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
138984971|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984972|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138984973|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
138984974|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
138984975|NCT00485758|Vitamins|vitamins|mesh-ancestor
138984976|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
138984977|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984978|NCT02577341|Docetaxel|docetaxel|mesh-list
138984979|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
138984980|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138984981|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
138984982|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
138984983|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
138984984|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984985|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138984986|NCT02577497|Fluticasone|fluticasone|mesh-list
138984987|NCT02577497|Beclomethasone|beclomethasone|mesh-list
138984988|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138984989|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138984990|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
138984991|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138984992|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984993|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138984994|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
138984995|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
138984996|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138984997|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
138984998|NCT02577497|Hormones|hormones|mesh-ancestor
138984999|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138985000|NCT02575859|Cisplatin|cisplatin|mesh-list
138985001|NCT02575859|Mitomycins|mitomycins|mesh-list
138985002|NCT02575859|Mitomycin|mitomycin|mesh-list
138985003|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985004|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138985005|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
138985006|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985007|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138985008|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985009|NCT00469456|Memantine|memantine|mesh-list
138985010|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138985011|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139011625|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011626|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139011627|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011629|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139011630|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139011631|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011632|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011633|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
139011634|NCT00861419|Niacinamide|niacinamide|mesh-list
139011635|NCT00861419|Bevacizumab|bevacizumab|mesh-list
139011636|NCT00861419|Sunitinib|sunitinib|mesh-list
139011637|NCT00861419|Trebananib|trebananib|mesh-list
139011638|NCT00861419|Sorafenib|sorafenib|mesh-list
139011639|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
139011640|NCT00861419|Imetelstat|imetelstat|mesh-list
139011641|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139011642|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011643|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139011644|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139011645|NCT00861419|Growth Substances|growth substances|mesh-ancestor
139011646|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011647|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
139011648|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139011649|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011650|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011651|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
139011652|NCT00861419|Vitamins|vitamins|mesh-ancestor
139011653|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
139011654|NCT00527514|Amlodipine|amlodipine|mesh-list
139011655|NCT00527514|Olmesartan|olmesartan|mesh-list
138526328|NCT00026156|Docetaxel|docetaxel|mesh-list
138985012|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
138985013|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610260|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
138985014|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985015|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985016|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138985017|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138985018|NCT00581555|Etanercept|etanercept|mesh-list
138985019|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138985020|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138985021|NCT00581555|Analgesics|analgesics|mesh-ancestor
138985022|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
138985023|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985024|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011656|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139011657|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139011658|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139011659|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139011660|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011661|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139011662|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011663|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
139011664|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139011665|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139011666|NCT03998826|Piroxicam|piroxicam|mesh-list
139011667|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139011668|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139011669|NCT03998826|Analgesics|analgesics|mesh-ancestor
139011670|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
139011671|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011672|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011673|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011674|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139011675|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139011676|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011677|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011678|NCT00853931|Panitumumab|panitumumab|mesh-list
139011679|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139011680|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011681|NCT00854009|BLI-489|bli-489|mesh-list
139011682|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139011683|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985025|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138985026|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138985027|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138985028|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138985029|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
138985030|NCT00469144|Fludarabine|fludarabine|mesh-list
138985031|NCT00469144|Busulfan|busulfan|mesh-list
138985032|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985033|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985034|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138985035|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
138985036|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985037|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
138985038|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138985039|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138985040|NCT03987022|Acetaminophen|acetaminophen|mesh-list
138985041|NCT03987022|Ketorolac|ketorolac|mesh-list
139011684|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011685|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139011686|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011688|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
139011689|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011690|NCT00861731|Simvastatin|simvastatin|mesh-list
139011691|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139011692|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139011693|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
139011694|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011695|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139011696|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139011697|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011698|NCT02544659|Pamidronate|pamidronate|mesh-list
139011699|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139011700|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011701|NCT00861887|Vancomycin|vancomycin|mesh-list
139011702|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139011703|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011704|NCT00857519|Carboplatin|carboplatin|mesh-list
139011705|NCT00857519|Melphalan|melphalan|mesh-list
139011706|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011707|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138526422|NCT00026351|Rituximab|rituximab|mesh-list
138985042|NCT03987022|Oxycodone|oxycodone|mesh-list
138985043|NCT03987022|Hydromorphone|hydromorphone|mesh-list
138985044|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138985045|NCT03987022|Narcotics|narcotics|mesh-ancestor
138985046|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138985047|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985048|NCT03987022|Analgesics|analgesics|mesh-ancestor
138985049|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
138985050|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985051|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138985052|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138985053|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138985054|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138985055|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138985056|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985057|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985058|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
138985059|NCT01025128|Vitamin D|vitamin d|mesh-list
138985060|NCT01025128|Vitamins|vitamins|mesh-ancestor
138985061|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
138985062|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985063|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138985064|NCT00468910|Aspirin|aspirin|mesh-list
138940344|NCT00711594|Afatinib|afatinib|mesh-list
138985065|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138985066|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138985067|NCT00468910|Analgesics|analgesics|mesh-ancestor
139011708|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
139011709|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011710|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139011711|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139011712|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
139011713|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011714|NCT00618449|Azithromycin|azithromycin|mesh-list
139011715|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139011716|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011717|NCT00857597|Esomeprazole|esomeprazole|mesh-list
139011718|NCT00857597|Omeprazole|omeprazole|mesh-list
139011719|NCT00857597|Rabeprazole|rabeprazole|mesh-list
139011720|NCT00857597|Pantoprazole|pantoprazole|mesh-list
139011721|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139011722|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139011723|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139011724|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011725|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011726|NCT00857753|Fentanyl|fentanyl|mesh-list
139011727|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139011728|NCT00857753|Narcotics|narcotics|mesh-ancestor
139011729|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139011730|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011731|NCT00857753|Analgesics|analgesics|mesh-ancestor
139011732|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
139011733|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011734|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139011735|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139011736|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
139011737|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
139011738|NCT00854321|Rituximab|rituximab|mesh-list
139011739|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139011740|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985068|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
138985069|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985070|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985071|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138985072|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138985073|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138985074|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138985075|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985076|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138985077|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138985078|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011741|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
139011742|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011743|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139011744|NCT03684642|Metformin|metformin|mesh-list
139011745|NCT03684642|Dulaglutide|dulaglutide|mesh-list
139011746|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
139011747|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139011748|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011749|NCT00857831|Vitamin D|vitamin d|mesh-list
139011750|NCT00857831|Calcium|calcium|mesh-list
139011751|NCT00857831|Vitamins|vitamins|mesh-ancestor
139011752|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
139011753|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011754|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139011755|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139011756|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
139039570|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138985079|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
138985080|NCT01412333|Interferons|interferons|mesh-list
138985081|NCT01412333|Interferon-beta|interferon-beta|mesh-list
138985082|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
138985083|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
138985084|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985085|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
138985086|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985087|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
138985088|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985089|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138985091|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138985092|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138985093|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138985094|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138985095|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985096|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
138985097|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985098|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985099|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138985100|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985101|NCT00519285|Prednisone|prednisone|mesh-list
138985102|NCT00519285|Prednisolone|prednisolone|mesh-list
138985103|NCT00519285|Docetaxel|docetaxel|mesh-list
138985104|NCT00519285|Aflibercept|aflibercept|mesh-list
138985105|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985106|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
138985107|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
138985108|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
138985109|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985110|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138985111|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
138985112|NCT00519285|Hormones|hormones|mesh-ancestor
138985113|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735943|NCT00600158|Lidocaine|lidocaine|mesh-list
138985114|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985115|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138985116|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138985117|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138985118|NCT00519285|Growth Substances|growth substances|mesh-ancestor
138985119|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
138985121|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940372|NCT00736814|Carboplatin|carboplatin|mesh-list
138985122|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138985123|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011757|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011758|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
139011759|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139011760|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139011761|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011762|NCT00862043|Urological Agents|urological agents|mesh-ancestor
139011763|NCT00519636|Fluticasone|fluticasone|mesh-list
139011765|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011766|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139011767|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
139011768|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011769|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011770|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139011771|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
139011772|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
139011773|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139011774|NCT00857909|Amiloride|amiloride|mesh-list
139011775|NCT00857909|Spironolactone|spironolactone|mesh-list
139011776|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139011777|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
139011778|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139011779|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985124|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985125|NCT05212857|Leuprolide|leuprolide|mesh-list
138985126|NCT05212857|Goserelin|goserelin|mesh-list
138985127|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138985128|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
138985129|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138985130|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
138985131|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138985132|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985133|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138985134|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985135|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138985136|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985137|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985138|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
138985139|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138985140|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138985141|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
138985142|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138985143|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
138985144|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138985145|NCT02099123|Atorvastatin|atorvastatin|mesh-list
138985146|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138985147|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138985148|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
138985149|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985150|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139011780|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139011781|NCT00857909|Diuretics|diuretics|mesh-ancestor
139011782|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
139011783|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139011784|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139011785|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139011786|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011787|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139011788|NCT00857987|Expectorants|expectorants|mesh-list
139011789|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
139011790|NCT00854477|Capecitabine|capecitabine|mesh-list
139011791|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139011792|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
139011793|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011794|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011795|NCT00854633|Lactoferrin|lactoferrin|mesh-list
139011796|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
139011797|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011798|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011799|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
138985151|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138985152|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985153|NCT00464542|Metronidazole|metronidazole|mesh-list
138985154|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985155|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138985156|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138985157|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138985158|NCT02578823|Antipyretics|antipyretics|mesh-list
138985159|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985160|NCT01969643|Trastuzumab|trastuzumab|mesh-list
138985161|NCT01969643|SGN-LIV1A|sgn-liv1a|mesh-list
138985162|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138985163|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985164|NCT01969643|Immunoconjugates|immunoconjugates|mesh-ancestor
138985165|NCT01969643|Immunologic Factors|immunologic factors|mesh-ancestor
138985166|NCT01969643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985167|NCT00464308|Esomeprazole|esomeprazole|mesh-list
138985168|NCT00464308|Rabeprazole|rabeprazole|mesh-list
138985169|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138985170|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138985171|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138985172|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985173|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985174|NCT00463840|Fluorouracil|fluorouracil|mesh-list
138985175|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
138985176|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
138985177|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985178|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138985179|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985180|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138985181|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
138985182|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985183|NCT00129389|Paclitaxel|paclitaxel|mesh-list
138985184|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
138985185|NCT00129389|Doxorubicin|doxorubicin|mesh-list
138985186|NCT00129389|Fluorouracil|fluorouracil|mesh-list
139011800|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139011801|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139011802|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
139011803|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011804|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139011805|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139011806|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011807|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011808|NCT00858299|Valsartan|valsartan|mesh-list
139011809|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139011810|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139011811|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139011812|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011813|NCT00526890|Selenium|selenium|mesh-list
139011814|NCT00526890|Paclitaxel|paclitaxel|mesh-list
138940411|NCT00711516|Modafinil|modafinil|mesh-list
139011815|NCT00526890|Carboplatin|carboplatin|mesh-list
138526717|NCT00027716|Bortezomib|bortezomib|mesh-list
138985187|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138985188|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985189|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
138985190|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
138985191|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
138985192|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985193|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138985194|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
138985195|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985196|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138985197|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138985198|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
138985199|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138985200|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138985201|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138985202|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138985203|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985204|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
138985205|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138985206|NCT00468052|Fentanyl|fentanyl|mesh-list
138985207|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
138985208|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138985209|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138985210|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985211|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138985212|NCT00468052|Analgesics|analgesics|mesh-ancestor
138985213|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
138610549|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
138985214|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985215|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138985216|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138985217|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138985218|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
138985219|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985220|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985221|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138985222|NCT00468052|Narcotics|narcotics|mesh-ancestor
138985223|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138985224|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138985225|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
138985226|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
138985227|NCT00453310|Sunitinib|sunitinib|mesh-list
139011816|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139011817|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011818|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
139011819|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
139011820|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
139011821|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011822|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
139011823|NCT00526890|Protective Agents|protective agents|mesh-ancestor
139011824|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762512|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011825|NCT00526890|Trace Elements|trace elements|mesh-ancestor
139011826|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
139011827|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
139011828|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
139011829|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011830|NCT04041167|Protective Agents|protective agents|mesh-ancestor
138985228|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985229|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138985230|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138985231|NCT00453310|Growth Substances|growth substances|mesh-ancestor
138985232|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985233|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
138985234|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138985235|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985236|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985237|NCT00128843|Anastrozole|anastrozole|mesh-list
138985238|NCT00128843|Exemestane|exemestane|mesh-list
138985239|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138985240|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985241|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138985242|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138985243|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985244|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985245|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138985246|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
138985247|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138985248|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985249|NCT04073927|Butyric Acid|butyric acid|mesh-list
138985250|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
138985251|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
138985252|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985253|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610622|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
138985254|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985255|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138985256|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985257|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138985258|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985259|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985260|NCT02578277|BMS-955176|bms-955176|mesh-list
138985261|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138985262|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138985263|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
138985264|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985265|NCT00555906|Dexamethasone|dexamethasone|mesh-list
138985266|NCT00555906|Bortezomib|bortezomib|mesh-list
138985267|NCT00555906|Palbociclib|palbociclib|mesh-list
138985268|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138985269|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
139011831|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011832|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
139011833|NCT04041167|Vitamins|vitamins|mesh-ancestor
139011834|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
139011835|NCT00858377|Complement Factor H|complement factor h|mesh-list
139011836|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139011837|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139011838|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
139011839|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011840|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
139011841|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139011842|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
139011843|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011844|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011845|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139011846|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
139011847|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138985270|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
138985271|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985272|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985273|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138985274|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
138985275|NCT00555906|Hormones|hormones|mesh-ancestor
138985276|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138985277|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138985278|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985279|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138985280|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985281|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985282|NCT04071353|Interferons|interferons|mesh-list
138985283|NCT04071353|Ribavirin|ribavirin|mesh-list
138985284|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985285|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
138985286|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985287|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
138985288|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985289|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
138985290|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138985291|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985292|NCT00555672|Fluorouracil|fluorouracil|mesh-list
138985293|NCT00555672|Sunitinib|sunitinib|mesh-list
138985294|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985295|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
138985296|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985297|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138985298|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138985299|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
138985300|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985301|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138985302|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138985303|NCT00555672|Growth Substances|growth substances|mesh-ancestor
138985304|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
138985305|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138985306|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985307|NCT02575547|Docetaxel|docetaxel|mesh-list
138985308|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985309|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
138985310|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
138985311|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
139011848|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
139011849|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011850|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139011851|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139011852|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
139011853|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
139011854|NCT00854711|Protective Agents|protective agents|mesh-ancestor
139011855|NCT00858455|Dolutegravir|dolutegravir|mesh-list
139011856|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139011857|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139011858|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011859|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011860|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139011861|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139011862|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
139011863|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139011864|NCT02544737|Apatinib|apatinib|mesh-list
139011865|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011866|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139011867|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011868|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985312|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985313|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
138985314|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
138985315|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985316|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985317|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138985318|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
138985319|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
138985320|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138985321|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138985322|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985323|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985325|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138985326|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138985327|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138985328|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985329|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138985330|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138985331|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138985332|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138985333|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
138985334|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
138985335|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
138985336|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
138985337|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736162|NCT01323920|Bortezomib|bortezomib|mesh-list
138985338|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985339|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
138985340|NCT03958656|Fludarabine|fludarabine|mesh-list
138985341|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138985342|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
138985343|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011869|NCT00526656|Sunitinib|sunitinib|mesh-list
139011870|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011871|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139011872|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139011873|NCT00526656|Growth Substances|growth substances|mesh-ancestor
139011874|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011875|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
139011876|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139011877|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011878|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011879|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
139011880|NCT00858767|Vitamin K|vitamin k|mesh-list
139011881|NCT00858767|Menaquinone 7|menaquinone 7|mesh-list
139011882|NCT00858767|Caseins|caseins|mesh-list
139011883|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
139011884|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
139011885|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011886|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139011887|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139011888|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
139011889|NCT00858767|Coagulants|coagulants|mesh-ancestor
139011890|NCT00858767|Vitamins|vitamins|mesh-ancestor
139011891|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
139011892|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011893|NCT00617903|Azelaic acid|azelaic acid|mesh-list
139011894|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011895|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
139011922|NCT02544425|Ifosfamide|ifosfamide|mesh-list
139011923|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139011924|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
139011925|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
139011926|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139011927|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011928|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139011929|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
139011930|NCT02544425|Hormones|hormones|mesh-ancestor
139011931|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139011932|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139011933|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011934|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139011935|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139011936|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139011937|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011938|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011978|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762660|NCT00604006|Diuretics|diuretics|mesh-ancestor
139011979|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139011980|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139011981|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011982|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011983|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139011984|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
139011985|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139011986|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139011987|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139011988|NCT00573755|Sorafenib|sorafenib|mesh-list
139011989|NCT00573755|Letrozole|letrozole|mesh-list
139011990|NCT00573755|Anastrozole|anastrozole|mesh-list
139011991|NCT00573755|Exemestane|exemestane|mesh-list
139011992|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139011993|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139011994|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139011995|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139011996|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139011997|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139011998|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139011999|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
139012000|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139012001|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012002|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139012003|NCT02544191|Goserelin|goserelin|mesh-list
139012004|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138985344|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138985345|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138985346|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
138985347|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985348|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985349|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138985350|NCT00561912|Interferons|interferons|mesh-list
138985351|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
138985352|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
138985353|NCT00561912|Decitabine|decitabine|mesh-list
138985354|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985355|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
138985356|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985357|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
138985358|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012005|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012006|NCT00524316|Doxorubicin|doxorubicin|mesh-list
139012007|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139012008|NCT00524316|Sunitinib|sunitinib|mesh-list
139012009|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139012010|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012011|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139012012|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139012013|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012014|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012015|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139012016|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139012017|NCT00524316|Growth Substances|growth substances|mesh-ancestor
139012018|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012019|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
139012020|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139012021|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
139012022|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139012023|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139012024|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139012025|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139012026|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012027|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
139012028|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012029|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012030|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139012031|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012032|NCT02544269|Bupivacaine|bupivacaine|mesh-list
139012033|NCT02544269|Ropivacaine|ropivacaine|mesh-list
139012034|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
138940521|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
138985359|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138985360|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
138985361|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985362|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985363|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
138985364|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138985365|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138985366|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985367|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138985368|NCT00561678|Analgesics|analgesics|mesh-ancestor
138985369|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
138985370|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985371|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138985372|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139012035|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
139012036|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012037|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012038|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
139012039|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012040|NCT00434577|Vaccines|vaccines|mesh-list
139012041|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
139012042|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012043|NCT00865085|Dexetimide|dexetimide|mesh-list
139012044|NCT00865085|Citalopram|citalopram|mesh-list
139012045|NCT00865085|Escitalopram|escitalopram|mesh-list
139012046|NCT00865085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139012047|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139012048|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139012049|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012050|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012051|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
139012052|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012053|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139012054|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
139012055|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139012056|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139012057|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139012058|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
139012059|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
139012060|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012061|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139012062|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139012063|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
139012064|NCT00796068|Cyclosporine|cyclosporine|mesh-list
139012065|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
139012066|NCT00796068|Fludarabine|fludarabine|mesh-list
139012067|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
139012068|NCT00796068|Treosulfan|treosulfan|mesh-list
139012069|NCT00796068|Busulfan|busulfan|mesh-list
139012070|NCT00796068|Cyclosporins|cyclosporins|mesh-list
139012071|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039571|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
138985373|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138985374|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
139012072|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139012073|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
139012074|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012075|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139012076|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
139012077|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012078|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012079|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
139012080|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012081|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
139012082|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139012083|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139012084|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139012085|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139012086|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
139012087|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139012088|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139012089|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
139012090|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139012091|NCT04732182|Donepezil|donepezil|mesh-list
139012092|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139012093|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527084|NCT00029159|Estrogens|estrogens|mesh-list
138985375|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985376|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985378|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
138985379|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
138985380|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138985381|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138985382|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138985383|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
138985384|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
138985385|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985386|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985387|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985388|NCT00463684|Vaccines|vaccines|mesh-list
138985389|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
138985390|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985391|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
138985392|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138985393|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
138985395|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138985396|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985397|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138985398|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138985399|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138985400|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
138985401|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985402|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138985403|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138985404|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012094|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012095|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
139012096|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012097|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012098|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
139012099|NCT01009476|Nicergoline|nicergoline|mesh-list
139012100|NCT01009476|Piracetam|piracetam|mesh-list
139012101|NCT01009476|Galantamine|galantamine|mesh-list
139012102|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
139012103|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139012104|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012105|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493051|NCT00006104|Docetaxel|docetaxel|mesh-list
139012106|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
139012107|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012108|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012109|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139012110|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
139012111|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012112|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139012113|NCT01009476|Protective Agents|protective agents|mesh-ancestor
139012114|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139012115|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139012116|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
139012117|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
139012118|NCT00517296|Adalimumab|adalimumab|mesh-list
139012119|NCT00517296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138527141|NCT02970084|Vitamin K|vitamin k|mesh-list
138985405|NCT03961308|Vedolizumab|vedolizumab|mesh-list
138985406|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138985407|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138985408|NCT00956436|Sorafenib|sorafenib|mesh-list
138985409|NCT00956436|Liver Extracts|liver extracts|mesh-list
138985410|NCT00956436|Antibodies|antibodies|mesh-list
138985411|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
138985412|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138985413|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
138736241|NCT00600405|Ibuprofen|ibuprofen|mesh-list
138985414|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985415|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985416|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138985417|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985418|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985419|NCT00956436|Hematinics|hematinics|mesh-ancestor
138985420|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
138985421|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
138985422|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
138985423|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138985424|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138985425|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985426|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012120|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139012121|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139012123|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139012124|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139012125|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012126|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
139012127|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
139012128|NCT00523848|Thalidomide|thalidomide|mesh-list
138762844|NCT05225545|Iron|iron|mesh-list
139012130|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139012131|NCT00523848|Bortezomib|bortezomib|mesh-list
139012132|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139012133|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012134|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139012135|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139012136|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012137|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012138|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139012139|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
139012140|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012141|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
139012142|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139012143|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012144|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139012145|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139012146|NCT00523848|Growth Substances|growth substances|mesh-ancestor
139012147|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
139012148|NCT00617669|Docetaxel|docetaxel|mesh-list
139012149|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527195|NCT00029861|Rimonabant|rimonabant|mesh-list
138985427|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985429|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138985430|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
138985431|NCT00946686|Leflunomide|leflunomide|mesh-list
138985432|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985433|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985434|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138985435|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
138985436|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985437|NCT02531737|Docetaxel|docetaxel|mesh-list
138985438|NCT02531737|Nintedanib|nintedanib|mesh-list
138985439|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985440|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
138985441|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
138985442|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
138985443|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012150|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
139012151|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
139012152|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
139012153|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012154|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
139012155|NCT04018157|Ketamine|ketamine|mesh-list
139012156|NCT04018157|Propofol|propofol|mesh-list
139012157|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139012158|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012159|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012160|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139012161|NCT04018157|Analgesics|analgesics|mesh-ancestor
139012162|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
139012163|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012164|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139012165|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139012166|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139012167|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
139012168|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012169|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012170|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139012171|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
139012172|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
139012173|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139012174|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139012175|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139012176|NCT00865241|Metformin|metformin|mesh-list
139012177|NCT00865241|Glyburide|glyburide|mesh-list
139012178|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138641301|NCT00261599|Midazolam|midazolam|mesh-list
139012179|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012180|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139012181|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
139012182|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139012193|NCT00863291|Analgesics|analgesics|mesh-ancestor
139012194|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
139012195|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012196|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139012197|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
139012198|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139012199|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139012200|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012201|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
139012202|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
139012203|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012204|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
139012205|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139012206|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139012207|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012208|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139012209|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139012210|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012211|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012212|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012213|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139012214|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
139012215|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139012216|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012217|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139012218|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139012219|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139012220|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
139012221|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139012222|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012237|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139012238|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
139012239|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139012240|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012241|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139012242|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139012243|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
139012244|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
139012245|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
139012246|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139012247|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012248|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012249|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
139012250|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139012251|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012252|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012253|NCT00865631|Gabapentin|gabapentin|mesh-list
139012254|NCT00865631|Analgesics|analgesics|mesh-ancestor
139012255|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
139012256|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940615|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
139012257|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012258|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
139012259|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139012260|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139012261|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012262|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139012263|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139012264|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139012265|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012266|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012267|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
139012268|NCT00863837|Terlipressin|terlipressin|mesh-list
139012269|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139012270|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139012271|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012274|NCT00863915|Ramipril|ramipril|mesh-list
139012276|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
139012277|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012278|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012279|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139012280|NCT01009944|Atenolol|atenolol|mesh-list
139012281|NCT01009944|Lisinopril|lisinopril|mesh-list
139012282|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139012283|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
139012284|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012285|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012286|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139012287|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139012288|NCT01009944|Protective Agents|protective agents|mesh-ancestor
139012289|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012290|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139012291|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
139012292|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
139012293|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012294|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139012295|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139012296|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139012297|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
139012298|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012299|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
139012300|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
139012301|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
139012302|NCT00864071|Griseofulvin|griseofulvin|mesh-list
139012303|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
139012304|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012305|NCT00864149|Carvedilol|carvedilol|mesh-list
138527328|NCT00057720|Doxorubicin|doxorubicin|mesh-list
138985444|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138985445|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985446|NCT01326559|Docetaxel|docetaxel|mesh-list
138985447|NCT01326559|Cetuximab|cetuximab|mesh-list
138985448|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985449|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
138985450|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
138985451|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
138985452|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985453|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138985454|NCT04069949|Sorafenib|sorafenib|mesh-list
138985455|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985456|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138985457|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012306|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139012307|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139012308|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
139012309|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012310|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012311|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012312|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139012314|NCT00864149|Protective Agents|protective agents|mesh-ancestor
139012315|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139012316|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139012317|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139012318|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
139012319|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139012320|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139012321|NCT01010100|Acarbose|acarbose|mesh-list
139012322|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139012323|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012324|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012325|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139012326|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012327|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138527377|NCT02969733|Lidocaine|lidocaine|mesh-list
138985458|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985459|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
138985460|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138985461|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985462|NCT00467740|Olodaterol|olodaterol|mesh-list
138985463|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138985464|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
138985465|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985466|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985467|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138985468|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
138985469|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
138985470|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
138985471|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138985472|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138985473|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985474|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985475|NCT00710099|Urological Agents|urological agents|mesh-ancestor
138985476|NCT03944044|Acetaminophen|acetaminophen|mesh-list
138985477|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138985478|NCT03944044|Analgesics|analgesics|mesh-ancestor
138985479|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
138985480|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610996|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
138985481|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985482|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
138985483|NCT00714623|Sirolimus|sirolimus|mesh-list
138985484|NCT00714623|Temsirolimus|temsirolimus|mesh-list
139012328|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139012329|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
139012330|NCT01010178|Theophylline|theophylline|mesh-list
139012331|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139012332|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
139012333|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012334|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012335|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139012336|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
139012337|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139012338|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012339|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012340|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
139012341|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139012342|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139012343|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
139012344|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012345|NCT00617591|Dexamethasone|dexamethasone|mesh-list
139012346|NCT00617591|Doxorubicin|doxorubicin|mesh-list
139012347|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139012348|NCT00617591|Lenalidomide|lenalidomide|mesh-list
139012349|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139012350|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
139012351|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
139012352|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012353|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012354|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139012355|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
139012356|NCT00617591|Hormones|hormones|mesh-ancestor
139012357|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139012358|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139012359|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012371|NCT00864305|Analgesics|analgesics|mesh-ancestor
139012372|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
139012373|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012374|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012375|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
139012376|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139012377|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139012378|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012379|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139012380|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139012381|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139012382|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012383|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012384|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
139012385|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139012386|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139012387|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139012388|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139012389|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012390|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
139012391|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012392|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012393|NCT00864617|Nifedipine|nifedipine|mesh-list
139012394|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139012395|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139012396|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012397|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139012398|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012399|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
139012400|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
139012401|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139012402|NCT00865943|Dexetimide|dexetimide|mesh-list
139012403|NCT00865943|Citalopram|citalopram|mesh-list
138985485|NCT00714623|MTOR Inhibitors|mtor inhibitors|mesh-list
138985486|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138985487|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985488|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138985489|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985490|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
139012404|NCT00865943|Escitalopram|escitalopram|mesh-list
139012405|NCT00865943|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139012406|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139012407|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139012408|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012409|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012410|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
139012411|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012412|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139012413|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
139012414|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139012415|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139012416|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139012417|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
139012418|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
139012419|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012420|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139012421|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139012422|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
139012423|NCT00866021|Ritonavir|ritonavir|mesh-list
139012424|NCT00866021|Lopinavir|lopinavir|mesh-list
139012425|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139012426|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139012428|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012429|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012430|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138527499|NCT00031070|Cyclosporins|cyclosporins|mesh-list
138985491|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138985492|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
138985493|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985494|NCT00714623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138985495|NCT00714623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985496|NCT00714623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985497|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
138985498|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138985499|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138985500|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
138985501|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985502|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138985503|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138985504|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985505|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985506|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
138985507|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138985508|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138985509|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138985510|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139012431|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139012432|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
139012433|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012434|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139012435|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139012436|NCT00871247|Finasteride|finasteride|mesh-list
139012437|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138940681|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
139012438|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139012439|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012440|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012441|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
139012442|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139012443|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012444|NCT00871247|Urological Agents|urological agents|mesh-ancestor
139012445|NCT04137120|Aflibercept|aflibercept|mesh-list
139012446|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139012447|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139012448|NCT04137120|Growth Substances|growth substances|mesh-ancestor
139012449|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012450|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
139012451|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012452|NCT00616655|Eszopiclone|eszopiclone|mesh-list
139012453|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139012454|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012455|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012456|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
139012457|NCT00864773|Growth Substances|growth substances|mesh-ancestor
139012458|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012459|NCT01010490|Dipivefrin|dipivefrin|mesh-list
139012460|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139012461|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
139012462|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012463|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012464|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012465|NCT00516048|Exenatide|exenatide|mesh-list
139012466|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139012468|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139012469|NCT00516048|Incretins|incretins|mesh-ancestor
139012470|NCT00516048|Hormones|hormones|mesh-ancestor
139012471|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139012472|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
139012473|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012474|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139012475|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012476|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012477|NCT00865007|Ritonavir|ritonavir|mesh-list
139012478|NCT00865007|Lopinavir|lopinavir|mesh-list
139012479|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139012480|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139012481|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
139012482|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527583|NCT00031187|Docetaxel|docetaxel|mesh-list
138985511|NCT01021930|Sirolimus|sirolimus|mesh-list
138985512|NCT01021930|Paclitaxel|paclitaxel|mesh-list
138985513|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138985514|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985515|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
138985516|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
138985517|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
138985518|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985519|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138985520|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985521|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138985522|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
138985523|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138985524|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
138940701|NCT00710606|NuvaRing|nuvaring|mesh-list
138985525|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985526|NCT00946764|Imipramine|imipramine|mesh-list
138985527|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138985528|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
138985529|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138985530|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138985531|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138985532|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138985533|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985534|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
138985535|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985536|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985537|NCT00950820|Capecitabine|capecitabine|mesh-list
138985538|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
138985539|NCT00950820|Panitumumab|panitumumab|mesh-list
138985540|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138985541|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
138985542|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985543|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985544|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138985545|NCT00950898|Caffeine|caffeine|mesh-list
138985546|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138985547|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985548|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138985549|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985550|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985551|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138985552|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138985553|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
139012483|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012484|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139012485|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139012486|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
139012487|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012488|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139012489|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139012490|NCT00872417|Lamivudine|lamivudine|mesh-list
139012491|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139012492|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138940717|NCT00713544|Etanercept|etanercept|mesh-list
139012493|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012494|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012495|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
139012496|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012497|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139012498|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139012499|NCT00876317|Etoricoxib|etoricoxib|mesh-list
139012500|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139012501|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139012502|NCT00876317|Analgesics|analgesics|mesh-ancestor
139012503|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
139012504|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012505|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012506|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139012507|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139012508|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139012509|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139012510|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012511|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985554|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985556|NCT00168805|Dabigatran|dabigatran|mesh-list
138985557|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
138985558|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138985559|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138985560|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985561|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
138985562|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138985563|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
138985564|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985565|NCT00467584|Aspirin|aspirin|mesh-list
138985566|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138985567|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138985568|NCT00467584|Analgesics|analgesics|mesh-ancestor
138985569|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
139012512|NCT00866645|Haloperidol|haloperidol|mesh-list
139012513|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
139012515|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139012516|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
139012517|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
139012518|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012519|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012520|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139012521|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139012522|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139012523|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012524|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139012525|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139012526|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
139012527|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012528|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527731|NCT00031733|Antacids|antacids|mesh-ancestor
138985570|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985571|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985572|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138985573|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138985574|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138985575|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138985576|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985577|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138985578|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138985579|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985580|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
138985581|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
138985582|NCT02574611|Neostigmine|neostigmine|mesh-list
138985583|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138985584|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985585|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985586|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
138985587|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985588|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985589|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138985591|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985592|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138985593|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138985594|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138985595|NCT00714779|Fluoxetine|fluoxetine|mesh-list
138985596|NCT00714779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138985597|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138985598|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138985599|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985600|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985601|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
138985602|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985603|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138985604|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
138985605|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138985606|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138985607|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138985608|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985609|NCT00168103|Complement C1s|complement c1s|mesh-list
138985610|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139012529|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139012530|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139012531|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
139012532|NCT00872651|Timolol|timolol|mesh-list
139012533|NCT00872651|Travoprost|travoprost|mesh-list
139012534|NCT00872651|Latanoprost|latanoprost|mesh-list
139012535|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139012536|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139012537|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
139012538|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012539|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012540|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012541|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139012542|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139012543|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139012544|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139012545|NCT00872963|Vaccines|vaccines|mesh-list
139012546|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
139012547|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012548|NCT00873197|Granisetron|granisetron|mesh-list
139012549|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
139012550|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
139012551|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012552|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012553|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139012554|NCT00873197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139012555|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139012556|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
139012557|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012558|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012559|NCT00873353|Capecitabine|capecitabine|mesh-list
139012560|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139012561|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139012562|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
138985611|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138985612|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
138985613|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985614|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138985615|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138985616|NCT00463060|Sunitinib|sunitinib|mesh-list
138985617|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985618|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139012563|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012564|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012565|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139012566|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012567|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
139012568|NCT00877097|Trisequens|trisequens|mesh-list
139012569|NCT00877097|Norethindrone|norethindrone|mesh-list
139012570|NCT00877097|Estradiol|estradiol|mesh-list
139012571|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139012572|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012573|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139012574|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139012576|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
139012577|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139012578|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139012579|NCT00877097|Estrogens|estrogens|mesh-ancestor
139012580|NCT00877097|Hormones|hormones|mesh-ancestor
139012581|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139012582|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139012583|NCT00877175|Phenylephrine|phenylephrine|mesh-list
139012584|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
139012585|NCT00877175|Tropicamide|tropicamide|mesh-list
139012586|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138985619|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138985620|NCT00463060|Growth Substances|growth substances|mesh-ancestor
138985621|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985622|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
138985623|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138985624|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985625|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985626|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
138985627|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
138985628|NCT00956748|Dexamethasone|dexamethasone|mesh-list
138985629|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138985630|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
138985631|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
138940784|NCT00713258|Hormones|hormones|mesh-list
138985632|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985633|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611286|NCT00216684|Fentanyl|fentanyl|mesh-list
138985634|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138985635|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
138736473|NCT01317615|Paclitaxel|paclitaxel|mesh-list
138985637|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138985638|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138985639|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985640|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985641|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985642|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
138985643|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985644|NCT00956748|Expectorants|expectorants|mesh-ancestor
138985645|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
138985646|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138985647|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
138985648|NCT00956748|Protective Agents|protective agents|mesh-ancestor
139012587|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
139012588|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
139012589|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012590|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012591|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
139012592|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139012593|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
139012594|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
139012595|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139012596|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139012597|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139012598|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
139012599|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012600|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012601|NCT00877175|Protective Agents|protective agents|mesh-ancestor
139012602|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139012603|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139012604|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
139012605|NCT00420927|Adalimumab|adalimumab|mesh-list
139012606|NCT00420927|Methotrexate|methotrexate|mesh-list
139012607|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139012608|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
139012609|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139012610|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012611|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139012612|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
139012613|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012614|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012615|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
139012616|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012617|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139012618|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138985649|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138985650|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138985651|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138985652|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138985653|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138985654|NCT01079923|Vitamin D|vitamin d|mesh-list
138985655|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
138985656|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
138985657|NCT01079923|Vitamins|vitamins|mesh-list
138985658|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
138985659|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012619|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
139012620|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139012621|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139012622|NCT00420927|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139012623|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139012624|NCT00573443|Quinidine|quinidine|mesh-list
139012625|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
139012626|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
139012627|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
139012628|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
139012629|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139012630|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139012631|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012632|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012633|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012634|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139012635|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139012636|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
139012637|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139012638|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
139012639|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139012640|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139012641|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012642|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012643|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139012644|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139012645|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
139039572|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985660|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138985661|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138985662|NCT00947076|Fluoxetine|fluoxetine|mesh-list
138985663|NCT00947076|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138985664|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138985665|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138985666|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985667|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985668|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
138985669|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985670|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138985671|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
138985672|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138985673|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138985674|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138985675|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985676|NCT00462982|Sunitinib|sunitinib|mesh-list
139012646|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139012647|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138763337|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139012648|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139012649|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139012650|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139012651|NCT05225831|Cyclophosphamide|cyclophosphamide|mesh-list
139012652|NCT05225831|Fludarabine|fludarabine|mesh-list
139012653|NCT05225831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139012654|NCT05225831|Immunologic Factors|immunologic factors|mesh-ancestor
139012655|NCT05225831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012656|NCT05225831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139012657|NCT05225831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139012658|NCT05225831|Alkylating Agents|alkylating agents|mesh-ancestor
139012659|NCT05225831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940811|NCT00414973|Calcitonin|calcitonin|mesh-list
139012660|NCT05225831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012661|NCT05225831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139012662|NCT00873509|Buspirone|buspirone|mesh-list
139012663|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139012664|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139012665|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012666|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012667|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139012668|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139012669|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
139012670|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012671|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012672|NCT00877253|Carboplatin|carboplatin|mesh-list
139012673|NCT00877253|genexol-PM|genexol-pm|mesh-list
139012674|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012675|NCT00877253|Tubulin Modulators|tubulin modulators|mesh-ancestor
139012676|NCT00877253|Antimitotic Agents|antimitotic agents|mesh-ancestor
139012677|NCT00877253|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527933|NCT00060411|Leucovorin|leucovorin|mesh-list
138985677|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985678|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138985679|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138985680|NCT00462982|Growth Substances|growth substances|mesh-ancestor
138985681|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985682|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
139012678|NCT00877253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012679|NCT05225753|Chrysarobin|chrysarobin|mesh-list
139012680|NCT05225753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139012681|NCT05225753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139012682|NCT05225753|Analgesics|analgesics|mesh-ancestor
139012683|NCT05225753|Sensory System Agents|sensory system agents|mesh-ancestor
139012684|NCT05225753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012685|NCT05225753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012686|NCT05225753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139012687|NCT05225753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139012688|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139012689|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
139012690|NCT00874133|Domperidone|domperidone|mesh-list
139012691|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
139012692|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
139012693|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012694|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012695|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139012696|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139012697|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
139012698|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012699|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012700|NCT00867737|Fluticasone|fluticasone|mesh-list
139012701|NCT00867737|Budesonide|budesonide|mesh-list
139012702|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
139012703|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139012704|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139012705|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138985683|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138985684|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985685|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985686|NCT02573597|Sufentanil|sufentanil|mesh-list
138985687|NCT02573597|Bupivacaine|bupivacaine|mesh-list
138985688|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
138985689|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
138985690|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138985691|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985692|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
138985693|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985694|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138985695|NCT02573597|Narcotics|narcotics|mesh-ancestor
138985696|NCT02573597|Analgesics|analgesics|mesh-ancestor
138985697|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138985698|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138985699|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
138985700|NCT05300958|Deferoxamine|deferoxamine|mesh-list
138985701|NCT05300958|Siderophores|siderophores|mesh-ancestor
139012706|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139012707|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139012708|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
139012709|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012710|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012711|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139012712|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
139012713|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
139012714|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139012715|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
139012716|NCT00867737|Hormones|hormones|mesh-ancestor
139012717|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139012718|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139012719|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139012720|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138763412|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139012722|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012723|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012724|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
139012725|NCT04040465|Aspirin|aspirin|mesh-list
139012726|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139012727|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139012728|NCT04040465|Analgesics|analgesics|mesh-ancestor
139012729|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
139012730|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012731|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012732|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139012733|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139012734|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139012735|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138528021|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985702|NCT05300958|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138985703|NCT05300958|Chelating Agents|chelating agents|mesh-ancestor
138985704|NCT05300958|Sequestering Agents|sequestering agents|mesh-ancestor
138985705|NCT05300958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985706|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
138985707|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138985708|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
138985709|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985710|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
138985711|NCT04070729|Protective Agents|protective agents|mesh-ancestor
138985712|NCT00467272|Daptomycin|daptomycin|mesh-list
138985713|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139012736|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012737|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139012738|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139012739|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012741|NCT00420849|Dexamethasone|dexamethasone|mesh-list
139012742|NCT00420849|Lenalidomide|lenalidomide|mesh-list
139012743|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139012744|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
139012745|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
139012746|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012747|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012748|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139012749|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
139012750|NCT00420849|Hormones|hormones|mesh-ancestor
139012751|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139012752|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139012753|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012754|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
139012755|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139012756|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139012757|NCT00420849|Growth Substances|growth substances|mesh-ancestor
139012758|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
139012759|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
139012760|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139012761|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139012762|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139012763|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
139012764|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012765|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139012766|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138985714|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985715|NCT00956982|Interferons|interferons|mesh-list
138985716|NCT00956982|Ribavirin|ribavirin|mesh-list
138985717|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
138985718|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
138985719|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138985720|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985721|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
138985722|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985724|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985725|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
138985726|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985727|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
138985728|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138985729|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012767|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012768|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012769|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139012770|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139012771|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
139012772|NCT00874601|Valsartan|valsartan|mesh-list
139012773|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139012774|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139012775|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139012776|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012777|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139012778|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
139012779|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139012780|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139012781|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012782|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012783|NCT00874679|Urological Agents|urological agents|mesh-ancestor
139012784|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139012785|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139012786|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139012787|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139012788|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012789|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
139012790|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012791|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012792|NCT00420303|Etanercept|etanercept|mesh-list
138763485|NCT00405613|Aspirin|aspirin|mesh-list
139012793|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139012795|NCT00420303|Analgesics|analgesics|mesh-ancestor
139012796|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
139012808|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012809|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012810|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139012811|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139012812|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139012813|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
139012814|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
139012815|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012816|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012817|NCT00419757|Budesonide|budesonide|mesh-list
139012818|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
139012819|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139012820|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139012821|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139012822|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
139012823|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012824|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012825|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139012826|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
139012827|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
139012828|NCT00419757|Hormones|hormones|mesh-ancestor
139012829|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139012830|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139012831|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139012832|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139012833|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
139012834|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012835|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012853|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
139012854|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138940883|NCT03904381|Fluorouracil|fluorouracil|mesh-list
139012855|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012856|NCT00875147|Bevacizumab|bevacizumab|mesh-list
139012857|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139012858|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012859|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139012860|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139012861|NCT00875147|Growth Substances|growth substances|mesh-ancestor
139012862|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012863|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
139012864|NCT00433329|Bosentan|bosentan|mesh-list
139012865|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
139012866|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
139012867|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139012868|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139012869|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012870|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985730|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985731|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138985732|NCT00714857|Analgesics|analgesics|mesh-ancestor
138985733|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
138985734|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985735|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138985736|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138985737|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138985738|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
138985739|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985740|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985741|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138985742|NCT00957060|Glimepiride|glimepiride|mesh-list
138985743|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138985744|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985745|NCT00957060|Incretins|incretins|mesh-ancestor
138985746|NCT00957060|Hormones|hormones|mesh-ancestor
138985747|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138985748|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138985749|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
138985750|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985751|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985752|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138985753|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138985754|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
138985756|NCT02573519|Donepezil|donepezil|mesh-list
138985757|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138985758|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138985759|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985760|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985761|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
138985762|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985763|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985764|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
138985765|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
138985766|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138985767|NCT02572583|Oseltamivir|oseltamivir|mesh-list
138985768|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
138985769|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012871|NCT00433329|Urological Agents|urological agents|mesh-ancestor
139012872|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139012873|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139012874|NCT01035021|Rocuronium|rocuronium|mesh-list
139012875|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139012876|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139012877|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139012878|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012879|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012880|NCT00878345|Pentobarbital|pentobarbital|mesh-list
139012881|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
139012882|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139012883|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139012884|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012885|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139012886|NCT00878345|Analgesics|analgesics|mesh-ancestor
139012887|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
139012888|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012889|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139012890|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139012891|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139012892|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
139012893|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139012894|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012895|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139012896|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
139012897|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
139012898|NCT00433017|Ranibizumab|ranibizumab|mesh-list
139012899|NCT00433017|Verteporfin|verteporfin|mesh-list
139012900|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139012901|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139012902|NCT00433017|Growth Substances|growth substances|mesh-ancestor
139012903|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012904|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
139012905|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012906|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139012910|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139012911|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
139012912|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012913|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139012914|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139012915|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
139012916|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
139012917|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139012918|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012919|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139012920|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
139012921|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138940921|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139012922|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012923|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012924|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012925|NCT00875537|Capsaicin|capsaicin|mesh-list
139012926|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
139012927|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
139012928|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
139012929|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012930|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012931|NCT00875771|Bevacizumab|bevacizumab|mesh-list
139012932|NCT00875771|Capecitabine|capecitabine|mesh-list
139012933|NCT00875771|Irinotecan|irinotecan|mesh-list
139012934|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139012935|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012936|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139012937|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139012938|NCT00875771|Growth Substances|growth substances|mesh-ancestor
139012957|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139012958|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
139012959|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012960|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012961|NCT00868829|Chromium|chromium|mesh-list
139012962|NCT00868829|Sirolimus|sirolimus|mesh-list
139012963|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139012964|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139012965|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139012966|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139012967|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
139012968|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139012969|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
139012970|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012971|NCT00868829|Trace Elements|trace elements|mesh-ancestor
139012972|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
139012973|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
139012974|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
139012975|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138985770|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985771|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985772|NCT00951444|Carboplatin|carboplatin|mesh-list
138985773|NCT00951444|Gemcitabine|gemcitabine|mesh-list
138985774|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985775|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138985776|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
138985777|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985778|NCT00462826|Aflibercept|aflibercept|mesh-list
138985779|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
138985780|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138985781|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138985782|NCT00462826|Growth Substances|growth substances|mesh-ancestor
138985783|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985784|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
138985785|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985787|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
138985788|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985789|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985790|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138985791|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138985792|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
138985793|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138985794|NCT00947388|Antibodies|antibodies|mesh-list
138985795|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
138985796|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138985797|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
138985798|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985799|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985800|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138985801|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
138985802|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985803|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
138985804|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
138985805|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138985806|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138985807|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139012976|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139012977|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012978|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139012979|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012980|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139012981|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139012982|NCT00868985|Laxatives|laxatives|mesh-ancestor
139012983|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139012984|NCT00869063|Diclofenac|diclofenac|mesh-list
139012985|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139012986|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139012987|NCT00869063|Analgesics|analgesics|mesh-ancestor
139012988|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
139012989|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139012990|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139012991|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139012992|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139012993|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139012994|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139012995|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139012996|NCT00869219|Nepafenac|nepafenac|mesh-list
139012997|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138528349|NCT00034229|Felbamate|felbamate|mesh-list
138985808|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985809|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138985810|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138985811|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
138985812|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138985813|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
138985814|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985815|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985816|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138985817|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
138940982|NCT00712920|Azelastine|azelastine|mesh-list
138985819|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
138985820|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
138985821|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985822|NCT00957216|Vitamins|vitamins|mesh-ancestor
138985823|NCT00718757|Dexamethasone|dexamethasone|mesh-list
138985824|NCT00718757|Irinotecan|irinotecan|mesh-list
138985825|NCT00718757|Vincristine|vincristine|mesh-list
138611538|NCT00589732|Valsartan|valsartan|mesh-list
138985826|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138985827|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
138985828|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
138985829|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985830|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985831|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138985832|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
138985833|NCT00718757|Hormones|hormones|mesh-ancestor
138985834|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139012998|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139012999|NCT00869219|Analgesics|analgesics|mesh-ancestor
139013000|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
139013001|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013002|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013003|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139013004|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139013005|NCT03994965|Pimavanserin|pimavanserin|mesh-list
139013006|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139013007|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139013008|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139013009|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139013010|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013011|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013012|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139013013|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139013014|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139013015|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
139013016|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985835|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138985836|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985837|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138985838|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138985839|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985840|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985841|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138985842|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
138985843|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
138985844|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
138985845|NCT00947466|Buprenorphine|buprenorphine|mesh-list
138985846|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138985847|NCT00947466|Narcotics|narcotics|mesh-ancestor
138985848|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138985849|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985850|NCT00947466|Analgesics|analgesics|mesh-ancestor
138985851|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
138985852|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985853|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138985854|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138985856|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985857|NCT00951834|Protective Agents|protective agents|mesh-ancestor
138985858|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985859|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138985860|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138985861|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985862|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138985863|NCT00715013|Epothilone B|epothilone b|mesh-list
138985864|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985865|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
138985866|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
138985867|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
138985868|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985869|NCT00715091|Diclofenac|diclofenac|mesh-list
138985870|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138985871|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138985872|NCT00715091|Analgesics|analgesics|mesh-ancestor
139013017|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013018|NCT00531284|Dexamethasone|dexamethasone|mesh-list
139013019|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139013020|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
139013021|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
139013022|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013023|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013024|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139013025|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
139013026|NCT00531284|Hormones|hormones|mesh-ancestor
139013027|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139013028|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139013029|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013030|NCT00531206|Ritonavir|ritonavir|mesh-list
139013031|NCT00531206|Tipranavir|tipranavir|mesh-list
139013032|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139013033|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139013034|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
139013035|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013036|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013037|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139013038|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139013039|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
139013040|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013041|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139013042|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139013043|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
139013044|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
139013045|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
139013046|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139013047|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013048|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
139013049|NCT00994994|Coagulants|coagulants|mesh-ancestor
139013050|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
139013051|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138985873|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
138985874|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138985875|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985876|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138985877|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139013052|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139013053|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013054|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139013055|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139013056|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013057|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013058|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139013059|NCT00999752|Nebivolol|nebivolol|mesh-list
139013060|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139013061|NCT00999752|Diuretics|diuretics|mesh-ancestor
139013062|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
139013063|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013064|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139013065|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139013066|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013067|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
139013068|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139013069|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139013070|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139013071|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
139013072|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139013073|NCT01005758|Cytarabine|cytarabine|mesh-list
139013074|NCT01005758|Dexamethasone|dexamethasone|mesh-list
139013075|NCT01005758|Prednisone|prednisone|mesh-list
139013076|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
139013077|NCT01005758|Prednisolone|prednisolone|mesh-list
139013078|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
139013079|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139013080|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139013081|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139013082|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
139013099|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013100|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139013101|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139013102|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
139013103|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
139013104|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013105|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139013106|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
139013107|NCT01005758|Hormones|hormones|mesh-ancestor
139013108|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139013109|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139013110|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139013111|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139013112|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139013113|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013114|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139013115|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
139013116|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139013117|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139013118|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
139013119|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
139013120|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139013121|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139013122|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139013123|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
139013124|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013125|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
139013126|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
139013127|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
139013128|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139013129|NCT01005758|Protective Agents|protective agents|mesh-ancestor
139013130|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139013131|NCT00879047|Ethanol|ethanol|mesh-list
139013132|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139013133|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013134|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013136|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
139013137|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139013138|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
139013139|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013140|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139013141|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139013142|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
139013143|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013144|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013145|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139013146|NCT01000220|Omeprazole|omeprazole|mesh-list
139013147|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139013148|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139013149|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139013150|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013151|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013152|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
139013153|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139013154|NCT01000298|Amoxicillin|amoxicillin|mesh-list
139013155|NCT01000298|Cefdinir|cefdinir|mesh-list
139013156|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139013157|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013158|NCT00614939|Saxagliptin|saxagliptin|mesh-list
139013159|NCT00614939|Incretins|incretins|mesh-ancestor
139013160|NCT00614939|Hormones|hormones|mesh-ancestor
139013161|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139013162|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013163|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139013164|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
139013165|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013166|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013167|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139013168|NCT00879827|PENTA|penta|mesh-list
139013169|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
139013170|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139013171|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139013173|NCT01007084|Propranolol|propranolol|mesh-list
139013177|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139013178|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013179|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013180|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139013181|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139013182|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
139013183|NCT04040309|Lidocaine|lidocaine|mesh-list
139013184|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
139013185|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
139013186|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013187|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013188|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
139013189|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013190|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139013191|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139013192|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139013193|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139013194|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013195|NCT01000688|Vildagliptin|vildagliptin|mesh-list
139013196|NCT01000688|Acarbose|acarbose|mesh-list
139013197|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139013198|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013199|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139013200|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
138528618|NCT00062283|Alanosine|alanosine|mesh-list
138985878|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138985879|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985880|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985881|NCT00718913|Docetaxel|docetaxel|mesh-list
138985882|NCT00718913|Capecitabine|capecitabine|mesh-list
138985883|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985884|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
138985885|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
138985886|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
138985887|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985888|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138985889|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
138985890|NCT04011930|Vitamin D|vitamin d|mesh-list
138985891|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
138985892|NCT04011930|Calcitriol|calcitriol|mesh-list
138985893|NCT04011930|Vitamins|vitamins|mesh-ancestor
138985894|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
138985895|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985896|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138985897|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138985898|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138985899|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138985900|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013201|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013202|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013203|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139013205|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139013206|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013207|NCT00880061|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
139013208|NCT00880061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013209|NCT00869765|Cycloserine|cycloserine|mesh-list
139013210|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139013211|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013212|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139013213|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
139013214|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139013215|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
139013216|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013217|NCT00880373|Ibuprofen|ibuprofen|mesh-list
139013218|NCT00880373|Morphine|morphine|mesh-list
139013219|NCT00880373|Heroin|heroin|mesh-list
139013220|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139013221|NCT00880373|Narcotics|narcotics|mesh-ancestor
139013222|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013223|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013224|NCT00880373|Analgesics|analgesics|mesh-ancestor
139013225|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
138941056|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
139013226|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013227|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139013228|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139013229|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139013230|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139013231|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138528685|NCT00035282|Aprepitant|aprepitant|mesh-list
138985901|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138985902|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
138985903|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138985904|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
138985905|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138985906|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985907|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138985908|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138985909|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138985910|NCT02574221|Fluorides|fluorides|mesh-list
138985911|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
138985912|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
139013232|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013233|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013235|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139013236|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013237|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013238|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139013239|NCT01007630|Protective Agents|protective agents|mesh-ancestor
139013240|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013241|NCT05883384|Caseins|caseins|mesh-list
139013243|NCT05883384|Sequestering Agents|sequestering agents|mesh-ancestor
139013244|NCT05883384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013245|NCT05883345|Immunoglobulins|immunoglobulins|mesh-list
139013246|NCT05883345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139013247|NCT05883345|Antibodies|antibodies|mesh-list
139013248|NCT05883345|Immunoglobulin G|immunoglobulin g|mesh-list
139013249|NCT05883345|Gastrins|gastrins|mesh-list
139013250|NCT05883345|Immunologic Factors|immunologic factors|mesh-ancestor
139013251|NCT05883345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013252|NCT05883345|Hormones|hormones|mesh-ancestor
139013253|NCT05883345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139013254|NCT05883332|Nitrous Oxide|nitrous oxide|mesh-list
139013255|NCT05883332|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139013256|NCT05883332|Anesthetics, General|anesthetics, general|mesh-ancestor
139013257|NCT05883332|Anesthetics|anesthetics|mesh-ancestor
139013258|NCT05883332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013259|NCT05883332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013260|NCT05883332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139013261|NCT05883332|Analgesics|analgesics|mesh-ancestor
139013262|NCT05883332|Sensory System Agents|sensory system agents|mesh-ancestor
139013263|NCT05883332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013264|NCT05883176|Bevacizumab|bevacizumab|mesh-list
138528695|NCT00062556|Lovastatin|lovastatin|mesh-list
138985913|NCT02574221|Protective Agents|protective agents|mesh-ancestor
138985914|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985915|NCT00452530|Enoxaparin|enoxaparin|mesh-list
138985916|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
138985917|NCT00452530|Apixaban|apixaban|mesh-list
138985918|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
138985919|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138985920|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138985921|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985922|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138985923|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
139013265|NCT05883176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139013266|NCT05883176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013267|NCT05883176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139013268|NCT05883176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139013269|NCT05883176|Growth Substances|growth substances|mesh-ancestor
139013270|NCT05883176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013271|NCT05883176|Growth Inhibitors|growth inhibitors|mesh-ancestor
139013273|NCT05883124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139013274|NCT05883124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013275|NCT05883124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013276|NCT05883124|Cholinergic Agents|cholinergic agents|mesh-ancestor
139013277|NCT05883124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139013278|NCT05883124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013279|NCT05883124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139013280|NCT05883124|Protective Agents|protective agents|mesh-ancestor
139013281|NCT05883046|Performance-Enhancing Substances|performance-enhancing substances|mesh-list
139013282|NCT05883046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013283|NCT05882864|Triamcinolone|triamcinolone|mesh-list
139013284|NCT05882864|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139013285|NCT05882864|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139013286|NCT05882864|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139013287|NCT05882864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139013288|NCT05882864|Glucocorticoids|glucocorticoids|mesh-ancestor
139013289|NCT05882864|Hormones|hormones|mesh-ancestor
139013290|NCT05882864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139013291|NCT05882864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013292|NCT05882864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139013293|NCT05882864|Immunologic Factors|immunologic factors|mesh-ancestor
139013294|NCT05882864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528737|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
138985924|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138985925|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
138985926|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985927|NCT00549198|Tenofovir|tenofovir|mesh-list
138985928|NCT00549198|Lamivudine|lamivudine|mesh-list
138985929|NCT00549198|Emtricitabine|emtricitabine|mesh-list
138985930|NCT00549198|Efavirenz|efavirenz|mesh-list
138985931|NCT00549198|Abacavir|abacavir|mesh-list
138985932|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
138985933|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138985934|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138985935|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138985936|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013295|NCT05882864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013296|NCT05882630|Carboplatin|carboplatin|mesh-list
139013297|NCT05882630|Etoposide|etoposide|mesh-list
139013298|NCT05882630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013299|NCT05882630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139013300|NCT05882630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139013301|NCT05882630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139013302|NCT05882630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013303|NCT05882630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013304|NCT05881980|Itraconazole|itraconazole|mesh-list
139013305|NCT05881980|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139013306|NCT05881980|Terbinafine|terbinafine|mesh-list
139013307|NCT05881980|Antifungal Agents|antifungal agents|mesh-ancestor
139013308|NCT05881980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013309|NCT05881980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139013310|NCT05881980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139013311|NCT05881980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013312|NCT05881980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528780|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
138985937|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985939|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138985940|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138985941|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138611669|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138985942|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138985943|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138985944|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138985945|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138985947|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138985948|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985949|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985950|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
138985951|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138985952|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985953|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138985954|NCT00506415|Protective Agents|protective agents|mesh-ancestor
138985955|NCT04036526|Vaccines|vaccines|mesh-list
138985956|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
138985957|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985958|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138985959|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
138985960|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985961|NCT01009437|Ritonavir|ritonavir|mesh-list
138985962|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138985963|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138985964|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
138985965|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138985966|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138985967|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138985968|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138985969|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
138985970|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013313|NCT05881980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139013314|NCT05881980|Hormone Antagonists|hormone antagonists|mesh-ancestor
138764008|NCT05410223|Amoxicillin|amoxicillin|mesh-list
139013315|NCT05881980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139013316|NCT05881980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013317|NCT05881980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139013319|NCT05881746|Hematinics|hematinics|mesh-ancestor
139013320|NCT05881525|Paclitaxel|paclitaxel|mesh-list
139013321|NCT05881525|Cyclophosphamide|cyclophosphamide|mesh-list
139013322|NCT05881525|Fludarabine|fludarabine|mesh-list
139013323|NCT05881525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139013324|NCT05881525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013325|NCT05881525|Tubulin Modulators|tubulin modulators|mesh-ancestor
139013326|NCT05881525|Antimitotic Agents|antimitotic agents|mesh-ancestor
139013327|NCT05881525|Mitosis Modulators|mitosis modulators|mesh-ancestor
139013328|NCT05881525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013329|NCT05881525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139013330|NCT05881525|Immunologic Factors|immunologic factors|mesh-ancestor
139013331|NCT05881525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013332|NCT05881525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139013333|NCT05881525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139013334|NCT05881525|Alkylating Agents|alkylating agents|mesh-ancestor
139013335|NCT05881525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139013336|NCT05881187|Riboflavin|riboflavin|mesh-list
139013337|NCT05881187|Antifungal Agents|antifungal agents|mesh-list
139013338|NCT05881187|Clotrimazole|clotrimazole|mesh-list
139013339|NCT05881187|Miconazole|miconazole|mesh-list
139013340|NCT05881187|Vitamin B Complex|vitamin b complex|mesh-ancestor
139013341|NCT05881187|Vitamins|vitamins|mesh-ancestor
139013342|NCT05881187|Micronutrients|micronutrients|mesh-ancestor
139013343|NCT05881187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013344|NCT05881187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139013345|NCT05881187|Dermatologic Agents|dermatologic agents|mesh-ancestor
139013346|NCT05881187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013347|NCT05881187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138941092|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139013348|NCT05881187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139013349|NCT05881187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139013351|NCT05881187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013352|NCT05881187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139013353|NCT05881187|Hormone Antagonists|hormone antagonists|mesh-ancestor
139013354|NCT05881187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139013355|NCT05881187|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139013356|NCT05881187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139013357|NCT05880732|Magnesium Sulfate|magnesium sulfate|mesh-list
139013358|NCT05880732|Analgesics|analgesics|mesh-ancestor
139013359|NCT05880732|Sensory System Agents|sensory system agents|mesh-ancestor
139013360|NCT05880732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013361|NCT05880732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013362|NCT05880732|Anesthetics|anesthetics|mesh-ancestor
139013363|NCT05880732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013364|NCT05880732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139013365|NCT05880732|Anticonvulsants|anticonvulsants|mesh-ancestor
139013366|NCT05880732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139013367|NCT05880732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139013368|NCT05880732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013369|NCT05880732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139013370|NCT05880732|Tocolytic Agents|tocolytic agents|mesh-ancestor
139013371|NCT05880732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139013372|NCT05880693|Magnesium Sulfate|magnesium sulfate|mesh-list
139013373|NCT05880693|Dexmedetomidine|dexmedetomidine|mesh-list
139013374|NCT05880693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139013375|NCT05880693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013376|NCT05880693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013377|NCT05880693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139013378|NCT05880693|Analgesics|analgesics|mesh-ancestor
139013379|NCT05880693|Sensory System Agents|sensory system agents|mesh-ancestor
139013380|NCT05880693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528874|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
138985971|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138985972|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138985973|NCT00719381|Pioglitazone|pioglitazone|mesh-list
138985974|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138985975|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985976|NCT00510783|Phenytoin|phenytoin|mesh-list
138985977|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
138985978|NCT00510783|Levetiracetam|levetiracetam|mesh-list
138985979|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
138985980|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
139013381|NCT05880693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139013382|NCT05880693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139013383|NCT05880693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139013384|NCT05880693|Adrenergic Agents|adrenergic agents|mesh-ancestor
139013385|NCT05880693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139013386|NCT05880693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013387|NCT05880693|Anesthetics|anesthetics|mesh-ancestor
139013388|NCT05880693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139013390|NCT05880693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138941103|NCT05733078|Ascorbic Acid|ascorbic acid|mesh-list
139013391|NCT05880693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139013392|NCT05880693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139013393|NCT05880693|Tocolytic Agents|tocolytic agents|mesh-ancestor
139013394|NCT05880693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139013395|NCT05880342|Methylphenidate|methylphenidate|mesh-list
139013396|NCT05880342|Reboxetine|reboxetine|mesh-list
139013397|NCT05880342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139013398|NCT05880342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013399|NCT05880342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139013400|NCT05880342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139013401|NCT05880342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139013402|NCT05880342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013403|NCT05880342|Dopamine Agents|dopamine agents|mesh-ancestor
139013404|NCT05880342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139013405|NCT05880342|Antidepressive Agents|antidepressive agents|mesh-ancestor
139013406|NCT05880342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139013407|NCT05880342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139013408|NCT05880342|Adrenergic Agents|adrenergic agents|mesh-ancestor
139013409|NCT05880186|Caffeine|caffeine|mesh-list
139013410|NCT05880186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139013411|NCT05880186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013412|NCT05880186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139013424|NCT05880082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139013425|NCT05880030|Vitamin D|vitamin d|mesh-list
139013426|NCT05880030|Cholecalciferol|cholecalciferol|mesh-list
139013427|NCT05880030|Vitamins|vitamins|mesh-ancestor
139013428|NCT05880030|Micronutrients|micronutrients|mesh-ancestor
139013429|NCT05880030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013430|NCT05880030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139013431|NCT05880030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139013432|NCT05880017|Morphine|morphine|mesh-list
139013433|NCT05880017|Bupivacaine|bupivacaine|mesh-list
139013434|NCT05880017|Anesthetics, Local|anesthetics, local|mesh-ancestor
139013435|NCT05880017|Anesthetics|anesthetics|mesh-ancestor
139013436|NCT05880017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013437|NCT05880017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013438|NCT05880017|Sensory System Agents|sensory system agents|mesh-ancestor
139013439|NCT05880017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013440|NCT05880017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139013441|NCT05880017|Narcotics|narcotics|mesh-ancestor
139013442|NCT05880017|Analgesics|analgesics|mesh-ancestor
139013443|NCT05879796|Cisplatin|cisplatin|mesh-list
139013444|NCT05879796|Endostatins|endostatins|mesh-list
139013445|NCT05879796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013446|NCT05879796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139013447|NCT05879796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139013448|NCT05879796|Growth Substances|growth substances|mesh-ancestor
139013449|NCT05879796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013450|NCT05879796|Growth Inhibitors|growth inhibitors|mesh-ancestor
139013451|NCT05879627|Exatecan|exatecan|mesh-list
139013452|NCT05879627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139013453|NCT05879627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139013454|NCT05879627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013455|NCT05879627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013456|NCT05879627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013457|NCT05879536|Tramadol|tramadol|mesh-list
139013458|NCT05879536|Ondansetron|ondansetron|mesh-list
139013459|NCT05879536|Ropivacaine|ropivacaine|mesh-list
139013460|NCT05879536|Anesthetics, Local|anesthetics, local|mesh-ancestor
139013461|NCT05879536|Anesthetics|anesthetics|mesh-ancestor
138528949|NCT00063804|Ritonavir|ritonavir|mesh-list
139013464|NCT05879536|Sensory System Agents|sensory system agents|mesh-ancestor
139013465|NCT05879536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013466|NCT05879536|Antiemetics|antiemetics|mesh-ancestor
139013467|NCT05879536|Autonomic Agents|autonomic agents|mesh-ancestor
139013468|NCT05879536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139013469|NCT05879536|Antipruritics|antipruritics|mesh-ancestor
139013470|NCT05879536|Dermatologic Agents|dermatologic agents|mesh-ancestor
139013471|NCT05879536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138941114|NCT00874978|Growth Substances|growth substances|mesh-ancestor
139013472|NCT05879536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139013473|NCT05879536|Serotonin Agents|serotonin agents|mesh-ancestor
139013474|NCT05879536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139013475|NCT05879536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013476|NCT05879536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139013477|NCT05879536|Narcotics|narcotics|mesh-ancestor
139013478|NCT05879536|Analgesics|analgesics|mesh-ancestor
139013479|NCT05879276|Empagliflozin|empagliflozin|mesh-list
139013480|NCT05879276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139013481|NCT05879276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013482|NCT05879276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139013483|NCT05879276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013484|NCT05879237|Vitamin D|vitamin d|mesh-list
139013485|NCT05879237|Cholecalciferol|cholecalciferol|mesh-list
139013486|NCT05879237|Vitamins|vitamins|mesh-ancestor
139013487|NCT05879237|Micronutrients|micronutrients|mesh-ancestor
139013488|NCT05879237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013489|NCT05879237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139013490|NCT05879237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139013491|NCT05879068|Paclitaxel|paclitaxel|mesh-list
139013492|NCT05879068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139013493|NCT05879068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013494|NCT05879068|Tubulin Modulators|tubulin modulators|mesh-ancestor
139013495|NCT05879068|Antimitotic Agents|antimitotic agents|mesh-ancestor
139013496|NCT05879068|Mitosis Modulators|mitosis modulators|mesh-ancestor
139013497|NCT05879068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528985|NCT00037037|Sargramostim|sargramostim|mesh-list
138985981|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138985982|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138985983|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138985984|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013498|NCT05878977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139013499|NCT05878977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013500|NCT05878977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139013501|NCT05878977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013502|NCT05878964|Mitogens|mitogens|mesh-list
139013503|NCT05878964|Mitosis Modulators|mitosis modulators|mesh-ancestor
139013504|NCT05878964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013505|NCT05878535|Metformin|metformin|mesh-list
139013506|NCT05878535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139013507|NCT05878535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013508|NCT05875506|Doxycycline|doxycycline|mesh-list
139013509|NCT05875506|Chitosan|chitosan|mesh-list
139013510|NCT05875506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139013511|NCT05875506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013512|NCT05875506|Antimalarials|antimalarials|mesh-ancestor
139013513|NCT05875506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139013514|NCT05875506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139013515|NCT05875506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139013516|NCT05875506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139013517|NCT05875506|Antimetabolites|antimetabolites|mesh-ancestor
139013518|NCT05875506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013519|NCT05875506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139013520|NCT05875506|Chelating Agents|chelating agents|mesh-ancestor
139013521|NCT05875506|Sequestering Agents|sequestering agents|mesh-ancestor
139013522|NCT05875506|Hemostatics|hemostatics|mesh-ancestor
139013523|NCT05875506|Coagulants|coagulants|mesh-ancestor
139013524|NCT05875350|Anesthetics|anesthetics|mesh-list
139013525|NCT05875350|Anesthetics, Local|anesthetics, local|mesh-list
139013526|NCT05875350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013527|NCT05875350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013528|NCT05875350|Sensory System Agents|sensory system agents|mesh-ancestor
139013529|NCT05875350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013530|NCT05871086|Ubiquinone|ubiquinone|mesh-list
139013531|NCT05871086|Coenzyme Q10|coenzyme q10|mesh-list
139013532|NCT05871086|Micronutrients|micronutrients|mesh-ancestor
139013533|NCT05871086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013534|NCT05871086|Vitamins|vitamins|mesh-ancestor
139013535|NCT05864755|Bevacizumab|bevacizumab|mesh-list
138985985|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138985986|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139013536|NCT05864755|Durvalumab|durvalumab|mesh-list
139013537|NCT05864755|Tremelimumab|tremelimumab|mesh-list
139013538|NCT05864755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139013539|NCT05864755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013540|NCT05864755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139013541|NCT05864755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139013542|NCT05864755|Growth Substances|growth substances|mesh-ancestor
139013543|NCT05864755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013544|NCT05864755|Growth Inhibitors|growth inhibitors|mesh-ancestor
139013545|NCT05864404|Dexmedetomidine|dexmedetomidine|mesh-list
139013546|NCT05864404|Remifentanil|remifentanil|mesh-list
139013547|NCT05864404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139013548|NCT05864404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013549|NCT05864404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013550|NCT05864404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139013551|NCT05864404|Analgesics|analgesics|mesh-ancestor
139013552|NCT05864404|Sensory System Agents|sensory system agents|mesh-ancestor
139013553|NCT05864404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013554|NCT05864404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139013555|NCT05864404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139013556|NCT05864404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139013557|NCT05864404|Adrenergic Agents|adrenergic agents|mesh-ancestor
139013558|NCT05864404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139013559|NCT05864404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013560|NCT05864404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139013561|NCT05864404|Narcotics|narcotics|mesh-ancestor
139013562|NCT05856981|Pembrolizumab|pembrolizumab|mesh-list
138205404|NCT00005032|Paclitaxel|paclitaxel|mesh-list
138985988|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138985989|NCT00952302|Trace Elements|trace elements|mesh-ancestor
138985990|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
138985991|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985992|NCT00952302|Hematinics|hematinics|mesh-ancestor
138985993|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138985994|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
138985995|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138985996|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138985997|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138985998|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138985999|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986000|NCT05300334|Adenosine|adenosine|mesh-list
138986001|NCT05300334|Analgesics|analgesics|mesh-ancestor
138986002|NCT05300334|Sensory System Agents|sensory system agents|mesh-ancestor
138986003|NCT05300334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986004|NCT05300334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986005|NCT05300334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138986006|NCT05300334|Vasodilator Agents|vasodilator agents|mesh-ancestor
138941144|NCT00612586|Antidotes|antidotes|mesh-ancestor
138986007|NCT05300334|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138986008|NCT05300334|Purinergic Agonists|purinergic agonists|mesh-ancestor
139013563|NCT05856981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139013564|NCT05856981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013565|NCT05856981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139013566|NCT05856981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013567|NCT05856357|Pyrimethamine|pyrimethamine|mesh-list
139013568|NCT05856357|Sulfadoxine|sulfadoxine|mesh-list
139013569|NCT05856357|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139013570|NCT05856357|Antimalarials|antimalarials|mesh-ancestor
139013571|NCT05856357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139013572|NCT05856357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139013573|NCT05856357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013574|NCT05856357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139013575|NCT05856357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013576|NCT05856357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013577|NCT05856357|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139013578|NCT05846906|Sildenafil Citrate|sildenafil citrate|mesh-list
139013579|NCT05846906|Citric Acid|citric acid|mesh-list
139013580|NCT05846906|Sodium Citrate|sodium citrate|mesh-list
139013582|NCT05846906|Enclomiphene|enclomiphene|mesh-list
139013583|NCT05846906|Zuclomiphene|zuclomiphene|mesh-list
139013584|NCT05846906|Anticoagulants|anticoagulants|mesh-ancestor
139013585|NCT05846906|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139013586|NCT05846906|Chelating Agents|chelating agents|mesh-ancestor
139013587|NCT05846906|Sequestering Agents|sequestering agents|mesh-ancestor
139013588|NCT05846906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013589|NCT05846906|Vasodilator Agents|vasodilator agents|mesh-ancestor
139013590|NCT05846906|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139013591|NCT05846906|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139013592|NCT05846906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013593|NCT05846906|Urological Agents|urological agents|mesh-ancestor
139013594|NCT05846906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139013595|NCT05846906|Hormone Antagonists|hormone antagonists|mesh-ancestor
139013596|NCT05846906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139013598|NCT05846906|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139013603|NCT05844462|Tadalafil|tadalafil|mesh-list
139013604|NCT05844462|Vasodilator Agents|vasodilator agents|mesh-ancestor
139013605|NCT05844462|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139013606|NCT05844462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138941164|NCT00738192|Fentanyl|fentanyl|mesh-list
139013607|NCT05844462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013608|NCT05844462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013609|NCT05844462|Urological Agents|urological agents|mesh-ancestor
139013610|NCT05835245|Lenvatinib|lenvatinib|mesh-list
139013611|NCT05835245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013612|NCT05835245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139013613|NCT05835245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013614|NCT05835245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013615|NCT05832255|Psilocybin|psilocybin|mesh-list
139013616|NCT05832255|Hallucinogens|hallucinogens|mesh-ancestor
139013617|NCT05832255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013618|NCT05832255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139013620|NCT05826327|Esketamine|esketamine|mesh-list
139013621|NCT05826327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139013622|NCT05826327|Narcotics|narcotics|mesh-ancestor
139013623|NCT05826327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013624|NCT05826327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013625|NCT05826327|Analgesics|analgesics|mesh-ancestor
139013626|NCT05826327|Sensory System Agents|sensory system agents|mesh-ancestor
139013627|NCT05826327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013628|NCT05826327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139013629|NCT05826327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139013630|NCT05826327|Anesthetics, General|anesthetics, general|mesh-ancestor
139013631|NCT05826327|Anesthetics|anesthetics|mesh-ancestor
139013632|NCT05826327|Antidepressive Agents|antidepressive agents|mesh-ancestor
138529149|NCT00065130|Insulin|insulin|mesh-list
138986009|NCT05300334|Purinergic Agents|purinergic agents|mesh-ancestor
138986010|NCT05300334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736836|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
138986011|NCT05300334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986013|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138986014|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986015|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138986016|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
138986017|NCT01022164|Coagulants|coagulants|mesh-ancestor
138986018|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138986019|NCT01012479|Candesartan|candesartan|mesh-list
138986020|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
138986021|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138986022|NCT01012479|Diuretics|diuretics|mesh-ancestor
138986023|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
138986024|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986025|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139013633|NCT05826327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139013634|NCT05823116|Vancomycin|vancomycin|mesh-list
139013635|NCT05823116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139013636|NCT05823116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013637|NCT05817721|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139013638|NCT05817721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013639|NCT05817721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013640|NCT05814991|Nitroglycerin|nitroglycerin|mesh-list
139013641|NCT05814991|Vasodilator Agents|vasodilator agents|mesh-ancestor
139013642|NCT05814367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139013643|NCT05814367|Lubricant Eye Drops|lubricant eye drops|mesh-list
139013644|NCT05814367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139013645|NCT05794399|Warfarin|warfarin|mesh-list
139013646|NCT05794399|Rivaroxaban|rivaroxaban|mesh-list
139013647|NCT05794399|Anticoagulants|anticoagulants|mesh-ancestor
139013648|NCT05794399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139013649|NCT05794399|Antithrombins|antithrombins|mesh-ancestor
139013650|NCT05794399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139013651|NCT05794399|Protease Inhibitors|protease inhibitors|mesh-ancestor
139013652|NCT05794399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013653|NCT05794399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013654|NCT05788510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139013655|NCT05788510|Immunologic Factors|immunologic factors|mesh-ancestor
139013656|NCT05788510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013657|NCT05764395|Pembrolizumab|pembrolizumab|mesh-list
139013658|NCT05764395|ON 01910|on 01910|mesh-list
139013659|NCT05764395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139013660|NCT05764395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013661|NCT05764395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139013681|NCT05706259|Cholecalciferol|cholecalciferol|mesh-list
139013682|NCT05706259|Vitamins|vitamins|mesh-list
139013683|NCT05706259|Micronutrients|micronutrients|mesh-ancestor
139013684|NCT05706259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013685|NCT05706259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138764377|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139013686|NCT05706259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139013687|NCT05704374|Pregabalin|pregabalin|mesh-list
139013688|NCT05704374|Analgesics|analgesics|mesh-ancestor
139013689|NCT05704374|Sensory System Agents|sensory system agents|mesh-ancestor
139013690|NCT05704374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013691|NCT05704374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013692|NCT05704374|Anticonvulsants|anticonvulsants|mesh-ancestor
139013693|NCT05704374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139013694|NCT05704374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139013695|NCT05704374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013696|NCT05704374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139013697|NCT05704374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139013698|NCT05704374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139013699|NCT05704374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013700|NCT05704374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139013701|NCT05704166|Pirfenidone|pirfenidone|mesh-list
139013702|NCT05704166|Analgesics|analgesics|mesh-ancestor
139013703|NCT05704166|Sensory System Agents|sensory system agents|mesh-ancestor
139013704|NCT05704166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013705|NCT05704166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013706|NCT05704166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139013707|NCT05704166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139013708|NCT05704166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139013709|NCT05704166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139013711|NCT05680558|Methoxsalen|methoxsalen|mesh-list
139013724|NCT05667324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139013725|NCT05667324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139013726|NCT05667324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013727|NCT05667324|Anesthetics, Local|anesthetics, local|mesh-ancestor
139013728|NCT05667324|Anesthetics|anesthetics|mesh-ancestor
139013729|NCT05667324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013730|NCT05667324|Sensory System Agents|sensory system agents|mesh-ancestor
139013731|NCT05663242|Anesthetics|anesthetics|mesh-list
139013732|NCT05663242|Propofol|propofol|mesh-list
139013733|NCT05663242|Sevoflurane|sevoflurane|mesh-list
139013734|NCT05663242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013735|NCT05663242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013736|NCT05663242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139013737|NCT05663242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139013738|NCT05663242|Anesthetics, General|anesthetics, general|mesh-ancestor
139013739|NCT05663242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139013740|NCT05663242|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139013741|NCT05661851|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139013742|NCT05661851|Lubricant Eye Drops|lubricant eye drops|mesh-list
139013743|NCT05661851|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139013744|NCT05656521|Dexamethasone|dexamethasone|mesh-list
139013745|NCT05656521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139013746|NCT05656521|Antiemetics|antiemetics|mesh-ancestor
139013747|NCT05656521|Autonomic Agents|autonomic agents|mesh-ancestor
139013748|NCT05656521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013749|NCT05656521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013750|NCT05656521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139013751|NCT05656521|Glucocorticoids|glucocorticoids|mesh-ancestor
139013752|NCT05656521|Hormones|hormones|mesh-ancestor
139013753|NCT05656521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139013754|NCT05656521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139013755|NCT05656521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013756|NCT05644184|Vaccines|vaccines|mesh-list
139013757|NCT05644184|Immunologic Factors|immunologic factors|mesh-ancestor
139013758|NCT05644184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013759|NCT05644041|Gemcitabine|gemcitabine|mesh-list
139013760|NCT05644041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139013762|NCT05644041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013763|NCT05644041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013764|NCT05633992|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139013765|NCT05633992|Immunologic Factors|immunologic factors|mesh-ancestor
139013766|NCT05633992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013767|NCT05628623|Cytarabine|cytarabine|mesh-list
139013768|NCT05628623|Azacitidine|azacitidine|mesh-list
139013769|NCT05628623|Daunorubicin|daunorubicin|mesh-list
139013770|NCT05628623|Venetoclax|venetoclax|mesh-list
139013771|NCT05628623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139013772|NCT05628623|Antimetabolites|antimetabolites|mesh-ancestor
138941258|NCT02543710|Taxane|taxane|mesh-list
139013773|NCT05628623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013774|NCT05628623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013775|NCT05628623|Antiviral Agents|antiviral agents|mesh-ancestor
139013776|NCT05628623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013777|NCT05628623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139013778|NCT05628623|Immunologic Factors|immunologic factors|mesh-ancestor
139013779|NCT05628623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013780|NCT05628623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013781|NCT05628623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139013782|NCT05628623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139013783|NCT05628623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139013784|NCT05616923|Trametinib|trametinib|mesh-list
139013785|NCT05616923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013786|NCT05616923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139013787|NCT05616923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013788|NCT05616923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986026|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138986027|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986028|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138986029|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138986031|NCT02541734|Polygeline|polygeline|mesh-list
138986032|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138986033|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986034|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138986035|NCT02541734|Incretins|incretins|mesh-ancestor
138986036|NCT02541734|Hormones|hormones|mesh-ancestor
138986037|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138986038|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
138986039|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
138986040|NCT00462670|Tolvaptan|tolvaptan|mesh-list
138986041|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138986042|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986043|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
138986044|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986045|NCT01009593|Sorafenib|sorafenib|mesh-list
139013789|NCT05608200|Lenvatinib|lenvatinib|mesh-list
139013790|NCT05608200|Chlorotrianisene|chlorotrianisene|mesh-list
139013791|NCT05608200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013792|NCT05608200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139013793|NCT05608200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013794|NCT05608200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013795|NCT05608200|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139013796|NCT05608200|Estrogens|estrogens|mesh-ancestor
139013797|NCT05608200|Hormones|hormones|mesh-ancestor
139013798|NCT05608200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139013799|NCT05608200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013800|NCT05608200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139013801|NCT05606692|Propofol|propofol|mesh-list
139013802|NCT05606692|Sevoflurane|sevoflurane|mesh-list
138529339|NCT00069966|Cytarabine|cytarabine|mesh-list
138986046|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986047|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138986048|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986049|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986050|NCT00719459|Iron|iron|mesh-list
138986051|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138986052|NCT00719459|Trace Elements|trace elements|mesh-ancestor
138986053|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
138986054|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986055|NCT00719459|Hematinics|hematinics|mesh-ancestor
138986056|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138986057|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138986058|NCT00948168|Exenatide|exenatide|mesh-list
138986059|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138986060|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986061|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138986062|NCT00948168|Incretins|incretins|mesh-ancestor
138986063|NCT00948168|Hormones|hormones|mesh-ancestor
138986064|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138986065|NCT00958386|Irinotecan|irinotecan|mesh-list
138986066|NCT00958386|Panitumumab|panitumumab|mesh-list
138986068|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138986069|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986070|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986071|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986072|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138986073|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
138986074|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138986075|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
138986076|NCT00719693|Fenofibrate|fenofibrate|mesh-list
138986077|NCT00719693|Calcium|calcium|mesh-list
138986078|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138986079|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986080|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138986081|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138986082|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138986083|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
138986084|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986085|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138986086|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138986087|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986089|NCT00948402|Biguanides|biguanides|mesh-list
138986090|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
138986091|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
138986092|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138986093|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013804|NCT05606692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013805|NCT05606692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013807|NCT05606692|Anesthetics, General|anesthetics, general|mesh-ancestor
139013808|NCT05606692|Anesthetics|anesthetics|mesh-ancestor
139013809|NCT05606692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139013810|NCT05606692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139013811|NCT05601336|Metformin|metformin|mesh-list
139013812|NCT05601336|Dapagliflozin|dapagliflozin|mesh-list
139013813|NCT05601336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139013814|NCT05601336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013815|NCT05601336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139013816|NCT05601336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013817|NCT05599243|Dutasteride|dutasteride|mesh-list
139013818|NCT05599243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139013819|NCT05599243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139013820|NCT05599243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013821|NCT05599243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013822|NCT05599243|Hormone Antagonists|hormone antagonists|mesh-ancestor
139013823|NCT05599243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139013824|NCT05599243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013825|NCT05580666|Azithromycin|azithromycin|mesh-list
139013826|NCT05580666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139013827|NCT05580666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013828|NCT05556889|Iodine|iodine|mesh-list
139013829|NCT05556889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139013830|NCT05556889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013831|NCT05556889|Trace Elements|trace elements|mesh-ancestor
139013832|NCT05556889|Micronutrients|micronutrients|mesh-ancestor
139013833|NCT05556889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013836|NCT05541471|Digoxin|digoxin|mesh-list
139013837|NCT05541471|Midazolam|midazolam|mesh-list
139013838|NCT05541471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138529401|NCT00070083|Prednisone|prednisone|mesh-list
138986094|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138986095|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139013839|NCT05541471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139013840|NCT05541471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013841|NCT05541471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013842|NCT05541471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139013843|NCT05541471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139013844|NCT05541471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139013845|NCT05541471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139013846|NCT05541471|Anesthetics, General|anesthetics, general|mesh-ancestor
139013847|NCT05541471|Anesthetics|anesthetics|mesh-ancestor
139013848|NCT05541471|GABA Modulators|gaba modulators|mesh-ancestor
139013849|NCT05541471|GABA Agents|gaba agents|mesh-ancestor
139013850|NCT05541471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139013851|NCT05541471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013852|NCT05541471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139013853|NCT05541471|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139013854|NCT05541471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013855|NCT05541471|Protective Agents|protective agents|mesh-ancestor
139013856|NCT05504278|Carboplatin|carboplatin|mesh-list
139013857|NCT05504278|Pemetrexed|pemetrexed|mesh-list
139013858|NCT05504278|Cisplatin|cisplatin|mesh-list
139013859|NCT05504278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013860|NCT05504278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013861|NCT05504278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013862|NCT05504278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139013863|NCT05504278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139013864|NCT05498792|Nivolumab|nivolumab|mesh-list
139013865|NCT05498792|Ipilimumab|ipilimumab|mesh-list
139013866|NCT05498792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139013867|NCT05498792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013868|NCT05498792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139013869|NCT05498792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013883|NCT05418049|Memantine|memantine|mesh-list
139013884|NCT05418049|Baclofen|baclofen|mesh-list
139013885|NCT05418049|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139013886|NCT05418049|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139013887|NCT05418049|Dopamine Agents|dopamine agents|mesh-ancestor
139013888|NCT05418049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139013889|NCT05418049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013890|NCT05418049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013891|NCT05418049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139013892|NCT05418049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139013893|NCT05418049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139013894|NCT05418049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139013895|NCT05418049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013896|NCT05418049|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139013897|NCT05418049|GABA Agonists|gaba agonists|mesh-ancestor
139013898|NCT05418049|GABA Agents|gaba agents|mesh-ancestor
139013899|NCT05369676|Ritonavir|ritonavir|mesh-list
139013900|NCT05369676|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139013901|NCT05369676|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139013902|NCT05369676|Protease Inhibitors|protease inhibitors|mesh-ancestor
139013903|NCT05369676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013904|NCT05369676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013905|NCT05369676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139013906|NCT05369676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139013907|NCT05369676|Antiviral Agents|antiviral agents|mesh-ancestor
139013908|NCT05369676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139013909|NCT05369676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139013910|NCT05369676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139013911|NCT06014853|Abiraterone Acetate|abiraterone acetate|mesh-list
139013912|NCT06014853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013913|NCT06014853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139013914|NCT06014853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013915|NCT06014853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013916|NCT06014853|Hormone Antagonists|hormone antagonists|mesh-ancestor
138764599|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
138529469|NCT00070200|Etoposide|etoposide|mesh-list
138986096|NCT05352126|Disinfectants|disinfectants|mesh-list
138986097|NCT05352126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986098|NCT00948480|Sargramostim|sargramostim|mesh-list
138986099|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
139013917|NCT06014853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139013918|NCT06014853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013919|NCT06014853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139013920|NCT06014827|Osimertinib|osimertinib|mesh-list
139013921|NCT06014827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013922|NCT06014827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139013923|NCT06014827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013924|NCT06014827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013925|NCT06014749|Anesthetics|anesthetics|mesh-list
139013926|NCT06014749|Anesthetics, Local|anesthetics, local|mesh-list
139013927|NCT06014749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013928|NCT06014749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013929|NCT06014749|Sensory System Agents|sensory system agents|mesh-ancestor
139013930|NCT06014749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013931|NCT06014606|Propranolol|propranolol|mesh-list
139013932|NCT06014606|Haloperidol|haloperidol|mesh-list
139013933|NCT06014606|Haloperidol decanoate|haloperidol decanoate|mesh-list
139013934|NCT06014606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139013935|NCT06014606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139013936|NCT06014606|Adrenergic Agents|adrenergic agents|mesh-ancestor
139013937|NCT06014606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139013938|NCT06014606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013939|NCT06014606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013940|NCT06014606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139013941|NCT06014606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139013942|NCT06014606|Vasodilator Agents|vasodilator agents|mesh-ancestor
139013943|NCT06014606|Antiemetics|antiemetics|mesh-ancestor
139013944|NCT06014606|Autonomic Agents|autonomic agents|mesh-ancestor
139013945|NCT06014606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139013946|NCT06014606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139013947|NCT06014606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139013948|NCT06014606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138529509|NCT00070278|Gemcitabine|gemcitabine|mesh-list
138986100|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986101|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
138986102|NCT03753555|Atorvastatin|atorvastatin|mesh-list
138986103|NCT03753555|Probucol|probucol|mesh-list
138986104|NCT03753555|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
138986105|NCT03753555|Calcium|calcium|mesh-list
138986106|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138986107|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013949|NCT06014606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013950|NCT06014606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139013951|NCT06014606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139013952|NCT06014606|Dopamine Agents|dopamine agents|mesh-ancestor
139013953|NCT06014606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139013954|NCT06014528|Doxorubicin|doxorubicin|mesh-list
139013955|NCT06014528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139013956|NCT06014528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139013957|NCT06014528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013958|NCT06014528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139013959|NCT06014528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139013960|NCT06014528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013961|NCT06014528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013962|NCT06014138|Propofol|propofol|mesh-list
139013963|NCT06014138|Isoflurane|isoflurane|mesh-list
139013964|NCT06014138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139013965|NCT06014138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139013966|NCT06014138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013967|NCT06014138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139013968|NCT06014138|Anesthetics, General|anesthetics, general|mesh-ancestor
139013969|NCT06014138|Anesthetics|anesthetics|mesh-ancestor
139013970|NCT06014138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139013971|NCT06013956|Levodopa|levodopa|mesh-list
139013972|NCT06013956|Carbidopa|carbidopa|mesh-list
139013973|NCT06013956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139013974|NCT06013956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139013975|NCT06013956|Dopamine Agents|dopamine agents|mesh-ancestor
139013976|NCT06013956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139013977|NCT06013956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013978|NCT06013956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013979|NCT06013956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139013980|NCT06013956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139013981|NCT06013735|Listerine|listerine|mesh-list
139013982|NCT06013735|Fluorides|fluorides|mesh-list
139013992|NCT06013540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139013994|NCT06013540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139013995|NCT06013540|Protective Agents|protective agents|mesh-ancestor
139013996|NCT06013540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139013997|NCT06013540|Keratolytic Agents|keratolytic agents|mesh-ancestor
139013998|NCT06013540|Dermatologic Agents|dermatologic agents|mesh-ancestor
139013999|NCT06013540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139014001|NCT06013540|Hormones|hormones|mesh-ancestor
139014002|NCT06013540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139014003|NCT06013540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139014004|NCT06013436|Cyclosporine|cyclosporine|mesh-list
139014005|NCT06013436|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139014006|NCT06013436|Cyclosporins|cyclosporins|mesh-list
139014007|NCT06013436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014008|NCT06013436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014009|NCT06013436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139014010|NCT06013436|Immunologic Factors|immunologic factors|mesh-ancestor
139014011|NCT06013436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014012|NCT06013436|Antifungal Agents|antifungal agents|mesh-ancestor
139014013|NCT06013436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139014014|NCT06013436|Dermatologic Agents|dermatologic agents|mesh-ancestor
139014015|NCT06013436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139014016|NCT06013436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139014017|NCT06013436|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139014018|NCT06013293|Zinc Oxide|zinc oxide|mesh-list
139014019|NCT06013293|Dermatologic Agents|dermatologic agents|mesh-ancestor
139014020|NCT06013293|Sunscreening Agents|sunscreening agents|mesh-ancestor
139014021|NCT06013293|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139014022|NCT06013293|Protective Agents|protective agents|mesh-ancestor
139014023|NCT06013293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014024|NCT06013150|Epinephrine|epinephrine|mesh-list
138986108|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138986109|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138986110|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138986111|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
138986112|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986113|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138986114|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138986115|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986116|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
138986117|NCT03753555|Protective Agents|protective agents|mesh-ancestor
138986118|NCT03753555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139014025|NCT06013150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139014026|NCT06013150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139014027|NCT06013150|Adrenergic Agents|adrenergic agents|mesh-ancestor
139014028|NCT06013150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014029|NCT06013150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014030|NCT06013150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014031|NCT06013150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139014032|NCT06013150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139014033|NCT06013150|Autonomic Agents|autonomic agents|mesh-ancestor
139014034|NCT06013150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014035|NCT06013150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139014036|NCT06013150|Respiratory System Agents|respiratory system agents|mesh-ancestor
139014037|NCT06013150|Mydriatics|mydriatics|mesh-ancestor
139014038|NCT06013150|Sympathomimetics|sympathomimetics|mesh-ancestor
139014039|NCT06013150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139014040|NCT06013111|Cyclophosphamide|cyclophosphamide|mesh-list
139014041|NCT06013111|Fludarabine|fludarabine|mesh-list
139014042|NCT06013111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139014043|NCT06013111|Immunologic Factors|immunologic factors|mesh-ancestor
139014044|NCT06013111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014045|NCT06013111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139014046|NCT06013111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139014047|NCT06013111|Alkylating Agents|alkylating agents|mesh-ancestor
139014048|NCT06013111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014049|NCT06013111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014050|NCT06013111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139014051|NCT06012916|Esketamine|esketamine|mesh-list
139014052|NCT06012916|Antidepressive Agents|antidepressive agents|mesh-ancestor
139014053|NCT06012916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139014054|NCT05997004|Glycopyrrolate|glycopyrrolate|mesh-list
139014055|NCT05997004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139014056|NCT05997004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139014057|NCT05997004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139014058|NCT05997004|Cholinergic Agents|cholinergic agents|mesh-ancestor
139014059|NCT05997004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014060|NCT05997004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986119|NCT03753555|Protease Inhibitors|protease inhibitors|mesh-ancestor
138986120|NCT00606086|Interferons|interferons|mesh-list
138986121|NCT00606086|Ribavirin|ribavirin|mesh-list
139014061|NCT05997004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014062|NCT05995301|Ropivacaine|ropivacaine|mesh-list
139014063|NCT05995301|Anesthetics, Local|anesthetics, local|mesh-ancestor
139014064|NCT05995301|Anesthetics|anesthetics|mesh-ancestor
139014065|NCT05995301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139014066|NCT05995301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014067|NCT05995301|Sensory System Agents|sensory system agents|mesh-ancestor
139014068|NCT05995301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014069|NCT05981131|BCG Vaccine|bcg vaccine|mesh-list
139014070|NCT05981131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139014071|NCT05981131|Immunologic Factors|immunologic factors|mesh-ancestor
139014072|NCT05981131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014073|NCT05759442|Metformin|metformin|mesh-list
139014074|NCT05759442|Acetic Acid|acetic acid|mesh-list
139014075|NCT05759442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139014076|NCT05759442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014077|NCT05759442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139014078|NCT05759442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139014079|NCT05730218|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139014080|NCT05730218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139014081|NCT05728346|Hyaluronic Acid|hyaluronic acid|mesh-list
139014082|NCT05728346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139014083|NCT05728346|Immunologic Factors|immunologic factors|mesh-ancestor
139014084|NCT05728346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014085|NCT05728346|Viscosupplements|viscosupplements|mesh-ancestor
139014086|NCT05728346|Protective Agents|protective agents|mesh-ancestor
139014087|NCT05631899|Cyclophosphamide|cyclophosphamide|mesh-list
139014088|NCT05631899|Ipilimumab|ipilimumab|mesh-list
139014089|NCT05631899|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139014090|NCT05631899|Paclitaxel|paclitaxel|mesh-list
139014091|NCT05631899|Antibodies|antibodies|mesh-list
139014092|NCT05631899|Immunoglobulins|immunoglobulins|mesh-list
139014093|NCT05631899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139014094|NCT05631899|Antibodies, Blocking|antibodies, blocking|mesh-list
139014095|NCT05631899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138986122|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138986123|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
138986124|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986125|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
138986126|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986127|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
138986128|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986129|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
138986130|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986131|NCT02573363|Cytarabine|cytarabine|mesh-list
139014096|NCT05631899|Immunologic Factors|immunologic factors|mesh-ancestor
139014097|NCT05631899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014098|NCT05631899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139014099|NCT05631899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139014100|NCT05631899|Alkylating Agents|alkylating agents|mesh-ancestor
139014101|NCT05631899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014102|NCT05631899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014103|NCT05631899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139014104|NCT05631899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014105|NCT05631899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139014106|NCT05631899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139014107|NCT05631899|Tubulin Modulators|tubulin modulators|mesh-ancestor
139014108|NCT05631899|Antimitotic Agents|antimitotic agents|mesh-ancestor
139014109|NCT05631899|Mitosis Modulators|mitosis modulators|mesh-ancestor
139014110|NCT05631886|Cyclophosphamide|cyclophosphamide|mesh-list
139014111|NCT05631886|Ipilimumab|ipilimumab|mesh-list
138986132|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
138986133|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138986134|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
138986135|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986136|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986137|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
138986138|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138611901|NCT00408941|Propofol|propofol|mesh-list
138986139|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138986140|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
138986141|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986142|NCT02573363|Analgesics|analgesics|mesh-ancestor
138986143|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
138986144|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986145|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138986146|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138986147|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986148|NCT00715637|Cytarabine|cytarabine|mesh-list
138986149|NCT00715637|Amonafide|amonafide|mesh-list
138986150|NCT00715637|Daunorubicin|daunorubicin|mesh-list
138986151|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138986152|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
138986153|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986154|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986155|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
138986156|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986157|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138986158|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
138986159|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986160|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138737015|NCT01309659|Iron|iron|mesh-list
138986161|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138986162|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138986163|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986164|NCT05300490|Prednisolone|prednisolone|mesh-list
138986165|NCT05300490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138986166|NCT05300490|Glucocorticoids|glucocorticoids|mesh-ancestor
138986167|NCT05300490|Hormones|hormones|mesh-ancestor
138986168|NCT05300490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138986169|NCT05300490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986170|NCT05300490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138986171|NCT05300490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986172|NCT00893594|Naproxen|naproxen|mesh-list
138986173|NCT00893594|Sumatriptan|sumatriptan|mesh-list
139014116|NCT05631886|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139014117|NCT05631886|Antibodies, Blocking|antibodies, blocking|mesh-list
139014118|NCT05631886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139014119|NCT05631886|Immunologic Factors|immunologic factors|mesh-ancestor
139014120|NCT05631886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014121|NCT05631886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139014122|NCT05631886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139014123|NCT05631886|Alkylating Agents|alkylating agents|mesh-ancestor
139014124|NCT05631886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014125|NCT05631886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014126|NCT05631886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139014127|NCT05631886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014128|NCT05631886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139014129|NCT05631886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139014130|NCT05631886|Tubulin Modulators|tubulin modulators|mesh-ancestor
139014131|NCT05631886|Antimitotic Agents|antimitotic agents|mesh-ancestor
139014132|NCT05631886|Mitosis Modulators|mitosis modulators|mesh-ancestor
139014133|NCT05601752|Nivolumab|nivolumab|mesh-list
139014134|NCT05601752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014135|NCT05601752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014136|NCT05601752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139014137|NCT05601752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764826|NCT00622687|Iloprost|iloprost|mesh-list
138986174|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138986175|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138986176|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138986177|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
138986178|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138986179|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986180|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986181|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138986182|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138986183|NCT00893594|Analgesics|analgesics|mesh-ancestor
138611981|NCT00184106|Paroxetine|paroxetine|mesh-list
138986184|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
138986185|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014152|NCT05341115|Leuprolide|leuprolide|mesh-list
139014153|NCT05341115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139014154|NCT05341115|Fertility Agents|fertility agents|mesh-ancestor
139014155|NCT05341115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139014156|NCT05341115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014157|NCT05341115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139014158|NCT05341115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014159|NCT05262855|FAPI-46|fapi-46|mesh-list
139014160|NCT05262855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139014161|NCT05262855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014162|NCT05233228|Nicotine|nicotine|mesh-list
139014163|NCT05233228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139014164|NCT05233228|Autonomic Agents|autonomic agents|mesh-ancestor
139014165|NCT05233228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014166|NCT05233228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014167|NCT05233228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139014168|NCT05233228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139014169|NCT05233228|Cholinergic Agents|cholinergic agents|mesh-ancestor
139014170|NCT05233228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014171|NCT05233228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986186|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138986187|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138986188|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
138986189|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138986190|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986191|NCT00715715|Prednisone|prednisone|mesh-list
138986192|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138986193|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
138986194|NCT00715715|Hormones|hormones|mesh-ancestor
138986195|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138986196|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986197|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138986198|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986199|NCT00953394|Octreotide|octreotide|mesh-list
139014172|NCT05119712|Terbinafine|terbinafine|mesh-list
139014173|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
139014174|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139014175|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014176|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014178|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139014179|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
139014180|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014181|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014182|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139014183|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139014184|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
139014185|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014186|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014187|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
139014188|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
139014189|NCT05101629|Lenvatinib|lenvatinib|mesh-list
139014190|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014191|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014192|NCT05101629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138529865|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138986200|NCT00953394|Fluorouracil|fluorouracil|mesh-list
138986201|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138986202|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138986203|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986204|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
138986205|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986206|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138986207|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138986208|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
138986209|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986210|NCT00720161|Metformin|metformin|mesh-list
138986211|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138986212|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986213|NCT00898508|Antibodies|antibodies|mesh-list
138986214|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
138986215|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986216|NCT00609986|Insulin|insulin|mesh-list
138986217|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138986218|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
138986219|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
138986220|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
138986221|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
138986222|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138986223|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986224|NCT00715871|Nicotine|nicotine|mesh-list
138986225|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138986226|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
138986227|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986228|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986229|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138986230|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138986231|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
139014193|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014194|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139014195|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014196|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139014197|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139014198|NCT04985344|Propranolol|propranolol|mesh-list
139014199|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139014200|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139014201|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
139014202|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014203|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014204|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014205|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139014206|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139014207|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
139014208|NCT04974970|Immunomodulating Agents|immunomodulating agents|mesh-list
139014209|NCT04974970|Immunologic Factors|immunologic factors|mesh-ancestor
139014210|NCT04974970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014211|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
139014212|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139014213|NCT04946370|Androgens|androgens|mesh-list
139014214|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014215|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014216|NCT04946370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138986232|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138986233|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737060|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138986234|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
138986236|NCT00712049|Niacinamide|niacinamide|mesh-list
138986237|NCT00712049|Simvastatin|simvastatin|mesh-list
138986238|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138986239|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138986240|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
138986241|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986242|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138986243|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138986244|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986245|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
138986246|NCT00712049|Vitamins|vitamins|mesh-ancestor
138986247|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
138986248|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986249|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
138986250|NCT00712205|Calcitriol|calcitriol|mesh-list
138986251|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138986252|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986253|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138986254|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138986255|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986256|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139014217|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014219|NCT04946370|Hormones|hormones|mesh-ancestor
139014220|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139014221|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014222|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
139014223|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139014224|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
139014225|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014226|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014227|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139014228|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
139014229|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139014230|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
139039575|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
138986257|NCT00712205|Vitamins|vitamins|mesh-ancestor
138986258|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
138612014|NCT00217386|Etanercept|etanercept|mesh-list
138986259|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138986260|NCT00451906|Bevacizumab|bevacizumab|mesh-list
138986261|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138986262|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941555|NCT00814047|Urological Agents|urological agents|mesh-ancestor
138986263|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138986264|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138986265|NCT00451906|Growth Substances|growth substances|mesh-ancestor
138986266|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986267|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
138986268|NCT04070495|Clarithromycin|clarithromycin|mesh-list
138986269|NCT04070495|Rifampin|rifampin|mesh-list
138986270|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138986271|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986272|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138986273|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986274|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986275|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138986276|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138986277|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138986278|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
138986279|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
138986280|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138986281|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138986282|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138986283|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138986284|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138986285|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138986286|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138986287|NCT00712439|Gabapentin|gabapentin|mesh-list
138986288|NCT00712439|Analgesics|analgesics|mesh-ancestor
138986289|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
138986290|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986291|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986292|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
138986293|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138986294|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138986295|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138986296|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138612063|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
138986297|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138986298|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138986299|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014231|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014232|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014233|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139014234|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
139014236|NCT04920695|Protective Agents|protective agents|mesh-ancestor
139014237|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139014238|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
139014239|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014240|NCT04646707|Lidocaine|lidocaine|mesh-list
139014241|NCT04646707|Bupivacaine|bupivacaine|mesh-list
139014242|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
139014243|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
139014244|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139014245|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530042|NCT00038519|Ritonavir|ritonavir|mesh-list
138986300|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986301|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
138986302|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138986303|NCT00716183|Amoxicillin|amoxicillin|mesh-list
138986304|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
138986305|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
138986306|NCT00716183|Lactams|lactams|mesh-list
138986307|NCT00716183|beta-Lactams|beta-lactams|mesh-list
138986308|NCT00716183|Cloxacillin|cloxacillin|mesh-list
138986309|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986310|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737133|NCT02893709|Omeprazole|omeprazole|mesh-list
138986311|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986312|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138986313|NCT00712517|Propofol|propofol|mesh-list
138986314|NCT00712517|Sevoflurane|sevoflurane|mesh-list
138986315|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138986316|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138986317|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986318|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138986319|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
138986320|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
138986321|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138986322|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138986323|NCT00712595|Mifepristone|mifepristone|mesh-list
138986324|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138986325|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
138986326|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138986327|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986328|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138986329|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138986330|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138986331|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
138986332|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138986333|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138986334|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
138986335|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138986336|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
138986337|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138986338|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138986340|NCT00115765|Panitumumab|panitumumab|mesh-list
138986341|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
138986342|NCT00115765|Irinotecan|irinotecan|mesh-list
138986343|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014246|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
139014247|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014248|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139014249|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139014250|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139014251|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139014252|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014253|NCT04646694|Ketamine|ketamine|mesh-list
139014254|NCT04646694|Analgesics|analgesics|mesh-ancestor
139014255|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
139014256|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014257|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014258|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139014259|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139014260|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
139014261|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
139014262|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139014263|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139014264|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139014265|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014266|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014267|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
139039576|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
138986344|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986345|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138986346|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138986347|NCT00115765|Growth Substances|growth substances|mesh-ancestor
138986348|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986349|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
138986350|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138986351|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138986352|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986353|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986354|NCT00606008|Sunitinib|sunitinib|mesh-list
138986355|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986356|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138986357|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138986358|NCT00606008|Growth Substances|growth substances|mesh-ancestor
138986359|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986360|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
138986361|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138986362|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986363|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986364|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
138986365|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138986366|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
138612148|NCT04722471|Progesterone|progesterone|mesh-list
138986367|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138986368|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
138986369|NCT00721331|Loratadine|loratadine|mesh-list
139014268|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139014269|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014270|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139014271|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014272|NCT04543942|Ethanol|ethanol|mesh-list
139014273|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139014274|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139014275|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139014276|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014277|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139014278|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139014279|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014280|NCT04361708|Leucovorin|leucovorin|mesh-list
139014281|NCT04361708|Docetaxel|docetaxel|mesh-list
139014282|NCT04361708|Fluorouracil|fluorouracil|mesh-list
139014283|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
138986370|NCT00721331|Nortriptyline|nortriptyline|mesh-list
138986371|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138986372|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
138986373|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138986374|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
138986375|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138986376|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138986377|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
138986378|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
138986379|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138986380|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986381|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986382|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138986383|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
138986384|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138986385|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138986386|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138986387|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138986388|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
138986389|NCT00123955|Spironolactone|spironolactone|mesh-list
138986390|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138986391|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
138986392|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138986393|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986394|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138986395|NCT00123955|Diuretics|diuretics|mesh-ancestor
138986396|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
138986397|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
138986398|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138986399|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138986400|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986401|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
138986402|NCT01027546|Coagulants|coagulants|mesh-ancestor
138986404|NCT00115063|Sibutramine|sibutramine|mesh-list
138986405|NCT00115063|Diethylpropion|diethylpropion|mesh-list
138986406|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986407|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986408|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138986409|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138986410|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
138986411|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138986412|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
139014285|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014286|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
139014287|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
139014288|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
138764976|NCT05392127|Anesthetics, General|anesthetics, general|mesh-ancestor
139014289|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014291|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139014292|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139014293|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
139014294|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941646|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
139014295|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139014296|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139014297|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014298|NCT04361708|Antidotes|antidotes|mesh-ancestor
139014299|NCT04361708|Protective Agents|protective agents|mesh-ancestor
139014300|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
139014301|NCT04361708|Vitamins|vitamins|mesh-ancestor
139014302|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
139014303|NCT04345146|Bevacizumab|bevacizumab|mesh-list
139014304|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014305|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014306|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138986413|NCT01026064|Azithromycin|azithromycin|mesh-list
138986414|NCT01026064|Cantharidin|cantharidin|mesh-list
138986415|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138986416|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986417|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986418|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986419|NCT02571959|Amoxicillin|amoxicillin|mesh-list
138986420|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
138986421|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
138986422|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138986423|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986424|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986425|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986426|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138986427|NCT00461500|Fluticasone|fluticasone|mesh-list
138986428|NCT00461500|Xhance|xhance|mesh-list
138986429|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138986430|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138986431|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138986432|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
138986433|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986434|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986435|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138986436|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
138986437|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
138986438|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138986439|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138986440|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138986441|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138986442|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
138986443|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014307|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139014308|NCT04345146|Growth Substances|growth substances|mesh-ancestor
139014309|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014310|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
139014311|NCT04336098|Paclitaxel|paclitaxel|mesh-list
139014312|NCT04336098|Gemcitabine|gemcitabine|mesh-list
139014313|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
139014314|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139014315|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139014316|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014317|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
139014318|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
139014319|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
139014320|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014321|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139014322|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
139014323|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014324|NCT04336098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139014325|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
139014326|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
139014327|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139014328|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139014329|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139014330|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014331|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014332|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139014333|NCT04138277|Miglustat|miglustat|mesh-list
139014334|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014335|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014336|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138986444|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986446|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
138986447|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986448|NCT00721487|Fluconazole|fluconazole|mesh-list
138986449|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
138986450|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986451|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138986452|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138986453|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986454|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986455|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138986456|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
138986457|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138986458|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014337|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139014338|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
139014339|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139014340|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139014341|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139014342|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014344|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139014345|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
139014346|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014347|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014348|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139014349|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
139014350|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139014351|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
139014352|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014353|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014354|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139014355|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
139014356|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
139014357|NCT04069052|Protective Agents|protective agents|mesh-ancestor
139014358|NCT03963414|Carboplatin|carboplatin|mesh-list
139014359|NCT03963414|Etoposide|etoposide|mesh-list
139014360|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
139014361|NCT03963414|Durvalumab|durvalumab|mesh-list
139014362|NCT03963414|Tremelimumab|tremelimumab|mesh-list
139014363|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139014364|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014365|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139014366|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139014367|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139014368|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014369|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014370|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014371|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
139014372|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014373|NCT03861390|Prednisone|prednisone|mesh-list
138986459|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139014374|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139014375|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
139014376|NCT03861390|Hormones|hormones|mesh-ancestor
139014377|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139014378|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014379|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139014380|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014381|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
139014382|NCT03829683|Vitamins|vitamins|mesh-ancestor
139014383|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
139014384|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014385|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
139014386|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014387|NCT03829683|Protective Agents|protective agents|mesh-ancestor
139014388|NCT03530696|Palbociclib|palbociclib|mesh-list
139014389|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014390|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139014391|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014392|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014393|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
139014394|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139014395|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139014396|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139014397|NCT03520686|Paclitaxel|paclitaxel|mesh-list
139014398|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139014399|NCT03520686|Cisplatin|cisplatin|mesh-list
139014400|NCT03520686|Carboplatin|carboplatin|mesh-list
139014401|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
139014402|NCT03520686|Pemetrexed|pemetrexed|mesh-list
139014403|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139014404|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014405|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
139014406|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
139014407|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
138530341|NCT02966652|Hormones|hormones|mesh-ancestor
138986460|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138986461|NCT00167245|Topiramate|topiramate|mesh-list
138986462|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
138986463|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138986464|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986465|NCT00894062|Everolimus|everolimus|mesh-list
138986466|NCT00894062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138986467|NCT00894062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138986468|NCT00894062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014408|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014409|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139014410|NCT03520686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139014411|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139014412|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139014413|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139014414|NCT03450057|Dexamethasone|dexamethasone|mesh-list
139014415|NCT03450057|Daratumumab|daratumumab|mesh-list
139014416|NCT03450057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139014417|NCT03450057|Antiemetics|antiemetics|mesh-ancestor
139014418|NCT03450057|Autonomic Agents|autonomic agents|mesh-ancestor
139014419|NCT03450057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139014420|NCT03450057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139014421|NCT03450057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139014422|NCT03450057|Glucocorticoids|glucocorticoids|mesh-ancestor
139014423|NCT03450057|Hormones|hormones|mesh-ancestor
139014424|NCT03450057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139014425|NCT03450057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139014426|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139014427|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139014428|NCT03270059|Hematinics|hematinics|mesh-ancestor
139014429|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139039577|NCT00419744|Hormones|hormones|mesh-ancestor
138986469|NCT00894062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986470|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138986471|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
138986472|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986473|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986474|NCT00443560|Fentanyl|fentanyl|mesh-list
138986475|NCT00443560|Bupivacaine|bupivacaine|mesh-list
138986476|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
138986477|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
138986478|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138986479|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986480|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
138986481|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986482|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138986483|NCT00443560|Narcotics|narcotics|mesh-ancestor
138986484|NCT00443560|Analgesics|analgesics|mesh-ancestor
138986485|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138986486|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138986487|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
138986488|NCT01022632|Curcumin|curcumin|mesh-list
138986489|NCT01022632|Fluoxetine|fluoxetine|mesh-list
138986490|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138986491|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138986492|NCT01022632|Analgesics|analgesics|mesh-ancestor
138986493|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
138986494|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986495|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986496|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138986497|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138848397|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138848398|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138848399|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848400|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138848401|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
138848402|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138848403|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138848404|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138848405|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848406|NCT02382549|Vaccines|vaccines|mesh-list
138848407|NCT02382549|Immunologic Factors|immunologic factors|mesh-ancestor
138848408|NCT02382549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848409|NCT02312622|Irinotecan|irinotecan|mesh-list
138848410|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
138848411|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138848412|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138848413|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848414|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848415|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848416|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138848417|NCT02297698|Trastuzumab|trastuzumab|mesh-list
138848418|NCT02297698|Sargramostim|sargramostim|mesh-list
138848419|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848420|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848421|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
138848422|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500437|NCT00000461|Niacin|niacin|mesh-list
138848423|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138848424|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138591659|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138848425|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848426|NCT02007044|Rituximab|rituximab|mesh-list
138848427|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138848428|NCT02007044|Antibodies|antibodies|mesh-list
138848429|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
138848430|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138848431|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
138848432|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848433|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848434|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138848435|NCT01886404|Efavirenz|efavirenz|mesh-list
138624018|NCT05996185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138848436|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138848437|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138848438|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848439|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848440|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
138848441|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848442|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138848443|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138848444|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138848445|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138848446|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138848447|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138848448|NCT01864746|Palbociclib|palbociclib|mesh-list
138848449|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848450|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138848451|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848452|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848453|NCT01729091|Lenalidomide|lenalidomide|mesh-list
138848454|NCT01729091|Melphalan|melphalan|mesh-list
138848455|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
138848456|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138848457|NCT01729091|Elotuzumab|elotuzumab|mesh-list
138848458|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
138848459|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848460|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138848461|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138941814|NCT00403585|Adefovir|adefovir|mesh-list
138848462|NCT01729091|Growth Substances|growth substances|mesh-ancestor
138848463|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
138848464|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848465|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138848466|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
139014476|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138848467|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848468|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138848469|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138848470|NCT01475500|Dimercaprol|dimercaprol|mesh-list
138848471|NCT01475500|Chelating Agents|chelating agents|mesh-ancestor
138848472|NCT01475500|Sequestering Agents|sequestering agents|mesh-ancestor
138848473|NCT01475500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848474|NCT01258296|Fentanyl|fentanyl|mesh-list
138848475|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138848476|NCT01258296|Narcotics|narcotics|mesh-ancestor
138848477|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138848478|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848479|NCT01258296|Analgesics|analgesics|mesh-ancestor
138848480|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
138848481|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848482|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138848483|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138848484|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
138848485|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
138848486|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
138848487|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138848488|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848489|NCT00587717|Simvastatin|simvastatin|mesh-list
138848490|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138848491|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138848492|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
138848493|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848494|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138848495|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138848496|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848497|NCT00375830|Diphosphonates|diphosphonates|mesh-list
139014508|NCT02833701|Antibodies|antibodies|mesh-list
138848498|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
138848500|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
138848501|NCT00375830|Fluorides|fluorides|mesh-list
138848502|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
138848503|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138848504|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
138848505|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
138848506|NCT00375830|Protective Agents|protective agents|mesh-ancestor
138848507|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848508|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138848509|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848510|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138848511|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848512|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
138848513|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
138848514|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138848515|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
138848516|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138848517|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
138848518|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848519|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848520|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848521|NCT00875875|Rifaximin|rifaximin|mesh-list
138848522|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138848523|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848524|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138848525|NCT01716312|Omalizumab|omalizumab|mesh-list
138848526|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138941837|NCT00885274|Citric Acid|citric acid|mesh-list
138848527|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138848528|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
138848529|NCT00880243|Cytarabine|cytarabine|mesh-list
138848530|NCT00880243|Etoposide|etoposide|mesh-list
138848531|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
138848532|NCT00880243|Daunorubicin|daunorubicin|mesh-list
138848533|NCT00880243|Molgramostim|molgramostim|mesh-list
138848534|NCT00880243|Sargramostim|sargramostim|mesh-list
139014549|NCT02670707|Vinblastine|vinblastine|mesh-list
138848535|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138848536|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848537|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138848538|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138848539|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848540|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848541|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138848542|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
138848543|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
138848544|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848545|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138848546|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
138848547|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848548|NCT00880243|Analgesics|analgesics|mesh-ancestor
138848549|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
138848550|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848551|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138848552|NCT02783586|Bupivacaine|bupivacaine|mesh-list
138848553|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
138848554|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
138848555|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138848556|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848557|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
138848558|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848559|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138848560|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138848561|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138848562|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138848563|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848564|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138848565|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138848566|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138848567|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
138848568|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848569|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848570|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138848571|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139014593|NCT02597062|Hormones|hormones|mesh-ancestor
138848572|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
138848573|NCT00880321|Dabrafenib|dabrafenib|mesh-list
138848575|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138848576|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138848577|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138848578|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848579|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138848580|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138848581|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138848582|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138848583|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
138848584|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
138848585|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
138848586|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
138848588|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848589|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848590|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138848591|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848592|NCT02608437|Ipilimumab|ipilimumab|mesh-list
138848593|NCT02608437|Guadecitabine|guadecitabine|mesh-list
138848594|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848595|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848596|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138848597|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848598|NCT04230330|Dexamethasone|dexamethasone|mesh-list
138848599|NCT04230330|Gemcitabine|gemcitabine|mesh-list
138848600|NCT04230330|Nivolumab|nivolumab|mesh-list
138848601|NCT04230330|Asparaginase|asparaginase|mesh-list
138848602|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138848603|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
138848604|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
138848605|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848606|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848607|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138848608|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
138848609|NCT04230330|Hormones|hormones|mesh-ancestor
138848610|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138848611|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138848612|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848613|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138848614|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
138848615|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848616|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848617|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138848618|NCT02785068|Leucovorin|leucovorin|mesh-list
138848619|NCT02785068|Fluorouracil|fluorouracil|mesh-list
138848620|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
138848621|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848622|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138848623|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848624|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138848625|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
138848626|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848627|NCT02785068|Antidotes|antidotes|mesh-ancestor
138848628|NCT02785068|Protective Agents|protective agents|mesh-ancestor
138848629|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
138848630|NCT02785068|Vitamins|vitamins|mesh-ancestor
138848631|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
138848632|NCT05752929|Insulin|insulin|mesh-list
138848633|NCT05752929|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138848634|NCT05752929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138848635|NCT05752929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848636|NCT00880477|Edetic Acid|edetic acid|mesh-list
138848637|NCT00880477|Vaccines|vaccines|mesh-list
138848638|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
138848639|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
138848640|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848641|NCT00880477|Antidotes|antidotes|mesh-ancestor
138848642|NCT00880477|Protective Agents|protective agents|mesh-ancestor
138848643|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
138848644|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
138848645|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848646|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138848647|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
138848648|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138848649|NCT00882739|Clopidogrel|clopidogrel|mesh-list
138848650|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138848651|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138848652|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138848653|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138848654|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
138848655|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848656|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848657|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848659|NCT02783040|Midazolam|midazolam|mesh-list
138848660|NCT02783040|BI 425809|bi 425809|mesh-list
138848661|NCT02783040|Omeprazole|omeprazole|mesh-list
138848662|NCT02783040|Warfarin|warfarin|mesh-list
138848663|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138848664|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138848665|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138848666|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848667|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138848668|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138848669|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138848670|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138848671|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
138848673|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
138848674|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
139014715|NCT05290207|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138848675|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848676|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848677|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
138848678|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138848679|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138848680|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138848681|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848682|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138848683|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138848684|NCT02783040|Protective Agents|protective agents|mesh-ancestor
138848685|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
138848686|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138848687|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138848688|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138848689|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848690|NCT05275686|Fluticasone|fluticasone|mesh-list
138848692|NCT05275686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138848693|NCT05275686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138848694|NCT05275686|Autonomic Agents|autonomic agents|mesh-ancestor
138848695|NCT05275686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848696|NCT05275686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848697|NCT05275686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138848698|NCT05275686|Respiratory System Agents|respiratory system agents|mesh-ancestor
138848699|NCT05275686|Dermatologic Agents|dermatologic agents|mesh-ancestor
138848700|NCT05275686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138848701|NCT01503606|Clarithromycin|clarithromycin|mesh-list
138848702|NCT01503606|Cefazolin|cefazolin|mesh-list
138848703|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138848704|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848705|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138848706|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848707|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848708|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138848709|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138848710|NCT00882973|genexol-PM|genexol-pm|mesh-list
138848711|NCT00882973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848712|NCT00882973|Tubulin Modulators|tubulin modulators|mesh-ancestor
138848713|NCT00882973|Antimitotic Agents|antimitotic agents|mesh-ancestor
138848714|NCT00882973|Mitosis Modulators|mitosis modulators|mesh-ancestor
138848715|NCT00882973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848716|NCT00805935|Leuprolide|leuprolide|mesh-list
138848717|NCT00805935|Menotropins|menotropins|mesh-list
138848718|NCT00805935|Progesterone|progesterone|mesh-list
138848719|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138848720|NCT00805935|Progestins|progestins|mesh-ancestor
138848721|NCT00805935|Hormones|hormones|mesh-ancestor
138848722|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138848723|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848724|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138848725|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
138848726|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138848727|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138848728|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848729|NCT00878917|Dorzolamide|dorzolamide|mesh-list
138848730|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138848731|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138848732|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138848733|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138848734|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848735|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848736|NCT00638118|Fexofenadine|fexofenadine|mesh-list
138848737|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138848738|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138848739|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138848740|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
138848741|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
138848742|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848743|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848744|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848745|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138848746|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138848747|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848748|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
138848749|NCT00590031|Irinotecan|irinotecan|mesh-list
138848750|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941957|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
138941958|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138941959|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138848751|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138848752|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138848753|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848754|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848755|NCT02783196|Liraglutide|liraglutide|mesh-list
138848756|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138848757|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848758|NCT02783196|Incretins|incretins|mesh-ancestor
138848759|NCT02783196|Hormones|hormones|mesh-ancestor
138848760|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138848761|NCT02782338|Diclofenac|diclofenac|mesh-list
138848762|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138848763|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138848764|NCT02782338|Analgesics|analgesics|mesh-ancestor
138848765|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
138848766|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848767|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848768|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138848769|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138848770|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138848771|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848772|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848773|NCT02782260|Dipyridamole|dipyridamole|mesh-list
138848774|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138848775|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848776|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848777|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138848778|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
138848779|NCT05031936|Ropivacaine|ropivacaine|mesh-list
138848780|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
138848781|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
138848782|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138848783|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848784|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
138848785|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848786|NCT03577704|Paclitaxel|paclitaxel|mesh-list
138848787|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138848788|NCT03577704|Cisplatin|cisplatin|mesh-list
138848789|NCT03577704|Carboplatin|carboplatin|mesh-list
138848790|NCT03577704|Gemcitabine|gemcitabine|mesh-list
138848791|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
138848792|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138848793|NCT03577704|Antibodies|antibodies|mesh-list
138848794|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
138848795|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138848796|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138848797|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848798|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
138848799|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
138848800|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
138848801|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848802|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
138848803|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848804|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138848805|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
138848806|NCT00615199|Tofacitinib|tofacitinib|mesh-list
138848807|NCT00615199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138848808|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138848809|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848810|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848811|NCT05328024|Immunomodulating Agents|immunomodulating agents|mesh-list
139210357|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138848812|NCT05328024|Immunologic Factors|immunologic factors|mesh-ancestor
138848813|NCT05328024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848814|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138848815|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138848816|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
138848817|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848818|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848819|NCT00880867|Poly ICLC|poly iclc|mesh-list
138848820|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
139014792|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
138848821|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
138848822|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848823|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138848824|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138848825|NCT02782182|Leucovorin|leucovorin|mesh-list
138848826|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
138848827|NCT02782182|Irinotecan|irinotecan|mesh-list
138848828|NCT02782182|Folfirinox|folfirinox|mesh-list
138848829|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848830|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138848831|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138848832|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848833|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848834|NCT02782182|Antidotes|antidotes|mesh-ancestor
138848835|NCT02782182|Protective Agents|protective agents|mesh-ancestor
138848836|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848837|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
138848838|NCT02782182|Vitamins|vitamins|mesh-ancestor
138848839|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
138848840|NCT02780778|Docetaxel|docetaxel|mesh-list
138848841|NCT02780778|Apatinib|apatinib|mesh-list
138848842|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848843|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
138848844|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
138848845|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
138848846|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848847|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138848848|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848849|NCT00881101|Paclitaxel|paclitaxel|mesh-list
138848850|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138848851|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848852|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
138848853|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
138848854|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
138848855|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848856|NCT00883909|Dutasteride|dutasteride|mesh-list
138848857|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138848858|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138848859|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848860|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848861|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
138848862|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138848863|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848864|NCT00634686|Vitamin D|vitamin d|mesh-list
138848865|NCT00634686|Calcium|calcium|mesh-list
138848866|NCT00634686|Vitamins|vitamins|mesh-ancestor
138848867|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
138848868|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848869|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138848870|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138848871|NCT05340192|Octreotide|octreotide|mesh-list
138848872|NCT05340192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138848873|NCT05340192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138848874|NCT05340192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848875|NCT03955861|Adalimumab|adalimumab|mesh-list
138848876|NCT03955861|Golimumab|golimumab|mesh-list
138848877|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
138848878|NCT03955861|Etanercept|etanercept|mesh-list
138848879|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138848880|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138848881|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138848882|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138848883|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138848884|NCT03955861|Analgesics|analgesics|mesh-ancestor
138848885|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
138848886|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848887|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210358|NCT03564340|Cemiplimab|cemiplimab|mesh-list
138848888|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138848889|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138848890|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
138848891|NCT00881179|Clarithromycin|clarithromycin|mesh-list
138848892|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138848893|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848894|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138848895|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848896|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848897|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138848898|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138848899|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
138848900|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138848901|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138848902|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848903|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138848904|NCT02781246|Analgesics|analgesics|mesh-ancestor
138848905|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
138848906|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848907|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138848908|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138848909|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138848910|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
138848911|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848912|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848913|NCT00613951|Insulin|insulin|mesh-list
138848914|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138848915|NCT00613951|Metformin|metformin|mesh-list
138848916|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
138848917|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
138848918|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138848919|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
138848920|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138848921|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848922|NCT00881413|Esomeprazole|esomeprazole|mesh-list
138848923|NCT00881413|Pantoprazole|pantoprazole|mesh-list
138848924|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138848925|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138848926|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138848927|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848928|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848929|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138848930|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138848931|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848932|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
138848933|NCT00958841|Pasireotide|pasireotide|mesh-list
138848934|NCT00958841|Hormones|hormones|mesh-ancestor
138848935|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138848936|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848937|NCT02937116|Cisplatin|cisplatin|mesh-list
138848938|NCT02937116|Gemcitabine|gemcitabine|mesh-list
138848939|NCT02937116|Capecitabine|capecitabine|mesh-list
138848940|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
138848941|NCT02937116|Irinotecan|irinotecan|mesh-list
138848942|NCT02937116|Etoposide|etoposide|mesh-list
138848943|NCT02937116|Pemetrexed|pemetrexed|mesh-list
138848944|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848945|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138848946|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
138848947|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848948|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138848949|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138848950|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848951|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138848952|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138848953|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138848954|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138848955|NCT03927105|Nivolumab|nivolumab|mesh-list
138848956|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138848957|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848958|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138848959|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848960|NCT00613327|Oxybutynin|oxybutynin|mesh-list
138848961|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
138848962|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
138848963|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138848964|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848966|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138848967|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
138848968|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138848969|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848970|NCT00613327|Urological Agents|urological agents|mesh-ancestor
138848971|NCT04273997|Metronidazole|metronidazole|mesh-list
138848972|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848973|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138848974|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138848975|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138848976|NCT05339802|Linezolid|linezolid|mesh-list
138848977|NCT05339802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138848978|NCT05339802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138848979|NCT05339802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138848980|NCT05339802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138848981|NCT05339802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848982|NCT04649203|Niacinamide|niacinamide|mesh-list
138848983|NCT04649203|Niacin|niacin|mesh-list
138848984|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
138848985|NCT04649203|Riboflavin|riboflavin|mesh-list
138848986|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
138848987|NCT04649203|Vitamins|vitamins|mesh-ancestor
138848988|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
138848989|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848990|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138848991|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
138848992|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138848993|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138848994|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
138848995|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138848996|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
138848997|NCT00881725|Metformin|metformin|mesh-list
138848998|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138848999|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849000|NCT00954941|Ondansetron|ondansetron|mesh-list
138849001|NCT00954941|Aprepitant|aprepitant|mesh-list
138849002|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
138849003|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
139014913|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
139014914|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
139014915|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139014916|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139014917|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139014918|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
139014929|NCT04902625|Naltrexone|naltrexone|mesh-list
138849004|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849005|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849006|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138849007|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
138849008|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
138849009|NCT00954941|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138849010|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138849011|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
138849012|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849013|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849014|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138849016|NCT05339646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138849017|NCT05339646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138849018|NCT05339646|Protease Inhibitors|protease inhibitors|mesh-ancestor
138849019|NCT05339646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849020|NCT05339646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849021|NCT05339646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138849022|NCT05339646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138849023|NCT05339646|Antiviral Agents|antiviral agents|mesh-ancestor
138849024|NCT05339646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849025|NCT05339646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138849026|NCT05339646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138849027|NCT00630695|Lanreotide|lanreotide|mesh-list
138849028|NCT00630695|Somatostatin|somatostatin|mesh-list
138849029|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849030|NCT00630695|Hormones|hormones|mesh-ancestor
138849031|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138849032|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849033|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138849035|NCT00954707|Clopidogrel|clopidogrel|mesh-list
138849036|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138849037|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138849038|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138849039|NCT00954707|Analgesics|analgesics|mesh-ancestor
138849040|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
139210359|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138849041|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849042|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849043|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138849044|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139014950|NCT04848792|Sulforaphane|sulforaphane|mesh-list
138849045|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138849046|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138849047|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849048|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138849049|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138849050|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849051|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
138849052|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138849053|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138849054|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138849055|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
138849056|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849057|NCT00630851|Donepezil|donepezil|mesh-list
138849058|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138849059|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849060|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849061|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
138849062|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849063|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849064|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
138849065|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
138849066|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849067|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138849068|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849069|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849070|NCT05156892|Tamoxifen|tamoxifen|mesh-list
138849071|NCT05156892|Itraconazole|itraconazole|mesh-list
138849072|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138849073|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
138849074|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138849075|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849076|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138849077|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849078|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138849079|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138849080|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138849081|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
138849082|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849083|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138849084|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138849085|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849086|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849087|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138849088|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138849090|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138849091|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138849092|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138849093|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138849094|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
138849095|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849096|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849097|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849098|NCT02859077|Carboplatin|carboplatin|mesh-list
138849099|NCT02859077|Gemcitabine|gemcitabine|mesh-list
138849100|NCT02859077|Pemetrexed|pemetrexed|mesh-list
138849101|NCT02859077|Gefitinib|gefitinib|mesh-list
138849102|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849103|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138849104|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
138849105|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849106|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849107|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138849108|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138849109|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138849110|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138849111|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
138849112|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138849113|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138849114|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138849115|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849116|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849118|NCT00879385|Panitumumab|panitumumab|mesh-list
138849119|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138849120|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
138849121|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849122|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849123|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849124|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138849125|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
138849126|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138849127|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849128|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138849129|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138849130|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849131|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849132|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849133|NCT00953225|Vitamin D|vitamin d|mesh-list
138849134|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
138849135|NCT00953225|Vitamins|vitamins|mesh-ancestor
138849136|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
138849137|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849138|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138849139|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138849140|NCT03819231|Oxytocin|oxytocin|mesh-list
138849141|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
138942183|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849142|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138849143|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849144|NCT00613015|Guanfacine|guanfacine|mesh-list
138849145|NCT00613015|Modafinil|modafinil|mesh-list
138849146|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138849147|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849148|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138849149|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138849150|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138849151|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849152|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138849153|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138849154|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138849155|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138849156|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
138849157|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849158|NCT02779608|Docetaxel|docetaxel|mesh-list
138849159|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849160|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
138849161|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
138849162|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
138849163|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849164|NCT02543671|Vitamin D|vitamin d|mesh-list
138849165|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
138849166|NCT02543671|Vitamins|vitamins|mesh-ancestor
138849167|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
138849168|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849169|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138849170|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138849171|NCT02838992|Cyclosporine|cyclosporine|mesh-list
138849172|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
138849173|NCT02838992|Cyclosporins|cyclosporins|mesh-list
138849174|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
138849175|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138849176|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
138849177|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849178|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849179|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138849180|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
138849181|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139015042|NCT04585893|Rituximab|rituximab|mesh-list
138849182|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849183|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138849184|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849185|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
138624767|NCT04283604|Methylphenidate|methylphenidate|mesh-list
138849186|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849187|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
138849188|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138849190|NCT00879541|Coagulants|coagulants|mesh-ancestor
138849191|NCT00884299|Antioxidants|antioxidants|mesh-list
138849192|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849193|NCT00884299|Protective Agents|protective agents|mesh-ancestor
138849194|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849195|NCT02843126|Trastuzumab|trastuzumab|mesh-list
138849196|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138849197|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849198|NCT04201652|Anesthetics|anesthetics|mesh-list
138849199|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
138849200|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849201|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849202|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
138942195|NCT00649389|Diuretics|diuretics|mesh-ancestor
138849203|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849204|NCT05338476|Midazolam|midazolam|mesh-list
138849205|NCT05338476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138849206|NCT05338476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138849207|NCT05338476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849208|NCT05338476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849209|NCT05338476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138849210|NCT05338476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138849211|NCT05338476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138849212|NCT05338476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138849213|NCT05338476|Anesthetics, General|anesthetics, general|mesh-ancestor
138849214|NCT05338476|Anesthetics|anesthetics|mesh-ancestor
138849215|NCT05338476|GABA Modulators|gaba modulators|mesh-ancestor
138849216|NCT05338476|GABA Agents|gaba agents|mesh-ancestor
138849217|NCT05338476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849218|NCT05338476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849219|NCT02838758|Lidocaine|lidocaine|mesh-list
138849220|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
138849221|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
138849222|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849223|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849224|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
138849225|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849226|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138849227|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138849228|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138849229|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138849230|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849231|NCT00803595|Oseltamivir|oseltamivir|mesh-list
138849232|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
138849233|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849234|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592462|NCT04693897|Urological Agents|urological agents|mesh-ancestor
138849235|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849236|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
138849237|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138849238|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849239|NCT02843204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138849240|NCT02843204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849241|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
138849242|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138849243|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849244|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
138849245|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
138849246|NCT04227990|Docetaxel|docetaxel|mesh-list
138849247|NCT04227990|Doxorubicin|doxorubicin|mesh-list
138849248|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138849249|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
138849250|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849251|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849252|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138849253|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
138849254|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849255|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849256|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138849257|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
138849258|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210360|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849259|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
138849260|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138849261|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138849262|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138849264|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
138849265|NCT02606409|Propofol|propofol|mesh-list
138849266|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138849267|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849268|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849269|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138849270|NCT02606409|Analgesics|analgesics|mesh-ancestor
138849271|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
138849272|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849273|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138849274|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138849275|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138849276|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
138849277|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849278|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849279|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138849280|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
138849281|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
138849282|NCT00611767|Thiopental|thiopental|mesh-list
138849283|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
138849284|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138849285|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849286|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849287|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138849288|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
138849289|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
138849290|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
138849291|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
138849292|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849293|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849294|NCT04967508|Ustekinumab|ustekinumab|mesh-list
138849295|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
138849296|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138849297|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139015084|NCT04319627|Calcium|calcium|mesh-list
138849298|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138849299|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138849300|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849301|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849302|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849303|NCT00803361|Analgesics|analgesics|mesh-ancestor
138849304|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
138849305|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849306|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
138849307|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138849308|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
138849309|NCT02837198|Dotinurad|dotinurad|mesh-list
138849310|NCT02837198|FYX-051|fyx-051|mesh-list
138849311|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
138849312|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
138849313|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849314|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849315|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849316|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138849317|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138849318|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138849319|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138849320|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849321|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
138849322|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849323|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849324|NCT04038307|Acetaminophen|acetaminophen|mesh-list
138849325|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138849326|NCT04038307|Analgesics|analgesics|mesh-ancestor
138849327|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
138849328|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849329|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849330|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
138849331|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
138849332|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138849333|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849334|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138849335|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138849336|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849337|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849338|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849339|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
138849340|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
138849341|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
138849342|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138849343|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138849344|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849345|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849346|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849347|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849348|NCT02842814|Hormones|hormones|mesh-ancestor
138849349|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138849350|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849352|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138849353|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849354|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138849355|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138849356|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138849357|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849358|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
138849359|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849360|NCT00953147|Ciclesonide|ciclesonide|mesh-list
138849361|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
138849362|NCT00953147|Hormones|hormones|mesh-ancestor
138849363|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138849364|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849365|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138849366|NCT05333744|Prednisone|prednisone|mesh-list
138849367|NCT05333744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138849368|NCT05333744|Glucocorticoids|glucocorticoids|mesh-ancestor
138849369|NCT05333744|Hormones|hormones|mesh-ancestor
138849370|NCT05333744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138849371|NCT05333744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942293|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849372|NCT05333744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138849373|NCT05333744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849374|NCT04250246|Nivolumab|nivolumab|mesh-list
138849375|NCT04250246|Ipilimumab|ipilimumab|mesh-list
138849376|NCT04250246|Guadecitabine|guadecitabine|mesh-list
138849377|NCT04250246|Azacitidine|azacitidine|mesh-list
138849378|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138849379|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849380|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138849381|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849382|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138849384|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849385|NCT04273529|Thalidomide|thalidomide|mesh-list
138849386|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138849387|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
138849388|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849389|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
138849390|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138849391|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849392|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138849393|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138849394|NCT04273529|Growth Substances|growth substances|mesh-ancestor
138849395|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
138849396|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849397|NCT02858843|Ivacaftor|ivacaftor|mesh-list
138849398|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138849399|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138849400|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849401|NCT02779530|Diclofenac|diclofenac|mesh-list
138849402|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138849403|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138849404|NCT02779530|Analgesics|analgesics|mesh-ancestor
138849405|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
138849406|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849407|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849408|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138849409|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849410|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138849411|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849412|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849413|NCT00952523|Adapalene|adapalene|mesh-list
138849414|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
138849415|NCT00952523|Tretinoin|tretinoin|mesh-list
138849416|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138849417|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
138849418|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849419|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
138849420|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138849421|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138849422|NCT00952523|Analgesics|analgesics|mesh-ancestor
138849423|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
138849424|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849425|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849426|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138849427|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849428|NCT04249154|Leuprolide|leuprolide|mesh-list
138849429|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138849430|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
138849431|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138849432|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849433|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138849434|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849435|NCT02857361|Ketamine|ketamine|mesh-list
138849436|NCT02857361|Analgesics|analgesics|mesh-ancestor
138849437|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
138849438|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849439|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849440|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138849441|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138849442|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
138849443|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
138849444|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849445|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138849446|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138849447|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849448|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849449|NCT02778126|Prexasertib|prexasertib|mesh-list
138849450|NCT02778126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138849451|NCT02778126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849452|NCT02778126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849453|NCT02232737|Nicotine|nicotine|mesh-list
138849454|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138849455|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
138849456|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849457|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849458|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138849459|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138849460|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
138849461|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849462|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849463|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138849464|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849465|NCT02777814|Entecavir|entecavir|mesh-list
138849466|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
138849467|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849468|NCT02778906|Abatacept|abatacept|mesh-list
138849469|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138849470|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849471|NCT02778906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138849472|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849473|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138849474|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
138849475|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849476|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849477|NCT00630929|Ibuprofen|ibuprofen|mesh-list
138849478|NCT00630929|Celecoxib|celecoxib|mesh-list
138849479|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138849480|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138849481|NCT00630929|Analgesics|analgesics|mesh-ancestor
138849482|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
138849483|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849484|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849485|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138849486|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849487|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138849488|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849489|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849490|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138849491|NCT04204928|Pralsetinib|pralsetinib|mesh-list
138849492|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849493|NCT02834546|Sorafenib|sorafenib|mesh-list
138849494|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849495|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138849496|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942336|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138849497|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849498|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138849499|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138849500|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
138849501|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849502|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138849503|NCT04227912|Anesthetics|anesthetics|mesh-list
138849504|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
138849505|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849506|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849507|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
138849508|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849509|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138849510|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138849511|NCT04227912|Analgesics|analgesics|mesh-ancestor
138849512|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138849513|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849514|NCT02854787|Phenylephrine|phenylephrine|mesh-list
138849515|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
138849516|NCT02854787|Norepinephrine|norepinephrine|mesh-list
138849517|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138849518|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
138849519|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
138849520|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849521|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849522|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
138849523|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138849524|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
138849525|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
138849526|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138849527|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138849528|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138849529|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
138849530|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849531|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849532|NCT02854787|Protective Agents|protective agents|mesh-ancestor
138849533|NCT02778828|Linezolid|linezolid|mesh-list
138849534|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138849535|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849536|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138849537|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849538|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849539|NCT02777736|Methotrexate|methotrexate|mesh-list
138849540|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138849541|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
138849542|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138849543|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849544|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138849545|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
138849546|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849547|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849548|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
138501541|NCT00031291|Antibodies|antibodies|mesh-list
138849549|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849550|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138849551|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138849552|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
138849553|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849554|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138849555|NCT02836184|Niacin|niacin|mesh-list
138849556|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
138849557|NCT02836184|Niacinamide|niacinamide|mesh-list
138849558|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
138849559|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849560|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138849561|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
138849562|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849563|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138849564|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
138849565|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
138849566|NCT02836184|Vitamins|vitamins|mesh-ancestor
138849567|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
138849568|NCT02836184|Antacids|antacids|mesh-ancestor
138849569|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138849570|NCT02775474|Fentanyl|fentanyl|mesh-list
138849571|NCT02775474|Methadone|methadone|mesh-list
138849572|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138849573|NCT02775474|Narcotics|narcotics|mesh-ancestor
138849574|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849575|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849576|NCT02775474|Analgesics|analgesics|mesh-ancestor
138849577|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
138849578|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849579|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138849580|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138849581|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
138849582|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
138849583|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
138849584|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
138849585|NCT05158686|Paclitaxel|paclitaxel|mesh-list
138849586|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138849587|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849588|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
138849589|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
138849590|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
138849591|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849592|NCT02835794|Azacitidine|azacitidine|mesh-list
138849593|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
138849594|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138849595|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
138849596|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849597|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849598|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849599|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138849600|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138849601|NCT02836028|Temozolomide|temozolomide|mesh-list
138849602|NCT02836028|Talazoparib|talazoparib|mesh-list
138849603|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138849604|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
138849605|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849606|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849607|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138849608|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849609|NCT01778946|Nicotine|nicotine|mesh-list
138849610|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138849611|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
138849612|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849613|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849614|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138849615|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138849616|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
138849617|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849618|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849619|NCT04227210|Vaccines|vaccines|mesh-list
138849620|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
138849621|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849622|NCT02833766|Doxorubicin|doxorubicin|mesh-list
138849623|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138849624|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849625|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138849626|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138849627|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849628|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849629|NCT04813380|Immunomodulating Agents|immunomodulating agents|mesh-list
138849630|NCT04813380|Immunologic Factors|immunologic factors|mesh-ancestor
138849631|NCT04813380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210361|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138849632|NCT04951362|Ivermectin|ivermectin|mesh-list
138849633|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138849634|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849635|NCT02833610|Denosumab|denosumab|mesh-list
138849636|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138849637|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849638|NCT04225728|Iron|iron|mesh-list
138849639|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138849640|NCT04225728|Teferrol|teferrol|mesh-list
138849641|NCT04225728|Trace Elements|trace elements|mesh-ancestor
138849642|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
138849643|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849644|NCT04225728|Hematinics|hematinics|mesh-ancestor
138849645|NCT02835716|Ustekinumab|ustekinumab|mesh-list
138849646|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
138849647|NCT04247984|Bevacizumab|bevacizumab|mesh-list
138849648|NCT04247984|Capecitabine|capecitabine|mesh-list
138849649|NCT04247984|Fluorouracil|fluorouracil|mesh-list
138849650|NCT04247984|Irinotecan|irinotecan|mesh-list
138849651|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138849652|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849653|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138849654|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138849655|NCT04247984|Growth Substances|growth substances|mesh-ancestor
138849656|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849657|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
138849658|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138849659|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
138849660|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849661|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138849662|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
138849663|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138849664|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138849665|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849666|NCT00948389|Dasatinib|dasatinib|mesh-list
138849667|NCT00948389|Lomustine|lomustine|mesh-list
138849668|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849669|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138849670|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849671|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849672|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138849673|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
138849674|NCT02775318|Bupivacaine|bupivacaine|mesh-list
138849675|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
138849676|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
138849677|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849678|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849679|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
138849680|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849681|NCT00948155|Varenicline|varenicline|mesh-list
138849682|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138849683|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138849684|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
138849685|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849686|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849687|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849688|NCT02776956|Atorvastatin|atorvastatin|mesh-list
138849689|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138849690|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138849691|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
139015282|NCT03629418|Protective Agents|protective agents|mesh-ancestor
138849692|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849693|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138849694|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138849695|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849696|NCT04910178|Empagliflozin|empagliflozin|mesh-list
138849697|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
138849698|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138849699|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138849700|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849701|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138849702|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849703|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138849704|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849705|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138849706|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138849707|NCT04910178|Protective Agents|protective agents|mesh-ancestor
138849708|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
138849709|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138849710|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
138849711|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138849712|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138849714|NCT02778594|Benserazide|benserazide|mesh-list
138849715|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138849716|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138849717|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
138849718|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849719|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849720|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849721|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849723|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138849724|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849725|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
138849726|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
138849727|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
138849728|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849729|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138849730|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849731|NCT04851834|Cisplatin|cisplatin|mesh-list
138849732|NCT04851834|Carboplatin|carboplatin|mesh-list
138849733|NCT04851834|Temozolomide|temozolomide|mesh-list
138849734|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849735|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138849736|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
138849737|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849738|NCT02776722|Tagatose|tagatose|mesh-list
138849739|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138849740|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
138849741|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
138849742|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849743|NCT02776878|Dasatinib|dasatinib|mesh-list
138849744|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849745|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138849746|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849747|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849748|NCT02772822|Rituximab|rituximab|mesh-list
138849749|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138849750|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849751|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
138849752|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849753|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849755|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138849756|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849757|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849758|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138849759|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138849760|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138849761|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
138849762|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
138849763|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849764|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849765|NCT02772744|Ribavirin|ribavirin|mesh-list
138849766|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
138849767|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
138849768|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849769|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
138849770|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849771|NCT02774382|Vancomycin|vancomycin|mesh-list
138849772|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138849773|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849774|NCT02774460|Amlodipine|amlodipine|mesh-list
138849775|NCT02774460|Candesartan|candesartan|mesh-list
138849776|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
138849778|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138849779|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138849780|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138849781|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849782|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138849783|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849784|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
138849785|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138849786|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138849787|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138849788|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
138497633|NCT00118222|Ether|ether|mesh-list
138849789|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849790|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138849791|NCT02774460|Protective Agents|protective agents|mesh-ancestor
138849793|NCT02772354|Verapamil|verapamil|mesh-list
138849794|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138849795|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138849796|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
138849797|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
138849798|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849799|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849801|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138849802|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138849803|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
138849804|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849805|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849806|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138849807|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138849808|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138849809|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
138849810|NCT00611455|Ofatumumab|ofatumumab|mesh-list
138849811|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849812|NCT02767752|Gemcitabine|gemcitabine|mesh-list
138849813|NCT02767752|Capecitabine|capecitabine|mesh-list
138849814|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138849815|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
138849816|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849817|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849818|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138849819|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
138849820|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849821|NCT02835404|Nedaplatin|nedaplatin|mesh-list
138849822|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849823|NCT00885781|SMOFlipid|smoflipid|mesh-list
138849824|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138849825|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138849826|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138849827|NCT02767674|Prednisone|prednisone|mesh-list
138849828|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
138849830|NCT02767674|Gemcitabine|gemcitabine|mesh-list
138849831|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
138849832|NCT02767674|Epirubicin|epirubicin|mesh-list
138849833|NCT02767674|Vindesine|vindesine|mesh-list
138849834|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138849835|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
138849836|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849837|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138849838|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138849839|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
138849840|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849841|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849842|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138849843|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138849844|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138849845|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
138849846|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138849847|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
138849848|NCT02767674|Hormones|hormones|mesh-ancestor
138849849|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138849850|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138849851|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138849852|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138849854|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849855|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138849856|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
138849857|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
138849858|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
138625446|NCT02213497|Paclitaxel|paclitaxel|mesh-list
138849860|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138849861|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849862|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849863|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138849864|NCT02833688|Analgesics|analgesics|mesh-ancestor
138849865|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
138849866|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849867|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138849868|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138849869|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138849870|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
138849871|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849872|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849873|NCT00612313|Fluoxetine|fluoxetine|mesh-list
138849874|NCT00612313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138849875|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138849876|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138849877|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849878|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849879|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
138849880|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849881|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138849882|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
138849883|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138849884|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138849885|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138849886|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849887|NCT00890552|Dexamethasone|dexamethasone|mesh-list
138849888|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
138849889|NCT00890552|Lenalidomide|lenalidomide|mesh-list
138849890|NCT00890552|Melphalan|melphalan|mesh-list
138849891|NCT00890552|BB 1101|bb 1101|mesh-list
138849892|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138849893|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
138849894|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
138849895|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849896|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849897|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139015449|NCT02813135|Dexamethasone|dexamethasone|mesh-list
138849898|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
138849899|NCT00890552|Hormones|hormones|mesh-ancestor
138849900|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138849901|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138593138|NCT03156452|Prednisolone|prednisolone|mesh-list
138849902|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849903|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
138849904|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138849905|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849906|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
138849907|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138942449|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138849908|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138849909|NCT00890552|Growth Substances|growth substances|mesh-ancestor
138849910|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
138849911|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138849912|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
138849913|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138849914|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138849915|NCT02856503|Vitamin D|vitamin d|mesh-list
138849916|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
138849917|NCT02856503|Vitamins|vitamins|mesh-ancestor
138849918|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
138849919|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849920|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138849921|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138849922|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
138849923|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138849924|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138849925|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
138849926|NCT02542813|Oxytocin|oxytocin|mesh-list
138849927|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
138849928|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138849929|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849930|NCT02772120|Progesterone|progesterone|mesh-list
138849931|NCT02772120|Progestins|progestins|mesh-ancestor
138849932|NCT02772120|Hormones|hormones|mesh-ancestor
138625536|NCT01294072|Curcumin|curcumin|mesh-list
138849933|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138849934|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849935|NCT04248608|Morphine|morphine|mesh-list
138849936|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138849937|NCT04248608|Narcotics|narcotics|mesh-ancestor
139015477|NCT02813135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138849938|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849939|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849940|NCT04248608|Analgesics|analgesics|mesh-ancestor
138849941|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
138849942|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849943|NCT04783194|Dexamethasone|dexamethasone|mesh-list
138849944|NCT04783194|Bupivacaine|bupivacaine|mesh-list
138849945|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138849946|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
138849947|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
138849948|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138849949|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849950|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138849951|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
138849953|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138849954|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138849955|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849956|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
138849957|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
138849958|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849959|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
138849960|NCT02854241|Liver Extracts|liver extracts|mesh-list
138849961|NCT02854241|Hematinics|hematinics|mesh-ancestor
138849962|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
138849963|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138849964|NCT02835170|Antibodies|antibodies|mesh-list
138849965|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
138849966|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849967|NCT00946985|Risperidone|risperidone|mesh-list
138849968|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138849969|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138849970|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
138849971|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138849972|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849973|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849974|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138849975|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138849976|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138849977|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138849978|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138849979|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
138849980|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138849981|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138849982|NCT00611923|Flutamide|flutamide|mesh-list
138849983|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
138849984|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
138849985|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138849986|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138849987|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138849988|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849989|NCT04246502|Capecitabine|capecitabine|mesh-list
138849990|NCT04246502|Trastuzumab|trastuzumab|mesh-list
138849991|NCT04246502|Pertuzumab|pertuzumab|mesh-list
138849992|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138849993|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
138849994|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138849995|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138849996|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138849997|NCT02767362|Atorvastatin|atorvastatin|mesh-list
138849998|NCT02767362|Ezetimibe|ezetimibe|mesh-list
138849999|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138850000|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138850001|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
138850002|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850003|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138850004|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138850006|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
138850007|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138850008|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850009|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138850010|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138850011|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850012|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850013|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850014|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138850015|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138850017|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850018|NCT02696694|Progesterone|progesterone|mesh-list
138850019|NCT02696694|Progestins|progestins|mesh-ancestor
138850020|NCT02696694|Hormones|hormones|mesh-ancestor
138850021|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138850022|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850023|NCT04038073|Antibodies|antibodies|mesh-list
138850024|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
138850025|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
138850026|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850027|NCT04739592|Vitamin D|vitamin d|mesh-list
138850028|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
138850029|NCT04739592|Alendronate|alendronate|mesh-list
138850030|NCT04739592|Vitamins|vitamins|mesh-ancestor
138850031|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
138850032|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850033|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138850034|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138850035|NCT00633386|Celecoxib|celecoxib|mesh-list
138850036|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138850037|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138850038|NCT00633386|Analgesics|analgesics|mesh-ancestor
138850039|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
138850040|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850041|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850042|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138850043|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138850044|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138850045|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138850046|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850047|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850048|NCT02771418|Anesthetics|anesthetics|mesh-list
138850049|NCT02771418|Propofol|propofol|mesh-list
138850050|NCT02771418|Sevoflurane|sevoflurane|mesh-list
138850051|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850052|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850053|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138850054|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138850055|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
138850056|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138850057|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138850058|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138850060|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138850061|NCT00888901|Prednisolone|prednisolone|mesh-list
138850062|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
138850063|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138850064|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
138850065|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138850066|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
138850067|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
138850068|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850069|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850070|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138850071|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
138850072|NCT00888901|Hormones|hormones|mesh-ancestor
138850073|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138850074|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138850075|NCT00888901|Protective Agents|protective agents|mesh-ancestor
138850076|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138850077|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850078|NCT00803049|Teriflunomide|teriflunomide|mesh-list
138850079|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138850081|NCT00803049|Analgesics|analgesics|mesh-ancestor
138850082|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
138850083|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850084|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850085|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138850086|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138850087|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138850088|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
138850089|NCT00884767|Leucovorin|leucovorin|mesh-list
138850090|NCT00884767|Fluorouracil|fluorouracil|mesh-list
138850091|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
138850092|NCT00884767|Calcium|calcium|mesh-list
138850093|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
138850094|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138850095|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850096|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
138850097|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850098|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138850099|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850100|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138850101|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
138850102|NCT00884767|Antidotes|antidotes|mesh-ancestor
138850103|NCT00884767|Protective Agents|protective agents|mesh-ancestor
138850104|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
138850105|NCT00884767|Vitamins|vitamins|mesh-ancestor
138850106|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
138850107|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138850108|NCT00890084|Telmisartan|telmisartan|mesh-list
138850109|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
138850110|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138850111|NCT00890084|Diuretics|diuretics|mesh-ancestor
138850112|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
138850113|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850114|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138850115|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138850116|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850117|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138850118|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138850119|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138850120|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850121|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138850122|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850123|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850124|NCT02773602|Dexamethasone|dexamethasone|mesh-list
138850125|NCT02773602|Clonidine|clonidine|mesh-list
138850126|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138850127|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
138850128|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
138850129|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850130|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850131|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138850132|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
138850133|NCT02773602|Hormones|hormones|mesh-ancestor
138850134|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138850135|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138850136|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850137|NCT02773602|Analgesics|analgesics|mesh-ancestor
138850138|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
138850139|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138850140|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
138850141|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138850142|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138850143|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138850144|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
138850145|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850146|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850147|NCT02770950|Indomethacin|indomethacin|mesh-list
138850148|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138850149|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138850150|NCT02770950|Analgesics|analgesics|mesh-ancestor
138850151|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
138850152|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850153|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850154|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138850155|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138850156|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
138850158|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138850159|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139210362|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
138850160|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850161|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850162|NCT00889057|Sorafenib|sorafenib|mesh-list
138850163|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850164|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138850165|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850166|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850167|NCT02829008|Bevacizumab|bevacizumab|mesh-list
138850168|NCT02829008|Pemetrexed|pemetrexed|mesh-list
138850169|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138850170|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850171|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138850172|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138850173|NCT02829008|Growth Substances|growth substances|mesh-ancestor
138850174|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850175|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
138850176|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850177|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850178|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138850179|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138850180|NCT00889135|Droxidopa|droxidopa|mesh-list
138850181|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138850182|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138850183|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138850184|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
138850185|NCT00889213|Coagulants|coagulants|mesh-ancestor
138850186|NCT00382200|Decitabine|decitabine|mesh-list
138850187|NCT00382200|Tretinoin|tretinoin|mesh-list
138850188|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138850189|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
138850190|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850191|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850192|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850193|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
138850194|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
138850195|NCT02696928|Lumefantrine|lumefantrine|mesh-list
138850196|NCT02696928|Primaquine|primaquine|mesh-list
138850197|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
138850198|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138850199|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138850200|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850201|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
138850202|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
138850203|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138850204|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138850205|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138850206|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138850207|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850208|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850209|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850210|NCT00889369|Analgesics|analgesics|mesh-ancestor
138850211|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
138850212|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850213|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
138850214|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138850215|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
138850216|NCT02766192|Ketamine|ketamine|mesh-list
138850217|NCT02766192|Analgesics|analgesics|mesh-ancestor
138850218|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
138850219|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850220|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850221|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138850222|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138850223|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
138850224|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
138850225|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850226|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138850227|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138850228|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850229|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850230|NCT05278897|Hyaluronic Acid|hyaluronic acid|mesh-list
138850231|NCT05278897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138850232|NCT05278897|Immunologic Factors|immunologic factors|mesh-ancestor
138850233|NCT05278897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850234|NCT05278897|Viscosupplements|viscosupplements|mesh-ancestor
138850235|NCT05278897|Protective Agents|protective agents|mesh-ancestor
138850236|NCT00889525|Cabergoline|cabergoline|mesh-list
138850237|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138850238|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138850239|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
138850240|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
138850241|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942559|NCT04061538|Zinc|zinc|mesh-list
138850242|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850243|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850244|NCT02770794|Infliximab|infliximab|mesh-list
138850245|NCT02770794|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138850246|NCT02770794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138850247|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
138850248|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138850249|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138850250|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
138850251|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138850252|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138850253|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
138850254|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
138850255|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850256|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850257|NCT02766270|Temozolomide|temozolomide|mesh-list
138850258|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138850259|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
138850260|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850261|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850262|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138850263|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
138850264|NCT02766348|Gemcitabine|gemcitabine|mesh-list
138850265|NCT02766348|Cisplatin|cisplatin|mesh-list
138850266|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138850267|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
138850268|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850269|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850270|NCT00608569|Ritonavir|ritonavir|mesh-list
138850271|NCT00608569|Lopinavir|lopinavir|mesh-list
138850272|NCT00608569|Tenofovir|tenofovir|mesh-list
138850273|NCT00608569|Emtricitabine|emtricitabine|mesh-list
138850274|NCT00608569|Zidovudine|zidovudine|mesh-list
139015607|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138850275|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138850277|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138850278|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
138850279|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850280|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850281|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138850282|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138850283|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
138850284|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850285|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138850286|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138850287|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138850288|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138850289|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
138850290|NCT04699422|Pirinitramide|pirinitramide|mesh-list
138850291|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138850292|NCT04699422|Narcotics|narcotics|mesh-ancestor
138850293|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850294|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850295|NCT04699422|Analgesics|analgesics|mesh-ancestor
138850296|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
138850297|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850298|NCT02828384|Psyllium|psyllium|mesh-list
138850299|NCT02828384|Cathartics|cathartics|mesh-ancestor
138850300|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138850301|NCT00886717|Paclitaxel|paclitaxel|mesh-list
138850302|NCT00886717|genexol-PM|genexol-pm|mesh-list
138850303|NCT00886717|Carboplatin|carboplatin|mesh-list
138850304|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138850305|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850306|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
138850307|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
138850308|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
138850309|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850310|NCT00889837|Loxapine|loxapine|mesh-list
138625909|NCT00563914|Ferroquine|ferroquine|mesh-list
138850311|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138850312|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138850313|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850314|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850315|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138850316|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138850317|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
138850318|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850319|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850320|NCT02770404|Nafithromycin|nafithromycin|mesh-list
139015635|NCT01025089|Doxorubicin|doxorubicin|mesh-list
138850321|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138850322|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850323|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138850324|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850325|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850326|NCT00886873|Mifepristone|mifepristone|mesh-list
138850327|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138850328|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
138850329|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138850330|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850331|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138850332|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138850333|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138850334|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
138850335|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138850336|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138850337|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
138850338|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138850339|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
138850340|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138850341|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138850342|NCT04243850|Empagliflozin|empagliflozin|mesh-list
138850343|NCT04243850|Caffeine|caffeine|mesh-list
138850344|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138850345|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850346|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138641737|NCT00425594|Bisacodyl|bisacodyl|mesh-list
138850347|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787894|NCT00640198|Memantine|memantine|mesh-list
138850348|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850349|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138850350|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138850351|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
138850352|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850353|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138850354|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138850355|NCT00892801|Everolimus|everolimus|mesh-list
138850356|NCT00892801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138850357|NCT00892801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138850358|NCT00892801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850359|NCT00892801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850360|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138850361|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
138850362|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850363|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850364|NCT04222842|Vorolanib|vorolanib|mesh-list
139015667|NCT00696111|Leuprolide|leuprolide|mesh-list
138850365|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138850366|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850367|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850368|NCT00633542|Interferons|interferons|mesh-list
138850369|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
138850370|NCT00633542|Thalidomide|thalidomide|mesh-list
138850371|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850372|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
138850373|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850374|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
138850375|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850376|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138850377|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
138502390|NCT00034528|Prednisone|prednisone|mesh-list
138850378|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138850379|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138850380|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138850381|NCT00633542|Growth Substances|growth substances|mesh-ancestor
138850382|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
138850384|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850385|NCT00610675|Mirtazapine|mirtazapine|mesh-list
138850386|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
138850387|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138850388|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138850389|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
138850390|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
138850391|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850392|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850393|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850394|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138850395|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138850396|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850397|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138850398|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138850399|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138850400|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
138850401|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138850402|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138850403|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
138850404|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138850405|NCT02828228|Vitamin D|vitamin d|mesh-list
138850406|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
138850407|NCT02828228|Vitamins|vitamins|mesh-ancestor
138850408|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
138850409|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850410|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138850411|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138850412|NCT02769936|Cycloserine|cycloserine|mesh-list
138850413|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138850414|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850415|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138850416|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
138850417|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138850418|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
138850419|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850420|NCT00887029|Timolol|timolol|mesh-list
138850421|NCT00887029|Travoprost|travoprost|mesh-list
138850423|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138850424|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138850425|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138850426|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
138850427|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850428|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850429|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850430|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138850431|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138850432|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138850433|NCT00635310|Liver Extracts|liver extracts|mesh-list
138850434|NCT00635310|Hematinics|hematinics|mesh-ancestor
138850435|NCT02762448|Asunaprevir|asunaprevir|mesh-list
138850436|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
138850437|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850438|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850439|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
138850440|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138850441|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850442|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138850443|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
138850444|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138850445|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850446|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850447|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850448|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138850449|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
138850450|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
138502449|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
138850452|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850453|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138850454|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942652|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138850455|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850456|NCT00802737|Ofatumumab|ofatumumab|mesh-list
138850457|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850458|NCT02769390|Clonidine|clonidine|mesh-list
138850459|NCT02769390|Diazepam|diazepam|mesh-list
138850460|NCT02769390|Analgesics|analgesics|mesh-ancestor
138850461|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
138850462|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850463|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850464|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138850465|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
138850466|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
138850467|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138850468|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138850469|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138850470|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
138850471|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850472|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850473|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138850474|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
138850475|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
138850476|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138850477|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138850478|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850479|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138850480|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138850481|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138850482|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138850483|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138850484|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138850485|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
138850486|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
138850487|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
138850488|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
138850489|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
138850490|NCT00890539|Miotics|miotics|mesh-ancestor
138850491|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
138850492|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850493|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850494|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138850495|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138850496|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
138850497|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138850498|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138850499|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
138850500|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942672|NCT00609466|Analgesics|analgesics|mesh-ancestor
138850501|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850503|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138850504|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138850505|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
138850506|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850507|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850508|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138850509|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
138850510|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
138850511|NCT00887263|Hormones|hormones|mesh-ancestor
138850512|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138850513|NCT00914667|Warfarin|warfarin|mesh-list
138850514|NCT00914667|Fesoterodine|fesoterodine|mesh-list
138850515|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
138850516|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138850517|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138850518|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
138850519|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850520|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850521|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850522|NCT00914667|Urological Agents|urological agents|mesh-ancestor
138850523|NCT00887978|Treprostinil|treprostinil|mesh-list
138850524|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138850525|NCT00608023|Tesamorelin|tesamorelin|mesh-list
138850526|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
138850527|NCT00608023|Growth Substances|growth substances|mesh-ancestor
138502526|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
138850528|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850529|NCT00608023|Hormones|hormones|mesh-ancestor
138850530|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138850531|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138850532|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138850533|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
138850534|NCT02765022|Hormones|hormones|mesh-ancestor
138850535|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138850536|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850537|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850538|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850539|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138850540|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138850541|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138850542|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138850543|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850544|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850545|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850547|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
138850548|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850549|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
138850550|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138850551|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
138850552|NCT02761512|Lansoprazole|lansoprazole|mesh-list
138850553|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
138850554|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138850555|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138850556|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138850557|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850558|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850559|NCT00893269|Zolpidem|zolpidem|mesh-list
138942702|NCT00822393|Busulfan|busulfan|mesh-list
138850560|NCT00893269|Eszopiclone|eszopiclone|mesh-list
138850561|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138850562|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138850563|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850564|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850565|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138850566|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
138850567|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
138850568|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850570|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
138850571|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138850572|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850573|NCT00887822|Bevacizumab|bevacizumab|mesh-list
138850574|NCT00887822|Capecitabine|capecitabine|mesh-list
138850575|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138850576|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850577|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138850578|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138850579|NCT00887822|Growth Substances|growth substances|mesh-ancestor
138850580|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850581|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
138850582|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138850583|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
138850584|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850585|NCT02542111|Dexamethasone|dexamethasone|mesh-list
138850586|NCT02542111|Gemcitabine|gemcitabine|mesh-list
138850587|NCT02542111|Bortezomib|bortezomib|mesh-list
138850588|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138850589|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
138850590|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
138850591|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850592|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850593|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138850594|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
138850595|NCT02542111|Hormones|hormones|mesh-ancestor
138850596|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138850597|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138850598|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850599|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138850600|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
138850601|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850603|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138850604|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850605|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850606|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138850607|NCT02768688|Analgesics|analgesics|mesh-ancestor
138850608|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
138850609|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850610|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138850611|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138850612|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138850613|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
139015859|NCT00529100|Cisplatin|cisplatin|mesh-list
138850614|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942719|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
138850615|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850617|NCT00891163|Tetracaine|tetracaine|mesh-list
138850618|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
138850619|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
138850620|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850621|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850622|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
138850623|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850624|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138850625|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138850626|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138850627|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138850628|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850629|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
138850630|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138850631|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
138850632|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850633|NCT00893425|Ramipril|ramipril|mesh-list
138850634|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138850635|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
138850636|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850637|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850638|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138850639|NCT00951665|Paclitaxel|paclitaxel|mesh-list
138850640|NCT00951665|Maytansine|maytansine|mesh-list
138850641|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138850642|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138850643|NCT00951665|Trastuzumab|trastuzumab|mesh-list
138850644|NCT00951665|Pertuzumab|pertuzumab|mesh-list
138850645|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138850646|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850647|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
138850648|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
138850649|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
138850650|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850651|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138850652|NCT00951665|Immunotoxins|immunotoxins|mesh-ancestor
138850653|NCT00951665|Immunoconjugates|immunoconjugates|mesh-ancestor
138850654|NCT00951665|Immunologic Factors|immunologic factors|mesh-ancestor
138850655|NCT00951665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850656|NCT02769078|Warfarin|warfarin|mesh-list
138850657|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
138850658|NCT02769078|Dabigatran|dabigatran|mesh-list
138850659|NCT02769078|Apixaban|apixaban|mesh-list
138850660|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
138850661|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138850662|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
138850663|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138850664|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
138850665|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850666|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850667|NCT04036201|Bupivacaine|bupivacaine|mesh-list
138850668|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
138850669|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
138850670|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
138850671|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850672|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850673|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
138850674|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502677|NCT00035152|Carboplatin|carboplatin|mesh-list
138850675|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138850676|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
138850677|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
138850678|NCT04036201|Protective Agents|protective agents|mesh-ancestor
138850679|NCT00801099|Amoxicillin|amoxicillin|mesh-list
138850680|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138850681|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
138850682|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
138850683|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138850684|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850685|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138850686|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850687|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850688|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
138850689|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138850690|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139015926|NCT00614393|Irinotecan|irinotecan|mesh-list
138850691|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850692|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138850693|NCT02768610|Analgesics|analgesics|mesh-ancestor
138850694|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
138850695|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850696|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138850697|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138850698|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138850699|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
138850700|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850701|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850702|NCT02764710|Amoxicillin|amoxicillin|mesh-list
138850703|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
138850704|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
138850705|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138850706|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138850707|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850708|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138850709|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850710|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850711|NCT00923169|Mitogens|mitogens|mesh-list
138850712|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
138850713|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850714|NCT02541019|Ondansetron|ondansetron|mesh-list
138850715|NCT02541019|Palonosetron|palonosetron|mesh-list
138850716|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
138850717|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
138850718|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850719|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850720|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138850721|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
138850722|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
138850723|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138850724|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138850725|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
138850726|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850727|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850728|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138850729|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
138850730|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138850731|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138850732|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138850733|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850734|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850735|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
138850736|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850737|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138850738|NCT04114383|Protective Agents|protective agents|mesh-ancestor
138850739|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850740|NCT04114461|Tofacitinib|tofacitinib|mesh-list
138850741|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850742|NCT04114461|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138850743|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138850744|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850745|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138850746|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850747|NCT02768376|Fentanyl|fentanyl|mesh-list
138850748|NCT02768376|Bupivacaine|bupivacaine|mesh-list
138502753|NCT00014430|Trastuzumab|trastuzumab|mesh-list
138850749|NCT02768376|Anesthetics|anesthetics|mesh-list
138850750|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
138850751|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850752|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850753|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
138850754|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850755|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138850757|NCT02768376|Analgesics|analgesics|mesh-ancestor
138850758|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138850759|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138850760|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
138850761|NCT02696460|Lidocaine|lidocaine|mesh-list
138850762|NCT02696460|Prilocaine|prilocaine|mesh-list
138850763|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139016076|NCT00881855|Cefprozil|cefprozil|mesh-list
138850764|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
138850766|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850767|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850768|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
138850769|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850770|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138850771|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138850772|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138850773|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138850774|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850775|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138850776|NCT00888043|Bevacizumab|bevacizumab|mesh-list
138850777|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138850778|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850779|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138850780|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138850781|NCT00888043|Growth Substances|growth substances|mesh-ancestor
138850782|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850783|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
138850784|NCT02768220|Empagliflozin|empagliflozin|mesh-list
138850785|NCT02768220|Linagliptin|linagliptin|mesh-list
138850786|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138850787|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850788|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138850789|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850790|NCT02768220|Incretins|incretins|mesh-ancestor
138850792|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138850793|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138850794|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
138850795|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850797|NCT02760888|Tramadol|tramadol|mesh-list
138942818|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138850798|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138850799|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138850800|NCT02760888|Analgesics|analgesics|mesh-ancestor
138850801|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
138850802|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850803|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850804|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138850805|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138850806|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138850807|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850808|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850809|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138850810|NCT02760888|Narcotics|narcotics|mesh-ancestor
138850811|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850812|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
138850813|NCT00799617|Testosterone|testosterone|mesh-list
138850814|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
138850815|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
138850816|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138850817|NCT00799617|Androgens|androgens|mesh-ancestor
138850818|NCT00799617|Hormones|hormones|mesh-ancestor
138850819|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138850820|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850821|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138850822|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850824|NCT00607087|Insulin|insulin|mesh-list
138850825|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138850826|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
138850827|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
138850828|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
138850829|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138850830|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850831|NCT00610363|Rilonacept|rilonacept|mesh-list
138850832|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138850833|NCT00887588|Valsartan|valsartan|mesh-list
139016167|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
138850834|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138850835|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138850836|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138850837|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138850838|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850839|NCT00799383|Vitamin D|vitamin d|mesh-list
138850840|NCT00799383|Calcium|calcium|mesh-list
138850841|NCT00799383|Vitamins|vitamins|mesh-ancestor
138850842|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
138850843|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850844|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138850845|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138942850|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
138850846|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
138850847|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850848|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850849|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
138850850|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850851|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850852|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
138850853|NCT04114149|Narcotics|narcotics|mesh-ancestor
138850854|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850855|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850856|NCT04114149|Analgesics|analgesics|mesh-ancestor
138850857|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
138850858|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850859|NCT00891397|Pregabalin|pregabalin|mesh-list
138850860|NCT00891397|Analgesics|analgesics|mesh-ancestor
138850861|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
138850862|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850863|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850864|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
139016203|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
138850865|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138850866|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138850867|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850868|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138850869|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138850870|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138850871|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850872|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138850873|NCT02767596|Lixisenatide|lixisenatide|mesh-list
138850874|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138850875|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850876|NCT02826902|Remifentanil|remifentanil|mesh-list
138850877|NCT02826902|Propofol|propofol|mesh-list
138850878|NCT02826902|Desflurane|desflurane|mesh-list
138850879|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138850880|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850881|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850882|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138850883|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
138850884|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
138850885|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138850886|NCT02826902|Narcotics|narcotics|mesh-ancestor
138850887|NCT02826902|Analgesics|analgesics|mesh-ancestor
138850888|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
138850889|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850890|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138850891|NCT00798759|Travoprost|travoprost|mesh-list
138850892|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138850893|NCT00798759|Latanoprost|latanoprost|mesh-list
138850894|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138850895|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138850896|NCT00891475|Interferons|interferons|mesh-list
138850897|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
138850898|NCT00891475|Sunitinib|sunitinib|mesh-list
138850899|NCT00891475|Maleic acid|maleic acid|mesh-list
138850900|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850901|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
138850902|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850903|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
138850904|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850905|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138850906|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138850907|NCT00891475|Growth Substances|growth substances|mesh-ancestor
138850908|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
138850909|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138850910|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850911|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850912|NCT00887432|Vitamin D|vitamin d|mesh-list
138850913|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
138850914|NCT00887432|Vitamins|vitamins|mesh-ancestor
138850915|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
138850916|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850917|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138850918|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138850919|NCT04222686|Losartan|losartan|mesh-list
138850920|NCT04222686|Perindopril|perindopril|mesh-list
138850921|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138850922|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138850923|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138850924|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138850925|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850926|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138850927|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
138850928|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850929|NCT04113915|Cyclosporine|cyclosporine|mesh-list
138850930|NCT04113915|Dexamethasone|dexamethasone|mesh-list
138850931|NCT04113915|Cyclosporins|cyclosporins|mesh-list
138850932|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138850933|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
139016293|NCT00889343|Leucovorin|leucovorin|mesh-list
138850934|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
138850935|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850936|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850937|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138850938|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
138850939|NCT04113915|Hormones|hormones|mesh-ancestor
138850940|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138850941|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138850942|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850943|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850944|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850945|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
138850946|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138850947|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138850948|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
138850949|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850950|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
138850951|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138850953|NCT02758470|Methazolamide|methazolamide|mesh-list
138850954|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
138850955|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138850956|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850957|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850958|NCT02758470|Diuretics|diuretics|mesh-ancestor
138850959|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
138850960|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850961|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
138850962|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138850963|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138850964|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138850965|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
138850966|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
138850967|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
138850968|NCT02764008|Bupivacaine|bupivacaine|mesh-list
138850969|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
138850970|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
139016328|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
138850971|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138850972|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850973|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
138850974|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138850975|NCT00798603|Bevacizumab|bevacizumab|mesh-list
138850976|NCT00798603|Carboplatin|carboplatin|mesh-list
138850978|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138850979|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138850980|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138850981|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138850982|NCT00798603|Growth Substances|growth substances|mesh-ancestor
138850983|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850984|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
138850985|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138850986|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850987|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138850988|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138850989|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
138850990|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138850991|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138850992|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138850993|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138850994|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138850995|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
138850996|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850997|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138850998|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138850999|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851000|NCT00887354|Vitamin D|vitamin d|mesh-list
138851001|NCT00887354|Teriparatide|teriparatide|mesh-list
138851002|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
138851003|NCT00887354|Calcium|calcium|mesh-list
138851004|NCT00887354|Vitamins|vitamins|mesh-ancestor
138851005|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
138851006|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851007|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138851008|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138851009|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138851010|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138942927|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138851011|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851012|NCT00951041|Vaccines|vaccines|mesh-list
138851013|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
138851014|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851015|NCT02832596|Norepinephrine|norepinephrine|mesh-list
138851016|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138851017|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138851019|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851020|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851021|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851022|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
138851023|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
138851024|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851025|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138851026|NCT02760420|Amoxicillin|amoxicillin|mesh-list
138851027|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138851028|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138851029|NCT04612530|Nivolumab|nivolumab|mesh-list
138851030|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138851031|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851032|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138851033|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851034|NCT00945815|Cytarabine|cytarabine|mesh-list
138851035|NCT00945815|Clofarabine|clofarabine|mesh-list
138851036|NCT00945815|Epratuzumab|epratuzumab|mesh-list
138851037|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138851038|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
138851039|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851040|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851041|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
138851042|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138851043|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851044|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
138851045|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851046|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138851047|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
138851048|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138851049|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851050|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851051|NCT00798369|Triamcinolone|triamcinolone|mesh-list
138851052|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138851053|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138851054|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138851055|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138851056|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138851057|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
138851058|NCT00798369|Hormones|hormones|mesh-ancestor
138851059|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138851060|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851061|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851062|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
138851063|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851064|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851065|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
138851066|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138851067|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138851068|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
138851069|NCT02760342|Metformin|metformin|mesh-list
138851070|NCT02760342|Peficitinib|peficitinib|mesh-list
138851071|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138851072|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851073|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851074|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851075|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851076|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
138851077|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138851078|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
138851079|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138851080|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138851081|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138851082|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851083|NCT00894283|Enoxaparin|enoxaparin|mesh-list
138851084|NCT00894283|PENTA|penta|mesh-list
138851085|NCT00894283|Fondaparinux|fondaparinux|mesh-list
138851086|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
138851087|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138851088|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138851089|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851090|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138851091|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
138851092|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138851093|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
138851094|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851096|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138851097|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851098|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851099|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
138851100|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851101|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851102|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138851103|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
138851104|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851105|NCT00894439|Piperacillin|piperacillin|mesh-list
138851106|NCT00894439|BLI-489|bli-489|mesh-list
138851107|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138851108|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138851109|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138851110|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851111|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851113|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
138851114|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851115|NCT04035889|Protective Agents|protective agents|mesh-ancestor
138851116|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851117|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138851118|NCT00895687|Bortezomib|bortezomib|mesh-list
138851119|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138851120|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851121|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138851122|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851123|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851124|NCT02762838|Folic Acid|folic acid|mesh-list
138851125|NCT02762838|Infliximab|infliximab|mesh-list
138851126|NCT02762838|Methotrexate|methotrexate|mesh-list
138851127|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138851128|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
138851129|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138851130|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851131|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138851132|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
138851133|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851134|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851135|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
138851136|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851137|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138851138|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851139|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
138851140|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138851141|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138851142|NCT02762838|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138851143|NCT02762838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138851144|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138851145|NCT02762838|Hematinics|hematinics|mesh-ancestor
138851146|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
138851147|NCT02762838|Vitamins|vitamins|mesh-ancestor
138851148|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
138851149|NCT02753166|Dexamethasone|dexamethasone|mesh-list
138851150|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138851151|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
138851152|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
138851153|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851154|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851155|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138851156|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
138851157|NCT02753166|Hormones|hormones|mesh-ancestor
138851158|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138851159|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138851160|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851161|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
138851162|NCT02753088|Mannitol|mannitol|mesh-list
138851163|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
138851164|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138851165|NCT02753088|Diuretics|diuretics|mesh-ancestor
138851166|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
138851167|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851168|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138851169|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
138851170|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851171|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138851172|NCT02757534|Domperidone|domperidone|mesh-list
138851173|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
138851174|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
138851175|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851176|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851177|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138851178|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138851179|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
138851180|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851181|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851182|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138851183|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138851184|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
138851185|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851186|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851187|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138851188|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
138851189|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138851190|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138851191|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138851192|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
138851193|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851194|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851195|NCT00797823|Insulin|insulin|mesh-list
138851196|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138851197|NCT00797823|Glucagon|glucagon|mesh-list
138851198|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138851199|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851200|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138503201|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
138851201|NCT00797823|Hormones|hormones|mesh-ancestor
138851202|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138851203|NCT02757144|Esomeprazole|esomeprazole|mesh-list
138851204|NCT02757144|Fexuprazan|fexuprazan|mesh-list
138851205|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138851206|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138851207|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138851208|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851209|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851210|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
138851211|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138851212|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
138851213|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851214|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851215|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138851216|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
138851217|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
138851218|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138851219|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
138851220|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851221|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851222|NCT00608881|Ubiquinone|ubiquinone|mesh-list
138851223|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
138851224|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
138851225|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851226|NCT00608881|Vitamins|vitamins|mesh-ancestor
138851227|NCT05608395|Carbon-11 methionine|carbon-11 methionine|mesh-list
138851228|NCT05608395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138851229|NCT05608395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851230|NCT04221906|Betamethasone|betamethasone|mesh-list
138851231|NCT04221906|Calcipotriene|calcipotriene|mesh-list
138851232|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138851233|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138851234|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
138851235|NCT04221906|Hormones|hormones|mesh-ancestor
138851236|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138851237|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851238|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138851239|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
138851240|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
138851241|NCT00945191|Paclitaxel|paclitaxel|mesh-list
138851242|NCT00945191|Carboplatin|carboplatin|mesh-list
138851243|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138851244|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851245|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
138851246|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
138851247|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
138851248|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851249|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
138851250|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
138851251|NCT01082393|Tacrolimus|tacrolimus|mesh-list
138851252|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851253|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
138851254|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851255|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138851256|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851257|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851258|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138851259|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
138851260|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138851261|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138851262|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138851263|NCT01082393|Analgesics|analgesics|mesh-ancestor
138851264|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
138851265|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851266|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138851267|NCT02757066|Melatonin|melatonin|mesh-list
138851268|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
138851269|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851270|NCT02757066|Protective Agents|protective agents|mesh-ancestor
138851271|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851272|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138851273|NCT00894673|Heparin|heparin|mesh-list
138851274|NCT00894673|Calcium heparin|calcium heparin|mesh-list
138851275|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
138851276|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138851277|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138851278|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851279|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138851280|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138851281|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138851282|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139210364|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138851283|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851284|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138851285|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138851286|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138851288|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851289|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851290|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138851291|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138851292|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
138851293|NCT02752308|Atropine|atropine|mesh-list
138851294|NCT02752308|Epinephrine|epinephrine|mesh-list
138851295|NCT02752308|Fentanyl|fentanyl|mesh-list
138851296|NCT02752308|Bupivacaine|bupivacaine|mesh-list
138851297|NCT02752308|Neostigmine|neostigmine|mesh-list
138851298|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
138851299|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
138851300|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138851301|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851302|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
138851303|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851304|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138851305|NCT02752308|Narcotics|narcotics|mesh-ancestor
138851306|NCT02752308|Analgesics|analgesics|mesh-ancestor
138851307|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138851308|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138851309|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
138851310|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138851311|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138851312|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
138851313|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942987|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
138851314|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851315|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138851316|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138851317|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
138851318|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138851319|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
138851320|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
138851321|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
138851322|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138851323|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138851324|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
138851325|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138851326|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138851327|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
138851328|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138851329|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851330|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138851331|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
138851332|NCT00894751|Propofol|propofol|mesh-list
138851333|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138851334|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138851335|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851336|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138851337|NCT00894751|Analgesics|analgesics|mesh-ancestor
138851338|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
138851339|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851340|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138851341|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138851342|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138851343|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
138851344|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851345|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851346|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138851347|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
138851348|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
138851349|NCT00896077|Lisofylline|lisofylline|mesh-list
138851350|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138851351|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
138851352|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851353|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138851356|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
138851357|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851358|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138851359|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138851360|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851362|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138851363|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
138851364|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851365|NCT00896155|Tamoxifen|tamoxifen|mesh-list
138851366|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138851367|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
138851368|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138851369|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851370|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138851371|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851372|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138851373|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138851374|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138851375|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
138943014|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
138851376|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
138851377|NCT02751996|Tenofovir|tenofovir|mesh-list
138851378|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
138851379|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138851380|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138851381|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138851382|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851383|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851384|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138851385|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138851386|NCT00944645|Niacin|niacin|mesh-list
138851387|NCT00944645|Niacinamide|niacinamide|mesh-list
138851388|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
138851389|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138851390|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
138851391|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851392|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138851393|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
138851394|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
138851395|NCT00944645|Vitamins|vitamins|mesh-ancestor
138851396|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
138851397|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851398|NCT02751918|Doxorubicin|doxorubicin|mesh-list
139016517|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
138851399|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138851400|NCT02751918|Maytansine|maytansine|mesh-list
138851401|NCT02751918|Anetumab ravtansine|anetumab ravtansine|mesh-list
138851402|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138851403|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851404|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138851405|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138851406|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851407|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851408|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138851409|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
138851410|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
138594642|NCT00407589|Besifloxacin|besifloxacin|mesh-list
138851411|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
138851412|NCT02751918|Immunoconjugates|immunoconjugates|mesh-ancestor
138851413|NCT02751918|Immunologic Factors|immunologic factors|mesh-ancestor
138851414|NCT02751918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851415|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
138851416|NCT00901069|Rituximab|rituximab|mesh-list
138851417|NCT00901069|Vincristine|vincristine|mesh-list
138851418|NCT00901069|Azacitidine|azacitidine|mesh-list
138851419|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851420|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
138851421|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851422|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138851423|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138851424|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
138851425|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851426|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851427|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138851428|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138851429|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138851430|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
138851431|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
138851432|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
138851433|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138851434|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
138851435|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851436|NCT02853539|Denosumab|denosumab|mesh-list
138851437|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138851438|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851439|NCT02751840|Caffeine|caffeine|mesh-list
138851440|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138851441|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851442|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138851443|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851444|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851445|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138851446|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138851447|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
138851448|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851449|NCT00894829|Heparin|heparin|mesh-list
138851450|NCT00894829|Calcium heparin|calcium heparin|mesh-list
138851451|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
138851452|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138851453|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138851454|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016541|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851455|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138851456|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
138851457|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851458|NCT00606229|Aripiprazole|aripiprazole|mesh-list
138851459|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
138851460|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138851461|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138851462|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138851463|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138851464|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851465|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
138851466|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
138851467|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851468|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851469|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138851470|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138851471|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
138851472|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138851473|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138851474|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138851475|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138851476|NCT02756598|Sufentanil|sufentanil|mesh-list
138851477|NCT02756598|Dsuvia|dsuvia|mesh-list
138851478|NCT02756598|Propofol|propofol|mesh-list
138851479|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138851480|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138851481|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851482|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138851483|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
138851484|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
138851485|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138851487|NCT02756598|Analgesics|analgesics|mesh-ancestor
138851488|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
138851489|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851490|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138851491|NCT00950651|Tramadol|tramadol|mesh-list
138851492|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138851493|NCT00950651|Narcotics|narcotics|mesh-ancestor
138851494|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138851495|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851496|NCT00950651|Analgesics|analgesics|mesh-ancestor
138851497|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
138851498|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851499|NCT00901147|Bortezomib|bortezomib|mesh-list
138851500|NCT00901147|Panobinostat|panobinostat|mesh-list
138851501|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851502|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138851503|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851504|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851505|NCT04268537|Antibodies|antibodies|mesh-list
138851506|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
138851507|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
138851508|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851509|NCT02756130|Carboplatin|carboplatin|mesh-list
138851510|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851511|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
138851512|NCT00605293|Hematinics|hematinics|mesh-ancestor
138851513|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138851514|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138851515|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
138851516|NCT00602303|Torsemide|torsemide|mesh-list
138851517|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138851518|NCT00602303|Diuretics|diuretics|mesh-ancestor
138851519|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
138851520|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851521|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138851522|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138851523|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851524|NCT00631085|Tocopherols|tocopherols|mesh-list
138851525|NCT00631085|Vitamin E|vitamin e|mesh-list
138851526|NCT00631085|Tocotrienols|tocotrienols|mesh-list
138851527|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
138851528|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
138851529|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
138851530|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851531|NCT00631085|Protective Agents|protective agents|mesh-ancestor
138851532|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851533|NCT00631085|Vitamins|vitamins|mesh-ancestor
138851534|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
138851535|NCT04269863|Aspirin|aspirin|mesh-list
138851536|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138851537|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138851538|NCT04269863|Analgesics|analgesics|mesh-ancestor
138851539|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
138851540|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851541|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851542|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138851543|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138851544|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138851545|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138851546|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851547|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138851548|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138851549|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851550|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
138851551|NCT00901381|Lenograstim|lenograstim|mesh-list
138851552|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138851553|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
138851554|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851555|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
138851556|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
138851557|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138851558|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851559|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851560|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
138851561|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138851562|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138851563|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851565|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
138851566|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851567|NCT00901537|Azacitidine|azacitidine|mesh-list
138851568|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851569|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138851570|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
138851571|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851572|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851573|NCT00894985|Heparin|heparin|mesh-list
138851574|NCT00894985|Calcium heparin|calcium heparin|mesh-list
138503577|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138851575|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
138851576|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138851577|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138851578|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851579|NCT04585152|Rituximab|rituximab|mesh-list
138851580|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138851581|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851582|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
138851583|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851584|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138851585|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138851586|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851587|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
138851588|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138851589|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138851590|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851591|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
138851592|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851593|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851595|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
138851596|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138851597|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138851598|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138851599|NCT00901615|Lenalidomide|lenalidomide|mesh-list
138851600|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
138851601|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851602|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138851603|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138851604|NCT00901615|Growth Substances|growth substances|mesh-ancestor
138851605|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
138851606|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851607|NCT00949325|Sirolimus|sirolimus|mesh-list
138851608|NCT00949325|Doxorubicin|doxorubicin|mesh-list
138851609|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138851610|NCT00949325|Temsirolimus|temsirolimus|mesh-list
138851611|NCT00949325|MTOR Inhibitors|mtor inhibitors|mesh-list
138851612|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138851613|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851614|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138851615|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138851616|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851617|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139016602|NCT00527618|Valacyclovir|valacyclovir|mesh-list
138851618|NCT00949325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138851619|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851620|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
138851621|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851622|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138851623|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138851624|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
138851625|NCT02853071|Estramustine|estramustine|mesh-list
138851626|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138851627|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
138851628|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851629|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851630|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138851631|NCT02603757|Vitamin D|vitamin d|mesh-list
138851632|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
138851633|NCT02603757|Vitamins|vitamins|mesh-ancestor
138851634|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
138851635|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851636|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138851637|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138851639|NCT02758782|Golimumab|golimumab|mesh-list
138851640|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138851641|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138851642|NCT02758782|Analgesics|analgesics|mesh-ancestor
138851643|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
138851644|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851645|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851646|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138851647|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138851648|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138851649|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138851650|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851651|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851652|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138503649|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851653|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851654|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
138851655|NCT04221672|Terlipressin|terlipressin|mesh-list
138851656|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138851657|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138851658|NCT00895297|Dasatinib|dasatinib|mesh-list
138851659|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851660|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138851661|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851662|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851663|NCT00943319|Fludarabine|fludarabine|mesh-list
138851664|NCT00943319|Busulfan|busulfan|mesh-list
138851665|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
138851666|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851667|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943096|NCT02550483|Provitamins|provitamins|mesh-ancestor
138851668|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851669|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
138851670|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851671|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
138851672|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138851673|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138851674|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138851675|NCT02603991|Levetiracetam|levetiracetam|mesh-list
138851676|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
138851677|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
138851678|NCT02540785|Levofloxacin|levofloxacin|mesh-list
138851679|NCT02540785|Ofloxacin|ofloxacin|mesh-list
138851680|NCT02540785|Tobramycin|tobramycin|mesh-list
138851681|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
138851682|NCT02540785|Dexamethasone|dexamethasone|mesh-list
138851683|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
138851684|NCT02540785|BB 1101|bb 1101|mesh-list
138851685|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
138851686|NCT02540785|Dipivefrin|dipivefrin|mesh-list
138851687|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138851688|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
138851689|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
138851690|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851691|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851692|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138851693|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
138851694|NCT02540785|Hormones|hormones|mesh-ancestor
138851695|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138851696|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138851697|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851698|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
138851699|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851700|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851701|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138851702|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138851703|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138851704|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138851705|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138851706|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138851707|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138851708|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138594937|NCT00148070|Docetaxel|docetaxel|mesh-list
138851709|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
138851710|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
138851711|NCT02540785|Protective Agents|protective agents|mesh-ancestor
138851712|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138851713|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
138851714|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851715|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138943110|NCT00631917|Ramipril|ramipril|mesh-list
138851716|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138851717|NCT04243278|Aspirin|aspirin|mesh-list
139016650|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
138851718|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138851719|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138851720|NCT04243278|Analgesics|analgesics|mesh-ancestor
138851721|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
138851722|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851723|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851724|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138851725|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138851726|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138851727|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138851728|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851729|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138851730|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138851731|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851732|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
138851733|NCT00915369|Paclitaxel|paclitaxel|mesh-list
138851734|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138851735|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851736|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
138851737|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
138851738|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
138851739|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851740|NCT00901849|Sirolimus|sirolimus|mesh-list
138851741|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138851742|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138851743|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138851744|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138851745|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851746|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
138851747|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851748|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
138851749|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851750|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138851751|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851752|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851753|NCT04268927|Letrozole|letrozole|mesh-list
138851754|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
138851755|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138851756|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851757|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138851758|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138851759|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851760|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851761|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138851762|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
138851763|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138851764|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851765|NCT04268927|Hormones|hormones|mesh-ancestor
138851767|NCT00790647|Melphalan|melphalan|mesh-list
138851768|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
138851769|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851770|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851771|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138851772|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
138851773|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851774|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138851775|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851776|NCT00286013|Gemcitabine|gemcitabine|mesh-list
138851777|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
138851778|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138851779|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
138851780|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851781|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851782|NCT02754882|Paclitaxel|paclitaxel|mesh-list
138851783|NCT02754882|Bevacizumab|bevacizumab|mesh-list
138851784|NCT02754882|Carboplatin|carboplatin|mesh-list
138851785|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138851786|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851787|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
138851788|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
138851789|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
138851790|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851791|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138851792|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138851793|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138851794|NCT02754882|Growth Substances|growth substances|mesh-ancestor
138851795|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851796|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
138851797|NCT00790569|Nicotine|nicotine|mesh-list
138851798|NCT00790569|Varenicline|varenicline|mesh-list
138851799|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138851800|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
138851801|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851802|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851803|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138851804|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138851805|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
138851806|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851807|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851808|NCT00939029|Nicotine|nicotine|mesh-list
138851809|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138851810|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
138851811|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851812|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851813|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138851814|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138851815|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
138851817|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851818|NCT00602615|Torsemide|torsemide|mesh-list
138851819|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138851820|NCT00602615|Diuretics|diuretics|mesh-ancestor
138851821|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
138851822|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851823|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138851824|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138851825|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851826|NCT00604253|Insulin|insulin|mesh-list
138851827|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138851828|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
138851829|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
138851830|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
138851831|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
138851832|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138851833|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851834|NCT02754960|Thalidomide|thalidomide|mesh-list
138851835|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851836|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
138851837|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851838|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
138851839|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138851840|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138851841|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138851842|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138851843|NCT02754960|Growth Substances|growth substances|mesh-ancestor
138851844|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
138851845|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851846|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
138851847|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138851848|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851849|NCT02540239|Simethicone|simethicone|mesh-list
138851850|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
138851851|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851852|NCT02540239|Emollients|emollients|mesh-ancestor
138851853|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
138851854|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
138851855|NCT02540395|Prednisolone|prednisolone|mesh-list
138851856|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138851857|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
138851858|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138851859|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
138851860|NCT02540395|Tacrolimus|tacrolimus|mesh-list
138851861|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138851862|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
138851863|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851864|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
138851865|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851867|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851868|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851869|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138851870|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851871|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138851872|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
138851873|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138851874|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138851875|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138851876|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
138851877|NCT02540395|Hormones|hormones|mesh-ancestor
138851878|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138851879|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138851880|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
138851881|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
138851882|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851883|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138851884|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138851885|NCT02540395|Protective Agents|protective agents|mesh-ancestor
138851886|NCT04547166|Bevacizumab|bevacizumab|mesh-list
138851887|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138851888|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851889|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138851890|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138851891|NCT04547166|Growth Substances|growth substances|mesh-ancestor
138851892|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851893|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
138851894|NCT00602693|Sirolimus|sirolimus|mesh-list
138851895|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
138851896|NCT00602693|Fludarabine|fludarabine|mesh-list
138851897|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
138851898|NCT00602693|Allopurinol|allopurinol|mesh-list
138851899|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138851900|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
138851901|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851902|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138851903|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138851904|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
138851905|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851906|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851907|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138851908|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138851909|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
138851910|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138851911|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138851912|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138851913|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
138851914|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851915|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
138851916|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138851917|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
138851918|NCT00602693|Protective Agents|protective agents|mesh-ancestor
138851919|NCT00902395|Midazolam|midazolam|mesh-list
138851920|NCT00902395|Ketamine|ketamine|mesh-list
138851921|NCT00902395|Analgesics|analgesics|mesh-ancestor
138851922|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
138851923|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851924|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851925|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138851926|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138851927|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
138851928|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
138851929|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138851930|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138851931|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138851932|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851933|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851934|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138851935|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138851936|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138851937|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138851938|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138851939|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
138851940|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
138851941|NCT04213404|Spartalizumab|spartalizumab|mesh-list
138851942|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138851943|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943196|NCT00399529|Trastuzumab|trastuzumab|mesh-list
138851944|NCT04213404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138851945|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851946|NCT00604409|Capecitabine|capecitabine|mesh-list
138851947|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138851948|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
138851949|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851950|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851951|NCT00905905|Simvastatin|simvastatin|mesh-list
138851952|NCT00905905|Ezetimibe|ezetimibe|mesh-list
138503955|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
138851953|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138851954|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138851955|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138851956|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
138851957|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851958|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138851959|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138851960|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138851962|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
138851963|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138851964|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851965|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
138851966|NCT04104789|Tetracaine|tetracaine|mesh-list
138851967|NCT04104789|Carticaine|carticaine|mesh-list
138851968|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
138851969|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
138851970|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138851971|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851972|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
138851973|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138851974|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138851975|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138851976|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
138851977|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138851978|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851979|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
138851980|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
138851981|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
138851982|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138851983|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
138851984|NCT00938717|Linaclotide|linaclotide|mesh-list
138851985|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138851986|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
138851987|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851988|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138851989|NCT00905983|Gemcitabine|gemcitabine|mesh-list
138851990|NCT00905983|Docetaxel|docetaxel|mesh-list
138851991|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138851992|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
138851993|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138851994|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138851995|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
138851996|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
138851997|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
138851998|NCT00906061|Gemcitabine|gemcitabine|mesh-list
138851999|NCT00906061|Docetaxel|docetaxel|mesh-list
138852000|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138852001|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
138852002|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852003|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852004|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
138852005|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
138852006|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
138852008|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
138852009|NCT02602509|Celecoxib|celecoxib|mesh-list
138852010|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138852011|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138852012|NCT02602509|Analgesics|analgesics|mesh-ancestor
138852013|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
138852014|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852015|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852016|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852017|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138852018|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138852019|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138852020|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852021|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852022|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138852023|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
138852024|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138852025|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138852026|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
138852027|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138852028|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138852029|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138852030|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138852031|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138852032|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138852033|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138852035|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852036|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
138852037|NCT00897871|Carboplatin|carboplatin|mesh-list
138852038|NCT00897871|Etoposide|etoposide|mesh-list
138852039|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
139016848|NCT06180759|Ketamine|ketamine|mesh-list
138852040|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138852041|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
138852042|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852043|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138852044|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138852045|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
138852046|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852047|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852048|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138852049|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138852050|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138852051|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138852052|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852053|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
138852054|NCT00902707|Guaifenesin|guaifenesin|mesh-list
138852055|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
138852056|NCT00902707|Expectorants|expectorants|mesh-ancestor
138852057|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
138852058|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138852059|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138852060|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
138852061|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852062|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852063|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852064|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
138943210|NCT00712712|Narcotics|narcotics|mesh-ancestor
138852065|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138852066|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
138852067|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
138852068|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852069|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
138852070|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138852071|NCT00906139|Midazolam|midazolam|mesh-list
138852072|NCT00906139|Fentanyl|fentanyl|mesh-list
138852073|NCT00906139|Propofol|propofol|mesh-list
138852074|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138852075|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138852076|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852077|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138852078|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
138852079|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
138852080|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138852081|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138852082|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138852083|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138852084|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
138852085|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
138852086|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852087|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852088|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138852089|NCT00906139|Narcotics|narcotics|mesh-ancestor
138852090|NCT00906139|Analgesics|analgesics|mesh-ancestor
138852091|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
138852092|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852093|NCT00906295|Chrysarobin|chrysarobin|mesh-list
138852094|NCT00906295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138852095|NCT00906295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138852096|NCT00906295|Analgesics|analgesics|mesh-ancestor
138852097|NCT00906295|Sensory System Agents|sensory system agents|mesh-ancestor
138852098|NCT00906295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852099|NCT00906295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852100|NCT00906295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852101|NCT00906295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138852102|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
138852103|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138852104|NCT02754102|Protective Agents|protective agents|mesh-ancestor
138852105|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852106|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
138852107|NCT00134303|Metformin|metformin|mesh-list
138852108|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138852109|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852110|NCT00902941|Rasagiline|rasagiline|mesh-list
138852111|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138852112|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852113|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852114|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138852115|NCT00902941|Protective Agents|protective agents|mesh-ancestor
138852116|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852117|NCT02754258|Methylphenidate|methylphenidate|mesh-list
138852118|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138852119|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852120|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138852121|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138852122|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138852123|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852124|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
138852125|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852126|NCT04267991|Tacrolimus|tacrolimus|mesh-list
138852127|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138852128|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
138852129|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852130|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138852131|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852132|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852133|NCT02852681|Drospirenone|drospirenone|mesh-list
138852134|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138852135|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
138852136|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852137|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016900|NCT06180590|Sofosbuvir|sofosbuvir|mesh-list
138852138|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138852140|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
138852141|NCT02754180|Gemcitabine|gemcitabine|mesh-list
138852142|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138852143|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
138852144|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852145|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852146|NCT00602849|Sertraline|sertraline|mesh-list
138852147|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
138852148|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138852149|NCT00602849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138852150|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138852151|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138852152|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852153|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852154|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
138852155|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852156|NCT00906451|Simvastatin|simvastatin|mesh-list
138852157|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138852158|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138852159|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
138852160|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852161|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138852162|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138852163|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852164|NCT00898417|Paclitaxel|paclitaxel|mesh-list
138852165|NCT00898417|Bevacizumab|bevacizumab|mesh-list
138852166|NCT00898417|Carboplatin|carboplatin|mesh-list
138852167|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138852168|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852169|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
138852170|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
138852171|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
138852172|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852173|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138852174|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138852175|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138852176|NCT00898417|Growth Substances|growth substances|mesh-ancestor
138852177|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852178|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
138852180|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
138852181|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138852182|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852183|NCT00783705|Inositol|inositol|mesh-list
138852184|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
138852185|NCT00783705|Vitamins|vitamins|mesh-ancestor
138852186|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
138852187|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139016930|NCT06180070|Ibuprofen|ibuprofen|mesh-list
139210365|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852188|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138852189|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138852190|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138852191|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852192|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852193|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
138852194|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138852195|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138852196|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138852197|NCT04103697|Capecitabine|capecitabine|mesh-list
138852198|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
138852199|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138852200|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
138852201|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852202|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852204|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852205|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138852206|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852207|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852208|NCT04321668|Hylan|hylan|mesh-list
138852209|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
138852210|NCT04321668|Protective Agents|protective agents|mesh-ancestor
138852211|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852212|NCT02851745|Linagliptin|linagliptin|mesh-list
138852213|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138852214|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852215|NCT02851745|Incretins|incretins|mesh-ancestor
138852216|NCT02851745|Hormones|hormones|mesh-ancestor
138852217|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852218|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138852219|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
138852220|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852221|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852222|NCT02602197|Acetaminophen|acetaminophen|mesh-list
138852223|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138852224|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138852225|NCT02602197|Analgesics|analgesics|mesh-ancestor
138852226|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
138852227|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852228|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852229|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
138852230|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138852231|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852233|NCT02753712|Fluticasone|fluticasone|mesh-list
138852234|NCT02753712|Xhance|xhance|mesh-list
138852235|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
138852236|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852237|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138852238|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
138852239|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852240|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852241|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138852242|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
138852243|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
138852244|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138852245|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138852246|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138852247|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138852248|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
138852249|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852250|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852251|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
138852252|NCT04220892|Pemetrexed|pemetrexed|mesh-list
138852253|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138852254|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852255|NCT04220892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138852256|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852257|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852258|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138852259|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138852260|NCT02696148|Liraglutide|liraglutide|mesh-list
138852261|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138852262|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852263|NCT02696148|Incretins|incretins|mesh-ancestor
138852264|NCT02696148|Hormones|hormones|mesh-ancestor
138852265|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852266|NCT00887198|Prednisone|prednisone|mesh-list
138852267|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
138852268|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852269|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
138852270|NCT00887198|Hormones|hormones|mesh-ancestor
138852271|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852272|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852273|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138852274|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852275|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138852276|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852277|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852278|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
138852279|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138852280|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138852281|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138852282|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852283|NCT00782067|Midostaurin|midostaurin|mesh-list
138852284|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852285|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138852286|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852287|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852288|NCT05520723|Loperamide|loperamide|mesh-list
138852289|NCT05520723|Antidiarrheals|antidiarrheals|mesh-list
138852290|NCT05520723|Lenograstim|lenograstim|mesh-list
138852291|NCT05520723|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138852292|NCT05520723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138852293|NCT05520723|Immunologic Factors|immunologic factors|mesh-ancestor
138852294|NCT05520723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852295|NCT05520723|Immunoconjugates|immunoconjugates|mesh-ancestor
138852296|NCT05520723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138852297|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
138852298|NCT02826746|Analgesics|analgesics|mesh-ancestor
138852299|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
138852300|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852301|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852302|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
138852303|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138852304|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138852305|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
138943274|NCT00893854|Triamcinolone|triamcinolone|mesh-list
138852306|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138852307|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138852308|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852309|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138852310|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
138852311|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138852312|NCT02750904|Nicotine|nicotine|mesh-list
138852313|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138852314|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
138852315|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852316|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852317|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138852318|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138852319|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
138852320|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852321|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852322|NCT02831972|Itraconazole|itraconazole|mesh-list
138852323|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
138852324|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138852325|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138852326|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138852327|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852328|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852329|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138852330|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
138852331|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852332|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017012|NCT06162806|Fentanyl|fentanyl|mesh-list
138852333|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138852336|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
138852337|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138852338|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852339|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
138852340|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852341|NCT00605215|Interferons|interferons|mesh-list
138852342|NCT00605215|Interferon beta-1a|interferon beta-1a|mesh-list
138852343|NCT00605215|Interferon-beta|interferon-beta|mesh-list
138852344|NCT00605215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852345|NCT00605215|Antiviral Agents|antiviral agents|mesh-ancestor
138852346|NCT00605215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138852347|NCT00605215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138852348|NCT00605215|Immunologic Factors|immunologic factors|mesh-ancestor
138852349|NCT00605215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852350|NCT02827682|Anesthetics|anesthetics|mesh-list
138852351|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138852352|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852353|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
138852354|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
138852355|NCT04244708|Temozolomide|temozolomide|mesh-list
138852356|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138852357|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
138852358|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852359|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852361|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138852362|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138852363|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852364|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
138852365|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852366|NCT00604279|Risperidone|risperidone|mesh-list
138852367|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138852368|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138852369|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
138852370|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852371|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852373|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138852374|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138852375|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138852376|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138852377|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138852378|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
138852379|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138852380|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138852381|NCT00635856|Gefitinib|gefitinib|mesh-list
138852382|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852383|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138852384|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852385|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852386|NCT00906685|Bevacizumab|bevacizumab|mesh-list
138852387|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138852388|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852389|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139017032|NCT06162806|Tocolytic Agents|tocolytic agents|mesh-ancestor
138852390|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138852391|NCT00906685|Growth Substances|growth substances|mesh-ancestor
138852392|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852393|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
138852395|NCT05660720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138852396|NCT05660720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138852397|NCT05660720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138852398|NCT05660720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138852399|NCT05660720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138852400|NCT05660720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852401|NCT05660720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852402|NCT05660720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852403|NCT05660720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138852404|NCT05660720|Contraceptive Agents|contraceptive agents|mesh-ancestor
138852405|NCT05660720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138852406|NCT05660720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852407|NCT05660720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138852408|NCT05660720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138852409|NCT05660720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138852411|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138852412|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138852413|NCT02695212|Analgesics|analgesics|mesh-ancestor
138852414|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
138852415|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852416|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852417|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852418|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138852419|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138852420|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138852421|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852422|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852423|NCT05381207|Fluticasone|fluticasone|mesh-list
138852424|NCT05381207|Xhance|xhance|mesh-list
138852425|NCT05381207|Montelukast|montelukast|mesh-list
138852426|NCT05381207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852427|NCT05381207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138852428|NCT05381207|Autonomic Agents|autonomic agents|mesh-ancestor
138852429|NCT05381207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852430|NCT05381207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852431|NCT05381207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138852432|NCT05381207|Respiratory System Agents|respiratory system agents|mesh-ancestor
138852433|NCT05381207|Dermatologic Agents|dermatologic agents|mesh-ancestor
138852434|NCT05381207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138852435|NCT05381207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138852436|NCT05381207|Hormone Antagonists|hormone antagonists|mesh-ancestor
138852437|NCT05381207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852438|NCT05381207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138852439|NCT05381207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138852440|NCT05381207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852441|NCT02750670|Dexamethasone|dexamethasone|mesh-list
138852442|NCT02750670|Gemcitabine|gemcitabine|mesh-list
138852443|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
138852444|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852446|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
138852447|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852448|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852449|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138852450|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
138852451|NCT02750670|Hormones|hormones|mesh-ancestor
138852452|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852453|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138852454|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852455|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138852456|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
138852457|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852458|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138852459|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138852460|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138852461|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
138852462|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852463|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852464|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138852465|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
138852466|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138852467|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138852468|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138852469|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
138852470|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852471|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852472|NCT05122208|Famotidine|famotidine|mesh-list
138852473|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138852474|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138852475|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138852476|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
138852477|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
138852478|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852479|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852480|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852481|NCT00781911|Octreotide|octreotide|mesh-list
139210366|NCT03516981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138852482|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138852483|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138852484|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852486|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
138852487|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138852488|NCT00605917|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138852489|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138852490|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138852491|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852492|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852493|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
138852494|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852495|NCT04919096|Aflibercept|aflibercept|mesh-list
138852496|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138852497|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138852498|NCT04919096|Growth Substances|growth substances|mesh-ancestor
138852499|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852500|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
138852501|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852502|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138852503|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138852504|NCT00781599|Varenicline|varenicline|mesh-list
138852505|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138852506|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138852507|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
138852508|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852509|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852510|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852511|NCT00904111|Lidocaine|lidocaine|mesh-list
138852512|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
138852513|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
138852514|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138852515|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852516|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
138852517|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852519|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138852520|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138852521|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138852522|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852523|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
138852524|NCT03240211|Decitabine|decitabine|mesh-list
138852525|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138852526|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852527|NCT03240211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138852528|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852529|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138852530|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
138852531|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852532|NCT00899197|Tamoxifen|tamoxifen|mesh-list
138852533|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138852534|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
138852535|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852536|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852537|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138852538|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852539|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138852540|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138852541|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138852542|NCT00603083|Ketorolac|ketorolac|mesh-list
138852543|NCT00603083|Ropivacaine|ropivacaine|mesh-list
138852544|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
138852545|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
138852546|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138852547|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852548|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
138852549|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852550|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138852551|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138852552|NCT00603083|Analgesics|analgesics|mesh-ancestor
138852553|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852554|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138852555|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138852556|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852557|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852558|NCT05379257|Furosemide|furosemide|mesh-list
138852559|NCT05379257|Diuretics|diuretics|mesh-ancestor
138852560|NCT05379257|Natriuretic Agents|natriuretic agents|mesh-ancestor
138852561|NCT05379257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852562|NCT05379257|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138852563|NCT05379257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138852564|NCT05379257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852565|NCT04241744|Vancomycin|vancomycin|mesh-list
138852566|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138852567|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138852568|NCT02824094|Crizotinib|crizotinib|mesh-list
138852569|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852570|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138852571|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852572|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852573|NCT00899587|Enalapril|enalapril|mesh-list
138852574|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138852575|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
138852576|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852577|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852578|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138852579|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138852580|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138852581|NCT02824406|Acetazolamide|acetazolamide|mesh-list
138852582|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
138852583|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138852584|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852585|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852586|NCT02824406|Diuretics|diuretics|mesh-ancestor
138852587|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
138595835|NCT05091242|Clonidine|clonidine|mesh-list
138852589|NCT04267679|Cannabidiol|cannabidiol|mesh-list
138852590|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
138852591|NCT04951388|Somatomedin B|somatomedin b|mesh-list
138852592|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138852593|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138852594|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
138852595|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852596|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852597|NCT04242914|Midazolam|midazolam|mesh-list
138852598|NCT04242914|Ketamine|ketamine|mesh-list
138852599|NCT04242914|Analgesics|analgesics|mesh-ancestor
138852600|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
138852601|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852602|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852603|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138852604|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138852605|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
138852606|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
138852607|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138852608|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138852609|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138852610|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852611|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852612|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138852613|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138852614|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138852615|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138504635|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
138852617|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
138852618|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
138852619|NCT00780273|Cimetidine|cimetidine|mesh-list
138852620|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138852621|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138852622|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138852623|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
138852624|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
138852625|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852626|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943388|NCT00410605|Antibodies|antibodies|mesh-list
138852627|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852628|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138852629|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138852630|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852631|NCT02827136|Lidocaine|lidocaine|mesh-list
138852632|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
138852633|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
138852634|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138852635|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852636|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
138852637|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852638|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138852639|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138852640|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138852641|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139017147|NCT06083571|Antiemetics|antiemetics|mesh-ancestor
138852642|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852643|NCT04102995|Pregnanolone|pregnanolone|mesh-list
138852644|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
138852645|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138852646|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852647|NCT00899821|Aldesleukin|aldesleukin|mesh-list
138852648|NCT00899821|Interleukin-12|interleukin-12|mesh-list
138852649|NCT00899821|Sargramostim|sargramostim|mesh-list
138852650|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
138852651|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852652|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852653|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138852654|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138852655|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
138852656|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138852657|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138852658|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138852659|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138852660|NCT00899821|Growth Substances|growth substances|mesh-ancestor
138852661|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
138852662|NCT00005112|Hormones|hormones|mesh-list
138852663|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852664|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852665|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
138852666|NCT04163406|Trace Elements|trace elements|mesh-ancestor
138852667|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
138852668|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852669|NCT04218552|Amlodipine|amlodipine|mesh-list
138852670|NCT04218552|Telmisartan|telmisartan|mesh-list
138852671|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138852672|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138852673|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138852674|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852675|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138852676|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852677|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
138852678|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138852679|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138852680|NCT00904657|Sunitinib|sunitinib|mesh-list
138852681|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943407|NCT00742638|Valproic Acid|valproic acid|mesh-list
138852682|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138852683|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138852684|NCT00904657|Growth Substances|growth substances|mesh-ancestor
138852685|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852686|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
138852687|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138852688|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504718|NCT00040690|Antidotes|antidotes|mesh-ancestor
138852689|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852690|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
138852691|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
138852692|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852693|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138852694|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017172|NCT06060587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852695|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852696|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
138852697|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138852698|NCT02823626|Spironolactone|spironolactone|mesh-list
138852699|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138852700|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
138852701|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852702|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852703|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138852704|NCT02823626|Diuretics|diuretics|mesh-ancestor
138852705|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
138852706|NCT00779259|Quinine|quinine|mesh-list
138852707|NCT00779259|Theophylline|theophylline|mesh-list
138852708|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138852709|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
138852710|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852711|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852712|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138852713|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
138852714|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138852715|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852716|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852717|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
138852718|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138852719|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138852720|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
138852721|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852722|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
138852723|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138852724|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138852725|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138852726|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138852727|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138852728|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138852729|NCT00779259|Analgesics|analgesics|mesh-ancestor
138852730|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
138852731|NCT02746380|Adalimumab|adalimumab|mesh-list
138852732|NCT02746380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138852733|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852734|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138852735|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
138852736|NCT02745990|Hematinics|hematinics|mesh-ancestor
138852737|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138852739|NCT00915915|Femovan|femovan|mesh-list
139017193|NCT06017297|Antimetabolites|antimetabolites|mesh-ancestor
138852740|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138852741|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138852742|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138852743|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
138852744|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138852745|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852746|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138852748|NCT00915915|Hormones|hormones|mesh-ancestor
138852749|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852750|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138852751|NCT00915915|Progestins|progestins|mesh-ancestor
138852752|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138852753|NCT02538367|Prucalopride|prucalopride|mesh-list
138852754|NCT02538367|YH12852|yh12852|mesh-list
138852755|NCT02538367|Laxatives|laxatives|mesh-ancestor
138852756|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138852757|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138852758|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138852759|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
138852760|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852761|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852762|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852763|NCT00900445|Prednisone|prednisone|mesh-list
138852764|NCT00900445|Prednisolone|prednisolone|mesh-list
138852765|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138852766|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
138852767|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138852768|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
138852769|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
138852770|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138852771|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138852772|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138852773|NCT00900445|Cortisone|cortisone|mesh-list
138852774|NCT00900445|Vincristine|vincristine|mesh-list
138852775|NCT00900445|Daunorubicin|daunorubicin|mesh-list
138852776|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138852777|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
138852778|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852779|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
138852780|NCT00900445|Hormones|hormones|mesh-ancestor
138852781|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852782|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852783|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138852784|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852785|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138852786|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
138852787|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
138852788|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
138852789|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852790|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
138852791|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
138852792|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852793|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138852794|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138852795|NCT00900445|Protective Agents|protective agents|mesh-ancestor
138852796|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138852797|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138852798|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138852799|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852800|NCT03994419|Anesthetics|anesthetics|mesh-list
138852801|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138852802|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852803|NCT00936065|Etanercept|etanercept|mesh-list
138852804|NCT00936065|Acitretin|acitretin|mesh-list
138852805|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138852806|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138852807|NCT00936065|Analgesics|analgesics|mesh-ancestor
138852808|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
138852809|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852810|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852811|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852812|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138852813|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138852814|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138852815|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
138852816|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
138852817|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
138852818|NCT04241276|Paclitaxel|paclitaxel|mesh-list
138852819|NCT04241276|Gemcitabine|gemcitabine|mesh-list
138852820|NCT04241276|Tretinoin|tretinoin|mesh-list
139017268|NCT05908786|Atezolizumab|atezolizumab|mesh-list
138852821|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138852822|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852823|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
138852824|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
138852825|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
138852826|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852827|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138852828|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
138852829|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
138852830|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
138852831|NCT00905047|Leucovorin|leucovorin|mesh-list
138852832|NCT00905047|Folic Acid|folic acid|mesh-list
138852833|NCT00905047|Tegafur|tegafur|mesh-list
138852834|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
138852835|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138852836|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
138852837|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852838|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852839|NCT00905047|Antidotes|antidotes|mesh-ancestor
138852840|NCT00905047|Protective Agents|protective agents|mesh-ancestor
138852841|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852842|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
138852843|NCT00905047|Vitamins|vitamins|mesh-ancestor
138852844|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
138852845|NCT00905047|Hematinics|hematinics|mesh-ancestor
138852846|NCT04102449|Apremilast|apremilast|mesh-list
138852847|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138852848|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138852849|NCT04102449|Analgesics|analgesics|mesh-ancestor
138852850|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
138852851|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852852|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852853|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852854|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138852855|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138852856|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138852857|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852858|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852860|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138852861|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138852862|NCT02823236|Pirfenidone|pirfenidone|mesh-list
139017301|NCT05888532|Copper|copper|mesh-list
138852864|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852865|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
138852866|NCT02823236|Hormones|hormones|mesh-ancestor
138852867|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852868|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852869|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138852870|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
138852871|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852872|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852873|NCT02823236|Analgesics|analgesics|mesh-ancestor
138852874|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
138852875|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852876|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138852877|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138852878|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138852879|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852880|NCT00633698|Niacin|niacin|mesh-list
138852881|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
138852882|NCT00633698|Niacinamide|niacinamide|mesh-list
138852883|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138852884|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
138852885|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852886|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138852887|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
138852888|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
138852889|NCT00633698|Vitamins|vitamins|mesh-ancestor
138852890|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
138852891|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852892|NCT02825342|Citalopram|citalopram|mesh-list
138852893|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138852894|NCT02825342|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138852895|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138852896|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138852897|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852898|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852899|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
138852900|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852901|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138852902|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
138852903|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138852904|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852905|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
138852906|NCT02749890|Lixisenatide|lixisenatide|mesh-list
138852907|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138852908|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852909|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
138852912|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852913|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138504939|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
138852914|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852915|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138852916|NCT04242758|Diuretics|diuretics|mesh-ancestor
138852917|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
138852918|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138852919|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138852920|NCT02745912|Metformin|metformin|mesh-list
138852921|NCT02745912|Naltrexone|naltrexone|mesh-list
138852922|NCT02745912|Bupropion|bupropion|mesh-list
138852923|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138852924|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852925|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138628509|NCT00574600|Vaccines|vaccines|mesh-list
138852926|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138852927|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
138852928|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852929|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138852930|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
138852931|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138852932|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138852933|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138852934|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138852935|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852936|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
139017355|NCT05808764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139017356|NCT05808764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139017357|NCT05808764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139017358|NCT05785754|Pembrolizumab|pembrolizumab|mesh-list
139017359|NCT05785754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139017360|NCT05785754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139017361|NCT05785754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017362|NCT05785754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852937|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852938|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138852939|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138852940|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852941|NCT02825186|Dexamethasone|dexamethasone|mesh-list
138852942|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138852943|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
138852944|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
138852945|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138852946|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852947|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138852948|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
138852949|NCT02825186|Hormones|hormones|mesh-ancestor
138852950|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852951|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138852952|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852953|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138852954|NCT00604825|Estrogens|estrogens|mesh-ancestor
138852955|NCT00604825|Hormones|hormones|mesh-ancestor
138852956|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138852957|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852959|NCT04239560|Trace Elements|trace elements|mesh-ancestor
138852960|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
138852961|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852962|NCT04218162|Lasmiditan|lasmiditan|mesh-list
138852963|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138852965|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138852966|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852967|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852968|NCT00606125|Sorafenib|sorafenib|mesh-list
138852969|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138852970|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138852971|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852972|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852973|NCT04242212|Misoprostol|misoprostol|mesh-list
138852974|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138852975|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
138852976|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138852977|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852978|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138852979|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138852980|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
138852981|NCT02851433|Anesthetics|anesthetics|mesh-list
138852982|NCT02851433|Propofol|propofol|mesh-list
138852983|NCT02851433|Sevoflurane|sevoflurane|mesh-list
138852984|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138852985|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852986|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138852987|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138852988|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
138852989|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138852990|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138852991|NCT05629806|Metformin|metformin|mesh-list
138852992|NCT05629806|Pioglitazone|pioglitazone|mesh-list
138852993|NCT05629806|Acarbose|acarbose|mesh-list
138852994|NCT05629806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138852995|NCT05629806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138852996|NCT05629806|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138852997|NCT05629806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138852998|NCT05629806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138852999|NCT02745756|Vaccines|vaccines|mesh-list
138853000|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
138853001|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853002|NCT04242368|Fluticasone|fluticasone|mesh-list
138853003|NCT04242368|Xhance|xhance|mesh-list
138853004|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853005|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138853006|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
138853007|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853008|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853009|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138853010|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
138853011|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
138853012|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138853013|NCT04217148|Dexamethasone|dexamethasone|mesh-list
138853014|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
138853015|NCT04217148|Tretinoin|tretinoin|mesh-list
138853016|NCT04217148|BB 1101|bb 1101|mesh-list
138853017|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853018|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
138853019|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
138853020|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853021|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853022|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138853023|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
138853024|NCT04217148|Hormones|hormones|mesh-ancestor
138853025|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138853026|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138853027|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853028|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
138853029|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853030|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853031|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
138853032|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
138853033|NCT00900913|Ropivacaine|ropivacaine|mesh-list
139017429|NCT05713994|Bevacizumab|bevacizumab|mesh-list
138853034|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
138853035|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
138853036|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138853037|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853038|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
138853039|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853040|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
138853041|NCT04216836|Antacids|antacids|mesh-ancestor
138853042|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853043|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138853044|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
138853045|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
138853046|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138853047|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
138853048|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853049|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138853050|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138853051|NCT04034173|Leucovorin|leucovorin|mesh-list
138853052|NCT04034173|Folic Acid|folic acid|mesh-list
138853053|NCT04034173|Irinotecan|irinotecan|mesh-list
138853054|NCT04034173|Panitumumab|panitumumab|mesh-list
138853055|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
138853056|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138853057|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138853058|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853059|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853060|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853061|NCT04034173|Antidotes|antidotes|mesh-ancestor
138853062|NCT04034173|Protective Agents|protective agents|mesh-ancestor
138853063|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853064|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
138853065|NCT04034173|Vitamins|vitamins|mesh-ancestor
138853066|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
138505092|NCT00042874|Vitamins|vitamins|mesh-ancestor
138853067|NCT04034173|Hematinics|hematinics|mesh-ancestor
138853068|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138853069|NCT00606203|Milnacipran|milnacipran|mesh-list
138853070|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
138853071|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138853072|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138853073|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138853074|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853075|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138853076|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853077|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138853078|NCT00606203|Analgesics|analgesics|mesh-ancestor
138853079|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
138853080|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853081|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
138853082|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138853083|NCT02539849|Adalimumab|adalimumab|mesh-list
138853084|NCT02539849|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138853085|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853086|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138853087|NCT02749578|Atorvastatin|atorvastatin|mesh-list
138853088|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138853089|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138853090|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
138853091|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853093|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138853094|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853095|NCT05378867|Bevacizumab|bevacizumab|mesh-list
138853096|NCT05378867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138853097|NCT05378867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853098|NCT05378867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138853099|NCT05378867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138853100|NCT05378867|Growth Substances|growth substances|mesh-ancestor
138853101|NCT05378867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853102|NCT05378867|Growth Inhibitors|growth inhibitors|mesh-ancestor
138853103|NCT02749656|Desoximetasone|desoximetasone|mesh-list
138853104|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853105|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
138853106|NCT02749656|Hormones|hormones|mesh-ancestor
138853107|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138853108|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853109|NCT00603317|Amoxicillin|amoxicillin|mesh-list
138853110|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
138853111|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
138853112|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138853113|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138853114|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853116|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853117|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138853118|NCT02745522|Oxytocin|oxytocin|mesh-list
138853119|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
138853120|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138853121|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853122|NCT02824718|Teriparatide|teriparatide|mesh-list
138853123|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
138853124|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138853125|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
138853126|NCT02824718|Diuretics|diuretics|mesh-list
138853127|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
138853128|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138853129|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853130|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138853131|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
138853132|NCT02824718|Vitamins|vitamins|mesh-ancestor
138853133|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
138853134|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138853135|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853136|NCT05378711|Fluoxetine|fluoxetine|mesh-list
138853137|NCT05378711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138853138|NCT05378711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138853139|NCT05378711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138943545|NCT00894712|Protective Agents|protective agents|mesh-ancestor
138853140|NCT05378711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853141|NCT05378711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138853143|NCT05378711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853144|NCT05378711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138853145|NCT05378711|Antidepressive Agents|antidepressive agents|mesh-ancestor
138853146|NCT05378711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138853147|NCT05378711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138853148|NCT05378711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138853149|NCT05378711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853151|NCT00777153|Lomustine|lomustine|mesh-list
138853152|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853153|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138853154|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853155|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853156|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138853157|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
138853158|NCT02821520|Verteporfin|verteporfin|mesh-list
138853159|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138853160|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
138853161|NCT00604955|Paromomycin|paromomycin|mesh-list
138853162|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138853163|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853164|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138853165|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138853166|NCT04266509|Rifampin|rifampin|mesh-list
138853167|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138853168|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
138853169|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138853170|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853171|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
138853172|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138853173|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853174|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853175|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138853176|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138853177|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138853178|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138853179|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138853180|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138853181|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138853182|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138853183|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853184|NCT02824874|Incretins|incretins|mesh-ancestor
138853185|NCT02824874|Hormones|hormones|mesh-ancestor
138853186|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138853187|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138853188|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
138853189|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853190|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853191|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
138853192|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138853193|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
138853194|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853195|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
138853196|NCT04204265|Protective Agents|protective agents|mesh-ancestor
138853197|NCT04267913|Dexamethasone|dexamethasone|mesh-list
138853198|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
138853199|NCT04267913|Docetaxel|docetaxel|mesh-list
138853200|NCT04267913|Ramucirumab|ramucirumab|mesh-list
138853201|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138853202|NCT04267913|Antibodies|antibodies|mesh-list
138853203|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
138853204|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138853205|NCT04267913|Lexatumumab|lexatumumab|mesh-list
138853206|NCT04267913|BB 1101|bb 1101|mesh-list
138853207|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
138853208|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853209|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853210|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
138853211|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
138853212|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138505238|NCT00043654|Mifepristone|mifepristone|mesh-list
138853213|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138853214|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
138853215|NCT04267913|Hormones|hormones|mesh-ancestor
138853216|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138853217|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138853218|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853219|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
138853220|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853221|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853223|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
138853224|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
138853225|NCT04216758|Paclitaxel|paclitaxel|mesh-list
138853226|NCT04216758|Gemcitabine|gemcitabine|mesh-list
138853227|NCT04216758|Tegafur|tegafur|mesh-list
138853228|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138853229|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853230|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
138853231|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
138853232|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
138853233|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853234|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138853235|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
138853236|NCT00606437|Fludarabine|fludarabine|mesh-list
138853237|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853238|NCT02538211|Vaccines|vaccines|mesh-list
138853239|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138853240|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
138853241|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853242|NCT02821676|Anesthetics|anesthetics|mesh-list
138853243|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138853244|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853245|NCT02745054|Anticoagulants|anticoagulants|mesh-list
138853246|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
138853248|NCT00908089|Prednisolone|prednisolone|mesh-list
138853249|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138853250|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
138853251|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138853252|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
138853253|NCT00908089|Infliximab|infliximab|mesh-list
138853254|NCT00908089|Naltrexone|naltrexone|mesh-list
138853255|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138853256|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
138853257|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853258|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
138853259|NCT00908089|Hormones|hormones|mesh-ancestor
138853260|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138943573|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138853261|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853262|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138853263|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853264|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
138853265|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
138853266|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853267|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138853268|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138853269|NCT00908089|Protective Agents|protective agents|mesh-ancestor
138853270|NCT00908089|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138853271|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
138853272|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138853273|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853274|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138853275|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138853276|NCT00908089|Analgesics|analgesics|mesh-ancestor
138853277|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
138853278|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138853279|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138853280|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
138853281|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138853282|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138853283|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853284|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853285|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138853286|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138853287|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853288|NCT03553446|Sevoflurane|sevoflurane|mesh-list
138853289|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138505311|NCT00018018|Zidovudine|zidovudine|mesh-list
138853290|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138853291|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
138853293|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138853294|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853296|NCT00908167|Clofarabine|clofarabine|mesh-list
138853297|NCT00908167|Sorafenib|sorafenib|mesh-list
138853298|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138853299|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
138853300|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853301|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853302|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
138853303|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853304|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138853305|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
138853306|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853307|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138853308|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853309|NCT02821052|Insulin|insulin|mesh-list
138853310|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
138853311|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138853312|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853313|NCT05659628|Tislelizumab|tislelizumab|mesh-list
138853314|NCT05659628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138853315|NCT05659628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853316|NCT00606515|Paclitaxel|paclitaxel|mesh-list
138853317|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138853318|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138853319|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853320|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
138853321|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
138853322|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
138853323|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853324|NCT00908323|Vaccines|vaccines|mesh-list
138853325|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
138853326|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853327|NCT02749032|Metformin|metformin|mesh-list
138853328|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138853329|NCT02749032|Vildagliptin|vildagliptin|mesh-list
138853330|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138853331|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853332|NCT02749032|Incretins|incretins|mesh-ancestor
138853333|NCT02749032|Hormones|hormones|mesh-ancestor
138853334|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138853335|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138853336|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
138853337|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787973|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
138853338|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853339|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
138853340|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138853341|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138853342|NCT00908713|Prednisolone|prednisolone|mesh-list
138853343|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
138853344|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138853345|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
138853346|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853347|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
138853348|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
138853349|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853350|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853351|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138853352|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
138853353|NCT00908713|Hormones|hormones|mesh-ancestor
138853354|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138853355|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138853356|NCT00908713|Protective Agents|protective agents|mesh-ancestor
138853357|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138853358|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853359|NCT00908869|Interferons|interferons|mesh-list
138853360|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
138853361|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
138853362|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
138853363|NCT00908869|Vinorelbine|vinorelbine|mesh-list
138853364|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138853365|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
138853366|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505399|NCT00044551|Taxane|taxane|mesh-list
138853368|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138853369|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
138853370|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853371|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853372|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138853373|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
138853374|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853375|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138853376|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
138853377|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
138853378|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
138853379|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
138853380|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
138853381|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138853382|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853383|NCT04240496|Clozapine|clozapine|mesh-list
138853384|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138853385|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
138853386|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138853387|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853388|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853389|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138853390|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138853391|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138853392|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138853393|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
138853394|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
138853395|NCT00909337|Bosentan|bosentan|mesh-list
138853396|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138853397|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138853398|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853399|NCT00909571|Tacrolimus|tacrolimus|mesh-list
138853400|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138853401|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
138853402|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853403|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138853404|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853405|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853406|NCT04015375|Dapsone|dapsone|mesh-list
138853407|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853408|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
138853409|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138853410|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138853411|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138853412|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787974|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138853413|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853414|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
138853415|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138853416|NCT02850887|Anesthetics|anesthetics|mesh-list
138853417|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138853418|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853419|NCT00931645|Cytarabine|cytarabine|mesh-list
138853420|NCT00931645|Dexamethasone|dexamethasone|mesh-list
138853421|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
138853422|NCT00931645|Cisplatin|cisplatin|mesh-list
138853423|NCT00931645|Fludarabine|fludarabine|mesh-list
138853424|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138853425|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
138853426|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853427|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138853428|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138853429|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
138853430|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853431|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853432|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138853433|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853434|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
138853435|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
138853436|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853437|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138853438|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
138853439|NCT00931645|Hormones|hormones|mesh-ancestor
138853440|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138853441|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138853442|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138853443|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
138853444|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
138853445|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853446|NCT05658692|Anti-Infective Agents|anti-infective agents|mesh-list
138853447|NCT05658692|Dexamethasone|dexamethasone|mesh-list
138853448|NCT05658692|Hydrocortisone|hydrocortisone|mesh-list
138853449|NCT05658692|Simendan|simendan|mesh-list
138853450|NCT05658692|Dopamine|dopamine|mesh-list
138853451|NCT05658692|Isoproterenol|isoproterenol|mesh-list
138853452|NCT05658692|Olprinone|olprinone|mesh-list
138853453|NCT05658692|Epinephrine|epinephrine|mesh-list
138853454|NCT05658692|Norepinephrine|norepinephrine|mesh-list
138853455|NCT05658692|Metaraminol|metaraminol|mesh-list
138853456|NCT05658692|Midazolam|midazolam|mesh-list
138853457|NCT05658692|Dexmedetomidine|dexmedetomidine|mesh-list
138853458|NCT05658692|Bromides|bromides|mesh-list
138853459|NCT05658692|Propofol|propofol|mesh-list
138853460|NCT05658692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138943674|NCT00606892|Nicotine|nicotine|mesh-list
138853461|NCT05658692|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138853462|NCT05658692|Simvastatin|simvastatin|mesh-list
138853463|NCT05658692|Glucocorticoids|glucocorticoids|mesh-list
138853464|NCT05658692|Succinylcholine|succinylcholine|mesh-list
138853465|NCT05658692|Vecuronium Bromide|vecuronium bromide|mesh-list
138853466|NCT05658692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853467|NCT05658692|Antiemetics|antiemetics|mesh-ancestor
138853468|NCT05658692|Autonomic Agents|autonomic agents|mesh-ancestor
138853469|NCT05658692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853470|NCT05658692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853471|NCT05658692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138853472|NCT05658692|Hormones|hormones|mesh-ancestor
138853473|NCT05658692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138853474|NCT05658692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138853475|NCT05658692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853476|NCT05658692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853477|NCT05658692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853478|NCT05658692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138853479|NCT05658692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138853480|NCT05658692|Analgesics|analgesics|mesh-ancestor
138853481|NCT05658692|Sensory System Agents|sensory system agents|mesh-ancestor
138853482|NCT05658692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138853483|NCT05658692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138853484|NCT05658692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138853485|NCT05658692|Adrenergic Agents|adrenergic agents|mesh-ancestor
138853486|NCT05658692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138853487|NCT05658692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138853488|NCT05658692|Anesthetics, General|anesthetics, general|mesh-ancestor
138853489|NCT05658692|Anesthetics|anesthetics|mesh-ancestor
138853490|NCT05658692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138853491|NCT05658692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138853492|NCT05658692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138853493|NCT05658692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138853494|NCT05658692|GABA Modulators|gaba modulators|mesh-ancestor
138853496|NCT05658692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138853497|NCT05658692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138853498|NCT05658692|Antimetabolites|antimetabolites|mesh-ancestor
138853499|NCT05658692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138853500|NCT05658692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138853501|NCT05658692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138853502|NCT05658692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138853503|NCT05658692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138853504|NCT05658692|Respiratory System Agents|respiratory system agents|mesh-ancestor
138853505|NCT05658692|Mydriatics|mydriatics|mesh-ancestor
138853506|NCT05658692|Sympathomimetics|sympathomimetics|mesh-ancestor
138853507|NCT05658692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138853508|NCT05658692|Anticonvulsants|anticonvulsants|mesh-ancestor
138853509|NCT05658692|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138853510|NCT05658692|Vasodilator Agents|vasodilator agents|mesh-ancestor
138853511|NCT05658692|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138853512|NCT05658692|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138853513|NCT05658692|Protective Agents|protective agents|mesh-ancestor
138853514|NCT05658692|Dopamine Agents|dopamine agents|mesh-ancestor
138853515|NCT05658692|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138853516|NCT05658692|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138853517|NCT05658692|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138853518|NCT05658692|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138505542|NCT00044863|Cetuximab|cetuximab|mesh-list
138853519|NCT05658692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138853520|NCT05658692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138853522|NCT05658692|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138853523|NCT02744508|Dexamethasone|dexamethasone|mesh-list
138853524|NCT02744508|Palonosetron|palonosetron|mesh-list
138853525|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853526|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
138853527|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
138853528|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853529|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853530|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138853531|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
138853532|NCT02744508|Hormones|hormones|mesh-ancestor
139017696|NCT05382299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853533|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138853534|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138853536|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138853537|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138853538|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
138853539|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138853540|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853541|NCT00927511|Fulvestrant|fulvestrant|mesh-list
138853542|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138853543|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853544|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138853545|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138853546|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
138853547|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138853548|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853549|NCT03211338|Progesterone|progesterone|mesh-list
138853550|NCT03211338|Mitogens|mitogens|mesh-list
138853551|NCT03211338|Progestins|progestins|mesh-ancestor
138853552|NCT03211338|Hormones|hormones|mesh-ancestor
138853553|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138853554|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853555|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
138853556|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853557|NCT00936611|Panobinostat|panobinostat|mesh-list
138853558|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853559|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138853560|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853561|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853562|NCT02744196|Methotrexate|methotrexate|mesh-list
138853563|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853564|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
138853565|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853566|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138853567|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138853568|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
138853569|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138853570|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138853571|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
138853572|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853573|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
138853574|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853575|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138853576|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138853577|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138853578|NCT02139852|Capsaicin|capsaicin|mesh-list
138853580|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
138853581|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
138853582|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853583|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853584|NCT05379647|Cyclophosphamide|cyclophosphamide|mesh-list
138853585|NCT05379647|Rituximab|rituximab|mesh-list
138853586|NCT05379647|Fludarabine|fludarabine|mesh-list
138853587|NCT05379647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138853588|NCT05379647|Immunologic Factors|immunologic factors|mesh-ancestor
138853589|NCT05379647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853590|NCT05379647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138853591|NCT05379647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138853592|NCT05379647|Alkylating Agents|alkylating agents|mesh-ancestor
138853593|NCT05379647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853594|NCT05379647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853595|NCT05379647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138853596|NCT05379647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138853597|NCT02748330|Aspirin|aspirin|mesh-list
138853598|NCT02748330|Clopidogrel|clopidogrel|mesh-list
138853599|NCT02748330|Ticagrelor|ticagrelor|mesh-list
138853600|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138853601|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138853602|NCT02748330|Analgesics|analgesics|mesh-ancestor
138853603|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
138853604|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853605|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853606|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853607|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138853608|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138853609|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138853610|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853611|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138853612|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138853613|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853614|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
138853615|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138853616|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138853617|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138853618|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
138853619|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138853620|NCT05379569|Cyclophosphamide|cyclophosphamide|mesh-list
138853621|NCT05379569|Fludarabine|fludarabine|mesh-list
138853622|NCT05379569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138853623|NCT05379569|Immunologic Factors|immunologic factors|mesh-ancestor
138853624|NCT05379569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853625|NCT05379569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138853626|NCT05379569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138853627|NCT05379569|Alkylating Agents|alkylating agents|mesh-ancestor
138853628|NCT05379569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943743|NCT02550249|Nivolumab|nivolumab|mesh-list
138853629|NCT05379569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853630|NCT05379569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138853631|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
138853632|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138853633|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
139017747|NCT05285891|Ocrelizumab|ocrelizumab|mesh-list
138853634|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853635|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
138853636|NCT02818556|Protective Agents|protective agents|mesh-ancestor
138853637|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138853638|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853639|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138853640|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138853642|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138853643|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138853644|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853645|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853646|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853647|NCT00936221|Dacarbazine|dacarbazine|mesh-list
138853648|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138853649|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
138853650|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853651|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853652|NCT00776919|Clindamycin|clindamycin|mesh-list
138853653|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
138853654|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
138853655|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138853656|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138853657|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853658|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138853659|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853660|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853661|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
138853662|NCT05657678|Vitamin D|vitamin d|mesh-list
138853663|NCT05657678|Ergocalciferols|ergocalciferols|mesh-list
138853664|NCT05657678|Cholecalciferol|cholecalciferol|mesh-list
138853665|NCT05657678|Vitamins|vitamins|mesh-list
138853666|NCT05657678|Micronutrients|micronutrients|mesh-ancestor
138853667|NCT05657678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853668|NCT05657678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138853669|NCT05657678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138853670|NCT02747940|Pregabalin|pregabalin|mesh-list
138853671|NCT02747940|Flunarizine|flunarizine|mesh-list
138853672|NCT02747940|Analgesics|analgesics|mesh-ancestor
138853673|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
138853674|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853675|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853676|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
138853677|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138853678|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138853679|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853680|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138853681|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138853683|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138853684|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138853685|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138853686|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
138853687|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
138853688|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138853689|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
138853690|NCT04238702|Empagliflozin|empagliflozin|mesh-list
138853691|NCT04238702|Losartan|losartan|mesh-list
138853692|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138853693|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138853694|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138943752|NCT00824811|Cyclosporins|cyclosporins|mesh-list
138853695|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138853696|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853697|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138853698|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138853699|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853700|NCT00603785|Omalizumab|omalizumab|mesh-list
138853701|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138853702|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138853703|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
138853704|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
138853705|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138853706|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
138853707|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853708|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853709|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138853710|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
138853711|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138853712|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138853713|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138853714|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
138853715|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138853716|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853718|NCT05382923|Antioxidants|antioxidants|mesh-ancestor
138853719|NCT05382923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853720|NCT05382923|Protective Agents|protective agents|mesh-ancestor
138853721|NCT05382923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853722|NCT05382923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138853723|NCT02743572|Iron|iron|mesh-list
138853724|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138853725|NCT02743572|Trace Elements|trace elements|mesh-ancestor
138853726|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
138853727|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853728|NCT02743572|Hematinics|hematinics|mesh-ancestor
138853729|NCT00775593|Sirolimus|sirolimus|mesh-list
138853730|NCT00775593|Temsirolimus|temsirolimus|mesh-list
138853731|NCT00775593|MTOR Inhibitors|mtor inhibitors|mesh-list
138853732|NCT00775593|Clofarabine|clofarabine|mesh-list
138853733|NCT00775593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138853734|NCT00775593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853735|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853736|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138853737|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
138853738|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853739|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505761|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138853740|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138853741|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853742|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138853743|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
138853744|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138853745|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
138853746|NCT00606983|Tamsulosin|tamsulosin|mesh-list
138853747|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139017783|NCT05141721|Atezolizumab|atezolizumab|mesh-list
138853748|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138853749|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138853750|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
138853751|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138853752|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853753|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853754|NCT00606983|Urological Agents|urological agents|mesh-ancestor
138853756|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138853757|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138853758|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853759|NCT02743260|Metformin|metformin|mesh-list
138853760|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138853761|NCT02743260|Adefovir|adefovir|mesh-list
138853762|NCT02743260|Digoxin|digoxin|mesh-list
138853763|NCT02743260|Pitavastatin|pitavastatin|mesh-list
138853764|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138853765|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853766|NCT02743260|Incretins|incretins|mesh-ancestor
138853767|NCT02743260|Hormones|hormones|mesh-ancestor
138853768|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138853769|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138853770|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
138853771|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853772|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853773|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138853774|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138853775|NCT02743260|Protective Agents|protective agents|mesh-ancestor
138853776|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
138853777|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853778|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138853779|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138853780|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138853781|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138853782|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138853783|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
138853784|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138853785|NCT02819648|Prednisolone|prednisolone|mesh-list
138853786|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
138853787|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853788|NCT02819648|Hormones|hormones|mesh-ancestor
138853789|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138853790|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853791|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138853792|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853793|NCT00934661|Morphine|morphine|mesh-list
138853794|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138853795|NCT00934661|Narcotics|narcotics|mesh-ancestor
138853796|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138853797|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853798|NCT00934661|Analgesics|analgesics|mesh-ancestor
138853799|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
138853800|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853801|NCT02743182|Interferons|interferons|mesh-list
138853802|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
138853803|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
138853804|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138853805|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853806|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
138853807|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853808|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
138853809|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853810|NCT00775437|Adalimumab|adalimumab|mesh-list
138853811|NCT00775437|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138853812|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853813|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138853814|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
138853815|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138853816|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853817|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
138505833|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138853818|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138853819|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853820|NCT02819414|Acetaminophen|acetaminophen|mesh-list
138853821|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138853822|NCT02819414|Analgesics|analgesics|mesh-ancestor
138853823|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
138853824|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853825|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853826|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
138853827|NCT02743104|Lidocaine|lidocaine|mesh-list
138853828|NCT02743104|Atropine|atropine|mesh-list
138853829|NCT02743104|Midazolam|midazolam|mesh-list
138853830|NCT02743104|Ketamine|ketamine|mesh-list
138853832|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
138853833|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
138853834|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138853835|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853836|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
138853837|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853838|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138853839|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138853840|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138853841|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138853842|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853843|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138853844|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138853845|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
138853846|NCT02743104|Analgesics|analgesics|mesh-ancestor
138853847|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138853848|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138853849|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138853850|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138853851|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138853852|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138853853|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138853854|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138853855|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
138853856|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
138853857|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138853858|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
138853859|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138853860|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
138853861|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
138853862|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
138853863|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138853864|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138853865|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
138853867|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138853868|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138853869|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138853870|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853871|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138853872|NCT00775203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138853873|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138853874|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138853875|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853876|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138853877|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
138853878|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138853879|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
138853880|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138853881|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
138853882|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853883|NCT00607217|Vaccines|vaccines|mesh-list
138853884|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
138853885|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853887|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138853888|NCT02747316|Trace Elements|trace elements|mesh-ancestor
138853889|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
138853890|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853891|NCT05648708|Bupivacaine|bupivacaine|mesh-list
138853892|NCT05648708|Prilocaine|prilocaine|mesh-list
138853893|NCT05648708|Anesthetics, Local|anesthetics, local|mesh-ancestor
138853894|NCT05648708|Anesthetics|anesthetics|mesh-ancestor
138853895|NCT05648708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138853896|NCT05648708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853897|NCT05648708|Sensory System Agents|sensory system agents|mesh-ancestor
138853898|NCT05648708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853899|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
138853900|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138853901|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853902|NCT00636246|Sertraline|sertraline|mesh-list
138853903|NCT00636246|Reboxetine|reboxetine|mesh-list
138853904|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
138853905|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138853906|NCT00636246|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138853907|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138853908|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138853909|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853910|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138853911|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
138853912|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853913|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138853914|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
138853915|NCT02819570|Ampicillin|ampicillin|mesh-list
138853916|NCT02819570|Cefuroxime|cefuroxime|mesh-list
138853917|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
138853918|NCT02819570|Roxithromycin|roxithromycin|mesh-list
138853919|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138853920|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138853921|NCT04239170|Gemcitabine|gemcitabine|mesh-list
138853922|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
138853923|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138853924|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
138853925|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853926|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853927|NCT04480190|Gemcitabine|gemcitabine|mesh-list
138853928|NCT04480190|Fluorouracil|fluorouracil|mesh-list
138853929|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853930|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138853931|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
138853932|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853933|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138853934|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
138853935|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853936|NCT02741856|Paclitaxel|paclitaxel|mesh-list
138853937|NCT02741856|Carboplatin|carboplatin|mesh-list
138853938|NCT02741856|Capecitabine|capecitabine|mesh-list
138853939|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138853940|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853941|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
138853942|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
138853943|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
138853944|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853945|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138853946|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
138853947|NCT02741232|Lidocaine|lidocaine|mesh-list
138853948|NCT02741232|Epinephrine|epinephrine|mesh-list
138853949|NCT02741232|Racepinephrine|racepinephrine|mesh-list
138853950|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
138853951|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
138853952|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
138853953|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138853954|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853955|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
138853956|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853957|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138853958|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138853959|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138853960|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138853961|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853962|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138853963|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138853964|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
138853965|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138853966|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138853967|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138853968|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
138853969|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138853970|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
138853971|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
138853972|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
138853973|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138853974|NCT04239014|Olaparib|olaparib|mesh-list
138853975|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138853976|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853977|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853978|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138853979|NCT00568321|Tanezumab|tanezumab|mesh-list
138853980|NCT00568321|Analgesics|analgesics|mesh-ancestor
138853981|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
138853982|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853984|NCT02742480|Dabigatran|dabigatran|mesh-list
138853985|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
138853986|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
138853987|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138853988|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
138853989|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138853990|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853991|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
138853992|NCT00774345|Lenalidomide|lenalidomide|mesh-list
139017902|NCT04931342|Growth Substances|growth substances|mesh-ancestor
139017903|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
139017904|NCT04931342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139017905|NCT04931342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139017906|NCT04931342|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139017907|NCT04931342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139017908|NCT04931342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139017909|NCT04931342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139017910|NCT04931342|Hormone Antagonists|hormone antagonists|mesh-ancestor
139017911|NCT04931342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139017912|NCT04931342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139017918|NCT04925479|Vitamins|vitamins|mesh-ancestor
138853993|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
138853994|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138853995|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138853996|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138853997|NCT00774345|Growth Substances|growth substances|mesh-ancestor
138853998|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
138853999|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854000|NCT02819102|Berotralstat|berotralstat|mesh-list
138854001|NCT02819102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138854002|NCT02819102|Protease Inhibitors|protease inhibitors|mesh-ancestor
138854003|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854004|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854005|NCT02819180|Vaccines|vaccines|mesh-list
138854006|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
138854007|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854008|NCT04661930|Fenofibrate|fenofibrate|mesh-list
138854009|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138854010|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
138854011|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854012|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138854013|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
138854014|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138854015|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138854016|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138854017|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138854018|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854019|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
138854020|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854021|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854022|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138854023|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854024|NCT02601963|Minocycline|minocycline|mesh-list
138854025|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138854026|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854027|NCT00927979|Ropivacaine|ropivacaine|mesh-list
138854028|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
138854029|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
138854030|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138854031|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854032|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
138854033|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854034|NCT00931957|Prednisolone|prednisolone|mesh-list
138854035|NCT00931957|Etanercept|etanercept|mesh-list
138854036|NCT00931957|Methotrexate|methotrexate|mesh-list
138854037|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138854038|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
138854039|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138854040|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854041|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138854042|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
138854043|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854044|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854045|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
138854046|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854047|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138854048|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138854049|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
138854050|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138854051|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138854052|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138854053|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
138854054|NCT00931957|Hormones|hormones|mesh-ancestor
138854055|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138854056|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138854057|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854058|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138854059|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138854060|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138854061|NCT00931957|Analgesics|analgesics|mesh-ancestor
138854062|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
138854063|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
138854064|NCT02731950|Bupivacaine|bupivacaine|mesh-list
138854065|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
138854066|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
138854067|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138854068|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854069|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
138854070|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854071|NCT02731950|Analgesics|analgesics|mesh-ancestor
138854072|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138854073|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
138854074|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138854075|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138854076|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854077|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138854078|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
138854079|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138854081|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138854082|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138854083|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138854084|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138854085|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854086|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
138854087|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854088|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854089|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138854090|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854091|NCT00928213|Heparin|heparin|mesh-list
138854092|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138854093|NCT00928213|Tinzaparin|tinzaparin|mesh-list
138854094|NCT00928213|Dalteparin|dalteparin|mesh-list
138854095|NCT00928213|Progesterone|progesterone|mesh-list
138854096|NCT00928213|Hormones|hormones|mesh-ancestor
138854097|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138854098|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854099|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
138854100|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138854101|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138854102|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854103|NCT00928213|Progestins|progestins|mesh-ancestor
138854104|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138854105|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854106|NCT02736240|Vaccines|vaccines|mesh-list
138854107|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138854108|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
138854109|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854110|NCT02741154|Letrozole|letrozole|mesh-list
138854111|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138854112|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854113|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138854114|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138854115|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854116|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854117|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138854118|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
138854119|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138506134|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
138854120|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854121|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
138854122|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138854123|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
138854124|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138854125|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138943915|NCT00900172|Paclitaxel|paclitaxel|mesh-list
138854126|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138854127|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
138854128|NCT04287816|Antithrombins|antithrombins|mesh-list
138854129|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138854131|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854132|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854133|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
138854134|NCT02731560|Rituximab|rituximab|mesh-list
138854135|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138854136|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854137|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
138854138|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854139|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138854140|NCT00773097|Poly ICLC|poly iclc|mesh-list
138854142|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
138854143|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854144|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
138854145|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854146|NCT02814110|Lenograstim|lenograstim|mesh-list
138854147|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138854148|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
138854149|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854150|NCT04264481|Lidocaine|lidocaine|mesh-list
138854151|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
138854152|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
138854153|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138854154|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854155|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
138854156|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854157|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138854158|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138854159|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138854160|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138854161|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854162|NCT05303909|Gentamicins|gentamicins|mesh-list
138854163|NCT05303909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138854164|NCT05303909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854165|NCT05303909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138854166|NCT05303909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854167|NCT05303909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854168|NCT04306692|Inositol|inositol|mesh-list
138854169|NCT04306692|Clomiphene|clomiphene|mesh-list
138854170|NCT04306692|Enclomiphene|enclomiphene|mesh-list
138854171|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
138854172|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138854173|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
138854174|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138854175|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854176|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138854177|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
138854178|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138854179|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138854180|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138854181|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
138854182|NCT04306692|Vitamins|vitamins|mesh-ancestor
138854183|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
138854184|NCT00772941|Varenicline|varenicline|mesh-list
138854185|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138854186|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138854187|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
138854188|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854189|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854190|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854191|NCT02735694|Cycloserine|cycloserine|mesh-list
138854192|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138854193|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854194|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138854195|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
138854196|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138854197|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
138854198|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854199|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
138854200|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138854201|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138854202|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854203|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138854205|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
138854206|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854207|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138854208|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138854209|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138854210|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
138854211|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854212|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854213|NCT02731092|Lactoferrin|lactoferrin|mesh-list
138854214|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854216|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138854217|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138854218|NCT00928837|Analgesics|analgesics|mesh-ancestor
138854219|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
138854220|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854221|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854222|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138854223|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138854224|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
138854225|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138854226|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854227|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854228|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
138854229|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138854230|NCT00925093|Vancomycin|vancomycin|mesh-list
138854231|NCT00925093|Linezolid|linezolid|mesh-list
138854232|NCT00925093|Teicoplanin|teicoplanin|mesh-list
138854233|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138854234|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854235|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138854236|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854237|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854238|NCT01562977|Rituximab|rituximab|mesh-list
138854239|NCT01562977|Gemcitabine|gemcitabine|mesh-list
138854240|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
138854241|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138854242|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854243|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
138854244|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854245|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138854246|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138854247|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
138854248|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854249|NCT00607685|Fluorouracil|fluorouracil|mesh-list
138854250|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
138854251|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
138854252|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854253|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138854254|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854255|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138854256|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
138854257|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854258|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138854259|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
138854260|NCT00607685|Protective Agents|protective agents|mesh-ancestor
138854261|NCT04265027|Opicapone|opicapone|mesh-list
138854262|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138854263|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854264|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854265|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138854266|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138854267|NCT00607763|Micafungin|micafungin|mesh-list
138854268|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
138854269|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854270|NCT00928915|Thrombin|thrombin|mesh-list
138854271|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
138854272|NCT00928915|Coagulants|coagulants|mesh-ancestor
138854273|NCT02814500|Amlodipine|amlodipine|mesh-list
138854274|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138854275|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138854276|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138854277|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138854278|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854279|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138854280|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854281|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
138854282|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138854283|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138854284|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
138854285|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138854286|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138854287|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854288|NCT00939341|Budesonide|budesonide|mesh-list
138854289|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
138854290|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138854291|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138854292|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138854293|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
138854294|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854295|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854296|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138854297|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
138854298|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
138854299|NCT00939341|Hormones|hormones|mesh-ancestor
138854300|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138854301|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138854302|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138854303|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138854304|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
138854305|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854306|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854307|NCT00925327|Riboflavin|riboflavin|mesh-list
138854308|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
138854309|NCT00925327|Vitamins|vitamins|mesh-ancestor
138854310|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
138854311|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854312|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138854313|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
138854314|NCT04237376|Tenofovir|tenofovir|mesh-list
138854315|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
138854316|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854317|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138854318|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138854319|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854320|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854321|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138854322|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138854323|NCT04015687|Lamotrigine|lamotrigine|mesh-list
138854324|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
138854325|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138854326|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138854327|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854328|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138854329|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854330|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138854331|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138854332|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138854333|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138854334|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138854336|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138854337|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
138854338|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138854339|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854340|NCT02739672|Amlodipine|amlodipine|mesh-list
138854341|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138854342|NCT02739672|Telmisartan|telmisartan|mesh-list
138854343|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138854344|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138854346|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138854347|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854348|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138854349|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854350|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
138854351|NCT02739672|Diuretics|diuretics|mesh-ancestor
138854352|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
138854353|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138854354|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138854355|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138854356|NCT00932971|Tenofovir|tenofovir|mesh-list
138854357|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138854358|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
138854359|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
138854360|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138854361|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
138854362|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854363|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138854364|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138854365|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854366|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854367|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138854368|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138854369|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
138854370|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854371|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854372|NCT05382143|Atosiban|atosiban|mesh-list
138854373|NCT05382143|Hormone Antagonists|hormone antagonists|mesh-ancestor
138854374|NCT05382143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138854375|NCT05382143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854377|NCT05382143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138854378|NCT00933049|Amoxicillin|amoxicillin|mesh-list
138854379|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138854380|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138854381|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854382|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138854383|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
138854384|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138854385|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138854386|NCT05788393|Lidocaine|lidocaine|mesh-list
138854387|NCT05788393|Dexmedetomidine|dexmedetomidine|mesh-list
138854388|NCT05788393|Anesthetics, Local|anesthetics, local|mesh-ancestor
138854389|NCT05788393|Anesthetics|anesthetics|mesh-ancestor
138854390|NCT05788393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138854391|NCT05788393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018125|NCT04547907|Paclitaxel|paclitaxel|mesh-list
138854402|NCT05788393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138854403|NCT05788393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138854404|NCT05788393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138854405|NCT05788393|Adrenergic Agents|adrenergic agents|mesh-ancestor
138854406|NCT05788393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854408|NCT05788159|Anticonvulsants|anticonvulsants|mesh-ancestor
138854409|NCT05788159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138854410|NCT05788159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138854411|NCT05788159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138854412|NCT05788159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854413|NCT05787925|Vitamin E|vitamin e|mesh-list
138854414|NCT05787925|Vitamins|vitamins|mesh-ancestor
138854415|NCT05787925|Micronutrients|micronutrients|mesh-ancestor
138854416|NCT05787925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854417|NCT05787925|Antioxidants|antioxidants|mesh-ancestor
138854418|NCT05787925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854419|NCT05787925|Protective Agents|protective agents|mesh-ancestor
138854420|NCT05787912|Hyaluronic Acid|hyaluronic acid|mesh-list
138854421|NCT05787912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138854422|NCT05787912|Immunologic Factors|immunologic factors|mesh-ancestor
138854423|NCT05787912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854424|NCT05787912|Viscosupplements|viscosupplements|mesh-ancestor
138854425|NCT05787912|Protective Agents|protective agents|mesh-ancestor
138854426|NCT05787808|Vitamin D|vitamin d|mesh-list
138854427|NCT05787808|Vitamins|vitamins|mesh-ancestor
138854428|NCT05787808|Micronutrients|micronutrients|mesh-ancestor
138854429|NCT05787808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854430|NCT05787808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138854445|NCT05787535|Fludarabine|fludarabine|mesh-list
138854446|NCT05787535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138854447|NCT05787535|Immunologic Factors|immunologic factors|mesh-ancestor
138854448|NCT05787535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854449|NCT05787535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138854450|NCT05787535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138854451|NCT05787535|Alkylating Agents|alkylating agents|mesh-ancestor
138854452|NCT05787535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854453|NCT05787535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854454|NCT05787535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138854455|NCT05787509|Progesterone|progesterone|mesh-list
138854456|NCT05787509|Progestins|progestins|mesh-ancestor
138854457|NCT05787509|Hormones|hormones|mesh-ancestor
138854458|NCT05787509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138854459|NCT05787509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854460|NCT05787002|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138854461|NCT05787002|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138854462|NCT05787002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138854463|NCT05787002|Antimetabolites|antimetabolites|mesh-ancestor
138854464|NCT05787002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854465|NCT05787002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138854466|NCT05787002|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138854467|NCT05787002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854468|NCT05786950|Bromides|bromides|mesh-list
138854469|NCT05786950|Albuterol|albuterol|mesh-list
138854470|NCT05786950|Ipratropium|ipratropium|mesh-list
138854471|NCT05786950|Anticonvulsants|anticonvulsants|mesh-ancestor
138854472|NCT05786950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138854473|NCT05786950|Autonomic Agents|autonomic agents|mesh-ancestor
138854474|NCT05786950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854475|NCT05786950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854476|NCT05786950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138854477|NCT05786950|Respiratory System Agents|respiratory system agents|mesh-ancestor
138854478|NCT05786950|Tocolytic Agents|tocolytic agents|mesh-ancestor
138854479|NCT05786950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138854480|NCT05786950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138854481|NCT05786950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138854482|NCT05786950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138854483|NCT05786950|Adrenergic Agents|adrenergic agents|mesh-ancestor
138854484|NCT05786950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854485|NCT05786950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854486|NCT05786950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138854487|NCT05786950|Cholinergic Agents|cholinergic agents|mesh-ancestor
138854488|NCT05786885|Vitamins|vitamins|mesh-list
138854489|NCT05786885|Ascorbic Acid|ascorbic acid|mesh-list
138854490|NCT05786885|Micronutrients|micronutrients|mesh-ancestor
138854491|NCT05786885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854492|NCT05786885|Antioxidants|antioxidants|mesh-ancestor
138854493|NCT05786885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854494|NCT05786885|Protective Agents|protective agents|mesh-ancestor
138854496|NCT05786859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138854497|NCT05786859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854498|NCT05786859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138854499|NCT05786638|Immunomodulating Agents|immunomodulating agents|mesh-list
138854500|NCT05786638|Immunologic Factors|immunologic factors|mesh-ancestor
138854501|NCT05786638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854502|NCT05784688|Pembrolizumab|pembrolizumab|mesh-list
138854503|NCT05784688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138854504|NCT05784688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854505|NCT05784688|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138854506|NCT05784688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854507|NCT05764044|Gemcitabine|gemcitabine|mesh-list
138854508|NCT05764044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854509|NCT05764044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138854510|NCT05764044|Antimetabolites|antimetabolites|mesh-ancestor
138854511|NCT05764044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854512|NCT05737030|N-Methylaspartate|n-methylaspartate|mesh-list
138854513|NCT05737030|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138854514|NCT05737030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138854515|NCT05737030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854516|NCT05737030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854517|NCT05737030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854518|NCT05716295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138854519|NCT05716295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854520|NCT05716295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138854521|NCT05716295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854522|NCT05706844|Anesthetics|anesthetics|mesh-list
138854523|NCT05706844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138854524|NCT05706844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854525|NCT05702827|Meloxicam|meloxicam|mesh-list
138854526|NCT05702827|Bupivacaine|bupivacaine|mesh-list
138854527|NCT05702827|Anesthetics, Local|anesthetics, local|mesh-ancestor
138854528|NCT05702827|Anesthetics|anesthetics|mesh-ancestor
138854529|NCT05702827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138854530|NCT05702827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854531|NCT05702827|Sensory System Agents|sensory system agents|mesh-ancestor
138854532|NCT05702827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854533|NCT05702827|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138854534|NCT05702827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138854535|NCT05702827|Analgesics|analgesics|mesh-ancestor
138854536|NCT05702827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138854537|NCT05702827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138854538|NCT05702827|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138854539|NCT05702827|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138854540|NCT05702827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854541|NCT05702827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854542|NCT05685628|Charcoal|charcoal|mesh-list
138854543|NCT05685628|Antidotes|antidotes|mesh-ancestor
138854544|NCT05685628|Protective Agents|protective agents|mesh-ancestor
138854545|NCT05685628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854546|NCT05673889|Dabigatran|dabigatran|mesh-list
138854547|NCT05673889|Antithrombins|antithrombins|mesh-ancestor
138854548|NCT05673889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138854549|NCT05673889|Protease Inhibitors|protease inhibitors|mesh-ancestor
138854550|NCT05673889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854551|NCT05673889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854552|NCT05673889|Anticoagulants|anticoagulants|mesh-ancestor
138854553|NCT05654298|Sumatriptan|sumatriptan|mesh-list
138854554|NCT05654298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138854555|NCT05654298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138854556|NCT05654298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138854557|NCT05654298|Serotonin Agents|serotonin agents|mesh-ancestor
138854558|NCT05654298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854559|NCT05654298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854560|NCT05654298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854561|NCT05649293|Vitamin B 6|vitamin b 6|mesh-list
138854562|NCT05649293|Pyridoxal|pyridoxal|mesh-list
138854563|NCT05649293|Pyridoxine|pyridoxine|mesh-list
138854564|NCT05649293|Vitamins|vitamins|mesh-ancestor
138854565|NCT05649293|Micronutrients|micronutrients|mesh-ancestor
138854566|NCT05649293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854567|NCT05649293|Vitamin B Complex|vitamin b complex|mesh-ancestor
138854568|NCT05618613|Onapristone|onapristone|mesh-list
138854569|NCT05618613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854570|NCT05618613|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138854571|NCT05618613|Fertility Agents|fertility agents|mesh-ancestor
138854572|NCT05618613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138854573|NCT05618613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854574|NCT05618613|Hormone Antagonists|hormone antagonists|mesh-ancestor
138854575|NCT05618613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138854576|NCT05617963|Durvalumab|durvalumab|mesh-list
138854577|NCT05617963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138854578|NCT05617963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854579|NCT05587036|Rifaximin|rifaximin|mesh-list
138854580|NCT05587036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138854581|NCT05587036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854582|NCT05587036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138854583|NCT05506046|Nicotine|nicotine|mesh-list
138854584|NCT05506046|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138854585|NCT05506046|Autonomic Agents|autonomic agents|mesh-ancestor
138854586|NCT05506046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854587|NCT05506046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854588|NCT05506046|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138854589|NCT05506046|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138854590|NCT05506046|Cholinergic Agents|cholinergic agents|mesh-ancestor
138854591|NCT05506046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854592|NCT05506046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854593|NCT05487950|Rivaroxaban|rivaroxaban|mesh-list
138854594|NCT05487950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138854595|NCT05487950|Antithrombins|antithrombins|mesh-ancestor
138854596|NCT05487950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138854597|NCT05487950|Protease Inhibitors|protease inhibitors|mesh-ancestor
138854598|NCT05487950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854599|NCT05487950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854600|NCT05487950|Anticoagulants|anticoagulants|mesh-ancestor
138854601|NCT05452512|Vitamin D|vitamin d|mesh-list
138854602|NCT05452512|Vitamins|vitamins|mesh-list
138854603|NCT05452512|Micronutrients|micronutrients|mesh-ancestor
138854604|NCT05452512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854605|NCT05452512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138854606|NCT05432089|Oxytocin|oxytocin|mesh-list
138854607|NCT05432089|Oxytocics|oxytocics|mesh-ancestor
138854608|NCT05432089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138854609|NCT05432089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854610|NCT05427513|Tranexamic Acid|tranexamic acid|mesh-list
138854611|NCT05427513|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138854612|NCT05427513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138854613|NCT05427513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854614|NCT05427513|Hemostatics|hemostatics|mesh-ancestor
138854615|NCT05427513|Coagulants|coagulants|mesh-ancestor
138854616|NCT05403723|Carboplatin|carboplatin|mesh-list
138854617|NCT05403723|Etoposide|etoposide|mesh-list
138854618|NCT05403723|Durvalumab|durvalumab|mesh-list
138854619|NCT05403723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854620|NCT05403723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138854621|NCT05403723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138854622|NCT05403723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138854623|NCT05403723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854624|NCT05403723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854625|NCT05403723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138854626|NCT05386095|Bupivacaine|bupivacaine|mesh-list
138854627|NCT05386095|Anesthetics, Local|anesthetics, local|mesh-ancestor
138854628|NCT05386095|Anesthetics|anesthetics|mesh-ancestor
138854629|NCT05386095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138854630|NCT05386095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854631|NCT05386095|Sensory System Agents|sensory system agents|mesh-ancestor
138854632|NCT05386095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854633|NCT05360264|Decitabine|decitabine|mesh-list
138854634|NCT05360264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138854635|NCT05360264|Antimetabolites|antimetabolites|mesh-ancestor
138854636|NCT05360264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854637|NCT05360264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854638|NCT05360264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854639|NCT05321524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138854640|NCT05321524|Cathartics|cathartics|mesh-ancestor
138854641|NCT05321524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138854642|NCT05280496|Metformin|metformin|mesh-list
138854643|NCT05280496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138854644|NCT05280496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854646|NCT05280457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138854647|NCT05280457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854648|NCT05280457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138854649|NCT05280457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854650|NCT05247268|Letrozole|letrozole|mesh-list
138854651|NCT05247268|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138854652|NCT05247268|Megestrol|megestrol|mesh-list
138854653|NCT05247268|Megestrol Acetate|megestrol acetate|mesh-list
138854654|NCT05247268|Medroxyprogesterone|medroxyprogesterone|mesh-list
138854655|NCT05247268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854656|NCT05247268|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138854657|NCT05247268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138854658|NCT05247268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854659|NCT05247268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854660|NCT05247268|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138854661|NCT05247268|Hormone Antagonists|hormone antagonists|mesh-ancestor
138854662|NCT05247268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138854663|NCT05247268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854664|NCT05247268|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138854665|NCT05247268|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138854666|NCT05247268|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138854667|NCT05247268|Contraceptive Agents|contraceptive agents|mesh-ancestor
138854668|NCT05247268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138854669|NCT05247268|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138854670|NCT05247268|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138854671|NCT05247268|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138854672|NCT05247268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138854673|NCT05247268|Appetite Stimulants|appetite stimulants|mesh-ancestor
138854674|NCT05247268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138854675|NCT05211804|Ranibizumab|ranibizumab|mesh-list
138854676|NCT05211804|Aflibercept|aflibercept|mesh-list
138854677|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854678|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138854679|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138854680|NCT05211804|Growth Substances|growth substances|mesh-ancestor
138854681|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854682|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
138854683|NCT05136560|Dexamethasone|dexamethasone|mesh-list
138854684|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
138854685|NCT05136560|BB 1101|bb 1101|mesh-list
138854686|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138854687|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
138854688|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
138854689|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854690|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854691|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138854692|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
138854693|NCT05136560|Hormones|hormones|mesh-ancestor
138854694|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138854695|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138854696|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854697|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
138854698|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854699|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854700|NCT05084586|Epirubicin|epirubicin|mesh-list
138854701|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138854702|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138854703|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854704|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138854705|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138854706|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854707|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854708|NCT05077085|Vancomycin|vancomycin|mesh-list
138854709|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138854710|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854711|NCT04930744|Metformin|metformin|mesh-list
138854712|NCT04930744|Rifampin|rifampin|mesh-list
138854713|NCT04930744|Isoniazid|isoniazid|mesh-list
138854714|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
138854715|NCT04930744|Ethambutol|ethambutol|mesh-list
139018259|NCT04360941|Avelumab|avelumab|mesh-list
138854716|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138854717|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854718|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138854719|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
138854720|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138854721|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854722|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
138854723|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138854724|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854725|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944083|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138854726|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138854727|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138854728|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138854729|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138854730|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138854731|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138854732|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138854734|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
138854735|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138854736|NCT04877093|Clonidine|clonidine|mesh-list
138854737|NCT04877093|Analgesics|analgesics|mesh-ancestor
138854738|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
138854739|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854740|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854741|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138854742|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
138854743|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
138854744|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138854745|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138854746|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138854747|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
138854748|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854749|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854750|NCT04850911|Ketamine|ketamine|mesh-list
138854751|NCT04850911|Analgesics|analgesics|mesh-ancestor
138854752|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
138854753|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854754|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854755|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138854756|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138854757|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
138854758|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
138854759|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138854760|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138854761|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138854762|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854763|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854764|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
138854765|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138854766|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
138854767|NCT04807127|Durvalumab|durvalumab|mesh-list
138854768|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138854769|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138854770|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854771|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854772|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
138854773|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138854774|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138854775|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854776|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854777|NCT04642404|Cannabidiol|cannabidiol|mesh-list
138944104|NCT02548533|Lidocaine|lidocaine|mesh-list
138854778|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
138854779|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138854780|NCT04642352|Bupivacaine|bupivacaine|mesh-list
138854781|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
138854782|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
138854783|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138854784|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854785|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
138854786|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854787|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138854788|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
138854789|NCT04642352|Hormones|hormones|mesh-ancestor
138854790|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138854791|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506813|NCT00052936|Doxorubicin|doxorubicin|mesh-list
138854792|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
138854794|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138854795|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
138854796|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854797|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138854798|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138854799|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138854800|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854801|NCT04594408|Epinephrine|epinephrine|mesh-list
138854802|NCT04594408|Racepinephrine|racepinephrine|mesh-list
138854803|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
138854804|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
138854805|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138854806|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139018296|NCT04076059|Androgens|androgens|mesh-list
138854807|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854808|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
138854809|NCT04594408|Coagulants|coagulants|mesh-ancestor
138854810|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138854811|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138854812|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
138854813|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854814|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854815|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138854816|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138854817|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
138854818|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854819|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138854820|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
138854821|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
138854822|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
138854823|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138854824|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
138854826|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138854827|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
138854828|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854829|NCT04557215|Expectorants|expectorants|mesh-ancestor
138854830|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
138854831|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138854832|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
138854833|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854834|NCT04557215|Protective Agents|protective agents|mesh-ancestor
138854835|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854836|NCT04557215|Antidotes|antidotes|mesh-ancestor
138854837|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138854838|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138854839|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138854840|NCT04423627|Clonidine|clonidine|mesh-list
138854841|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138854842|NCT04423627|Diuretics|diuretics|mesh-ancestor
138854843|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
138854844|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854845|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138854846|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138854847|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854848|NCT04423627|Analgesics|analgesics|mesh-ancestor
138854849|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
138854850|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854851|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
138854852|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
138854853|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138854854|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138854855|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138854856|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
138854857|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854858|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138854859|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138854860|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138854861|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138854862|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854868|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
138854869|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138854870|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
138854871|NCT04391764|Naltrexone|naltrexone|mesh-list
138854872|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138854873|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138854874|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854875|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
138854876|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854883|NCT04292470|Amitriptyline|amitriptyline|mesh-list
138854884|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138854885|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
138854886|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138854887|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138854888|NCT04292470|Analgesics|analgesics|mesh-ancestor
138854889|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
138854890|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854891|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854892|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138854893|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138854894|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138854895|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854896|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
138854897|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854898|NCT04208334|Curcumin|curcumin|mesh-list
138854900|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138854901|NCT04208334|Analgesics|analgesics|mesh-ancestor
138854902|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
138854903|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854904|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854905|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138854906|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138854907|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854908|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854909|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854910|NCT04073797|Colchicine|colchicine|mesh-list
138854911|NCT04073797|Gout Suppressants|gout suppressants|mesh-ancestor
138854912|NCT04073797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138854913|NCT04073797|Tubulin Modulators|tubulin modulators|mesh-ancestor
138854914|NCT04073797|Antimitotic Agents|antimitotic agents|mesh-ancestor
138854915|NCT04073797|Mitosis Modulators|mitosis modulators|mesh-ancestor
138854916|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854917|NCT04073797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854918|NCT04027309|Midostaurin|midostaurin|mesh-list
138854919|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854920|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138854921|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018344|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138854922|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854924|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138854925|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
138854926|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138854927|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854928|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
138854929|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138854930|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854931|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854932|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138854933|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138854934|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138854935|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138854936|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138854937|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138854938|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
138854939|NCT03958565|Denosumab|denosumab|mesh-list
138506964|NCT00053911|Anastrozole|anastrozole|mesh-list
138854940|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138854941|NCT03958565|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138854942|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138854943|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138854944|NCT03958565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138854945|NCT03958565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854946|NCT03958565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854948|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138854949|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854950|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138854951|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854952|NCT03752398|Ipilimumab|ipilimumab|mesh-list
138854953|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138854954|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854955|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138854956|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854958|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
138854959|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854960|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138854961|NCT03734692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138854962|NCT03734692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854963|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
138854964|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854965|NCT03700476|Gemcitabine|gemcitabine|mesh-list
138854966|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854967|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138854968|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
138854969|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854970|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
138854971|NCT03644667|Prednisone|prednisone|mesh-list
138854972|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
138854973|NCT03644667|Tacrolimus|tacrolimus|mesh-list
138854974|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138854975|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138854976|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
138854977|NCT03644667|Hormones|hormones|mesh-ancestor
138854978|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138854979|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139018360|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
138854980|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138854981|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854982|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138854983|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
138854984|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138854985|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854986|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138854987|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138854988|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
138854989|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138854990|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138854991|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
138854992|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
138854993|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138854994|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138854995|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138854996|NCT03644667|Protective Agents|protective agents|mesh-ancestor
138854997|NCT03330106|Paclitaxel|paclitaxel|mesh-list
138854998|NCT03330106|Docetaxel|docetaxel|mesh-list
138854999|NCT03330106|Carboplatin|carboplatin|mesh-list
138855000|NCT03330106|Pevonedistat|pevonedistat|mesh-list
138855001|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138855002|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855003|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
138855004|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
138855005|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
138855006|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855007|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855008|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
138855009|NCT03239145|Trebananib|trebananib|mesh-list
138855010|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138855011|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855012|NCT03239145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138507042|NCT00054418|Antacids|antacids|mesh-ancestor
138855013|NCT03239145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855014|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138855015|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138855016|NCT03239145|Growth Substances|growth substances|mesh-ancestor
138855017|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855018|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
138855019|NCT03164564|Tenofovir|tenofovir|mesh-list
138855020|NCT03164564|Emtricitabine|emtricitabine|mesh-list
138855021|NCT03164564|Cabotegravir|cabotegravir|mesh-list
138855022|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
138855023|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855024|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138855025|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138855026|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855027|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855028|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138855029|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138855030|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138855031|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138855033|NCT03070886|Leuprolide|leuprolide|mesh-list
138855034|NCT03070886|Goserelin|goserelin|mesh-list
138855035|NCT03070886|Bicalutamide|bicalutamide|mesh-list
138855036|NCT03070886|Flutamide|flutamide|mesh-list
138855037|NCT03070886|Nilutamide|nilutamide|mesh-list
138855038|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855039|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
138855040|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
138855041|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
138855042|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855043|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138855044|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
138855045|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138855046|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855047|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138855048|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
138855049|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
138855050|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138855051|NCT02987257|Cyclosporine|cyclosporine|mesh-list
138855052|NCT02987257|Etanercept|etanercept|mesh-list
138855053|NCT02987257|Cyclosporins|cyclosporins|mesh-list
138855054|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855055|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855056|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855057|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
138855058|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855059|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
138855060|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855061|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
138855062|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138855063|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138855064|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138855065|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138855066|NCT02987257|Analgesics|analgesics|mesh-ancestor
138855067|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
138855068|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855069|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138855070|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138855071|NCT02896335|Palbociclib|palbociclib|mesh-list
138855072|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139018403|NCT03730194|Melatonin|melatonin|mesh-list
138855073|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138855074|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855075|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855077|NCT02821754|Tremelimumab|tremelimumab|mesh-list
138855078|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138855079|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855080|NCT02781883|Decitabine|decitabine|mesh-list
138855081|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138855082|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
138855083|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855084|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855085|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507121|NCT00055042|Vitamin E|vitamin e|mesh-list
138855086|NCT02617589|Nivolumab|nivolumab|mesh-list
138855087|NCT02617589|Temozolomide|temozolomide|mesh-list
138855088|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138855089|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855090|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138855091|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855092|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138855093|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
138855094|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
138855095|NCT02540707|Mirabegron|mirabegron|mesh-list
138855096|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138855097|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138855098|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
138855099|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855100|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855101|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855102|NCT02540707|Urological Agents|urological agents|mesh-ancestor
138855103|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138855104|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138855105|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138855106|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
138855107|NCT02531932|Carboplatin|carboplatin|mesh-list
138855108|NCT02531932|Everolimus|everolimus|mesh-list
138855109|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855110|NCT02531932|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138855111|NCT02531932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138855112|NCT02531932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855113|NCT02531932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855114|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855115|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
138855116|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855117|NCT02504346|Osimertinib|osimertinib|mesh-list
138855118|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855119|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138855121|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855122|NCT02340169|Desoximetasone|desoximetasone|mesh-list
138855123|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138855124|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
138855125|NCT02340169|Hormones|hormones|mesh-ancestor
138855126|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138855127|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855128|NCT01899326|Desipramine|desipramine|mesh-list
138855129|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855130|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138855131|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
138855132|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138855133|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855134|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855135|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138855136|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138855137|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138855138|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
138855139|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855140|NCT01572480|Dexamethasone|dexamethasone|mesh-list
138855141|NCT01572480|Lenalidomide|lenalidomide|mesh-list
138855142|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138855143|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
138855144|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
138855145|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855146|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855147|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138855148|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
138855149|NCT01572480|Hormones|hormones|mesh-ancestor
138855150|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138855151|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138855152|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855153|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
138855154|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138855155|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138855156|NCT01572480|Growth Substances|growth substances|mesh-ancestor
138855157|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
138855158|NCT01515137|Sulindac|sulindac|mesh-list
138855159|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138855160|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855161|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138855162|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855163|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855164|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138855165|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138855167|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
138855168|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855169|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855170|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138855171|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138855172|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138855173|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
138855174|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855175|NCT01126190|Docetaxel|docetaxel|mesh-list
138855177|NCT01126190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855178|NCT01126190|Tubulin Modulators|tubulin modulators|mesh-ancestor
138855179|NCT01126190|Antimitotic Agents|antimitotic agents|mesh-ancestor
138855180|NCT01126190|Mitosis Modulators|mitosis modulators|mesh-ancestor
138855181|NCT01126190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855182|NCT01126190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138855183|NCT01126190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138855184|NCT01126190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138855185|NCT01126190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855186|NCT00472654|Vitamin D|vitamin d|mesh-list
138855187|NCT00472654|Vitamins|vitamins|mesh-ancestor
138855188|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
138855189|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855190|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138855191|NCT00323037|Carvedilol|carvedilol|mesh-list
138855192|NCT00323037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138855193|NCT00323037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138855194|NCT00323037|Adrenergic Agents|adrenergic agents|mesh-ancestor
138855195|NCT00323037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855196|NCT00323037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855197|NCT00323037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855198|NCT00323037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138855199|NCT00323037|Antioxidants|antioxidants|mesh-ancestor
138855200|NCT00323037|Protective Agents|protective agents|mesh-ancestor
138855201|NCT00323037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138855202|NCT00323037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138855203|NCT00323037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138855204|NCT00323037|Vasodilator Agents|vasodilator agents|mesh-ancestor
138855205|NCT00323037|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138855206|NCT00323037|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138855207|NCT00128297|Pamidronate|pamidronate|mesh-list
138855208|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138855209|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855210|NCT00939185|Azithromycin|azithromycin|mesh-list
138944204|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
138855211|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138855212|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855214|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138855215|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855216|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138855217|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138855218|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138855219|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855220|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
138855221|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855222|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138855223|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
138855224|NCT05165771|Tofacitinib|tofacitinib|mesh-list
138855225|NCT05165771|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138855226|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138855227|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855228|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855229|NCT02730624|Tazobactam|tazobactam|mesh-list
138855230|NCT02730624|Piperacillin|piperacillin|mesh-list
138855231|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138855232|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138855233|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139018475|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
138855234|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138855235|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855236|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855238|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138855239|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855240|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138855241|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138855242|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138855243|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855244|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
138855245|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855246|NCT00925873|Vidarabine|vidarabine|mesh-list
138855247|NCT00925873|Fludarabine|fludarabine|mesh-list
138855248|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
138855249|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855250|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138855251|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
138855252|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855253|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855254|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
138855255|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855256|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
138855257|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855258|NCT00925951|Acetaminophen|acetaminophen|mesh-list
138855259|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138855260|NCT00925951|Analgesics|analgesics|mesh-ancestor
138855261|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
138855262|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855263|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855264|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
138855265|NCT00933205|Tipranavir|tipranavir|mesh-list
138855266|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138855267|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138855268|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
138855269|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855270|NCT02813486|Vaccines|vaccines|mesh-list
138855271|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
138855272|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855273|NCT02739516|Letrozole|letrozole|mesh-list
138855274|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138855275|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855276|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138855277|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138855278|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855279|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855280|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138855281|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
138855282|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138855283|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855284|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138855285|NCT00933283|Methadone|methadone|mesh-list
138855286|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138855287|NCT00933283|Narcotics|narcotics|mesh-ancestor
138855288|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855289|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855290|NCT00933283|Analgesics|analgesics|mesh-ancestor
138855291|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
138855292|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855293|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
138855294|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
138855295|NCT02813018|Ropivacaine|ropivacaine|mesh-list
138855296|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
138855297|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
138855298|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855299|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855300|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
138855301|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855302|NCT02810132|Metformin|metformin|mesh-list
138855303|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138855304|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855305|NCT02734524|Carboplatin|carboplatin|mesh-list
138855306|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855307|NCT04173962|Midazolam|midazolam|mesh-list
138855308|NCT04173962|Ketamine|ketamine|mesh-list
138855309|NCT04173962|Analgesics|analgesics|mesh-ancestor
138855310|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
138855311|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855312|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855313|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138855315|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
138855316|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
138855317|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855318|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138855319|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138855320|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855321|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855322|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138855323|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138855324|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138855325|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139210367|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855326|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138855327|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
138855328|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
138855329|NCT00772005|Modafinil|modafinil|mesh-list
138855330|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138855331|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855332|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138855333|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138855334|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138855335|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855336|NCT04262999|Levetiracetam|levetiracetam|mesh-list
138855337|NCT04262999|Valproic Acid|valproic acid|mesh-list
138855338|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
138855339|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
138855340|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018520|NCT03424005|Immunoconjugates|immunoconjugates|mesh-ancestor
138855341|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855342|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
138855343|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855344|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855345|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
138855346|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138855347|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855348|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138855349|NCT00926107|Sirolimus|sirolimus|mesh-list
138855350|NCT00926107|Temsirolimus|temsirolimus|mesh-list
138855351|NCT00926107|MTOR Inhibitors|mtor inhibitors|mesh-list
138855352|NCT00926107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138855353|NCT00926107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855354|NCT00926107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855355|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855356|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
138855357|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855358|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855359|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138855360|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855361|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138855362|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
138855363|NCT02729766|Empagliflozin|empagliflozin|mesh-list
138855364|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138855365|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855366|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138855367|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855368|NCT02812940|Everolimus|everolimus|mesh-list
138855369|NCT02812940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138855370|NCT02812940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138855371|NCT02812940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855372|NCT02812940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855373|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855374|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
138855375|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855376|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855377|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138855378|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138855379|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138855380|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138855381|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855382|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855383|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855385|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
138855386|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855387|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
138855388|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138855389|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
138855390|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
138855391|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
138855392|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138855393|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855394|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855395|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
138855396|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138855397|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855398|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855399|NCT02809742|Ropivacaine|ropivacaine|mesh-list
138855400|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
138855401|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
138855402|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855404|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
138855405|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855406|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
138855407|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138855408|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
138855409|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855410|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855411|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138855412|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
138855413|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138855414|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138855415|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138855416|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
138855417|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855418|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855419|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
138855420|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855421|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855422|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
138855423|NCT00933517|Docetaxel|docetaxel|mesh-list
138855424|NCT00933517|Panitumumab|panitumumab|mesh-list
138855425|NCT00933517|Epirubicin|epirubicin|mesh-list
138855426|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855427|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
138855428|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855429|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138855430|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138855431|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
138855432|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855433|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855434|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138855435|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
138855436|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
138855437|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
138855438|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138855439|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138855440|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138855441|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138855442|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855443|NCT00926341|Pioglitazone|pioglitazone|mesh-list
138855444|NCT00926341|Telmisartan|telmisartan|mesh-list
138855445|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138855446|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855447|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138855448|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138855449|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138855450|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855451|NCT00926419|Vaccines|vaccines|mesh-list
138855452|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
138855453|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855454|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
138855455|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138855456|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855457|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855458|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138855460|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
138855461|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855462|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138855463|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138855464|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138855465|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
138855466|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855467|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855468|NCT02739204|Celecoxib|celecoxib|mesh-list
138855469|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138855470|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138855471|NCT02739204|Analgesics|analgesics|mesh-ancestor
139210368|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138855472|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
138855473|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855474|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855475|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138855476|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138855477|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138855478|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138855479|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855480|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855481|NCT00927485|Curcumin|curcumin|mesh-list
138855482|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138855483|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138855484|NCT00927485|Analgesics|analgesics|mesh-ancestor
138855485|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
138855486|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855487|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855488|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138855489|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138855490|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855491|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944292|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
138855492|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855493|NCT00926653|Escitalopram|escitalopram|mesh-list
138855494|NCT00926653|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138855495|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138855496|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138855497|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855498|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855499|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
138855500|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855501|NCT02733822|Naloxone|naloxone|mesh-list
138855502|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138855503|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855504|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
138855505|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855506|NCT00930241|Tacrolimus|tacrolimus|mesh-list
138855507|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855508|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
138855509|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855510|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138855511|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855512|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855513|NCT04260269|Trifluridine|trifluridine|mesh-list
138855514|NCT04260269|Capecitabine|capecitabine|mesh-list
138855515|NCT04260269|Fluorouracil|fluorouracil|mesh-list
138855516|NCT04260269|Tegafur|tegafur|mesh-list
138855517|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138855518|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
138855519|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855520|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855521|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855522|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
138855523|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855524|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
138855525|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855526|NCT02738970|Trastuzumab|trastuzumab|mesh-list
138855527|NCT02738970|Pertuzumab|pertuzumab|mesh-list
138855528|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138855529|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855530|NCT00926731|Cytarabine|cytarabine|mesh-list
138855531|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138855532|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
138855533|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855534|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855535|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
138855536|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855537|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855538|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
138855539|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855540|NCT00926809|Amoxicillin|amoxicillin|mesh-list
138855541|NCT00926809|Clarithromycin|clarithromycin|mesh-list
138855542|NCT00926809|Lansoprazole|lansoprazole|mesh-list
138855543|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
138855544|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138855545|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138855546|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855547|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138855548|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855549|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855550|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138855551|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138855552|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138855553|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138855554|NCT02805920|Bupivacaine|bupivacaine|mesh-list
138855555|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
138855556|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
138855557|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855558|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855559|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
138855560|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855561|NCT04262765|Amlodipine|amlodipine|mesh-list
138855562|NCT04262765|Ramipril|ramipril|mesh-list
138855563|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
138855564|NCT04262765|Atorvastatin|atorvastatin|mesh-list
138855565|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138855566|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138855567|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
138855568|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139018587|NCT03054896|Venetoclax|venetoclax|mesh-list
138855569|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138855570|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138855571|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855572|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138855573|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138855574|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138855575|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138855576|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855577|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
138855578|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138855579|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
138855580|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
138855581|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138855582|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138855583|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138855584|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138855585|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855586|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
138855587|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855588|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855589|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138855590|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855591|NCT02738814|Propofol|propofol|mesh-list
138855592|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138855593|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855594|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855595|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138855596|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
138855597|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
138855598|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138855599|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138855600|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855601|NCT02729064|Insulin|insulin|mesh-list
138855602|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138855603|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138855604|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855605|NCT00609401|Sorafenib|sorafenib|mesh-list
138855606|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855607|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138855608|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855609|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855610|NCT02805842|Tacrolimus|tacrolimus|mesh-list
138855611|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855612|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
138855613|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855614|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138855615|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855616|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855617|NCT00926965|Olanzapine|olanzapine|mesh-list
138855618|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
138855619|NCT00926965|Amisulpride|amisulpride|mesh-list
138855620|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
138855621|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
138855622|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855623|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855624|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138855625|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138855626|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855627|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138855628|NCT00926965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138855629|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138855630|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138855631|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855632|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855633|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
138855634|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138855635|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
138855636|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138855637|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
138855638|NCT04260113|Apatinib|apatinib|mesh-list
138855639|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855640|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138855641|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855642|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855643|NCT02738658|Everolimus|everolimus|mesh-list
138855644|NCT02738658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138855645|NCT02738658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138855646|NCT02738658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855647|NCT02738658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855648|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855649|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
138855650|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855651|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855652|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
138855653|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138855654|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138855655|NCT02733510|Prednisolone|prednisolone|mesh-list
138855656|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
138855657|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138855658|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
138855659|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138855660|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
138855661|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
138855662|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855663|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855664|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138855665|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
138855666|NCT02733510|Hormones|hormones|mesh-ancestor
138855667|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138855668|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138855669|NCT02733510|Protective Agents|protective agents|mesh-ancestor
138855670|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138855671|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855672|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138855673|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138855674|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855675|NCT00933985|Doxorubicin|doxorubicin|mesh-list
138855676|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138855677|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
138855678|NCT00933985|Vincristine|vincristine|mesh-list
138855679|NCT00933985|Razoxane|razoxane|mesh-list
138855680|NCT00933985|Obatoclax|obatoclax|mesh-list
138855681|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138855682|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855683|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138855684|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138855685|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855686|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855687|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138855688|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
138855689|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
138855690|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
138855691|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138855692|NCT00933985|Protective Agents|protective agents|mesh-ancestor
138855693|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855694|NCT02812394|Levodopa|levodopa|mesh-list
138855695|NCT02812394|Carbidopa|carbidopa|mesh-list
139210369|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139018667|NCT02583672|Antidotes|antidotes|mesh-ancestor
138855696|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138855698|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138855699|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
138855700|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855701|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855702|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855703|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138855704|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855705|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138855706|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
138944375|NCT00924586|Landiolol|landiolol|mesh-list
138855707|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
138855708|NCT00930475|Carboplatin|carboplatin|mesh-list
138855709|NCT00930475|Everolimus|everolimus|mesh-list
138855710|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855711|NCT00930475|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138855712|NCT00930475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138855713|NCT00930475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855714|NCT00930475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855715|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855716|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
138855717|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855718|NCT05623592|Methotrexate|methotrexate|mesh-list
138855719|NCT05623592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138855720|NCT05623592|Abortifacient Agents|abortifacient agents|mesh-ancestor
138855721|NCT05623592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138855722|NCT05623592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855723|NCT05623592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138855724|NCT05623592|Antimetabolites|antimetabolites|mesh-ancestor
138855725|NCT05623592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855726|NCT05623592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855727|NCT05623592|Dermatologic Agents|dermatologic agents|mesh-ancestor
138855728|NCT05623592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855729|NCT05623592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138855730|NCT05623592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855731|NCT05623592|Immunologic Factors|immunologic factors|mesh-ancestor
138855732|NCT05623592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138855733|NCT05623592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138855734|NCT02728518|Amikacin|amikacin|mesh-list
138855735|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138855736|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855737|NCT00634400|Candesartan|candesartan|mesh-list
138855738|NCT00634400|Candesartan cilexetil|candesartan cilexetil|mesh-list
138855739|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138855740|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138855741|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138855742|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855743|NCT04262375|Durvalumab|durvalumab|mesh-list
138855744|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138855745|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855746|NCT00936793|Ritonavir|ritonavir|mesh-list
138855747|NCT00936793|Darunavir|darunavir|mesh-list
138855748|NCT00936793|Beclomethasone|beclomethasone|mesh-list
138855749|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138855750|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138855751|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
138944395|NCT00924742|Tazobactam|tazobactam|mesh-list
138855752|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855753|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855754|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138855755|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138855756|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
138855757|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855758|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138855759|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138855760|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138855761|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
138855762|NCT00936793|Hormones|hormones|mesh-ancestor
138855763|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138855764|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855765|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138855766|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
138855767|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
138855768|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138855769|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138855770|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
138855771|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855772|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855773|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855774|NCT02805452|Urological Agents|urological agents|mesh-ancestor
138855775|NCT00937027|Aminopterin|aminopterin|mesh-list
138855776|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138855777|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855778|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855780|NCT02738502|Darunavir|darunavir|mesh-list
138855781|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138855782|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138855783|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
138855784|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855785|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855786|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138855787|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138855788|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
138855789|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855790|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138855791|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138855792|NCT04261907|Ritonavir|ritonavir|mesh-list
138855793|NCT04261907|Lopinavir|lopinavir|mesh-list
138855794|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138855795|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138855796|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
138855797|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855798|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855799|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138855800|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138855801|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
138855802|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855803|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138855804|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138855805|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
138855806|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138855807|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138855808|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138855809|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138855810|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855811|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
138944417|NCT00906724|Insulin|insulin|mesh-list
138855812|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855813|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855814|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138855815|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855816|NCT02738346|Carboplatin|carboplatin|mesh-list
138855817|NCT02738346|Etoposide|etoposide|mesh-list
138855818|NCT02738346|Topotecan|topotecan|mesh-list
138855819|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855820|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138855821|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138855822|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138855823|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855824|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855825|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138855826|NCT00932165|Exemestane|exemestane|mesh-list
138855827|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855828|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138855829|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138855830|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855831|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855832|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138855833|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
138855834|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138855835|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855836|NCT00937183|Vaccines|vaccines|mesh-list
138855837|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
138855838|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855839|NCT00937261|Risperidone|risperidone|mesh-list
138855840|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138855841|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138855842|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
138855843|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855844|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855845|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855846|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138855847|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138855848|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855849|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138855850|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138855852|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138855853|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138855854|NCT05906433|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138855855|NCT05906433|Triamcinolone|triamcinolone|mesh-list
138855856|NCT05906433|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138855857|NCT05906433|Bupivacaine|bupivacaine|mesh-list
138855858|NCT05906433|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138855859|NCT05906433|Anesthetics, Local|anesthetics, local|mesh-ancestor
138855860|NCT05906433|Anesthetics|anesthetics|mesh-ancestor
139018817|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
138855862|NCT05906433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855863|NCT05906433|Sensory System Agents|sensory system agents|mesh-ancestor
138855864|NCT05906433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855865|NCT05906433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138855866|NCT05906433|Glucocorticoids|glucocorticoids|mesh-ancestor
138855867|NCT05906433|Hormones|hormones|mesh-ancestor
138855868|NCT05906433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138855869|NCT05906433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138855870|NCT05906433|Immunologic Factors|immunologic factors|mesh-ancestor
138855871|NCT05906433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944426|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
138855872|NCT05906433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855873|NCT05906225|Anesthetics|anesthetics|mesh-list
138855874|NCT05906225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855875|NCT05906225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855876|NCT05906199|Aspirin|aspirin|mesh-list
138855877|NCT05906199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138855878|NCT05906199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138855879|NCT05906199|Analgesics|analgesics|mesh-ancestor
138855880|NCT05906199|Sensory System Agents|sensory system agents|mesh-ancestor
138855881|NCT05906199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855882|NCT05906199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855883|NCT05906199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138855884|NCT05906199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138855885|NCT05906199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138855886|NCT05906199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138855887|NCT05906199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855888|NCT05906199|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138855889|NCT05906199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138855890|NCT05906199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855891|NCT05906199|Antipyretics|antipyretics|mesh-ancestor
138855892|NCT05905965|Empagliflozin|empagliflozin|mesh-list
138855893|NCT05905965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138855894|NCT05905965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855895|NCT05905965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138855896|NCT05905965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855897|NCT05905913|Meropenem|meropenem|mesh-list
138855898|NCT05905913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138855899|NCT05905913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855900|NCT05905887|Paclitaxel|paclitaxel|mesh-list
138855901|NCT05905887|Apatinib|apatinib|mesh-list
138855902|NCT05905887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138855903|NCT05905887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855904|NCT05905887|Tubulin Modulators|tubulin modulators|mesh-ancestor
138855905|NCT05905887|Antimitotic Agents|antimitotic agents|mesh-ancestor
138855906|NCT05905887|Mitosis Modulators|mitosis modulators|mesh-ancestor
138855907|NCT05905887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855908|NCT05905887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138855909|NCT05905887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855910|NCT05905757|Tramadol|tramadol|mesh-list
138855911|NCT05905757|Dexmedetomidine|dexmedetomidine|mesh-list
138855912|NCT05905757|Bupivacaine|bupivacaine|mesh-list
138855913|NCT05905757|Anesthetics, Local|anesthetics, local|mesh-ancestor
138855915|NCT05905757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855916|NCT05905757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855917|NCT05905757|Sensory System Agents|sensory system agents|mesh-ancestor
138855918|NCT05905757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855919|NCT05905757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138855920|NCT05905757|Narcotics|narcotics|mesh-ancestor
138855921|NCT05905757|Analgesics|analgesics|mesh-ancestor
138855922|NCT05905757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138855923|NCT05905757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138855924|NCT05905757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138855925|NCT05905757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138855926|NCT05905757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138855927|NCT05905757|Adrenergic Agents|adrenergic agents|mesh-ancestor
138855928|NCT05905757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855929|NCT05905757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855930|NCT05905653|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138855931|NCT05905653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138855932|NCT05905484|Moxifloxacin|moxifloxacin|mesh-list
138855933|NCT05905484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138855934|NCT05905484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138855935|NCT05905484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138855936|NCT05905484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138855937|NCT05905484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138855938|NCT05905484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855939|NCT05905484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855940|NCT05905315|Paclitaxel|paclitaxel|mesh-list
138855941|NCT05905315|Carboplatin|carboplatin|mesh-list
138855942|NCT05905315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138855943|NCT05905315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855944|NCT05905315|Tubulin Modulators|tubulin modulators|mesh-ancestor
138855945|NCT05905315|Antimitotic Agents|antimitotic agents|mesh-ancestor
138855946|NCT05905315|Mitosis Modulators|mitosis modulators|mesh-ancestor
138855947|NCT05905315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855948|NCT05905185|Vitamin E|vitamin e|mesh-list
138855949|NCT05905185|Tocopherols|tocopherols|mesh-list
138855950|NCT05905185|Tocotrienols|tocotrienols|mesh-list
138855951|NCT05905185|Vitamins|vitamins|mesh-ancestor
138855952|NCT05905185|Micronutrients|micronutrients|mesh-ancestor
138855953|NCT05905185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855954|NCT05905185|Antioxidants|antioxidants|mesh-ancestor
138855955|NCT05905185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855956|NCT05905185|Protective Agents|protective agents|mesh-ancestor
138855957|NCT05843565|Cobalt|cobalt|mesh-list
138855958|NCT05843565|Trace Elements|trace elements|mesh-ancestor
138855959|NCT05843565|Micronutrients|micronutrients|mesh-ancestor
138855960|NCT05843565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855961|NCT05838703|Bromides|bromides|mesh-list
138855962|NCT05838703|Tiotropium Bromide|tiotropium bromide|mesh-list
138855963|NCT05838703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138855964|NCT05838703|Autonomic Agents|autonomic agents|mesh-ancestor
138855965|NCT05838703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855966|NCT05838703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855967|NCT05838703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138855968|NCT05838703|Respiratory System Agents|respiratory system agents|mesh-ancestor
138855969|NCT05838703|Parasympatholytics|parasympatholytics|mesh-ancestor
138855970|NCT05838703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138855971|NCT05838703|Cholinergic Agents|cholinergic agents|mesh-ancestor
138855972|NCT05838703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138855973|NCT05838703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138855975|NCT05807048|Daratumumab|daratumumab|mesh-list
138855976|NCT05807048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855977|NCT05789992|Remifentanil|remifentanil|mesh-list
138855998|NCT05720325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138855999|NCT05720325|Immunologic Factors|immunologic factors|mesh-ancestor
138856000|NCT05720325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856001|NCT05701501|Pantothenic Acid|pantothenic acid|mesh-list
138856002|NCT05701501|Vitamins|vitamins|mesh-ancestor
138856003|NCT05701501|Micronutrients|micronutrients|mesh-ancestor
138856004|NCT05701501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856005|NCT05701501|Vitamin B Complex|vitamin b complex|mesh-ancestor
138856006|NCT05700812|Levonorgestrel|levonorgestrel|mesh-list
138856007|NCT05700812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138856008|NCT05700812|Contraceptive Agents|contraceptive agents|mesh-ancestor
138856009|NCT05700812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138856010|NCT05700812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856011|NCT05700812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138856012|NCT05700812|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138856013|NCT05700812|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138856014|NCT05681273|Empagliflozin|empagliflozin|mesh-list
138856016|NCT05681273|Atorvastatin|atorvastatin|mesh-list
138856017|NCT05681273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138856018|NCT05681273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138856019|NCT05681273|Antimetabolites|antimetabolites|mesh-ancestor
138856020|NCT05681273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856021|NCT05681273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138856022|NCT05681273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138856023|NCT05681273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856024|NCT05681273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138856025|NCT05681273|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138856026|NCT05681273|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138856027|NCT05681273|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138856028|NCT05681273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138856029|NCT05681273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856031|NCT05656742|Vitamins|vitamins|mesh-ancestor
138856032|NCT05656742|Micronutrients|micronutrients|mesh-ancestor
138856033|NCT05656742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856034|NCT05656742|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138856035|NCT05538767|Albendazole|albendazole|mesh-list
138856036|NCT05538767|Emodepside|emodepside|mesh-list
138856037|NCT05538767|Anthelmintics|anthelmintics|mesh-ancestor
138856038|NCT05538767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138856039|NCT05538767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138856040|NCT05538767|Anticestodal Agents|anticestodal agents|mesh-ancestor
138856041|NCT05538767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138856042|NCT05538767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138856043|NCT05538767|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856044|NCT05538767|Antimitotic Agents|antimitotic agents|mesh-ancestor
138856045|NCT05538767|Mitosis Modulators|mitosis modulators|mesh-ancestor
138856046|NCT05538767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856047|NCT05538767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856048|NCT05524168|Gemcitabine|gemcitabine|mesh-list
138856049|NCT05524168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856050|NCT05524168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138856051|NCT05524168|Antimetabolites|antimetabolites|mesh-ancestor
138856052|NCT05524168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856053|NCT05464420|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138856054|NCT05464420|Immunologic Factors|immunologic factors|mesh-ancestor
138856055|NCT05464420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856056|NCT05431582|Bevacizumab|bevacizumab|mesh-list
138856057|NCT05431582|Pembrolizumab|pembrolizumab|mesh-list
138856058|NCT05431582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856059|NCT05431582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856060|NCT05431582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138856061|NCT05431582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138856062|NCT05431582|Growth Substances|growth substances|mesh-ancestor
138856063|NCT05431582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856064|NCT05431582|Growth Inhibitors|growth inhibitors|mesh-ancestor
138856065|NCT05431582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138856066|NCT05431582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856067|NCT05412030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138856068|NCT05412030|Immunologic Factors|immunologic factors|mesh-ancestor
138856069|NCT05412030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856070|NCT05384756|Sirolimus|sirolimus|mesh-list
138856071|NCT05384756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138856072|NCT05384756|Alemtuzumab|alemtuzumab|mesh-list
138856073|NCT05384756|Antibodies|antibodies|mesh-list
138856074|NCT05384756|Immunoglobulins|immunoglobulins|mesh-list
138856075|NCT05384756|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138856076|NCT05384756|Immunologic Factors|immunologic factors|mesh-ancestor
138856077|NCT05384756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856078|NCT05384756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856079|NCT05384756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138856080|NCT05384756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138856081|NCT05384756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138856082|NCT05384756|Antifungal Agents|antifungal agents|mesh-ancestor
138856083|NCT05384756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138856084|NCT05364866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138856085|NCT05331027|Sevoflurane|sevoflurane|mesh-list
138856086|NCT05331027|Desflurane|desflurane|mesh-list
138856087|NCT05331027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138599299|NCT05469529|Analgesics|analgesics|mesh-ancestor
138856089|NCT05331027|Anesthetics, General|anesthetics, general|mesh-ancestor
138856090|NCT05331027|Anesthetics|anesthetics|mesh-ancestor
138856091|NCT05331027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138856092|NCT05331027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856093|NCT05299242|Adalimumab|adalimumab|mesh-list
138856094|NCT05299242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138856095|NCT05299242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138856096|NCT05299242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856097|NCT05282706|Peppermint oil|peppermint oil|mesh-list
138856098|NCT05282706|Antiemetics|antiemetics|mesh-ancestor
138856099|NCT05282706|Autonomic Agents|autonomic agents|mesh-ancestor
138856100|NCT05282706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138856101|NCT05282706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856102|NCT05282706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138856103|NCT05282706|Parasympatholytics|parasympatholytics|mesh-ancestor
138856104|NCT05222984|Decitabine|decitabine|mesh-list
138856105|NCT05222984|Venetoclax|venetoclax|mesh-list
138856106|NCT05222984|Navitoclax|navitoclax|mesh-list
138856107|NCT05222984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138856108|NCT05222984|Antimetabolites|antimetabolites|mesh-ancestor
138856109|NCT05222984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856110|NCT05222984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856111|NCT05222984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856112|NCT05177848|Nicotine|nicotine|mesh-list
138856113|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138856114|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
138856115|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138856116|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856117|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138856118|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138856119|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
138856120|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138856121|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856122|NCT05169008|Vaccines|vaccines|mesh-list
138856123|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
138856124|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856125|NCT05059860|Insulin|insulin|mesh-list
138856126|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138856127|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856128|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
138856129|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138856130|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138856131|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
138856132|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856133|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
138856134|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856135|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856136|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138856137|NCT04537156|Vaccines|vaccines|mesh-list
138856138|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
138856139|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856140|NCT04465318|Nicotine|nicotine|mesh-list
138856141|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138856142|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
138856143|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138856144|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856145|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138856146|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138856147|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
138856148|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138856149|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856150|NCT04462523|Prednisolone|prednisolone|mesh-list
138856151|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138856152|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
138856153|NCT04462523|Hormones|hormones|mesh-ancestor
138856154|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138856155|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856156|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138856157|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856158|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
138856159|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138856160|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138856161|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
138856162|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599376|NCT00156689|Levetiracetam|levetiracetam|mesh-list
138944539|NCT00396409|Omalizumab|omalizumab|mesh-list
138856163|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856164|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856165|NCT04437108|Urological Agents|urological agents|mesh-ancestor
138856166|NCT04395079|Durvalumab|durvalumab|mesh-list
138856167|NCT04395079|Ipilimumab|ipilimumab|mesh-list
138856168|NCT04395079|Tremelimumab|tremelimumab|mesh-list
138856169|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
138856170|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138856171|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
138856172|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856173|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856174|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
138856175|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856176|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138856177|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856178|NCT04391309|Remdesivir|remdesivir|mesh-list
138856179|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
138856180|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856181|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
138856182|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138856183|NCT04356690|Etoposide|etoposide|mesh-list
138856184|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138856185|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856186|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138508236|NCT06183437|Tin Fluorides|tin fluorides|mesh-list
138856187|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138856188|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856189|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856190|NCT04352205|Thalidomide|thalidomide|mesh-list
138856191|NCT04352205|Dexamethasone|dexamethasone|mesh-list
138856192|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
138856193|NCT04352205|Lenalidomide|lenalidomide|mesh-list
138856195|NCT04352205|Daratumumab|daratumumab|mesh-list
138856196|NCT04352205|Ichthammol|ichthammol|mesh-list
138856197|NCT04352205|BB 1101|bb 1101|mesh-list
138856198|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138856199|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
138856200|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
138856201|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138856202|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856203|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138856204|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
138856205|NCT04352205|Hormones|hormones|mesh-ancestor
138856206|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138856207|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138856208|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856209|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
138856210|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856211|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856212|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
138856213|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138856214|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138856215|NCT04352205|Growth Substances|growth substances|mesh-ancestor
138856216|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
138944552|NCT00925912|Bupivacaine|bupivacaine|mesh-list
138856217|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138856218|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
138856219|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138856220|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138856221|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
138856222|NCT04339140|Zafirlukast|zafirlukast|mesh-list
138856223|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138856224|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
138856225|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138856226|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
138856227|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138856228|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856229|NCT04337827|Rituximab|rituximab|mesh-list
138856230|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
138856231|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139018986|NCT06040034|Lidocaine|lidocaine|mesh-list
138856232|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856233|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
138856234|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856235|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856236|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
138856237|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856238|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856239|NCT04251117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210370|NCT03515837|Carboplatin|carboplatin|mesh-list
138856240|NCT04251117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856241|NCT04221529|Atezolizumab|atezolizumab|mesh-list
138856242|NCT04221529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138856243|NCT04221529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856244|NCT04221529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856245|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856246|NCT04219774|Aspirin|aspirin|mesh-list
138856247|NCT04219774|Clopidogrel|clopidogrel|mesh-list
138856248|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138856249|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138856250|NCT04219774|Analgesics|analgesics|mesh-ancestor
138856251|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
138856252|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138856253|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856254|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138856255|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856256|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138856257|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138856258|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856259|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138856260|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138856261|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856263|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138856264|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138856265|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138856266|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
138856267|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138856268|NCT04195139|Nivolumab|nivolumab|mesh-list
138856269|NCT04195139|Temozolomide|temozolomide|mesh-list
138856270|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856271|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856272|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138856273|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856274|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138856275|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
138856276|NCT04174352|Tamoxifen|tamoxifen|mesh-list
138856277|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138856278|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
138856279|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138856280|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856281|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138856282|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856283|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139019022|NCT05970731|Hormones|hormones|mesh-ancestor
138856284|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138856285|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138856286|NCT04150289|Panobinostat|panobinostat|mesh-list
138856287|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856288|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138856289|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856290|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856291|NCT04136756|Rituximab|rituximab|mesh-list
138856292|NCT04136756|Daratumumab|daratumumab|mesh-list
138856293|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856294|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856295|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
138856296|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856297|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856298|NCT04056624|Carotenoids|carotenoids|mesh-list
138856299|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
138856300|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856301|NCT04056624|Protective Agents|protective agents|mesh-ancestor
138856302|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856303|NCT04052880|Dexamethasone|dexamethasone|mesh-list
138856304|NCT04052880|Lenalidomide|lenalidomide|mesh-list
138856305|NCT04052880|Bortezomib|bortezomib|mesh-list
138856306|NCT04052880|Daratumumab|daratumumab|mesh-list
138856307|NCT04052880|Ixazomib|ixazomib|mesh-list
138856308|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138856309|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
138856310|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
138856311|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138856312|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856313|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139210371|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
138856314|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
138856316|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138856317|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138856318|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856319|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
138856320|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138856321|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138856322|NCT04052880|Growth Substances|growth substances|mesh-ancestor
138856323|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
138856324|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
138856325|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856326|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856327|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138856328|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138856329|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138856330|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138856331|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138856332|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138856333|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139019038|NCT05855577|Terazosin|terazosin|mesh-list
138856335|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138856336|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856337|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856339|NCT03900715|Hematinics|hematinics|mesh-ancestor
138856340|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138856341|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
138856342|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138856343|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
138856344|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856345|NCT03858231|Acetaminophen|acetaminophen|mesh-list
138856346|NCT03858231|Ibuprofen|ibuprofen|mesh-list
138856347|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138856348|NCT03858231|Analgesics|analgesics|mesh-ancestor
138856349|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
138856350|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138856351|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856352|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
138856353|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138856354|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138856355|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856356|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138856357|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856358|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856359|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
138856360|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138856361|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
138856362|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
138856363|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138856364|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856365|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
138856366|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856367|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
138856368|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856369|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856370|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138856371|NCT03728556|Antibodies|antibodies|mesh-list
138856372|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138856373|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
138856374|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856376|NCT03634228|Venetoclax|venetoclax|mesh-list
138856377|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138856378|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
138856379|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856380|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856381|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
138856382|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138856383|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138856384|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
138856385|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856386|NCT03612973|Insulin|insulin|mesh-list
138856387|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138856388|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856389|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
138856390|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856391|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856392|NCT03603223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138856393|NCT03603223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856394|NCT03587142|Buspirone|buspirone|mesh-list
138856395|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138856396|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138856397|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138856398|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856399|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138856400|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138856401|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
138944653|NCT00746070|Diuretics|diuretics|mesh-ancestor
138856402|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138856403|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856404|NCT03532139|Enoxaparin|enoxaparin|mesh-list
138856405|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
138856406|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138856407|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138856408|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138856409|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
138856410|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856411|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138856412|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138856413|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856414|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
138856415|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138856416|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138856417|NCT03509584|Nivolumab|nivolumab|mesh-list
138856418|NCT03509584|Ipilimumab|ipilimumab|mesh-list
138856419|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856420|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856421|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138856422|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856423|NCT03493854|Paclitaxel|paclitaxel|mesh-list
138856424|NCT03493854|Docetaxel|docetaxel|mesh-list
138856425|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
138856426|NCT03493854|Doxorubicin|doxorubicin|mesh-list
138856427|NCT03493854|Trastuzumab|trastuzumab|mesh-list
138856428|NCT03493854|Pertuzumab|pertuzumab|mesh-list
138856429|NCT03493854|Hormones|hormones|mesh-list
138856430|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138856431|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856432|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856433|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
138856434|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
138856435|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856436|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138856437|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
138856438|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856439|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856440|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138856441|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
138856442|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138856443|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138856444|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138856445|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138856446|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856447|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138788018|NCT02683564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138856448|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138856449|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
138856450|NCT03384277|Rituximab|rituximab|mesh-list
138856451|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138856452|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
138856453|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856454|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856455|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138856456|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
138856457|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856458|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856459|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138856460|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856461|NCT03370367|Tretinoin|tretinoin|mesh-list
138856462|NCT03370367|Isotretinoin|isotretinoin|mesh-list
138856463|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856464|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
138856465|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
138856466|NCT03317457|Doxorubicin|doxorubicin|mesh-list
138856468|NCT03317457|Tremelimumab|tremelimumab|mesh-list
138856469|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138856470|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856471|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138856472|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138856473|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856474|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856475|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856476|NCT03267836|Avelumab|avelumab|mesh-list
138856477|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856478|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856479|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
138856480|NCT03197506|Temozolomide|temozolomide|mesh-list
138856481|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856482|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856483|NCT03197506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138856484|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856485|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138856486|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
138856487|NCT03188705|Aspirin|aspirin|mesh-list
138856488|NCT03188705|Clopidogrel|clopidogrel|mesh-list
138856489|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138856490|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138856491|NCT03188705|Analgesics|analgesics|mesh-ancestor
138856492|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
138856493|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138856494|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856495|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138856496|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856497|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138856498|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138856499|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856500|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138856501|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138856502|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856503|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
138856504|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138856505|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138856506|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138856507|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
138856508|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138856509|NCT03032484|Bevacizumab|bevacizumab|mesh-list
138856510|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856511|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856512|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138856513|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138856514|NCT03032484|Growth Substances|growth substances|mesh-ancestor
138856515|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856516|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
138856517|NCT03003546|Paclitaxel|paclitaxel|mesh-list
138856518|NCT03003546|Rituximab|rituximab|mesh-list
138856519|NCT03003546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138856520|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138856521|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856522|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856523|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
138856525|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856526|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856527|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
138856528|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856529|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856530|NCT02996825|Gemcitabine|gemcitabine|mesh-list
138856531|NCT02996825|Maytansine|maytansine|mesh-list
138856532|NCT02996825|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
138856533|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138856534|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
138856535|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856536|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856537|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138632102|NCT00268593|Hormones|hormones|mesh-ancestor
138856538|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856539|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
138856540|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
138856541|NCT02996825|Immunoconjugates|immunoconjugates|mesh-ancestor
138856542|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
138856543|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856544|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138856545|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
138856546|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138856547|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
138856548|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856549|NCT02955394|Fulvestrant|fulvestrant|mesh-list
138856550|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138856551|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856552|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138856553|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138856554|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
138856555|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138856556|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856557|NCT02768532|Vedolizumab|vedolizumab|mesh-list
138856558|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138856559|NCT02710851|Vaccines|vaccines|mesh-list
138856560|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
138856561|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856563|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138856564|NCT02675829|Maytansine|maytansine|mesh-list
138856565|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856566|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856567|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138856568|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856569|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
138856570|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
138856571|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856572|NCT02675829|Immunotoxins|immunotoxins|mesh-ancestor
138856573|NCT02675829|Immunoconjugates|immunoconjugates|mesh-ancestor
138856574|NCT02675829|Immunologic Factors|immunologic factors|mesh-ancestor
138856575|NCT02675829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856576|NCT02554851|Mitogens|mitogens|mesh-list
138856577|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
138856578|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856579|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138856580|NCT02520141|Ramucirumab|ramucirumab|mesh-list
138856581|NCT02520141|Antibodies|antibodies|mesh-list
138856582|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
138856583|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138856584|NCT02520141|Lexatumumab|lexatumumab|mesh-list
138856585|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
138856586|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856587|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856588|NCT02513875|Vitamin D|vitamin d|mesh-list
138856589|NCT02513875|Vitamins|vitamins|mesh-ancestor
138856590|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
138856591|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856592|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138856593|NCT02329847|Nivolumab|nivolumab|mesh-list
138856594|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856595|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856596|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138856597|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856598|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
138856599|NCT02287428|Temozolomide|temozolomide|mesh-list
138856600|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856601|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856602|NCT02287428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138856603|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856604|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138856605|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
138856606|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138856607|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
138856608|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856609|NCT02192359|Irinotecan|irinotecan|mesh-list
138856610|NCT02192359|Camptothecin|camptothecin|mesh-list
138856611|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138856612|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138856613|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210372|NCT03515837|Pemetrexed|pemetrexed|mesh-list
139210373|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138856614|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856615|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856616|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138856617|NCT02145143|Vemurafenib|vemurafenib|mesh-list
138856618|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856619|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138856620|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856621|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856622|NCT02119468|Dexamethasone|dexamethasone|mesh-list
138856623|NCT02119468|Pomalidomide|pomalidomide|mesh-list
138856624|NCT02119468|Ixazomib|ixazomib|mesh-list
138856625|NCT02119468|Glycine|glycine|mesh-list
138856626|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
138856627|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138856628|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
138856629|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
138856630|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138856631|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856632|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138856633|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
138856634|NCT02119468|Hormones|hormones|mesh-ancestor
138856635|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138856636|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138856637|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856638|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856639|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
138856640|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138856641|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138856642|NCT02119468|Growth Substances|growth substances|mesh-ancestor
138856643|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
138856644|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
138856645|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856646|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
138856647|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138856648|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138856649|NCT01935921|Cetuximab|cetuximab|mesh-list
138856650|NCT01935921|Ipilimumab|ipilimumab|mesh-list
138856651|NCT01935921|Antibodies|antibodies|mesh-list
138856652|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
138856653|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138856654|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
138856655|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856656|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856657|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138856658|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856659|NCT01552434|Sirolimus|sirolimus|mesh-list
138856660|NCT01552434|Bevacizumab|bevacizumab|mesh-list
138856661|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138856662|NCT01552434|Cetuximab|cetuximab|mesh-list
138856663|NCT01552434|Temsirolimus|temsirolimus|mesh-list
138856664|NCT01552434|MTOR Inhibitors|mtor inhibitors|mesh-list
138856665|NCT01552434|Valproic Acid|valproic acid|mesh-list
138856666|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
138856667|NCT01552434|Antibodies|antibodies|mesh-list
138856668|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
138856669|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138856670|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
138856671|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856672|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138856673|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138856674|NCT01552434|Growth Substances|growth substances|mesh-ancestor
138856675|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856676|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
138856677|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
138856678|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138856679|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138856680|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138856681|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
138856682|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138856683|NCT01552434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138856684|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856685|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856686|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
138856687|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
138856688|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138856689|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
138856690|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138856691|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138856692|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138856694|NCT01164228|Sunitinib|sunitinib|mesh-list
138856695|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138856696|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
138856697|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856698|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856699|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138856700|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138856701|NCT01164228|Growth Substances|growth substances|mesh-ancestor
138856702|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019279|NCT05159245|Trastuzumab|trastuzumab|mesh-list
138856703|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
138856704|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138856705|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856706|NCT00641030|Melphalan|melphalan|mesh-list
138856707|NCT00641030|Clofarabine|clofarabine|mesh-list
138856708|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138856709|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
138856710|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856711|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856712|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138856713|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138856714|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
138856715|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856716|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138856717|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
138856718|NCT00554515|Aldesleukin|aldesleukin|mesh-list
138856719|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856720|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138856721|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138856722|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
138856723|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138856724|NCT00209586|Fospropofol|fospropofol|mesh-list
138856725|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138856726|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138856727|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856728|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138856729|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856730|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856731|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856732|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138856733|NCT00082797|Leucovorin|leucovorin|mesh-list
138856734|NCT00082797|Methotrexate|methotrexate|mesh-list
138856735|NCT00082797|Calcium|calcium|mesh-list
138856736|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
138856737|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138856738|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856739|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138856740|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
138856741|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138856742|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138856743|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
138856744|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856745|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856746|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
138856747|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856748|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138856749|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138856750|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
138856751|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856752|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138856753|NCT00082797|Antidotes|antidotes|mesh-ancestor
138856754|NCT00082797|Protective Agents|protective agents|mesh-ancestor
138856755|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
138856756|NCT00082797|Vitamins|vitamins|mesh-ancestor
138856757|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
138856758|NCT00060398|Dexamethasone|dexamethasone|mesh-list
138856759|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
138856760|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138856761|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
138856762|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
138856763|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138856764|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856765|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138856766|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
138856767|NCT00060398|Hormones|hormones|mesh-ancestor
138856768|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138856769|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138856770|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856771|NCT00060398|Hematinics|hematinics|mesh-ancestor
138856772|NCT00054561|Vitamin E|vitamin e|mesh-list
138856773|NCT00054561|Interferons|interferons|mesh-list
138856774|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
138856775|NCT00054561|Isotretinoin|isotretinoin|mesh-list
138856776|NCT00054561|Vitamins|vitamins|mesh-ancestor
138856777|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
138856778|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856779|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856780|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
138856781|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138856782|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
138856783|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
138856784|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856785|NCT00054561|Protective Agents|protective agents|mesh-ancestor
138856786|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
138856787|NCT00049517|Cytarabine|cytarabine|mesh-list
138856788|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
138856789|NCT00049517|Busulfan|busulfan|mesh-list
138856790|NCT00049517|Daunorubicin|daunorubicin|mesh-list
138856791|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
138856793|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138856794|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
138856795|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856796|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856797|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138856798|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
138856799|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856800|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856801|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138856802|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138856803|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
138856804|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
138856805|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138856806|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138856807|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138856808|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138856809|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856810|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856811|NCT00049517|Immunotoxins|immunotoxins|mesh-ancestor
138856812|NCT00049517|Immunoconjugates|immunoconjugates|mesh-ancestor
138856813|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
138856814|NCT00041314|Carboplatin|carboplatin|mesh-list
138856815|NCT00041314|Gemcitabine|gemcitabine|mesh-list
138856816|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019309|NCT05116917|Nivolumab|nivolumab|mesh-list
138856817|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138856818|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
138856819|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856820|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138856821|NCT00041314|Protective Agents|protective agents|mesh-ancestor
138856822|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856823|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138856824|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856825|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138856826|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138856827|NCT00041314|Analgesics|analgesics|mesh-ancestor
138856828|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
138856829|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138856830|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138856831|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856832|NCT00028990|Paclitaxel|paclitaxel|mesh-list
138856833|NCT00028990|Bevacizumab|bevacizumab|mesh-list
138856834|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138856835|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856836|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856837|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
138856838|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
138856839|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856840|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138856841|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138856842|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138856843|NCT00028990|Growth Substances|growth substances|mesh-ancestor
138856844|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856845|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
138856846|NCT00027859|Ketoconazole|ketoconazole|mesh-list
138856847|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
138856848|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138856849|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138856850|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138856851|NCT00027859|Docetaxel|docetaxel|mesh-list
138856852|NCT00027859|Estramustine|estramustine|mesh-list
138856853|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856854|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856855|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
138856856|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
138856857|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856858|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138856859|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
138856860|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138856861|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138856862|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138856863|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856864|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138856865|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
138856866|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138856867|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856868|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138856869|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138856870|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
138856871|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138856872|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138856873|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
138856874|NCT00026286|Estrogens|estrogens|mesh-list
138856875|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138856876|NCT00026286|Hormones|hormones|mesh-ancestor
138856877|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138856878|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856879|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138856880|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138856881|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138856882|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
138856883|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138856884|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138856885|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138856886|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138856887|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138856888|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856889|NCT00014118|Paclitaxel|paclitaxel|mesh-list
138856890|NCT00014118|Carboplatin|carboplatin|mesh-list
138856891|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138856892|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856893|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856894|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
138856895|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
138600110|NCT00538486|Metformin|metformin|mesh-list
138856896|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856897|NCT00006004|Paclitaxel|paclitaxel|mesh-list
138856898|NCT00006004|Carboplatin|carboplatin|mesh-list
138856899|NCT00006004|Gemcitabine|gemcitabine|mesh-list
139019362|NCT04977167|Antibodies|antibodies|mesh-list
138856900|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138856901|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856902|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856903|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
138856904|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
138856905|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856906|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138856907|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
138856909|NCT00004860|Tegafur|tegafur|mesh-list
138856910|NCT00004860|Calcium|calcium|mesh-list
138856911|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
138856912|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138856913|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856914|NCT00004860|Antidotes|antidotes|mesh-ancestor
138856915|NCT00004860|Protective Agents|protective agents|mesh-ancestor
138856916|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
138856917|NCT00004860|Vitamins|vitamins|mesh-ancestor
138856918|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
138856919|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138856921|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856922|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856923|NCT00003864|Carboplatin|carboplatin|mesh-list
138856924|NCT00003864|Docetaxel|docetaxel|mesh-list
138856925|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856926|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856927|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
138856928|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
138856929|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856930|NCT00003810|Gemcitabine|gemcitabine|mesh-list
138856931|NCT00003810|Docetaxel|docetaxel|mesh-list
138856932|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138856933|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
138856934|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856935|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856936|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856937|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
138856938|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
138856939|NCT00003701|Paclitaxel|paclitaxel|mesh-list
138856940|NCT00003701|Vinblastine|vinblastine|mesh-list
138856941|NCT00003701|Carboplatin|carboplatin|mesh-list
138856943|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138856944|NCT00003701|Methotrexate|methotrexate|mesh-list
138856945|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138856946|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856947|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856948|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
139019393|NCT04741997|Nivolumab|nivolumab|mesh-list
138856949|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
138856950|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856951|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138856952|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138856953|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138856954|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138856955|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138856956|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
138856957|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138856958|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856959|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138856960|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
138856961|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
138856962|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138856963|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138856964|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
138856965|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856966|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138856967|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
138856968|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856969|NCT00003614|Paclitaxel|paclitaxel|mesh-list
138856970|NCT00003614|Estramustine|estramustine|mesh-list
138856971|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138856972|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856973|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856974|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
138856975|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
138856976|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856977|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138856978|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
138856979|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138856980|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
138856981|NCT00003519|Docetaxel|docetaxel|mesh-list
138856982|NCT00003519|Doxorubicin|doxorubicin|mesh-list
138856983|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138856984|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138856985|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
138856986|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856987|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138856988|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138856989|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
138856990|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138856991|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138856992|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138856993|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
138856994|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
138856995|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
138856996|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138856997|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138856998|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138856999|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857001|NCT00003283|Octreotide|octreotide|mesh-list
138944961|NCT00395629|Deferasirox|deferasirox|mesh-list
138857002|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138857003|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
138857004|NCT00003283|Hormones|hormones|mesh-ancestor
138857005|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857006|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857007|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138857008|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857009|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138857010|NCT00003235|Paclitaxel|paclitaxel|mesh-list
138857011|NCT00003235|Carboplatin|carboplatin|mesh-list
138857012|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138857013|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857014|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
138857015|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
138857016|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
138857017|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857018|NCT00003206|Paclitaxel|paclitaxel|mesh-list
138857019|NCT00003206|Carboplatin|carboplatin|mesh-list
138857020|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138857021|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857022|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
138857023|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
138857024|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
138857025|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857026|NCT00003010|Marimastat|marimastat|mesh-list
138857027|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857028|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857029|NCT00003008|Ritonavir|ritonavir|mesh-list
138857030|NCT00003008|Nelfinavir|nelfinavir|mesh-list
138857031|NCT00003008|Indinavir|indinavir|mesh-list
138857032|NCT00003008|Saquinavir|saquinavir|mesh-list
138857033|NCT00003008|Paclitaxel|paclitaxel|mesh-list
138857034|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138857035|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857036|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
139019445|NCT04525157|Afamelanotide|afamelanotide|mesh-list
138857037|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
138857038|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
138857039|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857040|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138857041|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138857042|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
138857043|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857044|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138857045|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138857046|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
138857047|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857048|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138857049|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138857051|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138857052|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138857053|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138857054|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138857055|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857056|NCT00002878|Dexamethasone|dexamethasone|mesh-list
138857057|NCT00002878|Doxorubicin|doxorubicin|mesh-list
138857058|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138857059|NCT00002878|Vincristine|vincristine|mesh-list
138857060|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138857061|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
138857062|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
138857063|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857064|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857065|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138857066|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
138857067|NCT00002878|Hormones|hormones|mesh-ancestor
138857068|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857069|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138857070|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857071|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138857072|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138857073|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138857074|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857075|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857076|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138857077|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
138857078|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
138857079|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
138857080|NCT00002632|Paclitaxel|paclitaxel|mesh-list
138857081|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138857082|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857083|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
138857084|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
138857085|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
138857086|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857087|NCT00002520|Nicotine|nicotine|mesh-list
138857088|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138857089|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
138857090|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857091|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857092|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138857093|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138857094|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
139019482|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
138857095|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857096|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857097|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138857098|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138857099|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138857100|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138857101|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857102|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857103|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857105|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
138857106|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857107|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
138857108|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138857109|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
138857110|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
138857111|NCT05122481|Vitamins|vitamins|mesh-ancestor
138857112|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
138857113|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857114|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
138857115|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857116|NCT05122481|Protective Agents|protective agents|mesh-ancestor
138857117|NCT00937417|Docetaxel|docetaxel|mesh-list
138857118|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857119|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
138857120|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
138857121|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
138857122|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857123|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138857124|NCT02728440|Menotropins|menotropins|mesh-list
138857125|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138857126|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857127|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138857129|NCT05358912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138857130|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
138857131|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
138857132|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138857133|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138857134|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857135|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857136|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857137|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138857138|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
138857139|NCT00930865|Bumetanide|bumetanide|mesh-list
138857140|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138857141|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857142|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138857143|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857144|NCT00930865|Diuretics|diuretics|mesh-ancestor
138857145|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
138857146|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138857147|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138857148|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138857149|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
138857150|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138857151|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
138857152|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138857153|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857154|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138857155|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138857156|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857157|NCT00934531|Donepezil|donepezil|mesh-list
138857158|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138857159|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857160|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857161|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
138857162|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857163|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857164|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
138857165|NCT00931021|Nicotine|nicotine|mesh-list
138857166|NCT00931021|Varenicline|varenicline|mesh-list
138857167|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138857168|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
138857169|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857170|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857171|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138857172|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138857173|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
138857174|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857175|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857176|NCT00937807|Sevoflurane|sevoflurane|mesh-list
138857177|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138857178|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138857179|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
138857180|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
138857181|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138857182|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857183|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
138857184|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138857185|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138857186|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138857187|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138857188|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857189|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
138857190|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857191|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857192|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138857193|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857194|NCT02808728|Bupivacaine|bupivacaine|mesh-list
138857195|NCT02808728|Ropivacaine|ropivacaine|mesh-list
138857196|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
138857197|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
138788026|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857198|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138857199|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857200|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
138857201|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857202|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138857203|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138857204|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138857206|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857207|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
138857208|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857209|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138857210|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138857211|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
138857212|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138857213|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
138857214|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857215|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857216|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138857217|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
138857218|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138857219|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
138945036|NCT01049347|Analgesics|analgesics|mesh-ancestor
138857220|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857221|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857222|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138857223|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
138857224|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
138857225|NCT04996667|Protective Agents|protective agents|mesh-ancestor
138857226|NCT00929669|Pasireotide|pasireotide|mesh-list
138857227|NCT00929669|Hormones|hormones|mesh-ancestor
138857228|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857229|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857230|NCT02804360|Dexamethasone|dexamethasone|mesh-list
138857231|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
138857232|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138857233|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
138857234|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
138857235|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857236|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857237|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138857238|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
138857239|NCT02804360|Hormones|hormones|mesh-ancestor
139019556|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
138857240|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857241|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138857242|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857243|NCT02727738|Selenium|selenium|mesh-list
138857244|NCT02727738|Methimazole|methimazole|mesh-list
138857245|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
138857246|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857247|NCT02727738|Protective Agents|protective agents|mesh-ancestor
138857248|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857249|NCT02727738|Trace Elements|trace elements|mesh-ancestor
138857250|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
138857251|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
138857252|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
138857253|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857254|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138857255|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
138857256|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
138857257|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138857258|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857259|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138857260|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138857261|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138857262|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138857263|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857264|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138857265|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138857266|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138857267|NCT02811692|Aflibercept|aflibercept|mesh-list
138857268|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138857269|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138857271|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857272|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
138857273|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857274|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
138857275|NCT04004078|Clotrimazole|clotrimazole|mesh-list
138857276|NCT04004078|Miconazole|miconazole|mesh-list
138857277|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857278|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138857279|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138857280|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138857281|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857282|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857283|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138857284|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
138857285|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857286|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857287|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138857288|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138857289|NCT02732262|Oxycodone|oxycodone|mesh-list
138857290|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138857291|NCT02732262|Narcotics|narcotics|mesh-ancestor
138857292|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138857293|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857294|NCT02732262|Analgesics|analgesics|mesh-ancestor
138857295|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
138857296|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857297|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138857298|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
138857299|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138857300|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138857301|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138857302|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138857303|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857305|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
138857306|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138857307|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857308|NCT00938197|Amlodipine|amlodipine|mesh-list
138857309|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138857310|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138857311|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138857312|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857313|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138857314|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857315|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
138857316|NCT02727504|Dobutamine|dobutamine|mesh-list
138857317|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138857318|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
138857319|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
138857320|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857321|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857322|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138857323|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138857324|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138857325|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
138857326|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857327|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857328|NCT02727504|Protective Agents|protective agents|mesh-ancestor
138857329|NCT02727348|Anesthetics|anesthetics|mesh-list
138857330|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138857331|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857332|NCT04013815|Ropivacaine|ropivacaine|mesh-list
138857333|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
138857334|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
138857335|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138857336|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857337|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
138857338|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857339|NCT00610103|Apomorphine|apomorphine|mesh-list
138857340|NCT00610103|Emetics|emetics|mesh-ancestor
138857341|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857342|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
138857343|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857344|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138857345|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
138857346|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
138857347|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857348|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857349|NCT05624190|Plasminogen|plasminogen|mesh-list
138857350|NCT05624190|Tenecteplase|tenecteplase|mesh-list
138857351|NCT05624190|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138857352|NCT05624190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138857353|NCT05624190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138857354|NCT05624190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857355|NCT00938353|Beclomethasone|beclomethasone|mesh-list
138857356|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138857357|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
138857359|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857360|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857361|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138857362|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
138857363|NCT04259333|Acetaminophen|acetaminophen|mesh-list
138857364|NCT04259333|Celecoxib|celecoxib|mesh-list
138857365|NCT04259333|Codeine|codeine|mesh-list
138857366|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138857368|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
138857369|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857370|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857371|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
138857372|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138857373|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138857374|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138857375|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138857376|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138857377|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857378|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857379|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138857380|NCT04259333|Narcotics|narcotics|mesh-ancestor
138857381|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138857382|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
138857383|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
138857384|NCT02721420|Piperaquine|piperaquine|mesh-list
138857385|NCT02721420|Artenimol|artenimol|mesh-list
138857386|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
138857387|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138509437|NCT04310007|Antibodies|antibodies|mesh-list
138857388|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138857389|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857390|NCT00608699|Niacin|niacin|mesh-list
138857391|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138857392|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
138857393|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857394|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138857395|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
138857396|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
138857397|NCT00608699|Vitamins|vitamins|mesh-ancestor
139019642|NCT04275999|Ivermectin|ivermectin|mesh-list
138857398|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
138857399|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857400|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
138857401|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138857402|NCT02726490|Metformin|metformin|mesh-list
138857403|NCT02726490|Glyburide|glyburide|mesh-list
138857404|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138945127|NCT00624585|Dasatinib|dasatinib|mesh-list
138857405|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857406|NCT02726646|Doxycycline|doxycycline|mesh-list
138857407|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138857408|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857409|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
138857410|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138857411|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138857412|NCT02803892|Vildagliptin|vildagliptin|mesh-list
138857413|NCT02803892|Sirolimus|sirolimus|mesh-list
138857414|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138857415|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857416|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138857417|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857418|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
138857419|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138857420|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
138857421|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857422|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857423|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857424|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138857425|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138857426|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
138857427|NCT02721186|Piperaquine|piperaquine|mesh-list
138857428|NCT02721186|Primaquine|primaquine|mesh-list
138857429|NCT02721186|Artenimol|artenimol|mesh-list
138857430|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
138857431|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138857432|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138857433|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857434|NCT02716428|Ribavirin|ribavirin|mesh-list
138857435|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
138857436|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857437|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
138857438|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857439|NCT00931463|Ritonavir|ritonavir|mesh-list
138857440|NCT00931463|Lopinavir|lopinavir|mesh-list
138857441|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
138857442|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138857443|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139210374|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857444|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
138857445|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857446|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857447|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138857448|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138857449|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
138857450|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857451|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138857452|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138857453|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138857454|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138857455|NCT03974594|Trifluridine|trifluridine|mesh-list
138857456|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
138857457|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857458|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
138857459|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857460|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
138857461|NCT03964688|Vitamins|vitamins|mesh-ancestor
138857462|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
138945168|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138857463|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857464|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
138857465|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857466|NCT03964688|Protective Agents|protective agents|mesh-ancestor
138857467|NCT00929201|Metformin|metformin|mesh-list
138857468|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138857469|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138857470|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857471|NCT00929201|Incretins|incretins|mesh-ancestor
138857472|NCT00929201|Hormones|hormones|mesh-ancestor
138857473|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857474|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138857475|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
138857476|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857477|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857478|NCT02800772|Acetic Acid|acetic acid|mesh-list
138857479|NCT02800772|Retinol acetate|retinol acetate|mesh-list
138857480|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138857481|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857482|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138857483|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
138857484|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857485|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138857486|NCT02800772|Protective Agents|protective agents|mesh-ancestor
138857487|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857488|NCT02773212|Amphetamine|amphetamine|mesh-list
138857489|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
138857490|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138857491|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857492|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
138857493|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
138857494|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019683|NCT06082934|Hormones|hormones|mesh-ancestor
138857495|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
138857497|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857498|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
138857499|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138857500|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138857501|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138857502|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138857503|NCT00610493|Sirolimus|sirolimus|mesh-list
138857504|NCT00610493|Bevacizumab|bevacizumab|mesh-list
138857505|NCT00610493|Temsirolimus|temsirolimus|mesh-list
138857506|NCT00610493|MTOR Inhibitors|mtor inhibitors|mesh-list
138857507|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138857508|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857509|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138857510|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138857511|NCT00610493|Growth Substances|growth substances|mesh-ancestor
138857512|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857513|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
138857514|NCT00610493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138857515|NCT00610493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857516|NCT00610493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857517|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138857519|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138857520|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857521|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138857522|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
138857523|NCT02716272|Nivolumab|nivolumab|mesh-list
138857524|NCT02716272|Ipilimumab|ipilimumab|mesh-list
138857525|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138857526|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857527|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138857528|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857529|NCT02720406|Ketamine|ketamine|mesh-list
138857530|NCT02720406|Analgesics|analgesics|mesh-ancestor
138857531|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
138857532|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857533|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857534|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138857535|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138857536|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
138857537|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
138857538|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138857539|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138857540|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138857542|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857544|NCT05504876|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138857545|NCT05504876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138857546|NCT05504876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138857547|NCT05504876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857548|NCT05504876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138857549|NCT05504876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138857550|NCT05504876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138857551|NCT05504876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138857552|NCT05504876|Anesthetics, General|anesthetics, general|mesh-ancestor
138857553|NCT05504876|Anesthetics|anesthetics|mesh-ancestor
138857554|NCT05504876|GABA Modulators|gaba modulators|mesh-ancestor
138857555|NCT05504876|GABA Agents|gaba agents|mesh-ancestor
138857556|NCT05504876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857557|NCT05504876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857558|NCT02802722|Vitamin D|vitamin d|mesh-list
138857559|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
138857560|NCT02802722|Vitamins|vitamins|mesh-ancestor
138857561|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
138857562|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857563|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138857564|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138857565|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138857566|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138857567|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857568|NCT02802644|Incretins|incretins|mesh-ancestor
138857569|NCT02802644|Hormones|hormones|mesh-ancestor
138857570|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857571|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138857572|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
138857573|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857574|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857575|NCT02744976|Metformin|metformin|mesh-list
138857576|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138857577|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857578|NCT00928889|Acarbose|acarbose|mesh-list
138857579|NCT00928889|Nateglinide|nateglinide|mesh-list
138857580|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138857581|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857582|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857583|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138857584|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857586|NCT02725398|Bromides|bromides|mesh-list
138857587|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138857588|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
138857589|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138857590|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
138857591|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
138857592|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633154|NCT04538365|Triclosan|triclosan|mesh-list
138857593|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857595|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
138857596|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138857597|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
138857598|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857599|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857600|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138857601|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
138857602|NCT02795546|Alendronate|alendronate|mesh-list
138857603|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138857604|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857605|NCT03978091|Ceftazidime|ceftazidime|mesh-list
138857606|NCT03978091|Avibactam|avibactam|mesh-list
138857607|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
138857608|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138857609|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857610|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138857611|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857612|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857613|NCT00610571|Temozolomide|temozolomide|mesh-list
138857614|NCT00610571|Topotecan|topotecan|mesh-list
138857615|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138857616|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
138945248|NCT02548923|Propofol|propofol|mesh-list
138857617|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857618|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857619|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138857620|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138857622|NCT02725242|Budesonide|budesonide|mesh-list
138857623|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
138857624|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138857625|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138857626|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
138857627|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857628|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857629|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138857630|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
138857631|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
138857632|NCT02725242|Hormones|hormones|mesh-ancestor
138857633|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857634|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138857635|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138857636|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138857637|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
138857638|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857639|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857640|NCT00564733|Paclitaxel|paclitaxel|mesh-list
138857641|NCT00564733|Docetaxel|docetaxel|mesh-list
138857642|NCT00564733|Carboplatin|carboplatin|mesh-list
138857643|NCT00564733|Gemcitabine|gemcitabine|mesh-list
138857644|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138857645|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138857647|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
138857648|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
138857649|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
138857650|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857651|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138857652|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
138857653|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138857654|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
138857655|NCT02725164|Sevoflurane|sevoflurane|mesh-list
138857656|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138857657|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138857658|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
138857659|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
138857660|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138857661|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857662|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138857663|NCT02725164|Analgesics|analgesics|mesh-ancestor
138857664|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
138945264|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
138857665|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857666|NCT02800694|Fentanyl|fentanyl|mesh-list
138857667|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138857668|NCT02800694|Narcotics|narcotics|mesh-ancestor
138857669|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138857670|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857672|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
138857673|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019813|NCT06081868|Fluorides|fluorides|mesh-list
138857675|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138857676|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
138857677|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
138857678|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
138857679|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138857680|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
138857681|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857682|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857683|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138857684|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
138857685|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138857686|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138857687|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138857688|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
138857689|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857690|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857691|NCT00938509|Ibuprofen|ibuprofen|mesh-list
138857692|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138857693|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138857695|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
138857696|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857697|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857698|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138857699|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138857700|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138857701|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857702|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857703|NCT02724618|Curcumin|curcumin|mesh-list
138857704|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138857705|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138857706|NCT02724618|Analgesics|analgesics|mesh-ancestor
138857707|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
138857708|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857709|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857710|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138857711|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138857712|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857713|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857714|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857715|NCT02801786|Tamoxifen|tamoxifen|mesh-list
138857716|NCT02801786|Lidocaine|lidocaine|mesh-list
138857717|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
138857718|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
138857719|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138600926|NCT00190632|Analgesics|analgesics|mesh-ancestor
138857720|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857721|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
138857722|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857723|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138857724|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138945292|NCT00828477|Bromfenac|bromfenac|mesh-list
138857725|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138857726|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138857727|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857728|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138857729|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
138857730|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857731|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138857732|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857733|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138857734|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138857735|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138857736|NCT04258553|Antioxidants|antioxidants|mesh-list
138857737|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857738|NCT04258553|Protective Agents|protective agents|mesh-ancestor
138857739|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857740|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138857741|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138857742|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138857743|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138857744|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857745|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
138857746|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857747|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857748|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
138857749|NCT02719392|Minocycline|minocycline|mesh-list
138857750|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138857751|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
138857752|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857753|NCT02719392|Expectorants|expectorants|mesh-ancestor
138857754|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
138857755|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138857756|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
138857757|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857758|NCT02719392|Protective Agents|protective agents|mesh-ancestor
138857759|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857760|NCT02719392|Antidotes|antidotes|mesh-ancestor
138857761|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138857762|NCT02802098|Bevacizumab|bevacizumab|mesh-list
138857763|NCT02802098|Durvalumab|durvalumab|mesh-list
138857764|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138857765|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857766|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138857767|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138857768|NCT02802098|Growth Substances|growth substances|mesh-ancestor
138857769|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857770|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
138857771|NCT00938821|Morphine|morphine|mesh-list
138857772|NCT00938821|Bupivacaine|bupivacaine|mesh-list
138857773|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
138857774|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
138857775|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138857776|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857777|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
138857778|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857779|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138857780|NCT00938821|Narcotics|narcotics|mesh-ancestor
138857782|NCT04013581|Empagliflozin|empagliflozin|mesh-list
138857783|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138857784|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857785|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138857786|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857787|NCT02715960|Vitamin A|vitamin a|mesh-list
138857788|NCT02715960|Tretinoin|tretinoin|mesh-list
138857789|NCT02715960|Acitretin|acitretin|mesh-list
138857790|NCT02715960|Vitamins|vitamins|mesh-ancestor
138857791|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
138857792|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857793|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857794|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
138857795|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
138857797|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138857798|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857799|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
138857800|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857801|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138857802|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
138857803|NCT02794922|Vitamins|vitamins|mesh-ancestor
138857804|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
138857805|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857806|NCT00935467|Saxagliptin|saxagliptin|mesh-list
138857807|NCT00935467|Incretins|incretins|mesh-ancestor
138857808|NCT00935467|Hormones|hormones|mesh-ancestor
138857809|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857810|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857811|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138857812|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
138857813|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857814|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857815|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138857816|NCT00935545|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138857817|NCT00935545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138857818|NCT00935545|Immunologic Factors|immunologic factors|mesh-ancestor
138857819|NCT00935545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857820|NCT00936013|Oseltamivir|oseltamivir|mesh-list
138857821|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
138857822|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857823|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857824|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857825|NCT00936091|Vitamin A|vitamin a|mesh-list
138857826|NCT00936091|Vitamins|vitamins|mesh-ancestor
138857827|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
138857828|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857829|NCT00563797|Mecamylamine|mecamylamine|mesh-list
138857830|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138857831|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138857832|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
138857833|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857834|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857835|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138857836|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138857837|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
138857838|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857839|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857840|NCT01192698|Interferons|interferons|mesh-list
138857841|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857842|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
138857843|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857844|NCT04014361|Itraconazole|itraconazole|mesh-list
138857845|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
138857846|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857847|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138857848|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138857849|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857850|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857851|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138857852|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
138857853|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857854|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857855|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138857856|NCT00771927|Lacosamide|lacosamide|mesh-list
138945322|NCT00839553|Minocycline|minocycline|mesh-list
138857857|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
138857858|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138857859|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138857860|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138857861|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857862|NCT02715492|Enoxaparin|enoxaparin|mesh-list
138857863|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
138857864|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138857865|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138857866|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857867|NCT03940196|Paclitaxel|paclitaxel|mesh-list
138857868|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138857869|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138857870|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857871|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
138857872|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
138857873|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
138857874|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857875|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
138857876|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857877|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857878|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
138857879|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857880|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857881|NCT02724150|Omeprazole|omeprazole|mesh-list
138857882|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138857883|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138857884|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138857885|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857886|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857887|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138857888|NCT02715336|Leuprolide|leuprolide|mesh-list
138857889|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138857890|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
138857891|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138857892|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857893|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138857894|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857895|NCT02794610|Tacrolimus|tacrolimus|mesh-list
138857896|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138857897|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
138857898|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857900|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857901|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857902|NCT02799758|Pitavastatin|pitavastatin|mesh-list
138857903|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138857904|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138857905|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138857906|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
138857907|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857908|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857909|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138857910|NCT00938899|Simeprevir|simeprevir|mesh-list
138857911|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
138857912|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857913|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
138857914|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138857915|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857916|NCT03259165|Diuretics|diuretics|mesh-list
138857917|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138857918|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
138857919|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857920|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138857921|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857922|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138857923|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138857924|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138857925|NCT00939133|Tretinoin|tretinoin|mesh-list
138857926|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857927|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
138857928|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
138857929|NCT02799446|Reslizumab|reslizumab|mesh-list
138857930|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138857931|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
138857932|NCT00564889|Dexamethasone|dexamethasone|mesh-list
138857933|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
138857934|NCT00564889|Lenalidomide|lenalidomide|mesh-list
138857935|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138857936|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
138857937|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857938|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138857939|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138857940|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
138857941|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857942|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138857943|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138857944|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138857945|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
138857946|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
138857947|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857948|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138857949|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
138857950|NCT00564889|Hormones|hormones|mesh-ancestor
138857951|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138857952|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138857953|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138857954|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138857955|NCT00564889|Growth Substances|growth substances|mesh-ancestor
138857956|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
138857957|NCT02790164|Rocuronium|rocuronium|mesh-list
138945358|NCT00365365|Docetaxel|docetaxel|mesh-list
138857958|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138857959|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138857960|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138857961|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857962|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857963|NCT00939757|Mirabegron|mirabegron|mesh-list
138857964|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138857965|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138857967|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
138857968|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857969|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857970|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857971|NCT00939757|Urological Agents|urological agents|mesh-ancestor
138857972|NCT05415644|Metformin|metformin|mesh-list
138857973|NCT05415644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138857974|NCT05415644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857975|NCT00939835|Dexetimide|dexetimide|mesh-list
138857976|NCT00939835|Citalopram|citalopram|mesh-list
138857977|NCT00939835|Escitalopram|escitalopram|mesh-list
138857978|NCT00939835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138857979|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138857980|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138857981|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857982|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138857983|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
138857984|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138857985|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138857986|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
138510047|NCT02567435|Vinorelbine|vinorelbine|mesh-list
138857987|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138857988|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138857989|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138857990|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
138857991|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
138857992|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138857993|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138857994|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138857995|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
138857996|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
138857997|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
138857998|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138857999|NCT02690012|Cathartics|cathartics|mesh-ancestor
138858000|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138858001|NCT02690012|Antacids|antacids|mesh-ancestor
138858002|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
138858003|NCT02793986|Propofol|propofol|mesh-list
138858004|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138858005|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858006|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858007|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138858008|NCT02793986|Analgesics|analgesics|mesh-ancestor
138858009|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
138858010|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858011|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138858012|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138858013|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138858014|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
138858015|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858016|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858017|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138858018|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
138858019|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
138858021|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858022|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858023|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858024|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138945374|NCT00365365|Growth Substances|growth substances|mesh-ancestor
138858025|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138858026|NCT00940303|Leucovorin|leucovorin|mesh-list
138858027|NCT00940303|Bevacizumab|bevacizumab|mesh-list
138858028|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
138858029|NCT00940303|Irinotecan|irinotecan|mesh-list
138858030|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138858031|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858032|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138858033|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138858034|NCT00940303|Growth Substances|growth substances|mesh-ancestor
138858035|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858036|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
138858037|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138858038|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138858039|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858040|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858041|NCT00940303|Antidotes|antidotes|mesh-ancestor
138858042|NCT00940303|Protective Agents|protective agents|mesh-ancestor
138858043|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
138858044|NCT00940303|Vitamins|vitamins|mesh-ancestor
138858045|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
138858046|NCT02794220|Nicotine|nicotine|mesh-list
138858047|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138858048|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
138858049|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858050|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858051|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138858052|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138858053|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
138858054|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858055|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858056|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
138858057|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138858058|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138858059|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
138858060|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858061|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138858062|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138510139|NCT02245230|Trimethaphan|trimethaphan|mesh-list
138858063|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858064|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858065|NCT04405999|Bromhexine|bromhexine|mesh-list
138858066|NCT04405999|Expectorants|expectorants|mesh-ancestor
138858067|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
138858068|NCT02793908|Progesterone|progesterone|mesh-list
138858069|NCT02793908|Progestins|progestins|mesh-ancestor
138858070|NCT02793908|Hormones|hormones|mesh-ancestor
138858071|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138858072|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858073|NCT02789930|Anesthetics|anesthetics|mesh-list
138858074|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858075|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858076|NCT00560833|Mirtazapine|mirtazapine|mesh-list
138858077|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858078|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
138858079|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138858080|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138858081|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
138858082|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
138858083|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858084|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858085|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138858086|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138858087|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858088|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138858089|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138858090|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138858091|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
138858092|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138858093|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138858094|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
138858095|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138858096|NCT00941161|Metformin|metformin|mesh-list
138858097|NCT00941161|Glimepiride|glimepiride|mesh-list
138858098|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138858099|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858100|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138858101|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138858102|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
138858103|NCT00944515|Azithromycin|azithromycin|mesh-list
138858104|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138858105|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858106|NCT00771654|Phentermine|phentermine|mesh-list
138858107|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138858108|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858109|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
138858110|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138858111|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
138858112|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
138858113|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858114|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
138858115|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858116|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858117|NCT00941239|Metformin|metformin|mesh-list
138858118|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138858119|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858120|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
138858121|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
138858122|NCT04235426|Diclofenac|diclofenac|mesh-list
138858123|NCT04235426|Vitamins|vitamins|mesh-ancestor
138858124|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
138858125|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858126|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138858127|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138858128|NCT04235426|Analgesics|analgesics|mesh-ancestor
138858129|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
138858130|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858131|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138858132|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138858133|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138858134|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858135|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858136|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
138858137|NCT04235426|Hematinics|hematinics|mesh-ancestor
138858138|NCT02793440|Cortivazol|cortivazol|mesh-list
138858139|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138858140|NCT02723838|Gemcitabine|gemcitabine|mesh-list
138858141|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858142|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138858143|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
138858144|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858145|NCT02789150|Norepinephrine|norepinephrine|mesh-list
138858146|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138858147|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138858148|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
138858149|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858150|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858151|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858152|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
138858153|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
138858154|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858155|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138858157|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
138858158|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138858159|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138858160|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138858161|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
138858162|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601357|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
138858163|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858164|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858166|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138858167|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138858168|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
138858169|NCT02798744|Empagliflozin|empagliflozin|mesh-list
138858170|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138858171|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858172|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138858173|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858174|NCT00925769|Bevacizumab|bevacizumab|mesh-list
138858175|NCT00925769|Capecitabine|capecitabine|mesh-list
138858176|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138858177|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138858178|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858179|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138858180|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138858181|NCT00925769|Growth Substances|growth substances|mesh-ancestor
138858182|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858183|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
138858184|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138858185|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
138858186|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858187|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138858188|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858189|NCT00770913|Rabeprazole|rabeprazole|mesh-list
138858190|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138858191|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138858192|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138858193|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858194|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858195|NCT00562861|Lamotrigine|lamotrigine|mesh-list
138858196|NCT00562861|Carbamazepine|carbamazepine|mesh-list
138858197|NCT00562861|Valproic Acid|valproic acid|mesh-list
138858198|NCT00562861|Citalopram|citalopram|mesh-list
138858199|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
138945405|NCT01046539|ALKS-33|alks-33|mesh-list
138858200|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138858201|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138858202|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858203|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138858204|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858205|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138858206|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138858207|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858208|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138858209|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138858210|NCT00562861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138510278|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
138858211|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138858212|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858213|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
138858214|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138858215|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
138858216|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858217|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858218|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
138858219|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
138858220|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138858221|NCT00562861|Analgesics|analgesics|mesh-ancestor
138858222|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
138858223|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138858224|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138858225|NCT02723448|Aclarubicin|aclarubicin|mesh-list
138858226|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
138858227|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138858228|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858229|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138858230|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138858231|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858232|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858233|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138858234|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
138858235|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858237|NCT02798510|Capecitabine|capecitabine|mesh-list
138858238|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138858239|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
138858240|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858241|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858242|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138858243|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138858244|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
138858245|NCT00941473|Hormones|hormones|mesh-ancestor
138858246|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138858247|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858248|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138858249|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
138858250|NCT00609011|Temozolomide|temozolomide|mesh-list
138858251|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138858252|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
138858253|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858254|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858255|NCT00770679|Atorvastatin|atorvastatin|mesh-list
138858256|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138858257|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138858258|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
138858259|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858260|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138945430|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138858261|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138858262|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858263|NCT04042116|Nivolumab|nivolumab|mesh-list
138858264|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138858265|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858266|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138858267|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858268|NCT04260581|Amantadine|amantadine|mesh-list
138858269|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138858270|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138858271|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
138858272|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858273|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
138858274|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858275|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858276|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858277|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138858278|NCT04260581|Analgesics|analgesics|mesh-ancestor
138858279|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
138858280|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858281|NCT00770367|Pioglitazone|pioglitazone|mesh-list
138858282|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138858283|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858284|NCT00941785|Amodiaquine|amodiaquine|mesh-list
138858285|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
138858286|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138858287|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138858288|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858289|NCT02793050|Trabectedin|trabectedin|mesh-list
138858290|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138858291|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
138858292|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858293|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858294|NCT00944905|MDX-1203|mdx-1203|mesh-list
138858295|NCT00944905|Immunoconjugates|immunoconjugates|mesh-ancestor
138858296|NCT00944905|Immunologic Factors|immunologic factors|mesh-ancestor
138858297|NCT00944905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858298|NCT00942253|Dopamine|dopamine|mesh-list
138858299|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
138858300|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138858301|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
138858302|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
138858303|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858304|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858305|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
138858306|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858307|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858308|NCT00942253|Protective Agents|protective agents|mesh-ancestor
138858309|NCT02792816|Artesunate|artesunate|mesh-list
138858310|NCT02792816|Artemether|artemether|mesh-list
138858311|NCT02792816|Piperaquine|piperaquine|mesh-list
138858312|NCT02792816|Artenimol|artenimol|mesh-list
138858313|NCT02792816|Mefloquine|mefloquine|mesh-list
138858314|NCT02792816|Antimalarials|antimalarials|mesh-list
138858315|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138858316|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138858317|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858318|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858319|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
138858320|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
138858321|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138858322|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
138858323|NCT00940381|Sirolimus|sirolimus|mesh-list
138858324|NCT00940381|Cetuximab|cetuximab|mesh-list
138858325|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138858326|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858327|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138858328|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858329|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138858330|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
138858331|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138858332|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
138858333|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858334|NCT00637988|Aspirin|aspirin|mesh-list
138858335|NCT00637988|Rofecoxib|rofecoxib|mesh-list
138858336|NCT00637988|Esomeprazole|esomeprazole|mesh-list
138858337|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138858338|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138858339|NCT00637988|Analgesics|analgesics|mesh-ancestor
138858340|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
138858341|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858342|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858343|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138858344|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138858345|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138858346|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138858347|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858348|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138858349|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138858350|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858351|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
138858352|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138858353|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138858354|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138858355|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138858356|NCT04258163|Gemcitabine|gemcitabine|mesh-list
138858357|NCT04258163|Capecitabine|capecitabine|mesh-list
138858358|NCT04258163|Doxorubicin|doxorubicin|mesh-list
138858359|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138858360|NCT04258163|Letrozole|letrozole|mesh-list
138858361|NCT04258163|Fulvestrant|fulvestrant|mesh-list
138858362|NCT04258163|Anastrozole|anastrozole|mesh-list
138858363|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138858364|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
138858365|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858366|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858367|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138858368|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138858369|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138858370|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858371|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138858372|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138858373|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138858374|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
138858375|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138858376|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858377|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138858378|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138858379|NCT00942487|Nebivolol|nebivolol|mesh-list
138858380|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138858381|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
138858382|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138858383|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138858384|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138858385|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
138858386|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858387|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858388|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858389|NCT00611039|Ritonavir|ritonavir|mesh-list
138858390|NCT00611039|Darunavir|darunavir|mesh-list
138858391|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138858392|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138858393|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
138858394|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858395|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858396|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138858397|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138858398|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
138858399|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858400|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138858401|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138858402|NCT00942565|Acetaminophen|acetaminophen|mesh-list
138858403|NCT00942565|Tramadol|tramadol|mesh-list
138858404|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138858405|NCT00942565|Analgesics|analgesics|mesh-ancestor
138858406|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
138858407|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858408|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858409|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
138858410|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138858411|NCT00942565|Narcotics|narcotics|mesh-ancestor
138858412|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858413|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
138858414|NCT00945373|Calcium|calcium|mesh-list
138858415|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138858416|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858417|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
138858418|NCT00945373|Coagulants|coagulants|mesh-ancestor
138858419|NCT04100655|Molgramostim|molgramostim|mesh-list
138858420|NCT04100655|Estradiol|estradiol|mesh-list
138858421|NCT04100655|Sargramostim|sargramostim|mesh-list
138858422|NCT04100655|Estrogens|estrogens|mesh-ancestor
138858423|NCT04100655|Hormones|hormones|mesh-ancestor
138858424|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138858425|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858426|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
138858427|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858428|NCT02792426|Nicotine|nicotine|mesh-list
138858429|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138858430|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
138858431|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858432|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858433|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138858434|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138858435|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
138858436|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858437|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858438|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
138858439|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138540343|NCT00169624|Metformin|metformin|mesh-list
138858440|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138858441|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138858442|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138858443|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138858444|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858445|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
138858446|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858447|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858448|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138858449|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858450|NCT02792036|Carboplatin|carboplatin|mesh-list
138858451|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858452|NCT02797340|Metformin|metformin|mesh-list
138858453|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138858454|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858455|NCT00928187|Ritonavir|ritonavir|mesh-list
138858456|NCT00928187|Lopinavir|lopinavir|mesh-list
138858457|NCT00928187|Darunavir|darunavir|mesh-list
138858458|NCT00928187|Tenofovir|tenofovir|mesh-list
138858459|NCT00928187|Emtricitabine|emtricitabine|mesh-list
138858460|NCT00928187|Abacavir|abacavir|mesh-list
138858461|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138858462|NCT00928187|Didanosine|didanosine|mesh-list
138858463|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138858464|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138858465|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
138858466|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858467|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858468|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138858469|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138858470|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
138858471|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858472|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138858473|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138858474|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138858475|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138858476|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
138858477|NCT04235270|Tadalafil|tadalafil|mesh-list
138858478|NCT04235270|Macitentan|macitentan|mesh-list
138858479|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
138858480|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138858481|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138858482|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858483|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858484|NCT04235270|Urological Agents|urological agents|mesh-ancestor
138858485|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138858486|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138858487|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138858488|NCT04256525|Aspirin|aspirin|mesh-list
138858489|NCT04256525|Heparin|heparin|mesh-list
138858490|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
138858491|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138858492|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138858493|NCT04256525|Analgesics|analgesics|mesh-ancestor
138858494|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
138858495|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858496|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858497|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138858498|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138858499|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138858500|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138858501|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858502|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138858503|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138858504|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858505|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
138858506|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
138858507|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138858508|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
138858509|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138858510|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
138858511|NCT02791958|Ramipril|ramipril|mesh-list
138858512|NCT02791958|Atorvastatin|atorvastatin|mesh-list
138858513|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138858514|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138858515|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
138858516|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858518|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138858519|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858520|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138858521|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
138858522|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138858523|NCT02601651|Lidocaine|lidocaine|mesh-list
138858524|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
138858525|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
138858526|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858527|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858528|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
138858529|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858530|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138858531|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138858532|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138858533|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138858534|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858535|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138858536|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858537|NCT00945919|Oxymorphone|oxymorphone|mesh-list
138858538|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138858539|NCT00945919|Narcotics|narcotics|mesh-ancestor
138858540|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858541|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858542|NCT00945919|Analgesics|analgesics|mesh-ancestor
138858543|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
138858544|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858545|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138858546|NCT00945997|Misoprostol|misoprostol|mesh-list
138858547|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138858548|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
138858549|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138858550|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858551|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138858552|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138858553|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
138858554|NCT00943345|Indomethacin|indomethacin|mesh-list
138945508|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
138858555|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138858556|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138858557|NCT00943345|Analgesics|analgesics|mesh-ancestor
138858558|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
138858559|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858560|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858561|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138858562|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138858563|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
138858564|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
138858565|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138858566|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138858567|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858568|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858569|NCT02797028|Allopurinol|allopurinol|mesh-list
138858571|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858572|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858573|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
138858574|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138858575|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138858576|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
138858577|NCT02797028|Protective Agents|protective agents|mesh-ancestor
138858578|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858579|NCT00916461|Minocycline|minocycline|mesh-list
138858580|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138858581|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858582|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
138858583|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138858584|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
138858585|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138858586|NCT04260035|Protective Agents|protective agents|mesh-ancestor
138858587|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858588|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138858589|NCT00768651|Pantoprazole|pantoprazole|mesh-list
138858590|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138858591|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858592|NCT00768651|Incretins|incretins|mesh-ancestor
138858593|NCT00768651|Hormones|hormones|mesh-ancestor
139020160|NCT05688436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858594|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138858595|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138858596|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
138858597|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858598|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858599|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138858600|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138858601|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138858602|NCT00943501|Liraglutide|liraglutide|mesh-list
138858603|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138858604|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858605|NCT00943501|Incretins|incretins|mesh-ancestor
138858606|NCT00943501|Hormones|hormones|mesh-ancestor
138858607|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138858608|NCT04258241|Bupivacaine|bupivacaine|mesh-list
138858609|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
138858610|NCT04258241|Anesthetics|anesthetics|mesh-list
138858611|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138858612|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858613|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858614|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
138858615|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858616|NCT02796794|Genistein|genistein|mesh-list
138858617|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138858618|NCT02796794|Protective Agents|protective agents|mesh-ancestor
138858619|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858620|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858621|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138858622|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858623|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858624|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
138858625|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138858626|NCT02796794|Estrogens|estrogens|mesh-ancestor
138858627|NCT02796794|Hormones|hormones|mesh-ancestor
138858628|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138858629|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
138858630|NCT04097613|Budesonide|budesonide|mesh-list
138858631|NCT04097613|Povidone|povidone|mesh-list
138858632|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138858633|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138858634|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
138858635|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858636|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858637|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138858638|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
138858640|NCT04097613|Hormones|hormones|mesh-ancestor
138858641|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138858642|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
138858643|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
139210375|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138858644|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138858645|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858646|NCT00946387|Ondansetron|ondansetron|mesh-list
138858647|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
138858648|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
138858649|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858650|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858651|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138858652|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
138858653|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
138858654|NCT00946387|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138858655|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138858656|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
138858657|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858658|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858659|NCT00916695|Everolimus|everolimus|mesh-list
138858660|NCT00916695|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138858661|NCT00916695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138858662|NCT00916695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858663|NCT00916695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858664|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138858665|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
138858666|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858667|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858668|NCT00946465|Ramipril|ramipril|mesh-list
138858669|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138858670|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
138858671|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858672|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858673|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138858674|NCT00756717|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
138858675|NCT00756717|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138858676|NCT00756717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858677|NCT00756717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858678|NCT06005714|Cyclosporine|cyclosporine|mesh-list
138858679|NCT06005714|Clarithromycin|clarithromycin|mesh-list
138858680|NCT06005714|Cyclosporins|cyclosporins|mesh-list
138858681|NCT06005714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858682|NCT06005714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858683|NCT06005714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138858684|NCT06005714|Immunologic Factors|immunologic factors|mesh-ancestor
138858685|NCT06005714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858686|NCT06005714|Antifungal Agents|antifungal agents|mesh-ancestor
138858687|NCT06005714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858688|NCT06005714|Dermatologic Agents|dermatologic agents|mesh-ancestor
138858689|NCT06005714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138858690|NCT06005714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138858691|NCT06005714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138858692|NCT06005714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138858693|NCT06005714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138858694|NCT06005714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138858695|NCT06005571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138858696|NCT06005558|Methylene Blue|methylene blue|mesh-list
138858697|NCT06005558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858698|NCT06005558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858699|NCT06005363|Dexmedetomidine|dexmedetomidine|mesh-list
138858700|NCT06005363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858701|NCT06005363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858702|NCT06005363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138858703|NCT06005363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138858704|NCT06005363|Analgesics|analgesics|mesh-ancestor
138858705|NCT06005363|Sensory System Agents|sensory system agents|mesh-ancestor
138858706|NCT06005363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858707|NCT06005363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138858708|NCT06005363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138858709|NCT06005363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138858710|NCT06005363|Adrenergic Agents|adrenergic agents|mesh-ancestor
138858711|NCT06005363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858712|NCT06005363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858713|NCT06005324|Paclitaxel|paclitaxel|mesh-list
138858714|NCT06005324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138858715|NCT06005324|Carboplatin|carboplatin|mesh-list
138858716|NCT06005324|Fluorouracil|fluorouracil|mesh-list
138858718|NCT06005324|Hydroxyurea|hydroxyurea|mesh-list
138858719|NCT06005324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138858720|NCT06005324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858721|NCT06005324|Tubulin Modulators|tubulin modulators|mesh-ancestor
138858722|NCT06005324|Antimitotic Agents|antimitotic agents|mesh-ancestor
138858723|NCT06005324|Mitosis Modulators|mitosis modulators|mesh-ancestor
138858724|NCT06005324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858725|NCT06005324|Antimetabolites|antimetabolites|mesh-ancestor
138858726|NCT06005324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138858727|NCT06005324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138858728|NCT06005324|Immunologic Factors|immunologic factors|mesh-ancestor
138858729|NCT06005324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858730|NCT06005324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138858731|NCT06005324|Antisickling Agents|antisickling agents|mesh-ancestor
138858732|NCT06005324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858733|NCT06005324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138858734|NCT06005259|Spironolactone|spironolactone|mesh-list
138858735|NCT06005259|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138858736|NCT06005259|Hormone Antagonists|hormone antagonists|mesh-ancestor
138858737|NCT06005259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138858738|NCT06005259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858739|NCT06005259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138858741|NCT06005259|Natriuretic Agents|natriuretic agents|mesh-ancestor
138858742|NCT06005207|Progesterone|progesterone|mesh-list
138858743|NCT06005207|Progestins|progestins|mesh-ancestor
138858744|NCT06005207|Hormones|hormones|mesh-ancestor
138858745|NCT06005207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138858746|NCT06005207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858747|NCT06005168|Cefazolin|cefazolin|mesh-list
138858748|NCT06005168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138858749|NCT06005168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858750|NCT06005155|Valproic Acid|valproic acid|mesh-list
138858751|NCT06005155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138858752|NCT06005155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858753|NCT06005155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858754|NCT06005155|Antimanic Agents|antimanic agents|mesh-ancestor
138858755|NCT06005155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138858756|NCT06005155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858757|NCT06005155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858758|NCT06005155|Anticonvulsants|anticonvulsants|mesh-ancestor
138858759|NCT06005155|GABA Agents|gaba agents|mesh-ancestor
138858760|NCT06005155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858761|NCT06004947|Itraconazole|itraconazole|mesh-list
138858762|NCT06004947|Rifampin|rifampin|mesh-list
138858763|NCT06004947|Celecoxib|celecoxib|mesh-list
138858764|NCT06004947|Midazolam|midazolam|mesh-list
138858765|NCT06004947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138858766|NCT06004947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138858767|NCT06004947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858768|NCT06004947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858769|NCT06004947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138858770|NCT06004947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138858771|NCT06004947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138858772|NCT06004947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138858773|NCT06004947|Anesthetics, General|anesthetics, general|mesh-ancestor
138858774|NCT06004947|Anesthetics|anesthetics|mesh-ancestor
138858775|NCT06004947|GABA Modulators|gaba modulators|mesh-ancestor
138858776|NCT06004947|GABA Agents|gaba agents|mesh-ancestor
138858777|NCT06004947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858778|NCT06004947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858779|NCT06004947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138858780|NCT06004947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138858781|NCT06004947|Analgesics|analgesics|mesh-ancestor
138858782|NCT06004947|Sensory System Agents|sensory system agents|mesh-ancestor
138858783|NCT06004947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858784|NCT06004947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138858785|NCT06004947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138858786|NCT06004947|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138858787|NCT06004947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138858788|NCT06004947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858789|NCT06004947|Antifungal Agents|antifungal agents|mesh-ancestor
138858790|NCT06004947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858791|NCT06004947|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138858792|NCT06004947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138858794|NCT06004947|Hormone Antagonists|hormone antagonists|mesh-ancestor
138858795|NCT06004947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138858796|NCT06004947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138858797|NCT06004947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138858798|NCT06004947|Antitubercular Agents|antitubercular agents|mesh-ancestor
138858799|NCT06004947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138858800|NCT06004947|Leprostatic Agents|leprostatic agents|mesh-ancestor
138858801|NCT06004947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138858802|NCT06004947|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138858803|NCT06004947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138858804|NCT06004947|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138858805|NCT06004947|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138858806|NCT06004947|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138858807|NCT06004947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138858808|NCT06004882|Triamcinolone|triamcinolone|mesh-list
138858809|NCT06004882|Bupivacaine|bupivacaine|mesh-list
138858810|NCT06004882|Anesthetics, Local|anesthetics, local|mesh-ancestor
138858811|NCT06004882|Anesthetics|anesthetics|mesh-ancestor
138510881|NCT00066586|Exemestane|exemestane|mesh-list
138858812|NCT06004882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858813|NCT06004882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858814|NCT06004882|Sensory System Agents|sensory system agents|mesh-ancestor
138858815|NCT06004882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858816|NCT06004882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138858817|NCT06004882|Glucocorticoids|glucocorticoids|mesh-ancestor
138858818|NCT06004882|Hormones|hormones|mesh-ancestor
138858819|NCT06004882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138858820|NCT06004843|Propofol|propofol|mesh-list
138858821|NCT06004843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138858822|NCT06004843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858823|NCT06004843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858824|NCT06004843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138858825|NCT06004843|Anesthetics, General|anesthetics, general|mesh-ancestor
138858826|NCT06004843|Anesthetics|anesthetics|mesh-ancestor
138858827|NCT06004765|Lenalidomide|lenalidomide|mesh-list
138858828|NCT06004765|Azacitidine|azacitidine|mesh-list
138858829|NCT06004765|Immunologic Factors|immunologic factors|mesh-ancestor
138858830|NCT06004765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858831|NCT06004765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138858832|NCT06004765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138858834|NCT06004765|Growth Inhibitors|growth inhibitors|mesh-ancestor
138858835|NCT06004765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858836|NCT06004765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138858837|NCT06004765|Antimetabolites|antimetabolites|mesh-ancestor
138858838|NCT06004765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858839|NCT06004765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858840|NCT06004687|Acetaminophen|acetaminophen|mesh-list
138858841|NCT06004687|Mannitol|mannitol|mesh-list
138858842|NCT06004687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138858843|NCT06004687|Analgesics|analgesics|mesh-ancestor
138858844|NCT06004687|Sensory System Agents|sensory system agents|mesh-ancestor
138858845|NCT06004687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858846|NCT06004687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858847|NCT06004687|Antipyretics|antipyretics|mesh-ancestor
138858848|NCT06004687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138858849|NCT06004687|Diuretics|diuretics|mesh-ancestor
138858850|NCT06004687|Natriuretic Agents|natriuretic agents|mesh-ancestor
138858851|NCT06004661|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138858852|NCT06004661|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138858853|NCT06004661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858854|NCT06004401|Amoxicillin|amoxicillin|mesh-list
138945663|NCT00833157|Ibuprofen|ibuprofen|mesh-list
138858855|NCT06004401|Metronidazole|metronidazole|mesh-list
138858856|NCT06004401|Clarithromycin|clarithromycin|mesh-list
138858857|NCT06004401|Minocycline|minocycline|mesh-list
138858858|NCT06004401|Rabeprazole|rabeprazole|mesh-list
138858859|NCT06004401|Bismuth|bismuth|mesh-list
138858860|NCT06004401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138858861|NCT06004401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858862|NCT06004401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138858863|NCT06004401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138858864|NCT06004401|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138858865|NCT06004401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858866|NCT06004401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858867|NCT06004401|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138858868|NCT06004401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138858869|NCT06004401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138858870|NCT06004401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138858871|NCT06004401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138858872|NCT06004401|Antacids|antacids|mesh-ancestor
138858873|NCT06003998|Bevacizumab|bevacizumab|mesh-list
138858874|NCT06003998|Oxaliplatin|oxaliplatin|mesh-list
138858875|NCT06003998|Irinotecan|irinotecan|mesh-list
138858876|NCT06003998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138858877|NCT06003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858878|NCT06003998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138858879|NCT06003998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138858880|NCT06003998|Growth Substances|growth substances|mesh-ancestor
138858881|NCT06003998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858882|NCT06003998|Growth Inhibitors|growth inhibitors|mesh-ancestor
138858883|NCT06003998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138858884|NCT06003998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138858885|NCT06003998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020260|NCT05414305|Anesthetics|anesthetics|mesh-ancestor
138858886|NCT06003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858887|NCT06003972|Glatiramer Acetate|glatiramer acetate|mesh-list
138858888|NCT06003972|(T,G)-A-L|(t,g)-a-l|mesh-list
138858889|NCT06003972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138858890|NCT06003972|Immunologic Factors|immunologic factors|mesh-ancestor
138858891|NCT06003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858892|NCT06003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138858893|NCT06003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138858895|NCT06003608|Carbidopa|carbidopa|mesh-list
138858896|NCT06003608|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138858897|NCT06003608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138858898|NCT06003608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138858899|NCT06003608|Dopamine Agents|dopamine agents|mesh-ancestor
138858900|NCT06003608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858901|NCT06003608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858902|NCT06003608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858903|NCT06003608|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138858904|NCT06003608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858905|NCT06003608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138858906|NCT06003608|Immunologic Factors|immunologic factors|mesh-ancestor
138858907|NCT06003608|Dopamine Agonists|dopamine agonists|mesh-ancestor
138858908|NCT05999630|Lubricant Eye Drops|lubricant eye drops|mesh-list
138858909|NCT05999630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138858910|NCT05999630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138858911|NCT05999175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138858912|NCT05999175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858914|NCT05949099|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138858915|NCT05949099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858916|NCT05949099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858917|NCT05933603|Oxybutynin|oxybutynin|mesh-list
138858918|NCT05933603|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138858919|NCT05933603|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138858920|NCT05933603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138858921|NCT05933603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138945673|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858922|NCT05933603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858923|NCT05933603|Adrenergic Agents|adrenergic agents|mesh-ancestor
138858924|NCT05933603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858925|NCT05933603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858926|NCT05933603|Parasympatholytics|parasympatholytics|mesh-ancestor
138858927|NCT05933603|Autonomic Agents|autonomic agents|mesh-ancestor
138858928|NCT05933603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858929|NCT05933603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138858930|NCT05933603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138858931|NCT05933603|Cholinergic Agents|cholinergic agents|mesh-ancestor
138858932|NCT05933603|Urological Agents|urological agents|mesh-ancestor
138858933|NCT05888233|Allopurinol|allopurinol|mesh-list
138858934|NCT05888233|Antimetabolites|antimetabolites|mesh-ancestor
138858935|NCT05888233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858936|NCT05888233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858937|NCT05888233|Gout Suppressants|gout suppressants|mesh-ancestor
138858938|NCT05888233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138858939|NCT05888233|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138858940|NCT05888233|Antioxidants|antioxidants|mesh-ancestor
138858941|NCT05888233|Protective Agents|protective agents|mesh-ancestor
138858942|NCT05888233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858944|NCT05887882|Mitosis Modulators|mitosis modulators|mesh-ancestor
138858945|NCT05887882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858946|NCT05874219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138858947|NCT05874219|Mupirocin|mupirocin|mesh-list
138858948|NCT05874219|Neomycin|neomycin|mesh-list
138858949|NCT05874219|Bacitracin|bacitracin|mesh-list
138858950|NCT05874219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138858951|NCT05874219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138858952|NCT05874219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858953|NCT05874219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858954|NCT05874219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138858955|NCT05873244|Sorafenib|sorafenib|mesh-list
138858956|NCT05873244|Lenvatinib|lenvatinib|mesh-list
138858957|NCT05873244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858958|NCT05873244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138858959|NCT05873244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858960|NCT05873244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858961|NCT05869136|Hyaluronic Acid|hyaluronic acid|mesh-list
138511026|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138858962|NCT05869136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138858964|NCT05869136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858965|NCT05869136|Viscosupplements|viscosupplements|mesh-ancestor
138858966|NCT05869136|Protective Agents|protective agents|mesh-ancestor
138858967|NCT05862194|Lazertinib|lazertinib|mesh-list
138858968|NCT05862194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138858969|NCT05862194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138858970|NCT05862194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858971|NCT05855811|Dostarlimab|dostarlimab|mesh-list
138858972|NCT05855811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858973|NCT05825781|Pertuzumab|pertuzumab|mesh-list
138858974|NCT05825781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138858975|NCT05825781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138858976|NCT05825417|Selexipag|selexipag|mesh-list
138858977|NCT05825417|Riociguat|riociguat|mesh-list
138858978|NCT05825417|Enzyme Activators|enzyme activators|mesh-ancestor
138858979|NCT05825417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858980|NCT05825417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138858981|NCT05790044|Clonidine|clonidine|mesh-list
138858982|NCT05790044|Bupivacaine|bupivacaine|mesh-list
138858983|NCT05790044|Anesthetics, Local|anesthetics, local|mesh-ancestor
138858984|NCT05790044|Anesthetics|anesthetics|mesh-ancestor
138858985|NCT05790044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138858986|NCT05790044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138858987|NCT05790044|Sensory System Agents|sensory system agents|mesh-ancestor
138858988|NCT05790044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138858989|NCT05790044|Analgesics|analgesics|mesh-ancestor
138858990|NCT05790044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138858991|NCT05790044|Sympatholytics|sympatholytics|mesh-ancestor
138858992|NCT05790044|Autonomic Agents|autonomic agents|mesh-ancestor
138858993|NCT05790044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138858994|NCT05790044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138858995|NCT05790044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138858996|NCT05790044|Adrenergic Agents|adrenergic agents|mesh-ancestor
138858997|NCT05790044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138858998|NCT05790044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138858999|NCT05776030|Methamphetamine|methamphetamine|mesh-list
138859000|NCT05776030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138859001|NCT05776030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859002|NCT05776030|Sympathomimetics|sympathomimetics|mesh-ancestor
138859003|NCT05776030|Autonomic Agents|autonomic agents|mesh-ancestor
138859004|NCT05776030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859005|NCT05776030|Dopamine Agents|dopamine agents|mesh-ancestor
138859006|NCT05776030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859007|NCT05776030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859008|NCT05776030|Adrenergic Agents|adrenergic agents|mesh-ancestor
138859009|NCT05776030|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138859010|NCT05776030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138859011|NCT05776030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138859012|NCT05776030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138859013|NCT05773950|Fosaprepitant|fosaprepitant|mesh-list
138859014|NCT05773950|Aprepitant|aprepitant|mesh-list
138859015|NCT05773950|Antiemetics|antiemetics|mesh-ancestor
138859016|NCT05773950|Autonomic Agents|autonomic agents|mesh-ancestor
138859017|NCT05773950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859018|NCT05773950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859020|NCT05773950|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138859021|NCT05773950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859022|NCT05773950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859023|NCT05766553|Nicotine|nicotine|mesh-list
138859024|NCT05766553|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138859025|NCT05766553|Autonomic Agents|autonomic agents|mesh-ancestor
138859026|NCT05766553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859027|NCT05766553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859028|NCT05766553|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138859029|NCT05766553|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138859030|NCT05766553|Cholinergic Agents|cholinergic agents|mesh-ancestor
138859031|NCT05766553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859032|NCT05766553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859033|NCT05741632|Moxifloxacin|moxifloxacin|mesh-list
138859034|NCT05741632|Levofloxacin|levofloxacin|mesh-list
138859035|NCT05741632|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138859036|NCT05741632|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138859037|NCT05741632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138859038|NCT05741632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859039|NCT05741632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138859040|NCT05741632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138859041|NCT05741632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859042|NCT05741632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859043|NCT05741632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859044|NCT05741632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138859045|NCT05741632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138859046|NCT05741632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138859047|NCT05728645|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138859048|NCT05728645|Plasma Substitutes|plasma substitutes|mesh-ancestor
138859049|NCT05728645|Blood Substitutes|blood substitutes|mesh-ancestor
138859051|NCT05685342|Ibuprofen|ibuprofen|mesh-list
138859052|NCT05685342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138859053|NCT05685342|Analgesics|analgesics|mesh-ancestor
138859054|NCT05685342|Sensory System Agents|sensory system agents|mesh-ancestor
138859055|NCT05685342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859056|NCT05685342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859057|NCT05685342|Antipyretics|antipyretics|mesh-ancestor
138859058|NCT05685342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138859059|NCT05685342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138859060|NCT05685342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138859061|NCT05685342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138859062|NCT05685342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859063|NCT05685342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859064|NCT05681312|Amoxicillin|amoxicillin|mesh-list
138859065|NCT05681312|Metronidazole|metronidazole|mesh-list
138859066|NCT05681312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138859067|NCT05681312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859068|NCT05681312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138859069|NCT05681312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138859070|NCT05625503|Verapamil|verapamil|mesh-list
138859071|NCT05625503|Nicardipine|nicardipine|mesh-list
138859072|NCT05625503|Calcium Channel Blockers|calcium channel blockers|mesh-list
138859073|NCT05625503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138859074|NCT05625503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859075|NCT05625503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138859076|NCT05625503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138859077|NCT05625503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859078|NCT05625503|Vasodilator Agents|vasodilator agents|mesh-ancestor
138859079|NCT05625503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138859080|NCT05537402|Bevacizumab|bevacizumab|mesh-list
138859081|NCT05537402|Atezolizumab|atezolizumab|mesh-list
138859082|NCT05537402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138859083|NCT05537402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859084|NCT05537402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138859085|NCT05537402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138859086|NCT05537402|Growth Substances|growth substances|mesh-ancestor
138859087|NCT05537402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859088|NCT05537402|Growth Inhibitors|growth inhibitors|mesh-ancestor
138859089|NCT05537402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138859090|NCT05537402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859091|NCT05529290|Acetaminophen|acetaminophen|mesh-list
138859092|NCT05529290|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138859093|NCT05529290|Ketoprofen|ketoprofen|mesh-list
138859094|NCT05529290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138859095|NCT05529290|Analgesics|analgesics|mesh-ancestor
138859096|NCT05529290|Sensory System Agents|sensory system agents|mesh-ancestor
138859097|NCT05529290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859098|NCT05529290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859099|NCT05529290|Antipyretics|antipyretics|mesh-ancestor
138859100|NCT05529290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138859101|NCT05529290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138859102|NCT05529290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138859103|NCT05529290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138859104|NCT05529290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859105|NCT05529290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859106|NCT05435677|Insulin|insulin|mesh-list
138859107|NCT05435677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138859108|NCT05435677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859109|NCT05415917|Gemcitabine|gemcitabine|mesh-list
138859110|NCT05415917|Capecitabine|capecitabine|mesh-list
138859111|NCT05415917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138859112|NCT05415917|Antimetabolites|antimetabolites|mesh-ancestor
138859113|NCT05415917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859114|NCT05415917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859115|NCT05407441|Nivolumab|nivolumab|mesh-list
138859116|NCT05407441|Ipilimumab|ipilimumab|mesh-list
138859117|NCT05407441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138859118|NCT05407441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859119|NCT05407441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138859120|NCT05407441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859122|NCT05367687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859123|NCT05367687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138859124|NCT05367687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859125|NCT05367687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859126|NCT05353829|Methotrexate|methotrexate|mesh-list
138859127|NCT05353829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138859128|NCT05353829|Abortifacient Agents|abortifacient agents|mesh-ancestor
138859129|NCT05353829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138859130|NCT05353829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859131|NCT05353829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138859132|NCT05353829|Antimetabolites|antimetabolites|mesh-ancestor
138859133|NCT05353829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859134|NCT05353829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859135|NCT05353829|Dermatologic Agents|dermatologic agents|mesh-ancestor
138859136|NCT05353829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859137|NCT05353829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138859138|NCT05353829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138859139|NCT05353829|Immunologic Factors|immunologic factors|mesh-ancestor
138859140|NCT05353829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138859141|NCT05353829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138859143|NCT05345509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138859144|NCT05345509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859145|NCT05345509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859146|NCT05345509|Cholinergic Agents|cholinergic agents|mesh-ancestor
138859147|NCT05345509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859148|NCT05345509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859149|NCT05345509|Nootropic Agents|nootropic agents|mesh-ancestor
138859150|NCT05307731|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138859151|NCT05307731|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138859152|NCT05307731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859153|NCT05307731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138859154|NCT05307731|Immunologic Factors|immunologic factors|mesh-ancestor
138859155|NCT05307731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859156|NCT05287035|Dexamethasone|dexamethasone|mesh-list
138859157|NCT05287035|Dexamethasone acetate|dexamethasone acetate|mesh-list
138859158|NCT05287035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138859159|NCT05287035|Antiemetics|antiemetics|mesh-ancestor
138859160|NCT05287035|Autonomic Agents|autonomic agents|mesh-ancestor
138859161|NCT05287035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859162|NCT05287035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859163|NCT05287035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138859164|NCT05287035|Glucocorticoids|glucocorticoids|mesh-ancestor
138859165|NCT05287035|Hormones|hormones|mesh-ancestor
138859166|NCT05287035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138859167|NCT05287035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138859168|NCT05287035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859169|NCT05282069|Solifenacin Succinate|solifenacin succinate|mesh-list
138859170|NCT05282069|DA-8010|da-8010|mesh-list
138859171|NCT05282069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138859172|NCT05282069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138859173|NCT05282069|Cholinergic Agents|cholinergic agents|mesh-ancestor
138859174|NCT05282069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859175|NCT05282069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859176|NCT05282069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859177|NCT05282069|Urological Agents|urological agents|mesh-ancestor
138859178|NCT05251090|Factor VIII|factor viii|mesh-list
138859179|NCT05251090|Coagulants|coagulants|mesh-ancestor
138859180|NCT05249920|Edaravone|edaravone|mesh-list
138859181|NCT05249920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138859182|NCT05249920|Antioxidants|antioxidants|mesh-ancestor
138859183|NCT05249920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859184|NCT05249920|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138511251|NCT00070213|Vitamins|vitamins|mesh-ancestor
138859186|NCT05249920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859187|NCT05193071|Aspirin|aspirin|mesh-list
138859188|NCT05193071|Clopidogrel|clopidogrel|mesh-list
138859189|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138859190|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138859191|NCT05193071|Analgesics|analgesics|mesh-ancestor
138859192|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
138859193|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859194|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859195|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138859196|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138859197|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138859198|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138859199|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859200|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138859201|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138859202|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859203|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
138859204|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138859205|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138859206|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138859207|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
138859208|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859209|NCT05145010|Infigratinib|infigratinib|mesh-list
138859210|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859211|NCT05113940|Midazolam|midazolam|mesh-list
138859212|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138859213|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138859214|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138859215|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859216|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138859217|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138859218|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138859219|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138859220|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
138859221|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
138859222|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
138859223|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
138859224|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859225|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859226|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
138859227|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138859228|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859229|NCT05082259|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138859230|NCT05082259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859231|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
138859232|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138859233|NCT05073172|Hydrocortisone|hydrocortisone|mesh-list
138859234|NCT05073172|Petrolatum|petrolatum|mesh-list
138859235|NCT05073172|Mineral Oil|mineral oil|mesh-list
138859236|NCT05073172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138859237|NCT05073172|Emollients|emollients|mesh-ancestor
138859238|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
138859239|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138859240|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859241|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138859242|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138859243|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
138859244|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138859246|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138859247|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859248|NCT04962672|Anesthetics|anesthetics|mesh-list
138859249|NCT04962672|Propofol|propofol|mesh-list
138859250|NCT04962672|Sevoflurane|sevoflurane|mesh-list
138859251|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138859252|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859253|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138859254|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138859255|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
138859256|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138945784|NCT00939328|Rituximab|rituximab|mesh-list
138859257|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138859258|NCT04951206|Clobetasol|clobetasol|mesh-list
138859259|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138859260|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
138859261|NCT04951206|Hormones|hormones|mesh-ancestor
139020382|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138859262|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138859263|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859265|NCT04936126|Pramipexole|pramipexole|mesh-list
138859266|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138859267|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
138859268|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138859269|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138859270|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138859271|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138859272|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859273|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
138859274|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859275|NCT04936126|Protective Agents|protective agents|mesh-ancestor
138859276|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138859277|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138859278|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
138859279|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
138859280|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859281|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
138859282|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859284|NCT04936126|Analgesics|analgesics|mesh-ancestor
138859285|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
138859286|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859287|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138859288|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
138859289|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
138859290|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859291|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
138859292|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859293|NCT04839042|Cloricromen|cloricromen|mesh-list
138859294|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138859295|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
138859296|NCT04664946|Protective Agents|protective agents|mesh-ancestor
138859297|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859298|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
138859299|NCT04541355|Cisplatin|cisplatin|mesh-list
138859300|NCT04541355|Antidotes|antidotes|mesh-list
138859301|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859302|NCT04541355|Protective Agents|protective agents|mesh-ancestor
138859303|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859304|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
138859305|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859306|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
138859307|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138859308|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859309|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
138859310|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
138859311|NCT04516915|Oseltamivir|oseltamivir|mesh-list
138859312|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
138859313|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859314|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859315|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859316|NCT04485104|Cannabidiol|cannabidiol|mesh-list
138859317|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
138859318|NCT04483466|Methotrexate|methotrexate|mesh-list
138859319|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138859320|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
138859321|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138859322|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859323|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138859324|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
138859325|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859326|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859327|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
138859328|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859329|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138774030|NCT00667303|Antibodies|antibodies|mesh-list
138859330|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138859331|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
138859332|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138859333|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138859334|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
138859335|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138511410|NCT00071695|Analgesics|analgesics|mesh-ancestor
138859336|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138859337|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859338|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
138859339|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
138859340|NCT04365088|Deflazacort|deflazacort|mesh-list
138859341|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138859342|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138859343|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
138859344|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859345|NCT04360421|Bupivacaine|bupivacaine|mesh-list
138859346|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
138859347|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
138859348|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138859349|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859350|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
138859351|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859352|NCT04349579|Rifamycins|rifamycins|mesh-list
138859353|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
138859354|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138859355|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859356|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138859357|NCT04300296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138859358|NCT04300296|Immunologic Factors|immunologic factors|mesh-ancestor
138859360|NCT04158713|Piperaquine|piperaquine|mesh-list
138859361|NCT04158713|Artenimol|artenimol|mesh-list
138859362|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
138859363|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138859364|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138859365|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859366|NCT04047836|Nicotine|nicotine|mesh-list
138859367|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138859368|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
138859369|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859370|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859371|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138859372|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138859373|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
138859374|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859375|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859376|NCT03994146|Remifentanil|remifentanil|mesh-list
138859377|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138859378|NCT03994146|Narcotics|narcotics|mesh-ancestor
138859379|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138859380|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859381|NCT03994146|Analgesics|analgesics|mesh-ancestor
138859382|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
138859383|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859384|NCT03962465|Cytarabine|cytarabine|mesh-list
138859385|NCT03962465|Prednisone|prednisone|mesh-list
138859386|NCT03962465|Methotrexate|methotrexate|mesh-list
138859387|NCT03962465|Vincristine|vincristine|mesh-list
138859388|NCT03962465|Daunorubicin|daunorubicin|mesh-list
138859389|NCT03962465|Pegaspargase|pegaspargase|mesh-list
138859390|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138859391|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138859392|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
138859393|NCT03962465|Hormones|hormones|mesh-ancestor
138859394|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138859395|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859396|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138859397|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859398|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138859399|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
138859400|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138859401|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138859402|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
138859403|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859404|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
138859405|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859406|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138859407|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138859408|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
138859409|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138511476|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
138859410|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138859411|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
138859412|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859413|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138859414|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
138859415|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
138859416|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
138859417|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138859418|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138859419|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138859420|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138859421|NCT03962465|Immunotoxins|immunotoxins|mesh-ancestor
138859422|NCT03962465|Immunoconjugates|immunoconjugates|mesh-ancestor
138859423|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
138859424|NCT03952299|Oxybutynin|oxybutynin|mesh-list
138859425|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
138859426|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
138859427|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859428|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859429|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138859430|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138859431|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
138859432|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859433|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859434|NCT03952299|Urological Agents|urological agents|mesh-ancestor
138859435|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138859436|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859437|NCT03908437|Buprenorphine|buprenorphine|mesh-list
138859438|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138859439|NCT03908437|Naloxone|naloxone|mesh-list
138859440|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138859441|NCT03908437|Narcotics|narcotics|mesh-ancestor
138859442|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138859443|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859444|NCT03908437|Analgesics|analgesics|mesh-ancestor
138859445|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
138859446|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859447|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138859448|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
138859449|NCT03903185|Ledipasvir|ledipasvir|mesh-list
138859450|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138859451|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
138859452|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859453|NCT03834948|Paclitaxel|paclitaxel|mesh-list
138859454|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
138859455|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138859456|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859457|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
138859458|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
138859459|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
138859460|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859461|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138859462|NCT03834948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138859463|NCT03695250|Nivolumab|nivolumab|mesh-list
138859464|NCT03695250|Linrodostat|linrodostat|mesh-list
138859465|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138859466|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859467|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138859468|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859469|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859470|NCT03663543|Estrogens|estrogens|mesh-list
138859471|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138859472|NCT03663543|Hormones|hormones|mesh-ancestor
139210376|NCT03515837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138859473|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138859474|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859475|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
138859476|NCT03615105|Melphalan|melphalan|mesh-list
138859477|NCT03615105|Busulfan|busulfan|mesh-list
138859478|NCT03615105|Thiotepa|thiotepa|mesh-list
138859479|NCT03615105|Rituximab|rituximab|mesh-list
138859480|NCT03615105|Fludarabine|fludarabine|mesh-list
138859481|NCT03615105|Clofarabine|clofarabine|mesh-list
138859482|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138859483|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
138859484|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138859485|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
138859486|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859487|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138859488|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138859489|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
138859490|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859491|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859492|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138859493|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138859494|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138859495|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
138859496|NCT03603899|Xenon|xenon|mesh-list
138859497|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138859498|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
138859499|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
138859500|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138859501|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859502|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
138859503|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
138859504|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138859505|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138859506|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859507|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138859508|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
138859509|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859510|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859511|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
138859512|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
138859513|NCT03329378|Paclitaxel|paclitaxel|mesh-list
138859514|NCT03329378|Docetaxel|docetaxel|mesh-list
138859515|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138859516|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
138859517|NCT03329378|Carboplatin|carboplatin|mesh-list
138859518|NCT03329378|Doxorubicin|doxorubicin|mesh-list
138859519|NCT03329378|Trastuzumab|trastuzumab|mesh-list
138859520|NCT03329378|Pertuzumab|pertuzumab|mesh-list
138945835|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
138859521|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138859522|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859523|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
138859524|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
138859525|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
138859526|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859527|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138859528|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
138859529|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859530|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138859531|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138859532|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
138859533|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138859534|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138859535|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138859536|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138859537|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859538|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138859539|NCT03274895|Biguanides|biguanides|mesh-list
138859540|NCT03274895|Polihexanide|polihexanide|mesh-list
138859541|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
138859542|NCT03274895|Propamidine|propamidine|mesh-list
138859543|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
138859544|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859545|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138859546|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859547|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138859548|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138859549|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138859550|NCT03057106|Durvalumab|durvalumab|mesh-list
139210377|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859551|NCT03057106|Tremelimumab|tremelimumab|mesh-list
138859552|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138859553|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859554|NCT03054831|Oxycodone|oxycodone|mesh-list
138859555|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138859556|NCT03054831|Narcotics|narcotics|mesh-ancestor
138859557|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138859558|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859559|NCT03054831|Analgesics|analgesics|mesh-ancestor
138859560|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
138859561|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859562|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
138859563|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
138859564|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138859565|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138859566|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859567|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859568|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859570|NCT03003065|Temoporfin|temoporfin|mesh-list
138859571|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859572|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138859573|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
138859574|NCT02906332|Dexamethasone|dexamethasone|mesh-list
138859575|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
138859576|NCT02906332|Lenalidomide|lenalidomide|mesh-list
138859577|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138859578|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
138859579|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
138859580|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859581|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859582|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138859583|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
138859584|NCT02906332|Hormones|hormones|mesh-ancestor
138602770|NCT05807776|Lenvatinib|lenvatinib|mesh-list
138859585|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138859586|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138859587|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859588|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138859589|NCT02906332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138859590|NCT02906332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859591|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
138859592|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138859593|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138859594|NCT02906332|Growth Substances|growth substances|mesh-ancestor
138859595|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
138859597|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138859598|NCT02827877|Trastuzumab|trastuzumab|mesh-list
138859599|NCT02827877|Pertuzumab|pertuzumab|mesh-list
138859600|NCT02827877|Antibodies|antibodies|mesh-list
138859601|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
138859602|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138859603|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
138859604|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859605|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859606|NCT02827877|Trace Elements|trace elements|mesh-ancestor
138859607|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
138859608|NCT02823665|Atropine|atropine|mesh-list
138859609|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138859610|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138859611|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138859612|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
138859613|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859614|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859615|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138859616|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
138859617|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
138859618|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
138859619|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138859620|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139020537|NCT04379596|Durvalumab|durvalumab|mesh-list
138859621|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
138859622|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945866|NCT00840957|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138859623|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859624|NCT02755597|Dexamethasone|dexamethasone|mesh-list
138859626|NCT02755597|Venetoclax|venetoclax|mesh-list
138859627|NCT02755597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138859628|NCT02755597|Antiemetics|antiemetics|mesh-ancestor
138859629|NCT02755597|Autonomic Agents|autonomic agents|mesh-ancestor
138859630|NCT02755597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859631|NCT02755597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859632|NCT02755597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138859633|NCT02755597|Glucocorticoids|glucocorticoids|mesh-ancestor
138859634|NCT02755597|Hormones|hormones|mesh-ancestor
138859635|NCT02755597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138859636|NCT02755597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138859637|NCT02755597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859638|NCT02715284|Dostarlimab|dostarlimab|mesh-list
138859639|NCT02715284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859640|NCT02705300|Leucovorin|leucovorin|mesh-list
138859641|NCT02705300|Tocotrienols|tocotrienols|mesh-list
138859642|NCT02705300|Vitamin E|vitamin e|mesh-list
138859643|NCT02705300|Tocopherols|tocopherols|mesh-list
138859644|NCT02705300|Fluorouracil|fluorouracil|mesh-list
138859645|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
138859646|NCT02705300|Irinotecan|irinotecan|mesh-list
138859647|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
138859648|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859649|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
138859650|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859651|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138859652|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859653|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138859654|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
138859655|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138859656|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138859657|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859658|NCT02705300|Antidotes|antidotes|mesh-ancestor
138859659|NCT02705300|Protective Agents|protective agents|mesh-ancestor
138859660|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
138859661|NCT02705300|Vitamins|vitamins|mesh-ancestor
138859662|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
138859663|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
138859665|NCT02598557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859666|NCT02598557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138859667|NCT02598557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138859668|NCT02598557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859669|NCT02598557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859670|NCT02598557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138859671|NCT02598557|Hormone Antagonists|hormone antagonists|mesh-ancestor
138859672|NCT02598557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138859673|NCT02598557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859674|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
138859675|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859676|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
138859677|NCT02317783|Flutemetamol|flutemetamol|mesh-list
138859678|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
138859679|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859680|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
138859681|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859682|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138859683|NCT02044497|Oxycodone|oxycodone|mesh-list
138859684|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138859685|NCT02044497|Narcotics|narcotics|mesh-ancestor
138859686|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138859687|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859688|NCT02044497|Analgesics|analgesics|mesh-ancestor
138859689|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
139020538|NCT04379596|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138859690|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859692|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138859693|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138859694|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859695|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
138859696|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
138859697|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
138859698|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859699|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138859700|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138859701|NCT01470417|Gemcitabine|gemcitabine|mesh-list
138859702|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138859703|NCT01470417|Paclitaxel|paclitaxel|mesh-list
138859704|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138859705|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
138859706|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210378|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859707|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859708|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138859709|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
138859710|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
138859711|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
138859713|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138859714|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138859715|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859716|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
138859717|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
138859718|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
138859719|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859720|NCT01409772|Ethanol|ethanol|mesh-list
138859721|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138859722|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859723|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138859724|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859725|NCT01241708|Bortezomib|bortezomib|mesh-list
138859726|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859727|NCT01208766|Dexamethasone|dexamethasone|mesh-list
138859728|NCT01208766|Prednisone|prednisone|mesh-list
138859729|NCT01208766|Lenalidomide|lenalidomide|mesh-list
138859730|NCT01208766|Bortezomib|bortezomib|mesh-list
138859731|NCT01208766|Melphalan|melphalan|mesh-list
138859732|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138859733|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
138859734|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
138859735|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859736|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859737|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138859738|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
138859739|NCT01208766|Hormones|hormones|mesh-ancestor
138859740|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138859741|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138859742|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859743|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
138859744|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138859745|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138859746|NCT01208766|Growth Substances|growth substances|mesh-ancestor
138859747|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
138859748|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138859749|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
138859750|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859751|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138859752|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138859753|NCT00999336|Betrixaban|betrixaban|mesh-list
138859754|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138859755|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
138859756|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138859757|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
138859758|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859759|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859760|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
138859761|NCT00992901|Atropine|atropine|mesh-list
138859762|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138859763|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138859764|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138859765|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138859766|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
138859767|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859768|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859769|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138859770|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
138859771|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
138859772|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
138859773|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138859774|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138859775|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
138859776|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859777|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859778|NCT00992901|Incretins|incretins|mesh-ancestor
138859779|NCT00992901|Hormones|hormones|mesh-ancestor
138859780|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138859781|NCT00820248|Panitumumab|panitumumab|mesh-list
138859783|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138859784|NCT00795340|Paclitaxel|paclitaxel|mesh-list
138859785|NCT00795340|Carboplatin|carboplatin|mesh-list
138859786|NCT00795340|Cediranib|cediranib|mesh-list
138859787|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138859788|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859789|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
138859790|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
138859791|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
138859792|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859793|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859794|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138859796|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138859797|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138859798|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859799|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859800|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
138859801|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138945924|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
138859802|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859803|NCT00609791|Paclitaxel|paclitaxel|mesh-list
138859804|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138859805|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138859806|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859807|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
138859808|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
138859809|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
138859810|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859811|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138859812|NCT00489710|Immunomodulating Agents|immunomodulating agents|mesh-list
138859813|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859814|NCT00489710|Immunologic Factors|immunologic factors|mesh-ancestor
138859815|NCT00489710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859816|NCT00482677|Temozolomide|temozolomide|mesh-list
138859817|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138859818|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
138859819|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859820|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859821|NCT00314756|Imiquimod|imiquimod|mesh-list
138859822|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138859823|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
138859824|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859825|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859826|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
138859827|NCT00101101|Aldesleukin|aldesleukin|mesh-list
138859828|NCT00101101|Dexamethasone|dexamethasone|mesh-list
138859829|NCT00101101|Prednisone|prednisone|mesh-list
138859830|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
138859831|NCT00101101|Doxorubicin|doxorubicin|mesh-list
138859832|NCT00101101|Vincristine|vincristine|mesh-list
138859833|NCT00101101|Interleukin-2|interleukin-2|mesh-list
138859834|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138859835|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
138859836|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859837|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138859838|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138859839|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
138859840|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859841|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859842|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138859843|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138859844|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
138859845|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
138859846|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859847|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138859848|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
138859849|NCT00101101|Hormones|hormones|mesh-ancestor
138859850|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138859851|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138859852|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138859853|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138859854|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138859855|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859856|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138859857|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
138859858|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
138859859|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
138859860|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138859862|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
138859863|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138859864|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138859865|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
138945952|NCT00841191|Siltuximab|siltuximab|mesh-list
138859866|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859867|NCT00946621|Ramipril|ramipril|mesh-list
138859868|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138859869|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
138859870|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859871|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859872|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138859873|NCT02600793|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138859874|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138859875|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859876|NCT04235894|Propofol|propofol|mesh-list
138859877|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138859878|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138859879|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859880|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138859881|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
138859882|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
138859883|NCT04096599|Fluorides|fluorides|mesh-list
138859884|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
138859885|NCT04096599|Protective Agents|protective agents|mesh-ancestor
138859886|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859887|NCT00923351|Vaccines|vaccines|mesh-list
138859888|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
138859889|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859890|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
138859891|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138859892|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
138859893|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138859894|NCT02788292|Expectorants|expectorants|mesh-ancestor
138859895|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
138859896|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138859897|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
138859898|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859899|NCT02788292|Protective Agents|protective agents|mesh-ancestor
138859900|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859901|NCT02788292|Antidotes|antidotes|mesh-ancestor
138859902|NCT00944359|Zinc|zinc|mesh-list
138859903|NCT00944359|Trace Elements|trace elements|mesh-ancestor
138859904|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
138859905|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859906|NCT02791256|Ribavirin|ribavirin|mesh-list
138859907|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138859908|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
138859909|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859910|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
139020621|NCT04047251|Topotecan|topotecan|mesh-list
138859918|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859919|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138859920|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
138859921|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859922|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138859923|NCT02787824|Hematinics|hematinics|mesh-ancestor
138859924|NCT02796950|Acipimox|acipimox|mesh-list
138859925|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138859926|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
138859927|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859928|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138859929|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
138859930|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
138859931|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859932|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859933|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859934|NCT00950209|Heparin|heparin|mesh-list
138859935|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
138859936|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138859937|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138859938|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859946|NCT00947323|Simvastatin|simvastatin|mesh-list
138859947|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139020635|NCT04042831|Olaparib|olaparib|mesh-list
138859948|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138859949|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
138859950|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859951|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138859952|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138859954|NCT04236050|Rocuronium|rocuronium|mesh-list
138859955|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138859956|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138859957|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138859958|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859959|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859960|NCT02790632|Nimodipine|nimodipine|mesh-list
138859961|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138859962|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138859963|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138859964|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603139|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138859965|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138859966|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859967|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
138859968|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
138859970|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138859971|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859972|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138859973|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859974|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138859975|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138859976|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859977|NCT02788058|Gefitinib|gefitinib|mesh-list
138859978|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138859979|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138859980|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138859981|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859982|NCT04200092|Granisetron|granisetron|mesh-list
138859983|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
138859984|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
138859985|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859986|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859987|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138859988|NCT04200092|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138859989|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138859990|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
138859991|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138859992|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138859994|NCT00754065|Dienogest|dienogest|mesh-list
138859995|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138859996|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138859997|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138859998|NCT00754065|Estradiol|estradiol|mesh-list
138859999|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138860000|NCT00754065|Estrogens|estrogens|mesh-ancestor
138860001|NCT00754065|Hormones|hormones|mesh-ancestor
138860002|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138860003|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860004|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138860005|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
138860006|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138945967|NCT00921726|Zanamivir|zanamivir|mesh-list
138860007|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138860008|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138860009|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138860010|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138860011|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
138860012|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138860013|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860014|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138860015|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138860016|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138860017|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138860018|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138860019|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860020|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860021|NCT02787746|Donepezil|donepezil|mesh-list
138860022|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138860023|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860024|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860026|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860027|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860028|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
138860029|NCT03254654|Apatinib|apatinib|mesh-list
138860030|NCT03254654|Vinorelbine|vinorelbine|mesh-list
138860031|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860032|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138860033|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860034|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860035|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138860036|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
138860037|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603212|NCT03528408|Nivolumab|nivolumab|mesh-list
138860038|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
138860039|NCT02785718|Hemostatics|hemostatics|mesh-list
138860040|NCT02785718|Coagulants|coagulants|mesh-ancestor
138860041|NCT04094805|Calcitriol|calcitriol|mesh-list
138860042|NCT04094805|Dexamethasone|dexamethasone|mesh-list
138860043|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138860044|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
138860045|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
138860046|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860047|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860048|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138860049|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
138860050|NCT04094805|Hormones|hormones|mesh-ancestor
138860051|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138860052|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138860053|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860054|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138860055|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138860056|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138860057|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860058|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138860059|NCT04094805|Vitamins|vitamins|mesh-ancestor
138860060|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
138860061|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138860062|NCT04094727|Lumefantrine|lumefantrine|mesh-list
138860063|NCT04094727|Artemether|artemether|mesh-list
138860064|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138860065|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
138860066|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138860067|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138860068|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138860069|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
138860070|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138860071|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138860072|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138860073|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138860074|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860075|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
138860076|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860077|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860078|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138860079|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860080|NCT02786732|Ustekinumab|ustekinumab|mesh-list
138860081|NCT02786732|Brodalumab|brodalumab|mesh-list
138860082|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138860083|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
138860084|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
138860085|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860086|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
138860087|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138860088|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
138860089|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860090|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138860091|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138860092|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
138860093|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860094|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860095|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138860096|NCT02787356|Lidocaine|lidocaine|mesh-list
138860097|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
138860098|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
138860099|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860100|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860101|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
138860102|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860103|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138860104|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138860105|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138860106|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138860107|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860108|NCT02787278|Otaplimastat|otaplimastat|mesh-list
138860109|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138860110|NCT02787278|Protective Agents|protective agents|mesh-ancestor
138860111|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860112|NCT03083678|Afatinib|afatinib|mesh-list
138860113|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860114|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138860115|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860116|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860117|NCT04232150|Midazolam|midazolam|mesh-list
138860118|NCT04232150|Anesthetics|anesthetics|mesh-list
138860119|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860120|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860121|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138860122|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138860123|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138860124|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138860125|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138860126|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138860127|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
138860128|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
138860129|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
138860130|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860131|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860132|NCT04197752|Anesthetics|anesthetics|mesh-list
138860133|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860134|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860135|NCT02336750|Aprepitant|aprepitant|mesh-list
138860136|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
138860137|NCT02336750|Mirtazapine|mirtazapine|mesh-list
138860138|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
138860139|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
138860140|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860141|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860142|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138860143|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138860144|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860145|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860146|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
138860147|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138860148|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138860149|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
138860150|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
138860151|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138860152|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138860153|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860154|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138860155|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138860156|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138860157|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
138860158|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138860159|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138860161|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138860162|NCT02784392|Metoclopramide|metoclopramide|mesh-list
138860163|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
138860164|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
138860165|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860166|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860167|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138860168|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138860169|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138860170|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
138860171|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138512228|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
138860172|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860174|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
138860175|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138860176|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138860177|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
138860178|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860179|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860180|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860181|NCT02784080|Isoantibodies|isoantibodies|mesh-list
138860182|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
138860183|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860184|NCT02784860|Lidocaine|lidocaine|mesh-list
138860185|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
138860186|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
138860187|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860188|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860189|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
138860190|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860191|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138860192|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138860193|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138860194|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138860195|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860196|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
138860197|NCT02783924|Vitamin D|vitamin d|mesh-list
138860198|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138860199|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860200|NCT02783924|Vitamins|vitamins|mesh-ancestor
138860201|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
138860202|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138860203|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
138860204|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138860205|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860206|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860207|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138860209|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
138860210|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860211|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138860212|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138860213|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138860214|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
138860215|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860216|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860217|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
138860218|NCT02783378|Antacids|antacids|mesh-ancestor
138860219|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860220|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138860221|NCT05237726|Heparin|heparin|mesh-list
138860222|NCT05237726|Enoxaparin|enoxaparin|mesh-list
138860223|NCT05237726|Calcium heparin|calcium heparin|mesh-list
138860224|NCT05237726|Enoxaparin sodium|enoxaparin sodium|mesh-list
138860225|NCT05237726|Anticoagulants|anticoagulants|mesh-ancestor
138860226|NCT05237726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138860227|NCT05237726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138860228|NCT05237726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860229|NCT02783144|Dexamethasone|dexamethasone|mesh-list
138860230|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
138860231|NCT02783144|BB 1101|bb 1101|mesh-list
138860232|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138860233|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
138860234|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
138860235|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860236|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860237|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138860238|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
138860239|NCT02783144|Hormones|hormones|mesh-ancestor
138860240|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138860241|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138860242|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860243|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
138860244|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860245|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860247|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138860248|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860249|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
138860250|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
138860251|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
138860252|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860253|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
138860254|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138860255|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138860256|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138860257|NCT02689856|Lidocaine|lidocaine|mesh-list
138860258|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
138860259|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
138860260|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860261|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860262|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
138860263|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860264|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138860265|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138860266|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138860267|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138860268|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860269|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138860270|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138860271|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138860272|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138860273|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138860274|NCT02722746|Epinephrine|epinephrine|mesh-list
138860275|NCT02722746|Ropivacaine|ropivacaine|mesh-list
138860276|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
138860277|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
138860278|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860279|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860280|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
138860281|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860282|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138860283|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138860284|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
138860285|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860286|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860287|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138860288|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138860289|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
138860290|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138860291|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
138860292|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
138860293|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
138860294|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138860295|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
138860296|NCT02784626|Propofol|propofol|mesh-list
138860297|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138860298|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860299|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860300|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138860301|NCT02784626|Analgesics|analgesics|mesh-ancestor
138860302|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
138860303|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860304|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138860306|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138860307|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
138860308|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860309|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860310|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138860311|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
138860312|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
138860313|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
138860314|NCT02782754|Carboplatin|carboplatin|mesh-list
138860315|NCT02782754|Etoposide|etoposide|mesh-list
138860316|NCT02782754|Bleomycin|bleomycin|mesh-list
138860317|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138860318|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
138860319|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860320|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138860321|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138860322|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
138860323|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860324|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860325|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138860326|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138860327|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138860328|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138860329|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860330|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138860332|NCT05341076|Oxytocics|oxytocics|mesh-ancestor
138860333|NCT05341076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138860334|NCT05341076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860335|NCT05133518|Midazolam|midazolam|mesh-list
138860336|NCT05133518|Ketamine|ketamine|mesh-list
139020796|NCT02758717|Nivolumab|nivolumab|mesh-list
138860338|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
138860339|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860340|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860341|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138860342|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138860343|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
138860344|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
138860345|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860346|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138860347|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138860348|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860349|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860350|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138860351|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138860352|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138860353|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138860354|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138860355|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
138860356|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
138860357|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138860358|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
138860359|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138860360|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
138860361|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138860362|NCT02714166|Protective Agents|protective agents|mesh-ancestor
138860363|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860364|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
138860365|NCT04231682|Denosumab|denosumab|mesh-list
138860366|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138860367|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860368|NCT02722356|Oxytocin|oxytocin|mesh-list
138860369|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
138860370|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138860371|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860372|NCT00753675|Gemcitabine|gemcitabine|mesh-list
138860373|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138860374|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
138860375|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860376|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860377|NCT05131178|Bupivacaine|bupivacaine|mesh-list
138860378|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
138860379|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
138635913|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
138860380|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860381|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860382|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
138860383|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860384|NCT02546934|Cisplatin|cisplatin|mesh-list
138860385|NCT02546934|Gemcitabine|gemcitabine|mesh-list
138860386|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860387|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138860388|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
138860389|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860390|NCT00586521|Factor VIII|factor viii|mesh-list
138860391|NCT00586521|Coagulants|coagulants|mesh-ancestor
138860392|NCT02782286|Ketorolac|ketorolac|mesh-list
138860393|NCT02782286|Morphine|morphine|mesh-list
138860394|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138860395|NCT02782286|Narcotics|narcotics|mesh-ancestor
138860396|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860397|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860398|NCT02782286|Analgesics|analgesics|mesh-ancestor
139020807|NCT02758717|Immunotoxins|immunotoxins|mesh-ancestor
138860399|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
138860400|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860401|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138860402|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138860403|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138860404|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138603590|NCT00193284|Carboplatin|carboplatin|mesh-list
138860405|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138860406|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860407|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860408|NCT02600247|Acetaminophen|acetaminophen|mesh-list
138860410|NCT02600247|Pregabalin|pregabalin|mesh-list
138860411|NCT02600247|Oxycodone|oxycodone|mesh-list
138860412|NCT02600247|Tramadol|tramadol|mesh-list
138860413|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138860414|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138860415|NCT02600247|Analgesics|analgesics|mesh-ancestor
138860416|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
138860417|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860418|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860419|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
138860420|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
138860421|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138860422|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138860423|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860424|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138860425|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138860426|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138860427|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860428|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138860429|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138860430|NCT02600247|Narcotics|narcotics|mesh-ancestor
138860431|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138860432|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138860433|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138860434|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138860435|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138860436|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860437|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138860438|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138860439|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860440|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
138860441|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
138860442|NCT05453253|Vaccines|vaccines|mesh-list
138860443|NCT05453253|Immunologic Factors|immunologic factors|mesh-ancestor
138860444|NCT05453253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860445|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138860446|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138860447|NCT02717052|Ketamine|ketamine|mesh-list
138860448|NCT02717052|Esketamine|esketamine|mesh-list
138860449|NCT02717052|Analgesics|analgesics|mesh-ancestor
138860450|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
138860451|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860452|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860453|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138860454|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138860455|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
138860456|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
138860457|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860458|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138860459|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138860460|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860461|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860462|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
138946091|NCT04249167|Paclitaxel|paclitaxel|mesh-list
138860463|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138860464|NCT05342558|Fluticasone|fluticasone|mesh-list
138860465|NCT05342558|Xhance|xhance|mesh-list
138860466|NCT05342558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138860467|NCT05342558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138860468|NCT05342558|Autonomic Agents|autonomic agents|mesh-ancestor
138860469|NCT05342558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860470|NCT05342558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860471|NCT05342558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138860472|NCT05342558|Respiratory System Agents|respiratory system agents|mesh-ancestor
138860473|NCT05342558|Dermatologic Agents|dermatologic agents|mesh-ancestor
138860474|NCT05342558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138860475|NCT00923273|Folic Acid|folic acid|mesh-list
138860476|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
138860477|NCT00923273|Sirolimus|sirolimus|mesh-list
138860478|NCT00923273|Dexamethasone|dexamethasone|mesh-list
138860479|NCT00923273|Pemetrexed|pemetrexed|mesh-list
138860480|NCT00923273|Vitamins|vitamins|mesh-ancestor
138860481|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
138860482|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860483|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138860484|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
138860485|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
138860486|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860487|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138860488|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
138860489|NCT00923273|Hormones|hormones|mesh-ancestor
138860490|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138860491|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138860492|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860493|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860494|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860495|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138946123|NCT00574119|Diuretics|diuretics|mesh-ancestor
138860496|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138860497|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138860498|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138860499|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138860500|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
138860501|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138860502|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
138860503|NCT00923273|Hematinics|hematinics|mesh-ancestor
138860504|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
138860505|NCT04231370|Lenalidomide|lenalidomide|mesh-list
138860506|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
138860507|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860508|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138860509|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138860510|NCT04231370|Growth Substances|growth substances|mesh-ancestor
138860511|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
138860512|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860513|NCT05340530|Meropenem|meropenem|mesh-list
138860514|NCT05340530|Avibactam|avibactam|mesh-list
138860515|NCT05340530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138860516|NCT05340530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138860517|NCT05340530|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138860519|NCT05340530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860520|NCT00634712|Candesartan|candesartan|mesh-list
138860521|NCT00634712|Candesartan cilexetil|candesartan cilexetil|mesh-list
138860522|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138860523|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138860524|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138860525|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860526|NCT00923195|Aldesleukin|aldesleukin|mesh-list
138860527|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
138860528|NCT00923195|Fludarabine|fludarabine|mesh-list
138860529|NCT00923195|Interleukin-2|interleukin-2|mesh-list
138860530|NCT00923195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138860531|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138860532|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
138860533|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860535|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138860536|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
138860537|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860538|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860539|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138860540|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138860541|NCT00923195|Analgesics|analgesics|mesh-ancestor
138860542|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
138860543|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860544|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138860545|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138860546|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
138860547|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138860548|NCT00923195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138860549|NCT02721888|Liraglutide|liraglutide|mesh-list
138860550|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138860551|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860552|NCT02721888|Incretins|incretins|mesh-ancestor
138860553|NCT02721888|Hormones|hormones|mesh-ancestor
138860554|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138860555|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
138860556|NCT04256057|Analgesics|analgesics|mesh-ancestor
138860557|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
138860558|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860559|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860560|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
138860561|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860562|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138860563|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
138860564|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138860565|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138860566|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860567|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138860568|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
138860569|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138860570|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
138860571|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
138860572|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
138860573|NCT02714010|Gefitinib|gefitinib|mesh-list
138860574|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860575|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138860576|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860577|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860578|NCT00917241|Dexamethasone|dexamethasone|mesh-list
138860579|NCT00917241|Methimazole|methimazole|mesh-list
138860580|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138860581|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
138860582|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
138860583|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860584|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860585|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138860586|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
138860587|NCT00917241|Hormones|hormones|mesh-ancestor
138860588|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138860589|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138860590|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860591|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
138860592|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
138860593|NCT00919061|Gemcitabine|gemcitabine|mesh-list
138860594|NCT00919061|Sorafenib|sorafenib|mesh-list
138860595|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860596|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138860597|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
138860598|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860599|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138860600|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860601|NCT02598687|Paclitaxel|paclitaxel|mesh-list
138860602|NCT02598687|Carboplatin|carboplatin|mesh-list
138860603|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138860604|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860605|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
138860606|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
138860607|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
138860608|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860609|NCT04908605|Melatonin|melatonin|mesh-list
138860610|NCT04908605|Mirtazapine|mirtazapine|mesh-list
138860611|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
138860612|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860613|NCT04908605|Protective Agents|protective agents|mesh-ancestor
138860614|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860615|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860616|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
138860617|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138860618|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138860619|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
138512699|NCT00080275|Niacin|niacin|mesh-list
138860620|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
138860621|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946181|NCT00835965|Dexamethasone|dexamethasone|mesh-list
138860622|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138860623|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139020880|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138860624|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138860625|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138860626|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138860627|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
138860628|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138860629|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138603811|NCT00176280|Hormones|hormones|mesh-ancestor
138860631|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138860632|NCT02782208|Acipimox|acipimox|mesh-list
138860633|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138860634|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
138860635|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860636|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138860637|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
138860638|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138860639|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860640|NCT00611286|Sirolimus|sirolimus|mesh-list
138860641|NCT00611286|Paclitaxel|paclitaxel|mesh-list
138860642|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138860643|NCT00611286|Everolimus|everolimus|mesh-list
138860644|NCT00611286|Clopidogrel|clopidogrel|mesh-list
138860645|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
138860646|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138860647|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860648|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
138860649|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
138860650|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
138860651|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860652|NCT00611286|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138860653|NCT00611286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138860654|NCT00611286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860655|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138860656|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
138860657|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860658|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138860659|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138860660|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138860661|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
138860662|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860663|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138860664|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138860665|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138860666|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
138860667|NCT04257851|Sumatriptan|sumatriptan|mesh-list
138860668|NCT04257851|Theophylline|theophylline|mesh-list
138860669|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138860670|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138860671|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138860672|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
138860673|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860674|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860675|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860676|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138860677|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
138860678|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020896|NCT00494728|Nicotine|nicotine|mesh-list
138860679|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138860680|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
138860681|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138860682|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860683|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
138860684|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138860685|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138860686|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
138860687|NCT02780102|Methylphenidate|methylphenidate|mesh-list
138860688|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138860689|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860690|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138860691|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138860692|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138860693|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860694|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
138860695|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138512765|NCT00080626|Docetaxel|docetaxel|mesh-list
138860696|NCT04197050|Valsartan|valsartan|mesh-list
138860697|NCT04197050|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138860698|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138860699|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138860700|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138860701|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860702|NCT04090047|Itraconazole|itraconazole|mesh-list
138860703|NCT04090047|PF-06700841|pf-06700841|mesh-list
138860704|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
138860705|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138860706|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138860707|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138860708|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860709|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860710|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138860711|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
138860712|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138860713|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860714|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138860715|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138860716|NCT02782052|Bromides|bromides|mesh-list
138860717|NCT02782052|Albuterol|albuterol|mesh-list
138860718|NCT02782052|Ipratropium|ipratropium|mesh-list
138860719|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
138860720|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138860721|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
138860722|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860723|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860724|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138860725|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
138860726|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
138860727|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138860728|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138860730|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138860731|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
138860732|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860733|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860734|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138860735|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
138860736|NCT02708628|Heparin|heparin|mesh-list
138860737|NCT02708628|Allantoin|allantoin|mesh-list
138860738|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
138860739|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138860740|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138946193|NCT00835965|Hormones|hormones|mesh-ancestor
138860741|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860742|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
138860743|NCT00746733|Amphetamine|amphetamine|mesh-list
138860744|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138860745|NCT00746733|Adderall|adderall|mesh-list
138860746|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138860747|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860748|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
138860749|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
138860750|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860751|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
138860752|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860753|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860754|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
138860755|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138860756|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138860757|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138860758|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138860759|NCT00636870|Fexofenadine|fexofenadine|mesh-list
138860760|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138860761|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138860762|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138860763|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
138860764|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
138860765|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860766|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860767|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860768|NCT00634790|Alprazolam|alprazolam|mesh-list
138860769|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138860770|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860771|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860772|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138860773|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138860774|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138860775|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
138860776|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
138860777|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860778|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860779|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
138860780|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860781|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
138860782|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
138860783|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138860784|NCT00917397|Sertraline|sertraline|mesh-list
138860785|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
138860786|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138860787|NCT00917397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138860788|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138860789|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138860790|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860791|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860792|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
138860793|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860795|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
138860796|NCT02708160|Protective Agents|protective agents|mesh-ancestor
138860797|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860798|NCT04257461|Capecitabine|capecitabine|mesh-list
138860799|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
138860800|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138860801|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
138860802|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860803|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860804|NCT02712528|Sufentanil|sufentanil|mesh-list
138860805|NCT02712528|Remifentanil|remifentanil|mesh-list
138860806|NCT02712528|Sevoflurane|sevoflurane|mesh-list
138860807|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138860808|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138860809|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
138860810|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
138860811|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860812|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860813|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138860814|NCT02712528|Narcotics|narcotics|mesh-ancestor
138860815|NCT02712528|Analgesics|analgesics|mesh-ancestor
138860816|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
138860817|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860818|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138860819|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138860820|NCT04089657|Apatinib|apatinib|mesh-list
138860821|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860822|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138860823|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860824|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860825|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
138860826|NCT02713074|Povidone|povidone|mesh-list
138860827|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
138860829|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138860830|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138860831|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
138860832|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138860833|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138860834|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
138860835|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860836|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860837|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860838|NCT00745875|Pemetrexed|pemetrexed|mesh-list
138860839|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860840|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860841|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138512911|NCT00399685|Efavirenz|efavirenz|mesh-list
138860842|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138860843|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138860844|NCT04089813|Metformin|metformin|mesh-list
138860845|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138860846|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860847|NCT00555217|Losartan|losartan|mesh-list
138860848|NCT00555217|Lisinopril|lisinopril|mesh-list
138860849|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138860850|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138860851|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138860852|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138860853|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860854|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138860855|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
138860856|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860857|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138860858|NCT00555217|Protective Agents|protective agents|mesh-ancestor
138860859|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860860|NCT02711904|Remifentanil|remifentanil|mesh-list
138860861|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138860862|NCT02711904|Narcotics|narcotics|mesh-ancestor
138860863|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138860864|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860865|NCT02711904|Analgesics|analgesics|mesh-ancestor
138860866|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
138860867|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860868|NCT05326490|Metformin|metformin|mesh-list
138860869|NCT05326490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138860870|NCT05326490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860871|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
138860872|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138860873|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
138860874|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860875|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
138860876|NCT02693808|Protective Agents|protective agents|mesh-ancestor
138860877|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
138860878|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138860879|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138860880|NCT02711982|Prednisolone|prednisolone|mesh-list
138860881|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
138860882|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138860883|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
138860884|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138860885|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
138860886|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
138860887|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860888|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860889|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138860890|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
138860891|NCT02711982|Hormones|hormones|mesh-ancestor
138860892|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138860893|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138860894|NCT02711982|Protective Agents|protective agents|mesh-ancestor
138860895|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138860896|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860897|NCT00745095|Neostigmine|neostigmine|mesh-list
138860898|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138860899|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946242|NCT05664542|Ropivacaine|ropivacaine|mesh-list
138860900|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860902|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860903|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860904|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138860905|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
138860906|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860907|NCT05181462|Carboplatin|carboplatin|mesh-list
138860908|NCT05181462|Gemcitabine|gemcitabine|mesh-list
138860909|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860910|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138860911|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
138860912|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860913|NCT00612612|Rituximab|rituximab|mesh-list
138860914|NCT00612612|Fludarabine|fludarabine|mesh-list
138860915|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
138860916|NCT00612612|Obatoclax|obatoclax|mesh-list
138860917|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138860918|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860919|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
138860920|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860921|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138860922|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138860923|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
138860924|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860925|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138860927|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138860928|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138860929|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860930|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138860931|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138860932|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138860933|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138860934|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860935|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138860936|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860937|NCT00940693|Analgesics|analgesics|mesh-ancestor
138860938|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
138860939|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138860940|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
138860941|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138860942|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
138860943|NCT02598063|Lamivudine|lamivudine|mesh-list
138860944|NCT02598063|Adefovir|adefovir|mesh-list
138860945|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138860946|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138860947|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138860948|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138860949|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138860950|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860951|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
138860952|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138860953|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138860954|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138860955|NCT02707458|Probucol|probucol|mesh-list
138860956|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138860957|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138860958|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
138788093|NCT02682082|Bupivacaine|bupivacaine|mesh-list
138860959|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860960|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138860961|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
138860962|NCT02707458|Protective Agents|protective agents|mesh-ancestor
138860963|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860964|NCT00950677|Exenatide|exenatide|mesh-list
138860965|NCT00950677|Pramlintide|pramlintide|mesh-list
138860966|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138860967|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860968|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138860969|NCT00950677|Incretins|incretins|mesh-ancestor
138860970|NCT00950677|Hormones|hormones|mesh-ancestor
138860971|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138860972|NCT05174598|Calcitriol|calcitriol|mesh-list
138860973|NCT05174598|Calcipotriene|calcipotriene|mesh-list
138860974|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
138860975|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138860976|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860977|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138860978|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138860979|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860980|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138860981|NCT05174598|Vitamins|vitamins|mesh-ancestor
138860982|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
138860983|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138860984|NCT05341856|Isosorbide|isosorbide|mesh-list
138860985|NCT05341856|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138860986|NCT05341856|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138860987|NCT05341856|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138860988|NCT05341856|Diuretics|diuretics|mesh-ancestor
138860989|NCT05341856|Natriuretic Agents|natriuretic agents|mesh-ancestor
138860990|NCT05341856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138860991|NCT05341856|Vasodilator Agents|vasodilator agents|mesh-ancestor
138860992|NCT05341856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138860993|NCT05341856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138860994|NCT00951223|Interferons|interferons|mesh-list
138860995|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
138860996|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138860997|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
138860998|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138860999|NCT02711592|Analgesics|analgesics|mesh-list
138861000|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
138861001|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861002|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861003|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
138861004|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138861005|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
138861006|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
138861007|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861008|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861009|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138861010|NCT00948103|Analgesics|analgesics|mesh-ancestor
138861011|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
138861012|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861013|NCT02012114|Cysteamine|cysteamine|mesh-list
138861014|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138861015|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861016|NCT05301205|Gabapentin|gabapentin|mesh-list
138861017|NCT05301205|Analgesics|analgesics|mesh-ancestor
138861018|NCT05301205|Sensory System Agents|sensory system agents|mesh-ancestor
138861019|NCT05301205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861020|NCT05301205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861021|NCT05301205|Anticonvulsants|anticonvulsants|mesh-ancestor
138861022|NCT05301205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138861023|NCT05301205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138946295|NCT00842595|Analgesics|analgesics|mesh-ancestor
138861024|NCT05301205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861025|NCT05301205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138861026|NCT05301205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138861027|NCT05301205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138861028|NCT05301205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861029|NCT05301205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861030|NCT05301205|Antimanic Agents|antimanic agents|mesh-ancestor
138861031|NCT02707224|Candesartan|candesartan|mesh-list
138861032|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
138861033|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138861034|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138861035|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138861036|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
138861037|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861038|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138861039|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138861040|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861041|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138861042|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138861043|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138861045|NCT04229264|Clopidogrel|clopidogrel|mesh-list
138861046|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138861047|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138861048|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138861049|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138861050|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
138861051|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861052|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861053|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861054|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138861055|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
138861056|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138861057|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
138861058|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861059|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
138861060|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
138861061|NCT02597829|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138861062|NCT02597829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138861063|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861064|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
138861065|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861066|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138861069|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
138861070|NCT02711202|Tacrolimus|tacrolimus|mesh-list
138861071|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861072|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
138861073|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861074|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138861075|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861076|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861077|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138861078|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861079|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138861080|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861081|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
138861082|NCT02711202|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138861083|NCT02711202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138861084|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
138861085|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138861086|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138861087|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138861088|NCT04227938|ALPN-101|alpn-101|mesh-list
138861089|NCT04227938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861090|NCT04227938|Immunologic Factors|immunologic factors|mesh-ancestor
138861091|NCT04227938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861092|NCT02711358|Indomethacin|indomethacin|mesh-list
138861093|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138861094|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138861095|NCT02711358|Analgesics|analgesics|mesh-ancestor
138771739|NCT00909532|Ivacaftor|ivacaftor|mesh-list
138861096|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
138861097|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861098|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861099|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138861100|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138861101|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
138861102|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
138861103|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138861104|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138861105|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861106|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861108|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138861109|NCT04962152|Narcotics|narcotics|mesh-ancestor
138861110|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861111|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861113|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
138861114|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861115|NCT00744627|Vortioxetine|vortioxetine|mesh-list
138861116|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
138861117|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138861118|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138861119|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138861120|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861121|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861122|NCT00744627|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138861123|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138861124|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138861125|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861126|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861127|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
138861128|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138861129|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138861130|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138861131|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138861132|NCT04942886|Entecavir|entecavir|mesh-list
138861133|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
138861134|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861135|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
138861136|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
138861137|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138861138|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138861139|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138513203|NCT00135499|Hormones|hormones|mesh-ancestor
138861140|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861141|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138861142|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138861144|NCT02711280|Sevoflurane|sevoflurane|mesh-list
138861145|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138861146|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861147|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861148|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138861149|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
138861150|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
138861151|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138861152|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138861153|NCT00948493|Insulin|insulin|mesh-list
138861154|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138861155|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138861156|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861157|NCT00952003|Bevacizumab|bevacizumab|mesh-list
138861158|NCT00952003|Docetaxel|docetaxel|mesh-list
138861159|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
138861160|NCT00952003|Irinotecan|irinotecan|mesh-list
138861161|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138861162|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861163|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138861164|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138861165|NCT00952003|Growth Substances|growth substances|mesh-ancestor
138861166|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861167|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
138861168|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
138861169|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
138861170|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
138946346|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138861171|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861172|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138788100|NCT00640432|Celecoxib|celecoxib|mesh-list
138861173|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138861174|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861175|NCT00612144|Metformin|metformin|mesh-list
138861176|NCT00612144|Glimepiride|glimepiride|mesh-list
138861177|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138861178|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861179|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138861180|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861181|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
138861182|NCT02597361|Irbesartan|irbesartan|mesh-list
138861183|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138861184|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138861185|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138861186|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861187|NCT00562627|Ketorolac|ketorolac|mesh-list
138861188|NCT00562627|Epinephrine|epinephrine|mesh-list
138861189|NCT00562627|Racepinephrine|racepinephrine|mesh-list
138861190|NCT00562627|Fentanyl|fentanyl|mesh-list
138861191|NCT00562627|Morphine|morphine|mesh-list
138861192|NCT00562627|Bupivacaine|bupivacaine|mesh-list
138861193|NCT00562627|Ropivacaine|ropivacaine|mesh-list
138861194|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
138861195|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
138861196|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
138861197|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861198|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861199|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
138861200|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861201|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138861202|NCT00562627|Narcotics|narcotics|mesh-ancestor
138861203|NCT00562627|Analgesics|analgesics|mesh-ancestor
138861204|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138861205|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138861207|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138861208|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138861209|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
138861210|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861211|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861212|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138861213|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138513280|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861214|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
138861215|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138861216|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
138861217|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
138861218|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
138861219|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138861220|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138861221|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138861222|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138861223|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138946380|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861224|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138861225|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861226|NCT02597283|Sirolimus|sirolimus|mesh-list
138861227|NCT02597283|Temsirolimus|temsirolimus|mesh-list
138543085|NCT03238365|Tadalafil|tadalafil|mesh-list
138861228|NCT02597283|MTOR Inhibitors|mtor inhibitors|mesh-list
138861229|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138861230|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861231|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138861232|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861233|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
138861234|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861235|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
138861236|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861237|NCT02597283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138861238|NCT02597283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861239|NCT02597283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861240|NCT00948649|Varenicline|varenicline|mesh-list
138861241|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138861242|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138861243|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
138861244|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861245|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861246|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861247|NCT00952159|Tramadol|tramadol|mesh-list
138861248|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
138861249|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138861250|NCT00952159|Narcotics|narcotics|mesh-ancestor
138861251|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861252|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861253|NCT00952159|Analgesics|analgesics|mesh-ancestor
138861254|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
138861255|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861256|NCT00948727|Cyclosporine|cyclosporine|mesh-list
138861257|NCT00948727|Cyclosporins|cyclosporins|mesh-list
138861258|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861259|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861260|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861261|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
138861262|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861263|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
138861264|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861265|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
138861266|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138861267|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138861268|NCT02778776|Metformin|metformin|mesh-list
138861269|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138861270|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861271|NCT00948805|Goserelin|goserelin|mesh-list
138861272|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138861273|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138861274|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861275|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138861276|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861277|NCT02710656|Paclitaxel|paclitaxel|mesh-list
138636805|NCT00247715|Pantoprazole|pantoprazole|mesh-list
138861278|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138861279|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861280|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
138861281|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
138861282|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
138861283|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861284|NCT02780882|Pasireotide|pasireotide|mesh-list
138861285|NCT02780882|Hormones|hormones|mesh-ancestor
138861286|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138861287|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861288|NCT02710266|Gabexate|gabexate|mesh-list
138861289|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
138861290|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138861291|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
138861292|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861293|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861294|NCT00562159|Fluticasone|fluticasone|mesh-list
138861295|NCT00562159|Xhance|xhance|mesh-list
138861296|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
138861297|NCT00562159|Loratadine|loratadine|mesh-list
138861298|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138861299|NCT00562159|Prednisone|prednisone|mesh-list
138861300|NCT00562159|Albuterol|albuterol|mesh-list
138861301|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138861302|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
138861303|NCT00562159|Hormones|hormones|mesh-ancestor
138861304|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138861305|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861306|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138861307|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861308|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138861309|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
138861310|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861311|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138861312|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
138861313|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
138861314|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138861315|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
138861316|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138861317|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138861318|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138861319|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138861320|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
138861321|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861322|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861323|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
138861324|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138861325|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138861326|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
138861327|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
138861328|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138861329|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138861330|NCT00562159|Analgesics|analgesics|mesh-ancestor
138861331|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
138861332|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138861333|NCT02710110|Capsaicin|capsaicin|mesh-list
138861334|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
138861335|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
138861336|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
138861337|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861338|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861339|NCT00952627|Pycnogenols|pycnogenols|mesh-list
138861341|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
138861342|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861343|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
138861344|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861345|NCT00952627|Protective Agents|protective agents|mesh-ancestor
138861346|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138861347|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138861348|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138861349|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138861350|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138636881|NCT00278265|Methotrexate|methotrexate|mesh-list
139210379|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138861351|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861352|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861353|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861354|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138861355|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
138861356|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138861357|NCT04848714|Antivenins|antivenins|mesh-list
138861358|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
138861359|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861360|NCT00952861|Doxycycline|doxycycline|mesh-list
138861361|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138861362|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861363|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
138861364|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138861365|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138861366|NCT04223778|Islatravir|islatravir|mesh-list
138861367|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
138861368|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861369|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861370|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861371|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138861372|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138861373|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138861374|NCT05109416|Bupivacaine|bupivacaine|mesh-list
138861375|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
138861376|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
138861377|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861378|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861379|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
138861380|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861381|NCT02778308|Gemcitabine|gemcitabine|mesh-list
138861382|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861383|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138861384|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
138861385|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861386|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
138861387|NCT02776202|Sirolimus|sirolimus|mesh-list
138861388|NCT02776202|Fludarabine|fludarabine|mesh-list
138861389|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
138861390|NCT02776202|Melphalan|melphalan|mesh-list
138861391|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861392|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138861393|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
138861394|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861395|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861396|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
138861397|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861398|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138861399|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138861400|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
138861401|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139021144|NCT03367533|Ketamine|ketamine|mesh-list
138861402|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861403|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861404|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
138861405|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138861406|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
138861407|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138861408|NCT00921557|Vitamin D|vitamin d|mesh-list
138861409|NCT00921557|Alendronate|alendronate|mesh-list
138861410|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
138861411|NCT00921557|Calcium|calcium|mesh-list
138861412|NCT00921557|Vitamins|vitamins|mesh-ancestor
138861413|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
138861414|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861415|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138861416|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138861417|NCT00921557|Antacids|antacids|mesh-ancestor
138861418|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861419|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138861420|NCT00611754|Fluorouracil|fluorouracil|mesh-list
138861421|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
138861422|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
138861423|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861424|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138861425|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861426|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861427|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
138861428|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861430|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
138861431|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861432|NCT02779634|Vitamins|vitamins|mesh-ancestor
138861433|NCT04255589|Ethanol|ethanol|mesh-list
138861434|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138861435|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861436|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861437|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861438|NCT00744471|Tanezumab|tanezumab|mesh-list
138861439|NCT00744471|Analgesics|analgesics|mesh-ancestor
138861440|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
138861441|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861442|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861443|NCT02776436|Dexamethasone|dexamethasone|mesh-list
138861444|NCT02776436|Prednisone|prednisone|mesh-list
138861445|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138861446|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
138861447|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
138861448|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861449|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861450|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138861451|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
138861452|NCT02776436|Hormones|hormones|mesh-ancestor
138861453|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138861454|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138861455|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861456|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138861457|NCT02775968|Azithromycin|azithromycin|mesh-list
138861458|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
138861459|NCT02775968|Erythromycin|erythromycin|mesh-list
138861460|NCT02775968|Cephalosporins|cephalosporins|mesh-list
138861461|NCT02775968|Cefamandole|cefamandole|mesh-list
138861462|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138946443|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
138861463|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138861464|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138861465|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861466|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861467|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
138861468|NCT02775734|Clomiphene|clomiphene|mesh-list
138861469|NCT02775734|Enclomiphene|enclomiphene|mesh-list
138861470|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
138861471|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138861472|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861473|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138861474|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
138861475|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138861476|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861477|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138861478|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
138861479|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138861480|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138861481|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138861482|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
138861483|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861484|NCT02775734|Expectorants|expectorants|mesh-ancestor
138861485|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
138861486|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138861487|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
138861488|NCT02775734|Protective Agents|protective agents|mesh-ancestor
138861489|NCT02775734|Antidotes|antidotes|mesh-ancestor
138861490|NCT02772926|Benphothiamine|benphothiamine|mesh-list
138861491|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138861492|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
138861493|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861494|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
138861495|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
138861496|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861497|NCT02709564|Misoprostol|misoprostol|mesh-list
138946463|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861498|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138861499|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
138861500|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138861501|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861502|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138637041|NCT00285519|Doxazosin|doxazosin|mesh-list
138861503|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138861504|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
138861506|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138861507|NCT04688814|Narcotics|narcotics|mesh-ancestor
138861508|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861509|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861510|NCT04688814|Analgesics|analgesics|mesh-ancestor
138861511|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
138861512|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861513|NCT00744237|Metoprolol|metoprolol|mesh-list
138861514|NCT00744237|Nebivolol|nebivolol|mesh-list
138861515|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138861516|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138861517|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
138861518|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
138861519|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861520|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861521|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138861522|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138861523|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138861524|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
138861525|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861526|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861527|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
138861528|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138861529|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138861530|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138861532|NCT05260554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138861533|NCT05260554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861534|NCT04089345|Ustekinumab|ustekinumab|mesh-list
138861535|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
138861536|NCT02693574|Amoxicillin|amoxicillin|mesh-list
138861537|NCT02693574|Clarithromycin|clarithromycin|mesh-list
138861538|NCT02693574|Levofloxacin|levofloxacin|mesh-list
138861539|NCT02693574|Esomeprazole|esomeprazole|mesh-list
138861540|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138861541|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861542|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138861543|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138861544|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138861545|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861546|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861547|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138861548|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138861549|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138861550|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138861551|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138861552|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138861553|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861554|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138861556|NCT04179266|Analgesics|analgesics|mesh-ancestor
138861557|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
138861558|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861559|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861560|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138861561|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138861562|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
138861563|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
138861564|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861565|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138861566|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138861567|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861568|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861569|NCT00743145|Naltrexone|naltrexone|mesh-list
138861570|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138861571|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138861572|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861573|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
138861574|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861575|NCT00611910|Sirolimus|sirolimus|mesh-list
138861576|NCT00611910|Paclitaxel|paclitaxel|mesh-list
138861577|NCT00611910|Temsirolimus|temsirolimus|mesh-list
138861578|NCT00611910|MTOR Inhibitors|mtor inhibitors|mesh-list
138861579|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138861580|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861581|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
138861582|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
138861583|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
138861584|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861585|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138861586|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861587|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138861588|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
138861589|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861590|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
138861591|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861592|NCT00611910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138861593|NCT00611910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861594|NCT00920855|Bortezomib|bortezomib|mesh-list
138861595|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138861596|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861597|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138861598|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
138861599|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861600|NCT04251845|Melatonin|melatonin|mesh-list
138861601|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
138861602|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861603|NCT04251845|Protective Agents|protective agents|mesh-ancestor
138861604|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861605|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861606|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
138861607|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
138861608|NCT05207358|Rituximab|rituximab|mesh-list
138861609|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861610|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
138861611|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861612|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138861613|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138861614|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
138861615|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861616|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861617|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138861618|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138861619|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138861620|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138861621|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
138861622|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138861623|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861624|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861625|NCT05387031|Ustekinumab|ustekinumab|mesh-list
138861626|NCT05387031|Dermatologic Agents|dermatologic agents|mesh-ancestor
138861627|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
138861628|NCT04570644|Ibuprofen|ibuprofen|mesh-list
138861629|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138861630|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138861631|NCT04570644|Analgesics|analgesics|mesh-ancestor
138861632|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
138861633|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861634|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861635|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138861636|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138861637|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138861638|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861639|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861640|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
138861641|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
138861642|NCT04570644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138861643|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138861644|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
138861645|NCT02775110|Natalizumab|natalizumab|mesh-list
138861646|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
138861647|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861648|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
138861649|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
138861650|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861651|NCT02775266|Protective Agents|protective agents|mesh-ancestor
138861652|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861653|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
138861654|NCT02775266|Vitamins|vitamins|mesh-ancestor
138861655|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
138861656|NCT02774876|Insulin|insulin|mesh-list
138861657|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138861658|NCT02774876|Hormones|hormones|mesh-list
138861659|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138861660|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861661|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138861662|NCT04225364|Paclitaxel|paclitaxel|mesh-list
138861663|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138861664|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138861665|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861666|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
138861667|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
138861668|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
138861669|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861670|NCT02771834|Vitamin D|vitamin d|mesh-list
138861671|NCT02771834|Vitamins|vitamins|mesh-ancestor
138861672|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
138861673|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861674|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138861675|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138861676|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138861677|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
138861678|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861679|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138861680|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138861681|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
138861682|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
138861683|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861684|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861685|NCT00613470|Citalopram|citalopram|mesh-list
138861686|NCT00613470|Escitalopram|escitalopram|mesh-list
138604858|NCT02904304|Analgesics|analgesics|mesh-ancestor
138861687|NCT00613470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138861688|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138861689|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138861690|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861692|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
138861693|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946521|NCT00372385|Interferons|interferons|mesh-list
138861694|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138861695|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
138861696|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138861697|NCT02771912|Propofol|propofol|mesh-list
138861698|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138861699|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138861700|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861701|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861702|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138861703|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
138861704|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
138861705|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138861706|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138861707|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138861708|NCT00741819|Treprostinil|treprostinil|mesh-list
138861709|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138861710|NCT04457466|Mitogens|mitogens|mesh-list
138861711|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
138861712|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861713|NCT04954742|Riociguat|riociguat|mesh-list
138861714|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
138861715|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861716|NCT04193696|Immunomodulating Agents|immunomodulating agents|mesh-list
138861717|NCT04193696|Immunologic Factors|immunologic factors|mesh-ancestor
138861718|NCT04193696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861719|NCT02774096|Xenon|xenon|mesh-list
138861720|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138861721|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
138861722|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
138861723|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861724|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861725|NCT04181385|Bromocriptine|bromocriptine|mesh-list
138861726|NCT04181385|Olanzapine|olanzapine|mesh-list
138861727|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
138861728|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
138861729|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861730|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861731|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138861732|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138861733|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138861734|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861735|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138861736|NCT04181385|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138861737|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138861738|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138861739|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861740|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861741|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
138861742|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138861743|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138513805|NCT00139750|Varenicline|varenicline|mesh-list
138861744|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
138861745|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138861746|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
138861747|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
138861748|NCT00924443|Clofarabine|clofarabine|mesh-list
138861749|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138946535|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
138861750|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
138861751|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861752|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861753|NCT02677155|Rituximab|rituximab|mesh-list
138861754|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
138861755|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138861756|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861757|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
138861758|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861759|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138861760|NCT02677155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138861761|NCT02677155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861762|NCT02537691|Theophylline|theophylline|mesh-list
138861763|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138861764|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
138861765|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861766|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861767|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138861768|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
138861769|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138861770|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861771|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861772|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
138861773|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138861774|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138861775|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
138861776|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861777|NCT04225052|Varenicline|varenicline|mesh-list
138861778|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138861779|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138861780|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
138861781|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861782|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861783|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861784|NCT04255121|Lidocaine|lidocaine|mesh-list
138861785|NCT04255121|Epinephrine|epinephrine|mesh-list
138861786|NCT04255121|Racepinephrine|racepinephrine|mesh-list
138861787|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
138861788|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
138861789|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
138861790|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861791|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861792|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
138861793|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861794|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138861795|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138861796|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138861797|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139021268|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
138861798|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861799|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138861800|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138861801|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
138861802|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861803|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138861804|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138861805|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
138861806|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138861807|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
138861808|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
138861809|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
138861810|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138861811|NCT03521232|Niclosamide|niclosamide|mesh-list
138861812|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
138861813|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138861814|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
138861815|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138861816|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861817|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
138861818|NCT00924287|Aldesleukin|aldesleukin|mesh-list
138861819|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
138861821|NCT00924287|Interleukin-2|interleukin-2|mesh-list
138861823|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861824|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
138861825|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861826|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138861827|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138861828|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
138861829|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861830|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861831|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138861832|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138861833|NCT00924287|Analgesics|analgesics|mesh-ancestor
138861834|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
138861835|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861837|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138861838|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
138861839|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861840|NCT00924287|Protective Agents|protective agents|mesh-ancestor
138861841|NCT02696954|Lumefantrine|lumefantrine|mesh-list
138861842|NCT02696954|Artemether|artemether|mesh-list
138861843|NCT02696954|Primaquine|primaquine|mesh-list
138861844|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138861845|NCT02696954|Amodiaquine|amodiaquine|mesh-list
138861846|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
138861847|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138861848|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138861849|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861850|NCT02677077|Natalizumab|natalizumab|mesh-list
138861851|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
138861852|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861853|NCT02771600|Anesthetics|anesthetics|mesh-list
138861854|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
138861855|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861856|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861857|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
138861858|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861859|NCT02773316|Morphine|morphine|mesh-list
138861860|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138861861|NCT02773316|Narcotics|narcotics|mesh-ancestor
138861862|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139021282|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
138861863|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861865|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
138861866|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861867|NCT00642681|Insulin|insulin|mesh-list
138861868|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138861869|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861870|NCT02773550|Prednisone|prednisone|mesh-list
138861871|NCT02773550|Bortezomib|bortezomib|mesh-list
138861872|NCT02773550|Melphalan|melphalan|mesh-list
138861873|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138861874|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
138861875|NCT02773550|Hormones|hormones|mesh-ancestor
138861876|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138861877|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861878|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138861879|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861880|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138861881|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
138861882|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861883|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138861884|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861885|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
138861886|NCT02773472|Morphine|morphine|mesh-list
138861887|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138861888|NCT02773472|Narcotics|narcotics|mesh-ancestor
138861889|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861890|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861891|NCT02773472|Analgesics|analgesics|mesh-ancestor
138861892|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
138861893|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861894|NCT00637871|Tamoxifen|tamoxifen|mesh-list
138861895|NCT00637871|Bicalutamide|bicalutamide|mesh-list
138861896|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138861897|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
138861898|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138861899|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861900|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138861901|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861902|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138861903|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138861904|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138861905|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
138861906|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138861907|NCT00635258|Ganirelix|ganirelix|mesh-list
138861908|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138605083|NCT05880459|Narcotics|narcotics|mesh-ancestor
138861909|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861911|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138861912|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
138861913|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138861914|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138861915|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138861916|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138861917|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
138861918|NCT00642837|Acetaminophen|acetaminophen|mesh-list
138861919|NCT00642837|Tramadol|tramadol|mesh-list
138861920|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138861921|NCT00642837|Analgesics|analgesics|mesh-ancestor
138861922|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
138861923|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861924|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861926|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138861927|NCT00642837|Narcotics|narcotics|mesh-ancestor
138861928|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861929|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138861930|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138861931|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138861932|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861933|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861934|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
138861935|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138861936|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138861937|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138861938|NCT02676609|Insulin|insulin|mesh-list
138861939|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138861940|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861941|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
138861942|NCT00642915|Glimepiride|glimepiride|mesh-list
138861943|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138861944|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861945|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138861946|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861947|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
138861948|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
138861949|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138861950|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
138861951|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861952|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861953|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138861954|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
138861955|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
138861956|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138861957|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
138861958|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138861959|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861960|NCT02696720|Lidocaine|lidocaine|mesh-list
138861961|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
138861962|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
138861963|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861964|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861965|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
138861966|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861967|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138861968|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138861969|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138861970|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138861971|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861972|NCT00643071|Tacrolimus|tacrolimus|mesh-list
138861973|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138861974|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
138861975|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861976|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138861977|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861978|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861979|NCT03728634|Vitamin A|vitamin a|mesh-list
138861980|NCT03728634|Vitamins|vitamins|mesh-ancestor
138861981|NCT03728634|Micronutrients|micronutrients|mesh-ancestor
138861982|NCT03728634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861984|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138861985|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138861986|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
138861987|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138861988|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138861989|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138861990|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138861991|NCT04353414|Bupivacaine|bupivacaine|mesh-list
138861992|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
138861993|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
138861994|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138861995|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138861996|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
138861997|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138861998|NCT00643149|Amoxicillin|amoxicillin|mesh-list
138861999|NCT00643149|Azithromycin|azithromycin|mesh-list
138862000|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138862001|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862002|NCT05141682|Azacitidine|azacitidine|mesh-list
138862003|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138862004|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
138862005|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862006|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862007|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862008|NCT00643227|Azithromycin|azithromycin|mesh-list
138862009|NCT00643227|Clarithromycin|clarithromycin|mesh-list
138862010|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138862011|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862012|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138862013|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862014|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862015|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138862016|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138862017|NCT00613392|Antioxidants|antioxidants|mesh-list
138862018|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862019|NCT00613392|Protective Agents|protective agents|mesh-ancestor
138862020|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862021|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
138862022|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138862023|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
138862024|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138862025|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
138862026|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862027|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862028|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
138862029|NCT02762864|Clopidogrel|clopidogrel|mesh-list
138862030|NCT02762864|Ticagrelor|ticagrelor|mesh-list
138862031|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862032|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862033|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138862034|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138946639|NCT02563704|Quinine|quinine|mesh-list
138862035|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138862036|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138862037|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
138862038|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138862039|NCT02767154|Mannitol|mannitol|mesh-list
138862040|NCT02767154|Dextrans|dextrans|mesh-list
138862041|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138862042|NCT02767154|Diuretics|diuretics|mesh-ancestor
138862043|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
138514105|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862044|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862045|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
138862046|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
138862047|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
138862048|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138862049|NCT02767232|Plasminogen|plasminogen|mesh-list
138862050|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138862051|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138862052|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862053|NCT02767076|Anesthetics|anesthetics|mesh-list
138862054|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138862055|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862057|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138862058|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862059|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
138862060|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138862061|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862062|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862063|NCT02770508|Ritonavir|ritonavir|mesh-list
138862064|NCT02770508|Darunavir|darunavir|mesh-list
138862065|NCT02770508|Tenofovir|tenofovir|mesh-list
138862066|NCT02770508|Lamivudine|lamivudine|mesh-list
138862067|NCT02770508|Emtricitabine|emtricitabine|mesh-list
138862068|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138862069|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138862070|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
138862071|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862072|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862073|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138862074|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138862075|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
138862076|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862077|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138862078|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138862079|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138862080|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138862081|NCT02762942|Misoprostol|misoprostol|mesh-list
138862082|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138862083|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
138862084|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138862085|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862086|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138862087|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138862088|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
138862089|NCT02770430|Infliximab|infliximab|mesh-list
138862090|NCT02770430|Basiliximab|basiliximab|mesh-list
138862091|NCT02770430|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138862092|NCT02770430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138862093|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
138862094|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138862095|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138862096|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138862097|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
138862098|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862099|NCT00918203|Paclitaxel|paclitaxel|mesh-list
138862100|NCT00918203|Carboplatin|carboplatin|mesh-list
138862101|NCT00918203|Olaratumab|olaratumab|mesh-list
138862102|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138862103|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862104|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
138862105|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
138862106|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
138862107|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862108|NCT00644319|Ibuprofen|ibuprofen|mesh-list
138862109|NCT00644319|Morphine|morphine|mesh-list
138862110|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138862111|NCT00644319|Narcotics|narcotics|mesh-ancestor
138862112|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138862113|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862114|NCT00644319|Analgesics|analgesics|mesh-ancestor
138862115|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
138862116|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862117|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138862118|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138862119|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138862120|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138862121|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138862122|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862123|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862124|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
138862125|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138862126|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138862127|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862128|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
138862129|NCT04224116|Coagulants|coagulants|mesh-ancestor
138862130|NCT02672709|Apixaban|apixaban|mesh-list
138862131|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138862132|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
138946672|NCT00742404|Hormones|hormones|mesh-ancestor
138862133|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138862134|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
138862135|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862136|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862137|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
138862138|NCT02770274|Aspirin|aspirin|mesh-list
138862139|NCT02770274|Cilostazol|cilostazol|mesh-list
138862140|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138862141|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138862142|NCT02770274|Analgesics|analgesics|mesh-ancestor
138862143|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
138862144|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862145|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862146|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138862147|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138862148|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138862149|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138862150|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862151|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138862152|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138862153|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862154|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
138862155|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138862156|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
138862157|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138862158|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
138862159|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
138862160|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138862161|NCT02770274|Protective Agents|protective agents|mesh-ancestor
138862162|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138862163|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138862164|NCT00910221|Atorvastatin|atorvastatin|mesh-list
138862165|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138862166|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138862167|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
138862168|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862169|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138862170|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138862171|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862172|NCT04657562|Tacrolimus|tacrolimus|mesh-list
138862173|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138862174|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
138862175|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862176|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138862177|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862178|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862179|NCT05252117|Carticaine|carticaine|mesh-list
138862180|NCT05252117|Mepivacaine|mepivacaine|mesh-list
138862181|NCT05252117|Anesthetics, Local|anesthetics, local|mesh-ancestor
138862182|NCT05252117|Anesthetics|anesthetics|mesh-ancestor
138862183|NCT05252117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138862184|NCT05252117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862185|NCT05252117|Sensory System Agents|sensory system agents|mesh-ancestor
138862186|NCT05252117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862187|NCT04224350|Tacrolimus|tacrolimus|mesh-list
138862188|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138862189|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
138946700|NCT00749112|Rituximab|rituximab|mesh-list
138862190|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862191|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138862192|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862193|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862194|NCT02770716|Terlipressin|terlipressin|mesh-list
138862195|NCT02770716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138862196|NCT02770716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138862197|NCT02672241|Temozolomide|temozolomide|mesh-list
138862198|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
138862199|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138862200|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
138862201|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862202|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862203|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138862204|NCT04177875|Paclitaxel|paclitaxel|mesh-list
138862205|NCT04177875|Docetaxel|docetaxel|mesh-list
138862206|NCT04177875|Cisplatin|cisplatin|mesh-list
138862207|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138862208|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138862209|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862210|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
138862211|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
138862212|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
138862213|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862214|NCT00917579|Atorvastatin|atorvastatin|mesh-list
138862215|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138862216|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138862217|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
138862218|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862219|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138862220|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138862221|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862222|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138862223|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138862224|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138862225|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138862226|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862227|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
138862228|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138862229|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862230|NCT02766140|Docetaxel|docetaxel|mesh-list
138862231|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862232|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
138862233|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
138862234|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
138862235|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862236|NCT04177641|Antioxidants|antioxidants|mesh-list
138862237|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862238|NCT04177641|Protective Agents|protective agents|mesh-ancestor
138862239|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862240|NCT04178109|Acetaminophen|acetaminophen|mesh-list
138862241|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138862242|NCT04178109|Tramadol|tramadol|mesh-list
138862243|NCT04178109|Ropivacaine|ropivacaine|mesh-list
138862244|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
138862245|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
138862246|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
138862247|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138862248|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862249|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
138862250|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862251|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138862252|NCT04178109|Analgesics|analgesics|mesh-ancestor
138862253|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
139210380|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138862254|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138862255|NCT04178109|Narcotics|narcotics|mesh-ancestor
138862256|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138862257|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138862258|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138862259|NCT00644475|Candesartan|candesartan|mesh-list
138862260|NCT00644475|Candesartan cilexetil|candesartan cilexetil|mesh-list
138862261|NCT00644475|Imidapril|imidapril|mesh-list
138862262|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138862263|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138862264|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138862265|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862266|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138862267|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
138862268|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862269|NCT04177719|Oxytocin|oxytocin|mesh-list
138862270|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
138862271|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138862272|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862273|NCT00644553|Amoxicillin|amoxicillin|mesh-list
138862274|NCT00644553|Clarithromycin|clarithromycin|mesh-list
138862275|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
138862276|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138862277|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138862278|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862279|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138862280|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862281|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862282|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138862283|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138862284|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138862285|NCT02762474|Paclitaxel|paclitaxel|mesh-list
138862286|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138862287|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862288|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
138862289|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
138862290|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
138862291|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862292|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
138862293|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138862294|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138862295|NCT00915473|Prednisolone|prednisolone|mesh-list
138862296|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
138862297|NCT00915473|Lidocaine|lidocaine|mesh-list
138862298|NCT00915473|Bupivacaine|bupivacaine|mesh-list
138862299|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138862300|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
138862301|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
138862302|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
138862303|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138862304|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862305|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
138946741|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
138862306|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862307|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138862308|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138862309|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138862310|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138862311|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862312|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138862313|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
138862314|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
138862315|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138862316|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
138862317|NCT00915473|Hormones|hormones|mesh-ancestor
138862318|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138862319|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138862320|NCT00915473|Protective Agents|protective agents|mesh-ancestor
138862321|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138862322|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862323|NCT04691726|Dipyrone|dipyrone|mesh-list
138862324|NCT04691726|Lidocaine|lidocaine|mesh-list
138862325|NCT04691726|Morphine|morphine|mesh-list
138862326|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
138862327|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
138862328|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138862329|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862330|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
138862331|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862332|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138862333|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138862334|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138862335|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139021412|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
138862336|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862337|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138862338|NCT04691726|Narcotics|narcotics|mesh-ancestor
138862339|NCT04691726|Analgesics|analgesics|mesh-ancestor
138862340|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138862341|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138862342|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138514400|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138862343|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138862344|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
138862346|NCT00614328|Baclofen|baclofen|mesh-list
138862347|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138862349|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862350|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
138862351|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862352|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138862353|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138862354|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138862355|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
138862356|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
138862357|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138862358|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862359|NCT04177173|Methotrexate|methotrexate|mesh-list
138862360|NCT04177173|Simvastatin|simvastatin|mesh-list
138862361|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138862362|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
138862363|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138862364|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862365|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138862366|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
138862367|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862368|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862369|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
138862370|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862371|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138862372|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138862373|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
138862374|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138862375|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138862376|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138862377|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138862378|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138862379|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138862380|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138862381|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138862382|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
138862383|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138862384|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
138862385|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138862386|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862387|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138862388|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138862389|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862390|NCT03651804|Acetaminophen|acetaminophen|mesh-list
138862391|NCT03651804|Diphosphonates|diphosphonates|mesh-list
138862392|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138862393|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138862394|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138862395|NCT03651804|Analgesics|analgesics|mesh-ancestor
138862396|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
138862397|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862398|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862399|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
139210381|NCT03495713|Nivolumab|nivolumab|mesh-list
138862400|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138862401|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138862402|NCT00917267|Exenatide|exenatide|mesh-list
138862403|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138862404|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862405|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138862406|NCT00917267|Incretins|incretins|mesh-ancestor
138862407|NCT00917267|Hormones|hormones|mesh-ancestor
138862408|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138862409|NCT02670759|Bupivacaine|bupivacaine|mesh-list
138862410|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
138862411|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
138862412|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138862413|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862414|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
138862415|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862416|NCT00644943|Amoxicillin|amoxicillin|mesh-list
138862417|NCT00644943|Cefdinir|cefdinir|mesh-list
138862418|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138862419|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862420|NCT02762006|Durvalumab|durvalumab|mesh-list
138862421|NCT02762006|Tremelimumab|tremelimumab|mesh-list
138862422|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138862423|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862425|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138862426|NCT05213507|Amikacin|amikacin|mesh-list
138862427|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138862428|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862429|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138862430|NCT04253873|Temozolomide|temozolomide|mesh-list
138862431|NCT04253873|Apatinib|apatinib|mesh-list
138862432|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138862433|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
138862434|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862435|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862436|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138862437|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862438|NCT05147727|Fluconazole|fluconazole|mesh-list
138862439|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
138862440|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862441|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138862442|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138862443|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862444|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862445|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138862446|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
138862447|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138862448|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862449|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138862450|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138862451|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
138862452|NCT02765594|Valsartan|valsartan|mesh-list
138862453|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138862454|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138862455|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138862456|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862457|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
138862458|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138862459|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138862460|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862461|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862462|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138862463|NCT00920699|Ubiquinone|ubiquinone|mesh-list
138862464|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
138862465|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
138862466|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862467|NCT00920699|Vitamins|vitamins|mesh-ancestor
138862468|NCT02670135|Triclosan|triclosan|mesh-list
138862469|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138862470|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139021430|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138862471|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138862472|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138862473|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
138862474|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862475|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138862476|NCT02769494|Riboflavin|riboflavin|mesh-list
138862477|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
138862478|NCT02769494|Mesalamine|mesalamine|mesh-list
138862479|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
138862480|NCT02769494|Vitamins|vitamins|mesh-ancestor
138862481|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
138862482|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862483|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138862484|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
138862485|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138862486|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138862487|NCT02769494|Analgesics|analgesics|mesh-ancestor
138862488|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
138862489|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862490|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138862491|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138862492|NCT02769572|Diclofenac|diclofenac|mesh-list
138862493|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138862494|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138862495|NCT02769572|Analgesics|analgesics|mesh-ancestor
138862496|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
138862497|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862498|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862499|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138862501|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138862502|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862503|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862504|NCT02669589|Heparin|heparin|mesh-list
138862505|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
138862506|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862507|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138862508|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138862509|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
138862510|NCT02765204|Saxagliptin|saxagliptin|mesh-list
138862511|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138862512|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862513|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138862514|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862515|NCT02765204|Incretins|incretins|mesh-ancestor
138862516|NCT02765204|Hormones|hormones|mesh-ancestor
138862517|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138862518|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138862519|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
138862520|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862521|NCT03342456|Amoxicillin|amoxicillin|mesh-list
138862522|NCT03342456|Doxycycline|doxycycline|mesh-list
138862523|NCT03342456|Furazolidone|furazolidone|mesh-list
138862524|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
138862525|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862526|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138862527|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862528|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
138862529|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138862530|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138862531|NCT03342456|Diuretics|diuretics|mesh-ancestor
138862533|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862534|NCT03342456|Expectorants|expectorants|mesh-ancestor
138862535|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
138862536|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138862537|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138862538|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138862539|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138862540|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862541|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138862542|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
138862543|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138862544|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
138862545|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862546|NCT02769104|Docetaxel|docetaxel|mesh-list
138862547|NCT02769104|Letrozole|letrozole|mesh-list
138862548|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138862549|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862550|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
138862551|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
138862552|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
138862553|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862554|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138862555|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862556|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138862557|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
138862558|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138862559|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862560|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
138862561|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138862562|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862563|NCT00645255|Sibutramine|sibutramine|mesh-list
138862564|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
138862565|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138862566|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
138862567|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138862568|NCT00910455|SRX246|srx246|mesh-list
138862569|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138514638|NCT05461807|Apixaban|apixaban|mesh-list
138862570|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862572|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862573|NCT02765126|Vaccines|vaccines|mesh-list
138862574|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
138862575|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862576|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138862577|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138862578|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862579|NCT00916721|Propranolol|propranolol|mesh-list
138862580|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138862581|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138862582|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
138862583|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138862584|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862585|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862586|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138862587|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138862588|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
138862589|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
138862590|NCT00613782|Testosterone|testosterone|mesh-list
138862591|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
138862592|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
138862593|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138862594|NCT00613782|Androgens|androgens|mesh-ancestor
138862595|NCT00613782|Hormones|hormones|mesh-ancestor
138862596|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138862597|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862598|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138862599|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862600|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
138862601|NCT02764736|Atorvastatin|atorvastatin|mesh-list
138862602|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138862603|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138862604|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
138862605|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862606|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138862607|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138862608|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862609|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
138862610|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138862611|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862612|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138862613|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
138862614|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138862615|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862616|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862617|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862618|NCT00646815|Hormones|hormones|mesh-list
138862619|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138862620|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862621|NCT00915005|Paclitaxel|paclitaxel|mesh-list
138862622|NCT00915005|Carboplatin|carboplatin|mesh-list
138862623|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138862624|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862625|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
138862626|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
138862627|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138862628|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862629|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
138862630|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138862631|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862632|NCT02696642|Maytansine|maytansine|mesh-list
138862633|NCT02696642|Anetumab ravtansine|anetumab ravtansine|mesh-list
138862634|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138862635|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862636|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
138862637|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
138862638|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
138862639|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862640|NCT02696642|Immunoconjugates|immunoconjugates|mesh-ancestor
138862641|NCT02696642|Immunologic Factors|immunologic factors|mesh-ancestor
138862642|NCT02696642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862644|NCT00647049|Rituximab|rituximab|mesh-list
138862645|NCT00647049|Methotrexate|methotrexate|mesh-list
138862646|NCT00647049|Thiotepa|thiotepa|mesh-list
138862647|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138862648|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862649|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
138862650|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862651|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138862652|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138862653|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
138862654|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138862655|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138862656|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
138862657|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862658|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
138862659|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946893|NCT00749736|Vitamin D|vitamin d|mesh-list
138862660|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138862661|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138862662|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138862663|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
138862664|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862665|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138862666|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
138862667|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138862668|NCT02696330|Enoxaparin|enoxaparin|mesh-list
138862669|NCT02696330|Clopidogrel|clopidogrel|mesh-list
138862670|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138862671|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138862672|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138862673|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138862674|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
138862675|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138862676|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862677|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862678|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
138862679|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138862680|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138862681|NCT04172727|Bupivacaine|bupivacaine|mesh-list
138862682|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
138862683|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
138862684|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138862685|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862686|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
138862687|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862688|NCT04648319|Nivolumab|nivolumab|mesh-list
138862689|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138862690|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862691|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138862692|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862693|NCT00647127|Fentanyl|fentanyl|mesh-list
138862694|NCT00647127|Buprenorphine|buprenorphine|mesh-list
138862695|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138862696|NCT00647127|Narcotics|narcotics|mesh-ancestor
138862697|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138862698|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862699|NCT00647127|Analgesics|analgesics|mesh-ancestor
138862700|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
138862701|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862702|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138862703|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138862704|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
138862705|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
138862706|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138862707|NCT04750070|Dopamine|dopamine|mesh-list
138862708|NCT04750070|Epinephrine|epinephrine|mesh-list
138862709|NCT04750070|Racepinephrine|racepinephrine|mesh-list
138862710|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
138862711|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138862712|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138862713|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
138862714|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138862715|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138514775|NCT02964403|Analgesics|analgesics|mesh-ancestor
138862716|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605909|NCT02901145|Nivolumab|nivolumab|mesh-list
138862717|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139021490|NCT00346216|Ibuprofen|ibuprofen|mesh-list
138862718|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138862719|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
138862720|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862721|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138862722|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
138862723|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
138862724|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
138862725|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138862726|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138862727|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
138862728|NCT04750070|Protective Agents|protective agents|mesh-ancestor
138862730|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
138862731|NCT01143246|Terlipressin|terlipressin|mesh-list
138862732|NCT01143246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138862733|NCT01143246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138862734|NCT00647673|Verapamil|verapamil|mesh-list
138862735|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138862736|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138862737|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138862738|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862739|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138862740|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862741|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
138862742|NCT00561925|Nevirapine|nevirapine|mesh-list
138862743|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138862744|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138862745|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862746|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862747|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
138862748|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862749|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138862750|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138862751|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138862752|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138862753|NCT02760992|Baclofen|baclofen|mesh-list
138862754|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138862755|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862756|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138862757|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862758|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138862759|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
138862760|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
138862761|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138862762|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862763|NCT00647751|Lamotrigine|lamotrigine|mesh-list
138862764|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
138862765|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138862766|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138862767|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862768|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138862769|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862770|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138862771|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139021491|NCT00346216|Celecoxib|celecoxib|mesh-list
138862772|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138862773|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138862774|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138862775|NCT02536989|Omeprazole|omeprazole|mesh-list
138862777|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138862778|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138862779|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862780|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862781|NCT00647829|Valdecoxib|valdecoxib|mesh-list
138862782|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138862783|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138862784|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862785|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862786|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138862787|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138862788|NCT00647829|Analgesics|analgesics|mesh-ancestor
138862789|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
138862790|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605986|NCT00169169|Rituximab|rituximab|mesh-list
138862791|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862793|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138862794|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
138862795|NCT02517918|Sirolimus|sirolimus|mesh-list
138862796|NCT02517918|Methotrexate|methotrexate|mesh-list
138862797|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138862798|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
138862799|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138862800|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862801|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138862802|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
138862803|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946975|NCT00852189|Folic Acid|folic acid|mesh-list
138862804|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862805|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
138862806|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862807|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138862808|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138862809|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
138862810|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138862811|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138862812|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138862813|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862814|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138862815|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
138862816|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138862817|NCT00647907|Voriconazole|voriconazole|mesh-list
139021512|NCT01051648|Hormones|hormones|mesh-ancestor
138862818|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
138862819|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862820|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138862821|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138862822|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862823|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862824|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138862825|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
138862826|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138862827|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862828|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138862830|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862831|NCT04003818|Teicoplanin|teicoplanin|mesh-list
138862832|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138862833|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862834|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
138862835|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138862836|NCT00949663|Incretins|incretins|mesh-ancestor
138862837|NCT00949663|Hormones|hormones|mesh-ancestor
138862838|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138862839|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862840|NCT00647985|Fexofenadine|fexofenadine|mesh-list
138862841|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138862842|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138862843|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138862844|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
138862845|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
138862846|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138862847|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210382|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138862848|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862849|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
138862850|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
138862851|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
138862852|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862853|NCT02664051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138947004|NCT05301010|Docetaxel|docetaxel|mesh-list
138862854|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138862855|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138862856|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
138862857|NCT00648063|Letrozole|letrozole|mesh-list
138862858|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862859|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138862860|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138862861|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606057|NCT00553618|Aldesleukin|aldesleukin|mesh-list
138862862|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862863|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138862864|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
138862865|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138862866|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862867|NCT00648141|Celecoxib|celecoxib|mesh-list
138862868|NCT00648141|Diclofenac|diclofenac|mesh-list
138862869|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138862870|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138862871|NCT00648141|Analgesics|analgesics|mesh-ancestor
138862872|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
138862873|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862874|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862875|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138862876|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138862877|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138862878|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138862879|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862880|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862881|NCT00953641|Misoprostol|misoprostol|mesh-list
138862882|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138862883|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
138862884|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138862885|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862886|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138862887|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138862888|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
138862889|NCT02763098|Remifentanil|remifentanil|mesh-list
138862890|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138862891|NCT02763098|Narcotics|narcotics|mesh-ancestor
138862892|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138862893|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862894|NCT02763098|Analgesics|analgesics|mesh-ancestor
138862895|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
138862896|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862897|NCT00648219|Olmesartan|olmesartan|mesh-list
138862898|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138862899|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138862900|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138862901|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138862902|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862903|NCT00648297|Nadolol|nadolol|mesh-list
138862904|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
138862905|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138862906|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138862907|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
138862908|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138862909|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862910|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862911|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138862912|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138862913|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
138862914|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
138862915|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862917|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
138862918|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138862919|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138862920|NCT00648453|Clopidogrel|clopidogrel|mesh-list
138862921|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138862922|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138862923|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138862925|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
138862926|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138862927|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862928|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862929|NCT00549445|Azithromycin|azithromycin|mesh-list
138862930|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138862931|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862932|NCT00637026|Gefitinib|gefitinib|mesh-list
138862933|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862934|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138862936|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862937|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
138862938|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138862939|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862940|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138862941|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138862942|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862943|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862944|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862945|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138862946|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138862947|NCT02758340|Misoprostol|misoprostol|mesh-list
138862948|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138862949|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
138862950|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138862951|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862952|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138862953|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138862954|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
138862955|NCT02768168|Dezocine|dezocine|mesh-list
138862956|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138862957|NCT02768168|Narcotics|narcotics|mesh-ancestor
138862958|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138862959|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862960|NCT02768168|Analgesics|analgesics|mesh-ancestor
138862961|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
138862962|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862963|NCT02659683|Esomeprazole|esomeprazole|mesh-list
138862964|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138862965|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138862966|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138862967|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862968|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862969|NCT02659761|Lamivudine|lamivudine|mesh-list
138862970|NCT02659761|Abacavir|abacavir|mesh-list
138862971|NCT02659761|Dolutegravir|dolutegravir|mesh-list
138862972|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138862973|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138862974|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138862975|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138862976|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
138862977|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138862978|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138862979|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138862980|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138862981|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138862982|NCT05343546|Copper|copper|mesh-list
138862983|NCT05343546|Levonorgestrel|levonorgestrel|mesh-list
139021631|NCT02533492|Triclosan|triclosan|mesh-list
138862984|NCT05343546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138862985|NCT05343546|Contraceptive Agents|contraceptive agents|mesh-ancestor
138862986|NCT05343546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138862987|NCT05343546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862988|NCT05343546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138862989|NCT05343546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138862990|NCT05343546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138862991|NCT05343546|Trace Elements|trace elements|mesh-ancestor
138862992|NCT05343546|Micronutrients|micronutrients|mesh-ancestor
138862993|NCT02659917|Methamphetamine|methamphetamine|mesh-list
138862994|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139210383|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138862995|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138862996|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
138862997|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
138862998|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138862999|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
138863000|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863001|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863002|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
138863003|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138863004|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138863005|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138863006|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138863007|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138863008|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138863009|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863011|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863012|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863013|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
138515078|NCT02825641|Oxytocin|oxytocin|mesh-list
138863014|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138863015|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138863016|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138863017|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138863018|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138863019|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947054|NCT00852423|Artemether|artemether|mesh-list
138863020|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863021|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863022|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138863023|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
138863024|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138863025|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863026|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138863027|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138863028|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138863029|NCT00649233|Metoprolol|metoprolol|mesh-list
138863030|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138863031|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138863032|NCT00649233|Diuretics|diuretics|mesh-ancestor
138863033|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
138863034|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863035|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138863036|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138863037|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863038|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138863039|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
138863040|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
138863041|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863042|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138863043|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138863044|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138863045|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
138863046|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863047|NCT00954811|Progesterone|progesterone|mesh-list
138863048|NCT00954811|Progestins|progestins|mesh-ancestor
138863049|NCT00954811|Hormones|hormones|mesh-ancestor
138863050|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138863051|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863052|NCT00954889|Tamsulosin|tamsulosin|mesh-list
138863053|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138863054|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138863055|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138863056|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
138863057|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863058|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863059|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863060|NCT00954889|Urological Agents|urological agents|mesh-ancestor
138863061|NCT02692248|Dexamethasone|dexamethasone|mesh-list
138863062|NCT02692248|Rituximab|rituximab|mesh-list
138863063|NCT02692248|Gemcitabine|gemcitabine|mesh-list
138863064|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
138863065|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138863066|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
138863067|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
138863068|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863069|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863070|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138863071|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
138863073|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138863074|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138863075|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863076|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138863077|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
138863078|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138863079|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138863080|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
138863081|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863082|NCT02851290|Anesthetics|anesthetics|mesh-list
138863083|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863084|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863085|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138515157|NCT01466361|Nicotine|nicotine|mesh-list
138863086|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138863087|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863088|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863089|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138863090|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138863091|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863092|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
138863093|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863094|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138863095|NCT00601107|Vitamins|vitamins|mesh-ancestor
138863096|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
138863097|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863098|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138863099|NCT00957385|Lenalidomide|lenalidomide|mesh-list
138863100|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
138863101|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863102|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138863103|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138863104|NCT00957385|Growth Substances|growth substances|mesh-ancestor
138863105|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
138863106|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863107|NCT04169841|Durvalumab|durvalumab|mesh-list
138863108|NCT04169841|Olaparib|olaparib|mesh-list
138863109|NCT04169841|Tremelimumab|tremelimumab|mesh-list
138863110|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138863111|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863112|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138863113|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863114|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863115|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
138863116|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139021736|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138863117|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863118|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138863119|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863120|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863121|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138642890|NCT00269126|Hormones|hormones|mesh-ancestor
138863122|NCT02462538|Immunotoxins|immunotoxins|mesh-ancestor
138863123|NCT02462538|Immunoconjugates|immunoconjugates|mesh-ancestor
138863124|NCT02462538|Immunologic Factors|immunologic factors|mesh-ancestor
138863125|NCT02462538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863126|NCT02752646|Ketorolac|ketorolac|mesh-list
138863127|NCT02752646|Nepafenac|nepafenac|mesh-list
138863128|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138863129|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138863130|NCT02752646|Analgesics|analgesics|mesh-ancestor
138863131|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
138863132|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863133|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863134|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138863135|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138863136|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138863137|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638698|NCT00253721|Melphalan|melphalan|mesh-list
138863138|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863140|NCT04169919|Povidone|povidone|mesh-list
138863141|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
138863142|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
138863143|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138863144|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138863145|NCT02757248|Romidepsin|romidepsin|mesh-list
138863146|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138863147|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863148|NCT02757248|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138863149|NCT02757248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863150|NCT02757248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863151|NCT00649311|Losartan|losartan|mesh-list
138863152|NCT00649311|Eplerenone|eplerenone|mesh-list
138863153|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138863154|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138863155|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138863156|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138863157|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863158|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138863159|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
138863160|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138863161|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863162|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138863164|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
138863166|NCT02704494|Resveratrol|resveratrol|mesh-list
138863167|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138863168|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138863169|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138863170|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138863171|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863172|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
138863173|NCT02704494|Protective Agents|protective agents|mesh-ancestor
138863174|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863175|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863176|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138863177|NCT00649467|Topiramate|topiramate|mesh-list
138863178|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
138863179|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138863180|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863181|NCT00649545|Adalimumab|adalimumab|mesh-list
138947127|NCT00688740|Docetaxel|docetaxel|mesh-list
138863182|NCT00649545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138863183|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138863184|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138863185|NCT00635414|Esomeprazole|esomeprazole|mesh-list
138863186|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138863187|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138863188|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138863189|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863190|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863191|NCT02658435|Tafenoquine|tafenoquine|mesh-list
138863192|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
138863193|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138863194|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138863195|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138863196|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
138863197|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
138863198|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
138863199|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138863200|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
138863201|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863202|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138863203|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138863204|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
138863205|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021792|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138863206|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863207|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138863208|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138863209|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
138863210|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138863211|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138863212|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138863213|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863215|NCT02759666|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138863216|NCT02759666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863217|NCT02759666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863218|NCT02759666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863219|NCT02752724|Ketamine|ketamine|mesh-list
138863220|NCT02752724|Methohexital|methohexital|mesh-list
138863221|NCT02752724|Analgesics|analgesics|mesh-ancestor
138863222|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
138863223|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863224|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863225|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138863226|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138863227|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
138863228|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
138863229|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863230|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138863231|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138947148|NCT05323058|Benzydamine|benzydamine|mesh-list
138863232|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863233|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863234|NCT00649623|Olmesartan|olmesartan|mesh-list
138863235|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138863236|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138863237|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138863238|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138863239|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863241|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863242|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863243|NCT02657187|Rocuronium|rocuronium|mesh-list
138863244|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138863245|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138863246|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138863247|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863248|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863249|NCT00649779|Albuterol|albuterol|mesh-list
138863250|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138863251|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
138863252|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863253|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863254|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138863255|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
138863256|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
138863257|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138863258|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138863259|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138863260|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138863261|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
138863262|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863263|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863264|NCT00615186|Temozolomide|temozolomide|mesh-list
138863265|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138947168|NCT00942136|Omeprazole|omeprazole|mesh-list
138863266|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
138863267|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863268|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863269|NCT00616044|Anesthetics|anesthetics|mesh-list
138863270|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863271|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863272|NCT02536911|Eliglustat|eliglustat|mesh-list
138863273|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863274|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863275|NCT04221152|Empagliflozin|empagliflozin|mesh-list
138863276|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138863277|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021864|NCT00512252|Cytarabine|cytarabine|mesh-list
138863278|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138863279|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863280|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138863281|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863282|NCT02759510|Phenylephrine|phenylephrine|mesh-list
138863283|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
138863284|NCT02759510|Norepinephrine|norepinephrine|mesh-list
138863285|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138863286|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
138863287|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
138863288|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863289|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863290|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
138863291|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138863292|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
138863293|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
138863294|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138863295|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138863296|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138863297|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
138863298|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863299|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863300|NCT02759510|Protective Agents|protective agents|mesh-ancestor
138863301|NCT04220528|Capecitabine|capecitabine|mesh-list
138947202|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
138863302|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138863303|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
138863304|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863305|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863306|NCT02759042|Leronlimab|leronlimab|mesh-list
138863307|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138863308|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138863309|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863310|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138863311|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138863312|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
138863313|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138863314|NCT02755532|Bupivacaine|bupivacaine|mesh-list
138863315|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
138863316|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
138863317|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863318|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863319|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
138863320|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863321|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
138863322|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138863323|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
138863324|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863325|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
138863326|NCT02755376|Protective Agents|protective agents|mesh-ancestor
138863327|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
138863328|NCT02752334|Bupivacaine|bupivacaine|mesh-list
138863329|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
138863330|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
138863331|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863332|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863333|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
138863334|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863335|NCT02752334|Analgesics|analgesics|mesh-ancestor
138863336|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138863337|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
138863338|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138863339|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138863340|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863341|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138863342|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
138863343|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138863344|NCT02755298|Acetazolamide|acetazolamide|mesh-list
138863345|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
138863346|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138863347|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863348|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863349|NCT02755298|Diuretics|diuretics|mesh-ancestor
138863350|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
138863351|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863352|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138863353|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138863354|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
138863355|NCT02759198|Celecoxib|celecoxib|mesh-list
138863356|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138863357|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138863358|NCT02759198|Analgesics|analgesics|mesh-ancestor
138863359|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
138863360|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863361|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863363|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138863364|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138863365|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138863366|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863367|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863369|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
138863370|NCT02755064|Erythromycin|erythromycin|mesh-list
138863371|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
138863372|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138863373|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
138863374|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
138863375|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138863376|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138863377|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138863378|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138863379|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863380|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863381|NCT02705976|Warfarin|warfarin|mesh-list
138515458|NCT00010361|Cyclosporine|cyclosporine|mesh-list
138863382|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
138863383|NCT02752412|Insulin|insulin|mesh-list
138863384|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138863385|NCT02752412|Metformin|metformin|mesh-list
138863386|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
138863387|NCT02752412|Lixisenatide|lixisenatide|mesh-list
138863388|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138863389|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863390|NCT02703090|Remifentanil|remifentanil|mesh-list
138863391|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138863392|NCT02703090|Narcotics|narcotics|mesh-ancestor
138863393|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863394|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863395|NCT02703090|Analgesics|analgesics|mesh-ancestor
138863396|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
138863397|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863398|NCT02754362|Bevacizumab|bevacizumab|mesh-list
138863399|NCT02754362|Poly ICLC|poly iclc|mesh-list
138863400|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138863401|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
138863402|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138863403|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863404|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138863405|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138863406|NCT02754362|Growth Substances|growth substances|mesh-ancestor
138863407|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863408|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
138863409|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
138863410|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
138863411|NCT03373188|Nivolumab|nivolumab|mesh-list
138863412|NCT03373188|Ipilimumab|ipilimumab|mesh-list
138863413|NCT03373188|Antibodies|antibodies|mesh-list
138947268|NCT00619983|Gabapentin|gabapentin|mesh-list
138863414|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138863415|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
138863416|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863417|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138863418|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863419|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138863420|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863421|NCT02698098|Methadone|methadone|mesh-list
138863422|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138863423|NCT02698098|Narcotics|narcotics|mesh-ancestor
138863424|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863425|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863426|NCT02698098|Analgesics|analgesics|mesh-ancestor
138863427|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
138863428|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863429|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
138863430|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
138863431|NCT04220996|Vortioxetine|vortioxetine|mesh-list
138863432|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
138863433|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138863434|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138863435|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138863436|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863437|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863438|NCT04220996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138863439|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138863440|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138863441|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863442|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863443|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
138863444|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138863445|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138863446|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138863447|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138863448|NCT02702700|Verteporfin|verteporfin|mesh-list
138863449|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138863450|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
138863451|NCT02702622|Provitamins|provitamins|mesh-list
138863452|NCT02702622|Beta Carotene|beta carotene|mesh-list
138863454|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
138863455|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863456|NCT04214808|Dutasteride|dutasteride|mesh-list
138863457|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138863458|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138863459|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863460|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863461|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
138863462|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138863463|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863465|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138863466|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
138863468|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138863469|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863470|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138863471|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863472|NCT02753738|Escitalopram|escitalopram|mesh-list
138863473|NCT02753738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138863474|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138863475|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138947284|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
138863476|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863477|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863478|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
138863479|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863480|NCT02751632|Fluoxetine|fluoxetine|mesh-list
138863481|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-list
138863482|NCT02751632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138863483|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138863484|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138863485|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863486|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863487|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
138863488|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863489|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139022098|NCT00416715|Antacids|antacids|mesh-ancestor
138863490|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138863491|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138863492|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138863493|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863494|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138863495|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138863496|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863497|NCT02751476|Disinfectants|disinfectants|mesh-list
138863498|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138863499|NCT02705664|Amorolfine|amorolfine|mesh-list
138863500|NCT02705664|Bifonazole|bifonazole|mesh-list
138863501|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
138863502|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138863503|NCT02753426|Doxycycline|doxycycline|mesh-list
138863504|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138863505|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138863506|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
138863507|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138863508|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138863509|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
138606710|NCT05349448|Hormones|hormones|mesh-ancestor
138863510|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138863511|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863513|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863515|NCT02702076|Emetics|emetics|mesh-ancestor
138863516|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863517|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
138863518|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863519|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138863520|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
138863521|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
138863522|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863523|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863524|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
138863525|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138863526|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863527|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138863528|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863529|NCT02753114|Ketamine|ketamine|mesh-list
138515606|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
138863530|NCT02753114|Analgesics|analgesics|mesh-ancestor
138863531|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
138863532|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863533|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863534|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138863535|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138863536|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
138863537|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
138863538|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863539|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138863540|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138863541|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863542|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863543|NCT02705274|Bevacizumab|bevacizumab|mesh-list
138863544|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138863545|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863546|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138863547|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138863548|NCT02705274|Growth Substances|growth substances|mesh-ancestor
138863549|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863550|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
138863551|NCT00914849|Plerixafor|plerixafor|mesh-list
138863552|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138863553|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138863554|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
138863555|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138863556|NCT02704962|Olanzapine|olanzapine|mesh-list
138863557|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
138863558|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
138863559|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863560|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863561|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138863562|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138863563|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138863564|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863565|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138863566|NCT02704962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138863567|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138863568|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138863569|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863570|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863571|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
138863572|NCT00631943|Pregabalin|pregabalin|mesh-list
138863573|NCT00631943|Analgesics|analgesics|mesh-ancestor
138863574|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
138863575|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863576|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863577|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
138863578|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138863579|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138863580|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639134|NCT01607671|Timolol|timolol|mesh-list
138863581|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138863582|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138863583|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138863584|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863585|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138863586|NCT05429684|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138863587|NCT05429684|Capecitabine|capecitabine|mesh-list
138863588|NCT05429684|Trastuzumab|trastuzumab|mesh-list
138863589|NCT05429684|Everolimus|everolimus|mesh-list
138863590|NCT05429684|Letrozole|letrozole|mesh-list
138863591|NCT05429684|Palbociclib|palbociclib|mesh-list
138863592|NCT05429684|Pertuzumab|pertuzumab|mesh-list
138863593|NCT05429684|Antibodies|antibodies|mesh-list
138863594|NCT05429684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138863595|NCT05429684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863596|NCT05429684|Tubulin Modulators|tubulin modulators|mesh-ancestor
138863597|NCT05429684|Antimitotic Agents|antimitotic agents|mesh-ancestor
138863598|NCT05429684|Mitosis Modulators|mitosis modulators|mesh-ancestor
138863599|NCT05429684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863600|NCT05429684|Immunologic Factors|immunologic factors|mesh-ancestor
138863601|NCT05429684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863602|NCT05429684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138863603|NCT05429684|Antimetabolites|antimetabolites|mesh-ancestor
138863604|NCT05429684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138863605|NCT05429684|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138863606|NCT05429684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138863607|NCT05429684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863608|NCT05429684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138863609|NCT05429684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138863610|NCT05429684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138863611|NCT05429684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138863612|NCT05429684|Hormone Antagonists|hormone antagonists|mesh-ancestor
138863613|NCT05429684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138863614|NCT05429684|Immunotoxins|immunotoxins|mesh-ancestor
138863615|NCT05429684|Immunoconjugates|immunoconjugates|mesh-ancestor
138863616|NCT05324592|Aflibercept|aflibercept|mesh-list
138863617|NCT05324592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138863618|NCT05324592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138863619|NCT05324592|Growth Substances|growth substances|mesh-ancestor
138863620|NCT05324592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863621|NCT05324592|Growth Inhibitors|growth inhibitors|mesh-ancestor
138863622|NCT05324592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863624|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
138863625|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863626|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138863627|NCT02750696|Acetaminophen|acetaminophen|mesh-list
138863628|NCT02750696|Tramadol|tramadol|mesh-list
138863629|NCT02750696|Codeine|codeine|mesh-list
138863630|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138863631|NCT02750696|Analgesics|analgesics|mesh-ancestor
138863632|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
138863633|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863634|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863635|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
138863636|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138863637|NCT02750696|Narcotics|narcotics|mesh-ancestor
138863638|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863639|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
138863640|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
138863641|NCT02695550|Conteltinib|conteltinib|mesh-list
138863642|NCT02695550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138863643|NCT02695550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863644|NCT02695550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863645|NCT00912743|Olaparib|olaparib|mesh-list
138863646|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138863647|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863648|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863649|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863650|NCT04432610|Nebivolol|nebivolol|mesh-list
138863651|NCT04432610|Bisoprolol|bisoprolol|mesh-list
138863652|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138863653|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
138863654|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139210384|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138863655|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138863656|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138863657|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
138863659|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863660|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863661|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
138863662|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
138863663|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863664|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138863665|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138863666|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138863667|NCT04643093|Ezetimibe|ezetimibe|mesh-list
138863668|NCT04643093|Pitavastatin|pitavastatin|mesh-list
138863669|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138863670|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138863671|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
138863672|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863673|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138863674|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138863675|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863676|NCT00914459|Factor VIII|factor viii|mesh-list
138863677|NCT00914459|Coagulants|coagulants|mesh-ancestor
138863678|NCT02701608|Levofloxacin|levofloxacin|mesh-list
138863679|NCT02701608|Rifampin|rifampin|mesh-list
139022230|NCT00509262|Incretins|incretins|mesh-ancestor
138515752|NCT01818323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863681|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138863682|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138863683|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138863684|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138863685|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138863686|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863687|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863688|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863689|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138863690|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138863691|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138863692|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
138863693|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
138863694|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138863695|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138863696|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138863697|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138863698|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138863699|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138863700|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138863701|NCT00635960|Hormones|hormones|mesh-list
138863702|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138863703|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863704|NCT05429294|Paclitaxel|paclitaxel|mesh-list
138863705|NCT05429294|Trastuzumab|trastuzumab|mesh-list
138863706|NCT05429294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138863707|NCT05429294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863708|NCT05429294|Tubulin Modulators|tubulin modulators|mesh-ancestor
138863709|NCT05429294|Antimitotic Agents|antimitotic agents|mesh-ancestor
138863710|NCT05429294|Mitosis Modulators|mitosis modulators|mesh-ancestor
138863711|NCT05429294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863712|NCT05429294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138863713|NCT04219046|Naloxegol|naloxegol|mesh-list
138863714|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138863715|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863716|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
138863717|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863718|NCT00912509|Riboflavin|riboflavin|mesh-list
138863719|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
138863720|NCT00912509|Vitamins|vitamins|mesh-ancestor
138863721|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
138863722|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863723|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138863724|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
138863725|NCT02873598|Paclitaxel|paclitaxel|mesh-list
138863726|NCT02873598|Gemcitabine|gemcitabine|mesh-list
138863727|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138863728|NCT02873598|Folfirinox|folfirinox|mesh-list
138863729|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138863731|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
138863732|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
138863733|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
138863734|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863735|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138863736|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
138863737|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138863738|NCT02749994|Ezetimibe|ezetimibe|mesh-list
138863739|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138863740|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138863741|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
138863742|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863743|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138863744|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138863746|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
138863747|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138863748|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863749|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863750|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138863751|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138863752|NCT04417049|Protective Agents|protective agents|mesh-ancestor
138863753|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863754|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
138863755|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138863756|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
138863757|NCT05323422|Ketamine|ketamine|mesh-list
138863758|NCT05323422|Analgesics|analgesics|mesh-ancestor
138863759|NCT05323422|Sensory System Agents|sensory system agents|mesh-ancestor
138863760|NCT05323422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863761|NCT05323422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863762|NCT05323422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138863763|NCT05323422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138863764|NCT05323422|Anesthetics, General|anesthetics, general|mesh-ancestor
138863765|NCT05323422|Anesthetics|anesthetics|mesh-ancestor
138863766|NCT05323422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863767|NCT05323422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138863768|NCT05323422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138947362|NCT00750126|Fludarabine|fludarabine|mesh-list
138863769|NCT05323422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863770|NCT05323422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863771|NCT02700906|Lidocaine|lidocaine|mesh-list
138863772|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
138863773|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
138863774|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863775|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863776|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
138863777|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863778|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138863779|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138863780|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138863781|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138863782|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863783|NCT00636038|Beta Carotene|beta carotene|mesh-list
138863784|NCT00636038|Carotenoids|carotenoids|mesh-list
138863785|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
138863786|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863787|NCT00636038|Protective Agents|protective agents|mesh-ancestor
138863788|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863789|NCT00636038|Provitamins|provitamins|mesh-ancestor
138863790|NCT00636038|Vitamins|vitamins|mesh-ancestor
138863791|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
138863792|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
138863793|NCT04213716|Calcium|calcium|mesh-list
138863794|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138863795|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863796|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138863797|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
138863798|NCT04218890|Thromboplastin|thromboplastin|mesh-list
138863799|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138863800|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138863801|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863804|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
138863805|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138863806|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
138863807|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863808|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138863809|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
138863810|NCT00636116|Antivenins|antivenins|mesh-list
138863811|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
138863812|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863813|NCT05428670|Rituximab|rituximab|mesh-list
138863814|NCT05428670|Lenalidomide|lenalidomide|mesh-list
138863815|NCT05428670|Zanubrutinib|zanubrutinib|mesh-list
139022374|NCT02541071|Clonidine|clonidine|mesh-list
138863816|NCT05428670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138863817|NCT05428670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863818|NCT05428670|Immunologic Factors|immunologic factors|mesh-ancestor
138863819|NCT05428670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863820|NCT05428670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138863821|NCT05428670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138863822|NCT05428670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138863823|NCT05428670|Growth Substances|growth substances|mesh-ancestor
138863824|NCT05428670|Growth Inhibitors|growth inhibitors|mesh-ancestor
138863825|NCT05428670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138863826|NCT05428670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515939|NCT00394056|Paroxetine|paroxetine|mesh-list
138863827|NCT05428670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863828|NCT00635726|Cisplatin|cisplatin|mesh-list
138863829|NCT00635726|Gemcitabine|gemcitabine|mesh-list
138863830|NCT00635726|Doxorubicin|doxorubicin|mesh-list
138863831|NCT00635726|Methotrexate|methotrexate|mesh-list
138863832|NCT00635726|Vinblastine|vinblastine|mesh-list
138947374|NCT00755976|Epirubicin|epirubicin|mesh-list
138863833|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863834|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138863835|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
138863836|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863837|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138863838|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138863839|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138863840|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863841|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138863842|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
138863843|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138863844|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863845|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
138863846|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138863847|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138863848|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
138863849|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138863850|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138863851|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138863852|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
138863853|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
138863854|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
138863855|NCT04219982|Scopolamine|scopolamine|mesh-list
138863856|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138863857|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138863858|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
138863859|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
138863860|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863861|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863862|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138863863|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
138863864|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138863865|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
138863866|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138863867|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863868|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138863869|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
138863870|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
138863871|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
138863872|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
138863873|NCT04216706|Sympatholytics|sympatholytics|mesh-list
138863874|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138863875|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863876|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138863877|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863878|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
138863879|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863880|NCT00913835|Doxorubicin|doxorubicin|mesh-list
138863881|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138863883|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138863884|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863885|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138863886|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138863887|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863888|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863889|NCT05322720|Paclitaxel|paclitaxel|mesh-list
138863890|NCT05322720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138863891|NCT05322720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138863892|NCT05322720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863893|NCT05322720|Tubulin Modulators|tubulin modulators|mesh-ancestor
138863894|NCT05322720|Antimitotic Agents|antimitotic agents|mesh-ancestor
138863895|NCT05322720|Mitosis Modulators|mitosis modulators|mesh-ancestor
138863896|NCT05322720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863897|NCT04213170|Bevacizumab|bevacizumab|mesh-list
138863898|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138863899|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863900|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138863901|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138863902|NCT04213170|Growth Substances|growth substances|mesh-ancestor
138515975|NCT00846144|Protective Agents|protective agents|mesh-ancestor
138863903|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863905|NCT05322564|Opiate Alkaloids|opiate alkaloids|mesh-list
138863906|NCT05322564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138863908|NCT05322564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138863909|NCT05322564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863910|NCT05322564|Analgesics|analgesics|mesh-ancestor
138863911|NCT05322564|Sensory System Agents|sensory system agents|mesh-ancestor
138863912|NCT05322564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863913|NCT02749136|Gemcitabine|gemcitabine|mesh-list
138863914|NCT02749136|Folfirinox|folfirinox|mesh-list
138863915|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138863916|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
138863917|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863918|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863919|NCT00631631|Mifamurtide|mifamurtide|mesh-list
138863920|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138863921|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
138863922|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863923|NCT04238741|Anesthetics|anesthetics|mesh-list
138863924|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139022479|NCT00506142|Vincristine|vincristine|mesh-list
138863925|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863926|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
138863927|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138863928|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138863929|NCT04218500|Niacinamide|niacinamide|mesh-list
138863931|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
138863932|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
138863934|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
138863935|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863936|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138863937|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
138863938|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863939|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138863940|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
138863941|NCT05412056|Metformin|metformin|mesh-list
138863942|NCT05412056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138863943|NCT05412056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863944|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
138863945|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138863946|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863947|NCT04453046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138863948|NCT04453046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863949|NCT04217096|Paclitaxel|paclitaxel|mesh-list
138863950|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138863951|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863952|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
138863953|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
138863954|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
138863955|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863956|NCT05411978|Ubiquinone|ubiquinone|mesh-list
138863957|NCT05411978|Idebenone|idebenone|mesh-list
138863958|NCT05411978|Antioxidants|antioxidants|mesh-ancestor
138863959|NCT05411978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863960|NCT05411978|Protective Agents|protective agents|mesh-ancestor
138863961|NCT05411978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863962|NCT05411978|Micronutrients|micronutrients|mesh-ancestor
138863963|NCT00617370|Paclitaxel|paclitaxel|mesh-list
138863964|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
138863965|NCT00617370|Epirubicin|epirubicin|mesh-list
138863966|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138863967|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863968|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
138863969|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
138863970|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
138863971|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863972|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138863973|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
138863974|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863975|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138863976|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138863977|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
138863978|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138863979|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138863980|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138863981|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138863982|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863983|NCT02699658|Levofloxacin|levofloxacin|mesh-list
138863984|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138863985|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138863986|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138863987|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138863988|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138863989|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138863990|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138863991|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138863992|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138863993|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138863995|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138863996|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138863997|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138863998|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138863999|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
138864000|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864001|NCT04032626|Lenalidomide|lenalidomide|mesh-list
138864002|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
138864003|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864004|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138864005|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138864006|NCT04032626|Growth Substances|growth substances|mesh-ancestor
138864007|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
138864008|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864009|NCT04214106|Thiamine|thiamine|mesh-list
138864010|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
138864011|NCT04214106|Vitamins|vitamins|mesh-ancestor
138864012|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
138864013|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864014|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138864015|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864016|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138864017|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
138864018|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864019|NCT02695862|Terlipressin|terlipressin|mesh-list
138864020|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138864021|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138864022|NCT00617448|Anesthetics|anesthetics|mesh-list
138864023|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864024|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864025|NCT04308863|Chitosan|chitosan|mesh-list
138864026|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864028|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138864029|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
138864030|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138864031|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
138864032|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
138864033|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
138864034|NCT04308863|Coagulants|coagulants|mesh-ancestor
138864035|NCT00615810|Efavirenz|efavirenz|mesh-list
138864036|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138864037|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138864038|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138864039|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864040|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864041|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
138864042|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864043|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138864044|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138864045|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138864046|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138864047|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138864048|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138864049|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138864050|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138864051|NCT03355157|Tamoxifen|tamoxifen|mesh-list
138864052|NCT03355157|Paclitaxel|paclitaxel|mesh-list
138864053|NCT03355157|Vinorelbine|vinorelbine|mesh-list
138864054|NCT03355157|Capecitabine|capecitabine|mesh-list
138864056|NCT03355157|Epirubicin|epirubicin|mesh-list
138864057|NCT03355157|Fulvestrant|fulvestrant|mesh-list
138864058|NCT03355157|Palbociclib|palbociclib|mesh-list
138864059|NCT03355157|Exemestane|exemestane|mesh-list
138864060|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138864061|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864062|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
138864063|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
138864064|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
138864065|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864066|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138864067|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
138864068|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138864069|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138864070|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864071|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138864072|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
138864073|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138864074|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864075|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138864076|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138864077|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138864078|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138864079|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138864080|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138864081|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138864082|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138864083|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138864084|NCT04215432|Propolis|propolis|mesh-list
138864085|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864086|NCT02747342|Fluzoparib|fluzoparib|mesh-list
138864087|NCT02747342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138864088|NCT02747342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022628|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138864089|NCT02747342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864090|NCT02747342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864091|NCT03324035|Tramadol|tramadol|mesh-list
138864092|NCT03324035|Amitriptyline|amitriptyline|mesh-list
138864093|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138864094|NCT03324035|Narcotics|narcotics|mesh-ancestor
138864095|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864096|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864097|NCT03324035|Analgesics|analgesics|mesh-ancestor
138864098|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
138864099|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864101|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
138864102|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138864103|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138864104|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138864105|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138864106|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138864107|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864108|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
138864109|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864110|NCT00616746|Ethanol|ethanol|mesh-list
138864111|NCT00616746|Nicotine|nicotine|mesh-list
138864112|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138864113|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
138864114|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864115|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864116|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138864117|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138864118|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
138864119|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864120|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864121|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138864122|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864123|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864124|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
138864125|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864126|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138516202|NCT00014339|Hormones|hormones|mesh-ancestor
138864127|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864128|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864129|NCT05271578|Nicotine|nicotine|mesh-list
138864130|NCT05271578|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138864131|NCT05271578|Autonomic Agents|autonomic agents|mesh-ancestor
138864132|NCT05271578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864133|NCT05271578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864134|NCT05271578|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138864135|NCT05271578|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138864136|NCT05271578|Cholinergic Agents|cholinergic agents|mesh-ancestor
138864137|NCT05271578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864138|NCT05271578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864139|NCT04203485|Paclitaxel|paclitaxel|mesh-list
138864140|NCT04203485|Carboplatin|carboplatin|mesh-list
138864141|NCT04203485|Pemetrexed|pemetrexed|mesh-list
138864142|NCT04203485|Apatinib|apatinib|mesh-list
138864143|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138864144|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864145|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
138864146|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
138864147|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
138864148|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864149|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864150|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138864151|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138864152|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138864153|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
138864154|NCT03851627|Testosterone|testosterone|mesh-list
138864155|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
138864156|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
138864157|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138864158|NCT03851627|Androgens|androgens|mesh-ancestor
138864159|NCT03851627|Hormones|hormones|mesh-ancestor
138864160|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138864161|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864162|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138864163|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864164|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
138864165|NCT03116126|Guanfacine|guanfacine|mesh-list
138864166|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138864167|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138864168|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138864169|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138864170|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
138864171|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788151|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
138864173|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864174|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138864175|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
138864176|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138864178|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138864179|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864180|NCT04217798|Etoposide|etoposide|mesh-list
138864181|NCT04217798|Niraparib|niraparib|mesh-list
138864182|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138864183|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864184|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138864185|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138864186|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864187|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864188|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138864189|NCT02742038|Fluorides|fluorides|mesh-list
138864190|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
138864191|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
138864192|NCT02742038|Protective Agents|protective agents|mesh-ancestor
138864193|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864194|NCT02022098|Cisplatin|cisplatin|mesh-list
138864195|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864196|NCT02746250|Amitriptyline|amitriptyline|mesh-list
138864197|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
138864198|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
138864199|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138864200|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138864201|NCT02746250|Analgesics|analgesics|mesh-ancestor
138864202|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
138864203|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864204|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864205|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138864206|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138864207|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138864208|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864209|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
138864210|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864212|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138864213|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864214|NCT00910091|Megestrol|megestrol|mesh-list
138864215|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
138864216|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138864217|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138864218|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138864219|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
138864220|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138864221|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864222|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138864223|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138864224|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138864225|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864226|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
138864227|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138864229|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864230|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138864231|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864232|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864233|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
138864234|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138864235|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
138864236|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138864237|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
138864238|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864239|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864240|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
138864241|NCT00909857|Dienogest|dienogest|mesh-list
138864242|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138864243|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138864244|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
138864245|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138864246|NCT00909857|Estradiol|estradiol|mesh-list
138864247|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138864248|NCT00909857|Estrogens|estrogens|mesh-ancestor
138864249|NCT00909857|Hormones|hormones|mesh-ancestor
138864250|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138864251|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864252|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138864253|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
138864254|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138864255|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138864256|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138864257|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138864258|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138864259|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138864260|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
138864261|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138864262|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864263|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
138864265|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138864266|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947463|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
138864267|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864268|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
138864269|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864270|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864271|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
138864272|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138864273|NCT00911807|Protective Agents|protective agents|mesh-ancestor
138864274|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138864275|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138864276|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864277|NCT04117451|Propolis|propolis|mesh-list
138864278|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864279|NCT03690089|Atropine|atropine|mesh-list
138864280|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138864281|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138864282|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138864283|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
138864284|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864285|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864286|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138864287|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
138864288|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
138864289|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
138864290|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138864291|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138864292|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
138864293|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022868|NCT02539745|Vitamin D|vitamin d|mesh-list
138864294|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864295|NCT03812588|Escitalopram|escitalopram|mesh-list
138864296|NCT03812588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138864297|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138864298|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138864299|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864300|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864301|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
138864302|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864303|NCT02387099|Everolimus|everolimus|mesh-list
138864304|NCT02387099|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138864305|NCT02387099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138864306|NCT02387099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864307|NCT02387099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864308|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138864309|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
138864310|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864311|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864312|NCT02745860|Selexipag|selexipag|mesh-list
138864313|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138864314|NCT04788641|Cyclosporine|cyclosporine|mesh-list
138864315|NCT04788641|Tacrolimus|tacrolimus|mesh-list
138864316|NCT04788641|Cyclosporins|cyclosporins|mesh-list
138864317|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138864318|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
139022911|NCT00901823|Diazoxide|diazoxide|mesh-list
138864319|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864320|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138864321|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864322|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864323|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
138864324|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864325|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
138864326|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138864328|NCT02745470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138864329|NCT02745470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864330|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138864331|NCT02741414|Amoxicillin|amoxicillin|mesh-list
138864332|NCT02741414|Metronidazole|metronidazole|mesh-list
138864333|NCT02741414|Clarithromycin|clarithromycin|mesh-list
138864334|NCT02741414|Levofloxacin|levofloxacin|mesh-list
138864335|NCT02741414|Tetracycline|tetracycline|mesh-list
138864336|NCT02741414|Furazolidone|furazolidone|mesh-list
138864337|NCT02741414|Esomeprazole|esomeprazole|mesh-list
138864338|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864339|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138864340|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138864341|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138864342|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138864343|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138864344|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864345|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864346|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138864347|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138864348|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138864349|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138864350|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138864351|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138864352|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864353|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138864354|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138864356|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138864357|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138864358|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138864359|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864360|NCT05629598|Epoetin Alfa|epoetin alfa|mesh-list
138864361|NCT05629598|Hematinics|hematinics|mesh-ancestor
138864362|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138864363|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138864364|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138864365|NCT02736032|Estradiol|estradiol|mesh-list
138864366|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138864367|NCT02736032|Progesterone|progesterone|mesh-list
138864368|NCT02736032|Estrogens|estrogens|mesh-ancestor
138864369|NCT02736032|Hormones|hormones|mesh-ancestor
138864370|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138864371|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864372|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138864373|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
138864374|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138864375|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138864376|NCT02736032|Progestins|progestins|mesh-ancestor
138864377|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
138864378|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138864379|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864380|NCT02744768|Dasatinib|dasatinib|mesh-list
138864381|NCT02744768|Blinatumomab|blinatumomab|mesh-list
138864382|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864383|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138864384|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864385|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864386|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
138864387|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138864388|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
138864389|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864390|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864391|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138864392|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
138864393|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138864394|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138864395|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138864396|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
138864397|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023019|NCT00902915|Hormones|hormones|mesh-ancestor
138864398|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864399|NCT04096391|Analgesics|analgesics|mesh-list
138864400|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
138864401|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864402|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864404|NCT02744378|Tacrolimus|tacrolimus|mesh-list
138864405|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138864406|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
138864407|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864408|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138864409|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864410|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864411|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138864412|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
138864413|NCT02744378|Hormones|hormones|mesh-ancestor
138864414|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138864415|NCT04318730|Apatinib|apatinib|mesh-list
138864416|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864417|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138864418|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864419|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864420|NCT00632333|Fluorouracil|fluorouracil|mesh-list
138864421|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864422|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
138864423|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864424|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138516504|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
138864425|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138864426|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
138864427|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864428|NCT02744456|Losartan|losartan|mesh-list
138864429|NCT02744456|Amlodipine|amlodipine|mesh-list
138864430|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138864431|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138864432|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138864433|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138864434|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864435|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138864436|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864437|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
138864438|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138864439|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138864440|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138864441|NCT02744456|Diuretics|diuretics|mesh-ancestor
138864442|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
138864443|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138864444|NCT02744222|Interferons|interferons|mesh-list
138864445|NCT02744222|Interferon-beta|interferon-beta|mesh-list
138864446|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
138864447|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864448|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
138864449|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864450|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
138864451|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864452|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138864453|NCT02741024|Artesunate|artesunate|mesh-list
138864454|NCT02741024|Lumefantrine|lumefantrine|mesh-list
138864455|NCT02741024|Artemether|artemether|mesh-list
138864456|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138864458|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
138864459|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138864460|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138864461|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864462|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864463|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
138864464|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
138864465|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138864466|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
138864467|NCT02735876|Rituximab|rituximab|mesh-list
138864468|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
138864469|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138864470|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864471|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
138864472|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864473|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138864474|NCT00910871|Bedaquiline|bedaquiline|mesh-list
138864475|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
138864476|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138864478|NCT04230707|Melatonin|melatonin|mesh-list
138864479|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
138864480|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864481|NCT04230707|Protective Agents|protective agents|mesh-ancestor
138864482|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864483|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864484|NCT02735798|Trastuzumab|trastuzumab|mesh-list
138864485|NCT02735798|Gancotamab|gancotamab|mesh-list
138864486|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138864487|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864488|NCT02735798|Immunoconjugates|immunoconjugates|mesh-ancestor
139023124|NCT00904085|Narcotics|narcotics|mesh-ancestor
138864489|NCT02735798|Immunologic Factors|immunologic factors|mesh-ancestor
138864490|NCT02735798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864491|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
138864492|NCT03760718|Procaine|procaine|mesh-list
138864493|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
138864494|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
138864495|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864496|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864497|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
138864498|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864499|NCT05590286|Amoxicillin|amoxicillin|mesh-list
138864500|NCT05590286|Esomeprazole|esomeprazole|mesh-list
138864501|NCT05590286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138864502|NCT05590286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864503|NCT05590286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138864504|NCT05590286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138864505|NCT05590286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138864506|NCT05590286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864507|NCT05590286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864509|NCT05580029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138864510|NCT05580029|Glucocorticoids|glucocorticoids|mesh-ancestor
138864511|NCT05580029|Hormones|hormones|mesh-ancestor
138864512|NCT05580029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138864513|NCT05580029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864514|NCT03724994|Paclitaxel|paclitaxel|mesh-list
138864515|NCT03724994|Gemcitabine|gemcitabine|mesh-list
138864516|NCT03724994|Fluorouracil|fluorouracil|mesh-list
138864517|NCT03724994|Folfirinox|folfirinox|mesh-list
138864518|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138864519|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864520|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
138864521|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
138864522|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
138864523|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864524|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138864525|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
138864526|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138864527|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
138864528|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864529|NCT02735330|Ethanol|ethanol|mesh-list
138864530|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138864531|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864532|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864533|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864534|NCT02631941|Budesonide|budesonide|mesh-list
138864535|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
138864536|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138864537|NCT02631941|Charcoal|charcoal|mesh-list
138864538|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138864539|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138864540|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
138864541|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864542|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864543|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138864544|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
138864545|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
138864546|NCT02631941|Hormones|hormones|mesh-ancestor
138864547|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138864548|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138864549|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138864551|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
138864552|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864553|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864554|NCT02631941|Antidotes|antidotes|mesh-ancestor
138864555|NCT02631941|Protective Agents|protective agents|mesh-ancestor
138864556|NCT02690987|Exenatide|exenatide|mesh-list
138864557|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138864558|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864559|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138864561|NCT02690987|Hormones|hormones|mesh-ancestor
138864562|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138864563|NCT02740166|Propranolol|propranolol|mesh-list
138864564|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138864565|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138864566|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
138864567|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864568|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864569|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864570|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138864571|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138864572|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
138864573|NCT02735018|Epinephrine|epinephrine|mesh-list
138864574|NCT02735018|Racepinephrine|racepinephrine|mesh-list
138864575|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
138864576|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138864577|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138864579|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864580|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864581|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864582|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138864583|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138864584|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
138864585|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864586|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138864587|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
138864588|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
138864589|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
138864590|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138864591|NCT00908375|Pregabalin|pregabalin|mesh-list
138864592|NCT00908375|Analgesics|analgesics|mesh-ancestor
138864593|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
138864594|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864595|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864596|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
138864597|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138864598|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139023253|NCT00340678|Losartan|losartan|mesh-list
138864599|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864600|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138864601|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138864602|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138864603|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864604|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138864606|NCT04247867|Cathartics|cathartics|mesh-ancestor
138864607|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138864608|NCT02731664|Glucagon|glucagon|mesh-list
138864609|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138864610|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138864611|NCT02731664|Hormones|hormones|mesh-ancestor
138864612|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138864613|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864614|NCT02731664|Incretins|incretins|mesh-ancestor
138864615|NCT02543255|Prednisone|prednisone|mesh-list
138864616|NCT02543255|Leuprolide|leuprolide|mesh-list
138864617|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
138864618|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138864619|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
138864620|NCT02543255|Hormones|hormones|mesh-ancestor
138864621|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138864622|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864623|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138864624|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864625|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138864626|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
138864627|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138864628|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138864629|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864630|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864631|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
138864632|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138864634|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138864635|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864636|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864637|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
138864638|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864639|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864640|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
138864641|NCT00909389|Simvastatin|simvastatin|mesh-list
138864642|NCT00909389|Ezetimibe|ezetimibe|mesh-list
138864643|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138864644|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138864645|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138864646|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
138864647|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864648|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138864649|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138864650|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864651|NCT00910715|Doxycycline|doxycycline|mesh-list
138864652|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138864653|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864654|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
138864655|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138864656|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138864657|NCT02731430|Morphine|morphine|mesh-list
138864658|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138864659|NCT02731430|Narcotics|narcotics|mesh-ancestor
138864660|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864661|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864662|NCT02731430|Analgesics|analgesics|mesh-ancestor
138864663|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
138864664|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864665|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
138864666|NCT03695510|Afatinib|afatinib|mesh-list
138864667|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138864668|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864670|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864671|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138864672|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864673|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
138864674|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
138864675|NCT02731040|Diphosphonates|diphosphonates|mesh-list
138864676|NCT02731040|Etidronic Acid|etidronic acid|mesh-list
138864677|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138864678|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864679|NCT02734160|Durvalumab|durvalumab|mesh-list
138864680|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138947659|NCT00865137|Tacrolimus|tacrolimus|mesh-list
138864681|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864682|NCT02730572|Methylphenidate|methylphenidate|mesh-list
138864683|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138864684|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864685|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138864686|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138864687|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138864688|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864689|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
138864690|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864691|NCT02730026|Ketoprofen|ketoprofen|mesh-list
138864692|NCT02730026|Omeprazole|omeprazole|mesh-list
138864693|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138864694|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138864695|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138864696|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864697|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864698|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138864699|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138864701|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
138864702|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210385|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864703|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864704|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138864705|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138864706|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138864707|NCT02738918|Abatacept|abatacept|mesh-list
138864708|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138864709|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864710|NCT02738918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139023366|NCT00907985|Lamotrigine|lamotrigine|mesh-list
138864711|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864712|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138864713|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
138864714|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864715|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138864716|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
138864717|NCT03195374|Narcotics|narcotics|mesh-ancestor
138864718|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864719|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864720|NCT03195374|Analgesics|analgesics|mesh-ancestor
138864721|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
138864722|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864723|NCT02739386|Ipilimumab|ipilimumab|mesh-list
138864724|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138864725|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864726|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138864727|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864728|NCT00636428|Midazolam|midazolam|mesh-list
138864729|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138864730|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138864731|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864732|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864733|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138864734|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138864735|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138864736|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138864737|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
138864738|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
138864739|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
138864740|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
138864741|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864742|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864743|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138864744|NCT02729870|Laxatives|laxatives|mesh-ancestor
138864745|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138864746|NCT05628662|Insulin|insulin|mesh-list
138864747|NCT05628662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138864748|NCT05628662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864749|NCT02694848|Aspirin|aspirin|mesh-list
138864750|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138864751|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138864752|NCT02694848|Analgesics|analgesics|mesh-ancestor
139023395|NCT00908219|Bevacizumab|bevacizumab|mesh-list
138864753|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
138864754|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864755|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864756|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138864757|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138864758|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138864759|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138864760|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864761|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138864762|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138864763|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864764|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
138864765|NCT02729324|Protective Agents|protective agents|mesh-list
138864766|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
138864767|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864768|NCT02733458|Dexamethasone|dexamethasone|mesh-list
138864769|NCT02733458|Gemcitabine|gemcitabine|mesh-list
138864770|NCT02733458|Etoposide|etoposide|mesh-list
138864771|NCT02733458|Pegaspargase|pegaspargase|mesh-list
138864772|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138864773|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
138864775|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864776|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864777|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138864778|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
138864780|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138864781|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138864782|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864783|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864784|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864785|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138864786|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
138864787|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138864788|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138864789|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138864790|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138864791|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
138864792|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138864793|NCT02728856|Protective Agents|protective agents|mesh-ancestor
138864794|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864795|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
138864797|NCT02728934|Golimumab|golimumab|mesh-list
138864798|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138864799|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138864800|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
138864801|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138864802|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138864803|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138864804|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
138864805|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864806|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
138864807|NCT02728700|Sirolimus|sirolimus|mesh-list
138864808|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138864809|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864810|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138864811|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
138864812|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947738|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
138864813|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864814|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864815|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864816|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
138864817|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138864818|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
138864819|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864820|NCT02728622|Tamoxifen|tamoxifen|mesh-list
138864821|NCT02728622|Paclitaxel|paclitaxel|mesh-list
138864822|NCT02728622|Doxorubicin|doxorubicin|mesh-list
138864823|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138864824|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138864825|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864826|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
138864827|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
138864828|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
138864829|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864830|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138864831|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138864832|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138864833|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864834|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138864835|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
138864836|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138864837|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864838|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139023467|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
138864839|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138864840|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138864841|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138864843|NCT02728466|Procyanidin|procyanidin|mesh-list
138864844|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
138864845|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864846|NCT02728466|Protective Agents|protective agents|mesh-ancestor
138864847|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864849|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138864850|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864851|NCT02733380|Thalidomide|thalidomide|mesh-list
138864852|NCT02733380|Dexamethasone|dexamethasone|mesh-list
138864853|NCT02733380|Doxorubicin|doxorubicin|mesh-list
138864854|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138864855|NCT02733380|Vinorelbine|vinorelbine|mesh-list
138864856|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
138864857|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138864858|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
138864859|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
138864860|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864861|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864862|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138864863|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
138864865|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138864866|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138864867|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864868|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138864869|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138864870|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138864871|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864872|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864873|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138864874|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
138864875|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
138864876|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
138516963|NCT00129519|Imiquimod|imiquimod|mesh-list
138864877|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138864878|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
139023493|NCT03547427|Insulin|insulin|mesh-list
138864879|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
138864880|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138864881|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138864882|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138864883|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138864884|NCT02733380|Growth Substances|growth substances|mesh-ancestor
138864885|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
138864886|NCT02733380|Analgesics|analgesics|mesh-ancestor
138864887|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
138864888|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
138864889|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
138864890|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138864891|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
138864892|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864893|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138864894|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138864895|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138864896|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138864897|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864898|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
138864899|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
138864900|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
138864901|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864902|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864903|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
138864904|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864905|NCT00636584|Nitroprusside|nitroprusside|mesh-list
138864906|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138864907|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
138864908|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138864909|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864910|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
138864911|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138864912|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138864913|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
138864914|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023532|NCT00338728|Letrozole|letrozole|mesh-list
138864915|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864916|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864917|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
138864918|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
138864919|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864920|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
138864921|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138864922|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
138864924|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138864925|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
138864926|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138864927|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864928|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138864929|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138864931|NCT02732678|Propranolol|propranolol|mesh-list
138864932|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138864933|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138864934|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
138864935|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864936|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864937|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864938|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138864939|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138864940|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
138864941|NCT02727608|Eculizumab|eculizumab|mesh-list
138864942|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138864943|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138864944|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
138864945|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864946|NCT02727296|Propofol|propofol|mesh-list
138864947|NCT02727296|Sevoflurane|sevoflurane|mesh-list
138864948|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138517034|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
138864949|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864950|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864951|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138864952|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
138864953|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
138864954|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138864955|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138864956|NCT02732132|Midazolam|midazolam|mesh-list
138864957|NCT02732132|Fentanyl|fentanyl|mesh-list
138864958|NCT02732132|Ketamine|ketamine|mesh-list
138864959|NCT02732132|Propofol|propofol|mesh-list
138864960|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138864961|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864962|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864963|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138864964|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
138864965|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
138864966|NCT02732132|Analgesics|analgesics|mesh-ancestor
138864967|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
138864968|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864969|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138864970|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138864971|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138864972|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138864973|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864974|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138864975|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138864976|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138864977|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138864978|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
138864980|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138864981|NCT02732132|Narcotics|narcotics|mesh-ancestor
138864982|NCT02737202|Saracatinib|saracatinib|mesh-list
138864983|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138864984|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138864985|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864986|NCT02721368|Lidocaine|lidocaine|mesh-list
138864987|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
138864988|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
138864989|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138864990|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138864991|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
138864992|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138864993|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138864994|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138864995|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138864996|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138864997|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864999|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138865000|NCT02737124|Analgesics|analgesics|mesh-ancestor
138865001|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
138865002|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865003|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865004|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
138865005|NCT02721290|Ropivacaine|ropivacaine|mesh-list
138865006|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
138865007|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
138865008|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865009|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865010|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
138865011|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865012|NCT02720978|Oxytocin|oxytocin|mesh-list
138865013|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
138865014|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138865015|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865016|NCT02726984|Listerine|listerine|mesh-list
138865017|NCT02726984|Fluorides|fluorides|mesh-list
138865018|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
138865019|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
138865020|NCT02726984|Protective Agents|protective agents|mesh-ancestor
138865021|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865022|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138865023|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138865024|NCT02726828|Ketamine|ketamine|mesh-list
138865025|NCT02726828|Morphine|morphine|mesh-list
138865026|NCT02726828|Analgesics|analgesics|mesh-ancestor
138865027|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
138865028|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865029|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865030|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138865031|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138865032|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
138865033|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
138865034|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865035|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138947898|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
138865036|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138865037|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865038|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865039|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138865040|NCT02726828|Narcotics|narcotics|mesh-ancestor
138865041|NCT02799134|Dexamethasone|dexamethasone|mesh-list
138865042|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865043|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138865044|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
138865045|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
139023621|NCT00928967|Interferons|interferons|mesh-list
138865046|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865047|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138865048|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
138865049|NCT02799134|Hormones|hormones|mesh-ancestor
138865050|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138865051|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138865052|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865053|NCT02720822|Morphine|morphine|mesh-list
138865054|NCT02720822|Laxatives|laxatives|mesh-list
138865055|NCT02720822|Cathartics|cathartics|mesh-list
138865056|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138865057|NCT02720822|Narcotics|narcotics|mesh-ancestor
138865058|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865059|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865060|NCT02720822|Analgesics|analgesics|mesh-ancestor
138865061|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
138865062|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865063|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138865064|NCT02757872|Vitamin D|vitamin d|mesh-list
138865065|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
138865066|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
138865067|NCT02757872|Vitamins|vitamins|mesh-list
138865068|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
138865069|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865070|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138865071|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138865072|NCT04167176|Lidocaine|lidocaine|mesh-list
138865073|NCT04167176|Bupivacaine|bupivacaine|mesh-list
138865074|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
138865075|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
138865076|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865077|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865078|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
138865079|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023677|NCT00929279|Abciximab|abciximab|mesh-list
138865080|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138865081|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138865082|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138865083|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138865084|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865085|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
138865086|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
138865087|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865088|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
138865089|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
138865090|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865091|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
138865092|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865093|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865095|NCT02726126|Melatonin|melatonin|mesh-list
138865096|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138865097|NCT02726126|Narcotics|narcotics|mesh-ancestor
138865098|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865099|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865100|NCT02726126|Analgesics|analgesics|mesh-ancestor
138865101|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
138865102|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865103|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138865104|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138865105|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
138865106|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
138865107|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
138865108|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865109|NCT02726126|Protective Agents|protective agents|mesh-ancestor
138865110|NCT02694458|Vancomycin|vancomycin|mesh-list
138865111|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138865112|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138865113|NCT02719808|Tenofovir|tenofovir|mesh-list
138865114|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
138865115|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138865116|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138865117|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138865118|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865119|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865120|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138865121|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138865122|NCT02719418|Tinzaparin|tinzaparin|mesh-list
138865123|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138865124|NCT02719418|Dalteparin|dalteparin|mesh-list
138865125|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
138865126|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138865127|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138865128|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865129|NCT02725736|Nifedipine|nifedipine|mesh-list
138865130|NCT02725736|Atosiban|atosiban|mesh-list
138865131|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138865132|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138865133|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865134|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138865135|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865136|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
138865137|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
138865138|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138865139|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
138865140|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138865141|NCT02716142|Misoprostol|misoprostol|mesh-list
138865142|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138865143|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
138865144|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138865145|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865146|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138865147|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138865148|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
138865153|NCT02718950|Hormones|hormones|mesh-ancestor
138947955|NCT00752544|Simeprevir|simeprevir|mesh-list
138865154|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138865155|NCT02725502|Linagliptin|linagliptin|mesh-list
138865156|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138865157|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865158|NCT02725502|Incretins|incretins|mesh-ancestor
138865159|NCT02725502|Hormones|hormones|mesh-ancestor
138865160|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138865161|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138865162|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
138865163|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865164|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865169|NCT01959464|Progesterone|progesterone|mesh-list
138865170|NCT01959464|Progestins|progestins|mesh-ancestor
138865171|NCT01959464|Hormones|hormones|mesh-ancestor
138865172|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138865173|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865174|NCT02718482|Gemcitabine|gemcitabine|mesh-list
138865175|NCT02718482|Docetaxel|docetaxel|mesh-list
138865176|NCT02718482|Ifosfamide|ifosfamide|mesh-list
138865177|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
138865178|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138865179|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
138517266|NCT00017576|Calcitriol|calcitriol|mesh-list
138865180|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865181|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865182|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
138865183|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
138865184|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
138865185|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138865186|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
138865187|NCT02717858|Liraglutide|liraglutide|mesh-list
138865188|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138865189|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865190|NCT02717858|Incretins|incretins|mesh-ancestor
138865191|NCT02717858|Hormones|hormones|mesh-ancestor
138865192|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138865193|NCT02725112|Pregabalin|pregabalin|mesh-list
138865194|NCT02725112|Analgesics|analgesics|mesh-ancestor
138865195|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
138865196|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865197|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865198|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
138865199|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139023781|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
138865200|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138865201|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865202|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138865203|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138865204|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138865205|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865206|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138865207|NCT02724332|Sirolimus|sirolimus|mesh-list
138865208|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138865209|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138865210|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138865211|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865212|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
138865213|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138865214|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
138865215|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865216|NCT02717780|Fentanyl|fentanyl|mesh-list
138865217|NCT02717780|Remifentanil|remifentanil|mesh-list
138865218|NCT02717780|Sevoflurane|sevoflurane|mesh-list
138865219|NCT02717780|Desflurane|desflurane|mesh-list
138865220|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138865221|NCT02717780|Narcotics|narcotics|mesh-ancestor
138865222|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865223|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865224|NCT02717780|Analgesics|analgesics|mesh-ancestor
138865225|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
138865226|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865227|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138865228|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138865229|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
138865231|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138865232|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138865233|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
138865234|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138865235|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865236|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023822|NCT00506922|Tacrolimus|tacrolimus|mesh-list
138865238|NCT02724098|Analgesics|analgesics|mesh-ancestor
138865239|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
138865240|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865241|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138865242|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138865243|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138865244|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
138865245|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865246|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865247|NCT02723942|Immunomodulating Agents|immunomodulating agents|mesh-list
138865248|NCT02723942|Immunologic Factors|immunologic factors|mesh-ancestor
138865249|NCT02723942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865250|NCT04138316|Candesartan|candesartan|mesh-list
138865251|NCT04138316|Candesartan cilexetil|candesartan cilexetil|mesh-list
138517333|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138865252|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138865253|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138865254|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138865255|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865256|NCT05291390|Pyronaridine|pyronaridine|mesh-list
138865257|NCT05291390|Antimalarials|antimalarials|mesh-ancestor
138865258|NCT05291390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138865259|NCT05291390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138865260|NCT05291390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138865261|NCT04189484|Evolocumab|evolocumab|mesh-list
138865262|NCT04189484|Alirocumab|alirocumab|mesh-list
138865263|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138865264|NCT04189484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138865265|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138865266|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138865267|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
138865268|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865269|NCT04189484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138865270|NCT04189484|Protease Inhibitors|protease inhibitors|mesh-ancestor
138865271|NCT04189484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865272|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138865273|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
138865274|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865275|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
138865276|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138865277|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865278|NCT02716766|Capecitabine|capecitabine|mesh-list
138865279|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
138865280|NCT02716766|Sorafenib|sorafenib|mesh-list
138865281|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138865282|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
138865283|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865284|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865285|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138865286|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865287|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
138865288|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138865289|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865290|NCT02694224|Paclitaxel|paclitaxel|mesh-list
138865291|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
138865292|NCT02694224|Epirubicin|epirubicin|mesh-list
138865293|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138865294|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865295|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
138865296|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
138865297|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
138865298|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865300|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
138865301|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865302|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138865303|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138948032|NCT00751764|Moxidectin|moxidectin|mesh-list
138865304|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
138865305|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138865306|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138865307|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138865308|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138865309|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865311|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138865312|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138865313|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865314|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865315|NCT00782288|Protective Agents|protective agents|mesh-ancestor
138865316|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865318|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865319|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138865320|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138865321|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138865322|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865323|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865324|NCT02712944|Testosterone|testosterone|mesh-list
138865325|NCT02712944|Androgens|androgens|mesh-ancestor
138865326|NCT02712944|Hormones|hormones|mesh-ancestor
138865327|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138865328|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517425|NCT00018759|Paroxetine|paroxetine|mesh-list
138865329|NCT02712866|Vedolizumab|vedolizumab|mesh-list
138865330|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138865331|NCT00600483|Gentamicins|gentamicins|mesh-list
138865332|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138865333|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138865334|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138865335|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865336|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865337|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
138865338|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
138865339|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865340|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
138865341|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865342|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865343|NCT00649857|Cetirizine|cetirizine|mesh-list
138865344|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138865345|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138865346|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138865347|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
138865348|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
138865349|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865350|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865351|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865352|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
138865353|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
138865354|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865355|NCT00764270|Protective Agents|protective agents|mesh-ancestor
138865356|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865357|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
138865358|NCT00764270|Vitamins|vitamins|mesh-ancestor
138865359|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
138865360|NCT00650481|Oxybutynin|oxybutynin|mesh-list
138865361|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
138865362|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
138948040|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138865363|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865364|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865365|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138865366|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138865367|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
138865368|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865369|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865370|NCT00650481|Urological Agents|urological agents|mesh-ancestor
138865371|NCT02712476|Furosemide|furosemide|mesh-list
138865372|NCT02712476|Mannitol|mannitol|mesh-list
138865374|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
138865375|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865376|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138865377|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139210386|NCT03436745|Zolpidem|zolpidem|mesh-list
138865378|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865379|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138865380|NCT02651727|Paclitaxel|paclitaxel|mesh-list
138865381|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138865382|NCT02651727|Gemcitabine|gemcitabine|mesh-list
138865383|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138865384|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865385|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
138865386|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
138865387|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
138865388|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865389|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138865390|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
138865391|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
138865392|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138865393|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138865394|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865395|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
138865396|NCT02650791|Coagulants|coagulants|mesh-ancestor
138865397|NCT04035668|Remibrutinib|remibrutinib|mesh-list
138865398|NCT04035668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138865399|NCT04035668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865400|NCT04035668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865401|NCT02650713|Atezolizumab|atezolizumab|mesh-list
138865402|NCT02650713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138517493|NCT00018278|Donepezil|donepezil|mesh-list
138865403|NCT02650713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865404|NCT02650713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138865405|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865406|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
138865407|NCT02650635|Lenograstim|lenograstim|mesh-list
138865408|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138865409|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
138865410|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865411|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138865412|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138865413|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
138865414|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948057|NCT02866136|Etoposide|etoposide|mesh-list
138865415|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865416|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138865417|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138865418|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
138865419|NCT00650637|Lamivudine|lamivudine|mesh-list
138865420|NCT00650637|Zidovudine|zidovudine|mesh-list
138865421|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138865423|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
138865424|NCT00650637|Loperamide|loperamide|mesh-list
138865425|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
138865426|NCT00650637|Calcium|calcium|mesh-list
138865427|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138865428|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865429|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138865430|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138865431|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138865432|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865433|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865434|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
138865435|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138865436|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138865437|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138865438|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
138865439|NCT00650637|Antacids|antacids|mesh-ancestor
138865440|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138865441|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138865442|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138865443|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
138865444|NCT02650479|Exenatide|exenatide|mesh-list
138865445|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
138865446|NCT02650479|Palonosetron|palonosetron|mesh-list
138865447|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138865448|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138865449|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138865450|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138865451|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865452|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865453|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865454|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865455|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139024047|NCT04015661|Paclitaxel|paclitaxel|mesh-list
138865456|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138865457|NCT02650479|Incretins|incretins|mesh-ancestor
138865459|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138865460|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
138865461|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
138865462|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865463|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138865464|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138865465|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138865466|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
138865467|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865468|NCT02722772|Etanercept|etanercept|mesh-list
138865469|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138865470|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138865471|NCT02722772|Analgesics|analgesics|mesh-ancestor
138865472|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
138865473|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865474|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865475|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138517555|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138865476|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138865477|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138865478|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138865479|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
138865480|NCT02650245|Lactulose|lactulose|mesh-list
138865481|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138865482|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138865483|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138865484|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138865485|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865486|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865487|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138865488|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138865489|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138865490|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
138865491|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865492|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865493|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138865494|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138865495|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
138865497|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138865498|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865499|NCT02722694|Methotrexate|methotrexate|mesh-list
138865500|NCT02722694|Abatacept|abatacept|mesh-list
138865501|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138865502|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
138865503|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138865504|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865505|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138865506|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
138865507|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865508|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865509|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
138865510|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865511|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138865512|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138865513|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
138865514|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138865515|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138865516|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138865517|NCT02722694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138865518|NCT00650871|Casopitant|casopitant|mesh-list
138865519|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
138865520|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
138865521|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024141|NCT00930995|Candesartan|candesartan|mesh-list
138865522|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865523|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138865524|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138865525|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865526|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865527|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138865528|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138865529|NCT02649465|Glimepiride|glimepiride|mesh-list
138865530|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
138865531|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138865532|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138865533|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865534|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138865535|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
138865536|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138865537|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865538|NCT00651105|Vildagliptin|vildagliptin|mesh-list
138865539|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138865540|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865541|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138865542|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
138865543|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865544|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865546|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
138865547|NCT02694146|Protective Agents|protective agents|mesh-ancestor
138865548|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865549|NCT04167267|Fexuprazan|fexuprazan|mesh-list
138865550|NCT04167267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138865551|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
138865552|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138865553|NCT02649075|Antibodies|antibodies|mesh-list
138865554|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
138865555|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865556|NCT02644785|Protamines|protamines|mesh-list
138865557|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
138865558|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865559|NCT02644785|Coagulants|coagulants|mesh-ancestor
138865560|NCT02644707|Selenium|selenium|mesh-list
138865561|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
138865562|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865563|NCT02644707|Protective Agents|protective agents|mesh-ancestor
138865564|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865565|NCT02644707|Trace Elements|trace elements|mesh-ancestor
138865566|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
138865567|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
138865568|NCT02711228|Antibodies|antibodies|mesh-list
138865569|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
138865570|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138865571|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138865572|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
138948132|NCT05325008|Immunoglobulins|immunoglobulins|mesh-list
138865573|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865574|NCT02644863|Paclitaxel|paclitaxel|mesh-list
138865575|NCT02644863|Cisplatin|cisplatin|mesh-list
138865576|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138865577|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865578|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
138865579|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
138865580|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
138865581|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865582|NCT00302744|Niacin|niacin|mesh-list
138865583|NCT00302744|Psilocybin|psilocybin|mesh-list
138865584|NCT00302744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138865585|NCT00302744|Antimetabolites|antimetabolites|mesh-ancestor
138865586|NCT00302744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865587|NCT00302744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138865588|NCT00302744|Vasodilator Agents|vasodilator agents|mesh-ancestor
138865589|NCT00302744|Vitamin B Complex|vitamin b complex|mesh-ancestor
138865590|NCT00302744|Vitamins|vitamins|mesh-ancestor
138865591|NCT00302744|Micronutrients|micronutrients|mesh-ancestor
138865592|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865593|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
138865594|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138865597|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
138865598|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865599|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865600|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138865601|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138865602|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
138865604|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865605|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138865606|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138865607|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865608|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865609|NCT00652665|Leflunomide|leflunomide|mesh-list
138865610|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865611|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865612|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138865613|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
138865614|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865615|NCT02644551|Ciclopirox|ciclopirox|mesh-list
138865616|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
138865617|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138865618|NCT02644395|Amlodipine|amlodipine|mesh-list
138865619|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
138865620|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138865621|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138865622|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138865623|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865624|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138865625|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865626|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
138865627|NCT02644395|Diuretics|diuretics|mesh-ancestor
138865628|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
138865629|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138865630|NCT04166565|Dexamethasone|dexamethasone|mesh-list
138865631|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
138865633|NCT04166565|Daratumumab|daratumumab|mesh-list
138865634|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138865635|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
138865636|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865637|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138865638|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138865639|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
138865640|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865641|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865642|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138865643|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138865644|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
138865645|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
138865646|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865647|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138865648|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
138865649|NCT04166565|Hormones|hormones|mesh-ancestor
138865650|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138865651|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138865652|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
138865653|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138865654|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138865655|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865656|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
138865657|NCT02644473|Coagulants|coagulants|mesh-ancestor
138865658|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138865659|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
138865660|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138865661|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
138865662|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865663|NCT04005872|Calcium|calcium|mesh-list
138865664|NCT04005872|Fluorides|fluorides|mesh-list
138865665|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138865666|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865667|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
138865668|NCT04005872|Protective Agents|protective agents|mesh-ancestor
138865669|NCT00652821|Tramadol|tramadol|mesh-list
138865670|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138865672|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865673|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865674|NCT00652821|Analgesics|analgesics|mesh-ancestor
138865675|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
138865676|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865677|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
138641246|NCT00293163|Hylan|hylan|mesh-list
138865679|NCT02535975|Metformin|metformin|mesh-list
138865680|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138865681|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865682|NCT02714036|Ibudilast|ibudilast|mesh-list
138865683|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138865684|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
138865685|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865686|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865687|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138865688|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
138865689|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138865690|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865691|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865692|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138865693|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
138865694|NCT02710448|Metformin|metformin|mesh-list
138865695|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138865696|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865697|NCT04166253|Vitamin D|vitamin d|mesh-list
138865698|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
138865699|NCT04166253|Vitamins|vitamins|mesh-ancestor
138865700|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
138865701|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865702|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138865703|NCT00653055|Cabergoline|cabergoline|mesh-list
138865704|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138865705|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138865706|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
138865707|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
138865708|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865709|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865710|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865712|NCT02643147|Diuretics|diuretics|mesh-list
138948231|NCT04049916|Artesunate|artesunate|mesh-list
138865713|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138865714|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
138865715|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865716|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138865717|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865718|NCT02642913|Sorafenib|sorafenib|mesh-list
138865719|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865720|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138865721|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865722|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865723|NCT04165629|Aspirin|aspirin|mesh-list
138865724|NCT04165629|Clopidogrel|clopidogrel|mesh-list
138865725|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138865726|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138865727|NCT04165629|Analgesics|analgesics|mesh-ancestor
138865728|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
138865729|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865730|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865731|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138865732|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138865733|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138865734|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138865735|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865736|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138865737|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138865738|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865739|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
138865740|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138865741|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138865742|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138865743|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
138865744|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865745|NCT02642523|Insulin|insulin|mesh-list
138865746|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138865747|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138865748|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138865749|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865750|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
138865751|NCT02713802|Propofol|propofol|mesh-list
138865752|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138865753|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865754|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865755|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138865756|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
138865757|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
138865758|NCT02642601|Indomethacin|indomethacin|mesh-list
139024297|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
138865759|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138865760|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138865761|NCT02642601|Analgesics|analgesics|mesh-ancestor
138865762|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
138865763|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865764|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865765|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138865766|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138865767|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
138865768|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
138865769|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138865770|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138865771|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865772|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865773|NCT02709902|Adapalene|adapalene|mesh-list
138865774|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
138865775|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138865776|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
138865777|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138517860|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138865778|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138865779|NCT02709902|Analgesics|analgesics|mesh-ancestor
138865780|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
138865781|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865782|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865783|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138865784|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138865786|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
138865787|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
138865788|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138865789|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138865790|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138865791|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865792|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865793|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138865794|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138865795|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
138865796|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138865797|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138865798|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138865799|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
138865800|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
138865801|NCT02642367|Rocuronium|rocuronium|mesh-list
138865802|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138865803|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138865804|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138865805|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865806|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865807|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138865808|NCT00653445|Ezetimibe|ezetimibe|mesh-list
138865809|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138865810|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138865811|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
138865812|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865813|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138865814|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138865815|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865816|NCT02641899|Acetaminophen|acetaminophen|mesh-list
138865817|NCT02641899|Exenatide|exenatide|mesh-list
138865818|NCT02641899|Digoxin|digoxin|mesh-list
138865819|NCT02641899|Lisinopril|lisinopril|mesh-list
138865820|NCT02641899|Warfarin|warfarin|mesh-list
138865822|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138865823|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138865824|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
138865825|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865826|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139210387|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138865827|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138865828|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865829|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138865830|NCT02641899|Analgesics|analgesics|mesh-ancestor
138865831|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
138865832|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865833|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865834|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
138865835|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
138865836|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138865837|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138865838|NCT02641899|Protective Agents|protective agents|mesh-ancestor
138865839|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138865840|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
138865841|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138865842|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138865843|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138865845|NCT02641899|Hormones|hormones|mesh-ancestor
138865846|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138865847|NCT02641821|Nifedipine|nifedipine|mesh-list
138865848|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138865849|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138865850|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138517937|NCT00018161|Mecamylamine|mecamylamine|mesh-list
138865851|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138865852|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865853|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
138865854|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
138865855|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138865856|NCT01320345|Fenofibrate|fenofibrate|mesh-list
138865857|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138865858|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
138865859|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865860|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138865861|NCT04164615|Capecitabine|capecitabine|mesh-list
138865862|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138865863|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
138865864|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865865|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865866|NCT04164459|Latanoprost|latanoprost|mesh-list
138865867|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138865868|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138865869|NCT04164693|Heparin|heparin|mesh-list
138865870|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138865871|NCT04164693|Tinzaparin|tinzaparin|mesh-list
138865872|NCT04164693|Dalteparin|dalteparin|mesh-list
138865873|NCT04164693|Warfarin|warfarin|mesh-list
138865874|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
138865876|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138865877|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865878|NCT00655785|Gemcitabine|gemcitabine|mesh-list
138865879|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138865880|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
138865881|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865882|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865883|NCT00885495|Ritonavir|ritonavir|mesh-list
138865884|NCT00885495|Darunavir|darunavir|mesh-list
138865885|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138948318|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
138865886|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138865887|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138865888|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
138865889|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865890|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865891|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138865892|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138865893|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
138865894|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138865895|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138865896|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138865897|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138865898|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138865899|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
138865900|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139210388|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138865901|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138865903|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
138865904|NCT02637375|Doxorubicin|doxorubicin|mesh-list
138865905|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138865906|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865907|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
138865908|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
138865909|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
138865910|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865911|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138865912|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
138865913|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865914|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138948365|NCT03992365|Bisacodyl|bisacodyl|mesh-list
138865915|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138865916|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
138865917|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138865918|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138865919|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138865920|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138865921|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865922|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
138865923|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865924|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138865925|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865926|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865927|NCT00885105|Vaccines|vaccines|mesh-list
138865928|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
138865929|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865930|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
138865931|NCT02709668|Vitamins|vitamins|mesh-ancestor
138865932|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
138865933|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865934|NCT04188782|Sevoflurane|sevoflurane|mesh-list
138865935|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138865936|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138865937|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
138865938|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
138865939|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865940|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865941|NCT02709590|Diclofenac|diclofenac|mesh-list
138865942|NCT02709590|Lidocaine|lidocaine|mesh-list
138865943|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
138865944|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
138865945|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865946|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865947|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
138865948|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865949|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138865950|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138865951|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138865952|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138865953|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865954|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138865955|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138865957|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138865958|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138865959|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138865960|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138865961|NCT02707874|Ropivacaine|ropivacaine|mesh-list
138865962|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
138865963|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
138865964|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865965|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865966|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
138865967|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865968|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
138865969|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138865970|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138865971|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865972|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138865974|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
138865975|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138865976|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138865978|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138865979|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
138865980|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865981|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865982|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138865983|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138865984|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138865985|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138865986|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865987|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
138865988|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138865989|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138865990|NCT02707328|Paclitaxel|paclitaxel|mesh-list
138865991|NCT02707328|Gemcitabine|gemcitabine|mesh-list
139024494|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138865992|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138865993|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138865994|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
138865995|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
138865996|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
138865997|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865998|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138865999|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
138866000|NCT00612638|Irinotecan|irinotecan|mesh-list
138866001|NCT00612638|Temozolomide|temozolomide|mesh-list
138866002|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138866003|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138866004|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138866005|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866006|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866007|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866008|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138866009|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
138866011|NCT05151848|Tofacitinib|tofacitinib|mesh-list
138866012|NCT05151848|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138866013|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138866014|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138866015|NCT05151848|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138866016|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138866017|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866018|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866019|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
138866020|NCT05134688|Analgesics|analgesics|mesh-ancestor
138866021|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
138866022|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866023|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866024|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
138866025|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866026|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138866027|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
138866028|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138866029|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138866030|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866031|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138866032|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
138866033|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138866034|NCT02693288|Anesthetics|anesthetics|mesh-list
138866035|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866036|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866037|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
138866040|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138866041|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
138866042|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866043|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138866044|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138866045|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
138866046|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866047|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866049|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138866050|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138866051|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
138866052|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138866053|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138866054|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
138866055|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
138866056|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866057|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138866058|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138866059|NCT05024006|Interferons|interferons|mesh-list
138866060|NCT05024006|Ritonavir|ritonavir|mesh-list
138866061|NCT05024006|Lopinavir|lopinavir|mesh-list
138866062|NCT05024006|Interferon-beta|interferon-beta|mesh-list
138866063|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
138866064|NCT05024006|Remdesivir|remdesivir|mesh-list
138866065|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
138866066|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
138866067|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866068|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
138866069|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138866070|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138866071|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138866072|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
138866073|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866074|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866075|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138518163|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
138866076|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138866077|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138866078|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138866079|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
138866080|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138866081|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138866082|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138866083|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
138866084|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866085|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138866086|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
138866088|NCT02707250|Bupivacaine|bupivacaine|mesh-list
138866089|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
138866090|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
138866091|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866092|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866093|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
138866094|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866095|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138866096|NCT02707250|Narcotics|narcotics|mesh-ancestor
138866097|NCT02707250|Analgesics|analgesics|mesh-ancestor
138866098|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138866099|NCT03781544|Acetaminophen|acetaminophen|mesh-list
138866101|NCT03781544|Tramadol|tramadol|mesh-list
138866102|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138866103|NCT03781544|Analgesics|analgesics|mesh-ancestor
138866104|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
138866105|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866106|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866107|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
138866108|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138866109|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138866110|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138866111|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138866112|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866113|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866114|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138866115|NCT03781544|Narcotics|narcotics|mesh-ancestor
138866116|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866117|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
138866118|NCT02707094|Immunomodulating Agents|immunomodulating agents|mesh-list
138866119|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866120|NCT02707016|Sevoflurane|sevoflurane|mesh-list
138866121|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138866122|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138866123|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
138866124|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
138866125|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866126|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866127|NCT04956146|Carboplatin|carboplatin|mesh-list
138866128|NCT04956146|Pemetrexed|pemetrexed|mesh-list
138866129|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866130|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866131|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866132|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138866133|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138866134|NCT00612794|Exenatide|exenatide|mesh-list
138866135|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138866136|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866137|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138866138|NCT00612794|Incretins|incretins|mesh-ancestor
138866139|NCT00612794|Hormones|hormones|mesh-ancestor
138866140|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138866141|NCT03773276|Norepinephrine|norepinephrine|mesh-list
138866142|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138866143|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139024575|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
138866144|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
138866145|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866146|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866147|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866148|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
138866149|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
138866150|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866151|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138866152|NCT02706860|Atorvastatin|atorvastatin|mesh-list
138866153|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138866154|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138866155|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
138866156|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866157|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138866158|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138866159|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866160|NCT02706470|Cyclosporine|cyclosporine|mesh-list
138866161|NCT02706470|Cyclosporins|cyclosporins|mesh-list
138866162|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
138866163|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866164|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866165|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138866166|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
138866167|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866168|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
138866169|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138866170|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
138866171|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138866172|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138866173|NCT02706470|Progestins|progestins|mesh-ancestor
138866174|NCT02706470|Hormones|hormones|mesh-ancestor
138866175|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138866176|NCT03764540|Prednisone|prednisone|mesh-list
138866177|NCT03764540|Docetaxel|docetaxel|mesh-list
138866178|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866179|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
138866180|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
138866181|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
138866182|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866183|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138866184|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
138866185|NCT03764540|Hormones|hormones|mesh-ancestor
139024606|NCT00522392|Hormones|hormones|mesh-ancestor
138866186|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138866187|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866188|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138866190|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
138866191|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866193|NCT02706236|Pancreatin|pancreatin|mesh-list
138866194|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138866195|NCT00613496|Irbesartan|irbesartan|mesh-list
138866196|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138866197|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138866198|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138948624|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138866199|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866200|NCT00612950|Glucagon|glucagon|mesh-list
138866201|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
138866202|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138866203|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138866204|NCT00612950|Hormones|hormones|mesh-ancestor
138866205|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138866206|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866207|NCT00612950|Incretins|incretins|mesh-ancestor
138866208|NCT00884793|Ritonavir|ritonavir|mesh-list
138866209|NCT00884793|Lopinavir|lopinavir|mesh-list
138866210|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138866211|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
138866212|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
138866213|NCT00884793|Efavirenz|efavirenz|mesh-list
138866214|NCT00884793|Etravirine|etravirine|mesh-list
138866215|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138866216|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138866217|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
138866218|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866219|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866220|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138866221|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138866222|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
138866223|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138866224|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138866225|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138866226|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138866227|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138866228|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138866229|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138866230|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138866231|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138866232|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138866233|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138866234|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138866236|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138866237|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866238|NCT00884325|Levocetirizine|levocetirizine|mesh-list
138866239|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138866240|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138866241|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
138866242|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
138948656|NCT00371761|Adefovir|adefovir|mesh-list
138866243|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866244|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866245|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866246|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138866247|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
138866248|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866249|NCT04705844|Adalimumab|adalimumab|mesh-list
138866250|NCT04705844|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138866251|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138866252|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138866253|NCT00636896|Olanzapine|olanzapine|mesh-list
138866254|NCT00636896|Modafinil|modafinil|mesh-list
138866255|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
138866256|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
138866257|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866258|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866259|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138866260|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138866261|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138866262|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866263|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138866264|NCT00636896|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138866265|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138866266|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138866267|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866268|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866269|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
138866270|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138866271|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138866272|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138866273|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138866274|NCT04470674|Carboplatin|carboplatin|mesh-list
138866275|NCT04470674|Pemetrexed|pemetrexed|mesh-list
138866276|NCT04470674|Durvalumab|durvalumab|mesh-list
138866277|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866278|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866279|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866280|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138866281|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138866282|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138866283|NCT00883779|Carboplatin|carboplatin|mesh-list
138866284|NCT00883779|Gemcitabine|gemcitabine|mesh-list
138866285|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138866286|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866287|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138866288|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
138866289|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866290|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138866291|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866292|NCT05263778|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138866293|NCT05263778|Ezetimibe|ezetimibe|mesh-list
138866294|NCT05263778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138866295|NCT05263778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138866296|NCT05263778|Antimetabolites|antimetabolites|mesh-ancestor
138866297|NCT05263778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866298|NCT05263778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138866299|NCT05263778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866300|NCT05263778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138866301|NCT05263778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866302|NCT02693444|Lidocaine|lidocaine|mesh-list
138866303|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
138866304|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
138866305|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866306|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866307|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
138866308|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866309|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138866310|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138866311|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138866312|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138866313|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866314|NCT04162743|Trazodone|trazodone|mesh-list
138866315|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138866316|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138866317|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866318|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866319|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138866320|NCT04162743|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138866321|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138866322|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138866323|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866324|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866325|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
138866326|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138866327|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
138866328|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
138866329|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
138866330|NCT04302896|Tenofovir|tenofovir|mesh-list
138866331|NCT04302896|Lamivudine|lamivudine|mesh-list
138866332|NCT04302896|Emtricitabine|emtricitabine|mesh-list
138866333|NCT04302896|Dolutegravir|dolutegravir|mesh-list
138788163|NCT00641914|Budesonide|budesonide|mesh-list
138866334|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138866335|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
138866336|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948778|NCT03897348|Lacosamide|lacosamide|mesh-list
138866337|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139024744|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138866338|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138866339|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866340|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866341|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138866342|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138866343|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138866344|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138866345|NCT00656643|Sirolimus|sirolimus|mesh-list
138866346|NCT00656643|Temsirolimus|temsirolimus|mesh-list
138866347|NCT00656643|MTOR Inhibitors|mtor inhibitors|mesh-list
138866349|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138866350|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138866351|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866352|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
138866353|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138866354|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
138866355|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866356|NCT00656643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138866357|NCT00656643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866358|NCT00656643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866359|NCT02635971|Gemcitabine|gemcitabine|mesh-list
138866360|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
138866361|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138866362|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
138866363|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866364|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866365|NCT00657423|Cisplatin|cisplatin|mesh-list
138866366|NCT00657423|Docetaxel|docetaxel|mesh-list
138866367|NCT00657423|Endostar protein|endostar protein|mesh-list
138866368|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866369|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
138866370|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
138866371|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
139024783|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866372|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866373|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138518477|NCT00023946|Epothilones|epothilones|mesh-list
138866374|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138866375|NCT00657423|Growth Substances|growth substances|mesh-ancestor
138866376|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866377|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
138866378|NCT00911235|Fluconazole|fluconazole|mesh-list
138866379|NCT00911235|Fesoterodine|fesoterodine|mesh-list
138866380|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
138866381|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138866382|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138866383|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138866384|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866385|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866386|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138866387|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
138866388|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138866389|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866390|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138866391|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138866392|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138866393|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138866394|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
138948816|NCT00868569|Antidotes|antidotes|mesh-ancestor
138866395|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866396|NCT00911235|Urological Agents|urological agents|mesh-ancestor
138866397|NCT00636974|Anesthetics|anesthetics|mesh-list
138866398|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866399|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866400|NCT02535351|Sunitinib|sunitinib|mesh-list
138866401|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866402|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138866403|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138866404|NCT02535351|Growth Substances|growth substances|mesh-ancestor
138866405|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866406|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
138866407|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138866408|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866409|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866410|NCT00613964|Diuretics|diuretics|mesh-list
138866411|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138866412|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
138866413|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866414|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138866415|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866416|NCT05342870|Dexmedetomidine|dexmedetomidine|mesh-list
138866417|NCT05342870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138866418|NCT05342870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866419|NCT05342870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866420|NCT05342870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138866421|NCT05342870|Analgesics|analgesics|mesh-ancestor
138866422|NCT05342870|Sensory System Agents|sensory system agents|mesh-ancestor
138866423|NCT05342870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866424|NCT05342870|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138866425|NCT05342870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138866426|NCT05342870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138866427|NCT05342870|Adrenergic Agents|adrenergic agents|mesh-ancestor
138866428|NCT05342870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866429|NCT05342870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866430|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138866431|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138866432|NCT05342792|Capecitabine|capecitabine|mesh-list
138866433|NCT05342792|Tislelizumab|tislelizumab|mesh-list
138866434|NCT05342792|Antibodies|antibodies|mesh-list
138866435|NCT05342792|Immunologic Factors|immunologic factors|mesh-ancestor
138866436|NCT05342792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866437|NCT05342792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138866438|NCT05342792|Antimetabolites|antimetabolites|mesh-ancestor
139024864|NCT03997058|Estazolam|estazolam|mesh-list
138866439|NCT05342792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866440|NCT05342792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866441|NCT05342792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138866442|NCT00657891|Omalizumab|omalizumab|mesh-list
138866443|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138866444|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138866445|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
138866446|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
138866447|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138866448|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138948828|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138866449|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866450|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
138866451|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866452|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866453|NCT04159077|Tamsulosin|tamsulosin|mesh-list
138866454|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138866455|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138866456|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138866457|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
138866458|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866459|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866460|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866461|NCT04159077|Urological Agents|urological agents|mesh-ancestor
138866462|NCT02690480|Fulvestrant|fulvestrant|mesh-list
138866463|NCT02690480|Palbociclib|palbociclib|mesh-list
139024906|NCT01009892|Narcotics|narcotics|mesh-ancestor
138866464|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138866465|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866466|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138866467|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138866468|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
138866469|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138866470|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866471|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138866472|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866473|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866474|NCT00880269|Panobinostat|panobinostat|mesh-list
138866475|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866476|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138866477|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866478|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866479|NCT00880191|Dexamethasone|dexamethasone|mesh-list
138866481|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138866482|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
138866483|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
138866484|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866485|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866486|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138866487|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
138866488|NCT00880191|Hormones|hormones|mesh-ancestor
138866489|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138866490|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138866491|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024981|NCT04012775|Insulin|insulin|mesh-list
138866493|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
138866494|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
138866495|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138866496|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138866497|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866498|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138866499|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138866500|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138866501|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866502|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866503|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
138866504|NCT00659451|Losartan|losartan|mesh-list
138866505|NCT00659451|Amlodipine|amlodipine|mesh-list
138866506|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138866507|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138866508|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138866509|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866510|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138866511|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866512|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
138866513|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138866514|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138866515|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138866516|NCT00911313|Metformin|metformin|mesh-list
138866517|NCT00911313|Letrozole|letrozole|mesh-list
138866518|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138866519|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866520|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866521|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138866522|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138866523|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866524|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866525|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138866526|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
138866527|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138866528|NCT00659685|Ondansetron|ondansetron|mesh-list
138866529|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
138866530|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
138866531|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866532|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866533|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138866534|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
138866535|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
138866536|NCT00659685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138866537|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138866538|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
138866539|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866540|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866541|NCT00659841|Ciclesonide|ciclesonide|mesh-list
138866542|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
138866543|NCT00659841|Hormones|hormones|mesh-ancestor
138866544|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138866545|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866546|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138866547|NCT00659919|Trazodone|trazodone|mesh-list
138866548|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138866549|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138866550|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866551|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866552|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138866553|NCT00659919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138866554|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138866555|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138866556|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866558|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
139025039|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866559|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138866560|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
138866561|NCT00659997|Albendazole|albendazole|mesh-list
138866562|NCT00659997|Levamisole|levamisole|mesh-list
138866563|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
138866564|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138866565|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138866566|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
138866567|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138866568|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138866569|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
138948909|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
138866570|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
138866571|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
138866572|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866573|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866574|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138866575|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
138866576|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866577|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
138866578|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138866580|NCT00660153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138866581|NCT00660153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866582|NCT00660153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866583|NCT00660231|Gemcitabine|gemcitabine|mesh-list
138866584|NCT00660231|Bexarotene|bexarotene|mesh-list
138866585|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138866586|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
138866587|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866588|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866589|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
138866590|NCT00597519|Fludarabine|fludarabine|mesh-list
138866600|NCT00660621|Bevacizumab|bevacizumab|mesh-list
138866601|NCT00660621|Temozolomide|temozolomide|mesh-list
138866602|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138866603|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866604|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138866605|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138866606|NCT00660621|Growth Substances|growth substances|mesh-ancestor
138866607|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866608|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
138866609|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138866610|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
138866611|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866622|NCT02631993|Furocoumarins|furocoumarins|mesh-list
138866623|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
138866624|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138866625|NCT00660855|Parecoxib|parecoxib|mesh-list
138866626|NCT00660855|Valdecoxib|valdecoxib|mesh-list
138866627|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138866628|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138866629|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866630|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866631|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138866632|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138866633|NCT00660855|Analgesics|analgesics|mesh-ancestor
138866634|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
138866635|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866636|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866637|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138866638|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138866639|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138866640|NCT00660933|Hematinics|hematinics|mesh-ancestor
138866642|NCT02632071|Ricolinostat|ricolinostat|mesh-list
138866643|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138866644|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866645|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
138866646|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
138866647|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
138866648|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866649|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138866650|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866651|NCT00879333|Everolimus|everolimus|mesh-list
138866652|NCT00879333|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138866653|NCT00879333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138866654|NCT00879333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866655|NCT00879333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866656|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138866657|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
138866658|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866659|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866660|NCT02630823|Paclitaxel|paclitaxel|mesh-list
138866661|NCT02630823|Carboplatin|carboplatin|mesh-list
138866662|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
138866663|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138866664|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866665|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
138866666|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
138866667|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
138866668|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866669|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138866670|NCT02630823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138866672|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
138866673|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138866674|NCT02630511|Diuretics|diuretics|mesh-ancestor
138866675|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
138866676|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866678|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
138866679|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866680|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138866681|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138866682|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
138866683|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138866684|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138866685|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
138866686|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866687|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866688|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
138866689|NCT00666159|Tacrolimus|tacrolimus|mesh-list
138866690|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138866691|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
138866692|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866693|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138866694|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025212|NCT00500370|Exenatide|exenatide|mesh-list
138866695|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866696|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138866697|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138866698|NCT00666159|Analgesics|analgesics|mesh-ancestor
138866699|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
138866700|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866701|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138866702|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138866703|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
138866704|NCT00666393|Fentanyl|fentanyl|mesh-list
138866705|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138866707|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138949016|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866708|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866709|NCT00666393|Analgesics|analgesics|mesh-ancestor
139025262|NCT00503984|Hormones|hormones|mesh-ancestor
138866710|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
138866711|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866712|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138866713|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138866714|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
138866715|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
138866717|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
138866718|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
138866719|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138866720|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866721|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138866722|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138866723|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866724|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138866725|NCT00666783|Palonosetron|palonosetron|mesh-list
138866726|NCT00666783|Granisetron|granisetron|mesh-list
138866727|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
138866728|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
138866729|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025317|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866730|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866731|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138866732|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138866733|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138866734|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
138866735|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866736|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866737|NCT00666939|Gabapentin|gabapentin|mesh-list
138866738|NCT00666939|Analgesics|analgesics|mesh-ancestor
138866739|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
138866740|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866741|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866742|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
138866744|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138866745|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866746|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138866747|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138866748|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138866749|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866750|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866751|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
138866752|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138866753|NCT00667407|Albuterol|albuterol|mesh-list
138866754|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138866755|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
138866756|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866757|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025393|NCT03984760|Sevelamer|sevelamer|mesh-list
138866758|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138866759|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
138866760|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
138866761|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138866762|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138866763|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138866764|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138866765|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
138866766|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866767|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866768|NCT00667485|Sirolimus|sirolimus|mesh-list
138866769|NCT00667485|Bevacizumab|bevacizumab|mesh-list
138866770|NCT00667485|Temsirolimus|temsirolimus|mesh-list
138866771|NCT00667485|MTOR Inhibitors|mtor inhibitors|mesh-list
138866772|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138866773|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866774|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138866775|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138866776|NCT00667485|Growth Substances|growth substances|mesh-ancestor
138866777|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866778|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
138866779|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138866780|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138866781|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138866782|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
138866783|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138866784|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
138866785|NCT00667485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138866786|NCT00667485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866787|NCT00667485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866789|NCT00667641|Bortezomib|bortezomib|mesh-list
138642369|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
138866790|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138866791|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866792|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
138866793|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
138866794|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
138866795|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866796|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138866798|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138866799|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
138866800|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866801|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866802|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138866803|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
138866804|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
138866805|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138866806|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138866807|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138866808|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138866809|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
138866810|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866811|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866813|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
138866815|NCT03481556|Melphalan|melphalan|mesh-list
138866816|NCT03481556|Daratumumab|daratumumab|mesh-list
138518928|NCT00027339|Ritonavir|ritonavir|mesh-list
138866817|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138866818|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
138866819|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
138866820|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866821|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866822|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138866823|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
138866824|NCT03481556|Hormones|hormones|mesh-ancestor
138866825|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138866826|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138866827|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866828|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138866829|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
138866830|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866831|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138866832|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138866833|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
138866834|NCT00668031|Aprotinin|aprotinin|mesh-list
138866835|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
138866836|NCT00668031|Coagulants|coagulants|mesh-ancestor
138866837|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138866838|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138866839|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
138866840|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866841|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866842|NCT00668109|Tadalafil|tadalafil|mesh-list
138866843|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138866844|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
138866845|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138866846|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138866847|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866848|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866849|NCT00668109|Urological Agents|urological agents|mesh-ancestor
138866850|NCT00668343|Simvastatin|simvastatin|mesh-list
138866851|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138866852|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138866853|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
138866854|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866855|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138866856|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138866857|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866858|NCT04717700|Dexamethasone|dexamethasone|mesh-list
138866859|NCT04717700|Lenalidomide|lenalidomide|mesh-list
138866860|NCT04717700|Bortezomib|bortezomib|mesh-list
138866861|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138866862|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
138866863|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
138642437|NCT00266786|Ketorolac|ketorolac|mesh-list
138866864|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866865|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866866|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138866867|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
138866868|NCT04717700|Hormones|hormones|mesh-ancestor
138866869|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138866870|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138866871|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866872|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
138866873|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138866874|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138866875|NCT04717700|Growth Substances|growth substances|mesh-ancestor
138866876|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
138866877|NCT02630277|Aflibercept|aflibercept|mesh-list
138866878|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138866879|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138866880|NCT02630277|Growth Substances|growth substances|mesh-ancestor
138866881|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866882|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
138866883|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866884|NCT00668499|Pemetrexed|pemetrexed|mesh-list
138866885|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866886|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866887|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866888|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138866889|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138866890|NCT05201846|Insulin|insulin|mesh-list
138866891|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138866893|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866894|NCT00668967|Verapamil|verapamil|mesh-list
138866895|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138866896|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138866897|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138866898|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866899|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138866900|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866901|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
138866902|NCT03583658|Ambroxol|ambroxol|mesh-list
138866903|NCT03583658|Expectorants|expectorants|mesh-ancestor
138866904|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
138866905|NCT03555968|Dronabinol|dronabinol|mesh-list
138866906|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
138866907|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866908|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138866909|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138866910|NCT03555968|Analgesics|analgesics|mesh-ancestor
138866911|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
138866912|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866913|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138866914|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138866915|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866916|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866917|NCT03555968|Hormones|hormones|mesh-ancestor
138866918|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138866919|NCT04593680|Tenofovir|tenofovir|mesh-list
138866920|NCT04593680|Emtricitabine|emtricitabine|mesh-list
138866921|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
138866922|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138866923|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138866924|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138866925|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866926|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866927|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138610157|NCT00575848|Glycine|glycine|mesh-list
138866928|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138866929|NCT00669435|Losartan|losartan|mesh-list
138866930|NCT00669435|Amlodipine|amlodipine|mesh-list
138866931|NCT00669435|Simvastatin|simvastatin|mesh-list
138866932|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138866933|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139025592|NCT01017354|Vitamins|vitamins|mesh-ancestor
138866934|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138866935|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866936|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138866937|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866938|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
138866939|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138866940|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138866941|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
138866942|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138866943|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138866944|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866945|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138866946|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138866947|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138866948|NCT00669591|Bavituximab|bavituximab|mesh-list
138866949|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138866950|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866951|NCT00669747|Carboplatin|carboplatin|mesh-list
138866952|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866953|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138866954|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138866955|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138866956|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
138866957|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866958|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138866959|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
138866960|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138866961|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138866962|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138866963|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138866964|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866965|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866966|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138866967|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138866968|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138866969|NCT00670293|Raclopride|raclopride|mesh-list
138866970|NCT00670293|Methylphenidate|methylphenidate|mesh-list
138866971|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138866972|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866973|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138866974|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139025624|NCT00488514|Naproxen|naproxen|mesh-list
138866975|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138866976|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138866977|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
138866978|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138866979|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138866980|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138866981|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138866982|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138866983|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138866984|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
138866985|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138866986|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866987|NCT00670761|Misoprostol|misoprostol|mesh-list
138866988|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138866989|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
138866990|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138866991|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866992|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138866993|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138866994|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
138866995|NCT00680433|Ketamine|ketamine|mesh-list
138866996|NCT00680433|Analgesics|analgesics|mesh-ancestor
138866997|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
138866998|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138866999|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867000|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138867001|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138867002|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
138867003|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
138867004|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867005|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138867006|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138867007|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867008|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867009|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
138867010|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138867011|NCT03322280|Estrogens|estrogens|mesh-ancestor
138867012|NCT03322280|Hormones|hormones|mesh-ancestor
138867013|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138867014|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867015|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138867016|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867018|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138867019|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138949159|NCT04039815|Thiamine|thiamine|mesh-list
138867020|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867021|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
138867022|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
138867023|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
138867024|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867025|NCT04349306|Rasburicase|rasburicase|mesh-list
138867026|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
138867027|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138867028|NCT00614588|Anesthetics|anesthetics|mesh-list
138867029|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867030|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867031|NCT02699840|Vaccines|vaccines|mesh-list
138867032|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
138867033|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867034|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
138867035|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138867036|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
139025701|NCT00304954|Sirolimus|sirolimus|mesh-list
138867037|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138519149|NCT00392561|Selenium|selenium|mesh-list
138867038|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867039|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138867040|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
138867041|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138867042|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
138867043|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867044|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867045|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138867046|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
138867047|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
138867048|NCT00613808|Protective Agents|protective agents|mesh-ancestor
138867049|NCT05344742|Paclitaxel|paclitaxel|mesh-list
138867050|NCT05344742|Capecitabine|capecitabine|mesh-list
138867051|NCT05344742|Mitoxantrone|mitoxantrone|mesh-list
138867052|NCT05344742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138867053|NCT05344742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867054|NCT05344742|Tubulin Modulators|tubulin modulators|mesh-ancestor
138867055|NCT05344742|Antimitotic Agents|antimitotic agents|mesh-ancestor
138867056|NCT05344742|Mitosis Modulators|mitosis modulators|mesh-ancestor
138867057|NCT05344742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867058|NCT05344742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138867059|NCT05344742|Antimetabolites|antimetabolites|mesh-ancestor
138867060|NCT05344742|Analgesics|analgesics|mesh-ancestor
138867061|NCT05344742|Sensory System Agents|sensory system agents|mesh-ancestor
138867062|NCT05344742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867063|NCT05344742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867064|NCT05344742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138867065|NCT05344742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138867066|NCT05344742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867067|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138867069|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138867070|NCT02046434|Protective Agents|protective agents|mesh-ancestor
138867071|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867072|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867073|NCT03930446|Ethanol|ethanol|mesh-list
138867074|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138867075|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138867076|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867077|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867078|NCT00614666|Nikkomycin|nikkomycin|mesh-list
138867079|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
138867080|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138867081|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867082|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867083|NCT03794336|Aspirin|aspirin|mesh-list
138867084|NCT03794336|Metformin|metformin|mesh-list
138867085|NCT03794336|Alogliptin|alogliptin|mesh-list
138867086|NCT03794336|Acarbose|acarbose|mesh-list
138867087|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138867088|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867089|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138867090|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138867091|NCT03794336|Analgesics|analgesics|mesh-ancestor
138867092|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
138867093|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867094|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138867096|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138867097|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138867098|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867099|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138867100|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138867101|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867102|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
138867103|NCT03794336|Incretins|incretins|mesh-ancestor
138867104|NCT03794336|Hormones|hormones|mesh-ancestor
138867105|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138867106|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138867107|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
138867108|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138867109|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
138867110|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138867111|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867112|NCT03687554|Venglustat|venglustat|mesh-list
138519224|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138867113|NCT03687554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867114|NCT03687554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867115|NCT03681158|Valproic Acid|valproic acid|mesh-list
138867116|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
138867117|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867118|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867119|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
138867120|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867121|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867122|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
138867123|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138867124|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867125|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138867126|NCT05343728|Hemostatics|hemostatics|mesh-list
138867127|NCT05343728|Coagulants|coagulants|mesh-ancestor
138867128|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
138867129|NCT00436748|Hematinics|hematinics|mesh-ancestor
138867130|NCT02704598|Warfarin|warfarin|mesh-list
138867131|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
138867132|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
138867133|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138867134|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
138867135|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138867136|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
138867137|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867138|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867139|NCT05343338|Sivelestat|sivelestat|mesh-list
138867140|NCT05343338|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138867141|NCT05343338|Protease Inhibitors|protease inhibitors|mesh-ancestor
138867142|NCT05343338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867143|NCT05343338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867144|NCT02704052|Enoxaparin|enoxaparin|mesh-list
138867145|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
138867146|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
138867147|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138867148|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138867149|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867150|NCT02703896|Esomeprazole|esomeprazole|mesh-list
138867151|NCT02703896|Omeprazole|omeprazole|mesh-list
138867152|NCT02703896|Pantoprazole|pantoprazole|mesh-list
138867153|NCT02703896|Lansoprazole|lansoprazole|mesh-list
138867154|NCT02703896|Famotidine|famotidine|mesh-list
138867155|NCT02703896|Ranitidine|ranitidine|mesh-list
138867156|NCT02703896|Cimetidine|cimetidine|mesh-list
138867157|NCT02703896|Nizatidine|nizatidine|mesh-list
138867158|NCT02703896|Lafutidine|lafutidine|mesh-list
138867159|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138867160|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139210389|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867161|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138867162|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867163|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867164|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138867165|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
138867166|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
138867167|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867168|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867169|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138867170|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138867171|NCT02737436|Oxytocin|oxytocin|mesh-list
138867172|NCT02737436|Oxytocics|oxytocics|mesh-ancestor
138867173|NCT02737436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138867174|NCT02737436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867175|NCT00614978|Temozolomide|temozolomide|mesh-list
138867176|NCT00614978|Lapatinib|lapatinib|mesh-list
138867177|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138867178|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
138867179|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867180|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867181|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138867182|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867183|NCT02703740|Lidocaine|lidocaine|mesh-list
138867184|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
138867185|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
138867186|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
138867187|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867188|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867189|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
138867190|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867191|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138867192|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138867193|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138867194|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138867195|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867196|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138867198|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
138867199|NCT02703740|Protective Agents|protective agents|mesh-ancestor
138867200|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
138867201|NCT00615368|Hematinics|hematinics|mesh-ancestor
138867202|NCT00615446|Gemcitabine|gemcitabine|mesh-list
138867203|NCT00615446|Sunitinib|sunitinib|mesh-list
138867204|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138867205|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
138867206|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867207|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867208|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138867209|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138867210|NCT00615446|Growth Substances|growth substances|mesh-ancestor
138867211|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867212|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
138867213|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138867214|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867216|NCT02703272|Rituximab|rituximab|mesh-list
138867217|NCT02703272|Carboplatin|carboplatin|mesh-list
138867218|NCT02703272|Etoposide|etoposide|mesh-list
138867219|NCT02703272|Vincristine|vincristine|mesh-list
138867220|NCT02703272|Ifosfamide|ifosfamide|mesh-list
138867221|NCT02703272|Idarubicin|idarubicin|mesh-list
138867222|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138867223|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
138867224|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
138867225|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867226|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867227|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138867228|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
138867230|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138867231|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138867232|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867233|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138867234|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
138867235|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138867236|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138867237|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138867238|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138867239|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867240|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867241|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
138867242|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
138867243|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
139025943|NCT00402987|Analgesics|analgesics|mesh-ancestor
138867244|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138867245|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
138949252|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
138867246|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138867247|NCT02703194|Prednisone|prednisone|mesh-list
138867248|NCT02703194|Prednisolone|prednisolone|mesh-list
138867249|NCT02703194|Leflunomide|leflunomide|mesh-list
138867250|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138867251|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
138867252|NCT02703194|Hormones|hormones|mesh-ancestor
138867253|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138867254|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867255|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138867256|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867257|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867258|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867259|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138867260|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
138867261|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
138867262|NCT02702960|Prednisone|prednisone|mesh-list
138867263|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
138867264|NCT02702960|Fludarabine|fludarabine|mesh-list
138867265|NCT02702960|Tacrolimus|tacrolimus|mesh-list
138519377|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138867266|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138867267|NCT02702960|Mesna|mesna|mesh-list
138867268|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138867269|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
138867270|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867271|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138867272|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138867273|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
138867274|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867275|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867276|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138867277|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138867278|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
138867279|NCT02702960|Hormones|hormones|mesh-ancestor
138867280|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138867281|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138867282|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138867283|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867284|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138867285|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138867286|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
138867287|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138867288|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138867289|NCT02702960|Protective Agents|protective agents|mesh-ancestor
138867290|NCT02699528|Methylphenidate|methylphenidate|mesh-list
138867291|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138867292|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867293|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138867294|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138867295|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139025988|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138867296|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867297|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
138867298|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867299|NCT04215770|Penicillins|penicillins|mesh-list
138867300|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138867301|NCT04215770|Penicillin G|penicillin g|mesh-list
138867302|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138867303|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
138867304|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138867305|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138867306|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138867307|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867308|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867309|NCT02702882|Fenugreek seed meal|fenugreek seed meal|mesh-list
138867310|NCT02702882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138867311|NCT02702882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867312|NCT02699138|Trazodone|trazodone|mesh-list
138867313|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138867314|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138867315|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867316|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867317|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138867318|NCT02699138|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138867319|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138867320|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138867321|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867322|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867323|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
138867324|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138867325|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
138867327|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138867328|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138867329|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867330|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138867331|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138867332|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
138867333|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138867334|NCT01831076|Tamoxifen|tamoxifen|mesh-list
138867335|NCT01831076|Exemestane|exemestane|mesh-list
138867336|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138867337|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
138867338|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138867339|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867340|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138867341|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867342|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138867343|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138867344|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139026021|NCT00496782|Maraviroc|maraviroc|mesh-list
138867345|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138867346|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138867347|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867348|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867349|NCT02698982|Anesthetics|anesthetics|mesh-list
138867350|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867351|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867352|NCT00615524|Exemestane|exemestane|mesh-list
138867353|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867354|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138867355|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138867356|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867357|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867358|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138867359|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
138867360|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138867361|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867362|NCT00908141|Sargramostim|sargramostim|mesh-list
138867363|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
138867364|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867365|NCT01246310|Inositol|inositol|mesh-list
138867366|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
138867367|NCT01246310|Vitamins|vitamins|mesh-ancestor
138867368|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
138867369|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867370|NCT00700076|Ketamine|ketamine|mesh-list
138867371|NCT00700076|Analgesics|analgesics|mesh-ancestor
138867372|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
138867373|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867374|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867375|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138867377|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
138867378|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
138867379|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867380|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138867381|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139026036|NCT01020708|Expectorants|expectorants|mesh-ancestor
138867382|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867383|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867384|NCT02698514|Sevoflurane|sevoflurane|mesh-list
138867386|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138867388|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
138867389|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
138867390|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867391|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867392|NCT02706158|Vitamin D|vitamin d|mesh-list
138867393|NCT02706158|Calcium|calcium|mesh-list
138867394|NCT02706158|Vitamins|vitamins|mesh-ancestor
138867395|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
138867396|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867397|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138867398|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138867399|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
138867400|NCT00615602|Docetaxel|docetaxel|mesh-list
138867401|NCT00615602|Trastuzumab|trastuzumab|mesh-list
138867402|NCT00615602|Epirubicin|epirubicin|mesh-list
138867403|NCT00615602|Fluorouracil|fluorouracil|mesh-list
138867404|NCT00615602|Lenograstim|lenograstim|mesh-list
138867405|NCT00615602|Mitogens|mitogens|mesh-list
138867406|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138867407|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
138867408|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867409|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138867410|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138867411|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
138867412|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867413|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867414|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138867415|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
138867416|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
138867417|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
138867418|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138867419|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138867420|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138867421|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138867422|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867423|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
138867424|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138867425|NCT00615602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138867426|NCT02698748|Chloroquine|chloroquine|mesh-list
138867427|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138867428|NCT02698748|Amebicides|amebicides|mesh-ancestor
138867429|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138867430|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138867431|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138867432|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
138867433|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138867434|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138867435|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138867436|NCT02698748|Analgesics|analgesics|mesh-ancestor
138867437|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
138867438|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867439|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867440|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138867441|NCT02698748|Filaricides|filaricides|mesh-ancestor
138867442|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
138867443|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
138867444|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138867446|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
138867447|NCT00615212|Midazolam|midazolam|mesh-list
138867448|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138867449|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138610663|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
138867450|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867451|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867452|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138867453|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138867454|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138867455|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138867456|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
138867457|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
138867458|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
138867459|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
138867460|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867461|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867462|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138867463|NCT00615212|Analgesics|analgesics|mesh-ancestor
138867464|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
138867465|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867466|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138867467|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138867468|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138867469|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138867470|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138867471|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867473|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138867474|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
138867475|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
138867476|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867477|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867478|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138867479|NCT02701478|Analgesics|analgesics|mesh-ancestor
138867480|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
138867481|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867482|NCT03314363|Trace Elements|trace elements|mesh-list
138867483|NCT03314363|Micronutrients|micronutrients|mesh-list
138867484|NCT03314363|Citric Acid|citric acid|mesh-list
138867485|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
138867486|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867487|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
138867488|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138867489|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
138867490|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
138867491|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867492|NCT00906347|Misoprostol|misoprostol|mesh-list
138867493|NCT00906347|Oxytocin|oxytocin|mesh-list
138867494|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
138867495|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138867496|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867497|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138867498|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
138867499|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138867500|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138867501|NCT02705768|Carbamazepine|carbamazepine|mesh-list
138867502|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
138867503|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
138867504|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
138867505|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138867506|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867507|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867508|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138867509|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138867510|NCT02705768|Analgesics|analgesics|mesh-ancestor
138867511|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
138867512|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867513|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138867514|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138867515|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867516|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138867517|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138867518|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138867519|NCT00616070|Difluprednate|difluprednate|mesh-list
138867520|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
138867521|NCT00616070|Hormones|hormones|mesh-ancestor
138867522|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138867523|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867524|NCT02705534|Ribavirin|ribavirin|mesh-list
138867525|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
138867527|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
138867528|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867529|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
138867530|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138867531|NCT02701166|Bezafibrate|bezafibrate|mesh-list
138867532|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138867533|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
138867534|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867535|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138867536|NCT03141203|Romidepsin|romidepsin|mesh-list
138867537|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138867538|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867539|NCT03141203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138867540|NCT03141203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210390|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867541|NCT03141203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867542|NCT05320991|Ketamine|ketamine|mesh-list
138867543|NCT05320991|Analgesics|analgesics|mesh-ancestor
138867544|NCT05320991|Sensory System Agents|sensory system agents|mesh-ancestor
138867545|NCT05320991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867546|NCT05320991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867547|NCT05320991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138867548|NCT05320991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138867549|NCT05320991|Anesthetics, General|anesthetics, general|mesh-ancestor
138867550|NCT05320991|Anesthetics|anesthetics|mesh-ancestor
138867551|NCT05320991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867552|NCT05320991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138867553|NCT05320991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138867554|NCT05320991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867555|NCT05320991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867556|NCT04215614|Lidocaine|lidocaine|mesh-list
138867557|NCT04215614|Bupivacaine|bupivacaine|mesh-list
138867558|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
138867559|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
138867560|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867561|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867562|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
138867563|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867564|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138867565|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138867566|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138867567|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138867568|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867569|NCT00906035|Aspirin|aspirin|mesh-list
138867570|NCT00906035|Dipyridamole|dipyridamole|mesh-list
138867571|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138867572|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138867573|NCT00906035|Analgesics|analgesics|mesh-ancestor
138867574|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
138867575|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867576|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867577|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138867578|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138867579|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138867580|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138867581|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867582|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138867583|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138867584|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867585|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
138867586|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138867587|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
138867588|NCT02698280|Bevacizumab|bevacizumab|mesh-list
138867589|NCT02698280|Nimustine|nimustine|mesh-list
138867590|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138867591|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867592|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138867593|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138867594|NCT02698280|Growth Substances|growth substances|mesh-ancestor
138867595|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867596|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
138867597|NCT03087773|Empagliflozin|empagliflozin|mesh-list
138867598|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138867599|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867600|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138867601|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867602|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
138867603|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867604|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138867605|NCT05333159|Dapagliflozin|dapagliflozin|mesh-list
138867606|NCT05333159|Empagliflozin|empagliflozin|mesh-list
138867607|NCT05333159|Canagliflozin|canagliflozin|mesh-list
138867608|NCT05333159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138867609|NCT05333159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867610|NCT05333159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138867611|NCT05333159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867613|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138867614|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
138867615|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867616|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867617|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867618|NCT00905489|Nevirapine|nevirapine|mesh-list
138867619|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138867620|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138867621|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867622|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867623|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
138867624|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138867625|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138867626|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138867627|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138867628|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138867629|NCT02705378|Naloxegol|naloxegol|mesh-list
138867630|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138867631|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867632|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
138867633|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867634|NCT03059147|Nivolumab|nivolumab|mesh-list
138867635|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138867636|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867637|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138867638|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519751|NCT00393107|Rituximab|rituximab|mesh-list
138867639|NCT03356834|Tenofovir|tenofovir|mesh-list
138867640|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
138867642|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138867643|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138867644|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867645|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867646|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138867647|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138867648|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138867649|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
138867650|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138867651|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867652|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138867653|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867654|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867655|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138867656|NCT02704754|Suvorexant|suvorexant|mesh-list
138867657|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138867658|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138867659|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867660|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867661|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138867662|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867663|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949423|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138867664|NCT04214054|Calcium|calcium|mesh-list
138867665|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138867666|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867667|NCT04213898|Paclitaxel|paclitaxel|mesh-list
138867668|NCT04213898|Epirubicin|epirubicin|mesh-list
138867669|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138867670|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138867671|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867672|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
138867673|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
138867674|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
138867675|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867676|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138867677|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138867678|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138867679|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867682|NCT03170882|Ixazomib|ixazomib|mesh-list
138867683|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138867684|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
138867685|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
138867686|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867687|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867688|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138867689|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
138867691|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138867692|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138867693|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867694|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
138867695|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138867696|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138867697|NCT03170882|Growth Substances|growth substances|mesh-ancestor
138867698|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
138867699|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
138867700|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867701|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867702|NCT00616850|Lidocaine|lidocaine|mesh-list
138867703|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
138867704|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
138867705|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867706|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867707|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
138867708|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867709|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138867710|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138867711|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138867712|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138519826|NCT00031395|Clonidine|clonidine|mesh-list
138867713|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867715|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138867716|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138867717|NCT00618644|Growth Substances|growth substances|mesh-ancestor
138867718|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867719|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
138867720|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867721|NCT05324774|Aflibercept|aflibercept|mesh-list
138867722|NCT05324774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138867723|NCT05324774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138867724|NCT05324774|Growth Substances|growth substances|mesh-ancestor
138867725|NCT05324774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867726|NCT05324774|Growth Inhibitors|growth inhibitors|mesh-ancestor
138867727|NCT05324774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867728|NCT05324618|Hydrocortisone|hydrocortisone|mesh-list
138949448|NCT01050517|Praziquantel|praziquantel|mesh-list
138867729|NCT05324618|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138867730|NCT05324618|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138867731|NCT05324618|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138867732|NCT05324618|Tacrolimus|tacrolimus|mesh-list
138867733|NCT05324618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138867734|NCT05324618|Immunologic Factors|immunologic factors|mesh-ancestor
138867735|NCT05324618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867736|NCT05324618|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138867737|NCT05324618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867738|NCT05324618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867739|NCT05324618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138867740|NCT00907517|Cytarabine|cytarabine|mesh-list
138867741|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138788172|NCT00641914|Hormones|hormones|mesh-ancestor
139091734|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091735|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139091737|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091738|NCT04222972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139091739|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091740|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139091741|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139091742|NCT04205630|Trastuzumab|trastuzumab|mesh-list
139091743|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091744|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091745|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
139091746|NCT04199104|Lenvatinib|lenvatinib|mesh-list
139091747|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091748|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091749|NCT04199104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139091750|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091751|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139091752|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091754|NCT04165772|Dostarlimab|dostarlimab|mesh-list
139091755|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139091756|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
139091757|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091758|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091759|NCT04029688|Cytarabine|cytarabine|mesh-list
139091760|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
139091761|NCT04029688|Fludarabine|fludarabine|mesh-list
139091762|NCT04029688|Venetoclax|venetoclax|mesh-list
139091763|NCT04029688|Topotecan|topotecan|mesh-list
139091764|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139091765|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
139091766|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091767|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139091768|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139091769|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
139091770|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091771|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091772|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139091773|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139091774|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
139091775|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
139091776|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091777|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139091778|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139091779|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091781|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139091782|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139091783|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139091784|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139091785|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
139091786|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949460|NCT02534467|Montelukast|montelukast|mesh-list
139091787|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091788|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091789|NCT04003805|Nicotine|nicotine|mesh-list
139091790|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139091791|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
139091792|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139091793|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091794|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139091795|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139091796|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
139091797|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091798|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091799|NCT03915769|Ozanimod|ozanimod|mesh-list
139091800|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139091801|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091802|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139091803|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
139091804|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091805|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139091806|NCT03910972|Vaccines|vaccines|mesh-list
139091807|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
139091808|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091809|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139091811|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091812|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139091813|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
139091814|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
139091815|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091816|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
139091817|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091818|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091819|NCT03875911|Mitomycins|mitomycins|mesh-list
139091820|NCT03875911|Mitomycin|mitomycin|mesh-list
139091821|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139091822|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091823|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
139091824|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091825|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139091826|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091827|NCT03854019|Quinidine|quinidine|mesh-list
139091828|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
139091829|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
139091830|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
139091831|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139091832|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139091833|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091834|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091835|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091836|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139091837|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139026495|NCT00413049|Amlodipine|amlodipine|mesh-list
139091838|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
139091839|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139091840|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
139091841|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139091842|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139091844|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091845|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139091846|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139091847|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
139091848|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139091849|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139091850|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139091851|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139091852|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139091853|NCT03816163|Paclitaxel|paclitaxel|mesh-list
139091854|NCT03816163|Gemcitabine|gemcitabine|mesh-list
139091855|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139091856|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091857|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
139091858|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
139091859|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
139091860|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091861|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139091862|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
139091863|NCT03780829|Cycloserine|cycloserine|mesh-list
139091864|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139091865|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139091866|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139091867|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
139091868|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139091869|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
139091870|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091872|NCT03728673|Citalopram|citalopram|mesh-list
139091873|NCT03728673|Escitalopram|escitalopram|mesh-list
139091874|NCT03728673|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139091875|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139091876|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139091877|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091878|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091879|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
139091880|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091881|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139091882|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139091883|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
139091884|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
139091885|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139091886|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139091887|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139091888|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
139091889|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139091890|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
139091891|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139091892|NCT03727061|Carboplatin|carboplatin|mesh-list
139091893|NCT03727061|Pembrolizumab|pembrolizumab|mesh-list
139091894|NCT03727061|Fluorouracil|fluorouracil|mesh-list
139091895|NCT03727061|Nivolumab|nivolumab|mesh-list
139091896|NCT03727061|Cetuximab|cetuximab|mesh-list
139091897|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
139026560|NCT00303316|Vaccines|vaccines|mesh-list
139091898|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
139091900|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091901|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091902|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139091903|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091904|NCT03727061|Antimetabolites|antimetabolites|mesh-ancestor
139091905|NCT03727061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139091906|NCT03727061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139091907|NCT03727061|Immunologic Factors|immunologic factors|mesh-ancestor
139091908|NCT03727061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091909|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
139091910|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139091916|NCT03711058|Nivolumab|nivolumab|mesh-list
139091917|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091918|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091919|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139091920|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091921|NCT03704480|Durvalumab|durvalumab|mesh-list
139091922|NCT03704480|Tremelimumab|tremelimumab|mesh-list
139091923|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091924|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091925|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
139091926|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139091927|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
139091928|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091929|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
139091930|NCT03697876|Protective Agents|protective agents|mesh-ancestor
139091931|NCT03681561|Nivolumab|nivolumab|mesh-list
139091932|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091933|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091934|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139091935|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091936|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139091937|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
139091938|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091939|NCT03656549|Pemetrexed|pemetrexed|mesh-list
139091940|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091941|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091942|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091943|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139091944|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139091945|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139091946|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139091947|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
139091948|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139091949|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091950|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091951|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
139091952|NCT03615326|Capecitabine|capecitabine|mesh-list
139091953|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
139091954|NCT03615326|Trastuzumab|trastuzumab|mesh-list
139091955|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091956|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091957|NCT03615326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139091958|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091959|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139091960|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
139091961|NCT03599635|Bupivacaine|bupivacaine|mesh-list
139091962|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
139091963|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
139091964|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139091965|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091966|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
139091967|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139091968|NCT03540420|Atezolizumab|atezolizumab|mesh-list
139091969|NCT03540420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139091970|NCT03540420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091971|NCT03540420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091972|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091973|NCT03521154|Osimertinib|osimertinib|mesh-list
139091974|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091975|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139091977|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139091978|NCT03500731|Rituximab|rituximab|mesh-list
139091979|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
139091980|NCT03500731|Fludarabine|fludarabine|mesh-list
139091981|NCT03500731|Thiotepa|thiotepa|mesh-list
139091982|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
139091983|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139091984|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139091985|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
139091986|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139091987|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139091988|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842577|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139091989|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139091990|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139091991|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
139091992|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139091993|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
139091994|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139091995|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139091996|NCT03481660|Aflibercept|aflibercept|mesh-list
139091997|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139091998|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139091999|NCT03481660|Growth Substances|growth substances|mesh-ancestor
139092000|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092001|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
139092002|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092003|NCT03467373|Prednisone|prednisone|mesh-list
139092004|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
139092005|NCT03467373|Rituximab|rituximab|mesh-list
139092006|NCT03467373|Doxorubicin|doxorubicin|mesh-list
139092007|NCT03467373|Vincristine|vincristine|mesh-list
139092008|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
139092009|NCT03467373|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139092010|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139092011|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
139092012|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092013|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139092014|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139092015|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
139092016|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092017|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092018|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139092019|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139092020|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139092021|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139092022|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139092023|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092024|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139092025|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
139092026|NCT03467373|Hormones|hormones|mesh-ancestor
138867742|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
139092027|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139092028|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139092029|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139092030|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
139092031|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
139092032|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
139092033|NCT03467373|Immunoconjugates|immunoconjugates|mesh-ancestor
139092034|NCT03404193|Decitabine|decitabine|mesh-list
139092035|NCT03404193|Venetoclax|venetoclax|mesh-list
139092036|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139092037|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
139026722|NCT00465972|Doxepin|doxepin|mesh-list
139092038|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092039|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092040|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092041|NCT03381183|Durvalumab|durvalumab|mesh-list
139092042|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139092043|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092044|NCT03370133|Ustekinumab|ustekinumab|mesh-list
139092045|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
139092046|NCT03304717|Tenofovir|tenofovir|mesh-list
139092047|NCT03304717|Emtricitabine|emtricitabine|mesh-list
139092048|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
139092049|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139092050|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139092051|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139092052|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092053|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092054|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139092055|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139092056|NCT03221751|Prazosin|prazosin|mesh-list
139092057|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139092058|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139092059|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139092060|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139092061|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
139092062|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092063|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092064|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138842651|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139092065|NCT03182296|Exenatide|exenatide|mesh-list
139092066|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139092067|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092068|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139092069|NCT03182296|Incretins|incretins|mesh-ancestor
139092070|NCT03182296|Hormones|hormones|mesh-ancestor
139026761|NCT00330460|Alendronate|alendronate|mesh-list
139092071|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139092072|NCT03014167|Albendazole|albendazole|mesh-list
139092073|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
139092074|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139092075|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139092076|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
139092077|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139092078|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139092079|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
139092080|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
139092081|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
139092082|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092083|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092084|NCT02931695|Hormones|hormones|mesh-list
139092085|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139092086|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092087|NCT02879617|Durvalumab|durvalumab|mesh-list
139092088|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139092089|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092090|NCT02734602|Ketamine|ketamine|mesh-list
139092091|NCT02734602|Analgesics|analgesics|mesh-ancestor
139092092|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
139092093|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092094|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092095|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139092096|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139092097|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
139092098|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
139092099|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139092100|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139092105|NCT02627092|Trace Elements|trace elements|mesh-ancestor
139092106|NCT02627092|Micronutrients|micronutrients|mesh-ancestor
139092107|NCT02627092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092108|NCT02562235|Riociguat|riociguat|mesh-list
139092109|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
138949635|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092110|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092115|NCT02404870|Canagliflozin|canagliflozin|mesh-list
139092116|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139092117|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092118|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139092119|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092120|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
139092121|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139092122|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092123|NCT02359565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139092124|NCT02359565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092125|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
139092126|NCT02316340|Vorinostat|vorinostat|mesh-list
139092127|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
139092128|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139092129|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139092130|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139092131|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092132|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092133|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139092134|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092135|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139092136|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
139092137|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092138|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139092139|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092140|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092142|NCT02143401|Navitoclax|navitoclax|mesh-list
139092143|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092144|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139092145|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092146|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092147|NCT01997840|Dexamethasone|dexamethasone|mesh-list
139092148|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
139092149|NCT01997840|Pomalidomide|pomalidomide|mesh-list
139092150|NCT01997840|Ricolinostat|ricolinostat|mesh-list
139092151|NCT01997840|BB 1101|bb 1101|mesh-list
139092152|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139092153|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
139092154|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
139092155|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092156|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092157|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139092158|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
139092159|NCT01997840|Hormones|hormones|mesh-ancestor
138949676|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092160|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139092161|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139092162|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092163|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
139092164|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092165|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092166|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
139092167|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139092168|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139092169|NCT01997840|Growth Substances|growth substances|mesh-ancestor
139092170|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
139092171|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139092173|NCT01972919|Capecitabine|capecitabine|mesh-list
139092174|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139092175|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
139092176|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092177|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092178|NCT01782599|Nicotine|nicotine|mesh-list
139092179|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139092180|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
139092181|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092182|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092183|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139092184|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139092185|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
139092186|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092187|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092188|NCT01765140|Amifampridine|amifampridine|mesh-list
139092189|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139092190|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092191|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092192|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139092193|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139026942|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949704|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
139092194|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092195|NCT01758328|Fludarabine|fludarabine|mesh-list
139092196|NCT01758328|Melphalan|melphalan|mesh-list
139092197|NCT01758328|Busulfan|busulfan|mesh-list
139092198|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139092199|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092200|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092201|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139092202|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
139092203|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092204|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139092205|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
139092206|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139092207|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
139092208|NCT01746849|Thiotepa|thiotepa|mesh-list
139026983|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139092209|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139092210|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
139092211|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092212|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139092213|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138842802|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
139092214|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
139092215|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092216|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092217|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139092219|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139092220|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092221|NCT01722266|Incretins|incretins|mesh-ancestor
139092222|NCT01722266|Hormones|hormones|mesh-ancestor
139092223|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139092224|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139092225|NCT01468896|Cetuximab|cetuximab|mesh-list
139092226|NCT01468896|Interleukin-12|interleukin-12|mesh-list
139092227|NCT01468896|Antibodies|antibodies|mesh-list
139092228|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
139092229|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139092230|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
139092231|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092232|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092233|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139092235|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139092236|NCT01468896|Growth Substances|growth substances|mesh-ancestor
139092237|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
139092238|NCT01261728|Gemcitabine|gemcitabine|mesh-list
139092239|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092240|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139092241|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
139092242|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092251|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
139092252|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139092253|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092254|NCT00862433|Vitamins|vitamins|mesh-list
139092255|NCT00862433|Vitamin E|vitamin e|mesh-list
139092256|NCT00862433|Tocopherols|tocopherols|mesh-list
139092257|NCT00862433|Tocotrienols|tocotrienols|mesh-list
139092258|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
139092259|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
138949750|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
139092260|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092261|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
139092262|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092263|NCT00862433|Protective Agents|protective agents|mesh-ancestor
139092264|NCT00711490|Sirolimus|sirolimus|mesh-list
139092265|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139092266|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139092267|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139092268|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092269|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
139092270|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139092271|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
139092272|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092274|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092275|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139092276|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139092277|NCT00673816|Growth Substances|growth substances|mesh-ancestor
139092278|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092279|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
139092280|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139092281|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092282|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092283|NCT00533117|Fluoxetine|fluoxetine|mesh-list
139092284|NCT00533117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139092285|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139092286|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139092287|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138842883|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
139092288|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092289|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
139092290|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092291|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139092292|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
139092293|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139092294|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139092295|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139092296|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092298|NCT00026312|Aldesleukin|aldesleukin|mesh-list
139092299|NCT00026312|Interleukin-2|interleukin-2|mesh-list
139092300|NCT00026312|Tretinoin|tretinoin|mesh-list
139092301|NCT00026312|Dinutuximab|dinutuximab|mesh-list
139092302|NCT00026312|Isotretinoin|isotretinoin|mesh-list
139092303|NCT00026312|Sargramostim|sargramostim|mesh-list
139092304|NCT00026312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139092305|NCT00026312|Vitamins|vitamins|mesh-ancestor
139092306|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
139092307|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092308|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092309|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139092310|NCT00026312|Analgesics|analgesics|mesh-ancestor
139092311|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
139092312|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092313|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
139092314|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139092315|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139092316|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
139092317|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139092318|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
139092319|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
139092320|NCT01089348|Metronidazole|metronidazole|mesh-list
139092321|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139092322|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139092323|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139092324|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139092325|NCT01291316|Clonazepam|clonazepam|mesh-list
139092326|NCT01291316|Clobazam|clobazam|mesh-list
139092327|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139092328|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139092329|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139092330|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
139092331|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092332|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092333|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092334|NCT01291316|Urological Agents|urological agents|mesh-ancestor
139092335|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
139092336|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
139092338|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139092339|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139092340|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139092341|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139092342|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139092343|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
139092344|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
139092345|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139092346|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
139092347|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092348|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092349|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139092350|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
139092351|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139092352|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
139092353|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092354|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092355|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139092356|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
139092357|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
139092358|NCT00060840|Protective Agents|protective agents|mesh-ancestor
139092359|NCT01185860|Ritonavir|ritonavir|mesh-list
139092360|NCT01185860|Ribavirin|ribavirin|mesh-list
139092361|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138842968|NCT02823912|Capsaicin|capsaicin|mesh-list
139092362|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139092363|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139092364|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
139092365|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092366|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092368|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139092369|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
139092370|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139092371|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139092372|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139092373|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
139092374|NCT01290302|Azacitidine|azacitidine|mesh-list
139092375|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139092376|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
138949784|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
139092377|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092378|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092379|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092380|NCT01089660|Vaccines|vaccines|mesh-list
139092381|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
139092382|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092383|NCT01182662|Cyclosporine|cyclosporine|mesh-list
139092384|NCT01182662|Cyclosporins|cyclosporins|mesh-list
139092385|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092386|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092387|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139092388|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
139092389|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092390|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
139092391|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139092392|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
139092393|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139092394|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139092395|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139027287|NCT00385593|Budesonide|budesonide|mesh-list
139092397|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139092398|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
139092399|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887315|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
139092401|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139092402|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092403|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139092404|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139092405|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139092406|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
139092407|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139092408|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139092409|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139092410|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139092411|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092412|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
139092413|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092414|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092415|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139092416|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092417|NCT03854942|Naltrexone|naltrexone|mesh-list
139092418|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139092419|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139092420|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092421|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
139092422|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092423|NCT03278626|Paclitaxel|paclitaxel|mesh-list
139092424|NCT03278626|Carboplatin|carboplatin|mesh-list
139092425|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139027314|NCT00495170|Paclitaxel|paclitaxel|mesh-list
139092426|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092427|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
139092428|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
139092429|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
139092430|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092431|NCT01186094|Sirolimus|sirolimus|mesh-list
139092432|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139092433|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139092434|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139092435|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092436|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
139092437|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139092438|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
138843027|NCT00835393|Pantoprazole|pantoprazole|mesh-list
139092439|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092440|NCT01287806|Urinastatin|urinastatin|mesh-list
139092441|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139092442|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139092443|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
139092444|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092445|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092446|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139092447|NCT01186172|Ethanol|ethanol|mesh-list
139092448|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139092449|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139092450|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139092451|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092452|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
139092453|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139092454|NCT03854708|Hormones|hormones|mesh-ancestor
139092455|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139092456|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092457|NCT03860870|Clenbuterol|clenbuterol|mesh-list
139092458|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139092459|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139092460|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
139092461|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092462|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092463|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092464|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139092465|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
139092466|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092467|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139092468|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
139092469|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
139092470|NCT01177514|Gabapentin|gabapentin|mesh-list
139092471|NCT01177514|Analgesics|analgesics|mesh-ancestor
139092472|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
139092473|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092474|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092476|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139092477|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139092478|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139092479|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139092480|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139092481|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139092482|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092483|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092484|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
139092485|NCT00073008|Lapatinib|lapatinib|mesh-list
139092486|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092487|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139092488|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092489|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092490|NCT01182974|Acetaminophen|acetaminophen|mesh-list
139092491|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139092492|NCT01182974|Analgesics|analgesics|mesh-ancestor
139092493|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
139092494|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092495|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092496|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
139092497|NCT03856502|Dexamethasone|dexamethasone|mesh-list
139092498|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
139092499|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
139092500|NCT03856502|BB 1101|bb 1101|mesh-list
139092501|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139092502|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
139092503|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
139092504|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092505|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092506|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139092507|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
139092508|NCT03856502|Hormones|hormones|mesh-ancestor
139092509|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139092510|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139092511|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092512|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
139092513|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092514|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092515|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
139092516|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
139092517|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139092518|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
139092519|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139092520|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139092521|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092522|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092523|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139092524|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139092525|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092526|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
139092527|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092528|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139092529|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139092530|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
139092531|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092532|NCT01093638|Insulin|insulin|mesh-list
139092533|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139092534|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092535|NCT01287962|Apatinib|apatinib|mesh-list
139092536|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092537|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139092538|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092539|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092540|NCT00058422|Prednisone|prednisone|mesh-list
139092541|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
139092542|NCT00058422|Rituximab|rituximab|mesh-list
139092543|NCT00058422|Doxorubicin|doxorubicin|mesh-list
139092544|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139092545|NCT00058422|Vincristine|vincristine|mesh-list
139092546|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
139092547|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139092548|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139092549|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
139092550|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092551|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139092552|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139092553|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
139092554|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092555|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092556|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139092557|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139092558|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139092559|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139092560|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139092561|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092562|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139092563|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
139092564|NCT00058422|Hormones|hormones|mesh-ancestor
139092565|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139092566|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139092567|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139092568|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
139092569|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
139092570|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
139092571|NCT00058422|Hematinics|hematinics|mesh-ancestor
139092572|NCT01094964|Interferons|interferons|mesh-list
139092573|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
139092575|NCT01094964|Mitomycins|mitomycins|mesh-list
139092576|NCT01094964|Mitomycin|mitomycin|mesh-list
139092577|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092578|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
139092579|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139092580|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
139092581|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092582|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139092583|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139092584|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139092585|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092586|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092587|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
139092588|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139092589|NCT01291472|Ketorolac|ketorolac|mesh-list
139092591|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139092592|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139092593|NCT01291472|Analgesics|analgesics|mesh-ancestor
139092594|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
139092595|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092596|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092597|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139092598|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139092599|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139092600|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092601|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092602|NCT02530632|Propofol|propofol|mesh-list
139092603|NCT02530632|Sevoflurane|sevoflurane|mesh-list
139092604|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
139092605|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139092606|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092607|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139092608|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139092609|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
139092610|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139092611|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139092612|NCT01183364|Docetaxel|docetaxel|mesh-list
139092613|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092614|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
139092615|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
139092616|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
139092617|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092618|NCT00072384|Carboplatin|carboplatin|mesh-list
139092619|NCT00072384|Etoposide|etoposide|mesh-list
139092620|NCT00072384|Vincristine|vincristine|mesh-list
139092621|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
139092622|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092623|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139092624|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139092625|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139092626|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092627|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092628|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
139092629|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
139092630|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
139092631|NCT01183442|Vitamin D|vitamin d|mesh-list
139092632|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
139092633|NCT01183442|Cholecalciferol|cholecalciferol|mesh-list
139092634|NCT01183442|Vitamins|vitamins|mesh-list
139092635|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
139027630|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
139092636|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092637|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139092638|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139092639|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
139092640|NCT01187108|Acetazolamide|acetazolamide|mesh-list
139092641|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139092642|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
139092643|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139092644|NCT01187108|Expectorants|expectorants|mesh-ancestor
139092645|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
139092646|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139092647|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
139092648|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092649|NCT01187108|Protective Agents|protective agents|mesh-ancestor
139092650|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092651|NCT01187108|Antidotes|antidotes|mesh-ancestor
139092652|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
139092653|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139092654|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092655|NCT01187108|Diuretics|diuretics|mesh-ancestor
139092656|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
139092657|NCT01187888|Rasagiline|rasagiline|mesh-list
139092658|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139092659|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092660|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092661|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139092662|NCT01187888|Protective Agents|protective agents|mesh-ancestor
139092663|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092664|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
139092665|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139092666|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027674|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
139092668|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092669|NCT00054132|Bevacizumab|bevacizumab|mesh-list
139092670|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139092671|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139092672|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
139092673|NCT00054132|Antibodies|antibodies|mesh-list
139092674|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
139092675|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139092676|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
139092677|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092678|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139092679|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139092680|NCT00054132|Growth Substances|growth substances|mesh-ancestor
139092681|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092682|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
139092683|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
139092684|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139092685|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092686|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092687|NCT01187264|Methotrexate|methotrexate|mesh-list
139092688|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139092689|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
139092690|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139092691|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092692|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139092693|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
139092694|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092695|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092696|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
138611962|NCT00183989|Rituximab|rituximab|mesh-list
139092697|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092698|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139092699|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139092700|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
139092701|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139092702|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139092703|NCT01183676|Valproic Acid|valproic acid|mesh-list
139092705|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092706|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092707|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
139092708|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092709|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092710|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
139092711|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139092712|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139092713|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139092714|NCT03856112|Dexamethasone|dexamethasone|mesh-list
139092715|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
139092716|NCT03856112|Venetoclax|venetoclax|mesh-list
139092717|NCT03856112|Ixazomib|ixazomib|mesh-list
139092718|NCT03856112|Ichthammol|ichthammol|mesh-list
139092719|NCT03856112|BB 1101|bb 1101|mesh-list
139092720|NCT03856112|Glycine|glycine|mesh-list
139092721|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139092722|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
139092723|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
139092724|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092725|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092726|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139092727|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
139092728|NCT03856112|Hormones|hormones|mesh-ancestor
139092729|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139092730|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139092731|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092732|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092733|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
139027751|NCT01040325|Vaccines|vaccines|mesh-list
139092734|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092735|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
139092736|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092737|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
139092738|NCT01290380|Vadimezan|vadimezan|mesh-list
139092739|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092740|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
139092741|NCT01183910|Calcium|calcium|mesh-list
139092742|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139092743|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092744|NCT01183910|Antacids|antacids|mesh-ancestor
139092745|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950008|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
139092746|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139092747|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
139092748|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139092749|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
139092750|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092751|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
139092752|NCT03852914|Protective Agents|protective agents|mesh-ancestor
139092753|NCT03853538|Petrolatum|petrolatum|mesh-list
139092754|NCT03853538|Emollients|emollients|mesh-ancestor
139092755|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
139092756|NCT01290458|Vitamins|vitamins|mesh-list
139092757|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
139092758|NCT01290458|Vitamin E|vitamin e|mesh-list
139092759|NCT01290458|Tocopherols|tocopherols|mesh-list
139092760|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
139092761|NCT01290458|Antioxidants|antioxidants|mesh-list
139092762|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
139092763|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092764|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027794|NCT00951431|Esomeprazole|esomeprazole|mesh-list
139092765|NCT01290458|Protective Agents|protective agents|mesh-ancestor
139092766|NCT01184144|Pioglitazone|pioglitazone|mesh-list
139092767|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139092768|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092769|NCT01291628|Copper|copper|mesh-list
139092770|NCT01291628|Trace Elements|trace elements|mesh-ancestor
139092771|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
139092772|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092773|NCT00053898|Tamoxifen|tamoxifen|mesh-list
139092774|NCT00053898|Anastrozole|anastrozole|mesh-list
139092775|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092776|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139092777|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
139092778|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139092779|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092780|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139092781|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092782|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139092783|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139092784|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139092785|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139092786|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139092787|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092788|NCT01293734|Budesonide|budesonide|mesh-list
139092789|NCT01293734|Theophylline|theophylline|mesh-list
139092790|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139092791|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139092792|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
139092793|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092794|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092795|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139092796|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
139092797|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
139092798|NCT01293734|Hormones|hormones|mesh-ancestor
139092799|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139092800|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139092801|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092802|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092803|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
139092804|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139092805|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139092806|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
139092807|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092808|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139092809|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139092810|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
139092811|NCT01188278|Dasatinib|dasatinib|mesh-list
139092812|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092813|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139092814|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092815|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092816|NCT01184378|Caseins|caseins|mesh-list
139092817|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
139092819|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092820|NCT03852602|Analgesics|analgesics|mesh-list
139092821|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
139092822|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092823|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092824|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139092825|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
139092826|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139092828|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
139092829|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
139092830|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139092831|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
139092832|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139092833|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
139092834|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092835|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
139092836|NCT02459392|Protective Agents|protective agents|mesh-ancestor
139092837|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139092838|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
139092839|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
139092840|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092841|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139092842|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
139092843|NCT02459392|Hormones|hormones|mesh-ancestor
139092844|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139092845|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139092846|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139092847|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092848|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
139092849|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139092850|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139092851|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139092853|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092854|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092855|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092856|NCT03852446|Tryptophan|tryptophan|mesh-list
139092857|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139092858|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
139092859|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139092860|NCT03637582|Lidocaine|lidocaine|mesh-list
139092861|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
139092862|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
139092863|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139092864|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092865|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
139092866|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092867|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139092868|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139092869|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139092870|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139092871|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092872|NCT00053352|Etoposide|etoposide|mesh-list
139092873|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
139092874|NCT00053352|Bleomycin|bleomycin|mesh-list
139092875|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092876|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139092877|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139092878|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139092879|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092880|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092881|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139092882|NCT01193816|Loxapine|loxapine|mesh-list
139092883|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139092884|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139092885|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139092886|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092887|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139092888|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139092889|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
139092890|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138843472|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139092891|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092892|NCT05571202|Anesthetics|anesthetics|mesh-list
139092893|NCT05571202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139092894|NCT05571202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092895|NCT03245398|Mebendazole|mebendazole|mesh-list
139092896|NCT03245398|Piperazine|piperazine|mesh-list
139092897|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
139092898|NCT03245398|DMP 777|dmp 777|mesh-list
139092899|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
139092900|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
139092901|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139092902|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139092903|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
139092904|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
139092905|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
139092906|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092907|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092908|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092909|NCT01291940|Petrolatum|petrolatum|mesh-list
139092910|NCT01291940|Emollients|emollients|mesh-ancestor
139092911|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
139092912|NCT03244618|Fluorides|fluorides|mesh-list
139092913|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
139092914|NCT03244618|Protective Agents|protective agents|mesh-ancestor
139092915|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092916|NCT03849404|Adalimumab|adalimumab|mesh-list
139092917|NCT03849404|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139092918|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139092919|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139092920|NCT00051636|Vitamin D|vitamin d|mesh-list
139092921|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
139092922|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
139092923|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
139092924|NCT00051636|Calcium|calcium|mesh-list
139092925|NCT00051636|Vitamins|vitamins|mesh-ancestor
139092926|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
139092927|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950122|NCT00611559|PENTA|penta|mesh-list
139092928|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139092929|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139092930|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139092931|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139092932|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092933|NCT01294826|Cetuximab|cetuximab|mesh-list
139092934|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139092935|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092936|NCT03847922|Lidocaine|lidocaine|mesh-list
139092937|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
139092938|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
139092939|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
139092940|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139092941|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092942|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
139092943|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139092944|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139092945|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139092946|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139092947|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139092948|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092949|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139092950|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
139092951|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139092952|NCT03847922|Analgesics|analgesics|mesh-ancestor
139092953|NCT01194284|Mifamurtide|mifamurtide|mesh-list
139092954|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139092955|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
139092956|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092957|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139092958|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
139092959|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139092960|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
139092961|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092962|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
138843555|NCT00818259|Hormones|hormones|mesh-ancestor
139092963|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139092964|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139092965|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092966|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
139092967|NCT01191554|Coagulants|coagulants|mesh-ancestor
139092968|NCT01296464|Carbidopa|carbidopa|mesh-list
139092969|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139092970|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139092971|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
139092972|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139092973|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092974|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092975|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139092976|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092977|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
139092978|NCT00038142|Doxorubicin|doxorubicin|mesh-list
139092979|NCT00038142|Vincristine|vincristine|mesh-list
139092980|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
139092981|NCT00038142|Razoxane|razoxane|mesh-list
139092982|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139092983|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
139092984|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139092985|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139092986|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139092987|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
139092988|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139092989|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139092990|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139092991|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139092992|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139092993|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139092994|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139092995|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139092996|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
139092997|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
139092998|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
139092999|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139093000|NCT00038142|Protective Agents|protective agents|mesh-ancestor
139093002|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139093003|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
139093004|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093005|NCT03847376|Rilpivirine|rilpivirine|mesh-list
139093006|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139093007|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139093008|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093009|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093010|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
139093011|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093012|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139093013|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139093014|NCT01090128|Paclitaxel|paclitaxel|mesh-list
139093015|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
139093016|NCT01090128|Doxorubicin|doxorubicin|mesh-list
139093017|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139093018|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139093019|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093020|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
139093021|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
139093022|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
139093023|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093024|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139093025|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
139093026|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093027|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139093028|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139093029|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
139093030|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139093031|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139093032|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139093033|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139093034|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093035|NCT01292174|Ibalizumab|ibalizumab|mesh-list
139093036|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139093037|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139093038|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139093039|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
139093040|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093041|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
139093042|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093043|NCT01090206|Vitamin D|vitamin d|mesh-list
139093045|NCT01090206|Vitamins|vitamins|mesh-ancestor
139093046|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
138950168|NCT00611247|Temozolomide|temozolomide|mesh-list
139093047|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093048|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139093049|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139093051|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139093052|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
139093053|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
139093054|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093055|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093056|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139093057|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
139093058|NCT04728646|Hormones|hormones|mesh-ancestor
139093059|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139093060|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139093061|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093062|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139093063|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
139093064|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093065|NCT01295138|Lactulose|lactulose|mesh-list
139093066|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139093067|NCT01188824|Cilostazol|cilostazol|mesh-list
139093068|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139093069|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
139093070|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093071|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093072|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139093073|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
139093074|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139093075|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139093076|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093077|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139093078|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
139093079|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139093080|NCT01188824|Protective Agents|protective agents|mesh-ancestor
139093081|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139093082|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139093083|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093084|NCT01060475|Tacrolimus|tacrolimus|mesh-list
139093085|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139093087|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093088|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139093089|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093090|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093091|NCT01060631|Propofol|propofol|mesh-list
139093092|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139093093|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139093094|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093095|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139093096|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
139093097|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
139093098|NCT03254134|Warfarin|warfarin|mesh-list
139093099|NCT03254134|Dabigatran|dabigatran|mesh-list
139093100|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
139093101|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
139093102|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139093103|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
139093104|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093105|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093106|NCT03953196|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139093107|NCT03953196|Antiviral Agents|antiviral agents|mesh-ancestor
139093108|NCT03953196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093109|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
139093110|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
139093111|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
139093112|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139093113|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139093114|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093115|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
139093116|NCT01295294|Coagulants|coagulants|mesh-ancestor
139093117|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139093118|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
139093119|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139093120|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093121|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139093122|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139093123|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139093124|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139093125|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139093127|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
139093128|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093129|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139093130|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139093131|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139093132|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093133|NCT01191710|Progesterone|progesterone|mesh-list
139093134|NCT01191710|Progestins|progestins|mesh-ancestor
139093135|NCT01191710|Hormones|hormones|mesh-ancestor
139093136|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139093137|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093138|NCT04367740|Antibodies|antibodies|mesh-list
139093139|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
139093140|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
139093141|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093142|NCT03852056|Fluorides|fluorides|mesh-list
139093143|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
139093144|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
139093145|NCT03852056|Protective Agents|protective agents|mesh-ancestor
139093146|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093148|NCT03242434|Lactulose|lactulose|mesh-list
139093149|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139093150|NCT03242434|Diuretics|diuretics|mesh-ancestor
139093151|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
139093152|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093153|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139093154|NCT04222426|Atezolizumab|atezolizumab|mesh-list
139093155|NCT04222426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139093156|NCT04222426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093157|NCT04222426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139093158|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093159|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
139093160|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
138950218|NCT00610857|Antibodies|antibodies|mesh-list
139093161|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139093162|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139093163|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093164|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093165|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093166|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139093167|NCT01295372|Risperidone|risperidone|mesh-list
139093168|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139093169|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
139093170|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139093171|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093172|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093173|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139093174|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139093175|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139093176|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139093177|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139093178|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
139093179|NCT05283278|Lactoferrin|lactoferrin|mesh-list
139093180|NCT05283278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093181|NCT05179018|Autoantibodies|autoantibodies|mesh-list
139093182|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
139093183|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093184|NCT01295450|Vitamins|vitamins|mesh-list
139093185|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
139093186|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093187|NCT01297010|Dexamethasone|dexamethasone|mesh-list
139093188|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
139093189|NCT01297010|BB 1101|bb 1101|mesh-list
139093190|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139093191|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
139093192|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
139093193|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093194|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093195|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139093197|NCT01297010|Hormones|hormones|mesh-ancestor
139093198|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139093199|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139093200|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093201|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
139093202|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093203|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093204|NCT03851432|Metformin|metformin|mesh-list
139093205|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139093206|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093207|NCT01192490|Lidocaine|lidocaine|mesh-list
139093208|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
139093209|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
139093210|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139093211|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093212|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
139093213|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093214|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139093215|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139093216|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139093217|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139093218|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093219|NCT01295606|Cefazolin|cefazolin|mesh-list
139093220|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139093221|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093223|NCT01192724|Cilostazol|cilostazol|mesh-list
139093224|NCT01192724|Clopidogrel|clopidogrel|mesh-list
139093225|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139093226|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139093227|NCT01192724|Analgesics|analgesics|mesh-ancestor
139093228|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
139093229|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093230|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093231|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139093232|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139093233|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139093234|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139093235|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093236|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139093237|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139093238|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093239|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
139093240|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139093241|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139093242|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139093243|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
139093244|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139093245|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139093246|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
139093247|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139093248|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
139093249|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
139093250|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139093251|NCT01192724|Protective Agents|protective agents|mesh-ancestor
139093252|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139093253|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139093254|NCT01192802|Albendazole|albendazole|mesh-list
139093255|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
139093256|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139093257|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093258|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
139093259|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139093260|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139093261|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
139093262|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
139093263|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
139093264|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093265|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093266|NCT01292720|Vitamin D|vitamin d|mesh-list
139093267|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
138843848|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
139093268|NCT01292720|Vitamins|vitamins|mesh-ancestor
139093269|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
139093270|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093271|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139093272|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139093273|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139093274|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139093275|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093276|NCT02939014|Immunotoxins|immunotoxins|mesh-ancestor
139093277|NCT02939014|Immunoconjugates|immunoconjugates|mesh-ancestor
139093278|NCT02939014|Immunologic Factors|immunologic factors|mesh-ancestor
139093279|NCT02939014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093280|NCT05177926|Tenofovir|tenofovir|mesh-list
139093281|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
139093282|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093283|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139093284|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139093285|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093286|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093287|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139093288|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139093289|NCT01193192|Vitamins|vitamins|mesh-list
139093290|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
139093291|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093292|NCT01193270|Vitamin E|vitamin e|mesh-list
139093293|NCT01193270|Vitamins|vitamins|mesh-ancestor
139093294|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
139093295|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093296|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
139093297|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093298|NCT01193270|Protective Agents|protective agents|mesh-ancestor
139093299|NCT01189214|Memantine|memantine|mesh-list
139093300|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139093301|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139093302|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
139093303|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139093304|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093305|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093306|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139093307|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139093308|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139093309|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
139093310|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139093311|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
139093312|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139093313|NCT01193504|Prednisolone|prednisolone|mesh-list
139093314|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139093315|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
139093316|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139093317|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
139093318|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
139093319|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093320|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093321|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139093322|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
139093323|NCT01193504|Hormones|hormones|mesh-ancestor
139093324|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139093325|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139093326|NCT01193504|Protective Agents|protective agents|mesh-ancestor
139093327|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139093328|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093329|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139093330|NCT03848780|Desflurane|desflurane|mesh-list
139093331|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139093332|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
139093333|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
139093334|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139093335|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093336|NCT05599802|Vaccines|vaccines|mesh-list
139093337|NCT05599802|Immunologic Factors|immunologic factors|mesh-ancestor
139093338|NCT05599802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093339|NCT00051558|Alendronate|alendronate|mesh-list
139093340|NCT00051558|Teriparatide|teriparatide|mesh-list
139093341|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139093342|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093343|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139093344|NCT03848234|Estradiol|estradiol|mesh-list
139093345|NCT03848234|Estrogens|estrogens|mesh-ancestor
139093346|NCT03848234|Hormones|hormones|mesh-ancestor
139028650|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
139093347|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139093348|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093349|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139093350|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093351|NCT01195298|Bevacizumab|bevacizumab|mesh-list
139093352|NCT01195298|Capecitabine|capecitabine|mesh-list
139093353|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139093354|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093355|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139093356|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139093357|NCT01195298|Growth Substances|growth substances|mesh-ancestor
139093358|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093359|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
139093360|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139093361|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
139093362|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093363|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139093364|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139093365|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
139093367|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139093368|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093369|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139093370|NCT01296074|Protective Agents|protective agents|mesh-ancestor
139093371|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139093372|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093373|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
139093374|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
139093375|NCT01189448|Spiramycin|spiramycin|mesh-list
139093376|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
139093377|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139093378|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139093379|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093380|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139093381|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093382|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093383|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139093384|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
139093385|NCT01195376|Dactolisib|dactolisib|mesh-list
139093386|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093387|NCT01189526|Ranibizumab|ranibizumab|mesh-list
139093388|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139093389|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139093390|NCT01189526|Growth Substances|growth substances|mesh-ancestor
139093391|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093392|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
139093393|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093394|NCT01296230|Hormones|hormones|mesh-list
139093395|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139093396|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093397|NCT01580696|Molgramostim|molgramostim|mesh-list
139093398|NCT01580696|Vaccines|vaccines|mesh-list
139093399|NCT01580696|Sargramostim|sargramostim|mesh-list
139093400|NCT01580696|Immunologic Factors|immunologic factors|mesh-ancestor
139093401|NCT01580696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093402|NCT01580696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093403|NCT01197014|Losartan|losartan|mesh-list
139093404|NCT01197014|Amlodipine|amlodipine|mesh-list
139093405|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139093406|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139093407|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139093408|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093409|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139093410|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093412|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139093413|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139093414|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139093415|NCT01195454|Insulin|insulin|mesh-list
139093416|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139093417|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
139093418|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139093419|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093420|NCT01197170|Bevacizumab|bevacizumab|mesh-list
139093421|NCT01197170|Everolimus|everolimus|mesh-list
139093422|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139093423|NCT01197170|Sorafenib|sorafenib|mesh-list
139093424|NCT01197170|Anastrozole|anastrozole|mesh-list
139093425|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139093426|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093427|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139093428|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139093429|NCT01197170|Growth Substances|growth substances|mesh-ancestor
139093430|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093431|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
139093432|NCT01197170|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139093433|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139093434|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093435|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093436|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139093437|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
139028786|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
139093438|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139093439|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139093440|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139093441|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139093442|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
139093443|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139093444|NCT05516966|Dulaglutide|dulaglutide|mesh-list
139093445|NCT05516966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139093446|NCT05516966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093448|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093449|NCT03850886|Niacinamide|niacinamide|mesh-list
139093450|NCT03850886|Niacin|niacin|mesh-list
139093451|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
139093452|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139093453|NCT03850886|Vitamins|vitamins|mesh-ancestor
139093454|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
139093455|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093456|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
139093457|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139093458|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
139093459|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093460|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139093461|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
139093462|NCT03251482|Apixaban|apixaban|mesh-list
139093463|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139093464|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
139093465|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139093466|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
139093467|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093468|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093469|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
139093470|NCT03732248|Sirolimus|sirolimus|mesh-list
139093471|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139093472|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093473|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139093474|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093475|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
139093476|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139093477|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
139093478|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093479|NCT00310037|Bortezomib|bortezomib|mesh-list
139093480|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093481|NCT01196234|Paclitaxel|paclitaxel|mesh-list
139093482|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139093483|NCT01196234|Carboplatin|carboplatin|mesh-list
139093484|NCT01196234|Gefitinib|gefitinib|mesh-list
139093485|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139093486|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093487|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
139093488|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
139093489|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
139093490|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093491|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139093492|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093493|NCT00309959|Paclitaxel|paclitaxel|mesh-list
139093494|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139093495|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139093496|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093497|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
139093498|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
139093499|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
139093500|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093502|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
139093503|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139093504|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093505|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
139093506|NCT01190384|Antioxidants|antioxidants|mesh-list
139093507|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093508|NCT01190384|Protective Agents|protective agents|mesh-ancestor
139093509|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093510|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139093511|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093512|NCT02532413|Entecavir|entecavir|mesh-list
139093513|NCT02532413|Poly I-C|poly i-c|mesh-list
139093514|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
139093515|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093516|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
139093517|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
139093518|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093519|NCT01190462|Cetuximab|cetuximab|mesh-list
139093520|NCT01190462|Simvastatin|simvastatin|mesh-list
139093521|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139093522|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093523|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139093524|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139093525|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
139093526|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093528|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139093529|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093531|NCT01198106|Scopolamine|scopolamine|mesh-list
139093532|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139093533|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139093534|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
139093535|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
138950296|NCT02543385|Ketamine|ketamine|mesh-list
139093536|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093537|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093538|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139093539|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
139093540|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139093541|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
139093542|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139093543|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093544|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139093545|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
139093546|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139093547|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139093548|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139093549|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139093550|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
139093551|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
139093552|NCT02918500|Nicotine|nicotine|mesh-list
139093553|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139093554|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
139093555|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093556|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093557|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139093558|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139093559|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
139093560|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028962|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139093561|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093563|NCT03850652|Trace Elements|trace elements|mesh-ancestor
139093564|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
139093565|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093566|NCT01198184|Sirolimus|sirolimus|mesh-list
139093567|NCT01198184|Temsirolimus|temsirolimus|mesh-list
139093568|NCT01198184|MTOR Inhibitors|mtor inhibitors|mesh-list
139093569|NCT01198184|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139093570|NCT01198184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139093571|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093572|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093573|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139093574|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
139093575|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093576|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093577|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139093578|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093579|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139093580|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
139093581|NCT01198184|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139093582|NCT00333359|Gabapentin|gabapentin|mesh-list
139093583|NCT00333359|Analgesics|analgesics|mesh-ancestor
139093584|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
139093585|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093586|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093587|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
139093588|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139093589|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139093590|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139093591|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139093592|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139093593|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139093594|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139093595|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093596|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
139093597|NCT03246724|Midazolam|midazolam|mesh-list
139093598|NCT03246724|Triazolam|triazolam|mesh-list
139093599|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139029005|NCT02748707|Celecoxib|celecoxib|mesh-list
138950312|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139093600|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139093601|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139093602|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093604|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139093605|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139093606|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139093607|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
139093608|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
139093609|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
139093610|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
139093611|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139093612|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093613|NCT01196546|Metformin|metformin|mesh-list
139093614|NCT01196546|Vildagliptin|vildagliptin|mesh-list
139093615|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139093616|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093617|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139093618|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
139093619|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093620|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093621|NCT01293266|Propofol|propofol|mesh-list
139093622|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139093623|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139093624|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093625|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139093626|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
139093627|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
139093628|NCT03948646|Bromides|bromides|mesh-list
139093629|NCT03948646|Anticonvulsants|anticonvulsants|mesh-ancestor
139093630|NCT01198340|Ropivacaine|ropivacaine|mesh-list
139093631|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
139093632|NCT01198340|Anesthetics|anesthetics|mesh-list
139093633|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139093634|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093635|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
139093636|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093637|NCT01347112|Varenicline|varenicline|mesh-list
139093638|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139093639|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139093640|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
139093641|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139093642|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093643|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093644|NCT00308711|Misoprostol|misoprostol|mesh-list
139093645|NCT00308711|Dinoprostone|dinoprostone|mesh-list
139093646|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139093647|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
139093648|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139093649|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093650|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139093651|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139093652|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
139093653|NCT01198496|Losartan|losartan|mesh-list
139093654|NCT01198496|Amlodipine|amlodipine|mesh-list
139093655|NCT01198496|Valsartan|valsartan|mesh-list
139093656|NCT01198496|Telmisartan|telmisartan|mesh-list
139093657|NCT01198496|Candesartan|candesartan|mesh-list
139093658|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
139093659|NCT01198496|Olmesartan|olmesartan|mesh-list
139093660|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139093661|NCT01198496|Spironolactone|spironolactone|mesh-list
139093662|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139093663|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139093664|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139093665|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093666|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138950317|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139093667|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093668|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
139093669|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139093670|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139093671|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139093672|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139093673|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
139093674|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139093676|NCT01198496|Diuretics|diuretics|mesh-ancestor
139093677|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
139093678|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
139093679|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139093680|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
139093681|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093682|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093683|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
139093685|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
139093686|NCT03846284|Anesthetics|anesthetics|mesh-list
139093687|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
139093688|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139093689|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093690|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
139093691|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093692|NCT03846284|Analgesics|analgesics|mesh-ancestor
139093693|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139093694|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
139093695|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139093696|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139093697|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093698|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139093699|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
139093700|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139093701|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
139093702|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139093703|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139093704|NCT01066169|Lactitol|lactitol|mesh-list
139093705|NCT01066169|Cathartics|cathartics|mesh-ancestor
139093706|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139093707|NCT05572060|Metformin|metformin|mesh-list
139093708|NCT05572060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139093709|NCT05572060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093710|NCT05431244|Antiviral Agents|antiviral agents|mesh-list
139093711|NCT05431244|Gemcitabine|gemcitabine|mesh-list
139093712|NCT05431244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139093713|NCT05431244|Antimetabolites|antimetabolites|mesh-ancestor
139093714|NCT05431244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093715|NCT05431244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093716|NCT05431244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093717|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
139093718|NCT01199432|Fluorouracil|fluorouracil|mesh-list
139093719|NCT01199432|Epirubicin|epirubicin|mesh-list
139093720|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139093721|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
139093722|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093724|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139093725|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
139093726|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093727|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093728|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139093729|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
139093730|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139093731|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138950329|NCT00546364|Epothilones|epothilones|mesh-list
139093732|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139093733|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139093734|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093736|NCT05064020|Emtricitabine|emtricitabine|mesh-list
139093737|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139093738|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
139093739|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093740|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139093741|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139093742|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093743|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093744|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139093745|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139093746|NCT05058560|Tislelizumab|tislelizumab|mesh-list
139093747|NCT05058560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139093748|NCT05058560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093749|NCT01293422|Rifampin|rifampin|mesh-list
139093750|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139093751|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
139093752|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139093753|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093754|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
139093755|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139093756|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093757|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093758|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139093759|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139093760|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139093761|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139093762|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139093763|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139093764|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139093765|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
139093766|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093767|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139093769|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139093770|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093771|NCT00050778|Interferons|interferons|mesh-list
139093772|NCT00050778|Interferon-beta|interferon-beta|mesh-list
139093773|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
139093774|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
139093775|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093776|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
139093777|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093778|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139093779|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
139093780|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093781|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139093782|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139093783|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
139093784|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139093785|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
139093786|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139093787|NCT00050622|Methylphenidate|methylphenidate|mesh-list
139093788|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139093789|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093790|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139093791|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139093792|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139093793|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093794|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
139093795|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139093796|NCT00308087|Rituximab|rituximab|mesh-list
139093797|NCT00308087|Molgramostim|molgramostim|mesh-list
139093798|NCT00308087|Sargramostim|sargramostim|mesh-list
139093799|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139093800|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093801|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
139093802|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093803|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139093804|NCT04942184|Complement Factor H|complement factor h|mesh-list
139093805|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139093806|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139093807|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
139093808|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093809|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
139093810|NCT00307931|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139093811|NCT00307931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139093812|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139093813|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
139093814|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093815|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139093816|NCT01097148|Atracurium|atracurium|mesh-list
139093817|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139093818|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139093819|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139093820|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093821|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093822|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139093823|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139093824|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
139093825|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139093826|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093827|NCT01199276|Sevoflurane|sevoflurane|mesh-list
139093828|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139093829|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139093830|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
139093831|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
139093832|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139093833|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093834|NCT01202084|Fluticasone|fluticasone|mesh-list
139093836|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
139093837|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139093838|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139093839|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
139029234|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093840|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093841|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093842|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139093843|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
139093844|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
139093845|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139093846|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139093847|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139093848|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139093849|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
139093850|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139093851|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093852|NCT04133792|Simvastatin|simvastatin|mesh-list
139093853|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139093854|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139093855|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
139093856|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093857|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139093858|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139093859|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093860|NCT01202240|Ketoconazole|ketoconazole|mesh-list
139093861|NCT01202240|Tofacitinib|tofacitinib|mesh-list
139093862|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
139093863|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093864|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139093865|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139093866|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093867|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093868|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139093869|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
139093870|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138844453|NCT05978167|Dopamine Agents|dopamine agents|mesh-ancestor
139093871|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093872|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139093873|NCT01202240|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139093874|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139093875|NCT01204112|Rifampin|rifampin|mesh-list
139093876|NCT01204112|Tofacitinib|tofacitinib|mesh-list
139093877|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139093878|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
139093879|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139093880|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093881|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
139093882|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139029254|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
139093884|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093885|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139093886|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139093887|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139093888|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139093889|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139093890|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139093891|NCT01204112|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139093892|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139093893|NCT01204190|Gestodene|gestodene|mesh-list
139093894|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139093895|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139093896|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139093897|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
139093898|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139093899|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093900|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139093901|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139093902|NCT01204190|Progestins|progestins|mesh-ancestor
139093903|NCT01204190|Hormones|hormones|mesh-ancestor
139093904|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139093905|NCT01204268|Sevoflurane|sevoflurane|mesh-list
139093906|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139093907|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139093908|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
139093909|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
139093910|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139093911|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093912|NCT02965898|Vitamin D|vitamin d|mesh-list
139093913|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
139093914|NCT02965898|Cholecalciferol|cholecalciferol|mesh-list
139093915|NCT02965898|Vitamins|vitamins|mesh-list
139093916|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
139093917|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093918|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139093919|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139093920|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
139093921|NCT02796170|Dapagliflozin|dapagliflozin|mesh-list
139093922|NCT02796170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139093923|NCT02796170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093924|NCT02796170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139093925|NCT02796170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093926|NCT03844178|Tetracaine|tetracaine|mesh-list
139093927|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
139093928|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
139093929|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139093930|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093931|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
139093932|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093933|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139093934|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
139093935|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093936|NCT00307151|Ritonavir|ritonavir|mesh-list
139093937|NCT00307151|Lopinavir|lopinavir|mesh-list
139093938|NCT00307151|Lamivudine|lamivudine|mesh-list
139093939|NCT00307151|Zidovudine|zidovudine|mesh-list
139093940|NCT00307151|Nevirapine|nevirapine|mesh-list
139093941|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139093942|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139093943|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
139093944|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093945|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093946|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139093947|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139093948|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
139093949|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139093950|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139093951|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139093952|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139093953|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139093954|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
139093955|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139093956|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139093957|NCT03981029|Folic Acid|folic acid|mesh-list
139093958|NCT03981029|Hematinics|hematinics|mesh-ancestor
139093959|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
139093960|NCT03981029|Vitamins|vitamins|mesh-ancestor
139093961|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
139093962|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093963|NCT02654132|Dexamethasone|dexamethasone|mesh-list
139093964|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
139093965|NCT02654132|Pomalidomide|pomalidomide|mesh-list
139093966|NCT02654132|Elotuzumab|elotuzumab|mesh-list
139093967|NCT02654132|BB 1101|bb 1101|mesh-list
139093969|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
139093970|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
139093971|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139093972|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093973|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139093974|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
139093975|NCT02654132|Hormones|hormones|mesh-ancestor
139093976|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139093977|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139093978|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139093979|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
139093980|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139093981|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093982|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
139093983|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139093984|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139093985|NCT02654132|Growth Substances|growth substances|mesh-ancestor
139093986|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
139093987|NCT01064141|Vaccines|vaccines|mesh-list
139093988|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
139093989|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093990|NCT03837470|Furosemide|furosemide|mesh-list
139093991|NCT03837470|Diuretics|diuretics|mesh-ancestor
139093992|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
139093993|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139093994|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139093995|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139093996|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139093997|NCT01199900|Prednisone|prednisone|mesh-list
139093998|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139093999|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
139094000|NCT01199900|Hormones|hormones|mesh-ancestor
139094001|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139094002|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094003|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139094004|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094005|NCT01200056|Atorvastatin|atorvastatin|mesh-list
139094006|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139094007|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139094008|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
139094009|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094010|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139094011|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139094012|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094013|NCT01200212|Bevacizumab|bevacizumab|mesh-list
139094015|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139094016|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094017|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139094018|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139094019|NCT01200212|Growth Substances|growth substances|mesh-ancestor
138844601|NCT05782270|Warfarin|warfarin|mesh-list
139094020|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094021|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
139094023|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
139094024|NCT03978845|Anesthetics|anesthetics|mesh-list
139094025|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094026|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094027|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
139094028|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094029|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139094030|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139094031|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139094032|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139094033|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094034|NCT02387996|Nivolumab|nivolumab|mesh-list
139094035|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139094036|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094037|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139094038|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094039|NCT01204580|Metformin|metformin|mesh-list
139094040|NCT01204580|Glimepiride|glimepiride|mesh-list
139094041|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139094042|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613256|NCT00190502|Antibodies|antibodies|mesh-list
139094043|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139094044|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139094045|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
139094046|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139094047|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139094048|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139094049|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139094051|NCT03229486|Neostigmine|neostigmine|mesh-list
139094052|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139094053|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094054|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094055|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
139094056|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094057|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094058|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139094060|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094061|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139094062|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139094063|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139094064|NCT03833570|Melatonin|melatonin|mesh-list
139094065|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
139094066|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094067|NCT03833570|Protective Agents|protective agents|mesh-ancestor
139094068|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094069|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094070|NCT01779050|Paclitaxel|paclitaxel|mesh-list
139094071|NCT01779050|Docetaxel|docetaxel|mesh-list
139094072|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
139094073|NCT01779050|Carboplatin|carboplatin|mesh-list
139094074|NCT01779050|Doxorubicin|doxorubicin|mesh-list
139094075|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139094076|NCT01779050|Fluorouracil|fluorouracil|mesh-list
139094077|NCT01779050|Trastuzumab|trastuzumab|mesh-list
139094078|NCT01779050|Epirubicin|epirubicin|mesh-list
139094079|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139094080|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094081|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
139094082|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
139094083|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
139094084|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094085|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139094086|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
139094087|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094088|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139094089|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139094090|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
139094091|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139094092|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139094093|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139094094|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138844686|NCT05193591|Autoantibodies|autoantibodies|mesh-list
139094095|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094096|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
139094097|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139094098|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139094099|NCT03841136|Etoposide|etoposide|mesh-list
139094100|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139094101|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094102|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139094103|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139094104|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094105|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094106|NCT05669768|Tamoxifen|tamoxifen|mesh-list
139094107|NCT05669768|Pamiparib|pamiparib|mesh-list
139094108|NCT05669768|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139094109|NCT05669768|Hormone Antagonists|hormone antagonists|mesh-ancestor
139094110|NCT05669768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139094111|NCT05669768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950476|NCT05895201|Immunologic Factors|immunologic factors|mesh-ancestor
139094112|NCT05669768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139094113|NCT05669768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094114|NCT05669768|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139094115|NCT05669768|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138613331|NCT00220584|Donepezil|donepezil|mesh-list
139094117|NCT05669768|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139094118|NCT05669768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094119|NCT05669768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094120|NCT00306527|Vaccines|vaccines|mesh-list
139094121|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
139094122|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094123|NCT01066247|Midazolam|midazolam|mesh-list
139094124|NCT01066247|Morphine|morphine|mesh-list
139094125|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139094126|NCT01066247|Narcotics|narcotics|mesh-ancestor
139094127|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094128|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094129|NCT01066247|Analgesics|analgesics|mesh-ancestor
139094130|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
139094131|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094132|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139094133|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139094134|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139094135|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139094136|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139094137|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139094138|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
139094139|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
139094140|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
139094141|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
139094142|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094143|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094144|NCT00306293|Valacyclovir|valacyclovir|mesh-list
139094145|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
139094146|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139094147|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
139094148|NCT03980951|Narcotics|narcotics|mesh-ancestor
139094149|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094150|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094151|NCT03980951|Analgesics|analgesics|mesh-ancestor
139094152|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
139094153|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094154|NCT02532491|Risperidone|risperidone|mesh-list
139094155|NCT02532491|Aripiprazole|aripiprazole|mesh-list
139094156|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139094157|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
139094158|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094159|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094160|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094161|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139094162|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139094163|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094164|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139094165|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139094166|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
139094167|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
139094168|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
139094169|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139094170|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139094171|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139094172|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139094174|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
139094175|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
139094176|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094177|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094178|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094179|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139094180|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139094181|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094182|NCT00294671|Diflunisal|diflunisal|mesh-list
139094183|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139094184|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139094185|NCT00294671|Analgesics|analgesics|mesh-ancestor
139094186|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
139094187|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094188|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094189|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139094190|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139094191|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139094192|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094193|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094194|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139094195|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139094196|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094197|NCT03980249|Carvedilol|carvedilol|mesh-list
139094198|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139094199|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139094200|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
139094201|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094202|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094203|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094204|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139094205|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
139094206|NCT03980249|Protective Agents|protective agents|mesh-ancestor
139094207|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139094208|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139094209|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139094210|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
139094211|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139094212|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139094213|NCT01495598|Pomalidomide|pomalidomide|mesh-list
139094214|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
139094215|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094216|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139094217|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139094218|NCT01495598|Growth Substances|growth substances|mesh-ancestor
139094219|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
138950504|NCT05843383|Anesthetics, General|anesthetics, general|mesh-ancestor
139094220|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094221|NCT01297166|Calcitriol|calcitriol|mesh-list
139094222|NCT01297166|Calcipotriene|calcipotriene|mesh-list
139094223|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
139094224|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139094225|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094226|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139094227|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139094228|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094229|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139094231|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
139094232|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139094233|NCT01202474|Insulin|insulin|mesh-list
139094234|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139094235|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
139094236|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
139094237|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139094238|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094239|NCT05667818|Norfloxacin|norfloxacin|mesh-list
139094240|NCT05667818|Amlodipine|amlodipine|mesh-list
139094241|NCT05667818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139094242|NCT05667818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139094243|NCT05667818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139094244|NCT05667818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094245|NCT05667818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139094246|NCT05667818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094247|NCT05667818|Vasodilator Agents|vasodilator agents|mesh-ancestor
139094248|NCT05667818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139094249|NCT05667818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139094250|NCT05667818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139094252|NCT05667818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094253|NCT05667818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094254|NCT05667818|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139094255|NCT05667818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139094256|NCT01205204|Clonidine|clonidine|mesh-list
139094257|NCT01205204|Fentanyl|fentanyl|mesh-list
139094258|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139094259|NCT01205204|Narcotics|narcotics|mesh-ancestor
139094260|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094261|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094262|NCT01205204|Analgesics|analgesics|mesh-ancestor
139094263|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
139094264|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094265|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139094266|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139094267|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
139094268|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
139094269|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139094270|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
139094271|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
139094272|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139094273|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139094274|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139094275|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
139094276|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094277|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094278|NCT01205282|Pioglitazone|pioglitazone|mesh-list
139094279|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139094280|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094282|NCT01205360|Bupivacaine|bupivacaine|mesh-list
139094283|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
139094284|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
139094285|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094286|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094287|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
139094288|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094289|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139094290|NCT01205360|Narcotics|narcotics|mesh-ancestor
139094291|NCT01205360|Analgesics|analgesics|mesh-ancestor
139094292|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139094293|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139094294|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
139094295|NCT01200914|Heparin|heparin|mesh-list
139094296|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
139094297|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139094298|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139094299|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094300|NCT01205516|Morphine|morphine|mesh-list
139094301|NCT01205516|Methadone|methadone|mesh-list
139094302|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139094303|NCT01205516|Narcotics|narcotics|mesh-ancestor
139094304|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094305|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094306|NCT01205516|Analgesics|analgesics|mesh-ancestor
139094307|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
139094308|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094309|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
139094310|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
139094311|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
139094312|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139094313|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139094314|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139094315|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139094316|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094317|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
139094318|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029634|NCT00967109|Analgesics|analgesics|mesh-ancestor
139094319|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094320|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139094321|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094324|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139094325|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
139094326|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094327|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094328|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
139094329|NCT01205672|Metformin|metformin|mesh-list
139094330|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139094331|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094332|NCT01205750|Insulin|insulin|mesh-list
139094333|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139094334|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139094335|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094336|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
139094337|NCT03012386|Citric Acid|citric acid|mesh-list
139094338|NCT03012386|Sodium Citrate|sodium citrate|mesh-list
139094339|NCT03012386|Anticoagulants|anticoagulants|mesh-ancestor
139094340|NCT03012386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139094341|NCT03012386|Chelating Agents|chelating agents|mesh-ancestor
139094342|NCT03012386|Sequestering Agents|sequestering agents|mesh-ancestor
139094343|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094344|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
139094345|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139094346|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139094347|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094348|NCT03012386|Urological Agents|urological agents|mesh-ancestor
139094349|NCT01202552|Vaccines|vaccines|mesh-list
139094350|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
139094351|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094352|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139094353|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
139094354|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139094355|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139094356|NCT01205984|Prednisolone|prednisolone|mesh-list
139094357|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
139094358|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139094359|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
139094360|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139094361|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
139094362|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
139094363|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094364|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094365|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139094366|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
139094367|NCT01205984|Hormones|hormones|mesh-ancestor
139094368|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139094369|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139094370|NCT01205984|Protective Agents|protective agents|mesh-ancestor
139094371|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139094372|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094373|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139094374|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139094375|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139094376|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094377|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094378|NCT01297946|Hormones|hormones|mesh-list
139094379|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094380|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139094381|NCT03211858|Insulin|insulin|mesh-list
139094382|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139094383|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
139094384|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
139094385|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
139094386|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139094387|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139094388|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094389|NCT01298180|Hormones|hormones|mesh-list
138844979|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094390|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139094391|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094392|NCT03211156|Amoxicillin|amoxicillin|mesh-list
139094393|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139094394|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139094395|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
139094396|NCT01298336|Clarithromycin|clarithromycin|mesh-list
139094397|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139094398|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139094399|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139094400|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139094401|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094402|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094403|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094404|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139094405|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139094406|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139094408|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139094409|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094410|NCT04472494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139094411|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094412|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139094413|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
139094414|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094415|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139094417|NCT04568200|Carboplatin|carboplatin|mesh-list
139094418|NCT04568200|Durvalumab|durvalumab|mesh-list
139094419|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139094420|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094421|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
139094422|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
139094423|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
139094424|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094425|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139094426|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
139094427|NCT03236506|Grazoprevir|grazoprevir|mesh-list
139094428|NCT03236506|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139094429|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
139094430|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139094431|NCT01298882|Diacerein|diacerein|mesh-list
139094432|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139094433|NCT01206530|Leucovorin|leucovorin|mesh-list
139094434|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
139094435|NCT01206530|Bevacizumab|bevacizumab|mesh-list
139094436|NCT01206530|Fluorouracil|fluorouracil|mesh-list
139094437|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
139094438|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139094439|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094440|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139094441|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139094442|NCT01206530|Growth Substances|growth substances|mesh-ancestor
139094443|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094444|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
139094445|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
139094446|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094447|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139094448|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139094449|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
139094450|NCT01206530|Antidotes|antidotes|mesh-ancestor
139094451|NCT01206530|Protective Agents|protective agents|mesh-ancestor
139094452|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
139094453|NCT01206530|Vitamins|vitamins|mesh-ancestor
139094454|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
139094455|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
139094456|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139094457|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139094458|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139094459|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094460|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139094461|NCT03209518|Leuprolide|leuprolide|mesh-list
139094462|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139094463|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
139094464|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139094465|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094466|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139094467|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094468|NCT05282420|Ranibizumab|ranibizumab|mesh-list
139094469|NCT05282420|Aflibercept|aflibercept|mesh-list
139094470|NCT05282420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139094471|NCT05282420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139094472|NCT05282420|Growth Substances|growth substances|mesh-ancestor
139094473|NCT05282420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094474|NCT05282420|Growth Inhibitors|growth inhibitors|mesh-ancestor
139094475|NCT05282420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094476|NCT00304031|Temozolomide|temozolomide|mesh-list
139094477|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139094478|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
139094479|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094480|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094481|NCT01567124|Moxonidine|moxonidine|mesh-list
139094482|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139094483|NCT01299194|Atorvastatin|atorvastatin|mesh-list
139094484|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139094485|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139094486|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
139094487|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029835|NCT00590187|Sapacitabine|sapacitabine|mesh-list
139094488|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138613616|NCT06111573|Vitamin D|vitamin d|mesh-list
139094489|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139094490|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094491|NCT03827408|Midazolam|midazolam|mesh-list
139094492|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
139094493|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139094494|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094495|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094496|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139094497|NCT03827408|Analgesics|analgesics|mesh-ancestor
139094498|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
139094499|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094500|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139094501|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139094502|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139094503|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
139094504|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094505|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094506|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139094507|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139094508|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139094509|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139094510|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139094511|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
139094512|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
139094513|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
139094514|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
139094515|NCT03556904|Docetaxel|docetaxel|mesh-list
139094516|NCT03556904|Hormones|hormones|mesh-list
139029877|NCT03933449|Irinotecan|irinotecan|mesh-list
139094517|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094518|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
139094519|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
139094520|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
139094521|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094522|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139094523|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094524|NCT00332189|Verapamil|verapamil|mesh-list
139094525|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139094526|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139094527|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139094528|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094529|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139094530|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094531|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
139094532|NCT01206998|Progesterone|progesterone|mesh-list
139094533|NCT01206998|Progestins|progestins|mesh-ancestor
139094534|NCT01206998|Hormones|hormones|mesh-ancestor
139094535|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139094536|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094537|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138950570|NCT05753436|Curcumin|curcumin|mesh-list
139094538|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139094539|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139094540|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139094541|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094542|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094543|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094544|NCT00331799|Analgesics|analgesics|mesh-ancestor
139094545|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
139094546|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094547|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
139094548|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139094549|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
139094551|NCT03826940|L 647318|l 647318|mesh-list
139094552|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
139094553|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139094554|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139094555|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
139094556|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094557|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139094558|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139094559|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094560|NCT01201694|Curcumin|curcumin|mesh-list
139094561|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139094562|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139094563|NCT01201694|Analgesics|analgesics|mesh-ancestor
139094564|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
139094565|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094566|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094567|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139094568|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029969|NCT00290758|Protective Agents|protective agents|mesh-ancestor
139094569|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094570|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094571|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094572|NCT01201928|Insulin|insulin|mesh-list
139094573|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139094574|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094575|NCT00303719|Cyclosporine|cyclosporine|mesh-list
139094576|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
139094577|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
139094578|NCT00303719|Fludarabine|fludarabine|mesh-list
139094579|NCT00303719|Cyclosporins|cyclosporins|mesh-list
139094580|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139094581|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139094582|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
139094583|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094584|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139094585|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139094586|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
139094587|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094588|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094589|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139094590|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094591|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
139094592|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139094593|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
139094594|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139094595|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139094596|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139094597|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
139094598|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139094599|NCT01207310|Nicotine|nicotine|mesh-list
139094600|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139094601|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
139094602|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094603|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094604|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139094605|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139094606|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
139094607|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094608|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094609|NCT00331409|Everolimus|everolimus|mesh-list
139094610|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
139094611|NCT00331409|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139094612|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139094613|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094614|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094615|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139094616|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
139094617|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845213|NCT02806362|Ritonavir|ritonavir|mesh-list
139094618|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094619|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139094620|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139094621|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139094623|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094624|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139094625|NCT01064921|Vorinostat|vorinostat|mesh-list
139094626|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094627|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139094628|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094629|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094630|NCT01299662|Poly ICLC|poly iclc|mesh-list
139094631|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
139094632|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
139094633|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094634|NCT00303485|Vitamin D|vitamin d|mesh-list
139094635|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
139094636|NCT00303485|Calcium|calcium|mesh-list
139094637|NCT00303485|Vitamins|vitamins|mesh-ancestor
139094638|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
139094639|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094640|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139094641|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139094642|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
139094643|NCT03983915|Remifentanil|remifentanil|mesh-list
139094644|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139094645|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094646|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094647|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139094648|NCT03983915|Analgesics|analgesics|mesh-ancestor
139094649|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
139094650|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094651|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139094652|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139094653|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139094654|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
139094655|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094656|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094657|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139094658|NCT03983915|Narcotics|narcotics|mesh-ancestor
139094659|NCT01300754|Lidocaine|lidocaine|mesh-list
139094660|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
139094661|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
139094662|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094663|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094664|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
139094665|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094666|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139094667|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139094668|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139094669|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139094670|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094671|NCT00303953|Belinostat|belinostat|mesh-list
139094672|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094673|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139094674|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094675|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094676|NCT03840122|Anesthetics|anesthetics|mesh-list
139094677|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
139094678|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094679|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094680|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
139094681|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094682|NCT04343872|Metformin|metformin|mesh-list
139094683|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139094684|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094685|NCT01314274|Bevacizumab|bevacizumab|mesh-list
139094686|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139094687|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094688|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139094689|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139094690|NCT01314274|Growth Substances|growth substances|mesh-ancestor
139094691|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138845284|NCT02798874|Ticagrelor|ticagrelor|mesh-list
139094692|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
139094693|NCT02935894|Ibuprofen|ibuprofen|mesh-list
139094694|NCT02935894|Pilocarpine|pilocarpine|mesh-list
139094695|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139094696|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139094697|NCT02935894|Analgesics|analgesics|mesh-ancestor
139094698|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
139094699|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094700|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094701|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139094702|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139094703|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139094704|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094705|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094706|NCT02935894|Miotics|miotics|mesh-ancestor
139094707|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
139094708|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139094709|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139094710|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
139094711|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094712|NCT03224182|Apaziquone|apaziquone|mesh-list
139094713|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094714|NCT03821480|Fluconazole|fluconazole|mesh-list
139094715|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
139094716|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950613|NCT05658380|Mydriatics|mydriatics|mesh-ancestor
139094717|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139094718|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139094719|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094720|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094721|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139094722|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
139094723|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139094724|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094725|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139094726|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139094727|NCT01203488|Vitamin A|vitamin a|mesh-list
139094728|NCT01203488|Vitamins|vitamins|mesh-ancestor
139094729|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
139094730|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094731|NCT01314352|Desloratadine|desloratadine|mesh-list
139094732|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139094733|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
139094734|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094735|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094736|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094737|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139094738|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139094739|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
139094740|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
139094741|NCT03818282|Paclitaxel|paclitaxel|mesh-list
139030176|NCT01069822|Midazolam|midazolam|mesh-list
139094742|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139094743|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094744|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
139094745|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
139094746|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
139094747|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094748|NCT01300364|Citalopram|citalopram|mesh-list
139094749|NCT01300364|Reboxetine|reboxetine|mesh-list
139094750|NCT01300364|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139094751|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139094752|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139094753|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094754|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094755|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
139094756|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094757|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139094758|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
139094759|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139094760|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139094761|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
139094762|NCT03221842|Complement C1s|complement c1s|mesh-list
139094763|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139094764|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
139094765|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
139094766|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094767|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139094768|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139094769|NCT05622890|Maytansine|maytansine|mesh-list
139094770|NCT05622890|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
139094771|NCT05622890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139094772|NCT05622890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094773|NCT05622890|Tubulin Modulators|tubulin modulators|mesh-ancestor
139094774|NCT05622890|Antimitotic Agents|antimitotic agents|mesh-ancestor
139094775|NCT05622890|Mitosis Modulators|mitosis modulators|mesh-ancestor
139094776|NCT05622890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094777|NCT05622890|Immunoconjugates|immunoconjugates|mesh-ancestor
139094778|NCT05622890|Immunologic Factors|immunologic factors|mesh-ancestor
139094779|NCT05622890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094780|NCT00303329|Deferasirox|deferasirox|mesh-list
139094781|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139094782|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
139094783|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
139094784|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094785|NCT01300988|Aprepitant|aprepitant|mesh-list
139094786|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
139094787|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
139094788|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
139094789|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094790|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094791|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139094792|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139094793|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094794|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094795|NCT01064999|Capecitabine|capecitabine|mesh-list
139094796|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
139030219|NCT01046721|Exenatide|exenatide|mesh-list
139094797|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139094799|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094800|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094801|NCT03818048|Propofol|propofol|mesh-list
139094802|NCT03818048|Sevoflurane|sevoflurane|mesh-list
139094803|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139094804|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094805|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094806|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139094807|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
139094808|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
139094809|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139094810|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139094811|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
139094812|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139094813|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139094814|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139094815|NCT00329849|Vaccines|vaccines|mesh-list
139094816|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
139094817|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094818|NCT05655806|Aminophylline|aminophylline|mesh-list
139094819|NCT05655806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139094820|NCT05655806|Autonomic Agents|autonomic agents|mesh-ancestor
139094821|NCT05655806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139094822|NCT05655806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094823|NCT05655806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139094824|NCT05655806|Respiratory System Agents|respiratory system agents|mesh-ancestor
139094825|NCT05655806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139094826|NCT05655806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139094827|NCT05655806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094828|NCT05655806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094829|NCT05655806|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139094830|NCT05655806|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139094831|NCT05655806|Purinergic Agents|purinergic agents|mesh-ancestor
139094832|NCT05655806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094833|NCT05655806|Protective Agents|protective agents|mesh-ancestor
139094835|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
139094836|NCT01300676|Estrogens|estrogens|mesh-ancestor
139094837|NCT01300676|Hormones|hormones|mesh-ancestor
139094838|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139094839|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094840|NCT01300676|Progestins|progestins|mesh-ancestor
139094841|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
139094842|NCT00329303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139094843|NCT00329303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139094844|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139094845|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
139094846|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094847|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139094848|NCT03806816|Melatonin|melatonin|mesh-list
139094849|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
139094850|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094851|NCT03806816|Protective Agents|protective agents|mesh-ancestor
139094852|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094853|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094854|NCT01301222|Octreotide|octreotide|mesh-list
139094855|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139094856|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139094857|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094859|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
139094860|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094861|NCT01302002|Metformin|metformin|mesh-list
139094862|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139094863|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094864|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
139094865|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
139094866|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
139094868|NCT03814616|Pyronaridine|pyronaridine|mesh-list
139094869|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
139094870|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139094871|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139094872|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139094873|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094874|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
139094875|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
139094876|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139094877|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
139094878|NCT00302159|Temozolomide|temozolomide|mesh-list
139094879|NCT00302159|Valproic Acid|valproic acid|mesh-list
139094880|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139094881|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
139094882|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094883|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094884|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
139094885|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094886|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
139094887|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094888|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094889|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
139094890|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139094891|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094892|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139094893|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
139094894|NCT03814226|Growth Substances|growth substances|mesh-ancestor
139094895|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094896|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
139094897|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094898|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094899|NCT00302081|Ribavirin|ribavirin|mesh-list
139094900|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139094901|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
139094902|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
139094903|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094904|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
139094905|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139094906|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
139094907|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094908|NCT00302003|Cytarabine|cytarabine|mesh-list
139094909|NCT00302003|Dexamethasone|dexamethasone|mesh-list
139094910|NCT00302003|Prednisone|prednisone|mesh-list
139094911|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
139094912|NCT00302003|Ifosfamide|ifosfamide|mesh-list
139094913|NCT00302003|Doxorubicin|doxorubicin|mesh-list
139094914|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139094915|NCT00302003|Etoposide|etoposide|mesh-list
139094916|NCT00302003|Vincristine|vincristine|mesh-list
139094917|NCT00302003|Vinorelbine|vinorelbine|mesh-list
139094918|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
139094919|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139094920|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
139094921|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094922|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139094923|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139094924|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
139094925|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094926|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094927|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139094928|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139094929|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
139094930|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
139094931|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614056|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
139094932|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139094933|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
139094935|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139094936|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139094937|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139094938|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139094939|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139094940|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094941|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139094942|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139094943|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
139094944|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
139094945|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139094946|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
138950681|NCT05389813|Sensory System Agents|sensory system agents|mesh-ancestor
138950682|NCT05389813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950683|NCT05389813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094947|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
139094948|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
139094949|NCT00036270|Tamoxifen|tamoxifen|mesh-list
139094950|NCT00036270|Exemestane|exemestane|mesh-list
139094951|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139094952|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
139094953|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139094954|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094955|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139094956|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094957|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139094958|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139094959|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139094960|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139094961|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139094962|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094963|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094964|NCT01097382|Zolpidem|zolpidem|mesh-list
139094965|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139094966|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139094967|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094968|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094969|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139094970|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
139094971|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
139094972|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139094973|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094974|NCT00301067|Calcitriol|calcitriol|mesh-list
139094975|NCT00301067|Temozolomide|temozolomide|mesh-list
139094976|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139094977|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
139094978|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094979|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139094980|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139094981|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139094982|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139094983|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139094984|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139094985|NCT00301067|Vitamins|vitamins|mesh-ancestor
139094986|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
139094987|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139094988|NCT03979859|Nafithromycin|nafithromycin|mesh-list
139094989|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139094990|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139094991|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139094992|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139094993|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139094995|NCT03955458|Ropivacaine|ropivacaine|mesh-list
139094996|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
139094997|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
139094998|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139094999|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095000|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
139095001|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095002|NCT00007020|Cholic Acids|cholic acids|mesh-list
139095003|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139095004|NCT00300755|Pantoprazole|pantoprazole|mesh-list
139095005|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139095006|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139095007|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139095008|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095009|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095010|NCT00033540|Gemcitabine|gemcitabine|mesh-list
139095011|NCT00033540|Capecitabine|capecitabine|mesh-list
139095012|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139095013|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
139095014|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095015|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095016|NCT00300365|Aspirin|aspirin|mesh-list
139095017|NCT00300365|Niacin|niacin|mesh-list
139095018|NCT00300365|Pioglitazone|pioglitazone|mesh-list
139095019|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139095020|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139095021|NCT00300365|Analgesics|analgesics|mesh-ancestor
139095022|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
139095023|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095024|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095025|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139095026|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139095027|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139095028|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139095029|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095030|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139095031|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139095032|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095033|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
139095034|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139095035|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139095036|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
139095037|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139095038|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
139095039|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
139095040|NCT00300365|Vitamins|vitamins|mesh-ancestor
139095041|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
139095042|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139095043|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139095044|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
139095045|NCT00048048|Hematinics|hematinics|mesh-ancestor
139095046|NCT03953118|Azithromycin|azithromycin|mesh-list
139095047|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139095048|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139095049|NCT01101204|Metformin|metformin|mesh-list
139095050|NCT01101204|Simvastatin|simvastatin|mesh-list
139095051|NCT01101204|Fenofibrate|fenofibrate|mesh-list
139095052|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139095053|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095054|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139095055|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139095056|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
139095057|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095058|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139095059|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139095060|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095061|NCT01095822|Valsartan|valsartan|mesh-list
139095062|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139095063|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139095064|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139095065|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095066|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
139095067|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139095068|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139095069|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095070|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
139095071|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139095072|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095073|NCT00300053|Lenograstim|lenograstim|mesh-list
139095074|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139095075|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
139095076|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095077|NCT01098084|Decitabine|decitabine|mesh-list
139095078|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139095079|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
139095080|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095081|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095082|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095084|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
139095085|NCT03952572|Doxorubicin|doxorubicin|mesh-list
139095086|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139095087|NCT03952572|Vincristine|vincristine|mesh-list
139095088|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139095089|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
139095090|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095091|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139095092|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139095093|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
139095094|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095095|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095096|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139095097|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139095098|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139095099|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139095100|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095101|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139095102|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
139095103|NCT03952572|Hormones|hormones|mesh-ancestor
139095104|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095105|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139030558|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
139095106|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139095107|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
139095108|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
139095109|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
139095111|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095112|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139095113|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095114|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095115|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
139095116|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139095117|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139095118|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095119|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139095120|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139095121|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
139095122|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139095123|NCT00326885|Catumaxomab|catumaxomab|mesh-list
139095124|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139095125|NCT00326495|Cetuximab|cetuximab|mesh-list
139095126|NCT00326495|Sorafenib|sorafenib|mesh-list
139095127|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139095128|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095129|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139095130|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095131|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095132|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
139095133|NCT00326417|Fludarabine|fludarabine|mesh-list
139095134|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139030611|NCT00988403|Levan|levan|mesh-list
139095135|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
139095136|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095137|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139095138|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139095139|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
139095140|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095141|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095142|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139095143|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139095144|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139095145|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
139095147|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095148|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095149|NCT01065467|Panobinostat|panobinostat|mesh-list
139095150|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095151|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139095152|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095153|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095154|NCT01065545|Clofarabine|clofarabine|mesh-list
139095155|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139095157|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095158|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095159|NCT03979469|Fentanyl|fentanyl|mesh-list
139095160|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
139095161|NCT03979469|Ketamine|ketamine|mesh-list
139095162|NCT03979469|Remifentanil|remifentanil|mesh-list
139095163|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139095164|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139030679|NCT03975166|Xhance|xhance|mesh-list
139095165|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095166|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139095167|NCT03979469|Analgesics|analgesics|mesh-ancestor
139095168|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
139095169|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095170|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139095171|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139095172|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139095173|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
139095174|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139095175|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095176|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139095177|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139095178|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
139095179|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
139095180|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139095181|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139095182|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139095183|NCT03979469|Narcotics|narcotics|mesh-ancestor
139095184|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139095185|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
139095186|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139095187|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139095188|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095189|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139095190|NCT01065701|Analgesics|analgesics|mesh-ancestor
139095191|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
139095192|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095193|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139095194|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139095195|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139095196|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
139095197|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139095198|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095199|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
139095200|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095201|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
139095202|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095203|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095204|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139030702|NCT01325818|Pravastatin|pravastatin|mesh-list
139095205|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
139095206|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
139095208|NCT01065857|Citric Acid|citric acid|mesh-list
139095209|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
139095210|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
139095211|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139095212|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
139095213|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
139095214|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095215|NCT01065857|Antacids|antacids|mesh-ancestor
139095216|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139095217|NCT01065857|Cathartics|cathartics|mesh-ancestor
139095218|NCT00297479|Nicotine|nicotine|mesh-list
139095219|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139095221|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095222|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095223|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139095224|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139095225|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
139095226|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139095227|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095228|NCT00688870|Vaccines|vaccines|mesh-list
139095229|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139095230|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
139095231|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095232|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
139095233|NCT02532335|Cathartics|cathartics|mesh-ancestor
139095234|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139095236|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139095237|NCT03216226|Hormones|hormones|mesh-ancestor
139095238|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095239|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095240|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
139095241|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
139095242|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095243|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139095244|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095245|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095246|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
139095247|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139095248|NCT00290693|Docetaxel|docetaxel|mesh-list
139095249|NCT00290693|Capecitabine|capecitabine|mesh-list
139095250|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095251|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
139095252|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
139095253|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
139095254|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095255|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139095256|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
139095257|NCT00274469|Fulvestrant|fulvestrant|mesh-list
139095258|NCT00274469|Anastrozole|anastrozole|mesh-list
139095259|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139095260|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095261|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139095262|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139095263|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
139095264|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095265|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095266|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139095267|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139095268|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095269|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095270|NCT01556776|Lenalidomide|lenalidomide|mesh-list
139095271|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
139095272|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095273|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139095274|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139095275|NCT01556776|Growth Substances|growth substances|mesh-ancestor
139095276|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
139095277|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095278|NCT02422498|Cisplatin|cisplatin|mesh-list
139095279|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095280|NCT01314976|Metronidazole|metronidazole|mesh-list
139095281|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139095282|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139095283|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139095284|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139095285|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
139095286|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139095287|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139095288|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095289|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139095290|NCT01973452|Analgesics|analgesics|mesh-ancestor
139095291|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
139095292|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095293|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139095294|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139095295|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139095296|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
139095297|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139095298|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095299|NCT04504942|Leronlimab|leronlimab|mesh-list
139095300|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139095301|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139095302|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095303|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139095304|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139095305|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
139095306|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139095307|NCT01882816|Doxorubicin|doxorubicin|mesh-list
139095308|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139095309|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095310|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139095311|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139095312|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095313|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095314|NCT00272987|Paclitaxel|paclitaxel|mesh-list
139095315|NCT00272987|Trastuzumab|trastuzumab|mesh-list
139095316|NCT00272987|Lapatinib|lapatinib|mesh-list
139095317|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139095318|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095319|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
139095320|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
139095321|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
139095322|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095323|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139095324|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139095325|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095326|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139095327|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095329|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095330|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095331|NCT01070927|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139095332|NCT01070927|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139095333|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950757|NCT05231980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139095334|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095335|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139095336|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095337|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139095338|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
139095339|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139095340|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
139095341|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095342|NCT01730950|Bevacizumab|bevacizumab|mesh-list
139095343|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139095344|NCT01730950|Antibodies|antibodies|mesh-list
139095345|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
139095346|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139095347|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095348|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139095349|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139095350|NCT01730950|Growth Substances|growth substances|mesh-ancestor
139095351|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095352|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
139095353|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
139095354|NCT00271505|Bevacizumab|bevacizumab|mesh-list
139095355|NCT00271505|Carboplatin|carboplatin|mesh-list
139095356|NCT00271505|Docetaxel|docetaxel|mesh-list
139095357|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139095358|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095359|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139095360|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139095361|NCT00271505|Growth Substances|growth substances|mesh-ancestor
139095362|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095363|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
139095364|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
139095365|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
139095366|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
139095367|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095368|NCT01642186|Everolimus|everolimus|mesh-list
139095369|NCT01642186|Letrozole|letrozole|mesh-list
139095370|NCT01642186|Leuprolide|leuprolide|mesh-list
139095371|NCT01642186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139095372|NCT01642186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139095373|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095374|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095375|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139095376|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
139095377|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095378|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095379|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139095380|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139095381|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139095382|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
139095383|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095384|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139095385|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
139095386|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139095387|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139095388|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
139095389|NCT00423514|Melphalan|melphalan|mesh-list
139095390|NCT00423514|Thiotepa|thiotepa|mesh-list
139095391|NCT00423514|Clofarabine|clofarabine|mesh-list
139095392|NCT00423514|Tacrolimus|tacrolimus|mesh-list
139095393|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
139095394|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095395|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139095396|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139095397|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095398|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950773|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
139095399|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139095400|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095401|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139095402|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
139095403|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139095404|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139095405|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139095406|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
139095407|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139095408|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139095409|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
139095410|NCT00120952|Cobalt|cobalt|mesh-list
139095411|NCT00120952|Chromium|chromium|mesh-list
139095412|NCT00120952|Trace Elements|trace elements|mesh-ancestor
139095413|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
139095414|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095415|NCT00289991|Itraconazole|itraconazole|mesh-list
139095416|NCT00289991|Voriconazole|voriconazole|mesh-list
139095417|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
139095418|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139095419|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139095420|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139095421|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095422|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095423|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139095424|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
139095425|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095426|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095427|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139095428|NCT00270413|Sunitinib|sunitinib|mesh-list
139095429|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095430|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139095431|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139095432|NCT00270413|Growth Substances|growth substances|mesh-ancestor
139095433|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095434|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
139030926|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139095435|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139095437|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095438|NCT00270257|Buprenorphine|buprenorphine|mesh-list
139095439|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139095440|NCT00270257|Naloxone|naloxone|mesh-list
139095441|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139095442|NCT00270257|Narcotics|narcotics|mesh-ancestor
139095443|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139095444|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095445|NCT00270257|Analgesics|analgesics|mesh-ancestor
138950781|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095446|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
139095447|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095448|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139095449|NCT00269399|Vancomycin|vancomycin|mesh-list
139095450|NCT00269399|Rifaximin|rifaximin|mesh-list
139095451|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139095452|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139095453|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139095454|NCT00269087|Fluticasone|fluticasone|mesh-list
139095455|NCT00269087|Xhance|xhance|mesh-list
139095456|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139095457|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139095458|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139095459|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
139095460|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095461|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095462|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139095463|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
139095464|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
139095465|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139095466|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139095467|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139095468|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139095469|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
139095470|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139095471|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095472|NCT00288587|Diuretics|diuretics|mesh-list
139030950|NCT00456300|Exenatide|exenatide|mesh-list
139095473|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
139095475|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095476|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139095477|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095478|NCT00268463|Capecitabine|capecitabine|mesh-list
139095479|NCT00268463|Floxuridine|floxuridine|mesh-list
139095480|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
139095481|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139095482|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
139095483|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095484|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095485|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
139095486|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139095487|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139095488|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139095489|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138950807|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950808|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138950809|NCT04981951|Analgesics|analgesics|mesh-ancestor
138950810|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
138950813|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139095490|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095491|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
139095492|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139095493|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095494|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139095495|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095496|NCT01071005|Leuprolide|leuprolide|mesh-list
139095497|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139095498|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
139095499|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139095500|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095501|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139095502|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095503|NCT03976037|Misoprostol|misoprostol|mesh-list
139095504|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139095505|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
139095506|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139030988|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095507|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095508|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139095509|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139095510|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
139095511|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
139095512|NCT00265889|Melphalan|melphalan|mesh-list
139095513|NCT00265889|Busulfan|busulfan|mesh-list
139095514|NCT00265889|Etoposide|etoposide|mesh-list
139095515|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139095516|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
139095517|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095518|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139095519|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139095520|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
139095521|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095522|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095523|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139095524|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139095525|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139095526|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139095527|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095528|NCT01333696|Pemetrexed|pemetrexed|mesh-list
139095529|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095530|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095531|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095532|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139095533|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139095534|NCT01333774|Acarbose|acarbose|mesh-list
139095535|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139095536|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095537|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095538|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139095539|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095540|NCT01333852|Metformin|metformin|mesh-list
139095541|NCT01333852|Paclitaxel|paclitaxel|mesh-list
139095542|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139031045|NCT01011920|Cytarabine|cytarabine|mesh-list
139095543|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095544|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
139095545|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
139095546|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
139095547|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095548|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139095549|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095551|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139095552|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139095553|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
139095554|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139095555|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095556|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095557|NCT03206788|Losartan|losartan|mesh-list
139095558|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139095559|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139095560|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139095561|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139095562|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095563|NCT03205150|Licogliflozin|licogliflozin|mesh-list
139095564|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139095565|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095566|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139095567|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095568|NCT04936984|Abaloparatide|abaloparatide|mesh-list
139095569|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
139095570|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139095571|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095572|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139095573|NCT02931838|Deucravacitinib|deucravacitinib|mesh-list
139095574|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
139095575|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139095576|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095577|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095579|NCT03201562|Aceclidine|aceclidine|mesh-list
139095580|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
139095581|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
139095582|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095583|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095584|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139095585|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139095586|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
139095587|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139095588|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095589|NCT03201562|Miotics|miotics|mesh-ancestor
139095590|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139095591|NCT03200860|Empagliflozin|empagliflozin|mesh-list
139095592|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139095593|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095594|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139095595|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095596|NCT01314508|Mecasermin|mecasermin|mesh-list
139095597|NCT01314508|Growth Substances|growth substances|mesh-ancestor
139095598|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095599|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
139095600|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
139095601|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139095602|NCT01314586|Estrogens|estrogens|mesh-ancestor
139095603|NCT01314586|Hormones|hormones|mesh-ancestor
139095604|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095605|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095606|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
139095607|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139095608|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
139095609|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095610|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139095611|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139095612|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
139095613|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095614|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095615|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139095616|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
139095617|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139095618|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095619|NCT03184558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139095620|NCT03184558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095621|NCT03180736|Dexamethasone|dexamethasone|mesh-list
139095622|NCT03180736|Daratumumab|daratumumab|mesh-list
139095623|NCT03180736|Pomalidomide|pomalidomide|mesh-list
139095624|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139095625|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
139095626|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
139095627|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095628|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095629|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139095630|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
139095631|NCT03180736|Hormones|hormones|mesh-ancestor
139095632|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095633|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139095634|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095635|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
139095636|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139095637|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139095638|NCT03180736|Growth Substances|growth substances|mesh-ancestor
139095639|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
139095640|NCT03178942|Permethrin|permethrin|mesh-list
139095641|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095642|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095643|NCT03175198|Dabigatran|dabigatran|mesh-list
139095644|NCT03175198|Antithrombins|antithrombins|mesh-ancestor
139095645|NCT03175198|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139095646|NCT03175198|Protease Inhibitors|protease inhibitors|mesh-ancestor
139095647|NCT03175198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095648|NCT03175198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095649|NCT03175198|Anticoagulants|anticoagulants|mesh-ancestor
139095650|NCT03087448|Trametinib|trametinib|mesh-list
139095651|NCT03087448|Ceritinib|ceritinib|mesh-list
138950887|NCT04710927|Fluorides|fluorides|mesh-list
139095652|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095653|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139095655|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095656|NCT03175120|Insulin|insulin|mesh-list
139095657|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139095658|NCT03175120|Liraglutide|liraglutide|mesh-list
139095659|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
138846248|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139095660|NCT03175120|Xultophy|xultophy|mesh-list
139095661|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139095662|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095663|NCT03175120|Incretins|incretins|mesh-ancestor
139095665|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095666|NCT02795182|Tislelizumab|tislelizumab|mesh-list
139095667|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
139095668|NCT02795182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139095669|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095670|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139095671|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095672|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095674|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139095675|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139095676|NCT03054766|Growth Substances|growth substances|mesh-ancestor
139095677|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095678|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
139095679|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095680|NCT03036748|Amiloride|amiloride|mesh-list
139095681|NCT03036748|Diuretics|diuretics|mesh-ancestor
139095682|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
139095683|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095684|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139095685|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139095686|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139095687|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095688|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139095689|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139095690|NCT03167242|Lumefantrine|lumefantrine|mesh-list
139095691|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139095692|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
139095693|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139095694|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139095695|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139095696|NCT03636178|Daminozide|daminozide|mesh-list
139095697|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
139095698|NCT03636178|Growth Substances|growth substances|mesh-ancestor
139095699|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095700|NCT01330654|Metoprolol|metoprolol|mesh-list
139095701|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139095702|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139095703|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
139095704|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
139095705|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095706|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095707|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139095708|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139095709|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139095710|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
139095711|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139095712|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095713|NCT01330810|Curcumin|curcumin|mesh-list
139095714|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139095715|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139095716|NCT01330810|Analgesics|analgesics|mesh-ancestor
139095717|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
139031175|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
139095718|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095719|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095720|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139095721|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139095722|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095723|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095724|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095725|NCT01331122|Droxidopa|droxidopa|mesh-list
139095726|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139095727|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139095728|NCT01320280|Afatinib|afatinib|mesh-list
139095729|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095730|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139095731|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095732|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095733|NCT01331434|Exemestane|exemestane|mesh-list
139095734|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095735|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139095736|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138846324|NCT04040023|Vitamins|vitamins|mesh-list
139095737|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095738|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095739|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139095740|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
139095741|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095742|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095743|NCT01331590|Dexamethasone|dexamethasone|mesh-list
139095744|NCT01331590|Etoposide|etoposide|mesh-list
139095745|NCT01331590|Ifosfamide|ifosfamide|mesh-list
139095746|NCT01331590|Lenograstim|lenograstim|mesh-list
139095747|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139095748|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
139095749|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
139095750|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095751|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095752|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139095753|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
139095754|NCT01331590|Hormones|hormones|mesh-ancestor
139095755|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095756|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139095757|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095758|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139095759|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139095760|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139095761|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095762|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095763|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139095764|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
139095765|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139095766|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
139095767|NCT01331902|Nicorandil|nicorandil|mesh-list
139095768|NCT01331902|Adenosine|adenosine|mesh-list
139095769|NCT01331902|Analgesics|analgesics|mesh-ancestor
139095770|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
139095771|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095772|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095773|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139095774|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
139095775|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139095776|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
139095777|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
139095778|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139095779|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095780|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139095781|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
139095782|NCT01331902|Vitamins|vitamins|mesh-ancestor
139095783|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
139095784|NCT01332370|Metformin|metformin|mesh-list
139095785|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139095786|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
139095787|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139095788|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095789|NCT01332370|Incretins|incretins|mesh-ancestor
139095790|NCT01332370|Hormones|hormones|mesh-ancestor
139095791|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095792|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139095793|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
139095794|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095795|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095796|NCT01332448|Orlistat|orlistat|mesh-list
139095797|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095798|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095799|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139095800|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139095801|NCT04484428|Menthol|menthol|mesh-list
139095802|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
139095803|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
139095804|NCT01332604|Bevacizumab|bevacizumab|mesh-list
139095805|NCT01332604|Capecitabine|capecitabine|mesh-list
139095806|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139095807|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139095808|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139095809|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139095810|NCT01332604|Growth Substances|growth substances|mesh-ancestor
139095811|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138846396|NCT00873223|Incretins|incretins|mesh-ancestor
139095812|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
138950934|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139095813|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139095814|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
139095815|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095816|NCT01333150|Propranolol|propranolol|mesh-list
139095817|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139095818|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139095819|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
139095820|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139095821|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095822|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095823|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139095824|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139095825|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
139095826|NCT02913664|Losartan|losartan|mesh-list
139095827|NCT02913664|Amlodipine|amlodipine|mesh-list
139095828|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
139095829|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
139095830|NCT02913664|Giapreza|giapreza|mesh-list
139095831|NCT02913664|Calcium|calcium|mesh-list
139095832|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139095833|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
139095834|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139095835|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095836|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139095837|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139095838|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095839|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
139095840|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139095841|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139095842|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139095843|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139095844|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
139095845|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095846|NCT02818582|Remdesivir|remdesivir|mesh-list
139095847|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
139095848|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095849|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
139095850|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139095851|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139095852|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139095853|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139095854|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095855|NCT01337440|Incretins|incretins|mesh-ancestor
139095856|NCT01337440|Hormones|hormones|mesh-ancestor
139095857|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095858|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139095859|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
139095860|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095861|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095862|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139095863|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139095864|NCT01337518|Androgens|androgens|mesh-list
139095865|NCT01337518|Hormones|hormones|mesh-ancestor
139095866|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139095867|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095868|NCT05186194|Vitamin D|vitamin d|mesh-list
139095869|NCT05186194|Calcium|calcium|mesh-list
139095870|NCT05186194|Vitamins|vitamins|mesh-ancestor
139095871|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
139095872|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095873|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139095874|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139095875|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
139095876|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139095877|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139095878|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095879|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
139095880|NCT01338454|Coagulants|coagulants|mesh-ancestor
139095881|NCT02882152|Morphine|morphine|mesh-list
139095882|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139095883|NCT02882152|Narcotics|narcotics|mesh-ancestor
139095884|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139095885|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095886|NCT02882152|Analgesics|analgesics|mesh-ancestor
139095887|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
139095888|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095889|NCT05185804|Enoxaparin|enoxaparin|mesh-list
139095890|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
139095891|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
139095892|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139095893|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139095894|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095895|NCT01338844|Inositol|inositol|mesh-list
139095896|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
139095897|NCT01338844|Vitamins|vitamins|mesh-ancestor
139095898|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
139095899|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095900|NCT01338922|Insulin|insulin|mesh-list
139095901|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139095902|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095903|NCT01339312|Vaccines|vaccines|mesh-list
139095904|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
139095905|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095906|NCT01339468|Tacrolimus|tacrolimus|mesh-list
139095907|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139095908|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
139095909|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095910|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139095911|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095912|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095913|NCT01339624|Ketorolac|ketorolac|mesh-list
139095914|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139095915|NCT01339624|Fentanyl|fentanyl|mesh-list
139095916|NCT01339624|Morphine|morphine|mesh-list
139095917|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139095918|NCT01339624|Narcotics|narcotics|mesh-ancestor
139095919|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139095920|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095921|NCT01339624|Analgesics|analgesics|mesh-ancestor
139095922|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
139095923|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139095924|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139095925|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139095926|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
139095927|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
139095928|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139095929|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139095930|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139095931|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139095932|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139095933|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095934|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095935|NCT01340248|Carvedilol|carvedilol|mesh-list
139095936|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139095937|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139095938|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
139095939|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139095940|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095941|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095942|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139095943|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
139095944|NCT01340248|Protective Agents|protective agents|mesh-ancestor
139095945|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139095946|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139095947|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139095948|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
139095949|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139095950|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139095951|NCT01340326|Valsartan|valsartan|mesh-list
139095952|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139095953|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139095954|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139095955|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095956|NCT00286091|Denosumab|denosumab|mesh-list
139095957|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139095958|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139095959|NCT01340950|Tenofovir|tenofovir|mesh-list
139095960|NCT01340950|Lamivudine|lamivudine|mesh-list
139095961|NCT01340950|Zidovudine|zidovudine|mesh-list
139095962|NCT01340950|Efavirenz|efavirenz|mesh-list
139095963|NCT01340950|Nevirapine|nevirapine|mesh-list
139095964|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139095966|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138887348|NCT02713139|Metronidazole|metronidazole|mesh-list
139095967|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139095968|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139095969|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095970|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095971|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139095972|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139095973|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
139095974|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139095975|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139095976|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139095977|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139095978|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139095979|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139095980|NCT01341106|Entecavir|entecavir|mesh-list
139095981|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
139095982|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139095983|NCT01341184|Rifampin|rifampin|mesh-list
139095984|NCT01341184|Rifabutin|rifabutin|mesh-list
139095985|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139095986|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
139095987|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139095988|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139095989|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
139095990|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139095991|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139095992|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139095993|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139095994|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139095995|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139095996|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139095997|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139095998|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139095999|NCT00285857|Lovastatin|lovastatin|mesh-list
139096000|NCT00285857|L 647318|l 647318|mesh-list
139096001|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
139096002|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139096003|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
139096004|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096005|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139096006|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139096007|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139096008|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096009|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
139096010|NCT01341262|Thalidomide|thalidomide|mesh-list
139096011|NCT01341262|Dexamethasone|dexamethasone|mesh-list
139096012|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
139096013|NCT01341262|Melphalan|melphalan|mesh-list
139096014|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139096015|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
139096016|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096017|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139096019|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
139096020|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096021|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096022|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139096023|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096024|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
139096025|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
139096026|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096027|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139096028|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
139096029|NCT01341262|Hormones|hormones|mesh-ancestor
139096030|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139096031|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139096032|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
139096033|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139096034|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139096035|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138846622|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139096036|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139096038|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
139096039|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139096040|NCT01341340|Everolimus|everolimus|mesh-list
139096041|NCT01341340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139096042|NCT01341340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139096043|NCT01341340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096044|NCT01341340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096045|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139096046|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
139096047|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096048|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096049|NCT01341496|Celecoxib|celecoxib|mesh-list
139096050|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
139096051|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139096052|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
139096053|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096054|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139096055|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139096056|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
139096057|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096058|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096059|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139096060|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139096061|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139096062|NCT01341496|Analgesics|analgesics|mesh-ancestor
139096063|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
139096064|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096065|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096066|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139096067|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139096068|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096069|NCT00284141|Aflibercept|aflibercept|mesh-list
139096070|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139096071|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139031415|NCT00445770|Analgesics|analgesics|mesh-ancestor
139096072|NCT00284141|Growth Substances|growth substances|mesh-ancestor
139096073|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096074|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
139096075|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096076|NCT05182138|Zinc|zinc|mesh-list
139096077|NCT05182138|Trace Elements|trace elements|mesh-ancestor
139096078|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
139096079|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096080|NCT01315990|Cetuximab|cetuximab|mesh-list
139096081|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139096082|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096083|NCT00265343|Olanzapine|olanzapine|mesh-list
139096084|NCT00265343|Asenapine|asenapine|mesh-list
139096085|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
139096086|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
139096087|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096088|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096089|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139096090|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139096091|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139096092|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096093|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139096094|NCT00265343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139096095|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139096096|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139096097|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096098|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139096099|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
139096100|NCT01341886|Metformin|metformin|mesh-list
139096101|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139096102|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096103|NCT00283595|Hormones|hormones|mesh-list
139096104|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139096105|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096106|NCT00265109|Levetiracetam|levetiracetam|mesh-list
139096107|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
139096108|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
139096109|NCT01342198|Erythromycin|erythromycin|mesh-list
139096110|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
139096111|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139096112|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
139096113|NCT01342198|Pregabalin|pregabalin|mesh-list
139096114|NCT01342198|Analgesics|analgesics|mesh-ancestor
139096115|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
139096116|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096117|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096118|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
139096119|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139096120|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139096121|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096122|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139096123|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139096124|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139096125|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096126|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139096127|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139096128|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139096129|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139096130|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139096131|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096133|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139096134|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096135|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
139096136|NCT05150782|Curcumin|curcumin|mesh-list
139096137|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
139096138|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096139|NCT05150782|Protective Agents|protective agents|mesh-ancestor
139096140|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096142|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
139096143|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139096144|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139096145|NCT05150782|Analgesics|analgesics|mesh-ancestor
139096146|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
139096147|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096148|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096149|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139096150|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096151|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096152|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
139096153|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
139096154|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139096155|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
139096156|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096157|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139096158|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139096159|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139096160|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139096161|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096162|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139096163|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139096164|NCT00283049|Insulin|insulin|mesh-list
139096165|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139096166|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
139096167|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
139096168|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139096169|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096170|NCT00264875|Pregabalin|pregabalin|mesh-list
139096171|NCT00264875|Analgesics|analgesics|mesh-ancestor
139096172|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
139096173|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096174|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096175|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
139096176|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139096177|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139096178|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951049|NCT04055012|Metformin|metformin|mesh-list
139096179|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139096180|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139096181|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139096182|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096183|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139096184|NCT03635398|Midazolam|midazolam|mesh-list
139096185|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139096186|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139096187|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096188|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096189|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139096190|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139096191|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139096192|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139096193|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
139096195|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
139096196|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
139096197|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139096198|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096199|NCT03151408|Azacitidine|azacitidine|mesh-list
139096200|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139096201|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
139096202|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096203|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096204|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096205|NCT05226442|Heparin|heparin|mesh-list
139096206|NCT05226442|Calcium heparin|calcium heparin|mesh-list
139096207|NCT05226442|Argatroban|argatroban|mesh-list
139096208|NCT05226442|Anticoagulants|anticoagulants|mesh-ancestor
139096209|NCT05226442|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139096210|NCT05226442|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139096211|NCT05226442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096212|NCT05226442|Antithrombins|antithrombins|mesh-ancestor
139096213|NCT05226442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139096214|NCT05226442|Protease Inhibitors|protease inhibitors|mesh-ancestor
139096215|NCT05226442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096216|NCT05226442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139096217|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
139096218|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096219|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139096220|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096221|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096222|NCT05198128|Calcium|calcium|mesh-list
139096223|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139096224|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096226|NCT01316848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139096227|NCT01316848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096228|NCT01316848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096229|NCT02121184|Oxytocin|oxytocin|mesh-list
139096230|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
139096231|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139096232|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096233|NCT01485874|Doxorubicin|doxorubicin|mesh-list
139096234|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139096235|NCT01485874|Nintedanib|nintedanib|mesh-list
139096236|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139096237|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096238|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138951063|NCT03948074|Analgesics|analgesics|mesh-ancestor
139096239|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139096240|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096241|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096242|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139096243|NCT04786756|Bupivacaine|bupivacaine|mesh-list
139096244|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
139096245|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
139096246|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096247|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096248|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
139096249|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096250|NCT00546754|Losartan|losartan|mesh-list
139096251|NCT00546754|Valsartan|valsartan|mesh-list
139096252|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139096253|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139096254|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139096255|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139096256|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096257|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139096258|NCT00546754|Diuretics|diuretics|mesh-ancestor
139096259|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
139096260|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096261|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139096262|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139096263|NCT04768426|Capecitabine|capecitabine|mesh-list
139096264|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139096265|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
139096266|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096267|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096268|NCT04473508|Ropivacaine|ropivacaine|mesh-list
139096269|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
139096270|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
139096271|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096272|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096273|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
139096274|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096275|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
139096276|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139096277|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096278|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096279|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139096280|NCT04471402|Analgesics|analgesics|mesh-ancestor
139096281|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
139096282|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096283|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139096284|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139096285|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139096286|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
139096287|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139096288|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096289|NCT00282347|Acetaminophen|acetaminophen|mesh-list
139096290|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
139096291|NCT00282347|Promethazine|promethazine|mesh-list
139096292|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
139096294|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
139096295|NCT00282347|Rituximab|rituximab|mesh-list
139096296|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139096297|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096298|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
139096299|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096300|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139096301|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096302|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
139096303|NCT00282347|Hormones|hormones|mesh-ancestor
139096304|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139096305|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139096306|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139096307|NCT00282347|Analgesics|analgesics|mesh-ancestor
139096308|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
139096309|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096310|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
139096311|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139096312|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139096313|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
139096314|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139096315|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139096316|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096317|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096318|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
139096319|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
139096320|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139096321|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139096322|NCT00282347|Protective Agents|protective agents|mesh-ancestor
139096323|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139096324|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139096325|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096326|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
139096327|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
139096328|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139096329|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
139096330|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
139096331|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139096332|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139096333|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
139096334|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
139096335|NCT01334632|Morphine|morphine|mesh-list
139096336|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139096337|NCT01334632|Narcotics|narcotics|mesh-ancestor
139096338|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096339|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096340|NCT01334632|Analgesics|analgesics|mesh-ancestor
139096341|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
139096342|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096343|NCT00405964|Desloratadine|desloratadine|mesh-list
139096344|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139096345|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
139096346|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139096347|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096348|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096349|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139096350|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138951113|NCT03864926|Tacrolimus|tacrolimus|mesh-list
139096351|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
139096352|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
139096353|NCT00264797|Methylphenidate|methylphenidate|mesh-list
139096354|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139096355|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096356|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139096357|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139096358|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139096359|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096360|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
139096361|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139096362|NCT03148756|Dalbavancin|dalbavancin|mesh-list
139096363|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139096364|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139096365|NCT01343680|Heparin|heparin|mesh-list
139096366|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
139096367|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139096368|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139096369|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096370|NCT00281957|Sirolimus|sirolimus|mesh-list
139096371|NCT00281957|Sorafenib|sorafenib|mesh-list
139096372|NCT00281957|Temsirolimus|temsirolimus|mesh-list
139096373|NCT00281957|Tipifarnib|tipifarnib|mesh-list
139096374|NCT00281957|MTOR Inhibitors|mtor inhibitors|mesh-list
139031559|NCT00543569|Alefacept|alefacept|mesh-list
139096375|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096376|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139096377|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096378|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096379|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139096380|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
139096381|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096382|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139096383|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139096384|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139096385|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
139096386|NCT01071161|Azithromycin|azithromycin|mesh-list
139096387|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139096388|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139096389|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
139096390|NCT01070225|Propranolol|propranolol|mesh-list
139096391|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096392|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139096393|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139096394|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
139096395|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139096396|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096397|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096398|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139096399|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139096400|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
139096401|NCT01070615|Prucalopride|prucalopride|mesh-list
139096402|NCT01070615|Laxatives|laxatives|mesh-ancestor
139096403|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139096404|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139096405|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139096406|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
139096407|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951120|NCT03836261|Venetoclax|venetoclax|mesh-list
138951125|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
139096408|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096409|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096410|NCT00262925|Leucovorin|leucovorin|mesh-list
139096411|NCT00262925|Dexamethasone|dexamethasone|mesh-list
139096412|NCT00262925|Methotrexate|methotrexate|mesh-list
139096413|NCT00262925|Vincristine|vincristine|mesh-list
139096414|NCT00262925|Asparaginase|asparaginase|mesh-list
139096415|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
139096416|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
139096417|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139096418|NCT00262925|Antibodies|antibodies|mesh-list
139096419|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
139096420|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139096421|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
139096422|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
139096423|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096424|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096425|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
139096426|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
139096427|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096428|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139096429|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
139096430|NCT00262925|Hormones|hormones|mesh-ancestor
139096431|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139096432|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139096433|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096434|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139096435|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
139096436|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139096437|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139096438|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
139096439|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096440|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
139096441|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096442|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139096443|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139096444|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139096445|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139096446|NCT00262925|Antidotes|antidotes|mesh-ancestor
139096447|NCT00262925|Protective Agents|protective agents|mesh-ancestor
139096448|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
139096449|NCT00262925|Vitamins|vitamins|mesh-ancestor
139096450|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
139096451|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139096452|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
139096453|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
139096454|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
139096455|NCT01581515|Everolimus|everolimus|mesh-list
139096456|NCT01581515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139096457|NCT01581515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139096458|NCT01581515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096459|NCT01581515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096460|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139096461|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
139096462|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096463|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096464|NCT03720470|Abrocitinib|abrocitinib|mesh-list
139096465|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139096466|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096467|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096469|NCT00262847|Bevacizumab|bevacizumab|mesh-list
139096470|NCT00262847|Carboplatin|carboplatin|mesh-list
139096471|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139096472|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139096473|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
139096474|NCT00262847|Antibodies|antibodies|mesh-list
139096475|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
139096476|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139096477|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
139096478|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138951139|NCT03643107|Prednisolone|prednisolone|mesh-list
139096479|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096480|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
139096481|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
139096482|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
139096483|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096484|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139096485|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139096486|NCT00262847|Growth Substances|growth substances|mesh-ancestor
139096487|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096488|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
139096489|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
139096490|NCT05329532|Pembrolizumab|pembrolizumab|mesh-list
139096491|NCT05329532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139096492|NCT05329532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096493|NCT05329532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139096494|NCT05329532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096495|NCT01303640|Everolimus|everolimus|mesh-list
139096496|NCT01303640|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139096497|NCT01303640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139096498|NCT01303640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096499|NCT01303640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096500|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139096501|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
139096502|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096503|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096504|NCT03817268|Capecitabine|capecitabine|mesh-list
139096505|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139096506|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
139096507|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096508|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096509|NCT00280397|Lenvatinib|lenvatinib|mesh-list
139096510|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096511|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139096512|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096513|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096514|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
139096515|NCT03817112|Propofol|propofol|mesh-list
139096516|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139096517|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096518|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096519|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139096520|NCT03817112|Analgesics|analgesics|mesh-ancestor
139096521|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
139096522|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096523|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139096524|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139096525|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139096526|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
139096527|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139096528|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096529|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139096530|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
139096531|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
139096532|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139096533|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139096534|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139096535|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
139096536|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096537|NCT03814148|Indapamide|indapamide|mesh-list
139096538|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139096539|NCT03814148|Diuretics|diuretics|mesh-ancestor
139096540|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
139096541|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096542|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139096543|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139096544|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096546|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139096547|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096548|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
139096549|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096550|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139096551|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
139096552|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139096553|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
139096554|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096555|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
139096556|NCT03800810|Protective Agents|protective agents|mesh-ancestor
139096557|NCT03974867|Prednisone|prednisone|mesh-list
139096558|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
139096559|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139096560|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139096561|NCT03974867|Prednisolone|prednisolone|mesh-list
139096562|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
138847147|NCT05904912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096563|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139096565|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096566|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
139096567|NCT03974867|Hormones|hormones|mesh-ancestor
139096568|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139096569|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096570|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139096571|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096572|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
139096573|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
139096574|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096575|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139096576|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139096577|NCT03974867|Protective Agents|protective agents|mesh-ancestor
139096578|NCT03799406|Vitamin D|vitamin d|mesh-list
139096579|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
139096580|NCT03799406|Vitamins|vitamins|mesh-ancestor
139096581|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
139096582|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096583|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139096584|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139096585|NCT03799172|Echinocandins|echinocandins|mesh-list
139096586|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
139096587|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139096588|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
139096589|NCT03799094|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139096590|NCT03799094|Vitamins|vitamins|mesh-ancestor
139096591|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
139096592|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096593|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
139096594|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096595|NCT03799094|Protective Agents|protective agents|mesh-ancestor
139096596|NCT03799094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139096597|NCT03799094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096598|NCT00277355|Minocycline|minocycline|mesh-list
139096599|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139096600|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139096601|NCT00262223|Sertraline|sertraline|mesh-list
139096602|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
139096603|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139096604|NCT00262223|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139096605|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138951157|NCT03619707|Progesterone|progesterone|mesh-list
139096606|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139096607|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096608|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139096609|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
139096610|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096611|NCT05575700|Ibuprofen|ibuprofen|mesh-list
139096612|NCT05575700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139096613|NCT05575700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139096614|NCT05575700|Analgesics|analgesics|mesh-ancestor
139096615|NCT05575700|Sensory System Agents|sensory system agents|mesh-ancestor
139096616|NCT05575700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096617|NCT05575700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096618|NCT05575700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096619|NCT05575700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139096620|NCT05575700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139096621|NCT05575700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096622|NCT05575700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096623|NCT00276419|Diclofenac|diclofenac|mesh-list
139096624|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139096625|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139096626|NCT00276419|Analgesics|analgesics|mesh-ancestor
139096627|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
139096628|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096629|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096630|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096631|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139096632|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139096633|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096634|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096635|NCT03798392|Anesthetics|anesthetics|mesh-list
139096636|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096637|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096638|NCT03816020|Niacinamide|niacinamide|mesh-list
139096639|NCT03816020|Niacin|niacin|mesh-list
139096640|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
139096641|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
139096642|NCT03816020|Vitamins|vitamins|mesh-ancestor
139096643|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
139096644|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096645|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139096646|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
139096647|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096648|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139096649|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
139096650|NCT03815864|Antibodies|antibodies|mesh-list
139096651|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
139096652|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
139096653|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096654|NCT03815942|Nivolumab|nivolumab|mesh-list
139096655|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139096656|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096657|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139096658|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096659|NCT01303874|Etanercept|etanercept|mesh-list
139096660|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139096661|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139096662|NCT01303874|Analgesics|analgesics|mesh-ancestor
139096663|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
139096664|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096665|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096666|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096667|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139096668|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139096669|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139096670|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
139096671|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139096672|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
139096673|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139096674|NCT01301612|Cisplatin|cisplatin|mesh-list
139096676|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096677|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139096678|NCT01303952|Eculizumab|eculizumab|mesh-list
139096679|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139096680|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139096681|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
139096682|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096683|NCT03970616|Durvalumab|durvalumab|mesh-list
139096684|NCT03970616|Tivozanib|tivozanib|mesh-list
139096685|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139096686|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096687|NCT03970616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139096688|NCT03970616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096689|NCT03970616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096690|NCT03815474|Epirubicin|epirubicin|mesh-list
139096691|NCT03815474|Ifosfamide|ifosfamide|mesh-list
139096692|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139096693|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096694|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139096695|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139096696|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096697|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096698|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139096699|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
139096700|NCT01302158|Glimepiride|glimepiride|mesh-list
139096701|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
139096702|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139096703|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139096704|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096705|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139096706|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
139096707|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139096708|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096709|NCT01302236|Eplerenone|eplerenone|mesh-list
139096710|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139096711|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
139096712|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139096713|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096714|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139096716|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
139096717|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139096718|NCT01304264|Maleic acid|maleic acid|mesh-list
139096719|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096720|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096721|NCT01304342|Fentanyl|fentanyl|mesh-list
139096722|NCT01304342|Remifentanil|remifentanil|mesh-list
139096723|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139096724|NCT01304342|Narcotics|narcotics|mesh-ancestor
139096725|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096726|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096727|NCT01304342|Analgesics|analgesics|mesh-ancestor
139096728|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
139096729|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096730|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139096731|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139096732|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
139096733|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
139096734|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139096735|NCT03653546|Gefitinib|gefitinib|mesh-list
139096736|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096737|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138951177|NCT03593408|Analgesics|analgesics|mesh-ancestor
139096738|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096739|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096740|NCT03812354|Nicotine|nicotine|mesh-list
139096741|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139096742|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
139096743|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096744|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096745|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139096746|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139096747|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
139096748|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139096749|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096750|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139096751|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
139096752|NCT03812120|Coagulants|coagulants|mesh-ancestor
139096753|NCT03796364|Endostar protein|endostar protein|mesh-list
139096754|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139096755|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139096756|NCT03796364|Growth Substances|growth substances|mesh-ancestor
139096757|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096758|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
139096759|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096760|NCT03795584|Hemostatics|hemostatics|mesh-list
139096761|NCT03795584|Coagulants|coagulants|mesh-ancestor
139096762|NCT03792776|Lidocaine|lidocaine|mesh-list
139096763|NCT03792776|Anesthetics|anesthetics|mesh-list
139096764|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
139096765|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139096766|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096767|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
139096768|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096769|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139096770|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139096771|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139096772|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139096773|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096774|NCT03795272|Rucaparib|rucaparib|mesh-list
139096775|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139096776|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096777|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096778|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096779|NCT00956930|Doxorubicin|doxorubicin|mesh-list
139096780|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139096781|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139096782|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096783|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139096784|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139096786|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096787|NCT03792620|Daratumumab|daratumumab|mesh-list
139096788|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096790|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096791|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
139096792|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
139096793|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096794|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096795|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139096796|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
139096797|NCT05027594|Hormones|hormones|mesh-ancestor
139096798|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139096799|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139096800|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096801|NCT03811418|Docetaxel|docetaxel|mesh-list
139096802|NCT03811418|Trastuzumab|trastuzumab|mesh-list
139096803|NCT03811418|Vinorelbine|vinorelbine|mesh-list
139096804|NCT03811418|Pertuzumab|pertuzumab|mesh-list
139096805|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096806|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
138951187|NCT03593408|Narcotics|narcotics|mesh-ancestor
139096807|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
139096808|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
139096809|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096810|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139096811|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139096812|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
139096813|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
139096814|NCT03794492|Prednisolone|prednisolone|mesh-list
139096815|NCT03794492|Tacrolimus|tacrolimus|mesh-list
139096816|NCT03794492|Basiliximab|basiliximab|mesh-list
139096817|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139096818|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
139096819|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096820|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139096821|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096822|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096823|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139096824|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096825|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139096826|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
139096827|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139096828|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139096829|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096831|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
139096832|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096833|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139096834|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
139096835|NCT03794492|Hormones|hormones|mesh-ancestor
139096836|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139096837|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139096838|NCT03794492|Protective Agents|protective agents|mesh-ancestor
139096839|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139096840|NCT03792152|Warfarin|warfarin|mesh-list
139096841|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
139096842|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
139096843|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139096844|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
139096845|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139096846|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
139096847|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096848|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096849|NCT00262067|Bevacizumab|bevacizumab|mesh-list
139096850|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139096851|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096853|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139096854|NCT00262067|Growth Substances|growth substances|mesh-ancestor
139096855|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096856|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
139096857|NCT00275561|Fluticasone|fluticasone|mesh-list
139096858|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096859|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139096860|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
139096861|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096862|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096863|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139096864|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
139096865|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
139096866|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139096867|NCT03810872|Paclitaxel|paclitaxel|mesh-list
139096868|NCT03810872|Afatinib|afatinib|mesh-list
139096869|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139096870|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096871|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
139096872|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
139096873|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
139096874|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096875|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139096876|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096877|NCT03794180|Plonmarlimab|plonmarlimab|mesh-list
139096878|NCT03794180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096879|NCT03794180|Antiviral Agents|antiviral agents|mesh-ancestor
139096880|NCT03794180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139096881|NCT00274937|Cisplatin|cisplatin|mesh-list
139096882|NCT00274937|Fluorouracil|fluorouracil|mesh-list
139096883|NCT00274937|Amifostine|amifostine|mesh-list
139096884|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096885|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
139096886|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096887|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139096888|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139096889|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
139096890|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096891|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139096892|NCT00274937|Protective Agents|protective agents|mesh-ancestor
139096893|NCT03792074|Paclitaxel|paclitaxel|mesh-list
139096894|NCT03792074|Bevacizumab|bevacizumab|mesh-list
139096895|NCT03792074|Carboplatin|carboplatin|mesh-list
139096896|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139096897|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096898|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
139096899|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
139096900|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
139096901|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096902|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139096903|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139096904|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139096905|NCT03792074|Growth Substances|growth substances|mesh-ancestor
139096906|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096907|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
139096908|NCT00251693|Lansoprazole|lansoprazole|mesh-list
139096909|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
139096910|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139096911|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139096912|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139096914|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096915|NCT03791918|Lenvatinib|lenvatinib|mesh-list
139096916|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
139096917|NCT03791918|Antibodies|antibodies|mesh-list
139096918|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
139096919|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
139096920|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096921|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096922|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139096923|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096924|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096925|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139096926|NCT03791918|Estrogens|estrogens|mesh-ancestor
139096927|NCT03791918|Hormones|hormones|mesh-ancestor
139096928|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139096929|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139096930|NCT00250835|Celecoxib|celecoxib|mesh-list
139096931|NCT00250835|Capecitabine|capecitabine|mesh-list
139096932|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
139096933|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139096934|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
139096935|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096936|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096937|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139096938|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139096939|NCT00250835|Analgesics|analgesics|mesh-ancestor
138847531|NCT04860960|Betadex|betadex|mesh-list
139096940|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
139096941|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096942|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096943|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139096944|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139096945|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139096946|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139096947|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096949|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139096950|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
139096951|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096952|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139096953|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
139096954|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
139096955|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139096956|NCT03791762|Protective Agents|protective agents|mesh-ancestor
139096957|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096958|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
139096959|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139096960|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
139096961|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139096962|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096963|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139096964|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139096965|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139096966|NCT03789032|Rabeprazole|rabeprazole|mesh-list
139096967|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139096968|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139096969|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139096970|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096971|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096972|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
139096973|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139096974|NCT01306370|Hemostatics|hemostatics|mesh-list
139096975|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139096976|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139096977|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096978|NCT01306370|Coagulants|coagulants|mesh-ancestor
139096979|NCT03716024|Linezolid|linezolid|mesh-list
139096980|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139096981|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139096982|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139096983|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139096984|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096985|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
139096986|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139096987|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
139096988|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139096989|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139096990|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139096991|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
139096992|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139096993|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139096994|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139096995|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
139096996|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139096997|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139096998|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
139096999|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
139097000|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139097001|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
139097002|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097003|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
139097004|NCT03791294|Protective Agents|protective agents|mesh-ancestor
139097005|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
139097006|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139097007|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
139097008|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139097009|NCT01567358|Infliximab|infliximab|mesh-list
139097010|NCT01567358|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139097011|NCT01567358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139097012|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
139097013|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139097014|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139097015|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
139097016|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139097017|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097018|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097019|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139097020|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139097021|NCT01308242|Sevelamer|sevelamer|mesh-list
139097022|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
139097023|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
139097024|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097025|NCT01308320|Fentanyl|fentanyl|mesh-list
139097026|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139097028|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097029|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097030|NCT01308320|Analgesics|analgesics|mesh-ancestor
139097031|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
139097032|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097033|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139097034|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139097035|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
139097036|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
139097037|NCT01306760|Ketamine|ketamine|mesh-list
139097038|NCT01306760|Propofol|propofol|mesh-list
139097039|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139097040|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097041|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097042|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139097043|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
139097044|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
139097046|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
139097047|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097048|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139097049|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139097050|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139097051|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097052|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097053|NCT03787940|Isoniazid|isoniazid|mesh-list
139097054|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
139097055|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139097056|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097057|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139097058|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139097059|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
139097060|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097061|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139097062|NCT03788018|Lidocaine|lidocaine|mesh-list
139097063|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
139097064|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
139097065|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
139097066|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097067|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097068|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
139097069|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097070|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139097071|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139097072|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139097073|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139097074|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097075|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139097076|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139097077|NCT03788018|Analgesics|analgesics|mesh-ancestor
139097078|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139097079|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139097080|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139097081|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
139097082|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097083|NCT03785756|Ibuprofen|ibuprofen|mesh-list
139097084|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139097085|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139097086|NCT03785756|Analgesics|analgesics|mesh-ancestor
139097087|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
139097088|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031771|NCT00481832|Prednisolone|prednisolone|mesh-list
139097089|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097090|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139097091|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139097092|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139097093|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097094|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097095|NCT03788174|Apatinib|apatinib|mesh-list
139097096|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097097|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139097098|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097099|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097100|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139097101|NCT03787550|Analgesics|analgesics|mesh-list
139097102|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139097103|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097104|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
139097105|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097106|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097107|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097108|NCT03789890|Itraconazole|itraconazole|mesh-list
139097109|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
139097110|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097111|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139097112|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139097113|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097114|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097115|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139097116|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
139097117|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139097118|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097119|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139097120|NCT01308554|Bupivacaine|bupivacaine|mesh-list
139097121|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
139097122|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
139097123|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097124|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097125|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
139097126|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097127|NCT05693402|Analgesics, Opioid|analgesics, opioid|mesh-list
139097128|NCT05693402|Anesthetics|anesthetics|mesh-list
139097129|NCT05693402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097130|NCT05693402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097131|NCT05693402|Narcotics|narcotics|mesh-ancestor
139097132|NCT05693402|Analgesics|analgesics|mesh-ancestor
139097133|NCT05693402|Sensory System Agents|sensory system agents|mesh-ancestor
139097134|NCT05693402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097136|NCT05694728|Immunologic Factors|immunologic factors|mesh-ancestor
139097137|NCT05694728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097138|NCT01308632|Irinotecan|irinotecan|mesh-list
139097139|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139097140|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139097141|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097142|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097143|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097144|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
139097145|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139097146|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097147|NCT03785522|Insulin|insulin|mesh-list
139097148|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139097149|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097150|NCT05694416|Etoposide|etoposide|mesh-list
139031785|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139097151|NCT05694416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097152|NCT05694416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139097153|NCT05694416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139097154|NCT05694416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139097155|NCT05694416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097156|NCT05694416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097157|NCT03789422|Cetirizine|cetirizine|mesh-list
139097158|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
139097159|NCT03789422|Levocetirizine|levocetirizine|mesh-list
139097160|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139097161|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139097162|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097163|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
139097164|NCT03789422|Coagulants|coagulants|mesh-ancestor
139097165|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139097166|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139097167|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
139097168|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
139097169|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097170|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097171|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139097172|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139097173|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
139097174|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
139097175|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097176|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097177|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139097178|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139097179|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
139097180|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097181|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097182|NCT05690048|Vancomycin|vancomycin|mesh-list
139097183|NCT05690048|Bevacizumab|bevacizumab|mesh-list
139097184|NCT05690048|Atezolizumab|atezolizumab|mesh-list
139097185|NCT05690048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139097186|NCT05690048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097187|NCT05690048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139097188|NCT05690048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139097189|NCT05690048|Growth Substances|growth substances|mesh-ancestor
138616319|NCT00472420|Rituximab|rituximab|mesh-list
139097190|NCT05690048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097191|NCT05690048|Growth Inhibitors|growth inhibitors|mesh-ancestor
139097192|NCT05690048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139097193|NCT05690048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097194|NCT05690048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139097195|NCT05690048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097196|NCT01308086|Leucovorin|leucovorin|mesh-list
139097197|NCT01308086|Capecitabine|capecitabine|mesh-list
139097198|NCT01308086|Fluorouracil|fluorouracil|mesh-list
139097199|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
139097200|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
139097201|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139097202|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
139097203|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097204|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097205|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139097206|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
139097207|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097208|NCT01308086|Antidotes|antidotes|mesh-ancestor
139097209|NCT01308086|Protective Agents|protective agents|mesh-ancestor
139097210|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
139097211|NCT01308086|Vitamins|vitamins|mesh-ancestor
139097212|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
139097213|NCT05443802|Insulin|insulin|mesh-list
139097214|NCT05443802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139097215|NCT05443802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139097216|NCT05443802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097217|NCT01308944|Propranolol|propranolol|mesh-list
139097218|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139097219|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139097220|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
139097221|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097222|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097223|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097224|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139097225|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139097226|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
139097227|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
139097228|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139097229|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139097230|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097231|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
139097232|NCT03777488|Coagulants|coagulants|mesh-ancestor
139097233|NCT03777254|RC28-E protein|rc28-e protein|mesh-list
139097234|NCT03777254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139097235|NCT03777254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139097236|NCT03777254|Growth Substances|growth substances|mesh-ancestor
139097237|NCT03777254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097238|NCT03777254|Growth Inhibitors|growth inhibitors|mesh-ancestor
138847823|NCT04430738|Vitamins|vitamins|mesh-ancestor
139097239|NCT03777254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097240|NCT01312298|Bupivacaine|bupivacaine|mesh-list
139097241|NCT01312298|Anesthetics|anesthetics|mesh-list
139097243|NCT01312298|Succinylcholine|succinylcholine|mesh-list
139097244|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
139097245|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097246|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097247|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
139097248|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097249|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139097250|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139097251|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
139097252|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139097253|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139097254|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139097255|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
139097256|NCT01309022|Sirolimus|sirolimus|mesh-list
139097257|NCT01309022|Tacrolimus|tacrolimus|mesh-list
139097258|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139097259|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
139097260|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097261|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139097262|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097263|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097264|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138951260|NCT03258853|Pancrelipase|pancrelipase|mesh-list
139097265|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097266|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139097267|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
139097268|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139097269|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097271|NCT01560962|Azithromycin|azithromycin|mesh-list
139097272|NCT01560962|Tobramycin|tobramycin|mesh-list
139097273|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
139097274|NCT01560962|Povidone|povidone|mesh-list
139097275|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139097276|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097277|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
139097278|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
139097279|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139097281|NCT05401058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139097282|NCT05401058|Antiemetics|antiemetics|mesh-ancestor
139097283|NCT05401058|Autonomic Agents|autonomic agents|mesh-ancestor
139097284|NCT05401058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097285|NCT05401058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097286|NCT05401058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139097287|NCT05401058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139097288|NCT05401058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139097289|NCT05401058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097290|NCT05401058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139097291|NCT05401058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139097292|NCT05401058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139097293|NCT05401058|Dopamine Agents|dopamine agents|mesh-ancestor
139097294|NCT05401058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097295|NCT05401058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097296|NCT03781466|Progesterone|progesterone|mesh-list
139097297|NCT03781466|Progestins|progestins|mesh-ancestor
139097298|NCT03781466|Hormones|hormones|mesh-ancestor
139097299|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139097300|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097301|NCT03150862|Pamiparib|pamiparib|mesh-list
139097302|NCT03150862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139097303|NCT03150862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097304|NCT03150862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097305|NCT03150862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097306|NCT01318928|Metronidazole|metronidazole|mesh-list
139097307|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097308|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139097309|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139097310|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139097311|NCT01309178|Mannitol|mannitol|mesh-list
139097312|NCT01309178|Amitriptyline|amitriptyline|mesh-list
139097313|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139097314|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
138847903|NCT04166331|Dobutamine|dobutamine|mesh-list
139097315|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139097316|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139097317|NCT01309178|Analgesics|analgesics|mesh-ancestor
139097318|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
139097319|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097320|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097321|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139097322|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139097323|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139097324|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097325|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
139097326|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097327|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139097328|NCT01309178|Diuretics|diuretics|mesh-ancestor
139097329|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
139097330|NCT01335334|Metronidazole|metronidazole|mesh-list
139097331|NCT01335334|Tetracycline|tetracycline|mesh-list
139097332|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
139097333|NCT01335334|Omeprazole|omeprazole|mesh-list
139097334|NCT01335334|Bismuth|bismuth|mesh-list
139097335|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097336|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139097337|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139097338|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139097339|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139097340|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139097341|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139097342|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097343|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097344|NCT01335334|Antacids|antacids|mesh-ancestor
139097345|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139097347|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
139097348|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
139097349|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
139097350|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097351|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097352|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139097353|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139097354|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097355|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097356|NCT01320020|Catumaxomab|catumaxomab|mesh-list
139097357|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139097358|NCT00379288|Fluticasone|fluticasone|mesh-list
139097360|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
139097361|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139097362|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139097363|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139097364|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139097365|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
139097366|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097367|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097368|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139097369|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
139097370|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
139097371|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139097372|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139097373|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139097374|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139097375|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
139097376|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097377|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097378|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
139097379|NCT00379288|Hormones|hormones|mesh-ancestor
139097380|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139097381|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
139097382|NCT03784040|Nivolumab|nivolumab|mesh-list
139097383|NCT03784040|Ipilimumab|ipilimumab|mesh-list
139097384|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139097385|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097386|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139097387|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097388|NCT00243503|Trastuzumab|trastuzumab|mesh-list
139097389|NCT00243503|Sunitinib|sunitinib|mesh-list
139097390|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139097391|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097392|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139097393|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139097394|NCT00243503|Growth Substances|growth substances|mesh-ancestor
139097395|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097396|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
139097397|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139097398|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097399|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097400|NCT03780686|Dopamine|dopamine|mesh-list
139097401|NCT03780686|Norepinephrine|norepinephrine|mesh-list
139097402|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139097403|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139097404|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
139097405|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097406|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097407|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097408|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
139097409|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
139097410|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097411|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139097412|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139097414|NCT03780686|Protective Agents|protective agents|mesh-ancestor
139097416|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
139097417|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097418|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097419|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097420|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
139097421|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097422|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139097423|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139097424|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
139097425|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139097426|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139097427|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139097428|NCT03775928|Capecitabine|capecitabine|mesh-list
139097429|NCT03775928|Apatinib|apatinib|mesh-list
139097430|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139097431|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
139097432|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097433|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097434|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139097435|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097436|NCT03775538|Dopamine|dopamine|mesh-list
139097437|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139097438|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
139097439|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
139097440|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097441|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097442|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
139097443|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097444|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097445|NCT03775538|Protective Agents|protective agents|mesh-ancestor
139097446|NCT00259649|Eletriptan|eletriptan|mesh-list
139097447|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139097448|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
139097449|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097450|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097451|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097452|NCT01320176|Vaccines|vaccines|mesh-list
139097453|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
139097454|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097455|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139097456|NCT01335646|Analgesics|analgesics|mesh-list
139097457|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
139097458|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097459|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097460|NCT01309412|Siltuximab|siltuximab|mesh-list
139097461|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097462|NCT00307060|Losartan|losartan|mesh-list
139097463|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139097464|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138848049|NCT03847428|Bevacizumab|bevacizumab|mesh-list
139097465|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139097466|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139097467|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139097468|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097469|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097471|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
139097472|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139097473|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139097475|NCT01320254|Gemcitabine|gemcitabine|mesh-list
139097476|NCT01320254|Panitumumab|panitumumab|mesh-list
139097477|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139097478|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097479|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139097480|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
139097481|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097482|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139097483|NCT00092638|Ezetimibe|ezetimibe|mesh-list
139097484|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139097485|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139097486|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
139097487|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097488|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139097489|NCT03783728|Pyridoxine|pyridoxine|mesh-list
139097490|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
139097491|NCT03783728|Isoniazid|isoniazid|mesh-list
139097492|NCT03783728|Rifapentine|rifapentine|mesh-list
139097493|NCT03783728|Vitamins|vitamins|mesh-ancestor
139097494|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
139097495|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097496|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
139097497|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
139097498|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139097499|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097500|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139097501|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139097502|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
139097503|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097504|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139097505|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139097506|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
139097507|NCT03620422|Mannitol|mannitol|mesh-list
139097508|NCT03620422|Albuterol|albuterol|mesh-list
139097509|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139097510|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
139097511|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097512|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097513|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139097514|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
139097515|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
139097516|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139097517|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139097518|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139097519|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139097520|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
139097521|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097522|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097523|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139097524|NCT03620422|Diuretics|diuretics|mesh-ancestor
139097525|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
139097526|NCT01309490|Ribavirin|ribavirin|mesh-list
139097527|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
139097528|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097529|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
139097530|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097531|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139097532|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139097533|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139097534|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
139097535|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097536|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139097537|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139097538|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097539|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
139097540|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097541|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139097542|NCT03774836|Morphine|morphine|mesh-list
139097543|NCT03774836|Tramadol|tramadol|mesh-list
139097544|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139097545|NCT03774836|Narcotics|narcotics|mesh-ancestor
139097546|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097547|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097548|NCT03774836|Analgesics|analgesics|mesh-ancestor
139097549|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
139097550|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097551|NCT03774680|Cetuximab|cetuximab|mesh-list
139097552|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139097553|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097554|NCT03783338|Vitamin D|vitamin d|mesh-list
139097555|NCT03783338|Vitamins|vitamins|mesh-ancestor
139097556|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
139097557|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097558|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139097559|NCT03774524|Misoprostol|misoprostol|mesh-list
139097560|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139097561|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
139097562|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139097563|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097564|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139097565|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139097567|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
139097568|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
139097569|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139097570|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
139097571|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097572|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139097573|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139097574|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
139097575|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097576|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097577|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139097578|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139097579|NCT03773744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139097580|NCT03779516|Lidocaine|lidocaine|mesh-list
139097581|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
139097582|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
139097583|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097584|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097585|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
139097586|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097587|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139097588|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139031882|NCT00987779|Gabapentin|gabapentin|mesh-list
139097589|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139097590|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139097591|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097592|NCT03779594|Acetazolamide|acetazolamide|mesh-list
139097593|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
139097594|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139097595|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951385|NCT02501096|Lenvatinib|lenvatinib|mesh-list
139097596|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097597|NCT03779594|Diuretics|diuretics|mesh-ancestor
139097598|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
139097599|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097600|NCT03779672|Memantine|memantine|mesh-list
139097601|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139097602|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139097603|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
139097604|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097605|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097606|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097607|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139097608|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139097609|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
139097610|NCT03779282|Ketamine|ketamine|mesh-list
139097611|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139097612|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097613|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097614|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138848210|NCT03472885|Eculizumab|eculizumab|mesh-list
139097615|NCT03779282|Analgesics|analgesics|mesh-ancestor
139097616|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
139097617|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097618|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139097619|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139097620|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139097621|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
139097622|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097623|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097624|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139097625|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139097626|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
139097627|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
139097628|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139097629|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139097630|NCT03773588|Propofol|propofol|mesh-list
139097631|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139097632|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616762|NCT00195533|Tazobactam|tazobactam|mesh-list
139097633|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097634|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139097635|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
139097636|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
139097637|NCT03773510|Trabectedin|trabectedin|mesh-list
139097638|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139097640|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097641|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097642|NCT03779360|Clindamycin|clindamycin|mesh-list
139097643|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
139097644|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
139097645|NCT03779360|Erythromycin|erythromycin|mesh-list
139097646|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
139097647|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139097648|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
139097649|NCT03779360|Prednisolone|prednisolone|mesh-list
139097650|NCT03779360|Clobetasol|clobetasol|mesh-list
139097651|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139097652|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
139097653|NCT03779360|Hormones|hormones|mesh-ancestor
139097654|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139097655|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097656|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139097657|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097658|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139097659|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139097660|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097661|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139097662|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097663|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097664|NCT01320878|Iloprost|iloprost|mesh-list
139097665|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139097666|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139097667|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
139097669|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139097670|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
139097671|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097672|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139097673|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
139097674|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
139097675|NCT01321034|Vitamins|vitamins|mesh-ancestor
139097676|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
139097677|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097678|NCT03773042|Propofol|propofol|mesh-list
139097679|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139097680|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097681|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097682|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139097683|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
139097684|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
139097685|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139097686|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139097687|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
139097688|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848276|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
139097689|NCT03712280|Rifaximin|rifaximin|mesh-list
139097690|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
139097691|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139097692|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097693|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139097694|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139097695|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
139097696|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097697|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097698|NCT01561508|Butyric Acid|butyric acid|mesh-list
139097699|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
139097700|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
139097701|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097702|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031912|NCT01020734|Cyclosporine|cyclosporine|mesh-list
139097703|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097704|NCT03772262|Metformin|metformin|mesh-list
139097705|NCT03772262|Furosemide|furosemide|mesh-list
139097706|NCT03772262|Midazolam|midazolam|mesh-list
139097707|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139097708|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139097709|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097710|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139097711|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139097712|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097713|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139097714|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139097715|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139097716|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139097717|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
139097718|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
139097719|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
139097720|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
139097721|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097722|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097723|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139097724|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139097725|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
139097726|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139097727|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139097728|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097729|NCT03772262|Diuretics|diuretics|mesh-ancestor
139097730|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
139097731|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139097732|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139097733|NCT03772106|Propofol|propofol|mesh-list
139097734|NCT03772106|Sevoflurane|sevoflurane|mesh-list
139097735|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139097736|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097737|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097738|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139097739|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
139097740|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
139097741|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139097742|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139097743|NCT01345240|Vaccines|vaccines|mesh-list
139097744|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
139097745|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097746|NCT03771638|Tenofovir|tenofovir|mesh-list
139097747|NCT03771638|Emtricitabine|emtricitabine|mesh-list
139097748|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
139097749|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097750|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139097751|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139097752|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097753|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097754|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139097755|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139097756|NCT00092560|Ezetimibe|ezetimibe|mesh-list
139097757|NCT00092560|Fenofibrate|fenofibrate|mesh-list
139097758|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139097759|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139097760|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
139097761|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097762|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139097763|NCT03769064|Methylphenidate|methylphenidate|mesh-list
139097764|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139097765|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097766|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139097767|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139097768|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139097769|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097771|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097772|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139097774|NCT00090298|Ezetimibe|ezetimibe|mesh-list
139097775|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139097776|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139097777|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
139097778|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097779|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139097780|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139097781|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097782|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
139097783|NCT03771092|Hematinics|hematinics|mesh-ancestor
139097784|NCT03768908|Artesunate|artesunate|mesh-list
139097785|NCT03768908|Lumefantrine|lumefantrine|mesh-list
139097786|NCT03768908|Artemether|artemether|mesh-list
139097787|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139097788|NCT03768908|Amodiaquine|amodiaquine|mesh-list
139097789|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
139097790|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139097791|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139097792|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097793|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097794|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
139097795|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
139097796|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139097797|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
139097798|NCT03777878|Oxytocin|oxytocin|mesh-list
139097799|NCT03777878|Carbetocin|carbetocin|mesh-list
139097800|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
139097801|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139097802|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097803|NCT03246958|Nivolumab|nivolumab|mesh-list
139097804|NCT03246958|Ipilimumab|ipilimumab|mesh-list
139097805|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139097806|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097807|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139097808|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097809|NCT01321268|Beta Carotene|beta carotene|mesh-list
139097810|NCT01321268|Lycopene|lycopene|mesh-list
139097811|NCT01321268|Resveratrol|resveratrol|mesh-list
139097812|NCT01321268|Carotenoids|carotenoids|mesh-list
139097813|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
139097814|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097815|NCT01321268|Protective Agents|protective agents|mesh-ancestor
139097816|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097817|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097818|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139097819|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139097820|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139097821|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139097822|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097823|NCT01321268|Provitamins|provitamins|mesh-ancestor
139097824|NCT01321268|Vitamins|vitamins|mesh-ancestor
139097825|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
139097826|NCT01335958|DMUC5754A|dmuc5754a|mesh-list
139097827|NCT01335958|Immunoconjugates|immunoconjugates|mesh-ancestor
139097828|NCT01335958|Immunologic Factors|immunologic factors|mesh-ancestor
138951450|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
139097829|NCT01335958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097830|NCT01561274|Bupivacaine|bupivacaine|mesh-list
139097831|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
139097832|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
139097833|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097834|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097835|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
139097836|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097837|NCT02882854|Guanfacine|guanfacine|mesh-list
139097838|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139097839|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139097840|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139097841|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139097842|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
139097843|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097844|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097845|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097846|NCT03770936|Candesartan|candesartan|mesh-list
139097847|NCT03770936|Candesartan cilexetil|candesartan cilexetil|mesh-list
139097848|NCT03770936|Ramipril|ramipril|mesh-list
139097849|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139097850|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139097851|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139097852|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097853|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139097854|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
139097855|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097856|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
139097857|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139097858|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097859|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139097860|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139097861|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097862|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097863|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097864|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139097865|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139097866|NCT01321346|Cytarabine|cytarabine|mesh-list
139097867|NCT01321346|Panobinostat|panobinostat|mesh-list
139097868|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139097869|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
139097870|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097871|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097872|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
139097873|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097874|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139097875|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
139097876|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097877|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139097878|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097879|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
139097880|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139097881|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139097882|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139097883|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139097884|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097885|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139097886|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097887|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139097888|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139097889|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097890|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139097891|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139097892|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
139097893|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097894|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
139097895|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139097896|NCT02118610|Analgesics|analgesics|mesh-ancestor
139097897|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
139097898|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097899|NCT01561742|Minocycline|minocycline|mesh-list
139097900|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139097901|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139097902|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139097903|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097904|NCT01345708|Prednisone|prednisone|mesh-list
139097905|NCT01345708|Rituximab|rituximab|mesh-list
139097906|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139097907|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097908|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
139097909|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097910|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139097911|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139097912|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
139097913|NCT01345708|Hormones|hormones|mesh-ancestor
139097914|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139097915|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139097916|NCT01345864|Scopolamine|scopolamine|mesh-list
139097917|NCT01345864|Donepezil|donepezil|mesh-list
139097918|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139097919|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139097920|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097921|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097922|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
139097923|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097924|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097925|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
139097926|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139097927|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
139097928|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
139097929|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097930|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139097931|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
139097932|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139097933|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139097934|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
139097935|NCT04320602|Eculizumab|eculizumab|mesh-list
139097936|NCT04320602|Ravulizumab|ravulizumab|mesh-list
139097937|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139097938|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139097939|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
139097940|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097941|NCT03948022|Progesterone|progesterone|mesh-list
139097942|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
139097943|NCT03948022|Progestins|progestins|mesh-ancestor
139097944|NCT03948022|Hormones|hormones|mesh-ancestor
139097945|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139097946|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097947|NCT03777644|Morphine|morphine|mesh-list
139097948|NCT03777644|Ropivacaine|ropivacaine|mesh-list
139097949|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139097950|NCT03777644|Narcotics|narcotics|mesh-ancestor
138951481|NCT01267604|Inositol|inositol|mesh-list
139097951|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097952|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097954|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
139097955|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139097956|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
139097957|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
139097958|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
139097959|NCT04345666|Testosterone|testosterone|mesh-list
139097960|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
139097961|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
139097962|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139097963|NCT04345666|Androgens|androgens|mesh-ancestor
139097964|NCT04345666|Hormones|hormones|mesh-ancestor
139097965|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139097966|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097967|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139097968|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097969|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
139097970|NCT01336192|Gemcitabine|gemcitabine|mesh-list
139097971|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139097972|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
139097973|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097974|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139097975|NCT01336348|Tirofiban|tirofiban|mesh-list
139097976|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139097977|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139097978|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139097979|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139097980|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097981|NCT01346254|Pioglitazone|pioglitazone|mesh-list
139097982|NCT01346254|Vildagliptin|vildagliptin|mesh-list
139097983|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139097984|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139097985|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139097986|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
139097987|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139097988|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139097989|NCT04592536|Alprazolam|alprazolam|mesh-list
139097990|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139097991|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139097992|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138848574|NCT00880321|Midazolam|midazolam|mesh-list
139097993|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139097994|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139097995|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139097997|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
139097998|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139097999|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098000|NCT01336582|Docetaxel|docetaxel|mesh-list
139098001|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098002|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
139098003|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
139098004|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
139098005|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098006|NCT03149848|Rifabutin|rifabutin|mesh-list
139098007|NCT03149848|Cabotegravir|cabotegravir|mesh-list
139098008|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139098009|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098010|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139098012|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139098013|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139098014|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031974|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139098015|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098016|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139098017|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139098018|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
139098019|NCT01346800|Ritonavir|ritonavir|mesh-list
139098020|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139098021|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139098022|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139098023|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
139098024|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098025|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098026|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139098027|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139098028|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
139098029|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098030|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139098031|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139098032|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139098033|NCT03902314|Lidocaine|lidocaine|mesh-list
139098034|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
139098035|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
139098036|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139098037|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098038|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
139098039|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098040|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139098041|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139098042|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139098043|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139098044|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098045|NCT01336660|Antivenins|antivenins|mesh-list
139098046|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
139098047|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098048|NCT03768518|Exenatide|exenatide|mesh-list
139098049|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139098050|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098051|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139098052|NCT03768518|Incretins|incretins|mesh-ancestor
139098053|NCT03768518|Hormones|hormones|mesh-ancestor
139098054|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139098055|NCT04276376|Atezolizumab|atezolizumab|mesh-list
139098056|NCT04276376|Rucaparib|rucaparib|mesh-list
139098057|NCT04276376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139098058|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098059|NCT04276376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139098060|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098061|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139098062|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098064|NCT03770000|Tenalisib|tenalisib|mesh-list
139098065|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139098066|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138848658|NCT02783040|Digoxin|digoxin|mesh-list
139098067|NCT03770000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139098068|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098069|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098070|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139098071|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139098072|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139098073|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139098074|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
139098075|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098076|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098077|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139098078|NCT03158272|Nivolumab|nivolumab|mesh-list
139098079|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139098080|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098081|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138887411|NCT02615574|Celecoxib|celecoxib|mesh-list
139098082|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098083|NCT01431508|Losartan|losartan|mesh-list
139098084|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139098085|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139098086|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139098087|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139098088|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098089|NCT01321502|Famciclovir|famciclovir|mesh-list
139032021|NCT01070446|Choline|choline|mesh-list
139098090|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
139098091|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098092|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139098093|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098094|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098095|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139098096|NCT01347268|Hormones|hormones|mesh-ancestor
139098097|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139098098|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098099|NCT01347424|Paclitaxel|paclitaxel|mesh-list
139098100|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139098101|NCT01347424|Carboplatin|carboplatin|mesh-list
139098102|NCT01347424|Endostatins|endostatins|mesh-list
139098103|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139098104|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098105|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
139098106|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
139098107|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
139098108|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098109|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139098110|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139098111|NCT01347424|Growth Substances|growth substances|mesh-ancestor
139098112|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098113|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
139098114|NCT01322438|Rifampin|rifampin|mesh-list
139098115|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139098116|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
139098117|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139098118|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098119|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
139098120|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139098121|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098122|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098123|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139098124|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139098125|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139098126|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139098127|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139098128|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139098129|NCT00654628|Simvastatin|simvastatin|mesh-list
139098130|NCT00654628|Ezetimibe|ezetimibe|mesh-list
139098131|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139098132|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139098133|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
138951522|NCT00964834|Doxycycline|doxycycline|mesh-list
139098134|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098135|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139098136|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139098137|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098138|NCT00536380|Loratadine|loratadine|mesh-list
139098139|NCT00536380|Desloratadine|desloratadine|mesh-list
139098140|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139098141|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
139098142|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098143|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098144|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098145|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139098146|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139098147|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
139098148|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
139098149|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
139098150|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
139098151|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139098152|NCT01337362|Insulin|insulin|mesh-list
139098153|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139098154|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139098155|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098157|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139098158|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
139098159|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098160|NCT00496834|Losartan|losartan|mesh-list
139098161|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139098162|NCT00496834|Carvedilol|carvedilol|mesh-list
139098163|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139098164|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139098165|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139098166|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139098167|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098168|NCT00496834|Diuretics|diuretics|mesh-ancestor
139098169|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
139098170|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098171|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139098172|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139098173|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139098174|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139098175|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
139098176|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098177|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
139098178|NCT00496834|Protective Agents|protective agents|mesh-ancestor
139098179|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139098180|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139098181|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
139098182|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139098183|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139098184|NCT00189280|Imiquimod|imiquimod|mesh-list
139098185|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139098186|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
139098187|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098188|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098189|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
139098190|NCT01352494|Gemcitabine|gemcitabine|mesh-list
139098191|NCT01352494|Docetaxel|docetaxel|mesh-list
139098192|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139098193|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
139098194|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098195|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098196|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
139098197|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
139098198|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
139098199|NCT01347814|Domperidone|domperidone|mesh-list
139098200|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
139098201|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
139098202|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098203|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098204|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139098205|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139098206|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
139098207|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098208|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098209|NCT01348126|Docetaxel|docetaxel|mesh-list
139098210|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098211|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
139098212|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
139098213|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
139098214|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098215|NCT01348204|Quercetin|quercetin|mesh-list
139098216|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
139098217|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098218|NCT01348204|Protective Agents|protective agents|mesh-ancestor
139098219|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098220|NCT00166504|Atorvastatin|atorvastatin|mesh-list
139098221|NCT00166504|Simvastatin|simvastatin|mesh-list
139098222|NCT00166504|Ezetimibe|ezetimibe|mesh-list
139098223|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139098224|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139098225|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
139098226|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098227|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139098228|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138887412|NCT02615574|Vaccines|vaccines|mesh-list
139098229|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098230|NCT01348282|Rivastigmine|rivastigmine|mesh-list
139098231|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098232|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098233|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098234|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139098235|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
139098236|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098237|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139098238|NCT01348282|Protective Agents|protective agents|mesh-ancestor
139098239|NCT03137992|Bromides|bromides|mesh-list
139098240|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
139098241|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139098242|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
139098243|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098244|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098245|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139098246|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
139098247|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
139098248|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139098249|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
139098250|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098251|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098252|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
139098253|NCT04470778|Famotidine|famotidine|mesh-list
139098254|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139098255|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139098256|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139098257|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
139098258|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
139098259|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098260|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098261|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098263|NCT01352572|Mirtazapine|mirtazapine|mesh-list
139098264|NCT01352572|Sertraline|sertraline|mesh-list
139098265|NCT01352572|Fluoxetine|fluoxetine|mesh-list
139098266|NCT01352572|Paroxetine|paroxetine|mesh-list
139098267|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139098268|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
139098269|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
139098270|NCT01352572|Nortriptyline|nortriptyline|mesh-list
139098271|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139098272|NCT01352572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139098273|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139098274|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139098275|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098276|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098277|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
139098278|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098279|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139098280|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139098281|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139098282|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098283|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139098284|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139098285|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
139098286|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
139098287|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139098288|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139098289|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139098290|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139098291|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139098292|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139098293|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
139098294|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139098295|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139098296|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139098297|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139098298|NCT01352572|Analgesics|analgesics|mesh-ancestor
139098299|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
139098300|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098301|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139098302|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139098304|NCT01352650|Decitabine|decitabine|mesh-list
139098305|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139098306|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
139098307|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098308|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098309|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098310|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139098311|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139098312|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
139098313|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098314|NCT01352728|Axitinib|axitinib|mesh-list
139098315|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098316|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139098317|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098318|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098319|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
139098320|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139098321|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098322|NCT03997448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139098323|NCT03997448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098324|NCT03767660|Sirolimus|sirolimus|mesh-list
139098325|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139098326|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032152|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
139098327|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139098328|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098329|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
139098330|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139098331|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
139098332|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098333|NCT03767504|Thymol|thymol|mesh-list
139098334|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098335|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139098336|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
139098337|NCT01343290|Canagliflozin|canagliflozin|mesh-list
139098338|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139098339|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098340|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139098341|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098342|NCT03761264|Amoxicillin|amoxicillin|mesh-list
139098343|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
139098344|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098345|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139098346|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098347|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
139098348|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
139098349|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139098350|NCT03761264|Protective Agents|protective agents|mesh-ancestor
139098351|NCT05096312|Zinc|zinc|mesh-list
139098352|NCT05096312|Adapalene|adapalene|mesh-list
139098353|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
139098354|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139098355|NCT05096312|Trace Elements|trace elements|mesh-ancestor
139098356|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
139098357|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098358|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
139098359|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139098360|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139098361|NCT05096312|Analgesics|analgesics|mesh-ancestor
139098362|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
139098363|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098364|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139098365|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139098366|NCT03767036|Ketorolac|ketorolac|mesh-list
139098367|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139098369|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139098370|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139098371|NCT03767036|Analgesics|analgesics|mesh-ancestor
139098372|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
139098373|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098374|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098375|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139098376|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139098377|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139098379|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098380|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139098381|NCT03767036|Narcotics|narcotics|mesh-ancestor
139098382|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139098383|NCT03758144|Rifaximin|rifaximin|mesh-list
139098384|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139098385|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098386|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139098387|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
139098388|NCT03766724|Empagliflozin|empagliflozin|mesh-list
138951564|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139098389|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139098390|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098391|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139098392|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098393|NCT04860518|Dexamethasone|dexamethasone|mesh-list
139098394|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139098395|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
139098396|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
139098397|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098398|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098399|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139098400|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
139098401|NCT04860518|Hormones|hormones|mesh-ancestor
139098402|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139098403|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139098404|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098405|NCT03110380|Dolutegravir|dolutegravir|mesh-list
139098406|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139098407|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139098408|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139098409|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098410|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098411|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139098412|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139098413|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
139098414|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098415|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139098416|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139098417|NCT03757910|Corticosterone|corticosterone|mesh-list
139098418|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139098419|NCT01322204|Codeine|codeine|mesh-list
139098420|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139098421|NCT01322204|Narcotics|narcotics|mesh-ancestor
139098422|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139098423|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098424|NCT01322204|Analgesics|analgesics|mesh-ancestor
139098425|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
139098426|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098427|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
139098428|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
139098429|NCT03766490|Gefitinib|gefitinib|mesh-list
139098430|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098431|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139098432|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098433|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098434|NCT01348984|Fentanyl|fentanyl|mesh-list
139098435|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138849034|NCT00954707|Aspirin|aspirin|mesh-list
139098436|NCT01348984|Narcotics|narcotics|mesh-ancestor
139098437|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139098438|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098439|NCT01348984|Analgesics|analgesics|mesh-ancestor
139098440|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
139098441|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098442|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139098443|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139098444|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
139098445|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
139098446|NCT01567670|Naloxone|naloxone|mesh-list
139098447|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139098448|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098449|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
139098450|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098451|NCT01349062|Immunomodulating Agents|immunomodulating agents|mesh-list
139098452|NCT01349062|Immunologic Factors|immunologic factors|mesh-ancestor
139098453|NCT01349062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098455|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139098456|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139098457|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
139098458|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098459|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098460|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139098461|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
139098462|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
139098463|NCT04848662|Hormones|hormones|mesh-ancestor
139098464|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139098465|NCT04351256|Durvalumab|durvalumab|mesh-list
139098466|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139098468|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
139098469|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139098470|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098471|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139098472|NCT03700892|Protective Agents|protective agents|mesh-ancestor
139098473|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098474|NCT01322282|Cetirizine|cetirizine|mesh-list
139098475|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139098476|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139098477|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139098478|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
139098479|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
139098480|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098481|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098482|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098483|NCT03757364|Methotrexate|methotrexate|mesh-list
139098484|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139098485|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
139098486|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139098487|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098488|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139098489|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
139098490|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098491|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098492|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
139098493|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098494|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139098495|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139098496|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
139098497|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139098498|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139098499|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
139098500|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139098501|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098502|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
139098503|NCT04737278|Niacin|niacin|mesh-list
139098504|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
139098505|NCT04737278|Vitamins|vitamins|mesh-ancestor
139098506|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
139098507|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098508|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139098509|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
139098510|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098511|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139098512|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
139098513|NCT03759860|Ranibizumab|ranibizumab|mesh-list
139098514|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139098515|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139098516|NCT03759860|Growth Substances|growth substances|mesh-ancestor
139098517|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098518|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
139098519|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098520|NCT03759782|Tenofovir|tenofovir|mesh-list
139098521|NCT03759782|Ribavirin|ribavirin|mesh-list
139098522|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
139098523|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098524|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139098525|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139098526|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098527|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098528|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139098529|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139098530|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
139098531|NCT03757052|Amoxicillin|amoxicillin|mesh-list
139098532|NCT03757052|Penicillins|penicillins|mesh-list
139098533|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139098534|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098535|NCT03765944|Sirolimus|sirolimus|mesh-list
139098536|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139098537|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098538|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139098539|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098540|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
139098541|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139098542|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
139098543|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098544|NCT04684394|Aflibercept|aflibercept|mesh-list
139098545|NCT04684394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139098546|NCT04684394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139098547|NCT04684394|Growth Substances|growth substances|mesh-ancestor
139098548|NCT04684394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098549|NCT04684394|Growth Inhibitors|growth inhibitors|mesh-ancestor
139098550|NCT04684394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098551|NCT03765554|PF-06700841|pf-06700841|mesh-list
139098552|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139098553|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098554|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098555|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
139098556|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139098557|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139098558|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139098559|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098560|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139098561|NCT04668950|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139098562|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139098563|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139098564|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098565|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098566|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
139098567|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139098568|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
139098569|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139098570|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139098571|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032432|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139098572|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139098573|NCT03078478|Insulin|insulin|mesh-list
139098574|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139098575|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
139098576|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139098577|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098578|NCT01349296|Everolimus|everolimus|mesh-list
139098579|NCT01349296|Nintedanib|nintedanib|mesh-list
139098580|NCT01349296|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139098581|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139098582|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098583|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098584|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139098585|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
139098586|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098587|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098588|NCT03522844|Escitalopram|escitalopram|mesh-list
139098589|NCT03522844|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139098590|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139098591|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139098592|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098593|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098594|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
139098595|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098596|NCT00045942|Itraconazole|itraconazole|mesh-list
139098598|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
139098599|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098600|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139098601|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139098602|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098603|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098604|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139098605|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
139098606|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139098607|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098608|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139098609|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098610|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139098611|NCT04386616|Astegolimab|astegolimab|mesh-list
139098612|NCT04386616|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139098613|NCT04386616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139098614|NCT04386616|Antiviral Agents|antiviral agents|mesh-ancestor
139098615|NCT04386616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098616|NCT00045708|Epothilones|epothilones|mesh-list
139098617|NCT00045708|Epothilone B|epothilone b|mesh-list
139098618|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
139098619|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
139098620|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
139098621|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
139098622|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098623|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098624|NCT01349452|Ganciclovir|ganciclovir|mesh-list
139098625|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139098626|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
139098627|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139098628|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139098629|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
139098630|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098631|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139098632|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098633|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098634|NCT00045630|Paclitaxel|paclitaxel|mesh-list
139098635|NCT00045630|Carboplatin|carboplatin|mesh-list
139098636|NCT00045630|Gemcitabine|gemcitabine|mesh-list
139098637|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139098638|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098639|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
139098640|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
139098641|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
139098642|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098643|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139098644|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
139098645|NCT01357252|Vildagliptin|vildagliptin|mesh-list
139098646|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139098647|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098648|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139098649|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
139098650|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098651|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098652|NCT03465280|Interferons|interferons|mesh-list
139098653|NCT03465280|Acyclovir|acyclovir|mesh-list
139098654|NCT03465280|Cidofovir|cidofovir|mesh-list
139098655|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
139098656|NCT03465280|Artemisinins|artemisinins|mesh-list
139098657|NCT03465280|Artemisinin|artemisinin|mesh-list
139098658|NCT03465280|Celecoxib|celecoxib|mesh-list
139098659|NCT03465280|Methotrexate|methotrexate|mesh-list
139098660|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
139098661|NCT03465280|Isotretinoin|isotretinoin|mesh-list
139098662|NCT03465280|Cimetidine|cimetidine|mesh-list
139098663|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098664|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098665|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139098667|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139098668|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139098669|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
139098670|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098671|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
139098672|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098673|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139098674|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139098675|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
139098676|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139098677|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139098678|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
139098679|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098680|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139098681|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139098682|NCT03465280|Analgesics|analgesics|mesh-ancestor
139098683|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
139098684|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098685|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139098686|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139098687|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139098688|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139098689|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139098690|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139098691|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
139098692|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
139098693|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098694|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139098695|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139098696|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
139098697|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139098698|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139098699|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139098700|NCT03465280|Protective Agents|protective agents|mesh-ancestor
139098701|NCT01349764|Vitamin D|vitamin d|mesh-list
139098702|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
139098703|NCT01349764|Vitamins|vitamins|mesh-ancestor
139098704|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
139098705|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098706|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139098707|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139098708|NCT02924272|Ixazomib|ixazomib|mesh-list
139098709|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098710|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
139098711|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098712|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098713|NCT01353742|Lamivudine|lamivudine|mesh-list
139098714|NCT01353742|Adefovir|adefovir|mesh-list
139098715|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139098716|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139098717|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139098718|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098719|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098720|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
139098721|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098722|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139098723|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139098725|NCT00003702|Cactinomycin|cactinomycin|mesh-list
139098726|NCT00003702|Methotrexate|methotrexate|mesh-list
139098727|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139098728|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
139098729|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139098730|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098731|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139098732|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
139098733|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098734|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098735|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
139098736|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098737|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139098738|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139098739|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
139098740|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139098741|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139098742|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139098743|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098744|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139098745|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139098746|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
139098747|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
139098748|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139098749|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139098750|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098751|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098752|NCT01350154|Urological Agents|urological agents|mesh-ancestor
139098753|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
139098754|NCT00031590|Lomustine|lomustine|mesh-list
139098755|NCT00031590|Etoposide|etoposide|mesh-list
139098756|NCT00031590|Vincristine|vincristine|mesh-list
139098757|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139098758|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
139098759|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098760|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139098761|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139098762|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
139098763|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098764|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098765|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139098766|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139098767|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139098768|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139098769|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098770|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
139098771|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
139098772|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
139098773|NCT01318096|Tenofovir|tenofovir|mesh-list
139098774|NCT01318096|Lamivudine|lamivudine|mesh-list
139098775|NCT01318096|Efavirenz|efavirenz|mesh-list
139098776|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
139098777|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
139098778|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098779|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139098780|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139098781|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098782|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098783|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139098784|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139098785|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139098786|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139098787|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139098788|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139098789|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139098790|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139098791|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139098792|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139098793|NCT02530320|Palbociclib|palbociclib|mesh-list
139098794|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032673|NCT00989729|Prednisolone|prednisolone|mesh-list
139098795|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139098796|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098797|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098798|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139098799|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139098800|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139098801|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
139098802|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098803|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139098804|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139098805|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098807|NCT00238433|Busulfan|busulfan|mesh-list
139098808|NCT00238433|Thiotepa|thiotepa|mesh-list
139098809|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
138951671|NCT00610155|Pregabalin|pregabalin|mesh-list
139098810|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098811|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139098812|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
139098813|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098814|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098815|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139098816|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139098817|NCT02532023|Curcumin|curcumin|mesh-list
139098818|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139098819|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139098820|NCT02532023|Analgesics|analgesics|mesh-ancestor
139098821|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
139098822|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098823|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098824|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139098825|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139098826|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098827|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098828|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098829|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
139098830|NCT01354522|Docetaxel|docetaxel|mesh-list
139098831|NCT01354522|Doxorubicin|doxorubicin|mesh-list
139098832|NCT01354522|Capecitabine|capecitabine|mesh-list
139098833|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139098834|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
139098835|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098836|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139098837|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139098838|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
139098839|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098840|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098841|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139098842|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
139098843|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
139098844|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
139098845|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139098846|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139098847|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139098848|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098849|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139098850|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
139098851|NCT00045162|Irinotecan|irinotecan|mesh-list
139098852|NCT00045162|Etoposide|etoposide|mesh-list
139098853|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098854|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139098855|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139098856|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098857|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098858|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139098859|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139098860|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139098861|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139098862|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139098863|NCT00238121|Sorafenib|sorafenib|mesh-list
139098864|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098865|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139098866|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098867|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098868|NCT01350622|Diclofenac|diclofenac|mesh-list
139098869|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
139098870|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139098871|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139098872|NCT01350622|Analgesics|analgesics|mesh-ancestor
139098873|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
139098874|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098875|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098876|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139098877|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139098878|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139098879|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098880|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098881|NCT01096212|Sevoflurane|sevoflurane|mesh-list
139098882|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139098883|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139098884|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
139098885|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
139098886|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139098887|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098889|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139098890|NCT03139240|Narcotics|narcotics|mesh-ancestor
139098891|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139098892|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098893|NCT03139240|Analgesics|analgesics|mesh-ancestor
139098894|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
139098895|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139098896|NCT01350856|Artesunate|artesunate|mesh-list
139098897|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
139098898|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139098899|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139098900|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139098901|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098903|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
139098904|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139098905|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
139098906|NCT03973775|Permethrin|permethrin|mesh-list
139098907|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098908|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098909|NCT01351168|Levodopa|levodopa|mesh-list
139098910|NCT01351168|Zolpidem|zolpidem|mesh-list
139098911|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139098912|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139098913|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
139098914|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098915|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098916|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098917|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139098918|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139098919|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139098920|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139098921|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
139098922|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
139098923|NCT01351636|Arotinolol|arotinolol|mesh-list
139098924|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139098925|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139098926|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
139098927|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139098928|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098929|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098930|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139098931|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139098932|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139098933|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
139098934|NCT03952260|Anesthetics|anesthetics|mesh-list
139098935|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138951692|NCT00960544|Capecitabine|capecitabine|mesh-list
139098936|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098937|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139098938|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139098939|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
139098940|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098941|NCT01351948|Antacids|antacids|mesh-ancestor
139098942|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098943|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139098944|NCT01352026|Metformin|metformin|mesh-list
139098945|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139098946|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098947|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
139098948|NCT03136198|Diuretics|diuretics|mesh-list
139098949|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
139098950|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
139098951|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098952|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139098953|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098954|NCT01357486|Sorafenib|sorafenib|mesh-list
139098955|NCT01357486|Pravastatin|pravastatin|mesh-list
139098956|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098957|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139098958|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139098959|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098960|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139098961|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139098962|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
139098963|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139098964|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139098965|NCT01318564|Metformin|metformin|mesh-list
139098966|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139098967|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098968|NCT00042432|Cinacalcet|cinacalcet|mesh-list
139098969|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139098970|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098972|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
139098973|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139098974|NCT01352338|Prednisone|prednisone|mesh-list
139098975|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
139098976|NCT01352338|Lenalidomide|lenalidomide|mesh-list
139098977|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139098978|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
139098979|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139098980|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139098981|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139098982|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
139098983|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139098984|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098985|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139098986|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032914|NCT03742323|Idelalisib|idelalisib|mesh-list
139098987|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
139098988|NCT01352338|Hormones|hormones|mesh-ancestor
139098989|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139098990|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139098991|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139098992|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139098993|NCT01352338|Growth Substances|growth substances|mesh-ancestor
139098994|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
139098995|NCT01542736|Carboplatin|carboplatin|mesh-list
139098996|NCT01542736|Vincristine|vincristine|mesh-list
139098997|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139098998|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139098999|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
139099000|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
139099001|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
139099002|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099003|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139099004|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139099005|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139099006|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139099007|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
139099008|NCT01361542|Infliximab|infliximab|mesh-list
139099009|NCT01361542|Etanercept|etanercept|mesh-list
139099010|NCT01361542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139099011|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139099012|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
139099013|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139099014|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139099015|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139099016|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139099017|NCT01361542|Analgesics|analgesics|mesh-ancestor
139099018|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
139099019|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099020|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099021|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139099022|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
139099023|NCT03950700|Epinephrine|epinephrine|mesh-list
139099024|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139099025|NCT03950700|Bupivacaine|bupivacaine|mesh-list
139099026|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139099027|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
139099028|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
139099029|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139099030|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099031|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
139099032|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099033|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139099034|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139099035|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099036|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099037|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099038|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139099039|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139099040|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
139099041|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139099042|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
139099043|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
139099044|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
139099046|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099047|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139099048|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099049|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099050|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
139099051|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139099052|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139099053|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139099054|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139099055|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099056|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
139099057|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099058|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099059|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139099060|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099061|NCT00003222|Aldesleukin|aldesleukin|mesh-list
139099062|NCT00003222|Interleukin-2|interleukin-2|mesh-list
139099063|NCT00003222|Sargramostim|sargramostim|mesh-list
139099064|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
139099065|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099066|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139099067|NCT00003222|Analgesics|analgesics|mesh-ancestor
139099068|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
139099069|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099070|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099071|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
139099072|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139099073|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139099074|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
139099075|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099076|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139099078|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139099079|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099080|NCT02877082|Bortezomib|bortezomib|mesh-list
139099081|NCT02877082|Tacrolimus|tacrolimus|mesh-list
139099082|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
139099083|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139099084|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139099085|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
139099086|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099087|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139099088|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099089|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099090|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099091|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139099092|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139099093|NCT03951558|Diuretics|diuretics|mesh-ancestor
139099094|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
139099095|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099096|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139099097|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139099098|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099099|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139099100|NCT01362010|Minocycline|minocycline|mesh-list
139099101|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099102|NCT02875366|Ivacaftor|ivacaftor|mesh-list
139099103|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139099104|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139099105|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099106|NCT01362400|Docetaxel|docetaxel|mesh-list
139099107|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099108|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
139099109|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
139099110|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
139099111|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099113|NCT00002850|Ofloxacin|ofloxacin|mesh-list
139099114|NCT00002850|Trimethoprim|trimethoprim|mesh-list
138849713|NCT02778594|Levodopa|levodopa|mesh-list
139099115|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
139099116|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139099117|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099118|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139099119|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139099121|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099122|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099123|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139099124|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139099125|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139099126|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
139099127|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139099128|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139099129|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139099130|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139099131|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139099132|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
139099133|NCT04234906|Amiodarone|amiodarone|mesh-list
139099134|NCT04234906|Procainamide|procainamide|mesh-list
139099135|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
139099136|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139099137|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139099138|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099139|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139099140|NCT04234906|Analgesics|analgesics|mesh-ancestor
139099141|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
139099142|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099143|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139099144|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139099145|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139099146|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099147|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099148|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099149|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
139099150|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139099151|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
139099152|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139099153|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139099154|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139099155|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
139099156|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139099157|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
139099158|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139099159|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139099160|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139099161|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139099162|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099163|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139099164|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139099165|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139099166|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139099167|NCT00002766|Cytarabine|cytarabine|mesh-list
139099168|NCT00002766|Dactinomycin|dactinomycin|mesh-list
139099169|NCT00002766|Prednisone|prednisone|mesh-list
139099170|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
139099171|NCT00002766|Carmustine|carmustine|mesh-list
139099172|NCT00002766|Doxorubicin|doxorubicin|mesh-list
139099173|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139099174|NCT00002766|Methotrexate|methotrexate|mesh-list
139099175|NCT00002766|Etoposide|etoposide|mesh-list
139099176|NCT00002766|Vincristine|vincristine|mesh-list
139099177|NCT00002766|Daunorubicin|daunorubicin|mesh-list
139099178|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
139099179|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
139099180|NCT00002766|Pegaspargase|pegaspargase|mesh-list
139099181|NCT00002766|Sargramostim|sargramostim|mesh-list
139099182|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139099183|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
139099184|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099185|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139099186|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139099187|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
139099188|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099189|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099190|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139099191|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139099192|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139099193|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139099194|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099195|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139099197|NCT00002766|Hormones|hormones|mesh-ancestor
139099198|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139033108|NCT00438360|Cyclosporine|cyclosporine|mesh-list
139099199|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139099200|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139099201|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
139099202|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139099203|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139099204|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
139099205|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
139099206|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139099207|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139099208|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139099209|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
139099210|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099211|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
139099212|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
139099213|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
139099214|NCT00002766|Analgesics|analgesics|mesh-ancestor
139099215|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
139099216|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099217|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139099218|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139099219|NCT01355380|Iloprost|iloprost|mesh-list
139099220|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139099221|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
139099222|NCT01355614|Infliximab|infliximab|mesh-list
139099223|NCT01355614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139099224|NCT01355614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139099225|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
139099226|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139099227|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139099228|NCT01584492|Beclomethasone|beclomethasone|mesh-list
139099229|NCT01584492|Albuterol|albuterol|mesh-list
139099230|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
139099231|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139099232|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
139099233|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099234|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099235|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139099236|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
139099237|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139099238|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139099239|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139099240|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099241|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099242|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099243|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139099244|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
139099245|NCT01584492|Hormones|hormones|mesh-ancestor
139099246|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139099247|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
139099248|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139099249|NCT00001962|Daclizumab|daclizumab|mesh-list
139099250|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139099251|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
139099252|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099253|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139099254|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139099255|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
139099256|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139099257|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
139033146|NCT04002635|Letrozole|letrozole|mesh-list
139099258|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099259|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
139099260|NCT01101984|Protective Agents|protective agents|mesh-ancestor
139099261|NCT01103154|Nadolol|nadolol|mesh-list
139099262|NCT01103154|Carvedilol|carvedilol|mesh-list
139099263|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139099264|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139099265|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099266|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099267|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099268|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099269|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139099271|NCT01103154|Protective Agents|protective agents|mesh-ancestor
139099272|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139099273|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139099274|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139099275|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
139099276|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139099277|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139099278|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139099279|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
139099280|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
139099281|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099282|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139099283|NCT01100346|Hormones|hormones|mesh-ancestor
139099284|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139099285|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099286|NCT01103388|Rituximab|rituximab|mesh-list
139099287|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139099288|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099289|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
139099290|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099291|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139099292|NCT01327326|Naltrexone|naltrexone|mesh-list
139099293|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139099294|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139099295|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099296|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
139099297|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099298|NCT03950544|Meropenem|meropenem|mesh-list
139099299|NCT03950544|Fosfomycin|fosfomycin|mesh-list
139099300|NCT03950544|Tigecycline|tigecycline|mesh-list
139099301|NCT03950544|Polymyxins|polymyxins|mesh-list
139099302|NCT03950544|Polymyxin B|polymyxin b|mesh-list
139099303|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139099304|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099305|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139099306|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099307|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099309|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099310|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139099311|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099312|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099313|NCT00256997|Risperidone|risperidone|mesh-list
139099314|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
139099315|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139099316|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
139099317|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099318|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099319|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099320|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139099321|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139099322|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139099323|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139099324|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
139099325|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
139099326|NCT00027846|Carboplatin|carboplatin|mesh-list
139099327|NCT00027846|Etoposide|etoposide|mesh-list
139099328|NCT00027846|Vincristine|vincristine|mesh-list
139099329|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
139099330|NCT00027846|Lenograstim|lenograstim|mesh-list
139099331|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139099332|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
139099333|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099334|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139099335|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139099336|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
139099337|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099338|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099339|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139033193|NCT02533557|Lidocaine|lidocaine|mesh-list
139099340|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139099341|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139099342|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139099343|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099344|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139099345|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
139099346|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
139099347|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
139099348|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
139099349|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
139099350|NCT00027378|Fluoxetine|fluoxetine|mesh-list
139099351|NCT00027378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139099352|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139099353|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139099354|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099355|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099356|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
139099357|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099358|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139099359|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
139099360|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139099361|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139099362|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139099363|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099364|NCT03949062|Rituximab|rituximab|mesh-list
139099365|NCT03949062|Lenalidomide|lenalidomide|mesh-list
139099366|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139099367|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099368|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
139099369|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099370|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139099371|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139099372|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139099373|NCT03949062|Growth Substances|growth substances|mesh-ancestor
139099374|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
139099375|NCT00235391|Deferasirox|deferasirox|mesh-list
139099376|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139099378|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
139099379|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099380|NCT01103622|Digoxin|digoxin|mesh-list
139099381|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139099382|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139099383|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099384|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099385|NCT01103622|Protective Agents|protective agents|mesh-ancestor
139099386|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099387|NCT01072955|Heparin|heparin|mesh-list
139099388|NCT01072955|Calcium heparin|calcium heparin|mesh-list
139099389|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
139099390|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139099391|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139099392|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099393|NCT00026208|Prednisone|prednisone|mesh-list
139099394|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
139099395|NCT00026208|Doxorubicin|doxorubicin|mesh-list
139099396|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139099397|NCT00026208|Etoposide|etoposide|mesh-list
139099398|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
139099399|NCT00026208|Vincristine|vincristine|mesh-list
139099400|NCT00026208|Bleomycin|bleomycin|mesh-list
139099401|NCT00026208|Vinblastine|vinblastine|mesh-list
139099402|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139099403|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
139099404|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099405|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139099406|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139099407|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
139099408|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099409|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099410|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139099411|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139099412|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139099413|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139099414|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099415|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139099416|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
138850005|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099417|NCT00026208|Hormones|hormones|mesh-ancestor
139099418|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139099419|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139099420|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139099421|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
139099422|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
139099423|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
139099424|NCT00025662|Interleukin-2|interleukin-2|mesh-list
139099425|NCT00025662|Immunotoxins|immunotoxins|mesh-list
139099426|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099427|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139099428|NCT00025662|Analgesics|analgesics|mesh-ancestor
139099429|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
139033259|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139099430|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099431|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099432|NCT00025662|Immunoconjugates|immunoconjugates|mesh-ancestor
139099433|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
139099434|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
139099435|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139099436|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
139099437|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099438|NCT03759158|Expectorants|expectorants|mesh-ancestor
139099439|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
139099440|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139099441|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
139099442|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099443|NCT03759158|Protective Agents|protective agents|mesh-ancestor
139099444|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099445|NCT03759158|Antidotes|antidotes|mesh-ancestor
139099446|NCT00025506|Thalidomide|thalidomide|mesh-list
139099447|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139099448|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
139099449|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099450|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
139099451|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139099452|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099453|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139099454|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139099455|NCT00025506|Growth Substances|growth substances|mesh-ancestor
139099456|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
139099457|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099458|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
139099459|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099460|NCT03756272|Bupivacaine|bupivacaine|mesh-list
139099461|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
139099462|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
139099463|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139099464|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099465|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
139099466|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099467|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139099468|NCT03756116|Epinephrine|epinephrine|mesh-list
139099469|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139099470|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139099471|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099472|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099473|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099474|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099475|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139099476|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139099477|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
139099478|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099479|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139099480|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
139099481|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
139033282|NCT01053585|Baclofen|baclofen|mesh-list
139099482|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
139099483|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139099484|NCT00023712|Bortezomib|bortezomib|mesh-list
139099485|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099486|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139099487|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
139099488|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099489|NCT04640168|Remdesivir|remdesivir|mesh-list
139099490|NCT04640168|Dexamethasone|dexamethasone|mesh-list
138850080|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139099491|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139099492|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
139099493|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
139099494|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099495|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099496|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139099497|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
139099498|NCT04640168|Hormones|hormones|mesh-ancestor
139099499|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139099500|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139099501|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099502|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
139099503|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099504|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
139099505|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099506|NCT00022698|Capecitabine|capecitabine|mesh-list
139099507|NCT00022698|Irinotecan|irinotecan|mesh-list
139099508|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139099509|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
139099510|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099511|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099512|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138503625|NCT00000986|Zidovudine|zidovudine|mesh-list
139099513|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139099514|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099515|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
139099516|NCT03951402|Tapentadol|tapentadol|mesh-list
139099517|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139099518|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139099519|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099520|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139099521|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139099522|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099523|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099524|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099525|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139099526|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
139099527|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139099528|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099529|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139099530|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139099531|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139099532|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139099533|NCT03951402|Narcotics|narcotics|mesh-ancestor
139099534|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139099535|NCT03951402|Analgesics|analgesics|mesh-ancestor
139099536|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
139099537|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099538|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139099539|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139099540|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139099541|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099542|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099543|NCT01100736|Bosentan|bosentan|mesh-list
139099544|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
139099545|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139099546|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139099547|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099548|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
139099549|NCT01584726|Analgesics|analgesics|mesh-ancestor
139099550|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
139099551|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099552|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099553|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
139099554|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139099555|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139099556|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
139099557|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139099558|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139099559|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099560|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139099561|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
139099562|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139099563|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
139099564|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
139099565|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
138850157|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
139099567|NCT06159504|Sofosbuvir|sofosbuvir|mesh-list
139099568|NCT06159504|Velpatasvir|velpatasvir|mesh-list
139099569|NCT06159504|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139099570|NCT06159504|Antiviral Agents|antiviral agents|mesh-ancestor
139099571|NCT06159504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033329|NCT05355467|Tenofovir|tenofovir|mesh-list
139099572|NCT06159491|Azacitidine|azacitidine|mesh-list
139099573|NCT06159491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139099574|NCT06159491|Antimetabolites|antimetabolites|mesh-ancestor
139099575|NCT06159491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099576|NCT06159491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099577|NCT06159491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099578|NCT06159348|Chrysarobin|chrysarobin|mesh-list
139099579|NCT06159348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139099580|NCT06159348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139099581|NCT06159348|Analgesics|analgesics|mesh-ancestor
139099582|NCT06159348|Sensory System Agents|sensory system agents|mesh-ancestor
139099583|NCT06159348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099584|NCT06159348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099585|NCT06159348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139099586|NCT06159348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139099587|NCT06159322|Olanzapine|olanzapine|mesh-list
139099588|NCT06159322|Clozapine|clozapine|mesh-list
139099589|NCT06159322|Antiemetics|antiemetics|mesh-ancestor
139099590|NCT06159322|Autonomic Agents|autonomic agents|mesh-ancestor
139099591|NCT06159322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099592|NCT06159322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099593|NCT06159322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139099594|NCT06159322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139099595|NCT06159322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139099596|NCT06159322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139099597|NCT06159322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139099598|NCT06159322|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139099599|NCT06159322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139099600|NCT06159322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139099601|NCT06159322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099602|NCT06159322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099603|NCT06159322|Serotonin Agents|serotonin agents|mesh-ancestor
139099604|NCT06159322|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139099605|NCT06159322|GABA Antagonists|gaba antagonists|mesh-ancestor
139099606|NCT06159322|GABA Agents|gaba agents|mesh-ancestor
139099607|NCT06159283|Immunoglobulins|immunoglobulins|mesh-list
139099608|NCT06159283|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139099609|NCT06159283|Antibodies|antibodies|mesh-list
139099610|NCT06159283|Immunologic Factors|immunologic factors|mesh-ancestor
139099611|NCT06159283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099612|NCT06159114|Celecoxib|celecoxib|mesh-list
139099613|NCT06159114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139099614|NCT06159114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139099615|NCT06159114|Analgesics|analgesics|mesh-ancestor
139099616|NCT06159114|Sensory System Agents|sensory system agents|mesh-ancestor
139099617|NCT06159114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099618|NCT06159114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099619|NCT06159114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139099620|NCT06159114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139099621|NCT06159114|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139099622|NCT06159114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139099623|NCT06159114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099624|NCT06159114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099625|NCT06159101|Ipilimumab|ipilimumab|mesh-list
139099626|NCT06159101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139099627|NCT06159101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099628|NCT06159101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139099629|NCT06159101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099630|NCT06158932|Vitamin D|vitamin d|mesh-list
139099631|NCT06158932|Inositol|inositol|mesh-list
139099632|NCT06158932|Vitamins|vitamins|mesh-ancestor
139099633|NCT06158932|Micronutrients|micronutrients|mesh-ancestor
139099634|NCT06158932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099635|NCT06158932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139099636|NCT06158932|Vitamin B Complex|vitamin b complex|mesh-ancestor
139099637|NCT06158919|Capecitabine|capecitabine|mesh-list
139099638|NCT06158919|Oxaliplatin|oxaliplatin|mesh-list
139099639|NCT06158919|Nivolumab|nivolumab|mesh-list
139099640|NCT06158919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139099641|NCT06158919|Antimetabolites|antimetabolites|mesh-ancestor
139099642|NCT06158919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099643|NCT06158919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099644|NCT06158919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139099645|NCT06158919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139099646|NCT06158893|Budesonide|budesonide|mesh-list
139099647|NCT06158893|Albuterol|albuterol|mesh-list
139099648|NCT06158893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139099649|NCT06158893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139099650|NCT06158893|Autonomic Agents|autonomic agents|mesh-ancestor
139099651|NCT06158893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099652|NCT06158893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099653|NCT06158893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139099654|NCT06158893|Respiratory System Agents|respiratory system agents|mesh-ancestor
139099655|NCT06158893|Glucocorticoids|glucocorticoids|mesh-ancestor
139099656|NCT06158893|Hormones|hormones|mesh-ancestor
139099657|NCT06158893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139099658|NCT06158893|Tocolytic Agents|tocolytic agents|mesh-ancestor
139099659|NCT06158893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139099660|NCT06158893|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139099661|NCT06158893|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139099662|NCT06158893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139099663|NCT06158893|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099664|NCT06158893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099665|NCT06158893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099666|NCT06158828|Plerixafor|plerixafor|mesh-list
139099667|NCT06158828|Fludarabine|fludarabine|mesh-list
139099668|NCT06158828|Melphalan|melphalan|mesh-list
139099669|NCT06158828|Busulfan|busulfan|mesh-list
139099670|NCT06158828|Thiotepa|thiotepa|mesh-list
139099671|NCT06158828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139099672|NCT06158828|Thymoglobulin|thymoglobulin|mesh-list
139099673|NCT06158828|Lenograstim|lenograstim|mesh-list
139099674|NCT06158828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099675|NCT06158828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099676|NCT06158828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139099677|NCT06158828|Immunologic Factors|immunologic factors|mesh-ancestor
139099678|NCT06158828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099679|NCT06158828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139099680|NCT06158828|Alkylating Agents|alkylating agents|mesh-ancestor
139099681|NCT06158828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139099682|NCT06158828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139099683|NCT06158828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139099684|NCT06158828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139099685|NCT06158828|Antiviral Agents|antiviral agents|mesh-ancestor
139099686|NCT06158828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099687|NCT06158334|Hemostatics|hemostatics|mesh-list
139033421|NCT01057563|Paclitaxel|paclitaxel|mesh-list
139099688|NCT06158334|Coagulants|coagulants|mesh-ancestor
139099689|NCT06158230|Propranolol|propranolol|mesh-list
139099690|NCT06158230|Amitriptyline|amitriptyline|mesh-list
139099691|NCT06158230|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139099692|NCT06158230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139099693|NCT06158230|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099694|NCT06158230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099695|NCT06158230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099696|NCT06158230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099697|NCT06158230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139099698|NCT06158230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139099699|NCT06158230|Vasodilator Agents|vasodilator agents|mesh-ancestor
139099700|NCT06158230|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139099701|NCT06158230|Antidepressive Agents|antidepressive agents|mesh-ancestor
139099702|NCT06158230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139099703|NCT06158230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139099704|NCT06158230|Analgesics|analgesics|mesh-ancestor
139099705|NCT06158230|Sensory System Agents|sensory system agents|mesh-ancestor
139099706|NCT06158230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099707|NCT06158230|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139099708|NCT06158230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139099709|NCT06158230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139099710|NCT06158152|Immunoferon|immunoferon|mesh-list
139099711|NCT06158152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139099712|NCT06158152|Immunologic Factors|immunologic factors|mesh-ancestor
139099713|NCT06158152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099714|NCT06158126|Tenofovir|tenofovir|mesh-list
139099715|NCT06158126|Lamivudine|lamivudine|mesh-list
139099716|NCT06158126|Emtricitabine|emtricitabine|mesh-list
139099717|NCT06158126|Antiviral Agents|antiviral agents|mesh-ancestor
139099718|NCT06158126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099719|NCT06158126|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139099720|NCT06158126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139099721|NCT06158126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099722|NCT06158126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099723|NCT06158126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139099724|NCT06158126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139099725|NCT06158100|Azacitidine|azacitidine|mesh-list
139099726|NCT06158100|Venetoclax|venetoclax|mesh-list
139099727|NCT06158100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139099728|NCT06158100|Antimetabolites|antimetabolites|mesh-ancestor
139099729|NCT06158100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099730|NCT06158100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099731|NCT06158100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099732|NCT06158048|Phenylephrine|phenylephrine|mesh-list
139099733|NCT06158048|Oxymetazoline|oxymetazoline|mesh-list
139099734|NCT06158048|Norepinephrine|norepinephrine|mesh-list
139099735|NCT06158048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139099736|NCT06158048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139099737|NCT06158048|Mydriatics|mydriatics|mesh-ancestor
139099738|NCT06158048|Autonomic Agents|autonomic agents|mesh-ancestor
139099739|NCT06158048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099740|NCT06158048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099741|NCT06158048|Sympathomimetics|sympathomimetics|mesh-ancestor
139099742|NCT06158048|Nasal Decongestants|nasal decongestants|mesh-ancestor
139099743|NCT06158048|Respiratory System Agents|respiratory system agents|mesh-ancestor
139099744|NCT06158048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139099745|NCT06158048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139099746|NCT06158048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139099747|NCT06158048|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099748|NCT06158048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099749|NCT06158048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099750|NCT06158048|Protective Agents|protective agents|mesh-ancestor
139099751|NCT06158035|Phenylephrine|phenylephrine|mesh-list
139099752|NCT06158035|Oxymetazoline|oxymetazoline|mesh-list
139099753|NCT06158035|Norepinephrine|norepinephrine|mesh-list
139099754|NCT06158035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139099755|NCT06158035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139099756|NCT06158035|Mydriatics|mydriatics|mesh-ancestor
139099757|NCT06158035|Autonomic Agents|autonomic agents|mesh-ancestor
139099758|NCT06158035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099759|NCT06158035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099760|NCT06158035|Sympathomimetics|sympathomimetics|mesh-ancestor
139099761|NCT06158035|Nasal Decongestants|nasal decongestants|mesh-ancestor
139099762|NCT06158035|Respiratory System Agents|respiratory system agents|mesh-ancestor
139099763|NCT06158035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139099764|NCT06158035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139099765|NCT06158035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139099766|NCT06158035|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099767|NCT06158035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099768|NCT06158035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099769|NCT06158035|Protective Agents|protective agents|mesh-ancestor
139099770|NCT06158022|Phenylephrine|phenylephrine|mesh-list
139099771|NCT06158022|Oxymetazoline|oxymetazoline|mesh-list
139099772|NCT06158022|Norepinephrine|norepinephrine|mesh-list
139099773|NCT06158022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139099774|NCT06158022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139099775|NCT06158022|Mydriatics|mydriatics|mesh-ancestor
139099776|NCT06158022|Autonomic Agents|autonomic agents|mesh-ancestor
139099777|NCT06158022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099778|NCT06158022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099779|NCT06158022|Sympathomimetics|sympathomimetics|mesh-ancestor
139099780|NCT06158022|Nasal Decongestants|nasal decongestants|mesh-ancestor
139099781|NCT06158022|Respiratory System Agents|respiratory system agents|mesh-ancestor
139099782|NCT06158022|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139099783|NCT06158022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139099784|NCT06158022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139099785|NCT06158022|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099786|NCT06158022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099787|NCT06158022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099788|NCT06158022|Protective Agents|protective agents|mesh-ancestor
139099789|NCT06158009|Phenylephrine|phenylephrine|mesh-list
139099790|NCT06158009|Oxymetazoline|oxymetazoline|mesh-list
139099791|NCT06158009|Norepinephrine|norepinephrine|mesh-list
139099792|NCT06158009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139099793|NCT06158009|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138850383|NCT02766036|Propolis|propolis|mesh-list
139099794|NCT06158009|Mydriatics|mydriatics|mesh-ancestor
139099795|NCT06158009|Autonomic Agents|autonomic agents|mesh-ancestor
139099796|NCT06158009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099797|NCT06158009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099798|NCT06158009|Sympathomimetics|sympathomimetics|mesh-ancestor
139099799|NCT06158009|Nasal Decongestants|nasal decongestants|mesh-ancestor
139099800|NCT06158009|Respiratory System Agents|respiratory system agents|mesh-ancestor
139099801|NCT06158009|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139099802|NCT06158009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139099803|NCT06158009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139099804|NCT06158009|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099805|NCT06158009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099806|NCT06158009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099807|NCT06158009|Protective Agents|protective agents|mesh-ancestor
139099808|NCT06157996|Lenvatinib|lenvatinib|mesh-list
139099809|NCT06157996|Tislelizumab|tislelizumab|mesh-list
139099810|NCT06157996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099811|NCT06157996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139099812|NCT06157996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099813|NCT06157996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099814|NCT06157996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139099815|NCT06157918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139099816|NCT06157905|Tofacitinib|tofacitinib|mesh-list
139099817|NCT06157905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099818|NCT06157905|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139099819|NCT06157905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139099820|NCT06157905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099821|NCT06157892|Tucatinib|tucatinib|mesh-list
139099822|NCT06157892|Disitamab vedotin|disitamab vedotin|mesh-list
139099823|NCT06157892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099824|NCT06157892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139099825|NCT06157892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099826|NCT06157892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099827|NCT06157892|Immunoconjugates|immunoconjugates|mesh-ancestor
139099828|NCT06157892|Immunologic Factors|immunologic factors|mesh-ancestor
139099829|NCT06157892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099830|NCT06157853|Sunscreening Agents|sunscreening agents|mesh-list
139099831|NCT06157853|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139099832|NCT06157853|Protective Agents|protective agents|mesh-ancestor
139099833|NCT06157853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099834|NCT06157853|Dermatologic Agents|dermatologic agents|mesh-ancestor
139099835|NCT06157580|Compound 21|compound 21|mesh-list
139099836|NCT06157580|Angiotensin II|angiotensin ii|mesh-list
139099837|NCT06157580|Giapreza|giapreza|mesh-list
139099838|NCT06157580|Angiotensinogen|angiotensinogen|mesh-list
139099839|NCT06157580|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139099840|NCT06157580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139099841|NCT06157580|Protease Inhibitors|protease inhibitors|mesh-ancestor
139099842|NCT06157580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099843|NCT06157580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099844|NCT06157580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139099845|NCT06152861|Timolol|timolol|mesh-list
139099846|NCT06152861|Travoprost|travoprost|mesh-list
139099847|NCT06152861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139099848|NCT06152861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139099849|NCT06152861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099850|NCT06152861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139099851|NCT06152861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139099852|NCT06152861|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099853|NCT06152861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099854|NCT06152861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099855|NCT06152861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139099856|NCT06152861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139099857|NCT06132880|Kallikreins|kallikreins|mesh-list
139099858|NCT06132880|Coagulants|coagulants|mesh-ancestor
139099859|NCT06132880|Fertility Agents, Male|fertility agents, male|mesh-ancestor
139099860|NCT06132880|Fertility Agents|fertility agents|mesh-ancestor
139099861|NCT06132880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139099862|NCT06132880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099863|NCT06126276|Palbociclib|palbociclib|mesh-list
139099864|NCT06126276|Maleic acid|maleic acid|mesh-list
139099865|NCT06126276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099866|NCT06126276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099867|NCT06126276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099868|NCT06126276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139099869|NCT06096844|Paclitaxel|paclitaxel|mesh-list
139099870|NCT06096844|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139099871|NCT06096844|Carboplatin|carboplatin|mesh-list
139099872|NCT06096844|Pembrolizumab|pembrolizumab|mesh-list
139099874|NCT06096844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139099875|NCT06096844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099876|NCT06096844|Tubulin Modulators|tubulin modulators|mesh-ancestor
139099877|NCT06096844|Antimitotic Agents|antimitotic agents|mesh-ancestor
139099878|NCT06096844|Mitosis Modulators|mitosis modulators|mesh-ancestor
139099879|NCT06096844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099880|NCT06096844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139099881|NCT06096844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139099882|NCT06096844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139099883|NCT06096844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139099884|NCT06096844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139099885|NCT06094881|Obinutuzumab|obinutuzumab|mesh-list
139099886|NCT06094881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139099887|NCT06094881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099888|NCT06085573|Dexmedetomidine|dexmedetomidine|mesh-list
139099889|NCT06085573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139099890|NCT06085573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139099891|NCT06085573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099892|NCT06085573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139099893|NCT06085573|Analgesics|analgesics|mesh-ancestor
139099894|NCT06085573|Sensory System Agents|sensory system agents|mesh-ancestor
139099895|NCT06085573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099896|NCT06085573|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139099897|NCT06085573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139099898|NCT06085573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139099899|NCT06085573|Adrenergic Agents|adrenergic agents|mesh-ancestor
139099900|NCT06085573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099901|NCT06085573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099902|NCT06066996|Nicotine|nicotine|mesh-list
139099903|NCT06066996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139099904|NCT06066996|Autonomic Agents|autonomic agents|mesh-ancestor
139099905|NCT06066996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099906|NCT06066996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099907|NCT06066996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139099908|NCT06066996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139099909|NCT06066996|Cholinergic Agents|cholinergic agents|mesh-ancestor
139099910|NCT06066996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099911|NCT06066996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099912|NCT06035081|Prednisolone|prednisolone|mesh-list
139099913|NCT06035081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139099914|NCT06035081|Glucocorticoids|glucocorticoids|mesh-ancestor
139099915|NCT06035081|Hormones|hormones|mesh-ancestor
139099916|NCT06035081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139099917|NCT06035081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099918|NCT06035081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139099919|NCT06035081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099920|NCT06034925|Valganciclovir|valganciclovir|mesh-list
139099921|NCT06034925|Maribavir|maribavir|mesh-list
139099922|NCT06034925|Antiviral Agents|antiviral agents|mesh-ancestor
139099923|NCT06034925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099924|NCT06031454|Rifampin|rifampin|mesh-list
139099925|NCT06031454|Verapamil|verapamil|mesh-list
139099926|NCT06031454|Midazolam|midazolam|mesh-list
139099927|NCT06031454|Omeprazole|omeprazole|mesh-list
139099928|NCT06031454|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139099929|NCT06031454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139099930|NCT06031454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139099931|NCT06031454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139099932|NCT06031454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099933|NCT06031454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139099934|NCT06031454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139099935|NCT06031454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139099936|NCT06031454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139099937|NCT06031454|Anesthetics, General|anesthetics, general|mesh-ancestor
139099938|NCT06031454|Anesthetics|anesthetics|mesh-ancestor
139099939|NCT06031454|GABA Modulators|gaba modulators|mesh-ancestor
139099940|NCT06031454|GABA Agents|gaba agents|mesh-ancestor
139099941|NCT06031454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139099942|NCT06031454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099943|NCT06031454|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139099944|NCT06031454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139099945|NCT06031454|Antimetabolites|antimetabolites|mesh-ancestor
139099946|NCT06031454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138887419|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139099947|NCT06031454|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139099949|NCT06031454|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139099950|NCT06031454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139099951|NCT06031454|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139099952|NCT06031454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139099953|NCT06031454|Antitubercular Agents|antitubercular agents|mesh-ancestor
139099954|NCT06031454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139099955|NCT06031454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139099956|NCT06031454|Leprostatic Agents|leprostatic agents|mesh-ancestor
139099957|NCT06031454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139099958|NCT06031454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139099959|NCT06031454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139099960|NCT06031454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139099961|NCT06031454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139099962|NCT06031454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139099963|NCT06031454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139099964|NCT06031454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139099965|NCT06031454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139099966|NCT06031454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139099967|NCT06031454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139099968|NCT06031454|Vasodilator Agents|vasodilator agents|mesh-ancestor
139099970|NCT06024928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139099971|NCT06024928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099972|NCT06018883|Paclitaxel|paclitaxel|mesh-list
139099973|NCT06018883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139099974|NCT06018883|Gemcitabine|gemcitabine|mesh-list
139099975|NCT06018883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139099976|NCT06018883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099977|NCT06018883|Tubulin Modulators|tubulin modulators|mesh-ancestor
139099978|NCT06018883|Antimitotic Agents|antimitotic agents|mesh-ancestor
139099979|NCT06018883|Mitosis Modulators|mitosis modulators|mesh-ancestor
139099980|NCT06018883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139099981|NCT06018883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139099982|NCT06018883|Antimetabolites|antimetabolites|mesh-ancestor
139099983|NCT06015308|Vaccines|vaccines|mesh-list
139099984|NCT06015308|Immunologic Factors|immunologic factors|mesh-ancestor
139099985|NCT06015308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099986|NCT06008795|Dexamethasone|dexamethasone|mesh-list
139099987|NCT06008795|Ropivacaine|ropivacaine|mesh-list
139099988|NCT06008795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139099989|NCT06008795|Antiemetics|antiemetics|mesh-ancestor
139099990|NCT06008795|Autonomic Agents|autonomic agents|mesh-ancestor
139099991|NCT06008795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139099992|NCT06008795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139099993|NCT06008795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139099994|NCT06008795|Glucocorticoids|glucocorticoids|mesh-ancestor
139099995|NCT06008795|Hormones|hormones|mesh-ancestor
139099996|NCT06008795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139099997|NCT06008795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139099998|NCT06008795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139099999|NCT06008795|Anesthetics, Local|anesthetics, local|mesh-ancestor
139100000|NCT06008795|Anesthetics|anesthetics|mesh-ancestor
139100001|NCT06008795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139100002|NCT06008795|Sensory System Agents|sensory system agents|mesh-ancestor
139100003|NCT06006884|Dimercaprol|dimercaprol|mesh-list
139100004|NCT06006884|Chelating Agents|chelating agents|mesh-ancestor
139100005|NCT06006884|Sequestering Agents|sequestering agents|mesh-ancestor
139100006|NCT06006884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100007|NCT06003166|4-Aminopyridine|4-aminopyridine|mesh-list
139100008|NCT06003166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139100009|NCT06003166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139100010|NCT06003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100011|NCT05993234|Trastuzumab|trastuzumab|mesh-list
139100012|NCT05993234|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139100013|NCT05993234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139033719|NCT00473330|Ranibizumab|ranibizumab|mesh-list
139100014|NCT05993234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100015|NCT05993234|Immunoconjugates|immunoconjugates|mesh-ancestor
139100016|NCT05993234|Immunologic Factors|immunologic factors|mesh-ancestor
139100017|NCT05993234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100018|NCT05980117|Midazolam|midazolam|mesh-list
139100019|NCT05980117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139100020|NCT05980117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138850602|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
139100021|NCT05980117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139100022|NCT05980117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100023|NCT05980117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139100024|NCT05980117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139100025|NCT05980117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139100026|NCT05980117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139100027|NCT05980117|Anesthetics, General|anesthetics, general|mesh-ancestor
139100029|NCT05980117|GABA Modulators|gaba modulators|mesh-ancestor
139100030|NCT05980117|GABA Agents|gaba agents|mesh-ancestor
139100031|NCT05980117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139100032|NCT05980117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100033|NCT05976763|Rituximab|rituximab|mesh-list
139100034|NCT05976763|Zanubrutinib|zanubrutinib|mesh-list
139100035|NCT05976763|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139100036|NCT05976763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100037|NCT05976763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100038|NCT05976763|Immunologic Factors|immunologic factors|mesh-ancestor
139100039|NCT05976763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100040|NCT05976763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139100041|NCT05976763|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139100042|NCT05976763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100043|NCT05976763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139100044|NCT05976763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100071|NCT05951023|Eszopiclone|eszopiclone|mesh-list
139100072|NCT05951023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139100073|NCT05951023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139100074|NCT05951023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100075|NCT05949203|Cabotegravir|cabotegravir|mesh-list
139100076|NCT05949203|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139100077|NCT05949203|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139100078|NCT05949203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100079|NCT05949203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100080|NCT05949203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139100081|NCT05949203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139100082|NCT05949203|Antiviral Agents|antiviral agents|mesh-ancestor
139100083|NCT05949203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139100084|NCT05945732|Trastuzumab|trastuzumab|mesh-list
139100085|NCT05945732|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139100086|NCT05945732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100087|NCT05945732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100088|NCT05945732|Immunoconjugates|immunoconjugates|mesh-ancestor
139100089|NCT05945732|Immunologic Factors|immunologic factors|mesh-ancestor
139100090|NCT05945732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100091|NCT05938712|Dapagliflozin|dapagliflozin|mesh-list
139100092|NCT05938712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139100093|NCT05938712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100094|NCT05938712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139100095|NCT05938712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100096|NCT05937854|Tadalafil|tadalafil|mesh-list
139100097|NCT05937854|Vasodilator Agents|vasodilator agents|mesh-ancestor
139100098|NCT05937854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139100099|NCT05937854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139100100|NCT05937854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100101|NCT05937854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100102|NCT05937854|Urological Agents|urological agents|mesh-ancestor
139100103|NCT05923060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139100104|NCT05923060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139100105|NCT05923060|Dermatologic Agents|dermatologic agents|mesh-ancestor
139100106|NCT05870761|Niraparib|niraparib|mesh-list
139100107|NCT05870761|Dostarlimab|dostarlimab|mesh-list
139100108|NCT05870761|Immunoglobulins|immunoglobulins|mesh-list
139100109|NCT05870761|Immunoglobulin G|immunoglobulin g|mesh-list
139100110|NCT05870761|Immunologic Factors|immunologic factors|mesh-ancestor
139100111|NCT05870761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100112|NCT05870761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139100113|NCT05870761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100114|NCT05870761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100115|NCT05870761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100116|NCT05850455|Lidocaine|lidocaine|mesh-list
139100117|NCT05850455|Dexmedetomidine|dexmedetomidine|mesh-list
139100118|NCT05850455|Bupivacaine|bupivacaine|mesh-list
139100119|NCT05850455|Anesthetics, Local|anesthetics, local|mesh-ancestor
139100120|NCT05850455|Anesthetics|anesthetics|mesh-ancestor
139100121|NCT05850455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139100122|NCT05850455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100123|NCT05850455|Sensory System Agents|sensory system agents|mesh-ancestor
139100124|NCT05850455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100125|NCT05850455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139100126|NCT05850455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139100127|NCT05850455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139100128|NCT05850455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139100129|NCT05850455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100130|NCT05850455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139100131|NCT05850455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138951936|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
139100133|NCT05850455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139100134|NCT05850455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139100135|NCT05850455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139100136|NCT05850455|Adrenergic Agents|adrenergic agents|mesh-ancestor
139100137|NCT05850455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139100138|NCT05822362|Cannabidiol|cannabidiol|mesh-list
139100139|NCT05822362|Anticonvulsants|anticonvulsants|mesh-ancestor
139100140|NCT05798390|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139100141|NCT05798390|Ezetimibe|ezetimibe|mesh-list
139100142|NCT05798390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139100143|NCT05798390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139100144|NCT05798390|Antimetabolites|antimetabolites|mesh-ancestor
139100145|NCT05798390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100146|NCT05798390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139100147|NCT05798390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100148|NCT05798390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139100149|NCT05798390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100150|NCT05796388|Linaclotide|linaclotide|mesh-list
139100151|NCT05796388|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139100152|NCT05796388|Enzyme Activators|enzyme activators|mesh-ancestor
139100153|NCT05796388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100154|NCT05796388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139100155|NCT05755997|Cerebrolysin|cerebrolysin|mesh-list
139100156|NCT05755997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139100157|NCT05755997|Protective Agents|protective agents|mesh-ancestor
139100158|NCT05755997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100159|NCT05755997|Nootropic Agents|nootropic agents|mesh-ancestor
139100160|NCT05754593|Hormones|hormones|mesh-list
139100161|NCT05754593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100162|NCT05754593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100163|NCT05752305|Dexamethasone|dexamethasone|mesh-list
139100164|NCT05752305|Methylprednisolone|methylprednisolone|mesh-list
139100165|NCT05752305|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139100166|NCT05752305|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139100168|NCT05752305|Prednisolone acetate|prednisolone acetate|mesh-list
139100169|NCT05752305|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139100171|NCT05752305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139100172|NCT05752305|Antiemetics|antiemetics|mesh-ancestor
139100173|NCT05752305|Autonomic Agents|autonomic agents|mesh-ancestor
139100174|NCT05752305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100175|NCT05752305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100176|NCT05752305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139100177|NCT05752305|Glucocorticoids|glucocorticoids|mesh-ancestor
139100178|NCT05752305|Hormones|hormones|mesh-ancestor
139100179|NCT05752305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100180|NCT05752305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139100181|NCT05752305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100182|NCT05752305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139100183|NCT05752305|Protective Agents|protective agents|mesh-ancestor
139100184|NCT05752110|Ketamine|ketamine|mesh-list
139100185|NCT05752110|Analgesics|analgesics|mesh-ancestor
139100186|NCT05752110|Sensory System Agents|sensory system agents|mesh-ancestor
139100187|NCT05752110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100188|NCT05752110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100189|NCT05752110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139100190|NCT05752110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139100191|NCT05752110|Anesthetics, General|anesthetics, general|mesh-ancestor
139100192|NCT05752110|Anesthetics|anesthetics|mesh-ancestor
139100193|NCT05752110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139100194|NCT05752110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139100195|NCT05752110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139100196|NCT05752110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139100197|NCT05752110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100198|NCT05702879|Prednisolone|prednisolone|mesh-list
139100199|NCT05702879|Adalimumab|adalimumab|mesh-list
139100200|NCT05702879|Infliximab|infliximab|mesh-list
139100201|NCT05702879|Etanercept|etanercept|mesh-list
139100202|NCT05702879|Golimumab|golimumab|mesh-list
139100203|NCT05702879|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139100204|NCT05702879|Ustekinumab|ustekinumab|mesh-list
139100205|NCT05702879|Vedolizumab|vedolizumab|mesh-list
139100206|NCT05702879|Ozanimod|ozanimod|mesh-list
139100207|NCT05702879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139100208|NCT05702879|Glucocorticoids|glucocorticoids|mesh-ancestor
139100209|NCT05702879|Hormones|hormones|mesh-ancestor
139100210|NCT05702879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100211|NCT05702879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100212|NCT05702879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139100213|NCT05702879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100214|NCT05702879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100215|NCT05702879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139100216|NCT05702879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139100217|NCT05702879|Dermatologic Agents|dermatologic agents|mesh-ancestor
139100218|NCT05702879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139100219|NCT05702879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139100220|NCT05702879|Analgesics|analgesics|mesh-ancestor
139100221|NCT05702879|Sensory System Agents|sensory system agents|mesh-ancestor
139100222|NCT05702879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139100223|NCT05702879|Immunologic Factors|immunologic factors|mesh-ancestor
139100224|NCT05702879|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139100225|NCT05702879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100226|NCT05691491|Temozolomide|temozolomide|mesh-list
139100227|NCT05691491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139100228|NCT05691491|Alkylating Agents|alkylating agents|mesh-ancestor
139100229|NCT05691491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100230|NCT05691491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100231|NCT05687136|Peposertib|peposertib|mesh-list
139100232|NCT05687136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139100233|NCT05687136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100234|NCT05687136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100235|NCT05631236|Methamphetamine|methamphetamine|mesh-list
139100236|NCT05631236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139100237|NCT05631236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100238|NCT05631236|Sympathomimetics|sympathomimetics|mesh-ancestor
139100239|NCT05631236|Autonomic Agents|autonomic agents|mesh-ancestor
139100240|NCT05631236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100241|NCT05631236|Dopamine Agents|dopamine agents|mesh-ancestor
139100242|NCT05631236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138850823|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
139100243|NCT05631236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100244|NCT05631236|Adrenergic Agents|adrenergic agents|mesh-ancestor
139100245|NCT05631236|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139100246|NCT05631236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139100247|NCT05631236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139100248|NCT05631236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139100250|NCT05577702|Carboplatin|carboplatin|mesh-list
139100251|NCT05577702|Pemetrexed|pemetrexed|mesh-list
139100252|NCT05577702|Tislelizumab|tislelizumab|mesh-list
139100253|NCT05577702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139100254|NCT05577702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100255|NCT05577702|Tubulin Modulators|tubulin modulators|mesh-ancestor
139100256|NCT05577702|Antimitotic Agents|antimitotic agents|mesh-ancestor
139100257|NCT05577702|Mitosis Modulators|mitosis modulators|mesh-ancestor
139100258|NCT05577702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100259|NCT05577702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100260|NCT05577702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139100261|NCT05577702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139100262|NCT05577702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100263|NCT05576194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139100264|NCT05576194|Taurolidine|taurolidine|mesh-list
139100265|NCT05576194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139100266|NCT05576194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139100267|NCT05576194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100268|NCT05563766|Itraconazole|itraconazole|mesh-list
139100269|NCT05563766|Antifungal Agents|antifungal agents|mesh-ancestor
139100270|NCT05563766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033878|NCT03988725|Vitamin E|vitamin e|mesh-list
139100271|NCT05563766|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139100272|NCT05563766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139100273|NCT05563766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100274|NCT05563766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100275|NCT05563766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139100276|NCT05563766|Hormone Antagonists|hormone antagonists|mesh-ancestor
139100277|NCT05563766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100278|NCT05563766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100279|NCT05563766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139100280|NCT05537948|Pitavastatin|pitavastatin|mesh-list
139100281|NCT05537948|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139100282|NCT05537948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139100283|NCT05537948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139100284|NCT05537948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139100285|NCT05537948|Antimetabolites|antimetabolites|mesh-ancestor
139100286|NCT05537948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100287|NCT05537948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100288|NCT05537948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139100289|NCT05537948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139100290|NCT05537948|Protease Inhibitors|protease inhibitors|mesh-ancestor
139100291|NCT05520567|Azacitidine|azacitidine|mesh-list
139100292|NCT05520567|Venetoclax|venetoclax|mesh-list
139100293|NCT05520567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139100294|NCT05520567|Antimetabolites|antimetabolites|mesh-ancestor
139100295|NCT05520567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100296|NCT05520567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100297|NCT05520567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100298|NCT05489406|Dolutegravir|dolutegravir|mesh-list
139100299|NCT05489406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139100300|NCT05489406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139100301|NCT05489406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100302|NCT05489406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100303|NCT05489406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139100304|NCT05489406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139100305|NCT05489406|Antiviral Agents|antiviral agents|mesh-ancestor
139100306|NCT05489406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139100307|NCT05470881|Atropine|atropine|mesh-list
139100308|NCT05470881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139100309|NCT05470881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139100310|NCT05470881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139100311|NCT05470881|Autonomic Agents|autonomic agents|mesh-ancestor
139100312|NCT05470881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100313|NCT05470881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100314|NCT05470881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139100315|NCT05470881|Respiratory System Agents|respiratory system agents|mesh-ancestor
139100316|NCT05470881|Mydriatics|mydriatics|mesh-ancestor
139100317|NCT05470881|Parasympatholytics|parasympatholytics|mesh-ancestor
139100318|NCT05470881|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139100319|NCT05470881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139100320|NCT05470881|Cholinergic Agents|cholinergic agents|mesh-ancestor
139100321|NCT05470881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139100322|NCT05470881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100323|NCT05422144|Anti-Infective Agents|anti-infective agents|mesh-list
139100324|NCT05422144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139100325|NCT05419830|Antihypertensive Agents|antihypertensive agents|mesh-list
139100326|NCT05394493|Avelumab|avelumab|mesh-list
139100327|NCT05394493|Axitinib|axitinib|mesh-list
139100328|NCT05394493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100329|NCT05394493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100330|NCT05394493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139100331|NCT05394493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100332|NCT05394493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100333|NCT05379634|Glucocorticoids|glucocorticoids|mesh-list
139100334|NCT05379634|Hormones|hormones|mesh-ancestor
139100335|NCT05379634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100336|NCT05379634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100337|NCT05364099|Triamcinolone|triamcinolone|mesh-list
139100338|NCT05364099|Lidocaine|lidocaine|mesh-list
139100339|NCT05364099|Anesthetics, Local|anesthetics, local|mesh-ancestor
139100340|NCT05364099|Anesthetics|anesthetics|mesh-ancestor
139100341|NCT05364099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139100342|NCT05364099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100343|NCT05364099|Sensory System Agents|sensory system agents|mesh-ancestor
139100344|NCT05364099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100345|NCT05364099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139100346|NCT05364099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139100347|NCT05364099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139100348|NCT05364099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139100349|NCT05364099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100350|NCT05364099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139100351|NCT05364099|Glucocorticoids|glucocorticoids|mesh-ancestor
139100352|NCT05364099|Hormones|hormones|mesh-ancestor
139100353|NCT05364099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100354|NCT05347485|Cyclophosphamide|cyclophosphamide|mesh-list
139100355|NCT05347485|Fludarabine|fludarabine|mesh-list
139100356|NCT05347485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139100357|NCT05347485|Immunologic Factors|immunologic factors|mesh-ancestor
139100358|NCT05347485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100359|NCT05347485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139100360|NCT05347485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139100361|NCT05347485|Alkylating Agents|alkylating agents|mesh-ancestor
139100362|NCT05347485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100363|NCT05347485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100364|NCT05347485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139100365|NCT05275023|Tenofovir|tenofovir|mesh-list
139100366|NCT05275023|Entecavir|entecavir|mesh-list
139100367|NCT05275023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139100368|NCT05275023|Antiviral Agents|antiviral agents|mesh-ancestor
139100369|NCT05275023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139100370|NCT05275023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139100371|NCT05275023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139100372|NCT05275023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100373|NCT05275023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100374|NCT05275023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139100375|NCT05275023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139100376|NCT05275023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100377|NCT05275023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100378|NCT05245006|Antibodies|antibodies|mesh-list
139100379|NCT05245006|Immunoglobulins|immunoglobulins|mesh-list
139100380|NCT05245006|Immunologic Factors|immunologic factors|mesh-ancestor
139100381|NCT05245006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100382|NCT05217680|Bevacizumab|bevacizumab|mesh-list
139100383|NCT05217680|Ranibizumab|ranibizumab|mesh-list
139100384|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100385|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100386|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139100387|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139100388|NCT05217680|Growth Substances|growth substances|mesh-ancestor
139100389|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100390|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
139100391|NCT05210374|Copper|copper|mesh-list
139100392|NCT05210374|Doxorubicin|doxorubicin|mesh-list
139100393|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139100394|NCT05210374|Disulfiram|disulfiram|mesh-list
139100395|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139100396|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100397|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139100398|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139100399|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100400|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100401|NCT05210374|Trace Elements|trace elements|mesh-ancestor
139100402|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
139100403|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100404|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139100405|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139100406|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
139100407|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139100409|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139100410|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100411|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139100412|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139100413|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139100414|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
139100415|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139100416|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
139100417|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100418|NCT05172934|Tenecteplase|tenecteplase|mesh-list
139100419|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139100420|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139100421|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100422|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
139100423|NCT05166811|Analgesics|analgesics|mesh-ancestor
139100424|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
139100425|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100426|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100427|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
139100428|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139100429|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139100430|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
139100431|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139100432|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139100433|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100434|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139100435|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
139100436|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139100437|NCT05142189|Paclitaxel|paclitaxel|mesh-list
139100438|NCT05142189|Docetaxel|docetaxel|mesh-list
139100439|NCT05142189|Carboplatin|carboplatin|mesh-list
139100440|NCT05142189|Cemiplimab|cemiplimab|mesh-list
139033985|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139100441|NCT05142189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139100443|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
139100444|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
139100445|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
139100446|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100447|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100448|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139100449|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
139100450|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139100451|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139100452|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139100453|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100454|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100455|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139100456|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139100457|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139100458|NCT05105633|Tenecteplase|tenecteplase|mesh-list
139100459|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139100460|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139100461|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100462|NCT05090033|Ofatumumab|ofatumumab|mesh-list
139100463|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100464|NCT05085002|Letrozole|letrozole|mesh-list
139100465|NCT05085002|Fulvestrant|fulvestrant|mesh-list
139100466|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100467|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139100468|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139100469|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100470|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100471|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139100472|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
139100473|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100474|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100475|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139100476|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139100477|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
139100478|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
139100479|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100481|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139100482|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
139100483|NCT05075993|Bevacizumab|bevacizumab|mesh-list
139100484|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139100485|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100486|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
139100487|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
139100488|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
139100489|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100490|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139100491|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
139100492|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100493|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139100494|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139100495|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
139100496|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139100497|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100498|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139100499|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139100500|NCT05075993|Growth Substances|growth substances|mesh-ancestor
139100501|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
139100502|NCT05070260|Glenzocimab|glenzocimab|mesh-list
139100503|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
139100504|NCT05038592|Decitabine|decitabine|mesh-list
139100505|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139100506|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
139100507|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100508|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100509|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100510|NCT05012865|Avelumab|avelumab|mesh-list
139100511|NCT05012865|Axitinib|axitinib|mesh-list
139100512|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100513|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100514|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139100515|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100516|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100517|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
139100518|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
139100519|NCT04904588|Melphalan|melphalan|mesh-list
139100520|NCT04904588|Busulfan|busulfan|mesh-list
139100521|NCT04904588|Fludarabine|fludarabine|mesh-list
139100522|NCT04904588|Tacrolimus|tacrolimus|mesh-list
139100523|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139034081|NCT01055301|Melphalan|melphalan|mesh-list
139100524|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
139100525|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100526|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139100527|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139100528|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
139100529|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100530|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100531|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139100532|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139100533|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100534|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139100535|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139100536|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
139100537|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139100538|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139100539|NCT04877275|Dexamethasone|dexamethasone|mesh-list
139100540|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
139100541|NCT04877275|Doxorubicin|doxorubicin|mesh-list
139100542|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139100543|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139100544|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
139100545|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100546|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139100547|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139100548|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
139100549|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100550|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100551|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139100552|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139100553|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
139100554|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
139100555|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100556|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139100557|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
139100558|NCT04877275|Hormones|hormones|mesh-ancestor
139100559|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100560|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139100561|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139100562|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139100563|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139100564|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100565|NCT04873453|Cannabidiol|cannabidiol|mesh-list
139100566|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
139100567|NCT04765111|Rituximab|rituximab|mesh-list
139100568|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139100569|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
139100570|NCT04765111|Antibodies|antibodies|mesh-list
139100571|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
139100572|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139100573|NCT04765111|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139100574|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
139100575|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100576|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100577|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139100578|NCT04765111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139100579|NCT04765111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100580|NCT04765111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100581|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139100582|NCT04750954|Peposertib|peposertib|mesh-list
139100583|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100584|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139100585|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139100586|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100587|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
139100588|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139100589|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
139100590|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100591|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
139100592|NCT04704518|Protective Agents|protective agents|mesh-ancestor
139100593|NCT04633239|Olaparib|olaparib|mesh-list
139100594|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139100595|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100596|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100597|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100598|NCT04617015|Bromides|bromides|mesh-list
139100599|NCT04617015|Ipratropium|ipratropium|mesh-list
139100600|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
139100601|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139100602|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
139100603|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100604|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100605|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139100606|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
139100607|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139100608|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
139100609|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139100610|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100611|NCT04616547|Edetic Acid|edetic acid|mesh-list
139100612|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
139100613|NCT04616547|Antidotes|antidotes|mesh-ancestor
139100614|NCT04616547|Protective Agents|protective agents|mesh-ancestor
139100615|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100616|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
139100617|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
139100618|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100619|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139100620|NCT04616547|Anticoagulants|anticoagulants|mesh-ancestor
139100621|NCT04616547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139100622|NCT04616248|Poly I-C|poly i-c|mesh-list
139100623|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139100624|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139100625|NCT04616248|Antibodies|antibodies|mesh-list
139100626|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
139100627|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139100628|NCT04616248|Poly ICLC|poly iclc|mesh-list
139100629|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
139100630|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
139100631|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100632|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100633|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
139100634|NCT04616248|Laxatives|laxatives|mesh-ancestor
139100635|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139100636|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
139100637|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139100638|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139100639|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139100640|NCT04616248|Protective Agents|protective agents|mesh-ancestor
139100641|NCT04597372|Tamsulosin|tamsulosin|mesh-list
139100642|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139100643|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139100644|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139100645|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
139100646|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139100647|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100648|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100649|NCT04597372|Urological Agents|urological agents|mesh-ancestor
139100650|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139100651|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100652|NCT04585815|Axitinib|axitinib|mesh-list
139100653|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100654|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139100655|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100656|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100657|NCT04570436|Diazepam|diazepam|mesh-list
139100658|NCT04570436|Gabapentin|gabapentin|mesh-list
139100659|NCT04570436|Analgesics|analgesics|mesh-ancestor
139100660|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
139100661|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100662|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100663|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
139100664|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139100665|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139100666|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139100667|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139100668|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139100669|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139100670|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139100671|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100672|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
139100673|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139100674|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
139100675|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
139100676|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139100677|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139100678|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139100679|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138952077|NCT00890253|Everolimus|everolimus|mesh-list
139100680|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139100681|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
139100682|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
139100683|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
139100685|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
139100686|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139100687|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139100688|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139100689|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139100690|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100691|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100692|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100694|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139100695|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139100696|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139100697|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
139100698|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139100699|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100700|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100701|NCT04551040|Urological Agents|urological agents|mesh-ancestor
139100702|NCT04550494|Talazoparib|talazoparib|mesh-list
139100703|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139100704|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100705|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100706|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100707|NCT04514484|Nivolumab|nivolumab|mesh-list
139100708|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100709|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100710|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139100711|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100712|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
139100713|NCT04484272|Narcotics|narcotics|mesh-ancestor
139100714|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139100715|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100716|NCT04484272|Analgesics|analgesics|mesh-ancestor
139100717|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
139100718|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100719|NCT04433767|Nicotine|nicotine|mesh-list
139100720|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139100721|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
139100722|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100723|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100724|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139100725|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139100726|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
139100727|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139100728|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100729|NCT04382326|Vaccines|vaccines|mesh-list
139034237|NCT00436332|Bevacizumab|bevacizumab|mesh-list
139100730|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139100732|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100733|NCT04379739|Apatinib|apatinib|mesh-list
139100734|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100735|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139100736|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100737|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100738|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139100739|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
139100740|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
139100741|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139100742|NCT04349826|Azithromycin|azithromycin|mesh-list
139100743|NCT04349826|Cefixime|cefixime|mesh-list
139100744|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139100745|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139100746|NCT04339738|Paclitaxel|paclitaxel|mesh-list
139100747|NCT04339738|Nivolumab|nivolumab|mesh-list
139100748|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139100749|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139100750|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100751|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
139100752|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
139100753|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
139100754|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100755|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100756|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139100757|NCT04324229|Liraglutide|liraglutide|mesh-list
139100758|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139100759|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100760|NCT04324229|Incretins|incretins|mesh-ancestor
139100762|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100763|NCT04251585|Insulin|insulin|mesh-list
139100764|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139100765|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138851354|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139100766|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139100767|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100769|NCT04224272|Fulvestrant|fulvestrant|mesh-list
139100770|NCT04224272|Palbociclib|palbociclib|mesh-list
139100771|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139100772|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100773|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139100774|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139100775|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
139100776|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100777|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100778|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139100779|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100780|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100781|NCT04223856|Carboplatin|carboplatin|mesh-list
139100782|NCT04223856|Gemcitabine|gemcitabine|mesh-list
139100783|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
139100784|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100785|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139100786|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
139100787|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100788|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100789|NCT04223856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139100790|NCT04216290|Cisplatin|cisplatin|mesh-list
139100791|NCT04216290|Gemcitabine|gemcitabine|mesh-list
139100792|NCT04216290|Fluorouracil|fluorouracil|mesh-list
139100793|NCT04216290|Durvalumab|durvalumab|mesh-list
139100794|NCT04216290|Mitomycins|mitomycins|mesh-list
139100795|NCT04216290|Mitomycin|mitomycin|mesh-list
139100796|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
139100797|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139100798|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
139100799|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100800|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139100801|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
139100802|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100803|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139100804|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
139100805|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100806|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100808|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
139100809|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139100810|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100811|NCT04127578|Sirolimus|sirolimus|mesh-list
139100812|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
139100813|NCT04127578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139100814|NCT04127578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139100815|NCT04127578|Prednisolone|prednisolone|mesh-list
139100816|NCT04127578|Prednisolone acetate|prednisolone acetate|mesh-list
139100817|NCT04127578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139100818|NCT04127578|Prednisolone phosphate|prednisolone phosphate|mesh-list
139100819|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139100820|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139100821|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139100822|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100823|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
139100824|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139100825|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
139100826|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100827|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139100828|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
139100829|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
139100830|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100831|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139100832|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
139100833|NCT04127578|Hormones|hormones|mesh-ancestor
139100834|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100835|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139100836|NCT04127578|Protective Agents|protective agents|mesh-ancestor
139100837|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139100838|NCT04092270|Doxorubicin|doxorubicin|mesh-list
139100839|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139100840|NCT04092270|Peposertib|peposertib|mesh-list
139100841|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139100842|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100843|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139100844|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139100845|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100846|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100847|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139100848|NCT04080739|Ropivacaine|ropivacaine|mesh-list
139100849|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
139100850|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
139100851|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139100852|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100853|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
139100854|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100855|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
139100856|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100857|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100858|NCT04074096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139100859|NCT04074096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100860|NCT04046575|Paclitaxel|paclitaxel|mesh-list
139100861|NCT04046575|Carboplatin|carboplatin|mesh-list
139100862|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139100863|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100864|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
139100865|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
139100866|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
139100867|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100868|NCT03953898|Olaparib|olaparib|mesh-list
139100869|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139100870|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100871|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100872|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100873|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
139100874|NCT03945591|Bortezomib|bortezomib|mesh-list
139100875|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139100876|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
139100877|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100878|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139100879|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139100880|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
139100881|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100882|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100883|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139100884|NCT03878095|Olaparib|olaparib|mesh-list
139100885|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139100886|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100887|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100888|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100889|NCT03799835|Atezolizumab|atezolizumab|mesh-list
139100890|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
139100891|NCT03799835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139100892|NCT03799835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100893|NCT03799835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100894|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100895|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139100896|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
139100897|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100898|NCT03778554|Metoprolol|metoprolol|mesh-list
139100899|NCT03778554|Carvedilol|carvedilol|mesh-list
139100900|NCT03778554|Nebivolol|nebivolol|mesh-list
139100901|NCT03778554|Bisoprolol|bisoprolol|mesh-list
139100902|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139100903|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139100904|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
139100905|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
139034362|NCT01005797|Sorafenib|sorafenib|mesh-list
139100906|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100907|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100908|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139100909|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139100910|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139100911|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
139100912|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139100913|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100914|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
139100915|NCT03778554|Protective Agents|protective agents|mesh-ancestor
139100916|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139100917|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139100918|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139100919|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
139100920|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139100921|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139100922|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139100923|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139100924|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139100926|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100927|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100928|NCT03752333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139100929|NCT03752333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100931|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139100932|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100933|NCT03742921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139100934|NCT03742921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100935|NCT03742921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100936|NCT03738553|Trastuzumab|trastuzumab|mesh-list
139100937|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100938|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100939|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
139100940|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139100941|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
139100942|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
139100943|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139100944|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100945|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139100946|NCT03736538|Analgesics|analgesics|mesh-ancestor
139100947|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
139100948|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139100949|NCT03734653|Testosterone|testosterone|mesh-list
139100950|NCT03734653|Androgens|androgens|mesh-ancestor
139100951|NCT03734653|Hormones|hormones|mesh-ancestor
139100952|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100953|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100954|NCT03732820|Olaparib|olaparib|mesh-list
139100955|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
139100956|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139100957|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100958|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100959|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100960|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139100961|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
139100962|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100963|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100964|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139100965|NCT03701282|Venetoclax|venetoclax|mesh-list
139100966|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
139100967|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100968|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100969|NCT03678753|Cenobamate|cenobamate|mesh-list
139100970|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
139100971|NCT03660826|Durvalumab|durvalumab|mesh-list
139100972|NCT03660826|Olaparib|olaparib|mesh-list
139100973|NCT03660826|Cediranib|cediranib|mesh-list
139100974|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139100975|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
139100976|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139100977|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
139100978|NCT03660826|Maleic acid|maleic acid|mesh-list
139100979|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139100980|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139100981|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
139100982|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100983|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100984|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100985|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139100986|NCT03656081|Itraconazole|itraconazole|mesh-list
139100987|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139100988|NCT03656081|Amphotericin B|amphotericin b|mesh-list
138851594|NCT02751294|Tafenoquine|tafenoquine|mesh-list
139100989|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
139100990|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139100991|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139100992|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139100993|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139100994|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139100995|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139100996|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
139100997|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139100998|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139100999|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139101000|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139101001|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139101002|NCT03656081|Amebicides|amebicides|mesh-ancestor
139101003|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139101004|NCT03620032|Vinorelbine|vinorelbine|mesh-list
139101005|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
139101006|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139101007|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101008|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
139101009|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
139101010|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
139101011|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101012|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101013|NCT03600701|Atezolizumab|atezolizumab|mesh-list
139101014|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139101015|NCT03600701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139101016|NCT03600701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101017|NCT03600701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101018|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101019|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
139101020|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101021|NCT03600350|Nivolumab|nivolumab|mesh-list
139101022|NCT03600350|Sargramostim|sargramostim|mesh-list
139101023|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101024|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101025|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139101026|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101027|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
139101028|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101029|NCT03582033|Dexamethasone|dexamethasone|mesh-list
139101030|NCT03582033|Pomalidomide|pomalidomide|mesh-list
139101031|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139101032|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
139101033|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
139101034|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101035|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101036|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139101037|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
139101038|NCT03582033|Hormones|hormones|mesh-ancestor
139034438|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139101039|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139101040|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139101041|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101042|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
139101043|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139101044|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139101045|NCT03582033|Growth Substances|growth substances|mesh-ancestor
139101046|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
139101047|NCT03513952|Atezolizumab|atezolizumab|mesh-list
139101048|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139101049|NCT03513952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139101050|NCT03513952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101051|NCT03513952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101053|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
139101054|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101055|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139101056|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139101057|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
139101058|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139101059|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101060|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101061|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139101062|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139101063|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139101064|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
139101065|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101066|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101067|NCT03385226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139101068|NCT03385226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101069|NCT03382561|Cisplatin|cisplatin|mesh-list
139101070|NCT03382561|Carboplatin|carboplatin|mesh-list
139101071|NCT03382561|Nivolumab|nivolumab|mesh-list
139101072|NCT03382561|Etoposide|etoposide|mesh-list
139101073|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
139101074|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
139101075|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101076|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101077|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139101078|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101079|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139101080|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139101081|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139101082|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101083|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
139101084|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
139101085|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
139101086|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
139101097|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101098|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101100|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139101101|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
139101102|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101103|NCT03321643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139101113|NCT03252808|Paclitaxel|paclitaxel|mesh-list
139101114|NCT03252808|Gemcitabine|gemcitabine|mesh-list
139101115|NCT03252808|Tegafur|tegafur|mesh-list
139101116|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139101117|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101118|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
139101119|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
139101120|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
139101121|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101122|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139101123|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
139101125|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139101126|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
139101127|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101128|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139101129|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139101130|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
139101131|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101132|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101133|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139101134|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
139101135|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139101136|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
139101137|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101139|NCT03229278|Nivolumab|nivolumab|mesh-list
139101140|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139101141|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101142|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101143|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139101144|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101145|NCT03199885|Paclitaxel|paclitaxel|mesh-list
139101146|NCT03199885|Docetaxel|docetaxel|mesh-list
139101147|NCT03199885|Trastuzumab|trastuzumab|mesh-list
139101148|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139101149|NCT03199885|Atezolizumab|atezolizumab|mesh-list
139101150|NCT03199885|Pertuzumab|pertuzumab|mesh-list
138785088|NCT04216186|Vitamins|vitamins|mesh-ancestor
139101151|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139101152|NCT03199885|Antibodies|antibodies|mesh-list
139101153|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
139101154|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139101155|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139101156|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101157|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
139101158|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
139101159|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
139101160|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101161|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
139101162|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101163|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101164|NCT03199885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139101165|NCT03193333|Timolol|timolol|mesh-list
139101166|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139101167|NCT03193333|Dorzolamide|dorzolamide|mesh-list
139101168|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139101169|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139101170|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139101171|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139101172|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
139101173|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139101174|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101175|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101176|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139101177|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139101178|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139101179|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139101180|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139101181|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139101182|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101183|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139101184|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101185|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
139034512|NCT01008293|Lactulose|lactulose|mesh-list
139101186|NCT03112044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139101187|NCT03112044|Velpatasvir|velpatasvir|mesh-list
139101188|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
139101189|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101190|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
139101191|NCT03030378|Interleukin-12|interleukin-12|mesh-list
139101192|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101193|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101194|NCT03030378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139101195|NCT03030378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101196|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139101197|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
138887435|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
139101198|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101199|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139101200|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139101201|NCT03030378|Growth Substances|growth substances|mesh-ancestor
139101202|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
139101204|NCT03015974|Prednisone|prednisone|mesh-list
139101205|NCT03015974|Prednisolone|prednisolone|mesh-list
139101206|NCT03015974|Deflazacort|deflazacort|mesh-list
139101207|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
139101208|NCT03015974|Dipyridamole|dipyridamole|mesh-list
139101209|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139101210|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139101211|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139101212|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
139101213|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101214|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139101215|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139101216|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
139101217|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101218|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101219|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139101220|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139101221|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
139101222|NCT03015974|Hormones|hormones|mesh-ancestor
139101223|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139101224|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139101225|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139101226|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139101227|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
139101228|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139101229|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101230|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101231|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
139101232|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139101233|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139101234|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
139101235|NCT03008408|Everolimus|everolimus|mesh-list
139101236|NCT03008408|Letrozole|letrozole|mesh-list
139101237|NCT03008408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139101238|NCT03008408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139101239|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101240|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101241|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139101242|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
139101243|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101244|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101245|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139101246|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139101247|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139101248|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
139101249|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139101250|NCT02960230|Nivolumab|nivolumab|mesh-list
139101251|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101252|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101253|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139101254|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101255|NCT02862275|Atezolizumab|atezolizumab|mesh-list
139101256|NCT02862275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139101257|NCT02862275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139101258|NCT02862275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101259|NCT02862275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101260|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101261|NCT02862275|Immunologic Factors|immunologic factors|mesh-ancestor
139101262|NCT02862275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620409|NCT00211445|Verteporfin|verteporfin|mesh-list
139101274|NCT02834637|Vaccines|vaccines|mesh-list
139101275|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
139101276|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101277|NCT02773407|Azithromycin|azithromycin|mesh-list
139101278|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139101279|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139101280|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101281|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139101282|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
139101283|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139101284|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139101285|NCT02642042|Docetaxel|docetaxel|mesh-list
139101286|NCT02642042|Trametinib|trametinib|mesh-list
139101287|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101288|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
139101289|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
139101290|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
139101291|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101292|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139101293|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101294|NCT02631733|Irinotecan|irinotecan|mesh-list
139101295|NCT02631733|Veliparib|veliparib|mesh-list
139101296|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139101297|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139101298|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139101299|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101300|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101301|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101302|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139101303|NCT02631733|Hematinics|hematinics|mesh-ancestor
139101304|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139101305|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139101306|NCT02608268|Decitabine|decitabine|mesh-list
139101307|NCT02608268|Spartalizumab|spartalizumab|mesh-list
139101308|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139101309|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
139101310|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101311|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101312|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101313|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139101314|NCT02608268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101315|NCT02595879|Deoxyglucose|deoxyglucose|mesh-list
139101316|NCT02595879|Cisplatin|cisplatin|mesh-list
139101317|NCT02595879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139101318|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101319|NCT02595879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139101320|NCT02595879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101321|NCT02595879|Antimetabolites|antimetabolites|mesh-ancestor
139101322|NCT02595879|Antiviral Agents|antiviral agents|mesh-ancestor
139101323|NCT02595879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101324|NCT02506192|Prednisone|prednisone|mesh-list
139101325|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139101326|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
139101327|NCT02506192|Hormones|hormones|mesh-ancestor
139101328|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139101329|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101330|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139101331|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101332|NCT02476825|Fluticasone|fluticasone|mesh-list
139101334|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139101335|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139101336|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
139101337|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101338|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101339|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139101340|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
139101341|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
139101342|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139101343|NCT02453984|Atezolizumab|atezolizumab|mesh-list
139101344|NCT02453984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138620481|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
139101345|NCT02453984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101346|NCT02453984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101347|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101348|NCT02395666|Eflornithine|eflornithine|mesh-list
139101349|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101350|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139101351|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139101352|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139101353|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101354|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139101355|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101356|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101357|NCT02257528|Nivolumab|nivolumab|mesh-list
139101358|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101359|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101360|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138851961|NCT00902473|Topiramate|topiramate|mesh-list
139101361|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101362|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
139101363|NCT02245321|Hematinics|hematinics|mesh-ancestor
139101364|NCT02223819|Crizotinib|crizotinib|mesh-list
139101365|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101366|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139101367|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101368|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101369|NCT02160015|Rituximab|rituximab|mesh-list
139101370|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139101371|NCT02160015|Lenalidomide|lenalidomide|mesh-list
139101372|NCT02160015|Antibodies|antibodies|mesh-list
139101373|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
139101374|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139101375|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
139101376|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101377|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101378|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139101379|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139101380|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139101381|NCT02160015|Growth Substances|growth substances|mesh-ancestor
139101382|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
139101383|NCT02078648|Poly I-C|poly i-c|mesh-list
139101384|NCT02078648|Bevacizumab|bevacizumab|mesh-list
139101385|NCT02078648|Imiquimod|imiquimod|mesh-list
139101386|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139101387|NCT02078648|Poly ICLC|poly iclc|mesh-list
139101388|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101389|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101390|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139101391|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139101392|NCT02078648|Growth Substances|growth substances|mesh-ancestor
139101393|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101394|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
139101395|NCT02078648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139101396|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
139101397|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
139101398|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
139101399|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101400|NCT02078648|Laxatives|laxatives|mesh-ancestor
139101401|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139101402|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
139101403|NCT02048813|Rituximab|rituximab|mesh-list
139101404|NCT02048813|Fludarabine|fludarabine|mesh-list
139101405|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
139101406|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139101407|NCT02048813|Antibodies|antibodies|mesh-list
139101408|NCT02048813|Immunoglobulins|immunoglobulins|mesh-list
139101409|NCT02048813|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139101410|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139101411|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
139101412|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101413|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139101414|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139101415|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
138952274|NCT00890643|Prazosin|prazosin|mesh-list
139101416|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101417|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101418|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139101419|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139101420|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
139101421|NCT02027935|Aldesleukin|aldesleukin|mesh-list
139101422|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
139101423|NCT02027935|Ipilimumab|ipilimumab|mesh-list
139101424|NCT02027935|Interleukin-2|interleukin-2|mesh-list
139101425|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139101426|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
139101427|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101428|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139101429|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139101430|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
139101431|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101432|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101433|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139101434|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101435|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138852034|NCT02852837|Daratumumab|daratumumab|mesh-list
139101436|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139101437|NCT02027935|Analgesics|analgesics|mesh-ancestor
139101438|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
139101439|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101441|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139101442|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
139101443|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101444|NCT02003209|Carboplatin|carboplatin|mesh-list
139101445|NCT02003209|Docetaxel|docetaxel|mesh-list
139101446|NCT02003209|Trastuzumab|trastuzumab|mesh-list
139101447|NCT02003209|Pertuzumab|pertuzumab|mesh-list
139101448|NCT02003209|Goserelin|goserelin|mesh-list
139101449|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139101450|NCT02003209|Antibodies|antibodies|mesh-list
139101451|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
139101452|NCT02003209|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139101453|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139101454|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
139101455|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101456|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101457|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
139101458|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
139101459|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
139101460|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101461|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101462|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139101463|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139101464|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101465|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139101466|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
139101467|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139101468|NCT01788020|Dexamethasone|dexamethasone|mesh-list
139101469|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
139101470|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
139101471|NCT01788020|Rituximab|rituximab|mesh-list
139101472|NCT01788020|Bortezomib|bortezomib|mesh-list
139101473|NCT01788020|BB 1101|bb 1101|mesh-list
139101474|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139101475|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
139101476|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101477|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139101478|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139101479|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
139101480|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101481|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101482|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139101483|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139101484|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
139101485|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
139101486|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101487|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139101488|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
139101489|NCT01788020|Hormones|hormones|mesh-ancestor
139101490|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139101491|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139101492|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
139101493|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101494|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101495|NCT01708941|Interferons|interferons|mesh-list
139101496|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
139101497|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
139101498|NCT01708941|Ipilimumab|ipilimumab|mesh-list
139101499|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101500|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
139101501|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101502|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101503|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139101504|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101505|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
139101506|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101508|NCT01495676|Gemcitabine|gemcitabine|mesh-list
139101509|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101510|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139101511|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
139101512|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101513|NCT00762645|Travoprost|travoprost|mesh-list
139101514|NCT00762645|Pilocarpine|pilocarpine|mesh-list
139101515|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139101516|NCT00762645|Miotics|miotics|mesh-ancestor
139101517|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
139101518|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101519|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101520|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139101521|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139101522|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
139101523|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139101524|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101525|NCT00274599|Telmisartan|telmisartan|mesh-list
139101526|NCT00274599|Ramipril|ramipril|mesh-list
139101527|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139101528|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139101529|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139101530|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101531|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139101532|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
139101533|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101534|NCT03949686|Bupivacaine|bupivacaine|mesh-list
139101535|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
139101536|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
139101537|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139101538|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101539|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
139101540|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101541|NCT03949842|Fluticasone|fluticasone|mesh-list
139101542|NCT03949842|Xhance|xhance|mesh-list
139101543|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
139101544|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
139101545|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
139101546|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139101547|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139101548|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
138952294|NCT00767598|Udenafil|udenafil|mesh-list
139101549|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101550|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101551|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139101552|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
139101553|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
139101554|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139101555|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139101556|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101557|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139101558|NCT01102608|Ifosfamide|ifosfamide|mesh-list
139101559|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139101560|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
139101561|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101562|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101563|NCT01102686|Leucovorin|leucovorin|mesh-list
139101564|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
139101565|NCT01102686|Antidotes|antidotes|mesh-ancestor
139101566|NCT01102686|Protective Agents|protective agents|mesh-ancestor
139101567|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101568|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
139101569|NCT01102686|Vitamins|vitamins|mesh-ancestor
139101570|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
139101571|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
139101572|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139101573|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139101574|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101575|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139101576|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101577|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101578|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139101579|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139101580|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139101581|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
139101582|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101583|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139101584|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139101585|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101587|NCT05626140|Lacosamide|lacosamide|mesh-list
139101588|NCT05626140|Codeine|codeine|mesh-list
139101589|NCT05626140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138852179|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
139101590|NCT05626140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139101591|NCT05626140|Analgesics|analgesics|mesh-ancestor
139101592|NCT05626140|Sensory System Agents|sensory system agents|mesh-ancestor
139101593|NCT05626140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101594|NCT05626140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101595|NCT05626140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139101596|NCT05626140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139101597|NCT05626140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139101598|NCT05626140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101599|NCT05626140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101600|NCT05626140|Anticonvulsants|anticonvulsants|mesh-ancestor
139101601|NCT05626140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139101602|NCT05626140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139101603|NCT05626140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139101604|NCT05626140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139101605|NCT05626140|Narcotics|narcotics|mesh-ancestor
139101606|NCT05626140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139101607|NCT05626140|Antitussive Agents|antitussive agents|mesh-ancestor
139101608|NCT05626140|Respiratory System Agents|respiratory system agents|mesh-ancestor
139101609|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139101610|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139101611|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101612|NCT04813614|Lidocaine|lidocaine|mesh-list
139101613|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
139101614|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
139101615|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139101616|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101617|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
139101618|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101619|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139101620|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139101621|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139101622|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139101623|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101624|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139101625|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
139101626|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139101627|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139101628|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101629|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101630|NCT01106118|Urological Agents|urological agents|mesh-ancestor
139101631|NCT00234065|Aspirin|aspirin|mesh-list
139101632|NCT00234065|Cilostazol|cilostazol|mesh-list
139034623|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139101633|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139101634|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139101635|NCT00234065|Analgesics|analgesics|mesh-ancestor
139101636|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
139101637|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101638|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101639|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139101640|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139101641|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139101642|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139101643|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101644|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139101645|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139101647|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
139101648|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139101649|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
139101650|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139101651|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
139101652|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
139101653|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139101654|NCT00234065|Protective Agents|protective agents|mesh-ancestor
139101655|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139101656|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139101657|NCT01108848|Complement C1s|complement c1s|mesh-list
139101658|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139101659|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
139101660|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
139101661|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101662|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139101663|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139101664|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
139101666|NCT00233987|Carmustine|carmustine|mesh-list
139101667|NCT00233987|Etoposide|etoposide|mesh-list
139101668|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139101669|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
139101670|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101671|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139101672|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139101673|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
139101674|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101675|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101676|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139101677|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139101678|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139101679|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139101680|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101681|NCT01108926|Tenofovir|tenofovir|mesh-list
139101682|NCT01108926|Emtricitabine|emtricitabine|mesh-list
139101683|NCT01108926|Efavirenz|efavirenz|mesh-list
139101684|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139101685|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
139101686|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101687|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139101688|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139101689|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101690|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101691|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139101692|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139101693|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139101694|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139034636|NCT01021358|Ketoconazole|ketoconazole|mesh-list
139101695|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139101696|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139101697|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139101698|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139101700|NCT04623242|Immunologic Factors|immunologic factors|mesh-ancestor
139101701|NCT04623242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101702|NCT00233363|Rebamipide|rebamipide|mesh-list
139101703|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139101704|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139101705|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
139101706|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101707|NCT00233363|Protective Agents|protective agents|mesh-ancestor
139101708|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101709|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101710|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
139101711|NCT01147666|Hematinics|hematinics|mesh-ancestor
139101712|NCT01073111|Sirolimus|sirolimus|mesh-list
139101713|NCT01073111|Everolimus|everolimus|mesh-list
139101714|NCT01073111|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139101715|NCT01073111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139101716|NCT01073111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101717|NCT01073111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101718|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139101719|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
139101720|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101721|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101722|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139101723|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101724|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139101725|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
139101726|NCT01325987|Vitamin D|vitamin d|mesh-list
139101727|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
139101728|NCT01325987|Cholecalciferol|cholecalciferol|mesh-list
139101729|NCT01325987|Vitamins|vitamins|mesh-list
139101730|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
139101731|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101732|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139101733|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139101734|NCT00256295|Gemcitabine|gemcitabine|mesh-list
139101735|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
138852360|NCT02750748|Naltrexone|naltrexone|mesh-list
139101736|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139101737|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
139101738|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101739|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101741|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
139101742|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139101743|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139101744|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101745|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952315|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139101746|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101747|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139101748|NCT01109160|Azithromycin|azithromycin|mesh-list
139101749|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139101750|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101751|NCT01363336|Nifedipine|nifedipine|mesh-list
139101752|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139101753|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139101754|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101755|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139101756|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101757|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
139101758|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
139101759|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139101760|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
139101761|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139101762|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
139101763|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101764|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
139101765|NCT01363414|Protective Agents|protective agents|mesh-ancestor
139101766|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
139101767|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139101768|NCT02223520|Mupirocin|mupirocin|mesh-list
139101769|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139101770|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101771|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
139101772|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
139101773|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139101774|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139101775|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101776|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101777|NCT01356472|Imipenem|imipenem|mesh-list
139101778|NCT01356472|Cilastatin|cilastatin|mesh-list
139101779|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139101780|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101781|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
139101782|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101783|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101784|NCT02122198|Leuprolide|leuprolide|mesh-list
139101785|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139101786|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
139101787|NCT02122198|Estradiol|estradiol|mesh-list
139101788|NCT02122198|Estrogens|estrogens|mesh-ancestor
139101789|NCT02122198|Hormones|hormones|mesh-ancestor
139101790|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139101791|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101792|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139101793|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
139101794|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139101795|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139101796|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139101797|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
139101798|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139101799|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101800|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139101801|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139101802|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139101803|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139101804|NCT01363570|Ranibizumab|ranibizumab|mesh-list
139101805|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139101806|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139101807|NCT01363570|Growth Substances|growth substances|mesh-ancestor
139101808|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101809|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
139101810|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101811|NCT04608500|Minocycline|minocycline|mesh-list
139101812|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139101813|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101814|NCT01363648|Choline|choline|mesh-list
139101815|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
139101816|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139101817|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
139101818|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034657|NCT01021436|Amikacin|amikacin|mesh-list
139101819|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139101820|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139101821|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
139101822|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
139101823|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139101824|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101825|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139101826|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139101827|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101828|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101829|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101830|NCT03944070|Ranibizumab|ranibizumab|mesh-list
139101831|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139101832|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139101833|NCT03944070|Growth Substances|growth substances|mesh-ancestor
139101834|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101835|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
139101836|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101837|NCT01363804|Tivozanib|tivozanib|mesh-list
139101838|NCT01363804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139101839|NCT01363804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101840|NCT01363804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101841|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139101842|NCT03764462|AD 101|ad 101|mesh-list
139101843|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139101844|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
139101845|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139101846|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101847|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139101848|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139101849|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139101850|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139101851|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101852|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139101853|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139101854|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
139101855|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101856|NCT05460416|Aspirin|aspirin|mesh-list
139101857|NCT05460416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139101858|NCT05460416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139101859|NCT05460416|Analgesics|analgesics|mesh-ancestor
139101860|NCT05460416|Sensory System Agents|sensory system agents|mesh-ancestor
139101861|NCT05460416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952349|NCT00764244|Hormones|hormones|mesh-ancestor
139101862|NCT05460416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101863|NCT05460416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139101864|NCT05460416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139101865|NCT05460416|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139101866|NCT05460416|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139101867|NCT05460416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101868|NCT05460416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139101869|NCT05460416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139101871|NCT05460416|Antipyretics|antipyretics|mesh-ancestor
139101872|NCT01364194|Bupivacaine|bupivacaine|mesh-list
139101873|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
139101874|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
139101875|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139101876|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101877|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
139101878|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101879|NCT04575038|Brequinar|brequinar|mesh-list
139101880|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101881|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101882|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101883|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139101884|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
139101885|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101886|NCT03066622|Olanzapine|olanzapine|mesh-list
139101887|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
139101888|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
139101889|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101890|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101891|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139101892|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139101893|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139101894|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139101895|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139101896|NCT03066622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139101897|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139101898|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139101899|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101900|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139101901|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
139101902|NCT01364974|Peficitinib|peficitinib|mesh-list
139101903|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101904|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101905|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139101906|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
139101907|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101908|NCT05323214|Fentanyl|fentanyl|mesh-list
139101909|NCT05323214|Dexmedetomidine|dexmedetomidine|mesh-list
139101910|NCT05323214|Analgesics|analgesics|mesh-list
139101911|NCT05323214|Bupivacaine|bupivacaine|mesh-list
139101912|NCT05323214|Anesthetics, Local|anesthetics, local|mesh-ancestor
139101913|NCT05323214|Anesthetics|anesthetics|mesh-ancestor
139101914|NCT05323214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139101915|NCT05323214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101916|NCT05323214|Sensory System Agents|sensory system agents|mesh-ancestor
139101917|NCT05323214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101918|NCT05323214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139101919|NCT05323214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138952356|NCT00770640|Insulin|insulin|mesh-list
139101920|NCT05323214|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139101921|NCT05323214|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139101922|NCT05323214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139101923|NCT05323214|Adrenergic Agents|adrenergic agents|mesh-ancestor
139101924|NCT05323214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139101925|NCT05323214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101926|NCT05323214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139101927|NCT05323214|Narcotics|narcotics|mesh-ancestor
139101928|NCT05323214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139101929|NCT05323214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139101930|NCT05323214|Anesthetics, General|anesthetics, general|mesh-ancestor
139101931|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
139101932|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139101933|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101934|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139101935|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139101936|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101937|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101938|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101939|NCT01356862|Pasireotide|pasireotide|mesh-list
139101940|NCT01356862|Hormones|hormones|mesh-ancestor
139101941|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139101942|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101944|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139101945|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
139101946|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
139101947|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139101948|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101949|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139101950|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
139101951|NCT03763760|Hormones|hormones|mesh-ancestor
139101952|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139101953|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139101954|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101955|NCT04501952|Remdesivir|remdesivir|mesh-list
139101956|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
139101957|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101958|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
139101959|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101960|NCT00321100|Bevacizumab|bevacizumab|mesh-list
139101961|NCT00321100|Cetuximab|cetuximab|mesh-list
139101962|NCT00321100|Capecitabine|capecitabine|mesh-list
139101963|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
139101964|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139101965|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101966|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139101967|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139101968|NCT00321100|Growth Substances|growth substances|mesh-ancestor
139101969|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101970|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
139101971|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139101972|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
139101973|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101974|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139101975|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139101976|NCT01365598|Primaquine|primaquine|mesh-list
139101977|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
139101978|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139101979|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139101980|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101981|NCT01365676|Hypericin|hypericin|mesh-list
139101982|NCT01365676|Antidepressive Agents|antidepressive agents|mesh-ancestor
139101983|NCT01365676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139101984|NCT01365676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139101985|NCT01365676|Antiviral Agents|antiviral agents|mesh-ancestor
139101986|NCT01365676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139101987|NCT01365676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139101988|NCT01365676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139101989|NCT01365676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139101990|NCT01365676|Immunologic Factors|immunologic factors|mesh-ancestor
139101991|NCT01365676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101992|NCT03754712|Vitamin D|vitamin d|mesh-list
139101993|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
139101994|NCT03754712|Vitamins|vitamins|mesh-ancestor
139101995|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
139101996|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139101997|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139101998|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139101999|NCT01318954|Immunomodulating Agents|immunomodulating agents|mesh-list
139102000|NCT01318954|Immunologic Factors|immunologic factors|mesh-ancestor
139102001|NCT01318954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102002|NCT00070018|Prednisone|prednisone|mesh-list
139102003|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
139102004|NCT00070018|Rituximab|rituximab|mesh-list
139102005|NCT00070018|Doxorubicin|doxorubicin|mesh-list
139102006|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139102007|NCT00070018|Vincristine|vincristine|mesh-list
139102008|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139102009|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139102010|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
139102011|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102012|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139102013|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139102014|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
139102015|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621146|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
139102016|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102017|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139102018|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139102019|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139102020|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139102021|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139102022|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102023|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139102024|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
139102026|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139102027|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139102028|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139102029|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
139102030|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
139102031|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
139102032|NCT03991988|Montelukast|montelukast|mesh-list
139102033|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138852616|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139102034|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
139102035|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139102036|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
139102037|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139034722|NCT05405387|Budesonide|budesonide|mesh-list
139102039|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139102040|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139102041|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102043|NCT01073189|Furosemide|furosemide|mesh-list
139102044|NCT01073189|Diuretics|diuretics|mesh-ancestor
139102045|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
139102046|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102047|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139102048|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139102049|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102050|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139102051|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
139102052|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
139102053|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
139102054|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102055|NCT05191186|Immunomodulating Agents|immunomodulating agents|mesh-list
139102056|NCT05191186|Immunologic Factors|immunologic factors|mesh-ancestor
139102057|NCT05191186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102058|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
139102059|NCT03750656|Tamsulosin|tamsulosin|mesh-list
139102060|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139102061|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139102062|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139102063|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
139102064|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102065|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102066|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102067|NCT03750656|Urological Agents|urological agents|mesh-ancestor
139102068|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139102069|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139102070|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139102071|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
139102072|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102073|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139102074|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
139102075|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
139102076|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
139102077|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139102078|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139102079|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
139102080|NCT03752294|Dabigatran|dabigatran|mesh-list
139102081|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
139102082|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139102083|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
139102084|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102085|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102086|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
139102087|NCT03135028|Cytarabine|cytarabine|mesh-list
139102089|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139102090|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
139034752|NCT05637281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102091|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102092|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102093|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
139102094|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139102095|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139102096|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
139102097|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102098|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139102099|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139102100|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139102101|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102102|NCT03752138|Decitabine|decitabine|mesh-list
138952396|NCT00609609|Prednisolone|prednisolone|mesh-list
139102103|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139102104|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
139102105|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102106|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102107|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102108|NCT01370434|Dexamethasone|dexamethasone|mesh-list
139102109|NCT01370434|Doxorubicin|doxorubicin|mesh-list
139102110|NCT01370434|Vincristine|vincristine|mesh-list
139102111|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139102112|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
139102113|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
139102114|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102115|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102116|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139102117|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
139102118|NCT01370434|Hormones|hormones|mesh-ancestor
139102119|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139102120|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139102121|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102122|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102123|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102124|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139102125|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139102126|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139102127|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139102128|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
139102129|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
139102130|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
139102131|NCT05190952|Dexamethasone|dexamethasone|mesh-list
139102132|NCT05190952|Ketamine|ketamine|mesh-list
139102133|NCT05190952|Bupivacaine|bupivacaine|mesh-list
139102134|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139102135|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
139102136|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
139102137|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102138|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102139|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139102140|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
139102141|NCT05190952|Hormones|hormones|mesh-ancestor
139102142|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139102143|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139102144|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102145|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
139102146|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
139102147|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102148|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
139102149|NCT05190952|Analgesics|analgesics|mesh-ancestor
139102150|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139102151|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139102152|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
139102153|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139102154|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139102155|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102156|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102158|NCT03972683|Adenosine|adenosine|mesh-list
139102159|NCT03972683|Nitroprusside|nitroprusside|mesh-list
139102160|NCT03972683|Phenylephrine|phenylephrine|mesh-list
139102161|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
139102162|NCT03972683|Acetylcholine|acetylcholine|mesh-list
139102163|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139102164|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
139102165|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
139102166|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102167|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102168|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
139102169|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139102170|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
139102171|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
139102172|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139102173|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139102174|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139102175|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
139102176|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102177|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102178|NCT03972683|Protective Agents|protective agents|mesh-ancestor
139102179|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139102180|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139102181|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139102182|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139102183|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
139102184|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139102185|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139102186|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
139102187|NCT03972683|Analgesics|analgesics|mesh-ancestor
139102188|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
139102189|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
139102190|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139102191|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
139102192|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
139102193|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139102194|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139102195|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139102196|NCT04411628|Bamlanivimab|bamlanivimab|mesh-list
139102197|NCT04411628|Antiviral Agents|antiviral agents|mesh-ancestor
139102198|NCT04411628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139102199|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
139102200|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139102201|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
139102202|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102203|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
139102204|NCT03754010|Protective Agents|protective agents|mesh-ancestor
139102205|NCT00227591|Prednisone|prednisone|mesh-list
139102206|NCT00227591|Lenalidomide|lenalidomide|mesh-list
139102207|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139102208|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
139102209|NCT00227591|Hormones|hormones|mesh-ancestor
139102210|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139102211|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102212|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139102213|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102214|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
139102215|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139102216|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139102217|NCT00227591|Growth Substances|growth substances|mesh-ancestor
139102218|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
139102219|NCT01358344|Pantoprazole|pantoprazole|mesh-list
139102221|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139102222|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139102223|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139102224|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102225|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102226|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139102227|NCT01366300|Lidocaine|lidocaine|mesh-list
139102228|NCT01366300|Propofol|propofol|mesh-list
139102229|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
139102230|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
139102231|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102232|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102233|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
139102234|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102235|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139102236|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139102237|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139102238|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139102239|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102240|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139102241|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139102242|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
139102243|NCT00226811|Sunitinib|sunitinib|mesh-list
139102244|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102245|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139102246|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139102247|NCT00226811|Growth Substances|growth substances|mesh-ancestor
139102248|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102249|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
139102250|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139102251|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102252|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102253|NCT05261516|Magnesium Sulfate|magnesium sulfate|mesh-list
139102254|NCT05261516|Analgesics|analgesics|mesh-ancestor
139102255|NCT05261516|Sensory System Agents|sensory system agents|mesh-ancestor
139102256|NCT05261516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102257|NCT05261516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102258|NCT05261516|Anesthetics|anesthetics|mesh-ancestor
139102259|NCT05261516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102260|NCT05261516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139102261|NCT05261516|Anticonvulsants|anticonvulsants|mesh-ancestor
139102262|NCT05261516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139102263|NCT05261516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139102264|NCT05261516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102265|NCT05261516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139102267|NCT05261516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139102268|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
139102269|NCT00226655|Hormones|hormones|mesh-ancestor
139102270|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139102271|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102272|NCT01371058|Clopidogrel|clopidogrel|mesh-list
139102273|NCT01371058|Policosanol|policosanol|mesh-list
139102274|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139102275|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139102276|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139102277|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139102278|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
139102279|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102280|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102281|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102282|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139102283|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139102284|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
139102285|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139102286|NCT01105338|Lycopene|lycopene|mesh-list
139102287|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139102288|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
139102289|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102290|NCT01105338|Protective Agents|protective agents|mesh-ancestor
139102291|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102292|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139102293|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139102294|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102295|NCT03747614|Fluorometholone|fluorometholone|mesh-list
139102296|NCT03747614|Tacrolimus|tacrolimus|mesh-list
139102297|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139102298|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
139102299|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102300|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139102301|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102302|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102303|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139102304|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
139102305|NCT03747614|Hormones|hormones|mesh-ancestor
139102306|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139102307|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139102308|NCT05347004|BI 425809|bi 425809|mesh-list
139102309|NCT05347004|Nootropic Agents|nootropic agents|mesh-ancestor
139102310|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139102311|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139102312|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
139102313|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102314|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102315|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
139102316|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139102317|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102318|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
139102319|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102320|NCT03747536|Bromides|bromides|mesh-list
139102321|NCT03747536|Ipratropium|ipratropium|mesh-list
139102322|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
139102323|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139102324|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
139102325|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102326|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102327|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139102328|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
139102329|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139102330|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
139102331|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102332|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102333|NCT01358500|Fentanyl|fentanyl|mesh-list
139102334|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139102335|NCT01358500|Narcotics|narcotics|mesh-ancestor
139102336|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102337|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102338|NCT01358500|Analgesics|analgesics|mesh-ancestor
139102339|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
139102340|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102341|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139102342|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139102343|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
139102344|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
139102345|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
139102346|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
139102347|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102348|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102349|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102350|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
139102351|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
139102352|NCT03751514|Azithromycin|azithromycin|mesh-list
139102353|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139102354|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139102355|NCT03615664|Dexamethasone|dexamethasone|mesh-list
139102356|NCT03615664|Gemcitabine|gemcitabine|mesh-list
139102357|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139102358|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139102359|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
139102360|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
139102361|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102362|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102363|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139102364|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
139102365|NCT03615664|Hormones|hormones|mesh-ancestor
139102366|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139102367|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139102368|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102369|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139102370|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
139102371|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102372|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139102373|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
139102374|NCT03513250|Scopolamine|scopolamine|mesh-list
139102375|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139102376|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139102377|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
139102378|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
139102379|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102380|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102381|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139102382|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
139102383|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139102384|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
139102385|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102386|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102387|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139102388|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
139102389|NCT01358812|Panitumumab|panitumumab|mesh-list
139102390|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139102391|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102392|NCT01371448|Paroxetine|paroxetine|mesh-list
139102393|NCT01371448|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139102394|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139102395|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139102396|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102397|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102398|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
139102399|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102400|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139102401|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
139102402|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139102403|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139102404|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139102405|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102407|NCT01371526|Hormones|hormones|mesh-ancestor
139102408|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139102409|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102411|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139102412|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139102413|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139102414|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102415|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102416|NCT01371604|Ribavirin|ribavirin|mesh-list
139102417|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139102418|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
139102419|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102420|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
139102421|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139102422|NCT01371682|Ropinirole|ropinirole|mesh-list
139102423|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139102424|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139102425|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
139102426|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
139102427|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102428|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102429|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102430|NCT01107756|Lenograstim|lenograstim|mesh-list
139102431|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139102432|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
139102433|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102434|NCT03127384|Lidocaine|lidocaine|mesh-list
139102435|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
139102436|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
139102437|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102438|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102439|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
139102440|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102441|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139102442|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139102443|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139102444|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139102445|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102446|NCT01111656|Interferons|interferons|mesh-list
139102447|NCT01111656|Interferon-beta|interferon-beta|mesh-list
139102448|NCT01111656|Atorvastatin|atorvastatin|mesh-list
139102449|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
139102450|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102451|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
139102452|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139102453|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139102454|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139102455|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
139102456|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102457|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139102458|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139102459|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102460|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
139102461|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102462|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139102464|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139102465|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102466|NCT02819752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139102467|NCT02819752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102468|NCT02567578|YH12852|yh12852|mesh-list
139102469|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139102470|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139102471|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
139102472|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102473|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102474|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102475|NCT02523274|Resveratrol|resveratrol|mesh-list
139102476|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
139102477|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102478|NCT02523274|Protective Agents|protective agents|mesh-ancestor
138952474|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139102479|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102480|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102481|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139102482|NCT02432560|Sirolimus|sirolimus|mesh-list
139102483|NCT02432560|Everolimus|everolimus|mesh-list
139102484|NCT02432560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139102485|NCT02432560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139102486|NCT02432560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102487|NCT02432560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102488|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139102489|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
139102490|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102491|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102492|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139102493|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139102494|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139102495|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
139102496|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
139102497|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139102498|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102499|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
139102500|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139102501|NCT01111734|Expectorants|expectorants|mesh-ancestor
139102502|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
139102503|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139102504|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
139102505|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102506|NCT01111734|Protective Agents|protective agents|mesh-ancestor
139102507|NCT01111734|Antidotes|antidotes|mesh-ancestor
139102508|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139102509|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139102510|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139102511|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102512|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102513|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139102514|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139034861|NCT03836664|Timolol|timolol|mesh-list
139102515|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102517|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102518|NCT01111890|Timolol|timolol|mesh-list
139102519|NCT01111890|Dorzolamide|dorzolamide|mesh-list
139102520|NCT01111890|Brinzolamide|brinzolamide|mesh-list
139102521|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139102522|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139102523|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
139102524|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102525|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102526|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102527|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139102528|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139102529|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138952496|NCT00968578|Hormones|hormones|mesh-ancestor
139102530|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102531|NCT01111968|Vaccines|vaccines|mesh-list
139102533|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102534|NCT04398134|Entecavir|entecavir|mesh-list
139102535|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
139102536|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139102537|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
139102538|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139102539|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139102540|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139102541|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139102542|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102543|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102544|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102545|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
139102546|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139102547|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139102548|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139102549|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139102550|NCT01108302|Oxytocin|oxytocin|mesh-list
139102551|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
139102552|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139102553|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102554|NCT03122860|Lorecivivint|lorecivivint|mesh-list
139102555|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139102556|NCT01319188|Ranibizumab|ranibizumab|mesh-list
139102557|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138853142|NCT05378711|Serotonin Agents|serotonin agents|mesh-ancestor
138853150|NCT00777153|Cediranib|cediranib|mesh-list
139102558|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139102559|NCT01319188|Growth Substances|growth substances|mesh-ancestor
139102560|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102561|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
139102562|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102564|NCT05167084|Metyrapone|metyrapone|mesh-list
139102565|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139102566|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
139102567|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102568|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102569|NCT00867178|Vitamin A|vitamin a|mesh-list
139102570|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
139102571|NCT00867178|Thiotepa|thiotepa|mesh-list
139102572|NCT00867178|Cisplatin|cisplatin|mesh-list
139102573|NCT00867178|Carboplatin|carboplatin|mesh-list
139102574|NCT00867178|Etoposide|etoposide|mesh-list
139102575|NCT00867178|Vincristine|vincristine|mesh-list
139102577|NCT00867178|Tretinoin|tretinoin|mesh-list
139102578|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
139102579|NCT00867178|Isotretinoin|isotretinoin|mesh-list
139102580|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139102581|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
139102582|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102583|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139102584|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139102585|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
139102586|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102587|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102588|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139102589|NCT00867178|Vitamins|vitamins|mesh-ancestor
139102590|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
139102591|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139102592|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139102593|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139102594|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102595|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
139102596|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
139102597|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
139102598|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139102599|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
139102600|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
139102601|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
139102602|NCT03945396|Antacids|antacids|mesh-ancestor
139102603|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102604|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139102605|NCT01109784|Clopidogrel|clopidogrel|mesh-list
139102606|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139102607|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139102608|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139102609|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139102610|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139102611|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
139102612|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102613|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102614|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102615|NCT01328340|Methamphetamine|methamphetamine|mesh-list
139102616|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139102617|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102618|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
139102619|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
139102620|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102621|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
139102622|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102623|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102624|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
139102625|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139102626|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139102627|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139102628|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139102630|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
139102631|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
139102632|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102633|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102635|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102636|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139102637|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139102638|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139102639|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139102640|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102641|NCT01328106|Trametinib|trametinib|mesh-list
139102642|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102643|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139102644|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102645|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102646|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
139102647|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139102648|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102649|NCT03122548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139102650|NCT03122548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102651|NCT03749642|Gabapentin|gabapentin|mesh-list
139102652|NCT03749642|Trazodone|trazodone|mesh-list
139102653|NCT03749642|Analgesics|analgesics|mesh-ancestor
139102654|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
139102655|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102656|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102657|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
139102658|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139102659|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139102660|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102661|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139102662|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139102663|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139102664|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102665|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102666|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
139102667|NCT03749642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139102668|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139102669|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139102670|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
139102671|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139102672|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
139102673|NCT03751358|Anesthetics|anesthetics|mesh-list
139102674|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
139102675|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102676|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102677|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
139102678|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102679|NCT05193292|Trastuzumab|trastuzumab|mesh-list
139102680|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139102681|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102682|NCT05193214|Antibodies|antibodies|mesh-list
139102683|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139102684|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
139102685|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102686|NCT02529774|Leucovorin|leucovorin|mesh-list
139102687|NCT02529774|Dexamethasone|dexamethasone|mesh-list
139102688|NCT02529774|Capecitabine|capecitabine|mesh-list
139102689|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
139102690|NCT02529774|Fluorouracil|fluorouracil|mesh-list
139102691|NCT02529774|Floxuridine|floxuridine|mesh-list
139102692|NCT02529774|Heparin|heparin|mesh-list
139102693|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
139102694|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139102695|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
139102696|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
139102697|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102698|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102699|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139102700|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
139102701|NCT02529774|Hormones|hormones|mesh-ancestor
139102702|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139102703|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139102704|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102705|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139102706|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
138853292|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
139102707|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102708|NCT02529774|Antidotes|antidotes|mesh-ancestor
139102709|NCT02529774|Protective Agents|protective agents|mesh-ancestor
139102710|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
139102711|NCT02529774|Vitamins|vitamins|mesh-ancestor
139102712|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
139102713|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139102714|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
139102715|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
139102716|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139102717|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139102718|NCT04459598|Efavirenz|efavirenz|mesh-list
139102719|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139102720|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139102721|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102722|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102723|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
139102724|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139102725|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139102726|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139102727|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139102728|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139102729|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139102730|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139102731|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
139102732|NCT03942354|Linezolid|linezolid|mesh-list
139102733|NCT03942354|Bedaquiline|bedaquiline|mesh-list
139102734|NCT03942354|Clofazimine|clofazimine|mesh-list
139102735|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139102736|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139102737|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139102738|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139102739|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102740|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102741|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102742|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139102743|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
139102744|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139102745|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
139102746|NCT05165992|Fentanyl|fentanyl|mesh-list
139102747|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139102748|NCT05165992|Narcotics|narcotics|mesh-ancestor
139102749|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102750|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102751|NCT05165992|Analgesics|analgesics|mesh-ancestor
139102752|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
139102753|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102754|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139102755|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139102756|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
139102758|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139102759|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
139102760|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139102761|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102762|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
139102763|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102764|NCT01367626|Letrozole|letrozole|mesh-list
139102765|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102766|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139102767|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139102768|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102769|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102770|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139102771|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
139102772|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139102773|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102774|NCT01112748|Lidocaine|lidocaine|mesh-list
139102775|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
139102776|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
139102777|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102778|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102779|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
139102780|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138853367|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139102781|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139102782|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139102783|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139102784|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139102785|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102786|NCT05192902|Anesthetics|anesthetics|mesh-list
139102787|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102788|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102789|NCT01211808|Diltiazem|diltiazem|mesh-list
139102790|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139102791|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139102792|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139102793|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102794|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139102795|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102796|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
139102797|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139102798|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
139102799|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139102800|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
139102801|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139102802|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102803|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139102804|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139102805|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139102806|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139102807|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139102808|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
139102809|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139102810|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139102811|NCT05191888|Amoxicillin|amoxicillin|mesh-list
139102812|NCT05191888|Metronidazole|metronidazole|mesh-list
139102813|NCT05191888|Clarithromycin|clarithromycin|mesh-list
139102814|NCT05191888|Rabeprazole|rabeprazole|mesh-list
139102815|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139102816|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139102817|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139102818|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139102819|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139102820|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102821|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102822|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139102823|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139102824|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139102825|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139102826|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139102827|NCT01112826|Capecitabine|capecitabine|mesh-list
139102828|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139102829|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
139102830|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102831|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102832|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
139102833|NCT01210014|Astringents|astringents|mesh-ancestor
139102834|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102835|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
139102836|NCT05118256|Pirfenidone|pirfenidone|mesh-list
139102837|NCT05118256|Analgesics|analgesics|mesh-ancestor
139102838|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
139102839|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102840|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102841|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139102842|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139102843|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139102844|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139102845|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102846|NCT01114542|Insulin|insulin|mesh-list
139102847|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139102848|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
139102849|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139102850|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102851|NCT02529540|Methamphetamine|methamphetamine|mesh-list
139102852|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139102853|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102854|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
139102855|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
139102856|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102857|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
139102858|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102859|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102860|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
139102861|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139102862|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139102863|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139102864|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139102865|NCT01359436|Antibodies|antibodies|mesh-list
139102866|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
139102867|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102868|NCT01359514|Pregabalin|pregabalin|mesh-list
139102869|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
139102870|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139102871|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139102872|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102873|NCT01359514|Analgesics|analgesics|mesh-ancestor
139102874|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
139102875|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102876|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
139102877|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139102878|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102879|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139102880|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139102881|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102882|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139102883|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139102884|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139102885|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102886|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
139102887|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
139102888|NCT01368016|Nicotine|nicotine|mesh-list
139102889|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139102890|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
139102891|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102892|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102893|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139102894|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139102895|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
139102896|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102897|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102898|NCT01208454|Vitamin A|vitamin a|mesh-list
139102899|NCT01208454|Vorinostat|vorinostat|mesh-list
139102900|NCT01208454|Tretinoin|tretinoin|mesh-list
139102901|NCT01208454|Isotretinoin|isotretinoin|mesh-list
139102902|NCT01208454|Vitamins|vitamins|mesh-ancestor
139102903|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
139102904|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102905|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102906|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139102907|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952573|NCT04035382|Misoprostol|misoprostol|mesh-list
139102908|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102909|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
139102910|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
139102911|NCT01110486|Carboplatin|carboplatin|mesh-list
139102912|NCT01110486|Docetaxel|docetaxel|mesh-list
139102913|NCT01110486|Ilorasertib|ilorasertib|mesh-list
139102914|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102915|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
139102916|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
139102917|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
139102918|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102919|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139102920|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102921|NCT01372306|Galantamine|galantamine|mesh-list
139102922|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139102923|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102924|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138853521|NCT05658692|Cholinergic Agents|cholinergic agents|mesh-ancestor
139102925|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
139102926|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102927|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102929|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
139102930|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102931|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
139102932|NCT01114854|Topiramate|topiramate|mesh-list
139102933|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
139102934|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139102935|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102936|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
139102937|NCT01359670|Tadalafil|tadalafil|mesh-list
139102938|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
139102939|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139102940|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139102941|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102942|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102943|NCT01359670|Urological Agents|urological agents|mesh-ancestor
139102944|NCT05188768|Mitogens|mitogens|mesh-list
139102945|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
139102946|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102947|NCT01368328|Chromium|chromium|mesh-list
139102948|NCT01368328|Niacin|niacin|mesh-list
139102949|NCT01368328|Trace Elements|trace elements|mesh-ancestor
139102950|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
139102951|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102952|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139102953|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
139102954|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102955|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139102956|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
139102957|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
139102958|NCT01368328|Vitamins|vitamins|mesh-ancestor
139102959|NCT01110642|Lovastatin|lovastatin|mesh-list
139102960|NCT01110642|L 647318|l 647318|mesh-list
139102961|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
139102962|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139102963|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139102964|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
139102965|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102966|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139102967|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139102968|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102969|NCT02929498|Azacitidine|azacitidine|mesh-list
139102970|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139102971|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
139102972|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102973|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139102974|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139102975|NCT01359826|Milnacipran|milnacipran|mesh-list
139102976|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
139102977|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139102978|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139102979|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139102980|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139102981|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139102982|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102983|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139102984|NCT01359826|Analgesics|analgesics|mesh-ancestor
139102985|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
139102986|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102987|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
139102988|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139102989|NCT03792672|Ketamine|ketamine|mesh-list
139102990|NCT03792672|Analgesics|analgesics|mesh-ancestor
139102991|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
139102992|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139102993|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139102994|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139102995|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139102996|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
139102997|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
139102998|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139102999|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139103000|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139103001|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103002|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103003|NCT01372540|Filanesib|filanesib|mesh-list
139103004|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
139103005|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
139103006|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103007|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103008|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
139103009|NCT01113138|Analgesics|analgesics|mesh-ancestor
139103010|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
139103011|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103012|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103013|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
139103014|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139103015|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139103016|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
139103017|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139103018|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103019|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103020|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139103021|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
139103022|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139103023|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
139103024|NCT01115322|Tazarotene|tazarotene|mesh-list
138952611|NCT04008316|Colchicine|colchicine|mesh-list
139103025|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
139103026|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
139103027|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
139103028|NCT01115322|Vitamins|vitamins|mesh-ancestor
139103029|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
139103030|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103031|NCT01111188|Bortezomib|bortezomib|mesh-list
139103032|NCT01111188|Palbociclib|palbociclib|mesh-list
139103033|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103034|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139103035|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103036|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103037|NCT01210482|Sirolimus|sirolimus|mesh-list
139103038|NCT01210482|Temsirolimus|temsirolimus|mesh-list
139103039|NCT01210482|MTOR Inhibitors|mtor inhibitors|mesh-list
139103040|NCT01210482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139103041|NCT01210482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103042|NCT01210482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103043|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139103044|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
139103045|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103046|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103047|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139103049|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139103050|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
139103051|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
139103052|NCT01360060|Analgesics|analgesics|mesh-ancestor
139103053|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
139103054|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103055|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103056|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
139103057|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139103058|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139103059|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
139103060|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139103061|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103062|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103063|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139103064|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
139103065|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139103066|NCT01210638|Oxymorphone|oxymorphone|mesh-list
139103067|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139103068|NCT01210638|Narcotics|narcotics|mesh-ancestor
139103069|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139103070|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103071|NCT01210638|Analgesics|analgesics|mesh-ancestor
139103072|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
139103073|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103074|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139103075|NCT03120676|Atezolizumab|atezolizumab|mesh-list
139103076|NCT03120676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139103077|NCT03120676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103078|NCT03120676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139103079|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103080|NCT01115478|Vitamin A|vitamin a|mesh-list
139103081|NCT01115478|Vitamins|vitamins|mesh-ancestor
139103082|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
139103083|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103084|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
139103085|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139103086|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
139103087|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139103088|NCT01111422|Expectorants|expectorants|mesh-ancestor
139103089|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
139103090|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139103091|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
139103092|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103093|NCT01111422|Protective Agents|protective agents|mesh-ancestor
139103094|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103095|NCT01111422|Antidotes|antidotes|mesh-ancestor
139103096|NCT01212432|Daptomycin|daptomycin|mesh-list
139103097|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139103098|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139103099|NCT01213368|Dronedarone|dronedarone|mesh-list
139103100|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139103101|NCT01369186|Morphine|morphine|mesh-list
139103102|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139103103|NCT01369186|Narcotics|narcotics|mesh-ancestor
139103104|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139103105|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103106|NCT01369186|Analgesics|analgesics|mesh-ancestor
139103107|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
139103108|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103110|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139103111|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103112|NCT01117662|Rituximab|rituximab|mesh-list
139103113|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139103114|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103115|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
139103116|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103117|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139103118|NCT01319266|Hydrocodone|hydrocodone|mesh-list
139103119|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139103120|NCT01319266|Narcotics|narcotics|mesh-ancestor
139103121|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139103122|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103123|NCT01319266|Analgesics|analgesics|mesh-ancestor
139103124|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
139103125|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103126|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
139103127|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
139103128|NCT01115790|Prexasertib|prexasertib|mesh-list
139103129|NCT01115790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139103130|NCT01115790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103131|NCT01115790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103132|NCT01115946|Enalapril|enalapril|mesh-list
139103133|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139103134|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
139103135|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103136|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103137|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139103138|NCT01113372|Clopidogrel|clopidogrel|mesh-list
139103139|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139103140|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139103141|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139103142|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139103143|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
139103144|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103145|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103146|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103147|NCT03120520|Plecanatide|plecanatide|mesh-list
139103148|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139103149|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
139103150|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103151|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139103152|NCT03941340|Aflutinib|aflutinib|mesh-list
139103153|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139103155|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103156|NCT01372930|Etanercept|etanercept|mesh-list
138952631|NCT00969046|Epothilone B|epothilone b|mesh-list
139103157|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139103158|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139103159|NCT01372930|Analgesics|analgesics|mesh-ancestor
139103160|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
139103161|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103162|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035030|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139103163|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139103164|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139103165|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139103166|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139103167|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
139103169|NCT01328652|Lansoprazole|lansoprazole|mesh-list
139103170|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139103171|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103172|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103173|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139103174|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139103175|NCT01373008|Beclomethasone|beclomethasone|mesh-list
139103176|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139103177|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
139103178|NCT01373008|Hormones|hormones|mesh-ancestor
139103179|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139103180|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103181|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139103182|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
139103183|NCT01116180|Candesartan|candesartan|mesh-list
139103184|NCT01116180|Candesartan cilexetil|candesartan cilexetil|mesh-list
139103185|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
139103186|NCT01116180|Giapreza|giapreza|mesh-list
139103187|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139103188|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
139103189|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139103190|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139103191|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103192|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139103193|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139103194|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
139103195|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103196|NCT01113528|Aspirin|aspirin|mesh-list
139103197|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139103198|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139103199|NCT01113528|Analgesics|analgesics|mesh-ancestor
139103200|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
139103201|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103202|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103203|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139103204|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139103205|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139103206|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139103207|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103208|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139103209|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139103210|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103212|NCT01369576|Zopiclone|zopiclone|mesh-list
139103213|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139103214|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139103215|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103216|NCT01113762|Cimetidine|cimetidine|mesh-list
139103217|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138330180|NCT05175768|Niacin|niacin|mesh-list
139103218|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139103219|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139103220|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
139103221|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
139103222|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103223|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103224|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103225|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138853886|NCT02747316|Iron|iron|mesh-list
139103226|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139103227|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103228|NCT01212666|Ropivacaine|ropivacaine|mesh-list
139103229|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
139103230|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
139103231|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139103232|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103233|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
139103234|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103235|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139103236|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103237|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139103238|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103239|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103240|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
139103241|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139103242|NCT01213680|Hematinics|hematinics|mesh-ancestor
139103243|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
139103244|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139103245|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103246|NCT01211496|Methamphetamine|methamphetamine|mesh-list
139103247|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139103248|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103249|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
139103250|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
139103251|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103252|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
139103253|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103254|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103255|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
139103256|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139103257|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139103258|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103259|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139103260|NCT01118286|Nifedipine|nifedipine|mesh-list
139103261|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139103262|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103263|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103264|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139103265|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103266|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
139103267|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
139103268|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139103269|NCT01585350|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139103270|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
139103271|NCT01585350|Poly ICLC|poly iclc|mesh-list
139103272|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139103274|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103276|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
139103277|NCT01118598|Niacin|niacin|mesh-list
139103278|NCT01118598|Niacinamide|niacinamide|mesh-list
139103279|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
139103280|NCT01118598|Vitamins|vitamins|mesh-ancestor
139103281|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
139103282|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103283|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139103284|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
139103285|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103286|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139103287|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
139103288|NCT01216020|Cisplatin|cisplatin|mesh-list
139103289|NCT01216020|Cetuximab|cetuximab|mesh-list
139103290|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103291|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139103292|NCT01121796|Vitamin D|vitamin d|mesh-list
139103293|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
139103294|NCT01121796|Cholecalciferol|cholecalciferol|mesh-list
139103295|NCT01121796|Vitamins|vitamins|mesh-list
139103296|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
139103297|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103298|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139103299|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139103300|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139103301|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
139103302|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103303|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103304|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139103305|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103306|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
139103307|NCT01119144|Calcium|calcium|mesh-list
139103308|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139103309|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103310|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139103311|NCT01117038|Amlodipine|amlodipine|mesh-list
139103312|NCT01117038|Enalapril|enalapril|mesh-list
139103313|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139103314|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139103315|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103316|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103317|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139103318|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103319|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
139103320|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139103321|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
139103322|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103323|NCT01119534|Camphor|camphor|mesh-list
139103324|NCT01119534|Eucalyptol|eucalyptol|mesh-list
139103325|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
139103326|NCT01119534|Menthol|menthol|mesh-list
139103327|NCT01119534|Guaifenesin|guaifenesin|mesh-list
139103328|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139103329|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
138952686|NCT03617913|Cisplatin|cisplatin|mesh-list
139103330|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
139103331|NCT01119534|Expectorants|expectorants|mesh-ancestor
139103332|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
139103333|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139103334|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139103335|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
139103336|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103337|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103338|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103339|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
139103340|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139103341|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
139103342|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
139103343|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103344|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
139103345|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139103346|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139103347|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139103348|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
139103350|NCT01119534|Protective Agents|protective agents|mesh-ancestor
139103351|NCT01117116|Fluticasone|fluticasone|mesh-list
139103352|NCT01117116|Xhance|xhance|mesh-list
139103353|NCT01117116|Budesonide|budesonide|mesh-list
139103354|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
139103355|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139103356|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139103357|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139103358|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
139103359|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103360|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103361|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139103362|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
139103363|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
139103364|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139103365|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
139103366|NCT01117116|Hormones|hormones|mesh-ancestor
139103367|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139103368|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139103369|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139103370|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139103371|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
139103372|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103373|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103374|NCT01216488|Lidocaine|lidocaine|mesh-list
139103375|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
139103376|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
139103377|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139103378|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103379|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
139103380|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103381|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139103382|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139103383|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139103384|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139035107|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
138952696|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139103385|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103386|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
139103387|NCT01122342|Testosterone|testosterone|mesh-list
139103388|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
139103389|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
139103390|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139103391|NCT01122342|Androgens|androgens|mesh-ancestor
139103392|NCT01122342|Hormones|hormones|mesh-ancestor
139103393|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139103394|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103395|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139103396|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103397|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
139103398|NCT01213992|Iron|iron|mesh-list
139103399|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139103400|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
139103401|NCT01213992|Trace Elements|trace elements|mesh-ancestor
139103402|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
139103403|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103404|NCT01213992|Hematinics|hematinics|mesh-ancestor
139103405|NCT01216644|Leucovorin|leucovorin|mesh-list
139103406|NCT01216644|Docetaxel|docetaxel|mesh-list
139103407|NCT01216644|Fluorouracil|fluorouracil|mesh-list
139103408|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
139103409|NCT01216644|Epirubicin|epirubicin|mesh-list
139103410|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103411|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
139103412|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
139103413|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
139103414|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103415|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
139103416|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139103417|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139103418|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
139103419|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103420|NCT01216644|Antidotes|antidotes|mesh-ancestor
139103421|NCT01216644|Protective Agents|protective agents|mesh-ancestor
139103422|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
139103423|NCT01216644|Vitamins|vitamins|mesh-ancestor
139103424|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
139103425|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139103426|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139103427|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139103428|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103429|NCT04959760|Antibodies|antibodies|mesh-list
139103430|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
139103431|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
139103432|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
139103433|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103434|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
139103435|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139103436|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103437|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103438|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139103439|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139103440|NCT01214226|Protective Agents|protective agents|mesh-ancestor
139103441|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103442|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
139103443|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139103444|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
139103445|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
139103446|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139103447|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103448|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
139103449|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103450|NCT01219062|Morphine|morphine|mesh-list
139103451|NCT01219062|Bupivacaine|bupivacaine|mesh-list
139103452|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
139103453|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
139103454|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139103455|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103456|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
139103457|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103458|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139103459|NCT01219062|Narcotics|narcotics|mesh-ancestor
139103460|NCT01219062|Analgesics|analgesics|mesh-ancestor
139103461|NCT01120158|Paclitaxel|paclitaxel|mesh-list
139103462|NCT01120158|Bevacizumab|bevacizumab|mesh-list
139103463|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139103464|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103465|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
139103466|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
139103467|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
139103468|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103469|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139103470|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139103471|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139103472|NCT01120158|Growth Substances|growth substances|mesh-ancestor
139103473|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103474|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
139103475|NCT01373398|Apaziquone|apaziquone|mesh-list
139103476|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103477|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
139103478|NCT01124526|Rituximab|rituximab|mesh-list
139103479|NCT01124526|Fludarabine|fludarabine|mesh-list
139103480|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139103481|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
139103482|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103483|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139035138|NCT00467558|Naltrexone|naltrexone|mesh-list
139103484|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139103485|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
139103486|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103487|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103488|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139103489|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139103490|NCT01120314|Otamixaban|otamixaban|mesh-list
139103491|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139103492|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
139103493|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139103494|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
139103495|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103496|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103497|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
139103498|NCT03633994|Heparin|heparin|mesh-list
139103499|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
139103500|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139103501|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139103502|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103503|NCT01328886|Omalizumab|omalizumab|mesh-list
139103504|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139103505|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139103506|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
139103507|NCT01216878|Losartan|losartan|mesh-list
139103508|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139103509|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139103510|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139103511|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139103512|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103513|NCT04624984|Gemcitabine|gemcitabine|mesh-list
139103514|NCT04624984|Doxorubicin|doxorubicin|mesh-list
139103515|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139103516|NCT04624984|Vinorelbine|vinorelbine|mesh-list
139103517|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139103518|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139103519|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
139103520|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103521|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103522|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139103523|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139103524|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139103525|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103526|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139103527|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
139103528|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
139103529|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
139103530|NCT04624984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139103531|NCT01214382|Sertraline|sertraline|mesh-list
139103532|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
139103533|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139103534|NCT01214382|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139103535|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139103536|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103537|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103538|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103539|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
139103540|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035191|NCT00320385|Lapatinib|lapatinib|mesh-list
139103541|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
139103542|NCT01216956|Niacin|niacin|mesh-list
139103543|NCT01216956|Niacinamide|niacinamide|mesh-list
139103544|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
139103545|NCT01216956|Vitamins|vitamins|mesh-ancestor
139103546|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
139103547|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103548|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139103549|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
139103550|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103551|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139103552|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
139103553|NCT01217034|Sorafenib|sorafenib|mesh-list
139103554|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
139103555|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103556|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139103557|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103558|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103559|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139103560|NCT01217034|Estrogens|estrogens|mesh-ancestor
139103561|NCT01217034|Hormones|hormones|mesh-ancestor
139103562|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139103563|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103564|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139103565|NCT01373554|Oltipraz|oltipraz|mesh-list
139103566|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
139103567|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139103568|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
139103569|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139103570|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
139103571|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139103572|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139103573|NCT01373554|Protective Agents|protective agents|mesh-ancestor
139103574|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103575|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103576|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139103577|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139103578|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103579|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103580|NCT01319344|Eplerenone|eplerenone|mesh-list
139103581|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139103582|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
139103583|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139103584|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103585|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139103586|NCT01319344|Diuretics|diuretics|mesh-ancestor
139103587|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
139103588|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139103589|NCT01373632|Sirolimus|sirolimus|mesh-list
139103590|NCT01373632|Temsirolimus|temsirolimus|mesh-list
139103591|NCT01373632|MTOR Inhibitors|mtor inhibitors|mesh-list
139103592|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139103593|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139103594|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139103595|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103596|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
139103597|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139103598|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
139103599|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103600|NCT01373632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139103601|NCT01373632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103602|NCT01373632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103603|NCT01124760|Ketoconazole|ketoconazole|mesh-list
139103604|NCT01124760|Diltiazem|diltiazem|mesh-list
139103605|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
139103606|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139103608|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139103609|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103610|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103611|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139103612|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
139103613|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139103614|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103615|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139103616|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139103617|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139103618|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103619|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139103620|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
139103621|NCT01214772|Heparin|heparin|mesh-list
139103622|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
139103623|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139103624|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139103625|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103626|NCT01125150|Metformin|metformin|mesh-list
139103627|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139103628|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103629|NCT01373710|Trastuzumab|trastuzumab|mesh-list
139103630|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139103631|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103632|NCT03869866|Vaccines|vaccines|mesh-list
139103633|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
139103634|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103635|NCT03783702|Acetaminophen|acetaminophen|mesh-list
139103636|NCT03783702|Ibuprofen|ibuprofen|mesh-list
139103637|NCT03783702|Oxycodone|oxycodone|mesh-list
139103638|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139103639|NCT03783702|Analgesics|analgesics|mesh-ancestor
139103640|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
139103641|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103642|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103643|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
139103644|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139103645|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139103646|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139103647|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139103648|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103649|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103650|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139103652|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139103653|NCT01319734|Glyburide|glyburide|mesh-list
139035211|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
139103654|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103655|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139103657|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139103658|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
139103659|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139103660|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
139103661|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139103662|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103663|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139103664|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139103665|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103666|NCT03575572|Colchicine|colchicine|mesh-list
139103667|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
139103668|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139103669|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
139103670|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
139103671|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
139103672|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103673|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103674|NCT01214928|Vitamin D|vitamin d|mesh-list
139103675|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
139103676|NCT01214928|Vitamins|vitamins|mesh-ancestor
139103677|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
139103678|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103679|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139103680|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139103682|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139103683|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103684|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139103685|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139103686|NCT01122966|Growth Substances|growth substances|mesh-ancestor
139103687|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103688|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
139103689|NCT01219686|Pindolol|pindolol|mesh-list
139103690|NCT01219686|Dexetimide|dexetimide|mesh-list
139103691|NCT01219686|Citalopram|citalopram|mesh-list
139103692|NCT01219686|Escitalopram|escitalopram|mesh-list
139103693|NCT01219686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139103694|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139103695|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103696|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103697|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103698|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
139103699|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103700|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139103701|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139035240|NCT00319449|Atorvastatin|atorvastatin|mesh-list
139103702|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
139103703|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
139103704|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103705|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139103706|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139103707|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
139103708|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139103709|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
139103710|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139103711|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139103712|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139103713|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
139103714|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139103715|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139103716|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
139103717|NCT01219764|Amoxicillin|amoxicillin|mesh-list
139103718|NCT01219764|Metronidazole|metronidazole|mesh-list
139103719|NCT01219764|Clarithromycin|clarithromycin|mesh-list
139103720|NCT01219764|Rabeprazole|rabeprazole|mesh-list
139103721|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139103722|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139103723|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139103724|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139103725|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139103726|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103727|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103728|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139103729|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139103730|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139103731|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139103732|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139103734|NCT03936426|Trace Elements|trace elements|mesh-ancestor
139103735|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
139103736|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103737|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
139103738|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139103739|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103740|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103741|NCT01125696|Ritonavir|ritonavir|mesh-list
139103742|NCT01125696|Lopinavir|lopinavir|mesh-list
139103743|NCT01125696|Tenofovir|tenofovir|mesh-list
139103744|NCT01125696|Lamivudine|lamivudine|mesh-list
139103745|NCT01125696|Zidovudine|zidovudine|mesh-list
139103746|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139103747|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139103748|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
139103749|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103750|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103751|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138854345|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139035256|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
139103752|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139103753|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
139103754|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139103755|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139103756|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139103757|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139103758|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139103759|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
139103761|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139103762|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103763|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103764|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
139103765|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103766|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103767|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
139103768|NCT03116152|Paclitaxel|paclitaxel|mesh-list
139103769|NCT03116152|Irinotecan|irinotecan|mesh-list
139103770|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139103771|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103772|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
139103773|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
139103774|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
139103775|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103776|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139103777|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139103778|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103779|NCT01123278|Testosterone|testosterone|mesh-list
139103780|NCT01123278|Androgens|androgens|mesh-ancestor
139103781|NCT01123278|Hormones|hormones|mesh-ancestor
139103782|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139103783|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103784|NCT01219920|Leucovorin|leucovorin|mesh-list
139103785|NCT01219920|Irinotecan|irinotecan|mesh-list
139103786|NCT01219920|Antidotes|antidotes|mesh-ancestor
139103787|NCT01219920|Protective Agents|protective agents|mesh-ancestor
139103788|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103789|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
139103790|NCT01219920|Vitamins|vitamins|mesh-ancestor
139103791|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
139103792|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103793|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103794|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139103795|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139103796|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103797|NCT01400776|Estradiol|estradiol|mesh-list
139103798|NCT01400776|Estrogens|estrogens|mesh-ancestor
139103799|NCT01400776|Hormones|hormones|mesh-ancestor
139103800|NCT01400776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139103801|NCT01400776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103803|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139103804|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
139103805|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139103806|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103807|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139103808|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103809|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139103810|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139103811|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139103813|NCT01220154|Bevacizumab|bevacizumab|mesh-list
139103814|NCT01220154|Carboplatin|carboplatin|mesh-list
139103815|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139103816|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103817|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
139103818|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
139103819|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
139103820|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103821|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139103822|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139103823|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139103824|NCT01220154|Growth Substances|growth substances|mesh-ancestor
139103825|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103826|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
139103827|NCT01182766|Topiramate|topiramate|mesh-list
139103828|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
139103829|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139103830|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103831|NCT01220232|Lamivudine|lamivudine|mesh-list
139103832|NCT01220232|Abacavir|abacavir|mesh-list
139103833|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
139103834|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139103835|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139103836|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103837|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103838|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
139103839|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139103840|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139103841|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139103842|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
139103843|NCT01126008|Docetaxel|docetaxel|mesh-list
139103844|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103845|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
139103846|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
139103847|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
139103848|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103849|NCT01123824|Clopidogrel|clopidogrel|mesh-list
139103850|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139103851|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139103852|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139103853|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139103854|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
139103855|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035315|NCT00422058|Orlistat|orlistat|mesh-list
139103856|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103857|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103858|NCT01126086|Otamixaban|otamixaban|mesh-list
139103859|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139103860|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
139103861|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139103862|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
139103863|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103864|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103865|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
139103866|NCT03009838|Letrozole|letrozole|mesh-list
139103867|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103868|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139103869|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139103870|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103871|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103872|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139103873|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
138623015|NCT00220064|Leucovorin|leucovorin|mesh-list
139103874|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139103875|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103876|NCT01124058|Heparin|heparin|mesh-list
139103877|NCT01124058|Calcium heparin|calcium heparin|mesh-list
139103878|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139103879|NCT01124058|Tinzaparin|tinzaparin|mesh-list
139103880|NCT01124058|Dalteparin|dalteparin|mesh-list
139103881|NCT01124058|Warfarin|warfarin|mesh-list
139103882|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
139103883|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138952812|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
139103884|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139103885|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103886|NCT01375972|Cisplatin|cisplatin|mesh-list
139103887|NCT01375972|Gemcitabine|gemcitabine|mesh-list
139103888|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139103889|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139103890|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
139103891|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103892|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139103893|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
139103894|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139103895|NCT01220622|Nimodipine|nimodipine|mesh-list
139103896|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139103897|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139103898|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103899|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103900|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139103901|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103902|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
139103903|NCT05123170|Lidocaine|lidocaine|mesh-list
138854495|NCT05786859|Rifaximin|rifaximin|mesh-list
139103904|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
139103905|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
139103906|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
139103907|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139103908|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103909|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
139103910|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103911|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139103912|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139103913|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139103914|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103915|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103916|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139103917|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139103918|NCT05123170|Analgesics|analgesics|mesh-ancestor
139035332|NCT00413244|Testosterone|testosterone|mesh-list
139103919|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139103920|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139103921|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139103922|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
139103923|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103924|NCT01215708|Tamsulosin|tamsulosin|mesh-list
139103925|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139103926|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139103927|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139103928|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
139103929|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103930|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952822|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139103931|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103932|NCT01215708|Urological Agents|urological agents|mesh-ancestor
139103933|NCT01222026|Vitamin D|vitamin d|mesh-list
139103934|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
139103935|NCT01222026|Vitamins|vitamins|mesh-ancestor
139103936|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
139103937|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103938|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139103939|NCT00225251|Bupropion|bupropion|mesh-list
139103940|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139103941|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
139103942|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139103943|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139103944|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139103945|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103946|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103947|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
139103948|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103949|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103950|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139103951|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139103952|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103953|NCT01376128|Paroxetine|paroxetine|mesh-list
139103954|NCT01376128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139103955|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139103956|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103957|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103958|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139103959|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
139103960|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103961|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139103962|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
139103963|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139103964|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139103965|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139103966|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139103967|NCT01376206|Fluticasone|fluticasone|mesh-list
139103968|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139103969|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139103970|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
139103971|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103972|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103973|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139103974|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
139103975|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
139103976|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139103977|NCT01073501|Pregabalin|pregabalin|mesh-list
139103978|NCT01073501|Analgesics|analgesics|mesh-ancestor
139103979|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
139035337|NCT01033032|Amrubicin|amrubicin|mesh-list
139103980|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139103981|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139103982|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
139103983|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139103984|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139103985|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103986|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139103987|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139103988|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139103989|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139103990|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139103991|NCT01222182|Atorvastatin|atorvastatin|mesh-list
139103992|NCT01222182|Simvastatin|simvastatin|mesh-list
139103993|NCT01222182|Pravastatin|pravastatin|mesh-list
139103994|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139103995|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139103996|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
139103997|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139103998|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139103999|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139104000|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104001|NCT01218750|Bevacizumab|bevacizumab|mesh-list
139104002|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139104003|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104004|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139104005|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139104006|NCT01218750|Growth Substances|growth substances|mesh-ancestor
139104007|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104008|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
139104009|NCT01376284|Dutasteride|dutasteride|mesh-list
139104010|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139104011|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139104012|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104013|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104014|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
139104015|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139104016|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104017|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139104019|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
139104020|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104021|NCT01329042|Citric Acid|citric acid|mesh-list
139104022|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
139104023|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
139104024|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139104025|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
139104026|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
139104027|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104028|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139104029|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
139104030|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104031|NCT00253643|Protective Agents|protective agents|mesh-ancestor
139104032|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104033|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139104034|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139104035|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104036|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139104037|NCT01222650|Silodosin|silodosin|mesh-list
139104038|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139104039|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139104040|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139104041|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
139104042|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104043|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104044|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104045|NCT01222650|Urological Agents|urological agents|mesh-ancestor
139104046|NCT01073579|Vigabatrin|vigabatrin|mesh-list
139104047|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
139104048|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104049|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138854645|NCT05280457|Nivolumab|nivolumab|mesh-list
139104050|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
138952848|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139104051|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104052|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104053|NCT00221195|Thrombin|thrombin|mesh-list
139104054|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
139104055|NCT00221195|Coagulants|coagulants|mesh-ancestor
139104056|NCT04646590|Vaccines|vaccines|mesh-list
139104057|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
139104058|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104059|NCT03931668|Maleic acid|maleic acid|mesh-list
139104060|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104061|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104062|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
139104063|NCT00220805|Antibodies|antibodies|mesh-list
139104064|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
139104065|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139104066|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139104067|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
139104068|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
139104069|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104070|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
139104071|NCT00220727|Antibodies|antibodies|mesh-list
139104072|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
139104073|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139104074|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139104075|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
139104076|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
139104077|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104078|NCT01072097|Atorvastatin|atorvastatin|mesh-list
139104079|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139104080|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139104081|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
139104082|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104083|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139104084|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139104085|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104086|NCT05760430|Bevacizumab|bevacizumab|mesh-list
139104087|NCT05760430|Apatinib|apatinib|mesh-list
139104088|NCT05760430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139104089|NCT05760430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104090|NCT05760430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139104091|NCT05760430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139104092|NCT05760430|Growth Substances|growth substances|mesh-ancestor
139104093|NCT05760430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104094|NCT05760430|Growth Inhibitors|growth inhibitors|mesh-ancestor
139104095|NCT05760430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139104096|NCT05760430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104097|NCT05760430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104099|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139104100|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
139104101|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104102|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139104103|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
139104104|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
139104105|NCT01221402|Vitamins|vitamins|mesh-ancestor
139104106|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
139104107|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104108|NCT04214860|Azacitidine|azacitidine|mesh-list
139104109|NCT04214860|Venetoclax|venetoclax|mesh-list
139104110|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139104111|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
139104112|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104113|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104114|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104115|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139104116|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139104117|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138952867|NCT00980356|Vildagliptin|vildagliptin|mesh-list
139104118|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139104119|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104120|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104121|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104122|NCT01127490|Analgesics|analgesics|mesh-ancestor
139104123|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
139104124|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104125|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
139104126|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139104127|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
139104128|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139104129|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
139104130|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139104131|NCT01126866|Bevacizumab|bevacizumab|mesh-list
139104132|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139104133|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104134|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139104135|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139104136|NCT01126866|Growth Substances|growth substances|mesh-ancestor
139104137|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104138|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
139104139|NCT04103554|Valsartan|valsartan|mesh-list
139104140|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139104141|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139104142|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139104143|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139104144|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104145|NCT03740568|Progesterone|progesterone|mesh-list
139104146|NCT03740568|Progestins|progestins|mesh-ancestor
139104147|NCT03740568|Hormones|hormones|mesh-ancestor
139104148|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139104149|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104150|NCT00252239|Plasminogen|plasminogen|mesh-list
139104151|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139104152|NCT00252239|Tenecteplase|tenecteplase|mesh-list
139104153|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139104154|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139104155|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104156|NCT01127022|Choline|choline|mesh-list
139104157|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
139104158|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139104159|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
139104160|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104161|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139104162|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138623307|NCT00220649|Antidotes|antidotes|mesh-ancestor
139104163|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
139104164|NCT01221558|Lycopene|lycopene|mesh-list
139104165|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139104166|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
139104167|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104168|NCT01221558|Protective Agents|protective agents|mesh-ancestor
139104169|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104170|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139104171|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139104172|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104173|NCT01221636|Abatacept|abatacept|mesh-list
139104174|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139104175|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104176|NCT01221636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139104177|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104178|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139104179|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
139104180|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104181|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139104182|NCT05731804|Ritonavir|ritonavir|mesh-list
139104183|NCT05731804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139104184|NCT05731804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139104185|NCT05731804|Protease Inhibitors|protease inhibitors|mesh-ancestor
139104186|NCT05731804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104187|NCT05731804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104188|NCT05731804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139104189|NCT05731804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139104190|NCT05731804|Antiviral Agents|antiviral agents|mesh-ancestor
139104191|NCT05731804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104192|NCT05731804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139104193|NCT05731804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139104194|NCT01127568|Propranolol|propranolol|mesh-list
139104195|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139104196|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139104197|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
139104198|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138854793|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
139104199|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104200|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104201|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139104202|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139104203|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
139104204|NCT03932292|Calcium|calcium|mesh-list
139104205|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139104206|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104207|NCT01127100|Fentanyl|fentanyl|mesh-list
139104208|NCT01127100|Gabapentin|gabapentin|mesh-list
139104209|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139104210|NCT01127100|Narcotics|narcotics|mesh-ancestor
139104211|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139104212|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104213|NCT01127100|Analgesics|analgesics|mesh-ancestor
139104214|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
139104215|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104216|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139104217|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139104218|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
139104219|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
138952918|NCT00970528|Acarbose|acarbose|mesh-list
139104220|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
139104221|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139104222|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139104223|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139104224|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139104225|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139104226|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104227|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104228|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
139104229|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
139104230|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139104231|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104232|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104233|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104234|NCT01221792|Carvedilol|carvedilol|mesh-list
139104236|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139104237|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
139104238|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104239|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104240|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104241|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139104242|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
139104243|NCT01221792|Protective Agents|protective agents|mesh-ancestor
139104244|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139104245|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139104246|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139104247|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
139104248|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139104249|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139104250|NCT03932526|Apatinib|apatinib|mesh-list
139104251|NCT03932526|Vinorelbine|vinorelbine|mesh-list
139104252|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104253|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139104254|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104255|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104256|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139104257|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
139104258|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
139104259|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
139104260|NCT01127724|Vitamins|vitamins|mesh-list
139104261|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
139104262|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
139104263|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
139104264|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
139104265|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104266|NCT01127724|Hematinics|hematinics|mesh-ancestor
139104267|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
139104268|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139104269|NCT03103906|Protective Agents|protective agents|mesh-ancestor
139104270|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104271|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
139104272|NCT05675098|Methylphenidate|methylphenidate|mesh-list
139104273|NCT05675098|Modafinil|modafinil|mesh-list
139104274|NCT05675098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139104275|NCT05675098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104276|NCT05675098|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139104277|NCT05675098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139104278|NCT05675098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139104279|NCT05675098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104280|NCT05675098|Dopamine Agents|dopamine agents|mesh-ancestor
139104281|NCT05675098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104282|NCT05675098|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139104283|NCT05675098|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139104284|NCT05675098|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139104285|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
139104286|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
139104287|NCT01223742|Vitamins|vitamins|mesh-ancestor
139104288|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
139104289|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104290|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
139104291|NCT01129518|Vaccines|vaccines|mesh-list
139104292|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
139104293|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104294|NCT01223820|Capsaicin|capsaicin|mesh-list
139104295|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
139104296|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
139104297|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
139104298|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104299|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104300|NCT01131234|Cediranib|cediranib|mesh-list
139104301|NCT01131234|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139104302|NCT01131234|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139104303|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104304|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104305|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104306|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139104307|NCT01129596|Donepezil|donepezil|mesh-list
139104308|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139104309|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104310|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104311|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
139104312|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104313|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104314|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
139104316|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
139104317|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
139104318|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139104319|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104320|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139104321|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104322|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104323|NCT01228344|Lumefantrine|lumefantrine|mesh-list
139104324|NCT01228344|Artemether|artemether|mesh-list
139104325|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139104326|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
139104327|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139104328|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139104329|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104330|NCT03927456|Fulvestrant|fulvestrant|mesh-list
139104331|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139104332|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104333|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139104334|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139104335|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
139104336|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139104337|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104338|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139104339|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139104340|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
139104341|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104342|NCT01228422|Interferons|interferons|mesh-list
139104343|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
139104344|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
139104345|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138854947|NCT03785925|Nivolumab|nivolumab|mesh-list
139104347|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104348|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
139104349|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104350|NCT01319422|Pomalidomide|pomalidomide|mesh-list
139104351|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
139104352|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104353|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139104354|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139104355|NCT01319422|Growth Substances|growth substances|mesh-ancestor
139104356|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
139104357|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104358|NCT01227174|Propofol|propofol|mesh-list
139104359|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139104360|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139104361|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104362|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139104363|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
139104364|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
139104365|NCT03924492|Pregnanolone|pregnanolone|mesh-list
139104366|NCT03924492|Brexanolone|brexanolone|mesh-list
139104367|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
139104368|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104369|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104370|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104371|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
139104372|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
139104373|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
139104374|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139104375|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139104376|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139104377|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
139104378|NCT01224366|Vildagliptin|vildagliptin|mesh-list
139104379|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139104380|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104381|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139104383|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104384|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104385|NCT05415826|Dexamethasone|dexamethasone|mesh-list
139104386|NCT05415826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139104387|NCT05415826|Antiemetics|antiemetics|mesh-ancestor
139104388|NCT05415826|Autonomic Agents|autonomic agents|mesh-ancestor
139104389|NCT05415826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104390|NCT05415826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104391|NCT05415826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139104392|NCT05415826|Glucocorticoids|glucocorticoids|mesh-ancestor
139104393|NCT05415826|Hormones|hormones|mesh-ancestor
139104394|NCT05415826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139104395|NCT05415826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139104396|NCT05415826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104397|NCT05415748|Tamsulosin|tamsulosin|mesh-list
139104398|NCT05415748|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139104399|NCT05415748|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139104400|NCT05415748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139104401|NCT05415748|Adrenergic Agents|adrenergic agents|mesh-ancestor
139104402|NCT05415748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104403|NCT05415748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104404|NCT05415748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104405|NCT05415748|Urological Agents|urological agents|mesh-ancestor
139104406|NCT03774576|Itraconazole|itraconazole|mesh-list
139104407|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
139104408|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104409|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139104410|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139104411|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104412|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104413|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139104414|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
139104415|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139104416|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104417|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139104418|NCT05415436|Propofol|propofol|mesh-list
139104419|NCT05415436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139104420|NCT05415436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139104421|NCT05415436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104422|NCT05415436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139104423|NCT05415436|Anesthetics, General|anesthetics, general|mesh-ancestor
139104424|NCT05415436|Anesthetics|anesthetics|mesh-ancestor
139104425|NCT01227408|Paclitaxel|paclitaxel|mesh-list
139104426|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
139104427|NCT01227408|Doxorubicin|doxorubicin|mesh-list
139104428|NCT01227408|Capecitabine|capecitabine|mesh-list
139104429|NCT01227408|Methotrexate|methotrexate|mesh-list
139104430|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138953002|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
139104431|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139104432|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104433|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
139104434|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
139104435|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
139104436|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104437|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139104438|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
139104439|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104440|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139104441|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139104442|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
139104443|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139104444|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139104445|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139104446|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139104447|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104448|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139104449|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
139104450|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139104451|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
139104452|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139104453|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
139104454|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139104455|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139104456|NCT03773796|Nabilone|nabilone|mesh-list
139104457|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
139104458|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
139104459|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104460|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104461|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139104462|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139104463|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139104464|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139104465|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139104466|NCT02927938|Cytarabine|cytarabine|mesh-list
139104467|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139104468|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
139104469|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104470|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104471|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
139104472|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104473|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139104474|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
139104475|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104476|NCT03863860|Fluzoparib|fluzoparib|mesh-list
139104477|NCT03863860|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139104478|NCT03863860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104479|NCT03863860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104480|NCT03863860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104481|NCT03923166|Capecitabine|capecitabine|mesh-list
139104482|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139104483|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
139104484|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104485|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104486|NCT01224756|Tinoridine|tinoridine|mesh-list
139104487|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139104488|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139104489|NCT01224756|Analgesics|analgesics|mesh-ancestor
139104490|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
139104491|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104492|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104493|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139104494|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139104495|NCT03392428|177Lu-PSMA-617|177lu-psma-617|mesh-list
139104496|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139104497|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104498|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
139104499|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139104500|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104501|NCT03222856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139104502|NCT03222856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104503|NCT01130298|Testosterone|testosterone|mesh-list
139104504|NCT01130298|Androgens|androgens|mesh-ancestor
139104505|NCT01130298|Hormones|hormones|mesh-ancestor
139104506|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139104507|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104508|NCT01227720|Nicotine|nicotine|mesh-list
139104509|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139104510|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
139104511|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104512|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104513|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139104514|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139104515|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
139104516|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104517|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104518|NCT03175978|Methotrexate|methotrexate|mesh-list
139104519|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104520|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139104521|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
139104522|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139104523|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139104524|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
139104525|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104526|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104527|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
139104528|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104529|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139104530|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139104531|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
139104532|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139104533|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139104535|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
139104536|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104537|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139104538|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139104539|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104540|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104541|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139104542|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
139104543|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139104544|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104545|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139104546|NCT01227798|Interferons|interferons|mesh-list
139104547|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
139104548|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104549|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
139104550|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104551|NCT01130376|Aldesleukin|aldesleukin|mesh-list
139104552|NCT01130376|Interleukin-2|interleukin-2|mesh-list
139104553|NCT01130376|Hormones|hormones|mesh-list
139104554|NCT01130376|Sargramostim|sargramostim|mesh-list
139104555|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139104556|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104557|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104558|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139104559|NCT01130376|Analgesics|analgesics|mesh-ancestor
139104560|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
139104561|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104562|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
139104563|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139104564|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139104565|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
138855166|NCT01515137|Analgesics|analgesics|mesh-ancestor
139104566|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104567|NCT03740178|Donepezil|donepezil|mesh-list
139104568|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139104569|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104570|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104571|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
139104572|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104573|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104574|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
139104575|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
139104576|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139104577|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
139104578|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104579|NCT01131468|Expectorants|expectorants|mesh-ancestor
139104580|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
139104581|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139104582|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
139104583|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104584|NCT01131468|Protective Agents|protective agents|mesh-ancestor
139104585|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104586|NCT01131468|Antidotes|antidotes|mesh-ancestor
139104587|NCT01225224|Peficitinib|peficitinib|mesh-list
139104588|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035535|NCT01026350|Antibodies|antibodies|mesh-list
139104589|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104590|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139104591|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
139104592|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104594|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139104595|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139104596|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139104597|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104598|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139104599|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104600|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
139104601|NCT01225302|Paclitaxel|paclitaxel|mesh-list
139104602|NCT01225302|Carboplatin|carboplatin|mesh-list
139104603|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139104604|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104605|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
139104606|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
139104607|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
139104608|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104609|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
139104610|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
139104611|NCT01229046|Ticarcillin|ticarcillin|mesh-list
139104612|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
139104613|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139104614|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104615|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104616|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104617|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139104618|NCT03921684|Capecitabine|capecitabine|mesh-list
139104619|NCT03921684|Nivolumab|nivolumab|mesh-list
139104620|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139104621|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
139104622|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104623|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104624|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139104625|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139104626|NCT03929094|Paclitaxel|paclitaxel|mesh-list
139104627|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139104628|NCT03929094|Gemcitabine|gemcitabine|mesh-list
139104629|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139104630|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104631|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
139104632|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
139035577|NCT01062477|Vaccines|vaccines|mesh-list
139104633|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
139104634|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104635|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139104636|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
139104637|NCT01131702|Ranitidine|ranitidine|mesh-list
139104638|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139104639|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139104640|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139104641|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139104642|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
139104643|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
139104644|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104645|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104646|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104647|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
139104648|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139104649|NCT03925818|Metronidazole|metronidazole|mesh-list
139104650|NCT03925818|Tetracycline|tetracycline|mesh-list
139104651|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
139104652|NCT03925818|Pantoprazole|pantoprazole|mesh-list
139104653|NCT03925818|Bismuth|bismuth|mesh-list
139104654|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104655|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139104656|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139104657|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139104658|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139104659|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139104660|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139104661|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104662|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104664|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139104665|NCT03925740|Listerine|listerine|mesh-list
139104666|NCT03925740|Fluorides|fluorides|mesh-list
139104667|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
139104668|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
139104669|NCT03925740|Protective Agents|protective agents|mesh-ancestor
139104670|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104671|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139104672|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104673|NCT01130688|Zileuton|zileuton|mesh-list
139104674|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139104675|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139104677|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
139104678|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104679|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104680|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139104681|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139104682|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139104683|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104684|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104685|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139104686|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
139104687|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139104688|NCT03925662|Mebendazole|mebendazole|mesh-list
139104689|NCT03925662|Piperazine|piperazine|mesh-list
139104690|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
139104691|NCT03925662|Bevacizumab|bevacizumab|mesh-list
139104692|NCT03925662|DMP 777|dmp 777|mesh-list
139104693|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139104694|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104695|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139104696|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139104697|NCT03925662|Growth Substances|growth substances|mesh-ancestor
139104698|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104699|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
139104700|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
139104701|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
139104702|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139104703|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104704|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
139104705|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
139104706|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
139104707|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104708|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104709|NCT01229202|Bevacizumab|bevacizumab|mesh-list
139104710|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139104711|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104712|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139104713|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138855314|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139104714|NCT01229202|Growth Substances|growth substances|mesh-ancestor
139104715|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104716|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
139104717|NCT01229280|Darifenacin|darifenacin|mesh-list
139104718|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
139104719|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
139104720|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139104721|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104722|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104723|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104724|NCT01229280|Urological Agents|urological agents|mesh-ancestor
139104725|NCT01131780|Ibuprofen|ibuprofen|mesh-list
139104726|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
139104727|NCT01131780|Ephedrine|ephedrine|mesh-list
139104728|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139104729|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139104730|NCT01131780|Analgesics|analgesics|mesh-ancestor
139104731|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
139104732|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104733|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104734|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139104735|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138953067|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139104736|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139104737|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104738|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104739|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139104740|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
139104741|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139104742|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
139104743|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
139104744|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139104745|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139104746|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
139104747|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
139104748|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104749|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
139104750|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139104751|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139104752|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104753|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139104754|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139104755|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104756|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104757|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104758|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139104759|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
139104760|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139104761|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104762|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139104763|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139104764|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139104765|NCT01131000|Ibuprofen|ibuprofen|mesh-list
139104766|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139104767|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139104768|NCT01131000|Analgesics|analgesics|mesh-ancestor
139104769|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
139104770|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104771|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104772|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139104773|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139104774|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139104775|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104776|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104777|NCT01132170|Valproic Acid|valproic acid|mesh-list
139104778|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
139104779|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104780|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104781|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
139104782|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104783|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104784|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
139104785|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139104786|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139104787|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139104788|NCT03925428|Entinostat|entinostat|mesh-list
139104789|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139104790|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138855384|NCT00933439|Analgesics|analgesics|mesh-ancestor
139104791|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104792|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104793|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139104794|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139104795|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104796|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
139104797|NCT03919812|Vitamin D|vitamin d|mesh-list
139104798|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139104799|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104800|NCT03919812|Vitamins|vitamins|mesh-ancestor
139104801|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
139104802|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139104803|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
139104804|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139104805|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104806|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139104807|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104808|NCT01132248|Mefloquine|mefloquine|mesh-list
139104809|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
139104810|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139104811|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139104812|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104813|NCT01229592|Ethanol|ethanol|mesh-list
139104814|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139104815|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104816|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139104817|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104818|NCT01131936|Amlodipine|amlodipine|mesh-list
139104819|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139104820|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139104821|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139104822|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035684|NCT01023542|Everolimus|everolimus|mesh-list
139104823|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139104824|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104826|NCT01132404|Leuprolide|leuprolide|mesh-list
139104827|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139104828|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
139104829|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139104830|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104831|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139104832|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104833|NCT01231854|Cyclosporine|cyclosporine|mesh-list
139104834|NCT01231854|Alitretinoin|alitretinoin|mesh-list
139104835|NCT01231854|Cyclosporins|cyclosporins|mesh-list
139104836|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104837|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104838|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139104839|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
139104840|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104841|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
139104842|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104843|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
139104844|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139104845|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139104846|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104847|NCT01132638|Esomeprazole|esomeprazole|mesh-list
139104848|NCT01132638|Pantoprazole|pantoprazole|mesh-list
139104849|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139104850|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139104851|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139104852|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104853|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104854|NCT05402124|Aspirin|aspirin|mesh-list
139104855|NCT05402124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139104856|NCT05402124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139104857|NCT05402124|Analgesics|analgesics|mesh-ancestor
139104858|NCT05402124|Sensory System Agents|sensory system agents|mesh-ancestor
139104859|NCT05402124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104860|NCT05402124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104861|NCT05402124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139104862|NCT05402124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139104863|NCT05402124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138855459|NCT00608231|Analgesics|analgesics|mesh-ancestor
139104864|NCT05402124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139104865|NCT05402124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104866|NCT05402124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139104867|NCT05402124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139104868|NCT05402124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104869|NCT05402124|Antipyretics|antipyretics|mesh-ancestor
139104870|NCT01134432|Prednisolone|prednisolone|mesh-list
139104871|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139104872|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
139104873|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139104874|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
139104875|NCT01134432|Rituximab|rituximab|mesh-list
139104876|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139104877|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
139104878|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139104879|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104880|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
139104881|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035693|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
139104882|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139104883|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139104884|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
139104885|NCT01134432|Hormones|hormones|mesh-ancestor
138953125|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104886|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139104887|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139104888|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
139104889|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
139104890|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104891|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139104892|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139104893|NCT01134432|Protective Agents|protective agents|mesh-ancestor
139104894|NCT01232010|Mirodenafil|mirodenafil|mesh-list
139104895|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139104896|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139104897|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104898|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104899|NCT01132716|Valacyclovir|valacyclovir|mesh-list
139104900|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
139104901|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104902|NCT05401812|Glucocorticoids|glucocorticoids|mesh-list
139104903|NCT05401812|Hormones|hormones|mesh-ancestor
139104904|NCT05401812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139104905|NCT05401812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104906|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
139104907|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139104908|NCT01137708|Tofacitinib|tofacitinib|mesh-list
139104909|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139104910|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
139104911|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139104912|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104913|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139104914|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139104915|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139104916|NCT01137708|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139104917|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139104918|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104919|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104920|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139104921|NCT01137708|Estrogens|estrogens|mesh-ancestor
139104922|NCT01137708|Hormones|hormones|mesh-ancestor
139104923|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139104924|NCT03765138|Pramipexole|pramipexole|mesh-list
139104925|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
139035709|NCT00441974|Adefovir|adefovir|mesh-list
139104926|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104927|NCT03765138|Protective Agents|protective agents|mesh-ancestor
139104928|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104929|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139104930|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139104931|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
139104932|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
139104933|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104934|NCT01134666|Cetuximab|cetuximab|mesh-list
139104935|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139104936|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104937|NCT03739788|Deucravacitinib|deucravacitinib|mesh-list
139104938|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
139104939|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139104940|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104941|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104942|NCT01137942|Metronidazole|metronidazole|mesh-list
139104943|NCT01137942|Clarithromycin|clarithromycin|mesh-list
139104944|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138953153|NCT00978718|Selenium|selenium|mesh-list
139104945|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139104946|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139104947|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139104948|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139104949|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139104950|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104951|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104952|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139104953|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139104954|NCT01233492|Mannitol|mannitol|mesh-list
139104955|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139104956|NCT01233492|Diuretics|diuretics|mesh-ancestor
139104957|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
139104958|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104959|NCT01135056|Sorafenib|sorafenib|mesh-list
139104960|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139104961|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139104962|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104963|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104964|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
139104965|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139104966|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139104967|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104968|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139104970|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
139104971|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139104972|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139104973|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139104974|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139104975|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
139104976|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139104977|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104978|NCT01135212|Candesartan|candesartan|mesh-list
139104979|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
139104980|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139104981|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139104982|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139104983|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104984|NCT01233570|Tacrolimus|tacrolimus|mesh-list
139104985|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139104986|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
139104987|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104988|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139104989|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139104990|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104991|NCT01135290|Petrolatum|petrolatum|mesh-list
139104992|NCT01135290|Emollients|emollients|mesh-ancestor
139104993|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
139104994|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
139104995|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139104996|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139104997|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139104998|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139104999|NCT01135602|Topiramate|topiramate|mesh-list
139105000|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
139105001|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139105002|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105003|NCT05308212|Vaccines|vaccines|mesh-list
139105004|NCT05308212|Immunologic Factors|immunologic factors|mesh-ancestor
139105005|NCT05308212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105006|NCT01138488|Insulin|insulin|mesh-list
139105007|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
139105008|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139105009|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105010|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
139105011|NCT01135680|Glycerol|glycerol|mesh-list
139105012|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139105013|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105014|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139105015|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139105016|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105017|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105018|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105019|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105020|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139105021|NCT01135680|Protective Agents|protective agents|mesh-ancestor
139105022|NCT01135758|Ketamine|ketamine|mesh-list
139105023|NCT01135758|Analgesics|analgesics|mesh-ancestor
139105024|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
139105025|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105026|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105027|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139105028|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139105029|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
139105030|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
139105031|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105032|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139105033|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139105034|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139105035|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105036|NCT05401032|Tamsulosin|tamsulosin|mesh-list
139105037|NCT05401032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139105038|NCT05401032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138624195|NCT05677282|Loperamide|loperamide|mesh-list
139105041|NCT05401032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139105042|NCT05401032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105043|NCT05401032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105044|NCT05401032|Urological Agents|urological agents|mesh-ancestor
139105045|NCT03768726|Ziprasidone|ziprasidone|mesh-list
139105046|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139105047|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
139105048|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139105049|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105050|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105051|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139105052|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139105053|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105054|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139105055|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139105056|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
139105057|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
139105058|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139105059|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
139105060|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105061|NCT01138956|Expectorants|expectorants|mesh-ancestor
139105062|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
139105063|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139105064|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
139105065|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105066|NCT01138956|Protective Agents|protective agents|mesh-ancestor
139105067|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105068|NCT01138956|Antidotes|antidotes|mesh-ancestor
139105069|NCT05287542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139105070|NCT05287542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105071|NCT05287542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105072|NCT01232244|Glucagon|glucagon|mesh-list
139105073|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139105074|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139105075|NCT01232244|Hormones|hormones|mesh-ancestor
139105076|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105077|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105078|NCT01232244|Incretins|incretins|mesh-ancestor
139105079|NCT03917784|Curcumin|curcumin|mesh-list
139105080|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139105081|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139105082|NCT03917784|Analgesics|analgesics|mesh-ancestor
139105083|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
139105084|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105085|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105086|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139105087|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139105088|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105089|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105090|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105091|NCT01133496|Alendronate|alendronate|mesh-list
139105092|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139105093|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105094|NCT01232400|Esmolol|esmolol|mesh-list
139105095|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139105096|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139105097|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139105098|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
139105099|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035777|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139105100|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105101|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105102|NCT02528760|Erythromycin|erythromycin|mesh-list
139105103|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
139105104|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139105105|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
139105106|NCT02528760|Metoclopramide|metoclopramide|mesh-list
139105108|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
139105109|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105110|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105111|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139105112|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139105113|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139105114|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
139105115|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139105116|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105117|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139105118|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105119|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139105120|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105121|NCT05594472|Gentamicins|gentamicins|mesh-list
139105122|NCT05594472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139105123|NCT05594472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105124|NCT05594472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139105125|NCT05594472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105126|NCT05594472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105127|NCT01136538|Valacyclovir|valacyclovir|mesh-list
139105128|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
139105129|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105131|NCT03917628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139105132|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139105133|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139105134|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139105135|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105136|NCT01136850|Azithromycin|azithromycin|mesh-list
139105137|NCT01136850|Chloroquine|chloroquine|mesh-list
139105138|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
139105139|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
139105140|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139105141|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139105142|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105143|NCT01136850|Amebicides|amebicides|mesh-ancestor
139105144|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139105145|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139105146|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
139105147|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139105148|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139105149|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105150|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105151|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139105152|NCT01234116|Tenofovir|tenofovir|mesh-list
139105153|NCT01234116|Emtricitabine|emtricitabine|mesh-list
139105154|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139105155|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
139105156|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105157|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139105158|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139105159|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105160|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105161|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139105162|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139105163|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
139105164|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
139105165|NCT01230996|Cisplatin|cisplatin|mesh-list
139105166|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105167|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
139105168|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139105169|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139105170|NCT01137084|Prednisolone|prednisolone|mesh-list
139105171|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
139105172|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139105173|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
139105174|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139105175|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
139105176|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
139105177|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105178|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105179|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139105180|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
139105181|NCT01137084|Hormones|hormones|mesh-ancestor
138624341|NCT05351554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105182|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105183|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139105184|NCT01137084|Protective Agents|protective agents|mesh-ancestor
139105185|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139105186|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105187|NCT01133886|Decitabine|decitabine|mesh-list
139105188|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139105189|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
139105190|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105191|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105192|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105193|NCT01140126|UB-421|ub-421|mesh-list
139105194|NCT01140126|Antibodies|antibodies|mesh-list
139105195|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
139105196|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105197|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139105198|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
139105199|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105200|NCT01231074|Metformin|metformin|mesh-list
139105201|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139105202|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105203|NCT03917394|Iron|iron|mesh-list
139105204|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139105205|NCT03917394|Trace Elements|trace elements|mesh-ancestor
139105206|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
139105207|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105208|NCT03917394|Hematinics|hematinics|mesh-ancestor
139105209|NCT03769896|Nabilone|nabilone|mesh-list
139105210|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
139105211|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
139105212|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105213|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035808|NCT00441116|Dutasteride|dutasteride|mesh-list
139105215|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139105216|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139105217|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105218|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139105219|NCT01234194|Remifentanil|remifentanil|mesh-list
139105220|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139105221|NCT01234194|Narcotics|narcotics|mesh-ancestor
139105222|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105223|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105224|NCT01234194|Analgesics|analgesics|mesh-ancestor
139105225|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
139105226|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105227|NCT04913922|Nivolumab|nivolumab|mesh-list
139105228|NCT04913922|Relatlimab|relatlimab|mesh-list
139105229|NCT04913922|Azacitidine|azacitidine|mesh-list
139105230|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139105231|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105232|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139105233|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105234|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139105235|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
139105236|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105237|NCT01234272|Morphine|morphine|mesh-list
139105238|NCT01234272|Ropivacaine|ropivacaine|mesh-list
139105239|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139105240|NCT01234272|Narcotics|narcotics|mesh-ancestor
139105241|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105242|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105243|NCT01234272|Analgesics|analgesics|mesh-ancestor
139105244|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
139105245|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105246|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
139105247|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
139105248|NCT01140438|Metformin|metformin|mesh-list
139105249|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139105250|NCT01140438|Repaglinide|repaglinide|mesh-list
139105251|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
139105252|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
139105253|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
139105254|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139105255|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105256|NCT01140438|Incretins|incretins|mesh-ancestor
139105257|NCT01140438|Hormones|hormones|mesh-ancestor
139105258|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105259|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139105260|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
139105261|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105262|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105264|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
139105265|NCT01234506|Vitamins|vitamins|mesh-ancestor
139105266|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
139105267|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105268|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139105269|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
139105270|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139105271|NCT01234506|Estrogens|estrogens|mesh-ancestor
139105272|NCT01234506|Hormones|hormones|mesh-ancestor
139105273|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105274|NCT04751604|Niacinamide|niacinamide|mesh-list
139105276|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
139105277|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
139105278|NCT04751604|Vitamins|vitamins|mesh-ancestor
139105279|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
139105280|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105281|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139105282|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
139105283|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105284|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139105285|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
139105286|NCT01231542|Rifampin|rifampin|mesh-list
139105287|NCT01231542|Rifabutin|rifabutin|mesh-list
139105288|NCT01231542|Dolutegravir|dolutegravir|mesh-list
139105289|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139105290|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
139105291|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139105292|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105293|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
139105294|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139105295|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105296|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105297|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139105298|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139105299|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139105300|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139105301|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139105302|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139105303|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139105304|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139105305|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139105306|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139105307|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
139105308|NCT01231698|Esmolol|esmolol|mesh-list
139105309|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139105310|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139105311|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139105312|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
139105313|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139105314|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105315|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105316|NCT01142778|Bevacizumab|bevacizumab|mesh-list
139105317|NCT01142778|Trastuzumab|trastuzumab|mesh-list
139105318|NCT01142778|Docetaxel|docetaxel|mesh-list
139105319|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139105320|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105321|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139105322|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139105323|NCT01142778|Growth Substances|growth substances|mesh-ancestor
139105324|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105325|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
139105326|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
139105327|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
139105328|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
139105329|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105330|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
139105331|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139105332|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139105333|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105334|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
139105335|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
139105336|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139105337|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
139105338|NCT04722978|Carboplatin|carboplatin|mesh-list
139105339|NCT04722978|Gemcitabine|gemcitabine|mesh-list
139105340|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139105341|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105342|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139105343|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
139105344|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105345|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105346|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139105347|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139105348|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105349|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139105350|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
139105351|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139105352|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105353|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139105354|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139105355|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139105356|NCT01140828|Rabeprazole|rabeprazole|mesh-list
138855978|NCT05789992|Propofol|propofol|mesh-list
138855979|NCT05789992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138855980|NCT05789992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138855981|NCT05789992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855982|NCT05789992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138855983|NCT05789992|Anesthetics, General|anesthetics, general|mesh-ancestor
138855984|NCT05789992|Anesthetics|anesthetics|mesh-ancestor
138855985|NCT05789992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138855986|NCT05789992|Narcotics|narcotics|mesh-ancestor
138855987|NCT05789992|Analgesics|analgesics|mesh-ancestor
138855988|NCT05789992|Sensory System Agents|sensory system agents|mesh-ancestor
138855989|NCT05789992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138855990|NCT05764993|Immunoglobulins|immunoglobulins|mesh-list
138855991|NCT05764993|gamma-Globulins|gamma-globulins|mesh-list
138855992|NCT05764993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138855993|NCT05764993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138855994|NCT05764993|Immunologic Factors|immunologic factors|mesh-ancestor
138855995|NCT05764993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138855996|NCT05743192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138855997|NCT05743192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105357|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139105358|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139105359|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139105360|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105361|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105362|NCT01234740|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139105363|NCT01234740|Bafetinib|bafetinib|mesh-list
139105364|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139105365|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105366|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105368|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139105369|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
139105370|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139105371|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105372|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139105373|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139105375|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
139105376|NCT03714594|Saxagliptin|saxagliptin|mesh-list
139105377|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139105378|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105379|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139105380|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105381|NCT03714594|Incretins|incretins|mesh-ancestor
139105382|NCT03714594|Hormones|hormones|mesh-ancestor
139105383|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105384|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139105385|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
139105386|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105387|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
139105388|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139105389|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139105390|NCT04624776|Prednisolone|prednisolone|mesh-list
139105391|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
139105392|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139105393|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
139105394|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139105395|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
139105396|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
139105397|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105398|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105399|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139105400|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
139105401|NCT04624776|Hormones|hormones|mesh-ancestor
139105402|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105403|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139105404|NCT04624776|Protective Agents|protective agents|mesh-ancestor
139105405|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139105406|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105407|NCT01234896|Nicotine|nicotine|mesh-list
139105408|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139105409|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
139105410|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105411|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105412|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139105413|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139105414|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
139105415|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139105416|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105417|NCT01238094|Simvastatin|simvastatin|mesh-list
139105418|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139105419|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139105420|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
139105421|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105422|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139105423|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139105424|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105425|NCT01236612|Chloroquine|chloroquine|mesh-list
139105426|NCT01236612|Proguanil|proguanil|mesh-list
139105427|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
139105428|NCT01236612|Amebicides|amebicides|mesh-ancestor
139105429|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139105430|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139105431|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105432|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
139105433|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139105434|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
139105435|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105436|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
139105437|NCT03633630|Antacids|antacids|mesh-ancestor
139105438|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105439|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139105440|NCT01234974|Everolimus|everolimus|mesh-list
139105441|NCT01234974|Pasireotide|pasireotide|mesh-list
139105442|NCT01234974|Somatostatin|somatostatin|mesh-list
139105443|NCT01234974|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139105444|NCT01234974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139105445|NCT01234974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105446|NCT01234974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105447|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139105448|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
139105449|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105450|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105451|NCT01234974|Hormones|hormones|mesh-ancestor
139105452|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105453|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
139105454|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139105455|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139105456|NCT01140984|Prednisolone|prednisolone|mesh-list
139105457|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
139105458|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139105459|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
139105460|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139105461|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
139105462|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
139105463|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105464|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105465|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139105466|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
139105467|NCT01140984|Hormones|hormones|mesh-ancestor
139105468|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105469|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139105470|NCT01140984|Protective Agents|protective agents|mesh-ancestor
139105471|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139105472|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105473|NCT01145430|Doxorubicin|doxorubicin|mesh-list
139105474|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139105475|NCT01145430|Veliparib|veliparib|mesh-list
139105476|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139105477|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105478|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139105479|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139105480|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105481|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105482|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139105483|NCT03389724|Captopril|captopril|mesh-list
139105484|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139105485|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
139105486|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105487|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105488|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139105489|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
139105490|NCT01586052|Hematinics|hematinics|mesh-ancestor
139105491|NCT05796635|Allantoin|allantoin|mesh-list
139105492|NCT05796635|Dermatologic Agents|dermatologic agents|mesh-ancestor
139105493|NCT05796362|Azithromycin|azithromycin|mesh-list
139105494|NCT05796362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139105495|NCT05796362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105496|NCT05796115|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139105497|NCT05796115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139105498|NCT05796115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105499|NCT05796115|Antitubercular Agents|antitubercular agents|mesh-ancestor
139105500|NCT05795946|Vitamin D|vitamin d|mesh-list
139105501|NCT05795946|Vitamins|vitamins|mesh-ancestor
139105502|NCT05795946|Micronutrients|micronutrients|mesh-ancestor
139105503|NCT05795946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105504|NCT05795946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139105505|NCT05795920|Gemcitabine|gemcitabine|mesh-list
139105506|NCT05795920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139105507|NCT05795920|Antimetabolites|antimetabolites|mesh-ancestor
139105508|NCT05795920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105509|NCT05795920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105510|NCT05849246|Cisplatin|cisplatin|mesh-list
139105511|NCT05849246|Carboplatin|carboplatin|mesh-list
139105512|NCT05849246|Pemetrexed|pemetrexed|mesh-list
139105513|NCT05849246|Maytansine|maytansine|mesh-list
139105514|NCT05849246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105515|NCT05849246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105516|NCT05849246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105517|NCT05849246|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139105518|NCT05849246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139105519|NCT05849246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138887469|NCT01005199|Everolimus|everolimus|mesh-list
139035938|NCT00418938|Panitumumab|panitumumab|mesh-list
139105520|NCT05849246|Tubulin Modulators|tubulin modulators|mesh-ancestor
139105521|NCT05849246|Antimitotic Agents|antimitotic agents|mesh-ancestor
139105522|NCT05849246|Mitosis Modulators|mitosis modulators|mesh-ancestor
139105524|NCT05849220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139105525|NCT05849220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105526|NCT05849220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139105527|NCT05849220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105528|NCT05848635|Morphine|morphine|mesh-list
139105529|NCT05848635|Hydromorphone|hydromorphone|mesh-list
139105530|NCT05848635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139105531|NCT05848635|Narcotics|narcotics|mesh-ancestor
139105532|NCT05848635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105533|NCT05848635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105534|NCT05848635|Analgesics|analgesics|mesh-ancestor
139105535|NCT05848635|Sensory System Agents|sensory system agents|mesh-ancestor
139105536|NCT05848635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105537|NCT05848531|Clonidine|clonidine|mesh-list
139105538|NCT05848531|Analgesics|analgesics|mesh-ancestor
139105539|NCT05848531|Sensory System Agents|sensory system agents|mesh-ancestor
139105540|NCT05848531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105541|NCT05848531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105542|NCT05848531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139105543|NCT05848531|Sympatholytics|sympatholytics|mesh-ancestor
139105544|NCT05848531|Autonomic Agents|autonomic agents|mesh-ancestor
139105545|NCT05848531|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139105546|NCT05848531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139105547|NCT05848531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139105548|NCT05848531|Adrenergic Agents|adrenergic agents|mesh-ancestor
139105549|NCT05848531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139105550|NCT05848531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105551|NCT05848505|Dexmedetomidine|dexmedetomidine|mesh-list
139105552|NCT05848505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139105553|NCT05848505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105554|NCT05848505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105555|NCT05848505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139105556|NCT05848505|Analgesics|analgesics|mesh-ancestor
139105557|NCT05848505|Sensory System Agents|sensory system agents|mesh-ancestor
139105558|NCT05848505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105559|NCT05848505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139105560|NCT05848505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139105561|NCT05848505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139105562|NCT05848505|Adrenergic Agents|adrenergic agents|mesh-ancestor
139105563|NCT05848505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139105564|NCT05848505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105565|NCT05848492|Fluconazole|fluconazole|mesh-list
139105566|NCT05848492|Antifungal Agents|antifungal agents|mesh-ancestor
139105567|NCT05848492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105568|NCT05848492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139105569|NCT05848492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139105570|NCT05848492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105571|NCT05848492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105572|NCT05848492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139105573|NCT05848492|Hormone Antagonists|hormone antagonists|mesh-ancestor
139105574|NCT05848492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105575|NCT05848492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105576|NCT05848492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139105577|NCT05848492|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139105579|NCT05848336|Chelating Agents|chelating agents|mesh-ancestor
139105580|NCT05848336|Sequestering Agents|sequestering agents|mesh-ancestor
139105581|NCT05848336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105582|NCT05848102|Dapagliflozin|dapagliflozin|mesh-list
139105583|NCT05848102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139105584|NCT05848102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105585|NCT05848102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139105586|NCT05848102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105587|NCT05847764|Carboplatin|carboplatin|mesh-list
139105588|NCT05847764|Tislelizumab|tislelizumab|mesh-list
139105589|NCT05847764|Aflutinib|aflutinib|mesh-list
139105590|NCT05847764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105591|NCT05847764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139105592|NCT05847764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139105593|NCT05847764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105594|NCT05847764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105595|NCT05846373|Niacin|niacin|mesh-list
139105596|NCT05846373|Niacinamide|niacinamide|mesh-list
139105597|NCT05846373|Nicotinic Acids|nicotinic acids|mesh-list
139105598|NCT05846373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139105599|NCT05846373|Antimetabolites|antimetabolites|mesh-ancestor
139105600|NCT05846373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105601|NCT05846373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139105602|NCT05846373|Vasodilator Agents|vasodilator agents|mesh-ancestor
139105603|NCT05846373|Vitamin B Complex|vitamin b complex|mesh-ancestor
139105604|NCT05846373|Vitamins|vitamins|mesh-ancestor
139105605|NCT05846373|Micronutrients|micronutrients|mesh-ancestor
139105606|NCT05846373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105607|NCT05846243|Vaccines|vaccines|mesh-list
139105608|NCT05846243|Immunologic Factors|immunologic factors|mesh-ancestor
139105609|NCT05846243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105610|NCT05846139|Chlorhexidine|chlorhexidine|mesh-list
139105611|NCT05846139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139105612|NCT05846139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105613|NCT05846139|Disinfectants|disinfectants|mesh-ancestor
139105614|NCT05845723|Cyclophosphamide|cyclophosphamide|mesh-list
139105615|NCT05845723|Tofacitinib|tofacitinib|mesh-list
139105616|NCT05845723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139105617|NCT05845723|Immunologic Factors|immunologic factors|mesh-ancestor
139105618|NCT05845723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105619|NCT05845723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139105620|NCT05845723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139105621|NCT05845723|Alkylating Agents|alkylating agents|mesh-ancestor
139105622|NCT05845723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105623|NCT05845723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105624|NCT05845723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139105625|NCT05845723|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139105626|NCT05845723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139105627|NCT05845723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105628|NCT05845567|Clarithromycin|clarithromycin|mesh-list
139105629|NCT05845567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139105630|NCT05845567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105631|NCT05845567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139105632|NCT05845567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105633|NCT05845567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105634|NCT05845567|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139105635|NCT05845567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139105636|NCT05845424|Ezetimibe|ezetimibe|mesh-list
139105637|NCT05845424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139105638|NCT05845424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139105639|NCT05845424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139105640|NCT05845424|Antimetabolites|antimetabolites|mesh-ancestor
139105641|NCT05845424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105642|NCT05845424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139105643|NCT05845424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105644|NCT05845385|Analgesics|analgesics|mesh-list
139105645|NCT05845385|Sensory System Agents|sensory system agents|mesh-ancestor
139105646|NCT05845385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105647|NCT05845385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105648|NCT05845268|Tislelizumab|tislelizumab|mesh-list
139105649|NCT05845268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139105650|NCT05845268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139105651|NCT05845268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105652|NCT05845268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105653|NCT05845125|Triamcinolone|triamcinolone|mesh-list
139105654|NCT05845125|Bupivacaine|bupivacaine|mesh-list
139105655|NCT05845125|Anesthetics, Local|anesthetics, local|mesh-ancestor
139105656|NCT05845125|Anesthetics|anesthetics|mesh-ancestor
139105657|NCT05845125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105658|NCT05845125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105659|NCT05845125|Sensory System Agents|sensory system agents|mesh-ancestor
139105660|NCT05845125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105661|NCT05845125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139105662|NCT05845125|Glucocorticoids|glucocorticoids|mesh-ancestor
139105663|NCT05845125|Hormones|hormones|mesh-ancestor
139105664|NCT05845125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105665|NCT05844930|Triamcinolone|triamcinolone|mesh-list
139105666|NCT05844930|Lidocaine|lidocaine|mesh-list
139105667|NCT05844930|Anesthetics, Local|anesthetics, local|mesh-ancestor
139105668|NCT05844930|Anesthetics|anesthetics|mesh-ancestor
139105669|NCT05844930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105670|NCT05844930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138856262|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
139105671|NCT05844930|Sensory System Agents|sensory system agents|mesh-ancestor
139105672|NCT05844930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105673|NCT05844930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139105674|NCT05844930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139105675|NCT05844930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139105676|NCT05844930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139105677|NCT05844930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105678|NCT05844930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139105679|NCT05844930|Glucocorticoids|glucocorticoids|mesh-ancestor
139105680|NCT05844930|Hormones|hormones|mesh-ancestor
139105681|NCT05844930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105682|NCT05844800|Bupivacaine|bupivacaine|mesh-list
139105683|NCT05844800|Anesthetics, Local|anesthetics, local|mesh-ancestor
139105684|NCT05844800|Anesthetics|anesthetics|mesh-ancestor
139105685|NCT05844800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105686|NCT05844800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105687|NCT05844800|Sensory System Agents|sensory system agents|mesh-ancestor
139105688|NCT05844800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105689|NCT05844683|Chlorhexidine|chlorhexidine|mesh-list
139105690|NCT05844683|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139105691|NCT05844683|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139105692|NCT05844683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105693|NCT05844683|Disinfectants|disinfectants|mesh-ancestor
139105694|NCT05844683|Dermatologic Agents|dermatologic agents|mesh-ancestor
139105695|NCT05844670|Vincristine|vincristine|mesh-list
139105696|NCT05844670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139105697|NCT05844670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105698|NCT05844670|Tubulin Modulators|tubulin modulators|mesh-ancestor
139105699|NCT05844670|Antimitotic Agents|antimitotic agents|mesh-ancestor
139105700|NCT05844670|Mitosis Modulators|mitosis modulators|mesh-ancestor
139105701|NCT05844670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105702|NCT05844553|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139105703|NCT05844553|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139105704|NCT05844553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105705|NCT05844371|Oxaliplatin|oxaliplatin|mesh-list
139105706|NCT05844371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105707|NCT05844306|Deoxyglucose|deoxyglucose|mesh-list
139105708|NCT05844306|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139105709|NCT05844306|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139105710|NCT05844306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105711|NCT05844306|Antimetabolites|antimetabolites|mesh-ancestor
139105712|NCT05844306|Antiviral Agents|antiviral agents|mesh-ancestor
139105713|NCT05844306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105714|NCT05844046|Bevacizumab|bevacizumab|mesh-list
139105715|NCT05844046|Durvalumab|durvalumab|mesh-list
139105716|NCT05844046|Tremelimumab|tremelimumab|mesh-list
139105717|NCT05844046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139105718|NCT05844046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105719|NCT05844046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139105720|NCT05844046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139105721|NCT05844046|Growth Substances|growth substances|mesh-ancestor
139105722|NCT05844046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105723|NCT05844046|Growth Inhibitors|growth inhibitors|mesh-ancestor
139105724|NCT05843812|Magnesium Sulfate|magnesium sulfate|mesh-list
139105725|NCT05843812|Analgesics|analgesics|mesh-ancestor
139105726|NCT05843812|Sensory System Agents|sensory system agents|mesh-ancestor
139105727|NCT05843812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105728|NCT05843812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105729|NCT05843812|Anesthetics|anesthetics|mesh-ancestor
139105730|NCT05843812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105731|NCT05843812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139105732|NCT05843812|Anticonvulsants|anticonvulsants|mesh-ancestor
139105733|NCT05843812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139105734|NCT05843812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139105735|NCT05843812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105736|NCT05843812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139105737|NCT05843812|Tocolytic Agents|tocolytic agents|mesh-ancestor
139105738|NCT05843812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139105739|NCT05843617|Vitamins|vitamins|mesh-list
139105740|NCT05843617|Ascorbic Acid|ascorbic acid|mesh-list
139105741|NCT05843617|Micronutrients|micronutrients|mesh-ancestor
139105742|NCT05843617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105743|NCT05843617|Antioxidants|antioxidants|mesh-ancestor
139105744|NCT05843617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105745|NCT05843617|Protective Agents|protective agents|mesh-ancestor
138856338|NCT03900715|Luspatercept|luspatercept|mesh-list
139105747|NCT05843344|Morphine|morphine|mesh-list
139105748|NCT05843344|Ropivacaine|ropivacaine|mesh-list
139105749|NCT05843344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139105750|NCT05843344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105751|NCT05843344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105752|NCT05843344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139105753|NCT05843344|Analgesics|analgesics|mesh-ancestor
139105754|NCT05843344|Sensory System Agents|sensory system agents|mesh-ancestor
139105755|NCT05843344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105756|NCT05843344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139105757|NCT05843344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139105758|NCT05843344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139105759|NCT05843344|Adrenergic Agents|adrenergic agents|mesh-ancestor
139105760|NCT05843344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139105761|NCT05843344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105762|NCT05843344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139105763|NCT05843344|Narcotics|narcotics|mesh-ancestor
139105764|NCT05843344|Anesthetics, Local|anesthetics, local|mesh-ancestor
139105765|NCT05843344|Anesthetics|anesthetics|mesh-ancestor
139105766|NCT05843292|Carboplatin|carboplatin|mesh-list
139105767|NCT05843292|Taxane|taxane|mesh-list
139105768|NCT05843292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105769|NCT05843162|Losartan|losartan|mesh-list
139105770|NCT05843162|Telmisartan|telmisartan|mesh-list
139105771|NCT05843162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139105772|NCT05843162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139105773|NCT05843162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139105774|NCT05843162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139105775|NCT05843162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105776|NCT05842681|Azithromycin|azithromycin|mesh-list
139105777|NCT05842681|Methylprednisolone|methylprednisolone|mesh-list
139105778|NCT05842681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139105779|NCT05842681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139105780|NCT05842681|Prednisolone|prednisolone|mesh-list
139105781|NCT05842681|Prednisolone acetate|prednisolone acetate|mesh-list
139105782|NCT05842681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139105783|NCT05842681|Prednisolone phosphate|prednisolone phosphate|mesh-list
139105784|NCT05842681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139105785|NCT05842681|Antiemetics|antiemetics|mesh-ancestor
139105786|NCT05842681|Autonomic Agents|autonomic agents|mesh-ancestor
139105787|NCT05842681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105788|NCT05842681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105789|NCT05842681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139105790|NCT05842681|Glucocorticoids|glucocorticoids|mesh-ancestor
139105791|NCT05842681|Hormones|hormones|mesh-ancestor
139105792|NCT05842681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105793|NCT05842681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139105794|NCT05842681|Protective Agents|protective agents|mesh-ancestor
139105795|NCT05842681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139105796|NCT05842681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105797|NCT05842681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139105798|NCT05842681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105799|NCT05842486|Antibodies|antibodies|mesh-list
139105800|NCT05842486|Immunologic Factors|immunologic factors|mesh-ancestor
139105801|NCT05842486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105802|NCT05842317|Lenvatinib|lenvatinib|mesh-list
139105803|NCT05842317|Tislelizumab|tislelizumab|mesh-list
139105804|NCT05842317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105805|NCT05842317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139105806|NCT05842317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105807|NCT05842317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105808|NCT05842317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139105809|NCT05840848|Beta Carotene|beta carotene|mesh-list
139105810|NCT05840848|Carotenoids|carotenoids|mesh-list
139105811|NCT05840848|Antioxidants|antioxidants|mesh-ancestor
139105812|NCT05840848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105813|NCT05840848|Protective Agents|protective agents|mesh-ancestor
139105814|NCT05840848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105815|NCT05840848|Provitamins|provitamins|mesh-ancestor
139105816|NCT05840848|Vitamins|vitamins|mesh-ancestor
139105817|NCT05840848|Micronutrients|micronutrients|mesh-ancestor
139105818|NCT05840835|Tislelizumab|tislelizumab|mesh-list
139105819|NCT05840835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139105820|NCT05840835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105821|NCT05840562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139105822|NCT05840562|Capsaicin|capsaicin|mesh-list
139105823|NCT05840562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139105824|NCT05840562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139105825|NCT05840562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139105826|NCT05840562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105827|NCT05840562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139105828|NCT05840562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105830|NCT05840562|Sensory System Agents|sensory system agents|mesh-ancestor
139105831|NCT05840562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105832|NCT05840562|Antidepressive Agents|antidepressive agents|mesh-ancestor
139105833|NCT05840562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139105834|NCT05840562|Dopamine Agents|dopamine agents|mesh-ancestor
139105835|NCT05840562|Antipruritics|antipruritics|mesh-ancestor
139105836|NCT05840562|Dermatologic Agents|dermatologic agents|mesh-ancestor
139105837|NCT05840471|Tranexamic Acid|tranexamic acid|mesh-list
139105838|NCT05840471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139105839|NCT05840471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139105840|NCT05840471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105841|NCT05840471|Hemostatics|hemostatics|mesh-ancestor
139105842|NCT05840471|Coagulants|coagulants|mesh-ancestor
139105843|NCT05840289|Rituximab|rituximab|mesh-list
139105844|NCT05840289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139105845|NCT05840289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105846|NCT05840289|Immunologic Factors|immunologic factors|mesh-ancestor
139105847|NCT05840289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105848|NCT05840289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139105849|NCT05839938|Vitamin D|vitamin d|mesh-list
139105850|NCT05839938|Vitamins|vitamins|mesh-ancestor
139105851|NCT05839938|Micronutrients|micronutrients|mesh-ancestor
139105852|NCT05839938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105853|NCT05839938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139105854|NCT05839756|Budesonide|budesonide|mesh-list
139105855|NCT05839756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139105856|NCT05839756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139105857|NCT05839756|Autonomic Agents|autonomic agents|mesh-ancestor
139105858|NCT05839756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105859|NCT05839756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105860|NCT05839756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139105861|NCT05839756|Respiratory System Agents|respiratory system agents|mesh-ancestor
139105862|NCT05839756|Glucocorticoids|glucocorticoids|mesh-ancestor
139105863|NCT05839756|Hormones|hormones|mesh-ancestor
139105864|NCT05839756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139105865|NCT05829499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139105866|NCT05829499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139105867|NCT05825573|Vitamin K|vitamin k|mesh-list
139105868|NCT05825573|Anticoagulants|anticoagulants|mesh-list
139105869|NCT05825573|Vitamins|vitamins|mesh-ancestor
139105870|NCT05825573|Micronutrients|micronutrients|mesh-ancestor
139105871|NCT05825573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105872|NCT05825573|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139105873|NCT05825573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139105874|NCT05825573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105875|NCT05825573|Hemostatics|hemostatics|mesh-ancestor
139105876|NCT05825573|Coagulants|coagulants|mesh-ancestor
139105877|NCT05825352|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139036118|NCT01030016|Atenolol|atenolol|mesh-list
139105878|NCT05825352|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139105879|NCT05824494|Paclitaxel|paclitaxel|mesh-list
139105880|NCT05824494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139105881|NCT05824494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105882|NCT05824494|Tubulin Modulators|tubulin modulators|mesh-ancestor
139105883|NCT05824494|Antimitotic Agents|antimitotic agents|mesh-ancestor
139105884|NCT05824494|Mitosis Modulators|mitosis modulators|mesh-ancestor
138953390|NCT00972946|Dextrans|dextrans|mesh-list
139105885|NCT05824494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105886|NCT05824000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139105887|NCT05824000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139105888|NCT05823961|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139105889|NCT05823961|Hyaluronic Acid|hyaluronic acid|mesh-list
139105890|NCT05823961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139105891|NCT05823961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139105892|NCT05823961|Immunologic Factors|immunologic factors|mesh-ancestor
139105893|NCT05823961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105894|NCT05823961|Viscosupplements|viscosupplements|mesh-ancestor
139105895|NCT05823961|Protective Agents|protective agents|mesh-ancestor
139105896|NCT05823506|Tadalafil|tadalafil|mesh-list
139105897|NCT05823506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
139105898|NCT05823506|Vasodilator Agents|vasodilator agents|mesh-ancestor
139105899|NCT05823506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139105900|NCT05823506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105901|NCT05823506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105902|NCT05823506|Urological Agents|urological agents|mesh-ancestor
139105903|NCT05822817|Propofol|propofol|mesh-list
139105904|NCT05822817|Sevoflurane|sevoflurane|mesh-list
139105905|NCT05822817|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139105906|NCT05822817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105907|NCT05822817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105908|NCT05822817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139105909|NCT05822817|Anesthetics, General|anesthetics, general|mesh-ancestor
139105910|NCT05822817|Anesthetics|anesthetics|mesh-ancestor
139105911|NCT05822817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139105912|NCT05822817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139105913|NCT05817903|Nivolumab|nivolumab|mesh-list
139105914|NCT05817903|Axitinib|axitinib|mesh-list
139105915|NCT05817903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139105916|NCT05817903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105917|NCT05817903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139105918|NCT05817903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105919|NCT05817903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139105920|NCT05817903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105921|NCT05805605|Mycophenolic Acid|mycophenolic acid|mesh-list
139105922|NCT05805605|Sirolimus|sirolimus|mesh-list
139105923|NCT05805605|Cyclophosphamide|cyclophosphamide|mesh-list
139105924|NCT05805605|Fludarabine|fludarabine|mesh-list
139105925|NCT05805605|Allopurinol|allopurinol|mesh-list
139105926|NCT05805605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139105927|NCT05805605|Immunologic Factors|immunologic factors|mesh-ancestor
139105928|NCT05805605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105929|NCT05805605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139105930|NCT05805605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139105931|NCT05805605|Alkylating Agents|alkylating agents|mesh-ancestor
139105932|NCT05805605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105933|NCT05805605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105934|NCT05805605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139105935|NCT05805605|Antimetabolites|antimetabolites|mesh-ancestor
139105936|NCT05805605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139105937|NCT05805605|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139105938|NCT05805605|Antitubercular Agents|antitubercular agents|mesh-ancestor
139105939|NCT05805605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139105940|NCT05805605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105941|NCT05805605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139105942|NCT05805605|Antifungal Agents|antifungal agents|mesh-ancestor
139105943|NCT05805605|Gout Suppressants|gout suppressants|mesh-ancestor
139105944|NCT05805605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139105945|NCT05805605|Antioxidants|antioxidants|mesh-ancestor
139105946|NCT05805605|Protective Agents|protective agents|mesh-ancestor
139105947|NCT05805072|Cytarabine|cytarabine|mesh-list
139105948|NCT05805072|Azacitidine|azacitidine|mesh-list
139105949|NCT05805072|Decitabine|decitabine|mesh-list
139105950|NCT05805072|Homoharringtonine|homoharringtonine|mesh-list
139105951|NCT05805072|Aclacinomycins|aclacinomycins|mesh-list
139105952|NCT05805072|Lenograstim|lenograstim|mesh-list
139105953|NCT05805072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139105954|NCT05805072|Antimetabolites|antimetabolites|mesh-ancestor
139105955|NCT05805072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105956|NCT05805072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139105957|NCT05805072|Antiviral Agents|antiviral agents|mesh-ancestor
139105958|NCT05805072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139105959|NCT05805072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139105960|NCT05805072|Immunologic Factors|immunologic factors|mesh-ancestor
139105987|NCT05753592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139105989|NCT05753592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139105990|NCT05704673|Morphine|morphine|mesh-list
139105991|NCT05704673|Nalbuphine|nalbuphine|mesh-list
139105992|NCT05704673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139105993|NCT05704673|Narcotics|narcotics|mesh-ancestor
139105994|NCT05704673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139105995|NCT05704673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139105996|NCT05704673|Analgesics|analgesics|mesh-ancestor
139105997|NCT05704673|Sensory System Agents|sensory system agents|mesh-ancestor
139105998|NCT05704673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139105999|NCT05702671|Immunoglobulins|immunoglobulins|mesh-list
139106000|NCT05702671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139106001|NCT05702671|Antibodies|antibodies|mesh-list
139106002|NCT05702671|Immunologic Factors|immunologic factors|mesh-ancestor
139106003|NCT05702671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106031|NCT05678205|Cyclophosphamide|cyclophosphamide|mesh-list
139106032|NCT05678205|Fludarabine|fludarabine|mesh-list
139106033|NCT05678205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139106034|NCT05678205|Immunologic Factors|immunologic factors|mesh-ancestor
139106035|NCT05678205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106036|NCT05678205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139106037|NCT05678205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139106039|NCT05678205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106040|NCT05678205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106041|NCT05678205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139106042|NCT05671562|Lycopene|lycopene|mesh-list
139106043|NCT05671562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139106044|NCT05671562|Antioxidants|antioxidants|mesh-ancestor
139106045|NCT05671562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106046|NCT05671562|Protective Agents|protective agents|mesh-ancestor
139106047|NCT05671562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106048|NCT05671562|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139106049|NCT05671562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139106051|NCT05654818|Vitamin D|vitamin d|mesh-list
139106052|NCT05654818|Vitamins|vitamins|mesh-ancestor
139106053|NCT05654818|Micronutrients|micronutrients|mesh-ancestor
139036143|NCT01030094|Topiramate|topiramate|mesh-list
139106054|NCT05654818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106055|NCT05654818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139106056|NCT05613205|Vaccines|vaccines|mesh-list
139106057|NCT05613205|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
139106058|NCT05613205|Immunologic Factors|immunologic factors|mesh-ancestor
139106059|NCT05613205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106060|NCT05613205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139106061|NCT05589181|Buprenorphine|buprenorphine|mesh-list
139106062|NCT05589181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139106063|NCT05589181|Narcotics|narcotics|mesh-ancestor
139106064|NCT05589181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106065|NCT05589181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106066|NCT05589181|Analgesics|analgesics|mesh-ancestor
139106067|NCT05589181|Sensory System Agents|sensory system agents|mesh-ancestor
138953417|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
139106068|NCT05589181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106069|NCT05589181|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139106070|NCT05562349|Clavulanic Acids|clavulanic acids|mesh-list
139106071|NCT05562349|Clavulanic Acid|clavulanic acid|mesh-list
139106072|NCT05562349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139106073|NCT05562349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106074|NCT05562349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106075|NCT05562349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106076|NCT05562349|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139106077|NCT05561673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139106078|NCT05561673|Vaccines|vaccines|mesh-list
139106079|NCT05561673|Immunologic Factors|immunologic factors|mesh-ancestor
139106080|NCT05561673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106081|NCT05561673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139106082|NCT05561673|Antacids|antacids|mesh-ancestor
139106083|NCT05561673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106084|NCT05561673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139106085|NCT05505617|Nitric Oxide|nitric oxide|mesh-list
139106086|NCT05505617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139106087|NCT05505617|Autonomic Agents|autonomic agents|mesh-ancestor
139106088|NCT05505617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106089|NCT05505617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106090|NCT05505617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139106091|NCT05505617|Respiratory System Agents|respiratory system agents|mesh-ancestor
139106092|NCT05505617|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139106093|NCT05505617|Antioxidants|antioxidants|mesh-ancestor
139106094|NCT05505617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106095|NCT05505617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106096|NCT05505617|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139106097|NCT05505617|Vasodilator Agents|vasodilator agents|mesh-ancestor
139106098|NCT05505617|Gasotransmitters|gasotransmitters|mesh-ancestor
139106099|NCT05505617|Protective Agents|protective agents|mesh-ancestor
139106100|NCT05484466|Entecavir|entecavir|mesh-list
139106101|NCT05484466|Antiviral Agents|antiviral agents|mesh-ancestor
139106102|NCT05484466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106103|NCT05466747|Protease Inhibitors|protease inhibitors|mesh-list
139106104|NCT05466747|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139106105|NCT05466747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106106|NCT05466747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106107|NCT05466747|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139106108|NCT05466747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139106109|NCT05408988|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139106110|NCT05408988|Natriuretic Agents|natriuretic agents|mesh-ancestor
139106111|NCT05408988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106112|NCT05393791|Abiraterone Acetate|abiraterone acetate|mesh-list
139106113|NCT05393791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106114|NCT05393791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139106115|NCT05393791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106116|NCT05393791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106117|NCT05393791|Hormone Antagonists|hormone antagonists|mesh-ancestor
139036161|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139106118|NCT05393791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139106119|NCT05393791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106120|NCT05393791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139106122|NCT05388773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106123|NCT05383521|Tinidazole|tinidazole|mesh-list
138953427|NCT00359281|Niacin|niacin|mesh-list
139106124|NCT05383521|Alkylating Agents|alkylating agents|mesh-ancestor
139106125|NCT05383521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106126|NCT05383521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139106127|NCT05383521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106128|NCT05383521|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139106129|NCT05383521|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139106130|NCT05383521|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139106131|NCT05358938|Pembrolizumab|pembrolizumab|mesh-list
139106132|NCT05358938|Nivolumab|nivolumab|mesh-list
139106133|NCT05358938|Ipilimumab|ipilimumab|mesh-list
139106134|NCT05358938|Avelumab|avelumab|mesh-list
139106135|NCT05358938|Cemiplimab|cemiplimab|mesh-list
139106136|NCT05358938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139106137|NCT05358938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139106138|NCT05358938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106139|NCT05358938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106140|NCT05349474|Metformin|metformin|mesh-list
139106141|NCT05349474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139106142|NCT05349474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106143|NCT05343481|Nivolumab|nivolumab|mesh-list
139106144|NCT05343481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139106145|NCT05343481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106146|NCT05343481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139106147|NCT05343481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106148|NCT05340764|Infliximab|infliximab|mesh-list
139106149|NCT05340764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139106150|NCT05340764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139106151|NCT05340764|Dermatologic Agents|dermatologic agents|mesh-ancestor
139106152|NCT05340764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139106153|NCT05340764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139106154|NCT05327361|Sunscreening Agents|sunscreening agents|mesh-list
139106155|NCT05327361|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139106156|NCT05327361|Protective Agents|protective agents|mesh-ancestor
139106157|NCT05327361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106158|NCT05327361|Dermatologic Agents|dermatologic agents|mesh-ancestor
139106159|NCT05305014|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139106160|NCT05305014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139106161|NCT05302986|Tranexamic Acid|tranexamic acid|mesh-list
139106162|NCT05302986|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139106163|NCT05302986|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139106164|NCT05302986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106165|NCT05302986|Hemostatics|hemostatics|mesh-ancestor
139106166|NCT05302986|Coagulants|coagulants|mesh-ancestor
139106167|NCT05300451|Daratumumab|daratumumab|mesh-list
139106168|NCT05300451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106169|NCT05285904|Ofatumumab|ofatumumab|mesh-list
139106170|NCT05285904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106171|NCT05283083|Dexmedetomidine|dexmedetomidine|mesh-list
139106172|NCT05283083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139106173|NCT05283083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106174|NCT05283083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106175|NCT05283083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139106176|NCT05283083|Analgesics|analgesics|mesh-ancestor
139106177|NCT05283083|Sensory System Agents|sensory system agents|mesh-ancestor
139106178|NCT05283083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106179|NCT05283083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139106180|NCT05283083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139106181|NCT05283083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139106182|NCT05283083|Adrenergic Agents|adrenergic agents|mesh-ancestor
139106183|NCT05283083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106184|NCT05283083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106185|NCT05248321|Tranexamic Acid|tranexamic acid|mesh-list
139106186|NCT05248321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139106187|NCT05248321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139106196|NCT05241093|Antiviral Agents|antiviral agents|mesh-ancestor
139106197|NCT05241093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138856792|NCT00049517|Sargramostim|sargramostim|mesh-list
139106198|NCT05241093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139106199|NCT05241093|Immunologic Factors|immunologic factors|mesh-ancestor
139106200|NCT05241093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106201|NCT05233163|Empagliflozin|empagliflozin|mesh-list
139106202|NCT05233163|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139106203|NCT05233163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106204|NCT05233163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139106205|NCT05233163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106207|NCT05229991|Lonafarnib|lonafarnib|mesh-list
139106208|NCT05229991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139106209|NCT05229991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139106210|NCT05229991|Protease Inhibitors|protease inhibitors|mesh-ancestor
139106211|NCT05229991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106212|NCT05229991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106213|NCT05229991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139106214|NCT05229991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139106215|NCT05229991|Antiviral Agents|antiviral agents|mesh-ancestor
139106216|NCT05229991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106217|NCT05229991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139106218|NCT05229991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139106219|NCT05213884|Cisplatin|cisplatin|mesh-list
139106220|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106221|NCT05211024|Penicillins|penicillins|mesh-list
139106222|NCT05211024|Penicillin G|penicillin g|mesh-list
139106223|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139106224|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
139106225|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139106226|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106227|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139106228|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139106229|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106230|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
139106245|NCT05176080|Fulvestrant|fulvestrant|mesh-list
139106246|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139106247|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106248|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139106249|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139106250|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
139106251|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139106252|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106253|NCT05165082|Timolol|timolol|mesh-list
139106254|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139106255|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139106256|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106257|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139106258|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139106259|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
139106260|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106261|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106262|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139106263|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139106265|NCT05159531|Emtricitabine|emtricitabine|mesh-list
139106266|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
139106267|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106268|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139106269|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139106270|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106271|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106272|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139106273|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139106274|NCT05128071|Progesterone|progesterone|mesh-list
139106276|NCT05128071|Hormones|hormones|mesh-ancestor
139106277|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139106278|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106279|NCT05121324|Midazolam|midazolam|mesh-list
139106280|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139106281|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139106282|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106283|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106284|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139106285|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139106286|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139106287|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139106288|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
139106289|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
139106290|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
139106291|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
139106292|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106293|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106294|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
139106295|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139106296|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
139106297|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106298|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106299|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139106300|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
139106301|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139106302|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
139106303|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106304|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106305|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139106306|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
139106307|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
139106308|NCT05109611|Protective Agents|protective agents|mesh-ancestor
139106309|NCT05106153|Zolpidem|zolpidem|mesh-list
139106310|NCT05106153|Suvorexant|suvorexant|mesh-list
139106311|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139106312|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139106313|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106314|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106315|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139106316|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
139106317|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
139106318|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106319|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106320|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139106321|NCT05102591|Ketorolac|ketorolac|mesh-list
139106322|NCT05102591|Metoclopramide|metoclopramide|mesh-list
139106323|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139106324|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139106325|NCT05102591|Analgesics|analgesics|mesh-ancestor
139106326|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
139106327|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106328|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106329|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139106330|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139106331|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139106332|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106333|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106334|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
139106335|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
139106336|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139106337|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139106338|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139106339|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
138953475|NCT01052311|Niacin|niacin|mesh-list
139106340|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106342|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139106343|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106344|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139106345|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106346|NCT05063656|Gabapentin|gabapentin|mesh-list
139106347|NCT05063656|Analgesics|analgesics|mesh-ancestor
139106348|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
138856942|NCT00003701|Doxorubicin|doxorubicin|mesh-list
139106349|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106350|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106351|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
139106352|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139106353|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139106354|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106355|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139106356|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139106357|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139106358|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106359|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106360|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
139106361|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139106362|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139106363|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
139106364|NCT05047601|Ritonavir|ritonavir|mesh-list
139106365|NCT05047601|Nirmatrelvir|nirmatrelvir|mesh-list
139106366|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139106367|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139106368|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
139106369|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106370|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106371|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139106372|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139106373|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
139106374|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106375|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139106376|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139106377|NCT05043506|Palbociclib|palbociclib|mesh-list
139106378|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139106379|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106380|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139106381|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106382|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106383|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139106385|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
139106386|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139106387|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106388|NCT05022329|Vaccines|vaccines|mesh-list
139106389|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
139106390|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106391|NCT05011760|Amphetamine|amphetamine|mesh-list
139106392|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
139106393|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139106394|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106395|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
139106396|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
139106397|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106398|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
139106399|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106400|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106401|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
139106402|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139106403|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139106404|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139106405|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139106406|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
139106407|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139106408|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139106409|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139106410|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139106411|NCT05006599|Insulin|insulin|mesh-list
139106413|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139106414|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106415|NCT04998669|Rituximab|rituximab|mesh-list
139106416|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139106417|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139106418|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106419|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
139106420|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106421|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139106422|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
139106423|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139106424|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106425|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
139106426|NCT04958811|Bevacizumab|bevacizumab|mesh-list
139106427|NCT04958811|Atezolizumab|atezolizumab|mesh-list
139106428|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139106429|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106430|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139106431|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139106432|NCT04958811|Growth Substances|growth substances|mesh-ancestor
139106433|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106434|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
139106435|NCT04958811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139106436|NCT04958811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106437|NCT04950530|Emtricitabine|emtricitabine|mesh-list
139106438|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
139106439|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106440|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139106441|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139106442|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106443|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106444|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139106445|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139106446|NCT04937699|Aspirin|aspirin|mesh-list
139106447|NCT04937699|Clopidogrel|clopidogrel|mesh-list
139106448|NCT04937699|Ticagrelor|ticagrelor|mesh-list
139106449|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139106450|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139106451|NCT04937699|Analgesics|analgesics|mesh-ancestor
139106452|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
139106453|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106454|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106455|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139106456|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139106457|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139106458|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139106459|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106460|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139106461|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139106462|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106463|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
139106464|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139106465|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139106466|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139106467|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
139106468|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106469|NCT04891068|Azacitidine|azacitidine|mesh-list
139106470|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139106471|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
139106472|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106473|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106474|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106475|NCT04880499|Folic Acid|folic acid|mesh-list
139106476|NCT04880499|Riboflavin|riboflavin|mesh-list
139106477|NCT04880499|Vitamins|vitamins|mesh-ancestor
139106478|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
139106479|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106480|NCT04880499|Hematinics|hematinics|mesh-ancestor
139106481|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
139106482|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139106483|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
139106484|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
139106485|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106486|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106487|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139106488|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
139106489|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139106490|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
139106491|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
139106493|NCT04852484|Morphine|morphine|mesh-list
139106494|NCT04852484|Anesthetics|anesthetics|mesh-list
139106495|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
139106496|NCT04852484|Analgesics|analgesics|mesh-ancestor
139106497|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
139106498|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106499|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106500|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139106501|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139106502|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
139106503|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106504|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139106505|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139106506|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106507|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106508|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139106509|NCT04852484|Narcotics|narcotics|mesh-ancestor
139106510|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
139106511|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
139106512|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
139106513|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106514|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106515|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
139106516|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106517|NCT04827147|Methamphetamine|methamphetamine|mesh-list
139106518|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139106519|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106520|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
139106521|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
139106522|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106523|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
139106524|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106525|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106526|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
139106527|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139106528|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139106529|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139106530|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139106532|NCT04786873|Analgesics|analgesics|mesh-ancestor
139106533|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
139106534|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106535|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106536|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139106537|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
139106538|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
139036273|NCT03847610|Penicillins|penicillins|mesh-list
139106539|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139106540|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139106541|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139106542|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
139106543|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106544|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106545|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139106546|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139106547|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106549|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106550|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139106551|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139106552|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139106553|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
139106554|NCT04767074|Guaifenesin|guaifenesin|mesh-list
139106555|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139106556|NCT04767074|Expectorants|expectorants|mesh-ancestor
139106557|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
139106558|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139106559|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139106560|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
139106561|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106562|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106563|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106564|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
139106565|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139106566|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
139106567|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
139106568|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106569|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
139106570|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139106571|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
139106572|NCT04761614|Leucovorin|leucovorin|mesh-list
139106573|NCT04761614|Folic Acid|folic acid|mesh-list
139106574|NCT04761614|Bevacizumab|bevacizumab|mesh-list
139106575|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139106576|NCT04761614|Fluorouracil|fluorouracil|mesh-list
139106577|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
139106578|NCT04761614|Riluzole|riluzole|mesh-list
139106579|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
139106580|NCT04761614|Antibodies|antibodies|mesh-list
139106581|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
139106582|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139106583|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
139106584|NCT04761614|Calcium|calcium|mesh-list
139106585|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
139106586|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106587|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139106588|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139106589|NCT04761614|Growth Substances|growth substances|mesh-ancestor
139106590|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106591|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
139106592|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
139106593|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139106594|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139106595|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
139106596|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106597|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139036303|NCT00439556|Cytarabine|cytarabine|mesh-list
139106598|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139106599|NCT04761614|Antidotes|antidotes|mesh-ancestor
139106600|NCT04761614|Protective Agents|protective agents|mesh-ancestor
139106601|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
139106602|NCT04761614|Vitamins|vitamins|mesh-ancestor
139106603|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
139106604|NCT04761614|Hematinics|hematinics|mesh-ancestor
139106605|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
139106606|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139106607|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139106608|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106609|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139106610|NCT04760860|Prazosin|prazosin|mesh-list
139106611|NCT04760860|Terazosin|terazosin|mesh-list
139106612|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139106613|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139106614|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139106615|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
139106616|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106617|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106618|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106619|NCT04760860|Urological Agents|urological agents|mesh-ancestor
139106620|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139106621|NCT04710199|Maraviroc|maraviroc|mesh-list
139106622|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139106623|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139106624|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106625|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139106626|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139106627|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
139106628|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106629|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139106630|NCT04699240|Clotrimazole|clotrimazole|mesh-list
139106631|NCT04699240|Miconazole|miconazole|mesh-list
139106632|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139106633|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106634|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
139106635|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139106636|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139106637|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106638|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106639|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139106640|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
139106641|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139106642|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106643|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139106644|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139106645|NCT04688658|Nivolumab|nivolumab|mesh-list
139106646|NCT04688658|Axitinib|axitinib|mesh-list
139106647|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139106648|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106649|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139106650|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106651|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139106652|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106653|NCT04658784|Cyclopropane|cyclopropane|mesh-list
139106654|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
139106655|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106656|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106657|NCT04657640|Iron|iron|mesh-list
139106658|NCT04657640|Trace Elements|trace elements|mesh-list
139106659|NCT04657640|Folic Acid|folic acid|mesh-list
139106660|NCT04657640|Micronutrients|micronutrients|mesh-list
139106661|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
139106662|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106663|NCT04657640|Hematinics|hematinics|mesh-ancestor
139106664|NCT04657640|Vitamins|vitamins|mesh-ancestor
139106665|NCT04622813|Acetaminophen|acetaminophen|mesh-list
139106666|NCT04622813|Ketoprofen|ketoprofen|mesh-list
139106667|NCT04622813|Nefopam|nefopam|mesh-list
139106668|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139106669|NCT04622813|Analgesics|analgesics|mesh-ancestor
139106670|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
139106671|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106672|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106673|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
139106674|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139106675|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139106676|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139106677|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139106678|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106679|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106680|NCT04616963|Tenofovir|tenofovir|mesh-list
139106681|NCT04616963|Emtricitabine|emtricitabine|mesh-list
139106682|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139106683|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
139106684|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106685|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139106686|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139106687|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106688|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106689|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139106690|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139106691|NCT04606394|Albuterol|albuterol|mesh-list
139106692|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139106693|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
139106694|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106695|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106696|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139106697|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
139106699|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139106700|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139106701|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139106702|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139106703|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
139106704|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106705|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106706|NCT04586088|Apatinib|apatinib|mesh-list
139106707|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106708|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139106709|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106710|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106711|NCT04579510|Vaccines|vaccines|mesh-list
139106712|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
139036346|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139106713|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106714|NCT04579120|Corticosterone|corticosterone|mesh-list
139106715|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139106716|NCT04557735|Ravulizumab|ravulizumab|mesh-list
139106717|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139106718|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139106719|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
139106720|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106721|NCT04527900|Paclitaxel|paclitaxel|mesh-list
139106722|NCT04527900|Carboplatin|carboplatin|mesh-list
139106723|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139106724|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106725|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
139106726|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
139106727|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
139106728|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106729|NCT04549168|Lemborexant|lemborexant|mesh-list
139106730|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139106731|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106732|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106733|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139106734|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139106735|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106736|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106737|NCT04509050|Ivacaftor|ivacaftor|mesh-list
139106738|NCT04509050|Elexacaftor|elexacaftor|mesh-list
139106739|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139106740|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139106741|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106742|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
139106743|NCT04456439|Promethazine|promethazine|mesh-list
139106744|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
139106745|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
139106746|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139106747|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139106748|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139106749|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106750|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106751|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
139106752|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
139106753|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
139106754|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106755|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
139106756|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
139106757|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139106758|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139106759|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
139106760|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
139106761|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106762|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106763|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139106764|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
139106765|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
139106766|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
139106767|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106768|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
139106769|NCT04445714|Saxagliptin|saxagliptin|mesh-list
139106770|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138887508|NCT02635802|Narcotics|narcotics|mesh-ancestor
139106771|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106772|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139106773|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106774|NCT04445714|Incretins|incretins|mesh-ancestor
139106776|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139106777|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139106778|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
139106779|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106780|NCT04435704|Oxytocin|oxytocin|mesh-list
139106781|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
139106782|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139106783|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106784|NCT04433741|Oxytocin|oxytocin|mesh-list
139106785|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
139106786|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139106787|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106788|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139106789|NCT04431206|Oxytocin|oxytocin|mesh-list
139106790|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
139106791|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139106792|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106793|NCT04427709|Oxytocin|oxytocin|mesh-list
139106794|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
139106795|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139106796|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106797|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
139106798|NCT04415476|Sirolimus|sirolimus|mesh-list
139106799|NCT04415476|Prednisone|prednisone|mesh-list
139106800|NCT04415476|Tacrolimus|tacrolimus|mesh-list
139106801|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139106802|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
139106804|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139106805|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106806|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139106807|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106808|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139106809|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
139106810|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139106811|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953667|NCT00349921|Adenosine|adenosine|mesh-list
139106812|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106813|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139106814|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139106815|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
139106816|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139106817|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106818|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
139106819|NCT04389567|Famotidine|famotidine|mesh-list
139106820|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139106821|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139106822|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139106823|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
139106824|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
139106825|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106826|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106827|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106828|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
139106829|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139106830|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106831|NCT04386967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139106832|NCT04386967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106833|NCT04384367|Naproxen|naproxen|mesh-list
139106834|NCT04384367|Rizatriptan|rizatriptan|mesh-list
139106835|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139106836|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139106837|NCT04384367|Analgesics|analgesics|mesh-ancestor
139106838|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
139106839|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106840|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106841|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139106842|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139106843|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
139106844|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139106845|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106846|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106847|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139106848|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
139106849|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106850|NCT04378933|Methamphetamine|methamphetamine|mesh-list
139106851|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139106852|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106853|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
139106854|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
139106855|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106856|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
139106857|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106858|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106859|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
139106860|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139106861|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139106862|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139106863|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139106864|NCT04341259|Ipatasertib|ipatasertib|mesh-list
139106865|NCT04341259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106866|NCT04341259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139106867|NCT04341259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106868|NCT04341259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106869|NCT04341116|Plonmarlimab|plonmarlimab|mesh-list
139106870|NCT04341116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139106871|NCT04341116|Antiviral Agents|antiviral agents|mesh-ancestor
139106872|NCT04341116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106873|NCT04335006|Paclitaxel|paclitaxel|mesh-list
139106874|NCT04335006|Apatinib|apatinib|mesh-list
139106875|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139106876|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106877|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
139106878|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
139106879|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
139106880|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106881|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139106882|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106883|NCT04315233|Belinostat|belinostat|mesh-list
139106884|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106885|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139106886|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139106887|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106888|NCT04313088|Eluxadoline|eluxadoline|mesh-list
139106889|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139106890|NCT04299373|Ethanol|ethanol|mesh-list
139106891|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139106892|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139106893|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106894|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106895|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
139106896|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139106897|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
139106898|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
139106899|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106900|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106901|NCT04250805|Lidocaine|lidocaine|mesh-list
139106902|NCT04250805|Ropivacaine|ropivacaine|mesh-list
139106903|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
139106904|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
139106905|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106906|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106907|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
139106908|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106909|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139106910|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139106911|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139106912|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139106913|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106914|NCT04233190|Budesonide|budesonide|mesh-list
139106915|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
139106916|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139106917|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
139106918|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106919|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106920|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139106921|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
139106922|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139106923|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139106924|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139106925|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
139106926|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106927|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106928|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139106929|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
139106930|NCT04233190|Hormones|hormones|mesh-ancestor
139106931|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139106932|NCT04214834|Morphine|morphine|mesh-list
139106933|NCT04214834|Methadone|methadone|mesh-list
139106934|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139106935|NCT04214834|Narcotics|narcotics|mesh-ancestor
139106936|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106937|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106938|NCT04214834|Analgesics|analgesics|mesh-ancestor
139106939|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
139106940|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106941|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
139106942|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
139106943|NCT04161118|Tisagenlecleucel|tisagenlecleucel|mesh-list
139106944|NCT04161118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139106945|NCT04161118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139106946|NCT04119037|Morphine|morphine|mesh-list
139106947|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139106948|NCT04119037|Narcotics|narcotics|mesh-ancestor
139106949|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138857543|NCT05504876|Midazolam|midazolam|mesh-list
139106950|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106952|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
139106953|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106954|NCT04071769|Xenon|xenon|mesh-list
139106955|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139106956|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
139106957|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
139106958|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139106959|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106960|NCT04052568|Psilocybin|psilocybin|mesh-list
139106961|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
139106962|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106963|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139106964|NCT04050670|Tirzepatide|tirzepatide|mesh-list
139106965|NCT04050670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139106966|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106967|NCT04050670|Incretins|incretins|mesh-ancestor
139106968|NCT04050670|Hormones|hormones|mesh-ancestor
139106969|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139106970|NCT04049084|Adenosine|adenosine|mesh-list
139106971|NCT04049084|Analgesics|analgesics|mesh-ancestor
139106972|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
139106973|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106974|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106975|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139106976|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
139106977|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139106978|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
139106979|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
139106980|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106981|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106982|NCT04016714|Vaccines|vaccines|mesh-list
139106983|NCT04016714|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139106984|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
139106985|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106986|NCT03988530|Scopolamine|scopolamine|mesh-list
139106987|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139106988|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139106989|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
139106990|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
139106991|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139106992|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139106993|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139106994|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
139106995|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139106996|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
139106997|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139106998|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139106999|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139107000|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
139107001|NCT03980769|Fludarabine|fludarabine|mesh-list
139107002|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
139107003|NCT03980769|Thiotepa|thiotepa|mesh-list
139107004|NCT03980769|Treosulfan|treosulfan|mesh-list
139107005|NCT03980769|Busulfan|busulfan|mesh-list
139107006|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139107007|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
139107008|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107009|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139107010|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
139107011|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107012|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139107013|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
139107014|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107015|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139107016|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
139107017|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139107018|NCT03972657|Cemiplimab|cemiplimab|mesh-list
139107019|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107020|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107021|NCT03948243|Tolbutamide|tolbutamide|mesh-list
139107022|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
139107023|NCT03948243|Alprazolam|alprazolam|mesh-list
139107024|NCT03948243|Caffeine|caffeine|mesh-list
138857621|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107025|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139107026|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107027|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139107028|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107029|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107030|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139107031|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139107032|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
139107033|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139107034|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
139107035|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
139107036|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139107037|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139107038|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139107039|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139107040|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139107041|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139107042|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139107043|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
139107045|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139107046|NCT03948035|Dexamethasone|dexamethasone|mesh-list
139107047|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
139107048|NCT03948035|Lenalidomide|lenalidomide|mesh-list
139107049|NCT03948035|Elotuzumab|elotuzumab|mesh-list
139107050|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139107051|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
139107052|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
139107053|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107054|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107055|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139107056|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
139107057|NCT03948035|Hormones|hormones|mesh-ancestor
139107058|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139107059|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139107060|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107062|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139107063|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139107064|NCT03948035|Growth Substances|growth substances|mesh-ancestor
139107065|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
139107066|NCT03946124|Fesoterodine|fesoterodine|mesh-list
139107067|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138887513|NCT00657410|Dexamethasone|dexamethasone|mesh-list
139107071|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107072|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107073|NCT03946124|Urological Agents|urological agents|mesh-ancestor
139107074|NCT03942224|Dexamethasone|dexamethasone|mesh-list
139107075|NCT03942224|Bortezomib|bortezomib|mesh-list
139107076|NCT03942224|Daratumumab|daratumumab|mesh-list
139107077|NCT03942224|Ixazomib|ixazomib|mesh-list
139107078|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139107079|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
139107080|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
139107081|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107082|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107083|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139107084|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
139107085|NCT03942224|Hormones|hormones|mesh-ancestor
139107086|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139107087|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139107088|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107089|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
139107090|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107091|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107092|NCT03938701|Adalimumab|adalimumab|mesh-list
139107093|NCT03938701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139107094|NCT03938701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139107095|NCT03938701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138857694|NCT00938509|Analgesics|analgesics|mesh-ancestor
139107099|NCT03879798|Irinotecan|irinotecan|mesh-list
139107100|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139107101|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139107102|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107103|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107104|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107105|NCT03818685|Capecitabine|capecitabine|mesh-list
139107106|NCT03818685|Nivolumab|nivolumab|mesh-list
139107107|NCT03818685|Ipilimumab|ipilimumab|mesh-list
139107108|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139107109|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
139107110|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107111|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107112|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107113|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139107114|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
139107115|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139107116|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139107117|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107118|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
139107119|NCT03801122|Coagulants|coagulants|mesh-ancestor
139107120|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139107121|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
139107122|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107123|NCT03771677|Interferons|interferons|mesh-list
139107124|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
139107125|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
139107126|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107127|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
139107128|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107129|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
139107130|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107131|NCT03770767|Insulin|insulin|mesh-list
139107132|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139107133|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
139107134|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139107135|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107136|NCT03769155|Nivolumab|nivolumab|mesh-list
139107137|NCT03769155|Ipilimumab|ipilimumab|mesh-list
139107138|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107139|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107140|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139107141|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107142|NCT03747575|Astegolimab|astegolimab|mesh-list
139107143|NCT03747575|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139107144|NCT03747575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139107145|NCT03747575|Antiviral Agents|antiviral agents|mesh-ancestor
139107146|NCT03747575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107147|NCT03747419|Avelumab|avelumab|mesh-list
139107148|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107149|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107150|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
139107151|NCT03733145|Giapreza|giapreza|mesh-list
139107152|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
139107153|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139107154|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139107155|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
139107156|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107157|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107158|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
139107159|NCT03715972|Acetazolamide|acetazolamide|mesh-list
139107160|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107161|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
139107162|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107163|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107164|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139107165|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
139107166|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139107167|NCT03715972|Diuretics|diuretics|mesh-ancestor
139107168|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
139107169|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107170|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
139107171|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107172|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
139107173|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107174|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107175|NCT03634540|Belzutifan|belzutifan|mesh-list
139107176|NCT03634540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107177|NCT03619876|Adalimumab|adalimumab|mesh-list
139107178|NCT03619876|Abatacept|abatacept|mesh-list
139107179|NCT03619876|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139107180|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139107181|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139107182|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139107183|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107184|NCT03619876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107185|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107186|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139107187|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
139107188|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107189|NCT03605901|Methadone|methadone|mesh-list
139107190|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139107191|NCT03605901|Narcotics|narcotics|mesh-ancestor
139107192|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139107193|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107194|NCT03605901|Analgesics|analgesics|mesh-ancestor
139107195|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
139107196|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107197|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
139107198|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
139107199|NCT03579771|Paclitaxel|paclitaxel|mesh-list
139107200|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139107201|NCT03579771|Gemcitabine|gemcitabine|mesh-list
139107202|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139107203|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107204|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
139107205|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
139107206|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
139107207|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107208|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139107209|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
139107210|NCT03578081|Dexamethasone|dexamethasone|mesh-list
139107211|NCT03578081|Ondansetron|ondansetron|mesh-list
139107212|NCT03578081|Olanzapine|olanzapine|mesh-list
139107213|NCT03578081|Palonosetron|palonosetron|mesh-list
139107214|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
139107215|NCT03578081|Aprepitant|aprepitant|mesh-list
139107216|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139107217|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
139107218|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
139107219|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107220|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107221|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139107222|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
139107223|NCT03578081|Hormones|hormones|mesh-ancestor
139107224|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139107225|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139107226|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107227|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
139107228|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
139107229|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139107230|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139107231|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
139107232|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139107233|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107234|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139107235|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139107236|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139107237|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139107238|NCT03578081|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139107239|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139107240|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139107241|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139107242|NCT03510884|Nicotinic Acids|nicotinic acids|mesh-list
139107243|NCT03510884|Niacin|niacin|mesh-list
139107244|NCT03510884|Niacinamide|niacinamide|mesh-list
139107245|NCT03510884|Atorvastatin|atorvastatin|mesh-list
139107246|NCT03510884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139107247|NCT03510884|Simvastatin|simvastatin|mesh-list
139107248|NCT03510884|Ezetimibe|ezetimibe|mesh-list
139107249|NCT03510884|Pravastatin|pravastatin|mesh-list
139107250|NCT03510884|Alirocumab|alirocumab|mesh-list
139107251|NCT03510884|Lovastatin|lovastatin|mesh-list
139107252|NCT03510884|Cholestyramine Resin|cholestyramine resin|mesh-list
139107253|NCT03510884|Fenofibrate|fenofibrate|mesh-list
139107254|NCT03510884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139107255|NCT03510884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139107256|NCT03510884|Antimetabolites|antimetabolites|mesh-ancestor
139107257|NCT03510884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107258|NCT03510884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139107259|NCT03510884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139107260|NCT03510884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107262|NCT03510884|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139107263|NCT03510884|Protease Inhibitors|protease inhibitors|mesh-ancestor
139107264|NCT03510884|Vitamin B Complex|vitamin b complex|mesh-ancestor
139107265|NCT03510884|Vitamins|vitamins|mesh-ancestor
139107266|NCT03510884|Micronutrients|micronutrients|mesh-ancestor
139107267|NCT03510884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107268|NCT03510884|Vasodilator Agents|vasodilator agents|mesh-ancestor
139107269|NCT03497975|Nalbuphine|nalbuphine|mesh-list
139107270|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139107271|NCT03497975|Narcotics|narcotics|mesh-ancestor
139107272|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139107273|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107274|NCT03497975|Analgesics|analgesics|mesh-ancestor
139107275|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
139107276|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107277|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139107278|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139107279|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107280|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139107281|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139107282|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139107283|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107284|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
139107285|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139107286|NCT03497143|Lamotrigine|lamotrigine|mesh-list
139107287|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
139107288|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139107289|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139107290|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107291|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139107292|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107293|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139107294|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139107295|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139107296|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139107297|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139107298|NCT03455829|Osimertinib|osimertinib|mesh-list
139107299|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107300|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139107301|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107302|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107303|NCT03453489|Tryptophan|tryptophan|mesh-list
139107304|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139107305|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
139036598|NCT00262600|Warfarin|warfarin|mesh-list
139107306|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139107307|NCT03440190|Methylphenidate|methylphenidate|mesh-list
139107308|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139107309|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107310|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139107311|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139107312|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139107313|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107314|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
139107315|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139107316|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139107317|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139107318|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107319|NCT03408587|Ipilimumab|ipilimumab|mesh-list
139107320|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107321|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107322|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139107323|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107324|NCT03314636|Dexamethasone|dexamethasone|mesh-list
139107325|NCT03314636|Lenalidomide|lenalidomide|mesh-list
139107326|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139107327|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
139107328|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
139107329|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107330|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107331|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139107332|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
139107333|NCT03314636|Hormones|hormones|mesh-ancestor
139107334|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139107335|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139107336|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107337|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
139107338|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139107339|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139107340|NCT03314636|Growth Substances|growth substances|mesh-ancestor
139107341|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
139107342|NCT03310541|Fulvestrant|fulvestrant|mesh-list
139107343|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139107344|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107345|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139107346|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139107347|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
139107348|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139107349|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107350|NCT03279861|Valsartan|valsartan|mesh-list
139107351|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139107352|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139107353|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139107354|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139107355|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107356|NCT03250832|Bevacizumab|bevacizumab|mesh-list
139107357|NCT03250832|Dostarlimab|dostarlimab|mesh-list
139107358|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107359|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107360|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139107361|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139107362|NCT03250832|Growth Substances|growth substances|mesh-ancestor
139107363|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107364|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
139107366|NCT03250117|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139107367|NCT03250117|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139107368|NCT03250117|Dopamine Agonists|dopamine agonists|mesh-ancestor
139107369|NCT03250117|Dopamine Agents|dopamine agents|mesh-ancestor
139107370|NCT03250117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139107371|NCT03250117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107372|NCT03250117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107373|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
139107374|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
139107375|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107376|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107377|NCT03236935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139107378|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107379|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107380|NCT03230838|Meropenem|meropenem|mesh-list
139107381|NCT03230838|Tazobactam|tazobactam|mesh-list
139107382|NCT03230838|Ceftolozane|ceftolozane|mesh-list
139107383|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
139107384|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139107385|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107386|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139107387|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107388|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107389|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139107390|NCT03217136|Metronidazole|metronidazole|mesh-list
139107391|NCT03217136|Meropenem|meropenem|mesh-list
139107392|NCT03217136|Tazobactam|tazobactam|mesh-list
139107393|NCT03217136|Ceftolozane|ceftolozane|mesh-list
139107394|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
139107395|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107396|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139107397|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139107398|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139107399|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139107400|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107401|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107402|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139107403|NCT03201939|Lisinopril|lisinopril|mesh-list
139107404|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139107405|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
139107406|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107407|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107408|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139107409|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139107410|NCT03201939|Protective Agents|protective agents|mesh-ancestor
139107411|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107412|NCT03179761|Vaccines|vaccines|mesh-list
139107413|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
139107414|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107415|NCT03158064|Durvalumab|durvalumab|mesh-list
139107416|NCT03158064|Tremelimumab|tremelimumab|mesh-list
139107417|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107418|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107419|NCT03087708|Naloxegol|naloxegol|mesh-list
139107420|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139107421|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107422|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
139107423|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107424|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
139107425|NCT03057847|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139107427|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
139107428|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107429|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
139107430|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139107431|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139107432|NCT03022773|Carotenoids|carotenoids|mesh-list
139107433|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
139107434|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107435|NCT03022773|Protective Agents|protective agents|mesh-ancestor
139107436|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107437|NCT02946463|Eculizumab|eculizumab|mesh-list
139107438|NCT02946463|Ravulizumab|ravulizumab|mesh-list
139107439|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139107440|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139107441|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
139107442|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107443|NCT02860039|Vaccines|vaccines|mesh-list
139107444|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
139107445|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107446|NCT02819024|Alovudine|alovudine|mesh-list
139107447|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
139107448|NCT02819024|Dexamethasone|dexamethasone|mesh-list
139107449|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
139107450|NCT02819024|Ichthammol|ichthammol|mesh-list
139107451|NCT02819024|BB 1101|bb 1101|mesh-list
139107452|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139107453|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
139107454|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
139107455|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107456|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107457|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139107458|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
139107459|NCT02819024|Hormones|hormones|mesh-ancestor
139107460|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139107461|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139107462|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107463|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
139107464|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107465|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107466|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
139107467|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
139107468|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107469|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
139107470|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139107471|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139107472|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
139107473|NCT02800785|Metronidazole|metronidazole|mesh-list
139107474|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
139107475|NCT02800785|Levofloxacin|levofloxacin|mesh-list
139107476|NCT02800785|Cefazolin|cefazolin|mesh-list
139107477|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
139107478|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
139107479|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
139107480|NCT02800785|Ertapenem|ertapenem|mesh-list
139107481|NCT02800785|Cefuroxime|cefuroxime|mesh-list
139107482|NCT02800785|Tigecycline|tigecycline|mesh-list
139107483|NCT02800785|Cefotaxime|cefotaxime|mesh-list
139107484|NCT02800785|Cefoxitin|cefoxitin|mesh-list
139107485|NCT02800785|Ticarcillin|ticarcillin|mesh-list
139107486|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
139107487|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139107488|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107489|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139107490|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139107491|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107492|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107493|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107494|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139107495|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139107496|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139107497|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139107498|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139107499|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139107500|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139107501|NCT02782663|Upadacitinib|upadacitinib|mesh-list
139107502|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139107503|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139107504|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107505|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107506|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139107507|NCT02765854|Dexamethasone|dexamethasone|mesh-list
139107508|NCT02765854|Lenalidomide|lenalidomide|mesh-list
139107509|NCT02765854|Ixazomib|ixazomib|mesh-list
139107510|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139107511|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
139107512|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
139107513|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107514|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107515|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139107516|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
139107517|NCT02765854|Hormones|hormones|mesh-ancestor
139107518|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139107519|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139107520|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107521|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
139107522|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139107523|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139107524|NCT02765854|Growth Substances|growth substances|mesh-ancestor
139107525|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
139107526|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107527|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
139107528|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107529|NCT02761694|Paclitaxel|paclitaxel|mesh-list
139107530|NCT02761694|Fulvestrant|fulvestrant|mesh-list
139107531|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139107532|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107533|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
139107534|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
139107535|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
139107536|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107537|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139107538|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139107539|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139107540|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
139107541|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139107542|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107543|NCT02760030|Fulvestrant|fulvestrant|mesh-list
139107544|NCT02760030|Palbociclib|palbociclib|mesh-list
139107545|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139107546|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139107547|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036655|NCT00394836|Ofatumumab|ofatumumab|mesh-list
139107548|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139107549|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139107550|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
139107551|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139107552|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107553|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138858156|NCT02715024|Tamsulosin|tamsulosin|mesh-list
138511495|NCT04730596|Ketamine|ketamine|mesh-list
139107554|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107555|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107556|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139107557|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
139107558|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107559|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107560|NCT02641093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139107561|NCT02641093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107562|NCT02578732|Leucovorin|leucovorin|mesh-list
139107563|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
139107564|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107565|NCT02578732|Antidotes|antidotes|mesh-ancestor
139107566|NCT02578732|Protective Agents|protective agents|mesh-ancestor
139107567|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107568|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
139107569|NCT02578732|Vitamins|vitamins|mesh-ancestor
139107570|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
139107571|NCT02519452|Daratumumab|daratumumab|mesh-list
139107572|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107573|NCT02505984|Oxytocin|oxytocin|mesh-list
139107574|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
139107575|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139107576|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107577|NCT02477280|Methylphenidate|methylphenidate|mesh-list
139107578|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139107579|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107580|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139107581|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139107582|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139107583|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107584|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
139107585|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139107586|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139107587|NCT02438722|Cetuximab|cetuximab|mesh-list
139107588|NCT02438722|Afatinib|afatinib|mesh-list
139107589|NCT02438722|Antibodies|antibodies|mesh-list
139107590|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
139107591|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139107592|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
139107593|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107594|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107595|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139107596|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107597|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107598|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
139107599|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139107600|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
139107601|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139107602|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107603|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139107604|NCT02368665|Amlodipine|amlodipine|mesh-list
139107605|NCT02368665|Candesartan|candesartan|mesh-list
139107606|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
139107607|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139107608|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139107609|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139107610|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107611|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139107612|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107613|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
139107614|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139107615|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139107617|NCT02368652|Candesartan|candesartan|mesh-list
139107618|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
139107619|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139107620|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139107621|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139107622|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107623|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139107624|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107625|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
139107626|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139107627|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139107628|NCT02332577|Amoxicillin|amoxicillin|mesh-list
139107629|NCT02332577|Pristinamycin|pristinamycin|mesh-list
139107630|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139107631|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107632|NCT02330926|Ibuprofen|ibuprofen|mesh-list
139107633|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139107634|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139107635|NCT02330926|Analgesics|analgesics|mesh-ancestor
139107636|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
139107637|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107638|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107639|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139107640|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139107641|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139107642|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107643|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107644|NCT02312245|Paclitaxel|paclitaxel|mesh-list
139107645|NCT02312245|Bevacizumab|bevacizumab|mesh-list
139107646|NCT02312245|Gemcitabine|gemcitabine|mesh-list
139107647|NCT02312245|Doxorubicin|doxorubicin|mesh-list
139107648|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139107649|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139107650|NCT02312245|Topotecan|topotecan|mesh-list
139107651|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139107652|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
139107653|NCT02312245|Antibodies|antibodies|mesh-list
139107654|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
139107655|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139107656|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
139107657|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139107658|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107659|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
139107660|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
139107661|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
139107662|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107663|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139107664|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139107665|NCT02312245|Growth Substances|growth substances|mesh-ancestor
139107666|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107667|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
139107668|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
139107669|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139107670|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
139107671|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139107672|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139107673|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139107674|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107675|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139107676|NCT02297438|Letrozole|letrozole|mesh-list
139107677|NCT02297438|Palbociclib|palbociclib|mesh-list
139107678|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036676|NCT01032122|Rituximab|rituximab|mesh-list
139107679|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139107680|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139107681|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107682|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107683|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139107684|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
138953934|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139107685|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139107686|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107687|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139107689|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107690|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139107691|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107692|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107693|NCT02137759|Temozolomide|temozolomide|mesh-list
139107694|NCT02137759|Belinostat|belinostat|mesh-list
139107695|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139107696|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
139107697|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107698|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107699|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139107700|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107701|NCT02090998|Lidocaine|lidocaine|mesh-list
139107702|NCT02090998|Amitriptyline|amitriptyline|mesh-list
139107703|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
139107704|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
139107705|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139107706|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107707|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
139107708|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107709|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139107710|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139107711|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139107712|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139107713|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107714|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139107715|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
139107716|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139107717|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139107718|NCT02090998|Analgesics|analgesics|mesh-ancestor
139107719|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139107720|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139107721|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
139107722|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139107723|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
139107724|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107725|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107726|NCT02043665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139107727|NCT02043665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107728|NCT01912651|Cephalexin|cephalexin|mesh-list
139107729|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139107730|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107731|NCT01912625|Paclitaxel|paclitaxel|mesh-list
139107732|NCT01912625|Carboplatin|carboplatin|mesh-list
139107733|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139107734|NCT01912625|Trametinib|trametinib|mesh-list
139107735|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139107736|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107737|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
139107738|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
139107739|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
139107740|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107741|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139036682|NCT00394524|Insulin|insulin|mesh-list
139107742|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107743|NCT01814813|Bevacizumab|bevacizumab|mesh-list
139107744|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107745|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953952|NCT00905073|Methotrexate|methotrexate|mesh-list
139107746|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139107747|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139107748|NCT01814813|Growth Substances|growth substances|mesh-ancestor
139107749|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107750|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
139107751|NCT01720836|Poly ICLC|poly iclc|mesh-list
139107752|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
139107753|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
139107754|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107755|NCT01667120|Ketorolac|ketorolac|mesh-list
139107756|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139107757|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139107758|NCT01667120|Analgesics|analgesics|mesh-ancestor
139107759|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
139107760|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107761|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107762|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139107763|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139107764|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139107765|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107766|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107767|NCT01642251|Cisplatin|cisplatin|mesh-list
139107768|NCT01642251|Etoposide|etoposide|mesh-list
139107769|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
139107770|NCT01642251|Veliparib|veliparib|mesh-list
139107771|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
139107772|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107773|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139107774|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139107775|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139107776|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107777|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107778|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139107779|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
139107780|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
139107781|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
139107782|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
139107783|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
139107784|NCT01606137|Nabiximols|nabiximols|mesh-list
139107785|NCT01606137|Analgesics|analgesics|mesh-ancestor
139107786|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
139107787|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107788|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107789|NCT01532518|MEN 11420|men 11420|mesh-list
139107790|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139107791|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
139107792|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107793|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107794|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139107795|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
139107796|NCT01489813|Genistein|genistein|mesh-list
139107797|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139107798|NCT01489813|Protective Agents|protective agents|mesh-ancestor
139107799|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107800|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107801|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139107802|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107803|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107804|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
139107805|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139107806|NCT01489813|Estrogens|estrogens|mesh-ancestor
139107807|NCT01489813|Hormones|hormones|mesh-ancestor
139107808|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139107809|NCT01420874|Leucovorin|leucovorin|mesh-list
139107810|NCT01420874|Fluorouracil|fluorouracil|mesh-list
139107812|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
139107813|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107814|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139107815|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107816|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139107817|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
139107818|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107819|NCT01420874|Antidotes|antidotes|mesh-ancestor
139107820|NCT01420874|Protective Agents|protective agents|mesh-ancestor
139107821|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
139107822|NCT01420874|Vitamins|vitamins|mesh-ancestor
139107823|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
139107824|NCT01405521|Vaccines|vaccines|mesh-list
139107825|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
139107826|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107827|NCT01027000|Sirolimus|sirolimus|mesh-list
139107828|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
139107829|NCT01027000|Busulfan|busulfan|mesh-list
139107830|NCT01027000|Rituximab|rituximab|mesh-list
139107831|NCT01027000|Methotrexate|methotrexate|mesh-list
139107832|NCT01027000|Fludarabine|fludarabine|mesh-list
139107833|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
139107834|NCT01027000|Tacrolimus|tacrolimus|mesh-list
139107835|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139107836|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
139107837|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107838|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139107839|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139107840|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
139107841|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107842|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107843|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139107844|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139107845|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139107846|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
139107847|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139107848|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139107849|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
139107850|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
139107851|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107852|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139107853|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139107854|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139107855|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139107856|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107857|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139107858|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
139107860|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
139107861|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139107862|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139107863|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139107864|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107865|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
139107866|NCT00844285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139107867|NCT00844285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139107868|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139107869|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
139036699|NCT00415610|Nicardipine|nicardipine|mesh-list
139107870|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107871|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139107872|NCT00841789|Etanercept|etanercept|mesh-list
139107873|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139107874|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139107875|NCT00841789|Analgesics|analgesics|mesh-ancestor
139107876|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
139107877|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107878|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107879|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139107880|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139107881|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139107882|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139107883|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
139107884|NCT00711646|Nabiximols|nabiximols|mesh-list
139107885|NCT00711646|Analgesics|analgesics|mesh-ancestor
139107886|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
139107887|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107888|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107889|NCT00702468|Nabiximols|nabiximols|mesh-list
139107890|NCT00702468|Analgesics|analgesics|mesh-ancestor
139107891|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
139107892|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107893|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107894|NCT00681538|Nabiximols|nabiximols|mesh-list
139107895|NCT00681538|Analgesics|analgesics|mesh-ancestor
139107896|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
139107897|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107898|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107899|NCT00497029|Fluorides|fluorides|mesh-list
139107900|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
139107901|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
139107902|NCT00497029|Protective Agents|protective agents|mesh-ancestor
139107903|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107904|NCT00455351|Vorinostat|vorinostat|mesh-list
139107905|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107906|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139107907|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107908|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107909|NCT00379340|Dactinomycin|dactinomycin|mesh-list
139107910|NCT00379340|Cactinomycin|cactinomycin|mesh-list
139107911|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
139107912|NCT00379340|Doxorubicin|doxorubicin|mesh-list
139107913|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139107914|NCT00379340|Etoposide|etoposide|mesh-list
139107915|NCT00379340|Vincristine|vincristine|mesh-list
139107916|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
139107917|NCT00379340|Podophyllotoxin|podophyllotoxin|mesh-list
139107918|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139107919|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
139107920|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107921|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139107922|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139107923|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
139107924|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107925|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107926|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139107927|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139107928|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139107929|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138858517|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139107930|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107931|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139107932|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
139107933|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
139107934|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
139107935|NCT00379340|Keratolytic Agents|keratolytic agents|mesh-ancestor
139107936|NCT00379340|Dermatologic Agents|dermatologic agents|mesh-ancestor
139107937|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139107938|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107939|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139107940|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139107941|NCT00301808|Docetaxel|docetaxel|mesh-list
139107942|NCT00301808|Pemetrexed|pemetrexed|mesh-list
139107943|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139107944|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
139107945|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
139107946|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
139107947|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107948|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139107949|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139107950|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139107951|NCT00254670|Naltrexone|naltrexone|mesh-list
139107952|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139107953|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139107954|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107955|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
139107956|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139107957|NCT00138801|Doxycycline|doxycycline|mesh-list
139107958|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
139107959|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139107960|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139107961|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
139107962|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139107963|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139107964|NCT05795478|Pregabalin|pregabalin|mesh-list
139107965|NCT05795478|Oxycodone|oxycodone|mesh-list
139107966|NCT05795478|Analgesics|analgesics|mesh-ancestor
139107967|NCT05795478|Sensory System Agents|sensory system agents|mesh-ancestor
139107968|NCT05795478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954003|NCT00336583|Cytarabine|cytarabine|mesh-list
139107969|NCT05795478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107970|NCT05795478|Anticonvulsants|anticonvulsants|mesh-ancestor
139107971|NCT05795478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139107972|NCT05795478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139107973|NCT05795478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107974|NCT05795478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139107975|NCT05795478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139107976|NCT05795478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139107977|NCT05795478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139107978|NCT05795478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139107979|NCT05795478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139107980|NCT05795478|Narcotics|narcotics|mesh-ancestor
139107981|NCT05795400|Dapagliflozin|dapagliflozin|mesh-list
139107982|NCT05795400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139107983|NCT05795400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107984|NCT05795400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139107985|NCT05795400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107986|NCT05795283|Dexetimide|dexetimide|mesh-list
139107987|NCT05795283|Citalopram|citalopram|mesh-list
139107988|NCT05795283|Escitalopram|escitalopram|mesh-list
139107989|NCT05795283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139107990|NCT05795283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139036725|NCT00278512|Fludarabine|fludarabine|mesh-list
139107991|NCT05795283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139107992|NCT05795283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139107993|NCT05795283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139107994|NCT05795283|Serotonin Agents|serotonin agents|mesh-ancestor
139107995|NCT05795283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139107996|NCT05795283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139107997|NCT05795283|Antidepressive Agents|antidepressive agents|mesh-ancestor
139107998|NCT05795283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139107999|NCT05795283|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139108000|NCT05795283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139108001|NCT05795283|Parasympatholytics|parasympatholytics|mesh-ancestor
139108002|NCT05795283|Autonomic Agents|autonomic agents|mesh-ancestor
139108003|NCT05795283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108004|NCT05795283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139108005|NCT05795283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139108006|NCT05795283|Cholinergic Agents|cholinergic agents|mesh-ancestor
139108007|NCT05794919|Calcium, Dietary|calcium, dietary|mesh-list
139108009|NCT05794919|Calcium|calcium|mesh-list
139108010|NCT05794919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139108011|NCT05794919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108012|NCT05794919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139108013|NCT05794919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139108014|NCT05794919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108015|NCT05794919|Disinfectants|disinfectants|mesh-ancestor
139108016|NCT05794919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139108017|NCT05794919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139108018|NCT05726097|Ascorbic Acid|ascorbic acid|mesh-list
139108019|NCT05726097|Prucalopride|prucalopride|mesh-list
139108020|NCT05726097|Picosulfate sodium|picosulfate sodium|mesh-list
139108021|NCT05726097|Antioxidants|antioxidants|mesh-ancestor
139108022|NCT05726097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108023|NCT05726097|Protective Agents|protective agents|mesh-ancestor
139108024|NCT05726097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108025|NCT05726097|Vitamins|vitamins|mesh-ancestor
139108026|NCT05726097|Micronutrients|micronutrients|mesh-ancestor
139108027|NCT05726097|Laxatives|laxatives|mesh-ancestor
139108028|NCT05726097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139108029|NCT05726097|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139108030|NCT05726097|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139108031|NCT05726097|Serotonin Agents|serotonin agents|mesh-ancestor
139108032|NCT05726097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108033|NCT05726097|Cathartics|cathartics|mesh-ancestor
139108034|NCT05712343|Valacyclovir|valacyclovir|mesh-list
139108035|NCT05712343|Antiviral Agents|antiviral agents|mesh-ancestor
139108036|NCT05712343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108037|NCT05703425|Sulfasalazine|sulfasalazine|mesh-list
139108038|NCT05703425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108039|NCT05703425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139108040|NCT05703425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139108041|NCT05703425|Analgesics|analgesics|mesh-ancestor
139108042|NCT05703425|Sensory System Agents|sensory system agents|mesh-ancestor
139108043|NCT05703425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108044|NCT05703425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108045|NCT05703425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139108046|NCT05703425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139108047|NCT05703425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139108048|NCT05690503|Ketamine|ketamine|mesh-list
139108049|NCT05690503|Analgesics|analgesics|mesh-ancestor
139108050|NCT05690503|Sensory System Agents|sensory system agents|mesh-ancestor
139108051|NCT05690503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108052|NCT05690503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108053|NCT05690503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139036747|NCT00427934|Maraviroc|maraviroc|mesh-list
139108054|NCT05690503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139108055|NCT05690503|Anesthetics, General|anesthetics, general|mesh-ancestor
139108056|NCT05690503|Anesthetics|anesthetics|mesh-ancestor
139108057|NCT05690503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139108058|NCT05690503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139108059|NCT05690503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139108060|NCT05690503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108061|NCT05690503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108062|NCT05624606|Vaccines|vaccines|mesh-list
139108063|NCT05624606|Immunologic Factors|immunologic factors|mesh-ancestor
139108064|NCT05624606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108065|NCT05588648|Vactosertib|vactosertib|mesh-list
139108066|NCT05588648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139108067|NCT05588648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108068|NCT05588648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108069|NCT05571267|Bevacizumab|bevacizumab|mesh-list
139108070|NCT05571267|Ranibizumab|ranibizumab|mesh-list
139108071|NCT05571267|Aflibercept|aflibercept|mesh-list
139108072|NCT05571267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108073|NCT05571267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108074|NCT05571267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139108075|NCT05571267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139108076|NCT05571267|Growth Substances|growth substances|mesh-ancestor
139108077|NCT05571267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108078|NCT05571267|Growth Inhibitors|growth inhibitors|mesh-ancestor
139108079|NCT05550194|Valacyclovir|valacyclovir|mesh-list
139108080|NCT05550194|Antiviral Agents|antiviral agents|mesh-ancestor
139108081|NCT05550194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108082|NCT05477459|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139108083|NCT05477459|Hallucinogens|hallucinogens|mesh-ancestor
139108084|NCT05477459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108085|NCT05477459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139108086|NCT05477459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139108087|NCT05477459|Serotonin Agents|serotonin agents|mesh-ancestor
139108088|NCT05477459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108089|NCT05477459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108090|NCT05477459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139108092|NCT05426486|Docetaxel|docetaxel|mesh-list
139108093|NCT05426486|Trastuzumab|trastuzumab|mesh-list
139108094|NCT05426486|Pertuzumab|pertuzumab|mesh-list
139108095|NCT05426486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108096|NCT05426486|Tubulin Modulators|tubulin modulators|mesh-ancestor
139108097|NCT05426486|Antimitotic Agents|antimitotic agents|mesh-ancestor
139108098|NCT05426486|Mitosis Modulators|mitosis modulators|mesh-ancestor
139108099|NCT05426486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108100|NCT05426486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108101|NCT05399290|Doxycycline|doxycycline|mesh-list
139108102|NCT05399290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139108103|NCT05399290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108104|NCT05399290|Antimalarials|antimalarials|mesh-ancestor
139108105|NCT05399290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139108106|NCT05399290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139108107|NCT05389852|Dexmedetomidine|dexmedetomidine|mesh-list
139108108|NCT05389852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139108109|NCT05389852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139108110|NCT05389852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108111|NCT05389852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139108112|NCT05389852|Analgesics|analgesics|mesh-ancestor
139108113|NCT05389852|Sensory System Agents|sensory system agents|mesh-ancestor
139108114|NCT05389852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108115|NCT05389852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139108117|NCT05389852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139108118|NCT05389852|Adrenergic Agents|adrenergic agents|mesh-ancestor
139108119|NCT05389852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036756|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139108120|NCT05389852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108121|NCT05386914|Sirolimus|sirolimus|mesh-list
139108122|NCT05386914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139108123|NCT05386914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108124|NCT05386914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139108125|NCT05386914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108126|NCT05386914|Antifungal Agents|antifungal agents|mesh-ancestor
139108127|NCT05386914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139108128|NCT05386914|Immunologic Factors|immunologic factors|mesh-ancestor
139108129|NCT05386914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108130|NCT05352828|Nivolumab|nivolumab|mesh-list
139108131|NCT05352828|Fludarabine|fludarabine|mesh-list
139108132|NCT05352828|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139108133|NCT05352828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108134|NCT05352828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108135|NCT05352828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139108136|NCT05352828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108137|NCT05352828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139108138|NCT05352828|Alkylating Agents|alkylating agents|mesh-ancestor
139108139|NCT05318248|Clonidine|clonidine|mesh-list
139108140|NCT05318248|Analgesics|analgesics|mesh-ancestor
139108141|NCT05318248|Sensory System Agents|sensory system agents|mesh-ancestor
139108142|NCT05318248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108143|NCT05318248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108144|NCT05318248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139108145|NCT05318248|Sympatholytics|sympatholytics|mesh-ancestor
139108146|NCT05318248|Autonomic Agents|autonomic agents|mesh-ancestor
139108147|NCT05318248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139108148|NCT05318248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139108149|NCT05318248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139108150|NCT05318248|Adrenergic Agents|adrenergic agents|mesh-ancestor
139108151|NCT05318248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108152|NCT05318248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108153|NCT05219266|Midostaurin|midostaurin|mesh-list
139108154|NCT05219266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108155|NCT05219266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139108156|NCT05219266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108157|NCT05219266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108158|NCT05204862|Antibodies|antibodies|mesh-list
138858740|NCT06005259|Diuretics|diuretics|mesh-ancestor
139108160|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108161|NCT05193851|Ricolinostat|ricolinostat|mesh-list
139108162|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108163|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139108164|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108165|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108166|NCT05193318|Ketamine|ketamine|mesh-list
139108167|NCT05193318|Analgesics|analgesics|mesh-ancestor
139108168|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
139036770|NCT01324076|Doxorubicin|doxorubicin|mesh-list
139108170|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108171|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139108172|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139108173|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
139108174|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
139108175|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139108176|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139108177|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139108178|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108179|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108180|NCT05163041|Nivolumab|nivolumab|mesh-list
139108181|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108182|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108183|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139108184|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108185|NCT05138575|Empagliflozin|empagliflozin|mesh-list
139108186|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139108187|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108188|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139108189|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108190|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
139108191|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139108192|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
139108193|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108194|NCT05122559|Expectorants|expectorants|mesh-ancestor
139108195|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
139108196|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139108197|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
139108198|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108199|NCT05122559|Protective Agents|protective agents|mesh-ancestor
139108200|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108201|NCT05122559|Antidotes|antidotes|mesh-ancestor
139108202|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
139108203|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139108204|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
139108205|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139108206|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
139108207|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108208|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108209|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
139108210|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139108211|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139108212|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
139108214|NCT05054725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139108215|NCT05054725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108216|NCT05054725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108217|NCT05054725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108218|NCT05046522|Palmidrol|palmidrol|mesh-list
139108219|NCT05046522|Analgesics|analgesics|mesh-ancestor
139108220|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
139108221|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108222|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108223|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139108224|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139108225|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139108226|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139108227|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
139108228|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108229|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139108230|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139108231|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108232|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108233|NCT05046522|Hormones|hormones|mesh-ancestor
139108234|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139108235|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
139108236|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139108237|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108238|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139108239|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139108240|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108241|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108242|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108243|NCT04915482|Antibodies|antibodies|mesh-list
139108244|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
139108245|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108246|NCT04897971|Antibodies|antibodies|mesh-list
139108247|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
139108248|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108249|NCT04857827|Timolol|timolol|mesh-list
139108250|NCT04857827|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139108251|NCT04857827|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139108252|NCT04857827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108253|NCT04857827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139108254|NCT04857827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139108255|NCT04857827|Adrenergic Agents|adrenergic agents|mesh-ancestor
139108256|NCT04857827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108257|NCT04857827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108258|NCT04857827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139108259|NCT04857827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139108260|NCT04796584|Antibodies|antibodies|mesh-list
139108261|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
138627446|NCT04584580|Heparin|heparin|mesh-list
139108262|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108263|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139108264|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
139108265|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108266|NCT04688931|Mitomycins|mitomycins|mesh-list
139108267|NCT04688931|Mitomycin|mitomycin|mesh-list
139108268|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139108269|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108270|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
139108271|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108272|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139108273|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108274|NCT04630769|Interleukin-2|interleukin-2|mesh-list
139108275|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108276|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139108277|NCT04630769|Analgesics|analgesics|mesh-ancestor
139108278|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
139108279|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108280|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108281|NCT04543188|Midazolam|midazolam|mesh-list
139108282|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139108283|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139108284|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139108285|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108286|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139108287|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139108288|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139108289|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139108290|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
139108291|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
139108292|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
139108293|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
139108294|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108295|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108296|NCT04477512|Prednisone|prednisone|mesh-list
139108297|NCT04477512|Nivolumab|nivolumab|mesh-list
139108298|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
139108299|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139108300|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
139108301|NCT04477512|Hormones|hormones|mesh-ancestor
139108302|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139108303|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108304|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139108305|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108306|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138858894|NCT06003608|Levodopa|levodopa|mesh-list
139108307|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139108308|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108309|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139108310|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108311|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
139108312|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139108314|NCT04349124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139108315|NCT04349124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139108316|NCT04349124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108317|NCT04349124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139108318|NCT04349124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108319|NCT04349124|Vasodilator Agents|vasodilator agents|mesh-ancestor
139108320|NCT04349124|Tocolytic Agents|tocolytic agents|mesh-ancestor
139108321|NCT04349124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139108322|NCT04348292|Sirolimus|sirolimus|mesh-list
139108323|NCT04348292|Durvalumab|durvalumab|mesh-list
139108324|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
139108325|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139108326|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
139108327|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139108328|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108329|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139108330|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108331|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
139108332|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139108333|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
139108334|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887522|NCT00657410|Hormones|hormones|mesh-ancestor
139108335|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108337|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139108338|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139108339|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
139108340|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
139108341|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108342|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108343|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108344|NCT03991403|Paclitaxel|paclitaxel|mesh-list
139108345|NCT03991403|Bevacizumab|bevacizumab|mesh-list
139108346|NCT03991403|Carboplatin|carboplatin|mesh-list
139108347|NCT03991403|Pemetrexed|pemetrexed|mesh-list
139108348|NCT03991403|Atezolizumab|atezolizumab|mesh-list
139108349|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139108350|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108351|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
139108352|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
139108353|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
139108354|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108355|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108356|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139108357|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139108358|NCT03991403|Growth Substances|growth substances|mesh-ancestor
139108359|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108360|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
139108361|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108362|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139108363|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139108364|NCT03991403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139108365|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
139108366|NCT03930680|Razoxane|razoxane|mesh-list
139108367|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108368|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139108369|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139108370|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139108371|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108372|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108373|NCT03930680|Protective Agents|protective agents|mesh-ancestor
139108374|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108375|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
139108376|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
139108377|NCT03897439|Bupropion|bupropion|mesh-list
139108378|NCT03897439|Nicotine|nicotine|mesh-list
139108379|NCT03897439|Varenicline|varenicline|mesh-list
139108380|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138858963|NCT05869136|Immunologic Factors|immunologic factors|mesh-ancestor
139108381|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
139108382|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108383|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108384|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139108385|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139108386|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
139108387|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108388|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108390|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
139108391|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139108392|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139108393|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139108394|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139108395|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
139108396|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139108397|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139108398|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108399|NCT03777436|Apremilast|apremilast|mesh-list
139108400|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139108401|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139108402|NCT03777436|Analgesics|analgesics|mesh-ancestor
139108403|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
139108404|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108405|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108406|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139108407|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139108408|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138954111|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
139108409|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139108410|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108411|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108412|NCT03773302|Gemcitabine|gemcitabine|mesh-list
139108413|NCT03773302|Infigratinib|infigratinib|mesh-list
139108414|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108415|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139108416|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
139108417|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108418|NCT03592992|Morphine|morphine|mesh-list
139108419|NCT03592992|Hydromorphone|hydromorphone|mesh-list
139108420|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139108421|NCT03592992|Narcotics|narcotics|mesh-ancestor
139108422|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139108423|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108424|NCT03592992|Analgesics|analgesics|mesh-ancestor
139108425|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
139108426|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108427|NCT03447808|Daratumumab|daratumumab|mesh-list
139108428|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108429|NCT03366766|Cisplatin|cisplatin|mesh-list
139108430|NCT03366766|Gemcitabine|gemcitabine|mesh-list
139108431|NCT03366766|Nivolumab|nivolumab|mesh-list
139108432|NCT03366766|Pemetrexed|pemetrexed|mesh-list
139108433|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108434|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139108435|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
139108436|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108437|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108438|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139108439|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108440|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139108441|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139108442|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
139108443|NCT03308448|Hematinics|hematinics|mesh-ancestor
139108444|NCT03299309|Vaccines|vaccines|mesh-list
139108445|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
139108446|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108447|NCT03254927|Cetuximab|cetuximab|mesh-list
139108448|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108449|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108450|NCT03039036|Misoprostol|misoprostol|mesh-list
139108451|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139108452|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
139108453|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139108454|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138859050|NCT05685342|Acetaminophen|acetaminophen|mesh-list
139108455|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139108456|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139108458|NCT03025880|Gemcitabine|gemcitabine|mesh-list
139108459|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
139108460|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139108462|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108463|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108464|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108465|NCT03025880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139108466|NCT02962297|Vitamin E|vitamin e|mesh-list
139108467|NCT02962297|Vitamins|vitamins|mesh-ancestor
139108468|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
139108469|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108470|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
139108471|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108472|NCT02962297|Protective Agents|protective agents|mesh-ancestor
139108473|NCT02518555|Vaccines|vaccines|mesh-list
139108474|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
139108475|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108476|NCT02027376|Docetaxel|docetaxel|mesh-list
139108477|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108478|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
139108479|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
139108480|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
139108481|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108482|NCT02005289|Lenalidomide|lenalidomide|mesh-list
139108483|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
139108485|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139108486|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139108487|NCT02005289|Growth Substances|growth substances|mesh-ancestor
139108488|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
139108489|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108490|NCT01924533|Paclitaxel|paclitaxel|mesh-list
139108491|NCT01924533|Olaparib|olaparib|mesh-list
139108492|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139108493|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108494|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
139108495|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
139108496|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
139108497|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108498|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139108499|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108500|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
139108501|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139108502|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139108503|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108504|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
139108505|NCT01683955|Coagulants|coagulants|mesh-ancestor
139108506|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
139108507|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139108508|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108509|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139108510|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139108511|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108512|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108513|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108514|NCT01453088|Bortezomib|bortezomib|mesh-list
139108515|NCT01453088|Melphalan|melphalan|mesh-list
139108516|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108517|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139108518|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
139108519|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108520|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139108521|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139108522|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
139108523|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108524|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139108525|NCT01345175|Metronidazole|metronidazole|mesh-list
139108526|NCT01345175|Rifaximin|rifaximin|mesh-list
139108527|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139108528|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108529|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
139108530|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139108531|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139108532|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139108534|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108535|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
139108536|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
139108537|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
139108538|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108539|NCT01243190|Ofatumumab|ofatumumab|mesh-list
139108540|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108541|NCT01141296|Fenofibrate|fenofibrate|mesh-list
139108542|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139108543|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
138954128|NCT01060501|Folic Acid|folic acid|mesh-list
139108544|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108545|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139108546|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
139108547|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139108548|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139108549|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
139108550|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108551|NCT01238406|Pancrelipase|pancrelipase|mesh-list
139108552|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139108553|NCT03724890|Avelumab|avelumab|mesh-list
139108554|NCT03724890|Peposertib|peposertib|mesh-list
139108555|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108556|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108557|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139108558|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108559|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108561|NCT01141452|Xhance|xhance|mesh-list
139108562|NCT01141452|Beclomethasone|beclomethasone|mesh-list
139108563|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139108564|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139108565|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
139108566|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108567|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108568|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139108569|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
139108570|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
139108571|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139108572|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
139108573|NCT01141452|Hormones|hormones|mesh-ancestor
139108574|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139108575|NCT00219557|Gemcitabine|gemcitabine|mesh-list
139108576|NCT00219557|Axitinib|axitinib|mesh-list
139108577|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139108578|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
139108579|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108580|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108581|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139108582|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108583|NCT05282940|Levonorgestrel|levonorgestrel|mesh-list
139108584|NCT05282940|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139108585|NCT05282940|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139108586|NCT05282940|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
139108587|NCT05282940|Estradiol|estradiol|mesh-list
139108588|NCT05282940|Estrogens|estrogens|mesh-ancestor
139108589|NCT05282940|Hormones|hormones|mesh-ancestor
139108590|NCT05282940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139108591|NCT05282940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108592|NCT05282940|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139108593|NCT05282940|Contraceptive Agents|contraceptive agents|mesh-ancestor
139108594|NCT05282940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139108595|NCT05282940|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139108596|NCT05282940|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139108598|NCT05282940|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139108599|NCT05282940|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139108600|NCT05282940|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
139108601|NCT05282940|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139108602|NCT05282940|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139108603|NCT01238562|Lenograstim|lenograstim|mesh-list
138954151|NCT00671658|Rituximab|rituximab|mesh-list
139108604|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138859185|NCT05249920|Protective Agents|protective agents|mesh-ancestor
139108605|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
139108606|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108608|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
139108609|NCT01329666|Vitamins|vitamins|mesh-ancestor
139108610|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
139108611|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108612|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139108613|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139108614|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
139108615|NCT01141998|Vitamin D|vitamin d|mesh-list
139108616|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
139108617|NCT01141998|Calcium|calcium|mesh-list
139108618|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139108619|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108620|NCT01141998|Vitamins|vitamins|mesh-ancestor
139108621|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
139108622|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139108623|NCT01238718|Lidocaine|lidocaine|mesh-list
139108624|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
139108625|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
139108626|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139108627|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108628|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
139108629|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108630|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139108631|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139108632|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139108633|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139108634|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108635|NCT01238796|Telavancin|telavancin|mesh-list
139108636|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139108637|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108638|NCT01143948|Insulin|insulin|mesh-list
139108639|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139108640|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139108641|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108642|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
139108643|NCT01145976|Fludarabine|fludarabine|mesh-list
139108644|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
139108645|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139108646|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139108647|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
139036935|NCT00414908|Pancrelipase|pancrelipase|mesh-list
139108648|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108650|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139108651|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
139108652|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108653|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108654|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139108655|NCT01238952|Carboplatin|carboplatin|mesh-list
139108656|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108657|NCT05158998|Propofol|propofol|mesh-list
139108658|NCT05158998|Sevoflurane|sevoflurane|mesh-list
139108659|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139108660|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139108661|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108662|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139108663|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
139108664|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
139108665|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139108666|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139108667|NCT01144260|Bafetinib|bafetinib|mesh-list
139108668|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139108669|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108670|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108671|NCT01239498|Lidocaine|lidocaine|mesh-list
139108672|NCT01239498|Epinephrine|epinephrine|mesh-list
139108673|NCT01239498|Racepinephrine|racepinephrine|mesh-list
139108674|NCT01239498|Anesthetics|anesthetics|mesh-list
139108675|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
139108676|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
139108677|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139108678|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108679|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
139108680|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138859264|NCT04936126|Amantadine|amantadine|mesh-list
139108681|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139108682|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139108683|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139108684|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139108685|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108686|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139108688|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
139108689|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108690|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139108691|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139108692|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
139108693|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139108694|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
139108695|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
139108696|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
139108697|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139108698|NCT00251927|Esomeprazole|esomeprazole|mesh-list
139108699|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139108700|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139108701|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139108702|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108703|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108704|NCT03971201|Sorafenib|sorafenib|mesh-list
139108705|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108706|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139108707|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108708|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108710|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139108711|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139108712|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
139108713|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108715|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
139108716|NCT02528526|Vitamins|vitamins|mesh-ancestor
139108717|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
139108718|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108719|NCT03971279|Dexamethasone|dexamethasone|mesh-list
139108720|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139108721|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
139108722|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
139108723|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108724|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108725|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139108726|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
139108727|NCT03971279|Hormones|hormones|mesh-ancestor
139108728|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139108729|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139108730|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108731|NCT01329744|Mecasermin|mecasermin|mesh-list
139108732|NCT01329744|Growth Substances|growth substances|mesh-ancestor
139108733|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108734|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
139108735|NCT00165503|Pemetrexed|pemetrexed|mesh-list
139108736|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108737|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108738|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108739|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139108740|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139108741|NCT00165503|Antidotes|antidotes|mesh-ancestor
139108742|NCT00165503|Protective Agents|protective agents|mesh-ancestor
139108743|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108744|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
139108745|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
139108746|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139108747|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108748|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
139108749|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
139108750|NCT01144650|Dapsone|dapsone|mesh-list
139108751|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108752|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
139108753|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139108754|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139108755|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139108756|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108757|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108758|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
139108759|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139108760|NCT00162773|Omalizumab|omalizumab|mesh-list
139108761|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139108762|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139108763|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
139108764|NCT03970577|Prednisone|prednisone|mesh-list
139108765|NCT03970577|Rituximab|rituximab|mesh-list
139108766|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108767|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108768|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
139108769|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108770|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139108771|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139108772|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
139108773|NCT03970577|Hormones|hormones|mesh-ancestor
139108774|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139108775|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139108776|NCT01073813|Minocycline|minocycline|mesh-list
139108777|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139108778|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108779|NCT03823391|Adalimumab|adalimumab|mesh-list
139108780|NCT03823391|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139108781|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139108782|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139108783|NCT01075529|Fluoxetine|fluoxetine|mesh-list
139108784|NCT01075529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139108785|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139108786|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139108787|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108789|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
139108790|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108791|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139108792|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
139108793|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139108794|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139108795|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139108796|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108797|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
139037049|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108798|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139108799|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139108800|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108801|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139108802|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139108803|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108804|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108805|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108806|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139108807|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
139108808|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139108809|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108810|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139108811|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139108812|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139108813|NCT00209027|Aripiprazole|aripiprazole|mesh-list
139108814|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
139108815|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139108816|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139108817|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139108818|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139108819|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108820|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
139108821|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
139108822|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108823|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108824|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139108825|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139108826|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
139108827|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139108828|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139108829|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139108830|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139108832|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
139108833|NCT00206375|Hormones|hormones|mesh-list
138954209|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139108834|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139108835|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108836|NCT00160199|Progesterone|progesterone|mesh-list
139108837|NCT00160199|Progestins|progestins|mesh-ancestor
139108838|NCT00160199|Hormones|hormones|mesh-ancestor
139108839|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139108840|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108841|NCT00157157|Factor VIII|factor viii|mesh-list
139108842|NCT00157157|Coagulants|coagulants|mesh-ancestor
139108843|NCT00203411|Bevacizumab|bevacizumab|mesh-list
139108844|NCT00203411|Capecitabine|capecitabine|mesh-list
139108845|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108846|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108847|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139108848|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139108849|NCT00203411|Growth Substances|growth substances|mesh-ancestor
139108850|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108851|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
139108852|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139108853|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
139037060|NCT01323608|Vitamin D|vitamin d|mesh-list
139108854|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108855|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
139108856|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
139108857|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139108858|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
139108860|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139108861|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139108862|NCT00201851|Tamoxifen|tamoxifen|mesh-list
139108863|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139108864|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
139108865|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139108866|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108867|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139108868|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108869|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139108870|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139108871|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139108872|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
139108873|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139108874|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108875|NCT01074281|Enalapril|enalapril|mesh-list
139108876|NCT01074281|Enalaprilat|enalaprilat|mesh-list
139108877|NCT01074281|Nitrendipine|nitrendipine|mesh-list
139108878|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108879|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108880|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139108881|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
139108882|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139108883|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139108884|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139108885|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139108886|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108887|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
139108888|NCT03129100|Ixekizumab|ixekizumab|mesh-list
139108889|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
139108890|NCT03100006|Nivolumab|nivolumab|mesh-list
139108891|NCT03100006|Oregovomab|oregovomab|mesh-list
139108892|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139108893|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108894|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139108895|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108896|NCT03099538|Ixekizumab|ixekizumab|mesh-list
139108897|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
139108898|NCT00883480|Gemcitabine|gemcitabine|mesh-list
139108899|NCT00883480|Docetaxel|docetaxel|mesh-list
139108900|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139108901|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108902|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139108903|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
139108904|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108905|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
139108906|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
139108907|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
139108908|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139108909|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108910|NCT05418946|Dapagliflozin|dapagliflozin|mesh-list
139108911|NCT05418946|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139108912|NCT05418946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108913|NCT05418946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139108914|NCT05418946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108915|NCT03097588|Palonosetron|palonosetron|mesh-list
139108916|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
139108917|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
139108918|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108919|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108920|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139108921|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139108922|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139108923|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
139108924|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139108925|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108927|NCT05418166|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139108928|NCT05418166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139108929|NCT05418166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139108930|NCT05418166|Antimetabolites|antimetabolites|mesh-ancestor
139108931|NCT05418166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108932|NCT05418166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139108933|NCT05418166|Protease Inhibitors|protease inhibitors|mesh-ancestor
139108934|NCT05418166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108935|NCT05418166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139108936|NCT01631214|Alendronate|alendronate|mesh-list
139108937|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139108938|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139108939|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108940|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
139108941|NCT01567774|Atorvastatin|atorvastatin|mesh-list
139108942|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139108943|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139108944|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139108945|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
139108946|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108947|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139108948|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139108949|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108950|NCT01567930|Sirolimus|sirolimus|mesh-list
139108951|NCT01567930|Temsirolimus|temsirolimus|mesh-list
139108952|NCT01567930|MTOR Inhibitors|mtor inhibitors|mesh-list
139108953|NCT01567930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139108954|NCT01567930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139108955|NCT01567930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108956|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139108957|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
139108958|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108959|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139108960|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139108961|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108962|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139108963|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
139108964|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
139108965|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
139108966|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108967|NCT04604548|Protective Agents|protective agents|mesh-ancestor
139108968|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108970|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
139108971|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
139108972|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139108973|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108974|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
139108975|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139108976|NCT01142700|Ribavirin|ribavirin|mesh-list
139108977|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139108978|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
138859569|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139108979|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139108980|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
139108981|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139108982|NCT01144728|Metformin|metformin|mesh-list
139108983|NCT01144728|Glimepiride|glimepiride|mesh-list
139108984|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139108985|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108986|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139108987|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139108988|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
139108989|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
139108990|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139108991|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
139108992|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139108993|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
139108994|NCT01239810|Protective Agents|protective agents|mesh-ancestor
139108995|NCT01239888|Tibolone|tibolone|mesh-list
139108996|NCT01239888|Oxytocin|oxytocin|mesh-list
139108997|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
139108998|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139108999|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109000|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
139109001|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
139109002|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139109003|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139109004|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139109005|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109007|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
139109008|NCT01239888|Hormones|hormones|mesh-ancestor
139109009|NCT01318486|Heparin|heparin|mesh-list
139109010|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
139109011|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139109012|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139109013|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109014|NCT03436108|Bisphenol A|bisphenol a|mesh-list
139109015|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139109016|NCT03436108|Estrogens|estrogens|mesh-ancestor
139109017|NCT03436108|Hormones|hormones|mesh-ancestor
139109018|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139109019|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109020|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139109021|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
139109022|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109023|NCT03436108|Protective Agents|protective agents|mesh-ancestor
139109024|NCT02870218|Nicotine|nicotine|mesh-list
139109025|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139109026|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
139109027|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109028|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109029|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139109030|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139109031|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
139109032|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109033|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109034|NCT02614690|Calpastatin|calpastatin|mesh-list
139109035|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139037114|NCT01041378|Dexamethasone|dexamethasone|mesh-list
139109036|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
139109037|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109038|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109039|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139109040|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139109041|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109042|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139109043|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
139109044|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109045|NCT00468130|Aripiprazole|aripiprazole|mesh-list
139109046|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
139109047|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139109048|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139109049|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139109050|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139109051|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109052|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
139109053|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
139109055|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109056|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139109057|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139109058|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
139109059|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139109060|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139109061|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139109062|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139109063|NCT05196256|Sufentanil|sufentanil|mesh-list
139109064|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
139109065|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139109066|NCT05196256|Narcotics|narcotics|mesh-ancestor
139109067|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139109068|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109069|NCT05196256|Analgesics|analgesics|mesh-ancestor
139109070|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
139109071|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109072|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139109073|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139109074|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
139109075|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
139109076|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
139109077|NCT01375348|Remifentanil|remifentanil|mesh-list
139109078|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139109079|NCT01375348|Narcotics|narcotics|mesh-ancestor
139109080|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139109081|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954272|NCT00768690|Ketoconazole|ketoconazole|mesh-list
139109083|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
139109084|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109085|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
139109086|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
139109087|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139109088|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
139109089|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109090|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139109091|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139109092|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
139109093|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109094|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109095|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139109096|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139109097|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139109098|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
139109099|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139109100|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139109101|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109102|NCT05194852|Anesthetics|anesthetics|mesh-list
139109103|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
139109104|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139109105|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109106|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
139109107|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109108|NCT01375426|Amoxicillin|amoxicillin|mesh-list
139109109|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139109110|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139109111|NCT05193838|Allopurinol|allopurinol|mesh-list
139109112|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
139109113|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109114|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109115|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
139109116|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139109117|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139109118|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
139109119|NCT05193838|Protective Agents|protective agents|mesh-ancestor
139109120|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109121|NCT01375816|Leucovorin|leucovorin|mesh-list
139109122|NCT01375816|Bevacizumab|bevacizumab|mesh-list
139109123|NCT01375816|Fluorouracil|fluorouracil|mesh-list
139109124|NCT01375816|Irinotecan|irinotecan|mesh-list
139109125|NCT01375816|Calcium|calcium|mesh-list
139109126|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
139109127|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139109128|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109129|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139109130|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139109131|NCT01375816|Growth Substances|growth substances|mesh-ancestor
139109132|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109133|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
139109134|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139109135|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
139109136|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109137|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139109138|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139109139|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
139109140|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139109141|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139109142|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109143|NCT01375816|Antidotes|antidotes|mesh-ancestor
139109144|NCT01375816|Protective Agents|protective agents|mesh-ancestor
139109145|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
139109146|NCT01375816|Vitamins|vitamins|mesh-ancestor
139109147|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
139109148|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
139109149|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138954284|NCT00768768|Terbinafine|terbinafine|mesh-list
139109150|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139109151|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109152|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
139109153|NCT03632824|Coagulants|coagulants|mesh-ancestor
139109154|NCT00911820|Bevacizumab|bevacizumab|mesh-list
139109155|NCT00911820|Cisplatin|cisplatin|mesh-list
139109156|NCT00911820|Docetaxel|docetaxel|mesh-list
139109157|NCT00911820|Irinotecan|irinotecan|mesh-list
139109158|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139109159|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037139|NCT01043952|Analgesics|analgesics|mesh-ancestor
139109160|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139109161|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139109162|NCT00911820|Growth Substances|growth substances|mesh-ancestor
139109163|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109164|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
139109165|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
139109166|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
139109167|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
139109168|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109169|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139109170|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139109171|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109172|NCT05348122|Dulaglutide|dulaglutide|mesh-list
139109173|NCT05348122|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
139109174|NCT05348122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139109175|NCT05348122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109176|NCT05348122|Immunologic Factors|immunologic factors|mesh-ancestor
139109177|NCT05038618|Somatomedin B|somatomedin b|mesh-list
139109178|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139109179|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139109180|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
139109181|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109182|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109184|NCT01244880|Analgesics|analgesics|mesh-ancestor
139109185|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
139109186|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109187|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109188|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139109189|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139109190|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
139109191|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
139109192|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139109193|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139109194|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139109195|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109196|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109197|NCT01244958|Rituximab|rituximab|mesh-list
139109198|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139109199|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109200|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
139109201|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109202|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139109203|NCT00246324|Interferons|interferons|mesh-list
138954290|NCT00775086|Norelgestromin|norelgestromin|mesh-list
139109204|NCT00246324|Interferon-beta|interferon-beta|mesh-list
139109205|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
139109206|NCT00246324|Doxycycline|doxycycline|mesh-list
139109207|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109208|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
139109209|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139109210|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139109211|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
139109212|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139109213|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139109214|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
139109215|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109216|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139109217|NCT01237782|Propolis|propolis|mesh-list
139109218|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139109219|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139109220|NCT01245660|Lapatinib|lapatinib|mesh-list
139109221|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037151|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
139109222|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139109223|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109224|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109225|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
139109226|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139109227|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139109228|NCT03913806|Bevacizumab|bevacizumab|mesh-list
139109229|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139109230|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109231|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139109232|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139109233|NCT03913806|Growth Substances|growth substances|mesh-ancestor
139109234|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109235|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
139109236|NCT01250808|Dexamethasone|dexamethasone|mesh-list
139109237|NCT01250808|Bortezomib|bortezomib|mesh-list
139109238|NCT01250808|Melphalan|melphalan|mesh-list
139109239|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139109240|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
139109241|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
139109242|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109243|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109244|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139109245|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
139109246|NCT01250808|Hormones|hormones|mesh-ancestor
139109247|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139109248|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139109249|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109250|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139109251|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
139109252|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109253|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139109254|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139109255|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
139109256|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
139109257|NCT01146678|Lixisenatide|lixisenatide|mesh-list
139109258|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139109259|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109260|NCT05429866|Nivolumab|nivolumab|mesh-list
139109261|NCT05429866|Atezolizumab|atezolizumab|mesh-list
139109262|NCT05429866|Durvalumab|durvalumab|mesh-list
139109263|NCT05429866|Avelumab|avelumab|mesh-list
139109264|NCT05429866|Cemiplimab|cemiplimab|mesh-list
139109265|NCT05429866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139109266|NCT05429866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139037192|NCT00414440|Everolimus|everolimus|mesh-list
139109267|NCT05429866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109268|NCT05429866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109269|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139109270|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
139109271|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
139109272|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
139109273|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109274|NCT03632590|Analgesics|analgesics|mesh-ancestor
139109275|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
139109276|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109277|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109278|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
139109279|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139109280|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139109281|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
139109282|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139109283|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139109284|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139109285|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
139109286|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139109287|NCT03632590|Cathartics|cathartics|mesh-ancestor
139109288|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139109289|NCT03632590|Antacids|antacids|mesh-ancestor
139109290|NCT05376670|Gentamicins|gentamicins|mesh-list
139109291|NCT05376670|Tobramycin|tobramycin|mesh-list
139109292|NCT05376670|Amikacin|amikacin|mesh-list
139109293|NCT05376670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139109294|NCT05376670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139109295|NCT05376670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139109296|NCT05376670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109297|NCT05376670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109298|NCT01242774|Panobinostat|panobinostat|mesh-list
139109299|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109300|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139109301|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109302|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109303|NCT01243086|Dexamethasone|dexamethasone|mesh-list
139109304|NCT01243086|Ranibizumab|ranibizumab|mesh-list
139109305|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139109306|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
139109307|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
139109308|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109309|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109310|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139109311|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
139109313|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139109314|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139109315|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109316|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139109317|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139109318|NCT01243086|Growth Substances|growth substances|mesh-ancestor
139109319|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
139109320|NCT03908814|Antibodies|antibodies|mesh-list
139109321|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
138644581|NCT00279539|Mitogens|mitogens|mesh-list
139109322|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109323|NCT01253382|Ecallantide|ecallantide|mesh-list
139109324|NCT01253382|Analgesics|analgesics|mesh-ancestor
139109325|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
139109326|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109327|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109328|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139109329|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139109330|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139109331|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139109332|NCT01148160|Voriconazole|voriconazole|mesh-list
139109334|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139109335|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139109336|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139109337|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109338|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109339|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139109340|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
139109341|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139109342|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109343|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139109344|NCT01147692|Simvastatin|simvastatin|mesh-list
139109345|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
139109346|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139109347|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139109348|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
139109349|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109350|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139109351|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139109352|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109353|NCT01147692|Incretins|incretins|mesh-ancestor
139109354|NCT01147692|Hormones|hormones|mesh-ancestor
138859953|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109355|NCT01147692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139109356|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109357|NCT03913182|Apatinib|apatinib|mesh-list
139109358|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109359|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139109360|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109361|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109362|NCT02713386|Paclitaxel|paclitaxel|mesh-list
139109363|NCT02713386|Carboplatin|carboplatin|mesh-list
139109364|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139109365|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139109366|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109367|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
139109368|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
139109369|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
139109370|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109371|NCT01967238|Vaccines|vaccines|mesh-list
139109372|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
139109373|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109374|NCT05616000|Folic Acid|folic acid|mesh-list
139109375|NCT05616000|Acetylcarnitine|acetylcarnitine|mesh-list
139109376|NCT05616000|Hematinics|hematinics|mesh-ancestor
139109377|NCT05616000|Vitamin B Complex|vitamin b complex|mesh-ancestor
139109378|NCT05616000|Vitamins|vitamins|mesh-ancestor
139109379|NCT05616000|Micronutrients|micronutrients|mesh-ancestor
139109380|NCT05616000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109381|NCT05616000|Nootropic Agents|nootropic agents|mesh-ancestor
139109382|NCT03912402|Paclitaxel|paclitaxel|mesh-list
139109383|NCT03912402|Bevacizumab|bevacizumab|mesh-list
139109384|NCT03912402|Carboplatin|carboplatin|mesh-list
138954341|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
139109385|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139109386|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109387|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
139109388|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
139109389|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
139109390|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109391|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139109392|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139109393|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139109394|NCT03912402|Growth Substances|growth substances|mesh-ancestor
139109395|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109396|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
139109397|NCT01147770|Progesterone|progesterone|mesh-list
139109398|NCT01147770|Progestins|progestins|mesh-ancestor
139109399|NCT01147770|Hormones|hormones|mesh-ancestor
139109400|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139109401|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109402|NCT01148316|Fluoxetine|fluoxetine|mesh-list
139109403|NCT01148316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139109404|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139109405|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139109406|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109407|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109408|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
139109409|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109410|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139109411|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
139109412|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139109413|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139109414|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139109415|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109416|NCT01249638|Bevacizumab|bevacizumab|mesh-list
139109417|NCT01249638|Capecitabine|capecitabine|mesh-list
139109418|NCT01249638|Irinotecan|irinotecan|mesh-list
139109419|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139109420|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109421|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139109422|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139109423|NCT01249638|Growth Substances|growth substances|mesh-ancestor
139109424|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109425|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
139109426|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139109427|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
139109428|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109429|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138860025|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
139109431|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109432|NCT03907098|Endostar protein|endostar protein|mesh-list
139109433|NCT03907098|Endostatins|endostatins|mesh-list
139109434|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139109435|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139109436|NCT03907098|Growth Substances|growth substances|mesh-ancestor
139109437|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527577|NCT00031109|Antacids|antacids|mesh-ancestor
139109438|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
139109439|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109440|NCT01251822|Prucalopride|prucalopride|mesh-list
139109441|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139109442|NCT01251822|Laxatives|laxatives|mesh-ancestor
139109443|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139109444|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139109445|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139109446|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
139109447|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109448|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109449|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109450|NCT01253694|Ranibizumab|ranibizumab|mesh-list
139109451|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139109452|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139109453|NCT01253694|Growth Substances|growth substances|mesh-ancestor
139109454|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109455|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
139109456|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109458|NCT01148004|Lopinavir|lopinavir|mesh-list
139109459|NCT01148004|Fenofibrate|fenofibrate|mesh-list
139109460|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139109461|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139109462|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
139109463|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109464|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109465|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139109466|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139109467|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
139109468|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139109469|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139109470|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139109471|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139109472|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
139109473|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139109474|NCT01252056|Cilostazol|cilostazol|mesh-list
139109475|NCT01252056|Probucol|probucol|mesh-list
139109476|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139109477|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
139109478|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109479|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109480|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139109481|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
139109482|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139109483|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139109484|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109485|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139109486|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
139109487|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139109488|NCT01252056|Protective Agents|protective agents|mesh-ancestor
139109489|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139109490|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139109491|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109492|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139109493|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139109494|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
139109495|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139109496|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
139109497|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
139109498|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139109499|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139109500|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139109501|NCT01148472|Escitalopram|escitalopram|mesh-list
138954370|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139109502|NCT01148472|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139109503|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138887526|NCT01009021|Diclofenac|diclofenac|mesh-list
139109504|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139109505|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109506|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109507|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
139109508|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109509|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109510|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
139109511|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139109512|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139109513|NCT01148472|Analgesics|analgesics|mesh-ancestor
139109514|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
139109515|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
139109516|NCT01147146|Midazolam|midazolam|mesh-list
139109517|NCT01147146|Fentanyl|fentanyl|mesh-list
139109518|NCT01147146|Bupivacaine|bupivacaine|mesh-list
139109519|NCT01147146|Propofol|propofol|mesh-list
139109520|NCT01147146|Atracurium|atracurium|mesh-list
139109521|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
139109522|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
139109523|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139109524|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109525|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
139109526|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109527|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139109528|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139109529|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
139109530|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139109531|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139109532|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139109533|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139109534|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
139109535|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
139109536|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139037272|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139109537|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109538|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139109539|NCT01147146|Narcotics|narcotics|mesh-ancestor
139109540|NCT01147146|Analgesics|analgesics|mesh-ancestor
139109541|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139109542|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139109543|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139109544|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139109545|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139109546|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
139109547|NCT01250340|Aspirin|aspirin|mesh-list
139109548|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139109549|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139109550|NCT01250340|Analgesics|analgesics|mesh-ancestor
139109551|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
139109552|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109553|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109554|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139109555|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139109556|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139109557|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139109558|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109559|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139109560|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139109561|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109562|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
139109563|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
139109564|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139109565|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109566|NCT01250652|Cetirizine|cetirizine|mesh-list
139109567|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
139109568|NCT01250652|Levocetirizine|levocetirizine|mesh-list
139109569|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139109570|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139109571|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
139109572|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
139109573|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109574|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109575|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109576|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139109577|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
139109578|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
139109579|NCT01253928|Pioglitazone|pioglitazone|mesh-list
139109580|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139109581|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109582|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
139109583|NCT01252524|Psyllium|psyllium|mesh-list
139109584|NCT01252524|Calcium|calcium|mesh-list
139109585|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139109586|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109587|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
139109588|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139109589|NCT01252524|Cathartics|cathartics|mesh-ancestor
139109590|NCT03914352|Antibodies|antibodies|mesh-list
139109591|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
139109592|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109593|NCT01254006|Thiamine|thiamine|mesh-list
139109594|NCT01254006|Vitamins|vitamins|mesh-ancestor
139109595|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
139109596|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109597|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
139109598|NCT02528136|Oxytocin|oxytocin|mesh-list
139109599|NCT02528136|Carbetocin|carbetocin|mesh-list
139109600|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
139109601|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139109602|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109603|NCT01252680|Vaccines|vaccines|mesh-list
139109604|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
139109605|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109606|NCT01252758|Albuterol|albuterol|mesh-list
139109607|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139109608|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
139109609|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109610|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109611|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139109612|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
139109613|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
139109614|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139109615|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139109616|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139109617|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139109618|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
139109619|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109620|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109621|NCT03913884|Mitogens|mitogens|mesh-list
139109622|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
139109623|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109624|NCT01147224|Ciclesonide|ciclesonide|mesh-list
139109625|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
139109626|NCT01147224|Hormones|hormones|mesh-ancestor
139109627|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139109628|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109629|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139109630|NCT03913650|Bupivacaine|bupivacaine|mesh-list
139109631|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
139109632|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
138954451|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109633|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139109634|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109635|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
139109636|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109637|NCT01149174|Mitomycins|mitomycins|mesh-list
139109638|NCT01149174|Mitomycin|mitomycin|mesh-list
139109639|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139109640|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109641|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
139109642|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109643|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139109644|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109645|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139109646|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139109647|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109648|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109650|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109651|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109652|NCT01148628|Everolimus|everolimus|mesh-list
139109653|NCT01148628|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139109654|NCT01148628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138860246|NCT02783222|Paclitaxel|paclitaxel|mesh-list
139109655|NCT01148628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109656|NCT01148628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109657|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139109658|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
139109659|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109660|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109661|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139109662|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
139109663|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139109664|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139109665|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139109666|NCT03909594|Ketamine|ketamine|mesh-list
139109667|NCT03909594|Bupivacaine|bupivacaine|mesh-list
139109668|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
139109669|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
139109670|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139109671|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109672|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
139109673|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109674|NCT03909594|Analgesics|analgesics|mesh-ancestor
139109675|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139109676|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139109677|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
139109678|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139109679|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139109680|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109681|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109682|NCT04492072|Misoprostol|misoprostol|mesh-list
139109683|NCT04492072|Oxytocin|oxytocin|mesh-list
139109684|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
139109685|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139109686|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109687|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139109688|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
139109689|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139109690|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139109691|NCT04181008|Amiloride|amiloride|mesh-list
139109692|NCT04181008|Diuretics|diuretics|mesh-ancestor
139109693|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
139109694|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109695|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139109696|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138954475|NCT00771888|Lanreotide|lanreotide|mesh-list
139109697|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139109698|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109699|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139109700|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139109701|NCT03904836|Tobramycin|tobramycin|mesh-list
139109702|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139109703|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139109704|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139109705|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139109706|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109707|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109708|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139109709|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139109710|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109711|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
139109712|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109713|NCT03904680|Vitamin D|vitamin d|mesh-list
139109714|NCT03904680|Methotrexate|methotrexate|mesh-list
139109715|NCT03904680|Vitamins|vitamins|mesh-ancestor
139109716|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
139109717|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109718|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139109719|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139109720|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
139109721|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139109722|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139109723|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
139109724|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109725|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109726|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
139109727|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109728|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139109729|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139109730|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
139109731|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139109732|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139109733|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139109734|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139109735|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139109736|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109737|NCT01256268|Paclitaxel|paclitaxel|mesh-list
139109738|NCT01256268|Carboplatin|carboplatin|mesh-list
139109739|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139109740|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109741|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
139109742|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
139109743|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
139109744|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109745|NCT03902106|Albuterol|albuterol|mesh-list
139109746|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139109747|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
139109748|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109749|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109750|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139109751|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
139109752|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
139109753|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139109754|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139109755|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139109756|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139109757|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
139109758|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109759|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109760|NCT03902340|Analgesics|analgesics|mesh-list
139109761|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
139109762|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109763|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109764|NCT01149330|Adapalene|adapalene|mesh-list
139109765|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139109766|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139109767|NCT01149330|Analgesics|analgesics|mesh-ancestor
139109768|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
139109769|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109770|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109771|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139109772|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139109774|NCT01150344|Artemether|artemether|mesh-list
139109775|NCT01150344|Atovaquone|atovaquone|mesh-list
139109776|NCT01150344|Proguanil|proguanil|mesh-list
139109777|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
139109778|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
139109779|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139109780|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139109781|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139109782|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109783|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109784|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
139109785|NCT01256580|Dexamethasone|dexamethasone|mesh-list
139109786|NCT01256580|Bevacizumab|bevacizumab|mesh-list
139109787|NCT01256580|Verteporfin|verteporfin|mesh-list
139109788|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139109789|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109790|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139109791|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139109792|NCT01256580|Growth Substances|growth substances|mesh-ancestor
139109793|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109794|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
139109795|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139109796|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
139109797|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
139109798|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109799|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139109800|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
139109801|NCT01256580|Hormones|hormones|mesh-ancestor
139109802|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139109803|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139109804|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139109805|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
139109806|NCT03901716|Midazolam|midazolam|mesh-list
139109807|NCT03901716|Fentanyl|fentanyl|mesh-list
139109808|NCT03901716|Sufentanil|sufentanil|mesh-list
139109809|NCT03901716|Remifentanil|remifentanil|mesh-list
139109810|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139109811|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139109812|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139109813|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109814|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139109815|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139109816|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139109817|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139109818|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
139109819|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
139109820|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
139109821|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
139109822|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109823|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109824|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139109825|NCT03901716|Narcotics|narcotics|mesh-ancestor
139109826|NCT03901716|Analgesics|analgesics|mesh-ancestor
139109827|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
139109828|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109829|NCT04113538|Aflibercept|aflibercept|mesh-list
139109830|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139109831|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139109832|NCT04113538|Growth Substances|growth substances|mesh-ancestor
139109833|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109834|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
139109835|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109836|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139109837|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139109838|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109839|NCT03922750|Insulin|insulin|mesh-list
139109840|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139109841|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
139109842|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139109843|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109844|NCT03898128|Immunotoxins|immunotoxins|mesh-list
139109845|NCT03898128|Immunoconjugates|immunoconjugates|mesh-ancestor
139109846|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
139109847|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109848|NCT01149408|Decitabine|decitabine|mesh-list
139109849|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139109850|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
139109851|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109852|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109853|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109854|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139109855|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139109856|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139109857|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109858|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
139109859|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109860|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109861|NCT01149018|Dronabinol|dronabinol|mesh-list
139109862|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
139109863|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109864|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139109865|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139109866|NCT01149018|Analgesics|analgesics|mesh-ancestor
139109867|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
139109868|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109869|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139109871|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109872|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109873|NCT01149018|Hormones|hormones|mesh-ancestor
139109874|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139109875|NCT03904056|Ranibizumab|ranibizumab|mesh-list
139109876|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139109877|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139109878|NCT03904056|Growth Substances|growth substances|mesh-ancestor
139109879|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109880|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
139109881|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109882|NCT03897660|Vitamins|vitamins|mesh-list
139109883|NCT03897660|Vitamin K|vitamin k|mesh-list
139109884|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
139109885|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
139109886|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109887|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139109888|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139109889|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109890|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
139109891|NCT03897660|Coagulants|coagulants|mesh-ancestor
139109892|NCT03901170|Letrozole|letrozole|mesh-list
139109893|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109894|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139109895|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139109896|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109897|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109898|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139109899|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
139109900|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139109901|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109902|NCT03900858|Isoniazid|isoniazid|mesh-list
139109903|NCT03900858|Rifapentine|rifapentine|mesh-list
139109904|NCT03900858|Rifampin|rifampin|mesh-list
139109905|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
139109906|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139109907|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139109908|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139109909|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139109910|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
139109911|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109912|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139109913|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139109914|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
139109915|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139109916|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109917|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139109918|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139109919|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139109920|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139109921|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139109922|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139109923|NCT01149564|Ibuprofen|ibuprofen|mesh-list
139109924|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139109925|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139109926|NCT01149564|Analgesics|analgesics|mesh-ancestor
139109927|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
139109928|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109929|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109930|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139109931|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139109932|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139109933|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109934|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109935|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
139109936|NCT02527746|Epirubicin|epirubicin|mesh-list
139109937|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139109938|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
139109939|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109940|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139109941|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139109942|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
139109943|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109944|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109945|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139109946|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139109947|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139109948|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139109949|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109950|NCT01586286|Nifedipine|nifedipine|mesh-list
139109951|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139109952|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139109953|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109954|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139109955|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109956|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
139109958|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139109959|NCT01257048|Budesonide|budesonide|mesh-list
139109960|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
139109961|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139109962|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139109963|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
139109964|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109965|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109966|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139109967|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
139109968|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
139109969|NCT01257048|Hormones|hormones|mesh-ancestor
139109970|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139109971|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139109972|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139109973|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139109974|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
139109975|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139109976|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109977|NCT01257126|Diclofenac|diclofenac|mesh-list
139109978|NCT01257126|Nimesulide|nimesulide|mesh-list
139109979|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139109980|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139109981|NCT01257126|Analgesics|analgesics|mesh-ancestor
139109982|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
139109983|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139109984|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139109985|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139109986|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139109987|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139109988|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109989|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109990|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
139109991|NCT02527824|Irinotecan|irinotecan|mesh-list
139109992|NCT02527824|Tegafur|tegafur|mesh-list
138530323|NCT00204061|Amisulpride|amisulpride|mesh-list
139109993|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139109994|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139109995|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139109996|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139109997|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139109998|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139109999|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
139110000|NCT01586208|Phenytoin|phenytoin|mesh-list
139110001|NCT01586208|Valproic Acid|valproic acid|mesh-list
139110002|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
139110003|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110004|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110005|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
139110006|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110007|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110008|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
139110009|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139110010|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139110011|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139110012|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139110013|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139110014|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139110015|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139110016|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139110017|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139110018|NCT03893526|Valsartan|valsartan|mesh-list
139110019|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139110020|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139110021|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110022|NCT03893526|Incretins|incretins|mesh-ancestor
139110023|NCT03893526|Hormones|hormones|mesh-ancestor
139110024|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139110025|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139110026|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
139110027|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110028|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110029|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139110030|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139110031|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139110032|NCT01149798|Cisplatin|cisplatin|mesh-list
139110033|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139110034|NCT01149798|Paclitaxel|paclitaxel|mesh-list
139110035|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110036|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139110037|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
139110038|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
139110039|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
139110040|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110042|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139110043|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110044|NCT01258452|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
139110045|NCT01258452|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139110046|NCT01258452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110047|NCT01258452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110048|NCT05943028|Esketamine|esketamine|mesh-list
139110049|NCT05943028|Antidepressive Agents|antidepressive agents|mesh-ancestor
139110050|NCT05943028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139110051|NCT05942963|Metformin|metformin|mesh-list
139110052|NCT05942963|Pioglitazone|pioglitazone|mesh-list
139110053|NCT05942963|Empagliflozin|empagliflozin|mesh-list
139110054|NCT05942963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139110055|NCT05942963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110056|NCT05942963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139110057|NCT05942963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110058|NCT05942768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139110059|NCT05942768|Antibodies|antibodies|mesh-list
139110060|NCT05942768|Immunologic Factors|immunologic factors|mesh-ancestor
139110061|NCT05942768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110062|NCT05942768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110063|NCT05942768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139110064|NCT05942768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110065|NCT05942573|Paclitaxel|paclitaxel|mesh-list
139110066|NCT05942573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139110067|NCT05942573|Apatinib|apatinib|mesh-list
139110068|NCT05942573|Ramucirumab|ramucirumab|mesh-list
139110069|NCT05942573|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139110070|NCT05942573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139110071|NCT05942573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110072|NCT05942573|Tubulin Modulators|tubulin modulators|mesh-ancestor
139110073|NCT05942573|Antimitotic Agents|antimitotic agents|mesh-ancestor
139110074|NCT05942573|Mitosis Modulators|mitosis modulators|mesh-ancestor
139110075|NCT05942573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110076|NCT05942573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139110077|NCT05942573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110078|NCT05942573|Immunologic Factors|immunologic factors|mesh-ancestor
139110079|NCT05942573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110080|NCT05942378|Vaccines|vaccines|mesh-list
139110081|NCT05942378|Immunologic Factors|immunologic factors|mesh-ancestor
139110082|NCT05942378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110083|NCT05942053|Vitamin K|vitamin k|mesh-list
139110084|NCT05942053|Vitamin K 2|vitamin k 2|mesh-list
139110085|NCT05942053|Menaquinone 7|menaquinone 7|mesh-list
139110086|NCT05942053|Vitamins|vitamins|mesh-ancestor
139110087|NCT05942053|Micronutrients|micronutrients|mesh-ancestor
139110088|NCT05942053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110089|NCT05942053|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139110090|NCT05942053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139110091|NCT05942053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110092|NCT05942053|Hemostatics|hemostatics|mesh-ancestor
139110093|NCT05942053|Coagulants|coagulants|mesh-ancestor
139110094|NCT05942027|Coenzyme Q10|coenzyme q10|mesh-list
139110095|NCT05942027|Ubiquinone|ubiquinone|mesh-list
139110096|NCT05942027|Vitamins|vitamins|mesh-ancestor
139110097|NCT05942027|Micronutrients|micronutrients|mesh-ancestor
139110098|NCT05942027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110099|NCT05941845|Interferons|interferons|mesh-list
139110100|NCT05941845|Interferon-alpha|interferon-alpha|mesh-list
139110101|NCT05941845|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139110102|NCT05941845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110103|NCT05941845|Antiviral Agents|antiviral agents|mesh-ancestor
139110104|NCT05941845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110105|NCT05941845|Immunologic Factors|immunologic factors|mesh-ancestor
139110106|NCT05941845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110108|NCT05941806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139110109|NCT05941806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139110110|NCT05941806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139110111|NCT05941806|Adrenergic Agents|adrenergic agents|mesh-ancestor
139110112|NCT05941806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110113|NCT05941806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110114|NCT05941806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110115|NCT05941806|Urological Agents|urological agents|mesh-ancestor
139110117|NCT05941637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110118|NCT05941637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139110119|NCT05941637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110120|NCT05941637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110121|NCT05941585|Cytarabine|cytarabine|mesh-list
139110122|NCT05941585|Venetoclax|venetoclax|mesh-list
139110123|NCT05941585|Mitoxantrone|mitoxantrone|mesh-list
139110124|NCT05941585|Homoharringtonine|homoharringtonine|mesh-list
139110125|NCT05941585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139110126|NCT05941585|Antimetabolites|antimetabolites|mesh-ancestor
139110127|NCT05941585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110128|NCT05941585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110129|NCT05941585|Antiviral Agents|antiviral agents|mesh-ancestor
139110130|NCT05941585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110131|NCT05941585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139110132|NCT05941585|Immunologic Factors|immunologic factors|mesh-ancestor
139110133|NCT05941585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110134|NCT05941585|Analgesics|analgesics|mesh-ancestor
139110135|NCT05941585|Sensory System Agents|sensory system agents|mesh-ancestor
139110136|NCT05941585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110137|NCT05941585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139110138|NCT05941585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139110139|NCT05941585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110140|NCT05941585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139110141|NCT05941585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139110142|NCT05941481|Tislelizumab|tislelizumab|mesh-list
139110143|NCT05941481|Antibodies|antibodies|mesh-list
139110144|NCT05941481|Immunologic Factors|immunologic factors|mesh-ancestor
139110145|NCT05941481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110146|NCT05941481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139110147|NCT05941481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110148|NCT05941429|Fluorides|fluorides|mesh-list
139110149|NCT05941429|Cariostatic Agents|cariostatic agents|mesh-ancestor
139110150|NCT05941429|Protective Agents|protective agents|mesh-ancestor
139110151|NCT05941429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110152|NCT05941338|Paclitaxel|paclitaxel|mesh-list
139110153|NCT05941338|Carboplatin|carboplatin|mesh-list
139110154|NCT05941338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139110155|NCT05941338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139110156|NCT05941338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110157|NCT05941338|Tubulin Modulators|tubulin modulators|mesh-ancestor
139110158|NCT05941338|Antimitotic Agents|antimitotic agents|mesh-ancestor
139110159|NCT05941338|Mitosis Modulators|mitosis modulators|mesh-ancestor
139110160|NCT05941338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110161|NCT05941130|Ibuprofen|ibuprofen|mesh-list
139110162|NCT05941130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139110163|NCT05941130|Methylprednisolone|methylprednisolone|mesh-list
139110164|NCT05941130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139110165|NCT05941130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139110166|NCT05941130|Analgesics|analgesics|mesh-ancestor
139110167|NCT05941130|Sensory System Agents|sensory system agents|mesh-ancestor
139110168|NCT05941130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110169|NCT05941130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110170|NCT05941130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139110171|NCT05941130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139110172|NCT05941130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110173|NCT05941130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110174|NCT05941130|Antiemetics|antiemetics|mesh-ancestor
139110175|NCT05941130|Autonomic Agents|autonomic agents|mesh-ancestor
139110176|NCT05941130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139110177|NCT05941130|Glucocorticoids|glucocorticoids|mesh-ancestor
139110178|NCT05941130|Hormones|hormones|mesh-ancestor
139110179|NCT05941130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139110180|NCT05941130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139110181|NCT05941130|Protective Agents|protective agents|mesh-ancestor
139110182|NCT05939921|Metformin|metformin|mesh-list
139110183|NCT05939921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139110184|NCT05939921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110185|NCT05939219|Vaccines|vaccines|mesh-list
139110186|NCT05939219|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139110187|NCT05939219|Immunologic Factors|immunologic factors|mesh-ancestor
139110188|NCT05939219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110189|NCT05938517|Betahistine|betahistine|mesh-list
139110190|NCT05938517|Selegiline|selegiline|mesh-list
139110191|NCT05938517|Antidepressive Agents|antidepressive agents|mesh-ancestor
139110192|NCT05938517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139110193|NCT05938517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139110194|NCT05938517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139110195|NCT05938517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139110196|NCT05938517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110197|NCT05938517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110198|NCT05938517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139110199|NCT05938517|Protective Agents|protective agents|mesh-ancestor
139110200|NCT05938517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110201|NCT05938517|Vasodilator Agents|vasodilator agents|mesh-ancestor
139110202|NCT05938517|Histamine Agonists|histamine agonists|mesh-ancestor
139110203|NCT05938517|Histamine Agents|histamine agents|mesh-ancestor
139110204|NCT05938517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110205|NCT05935657|Dexmedetomidine|dexmedetomidine|mesh-list
139110206|NCT05935657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139110207|NCT05935657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139110208|NCT05935657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110209|NCT05935657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139110210|NCT05935657|Analgesics|analgesics|mesh-ancestor
139110211|NCT05935657|Sensory System Agents|sensory system agents|mesh-ancestor
139110212|NCT05935657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110213|NCT05935657|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139110214|NCT05935657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139110215|NCT05935657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139110216|NCT05935657|Adrenergic Agents|adrenergic agents|mesh-ancestor
139110217|NCT05935657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110218|NCT05935657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110219|NCT05922982|Norepinephrine|norepinephrine|mesh-list
139110220|NCT05922982|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139110221|NCT05922982|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139110222|NCT05922982|Adrenergic Agents|adrenergic agents|mesh-ancestor
139110223|NCT05922982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110224|NCT05922982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110225|NCT05922982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110226|NCT05922982|Sympathomimetics|sympathomimetics|mesh-ancestor
139110227|NCT05922982|Autonomic Agents|autonomic agents|mesh-ancestor
139110228|NCT05922982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110229|NCT05922982|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139110230|NCT05907850|Riboflavin|riboflavin|mesh-list
139110231|NCT05907850|Vitamin B Complex|vitamin b complex|mesh-ancestor
139110232|NCT05907850|Vitamins|vitamins|mesh-ancestor
139110233|NCT05907850|Micronutrients|micronutrients|mesh-ancestor
139110234|NCT05907850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110235|NCT05907850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139110236|NCT05907850|Dermatologic Agents|dermatologic agents|mesh-ancestor
139110237|NCT05904730|Axitinib|axitinib|mesh-list
139110238|NCT05904730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110239|NCT05904730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139110240|NCT05904730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110241|NCT05904730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110243|NCT05860270|Cholecalciferol|cholecalciferol|mesh-list
139110244|NCT05860270|Vitamins|vitamins|mesh-ancestor
139110245|NCT05860270|Micronutrients|micronutrients|mesh-ancestor
139110246|NCT05860270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110247|NCT05860270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139110248|NCT05860270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139110249|NCT05855395|Dexamethasone|dexamethasone|mesh-list
139110250|NCT05855395|Prednisone|prednisone|mesh-list
139110251|NCT05855395|Methylprednisolone|methylprednisolone|mesh-list
139110252|NCT05855395|Glucocorticoids|glucocorticoids|mesh-list
139110253|NCT05855395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139110254|NCT05855395|Antiemetics|antiemetics|mesh-ancestor
139110255|NCT05855395|Autonomic Agents|autonomic agents|mesh-ancestor
139110256|NCT05855395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110257|NCT05855395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110258|NCT05855395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139110260|NCT05855395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139110261|NCT05855395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139110262|NCT05855395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110263|NCT05855395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139110264|NCT05855395|Protective Agents|protective agents|mesh-ancestor
139110265|NCT05853354|Denosumab|denosumab|mesh-list
139110266|NCT05853354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139110267|NCT05853354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110268|NCT05818826|Hydrocortisone|hydrocortisone|mesh-list
139110269|NCT05818826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139110270|NCT05818826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139110271|NCT05808881|Naloxone|naloxone|mesh-list
139110272|NCT05808881|Nalmefene|nalmefene|mesh-list
139110273|NCT05808881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139110274|NCT05808881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110275|NCT05808881|Sensory System Agents|sensory system agents|mesh-ancestor
139110276|NCT05808881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110277|NCT05802628|Cetylpyridinium|cetylpyridinium|mesh-list
139110278|NCT05802628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139110279|NCT05802628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110280|NCT05751187|Folic Acid|folic acid|mesh-list
139110281|NCT05751187|Vitamin B 12|vitamin b 12|mesh-list
139110282|NCT05751187|Dexamethasone|dexamethasone|mesh-list
139110283|NCT05751187|Bevacizumab|bevacizumab|mesh-list
139110284|NCT05751187|Pembrolizumab|pembrolizumab|mesh-list
139110285|NCT05751187|Carboplatin|carboplatin|mesh-list
139110286|NCT05751187|Pemetrexed|pemetrexed|mesh-list
139110287|NCT05751187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139110288|NCT05751187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110289|NCT05751187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139110290|NCT05751187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139110291|NCT05751187|Growth Substances|growth substances|mesh-ancestor
139110292|NCT05751187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110293|NCT05751187|Growth Inhibitors|growth inhibitors|mesh-ancestor
139110294|NCT05751187|Vitamins|vitamins|mesh-ancestor
139110295|NCT05751187|Micronutrients|micronutrients|mesh-ancestor
139110296|NCT05751187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139110297|NCT05751187|Antiemetics|antiemetics|mesh-ancestor
139110298|NCT05751187|Autonomic Agents|autonomic agents|mesh-ancestor
139110299|NCT05751187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110300|NCT05751187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139110301|NCT05751187|Glucocorticoids|glucocorticoids|mesh-ancestor
139110302|NCT05751187|Hormones|hormones|mesh-ancestor
139037808|NCT00290589|Prednisolone|prednisolone|mesh-list
139110303|NCT05751187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139110304|NCT05751187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139110305|NCT05751187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139110306|NCT05751187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110307|NCT05751187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110308|NCT05751187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139110309|NCT05751187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139110310|NCT05751187|Hematinics|hematinics|mesh-ancestor
139110311|NCT05751187|Vitamin B Complex|vitamin b complex|mesh-ancestor
139110312|NCT05701241|Octreotide|octreotide|mesh-list
139110313|NCT05701241|Lanreotide|lanreotide|mesh-list
139110314|NCT05701241|Somatostatin|somatostatin|mesh-list
139110315|NCT05701241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139110316|NCT05701241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139110317|NCT05701241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110318|NCT05701241|Hormones|hormones|mesh-ancestor
139110319|NCT05701241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139110320|NCT05701241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110321|NCT05698979|Botulinum Toxins|botulinum toxins|mesh-list
139110322|NCT05698979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139110323|NCT05698979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139110324|NCT05698979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110325|NCT05698979|Cholinergic Agents|cholinergic agents|mesh-ancestor
139110326|NCT05698979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110327|NCT05698979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110328|NCT05676216|Diphenhydramine|diphenhydramine|mesh-list
139037819|NCT00290589|Hormones|hormones|mesh-ancestor
139110329|NCT05676216|Promethazine|promethazine|mesh-list
139110330|NCT05676216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139110331|NCT05676216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139110332|NCT05676216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139110333|NCT05676216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110334|NCT05676216|Anesthetics, Local|anesthetics, local|mesh-ancestor
139110335|NCT05676216|Anesthetics|anesthetics|mesh-ancestor
139110336|NCT05676216|Sensory System Agents|sensory system agents|mesh-ancestor
139110337|NCT05676216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110338|NCT05676216|Antiemetics|antiemetics|mesh-ancestor
139110339|NCT05676216|Autonomic Agents|autonomic agents|mesh-ancestor
139110340|NCT05676216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139110341|NCT05676216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139110342|NCT05676216|Histamine Antagonists|histamine antagonists|mesh-ancestor
139110343|NCT05676216|Histamine Agents|histamine agents|mesh-ancestor
139110344|NCT05676216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110345|NCT05676216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110346|NCT05676216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139110347|NCT05676216|Antipruritics|antipruritics|mesh-ancestor
139110348|NCT05676216|Dermatologic Agents|dermatologic agents|mesh-ancestor
139110349|NCT05571592|Cannabidiol|cannabidiol|mesh-list
139110350|NCT05571592|Anticonvulsants|anticonvulsants|mesh-ancestor
139110351|NCT05559905|Molnupiravir|molnupiravir|mesh-list
139110352|NCT05559905|Antiviral Agents|antiviral agents|mesh-ancestor
139110353|NCT05559905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110354|NCT05536791|Dabigatran|dabigatran|mesh-list
139110355|NCT05536791|Antithrombins|antithrombins|mesh-ancestor
139110356|NCT05536791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139110357|NCT05536791|Protease Inhibitors|protease inhibitors|mesh-ancestor
139110358|NCT05536791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110359|NCT05536791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110360|NCT05536791|Anticoagulants|anticoagulants|mesh-ancestor
139110361|NCT05522231|Everolimus|everolimus|mesh-list
139110362|NCT05522231|Axitinib|axitinib|mesh-list
139110363|NCT05522231|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139110364|NCT05522231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139110365|NCT05522231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110366|NCT05522231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110367|NCT05522231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139110368|NCT05522231|Immunologic Factors|immunologic factors|mesh-ancestor
139110369|NCT05522231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110370|NCT05522231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110372|NCT05484154|Anticoagulants|anticoagulants|mesh-ancestor
139110373|NCT05484154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139110374|NCT05484154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139110375|NCT05484154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110376|NCT05377424|Istradefylline|istradefylline|mesh-list
139110377|NCT05377424|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
139110378|NCT05377424|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139110379|NCT05377424|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139110380|NCT05377424|Purinergic Agents|purinergic agents|mesh-ancestor
139110381|NCT05377424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110382|NCT05377424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110383|NCT05377424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110384|NCT05303311|Dexamethasone|dexamethasone|mesh-list
139110385|NCT05303311|Meperidine|meperidine|mesh-list
139110386|NCT05303311|Bupivacaine|bupivacaine|mesh-list
139110387|NCT05303311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139110388|NCT05303311|Antiemetics|antiemetics|mesh-ancestor
139110389|NCT05303311|Autonomic Agents|autonomic agents|mesh-ancestor
139110390|NCT05303311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110391|NCT05303311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110392|NCT05303311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139110393|NCT05303311|Glucocorticoids|glucocorticoids|mesh-ancestor
139110394|NCT05303311|Hormones|hormones|mesh-ancestor
139110395|NCT05303311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139110396|NCT05303311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139110397|NCT05303311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110398|NCT05303311|Anesthetics, Local|anesthetics, local|mesh-ancestor
139110400|NCT05303311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139110401|NCT05303311|Sensory System Agents|sensory system agents|mesh-ancestor
139110402|NCT05303311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139110403|NCT05303311|Narcotics|narcotics|mesh-ancestor
139110404|NCT05303311|Analgesics|analgesics|mesh-ancestor
139110405|NCT05303311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139110406|NCT05262764|Empagliflozin|empagliflozin|mesh-list
139110407|NCT05262764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139110408|NCT05262764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110409|NCT05262764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139110410|NCT05262764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110411|NCT05233579|Sulforaphane|sulforaphane|mesh-list
139110412|NCT05233579|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139110413|NCT05233579|Protective Agents|protective agents|mesh-ancestor
139110414|NCT05233579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110415|NCT05233579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110416|NCT05227612|Psilocybin|psilocybin|mesh-list
139110417|NCT05227612|Hallucinogens|hallucinogens|mesh-ancestor
139110418|NCT05227612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110419|NCT05227612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139110420|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
139110421|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139110422|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139110423|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110424|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139110425|NCT05208892|Analgesics|analgesics|mesh-ancestor
139110426|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
139110427|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110428|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139110429|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139110430|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139110431|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
139110432|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110433|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110434|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139110435|NCT05119920|Pilocarpine|pilocarpine|mesh-list
139110437|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
139110438|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110439|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110440|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139110441|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139110442|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
139110443|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110444|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110445|NCT05084638|Ofatumumab|ofatumumab|mesh-list
139110446|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110447|NCT05054868|Ketorolac|ketorolac|mesh-list
139110448|NCT05054868|Oxycodone|oxycodone|mesh-list
139110449|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139110450|NCT05054868|Narcotics|narcotics|mesh-ancestor
138532047|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
139110451|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139110452|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110453|NCT05054868|Analgesics|analgesics|mesh-ancestor
139110454|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
139110455|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110456|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139110457|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139110458|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139110459|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139110460|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139110461|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110462|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110463|NCT05046535|Nicotine|nicotine|mesh-list
139110464|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139110465|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
139110466|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110467|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110468|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139110469|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139110470|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
139110471|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110472|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110473|NCT05009342|Calpastatin|calpastatin|mesh-list
139110474|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139110475|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
139110476|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110477|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110478|NCT04922827|Infliximab|infliximab|mesh-list
139110479|NCT04922827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139110480|NCT04922827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139110481|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
139110482|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138861067|NCT02711202|Sirolimus|sirolimus|mesh-list
139110483|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139110484|NCT04921930|Artesunate|artesunate|mesh-list
139110485|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
139110486|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139110487|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139110488|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110489|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110491|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
139110492|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139110493|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
139110494|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
139110495|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139110496|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110497|NCT04909684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139110498|NCT04909684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110499|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
139110500|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
139110501|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110502|NCT04719273|Anastrozole|anastrozole|mesh-list
139110503|NCT04719273|Onapristone|onapristone|mesh-list
139110504|NCT04719273|Progesterone|progesterone|mesh-list
139110505|NCT04719273|Estrogens|estrogens|mesh-list
139110506|NCT04719273|Progestins|progestins|mesh-ancestor
139110507|NCT04719273|Hormones|hormones|mesh-ancestor
139110508|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139110509|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110510|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139110511|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110512|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139110513|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139110514|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110515|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110516|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139110517|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
139110518|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139110519|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
139110520|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138861143|NCT02711280|Propofol|propofol|mesh-list
139110522|NCT04631510|Analgesics|analgesics|mesh-ancestor
139110523|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
139110524|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110525|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110526|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
139110527|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139110528|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139110529|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139110530|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139110531|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139110532|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139110533|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110534|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110535|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
139110536|NCT04612257|Insulin|insulin|mesh-list
139110537|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139110538|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110539|NCT04559581|Nintedanib|nintedanib|mesh-list
139110540|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110541|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139110542|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110543|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110544|NCT04522050|Gemcitabine|gemcitabine|mesh-list
139110545|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110546|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139110547|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
139110548|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110549|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
139110550|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139110551|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
139110552|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110553|NCT04481048|Expectorants|expectorants|mesh-ancestor
139110554|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
139110555|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139110556|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
139110557|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110558|NCT04481048|Protective Agents|protective agents|mesh-ancestor
139110559|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110560|NCT04481048|Antidotes|antidotes|mesh-ancestor
139110561|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
139110562|NCT04357587|Capecitabine|capecitabine|mesh-list
139110563|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139110564|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110565|NCT04357587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139110566|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110567|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139110568|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
139110569|NCT04269408|Nicardipine|nicardipine|mesh-list
139110570|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139110571|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139110572|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139110573|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110574|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139110575|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110576|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
139110577|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139110578|NCT04122170|Aspirin|aspirin|mesh-list
139110579|NCT04122170|Ticagrelor|ticagrelor|mesh-list
139110580|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139110581|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139110582|NCT04122170|Analgesics|analgesics|mesh-ancestor
139110583|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
139110584|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110585|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110586|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139110587|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139110588|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139110589|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139110590|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110591|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139110592|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139110593|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110594|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
139110595|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139110596|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139110597|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139110598|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
139110599|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139038021|NCT00390780|Miconazole|miconazole|mesh-list
139110600|NCT03997266|Gentamicins|gentamicins|mesh-list
139110602|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139110603|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110604|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139110605|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110606|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110607|NCT03959293|Durvalumab|durvalumab|mesh-list
139110608|NCT03959293|Tremelimumab|tremelimumab|mesh-list
139110609|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139110610|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110611|NCT03782987|Itraconazole|itraconazole|mesh-list
139110612|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
139110613|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110614|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139110615|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139110616|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110617|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110618|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139110619|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
139110620|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139110621|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110622|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139110624|NCT03755791|Atezolizumab|atezolizumab|mesh-list
139110625|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110626|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139110627|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110628|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110629|NCT03755791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139110630|NCT03755791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139110631|NCT03755102|Osimertinib|osimertinib|mesh-list
139110632|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110633|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139110634|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110635|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110636|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139110637|NCT03575403|Methylphenidate|methylphenidate|mesh-list
139110638|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139110639|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110640|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139110641|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139110642|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139110643|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110644|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
139110645|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110646|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139110647|NCT03575403|Analgesics|analgesics|mesh-ancestor
139110648|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
139110649|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110650|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
139110651|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139110652|NCT03474029|Rifampin|rifampin|mesh-list
139110653|NCT03474029|Rifapentine|rifapentine|mesh-list
139110654|NCT03474029|Isoniazid|isoniazid|mesh-list
139110655|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139110656|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
139110657|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139110658|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110659|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
139110660|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139110661|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110662|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110663|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139110664|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139110665|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139110666|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139110667|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139110668|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139110669|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139110670|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139110671|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
139110672|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139110673|NCT03395080|Paclitaxel|paclitaxel|mesh-list
139110674|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139110675|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110676|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
139110677|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
139110678|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
139110679|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110680|NCT03356860|Paclitaxel|paclitaxel|mesh-list
139110681|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
139110682|NCT03356860|Durvalumab|durvalumab|mesh-list
139110683|NCT03356860|Epirubicin|epirubicin|mesh-list
139110684|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139110685|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110686|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
139110687|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
138629849|NCT00257634|Hormones|hormones|mesh-ancestor
139110689|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110690|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139110691|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
139110692|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110693|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139110694|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139110695|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
139110696|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139110697|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139110698|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139110699|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139110700|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139110701|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110702|NCT03245437|Oxytocin|oxytocin|mesh-list
139110703|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
139110704|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139110705|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110706|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139110707|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139110708|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110709|NCT03217643|Immunotoxins|immunotoxins|mesh-ancestor
139110710|NCT03217643|Immunoconjugates|immunoconjugates|mesh-ancestor
139110711|NCT03217643|Immunologic Factors|immunologic factors|mesh-ancestor
139110712|NCT03217643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110713|NCT03006432|Leucovorin|leucovorin|mesh-list
139110714|NCT03006432|Folic Acid|folic acid|mesh-list
139110715|NCT03006432|Docetaxel|docetaxel|mesh-list
139110716|NCT03006432|Fluorouracil|fluorouracil|mesh-list
139110717|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
139110718|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
139110719|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110720|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
139110721|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
139110722|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
139110723|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110724|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
139110725|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139110726|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139110727|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
139110728|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110729|NCT03006432|Antidotes|antidotes|mesh-ancestor
139110730|NCT03006432|Protective Agents|protective agents|mesh-ancestor
139110731|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
139110732|NCT03006432|Vitamins|vitamins|mesh-ancestor
139110733|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
139110734|NCT03006432|Hematinics|hematinics|mesh-ancestor
139110735|NCT02759185|Dronabinol|dronabinol|mesh-list
139110736|NCT02759185|Cannabidiol|cannabidiol|mesh-list
139110737|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
139110738|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
139110739|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110740|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139110741|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139110742|NCT02759185|Analgesics|analgesics|mesh-ancestor
139110743|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
139110744|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110745|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139110746|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139110747|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110748|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110750|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139110751|NCT02436993|Paclitaxel|paclitaxel|mesh-list
139110752|NCT02436993|Bevacizumab|bevacizumab|mesh-list
139110753|NCT02436993|Carboplatin|carboplatin|mesh-list
139110754|NCT02436993|Trastuzumab|trastuzumab|mesh-list
139110755|NCT02436993|Pertuzumab|pertuzumab|mesh-list
139110756|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139110757|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110758|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
139110759|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
139110760|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
139110761|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110762|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139110763|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139110764|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139110765|NCT02436993|Growth Substances|growth substances|mesh-ancestor
139110766|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110767|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
139110768|NCT02193841|Calcium|calcium|mesh-list
139110769|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139110770|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110771|NCT02011971|Vinpocetine|vinpocetine|mesh-list
139110772|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139110773|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110774|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110775|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
139110776|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139110777|NCT02011971|Protective Agents|protective agents|mesh-ancestor
139110778|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110779|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
139110780|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139110781|NCT01951339|Glimepiride|glimepiride|mesh-list
139110782|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139110783|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110784|NCT01951339|Incretins|incretins|mesh-ancestor
139110785|NCT01951339|Hormones|hormones|mesh-ancestor
139110786|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139110787|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139110788|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
139110789|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110790|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110791|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139110792|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139110793|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
139110794|NCT01844518|Abatacept|abatacept|mesh-list
139110795|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139110796|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110797|NCT01844518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139110798|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110799|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139110800|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
139110801|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110802|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139110803|NCT01835041|Leucovorin|leucovorin|mesh-list
139110804|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
139110805|NCT01835041|Fluorouracil|fluorouracil|mesh-list
139110806|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
139110807|NCT01835041|Irinotecan|irinotecan|mesh-list
139110808|NCT01835041|Calcium|calcium|mesh-list
139110809|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
139110810|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139110811|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110812|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
139110813|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110814|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139110815|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110816|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139110817|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
139110818|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139110819|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139110820|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110821|NCT01835041|Antidotes|antidotes|mesh-ancestor
139110822|NCT01835041|Protective Agents|protective agents|mesh-ancestor
139110823|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
139110824|NCT01835041|Vitamins|vitamins|mesh-ancestor
139110825|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
139110826|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
139110827|NCT01833572|Gefitinib|gefitinib|mesh-list
139110828|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110829|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139110830|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110831|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110832|NCT01639690|Busulfan|busulfan|mesh-list
139110833|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
139110834|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110835|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139110836|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
139110837|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110838|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139110839|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110840|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139110842|NCT01591577|Lapatinib|lapatinib|mesh-list
139110843|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139110844|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
139110845|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110846|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110847|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139110848|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110849|NCT01509586|Lobeline|lobeline|mesh-list
139110850|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139110851|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
139110852|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110853|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110854|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139110855|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139110856|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
139110857|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110858|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110859|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
139110860|NCT01364584|Exenatide|exenatide|mesh-list
139110861|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139110862|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110863|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139110864|NCT01364584|Incretins|incretins|mesh-ancestor
139110865|NCT01364584|Hormones|hormones|mesh-ancestor
139110866|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139110867|NCT01163383|Iodine|iodine|mesh-list
139110868|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
139110869|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139110870|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139110871|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110872|NCT01163383|Trace Elements|trace elements|mesh-ancestor
139110873|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
139110874|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110875|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110876|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110877|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110878|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139110879|NCT01044264|Clindamycin|clindamycin|mesh-list
139110880|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
139110881|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
139110882|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139110883|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139110884|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110885|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139110886|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110887|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110888|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
139110889|NCT01039584|Butoconazole|butoconazole|mesh-list
139110890|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
139110891|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110892|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139110893|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
139110894|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110895|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139110896|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139110898|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954697|NCT02538003|Delpazolid|delpazolid|mesh-list
139110899|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110900|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139110901|NCT00786019|Vitamins|vitamins|mesh-list
139110902|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
139110903|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
139110904|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110905|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
139110906|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110907|NCT00786019|Protective Agents|protective agents|mesh-ancestor
139110908|NCT00692484|Chlorhexidine|chlorhexidine|mesh-list
139110909|NCT00692484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139110910|NCT00692484|Povidone-Iodine|povidone-iodine|mesh-list
139110911|NCT00692484|Povidone|povidone|mesh-list
139110912|NCT00692484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139110913|NCT00692484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110914|NCT00692484|Disinfectants|disinfectants|mesh-ancestor
139110915|NCT00692484|Dermatologic Agents|dermatologic agents|mesh-ancestor
139110916|NCT00692484|Plasma Substitutes|plasma substitutes|mesh-ancestor
139110917|NCT00692484|Blood Substitutes|blood substitutes|mesh-ancestor
139110919|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139110920|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110921|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110922|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110923|NCT00152698|Irbesartan|irbesartan|mesh-list
139110924|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139110925|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139110926|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139110927|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110928|NCT01257516|Pregabalin|pregabalin|mesh-list
139110929|NCT01257516|Analgesics|analgesics|mesh-ancestor
139110930|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
139110931|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110932|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110933|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
139110934|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139110935|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139110936|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110937|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139110938|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139110939|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139110940|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139110941|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139110942|NCT01149954|Ibuprofen|ibuprofen|mesh-list
139110943|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139110944|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139110945|NCT01149954|Analgesics|analgesics|mesh-ancestor
139110946|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
139110947|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110948|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110949|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139110950|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139110951|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139110952|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110953|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110954|NCT03899610|Durvalumab|durvalumab|mesh-list
139110955|NCT03899610|Tremelimumab|tremelimumab|mesh-list
139110956|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139110957|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139110958|NCT02527668|Vitamin D|vitamin d|mesh-list
139110959|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
139110960|NCT02527668|Calcifediol|calcifediol|mesh-list
139110961|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139110962|NCT02527668|Vitamins|vitamins|mesh-ancestor
139110963|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
139110964|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110965|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139110966|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139110967|NCT03896256|Ketamine|ketamine|mesh-list
139110968|NCT03896256|Analgesics|analgesics|mesh-ancestor
139110969|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
139110970|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139110971|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110973|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139038187|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
139110975|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
139110976|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139110977|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139110978|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139110979|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139110980|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110981|NCT03893136|Leflunomide|leflunomide|mesh-list
139110982|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110983|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110984|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139110985|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
139110986|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110987|NCT01258530|Oseltamivir|oseltamivir|mesh-list
139110988|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
139110989|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110990|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139110991|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139110993|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
139110994|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139110995|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
139110996|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139110997|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
139110998|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
139110999|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
139111000|NCT01257672|Ondansetron|ondansetron|mesh-list
139111001|NCT01257672|Domperidone|domperidone|mesh-list
139111002|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
139111003|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
139111004|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111005|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111006|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139111007|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
139111008|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
139111009|NCT01257672|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139111010|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139111011|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
139111012|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111013|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111014|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139111015|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
139111016|NCT01258686|Silymarin|silymarin|mesh-list
139111017|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
139111018|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111019|NCT01258686|Protective Agents|protective agents|mesh-ancestor
139111020|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111021|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139111022|NCT01258764|Lisinopril|lisinopril|mesh-list
139111023|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139111024|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139111025|NCT01258764|Diuretics|diuretics|mesh-ancestor
139111026|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
139111027|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111028|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139111029|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139111030|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111031|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
139111032|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111033|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139111034|NCT01258764|Protective Agents|protective agents|mesh-ancestor
139111035|NCT03895788|Niraparib|niraparib|mesh-list
139111036|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139111037|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111038|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111039|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111041|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
139111042|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139111043|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139111044|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111045|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111046|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111047|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139111048|NCT01257828|Protective Agents|protective agents|mesh-ancestor
139111049|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
139111050|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139111051|NCT03899142|Antibodies|antibodies|mesh-list
139111052|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
139111053|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111054|NCT03892902|Zopiclone|zopiclone|mesh-list
139111055|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139111056|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111057|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111058|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
139111059|NCT03892668|Oxytocin|oxytocin|mesh-list
139111060|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
139111061|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139111062|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111063|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139111064|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139111065|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111066|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
139111067|NCT03892668|Coagulants|coagulants|mesh-ancestor
139111068|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139111069|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139111070|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139111071|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111072|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111073|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139111074|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139111075|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139111076|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
139111077|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111078|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111079|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139111080|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139111081|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
139111082|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
139111083|NCT03898752|Vitamins|vitamins|mesh-ancestor
139111084|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
139111085|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111086|NCT01255644|Valganciclovir|valganciclovir|mesh-list
139111087|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
139111088|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111089|NCT01255800|Cetuximab|cetuximab|mesh-list
138954723|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
139111090|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139111091|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111092|NCT01257906|Tretinoin|tretinoin|mesh-list
139111093|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111094|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
139111095|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
139111096|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
139111097|NCT03892512|Esmolol|esmolol|mesh-list
139111098|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139111099|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111100|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111101|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139111102|NCT03892512|Analgesics|analgesics|mesh-ancestor
139111103|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
139111104|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111105|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139111106|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139111107|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139111108|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
139111109|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111110|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111111|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139111112|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139111113|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139111114|NCT01255878|Gabapentin|gabapentin|mesh-list
139111115|NCT01255878|Analgesics|analgesics|mesh-ancestor
139111116|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
139111117|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111118|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111119|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
139111120|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139111121|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139111122|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111123|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139111124|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139111125|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139111126|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111127|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111128|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
139111129|NCT01255956|Sirolimus|sirolimus|mesh-list
139111130|NCT01255956|Paclitaxel|paclitaxel|mesh-list
139111131|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139111132|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111133|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
139111134|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
139111135|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
139111136|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111137|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139111138|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111139|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139111140|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
139111141|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139111142|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
139111143|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111144|NCT03892434|Dexamethasone|dexamethasone|mesh-list
139111145|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
139111146|NCT03892434|Bevacizumab|bevacizumab|mesh-list
139111147|NCT03892434|BB 1101|bb 1101|mesh-list
139111148|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139111149|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111150|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139111151|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139111152|NCT03892434|Growth Substances|growth substances|mesh-ancestor
139111153|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111154|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
139038230|NCT00430352|Rituximab|rituximab|mesh-list
139111155|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139111156|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
139111157|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
138534975|NCT00131482|Thrombin|thrombin|mesh-list
139111158|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111159|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139111160|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
139111161|NCT03892434|Hormones|hormones|mesh-ancestor
139111162|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139111163|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139111164|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
139111165|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111166|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111167|NCT03889626|Capecitabine|capecitabine|mesh-list
139111168|NCT03889626|Apatinib|apatinib|mesh-list
139111169|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139111170|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
139111171|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111172|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111173|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139111174|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111175|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
139111176|NCT03892122|Propofol|propofol|mesh-list
139111177|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139111178|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111179|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111180|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139111181|NCT03892122|Analgesics|analgesics|mesh-ancestor
139111182|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
139111183|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111184|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139111185|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139111186|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139111187|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
139111188|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111189|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111190|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139111191|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
139111192|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
139111193|NCT01589562|Megestrol|megestrol|mesh-list
139111194|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
138861820|NCT00924287|Fludarabine|fludarabine|mesh-list
139111195|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139111196|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139111197|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139111198|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
139111199|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139111200|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111201|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139111202|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139111203|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139111204|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111205|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
139111206|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139038236|NCT01068405|Methotrexate|methotrexate|mesh-list
139111209|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111210|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139111211|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
139111212|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139111213|NCT01259934|Interferons|interferons|mesh-list
139111214|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
139111215|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
139111216|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111217|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
139111218|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111219|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
139111220|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111221|NCT01153386|Treprostinil|treprostinil|mesh-list
139111222|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139111223|NCT01260012|Praziquantel|praziquantel|mesh-list
139111224|NCT01260012|Antioxidants|antioxidants|mesh-list
139111225|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111226|NCT01260012|Protective Agents|protective agents|mesh-ancestor
139111227|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111228|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
139111229|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139111230|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111231|NCT03888924|Vaccines|vaccines|mesh-list
139111232|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
139111233|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
139111234|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111235|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139111236|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139111237|NCT01151592|Hematinics|hematinics|mesh-ancestor
139111238|NCT01151670|Pioglitazone|pioglitazone|mesh-list
139111239|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139111240|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111241|NCT03888846|Colchicine|colchicine|mesh-list
139111242|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
139111243|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
139111244|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139111245|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
139111246|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
139111247|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
139111248|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111249|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111250|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139111251|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111252|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139111253|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139111254|NCT03888846|Protective Agents|protective agents|mesh-ancestor
139111255|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111256|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
139111257|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139111258|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
139111259|NCT03891420|Galidesivir|galidesivir|mesh-list
139111260|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
139111261|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111262|NCT01153542|Ivacaftor|ivacaftor|mesh-list
139111263|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139111264|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139111265|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111266|NCT01152606|Trastuzumab|trastuzumab|mesh-list
139111267|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139111268|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111269|NCT01153854|Racecadotril|racecadotril|mesh-list
139111270|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
139111271|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139111272|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
139111273|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111274|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111275|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139111276|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139111277|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111278|NCT01260246|Incretins|incretins|mesh-ancestor
139111279|NCT01260246|Hormones|hormones|mesh-ancestor
139111280|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139111281|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139111282|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
139111283|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111284|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111285|NCT03888534|Ixazomib|ixazomib|mesh-list
139111286|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111287|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
139111288|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111289|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111291|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139111292|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111293|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111294|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139111295|NCT03885804|Analgesics|analgesics|mesh-ancestor
139111296|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
139111297|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111298|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139111299|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139111300|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139111301|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
139111302|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111303|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111304|NCT03885258|Melatonin|melatonin|mesh-list
139111305|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
139111306|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111307|NCT03885258|Protective Agents|protective agents|mesh-ancestor
139111308|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111309|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111310|NCT01262196|Chrysarobin|chrysarobin|mesh-list
139111311|NCT01262196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139111312|NCT01262196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139111313|NCT01262196|Analgesics|analgesics|mesh-ancestor
139111314|NCT01262196|Sensory System Agents|sensory system agents|mesh-ancestor
139111315|NCT01262196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111316|NCT01262196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111317|NCT01262196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139111318|NCT01262196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139111319|NCT03885180|Warfarin|warfarin|mesh-list
139111320|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
139111321|NCT03888144|Ketorolac|ketorolac|mesh-list
139111322|NCT03888144|Oxycodone|oxycodone|mesh-list
139111323|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139111324|NCT03888144|Narcotics|narcotics|mesh-ancestor
139111325|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111326|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111327|NCT03888144|Analgesics|analgesics|mesh-ancestor
139111328|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
139111329|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111330|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139111331|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139111332|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139111333|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139111334|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139111335|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111336|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111337|NCT03890406|Rocuronium|rocuronium|mesh-list
139111338|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139111339|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139111340|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139111341|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111342|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111343|NCT01154400|Caseins|caseins|mesh-list
139111344|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
139111345|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
139111346|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111347|NCT01152840|Everolimus|everolimus|mesh-list
139111348|NCT01152840|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139111349|NCT01152840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139111350|NCT01152840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111351|NCT01152840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954775|NCT01581151|Hormones|hormones|mesh-ancestor
139111352|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139111353|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
139111354|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111355|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111356|NCT01262274|Anastrozole|anastrozole|mesh-list
139111357|NCT01262274|Tegafur|tegafur|mesh-list
139111358|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139111359|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111360|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139111361|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139111362|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887565|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139111363|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111364|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139111365|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
139111366|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139111367|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111368|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139111369|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
139111370|NCT01260558|Sirolimus|sirolimus|mesh-list
139111371|NCT01260558|Temsirolimus|temsirolimus|mesh-list
139111372|NCT01260558|MTOR Inhibitors|mtor inhibitors|mesh-list
139111373|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139111374|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111375|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139111376|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111377|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
139111378|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139111379|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
139111380|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111381|NCT01260558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139111382|NCT01260558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111383|NCT01260558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111384|NCT01260714|Etoposide|etoposide|mesh-list
139111385|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
139111386|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
139111387|NCT01260714|Azacitidine|azacitidine|mesh-list
139111388|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
139111389|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139111390|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111391|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139111392|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139111393|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111394|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111395|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139111396|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
139111397|NCT01260714|Analgesics|analgesics|mesh-ancestor
139111398|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
139111399|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111400|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111401|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
139111402|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
139111403|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
139111404|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
139111405|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
139111406|NCT03890094|Sufentanil|sufentanil|mesh-list
139111407|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139111408|NCT03890094|Narcotics|narcotics|mesh-ancestor
139111409|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111410|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111411|NCT03890094|Analgesics|analgesics|mesh-ancestor
139111412|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
139111413|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111414|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139111415|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139111416|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
139111417|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
139111418|NCT03887754|Risperidone|risperidone|mesh-list
139111419|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139111420|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
139111421|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111422|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111423|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111424|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139111425|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139111426|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111427|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139111428|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139111429|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
139111430|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
139111431|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
139111432|NCT01262586|Glimepiride|glimepiride|mesh-list
139111433|NCT01262586|Vildagliptin|vildagliptin|mesh-list
139111434|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139111435|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139111436|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111437|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139111438|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
139111439|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139111440|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
139111441|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111442|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111443|NCT01157052|Capecitabine|capecitabine|mesh-list
139111444|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
139111446|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139111447|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111448|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139111449|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
139111450|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111451|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111452|NCT03887130|Paclitaxel|paclitaxel|mesh-list
139111453|NCT03887130|Vinorelbine|vinorelbine|mesh-list
139111454|NCT03887130|Docetaxel|docetaxel|mesh-list
139111455|NCT03887130|Gemcitabine|gemcitabine|mesh-list
139111456|NCT03887130|Capecitabine|capecitabine|mesh-list
139111457|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139111458|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111459|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
139111460|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
139111461|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
139111462|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111463|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139111464|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
139111465|NCT01155960|Anastrozole|anastrozole|mesh-list
139111466|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139111467|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111468|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139111469|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139111470|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111471|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111472|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139111473|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
139111474|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139111475|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111476|NCT03883776|Octreotide|octreotide|mesh-list
139111477|NCT03883776|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
139111478|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139111479|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139111480|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111481|NCT03883776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139111482|NCT03883776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111483|NCT03886896|Lidocaine|lidocaine|mesh-list
139111484|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
139111485|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
139111486|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111487|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111488|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
139111489|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111490|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139111491|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139111492|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139111493|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139038411|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111494|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111495|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139111496|NCT03881904|Gestodene|gestodene|mesh-list
139111497|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139111498|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139111499|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139111500|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
139111501|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139111502|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111503|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139111504|NCT03881904|Estrogens|estrogens|mesh-ancestor
139111505|NCT03881904|Hormones|hormones|mesh-ancestor
139111506|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139111507|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139111508|NCT03881904|Progestins|progestins|mesh-ancestor
139111509|NCT01262742|Carbetocin|carbetocin|mesh-list
139111510|NCT01262742|Oxytocin|oxytocin|mesh-list
139111511|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
139111512|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139111513|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111514|NCT01261416|Levetiracetam|levetiracetam|mesh-list
139111515|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
139111516|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
139111517|NCT03617172|Misoprostol|misoprostol|mesh-list
139111518|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139111519|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
139111520|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139111521|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111522|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139111523|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139111524|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
139111525|NCT01154790|Naproxen|naproxen|mesh-list
139111526|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139111527|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139111528|NCT01154790|Analgesics|analgesics|mesh-ancestor
139111529|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
139111530|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111531|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111532|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139111533|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139111534|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
139111535|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139111536|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111537|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111538|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
139111539|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
139111540|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111541|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139111542|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
139111543|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111544|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
139111545|NCT01263288|Vitamin D|vitamin d|mesh-list
139111546|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139111547|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111548|NCT01263288|Vitamins|vitamins|mesh-ancestor
139111549|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
139111550|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139111551|NCT01263834|Bevacizumab|bevacizumab|mesh-list
139111552|NCT01263834|Mitomycins|mitomycins|mesh-list
139111553|NCT01263834|Mitomycin|mitomycin|mesh-list
139111554|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139111555|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111556|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139111557|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139038432|NCT00300495|Amiodarone|amiodarone|mesh-list
139111559|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111560|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
139111561|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139111562|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
139111563|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111564|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139111565|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111566|NCT01263366|Norepinephrine|norepinephrine|mesh-list
139111567|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139111568|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139111569|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
139111570|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111571|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111572|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111573|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
139111574|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
139111575|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111576|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139111577|NCT01155102|Anastrozole|anastrozole|mesh-list
139111578|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139111579|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111580|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139111581|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139111582|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111583|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111584|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139111586|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139111587|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111588|NCT01156350|Fludarabine|fludarabine|mesh-list
139111589|NCT01156350|Busulfan|busulfan|mesh-list
139111590|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111591|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111592|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139111593|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
139111594|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111595|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
139111596|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139111597|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139111599|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111600|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111601|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111602|NCT01155258|Sirolimus|sirolimus|mesh-list
139111603|NCT01155258|Vinorelbine|vinorelbine|mesh-list
139111604|NCT01155258|Temsirolimus|temsirolimus|mesh-list
139111605|NCT01155258|MTOR Inhibitors|mtor inhibitors|mesh-list
139111606|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139111607|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111608|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139111609|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111610|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
139111611|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139111612|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
139111613|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111614|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139111615|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
139111616|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
139111617|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
139111618|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111619|NCT01155258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139111620|NCT01155258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111621|NCT01156584|Flucytosine|flucytosine|mesh-list
139111622|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
139111623|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111624|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
139111625|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111626|NCT03879174|Tamoxifen|tamoxifen|mesh-list
139111627|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
139111628|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139111629|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111630|NCT03879174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139111631|NCT03879174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111632|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139111633|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
139111634|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139111635|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111636|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139111637|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139111638|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139111639|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139111640|NCT01159548|Promethazine|promethazine|mesh-list
139111641|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
139111642|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
139111643|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
139111644|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139111645|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
139111646|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
139111647|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111648|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111649|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111650|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139111651|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139111652|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139111653|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111654|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
139111655|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
139111656|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
138630859|NCT00266838|Hormones|hormones|mesh-ancestor
139111657|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111658|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
139111659|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
139111660|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139111661|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139111662|NCT01156740|Amoxicillin|amoxicillin|mesh-list
139111663|NCT01156740|Penicillins|penicillins|mesh-list
139111664|NCT01156740|beta-Lactams|beta-lactams|mesh-list
139111665|NCT01156740|Penicillin G|penicillin g|mesh-list
139111666|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139111667|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
139111668|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111669|NCT03880968|Etanercept|etanercept|mesh-list
139111670|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139111671|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139111672|NCT03880968|Analgesics|analgesics|mesh-ancestor
139111673|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
139111674|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111675|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111676|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139111677|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139111678|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139111679|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139111680|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
139111681|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
139111682|NCT03880734|Vitamin D|vitamin d|mesh-list
139111683|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139111684|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111685|NCT03880734|Vitamins|vitamins|mesh-ancestor
139111686|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
139111687|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139111688|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
139111689|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139111690|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
139111691|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139111692|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111693|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139111694|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139111695|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139111696|NCT01265940|Vinblastine|vinblastine|mesh-list
139111697|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139111698|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111699|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
139111700|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
139111701|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
139111702|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111703|NCT01264302|Finasteride|finasteride|mesh-list
139111704|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139111705|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139111706|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111707|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111708|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
139111709|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139111710|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111711|NCT01264302|Urological Agents|urological agents|mesh-ancestor
139111712|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139111713|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
139111714|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111715|NCT01161654|Naratriptan|naratriptan|mesh-list
139111716|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139111717|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139111718|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139111719|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
139111720|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887570|NCT00592839|Hormones|hormones|mesh-ancestor
139111721|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111722|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111724|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139111725|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
139111726|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111727|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111728|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111729|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
139111730|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139111731|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111732|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111733|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139111735|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
139111736|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111737|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139111738|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139111739|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139111740|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
139111741|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111742|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111743|NCT01266486|Metformin|metformin|mesh-list
139111744|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139111745|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111746|NCT01161888|Imiquimod|imiquimod|mesh-list
139111747|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139111748|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
139111749|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111750|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111751|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
139111752|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
139111753|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139111754|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111755|NCT03759600|Niraparib|niraparib|mesh-list
139111756|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139111757|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111758|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111759|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111760|NCT01161966|Zonisamide|zonisamide|mesh-list
139111761|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
139111762|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139111763|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139111764|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111765|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139111766|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111767|NCT01158144|Paclitaxel|paclitaxel|mesh-list
139111768|NCT01158144|Carboplatin|carboplatin|mesh-list
139111769|NCT01158144|Endostar protein|endostar protein|mesh-list
139111770|NCT01158144|Endostatins|endostatins|mesh-list
139111771|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139111772|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111773|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
139111774|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
139111775|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
139111776|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111777|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139111778|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139111779|NCT01158144|Growth Substances|growth substances|mesh-ancestor
139111780|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111781|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
139111782|NCT01264536|Lactoferrin|lactoferrin|mesh-list
139111783|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111784|NCT01160172|Vaccines|vaccines|mesh-list
139111785|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
139111786|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111787|NCT03878784|Sumatriptan|sumatriptan|mesh-list
139111788|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139111789|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139111790|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139111791|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
139111792|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111793|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111794|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111795|NCT01266720|Gemcitabine|gemcitabine|mesh-list
139111796|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139111797|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
139111798|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111799|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111800|NCT01589952|Interferons|interferons|mesh-list
139111801|NCT01589952|Entecavir|entecavir|mesh-list
139111802|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111803|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
139111804|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111805|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
139111806|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139111807|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139111808|NCT03876444|Prednisolone|prednisolone|mesh-list
139111809|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
139111810|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139111811|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
139111812|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139111813|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
139111814|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
139111815|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111816|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111817|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139111818|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
139111819|NCT03876444|Hormones|hormones|mesh-ancestor
139111820|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139111821|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139111822|NCT03876444|Protective Agents|protective agents|mesh-ancestor
139111823|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139111824|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111825|NCT01264692|Amlodipine|amlodipine|mesh-list
139111826|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139111827|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139111828|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139111829|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111830|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139111831|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111832|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
139111833|NCT01160328|Leuprolide|leuprolide|mesh-list
139111834|NCT01160328|Testosterone|testosterone|mesh-list
139111835|NCT01160328|Androgens|androgens|mesh-ancestor
139111836|NCT01160328|Hormones|hormones|mesh-ancestor
139111837|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139111838|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111839|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139111840|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111841|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139111842|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
139111843|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139111845|NCT01162746|Ranibizumab|ranibizumab|mesh-list
139111846|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139111847|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
139111848|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
139111849|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111850|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111851|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139111852|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
139111853|NCT01162746|Hormones|hormones|mesh-ancestor
138954861|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139111854|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139111855|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139111856|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111857|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139111858|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139111859|NCT01162746|Growth Substances|growth substances|mesh-ancestor
139111860|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
139111861|NCT01268202|Pravastatin|pravastatin|mesh-list
139111862|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139111863|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139111864|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
139111865|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111866|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139111867|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139111868|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111870|NCT01162824|Acetylcholine|acetylcholine|mesh-list
139111871|NCT01162824|Analgesics|analgesics|mesh-ancestor
139111872|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
139111873|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111874|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111875|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139111876|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
139111877|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139111878|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
139038599|NCT01044888|Heparin|heparin|mesh-list
139111879|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
139111880|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111881|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111882|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139111883|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
139111884|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139111885|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
139111886|NCT01265004|Coagulants|coagulants|mesh-ancestor
139111887|NCT01162902|Candesartan|candesartan|mesh-list
139111888|NCT01162902|Candesartan cilexetil|candesartan cilexetil|mesh-list
139111889|NCT01162902|Bisoprolol|bisoprolol|mesh-list
139111890|NCT01162902|Diltiazem|diltiazem|mesh-list
139111891|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139111892|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139111893|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139111894|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111895|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
139111896|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
139111897|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111898|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111899|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139111900|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139111901|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139111902|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
139111903|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111904|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139111905|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139111906|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139111907|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
139111908|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139111909|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139111910|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139111911|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
139111912|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111913|NCT02526888|Diltiazem|diltiazem|mesh-list
139111914|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139111915|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139111916|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139111917|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111918|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139111919|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111920|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
139111921|NCT01158612|Hormones|hormones|mesh-list
139111922|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139111923|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111924|NCT03877692|Labetalol|labetalol|mesh-list
139111925|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139111926|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139111927|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
139111928|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111929|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111930|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111931|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139111932|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
139111933|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
139111934|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111935|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139111936|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139111937|NCT01158846|Bivalirudin|bivalirudin|mesh-list
139111938|NCT01158846|Abciximab|abciximab|mesh-list
139111940|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139111941|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139111942|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139111943|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139111944|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139111946|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139111947|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111948|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111949|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
139111950|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139111951|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
139111952|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111953|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
139111954|NCT01268670|Ibuprofen|ibuprofen|mesh-list
139111955|NCT01268670|Oxycodone|oxycodone|mesh-list
139111956|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139111957|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139111958|NCT01268670|Analgesics|analgesics|mesh-ancestor
139111959|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
139111960|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139111961|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111962|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139111963|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139111964|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139111965|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111966|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111967|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139111968|NCT01268670|Narcotics|narcotics|mesh-ancestor
139111969|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139111970|NCT01160718|Fulvestrant|fulvestrant|mesh-list
139111971|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139111972|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111973|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139111974|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139111975|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
139111976|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139111977|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111978|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
139111979|NCT01159080|Tacrolimus|tacrolimus|mesh-list
139111980|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139111981|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
139111982|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139111983|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139111984|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111985|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111986|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139111987|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139111988|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139111989|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
139111990|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139111991|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111992|NCT01160952|Itraconazole|itraconazole|mesh-list
139111993|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
139111994|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139111995|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139111996|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139111997|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038641|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139111998|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139111999|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139112000|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
139112001|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112002|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112003|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139112004|NCT01159158|Nateglinide|nateglinide|mesh-list
139112005|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139112006|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112007|NCT01161108|Melatonin|melatonin|mesh-list
139112008|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
139112009|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112010|NCT01161108|Protective Agents|protective agents|mesh-ancestor
139112011|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112012|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139112013|NCT01161186|Paclitaxel|paclitaxel|mesh-list
139112015|NCT01161186|Gemcitabine|gemcitabine|mesh-list
139112016|NCT01161186|Capecitabine|capecitabine|mesh-list
139112017|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139112018|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112019|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
139112020|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
139112021|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
139112022|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112023|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139112024|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
139112026|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
139112027|NCT01159236|Bevacizumab|bevacizumab|mesh-list
139112028|NCT01159236|Doxorubicin|doxorubicin|mesh-list
139112029|NCT01159236|Fluorouracil|fluorouracil|mesh-list
139112030|NCT01159236|Epirubicin|epirubicin|mesh-list
139112031|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139112032|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112033|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
139112034|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
139112035|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
139112036|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112037|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139112038|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
139112039|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112040|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139112041|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139112042|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
139112043|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139112044|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112045|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139112046|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139112047|NCT01159236|Growth Substances|growth substances|mesh-ancestor
139112048|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
139112049|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139112050|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139112051|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139112052|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112053|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
139112054|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139112055|NCT01267344|Gemcitabine|gemcitabine|mesh-list
139112056|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
139112057|NCT01267344|Cetuximab|cetuximab|mesh-list
139112058|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139112059|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
139112060|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112061|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112062|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112063|NCT03879564|Ketamine|ketamine|mesh-list
139112064|NCT03879564|Analgesics|analgesics|mesh-ancestor
139112065|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
139112066|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112067|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112068|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139112069|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139112070|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
139112071|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
139112072|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139112073|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139112074|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139112075|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139112076|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112077|NCT01581840|Panitumumab|panitumumab|mesh-list
139112078|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112079|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112080|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
139112081|NCT03879486|Formaldehyde|formaldehyde|mesh-list
139112082|NCT03879486|Povidone|povidone|mesh-list
139112083|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
139112084|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
139112085|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139112086|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139112087|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
139112088|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
139112089|NCT01269294|Simeprevir|simeprevir|mesh-list
139112090|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139112091|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139112092|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139112093|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139112094|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139038700|NCT01324596|Hormones|hormones|mesh-ancestor
139112095|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112096|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112097|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112098|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139112099|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
139112100|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139112101|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112102|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139112103|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139112104|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139112105|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
139112106|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
139112107|NCT01163994|Doxycycline|doxycycline|mesh-list
139112108|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
139112109|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139112110|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139112111|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
139112112|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139112113|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139112114|NCT01267734|Everolimus|everolimus|mesh-list
139112115|NCT01267734|Clopidogrel|clopidogrel|mesh-list
139112116|NCT01267734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139112117|NCT01267734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139112118|NCT01267734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112119|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112120|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139112121|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
139112122|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112123|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112124|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139112125|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139112126|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139112127|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139112128|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
139112129|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139112130|NCT01164306|Nicotine|nicotine|mesh-list
139112131|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139112132|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
139112133|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112134|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112136|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139112137|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
138954941|NCT00924573|Metformin|metformin|mesh-list
139112138|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139112139|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112140|NCT01269450|Progesterone|progesterone|mesh-list
139112141|NCT01269450|Progestins|progestins|mesh-ancestor
139112142|NCT01269450|Hormones|hormones|mesh-ancestor
139112143|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112144|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112145|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
139112146|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
139112147|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139112148|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
139112149|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112150|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112151|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139112152|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
139112153|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139112154|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
139112155|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112156|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139112157|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139112158|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
139112159|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
139112160|NCT01269528|Protective Agents|protective agents|mesh-ancestor
139112161|NCT01269528|Miotics|miotics|mesh-ancestor
139112162|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139112163|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139112164|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139112165|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139112166|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
139112167|NCT01268904|Valproic Acid|valproic acid|mesh-list
139112168|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
139112169|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112170|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112171|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
139112172|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139112173|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112174|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
139112175|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139112176|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139112177|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139112178|NCT01269606|Insulin|insulin|mesh-list
139112179|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139112180|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
139112181|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
139112182|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139112183|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139112184|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112185|NCT03872232|Telmisartan|telmisartan|mesh-list
139112186|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139112187|NCT03872232|Ezetimibe|ezetimibe|mesh-list
139112188|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139112189|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139112190|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
139112191|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112192|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139112193|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139112194|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112195|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139112196|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139112197|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139112198|NCT01280214|Triamcinolone|triamcinolone|mesh-list
139112199|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139112200|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
139112201|NCT01280214|Hormones|hormones|mesh-ancestor
139112202|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112203|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112204|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139112205|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139112206|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139112207|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139112208|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139112209|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
139112210|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112211|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139112212|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139112213|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112214|NCT01269684|Everolimus|everolimus|mesh-list
139112215|NCT01269684|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139112216|NCT01269684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139112217|NCT01269684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112218|NCT01269684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112219|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139112220|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
139112221|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112222|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112223|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139112224|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
139112225|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139112226|NCT01280526|Romidepsin|romidepsin|mesh-list
139112227|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139112228|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112229|NCT01280526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139112230|NCT01280526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038785|NCT00232180|Eplerenone|eplerenone|mesh-list
139112231|NCT01280526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112233|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139112234|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
139112236|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112237|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139112238|NCT01269138|Thrombin|thrombin|mesh-list
139112239|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
139112240|NCT01269138|Coagulants|coagulants|mesh-ancestor
139112241|NCT02526810|Insulin|insulin|mesh-list
139112242|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139112243|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
139112244|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
139112245|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139112246|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112247|NCT01269216|Leucovorin|leucovorin|mesh-list
139112248|NCT01269216|Irinotecan|irinotecan|mesh-list
139112249|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139112250|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139112251|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112252|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112253|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112254|NCT01269216|Antidotes|antidotes|mesh-ancestor
139112255|NCT01269216|Protective Agents|protective agents|mesh-ancestor
139112256|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112257|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
139112258|NCT01269216|Vitamins|vitamins|mesh-ancestor
139112259|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
139112260|NCT03874806|Ropivacaine|ropivacaine|mesh-list
139112261|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139112262|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
139112263|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
139112264|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139112265|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112266|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
139112267|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112268|NCT01165476|Treprostinil|treprostinil|mesh-list
139112269|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139112270|NCT01283100|Dolutegravir|dolutegravir|mesh-list
139112271|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139112272|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139112273|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112274|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112275|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139112276|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139112277|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
139112278|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139112279|NCT01269996|Metformin|metformin|mesh-list
139112280|NCT01269996|Gliclazide|gliclazide|mesh-list
139112281|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139112282|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112283|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139112284|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139112285|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112286|NCT01281150|Paclitaxel|paclitaxel|mesh-list
139112287|NCT01281150|Carboplatin|carboplatin|mesh-list
139112288|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139112289|NCT01281150|Veliparib|veliparib|mesh-list
139112290|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139112291|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112292|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
139112293|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
139112294|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
139112295|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112296|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139112297|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112298|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
139112299|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139112300|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
139112301|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112302|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
139112303|NCT03871218|Protective Agents|protective agents|mesh-ancestor
139112304|NCT01281228|Exenatide|exenatide|mesh-list
139112305|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139112306|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112307|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139112308|NCT01281228|Incretins|incretins|mesh-ancestor
139112309|NCT01281228|Hormones|hormones|mesh-ancestor
139112310|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112311|NCT01283256|Zonisamide|zonisamide|mesh-list
139112312|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
139112313|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139112314|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139112315|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112316|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139112317|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112319|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139112320|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139112321|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139112322|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
139112323|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
139112325|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139112326|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
139112327|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112328|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139112329|NCT01281540|Cisapride|cisapride|mesh-list
139112330|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139112331|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139112332|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139112333|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
139112334|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139112335|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112336|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112337|NCT03874026|Cetuximab|cetuximab|mesh-list
139112338|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112339|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112340|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
139112341|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139112342|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139112343|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112344|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139112345|NCT01283412|Analgesics|analgesics|mesh-ancestor
139112346|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
139112347|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112348|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139112349|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139112350|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139112351|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
139112352|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139112353|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112354|NCT01271478|Telmisartan|telmisartan|mesh-list
139112355|NCT01271478|Captopril|captopril|mesh-list
139112356|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139112357|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139112358|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139112359|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112360|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139112361|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
139112362|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112363|NCT03871062|Anesthetics|anesthetics|mesh-list
139112364|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139112365|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112366|NCT01281696|Bevacizumab|bevacizumab|mesh-list
139112367|NCT01281696|Methotrexate|methotrexate|mesh-list
139112368|NCT01281696|Etoposide|etoposide|mesh-list
139112369|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112370|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112371|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139112372|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139112373|NCT01281696|Growth Substances|growth substances|mesh-ancestor
139112374|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112375|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
139112376|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139112377|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
139112378|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139112379|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139112380|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
139112381|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112382|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
139112383|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112384|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139112385|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139112386|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
139112387|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139112388|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139112389|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139112390|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139112391|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139112392|NCT05835713|Propofol|propofol|mesh-list
139112393|NCT05835713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139112394|NCT05835713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139112395|NCT05835713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112396|NCT05835713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139112397|NCT05835713|Anesthetics, General|anesthetics, general|mesh-ancestor
139112398|NCT05835713|Anesthetics|anesthetics|mesh-ancestor
139112399|NCT05835479|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139112400|NCT05835479|Rezafungin|rezafungin|mesh-list
139112401|NCT05835479|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139112402|NCT05835479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139112403|NCT05835479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139112404|NCT05835479|Antimalarials|antimalarials|mesh-ancestor
139112405|NCT05835479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139112406|NCT05835479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139112407|NCT05835479|Antifungal Agents|antifungal agents|mesh-ancestor
139112408|NCT05835089|Estradiol|estradiol|mesh-list
139112409|NCT05835089|Testosterone|testosterone|mesh-list
139112410|NCT05835089|Estrogens|estrogens|mesh-ancestor
139112411|NCT05835089|Hormones|hormones|mesh-ancestor
139112412|NCT05835089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112413|NCT05835089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112414|NCT05835089|Androgens|androgens|mesh-ancestor
139112415|NCT05834868|Insulin Lispro|insulin lispro|mesh-list
139112416|NCT05834868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139112417|NCT05834868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112418|NCT05834855|Rituximab|rituximab|mesh-list
139112419|NCT05834855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112420|NCT05834855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112421|NCT05834855|Immunologic Factors|immunologic factors|mesh-ancestor
139112422|NCT05834855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112423|NCT05834855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139112424|NCT05834764|Maleic acid|maleic acid|mesh-list
139112425|NCT05834764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112426|NCT05834764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112427|NCT05834647|Lidocaine|lidocaine|mesh-list
139112428|NCT05834647|Prilocaine|prilocaine|mesh-list
139112429|NCT05834647|Anesthetics, Local|anesthetics, local|mesh-ancestor
139112430|NCT05834647|Anesthetics|anesthetics|mesh-ancestor
139112431|NCT05834647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139112432|NCT05834647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112433|NCT05834647|Sensory System Agents|sensory system agents|mesh-ancestor
139112434|NCT05834647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112435|NCT05834647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139112436|NCT05834647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139112437|NCT05834647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139112438|NCT05834647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139112439|NCT05834647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112440|NCT05834582|Paclitaxel|paclitaxel|mesh-list
139112441|NCT05834582|Cyclophosphamide|cyclophosphamide|mesh-list
139112442|NCT05834582|Epirubicin|epirubicin|mesh-list
139112443|NCT05834582|Fluzoparib|fluzoparib|mesh-list
139112444|NCT05834582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139112445|NCT05834582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112446|NCT05834582|Tubulin Modulators|tubulin modulators|mesh-ancestor
139112447|NCT05834582|Antimitotic Agents|antimitotic agents|mesh-ancestor
139112448|NCT05834582|Mitosis Modulators|mitosis modulators|mesh-ancestor
139112449|NCT05834582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112450|NCT05834582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139112451|NCT05834582|Immunologic Factors|immunologic factors|mesh-ancestor
139112452|NCT05834582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112453|NCT05834582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139112454|NCT05834582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139112455|NCT05834582|Alkylating Agents|alkylating agents|mesh-ancestor
139112456|NCT05834582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139112457|NCT05834582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139112458|NCT05834582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139112459|NCT05834582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139112460|NCT05834582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112461|NCT05834582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139112462|NCT05834543|Paclitaxel|paclitaxel|mesh-list
139112463|NCT05834543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139112464|NCT05834543|Cisplatin|cisplatin|mesh-list
139112465|NCT05834543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139112466|NCT05834543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112467|NCT05834543|Tubulin Modulators|tubulin modulators|mesh-ancestor
139112468|NCT05834543|Antimitotic Agents|antimitotic agents|mesh-ancestor
139112469|NCT05834543|Mitosis Modulators|mitosis modulators|mesh-ancestor
139112470|NCT05834543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112471|NCT05834517|Hyaluronic Acid|hyaluronic acid|mesh-list
139112472|NCT05834517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139112473|NCT05834517|Immunologic Factors|immunologic factors|mesh-ancestor
139112474|NCT05834517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112475|NCT05834517|Viscosupplements|viscosupplements|mesh-ancestor
139112476|NCT05834517|Protective Agents|protective agents|mesh-ancestor
139112477|NCT05834361|Carboprost|carboprost|mesh-list
139112478|NCT05834361|Carboprost tromethamine|carboprost tromethamine|mesh-list
139112479|NCT05834361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139112480|NCT05834361|Abortifacient Agents|abortifacient agents|mesh-ancestor
139112481|NCT05834361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139112482|NCT05834361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112483|NCT05834361|Oxytocics|oxytocics|mesh-ancestor
139112484|NCT05834270|Tamsulosin|tamsulosin|mesh-list
139112485|NCT05834270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139112486|NCT05834270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139112487|NCT05834270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139038841|NCT00257920|Vitamins|vitamins|mesh-ancestor
139112488|NCT05834270|Adrenergic Agents|adrenergic agents|mesh-ancestor
139112489|NCT05834270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139112490|NCT05834270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112491|NCT05834270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112492|NCT05834270|Urological Agents|urological agents|mesh-ancestor
139112494|NCT05834231|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139112495|NCT05834231|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139112496|NCT05834231|Dopamine Agents|dopamine agents|mesh-ancestor
139112497|NCT05834231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139112498|NCT05834231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112499|NCT05834231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112500|NCT05834231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139112501|NCT05834231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139112502|NCT05830162|Amoxicillin|amoxicillin|mesh-list
139112503|NCT05830162|Clavulanic Acids|clavulanic acids|mesh-list
139112504|NCT05830162|Clavulanic Acid|clavulanic acid|mesh-list
139112505|NCT05830162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139112506|NCT05830162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139112507|NCT05830162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112508|NCT05830162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112509|NCT05830162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139112510|NCT05829707|Diclofenac|diclofenac|mesh-list
139112511|NCT05829707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139112512|NCT05829707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139112513|NCT05829707|Anesthetics|anesthetics|mesh-list
139112514|NCT05829707|Levobupivacaine|levobupivacaine|mesh-list
139112515|NCT05829707|Anesthetics, Local|anesthetics, local|mesh-list
139112516|NCT05829707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139112517|NCT05829707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112518|NCT05829707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139112519|NCT05829707|Analgesics|analgesics|mesh-ancestor
139112520|NCT05829707|Sensory System Agents|sensory system agents|mesh-ancestor
139112521|NCT05829707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112522|NCT05829707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139112523|NCT05829707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139112524|NCT05829707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112525|NCT05829707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112526|NCT05819918|Calcifediol|calcifediol|mesh-list
139112527|NCT05819918|Vitamins|vitamins|mesh-ancestor
139112528|NCT05819918|Micronutrients|micronutrients|mesh-ancestor
139112529|NCT05819918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112530|NCT05819918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139112531|NCT05810883|Insulin|insulin|mesh-list
139112532|NCT05810883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138631711|NCT04561687|Azelastine|azelastine|mesh-list
139112533|NCT05810883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112534|NCT05807074|Tranexamic Acid|tranexamic acid|mesh-list
139112535|NCT05807074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139112536|NCT05807074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139038846|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
139112537|NCT05807074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112538|NCT05807074|Hemostatics|hemostatics|mesh-ancestor
139112539|NCT05807074|Coagulants|coagulants|mesh-ancestor
139112540|NCT05772273|Azacitidine|azacitidine|mesh-list
138863163|NCT00649311|Diuretics|diuretics|mesh-ancestor
139112541|NCT05772273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139112542|NCT05772273|Antimetabolites|antimetabolites|mesh-ancestor
139112543|NCT05772273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112544|NCT05772273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112545|NCT05772273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112546|NCT05753098|Sildenafil Citrate|sildenafil citrate|mesh-list
139112547|NCT05753098|Clomiphene|clomiphene|mesh-list
139112548|NCT05753098|Enclomiphene|enclomiphene|mesh-list
139112549|NCT05753098|Zuclomiphene|zuclomiphene|mesh-list
139112550|NCT05753098|Estrogens|estrogens|mesh-list
139112551|NCT05753098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112552|NCT05753098|Vasodilator Agents|vasodilator agents|mesh-ancestor
139112553|NCT05753098|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139112554|NCT05753098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139112555|NCT05753098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112556|NCT05753098|Urological Agents|urological agents|mesh-ancestor
139112557|NCT05753098|Hormones|hormones|mesh-ancestor
139112558|NCT05753098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112559|NCT05753098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112560|NCT05753098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139112561|NCT05753098|Hormone Antagonists|hormone antagonists|mesh-ancestor
139112562|NCT05753098|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139112563|NCT05753098|Fertility Agents|fertility agents|mesh-ancestor
139112564|NCT05753098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139112565|NCT05753098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139112566|NCT05753098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139112567|NCT05726292|Androgens|androgens|mesh-list
139112568|NCT05726292|Hormones|hormones|mesh-ancestor
139112569|NCT05726292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112570|NCT05726292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112571|NCT05699811|Paclitaxel|paclitaxel|mesh-list
139112572|NCT05699811|Cyclophosphamide|cyclophosphamide|mesh-list
139112573|NCT05699811|Tislelizumab|tislelizumab|mesh-list
139112574|NCT05699811|Antibodies|antibodies|mesh-list
139112575|NCT05699811|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139112576|NCT05699811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139112577|NCT05699811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112578|NCT05699811|Tubulin Modulators|tubulin modulators|mesh-ancestor
139112579|NCT05699811|Antimitotic Agents|antimitotic agents|mesh-ancestor
139112580|NCT05699811|Mitosis Modulators|mitosis modulators|mesh-ancestor
139112581|NCT05699811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112582|NCT05699811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139112583|NCT05699811|Immunologic Factors|immunologic factors|mesh-ancestor
139112584|NCT05699811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112585|NCT05699811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139112586|NCT05699811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139112587|NCT05699811|Alkylating Agents|alkylating agents|mesh-ancestor
139112589|NCT05699811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138955026|NCT00329797|Vitamin D|vitamin d|mesh-list
139112590|NCT05692908|Immunoconjugates|immunoconjugates|mesh-list
139112591|NCT05692908|Immunologic Factors|immunologic factors|mesh-ancestor
139112592|NCT05692908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112593|NCT05692843|Cyclosporine|cyclosporine|mesh-list
139112594|NCT05692843|Cyclosporins|cyclosporins|mesh-list
139112595|NCT05692843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112596|NCT05692843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112597|NCT05692843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139112598|NCT05692843|Immunologic Factors|immunologic factors|mesh-ancestor
139112599|NCT05692843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112600|NCT05692843|Antifungal Agents|antifungal agents|mesh-ancestor
139112601|NCT05692843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139112602|NCT05692843|Dermatologic Agents|dermatologic agents|mesh-ancestor
139112603|NCT05692843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139112604|NCT05692843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139112605|NCT05660616|Gemcitabine|gemcitabine|mesh-list
139112606|NCT05660616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139112607|NCT05660616|Antimetabolites|antimetabolites|mesh-ancestor
139112608|NCT05660616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112609|NCT05660616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112610|NCT05659810|Gabapentin|gabapentin|mesh-list
139112611|NCT05659810|Analgesics|analgesics|mesh-ancestor
139112612|NCT05659810|Sensory System Agents|sensory system agents|mesh-ancestor
139112613|NCT05659810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112614|NCT05659810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112615|NCT05659810|Anticonvulsants|anticonvulsants|mesh-ancestor
139112616|NCT05659810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139112617|NCT05659810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139112618|NCT05659810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139112619|NCT05659810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139112620|NCT05659810|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139112621|NCT05659810|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139112622|NCT05659810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139112623|NCT05659810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112624|NCT05659810|Antimanic Agents|antimanic agents|mesh-ancestor
139112625|NCT05658497|Interferons|interferons|mesh-list
139112626|NCT05658497|Interferon-beta|interferon-beta|mesh-list
139112627|NCT05658497|Interferon beta-1a|interferon beta-1a|mesh-list
139112628|NCT05658497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139112629|NCT05658497|Natalizumab|natalizumab|mesh-list
139112630|NCT05658497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112631|NCT05658497|Antiviral Agents|antiviral agents|mesh-ancestor
139112632|NCT05658497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139112633|NCT05658497|Immunologic Factors|immunologic factors|mesh-ancestor
139112634|NCT05658497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112635|NCT05658497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139112636|NCT05658497|Dermatologic Agents|dermatologic agents|mesh-ancestor
139112637|NCT05658497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139112639|NCT05625347|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139112640|NCT05625347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139112641|NCT05625347|Analgesics|analgesics|mesh-ancestor
139112643|NCT05625347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112644|NCT05625347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112645|NCT05625347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138955040|NCT00541450|Hormones|hormones|mesh-ancestor
139112646|NCT05625347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139112647|NCT05625347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139112648|NCT05625347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139112649|NCT05625347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112650|NCT05625347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139112651|NCT05625347|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139112652|NCT05625347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112653|NCT05625347|Antipyretics|antipyretics|mesh-ancestor
139112654|NCT05594680|Methotrexate|methotrexate|mesh-list
139112655|NCT05594680|Cilostazol|cilostazol|mesh-list
139112656|NCT05594680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139112657|NCT05594680|Abortifacient Agents|abortifacient agents|mesh-ancestor
139112658|NCT05594680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139112659|NCT05594680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112660|NCT05594680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139112661|NCT05594680|Antimetabolites|antimetabolites|mesh-ancestor
139112662|NCT05594680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112663|NCT05594680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112664|NCT05594680|Dermatologic Agents|dermatologic agents|mesh-ancestor
139112665|NCT05594680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112666|NCT05594680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139112667|NCT05594680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139112668|NCT05594680|Immunologic Factors|immunologic factors|mesh-ancestor
139112669|NCT05594680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139112670|NCT05594680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139112671|NCT05594680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139112672|NCT05594680|Autonomic Agents|autonomic agents|mesh-ancestor
139112673|NCT05594680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112674|NCT05594680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139112675|NCT05594680|Respiratory System Agents|respiratory system agents|mesh-ancestor
139112676|NCT05594680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139112677|NCT05594680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139112678|NCT05594680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139112679|NCT05594680|Vasodilator Agents|vasodilator agents|mesh-ancestor
139112680|NCT05594680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139112681|NCT05594680|Protective Agents|protective agents|mesh-ancestor
139112683|NCT05594680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139112684|NCT05567029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139112685|NCT05567029|Immunologic Factors|immunologic factors|mesh-ancestor
139112686|NCT05567029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112687|NCT05557643|Psilocybin|psilocybin|mesh-list
139112688|NCT05557643|Hallucinogens|hallucinogens|mesh-ancestor
139112689|NCT05557643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112690|NCT05557643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139112691|NCT05526443|Antineoplastic Agents|antineoplastic agents|mesh-list
139112693|NCT05325593|Dexamethasone acetate|dexamethasone acetate|mesh-list
139112694|NCT05325593|BB 1101|bb 1101|mesh-list
139112695|NCT05325593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139112696|NCT05325593|Antiemetics|antiemetics|mesh-ancestor
139112697|NCT05325593|Autonomic Agents|autonomic agents|mesh-ancestor
139112698|NCT05325593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112699|NCT05325593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112700|NCT05325593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139112701|NCT05325593|Glucocorticoids|glucocorticoids|mesh-ancestor
139112702|NCT05325593|Hormones|hormones|mesh-ancestor
139112703|NCT05325593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112704|NCT05325593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139112705|NCT05325593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112706|NCT05325593|Protease Inhibitors|protease inhibitors|mesh-ancestor
139112707|NCT05325593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112708|NCT05325593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112709|NCT05322967|Antihypertensive Agents|antihypertensive agents|mesh-list
139112710|NCT05321121|Dexmedetomidine|dexmedetomidine|mesh-list
139112711|NCT05321121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139112712|NCT05321121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139112713|NCT05321121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112714|NCT05321121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139112715|NCT05321121|Analgesics|analgesics|mesh-ancestor
139112716|NCT05321121|Sensory System Agents|sensory system agents|mesh-ancestor
139112717|NCT05321121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112718|NCT05321121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139112719|NCT05321121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139112720|NCT05321121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139112721|NCT05321121|Adrenergic Agents|adrenergic agents|mesh-ancestor
139112722|NCT05321121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139112723|NCT05321121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112724|NCT05281614|Etanercept|etanercept|mesh-list
139112725|NCT05281614|Vedolizumab|vedolizumab|mesh-list
139112726|NCT05281614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139112727|NCT05281614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139112728|NCT05281614|Analgesics|analgesics|mesh-ancestor
139112729|NCT05281614|Sensory System Agents|sensory system agents|mesh-ancestor
139112730|NCT05281614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112731|NCT05281614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112732|NCT05281614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139112733|NCT05281614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139112734|NCT05281614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139112735|NCT05281614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139112736|NCT05281614|Immunologic Factors|immunologic factors|mesh-ancestor
139112737|NCT05228288|Pyrithione zinc|pyrithione zinc|mesh-list
139112738|NCT05228288|Keratolytic Agents|keratolytic agents|mesh-ancestor
139112739|NCT05228288|Dermatologic Agents|dermatologic agents|mesh-ancestor
139112740|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
139112741|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112742|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112743|NCT05215574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139112744|NCT05215574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112745|NCT04955938|Ivosidenib|ivosidenib|mesh-list
139112746|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112747|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112748|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112749|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
139112750|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112751|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139112752|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112753|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112754|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
138631933|NCT00268359|Irinotecan|irinotecan|mesh-list
139112755|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112756|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112757|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139112759|NCT04872608|Palbociclib|palbociclib|mesh-list
139112760|NCT04872608|Onapristone|onapristone|mesh-list
139112761|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112762|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139112763|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139112764|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112765|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112767|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
139112768|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112769|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112770|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139112771|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139112772|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
139112773|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139112774|NCT04869501|Atezolizumab|atezolizumab|mesh-list
139112775|NCT04869501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139112776|NCT04869501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112777|NCT04869501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112778|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112779|NCT04831398|Melatonin|melatonin|mesh-list
139112780|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
139112781|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112782|NCT04831398|Protective Agents|protective agents|mesh-ancestor
139112783|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112784|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139112785|NCT04801849|Vitamin E|vitamin e|mesh-list
139112786|NCT04801849|Tocopherols|tocopherols|mesh-list
139112787|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
139112788|NCT04801849|Vitamins|vitamins|mesh-ancestor
139112789|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
139112790|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112791|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
139112792|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112793|NCT04801849|Protective Agents|protective agents|mesh-ancestor
139112794|NCT04635839|Heparin|heparin|mesh-list
139112795|NCT04635839|Calcium heparin|calcium heparin|mesh-list
139112796|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
139112797|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139112798|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139112799|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112800|NCT04591275|Denosumab|denosumab|mesh-list
139112801|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139112802|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112803|NCT04560179|Tobramycin|tobramycin|mesh-list
139112804|NCT04560179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139112805|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139112806|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139112807|NCT04536337|Entecavir|entecavir|mesh-list
139112808|NCT04536337|Antiviral Agents|antiviral agents|mesh-ancestor
139112809|NCT04536337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139112810|NCT04515836|Olaparib|olaparib|mesh-list
139112811|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139112812|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112813|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112814|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112815|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
139112816|NCT04441034|Convulsants|convulsants|mesh-list
139112817|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
139112818|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139112819|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139112820|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112821|NCT04348006|Dexamethasone|dexamethasone|mesh-list
139112822|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
139112823|NCT04348006|Lenalidomide|lenalidomide|mesh-list
139112824|NCT04348006|Bortezomib|bortezomib|mesh-list
139112825|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139112826|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
139112827|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112828|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139112829|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139112830|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
139112831|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112832|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112833|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139112834|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139112835|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
139112836|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
139112837|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138863464|NCT02702778|Prednisone|prednisone|mesh-list
139112838|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139112839|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
139112840|NCT04348006|Hormones|hormones|mesh-ancestor
139112841|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112842|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139112844|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139112845|NCT04348006|Growth Substances|growth substances|mesh-ancestor
139112846|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
139112847|NCT04313972|Naltrexone|naltrexone|mesh-list
139112848|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139112849|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139112850|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112851|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
139112852|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112853|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
139112854|NCT04295863|Nivolumab|nivolumab|mesh-list
139112855|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112856|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112857|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139112858|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112859|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
139112860|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112861|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112862|NCT04231526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139112863|NCT04231526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112864|NCT04201873|Poly I-C|poly i-c|mesh-list
139112865|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
139112866|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139112867|NCT04201873|Vaccines|vaccines|mesh-list
139112868|NCT04201873|Poly ICLC|poly iclc|mesh-list
139112869|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
139112870|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112871|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112872|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112873|NCT04201873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139112874|NCT04201873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112876|NCT04201873|Laxatives|laxatives|mesh-ancestor
139112877|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139112878|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
139112879|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139112880|NCT03785678|Tenecteplase|tenecteplase|mesh-list
139112881|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139112882|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139112883|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112884|NCT03729804|Dexamethasone|dexamethasone|mesh-list
139112885|NCT03729804|Lenalidomide|lenalidomide|mesh-list
139112886|NCT03729804|Bortezomib|bortezomib|mesh-list
139112887|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139112888|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
139112889|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
139112890|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112891|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112892|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139112893|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
139112894|NCT03729804|Hormones|hormones|mesh-ancestor
139112895|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112896|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139112897|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112898|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
139112899|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139112900|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139112901|NCT03729804|Growth Substances|growth substances|mesh-ancestor
139112902|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
139112903|NCT03697564|Gemcitabine|gemcitabine|mesh-list
139112904|NCT03697564|Nivolumab|nivolumab|mesh-list
139112905|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139112906|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
139112931|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112932|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112933|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139112934|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112935|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
139112936|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112937|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112938|NCT03500445|Dexamethasone|dexamethasone|mesh-list
139112939|NCT03500445|Lenalidomide|lenalidomide|mesh-list
139112940|NCT03500445|Daratumumab|daratumumab|mesh-list
139112941|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139112942|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
139112943|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
139112944|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139112945|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112946|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139112947|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
139112948|NCT03500445|Hormones|hormones|mesh-ancestor
139112949|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139112950|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139112951|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112952|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
139112953|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139112954|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139112955|NCT03500445|Growth Substances|growth substances|mesh-ancestor
139112956|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
139112957|NCT03494530|Edoxaban|edoxaban|mesh-list
139112958|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139112959|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
139112960|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139112961|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
139112962|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139112963|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112964|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
139112965|NCT03466736|Flutemetamol|flutemetamol|mesh-list
139112966|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139112967|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887590|NCT02711267|Acyclovir|acyclovir|mesh-list
139112983|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
139112984|NCT03225547|Mifepristone|mifepristone|mesh-list
139112985|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139112986|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139112987|NCT03225547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139112988|NCT03225547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139112989|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139112990|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
139112991|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139112992|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139112993|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139112994|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139112995|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139112996|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
139112997|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139112998|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139112999|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
139113000|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113001|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
139113002|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139113003|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139113004|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
139113005|NCT02990533|Testosterone|testosterone|mesh-list
139113006|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
139113007|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
139113008|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139113009|NCT02990533|Androgens|androgens|mesh-ancestor
139113010|NCT02990533|Hormones|hormones|mesh-ancestor
139113011|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113012|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113013|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139113014|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113015|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
139113017|NCT02969837|Lenalidomide|lenalidomide|mesh-list
139113018|NCT02969837|Elotuzumab|elotuzumab|mesh-list
139113019|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139113020|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
139113021|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
139113022|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113023|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113024|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139113025|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
139113026|NCT02969837|Hormones|hormones|mesh-ancestor
139113027|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113028|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139113029|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113030|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
139113031|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139113032|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139113033|NCT02969837|Growth Substances|growth substances|mesh-ancestor
139113034|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
139113035|NCT02776917|Paclitaxel|paclitaxel|mesh-list
139113036|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139113037|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113038|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
139113039|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
139113040|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
139113041|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113042|NCT02751255|Tretinoin|tretinoin|mesh-list
139113043|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113044|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
139113045|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
139113046|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
139113047|NCT02707666|Pemetrexed|pemetrexed|mesh-list
139113048|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113049|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139113050|NCT02707666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139113051|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113052|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113053|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138955134|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
139113054|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139113056|NCT02659293|Lenalidomide|lenalidomide|mesh-list
139113057|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139113058|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
139113059|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
139113060|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113061|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113062|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139113063|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
139113064|NCT02659293|Hormones|hormones|mesh-ancestor
139113065|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113066|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139113067|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113068|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
139113069|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139113070|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139113071|NCT02659293|Growth Substances|growth substances|mesh-ancestor
139113072|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
139113074|NCT02656511|Emtricitabine|emtricitabine|mesh-list
139113075|NCT02656511|Dolutegravir|dolutegravir|mesh-list
139113076|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
139113077|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139113078|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139113079|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139113080|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113081|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113082|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139113083|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139113084|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139113085|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139113086|NCT02613169|Isoniazid|isoniazid|mesh-list
139113087|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
139113088|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139113089|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139113090|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139113091|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139113092|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
139113093|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113094|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139113095|NCT02572323|Tesamorelin|tesamorelin|mesh-list
139113096|NCT02572323|Growth Substances|growth substances|mesh-ancestor
139113097|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113098|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
139113099|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139113100|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
139113101|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113102|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139113103|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139113104|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
139113105|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113106|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113107|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139113108|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
139113109|NCT02431988|Fludarabine|fludarabine|mesh-list
139113110|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139113111|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
139113112|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113113|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139113114|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139113115|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
139113116|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955146|NCT01563718|Naltrexone|naltrexone|mesh-list
139113117|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113118|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139113119|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
139113120|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139113121|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113122|NCT02399371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139039054|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139113123|NCT02399371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113124|NCT02389517|Dexamethasone|dexamethasone|mesh-list
139113125|NCT02389517|Lenalidomide|lenalidomide|mesh-list
139113126|NCT02389517|Ixazomib|ixazomib|mesh-list
139113127|NCT02389517|Glycine|glycine|mesh-list
139113128|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
139113129|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139113130|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
139113131|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
139113132|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113133|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113134|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139113135|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
139113136|NCT02389517|Hormones|hormones|mesh-ancestor
139113137|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113138|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139113139|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113140|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
139113141|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139113142|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139113143|NCT02389517|Growth Substances|growth substances|mesh-ancestor
139113144|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
139113145|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113146|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
139113147|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113148|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
139113149|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113150|NCT02366819|Leucovorin|leucovorin|mesh-list
139113151|NCT02366819|Fluorouracil|fluorouracil|mesh-list
139113152|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
139113153|NCT02366819|Irinotecan|irinotecan|mesh-list
139113154|NCT02366819|Calcium|calcium|mesh-list
139113155|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
139113156|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139113157|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113158|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
139113159|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113160|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139113161|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113162|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139113163|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
139113164|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139113165|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139113166|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113167|NCT02366819|Antidotes|antidotes|mesh-ancestor
139113168|NCT02366819|Protective Agents|protective agents|mesh-ancestor
139113169|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
139113170|NCT02366819|Vitamins|vitamins|mesh-ancestor
139113171|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
139113194|NCT02281838|Enalapril|enalapril|mesh-list
139113195|NCT02281838|Labetalol|labetalol|mesh-list
139113196|NCT02281838|Hydralazine|hydralazine|mesh-list
139113197|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139113198|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
139113199|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113200|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113201|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139113202|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139113203|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139113204|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
139113226|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139113227|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
139113228|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113229|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113230|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139113231|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139113232|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139113233|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139113234|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139113235|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113236|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139113237|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
139113238|NCT02213913|Hormones|hormones|mesh-ancestor
139113239|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113240|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139113241|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139113242|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
139113243|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
139113244|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
139113245|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139113246|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139113247|NCT02213913|Growth Substances|growth substances|mesh-ancestor
139113248|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
139113268|NCT01665794|Dexamethasone|dexamethasone|mesh-list
139113269|NCT01665794|Daratumumab|daratumumab|mesh-list
139113270|NCT01665794|Pomalidomide|pomalidomide|mesh-list
139113271|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139113272|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
139113273|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
139113274|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113275|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113276|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139113277|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
139113278|NCT01665794|Hormones|hormones|mesh-ancestor
139113279|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113280|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139113281|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113282|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
139113283|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139113284|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139113285|NCT01665794|Growth Substances|growth substances|mesh-ancestor
139113286|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
138863904|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
139113302|NCT01369212|Tenofovir|tenofovir|mesh-list
139113303|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139113304|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
139113305|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139113306|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139113307|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139113308|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113309|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113310|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139113311|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139113312|NCT00800215|Lacosamide|lacosamide|mesh-list
139113313|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
139113314|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139113315|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139113316|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139113317|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113318|NCT00337649|Trastuzumab|trastuzumab|mesh-list
139113319|NCT00337649|Epothilones|epothilones|mesh-list
139113320|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
139113321|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139113322|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113323|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
139113324|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
139113325|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
139113326|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113327|NCT00071084|Zanolimumab|zanolimumab|mesh-list
139113328|NCT00071084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139113329|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139113330|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113331|NCT00071084|Immunologic Factors|immunologic factors|mesh-ancestor
139113332|NCT00071084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113333|NCT00042406|Zanolimumab|zanolimumab|mesh-list
139113334|NCT00042406|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139113335|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139113336|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113337|NCT00042406|Immunologic Factors|immunologic factors|mesh-ancestor
139113338|NCT00042406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113339|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
139113340|NCT01170078|Hematinics|hematinics|mesh-ancestor
139113341|NCT01283646|Vitamins|vitamins|mesh-list
139113342|NCT01283646|Folic Acid|folic acid|mesh-list
139113343|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
139113344|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
139113345|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113346|NCT01283646|Hematinics|hematinics|mesh-ancestor
139113347|NCT01283724|Dienogest|dienogest|mesh-list
139113348|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139113349|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
139113350|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139113351|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113352|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139113353|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139113354|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139113355|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139113356|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
139113357|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113358|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139113359|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113360|NCT01586442|Eplerenone|eplerenone|mesh-list
139113361|NCT01586442|Spironolactone|spironolactone|mesh-list
139113362|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139113363|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
139113364|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113365|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113366|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139113367|NCT01586442|Diuretics|diuretics|mesh-ancestor
139113368|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
139113369|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139113370|NCT01587066|Valproic Acid|valproic acid|mesh-list
139113371|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139113372|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
139113373|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139113374|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139113375|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139113376|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139113377|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039113|NCT00411788|Sirolimus|sirolimus|mesh-list
139113378|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
139113379|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113380|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113381|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
139113382|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113383|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
139113384|NCT01587144|Lucanthone|lucanthone|mesh-list
139113385|NCT01587144|Temozolomide|temozolomide|mesh-list
139113386|NCT01587144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139113387|NCT01587144|Alkylating Agents|alkylating agents|mesh-ancestor
139113388|NCT01587144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113389|NCT01587144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113390|NCT01587144|Schistosomicides|schistosomicides|mesh-ancestor
139113391|NCT01587144|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139113392|NCT01587144|Anthelmintics|anthelmintics|mesh-ancestor
139113393|NCT01587144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139113394|NCT01587144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139113395|NCT01587222|Octreotide|octreotide|mesh-list
139113396|NCT01587222|Midodrine|midodrine|mesh-list
139113397|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139113398|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139113399|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113400|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
139113401|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
139113402|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113403|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113404|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139113405|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139113406|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139113407|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139113408|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
139113409|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113410|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113411|NCT01167738|Metformin|metformin|mesh-list
139113412|NCT01167738|Gemcitabine|gemcitabine|mesh-list
139113413|NCT01167738|Capecitabine|capecitabine|mesh-list
139113414|NCT01167738|Epirubicin|epirubicin|mesh-list
139113415|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113416|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139113417|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
139113418|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113419|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139113420|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113421|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139113422|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139113423|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139113424|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113425|NCT01167816|Azacitidine|azacitidine|mesh-list
139113426|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139113427|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
139113428|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113429|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113430|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113431|NCT01167894|Simvastatin|simvastatin|mesh-list
139113432|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139113433|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139113434|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
139113435|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113436|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139113437|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139113438|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113439|NCT03870828|Dimercaprol|dimercaprol|mesh-list
139113440|NCT03870828|Chelating Agents|chelating agents|mesh-ancestor
139113441|NCT03870828|Sequestering Agents|sequestering agents|mesh-ancestor
139113442|NCT03870828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113443|NCT03870594|Chrysarobin|chrysarobin|mesh-list
139113444|NCT03870594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139113445|NCT03870594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139113446|NCT03870594|Analgesics|analgesics|mesh-ancestor
139113447|NCT03870594|Sensory System Agents|sensory system agents|mesh-ancestor
139113448|NCT03870594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113449|NCT03870594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113450|NCT03870594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139113451|NCT03870594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139113452|NCT01165866|Ondansetron|ondansetron|mesh-list
139113453|NCT01165866|Metoclopramide|metoclopramide|mesh-list
139113454|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
139113455|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
139113456|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955258|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139113457|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113458|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139113459|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
139113460|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
139113461|NCT01165866|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139113462|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139113463|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
139113464|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113465|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113466|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139113467|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139113468|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
139113469|NCT01170468|Vitamin D|vitamin d|mesh-list
139113470|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
139113471|NCT01170468|Vitamins|vitamins|mesh-ancestor
139113472|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
139113473|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113474|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139113475|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139113476|NCT01273584|Metformin|metformin|mesh-list
139113477|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139113478|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113479|NCT01281852|Paclitaxel|paclitaxel|mesh-list
139113480|NCT01281852|Cisplatin|cisplatin|mesh-list
139113481|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139113482|NCT01281852|Veliparib|veliparib|mesh-list
139113483|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139113484|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113485|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
139113486|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
139113487|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
139113488|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113489|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139113490|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113491|NCT01168440|Sunitinib|sunitinib|mesh-list
139113492|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113493|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139113494|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139113495|NCT01168440|Growth Substances|growth substances|mesh-ancestor
139113496|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113497|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
139113498|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139113499|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113500|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113501|NCT01170780|Dexamethasone|dexamethasone|mesh-list
139113502|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139113503|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
139113504|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
139113505|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113506|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113507|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139113508|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
139113509|NCT01170780|Hormones|hormones|mesh-ancestor
139113510|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113511|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139113512|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113513|NCT01165944|Pramlintide|pramlintide|mesh-list
139113514|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139113515|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113516|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139113517|NCT01170858|Icodextrin|icodextrin|mesh-list
139113518|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
139113519|NCT01171092|Bortezomib|bortezomib|mesh-list
139113520|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113521|NCT01171170|Paclitaxel|paclitaxel|mesh-list
139113522|NCT01171170|Bevacizumab|bevacizumab|mesh-list
139113523|NCT01171170|Carboplatin|carboplatin|mesh-list
139113524|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139113525|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
139113526|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139113527|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113528|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
139113529|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
139113530|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
139113531|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113532|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139113533|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139113534|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139113535|NCT01171170|Growth Substances|growth substances|mesh-ancestor
139113536|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113537|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
139113538|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
139113539|NCT01166100|Fluoxetine|fluoxetine|mesh-list
139113540|NCT01166100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139113541|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139113542|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139113543|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113544|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113545|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
139113546|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113547|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139113548|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
139113549|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139113550|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139113551|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139113552|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113553|NCT01277016|Melphalan|melphalan|mesh-list
139113554|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139113555|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
139113556|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113557|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113558|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139113559|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139113560|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
139113561|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113562|NCT01171326|Minocycline|minocycline|mesh-list
139113563|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139113564|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139113565|NCT01171482|Fluorouracil|fluorouracil|mesh-list
139113566|NCT01171482|Sorafenib|sorafenib|mesh-list
139113567|NCT01171482|Mitomycins|mitomycins|mesh-list
139113568|NCT01171482|Mitomycin|mitomycin|mesh-list
139113569|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
138955294|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
139113570|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113571|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139113572|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113573|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139113574|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
139113575|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113576|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139113577|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113578|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139113579|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
139113580|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139113581|NCT01282398|Simvastatin|simvastatin|mesh-list
139113582|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139113583|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139113584|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
139113585|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113586|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139113587|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139113588|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113589|NCT01169142|Vitamin D|vitamin d|mesh-list
139113590|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
139113591|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
139113592|NCT01169142|Vitamins|vitamins|mesh-list
139113593|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
138864211|NCT02741960|Metformin|metformin|mesh-list
139113594|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113595|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139113596|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139113597|NCT01169298|Lenalidomide|lenalidomide|mesh-list
139113598|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
139113599|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113600|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139113601|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139113602|NCT01169298|Growth Substances|growth substances|mesh-ancestor
139113603|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
139113604|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113605|NCT01277484|Decitabine|decitabine|mesh-list
139113606|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139113607|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
139113608|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113609|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113610|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113611|NCT01282632|Olanzapine|olanzapine|mesh-list
139113612|NCT01282632|Risperidone|risperidone|mesh-list
139113613|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139113614|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
139113615|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113616|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113617|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113618|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139113619|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139113620|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139113621|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139113622|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139113623|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
139113624|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
139113625|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
139113626|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113627|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139113628|NCT01282632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139113629|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139113630|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139113631|NCT01172028|Docetaxel|docetaxel|mesh-list
139113632|NCT01172028|Pemetrexed|pemetrexed|mesh-list
139113633|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113634|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
139113635|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
138955310|NCT05325580|Anesthetics|anesthetics|mesh-ancestor
139113636|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
139113637|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113638|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113639|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139113640|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139113641|NCT01278186|Paclitaxel|paclitaxel|mesh-list
139113642|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139113643|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113644|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
139113645|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
139113646|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
139113647|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113648|NCT01169688|Phenylephrine|phenylephrine|mesh-list
139113649|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
139113650|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
139113651|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139113652|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
139113653|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
139113654|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113655|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113656|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
139113657|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139113658|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
139113659|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
139113660|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139113661|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139113662|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139113663|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
139113664|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113665|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113666|NCT01169688|Protective Agents|protective agents|mesh-ancestor
139113667|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
139113668|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139113669|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139113670|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
139113671|NCT01278264|Ropivacaine|ropivacaine|mesh-list
139113672|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
139113673|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
139113674|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139113675|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113676|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
139113677|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113678|NCT01172652|Ziprasidone|ziprasidone|mesh-list
139113679|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139113680|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
139113681|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113682|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113683|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113684|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139113685|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139113686|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139113687|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139113688|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139113689|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
139113690|NCT02526030|Aripiprazole|aripiprazole|mesh-list
139113691|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139113692|NCT02526030|Ziprasidone|ziprasidone|mesh-list
139113693|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
139113694|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139113695|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139113696|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139113697|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139113698|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113699|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
139113700|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
139113701|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113702|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113703|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139113704|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139113705|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
139113706|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139113707|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139113708|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139113709|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139113710|NCT03867240|Gabapentin|gabapentin|mesh-list
139113711|NCT03867240|Analgesics|analgesics|mesh-ancestor
139113712|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
139113713|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113714|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113715|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
139113716|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139113717|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139113718|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139113719|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139113720|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139113721|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139113722|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113723|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113724|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
139113725|NCT01172964|Flucytosine|flucytosine|mesh-list
139113726|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
139113727|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139113728|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
139113729|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113730|NCT03866928|Stiripentol|stiripentol|mesh-list
139113731|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
139113732|NCT01172496|Treprostinil|treprostinil|mesh-list
139113733|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139113734|NCT01178034|Warfarin|warfarin|mesh-list
139113735|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
139113736|NCT01288170|Tobramycin|tobramycin|mesh-list
139113737|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139113738|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139113739|NCT01178112|Carboplatin|carboplatin|mesh-list
139113740|NCT01178112|Trientine|trientine|mesh-list
139113741|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113742|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
139113743|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
139113744|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113745|NCT01175460|Nedaplatin|nedaplatin|mesh-list
139113746|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113747|NCT01175538|Lactulose|lactulose|mesh-list
139113748|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139113749|NCT01288326|Liraglutide|liraglutide|mesh-list
139113750|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139113751|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113752|NCT01288326|Incretins|incretins|mesh-ancestor
139113753|NCT01288326|Hormones|hormones|mesh-ancestor
139113754|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113755|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
139113756|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139113757|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139113758|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139113759|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139113760|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
139113761|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139113762|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139113763|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139113764|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113765|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955327|NCT04004572|Pegaspargase|pegaspargase|mesh-list
139113766|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139113767|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139113768|NCT03435640|Nivolumab|nivolumab|mesh-list
139113769|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139113770|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113771|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139113772|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113773|NCT01175772|Celecoxib|celecoxib|mesh-list
139113774|NCT01175772|Methotrexate|methotrexate|mesh-list
139113775|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
139113776|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138955337|NCT01093976|Analgesics|analgesics|mesh-ancestor
139113777|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
139113778|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139113779|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113780|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139113781|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
139113782|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113783|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113784|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
139113785|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113786|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139113787|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139113788|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
139113789|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139113790|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139113791|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139113792|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139113793|NCT01175772|Analgesics|analgesics|mesh-ancestor
139113794|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
139113795|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113796|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139113797|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139113798|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139113799|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139113800|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
139113801|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139113802|NCT01536964|Morphine|morphine|mesh-list
139113803|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139113804|NCT01536964|Narcotics|narcotics|mesh-ancestor
139113805|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139113806|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113807|NCT01536964|Analgesics|analgesics|mesh-ancestor
139113808|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
139113809|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113810|NCT01288404|Fluorometholone|fluorometholone|mesh-list
139113811|NCT01288404|Bevacizumab|bevacizumab|mesh-list
139113812|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139113813|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113814|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139113815|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139113816|NCT01288404|Growth Substances|growth substances|mesh-ancestor
139113817|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113818|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
139113819|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139113821|NCT01288404|Hormones|hormones|mesh-ancestor
139113822|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113823|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139113824|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
139113825|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139113826|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139113827|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
139113828|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113829|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139113830|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139113831|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139113832|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139113833|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139113834|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113835|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139113836|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113837|NCT01286688|Terbinafine|terbinafine|mesh-list
139113838|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
139113839|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139113840|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113841|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113842|NCT01286766|Cisplatin|cisplatin|mesh-list
139113843|NCT01286766|Docetaxel|docetaxel|mesh-list
139113844|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113845|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
139113846|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
139113847|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
139113848|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113849|NCT02525484|Pirfenidone|pirfenidone|mesh-list
139113850|NCT02525484|Analgesics|analgesics|mesh-ancestor
139113851|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
139113852|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113853|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113854|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139113855|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139113856|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139113857|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139113858|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113859|NCT01173978|Prednisolone|prednisolone|mesh-list
139113860|NCT01173978|Hormones|hormones|mesh-list
139113861|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113862|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113863|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139113864|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
139113865|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139113866|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113867|NCT01174056|Pioglitazone|pioglitazone|mesh-list
139113868|NCT01174056|Zileuton|zileuton|mesh-list
139113869|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
139113870|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139113871|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113872|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139113873|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139113874|NCT01174056|Analgesics|analgesics|mesh-ancestor
139113875|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
139113876|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113877|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139113878|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139113879|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139113880|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113881|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113882|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139113883|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
139113884|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139113885|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113886|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
139113887|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139113888|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139113889|NCT01174212|Vancomycin|vancomycin|mesh-list
139113890|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138864508|NCT05580029|Triamcinolone|triamcinolone|mesh-list
139113891|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139113892|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
139113893|NCT01174290|Haloperidol|haloperidol|mesh-list
139113894|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
139113895|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
139113896|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
139113897|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113898|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113899|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139113900|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139113901|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139113902|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139113903|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139113904|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139113905|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
139113906|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113907|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113908|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139113909|NCT03862404|Epinephrine|epinephrine|mesh-list
139113910|NCT03862404|Bupivacaine|bupivacaine|mesh-list
139113911|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
139113912|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
139113913|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139113914|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113915|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
139113916|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113917|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139113918|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139113919|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
139113920|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113921|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113922|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139113923|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139113924|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
139113925|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139113926|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
139113927|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
139113928|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
139113929|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139113930|NCT03865680|Fluorides|fluorides|mesh-list
139113931|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
139113932|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
139113933|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
139113934|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113935|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
139113936|NCT03865680|Protective Agents|protective agents|mesh-ancestor
139113937|NCT01288716|Baclofen|baclofen|mesh-list
139113938|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139113939|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113940|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139113941|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139113942|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139113943|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
139113944|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
139113945|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139113946|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113947|NCT01285596|Mirabegron|mirabegron|mesh-list
139113948|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139113949|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139113950|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139113951|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
139113952|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955421|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
139113953|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113954|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113955|NCT01285596|Urological Agents|urological agents|mesh-ancestor
139113956|NCT00655876|Paclitaxel|paclitaxel|mesh-list
139113957|NCT00655876|Cetuximab|cetuximab|mesh-list
139113958|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139113959|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113960|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
139113961|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
139113962|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
139113963|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138864578|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
139113964|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139113965|NCT01176318|Erdosteine|erdosteine|mesh-list
139113967|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
139113968|NCT01178658|Cytarabine|cytarabine|mesh-list
139113969|NCT01178658|Etoposide|etoposide|mesh-list
139113970|NCT01178658|Melphalan|melphalan|mesh-list
139113971|NCT01178658|Busulfan|busulfan|mesh-list
139113972|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139113973|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139113974|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139113975|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139113976|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139113977|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139113978|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139113979|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
139113980|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
139113981|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139113982|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139113983|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
139113984|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113985|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139113986|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
139113987|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139113988|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139113989|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139113990|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139113991|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139113992|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139113993|NCT01174524|Gestodene|gestodene|mesh-list
139113994|NCT01174524|Femovan|femovan|mesh-list
139113995|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
139113996|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
139113997|NCT01174524|Estradiol|estradiol|mesh-list
139113998|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139113999|NCT01174524|Estrogens|estrogens|mesh-ancestor
139114000|NCT01174524|Hormones|hormones|mesh-ancestor
139114001|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139114002|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114003|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139114004|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139114005|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139114006|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139114007|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139114008|NCT01174524|Progestins|progestins|mesh-ancestor
139114009|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139114010|NCT02525172|Rituximab|rituximab|mesh-list
139114011|NCT02525172|Methotrexate|methotrexate|mesh-list
139114012|NCT02525172|Bortezomib|bortezomib|mesh-list
139114013|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
139114014|NCT02525172|Antibodies|antibodies|mesh-list
139114015|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
139114016|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139114017|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139114018|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139114019|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114020|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
139114021|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114022|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139114023|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139114024|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
139114025|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139114026|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139114027|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
139114028|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114029|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
139114030|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114031|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139114032|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139114033|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139114034|NCT01285674|Cisplatin|cisplatin|mesh-list
139114035|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114036|NCT03859362|Ertapenem|ertapenem|mesh-list
139114037|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139114038|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114039|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139114040|NCT01287546|Trametinib|trametinib|mesh-list
139114041|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114042|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139114043|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114044|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114046|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139114047|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139114048|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139114049|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
139114050|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114051|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
139114053|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114054|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139114055|NCT03864978|Rifaximin|rifaximin|mesh-list
139114056|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139114057|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114058|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139114059|NCT01568788|Vaccines|vaccines|mesh-list
139114060|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
139114061|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114062|NCT01287624|Paclitaxel|paclitaxel|mesh-list
139114063|NCT01287624|Gemcitabine|gemcitabine|mesh-list
139114064|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139114065|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114066|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
139114067|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
139114068|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
139114069|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114070|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139114071|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
139114072|NCT05597800|Nivolumab|nivolumab|mesh-list
139114073|NCT05597800|Ipilimumab|ipilimumab|mesh-list
139114074|NCT05597800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139114075|NCT05597800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114076|NCT05597800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139114077|NCT05597800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114078|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
139114079|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
139114080|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139114081|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
139114082|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114083|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
139114084|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114085|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114086|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
139114087|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139114088|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139114089|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114090|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139114091|NCT01179438|Analgesics|analgesics|mesh-ancestor
139114092|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
139114093|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114094|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139114095|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139114096|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139114097|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
139114098|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114099|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114100|NCT03864666|Cilostazol|cilostazol|mesh-list
139114101|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139114102|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
139114103|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114104|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114105|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139114106|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
139114107|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139114108|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139114109|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114110|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139114111|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
139114112|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139114113|NCT03864666|Protective Agents|protective agents|mesh-ancestor
139114114|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139114115|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139114116|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114117|NCT03858972|Capecitabine|capecitabine|mesh-list
139114118|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139114119|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
139114120|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114121|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114122|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
139114123|NCT03091348|Testosterone|testosterone|mesh-list
139114124|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
139114125|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
139114126|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139114127|NCT03091348|Androgens|androgens|mesh-ancestor
139114128|NCT03091348|Hormones|hormones|mesh-ancestor
139114129|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139114130|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114131|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139114132|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114133|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
139114134|NCT02525016|Lidocaine|lidocaine|mesh-list
139114135|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
139114136|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
139114137|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138955529|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
139114138|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114139|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
139114140|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114141|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139114142|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139114143|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139114144|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139114145|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114147|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
139114148|NCT01179594|Entecavir|entecavir|mesh-list
139114149|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
139114150|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114151|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
139114152|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114153|NCT03751098|Phenylephrine|phenylephrine|mesh-list
139114154|NCT03751098|Oxymetazoline|oxymetazoline|mesh-list
139114155|NCT03751098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139114156|NCT03751098|Tropicamide|tropicamide|mesh-list
139114157|NCT03751098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139114158|NCT03751098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139114159|NCT03751098|Mydriatics|mydriatics|mesh-ancestor
139114160|NCT03751098|Autonomic Agents|autonomic agents|mesh-ancestor
139114161|NCT03751098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114162|NCT03751098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114163|NCT03751098|Sympathomimetics|sympathomimetics|mesh-ancestor
139114164|NCT03751098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139114165|NCT03751098|Nasal Decongestants|nasal decongestants|mesh-ancestor
139114166|NCT03751098|Respiratory System Agents|respiratory system agents|mesh-ancestor
139114167|NCT03751098|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139114168|NCT03751098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139114169|NCT03751098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139114170|NCT03751098|Adrenergic Agents|adrenergic agents|mesh-ancestor
139114171|NCT03751098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114172|NCT03751098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114174|NCT03751098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139114175|NCT03751098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139114176|NCT03751098|Cholinergic Agents|cholinergic agents|mesh-ancestor
139114177|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139114178|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
139114179|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114180|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114181|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139114182|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114183|NCT01288794|Furosemide|furosemide|mesh-list
139114184|NCT01288794|Diuretics|diuretics|mesh-list
139114185|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
139114186|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114187|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139114188|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139114189|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114190|NCT01288872|Praziquantel|praziquantel|mesh-list
139114191|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
139114192|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139114193|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114194|NCT03864588|Ropivacaine|ropivacaine|mesh-list
139114195|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
139114196|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
139114197|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139114198|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114199|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
139114200|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114201|NCT01288950|Vitamin D|vitamin d|mesh-list
139114202|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
139114203|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
139114204|NCT01288950|Vitamins|vitamins|mesh-list
139114205|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
139114206|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114207|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139114208|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139114209|NCT01174914|Tenofovir|tenofovir|mesh-list
139114210|NCT01174914|Lamivudine|lamivudine|mesh-list
139114211|NCT01174914|Emtricitabine|emtricitabine|mesh-list
139114212|NCT01174914|Efavirenz|efavirenz|mesh-list
139114213|NCT01174914|Lopinavir|lopinavir|mesh-list
139114214|NCT01174914|Nevirapine|nevirapine|mesh-list
139114215|NCT01174914|Stavudine|stavudine|mesh-list
139114216|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
139114217|NCT01174914|Naltrexone|naltrexone|mesh-list
139114218|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
139114219|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114220|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139114221|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139114222|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114223|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114224|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139114225|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139114226|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139114227|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139114228|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114229|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
139114230|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114231|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139114232|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139114233|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139114234|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139114235|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139114236|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139114237|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139039297|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
139114238|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139114240|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139114241|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
139114242|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
139114243|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139114245|NCT01177176|Nicotine|nicotine|mesh-list
139114246|NCT01177176|Varenicline|varenicline|mesh-list
139114247|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139114248|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
139114249|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114250|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114251|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139114252|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139114253|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
139114254|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114255|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114256|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139114257|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
139114258|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139114259|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139114260|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139114261|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139114262|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
139114263|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139114264|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139114265|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114266|NCT01287780|Gentamicins|gentamicins|mesh-list
139114267|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139114268|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114269|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139114270|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114271|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114272|NCT01179828|Oxycodone|oxycodone|mesh-list
139114273|NCT01179828|Clobazam|clobazam|mesh-list
139114274|NCT01179828|Imipramine|imipramine|mesh-list
139114275|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139114276|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139114277|NCT01179828|Narcotics|narcotics|mesh-ancestor
139114278|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139114279|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114280|NCT01179828|Analgesics|analgesics|mesh-ancestor
139114281|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
139114282|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114283|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139114284|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139114285|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
139114286|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114287|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114288|NCT01179828|Urological Agents|urological agents|mesh-ancestor
139114289|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139114290|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
139114291|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139114292|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139114293|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139114294|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139114295|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
139114296|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
139114297|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139114298|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139114299|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139114300|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
139114301|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
139114302|NCT01180062|Latanoprost|latanoprost|mesh-list
139114303|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139114304|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139114305|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
139114306|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139114307|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114308|NCT03858582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139114309|NCT03858582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114310|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
139114311|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139114312|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139114313|NCT01177566|Analgesics|analgesics|mesh-ancestor
139114314|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
139114315|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114316|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114317|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139114318|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139114319|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
139114320|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139114321|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
139114322|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139114323|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114324|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114325|NCT01181154|Rituximab|rituximab|mesh-list
139114326|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139114327|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114328|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
139114329|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114330|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139114331|NCT03101566|Gemcitabine|gemcitabine|mesh-list
139114332|NCT03101566|Nivolumab|nivolumab|mesh-list
139114333|NCT03101566|Ipilimumab|ipilimumab|mesh-list
139114334|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114335|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139114336|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
138955571|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139114337|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114338|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138887650|NCT02707913|Amlodipine|amlodipine|mesh-list
139114339|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139114341|NCT01289496|Ribavirin|ribavirin|mesh-list
139114342|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
139114343|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
139114344|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139114345|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114346|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
139114347|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114348|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
139114349|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114350|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
139114351|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114352|NCT01181232|Zolpidem|zolpidem|mesh-list
139114353|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139114354|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139114355|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139114356|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114357|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139114358|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
139114359|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
139114360|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114361|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114362|NCT01181310|Scopolamine|scopolamine|mesh-list
139114364|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139114365|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139114366|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114367|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114368|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
139114369|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114370|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114371|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
139114372|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139114373|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
139114374|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
139114375|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114376|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139114377|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
139114378|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139114379|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139114380|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
139114381|NCT02525250|Lenalidomide|lenalidomide|mesh-list
139114382|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
139114383|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114384|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139114385|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139114386|NCT02525250|Growth Substances|growth substances|mesh-ancestor
139114387|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
139114388|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114389|NCT01288092|Dactolisib|dactolisib|mesh-list
139114390|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114391|NCT01290744|Clofazimine|clofazimine|mesh-list
139114392|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139114393|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
139114394|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139114395|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114396|NCT01181388|Tirofiban|tirofiban|mesh-list
139114397|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139114398|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138955580|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114399|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114400|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139114401|NCT01181544|Heparin|heparin|mesh-list
139114402|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
139114403|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139114404|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139114405|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114406|NCT01184664|Nicotine|nicotine|mesh-list
139114407|NCT01184664|Varenicline|varenicline|mesh-list
139114408|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139114410|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114411|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114412|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139114413|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139114414|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
139114415|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114416|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114417|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139114418|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114419|NCT01184820|Factor VIII|factor viii|mesh-list
139114420|NCT01184820|Coagulants|coagulants|mesh-ancestor
139114421|NCT03858270|Memantine|memantine|mesh-list
139114422|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139114423|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139114424|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
139114425|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114426|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114427|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114428|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139114429|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139114430|NCT01289730|Etanercept|etanercept|mesh-list
139114431|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139114432|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139114433|NCT01289730|Analgesics|analgesics|mesh-ancestor
139114434|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
139114435|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114436|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114437|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139114438|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139114439|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139114440|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139114441|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
139114442|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
139114443|NCT01290900|Ceftazidime|ceftazidime|mesh-list
139114444|NCT01290900|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139114445|NCT01290900|Avibactam|avibactam|mesh-list
139114446|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139114447|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114448|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139114449|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139114450|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114451|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114452|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114453|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139114454|NCT03855306|Glyburide|glyburide|mesh-list
139114455|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139114456|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114457|NCT03855384|Cisplatin|cisplatin|mesh-list
139114458|NCT03855384|Carboplatin|carboplatin|mesh-list
139114459|NCT03855384|Fluorouracil|fluorouracil|mesh-list
139114460|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114461|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
139114462|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114463|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139114464|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139114466|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114467|NCT01181934|Nicotine|nicotine|mesh-list
139114468|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139114469|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
139114470|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114471|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114472|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139114473|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139114474|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
139114475|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114476|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114477|NCT01187862|Efavirenz|efavirenz|mesh-list
139114478|NCT01187862|Losartan|losartan|mesh-list
139114479|NCT01187862|Metoprolol|metoprolol|mesh-list
139114480|NCT01187862|Midazolam|midazolam|mesh-list
139114481|NCT01187862|Caffeine|caffeine|mesh-list
139114482|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
139114483|NCT01187862|Omeprazole|omeprazole|mesh-list
139114484|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139114485|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139114486|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139114487|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114488|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139114489|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139114490|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139114491|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139114492|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
139114493|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
139114494|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
139114495|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
139114496|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114497|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114498|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139114499|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139114500|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139114501|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139114502|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139114503|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139114504|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114505|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139114506|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139114507|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
139114508|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139114509|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139114510|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139114511|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139114512|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139114514|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114515|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139114516|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139114517|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139114518|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139114519|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139114520|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139114521|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
139114522|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
139114523|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114524|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138887688|NCT03999775|Cholecalciferol|cholecalciferol|mesh-list
139114525|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139114526|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139114527|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
139114528|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139114529|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139114530|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139114531|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
139114532|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114533|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
139114534|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139114535|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
139114536|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114537|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
139114538|NCT01185444|Protective Agents|protective agents|mesh-ancestor
139114539|NCT03857334|Cortivazol|cortivazol|mesh-list
139114540|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139114541|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
139114542|NCT01185678|Desogestrel|desogestrel|mesh-list
139114543|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
139114544|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139114545|NCT01185678|Progestins|progestins|mesh-list
139114546|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139114547|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114548|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139114549|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139114550|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139114551|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139114552|NCT01185678|Hormones|hormones|mesh-ancestor
139039353|NCT00403130|Bevacizumab|bevacizumab|mesh-list
139114553|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139114555|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139114556|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
139114557|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114558|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114559|NCT01588002|Ritonavir|ritonavir|mesh-list
139114560|NCT01588002|Efavirenz|efavirenz|mesh-list
139114561|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139114562|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139114563|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
139114564|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114565|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114566|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139114567|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139114568|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
139114569|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114570|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139114571|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139114572|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139114573|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139114574|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139114575|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139114576|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139114577|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139114578|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139114579|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
139114580|NCT01291212|Testosterone|testosterone|mesh-list
139114581|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
139114582|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
139114583|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139114584|NCT01291212|Androgens|androgens|mesh-ancestor
139114585|NCT01291212|Hormones|hormones|mesh-ancestor
139114586|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139114587|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114588|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139114589|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114590|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
139114591|NCT01182168|Gemcitabine|gemcitabine|mesh-list
139114592|NCT01182168|Everolimus|everolimus|mesh-list
139114593|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114594|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139114595|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
139114596|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114597|NCT01182168|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139114598|NCT01182168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139114599|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114600|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139114601|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
139114602|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114604|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139114605|NCT01182246|Protective Agents|protective agents|mesh-ancestor
139114606|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114607|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114608|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139114609|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114610|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114611|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
139114612|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139114613|NCT01182246|Estrogens|estrogens|mesh-ancestor
139114614|NCT01182246|Hormones|hormones|mesh-ancestor
139114615|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139114616|NCT01588626|Ticagrelor|ticagrelor|mesh-list
139114617|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139114618|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139114619|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139114620|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139114621|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
139114622|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114623|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114624|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114625|NCT01290120|Rituximab|rituximab|mesh-list
139114626|NCT01290120|Doxorubicin|doxorubicin|mesh-list
139114627|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139114628|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114629|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
139114630|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114631|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139114632|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139114633|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139114634|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139114635|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114636|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114637|NCT01290198|Fluconazole|fluconazole|mesh-list
139114638|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
139114639|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
139114640|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114641|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139114642|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139114643|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114644|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114645|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139114646|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
139114647|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139114648|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114649|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139114650|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139114651|NCT01290276|Ondansetron|ondansetron|mesh-list
139114652|NCT01290276|Methylphenidate|methylphenidate|mesh-list
139114653|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
139114654|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
139114655|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114656|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114657|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139114658|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
139114659|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
139114660|NCT01290276|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139114661|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139114662|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
139114663|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114664|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114665|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139114666|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139114667|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139114668|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139114669|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
139114670|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
139114671|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
139114672|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139114673|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139114674|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114675|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114676|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114677|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139114678|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139114679|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114680|NCT01182636|Adapalene|adapalene|mesh-list
139114681|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139114682|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139114683|NCT01182636|Analgesics|analgesics|mesh-ancestor
139114684|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
139114685|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114686|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114687|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139114688|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139114689|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
139114690|NCT01290354|Lapatinib|lapatinib|mesh-list
139114691|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114692|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139114693|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114694|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114695|NCT01188408|Docetaxel|docetaxel|mesh-list
139114696|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114697|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
139114698|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
139114699|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
139114700|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114701|NCT01186146|Aspirin|aspirin|mesh-list
139114702|NCT01186146|Clopidogrel|clopidogrel|mesh-list
139114703|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139114704|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139114705|NCT01186146|Analgesics|analgesics|mesh-ancestor
139114706|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
139114707|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114708|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114709|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139114710|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139114711|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139114712|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139114713|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114714|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139114715|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139114716|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114717|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
139114718|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139114719|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139114720|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139114721|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
139114722|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114723|NCT01186224|Plerixafor|plerixafor|mesh-list
139114724|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139114725|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139114726|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
139114727|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114729|NCT01183494|Bevacizumab|bevacizumab|mesh-list
139114730|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139114731|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139114732|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114733|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114734|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114735|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139114736|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139114737|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139114738|NCT01183494|Growth Substances|growth substances|mesh-ancestor
139114739|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114740|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
139114741|NCT01183572|Iron|iron|mesh-list
139114742|NCT01183572|Folic Acid|folic acid|mesh-list
139114743|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
139114744|NCT01183572|Trace Elements|trace elements|mesh-ancestor
139114745|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
139114746|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114747|NCT01183572|Hematinics|hematinics|mesh-ancestor
139114748|NCT01183572|Vitamins|vitamins|mesh-ancestor
139114749|NCT03856242|Tamsulosin|tamsulosin|mesh-list
139114750|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139114751|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139114752|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139114753|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
139114754|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114755|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114756|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114757|NCT03856242|Urological Agents|urological agents|mesh-ancestor
139114758|NCT01291524|Pregabalin|pregabalin|mesh-list
139114759|NCT01291524|Analgesics|analgesics|mesh-ancestor
139114760|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
139114761|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114762|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114763|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
139114764|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139114765|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139114766|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114767|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139114768|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139114769|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139114770|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139114771|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139114772|NCT01183806|Rivastigmine|rivastigmine|mesh-list
139114773|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139114774|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114775|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114776|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
139114777|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114778|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114779|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139114780|NCT01183806|Protective Agents|protective agents|mesh-ancestor
139114781|NCT01188954|Doxycycline|doxycycline|mesh-list
139114782|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139114783|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114784|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
139114786|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139114787|NCT01183962|Vitamin D|vitamin d|mesh-list
139114788|NCT01183962|Vitamins|vitamins|mesh-ancestor
139114789|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
139114790|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114791|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139114792|NCT01187238|Cisplatin|cisplatin|mesh-list
139114793|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114794|NCT01588314|Gabapentin|gabapentin|mesh-list
139114795|NCT01588314|Analgesics|analgesics|mesh-ancestor
139114796|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
139114797|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114798|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114799|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
139114800|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139114801|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139114802|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139114803|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139114804|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139114806|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114807|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114808|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
139114809|NCT01290432|Folic Acid|folic acid|mesh-list
139114810|NCT01290432|Melatonin|melatonin|mesh-list
139114811|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
139114812|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114813|NCT01290432|Protective Agents|protective agents|mesh-ancestor
139114814|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114815|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139114816|NCT01290432|Hematinics|hematinics|mesh-ancestor
139114817|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
139114818|NCT01290432|Vitamins|vitamins|mesh-ancestor
139114819|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
139114820|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
139114821|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139114822|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
139114823|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114824|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
139114825|NCT01290510|Protective Agents|protective agents|mesh-ancestor
139114826|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
139114827|NCT01184196|Povidone|povidone|mesh-list
139114828|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
139114829|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
139114830|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139114831|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114832|NCT01292460|Timolol|timolol|mesh-list
139114833|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139114834|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139114835|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
139114836|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114837|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114838|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114839|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139114840|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139114841|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
139114842|NCT01292694|Losartan|losartan|mesh-list
139114843|NCT01292694|Captopril|captopril|mesh-list
139114844|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139114845|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139114846|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139114847|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139114848|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039434|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139114849|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139114850|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
139114851|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114852|NCT03851562|Alprostadil|alprostadil|mesh-list
139114853|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139114854|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
139114855|NCT03851562|Urological Agents|urological agents|mesh-ancestor
139114856|NCT01293630|Paclitaxel|paclitaxel|mesh-list
139114857|NCT01293630|Carboplatin|carboplatin|mesh-list
139114858|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139114859|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114860|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
139114861|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
139114862|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
139114863|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114864|NCT01191060|Lenalidomide|lenalidomide|mesh-list
139114865|NCT01191060|Bortezomib|bortezomib|mesh-list
139114866|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
139114867|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114868|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139114869|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139114870|NCT01191060|Growth Substances|growth substances|mesh-ancestor
139114872|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114873|NCT01291602|Avibactam|avibactam|mesh-list
139114874|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139114875|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114876|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114877|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139114878|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114879|NCT03851172|Ketorolac|ketorolac|mesh-list
139114880|NCT03851172|Nepafenac|nepafenac|mesh-list
139114881|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
139114882|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139114883|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139114884|NCT03851172|Analgesics|analgesics|mesh-ancestor
139114885|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
139114886|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139114887|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114888|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139114889|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139114890|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139114891|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114892|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114893|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
139114894|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
139114895|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
139114896|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139114897|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139114898|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
139114899|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139114900|NCT03853512|Petrolatum|petrolatum|mesh-list
139114901|NCT03853512|Emollients|emollients|mesh-ancestor
139114902|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
139114903|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
139114904|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139114905|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114906|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
139114907|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139114908|NCT03853200|Acetic Acid|acetic acid|mesh-list
139114909|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
139114910|NCT03853200|Edetic Acid|edetic acid|mesh-list
139114911|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
139114912|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139114913|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114914|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
139114915|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
139114916|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
139114917|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139114918|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
139114920|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114921|NCT03853200|Antidotes|antidotes|mesh-ancestor
139114922|NCT03853200|Protective Agents|protective agents|mesh-ancestor
139114923|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114924|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139114925|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139114926|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
139114927|NCT01293942|Bevacizumab|bevacizumab|mesh-list
139114928|NCT01293942|Capecitabine|capecitabine|mesh-list
139114929|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
139114930|NCT01293942|Irinotecan|irinotecan|mesh-list
139114931|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139114932|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114933|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139114934|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139114935|NCT01293942|Growth Substances|growth substances|mesh-ancestor
139114936|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114937|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
139114938|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139114939|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
139114940|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114941|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139114942|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139114943|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139114944|NCT01189656|Vaccines|vaccines|mesh-list
139114945|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
139114946|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114947|NCT01581138|Ribavirin|ribavirin|mesh-list
139114948|NCT01581138|Antimetabolites|antimetabolites|mesh-ancestor
139114949|NCT01581138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114950|NCT01581138|Antiviral Agents|antiviral agents|mesh-ancestor
139114951|NCT01581138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139114953|NCT01191216|Tryptophan|tryptophan|mesh-list
139114954|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114955|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
139114956|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
139114957|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
139114958|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114959|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139114960|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
139114961|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139114963|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
139114964|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114965|NCT01294176|Protective Agents|protective agents|mesh-ancestor
139114966|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114967|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
139114968|NCT01294176|Vitamins|vitamins|mesh-ancestor
139114969|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
139114970|NCT03847818|Carboplatin|carboplatin|mesh-list
139114971|NCT03847818|Docetaxel|docetaxel|mesh-list
139114972|NCT03847818|Trastuzumab|trastuzumab|mesh-list
139114973|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139114974|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
139114975|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
139114976|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
139114977|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114978|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139114979|NCT01294410|Antibodies|antibodies|mesh-list
139114980|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
139114981|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
139114982|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114983|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
139114984|NCT01191450|Amiloride|amiloride|mesh-list
139114985|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139114986|NCT01191450|Diuretics|diuretics|mesh-ancestor
139114987|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
139114988|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139114989|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139114990|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139114991|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139114992|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139114993|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139114994|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138955752|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
139114995|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139114996|NCT01194336|Huperzine A|huperzine a|mesh-list
139114997|NCT01194336|Donepezil|donepezil|mesh-list
139114998|NCT01194336|Galantamine|galantamine|mesh-list
139114999|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139115000|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115001|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115002|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
139115003|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139115004|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115005|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
139115006|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139115007|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
139115008|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115009|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139115010|NCT01194336|Protective Agents|protective agents|mesh-ancestor
139115011|NCT02660710|Rituximab|rituximab|mesh-list
139115012|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139115013|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115014|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
139115015|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115016|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139115017|NCT01294878|Omalizumab|omalizumab|mesh-list
139115018|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139115019|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139115020|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
139115021|NCT01296438|Insulin|insulin|mesh-list
139115022|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139115023|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
139115024|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
138865632|NCT04166565|Bortezomib|bortezomib|mesh-list
139115025|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139115026|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139115027|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115028|NCT03850626|Immunomodulating Agents|immunomodulating agents|mesh-list
139115029|NCT03850626|Immunologic Factors|immunologic factors|mesh-ancestor
139115030|NCT03850626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115031|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138887723|NCT01006681|Vaccines|vaccines|mesh-list
139115032|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139115033|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
139115034|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139115036|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139115037|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
139115038|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139115039|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115040|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
139115041|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115042|NCT01190358|Protective Agents|protective agents|mesh-ancestor
139115043|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115044|NCT01293162|Folic Acid|folic acid|mesh-list
139115045|NCT01293162|Policosanol|policosanol|mesh-list
139115046|NCT01293162|Hematinics|hematinics|mesh-ancestor
139115047|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
139115049|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
139115050|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115051|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139115052|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139115053|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
139115054|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115055|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139115056|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139115057|NCT01190670|Tacrolimus|tacrolimus|mesh-list
139115058|NCT01190670|Peficitinib|peficitinib|mesh-list
139115059|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139115060|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
139115061|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955758|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
139115062|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139115063|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115064|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115065|NCT01194882|Insulin|insulin|mesh-list
139115066|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139115067|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139115068|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115069|NCT01191684|Vaccines|vaccines|mesh-list
139115070|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
139115071|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115072|NCT02659540|Nivolumab|nivolumab|mesh-list
139115073|NCT02659540|Ipilimumab|ipilimumab|mesh-list
139115074|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139115075|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115076|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139115077|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115078|NCT01295268|Emu Oil|emu oil|mesh-list
139115079|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139115080|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
139115081|NCT01383694|Piperine|piperine|mesh-list
139115082|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139115083|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115084|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115085|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
139115086|NCT01191918|Donepezil|donepezil|mesh-list
139115087|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139115088|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115089|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115090|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
139115091|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139115092|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115093|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
139115094|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
139115095|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139115096|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
139115097|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139115098|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139115099|NCT03850314|Glycine|glycine|mesh-list
139115100|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
139115101|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139115102|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115103|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115105|NCT01097746|Bevacizumab|bevacizumab|mesh-list
139115106|NCT01097746|Carboplatin|carboplatin|mesh-list
139115107|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139115108|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139115109|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
139115110|NCT01097746|Antibodies|antibodies|mesh-list
139115111|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
139115112|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139115113|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
139115114|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139115115|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115116|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
139115117|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
139115118|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
139115119|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115120|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139115121|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139115122|NCT01097746|Growth Substances|growth substances|mesh-ancestor
139115123|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115124|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
139115125|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
139115126|NCT01190748|Galantamine|galantamine|mesh-list
139115127|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139115128|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115129|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115130|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
139115131|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139115132|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115133|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139115134|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
139115135|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115136|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
139115137|NCT01383538|Leucovorin|leucovorin|mesh-list
139115138|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
139115139|NCT01383538|Irinotecan|irinotecan|mesh-list
139115140|NCT01383538|Folfirinox|folfirinox|mesh-list
139115141|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115142|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139115143|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139115144|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115145|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115146|NCT01383538|Antidotes|antidotes|mesh-ancestor
139115147|NCT01383538|Protective Agents|protective agents|mesh-ancestor
139115148|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115149|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
139115150|NCT01383538|Vitamins|vitamins|mesh-ancestor
139115151|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
139115152|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
139115153|NCT01383460|Lenograstim|lenograstim|mesh-list
139115154|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139115155|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
139115156|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115157|NCT01383460|Hematinics|hematinics|mesh-ancestor
139115158|NCT01192230|Docetaxel|docetaxel|mesh-list
139115159|NCT01192230|Endostatins|endostatins|mesh-list
139115160|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115161|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
139115162|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
139115163|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
139115164|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115165|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139115166|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139115167|NCT01192230|Growth Substances|growth substances|mesh-ancestor
139115168|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115169|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
139115170|NCT05416840|Amlodipine|amlodipine|mesh-list
139115171|NCT05416840|Clonidine|clonidine|mesh-list
139115172|NCT05416840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139115173|NCT05416840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139115174|NCT05416840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138955780|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139115175|NCT05416840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138865785|NCT02710604|Tenofovir|tenofovir|mesh-list
139115176|NCT05416840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139115177|NCT05416840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115178|NCT05416840|Vasodilator Agents|vasodilator agents|mesh-ancestor
139115179|NCT05416840|Analgesics|analgesics|mesh-ancestor
139115180|NCT05416840|Sensory System Agents|sensory system agents|mesh-ancestor
139115181|NCT05416840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115182|NCT05416840|Sympatholytics|sympatholytics|mesh-ancestor
139115183|NCT05416840|Autonomic Agents|autonomic agents|mesh-ancestor
139115184|NCT05416840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139115185|NCT05416840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139115186|NCT05416840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139115187|NCT05416840|Adrenergic Agents|adrenergic agents|mesh-ancestor
139115188|NCT05416840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139115189|NCT01192308|Tamoxifen|tamoxifen|mesh-list
139115190|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139115191|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
139115192|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139115193|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115194|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139115195|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115196|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139115197|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139115198|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139115199|NCT01190982|Paclitaxel|paclitaxel|mesh-list
139115200|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139115201|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115202|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
139115203|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
139115204|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
139115205|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115206|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139115207|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
139115208|NCT01196754|Sevoflurane|sevoflurane|mesh-list
139115209|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139115210|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139115211|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
139115212|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
139115213|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139115214|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115215|NCT01295502|Paclitaxel|paclitaxel|mesh-list
139115216|NCT01295502|Cisplatin|cisplatin|mesh-list
139115217|NCT01295502|Carboplatin|carboplatin|mesh-list
139115218|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139115219|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139115220|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115221|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
139115222|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
139115223|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
139115224|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115225|NCT05207644|Letrozole|letrozole|mesh-list
139115226|NCT05207644|Misoprostol|misoprostol|mesh-list
139115227|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115228|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139115229|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139115230|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955806|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
139115231|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115232|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139115233|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
139115234|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139115235|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115236|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139115237|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
139115238|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139115239|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139115240|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139115241|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
139115242|NCT03846102|Acetaminophen|acetaminophen|mesh-list
139115243|NCT03846102|Morphine|morphine|mesh-list
139115244|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
139115245|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139115246|NCT03846102|Narcotics|narcotics|mesh-ancestor
139115247|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139115248|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115249|NCT03846102|Analgesics|analgesics|mesh-ancestor
139115250|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
139115251|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115252|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139115253|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
139115254|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
139115255|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
139115256|NCT01383148|Paclitaxel|paclitaxel|mesh-list
139115257|NCT01383148|Cisplatin|cisplatin|mesh-list
139115258|NCT01383148|Carboplatin|carboplatin|mesh-list
139115259|NCT01383148|Gemcitabine|gemcitabine|mesh-list
139115260|NCT01383148|Pemetrexed|pemetrexed|mesh-list
139115261|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139115263|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
139115264|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
139115265|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
139115266|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115267|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139115268|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
139115269|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115270|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139115271|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139115272|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
139115273|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139115274|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115275|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
139115276|NCT01195428|Simvastatin|simvastatin|mesh-list
139115277|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139115278|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139115279|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
139115280|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115281|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139115282|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139115283|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115284|NCT01193166|Olanzapine|olanzapine|mesh-list
139115285|NCT01193166|Risperidone|risperidone|mesh-list
139115286|NCT01193166|Aripiprazole|aripiprazole|mesh-list
139115287|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139115288|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139115289|NCT01193166|Perphenazine|perphenazine|mesh-list
139115290|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139115291|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
139115292|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139115293|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115294|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115295|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139115296|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139115297|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139115298|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139115299|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139115300|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
139115301|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
139115302|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
139115303|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115304|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139115305|NCT01193166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139115306|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139115307|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139115308|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
139115309|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
139115310|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139115311|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139115312|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139115313|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139115314|NCT01197144|Adalimumab|adalimumab|mesh-list
139115315|NCT01197144|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139115316|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139115317|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139115318|NCT01193400|Cytarabine|cytarabine|mesh-list
139115319|NCT01193400|Clofarabine|clofarabine|mesh-list
139115320|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139115321|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
139115322|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115323|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115324|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
139115325|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115326|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139115327|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
139115328|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115329|NCT03904888|Anesthetics|anesthetics|mesh-list
139115330|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
139115331|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139115332|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115333|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
139115334|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115335|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139115336|NCT01193478|Ledipasvir|ledipasvir|mesh-list
139115337|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
139115338|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115339|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
139115340|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
139115341|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139115342|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139115343|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115344|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115345|NCT01295736|Urological Agents|urological agents|mesh-ancestor
139115346|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
139115347|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
139115348|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139115349|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139115350|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115351|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115352|NCT03733470|Urological Agents|urological agents|mesh-ancestor
139115353|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139115354|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139115355|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115356|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
139115357|NCT04731376|Testosterone|testosterone|mesh-list
139115358|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
139115359|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
139115360|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139115361|NCT04731376|Androgens|androgens|mesh-ancestor
139115362|NCT04731376|Hormones|hormones|mesh-ancestor
139115363|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139115364|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115365|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139115366|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115367|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
139115368|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139115369|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139115370|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115371|NCT01196208|Immunotoxins|immunotoxins|mesh-ancestor
139115372|NCT01196208|Immunoconjugates|immunoconjugates|mesh-ancestor
139115373|NCT01196208|Immunologic Factors|immunologic factors|mesh-ancestor
139115374|NCT01196208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115375|NCT01295892|Estrogens|estrogens|mesh-list
139115376|NCT01295892|Hormones|hormones|mesh-ancestor
139115377|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139115378|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115379|NCT01296204|Antibodies|antibodies|mesh-list
139115380|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
139115381|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115382|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139115383|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
139115384|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139115385|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139115386|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139115387|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139115388|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115389|NCT01192854|Adefovir|adefovir|mesh-list
139115390|NCT01192854|Clevudine|clevudine|mesh-list
139115391|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
139115392|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115393|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139115394|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139115395|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115396|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115397|NCT05670678|Lactoferrin|lactoferrin|mesh-list
139115398|NCT05670678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115399|NCT02914366|Ambroxol|ambroxol|mesh-list
139115400|NCT02914366|Expectorants|expectorants|mesh-ancestor
139115401|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
138866010|NCT05151848|Adalimumab|adalimumab|mesh-list
139115403|NCT03846180|Terlipressin|terlipressin|mesh-list
139115404|NCT03846180|Somatostatin|somatostatin|mesh-list
139115405|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139115406|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139115407|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887728|NCT03893903|Avelumab|avelumab|mesh-list
139115408|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139115409|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139115410|NCT03846180|Hormones|hormones|mesh-ancestor
139115411|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139115412|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115413|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
139115414|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
139115415|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
139115416|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139115417|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115418|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
139115419|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115420|NCT02729116|Ertapenem|ertapenem|mesh-list
139115421|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
139115422|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139115423|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115424|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139115425|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139115426|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115427|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115428|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115429|NCT05289648|Niraparib|niraparib|mesh-list
139115430|NCT05289648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139115431|NCT05289648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115432|NCT05289648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115433|NCT05289648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115434|NCT01199562|Valganciclovir|valganciclovir|mesh-list
139115435|NCT01199562|Ganciclovir|ganciclovir|mesh-list
139115436|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139115437|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
139115438|NCT01199562|Foscarnet|foscarnet|mesh-list
139115439|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
139115440|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115441|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139115442|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115443|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115444|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139115445|NCT03845322|Curcumin|curcumin|mesh-list
139115446|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139115447|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139115448|NCT03845322|Analgesics|analgesics|mesh-ancestor
139115449|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
139115450|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115451|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115452|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139115453|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139115454|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115455|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115456|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115457|NCT03844932|Cyclosporine|cyclosporine|mesh-list
139115458|NCT03844932|Cyclosporins|cyclosporins|mesh-list
139115459|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115460|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115461|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139115462|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
139115463|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115464|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
139115465|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115466|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
139115467|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139115468|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139115469|NCT03726996|Desipramine|desipramine|mesh-list
139115470|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139115471|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
139115472|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139115473|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115474|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115475|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139115476|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138866087|NCT02707250|Meperidine|meperidine|mesh-list
139115477|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139115478|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
139115479|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139115480|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115481|NCT01202058|Sirolimus|sirolimus|mesh-list
139115482|NCT01202058|Everolimus|everolimus|mesh-list
139115483|NCT01202058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139115484|NCT01202058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139115485|NCT01202058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115486|NCT01202058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115487|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139115488|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
139115489|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115490|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115491|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139115492|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115493|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139115494|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
139115495|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
139115496|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115497|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
139115498|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
139115499|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
139115500|NCT03842046|Phenylephrine|phenylephrine|mesh-list
139115501|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
139115502|NCT03842046|Norepinephrine|norepinephrine|mesh-list
139115503|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139115504|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
139115505|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
139115506|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867840|NCT00618696|Antibodies|antibodies|mesh-list
139115507|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115508|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
139115509|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139115510|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
139115511|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
139115512|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139115513|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139115514|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139115515|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
139115516|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139115517|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115518|NCT03842046|Protective Agents|protective agents|mesh-ancestor
139115519|NCT01198236|Itraconazole|itraconazole|mesh-list
139115520|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
139115521|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115522|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139115523|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139115524|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115525|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115526|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139115527|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
139115528|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139115529|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115530|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139115531|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139115532|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
139115533|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115534|NCT03841890|Tolnaftate|tolnaftate|mesh-list
139115535|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
139115536|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115537|NCT01200108|Budesonide|budesonide|mesh-list
139115538|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139115539|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139115540|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
139115541|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115542|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115543|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139115544|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
139115545|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
139115546|NCT01200108|Hormones|hormones|mesh-ancestor
139115547|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139115548|NCT01200186|Progestins|progestins|mesh-list
139115549|NCT01200186|Hormones|hormones|mesh-ancestor
139115550|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139115551|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115552|NCT03841812|Propofol|propofol|mesh-list
138887731|NCT02706509|Tramadol|tramadol|mesh-list
139115553|NCT03841812|Sevoflurane|sevoflurane|mesh-list
139115554|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139115555|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139115556|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115557|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139115558|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
139115559|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
139115560|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139115561|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139115562|NCT03882970|Tirzepatide|tirzepatide|mesh-list
139115563|NCT03882970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139115564|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115565|NCT03882970|Incretins|incretins|mesh-ancestor
139115566|NCT03882970|Hormones|hormones|mesh-ancestor
139115567|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139115568|NCT05111808|Methylene Blue|methylene blue|mesh-list
139115569|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115570|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115571|NCT01198392|Cisplatin|cisplatin|mesh-list
139115572|NCT01198392|Tegafur|tegafur|mesh-list
139115573|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115574|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139115575|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
139115576|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115577|NCT01200264|Apremilast|apremilast|mesh-list
139115578|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139115579|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139115580|NCT01200264|Analgesics|analgesics|mesh-ancestor
139115581|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
139115582|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115583|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115584|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139115585|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139115586|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139115587|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139115588|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115589|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115590|NCT04799236|Amphotericin B|amphotericin b|mesh-list
139115591|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139115592|NCT04799236|Miltefosine|miltefosine|mesh-list
139115593|NCT04799236|Amebicides|amebicides|mesh-ancestor
139115594|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139115595|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139115596|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115597|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139115598|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
139115599|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115600|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
139115601|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139115602|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115603|NCT03630952|Aflibercept|aflibercept|mesh-list
139115604|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139115605|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139115606|NCT03630952|Growth Substances|growth substances|mesh-ancestor
139115607|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115608|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
139115609|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115610|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139115611|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
139115612|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139115613|NCT01200654|Linezolid|linezolid|mesh-list
139115614|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139115615|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115616|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139115617|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115618|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115619|NCT01200732|Tadalafil|tadalafil|mesh-list
139115620|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
139115621|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139115622|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139115623|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866235|NCT02636829|Calcium|calcium|mesh-list
139115624|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115625|NCT01200732|Urological Agents|urological agents|mesh-ancestor
139115626|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
139115627|NCT01198860|Tenofovir|tenofovir|mesh-list
139115628|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
139115629|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115630|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139115631|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139115632|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115633|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115634|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139115635|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139115636|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
139115637|NCT01198860|Protective Agents|protective agents|mesh-ancestor
139115638|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115639|NCT01198860|Vitamins|vitamins|mesh-ancestor
139115640|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
139115641|NCT01198938|Melatonin|melatonin|mesh-list
139115642|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
139115643|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115644|NCT01198938|Protective Agents|protective agents|mesh-ancestor
139115645|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115646|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139115647|NCT01201044|Gemcitabine|gemcitabine|mesh-list
139115648|NCT01201044|Nedaplatin|nedaplatin|mesh-list
139115649|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139115650|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
139115651|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115652|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115653|NCT03843060|Itraconazole|itraconazole|mesh-list
139115654|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
139115655|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115656|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139115657|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139115658|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115659|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115660|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139115661|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
139115662|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139115663|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115664|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139115665|NCT04427904|Lidocaine|lidocaine|mesh-list
139115666|NCT04427904|Epinephrine|epinephrine|mesh-list
139115667|NCT04427904|Racepinephrine|racepinephrine|mesh-list
139115668|NCT04427904|Bupivacaine|bupivacaine|mesh-list
139115669|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
139115670|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
139115671|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
139115672|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139115673|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115674|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
139115675|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115676|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139115677|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139115678|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139115679|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139115680|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115681|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139115682|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139115683|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
139115684|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139115685|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139115686|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139115687|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
139115688|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139115689|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
139115690|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
139115691|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
139115692|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139115693|NCT01201122|Mesalamine|mesalamine|mesh-list
139115694|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139115695|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139115696|NCT01201122|Analgesics|analgesics|mesh-ancestor
139115697|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
139115698|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115699|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115700|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139115701|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139115703|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139115704|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
139115705|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
139115706|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139115707|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115708|NCT05281926|Nivolumab|nivolumab|mesh-list
139115709|NCT05281926|Poly ICLC|poly iclc|mesh-list
139115710|NCT05281926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139115711|NCT05281926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115712|NCT05281926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139115713|NCT05281926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115714|NCT05281926|Interferon Inducers|interferon inducers|mesh-ancestor
139115715|NCT05281926|Immunologic Factors|immunologic factors|mesh-ancestor
139115716|NCT05281926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115717|NCT03844776|Acetaminophen|acetaminophen|mesh-list
139115718|NCT03844776|Amoxicillin|amoxicillin|mesh-list
139115719|NCT03844776|Metronidazole|metronidazole|mesh-list
139115720|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139115721|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
139115722|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139115723|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115724|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139115725|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
139115726|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139115727|NCT03844776|Analgesics|analgesics|mesh-ancestor
139115728|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
139115729|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115730|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115731|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
139115732|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139115733|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139115734|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139115735|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115736|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115737|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
139115738|NCT01566942|Irinotecan|irinotecan|mesh-list
139115739|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115740|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139115741|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139115742|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115743|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115744|NCT01201278|Insulin|insulin|mesh-list
139115745|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139115746|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
139115747|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139115748|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115749|NCT05667948|Immunomodulating Agents|immunomodulating agents|mesh-list
139115750|NCT05667948|Immunologic Factors|immunologic factors|mesh-ancestor
139115751|NCT05667948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115752|NCT01199328|Aspirin|aspirin|mesh-list
139115753|NCT01199328|Esomeprazole|esomeprazole|mesh-list
139115754|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139115755|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139115756|NCT01199328|Analgesics|analgesics|mesh-ancestor
139115757|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
139115758|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115759|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115760|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139115761|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139115762|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139115763|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139115764|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115765|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139115766|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139115767|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115768|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
139115769|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139115770|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139115771|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139115772|NCT02982954|Nivolumab|nivolumab|mesh-list
139115773|NCT02982954|Ipilimumab|ipilimumab|mesh-list
139115774|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139115775|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115776|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139115777|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115779|NCT01203228|Busulfan|busulfan|mesh-list
139115780|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
139115781|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139115782|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
139115783|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115784|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139115785|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139115786|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
139115787|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115788|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955933|NCT00744536|Lenalidomide|lenalidomide|mesh-list
139115789|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139115790|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139115791|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
139115792|NCT01203696|Amlodipine|amlodipine|mesh-list
139115793|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138867927|NCT00619398|Tacrolimus|tacrolimus|mesh-list
139115794|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139115795|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139115796|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115797|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139115798|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115799|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
139115800|NCT01203306|Bevacizumab|bevacizumab|mesh-list
139115801|NCT01203306|Capecitabine|capecitabine|mesh-list
139115803|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139115804|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115805|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139115806|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139115807|NCT01203306|Growth Substances|growth substances|mesh-ancestor
139115808|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115809|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
139115810|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139115811|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
139115812|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115813|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139115814|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139115815|NCT01203384|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
139115816|NCT01203384|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139115817|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115818|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115819|NCT03724968|Nivolumab|nivolumab|mesh-list
139115820|NCT03724968|Ipilimumab|ipilimumab|mesh-list
139115821|NCT03724968|Relatlimab|relatlimab|mesh-list
139115822|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139115823|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115824|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139115825|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115826|NCT01204086|Fluoxetine|fluoxetine|mesh-list
139115827|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139115828|NCT01204086|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139115829|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139115830|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139115831|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115832|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139115833|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
139115834|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115835|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139115836|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
139115837|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139115838|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139115839|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139115840|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115841|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139115842|NCT01201902|Vaccines|vaccines|mesh-list
139115843|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
139115844|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115845|NCT01204164|Dexamethasone|dexamethasone|mesh-list
139115846|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139115847|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
139115848|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
139115849|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115850|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115851|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139115854|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139115855|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139115856|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115857|NCT01206036|Sirolimus|sirolimus|mesh-list
139115858|NCT01206036|Docetaxel|docetaxel|mesh-list
139115859|NCT01206036|Temsirolimus|temsirolimus|mesh-list
139115860|NCT01206036|MTOR Inhibitors|mtor inhibitors|mesh-list
139115861|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115862|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
139115863|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
139115864|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
139115865|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115866|NCT01206036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139115867|NCT01206036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115868|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139115869|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
139115870|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115871|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139115872|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115873|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139115874|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
139115875|NCT01204320|Paclitaxel|paclitaxel|mesh-list
139115876|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139115877|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139115878|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115879|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
139115880|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
139115881|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
139115882|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115883|NCT03722238|Ibuprofen|ibuprofen|mesh-list
139115884|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139115885|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139115886|NCT03722238|Analgesics|analgesics|mesh-ancestor
139115887|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
139115888|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115889|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115890|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139115891|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139115892|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139115893|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115894|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115895|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139115896|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139115897|NCT01203618|Farletuzumab|farletuzumab|mesh-list
139115898|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115899|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
139115900|NCT01206270|Castor Oil|castor oil|mesh-list
139115901|NCT01206270|Testosterone|testosterone|mesh-list
139115902|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
139115903|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
139115904|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139115905|NCT01206270|Androgens|androgens|mesh-ancestor
139115906|NCT01206270|Hormones|hormones|mesh-ancestor
139115907|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139115908|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115909|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139115910|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115911|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
139115912|NCT01206270|Cathartics|cathartics|mesh-ancestor
139115913|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139115914|NCT01298310|Lidocaine|lidocaine|mesh-list
139115915|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
139115916|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
139115917|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138955952|NCT00744770|Rilpivirine|rilpivirine|mesh-list
139115918|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115919|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
139115920|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115921|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139115922|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139115923|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138635092|NCT02279758|Metformin|metformin|mesh-list
139115924|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138868013|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139115925|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115927|NCT01298466|Analgesics|analgesics|mesh-ancestor
139115928|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
139115929|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139115930|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115931|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
139115932|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139115933|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139115934|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115935|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139115936|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139115937|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139115938|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139115939|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139115940|NCT01206348|Minocycline|minocycline|mesh-list
139115941|NCT01206348|Clindamycin|clindamycin|mesh-list
139115942|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
139115943|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
139115944|NCT01206348|Tretinoin|tretinoin|mesh-list
139115945|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139115946|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139115947|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115948|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139115949|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115950|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115951|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
139115952|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115953|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
139115954|NCT01204476|Everolimus|everolimus|mesh-list
139115955|NCT01204476|Octreotide|octreotide|mesh-list
139115956|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139115957|NCT01204476|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139115958|NCT01204476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139115959|NCT01204476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115960|NCT01204476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115961|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139115962|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
139115963|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115964|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115965|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139115966|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139115967|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139115968|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139115969|NCT04630210|Atezolizumab|atezolizumab|mesh-list
139115970|NCT04630210|Letrozole|letrozole|mesh-list
139115971|NCT04630210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139115972|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115973|NCT04630210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139115974|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115975|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139115976|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139115977|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115978|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139115979|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
139019546|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115980|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139115981|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139115982|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
139115983|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
139115984|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139115985|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138868034|NCT02846909|Progesterone|progesterone|mesh-list
139115986|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139115987|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115988|NCT01382368|Urological Agents|urological agents|mesh-ancestor
139115989|NCT04546828|Gemcitabine|gemcitabine|mesh-list
139115990|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139115991|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139115992|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
139115993|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139115994|NCT01382134|Aspirin|aspirin|mesh-list
139115995|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139115996|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139115997|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139115998|NCT01382134|Analgesics|analgesics|mesh-ancestor
139115999|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
139116000|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116001|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116002|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139116003|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139116004|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139116005|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139116006|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116007|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139116008|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139116009|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116011|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
139116012|NCT01382134|Coagulants|coagulants|mesh-ancestor
139116013|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139116014|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
139116015|NCT05077488|Lidocaine|lidocaine|mesh-list
139116016|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
139116017|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
139116018|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116019|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116020|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
139116021|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116022|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139116023|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139116024|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139116025|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139116026|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116027|NCT05668572|Vaccines|vaccines|mesh-list
139116028|NCT05668572|Immunologic Factors|immunologic factors|mesh-ancestor
139116029|NCT05668572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116030|NCT02410980|Tretinoin|tretinoin|mesh-list
139116031|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116032|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
139116033|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
139116034|NCT01298934|Panobinostat|panobinostat|mesh-list
139116035|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116036|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139116037|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116038|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116039|NCT01299012|Liraglutide|liraglutide|mesh-list
139116040|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139116041|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116042|NCT01299012|Incretins|incretins|mesh-ancestor
139116043|NCT01299012|Hormones|hormones|mesh-ancestor
139116044|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139116046|NCT02155920|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139019547|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139116047|NCT02155920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139116048|NCT02155920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116049|NCT02155920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116050|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139116051|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
139116052|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116053|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116054|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
139116055|NCT01301040|Docetaxel|docetaxel|mesh-list
139116056|NCT01301040|Epirubicin|epirubicin|mesh-list
139116057|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139116058|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
139116059|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116060|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139116061|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139116062|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
139116063|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116064|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116065|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139116066|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
139116067|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
139116068|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
139116069|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139116070|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139116071|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139116072|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138866671|NCT02630511|Mannitol|mannitol|mesh-list
139116073|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
139116074|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
139116075|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139116076|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
139116077|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116078|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139116079|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139116080|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
139116081|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116082|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116083|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139116084|NCT01206972|Enoxaparin|enoxaparin|mesh-list
139116085|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
139116086|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139116087|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
139116088|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139116089|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
139116090|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116091|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116092|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
139116093|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139116094|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139116095|NCT03817476|BI 425809|bi 425809|mesh-list
139116096|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
139116097|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
139116098|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
139116099|NCT02918292|Fludarabine|fludarabine|mesh-list
139116100|NCT02918292|Tacrolimus|tacrolimus|mesh-list
139116101|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
139116102|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139116103|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139116104|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
139116105|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116106|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139116107|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139116108|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
139116109|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116110|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116111|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139116112|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139116113|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116114|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139116115|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139116116|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
139116117|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139116118|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116119|NCT01207128|Voriconazole|voriconazole|mesh-list
139116120|NCT01207128|Micafungin|micafungin|mesh-list
139116121|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
139116122|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116123|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139116124|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139116125|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116126|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116127|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139116128|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
139116129|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139116130|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116131|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139116132|NCT01299558|Fluticasone|fluticasone|mesh-list
139116133|NCT01299558|Xhance|xhance|mesh-list
139116134|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139116135|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139116136|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
139116137|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116138|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116139|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139116140|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
139116141|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
139116142|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139116143|NCT01207206|Ketamine|ketamine|mesh-list
139116144|NCT01207206|Analgesics|analgesics|mesh-ancestor
139116145|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
138866743|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139116146|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116147|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116148|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139116149|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139116150|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
139116152|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116153|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139116154|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139116155|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116156|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116157|NCT03719586|Remdesivir|remdesivir|mesh-list
139116158|NCT03719586|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
139116159|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
139116160|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116161|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
138955992|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139116162|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116163|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
139116164|NCT01205022|Leucovorin|leucovorin|mesh-list
139116165|NCT01205022|Bevacizumab|bevacizumab|mesh-list
139116166|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139116167|NCT01205022|Fluorouracil|fluorouracil|mesh-list
139116168|NCT01205022|Irinotecan|irinotecan|mesh-list
139116169|NCT01205022|Camptothecin|camptothecin|mesh-list
139116170|NCT01205022|Antibodies|antibodies|mesh-list
139116171|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
139116172|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139116173|NCT01205022|Calcium|calcium|mesh-list
139116174|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
139116175|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116176|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139116177|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139116178|NCT01205022|Growth Substances|growth substances|mesh-ancestor
139116179|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116180|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
139116181|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
139116182|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139116183|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139116184|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
139116185|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116186|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139116187|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139116188|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139116189|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139116190|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116191|NCT01205022|Antidotes|antidotes|mesh-ancestor
139116192|NCT01205022|Protective Agents|protective agents|mesh-ancestor
139116193|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
139116194|NCT01205022|Vitamins|vitamins|mesh-ancestor
139116195|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
139116196|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139116197|NCT01205178|Chloroquine|chloroquine|mesh-list
139116198|NCT01205178|Primaquine|primaquine|mesh-list
139116199|NCT01205178|Tafenoquine|tafenoquine|mesh-list
139116200|NCT01205178|Amebicides|amebicides|mesh-ancestor
139116201|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139116202|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139116203|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116204|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
139116205|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139116206|NCT01205256|Methadone|methadone|mesh-list
139116207|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139116208|NCT01205256|Narcotics|narcotics|mesh-ancestor
139116209|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116210|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116211|NCT01205256|Analgesics|analgesics|mesh-ancestor
139116212|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
139116213|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116214|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
139116215|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
139116216|NCT03823482|Lidocaine|lidocaine|mesh-list
139116217|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
139116218|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
139116219|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116220|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116221|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
139116222|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116223|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139116224|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139116225|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139116226|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139116227|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116228|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139116229|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139116230|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116232|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
139116233|NCT03816072|Propofol|propofol|mesh-list
139116234|NCT03816072|Sevoflurane|sevoflurane|mesh-list
139116235|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139116236|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116237|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116238|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139116239|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
139116240|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
139116241|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139116242|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139116243|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139116244|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
139116245|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
139116246|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116247|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
139116248|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139116249|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
139116250|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
139116251|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139116252|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139116253|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139116254|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
139116255|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116256|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116257|NCT03816072|Protective Agents|protective agents|mesh-ancestor
139116258|NCT01299948|Prednisolone|prednisolone|mesh-list
139116259|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139116260|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
139116261|NCT01299948|Hormones|hormones|mesh-ancestor
139116262|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139116263|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868124|NCT01497509|Epinephrine|epinephrine|mesh-list
139116264|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139116265|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116266|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
139116267|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116268|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116269|NCT01297452|Paclitaxel|paclitaxel|mesh-list
139116270|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139116271|NCT01297452|Carboplatin|carboplatin|mesh-list
139116272|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139116273|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116274|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
139116275|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
139116276|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
139116277|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116278|NCT01301586|Doxycycline|doxycycline|mesh-list
139116279|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139116280|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116281|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
139116282|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139116283|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139116284|NCT03815838|Fallypride|fallypride|mesh-list
139116285|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139116286|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139116287|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
139116288|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116289|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116290|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116291|NCT01205724|Factor VIII|factor viii|mesh-list
139116292|NCT01205724|Coagulants|coagulants|mesh-ancestor
139116293|NCT01301820|Lenalidomide|lenalidomide|mesh-list
139116294|NCT01301820|Azacitidine|azacitidine|mesh-list
139116295|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
139116296|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138866892|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139116297|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139116298|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139116299|NCT01301820|Growth Substances|growth substances|mesh-ancestor
139116300|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
139116301|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116302|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139116303|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
139116304|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116305|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116306|NCT01297686|Dexamethasone|dexamethasone|mesh-list
139116307|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139116308|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
139116309|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
139116310|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116311|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116312|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139116313|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
139116315|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139116316|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139116317|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116318|NCT01205880|Calcitriol|calcitriol|mesh-list
139116319|NCT01205880|Clobetasol|clobetasol|mesh-list
139116320|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139116321|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116322|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139116323|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139116324|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116325|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139116326|NCT01205880|Vitamins|vitamins|mesh-ancestor
139116327|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
139116328|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139116329|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139116330|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
139116331|NCT01205880|Hormones|hormones|mesh-ancestor
139116332|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139116333|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
139116334|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139116335|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139116336|NCT01205958|Analgesics|analgesics|mesh-ancestor
139116337|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
139116338|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116339|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116340|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139116341|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139116342|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
139116343|NCT01297842|Meropenem|meropenem|mesh-list
139116344|NCT01297842|Imipenem|imipenem|mesh-list
139116345|NCT01297842|Ertapenem|ertapenem|mesh-list
139116346|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139116347|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116348|NCT01297998|Cisplatin|cisplatin|mesh-list
139116349|NCT01297998|Gemcitabine|gemcitabine|mesh-list
139116350|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116351|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139116352|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
139116353|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116354|NCT01298076|Dexamethasone|dexamethasone|mesh-list
139116355|NCT01298076|Bevacizumab|bevacizumab|mesh-list
139116356|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139116357|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116358|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139116359|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139116360|NCT01298076|Growth Substances|growth substances|mesh-ancestor
139116361|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116362|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
139116363|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139116364|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
139116365|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
139116366|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116367|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139116368|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
139116369|NCT01298076|Hormones|hormones|mesh-ancestor
138635533|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
139116370|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139116371|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139116372|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
139116373|NCT03819348|Clotrimazole|clotrimazole|mesh-list
139116375|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116376|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139116377|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139116378|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139116379|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116380|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116381|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139116382|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
139116383|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139116384|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116385|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139116386|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139116387|NCT01560390|Ketamine|ketamine|mesh-list
139116388|NCT01560390|Analgesics|analgesics|mesh-ancestor
139116389|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
139116390|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116391|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116392|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139116393|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139116394|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
139116395|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
139116396|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116397|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139116398|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139116399|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116400|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116401|NCT03807882|Clozapine|clozapine|mesh-list
139116402|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139116403|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
139116404|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116405|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116406|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116407|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139116408|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139116409|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116410|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139116411|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
139116412|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
139116413|NCT01304472|Clopidogrel|clopidogrel|mesh-list
139116414|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139116415|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139116416|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139116417|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139116418|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139116419|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
139116420|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116421|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116422|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116423|NCT03795792|Curcumin|curcumin|mesh-list
139116424|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139116425|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139116426|NCT03795792|Analgesics|analgesics|mesh-ancestor
139116427|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
139116428|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116429|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116430|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139116431|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139116432|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116433|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116434|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116436|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
139116437|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
139116438|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116439|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116440|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139116441|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
139116442|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
139116443|NCT01303536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139116444|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139116445|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
139116446|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116447|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116448|NCT01303614|Lidocaine|lidocaine|mesh-list
139116449|NCT01303614|Prilocaine|prilocaine|mesh-list
139116450|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139116451|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
139116452|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
139116453|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116454|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116455|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
139116456|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116457|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138956069|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
139116458|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139116459|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139116460|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139116461|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116462|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139116463|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
139116464|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139116465|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
139116466|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
139116467|NCT03802422|Vitamins|vitamins|mesh-ancestor
139116468|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
139116469|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116470|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
139116471|NCT03802422|Hematinics|hematinics|mesh-ancestor
139116472|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
139116473|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139116474|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
139116475|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116476|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
139116477|NCT03801564|Protective Agents|protective agents|mesh-ancestor
139116478|NCT03813186|Decitabine|decitabine|mesh-list
139116479|NCT03813186|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139116480|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139116481|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
139116482|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116483|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116484|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116485|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
139116486|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139116487|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116488|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
138868193|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116489|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139116490|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116491|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139116492|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116494|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139116495|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139116496|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
139116497|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116498|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116499|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116500|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139116501|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
139116502|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
139116503|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116504|NCT03812796|Avelumab|avelumab|mesh-list
139116505|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139116506|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116507|NCT05759104|Adalimumab|adalimumab|mesh-list
139116508|NCT05759104|Infliximab|infliximab|mesh-list
139116509|NCT05759104|Ustekinumab|ustekinumab|mesh-list
139116510|NCT05759104|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139116511|NCT05759104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139116512|NCT05759104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139116513|NCT05759104|Dermatologic Agents|dermatologic agents|mesh-ancestor
139116514|NCT05759104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139116515|NCT01384240|Proflavine|proflavine|mesh-list
139116516|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139116517|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116518|NCT01381510|Finasteride|finasteride|mesh-list
139116519|NCT01381510|Dutasteride|dutasteride|mesh-list
139116520|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
139116521|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139116522|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019548|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139116523|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116524|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
139116525|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139116526|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116527|NCT01381510|Urological Agents|urological agents|mesh-ancestor
139116528|NCT04258072|Vactosertib|vactosertib|mesh-list
139116529|NCT04258072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139116530|NCT04258072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116531|NCT04258072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116532|NCT02984800|Anesthetics|anesthetics|mesh-list
139116533|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116534|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116535|NCT04188730|Lofexidine|lofexidine|mesh-list
139116536|NCT04188730|Clonidine|clonidine|mesh-list
139116537|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139116538|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139116539|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116540|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
139116541|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116542|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139116543|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139116544|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139116545|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
139116546|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116547|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116548|NCT04188730|Analgesics|analgesics|mesh-ancestor
139116549|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
139116550|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
139116551|NCT01381432|Azathioprine|azathioprine|mesh-list
139116552|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
139116553|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116554|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139116555|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116556|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139116557|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
139116558|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116559|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139116560|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
139116561|NCT01381354|Riboflavin|riboflavin|mesh-list
139116562|NCT01381354|Thiamine|thiamine|mesh-list
139116563|NCT01381354|Niacinamide|niacinamide|mesh-list
139116564|NCT01381354|Niacin|niacin|mesh-list
139116565|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
139116566|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
139116567|NCT01381354|Ubiquinone|ubiquinone|mesh-list
139116568|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
139116569|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
139116570|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139116571|NCT01381354|Vitamins|vitamins|mesh-ancestor
139116572|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
139116573|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116574|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
139116575|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116576|NCT01381354|Expectorants|expectorants|mesh-ancestor
139116577|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
139116578|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139116579|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
139116580|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116581|NCT01381354|Protective Agents|protective agents|mesh-ancestor
139116582|NCT01381354|Antidotes|antidotes|mesh-ancestor
139116583|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
139116584|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139116585|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
139116586|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139116587|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
139116588|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139116589|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
139116590|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139116591|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
139116592|NCT01381276|Beta Carotene|beta carotene|mesh-list
139116593|NCT01381276|Vitamin A|vitamin a|mesh-list
139116595|NCT01381276|Carotenoids|carotenoids|mesh-list
139116596|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
139116597|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116598|NCT01381276|Protective Agents|protective agents|mesh-ancestor
138867197|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
139116599|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116600|NCT01381276|Provitamins|provitamins|mesh-ancestor
139116601|NCT01381276|Vitamins|vitamins|mesh-ancestor
139116602|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
139116603|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139116604|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116605|NCT01569256|Cabergoline|cabergoline|mesh-list
139116606|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139116607|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139116608|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
139116609|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
139116610|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116611|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116612|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116613|NCT03794544|Durvalumab|durvalumab|mesh-list
139116614|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139116615|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116616|NCT01380808|Capecitabine|capecitabine|mesh-list
139116617|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139116618|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
139116619|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116620|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116621|NCT03799224|Decitabine|decitabine|mesh-list
139116622|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139116623|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
139116624|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116625|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116626|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116627|NCT03798912|Octreotide|octreotide|mesh-list
139116628|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139116629|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139116630|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116631|NCT03798834|Anesthetics|anesthetics|mesh-list
139116632|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116633|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116634|NCT03812562|Nivolumab|nivolumab|mesh-list
139116635|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139116636|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116637|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139116638|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116639|NCT01304784|Paclitaxel|paclitaxel|mesh-list
139116640|NCT01304784|Docetaxel|docetaxel|mesh-list
139116641|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139116642|NCT01304784|Capecitabine|capecitabine|mesh-list
139116643|NCT01304784|Trastuzumab|trastuzumab|mesh-list
139116644|NCT01304784|Lapatinib|lapatinib|mesh-list
139116645|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139116646|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139116647|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116648|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
139116649|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
139116650|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
139116651|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116652|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139116653|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
139116654|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139116655|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139116656|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116657|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
139116658|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116659|NCT03798600|Caspofungin|caspofungin|mesh-list
139116660|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
139116661|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116662|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116663|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116665|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139116666|NCT03798522|Narcotics|narcotics|mesh-ancestor
139116667|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138635820|NCT00242801|Gefitinib|gefitinib|mesh-list
139116668|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116669|NCT03798522|Analgesics|analgesics|mesh-ancestor
139116670|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
139116671|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116672|NCT01308034|Sunitinib|sunitinib|mesh-list
139116673|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116674|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139116675|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139116676|NCT01308034|Growth Substances|growth substances|mesh-ancestor
139116677|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116678|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
139116679|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139116680|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116681|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116682|NCT01302210|Mupirocin|mupirocin|mesh-list
139116683|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139116684|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116685|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139116686|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116687|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116688|NCT00005044|Bicalutamide|bicalutamide|mesh-list
139116689|NCT00005044|Flutamide|flutamide|mesh-list
139116690|NCT00005044|Hormones|hormones|mesh-list
139116691|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139116692|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139116693|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116694|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
139116695|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
139116696|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116697|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139116698|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139116699|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139116700|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139116701|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139116702|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116703|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116704|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116705|NCT03794154|Analgesics|analgesics|mesh-ancestor
139116706|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
139116707|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116708|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
139116709|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139116710|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
138956134|NCT02563340|Rituximab|rituximab|mesh-list
139116711|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
139116712|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
139116713|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139116714|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116715|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116716|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
139116717|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139116718|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116719|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116720|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
139116721|NCT02722668|Sirolimus|sirolimus|mesh-list
139116722|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
139116723|NCT02722668|Fludarabine|fludarabine|mesh-list
139116724|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139116725|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139116726|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
139116727|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116728|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139116729|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139116730|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
139116731|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116732|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116733|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139116734|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139116735|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139116736|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
139116737|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139116738|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116739|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116740|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
139116742|NCT01303926|Bevacizumab|bevacizumab|mesh-list
139116743|NCT01303926|Carboplatin|carboplatin|mesh-list
139116744|NCT01303926|Pemetrexed|pemetrexed|mesh-list
139116745|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139116746|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116747|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
139116748|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
139116749|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
139116750|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116751|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139116752|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139116753|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139116754|NCT01303926|Growth Substances|growth substances|mesh-ancestor
139116755|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116756|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
139116757|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116758|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139116759|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139116760|NCT03084796|Bromides|bromides|mesh-list
139116761|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
139116762|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139116763|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
139116764|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116765|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116766|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139116767|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
139116768|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
139116769|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139116770|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
139116771|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116772|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116773|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
139116774|NCT03717012|Nintedanib|nintedanib|mesh-list
139116775|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116776|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139116777|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116778|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116779|NCT01302756|Folic Acid|folic acid|mesh-list
139116780|NCT01302756|Hematinics|hematinics|mesh-ancestor
139116781|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
139116782|NCT01302756|Vitamins|vitamins|mesh-ancestor
139116783|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
139116784|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116785|NCT04893252|Durvalumab|durvalumab|mesh-list
139116786|NCT04893252|Vactosertib|vactosertib|mesh-list
139116787|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139116788|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116789|NCT04893252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139116790|NCT04893252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116791|NCT04893252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116792|NCT03797508|Progesterone|progesterone|mesh-list
139116793|NCT03797508|Progestins|progestins|mesh-ancestor
139116794|NCT03797508|Hormones|hormones|mesh-ancestor
139116795|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139116796|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116797|NCT01380496|Doxycycline|doxycycline|mesh-list
139116798|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139116799|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116800|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
139116801|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139116802|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139116803|NCT01304316|Phenylephrine|phenylephrine|mesh-list
139116804|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
139116805|NCT01304316|Tetracaine|tetracaine|mesh-list
139116806|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
139116807|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
139116808|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116809|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116810|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
139116811|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116812|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139116813|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139116814|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
139116815|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635973|NCT00273702|Antidotes|antidotes|mesh-ancestor
139116816|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116817|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
139116818|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
138956156|NCT00785382|Pregabalin|pregabalin|mesh-list
139116819|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
139116820|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139116821|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
139116822|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139116823|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
139116824|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139116825|NCT01304316|Protective Agents|protective agents|mesh-ancestor
139116826|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139116827|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139116828|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139116829|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139116830|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116831|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116832|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116833|NCT03792828|Analgesics|analgesics|mesh-ancestor
139116834|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
139116835|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116836|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
139116837|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139116838|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
139116839|NCT01379326|Mebendazole|mebendazole|mesh-list
139116840|NCT01379326|Piperazine|piperazine|mesh-list
139116841|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
139116842|NCT01379326|DMP 777|dmp 777|mesh-list
139116843|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
139116844|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
139116845|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139116846|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116847|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
139116848|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
139116849|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
139116850|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116851|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116852|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116853|NCT01560546|Testosterone|testosterone|mesh-list
139116854|NCT01560546|Androgens|androgens|mesh-ancestor
139116855|NCT01560546|Hormones|hormones|mesh-ancestor
139116856|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139116857|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116858|NCT03792984|Vitamin D|vitamin d|mesh-list
139116859|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
139116860|NCT03792984|Metformin|metformin|mesh-list
139116861|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
139116862|NCT03792984|Calcium|calcium|mesh-list
139116863|NCT03792984|Vitamins|vitamins|mesh-ancestor
139116864|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
139116865|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116866|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139116867|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139116868|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139116869|NCT03792984|Antacids|antacids|mesh-ancestor
139116870|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116871|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139116872|NCT03792906|Norepinephrine|norepinephrine|mesh-list
139116873|NCT03792906|Bupivacaine|bupivacaine|mesh-list
139116874|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
139116875|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
139116876|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116877|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116878|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
139116879|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116880|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139116881|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139116882|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
139116883|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116884|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116885|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
139116886|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
139116887|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139116888|NCT03078556|Lamivudine|lamivudine|mesh-list
139116889|NCT03078556|Dolutegravir|dolutegravir|mesh-list
139116890|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139116891|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139116892|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116893|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116894|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
139116895|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116896|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139116897|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139116898|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139116899|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139116900|NCT03949894|Tolvaptan|tolvaptan|mesh-list
139116901|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139116902|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116903|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
139116904|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116905|NCT03714672|Diclofenac|diclofenac|mesh-list
139116906|NCT03714672|Tramadol|tramadol|mesh-list
139116907|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139116908|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139116909|NCT03714672|Analgesics|analgesics|mesh-ancestor
139116910|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
139116911|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116912|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116913|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139116914|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139116915|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139116916|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116917|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116918|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139116919|NCT03714672|Narcotics|narcotics|mesh-ancestor
139116920|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116921|NCT03083470|Paclitaxel|paclitaxel|mesh-list
139116922|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139116923|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116924|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
139116925|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
139116926|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
139116927|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116928|NCT01377610|Naltrexone|naltrexone|mesh-list
139116929|NCT01377610|Buprenorphine|buprenorphine|mesh-list
139116930|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139116931|NCT01377610|Narcotics|narcotics|mesh-ancestor
139116932|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116933|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116934|NCT01377610|Analgesics|analgesics|mesh-ancestor
139116935|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
139116936|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116937|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139116938|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139116939|NCT03811080|Fexuprazan|fexuprazan|mesh-list
139116940|NCT03811080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139116941|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139116942|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116943|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116944|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116945|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139116946|NCT03810976|Gemcitabine|gemcitabine|mesh-list
139116947|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139116948|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
139116949|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116950|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116951|NCT05405244|Bromocriptine|bromocriptine|mesh-list
139116952|NCT05405244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116953|NCT05405244|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139116954|NCT05405244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139116955|NCT05405244|Hormone Antagonists|hormone antagonists|mesh-ancestor
139116956|NCT05405244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139116957|NCT05405244|Dopamine Agonists|dopamine agonists|mesh-ancestor
139116958|NCT05405244|Dopamine Agents|dopamine agents|mesh-ancestor
139116959|NCT05405244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116960|NCT05405244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116961|NCT03789006|Interleukin-2|interleukin-2|mesh-list
139116962|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
139116963|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139116964|NCT03789006|Antibodies|antibodies|mesh-list
139116965|NCT03789006|Basiliximab|basiliximab|mesh-list
139116966|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
139116967|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139116968|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
139116969|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116970|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116971|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139116972|NCT03789006|Analgesics|analgesics|mesh-ancestor
139116973|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
139116974|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139116975|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139116976|NCT01306266|Rizatriptan|rizatriptan|mesh-list
139116977|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139116978|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
139116979|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139116980|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116981|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116982|NCT03516214|Trametinib|trametinib|mesh-list
139116983|NCT03516214|Nazartinib|nazartinib|mesh-list
139116984|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139116985|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139116986|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139116987|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139116988|NCT03630796|Sevoflurane|sevoflurane|mesh-list
139116989|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139116990|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139116991|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
139116992|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
139116993|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139116994|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139116995|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139116996|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139116997|NCT01096966|Bupivacaine|bupivacaine|mesh-list
139116998|NCT01096966|Anesthetics, Local|anesthetics, local|mesh-ancestor
139116999|NCT01096966|Anesthetics|anesthetics|mesh-ancestor
139117000|NCT01096966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117001|NCT01096966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117002|NCT01096966|Sensory System Agents|sensory system agents|mesh-ancestor
139117003|NCT01096966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117004|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
139117005|NCT01379560|Dinoprost|dinoprost|mesh-list
139117006|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139117007|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139117008|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
139117009|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139117010|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117011|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
139117012|NCT01379482|Paclitaxel|paclitaxel|mesh-list
139117013|NCT01379482|Docetaxel|docetaxel|mesh-list
139117014|NCT01379482|Cisplatin|cisplatin|mesh-list
139117015|NCT01379482|Doxorubicin|doxorubicin|mesh-list
139117016|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
139117017|NCT01379482|Irinotecan|irinotecan|mesh-list
139117018|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139117019|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117020|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
139117021|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
139117022|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
139117023|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117024|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139117025|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139117026|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139117027|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117028|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139117029|NCT05624424|Sufentanil|sufentanil|mesh-list
139117030|NCT05624424|Remifentanil|remifentanil|mesh-list
139117031|NCT05624424|Propofol|propofol|mesh-list
139117032|NCT05624424|Sevoflurane|sevoflurane|mesh-list
139117033|NCT05624424|Cisatracurium|cisatracurium|mesh-list
139117034|NCT05624424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139117035|NCT05624424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117036|NCT05624424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117037|NCT05624424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139117038|NCT05624424|Anesthetics, General|anesthetics, general|mesh-ancestor
139117039|NCT05624424|Anesthetics|anesthetics|mesh-ancestor
139117040|NCT05624424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139117041|NCT05624424|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139117042|NCT05624424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139117043|NCT05624424|Narcotics|narcotics|mesh-ancestor
139117044|NCT05624424|Analgesics|analgesics|mesh-ancestor
139117045|NCT05624424|Sensory System Agents|sensory system agents|mesh-ancestor
139117046|NCT05624424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867641|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117047|NCT05624424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139117048|NCT05624424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139117049|NCT05624424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139117050|NCT05461690|Niraparib|niraparib|mesh-list
139117051|NCT05461690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139117052|NCT05461690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117053|NCT05461690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117054|NCT05461690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117055|NCT05456230|Midazolam|midazolam|mesh-list
139117056|NCT05456230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139117057|NCT05456230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139117058|NCT05456230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117059|NCT05456230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117060|NCT05456230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139117061|NCT05456230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139117062|NCT05456230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139117063|NCT05456230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139117064|NCT05456230|Anesthetics, General|anesthetics, general|mesh-ancestor
139117065|NCT05456230|Anesthetics|anesthetics|mesh-ancestor
139117066|NCT05456230|GABA Modulators|gaba modulators|mesh-ancestor
139117067|NCT05456230|GABA Agents|gaba agents|mesh-ancestor
139117068|NCT05456230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117069|NCT05456230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117070|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139117071|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
139117072|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117073|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139117074|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117075|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139117076|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117077|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117078|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
139117079|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139117080|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117081|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117082|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139117083|NCT03788538|Analgesics|analgesics|mesh-ancestor
139117084|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
139117085|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117086|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139117087|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139117088|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139117089|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
139117090|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117091|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117092|NCT05320120|Esketamine|esketamine|mesh-list
139117093|NCT05320120|Antidepressive Agents|antidepressive agents|mesh-ancestor
139117094|NCT05320120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139117095|NCT03077698|Megestrol|megestrol|mesh-list
139117096|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
139117097|NCT03077698|Progestins|progestins|mesh-list
139117098|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
139117099|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139117100|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139117101|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139117102|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
139117103|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139117104|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117105|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139117106|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139117107|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138868412|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
139117108|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117109|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
139117110|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139117112|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139117113|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
139117114|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
139117115|NCT01377220|Choline|choline|mesh-list
139117116|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
139117117|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139117118|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
139117119|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117120|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139117121|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139117122|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
139117123|NCT03079102|Nitric Oxide|nitric oxide|mesh-list
139117124|NCT03079102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139117125|NCT03079102|Autonomic Agents|autonomic agents|mesh-ancestor
138867714|NCT00618644|Ranibizumab|ranibizumab|mesh-list
139117126|NCT03079102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117127|NCT03079102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117128|NCT03079102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139117129|NCT03079102|Respiratory System Agents|respiratory system agents|mesh-ancestor
139117130|NCT03079102|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139117131|NCT03079102|Antioxidants|antioxidants|mesh-ancestor
139117132|NCT03079102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117133|NCT03079102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117134|NCT03079102|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139117135|NCT03079102|Vasodilator Agents|vasodilator agents|mesh-ancestor
139117136|NCT03079102|Gasotransmitters|gasotransmitters|mesh-ancestor
139117137|NCT03079102|Protective Agents|protective agents|mesh-ancestor
139117138|NCT03791424|Midazolam|midazolam|mesh-list
139117139|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139117140|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139117141|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117142|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117143|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139117144|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139117145|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139117146|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139117147|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
139117148|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
139117149|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
139117150|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
139117151|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117152|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117153|NCT03787992|Gefitinib|gefitinib|mesh-list
139117154|NCT03787992|Aflutinib|aflutinib|mesh-list
139117155|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868421|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
139117156|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139117157|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117158|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117159|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
139117160|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139117161|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117162|NCT02434354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139117163|NCT02434354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117164|NCT05764018|Caffeine|caffeine|mesh-list
139117165|NCT05764018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139117166|NCT05764018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117167|NCT05764018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139117168|NCT05764018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117169|NCT05764018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117170|NCT05764018|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139117171|NCT05764018|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139117172|NCT05764018|Purinergic Agents|purinergic agents|mesh-ancestor
139117173|NCT05764018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117174|NCT01308528|Enoxaparin|enoxaparin|mesh-list
139117175|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
139117176|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
139117177|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139117178|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139117179|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117180|NCT03785496|Spartalizumab|spartalizumab|mesh-list
139117181|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139117182|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117183|NCT03785496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139117184|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117185|NCT01307202|Gabapentin|gabapentin|mesh-list
138887742|NCT00529087|Bromides|bromides|mesh-list
139117187|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
139117188|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117189|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117190|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
139117191|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139117192|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139117193|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117194|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139117195|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139117196|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139117197|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117198|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117199|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
139117200|NCT01308606|Simeprevir|simeprevir|mesh-list
139117201|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
139117202|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117203|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
139117204|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117205|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117206|NCT04637386|Anesthetics|anesthetics|mesh-list
139117207|NCT04637386|Anesthetics, Local|anesthetics, local|mesh-list
139117208|NCT04637386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117209|NCT04637386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117210|NCT04637386|Sensory System Agents|sensory system agents|mesh-ancestor
139117211|NCT04637386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117212|NCT01308684|Bevacizumab|bevacizumab|mesh-list
139117213|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139117214|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117215|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139117216|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139117217|NCT01308684|Growth Substances|growth substances|mesh-ancestor
139117218|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117219|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
139117220|NCT05613114|4-Aminopyridine|4-aminopyridine|mesh-list
139117221|NCT05613114|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139117222|NCT05613114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139117223|NCT05613114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117224|NCT03790566|Bupivacaine|bupivacaine|mesh-list
139117225|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
139117226|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
139117227|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117228|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117229|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
139117230|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117231|NCT04436224|Fentanyl|fentanyl|mesh-list
139117232|NCT04436224|Hydromorphone|hydromorphone|mesh-list
139117233|NCT04436224|Butorphanol|butorphanol|mesh-list
139117234|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139117235|NCT04436224|Narcotics|narcotics|mesh-ancestor
139117236|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117237|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117238|NCT04436224|Analgesics|analgesics|mesh-ancestor
139117239|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
139117240|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117241|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139117242|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139117243|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
139117244|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
139117245|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
139117246|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
139117247|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139117248|NCT03785184|Dexamethasone|dexamethasone|mesh-list
139117249|NCT03785184|Lenalidomide|lenalidomide|mesh-list
139117250|NCT03785184|Venetoclax|venetoclax|mesh-list
139117251|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139117252|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
139117253|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
139117254|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117255|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117256|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139117257|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
139117258|NCT03785184|Hormones|hormones|mesh-ancestor
139117259|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139117260|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139117261|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117262|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
139117263|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139117264|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139117265|NCT03785184|Growth Substances|growth substances|mesh-ancestor
139117266|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
139117268|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
139117269|NCT03784794|Coagulants|coagulants|mesh-ancestor
139117270|NCT01378546|Amifampridine|amifampridine|mesh-list
139117271|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139117272|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117273|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868461|NCT00622206|Saquinavir|saquinavir|mesh-list
139117274|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139117275|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139117276|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117278|NCT05688384|Propofol|propofol|mesh-list
139117279|NCT05688384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139117280|NCT05688384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117281|NCT05688384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117282|NCT05688384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139117283|NCT05688384|Anesthetics, General|anesthetics, general|mesh-ancestor
139117284|NCT05688384|Anesthetics|anesthetics|mesh-ancestor
139117285|NCT05688384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139117286|NCT05688384|Narcotics|narcotics|mesh-ancestor
139117287|NCT05688384|Analgesics|analgesics|mesh-ancestor
139117288|NCT05688384|Sensory System Agents|sensory system agents|mesh-ancestor
139117289|NCT05688384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117290|NCT01307592|Rituximab|rituximab|mesh-list
139117291|NCT01307592|Gemcitabine|gemcitabine|mesh-list
139117292|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
139117293|NCT01307592|Lenalidomide|lenalidomide|mesh-list
139117294|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139117295|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117296|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
139117297|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117298|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139117299|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139117300|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
139117301|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117302|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139117303|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139117304|NCT01307592|Growth Substances|growth substances|mesh-ancestor
139117305|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
139117306|NCT03790020|Bupivacaine|bupivacaine|mesh-list
139117307|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
139117308|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
139117309|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117310|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117311|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
139117312|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117313|NCT03075826|Guadecitabine|guadecitabine|mesh-list
139117314|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117315|NCT01378156|Vaccines|vaccines|mesh-list
139117316|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
139117317|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117318|NCT04108234|Ketamine|ketamine|mesh-list
139117319|NCT04108234|Analgesics|analgesics|mesh-ancestor
139117320|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
139117321|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117322|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868478|NCT03582293|Coagulants|coagulants|mesh-ancestor
139117323|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139117324|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139117325|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
139117326|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
139117327|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117328|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139117329|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139117330|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117331|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117332|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139117333|NCT03687814|Laxatives|laxatives|mesh-ancestor
139117334|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139117335|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
139117336|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139117337|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117338|NCT03781596|Fluticasone|fluticasone|mesh-list
139117340|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139117341|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139117342|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
139117343|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117344|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117345|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139117346|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
139117347|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
139117348|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138867934|NCT00620646|Aspirin|aspirin|mesh-list
139117349|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139117350|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139117351|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139117352|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117353|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117354|NCT03781674|Progesterone|progesterone|mesh-list
139117355|NCT03781674|Progestins|progestins|mesh-ancestor
139117356|NCT03781674|Hormones|hormones|mesh-ancestor
139117357|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139117358|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117359|NCT03786120|Zolpidem|zolpidem|mesh-list
139117360|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139117361|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139117362|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117363|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117364|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139117365|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
139117366|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
139117367|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117368|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117369|NCT01561014|Fluorouracil|fluorouracil|mesh-list
139117370|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
139117371|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139117372|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139117373|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
138956293|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
139117374|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117375|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139117376|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117377|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139117378|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
139117379|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117380|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139117381|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117382|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139117383|NCT01561092|Escitalopram|escitalopram|mesh-list
139117384|NCT01561092|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139117385|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139117386|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139117387|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117388|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117389|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
139117390|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117392|NCT05494866|Paclitaxel|paclitaxel|mesh-list
139117393|NCT05494866|Gemcitabine|gemcitabine|mesh-list
139117394|NCT05494866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139117395|NCT05494866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117396|NCT05494866|Tubulin Modulators|tubulin modulators|mesh-ancestor
139117397|NCT05494866|Antimitotic Agents|antimitotic agents|mesh-ancestor
139117398|NCT05494866|Mitosis Modulators|mitosis modulators|mesh-ancestor
139117399|NCT05494866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117400|NCT05494866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139117401|NCT05494866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139117402|NCT05494866|Antiviral Agents|antiviral agents|mesh-ancestor
139117403|NCT05494866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117404|NCT05494866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139117405|NCT05494866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139117406|NCT05494866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117407|NCT05494866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139117408|NCT05494866|Antimetabolites|antimetabolites|mesh-ancestor
139117409|NCT01316874|Valrubicin|valrubicin|mesh-list
139117410|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117411|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139117412|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139117413|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117414|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117415|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139117416|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139117417|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139117418|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139117419|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117420|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117421|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117422|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
139117423|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139117424|NCT01309620|Zinc|zinc|mesh-list
138868010|NCT02848157|Analgesics|analgesics|mesh-ancestor
139117425|NCT01309620|Trace Elements|trace elements|mesh-ancestor
139117426|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
139117427|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117428|NCT03783312|Acetaminophen|acetaminophen|mesh-list
139117429|NCT03783312|Ibuprofen|ibuprofen|mesh-list
139117430|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139117431|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139117432|NCT03783312|Analgesics|analgesics|mesh-ancestor
139117433|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
139117434|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117435|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117436|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139117437|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139117438|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139117439|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117440|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117441|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
139117442|NCT03776916|Simethicone|simethicone|mesh-list
139117443|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
139117444|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117445|NCT03776916|Emollients|emollients|mesh-ancestor
139117446|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
139117447|NCT01560702|Epinephrine|epinephrine|mesh-list
139117448|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139117449|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139117450|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
139117451|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117452|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117453|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117454|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139117455|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139117456|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
139117457|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117458|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139117459|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
139117460|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
139117461|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
139117462|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139117463|NCT03776838|Fentanyl|fentanyl|mesh-list
139117464|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139117465|NCT03776838|Narcotics|narcotics|mesh-ancestor
139117466|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117467|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117468|NCT03776838|Analgesics|analgesics|mesh-ancestor
139117469|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
139117470|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117471|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139117472|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139117473|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
139117474|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
139117475|NCT03781050|Sirolimus|sirolimus|mesh-list
139117476|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139117477|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117478|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139117479|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117480|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
139117481|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139117482|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
139117483|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117484|NCT02865850|Darbepoetin alfa|darbepoetin alfa|mesh-list
139117485|NCT02865850|Hematinics|hematinics|mesh-ancestor
139117486|NCT01309698|Inositol|inositol|mesh-list
139117487|NCT01309698|Vildagliptin|vildagliptin|mesh-list
139117488|NCT01309698|Voglibose|voglibose|mesh-list
139117489|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139117490|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117491|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139117492|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
139117493|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117494|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117495|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139117496|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
139117497|NCT01309698|Vitamins|vitamins|mesh-ancestor
139117498|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
139117499|NCT01142284|Cilostazol|cilostazol|mesh-list
139117500|NCT01142284|Probucol|probucol|mesh-list
139117501|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139117502|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
139117503|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117504|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117505|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139117506|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
139117507|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139117508|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139117509|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117510|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139117511|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
139117512|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139117513|NCT01142284|Protective Agents|protective agents|mesh-ancestor
139117514|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139117515|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139117516|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117517|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139117518|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139117519|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
139117520|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139117521|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
139117522|NCT01309776|Tianeptine|tianeptine|mesh-list
139117523|NCT01309776|Escitalopram|escitalopram|mesh-list
139117524|NCT01309776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139117525|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139117526|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139117527|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117528|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117529|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
139117530|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117531|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
139117532|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139117533|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139117534|NCT03783000|BI 425809|bi 425809|mesh-list
139117535|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
139117536|NCT01309854|Pioglitazone|pioglitazone|mesh-list
139117537|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139117538|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117539|NCT03780192|Sirolimus|sirolimus|mesh-list
139117540|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139117541|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117542|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139117543|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117544|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
139117545|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139117546|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
139117547|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117548|NCT05305560|Ivermectin|ivermectin|mesh-list
139117549|NCT05305560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139117550|NCT05305560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117551|NCT03776448|Charcoal|charcoal|mesh-list
139117552|NCT03776448|Antidotes|antidotes|mesh-ancestor
139117553|NCT03776448|Protective Agents|protective agents|mesh-ancestor
139117554|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117555|NCT03780270|Fluorides|fluorides|mesh-list
139117556|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
139117557|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
139117558|NCT03780270|Protective Agents|protective agents|mesh-ancestor
139117559|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117560|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
139117561|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139117562|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117563|NCT03072160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139117564|NCT03072160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117565|NCT05517486|Bupivacaine|bupivacaine|mesh-list
139117566|NCT05517486|Anesthetics, Local|anesthetics, local|mesh-ancestor
139117567|NCT05517486|Anesthetics|anesthetics|mesh-ancestor
139117568|NCT05517486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117569|NCT05517486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117570|NCT05517486|Sensory System Agents|sensory system agents|mesh-ancestor
139117571|NCT05517486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117572|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
139117573|NCT01019356|Acarbose|acarbose|mesh-list
139117574|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139117575|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117576|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139117577|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117578|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117579|NCT01314066|Bevacizumab|bevacizumab|mesh-list
139117580|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139117581|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117582|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139117583|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139117584|NCT01314066|Growth Substances|growth substances|mesh-ancestor
139117585|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117586|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
139117587|NCT01314300|Lidocaine|lidocaine|mesh-list
139117588|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
139117589|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
139117590|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117591|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117592|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
139117593|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117594|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139117595|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139117596|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139117597|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139117598|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117599|NCT03776058|Cinacalcet|cinacalcet|mesh-list
139117600|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139117601|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117602|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139117603|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
139117604|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139117605|NCT05202496|Calcitriol|calcitriol|mesh-list
139117606|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139117607|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117608|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139117609|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139117610|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117611|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139117612|NCT05202496|Vitamins|vitamins|mesh-ancestor
139117613|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
139117614|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139117615|NCT03779568|Bupivacaine|bupivacaine|mesh-list
139117616|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
139117617|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
139117618|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117619|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117620|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
139117621|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117622|NCT05201560|Fentanyl|fentanyl|mesh-list
139117623|NCT05201560|Butorphanol|butorphanol|mesh-list
139117624|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139117625|NCT05201560|Narcotics|narcotics|mesh-ancestor
139117626|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117627|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117628|NCT05201560|Analgesics|analgesics|mesh-ancestor
139117629|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
139117630|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117631|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139117632|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139117633|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
139117634|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
139117635|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
139117636|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
139117637|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139117638|NCT05201326|Bevacizumab|bevacizumab|mesh-list
139117639|NCT05201326|Irinotecan|irinotecan|mesh-list
139117640|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139117641|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117642|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139117643|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139117644|NCT05201326|Growth Substances|growth substances|mesh-ancestor
139117645|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117646|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
139117647|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139117648|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139117649|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117650|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117651|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
139117652|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139117653|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117654|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117655|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139117656|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117657|NCT01561404|Everolimus|everolimus|mesh-list
139117658|NCT01561404|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139117659|NCT01561404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139117660|NCT01561404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117661|NCT01561404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117662|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139117663|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
139117664|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117665|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117666|NCT03775590|Acetic Acid|acetic acid|mesh-list
139117667|NCT03775590|Retinol acetate|retinol acetate|mesh-list
139117668|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139117669|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117670|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139117671|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
139117672|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117673|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138956360|NCT00930189|Triamcinolone|triamcinolone|mesh-list
139117674|NCT03775590|Protective Agents|protective agents|mesh-ancestor
139117675|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117676|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
139117677|NCT03775746|Clopidogrel|clopidogrel|mesh-list
139117678|NCT03775746|Ticagrelor|ticagrelor|mesh-list
139117679|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139117680|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139117681|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139117682|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139117683|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
139117684|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117685|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117686|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117687|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139117688|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
139117689|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139117690|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
139117691|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117692|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
139117693|NCT03779178|Landiolol|landiolol|mesh-list
139117694|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139117695|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139117696|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
139117697|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117698|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117699|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117700|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139117701|NCT03779100|Lenvatinib|lenvatinib|mesh-list
139117702|NCT03779100|Antibodies|antibodies|mesh-list
139117703|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
139117704|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
139117705|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117706|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117707|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139117708|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117709|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117710|NCT05711212|Xanthohumol|xanthohumol|mesh-list
139117711|NCT05711212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117712|NCT05711212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139117713|NCT05711212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139117714|NCT05711212|Growth Substances|growth substances|mesh-ancestor
139117715|NCT05711212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117716|NCT05711212|Growth Inhibitors|growth inhibitors|mesh-ancestor
139117717|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
139117718|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139117719|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
139117720|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139117721|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139117722|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117723|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
139117724|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
139117725|NCT03775356|Anesthetics|anesthetics|mesh-list
139117726|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117727|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117728|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
139117729|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
139117730|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139117731|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139117732|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139117733|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117734|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
139117735|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
139117736|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
139117737|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117738|NCT05211622|Protective Agents|protective agents|mesh-ancestor
139117739|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117740|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
139117742|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
139117743|NCT05705518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139117744|NCT05705518|Lubricant Eye Drops|lubricant eye drops|mesh-list
139117745|NCT05705518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139117747|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
139117748|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117749|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117750|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
139117751|NCT03778008|Gentamicins|gentamicins|mesh-list
139117752|NCT03778008|Dexamethasone|dexamethasone|mesh-list
139117753|NCT03778008|Lidocaine|lidocaine|mesh-list
139117754|NCT03778008|Mitogens|mitogens|mesh-list
139117755|NCT03778008|Vitamins|vitamins|mesh-ancestor
139117756|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
139117757|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117758|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139117759|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
139117760|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
139117761|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117762|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139117763|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
139117764|NCT03778008|Hormones|hormones|mesh-ancestor
139117765|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139117766|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139117767|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117768|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
139117769|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
139117770|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117771|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
139117772|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139117773|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139117774|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139117775|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139117776|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117777|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
139117778|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
139117779|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139117780|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117781|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139117782|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117783|NCT05697328|Pseudoephedrine|pseudoephedrine|mesh-list
139117784|NCT05697328|Ephedrine|ephedrine|mesh-list
139117785|NCT05697328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139117786|NCT05697328|Autonomic Agents|autonomic agents|mesh-ancestor
139117787|NCT05697328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117788|NCT05697328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117789|NCT05697328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139117790|NCT05697328|Respiratory System Agents|respiratory system agents|mesh-ancestor
139117791|NCT05697328|Nasal Decongestants|nasal decongestants|mesh-ancestor
139117792|NCT05697328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139117793|NCT05697328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139117794|NCT05697328|Sympathomimetics|sympathomimetics|mesh-ancestor
139117795|NCT05697328|Adrenergic Agents|adrenergic agents|mesh-ancestor
139117796|NCT05697328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117797|NCT05697328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117798|NCT03777930|Thalidomide|thalidomide|mesh-list
139117799|NCT03777930|Megestrol|megestrol|mesh-list
139117800|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
139117801|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139117802|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
139117803|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117804|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
139117805|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139117806|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117807|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139117808|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139117809|NCT03777930|Growth Substances|growth substances|mesh-ancestor
139117810|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
139117811|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117812|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139117813|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139117814|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139117815|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
139117816|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139117817|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139117818|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139117819|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139117820|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
139117821|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139117822|NCT03777696|Misoprostol|misoprostol|mesh-list
139117823|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139117824|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
139117825|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139117826|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117827|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139117828|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139117829|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
139117831|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
139117832|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
139117833|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117834|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
139117835|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
139117836|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139117837|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139117838|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
139117839|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117840|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117841|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117842|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117843|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139117844|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117845|NCT03774108|Metformin|metformin|mesh-list
139117846|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139117847|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117848|NCT03438526|Melatonin|melatonin|mesh-list
139117849|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
139117850|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117851|NCT03438526|Protective Agents|protective agents|mesh-ancestor
139117852|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117853|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117854|NCT02575144|Clarithromycin|clarithromycin|mesh-list
139117855|NCT02575144|Dexamethasone|dexamethasone|mesh-list
139117856|NCT02575144|Lenalidomide|lenalidomide|mesh-list
139117857|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139117858|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
139117859|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
139117860|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117861|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117862|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139117863|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
139117865|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139117866|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139117867|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117868|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
139117869|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139117870|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139117871|NCT02575144|Growth Substances|growth substances|mesh-ancestor
139117872|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
139117873|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139117874|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868673|NCT00092807|Ezetimibe|ezetimibe|mesh-list
139117875|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139117876|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117877|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117878|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139117879|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139117881|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139117882|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139117883|NCT03768882|Analgesics|analgesics|mesh-ancestor
139117884|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
139117885|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117886|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117887|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
139117888|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139117889|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139117890|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139117891|NCT02574286|Vitamin D|vitamin d|mesh-list
139117892|NCT02574286|Vitamins|vitamins|mesh-ancestor
139117893|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
139117894|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117895|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139117896|NCT01321944|Nicotine|nicotine|mesh-list
139117897|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139117898|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
139117899|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117900|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117901|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139117902|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139117903|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
139117904|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139117905|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117906|NCT03771846|Leucovorin|leucovorin|mesh-list
139117907|NCT03771846|Gemcitabine|gemcitabine|mesh-list
139117908|NCT03771846|Fluorouracil|fluorouracil|mesh-list
139117909|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
139117910|NCT03771846|Irinotecan|irinotecan|mesh-list
139117911|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139117912|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
139117913|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117914|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117915|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139117916|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
139117917|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117918|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139117919|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139117920|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117921|NCT03771846|Antidotes|antidotes|mesh-ancestor
139117922|NCT03771846|Protective Agents|protective agents|mesh-ancestor
139117923|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
139117924|NCT03771846|Vitamins|vitamins|mesh-ancestor
139117925|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
139117926|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139117927|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139117928|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139117929|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
139117931|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139117932|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139117933|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139117934|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139117935|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
139117937|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139117938|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117939|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139117940|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
139117941|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117942|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117943|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
139117945|NCT03768258|Testosterone|testosterone|mesh-list
139117946|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
139117947|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
139117948|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139117949|NCT03768258|Androgens|androgens|mesh-ancestor
139117950|NCT03768258|Hormones|hormones|mesh-ancestor
139117951|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139117952|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117953|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139117954|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117955|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
139117956|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139117957|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139117958|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117959|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117960|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139117961|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
139117962|NCT03771222|Decitabine|decitabine|mesh-list
139117963|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139117964|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
139117965|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117966|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117967|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117968|NCT03771066|Bisphenol A|bisphenol a|mesh-list
139117969|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139117970|NCT03771066|Estrogens|estrogens|mesh-ancestor
139117971|NCT03771066|Hormones|hormones|mesh-ancestor
139117972|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139117973|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117974|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139117975|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
139117976|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117977|NCT03771066|Protective Agents|protective agents|mesh-ancestor
139117978|NCT03768024|Hydromorphone|hydromorphone|mesh-list
139117979|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139117980|NCT03768024|Narcotics|narcotics|mesh-ancestor
139117981|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139117982|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139117983|NCT03768024|Analgesics|analgesics|mesh-ancestor
139117984|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
139117985|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139117986|NCT03999684|Tretinoin|tretinoin|mesh-list
139117987|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117988|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
139117989|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
139117990|NCT02083354|Trametinib|trametinib|mesh-list
139117991|NCT02083354|Dabrafenib|dabrafenib|mesh-list
139117992|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139117993|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139117994|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139117995|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139117996|NCT01399918|Bevacizumab|bevacizumab|mesh-list
139117997|NCT01399918|Everolimus|everolimus|mesh-list
139117998|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139117999|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118000|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139118001|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139118002|NCT01399918|Growth Substances|growth substances|mesh-ancestor
139118003|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118004|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
139118005|NCT01399918|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139118006|NCT01399918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139118007|NCT01399918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118008|NCT01399918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118009|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139118011|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
139118012|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139118013|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
139118014|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118015|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
139118016|NCT03761472|Protective Agents|protective agents|mesh-ancestor
139118017|NCT03767322|Allopurinol|allopurinol|mesh-list
139118018|NCT03767322|Febuxostat|febuxostat|mesh-list
139118019|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
139118020|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118021|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118022|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
139118023|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139118024|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139118025|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
139118026|NCT03767322|Protective Agents|protective agents|mesh-ancestor
139118027|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118028|NCT03761004|Levodopa|levodopa|mesh-list
139118029|NCT03761004|Carbidopa|carbidopa|mesh-list
139118030|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139118031|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139118032|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139118033|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
139118034|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118035|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118036|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118037|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139118038|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118039|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139118040|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
139118041|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
139118042|NCT03770208|Lidocaine|lidocaine|mesh-list
138868764|NCT00619034|Diclofenac|diclofenac|mesh-list
139118043|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
139118044|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
139118045|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118046|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118047|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
139118048|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118049|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139118050|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139118051|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139118052|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139118053|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118054|NCT03766854|Insulin|insulin|mesh-list
139118055|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139118056|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
139118057|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139118058|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118059|NCT01322100|Bleomycin|bleomycin|mesh-list
139118060|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139118061|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118062|NCT03760848|Midazolam|midazolam|mesh-list
139118063|NCT03760848|Atorvastatin|atorvastatin|mesh-list
139118064|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139118065|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139118066|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118067|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118068|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139118069|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139118070|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139118071|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139118072|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
139118073|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
139118074|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
139118075|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
139118076|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118077|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118078|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139118079|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139118080|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
139118081|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139118082|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139118083|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118084|NCT01567488|Everolimus|everolimus|mesh-list
139118085|NCT01567488|Octreotide|octreotide|mesh-list
139118086|NCT01567488|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139118087|NCT01567488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139118088|NCT01567488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118089|NCT01567488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118090|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139118091|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
139118092|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118093|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118094|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139118095|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139118096|NCT03760770|Riboflavin|riboflavin|mesh-list
139118097|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
139118098|NCT03760770|Vitamins|vitamins|mesh-ancestor
139118099|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
139118100|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118101|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139118102|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
139118103|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
139118104|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139118105|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118106|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139118107|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139118108|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118109|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118110|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118111|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139118112|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139118113|NCT01322178|Cetuximab|cetuximab|mesh-list
139118114|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139118115|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118116|NCT03760614|Entinostat|entinostat|mesh-list
139118117|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118118|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139118119|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118120|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118121|NCT00112840|Bevacizumab|bevacizumab|mesh-list
139118122|NCT00112840|Temsirolimus|temsirolimus|mesh-list
139118123|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139118124|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118125|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139118126|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139118127|NCT00112840|Growth Substances|growth substances|mesh-ancestor
139118128|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118129|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
139118130|NCT00112840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139118131|NCT00112840|Immunologic Factors|immunologic factors|mesh-ancestor
139118132|NCT00112840|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139118133|NCT00112840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139118134|NCT00112840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956594|NCT00932685|Midazolam|midazolam|mesh-list
139118135|NCT00112840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118136|NCT03769818|Dexamethasone|dexamethasone|mesh-list
139118137|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
139118138|NCT03769818|Bupivacaine|bupivacaine|mesh-list
139118139|NCT03769818|BB 1101|bb 1101|mesh-list
139118140|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139118141|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
139118142|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
139118143|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118144|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118145|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139118146|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
139118147|NCT03769818|Hormones|hormones|mesh-ancestor
139118148|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139118149|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139118150|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118151|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
139118152|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118153|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118154|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
139118155|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
139118156|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118157|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
139118158|NCT05223244|Triamcinolone|triamcinolone|mesh-list
139118159|NCT05223244|Heparin|heparin|mesh-list
139118161|NCT05223244|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139118162|NCT05223244|Anesthetics, Local|anesthetics, local|mesh-ancestor
139118163|NCT05223244|Anesthetics|anesthetics|mesh-ancestor
139118164|NCT05223244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118165|NCT05223244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118166|NCT05223244|Sensory System Agents|sensory system agents|mesh-ancestor
139118167|NCT05223244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118168|NCT05223244|Anticoagulants|anticoagulants|mesh-ancestor
139118169|NCT05223244|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139118170|NCT05223244|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139118171|NCT05223244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118172|NCT05223244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139118173|NCT05223244|Glucocorticoids|glucocorticoids|mesh-ancestor
139118174|NCT05223244|Hormones|hormones|mesh-ancestor
139118175|NCT05223244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139118176|NCT05223244|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139118177|NCT05223244|Protective Agents|protective agents|mesh-ancestor
139118178|NCT05223244|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139118179|NCT05223244|Antioxidants|antioxidants|mesh-ancestor
139118180|NCT03760302|Analgesics|analgesics|mesh-list
139118181|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139118182|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
139118183|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118184|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118185|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118187|NCT03766074|Vitamins|vitamins|mesh-ancestor
139118188|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
139118189|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118190|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139118191|NCT05219656|Cyclosporine|cyclosporine|mesh-list
139118192|NCT05219656|Cyclosporins|cyclosporins|mesh-list
139118193|NCT05219656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118194|NCT05219656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118195|NCT05219656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139118196|NCT05219656|Immunologic Factors|immunologic factors|mesh-ancestor
139118197|NCT05219656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118198|NCT05219656|Antifungal Agents|antifungal agents|mesh-ancestor
139118199|NCT05219656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118200|NCT05219656|Dermatologic Agents|dermatologic agents|mesh-ancestor
139118201|NCT05219656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139118202|NCT05219656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139118203|NCT05168644|Niclosamide|niclosamide|mesh-list
139118204|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
139118205|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139118206|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
139118207|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139118208|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118209|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
139118210|NCT05412888|Coenzyme Q10|coenzyme q10|mesh-list
139118211|NCT05412888|Ubiquinone|ubiquinone|mesh-list
139118212|NCT05412888|Vitamins|vitamins|mesh-ancestor
139118213|NCT05412888|Micronutrients|micronutrients|mesh-ancestor
139118214|NCT05412888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118215|NCT05087212|Plerixafor|plerixafor|mesh-list
139118216|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139118217|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139118218|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
139118219|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118220|NCT01532310|Belimumab|belimumab|mesh-list
139118221|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139118222|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
139118223|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118224|NCT01321788|Tinzaparin|tinzaparin|mesh-list
139118225|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139118226|NCT01321788|Dalteparin|dalteparin|mesh-list
139118227|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
139118228|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138868848|NCT02697162|Octenidine|octenidine|mesh-list
139118229|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139118230|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118231|NCT05053828|Clopidogrel|clopidogrel|mesh-list
139118232|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139118233|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139118234|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139118235|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139118236|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
139118237|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118238|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118239|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118241|NCT04920838|Ciclesonide|ciclesonide|mesh-list
139118242|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
139118243|NCT04920838|Budesonide|budesonide|mesh-list
139118244|NCT04920838|Telmisartan|telmisartan|mesh-list
139118245|NCT04920838|Fluoxetine|fluoxetine|mesh-list
139118246|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139118247|NCT04920838|Analgesics|analgesics|mesh-ancestor
139118248|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
139118249|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118250|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118251|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
139118252|NCT04920838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139118253|NCT04920838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139118254|NCT04920838|Autonomic Agents|autonomic agents|mesh-ancestor
139118255|NCT04920838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139118256|NCT04920838|Respiratory System Agents|respiratory system agents|mesh-ancestor
139118257|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
139118258|NCT04920838|Hormones|hormones|mesh-ancestor
139118259|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139118260|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139118261|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139118262|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139118263|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118264|NCT04920838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139118265|NCT04920838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139118266|NCT04920838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139118267|NCT04920838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118268|NCT04920838|Serotonin Agents|serotonin agents|mesh-ancestor
139118269|NCT04920838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139118270|NCT04920838|Antidepressive Agents|antidepressive agents|mesh-ancestor
139118271|NCT04920838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139118272|NCT04920838|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139118273|NCT04920838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139118274|NCT04920838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118275|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139118276|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118277|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139118278|NCT03764280|Insulin|insulin|mesh-list
139118279|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
139118280|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139118281|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118282|NCT03764202|Sufentanil|sufentanil|mesh-list
139118283|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139118284|NCT03764202|Narcotics|narcotics|mesh-ancestor
139118285|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118286|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118287|NCT03764202|Analgesics|analgesics|mesh-ancestor
139118288|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
138868890|NCT03451578|Hormones|hormones|mesh-ancestor
139118289|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118290|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139118291|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139118292|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
139118293|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
139118294|NCT04678492|Amoxicillin|amoxicillin|mesh-list
139118295|NCT04678492|Tetracycline|tetracycline|mesh-list
139118296|NCT04678492|Furazolidone|furazolidone|mesh-list
139118297|NCT04678492|Esomeprazole|esomeprazole|mesh-list
139118298|NCT04678492|Bismuth|bismuth|mesh-list
139118299|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139118300|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118301|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139118302|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139118303|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139118304|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118305|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118306|NCT04678492|Antacids|antacids|mesh-ancestor
139118307|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139118308|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139118309|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139118310|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139118311|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139118312|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138637460|NCT00416832|Hormones|hormones|mesh-ancestor
139118314|NCT03176784|Nicotine|nicotine|mesh-list
139118315|NCT03176784|Varenicline|varenicline|mesh-list
138956637|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
139118316|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139118317|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
139118318|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118319|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118320|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139118321|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139118322|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
139118323|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118324|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118325|NCT05091528|Capecitabine|capecitabine|mesh-list
139118326|NCT05091528|Trastuzumab|trastuzumab|mesh-list
139118327|NCT05091528|Tucatinib|tucatinib|mesh-list
139118328|NCT05091528|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139118329|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139118330|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
139118331|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118332|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118333|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139118334|NCT05091528|Immunoconjugates|immunoconjugates|mesh-ancestor
139118335|NCT05091528|Immunologic Factors|immunologic factors|mesh-ancestor
139118336|NCT05091528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118337|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139118338|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118340|NCT04236258|Nifedipine|nifedipine|mesh-list
139118341|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139118342|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139118343|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118344|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139118345|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118346|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
139118347|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
139118348|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139118349|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138868904|NCT00602472|Incretins|incretins|mesh-ancestor
139118350|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
139118351|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118352|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139118353|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139118354|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
139118355|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139118356|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118357|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139118358|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
139118359|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118360|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139118361|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
139118362|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139118363|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118364|NCT03049618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139118365|NCT03049618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118366|NCT05536102|Doxorubicin|doxorubicin|mesh-list
139118367|NCT05536102|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139118368|NCT05536102|Capecitabine|capecitabine|mesh-list
139118369|NCT05536102|Oxaliplatin|oxaliplatin|mesh-list
139118370|NCT05536102|Tislelizumab|tislelizumab|mesh-list
139118371|NCT05536102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139118372|NCT05536102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118373|NCT05536102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139118374|NCT05536102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139118375|NCT05536102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118376|NCT05536102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118377|NCT05536102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139118378|NCT05536102|Antimetabolites|antimetabolites|mesh-ancestor
139118379|NCT05536102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139118380|NCT05524714|Xanthohumol|xanthohumol|mesh-list
139118381|NCT05524714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118382|NCT05524714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139118383|NCT05524714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139118384|NCT05524714|Growth Substances|growth substances|mesh-ancestor
139118385|NCT05524714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118386|NCT05524714|Growth Inhibitors|growth inhibitors|mesh-ancestor
139118388|NCT05692804|Anticoagulants|anticoagulants|mesh-ancestor
139118389|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
139118390|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139118391|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
139118392|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118393|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118394|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139118395|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
139118396|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
139118397|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139118398|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
139118399|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118400|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118401|NCT05692570|Ritonavir|ritonavir|mesh-list
139118402|NCT05692570|Cobicistat|cobicistat|mesh-list
139118403|NCT05692570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139118404|NCT05692570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139118405|NCT05692570|Protease Inhibitors|protease inhibitors|mesh-ancestor
139118406|NCT05692570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118407|NCT05692570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118408|NCT05692570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139118409|NCT05692570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139118410|NCT05692570|Antiviral Agents|antiviral agents|mesh-ancestor
139118411|NCT05692570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118412|NCT05692570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139118413|NCT05692570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139118414|NCT05691556|Botulinum Toxins|botulinum toxins|mesh-list
139118415|NCT05691556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139118416|NCT05691556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139118417|NCT05691556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118418|NCT05691556|Cholinergic Agents|cholinergic agents|mesh-ancestor
139118419|NCT05691556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118420|NCT05691556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118421|NCT05689450|Amikacin|amikacin|mesh-list
139118422|NCT05689450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139118423|NCT05689450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118424|NCT05417308|Minoxidil|minoxidil|mesh-list
139118425|NCT05417308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139118426|NCT05417308|Vasodilator Agents|vasodilator agents|mesh-ancestor
139118427|NCT04650542|Paroxetine|paroxetine|mesh-list
138220310|NCT04743661|Hormones|hormones|mesh-ancestor
139118428|NCT04650542|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139118429|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139118430|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139118431|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118432|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118433|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
139118434|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118435|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139118436|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
139118437|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139118438|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139118439|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139118440|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118441|NCT04621058|Vitamin D|vitamin d|mesh-list
139118442|NCT04621058|Vitamins|vitamins|mesh-list
139118443|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
139118444|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118445|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139118446|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
139118447|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
139118448|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139118449|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139118450|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118451|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118452|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118453|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139118454|NCT04451330|Doxycycline|doxycycline|mesh-list
139118455|NCT04451330|Trifarotene|trifarotene|mesh-list
139118456|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139118457|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118458|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
139118459|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139118460|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139118462|NCT02493426|Oxytocin|oxytocin|mesh-list
139118463|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
139118464|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139118465|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118466|NCT03763734|Dexamethasone|dexamethasone|mesh-list
139118467|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139118468|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
139118469|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
139118470|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118471|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868933|NCT02685306|Paclitaxel|paclitaxel|mesh-list
139118472|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139118473|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
139118474|NCT03763734|Hormones|hormones|mesh-ancestor
139118475|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139118476|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139118477|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118478|NCT05063136|Capecitabine|capecitabine|mesh-list
139118479|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139118480|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
139118481|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118482|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118483|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139118484|NCT03756324|Cefdinir|cefdinir|mesh-list
139118485|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139118486|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118487|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
139118488|NCT03751202|Fluticasone|fluticasone|mesh-list
139118489|NCT03751202|Xhance|xhance|mesh-list
139118490|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139118491|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139118492|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139118493|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139118494|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
139118495|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118496|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118497|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139118498|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
139118499|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
139118500|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139118501|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139118502|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139118503|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139118504|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
139118505|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118506|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118507|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
139118508|NCT03751202|Hormones|hormones|mesh-ancestor
139118509|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139118510|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
139118511|NCT03749408|Mannitol|mannitol|mesh-list
139118512|NCT03749408|Bupivacaine|bupivacaine|mesh-list
139118513|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
139118514|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
139118515|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118516|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118517|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
139118518|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118519|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139118520|NCT03749408|Diuretics|diuretics|mesh-ancestor
139118521|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
139118522|NCT04387136|Sufentanil|sufentanil|mesh-list
139118523|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139118524|NCT04387136|Narcotics|narcotics|mesh-ancestor
139118525|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118526|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118527|NCT04387136|Analgesics|analgesics|mesh-ancestor
139118528|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
139118529|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118530|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139118531|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139118532|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
139118533|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
139118534|NCT04252586|Cannabidiol|cannabidiol|mesh-list
139118535|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
139118536|NCT04507776|Etanercept|etanercept|mesh-list
138637677|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
139118537|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139118538|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139118539|NCT04507776|Analgesics|analgesics|mesh-ancestor
139118540|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
139118541|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118542|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118543|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139118544|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139118545|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139118546|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139118547|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
139118548|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
139118549|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139118550|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
139118551|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139118552|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
139118553|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118554|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118555|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
139118556|NCT03756246|Vaccines|vaccines|mesh-list
139118557|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
139118558|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118559|NCT05460858|Acetylcysteine|acetylcysteine|mesh-list
139118560|NCT05460858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139118561|NCT05460858|Antiviral Agents|antiviral agents|mesh-ancestor
139118562|NCT05460858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118563|NCT05460858|Expectorants|expectorants|mesh-ancestor
139118564|NCT05460858|Respiratory System Agents|respiratory system agents|mesh-ancestor
139118565|NCT05460858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139118566|NCT05460858|Antioxidants|antioxidants|mesh-ancestor
139118567|NCT05460858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118568|NCT05460858|Protective Agents|protective agents|mesh-ancestor
139118569|NCT05460858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118570|NCT05460858|Antidotes|antidotes|mesh-ancestor
139118571|NCT05359224|Clopidogrel|clopidogrel|mesh-list
139118572|NCT05359224|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139118573|NCT05359224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139118574|NCT05359224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139118575|NCT05359224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139118576|NCT05359224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139118577|NCT05359224|Purinergic Agents|purinergic agents|mesh-ancestor
139118578|NCT05359224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118579|NCT05359224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118580|NCT05359224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118581|NCT03756090|Paclitaxel|paclitaxel|mesh-list
139118582|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
139118583|NCT03756090|Epirubicin|epirubicin|mesh-list
139118584|NCT03756090|Palbociclib|palbociclib|mesh-list
139118585|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139118586|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118587|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
139118588|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
139118589|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
139118590|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118591|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139118592|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
139118593|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118594|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139118595|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139118596|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
139118597|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139118598|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139118599|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139118600|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139118601|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118602|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139118603|NCT04605588|Ribavirin|ribavirin|mesh-list
139118604|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
139118605|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
139118606|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
139118607|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118608|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
139118609|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118610|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
139118611|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139118612|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139118614|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139118615|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
139118616|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139118617|NCT03752736|Protective Agents|protective agents|mesh-ancestor
139118618|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956718|NCT04014855|Lactoferrin|lactoferrin|mesh-list
139118619|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
139118620|NCT03752658|Tenofovir|tenofovir|mesh-list
139118621|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
139118622|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118623|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139118624|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139118625|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869003|NCT02680548|Hormones|hormones|mesh-ancestor
139118626|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118627|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139118628|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139118629|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
139118630|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139118631|NCT03755778|Itraconazole|itraconazole|mesh-list
139118632|NCT03755778|Rifampin|rifampin|mesh-list
139118633|NCT03755778|Quinidine|quinidine|mesh-list
139118634|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
139118635|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118636|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139118637|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139118638|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118639|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118640|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139118641|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
139118642|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139118643|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118644|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139118645|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139118646|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
139118647|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139118648|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
139118649|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139118650|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139118651|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139118652|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139118653|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139118654|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139118655|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139118656|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139118657|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139118658|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
139118659|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118660|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139118661|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
139118662|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139118663|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139118664|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139118665|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139118666|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
139118667|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139118668|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139118669|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139118670|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139118671|NCT03755700|Vitamin E|vitamin e|mesh-list
139118672|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
139118674|NCT03755700|Vitamins|vitamins|mesh-ancestor
139118675|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
139118676|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118677|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
139118678|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118679|NCT03755700|Protective Agents|protective agents|mesh-ancestor
139118680|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
139118681|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118682|NCT03755700|Expectorants|expectorants|mesh-ancestor
139118683|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
139118684|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139118685|NCT03755700|Antidotes|antidotes|mesh-ancestor
139118686|NCT03757650|Amoxicillin|amoxicillin|mesh-list
139118688|NCT03757650|Omeprazole|omeprazole|mesh-list
139118689|NCT03757650|Bismuth|bismuth|mesh-list
139118690|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
139118691|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139118692|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118693|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139118694|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139118695|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139118696|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118697|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118698|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139118699|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139118700|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139118701|NCT03757650|Antacids|antacids|mesh-ancestor
139118702|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
139118703|NCT03693404|Ketorolac|ketorolac|mesh-list
139118704|NCT03693404|Morphine|morphine|mesh-list
139118705|NCT03693404|Bupivacaine|bupivacaine|mesh-list
139118706|NCT03693404|Anesthetics|anesthetics|mesh-list
139118707|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
139118708|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
139118709|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118710|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118711|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
139118712|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118713|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138869281|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139118714|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139118715|NCT03693404|Analgesics|analgesics|mesh-ancestor
139118716|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139118717|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139118718|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139118719|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118720|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118721|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139118722|NCT03693404|Narcotics|narcotics|mesh-ancestor
139118723|NCT04219358|Imiquimod|imiquimod|mesh-list
139118724|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
139118725|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139118726|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
139118727|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118728|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118729|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
139118730|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139118731|NCT04219358|Protective Agents|protective agents|mesh-ancestor
139118732|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
139118733|NCT04218110|Ethanol|ethanol|mesh-list
139118734|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
139118735|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139118736|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139118737|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118738|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118739|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118740|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
139118741|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
139118742|NCT03752190|Cosyntropin|cosyntropin|mesh-list
139118743|NCT03752190|Hormones|hormones|mesh-ancestor
139118744|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139118745|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118746|NCT04210310|Oxytocin|oxytocin|mesh-list
139118747|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
139118748|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139118749|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118750|NCT03755466|Tofacitinib|tofacitinib|mesh-list
139118751|NCT03755466|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139118752|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139118753|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118754|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118755|NCT03755310|Suvorexant|suvorexant|mesh-list
139118756|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139118757|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139118758|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118759|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118760|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139118761|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887757|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139118762|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118763|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
139118764|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
139118765|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139118767|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118768|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888579|NCT00852969|Vitamins|vitamins|mesh-ancestor
139118769|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118770|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139118771|NCT03668392|Asparaginase|asparaginase|mesh-list
138889030|NCT03471767|Bupropion|bupropion|mesh-list
138889169|NCT00741364|Vitamin D|vitamin d|mesh-list
139118772|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118773|NCT04176016|Edetic Acid|edetic acid|mesh-list
138889771|NCT04161404|Analgesics|analgesics|mesh-ancestor
138889844|NCT02997605|Prednisone|prednisone|mesh-list
138889927|NCT02614482|Fesoterodine|fesoterodine|mesh-list
139118774|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
139118775|NCT04176016|Antidotes|antidotes|mesh-ancestor
139118776|NCT04176016|Protective Agents|protective agents|mesh-ancestor
139118777|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118778|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
139118779|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
139118780|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118781|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139118782|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
139118783|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139118784|NCT03695094|Lamotrigine|lamotrigine|mesh-list
139118785|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
139118786|NCT03695094|Levetiracetam|levetiracetam|mesh-list
139118787|NCT03695094|Brivaracetam|brivaracetam|mesh-list
139118788|NCT03695094|Padsevonil|padsevonil|mesh-list
139118789|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
139118790|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
138869360|NCT04183296|Propofol|propofol|mesh-list
139118791|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139118792|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139118793|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118794|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139118795|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118796|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139118797|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139118798|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118799|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139118800|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139118801|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139118802|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139118803|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139118804|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
139118805|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118807|NCT04495374|Analgesics|analgesics|mesh-ancestor
139118808|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
139118809|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118810|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118811|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
139118812|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139118813|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139118814|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118815|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139118816|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139118817|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139118818|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118819|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139118820|NCT03752112|Penicillins|penicillins|mesh-list
139118821|NCT03752112|Cefixime|cefixime|mesh-list
139118822|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139118823|NCT03752112|Penicillin G|penicillin g|mesh-list
139118824|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
139118825|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139118826|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118827|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139118828|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139118829|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118830|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139118831|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
139118832|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118833|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
138956781|NCT00686894|Infliximab|infliximab|mesh-list
139118834|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139118835|NCT04168190|Vaccines|vaccines|mesh-list
139118836|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139118837|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
139118838|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118839|NCT03501940|Fluorides|fluorides|mesh-list
139118840|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
139118841|NCT03501940|Protective Agents|protective agents|mesh-ancestor
139118842|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118843|NCT03754842|Niacinamide|niacinamide|mesh-list
139118845|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
139118846|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
139118847|NCT03754842|Vitamins|vitamins|mesh-ancestor
139118848|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
139118849|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118850|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139118851|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
139118852|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118853|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139118854|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
139118855|NCT01562210|Olaparib|olaparib|mesh-list
139118856|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118857|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139118858|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118859|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118860|NCT04189952|Rituximab|rituximab|mesh-list
139118861|NCT04189952|Carboplatin|carboplatin|mesh-list
139118862|NCT04189952|Etoposide|etoposide|mesh-list
139118863|NCT04189952|Ifosfamide|ifosfamide|mesh-list
139118864|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
139118865|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139118866|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118867|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
139118868|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118869|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139118870|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139118871|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139118872|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139118873|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118874|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118875|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139118876|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
139118877|NCT04716426|Tetracycline|tetracycline|mesh-list
139118878|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139118879|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118880|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139118881|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118882|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118883|NCT04164758|Pimavanserin|pimavanserin|mesh-list
139118884|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139118885|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
139118886|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139118887|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139118888|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139118889|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118890|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118891|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139118892|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139118893|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139118894|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139118895|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
139118896|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118897|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118898|NCT03754686|Acetaminophen|acetaminophen|mesh-list
139118899|NCT03754686|Oseltamivir|oseltamivir|mesh-list
139118900|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139118901|NCT03754686|Analgesics|analgesics|mesh-ancestor
139118902|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
139118903|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118904|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118905|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
139118906|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
139118907|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118908|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118909|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118910|NCT05200884|Lidocaine|lidocaine|mesh-list
139118911|NCT05200884|Carticaine|carticaine|mesh-list
139118912|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
139118913|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
139118914|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118915|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118916|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
139118917|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118918|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139118919|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139118920|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139118921|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139118922|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118923|NCT03746444|Anesthetics|anesthetics|mesh-list
139118924|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118925|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118926|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
139118927|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139118928|NCT03749096|Antibodies|antibodies|mesh-list
139118929|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
139118930|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139118931|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
139118932|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118933|NCT03748940|Mirikizumab|mirikizumab|mesh-list
139118934|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139118935|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139118936|NCT03748940|Analgesics|analgesics|mesh-ancestor
139118937|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
139118938|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869505|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139118939|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118940|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139118941|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139118942|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139118943|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139118944|NCT04177862|Fentanyl|fentanyl|mesh-list
139118945|NCT04177862|Sufentanil|sufentanil|mesh-list
139118946|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139118947|NCT04177862|Narcotics|narcotics|mesh-ancestor
139118948|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118949|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118950|NCT04177862|Analgesics|analgesics|mesh-ancestor
139118951|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
139118952|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139118953|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139118954|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139118955|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
139118956|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
139118957|NCT03746366|Corticosterone|corticosterone|mesh-list
139118958|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139118959|NCT04157738|Insulin|insulin|mesh-list
139118960|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139118961|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
139118962|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
139118963|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139118964|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118965|NCT04156646|Balovaptan|balovaptan|mesh-list
139118966|NCT04156646|Esomeprazole|esomeprazole|mesh-list
139118967|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139118968|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139118969|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139118970|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139118971|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118972|NCT04156646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139118973|NCT04156646|Natriuretic Agents|natriuretic agents|mesh-ancestor
139118974|NCT04156646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118975|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139118976|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139118977|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139118978|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118979|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118980|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139118981|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139118982|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139118983|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
139118984|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118985|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118986|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139118987|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139118988|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
139118989|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139118990|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139118991|NCT04537806|Pregnanolone|pregnanolone|mesh-list
139118992|NCT04537806|Brexanolone|brexanolone|mesh-list
139118993|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
139118994|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139118995|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139118996|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
139118997|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139118998|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139118999|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
139119000|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
139119001|NCT03744806|Bevacizumab|bevacizumab|mesh-list
139119002|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119003|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119004|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139119005|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139119006|NCT03744806|Growth Substances|growth substances|mesh-ancestor
139119007|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119008|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
139119009|NCT04531098|Vaccines|vaccines|mesh-list
139119010|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
138956850|NCT02561936|Rilpivirine|rilpivirine|mesh-list
139119011|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119012|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
139119013|NCT04529850|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139119014|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
138869587|NCT04178850|Folic Acid|folic acid|mesh-list
139119015|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119016|NCT04529850|Protective Agents|protective agents|mesh-ancestor
139119017|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119018|NCT04225676|Tisagenlecleucel|tisagenlecleucel|mesh-list
139119019|NCT04225676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119020|NCT04225676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119021|NCT01561950|Clopidogrel|clopidogrel|mesh-list
139119022|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139119023|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139119024|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139119025|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139119026|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
139119027|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119028|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119029|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119031|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139119032|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139119033|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
139119034|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119035|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119036|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119037|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139119038|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139119039|NCT05206318|Cysteamine|cysteamine|mesh-list
139119040|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
139119041|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119042|NCT04136444|Padsevonil|padsevonil|mesh-list
139119043|NCT04136444|Anticonvulsants|anticonvulsants|mesh-ancestor
139119044|NCT03751332|Tacrolimus|tacrolimus|mesh-list
139119045|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139119046|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
139119047|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119048|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139119049|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119050|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119051|NCT04425252|Brequinar|brequinar|mesh-list
139119052|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119053|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119054|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119055|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139119056|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
139119057|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119058|NCT04003610|Carboplatin|carboplatin|mesh-list
139119059|NCT04003610|Gemcitabine|gemcitabine|mesh-list
139119060|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
139119061|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119062|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139119063|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
139119064|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119065|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138869172|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
139119066|NCT04003610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138544046|NCT00196612|Emtricitabine|emtricitabine|mesh-list
139119068|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
139119069|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119070|NCT05280626|Prednisolone|prednisolone|mesh-list
139119071|NCT05280626|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139119072|NCT05280626|Methylprednisolone|methylprednisolone|mesh-list
139119073|NCT05280626|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139119074|NCT05280626|Prednisolone acetate|prednisolone acetate|mesh-list
139119075|NCT05280626|Cyclophosphamide|cyclophosphamide|mesh-list
139119076|NCT05280626|Rituximab|rituximab|mesh-list
139119077|NCT05280626|Doxorubicin|doxorubicin|mesh-list
139119078|NCT05280626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139119079|NCT05280626|Vincristine|vincristine|mesh-list
139119080|NCT05280626|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139119081|NCT05280626|Prednisolone phosphate|prednisolone phosphate|mesh-list
139119082|NCT05280626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139119083|NCT05280626|Immunologic Factors|immunologic factors|mesh-ancestor
139119084|NCT05280626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119085|NCT05280626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139119086|NCT05280626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139119087|NCT05280626|Alkylating Agents|alkylating agents|mesh-ancestor
139119088|NCT05280626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119089|NCT05280626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119090|NCT05280626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139119091|NCT05280626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119092|NCT05280626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139119093|NCT05280626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139119094|NCT05280626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139119095|NCT05280626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119096|NCT05280626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139119097|NCT05280626|Glucocorticoids|glucocorticoids|mesh-ancestor
139119098|NCT05280626|Hormones|hormones|mesh-ancestor
139119099|NCT05280626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139119100|NCT05280626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139119101|NCT05280626|Antiemetics|antiemetics|mesh-ancestor
139119102|NCT05280626|Autonomic Agents|autonomic agents|mesh-ancestor
139119103|NCT05280626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119104|NCT05280626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139119105|NCT05280626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139119106|NCT05280626|Protective Agents|protective agents|mesh-ancestor
139119107|NCT05280626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139119108|NCT05280626|Tubulin Modulators|tubulin modulators|mesh-ancestor
139119109|NCT05280626|Antimitotic Agents|antimitotic agents|mesh-ancestor
139119110|NCT05280626|Mitosis Modulators|mitosis modulators|mesh-ancestor
139119111|NCT04526574|Vaccines|vaccines|mesh-list
139119112|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139119113|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
139119114|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119115|NCT03993392|Buprenorphine|buprenorphine|mesh-list
139119116|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139119117|NCT03993392|Narcotics|narcotics|mesh-ancestor
139119118|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119119|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119120|NCT03993392|Analgesics|analgesics|mesh-ancestor
139119121|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
139119122|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119123|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139119124|NCT03751176|Leucovorin|leucovorin|mesh-list
139119125|NCT03751176|Folic Acid|folic acid|mesh-list
139119126|NCT03751176|Fluorouracil|fluorouracil|mesh-list
139119127|NCT03751176|Irinotecan|irinotecan|mesh-list
139119128|NCT03751176|Panitumumab|panitumumab|mesh-list
139119129|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
139119130|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
139119131|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119132|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139119133|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119134|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139119135|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
139119136|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956869|NCT00752882|Ceftazidime|ceftazidime|mesh-list
139119137|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139119138|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139119139|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119140|NCT03751176|Antidotes|antidotes|mesh-ancestor
139119141|NCT03751176|Protective Agents|protective agents|mesh-ancestor
139119142|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
139119143|NCT03751176|Vitamins|vitamins|mesh-ancestor
139119144|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
139119145|NCT03751176|Hematinics|hematinics|mesh-ancestor
139119146|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119147|NCT04377308|Fluoxetine|fluoxetine|mesh-list
139119148|NCT04377308|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139119149|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139119150|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139119151|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119152|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119153|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
139119154|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119155|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139119156|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
139119157|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139119158|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139119159|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139119160|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119161|NCT03743870|Bupivacaine|bupivacaine|mesh-list
139119162|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
139119163|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
139119164|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
139119165|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119166|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119167|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
139119168|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119169|NCT03988088|Lasmiditan|lasmiditan|mesh-list
139119170|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139119171|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
139119172|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119173|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119174|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119175|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
139119176|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
139119177|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119178|NCT05204524|Temozolomide|temozolomide|mesh-list
139119179|NCT05204524|Epirubicin|epirubicin|mesh-list
139119180|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139119181|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
139119182|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119183|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119184|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139119185|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139119186|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139119187|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119188|NCT05204056|Epinephrine|epinephrine|mesh-list
139119189|NCT05204056|Morphine|morphine|mesh-list
139119190|NCT05204056|Ropivacaine|ropivacaine|mesh-list
139119191|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
139119192|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139119193|NCT05204056|Narcotics|narcotics|mesh-ancestor
139119194|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119195|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119196|NCT05204056|Analgesics|analgesics|mesh-ancestor
139119197|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
139119198|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119199|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
139119200|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
139119201|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139119202|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139119203|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119204|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
139119205|NCT05204056|Coagulants|coagulants|mesh-ancestor
139119206|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139119207|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139119208|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
139119209|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119210|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139119211|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139119212|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
139119213|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139119214|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
139119215|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
139119216|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
139119217|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139119218|NCT05203744|Tafenoquine|tafenoquine|mesh-list
139119219|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
139119220|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139119221|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139119222|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119223|NCT03987074|Firsocostat|firsocostat|mesh-list
139119224|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119225|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119226|NCT05761366|PSMA-BCH|psma-bch|mesh-list
139119227|NCT05761366|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138956905|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139119228|NCT05761366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119229|NCT05302466|Silicon|silicon|mesh-list
139119230|NCT05302466|Trace Elements|trace elements|mesh-ancestor
139119231|NCT05302466|Micronutrients|micronutrients|mesh-ancestor
139119232|NCT05302466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119233|NCT05203588|Vitamin D|vitamin d|mesh-list
139119234|NCT05203588|Denosumab|denosumab|mesh-list
139119235|NCT05203588|Calcium|calcium|mesh-list
139119236|NCT05203588|Vitamins|vitamins|mesh-ancestor
139119237|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
139119238|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119239|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139119240|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139119241|NCT05203354|Acitretin|acitretin|mesh-list
139119242|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
139119243|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
139119245|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119246|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119247|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139119248|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119249|NCT03754062|Haloperidol|haloperidol|mesh-list
139119250|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
139119251|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
139119252|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
139119253|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119254|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119255|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139119256|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139119257|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139119258|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119259|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139119260|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139119261|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
139119262|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119263|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119264|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139119265|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
139119266|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
139119267|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139119268|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119269|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139119270|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139119271|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139119272|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139119273|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119274|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119275|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119276|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
139119277|NCT05761132|Pembrolizumab|pembrolizumab|mesh-list
139119278|NCT05761132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119279|NCT05761132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119280|NCT05761132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139119281|NCT05761132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119282|NCT04411680|Sargramostim|sargramostim|mesh-list
139119283|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
139119284|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119285|NCT05760976|Cisatracurium|cisatracurium|mesh-list
139119286|NCT05760976|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139119287|NCT05760976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139119288|NCT05760976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119289|NCT05760976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119290|NCT03747978|Amlodipine|amlodipine|mesh-list
139119291|NCT03747978|Perindopril|perindopril|mesh-list
139119292|NCT03747978|Indapamide|indapamide|mesh-list
139119293|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
139119294|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139119295|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139119296|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139119297|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119298|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139119299|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119300|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
139119301|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139119302|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
139119303|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119304|NCT03747978|Diuretics|diuretics|mesh-ancestor
139119305|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
139119306|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139119307|NCT04603846|Paclitaxel|paclitaxel|mesh-list
139119308|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139119309|NCT04603846|Antibodies|antibodies|mesh-list
139119310|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139119311|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119312|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
139119313|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
139119314|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
139119315|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869895|NCT00645372|Risperidone|risperidone|mesh-list
139119316|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
139119317|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119318|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
139119319|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139119320|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139119321|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139119322|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139119323|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119324|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
139119325|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119326|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119327|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139119328|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119329|NCT04578106|Trastuzumab|trastuzumab|mesh-list
139119330|NCT04578106|Pertuzumab|pertuzumab|mesh-list
139119331|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119332|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119333|NCT04472182|Calcium|calcium|mesh-list
139119334|NCT04472182|Fluorides|fluorides|mesh-list
139119335|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
139119336|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139119337|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119338|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
139119339|NCT04472182|Protective Agents|protective agents|mesh-ancestor
139119340|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
139119341|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139119342|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119343|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139119344|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139119345|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119346|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119347|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119348|NCT05759416|Melatonin|melatonin|mesh-list
139119349|NCT05759416|Antioxidants|antioxidants|mesh-ancestor
139119350|NCT05759416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119351|NCT05759416|Protective Agents|protective agents|mesh-ancestor
139119352|NCT05759416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119353|NCT05759416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119354|NCT03746340|Propofol|propofol|mesh-list
139119355|NCT03746340|Sevoflurane|sevoflurane|mesh-list
139119356|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139119357|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119358|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119359|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139119360|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
139119361|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
139119362|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139119363|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139119364|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
139119365|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
139119366|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139119367|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119368|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119369|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
139119370|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139119371|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119372|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119373|NCT04161144|Sirolimus|sirolimus|mesh-list
139119374|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139119375|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119376|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139119377|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119378|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
139119379|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139119380|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
139119381|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119382|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139119383|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119384|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119385|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
139119386|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119387|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119388|NCT04764630|Naloxone|naloxone|mesh-list
139119389|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139119390|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119391|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
139119392|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119393|NCT04153188|Phenylephrine|phenylephrine|mesh-list
139119394|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
139119395|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139119396|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139119397|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
139119398|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119399|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119400|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119401|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
139119402|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
139119403|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119404|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
139119405|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139119406|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
139119407|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139119408|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
139119409|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139119410|NCT04153188|Protective Agents|protective agents|mesh-ancestor
139119411|NCT03611010|Atorvastatin|atorvastatin|mesh-list
139119412|NCT03611010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139119413|NCT03611010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139119414|NCT03611010|Antimetabolites|antimetabolites|mesh-ancestor
139119415|NCT03611010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119416|NCT03611010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139119417|NCT03611010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139119418|NCT03611010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119419|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
139119420|NCT03749850|Doxorubicin|doxorubicin|mesh-list
139119421|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139119422|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139119423|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
139119424|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119425|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139119426|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139119427|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
139119428|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119429|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119430|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139119431|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139119432|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139119433|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139119434|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119435|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
139119436|NCT04357782|Vitamins|vitamins|mesh-ancestor
139119437|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
139119438|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119439|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
139119440|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119441|NCT04357782|Protective Agents|protective agents|mesh-ancestor
139119442|NCT03980522|Rilonacept|rilonacept|mesh-list
139119443|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139119444|NCT04400682|Favipiravir|favipiravir|mesh-list
139119445|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
139119446|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119447|NCT03066778|Carboplatin|carboplatin|mesh-list
139119448|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
139119449|NCT03066778|Etoposide|etoposide|mesh-list
139119450|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119451|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119452|NCT03066778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139119453|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119454|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139119455|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139119456|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139119457|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119458|NCT04136548|Fentanyl|fentanyl|mesh-list
139119459|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139119460|NCT04136548|Narcotics|narcotics|mesh-ancestor
139119461|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119462|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119463|NCT04136548|Analgesics|analgesics|mesh-ancestor
139119464|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
138870034|NCT02836847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139119465|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119466|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139119467|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139119468|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
139119469|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
139119470|NCT04347954|Iodine|iodine|mesh-list
139119471|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
139119472|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
139119473|NCT04347954|Povidone|povidone|mesh-list
139119474|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139119475|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119476|NCT04347954|Trace Elements|trace elements|mesh-ancestor
139119477|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
139119478|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119479|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
139119480|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
139119481|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
139119482|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139119483|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119484|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119485|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139119486|NCT03065530|Analgesics|analgesics|mesh-ancestor
139119487|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
139119488|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119489|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139119490|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139119491|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139119492|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
139119493|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119494|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119495|NCT03979820|Phenelzine|phenelzine|mesh-list
139119496|NCT03979820|Tyramine|tyramine|mesh-list
139119497|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
139119498|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139119499|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139119500|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119501|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119502|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
139119503|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
139119504|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119505|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119506|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139119507|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139119508|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139119509|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
139119510|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119511|NCT03647488|Docetaxel|docetaxel|mesh-list
139119512|NCT03647488|Spartalizumab|spartalizumab|mesh-list
139119513|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119514|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
139119515|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
139119516|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
138869252|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119517|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119518|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139119519|NCT03647488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119520|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
139119521|NCT03693950|Hematinics|hematinics|mesh-ancestor
139119522|NCT03579160|Timolol|timolol|mesh-list
139119523|NCT03579160|Petrolatum|petrolatum|mesh-list
139119524|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139119525|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139119526|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
139119527|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119528|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119529|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119530|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139119531|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139119532|NCT03579160|Emollients|emollients|mesh-ancestor
139119533|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
139119534|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
139119535|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139119536|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139119537|NCT03745664|Prednisolone|prednisolone|mesh-list
139119538|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
139119539|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139119540|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
139119541|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139119542|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
139119543|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
139119544|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119545|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119546|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139119547|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
139119549|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139119550|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139119551|NCT03745664|Protective Agents|protective agents|mesh-ancestor
139119552|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139119553|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119554|NCT03447262|Ivacaftor|ivacaftor|mesh-list
139119555|NCT03447262|VX-659|vx-659|mesh-list
139119556|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139119557|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139119558|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119559|NCT04094870|Sertraline|sertraline|mesh-list
139119560|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
139119561|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139119562|NCT04094870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139119563|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139119564|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139119565|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119566|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119567|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
139119568|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119569|NCT04399356|Niclosamide|niclosamide|mesh-list
139119570|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
138957004|NCT00753038|Paclitaxel|paclitaxel|mesh-list
139119571|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139119572|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
139119573|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139119574|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119575|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
139119576|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
139119577|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139119578|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
139119579|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119580|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119581|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139119582|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
139119583|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
139119584|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139119585|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
139119586|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119587|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119588|NCT04346628|Favipiravir|favipiravir|mesh-list
139119589|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
139119590|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119591|NCT03681470|Dapsone|dapsone|mesh-list
139119592|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119593|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
139119594|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139119595|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139119596|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139119597|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119598|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119599|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
139119600|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139119601|NCT02414750|Vemurafenib|vemurafenib|mesh-list
139119602|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119603|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138544087|NCT00060632|Sirolimus|sirolimus|mesh-list
139119604|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119605|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119606|NCT04343976|Interferons|interferons|mesh-list
139119607|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119608|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
139119609|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119610|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
139119611|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119612|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119613|NCT03322540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139119614|NCT03322540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119615|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
139119616|NCT02909452|Entinostat|entinostat|mesh-list
139119617|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119618|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119619|NCT02909452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139119620|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119621|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139119622|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119623|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139119624|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
139119625|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119626|NCT01935466|Pioglitazone|pioglitazone|mesh-list
139119627|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139119628|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119629|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
139119630|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
139119631|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139119632|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139119633|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119634|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119635|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119636|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139119637|NCT04399122|Acetaminophen|acetaminophen|mesh-list
139119638|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139119639|NCT04399122|Oxycodone|oxycodone|mesh-list
139119640|NCT04399122|Codeine|codeine|mesh-list
139119641|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139119642|NCT04399122|Analgesics|analgesics|mesh-ancestor
139119643|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
139119644|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119645|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119646|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
139119647|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139119648|NCT04399122|Narcotics|narcotics|mesh-ancestor
139119649|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119650|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
139119651|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
139119652|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139119653|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139119654|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139119655|NCT00826462|Triamcinolone|triamcinolone|mesh-list
139119656|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139119657|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139119658|NCT00826462|Naproxen|naproxen|mesh-list
139119659|NCT00826462|Lidocaine|lidocaine|mesh-list
139119660|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139119661|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
139119662|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
139119663|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119664|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119665|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
139119666|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119667|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139119668|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138957082|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
139119669|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139119670|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139119671|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119672|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139119673|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
139119674|NCT00826462|Hormones|hormones|mesh-ancestor
139119675|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139119676|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139119677|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
139119678|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119679|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139119680|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139119681|NCT00826462|Analgesics|analgesics|mesh-ancestor
139119682|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139119683|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
139119684|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139119685|NCT04398732|Etanercept|etanercept|mesh-list
139119686|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139119687|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139119688|NCT04398732|Analgesics|analgesics|mesh-ancestor
139119689|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
139119690|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119691|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119692|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139119693|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139119694|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139119695|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139119696|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
139119697|NCT04322682|Colchicine|colchicine|mesh-list
139119698|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
139119699|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139119700|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
139119701|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
139119702|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
139119703|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119704|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119705|NCT04322526|Naltrexone|naltrexone|mesh-list
139119706|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139119707|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139119708|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119709|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
139119710|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119711|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
139119712|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139119713|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
139119714|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119715|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
139119716|NCT04115358|Protective Agents|protective agents|mesh-ancestor
139119717|NCT05668884|Gemcitabine|gemcitabine|mesh-list
139119718|NCT05668884|Oxaliplatin|oxaliplatin|mesh-list
139119719|NCT05668884|Tislelizumab|tislelizumab|mesh-list
139119720|NCT05668884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139119721|NCT05668884|Antimetabolites|antimetabolites|mesh-ancestor
139119722|NCT05668884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119723|NCT05668884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119724|NCT05668884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119725|NCT05187208|Niraparib|niraparib|mesh-list
139119726|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139119727|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119728|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119729|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119730|NCT05081206|Propofol|propofol|mesh-list
139119731|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139119732|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119733|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119734|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138957093|NCT00688064|Doxycycline|doxycycline|mesh-list
139119735|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
139119736|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
139119737|NCT04105998|Oxytocin|oxytocin|mesh-list
139119738|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
139119739|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139119740|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119741|NCT04543968|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
139119742|NCT04543968|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
139119743|NCT04543968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119744|NCT04543968|Antioxidants|antioxidants|mesh-ancestor
139119745|NCT04543968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119746|NCT04543968|Protective Agents|protective agents|mesh-ancestor
139119747|NCT04543968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119748|NCT04543968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139119749|NCT04543968|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139119750|NCT04543968|Disinfectants|disinfectants|mesh-ancestor
139119751|NCT04368910|Artesunate|artesunate|mesh-list
139119752|NCT04368910|Chloroquine|chloroquine|mesh-list
139119753|NCT04368910|Pyronaridine|pyronaridine|mesh-list
139119754|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
139119755|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139119756|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139119757|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119758|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119759|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
139119760|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
139119761|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139119762|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
139119763|NCT04368910|Amebicides|amebicides|mesh-ancestor
139119764|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139119765|NCT04249258|Dobutamine|dobutamine|mesh-list
139119766|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139119767|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
139119768|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
139119769|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119770|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119771|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139119772|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139119773|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139119774|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
139119775|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119776|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119777|NCT04249258|Protective Agents|protective agents|mesh-ancestor
139119778|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
139119779|NCT03938584|Vitamins|vitamins|mesh-ancestor
139119780|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
139119781|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119782|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
139119783|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119784|NCT03938584|Protective Agents|protective agents|mesh-ancestor
139119785|NCT03269344|Gabapentin|gabapentin|mesh-list
139119786|NCT03269344|Analgesics|analgesics|mesh-ancestor
139119787|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
139119788|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119789|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119790|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
139119791|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139119792|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139119793|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119794|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139119795|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139119796|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139119797|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119798|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119799|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
139119800|NCT04389840|Heparin|heparin|mesh-list
139119801|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
139119802|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139119803|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139119804|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119805|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
139119806|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139119807|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
139119808|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139119809|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119810|NCT02933944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139119811|NCT02933944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119812|NCT04307940|Acetaminophen|acetaminophen|mesh-list
139119813|NCT04307940|Naproxen|naproxen|mesh-list
139119814|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139119815|NCT04307940|Hydrocodone|hydrocodone|mesh-list
139119816|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139119817|NCT04307940|Analgesics|analgesics|mesh-ancestor
139119818|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
139119819|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119820|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119821|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
139119822|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139119823|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139119824|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139119825|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
139119826|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139119827|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119828|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119829|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139119830|NCT04307940|Narcotics|narcotics|mesh-ancestor
139119831|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119832|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
139119833|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
139119834|NCT02717416|Hemostatics|hemostatics|mesh-list
139119836|NCT02054104|Celecoxib|celecoxib|mesh-list
139119837|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
139119838|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139119839|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
139119840|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119841|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139119842|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139119843|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
139119844|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119845|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119846|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139119847|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139119848|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139119849|NCT02054104|Analgesics|analgesics|mesh-ancestor
139119850|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
139119851|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119852|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139119853|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139119854|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139119855|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119856|NCT04229290|Dolutegravir|dolutegravir|mesh-list
139119857|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139119858|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139119859|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119860|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119861|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139119862|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139119863|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
139119864|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119865|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
139119866|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139119867|NCT04181476|Protective Agents|protective agents|mesh-ancestor
139119868|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119869|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
139119870|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139119871|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139119872|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119873|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119874|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139119875|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139119876|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119877|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
139119878|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119879|NCT04292730|Remdesivir|remdesivir|mesh-list
139119880|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
139119881|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119882|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
139119883|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119884|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
139119885|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
139119886|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119887|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
139119888|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119889|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139119890|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119891|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119892|NCT02737306|Leronlimab|leronlimab|mesh-list
139119893|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139119894|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139119895|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119896|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139119897|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139119898|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
139119899|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119900|NCT02728648|Oxycodone|oxycodone|mesh-list
139119901|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139119902|NCT02728648|Narcotics|narcotics|mesh-ancestor
139119903|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119904|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119905|NCT02728648|Analgesics|analgesics|mesh-ancestor
139119906|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
139119907|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119908|NCT01971970|Adalimumab|adalimumab|mesh-list
139119909|NCT01971970|Infliximab|infliximab|mesh-list
139119910|NCT01971970|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139119912|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139119913|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
139119914|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139119915|NCT01161394|Pioglitazone|pioglitazone|mesh-list
139119916|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139119917|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119918|NCT04079790|Gepotidacin|gepotidacin|mesh-list
139119919|NCT04079790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139119920|NCT04079790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119921|NCT04079790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119922|NCT04079790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139119923|NCT03749226|Aztreonam|aztreonam|mesh-list
139119924|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139119925|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119926|NCT04259346|Ixekizumab|ixekizumab|mesh-list
139119927|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
139119928|NCT03748836|ALPN-101|alpn-101|mesh-list
139119929|NCT03748836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139119930|NCT03748836|Immunologic Factors|immunologic factors|mesh-ancestor
139119931|NCT03748836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119932|NCT01348100|Iloperidone|iloperidone|mesh-list
139119933|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139119934|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139119935|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139119936|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119937|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139119938|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
139119939|NCT03673670|Olodaterol|olodaterol|mesh-list
139119940|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139119941|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
139119942|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139119943|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119944|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139119945|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
139119946|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
139119947|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139119948|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
139119949|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119950|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119951|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
139119952|NCT04369742|Calcium|calcium|mesh-list
139119953|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139119954|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119955|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869333|NCT02842931|Prednisone|prednisone|mesh-list
139119956|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
139119957|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139119958|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139119959|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139119960|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119961|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139119962|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
139119964|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139119965|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119966|NCT03055936|Levodopa|levodopa|mesh-list
139119967|NCT03055936|Carbidopa|carbidopa|mesh-list
139119968|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139119969|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139119970|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
139119971|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139119972|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119973|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957142|NCT00663234|Atorvastatin|atorvastatin|mesh-list
139119974|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139119975|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139119976|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
139119977|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
139119978|NCT05215366|Coagulants|coagulants|mesh-ancestor
139119979|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139119980|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139119981|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
139119982|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139119983|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139119984|NCT03891524|Enoxaparin|enoxaparin|mesh-list
139119985|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
139119986|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139119987|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139119988|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119989|NCT04695652|Somatomedin B|somatomedin b|mesh-list
139119990|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139119991|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139119992|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
139119993|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870555|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139119994|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139119995|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
139119996|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139119997|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139119998|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120000|NCT04489108|Coagulants|coagulants|mesh-ancestor
139120001|NCT03771586|Ketamine|ketamine|mesh-list
139120002|NCT03771586|Analgesics|analgesics|mesh-ancestor
139120003|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
139120004|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120005|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120006|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139120007|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139120008|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
139120009|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
139120010|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139120011|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139120012|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139120013|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139120014|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120015|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
139120016|NCT02335060|Dronabinol|dronabinol|mesh-list
139120017|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139120018|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
139120019|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120020|NCT02335060|Expectorants|expectorants|mesh-ancestor
139120021|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
139120022|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139120023|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
138957167|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120024|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120025|NCT02335060|Protective Agents|protective agents|mesh-ancestor
139120026|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120027|NCT02335060|Antidotes|antidotes|mesh-ancestor
139120028|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
139120029|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139120030|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139120031|NCT02335060|Analgesics|analgesics|mesh-ancestor
139120032|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
139120033|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120034|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139120035|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139120036|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139120037|NCT02335060|Hormones|hormones|mesh-ancestor
139120038|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120039|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
139120040|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139120041|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
139120042|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120043|NCT04075604|Nivolumab|nivolumab|mesh-list
139120044|NCT04075604|Palbociclib|palbociclib|mesh-list
139120045|NCT04075604|Anastrozole|anastrozole|mesh-list
139120046|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139120047|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120048|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138890207|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139120049|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120050|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139120051|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120052|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139120053|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139120054|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139120055|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139120056|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
139120057|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120058|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120059|NCT05217238|Remifentanil|remifentanil|mesh-list
139120060|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139120061|NCT05217238|Narcotics|narcotics|mesh-ancestor
139120062|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869373|NCT02678598|Micafungin|micafungin|mesh-list
139120063|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120064|NCT05217238|Analgesics|analgesics|mesh-ancestor
139120065|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
139120066|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120067|NCT05217160|Morphine|morphine|mesh-list
139120068|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139120069|NCT05217160|Narcotics|narcotics|mesh-ancestor
139120070|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139120071|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120072|NCT05217160|Analgesics|analgesics|mesh-ancestor
139120073|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
139120074|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120075|NCT05052970|Dexamethasone|dexamethasone|mesh-list
139120076|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
139120077|NCT05052970|Bortezomib|bortezomib|mesh-list
139120078|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
139120079|NCT05052970|BB 1101|bb 1101|mesh-list
139120080|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139120081|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
139120082|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
139120083|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120084|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120085|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139120086|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
139120087|NCT05052970|Hormones|hormones|mesh-ancestor
139120088|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120089|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139120090|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120091|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
139120092|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120093|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120094|NCT05052970|Analgesics|analgesics|mesh-ancestor
139120095|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
139120096|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139120097|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139120098|NCT04903210|Niacinamide|niacinamide|mesh-list
139120100|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
139120101|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
139120102|NCT04903210|Vitamins|vitamins|mesh-ancestor
139120103|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
139120104|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120105|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139120106|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
139120107|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120108|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139120109|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
139120110|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
139120111|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139120112|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139120113|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
139120114|NCT04719208|Listerine|listerine|mesh-list
139120115|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139120116|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139120117|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120118|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
139120119|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
139120120|NCT04701190|Norepinephrine|norepinephrine|mesh-list
139120121|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120122|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139120123|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139120124|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
139120125|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139120126|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120128|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
139120129|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120130|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139120131|NCT04496362|Heparin|heparin|mesh-list
139120132|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
139120133|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139120134|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139120135|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120136|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
139120137|NCT04423588|Lansoprazole|lansoprazole|mesh-list
139120138|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139120139|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139120140|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139120141|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120142|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120143|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
139120144|NCT04090684|Celecoxib|celecoxib|mesh-list
139120145|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139120146|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139120147|NCT04090684|Analgesics|analgesics|mesh-ancestor
139120148|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
139120149|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120150|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120151|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139120152|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139120153|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139120154|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139120155|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120156|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120157|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139120158|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957200|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
139120159|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139120160|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139120161|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120162|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139120163|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139120164|NCT04963816|Dexamethasone|dexamethasone|mesh-list
139120165|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
139120166|NCT04963816|Bupivacaine|bupivacaine|mesh-list
139120167|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139120168|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139120169|NCT04963816|BB 1101|bb 1101|mesh-list
139120170|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139120171|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
139120172|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
139120173|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120174|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120175|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139120176|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
139120177|NCT04963816|Hormones|hormones|mesh-ancestor
139120178|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120179|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139120180|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120181|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
139120182|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120183|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120184|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
139120186|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139120187|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
139120188|NCT04933240|Tamoxifen|tamoxifen|mesh-list
139120189|NCT04933240|Estradiol|estradiol|mesh-list
139120190|NCT04933240|Estrogens|estrogens|mesh-ancestor
139120191|NCT04933240|Hormones|hormones|mesh-ancestor
139120192|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120193|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120194|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139120195|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
139120196|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139120197|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120198|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139120199|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139120200|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139120202|NCT01317940|Vitamin D|vitamin d|mesh-list
139120203|NCT01317940|Calcitriol|calcitriol|mesh-list
139120204|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
139120205|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
139120206|NCT01317940|Calcium|calcium|mesh-list
139120207|NCT01317940|Vitamins|vitamins|mesh-ancestor
139120208|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
139120209|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120210|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139120211|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139120212|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120213|NCT01317940|Antacids|antacids|mesh-ancestor
139120214|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139120215|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139120216|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139120217|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139120218|NCT05706688|Anesthetics|anesthetics|mesh-list
139120219|NCT05706688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139120220|NCT05706688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120221|NCT05706454|Ramatroban|ramatroban|mesh-list
139120222|NCT05706454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139120223|NCT01317550|Minocycline|minocycline|mesh-list
139120224|NCT01317550|Modafinil|modafinil|mesh-list
139120225|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139120226|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120227|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139120228|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120229|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139120230|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139120231|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139120232|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120233|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
139120234|NCT01317472|Lansoprazole|lansoprazole|mesh-list
139120235|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139120236|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139120237|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139120238|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120239|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120240|NCT01345630|Ritonavir|ritonavir|mesh-list
139120241|NCT01345630|Darunavir|darunavir|mesh-list
139120242|NCT01345630|Tenofovir|tenofovir|mesh-list
139120243|NCT01345630|Emtricitabine|emtricitabine|mesh-list
138869427|NCT05662956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120244|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139120245|NCT01345630|Maraviroc|maraviroc|mesh-list
139120246|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139120247|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139120248|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
139120249|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120250|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120251|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139120252|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139120253|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
139120254|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120255|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139120256|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139120257|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139120258|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139120259|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139120260|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139120261|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139120262|NCT03693612|Paclitaxel|paclitaxel|mesh-list
139120263|NCT03693612|Docetaxel|docetaxel|mesh-list
139120264|NCT03693612|Cetuximab|cetuximab|mesh-list
139120265|NCT03693612|Tremelimumab|tremelimumab|mesh-list
139120266|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139120267|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120268|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
139120269|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
139120270|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
139120271|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120272|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139120273|NCT03746652|Dexamethasone|dexamethasone|mesh-list
139120274|NCT03746652|Daratumumab|daratumumab|mesh-list
139120275|NCT03746652|Ixazomib|ixazomib|mesh-list
139120276|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139120277|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
139120278|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
139120279|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120280|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120281|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139120282|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
139120283|NCT03746652|Hormones|hormones|mesh-ancestor
139120284|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120285|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139120286|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120287|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
139120288|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120289|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120290|NCT01562808|Aripiprazole|aripiprazole|mesh-list
139120291|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
139120292|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139120293|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139120294|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139120295|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139120296|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120297|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
139120298|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
139120299|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139120300|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120301|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139120302|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139120303|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
139120304|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139120305|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139120306|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139120307|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139120308|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
139120309|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139120310|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
139120311|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120312|NCT04067492|Diclofenac|diclofenac|mesh-list
139120313|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138957255|NCT00791856|Hormones|hormones|mesh-ancestor
139120314|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139120315|NCT04067492|Analgesics|analgesics|mesh-ancestor
139120316|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
139120317|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120318|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120319|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139120320|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139120321|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139120322|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120323|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120324|NCT04186806|Muramidase|muramidase|mesh-list
139120325|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120326|NCT03748446|Xenon|xenon|mesh-list
139120327|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139120328|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
139120329|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
139120330|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139120331|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120332|NCT04036110|Vitamins|vitamins|mesh-list
139120333|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
139120334|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
139120335|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120336|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
139120337|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120338|NCT04036110|Protective Agents|protective agents|mesh-ancestor
139120339|NCT03053050|Selonsertib|selonsertib|mesh-list
139120340|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139120341|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120342|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120343|NCT04369950|Lidocaine|lidocaine|mesh-list
139120344|NCT04369950|Epinephrine|epinephrine|mesh-list
139120345|NCT04369950|Morphine|morphine|mesh-list
139120346|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
139120347|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
139120348|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
139120349|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139120350|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120351|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
139120352|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120353|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139120354|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139120355|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139120356|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139120357|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120358|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139120359|NCT04369950|Narcotics|narcotics|mesh-ancestor
139120360|NCT04369950|Analgesics|analgesics|mesh-ancestor
139120361|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139120362|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139120363|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
139120364|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139120365|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139120366|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139120367|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
139120368|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139120369|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
139120370|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
139120371|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
139120372|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139120373|NCT02955602|Seladelpar|seladelpar|mesh-list
139120374|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139120376|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120377|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139120378|NCT03748290|Pregabalin|pregabalin|mesh-list
139120379|NCT03748290|Analgesics|analgesics|mesh-ancestor
139120380|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
139120381|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120382|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120383|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
139120384|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139120385|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139120386|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120387|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139120388|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139120389|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139120390|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139120391|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139120392|NCT05651074|Omeprazole|omeprazole|mesh-list
139120393|NCT05651074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139120394|NCT05651074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139120395|NCT05651074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139120396|NCT05651074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120397|NCT05651074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120398|NCT03738956|Tofacitinib|tofacitinib|mesh-list
139120399|NCT03738956|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139120400|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139120401|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120402|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120404|NCT05609656|Calcium|calcium|mesh-list
139120405|NCT05609656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139120406|NCT05609656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120407|NCT05609656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139120408|NCT05609656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120409|NCT05609656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139120410|NCT05609656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120411|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
139120412|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139120413|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120414|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139120415|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139120416|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120417|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120418|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120419|NCT05598424|Methylprednisolone|methylprednisolone|mesh-list
139120420|NCT05598424|Glucocorticoids|glucocorticoids|mesh-list
139120421|NCT05598424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139120422|NCT05598424|Antiemetics|antiemetics|mesh-ancestor
139120423|NCT05598424|Autonomic Agents|autonomic agents|mesh-ancestor
139120424|NCT05598424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120425|NCT05598424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120426|NCT05598424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139120427|NCT05598424|Hormones|hormones|mesh-ancestor
139120428|NCT05598424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120429|NCT05598424|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139120430|NCT05598424|Protective Agents|protective agents|mesh-ancestor
139120431|NCT05501860|Carticaine|carticaine|mesh-list
139120432|NCT05501860|Anesthetics, Local|anesthetics, local|mesh-ancestor
139120433|NCT05501860|Anesthetics|anesthetics|mesh-ancestor
139120434|NCT05501860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139120435|NCT05501860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120436|NCT05501860|Sensory System Agents|sensory system agents|mesh-ancestor
139120437|NCT05501860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120438|NCT03738176|Triamcinolone|triamcinolone|mesh-list
139120439|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139120440|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
139120441|NCT03738176|Hormones|hormones|mesh-ancestor
139120442|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120443|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120444|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139120445|NCT03051100|Atorvastatin|atorvastatin|mesh-list
139120446|NCT03051100|Ezetimibe|ezetimibe|mesh-list
139120447|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139120448|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139120449|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
139120450|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120451|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139120452|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139120453|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120454|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139120455|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120456|NCT05280028|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139120457|NCT05280028|Tibolone|tibolone|mesh-list
139120458|NCT05280028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139120459|NCT05280028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139120460|NCT05280028|Medroxyprogesterone|medroxyprogesterone|mesh-list
139120461|NCT05280028|Estradiol|estradiol|mesh-list
139120462|NCT05280028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139120463|NCT05280028|Estrogens|estrogens|mesh-ancestor
139120464|NCT05280028|Hormones|hormones|mesh-ancestor
139120465|NCT05280028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120466|NCT05280028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869514|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
139120467|NCT05280028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139120468|NCT05280028|Contraceptive Agents|contraceptive agents|mesh-ancestor
139120469|NCT05280028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139120470|NCT05280028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139120471|NCT05280028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139120472|NCT05280028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139120473|NCT05280028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139120474|NCT05280028|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139120475|NCT05280028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139120476|NCT05280028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120477|NCT05280028|Androgen Antagonists|androgen antagonists|mesh-ancestor
139120478|NCT05280028|Hormone Antagonists|hormone antagonists|mesh-ancestor
139120479|NCT05280028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139120480|NCT05280028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139120481|NCT05280028|Anabolic Agents|anabolic agents|mesh-ancestor
139120482|NCT05569876|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139120483|NCT05569876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120484|NCT01343368|Leuprolide|leuprolide|mesh-list
139120485|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139120486|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
139120487|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139120488|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120489|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139120490|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120491|NCT02955212|Upadacitinib|upadacitinib|mesh-list
139120492|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139120493|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139120494|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120495|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120496|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139120498|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120499|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139120500|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139120501|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120502|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120503|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139120504|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
139120505|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120506|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120507|NCT03626506|Amlodipine|amlodipine|mesh-list
139120508|NCT03626506|Indapamide|indapamide|mesh-list
139120509|NCT03626506|Spironolactone|spironolactone|mesh-list
139120510|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139120511|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139120512|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139120513|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120514|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139120515|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120516|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
138869521|NCT04250831|Chromium|chromium|mesh-list
139120517|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139120518|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
139120519|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120520|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139120521|NCT03626506|Diuretics|diuretics|mesh-ancestor
139120522|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
139120523|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139120524|NCT03737708|Adalimumab|adalimumab|mesh-list
139120525|NCT03737708|Methotrexate|methotrexate|mesh-list
139120526|NCT03737708|Abatacept|abatacept|mesh-list
139120527|NCT03737708|Tacrolimus|tacrolimus|mesh-list
139120528|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139120529|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
139120530|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139120531|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120532|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139120533|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
139120534|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120535|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120536|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
139120537|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120538|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139120539|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139120540|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
139120541|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139120542|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139120543|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139120544|NCT03737708|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139120545|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139120546|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139120547|NCT03737708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139120548|NCT05517928|Omeprazole|omeprazole|mesh-list
139120549|NCT05517928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139120550|NCT05517928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139120551|NCT05517928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139120552|NCT05517928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120553|NCT05517928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120554|NCT04052204|Avelumab|avelumab|mesh-list
139120555|NCT04052204|Talazoparib|talazoparib|mesh-list
139120556|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139120557|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120558|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139120559|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120560|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120561|NCT04050722|Listerine|listerine|mesh-list
139120562|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
139120563|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
139120564|NCT04050722|Protective Agents|protective agents|mesh-ancestor
139120565|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120566|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139120568|NCT04049552|Sirolimus|sirolimus|mesh-list
139120569|NCT04049552|Temsirolimus|temsirolimus|mesh-list
139120570|NCT04049552|MTOR Inhibitors|mtor inhibitors|mesh-list
139120571|NCT04049552|Petrolatum|petrolatum|mesh-list
139120572|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139120573|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120574|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139120575|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120576|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
139120577|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139120578|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
139120579|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120580|NCT04049552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139120581|NCT04049552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120582|NCT04049552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120583|NCT04049552|Emollients|emollients|mesh-ancestor
139120584|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
139120585|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
139120586|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
139120587|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139120588|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120589|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120590|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
139120591|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
139120592|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139120593|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139120594|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139120595|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139120596|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139120597|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
139120598|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139120599|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120600|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120601|NCT03047980|Sirolimus|sirolimus|mesh-list
139120602|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139120603|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120604|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139120605|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120606|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
139120607|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139120608|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
139120609|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120610|NCT03876028|Tisagenlecleucel|tisagenlecleucel|mesh-list
139120611|NCT03876028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139120612|NCT03876028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120613|NCT03732482|Temozolomide|temozolomide|mesh-list
139120614|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139120615|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
139120616|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120617|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120618|NCT04047446|Dexamethasone|dexamethasone|mesh-list
139120619|NCT04047446|Bupivacaine|bupivacaine|mesh-list
139120620|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139120621|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
139120622|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
139120623|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120624|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120625|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139120626|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
139120627|NCT04047446|Hormones|hormones|mesh-ancestor
139120628|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120629|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139120630|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120631|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
139120632|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
139120633|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139120634|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
139120635|NCT03629054|Metformin|metformin|mesh-list
139120636|NCT03629054|Empagliflozin|empagliflozin|mesh-list
139120637|NCT03629054|Linagliptin|linagliptin|mesh-list
139120638|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139120639|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120640|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139120641|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120643|NCT03629054|Hormones|hormones|mesh-ancestor
139120644|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120645|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139120646|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
139120647|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120648|NCT03045328|Venetoclax|venetoclax|mesh-list
139120649|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120650|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139120651|NCT02154490|Nivolumab|nivolumab|mesh-list
139120652|NCT02154490|Ipilimumab|ipilimumab|mesh-list
139120653|NCT02154490|Durvalumab|durvalumab|mesh-list
139120654|NCT02154490|Rilotumumab|rilotumumab|mesh-list
139120655|NCT02154490|Docetaxel|docetaxel|mesh-list
139120656|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139120657|NCT02154490|Palbociclib|palbociclib|mesh-list
139120658|NCT02154490|Tremelimumab|tremelimumab|mesh-list
139120659|NCT02154490|Talazoparib|talazoparib|mesh-list
139120660|NCT02154490|Antibodies|antibodies|mesh-list
139120661|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
139120662|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139120663|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
139120664|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
139120665|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120666|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120667|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
139120668|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
139120669|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
139120670|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120671|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139120672|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139120673|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120674|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139120675|NCT01512316|Cycloserine|cycloserine|mesh-list
139120676|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139120677|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120678|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139120679|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
139120680|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139120681|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
139120682|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120683|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139120684|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
139120685|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120686|NCT01048138|Biperiden|biperiden|mesh-list
139120687|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
139120688|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139120689|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139120690|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
139120691|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
139120692|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120693|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120694|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139120695|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139120696|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
139120697|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139120698|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120700|NCT00823342|Clevudine|clevudine|mesh-list
139120701|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
139120702|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120703|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139120704|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139120705|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120706|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120707|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139120708|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139120709|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
139120710|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139120711|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
139120712|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120713|NCT01082445|Expectorants|expectorants|mesh-ancestor
139120714|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
139120715|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139120716|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
139120717|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120718|NCT01082445|Protective Agents|protective agents|mesh-ancestor
139120719|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120720|NCT01082445|Antidotes|antidotes|mesh-ancestor
139120721|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139120722|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139120723|NCT01085877|Estradiol|estradiol|mesh-list
139120724|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139120725|NCT01085877|Estrogens|estrogens|mesh-ancestor
139120726|NCT01085877|Hormones|hormones|mesh-ancestor
139120727|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120728|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120729|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139120730|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
139120731|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139120732|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139120733|NCT01089855|Carbamazepine|carbamazepine|mesh-list
139120734|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
139120735|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
139120736|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139120737|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139120738|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120739|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139120740|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139120741|NCT01089855|Analgesics|analgesics|mesh-ancestor
139120742|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
139120743|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120744|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139120745|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139120746|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120747|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139120748|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139120749|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
139120750|NCT03674320|Testosterone|testosterone|mesh-list
139120751|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
139120752|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
139120753|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139120754|NCT03674320|Androgens|androgens|mesh-ancestor
139120755|NCT03674320|Hormones|hormones|mesh-ancestor
139120756|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120757|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120758|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139120759|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120760|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
139120761|NCT05457946|Vaccines|vaccines|mesh-list
139120762|NCT05457946|Immunologic Factors|immunologic factors|mesh-ancestor
139120763|NCT05457946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120764|NCT03625960|Cantharidin|cantharidin|mesh-list
139120765|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120766|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120767|NCT03042910|Talazoparib|talazoparib|mesh-list
139120768|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139120769|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120770|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120771|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120772|NCT03243838|Apatinib|apatinib|mesh-list
139120773|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120774|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139120775|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120776|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120777|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
139120778|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139120779|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120780|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139120781|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139120782|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
139120783|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120784|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
139120785|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120786|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120787|NCT02980666|Teduglutide|teduglutide|mesh-list
139120788|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139120789|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139120790|NCT02980666|Protective Agents|protective agents|mesh-ancestor
139120791|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120792|NCT02962102|Calcitriol|calcitriol|mesh-list
139120793|NCT02962102|Calcifediol|calcifediol|mesh-list
139120794|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139120795|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120796|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139120797|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139120798|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120799|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139120800|NCT02962102|Vitamins|vitamins|mesh-ancestor
139120801|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
139120802|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139120803|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
139120804|NCT02630368|Avelumab|avelumab|mesh-list
139120805|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139120806|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
139120807|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120808|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139120809|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139120810|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
139120811|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120812|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120813|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139120814|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139120815|NCT05244460|Diphenhydramine|diphenhydramine|mesh-list
139120816|NCT05244460|Promethazine|promethazine|mesh-list
139120817|NCT05244460|Droperidol|droperidol|mesh-list
139120818|NCT05244460|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139120819|NCT05244460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139120820|NCT05244460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139120821|NCT05244460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120822|NCT05244460|Anesthetics, Local|anesthetics, local|mesh-ancestor
139120823|NCT05244460|Anesthetics|anesthetics|mesh-ancestor
139120824|NCT05244460|Sensory System Agents|sensory system agents|mesh-ancestor
139120825|NCT05244460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120826|NCT05244460|Antiemetics|antiemetics|mesh-ancestor
139120827|NCT05244460|Autonomic Agents|autonomic agents|mesh-ancestor
139120828|NCT05244460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139120829|NCT05244460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139120830|NCT05244460|Histamine Antagonists|histamine antagonists|mesh-ancestor
139120831|NCT05244460|Histamine Agents|histamine agents|mesh-ancestor
139120832|NCT05244460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139120833|NCT05244460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120834|NCT05244460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139120835|NCT05244460|Antipruritics|antipruritics|mesh-ancestor
139120836|NCT05244460|Dermatologic Agents|dermatologic agents|mesh-ancestor
139120837|NCT05244460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139120838|NCT05244460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139120839|NCT05244460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139120840|NCT05244460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139120841|NCT05244460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139120842|NCT05244460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139120843|NCT05244460|Dopamine Agents|dopamine agents|mesh-ancestor
139120844|NCT00096993|Gemcitabine|gemcitabine|mesh-list
139120845|NCT00096993|Pertuzumab|pertuzumab|mesh-list
139120846|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139120847|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
139120848|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120849|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120850|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139120851|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
139120852|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957407|NCT00539500|Carboplatin|carboplatin|mesh-list
139120853|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139120854|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120855|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120856|NCT03040024|Ketamine|ketamine|mesh-list
139120857|NCT03040024|Analgesics|analgesics|mesh-ancestor
139120858|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
139120859|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120860|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120861|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139120862|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139120863|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
139120864|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
139120865|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139120866|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139120867|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139120868|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139120869|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120870|NCT03038620|Liraglutide|liraglutide|mesh-list
139120871|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139120872|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120873|NCT03038620|Incretins|incretins|mesh-ancestor
139120874|NCT03038620|Hormones|hormones|mesh-ancestor
139120875|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120876|NCT02032810|Ipilimumab|ipilimumab|mesh-list
139120877|NCT02032810|Panobinostat|panobinostat|mesh-list
139120878|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139120879|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120880|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139120881|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120882|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139120883|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120884|NCT01415674|Afatinib|afatinib|mesh-list
139120885|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120886|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139120887|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139120888|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120889|NCT01350934|Vitamin D|vitamin d|mesh-list
139120890|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
139120891|NCT01350934|Alendronate|alendronate|mesh-list
139120892|NCT01350934|Calcitriol|calcitriol|mesh-list
139120893|NCT01350934|Calcium|calcium|mesh-list
139120894|NCT01350934|Vitamins|vitamins|mesh-ancestor
139120895|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
139120896|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871481|NCT05989503|Valsartan|valsartan|mesh-list
139120897|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139120898|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139120899|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139120900|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139120901|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957423|NCT00662532|Minocycline|minocycline|mesh-list
139120902|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139120903|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139120904|NCT01146418|Hormones|hormones|mesh-ancestor
139120905|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120906|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120907|NCT05654896|Ceftriaxone|ceftriaxone|mesh-list
139120908|NCT05654896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139120909|NCT05654896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139120910|NCT00745108|Tibolone|tibolone|mesh-list
139120911|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120912|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139120913|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120914|NCT00745108|Hormones|hormones|mesh-ancestor
139120915|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120916|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
139120917|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
139120918|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139120919|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139120921|NCT00725374|Tibolone|tibolone|mesh-list
139120922|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
139120923|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
139120924|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120925|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120926|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139120927|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139120928|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120929|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139120930|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
139120931|NCT00725374|Hormones|hormones|mesh-ancestor
138957448|NCT00797160|Propofol|propofol|mesh-list
139120932|NCT03622580|Aflibercept|aflibercept|mesh-list
139120933|NCT03622580|Faricimab|faricimab|mesh-list
139120934|NCT03622580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139120935|NCT03622580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139120936|NCT03622580|Growth Substances|growth substances|mesh-ancestor
139120937|NCT03622580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120938|NCT03622580|Growth Inhibitors|growth inhibitors|mesh-ancestor
139120939|NCT03622580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139120940|NCT00461032|Montelukast|montelukast|mesh-list
139120941|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139120942|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
139120943|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139120944|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
139120945|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120946|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120947|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139120948|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139120949|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120950|NCT00446056|Ketotifen|ketotifen|mesh-list
139120951|NCT00446056|Montelukast|montelukast|mesh-list
139120952|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139120953|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120954|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120955|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
139120956|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139120957|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139120958|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
139120959|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120960|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139120961|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139120962|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
139120963|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
139120964|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139120965|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
139120966|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
139120967|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139120968|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139120969|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120970|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139120971|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
139120972|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120973|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139120974|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139120975|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139120976|NCT00092092|Budesonide|budesonide|mesh-list
139120977|NCT00092092|Montelukast|montelukast|mesh-list
139120978|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139120979|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139120980|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
139120981|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139120982|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139120983|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139120984|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
139120985|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
139120986|NCT00092092|Hormones|hormones|mesh-ancestor
138957482|NCT00681824|Aprotinin|aprotinin|mesh-list
139120987|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139120988|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139120989|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
139120990|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139120991|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139120992|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139120993|NCT00092014|Vitamin D|vitamin d|mesh-list
139120994|NCT00092014|Alendronate|alendronate|mesh-list
139120995|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
139120996|NCT00092014|Calcium|calcium|mesh-list
139120997|NCT00092014|Vitamins|vitamins|mesh-ancestor
139120998|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
139120999|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121000|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139121001|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139121002|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139121003|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139121004|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121005|NCT00090142|Montelukast|montelukast|mesh-list
139121006|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139121007|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
139121008|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139121009|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
139121010|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139121011|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121012|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139121013|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139121014|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121015|NCT00043108|Paclitaxel|paclitaxel|mesh-list
139121016|NCT00043108|Carboplatin|carboplatin|mesh-list
139121017|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139121018|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121019|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
139121020|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
139121021|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
139121022|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121023|NCT03619408|Antacids|antacids|mesh-list
139121024|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121025|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139121026|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
139121027|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139121028|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
139121029|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121030|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121031|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
139121032|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121033|NCT03620708|Nicotine|nicotine|mesh-list
139121034|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139121035|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
139121036|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121037|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121038|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139121039|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139121040|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
139121041|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121042|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121043|NCT03654326|Naproxen|naproxen|mesh-list
138871621|NCT05593731|Melatonin|melatonin|mesh-list
139121044|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139121045|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139121046|NCT03654326|Analgesics|analgesics|mesh-ancestor
139121047|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
139121048|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121049|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121050|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139121051|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139121052|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
139121053|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139121054|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121055|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121056|NCT03735446|Cytarabine|cytarabine|mesh-list
139121057|NCT03735446|Etoposide|etoposide|mesh-list
139121058|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
139121059|NCT03735446|Prexasertib|prexasertib|mesh-list
139121060|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139121061|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121062|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139121063|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139121064|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121065|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121066|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139121067|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
139121068|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
139121069|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121070|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139121071|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
139121072|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121073|NCT03735446|Analgesics|analgesics|mesh-ancestor
139121074|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
139121075|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121076|NCT03735446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139121077|NCT03735368|Pregabalin|pregabalin|mesh-list
139121078|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
139121079|NCT03735368|Benoxinate|benoxinate|mesh-list
139121080|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
138890230|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139121081|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121082|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121083|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139121084|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139121085|NCT03735368|Analgesics|analgesics|mesh-ancestor
139121086|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
139121087|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121088|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139121089|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139121090|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139121091|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
139121092|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121093|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121094|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
139121095|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139121096|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139121097|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139121098|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139121099|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139121100|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139121101|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
139121103|NCT00071799|Azacitidine|azacitidine|mesh-list
139121104|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139121105|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
139121106|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121107|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121108|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
139121109|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121110|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139121111|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
139121112|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121113|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121114|NCT03615482|Vaccines|vaccines|mesh-list
139121115|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
139121116|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121117|NCT03652610|Vaccines|vaccines|mesh-list
139121118|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
139121119|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121120|NCT03615404|Molgramostim|molgramostim|mesh-list
139121121|NCT03615404|Sargramostim|sargramostim|mesh-list
139121122|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
139121123|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121124|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121125|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
139121126|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139121127|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
139121128|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121129|NCT03730064|Expectorants|expectorants|mesh-ancestor
139121130|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
139121131|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139121132|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
139121133|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121134|NCT03730064|Protective Agents|protective agents|mesh-ancestor
139121135|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121136|NCT03730064|Antidotes|antidotes|mesh-ancestor
139121137|NCT03580382|Trametinib|trametinib|mesh-list
139121138|NCT03580382|Antibodies|antibodies|mesh-list
139121139|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
139121140|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121141|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121142|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139121143|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121144|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121145|NCT03577730|Caffeine|caffeine|mesh-list
139121146|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
139121147|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121148|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139121149|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121150|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139121151|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121152|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139121153|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139121154|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
139121155|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121156|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
139121157|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139121158|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121159|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
139121161|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
139121162|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139121163|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
139121164|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
139121165|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
139121166|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121167|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121168|NCT03608774|Azithromycin|azithromycin|mesh-list
139121169|NCT03608774|Doxycycline|doxycycline|mesh-list
139121170|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139121171|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121172|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
139121173|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139121174|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139121175|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
139121176|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139121177|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139121178|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139121179|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121180|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
139121181|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
139121182|NCT03729674|Infliximab|infliximab|mesh-list
139121183|NCT03729674|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139121184|NCT03729674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139121185|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
139121186|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139121187|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139121188|NCT03731468|Dexamethasone|dexamethasone|mesh-list
139121189|NCT03731468|Anesthetics|anesthetics|mesh-list
139121190|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
139121191|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139121192|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
139121193|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
139121194|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121195|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121196|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139121197|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
139121199|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139121200|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139121201|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121202|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121203|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
139121204|NCT03600428|Vaccines|vaccines|mesh-list
139121205|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
139121206|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121207|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139121208|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139121209|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139121210|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
139121211|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121212|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121213|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121214|NCT03575702|Urological Agents|urological agents|mesh-ancestor
139121215|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
139121216|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139121217|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121218|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121219|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139121220|NCT03639896|Analgesics|analgesics|mesh-ancestor
139121221|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
139121222|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121223|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139121224|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139121225|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139121226|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
139121227|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121228|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121229|NCT03573908|Linaclotide|linaclotide|mesh-list
139121230|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139121231|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
139121232|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121233|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139121234|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138869770|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139121235|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139121236|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139121237|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139121238|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121239|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121240|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121242|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
139121243|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121244|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
139121245|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139121246|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
139121247|NCT03729128|Memantine|memantine|mesh-list
139121248|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
139121249|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139121250|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139121251|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
139121252|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121253|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121254|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121255|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139121256|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139121257|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
139121258|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
139121259|NCT03728894|Midazolam|midazolam|mesh-list
139121260|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
139121261|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139121262|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139121263|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121264|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121265|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139121266|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139121267|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139121268|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139121269|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
139121270|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
139121271|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
139121272|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
139121273|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121274|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121275|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
139121276|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
139121277|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139121278|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
139121279|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
139121280|NCT03730766|Amoxicillin|amoxicillin|mesh-list
139121281|NCT03730766|Metronidazole|metronidazole|mesh-list
139121282|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
139121283|NCT03730766|Esomeprazole|esomeprazole|mesh-list
139121284|NCT03730766|Bismuth|bismuth|mesh-list
139121285|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121286|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139121287|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121288|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139121289|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139121290|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139121291|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139121292|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139121293|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121294|NCT03730766|Antacids|antacids|mesh-ancestor
139121295|NCT03730766|Diuretics|diuretics|mesh-ancestor
139121296|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
139121297|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121298|NCT03730766|Expectorants|expectorants|mesh-ancestor
139121299|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
139121300|NCT00071487|Belimumab|belimumab|mesh-list
139121301|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139121302|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
139121303|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121304|NCT03962283|Rifaximin|rifaximin|mesh-list
139121305|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139121306|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121307|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139121308|NCT03591146|Ropivacaine|ropivacaine|mesh-list
139121309|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
139121310|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
139121311|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121312|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121313|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
139121314|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121315|NCT00096447|Lapatinib|lapatinib|mesh-list
139121316|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121317|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139121318|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121319|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121320|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139121321|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139121322|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139121323|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139121324|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121325|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121326|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121327|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139121328|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
139121329|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139121330|NCT00070941|Escitalopram|escitalopram|mesh-list
139121331|NCT00070941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139121332|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139121333|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139121334|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121335|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121336|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
139121337|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121338|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
139121339|NCT00070707|Albuterol|albuterol|mesh-list
139121340|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139121341|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
139121342|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121343|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121344|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139121345|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
139121346|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
139121347|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139121348|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139121349|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139121350|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139121351|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
139121352|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121353|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121354|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139121355|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
139121356|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139121357|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
139121358|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138869815|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139121359|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121360|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139121361|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121362|NCT00070317|Methylene Blue|methylene blue|mesh-list
139121363|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
139121364|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121365|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121366|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139121367|NCT01086345|Bevacizumab|bevacizumab|mesh-list
139121368|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139121369|NCT01086345|Irinotecan|irinotecan|mesh-list
139121370|NCT01086345|Camptothecin|camptothecin|mesh-list
139121371|NCT01086345|Antibodies|antibodies|mesh-list
139121372|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
139121373|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139121374|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121375|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139121376|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139121377|NCT01086345|Growth Substances|growth substances|mesh-ancestor
139121378|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121379|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
139121380|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
139121381|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139121382|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139121383|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121384|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121385|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139121386|NCT03960411|Doxycycline|doxycycline|mesh-list
139121387|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139121388|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121389|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
139121390|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139121391|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139121392|NCT01090167|Clofarabine|clofarabine|mesh-list
139121393|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139121394|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
139121395|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121396|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121397|NCT03587636|Bupivacaine|bupivacaine|mesh-list
139121398|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
139121399|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
139121400|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121401|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121402|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
139121403|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121404|NCT03053362|Vortioxetine|vortioxetine|mesh-list
139121405|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
139121406|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139121407|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139121408|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139121409|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121410|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121411|NCT03053362|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139121412|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139121413|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139121414|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121415|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121416|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
139121417|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139121418|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139121419|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139121420|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139121421|NCT03733652|Interferons|interferons|mesh-list
139121422|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
139121423|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
139121424|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121425|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
139121426|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121427|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
139121428|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121429|NCT03586544|Albuterol|albuterol|mesh-list
139121430|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139121431|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
139121432|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121433|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121434|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139121435|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
139121436|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
139121437|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139121438|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139121439|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139121440|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139121441|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
139121442|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121443|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121444|NCT03737448|Trimetazidine|trimetazidine|mesh-list
139121445|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
139121446|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139121447|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139121448|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139121449|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139121450|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121451|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121452|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121453|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
139121454|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139121455|NCT03728192|Camptothecin|camptothecin|mesh-list
139121456|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139121457|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121458|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139121459|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139121460|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121461|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121462|NCT03589768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139121463|NCT03589768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139121464|NCT03589768|Immunologic Factors|immunologic factors|mesh-ancestor
139121465|NCT03589768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121466|NCT03589768|Antacids|antacids|mesh-ancestor
139121467|NCT03589768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121468|NCT03589768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139121469|NCT03733340|Imipenem|imipenem|mesh-list
139121470|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139121471|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121472|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
139121473|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139121474|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121475|NCT05137600|Clarithromycin|clarithromycin|mesh-list
139121476|NCT05137600|Midazolam|midazolam|mesh-list
139121477|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139121478|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139121479|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121480|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121481|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139121482|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139121483|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139121484|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139121485|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
139121486|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
139121487|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
139121488|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
139121489|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121490|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121491|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139121492|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121493|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139121494|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121495|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139121496|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139121497|NCT00089505|Ritonavir|ritonavir|mesh-list
139121498|NCT00089505|Lopinavir|lopinavir|mesh-list
139121499|NCT00089505|Tenofovir|tenofovir|mesh-list
139121500|NCT00089505|Emtricitabine|emtricitabine|mesh-list
139121501|NCT00089505|Nevirapine|nevirapine|mesh-list
139121502|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139121503|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139121504|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139121505|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
139121506|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121507|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121508|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139121509|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139121510|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
139121511|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121512|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139121513|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139121514|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139121515|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139121516|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139121517|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139121518|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139121519|NCT04009824|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139121520|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139121521|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
139121522|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121523|NCT04009824|Antacids|antacids|mesh-ancestor
139121524|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121525|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139121527|NCT05041426|Letermovir|letermovir|mesh-list
139121529|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121530|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139121531|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121532|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121533|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121534|NCT03555890|Cetirizine|cetirizine|mesh-list
139121535|NCT03555890|Levocetirizine|levocetirizine|mesh-list
139121536|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139121537|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139121538|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
139121539|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
139121540|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121541|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121542|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121543|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139121544|NCT04905862|Antipyretics|antipyretics|mesh-list
139121545|NCT04905862|Analgesics|analgesics|mesh-list
139121546|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
139121547|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121548|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121549|NCT03630120|Sorafenib|sorafenib|mesh-list
139121550|NCT03630120|Lenvatinib|lenvatinib|mesh-list
139121551|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121552|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139121553|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121554|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121555|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
139121556|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
139121557|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121558|NCT03744702|Protective Agents|protective agents|mesh-ancestor
139121559|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121560|NCT03744702|Vitamins|vitamins|mesh-ancestor
139121561|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
139121562|NCT03736980|Psilocybin|psilocybin|mesh-list
139121563|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
139121564|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121565|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139121566|NCT03727646|Niacinamide|niacinamide|mesh-list
138872135|NCT03747484|Interferon-gamma|interferon-gamma|mesh-list
139121568|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
139121569|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
139121570|NCT03727646|Vitamins|vitamins|mesh-ancestor
139121571|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
139121572|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121573|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139121574|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
139121575|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121576|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139121577|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
139121578|NCT03554486|Insulin|insulin|mesh-list
139121579|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139121580|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
139121581|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
139121582|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139121583|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139121584|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121585|NCT03554018|Acetaminophen|acetaminophen|mesh-list
139121586|NCT03554018|Ibuprofen|ibuprofen|mesh-list
139121587|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139121588|NCT03554018|Analgesics|analgesics|mesh-ancestor
139121589|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
139121590|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121591|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121592|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
139121593|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139121594|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139121595|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139121596|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139121597|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121598|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121599|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
139121600|NCT04787692|Narcotics|narcotics|mesh-ancestor
139121601|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121602|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121603|NCT04787692|Analgesics|analgesics|mesh-ancestor
139121604|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
139121605|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121606|NCT05462548|Luspatercept|luspatercept|mesh-list
139121607|NCT05462548|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
139121608|NCT05462548|Hematinics|hematinics|mesh-ancestor
139121609|NCT05462548|Immunologic Factors|immunologic factors|mesh-ancestor
139121610|NCT05462548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121611|NCT03408340|Fentanyl|fentanyl|mesh-list
139121612|NCT03408340|Ketamine|ketamine|mesh-list
139121613|NCT03408340|Propofol|propofol|mesh-list
139121614|NCT03408340|Sevoflurane|sevoflurane|mesh-list
139121615|NCT03408340|Rocuronium|rocuronium|mesh-list
139121616|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
139121617|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121618|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121619|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
139121620|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121621|NCT03408340|Analgesics|analgesics|mesh-ancestor
139121622|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139121623|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139121624|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
139121625|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139121626|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139121627|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121628|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121629|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139121630|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139121631|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139121632|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139121633|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139121634|NCT03408340|Narcotics|narcotics|mesh-ancestor
139121635|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139121636|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139121637|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139121638|NCT03570554|Acetaminophen|acetaminophen|mesh-list
139121639|NCT03570554|Celecoxib|celecoxib|mesh-list
139121640|NCT03570554|Naproxen|naproxen|mesh-list
139121641|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139121642|NCT03570554|Analgesics|analgesics|mesh-ancestor
139121643|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
138872214|NCT03088540|Paclitaxel|paclitaxel|mesh-list
139121644|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121645|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121646|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
139121647|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139121648|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139121649|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139121650|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139121651|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139121652|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121653|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121654|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
139121655|NCT04004208|Aflibercept|aflibercept|mesh-list
139121656|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139121657|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139121658|NCT04004208|Growth Substances|growth substances|mesh-ancestor
138957638|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
139121659|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121660|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
139121661|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121662|NCT03727412|Naproxen|naproxen|mesh-list
139121663|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139121664|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139121665|NCT03727412|Analgesics|analgesics|mesh-ancestor
139121666|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
139121667|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121668|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121669|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139121670|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139121671|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
139121672|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139121673|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121674|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121676|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139121677|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121678|NCT03035032|Leuprolide|leuprolide|mesh-list
139121679|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139121680|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
139121681|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139121682|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121683|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139121684|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121685|NCT03629184|Oseltamivir|oseltamivir|mesh-list
139121686|NCT03629184|Baloxavir|baloxavir|mesh-list
139121687|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
139121688|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121689|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121690|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121691|NCT03725228|Lidocaine|lidocaine|mesh-list
139121692|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
139121693|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
139121694|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
139121695|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121696|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121697|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
139121698|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121699|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139121700|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139121701|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139121702|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139121703|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121704|NCT03725228|Analgesics|analgesics|mesh-ancestor
139121705|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
139121706|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139121707|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139121708|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
139121709|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139121710|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
139121712|NCT03724838|Citric Acid|citric acid|mesh-list
139121713|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
139121714|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
139121715|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139121716|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
139121717|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
139121718|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121719|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
139121720|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139121721|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139121722|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121723|NCT03724838|Urological Agents|urological agents|mesh-ancestor
139121724|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139121725|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139121726|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139121727|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
139121728|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139121729|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
139121730|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139121731|NCT03358030|Riboflavin|riboflavin|mesh-list
139121732|NCT03358030|Vitamin B Complex|vitamin b complex|mesh-ancestor
139121733|NCT03358030|Vitamins|vitamins|mesh-ancestor
139121734|NCT03358030|Micronutrients|micronutrients|mesh-ancestor
139121735|NCT03358030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121736|NCT03358030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139121737|NCT03358030|Dermatologic Agents|dermatologic agents|mesh-ancestor
139121738|NCT03566810|Metformin|metformin|mesh-list
139121739|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139121740|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121741|NCT03628716|Atezolizumab|atezolizumab|mesh-list
139121742|NCT03628716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139121743|NCT03628716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121744|NCT03628716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139121745|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121746|NCT03840616|Fluconazole|fluconazole|mesh-list
139121747|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
139121748|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121749|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139121750|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139121751|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121752|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121753|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139121754|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
139121755|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139121756|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121757|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139121758|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139121759|NCT00088413|Molgramostim|molgramostim|mesh-list
139121760|NCT00088413|Sargramostim|sargramostim|mesh-list
139121761|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
139121762|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121763|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121764|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
139121765|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139121766|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139121767|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
139121768|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869928|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
139121769|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121770|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121771|NCT03787654|Urological Agents|urological agents|mesh-ancestor
139121773|NCT00086385|Nicotine|nicotine|mesh-list
139121774|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139121775|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
139121776|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121777|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121778|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139121779|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139121780|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
139121781|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121782|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019549|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121783|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139121784|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
139121785|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139121786|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139121787|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139121788|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139121789|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
139121790|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139121791|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139121792|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121793|NCT03993288|Iron|iron|mesh-list
139121794|NCT03993288|Trace Elements|trace elements|mesh-ancestor
139121795|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
138872359|NCT00891371|Lanreotide|lanreotide|mesh-list
139121796|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121797|NCT05093608|Bevacizumab|bevacizumab|mesh-list
139121798|NCT05093608|Atezolizumab|atezolizumab|mesh-list
139121799|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139121800|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121801|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139121802|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139121803|NCT05093608|Growth Substances|growth substances|mesh-ancestor
139121804|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121805|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
139121806|NCT05093608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139121807|NCT05093608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121808|NCT03991494|Pamiparib|pamiparib|mesh-list
139121809|NCT03991494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139121810|NCT03991494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121811|NCT03991494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121812|NCT03991494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121813|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139121814|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139121815|NCT03383770|Anesthetics|anesthetics|mesh-list
139121816|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121817|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121818|NCT00086307|Pramipexole|pramipexole|mesh-list
139121819|NCT00086307|Escitalopram|escitalopram|mesh-list
139121820|NCT00086307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138869947|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
139121821|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139121823|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121824|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121825|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
139121826|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121827|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139121828|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139121829|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
139121830|NCT00086307|Protective Agents|protective agents|mesh-ancestor
139121831|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
139121832|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
139121833|NCT01086579|Paclitaxel|paclitaxel|mesh-list
139121834|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139121835|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139121836|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121837|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
139121838|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
139121839|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
138957677|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139121840|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121841|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
139121842|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
139121843|NCT03743922|Vitamin D|vitamin d|mesh-list
139121844|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139121845|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121846|NCT03743922|Vitamins|vitamins|mesh-ancestor
139121847|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
139121848|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139121849|NCT03988842|Heparin|heparin|mesh-list
139121850|NCT03988842|Calcium heparin|calcium heparin|mesh-list
139121851|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139121852|NCT03988842|Plasminogen|plasminogen|mesh-list
139121853|NCT03988842|Apixaban|apixaban|mesh-list
139121854|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
139121855|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139121856|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139121857|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121858|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139121859|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
139121860|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139121861|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
139121862|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121863|NCT02668822|Ibuprofen|ibuprofen|mesh-list
139121864|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139121865|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139121866|NCT02668822|Analgesics|analgesics|mesh-ancestor
139121867|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
139121868|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121869|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121870|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139121871|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139121872|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139121873|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121874|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121875|NCT04112589|Cytarabine|cytarabine|mesh-list
139121876|NCT04112589|Fludarabine|fludarabine|mesh-list
139121877|NCT04112589|Idarubicin|idarubicin|mesh-list
139121878|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121879|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139121880|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
139121881|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121882|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139121883|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
139121884|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121885|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
139121886|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121887|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139121888|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139121889|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139121890|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121891|NCT03547154|Interferons|interferons|mesh-list
139121892|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
139121893|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
139121895|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121896|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
139121897|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139121898|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
139121899|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121900|NCT02275546|NuvaRing|nuvaring|mesh-list
139121901|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139121902|NCT02275546|Desogestrel|desogestrel|mesh-list
139121903|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139121904|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
139121905|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139121906|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121907|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139121908|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139121909|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139121910|NCT02275546|Estrogens|estrogens|mesh-ancestor
139121911|NCT02275546|Hormones|hormones|mesh-ancestor
139121912|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139121913|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139121914|NCT02275546|Progestins|progestins|mesh-ancestor
139121915|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139121916|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139121917|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121918|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139121919|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139121920|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139121921|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121922|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
139121923|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139121924|NCT01096797|Sevoflurane|sevoflurane|mesh-list
139121925|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139121926|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139121927|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
139121928|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
139121929|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121930|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121931|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
139121932|NCT00068601|Goserelin|goserelin|mesh-list
139121933|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139121934|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
139121935|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121936|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139121937|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139121938|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
139121939|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121940|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121941|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138872508|NCT02647086|Midazolam|midazolam|mesh-list
139121942|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139121943|NCT01670656|Ibuprofen|ibuprofen|mesh-list
139121944|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
139121945|NCT01670656|Etonogestrel|etonogestrel|mesh-list
139121946|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139121947|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139121948|NCT01670656|Analgesics|analgesics|mesh-ancestor
139121949|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
139121950|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121951|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121952|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139121953|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139121954|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139121955|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121956|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121957|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139121958|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139121959|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139121960|NCT00068445|Lamotrigine|lamotrigine|mesh-list
139121961|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
139121962|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139121963|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139121964|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492319|NCT00275431|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
139121965|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139121966|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121967|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139121968|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139121969|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139121970|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139121971|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139121972|NCT03033784|Oxytocin|oxytocin|mesh-list
139121973|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
139121974|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139121975|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121976|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
139121977|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139121978|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139121979|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121980|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121981|NCT02926690|OTS167|ots167|mesh-list
139121982|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139121983|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139121984|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121985|NCT03652818|Acetaminophen|acetaminophen|mesh-list
139121986|NCT03652818|Pregabalin|pregabalin|mesh-list
139121987|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139121988|NCT03652818|Analgesics|analgesics|mesh-ancestor
139121989|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
139121990|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139121991|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139121992|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
139121993|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
139121994|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139121995|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139121996|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139121997|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139121998|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139121999|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139122000|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122001|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139122002|NCT03723824|Grazoprevir|grazoprevir|mesh-list
139122003|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139122004|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
139122005|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122006|NCT00620464|Etonogestrel|etonogestrel|mesh-list
139122007|NCT00620464|Desogestrel|desogestrel|mesh-list
139122008|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139122009|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
139122010|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139122011|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957721|NCT00326209|Mesalamine|mesalamine|mesh-list
139122012|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139122013|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139122014|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139122015|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139122016|NCT00620464|Progestins|progestins|mesh-ancestor
139122017|NCT00620464|Hormones|hormones|mesh-ancestor
139122018|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139122019|NCT00541684|Atenolol|atenolol|mesh-list
139122020|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
139122021|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122022|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122023|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122024|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
139122025|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122026|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139122027|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139122028|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
139122029|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139122030|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139122031|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139122032|NCT00413764|Tibolone|tibolone|mesh-list
139122033|NCT00413764|Norethindrone|norethindrone|mesh-list
139122034|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
139122035|NCT00413764|Estradiol|estradiol|mesh-list
139122036|NCT00413764|Estrogens|estrogens|mesh-ancestor
139122037|NCT00413764|Hormones|hormones|mesh-ancestor
139122038|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139122039|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122040|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139122041|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
139122042|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139122043|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139122044|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
139122045|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
138870012|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
139122046|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139122047|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139122048|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122049|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139122050|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
139122051|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139122052|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139122053|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139122054|NCT03726788|Triamcinolone|triamcinolone|mesh-list
139122055|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139122056|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139122057|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
139122058|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139122059|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139122060|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139122061|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139122062|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139122063|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957748|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
139122064|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
139122065|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122066|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122067|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139122068|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122069|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139122070|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
139122072|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139122073|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139122074|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
139122075|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122076|NCT03735264|Docetaxel|docetaxel|mesh-list
139122077|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122078|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
139122079|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
139122080|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
139122081|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122082|NCT03560258|Vaccines|vaccines|mesh-list
139122083|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
139122084|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122085|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
139122086|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139122087|NCT02759380|Estrogens|estrogens|mesh-ancestor
139122088|NCT02759380|Hormones|hormones|mesh-ancestor
139122089|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139122090|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122091|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
139122092|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139122093|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
139122094|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122095|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139122096|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139122097|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139122098|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122099|NCT03615924|Ticagrelor|ticagrelor|mesh-list
139122100|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139122101|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139122102|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139122103|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139122104|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
139122105|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122106|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122107|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122108|NCT04660240|Sirolimus|sirolimus|mesh-list
139122109|NCT04660240|Temsirolimus|temsirolimus|mesh-list
139122110|NCT04660240|MTOR Inhibitors|mtor inhibitors|mesh-list
139122111|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139122112|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122113|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139122114|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122115|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
139122116|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139122117|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
139122118|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122119|NCT04660240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139122120|NCT04660240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122121|NCT04660240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122122|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139122123|NCT03033394|Penicillins|penicillins|mesh-list
139122124|NCT03033394|Lactams|lactams|mesh-list
139122125|NCT03033394|beta-Lactams|beta-lactams|mesh-list
139122126|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122127|NCT03639428|Midazolam|midazolam|mesh-list
139122128|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139122129|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139122130|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122131|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122132|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139122133|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139122134|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139122135|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139122136|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
139122137|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
139122138|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
139122139|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
139122140|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122141|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122142|NCT04575688|Bupivacaine|bupivacaine|mesh-list
139122143|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
139122144|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
139122145|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122146|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122147|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
139122148|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122149|NCT04561648|Heparin|heparin|mesh-list
139122150|NCT04561648|Calcium heparin|calcium heparin|mesh-list
139122151|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
139122152|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139122153|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139122154|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122155|NCT03981822|Cantharidin|cantharidin|mesh-list
139122156|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122157|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122158|NCT05506930|Morphine|morphine|mesh-list
139122159|NCT05506930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139122160|NCT05506930|Narcotics|narcotics|mesh-ancestor
139122161|NCT05506930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122162|NCT05506930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122163|NCT05506930|Analgesics|analgesics|mesh-ancestor
138872729|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
139122164|NCT05506930|Sensory System Agents|sensory system agents|mesh-ancestor
139122165|NCT05506930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122166|NCT01310738|Amphotericin B|amphotericin b|mesh-list
139122167|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139122168|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
139122169|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
139122170|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
139122171|NCT01310738|Amebicides|amebicides|mesh-ancestor
139122172|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139122173|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139122174|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122175|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139122176|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
139122177|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139122178|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139122179|NCT03704506|Amoxicillin|amoxicillin|mesh-list
139122180|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139122181|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122182|NCT03615144|Fludarabine|fludarabine|mesh-list
139122183|NCT03615144|Melphalan|melphalan|mesh-list
139122184|NCT03615144|Thiotepa|thiotepa|mesh-list
139122185|NCT03615144|Clofarabine|clofarabine|mesh-list
139122186|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
139122187|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139122188|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870097|NCT00647712|Valproic Acid|valproic acid|mesh-list
139122189|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139122190|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
139122191|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122192|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139122193|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
139122194|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122195|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139122196|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
139122197|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139122198|NCT03682302|Bupivacaine|bupivacaine|mesh-list
139122199|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
139122200|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
139122201|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122202|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122203|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
139122204|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122205|NCT03522506|Modafinil|modafinil|mesh-list
139122206|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139122207|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122208|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139122209|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139122210|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139122211|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122212|NCT03320434|Prednisolone acetate|prednisolone acetate|mesh-list
139122213|NCT03320434|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139122214|NCT03320434|Methylprednisolone|methylprednisolone|mesh-list
139122215|NCT03320434|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139122216|NCT03320434|Prednisolone|prednisolone|mesh-list
139122217|NCT03320434|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139122218|NCT03320434|Prednisolone phosphate|prednisolone phosphate|mesh-list
139122219|NCT03320434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139122220|NCT03320434|Antiemetics|antiemetics|mesh-ancestor
139122221|NCT03320434|Autonomic Agents|autonomic agents|mesh-ancestor
139122222|NCT03320434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122223|NCT03320434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122224|NCT03320434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139122225|NCT03320434|Glucocorticoids|glucocorticoids|mesh-ancestor
139122226|NCT03320434|Hormones|hormones|mesh-ancestor
139122227|NCT03320434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139122228|NCT03320434|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139122229|NCT03320434|Protective Agents|protective agents|mesh-ancestor
139122230|NCT03320434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139122231|NCT03320434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122232|NCT02892734|Nivolumab|nivolumab|mesh-list
139122233|NCT02892734|Ipilimumab|ipilimumab|mesh-list
139122234|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139122235|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122236|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139122237|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122238|NCT05231590|Myeloma Proteins|myeloma proteins|mesh-list
139122239|NCT05231590|Paraproteins|paraproteins|mesh-list
139122240|NCT05231590|Immunologic Factors|immunologic factors|mesh-ancestor
139122241|NCT05231590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122242|NCT00055497|Adalimumab|adalimumab|mesh-list
139122243|NCT00055497|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139122244|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139122245|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139122246|NCT03726398|Macitentan|macitentan|mesh-list
139122247|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139122248|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139122249|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122250|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139122251|NCT04050592|Estradiol|estradiol|mesh-list
139122252|NCT04050592|Estrogens|estrogens|mesh-ancestor
139122253|NCT04050592|Hormones|hormones|mesh-ancestor
139122254|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139122255|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122256|NCT03726242|Cromakalim|cromakalim|mesh-list
139122257|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139122258|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139122259|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
139122260|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122261|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122262|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139122263|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
139122264|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
139122265|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
139122266|NCT03731988|Lidocaine|lidocaine|mesh-list
139122267|NCT03731988|Prilocaine|prilocaine|mesh-list
138957854|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
139122268|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139122269|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
139122270|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
139122271|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122272|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122273|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
139122274|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122275|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139122276|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139122277|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139122278|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139122279|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122280|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139122281|NCT01094457|Aspirin|aspirin|mesh-list
139122282|NCT01094457|Cilostazol|cilostazol|mesh-list
139122283|NCT01094457|Clopidogrel|clopidogrel|mesh-list
139122284|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139122285|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139122286|NCT01094457|Analgesics|analgesics|mesh-ancestor
139122287|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
139122288|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122289|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122290|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139122291|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139122292|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139122293|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139122294|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122295|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139122296|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139122297|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122298|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
139122299|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139122300|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139122301|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139122302|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
139122303|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122304|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139122305|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
139122306|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139122307|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
139122308|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
139122309|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139122310|NCT01094457|Protective Agents|protective agents|mesh-ancestor
139122311|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139122312|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139122313|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
139122314|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139122315|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139122316|NCT03701698|Prednisolone|prednisolone|mesh-list
139122317|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
139122318|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139122319|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
139122320|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139122321|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
139122322|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
139122323|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122324|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122325|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139122326|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
139122327|NCT03701698|Hormones|hormones|mesh-ancestor
139122328|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139122329|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139122330|NCT03701698|Protective Agents|protective agents|mesh-ancestor
139122331|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139122332|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122333|NCT03734562|Amiodarone|amiodarone|mesh-list
139122334|NCT03734562|Sotalol|sotalol|mesh-list
139122335|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139122336|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
139122337|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139122338|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139122339|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122340|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139122341|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139122342|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139122343|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122344|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139122345|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139122346|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139122347|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139122348|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139122349|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
139122350|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122351|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122353|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
139122354|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122355|NCT03034096|Propofol|propofol|mesh-list
139122356|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139122357|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122358|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122359|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139122360|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
139122361|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
139122362|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
139122363|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139122364|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122365|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139122366|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122367|NCT03807843|Vaccines|vaccines|mesh-list
139122368|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
139122369|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122370|NCT01094535|Secretin|secretin|mesh-list
139122371|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139122372|NCT01094535|Hormones|hormones|mesh-ancestor
139122373|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139122374|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122375|NCT00038103|Celecoxib|celecoxib|mesh-list
139122376|NCT00038103|Exemestane|exemestane|mesh-list
139122377|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139122378|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139122379|NCT00038103|Analgesics|analgesics|mesh-ancestor
139122380|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
139122381|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122382|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122383|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139122384|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139122385|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139122386|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138544230|NCT00084669|Zolpidem|zolpidem|mesh-list
139122387|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122388|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122389|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122390|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138872949|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
139122391|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139122392|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139122393|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
139122394|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139122395|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
139122396|NCT03678870|Narcotics|narcotics|mesh-ancestor
139122397|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122398|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122399|NCT03678870|Analgesics|analgesics|mesh-ancestor
139122400|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
138870192|NCT00648492|Metformin|metformin|mesh-list
139122401|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122402|NCT03032380|Meropenem|meropenem|mesh-list
139122403|NCT03032380|Linezolid|linezolid|mesh-list
139122404|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139122405|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122406|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139122407|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122408|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122409|NCT03519854|Bromides|bromides|mesh-list
139122410|NCT03519854|Rocuronium|rocuronium|mesh-list
139122411|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
139122412|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139122413|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139122414|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139122415|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122416|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122417|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
139122418|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
139122419|NCT03479216|Bupivacaine|bupivacaine|mesh-list
139122420|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
139122421|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
139122422|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122423|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122424|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
139122425|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122426|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139122427|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139122428|NCT03479216|Analgesics|analgesics|mesh-ancestor
139122429|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139122430|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139122431|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139122432|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
139122433|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122434|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122435|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139122436|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
139122437|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139122438|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139122439|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139122440|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
139122441|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139122442|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
139122443|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139122444|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122445|NCT03717038|Trifluridine|trifluridine|mesh-list
139122446|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
139122447|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122448|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
139122449|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122450|NCT00143182|Olanzapine|olanzapine|mesh-list
139122451|NCT00143182|Asenapine|asenapine|mesh-list
139122452|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
139122453|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
139122454|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122455|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122456|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139122457|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139122458|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139122459|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122460|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139122461|NCT00143182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139122462|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139122463|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139122464|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122465|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122466|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
139122467|NCT03677934|Ranibizumab|ranibizumab|mesh-list
139122468|NCT03677934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139122469|NCT03677934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139122470|NCT03677934|Growth Substances|growth substances|mesh-ancestor
139122471|NCT03677934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122472|NCT03677934|Growth Inhibitors|growth inhibitors|mesh-ancestor
139122473|NCT03677934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122474|NCT03435692|Acetaminophen|acetaminophen|mesh-list
139122475|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
139122476|NCT03435692|Promethazine|promethazine|mesh-list
139122477|NCT03435692|Fentanyl|fentanyl|mesh-list
139122478|NCT03435692|Morphine|morphine|mesh-list
139122479|NCT03435692|Oxycodone|oxycodone|mesh-list
139122480|NCT03435692|Lorazepam|lorazepam|mesh-list
139122481|NCT03435692|Ondansetron|ondansetron|mesh-list
139122482|NCT03435692|Ropivacaine|ropivacaine|mesh-list
139122483|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139122484|NCT03435692|Narcotics|narcotics|mesh-ancestor
139122485|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122486|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122487|NCT03435692|Analgesics|analgesics|mesh-ancestor
139122488|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
139122489|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122490|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
139122491|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
139122492|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139122493|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139122494|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
139122495|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139122496|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
139122497|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
139122498|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
139122499|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139122500|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
139122501|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
139122502|NCT03435692|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139122503|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139122504|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
139122505|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122506|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122507|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139122508|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139122509|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139122510|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
139122511|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
139122512|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139122513|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
139122514|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139122515|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139122516|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139122517|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
139122518|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
139122519|NCT03705442|Loperamide|loperamide|mesh-list
139122520|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
139122521|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139122522|NCT03673956|Vancomycin|vancomycin|mesh-list
139122524|NCT03673956|Tobramycin|tobramycin|mesh-list
139122525|NCT03673956|Mupirocin|mupirocin|mesh-list
139122526|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139122527|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122528|NCT03673956|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139122529|NCT03673956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139122530|NCT03673956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139122531|NCT03673956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122532|NCT03673956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122533|NCT03673956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122534|NCT03673956|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139122535|NCT03673956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139122536|NCT03673956|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139122537|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
139122538|NCT03716804|Cefuroxime|cefuroxime|mesh-list
139122539|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
139122540|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
139122541|NCT03716804|Cefixime|cefixime|mesh-list
139122542|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139122543|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122544|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139122545|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139122547|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122548|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122549|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139122550|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139122551|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139122552|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139122553|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139122554|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122555|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139122556|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
139122557|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122558|NCT03733860|Alprostadil|alprostadil|mesh-list
139122559|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139122560|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
139122561|NCT03733860|Urological Agents|urological agents|mesh-ancestor
139122563|NCT03605862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139122564|NCT03605862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122565|NCT01310244|Paclitaxel|paclitaxel|mesh-list
139122566|NCT01310244|Carboplatin|carboplatin|mesh-list
139122567|NCT01310244|Belinostat|belinostat|mesh-list
138957924|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
139122568|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139122569|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122570|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
139122571|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
139122572|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
139122573|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122574|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139122575|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122576|NCT03672006|Heparin|heparin|mesh-list
139122577|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139122578|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
139122579|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139122580|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139122581|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122582|NCT03621072|Fluconazole|fluconazole|mesh-list
139122583|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
139122584|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122585|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139122586|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139122587|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122588|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122589|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139122590|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
139122591|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139122592|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122593|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139122594|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139122595|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139122596|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
139122597|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122599|NCT01311050|Capecitabine|capecitabine|mesh-list
139122600|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
139122601|NCT01311050|Irinotecan|irinotecan|mesh-list
139122602|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139122603|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122604|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139122605|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139122606|NCT01311050|Growth Substances|growth substances|mesh-ancestor
139122607|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122608|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
139122609|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139122610|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
139122611|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122612|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139122613|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139122614|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122615|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
139122616|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139122617|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
138957938|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122618|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122619|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139122620|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139122621|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
139122622|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122623|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122624|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139122626|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
139122627|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139122628|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122629|NCT04491526|Tamsulosin|tamsulosin|mesh-list
139122630|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139122631|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139122632|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139122633|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
139122634|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122635|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122636|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122637|NCT04491526|Urological Agents|urological agents|mesh-ancestor
139122639|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
139122640|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122641|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
139122642|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
139122643|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139122644|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122645|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122646|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
139122647|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139122648|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122649|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122650|NCT03696940|Atorvastatin|atorvastatin|mesh-list
139122651|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139122652|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139122653|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
138870238|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122654|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122655|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139122656|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139122657|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122658|NCT03731442|Paclitaxel|paclitaxel|mesh-list
139122659|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139122660|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122661|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
139122662|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
139122663|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
139122664|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122665|NCT03702400|Phenylephrine|phenylephrine|mesh-list
139122666|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
139122667|NCT03702400|Norepinephrine|norepinephrine|mesh-list
139122668|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139122669|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
139122670|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
139122671|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122672|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122673|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
139122674|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139122675|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
139122676|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
139122677|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139122678|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139122679|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139122680|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
139122681|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122682|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122683|NCT03702400|Protective Agents|protective agents|mesh-ancestor
139122684|NCT03699202|Ziresovir|ziresovir|mesh-list
139122685|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
139122686|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122687|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
139122688|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122689|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
139122690|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139122691|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139122692|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122693|NCT03598140|Urological Agents|urological agents|mesh-ancestor
139122694|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
139122695|NCT03644550|LMB-100|lmb-100|mesh-list
139122696|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138870252|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
139122697|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122698|NCT03644550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139122699|NCT03644550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122700|NCT03644550|Immunoconjugates|immunoconjugates|mesh-ancestor
139122701|NCT03644550|Immunologic Factors|immunologic factors|mesh-ancestor
139122702|NCT03644550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122703|NCT00054717|Ritonavir|ritonavir|mesh-list
139122704|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139122705|NCT00054717|Tipranavir|tipranavir|mesh-list
139122706|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
139122707|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139122708|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122709|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122710|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139122711|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139122712|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
139122713|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122714|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139122715|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139122716|NCT03430856|Insulin|insulin|mesh-list
139122717|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139122718|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
139122719|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139122720|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122721|NCT01097265|Capecitabine|capecitabine|mesh-list
139122722|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
139122723|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139122724|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
139122725|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122726|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122727|NCT03731286|Caffeine|caffeine|mesh-list
139122728|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139122729|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122730|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139122731|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122732|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122733|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139122734|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139122735|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
139122736|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122737|NCT00066807|Tamoxifen|tamoxifen|mesh-list
139122738|NCT00066807|Epirubicin|epirubicin|mesh-list
139122739|NCT00066807|Exemestane|exemestane|mesh-list
139122740|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139122741|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139122742|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122743|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139122744|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139122745|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122746|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122747|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139122748|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
139122749|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139122750|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122751|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139122752|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139122753|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139122754|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139122755|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139122756|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139122757|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
139122758|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139122759|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
139122760|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139122761|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139122762|NCT03619330|Liraglutide|liraglutide|mesh-list
139122763|NCT03619330|Testosterone|testosterone|mesh-list
139122764|NCT03619330|Androgens|androgens|mesh-ancestor
139122766|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139122767|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122768|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139122769|NCT03619330|Incretins|incretins|mesh-ancestor
139122770|NCT04457284|Nivolumab|nivolumab|mesh-list
139122771|NCT04457284|Temozolomide|temozolomide|mesh-list
139122772|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122773|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139122774|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139122775|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122776|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139122777|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
139122778|NCT00054639|Rituximab|rituximab|mesh-list
139122779|NCT00054639|Oblimersen|oblimersen|mesh-list
139122780|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139122781|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122782|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
138958018|NCT02560766|Gabapentin|gabapentin|mesh-list
139122783|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122784|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139122786|NCT02530359|Analgesics|analgesics|mesh-ancestor
139122787|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
139122788|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122789|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122790|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139122791|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139122792|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139122793|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139122794|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122795|NCT03428360|Diazepam|diazepam|mesh-list
139122796|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139122797|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
139122798|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
139122799|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
139122800|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122801|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122802|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139122803|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139122804|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122805|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139122806|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139122807|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139122808|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139122809|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139122810|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139122811|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
139122812|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
139122813|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
139122814|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
139122815|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122816|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122817|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
139122818|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
139122819|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122820|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122821|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122822|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
139122823|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
139122824|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
139122825|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139122826|NCT04867928|Azacitidine|azacitidine|mesh-list
139122827|NCT04867928|Venetoclax|venetoclax|mesh-list
139122828|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139122829|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
139122830|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122831|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122832|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122833|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
139122834|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139122835|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122836|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139122837|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
139122838|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139122839|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139122840|NCT03698734|Analgesics|analgesics|mesh-ancestor
139122841|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
139122842|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122843|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122844|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139122845|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139122846|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139122847|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
139122848|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122849|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139122850|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
139122851|NCT04070157|Lofexidine|lofexidine|mesh-list
139122852|NCT04070157|Clonidine|clonidine|mesh-list
139122853|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139122854|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139122855|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122856|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
139122857|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122858|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139122859|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139122860|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139122861|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
139122862|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122863|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122864|NCT04070157|Analgesics|analgesics|mesh-ancestor
139122865|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
139122866|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
139122867|NCT01091337|Albuterol|albuterol|mesh-list
139122868|NCT01091337|Procaterol|procaterol|mesh-list
139122869|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139122870|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
139122871|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122872|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122873|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139122874|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
139122875|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
139122876|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138958036|NCT00757874|Clobetasol|clobetasol|mesh-list
139122877|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139122878|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139122879|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139122880|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
139122881|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122882|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122883|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
139122884|NCT03955809|Ketamine|ketamine|mesh-list
139122885|NCT03955809|Analgesics|analgesics|mesh-ancestor
139122886|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
139122887|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122888|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122889|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139122890|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139122891|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
139122892|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
139122893|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122894|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139122895|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139122896|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122897|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122898|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
139122899|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
139122900|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122901|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139122902|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122903|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139122904|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
139122905|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122906|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139122907|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122908|NCT03953001|Lidocaine|lidocaine|mesh-list
139122909|NCT03953001|Epinephrine|epinephrine|mesh-list
139122910|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
139122911|NCT03953001|Anesthetics|anesthetics|mesh-list
139122912|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139122913|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122914|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
138873474|NCT02642484|Analgesics|analgesics|mesh-ancestor
139122915|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122916|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139122917|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139122918|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139122919|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139122920|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122921|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139122922|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139122923|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
139122924|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122925|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139122926|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139122927|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
139122928|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139122929|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
139122931|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
139122932|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139122933|NCT01091415|Calcium|calcium|mesh-list
139122934|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139122935|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122936|NCT00032487|Metformin|metformin|mesh-list
139122937|NCT00032487|Glimepiride|glimepiride|mesh-list
139122938|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
139122939|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139122940|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122941|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139122942|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139122943|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
139122944|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
139122945|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139122946|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139122947|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139122948|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139122949|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122950|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122951|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122952|NCT03692416|Prednisone|prednisone|mesh-list
139122953|NCT03692416|Ibuprofen|ibuprofen|mesh-list
139122954|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139122955|NCT03692416|Methotrexate|methotrexate|mesh-list
139122956|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139122957|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
139122958|NCT03692416|Hormones|hormones|mesh-ancestor
139122959|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139122960|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122961|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139122962|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139122963|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139122964|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
139122965|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139122966|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139122967|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
139122968|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122969|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
139122970|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139122971|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139122972|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139122973|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
139122974|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139122975|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139122976|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139122977|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139122979|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
139122980|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122981|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139122982|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139122983|NCT03692416|Protective Agents|protective agents|mesh-ancestor
139122984|NCT03594552|Baclofen|baclofen|mesh-list
139122985|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139122986|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139122987|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139122988|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139122989|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139122990|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
139122991|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
139122992|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139122993|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139122994|NCT03641508|Dexamethasone|dexamethasone|mesh-list
139122995|NCT03641508|Triamcinolone|triamcinolone|mesh-list
139122996|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139122997|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
139122998|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
139122999|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123000|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123001|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139123002|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
139123003|NCT03641508|Hormones|hormones|mesh-ancestor
139123004|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139123005|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139123006|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123007|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
139123008|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139123009|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123010|NCT01091571|Dipyridamole|dipyridamole|mesh-list
139123011|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139123012|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123013|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123014|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139123015|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
139123016|NCT01091649|Ritonavir|ritonavir|mesh-list
139123017|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139123018|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139123019|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
139123020|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123021|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123022|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139123023|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139123024|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
139123025|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123026|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139123027|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139123028|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
139123029|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139123030|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139123031|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139123032|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139123033|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123034|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
139123035|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123036|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123037|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139123038|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123039|NCT03421730|Budesonide|budesonide|mesh-list
139123040|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139123041|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139123042|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
139123043|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123044|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123045|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139123046|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
139123047|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
139123048|NCT03421730|Hormones|hormones|mesh-ancestor
139123049|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139123050|NCT01094925|Gabapentin|gabapentin|mesh-list
139123051|NCT01094925|Analgesics|analgesics|mesh-ancestor
139123052|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
139123053|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123054|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123055|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
139123056|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139123057|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139123058|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123059|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139123060|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139123061|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139123062|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123063|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123064|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
139123065|NCT03718676|Pemetrexed|pemetrexed|mesh-list
139123066|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123067|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123068|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123069|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139123070|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139123071|NCT00054327|Cytarabine|cytarabine|mesh-list
139123072|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
139123073|NCT00054327|Busulfan|busulfan|mesh-list
139123074|NCT00054327|Etoposide|etoposide|mesh-list
139123075|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
139123076|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139123077|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
139123078|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123079|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139123080|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139123082|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123083|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123084|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139123085|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139123086|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139123087|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139123088|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123089|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139123090|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
139123091|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
139123092|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123094|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139123095|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139123096|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
139123097|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
139123098|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123099|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123100|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139123101|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
139123102|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139123103|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
139123104|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123105|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123106|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139123107|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
139123108|NCT03462680|Niacin|niacin|mesh-list
139123109|NCT03462680|Vitamins|vitamins|mesh-ancestor
139123110|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
139123111|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123112|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
139123113|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139123114|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
139123115|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123116|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139123117|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
139123118|NCT03692026|Melatonin|melatonin|mesh-list
139123119|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
139123120|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
139123121|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123122|NCT03692026|Protective Agents|protective agents|mesh-ancestor
139123123|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958118|NCT00576056|Sorafenib|sorafenib|mesh-list
139123124|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123125|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139123126|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
139123127|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
139123128|NCT03624322|Olanzapine|olanzapine|mesh-list
139123129|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
139123130|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
139123131|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123132|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123133|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139123134|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139123135|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139123136|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123137|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139123138|NCT03624322|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139123139|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139123140|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139123141|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123142|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123143|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
139123145|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
139123146|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139123147|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
139123148|NCT01097811|Neomycin|neomycin|mesh-list
139123149|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139123150|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123151|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139123152|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139123153|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123154|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123156|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139123157|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
139123158|NCT03957291|Povidone|povidone|mesh-list
139123159|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139123160|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123161|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
139123162|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
139123163|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
139123164|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
139123165|NCT04044976|Caffeine|caffeine|mesh-list
139123166|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
139123167|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123168|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139123169|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123170|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139123171|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123172|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139123173|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139123174|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
139123175|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123176|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139123177|NCT03691636|Lifitegrast|lifitegrast|mesh-list
139123178|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139123179|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
139123180|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
139123181|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
139123182|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
139123183|NCT03956121|Analgesics|analgesics|mesh-ancestor
139123184|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
139123185|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123186|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123187|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
139123188|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123189|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139123190|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
139123191|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139123192|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139123193|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123194|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139123195|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
139123196|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139123197|NCT03636906|Vaccines|vaccines|mesh-list
139123198|NCT03636906|Immunologic Factors|immunologic factors|mesh-ancestor
139123199|NCT03636906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123200|NCT03028870|Naproxen|naproxen|mesh-list
139123201|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139123202|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139123203|NCT03028870|Analgesics|analgesics|mesh-ancestor
139123204|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
139123205|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123206|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123207|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139123208|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139123209|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
139123210|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139123211|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123212|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123213|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
139123214|NCT01098201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138873768|NCT02638506|Analgesics|analgesics|mesh-ancestor
139123215|NCT01098201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139123216|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139123217|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
139123218|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123219|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139123220|NCT01092039|Lactoferrin|lactoferrin|mesh-list
139123221|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123222|NCT03663582|Teduglutide|teduglutide|mesh-list
139123223|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139123224|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139123225|NCT03663582|Protective Agents|protective agents|mesh-ancestor
139123226|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123227|NCT01098357|Becaplermin|becaplermin|mesh-list
139123228|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
138493595|NCT00089557|Capsaicin|capsaicin|mesh-list
139123229|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
139123230|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139123231|NCT01098357|Growth Substances|growth substances|mesh-ancestor
139123232|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123233|NCT03730740|Lenalidomide|lenalidomide|mesh-list
139123234|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
139123235|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123236|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139123237|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139123238|NCT03730740|Growth Substances|growth substances|mesh-ancestor
139123239|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
138870465|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
139123240|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123241|NCT01098513|Dolutegravir|dolutegravir|mesh-list
139123242|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139123243|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139123244|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123245|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123246|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139123247|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139123248|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
139123249|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123250|NCT03693976|Xylometazoline|xylometazoline|mesh-list
139123251|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
139123252|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138958144|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
139123253|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
139123254|NCT03730584|Ropivacaine|ropivacaine|mesh-list
139123255|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
139123256|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
139123257|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123258|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123259|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
139123260|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123261|NCT03502616|Tofacitinib|tofacitinib|mesh-list
139123262|NCT03502616|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139123263|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139123264|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123265|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123266|NCT04003012|Lidocaine|lidocaine|mesh-list
139123267|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
139123268|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
139123269|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123270|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123271|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
139123272|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123273|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139123274|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139123275|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139123276|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139123277|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123278|NCT05666076|Bupivacaine|bupivacaine|mesh-list
139123279|NCT05666076|Prilocaine|prilocaine|mesh-list
139123280|NCT05666076|Anesthetics, Local|anesthetics, local|mesh-ancestor
139123281|NCT05666076|Anesthetics|anesthetics|mesh-ancestor
139123282|NCT05666076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123283|NCT05666076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123284|NCT05666076|Sensory System Agents|sensory system agents|mesh-ancestor
139123285|NCT05666076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123286|NCT03028012|Dexamethasone|dexamethasone|mesh-list
139123287|NCT03028012|Ketorolac|ketorolac|mesh-list
139123288|NCT03028012|Lidocaine|lidocaine|mesh-list
139123289|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139123290|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
139123291|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
139123292|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123293|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123294|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139123295|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
139123297|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139123298|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139123299|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123300|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
139123301|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
139123302|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123303|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
139123304|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138870493|NCT02834507|Levodopa|levodopa|mesh-list
139123305|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139123306|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139123307|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139123308|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123309|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139123310|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139123311|NCT03028012|Analgesics|analgesics|mesh-ancestor
139123312|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139123313|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139123314|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123315|NCT03634800|Nivolumab|nivolumab|mesh-list
139123316|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139123317|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123318|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139123319|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123320|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
139123321|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139123322|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123323|NCT02955186|Saracatinib|saracatinib|mesh-list
139123324|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123325|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123326|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123327|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139123328|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139123329|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139123330|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
139123331|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123332|NCT03690778|Metformin|metformin|mesh-list
139123333|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139123334|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139123335|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123336|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139123337|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139123338|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
139123339|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123340|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139123341|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139123342|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123343|NCT03715634|Buprenorphine|buprenorphine|mesh-list
139123344|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139123345|NCT03715634|Narcotics|narcotics|mesh-ancestor
139123346|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123347|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123348|NCT03715634|Analgesics|analgesics|mesh-ancestor
139123349|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
139123350|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123351|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139123352|NCT03502070|Tobramycin|tobramycin|mesh-list
139123353|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139123354|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123355|NCT04158934|Factor VIII|factor viii|mesh-list
139123356|NCT04158934|BAX 855|bax 855|mesh-list
139123357|NCT04158934|Coagulants|coagulants|mesh-ancestor
139123358|NCT03715556|Amiodarone|amiodarone|mesh-list
139123359|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139123360|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
139123361|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139123362|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139123363|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873927|NCT04239443|Apatinib|apatinib|mesh-list
139123364|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139123365|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139123366|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139123367|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123368|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139123369|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139123370|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139123371|NCT03730038|Pitavastatin|pitavastatin|mesh-list
139123372|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139123373|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139123374|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139123375|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
139123376|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123377|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123378|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139123379|NCT03725904|Progesterone|progesterone|mesh-list
139123380|NCT03725904|Progestins|progestins|mesh-ancestor
139123382|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139123383|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123384|NCT03730272|Analgesics|analgesics|mesh-list
139123385|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
139123386|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123387|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123388|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
139123389|NCT03585504|Etonogestrel|etonogestrel|mesh-list
139123390|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139123391|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123392|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139123393|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139123394|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
139123395|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139123396|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123397|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123398|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139123399|NCT03690622|Analgesics|analgesics|mesh-ancestor
139123400|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
139123401|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123402|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139123403|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139123404|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139123405|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
139123406|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123407|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123408|NCT03715322|Tobramycin|tobramycin|mesh-list
139123409|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139123410|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123411|NCT03687268|Naloxone|naloxone|mesh-list
139123412|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139123413|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123414|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
139123415|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123416|NCT03576066|Tenofovir|tenofovir|mesh-list
139123417|NCT03576066|Entecavir|entecavir|mesh-list
139123418|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
139123419|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123420|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139123421|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139123422|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123423|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123424|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139123425|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139123426|NCT03639480|Amlodipine|amlodipine|mesh-list
139123427|NCT03639480|Valsartan|valsartan|mesh-list
139123428|NCT03639480|Atorvastatin|atorvastatin|mesh-list
139123429|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139123430|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139123431|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
139123432|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123433|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139123434|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139123435|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123436|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139123437|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139123438|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139123439|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139123440|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123441|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
139123442|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139123443|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139123444|NCT03689998|Melatonin|melatonin|mesh-list
139123445|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
139123446|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123447|NCT03689998|Protective Agents|protective agents|mesh-ancestor
138493819|NCT00091741|Etanercept|etanercept|mesh-list
139123448|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123449|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123450|NCT03948178|Simendan|simendan|mesh-list
139123451|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139123452|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
139123453|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139123454|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139123455|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123456|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123457|NCT03948178|Protective Agents|protective agents|mesh-ancestor
139123458|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123459|NCT03687034|Temozolomide|temozolomide|mesh-list
139123460|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139123461|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
139123462|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123463|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123464|NCT03520920|Rituximab|rituximab|mesh-list
139123465|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
139123466|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139123467|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123468|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
139123469|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123470|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139123471|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139123472|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123473|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123474|NCT03686878|Lifitegrast|lifitegrast|mesh-list
139123475|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139123476|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139123477|NCT03682198|Phenylephrine|phenylephrine|mesh-list
139123478|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
139123479|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139123480|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
139123481|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
139123482|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123483|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123484|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
139123485|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139123486|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
139123487|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
139123488|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139123489|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139123490|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139123491|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
139123492|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123493|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123494|NCT03682198|Protective Agents|protective agents|mesh-ancestor
139123495|NCT02953340|Cyclophosphamide|cyclophosphamide|mesh-list
139123496|NCT02953340|Docetaxel|docetaxel|mesh-list
139123497|NCT02953340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139123498|NCT02953340|Immunologic Factors|immunologic factors|mesh-ancestor
139123499|NCT02953340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123500|NCT02953340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139123501|NCT02953340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139123502|NCT02953340|Alkylating Agents|alkylating agents|mesh-ancestor
139123503|NCT02953340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123504|NCT02953340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123505|NCT02953340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139123506|NCT02953340|Tubulin Modulators|tubulin modulators|mesh-ancestor
139123507|NCT02953340|Antimitotic Agents|antimitotic agents|mesh-ancestor
139123508|NCT02953340|Mitosis Modulators|mitosis modulators|mesh-ancestor
139123509|NCT03554772|Celecoxib|celecoxib|mesh-list
139123510|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139123511|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139123512|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139123513|NCT03554772|Analgesics|analgesics|mesh-ancestor
139123514|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
139123515|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123516|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123517|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139123518|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139123519|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139123520|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139123521|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123522|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123524|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139123525|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
139123526|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139123527|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139123528|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123529|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123530|NCT03624010|Protective Agents|protective agents|mesh-ancestor
139123531|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123532|NCT03686722|Metformin|metformin|mesh-list
139123533|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139123534|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123535|NCT04629976|Tenofovir|tenofovir|mesh-list
139123536|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
139123537|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123538|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138958223|NCT00801606|Zinc|zinc|mesh-list
139123539|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139123540|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123541|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123542|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139123543|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139123544|NCT03728946|Bupivacaine|bupivacaine|mesh-list
139123545|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
139123546|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
139123547|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123548|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123549|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
139123550|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123551|NCT03553758|Ketamine|ketamine|mesh-list
139123552|NCT03553758|Analgesics|analgesics|mesh-ancestor
139123553|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
139123554|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123555|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123556|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139123557|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139123558|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
139123559|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
139123560|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123561|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139123562|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139123563|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123564|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123565|NCT02954354|Oseltamivir|oseltamivir|mesh-list
139123566|NCT02954354|Baloxavir|baloxavir|mesh-list
139123567|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
139123568|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123569|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123570|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123571|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
139123572|NCT03519516|Levofloxacin|levofloxacin|mesh-list
139123573|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139123574|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139123575|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139123576|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123577|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139123578|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139123579|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123580|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123581|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123582|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139123583|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139123584|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138874144|NCT02687984|Risperidone|risperidone|mesh-list
139123585|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
139123586|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
139123587|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123588|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123589|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123590|NCT03519204|Lidocaine|lidocaine|mesh-list
139123591|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
139123592|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
139123593|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123594|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123595|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
139123596|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123597|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139123598|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139123599|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139123600|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139123601|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123602|NCT03624166|Ketamine|ketamine|mesh-list
139123603|NCT03624166|Anesthetics|anesthetics|mesh-list
139123604|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
139123605|NCT03624166|Analgesics|analgesics|mesh-ancestor
139123606|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
139123607|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123608|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123609|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139123610|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139123611|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123612|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139123613|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139123614|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123615|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123616|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
139123617|NCT03518112|Leucovorin|leucovorin|mesh-list
139123618|NCT03518112|Folic Acid|folic acid|mesh-list
139123619|NCT03518112|Cytarabine|cytarabine|mesh-list
139123620|NCT03518112|Dexamethasone|dexamethasone|mesh-list
139123621|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
139123622|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
139123623|NCT03518112|Rituximab|rituximab|mesh-list
139123624|NCT03518112|Methotrexate|methotrexate|mesh-list
139123625|NCT03518112|Vincristine|vincristine|mesh-list
139123626|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
139123627|NCT03518112|Blinatumomab|blinatumomab|mesh-list
139123628|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139123629|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
139123630|NCT03518112|Antibodies|antibodies|mesh-list
139123631|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
139123632|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139123633|NCT03518112|Lenograstim|lenograstim|mesh-list
139123634|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139123635|NCT03518112|BB 1101|bb 1101|mesh-list
139123636|NCT03518112|Calcium|calcium|mesh-list
139123637|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
139123638|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139123639|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
139123640|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123641|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139123642|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139123643|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
139123644|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123645|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123646|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139123647|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139123648|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
139123649|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
139123650|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123651|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139123652|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
139123653|NCT03518112|Hormones|hormones|mesh-ancestor
139123654|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139123655|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139123656|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
139123657|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123658|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139123659|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139123660|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139123661|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
139123662|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139123663|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139123664|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
139123665|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
139123666|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139123667|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139123668|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
139123669|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123670|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139123671|NCT03518112|Antidotes|antidotes|mesh-ancestor
139123672|NCT03518112|Protective Agents|protective agents|mesh-ancestor
139123673|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
139123674|NCT03518112|Vitamins|vitamins|mesh-ancestor
139123675|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
139123676|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139123677|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
139123678|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
139123679|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
139123680|NCT03518112|Hematinics|hematinics|mesh-ancestor
139123681|NCT03686254|Bevacizumab|bevacizumab|mesh-list
139123682|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139123683|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123684|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139123685|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139123686|NCT03686254|Growth Substances|growth substances|mesh-ancestor
139123687|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123688|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
139123689|NCT03679780|Nitroprusside|nitroprusside|mesh-list
139123690|NCT03679780|BQ 788|bq 788|mesh-list
139123691|NCT03679780|Nitroarginine|nitroarginine|mesh-list
139123692|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
139123693|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139123694|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
139123695|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139123696|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123697|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139123698|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139123699|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123700|NCT03680716|Ropivacaine|ropivacaine|mesh-list
139123701|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
139123702|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
139123703|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123704|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123705|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
139123706|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123707|NCT03680638|Allopurinol|allopurinol|mesh-list
139123708|NCT03680638|Tempol|tempol|mesh-list
139123709|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
138958276|NCT00677534|Vitamins|vitamins|mesh-ancestor
139123710|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123711|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123712|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
139123713|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139123714|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139123715|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
139123716|NCT03680638|Protective Agents|protective agents|mesh-ancestor
139123717|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123718|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139123719|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139123720|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139123721|NCT03680560|Trastuzumab|trastuzumab|mesh-list
139123722|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139123723|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123724|NCT03444298|Vitamin E|vitamin e|mesh-list
139123725|NCT03444298|Tocopherols|tocopherols|mesh-list
139123726|NCT03444298|Tocotrienols|tocotrienols|mesh-list
139123727|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
139123728|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
139123729|NCT03444298|Vitamins|vitamins|mesh-ancestor
139123730|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
139123731|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123732|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
139123733|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123734|NCT03444298|Protective Agents|protective agents|mesh-ancestor
139123735|NCT03639610|Dexamethasone|dexamethasone|mesh-list
139123736|NCT03639610|Melphalan|melphalan|mesh-list
139123737|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139123738|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
139123739|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
139123740|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123741|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123742|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139123744|NCT03639610|Hormones|hormones|mesh-ancestor
139123745|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139123746|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139123747|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123748|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139123749|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
139123750|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123751|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139123752|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139123753|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
139123754|NCT03680404|Allopurinol|allopurinol|mesh-list
139123755|NCT03680404|Phenylephrine|phenylephrine|mesh-list
139123756|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
139123757|NCT03680404|Tempol|tempol|mesh-list
139123758|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139123759|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
139123760|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
139123761|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123762|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123763|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
139123764|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139123765|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
139123766|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
138870623|NCT02657616|Anticoagulants|anticoagulants|mesh-list
139123767|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139123768|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139123769|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139123770|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
139123771|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123772|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123773|NCT03680404|Protective Agents|protective agents|mesh-ancestor
139123774|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
139123775|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123776|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
139123777|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139123778|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139123779|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
139123780|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139123781|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139123782|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139123783|NCT03685630|Brivaracetam|brivaracetam|mesh-list
139123784|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
139123785|NCT02954406|Rituximab|rituximab|mesh-list
139123786|NCT02954406|Gemcitabine|gemcitabine|mesh-list
139123787|NCT02954406|Lenalidomide|lenalidomide|mesh-list
139123788|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139123789|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139123790|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123791|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
139123792|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123793|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139123794|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139123795|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
139123796|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123797|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139123798|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139123799|NCT02954406|Growth Substances|growth substances|mesh-ancestor
139123800|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
139123801|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139123802|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
139123803|NCT01310478|Endostatins|endostatins|mesh-list
139123804|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139123805|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139123806|NCT01310478|Growth Substances|growth substances|mesh-ancestor
139123807|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123808|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
139123809|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123810|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
139123811|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139123812|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
138874376|NCT02810483|Topiramate|topiramate|mesh-list
139123813|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123814|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
139123815|NCT03728244|Protective Agents|protective agents|mesh-ancestor
139123816|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139123817|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139123818|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139123819|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
139123820|NCT03721614|Sirolimus|sirolimus|mesh-list
139123821|NCT03721614|Everolimus|everolimus|mesh-list
139123822|NCT03721614|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139123823|NCT03721614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139123824|NCT03721614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123825|NCT03721614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123826|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139123827|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
139123828|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123829|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123830|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139123831|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123832|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139123833|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
139123834|NCT03727620|Amoxicillin|amoxicillin|mesh-list
139123835|NCT03727620|Metronidazole|metronidazole|mesh-list
139123836|NCT03727620|Doxycycline|doxycycline|mesh-list
139123837|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139123838|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123839|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139123840|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139123841|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
139123842|NCT03727464|Propofol|propofol|mesh-list
139123843|NCT03727464|Sevoflurane|sevoflurane|mesh-list
139123844|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139123845|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123846|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123847|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139123848|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
139123849|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
139123850|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139123851|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139123852|NCT03508830|Bupivacaine|bupivacaine|mesh-list
139123853|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
139123854|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
139123855|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123856|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123857|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
139123858|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123859|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139123860|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139123861|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
139123862|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139123863|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
139123864|NCT03724578|Fluorides|fluorides|mesh-list
139123865|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
139123866|NCT03724578|Protective Agents|protective agents|mesh-ancestor
139123867|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123868|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139123869|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139123870|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
139123871|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123872|NCT03721380|Methadone|methadone|mesh-list
139123873|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139123874|NCT03721380|Narcotics|narcotics|mesh-ancestor
139123875|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123876|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123877|NCT03721380|Analgesics|analgesics|mesh-ancestor
139123878|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
139123879|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123880|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
139123881|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
139123882|NCT03568500|Olanzapine|olanzapine|mesh-list
139123883|NCT03568500|Risperidone|risperidone|mesh-list
139123884|NCT03568500|Aripiprazole|aripiprazole|mesh-list
139123885|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139123886|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139123887|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
139123888|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123889|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123890|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123891|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139123892|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139123893|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123894|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139123895|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139123896|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
139123897|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
139123898|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
139123899|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123901|NCT03568500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139123902|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139123903|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139123904|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
139123905|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
139123906|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139123907|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139123908|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139123909|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139123910|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139123911|NCT03685084|Piperacillin|piperacillin|mesh-list
139123912|NCT03685084|Cefepime|cefepime|mesh-list
139123913|NCT03685084|Lactams|lactams|mesh-list
139123914|NCT03685084|beta-Lactams|beta-lactams|mesh-list
139123915|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
139123916|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139123917|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139123918|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
139123919|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139123920|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123921|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123922|NCT03724266|Chitosan|chitosan|mesh-list
139123923|NCT03724266|Calcium|calcium|mesh-list
139123924|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139123925|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123926|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139123927|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139123928|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
139123929|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123930|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139123931|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
139123932|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
139123933|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
139123934|NCT03724266|Coagulants|coagulants|mesh-ancestor
139123935|NCT03679390|Ketamine|ketamine|mesh-list
139123936|NCT03679390|Analgesics|analgesics|mesh-ancestor
139123937|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
139123938|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123939|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123940|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139123941|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139123942|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
139123943|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
139123944|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123945|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139123946|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139123947|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123948|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123949|NCT03684772|Digoxin|digoxin|mesh-list
139123950|NCT03684772|Furosemide|furosemide|mesh-list
139123951|NCT03684772|Diuretics|diuretics|mesh-ancestor
139123952|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
139123953|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123954|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139123955|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139123956|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123957|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139123958|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139123959|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139123960|NCT03684772|Protective Agents|protective agents|mesh-ancestor
139123961|NCT03676114|Ketamine|ketamine|mesh-list
139123962|NCT03676114|Analgesics|analgesics|mesh-ancestor
139123963|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
139123964|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139123965|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123966|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139123967|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139123968|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
139123969|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
139123970|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139123971|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139123972|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139123973|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123974|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123975|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
139123976|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139123977|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
139123978|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139123979|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139123980|NCT03025828|Hormones|hormones|mesh-ancestor
139123981|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139123982|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123983|NCT03546816|Serlopitant|serlopitant|mesh-list
139123984|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139123985|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139123986|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139123987|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123988|NCT03675802|Misoprostol|misoprostol|mesh-list
139123989|NCT03675802|Dinoprostone|dinoprostone|mesh-list
139123990|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139123991|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
139123992|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139123993|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139123994|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139123995|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139123996|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
139123997|NCT03678610|Ionomycin|ionomycin|mesh-list
139123998|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
139123999|NCT03678610|Ionophores|ionophores|mesh-ancestor
139124000|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139124001|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124002|NCT03675646|Morphine|morphine|mesh-list
139124003|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139124004|NCT03675646|Narcotics|narcotics|mesh-ancestor
139124005|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124006|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124007|NCT03675646|Analgesics|analgesics|mesh-ancestor
139124008|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
139124009|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124010|NCT03678532|Midazolam|midazolam|mesh-list
139124011|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139124012|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139124013|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124014|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124015|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139124016|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139124017|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139124018|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139124019|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
139124020|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
139124021|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
139124022|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
139124023|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124024|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124025|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
139124026|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139124027|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139124028|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139124029|NCT03678142|Vancomycin|vancomycin|mesh-list
139124030|NCT03678142|Imipenem|imipenem|mesh-list
139124031|NCT03678142|Floxacillin|floxacillin|mesh-list
139124032|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139124033|NCT03522298|GDC-0084|gdc-0084|mesh-list
139124034|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124035|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124036|NCT03674866|Insulin|insulin|mesh-list
139124037|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139124038|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124039|NCT03623776|Carboplatin|carboplatin|mesh-list
139124040|NCT03623776|Pemetrexed|pemetrexed|mesh-list
138874588|NCT02811497|Azacitidine|azacitidine|mesh-list
139124041|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124042|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124043|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124044|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139124045|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139124046|NCT03683914|Dinoprostone|dinoprostone|mesh-list
139124047|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
139124048|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139124049|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124050|NCT03448406|Empagliflozin|empagliflozin|mesh-list
139124051|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139124052|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124053|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139124054|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124055|NCT00064701|Cyclosporine|cyclosporine|mesh-list
139124056|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
139124057|NCT00064701|Tacrolimus|tacrolimus|mesh-list
139124058|NCT00064701|Cyclosporins|cyclosporins|mesh-list
139124059|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139124060|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
139124061|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124062|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139124063|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124064|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124065|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
139124066|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139124067|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
139124068|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139124069|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139124070|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124071|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139124072|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
139124073|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139124074|NCT00064077|Paclitaxel|paclitaxel|mesh-list
139124075|NCT00064077|Vinorelbine|vinorelbine|mesh-list
139124076|NCT00064077|Cisplatin|cisplatin|mesh-list
139124077|NCT00064077|Gemcitabine|gemcitabine|mesh-list
139124078|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139124079|NCT00064077|Topotecan|topotecan|mesh-list
139124080|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139124081|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124082|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
139124083|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
139124084|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
139124085|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124086|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139124087|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
139124088|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139124089|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139124090|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124091|NCT03674008|Propofol|propofol|mesh-list
139124092|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139124093|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124094|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124095|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139124096|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
139124097|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
139124098|NCT00063999|Paclitaxel|paclitaxel|mesh-list
139124099|NCT00063999|Cisplatin|cisplatin|mesh-list
139124100|NCT00063999|Carboplatin|carboplatin|mesh-list
139124101|NCT00063999|Doxorubicin|doxorubicin|mesh-list
139124102|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139124103|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139124104|NCT00063999|Lenograstim|lenograstim|mesh-list
139124105|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139124106|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124107|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
139124108|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
139124109|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
139124110|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124111|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139124112|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139124113|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139124114|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124115|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139124116|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
139124117|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124118|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
139124119|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139124120|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139124121|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139124122|NCT03673384|Fluticasone|fluticasone|mesh-list
139124123|NCT03673384|Xhance|xhance|mesh-list
139124124|NCT03673384|Histamine|histamine|mesh-list
139124125|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139124126|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139124127|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
139124128|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124129|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124130|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139124131|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
139124132|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
139124133|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139124134|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
139124135|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
139124136|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124137|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124139|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
139124140|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124141|NCT03023878|Dexamethasone|dexamethasone|mesh-list
139124142|NCT03023878|Blinatumomab|blinatumomab|mesh-list
139124143|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139124144|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
139124145|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
139124146|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124147|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124148|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139124149|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
139124150|NCT03023878|Hormones|hormones|mesh-ancestor
139124151|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139124152|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139124153|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124154|NCT03670888|Rituximab|rituximab|mesh-list
139124155|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139124156|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124157|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
139124158|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124159|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139124160|NCT03023722|Maytansine|maytansine|mesh-list
139124161|NCT03023722|Anetumab ravtansine|anetumab ravtansine|mesh-list
139124162|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139124163|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124164|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
139124165|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
139124166|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
139124167|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124168|NCT03023722|Immunoconjugates|immunoconjugates|mesh-ancestor
139124169|NCT03023722|Immunologic Factors|immunologic factors|mesh-ancestor
139124170|NCT03023722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124171|NCT03623230|Bupivacaine|bupivacaine|mesh-list
139124172|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139124173|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
139124174|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
139124175|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124176|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124177|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
139124178|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124179|NCT03669562|Alprostadil|alprostadil|mesh-list
139124180|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139124181|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
139124182|NCT03669562|Urological Agents|urological agents|mesh-ancestor
139124183|NCT03669484|Fentanyl|fentanyl|mesh-list
139124184|NCT03669484|Bromides|bromides|mesh-list
139124185|NCT03669484|Propofol|propofol|mesh-list
139124186|NCT03669484|Rocuronium|rocuronium|mesh-list
139124187|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139124188|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124189|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124190|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139124191|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
139124192|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
139124193|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139124194|NCT03669484|Narcotics|narcotics|mesh-ancestor
139124195|NCT03669484|Analgesics|analgesics|mesh-ancestor
139124196|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
139124197|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124198|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139124199|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
139124200|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139124201|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139124202|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139124203|NCT02159404|Immunomodulating Agents|immunomodulating agents|mesh-list
139124204|NCT02159404|Immunologic Factors|immunologic factors|mesh-ancestor
139124205|NCT02159404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124206|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
139124207|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139124208|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124209|NCT03668860|Dexamethasone|dexamethasone|mesh-list
139124210|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
139124211|NCT03668860|Betamethasone|betamethasone|mesh-list
139124212|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
139124213|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139124214|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
139124215|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
139124216|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139124217|NCT03668860|BB 1101|bb 1101|mesh-list
139124218|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139124219|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
139124220|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
139124221|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124222|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124223|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139124224|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
139124225|NCT03668860|Hormones|hormones|mesh-ancestor
139124226|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139124227|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139124228|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124229|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
139124230|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124231|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124232|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139124233|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
139124234|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139124235|NCT00062751|Sirolimus|sirolimus|mesh-list
139124236|NCT00062751|Letrozole|letrozole|mesh-list
139124237|NCT00062751|Temsirolimus|temsirolimus|mesh-list
139124238|NCT00062751|MTOR Inhibitors|mtor inhibitors|mesh-list
139124239|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124240|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139124241|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139124242|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124243|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124244|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139124245|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
139124246|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139124247|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124248|NCT00062751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139124249|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139124250|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
139124251|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139124252|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139124253|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139124254|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
139124255|NCT00945724|Cytarabine|cytarabine|mesh-list
139124256|NCT00945724|Prednisolone|prednisolone|mesh-list
139124257|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
139124258|NCT00945724|Rituximab|rituximab|mesh-list
139124259|NCT00945724|Doxorubicin|doxorubicin|mesh-list
139124260|NCT00945724|Methotrexate|methotrexate|mesh-list
139124261|NCT00945724|Vincristine|vincristine|mesh-list
139124262|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139124263|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
139124264|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124265|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139124266|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139124267|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
139124268|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124269|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124270|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139124271|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139124272|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139124273|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139124274|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139124275|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124276|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139124277|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
139124278|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139124279|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139124280|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
139124281|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
139124282|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139124283|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139124284|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
139124285|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139124286|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139124287|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
139124288|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
139124289|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
139124290|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139124291|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
139124292|NCT00945724|Hormones|hormones|mesh-ancestor
139124293|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139124294|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139124295|NCT00258310|Capecitabine|capecitabine|mesh-list
139124296|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139124297|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
139124298|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124299|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124300|NCT00062439|Docetaxel|docetaxel|mesh-list
139124301|NCT00062439|Etoposide|etoposide|mesh-list
139124302|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124303|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
139124304|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
139124305|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
139124306|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124307|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139124308|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139124309|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139124310|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124311|NCT01099059|Amantadine|amantadine|mesh-list
139124312|NCT01099059|Methylphenidate|methylphenidate|mesh-list
139124313|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139124314|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124315|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139124316|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139124317|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139124318|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124319|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
139124320|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124321|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139124322|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139124323|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
139124324|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139124325|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139124326|NCT01099059|Analgesics|analgesics|mesh-ancestor
139124327|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
139124328|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124329|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
139124330|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124331|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139124332|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124333|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124334|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139124335|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
139124336|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124337|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
139124338|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139124339|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139124340|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
139124341|NCT00031551|Etanercept|etanercept|mesh-list
139124342|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139124343|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139124344|NCT00031551|Analgesics|analgesics|mesh-ancestor
139124345|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
139124346|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124347|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124348|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139124349|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139124350|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139124351|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139124352|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
139124353|NCT01099137|Vildagliptin|vildagliptin|mesh-list
139124354|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139124355|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124356|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139124357|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
139124358|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124359|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124360|NCT01092975|Phenylephrine|phenylephrine|mesh-list
139124361|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
139124362|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139124363|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
139124364|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
139124365|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124366|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124367|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
139124368|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139124369|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
139124370|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
139124371|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139124372|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139124373|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139124374|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
139124375|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124376|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124377|NCT01092975|Protective Agents|protective agents|mesh-ancestor
139124378|NCT01584297|Ketoconazole|ketoconazole|mesh-list
139124379|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
139124380|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139124381|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139124382|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139124383|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124384|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124385|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139124386|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
139124387|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139124388|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124389|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139124390|NCT00049257|Paclitaxel|paclitaxel|mesh-list
139124391|NCT00049257|Carboplatin|carboplatin|mesh-list
139124392|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139124393|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124394|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
139124395|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
139124396|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
139124397|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124398|NCT03951987|Charcoal|charcoal|mesh-list
139124399|NCT03951987|Antidotes|antidotes|mesh-ancestor
139124400|NCT03951987|Protective Agents|protective agents|mesh-ancestor
139124401|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124402|NCT03668470|Dulaglutide|dulaglutide|mesh-list
139124403|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139124404|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124405|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
139124406|NCT03020992|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139124407|NCT03020992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139124408|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139124409|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
139124410|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124411|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139124412|NCT03020914|Methamphetamine|methamphetamine|mesh-list
139124413|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139124414|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124415|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
139124416|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
139124417|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124418|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
139124419|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124420|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124421|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
139124422|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139124423|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139124424|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139124425|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139124426|NCT03018340|Pimavanserin|pimavanserin|mesh-list
139124427|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139124428|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139124429|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139124430|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139124431|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124432|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124433|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139124434|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139124435|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139124436|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
139124437|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124438|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124439|NCT00048165|Cyclosporine|cyclosporine|mesh-list
139124440|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
139124441|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
139124442|NCT00048165|Cyclosporins|cyclosporins|mesh-list
139124443|NCT00048165|Daclizumab|daclizumab|mesh-list
139124444|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870784|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139124445|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124446|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139124447|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
139124448|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124449|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
139124450|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139124451|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
139124452|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139124453|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139124454|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139124455|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124456|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139124457|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
139124458|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139124459|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139124460|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
139124461|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
139124462|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124463|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139124464|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
139124465|NCT00048165|Hormones|hormones|mesh-ancestor
139124466|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139124467|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139124468|NCT00048165|Protective Agents|protective agents|mesh-ancestor
139124469|NCT01099527|Capecitabine|capecitabine|mesh-list
139124470|NCT01099527|Everolimus|everolimus|mesh-list
139124471|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139124472|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
139124473|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124474|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124475|NCT01099527|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139124476|NCT01099527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139124477|NCT01099527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124478|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139124479|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
139124480|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124481|NCT01093365|Varenicline|varenicline|mesh-list
139124482|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139124483|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139124484|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
139124485|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124486|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124487|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124488|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
139124489|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139124490|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
139124491|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124492|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
139124493|NCT03955497|Protective Agents|protective agents|mesh-ancestor
139124494|NCT01099605|Bupivacaine|bupivacaine|mesh-list
139124495|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
139124496|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
139124497|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124498|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875043|NCT03549715|Durvalumab|durvalumab|mesh-list
139124499|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
139124500|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124502|NCT00059787|Carboplatin|carboplatin|mesh-list
139124503|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139124504|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139124505|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124506|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
139124507|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
139124508|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
139124509|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124510|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139124511|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124512|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
139124514|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139124515|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124516|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139124517|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124518|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124519|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139124520|NCT00058539|Pertuzumab|pertuzumab|mesh-list
138958522|NCT01057849|Olanzapine|olanzapine|mesh-list
139124521|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139124522|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124523|NCT03956823|Amlodipine|amlodipine|mesh-list
139124524|NCT03956823|Telmisartan|telmisartan|mesh-list
139124525|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139124526|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139124527|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139124528|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124529|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139124530|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124531|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
139124532|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139124533|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139124534|NCT03015532|Bupivacaine|bupivacaine|mesh-list
139124535|NCT03015532|Ropivacaine|ropivacaine|mesh-list
139124536|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
139124537|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
139124538|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124539|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124540|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
139124541|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124542|NCT03954873|Glucagon|glucagon|mesh-list
139124543|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139124544|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124545|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139124546|NCT03954873|Hormones|hormones|mesh-ancestor
139124547|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139124548|NCT03954873|Incretins|incretins|mesh-ancestor
139124549|NCT03954639|Bupivacaine|bupivacaine|mesh-list
139124550|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
139124551|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
139124552|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124553|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124554|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
139124555|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124556|NCT01095939|Benazepril|benazepril|mesh-list
139124557|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139124558|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
139124559|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124560|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124561|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139124562|NCT03015220|Dulaglutide|dulaglutide|mesh-list
139124563|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139124564|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124565|NCT00022659|Bevacizumab|bevacizumab|mesh-list
139124566|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139124567|NCT00022659|Antibodies|antibodies|mesh-list
139124568|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
139124569|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139124570|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124571|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139124573|NCT00022659|Growth Substances|growth substances|mesh-ancestor
139124574|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124575|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
139124576|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
139124577|NCT03018106|Estrogens|estrogens|mesh-list
139124578|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139124579|NCT03018106|Hormones|hormones|mesh-ancestor
139124580|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139124581|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124582|NCT03018028|Liraglutide|liraglutide|mesh-list
139124583|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139124584|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124585|NCT03018028|Incretins|incretins|mesh-ancestor
139124586|NCT03018028|Hormones|hormones|mesh-ancestor
139124587|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138958531|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139124588|NCT03667222|Minocycline|minocycline|mesh-list
139124589|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139124590|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139124591|NCT03667300|Linagliptin|linagliptin|mesh-list
139124592|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139124593|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124594|NCT03667300|Incretins|incretins|mesh-ancestor
139124595|NCT03667300|Hormones|hormones|mesh-ancestor
139124596|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139124597|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139124598|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
139124599|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124600|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124601|NCT03667066|Clopidogrel|clopidogrel|mesh-list
139124602|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139124603|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139124604|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139124605|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139124606|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
139124607|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124608|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124609|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124610|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
139124611|NCT00021255|Carboplatin|carboplatin|mesh-list
139124612|NCT00021255|Docetaxel|docetaxel|mesh-list
139124613|NCT00021255|Doxorubicin|doxorubicin|mesh-list
139124614|NCT00021255|Trastuzumab|trastuzumab|mesh-list
139124615|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139124616|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
139124617|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124618|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139124619|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139124620|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
139124621|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124622|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124623|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139124624|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
138870828|NCT00649974|Valacyclovir|valacyclovir|mesh-list
139124625|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
139124626|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
139124627|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139124628|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139124629|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139124630|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124631|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139124632|NCT03012334|Alprazolam|alprazolam|mesh-list
139124633|NCT03012334|Lasmiditan|lasmiditan|mesh-list
139124634|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139124635|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124636|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124637|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139124638|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139124639|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139124640|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
139124641|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
139124642|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124643|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124644|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139124645|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
139124647|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
139124649|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
139124650|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124651|NCT04571944|Suvorexant|suvorexant|mesh-list
139124652|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139124653|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139124654|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124655|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124656|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139124657|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124658|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124659|NCT04052932|Allopurinol|allopurinol|mesh-list
139124660|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
139124661|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124662|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124663|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
139124664|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139124665|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139124666|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
139124667|NCT04052932|Protective Agents|protective agents|mesh-ancestor
139124668|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124669|NCT03006562|Heparin|heparin|mesh-list
139124670|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
139124671|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139124672|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139124673|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124674|NCT03666208|Sirolimus|sirolimus|mesh-list
139124675|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139124676|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139124677|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139124678|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124679|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
139124680|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139124681|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
139124682|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124683|NCT03007966|Clonidine|clonidine|mesh-list
139124684|NCT03007966|Epinephrine|epinephrine|mesh-list
139124685|NCT03007966|Bupivacaine|bupivacaine|mesh-list
139124686|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
139124687|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
139124688|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124689|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124690|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
139124691|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124692|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139124693|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139124694|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
139124695|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124696|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124697|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139124698|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139124699|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
139124700|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139124701|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
139124702|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
139124703|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
139124704|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139124705|NCT03007966|Analgesics|analgesics|mesh-ancestor
139124706|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138958567|NCT00939939|Glimepiride|glimepiride|mesh-list
139124707|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
139124708|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139124709|NCT03007888|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139124710|NCT03007888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139124711|NCT03007888|Immunologic Factors|immunologic factors|mesh-ancestor
139124712|NCT03007888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124713|NCT03007888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139124714|NCT03007888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139124715|NCT03007888|Dopamine Agonists|dopamine agonists|mesh-ancestor
139124716|NCT03007888|Dopamine Agents|dopamine agents|mesh-ancestor
139124717|NCT03007888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124718|NCT03007888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124719|NCT03541044|Nicotine|nicotine|mesh-list
138875263|NCT02802137|Timolol|timolol|mesh-list
139124720|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139124721|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
139124722|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124723|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124724|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139124725|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139124726|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
139124727|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124728|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124729|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
139124730|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139124731|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124732|NCT03540030|Acetaminophen|acetaminophen|mesh-list
139124734|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139124735|NCT03540030|Lidocaine|lidocaine|mesh-list
139124736|NCT03540030|Gabapentin|gabapentin|mesh-list
139124737|NCT03540030|Propofol|propofol|mesh-list
139124738|NCT03540030|Sevoflurane|sevoflurane|mesh-list
139124739|NCT03540030|Desflurane|desflurane|mesh-list
139124740|NCT03540030|Rocuronium|rocuronium|mesh-list
139124741|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
139124742|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
139124743|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
139124744|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124745|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124746|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
139124747|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124748|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139124749|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139124750|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139124751|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139124752|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124753|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139124754|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139124755|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
139124756|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139124757|NCT03540030|Analgesics|analgesics|mesh-ancestor
139124758|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
138958586|NCT00805662|Oxytocin|oxytocin|mesh-list
139124759|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139124760|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139124761|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139124762|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139124763|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139124764|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139124765|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139124766|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124767|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
139124768|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139124769|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139124770|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139124771|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139124772|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139124773|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139124774|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
139124775|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139124776|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139124777|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139124778|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139124779|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139124780|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
139124781|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
139124782|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
139124783|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139124784|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
139124785|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124786|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139124787|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139124788|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
139124789|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124790|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124791|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139124792|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139124793|NCT03003676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139124794|NCT03665740|Resveratrol|resveratrol|mesh-list
139124795|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
139124796|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124797|NCT03665740|Protective Agents|protective agents|mesh-ancestor
139124798|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124799|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124800|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139124801|NCT03665350|Insulin|insulin|mesh-list
139124802|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139124803|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124804|NCT03665428|Bismuth|bismuth|mesh-list
139124805|NCT03665428|Antacids|antacids|mesh-ancestor
139124806|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124807|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139124808|NCT03669328|Anesthetics|anesthetics|mesh-list
139124809|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124810|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124811|NCT02912650|Acetaminophen|acetaminophen|mesh-list
139124812|NCT02912650|Ibuprofen|ibuprofen|mesh-list
139124813|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139124814|NCT02912650|Analgesics|analgesics|mesh-ancestor
139124815|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
139124816|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124817|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958595|NCT00803166|Clobetasol|clobetasol|mesh-list
139124818|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
139124819|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139124820|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139124821|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139124822|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139124823|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124824|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124825|NCT03002038|Rituximab|rituximab|mesh-list
139124826|NCT03002038|Azathioprine|azathioprine|mesh-list
139124827|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139124828|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124829|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
139124830|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124831|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139124832|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
139124833|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124834|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139124835|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139124836|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
139124837|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139124838|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124839|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124840|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139124841|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139124842|NCT03664414|Protective Agents|protective agents|mesh-ancestor
139124843|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124844|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
139124845|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139124846|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
139124847|NCT02911948|Insulin|insulin|mesh-list
139124848|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139124849|NCT02911948|Liraglutide|liraglutide|mesh-list
139124850|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
139124851|NCT02911948|Xultophy|xultophy|mesh-list
139124852|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139124853|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124854|NCT02911948|Incretins|incretins|mesh-ancestor
139124855|NCT02911948|Hormones|hormones|mesh-ancestor
139124856|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139124857|NCT03622918|Rifampin|rifampin|mesh-list
139124858|NCT03622918|Colistin|colistin|mesh-list
139124859|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139124860|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
139124861|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139124862|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139124863|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
139124864|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139124865|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124866|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124867|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139124868|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139124869|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139124870|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139124871|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139124872|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139124873|NCT03487666|Capecitabine|capecitabine|mesh-list
139124874|NCT03487666|Nivolumab|nivolumab|mesh-list
139124875|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139124876|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
139124877|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124878|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124879|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139124880|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139124881|NCT00027027|Pertuzumab|pertuzumab|mesh-list
138958609|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124882|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138870934|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
139124883|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124885|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
139124886|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139124887|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139124888|NCT00046839|Analgesics|analgesics|mesh-ancestor
139124889|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
139124890|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124891|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124892|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139124893|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139124894|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139124895|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124896|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124897|NCT00006903|Fulvestrant|fulvestrant|mesh-list
139124898|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139124899|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124900|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139124901|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139124902|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
139124903|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139124904|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124905|NCT03951597|Gemcitabine|gemcitabine|mesh-list
139124906|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
139124907|NCT03951597|Lenvatinib|lenvatinib|mesh-list
139124908|NCT03951597|Antibodies|antibodies|mesh-list
139124909|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
139124910|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124911|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139124912|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
139124913|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124914|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124915|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139124916|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124917|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
139124918|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139124919|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124920|NCT01101009|Amlodipine|amlodipine|mesh-list
139124921|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139124922|NCT01101009|Olmesartan|olmesartan|mesh-list
139124923|NCT01101009|Perindopril|perindopril|mesh-list
139124924|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139124925|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139124926|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139124927|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124928|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139124929|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124930|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
139124931|NCT01101009|Diuretics|diuretics|mesh-ancestor
139124932|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
139124933|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139124934|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139124935|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139124936|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139124937|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
139124938|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124939|NCT02996500|Tofacitinib|tofacitinib|mesh-list
139124940|NCT02996500|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139124941|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139124942|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139124943|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124945|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139124946|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139124947|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124948|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
139124949|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124950|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139124951|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124952|NCT03720756|Nickel|nickel|mesh-list
139124953|NCT03720756|Trace Elements|trace elements|mesh-ancestor
139124954|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
139124955|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124956|NCT00025233|Bevacizumab|bevacizumab|mesh-list
139124957|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139124958|NCT00025233|Antibodies|antibodies|mesh-list
139124959|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
139124960|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139124961|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124962|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139124963|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139124964|NCT00025233|Growth Substances|growth substances|mesh-ancestor
139124965|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124966|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
139124967|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
139124968|NCT00025155|Epothilones|epothilones|mesh-list
139124969|NCT00025155|Epothilone B|epothilone b|mesh-list
139124970|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
139124971|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
139124972|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
139124973|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124974|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139124975|NCT02998996|Endocine|endocine|mesh-list
139124976|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139124977|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
139124978|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124979|NCT03663478|Ropivacaine|ropivacaine|mesh-list
139124980|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
139124981|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
139124982|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139124983|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124984|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
139124985|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124986|NCT02994940|Acetaminophen|acetaminophen|mesh-list
139124987|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139124988|NCT02994940|Analgesics|analgesics|mesh-ancestor
139124989|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
139124990|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139124991|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124992|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
139124993|NCT02994394|Tolvaptan|tolvaptan|mesh-list
139124994|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139124995|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139124996|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
139124997|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139124998|NCT01063270|Rifampin|rifampin|mesh-list
139124999|NCT01063270|Clindamycin|clindamycin|mesh-list
139125000|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
139125001|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
139125002|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139125003|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
139125004|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139125005|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139125006|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
139125007|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139125008|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125009|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125010|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139125011|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139125012|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139125013|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139125014|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139125015|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139125016|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139125017|NCT00023673|Paclitaxel|paclitaxel|mesh-list
139125018|NCT00023673|Carboplatin|carboplatin|mesh-list
139125019|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139125020|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125021|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
139125022|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
139125023|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
139125024|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125026|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
139125027|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
139125028|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
139125029|NCT01069900|Ertapenem|ertapenem|mesh-list
139125030|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139125031|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139125032|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139125033|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139125034|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139125035|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139125036|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125037|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125038|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125039|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139125040|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
139125041|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139125042|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125043|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139125044|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139125045|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139125046|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139125047|NCT00006237|Interferons|interferons|mesh-list
139125048|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
139125049|NCT00006237|Aldesleukin|aldesleukin|mesh-list
139125050|NCT00006237|Interleukin-2|interleukin-2|mesh-list
139125051|NCT00006237|Dacarbazine|dacarbazine|mesh-list
139125052|NCT00006237|Vinblastine|vinblastine|mesh-list
139125053|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125054|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
139125055|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139125056|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
139125057|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125058|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139125059|NCT00006237|Analgesics|analgesics|mesh-ancestor
139125060|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
139125061|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125062|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139125063|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139125064|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139125065|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
139125066|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125067|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139125068|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
139125069|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
139125070|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
139125071|NCT04056754|Prednisone|prednisone|mesh-list
139125072|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
139125073|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139125074|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
139125075|NCT04056754|Hormones|hormones|mesh-ancestor
139125076|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139125077|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125078|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139125079|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125080|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139125081|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125082|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125083|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
139125084|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139125085|NCT04056442|Cannabidiol|cannabidiol|mesh-list
139125086|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
139125087|NCT02993926|Leuprolide|leuprolide|mesh-list
139125088|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139125089|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
139125090|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139125091|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125092|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139125093|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125094|NCT04055506|Ritonavir|ritonavir|mesh-list
139125095|NCT04055506|Deucravacitinib|deucravacitinib|mesh-list
139125096|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139125097|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139125098|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
139125099|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125100|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125101|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139125102|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139125103|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
139125104|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139125105|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139125106|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139125107|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
139125108|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138958757|NCT00680186|Warfarin|warfarin|mesh-list
139125109|NCT02993224|Deferasirox|deferasirox|mesh-list
139125110|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139125111|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
139125112|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
139125113|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125114|NCT02992132|Pimavanserin|pimavanserin|mesh-list
139125115|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139125116|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139125117|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139125118|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139125119|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125120|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125121|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139125122|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139125123|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139125124|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
139125125|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125126|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125128|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139125129|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125130|NCT03717740|Esomeprazole|esomeprazole|mesh-list
139125131|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139125132|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139125133|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139125134|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125135|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125136|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
139125137|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139125138|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139125139|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125140|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139125141|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125142|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139125143|NCT03717662|Nicotine|nicotine|mesh-list
139125144|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139125145|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
139125146|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125147|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125148|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139125149|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139125150|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
139125151|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125152|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125153|NCT03494816|Axitinib|axitinib|mesh-list
139125154|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125155|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139125156|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125157|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125158|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
139125159|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
139125160|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139125161|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125162|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125163|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
139125164|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139125165|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871025|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
139125166|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125167|NCT03713762|Lidocaine|lidocaine|mesh-list
139125168|NCT03713762|Fentanyl|fentanyl|mesh-list
139125169|NCT03713762|Bupivacaine|bupivacaine|mesh-list
139125170|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
139125171|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
138875712|NCT00684099|Pemetrexed|pemetrexed|mesh-list
139125172|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125173|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958765|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139125174|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
139125175|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125176|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139125177|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139125178|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139125179|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139125180|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125181|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139125182|NCT03713762|Narcotics|narcotics|mesh-ancestor
139125183|NCT03713762|Analgesics|analgesics|mesh-ancestor
139125184|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139125185|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139125186|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
139125187|NCT05975411|Anesthetics|anesthetics|mesh-list
139125188|NCT05975411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125189|NCT05975411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125190|NCT05975346|Ketamine|ketamine|mesh-list
139125191|NCT05975346|Analgesics|analgesics|mesh-ancestor
139125192|NCT05975346|Sensory System Agents|sensory system agents|mesh-ancestor
139125193|NCT05975346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125194|NCT05975346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125195|NCT05975346|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139125196|NCT05975346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139125197|NCT05975346|Anesthetics, General|anesthetics, general|mesh-ancestor
139125198|NCT05975346|Anesthetics|anesthetics|mesh-ancestor
139125199|NCT05975346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125200|NCT05975346|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139125201|NCT05975346|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139125202|NCT05975346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125203|NCT05975346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125204|NCT05975320|Warfarin|warfarin|mesh-list
139125205|NCT05975320|Apixaban|apixaban|mesh-list
139125206|NCT05975320|Anticoagulants|anticoagulants|mesh-ancestor
139125207|NCT05975320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139125208|NCT05975320|Antithrombins|antithrombins|mesh-ancestor
139125209|NCT05975320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139125210|NCT05975320|Protease Inhibitors|protease inhibitors|mesh-ancestor
139125211|NCT05975320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125212|NCT05975320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125213|NCT05975294|Dexamethasone|dexamethasone|mesh-list
139125214|NCT05975294|Ketorolac|ketorolac|mesh-list
139125215|NCT05975294|Fentanyl|fentanyl|mesh-list
139125216|NCT05975294|Nalbuphine|nalbuphine|mesh-list
139125217|NCT05975294|Bupivacaine|bupivacaine|mesh-list
139125218|NCT05975294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139125219|NCT05975294|Antiemetics|antiemetics|mesh-ancestor
139125220|NCT05975294|Autonomic Agents|autonomic agents|mesh-ancestor
139125221|NCT05975294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125222|NCT05975294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125223|NCT05975294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139125224|NCT05975294|Glucocorticoids|glucocorticoids|mesh-ancestor
139125225|NCT05975294|Hormones|hormones|mesh-ancestor
139125226|NCT05975294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139125227|NCT05975294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139125228|NCT05975294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125229|NCT05975294|Anesthetics, Local|anesthetics, local|mesh-ancestor
139125230|NCT05975294|Anesthetics|anesthetics|mesh-ancestor
139125231|NCT05975294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125232|NCT05975294|Sensory System Agents|sensory system agents|mesh-ancestor
139125233|NCT05975294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139125234|NCT05975294|Narcotics|narcotics|mesh-ancestor
139125235|NCT05975294|Analgesics|analgesics|mesh-ancestor
139125236|NCT05975294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139125237|NCT05975294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139125238|NCT05975294|Anesthetics, General|anesthetics, general|mesh-ancestor
139125239|NCT05975294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139125240|NCT05975294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139125241|NCT05975294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139125242|NCT05975294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139125243|NCT05975294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125244|NCT05975294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125245|NCT05975112|Plasminogen|plasminogen|mesh-list
139125246|NCT05975112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139125247|NCT05975112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139125248|NCT05975112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125249|NCT05974774|Ascorbic Acid|ascorbic acid|mesh-list
139125250|NCT05974774|Methyltestosterone|methyltestosterone|mesh-list
139125251|NCT05974774|Androgens|androgens|mesh-list
139125252|NCT05974774|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139125253|NCT05974774|Micronutrients|micronutrients|mesh-ancestor
139125254|NCT05974774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125255|NCT05974774|Hormones|hormones|mesh-ancestor
139125256|NCT05974774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139125257|NCT05974774|Antioxidants|antioxidants|mesh-ancestor
139125258|NCT05974774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125259|NCT05974774|Protective Agents|protective agents|mesh-ancestor
139125260|NCT05974774|Vitamins|vitamins|mesh-ancestor
139125261|NCT05974774|Estrogens|estrogens|mesh-ancestor
139125262|NCT05974774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139125263|NCT05974774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125264|NCT05974774|Anabolic Agents|anabolic agents|mesh-ancestor
139125265|NCT05974683|Mycophenolic Acid|mycophenolic acid|mesh-list
139125266|NCT05974683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139125267|NCT05974683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125268|NCT05974683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139125269|NCT05974683|Antitubercular Agents|antitubercular agents|mesh-ancestor
139125270|NCT05974683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139125271|NCT05974683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139125272|NCT05974683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125273|NCT05974683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125274|NCT05974527|Dexmedetomidine|dexmedetomidine|mesh-list
139125275|NCT05974527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139125276|NCT05974527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125277|NCT05974527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125278|NCT05974527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139125279|NCT05974527|Analgesics|analgesics|mesh-ancestor
139125280|NCT05974527|Sensory System Agents|sensory system agents|mesh-ancestor
139125281|NCT05974527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125282|NCT05974527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139125283|NCT05974527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139125284|NCT05974527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139125285|NCT05974527|Adrenergic Agents|adrenergic agents|mesh-ancestor
139125286|NCT05974527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125287|NCT05974527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125288|NCT05974501|Acetaminophen|acetaminophen|mesh-list
139125289|NCT05974501|Dexamethasone|dexamethasone|mesh-list
139125291|NCT05974501|Meloxicam|meloxicam|mesh-list
139125292|NCT05974501|Oxycodone|oxycodone|mesh-list
139125293|NCT05974501|Ropivacaine|ropivacaine|mesh-list
139125294|NCT05974501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139125295|NCT05974501|Antiemetics|antiemetics|mesh-ancestor
139125296|NCT05974501|Autonomic Agents|autonomic agents|mesh-ancestor
139125297|NCT05974501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125298|NCT05974501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125299|NCT05974501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139125300|NCT05974501|Glucocorticoids|glucocorticoids|mesh-ancestor
139125301|NCT05974501|Hormones|hormones|mesh-ancestor
139125302|NCT05974501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139125303|NCT05974501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139125304|NCT05974501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125305|NCT05974501|Anesthetics, Local|anesthetics, local|mesh-ancestor
139125306|NCT05974501|Anesthetics|anesthetics|mesh-ancestor
139125307|NCT05974501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125308|NCT05974501|Sensory System Agents|sensory system agents|mesh-ancestor
139125309|NCT05974501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139125310|NCT05974501|Analgesics|analgesics|mesh-ancestor
139125311|NCT05974501|Antipyretics|antipyretics|mesh-ancestor
139125312|NCT05974501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139125313|NCT05974501|Narcotics|narcotics|mesh-ancestor
139125314|NCT05974501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139125315|NCT05974501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139125316|NCT05974501|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139125317|NCT05974501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139125318|NCT05974501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125319|NCT05974501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125320|NCT05974436|Dialysis Solutions|dialysis solutions|mesh-list
139125321|NCT05974436|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139125323|NCT05974423|Ibuprofen|ibuprofen|mesh-list
139125324|NCT05974423|Oxycodone|oxycodone|mesh-list
139125325|NCT05974423|Narcotics|narcotics|mesh-list
139125326|NCT05974423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139125327|NCT05974423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139125328|NCT05974423|Analgesics|analgesics|mesh-ancestor
139125329|NCT05974423|Sensory System Agents|sensory system agents|mesh-ancestor
139125330|NCT05974423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125331|NCT05974423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125332|NCT05974423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139125333|NCT05974423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139125334|NCT05974423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139125335|NCT05974423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125336|NCT05974423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125337|NCT05974423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139125338|NCT05974423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125339|NCT05974423|Antipyretics|antipyretics|mesh-ancestor
139125340|NCT05974410|Hydrocortisone|hydrocortisone|mesh-list
139125341|NCT05974410|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139125342|NCT05974410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139125343|NCT05974410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125344|NCT05974410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125345|NCT05974332|Oncostatin M|oncostatin m|mesh-list
139125346|NCT05974332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125347|NCT05974332|Growth Inhibitors|growth inhibitors|mesh-ancestor
139125348|NCT05974332|Growth Substances|growth substances|mesh-ancestor
139125349|NCT05974332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125350|NCT05974059|Capecitabine|capecitabine|mesh-list
139125351|NCT05974059|Oxaliplatin|oxaliplatin|mesh-list
139125352|NCT05974059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139125353|NCT05974059|Antimetabolites|antimetabolites|mesh-ancestor
139125354|NCT05974059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125355|NCT05974059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125356|NCT05974007|Immunomodulating Agents|immunomodulating agents|mesh-list
139125357|NCT05974007|Immunologic Factors|immunologic factors|mesh-ancestor
139125358|NCT05974007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125359|NCT05973864|Pembrolizumab|pembrolizumab|mesh-list
139125360|NCT05973864|Capecitabine|capecitabine|mesh-list
139125361|NCT05973864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125362|NCT05973864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125363|NCT05973864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139125364|NCT05973864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125365|NCT05973864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139125366|NCT05973864|Antimetabolites|antimetabolites|mesh-ancestor
139125367|NCT05973747|Calcium, Dietary|calcium, dietary|mesh-list
139125368|NCT05973747|Calcium|calcium|mesh-list
139125369|NCT05973747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139125370|NCT05973747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125371|NCT05973747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139125372|NCT05973552|Iron|iron|mesh-list
139125373|NCT05973552|Trace Elements|trace elements|mesh-ancestor
139125374|NCT05973552|Micronutrients|micronutrients|mesh-ancestor
139125375|NCT05973552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125376|NCT05971667|Sildenafil Citrate|sildenafil citrate|mesh-list
139125377|NCT05971667|Tadalafil|tadalafil|mesh-list
139125378|NCT05971667|Pentoxifylline|pentoxifylline|mesh-list
139125379|NCT05971667|Vasodilator Agents|vasodilator agents|mesh-ancestor
139125380|NCT05971667|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139125381|NCT05971667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139125382|NCT05971667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125383|NCT05971667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125384|NCT05971667|Urological Agents|urological agents|mesh-ancestor
139125385|NCT05971667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139125386|NCT05971667|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139125387|NCT05971667|Protective Agents|protective agents|mesh-ancestor
139125388|NCT05971667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125389|NCT05971667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139125390|NCT05971667|Antioxidants|antioxidants|mesh-ancestor
139125391|NCT05970770|Norepinephrine|norepinephrine|mesh-list
139125392|NCT05970770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139125393|NCT05970770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139125394|NCT05970770|Adrenergic Agents|adrenergic agents|mesh-ancestor
139125395|NCT05970770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125396|NCT05970770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125397|NCT05970770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875937|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
139125398|NCT05970770|Sympathomimetics|sympathomimetics|mesh-ancestor
139125399|NCT05970770|Autonomic Agents|autonomic agents|mesh-ancestor
139125400|NCT05970770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125401|NCT05970770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139125402|NCT05953766|Ropivacaine|ropivacaine|mesh-list
139125403|NCT05953766|Anesthetics, Local|anesthetics, local|mesh-ancestor
139125404|NCT05953766|Anesthetics|anesthetics|mesh-ancestor
139125405|NCT05953766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125406|NCT05953766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125407|NCT05953766|Sensory System Agents|sensory system agents|mesh-ancestor
139125408|NCT05953766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125409|NCT05951400|Cetrorelix|cetrorelix|mesh-list
139125410|NCT05951400|Dydrogesterone|dydrogesterone|mesh-list
139125411|NCT05951400|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139125412|NCT05951400|Fertility Agents|fertility agents|mesh-ancestor
139125413|NCT05951400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139125414|NCT05951400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125415|NCT05951400|Hormone Antagonists|hormone antagonists|mesh-ancestor
139125416|NCT05951400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139125417|NCT05951400|Progestins|progestins|mesh-ancestor
139125418|NCT05951400|Hormones|hormones|mesh-ancestor
139125419|NCT05806164|Mirabegron|mirabegron|mesh-list
139125420|NCT05806164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139125421|NCT05806164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139125422|NCT05806164|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
139125423|NCT05806164|Adrenergic Agents|adrenergic agents|mesh-list
139125424|NCT05806164|Adrenergic Agonists|adrenergic agonists|mesh-list
139125425|NCT05806164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139125426|NCT05806164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125427|NCT05806164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125428|NCT05806164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139125429|NCT05806164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139125430|NCT05806164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125431|NCT05806164|Cholinergic Agents|cholinergic agents|mesh-ancestor
139125432|NCT05806164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125433|NCT05806164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139125434|NCT05806164|Urological Agents|urological agents|mesh-ancestor
138871126|NCT02832635|Temozolomide|temozolomide|mesh-list
139125436|NCT05805761|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139125437|NCT05701540|Esomeprazole|esomeprazole|mesh-list
139125438|NCT05701540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139125439|NCT05701540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139125440|NCT05701540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139125441|NCT05701540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125442|NCT05701540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125443|NCT05688371|Dexmedetomidine|dexmedetomidine|mesh-list
139125444|NCT05688371|Morphine|morphine|mesh-list
139125445|NCT05688371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139125446|NCT05688371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125447|NCT05688371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125448|NCT05688371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139125449|NCT05688371|Analgesics|analgesics|mesh-ancestor
139125450|NCT05688371|Sensory System Agents|sensory system agents|mesh-ancestor
139125451|NCT05688371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125452|NCT05688371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139125453|NCT05688371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139125454|NCT05688371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139125455|NCT05688371|Adrenergic Agents|adrenergic agents|mesh-ancestor
139125456|NCT05688371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125457|NCT05688371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125458|NCT05688371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139125459|NCT05688371|Narcotics|narcotics|mesh-ancestor
139125460|NCT05668949|Pembrolizumab|pembrolizumab|mesh-list
139125461|NCT05668949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125462|NCT05668949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125463|NCT05668949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139125464|NCT05668949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125465|NCT05662332|Insulin|insulin|mesh-list
139125466|NCT05662332|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139125467|NCT05662332|Insulin Glargine|insulin glargine|mesh-list
139125468|NCT05662332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139125469|NCT05662332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125470|NCT05618353|Colchicine|colchicine|mesh-list
139125471|NCT05618353|Gout Suppressants|gout suppressants|mesh-ancestor
139125472|NCT05618353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139125473|NCT05618353|Tubulin Modulators|tubulin modulators|mesh-ancestor
139125474|NCT05618353|Antimitotic Agents|antimitotic agents|mesh-ancestor
139125475|NCT05618353|Mitosis Modulators|mitosis modulators|mesh-ancestor
139125476|NCT05618353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125477|NCT05618353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125478|NCT05595044|Vitamin D|vitamin d|mesh-list
139125479|NCT05595044|Vitamins|vitamins|mesh-ancestor
139125480|NCT05595044|Micronutrients|micronutrients|mesh-ancestor
139125481|NCT05595044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125482|NCT05595044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139125483|NCT05535764|Interferons|interferons|mesh-list
139125484|NCT05535764|Interferon-alpha|interferon-alpha|mesh-list
139125485|NCT05535764|Interferon alpha-2|interferon alpha-2|mesh-list
139125486|NCT05535764|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139125487|NCT05535764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125488|NCT05535764|Antiviral Agents|antiviral agents|mesh-ancestor
139125489|NCT05535764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139125490|NCT05535764|Immunologic Factors|immunologic factors|mesh-ancestor
139125491|NCT05535764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125492|NCT05377905|Doxorubicin|doxorubicin|mesh-list
139125493|NCT05377905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139125494|NCT05377905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139125495|NCT05377905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125496|NCT05377905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139125497|NCT05377905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139125498|NCT05377905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125499|NCT05377905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125500|NCT05372133|Morphine|morphine|mesh-list
139125501|NCT05372133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139125502|NCT05372133|Narcotics|narcotics|mesh-ancestor
139125503|NCT05372133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125504|NCT05372133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125505|NCT05372133|Analgesics|analgesics|mesh-ancestor
139125506|NCT05372133|Sensory System Agents|sensory system agents|mesh-ancestor
139125507|NCT05372133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125508|NCT05347212|Nivolumab|nivolumab|mesh-list
139125509|NCT05347212|Relatlimab|relatlimab|mesh-list
139125510|NCT05347212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125511|NCT05347212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125512|NCT05347212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139125513|NCT05347212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125514|NCT05144009|Rituximab|rituximab|mesh-list
139125515|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139125516|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125517|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125518|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
139125519|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125520|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139125521|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
139125522|NCT05110742|Fludarabine|fludarabine|mesh-list
139125523|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
139125524|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139125525|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
139125526|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125527|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139125528|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139125529|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
139125530|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125531|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125532|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139125533|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139125534|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
139125535|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
139125536|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139125537|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
139125538|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125539|NCT05042440|Factor VIII|factor viii|mesh-list
139125540|NCT05042440|BAX 855|bax 855|mesh-list
139125541|NCT05042440|Coagulants|coagulants|mesh-ancestor
139125542|NCT05022563|Warfarin|warfarin|mesh-list
139125543|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
139125544|NCT05022563|Dabigatran|dabigatran|mesh-list
139125545|NCT05022563|Apixaban|apixaban|mesh-list
139125546|NCT05022563|Anticoagulants|anticoagulants|mesh-list
139125547|NCT05022563|Edoxaban|edoxaban|mesh-list
139125548|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139125549|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
139125550|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139125551|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
139125552|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125553|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125554|NCT05009069|Capecitabine|capecitabine|mesh-list
139125555|NCT05009069|Fluorouracil|fluorouracil|mesh-list
139125556|NCT05009069|Atezolizumab|atezolizumab|mesh-list
139125557|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139125558|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
139125559|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125560|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125561|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139125562|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
139125563|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125564|NCT05009069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139125565|NCT05009069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125566|NCT04968951|Metronidazole|metronidazole|mesh-list
139125567|NCT04968951|Vancomycin|vancomycin|mesh-list
139125568|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139125569|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139125570|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139125571|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139125572|NCT04950426|Propranolol|propranolol|mesh-list
139125573|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139125574|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139125575|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
139125576|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125577|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125578|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125579|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139125580|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139125581|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
139125582|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139125583|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139125584|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125585|NCT04884412|Anesthetics|anesthetics|mesh-list
139125586|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125587|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125588|NCT04863950|Lomustine|lomustine|mesh-list
139125589|NCT04863950|Imipramine|imipramine|mesh-list
139125590|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139125591|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
139125592|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125593|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125594|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139125595|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
139125596|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139125597|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139125598|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139125599|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139125600|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
139125601|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125602|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125603|NCT04826393|Cemiplimab|cemiplimab|mesh-list
139125604|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125605|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125606|NCT04824391|Vaccines|vaccines|mesh-list
139125607|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
139125608|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125609|NCT04822597|Lidocaine|lidocaine|mesh-list
139125610|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
139125611|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
139125612|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125613|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125614|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
139125615|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125616|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139125617|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139125618|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139125619|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139125620|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125621|NCT04821856|Cannabidiol|cannabidiol|mesh-list
139125622|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
139125623|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
139125624|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125625|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125626|NCT04808999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139125627|NCT04808999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125628|NCT04764227|Paclitaxel|paclitaxel|mesh-list
139125629|NCT04764227|Carboplatin|carboplatin|mesh-list
139125630|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139125631|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125632|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
139125633|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
139125634|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
139125635|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125636|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
139125637|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125638|NCT04706026|Anesthetics|anesthetics|mesh-list
139125639|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125640|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125641|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
139125642|NCT04639245|Fludarabine|fludarabine|mesh-list
139125643|NCT04639245|Atezolizumab|atezolizumab|mesh-list
139125644|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139125645|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139125646|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139125647|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
139125648|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125649|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139125650|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139125651|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
139125652|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125653|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125654|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139125655|NCT04639245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125656|NCT04599465|Ivacaftor|ivacaftor|mesh-list
139125657|NCT04599465|Elexacaftor|elexacaftor|mesh-list
139125658|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139125659|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139125660|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544416|NCT00409942|Furosemide|furosemide|mesh-list
139125661|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
139125662|NCT04589130|Naltrexone|naltrexone|mesh-list
139125663|NCT04589130|Bupropion|bupropion|mesh-list
139125664|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139125665|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139125666|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125667|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
139125668|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125669|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139125670|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
139125671|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139125672|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139125673|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139125674|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139125675|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125676|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
139125677|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125678|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139125679|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139125680|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125681|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139125682|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
139125683|NCT04587843|Naltrexone|naltrexone|mesh-list
139125684|NCT04587843|Bupropion|bupropion|mesh-list
139125685|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139125686|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139125687|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125688|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
139125689|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125690|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139125691|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
139125692|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139125694|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139125695|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139125696|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125697|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
139125698|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125699|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139125700|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139125701|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125702|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139125704|NCT04562441|Axitinib|axitinib|mesh-list
139125705|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125706|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125707|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139125708|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125709|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125710|NCT04433780|Tenofovir|tenofovir|mesh-list
139125711|NCT04433780|Lamivudine|lamivudine|mesh-list
139125712|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
139125713|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139125714|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139125715|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139125716|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125717|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125718|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139125719|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139125720|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
139125721|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
139125722|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
139125723|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125724|NCT04408664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139125725|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139125726|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139125727|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
139125728|NCT04362293|Sirolimus|sirolimus|mesh-list
139125729|NCT04362293|Plerixafor|plerixafor|mesh-list
139125730|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
139125731|NCT04362293|Thiotepa|thiotepa|mesh-list
139125732|NCT04362293|Temsirolimus|temsirolimus|mesh-list
139125733|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
139125734|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
139125735|NCT04362293|Azathioprine|azathioprine|mesh-list
139125736|NCT04362293|MTOR Inhibitors|mtor inhibitors|mesh-list
139125737|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139125738|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
139125739|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125740|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139125741|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139125742|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
139125743|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125744|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125745|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139125746|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139125747|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139125748|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139125749|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
139125750|NCT04362293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139125751|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125752|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125753|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
139125754|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139125755|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
139125756|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139125757|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139125758|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139125759|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
139125760|NCT04332367|Paclitaxel|paclitaxel|mesh-list
139125761|NCT04332367|Carboplatin|carboplatin|mesh-list
139125762|NCT04332367|Ramucirumab|ramucirumab|mesh-list
139125763|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139125764|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125765|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
139125766|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
139125767|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
139125768|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125770|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139125771|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125772|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125773|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139125774|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139125775|NCT04186559|Protective Agents|protective agents|mesh-ancestor
139125776|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125777|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
139125778|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139125779|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
139125780|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
139125781|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
139125782|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139125783|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
139125784|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139125785|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125786|NCT04183452|Progestins|progestins|mesh-ancestor
139125787|NCT04183452|Hormones|hormones|mesh-ancestor
139125788|NCT04104646|Morphine|morphine|mesh-list
139125789|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139125790|NCT04104646|Narcotics|narcotics|mesh-ancestor
139125791|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125792|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125793|NCT04104646|Analgesics|analgesics|mesh-ancestor
139125794|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
139125795|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125796|NCT04098874|Bupropion|bupropion|mesh-list
139125797|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139125798|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
139125799|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139125800|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139125801|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139125802|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139125803|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125804|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
139125805|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125806|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125807|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139125808|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139125809|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125810|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
139125811|NCT03622788|Fludarabine|fludarabine|mesh-list
139125812|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139125813|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139125814|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
139125815|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125816|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139125817|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139125818|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
139125819|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125820|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125821|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139125822|NCT03594110|Empagliflozin|empagliflozin|mesh-list
138871276|NCT06094946|Fentanyl|fentanyl|mesh-list
139125824|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125826|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125827|NCT03580824|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
139125828|NCT03580824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139125829|NCT03580824|Immunologic Factors|immunologic factors|mesh-ancestor
139125830|NCT03580824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125831|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139125832|NCT03497676|Rilpivirine|rilpivirine|mesh-list
139125833|NCT03497676|Cabotegravir|cabotegravir|mesh-list
139125834|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
139125835|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139125836|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139125837|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139125838|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125839|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125840|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138496208|NCT00109408|Methotrexate|methotrexate|mesh-list
139125841|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139125842|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139125843|NCT03366142|Ustekinumab|ustekinumab|mesh-list
139125844|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
139125847|NCT03300947|Lorazepam|lorazepam|mesh-list
139125848|NCT03300947|Psilocybin|psilocybin|mesh-list
138958916|NCT02558972|Droxidopa|droxidopa|mesh-list
139125849|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
139125850|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125851|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139125852|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
139125853|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
139125854|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
139125855|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125856|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139125857|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139125858|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139125859|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139125860|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139125861|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
139125862|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
139125863|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125864|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125865|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
139125866|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
139125867|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139125868|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125869|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125870|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
139125871|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
139125872|NCT03107884|Metformin|metformin|mesh-list
139125873|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138871295|NCT06094907|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
139125874|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125875|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
139125876|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125877|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125878|NCT03106415|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139125879|NCT03106415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125880|NCT03024996|Atezolizumab|atezolizumab|mesh-list
139125881|NCT03024996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139125882|NCT03024996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125883|NCT03024996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125884|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125885|NCT03003325|Aspirin|aspirin|mesh-list
139125886|NCT03003325|Interferons|interferons|mesh-list
138544424|NCT00084786|Docetaxel|docetaxel|mesh-list
139125887|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125888|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
139125889|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139125890|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139125891|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139125892|NCT03003325|Analgesics|analgesics|mesh-ancestor
139125893|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
139125894|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125895|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125896|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139125897|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139125898|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139125899|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139125900|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125901|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139125902|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139125903|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125904|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
139125906|NCT02969798|Pioglitazone|pioglitazone|mesh-list
139125907|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
139125908|NCT02969798|Saxagliptin|saxagliptin|mesh-list
139125909|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139125910|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125911|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139125912|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125913|NCT02969798|Incretins|incretins|mesh-ancestor
139125914|NCT02969798|Hormones|hormones|mesh-ancestor
139125915|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139125916|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139125917|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
139125918|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125919|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
139125920|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125921|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125922|NCT02855203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139125923|NCT02855203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125925|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
139125926|NCT02748564|Interleukin-2|interleukin-2|mesh-list
139125927|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125928|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125929|NCT02748564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139125930|NCT02748564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125931|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139125932|NCT02748564|Analgesics|analgesics|mesh-ancestor
139125933|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
139125934|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125935|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125936|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139125937|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139125938|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
139125939|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139125940|NCT02642965|Cytarabine|cytarabine|mesh-list
139125941|NCT02642965|Fludarabine|fludarabine|mesh-list
139125942|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
139125943|NCT02642965|Daunorubicin|daunorubicin|mesh-list
139125944|NCT02642965|Lenograstim|lenograstim|mesh-list
139125945|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125946|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139125947|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
139125948|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125949|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139125950|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
139125951|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125952|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
139125953|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139125954|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139125955|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139125956|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139125957|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139125958|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139125959|NCT02595892|Gemcitabine|gemcitabine|mesh-list
139125960|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139125961|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
138871361|NCT06094140|Antimetabolites|antimetabolites|mesh-ancestor
139125962|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125963|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125965|NCT01936532|Lenalidomide|lenalidomide|mesh-list
139125966|NCT01936532|Ixazomib|ixazomib|mesh-list
139125967|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139125968|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
139125969|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
139125970|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139125971|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139125972|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139125973|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
139125974|NCT01936532|Hormones|hormones|mesh-ancestor
139125975|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139125976|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139125977|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125978|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
139125979|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139125980|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139125981|NCT01936532|Growth Substances|growth substances|mesh-ancestor
139125982|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
139125983|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
139125984|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019550|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139125985|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139125986|NCT01054625|Zalutumumab|zalutumumab|mesh-list
139125987|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139125988|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125989|NCT01038778|Aldesleukin|aldesleukin|mesh-list
139125990|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
139125991|NCT01038778|Interleukin-2|interleukin-2|mesh-list
139125992|NCT01038778|Entinostat|entinostat|mesh-list
139125993|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139125994|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139125995|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139125996|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139125997|NCT01038778|Analgesics|analgesics|mesh-ancestor
139125998|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
139125999|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126000|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126001|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139126002|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139126003|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
139126004|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126005|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139126006|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126007|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
139126008|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126009|NCT00707655|Zalutumumab|zalutumumab|mesh-list
139126010|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139126011|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126012|NCT00542308|Zalutumumab|zalutumumab|mesh-list
139126013|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139126014|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126015|NCT00488605|Leucovorin|leucovorin|mesh-list
139126016|NCT00488605|Prednisone|prednisone|mesh-list
139126017|NCT00488605|Methotrexate|methotrexate|mesh-list
139126018|NCT00488605|Vinblastine|vinblastine|mesh-list
139126019|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
139126020|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139126021|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
139126022|NCT00488605|Hormones|hormones|mesh-ancestor
139126023|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139126024|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126025|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139126026|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126027|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139126028|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
139126029|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139126030|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139126031|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
139126032|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126033|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
139126034|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126035|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139126036|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139126037|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
139126038|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139126039|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139126040|NCT00488605|Antidotes|antidotes|mesh-ancestor
139126041|NCT00488605|Protective Agents|protective agents|mesh-ancestor
139126042|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
139126043|NCT00488605|Vitamins|vitamins|mesh-ancestor
139126044|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
139126045|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139126046|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
139126047|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
139126048|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
139126049|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
139126050|NCT00006734|Ifosfamide|ifosfamide|mesh-list
139126051|NCT00006734|Doxorubicin|doxorubicin|mesh-list
139126052|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139126053|NCT00006734|Etoposide|etoposide|mesh-list
139126054|NCT00006734|Vincristine|vincristine|mesh-list
139126055|NCT00006734|Lenograstim|lenograstim|mesh-list
139126056|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139126057|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
139126058|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126059|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139126060|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139126061|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
139126062|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126063|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126064|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139126065|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139126066|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139126067|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139126068|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126069|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139126070|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139126071|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
139126072|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
139126073|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
139126074|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139126075|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139126076|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
139126077|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126078|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139126079|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126080|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139126081|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126082|NCT02991040|Lidocaine|lidocaine|mesh-list
139126083|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
139126084|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
139126085|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139126086|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126087|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
139126088|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126089|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139126090|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139126091|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139126092|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139126093|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126094|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
139126095|NCT03660436|Deucravacitinib|deucravacitinib|mesh-list
139126096|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139126097|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126098|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139126099|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
139126100|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139126101|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126102|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126103|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126104|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
139126105|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139126106|NCT03662620|Amlodipine|amlodipine|mesh-list
139126107|NCT03662620|Telmisartan|telmisartan|mesh-list
139126108|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
139126109|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139126110|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139126111|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139126112|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126113|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139126114|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126115|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
139126116|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139126117|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139126118|NCT03662620|Diuretics|diuretics|mesh-ancestor
139126119|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
139126120|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139126121|NCT03415178|Atorvastatin|atorvastatin|mesh-list
139126122|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139126123|NCT03415178|Alirocumab|alirocumab|mesh-list
139126124|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139126125|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139126126|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
139126127|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126128|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138871416|NCT06090565|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139126129|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139126130|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126131|NCT03415178|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139126132|NCT03415178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139126133|NCT03415178|Protease Inhibitors|protease inhibitors|mesh-ancestor
139126134|NCT01068730|Metformin|metformin|mesh-list
139126135|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139126136|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126137|NCT01068652|Insulin|insulin|mesh-list
139126138|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139126139|NCT01068652|Metformin|metformin|mesh-list
139126140|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
139126141|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
139126142|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139126143|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
139126144|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
139126145|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139126146|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139126147|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126148|NCT03658720|Ibuprofen|ibuprofen|mesh-list
139126149|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138876679|NCT04232813|Estrogens|estrogens|mesh-ancestor
139126150|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139126151|NCT03658720|Analgesics|analgesics|mesh-ancestor
139126152|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
139126153|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126154|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126155|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139126156|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139126157|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139126158|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126159|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126160|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
139126161|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139126162|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139126163|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126164|NCT03658330|Naltrexone|naltrexone|mesh-list
139126165|NCT03658330|Ketamine|ketamine|mesh-list
139126166|NCT03658330|Analgesics|analgesics|mesh-ancestor
139126167|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
139126168|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126169|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126170|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139126171|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139126172|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
139126173|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
139126174|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139126175|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139126176|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139126177|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126178|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126179|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139126180|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139126181|NCT02920528|Ketamine|ketamine|mesh-list
139126182|NCT02920528|Analgesics|analgesics|mesh-ancestor
139126183|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
139126184|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126185|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126186|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139126187|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139126188|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
139126190|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139126191|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139126192|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139126193|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126194|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126195|NCT01068418|Vitamin D|vitamin d|mesh-list
139126196|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
139126197|NCT01068418|Vitamins|vitamins|mesh-ancestor
139126198|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
139126199|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126200|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139126201|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139126202|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
139126203|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139126204|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126205|NCT03657550|Niacin|niacin|mesh-list
139126206|NCT03657550|Amlodipine|amlodipine|mesh-list
139126207|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139126208|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139126209|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139126210|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126211|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139126212|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126213|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
139126214|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139126215|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
139126216|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139126217|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
139126218|NCT03657550|Vitamins|vitamins|mesh-ancestor
139126219|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
139126220|NCT02920450|Paclitaxel|paclitaxel|mesh-list
139126221|NCT02920450|Carboplatin|carboplatin|mesh-list
139126222|NCT02920450|Gedatolisib|gedatolisib|mesh-list
139126223|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139126224|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126225|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
139126226|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
139126227|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
139126228|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126229|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139126230|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126231|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
139126232|NCT03622450|Levofloxacin|levofloxacin|mesh-list
139126233|NCT03622450|Gentamicins|gentamicins|mesh-list
139126234|NCT03622450|Meropenem|meropenem|mesh-list
139126235|NCT03622450|Amikacin|amikacin|mesh-list
139126236|NCT03622450|Colistin|colistin|mesh-list
139126237|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139126238|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126239|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139126240|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139126241|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126242|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126243|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126244|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139126245|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139126246|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139126247|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139126248|NCT03657862|Fluorides|fluorides|mesh-list
139126249|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
139126250|NCT03657862|Protective Agents|protective agents|mesh-ancestor
139126251|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126252|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
139126253|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139126254|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126255|NCT02730130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139126256|NCT02730130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126257|NCT02919436|Tamsulosin|tamsulosin|mesh-list
139126258|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139126259|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139126260|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139126261|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
139126262|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126263|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126264|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126265|NCT02919436|Urological Agents|urological agents|mesh-ancestor
139126266|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
139126267|NCT03657472|Atorvastatin|atorvastatin|mesh-list
139126268|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139126269|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139126270|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
139126271|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126272|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139126273|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139126274|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126275|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139126277|NCT04438330|Trace Elements|trace elements|mesh-ancestor
139126278|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
139126279|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126280|NCT03803475|Edetic Acid|edetic acid|mesh-list
139126281|NCT03803475|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139126282|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
139126283|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
139126284|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126285|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
139126286|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139126287|NCT03803475|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139126288|NCT02682004|Serotonin|serotonin|mesh-list
139126289|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139126290|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
139126291|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126292|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126293|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126294|NCT00005937|Cyclosporine|cyclosporine|mesh-list
139126295|NCT00005937|Cyclosporins|cyclosporins|mesh-list
139126296|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139126297|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126298|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126299|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139126300|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
139126301|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126302|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
139126303|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126304|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
139126305|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139126306|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139126307|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
139126309|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
139126310|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
139126311|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139126312|NCT01096329|Androgens|androgens|mesh-ancestor
139126313|NCT01096329|Hormones|hormones|mesh-ancestor
139126314|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139126315|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126316|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139126317|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126318|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
139126319|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
139126320|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139126321|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139126322|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126323|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
139126324|NCT02908516|Coagulants|coagulants|mesh-ancestor
139126325|NCT03717350|Meropenem|meropenem|mesh-list
139126326|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139126327|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126328|NCT03713372|Antibodies|antibodies|mesh-list
139126329|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139126330|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
139126331|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126332|NCT03656614|Neostigmine|neostigmine|mesh-list
139126333|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139126334|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126335|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126336|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
139126337|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126338|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126339|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139126340|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
139126341|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126342|NCT02906644|Nicotine|nicotine|mesh-list
139126343|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139126344|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
139126345|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126346|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126347|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139126348|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139126349|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
138871557|NCT05804123|Nasal Decongestants|nasal decongestants|mesh-ancestor
139126350|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126351|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126352|NCT02982772|Nicotine|nicotine|mesh-list
139126353|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139126354|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
139126355|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126356|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126357|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139126358|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139126359|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
139126360|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126361|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126362|NCT03713216|Morphine|morphine|mesh-list
139126363|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139126364|NCT03713216|Narcotics|narcotics|mesh-ancestor
139126365|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139126366|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126367|NCT03713216|Analgesics|analgesics|mesh-ancestor
139126368|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
139126369|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126370|NCT03655834|Pemetrexed|pemetrexed|mesh-list
139126371|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126372|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876906|NCT02633514|Etoposide|etoposide|mesh-list
139126373|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126374|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139126375|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139126376|NCT03488108|Minoxidil|minoxidil|mesh-list
139126377|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139126378|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
139126379|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
139126380|NCT03712670|Aflibercept|aflibercept|mesh-list
139126381|NCT03712670|Carotenoids|carotenoids|mesh-list
139126382|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139126383|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139126384|NCT03712670|Growth Substances|growth substances|mesh-ancestor
139126385|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126386|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
139126387|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126389|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126390|NCT03712670|Protective Agents|protective agents|mesh-ancestor
139126391|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139126392|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139126393|NCT03712670|Analgesics|analgesics|mesh-ancestor
139126394|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
139126395|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126396|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139126397|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139126398|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
139126399|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
139126400|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139126401|NCT03486392|Liraglutide|liraglutide|mesh-list
139126402|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139126403|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126404|NCT03486392|Incretins|incretins|mesh-ancestor
139126405|NCT03486392|Hormones|hormones|mesh-ancestor
139126406|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139126407|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
139126408|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
139126409|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
139126410|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126411|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139126412|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139126413|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138959103|NCT00921830|Ibuprofen|ibuprofen|mesh-list
139126414|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
139126415|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126416|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126417|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139126418|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139126419|NCT02981524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139126420|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
139126421|NCT04297150|Apixaban|apixaban|mesh-list
139126422|NCT04297150|Edoxaban|edoxaban|mesh-list
139126423|NCT04297150|Dabigatran|dabigatran|mesh-list
139126424|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139126425|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
139126426|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139126427|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
139126428|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126429|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126430|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
139126431|NCT03486314|Rifampin|rifampin|mesh-list
139126432|NCT03486314|Paclitaxel|paclitaxel|mesh-list
139126433|NCT03486314|Docetaxel|docetaxel|mesh-list
139126434|NCT03486314|Carboplatin|carboplatin|mesh-list
139126435|NCT03486314|Pevonedistat|pevonedistat|mesh-list
139126436|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139126437|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126438|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
139126439|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
139126440|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
139126441|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126442|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139126443|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
139126444|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139126445|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126446|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
139126447|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139126448|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126449|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139126450|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139126451|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139126452|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139126453|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139126454|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139126455|NCT02975206|Serlopitant|serlopitant|mesh-list
139126456|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139126457|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126458|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126459|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126460|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139126461|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139126462|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
139126463|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139126464|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139126465|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139126466|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139126467|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126469|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
139126470|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139126471|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126472|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
139126473|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126474|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139126475|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
139126476|NCT01066000|Hematinics|hematinics|mesh-ancestor
139126477|NCT01065844|Nelfinavir|nelfinavir|mesh-list
139126478|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139126479|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139126480|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
139126481|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126482|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126483|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139126484|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139126485|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
139126486|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126487|NCT00004635|Thalidomide|thalidomide|mesh-list
139126488|NCT00004635|Leuprolide|leuprolide|mesh-list
139126489|NCT00004635|Goserelin|goserelin|mesh-list
139126490|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139126491|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
139126492|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126493|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
139126494|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139126495|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126496|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139126497|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138871658|NCT05443932|Dapagliflozin|dapagliflozin|mesh-list
139126498|NCT00004635|Growth Substances|growth substances|mesh-ancestor
139126499|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
139126500|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126501|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139126502|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
139126503|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139126504|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139126505|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
139126506|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139126507|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
139126508|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126509|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139126510|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139126511|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
139126512|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126513|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126514|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139126515|NCT03951051|Olmesartan|olmesartan|mesh-list
139126516|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139126517|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139126518|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139126519|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139126520|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126521|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
139126522|NCT01103115|Vitamin D|vitamin d|mesh-list
139126523|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
139126524|NCT01103115|Calcium|calcium|mesh-list
139126525|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139126526|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126527|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139126529|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
139126530|NCT01103115|Antacids|antacids|mesh-ancestor
139126531|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126532|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139126533|NCT01103193|Remifentanil|remifentanil|mesh-list
139126534|NCT01103193|Sevoflurane|sevoflurane|mesh-list
139126535|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139126536|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139126537|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
139126538|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
139126539|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139126540|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126541|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139126542|NCT01103193|Narcotics|narcotics|mesh-ancestor
139126543|NCT01103193|Analgesics|analgesics|mesh-ancestor
139126544|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
139126545|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126546|NCT03949101|Atropine|atropine|mesh-list
139126547|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139126548|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139126549|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139126550|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139126551|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139126552|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
139126553|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126554|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126555|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139126556|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
139126557|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
139126558|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
139126559|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139126560|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139126561|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
139126562|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126563|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126564|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
139126565|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139126566|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
139126567|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139126568|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126569|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139126570|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139126571|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139126573|NCT00003645|Goserelin|goserelin|mesh-list
139126574|NCT00003645|Flutamide|flutamide|mesh-list
139126575|NCT00003645|Bicalutamide|bicalutamide|mesh-list
139126576|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139126577|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
139126578|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139126579|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126580|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139126581|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126582|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
139126583|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
139126584|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139126585|NCT02918968|Flutamide|flutamide|mesh-list
139126586|NCT02918968|Androgens|androgens|mesh-list
139126587|NCT02918968|Hormones|hormones|mesh-ancestor
139019551|NCT04278404|Analgesics|analgesics|mesh-ancestor
139126588|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139126589|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126590|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
139126591|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
139126592|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139126593|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126594|NCT01065766|Metformin|metformin|mesh-list
139126595|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139126596|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139126597|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126598|NCT01065766|Incretins|incretins|mesh-ancestor
139126599|NCT01065766|Hormones|hormones|mesh-ancestor
139126600|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139126601|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139126602|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
139126603|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126604|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126605|NCT03653260|Lidocaine|lidocaine|mesh-list
139126606|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
139126607|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
139126608|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139126609|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126610|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
139126611|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126612|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139126613|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139126614|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139126615|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139126616|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126617|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139126618|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139126619|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139126620|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126621|NCT04054960|Levodopa|levodopa|mesh-list
139126622|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139126623|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139126624|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
139126625|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126626|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126627|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126628|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
139126629|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139126630|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139126631|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126632|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
139126633|NCT04055194|Coagulants|coagulants|mesh-ancestor
139126634|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
139126635|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126636|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
139126637|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126638|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126639|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139126640|NCT02530047|Interferons|interferons|mesh-list
139126641|NCT02530047|Interferon-beta|interferon-beta|mesh-list
139126642|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126643|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
139126644|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126645|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
139126646|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126647|NCT02529969|Curcumin|curcumin|mesh-list
139126648|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139126649|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139126650|NCT02529969|Analgesics|analgesics|mesh-ancestor
139126651|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
139126652|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126653|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126654|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139126655|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139126656|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126657|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126658|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126659|NCT01584687|Omalizumab|omalizumab|mesh-list
139126660|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139126661|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138496954|NCT00114283|Lapatinib|lapatinib|mesh-list
139126662|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
139126663|NCT01101789|Triclosan|triclosan|mesh-list
139126664|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139126665|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126666|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139126667|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139126668|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
139126669|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126670|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139126671|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
139126672|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126673|NCT01103739|Simvastatin|simvastatin|mesh-list
139126674|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139126675|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139126676|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
139126677|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126678|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139126679|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139126680|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126681|NCT04054024|Erenumab|erenumab|mesh-list
139126682|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139126683|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126684|NCT04054024|Analgesics|analgesics|mesh-ancestor
139126685|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
139126686|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126687|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126688|NCT00002931|Paclitaxel|paclitaxel|mesh-list
139126689|NCT00002931|Etoposide|etoposide|mesh-list
139126690|NCT00002931|Carboplatin|carboplatin|mesh-list
139126691|NCT00002931|Ifosfamide|ifosfamide|mesh-list
139126692|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139126693|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126694|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
139126695|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
139126696|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
139126697|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126698|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139126699|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139126700|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126701|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139126702|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
139126703|NCT02918266|Scopolamine|scopolamine|mesh-list
139126704|NCT02918266|Donepezil|donepezil|mesh-list
139126705|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139126706|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139126707|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126708|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126709|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
139126710|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126711|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126712|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
139126713|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139126714|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
139126715|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
139126716|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126717|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139126718|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
139126719|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139126720|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139126721|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
139126722|NCT00041067|Docetaxel|docetaxel|mesh-list
139126723|NCT00041067|Trastuzumab|trastuzumab|mesh-list
139126724|NCT00041067|Vinorelbine|vinorelbine|mesh-list
139126725|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126726|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
139126727|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
139126728|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
139126729|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126730|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139126731|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139126732|NCT01063036|Tenofovir|tenofovir|mesh-list
139126733|NCT01063036|Entecavir|entecavir|mesh-list
139126734|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
139126735|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126736|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138871718|NCT05366816|Growth Substances|growth substances|mesh-ancestor
139126737|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139126738|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126739|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126741|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139126742|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
139126743|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139126744|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139126745|NCT03652480|Prednisolone|prednisolone|mesh-list
139126746|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
139126747|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139126748|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
139126749|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139126750|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
139126751|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
139126752|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126753|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126754|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139126756|NCT03652480|Hormones|hormones|mesh-ancestor
139126757|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139126758|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139126759|NCT03652480|Protective Agents|protective agents|mesh-ancestor
139126760|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139126761|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126762|NCT03622060|Nicardipine|nicardipine|mesh-list
139126763|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
139126764|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
139126765|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139126766|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139126767|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139126768|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126769|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139126770|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126771|NCT00040365|Amifostine|amifostine|mesh-list
139126772|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139126773|NCT00040365|Protective Agents|protective agents|mesh-ancestor
139126774|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126775|NCT02974114|Acetaminophen|acetaminophen|mesh-list
139126776|NCT02974114|Caffeine|caffeine|mesh-list
139126777|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139126778|NCT02974114|Analgesics|analgesics|mesh-ancestor
139126779|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
139126780|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126781|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126782|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
139126783|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139126784|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139126785|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126786|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126787|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139126788|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139126789|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
139126790|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126791|NCT00001959|Pirfenidone|pirfenidone|mesh-list
139126792|NCT00001959|Analgesics|analgesics|mesh-ancestor
139126793|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
139126794|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126795|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126796|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139126797|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139126798|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139126799|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139126800|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126801|NCT03950505|Pioglitazone|pioglitazone|mesh-list
139126802|NCT03950505|Alogliptin|alogliptin|mesh-list
139126803|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139126804|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126805|NCT03950505|Incretins|incretins|mesh-ancestor
139126806|NCT03950505|Hormones|hormones|mesh-ancestor
139126807|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139126808|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139126809|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
139126810|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126811|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126812|NCT00001941|Daclizumab|daclizumab|mesh-list
139126813|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139126814|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
139126815|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126816|NCT01061866|Thalidomide|thalidomide|mesh-list
139126817|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139126818|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
139126819|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126820|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
138959218|NCT00575588|Metformin|metformin|mesh-list
139126821|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139126822|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126823|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139126824|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138871764|NCT05204667|Methocarbamol|methocarbamol|mesh-list
139126825|NCT01061866|Growth Substances|growth substances|mesh-ancestor
139126826|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
139126827|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126829|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
139126830|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139126831|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126832|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
139126833|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126834|NCT03948477|Pantoprazole|pantoprazole|mesh-list
139126835|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139126836|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139126837|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139126838|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126839|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126840|NCT03953781|Levetiracetam|levetiracetam|mesh-list
139126841|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
139126842|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
139126843|NCT01103817|Vitamin D|vitamin d|mesh-list
139126844|NCT01103817|Vitamins|vitamins|mesh-ancestor
139126845|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
139126846|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126847|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139126848|NCT01102101|Remifentanil|remifentanil|mesh-list
139126849|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139126850|NCT01102101|Narcotics|narcotics|mesh-ancestor
139126851|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139126852|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126853|NCT01102101|Analgesics|analgesics|mesh-ancestor
139126854|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
139126855|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126856|NCT03950271|Capecitabine|capecitabine|mesh-list
139126857|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
139126858|NCT03950271|Trastuzumab|trastuzumab|mesh-list
139126859|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139126860|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
139126861|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126862|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126863|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139126864|NCT01102335|Telbivudine|telbivudine|mesh-list
139126865|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
139126866|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126867|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139126868|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126869|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126870|NCT02973100|Dulaglutide|dulaglutide|mesh-list
139126871|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139126872|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126873|NCT01105611|Ritonavir|ritonavir|mesh-list
139126874|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139126875|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
138959229|NCT01058317|Propranolol|propranolol|mesh-list
139126876|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139126877|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139126878|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
139126879|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126880|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126881|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139126882|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139126883|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
139126884|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139126885|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139126886|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139126888|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139126889|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139126890|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139126891|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
139126892|NCT05415267|Vaccines|vaccines|mesh-list
139126893|NCT05415267|Immunologic Factors|immunologic factors|mesh-ancestor
139126894|NCT05415267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126895|NCT01482286|Metformin|metformin|mesh-list
139126896|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139126897|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126898|NCT03651934|Iron|iron|mesh-list
139126899|NCT03651934|Selenium|selenium|mesh-list
139126900|NCT03651934|Trace Elements|trace elements|mesh-ancestor
139126901|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
139126902|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126903|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
139126904|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126905|NCT03651934|Protective Agents|protective agents|mesh-ancestor
139126906|NCT02972632|Vortioxetine|vortioxetine|mesh-list
139126907|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
139126908|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139126909|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139126910|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139126911|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139126912|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126913|NCT02972632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139126914|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139126915|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139126916|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126917|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126918|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
139126919|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139126920|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139126921|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139126922|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139126923|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
139126924|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
139126925|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
139126926|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139126927|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126928|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
139126929|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139126931|NCT01327521|Gemcitabine|gemcitabine|mesh-list
139126932|NCT01327521|Doxorubicin|doxorubicin|mesh-list
139126933|NCT01327521|Fluorouracil|fluorouracil|mesh-list
139126934|NCT01327521|Epirubicin|epirubicin|mesh-list
139126935|NCT01327521|Mitomycins|mitomycins|mesh-list
139126936|NCT01327521|Mitomycin|mitomycin|mesh-list
139126937|NCT01327521|Maleic acid|maleic acid|mesh-list
139126938|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126939|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139126940|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
139126941|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126942|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139126943|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139126944|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139126945|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139126946|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139126947|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
139126948|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126949|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
139126950|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139126951|NCT01104519|Niacin|niacin|mesh-list
139126952|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
139126953|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139126954|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
139126955|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126956|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139126957|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
139126958|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
139126959|NCT01104519|Vitamins|vitamins|mesh-ancestor
139126960|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
139126961|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126962|NCT03944733|Iron|iron|mesh-list
139126963|NCT03944733|Trace Elements|trace elements|mesh-ancestor
139126965|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126966|NCT01060150|Methylphenidate|methylphenidate|mesh-list
139126967|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139126968|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126969|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139126970|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139126971|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139126972|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126973|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
139126974|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126975|NCT03863223|Docetaxel|docetaxel|mesh-list
139126976|NCT03863223|Trastuzumab|trastuzumab|mesh-list
139126977|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139126978|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
139126979|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
139126980|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
139126981|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126982|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139126983|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
139126984|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
139126985|NCT02970292|Pimavanserin|pimavanserin|mesh-list
139126986|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139126987|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139126988|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138871844|NCT04887194|Nivolumab|nivolumab|mesh-list
139126989|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139126990|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139126991|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139126992|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139126993|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139126994|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139126995|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
139126996|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139126997|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139126998|NCT03944655|Anesthetics|anesthetics|mesh-list
139126999|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139127000|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127001|NCT05276895|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
139127002|NCT05276895|Quercetin|quercetin|mesh-list
139127003|NCT05276895|Antioxidants|antioxidants|mesh-ancestor
139127004|NCT05276895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127005|NCT05276895|Protective Agents|protective agents|mesh-ancestor
139127006|NCT05276895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127007|NCT05276895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139127008|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
139127009|NCT02971228|Glucagon|glucagon|mesh-list
139127010|NCT02971228|Pancrelipase|pancrelipase|mesh-list
139127011|NCT02971228|Pancreatin|pancreatin|mesh-list
139127012|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139127013|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139127014|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127015|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139127016|NCT02971228|Hormones|hormones|mesh-ancestor
139127017|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127018|NCT02971228|Incretins|incretins|mesh-ancestor
139127019|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139127020|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139127021|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
139127022|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139127023|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139127024|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127025|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
139127026|NCT03741075|Coagulants|coagulants|mesh-ancestor
139127027|NCT01328223|Sorafenib|sorafenib|mesh-list
139127028|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127029|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139127030|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127031|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127032|NCT01104987|Alendronate|alendronate|mesh-list
139127033|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139127034|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127035|NCT01106235|Aldesleukin|aldesleukin|mesh-list
139127036|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
139127037|NCT01106235|Interleukin-2|interleukin-2|mesh-list
139127038|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139127039|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
139127040|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127041|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139127042|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139127043|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
139127044|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127045|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127046|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139127047|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139127048|NCT01106235|Analgesics|analgesics|mesh-ancestor
139127049|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
139127050|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127051|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139127052|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139127053|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
139127054|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127055|NCT02969590|Leuprolide|leuprolide|mesh-list
139127056|NCT02969590|Norethindrone|norethindrone|mesh-list
139127057|NCT02969590|Estradiol|estradiol|mesh-list
139127058|NCT02969590|Estrogens|estrogens|mesh-list
139127059|NCT02969590|Progesterone|progesterone|mesh-list
139127060|NCT02969590|Progestins|progestins|mesh-list
139127061|NCT02969590|Hormones|hormones|mesh-ancestor
139127062|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127063|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127064|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139127065|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
138871895|NCT04740008|Nicotine|nicotine|mesh-list
139127066|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139127067|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139127068|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139127069|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
139127070|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139127071|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127072|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139127073|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139127074|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139127076|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
139127077|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
139127078|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139127079|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127080|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
139127081|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127082|NCT04053400|Ketamine|ketamine|mesh-list
139127083|NCT04053400|Analgesics|analgesics|mesh-ancestor
139127084|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
139127085|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127086|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127087|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139127088|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139127089|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
139127090|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
139127091|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139127092|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139127093|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139127094|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139127095|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127096|NCT03345849|Upadacitinib|upadacitinib|mesh-list
139127097|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139127098|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139127099|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127100|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127101|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139127102|NCT01109043|Bisoprolol|bisoprolol|mesh-list
139127103|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139127104|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
139127105|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
139127106|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127107|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127108|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139127109|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139127110|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139127111|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
139127112|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139127113|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127115|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
138959293|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
139127116|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127117|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127118|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
139127119|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139127120|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139127121|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
139127122|NCT01109121|Protective Agents|protective agents|mesh-ancestor
139127123|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127124|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
139127125|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139127126|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139127128|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
139127129|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139127130|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
139127131|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139127132|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
139127133|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
139127134|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127135|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127136|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139127137|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
139127138|NCT01106547|Hormones|hormones|mesh-ancestor
139127139|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127140|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139127141|NCT01106547|Protective Agents|protective agents|mesh-ancestor
139127142|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139127143|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127144|NCT01105299|Anastrozole|anastrozole|mesh-list
139127145|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139127146|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127147|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139127148|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139127149|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127150|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127151|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139127152|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
139127153|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127154|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127155|NCT03947229|Clopidogrel|clopidogrel|mesh-list
139127156|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139127157|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139127158|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139127159|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139127160|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
139127161|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139127162|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127163|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127164|NCT03011307|Oxytocin|oxytocin|mesh-list
139127165|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
139127166|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139127167|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127168|NCT01327755|Selenium|selenium|mesh-list
139127169|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
139127170|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127171|NCT01327755|Protective Agents|protective agents|mesh-ancestor
139127172|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127173|NCT01327755|Trace Elements|trace elements|mesh-ancestor
139127174|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
139127175|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
139127176|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139127177|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
139127178|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138871944|NCT04392479|Growth Substances|growth substances|mesh-ancestor
139127179|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127180|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139127181|NCT01118793|Clopidogrel|clopidogrel|mesh-list
139127182|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139127183|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139127184|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139127185|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139127186|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
139127187|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139127188|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127189|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127190|NCT00127335|Atorvastatin|atorvastatin|mesh-list
139127191|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139127192|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139127193|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
139127194|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127195|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139127196|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139127197|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127198|NCT01109511|Oxycodone|oxycodone|mesh-list
139127199|NCT01109511|Naloxone|naloxone|mesh-list
139127200|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139127201|NCT01109511|Narcotics|narcotics|mesh-ancestor
139127202|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139127203|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127204|NCT01109511|Analgesics|analgesics|mesh-ancestor
139127205|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
139127206|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127207|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139127208|NCT01112085|Ranibizumab|ranibizumab|mesh-list
139127209|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139127210|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139127211|NCT01112085|Growth Substances|growth substances|mesh-ancestor
139127212|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127213|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
139127214|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127215|NCT01328301|Methamphetamine|methamphetamine|mesh-list
139127216|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139127217|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127218|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
139127219|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
139127220|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127221|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
139127222|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139127223|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127224|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
139127225|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139127226|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139127227|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139127228|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139127229|NCT01328457|Paromomycin|paromomycin|mesh-list
139127230|NCT01328457|Neomycin|neomycin|mesh-list
139127231|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139127232|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127233|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139127234|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139127235|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139127236|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127237|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127238|NCT01109823|Levofloxacin|levofloxacin|mesh-list
139127239|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139127240|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127241|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139127242|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139127243|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139127244|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127245|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127246|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127247|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139127248|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139127249|NCT03943407|Imiquimod|imiquimod|mesh-list
139127250|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
139127251|NCT03943407|Doxepin|doxepin|mesh-list
139127252|NCT03943407|Menthol|menthol|mesh-list
139127253|NCT03943407|Histamine|histamine|mesh-list
139127254|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
139127255|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
139127256|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
139127257|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
139127258|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139127259|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127260|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127261|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139127263|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127264|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
139127265|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139127266|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139127267|NCT03943407|Protective Agents|protective agents|mesh-ancestor
139127268|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139127269|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139127270|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139127271|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139127272|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
139127273|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139127274|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
139127275|NCT01209351|Teduglutide|teduglutide|mesh-list
139127276|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139127277|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139127278|NCT01209351|Protective Agents|protective agents|mesh-ancestor
139127279|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127280|NCT02529579|Gemcitabine|gemcitabine|mesh-list
139127281|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139127282|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
139127283|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127284|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127286|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127287|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127288|NCT01110291|Docetaxel|docetaxel|mesh-list
139127289|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127290|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
139127291|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
139127292|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
139127293|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127294|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139127295|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
139127296|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139127297|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139127298|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127299|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127300|NCT01207947|Urological Agents|urological agents|mesh-ancestor
139127301|NCT01107639|Docetaxel|docetaxel|mesh-list
139127302|NCT01107639|Cetuximab|cetuximab|mesh-list
139127303|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127304|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
139127305|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
139127306|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
139127307|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127308|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139127309|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
139127310|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139127311|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139127312|NCT03942861|Prednisolone|prednisolone|mesh-list
139127313|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
139127314|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139127316|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139127317|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
139127318|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
139127319|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127320|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127321|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139127322|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
139127323|NCT03942861|Hormones|hormones|mesh-ancestor
139127324|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127325|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139127326|NCT03942861|Protective Agents|protective agents|mesh-ancestor
139127327|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139127328|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127329|NCT01107951|Dexamethasone|dexamethasone|mesh-list
139127330|NCT01107951|Rituximab|rituximab|mesh-list
139127331|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139127332|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
139127333|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
139127334|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127335|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127336|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139127338|NCT01107951|Hormones|hormones|mesh-ancestor
139127339|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127340|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139127341|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127342|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139127343|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
139127344|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139127345|NCT01108029|Memantine|memantine|mesh-list
139127346|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139127347|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139127348|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
139127349|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139127350|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127351|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127352|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139127353|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139127355|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127356|NCT01110603|Paclitaxel|paclitaxel|mesh-list
139127357|NCT01110603|Carboplatin|carboplatin|mesh-list
139127358|NCT01110603|Doxorubicin|doxorubicin|mesh-list
139127359|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139127360|NCT01110603|Niraparib|niraparib|mesh-list
139127361|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139127362|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959347|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
139127363|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
139127364|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
139127365|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
139127366|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127367|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139127368|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139127369|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139127370|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127371|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139127372|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
139127373|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139127374|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127375|NCT04258683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139127376|NCT04258683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127377|NCT01112787|Tazarotene|tazarotene|mesh-list
139127378|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
139127379|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
139127380|NCT01108107|Capecitabine|capecitabine|mesh-list
139127381|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
139127382|NCT01108107|Panitumumab|panitumumab|mesh-list
139127383|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139127384|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
139127385|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127386|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127387|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139127388|NCT01111227|Propofol|propofol|mesh-list
139127389|NCT01111227|Isoflurane|isoflurane|mesh-list
139127390|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139127391|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139127392|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127393|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139127394|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
139127395|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
139127396|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139127397|NCT01111383|Tobramycin|tobramycin|mesh-list
139127398|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139127399|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127400|NCT01208649|Exenatide|exenatide|mesh-list
139127401|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139127402|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127403|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139127404|NCT01208649|Incretins|incretins|mesh-ancestor
139127405|NCT01208649|Hormones|hormones|mesh-ancestor
139127406|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127407|NCT01211847|Diazoxide|diazoxide|mesh-list
139127408|NCT01211847|Choline|choline|mesh-list
139127409|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
139127410|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139127411|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
139127412|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127413|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139127414|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139127416|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139127417|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
139127418|NCT01210287|Lamivudine|lamivudine|mesh-list
139127419|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139127420|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139127421|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127422|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127423|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
139127424|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127425|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139127426|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139127427|NCT01211925|Aspirin|aspirin|mesh-list
138959364|NCT00940953|Azelastine|azelastine|mesh-list
139127428|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139127429|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139127430|NCT01211925|Analgesics|analgesics|mesh-ancestor
139127431|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
139127432|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127433|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127434|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139127435|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139127436|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139127437|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139127438|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127439|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139127440|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139127441|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127442|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
139127443|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
139127444|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139127445|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139127446|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139127447|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
139127448|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127449|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139127450|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139127451|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127452|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127453|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139127454|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139127456|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139127457|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139127458|NCT01328145|Analgesics|analgesics|mesh-ancestor
139127459|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
139127460|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127461|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127462|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139127463|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139127464|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139127465|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139127466|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127467|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139127468|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139127469|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127470|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
139127471|NCT01210521|Vitamin D|vitamin d|mesh-list
139127472|NCT01210521|Vitamins|vitamins|mesh-ancestor
139127473|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
139127474|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127475|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139127476|NCT01210599|Pamidronate|pamidronate|mesh-list
139127477|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139127478|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127479|NCT03944889|Capsaicin|capsaicin|mesh-list
139127480|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
139127481|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
139127482|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
139127483|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127484|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127485|NCT01210677|Prednisone|prednisone|mesh-list
139127486|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139127487|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
139127488|NCT01210677|Hormones|hormones|mesh-ancestor
139127489|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127490|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127491|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139127492|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127493|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
139127494|NCT01210755|Dabigatran|dabigatran|mesh-list
139127495|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139127496|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
139127497|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139127498|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
139127499|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127500|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127501|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
139127502|NCT01210911|Metformin|metformin|mesh-list
139127503|NCT01210911|Gemcitabine|gemcitabine|mesh-list
139127504|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139127505|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139127506|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
139127507|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127508|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127509|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139127510|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127511|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139127512|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127513|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
139127514|NCT01115049|Hexetidine|hexetidine|mesh-list
139127515|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139127516|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127517|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
139127518|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
139127519|NCT03941535|Vitamin K|vitamin k|mesh-list
139127520|NCT03941535|Vitamins|vitamins|mesh-ancestor
139127521|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
139127522|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127523|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139127524|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139127525|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127526|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
139127527|NCT03941535|Coagulants|coagulants|mesh-ancestor
139127528|NCT01115127|Inositol|inositol|mesh-list
139127529|NCT01115127|Melatonin|melatonin|mesh-list
139127530|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
139127531|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127532|NCT01115127|Protective Agents|protective agents|mesh-ancestor
139127533|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127534|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139127535|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
139127536|NCT01115127|Vitamins|vitamins|mesh-ancestor
139127537|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
139127538|NCT01211223|Amoxicillin|amoxicillin|mesh-list
139127539|NCT01211223|Metronidazole|metronidazole|mesh-list
139127540|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139127541|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127542|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139127543|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139127545|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139127546|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
139127547|NCT01113489|Hormones|hormones|mesh-ancestor
139127548|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127549|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127550|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139127551|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
139127552|NCT01115439|Artesunate|artesunate|mesh-list
139127553|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
139127554|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
139127555|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139127556|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
139127557|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139127558|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139127559|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127560|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127561|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
139127562|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
139127563|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139127564|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
139127565|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139127566|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127567|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127568|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139127569|NCT01212315|Triclosan|triclosan|mesh-list
139127570|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139127571|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127572|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139127573|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139127574|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
139127575|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127576|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139127577|NCT03938259|Fentanyl|fentanyl|mesh-list
139127578|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138878119|NCT02781467|Fludarabine|fludarabine|mesh-list
139127579|NCT03938259|Narcotics|narcotics|mesh-ancestor
139127580|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139127581|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127582|NCT03938259|Analgesics|analgesics|mesh-ancestor
139127583|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
139127584|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127585|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139127586|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139127587|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
139127588|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
139127589|NCT03939663|Misoprostol|misoprostol|mesh-list
139127590|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139127591|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
139127592|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139127593|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127594|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139127595|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139127596|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
139127597|NCT01213407|Temozolomide|temozolomide|mesh-list
139127598|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139127599|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
139127600|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127601|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127604|NCT01211457|Sapacitabine|sapacitabine|mesh-list
139127605|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139127606|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
139127607|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127608|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127609|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127610|NCT01213563|Insulin|insulin|mesh-list
139127611|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139127612|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
139127613|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
139127614|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139127615|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127616|NCT01115985|Atorvastatin|atorvastatin|mesh-list
139127617|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139127618|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139127619|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
139127620|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127621|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139127622|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139127623|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127624|NCT01116063|Iloprost|iloprost|mesh-list
139127625|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139127626|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
139127627|NCT01116219|Bevacizumab|bevacizumab|mesh-list
139127628|NCT01116219|Pemetrexed|pemetrexed|mesh-list
139127629|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139127630|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139127631|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127632|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139127633|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139127634|NCT01116219|Growth Substances|growth substances|mesh-ancestor
139127635|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127636|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
139127637|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127638|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127639|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139127640|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139127641|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139127642|NCT01213719|Betaine|betaine|mesh-list
139127643|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139127644|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
139127645|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139127646|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
139127647|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127648|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139127649|NCT01114191|Ketoconazole|ketoconazole|mesh-list
139127650|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
139127651|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127652|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139127653|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139127654|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127655|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127656|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139127657|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
139127658|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127659|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127660|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139127661|NCT01211691|Antibodies|antibodies|mesh-list
139127662|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139127663|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
139127664|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127665|NCT03937869|Secnidazole|secnidazole|mesh-list
139127666|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139127667|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139127668|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127669|NCT01116531|Pregabalin|pregabalin|mesh-list
139127670|NCT01116531|Tramadol|tramadol|mesh-list
139127671|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139127672|NCT01116531|Analgesics|analgesics|mesh-ancestor
139127673|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
139127674|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127675|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127676|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
139127677|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139127678|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139127679|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127680|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139127681|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139127682|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139127683|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139127684|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139127685|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139127686|NCT01116531|Narcotics|narcotics|mesh-ancestor
139127687|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139127688|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139127689|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959475|NCT00941343|Alfuzosin|alfuzosin|mesh-list
139127690|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
139127691|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
139127692|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
139127693|NCT03939975|Nivolumab|nivolumab|mesh-list
139127694|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139127695|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127696|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138872257|NCT02888067|Bromides|bromides|mesh-list
139127697|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127698|NCT01116609|Epinephrine|epinephrine|mesh-list
139127699|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139127700|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139127701|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
139127702|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139127703|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127704|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127705|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139127706|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139127707|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
139127708|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127709|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139127710|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
139127711|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
139127712|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
139127713|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139127714|NCT01118403|Ampicillin|ampicillin|mesh-list
139127715|NCT01118403|Sulbactam|sulbactam|mesh-list
139127716|NCT01118403|Sultamicillin|sultamicillin|mesh-list
139127717|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139127718|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127719|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139127720|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127721|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127722|NCT01121835|Insulin|insulin|mesh-list
139127723|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139127724|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
139127725|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
139127726|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139127727|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127728|NCT03788967|Ertapenem|ertapenem|mesh-list
139127729|NCT03788967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139127730|NCT03788967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127731|NCT01118559|Darexaban|darexaban|mesh-list
139127732|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139127733|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
139127734|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139127735|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
139127736|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127737|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872307|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
138872308|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138872309|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872310|NCT02399085|Lenalidomide|lenalidomide|mesh-list
138872311|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
138872312|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872313|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138872314|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138872315|NCT02399085|Growth Substances|growth substances|mesh-ancestor
138872316|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
139127739|NCT01216293|Esomeprazole|esomeprazole|mesh-list
139127740|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
139127741|NCT01216293|Lansoprazole|lansoprazole|mesh-list
139127742|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139127743|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139127744|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139127745|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127746|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127747|NCT01216371|Sunitinib|sunitinib|mesh-list
139127748|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127749|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139127750|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139127751|NCT01216371|Growth Substances|growth substances|mesh-ancestor
139127752|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127753|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
139127754|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139127755|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127756|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127757|NCT01118871|Ritonavir|ritonavir|mesh-list
139127758|NCT01118871|Darunavir|darunavir|mesh-list
139127759|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139127760|NCT01118871|Etravirine|etravirine|mesh-list
139127761|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139127762|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139127763|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
139127764|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127765|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127766|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139127767|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139127768|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
139127769|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127770|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139127771|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139127772|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139127773|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139127774|NCT01216449|Citalopram|citalopram|mesh-list
139127775|NCT01216449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139127776|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139127777|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139127778|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127779|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139127780|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
139127781|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127782|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139127783|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
139127784|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139127785|NCT03937401|Oxytocin|oxytocin|mesh-list
139127786|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
139127787|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139127788|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127789|NCT03939273|Metronidazole|metronidazole|mesh-list
139127790|NCT03939273|Vancomycin|vancomycin|mesh-list
139127791|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
139127792|NCT03939273|Fluconazole|fluconazole|mesh-list
139127793|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127794|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139127795|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139127796|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139127797|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139127798|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139127799|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127800|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127801|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127802|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139127803|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139127804|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
139127805|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139127806|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139127807|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
139127808|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127809|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127810|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139127811|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139127812|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
139127813|NCT01213017|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139127814|NCT01213017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139127815|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139127816|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
139127817|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127818|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139127819|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
139127820|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139127821|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139127822|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127823|NCT01216605|Oxytocin|oxytocin|mesh-list
139127824|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
139127825|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139127826|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127827|NCT01213095|Rituximab|rituximab|mesh-list
139127828|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139127829|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127830|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
139127831|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127832|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139127833|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
139127834|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139127835|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
139127836|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127837|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
139127838|NCT03938883|Protective Agents|protective agents|mesh-ancestor
139127839|NCT01216839|Everolimus|everolimus|mesh-list
139127840|NCT01216839|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139127841|NCT01216839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139127842|NCT01216839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127843|NCT01216839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127844|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139127845|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
139127846|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127847|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127848|NCT01119651|Tazarotene|tazarotene|mesh-list
139127849|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
139127850|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
139127851|NCT03971877|Polymyxins|polymyxins|mesh-list
139127852|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139127853|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127854|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
139127855|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139127856|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127857|NCT01119885|Fentanyl|fentanyl|mesh-list
139127858|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139127860|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139127861|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127862|NCT01119885|Analgesics|analgesics|mesh-ancestor
139127863|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
139127864|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139127865|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139127866|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139127867|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
139127868|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
139127869|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
139127870|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127871|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
139127872|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139127873|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139127874|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127875|NCT01219023|Urological Agents|urological agents|mesh-ancestor
139127876|NCT01124487|Insulin|insulin|mesh-list
139127877|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139127878|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127879|NCT01120119|Calcitriol|calcitriol|mesh-list
138878406|NCT00971893|Prednisolone|prednisolone|mesh-list
139127880|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139127881|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127882|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139127883|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139127884|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127885|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139127886|NCT01120119|Vitamins|vitamins|mesh-ancestor
139127887|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
139127888|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139127889|NCT01219101|Citric Acid|citric acid|mesh-list
139127890|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
139127891|NCT01219101|Clomiphene|clomiphene|mesh-list
139127892|NCT01219101|Enclomiphene|enclomiphene|mesh-list
139127893|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
139127894|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
139127895|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139127896|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
139127897|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
139127898|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127899|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139127900|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
139127901|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127902|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127903|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139127904|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
139127905|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139127906|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139127907|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139127908|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138959548|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
139127909|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127910|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139127911|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127912|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127913|NCT01122615|Sirolimus|sirolimus|mesh-list
139127914|NCT01122615|Sunitinib|sunitinib|mesh-list
139127915|NCT01122615|Temsirolimus|temsirolimus|mesh-list
139127916|NCT01122615|MTOR Inhibitors|mtor inhibitors|mesh-list
139127917|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127918|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139127919|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139127920|NCT01122615|Growth Substances|growth substances|mesh-ancestor
139127921|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127922|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
139127923|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139127924|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127925|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127926|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139127927|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
139127928|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139127929|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127930|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139127931|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
139127933|NCT01217697|Prednisolone|prednisolone|mesh-list
139127934|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
139127935|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139127936|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
139127937|NCT01217697|Hormones|hormones|mesh-ancestor
139127938|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139127939|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127940|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139127941|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127942|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139127943|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127944|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127945|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
139127946|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139127947|NCT01214343|Sorafenib|sorafenib|mesh-list
138872383|NCT04210544|Caseins|caseins|mesh-list
139127948|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127949|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139127950|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127951|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127952|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139127953|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
139127954|NCT01124799|Simeprevir|simeprevir|mesh-list
139127955|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139127956|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127957|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139127958|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139127959|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127960|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127961|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139127962|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139127963|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139127964|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
139127965|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
139127966|NCT01124877|Ziprasidone|ziprasidone|mesh-list
139127967|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139127968|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
139127969|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139127970|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127971|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139127972|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139127973|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139127974|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139127975|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139127976|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139127977|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
139127978|NCT01219413|Perindopril|perindopril|mesh-list
139127979|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139127980|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
139127981|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139127982|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139127983|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139127984|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
139127985|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
139127986|NCT03783039|Coagulants|coagulants|mesh-ancestor
139127987|NCT03933501|Amoxicillin|amoxicillin|mesh-list
139127988|NCT03933501|Metronidazole|metronidazole|mesh-list
139127989|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139127990|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139127991|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139127992|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139127993|NCT01122771|Amphotericin B|amphotericin b|mesh-list
139127994|NCT01122771|Paromomycin|paromomycin|mesh-list
139127995|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139127996|NCT01122771|Miltefosine|miltefosine|mesh-list
139127997|NCT01122771|Amebicides|amebicides|mesh-ancestor
139127998|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139127999|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139128000|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128001|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139128002|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
139128003|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128004|NCT01125033|Vitamins|vitamins|mesh-list
139128005|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
139128006|NCT01125033|Vitamin E|vitamin e|mesh-list
139128007|NCT01125033|Tocopherols|tocopherols|mesh-list
139128008|NCT01125033|Tocotrienols|tocotrienols|mesh-list
139128010|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
139128011|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128012|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
139128013|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128014|NCT01125033|Protective Agents|protective agents|mesh-ancestor
139128015|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139128016|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139128017|NCT01120665|Estradiol|estradiol|mesh-list
139128018|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139128019|NCT01120665|Hormones|hormones|mesh-ancestor
139128020|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139128021|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128022|NCT01120665|Estrogens|estrogens|mesh-ancestor
139128023|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139128024|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
139128025|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139128026|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139128027|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
139128028|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128029|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139128030|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128031|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128032|NCT01125423|Milnacipran|milnacipran|mesh-list
138878561|NCT02779283|Hormones|hormones|mesh-ancestor
139128033|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
139128034|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139128035|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139128036|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139128037|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128038|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128039|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128040|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139128041|NCT01125423|Analgesics|analgesics|mesh-ancestor
139128042|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
139128043|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128044|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
139128045|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139128046|NCT01219569|Propofol|propofol|mesh-list
139128047|NCT01219569|Sevoflurane|sevoflurane|mesh-list
139128048|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139128049|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128050|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128051|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139128052|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
139128053|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
139128054|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139128055|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139128056|NCT03933345|Naloxone|naloxone|mesh-list
139128057|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139128058|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128059|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
139128060|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128061|NCT01121055|Lorazepam|lorazepam|mesh-list
139128062|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
139128063|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
139128064|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
139128065|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128066|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128067|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139128068|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139128069|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128070|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139128071|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139128072|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139128073|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
139128074|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
139128075|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128076|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128077|NCT01121133|Rifampin|rifampin|mesh-list
139128078|NCT01121133|Navitoclax|navitoclax|mesh-list
139128079|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139128080|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
139128081|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139128082|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128084|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139128085|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128086|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128087|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139128088|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139128089|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139128090|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139128091|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139128092|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139128093|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128095|NCT01214889|Vaccines|vaccines|mesh-list
139128096|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
139128097|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128098|NCT01123317|Oxytocin|oxytocin|mesh-list
139128099|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
139128100|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139128101|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128102|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
139128103|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139128104|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128105|NCT01123473|Capecitabine|capecitabine|mesh-list
138878645|NCT05236985|Oxytocin|oxytocin|mesh-list
139128106|NCT01123473|Fluorouracil|fluorouracil|mesh-list
139128107|NCT01123473|Epirubicin|epirubicin|mesh-list
139128108|NCT01123473|Lapatinib|lapatinib|mesh-list
139128109|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128110|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139128111|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
139128112|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128113|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139128114|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
139128115|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128116|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139128117|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139128118|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139128119|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128120|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139128121|NCT01123551|Morphine|morphine|mesh-list
139128122|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139128123|NCT01123551|Narcotics|narcotics|mesh-ancestor
139128124|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128125|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128126|NCT01123551|Analgesics|analgesics|mesh-ancestor
139128127|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
139128128|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128129|NCT01125657|Darexaban|darexaban|mesh-list
139128130|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139128131|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
139128132|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139128133|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
139128134|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128135|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128136|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
139128137|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
139128138|NCT03934203|BI 409306|bi 409306|mesh-list
139128139|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139128140|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128141|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139128142|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139128143|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128144|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959623|NCT00678392|Sorafenib|sorafenib|mesh-list
139128145|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128146|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139128147|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
138872425|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139128148|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139128149|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139128150|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128151|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
139128152|NCT03934047|Coagulants|coagulants|mesh-ancestor
139128153|NCT01218711|Losartan|losartan|mesh-list
139128154|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139128155|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138498453|NCT00018850|Haloperidol|haloperidol|mesh-list
139128156|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139128157|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139128158|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139128159|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128160|NCT01218711|Diuretics|diuretics|mesh-ancestor
139128161|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
139128162|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128163|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139128164|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139128165|NCT01125891|Gemcitabine|gemcitabine|mesh-list
139128166|NCT01125891|ON 01910|on 01910|mesh-list
139128167|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139128168|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
139128169|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128170|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128171|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139128172|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128173|NCT01124253|Endostatins|endostatins|mesh-list
139128174|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139128175|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139128176|NCT01124253|Growth Substances|growth substances|mesh-ancestor
139128177|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128178|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
138959636|NCT00804336|Everolimus|everolimus|mesh-list
139128179|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128180|NCT01215669|Vaccines|vaccines|mesh-list
139128181|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
139128182|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128183|NCT01222221|Temozolomide|temozolomide|mesh-list
139128184|NCT01222221|Sargramostim|sargramostim|mesh-list
139128185|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139128186|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
139128187|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128188|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128189|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
139128190|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128191|NCT01220661|Cefotetan|cefotetan|mesh-list
139128192|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139128193|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128194|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
139128195|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139128196|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128197|NCT02903914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139128198|NCT02903914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128199|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
139128200|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139128201|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139128202|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
139128203|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128204|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128205|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139128206|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139128207|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
139128208|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128209|NCT03928353|Ticagrelor|ticagrelor|mesh-list
139128210|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139128211|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139128212|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139128213|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139128214|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
139128215|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128216|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128217|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128218|NCT03931863|Ondansetron|ondansetron|mesh-list
139128219|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
139128220|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
139128221|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128222|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128223|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139128224|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
139128225|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
139128226|NCT03931863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139128227|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139128228|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
139128229|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128230|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128231|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139128232|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139128233|NCT01226355|Sirolimus|sirolimus|mesh-list
139128234|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138959676|NCT00950625|Lidocaine|lidocaine|mesh-list
139128235|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128236|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139128237|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128238|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
139128239|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139128240|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
139128241|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128242|NCT01129089|Micronutrients|micronutrients|mesh-list
139128243|NCT01129089|Trace Elements|trace elements|mesh-list
139128244|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128245|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
139128246|NCT01129323|Fludarabine|fludarabine|mesh-list
139128247|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
139128248|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139128249|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
139128250|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128251|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139128252|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139128253|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
139128254|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128255|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128256|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139128257|NCT01221129|Zinc|zinc|mesh-list
138878781|NCT04227041|Capecitabine|capecitabine|mesh-list
139128258|NCT01221129|Trace Elements|trace elements|mesh-ancestor
139128259|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
139128260|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128261|NCT01222923|Risperidone|risperidone|mesh-list
139128262|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139128263|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
139128264|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128265|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128266|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128267|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139128268|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139128269|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128270|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139128271|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139128272|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
139128273|NCT01223079|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139128274|NCT01223079|Hormones|hormones|mesh-ancestor
139128275|NCT01223079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139128276|NCT01223079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128277|NCT03648970|Pravastatin|pravastatin|mesh-list
139128278|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139128279|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139128280|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
139128281|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128282|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139128283|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139128284|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128285|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
139128286|NCT03927963|Propofol|propofol|mesh-list
139128287|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139128288|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128289|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128290|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139128291|NCT03927963|Analgesics|analgesics|mesh-ancestor
139128292|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
138959688|NCT00942591|Interferons|interferons|mesh-list
139128293|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128294|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139128295|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139128296|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139128297|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
139128298|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128299|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128300|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139128301|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
139128303|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139128304|NCT01127529|Protein C|protein c|mesh-list
139128305|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
139128306|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139128307|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139128308|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128309|NCT01226667|Pregabalin|pregabalin|mesh-list
139128310|NCT01226667|Analgesics|analgesics|mesh-ancestor
139128311|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
139128312|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128313|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128314|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
139128315|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139128316|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139128317|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128318|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139128319|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139128320|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139128321|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128322|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139128323|NCT03927807|Misoprostol|misoprostol|mesh-list
139128324|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139128325|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
139128326|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139128327|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128328|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139128329|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139128330|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
138878857|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
139128331|NCT05284942|Mycophenolic Acid|mycophenolic acid|mesh-list
139128332|NCT05284942|Prednisone|prednisone|mesh-list
139128333|NCT05284942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139128334|NCT05284942|Glucocorticoids|glucocorticoids|mesh-ancestor
139128335|NCT05284942|Hormones|hormones|mesh-ancestor
139128336|NCT05284942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139128337|NCT05284942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128338|NCT05284942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139128339|NCT05284942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128340|NCT05284942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139128341|NCT05284942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139128342|NCT05284942|Antitubercular Agents|antitubercular agents|mesh-ancestor
139128343|NCT05284942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139128344|NCT05284942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128345|NCT05284942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128346|NCT05284942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128347|NCT03648034|Ropivacaine|ropivacaine|mesh-list
139128348|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
139128349|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
139128350|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128351|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128352|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
139128353|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128354|NCT01129479|Galantamine|galantamine|mesh-list
139128355|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139128356|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128357|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128358|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
139128359|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128360|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128361|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139128362|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
139128363|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128364|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
139128365|NCT03647956|Bevacizumab|bevacizumab|mesh-list
139128366|NCT03647956|Atezolizumab|atezolizumab|mesh-list
139128367|NCT03647956|Carboplatin|carboplatin|mesh-list
139128368|NCT03647956|Pemetrexed|pemetrexed|mesh-list
139128369|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139128370|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128371|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139128372|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139128373|NCT03647956|Growth Substances|growth substances|mesh-ancestor
139128374|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890277|NCT00661856|Estrogens|estrogens|mesh-ancestor
139128375|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
139128376|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128377|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128378|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139128379|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139128380|NCT03647956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139128381|NCT01221675|Antibodies|antibodies|mesh-list
139128382|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
139128383|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128384|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
139128385|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139128386|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
139128387|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
139128388|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128389|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128390|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139128391|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139128392|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139128393|NCT02968576|Tenofovir|tenofovir|mesh-list
139128394|NCT02968576|Emtricitabine|emtricitabine|mesh-list
138872538|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
139128395|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139128396|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
139128397|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128398|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139128399|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139128400|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128401|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128402|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139128403|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139128404|NCT01127217|Losartan|losartan|mesh-list
139128405|NCT01127217|Amlodipine|amlodipine|mesh-list
139128406|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139128407|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139128408|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139128409|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128410|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139128411|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128412|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
139128413|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139128414|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139128415|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139128416|NCT01226901|Niraparib|niraparib|mesh-list
139128417|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139128418|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128419|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128420|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128421|NCT03648658|Acetaminophen|acetaminophen|mesh-list
139128422|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139128423|NCT03648658|Analgesics|analgesics|mesh-ancestor
139128424|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
139128425|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128426|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128427|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
139128428|NCT03931239|Vaccines|vaccines|mesh-list
139128429|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
139128430|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128431|NCT03927495|Paclitaxel|paclitaxel|mesh-list
139128432|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139128433|NCT03927495|Cisplatin|cisplatin|mesh-list
139128434|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139128435|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128436|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
139128437|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
139128438|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
139128439|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128440|NCT02966002|Aspirin|aspirin|mesh-list
139128441|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139128442|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139128443|NCT02966002|Analgesics|analgesics|mesh-ancestor
139128444|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
139128445|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128446|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128447|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139128448|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139128449|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139128450|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139128451|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128452|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139128453|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139128454|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128455|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
139128456|NCT01127295|Tamoxifen|tamoxifen|mesh-list
139128457|NCT01127295|Letrozole|letrozole|mesh-list
139128458|NCT01127295|Anastrozole|anastrozole|mesh-list
139128459|NCT01127295|Exemestane|exemestane|mesh-list
139128460|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128461|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139128462|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139128463|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128464|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959732|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
139128465|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139128466|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
139128467|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139128468|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128469|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139128470|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139128471|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139128472|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139128473|NCT01129713|Esomeprazole|esomeprazole|mesh-list
139128474|NCT01129713|Omeprazole|omeprazole|mesh-list
139128475|NCT01129713|Lansoprazole|lansoprazole|mesh-list
139128476|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139128477|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139128478|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139128479|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128480|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128482|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139128483|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139128484|NCT01221831|Estradiol|estradiol|mesh-list
139128485|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139128486|NCT01221831|Estrogens|estrogens|mesh-ancestor
139128487|NCT01221831|Hormones|hormones|mesh-ancestor
139128488|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139128489|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128490|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139128491|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
139128492|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139128493|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139128494|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139128495|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139128496|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139128497|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
139128498|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139128499|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128500|NCT03931317|Timolol|timolol|mesh-list
139128501|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128502|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139128503|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139128504|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
139128505|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128506|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128507|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139128508|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139128509|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
139128510|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139128511|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139128512|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128513|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
139128514|NCT01221909|Coagulants|coagulants|mesh-ancestor
139128515|NCT02900092|Ganaxolone|ganaxolone|mesh-list
139128516|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
139128517|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128518|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128519|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128520|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
139128521|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
139128523|NCT01130025|Warfarin|warfarin|mesh-list
139128524|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
139128525|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138544501|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
139128526|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139128527|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128528|NCT03925155|Iodine|iodine|mesh-list
139128529|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
139128530|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139128531|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128532|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
139128533|NCT03925155|Trace Elements|trace elements|mesh-ancestor
139128534|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
139128535|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128536|NCT01131195|Paclitaxel|paclitaxel|mesh-list
139128537|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
139128538|NCT01131195|Bevacizumab|bevacizumab|mesh-list
139128539|NCT01131195|Capecitabine|capecitabine|mesh-list
139128540|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139128541|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128542|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
139128543|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
139128544|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
139128545|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128546|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139128547|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
139128548|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128549|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139128550|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139128551|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
138879081|NCT00982891|Morphine|morphine|mesh-list
139128552|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139128553|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139128554|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139128555|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139128556|NCT01131195|Growth Substances|growth substances|mesh-ancestor
139128557|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
139128558|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139128559|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
139128560|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
139128561|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
139128562|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128563|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139128564|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128565|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128566|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
139128567|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139128568|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139128569|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128570|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139128571|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139128572|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139128573|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139128575|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128576|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139128577|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139128578|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128579|NCT01228227|Atorvastatin|atorvastatin|mesh-list
139128580|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139128581|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139128582|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139128583|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
139128584|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128585|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139128586|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139128587|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128588|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
139128589|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128590|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139128591|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019552|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
139128592|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128593|NCT03740373|Budesonide|budesonide|mesh-list
139128594|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
139128595|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
139128596|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139128597|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139128598|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
139128599|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128600|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128601|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139128602|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
139128603|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
139128604|NCT03740373|Hormones|hormones|mesh-ancestor
139128605|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139128606|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139128607|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139128608|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139128609|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
139128610|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128611|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128612|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139128613|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139128614|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139128615|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
139128616|NCT01228305|Acetaminophen|acetaminophen|mesh-list
139128617|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139128618|NCT01228305|Analgesics|analgesics|mesh-ancestor
139128619|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
139128620|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128621|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128622|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
139128623|NCT02902120|Grazoprevir|grazoprevir|mesh-list
139128624|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
139128625|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128626|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
139128627|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
139128628|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128629|NCT01131273|Buprenorphine|buprenorphine|mesh-list
139128630|NCT01131273|Methadone|methadone|mesh-list
139128631|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139128632|NCT01131273|Naloxone|naloxone|mesh-list
139128633|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139128634|NCT01131273|Narcotics|narcotics|mesh-ancestor
139128635|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128636|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128637|NCT01131273|Analgesics|analgesics|mesh-ancestor
139128638|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
139128639|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128640|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139128641|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
139128642|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
139128643|NCT03646318|Ketanserin|ketanserin|mesh-list
139128644|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139128645|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139128646|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139128647|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
139128648|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128649|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128650|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128651|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
139128652|NCT01130181|Vitamin D|vitamin d|mesh-list
139128653|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139128654|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128655|NCT01130181|Vitamins|vitamins|mesh-ancestor
139128656|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
139128657|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139128658|NCT03621514|Lidocaine|lidocaine|mesh-list
139128659|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
139128660|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
139128661|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128662|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128663|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
139128664|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128665|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139128666|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139128667|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139128668|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139128669|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128670|NCT01127841|Rituximab|rituximab|mesh-list
139128671|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139128672|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139128673|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128674|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
139128675|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128676|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139128677|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139128678|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
139128679|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128680|NCT01227603|Candesartan|candesartan|mesh-list
139128681|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
139128682|NCT01227603|Nifedipine|nifedipine|mesh-list
139128683|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139128684|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139128685|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138872617|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128686|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128687|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139128688|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139128689|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139128690|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128691|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
139128692|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
139128693|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139128694|NCT01130259|Iniparib|iniparib|mesh-list
139128695|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139128696|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128697|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128698|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128699|NCT01585623|Metoprolol|metoprolol|mesh-list
139128700|NCT01585623|Midazolam|midazolam|mesh-list
139128701|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139128702|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139128703|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128704|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128705|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139128706|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139128707|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139128708|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139128709|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
139128710|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
139128711|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
139128712|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
139128713|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128714|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128715|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139128716|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139128717|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
139128718|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
139128719|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128720|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139128721|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139128722|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139128723|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
139128724|NCT03926559|Morphine|morphine|mesh-list
139128725|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139128726|NCT03926559|Narcotics|narcotics|mesh-ancestor
139128727|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128728|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128729|NCT03926559|Analgesics|analgesics|mesh-ancestor
139128730|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
139128731|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128732|NCT01228617|Nicotine|nicotine|mesh-list
139128733|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139128734|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
139128735|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128736|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128737|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139128738|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139128739|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
139128740|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128741|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128742|NCT01227759|Tyrothricin|tyrothricin|mesh-list
139128743|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139128744|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128745|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139128746|NCT03923829|Zinc|zinc|mesh-list
139128747|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
139128748|NCT03923829|Trace Elements|trace elements|mesh-ancestor
139128749|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
139128750|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128752|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
139128753|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
139128754|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139128755|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
139128756|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128757|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128758|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
139128759|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128760|NCT03923751|Anesthetics|anesthetics|mesh-list
139128761|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128762|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128763|NCT03923361|Propofol|propofol|mesh-list
139128764|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139128765|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128766|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128767|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139128768|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
139128769|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
139128770|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139128771|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
139128772|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128773|NCT03740295|Protective Agents|protective agents|mesh-ancestor
139128774|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128775|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139128776|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139128777|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128778|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138879305|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139128779|NCT02965378|Docetaxel|docetaxel|mesh-list
139128780|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128781|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
139128782|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
139128783|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
139128784|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128785|NCT01224093|Rituximab|rituximab|mesh-list
139128786|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139128787|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128788|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
139128789|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128790|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139128791|NCT03772041|Tolvaptan|tolvaptan|mesh-list
139128792|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139128793|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128794|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
139128795|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128796|NCT03922815|Fentanyl|fentanyl|mesh-list
139128797|NCT03922815|Propofol|propofol|mesh-list
139128798|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139128799|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128800|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128801|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139128802|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
139128803|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
139128804|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139128805|NCT03922815|Narcotics|narcotics|mesh-ancestor
139128806|NCT03922815|Analgesics|analgesics|mesh-ancestor
139128807|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
139128808|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128809|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139128810|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
139128811|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139128812|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139128813|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128814|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
139128815|NCT01227915|Hormones|hormones|mesh-ancestor
139128816|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139128817|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128819|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139128820|NCT01224405|Docetaxel|docetaxel|mesh-list
139128821|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128822|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
139128823|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
139128824|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
139128825|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128826|NCT02899156|Flumazenil|flumazenil|mesh-list
139128827|NCT02899156|Antidotes|antidotes|mesh-ancestor
139128828|NCT02899156|Protective Agents|protective agents|mesh-ancestor
139128829|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128830|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
139128831|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
139128832|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128833|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128834|NCT01131429|Cisplatin|cisplatin|mesh-list
139128835|NCT01131429|Docetaxel|docetaxel|mesh-list
139128836|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139128837|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128838|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
139128839|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
139128840|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
139128841|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128842|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139128843|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128844|NCT03645304|Ropivacaine|ropivacaine|mesh-list
139128845|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
139128846|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
139128847|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128848|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128849|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
139128850|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128851|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
139128852|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
139128853|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
138879384|NCT02776865|Lidocaine|lidocaine|mesh-list
139128854|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128855|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
139128856|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139128857|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139128858|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139128859|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139128860|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128861|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
139128862|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128863|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128864|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139128865|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128867|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
139128868|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
139128869|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128870|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128871|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
139128872|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128873|NCT03854344|Lidocaine|lidocaine|mesh-list
139128874|NCT03854344|Bupivacaine|bupivacaine|mesh-list
139128875|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
139128876|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
139128877|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128878|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128879|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
139128880|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128881|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139128882|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139128883|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139128884|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139128885|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128886|NCT05284318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139128887|NCT05284318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139128888|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
139128889|NCT03609424|Spartalizumab|spartalizumab|mesh-list
139128890|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128891|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139128892|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128893|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128894|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139128895|NCT03609424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139128896|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139128897|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139128898|NCT03644446|Bisoprolol|bisoprolol|mesh-list
139128899|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139128900|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
139128901|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
139128902|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128903|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128904|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139128905|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139128906|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139128907|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
139128908|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128909|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128910|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
139128911|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139128912|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
139128913|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139128914|NCT05283850|Calcium, Dietary|calcium, dietary|mesh-list
139128915|NCT05283850|Calcium|calcium|mesh-list
139128916|NCT05283850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139128917|NCT05283850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128918|NCT05283850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139128919|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
139128920|NCT03925779|Remifentanil|remifentanil|mesh-list
139128921|NCT03925779|Propofol|propofol|mesh-list
139128922|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138872687|NCT00650910|Lapatinib|lapatinib|mesh-list
139128923|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139128924|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128925|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139128926|NCT03925779|Analgesics|analgesics|mesh-ancestor
139128927|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
139128928|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139128929|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139128930|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139128931|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139128932|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
139128933|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139128934|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128935|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139128936|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
139128937|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
139128938|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139128939|NCT03925779|Narcotics|narcotics|mesh-ancestor
139128940|NCT05283694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139128941|NCT05283694|Immunologic Factors|immunologic factors|mesh-ancestor
139128942|NCT05283694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128943|NCT03925701|Metformin|metformin|mesh-list
139128944|NCT03925701|Vildagliptin|vildagliptin|mesh-list
139128945|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139128946|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959858|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
139128947|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139128948|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
139128949|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139128950|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128951|NCT01224717|Teriparatide|teriparatide|mesh-list
139128952|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139128953|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128954|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139128955|NCT03925233|Tamoxifen|tamoxifen|mesh-list
139128956|NCT03925233|Toremifene|toremifene|mesh-list
139128957|NCT03925233|Vinorelbine|vinorelbine|mesh-list
139128958|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
139128959|NCT03925233|Bevacizumab|bevacizumab|mesh-list
139128960|NCT03925233|Carboplatin|carboplatin|mesh-list
139128961|NCT03925233|Gemcitabine|gemcitabine|mesh-list
139128962|NCT03925233|Doxorubicin|doxorubicin|mesh-list
139128963|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139128964|NCT03925233|Capecitabine|capecitabine|mesh-list
139128965|NCT03925233|Fluorouracil|fluorouracil|mesh-list
139128966|NCT03925233|Methotrexate|methotrexate|mesh-list
139128967|NCT03925233|Trastuzumab|trastuzumab|mesh-list
139128968|NCT03925233|Letrozole|letrozole|mesh-list
139128969|NCT03925233|Apatinib|apatinib|mesh-list
139128970|NCT03925233|Epirubicin|epirubicin|mesh-list
139128971|NCT03925233|Fulvestrant|fulvestrant|mesh-list
139128972|NCT03925233|Olaparib|olaparib|mesh-list
139128973|NCT03925233|Anastrozole|anastrozole|mesh-list
139128974|NCT03925233|Exemestane|exemestane|mesh-list
139128975|NCT03925233|Endostatins|endostatins|mesh-list
139128976|NCT03925233|Pirarubicin|pirarubicin|mesh-list
139128977|NCT03925233|Citric Acid|citric acid|mesh-list
139128978|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
139128979|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139128980|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139128981|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
139128982|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
139128983|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
139128984|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139128985|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139128986|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
139128987|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139128988|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872701|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
139128989|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139128990|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
139128991|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139128992|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139128993|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139128994|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139128995|NCT03925233|Growth Substances|growth substances|mesh-ancestor
139128996|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
139128997|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139128998|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
139128999|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139129000|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139129001|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139129002|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129003|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139129004|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
139129005|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139129006|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
139129007|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139129008|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139129009|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
139129010|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139129011|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
139129012|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
139129013|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139129014|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139129015|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139129016|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
139019553|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139129017|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139129018|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139129019|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139129020|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139129021|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139129022|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139129023|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139129024|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139129025|NCT01130805|Capecitabine|capecitabine|mesh-list
139129026|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
139129027|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139129028|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
139129029|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129030|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129031|NCT01345162|Ketorolac|ketorolac|mesh-list
139129032|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139129033|NCT01345162|Tramadol|tramadol|mesh-list
139129034|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139129035|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139129036|NCT01345162|Analgesics|analgesics|mesh-ancestor
139129037|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
139129038|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129039|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129040|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139129041|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139129042|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139129043|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129044|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129045|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139129046|NCT01345162|Narcotics|narcotics|mesh-ancestor
139129047|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139129048|NCT01131039|Bevacizumab|bevacizumab|mesh-list
139129049|NCT01131039|Gemcitabine|gemcitabine|mesh-list
139129050|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139129051|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129052|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139129053|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139129054|NCT01131039|Growth Substances|growth substances|mesh-ancestor
139129055|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129056|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
139129057|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139129058|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
139129059|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129060|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
139129061|NCT01229085|Salicylates|salicylates|mesh-list
139129062|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129063|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
139129064|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
139129065|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
139129066|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139129067|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139129068|NCT01229085|Analgesics|analgesics|mesh-ancestor
139129069|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
139129070|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129071|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129072|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139129073|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139129074|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139129075|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129076|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129077|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139129078|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129079|NCT03643666|Dexamethasone|dexamethasone|mesh-list
138879606|NCT00984217|Panitumumab|panitumumab|mesh-list
139129080|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
139129081|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139129082|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
139129083|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
139129084|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129085|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129086|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139129087|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
139129089|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139129090|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139129091|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129092|NCT03643666|Analgesics|analgesics|mesh-ancestor
139129093|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
139129094|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
139129095|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139129096|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139129097|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
139129098|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139129099|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139129100|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129101|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139129102|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
139129103|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139129104|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
139129105|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139129106|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
139129107|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129108|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
139129109|NCT03643588|Protective Agents|protective agents|mesh-ancestor
139129110|NCT01224951|Beclomethasone|beclomethasone|mesh-list
139129111|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139129112|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
138890283|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
139129114|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139129115|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129116|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139129117|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
139129118|NCT03641404|Ergothioneine|ergothioneine|mesh-list
139129119|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
139129120|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129121|NCT03641404|Protective Agents|protective agents|mesh-ancestor
139129122|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129123|NCT01131741|Epinephrine|epinephrine|mesh-list
139129124|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139129125|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139129126|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
139129127|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139129128|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129129|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129130|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139129131|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139129132|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
139129133|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129134|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139129135|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
139129136|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
139129137|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
139129138|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139129139|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139129140|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129141|NCT03921567|Lidocaine|lidocaine|mesh-list
139129142|NCT03921567|Ketamine|ketamine|mesh-list
139129143|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
139129144|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
139129145|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139129146|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129147|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
139129148|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129149|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139129150|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139129151|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139129152|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139129153|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129154|NCT03921567|Analgesics|analgesics|mesh-ancestor
139129155|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139129156|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139129157|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
139129158|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139129159|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139129160|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139129161|NCT01229241|Anesthetics|anesthetics|mesh-list
139129162|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
139129163|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139129164|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129165|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
139129166|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129167|NCT05252884|Calcium, Dietary|calcium, dietary|mesh-list
139129168|NCT05252884|Calcitriol|calcitriol|mesh-list
139129169|NCT05252884|Calcium Carbonate|calcium carbonate|mesh-list
139129170|NCT05252884|Calcium|calcium|mesh-list
139129171|NCT05252884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139129172|NCT05252884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129173|NCT05252884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139129174|NCT05252884|Antacids|antacids|mesh-ancestor
139129175|NCT05252884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129176|NCT05252884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139129177|NCT05252884|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139129178|NCT05252884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139129179|NCT05252884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139129180|NCT05252884|Vitamins|vitamins|mesh-ancestor
139129181|NCT05252884|Micronutrients|micronutrients|mesh-ancestor
139129182|NCT03921177|Micronutrients|micronutrients|mesh-list
139129183|NCT03921177|Trace Elements|trace elements|mesh-list
139129184|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129185|NCT01229319|Imiquimod|imiquimod|mesh-list
139129186|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139129187|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
139129188|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129189|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129190|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
139129191|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
139129192|NCT03921099|Vitamins|vitamins|mesh-ancestor
139129193|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
139129194|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129195|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
139129196|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129197|NCT03921099|Protective Agents|protective agents|mesh-ancestor
139129198|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139129199|NCT02962648|Hematinics|hematinics|mesh-ancestor
139129200|NCT03920631|Nivolumab|nivolumab|mesh-list
139129201|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139129202|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129203|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139129204|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129205|NCT03930069|Vasopressins|vasopressins|mesh-list
139129206|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
139129207|NCT03930069|Misoprostol|misoprostol|mesh-list
139129208|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139129209|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
139129210|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139129211|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129212|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139129213|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139129214|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
139129215|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
139129216|NCT03930069|Coagulants|coagulants|mesh-ancestor
139129217|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139129218|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139129219|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
139129220|NCT01132443|Clindamycin|clindamycin|mesh-list
139129221|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
139129222|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
139129223|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139129224|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139129225|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129226|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139129227|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129228|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129229|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
139129230|NCT01132521|Urinastatin|urinastatin|mesh-list
139129231|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
139129232|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139129233|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
139129234|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129235|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129236|NCT01132599|Choline|choline|mesh-list
139129237|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
139129238|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139129239|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
139129240|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129241|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139129242|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139129243|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
139129244|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
139129245|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139129246|NCT03929835|Protective Agents|protective agents|mesh-ancestor
139129247|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129248|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
139129249|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139129250|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139129251|NCT01132677|Prednisolone|prednisolone|mesh-list
139129252|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
139129253|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139129254|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
139129255|NCT01132677|Hylan|hylan|mesh-list
139129256|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139129257|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
139129258|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
138959917|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139129259|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129260|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129261|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139129262|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
139129263|NCT01132677|Hormones|hormones|mesh-ancestor
139129264|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139129265|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139129266|NCT01132677|Protective Agents|protective agents|mesh-ancestor
139129267|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139129268|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129269|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
139129270|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
139129271|NCT02961790|Oxybutynin|oxybutynin|mesh-list
139129272|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
139129273|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
139129274|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129275|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129276|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139129277|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139129278|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
139129279|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139129280|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129281|NCT02961790|Urological Agents|urological agents|mesh-ancestor
139129282|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139129283|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129284|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139129285|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139129286|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139129287|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129288|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129289|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139129290|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139129291|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129292|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
139129293|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139129294|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
139129295|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139129296|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
139129297|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129298|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
139129299|NCT03920553|Protective Agents|protective agents|mesh-ancestor
139129300|NCT03643900|Indomethacin|indomethacin|mesh-list
139129301|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139129302|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139129303|NCT03643900|Analgesics|analgesics|mesh-ancestor
139129304|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
139129305|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129306|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129308|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139129309|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
139129310|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
139129311|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139129312|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139129313|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129314|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129315|NCT03919383|Lenvatinib|lenvatinib|mesh-list
139129316|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129317|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139129318|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129319|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129320|NCT01131897|Levetiracetam|levetiracetam|mesh-list
139129321|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
139129322|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
139129323|NCT01225419|Plerixafor|plerixafor|mesh-list
139129324|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139129325|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139129326|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
139129327|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129328|NCT03919461|Etodolac|etodolac|mesh-list
139129329|NCT03919461|Propranolol|propranolol|mesh-list
139129330|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139129331|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139129332|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
139129333|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139129334|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129335|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129336|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139129337|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139129338|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
139129339|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139129340|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139129341|NCT03919461|Analgesics|analgesics|mesh-ancestor
139129342|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
139129343|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129344|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139129345|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139129346|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138872781|NCT04243733|Pemetrexed|pemetrexed|mesh-list
139129347|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139129348|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129350|NCT02528877|Fludarabine|fludarabine|mesh-list
139129351|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
139129352|NCT02528877|Melphalan|melphalan|mesh-list
139129353|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
139129354|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139129355|NCT02528877|Tacrolimus|tacrolimus|mesh-list
139129356|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129357|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139129358|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
139129359|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129360|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139129361|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
139129362|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129363|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139129364|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129365|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139129366|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129367|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139129368|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
139129369|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139129370|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
139129371|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139129372|NCT03918993|Tadalafil|tadalafil|mesh-list
139129373|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
139129374|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139129375|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139129376|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129377|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129378|NCT03918993|Urological Agents|urological agents|mesh-ancestor
139129379|NCT03920475|Sertraline|sertraline|mesh-list
139129380|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139129381|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
139129382|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139129383|NCT03920475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139129384|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139129385|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139129386|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129387|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139129388|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
139129389|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129390|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139129391|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139129392|NCT03920319|Bupropion|bupropion|mesh-list
139129393|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139129394|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
139129395|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139129396|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139129397|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139129398|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139129399|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129400|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
139129401|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139129402|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129403|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139129404|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139129405|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129406|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
139129407|NCT03920397|Vitamin D|vitamin d|mesh-list
139129408|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138872805|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
139129409|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129411|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
139129412|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139129413|NCT01131975|Lamotrigine|lamotrigine|mesh-list
139129414|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
139129415|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139129416|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139129417|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129418|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139129419|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129420|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139129421|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139129422|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139129423|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139129424|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139129425|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
139129426|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139129427|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129428|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139129429|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139129430|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129431|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129432|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129433|NCT01128699|Bevacizumab|bevacizumab|mesh-list
139129434|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139129435|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129436|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139129437|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139129438|NCT01128699|Growth Substances|growth substances|mesh-ancestor
139129439|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129440|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
139129441|NCT01329627|Paclitaxel|paclitaxel|mesh-list
139129442|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139129443|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
139129444|NCT01329627|Doxorubicin|doxorubicin|mesh-list
139129445|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139129446|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139129447|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129448|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
139129449|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
139129450|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
139129451|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129452|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139129453|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
139129454|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129455|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139129456|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139129457|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
139129458|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139129459|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139129460|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139129461|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139129462|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129464|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
139129465|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139129466|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139129467|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129468|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129469|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129470|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139129471|NCT01132911|Bortezomib|bortezomib|mesh-list
139129472|NCT01132911|Vorinostat|vorinostat|mesh-list
139129473|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129474|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139129475|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129476|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129477|NCT01132989|Lenalidomide|lenalidomide|mesh-list
139129478|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
139129479|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129480|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139129481|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139129482|NCT01132989|Growth Substances|growth substances|mesh-ancestor
139129483|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
139129484|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129485|NCT01225653|Latanoprost|latanoprost|mesh-list
139129486|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139129487|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139129488|NCT01134861|Cisplatin|cisplatin|mesh-list
139129489|NCT01134861|Etoposide|etoposide|mesh-list
139129490|NCT01134861|Vinblastine|vinblastine|mesh-list
139129491|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129492|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139129493|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139129494|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139129495|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129496|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129497|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
139129498|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
139129499|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
139129500|NCT01133223|Plasminogen|plasminogen|mesh-list
139129501|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139129502|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139129503|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139129504|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129505|NCT01233219|Morphine|morphine|mesh-list
139129506|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139129507|NCT01233219|Narcotics|narcotics|mesh-ancestor
139129508|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139129509|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129510|NCT01233219|Analgesics|analgesics|mesh-ancestor
139129511|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
139129512|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129513|NCT02960854|Nivolumab|nivolumab|mesh-list
139129514|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139129515|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129516|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139129517|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129518|NCT01133301|Naltrexone|naltrexone|mesh-list
139129519|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139129520|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139129521|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129522|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
139129523|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129524|NCT03918135|Acetaminophen|acetaminophen|mesh-list
139129525|NCT03918135|Ibuprofen|ibuprofen|mesh-list
139129526|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139129527|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139129528|NCT03918135|Analgesics|analgesics|mesh-ancestor
139129529|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
139129530|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129531|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129532|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139129533|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139129534|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139129535|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129536|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129537|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
139129538|NCT05480475|Dabigatran|dabigatran|mesh-list
139129539|NCT05480475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139129540|NCT05480475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139129541|NCT05480475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139129542|NCT05480475|Antimetabolites|antimetabolites|mesh-ancestor
139129543|NCT05480475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129544|NCT05480475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139129545|NCT05480475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139129546|NCT05480475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129547|NCT05480475|Antithrombins|antithrombins|mesh-ancestor
139129548|NCT05480475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139129549|NCT05480475|Protease Inhibitors|protease inhibitors|mesh-ancestor
139129550|NCT05480475|Anticoagulants|anticoagulants|mesh-ancestor
139129551|NCT03642184|Empagliflozin|empagliflozin|mesh-list
139129552|NCT03642184|Linagliptin|linagliptin|mesh-list
139129553|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139129554|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129555|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139129556|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129557|NCT03642184|Incretins|incretins|mesh-ancestor
139129558|NCT03642184|Hormones|hormones|mesh-ancestor
139129559|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139129560|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139129561|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
139129562|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129563|NCT01137591|Acetaminophen|acetaminophen|mesh-list
139129564|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
139129565|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139129566|NCT01137591|Analgesics|analgesics|mesh-ancestor
139129567|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
139129568|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129569|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129571|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
139129572|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129573|NCT01137591|Expectorants|expectorants|mesh-ancestor
139129574|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
139129575|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139129576|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
139129577|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129578|NCT01137591|Protective Agents|protective agents|mesh-ancestor
139129579|NCT01133457|Finasteride|finasteride|mesh-list
139129580|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139129581|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139129582|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129583|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129584|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
139129585|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139129586|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129587|NCT01133457|Urological Agents|urological agents|mesh-ancestor
139129588|NCT01135563|Sirolimus|sirolimus|mesh-list
139129589|NCT01135563|Vinblastine|vinblastine|mesh-list
139129590|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139129591|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129592|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139129593|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129594|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
139129595|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139129596|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
139129597|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129598|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129599|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139129600|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
139129601|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
139129602|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
139129603|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
139129604|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139129605|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139129606|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139129607|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139129608|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129609|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
139129610|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139129611|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129612|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139129613|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129614|NCT03764631|Empagliflozin|empagliflozin|mesh-list
139129615|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139129616|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139129617|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129618|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138960052|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139129619|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129620|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
139129621|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129622|NCT01135641|Cyclosporine|cyclosporine|mesh-list
139129624|NCT01135641|Cyclosporins|cyclosporins|mesh-list
139129625|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138872875|NCT04187456|Midazolam|midazolam|mesh-list
139129626|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129627|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
139129628|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129629|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139129630|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129631|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129632|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139129633|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
139129634|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129635|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
139129636|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139129637|NCT03640156|Oxytocin|oxytocin|mesh-list
139129638|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
139129639|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139129640|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129641|NCT01230723|Everolimus|everolimus|mesh-list
139129642|NCT01230723|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139129643|NCT01230723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139129644|NCT01230723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129645|NCT01230723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129646|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139129647|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
139129648|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129649|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129650|NCT01135953|Cycloserine|cycloserine|mesh-list
139129651|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139129652|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129653|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139129654|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
139129655|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139129656|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
139129657|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129658|NCT01136031|Paclitaxel|paclitaxel|mesh-list
139129659|NCT01136031|Irinotecan|irinotecan|mesh-list
139129660|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139129661|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129662|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
139129663|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
139129664|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
139129665|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129666|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139129667|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139129668|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129669|NCT01137903|Amoxicillin|amoxicillin|mesh-list
139129670|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
139129671|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
139129672|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
139129673|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139129674|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139129675|NCT01137903|Trimethoprim|trimethoprim|mesh-list
139129676|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
139129677|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139129678|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129679|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139129680|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139129681|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129682|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129683|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129684|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139129685|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139129686|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139129687|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
139129688|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139129689|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139129690|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139129691|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139129692|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139129693|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139129695|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
139129696|NCT03739671|Cholecalciferol|cholecalciferol|mesh-list
139129697|NCT03739671|Vitamins|vitamins|mesh-list
139129698|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
139129699|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129700|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139129701|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139129702|NCT01233453|Umirolimus|umirolimus|mesh-list
139129703|NCT01233453|Everolimus|everolimus|mesh-list
139129704|NCT01233453|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139129705|NCT01233453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139129706|NCT01233453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129707|NCT01233453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129708|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139129709|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
139129710|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129711|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129712|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139129713|NCT01133925|Sirolimus|sirolimus|mesh-list
139129714|NCT01133925|Paclitaxel|paclitaxel|mesh-list
139129715|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139129716|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129717|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
139129718|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
139129719|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
139129720|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129721|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139129722|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129723|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139129724|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
139129725|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139129726|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
139129727|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129728|NCT01232439|Aticaprant|aticaprant|mesh-list
139129729|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129730|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
139129731|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129732|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139129733|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
139129734|NCT01138137|Paclitaxel|paclitaxel|mesh-list
139129735|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139129736|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139129737|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129738|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
139129739|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
139129740|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
139129741|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129742|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
139129743|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129744|NCT01138137|Expectorants|expectorants|mesh-ancestor
139129745|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
139129746|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139129747|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
139129748|NCT01138137|Protective Agents|protective agents|mesh-ancestor
139129749|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129751|NCT01231113|Artesunate|artesunate|mesh-list
139129752|NCT01231113|Piperaquine|piperaquine|mesh-list
139129753|NCT01231113|Amodiaquine|amodiaquine|mesh-list
139129754|NCT01231113|Artenimol|artenimol|mesh-list
139129755|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
138880284|NCT02536352|Vitamins|vitamins|mesh-list
139129756|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139129757|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139129758|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129759|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129760|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
139129761|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
139129762|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139129763|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
139129764|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
139129766|NCT01136421|Ipratropium|ipratropium|mesh-list
139129767|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
139129768|NCT01136421|Analgesics|analgesics|mesh-ancestor
139129769|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
139129770|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129771|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129772|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
139129773|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139129774|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139129775|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139129776|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139129777|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129778|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139129779|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
139129780|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139129781|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139129782|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
139129783|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139129784|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
139129785|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139129786|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
139129787|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139129788|NCT01136499|Panobinostat|panobinostat|mesh-list
139129789|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129790|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139129791|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129792|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129793|NCT01231191|Acetaminophen|acetaminophen|mesh-list
139129794|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139129795|NCT01231191|Analgesics|analgesics|mesh-ancestor
139129796|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
139129797|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129798|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129799|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
139129800|NCT01138449|Vitamin A|vitamin a|mesh-list
139129801|NCT01138449|Vitamins|vitamins|mesh-ancestor
139129802|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
139129803|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129804|NCT05402865|Denosumab|denosumab|mesh-list
139129805|NCT05402865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139129806|NCT05402865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129807|NCT01138605|Ritonavir|ritonavir|mesh-list
139129808|NCT01138605|Darunavir|darunavir|mesh-list
139129809|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139129810|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139129811|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
139129812|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129813|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129814|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139129815|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139129816|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
139129817|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129818|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139129819|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139129820|NCT01138683|Diuretics|diuretics|mesh-list
139129821|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
139129822|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129823|NCT04767243|Methamphetamine|methamphetamine|mesh-list
139129824|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139129825|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129826|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
139129827|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
139129828|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129829|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
139129830|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139129831|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129832|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
139129833|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139129834|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139129835|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139129836|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139129837|NCT01138839|Dexamethasone|dexamethasone|mesh-list
139129838|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139129840|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
139129841|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129842|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129843|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139129844|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
139129845|NCT01138839|Hormones|hormones|mesh-ancestor
139129846|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139129847|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139129848|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129849|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139129850|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139129851|NCT01234701|Liver Extracts|liver extracts|mesh-list
139129852|NCT01234701|Hematinics|hematinics|mesh-ancestor
139129854|NCT05280717|Antiviral Agents|antiviral agents|mesh-ancestor
139129855|NCT05280717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129856|NCT05275179|Posaconazole|posaconazole|mesh-list
139129857|NCT05275179|Antifungal Agents|antifungal agents|mesh-ancestor
139129858|NCT05275179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129859|NCT05275179|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139129860|NCT05275179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139129861|NCT05275179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139129862|NCT05275179|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139129863|NCT05275179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139129864|NCT05275179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129865|NCT05275179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129866|NCT05275179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139129867|NCT05275179|Hormone Antagonists|hormone antagonists|mesh-ancestor
139129868|NCT05275179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139129869|NCT05275179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129870|NCT01139151|Cytarabine|cytarabine|mesh-list
139129871|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139129872|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
139129873|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129874|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129875|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
139129876|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129877|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139129878|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
139129879|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129880|NCT01234857|Sirolimus|sirolimus|mesh-list
139129881|NCT01234857|Exemestane|exemestane|mesh-list
139129882|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139129883|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129884|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139129885|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139129886|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129887|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129888|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139129889|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
139129890|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139129891|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129892|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138872976|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139129893|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129894|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139129895|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
139129896|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139129897|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
139129898|NCT01233843|Carboplatin|carboplatin|mesh-list
139129899|NCT01233843|Fluorouracil|fluorouracil|mesh-list
139129900|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129901|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
139129902|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129903|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139129904|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138880426|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139129905|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
139129906|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129908|NCT01234935|Dasatinib|dasatinib|mesh-list
139129909|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139129910|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
139129911|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129912|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129913|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139129914|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129916|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
139129917|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
139129918|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139129919|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139129920|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129921|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
139129922|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139129923|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129924|NCT01235013|Maraviroc|maraviroc|mesh-list
139129925|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139129926|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139129927|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129928|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139129929|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139129930|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
139129931|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139129932|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139129933|NCT01236495|Morphine|morphine|mesh-list
139129934|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139129935|NCT01236495|Narcotics|narcotics|mesh-ancestor
139129936|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139129937|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129938|NCT01236495|Analgesics|analgesics|mesh-ancestor
139129939|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
139129940|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129941|NCT01143129|Dexamethasone|dexamethasone|mesh-list
139129942|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139129943|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
139129944|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
139129945|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129946|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129947|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139129948|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
139129949|NCT01143129|Hormones|hormones|mesh-ancestor
138873007|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
139129950|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139129951|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139129952|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139129953|NCT01139463|Haloperidol|haloperidol|mesh-list
139129955|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
139129956|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
139129957|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
139129958|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129959|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129960|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139129961|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139129962|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139129963|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139129964|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139129965|NCT01139463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139129966|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139129967|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139129968|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129969|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139129970|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
139129971|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139129972|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
139129973|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139129974|NCT03640468|Lidocaine|lidocaine|mesh-list
139129975|NCT03640468|Midazolam|midazolam|mesh-list
139129976|NCT03640468|Ketamine|ketamine|mesh-list
139129977|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
139129978|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
138880504|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
139129979|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139129980|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139129981|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
139129982|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139129983|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138960166|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
139129984|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139129985|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139129986|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139129987|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139129988|NCT03640468|Analgesics|analgesics|mesh-ancestor
139129989|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139129990|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138873025|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
139129991|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
139129992|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139129993|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139129994|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139129995|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139129996|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139129997|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139129998|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139129999|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139130000|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
139130001|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
139130002|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
139130003|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
139130004|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139130005|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130006|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130007|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139130008|NCT03640390|Analgesics|analgesics|mesh-ancestor
139130009|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
139130010|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130011|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139130012|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139130013|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139130014|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
139130015|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130016|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130017|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
139130018|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139130019|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
139130020|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139130021|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139130022|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139130023|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
139130024|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139130025|NCT03618472|Metformin|metformin|mesh-list
139130026|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139130027|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130028|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
139130029|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139130030|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130031|NCT03618316|Cimetidine|cimetidine|mesh-list
139130032|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139130033|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139130034|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139130035|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
139130036|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
139130037|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130038|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130039|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130040|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139130041|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139130042|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130043|NCT03445533|Ipilimumab|ipilimumab|mesh-list
139130044|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139130045|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130046|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139130047|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130048|NCT01336972|Tolvaptan|tolvaptan|mesh-list
139130049|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139130050|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130051|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
139130052|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130053|NCT03618082|Desflurane|desflurane|mesh-list
139130054|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139130055|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
139130056|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
139130057|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130058|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130059|NCT01236651|Drotaverin|drotaverin|mesh-list
139130060|NCT01236651|Meperidine|meperidine|mesh-list
139130061|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139130062|NCT01236651|Narcotics|narcotics|mesh-ancestor
139130063|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130064|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130065|NCT01236651|Analgesics|analgesics|mesh-ancestor
139130066|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
139130067|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130068|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139130069|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
139130070|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
139130071|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
139130072|NCT04484025|Ebselen|ebselen|mesh-list
139130073|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139130074|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139130075|NCT04484025|Analgesics|analgesics|mesh-ancestor
139130076|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
139130077|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130078|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130079|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139130080|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139130081|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139130082|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139130083|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
139130084|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130085|NCT04484025|Protective Agents|protective agents|mesh-ancestor
139130086|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139130087|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130088|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139130089|NCT01064518|Botulinum Toxins|botulinum toxins|mesh-list
139130090|NCT01064518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139130091|NCT01064518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139130092|NCT01064518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139130093|NCT01064518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139130094|NCT01064518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130095|NCT01064518|Cholinergic Agents|cholinergic agents|mesh-ancestor
139130096|NCT01064518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130097|NCT01064518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130098|NCT01064518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139130099|NCT01064518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130100|NCT03616288|Thiamine|thiamine|mesh-list
139130101|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
139130102|NCT03616288|Vitamins|vitamins|mesh-ancestor
139130103|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
139130104|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130105|NCT03616132|Sirolimus|sirolimus|mesh-list
139130106|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139130107|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139130108|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139130109|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130110|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
139130111|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139130112|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
139130113|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130114|NCT02872012|Lidocaine|lidocaine|mesh-list
139130115|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
139130116|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
139130117|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130118|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130119|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
139130120|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130121|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139130122|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139130123|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139130124|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139130125|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130126|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
139130127|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139130128|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130129|NCT03617224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139130130|NCT03617224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130131|NCT03615430|Anesthetics|anesthetics|mesh-list
139130132|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
139130133|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130134|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130135|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
139130136|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130137|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139130138|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139130139|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139130140|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139130141|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139130142|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139130143|NCT04837768|Progesterone|progesterone|mesh-list
139130144|NCT04837768|Progestins|progestins|mesh-ancestor
139130145|NCT04837768|Hormones|hormones|mesh-ancestor
139130146|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139130147|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130148|NCT02869438|Benralizumab|benralizumab|mesh-list
139130149|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139130150|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
139130152|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130153|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960225|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
139130154|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130155|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139130156|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139130157|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
139130158|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139130159|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130160|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130161|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139130162|NCT03613558|Analgesics|analgesics|mesh-ancestor
139130163|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
139130164|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130165|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139130166|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139130167|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139130168|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
139130169|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873128|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139130170|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130171|NCT03613168|Trastuzumab|trastuzumab|mesh-list
139130172|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139130173|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130174|NCT01141881|Bevacizumab|bevacizumab|mesh-list
139130175|NCT01141881|Plasminogen|plasminogen|mesh-list
139130176|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139130177|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139130178|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130179|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139130180|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139130181|NCT01141881|Growth Substances|growth substances|mesh-ancestor
139130182|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130183|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
139130184|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139130185|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139130186|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130187|NCT04707430|Progesterone|progesterone|mesh-list
139130188|NCT04707430|Progestins|progestins|mesh-ancestor
139130189|NCT04707430|Hormones|hormones|mesh-ancestor
139130190|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139130191|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130192|NCT03611920|Tetracycline|tetracycline|mesh-list
139130193|NCT03611920|Dexamethasone|dexamethasone|mesh-list
139130194|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139130195|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
139130196|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
139130197|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130198|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130199|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139130200|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
139130201|NCT03611920|Hormones|hormones|mesh-ancestor
139130202|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139130203|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139130204|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130205|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139130206|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960233|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
139130207|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139130208|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130209|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130210|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139130211|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139130212|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
139130213|NCT02936752|Entinostat|entinostat|mesh-list
139130214|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139130215|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139130216|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130217|NCT02936752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139130218|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130219|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130220|NCT05383534|Propofol|propofol|mesh-list
139130221|NCT05383534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139130222|NCT05383534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130223|NCT05383534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130224|NCT05383534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139130225|NCT05383534|Anesthetics, General|anesthetics, general|mesh-ancestor
139130226|NCT05383534|Anesthetics|anesthetics|mesh-ancestor
139130227|NCT01235325|Vitamin K|vitamin k|mesh-list
139130228|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
139130229|NCT01235325|Vitamins|vitamins|mesh-ancestor
139130230|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
139130231|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130232|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139130233|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139130234|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130235|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
139130236|NCT01235325|Coagulants|coagulants|mesh-ancestor
139130237|NCT01140009|Vaccines|vaccines|mesh-list
139130238|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
139130239|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130240|NCT01235637|Sufentanil|sufentanil|mesh-list
139130241|NCT01235637|Alfentanil|alfentanil|mesh-list
139130242|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139130243|NCT01235637|Narcotics|narcotics|mesh-ancestor
139130244|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130245|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130246|NCT01235637|Analgesics|analgesics|mesh-ancestor
139130247|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
139130248|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130249|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139130250|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139130251|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
139130252|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
139130253|NCT01143831|Vitamins|vitamins|mesh-list
139130254|NCT01143831|Vitamin K|vitamin k|mesh-list
139130255|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
139130256|NCT01143831|Menatetrenone|menatetrenone|mesh-list
139130257|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
139130258|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130259|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139130260|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139130261|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130262|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
139130263|NCT01143831|Coagulants|coagulants|mesh-ancestor
139130264|NCT01143987|Cinacalcet|cinacalcet|mesh-list
139130265|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139130266|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130267|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139130268|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
139130269|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139130270|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
139130271|NCT01144065|Testosterone|testosterone|mesh-list
139130272|NCT01144065|Androgens|androgens|mesh-ancestor
139130273|NCT01144065|Hormones|hormones|mesh-ancestor
139130274|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139130275|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130276|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139130277|NCT01142505|Mannitol|mannitol|mesh-list
139130278|NCT01142505|Montelukast|montelukast|mesh-list
138873200|NCT04876937|Analgesics|analgesics|mesh-ancestor
139130279|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139130280|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
139130281|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139130282|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
139130283|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139130284|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130285|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139130286|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139130287|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130288|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139130289|NCT01142505|Diuretics|diuretics|mesh-ancestor
139130290|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
139130291|NCT01236963|Listerine|listerine|mesh-list
139130292|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139130293|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139130294|NCT02572167|Nivolumab|nivolumab|mesh-list
139130295|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139130296|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139130297|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130298|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139130299|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130300|NCT02572167|Immunotoxins|immunotoxins|mesh-ancestor
139130301|NCT02572167|Immunoconjugates|immunoconjugates|mesh-ancestor
139130302|NCT02572167|Immunologic Factors|immunologic factors|mesh-ancestor
139130303|NCT02572167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130304|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
139130305|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139130306|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
139130307|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139130308|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130309|NCT01336738|Incretins|incretins|mesh-ancestor
139130310|NCT01336738|Hormones|hormones|mesh-ancestor
139130311|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139130312|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139130313|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
139130314|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130315|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130316|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
139130317|NCT01336738|Vitamins|vitamins|mesh-ancestor
139130318|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
139130319|NCT01140399|Dopamine|dopamine|mesh-list
139130320|NCT01140399|Furosemide|furosemide|mesh-list
139130321|NCT01140399|Diuretics|diuretics|mesh-ancestor
139130322|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
139130323|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130324|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139130325|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139130326|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130327|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139130328|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
139130329|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
139130330|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130331|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
139130332|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130333|NCT01140399|Protective Agents|protective agents|mesh-ancestor
139130334|NCT02410317|Morphine|morphine|mesh-list
139130335|NCT02410317|Ropivacaine|ropivacaine|mesh-list
139130336|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139130337|NCT02410317|Narcotics|narcotics|mesh-ancestor
139130338|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130339|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130340|NCT02410317|Analgesics|analgesics|mesh-ancestor
139130341|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
139130342|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130343|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
139130344|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
139130345|NCT01237119|Liraglutide|liraglutide|mesh-list
139130346|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139130347|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130348|NCT01237119|Incretins|incretins|mesh-ancestor
139130349|NCT01237119|Hormones|hormones|mesh-ancestor
139130350|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139130351|NCT03760263|Tacrolimus|tacrolimus|mesh-list
139130352|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139130353|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
139130354|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880879|NCT02763059|Hormones|hormones|mesh-ancestor
139130355|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139130356|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130357|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130359|NCT01237275|Fluoxetine|fluoxetine|mesh-list
139130360|NCT01237275|Paroxetine|paroxetine|mesh-list
139130361|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
139130362|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139130363|NCT01237275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139130364|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139130365|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139130366|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130367|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130368|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
139130369|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130370|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139130371|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139130372|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139130373|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130374|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
139130375|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139130376|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139130377|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139130378|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138960294|NCT00654732|Rituximab|rituximab|mesh-list
139130379|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130380|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
139130381|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130382|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130383|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139130384|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130385|NCT02033434|Ketamine|ketamine|mesh-list
139130386|NCT02033434|Analgesics|analgesics|mesh-ancestor
139130387|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
139130388|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130389|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130390|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139130391|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139130392|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
139130393|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
139130394|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130395|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139130396|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139130397|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130398|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130399|NCT02033512|Hormones|hormones|mesh-list
139130400|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139130401|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130402|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
139130403|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130404|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139130405|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130406|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130407|NCT02860546|Nivolumab|nivolumab|mesh-list
139130408|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139130409|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130410|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139130411|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130412|NCT01982955|Carboplatin|carboplatin|mesh-list
139130413|NCT01982955|Pemetrexed|pemetrexed|mesh-list
139130414|NCT01982955|Gefitinib|gefitinib|mesh-list
139130415|NCT01982955|Tepotinib|tepotinib|mesh-list
139130416|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130417|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130418|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130419|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139130420|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139130421|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139130422|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
139130423|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139130424|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
139130425|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130426|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
139130427|NCT01144533|Protective Agents|protective agents|mesh-ancestor
139130428|NCT01238055|Docetaxel|docetaxel|mesh-list
139130429|NCT01238055|Sunitinib|sunitinib|mesh-list
139130430|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130431|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
139130432|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
139130433|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
139130434|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130435|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139130436|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139130437|NCT01238055|Growth Substances|growth substances|mesh-ancestor
139130438|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130439|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
139130440|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139130441|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130442|NCT01144923|Gabapentin|gabapentin|mesh-list
139130443|NCT01144923|Nortriptyline|nortriptyline|mesh-list
139130444|NCT01144923|Analgesics|analgesics|mesh-ancestor
139130445|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
139130446|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130447|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130448|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
139130449|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139130450|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139130451|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130452|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139130453|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139130454|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139130455|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130456|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130457|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
139130458|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139130459|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
139130460|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139130461|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139130462|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139130463|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
139130464|NCT01329783|Maraviroc|maraviroc|mesh-list
139130465|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139130466|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139130467|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130468|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139130469|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139130470|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
139130471|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139130472|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139130473|NCT01238133|Paclitaxel|paclitaxel|mesh-list
139130474|NCT01238133|Carboplatin|carboplatin|mesh-list
139130475|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139130476|NCT01238133|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139130477|NCT01238133|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139130478|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139130479|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130480|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
139130481|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
139130482|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
139130483|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130484|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130485|NCT01145079|Sirolimus|sirolimus|mesh-list
139130486|NCT01145079|Everolimus|everolimus|mesh-list
139130487|NCT01145079|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139130488|NCT01145079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139130489|NCT01145079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130490|NCT01145079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130491|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139130492|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
139130493|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130494|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130495|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139130496|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139130497|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139130498|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
139130499|NCT01146483|Pantoprazole|pantoprazole|mesh-list
139130500|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139130501|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139130502|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139130503|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
139130504|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130505|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139130506|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139130507|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130508|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139130509|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139130510|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139130511|NCT00396279|Vitamin D|vitamin d|mesh-list
139130512|NCT00396279|Denosumab|denosumab|mesh-list
139130513|NCT00396279|Calcium|calcium|mesh-list
139130514|NCT00396279|Vitamins|vitamins|mesh-ancestor
139130515|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
139130516|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130517|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139130518|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139130519|NCT01238367|Factor VIII|factor viii|mesh-list
139130520|NCT01238367|Coagulants|coagulants|mesh-ancestor
139130521|NCT01347866|Irinotecan|irinotecan|mesh-list
139130522|NCT01347866|Gedatolisib|gedatolisib|mesh-list
139130523|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139130524|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139130525|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130526|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130527|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130528|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139130529|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
139130530|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
139130531|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139130532|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130533|NCT03485222|Empagliflozin|empagliflozin|mesh-list
139130534|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139130535|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130536|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139130537|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130538|NCT01347554|Everolimus|everolimus|mesh-list
139130539|NCT01347554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139130540|NCT01347554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139130541|NCT01347554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873320|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
139130542|NCT01347554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130543|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139130544|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
139130545|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130546|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130547|NCT05567354|Oxycodone|oxycodone|mesh-list
139130548|NCT05567354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139130549|NCT05567354|Narcotics|narcotics|mesh-ancestor
139130550|NCT05567354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130551|NCT05567354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130552|NCT05567354|Analgesics|analgesics|mesh-ancestor
139130553|NCT05567354|Sensory System Agents|sensory system agents|mesh-ancestor
139130554|NCT05567354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130555|NCT03482882|Pimavanserin|pimavanserin|mesh-list
139130556|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139130557|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139130558|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139130559|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139130560|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130561|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130562|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139130563|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139130564|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139130565|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
139130566|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130567|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130568|NCT03480932|Interferons|interferons|mesh-list
139130569|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
139130570|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
139130571|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139130572|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
139130573|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130574|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
139130575|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139130576|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
139130577|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130579|NCT03387020|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139130580|NCT03387020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139130581|NCT03387020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130582|NCT03387020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130583|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139130584|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
139130585|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130586|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130587|NCT03386474|Aflibercept|aflibercept|mesh-list
139130588|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139130589|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139130590|NCT03386474|Growth Substances|growth substances|mesh-ancestor
139130591|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130592|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
139130593|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130594|NCT03405818|Tavaborole|tavaborole|mesh-list
139130595|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
139130596|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139130597|NCT03403634|Interferons|interferons|mesh-list
139130598|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
139130599|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
139130600|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
139130601|NCT03403634|Celecoxib|celecoxib|mesh-list
139130602|NCT03403634|Benzenesulfonamide|benzenesulfonamide|mesh-list
139130603|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130604|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
139130605|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139130606|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
139130607|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130608|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139130609|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139130610|NCT03403634|Analgesics|analgesics|mesh-ancestor
139130611|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
139130612|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130613|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139130614|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139130615|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139130616|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139130617|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130618|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130619|NCT03403634|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139130620|NCT02863354|Aflibercept|aflibercept|mesh-list
139130621|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139130622|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139130623|NCT02863354|Growth Substances|growth substances|mesh-ancestor
139130624|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130625|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
139130626|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130627|NCT02859454|Avelumab|avelumab|mesh-list
139130628|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139130629|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130630|NCT02862730|Pancrelipase|pancrelipase|mesh-list
139130631|NCT02862730|Pancreatin|pancreatin|mesh-list
139130632|NCT02862730|Hormones|hormones|mesh-list
139130633|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130634|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139130635|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139130637|NCT03609970|Vitamins|vitamins|mesh-ancestor
139130638|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
139130639|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130640|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139130641|NCT03610282|Propofol|propofol|mesh-list
139130642|NCT03610282|Methylphenidate|methylphenidate|mesh-list
139130643|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139130644|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130645|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130646|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139130647|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
139130648|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
139130649|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139130650|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139130651|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139130652|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139130653|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130654|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
139130655|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130656|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139130657|NCT02862574|Methotrexate|methotrexate|mesh-list
139130658|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139130659|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
139130660|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139130661|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130662|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139130663|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
139130664|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130665|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130666|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
139130667|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130668|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139130669|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139130670|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
139130671|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139130672|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139130673|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139130674|NCT05383300|Oxytocin|oxytocin|mesh-list
139130675|NCT05383300|Oxytocics|oxytocics|mesh-ancestor
139130677|NCT05383300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130678|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139130679|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139130680|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130681|NCT02862106|Vaccines|vaccines|mesh-list
139130682|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
139130683|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130684|NCT03609892|Amoxicillin|amoxicillin|mesh-list
139130685|NCT03609892|Tetracycline|tetracycline|mesh-list
139130686|NCT03609892|Furazolidone|furazolidone|mesh-list
139130687|NCT03609892|Esomeprazole|esomeprazole|mesh-list
139130688|NCT03609892|Bismuth|bismuth|mesh-list
139130689|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139130690|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139130691|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139130692|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139130693|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139130694|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130695|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130696|NCT03609892|Antacids|antacids|mesh-ancestor
139130697|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139130698|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139130699|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139130700|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139130701|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139130702|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139130703|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139130704|NCT03609814|Fludarabine|fludarabine|mesh-list
139130705|NCT03609814|Clofarabine|clofarabine|mesh-list
139130706|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130707|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139130708|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
139130709|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130710|NCT02859142|Nicotine|nicotine|mesh-list
139130711|NCT02859142|Varenicline|varenicline|mesh-list
139130712|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139130713|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
139130714|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130715|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130716|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139130717|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139130718|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
139130719|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130720|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130721|NCT03351608|Atropine|atropine|mesh-list
139130722|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
139130723|NCT03351608|Neostigmine|neostigmine|mesh-list
139130724|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139130725|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139130726|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139130727|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
138881248|NCT03912337|Erenumab|erenumab|mesh-list
139130728|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130729|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130730|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139130731|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
139130732|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
139130733|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
139130734|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139130735|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139130736|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
139130737|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130738|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130739|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139130740|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130741|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139130742|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139130743|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139130744|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
139130745|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130746|NCT03382418|Antacids|antacids|mesh-ancestor
139130747|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130748|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139130749|NCT02236936|Cetuximab|cetuximab|mesh-list
139130750|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130751|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139130752|NCT03638960|Bupivacaine|bupivacaine|mesh-list
139130753|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
139130754|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
139130755|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130756|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130757|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
139130758|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130759|NCT02259790|Amlodipine|amlodipine|mesh-list
139130760|NCT02259790|Telmisartan|telmisartan|mesh-list
139130761|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
139130762|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139130763|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139130764|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139130765|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130766|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139130767|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130768|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
139130769|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139130770|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139130771|NCT02857270|Paclitaxel|paclitaxel|mesh-list
139130772|NCT02857270|Gemcitabine|gemcitabine|mesh-list
139130773|NCT02857270|Cetuximab|cetuximab|mesh-list
139130774|NCT02857270|Midazolam|midazolam|mesh-list
138873456|NCT02642718|Ketorolac|ketorolac|mesh-list
139130775|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139130776|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130778|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
139130779|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
139130780|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130781|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139130782|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
139130783|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139130784|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139130785|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130786|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130787|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139130788|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139130789|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139130790|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139130791|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
139130792|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
139130793|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
139130794|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
139130795|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130796|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139130797|NCT03609190|Ketamine|ketamine|mesh-list
139130798|NCT03609190|Analgesics|analgesics|mesh-ancestor
139130799|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
139130800|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130801|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130802|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139130803|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139130804|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
139130805|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
139130806|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130807|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139130808|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139130809|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544624|NCT00410215|Bisacodyl|bisacodyl|mesh-list
139130810|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130811|NCT02856880|Zinc|zinc|mesh-list
139130812|NCT02856880|Trace Elements|trace elements|mesh-ancestor
139130813|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
139130814|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130815|NCT02856802|Sumatriptan|sumatriptan|mesh-list
139130816|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139130817|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139130818|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139130819|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
139130820|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130821|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130822|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130823|NCT02024230|Warfarin|warfarin|mesh-list
139130824|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
139130825|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
139130826|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139130827|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
139130828|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139130829|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
139130830|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130831|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130832|NCT03380390|Phenylephrine|phenylephrine|mesh-list
139130833|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
138873470|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
139130834|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139130835|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139130836|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
139130837|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130838|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130839|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130840|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
139130841|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
139130842|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130843|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
139130844|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139130845|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
139130846|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139130848|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139130849|NCT03380390|Protective Agents|protective agents|mesh-ancestor
139130850|NCT01935778|Docetaxel|docetaxel|mesh-list
139130851|NCT01935778|Capecitabine|capecitabine|mesh-list
139130852|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
139130853|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130854|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
139130855|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
139130856|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
139130857|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130858|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139130859|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
139130860|NCT02034292|Aspirin|aspirin|mesh-list
139130861|NCT02034292|Clopidogrel|clopidogrel|mesh-list
139130862|NCT02034292|APD791|apd791|mesh-list
139130863|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139130864|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139130865|NCT02034292|Analgesics|analgesics|mesh-ancestor
139130866|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
139130867|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130868|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130869|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139130870|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139130871|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139130872|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139130873|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130874|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139130875|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139130876|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130877|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
139130878|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139130879|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139130880|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139130881|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
139130882|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130883|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139130884|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139130885|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
139130887|NCT04125550|Sevoflurane|sevoflurane|mesh-list
139130888|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139130889|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130890|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130891|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139130893|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
139130894|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139130895|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139130896|NCT02237326|Acetic Acid|acetic acid|mesh-list
139130897|NCT02237326|Retinol acetate|retinol acetate|mesh-list
139130898|NCT02237326|Lugol's solution|lugol's solution|mesh-list
139130899|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139130900|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139130901|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139130902|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
139130903|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130904|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139130905|NCT02237326|Protective Agents|protective agents|mesh-ancestor
139130906|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130907|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
139130908|NCT02237326|Coagulants|coagulants|mesh-ancestor
139130909|NCT02034604|Tamsulosin|tamsulosin|mesh-list
139130910|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139130911|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139130912|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139130913|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
139130914|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130915|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130916|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130917|NCT02034604|Urological Agents|urological agents|mesh-ancestor
139130918|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
139130919|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139130920|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139130921|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
139130922|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130923|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130924|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130925|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
139130926|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
139130927|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130928|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
139130929|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139130930|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
139130931|NCT02035072|Gemcitabine|gemcitabine|mesh-list
139130932|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
139130933|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139130934|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
139130935|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130936|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130937|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
139130938|NCT00358215|Hematinics|hematinics|mesh-ancestor
139130939|NCT03605056|Dexamethasone|dexamethasone|mesh-list
139130940|NCT03605056|Lenalidomide|lenalidomide|mesh-list
139130941|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139130942|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
139130943|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
139130944|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130945|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130946|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139130947|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
139130948|NCT03605056|Hormones|hormones|mesh-ancestor
138873505|NCT02822729|Timolol|timolol|mesh-list
138873516|NCT02642250|Metronidazole|metronidazole|mesh-list
139130949|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139130950|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139130951|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130952|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
139130953|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139130954|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139130955|NCT03605056|Growth Substances|growth substances|mesh-ancestor
139130956|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
139130957|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
139130958|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139130959|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139130960|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139130961|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
139130962|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139130963|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139130964|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139130965|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130966|NCT03604744|Psilocybin|psilocybin|mesh-list
139130967|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
139130968|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130969|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139130970|NCT03604354|Pregabalin|pregabalin|mesh-list
139130971|NCT03604354|Tapentadol|tapentadol|mesh-list
139130972|NCT03604354|Analgesics|analgesics|mesh-ancestor
139130973|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
139130974|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130975|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139130976|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
139130977|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139130978|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139130979|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139130980|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139130981|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139130982|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139130983|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139130984|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139130985|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139130986|NCT03604354|Narcotics|narcotics|mesh-ancestor
139130987|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138960601|NCT00943293|Fludarabine|fludarabine|mesh-list
139130988|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139130989|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
139130990|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139130991|NCT03603418|Dexamethasone|dexamethasone|mesh-list
139130992|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
139130993|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139130994|NCT03603418|BB 1101|bb 1101|mesh-list
139130995|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139130996|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
139130997|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
139130998|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139130999|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131000|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139131001|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
139131002|NCT03603418|Hormones|hormones|mesh-ancestor
139131003|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139131004|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139131005|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131006|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
139131007|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131008|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131009|NCT02034838|Ritonavir|ritonavir|mesh-list
139131010|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139131011|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139131012|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139131013|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
139131014|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131015|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131016|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139131017|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139131018|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
139131019|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131020|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139131021|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139131022|NCT02852434|Lidocaine|lidocaine|mesh-list
139131023|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
139131024|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
139131025|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131026|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131027|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
138960617|NCT00946725|Atenolol|atenolol|mesh-list
139131028|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131029|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139131030|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139131031|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139131032|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139131033|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131034|NCT03606928|Leucovorin|leucovorin|mesh-list
139131035|NCT03606928|Docetaxel|docetaxel|mesh-list
139131036|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
139131037|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131038|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
139131039|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
139131040|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
139131041|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131042|NCT03606928|Antidotes|antidotes|mesh-ancestor
139131043|NCT03606928|Protective Agents|protective agents|mesh-ancestor
139131044|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131045|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
139131046|NCT03606928|Vitamins|vitamins|mesh-ancestor
139131047|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
139131048|NCT03602248|Methamphetamine|methamphetamine|mesh-list
139131049|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139131050|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131051|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
139131052|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
139131053|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131054|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
139131055|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131056|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131057|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
139131058|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139131059|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139131060|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139131061|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139131062|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139131063|NCT03602638|Acarbose|acarbose|mesh-list
139131064|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139131065|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131066|NCT03602638|Incretins|incretins|mesh-ancestor
139131067|NCT03602638|Hormones|hormones|mesh-ancestor
139131068|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139131069|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139131070|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
139131071|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131072|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131073|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139131074|NCT02237560|Camphor|camphor|mesh-list
139131075|NCT02237560|Salicylates|salicylates|mesh-list
139131076|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
139131077|NCT02237560|Menthol|menthol|mesh-list
139131078|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139131079|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131080|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
139131081|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
139131082|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139131083|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139131084|NCT02237560|Analgesics|analgesics|mesh-ancestor
139131085|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
139131086|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131087|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131088|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139131089|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139131090|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139131091|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131092|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131093|NCT03601624|Dexamethasone|dexamethasone|mesh-list
139131094|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
139131095|NCT03601624|Pomalidomide|pomalidomide|mesh-list
139131096|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139131097|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
139131098|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131099|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139131100|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139131101|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
139131102|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131103|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131104|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139131105|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139131106|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
139131107|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
139131108|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131109|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139131110|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
139131111|NCT03601624|Hormones|hormones|mesh-ancestor
139131112|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139131113|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139131114|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139131115|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139131116|NCT03601624|Growth Substances|growth substances|mesh-ancestor
139131117|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
139131118|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
139131119|NCT02238418|Vitamin D|vitamin d|mesh-list
139131120|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139131121|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131122|NCT02238418|Vitamins|vitamins|mesh-ancestor
139131123|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
139131124|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139131125|NCT02850016|Romidepsin|romidepsin|mesh-list
139131126|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139131127|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139131128|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131129|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131130|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131131|NCT02849704|Pancrelipase|pancrelipase|mesh-list
139131132|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139131133|NCT03600766|Mirabegron|mirabegron|mesh-list
139131134|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139131135|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139131136|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139131137|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
139131138|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131139|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131140|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131141|NCT03600766|Urological Agents|urological agents|mesh-ancestor
139131142|NCT03600454|Anesthetics|anesthetics|mesh-list
139131143|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960667|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139131144|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131145|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
139131146|NCT03594604|Norethindrone|norethindrone|mesh-list
139131147|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
139131148|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
139131149|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139131150|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139131151|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131152|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139131153|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139131154|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139131155|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139131156|NCT02238184|Ipratropium|ipratropium|mesh-list
139131157|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139131158|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
139131159|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131160|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131161|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139131162|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
139131163|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139131164|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
139131165|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131166|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131167|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
139131168|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
139131169|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139131170|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131171|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139131172|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139131173|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
139131174|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139131175|NCT03600064|Misoprostol|misoprostol|mesh-list
139131176|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138501508|NCT00031057|Vitamins|vitamins|mesh-ancestor
139131178|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139131179|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131180|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139131181|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139131182|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
139131183|NCT02721082|Nicotine|nicotine|mesh-list
139131184|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139131185|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
139131186|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131187|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131188|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139131189|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139131190|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
139131191|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131192|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131193|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139131194|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139131195|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
139131196|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131197|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131198|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139131199|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
139131200|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139131201|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139131202|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139131203|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
138873623|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139131204|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131205|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131206|NCT03577912|Anesthetics|anesthetics|mesh-list
139131207|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131208|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131209|NCT02238262|Telmisartan|telmisartan|mesh-list
139131210|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139131211|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139131212|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139131213|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131214|NCT03577834|Acetic Acid|acetic acid|mesh-list
139131215|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139131216|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131217|NCT03707678|Albuterol|albuterol|mesh-list
139131218|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139131219|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
139131220|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131221|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131222|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139131223|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
139131224|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
139131225|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139131226|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139131227|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139131228|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139131229|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
139131230|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131231|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131233|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139131234|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131235|NCT04773002|Anesthetics|anesthetics|mesh-list
139131236|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131237|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131238|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139131239|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139131240|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131241|NCT02849080|Incretins|incretins|mesh-ancestor
139131242|NCT02849080|Hormones|hormones|mesh-ancestor
139131243|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139131244|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139131245|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
139131246|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131247|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131248|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
139131249|NCT03346070|Rocuronium|rocuronium|mesh-list
139131250|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
139131251|NCT03346070|Neostigmine|neostigmine|mesh-list
139131252|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139131253|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139131254|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139131255|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131256|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131257|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139131258|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131259|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131260|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
139131261|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131262|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139131263|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
139131264|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139131265|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139131266|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139131267|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139131269|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139131270|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131271|NCT02238340|Ketoprofen|ketoprofen|mesh-list
139131272|NCT02238340|Morphine|morphine|mesh-list
139131273|NCT02238340|Oxycodone|oxycodone|mesh-list
139131274|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139131275|NCT02238340|Narcotics|narcotics|mesh-ancestor
139131276|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131277|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131278|NCT02238340|Analgesics|analgesics|mesh-ancestor
139131279|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
139131280|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131281|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139131282|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139131283|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139131284|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139131285|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138525843|NCT00052611|Celecoxib|celecoxib|mesh-list
139131286|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131287|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131288|NCT03577132|Atezolizumab|atezolizumab|mesh-list
139131289|NCT03577132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139131290|NCT03577132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131291|NCT03577132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139131292|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131293|NCT02250664|Nicotine|nicotine|mesh-list
139131294|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139131295|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
139131296|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131297|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131298|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139131299|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139131300|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
139131301|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131302|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131303|NCT02239276|Stiripentol|stiripentol|mesh-list
139131304|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
139131305|NCT03576820|Lidocaine|lidocaine|mesh-list
139131306|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139131307|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
139131308|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
139131309|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131310|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131311|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
139131312|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131313|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139131314|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139131315|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139131316|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139131317|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131318|NCT03579082|Decitabine|decitabine|mesh-list
139131319|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139131320|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
139131321|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131322|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131323|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131324|NCT03579004|Paclitaxel|paclitaxel|mesh-list
139131325|NCT03579004|Fluorouracil|fluorouracil|mesh-list
139131326|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139131327|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131328|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
139131329|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
139131330|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
139131331|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131332|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
139131333|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139131334|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139131335|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
139131336|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131337|NCT03576508|Lidocaine|lidocaine|mesh-list
139131338|NCT03576508|Epinephrine|epinephrine|mesh-list
139131339|NCT03576508|Capsaicin|capsaicin|mesh-list
139131340|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
139131341|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
139131342|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131343|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131344|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
139131345|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131346|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139131347|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139131348|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138873704|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
139131349|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139131350|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131351|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139131352|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139131353|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
139131354|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131355|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139131356|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139131357|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
139131358|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139131359|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
139131360|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
139131361|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
139131362|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139131363|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
139131364|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
139131365|NCT02646982|Candesartan|candesartan|mesh-list
139131366|NCT02646982|Candesartan cilexetil|candesartan cilexetil|mesh-list
139131367|NCT02646982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139131368|NCT02646982|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139131369|NCT02646982|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139131370|NCT02646982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131371|NCT03576040|Edotreotide|edotreotide|mesh-list
139131372|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139131373|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131374|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
139131375|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139131376|NCT03574246|Benzydamine|benzydamine|mesh-list
139131377|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139131378|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131379|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
139131380|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
139131381|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139131382|NCT02239900|Ipilimumab|ipilimumab|mesh-list
139131383|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139131384|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131385|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139131386|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131387|NCT03573934|Glucagon|glucagon|mesh-list
139131388|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139131389|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139131390|NCT03573934|Hormones|hormones|mesh-ancestor
139131391|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139131392|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131393|NCT03573934|Incretins|incretins|mesh-ancestor
139131394|NCT02229136|Prednisolone|prednisolone|mesh-list
139131395|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
139131396|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139131397|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
139131398|NCT02229136|Hormones|hormones|mesh-ancestor
138890317|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
139131399|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139131400|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131401|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138881927|NCT00677664|Mannitol|mannitol|mesh-list
139131402|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131403|NCT02523898|Metformin|metformin|mesh-list
139131404|NCT02523898|Clomiphene|clomiphene|mesh-list
139131405|NCT02523898|Enclomiphene|enclomiphene|mesh-list
139131406|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
139131407|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139131408|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131409|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139131410|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
139131411|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139131412|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139131413|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
139131414|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139131415|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139131416|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139131417|NCT02845336|Celecoxib|celecoxib|mesh-list
139131418|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
139131419|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139131420|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139131421|NCT02845336|Analgesics|analgesics|mesh-ancestor
139131422|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
139131423|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131424|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131425|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139131426|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139131427|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139131428|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139131429|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131430|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131431|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139131432|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139131433|NCT02244502|Paclitaxel|paclitaxel|mesh-list
139131434|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139131435|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131436|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
139131437|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
139131438|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
139131439|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131440|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
139131441|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139131442|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139131443|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131444|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139131445|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139131446|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
139131447|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131448|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131449|NCT02951156|Rituximab|rituximab|mesh-list
139131450|NCT02951156|Avelumab|avelumab|mesh-list
139131451|NCT02951156|Gemcitabine|gemcitabine|mesh-list
139131452|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
139131453|NCT02951156|Azacitidine|azacitidine|mesh-list
139131454|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139131455|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139131456|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131457|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
139131458|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131459|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139131460|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138873747|NCT00681213|Sirolimus|sirolimus|mesh-list
139131461|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
139131462|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131463|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131464|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139131465|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
139131466|NCT03571594|Octreotide|octreotide|mesh-list
139131467|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139131468|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139131469|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131470|NCT03571438|Sirolimus|sirolimus|mesh-list
139131471|NCT03571438|Sunitinib|sunitinib|mesh-list
139131472|NCT03571438|Temsirolimus|temsirolimus|mesh-list
139131473|NCT03571438|MTOR Inhibitors|mtor inhibitors|mesh-list
139131474|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131475|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139131476|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139131477|NCT03571438|Growth Substances|growth substances|mesh-ancestor
139131478|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131479|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
139131480|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139131481|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131482|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131483|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139131484|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
139131485|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139131486|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131487|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139131488|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
139131489|NCT01874860|Doxycycline|doxycycline|mesh-list
139131490|NCT01874860|Clindamycin|clindamycin|mesh-list
139131491|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
139131492|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
139131493|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
139131494|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
139131495|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139131496|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139131497|NCT01874860|Prednisolone|prednisolone|mesh-list
139131498|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
139131499|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
139131500|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139131501|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
139131502|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139131503|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139131504|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131505|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
139131506|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139131507|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139131508|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
139131509|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
139131510|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131511|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131512|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139131513|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
139131514|NCT01874860|Hormones|hormones|mesh-ancestor
139131515|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139131516|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139131517|NCT01874860|Protective Agents|protective agents|mesh-ancestor
139131518|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139131519|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131520|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139131521|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131522|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131523|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139131524|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
139131525|NCT03570346|Hemay005|hemay005|mesh-list
139131526|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
139131527|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139131528|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139131529|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131530|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131531|NCT03571126|Olanzapine|olanzapine|mesh-list
139131532|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
139131533|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
139131534|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131535|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131536|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139131537|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139131538|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139131539|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131540|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139131541|NCT03571126|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139131542|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139131543|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139131544|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131545|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131546|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
139131547|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
139131548|NCT03570112|Velpatasvir|velpatasvir|mesh-list
139131549|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
139131550|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131551|NCT03572686|Dexamethasone|dexamethasone|mesh-list
139131552|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
139131553|NCT03572686|Ropivacaine|ropivacaine|mesh-list
138624544|NCT05001776|PENTA|penta|mesh-list
139131554|NCT03572686|BB 1101|bb 1101|mesh-list
139131555|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139131556|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
139131557|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
139131558|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131559|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131560|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139131561|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
139131562|NCT03572686|Hormones|hormones|mesh-ancestor
139131563|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139131564|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139131565|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131566|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
139131567|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131568|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131569|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
139131570|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
139131571|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131572|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
139131573|NCT02523820|Fluticasone|fluticasone|mesh-list
139131575|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139131576|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139131577|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
139131578|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131579|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131580|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139131581|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
139131582|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
139131583|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139131584|NCT03369704|Omalizumab|omalizumab|mesh-list
139131585|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139131586|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139131587|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
139131588|NCT03709160|Bumetanide|bumetanide|mesh-list
139131589|NCT03709160|Diuretics|diuretics|mesh-ancestor
139131590|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
139131591|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131592|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139131593|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139131594|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131595|NCT05332496|Bevacizumab|bevacizumab|mesh-list
139131596|NCT05332496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139131597|NCT05332496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139131598|NCT05332496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131599|NCT05332496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139131600|NCT05332496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139131601|NCT05332496|Growth Substances|growth substances|mesh-ancestor
139131602|NCT05332496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131603|NCT05332496|Growth Inhibitors|growth inhibitors|mesh-ancestor
139131604|NCT05332496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131605|NCT03567304|Rilpivirine|rilpivirine|mesh-list
139131606|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139131607|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139131608|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131609|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131610|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
139131611|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131612|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139131613|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139131614|NCT05356858|Zanubrutinib|zanubrutinib|mesh-list
139131615|NCT05356858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131616|NCT05356858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139131617|NCT05356858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131618|NCT05356858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131619|NCT03566914|Tadalafil|tadalafil|mesh-list
139131620|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
139131621|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139131622|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139131623|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131624|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131625|NCT03566914|Urological Agents|urological agents|mesh-ancestor
139131626|NCT03366428|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139131627|NCT03366428|Immunoconjugates|immunoconjugates|mesh-ancestor
139131628|NCT03366428|Immunologic Factors|immunologic factors|mesh-ancestor
139131629|NCT03366428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131630|NCT03709082|Trastuzumab|trastuzumab|mesh-list
139131631|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139131632|NCT03709082|Letrozole|letrozole|mesh-list
139131633|NCT03709082|Palbociclib|palbociclib|mesh-list
139131634|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139131635|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131636|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139131637|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139131638|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131639|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131640|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139131641|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
139131642|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139131643|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131644|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139131645|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
139131646|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
139131647|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
139131648|NCT03709082|Immunotoxins|immunotoxins|mesh-ancestor
139131649|NCT03709082|Immunoconjugates|immunoconjugates|mesh-ancestor
139131650|NCT03709082|Immunologic Factors|immunologic factors|mesh-ancestor
139131651|NCT02839876|Acetaminophen|acetaminophen|mesh-list
139131652|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139131653|NCT02839876|Analgesics|analgesics|mesh-ancestor
139131654|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
139131655|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643030|NCT00269828|Paclitaxel|paclitaxel|mesh-list
139131656|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131657|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
139131658|NCT01312064|Rituximab|rituximab|mesh-list
139131659|NCT01312064|Everolimus|everolimus|mesh-list
139131660|NCT01312064|Tacrolimus|tacrolimus|mesh-list
139131661|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
139131662|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139131663|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131664|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
139131665|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131666|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139131667|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139131668|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139131669|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131670|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131671|NCT01312064|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139131672|NCT01312064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139131673|NCT05682716|Nitroglycerin|nitroglycerin|mesh-list
139131674|NCT05682716|Vasodilator Agents|vasodilator agents|mesh-ancestor
139131675|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
139131676|NCT03566134|DA-8010|da-8010|mesh-list
139131677|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139131678|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139131679|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
139131680|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131681|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131682|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131683|NCT03566134|Urological Agents|urological agents|mesh-ancestor
139131684|NCT03101722|Huperzine A|huperzine a|mesh-list
139131685|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
139131686|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131687|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131688|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
139131689|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131690|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131691|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139131692|NCT03101722|Protective Agents|protective agents|mesh-ancestor
139131693|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
139131694|NCT03088852|Cathartics|cathartics|mesh-ancestor
139131695|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139131696|NCT03568474|Fluorides|fluorides|mesh-list
139131697|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
139131698|NCT03568474|Protective Agents|protective agents|mesh-ancestor
139131699|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131700|NCT03345836|Upadacitinib|upadacitinib|mesh-list
139131701|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139131702|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139131703|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131704|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131705|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139131706|NCT03708926|Abaloparatide|abaloparatide|mesh-list
139131707|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139131708|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131709|NCT03567928|Propofol|propofol|mesh-list
139131710|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139131711|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131712|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131713|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139131714|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
139131715|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
139131716|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139131717|NCT03565354|Hematinics|hematinics|mesh-ancestor
139131718|NCT03363776|Nivolumab|nivolumab|mesh-list
139131719|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139131720|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131721|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139131722|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131723|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
139131724|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139131725|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139131726|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131727|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
139131728|NCT03565276|Coagulants|coagulants|mesh-ancestor
139131729|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
139131730|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139131731|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
139131732|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131733|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131734|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131735|NCT03708848|Metronidazole|metronidazole|mesh-list
139131736|NCT03708848|Clarithromycin|clarithromycin|mesh-list
139131737|NCT03708848|Levofloxacin|levofloxacin|mesh-list
139131738|NCT03708848|Tetracycline|tetracycline|mesh-list
139131739|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
139131740|NCT03708848|Esomeprazole|esomeprazole|mesh-list
139131741|NCT03708848|Bismuth|bismuth|mesh-list
139131742|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131743|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131744|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139131745|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139131746|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139131747|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139131748|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139131749|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139131750|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131751|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139131752|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139131753|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139131754|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139131755|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139131756|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139131757|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131758|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139131759|NCT03708848|Antacids|antacids|mesh-ancestor
139131760|NCT03708848|Diuretics|diuretics|mesh-ancestor
139131761|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
139131762|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131763|NCT03708848|Expectorants|expectorants|mesh-ancestor
139131764|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
139131765|NCT03564652|Azithromycin|azithromycin|mesh-list
139131766|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139131767|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131768|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139131769|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139131770|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139131771|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139131772|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
139131773|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139131774|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139131775|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131776|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
138882303|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139131777|NCT03710330|Coagulants|coagulants|mesh-ancestor
139131779|NCT03710252|Ribavirin|ribavirin|mesh-list
139131780|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139131781|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139131782|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
139131783|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131784|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131785|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139131786|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139131787|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
139131788|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131789|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139131790|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139131792|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
139131793|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131794|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131795|NCT03705884|Prednisolone|prednisolone|mesh-list
139131796|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139131797|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
139131798|NCT03705884|Hormones|hormones|mesh-ancestor
139131799|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139131800|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131801|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139131802|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131803|NCT03359174|Tretinoin|tretinoin|mesh-list
139131804|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131805|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
139131806|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
139131807|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
139131808|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139131809|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139131810|NCT03564106|Prednisolone|prednisolone|mesh-list
139131811|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
139131812|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139131813|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
139131814|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139131815|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
139131816|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
139131817|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131818|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131819|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139131820|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
139131821|NCT03564106|Hormones|hormones|mesh-ancestor
139131822|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139131823|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139131824|NCT03564106|Protective Agents|protective agents|mesh-ancestor
139131825|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139131826|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131827|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
139131828|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131829|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
139131830|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
139131831|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
139131832|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
139131833|NCT00093015|Hematinics|hematinics|mesh-ancestor
139131834|NCT01145703|Vitamin D|vitamin d|mesh-list
139131835|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
139131836|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
139131837|NCT01145703|Vitamins|vitamins|mesh-list
139131838|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
139131839|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131840|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139131841|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139131842|NCT05137587|Ketamine|ketamine|mesh-list
139131843|NCT05137587|Propofol|propofol|mesh-list
139131844|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139131845|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131846|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131847|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139131848|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
139131849|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
139131850|NCT05137587|Analgesics|analgesics|mesh-ancestor
139131851|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
139131852|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131853|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139131854|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139131855|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139131857|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131858|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
139131859|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139131860|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
139131861|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139131862|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
139131863|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131864|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131865|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
139131866|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139131867|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
139131868|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139131869|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139131870|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139131871|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131872|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131873|NCT01238523|Calpastatin|calpastatin|mesh-list
139131874|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139131875|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
139131876|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131877|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131878|NCT03708536|Bevacizumab|bevacizumab|mesh-list
139131879|NCT03708536|Capecitabine|capecitabine|mesh-list
139131880|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139131881|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131882|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139131883|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139131884|NCT03708536|Growth Substances|growth substances|mesh-ancestor
139131885|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131886|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
139131887|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139131888|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
139131889|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131890|NCT03705728|Remifentanil|remifentanil|mesh-list
139131891|NCT03705728|Propofol|propofol|mesh-list
139131892|NCT03705728|Sevoflurane|sevoflurane|mesh-list
139131893|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139131894|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131895|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131896|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139131897|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
139131898|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
139131899|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139131900|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139131901|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139131902|NCT03705728|Narcotics|narcotics|mesh-ancestor
139131903|NCT03705728|Analgesics|analgesics|mesh-ancestor
139131904|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
139131905|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131906|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
139131907|NCT05177666|Trastuzumab|trastuzumab|mesh-list
139131908|NCT05177666|Pertuzumab|pertuzumab|mesh-list
139131909|NCT05177666|Vemurafenib|vemurafenib|mesh-list
139131910|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139131911|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131912|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139131913|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131914|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131915|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
139131916|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139131917|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
139131918|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
139131919|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139131920|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
139131921|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131922|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139131923|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139131924|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
139131925|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131926|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131927|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139131928|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139131929|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
139131930|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
139131931|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131933|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
139131934|NCT03342638|Hormones|hormones|mesh-ancestor
139131935|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139131936|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139131937|NCT03342638|Protective Agents|protective agents|mesh-ancestor
139131938|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139131939|NCT01246323|Fentanyl|fentanyl|mesh-list
139131940|NCT01246323|Morphine|morphine|mesh-list
139131941|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
139131942|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139131943|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131944|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139131945|NCT01246323|Narcotics|narcotics|mesh-ancestor
139131946|NCT01246323|Analgesics|analgesics|mesh-ancestor
138706460|NCT04675086|Remdesivir|remdesivir|mesh-list
139131947|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
139131948|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131949|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139131950|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139131951|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
139131952|NCT05160363|Piperaquine|piperaquine|mesh-list
139131953|NCT05160363|Pyronaridine|pyronaridine|mesh-list
139131954|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
139131955|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139131956|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139131957|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131958|NCT05177276|Irinotecan|irinotecan|mesh-list
139131959|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139131960|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139131961|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131962|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131963|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139131964|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
139131965|NCT03708458|Indomethacin|indomethacin|mesh-list
139131966|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139131967|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
139131968|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139131969|NCT03708458|Expectorants|expectorants|mesh-ancestor
139131970|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
139131971|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139131972|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
139131973|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131974|NCT03708458|Protective Agents|protective agents|mesh-ancestor
139131975|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131977|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139131978|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139131979|NCT03708458|Analgesics|analgesics|mesh-ancestor
139131980|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
139131981|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139131982|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139131983|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139131984|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
139131985|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
139131986|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139131987|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139131988|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139131989|NCT01251471|Escitalopram|escitalopram|mesh-list
139131990|NCT01251471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139131991|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139131992|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139131993|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139131994|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139131995|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
139131996|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139131997|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
139131998|NCT01247805|Citric Acid|citric acid|mesh-list
139131999|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
139132000|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
139132001|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139132002|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
139132003|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
139132004|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132005|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
138706489|NCT02910050|Exemestane|exemestane|mesh-list
139132006|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139132007|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139132009|NCT01247805|Urological Agents|urological agents|mesh-ancestor
139132010|NCT05631717|Aldesleukin|aldesleukin|mesh-list
139132011|NCT05631717|Interleukin-2|interleukin-2|mesh-list
139132012|NCT05631717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132013|NCT05631717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139132014|NCT05631717|Analgesics|analgesics|mesh-ancestor
139132015|NCT05631717|Sensory System Agents|sensory system agents|mesh-ancestor
139132016|NCT05631717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132017|NCT05631717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132018|NCT05631717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139132019|NCT05631717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139132020|NCT05631717|Antiviral Agents|antiviral agents|mesh-ancestor
139132021|NCT05631717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132022|NCT01147731|Warfarin|warfarin|mesh-list
139132023|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
139132024|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
139132025|NCT01147731|Incretins|incretins|mesh-ancestor
139132026|NCT01147731|Hormones|hormones|mesh-ancestor
139132027|NCT01147731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139132028|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132029|NCT03912285|Losartan|losartan|mesh-list
139132030|NCT03912285|Amlodipine|amlodipine|mesh-list
139132031|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139132032|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139132033|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139132034|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132035|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139132036|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132037|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
139132038|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139132039|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139132040|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139132041|NCT01251627|Decitabine|decitabine|mesh-list
139132042|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139132043|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
139132044|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132045|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132046|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132047|NCT01146093|Pravastatin|pravastatin|mesh-list
139132048|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139132049|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139132050|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
139132051|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132052|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139132053|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139132054|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132055|NCT02452983|Sertraline|sertraline|mesh-list
139132056|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
139132057|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139132058|NCT02452983|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139132059|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139132060|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139132061|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132062|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132063|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
139132064|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132065|NCT03911817|Midodrine|midodrine|mesh-list
139132066|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
139132067|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
139132068|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132069|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132070|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139132071|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139132072|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139132073|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139132074|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
139132075|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132076|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132077|NCT01239849|Atorvastatin|atorvastatin|mesh-list
139132078|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139132079|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139132080|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
139132081|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873934|NCT04200599|Oxytocin|oxytocin|mesh-list
139132082|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139132083|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139132084|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132085|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
139132086|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139132087|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
139132088|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
139132089|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139132090|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139132091|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132092|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132093|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132094|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139132095|NCT04865835|Metformin|metformin|mesh-list
139132096|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139132097|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132098|NCT01248195|Olanzapine|olanzapine|mesh-list
139132099|NCT01248195|Clozapine|clozapine|mesh-list
139132100|NCT01248195|Amisulpride|amisulpride|mesh-list
139132101|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
139132102|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
139132103|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132104|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132105|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139132106|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139132107|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139132108|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132109|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139132110|NCT01248195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139132111|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139132112|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139132113|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132114|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132115|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
139132116|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138873963|NCT02819999|Etoposide|etoposide|mesh-list
139132117|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
139132118|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
139132119|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139132120|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
139132121|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139132122|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
139132124|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
139132125|NCT03910647|Pantoprazole|pantoprazole|mesh-list
139132126|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139132127|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139132128|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139132129|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132130|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132131|NCT03709940|Methylphenidate|methylphenidate|mesh-list
139132132|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139132133|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132134|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139132135|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139132136|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139132137|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132138|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
139132139|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132140|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
139132141|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139132142|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132143|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
139132144|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139132145|NCT01147029|Growth Substances|growth substances|mesh-ancestor
139132146|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132147|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
139132148|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132149|NCT01239459|Teriflunomide|teriflunomide|mesh-list
139132150|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
139132151|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139132152|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138882674|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
139132153|NCT01239459|Analgesics|analgesics|mesh-ancestor
139132154|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
139132155|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132156|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132157|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139132158|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139132159|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139132160|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
139132161|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139132162|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139132163|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
139132164|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132165|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139132166|NCT03915561|Parecoxib|parecoxib|mesh-list
139132167|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139132168|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139132169|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132170|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874003|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132171|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139132172|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139132173|NCT03915561|Analgesics|analgesics|mesh-ancestor
139132174|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
139132175|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132176|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132177|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139132178|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139132179|NCT01148277|Midazolam|midazolam|mesh-list
139132180|NCT01148277|Fentanyl|fentanyl|mesh-list
139132181|NCT01148277|Propofol|propofol|mesh-list
139132182|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139132183|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132184|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132185|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139132186|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
139132187|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
139132188|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139132189|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139132190|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139132191|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139132192|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
139132193|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
139132194|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132195|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132196|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139132197|NCT01148277|Narcotics|narcotics|mesh-ancestor
139132198|NCT01148277|Analgesics|analgesics|mesh-ancestor
139132199|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
139132200|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132201|NCT03907371|Donepezil|donepezil|mesh-list
139132202|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139132203|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132204|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132205|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
139132206|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132207|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132208|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
139132209|NCT03908619|Esomeprazole|esomeprazole|mesh-list
139132210|NCT03908619|Omeprazole|omeprazole|mesh-list
139132211|NCT03908619|Rabeprazole|rabeprazole|mesh-list
139132212|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139132213|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139132214|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139132215|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132216|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132217|NCT01358734|Lenalidomide|lenalidomide|mesh-list
139132218|NCT01358734|Azacitidine|azacitidine|mesh-list
139132219|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
139132220|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132221|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139132222|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139132223|NCT01358734|Growth Substances|growth substances|mesh-ancestor
139132224|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
139132225|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132226|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139132227|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
138882750|NCT02748395|Lidocaine|lidocaine|mesh-list
139132228|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132229|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132230|NCT03907215|Citalopram|citalopram|mesh-list
139132231|NCT03907215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139132232|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139132233|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139132234|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132235|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132236|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
139132237|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132238|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139132239|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
139132240|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139132241|NCT05335954|Norepinephrine|norepinephrine|mesh-list
139132242|NCT05335954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139132243|NCT05335954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139132244|NCT05335954|Adrenergic Agents|adrenergic agents|mesh-ancestor
139132245|NCT05335954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132246|NCT05335954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132247|NCT05335954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132248|NCT05335954|Sympathomimetics|sympathomimetics|mesh-ancestor
139132249|NCT05335954|Autonomic Agents|autonomic agents|mesh-ancestor
139132250|NCT05335954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132251|NCT05335954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139132252|NCT01250457|Timolol|timolol|mesh-list
139132253|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139132254|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139132255|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
139132256|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132257|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132258|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132259|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139132260|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139132261|NCT03902925|Lidocaine|lidocaine|mesh-list
139132262|NCT03902925|Ropivacaine|ropivacaine|mesh-list
139132263|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
139132264|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
139132265|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132266|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132267|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
139132268|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132269|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139132270|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139132272|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139132273|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132274|NCT01250535|Warfarin|warfarin|mesh-list
139132275|NCT01250535|Lovastatin|lovastatin|mesh-list
139132276|NCT01250535|L 647318|l 647318|mesh-list
139132277|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
139132278|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
139132279|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139132280|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139132282|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132283|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139132284|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139132285|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132286|NCT02527941|Metronidazole|metronidazole|mesh-list
139132287|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132288|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139132289|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139132290|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139132291|NCT01254825|Ropivacaine|ropivacaine|mesh-list
139132292|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
139132293|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
139132294|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132295|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706565|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
139132296|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
139132297|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132298|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
139132299|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139132300|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139132301|NCT03906123|Protective Agents|protective agents|mesh-ancestor
139132302|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132303|NCT01341652|Molgramostim|molgramostim|mesh-list
138882821|NCT00679146|Analgesics|analgesics|mesh-ancestor
139132304|NCT01341652|Sargramostim|sargramostim|mesh-list
139132305|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
139132306|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132308|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
139132309|NCT03563794|Vildagliptin|vildagliptin|mesh-list
139132310|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139132311|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132312|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139132313|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
139132314|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132315|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132316|NCT03905967|Lenvatinib|lenvatinib|mesh-list
139132317|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132318|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139132319|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132320|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132321|NCT03563950|Rifampin|rifampin|mesh-list
139132322|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139132323|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
139132324|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139132325|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132326|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
139132327|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139132328|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132329|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132330|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139132331|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139132332|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139132333|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139132334|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139132335|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139132336|NCT03914235|Lidocaine|lidocaine|mesh-list
139132337|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
139132338|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
139132339|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132340|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132341|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
138502684|NCT00014352|Ketoconazole|ketoconazole|mesh-list
139132342|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132343|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139132344|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139132345|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139132346|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139132347|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132348|NCT01148667|Caseins|caseins|mesh-list
139132349|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
139132350|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
139132351|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132352|NCT01254123|Exenatide|exenatide|mesh-list
139132353|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139132354|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132355|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139132356|NCT01254123|Incretins|incretins|mesh-ancestor
139132357|NCT01254123|Hormones|hormones|mesh-ancestor
139132358|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139132359|NCT03898635|Linezolid|linezolid|mesh-list
139132360|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139132361|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132362|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139132363|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132364|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132365|NCT02528019|Glimepiride|glimepiride|mesh-list
139132366|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139132367|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139132368|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139132369|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132370|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139132371|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
139132372|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132373|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
139132374|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139132375|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
139132376|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132377|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132378|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139132379|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
139132380|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139132381|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
139132382|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132383|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132384|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139132385|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
139132386|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
139132387|NCT01255215|Protective Agents|protective agents|mesh-ancestor
139132388|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
139132389|NCT02527785|Irinotecan|irinotecan|mesh-list
139132390|NCT02527785|Tegafur|tegafur|mesh-list
139132391|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132392|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139132393|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139132394|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132395|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132396|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139132397|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
139132398|NCT02527863|Tolvaptan|tolvaptan|mesh-list
139132399|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139132400|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132401|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
139132402|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132403|NCT01256541|Lactulose|lactulose|mesh-list
139132404|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139132405|NCT03904719|Vorolanib|vorolanib|mesh-list
139132406|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139132407|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706598|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139132408|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132409|NCT01148901|Infliximab|infliximab|mesh-list
139132410|NCT01148901|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139132411|NCT01148901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139132412|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
139132413|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139132414|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139132415|NCT01150617|Insulin|insulin|mesh-list
139132416|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139132417|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
139132418|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139132419|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
139132420|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132421|NCT01256619|Desogestrel|desogestrel|mesh-list
139132422|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139132423|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139132424|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139132425|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
139132426|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139132427|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132428|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139132429|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139132430|NCT01256619|Progestins|progestins|mesh-ancestor
139132431|NCT01256619|Hormones|hormones|mesh-ancestor
139132432|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139132433|NCT03898011|Lamotrigine|lamotrigine|mesh-list
139132434|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
139132435|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139132436|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139132437|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132438|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139132439|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132440|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139132441|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139132442|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132443|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139132444|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139132445|NCT01254513|Prednisone|prednisone|mesh-list
139132446|NCT01254513|Docetaxel|docetaxel|mesh-list
139132447|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132448|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
139132449|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
139132450|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
139132451|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132452|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139132453|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
139132454|NCT01254513|Hormones|hormones|mesh-ancestor
139132455|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139132456|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132457|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139132458|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139132459|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139019554|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139132460|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132461|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
139132462|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
139132463|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139132464|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
139132465|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132466|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139132467|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139132468|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132469|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139132470|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
139132471|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139132472|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132473|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132474|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132475|NCT01255371|Lopinavir|lopinavir|mesh-list
139132476|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139132477|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139132478|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139132479|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
139132480|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132481|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132482|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139132483|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139132484|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
139132485|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132486|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139132487|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139132488|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
139132489|NCT03903783|Cefotaxime|cefotaxime|mesh-list
139132490|NCT03903783|Cefoxitin|cefoxitin|mesh-list
139132491|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139132492|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132494|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
139132495|NCT03899337|Rituximab|rituximab|mesh-list
139132496|NCT03899337|Doxorubicin|doxorubicin|mesh-list
139132497|NCT03899337|Vincristine|vincristine|mesh-list
139132498|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
139132499|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139132500|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
139132501|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132502|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139132503|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139132504|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
139132505|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132506|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132507|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139132508|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139132509|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139132510|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139132511|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139132512|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132513|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139132514|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
139132515|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
139132516|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
139132517|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139132518|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
139132519|NCT03899337|Hormones|hormones|mesh-ancestor
139132520|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139132521|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139132522|NCT01586169|Azithromycin|azithromycin|mesh-list
139132523|NCT01586169|Ivermectin|ivermectin|mesh-list
139132524|NCT01586169|Albendazole|albendazole|mesh-list
139132525|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139132526|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132527|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139132528|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
139132529|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
139132530|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139132531|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139132532|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
139132533|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
139132534|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
139132535|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132536|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132538|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
139132539|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139132540|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139132541|NCT01256775|Analgesics|analgesics|mesh-ancestor
139132542|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
139132543|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132544|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132545|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139132546|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139132547|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139132548|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139132549|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132550|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139132551|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139132552|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
139132553|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132554|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139132555|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
139132556|NCT03899571|Oseltamivir|oseltamivir|mesh-list
139132557|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
139132558|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132559|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132560|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132561|NCT01257009|Atorvastatin|atorvastatin|mesh-list
139132562|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139132563|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139132564|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
139132565|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132566|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139132567|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139132568|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132569|NCT01255527|Bortezomib|bortezomib|mesh-list
139132570|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132571|NCT01151787|Amitriptyline|amitriptyline|mesh-list
139132572|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
139132573|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139132574|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
139132575|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139132576|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139132577|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132578|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139132579|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132580|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139132581|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132582|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139132583|NCT01151787|Analgesics|analgesics|mesh-ancestor
139132584|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
139132585|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139132586|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139132587|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139132588|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132589|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
139132590|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132591|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
139132592|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139132593|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132594|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132595|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139132596|NCT01151865|Analgesics|analgesics|mesh-ancestor
139132597|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
139132598|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132599|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139132600|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138883131|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
139132601|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139132602|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
139132603|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132604|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132605|NCT03893097|Artesunate|artesunate|mesh-list
139132606|NCT03893097|Mefloquine|mefloquine|mesh-list
139132607|NCT03893097|Praziquantel|praziquantel|mesh-list
139132608|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
139132609|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139132610|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139132611|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132612|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132613|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
139132614|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
139132615|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139132616|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
139132617|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
139132618|NCT01258491|Niacin|niacin|mesh-list
139132619|NCT01258491|Niacinamide|niacinamide|mesh-list
139132620|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
139132621|NCT01258491|Vitamins|vitamins|mesh-ancestor
139132622|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
139132623|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132624|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139132625|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
139132626|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132627|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139132628|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
139132629|NCT01257165|Ethanol|ethanol|mesh-list
139132630|NCT01257165|Zopiclone|zopiclone|mesh-list
139132631|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139132632|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132633|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132634|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132635|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139132636|NCT01151943|Anesthetics|anesthetics|mesh-list
139132637|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
139132638|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132639|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132640|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
139132641|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132642|NCT01256151|Alprazolam|alprazolam|mesh-list
139132643|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139132644|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132645|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132647|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139132648|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139132649|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
139132650|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
139132651|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132652|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132653|NCT01259973|Haloperidol|haloperidol|mesh-list
139132654|NCT01259973|Risperidone|risperidone|mesh-list
139132655|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
139132656|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139132657|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
139132658|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132659|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132660|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132661|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139132662|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139132663|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132664|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139132665|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139132666|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
139132667|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
139132668|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
139132669|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132670|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139132671|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139132672|NCT01257243|Potassium iodate|potassium iodate|mesh-list
139132673|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
139132674|NCT01257243|Guaifenesin|guaifenesin|mesh-list
139132675|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139132676|NCT01257243|Expectorants|expectorants|mesh-ancestor
139132677|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
139132678|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139132679|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139132680|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
139132681|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132682|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132683|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132684|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
139132685|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139132686|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
139132687|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
139132688|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132689|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
139132690|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139132691|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
139132692|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132693|NCT01258569|Alvimopan|alvimopan|mesh-list
139132694|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139132695|NCT01257399|Mesalamine|mesalamine|mesh-list
138874380|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
139132696|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139132697|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139132698|NCT01257399|Analgesics|analgesics|mesh-ancestor
139132699|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
139132700|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132701|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132702|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139132703|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139132704|NCT01258959|Anesthetics|anesthetics|mesh-list
139132705|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
139132706|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132707|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132708|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
139132709|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132710|NCT01153659|Esomeprazole|esomeprazole|mesh-list
139132711|NCT01153659|Rabeprazole|rabeprazole|mesh-list
139132712|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139132713|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139132714|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139132715|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132716|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132717|NCT01260129|Silodosin|silodosin|mesh-list
139132718|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139132719|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139132720|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139132721|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
139132722|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132723|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132724|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132725|NCT01260129|Urological Agents|urological agents|mesh-ancestor
139132726|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139132727|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
139132728|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139132729|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139132730|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132731|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132732|NCT01260285|Urological Agents|urological agents|mesh-ancestor
139132733|NCT03888729|Velpatasvir|velpatasvir|mesh-list
139132734|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
139132735|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132736|NCT01151241|Anesthetics|anesthetics|mesh-list
139132737|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
139132738|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132739|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132740|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
139132741|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132742|NCT02949362|Teduglutide|teduglutide|mesh-list
139132743|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139132744|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139132745|NCT02949362|Protective Agents|protective agents|mesh-ancestor
139132746|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132747|NCT03892161|Ritonavir|ritonavir|mesh-list
139132748|NCT03892161|Darunavir|darunavir|mesh-list
139132749|NCT03892161|Rifampin|rifampin|mesh-list
139132750|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139132751|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139132752|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
139132753|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883277|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
139132754|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132755|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139132756|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139132757|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
139132758|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132759|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139132760|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139132761|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139132762|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
139132763|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139132764|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
139132765|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139132766|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139132767|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139132768|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139132769|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139132770|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139132771|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139132772|NCT01154361|Cortisone|cortisone|mesh-list
139132773|NCT01154361|Icatibant|icatibant|mesh-list
139132774|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139132775|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139132776|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139132777|NCT01154361|Analgesics|analgesics|mesh-ancestor
139132778|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
139132779|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132780|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132781|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139132782|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
139132783|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
139132784|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132785|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139132786|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139132787|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
139132789|NCT01260519|Calcium heparin|calcium heparin|mesh-list
139132790|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
139132791|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139132792|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139132793|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132794|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
139132795|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139132796|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139132797|NCT03891615|Niraparib|niraparib|mesh-list
139132798|NCT03891615|Osimertinib|osimertinib|mesh-list
139132799|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139132800|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132801|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132802|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132803|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139132804|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
139132805|NCT02947022|Zinc|zinc|mesh-list
139132806|NCT02947022|Edetic Acid|edetic acid|mesh-list
139132807|NCT02947022|Calcium|calcium|mesh-list
139132808|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
139132809|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139132810|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132811|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139132812|NCT02947022|Trace Elements|trace elements|mesh-ancestor
139132813|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
139132814|NCT02947022|Antidotes|antidotes|mesh-ancestor
139132815|NCT02947022|Protective Agents|protective agents|mesh-ancestor
139132816|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
139132817|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
139132818|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132819|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139132820|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
139132821|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139132822|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
139132823|NCT01259193|Sorafenib|sorafenib|mesh-list
139132824|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132825|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139132826|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132827|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132828|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139132829|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132830|NCT05182892|Dopamine|dopamine|mesh-list
139132831|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
139132832|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139132833|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
139132834|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
139132835|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132836|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132837|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
139132838|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132839|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132840|NCT05182892|Protective Agents|protective agents|mesh-ancestor
139132841|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
139132842|NCT01312376|Bevacizumab|bevacizumab|mesh-list
139132843|NCT01312376|Fludarabine|fludarabine|mesh-list
139132844|NCT01312376|Vaccines|vaccines|mesh-list
139132845|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
139132846|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132847|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139132848|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139132849|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139132850|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
139132851|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132852|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132853|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139132854|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139132855|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138874427|NCT02809781|Etanercept|etanercept|mesh-list
139132856|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139132858|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
139132859|NCT01260675|Buprenorphine|buprenorphine|mesh-list
139132860|NCT01260675|Naloxone|naloxone|mesh-list
139132861|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139132862|NCT01260675|Narcotics|narcotics|mesh-ancestor
139132863|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132864|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132865|NCT01260675|Analgesics|analgesics|mesh-ancestor
139132866|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
139132867|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132868|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139132869|NCT03887871|Tamsulosin|tamsulosin|mesh-list
139132870|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139132871|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139132872|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139132873|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
139132874|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132875|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132876|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132877|NCT03887871|Urological Agents|urological agents|mesh-ancestor
139132878|NCT03708146|Zamicastat|zamicastat|mesh-list
139132879|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132880|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132881|NCT01260753|Fluticasone|fluticasone|mesh-list
139132882|NCT01260753|Xhance|xhance|mesh-list
139132883|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139132884|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139132885|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
139132886|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132887|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132888|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139132889|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
139132890|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
139132891|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139132892|NCT03895671|Azacitidine|azacitidine|mesh-list
139132893|NCT03895671|Ponatinib|ponatinib|mesh-list
139132894|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139132895|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
139132896|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132897|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132898|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132899|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139132900|NCT01152723|Nicotine|nicotine|mesh-list
139132901|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139132902|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
139132903|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132904|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132905|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139132906|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139132907|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
139132908|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132909|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132910|NCT01261065|Carvedilol|carvedilol|mesh-list
139132911|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139132912|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139132913|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
139132914|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132915|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132916|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132917|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139132918|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
139132919|NCT01261065|Protective Agents|protective agents|mesh-ancestor
139132920|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139132921|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139132922|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139132923|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
139132924|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139132925|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139132926|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
139132927|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
139132928|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139132929|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132930|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132931|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
139132932|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139132933|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132934|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132935|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
139132936|NCT03338972|Fludarabine|fludarabine|mesh-list
139132937|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139132938|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
139132939|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132940|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139132941|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139132942|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
139132943|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132944|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132945|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139132946|NCT01151397|Vitamin D|vitamin d|mesh-list
139132947|NCT01151397|Ribavirin|ribavirin|mesh-list
139132948|NCT01151397|Vitamins|vitamins|mesh-ancestor
139132949|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
139132950|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132951|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139132952|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
139132953|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132954|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
139132955|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139132956|NCT01152801|Everolimus|everolimus|mesh-list
138706815|NCT01825980|Ritonavir|ritonavir|mesh-list
139132957|NCT01152801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139132958|NCT01152801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139132959|NCT01152801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139132960|NCT01152801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132961|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139132962|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
139132963|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132964|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132965|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
139132966|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
139132967|NCT03887169|Vitamins|vitamins|mesh-ancestor
139132968|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
139132969|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132970|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
139132971|NCT03887169|Hematinics|hematinics|mesh-ancestor
139132972|NCT03886779|Nepafenac|nepafenac|mesh-list
139132973|NCT03886779|Bromfenac|bromfenac|mesh-list
139132974|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139132975|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139132976|NCT03886779|Analgesics|analgesics|mesh-ancestor
138883511|NCT00922584|Sorafenib|sorafenib|mesh-list
139132977|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
139132978|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139132979|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132980|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139132981|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139132982|NCT03887013|Trimetazidine|trimetazidine|mesh-list
139132983|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
139132984|NCT01261299|Carboplatin|carboplatin|mesh-list
139132985|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139132986|NCT01154829|Aripiprazole|aripiprazole|mesh-list
139132987|NCT01154829|Amisulpride|amisulpride|mesh-list
139132988|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
139132989|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139132990|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139132991|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139132992|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139132993|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139132994|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
139132995|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
139132996|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139132997|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139132998|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139132999|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139133000|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
139133001|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139133002|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139133003|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139133004|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139133005|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139133006|NCT01153191|Gentamicins|gentamicins|mesh-list
139133007|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138874508|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139133008|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139133009|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139133010|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133011|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133012|NCT01259817|Aspirin|aspirin|mesh-list
139133013|NCT01259817|Interferons|interferons|mesh-list
139133014|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
139133015|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
139133016|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139133017|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133018|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
139133019|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139133020|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139133021|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139133022|NCT01259817|Analgesics|analgesics|mesh-ancestor
139133023|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
139133024|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133025|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133026|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139133027|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139133028|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139133029|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139133030|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133031|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139133032|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139133033|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133034|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
139133035|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
139133036|NCT01261689|Sufentanil|sufentanil|mesh-list
139133038|NCT01261689|Ropivacaine|ropivacaine|mesh-list
139133039|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
139133040|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
139133041|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133042|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133043|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
139133044|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133045|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139133046|NCT01261689|Narcotics|narcotics|mesh-ancestor
139133047|NCT01261689|Analgesics|analgesics|mesh-ancestor
139133048|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139133049|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139133050|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
139133051|NCT01154907|Praziquantel|praziquantel|mesh-list
139133052|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
139133053|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139133054|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139133055|NCT01261923|Alitretinoin|alitretinoin|mesh-list
139133056|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133057|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
139133058|NCT01157247|Fentanyl|fentanyl|mesh-list
139133059|NCT01157247|Anesthetics|anesthetics|mesh-list
139133060|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
139133061|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139133062|NCT01157247|Narcotics|narcotics|mesh-ancestor
139133063|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133064|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133065|NCT01157247|Analgesics|analgesics|mesh-ancestor
139133066|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
139133067|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133069|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139133070|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
139133071|NCT03881787|Cetuximab|cetuximab|mesh-list
139133072|NCT03881787|Antibodies|antibodies|mesh-list
139133073|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139133074|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
139133075|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133076|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139133077|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133078|NCT01157481|Nifedipine|nifedipine|mesh-list
139133079|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139133080|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139133081|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133082|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139133083|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133084|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
139133085|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
139133086|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139133088|NCT03894189|Doxapram|doxapram|mesh-list
139133089|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139133090|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
139133091|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133092|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133093|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139133094|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
139133095|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139133096|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133097|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133098|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
139133099|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139133100|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139133101|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
139133102|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133103|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139133104|NCT03886311|Nivolumab|nivolumab|mesh-list
139133105|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139133106|NCT03886311|Trabectedin|trabectedin|mesh-list
139133107|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139133108|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133109|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139133110|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133111|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139133112|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
139133113|NCT01155453|Trametinib|trametinib|mesh-list
139133114|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133115|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138874549|NCT02811809|Leuprolide|leuprolide|mesh-list
139133116|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133117|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133118|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139133119|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
139133120|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133121|NCT03885219|Paclitaxel|paclitaxel|mesh-list
139133122|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139133123|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133124|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
139133125|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
139133126|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
139133127|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133128|NCT01157559|Ziprasidone|ziprasidone|mesh-list
139133129|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139133130|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
139133131|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133132|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133133|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133134|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139133135|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139133136|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133137|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139133138|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139133139|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
139133140|NCT01263951|Everolimus|everolimus|mesh-list
139133141|NCT01263951|Sorafenib|sorafenib|mesh-list
139133142|NCT01263951|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139133143|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139133144|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133145|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133146|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139133147|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
139133148|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706844|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
139133149|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133150|NCT01265433|Molgramostim|molgramostim|mesh-list
139133151|NCT01265433|Sargramostim|sargramostim|mesh-list
139133152|NCT01265433|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139133153|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
139133154|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133155|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133156|NCT01265433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139133157|NCT01265589|Vitamin A|vitamin a|mesh-list
139133158|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139133159|NCT01265589|Vitamins|vitamins|mesh-ancestor
139133160|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
139133161|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133162|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
139133164|NCT01159587|Coagulants|coagulants|mesh-ancestor
139133165|NCT03885297|Liraglutide|liraglutide|mesh-list
139133166|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139133167|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133168|NCT03885297|Incretins|incretins|mesh-ancestor
139133169|NCT03885297|Hormones|hormones|mesh-ancestor
139133170|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139133171|NCT01159821|Paroxetine|paroxetine|mesh-list
139133172|NCT01159821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139133173|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139133174|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139133175|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133176|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133177|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
139133178|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133179|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139133180|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
139133181|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139133182|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139133183|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139133184|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133185|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
139133186|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
139133187|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139133188|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133189|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139133190|NCT03885141|Zolpidem|zolpidem|mesh-list
139133191|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139133192|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139133193|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133194|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133195|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139133196|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
139133197|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
139133198|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133199|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133200|NCT03879057|Antibodies|antibodies|mesh-list
139133201|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139133202|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
139133203|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133204|NCT01266057|Sirolimus|sirolimus|mesh-list
139133205|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
139133206|NCT01266057|Vorinostat|vorinostat|mesh-list
139133207|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139133208|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706866|NCT01810575|Alprostadil|alprostadil|mesh-list
139133209|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139133210|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133211|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
139133212|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139133213|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
139133214|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133215|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133216|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133217|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
139133218|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139133219|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139133220|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139133221|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139133222|NCT01266213|Fulvestrant|fulvestrant|mesh-list
139133223|NCT01266213|Anastrozole|anastrozole|mesh-list
139133224|NCT01266213|Goserelin|goserelin|mesh-list
139133225|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139133226|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133227|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139133228|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139133229|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
139133230|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139133231|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133232|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139133233|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139133234|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133235|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133236|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
139133237|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139133238|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139133239|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
139133240|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133241|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133242|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133243|NCT01262391|Urological Agents|urological agents|mesh-ancestor
139133244|NCT03880695|Doxorubicin|doxorubicin|mesh-list
139133245|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139133246|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139133247|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133248|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139133249|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139133250|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133251|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133252|NCT01155765|Clopidogrel|clopidogrel|mesh-list
139133253|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139133254|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139133255|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139133256|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139133257|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139133258|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
139133259|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133260|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133261|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133262|NCT01264341|Sirolimus|sirolimus|mesh-list
139133263|NCT01264341|Bevacizumab|bevacizumab|mesh-list
139133264|NCT01264341|Temsirolimus|temsirolimus|mesh-list
139133265|NCT01264341|MTOR Inhibitors|mtor inhibitors|mesh-list
139133266|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139133267|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133268|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139133269|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139133270|NCT01264341|Growth Substances|growth substances|mesh-ancestor
139133271|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133272|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
139133273|NCT01264341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139133274|NCT01264341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133275|NCT01264341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133276|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139133277|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
139133278|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139133279|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139133280|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139133281|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
139133282|NCT01264497|Tesamorelin|tesamorelin|mesh-list
139133283|NCT01264497|Growth Substances|growth substances|mesh-ancestor
139133284|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133285|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
139133286|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
139133287|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133288|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139133289|NCT01262469|Capecitabine|capecitabine|mesh-list
139133290|NCT01262469|Lapatinib|lapatinib|mesh-list
139133291|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139133292|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
139133293|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133294|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133295|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139133296|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133297|NCT01155921|Risperidone|risperidone|mesh-list
139133298|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139133299|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
139133300|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133301|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133302|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133303|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139133304|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139133305|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133306|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139133307|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139133308|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
139133309|NCT03884127|Orlistat|orlistat|mesh-list
139133310|NCT03884127|Ezetimibe|ezetimibe|mesh-list
139133311|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139133312|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139133313|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
139133314|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133315|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139133316|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133317|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139133318|NCT01158105|Bortezomib|bortezomib|mesh-list
139133319|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133320|NCT03337490|Ivermectin|ivermectin|mesh-list
139133321|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139133322|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139133323|NCT01158183|Interferons|interferons|mesh-list
139133324|NCT01158183|Interferon-beta|interferon-beta|mesh-list
139133325|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
139133326|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133327|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
139133328|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139133329|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
139133330|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133331|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139133332|NCT01264575|Epinephrine|epinephrine|mesh-list
139133333|NCT01264575|Racepinephrine|racepinephrine|mesh-list
139133334|NCT01264575|Bupivacaine|bupivacaine|mesh-list
139133335|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
139133336|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
139133337|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
139133338|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133339|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133340|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
139133341|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133342|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139133343|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139133344|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
139133345|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133346|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133347|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139133348|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139133349|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
139133350|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139133351|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
139133352|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
139133353|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
139133354|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139133356|NCT01266681|Dronedarone|dronedarone|mesh-list
139133357|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139133358|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
139133359|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139133360|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139133361|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133362|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139133363|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139133364|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139133365|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133366|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139133367|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139133368|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139133369|NCT03638648|Capecitabine|capecitabine|mesh-list
139133370|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139133371|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
139133372|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133373|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133374|NCT01266759|NuvaRing|nuvaring|mesh-list
139133375|NCT01266759|Norethindrone|norethindrone|mesh-list
139133376|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
139133377|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139133378|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
139133379|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139133380|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133381|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139133382|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139133383|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139133384|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139133385|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
139133386|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
139133387|NCT03878667|Calcium|calcium|mesh-list
139133388|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139133389|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133390|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139133391|NCT03878667|Antacids|antacids|mesh-ancestor
139133392|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133393|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139133394|NCT01264653|Epinephrine|epinephrine|mesh-list
139133395|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139133396|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139133397|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
139133398|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133399|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133400|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133401|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139133402|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139133403|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
139133404|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133405|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139133406|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
139133407|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
139133408|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
139133409|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139133410|NCT01266837|Everolimus|everolimus|mesh-list
139133411|NCT01266837|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139133412|NCT01266837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139133413|NCT01266837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133414|NCT01266837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133415|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139133416|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
139133417|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133418|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133419|NCT01264731|Imiquimod|imiquimod|mesh-list
139133420|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139133421|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
139133422|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133423|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133424|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
139133425|NCT03879837|Fluticasone|fluticasone|mesh-list
139133426|NCT03879837|Xhance|xhance|mesh-list
139133427|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139133428|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139133429|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
139133430|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133431|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133432|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139133433|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
139133434|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
139133435|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139133436|NCT05308628|Complement C3|complement c3|mesh-list
139133437|NCT05308628|Immunologic Factors|immunologic factors|mesh-ancestor
139133438|NCT05308628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133439|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
139133440|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139133441|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139133442|NCT01158729|Antithrombins|antithrombins|mesh-list
139133443|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
139133444|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139133445|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
139133446|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133447|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133448|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
139133449|NCT01262859|Bevacizumab|bevacizumab|mesh-list
139133450|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139133451|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133452|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139133453|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139133454|NCT01262859|Growth Substances|growth substances|mesh-ancestor
139133455|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133456|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
139133457|NCT02527083|Ketamine|ketamine|mesh-list
139133458|NCT02527083|Remifentanil|remifentanil|mesh-list
139133459|NCT02527083|Propofol|propofol|mesh-list
139133460|NCT02527083|Sevoflurane|sevoflurane|mesh-list
139133461|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139133462|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133463|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133464|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139133465|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
139133466|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
139133467|NCT02527083|Analgesics|analgesics|mesh-ancestor
139133468|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
139133469|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133470|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139133471|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139133472|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139133473|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133474|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133475|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139133476|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139133477|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139133478|NCT02527083|Narcotics|narcotics|mesh-ancestor
139133479|NCT05156684|Zinc|zinc|mesh-list
139133480|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
139133481|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
139133482|NCT05156684|Trace Elements|trace elements|mesh-ancestor
139133483|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
139133484|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133485|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139133486|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133487|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133488|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139133489|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139133490|NCT05156684|Protective Agents|protective agents|mesh-ancestor
139133491|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
139133492|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139133493|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
139133494|NCT05156684|Astringents|astringents|mesh-ancestor
139133495|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
139133496|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
139133498|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139133499|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133500|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133501|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139133502|NCT03883347|Analgesics|analgesics|mesh-ancestor
139133503|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
139133504|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133505|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139133506|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138884035|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
139133507|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139133508|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
139133509|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133510|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133511|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139133512|NCT03883347|Narcotics|narcotics|mesh-ancestor
139133513|NCT01159275|Lopinavir|lopinavir|mesh-list
139133514|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139133515|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139133516|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
139133517|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133518|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133519|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139133520|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139133521|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
139133522|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139133523|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139133524|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139133525|NCT01159353|Insulin|insulin|mesh-list
139133526|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139133527|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
139133528|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
139133529|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139133530|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133531|NCT02943668|Deferasirox|deferasirox|mesh-list
139133532|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139133533|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
139133534|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
139133535|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133537|NCT01265199|Daunorubicin|daunorubicin|mesh-list
139133538|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139133539|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
139133540|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133541|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133542|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
139133543|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139133544|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139133545|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
139133546|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133547|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139133548|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139133549|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139133550|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133551|NCT01263171|Leucovorin|leucovorin|mesh-list
139133552|NCT01263171|Fluorouracil|fluorouracil|mesh-list
139133553|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
139133554|NCT01263171|Calcium|calcium|mesh-list
139133555|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
139133556|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139133557|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133558|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
139133559|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133560|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139133561|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133562|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139133563|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
139133564|NCT01263171|Antidotes|antidotes|mesh-ancestor
139133565|NCT01263171|Protective Agents|protective agents|mesh-ancestor
139133566|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
139133567|NCT01263171|Vitamins|vitamins|mesh-ancestor
139133568|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
139133569|NCT01156233|Anesthetics|anesthetics|mesh-list
139133570|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133571|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133572|NCT03883269|Ethanol|ethanol|mesh-list
139133573|NCT03883269|Clindamycin|clindamycin|mesh-list
139133574|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
139133575|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
139133576|NCT03883269|Erythromycin|erythromycin|mesh-list
139133577|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
139133578|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139133579|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
139133580|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139133581|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139133582|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133583|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133584|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139133585|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139133586|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133587|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133588|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139133589|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
139133591|NCT01267305|Nadroparin|nadroparin|mesh-list
139133592|NCT01267305|Fondaparinux|fondaparinux|mesh-list
139133593|NCT01267305|Calcium|calcium|mesh-list
139133594|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139133595|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133596|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139133597|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139133598|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
139133599|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139133600|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
139133601|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133602|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133603|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
139133604|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139133605|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139133606|NCT02891408|Fenofibrate|fenofibrate|mesh-list
139133607|NCT02891408|Firsocostat|firsocostat|mesh-list
139133608|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139133609|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
139133610|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133611|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138503959|NCT00015951|Analgesics|analgesics|mesh-ancestor
139133612|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133613|NCT01160991|Olanzapine|olanzapine|mesh-list
139133614|NCT01160991|Amisulpride|amisulpride|mesh-list
139133615|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
139133616|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
138874735|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
139133617|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133618|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133620|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139133621|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139133622|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133623|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139133624|NCT01160991|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139133625|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139133626|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139133627|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133628|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133629|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
139133630|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139133631|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
139133632|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139133633|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
139133634|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
139133635|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139133636|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139133637|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133638|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133639|NCT01161147|Meloxicam|meloxicam|mesh-list
139133640|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139133641|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139133642|NCT01161147|Analgesics|analgesics|mesh-ancestor
139133643|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
139133644|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133645|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133646|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139133647|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139133648|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139133649|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139133650|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133651|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133652|NCT01161927|Nizatidine|nizatidine|mesh-list
139133653|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139133654|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139133655|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139133656|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
139133657|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
138884179|NCT00722176|Risperidone|risperidone|mesh-list
139133658|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133659|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133660|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133661|NCT01267383|Sertraline|sertraline|mesh-list
139133662|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
139133663|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139133664|NCT01267383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139133665|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139133666|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139133667|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133668|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133669|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
138874749|NCT02684318|Olaparib|olaparib|mesh-list
139133670|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133671|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
139133672|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139133673|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
139133674|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
139133675|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133676|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133677|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139133678|NCT03283670|Analgesics|analgesics|mesh-ancestor
139133679|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
139133680|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133681|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
139133683|NCT03110432|Ezetimibe|ezetimibe|mesh-list
139133684|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139133685|NCT03110432|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139133686|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139133687|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139133688|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
139133689|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133690|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139133691|NCT03110432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139133692|NCT03110432|Protease Inhibitors|protease inhibitors|mesh-ancestor
139133693|NCT03110432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133694|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
139133695|NCT03110432|Vitamins|vitamins|mesh-ancestor
139133696|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
139133697|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133698|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
139133699|NCT03205358|Vaccines|vaccines|mesh-list
139133700|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
139133701|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133702|NCT01358578|Etanercept|etanercept|mesh-list
139133703|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139133704|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139133705|NCT01358578|Analgesics|analgesics|mesh-ancestor
139133706|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
139133707|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133708|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874764|NCT04182854|Diuretics|diuretics|mesh-ancestor
139133709|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139133710|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139133711|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139133712|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139133713|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
139133714|NCT01161459|Prednisone|prednisone|mesh-list
139133715|NCT01161459|Tacrolimus|tacrolimus|mesh-list
139133716|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139133717|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
139133718|NCT01161459|Hormones|hormones|mesh-ancestor
139133719|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139133720|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133721|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139133722|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133723|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139133724|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
139133725|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139133726|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133727|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133728|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
139133729|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
139133730|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
139133731|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133732|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133733|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
139133734|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133736|NCT03882099|Vitamins|vitamins|mesh-ancestor
139133737|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
139133738|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133739|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139133740|NCT01268163|Docetaxel|docetaxel|mesh-list
139133741|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133742|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
139133743|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
139133744|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
139133745|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133746|NCT04745780|Inositol|inositol|mesh-list
139133747|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
139133748|NCT04745780|Vitamins|vitamins|mesh-ancestor
139133749|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
139133750|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133751|NCT02833948|Aspirin|aspirin|mesh-list
139133752|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
139133753|NCT02833948|Clopidogrel|clopidogrel|mesh-list
139133754|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139133755|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139133756|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139133757|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139133758|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
139133759|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133760|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133761|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133762|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139133763|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
139133764|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139133765|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
139133766|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133767|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
139133768|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139133769|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139133770|NCT02833948|Analgesics|analgesics|mesh-ancestor
139133771|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
139133772|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133773|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139133774|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139133775|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139133776|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139133777|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139133778|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
139133779|NCT02527005|Azithromycin|azithromycin|mesh-list
139133780|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
139133781|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
139133782|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139133783|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139133784|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139133786|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139133787|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139133788|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139133789|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133790|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133791|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139133792|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
139133793|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133794|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139133795|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133796|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133797|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
139133798|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139133799|NCT01162941|Prednisolone|prednisolone|mesh-list
139133800|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139133801|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
139133802|NCT01162941|Hormones|hormones|mesh-ancestor
139133803|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139133804|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133805|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139133806|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133807|NCT00161044|Galantamine|galantamine|mesh-list
139133808|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139133809|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133810|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133811|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
139019555|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139133812|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133813|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133814|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139133815|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
139133816|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133817|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
139133818|NCT01156779|Exenatide|exenatide|mesh-list
139133819|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139133820|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133821|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139133823|NCT01156779|Hormones|hormones|mesh-ancestor
139133824|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139133825|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
139133826|NCT01156857|Progestins|progestins|mesh-list
139133827|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139133828|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
139133829|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139133830|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133831|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139133832|NCT01156857|Hormones|hormones|mesh-ancestor
139133833|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139133834|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
139133835|NCT01269333|Omeprazole|omeprazole|mesh-list
139133836|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139133837|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139133838|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139133839|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133840|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133841|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139133842|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139133843|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133844|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133845|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139133846|NCT01269333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139133847|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139133848|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139133849|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133850|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
139133851|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139133852|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
139133853|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139133854|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139133855|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139133856|NCT01269411|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139133857|NCT01269411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138707022|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
139133858|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133859|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133860|NCT03882255|Propranolol|propranolol|mesh-list
139133861|NCT03882255|Ponesimod|ponesimod|mesh-list
139133862|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139133863|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139133864|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
138874914|NCT00956059|Hormones|hormones|mesh-ancestor
139133865|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133866|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133867|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133868|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139133869|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139133871|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139133872|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139133873|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
139133874|NCT05433272|Vaccines|vaccines|mesh-list
139133875|NCT05433272|Immunologic Factors|immunologic factors|mesh-ancestor
139133876|NCT05433272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133877|NCT01268631|Pregabalin|pregabalin|mesh-list
139133878|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139133879|NCT01268631|Analgesics|analgesics|mesh-ancestor
139133880|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
139133881|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133882|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133883|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
139133884|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139133885|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139133886|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133887|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139133888|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139133889|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139133890|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133891|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139133892|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139133893|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139133894|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133895|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
139133896|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
139133898|NCT01268709|Nortriptyline|nortriptyline|mesh-list
139133899|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139133900|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
139133901|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139133902|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139133903|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139133904|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139133905|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133906|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
139133907|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133908|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133909|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139133910|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139133911|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133912|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
139133913|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
139133914|NCT03881943|Aspirin|aspirin|mesh-list
139133915|NCT03881943|Ticagrelor|ticagrelor|mesh-list
138874941|NCT00640640|Growth Substances|growth substances|mesh-ancestor
139133916|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139133917|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139133918|NCT03881943|Analgesics|analgesics|mesh-ancestor
139133919|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
139133920|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139133921|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133922|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139133923|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139133924|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139133925|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139133926|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133927|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139133928|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139133929|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133930|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
139133931|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139133932|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139133933|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139133934|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
139133935|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133936|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139133937|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139133938|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139133939|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139133940|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139133941|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
139133942|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133943|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133944|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133945|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139133946|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139133947|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
139133948|NCT04722848|Blinatumomab|blinatumomab|mesh-list
139133949|NCT04722848|Ponatinib|ponatinib|mesh-list
139133950|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139133951|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139133952|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133953|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133954|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139133955|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139133956|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133957|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139133958|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139133959|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139133960|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139133961|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133962|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139133963|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139133964|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139133965|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
138874973|NCT00961909|Metformin|metformin|mesh-list
139133966|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139133967|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133968|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139133969|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139133970|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
139133971|NCT05363384|Metformin|metformin|mesh-list
139133972|NCT05363384|Alogliptin|alogliptin|mesh-list
139133973|NCT05363384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139133974|NCT05363384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133975|NCT05363384|Incretins|incretins|mesh-ancestor
139133976|NCT05363384|Hormones|hormones|mesh-ancestor
139133977|NCT05363384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139133978|NCT05363384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139133980|NCT05363384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133981|NCT05363384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133982|NCT01165125|Ketoconazole|ketoconazole|mesh-list
139133983|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
139133984|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139133985|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139133986|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139133987|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139133988|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139133989|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139133990|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
139133991|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139133992|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133993|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139133994|NCT01163799|Alefacept|alefacept|mesh-list
139133995|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
139133996|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
139133997|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139133998|NCT02274662|Cyclosporine|cyclosporine|mesh-list
139133999|NCT02274662|Tacrolimus|tacrolimus|mesh-list
139134000|NCT02274662|Cyclosporins|cyclosporins|mesh-list
139134001|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139134002|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
139134003|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139134004|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
139134005|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134006|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139134007|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134008|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134009|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
139134010|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139134011|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
139134012|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139134013|NCT02891174|Acetaminophen|acetaminophen|mesh-list
139134014|NCT02891174|Ibuprofen|ibuprofen|mesh-list
139134015|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139134016|NCT02891174|Analgesics|analgesics|mesh-ancestor
139134017|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
139134018|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134019|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134020|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
139134021|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139134022|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139134023|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138874986|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
139134024|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139134025|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134026|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884553|NCT02645864|Apatinib|apatinib|mesh-list
139134027|NCT01280175|Charcoal|charcoal|mesh-list
139134028|NCT01280175|Antidotes|antidotes|mesh-ancestor
139134029|NCT01280175|Protective Agents|protective agents|mesh-ancestor
139134030|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134031|NCT01588431|Bevacizumab|bevacizumab|mesh-list
139134032|NCT01588431|Cetuximab|cetuximab|mesh-list
139134033|NCT01588431|Cisplatin|cisplatin|mesh-list
139134034|NCT01588431|Docetaxel|docetaxel|mesh-list
139134035|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139134036|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134037|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139134038|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139134039|NCT01588431|Growth Substances|growth substances|mesh-ancestor
139134040|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134041|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
139134042|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
139134043|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
139134044|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
139134045|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134046|NCT01583283|Dexamethasone|dexamethasone|mesh-list
139134047|NCT01583283|Lenalidomide|lenalidomide|mesh-list
139134048|NCT01583283|Ricolinostat|ricolinostat|mesh-list
139134049|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139134050|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139134051|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
139134052|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
139134053|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134054|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134055|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139134056|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
139134058|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139134059|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139134060|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134061|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
139134062|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139134063|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139134064|NCT01583283|Growth Substances|growth substances|mesh-ancestor
139134065|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
139134066|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134067|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134068|NCT02076620|Doxorubicin|doxorubicin|mesh-list
139134069|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139134070|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134071|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139134072|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139134073|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134074|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134075|NCT01270737|Daidzein|daidzein|mesh-list
139134076|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
139134077|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139134078|NCT01270737|Estrogens|estrogens|mesh-ancestor
139134079|NCT01270737|Hormones|hormones|mesh-ancestor
139134080|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139134081|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134082|NCT01270815|Pregabalin|pregabalin|mesh-list
139134083|NCT01270815|Analgesics|analgesics|mesh-ancestor
139134084|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
139134085|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134086|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134087|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
139134088|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139134089|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139134090|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134091|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139134092|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139134093|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139134094|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134095|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139134096|NCT01751984|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139134097|NCT01751984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139134098|NCT01751984|Antimetabolites|antimetabolites|mesh-ancestor
139134099|NCT01751984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134100|NCT01751984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139134101|NCT01751984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134102|NCT01751984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139134103|NCT01751984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134104|NCT03330236|Anesthetics|anesthetics|mesh-list
139134105|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134106|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134107|NCT01271361|Sirolimus|sirolimus|mesh-list
139134108|NCT01271361|Umirolimus|umirolimus|mesh-list
139134109|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139134110|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139134111|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
139134112|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134113|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139134114|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139134115|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139134116|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134117|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
139134118|NCT03638726|Atropine|atropine|mesh-list
139134119|NCT03638726|Phenylephrine|phenylephrine|mesh-list
139134120|NCT03638726|Epinephrine|epinephrine|mesh-list
139134121|NCT03638726|Racepinephrine|racepinephrine|mesh-list
139134122|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
139134123|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
139134124|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
139134125|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139134126|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139134127|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
139134128|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134129|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707138|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139134130|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134131|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139134132|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139134133|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
139134134|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134135|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139134136|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
139134137|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
139134138|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
139134139|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139134140|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139134141|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
139134142|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139134143|NCT03638726|Protective Agents|protective agents|mesh-ancestor
139134144|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139134145|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139134146|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
139134147|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139134148|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139134149|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
139134150|NCT01164189|Bevacizumab|bevacizumab|mesh-list
139134151|NCT01164189|Temozolomide|temozolomide|mesh-list
139134152|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139134153|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134154|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139134155|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139134156|NCT01164189|Growth Substances|growth substances|mesh-ancestor
139134157|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134158|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
139134159|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139134160|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
139134161|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134162|NCT01164267|Everolimus|everolimus|mesh-list
139134163|NCT01164267|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139134164|NCT01164267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139134165|NCT01164267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134166|NCT01164267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134167|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139134168|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
139134169|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134170|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134171|NCT01164345|Plerixafor|plerixafor|mesh-list
139134172|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139134173|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139134174|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
139134175|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139134176|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
139134177|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139134178|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139134179|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139134180|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139134181|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
139134182|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134183|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134184|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134185|NCT02259868|Ritonavir|ritonavir|mesh-list
139134186|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139134187|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139134188|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
139134189|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134190|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134191|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139134192|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139134193|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
139134194|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139134195|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139134196|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139134197|NCT01167231|Acarbose|acarbose|mesh-list
139134198|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139134199|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134200|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134201|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139134202|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134203|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139134204|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139134205|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
139134206|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134207|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134208|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134209|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
139134210|NCT01587261|Vitamins|vitamins|mesh-ancestor
139134211|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
139134212|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134213|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
139134214|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134215|NCT01587261|Protective Agents|protective agents|mesh-ancestor
139134216|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
139134217|NCT01269021|Prednisone|prednisone|mesh-list
139134218|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139134219|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
139134220|NCT01269021|Hormones|hormones|mesh-ancestor
139134221|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139134222|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134223|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139134224|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134225|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139134226|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139134227|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
139134228|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139134229|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139134230|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134231|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134232|NCT01269099|Fentanyl|fentanyl|mesh-list
139134233|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139134234|NCT01269099|Narcotics|narcotics|mesh-ancestor
139134235|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134236|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134237|NCT01269099|Analgesics|analgesics|mesh-ancestor
139134238|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
139134239|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134240|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139134241|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139134242|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
139134243|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
139134244|NCT01164813|Nabumetone|nabumetone|mesh-list
139134245|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139134246|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139134247|NCT01164813|Analgesics|analgesics|mesh-ancestor
139134248|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
139134249|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707160|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139134250|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134251|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139134252|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139134253|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139134254|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139134255|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134256|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134257|NCT01165905|Gemcitabine|gemcitabine|mesh-list
139134258|NCT01165905|ON 01910|on 01910|mesh-list
139134259|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139134260|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
139134261|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134262|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134263|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139134264|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134265|NCT01339000|Vaccines|vaccines|mesh-list
139134266|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139134267|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
139134268|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134269|NCT01269255|Cisplatin|cisplatin|mesh-list
139134270|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134271|NCT03563170|Leucovorin|leucovorin|mesh-list
139134273|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
139134274|NCT03563170|Capecitabine|capecitabine|mesh-list
139134275|NCT03563170|Fluorouracil|fluorouracil|mesh-list
139134276|NCT03563170|Cetuximab|cetuximab|mesh-list
139134277|NCT03563170|Sorafenib|sorafenib|mesh-list
139134278|NCT03563170|Avelumab|avelumab|mesh-list
139134279|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139134280|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134281|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
139134282|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
139134283|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
139134284|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134285|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139134286|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
139134287|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134288|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139134289|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139134290|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
139134291|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139134292|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139134293|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
139134294|NCT03563170|Antidotes|antidotes|mesh-ancestor
139134295|NCT03563170|Protective Agents|protective agents|mesh-ancestor
139134296|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
139134297|NCT03563170|Vitamins|vitamins|mesh-ancestor
139134298|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
139134299|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139134300|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139134301|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134302|NCT01281111|Aspirin|aspirin|mesh-list
139134303|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139134304|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139134305|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139134306|NCT01281111|Analgesics|analgesics|mesh-ancestor
139134307|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
139134308|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134309|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134310|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139134311|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139134312|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139134313|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139134314|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134315|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139134316|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139134317|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134318|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
139134319|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
139134320|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139134321|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
139134322|NCT03869931|Fenofibrate|fenofibrate|mesh-list
139134323|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139134324|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
139134325|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134326|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139134327|NCT04876066|Ketamine|ketamine|mesh-list
139134328|NCT04876066|Analgesics|analgesics|mesh-ancestor
138884876|NCT03675139|Hormones|hormones|mesh-ancestor
139134329|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
139134330|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875056|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139134331|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134332|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139134333|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139134334|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
139134335|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
139134336|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134337|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139134338|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139134339|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134340|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134341|NCT01169805|Ondansetron|ondansetron|mesh-list
139134342|NCT01169805|Palonosetron|palonosetron|mesh-list
139134343|NCT01169805|Ramosetron|ramosetron|mesh-list
139134344|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
139134345|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
139134346|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134347|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134348|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139134349|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
139134350|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
139134351|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139134352|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139134353|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
139134354|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134355|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134356|NCT01283061|Zafirlukast|zafirlukast|mesh-list
139134357|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139134358|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
139134359|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139134360|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
139134361|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139134362|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134363|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139134364|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134365|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
139134366|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
139134367|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
139134368|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139134369|NCT01167465|Protective Agents|protective agents|mesh-ancestor
139134370|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134371|NCT01283217|Cisplatin|cisplatin|mesh-list
139134372|NCT01283217|Docetaxel|docetaxel|mesh-list
139134373|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134374|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
139134375|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
139134376|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
139134377|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134378|NCT01276431|Buprenorphine|buprenorphine|mesh-list
139134379|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139134380|NCT01276431|Narcotics|narcotics|mesh-ancestor
139134381|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134382|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134383|NCT01276431|Analgesics|analgesics|mesh-ancestor
139134384|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
139134385|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134386|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139134387|NCT01281579|Canagliflozin|canagliflozin|mesh-list
139134388|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139134389|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134390|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139134391|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134392|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139134393|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139134394|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134395|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139134396|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
139134397|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134399|NCT01166451|Trace Elements|trace elements|mesh-ancestor
139134400|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
139134401|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134402|NCT02526615|Metformin|metformin|mesh-list
139134403|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
139134404|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139134405|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134406|NCT01283763|Imiquimod|imiquimod|mesh-list
139134407|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139134408|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
139134409|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134410|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134411|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
139134412|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
139134413|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139134414|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134415|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139134416|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
139134417|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139134418|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139134419|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134420|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134421|NCT03872661|Bevacizumab|bevacizumab|mesh-list
139134422|NCT03872661|Carboplatin|carboplatin|mesh-list
139134423|NCT03872661|Pemetrexed|pemetrexed|mesh-list
139134424|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139134425|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134426|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139134427|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139134428|NCT03872661|Growth Substances|growth substances|mesh-ancestor
139134429|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134430|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
139134431|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707205|NCT00533585|Paclitaxel|paclitaxel|mesh-list
139134432|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134433|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139134434|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139134435|NCT01167699|Oxycodone|oxycodone|mesh-list
139134436|NCT01167699|Naloxone|naloxone|mesh-list
139134437|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139134438|NCT01167699|Narcotics|narcotics|mesh-ancestor
139134439|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134440|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134441|NCT01167699|Analgesics|analgesics|mesh-ancestor
139134442|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
139134443|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134444|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139134445|NCT02526303|Nadroparin|nadroparin|mesh-list
139134446|NCT02526303|Warfarin|warfarin|mesh-list
139134447|NCT02526303|Calcium|calcium|mesh-list
139134448|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139134449|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134450|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
139134451|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139134452|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139134453|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134454|NCT03869073|Evolocumab|evolocumab|mesh-list
139134455|NCT03869073|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139134456|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139134457|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139134458|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
138875162|NCT00642512|Analgesics|analgesics|mesh-ancestor
139134459|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134460|NCT03869073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139134461|NCT03869073|Protease Inhibitors|protease inhibitors|mesh-ancestor
139134462|NCT03869073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134463|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139134464|NCT01587495|Ertapenem|ertapenem|mesh-list
139134465|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139134466|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139134467|NCT01170351|Cyclosporine|cyclosporine|mesh-list
139134468|NCT01170351|Cyclosporins|cyclosporins|mesh-list
139134469|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134470|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134471|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139134472|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
139134473|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134474|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
139134475|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139134476|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
139134477|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139134478|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139134479|NCT01170429|Procaterol|procaterol|mesh-list
139134480|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139134481|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
139134482|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134483|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134484|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139134485|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
139134486|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
139134487|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139134488|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139134489|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139134490|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
139134491|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134492|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134493|NCT01170507|Vitamin D|vitamin d|mesh-list
139134494|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
139134495|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
139134496|NCT01170507|Vitamins|vitamins|mesh-list
138707223|NCT04659057|Lidocaine|lidocaine|mesh-list
139134497|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
139134498|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134499|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139134500|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139134501|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139134502|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139134503|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139134504|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
139134505|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134506|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139134507|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139134508|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134509|NCT01170819|Dinoprostone|dinoprostone|mesh-list
138527360|NCT00030641|Docetaxel|docetaxel|mesh-list
139134510|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
139134511|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139134512|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134513|NCT03868137|Ibuprofen|ibuprofen|mesh-list
139134514|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139134515|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139134516|NCT03868137|Analgesics|analgesics|mesh-ancestor
139134517|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
139134518|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134519|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134520|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139134521|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139134522|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139134523|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134524|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134525|NCT01283919|Pantoprazole|pantoprazole|mesh-list
139134526|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139134527|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139134528|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139134529|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134530|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134531|NCT01167933|Simvastatin|simvastatin|mesh-list
139134532|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139134533|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139134534|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
139134535|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134536|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139134537|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139134538|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134539|NCT01168011|ON 01910|on 01910|mesh-list
139134540|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134541|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139134542|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134543|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134544|NCT01171209|Interferons|interferons|mesh-list
139134545|NCT01171209|Interferon-beta|interferon-beta|mesh-list
139134546|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
139134547|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
139134548|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134549|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
139134550|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139134551|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
139134552|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134553|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139134554|NCT01166685|Everolimus|everolimus|mesh-list
139134555|NCT01166685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139134556|NCT01166685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138885077|NCT05366062|Cyclophosphamide|cyclophosphamide|mesh-list
139134557|NCT01166685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134558|NCT01166685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134559|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139134560|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
139134561|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134562|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134563|NCT03870711|Lidocaine|lidocaine|mesh-list
139134564|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
139134565|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
139134566|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134567|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134568|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
139134569|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134570|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139134572|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139134573|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139134574|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134575|NCT03872505|Paclitaxel|paclitaxel|mesh-list
139134576|NCT03872505|Carboplatin|carboplatin|mesh-list
139134577|NCT03872505|Durvalumab|durvalumab|mesh-list
139134578|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139134579|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134580|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
139134581|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
139134582|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
139134583|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134584|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139134585|NCT01171365|Ciclesonide|ciclesonide|mesh-list
139134586|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
139134587|NCT01171365|Hormones|hormones|mesh-ancestor
139134588|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139134589|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134590|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139134591|NCT01281891|Morphine|morphine|mesh-list
139134592|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139134593|NCT01281891|Narcotics|narcotics|mesh-ancestor
139134594|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134595|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134596|NCT01281891|Analgesics|analgesics|mesh-ancestor
139134597|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
139134598|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134599|NCT01282047|Lenalidomide|lenalidomide|mesh-list
139134600|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
139134601|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134602|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139134603|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139134604|NCT01282047|Growth Substances|growth substances|mesh-ancestor
139134605|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
139134606|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134607|NCT02525991|Loxapine|loxapine|mesh-list
139134608|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139134609|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138707248|NCT00533741|Antacids|antacids|mesh-ancestor
139134610|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134611|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134612|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139134613|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139134614|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
139134615|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134616|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134617|NCT01171755|Gemcitabine|gemcitabine|mesh-list
139134618|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139134619|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
139134620|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134621|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134622|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
139134623|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139134624|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
139134625|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134626|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134627|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139134628|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
139134629|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139134630|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
138885170|NCT02974049|Ivermectin|ivermectin|mesh-list
139134631|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134632|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134633|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139134634|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
139134636|NCT01172691|Protective Agents|protective agents|mesh-ancestor
139134637|NCT01171833|Sevoflurane|sevoflurane|mesh-list
139134638|NCT01171833|Desflurane|desflurane|mesh-list
139134639|NCT01171833|Isoflurane|isoflurane|mesh-list
139134640|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139134641|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139134642|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
139134643|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
138505010|NCT00042562|Analgesics|analgesics|mesh-ancestor
139134644|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134645|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134646|NCT01172769|Sirolimus|sirolimus|mesh-list
139134647|NCT01172769|Temsirolimus|temsirolimus|mesh-list
139134648|NCT01172769|MTOR Inhibitors|mtor inhibitors|mesh-list
139134649|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
139134650|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134651|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134652|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139134653|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
139134654|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134655|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134656|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139134657|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139134658|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139134659|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
139134660|NCT01584531|ON 01910|on 01910|mesh-list
139134661|NCT01584531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134662|NCT01584531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139134663|NCT01584531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134664|NCT01584531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134665|NCT01171911|Nicardipine|nicardipine|mesh-list
139134666|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
139134667|NCT01171911|Esmolol|esmolol|mesh-list
139134668|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139134669|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134670|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139134671|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139134672|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139134673|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
139134674|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875223|NCT02676986|Exemestane|exemestane|mesh-list
139134675|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134676|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139134677|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139134678|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
139134679|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
139134680|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139134681|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
139134682|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134683|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134684|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139134685|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
139134686|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
139134687|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139134688|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
139134689|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134690|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134691|NCT01173003|Misoprostol|misoprostol|mesh-list
139134692|NCT01173003|Mifepristone|mifepristone|mesh-list
139134693|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139134694|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
139134695|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139134696|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134697|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139134698|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139134699|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
139134700|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139134701|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139134702|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139134703|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139134704|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
139134705|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139134706|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139134707|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
139134708|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139134709|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
139134710|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139134711|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139134712|NCT03435003|Dexamethasone|dexamethasone|mesh-list
139134714|NCT03435003|Scopolamine|scopolamine|mesh-list
139134715|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
139134716|NCT03435003|Ondansetron|ondansetron|mesh-list
139134717|NCT03435003|Aprepitant|aprepitant|mesh-list
139134718|NCT03435003|Metoclopramide|metoclopramide|mesh-list
139134719|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
139134720|NCT03435003|Propofol|propofol|mesh-list
139134721|NCT03435003|Sevoflurane|sevoflurane|mesh-list
139134722|NCT03435003|Desflurane|desflurane|mesh-list
139134723|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139134724|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139134725|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
139134726|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
139134727|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134728|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134729|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139134730|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
139134731|NCT03435003|Hormones|hormones|mesh-ancestor
139134732|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139134733|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138707277|NCT00533936|Trastuzumab|trastuzumab|mesh-list
139134734|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134735|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
139134736|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134737|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139134738|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139134739|NCT03435003|Analgesics|analgesics|mesh-ancestor
139134740|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
139134741|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139134742|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139134743|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139134744|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
139134745|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134746|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134747|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139134748|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
139134749|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139134750|NCT03435003|Narcotics|narcotics|mesh-ancestor
139134751|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139134752|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139134753|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139134754|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
139134755|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
139134756|NCT03435003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139134757|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139134758|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
139134759|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139134760|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139134761|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139134762|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
139134763|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
139134764|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139134765|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
139134766|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139134767|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
139134768|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139134769|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139134770|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139134771|NCT01172223|Paclitaxel|paclitaxel|mesh-list
139134772|NCT01172223|Doxorubicin|doxorubicin|mesh-list
139134773|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139134774|NCT01172223|Lapatinib|lapatinib|mesh-list
139134775|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139134776|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134777|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
139134778|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
139134779|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
139134780|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134781|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139134782|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139134783|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139134784|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134785|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139134786|NCT01173081|Teriparatide|teriparatide|mesh-list
139134787|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139134788|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134789|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139134790|NCT03866733|Narcotics|narcotics|mesh-list
139134791|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134792|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134793|NCT03866733|Analgesics|analgesics|mesh-ancestor
139134794|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
139134795|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134796|NCT01168791|Doxorubicin|doxorubicin|mesh-list
139134797|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139134798|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
139134799|NCT01168791|Ifosfamide|ifosfamide|mesh-list
139134800|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139134801|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134802|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139134803|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139134804|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134805|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134806|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139134807|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
139134808|NCT01284309|Mirabegron|mirabegron|mesh-list
139134809|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139134810|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139134811|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139134812|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
139134813|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134814|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134815|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134816|NCT01284309|Urological Agents|urological agents|mesh-ancestor
139134817|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139134818|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
139134819|NCT01169025|Fentanyl|fentanyl|mesh-list
139134820|NCT01169025|Ketamine|ketamine|mesh-list
139134821|NCT01169025|Analgesics|analgesics|mesh-ancestor
139134822|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
139134823|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134824|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134825|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139134826|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139134827|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
139134828|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
139134829|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134830|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139134831|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139134832|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134833|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134834|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139134835|NCT01169025|Narcotics|narcotics|mesh-ancestor
139134836|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139134837|NCT01582347|Buprenorphine|buprenorphine|mesh-list
139134838|NCT01582347|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139134839|NCT01582347|Naloxone|naloxone|mesh-list
139134840|NCT01582347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139134841|NCT01582347|Narcotics|narcotics|mesh-ancestor
139134842|NCT01582347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134843|NCT01582347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134844|NCT01582347|Analgesics|analgesics|mesh-ancestor
139134845|NCT01582347|Sensory System Agents|sensory system agents|mesh-ancestor
139134846|NCT01582347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134847|NCT01582347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139134848|NCT01336634|Trametinib|trametinib|mesh-list
139134849|NCT01336634|Dabrafenib|dabrafenib|mesh-list
139134850|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134851|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139134852|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134853|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134854|NCT01284855|Antivenins|antivenins|mesh-list
139134855|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
139134856|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134857|NCT00785798|Doxorubicin|doxorubicin|mesh-list
139134858|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139134859|NCT00785798|Vorinostat|vorinostat|mesh-list
139134860|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139134861|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134862|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139134863|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139134864|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134865|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134866|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139134867|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
139134868|NCT01175109|Panobinostat|panobinostat|mesh-list
139134869|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134870|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139134871|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134872|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134873|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139134874|NCT01282515|Clobetasol|clobetasol|mesh-list
139134875|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139134876|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
139134877|NCT01282515|Hormones|hormones|mesh-ancestor
139134878|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139134879|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134880|NCT04732910|Ivacaftor|ivacaftor|mesh-list
139134881|NCT04732910|Elexacaftor|elexacaftor|mesh-list
139134882|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139134883|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139134884|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134885|NCT03329846|Nivolumab|nivolumab|mesh-list
139134886|NCT03329846|Linrodostat|linrodostat|mesh-list
139134887|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139134888|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134889|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139134890|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134891|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139134892|NCT04020848|Melatonin|melatonin|mesh-list
139134893|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
139134894|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134895|NCT04020848|Protective Agents|protective agents|mesh-ancestor
139134896|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134897|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134898|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139134899|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139134900|NCT01355302|Capecitabine|capecitabine|mesh-list
139134901|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139134902|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139134903|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
139134904|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134905|NCT01355068|Phenytoin|phenytoin|mesh-list
139134906|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
139134907|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139134908|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139134909|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139134910|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134911|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139134912|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139134913|NCT03562780|Acetaminophen|acetaminophen|mesh-list
139134914|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139134915|NCT03562780|Analgesics|analgesics|mesh-ancestor
139134916|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
139134917|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134918|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134919|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
139134920|NCT02259946|Bromides|bromides|mesh-list
139134921|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
139134922|NCT02259946|Olodaterol|olodaterol|mesh-list
139134923|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139134924|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
139134925|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875297|NCT04032834|Hormones|hormones|mesh-ancestor
139134926|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134927|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139134928|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
139134929|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
139134930|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138885452|NCT00995293|Docetaxel|docetaxel|mesh-list
139134931|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
139134932|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134933|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134934|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
139134936|NCT03756129|Analgesics|analgesics|mesh-ancestor
139134937|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
139134938|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139134939|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134940|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139134941|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139134942|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
139134943|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
138505312|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
139134944|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134945|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139134946|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139134947|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134948|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134949|NCT03863691|Amisulpride|amisulpride|mesh-list
139134950|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139134951|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139134952|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134953|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134954|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139134955|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139134956|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
139134957|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134958|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134959|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139134960|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
139134962|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
139134963|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139134964|NCT02822794|Velpatasvir|velpatasvir|mesh-list
139134965|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
139134966|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134967|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
139134968|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139134969|NCT01173315|Vitamins|vitamins|mesh-list
139134970|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
139134971|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134972|NCT01173549|Canagliflozin|canagliflozin|mesh-list
139134973|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139134974|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134975|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139134976|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134977|NCT01338298|Aripiprazole|aripiprazole|mesh-list
139134978|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
139134979|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139134980|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139134981|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139134982|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139134983|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139134984|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
139134985|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
139134986|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139134987|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139134988|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139134989|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139134990|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
139134991|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139134992|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139134993|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139134994|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139134995|NCT01169415|Dexamethasone|dexamethasone|mesh-list
139134996|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
139134997|NCT01169415|BB 1101|bb 1101|mesh-list
139134998|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139134999|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
139135000|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
139135001|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135002|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135003|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138885538|NCT00653822|Alefacept|alefacept|mesh-list
139135004|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
139135005|NCT01169415|Hormones|hormones|mesh-ancestor
139135006|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139135007|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139135008|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135009|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
139135010|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135011|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135012|NCT01173627|Fentanyl|fentanyl|mesh-list
139135013|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139135014|NCT01173627|Narcotics|narcotics|mesh-ancestor
139135015|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135016|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135017|NCT01173627|Analgesics|analgesics|mesh-ancestor
139135018|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
139135019|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135020|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139135021|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139135022|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
139135023|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
139135024|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
139135025|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139135026|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135027|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135028|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139135029|NCT01169571|Analgesics|analgesics|mesh-ancestor
139135030|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
139135031|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135032|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139135034|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139135035|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
139135036|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139135037|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135038|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
139135039|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139135040|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
139135041|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135042|NCT01354132|Expectorants|expectorants|mesh-ancestor
139135043|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
139135044|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139135045|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
139135046|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135047|NCT01354132|Protective Agents|protective agents|mesh-ancestor
139135048|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135049|NCT01354132|Antidotes|antidotes|mesh-ancestor
139135050|NCT05707936|Heparin|heparin|mesh-list
139135051|NCT05707936|Anticoagulants|anticoagulants|mesh-ancestor
139135052|NCT05707936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139135053|NCT05707936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139135054|NCT05707936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135055|NCT01372150|Fluoxetine|fluoxetine|mesh-list
139135056|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139135057|NCT01372150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139135058|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139135059|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139135060|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135061|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139135062|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
139135063|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135064|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139135065|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
139135066|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139135067|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139135068|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139135069|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135070|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139135071|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139135072|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139135073|NCT01175577|Carotenoids|carotenoids|mesh-list
139135074|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
139135075|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135076|NCT01175577|Protective Agents|protective agents|mesh-ancestor
139135077|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135078|NCT01175733|Panitumumab|panitumumab|mesh-list
139135079|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139135080|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135081|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
139135082|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139135083|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135084|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135085|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139135086|NCT02035930|Analgesics|analgesics|mesh-ancestor
139135087|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
139135088|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135089|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139135090|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139135092|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
139135093|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139135094|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135095|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139135096|NCT01173939|Pravastatin|pravastatin|mesh-list
139135097|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139135098|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139135099|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
139135100|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135101|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139135102|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139135103|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135104|NCT01174017|Iodine|iodine|mesh-list
139135105|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
139135106|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139135107|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135108|NCT01174017|Trace Elements|trace elements|mesh-ancestor
139135109|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
139135110|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135111|NCT01288131|Cyclosporine|cyclosporine|mesh-list
139135112|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
139135113|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
139135114|NCT01288131|Cyclosporins|cyclosporins|mesh-list
139135115|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139135116|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
139135117|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135118|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139135119|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139135120|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
139135121|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135122|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135123|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139135124|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135125|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
139135126|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135127|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
139135128|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139135129|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139135130|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139135131|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
139135132|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139135133|NCT02525211|Ropivacaine|ropivacaine|mesh-list
139135134|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
139135135|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
139135136|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135137|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135138|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
139135139|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135140|NCT03865563|Gemcitabine|gemcitabine|mesh-list
139135141|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
139135142|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139135143|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
139135144|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875366|NCT00962299|Beclomethasone|beclomethasone|mesh-list
139135145|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135146|NCT01178151|Everolimus|everolimus|mesh-list
139135147|NCT01178151|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139135148|NCT01178151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139135149|NCT01178151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135150|NCT01178151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135151|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139135152|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
139135153|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135154|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135156|NCT03862287|Bupivacaine|bupivacaine|mesh-list
139135157|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
139135158|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
139135159|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135160|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135161|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
139135162|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135163|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139135164|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139135165|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139135166|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139135167|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135168|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139135169|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139135170|NCT01287351|Fluticasone|fluticasone|mesh-list
139135172|NCT01287351|Beclomethasone|beclomethasone|mesh-list
139135173|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139135174|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139135175|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
139135176|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135177|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135178|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139135179|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
139135180|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
139135181|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139135182|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
139135183|NCT01287351|Hormones|hormones|mesh-ancestor
139135184|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139135185|NCT03864783|Curcumin|curcumin|mesh-list
139135186|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139135187|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139135188|NCT03864783|Analgesics|analgesics|mesh-ancestor
139135189|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
139135190|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135191|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135192|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139135193|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139135194|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135195|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135196|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135197|NCT01287507|Lactoferrin|lactoferrin|mesh-list
139135198|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135199|NCT03864705|Metformin|metformin|mesh-list
139135200|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139135201|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135202|NCT01287663|Permethrin|permethrin|mesh-list
139135203|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135204|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135205|NCT01176669|Apatinib|apatinib|mesh-list
139135206|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135207|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139135208|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135209|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135210|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
139135211|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139135212|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
139135213|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135214|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135215|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139135216|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
139135217|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139135218|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139135219|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139135220|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
139135221|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139135222|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135223|NCT01174953|Finasteride|finasteride|mesh-list
139135224|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139135225|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139135226|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135227|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135228|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
139135229|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139135230|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135231|NCT01174953|Urological Agents|urological agents|mesh-ancestor
139135232|NCT01286103|Canagliflozin|canagliflozin|mesh-list
139135233|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138890359|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139135234|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135236|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135237|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
139135238|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
138707447|NCT05449522|Vitamins|vitamins|mesh-ancestor
139135239|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139135240|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
139135241|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135242|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135243|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139135244|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
139135245|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
139135246|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139135247|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
139135248|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139135249|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135250|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139135251|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139135253|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139135254|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135255|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135256|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139135257|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
139135258|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
139135259|NCT01178697|Triamcinolone|triamcinolone|mesh-list
139135260|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139135261|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139135262|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139135263|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139135264|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
139135265|NCT01178697|Hormones|hormones|mesh-ancestor
139135266|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139135267|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135268|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139135269|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
139135270|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135271|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135272|NCT03329690|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139135273|NCT03329690|Immunoconjugates|immunoconjugates|mesh-ancestor
139135274|NCT03329690|Immunologic Factors|immunologic factors|mesh-ancestor
139135275|NCT03329690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135276|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
139135277|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
139135278|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
139135279|NCT03328832|Thrombin|thrombin|mesh-list
139135280|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139135281|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139135282|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135283|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
139135284|NCT03328832|Coagulants|coagulants|mesh-ancestor
139135285|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139135286|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
139135287|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139135288|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
139135289|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135290|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
139135291|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
139135292|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139135293|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139135294|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139135295|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139135296|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135297|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135298|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138885834|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139135299|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135300|NCT02942576|Warfarin|warfarin|mesh-list
139135301|NCT02942576|Edoxaban|edoxaban|mesh-list
139135302|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
139135303|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
139135304|NCT02942576|Fluindione|fluindione|mesh-list
139135305|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
139135306|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139135307|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
139135308|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139135309|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
139135310|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135311|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135312|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
139135313|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138875426|NCT02801201|Midazolam|midazolam|mesh-list
139135314|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135316|NCT02036008|Hematinics|hematinics|mesh-ancestor
139135317|NCT02819440|Tadalafil|tadalafil|mesh-list
139135318|NCT02819440|Vasodilator Agents|vasodilator agents|mesh-ancestor
139135319|NCT02819440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139135320|NCT02819440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139135321|NCT02819440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135322|NCT02819440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135323|NCT02819440|Urological Agents|urological agents|mesh-ancestor
139135324|NCT03562468|Niacinamide|niacinamide|mesh-list
139135325|NCT03562468|Niacin|niacin|mesh-list
139135326|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
139135327|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
139135328|NCT03562468|Vitamins|vitamins|mesh-ancestor
139135329|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
139135330|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135331|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139135332|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
139135333|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135334|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139135335|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
139135336|NCT02036164|Paclitaxel|paclitaxel|mesh-list
139135337|NCT02036164|Cisplatin|cisplatin|mesh-list
139135338|NCT02036164|Carboplatin|carboplatin|mesh-list
139135339|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139135340|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135341|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
139135342|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
139135343|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
139135344|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135345|NCT02818036|Naltrexone|naltrexone|mesh-list
139135346|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139135347|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139135348|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135349|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
139135350|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135351|NCT01287741|Prednisone|prednisone|mesh-list
139135352|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
139135353|NCT01287741|Rituximab|rituximab|mesh-list
139135354|NCT01287741|Doxorubicin|doxorubicin|mesh-list
139135355|NCT01287741|Vincristine|vincristine|mesh-list
139135356|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
139135357|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139135358|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
139135359|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135360|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139135361|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139135362|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
139135363|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135364|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135365|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138875445|NCT04182932|Vaccines|vaccines|mesh-list
139135366|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139135367|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139135368|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139135369|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139135370|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135371|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139135372|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
139135373|NCT01287741|Hormones|hormones|mesh-ancestor
138885914|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
139135374|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139135375|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139135376|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139135377|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
139135378|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
139135379|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
139135380|NCT01180959|Bevacizumab|bevacizumab|mesh-list
139135381|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139135382|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139135383|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135384|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139135385|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139135386|NCT01180959|Growth Substances|growth substances|mesh-ancestor
139135387|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135388|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
139135389|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139135390|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135391|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135392|NCT01177371|Cyclosporine|cyclosporine|mesh-list
139135393|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
139135394|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139135395|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139135396|NCT01177371|Prednisolone|prednisolone|mesh-list
139135397|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
139135398|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
139135399|NCT01177371|Busulfan|busulfan|mesh-list
139135400|NCT01177371|Methotrexate|methotrexate|mesh-list
139135401|NCT01177371|Cyclosporins|cyclosporins|mesh-list
139135402|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139135403|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
139135404|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139135405|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
139135406|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135407|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139135408|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139135409|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
139135410|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135411|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135412|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139135413|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139135414|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
139135415|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139135416|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139135417|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
139135418|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
139135419|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135420|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139135421|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139135422|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
139135423|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135424|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139135425|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139135427|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
139135428|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135429|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139135430|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
139135431|NCT01177371|Hormones|hormones|mesh-ancestor
139135432|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139135433|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139135435|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139135436|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
139135437|NCT01178931|Progesterone|progesterone|mesh-list
139135438|NCT01178931|Progestins|progestins|mesh-ancestor
139135440|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139135441|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135442|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
139135443|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139135444|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
138890758|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135445|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135446|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135447|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
139135448|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135449|NCT01181193|Vitamin D|vitamin d|mesh-list
139135450|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
139135451|NCT01181193|Temozolomide|temozolomide|mesh-list
139135452|NCT01181193|Vitamins|vitamins|mesh-ancestor
139135453|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
139135454|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135455|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139135456|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139135457|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
139135458|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135459|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135460|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139135461|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
139135462|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135463|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135464|NCT03855579|Simendan|simendan|mesh-list
139135465|NCT03855579|Milrinone|milrinone|mesh-list
139135466|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139135467|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
139135468|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139135469|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139135470|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890831|NCT02701595|Penicillin G|penicillin g|mesh-list
139135471|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707510|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135473|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135474|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139135475|NCT03855423|Tocotrienols|tocotrienols|mesh-list
139135476|NCT03855423|Vitamin E|vitamin e|mesh-list
139135477|NCT03855423|Tocopherols|tocopherols|mesh-list
139135478|NCT03855423|Tocovid|tocovid|mesh-list
139135479|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
139135480|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135481|NCT03855423|Protective Agents|protective agents|mesh-ancestor
139135482|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135483|NCT03855423|Vitamins|vitamins|mesh-ancestor
139135485|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139135486|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139135487|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139135488|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
139135489|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138890953|NCT02701127|Vitamins|vitamins|mesh-ancestor
139135490|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135491|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135493|NCT01290783|Irinotecan|irinotecan|mesh-list
139135494|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139135495|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139135496|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135497|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135498|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135499|NCT03857763|Paclitaxel|paclitaxel|mesh-list
139135500|NCT03857763|Apatinib|apatinib|mesh-list
139135501|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139135502|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135503|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
139135504|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
139135505|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
139135506|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135507|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139135508|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135509|NCT06008522|Bevacizumab|bevacizumab|mesh-list
139135511|NCT06008522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135512|NCT06008522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139135513|NCT06008522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139135514|NCT06008522|Growth Substances|growth substances|mesh-ancestor
139135515|NCT06008522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135516|NCT06008522|Growth Inhibitors|growth inhibitors|mesh-ancestor
139135517|NCT06008327|Tretinoin|tretinoin|mesh-list
139135518|NCT06008327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135519|NCT06008327|Keratolytic Agents|keratolytic agents|mesh-ancestor
139135520|NCT06008327|Dermatologic Agents|dermatologic agents|mesh-ancestor
139135521|NCT06008249|Lithium Carbonate|lithium carbonate|mesh-list
139135522|NCT06008249|Antidepressive Agents|antidepressive agents|mesh-ancestor
139135523|NCT06008249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139135524|NCT06008249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135525|NCT06008249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135526|NCT06008249|Antimanic Agents|antimanic agents|mesh-ancestor
139135527|NCT06008249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139135528|NCT06008249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135529|NCT06008249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135530|NCT06008223|Vitamin B 6|vitamin b 6|mesh-list
139135531|NCT06008223|Pyridoxal|pyridoxal|mesh-list
139135532|NCT06008223|Pyridoxine|pyridoxine|mesh-list
139135533|NCT06008223|Vitamins|vitamins|mesh-ancestor
139135534|NCT06008223|Micronutrients|micronutrients|mesh-ancestor
139135535|NCT06008223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891514|NCT01015339|Paclitaxel|paclitaxel|mesh-list
139135536|NCT06008223|Vitamin B Complex|vitamin b complex|mesh-ancestor
139135537|NCT06008119|Bevacizumab|bevacizumab|mesh-list
139135538|NCT06008119|Cetuximab|cetuximab|mesh-list
139135539|NCT06008119|Vemurafenib|vemurafenib|mesh-list
138891612|NCT00920998|Z 338|z 338|mesh-list
139135540|NCT06008119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139135541|NCT06008119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135542|NCT06008119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139135543|NCT06008119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139135544|NCT06008119|Growth Substances|growth substances|mesh-ancestor
139135545|NCT06008119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135546|NCT06008119|Growth Inhibitors|growth inhibitors|mesh-ancestor
139135547|NCT06008119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139135548|NCT06008119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891660|NCT00676286|Choline|choline|mesh-list
139135549|NCT06008119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135550|NCT06008106|Paclitaxel|paclitaxel|mesh-list
139135551|NCT06008106|Cisplatin|cisplatin|mesh-list
139135552|NCT06008106|Carboplatin|carboplatin|mesh-list
139135553|NCT06008106|Temozolomide|temozolomide|mesh-list
139135554|NCT06008106|Dacarbazine|dacarbazine|mesh-list
138875497|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
139135555|NCT06008106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139135556|NCT06008106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135558|NCT06008106|Antimitotic Agents|antimitotic agents|mesh-ancestor
139135559|NCT06008106|Mitosis Modulators|mitosis modulators|mesh-ancestor
139135560|NCT06008106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135561|NCT06008106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139135562|NCT06008106|Alkylating Agents|alkylating agents|mesh-ancestor
139135563|NCT06007937|Ramucirumab|ramucirumab|mesh-list
139135564|NCT06007937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135565|NCT06007573|Nimodipine|nimodipine|mesh-list
139135566|NCT06007573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139135567|NCT06007573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139135568|NCT06007573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138891926|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139135569|NCT06007573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135570|NCT06007573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139135571|NCT06007573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135572|NCT06007573|Vasodilator Agents|vasodilator agents|mesh-ancestor
139135573|NCT06007222|Aspirin|aspirin|mesh-list
139135574|NCT06007222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139135575|NCT06007222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139135576|NCT06007222|Analgesics|analgesics|mesh-ancestor
139135577|NCT06007222|Sensory System Agents|sensory system agents|mesh-ancestor
139135578|NCT06007222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135579|NCT06007222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135580|NCT06007222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138892144|NCT06099184|Aflibercept|aflibercept|mesh-list
139135582|NCT06007222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139135583|NCT06007222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139135584|NCT06007222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135585|NCT06007222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139135586|NCT06007222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139135587|NCT06007222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135588|NCT06007222|Antipyretics|antipyretics|mesh-ancestor
139135589|NCT06006949|Luspatercept|luspatercept|mesh-list
139135590|NCT06006949|Hematinics|hematinics|mesh-ancestor
139135591|NCT06006923|Pembrolizumab|pembrolizumab|mesh-list
139135592|NCT06006923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139135594|NCT06006923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139135595|NCT06006923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135596|NCT06006663|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139135597|NCT06006663|Metronidazole|metronidazole|mesh-list
139135598|NCT06006663|Ciprofloxacin|ciprofloxacin|mesh-list
139135599|NCT06006663|Clindamycin|clindamycin|mesh-list
139135600|NCT06006663|Ibuprofen|ibuprofen|mesh-list
139135601|NCT06006663|Curcumin|curcumin|mesh-list
139135602|NCT06006663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135603|NCT06006663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139135604|NCT06006663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139135605|NCT06006663|Analgesics|analgesics|mesh-ancestor
139135606|NCT06006663|Sensory System Agents|sensory system agents|mesh-ancestor
139135607|NCT06006663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135608|NCT06006663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135609|NCT06006663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139135610|NCT06006663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139135611|NCT06006663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139135612|NCT06006663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135613|NCT06006663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135615|NCT06006663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139135616|NCT06006663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138892467|NCT05605366|Minocycline|minocycline|mesh-list
139135617|NCT06006663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139135618|NCT06006663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135619|NCT06006663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139135620|NCT06006663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139135621|NCT06006663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139135623|NCT06006650|Pembrolizumab|pembrolizumab|mesh-list
139135624|NCT06006650|Fluorouracil|fluorouracil|mesh-list
139135625|NCT06006650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139135627|NCT06006650|Tubulin Modulators|tubulin modulators|mesh-ancestor
139135628|NCT06006650|Antimitotic Agents|antimitotic agents|mesh-ancestor
139135630|NCT06006650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135631|NCT06006650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139135632|NCT06006650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139135633|NCT06006650|Antimetabolites|antimetabolites|mesh-ancestor
139135634|NCT06006650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139135635|NCT06006650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139135636|NCT06006650|Immunologic Factors|immunologic factors|mesh-ancestor
139135637|NCT06006650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135638|NCT06006624|Dexamethasone|dexamethasone|mesh-list
139135639|NCT06006624|Bupivacaine|bupivacaine|mesh-list
139135640|NCT06006624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139135641|NCT06006624|Antiemetics|antiemetics|mesh-ancestor
139135642|NCT06006624|Autonomic Agents|autonomic agents|mesh-ancestor
139135643|NCT06006624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135644|NCT06006624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135645|NCT06006624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139135646|NCT06006624|Glucocorticoids|glucocorticoids|mesh-ancestor
139135648|NCT06006624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139135649|NCT06006624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139135650|NCT06006624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135651|NCT06006624|Anesthetics, Local|anesthetics, local|mesh-ancestor
139135652|NCT06006624|Anesthetics|anesthetics|mesh-ancestor
139135653|NCT06006624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135654|NCT06006624|Sensory System Agents|sensory system agents|mesh-ancestor
139135655|NCT06006143|Varenicline|varenicline|mesh-list
139135656|NCT06006143|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139135657|NCT06006143|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139135658|NCT06006143|Cholinergic Agents|cholinergic agents|mesh-ancestor
139135659|NCT06006143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707561|NCT04663269|Dexamethasone|dexamethasone|mesh-list
139135660|NCT06006143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135661|NCT06006143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135663|NCT06006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135664|NCT06006091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138893179|NCT04292873|Vitamin D|vitamin d|mesh-list
139135665|NCT06006091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139135666|NCT06006091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135667|NCT06006091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135668|NCT06006091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139135669|NCT06006091|Hormone Antagonists|hormone antagonists|mesh-ancestor
139135670|NCT06006091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139135671|NCT06006091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135673|NCT06005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135674|NCT06005870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139135675|NCT06005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135676|NCT06005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135677|NCT06002789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139135679|NCT06002789|Immunoglobulins|immunoglobulins|mesh-list
138893396|NCT04038346|Acetaminophen|acetaminophen|mesh-list
139135680|NCT06002789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139135681|NCT06002789|Immunologic Factors|immunologic factors|mesh-ancestor
139135682|NCT06002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135683|NCT06002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135684|NCT06002295|Chlorhexidine|chlorhexidine|mesh-list
139135685|NCT06002295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139135686|NCT06002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135687|NCT06002295|Disinfectants|disinfectants|mesh-ancestor
139135688|NCT05995457|Haloperidol|haloperidol|mesh-list
139135689|NCT05995457|Haloperidol decanoate|haloperidol decanoate|mesh-list
139135690|NCT05995457|Antiemetics|antiemetics|mesh-ancestor
139135691|NCT05995457|Autonomic Agents|autonomic agents|mesh-ancestor
138875577|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
139135692|NCT05995457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135693|NCT05995457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135694|NCT05995457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139135695|NCT05995457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139135696|NCT05995457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139135697|NCT05995457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135698|NCT05995457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139135699|NCT05995457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139135700|NCT05995457|Dopamine Agents|dopamine agents|mesh-ancestor
139135701|NCT05995457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139135702|NCT05995457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135703|NCT05995457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139135705|NCT05988528|Mesalamine|mesalamine|mesh-list
139135706|NCT05988528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139135707|NCT05988528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139135708|NCT05988528|Analgesics|analgesics|mesh-ancestor
139135709|NCT05988528|Sensory System Agents|sensory system agents|mesh-ancestor
139135710|NCT05988528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893744|NCT03436862|Nivolumab|nivolumab|mesh-list
139135711|NCT05988528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135712|NCT05988528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139135713|NCT05988528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139135714|NCT05988528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893814|NCT03131765|Poly I-C|poly i-c|mesh-list
139135715|NCT05986318|Acetylcysteine|acetylcysteine|mesh-list
139135716|NCT05986318|Dexamethasone|dexamethasone|mesh-list
139135717|NCT05986318|Dexamethasone acetate|dexamethasone acetate|mesh-list
139135718|NCT05986318|BB 1101|bb 1101|mesh-list
139135719|NCT05986318|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138893878|NCT02795156|Afatinib|afatinib|mesh-list
139135720|NCT05986318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139135721|NCT05986318|Antiemetics|antiemetics|mesh-ancestor
139135722|NCT05986318|Autonomic Agents|autonomic agents|mesh-ancestor
138893948|NCT02501954|Carboplatin|carboplatin|mesh-list
139135723|NCT05986318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135724|NCT05986318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135725|NCT05986318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139135726|NCT05986318|Glucocorticoids|glucocorticoids|mesh-ancestor
139135728|NCT05986318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139135729|NCT05986318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139135730|NCT05986318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135731|NCT05986318|Protease Inhibitors|protease inhibitors|mesh-ancestor
139135732|NCT05986318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135733|NCT05986318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135734|NCT05986318|Antiviral Agents|antiviral agents|mesh-ancestor
139135735|NCT05986318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135736|NCT05986318|Expectorants|expectorants|mesh-ancestor
139135737|NCT05986318|Respiratory System Agents|respiratory system agents|mesh-ancestor
138894021|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
139135739|NCT05986318|Antioxidants|antioxidants|mesh-ancestor
139135740|NCT05986318|Protective Agents|protective agents|mesh-ancestor
139135742|NCT05981573|Methadone|methadone|mesh-list
139135743|NCT05981573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139135744|NCT05981573|Narcotics|narcotics|mesh-ancestor
139135745|NCT05981573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135746|NCT05981573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135747|NCT05981573|Analgesics|analgesics|mesh-ancestor
139135748|NCT05981573|Sensory System Agents|sensory system agents|mesh-ancestor
138894155|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139135749|NCT05981573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135750|NCT05981573|Antitussive Agents|antitussive agents|mesh-ancestor
139135751|NCT05981573|Respiratory System Agents|respiratory system agents|mesh-ancestor
139135752|NCT05962957|Pentoxifylline|pentoxifylline|mesh-list
139135753|NCT05962957|Levodopa|levodopa|mesh-list
139135754|NCT05962957|Carbidopa|carbidopa|mesh-list
139135755|NCT05962957|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139135756|NCT05962957|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139135757|NCT05962957|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139135758|NCT05962957|Dopamine Agents|dopamine agents|mesh-ancestor
139135759|NCT05962957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139135760|NCT05962957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135761|NCT05962957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135762|NCT05962957|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139135763|NCT05962957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135764|NCT05962957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139135765|NCT05962957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139135766|NCT05962957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139135767|NCT05962957|Protective Agents|protective agents|mesh-ancestor
138707603|NCT00535379|Sunitinib|sunitinib|mesh-list
139135768|NCT05962957|Vasodilator Agents|vasodilator agents|mesh-ancestor
139135769|NCT05962957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139135770|NCT05962957|Antioxidants|antioxidants|mesh-ancestor
139135771|NCT05962957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139135772|NCT05962957|Immunologic Factors|immunologic factors|mesh-ancestor
139135773|NCT05962957|Dopamine Agonists|dopamine agonists|mesh-ancestor
139135774|NCT05957848|Guanfacine|guanfacine|mesh-list
139135775|NCT05957848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139135776|NCT05957848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138894500|NCT00680732|Hematinics|hematinics|mesh-ancestor
139135777|NCT05957848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139135778|NCT05957848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139135779|NCT05957848|Adrenergic Agents|adrenergic agents|mesh-ancestor
139135780|NCT05957848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139135781|NCT05957848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135782|NCT05957848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135783|NCT05928871|Misoprostol|misoprostol|mesh-list
139135784|NCT05928871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139135785|NCT05928871|Abortifacient Agents|abortifacient agents|mesh-ancestor
139135786|NCT05928871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139135787|NCT05928871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135788|NCT05928871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139135789|NCT05928871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139135791|NCT05906914|Cytarabine|cytarabine|mesh-list
139135792|NCT05906914|Cladribine|cladribine|mesh-list
139135793|NCT05906914|Homoharringtonine|homoharringtonine|mesh-list
139135794|NCT05906914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139135795|NCT05906914|Antimetabolites|antimetabolites|mesh-ancestor
138894703|NCT00577096|Thalidomide|thalidomide|mesh-list
139135796|NCT05906914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135797|NCT05906914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135798|NCT05906914|Antiviral Agents|antiviral agents|mesh-ancestor
139135799|NCT05906914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135800|NCT05906914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138894784|NCT00863304|Naproxen|naproxen|mesh-list
139135801|NCT05906914|Immunologic Factors|immunologic factors|mesh-ancestor
139135802|NCT05906914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135803|NCT05906914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139135804|NCT05906914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139135805|NCT05906914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135806|NCT05902533|Capecitabine|capecitabine|mesh-list
139135807|NCT05902533|Mitomycins|mitomycins|mesh-list
139135808|NCT05902533|Mitomycin|mitomycin|mesh-list
139135809|NCT05902533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139135810|NCT05902533|Antimetabolites|antimetabolites|mesh-ancestor
139135811|NCT05902533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135812|NCT05902533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135813|NCT05902533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139135814|NCT05902533|Alkylating Agents|alkylating agents|mesh-ancestor
139135815|NCT05902533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139135816|NCT05902533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135817|NCT05892237|Immunomodulating Agents|immunomodulating agents|mesh-list
139135819|NCT05892237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135820|NCT05840016|Carboplatin|carboplatin|mesh-list
139135822|NCT05840016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135823|NCT05840016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139135824|NCT05802264|Amphotericin B|amphotericin b|mesh-list
139135825|NCT05802264|Amebicides|amebicides|mesh-ancestor
139135826|NCT05802264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139135827|NCT05802264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139135828|NCT05802264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135829|NCT05802264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139135830|NCT05802264|Antifungal Agents|antifungal agents|mesh-ancestor
139135831|NCT05797870|Ethiodized Oil|ethiodized oil|mesh-list
138886365|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
139135832|NCT05797870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135833|NCT05790213|Androgens|androgens|mesh-list
139135834|NCT05790213|Hormones|hormones|mesh-ancestor
139135835|NCT05790213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138895193|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139135836|NCT05790213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135837|NCT05777733|Acetylcysteine|acetylcysteine|mesh-list
139135838|NCT05777733|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139135839|NCT05777733|Antidotes|antidotes|mesh-ancestor
139135840|NCT05777733|Protective Agents|protective agents|mesh-ancestor
139135841|NCT05777733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135842|NCT05777733|Antioxidants|antioxidants|mesh-ancestor
138895268|NCT00621101|Sirolimus|sirolimus|mesh-list
139135843|NCT05777733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135844|NCT05777733|Antiviral Agents|antiviral agents|mesh-ancestor
139135845|NCT05777733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135846|NCT05777733|Expectorants|expectorants|mesh-ancestor
139135847|NCT05777733|Respiratory System Agents|respiratory system agents|mesh-ancestor
139135848|NCT05777733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139135849|NCT05777109|Denosumab|denosumab|mesh-list
138895331|NCT00700284|Dapivirine|dapivirine|mesh-list
139135850|NCT05777109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139135851|NCT05777109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135853|NCT05773365|Anesthetics, Local|anesthetics, local|mesh-list
139135854|NCT05773365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139135855|NCT05773365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135856|NCT05773365|Sensory System Agents|sensory system agents|mesh-ancestor
138895402|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135858|NCT05683223|Sertraline|sertraline|mesh-list
139135859|NCT05683223|Antidepressive Agents|antidepressive agents|mesh-ancestor
139135860|NCT05683223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138895471|NCT03854227|Docetaxel|docetaxel|mesh-list
139135861|NCT05683223|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139135862|NCT05683223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139135863|NCT05683223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139135864|NCT05683223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135865|NCT05683223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139135866|NCT05683223|Serotonin Agents|serotonin agents|mesh-ancestor
139135867|NCT05683223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135868|NCT05665387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139135869|NCT05665387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139135870|NCT05525455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139135871|NCT05525455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135872|NCT05525455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139135873|NCT05525455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135874|NCT05471609|Levodopa|levodopa|mesh-list
139135875|NCT05471609|Carbidopa|carbidopa|mesh-list
139135876|NCT05471609|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139135877|NCT05471609|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139135879|NCT05471609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139135880|NCT05471609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895747|NCT04187417|Tetracaine|tetracaine|mesh-list
139135881|NCT05471609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135882|NCT05471609|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139135884|NCT05410782|Vitamins|vitamins|mesh-list
139135885|NCT05410782|Micronutrients|micronutrients|mesh-ancestor
139135886|NCT05410782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135887|NCT05383482|Paclitaxel|paclitaxel|mesh-list
139135888|NCT05383482|Docetaxel|docetaxel|mesh-list
139135889|NCT05383482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139135890|NCT05383482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135891|NCT05383482|Tubulin Modulators|tubulin modulators|mesh-ancestor
139135892|NCT05383482|Antimitotic Agents|antimitotic agents|mesh-ancestor
139135893|NCT05383482|Mitosis Modulators|mitosis modulators|mesh-ancestor
138895878|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135894|NCT05383482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135895|NCT05372315|Dexamethasone|dexamethasone|mesh-list
139135896|NCT05372315|Dexamethasone acetate|dexamethasone acetate|mesh-list
139135898|NCT05372315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139135899|NCT05372315|Antiemetics|antiemetics|mesh-ancestor
139135900|NCT05372315|Autonomic Agents|autonomic agents|mesh-ancestor
139135901|NCT05372315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139135902|NCT05372315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895958|NCT00499681|Letrozole|letrozole|mesh-list
139135903|NCT05372315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139135904|NCT05372315|Glucocorticoids|glucocorticoids|mesh-ancestor
139135905|NCT05372315|Hormones|hormones|mesh-ancestor
139135906|NCT05372315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139135907|NCT05372315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139135908|NCT05372315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135910|NCT05372315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135911|NCT05372315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135912|NCT05242315|Tacrolimus|tacrolimus|mesh-list
139135913|NCT05242315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139135914|NCT05242315|Immunologic Factors|immunologic factors|mesh-ancestor
139135915|NCT05242315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135916|NCT05242315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139135917|NCT05242315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135918|NCT05242315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135920|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139135921|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139135922|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139135923|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138896222|NCT00809835|Galantamine|galantamine|mesh-list
139135924|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
139135925|NCT05190770|Hormones|hormones|mesh-ancestor
139135926|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139135927|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896296|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
139135928|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139135929|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
138875711|NCT00684099|Docetaxel|docetaxel|mesh-list
139135930|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896364|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139135931|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135933|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139135934|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
139135935|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135936|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139135937|NCT05121883|Protective Agents|protective agents|mesh-ancestor
139135938|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135940|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139135941|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135942|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139135943|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135944|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
139135945|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139135946|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
139135947|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135948|NCT04914741|Prednisolone|prednisolone|mesh-list
139135949|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
139135950|NCT04914741|Rituximab|rituximab|mesh-list
139135951|NCT04914741|Doxorubicin|doxorubicin|mesh-list
139135952|NCT04914741|Vincristine|vincristine|mesh-list
139135953|NCT04914741|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139135954|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139135955|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
139135956|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135957|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139135958|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139135959|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
138707629|NCT04679064|Niraparib|niraparib|mesh-list
139135960|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135961|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139135962|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139135963|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139135964|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139135965|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139135966|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139135967|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135968|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139135969|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
139135970|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
139135971|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
139135972|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139135973|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
139135974|NCT04914741|Hormones|hormones|mesh-ancestor
139135975|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139135976|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139135977|NCT04914741|Immunoconjugates|immunoconjugates|mesh-ancestor
139135978|NCT04913675|Sotrovimab|sotrovimab|mesh-list
139135979|NCT04913675|Antiviral Agents|antiviral agents|mesh-ancestor
139135980|NCT04913675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139135982|NCT04862260|Ezetimibe|ezetimibe|mesh-list
139135984|NCT04862260|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139135985|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139135987|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
139135988|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135989|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139135990|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139135991|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139135992|NCT04862260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139135993|NCT04862260|Protease Inhibitors|protease inhibitors|mesh-ancestor
139135994|NCT04795336|Melatonin|melatonin|mesh-list
139135995|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
139135996|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139135997|NCT04795336|Protective Agents|protective agents|mesh-ancestor
139135998|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139135999|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139136000|NCT04788615|Interferons|interferons|mesh-list
139136001|NCT04788615|Interferon-beta|interferon-beta|mesh-list
139136002|NCT04788615|Interferon beta-1a|interferon beta-1a|mesh-list
139136003|NCT04788615|Teriflunomide|teriflunomide|mesh-list
139136004|NCT04788615|Ofatumumab|ofatumumab|mesh-list
139136005|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
139136006|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139136007|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
139136008|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136009|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
139136010|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136011|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
139136012|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136013|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139136014|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
139136015|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139136016|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139136017|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139136018|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139136020|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
139136021|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136022|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139136023|NCT04725032|Propofol|propofol|mesh-list
139136024|NCT04725032|Sevoflurane|sevoflurane|mesh-list
139136025|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139136026|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139136027|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136028|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139136029|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
139136030|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
139136031|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139136032|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139136033|NCT04686786|PF-06372865|pf-06372865|mesh-list
139136034|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
139136035|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
139136036|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136037|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136038|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136039|NCT04678895|Naltrexone|naltrexone|mesh-list
139136040|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139136041|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139136042|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136043|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
139136044|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136045|NCT04677569|Azithromycin|azithromycin|mesh-list
139136046|NCT04677569|Amikacin|amikacin|mesh-list
139136047|NCT04677569|Ethambutol|ethambutol|mesh-list
139136048|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139136049|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136050|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
139136051|NCT04648930|Omalizumab|omalizumab|mesh-list
139136052|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139136053|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139136054|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
139136055|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
139136056|NCT04633148|Fludarabine|fludarabine|mesh-list
139136057|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139136058|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
139136059|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136060|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139136061|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139136062|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
139136063|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136064|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136065|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139136066|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
139136067|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136068|NCT04501861|Vasopressins|vasopressins|mesh-list
139136069|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
139136070|NCT04501861|Norepinephrine|norepinephrine|mesh-list
139136071|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139136072|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139136073|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
139136074|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136075|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136076|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136077|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
139136078|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
139136079|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136080|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139136081|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
139136082|NCT04501861|Coagulants|coagulants|mesh-ancestor
139136083|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139136084|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
139136085|NCT04494529|Betamethasone|betamethasone|mesh-list
139136086|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
139136087|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139136088|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
139136089|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139136090|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139136091|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
139136093|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139136094|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136095|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139136096|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
139136098|NCT04442022|Rituximab|rituximab|mesh-list
139136099|NCT04442022|Gemcitabine|gemcitabine|mesh-list
139136100|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139136101|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
139136102|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
139136103|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136104|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136105|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139136106|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
139136107|NCT04442022|Hormones|hormones|mesh-ancestor
139136108|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139136109|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139136110|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136111|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139136112|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
139136113|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139136114|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139136115|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
139136116|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136117|NCT04356209|Pravastatin|pravastatin|mesh-list
139136118|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139136119|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139136120|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
139136121|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136122|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139136123|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139136124|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136125|NCT04346394|Yohimbine|yohimbine|mesh-list
139136126|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
139136127|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
139136128|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136129|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136130|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139136131|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139136132|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139136133|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
138897474|NCT02619032|Fentanyl|fentanyl|mesh-list
139136134|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136135|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136137|NCT04299438|Propranolol|propranolol|mesh-list
139136138|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139136139|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139136140|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
139136141|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136142|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897512|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
139136143|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136144|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139136145|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139136146|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
139136147|NCT04240821|Theophylline|theophylline|mesh-list
139136148|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139136149|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
139136150|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136151|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136152|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139136153|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
139136154|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139136155|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136156|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136157|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
139136158|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139136159|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139136160|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
139136161|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136162|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139136163|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139136164|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
139136165|NCT04214678|Hormones|hormones|mesh-ancestor
139136166|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139136167|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136168|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136169|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136170|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139136171|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136172|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
139136173|NCT04196491|Fludarabine|fludarabine|mesh-list
139136174|NCT04196491|Lenalidomide|lenalidomide|mesh-list
139136175|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139136176|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
139136177|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136178|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139136179|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139136180|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
139136181|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136182|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136183|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139136184|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139136185|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139136186|NCT04196491|Growth Substances|growth substances|mesh-ancestor
139136187|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
139136188|NCT04165967|Nivolumab|nivolumab|mesh-list
139136189|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139136190|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136191|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139136192|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136193|NCT04044859|Pembrolizumab|pembrolizumab|mesh-list
139136194|NCT04044859|Nivolumab|nivolumab|mesh-list
139136195|NCT04044859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139136196|NCT04044859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136197|NCT04044859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139136198|NCT04044859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136199|NCT04007224|Oxytocin|oxytocin|mesh-list
139136200|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
139136201|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139136202|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136203|NCT03995628|Dexamethasone|dexamethasone|mesh-list
139136204|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139136205|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
139136206|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
139136207|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886739|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
139136208|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136209|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139136210|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
139136211|NCT03995628|Hormones|hormones|mesh-ancestor
139136212|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139136213|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139136214|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136215|NCT03923556|Neostigmine|neostigmine|mesh-list
139136216|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139136217|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136218|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136219|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
139136220|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136221|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136222|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139136223|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
139136224|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136225|NCT03913247|Metronidazole|metronidazole|mesh-list
139136226|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136227|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139136228|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139136229|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139136230|NCT03816982|Bupivacaine|bupivacaine|mesh-list
139136231|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
139136232|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
139136233|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139136234|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136235|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
139136236|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136237|NCT03816397|Adalimumab|adalimumab|mesh-list
139136238|NCT03816397|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139136239|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139136240|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139136241|NCT03736629|Azithromycin|azithromycin|mesh-list
139136242|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139136243|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136245|NCT03681639|Chromium|chromium|mesh-list
139136246|NCT03681639|Trace Elements|trace elements|mesh-ancestor
139136247|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
139136248|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136249|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
139136250|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136251|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139136252|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139136253|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139136254|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136255|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
139136256|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136257|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136258|NCT03217201|Methamphetamine|methamphetamine|mesh-list
139136259|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139136260|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136261|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
139136262|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
139136263|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136264|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
139136265|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136266|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136267|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
139136268|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139136269|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139136270|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139136271|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139136272|NCT03029429|Theophylline|theophylline|mesh-list
139136273|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139136274|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
139136275|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136276|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136277|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139136278|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
139136279|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139136280|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136281|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136282|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
139136283|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139136284|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139136285|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
139136286|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136287|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
139136288|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139136289|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136290|NCT02959463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139136291|NCT02959463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136292|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
139136293|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139136294|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136295|NCT02830594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139136296|NCT02830594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136297|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
139136298|NCT02754765|Levofloxacin|levofloxacin|mesh-list
139136299|NCT02754765|Linezolid|linezolid|mesh-list
139136300|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
139136301|NCT02754765|Bedaquiline|bedaquiline|mesh-list
139136302|NCT02754765|Clofazimine|clofazimine|mesh-list
139136303|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139136304|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898175|NCT04183361|Cortisone|cortisone|mesh-list
139136306|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139136307|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136308|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875988|NCT02789579|Levofloxacin|levofloxacin|mesh-list
139136311|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139136312|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139136313|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139136314|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
139136315|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139136317|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
139136318|NCT02620007|Rifaximin|rifaximin|mesh-list
139136319|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139136320|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136321|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139136322|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139136323|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136324|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136325|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898317|NCT02151604|Xenon|xenon|mesh-list
139136326|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139136327|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139136328|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139136329|NCT02586623|Droxidopa|droxidopa|mesh-list
139136330|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139136331|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139136332|NCT01622543|Leucovorin|leucovorin|mesh-list
139136333|NCT01622543|Bevacizumab|bevacizumab|mesh-list
139136334|NCT01622543|Fluorouracil|fluorouracil|mesh-list
139136335|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
139136336|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139136337|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136338|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138898368|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
139136339|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139136340|NCT01622543|Growth Substances|growth substances|mesh-ancestor
139136341|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136342|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
139136343|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
139136344|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136345|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139136346|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139136347|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
139136348|NCT01622543|Antidotes|antidotes|mesh-ancestor
139136349|NCT01622543|Protective Agents|protective agents|mesh-ancestor
139136350|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
139136351|NCT01622543|Vitamins|vitamins|mesh-ancestor
139136352|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
139136353|NCT01618357|Veliparib|veliparib|mesh-list
139136354|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139136355|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136356|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136357|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136386|NCT00662740|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139136387|NCT00662740|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139136388|NCT00662740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139136389|NCT00662740|Adrenergic Agents|adrenergic agents|mesh-ancestor
139136390|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
139136391|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138898618|NCT01025245|Remifentanil|remifentanil|mesh-list
139136392|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139136393|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139136394|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
139136395|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136396|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136397|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136398|NCT00233662|Alefacept|alefacept|mesh-list
139136399|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
139136400|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
138898745|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139136401|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136402|NCT00078949|Cytarabine|cytarabine|mesh-list
139136403|NCT00078949|Dexamethasone|dexamethasone|mesh-list
139136404|NCT00078949|Rituximab|rituximab|mesh-list
139136405|NCT00078949|Gemcitabine|gemcitabine|mesh-list
139136406|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139136407|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
139136408|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
139136409|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136410|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136411|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139136412|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
139136413|NCT00078949|Hormones|hormones|mesh-ancestor
139136414|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139136415|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139136417|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139136418|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
139136419|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139136420|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139136421|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
139136422|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136423|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
139136424|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136425|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139136426|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
139136427|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139136428|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139136429|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886977|NCT00855309|Acyclovir|acyclovir|mesh-list
139136430|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139136431|NCT01289769|Analgesics|analgesics|mesh-ancestor
139136432|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
139136433|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136434|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139136435|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139136436|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139136437|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
139136438|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136439|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136440|NCT01185015|Nicorandil|nicorandil|mesh-list
139136441|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139136442|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139136443|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
139136444|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
139136445|NCT01185015|Vitamins|vitamins|mesh-ancestor
139136446|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
139136447|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136448|NCT01289925|Selenium|selenium|mesh-list
139136449|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
139136450|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136451|NCT01289925|Protective Agents|protective agents|mesh-ancestor
139136452|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136453|NCT01289925|Trace Elements|trace elements|mesh-ancestor
139136454|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
139136455|NCT01290939|Bevacizumab|bevacizumab|mesh-list
139136456|NCT01290939|Lomustine|lomustine|mesh-list
139136457|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139136458|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136459|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139136460|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139136461|NCT01290939|Growth Substances|growth substances|mesh-ancestor
139136462|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136463|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
139136464|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139136465|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
139136466|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136467|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
139136468|NCT01288755|Rilpivirine|rilpivirine|mesh-list
139136469|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139136470|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139136471|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
139136472|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136473|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139136474|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139136475|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136476|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136477|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139136478|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139136479|NCT01290003|Tazobactam|tazobactam|mesh-list
139136480|NCT01290003|Piperacillin|piperacillin|mesh-list
139136481|NCT01290003|Amikacin|amikacin|mesh-list
139136482|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139136483|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139136484|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136485|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139136486|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136487|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136488|NCT01291095|Cisplatin|cisplatin|mesh-list
139136489|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136490|NCT03739203|Cariprazine|cariprazine|mesh-list
139136491|NCT03739203|Antidepressive Agents|antidepressive agents|mesh-list
139136492|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139136493|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139136494|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139136495|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139136496|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136497|NCT01185405|Voriconazole|voriconazole|mesh-list
139136498|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
139136499|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136500|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139136501|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139136502|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136503|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136504|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139136505|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
139136506|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139136507|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136508|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139136510|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139136511|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
139136512|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136513|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136514|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139136515|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139136516|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
139136517|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136518|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136519|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
139136520|NCT01587729|Serotonin|serotonin|mesh-list
139136521|NCT01587729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139136522|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139136523|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139136524|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
139136525|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136526|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136527|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136528|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139136529|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139136531|NCT03855267|Etomidate|etomidate|mesh-list
139136532|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139136533|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139136534|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136535|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139136536|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
139136537|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
139136538|NCT01185873|Ritonavir|ritonavir|mesh-list
139136539|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139136540|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139136541|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
139136542|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136543|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136544|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139136545|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139136546|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
139136547|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136548|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139136549|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139136550|NCT01182597|Pantoprazole|pantoprazole|mesh-list
139136551|NCT01182597|Lansoprazole|lansoprazole|mesh-list
139136552|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
139136553|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139136554|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139136555|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139136556|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136557|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136558|NCT01185951|Polidocanol|polidocanol|mesh-list
139136559|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139136560|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139136561|NCT01587807|Dimercaprol|dimercaprol|mesh-list
139136562|NCT01587807|Chelating Agents|chelating agents|mesh-ancestor
139136563|NCT01587807|Sequestering Agents|sequestering agents|mesh-ancestor
139136564|NCT01587807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136565|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
139136566|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139136568|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
139136569|NCT01180179|Famotidine|famotidine|mesh-list
139136570|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139136571|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139136572|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139136573|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136574|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136575|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139136576|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
139136577|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
139136578|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887116|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136579|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136580|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139136581|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139136582|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
139136583|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136584|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136585|NCT01186497|Rabeprazole|rabeprazole|mesh-list
139136586|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139136587|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139136588|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139136589|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136590|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136591|NCT03854409|Aripiprazole|aripiprazole|mesh-list
139136592|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
139136593|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139136594|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139136595|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139136596|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139136597|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136598|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
139136599|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
139136600|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136601|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136602|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139136603|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139136604|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
139136605|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139136606|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139136607|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139136608|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139136609|NCT01186653|Fluticasone|fluticasone|mesh-list
139136610|NCT01186653|Budesonide|budesonide|mesh-list
139136611|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
139136612|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139136613|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139136614|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139136615|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139136616|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
139136617|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136618|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136619|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139136620|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
139136621|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
139136622|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139136623|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
139136625|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139136626|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139136627|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139136628|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139136629|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
139136630|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136631|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136632|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
139136633|NCT01186731|Docetaxel|docetaxel|mesh-list
139136634|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136635|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
139136636|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
139136637|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
139136638|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136639|NCT01186887|Celecoxib|celecoxib|mesh-list
139136640|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139136641|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139136642|NCT01186887|Analgesics|analgesics|mesh-ancestor
139136643|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
139136644|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136645|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136646|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139136647|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139136648|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139136649|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139136650|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136651|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136652|NCT01180413|Losartan|losartan|mesh-list
139136653|NCT01180413|Amlodipine|amlodipine|mesh-list
139136654|NCT01180413|Ramipril|ramipril|mesh-list
139136656|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139136657|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139136658|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139136659|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707832|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
139136660|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139136661|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136662|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
139136663|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139136664|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138899901|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139136665|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139136666|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139136667|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
139136668|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136669|NCT03858387|Meropenem|meropenem|mesh-list
139136670|NCT03858387|Imipenem|imipenem|mesh-list
139136671|NCT03858387|Cilastatin|cilastatin|mesh-list
139136672|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139136673|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136674|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
139136675|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136676|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136677|NCT01289301|Cyclosporine|cyclosporine|mesh-list
139136679|NCT01289301|Everolimus|everolimus|mesh-list
139136680|NCT01289301|MTOR Inhibitors|mtor inhibitors|mesh-list
139136681|NCT01289301|Temsirolimus|temsirolimus|mesh-list
139136682|NCT01289301|Tacrolimus|tacrolimus|mesh-list
139136683|NCT01289301|Cyclosporins|cyclosporins|mesh-list
138900101|NCT01063348|Antidotes|antidotes|mesh-ancestor
139136684|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139136685|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139136686|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
139136687|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136688|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136689|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136690|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
139136691|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136692|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
139136693|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139136694|NCT01289301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139136695|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136696|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139136697|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139136699|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139136700|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138900183|NCT02648711|Vitamins|vitamins|mesh-ancestor
139136701|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139136702|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139136703|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
139136704|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136705|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136706|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136707|NCT02524821|Metformin|metformin|mesh-list
139136708|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139136709|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136710|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
139136711|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139136712|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136713|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136714|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139136715|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139136716|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
139136717|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139136718|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139136719|NCT03854175|Estradiol|estradiol|mesh-list
139136720|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138552397|NCT00269542|Iron|iron|mesh-list
139136721|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136723|NCT03854175|Hormones|hormones|mesh-ancestor
138900435|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139136724|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887268|NCT00883688|Bevacizumab|bevacizumab|mesh-list
139136725|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136726|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139136727|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
139136728|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139136729|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139136731|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139136732|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139136733|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136734|NCT03854175|Urological Agents|urological agents|mesh-ancestor
139136735|NCT01183611|Vaccines|vaccines|mesh-list
139136736|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
139136737|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136738|NCT01180569|Lenalidomide|lenalidomide|mesh-list
139136739|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
139136740|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136741|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139136742|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139136743|NCT01180569|Growth Substances|growth substances|mesh-ancestor
139136744|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
139136745|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136746|NCT02942264|Temozolomide|temozolomide|mesh-list
139136747|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138900650|NCT00652379|Hormones|hormones|mesh-ancestor
139136748|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
139136749|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136750|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136751|NCT01180725|Psyllium|psyllium|mesh-list
139136752|NCT01180725|Cathartics|cathartics|mesh-ancestor
139136753|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139136754|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139136755|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
139136756|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136757|NCT01183767|Protective Agents|protective agents|mesh-ancestor
139136758|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136759|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139136760|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139136761|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136762|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139136763|NCT03853785|Podophyllin|podophyllin|mesh-list
138900775|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136764|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139136765|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136766|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
139136767|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
138707902|NCT02462811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139136769|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139136770|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136771|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
139136772|NCT01291563|Bedaquiline|bedaquiline|mesh-list
139136773|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
138900911|NCT00703482|Vitamins|vitamins|mesh-ancestor
139136774|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139136775|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139136776|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136777|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139136778|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139136779|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900979|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139136780|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136781|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136782|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139136783|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
139136784|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139136785|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136786|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139136787|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139136788|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139136790|NCT01187589|Albuterol|albuterol|mesh-list
139136791|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139136792|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
139136793|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136794|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136795|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139136796|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
139136798|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139136799|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139136800|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139136801|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139136802|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
139136803|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136804|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136806|NCT01290549|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139136807|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139136808|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136809|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
139136810|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136811|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139136812|NCT01290549|Immunoconjugates|immunoconjugates|mesh-ancestor
139136813|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
139136814|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
139136815|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139136816|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139136817|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139136818|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136819|NCT01184391|Valproic Acid|valproic acid|mesh-list
139136820|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
139136821|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136822|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136823|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
139136824|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136825|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136826|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
139136827|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139136828|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139136829|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139136830|NCT02524743|Acetaminophen|acetaminophen|mesh-list
139136831|NCT02524743|Lidocaine|lidocaine|mesh-list
139136832|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
139136833|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
139136834|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139136835|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901513|NCT04162535|Propofol|propofol|mesh-list
139136836|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
139136837|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136838|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139136839|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139136840|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139136841|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139136842|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136843|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139136844|NCT02524743|Analgesics|analgesics|mesh-ancestor
139136845|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
139136846|NCT01188057|Alprazolam|alprazolam|mesh-list
139136847|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139136848|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139136849|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136850|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139136851|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139136852|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139136853|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
139136854|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
139136855|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136856|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136857|NCT01291641|Cilostazol|cilostazol|mesh-list
139136858|NCT01291641|Probucol|probucol|mesh-list
139136859|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138901716|NCT05861713|Dimenhydrinate|dimenhydrinate|mesh-list
139136860|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139136861|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
139136862|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136863|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136864|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139136865|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
139136866|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139136867|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139136868|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136869|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139136870|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
139136871|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139136872|NCT01291641|Protective Agents|protective agents|mesh-ancestor
139136873|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139136874|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138707932|NCT00538421|Propofol|propofol|mesh-list
139136875|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887416|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
139136876|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139136877|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139136878|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
139136879|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139136880|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
139136881|NCT03855501|Calcium|calcium|mesh-list
139136882|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139136883|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136884|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139136885|NCT01588587|Vildagliptin|vildagliptin|mesh-list
139136886|NCT01588587|Alogliptin|alogliptin|mesh-list
139136887|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139136888|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136889|NCT01588587|Incretins|incretins|mesh-ancestor
139136890|NCT01588587|Hormones|hormones|mesh-ancestor
139136891|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139136892|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139136893|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
139136894|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136895|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136896|NCT03325712|Midazolam|midazolam|mesh-list
139136897|NCT03325712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139136898|NCT03325712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139136899|NCT03325712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139136900|NCT03325712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136901|NCT03325712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139136902|NCT03325712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139136903|NCT03325712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139136904|NCT03325712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139136905|NCT03325712|Anesthetics, General|anesthetics, general|mesh-ancestor
139136906|NCT03325712|Anesthetics|anesthetics|mesh-ancestor
139136907|NCT03325712|GABA Modulators|gaba modulators|mesh-ancestor
139136908|NCT03325712|GABA Agents|gaba agents|mesh-ancestor
139136909|NCT03325712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136910|NCT03325712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136911|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139136912|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139136913|NCT01293747|Estradiol|estradiol|mesh-list
139136914|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139136915|NCT01293747|Progesterone|progesterone|mesh-list
139136916|NCT01293747|Estrogens|estrogens|mesh-ancestor
139136917|NCT01293747|Hormones|hormones|mesh-ancestor
139136918|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139136919|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136920|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139136921|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
139136922|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139136923|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138707977|NCT00554346|Etoricoxib|etoricoxib|mesh-list
139136924|NCT01293747|Progestins|progestins|mesh-ancestor
139136925|NCT03849729|Phentermine|phentermine|mesh-list
139136926|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139136927|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136928|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
139136929|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139136930|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
139136931|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
139136932|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136933|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
139136934|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136935|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136936|NCT03325556|Pimavanserin|pimavanserin|mesh-list
139136937|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139136938|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139136939|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139136940|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139136941|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139136942|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136943|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139136944|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139136945|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139136946|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
139136947|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136948|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136949|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
139136950|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139136951|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139136952|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139136953|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136955|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
139136956|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138876255|NCT00960037|Vitamin D|vitamin d|mesh-list
139136957|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139136958|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
139136959|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139136960|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139136961|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136962|NCT03325166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139136963|NCT03325166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136964|NCT03325166|Hematinics|hematinics|mesh-ancestor
139136965|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139136966|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139136967|NCT03847623|Curcumin|curcumin|mesh-list
139136968|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139136969|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139136970|NCT03847623|Analgesics|analgesics|mesh-ancestor
139136971|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
139136972|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136973|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136974|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139136975|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139136976|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139136977|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139136978|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139136979|NCT01294059|Milnacipran|milnacipran|mesh-list
139136980|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
139136981|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139136982|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139136983|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139136984|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707990|NCT00538655|Modafinil|modafinil|mesh-list
139136985|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139136986|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136987|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139136988|NCT01294059|Analgesics|analgesics|mesh-ancestor
139136989|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
139136990|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136991|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
139136992|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139136993|NCT03847155|Nicotine|nicotine|mesh-list
139136994|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139136995|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
139136996|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139136997|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139136998|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139136999|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139137000|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
139137001|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137002|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137003|NCT01294215|Nifedipine|nifedipine|mesh-list
139137004|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139137005|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139137006|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137007|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139137008|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137009|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
139137010|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
139137011|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139137012|NCT01296555|Letrozole|letrozole|mesh-list
139137013|NCT01296555|Fulvestrant|fulvestrant|mesh-list
139137014|NCT01296555|Midazolam|midazolam|mesh-list
139137015|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139137016|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139137017|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137018|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137019|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139137020|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139137021|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139137022|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139137023|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
139137024|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
138887566|NCT00592839|Estrogens|estrogens|mesh-list
139137025|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
139137026|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
139137027|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137028|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137029|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137030|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139137031|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139137032|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137033|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139137034|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
139137035|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139137036|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139137037|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139137038|NCT01294293|Paclitaxel|paclitaxel|mesh-list
139137039|NCT01294293|Doxorubicin|doxorubicin|mesh-list
139137040|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139137041|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139137042|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137043|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
139137044|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
139137045|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
139137046|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137047|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139137048|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139137049|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139137050|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137051|NCT01294605|Edetic Acid|edetic acid|mesh-list
139137052|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
139137053|NCT01294605|Antidotes|antidotes|mesh-ancestor
139137054|NCT01294605|Protective Agents|protective agents|mesh-ancestor
139137055|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137056|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
139137057|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
139137058|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137059|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139137060|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
139137061|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139137062|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
139137063|NCT01294761|Darunavir|darunavir|mesh-list
139137064|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139137065|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139137066|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
139137067|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137068|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139137069|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139137070|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137071|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137072|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139137073|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139137074|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
139137075|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
139137076|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
139137077|NCT03305666|Bupivacaine|bupivacaine|mesh-list
139137078|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
139137080|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137081|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137082|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
139137083|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137084|NCT01194843|Ropivacaine|ropivacaine|mesh-list
139137085|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
139137086|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
139137087|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137088|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137089|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
139137090|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137091|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
139137093|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
139137094|NCT01297023|Cholecalciferol|cholecalciferol|mesh-list
139137095|NCT01297023|Vitamins|vitamins|mesh-list
139137096|NCT01297023|Calcium|calcium|mesh-list
139137097|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
139137098|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137099|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139137100|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139137101|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
139137102|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139137103|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139137104|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
139137105|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137106|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137107|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139137108|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137109|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139137110|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137111|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137112|NCT04781426|Tenofovir|tenofovir|mesh-list
139137113|NCT04781426|Lamivudine|lamivudine|mesh-list
139137114|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
139137115|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137116|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139137117|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139137118|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137119|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137120|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139137121|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139137122|NCT01292031|Meropenem|meropenem|mesh-list
139137123|NCT01292031|Colistin|colistin|mesh-list
139137124|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139137125|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137126|NCT04633226|Vaccines|vaccines|mesh-list
139137127|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
139137128|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137129|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
139137130|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139137131|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
139137132|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
139137133|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137134|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137135|NCT01188759|Voriconazole|voriconazole|mesh-list
139137136|NCT01188759|Anidulafungin|anidulafungin|mesh-list
139137137|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
139137138|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137139|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139137140|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139137141|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876302|NCT00960349|Cisplatin|cisplatin|mesh-list
139137142|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137143|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139137144|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
139137145|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139137146|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137147|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139137148|NCT01295073|Trientine|trientine|mesh-list
139137149|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
139137150|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
139137151|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137152|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
139137153|NCT01292109|Cathartics|cathartics|mesh-ancestor
139137154|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139137155|NCT01191645|Remifentanil|remifentanil|mesh-list
139137156|NCT01191645|Metoclopramide|metoclopramide|mesh-list
139137157|NCT01191645|Naloxone|naloxone|mesh-list
139137158|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139137159|NCT01191645|Narcotics|narcotics|mesh-ancestor
139137160|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137161|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137162|NCT01191645|Analgesics|analgesics|mesh-ancestor
139137163|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
139137164|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137165|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139137166|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
139137167|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
139137168|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139137169|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139137170|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139137171|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
139137172|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137173|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137174|NCT03736785|Insulin|insulin|mesh-list
139137175|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139137176|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137177|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
139137178|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
139137179|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137181|NCT01295151|Infliximab|infliximab|mesh-list
139137182|NCT01295151|Golimumab|golimumab|mesh-list
139137183|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
139137184|NCT01295151|Etanercept|etanercept|mesh-list
139137185|NCT01295151|Rituximab|rituximab|mesh-list
139137186|NCT01295151|Abatacept|abatacept|mesh-list
139137187|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139137188|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137189|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
139137190|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137191|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139137192|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139137193|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139137194|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
139137195|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139137196|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139137197|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139137198|NCT01295151|Analgesics|analgesics|mesh-ancestor
139137199|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
139137200|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137201|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139137202|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139137203|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137204|NCT01295307|Clofarabine|clofarabine|mesh-list
139137205|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139137206|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
139137207|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137208|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137209|NCT01292343|Listerine|listerine|mesh-list
139137210|NCT01292343|Triclosan|triclosan|mesh-list
139137211|NCT01292343|Fluorides|fluorides|mesh-list
139137212|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
139137213|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
139137214|NCT01292343|Protective Agents|protective agents|mesh-ancestor
139137215|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137216|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139137217|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137218|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139137219|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139137220|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
139137221|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137222|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139137224|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
139137225|NCT01192113|Vitamins|vitamins|mesh-ancestor
139137226|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
139137227|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137228|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139137229|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
139137230|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137231|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139137232|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
139137233|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137234|NCT01192503|Rasagiline|rasagiline|mesh-list
139137235|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139137236|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137237|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137238|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138901860|NCT05265299|Antipyretics|antipyretics|mesh-ancestor
139137239|NCT01192503|Protective Agents|protective agents|mesh-ancestor
139137240|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137241|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
139137242|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
139137243|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
139137244|NCT03851289|Calcium|calcium|mesh-list
139137245|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139137246|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137247|NCT03733899|Anesthetics|anesthetics|mesh-list
139137248|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137249|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137250|NCT01196013|Clofarabine|clofarabine|mesh-list
139137251|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139137252|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
139137253|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137254|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137255|NCT01196169|Vancomycin|vancomycin|mesh-list
139137256|NCT01196169|Daptomycin|daptomycin|mesh-list
139137257|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139137258|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137259|NCT01196481|Carvedilol|carvedilol|mesh-list
139137260|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139137261|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139137262|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
139137263|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137264|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137265|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137266|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139137267|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
139137268|NCT01196481|Protective Agents|protective agents|mesh-ancestor
139137269|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138876379|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
139137270|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139137271|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139137272|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
139137273|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139137274|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139137275|NCT05283057|Empagliflozin|empagliflozin|mesh-list
139137276|NCT05283057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139137277|NCT05283057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137278|NCT05283057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139137279|NCT05283057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137280|NCT01193595|Bevacizumab|bevacizumab|mesh-list
139137281|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139137282|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137283|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139137284|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139137285|NCT01193595|Growth Substances|growth substances|mesh-ancestor
139137286|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137287|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
139137288|NCT01196559|Gemcitabine|gemcitabine|mesh-list
139137289|NCT01196559|Vinorelbine|vinorelbine|mesh-list
139137290|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139137291|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
139137292|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137293|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137294|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139137295|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
139137296|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
139137297|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
139137298|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
139137299|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
139137300|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139137301|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
139137302|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137303|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139137304|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139137305|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139137306|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139137307|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137308|NCT01581177|Albuterol|albuterol|mesh-list
139137309|NCT01581177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139137310|NCT01581177|Autonomic Agents|autonomic agents|mesh-ancestor
139137311|NCT01581177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137312|NCT01581177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137313|NCT01581177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139137314|NCT01581177|Respiratory System Agents|respiratory system agents|mesh-ancestor
139137315|NCT01581177|Tocolytic Agents|tocolytic agents|mesh-ancestor
139137316|NCT01581177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139137317|NCT01581177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139137318|NCT01581177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139137319|NCT01581177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139137320|NCT01581177|Adrenergic Agents|adrenergic agents|mesh-ancestor
139137321|NCT01581177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137322|NCT01581177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137323|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
139137324|NCT01580007|Vitamin D|vitamin d|mesh-list
139137325|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139137326|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139137327|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137328|NCT01580007|Vitamins|vitamins|mesh-ancestor
139137329|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
139137330|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139137331|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137332|NCT01189695|Ritonavir|ritonavir|mesh-list
139137333|NCT01189695|Lopinavir|lopinavir|mesh-list
139137334|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139137335|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139137336|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
139137337|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137338|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137339|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139137340|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139137341|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
139137342|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137343|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139137344|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139137345|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
139137346|NCT01196715|Hematinics|hematinics|mesh-ancestor
139137347|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139137348|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137349|NCT01189773|Ibuprofen|ibuprofen|mesh-list
139137350|NCT01189773|Codeine|codeine|mesh-list
139137351|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139137352|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139137353|NCT01189773|Analgesics|analgesics|mesh-ancestor
139137354|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
139137355|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137356|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137357|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139137358|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139137359|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139137360|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137361|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137362|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139137363|NCT01189773|Narcotics|narcotics|mesh-ancestor
139137364|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137365|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
139137366|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
139137367|NCT01189929|Gemcitabine|gemcitabine|mesh-list
139137368|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139137369|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139137370|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
139137371|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137372|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137373|NCT03845673|Psyllium|psyllium|mesh-list
139137374|NCT03845673|Cathartics|cathartics|mesh-ancestor
139137375|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139137376|NCT01190163|Oxytocin|oxytocin|mesh-list
139137377|NCT01190163|Dinoprostone|dinoprostone|mesh-list
139137378|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
139137379|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139137380|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137381|NCT01199445|Vitamin A|vitamin a|mesh-list
139137382|NCT01199445|Vitamins|vitamins|mesh-ancestor
139137383|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
139137384|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137385|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
139137386|NCT01199523|Mirabegron|mirabegron|mesh-list
139137387|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139137388|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137389|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139137390|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139137391|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137392|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137393|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137394|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137395|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139137396|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139137397|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139137398|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
139137399|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137400|NCT01199523|Urological Agents|urological agents|mesh-ancestor
139137401|NCT01190241|Everolimus|everolimus|mesh-list
139137402|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139137403|NCT01190241|Sorafenib|sorafenib|mesh-list
139137404|NCT01190241|Sunitinib|sunitinib|mesh-list
139137405|NCT01190241|Lapatinib|lapatinib|mesh-list
139137406|NCT01190241|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139137407|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139137408|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137409|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137410|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139137411|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
139137412|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137413|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137414|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139137415|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139137416|NCT01190241|Growth Substances|growth substances|mesh-ancestor
139137417|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
139137418|NCT01197261|Oxycodone|oxycodone|mesh-list
139137419|NCT01197261|Naloxone|naloxone|mesh-list
139137420|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139137421|NCT01197261|Narcotics|narcotics|mesh-ancestor
139137422|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137423|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137424|NCT01197261|Analgesics|analgesics|mesh-ancestor
139137425|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
139137426|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137427|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139137428|NCT01190553|Amantadine|amantadine|mesh-list
139137429|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139137430|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139137431|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
139137432|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137433|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
139137434|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137435|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137436|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137437|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139137438|NCT01190553|Analgesics|analgesics|mesh-ancestor
139137439|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
139137440|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137441|NCT01199757|Fluticasone|fluticasone|mesh-list
139137443|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
139137444|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139137445|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138541036|NCT00175357|Heroin|heroin|mesh-list
139137446|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
139137447|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137448|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137449|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139137450|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
139137451|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
139137452|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139137453|NCT03843879|Lidocaine|lidocaine|mesh-list
139137454|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
139137455|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
139137456|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137457|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137458|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
139137460|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139137461|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139137462|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139137463|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139137464|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137465|NCT03850587|Celecoxib|celecoxib|mesh-list
139137466|NCT03850587|Tramadol|tramadol|mesh-list
139137467|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139137468|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139137469|NCT03850587|Analgesics|analgesics|mesh-ancestor
139137470|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
139137471|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137472|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137473|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139137474|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139137475|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139137476|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139137477|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137478|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137479|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139137480|NCT03850587|Narcotics|narcotics|mesh-ancestor
139137481|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137483|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139137484|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137485|NCT05671497|Antirheumatic Agents|antirheumatic agents|mesh-list
139137486|NCT05671497|Cilostazol|cilostazol|mesh-list
139137487|NCT05671497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139137488|NCT05671497|Autonomic Agents|autonomic agents|mesh-ancestor
139137489|NCT05671497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137490|NCT05671497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137491|NCT05671497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139137492|NCT05671497|Respiratory System Agents|respiratory system agents|mesh-ancestor
139137493|NCT05671497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139137494|NCT05671497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139137495|NCT05671497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137496|NCT05671497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139137497|NCT05671497|Vasodilator Agents|vasodilator agents|mesh-ancestor
139137498|NCT05671497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139137499|NCT05671497|Protective Agents|protective agents|mesh-ancestor
139137500|NCT05671497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139137501|NCT05671497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139137502|NCT05671497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137503|NCT03915626|Rivastigmine|rivastigmine|mesh-list
139137504|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139137505|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137506|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137507|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
139137508|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137509|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137510|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139137511|NCT03915626|Protective Agents|protective agents|mesh-ancestor
139137512|NCT04491968|Methadone|methadone|mesh-list
139137513|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139137514|NCT04491968|Narcotics|narcotics|mesh-ancestor
139137515|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137516|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137517|NCT04491968|Analgesics|analgesics|mesh-ancestor
139137518|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
139137519|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137520|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
139137521|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
139137522|NCT03313076|Vitamin D|vitamin d|mesh-list
139137523|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
139137524|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
139137525|NCT03313076|Vitamins|vitamins|mesh-list
139137526|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
139137527|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137528|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139137529|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139137530|NCT01191021|Propofol|propofol|mesh-list
139137531|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
139137532|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137533|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137534|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139137535|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139137536|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
139137538|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
139137539|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
139137540|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139137541|NCT01200537|Estradiol|estradiol|mesh-list
139137542|NCT01200537|Estrogens|estrogens|mesh-ancestor
139137543|NCT01200537|Hormones|hormones|mesh-ancestor
139137544|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139137545|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137546|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139137547|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139137548|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139137549|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139137550|NCT01198353|Ziprasidone|ziprasidone|mesh-list
139137551|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139137552|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
139137553|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137554|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137555|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137556|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139137557|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139137558|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137559|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139137560|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139137562|NCT01200693|Sirolimus|sirolimus|mesh-list
139137563|NCT01200693|Everolimus|everolimus|mesh-list
139137564|NCT01200693|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139137565|NCT01200693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139137566|NCT01200693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137567|NCT01200693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137568|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139137569|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
139137570|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137571|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137572|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139137573|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137574|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139137575|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
139137576|NCT03844581|Propiverine|propiverine|mesh-list
139137577|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
139137578|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
139137579|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137580|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137581|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139137582|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139137583|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
139137584|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137585|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137586|NCT03844581|Urological Agents|urological agents|mesh-ancestor
139137587|NCT01202097|Fluticasone|fluticasone|mesh-list
139137588|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138708207|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
139137589|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139137590|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139137591|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139137592|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
139137593|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137594|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137595|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139137596|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
139137597|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
139137598|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139137599|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139137600|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139137601|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139137602|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
139137603|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137604|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137605|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
139137607|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139137608|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
139137609|NCT05670015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139137610|NCT05670015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139137611|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
139137612|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
139137613|NCT01201005|Hematinics|hematinics|mesh-ancestor
139137614|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
139137615|NCT01201005|Vitamins|vitamins|mesh-ancestor
139137616|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
139137617|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137618|NCT01198665|Prednisolone|prednisolone|mesh-list
139137619|NCT01198665|Doxorubicin|doxorubicin|mesh-list
139137620|NCT01198665|Vincristine|vincristine|mesh-list
139137621|NCT01198665|Everolimus|everolimus|mesh-list
139137622|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139137623|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137624|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139137625|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139137626|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137627|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137628|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139137629|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
139137630|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
139137631|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
139137632|NCT01198665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139137633|NCT01198665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139137634|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139137635|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
139137636|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137637|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139137638|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
139137639|NCT01198665|Hormones|hormones|mesh-ancestor
139137640|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139137641|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139137642|NCT01198821|Gemcitabine|gemcitabine|mesh-list
139137643|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139137644|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
139137645|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137646|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137647|NCT05013801|Hydroquinone|hydroquinone|mesh-list
139137648|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
139137649|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137650|NCT05013801|Protective Agents|protective agents|mesh-ancestor
139137651|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137652|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139137653|NCT01566669|Parecoxib|parecoxib|mesh-list
139137654|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139137655|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139137656|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137657|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137658|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139137659|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139137660|NCT01566669|Analgesics|analgesics|mesh-ancestor
139137661|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
139137662|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137663|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137664|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139137665|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139137666|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
139137667|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139137668|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
139137669|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139137670|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139137671|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137672|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139137673|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137674|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138901877|NCT05221892|Vitamins|vitamins|mesh-ancestor
139137675|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137676|NCT01201161|Ranibizumab|ranibizumab|mesh-list
139137677|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139137678|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139137679|NCT01201161|Growth Substances|growth substances|mesh-ancestor
139137680|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137681|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
139137682|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137683|NCT03841383|Dipyridamole|dipyridamole|mesh-list
139137684|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139137685|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137686|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137687|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139137688|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
139137689|NCT05667987|Lidocaine|lidocaine|mesh-list
139137690|NCT05667987|Anesthetics, Local|anesthetics, local|mesh-ancestor
139137691|NCT05667987|Anesthetics|anesthetics|mesh-ancestor
139137692|NCT05667987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137693|NCT05667987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876570|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
139137694|NCT05667987|Sensory System Agents|sensory system agents|mesh-ancestor
139137695|NCT05667987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137696|NCT05667987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139137697|NCT05667987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139137698|NCT05667987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139137699|NCT05667987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139137700|NCT05667987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137701|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
139137702|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139137703|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139137704|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
139137705|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137706|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139137707|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139137708|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137709|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137711|NCT01199367|Lapatinib|lapatinib|mesh-list
139137712|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137713|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139137714|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139137715|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137716|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137717|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139137718|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
139137719|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139137720|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137721|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139137722|NCT01203735|Valproic Acid|valproic acid|mesh-list
139137723|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
139137724|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137725|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137726|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
139137727|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137728|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137729|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
139137730|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139137731|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137732|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139137734|NCT03842631|Maleic acid|maleic acid|mesh-list
139137735|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137736|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137737|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139137738|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139137739|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
139137740|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137741|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137742|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139137743|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139137744|NCT05669781|Metoclopramide|metoclopramide|mesh-list
139137745|NCT05669781|Antiemetics|antiemetics|mesh-ancestor
139137746|NCT05669781|Autonomic Agents|autonomic agents|mesh-ancestor
139137747|NCT05669781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137748|NCT05669781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137749|NCT05669781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139137750|NCT05669781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139137751|NCT05669781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139137752|NCT05669781|Dopamine Agents|dopamine agents|mesh-ancestor
139137753|NCT05669781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137754|NCT05669781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137755|NCT01202331|Azithromycin|azithromycin|mesh-list
139137756|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139137757|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137758|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139137759|NCT01201551|Latanoprost|latanoprost|mesh-list
139137760|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139137761|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139137762|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139137763|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139137764|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139137765|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139137766|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
139137767|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137768|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137769|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137770|NCT01204125|Paclitaxel|paclitaxel|mesh-list
139137771|NCT01204125|Iniparib|iniparib|mesh-list
139137772|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139137773|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137774|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
139137775|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
139137776|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
139137777|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137778|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139137779|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137780|NCT03074240|Anesthetics|anesthetics|mesh-list
139137781|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
139137782|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137783|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137784|NCT03725085|Guaifenesin|guaifenesin|mesh-list
139137785|NCT03725085|Expectorants|expectorants|mesh-ancestor
139137786|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
139137787|NCT01566825|Amitriptyline|amitriptyline|mesh-list
139137788|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139137789|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
139137790|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139137791|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139137792|NCT01566825|Analgesics|analgesics|mesh-ancestor
139137793|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
139137794|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137795|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137796|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139137797|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139137798|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139137799|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137800|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
139137801|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137802|NCT03559010|Norgestrel|norgestrel|mesh-list
139137803|NCT03559010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139137804|NCT03559010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139137805|NCT03559010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139137806|NCT03559010|Contraceptive Agents|contraceptive agents|mesh-ancestor
139137807|NCT03559010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139137808|NCT03559010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137809|NCT03559010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139137810|NCT03559010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139137811|NCT03298412|Blinatumomab|blinatumomab|mesh-list
139137812|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137813|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
139137814|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
139137815|NCT03297398|Androgens|androgens|mesh-list
139137816|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139137817|NCT03297398|Hormones|hormones|mesh-ancestor
139137818|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139137819|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137820|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
139137821|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137822|NCT03297398|Protective Agents|protective agents|mesh-ancestor
139137823|NCT03297398|Vitamins|vitamins|mesh-ancestor
139137824|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
139137825|NCT03297398|Estrogens|estrogens|mesh-ancestor
139137826|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139137827|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137828|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
139137829|NCT03293654|Bevacizumab|bevacizumab|mesh-list
139137830|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139137831|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137832|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139137833|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139137834|NCT03293654|Growth Substances|growth substances|mesh-ancestor
139137835|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137836|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
139137838|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139137839|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137840|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137841|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137842|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
139137843|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137844|NCT03838029|Etodolac|etodolac|mesh-list
139137845|NCT03838029|Propranolol|propranolol|mesh-list
139137846|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139137847|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139137848|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
139137849|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137850|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137851|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137852|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139137853|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138888401|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
139137854|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
139137855|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139137856|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139137857|NCT03838029|Analgesics|analgesics|mesh-ancestor
139137858|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
139137859|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137860|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139137861|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139137862|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139137863|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139137864|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876667|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139137865|NCT04708340|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
139137866|NCT04708340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139137867|NCT04708340|Antioxidants|antioxidants|mesh-ancestor
139137868|NCT04708340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137869|NCT04708340|Protective Agents|protective agents|mesh-ancestor
139137870|NCT04708340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137871|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
139137872|NCT03292640|Tazarotene|tazarotene|mesh-list
139137873|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
139137874|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
139137875|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
139137876|NCT03292640|Vitamins|vitamins|mesh-ancestor
139137877|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
139137878|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137879|NCT01567215|Ethanol|ethanol|mesh-list
139137880|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
139137881|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139137882|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137883|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137884|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137885|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
139137886|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139137889|NCT01202487|Tetracaine|tetracaine|mesh-list
139137890|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
138708281|NCT00541112|Calcium|calcium|mesh-list
139137891|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
139137892|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137893|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137894|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
139137895|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137896|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139137897|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139137898|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139137899|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139137900|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137901|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139137902|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139137903|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
139137904|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137905|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139137906|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139137907|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
139137908|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139137909|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
139137910|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
139137911|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
139137912|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139137913|NCT01204437|Paclitaxel|paclitaxel|mesh-list
139137914|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
139137915|NCT01204437|Capecitabine|capecitabine|mesh-list
139137916|NCT01204437|Methotrexate|methotrexate|mesh-list
139137917|NCT01204437|Epirubicin|epirubicin|mesh-list
139137918|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139137919|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139137920|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
139137921|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
139137922|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
139137923|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137924|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139137925|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
139137926|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137927|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139137928|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139137929|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
139137930|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139137931|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139137932|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
139137933|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139137934|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
139137935|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139137936|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
139137937|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139137938|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139137939|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139137940|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139137941|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139137942|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139137943|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
139137944|NCT02633241|Propofol|propofol|mesh-list
139137945|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139137946|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139137947|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137948|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139137949|NCT02633241|Analgesics|analgesics|mesh-ancestor
139137950|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
139137951|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137952|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138708308|NCT02333643|Digoxin|digoxin|mesh-list
139137953|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139137954|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139137955|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
139137956|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137957|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508329|NCT06084364|Triamcinolone|triamcinolone|mesh-list
139137958|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139137959|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
139137960|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
139137961|NCT03292016|Apomorphine|apomorphine|mesh-list
139137963|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137964|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
139137965|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137966|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139137967|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
139137968|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
139137969|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137970|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137971|NCT05669391|Antidepressive Agents|antidepressive agents|mesh-list
139137972|NCT05669391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139137973|NCT01206075|Plerixafor|plerixafor|mesh-list
139137974|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139137975|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139137976|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
139137977|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139137978|NCT03289676|Nicotine|nicotine|mesh-list
139137979|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139137980|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
139137981|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139137982|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137983|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139137984|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139137985|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
139137986|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139137987|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137988|NCT03834831|Selenium|selenium|mesh-list
139137989|NCT03834831|Ubiquinone|ubiquinone|mesh-list
139137990|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
139137991|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
139137992|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139137993|NCT03834831|Protective Agents|protective agents|mesh-ancestor
139137994|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139137995|NCT03834831|Trace Elements|trace elements|mesh-ancestor
139137996|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
139137997|NCT03834831|Vitamins|vitamins|mesh-ancestor
139137998|NCT01206153|Metformin|metformin|mesh-list
139137999|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139138000|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138001|NCT01298271|Propranolol|propranolol|mesh-list
139138002|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139138003|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138888542|NCT00613145|Sorafenib|sorafenib|mesh-list
139138004|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
139138005|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138006|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138007|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138008|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139138009|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139138010|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
139138011|NCT05281965|Tretinoin|tretinoin|mesh-list
139138012|NCT05281965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138013|NCT05281965|Keratolytic Agents|keratolytic agents|mesh-ancestor
139138014|NCT05281965|Dermatologic Agents|dermatologic agents|mesh-ancestor
139138015|NCT04251884|Ropivacaine|ropivacaine|mesh-list
139138016|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
139138017|NCT04251884|Anesthetics|anesthetics|mesh-list
139138018|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138708320|NCT00541463|Nelfinavir|nelfinavir|mesh-list
139138019|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138020|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
139138021|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138022|NCT01202799|Diclofenac|diclofenac|mesh-list
139138023|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139138024|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139138025|NCT01202799|Analgesics|analgesics|mesh-ancestor
139138026|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
139138027|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138028|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138029|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139138030|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139138031|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139138032|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138033|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138034|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
139138035|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
139138036|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138037|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138038|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138039|NCT01298505|Fexofenadine|fexofenadine|mesh-list
139138040|NCT01298505|Terfenadine|terfenadine|mesh-list
139138041|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139138042|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139138043|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139138044|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
139138045|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
139138046|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138047|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138048|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138049|NCT01204593|Insulin|insulin|mesh-list
139138050|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139138051|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
139138052|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
139138053|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139138054|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138055|NCT03310970|Lidocaine|lidocaine|mesh-list
139138056|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
139138057|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
139138058|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138059|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138060|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
139138061|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138062|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139138063|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139138064|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139138065|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139138066|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138067|NCT05281419|Triamcinolone|triamcinolone|mesh-list
139138068|NCT05281419|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139138069|NCT05281419|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139138070|NCT05281419|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139138071|NCT05281419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139138072|NCT05281419|Glucocorticoids|glucocorticoids|mesh-ancestor
139138074|NCT05281419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139138075|NCT05281419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138076|NCT05281419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138888632|NCT04131582|Metformin|metformin|mesh-list
139138077|NCT05281419|Immunologic Factors|immunologic factors|mesh-ancestor
139138078|NCT05281419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138079|NCT05281419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138080|NCT01203111|Insulin|insulin|mesh-list
139138081|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139138082|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
139138083|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
139138084|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139138085|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138086|NCT02722941|Panobinostat|panobinostat|mesh-list
139138087|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138088|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139138089|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138090|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138091|NCT03420339|Adderall|adderall|mesh-list
139138092|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139138093|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138094|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
139138095|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139138096|NCT01297179|Mirabegron|mirabegron|mesh-list
139138097|NCT01297179|Estradiol|estradiol|mesh-list
139138098|NCT01297179|Estrogens|estrogens|mesh-ancestor
139138099|NCT01297179|Hormones|hormones|mesh-ancestor
139138100|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139138101|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138102|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139138103|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
139138104|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139138105|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139138106|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139138107|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139138108|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139138109|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139138110|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139138111|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139138112|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
139138113|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138114|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138115|NCT01297179|Urological Agents|urological agents|mesh-ancestor
139138116|NCT01205139|Simeprevir|simeprevir|mesh-list
139138117|NCT01205139|Rilpivirine|rilpivirine|mesh-list
139138118|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
139138119|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139138120|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
139138121|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138122|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138123|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139138124|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139138125|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139138126|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139138127|NCT01205217|Paclitaxel|paclitaxel|mesh-list
139138128|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
139138129|NCT01205217|Trastuzumab|trastuzumab|mesh-list
139138130|NCT01205217|Epirubicin|epirubicin|mesh-list
139138131|NCT01205217|Lapatinib|lapatinib|mesh-list
139138132|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139138133|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138134|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
139138135|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
139138136|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
139138137|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138138|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139138139|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
139138140|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138141|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138708339|NCT02324985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139138142|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139138143|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
139138144|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139138145|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139138146|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139138147|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139138148|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139138149|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138150|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139138151|NCT01203267|Paclitaxel|paclitaxel|mesh-list
139138152|NCT01203267|Carboplatin|carboplatin|mesh-list
139138153|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139138154|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138155|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
139138156|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
139138157|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
139138158|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138159|NCT01207245|Tobramycin|tobramycin|mesh-list
139138160|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139138161|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139138162|NCT01297569|Ranibizumab|ranibizumab|mesh-list
139138163|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139138164|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139138165|NCT01297569|Growth Substances|growth substances|mesh-ancestor
139138166|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138167|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
139138168|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138169|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139138170|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
139138171|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138172|NCT01299597|Atorvastatin|atorvastatin|mesh-list
139138173|NCT01299597|Simvastatin|simvastatin|mesh-list
139138174|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139138175|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139138176|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
139138177|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138178|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139138179|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139138181|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
139138182|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139138183|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138184|NCT03723915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139138185|NCT03723915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138186|NCT03840057|Azithromycin|azithromycin|mesh-list
139138187|NCT03840057|Metoclopramide|metoclopramide|mesh-list
139138188|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139138189|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139138190|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
139138191|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
139138192|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138193|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138194|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139138195|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139138196|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139138197|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
139138198|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138199|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138200|NCT01297803|Mitomycins|mitomycins|mesh-list
139138201|NCT01297803|Mitomycin|mitomycin|mesh-list
139138202|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139138203|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138204|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
139138205|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708349|NCT04659642|Analgesics|analgesics|mesh-ancestor
139138206|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139138207|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138208|NCT03824691|Durvalumab|durvalumab|mesh-list
139138209|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139138210|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138211|NCT01299831|Hormones|hormones|mesh-list
139138212|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139138213|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138214|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
139138215|NCT01205997|Fentanyl|fentanyl|mesh-list
139138216|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139138217|NCT01205997|Narcotics|narcotics|mesh-ancestor
139138218|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138219|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138220|NCT01205997|Analgesics|analgesics|mesh-ancestor
139138221|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
139138222|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138223|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139138224|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139138225|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
139138226|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
138888776|NCT05042531|Azacitidine|azacitidine|mesh-list
139138227|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139138228|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
139138229|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139138230|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139138231|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138232|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139138233|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
139138234|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139138235|NCT03818997|Paclitaxel|paclitaxel|mesh-list
139138236|NCT03818997|Atezolizumab|atezolizumab|mesh-list
139138237|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139138238|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138239|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
139138240|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
139138241|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
139138242|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138243|NCT03818997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139138244|NCT03818997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139138245|NCT03818919|Acetaminophen|acetaminophen|mesh-list
139138246|NCT03818919|Celecoxib|celecoxib|mesh-list
139138247|NCT03818919|Ketorolac|ketorolac|mesh-list
139138248|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139138249|NCT03818919|Diazepam|diazepam|mesh-list
139138250|NCT03818919|Gabapentin|gabapentin|mesh-list
139138251|NCT03818919|Hydrocodone|hydrocodone|mesh-list
139138252|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139138253|NCT03818919|Analgesics|analgesics|mesh-ancestor
139138254|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
139138255|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138256|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138257|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
139138258|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139138259|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139138260|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139138261|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139138262|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139138263|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138264|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138265|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
139138266|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139138267|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139138268|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138269|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139138270|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139138271|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139138272|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138273|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
139138274|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139138275|NCT03818919|Narcotics|narcotics|mesh-ancestor
139138276|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
139138277|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
139138278|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139138279|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
139138280|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
139138281|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139138282|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139138283|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139138284|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139138285|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139138286|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
139138287|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
139138288|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
139138289|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
139138290|NCT03821493|Itraconazole|itraconazole|mesh-list
139138291|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139138292|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
139138293|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139138294|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139138295|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139138296|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138297|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138298|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139138299|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
139138300|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139138301|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138302|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139138303|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
139138304|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139138305|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139138306|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139138307|NCT05618223|Dapagliflozin|dapagliflozin|mesh-list
139138308|NCT05618223|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139138309|NCT05618223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138310|NCT05618223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139138311|NCT05618223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138312|NCT03814629|Vitamins|vitamins|mesh-list
139138313|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
139138314|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138315|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139138316|NCT01585935|SMOFlipid|smoflipid|mesh-list
139138317|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139138318|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139138319|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139138320|NCT01300377|Lidocaine|lidocaine|mesh-list
139138321|NCT01300377|Bupivacaine|bupivacaine|mesh-list
139138322|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
139138323|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
139138324|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138325|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138326|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
139138327|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138328|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139138329|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139138330|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139138331|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139138332|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138333|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
139138334|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139138335|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
139138336|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138337|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
139138338|NCT03814707|Protective Agents|protective agents|mesh-ancestor
139138339|NCT03818295|Praliciguat|praliciguat|mesh-list
139138340|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139138341|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
139138342|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138343|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139138344|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
139138345|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139138346|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
139138347|NCT01301313|Simendan|simendan|mesh-list
139138348|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139138349|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
139138350|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139138351|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139138352|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138353|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138354|NCT01301313|Protective Agents|protective agents|mesh-ancestor
139138355|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138356|NCT03817359|Remifentanil|remifentanil|mesh-list
139138357|NCT03817359|Propofol|propofol|mesh-list
139138358|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139138359|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138360|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138361|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139138362|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
139138363|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
139138364|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139138365|NCT03817359|Narcotics|narcotics|mesh-ancestor
139138366|NCT03817359|Analgesics|analgesics|mesh-ancestor
139138367|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
139138368|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138369|NCT03813927|Vitamin D|vitamin d|mesh-list
139138370|NCT03813927|Vitamins|vitamins|mesh-ancestor
139138371|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
139138372|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138373|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139138374|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139138375|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138888918|NCT00636935|Pentamidine|pentamidine|mesh-list
139138376|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
139138377|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
139138378|NCT03813771|Etanercept|etanercept|mesh-list
139138379|NCT03813771|Methotrexate|methotrexate|mesh-list
139138380|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139138381|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
139138382|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139138383|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138384|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139138385|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
139138386|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138387|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138388|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
139138389|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138390|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139138391|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139138392|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
139138393|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138901906|NCT04971954|Nicotine|nicotine|mesh-list
139138394|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139138395|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
139138396|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139138397|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139138398|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139138399|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139138400|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139138401|NCT03813771|Analgesics|analgesics|mesh-ancestor
139138402|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
139138403|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138404|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139138405|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139138406|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
139138407|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139138408|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139138409|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139138410|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
139138411|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
139138412|NCT02036242|Sufentanil|sufentanil|mesh-list
139138413|NCT02036242|Ropivacaine|ropivacaine|mesh-list
139138414|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
139138415|NCT02036242|Anesthetics|anesthetics|mesh-list
139138416|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138417|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138418|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
139138419|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138420|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139138421|NCT02036242|Narcotics|narcotics|mesh-ancestor
139138422|NCT02036242|Analgesics|analgesics|mesh-ancestor
139138423|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139138424|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139138425|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
139138426|NCT05281107|Calcium, Dietary|calcium, dietary|mesh-list
139138427|NCT05281107|Vitamin D|vitamin d|mesh-list
139138428|NCT05281107|Ergocalciferols|ergocalciferols|mesh-list
139138429|NCT05281107|Cholecalciferol|cholecalciferol|mesh-list
139138430|NCT05281107|Vitamins|vitamins|mesh-list
139138431|NCT05281107|Calcium|calcium|mesh-list
139138432|NCT05281107|Micronutrients|micronutrients|mesh-ancestor
139138433|NCT05281107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138434|NCT05281107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139138435|NCT05281107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139138436|NCT02812186|Rocuronium|rocuronium|mesh-list
139138437|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139138438|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139138439|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139138440|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138441|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138442|NCT03310268|Listerine|listerine|mesh-list
139138443|NCT03310268|Fluorides|fluorides|mesh-list
139138444|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
139138445|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
139138446|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
139138447|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
139138448|NCT03310268|Protective Agents|protective agents|mesh-ancestor
139138449|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138450|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139138451|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139138452|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139138453|NCT02810392|Insulin|insulin|mesh-list
139138454|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139138455|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139138456|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138457|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
139138458|NCT03805035|Maleic acid|maleic acid|mesh-list
139138459|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
139138460|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
139138461|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139138462|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138463|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138464|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
139138465|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138466|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138467|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
139138468|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
139138469|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139138470|NCT02815540|Cannabidiol|cannabidiol|mesh-list
139138471|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
139138472|NCT03816267|Albuterol|albuterol|mesh-list
139138473|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139138474|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
139138475|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138476|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138477|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139138478|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
139138479|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
139138480|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139138481|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139138482|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139138483|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139138484|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
139138485|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138486|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138487|NCT03280550|Omalizumab|omalizumab|mesh-list
139138488|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139138489|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139138490|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
139138491|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
139138492|NCT02036554|Everolimus|everolimus|mesh-list
139138493|NCT02036554|Tacrolimus|tacrolimus|mesh-list
139138494|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139138495|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
139138496|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138497|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139138498|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138499|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138500|NCT02036554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139138501|NCT02036554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139138502|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138503|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139138504|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139138505|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
139138506|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139138507|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139138508|NCT05577117|Fentanyl|fentanyl|mesh-list
139138509|NCT05577117|Dexmedetomidine|dexmedetomidine|mesh-list
139138510|NCT05577117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139138511|NCT05577117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138512|NCT05577117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138513|NCT05577117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139138514|NCT05577117|Analgesics|analgesics|mesh-ancestor
139138515|NCT05577117|Sensory System Agents|sensory system agents|mesh-ancestor
139138516|NCT05577117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138517|NCT05577117|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139138518|NCT05577117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139138519|NCT05577117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139138520|NCT05577117|Adrenergic Agents|adrenergic agents|mesh-ancestor
139138521|NCT05577117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138522|NCT05577117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138523|NCT05577117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139138525|NCT05577117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139138526|NCT05577117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139138527|NCT05577117|Anesthetics, General|anesthetics, general|mesh-ancestor
139138528|NCT05577117|Anesthetics|anesthetics|mesh-ancestor
139138529|NCT03813303|Midazolam|midazolam|mesh-list
139138530|NCT03813303|Fentanyl|fentanyl|mesh-list
139138531|NCT03813303|Propofol|propofol|mesh-list
139138532|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139138533|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138534|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138535|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139138536|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
139138538|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139138539|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139138540|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139138541|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139138542|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
139138543|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
139138544|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138545|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138546|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139138548|NCT03813303|Analgesics|analgesics|mesh-ancestor
139138549|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
139138550|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138551|NCT03637790|Rifampin|rifampin|mesh-list
139138552|NCT03637790|Abrocitinib|abrocitinib|mesh-list
139138553|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139138554|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
139138555|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139138556|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139138557|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
139138558|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139138559|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138560|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138561|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139138562|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139138563|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139138564|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139138565|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139138566|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139138567|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139138568|NCT03813069|Permethrin|permethrin|mesh-list
139138569|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138570|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138571|NCT03276026|Neostigmine|neostigmine|mesh-list
139138572|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139138573|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876957|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139138574|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138575|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
139138576|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138577|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138578|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139138579|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
139138580|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138581|NCT01303497|Paclitaxel|paclitaxel|mesh-list
139138582|NCT01303497|Bevacizumab|bevacizumab|mesh-list
139138583|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139138584|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138585|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
139138586|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
139138587|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
139138588|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138589|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139138590|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139138591|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139138592|NCT01303497|Growth Substances|growth substances|mesh-ancestor
139138593|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138594|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
139138595|NCT01589523|Cholic Acids|cholic acids|mesh-list
139138596|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
139138597|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139138598|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139138599|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
139138600|NCT03804177|Melatonin|melatonin|mesh-list
139138601|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
139138602|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
139138603|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138604|NCT03804177|Protective Agents|protective agents|mesh-ancestor
139138605|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138606|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138607|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139138608|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
139138609|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
139138610|NCT03804177|Vitamins|vitamins|mesh-ancestor
139138611|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
139138612|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
139138613|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139138614|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138615|NCT03277352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139138616|NCT03277352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138617|NCT01302093|Racecadotril|racecadotril|mesh-list
139138618|NCT01302093|Thiorphan|thiorphan|mesh-list
139138619|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
139138620|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139138621|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
139138622|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138623|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138624|NCT03803007|Glenzocimab|glenzocimab|mesh-list
139138625|NCT03803007|Anticoagulants|anticoagulants|mesh-ancestor
139138626|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
139138627|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139138628|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
139138629|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139138630|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138631|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139138633|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139138634|NCT02047552|Oxandrolone|oxandrolone|mesh-list
139138635|NCT02047552|Trace Elements|trace elements|mesh-ancestor
139138636|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
139138637|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138638|NCT02047552|Hematinics|hematinics|mesh-ancestor
139138639|NCT02047552|Androgens|androgens|mesh-ancestor
139138640|NCT02047552|Hormones|hormones|mesh-ancestor
139138641|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139138642|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
139138643|NCT01303731|Fentanyl|fentanyl|mesh-list
139138644|NCT01303731|Bupivacaine|bupivacaine|mesh-list
139138645|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
139138646|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
139138647|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138648|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138649|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
139138650|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138651|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139138652|NCT01303731|Narcotics|narcotics|mesh-ancestor
139138653|NCT01303731|Analgesics|analgesics|mesh-ancestor
139138654|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139138655|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139138656|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
139138657|NCT03815487|Insulin|insulin|mesh-list
139138658|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139138659|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139138660|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138661|NCT03815422|Anesthetics|anesthetics|mesh-list
139138662|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138663|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138664|NCT02260024|Pramipexole|pramipexole|mesh-list
139138665|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
139138666|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138667|NCT02260024|Protective Agents|protective agents|mesh-ancestor
139138668|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138669|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138708472|NCT00542984|Teriparatide|teriparatide|mesh-list
139138670|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139138671|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
139138672|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
139138673|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138674|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
139138675|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
139138676|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138677|NCT03800667|Protective Agents|protective agents|mesh-ancestor
139138678|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138680|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
139138681|NCT01302171|Lenograstim|lenograstim|mesh-list
139138682|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139138683|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
139138684|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138685|NCT02047630|Latanoprost|latanoprost|mesh-list
139138686|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139138687|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139138688|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139138689|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139138690|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
139138691|NCT03799809|Voriconazole|voriconazole|mesh-list
139138692|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
139138693|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139138694|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139138695|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139138696|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138697|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138698|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139138699|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
139138700|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139138701|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138702|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139138703|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139138704|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139138705|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139138706|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139138707|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138708|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138709|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138710|NCT03812523|Analgesics|analgesics|mesh-ancestor
139138711|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
139138712|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138713|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
139138714|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139138715|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
139138716|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139138717|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139138718|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139138719|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
139138720|NCT02049970|Bupivacaine|bupivacaine|mesh-list
139138721|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
139138722|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
139138723|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138724|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138725|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
139138726|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138727|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139138728|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139138729|NCT02049970|Analgesics|analgesics|mesh-ancestor
139138730|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139138731|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139138732|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139138733|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
139138734|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138735|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138736|NCT02048020|Paclitaxel|paclitaxel|mesh-list
139138737|NCT02048020|Carboplatin|carboplatin|mesh-list
139138738|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139138739|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138740|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
139138741|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
139138742|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
139138743|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138744|NCT03562390|Irinotecan|irinotecan|mesh-list
139138745|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139138746|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139138747|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138748|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138749|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138750|NCT02048098|Misoprostol|misoprostol|mesh-list
139138751|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139138752|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
139138753|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139138754|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138755|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139138756|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139138757|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
139138758|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
139138759|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
139138760|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139138761|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139138762|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138763|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138765|NCT02940860|Iron|iron|mesh-list
139138766|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139138767|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
139138768|NCT02940860|Trace Elements|trace elements|mesh-ancestor
139138769|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
139138770|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138771|NCT02940860|Hematinics|hematinics|mesh-ancestor
139138772|NCT01303887|Prednisolone|prednisolone|mesh-list
139138773|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
139138774|NCT01303887|Rituximab|rituximab|mesh-list
139138775|NCT01303887|Fludarabine|fludarabine|mesh-list
139138776|NCT01303887|Vincristine|vincristine|mesh-list
139138777|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139138778|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
139138779|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138780|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139138781|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139138782|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
139138783|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138784|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138785|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139138786|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139138787|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139138788|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
139138789|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
139138790|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
139138791|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139138792|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
139138793|NCT01303887|Hormones|hormones|mesh-ancestor
139138794|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139138795|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139138796|NCT02050594|Ipilimumab|ipilimumab|mesh-list
139138797|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139138798|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138799|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138877103|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138800|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138801|NCT02806960|Glucagon|glucagon|mesh-list
139138802|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139138803|NCT02806960|Hormones|hormones|mesh-ancestor
139138804|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139138805|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138806|NCT03718143|Adavosertib|adavosertib|mesh-list
139138807|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138808|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138809|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
139138810|NCT02955134|Antacids|antacids|mesh-ancestor
139138811|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138812|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139138813|NCT02048488|Belizatinib|belizatinib|mesh-list
139138814|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139138815|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138816|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138817|NCT02050672|Inositol|inositol|mesh-list
139138818|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
139138819|NCT02050672|Vitamins|vitamins|mesh-ancestor
139138820|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
139138821|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138822|NCT03811366|Prednisone|prednisone|mesh-list
139138823|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139138824|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
139138825|NCT03811366|Hormones|hormones|mesh-ancestor
139138826|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139138827|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138828|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139138829|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138830|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139138831|NCT03274466|Laxatives|laxatives|mesh-ancestor
139138832|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139138833|NCT02037802|Fentanyl|fentanyl|mesh-list
139138834|NCT02037802|Meperidine|meperidine|mesh-list
139138835|NCT02037802|Bupivacaine|bupivacaine|mesh-list
139138836|NCT02037802|Propofol|propofol|mesh-list
139138838|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
139138839|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138840|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138841|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
139138842|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138843|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139138844|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139138845|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
139138846|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139138847|NCT02037802|Narcotics|narcotics|mesh-ancestor
139138848|NCT02037802|Analgesics|analgesics|mesh-ancestor
139138849|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139138850|NCT02051530|Tryptophan|tryptophan|mesh-list
139138851|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139138852|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
139138853|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139138854|NCT03797703|Lidocaine|lidocaine|mesh-list
139138855|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
139138856|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
139138857|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138858|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138859|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
139138860|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138861|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139138862|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139138863|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139138864|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138708517|NCT02252835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138865|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138866|NCT02048644|Beclomethasone|beclomethasone|mesh-list
139138867|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
139138868|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139138869|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
139138870|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138871|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138872|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139138873|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
139138874|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139138875|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139138876|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139138877|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
139138878|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138879|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138880|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139138881|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
139138883|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139138884|NCT02048800|Treosulfan|treosulfan|mesh-list
139138885|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139138886|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
139138887|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138888|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138889|NCT03797625|Cisplatin|cisplatin|mesh-list
139138890|NCT03797625|Irinotecan|irinotecan|mesh-list
139138891|NCT03797625|Endostar protein|endostar protein|mesh-list
139138892|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138893|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139138894|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139138895|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138896|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138897|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139138898|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139138899|NCT03797625|Growth Substances|growth substances|mesh-ancestor
139138900|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138901|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
139138903|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139138904|NCT02806414|Ivermectin|ivermectin|mesh-list
139138905|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139138906|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139138907|NCT02049034|Lixisenatide|lixisenatide|mesh-list
139138908|NCT02049034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139138909|NCT02049034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138911|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138912|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139138913|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
139138914|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139138915|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138916|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
139138917|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139138918|NCT03811509|Denosumab|denosumab|mesh-list
139138919|NCT03811509|Diphosphonates|diphosphonates|mesh-list
139138920|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139138921|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138922|NCT02037412|Clopidogrel|clopidogrel|mesh-list
139138923|NCT02037412|Ticagrelor|ticagrelor|mesh-list
139138924|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139138925|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139138926|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139138927|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138708533|NCT03456713|Analgesics|analgesics|mesh-ancestor
139138928|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
139138929|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138930|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138931|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138932|NCT02052154|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139138933|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
139138934|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138935|NCT03797079|Bupivacaine|bupivacaine|mesh-list
139138936|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
139138937|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
139138938|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138939|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138940|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
139138941|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138942|NCT02049268|Ethanol|ethanol|mesh-list
139138943|NCT02049268|Nicotine|nicotine|mesh-list
139138944|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139138945|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
139138946|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139138947|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138948|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139138949|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139138950|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
139138951|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138952|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138953|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139138954|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139138955|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138956|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
139138957|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
139138958|NCT02049346|Hematinics|hematinics|mesh-ancestor
139138959|NCT03564873|Azacitidine|azacitidine|mesh-list
139138960|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
139138961|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139138962|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
139138963|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138964|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138965|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138966|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139138967|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139138968|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
139138969|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139138970|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139019557|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139138971|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138972|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
139138973|NCT02806024|Coagulants|coagulants|mesh-ancestor
139138974|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139138975|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139138976|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138977|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
139138978|NCT02049580|Thiotepa|thiotepa|mesh-list
139138979|NCT02049580|Fludarabine|fludarabine|mesh-list
139138980|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139138981|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
139138982|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139138983|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139138984|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139138985|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
139138986|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138987|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138988|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139138989|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
139138990|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139138991|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138877207|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
139138992|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139138993|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139138994|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139138995|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139138996|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139138997|NCT03796533|Posaconazole|posaconazole|mesh-list
139138998|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
139138999|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139000|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139139001|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139139002|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139139003|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139139004|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139139005|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139006|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139007|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139139008|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
139139009|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139010|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139011|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
139139012|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139139013|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
139139014|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139139015|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
139139016|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139017|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139018|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
139139019|NCT02049736|Telbivudine|telbivudine|mesh-list
139139020|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
139139021|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139022|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139139023|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139024|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139025|NCT01303029|Gemcitabine|gemcitabine|mesh-list
139139026|NCT01303029|Capecitabine|capecitabine|mesh-list
139139027|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139139028|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139139029|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
139139030|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139031|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139032|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139139033|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139034|NCT02052388|Daptomycin|daptomycin|mesh-list
139139035|NCT02052388|Brilacidin|brilacidin|mesh-list
139139036|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139139037|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139038|NCT01303107|Bupivacaine|bupivacaine|mesh-list
139139039|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
139139040|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
139139041|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139042|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139043|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
139139044|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139045|NCT03795909|Dexamethasone|dexamethasone|mesh-list
139139046|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139139047|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
139139048|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
138877239|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
139139049|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139050|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139051|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139139052|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
139139053|NCT03795909|Hormones|hormones|mesh-ancestor
139139054|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139055|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139139056|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139057|NCT03795597|Melphalan|melphalan|mesh-list
139139058|NCT03795597|Busulfan|busulfan|mesh-list
139139059|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139139060|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
139139061|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139062|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139063|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139139064|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139139065|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
139139066|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139067|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
139139068|NCT02802592|Hematinics|hematinics|mesh-ancestor
139139069|NCT03637972|Nicotine|nicotine|mesh-list
139139070|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139139071|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
139139072|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139073|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139074|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139139075|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139139076|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
139139077|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139078|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139079|NCT03383679|Capecitabine|capecitabine|mesh-list
139139080|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139139081|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
139139082|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139083|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139084|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
139139085|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139139086|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139087|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
139139088|NCT02053402|Vitamin D|vitamin d|mesh-list
139139089|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
139139090|NCT02053402|Vitamins|vitamins|mesh-ancestor
139139091|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
139139092|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139093|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139139094|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139139095|NCT04639011|Norepinephrine|norepinephrine|mesh-list
138877258|NCT00660972|Tenofovir|tenofovir|mesh-list
139139096|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139139098|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139139099|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139139100|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139139101|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139102|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139103|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139104|NCT04639011|Analgesics|analgesics|mesh-ancestor
139139105|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
139139106|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139107|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
139139108|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139139109|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
139139110|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139139111|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139139112|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
139139113|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
139139114|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
139139115|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139139116|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139139117|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
139139118|NCT02053558|Lidocaine|lidocaine|mesh-list
139139119|NCT02053558|Ropivacaine|ropivacaine|mesh-list
139139120|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
139139121|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
139139122|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139123|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139124|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
139139125|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139126|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138901929|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
139139127|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139139128|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139139129|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139139130|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139131|NCT03809949|Fentanyl|fentanyl|mesh-list
139139132|NCT03809949|Anesthetics|anesthetics|mesh-list
139139133|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139134|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139135|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139139137|NCT03809949|Analgesics|analgesics|mesh-ancestor
139139138|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
139139139|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139140|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139139141|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139139142|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
139139143|NCT02052934|Vaccines|vaccines|mesh-list
139139144|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
139139145|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139146|NCT03810261|Vitamin D|vitamin d|mesh-list
139139147|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
139139148|NCT03810261|Cholecalciferol|cholecalciferol|mesh-list
139139149|NCT03810261|Vitamins|vitamins|mesh-list
139139150|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
139139151|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139152|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139139153|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139139154|NCT02037724|Iron|iron|mesh-list
139139155|NCT02037724|Trace Elements|trace elements|mesh-ancestor
139139156|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
139139157|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139158|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139139159|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139139160|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139161|NCT01569633|Erythromycin|erythromycin|mesh-list
139139162|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
139139163|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139139164|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
139139165|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139139166|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139167|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139139168|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139139169|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019558|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
139139170|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139171|NCT02054182|Vitamin D|vitamin d|mesh-list
139139172|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
139139173|NCT02054182|Vitamins|vitamins|mesh-ancestor
139139174|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
139139175|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139176|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139139177|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139139178|NCT02803138|Ritonavir|ritonavir|mesh-list
139139179|NCT02803138|Ribavirin|ribavirin|mesh-list
139139180|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139139181|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139139182|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
139139183|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139184|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139185|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139139186|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139139187|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
139139188|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139189|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139139190|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139139191|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
139139192|NCT03795207|Durvalumab|durvalumab|mesh-list
139139193|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139139194|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139195|NCT02056210|Plerixafor|plerixafor|mesh-list
139139196|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139139197|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139139198|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
139139199|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139200|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
139139201|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139139202|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139139203|NCT03794505|Prednisolone|prednisolone|mesh-list
139139204|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
139139205|NCT03794505|Lidocaine|lidocaine|mesh-list
139139206|NCT03794505|Ropivacaine|ropivacaine|mesh-list
139139207|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139139208|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
139139209|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
139139210|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
139139211|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139212|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139213|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
139139214|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139215|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139139216|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139139217|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139139218|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139139219|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139220|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139139222|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
139139223|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139139224|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
139139225|NCT03794505|Hormones|hormones|mesh-ancestor
139139226|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139227|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139139228|NCT03794505|Protective Agents|protective agents|mesh-ancestor
139139229|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139139230|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139231|NCT05625243|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
139139232|NCT05625243|Vasodilator Agents|vasodilator agents|mesh-ancestor
139139233|NCT05625243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139139234|NCT05625243|Protective Agents|protective agents|mesh-ancestor
139139235|NCT05625243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139236|NCT03023007|Anesthetics|anesthetics|mesh-list
139139237|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138877339|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
139139238|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139239|NCT01304901|Montelukast|montelukast|mesh-list
139139240|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139139241|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
139139242|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139139243|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
139139244|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139245|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139246|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139139247|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139139248|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139249|NCT03794271|Anesthetics|anesthetics|mesh-list
139139250|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139251|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139252|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
139139253|NCT03792321|Testosterone|testosterone|mesh-list
139139254|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
139139255|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
139139256|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139139257|NCT03792321|Androgens|androgens|mesh-ancestor
139139258|NCT03792321|Hormones|hormones|mesh-ancestor
139139259|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139260|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139261|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139139262|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139263|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
139139264|NCT01305057|Pyridoxine|pyridoxine|mesh-list
139139265|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
139139266|NCT01305057|Vitamins|vitamins|mesh-ancestor
139139267|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
139139268|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139269|NCT03792009|Bupivacaine|bupivacaine|mesh-list
139139270|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
139139271|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
139139272|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138509641|NCT03984448|Prednisone|prednisone|mesh-list
139139273|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139275|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139276|NCT01305135|Azacitidine|azacitidine|mesh-list
139139277|NCT01305135|Idarubicin|idarubicin|mesh-list
139139278|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139139279|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
139139280|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139281|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139282|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139283|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139139284|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139139285|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139139286|NCT01305603|Bupivacaine|bupivacaine|mesh-list
139139287|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
139139288|NCT01305603|Anesthetics|anesthetics|mesh-list
139139289|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139290|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139291|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
138708687|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139292|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139293|NCT03793725|Apatinib|apatinib|mesh-list
139139294|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139295|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139139296|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139297|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139298|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139139299|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139139300|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
139139301|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
138877366|NCT02607215|Vinorelbine|vinorelbine|mesh-list
139139302|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139303|NCT02056366|Protective Agents|protective agents|mesh-ancestor
139139304|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139305|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
139139306|NCT02056366|Vitamins|vitamins|mesh-ancestor
139139307|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
139139308|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
139139309|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139139310|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139139311|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139312|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
139139313|NCT02056444|Coagulants|coagulants|mesh-ancestor
139139314|NCT02665234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139139315|NCT02665234|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139139316|NCT05624229|Esomeprazole|esomeprazole|mesh-list
139139317|NCT05624229|Omeprazole|omeprazole|mesh-list
139139318|NCT05624229|Rabeprazole|rabeprazole|mesh-list
139139319|NCT05624229|Pantoprazole|pantoprazole|mesh-list
139139320|NCT05624229|Lansoprazole|lansoprazole|mesh-list
139139321|NCT05624229|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139139322|NCT05624229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139139323|NCT05624229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139139324|NCT05624229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139325|NCT05624229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139326|NCT05622370|Brivaracetam|brivaracetam|mesh-list
139139327|NCT05622370|Anticonvulsants|anticonvulsants|mesh-ancestor
139139328|NCT03791775|Polidocanol|polidocanol|mesh-list
139139329|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139139330|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139139331|NCT03789123|Dienogest|dienogest|mesh-list
139139332|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139139333|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139139334|NCT03789123|Estradiol|estradiol|mesh-list
139139335|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139139336|NCT03789123|Nandrolone|nandrolone|mesh-list
139139337|NCT03789123|Estrogens|estrogens|mesh-ancestor
139139338|NCT03789123|Hormones|hormones|mesh-ancestor
139139339|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139340|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139341|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139139342|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
139139343|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139139344|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139139345|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139139346|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139139347|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139139348|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
139139349|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139139350|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139351|NCT03789123|Androgens|androgens|mesh-ancestor
139139352|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
139139353|NCT05471817|Dabigatran|dabigatran|mesh-list
139139354|NCT05471817|Antithrombins|antithrombins|mesh-ancestor
139139355|NCT05471817|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139139356|NCT05471817|Protease Inhibitors|protease inhibitors|mesh-ancestor
139139357|NCT05471817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889892|NCT00857220|Eszopiclone|eszopiclone|mesh-list
139139358|NCT05471817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139359|NCT05471817|Anticoagulants|anticoagulants|mesh-ancestor
139139360|NCT03788889|Ketamine|ketamine|mesh-list
139139361|NCT03788889|Lorazepam|lorazepam|mesh-list
139139362|NCT03788889|Phenobarbital|phenobarbital|mesh-list
139139363|NCT03788889|Analgesics|analgesics|mesh-ancestor
139139364|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
139139365|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139366|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139367|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139139368|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139139369|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
139139370|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
139139371|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139372|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139139373|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139139374|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139375|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139376|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
139139377|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
139139378|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
139139379|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139139380|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139139381|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139139382|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139139383|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139139384|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
139139385|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
139139386|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139139387|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139139388|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139139390|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
139139391|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139392|NCT03788733|Protective Agents|protective agents|mesh-ancestor
139139393|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139394|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139395|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
139139396|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139397|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139398|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139399|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139139400|NCT04753515|Midazolam|midazolam|mesh-list
139139401|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
139139402|NCT04753515|Remifentanil|remifentanil|mesh-list
139139403|NCT04753515|Propofol|propofol|mesh-list
139139404|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139139405|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139406|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139407|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139139408|NCT04753515|Analgesics|analgesics|mesh-ancestor
139139409|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
139139410|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139411|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139139412|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139139413|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139139414|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
139139415|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139416|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139417|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139139418|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
139139419|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
139139420|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139139421|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139139422|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139139423|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139139424|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
139139425|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
139139426|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139139427|NCT04753515|Narcotics|narcotics|mesh-ancestor
139139428|NCT01306461|Timolol|timolol|mesh-list
139139429|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139139430|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139139431|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
139139432|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139433|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139434|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139435|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139139436|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139139437|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
139139438|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139139439|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139139440|NCT01305837|Prednisolone|prednisolone|mesh-list
139139441|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
139139442|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139139443|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
139139444|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139139445|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
139139446|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
139139447|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139448|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139449|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139139450|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
139139451|NCT01305837|Hormones|hormones|mesh-ancestor
139139452|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139453|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139139454|NCT01305837|Protective Agents|protective agents|mesh-ancestor
139139455|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139139456|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139457|NCT01306773|Oseltamivir|oseltamivir|mesh-list
139139458|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
139139459|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139460|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139461|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139462|NCT03790605|Curcumin|curcumin|mesh-list
139139463|NCT03790605|Iproplatin|iproplatin|mesh-list
139139464|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139139465|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139139466|NCT03790605|Analgesics|analgesics|mesh-ancestor
139139467|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
139139468|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139469|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139470|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139139471|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139139472|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139473|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139474|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139475|NCT03787953|Antibodies|antibodies|mesh-list
139139476|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
139139477|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139478|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139139479|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
139139480|NCT01306851|Coagulants|coagulants|mesh-ancestor
139139481|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
139139482|NCT03790215|Progestins|progestins|mesh-ancestor
139139483|NCT03790215|Hormones|hormones|mesh-ancestor
139139484|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139485|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139486|NCT03790371|Misoprostol|misoprostol|mesh-list
138708726|NCT00544232|Hematinics|hematinics|mesh-ancestor
139139487|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139139488|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
139139489|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139139490|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139491|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139139492|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139139493|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
139139494|NCT01307475|Adenosine|adenosine|mesh-list
139139495|NCT01307475|Analgesics|analgesics|mesh-ancestor
139139496|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
139139497|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139498|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139499|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139139500|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
139139501|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139139502|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
139139503|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
139139504|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139505|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139506|NCT03787641|Protamines|protamines|mesh-list
139139507|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
139139508|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139509|NCT03787641|Coagulants|coagulants|mesh-ancestor
139139510|NCT03790293|Rituximab|rituximab|mesh-list
139139511|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138890034|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139512|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139513|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
139139514|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139515|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139139516|NCT03245450|Irinotecan|irinotecan|mesh-list
139139517|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139139518|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139139519|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139520|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139521|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139522|NCT05694585|Esmolol|esmolol|mesh-list
139139523|NCT05694585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139139524|NCT05694585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139139525|NCT05694585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139139526|NCT05694585|Adrenergic Agents|adrenergic agents|mesh-ancestor
139139527|NCT05694585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877424|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
139139528|NCT05694585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139529|NCT05694585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139530|NCT03712917|Topiramate|topiramate|mesh-list
139139531|NCT03712917|Flunarizine|flunarizine|mesh-list
139139532|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
139139533|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139139534|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139535|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139139536|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139139537|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139538|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139139539|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139139540|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
139139541|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
139139542|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139543|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
139139544|NCT03787017|Metformin|metformin|mesh-list
139139545|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139139546|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139547|NCT01307865|Mannitol|mannitol|mesh-list
139139548|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139139549|NCT01307865|Diuretics|diuretics|mesh-ancestor
139139550|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
139139551|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139553|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139554|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139139555|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139139556|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
139139557|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139558|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139559|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139139560|NCT01308177|Protective Agents|protective agents|mesh-ancestor
139139561|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139562|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139563|NCT01308255|Vitamins|vitamins|mesh-list
139139564|NCT01308255|Folic Acid|folic acid|mesh-list
139139565|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
139139566|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139139567|NCT01308255|Infliximab|infliximab|mesh-list
139139568|NCT01308255|Methotrexate|methotrexate|mesh-list
139139569|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
139139570|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139571|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139139572|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
139139573|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139139574|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139139575|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
139139576|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139577|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139578|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
139139579|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139580|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139139581|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139139582|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
139139583|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139139584|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139139585|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139139586|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
139139587|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
139139588|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139589|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139139590|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
139139591|NCT01308255|Hormones|hormones|mesh-ancestor
139139592|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139593|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138877450|NCT00873093|Prednisone|prednisone|mesh-list
139139594|NCT01308255|Protective Agents|protective agents|mesh-ancestor
139139595|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139139596|NCT01308255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139139597|NCT01308255|Hematinics|hematinics|mesh-ancestor
139139598|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
139139599|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
139139600|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139139601|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139139602|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139603|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
139139604|NCT03782025|Coagulants|coagulants|mesh-ancestor
139139605|NCT03782025|Vitamins|vitamins|mesh-ancestor
139139606|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
139139607|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139608|NCT03781947|Antarelix|antarelix|mesh-list
139139609|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
139139610|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139611|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139612|NCT03781869|Cisplatin|cisplatin|mesh-list
139139613|NCT03781869|Etoposide|etoposide|mesh-list
139139614|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
139139615|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139616|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139139617|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139139618|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139139619|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139620|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139621|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139139622|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139623|NCT03781635|Ketamine|ketamine|mesh-list
139139624|NCT03781635|Analgesics|analgesics|mesh-ancestor
139139625|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
139139626|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877462|NCT00873093|Asparaginase|asparaginase|mesh-list
139139627|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139628|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139139629|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139139630|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
139139631|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
139139632|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139633|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139139634|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139139635|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139636|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139637|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
139139638|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139139639|NCT03785613|Buprenorphine|buprenorphine|mesh-list
139139640|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139139641|NCT03785613|Narcotics|narcotics|mesh-ancestor
139139642|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139643|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139645|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
139139646|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139647|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139139648|NCT01308723|Sorafenib|sorafenib|mesh-list
139139649|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139139650|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139651|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139139652|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139653|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139654|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
139139655|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139656|NCT01561131|Calcium|calcium|mesh-list
139139657|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139139658|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139659|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
139139660|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139139661|NCT03780621|Andrographolide|andrographolide|mesh-list
139139662|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139139663|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139139664|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139139665|NCT03780621|Analgesics|analgesics|mesh-ancestor
139139666|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
139139667|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139668|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139669|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139139670|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139139671|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139139672|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139673|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
139139674|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139139675|NCT03785067|Amlodipine|amlodipine|mesh-list
139139676|NCT03785067|Telmisartan|telmisartan|mesh-list
139139677|NCT03785067|Indapamide|indapamide|mesh-list
139139678|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139139679|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139139680|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139139681|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139682|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139139683|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139684|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
139139685|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139139686|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139139687|NCT03785067|Diuretics|diuretics|mesh-ancestor
139139688|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
139139689|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139139690|NCT02059018|Diclofenac|diclofenac|mesh-list
139139691|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
139139692|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
139139693|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139139694|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139139695|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139139696|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139139697|NCT02059018|Analgesics|analgesics|mesh-ancestor
139139698|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
139139699|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139700|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139701|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139139702|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139139703|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139704|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139705|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
139139706|NCT01561209|Amitriptyline|amitriptyline|mesh-list
139139707|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138877546|NCT00634595|Paclitaxel|paclitaxel|mesh-list
139139708|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
139139709|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139139710|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139139711|NCT01561209|Analgesics|analgesics|mesh-ancestor
139139712|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
139139713|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139714|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510091|NCT02539537|Vitamins|vitamins|mesh-ancestor
139139715|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139139716|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139139717|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139139718|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139720|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139721|NCT02800642|Aflibercept|aflibercept|mesh-list
139139722|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139139723|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139139724|NCT02800642|Growth Substances|growth substances|mesh-ancestor
139139725|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139726|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
139139727|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139728|NCT02056600|Metformin|metformin|mesh-list
139139729|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139139730|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139731|NCT02056678|Acetaminophen|acetaminophen|mesh-list
139139732|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139139733|NCT02056678|Analgesics|analgesics|mesh-ancestor
139139734|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
139139735|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139736|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139737|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
139139738|NCT04662567|Acetaminophen|acetaminophen|mesh-list
138890254|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139139739|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139139740|NCT04662567|Analgesics|analgesics|mesh-ancestor
139139741|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
139139742|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139743|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139744|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
139139745|NCT02799784|Albuterol|albuterol|mesh-list
139139746|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139139747|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
139139748|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139749|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139750|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139139751|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
139139752|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
139139753|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139139754|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139139755|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139139756|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139139757|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
139139758|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139759|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139760|NCT03779685|Anesthetics|anesthetics|mesh-list
139139761|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139762|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139763|NCT03779451|Progesterone|progesterone|mesh-list
139139764|NCT03779451|Progestins|progestins|mesh-ancestor
139139765|NCT03779451|Hormones|hormones|mesh-ancestor
139139766|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139767|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139768|NCT02059330|Palbociclib|palbociclib|mesh-list
139139769|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139770|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138646954|NCT05718843|BI 425809|bi 425809|mesh-list
139139771|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139772|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139773|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
139139774|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139139775|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139776|NCT02054806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139139777|NCT02054806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139778|NCT02054884|Paclitaxel|paclitaxel|mesh-list
139139779|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139139780|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139139781|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139782|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
139139783|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
139139784|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
139139785|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139786|NCT01333072|Risperidone|risperidone|mesh-list
139139787|NCT01333072|Aripiprazole|aripiprazole|mesh-list
139139789|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
139139790|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139791|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139792|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139793|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139139794|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139139795|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139796|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139139797|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139139798|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
139139799|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
139139800|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
139139801|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139139802|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139139803|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139139804|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139139805|NCT02059564|Liraglutide|liraglutide|mesh-list
139139806|NCT02059564|Exenatide|exenatide|mesh-list
139139807|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139139808|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139809|NCT02059564|Incretins|incretins|mesh-ancestor
139139810|NCT02059564|Hormones|hormones|mesh-ancestor
139139811|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139812|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139139813|NCT05622058|Cyclophosphamide|cyclophosphamide|mesh-list
139139814|NCT05622058|Docetaxel|docetaxel|mesh-list
139139815|NCT05622058|Doxorubicin|doxorubicin|mesh-list
139139816|NCT05622058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139139817|NCT05622058|Immunologic Factors|immunologic factors|mesh-ancestor
139139818|NCT05622058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139819|NCT05622058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139139820|NCT05622058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139139821|NCT05622058|Alkylating Agents|alkylating agents|mesh-ancestor
139139822|NCT05622058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139823|NCT05622058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139824|NCT05622058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139139825|NCT05622058|Tubulin Modulators|tubulin modulators|mesh-ancestor
139139826|NCT05622058|Antimitotic Agents|antimitotic agents|mesh-ancestor
139139827|NCT05622058|Mitosis Modulators|mitosis modulators|mesh-ancestor
139139828|NCT05622058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139139829|NCT05622058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139139830|NCT05622058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139139831|NCT05622058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139832|NCT02055196|Irinotecan|irinotecan|mesh-list
139139833|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139139834|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139139835|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139836|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139837|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139838|NCT02055274|Rotigotine|rotigotine|mesh-list
139139839|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
139139840|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
139139841|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139842|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139843|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139844|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139139845|NCT03783897|Norgestimate|norgestimate|mesh-list
139139846|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
139139847|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
139139848|NCT03783897|Estradiol|estradiol|mesh-list
139139849|NCT03783897|Estrogens|estrogens|mesh-ancestor
139139850|NCT03783897|Hormones|hormones|mesh-ancestor
139139851|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139852|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139853|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139139854|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139139855|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139139856|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139139857|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139139858|NCT03779061|Propofol|propofol|mesh-list
139139859|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139139860|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139861|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139863|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
139139864|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
139139865|NCT01316445|Midazolam|midazolam|mesh-list
139139866|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139139867|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139139868|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139869|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139870|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139139871|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139139872|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139139873|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139139874|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
139139875|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
139139876|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
139139877|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
139139878|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139879|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139880|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
139139881|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139139882|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139883|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139139884|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139139885|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
139139886|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139887|NCT03778359|Leuprolide|leuprolide|mesh-list
138890410|NCT03362099|Bupropion|bupropion|mesh-list
139139888|NCT03778359|Dienogest|dienogest|mesh-list
139139889|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
139139890|NCT03778359|Progestins|progestins|mesh-list
139139891|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139139892|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
139139893|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139139894|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139895|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139139896|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139139897|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139139898|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139139899|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
139139900|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139139901|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139902|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139139903|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139139904|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
139139905|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139139906|NCT03778359|Hormones|hormones|mesh-ancestor
139139907|NCT03560908|Dasatinib|dasatinib|mesh-list
139139908|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139909|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139139910|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139911|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139912|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
139139913|NCT02057770|Busulfan|busulfan|mesh-list
139139914|NCT02057770|Fludarabine|fludarabine|mesh-list
139139915|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
139139916|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139139917|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
139139918|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139919|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139139920|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139139921|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
139139922|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139923|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139924|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139139925|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139139926|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
139139927|NCT03778281|Baclofen|baclofen|mesh-list
139139928|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139139929|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139930|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139139931|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139932|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139139933|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
139139934|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
139139935|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139936|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139938|NCT02055586|Fluorides|fluorides|mesh-list
139139939|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
139139940|NCT02055586|Protective Agents|protective agents|mesh-ancestor
139139941|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139942|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
139139943|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139944|NCT03778593|Leucovorin|leucovorin|mesh-list
139139945|NCT03778593|Fluorouracil|fluorouracil|mesh-list
139139946|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
139139947|NCT03778593|Irinotecan|irinotecan|mesh-list
139139948|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
139139949|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139950|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139139951|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139952|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139139953|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
139139954|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139955|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139139956|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139139957|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139958|NCT03778593|Antidotes|antidotes|mesh-ancestor
139139959|NCT03778593|Protective Agents|protective agents|mesh-ancestor
139139960|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
139139961|NCT03778593|Vitamins|vitamins|mesh-ancestor
138890479|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139139962|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
139139963|NCT02055664|Ropivacaine|ropivacaine|mesh-list
139139964|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
139139965|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
139139966|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139967|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139968|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
139139969|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139970|NCT01309425|Tapentadol|tapentadol|mesh-list
139139971|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139139972|NCT01309425|Narcotics|narcotics|mesh-ancestor
139139973|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139139974|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139139975|NCT01309425|Analgesics|analgesics|mesh-ancestor
139139976|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
139139977|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139139978|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139139979|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139139980|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139139981|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139982|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
139139983|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139139984|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
139139985|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139139986|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139139987|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139988|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139989|NCT05648422|Nitazoxanide|nitazoxanide|mesh-list
138708882|NCT05817474|Lidocaine|lidocaine|mesh-list
138708885|NCT05817474|Anesthetics|anesthetics|mesh-ancestor
139139990|NCT05648422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139139991|NCT05648422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139992|NCT02057926|Tetracycline|tetracycline|mesh-list
139139993|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139139994|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139139995|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139139996|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139139997|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139139998|NCT03777579|Paclitaxel|paclitaxel|mesh-list
139139999|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139140000|NCT03777579|Antibodies|antibodies|mesh-list
139140001|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
139140002|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139140003|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140004|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
139140005|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
139140006|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
139140007|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140008|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
139140009|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140010|NCT02059876|Paclitaxel|paclitaxel|mesh-list
139140011|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139140012|NCT02059876|Carboplatin|carboplatin|mesh-list
138902031|NCT04560660|Midazolam|midazolam|mesh-list
139140013|NCT02059876|Trastuzumab|trastuzumab|mesh-list
138902095|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138902172|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139140014|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138902318|NCT02351765|Cisplatin|cisplatin|mesh-list
139140015|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140016|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
139140018|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
138902833|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138902907|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138902983|NCT05530356|Dextrans|dextrans|mesh-list
139140019|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140020|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139140021|NCT03777423|Cobalt|cobalt|mesh-list
138903208|NCT00705042|Etanercept|etanercept|mesh-list
138903288|NCT00672113|Nifedipine|nifedipine|mesh-list
139140023|NCT03777423|Trace Elements|trace elements|mesh-ancestor
139140024|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
138903420|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
138903503|NCT00674687|Gabapentin|gabapentin|mesh-list
138903724|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
139140025|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140026|NCT03777033|Alfacalcidol|alfacalcidol|mesh-list
139140027|NCT03777033|Calcium|calcium|mesh-list
138903940|NCT05958069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904015|NCT05957302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904177|NCT05626478|Hormones|hormones|mesh-ancestor
139140028|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138904317|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
138904393|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140029|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140030|NCT03777033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139140031|NCT02060032|Atorvastatin|atorvastatin|mesh-list
139140032|NCT02060032|Simvastatin|simvastatin|mesh-list
139140033|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139140034|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139140035|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
139140036|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140037|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139140038|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139140039|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905219|NCT00804687|Ephedrine|ephedrine|mesh-list
139140041|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
139140042|NCT03783273|Vitamins|vitamins|mesh-ancestor
138905360|NCT03168256|Apremilast|apremilast|mesh-list
139140043|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
139140044|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140045|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138905581|NCT00759460|Olanzapine|olanzapine|mesh-list
138905732|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
138905809|NCT00766402|Narcotics|narcotics|mesh-ancestor
138905877|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138905951|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138906097|NCT00774358|Interleukin-2|interleukin-2|mesh-list
138906178|NCT00881621|Capecitabine|capecitabine|mesh-list
139140046|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139140047|NCT03777345|Cobalt|cobalt|mesh-list
139140048|NCT03777345|Chromium|chromium|mesh-list
138906323|NCT00681005|Rabeprazole|rabeprazole|mesh-list
139140050|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
138906476|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138906551|NCT00685607|Emollients|emollients|mesh-ancestor
138906698|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
138906778|NCT00597701|Lorazepam|lorazepam|mesh-list
139140051|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140052|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
139140053|NCT01318005|Norinyl|norinyl|mesh-list
138907074|NCT00781378|Plasminogen|plasminogen|mesh-list
138907218|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
139140054|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
139140055|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138907437|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139140056|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907591|NCT00700466|Metoprolol|metoprolol|mesh-list
139140057|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139140058|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139140059|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138908126|NCT05263492|Lenvatinib|lenvatinib|mesh-list
139140061|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139140062|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138908562|NCT00845858|Metoclopramide|metoclopramide|mesh-list
139140063|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
138908636|NCT00792376|Diclofenac|diclofenac|mesh-list
139140064|NCT03710889|Abaloparatide|abaloparatide|mesh-list
138908781|NCT05755854|Antimetabolites|antimetabolites|mesh-ancestor
139140065|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139140066|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140068|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
139140069|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
139140070|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140071|NCT01318941|Ranibizumab|ranibizumab|mesh-list
139140072|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138708928|NCT05736640|Denosumab|denosumab|mesh-list
139140073|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139140074|NCT01318941|Growth Substances|growth substances|mesh-ancestor
139140075|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140076|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
139140077|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140079|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138909520|NCT00788320|Vitamin D|vitamin d|mesh-list
139140080|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139140081|NCT03776955|Carvedilol|carvedilol|mesh-list
139140082|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139140083|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138909968|NCT00802906|Bevacizumab|bevacizumab|mesh-list
139140084|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
138910189|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
139140085|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138910337|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139140086|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140087|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140088|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139140090|NCT03776955|Protective Agents|protective agents|mesh-ancestor
139140091|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138910858|NCT01026415|Immunotoxins|immunotoxins|mesh-ancestor
138910949|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
139140092|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139140093|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139140094|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
138911156|NCT02603679|Tamoxifen|tamoxifen|mesh-list
138911230|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138911305|NCT00848393|Fentanyl|fentanyl|mesh-list
138911382|NCT00787605|Diuretics|diuretics|mesh-ancestor
139140095|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139140096|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139140097|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138911839|NCT00811408|Cidofovir|cidofovir|mesh-list
139140099|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
139140100|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140101|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912418|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140102|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139140103|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
139140104|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138912869|NCT00455533|Paclitaxel|paclitaxel|mesh-list
138912952|NCT00913718|Fluoxetine|fluoxetine|mesh-list
139140106|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139140107|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
139140108|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913166|NCT00915408|Hormones|hormones|mesh-ancestor
139140109|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140112|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140113|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138913537|NCT00828646|BMS 708163|bms 708163|mesh-list
139140114|NCT03308786|Analgesics|analgesics|mesh-ancestor
138890628|NCT02701673|Pyridoxine|pyridoxine|mesh-list
139140115|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
139140116|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140117|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140118|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138914199|NCT00840112|Vitamin E|vitamin e|mesh-list
138914345|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
139140120|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
138708945|NCT05564221|Omalizumab|omalizumab|mesh-list
138914488|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139140121|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139140123|NCT03776409|Tazobactam|tazobactam|mesh-list
139140124|NCT03776409|Piperacillin|piperacillin|mesh-list
139140125|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139140126|NCT03776409|Lactams|lactams|mesh-list
139140127|NCT03776409|beta-Lactams|beta-lactams|mesh-list
138914791|NCT00849017|Hormones|hormones|mesh-ancestor
138915072|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
138915146|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139140129|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139140130|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139140131|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915521|NCT00833261|Paclitaxel|paclitaxel|mesh-list
138915595|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138915815|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139140132|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140133|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
139140134|NCT03782805|Vitamin D|vitamin d|mesh-list
138915974|NCT02606552|Aspirin|aspirin|mesh-list
138916039|NCT04093518|Hormones|hormones|mesh-ancestor
138916186|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138916408|NCT00748566|Ziprasidone|ziprasidone|mesh-list
139140135|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139140136|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916635|NCT00732303|Pemetrexed|pemetrexed|mesh-list
139140138|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
138916926|NCT02607332|Paclitaxel|paclitaxel|mesh-list
138916995|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917145|NCT02597868|Capecitabine|capecitabine|mesh-list
139140139|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139140140|NCT03775863|Liver Extracts|liver extracts|mesh-list
139140141|NCT03775863|Hematinics|hematinics|mesh-ancestor
139140142|NCT03274076|Tofacitinib|tofacitinib|mesh-list
138917444|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139140143|NCT03274076|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139140144|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139140145|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917679|NCT00734994|Mitomycins|mitomycins|mesh-list
138917738|NCT05366595|Zinc Sulfate|zinc sulfate|mesh-list
138877751|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
139140146|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140147|NCT03775707|Lenvatinib|lenvatinib|mesh-list
139140148|NCT03775707|Antibodies|antibodies|mesh-list
139140149|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
139140150|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140151|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140152|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139140153|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140154|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140155|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139140156|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140157|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139140159|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140160|NCT02764268|Apatinib|apatinib|mesh-list
138918475|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
139140161|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918623|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140162|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139140163|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918999|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138919081|NCT00728988|Atorvastatin|atorvastatin|mesh-list
138919228|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919302|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138919377|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
138919450|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139140164|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140166|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138919682|NCT00780416|Ribavirin|ribavirin|mesh-list
139140167|NCT01320111|Sorafenib|sorafenib|mesh-list
139140168|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139140169|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919822|NCT05674695|Cyclosporins|cyclosporins|mesh-list
139140170|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
139140171|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
138920047|NCT04114097|Tacrolimus|tacrolimus|mesh-list
139140172|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
138920193|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139140173|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140174|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139140175|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920568|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
138920649|NCT05559983|Aluminum phosphate|aluminum phosphate|mesh-list
138920719|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139140177|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139140178|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
139140180|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139140181|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921159|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139140182|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140183|NCT03775395|Sorafenib|sorafenib|mesh-list
139140184|NCT03775395|Lenvatinib|lenvatinib|mesh-list
138921310|NCT00436501|Growth Substances|growth substances|mesh-ancestor
139140185|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921532|NCT00581919|Vitamins|vitamins|mesh-ancestor
139140186|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139140187|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921757|NCT00743288|Melphalan|melphalan|mesh-list
139140188|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921909|NCT00719862|Azelastine|azelastine|mesh-list
138890704|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139140189|NCT02797522|Acetaminophen|acetaminophen|mesh-list
139140190|NCT02797522|Tenofovir|tenofovir|mesh-list
139140191|NCT02797522|Entecavir|entecavir|mesh-list
139140192|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
139140193|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138922284|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
139140194|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139140195|NCT02797522|Analgesics|analgesics|mesh-ancestor
138922580|NCT00710619|Coagulants|coagulants|mesh-ancestor
139140196|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
138922806|NCT00578565|Rituximab|rituximab|mesh-list
139140197|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140198|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140199|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
139140200|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
139140201|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139140202|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139140203|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139140204|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140205|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140207|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139140208|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
139140209|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140210|NCT03773367|Fluorouracil|fluorouracil|mesh-list
139140211|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
139140212|NCT03773367|Irinotecan|irinotecan|mesh-list
139140213|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
139140214|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140215|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139140216|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140217|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139140218|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
139140219|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140220|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139140221|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139140222|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140223|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
139140224|NCT02060656|Rituximab|rituximab|mesh-list
139140225|NCT02060656|Gemcitabine|gemcitabine|mesh-list
139140226|NCT02060656|Lenalidomide|lenalidomide|mesh-list
139140227|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139140228|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140229|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
139140230|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140231|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139140232|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139140233|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
139140234|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140235|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139140236|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139140237|NCT02060656|Growth Substances|growth substances|mesh-ancestor
139140238|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
139140239|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139140240|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
139140241|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
139140242|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140243|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139140244|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
139140245|NCT02060656|Hormones|hormones|mesh-ancestor
139140246|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139140247|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139140248|NCT02060656|Protective Agents|protective agents|mesh-ancestor
139140249|NCT03774771|Cinacalcet|cinacalcet|mesh-list
139140250|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139140251|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140252|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139140253|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
139140254|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139140255|NCT03774693|Fentanyl|fentanyl|mesh-list
139140256|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
139140257|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138877820|NCT04230083|Dienogest|dienogest|mesh-list
139140258|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140259|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139140260|NCT03774693|Narcotics|narcotics|mesh-ancestor
139140261|NCT03774693|Analgesics|analgesics|mesh-ancestor
139140262|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
139140263|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140264|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139140265|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139140266|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
139140267|NCT03774615|Ferric maltol|ferric maltol|mesh-list
139140268|NCT03774615|Hematinics|hematinics|mesh-ancestor
139140269|NCT01321047|Propofol|propofol|mesh-list
139140270|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139140271|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140272|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140273|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139140274|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
139140275|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
139140276|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
139140277|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139140278|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
139140279|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139140280|NCT01321125|Povidone|povidone|mesh-list
139140281|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139140282|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
139140283|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
139140284|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
139140285|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
139140286|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
139140287|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139140288|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
139140289|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140290|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140291|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139140292|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
139140293|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139140294|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
139140295|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140296|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140297|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139140298|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
139140299|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
139140300|NCT03773991|Protective Agents|protective agents|mesh-ancestor
139140301|NCT05435313|Oxaliplatin|oxaliplatin|mesh-list
139140302|NCT05435313|Irinotecan|irinotecan|mesh-list
139140303|NCT05435313|Tislelizumab|tislelizumab|mesh-list
139140304|NCT05435313|Raltitrexed|raltitrexed|mesh-list
139140305|NCT05435313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140306|NCT05435313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139140307|NCT05435313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139140308|NCT05435313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140309|NCT05435313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140310|NCT05435313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139140311|NCT05435313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139140312|NCT05435313|Antimetabolites|antimetabolites|mesh-ancestor
139140313|NCT05435313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139140314|NCT05472675|Bupivacaine|bupivacaine|mesh-list
139140315|NCT05472675|Botulinum Toxins|botulinum toxins|mesh-list
139140316|NCT05472675|Anesthetics, Local|anesthetics, local|mesh-ancestor
139140317|NCT05472675|Anesthetics|anesthetics|mesh-ancestor
139140318|NCT05472675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140319|NCT05472675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140320|NCT05472675|Sensory System Agents|sensory system agents|mesh-ancestor
139140321|NCT05472675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140322|NCT05472675|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139140323|NCT05472675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139140324|NCT05472675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140325|NCT05472675|Cholinergic Agents|cholinergic agents|mesh-ancestor
139140326|NCT05472675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140327|NCT01321905|Vitamin D|vitamin d|mesh-list
139140328|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
139140329|NCT01321905|Vitamins|vitamins|mesh-ancestor
139140330|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
139140331|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140332|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139140333|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139140334|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139140335|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
139140336|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139140337|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
139140338|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140339|NCT03763227|Ranibizumab|ranibizumab|mesh-list
139140340|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
139140341|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139140342|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139140344|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140345|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
139140346|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140347|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877939|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
139140348|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140349|NCT04929548|Maleic acid|maleic acid|mesh-list
139140350|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140351|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140352|NCT02060734|Lidocaine|lidocaine|mesh-list
139140353|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
139140355|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140356|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140357|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
139140358|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140359|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139140360|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139140361|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139140362|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139140363|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140364|NCT03270644|Propranolol|propranolol|mesh-list
139140365|NCT03270644|Lasmiditan|lasmiditan|mesh-list
139140366|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139140367|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139140368|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
139140369|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140370|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140371|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140372|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139140373|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139140374|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
139140375|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139140376|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
139140377|NCT04535102|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
139140378|NCT04535102|Immunoconjugates|immunoconjugates|mesh-ancestor
139140379|NCT04535102|Immunologic Factors|immunologic factors|mesh-ancestor
139140380|NCT04535102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140381|NCT04529720|Vaccines|vaccines|mesh-list
139140382|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
139140383|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140384|NCT03768609|Cyclosporine|cyclosporine|mesh-list
139140385|NCT03768609|Cyclosporins|cyclosporins|mesh-list
139140386|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140387|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140388|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139140389|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
139140390|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140391|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
139140392|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139140393|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
138878013|NCT00975325|Yohimbine|yohimbine|mesh-list
139140394|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139140395|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139140396|NCT03269552|Rituximab|rituximab|mesh-list
139140397|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139140398|NCT03269552|Antibodies|antibodies|mesh-list
139140399|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
139140400|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139140401|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
139140402|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140403|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140404|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139140405|NCT03771729|Valsartan|valsartan|mesh-list
139140406|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139140407|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139140408|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139140409|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139140410|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140411|NCT03560362|Epinephrine|epinephrine|mesh-list
139140412|NCT03560362|Bupivacaine|bupivacaine|mesh-list
139140413|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
139140414|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
139140415|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138890950|NCT02701127|Niacin|niacin|mesh-list
139140416|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140417|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
139140418|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140419|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139140420|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139140421|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
139140422|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140423|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140424|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139140425|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139140428|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
139140429|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
139140430|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
139140431|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139140432|NCT03768531|Nivolumab|nivolumab|mesh-list
139140433|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139140434|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140435|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139140436|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140437|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
139140438|NCT01322061|Vitamins|vitamins|mesh-ancestor
139140439|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
139140440|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140441|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
139140442|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140443|NCT01322061|Protective Agents|protective agents|mesh-ancestor
139140444|NCT02062996|Phenylephrine|phenylephrine|mesh-list
139140445|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
139140446|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139140447|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139140448|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
139140449|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140450|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140451|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140452|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
139140453|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
139140454|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140455|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
139140456|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139140457|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
139140458|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139140459|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
139140460|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139140461|NCT02062996|Protective Agents|protective agents|mesh-ancestor
139140462|NCT03762369|Latanoprost|latanoprost|mesh-list
139140463|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139140464|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139140465|NCT01321515|Famciclovir|famciclovir|mesh-list
139140466|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
139140467|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139140468|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139140469|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140470|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140471|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
139140472|NCT02065414|Listerine|listerine|mesh-list
139140473|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139140474|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139140475|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
139140476|NCT04233879|Tenofovir|tenofovir|mesh-list
139140477|NCT04233879|Emtricitabine|emtricitabine|mesh-list
139140478|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139140479|NCT04233879|Islatravir|islatravir|mesh-list
139140480|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
139140481|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139140482|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139140483|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139140484|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140485|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140486|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139140487|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139140488|NCT01370356|Varenicline|varenicline|mesh-list
139140489|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138891009|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
139140490|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139140491|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
139140492|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140493|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140494|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140495|NCT03792334|Anesthetics|anesthetics|mesh-list
139140496|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140497|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140498|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
139140499|NCT04545411|Volagidemab|volagidemab|mesh-list
139140500|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138510818|NCT00066196|Dacarbazine|dacarbazine|mesh-list
139140501|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140503|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140504|NCT02065492|Amlodipine|amlodipine|mesh-list
139140505|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
139140506|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139140507|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140508|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139140509|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139140510|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140511|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
139140512|NCT02063620|Ketamine|ketamine|mesh-list
139140513|NCT02063620|Analgesics|analgesics|mesh-ancestor
139140514|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
139140515|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140516|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140517|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139140518|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139140519|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
139140520|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
139140521|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140522|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139140523|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139140524|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140525|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140526|NCT03767439|Nivolumab|nivolumab|mesh-list
139140527|NCT03767439|Ipilimumab|ipilimumab|mesh-list
139140528|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139140529|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140530|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139140531|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140532|NCT04539405|Sevoflurane|sevoflurane|mesh-list
139140533|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139140534|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139140535|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
139140536|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
139140537|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140538|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140539|NCT02065804|Bupivacaine|bupivacaine|mesh-list
139140540|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
139140541|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
139140542|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140543|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140544|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
139140545|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140546|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
139140547|NCT02064010|Acamprosate|acamprosate|mesh-list
139140548|NCT02064010|Calcium|calcium|mesh-list
139140549|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139140550|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140551|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139140552|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139140553|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
139140554|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
139140555|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
139140556|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140557|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140558|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
139140559|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140560|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139140561|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140562|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138891084|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140563|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140564|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140565|NCT03766893|Naltrexone|naltrexone|mesh-list
139140566|NCT03766893|Buprenorphine|buprenorphine|mesh-list
139140567|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139140568|NCT03766893|Naloxone|naloxone|mesh-list
139140569|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139140570|NCT03766893|Narcotics|narcotics|mesh-ancestor
139140571|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138510891|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
139140572|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140573|NCT03766893|Analgesics|analgesics|mesh-ancestor
139140574|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
139140575|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140576|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139140577|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139140578|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
139140579|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139140580|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140581|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140582|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139140583|NCT03760809|Analgesics|analgesics|mesh-ancestor
139140584|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
139140585|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140586|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139140587|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139140588|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139140589|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
139140590|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140591|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140592|NCT01370590|Atorvastatin|atorvastatin|mesh-list
139140593|NCT01370590|Ezetimibe|ezetimibe|mesh-list
139140594|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139140595|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139140596|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
138878103|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139140597|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140598|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139140599|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139140600|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140601|NCT01567683|Imiquimod|imiquimod|mesh-list
139140602|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139140603|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
139140604|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140605|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140606|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
139140607|NCT01561911|Antibodies|antibodies|mesh-list
139140608|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139140609|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
139140610|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140611|NCT03770637|Glucagon|glucagon|mesh-list
139140612|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139140613|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139140614|NCT03770637|Hormones|hormones|mesh-ancestor
139140615|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138709166|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
139140616|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140617|NCT03770637|Incretins|incretins|mesh-ancestor
139140618|NCT03766269|Dronabinol|dronabinol|mesh-list
139140619|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
139140620|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140621|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139140622|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139140623|NCT03766269|Analgesics|analgesics|mesh-ancestor
139140624|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
139140625|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140626|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139140627|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139140628|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140629|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140630|NCT03766269|Hormones|hormones|mesh-ancestor
139140631|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139140637|NCT03765645|Tazobactam|tazobactam|mesh-list
139140638|NCT03765645|Piperacillin|piperacillin|mesh-list
139140639|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139140640|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139140641|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139140642|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139140643|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140644|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140645|NCT01321671|Pregabalin|pregabalin|mesh-list
139140646|NCT01321671|Analgesics|analgesics|mesh-ancestor
139140647|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
139140648|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140649|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140650|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
139140651|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139140652|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139140653|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140654|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139140655|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139140656|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139140657|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140658|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139140659|NCT03770013|Clonidine|clonidine|mesh-list
139140660|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
139140661|NCT03770013|Bupivacaine|bupivacaine|mesh-list
139140662|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
139140663|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
139140664|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140665|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140666|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
139140667|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140668|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139140669|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139140670|NCT03770013|Analgesics|analgesics|mesh-ancestor
139140671|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139140672|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139140673|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139140674|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
139140675|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140676|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140677|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139140678|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
139140679|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
139140680|NCT03769935|Etoposide|etoposide|mesh-list
139140681|NCT03769935|Cisplatin|cisplatin|mesh-list
139140682|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139140683|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140684|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139140685|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139140686|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140687|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140688|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
139140689|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139140690|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139140691|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140692|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
139140693|NCT03765021|Coagulants|coagulants|mesh-ancestor
139140694|NCT05418699|Insulin|insulin|mesh-list
139140695|NCT05418699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139140696|NCT05418699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140697|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139140698|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
139140699|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139140700|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
139140701|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140702|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
139140703|NCT03758859|Protective Agents|protective agents|mesh-ancestor
139140704|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139140705|NCT03764241|Vitamin K|vitamin k|mesh-list
139140706|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
139140707|NCT03764241|Vitamins|vitamins|mesh-ancestor
139140708|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
139140709|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140710|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139140711|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
139140712|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139140713|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
139140714|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140715|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140716|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
139140717|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139140718|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139140719|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
139140720|NCT03764241|Coagulants|coagulants|mesh-ancestor
139140722|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139140723|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
139140724|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
139140725|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140726|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140727|NCT01321827|Itraconazole|itraconazole|mesh-list
139140728|NCT01321827|Prednisolone|prednisolone|mesh-list
139140729|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
139140730|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139140731|NCT01321827|Hormones|hormones|mesh-ancestor
139140732|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139140733|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140734|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139140735|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140736|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
139140737|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139140738|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139140739|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139140740|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140741|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140742|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139140743|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
139140744|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139140745|NCT03753477|Amlodipine|amlodipine|mesh-list
139140746|NCT03753477|Olmesartan|olmesartan|mesh-list
139140747|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139140748|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
139140749|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139140750|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139140751|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139140752|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139140753|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140754|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139140755|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140756|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
139140757|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139140758|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139140759|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
139140760|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139140761|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139140762|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140763|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139140764|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139140765|NCT03758469|Rifampin|rifampin|mesh-list
139140766|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139140767|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
139140768|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139140769|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139140770|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
139140771|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139140772|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140773|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140774|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139140775|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139140776|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139140777|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139140778|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139140779|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139140780|NCT04646109|Azithromycin|azithromycin|mesh-list
139140781|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
139140782|NCT04646109|Ivermectin|ivermectin|mesh-list
139140783|NCT04646109|Favipiravir|favipiravir|mesh-list
138878151|NCT00980473|Timolol|timolol|mesh-list
139140784|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139140785|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891316|NCT02699645|Amlodipine|amlodipine|mesh-list
139140786|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
139140787|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139140788|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139140789|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140790|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140791|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139140792|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
139140795|NCT05320107|Sensory System Agents|sensory system agents|mesh-ancestor
139140796|NCT05320107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140797|NCT05320107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140798|NCT05320107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139140799|NCT05320107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139140800|NCT05320107|Anesthetics, General|anesthetics, general|mesh-ancestor
139140801|NCT05320107|Anesthetics|anesthetics|mesh-ancestor
139140802|NCT05320107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140803|NCT05320107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139140804|NCT05320107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139140805|NCT05320107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140806|NCT05320107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140807|NCT03752931|Celiprolol|celiprolol|mesh-list
139140808|NCT03752931|Diltiazem|diltiazem|mesh-list
139140809|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139140810|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139140811|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139140812|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140813|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139140814|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140815|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
139140816|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139140817|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
139140818|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
139140819|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140820|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139140821|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139140822|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139140823|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
139140824|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140825|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139140826|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139140827|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139140828|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139140829|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140830|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140831|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139140832|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139140833|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140834|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
139140835|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140836|NCT02066350|Pancrelipase|pancrelipase|mesh-list
139140837|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139140838|NCT02064946|Vitamin D|vitamin d|mesh-list
139140839|NCT02064946|Vitamins|vitamins|mesh-ancestor
139140840|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
139140841|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140842|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139140843|NCT02064556|Amlodipine|amlodipine|mesh-list
139140844|NCT02064556|Candesartan|candesartan|mesh-list
139140845|NCT02064556|Candesartan cilexetil|candesartan cilexetil|mesh-list
139140846|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139140847|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139140848|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139140849|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140850|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139140851|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140852|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
139140853|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139140854|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139140855|NCT03752229|Diazepam|diazepam|mesh-list
139140856|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139140857|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
139140858|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
139140859|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
139140860|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140861|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140863|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139140864|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140865|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139140866|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139140867|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139140868|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139140869|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139140870|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139140871|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
139140872|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
139140873|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
139140874|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
139140875|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140876|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140877|NCT03695367|Acetaminophen|acetaminophen|mesh-list
139140878|NCT03695367|Ibuprofen|ibuprofen|mesh-list
139140879|NCT03695367|Ketorolac|ketorolac|mesh-list
139140880|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139140881|NCT03695367|Analgesics|analgesics|mesh-ancestor
139140882|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
139140883|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140884|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140885|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
139140886|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139140887|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139140888|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139140889|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139140890|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140891|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140892|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139085337|NCT04259164|Cholinergic Agents|cholinergic agents|mesh-ancestor
139140893|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139140894|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
139140895|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140896|NCT03755427|Antacids|antacids|mesh-ancestor
139140897|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140898|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139140899|NCT03758079|Gabapentin|gabapentin|mesh-list
139140900|NCT03758079|Doxepin|doxepin|mesh-list
139140901|NCT03758079|Analgesics|analgesics|mesh-ancestor
139140902|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
139140903|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140904|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140905|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
139140906|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139140907|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139140908|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140909|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139140910|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139140911|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139140912|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139140913|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140914|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
139140915|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139140916|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139140917|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139140918|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
139140919|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
139140920|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
139140921|NCT02067910|Abatacept|abatacept|mesh-list
139140922|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139140923|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140924|NCT02067910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139140925|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140926|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139140927|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
139140928|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140929|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139140930|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
139140931|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
139140932|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139140933|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
138891456|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139140934|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139140935|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
139140936|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139140937|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140938|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
139140939|NCT05280873|Methylprednisolone|methylprednisolone|mesh-list
139140940|NCT05280873|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139140941|NCT05280873|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139140944|NCT05280873|Pirfenidone|pirfenidone|mesh-list
139140945|NCT05280873|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139140946|NCT05280873|Prednisolone phosphate|prednisolone phosphate|mesh-list
139140947|NCT05280873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139140948|NCT05280873|Antiemetics|antiemetics|mesh-ancestor
139140949|NCT05280873|Autonomic Agents|autonomic agents|mesh-ancestor
139140950|NCT05280873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140951|NCT05280873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140952|NCT05280873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139140953|NCT05280873|Glucocorticoids|glucocorticoids|mesh-ancestor
139140954|NCT05280873|Hormones|hormones|mesh-ancestor
139140955|NCT05280873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139140956|NCT05280873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139140957|NCT05280873|Protective Agents|protective agents|mesh-ancestor
139140958|NCT05280873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139140959|NCT05280873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139140960|NCT05280873|Analgesics|analgesics|mesh-ancestor
139140961|NCT05280873|Sensory System Agents|sensory system agents|mesh-ancestor
139140962|NCT05280873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139140963|NCT05280873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139140964|NCT05280873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139140965|NCT02066818|Lidocaine|lidocaine|mesh-list
139140966|NCT02066818|Tetracaine|tetracaine|mesh-list
139140967|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
139140968|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
139140969|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139140970|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140971|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
139140972|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139140973|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139140974|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139140975|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139140976|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139140977|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140978|NCT04558125|Heparin|heparin|mesh-list
139140979|NCT04558125|Calcium heparin|calcium heparin|mesh-list
139140980|NCT04558125|Enoxaparin|enoxaparin|mesh-list
139140981|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139140982|NCT04558125|Tinzaparin|tinzaparin|mesh-list
139140983|NCT04558125|Dalteparin|dalteparin|mesh-list
139140984|NCT04558125|Tenecteplase|tenecteplase|mesh-list
139140985|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
139140986|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
139140987|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139140988|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139140989|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139140990|NCT05460195|Immunomodulating Agents|immunomodulating agents|mesh-list
139140991|NCT05460195|Immunologic Factors|immunologic factors|mesh-list
139140992|NCT05460195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139140993|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
139140994|NCT02793622|Piperaquine|piperaquine|mesh-list
139140995|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
139140996|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139140997|NCT02793622|Artenimol|artenimol|mesh-list
139140998|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
139140999|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139141000|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139141001|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141002|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139141003|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141004|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141005|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139141006|NCT04493931|Rifampin|rifampin|mesh-list
139141007|NCT04493931|Gepotidacin|gepotidacin|mesh-list
139141008|NCT04493931|Digoxin|digoxin|mesh-list
139141009|NCT04493931|Midazolam|midazolam|mesh-list
139141010|NCT04493931|Cimetidine|cimetidine|mesh-list
138891528|NCT00673556|Alefacept|alefacept|mesh-list
139141011|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139141012|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139141013|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141014|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141015|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139141016|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139141017|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139141018|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139141019|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
139141020|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
139141021|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
139141022|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
139141023|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141024|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878211|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
139141025|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139141026|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
139141027|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139141028|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141029|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
139141030|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139141031|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141032|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139141033|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139141034|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139141035|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139141036|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139141037|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139141038|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139141039|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139141040|NCT04493931|Protective Agents|protective agents|mesh-ancestor
139141041|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139141042|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139141043|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139141044|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
139141045|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
139141046|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139141047|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139141048|NCT04493931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139141049|NCT04493931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141050|NCT02260336|Celecoxib|celecoxib|mesh-list
139141051|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139141052|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139141053|NCT02260336|Analgesics|analgesics|mesh-ancestor
139141054|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
139141055|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141056|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141057|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139141058|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141059|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139141060|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139141061|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141062|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141063|NCT03755193|Diphosphonates|diphosphonates|mesh-list
139141064|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139141065|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141066|NCT03755115|Epirubicin|epirubicin|mesh-list
139141067|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139141068|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141069|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139141070|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139141071|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878223|NCT05340803|Midazolam|midazolam|mesh-list
139141072|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141073|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139141074|NCT03755037|Estradiol|estradiol|mesh-list
139141075|NCT03755037|Estrogens|estrogens|mesh-ancestor
139141076|NCT03755037|Hormones|hormones|mesh-ancestor
139141077|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141078|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141079|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139141080|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
139141081|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139141082|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139141083|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139141084|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139141085|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
139141086|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141087|NCT04490499|Vaccines|vaccines|mesh-list
139141088|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
139141089|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141090|NCT01332994|Rituximab|rituximab|mesh-list
139141091|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139141092|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141093|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
139141094|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141095|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141096|NCT03754959|Midazolam|midazolam|mesh-list
139141097|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139141098|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139141099|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141100|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141101|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139141102|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139141103|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139141104|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139141105|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
139141106|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
139141107|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
139141108|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
139141109|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141110|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141111|NCT02068690|BI 425809|bi 425809|mesh-list
139141112|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
139141113|NCT02067442|Acetaminophen|acetaminophen|mesh-list
139141114|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139141115|NCT02067442|Analgesics|analgesics|mesh-ancestor
139141116|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
139141117|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141118|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141119|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
139141120|NCT02067520|Hydromorphone|hydromorphone|mesh-list
139141121|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139141122|NCT02067520|Narcotics|narcotics|mesh-ancestor
139141123|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141124|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141125|NCT02067520|Analgesics|analgesics|mesh-ancestor
139141126|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
139141127|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141128|NCT03757923|Metformin|metformin|mesh-list
139141129|NCT03757923|Pioglitazone|pioglitazone|mesh-list
139141130|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138878249|NCT05340803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139141131|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141132|NCT02071888|Dexamethasone|dexamethasone|mesh-list
139141133|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
139141134|NCT02071888|Pomalidomide|pomalidomide|mesh-list
139141135|NCT02071888|BB 1101|bb 1101|mesh-list
139141136|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139141137|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
139141138|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
139141139|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141140|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141141|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139141142|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
139141143|NCT02071888|Hormones|hormones|mesh-ancestor
139141144|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141145|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139141146|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141147|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
139141148|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141149|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141150|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
139141151|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139141152|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139141153|NCT02071888|Growth Substances|growth substances|mesh-ancestor
139141154|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
139141155|NCT02071966|Clopidogrel|clopidogrel|mesh-list
139141156|NCT02071966|Ticagrelor|ticagrelor|mesh-list
139141157|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139141158|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139141159|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139141160|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139141161|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
139141162|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141163|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141164|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141165|NCT02072278|Vortioxetine|vortioxetine|mesh-list
139141166|NCT02072278|Escitalopram|escitalopram|mesh-list
139141167|NCT02072278|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139141168|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139141169|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139141170|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141171|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141172|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
139141173|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141174|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
139141175|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139141176|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139141177|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139141178|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141179|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139141180|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139141181|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139141182|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139141183|NCT02072512|Fulvestrant|fulvestrant|mesh-list
139141184|NCT02072512|Anastrozole|anastrozole|mesh-list
139141185|NCT02072512|Goserelin|goserelin|mesh-list
139141186|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139141187|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141188|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139141189|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139141190|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
139141191|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138878267|NCT00980707|Fluticasone|fluticasone|mesh-list
139141192|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141193|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139141194|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139141195|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141196|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141197|NCT04534491|Oxybutynin|oxybutynin|mesh-list
139141198|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
139141199|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
139141200|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141201|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141202|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139141203|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139141204|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
139141205|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085414|NCT05400902|Apatinib|apatinib|mesh-list
139141206|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141207|NCT04534491|Urological Agents|urological agents|mesh-ancestor
139141208|NCT02069080|Plerixafor|plerixafor|mesh-list
139141209|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139141210|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139141211|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
139141212|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141213|NCT02077348|Hormones|hormones|mesh-list
139141214|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141215|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141216|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
139141217|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139141218|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139141219|NCT03694821|Prednisolone|prednisolone|mesh-list
139141220|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
139141221|NCT03694821|Ketorolac|ketorolac|mesh-list
139141222|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139141223|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139141224|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
139141225|NCT03694821|Hylan|hylan|mesh-list
139141226|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139141227|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
139141228|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
139141229|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141230|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141231|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139141232|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
139141233|NCT03694821|Hormones|hormones|mesh-ancestor
139141234|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141235|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139141236|NCT03694821|Protective Agents|protective agents|mesh-ancestor
139141237|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139141238|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141239|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139141241|NCT03694821|Analgesics|analgesics|mesh-ancestor
139141242|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
139141243|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141244|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139141245|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141246|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141247|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
139141248|NCT02069158|Paclitaxel|paclitaxel|mesh-list
139141249|NCT02069158|Carboplatin|carboplatin|mesh-list
139141250|NCT02069158|Gedatolisib|gedatolisib|mesh-list
139141251|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139141252|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141253|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
139141254|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
139141255|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
139141256|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141257|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139141258|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141259|NCT04531527|Butenafine|butenafine|mesh-list
139141260|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
139141261|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141262|NCT02078440|Bromocriptine|bromocriptine|mesh-list
139141263|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139141264|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139141265|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
139141266|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141267|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141268|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
139141269|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
139141270|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141271|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141272|NCT02070406|Aldesleukin|aldesleukin|mesh-list
139141273|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
139141274|NCT02070406|Fludarabine|fludarabine|mesh-list
139141275|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
139141276|NCT02070406|Interleukin-2|interleukin-2|mesh-list
139141277|NCT02070406|Vaccines|vaccines|mesh-list
139141278|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139141279|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139141280|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
139141281|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141282|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141283|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139141284|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
139141285|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141286|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141287|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139141288|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139141289|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
139141290|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139141291|NCT02070406|Analgesics|analgesics|mesh-ancestor
139141292|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
139141293|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141294|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139141295|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139141296|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
139141297|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141298|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139141299|NCT02078596|Valproic Acid|valproic acid|mesh-list
139141300|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
139141301|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141302|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141303|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
139141304|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141305|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141306|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
139141307|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139141308|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141309|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139141310|NCT02070718|Pentazocine|pentazocine|mesh-list
139141311|NCT02070718|Naloxone|naloxone|mesh-list
139141312|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139141313|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141314|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
139141315|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141317|NCT02070718|Narcotics|narcotics|mesh-ancestor
139141318|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141319|NCT02070718|Analgesics|analgesics|mesh-ancestor
139141320|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139141321|NCT02070796|Rotigotine|rotigotine|mesh-list
139141322|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
139141323|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
139141324|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141325|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141326|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141327|NCT02079064|Propofol|propofol|mesh-list
139141328|NCT02079064|Desflurane|desflurane|mesh-list
139141329|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139141330|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141331|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141332|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139141333|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
139141334|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
139141335|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139141336|NCT02079220|Capecitabine|capecitabine|mesh-list
139141337|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
139141338|NCT02079220|Aflibercept|aflibercept|mesh-list
139141339|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139141340|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
139141341|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141342|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141343|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139141344|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139141345|NCT02079220|Growth Substances|growth substances|mesh-ancestor
139141346|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141347|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
139141348|NCT02079298|Fluconazole|fluconazole|mesh-list
139141349|NCT02079298|Ibuprofen|ibuprofen|mesh-list
139141350|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139141351|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139141352|NCT02079298|Analgesics|analgesics|mesh-ancestor
139141353|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
139141354|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141355|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141356|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139141357|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141358|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139141359|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141360|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141361|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
139141362|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141363|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139141364|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139141365|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139141367|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141368|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139141369|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139141370|NCT02071342|Everolimus|everolimus|mesh-list
139141371|NCT02071342|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139141372|NCT02071342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139141373|NCT02071342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141374|NCT02071342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141375|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139141376|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
139141377|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141378|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141379|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139141380|NCT02080078|Theophylline|theophylline|mesh-list
139141381|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141382|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139141383|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141384|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141385|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139141386|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
139141387|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141388|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141390|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
139141391|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139141392|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
139141393|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139141394|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139141395|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
139141396|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141397|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
139141398|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139141399|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141400|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139141401|NCT03559504|Sevoflurane|sevoflurane|mesh-list
139141402|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139141403|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139141404|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
139141405|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
139141406|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141407|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141408|NCT02080234|Gemcitabine|gemcitabine|mesh-list
139141409|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
139141410|NCT02080234|Asparaginase|asparaginase|mesh-list
139141411|NCT02080234|Pegaspargase|pegaspargase|mesh-list
139141412|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139141413|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
139141414|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141415|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141416|NCT05070039|Antibodies|antibodies|mesh-list
139141417|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
139141418|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141419|NCT05459649|Cyclosporine|cyclosporine|mesh-list
139141420|NCT05459649|Prednisone|prednisone|mesh-list
139141421|NCT05459649|Cyclosporins|cyclosporins|mesh-list
139141422|NCT05459649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139141423|NCT05459649|Glucocorticoids|glucocorticoids|mesh-ancestor
139141424|NCT05459649|Hormones|hormones|mesh-ancestor
139141425|NCT05459649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138878333|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141426|NCT05459649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141427|NCT05459649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139141428|NCT05459649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141429|NCT05459649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141430|NCT05459649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141431|NCT05459649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139141432|NCT05459649|Immunologic Factors|immunologic factors|mesh-ancestor
139141433|NCT05459649|Antifungal Agents|antifungal agents|mesh-ancestor
139141434|NCT05459649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141435|NCT05459649|Dermatologic Agents|dermatologic agents|mesh-ancestor
139141436|NCT05459649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141437|NCT05459649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139141438|NCT04461795|Erenumab|erenumab|mesh-list
139141439|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139141440|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
139141441|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141442|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139141443|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141444|NCT04461795|Analgesics|analgesics|mesh-ancestor
139141445|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
139141446|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141447|NCT04461015|Insulin|insulin|mesh-list
139141448|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139141449|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139141450|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141451|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
139141452|NCT03754179|Trametinib|trametinib|mesh-list
139141453|NCT03754179|Dabrafenib|dabrafenib|mesh-list
139141454|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
139141455|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139141456|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139141457|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141458|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141459|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891981|NCT06157151|Pembrolizumab|pembrolizumab|mesh-list
139141460|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141461|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141462|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139141463|NCT03753867|Acitretin|acitretin|mesh-list
139141464|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
139141465|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
139141467|NCT04439253|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139141468|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141469|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139141470|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141471|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141472|NCT03750669|Folic Acid|folic acid|mesh-list
139141473|NCT03750669|Paclitaxel|paclitaxel|mesh-list
139141474|NCT03750669|Gemcitabine|gemcitabine|mesh-list
139141475|NCT03750669|Fluorouracil|fluorouracil|mesh-list
139141476|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
139141477|NCT03750669|Irinotecan|irinotecan|mesh-list
139141478|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139141479|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141480|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
139141481|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
139141482|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
139141483|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141484|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139141485|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
139141486|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139141487|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
139141488|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141489|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139141490|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139141491|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141492|NCT03750669|Hematinics|hematinics|mesh-ancestor
139141493|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
139141494|NCT03750669|Vitamins|vitamins|mesh-ancestor
139141495|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
139141496|NCT03757221|Daratumumab|daratumumab|mesh-list
139141497|NCT03757221|Ixazomib|ixazomib|mesh-list
139141498|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141499|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
139141500|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141501|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141502|NCT03757143|Ethanol|ethanol|mesh-list
139141503|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
139141504|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
139141505|NCT03757143|Povidone|povidone|mesh-list
139141506|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139141507|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141508|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141509|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141510|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
139141511|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
139141512|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
139141513|NCT04428411|Etanercept|etanercept|mesh-list
139141514|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139141515|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139141516|NCT04428411|Analgesics|analgesics|mesh-ancestor
139141517|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
139141518|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141519|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141520|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139141521|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141522|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139141523|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139141524|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
139141525|NCT03751059|Dexamethasone|dexamethasone|mesh-list
139141526|NCT03751059|Bromfenac|bromfenac|mesh-list
139141527|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139141528|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
139141529|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
139141530|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141531|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141532|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139141533|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
139141534|NCT03751059|Hormones|hormones|mesh-ancestor
139141535|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141536|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139141537|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141538|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139141539|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139141540|NCT03751059|Analgesics|analgesics|mesh-ancestor
138511856|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
139141542|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141543|NCT04422561|Ivermectin|ivermectin|mesh-list
139141544|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139141545|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141546|NCT03756987|Ropivacaine|ropivacaine|mesh-list
139141547|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
139141548|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
139141549|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141550|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141551|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
139141552|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141553|NCT02072746|Zinc|zinc|mesh-list
139141554|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
139141555|NCT02072746|Trace Elements|trace elements|mesh-ancestor
139141556|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
139141557|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141558|NCT02072746|Astringents|astringents|mesh-ancestor
139141559|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
139141560|NCT04940338|Dexamethasone|dexamethasone|mesh-list
139141561|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
139141562|NCT04940338|Bromfenac|bromfenac|mesh-list
139141563|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139141564|NCT04940338|BB 1101|bb 1101|mesh-list
139141565|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139141566|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
139141567|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
139141568|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141569|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141570|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139141571|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
139141572|NCT04940338|Hormones|hormones|mesh-ancestor
139141573|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141574|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139141575|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141576|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
139141577|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141578|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141579|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139141580|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139141581|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139141582|NCT04940338|Analgesics|analgesics|mesh-ancestor
139141583|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
139141584|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141585|NCT02083510|Colchicine|colchicine|mesh-list
139141586|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
139141587|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141588|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
139141589|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
139141590|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
139141591|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141592|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141593|NCT04407507|Ivermectin|ivermectin|mesh-list
139141594|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139141595|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141596|NCT02080624|Sirolimus|sirolimus|mesh-list
139141597|NCT02080624|Temsirolimus|temsirolimus|mesh-list
139141598|NCT02080624|MTOR Inhibitors|mtor inhibitors|mesh-list
139141599|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139141600|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141601|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139141602|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141603|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
139141604|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139141605|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
139141606|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280399|NCT02688829|Sirolimus|sirolimus|mesh-list
139141607|NCT02080624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139141608|NCT02080624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141609|NCT02080624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141610|NCT02080858|Apixaban|apixaban|mesh-list
139141611|NCT02080858|Ticagrelor|ticagrelor|mesh-list
139141612|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139141613|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139141614|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139141615|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139141616|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
139141617|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141618|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141619|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141620|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139141621|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
139141622|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139141623|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
139141624|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141625|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
139141626|NCT02073526|Adalimumab|adalimumab|mesh-list
139141627|NCT02073526|Infliximab|infliximab|mesh-list
139141628|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
139141629|NCT02073526|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139141630|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139141631|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141632|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
139141633|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139141634|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139141635|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
139141636|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141637|NCT02073916|Paclitaxel|paclitaxel|mesh-list
139141638|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139141639|NCT02073916|Trastuzumab|trastuzumab|mesh-list
139141640|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139141641|NCT02073916|Lapatinib|lapatinib|mesh-list
139141642|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139141643|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141644|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
139141645|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
139141646|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
139141647|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141648|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139141649|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139141650|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141651|NCT02073916|Immunotoxins|immunotoxins|mesh-ancestor
139141652|NCT02073916|Immunoconjugates|immunoconjugates|mesh-ancestor
139141653|NCT02073916|Immunologic Factors|immunologic factors|mesh-ancestor
139141654|NCT02073916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141655|NCT02084368|Bupivacaine|bupivacaine|mesh-list
139141656|NCT02084368|Ropivacaine|ropivacaine|mesh-list
139141657|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
139141658|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
139141659|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141660|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141661|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
139141662|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141663|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
139141664|NCT02084446|Prednisone|prednisone|mesh-list
139141665|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
139141666|NCT02084446|Everolimus|everolimus|mesh-list
139141667|NCT02084446|Tacrolimus|tacrolimus|mesh-list
139141668|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
139141669|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139141670|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139141671|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
139141672|NCT02084446|Hormones|hormones|mesh-ancestor
139141673|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141674|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141675|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139141676|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141677|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139141678|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
139141679|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139141680|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141681|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141682|NCT02084446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139141683|NCT02084446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139141684|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139141685|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139141686|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
139141687|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139141688|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141689|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
139141690|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
139141691|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141692|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139141693|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139141694|NCT02084446|Protective Agents|protective agents|mesh-ancestor
139141695|NCT02801656|Vancomycin|vancomycin|mesh-list
139141697|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141698|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139141699|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139141700|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141701|NCT02084602|Artesunate|artesunate|mesh-list
139141702|NCT02084602|Mefloquine|mefloquine|mesh-list
139141703|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
139141704|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139141705|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139141706|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141707|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141708|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
139141709|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
139141710|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139141711|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
139141712|NCT02081560|Colistin|colistin|mesh-list
139141713|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139141714|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141715|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139141716|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139141717|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139141718|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141719|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141720|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139141721|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139141722|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141723|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
139141724|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141725|NCT02074228|Methylphenidate|methylphenidate|mesh-list
139141726|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139141727|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141728|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139141729|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139085576|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
139141730|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139141731|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141732|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
139141733|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141734|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
139141735|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141736|NCT03558490|Immunomodulating Agents|immunomodulating agents|mesh-list
139141737|NCT03558490|Immunologic Factors|immunologic factors|mesh-ancestor
139141738|NCT03558490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141739|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
139141740|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
139141741|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139141742|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139141743|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141744|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141745|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141746|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141747|NCT02085304|Temozolomide|temozolomide|mesh-list
139141748|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139141749|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
139141750|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141751|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141752|NCT02260414|Tinzaparin|tinzaparin|mesh-list
139141753|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139141754|NCT02260414|Dalteparin|dalteparin|mesh-list
139141755|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
139141756|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139141757|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139141758|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141759|NCT02085538|Palbociclib|palbociclib|mesh-list
139141760|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141761|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139141762|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141763|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141764|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139141765|NCT04169061|Hormones|hormones|mesh-ancestor
139141766|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141767|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141768|NCT01562691|Petrolatum|petrolatum|mesh-list
139141769|NCT01562691|Emollients|emollients|mesh-ancestor
139141770|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
139141771|NCT02792218|Teriflunomide|teriflunomide|mesh-list
139141772|NCT02792218|Ofatumumab|ofatumumab|mesh-list
139141773|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139141774|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141775|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
139141776|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141777|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139141778|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139141779|NCT02792218|Analgesics|analgesics|mesh-ancestor
139141780|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
139141781|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141782|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139141783|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141784|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139141785|NCT02075086|Bevacizumab|bevacizumab|mesh-list
139141786|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139141787|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141788|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139141789|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139141790|NCT02075086|Growth Substances|growth substances|mesh-ancestor
139141791|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141792|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
139141793|NCT02082418|Caseins|caseins|mesh-list
139141794|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
139141795|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
139141796|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141797|NCT02082496|Liraglutide|liraglutide|mesh-list
139141798|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139141799|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878423|NCT02665208|Nicotine|nicotine|mesh-list
139141800|NCT02082496|Incretins|incretins|mesh-ancestor
139141801|NCT02082496|Hormones|hormones|mesh-ancestor
139141802|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141803|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
139141804|NCT02075242|Tacrolimus|tacrolimus|mesh-list
139141805|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139141806|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
139141807|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141808|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139141809|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141810|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141811|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139141812|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141813|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139141814|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
139141815|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139141816|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141817|NCT02082652|Etonogestrel|etonogestrel|mesh-list
139141818|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139141819|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
139141820|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139141821|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141822|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139141823|NCT00153101|Telmisartan|telmisartan|mesh-list
139141824|NCT00153101|Ramipril|ramipril|mesh-list
139141825|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139141826|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139141827|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139141828|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141829|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139141830|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
139141831|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141832|NCT03558412|Decitabine|decitabine|mesh-list
139141833|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139141834|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
139141835|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141836|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141837|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141838|NCT04401579|Remdesivir|remdesivir|mesh-list
139141839|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
139141840|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141841|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
139141842|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085608|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139141843|NCT03558880|Anesthetics|anesthetics|mesh-list
139141844|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141845|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141846|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
139141847|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138878433|NCT00977353|Citalopram|citalopram|mesh-list
139141848|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
139141849|NCT03749733|Megestrol|megestrol|mesh-list
139141850|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139141851|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139141852|NCT03749733|Estradiol|estradiol|mesh-list
139141853|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139141854|NCT03749733|Estrogens|estrogens|mesh-ancestor
139141855|NCT03749733|Hormones|hormones|mesh-ancestor
139141856|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141857|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141858|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139141859|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
139141860|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139141861|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139141862|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139141863|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139141864|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139141865|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139141866|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141867|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
139141868|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139141869|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141870|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
139141871|NCT01582607|Fentanyl|fentanyl|mesh-list
139141872|NCT01582607|Bupivacaine|bupivacaine|mesh-list
139141873|NCT01582607|Ropivacaine|ropivacaine|mesh-list
139141874|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
139141875|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
139141876|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
139141877|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141878|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141879|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
139141880|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141881|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139141882|NCT01582607|Narcotics|narcotics|mesh-ancestor
139141883|NCT01582607|Analgesics|analgesics|mesh-ancestor
139141884|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139141885|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139141886|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
139141887|NCT00149825|Dexetimide|dexetimide|mesh-list
139141888|NCT00149825|Citalopram|citalopram|mesh-list
139141889|NCT00149825|Escitalopram|escitalopram|mesh-list
139141890|NCT00149825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139141891|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139141892|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139141893|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141894|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141895|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
139141896|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141897|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139141898|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139141899|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
139141900|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
139141901|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141902|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139141903|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139141904|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
139141905|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139141906|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
139141907|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139141908|NCT02792062|Relugolix|relugolix|mesh-list
139141909|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
139141910|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
139141911|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141912|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141913|NCT05027295|Riboflavin|riboflavin|mesh-list
139141914|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139141916|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
139141917|NCT05027295|Vitamins|vitamins|mesh-ancestor
138923121|NCT04070391|Pyridoxal|pyridoxal|mesh-list
139141919|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141920|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139141921|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
139141922|NCT02090920|Nifedipine|nifedipine|mesh-list
139141923|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139141924|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139141925|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141926|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139141927|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141928|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
139141929|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
139141930|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139141931|NCT02086474|Bupivacaine|bupivacaine|mesh-list
139141932|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
139141933|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
139141934|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
139141935|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141936|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141937|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
139141938|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141939|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139141940|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
139141941|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
139141942|NCT02086474|Protective Agents|protective agents|mesh-ancestor
139141943|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
139141944|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139141945|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139141946|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139141947|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139141948|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139141949|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141950|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141951|NCT04397445|Ranitidine|ranitidine|mesh-list
139141952|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139141953|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139141954|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139141955|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139141956|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
139141957|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
139141958|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141959|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141960|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141961|NCT02091388|Risperidone|risperidone|mesh-list
139141962|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139141963|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
139141964|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139141965|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141966|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141967|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139141968|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139141969|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139141970|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139141971|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139141972|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
139141973|NCT02086942|Dexamethasone|dexamethasone|mesh-list
139141974|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
139141975|NCT02086942|Bortezomib|bortezomib|mesh-list
139141976|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139141977|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
139141978|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141979|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139141980|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139141981|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
139141982|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139141983|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139141984|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139141985|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139141986|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
139141987|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
139141988|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139141989|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139141990|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
138923123|NCT04070391|Vitamins|vitamins|mesh-ancestor
139141992|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139141993|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139141994|NCT02088424|Insulin|insulin|mesh-list
139141995|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139141996|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139141997|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139141998|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139141999|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139142000|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139142001|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142002|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
139142003|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142004|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142005|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139142006|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142007|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
139142008|NCT02088502|Theophylline|theophylline|mesh-list
139142009|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139142010|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
139142011|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142012|NCT02088502|Expectorants|expectorants|mesh-ancestor
139142013|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
139142014|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139142015|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
139142016|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142017|NCT02088502|Protective Agents|protective agents|mesh-ancestor
139142018|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142019|NCT02088502|Antidotes|antidotes|mesh-ancestor
139142020|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139142021|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
139142022|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142023|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139142024|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139142025|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142026|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
139142027|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139142028|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139142029|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
139142030|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142031|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
139142032|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139142033|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139142034|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
139142035|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142036|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142037|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142038|NCT02087098|Urological Agents|urological agents|mesh-ancestor
139142039|NCT01369342|Ustekinumab|ustekinumab|mesh-list
139142040|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
139142041|NCT00191477|Gemcitabine|gemcitabine|mesh-list
139142042|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139142043|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
139142044|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142045|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142046|NCT02087332|Torsemide|torsemide|mesh-list
139142047|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139142048|NCT02087332|Diuretics|diuretics|mesh-ancestor
139142049|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
139142050|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142051|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139142052|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139142053|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142054|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139142055|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
139142056|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139142057|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142058|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142059|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139142060|NCT02092012|Analgesics|analgesics|mesh-ancestor
139142061|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
139142062|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923124|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
139142063|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139142064|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139142065|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139142066|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
139142067|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142068|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142069|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138892585|NCT05292664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139142070|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139142071|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139142073|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139142075|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139142076|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142077|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139142078|NCT00187889|Diuretics|diuretics|mesh-ancestor
139142079|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
139142080|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139142081|NCT02087488|Eszopiclone|eszopiclone|mesh-list
139142082|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139142083|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142084|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142085|NCT02087566|Linezolid|linezolid|mesh-list
139142086|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139142087|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142088|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139142089|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142090|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142091|NCT00148109|Cetuximab|cetuximab|mesh-list
139142092|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139142093|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142094|NCT03746223|Rituximab|rituximab|mesh-list
139142095|NCT03746223|Methotrexate|methotrexate|mesh-list
139142096|NCT03746223|Lenalidomide|lenalidomide|mesh-list
139142097|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139142098|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142099|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
139142100|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142101|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139142102|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139142103|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
139142104|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139142105|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139142106|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
139142107|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142108|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
139142109|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142110|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139142111|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139142112|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139142113|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139142114|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139142115|NCT03746223|Growth Substances|growth substances|mesh-ancestor
139142116|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
139142117|NCT03969017|Interferons|interferons|mesh-list
139142118|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142119|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
139142120|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142121|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
139142122|NCT04596033|Fludarabine|fludarabine|mesh-list
139142123|NCT04596033|Interleukin-2|interleukin-2|mesh-list
139142124|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139142125|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
139142126|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142127|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139142128|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139142129|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
139142130|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142131|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142132|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139142133|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139142134|NCT04596033|Analgesics|analgesics|mesh-ancestor
138188840|NCT04736524|Antibodies|antibodies|mesh-list
139142136|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142137|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
139142138|NCT02092558|Cephalosporins|cephalosporins|mesh-list
139142139|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139142140|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142141|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139142142|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
139142143|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
139142144|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139142145|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
139142146|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142147|NCT01074359|Protective Agents|protective agents|mesh-ancestor
139142148|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142149|NCT02087722|Melatonin|melatonin|mesh-list
139142150|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
139142151|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142152|NCT02087722|Protective Agents|protective agents|mesh-ancestor
139142153|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142154|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142155|NCT01326221|Tenofovir|tenofovir|mesh-list
139142156|NCT01326221|Emtricitabine|emtricitabine|mesh-list
139142157|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
139142158|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142159|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139142160|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139142161|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142162|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142163|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139142164|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139142165|NCT04311177|Losartan|losartan|mesh-list
139142166|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139142167|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139142168|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139142169|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139142170|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142171|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
139142172|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139142173|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
139142174|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142175|NCT01074593|Interferons|interferons|mesh-list
139142176|NCT01074593|Interferon-beta|interferon-beta|mesh-list
139142177|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
139142178|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142179|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
139142180|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142181|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
139142182|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142183|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139142184|NCT02088970|Riboflavin|riboflavin|mesh-list
139142185|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139142186|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142187|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
139142188|NCT02088970|Vitamins|vitamins|mesh-ancestor
139142189|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
139142190|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142191|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139142192|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
139142193|NCT03968861|Xenon|xenon|mesh-list
139142194|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139142195|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
139142196|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
139142197|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142198|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142199|NCT04292535|Insulin|insulin|mesh-list
139142200|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139142201|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
139142202|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
139142203|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139142204|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139142205|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142206|NCT03747081|Warfarin|warfarin|mesh-list
139142207|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
139142208|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
139142209|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139142210|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
139142211|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139142212|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
139142213|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142214|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142216|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139142217|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142218|NCT01313390|Docetaxel|docetaxel|mesh-list
139142219|NCT01313390|Everolimus|everolimus|mesh-list
139142220|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142221|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
138892732|NCT05076292|Glucagon|glucagon|mesh-list
138892734|NCT05076292|Hormones|hormones|mesh-ancestor
139142222|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
139142223|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
139142224|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142225|NCT01313390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139142226|NCT01313390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139142227|NCT01313390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142228|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139142229|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
139142230|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142231|NCT05571332|Cyclosporine|cyclosporine|mesh-list
139142232|NCT05571332|Cyclosporins|cyclosporins|mesh-list
139142233|NCT05571332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142234|NCT05571332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142235|NCT05571332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139142236|NCT05571332|Immunologic Factors|immunologic factors|mesh-ancestor
139142237|NCT05571332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142238|NCT05571332|Antifungal Agents|antifungal agents|mesh-ancestor
139142239|NCT05571332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142240|NCT05571332|Dermatologic Agents|dermatologic agents|mesh-ancestor
139142241|NCT05571332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139142242|NCT05571332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139142243|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139142244|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139142245|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139142246|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142247|NCT02089048|Auranofin|auranofin|mesh-list
139142248|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139142249|NCT02089126|Glimepiride|glimepiride|mesh-list
139142250|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139142251|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139142252|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142253|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139142254|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
139142255|NCT05571176|Ketamine|ketamine|mesh-list
139142256|NCT05571176|Esketamine|esketamine|mesh-list
139142257|NCT05571176|Analgesics|analgesics|mesh-ancestor
139142258|NCT05571176|Sensory System Agents|sensory system agents|mesh-ancestor
139142259|NCT05571176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142260|NCT05571176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142261|NCT05571176|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139142262|NCT05571176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139142263|NCT05571176|Anesthetics, General|anesthetics, general|mesh-ancestor
139142264|NCT05571176|Anesthetics|anesthetics|mesh-ancestor
139142265|NCT05571176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142266|NCT05571176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139142267|NCT05571176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139142268|NCT05571176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142269|NCT05571176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142270|NCT05571176|Antidepressive Agents|antidepressive agents|mesh-ancestor
139142271|NCT05571176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139142272|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139142273|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139142274|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142275|NCT02095834|Dexamethasone|dexamethasone|mesh-list
139142276|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
139142277|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139142278|NCT02095834|Ichthammol|ichthammol|mesh-list
139142279|NCT02095834|BB 1101|bb 1101|mesh-list
139142280|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139142281|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
139142282|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
139142283|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142284|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142285|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139142286|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
139142287|NCT02095834|Hormones|hormones|mesh-ancestor
139142288|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139142289|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139142290|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142291|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139142292|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
139019559|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142293|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142294|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
139142295|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892810|NCT04920539|Dronabinol|dronabinol|mesh-list
139142297|NCT03556852|Misoprostol|misoprostol|mesh-list
139142298|NCT03556852|Carbetocin|carbetocin|mesh-list
139142299|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139142300|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
139142301|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139142302|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142303|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139142304|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139142305|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
139142306|NCT02808572|Mitogens|mitogens|mesh-list
139142307|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
139142308|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142309|NCT02093728|Itraconazole|itraconazole|mesh-list
139142310|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139142311|NCT02093728|Fluconazole|fluconazole|mesh-list
139142312|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
139142313|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142314|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139142315|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139142316|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142317|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142318|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139142319|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
139142320|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139142321|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142322|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139142323|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139142324|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139142325|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
139142326|NCT02089204|Fluorides|fluorides|mesh-list
139142327|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
139142328|NCT02089204|Protective Agents|protective agents|mesh-ancestor
139142329|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142330|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
139142331|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142332|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
139142333|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142334|NCT02095990|Hydroquinone|hydroquinone|mesh-list
139142335|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
139142336|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142337|NCT02095990|Protective Agents|protective agents|mesh-ancestor
139142338|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142339|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139085693|NCT05191394|Antibodies|antibodies|mesh-list
139142340|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
139142341|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139142342|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142343|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142344|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139142345|NCT02096068|Analgesics|analgesics|mesh-ancestor
139142346|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
139142347|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142348|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139142349|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139142350|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139142351|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
139142352|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142353|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142354|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139142355|NCT02089438|Vildagliptin|vildagliptin|mesh-list
139142356|NCT02089438|Saxagliptin|saxagliptin|mesh-list
139142357|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139142358|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142359|NCT02089438|Incretins|incretins|mesh-ancestor
139142360|NCT02089438|Hormones|hormones|mesh-ancestor
139142361|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139142362|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139142363|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
139142364|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142365|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142366|NCT05471674|Nivolumab|nivolumab|mesh-list
139142367|NCT05471674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139142368|NCT05471674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142369|NCT05471674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139142370|NCT05471674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142371|NCT02096224|Sevoflurane|sevoflurane|mesh-list
139142373|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139142374|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139142375|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
139142376|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
139142377|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142378|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142379|NCT02096380|Cisplatin|cisplatin|mesh-list
139142380|NCT02096380|Docetaxel|docetaxel|mesh-list
139142381|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142382|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
139142383|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
139142384|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
139142385|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142386|NCT02250118|Bevacizumab|bevacizumab|mesh-list
139142387|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139142388|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142389|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139142390|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139142391|NCT02250118|Growth Substances|growth substances|mesh-ancestor
139142392|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142393|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
139142394|NCT03060772|Pioglitazone|pioglitazone|mesh-list
139142395|NCT03060772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139142396|NCT03060772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142397|NCT02096536|Vancomycin|vancomycin|mesh-list
139142398|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139142399|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142400|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
139142401|NCT02096614|Fludarabine|fludarabine|mesh-list
139142402|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139142403|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
139142404|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142405|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139142406|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139142407|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
139142408|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142409|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142410|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139142411|NCT02094196|Ethanol|ethanol|mesh-list
139142412|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139142413|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142414|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142415|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142416|NCT02094274|Fluticasone|fluticasone|mesh-list
139142417|NCT02094274|Xhance|xhance|mesh-list
139142418|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139142419|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139142420|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139142421|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
139142422|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142423|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142424|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139142425|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
139142426|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
139142427|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139142428|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139142429|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139142431|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
139142432|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142433|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142434|NCT02096926|Ibuprofen|ibuprofen|mesh-list
139142435|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139142436|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139142437|NCT02096926|Analgesics|analgesics|mesh-ancestor
139142438|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
139142439|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142440|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142441|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139142442|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139142443|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139142444|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142445|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142446|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139142447|NCT02097004|Entecavir|entecavir|mesh-list
139142448|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
139142449|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142450|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
139142451|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142452|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
139142453|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142454|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142455|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139142456|NCT03691779|Ivacaftor|ivacaftor|mesh-list
139142457|NCT03691779|Elexacaftor|elexacaftor|mesh-list
139142458|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139142459|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139142460|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142461|NCT02095054|Cetuximab|cetuximab|mesh-list
139142462|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139142463|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142464|NCT03555994|Liraglutide|liraglutide|mesh-list
139142465|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139142466|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142467|NCT03555994|Incretins|incretins|mesh-ancestor
139142468|NCT03555994|Hormones|hormones|mesh-ancestor
139142469|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139142470|NCT02095366|Sufentanil|sufentanil|mesh-list
139142471|NCT02095366|Morphine|morphine|mesh-list
139142472|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139142473|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139142474|NCT02095366|Narcotics|narcotics|mesh-ancestor
139142475|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142476|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142477|NCT02095366|Analgesics|analgesics|mesh-ancestor
139142478|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
139142479|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142480|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139142481|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139142482|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
139142483|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
139142484|NCT02097082|Paclitaxel|paclitaxel|mesh-list
139142485|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139142486|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142487|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
139142488|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
139142489|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
139142490|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142491|NCT02097160|Vitamin D|vitamin d|mesh-list
139142492|NCT02097160|Vitamins|vitamins|mesh-ancestor
139142493|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
139142494|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142495|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139142496|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
139142497|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142498|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139142499|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
139142500|NCT02097316|Insulin|insulin|mesh-list
139142501|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139142502|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142503|NCT02095522|Colchicine|colchicine|mesh-list
139142504|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
139142505|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139142506|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
139142507|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
139142508|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
139142509|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142510|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142511|NCT02097394|Pancreatin|pancreatin|mesh-list
139142512|NCT02097394|Pancrelipase|pancrelipase|mesh-list
139142513|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139142514|NCT04123665|Fluorides|fluorides|mesh-list
139142515|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
139142516|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
139142517|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
138893035|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
139142518|NCT04123665|Protective Agents|protective agents|mesh-ancestor
139142519|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142520|NCT02250508|Factor VIII|factor viii|mesh-list
139142521|NCT02250508|Coagulants|coagulants|mesh-ancestor
139142522|NCT03555526|Amoxicillin|amoxicillin|mesh-list
139142523|NCT03555526|Metronidazole|metronidazole|mesh-list
139142524|NCT03555526|Clarithromycin|clarithromycin|mesh-list
139142525|NCT03555526|Levofloxacin|levofloxacin|mesh-list
139142526|NCT03555526|Tetracycline|tetracycline|mesh-list
139142527|NCT03555526|Esomeprazole|esomeprazole|mesh-list
139142528|NCT03555526|Bismuth|bismuth|mesh-list
139142529|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139142530|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142531|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139142532|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139142533|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139142534|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139142535|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139142536|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142537|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142538|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139142539|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139142540|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139142541|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139142542|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139142543|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139142544|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142545|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139142546|NCT03555526|Antacids|antacids|mesh-ancestor
139142547|NCT02102620|Lidocaine|lidocaine|mesh-list
139142548|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
139142549|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
139142550|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142551|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142552|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
139142553|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142554|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139142555|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139142556|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139142557|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139142558|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142560|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139142561|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139142562|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142563|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142564|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139142565|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139142566|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
139142567|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142568|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142569|NCT02102776|Mitomycins|mitomycins|mesh-list
139142570|NCT02102776|Mitomycin|mitomycin|mesh-list
139142571|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139142572|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142573|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
139142574|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142575|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139142576|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142577|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
139142578|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139142579|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
139019560|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139142580|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142581|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139142582|NCT02670044|Venetoclax|venetoclax|mesh-list
139142583|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142584|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139142585|NCT02307656|Cobicistat|cobicistat|mesh-list
139142586|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139142587|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139142588|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
139142589|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142590|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142591|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139142592|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139142593|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
139142594|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142595|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139142596|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139142597|NCT04232943|Vaccines|vaccines|mesh-list
139142598|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
139142599|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142600|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
139142601|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139142602|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139142603|NCT02098330|Prednisolone|prednisolone|mesh-list
139142604|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
139142605|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139142606|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
139142607|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139142608|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
139142609|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
139142610|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142611|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142612|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139142613|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
139142614|NCT02098330|Hormones|hormones|mesh-ancestor
139142615|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139142616|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139142617|NCT02098330|Protective Agents|protective agents|mesh-ancestor
139142618|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139142620|NCT02103166|Scopolamine|scopolamine|mesh-list
139142621|NCT02103166|Bromides|bromides|mesh-list
139142622|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
139142623|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139142624|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
139142625|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
139142626|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142627|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142628|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139142629|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
139142630|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139142631|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
139142632|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142633|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142634|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139142635|NCT02103244|Carboplatin|carboplatin|mesh-list
139142636|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142637|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
139142638|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
139142639|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139142640|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142641|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139085791|NCT01140308|Ubiquinone|ubiquinone|mesh-list
139142642|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139142643|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142644|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142645|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142646|NCT02250820|Pentobarbital|pentobarbital|mesh-list
139142647|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
139142648|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139142649|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142650|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142651|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139142652|NCT02250820|Analgesics|analgesics|mesh-ancestor
139142653|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
139142654|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142655|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139142656|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139142657|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139142658|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
139142659|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142660|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142661|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139142662|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
139142663|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
139142664|NCT02100046|Ethosuximide|ethosuximide|mesh-list
139142665|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
139142666|NCT02100202|Turmeric extract|turmeric extract|mesh-list
139142667|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
139142668|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142669|NCT02100202|Protective Agents|protective agents|mesh-ancestor
139142670|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142671|NCT05423392|Lidocaine|lidocaine|mesh-list
139142672|NCT05423392|Carticaine|carticaine|mesh-list
139142673|NCT05423392|Anesthetics|anesthetics|mesh-list
139142674|NCT05423392|Anesthetics, Local|anesthetics, local|mesh-ancestor
139142675|NCT05423392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142676|NCT05423392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142677|NCT05423392|Sensory System Agents|sensory system agents|mesh-ancestor
139142678|NCT05423392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142679|NCT05423392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139142680|NCT05423392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139142681|NCT05423392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139142682|NCT05423392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139142683|NCT05423392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142684|NCT02103556|Mineral Oil|mineral oil|mesh-list
139142685|NCT02103556|Emollients|emollients|mesh-ancestor
139142686|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
139142687|NCT02099890|Curcumin|curcumin|mesh-list
139142688|NCT02099890|Antioxidants|antioxidants|mesh-list
139142689|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139142690|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139142691|NCT02099890|Analgesics|analgesics|mesh-ancestor
139142692|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
139142693|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142694|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142695|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139142696|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139142697|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142698|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142699|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142700|NCT02099890|Protective Agents|protective agents|mesh-ancestor
139142701|NCT03555136|Vortioxetine|vortioxetine|mesh-list
139142702|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
139142703|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139142704|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139142705|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139085795|NCT01140308|Vitamins|vitamins|mesh-ancestor
139142706|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142707|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142708|NCT03555136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139142709|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139142710|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139142711|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142712|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142713|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
139142714|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139142715|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139142716|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139142717|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139142718|NCT03554980|Listerine|listerine|mesh-list
139142719|NCT03554980|Fluorides|fluorides|mesh-list
139142720|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
139142721|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
139142722|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
139142723|NCT03554980|Protective Agents|protective agents|mesh-ancestor
139142724|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142725|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139142726|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142727|NCT04230213|Adalimumab|adalimumab|mesh-list
139142728|NCT04230213|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139142729|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139142730|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139142731|NCT03746691|Citalopram|citalopram|mesh-list
139142732|NCT03746691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139142733|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139142734|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139142735|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142736|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142737|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
139142738|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142739|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139142740|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
139142741|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139142742|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139142743|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139142744|NCT03745911|Paclitaxel|paclitaxel|mesh-list
139142745|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139142746|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142747|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
139142748|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
139142749|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
139142750|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142751|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139142752|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139142753|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142754|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139142755|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142756|NCT03554590|Insulin|insulin|mesh-list
139142757|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139142758|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142759|NCT02106286|Bisoprolol|bisoprolol|mesh-list
139142760|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139142761|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
139142762|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
139142763|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142764|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019561|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139142765|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139142766|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139142767|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139142768|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
139142769|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142770|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142771|NCT04109391|Trastuzumab|trastuzumab|mesh-list
139142772|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139142773|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142774|NCT02106364|Insulin|insulin|mesh-list
139142775|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139142776|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
139142777|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139142778|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142779|NCT04077866|Temozolomide|temozolomide|mesh-list
139142780|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139142781|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
138878711|NCT04132479|Tinidazole|tinidazole|mesh-list
139142782|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142783|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142784|NCT02101138|Pramipexole|pramipexole|mesh-list
139142785|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
139142786|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142787|NCT02101138|Protective Agents|protective agents|mesh-ancestor
139142788|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142789|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139142790|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139142791|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
139142792|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
139142793|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142794|NCT02106520|Bevacizumab|bevacizumab|mesh-list
139142795|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139142796|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142797|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139142798|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139142799|NCT02106520|Growth Substances|growth substances|mesh-ancestor
139142800|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142801|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
139142802|NCT02101216|Abacavir|abacavir|mesh-list
139142803|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
139142804|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139085817|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
139142805|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139142806|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142807|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142808|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
139142809|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142810|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139142811|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139142812|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
139142813|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139142814|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
139142815|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142816|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139142817|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139142818|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142819|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142820|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139142821|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139142822|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
139142823|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139142824|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139142825|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142826|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139142827|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139142828|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878736|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
139142829|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142830|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142831|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139142832|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
139142833|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139142834|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142835|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139142836|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139142837|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139142838|NCT01562301|Carboplatin|carboplatin|mesh-list
139142839|NCT01562301|Docetaxel|docetaxel|mesh-list
139142840|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142841|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
139142842|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
139142843|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
139142844|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142845|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
139142846|NCT04094883|Vaccines|vaccines|mesh-list
139142847|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
139142848|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142849|NCT02101606|Tenecteplase|tenecteplase|mesh-list
139142850|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139142851|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139142852|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142853|NCT02101840|Oxycodone|oxycodone|mesh-list
139142854|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139142855|NCT02101840|Narcotics|narcotics|mesh-ancestor
139142856|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142857|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142858|NCT02101840|Analgesics|analgesics|mesh-ancestor
139142859|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
139142860|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142861|NCT02107378|Paclitaxel|paclitaxel|mesh-list
139142862|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139142863|NCT02107378|Doxorubicin|doxorubicin|mesh-list
139142864|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139142865|NCT02107378|Topotecan|topotecan|mesh-list
139142866|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139142867|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142868|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
139142869|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
139142870|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
138878761|NCT00867087|Immunotoxins|immunotoxins|mesh-ancestor
139142871|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142872|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139142873|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139142874|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139142875|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142876|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139142877|NCT02105350|Gemcitabine|gemcitabine|mesh-list
139142878|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
139142879|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139142880|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
139142881|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142882|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142883|NCT02102152|Tobramycin|tobramycin|mesh-list
139142884|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139142885|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142886|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
139142887|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139142888|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142889|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
139142890|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142891|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139142892|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138893409|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142893|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142894|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139142895|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142896|NCT02107690|Lidocaine|lidocaine|mesh-list
139142897|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
139142898|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
139142899|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139142900|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142901|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
139142902|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142903|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139142904|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139142905|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139142906|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139142907|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142908|NCT05568836|Vitamin D|vitamin d|mesh-list
139142909|NCT05568836|Vitamins|vitamins|mesh-ancestor
139142910|NCT05568836|Micronutrients|micronutrients|mesh-ancestor
139142911|NCT05568836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142912|NCT05568836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139142913|NCT03259490|Metformin|metformin|mesh-list
139142914|NCT03259490|Empagliflozin|empagliflozin|mesh-list
139142915|NCT03259490|Linagliptin|linagliptin|mesh-list
139142916|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139142917|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142918|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139142919|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142920|NCT03259490|Incretins|incretins|mesh-ancestor
139142921|NCT03259490|Hormones|hormones|mesh-ancestor
139142922|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139142923|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139142924|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
139142925|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142926|NCT02106130|Rebamipide|rebamipide|mesh-list
139142927|NCT02106130|Mosapride|mosapride|mesh-list
139142928|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142929|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139142930|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139142931|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
139142932|NCT02106130|Protective Agents|protective agents|mesh-ancestor
139142933|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142934|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142935|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139142936|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
139142937|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139142938|NCT02251132|Ritonavir|ritonavir|mesh-list
139142939|NCT02251132|Erythromycin|erythromycin|mesh-list
139142940|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
139142941|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139142942|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
139142943|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139142944|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139142945|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
139142946|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142947|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142948|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139142949|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139142950|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
139142951|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142952|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139142953|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138878818|NCT00978601|Analgesics|analgesics|mesh-list
139142954|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139142955|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139142956|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139142958|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139142959|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
139142960|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139142961|NCT05571722|Vancomycin|vancomycin|mesh-list
139142962|NCT05571722|Linezolid|linezolid|mesh-list
139142963|NCT05571722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139142964|NCT05571722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142965|NCT05571722|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139142966|NCT05571722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142967|NCT05571722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142968|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
139142969|NCT02110654|Montelukast|montelukast|mesh-list
139142970|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139142971|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
139142972|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139142973|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
139142974|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139142975|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142976|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139142977|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139142978|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142979|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139142980|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
139142981|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139142983|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
139142984|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139142985|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139142986|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139142987|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139142988|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139142989|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139142990|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139142991|NCT02110810|Indomethacin|indomethacin|mesh-list
139142992|NCT02110810|Glycerol|glycerol|mesh-list
139142993|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139142994|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139142995|NCT02110810|Analgesics|analgesics|mesh-ancestor
139142996|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
139142997|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139142998|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139142999|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139143000|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139143001|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
139143002|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
139143003|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139143004|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139143005|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143006|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143007|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139143008|NCT02110810|Protective Agents|protective agents|mesh-ancestor
139143009|NCT02107924|Vancomycin|vancomycin|mesh-list
139143010|NCT02107924|Tobramycin|tobramycin|mesh-list
138531047|NCT00040625|Pemetrexed|pemetrexed|mesh-list
139143011|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139143012|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143014|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143015|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139143016|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143017|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143018|NCT02114476|Progestins|progestins|mesh-list
139143019|NCT02114476|Hormones|hormones|mesh-ancestor
138513344|NCT00136747|Memantine|memantine|mesh-list
139143020|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139143021|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143023|NCT02110966|Mepivacaine|mepivacaine|mesh-list
139143024|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139143025|NCT02110966|Narcotics|narcotics|mesh-ancestor
139143026|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143027|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143028|NCT02110966|Analgesics|analgesics|mesh-ancestor
139143029|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
139143030|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143031|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
139143032|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
139143033|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
139143034|NCT02937740|Testosterone|testosterone|mesh-list
139143035|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
139143036|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
139143037|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139143038|NCT02937740|Androgens|androgens|mesh-ancestor
139143039|NCT02937740|Hormones|hormones|mesh-ancestor
139019562|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139143040|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139143041|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893560|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139143042|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139143043|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143044|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
139143045|NCT02111044|Octreotide|octreotide|mesh-list
139143046|NCT02111044|Somatostatin|somatostatin|mesh-list
139143047|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139143048|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139143049|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143050|NCT02111044|Hormones|hormones|mesh-ancestor
139143051|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139143052|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143053|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
139143054|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139143055|NCT02108548|Naproxen|naproxen|mesh-list
139143056|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139143057|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139143058|NCT02108548|Analgesics|analgesics|mesh-ancestor
139143059|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
139143060|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143061|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143062|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139143063|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139143064|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
139143065|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139143066|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143067|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143068|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
139143069|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139143070|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139143071|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
139143072|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
139143073|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143074|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143075|NCT02108626|Nicotine|nicotine|mesh-list
139143076|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139143077|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
139143078|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143079|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143080|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139143081|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139143082|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
139143083|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143084|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143107|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143108|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139143109|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139143110|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139143111|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143112|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143113|NCT02108782|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139143114|NCT02108782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139143115|NCT02108782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143116|NCT02108782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143117|NCT02111434|Testosterone|testosterone|mesh-list
139143118|NCT02111434|Androgens|androgens|mesh-ancestor
139143119|NCT02111434|Hormones|hormones|mesh-ancestor
139143120|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139143121|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143122|NCT03230864|Olanzapine|olanzapine|mesh-list
139143123|NCT03230864|Risperidone|risperidone|mesh-list
139143124|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139143125|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
139143126|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143127|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143128|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143129|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139143130|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139143131|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143132|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139143133|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139143134|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
139143135|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
139143136|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
139143137|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143138|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139143139|NCT03230864|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139143140|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139143141|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139143142|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
139143143|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139143144|NCT02111590|Antibodies|antibodies|mesh-list
139143145|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
139143146|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143147|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139143148|NCT02937350|Calcifediol|calcifediol|mesh-list
139143149|NCT02937350|Vitamins|vitamins|mesh-ancestor
139143150|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
139143151|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143152|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139143153|NCT02109328|Paclitaxel|paclitaxel|mesh-list
139143154|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139143155|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143156|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
139143157|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
139143158|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
139143159|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143160|NCT02115490|Diphosphonates|diphosphonates|mesh-list
139143161|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139143162|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143163|NCT02251288|Vaccines|vaccines|mesh-list
139143164|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
139143165|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143166|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
139143169|NCT02109718|Emollients|emollients|mesh-ancestor
139143170|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
139143171|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139143172|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143173|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139143174|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139143175|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
139143176|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139143177|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139143178|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143179|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143180|NCT02112292|Dronabinol|dronabinol|mesh-list
139143181|NCT02112292|Cannabidiol|cannabidiol|mesh-list
139143182|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
139143183|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
139143184|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143185|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139143186|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139143187|NCT02112292|Analgesics|analgesics|mesh-ancestor
138893719|NCT03462342|Olaparib|olaparib|mesh-list
139143188|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
139143189|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085917|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
139143190|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139143191|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139143192|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143193|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143195|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139143196|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
139143197|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139143198|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
139143199|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139143201|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143202|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143203|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
139143204|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
139143205|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139143206|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
139143207|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143208|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143209|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139143210|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
139143211|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
139143212|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139143213|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
139143214|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143215|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143216|NCT02118844|Rocuronium|rocuronium|mesh-list
139143217|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139143218|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139143219|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139143220|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143221|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143222|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
139143223|NCT02116348|Mitogens|mitogens|mesh-list
139143224|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
139143225|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143226|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139143227|NCT02116348|Protective Agents|protective agents|mesh-ancestor
139143228|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143229|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
139143230|NCT02119000|Bisacodyl|bisacodyl|mesh-list
139143231|NCT02119000|Cathartics|cathartics|mesh-ancestor
139143232|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139143233|NCT02119000|Laxatives|laxatives|mesh-ancestor
139143234|NCT02119234|Beclomethasone|beclomethasone|mesh-list
139143235|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
139143236|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
139143237|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139143238|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
139143239|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143240|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143241|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139143242|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
139143243|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139143244|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139143245|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139143246|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
139143247|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143248|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143249|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139143250|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139143251|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139143252|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
139143253|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139143254|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
139143255|NCT02119234|Hormones|hormones|mesh-ancestor
139143256|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139143257|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139143258|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143259|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143260|NCT03694197|Alirocumab|alirocumab|mesh-list
139143261|NCT03694197|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139143262|NCT03694197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139143263|NCT03694197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139143264|NCT03694197|Antimetabolites|antimetabolites|mesh-ancestor
139143265|NCT03694197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143266|NCT03694197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139143267|NCT03694197|Protease Inhibitors|protease inhibitors|mesh-ancestor
139143268|NCT03694197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143269|NCT03694197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139143270|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139143271|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
139143272|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143273|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
139143274|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
139143275|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143276|NCT03919617|Volagidemab|volagidemab|mesh-list
139143277|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139143278|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143279|NCT03748173|Calfactant|calfactant|mesh-list
139143280|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139143281|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
139143282|NCT03848403|Ixekizumab|ixekizumab|mesh-list
139143283|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
139143284|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
139143285|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139143286|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139143287|NCT03743883|Aspirin|aspirin|mesh-list
139143288|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139143289|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139143290|NCT03743883|Analgesics|analgesics|mesh-ancestor
139143291|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
139143292|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085967|NCT01143584|Dopamine|dopamine|mesh-list
139143293|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143294|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139143295|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139143296|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139143297|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139143298|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143299|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139143300|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139143301|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143302|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
139143303|NCT03988803|Memantine|memantine|mesh-list
139143304|NCT03988803|BI 425809|bi 425809|mesh-list
139143305|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139143306|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139143307|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
139143308|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143309|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143310|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143311|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139143312|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139143313|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
139143314|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139143315|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
139143316|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139143317|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139143318|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139143319|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143320|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143321|NCT00180713|Simvastatin|simvastatin|mesh-list
139143322|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139143323|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139143324|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
139143325|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143326|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139143327|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139143328|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143329|NCT02531477|Propofol|propofol|mesh-list
138878989|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
139143330|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139143331|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143332|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143333|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139143334|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
139143335|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
139143336|NCT04052139|Naltrexone|naltrexone|mesh-list
139143337|NCT04052139|Gabapentin|gabapentin|mesh-list
139143338|NCT04052139|Analgesics|analgesics|mesh-ancestor
139143339|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
139143340|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143341|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143342|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
139143343|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139143344|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139143345|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143346|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139143347|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139143348|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139143349|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143350|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143351|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
139143352|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139143353|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139143354|NCT03743805|Naloxone|naloxone|mesh-list
139143355|NCT03743805|Flumazenil|flumazenil|mesh-list
139143356|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139143357|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143358|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
139143359|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143360|NCT03743805|Antidotes|antidotes|mesh-ancestor
139143361|NCT03743805|Protective Agents|protective agents|mesh-ancestor
139143362|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
139143363|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
139143364|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143365|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143366|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
139143367|NCT03743727|Ledipasvir|ledipasvir|mesh-list
139143368|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139143369|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
139143370|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143371|NCT03981861|Metformin|metformin|mesh-list
139143372|NCT03981861|Spironolactone|spironolactone|mesh-list
139143373|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139143374|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143375|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139143376|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
139143377|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139143378|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139143379|NCT03981861|Diuretics|diuretics|mesh-ancestor
139143380|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
139143381|NCT03743649|Lorazepam|lorazepam|mesh-list
139143382|NCT03743649|Haloperidol|haloperidol|mesh-list
139143383|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
139143384|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
139143385|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
139143386|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143387|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143388|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139143389|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139143390|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139143391|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143392|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139143393|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139143394|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
139143395|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143396|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143397|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139143398|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
139143399|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139143400|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139143401|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
139143402|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
139143403|NCT01332266|Cetuximab|cetuximab|mesh-list
139143404|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139143405|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143406|NCT03255824|Midazolam|midazolam|mesh-list
139143407|NCT03255824|Fentanyl|fentanyl|mesh-list
139143408|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
139143409|NCT03255824|Propofol|propofol|mesh-list
139143410|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139143411|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143412|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143413|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139143414|NCT03255824|Analgesics|analgesics|mesh-ancestor
139143415|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
139143416|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143417|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139143418|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138893935|NCT02509546|Adenosine|adenosine|mesh-list
139143419|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139143420|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
139143421|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143422|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143423|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139143424|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
139143425|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
139143426|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139143427|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139143428|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139143429|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139143430|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
139143431|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
139143432|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139143433|NCT03255824|Narcotics|narcotics|mesh-ancestor
139143434|NCT03238352|Listerine|listerine|mesh-list
139143435|NCT03238352|Fluorides|fluorides|mesh-list
139143436|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
139143437|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
139143438|NCT03238352|Protective Agents|protective agents|mesh-ancestor
139143439|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143440|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139143441|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143442|NCT01222754|Lenalidomide|lenalidomide|mesh-list
139143443|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
139143444|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143445|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139143446|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139143447|NCT01222754|Growth Substances|growth substances|mesh-ancestor
139143448|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
139143449|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143450|NCT05256914|Chlorhexidine|chlorhexidine|mesh-list
139143451|NCT05256914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139143452|NCT05256914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143453|NCT05256914|Disinfectants|disinfectants|mesh-ancestor
139143454|NCT00180479|Paclitaxel|paclitaxel|mesh-list
139143455|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139143456|NCT00180479|Everolimus|everolimus|mesh-list
139143457|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139143458|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143459|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
139143460|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
139143461|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
139143462|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143463|NCT00180479|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139143464|NCT00180479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139143465|NCT00180479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143466|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139143467|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
139143468|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143469|NCT05169944|Magrolimab|magrolimab|mesh-list
139143470|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139143471|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143472|NCT02955069|Spartalizumab|spartalizumab|mesh-list
139143473|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138281417|NCT05449483|Paclitaxel|paclitaxel|mesh-list
139143474|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143475|NCT02955069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139143476|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143477|NCT03254108|Tolvaptan|tolvaptan|mesh-list
139143478|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139143479|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143480|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
139143481|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143482|NCT02585895|Evolocumab|evolocumab|mesh-list
139143483|NCT02585895|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139143484|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139143485|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139143486|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
139143487|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143488|NCT02585895|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139143489|NCT02585895|Protease Inhibitors|protease inhibitors|mesh-ancestor
139143490|NCT02585895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143491|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139143492|NCT03736161|Methotrexate|methotrexate|mesh-list
139143493|NCT03736161|Tofacitinib|tofacitinib|mesh-list
139143494|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139143495|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
139143496|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139143497|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143498|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139143499|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
139143500|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143501|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143502|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
139143503|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143504|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139143505|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139143506|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
139143507|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139143508|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139143509|NCT03736161|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139143510|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139143511|NCT02956005|Tacrolimus|tacrolimus|mesh-list
139143512|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139143513|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
139143514|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143515|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139143516|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143517|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143518|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139143519|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139143520|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139143521|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
139143522|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143523|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143524|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139143525|NCT03253094|Fluconazole|fluconazole|mesh-list
139143526|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
139143527|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
139143528|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143529|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139143530|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139143531|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143532|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143533|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139086026|NCT03478930|Omalizumab|omalizumab|mesh-list
139143534|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
139143535|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139143536|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143537|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139143538|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139143539|NCT05179070|Carvedilol|carvedilol|mesh-list
139143540|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139143541|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139143542|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
139143543|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143544|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143545|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143546|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139143547|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
139143548|NCT05179070|Protective Agents|protective agents|mesh-ancestor
139143549|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139143550|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139143551|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139143552|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
139143553|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139143554|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139143555|NCT00179621|Lenalidomide|lenalidomide|mesh-list
139143556|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
139143557|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143558|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139143559|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139143560|NCT00179621|Growth Substances|growth substances|mesh-ancestor
139143561|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
139143562|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143563|NCT00179309|Docetaxel|docetaxel|mesh-list
139143564|NCT00179309|Sargramostim|sargramostim|mesh-list
139143565|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143566|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
139143567|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
138894086|NCT01856023|Analgesics|analgesics|mesh-ancestor
139143568|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
139143569|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143570|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
139143571|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143572|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139143573|NCT00177671|Donepezil|donepezil|mesh-list
139143574|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139143575|NCT00177671|Escitalopram|escitalopram|mesh-list
139143576|NCT00177671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139143577|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139143578|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139143579|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143580|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143581|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
139143582|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143583|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143584|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
139143585|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139143586|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
139143587|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139143588|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139143589|NCT00177671|Analgesics|analgesics|mesh-ancestor
139143590|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
139143591|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
139143592|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139143593|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143594|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
139143595|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
139143596|NCT03235154|Velpatasvir|velpatasvir|mesh-list
139143597|NCT03235154|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139143598|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
139143599|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143600|NCT03233438|Dalbavancin|dalbavancin|mesh-list
139143601|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139143602|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143603|NCT02251600|Deflazacort|deflazacort|mesh-list
139143604|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139143605|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139143606|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
139143607|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143608|NCT02113072|Beclomethasone|beclomethasone|mesh-list
139143609|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139143610|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
139143612|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139143613|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143614|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139143615|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
139143616|NCT02113150|Ketamine|ketamine|mesh-list
139143617|NCT02113150|Remifentanil|remifentanil|mesh-list
139143618|NCT02113150|Analgesics|analgesics|mesh-ancestor
139143619|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
139143620|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143621|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143622|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139143623|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139143624|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
139143625|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
139143626|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143627|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139143628|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139143629|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143630|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143631|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139143633|NCT04647500|Methylphenidate|methylphenidate|mesh-list
139143634|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139143635|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143636|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139143637|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139143638|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139143639|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143640|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
139143641|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143642|NCT03553108|Olaparib|olaparib|mesh-list
139143643|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139143644|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143645|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143646|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143647|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139143648|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
139143649|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139143650|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139143651|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143652|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
139143653|NCT02117128|Coagulants|coagulants|mesh-ancestor
139143654|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
139143655|NCT00175877|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139143656|NCT00175877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139143657|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139143658|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
139143659|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143660|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139143661|NCT02117362|Ipilimumab|ipilimumab|mesh-list
139143662|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139143663|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143664|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139143665|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143666|NCT02113540|Atorvastatin|atorvastatin|mesh-list
139143667|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139143668|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139143669|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
139143670|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143671|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139143672|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139143673|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143674|NCT02123056|Metoprolol|metoprolol|mesh-list
139143675|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139143676|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139143677|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
139143679|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143680|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143681|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139143682|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139143683|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139143684|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
139143685|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143686|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143687|NCT02120092|Clopidogrel|clopidogrel|mesh-list
139143688|NCT02120092|Ticagrelor|ticagrelor|mesh-list
139143689|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139143690|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139143691|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139143692|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139143693|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
139143694|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143695|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143696|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143697|NCT02117596|Sirolimus|sirolimus|mesh-list
139143698|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139143699|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143700|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139143701|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143702|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
139143703|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139143704|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
139143705|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143706|NCT02117752|Dapsone|dapsone|mesh-list
139143707|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143708|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
139143709|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139143710|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139143711|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139143712|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143713|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143714|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
139143715|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139143716|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
139143717|NCT02117830|Enclomiphene|enclomiphene|mesh-list
139143718|NCT02117830|Clomiphene|clomiphene|mesh-list
139143719|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
139143720|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139143721|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143722|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139143723|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139143724|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143725|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143726|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143727|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139143728|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143729|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139143730|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
139143731|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139143732|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139143733|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
139143734|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139143735|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139143736|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
139143737|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
139143738|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139143739|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143740|NCT03552406|Cetuximab|cetuximab|mesh-list
139143741|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139143742|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143743|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
139143744|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139143745|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
139143746|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143748|NCT02123368|Protective Agents|protective agents|mesh-ancestor
139143749|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
139143750|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139143751|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
139143752|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139143753|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
139143754|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143755|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143756|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
139143757|NCT02117986|Colistin|colistin|mesh-list
139143758|NCT02117986|Polymyxins|polymyxins|mesh-list
139143759|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139143760|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139143761|NCT02118064|Irinotecan|irinotecan|mesh-list
139143762|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139143763|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139143764|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143765|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143766|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143767|NCT02120872|Simvastatin|simvastatin|mesh-list
139143768|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139143769|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139143770|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
139143771|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143772|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139143773|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139143774|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143775|NCT03552016|Riboflavin|riboflavin|mesh-list
139143776|NCT03552016|Vitamins|vitamins|mesh-ancestor
139143777|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
139143778|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143779|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
139143780|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139143781|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
139143782|NCT02118142|Betaine|betaine|mesh-list
139143783|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139143784|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
139143785|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139143786|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
139143787|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894312|NCT00696436|Valsartan|valsartan|mesh-list
139143788|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139143789|NCT02118376|Exenatide|exenatide|mesh-list
139143790|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139143791|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143792|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139143793|NCT02118376|Incretins|incretins|mesh-ancestor
139143795|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139143796|NCT02124070|Hormones|hormones|mesh-list
139143797|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138879132|NCT02778659|Zolpidem|zolpidem|mesh-list
139143798|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143799|NCT02118532|Paclitaxel|paclitaxel|mesh-list
139143800|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139143801|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143802|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
139143803|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
139143804|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
139143805|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143806|NCT02118688|Risperidone|risperidone|mesh-list
139143807|NCT02118688|Trazodone|trazodone|mesh-list
139143808|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139143809|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
139143810|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143811|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143812|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143813|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139143814|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139143815|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143816|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139143817|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139143818|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
139143819|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139143820|NCT02118688|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139143821|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139143822|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138514151|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
139143823|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139143824|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
139143825|NCT02126956|Ponesimod|ponesimod|mesh-list
139143826|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139143827|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143828|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139143829|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
139143830|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143831|NCT02124148|Leucovorin|leucovorin|mesh-list
139143832|NCT02124148|Fluorouracil|fluorouracil|mesh-list
139143833|NCT02124148|Pemetrexed|pemetrexed|mesh-list
139143834|NCT02124148|Cetuximab|cetuximab|mesh-list
139143835|NCT02124148|Prexasertib|prexasertib|mesh-list
139143836|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143837|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
139143838|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143839|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139143840|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139143841|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
139143842|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143843|NCT02124148|Antidotes|antidotes|mesh-ancestor
139143844|NCT02124148|Protective Agents|protective agents|mesh-ancestor
139143845|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
139143846|NCT02124148|Vitamins|vitamins|mesh-ancestor
139143847|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
139143848|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143849|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139143850|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139143851|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139143852|NCT02124148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139143853|NCT02124226|Methotrexate|methotrexate|mesh-list
139143854|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139143855|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
139143856|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139143857|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143858|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139143859|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
139143860|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143861|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143862|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
139143863|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143864|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138894384|NCT00617513|Prucalopride|prucalopride|mesh-list
139143865|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139143866|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
139143867|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139143868|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139143869|NCT02127034|Digoxin|digoxin|mesh-list
139143870|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
139143871|NCT02127034|Mirabegron|mirabegron|mesh-list
139143872|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139143873|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139143874|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143875|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143876|NCT02127034|Protective Agents|protective agents|mesh-ancestor
139143877|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143878|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139143879|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139143880|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
139143881|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143882|NCT02127034|Urological Agents|urological agents|mesh-ancestor
139143883|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139143884|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139143885|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139143886|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
139143887|NCT02787304|Volixibat|volixibat|mesh-list
139143888|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139143889|NCT02127190|CXA-10|cxa-10|mesh-list
139143890|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139143891|NCT02932904|Vortioxetine|vortioxetine|mesh-list
139143892|NCT02932904|Paroxetine|paroxetine|mesh-list
139143893|NCT02932904|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139143894|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139143895|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138923148|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143896|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143897|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143898|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
139143899|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143900|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139143901|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
139143902|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139143903|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139143904|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139143905|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143906|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139143907|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139143908|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143909|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139143910|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139143911|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139143912|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139143913|NCT02127736|Amitriptyline|amitriptyline|mesh-list
139143914|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139143915|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
139143916|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139143917|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139143918|NCT02127736|Analgesics|analgesics|mesh-ancestor
139143919|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
139143920|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143921|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143922|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139143923|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139143924|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139143925|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143926|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
139143927|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143928|NCT02124850|Nivolumab|nivolumab|mesh-list
139143929|NCT02124850|Cetuximab|cetuximab|mesh-list
139143930|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139143931|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143932|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139143933|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143934|NCT02125084|Everolimus|everolimus|mesh-list
139086200|NCT01146002|Guanfacine|guanfacine|mesh-list
139143935|NCT02125084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139143936|NCT02125084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139143937|NCT02125084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143938|NCT02125084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143939|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139143940|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
139143941|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143942|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143943|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
139143944|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139143945|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143946|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143947|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139143948|NCT02122510|Analgesics|analgesics|mesh-ancestor
139143949|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
139143950|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143951|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139143952|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139143953|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139143954|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
139143955|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139143956|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143957|NCT02125318|Anagrelide|anagrelide|mesh-list
139143958|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139143959|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139143960|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143961|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139143962|NCT02128126|Vaccines|vaccines|mesh-list
139143963|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
139143964|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143965|NCT02128204|Lidocaine|lidocaine|mesh-list
139143966|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
139143967|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
139143968|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139143969|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143970|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
139143971|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139143972|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139143973|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139143974|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139143975|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138879189|NCT00973219|Tenofovir|tenofovir|mesh-list
139143976|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143977|NCT02128282|Gemcitabine|gemcitabine|mesh-list
139143978|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143979|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139143980|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
139143981|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143983|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139143984|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143985|NCT03551548|Spironolactone|spironolactone|mesh-list
139143986|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139143987|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
139143988|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139143989|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139143990|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139143991|NCT03551548|Diuretics|diuretics|mesh-ancestor
139143992|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
139143993|NCT02128360|Letrozole|letrozole|mesh-list
139143994|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139143995|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139143996|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139143997|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139143998|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139143999|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139144000|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
139144001|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144002|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144003|NCT02126020|Infliximab|infliximab|mesh-list
139144004|NCT02126020|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139144005|NCT02126020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139144006|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
139144007|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139144008|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139144009|NCT00688376|Donepezil|donepezil|mesh-list
139144010|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139144011|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144012|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144013|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
139144014|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144015|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144016|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
139144017|NCT02126332|Acetaminophen|acetaminophen|mesh-list
139144018|NCT02126332|Sufentanil|sufentanil|mesh-list
139144019|NCT02126332|Nefopam|nefopam|mesh-list
139144020|NCT02126332|Tramadol|tramadol|mesh-list
139144021|NCT02126332|Ropivacaine|ropivacaine|mesh-list
139144022|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
139144023|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
139144024|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144025|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144026|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
139144027|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144028|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139144029|NCT02126332|Analgesics|analgesics|mesh-ancestor
139144030|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
139144031|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139144032|NCT02126332|Narcotics|narcotics|mesh-ancestor
139144033|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139144034|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139144035|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
139144036|NCT02131246|Insulin|insulin|mesh-list
139144037|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139144038|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
139144039|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
138879197|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144040|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139144041|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139144042|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144044|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
139144045|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
139144046|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
139144048|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139144049|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144050|NCT03550534|Antacids|antacids|mesh-ancestor
139144051|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144052|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139144053|NCT02131480|Doxorubicin|doxorubicin|mesh-list
139144054|NCT02131480|Trabectedin|trabectedin|mesh-list
139144055|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139144056|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144057|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139144058|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139144059|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144060|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144061|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139144062|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
139144063|NCT02128906|Docetaxel|docetaxel|mesh-list
139144064|NCT02128906|Cetuximab|cetuximab|mesh-list
139144065|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144066|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
139144067|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
139144068|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
139144069|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144070|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139144071|NCT02128984|Antioxidants|antioxidants|mesh-list
139144072|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144073|NCT02128984|Protective Agents|protective agents|mesh-ancestor
139144074|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144075|NCT06149117|Azithromycin|azithromycin|mesh-list
139144076|NCT06149117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139144077|NCT06149117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144078|NCT06149091|Tranexamic Acid|tranexamic acid|mesh-list
139144079|NCT06149091|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139144080|NCT06149091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139144081|NCT06149091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144082|NCT06149091|Hemostatics|hemostatics|mesh-ancestor
139144083|NCT06149091|Coagulants|coagulants|mesh-ancestor
139144084|NCT06149078|Uric Acid|uric acid|mesh-list
139144085|NCT06149078|Antioxidants|antioxidants|mesh-ancestor
139144086|NCT06149078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144087|NCT06149078|Protective Agents|protective agents|mesh-ancestor
139144088|NCT06149078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144089|NCT06149065|Testosterone|testosterone|mesh-list
139144090|NCT06149065|Androgens|androgens|mesh-ancestor
139144091|NCT06149065|Hormones|hormones|mesh-ancestor
139144092|NCT06149065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144093|NCT06149065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144094|NCT06148792|Tafenoquine|tafenoquine|mesh-list
139144095|NCT06148792|Antimalarials|antimalarials|mesh-ancestor
139144096|NCT06148792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139144097|NCT06148792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139144098|NCT06148792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144099|NCT06148766|Propolis|propolis|mesh-list
139144100|NCT06148766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144101|NCT06148753|Propolis|propolis|mesh-list
139144102|NCT06148753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144103|NCT06148740|Propolis|propolis|mesh-list
139144104|NCT06148740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144105|NCT06148649|Dulaglutide|dulaglutide|mesh-list
139144107|NCT06148649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144108|NCT06148558|Sunscreening Agents|sunscreening agents|mesh-list
139144109|NCT06148558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139144110|NCT06148558|Protective Agents|protective agents|mesh-ancestor
139144111|NCT06148558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144112|NCT06148558|Dermatologic Agents|dermatologic agents|mesh-ancestor
139144113|NCT06148545|Vitamin D|vitamin d|mesh-list
139144115|NCT06148545|Vitamins|vitamins|mesh-ancestor
139144116|NCT06148545|Micronutrients|micronutrients|mesh-ancestor
139144117|NCT06148545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144118|NCT06148545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139144119|NCT06148545|Trace Elements|trace elements|mesh-ancestor
139144120|NCT06148402|Capecitabine|capecitabine|mesh-list
139144121|NCT06148402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139144122|NCT06148402|Antimetabolites|antimetabolites|mesh-ancestor
139144123|NCT06148402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144124|NCT06148402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144125|NCT06148311|Dexmedetomidine|dexmedetomidine|mesh-list
139144126|NCT06148311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139144127|NCT06148311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086253|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144128|NCT06148311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144129|NCT06148311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139144130|NCT06148311|Analgesics|analgesics|mesh-ancestor
139144131|NCT06148311|Sensory System Agents|sensory system agents|mesh-ancestor
139144132|NCT06148311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144133|NCT06148311|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139144134|NCT06148311|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139144135|NCT06148311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139144136|NCT06148311|Adrenergic Agents|adrenergic agents|mesh-ancestor
139144137|NCT06148311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144138|NCT06148311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144139|NCT06148259|Chrysarobin|chrysarobin|mesh-list
139144140|NCT06148259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139144141|NCT06148259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139144142|NCT06148259|Analgesics|analgesics|mesh-ancestor
139144143|NCT06148259|Sensory System Agents|sensory system agents|mesh-ancestor
139144144|NCT06148259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144145|NCT06148259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144146|NCT06148259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139144147|NCT06148259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139144148|NCT06148168|Bupivacaine|bupivacaine|mesh-list
139144149|NCT06148168|Anesthetics, Local|anesthetics, local|mesh-ancestor
139144150|NCT06148168|Anesthetics|anesthetics|mesh-ancestor
139144151|NCT06148168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144152|NCT06148168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144153|NCT06148168|Sensory System Agents|sensory system agents|mesh-ancestor
139144154|NCT06148168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144155|NCT06148103|Fentanyl|fentanyl|mesh-list
139144157|NCT06148103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139144158|NCT06148103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144159|NCT06148103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144160|NCT06148103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139144161|NCT06148103|Anesthetics, General|anesthetics, general|mesh-ancestor
139144162|NCT06148103|Anesthetics|anesthetics|mesh-ancestor
139144163|NCT06148103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139144164|NCT06148103|Narcotics|narcotics|mesh-ancestor
139144165|NCT06148103|Analgesics|analgesics|mesh-ancestor
139144166|NCT06148103|Sensory System Agents|sensory system agents|mesh-ancestor
139144167|NCT06148103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144168|NCT06148103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139144169|NCT06148025|Vancomycin|vancomycin|mesh-list
139144170|NCT06148025|Neomycin|neomycin|mesh-list
139144171|NCT06148025|Vaccines|vaccines|mesh-list
139144172|NCT06148025|BCG Vaccine|bcg vaccine|mesh-list
139144173|NCT06148025|Immunologic Factors|immunologic factors|mesh-ancestor
139144174|NCT06148025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144175|NCT06148025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139144176|NCT06148025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144177|NCT06148025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139144178|NCT06148025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139144179|NCT06148025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144180|NCT06148025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144181|NCT06146101|Acetazolamide|acetazolamide|mesh-list
139144182|NCT06146101|Dronabinol|dronabinol|mesh-list
139144183|NCT06146101|Anticonvulsants|anticonvulsants|mesh-ancestor
139144184|NCT06146101|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139144185|NCT06146101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144186|NCT06146101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144187|NCT06146101|Diuretics|diuretics|mesh-ancestor
139144188|NCT06146101|Natriuretic Agents|natriuretic agents|mesh-ancestor
139144189|NCT06146101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144190|NCT06146101|Hallucinogens|hallucinogens|mesh-ancestor
139144191|NCT06146101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139144192|NCT06146101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139144193|NCT06146101|Analgesics|analgesics|mesh-ancestor
139144194|NCT06146101|Sensory System Agents|sensory system agents|mesh-ancestor
139144195|NCT06146101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144196|NCT06146101|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139144197|NCT06146101|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139144198|NCT06146101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144199|NCT06146101|Hormones|hormones|mesh-ancestor
139144200|NCT06146101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144201|NCT06145945|Ropivacaine|ropivacaine|mesh-list
139144202|NCT06145945|Anesthetics, Local|anesthetics, local|mesh-ancestor
139144203|NCT06145945|Anesthetics|anesthetics|mesh-ancestor
139144204|NCT06145945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144205|NCT06145945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144206|NCT06145945|Sensory System Agents|sensory system agents|mesh-ancestor
139144207|NCT06145945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144208|NCT06144866|Rivaroxaban|rivaroxaban|mesh-list
139144209|NCT06144866|Apixaban|apixaban|mesh-list
139144210|NCT06144866|Edoxaban|edoxaban|mesh-list
139144211|NCT06144866|Dabigatran|dabigatran|mesh-list
139144212|NCT06144866|Anticoagulants|anticoagulants|mesh-list
139144213|NCT06144866|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138879252|NCT04855513|Metformin|metformin|mesh-list
139144214|NCT06144866|Antithrombins|antithrombins|mesh-ancestor
139144215|NCT06144866|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139144216|NCT06144866|Protease Inhibitors|protease inhibitors|mesh-ancestor
139144217|NCT06144866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144218|NCT06144866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144219|NCT06136728|4-Aminopyridine|4-aminopyridine|mesh-list
139144220|NCT06136728|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139144221|NCT06136728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139144222|NCT06136728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144224|NCT06134284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139144225|NCT06134284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144226|NCT06134284|Immunologic Factors|immunologic factors|mesh-ancestor
139144227|NCT06134284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144228|NCT06134284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139144229|NCT06130527|Nicardipine|nicardipine|mesh-list
139144230|NCT06130527|Remifentanil|remifentanil|mesh-list
139144231|NCT06130527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139144232|NCT06130527|Narcotics|narcotics|mesh-ancestor
139144233|NCT06130527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144234|NCT06130527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144235|NCT06130527|Analgesics|analgesics|mesh-ancestor
139144236|NCT06130527|Sensory System Agents|sensory system agents|mesh-ancestor
139144237|NCT06130527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144238|NCT06130527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139144239|NCT06130527|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139144240|NCT06130527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139144241|NCT06130527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144242|NCT06130527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139144243|NCT06130527|Vasodilator Agents|vasodilator agents|mesh-ancestor
139144244|NCT06119490|Methylprednisolone|methylprednisolone|mesh-list
139144245|NCT06119490|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139144246|NCT06119490|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139144247|NCT06119490|Prednisolone|prednisolone|mesh-list
139144248|NCT06119490|Prednisolone acetate|prednisolone acetate|mesh-list
139144249|NCT06119490|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139144250|NCT06119490|Prednisolone phosphate|prednisolone phosphate|mesh-list
139144251|NCT06119490|Tofacitinib|tofacitinib|mesh-list
139144252|NCT06119490|Abrocitinib|abrocitinib|mesh-list
139144253|NCT06119490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139144254|NCT06119490|Antiemetics|antiemetics|mesh-ancestor
139144255|NCT06119490|Autonomic Agents|autonomic agents|mesh-ancestor
139144256|NCT06119490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144257|NCT06119490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144258|NCT06119490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139144259|NCT06119490|Glucocorticoids|glucocorticoids|mesh-ancestor
139144260|NCT06119490|Hormones|hormones|mesh-ancestor
139144261|NCT06119490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144262|NCT06119490|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139144263|NCT06119490|Protective Agents|protective agents|mesh-ancestor
139144264|NCT06119490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139144265|NCT06119490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144266|NCT06119490|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139144267|NCT06119490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139144268|NCT06119490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923151|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139144269|NCT06119490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144270|NCT06116201|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139144271|NCT06116201|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139144272|NCT06116201|Estradiol|estradiol|mesh-list
139144273|NCT06116201|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139144274|NCT06116201|Androgens|androgens|mesh-list
139144275|NCT06116201|Androgen Antagonists|androgen antagonists|mesh-list
139144276|NCT06116201|Estrogens|estrogens|mesh-ancestor
139144277|NCT06116201|Hormones|hormones|mesh-ancestor
139144278|NCT06116201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144279|NCT06116201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144280|NCT06116201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139144282|NCT06116201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139144283|NCT06116201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139144284|NCT06116201|Hormone Antagonists|hormone antagonists|mesh-ancestor
139144285|NCT06115538|Levodopa|levodopa|mesh-list
139144286|NCT06115538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139144287|NCT06115538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139144288|NCT06115538|Dopamine Agents|dopamine agents|mesh-ancestor
139144289|NCT06115538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144290|NCT06115538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144291|NCT06115538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144292|NCT06102915|Bromides|bromides|mesh-list
139144293|NCT06102915|Rocuronium|rocuronium|mesh-list
139144294|NCT06102915|Atracurium|atracurium|mesh-list
139144295|NCT06102915|Cisatracurium|cisatracurium|mesh-list
139144296|NCT06102915|Anticonvulsants|anticonvulsants|mesh-ancestor
139144297|NCT06102915|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139144298|NCT06102915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139144299|NCT06102915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139144300|NCT06102915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144301|NCT06102915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144302|NCT06102915|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139144303|NCT06102915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139144304|NCT06102915|Cholinergic Agents|cholinergic agents|mesh-ancestor
139144305|NCT06102915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144306|NCT06102915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144307|NCT06084754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139144308|NCT06084754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144309|NCT06077786|Ibuprofen|ibuprofen|mesh-list
139144310|NCT06077786|Pregabalin|pregabalin|mesh-list
139144311|NCT06077786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139144312|NCT06077786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139144313|NCT06077786|Analgesics|analgesics|mesh-ancestor
139144314|NCT06077786|Sensory System Agents|sensory system agents|mesh-ancestor
139144315|NCT06077786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144316|NCT06077786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144317|NCT06077786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139144318|NCT06077786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139144319|NCT06077786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139144320|NCT06077786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144321|NCT06077786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144322|NCT06077786|Anticonvulsants|anticonvulsants|mesh-ancestor
139144323|NCT06077786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139144324|NCT06077786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139144325|NCT06077786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139144326|NCT06077786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139144327|NCT06077786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139144328|NCT06077786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144329|NCT06077786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139144331|NCT06065176|Immunologic Factors|immunologic factors|mesh-ancestor
139144332|NCT06065176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144333|NCT06056583|Cimetidine|cimetidine|mesh-list
139144334|NCT06056583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139144335|NCT06056583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139144336|NCT06056583|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139144337|NCT06056583|Histamine Antagonists|histamine antagonists|mesh-ancestor
139144338|NCT06056583|Histamine Agents|histamine agents|mesh-ancestor
139144339|NCT06056583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144340|NCT06056583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144341|NCT06056583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144342|NCT06056583|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139144343|NCT06056583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139144344|NCT06056583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144345|NCT06043414|Triclosan|triclosan|mesh-list
139144346|NCT06043414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139144347|NCT06043414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144348|NCT06043414|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139144349|NCT06043414|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139144350|NCT06043414|Antimetabolites|antimetabolites|mesh-ancestor
139144351|NCT06043414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144352|NCT06043414|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139144353|NCT06042855|Metformin|metformin|mesh-list
139144354|NCT06042855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139144355|NCT06042855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144356|NCT06041438|Itraconazole|itraconazole|mesh-list
139144357|NCT06041438|Antifungal Agents|antifungal agents|mesh-ancestor
139144358|NCT06041438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144359|NCT06041438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139144360|NCT06041438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139144361|NCT06041438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144362|NCT06041438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144363|NCT06041438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139144364|NCT06041438|Hormone Antagonists|hormone antagonists|mesh-ancestor
139144365|NCT06041438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144366|NCT06041438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144367|NCT06041438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139144368|NCT06022302|Laxatives|laxatives|mesh-list
139144369|NCT06022302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139144370|NCT06015516|Minoxidil|minoxidil|mesh-list
139144371|NCT06015516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139144372|NCT06015516|Vasodilator Agents|vasodilator agents|mesh-ancestor
139144373|NCT06014801|Dialysis Solutions|dialysis solutions|mesh-list
139144374|NCT06014801|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139144375|NCT06013345|Propofol|propofol|mesh-list
139144376|NCT06013345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139144377|NCT06013345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144378|NCT06013345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144379|NCT06013345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139144380|NCT06013345|Anesthetics, General|anesthetics, general|mesh-ancestor
139144381|NCT06013345|Anesthetics|anesthetics|mesh-ancestor
139144382|NCT05999604|Ocrelizumab|ocrelizumab|mesh-list
139144383|NCT05999604|Immunologic Factors|immunologic factors|mesh-ancestor
139144384|NCT05999604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144385|NCT05986773|Metolazone|metolazone|mesh-list
139144386|NCT05986773|Furosemide|furosemide|mesh-list
139144387|NCT05986773|Acetazolamide|acetazolamide|mesh-list
139144388|NCT05986773|Diuretics|diuretics|mesh-ancestor
139144389|NCT05986773|Natriuretic Agents|natriuretic agents|mesh-ancestor
139144390|NCT05986773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894920|NCT00694096|Sunitinib|sunitinib|mesh-list
139144391|NCT05986773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139144392|NCT05986773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139144408|NCT05962424|Analgesics|analgesics|mesh-ancestor
139144409|NCT05962424|Sensory System Agents|sensory system agents|mesh-ancestor
139144410|NCT05962424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144411|NCT05962424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144412|NCT05962424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139144413|NCT05962424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139144414|NCT05962424|Anesthetics, General|anesthetics, general|mesh-ancestor
139144415|NCT05962424|Anesthetics|anesthetics|mesh-ancestor
139144416|NCT05962424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144417|NCT05962424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139144418|NCT05962424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139144419|NCT05962424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144420|NCT05962424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144422|NCT05934409|Nicotinic Acids|nicotinic acids|mesh-list
139144423|NCT05934409|Niacinamide|niacinamide|mesh-list
139144424|NCT05934409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139144425|NCT05934409|Antimetabolites|antimetabolites|mesh-ancestor
139144426|NCT05934409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144427|NCT05934409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139144428|NCT05934409|Vasodilator Agents|vasodilator agents|mesh-ancestor
139144429|NCT05934409|Vitamin B Complex|vitamin b complex|mesh-ancestor
139144430|NCT05934409|Vitamins|vitamins|mesh-ancestor
139144431|NCT05934409|Micronutrients|micronutrients|mesh-ancestor
139144432|NCT05934409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144433|NCT05857384|Acetazolamide|acetazolamide|mesh-list
139144434|NCT05857384|Dronabinol|dronabinol|mesh-list
139144435|NCT05857384|Anticonvulsants|anticonvulsants|mesh-ancestor
139144436|NCT05857384|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139144437|NCT05857384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144438|NCT05857384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144439|NCT05857384|Diuretics|diuretics|mesh-ancestor
139144440|NCT05857384|Natriuretic Agents|natriuretic agents|mesh-ancestor
139144441|NCT05857384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144442|NCT05857384|Hallucinogens|hallucinogens|mesh-ancestor
139144443|NCT05857384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139144444|NCT05857384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139144445|NCT05857384|Analgesics|analgesics|mesh-ancestor
139144446|NCT05857384|Sensory System Agents|sensory system agents|mesh-ancestor
139144447|NCT05857384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144448|NCT05857384|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139144449|NCT05857384|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139144450|NCT05857384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144451|NCT05857384|Hormones|hormones|mesh-ancestor
139144452|NCT05857384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144453|NCT05830136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139144454|NCT05824559|Bevacizumab|bevacizumab|mesh-list
139144455|NCT05824559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139144456|NCT05824559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144457|NCT05824559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139144458|NCT05824559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139144459|NCT05824559|Growth Substances|growth substances|mesh-ancestor
139144460|NCT05824559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144461|NCT05824559|Growth Inhibitors|growth inhibitors|mesh-ancestor
139144462|NCT05774691|Heparin|heparin|mesh-list
139144463|NCT05774691|Calcium heparin|calcium heparin|mesh-list
139144464|NCT05774691|Protamines|protamines|mesh-list
139144465|NCT05774691|Anticoagulants|anticoagulants|mesh-ancestor
139144466|NCT05774691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139144467|NCT05774691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139144468|NCT05774691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144469|NCT05774691|Heparin Antagonists|heparin antagonists|mesh-ancestor
139144470|NCT05774691|Coagulants|coagulants|mesh-ancestor
139144471|NCT05766670|Vancomycin|vancomycin|mesh-list
139144472|NCT05766670|Gentamicins|gentamicins|mesh-list
139144473|NCT05766670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139144474|NCT05766670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144475|NCT05766670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139144476|NCT05766670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144477|NCT05766670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144478|NCT05754996|Nifuroxazide|nifuroxazide|mesh-list
139144479|NCT05754996|Lactulose|lactulose|mesh-list
139144480|NCT05754996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139144481|NCT05754996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144482|NCT05700344|Avelumab|avelumab|mesh-list
139144483|NCT05700344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139144484|NCT05700344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144485|NCT05695508|Dexamethasone|dexamethasone|mesh-list
139144486|NCT05695508|Lenalidomide|lenalidomide|mesh-list
139144487|NCT05695508|Bortezomib|bortezomib|mesh-list
139144488|NCT05695508|Daratumumab|daratumumab|mesh-list
139144489|NCT05695508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139144490|NCT05695508|Antiemetics|antiemetics|mesh-ancestor
139144491|NCT05695508|Autonomic Agents|autonomic agents|mesh-ancestor
139144492|NCT05695508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144493|NCT05695508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144494|NCT05695508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139144495|NCT05695508|Glucocorticoids|glucocorticoids|mesh-ancestor
139144496|NCT05695508|Hormones|hormones|mesh-ancestor
139144497|NCT05695508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144498|NCT05695508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139144499|NCT05695508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144500|NCT05695508|Immunologic Factors|immunologic factors|mesh-ancestor
139144501|NCT05695508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139144502|NCT05695508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139144503|NCT05695508|Growth Substances|growth substances|mesh-ancestor
139144504|NCT05695508|Growth Inhibitors|growth inhibitors|mesh-ancestor
139144505|NCT05672524|Trastuzumab|trastuzumab|mesh-list
139144506|NCT05672524|Tucatinib|tucatinib|mesh-list
139144507|NCT05672524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139144508|NCT05672524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144509|NCT05672524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139144510|NCT05672524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144511|NCT05672524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144512|NCT05665140|Dexamethasone|dexamethasone|mesh-list
139144513|NCT05665140|Lenalidomide|lenalidomide|mesh-list
139144514|NCT05665140|Bortezomib|bortezomib|mesh-list
139144515|NCT05665140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139144516|NCT05665140|Antiemetics|antiemetics|mesh-ancestor
139144517|NCT05665140|Autonomic Agents|autonomic agents|mesh-ancestor
139144518|NCT05665140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144519|NCT05665140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144520|NCT05665140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139144521|NCT05665140|Glucocorticoids|glucocorticoids|mesh-ancestor
139144522|NCT05665140|Hormones|hormones|mesh-ancestor
139144523|NCT05665140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144524|NCT05665140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139144525|NCT05665140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144526|NCT05665140|Immunologic Factors|immunologic factors|mesh-ancestor
139144527|NCT05665140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139144528|NCT05665140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139144529|NCT05665140|Growth Substances|growth substances|mesh-ancestor
139144530|NCT05665140|Growth Inhibitors|growth inhibitors|mesh-ancestor
139144531|NCT05656170|Bupivacaine|bupivacaine|mesh-list
139144532|NCT05656170|Anesthetics, Local|anesthetics, local|mesh-ancestor
139144534|NCT05656170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144535|NCT05656170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144536|NCT05656170|Sensory System Agents|sensory system agents|mesh-ancestor
139144537|NCT05656170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144538|NCT05619328|Vitamins|vitamins|mesh-list
139144539|NCT05619328|Vitamin B Complex|vitamin b complex|mesh-list
139144540|NCT05619328|Micronutrients|micronutrients|mesh-ancestor
139144541|NCT05619328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144542|NCT05589766|Niacinamide|niacinamide|mesh-list
139144543|NCT05589766|Niacin|niacin|mesh-list
139144544|NCT05589766|Nicotinic Acids|nicotinic acids|mesh-list
139144545|NCT05589766|Vitamin B Complex|vitamin b complex|mesh-ancestor
139144546|NCT05589766|Vitamins|vitamins|mesh-ancestor
139144547|NCT05589766|Micronutrients|micronutrients|mesh-ancestor
139144548|NCT05589766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144549|NCT05589766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139144550|NCT05589766|Antimetabolites|antimetabolites|mesh-ancestor
139144551|NCT05589766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144552|NCT05589766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139144553|NCT05589766|Vasodilator Agents|vasodilator agents|mesh-ancestor
139144554|NCT05587374|Gemcitabine|gemcitabine|mesh-list
139144555|NCT05587374|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139144556|NCT05587374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144557|NCT05587374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139144558|NCT05587374|Antimetabolites|antimetabolites|mesh-ancestor
139144559|NCT05587374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144560|NCT05587374|Immunologic Factors|immunologic factors|mesh-ancestor
139144561|NCT05587374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144562|NCT05583175|Venetoclax|venetoclax|mesh-list
139144563|NCT05583175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144564|NCT05567952|Ritonavir|ritonavir|mesh-list
139144565|NCT05567952|Nirmatrelvir|nirmatrelvir|mesh-list
139144566|NCT05567952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139144567|NCT05567952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139144568|NCT05567952|Protease Inhibitors|protease inhibitors|mesh-ancestor
139144569|NCT05567952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144570|NCT05567952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144571|NCT05567952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139144572|NCT05567952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139144573|NCT05567952|Antiviral Agents|antiviral agents|mesh-ancestor
139144574|NCT05567952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144575|NCT05567952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139144576|NCT05567952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139144577|NCT05553184|Niacin|niacin|mesh-list
139144578|NCT05553184|Nicotinic Acids|nicotinic acids|mesh-list
139144579|NCT05553184|Niacinamide|niacinamide|mesh-list
139144580|NCT05553184|Formoterol Fumarate|formoterol fumarate|mesh-list
139144581|NCT05553184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139144582|NCT05553184|Autonomic Agents|autonomic agents|mesh-ancestor
139144583|NCT05553184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144584|NCT05553184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144585|NCT05553184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139144586|NCT05553184|Respiratory System Agents|respiratory system agents|mesh-ancestor
139144587|NCT05553184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139144588|NCT05553184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139144589|NCT05553184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139144590|NCT05553184|Adrenergic Agents|adrenergic agents|mesh-ancestor
139144591|NCT05553184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144592|NCT05553184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144593|NCT05553184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139144594|NCT05553184|Antimetabolites|antimetabolites|mesh-ancestor
139144595|NCT05553184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139144596|NCT05553184|Vasodilator Agents|vasodilator agents|mesh-ancestor
139144597|NCT05553184|Vitamin B Complex|vitamin b complex|mesh-ancestor
139144599|NCT05553184|Micronutrients|micronutrients|mesh-ancestor
139144600|NCT05544929|Tislelizumab|tislelizumab|mesh-list
139144601|NCT05544929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139144602|NCT05544929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144603|NCT05544721|Ropivacaine|ropivacaine|mesh-list
139144604|NCT05544721|Anesthetics, Local|anesthetics, local|mesh-ancestor
139144605|NCT05544721|Anesthetics|anesthetics|mesh-ancestor
139144606|NCT05544721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144607|NCT05544721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144608|NCT05544721|Sensory System Agents|sensory system agents|mesh-ancestor
139144609|NCT05544721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144610|NCT05523661|Dasatinib|dasatinib|mesh-list
139144611|NCT05523661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144612|NCT05523661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139144613|NCT05523661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144614|NCT05523661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144615|NCT05514899|Dronabinol|dronabinol|mesh-list
139144616|NCT05514899|Cannabidiol|cannabidiol|mesh-list
139144617|NCT05514899|Anticonvulsants|anticonvulsants|mesh-ancestor
139144618|NCT05514899|Hallucinogens|hallucinogens|mesh-ancestor
139144619|NCT05514899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144620|NCT05514899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139144621|NCT05514899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139144622|NCT05514899|Analgesics|analgesics|mesh-ancestor
139144623|NCT05514899|Sensory System Agents|sensory system agents|mesh-ancestor
139144624|NCT05514899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144625|NCT05514899|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139144626|NCT05514899|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139144627|NCT05514899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144628|NCT05514899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144630|NCT05514899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144631|NCT05503030|Nintedanib|nintedanib|mesh-list
139144632|NCT05503030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144633|NCT05503030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139144634|NCT05503030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144635|NCT05503030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144636|NCT05487807|Nicotine|nicotine|mesh-list
139144637|NCT05487807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139144638|NCT05487807|Autonomic Agents|autonomic agents|mesh-ancestor
139144639|NCT05487807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144640|NCT05487807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144641|NCT05487807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139144642|NCT05487807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139144643|NCT05487807|Cholinergic Agents|cholinergic agents|mesh-ancestor
139144644|NCT05487807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144645|NCT05487807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144646|NCT05443035|Anti-Infective Agents|anti-infective agents|mesh-list
139144647|NCT05443035|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139144648|NCT05440942|Trametinib|trametinib|mesh-list
139144649|NCT05440942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144650|NCT05440942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139144651|NCT05440942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144652|NCT05440942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144653|NCT05437575|Fentanyl|fentanyl|mesh-list
139144654|NCT05437575|Ketamine|ketamine|mesh-list
139144655|NCT05437575|Analgesics|analgesics|mesh-ancestor
139144656|NCT05437575|Sensory System Agents|sensory system agents|mesh-ancestor
139144657|NCT05437575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144658|NCT05437575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144659|NCT05437575|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139144660|NCT05437575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139144661|NCT05437575|Anesthetics, General|anesthetics, general|mesh-ancestor
139144662|NCT05437575|Anesthetics|anesthetics|mesh-ancestor
139144663|NCT05437575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144664|NCT05437575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139144665|NCT05437575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139144666|NCT05437575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144667|NCT05437575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144668|NCT05437575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139144669|NCT05437575|Narcotics|narcotics|mesh-ancestor
139144670|NCT05437575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139144671|NCT05418556|Aspirin|aspirin|mesh-list
139144672|NCT05418556|Clopidogrel|clopidogrel|mesh-list
139144673|NCT05418556|Ticagrelor|ticagrelor|mesh-list
139144674|NCT05418556|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139144675|NCT05418556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139144676|NCT05418556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139144677|NCT05418556|Analgesics|analgesics|mesh-ancestor
139144678|NCT05418556|Sensory System Agents|sensory system agents|mesh-ancestor
139144683|NCT05418556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139144684|NCT05418556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139144685|NCT05418556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144686|NCT05418556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139144687|NCT05418556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139144688|NCT05418556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144689|NCT05418556|Antipyretics|antipyretics|mesh-ancestor
139144690|NCT05418556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139144691|NCT05418556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139144692|NCT05418556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139144693|NCT05418556|Purinergic Agents|purinergic agents|mesh-ancestor
139144694|NCT05418556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144699|NCT05399602|Anesthetics|anesthetics|mesh-list
139144700|NCT05399602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144701|NCT05399602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144702|NCT05393817|Caffeine|caffeine|mesh-list
139144703|NCT05393817|Caffeine citrate|caffeine citrate|mesh-list
139144704|NCT05393817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144705|NCT05393817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139144706|NCT05393817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144707|NCT05393817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139144708|NCT05393817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144709|NCT05393817|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139144710|NCT05393817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139144711|NCT05393817|Purinergic Agents|purinergic agents|mesh-ancestor
139144712|NCT05393817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144713|NCT05363514|Naltrexone|naltrexone|mesh-list
139144714|NCT05363514|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139144715|NCT05363514|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139144716|NCT05363514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144717|NCT05363514|Sensory System Agents|sensory system agents|mesh-ancestor
139144718|NCT05363514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144719|NCT05363462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139144720|NCT05363462|Vancomycin|vancomycin|mesh-list
139144721|NCT05363462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144722|NCT05345249|Ropivacaine|ropivacaine|mesh-list
139144723|NCT05345249|Anesthetics, Local|anesthetics, local|mesh-ancestor
139144724|NCT05345249|Anesthetics|anesthetics|mesh-ancestor
139144725|NCT05345249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144726|NCT05345249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144727|NCT05345249|Sensory System Agents|sensory system agents|mesh-ancestor
139144728|NCT05345249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144729|NCT05303532|Durvalumab|durvalumab|mesh-list
139144730|NCT05303532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139144731|NCT05303532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144732|NCT05287321|Hydroxychloroquine|hydroxychloroquine|mesh-list
139144733|NCT05287321|Antimalarials|antimalarials|mesh-ancestor
139144734|NCT05287321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138879481|NCT04072198|Antidotes|antidotes|mesh-ancestor
139144735|NCT05287321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139144736|NCT05287321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144737|NCT05287321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144738|NCT05287321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144739|NCT05287321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139144741|NCT05284812|Immunologic Factors|immunologic factors|mesh-ancestor
139144742|NCT05284812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144743|NCT05283382|Cannabidiol|cannabidiol|mesh-list
139144744|NCT05283382|Anticonvulsants|anticonvulsants|mesh-ancestor
139144745|NCT05263388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139144746|NCT05263388|Hormones|hormones|mesh-ancestor
139144747|NCT05263388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144748|NCT05263388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144749|NCT05262335|Paclitaxel|paclitaxel|mesh-list
139144750|NCT05262335|Docetaxel|docetaxel|mesh-list
139144751|NCT05262335|Capecitabine|capecitabine|mesh-list
139144752|NCT05262335|Oxaliplatin|oxaliplatin|mesh-list
139086418|NCT00316589|Antiviral Agents|antiviral agents|mesh-ancestor
139144753|NCT05262335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139144754|NCT05262335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144755|NCT05262335|Tubulin Modulators|tubulin modulators|mesh-ancestor
139144756|NCT05262335|Antimitotic Agents|antimitotic agents|mesh-ancestor
139144757|NCT05262335|Mitosis Modulators|mitosis modulators|mesh-ancestor
139144758|NCT05262335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144759|NCT05262335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139144760|NCT05262335|Antimetabolites|antimetabolites|mesh-ancestor
139144761|NCT05249426|Cetuximab|cetuximab|mesh-list
139144762|NCT05249426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139144763|NCT05249426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144764|NCT05204927|Prednisone|prednisone|mesh-list
139144765|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139144766|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
139144767|NCT05204927|Hormones|hormones|mesh-ancestor
139144768|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144769|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144770|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139144771|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144772|NCT05185024|Iron|iron|mesh-list
139144773|NCT05185024|Trace Elements|trace elements|mesh-ancestor
139144774|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
139144775|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144776|NCT05092945|Niacin|niacin|mesh-list
139144777|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
139144778|NCT05092945|Niacinamide|niacinamide|mesh-list
139144779|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139144780|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
138515109|NCT00391313|Chloroquine|chloroquine|mesh-list
138879500|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
139144782|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139144783|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
139144784|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
139144786|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
139144787|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144788|NCT05088889|Nivolumab|nivolumab|mesh-list
139144789|NCT05088889|Ipilimumab|ipilimumab|mesh-list
139144790|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139144791|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144792|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139144793|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144794|NCT05065567|Droperidol|droperidol|mesh-list
139144795|NCT05065567|Haloperidol|haloperidol|mesh-list
139144796|NCT05065567|Ondansetron|ondansetron|mesh-list
139144797|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
139144798|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
139144799|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
139144800|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144801|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144802|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139144803|NCT05065567|Antipruritics|antipruritics|mesh-ancestor
139144804|NCT05065567|Dermatologic Agents|dermatologic agents|mesh-ancestor
139144805|NCT05065567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139144806|NCT05065567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139144807|NCT05065567|Serotonin Agents|serotonin agents|mesh-ancestor
139144808|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144809|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144810|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139144811|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139144812|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144813|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139144814|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139144815|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
139144816|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139144817|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139144818|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139144819|NCT05060731|Iron|iron|mesh-list
139144820|NCT05060731|Trace Elements|trace elements|mesh-ancestor
139144821|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
139144822|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144823|NCT04989335|Fludarabine|fludarabine|mesh-list
139144824|NCT04989335|Clofarabine|clofarabine|mesh-list
139144825|NCT04989335|Bisantrene|bisantrene|mesh-list
139144826|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144827|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139144828|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
139144829|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144830|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139144831|NCT04986631|Topiramate|topiramate|mesh-list
139144832|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
139144833|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139144834|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144864|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144865|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
139144866|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139144867|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144868|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139144869|NCT04904536|Atorvastatin|atorvastatin|mesh-list
139144870|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139144871|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139144872|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
139144873|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144874|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139144875|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139144876|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144877|NCT04895280|Triamcinolone|triamcinolone|mesh-list
139144878|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139144879|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139144880|NCT04895280|Ketorolac|ketorolac|mesh-list
139144881|NCT04895280|Bupivacaine|bupivacaine|mesh-list
139144882|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139144883|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
139144884|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
139144885|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144886|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144887|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
139144888|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144889|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139144890|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
139144891|NCT04895280|Hormones|hormones|mesh-ancestor
138282056|NCT04738045|Lopinavir|lopinavir|mesh-list
139144892|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144893|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139144894|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
139144895|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879554|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
139144896|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144897|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139144898|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139144899|NCT04895280|Analgesics|analgesics|mesh-ancestor
139144900|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139144901|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139144902|NCT04880707|Anesthetics|anesthetics|mesh-list
139144903|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
139144904|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144905|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144906|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
139144907|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144908|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139144909|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
139144910|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144911|NCT04854551|Naltrexone|naltrexone|mesh-list
139144912|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139144913|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139144914|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144915|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
139144916|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139144917|NCT04817254|Nivolumab|nivolumab|mesh-list
139144918|NCT04817254|Ipilimumab|ipilimumab|mesh-list
139144919|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139144920|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144921|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139144922|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144923|NCT04802746|Alprazolam|alprazolam|mesh-list
139144924|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139144925|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139144926|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144927|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139144928|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139144929|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139144932|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144933|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144934|NCT04800822|Cetuximab|cetuximab|mesh-list
139144935|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139144936|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144937|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139144938|NCT04773353|Hormones|hormones|mesh-ancestor
139144939|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139144940|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144941|NCT04757636|Aflibercept|aflibercept|mesh-list
139144942|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139144943|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139144944|NCT04757636|Growth Substances|growth substances|mesh-ancestor
139144945|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144946|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
139144947|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144948|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
139144949|NCT04757363|Nivolumab|nivolumab|mesh-list
139144950|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144951|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139144952|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139144953|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144954|NCT04746183|Ritonavir|ritonavir|mesh-list
139144955|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
139144956|NCT04746183|Favipiravir|favipiravir|mesh-list
139144957|NCT04746183|Nirmatrelvir|nirmatrelvir|mesh-list
139144958|NCT04746183|Sotrovimab|sotrovimab|mesh-list
139144959|NCT04746183|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139144960|NCT04746183|Molnupiravir|molnupiravir|mesh-list
139144961|NCT04746183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139144962|NCT04746183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139144963|NCT04746183|Protease Inhibitors|protease inhibitors|mesh-ancestor
139144964|NCT04746183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139144965|NCT04746183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144966|NCT04746183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139144967|NCT04746183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139144968|NCT04746183|Antiviral Agents|antiviral agents|mesh-ancestor
139144969|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139144970|NCT04746183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139144971|NCT04746183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139144972|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139144973|NCT04718220|Antibodies|antibodies|mesh-list
139144974|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
139144975|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144976|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
139144977|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
139144978|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
139144979|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139144980|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
139144981|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
139144982|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139144983|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144984|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139144985|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139144986|NCT04685616|Doxorubicin|doxorubicin|mesh-list
139144987|NCT04685616|Bleomycin|bleomycin|mesh-list
139144988|NCT04685616|Dacarbazine|dacarbazine|mesh-list
139144989|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139144990|NCT04685616|Vinblastine|vinblastine|mesh-list
139144991|NCT04685616|Mitogens|mitogens|mesh-list
139144992|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139144993|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139144994|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139144995|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139144996|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895511|NCT00621491|Anticoagulants|anticoagulants|mesh-list
139144997|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139144998|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
139144999|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139145000|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
139145001|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145002|NCT04685616|Immunotoxins|immunotoxins|mesh-ancestor
139145003|NCT04685616|Immunoconjugates|immunoconjugates|mesh-ancestor
139145004|NCT04685616|Immunologic Factors|immunologic factors|mesh-ancestor
139145005|NCT04685616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145006|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139145007|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
139145008|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
139145009|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139145010|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139145011|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139145012|NCT04681417|Carboplatin|carboplatin|mesh-list
139145013|NCT04681417|Etoposide|etoposide|mesh-list
139145014|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
139145015|NCT04681417|Vincristine|vincristine|mesh-list
139145016|NCT04681417|Melphalan|melphalan|mesh-list
139145017|NCT04681417|Topotecan|topotecan|mesh-list
139145018|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145019|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139145020|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139145021|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139145022|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145023|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145024|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
138879574|NCT00988897|Leucovorin|leucovorin|mesh-list
139145025|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
139145026|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
139145027|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139145028|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
139145029|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139145030|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145031|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
139145032|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145033|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139145034|NCT04676958|Vitamin K|vitamin k|mesh-list
139145035|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
139145036|NCT04676958|Vitamins|vitamins|mesh-ancestor
139145037|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
139145038|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145039|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139145040|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139145041|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145042|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
139145043|NCT04676958|Coagulants|coagulants|mesh-ancestor
139145044|NCT04672941|Bromides|bromides|mesh-list
139145045|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
139145046|NCT04672941|Olodaterol|olodaterol|mesh-list
139145047|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139145048|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
139145049|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145050|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145051|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139145052|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
139145053|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
139145054|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139145055|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
139145056|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139145057|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145058|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
139145059|NCT04670679|Pembrolizumab|pembrolizumab|mesh-list
139145060|NCT04670679|Cetuximab|cetuximab|mesh-list
139145061|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145062|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145063|NCT04670679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139145064|NCT04670679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145065|NCT04650841|Naloxone|naloxone|mesh-list
139145066|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139145067|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145068|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
139145069|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145070|NCT04599972|Pilocarpine|pilocarpine|mesh-list
139145071|NCT04599972|Miotics|miotics|mesh-ancestor
139145072|NCT04599972|Autonomic Agents|autonomic agents|mesh-ancestor
139145073|NCT04599972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145074|NCT04599972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895588|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
139145075|NCT04599972|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139145076|NCT04599972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139145077|NCT04599972|Cholinergic Agents|cholinergic agents|mesh-ancestor
139145078|NCT04599972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139145079|NCT04599972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145081|NCT04599933|Miotics|miotics|mesh-ancestor
139145082|NCT04599933|Autonomic Agents|autonomic agents|mesh-ancestor
138879589|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
139145085|NCT04599933|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139145086|NCT04599933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139145087|NCT04599933|Cholinergic Agents|cholinergic agents|mesh-ancestor
139145088|NCT04599933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019563|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139145089|NCT04599933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145090|NCT04570475|Vitamin D|vitamin d|mesh-list
139145091|NCT04570475|Vitamins|vitamins|mesh-ancestor
139145092|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
139145093|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145094|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139145095|NCT04558918|Eculizumab|eculizumab|mesh-list
139145096|NCT04558918|Ravulizumab|ravulizumab|mesh-list
139145097|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139145098|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145099|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
139145100|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145104|NCT04501939|Venetoclax|venetoclax|mesh-list
139145105|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145106|NCT04491136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139145107|NCT04491136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139145108|NCT04491136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145109|NCT04439110|Trastuzumab|trastuzumab|mesh-list
139145110|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139145111|NCT04439110|Maytansine|maytansine|mesh-list
139145112|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
139145113|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145114|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145115|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139145116|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
139145117|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
139145118|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
139145119|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145120|NCT04439110|Immunotoxins|immunotoxins|mesh-ancestor
139145121|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
139145122|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145123|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
139145124|NCT04422184|Diuretics|diuretics|mesh-ancestor
139145125|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
139145126|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145127|NCT04422184|Expectorants|expectorants|mesh-ancestor
139145128|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
139145129|NCT04416568|Nivolumab|nivolumab|mesh-list
139145130|NCT04416568|Ipilimumab|ipilimumab|mesh-list
139145131|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145132|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145133|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139145134|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145135|NCT04358393|Azacitidine|azacitidine|mesh-list
139145136|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139145137|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
139145138|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145139|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145140|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145141|NCT04260022|Blinatumomab|blinatumomab|mesh-list
139145142|NCT04260022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145143|NCT04227678|Heparin|heparin|mesh-list
139145144|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
139145145|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139145146|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139145147|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145148|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
139145149|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139145150|NCT04223765|Fludarabine|fludarabine|mesh-list
138787708|NCT01007448|Bexarotene|bexarotene|mesh-list
139145151|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145152|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
139145153|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145154|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138515487|NCT01464840|Azithromycin|azithromycin|mesh-list
139145155|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139145156|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
139145157|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145158|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145159|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139145161|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
139145162|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
139145163|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139145164|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139145165|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139145166|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139145167|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145168|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
139145169|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
139145170|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139145171|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145172|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139145173|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139145174|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
139145175|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139145176|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139145177|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139145178|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139145179|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
139145180|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139145181|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139145182|NCT04158141|Cisplatin|cisplatin|mesh-list
139145183|NCT04158141|Carboplatin|carboplatin|mesh-list
139145184|NCT04158141|Pemetrexed|pemetrexed|mesh-list
139145185|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145186|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145187|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145188|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139145189|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139145190|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
139145191|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139145192|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139145193|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
139145194|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139145195|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145196|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139145197|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
139145198|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145199|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145200|NCT04090528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139145201|NCT04090528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145202|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
139145203|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139145204|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
139145205|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139145206|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
139145207|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787719|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139145208|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145209|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
139145210|NCT03829501|Atezolizumab|atezolizumab|mesh-list
139145211|NCT03829501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138879614|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139145212|NCT03829501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145213|NCT03829501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145214|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145215|NCT03813147|Cytarabine|cytarabine|mesh-list
139145216|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
139145217|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139145218|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139145219|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139145220|NCT03813147|Methotrexate|methotrexate|mesh-list
139145221|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
139145222|NCT03813147|Azacitidine|azacitidine|mesh-list
138895783|NCT02167763|Copper|copper|mesh-list
139145223|NCT03813147|Fludarabine|fludarabine|mesh-list
139145224|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139145225|NCT03813147|Pevonedistat|pevonedistat|mesh-list
139145226|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138515569|NCT00011375|Rolipram|rolipram|mesh-list
139145227|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
139145228|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139145229|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145230|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139145231|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
139145232|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145233|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145234|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
139145235|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139145236|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145237|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
139145238|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139145239|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139145240|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
139145241|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139145242|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139145243|NCT03805932|Aspirin|aspirin|mesh-list
139145244|NCT03805932|Acetaminophen|acetaminophen|mesh-list
139145245|NCT03805932|Diphenhydramine|diphenhydramine|mesh-list
139145246|NCT03805932|Promethazine|promethazine|mesh-list
139145247|NCT03805932|Dexamethasone|dexamethasone|mesh-list
139145248|NCT03805932|Rituximab|rituximab|mesh-list
139145249|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
139145250|NCT03805932|Famotidine|famotidine|mesh-list
139145251|NCT03805932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139145252|NCT03805932|Antiemetics|antiemetics|mesh-ancestor
139145253|NCT03805932|Autonomic Agents|autonomic agents|mesh-ancestor
139145254|NCT03805932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145255|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879622|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
139145256|NCT03805932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139145257|NCT03805932|Glucocorticoids|glucocorticoids|mesh-ancestor
139145258|NCT03805932|Hormones|hormones|mesh-ancestor
139145259|NCT03805932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139145260|NCT03805932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139145261|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145262|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145263|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
139145264|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139145265|NCT03805932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139145266|NCT03805932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139145267|NCT03805932|Analgesics|analgesics|mesh-ancestor
139145268|NCT03805932|Sensory System Agents|sensory system agents|mesh-ancestor
139145269|NCT03805932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139145270|NCT03805932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139145271|NCT03805932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145272|NCT03805932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139145273|NCT03805932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139145274|NCT03805932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145275|NCT03805932|Antipyretics|antipyretics|mesh-ancestor
139145276|NCT03805932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139145277|NCT03805932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139145278|NCT03805932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139145279|NCT03805932|Anesthetics, Local|anesthetics, local|mesh-ancestor
139145280|NCT03805932|Anesthetics|anesthetics|mesh-ancestor
139145281|NCT03805932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139145282|NCT03805932|Histamine Antagonists|histamine antagonists|mesh-ancestor
139145283|NCT03805932|Histamine Agents|histamine agents|mesh-ancestor
139145284|NCT03805932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139145285|NCT03805932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139145286|NCT03805932|Antipruritics|antipruritics|mesh-ancestor
139145287|NCT03805932|Dermatologic Agents|dermatologic agents|mesh-ancestor
139145288|NCT03805932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139145289|NCT03805932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139145290|NCT03805932|Immunotoxins|immunotoxins|mesh-ancestor
139145291|NCT03805932|Immunoconjugates|immunoconjugates|mesh-ancestor
139145292|NCT03803787|Budesonide|budesonide|mesh-list
139145293|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139145294|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139145295|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
139145296|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145297|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145298|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139145299|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
139145300|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
139145301|NCT03803787|Hormones|hormones|mesh-ancestor
139145302|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139145303|NCT03774186|Pancrelipase|pancrelipase|mesh-list
139145304|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139145306|NCT03738228|Atezolizumab|atezolizumab|mesh-list
139145307|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139145308|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145309|NCT03738228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139145310|NCT03738228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145311|NCT03738228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145312|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
139145313|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145314|NCT03724409|Octreotide|octreotide|mesh-list
139145315|NCT03724409|Edotreotide|edotreotide|mesh-list
139145316|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139145317|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139145318|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145319|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139145320|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145321|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
139145322|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145323|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145324|NCT03694834|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139145325|NCT03694834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145326|NCT03689894|Rituximab|rituximab|mesh-list
139145327|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145328|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145329|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
139145330|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145331|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139145332|NCT03681275|Tofacitinib|tofacitinib|mesh-list
139145333|NCT03681275|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139145334|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139145335|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145336|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145337|NCT03537742|Alirocumab|alirocumab|mesh-list
139145338|NCT03537742|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139145339|NCT03537742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139145340|NCT03537742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139145341|NCT03537742|Antimetabolites|antimetabolites|mesh-ancestor
139145342|NCT03537742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145343|NCT03537742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139145344|NCT03537742|Protease Inhibitors|protease inhibitors|mesh-ancestor
139145345|NCT03537742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145346|NCT03537742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139145347|NCT03530397|Paclitaxel|paclitaxel|mesh-list
139145348|NCT03530397|Carboplatin|carboplatin|mesh-list
139145349|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
139145350|NCT03530397|Pemetrexed|pemetrexed|mesh-list
139145351|NCT03530397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139145352|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145353|NCT03530397|Tubulin Modulators|tubulin modulators|mesh-ancestor
139145354|NCT03530397|Antimitotic Agents|antimitotic agents|mesh-ancestor
139145355|NCT03530397|Mitosis Modulators|mitosis modulators|mesh-ancestor
139145356|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145357|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145358|NCT03530397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139145359|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145360|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139145361|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139145362|NCT03528694|Durvalumab|durvalumab|mesh-list
139145363|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
139145364|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145365|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145366|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139145367|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
139145368|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145369|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
139145370|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
139145371|NCT03516279|Dasatinib|dasatinib|mesh-list
139145372|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145373|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145374|NCT03516279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138895884|NCT01016665|Anastrozole|anastrozole|mesh-list
139145375|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145376|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138923174|NCT00722475|Antibodies|antibodies|mesh-list
139145377|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145378|NCT03511846|Capsaicin|capsaicin|mesh-list
139145379|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
139145380|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
139145381|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
139145382|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787766|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
139145383|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145384|NCT03507751|Meropenem|meropenem|mesh-list
139145385|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139145386|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139145387|NCT03466502|Vancomycin|vancomycin|mesh-list
139145388|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139145389|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139145390|NCT03415555|Acetaminophen|acetaminophen|mesh-list
139145391|NCT03415555|Oxycodone|oxycodone|mesh-list
139145392|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139145393|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145394|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139145395|NCT03415555|Analgesics|analgesics|mesh-ancestor
139145396|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
139145397|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145398|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
139145399|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139145400|NCT03415555|Narcotics|narcotics|mesh-ancestor
139145401|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
139145402|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139145403|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
139145404|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139145405|NCT03357159|Antibodies|antibodies|mesh-list
139145406|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145407|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
139145408|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145409|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139145410|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139145411|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
139145412|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145413|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145414|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139145415|NCT03346096|Thiotepa|thiotepa|mesh-list
139145416|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139145417|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
139145418|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145419|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145420|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139145421|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145422|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
139145423|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145424|NCT03345784|Cisplatin|cisplatin|mesh-list
139145425|NCT03345784|Adavosertib|adavosertib|mesh-list
139145426|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145427|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145428|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145429|NCT03332316|Dexamethasone|dexamethasone|mesh-list
139145430|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
139145431|NCT03332316|Ropivacaine|ropivacaine|mesh-list
139145432|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139145433|NCT03332316|BB 1101|bb 1101|mesh-list
138879685|NCT00649922|Adalimumab|adalimumab|mesh-list
139145437|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145438|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145439|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139145440|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
139145442|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139145443|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139145444|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145445|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
139145446|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
139145447|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139145448|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
139145449|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
139145450|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145451|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145453|NCT03292861|Sirolimus|sirolimus|mesh-list
139145454|NCT03292861|Tacrolimus|tacrolimus|mesh-list
139145455|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
139145456|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145457|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
139145458|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145459|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139145460|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145461|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145462|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139145463|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145464|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139145465|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
139145466|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139145467|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139145468|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
139145469|NCT03283930|Fluoxetine|fluoxetine|mesh-list
139145470|NCT03283930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139145471|NCT03283930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139145472|NCT03283930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139145473|NCT03283930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145474|NCT03283930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139145475|NCT03283930|Serotonin Agents|serotonin agents|mesh-ancestor
139145476|NCT03283930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145477|NCT03283930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139145478|NCT03283930|Antidepressive Agents|antidepressive agents|mesh-ancestor
139145479|NCT03283930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139145480|NCT03283930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139145481|NCT03283930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139145482|NCT03283930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145483|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
139145484|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145485|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145486|NCT03255018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139145487|NCT03255018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145491|NCT03246750|Cisplatin|cisplatin|mesh-list
139145492|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145493|NCT03216733|Sirolimus|sirolimus|mesh-list
139145494|NCT03216733|Temsirolimus|temsirolimus|mesh-list
139145495|NCT03216733|MTOR Inhibitors|mtor inhibitors|mesh-list
139145496|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139145497|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139145498|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139145499|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145500|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
139145501|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145502|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
139145503|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145504|NCT03216733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139145505|NCT03216733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145506|NCT03216733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145507|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
139145508|NCT03204188|Fludarabine|fludarabine|mesh-list
139145509|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145510|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145511|NCT03204188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139145512|NCT03204188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145513|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
139145514|NCT03179930|Entinostat|entinostat|mesh-list
139145515|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145516|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145517|NCT03179930|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139145518|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145519|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139145520|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145521|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139145522|NCT03159754|Metronidazole|metronidazole|mesh-list
139145523|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
139145524|NCT03159754|Tazobactam|tazobactam|mesh-list
139145525|NCT03159754|Piperacillin|piperacillin|mesh-list
139145526|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139145527|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139145528|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139145529|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139145530|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139145531|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139145532|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145533|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145534|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145535|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139145536|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139145537|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139145538|NCT03115424|Liraglutide|liraglutide|mesh-list
139145539|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139145540|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145541|NCT03115424|Incretins|incretins|mesh-ancestor
139145542|NCT03115424|Hormones|hormones|mesh-ancestor
139145543|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139145544|NCT03109080|Olaparib|olaparib|mesh-list
139145545|NCT03109080|Adenosine|adenosine|mesh-list
139145546|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139145547|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145548|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145549|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145550|NCT03109080|Analgesics|analgesics|mesh-ancestor
139145551|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
139145552|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145553|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145554|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139145555|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
139145556|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139145557|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
139145558|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
139145559|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139145560|NCT03089983|Isoniazid|isoniazid|mesh-list
139145561|NCT03089983|Rifapentine|rifapentine|mesh-list
139145562|NCT03089983|Buprenorphine|buprenorphine|mesh-list
139145563|NCT03089983|Methadone|methadone|mesh-list
139145564|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139145565|NCT03089983|Naloxone|naloxone|mesh-list
139145566|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139145567|NCT03089983|Narcotics|narcotics|mesh-ancestor
139145568|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139145569|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145570|NCT03089983|Analgesics|analgesics|mesh-ancestor
139145571|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
139145572|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145573|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139145574|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
139145575|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
139145576|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
139145577|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139145578|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139145579|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139145580|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139145581|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
139145582|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145583|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139145584|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139145585|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
139145586|NCT03072771|Cytarabine|cytarabine|mesh-list
139145587|NCT03072771|Etoposide|etoposide|mesh-list
139145588|NCT03072771|Melphalan|melphalan|mesh-list
139145589|NCT03072771|Carmustine|carmustine|mesh-list
139145590|NCT03072771|Blinatumomab|blinatumomab|mesh-list
139145591|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139145592|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145593|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139145594|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139145595|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145596|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145597|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139145598|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
139145599|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
139145600|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139145601|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145602|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
139145603|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145604|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139145605|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
139145606|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139145607|NCT02943057|Ganciclovir|ganciclovir|mesh-list
139145608|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139145609|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
139145610|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139145611|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139145612|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145613|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145614|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
139145615|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139145616|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139145617|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145618|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
139145619|NCT02918201|Coagulants|coagulants|mesh-ancestor
139145620|NCT02804126|Acetaminophen|acetaminophen|mesh-list
139145621|NCT02804126|Dipyrone|dipyrone|mesh-list
139145622|NCT02804126|Ketoprofen|ketoprofen|mesh-list
139145623|NCT02804126|Morphine|morphine|mesh-list
139145624|NCT02804126|Bupivacaine|bupivacaine|mesh-list
139145625|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
139145626|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
138879784|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145629|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
139145630|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145631|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139145633|NCT02804126|Analgesics|analgesics|mesh-ancestor
139145634|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139145635|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
139145636|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139145637|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139145638|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139145639|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139145640|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145641|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145642|NCT02799212|Somatostatin|somatostatin|mesh-list
139145643|NCT02799212|Hormones|hormones|mesh-ancestor
138581148|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145644|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139145645|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145646|NCT02726711|Trimethaphan|trimethaphan|mesh-list
139145647|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
139145648|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139145649|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139145650|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
139145651|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
139145652|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145653|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145654|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139145655|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139145656|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
139145657|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139145658|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145659|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
139145660|NCT02549092|Levodopa|levodopa|mesh-list
139145661|NCT02549092|Carbidopa|carbidopa|mesh-list
139145662|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139145663|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139145664|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139145665|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
139145666|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139145667|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145668|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145669|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139145670|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145671|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139145672|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
139145673|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
139145675|NCT02428192|Ipilimumab|ipilimumab|mesh-list
139145676|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145677|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145678|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139145679|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145696|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
139145697|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
139145698|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
139145699|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145700|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139145701|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
139145702|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139145703|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139145704|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139145705|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145706|NCT02237183|Iloprost|iloprost|mesh-list
139145707|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139145708|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
139145709|NCT02232386|Rituximab|rituximab|mesh-list
139145710|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145711|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145712|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
139145713|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145714|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139145715|NCT02196961|Nivolumab|nivolumab|mesh-list
139145716|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145717|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145718|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139145719|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145720|NCT02181738|Doxorubicin|doxorubicin|mesh-list
139145721|NCT02181738|Nivolumab|nivolumab|mesh-list
139145722|NCT02181738|Dacarbazine|dacarbazine|mesh-list
139145723|NCT02181738|Vinblastine|vinblastine|mesh-list
139145724|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139145725|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145726|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139145727|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139145728|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145729|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145730|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145731|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139145732|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139145733|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
139145734|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139145735|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
139145736|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
139145737|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
139145738|NCT02142803|Bevacizumab|bevacizumab|mesh-list
139145739|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139145740|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
139145741|NCT02142803|Antibodies|antibodies|mesh-list
139145742|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
139145743|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139145752|NCT01848951|Anesthetics|anesthetics|mesh-list
139145753|NCT01848951|Anesthetics, Local|anesthetics, local|mesh-list
139145754|NCT01848951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139145755|NCT01848951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145756|NCT01848951|Sensory System Agents|sensory system agents|mesh-ancestor
139145757|NCT01848951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145759|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139145760|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145761|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145762|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145771|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139145772|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139145773|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
139145774|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139145775|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145776|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139145777|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139145778|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139145779|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
139145780|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145781|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
139145782|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145783|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139145784|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139145785|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
139145786|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145787|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145788|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139145789|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
139145790|NCT01145209|Fludarabine|fludarabine|mesh-list
139145791|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
139145792|NCT01145209|Ofatumumab|ofatumumab|mesh-list
139145793|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145794|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
139145795|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145796|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139145797|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139145798|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
139145799|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145800|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145801|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139145802|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138879848|NCT02655614|Midazolam|midazolam|mesh-list
139145803|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
139145804|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139145805|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
139145806|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139145807|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139145808|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139145809|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139145810|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
139145811|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139145812|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145813|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145814|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139145815|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139145816|NCT00977691|Sirolimus|sirolimus|mesh-list
139145817|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
139145818|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
139145819|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145820|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
138516143|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
139145821|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145822|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139145823|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138896333|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139145824|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
139145825|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145826|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145827|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139145828|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139145829|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139145830|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139145831|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
139145832|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145834|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
139145835|NCT00823563|Analgesics|analgesics|mesh-ancestor
139145836|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
139145837|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145838|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145839|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139145840|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
139145841|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139145842|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
139145843|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
139145844|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139145845|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145846|NCT00697684|Clofarabine|clofarabine|mesh-list
139145847|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139145848|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139145849|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
139145850|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145851|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145852|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
139145853|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145854|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145856|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139145857|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
139145858|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145859|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145860|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139145861|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
139145862|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
139145863|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139145864|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139145865|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139145866|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139145867|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
139145868|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139145869|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145870|NCT02252614|Acetaminophen|acetaminophen|mesh-list
139145872|NCT02252614|Codeine|codeine|mesh-list
139145873|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139145874|NCT02252614|Analgesics|analgesics|mesh-ancestor
139145875|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
139145876|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145877|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145878|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
139145879|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139145880|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139145881|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139145882|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
139145883|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139145884|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145885|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145886|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139145887|NCT02252614|Narcotics|narcotics|mesh-ancestor
139145888|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139145889|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
139145890|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
139145891|NCT02260570|Tolcapone|tolcapone|mesh-list
139145892|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139145893|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139145894|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139145896|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145897|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
139145898|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145899|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145900|NCT03681951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139145901|NCT03681951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815821|NCT00714493|Infliximab|infliximab|mesh-list
139145903|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
139145904|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139145905|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145906|NCT02132026|Denosumab|denosumab|mesh-list
139145907|NCT02132026|Alendronate|alendronate|mesh-list
139145908|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139145909|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145910|NCT03735771|Bupivacaine|bupivacaine|mesh-list
139145911|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
139145912|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
139145913|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139145914|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145915|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
139145916|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145917|NCT02132104|Hormones|hormones|mesh-list
139145918|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139145919|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145920|NCT00174785|Dronedarone|dronedarone|mesh-list
139145921|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139145922|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
139145923|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
139145924|NCT03681093|Growth Substances|growth substances|mesh-ancestor
139145925|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145926|NCT00166439|Cytarabine|cytarabine|mesh-list
139145927|NCT00166439|Dexamethasone|dexamethasone|mesh-list
139145928|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
139145929|NCT00166439|Rituximab|rituximab|mesh-list
139145930|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139145931|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
139145932|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
138586128|NCT00467116|Cetuximab|cetuximab|mesh-list
139145933|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145934|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145935|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139145936|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
139145937|NCT00166439|Hormones|hormones|mesh-ancestor
139145938|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139145939|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139145940|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145941|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139145942|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
139145943|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139145944|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139145945|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
139145946|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139145947|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
139145948|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139145949|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145950|NCT01074905|Artesunate|artesunate|mesh-list
139145951|NCT01074905|Chloroquine|chloroquine|mesh-list
139145952|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139145953|NCT01074905|Primaquine|primaquine|mesh-list
139145954|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
139145955|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139145956|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139145957|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139145958|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139145959|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
139145960|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
139145961|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139145962|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
139145963|NCT01074905|Amebicides|amebicides|mesh-ancestor
139145964|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139145965|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139145966|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139145967|NCT01074905|Analgesics|analgesics|mesh-ancestor
139145968|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
139145969|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138516295|NCT00276081|Gabapentin|gabapentin|mesh-list
139145970|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145971|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139145972|NCT01074905|Filaricides|filaricides|mesh-ancestor
139145973|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
139145974|NCT03968237|Buprenorphine|buprenorphine|mesh-list
139145975|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139145977|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139145978|NCT03968237|Narcotics|narcotics|mesh-ancestor
139145979|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139145980|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145981|NCT03968237|Analgesics|analgesics|mesh-ancestor
139145982|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
139145983|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139145984|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139145985|NCT00138671|Insulin|insulin|mesh-list
139145986|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139145987|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139145988|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145989|NCT01367158|Vaccines|vaccines|mesh-list
139145990|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
139145991|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145992|NCT00130637|Daclizumab|daclizumab|mesh-list
139145993|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139145994|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
139145995|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145996|NCT01077479|Metformin|metformin|mesh-list
139145997|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138787838|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139145998|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139145999|NCT02136784|Morphine|morphine|mesh-list
139146000|NCT02136784|Oxycodone|oxycodone|mesh-list
139146001|NCT02136784|Buprenorphine|buprenorphine|mesh-list
139146002|NCT02136784|Hydromorphone|hydromorphone|mesh-list
139146003|NCT02136784|Hydrocodone|hydrocodone|mesh-list
139146004|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139146005|NCT02136784|Narcotics|narcotics|mesh-ancestor
139146006|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146007|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146008|NCT02136784|Analgesics|analgesics|mesh-ancestor
139146009|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
139146010|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146011|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139146012|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
139146013|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
139146014|NCT02129764|Prednisone|prednisone|mesh-list
139146015|NCT02129764|Allopurinol|allopurinol|mesh-list
139146016|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139146017|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
139146018|NCT02129764|Hormones|hormones|mesh-ancestor
139146019|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139146020|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146021|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139146022|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146023|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
139146024|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146025|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146026|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
139146027|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146028|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139146029|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
139146030|NCT02129764|Protective Agents|protective agents|mesh-ancestor
139146031|NCT00130247|Rifampin|rifampin|mesh-list
139146032|NCT00130247|Isoniazid|isoniazid|mesh-list
139146033|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
139146034|NCT00130247|Ethambutol|ethambutol|mesh-list
139146035|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139146036|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
139146037|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139146038|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139146039|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
139146040|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139146041|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146042|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146043|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139146044|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139146045|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139146046|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138896559|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
139146047|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139146048|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139146049|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139146050|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139146051|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
139146052|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139146053|NCT02252926|Acetaminophen|acetaminophen|mesh-list
139146054|NCT02252926|Lidocaine|lidocaine|mesh-list
139146055|NCT02252926|Morphine|morphine|mesh-list
139146056|NCT02252926|Gabapentin|gabapentin|mesh-list
139146057|NCT02252926|Bupivacaine|bupivacaine|mesh-list
139146058|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
139146059|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
139146060|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138787848|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146061|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146062|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
139146063|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146064|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139146065|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139146066|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139146067|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139146068|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146069|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139146070|NCT02252926|Narcotics|narcotics|mesh-ancestor
139146071|NCT02252926|Analgesics|analgesics|mesh-ancestor
139146072|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139146073|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
139146074|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
139146075|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139146076|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139146077|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139146078|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139146079|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139146080|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139146081|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
139146082|NCT02253004|Cilostazol|cilostazol|mesh-list
139146083|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139146084|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
139146085|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146086|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146087|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139146088|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
139146089|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139146090|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139146091|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146092|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139146093|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
139146094|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139146095|NCT02253004|Protective Agents|protective agents|mesh-ancestor
139146096|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139146097|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139146098|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146099|NCT02252458|Fentanyl|fentanyl|mesh-list
139146100|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139146101|NCT02252458|Narcotics|narcotics|mesh-ancestor
139146102|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146103|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146104|NCT02252458|Analgesics|analgesics|mesh-ancestor
139146105|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
139146106|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146107|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139146108|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139146109|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
139146110|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
139146111|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
139146112|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139146113|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
139146114|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146115|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146116|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
139146117|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139146118|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139146119|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139146120|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146121|NCT02132260|Naftifine|naftifine|mesh-list
139146122|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
139146123|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139146124|NCT02137564|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139146125|NCT02137564|Nirogacestat|nirogacestat|mesh-list
139146126|NCT02137564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146127|NCT02137564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146128|NCT02132416|Acetaminophen|acetaminophen|mesh-list
139146129|NCT02132416|Ibuprofen|ibuprofen|mesh-list
139146130|NCT02132416|Diclofenac|diclofenac|mesh-list
139146131|NCT02132416|Morphine|morphine|mesh-list
139146132|NCT02132416|Oxycodone|oxycodone|mesh-list
139146133|NCT02132416|Tramadol|tramadol|mesh-list
139146134|NCT02132416|Anesthetics|anesthetics|mesh-list
139146135|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146136|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146137|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139146138|NCT02132416|Narcotics|narcotics|mesh-ancestor
139146139|NCT02132416|Analgesics|analgesics|mesh-ancestor
139146140|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
139146141|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146142|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139146143|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139146144|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139146145|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146146|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139146147|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146148|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146149|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
139146150|NCT00137423|Sunitinib|sunitinib|mesh-list
139146151|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146152|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139146153|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139146154|NCT00137423|Growth Substances|growth substances|mesh-ancestor
139146155|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146156|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
139146157|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139146158|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146159|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146160|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139146161|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
139146162|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139146163|NCT02130700|Seviteronel|seviteronel|mesh-list
139146164|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146165|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139146166|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146167|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146168|NCT02137954|Lidocaine|lidocaine|mesh-list
139146169|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
139146170|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
139146171|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146172|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787860|NCT00641602|Esomeprazole|esomeprazole|mesh-list
139146173|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
139146174|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146175|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139146176|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139146177|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139146178|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139146179|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146180|NCT02131012|Celecoxib|celecoxib|mesh-list
139146181|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139146182|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139146183|NCT02131012|Analgesics|analgesics|mesh-ancestor
139146184|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
139146185|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146186|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146187|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138880063|NCT02630862|Aspirin|aspirin|mesh-list
139146188|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146189|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139146190|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139146191|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146192|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146193|NCT02138500|PF-06372865|pf-06372865|mesh-list
139146194|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
139146195|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
139146196|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139146197|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146198|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146199|NCT01561768|Vaccines|vaccines|mesh-list
139146200|NCT01561768|Immunologic Factors|immunologic factors|mesh-ancestor
139146201|NCT01561768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146202|NCT00137111|Cytarabine|cytarabine|mesh-list
139146203|NCT00137111|Dexamethasone|dexamethasone|mesh-list
139146204|NCT00137111|Prednisone|prednisone|mesh-list
139146205|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
139146206|NCT00137111|Doxorubicin|doxorubicin|mesh-list
139146207|NCT00137111|Methotrexate|methotrexate|mesh-list
139146208|NCT00137111|Etoposide|etoposide|mesh-list
139146209|NCT00137111|Vincristine|vincristine|mesh-list
139146210|NCT00137111|Daunorubicin|daunorubicin|mesh-list
139146211|NCT00137111|Asparaginase|asparaginase|mesh-list
139146212|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
139146213|NCT00137111|Pegaspargase|pegaspargase|mesh-list
139146214|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139146215|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
139146216|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146217|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146218|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139146219|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
139146220|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146221|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146222|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139146223|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139146224|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
139146225|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
139146226|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146227|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139146228|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
139146229|NCT00137111|Hormones|hormones|mesh-ancestor
139146230|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139146231|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139146232|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139146233|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139146234|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139146235|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146236|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139146237|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
139146238|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139146239|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139146240|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
139146241|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
139146242|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139146243|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139146244|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139146245|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
139146246|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139146247|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
139146248|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
139146249|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
139146250|NCT02133118|Pioglitazone|pioglitazone|mesh-list
139146251|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139146252|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146253|NCT02138812|Paclitaxel|paclitaxel|mesh-list
139146254|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139146255|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146256|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
139146257|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
139146258|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
139146259|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146260|NCT00136955|Irinotecan|irinotecan|mesh-list
139146261|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139146262|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139146263|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146264|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146265|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146266|NCT00135707|Vitamins|vitamins|mesh-list
139146267|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
139146268|NCT00135707|Vitamin E|vitamin e|mesh-list
139146269|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
139146270|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
139146271|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146272|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
139146273|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146274|NCT00135707|Protective Agents|protective agents|mesh-ancestor
139146275|NCT03548818|Interferons|interferons|mesh-list
139146276|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
139146277|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146278|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
139146279|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139146281|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139146282|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
139146283|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146284|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146286|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
139146287|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139146288|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
139146289|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146290|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
139146291|NCT03548662|Protective Agents|protective agents|mesh-ancestor
139146292|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139146293|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146294|NCT03966209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139146295|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146296|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
139146297|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139146298|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
139146299|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146300|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146301|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139146302|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
139146303|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139146304|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
139146305|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146306|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139146307|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139146308|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
139146309|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
139146310|NCT02252770|Protective Agents|protective agents|mesh-ancestor
139146311|NCT05578456|Aspirin|aspirin|mesh-list
139146312|NCT05578456|Prednisone|prednisone|mesh-list
139146313|NCT05578456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139146314|NCT05578456|Glucocorticoids|glucocorticoids|mesh-ancestor
139146315|NCT05578456|Hormones|hormones|mesh-ancestor
139146316|NCT05578456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139146317|NCT05578456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146318|NCT05578456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139146319|NCT05578456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146320|NCT05578456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139146321|NCT05578456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139146322|NCT05578456|Analgesics|analgesics|mesh-ancestor
139146323|NCT05578456|Sensory System Agents|sensory system agents|mesh-ancestor
139146324|NCT05578456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146325|NCT05578456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146326|NCT05578456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139146327|NCT05578456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139146328|NCT05578456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146329|NCT05578456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139146330|NCT05578456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139146331|NCT05578456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146332|NCT05578456|Antipyretics|antipyretics|mesh-ancestor
139146333|NCT02133820|Analgesics|analgesics|mesh-list
139146334|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
139146335|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146336|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146337|NCT05578378|Cytarabine|cytarabine|mesh-list
139146338|NCT05578378|Methotrexate|methotrexate|mesh-list
139146339|NCT05578378|Fludarabine|fludarabine|mesh-list
139146340|NCT05578378|Cladribine|cladribine|mesh-list
139146341|NCT05578378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139146342|NCT05578378|Abortifacient Agents|abortifacient agents|mesh-ancestor
139146343|NCT05578378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139146344|NCT05578378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146345|NCT05578378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139146346|NCT05578378|Antimetabolites|antimetabolites|mesh-ancestor
139146347|NCT05578378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146348|NCT05578378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146349|NCT05578378|Dermatologic Agents|dermatologic agents|mesh-ancestor
139146350|NCT05578378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146351|NCT05578378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139146352|NCT05578378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139146353|NCT05578378|Immunologic Factors|immunologic factors|mesh-ancestor
139146354|NCT05578378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146355|NCT05578378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139146356|NCT05578378|Antiviral Agents|antiviral agents|mesh-ancestor
139146357|NCT05578378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139146358|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
139146359|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139146360|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146361|NCT02139904|Vinorelbine|vinorelbine|mesh-list
139146362|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139146363|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146364|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
139146365|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
139146366|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
139146367|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146368|NCT05578222|Pembrolizumab|pembrolizumab|mesh-list
139146369|NCT05578222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139146370|NCT05578222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146371|NCT05578222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139146372|NCT05578222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146374|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
139146375|NCT02134288|Everolimus|everolimus|mesh-list
139146376|NCT02134288|Abatacept|abatacept|mesh-list
139146377|NCT02134288|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139146378|NCT02134288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139146379|NCT02134288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146380|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146381|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139146382|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
139146383|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146384|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146385|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139146386|NCT02134288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139146387|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146388|NCT00129467|Methylphenidate|methylphenidate|mesh-list
139146389|NCT00129467|Serotonin|serotonin|mesh-list
139146390|NCT00129467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139146391|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139146392|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146393|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139146394|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139146395|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139146396|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146397|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
139146398|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139146399|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139146400|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
139146401|NCT00129311|Selegiline|selegiline|mesh-list
139146402|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
139146403|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139146404|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139146405|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139146406|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139146407|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146408|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146409|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139146410|NCT00129311|Protective Agents|protective agents|mesh-ancestor
139146411|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146412|NCT01076621|Norethindrone|norethindrone|mesh-list
139146413|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
139146414|NCT01076621|Estradiol|estradiol|mesh-list
139146415|NCT01076621|Estrogens|estrogens|mesh-ancestor
139146416|NCT01076621|Hormones|hormones|mesh-ancestor
139146417|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139146418|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146419|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139146420|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
139146421|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139146422|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139146423|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139146424|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139146425|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138896935|NCT02686151|Hormones|hormones|mesh-ancestor
139146427|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139146428|NCT03965819|Analgesics|analgesics|mesh-ancestor
139146429|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
139146430|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146431|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146432|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
139146433|NCT02134366|Lorazepam|lorazepam|mesh-list
139146434|NCT02134366|Clonazepam|clonazepam|mesh-list
139146435|NCT02134366|Clobazam|clobazam|mesh-list
139146436|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
139146437|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
139146438|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
139146439|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146440|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146441|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139146442|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139146443|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146444|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139146445|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139146446|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139146447|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
139146448|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
139146449|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139146450|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146451|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139146452|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
139146453|NCT01077947|Anesthetics|anesthetics|mesh-list
139146454|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146455|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146456|NCT00133991|Leucovorin|leucovorin|mesh-list
139146457|NCT00133991|Cytarabine|cytarabine|mesh-list
139146458|NCT00133991|Prednisone|prednisone|mesh-list
139146459|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
139146460|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
139146461|NCT00133991|Rituximab|rituximab|mesh-list
139146462|NCT00133991|Methotrexate|methotrexate|mesh-list
139146463|NCT00133991|Vincristine|vincristine|mesh-list
139146464|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139146465|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
139146466|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146467|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146468|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139146469|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
139146470|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146471|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146472|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139146473|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139146474|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139146475|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
139146476|NCT00133991|Hormones|hormones|mesh-ancestor
139146477|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139146478|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139146479|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139146480|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
139146481|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139146482|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139146483|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
139146484|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
139146485|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146486|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139146487|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139146488|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
139146489|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139146490|NCT00133991|Antidotes|antidotes|mesh-ancestor
139146491|NCT00133991|Protective Agents|protective agents|mesh-ancestor
139146492|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
139146493|NCT00133991|Vitamins|vitamins|mesh-ancestor
139146494|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
139146495|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139146496|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
139146497|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
139146498|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
138516821|NCT00130065|Vitamins|vitamins|mesh-ancestor
139146499|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139146500|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
139146501|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146502|NCT02140450|Timolol|timolol|mesh-list
139146503|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139146504|NCT02140450|Mannitol|mannitol|mesh-list
139146505|NCT02140450|Acetazolamide|acetazolamide|mesh-list
139146506|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139146507|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139146508|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
139146509|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139146510|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146511|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146512|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139146513|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139146514|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139146515|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139146516|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139146517|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139146518|NCT02140450|Diuretics|diuretics|mesh-ancestor
139146519|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
139146520|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
139146521|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139146522|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146524|NCT03549832|Ribavirin|ribavirin|mesh-list
139146525|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
139146526|NCT03549832|Simeprevir|simeprevir|mesh-list
139146527|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139146528|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139146529|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
139146530|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146531|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146532|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139146533|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139146534|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
139146535|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139146536|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139146537|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139146538|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
139146539|NCT02134990|Docetaxel|docetaxel|mesh-list
139146540|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146541|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
139146542|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
139146543|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
139146544|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146545|NCT02135224|Fentanyl|fentanyl|mesh-list
139146546|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139146547|NCT02135224|Narcotics|narcotics|mesh-ancestor
139146548|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146549|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146550|NCT02135224|Analgesics|analgesics|mesh-ancestor
139146551|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
139146552|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146553|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139146554|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139146555|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
139146556|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
139146557|NCT02785900|Azacitidine|azacitidine|mesh-list
139146558|NCT02785900|Decitabine|decitabine|mesh-list
139146559|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139146560|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
139146561|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146562|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146563|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146564|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
139146565|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
139146566|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
139146567|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139146568|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146569|NCT02135770|Heparin|heparin|mesh-list
139146570|NCT02135770|Calcium heparin|calcium heparin|mesh-list
139146571|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
139146572|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139146573|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139146574|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146575|NCT05478850|Anesthetics|anesthetics|mesh-list
139146576|NCT05478850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146577|NCT05478850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146578|NCT01560754|Nicotine|nicotine|mesh-list
139146579|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139146580|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
139146581|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146582|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146583|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139146584|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139146585|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
139146586|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139146587|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146588|NCT03547804|Apatinib|apatinib|mesh-list
139146589|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146590|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139146591|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146592|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146593|NCT02217267|Lidocaine|lidocaine|mesh-list
139146594|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
139146595|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
139146596|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146597|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146598|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
139146599|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146600|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139146601|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139146602|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139146603|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139146604|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146605|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
139146606|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
139146607|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139146608|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146609|NCT03546400|Methylphenidate|methylphenidate|mesh-list
139146610|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139146611|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146612|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139146613|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139146614|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139146615|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146616|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
139146617|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139146618|NCT03669861|Abatacept|abatacept|mesh-list
139146619|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139146620|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146621|NCT03669861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139146622|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146623|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139146624|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
139146625|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146626|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146627|NCT00127127|Vorinostat|vorinostat|mesh-list
139146628|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146629|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139146630|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146631|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146632|NCT00126659|Sorafenib|sorafenib|mesh-list
139146633|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146634|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139146635|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146636|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146637|NCT03669081|Ketorolac|ketorolac|mesh-list
139146638|NCT03669081|Pregabalin|pregabalin|mesh-list
139146639|NCT03669081|Analgesics|analgesics|mesh-ancestor
139146640|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
138880204|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139146641|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146642|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146644|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139146645|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139146646|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146647|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139146649|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139146650|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146651|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139146652|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138897162|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
139146653|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139146654|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139146655|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146656|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139146657|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146659|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139146660|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139146661|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
139146662|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146663|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146664|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139146665|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139146666|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
139146667|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139146668|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139146669|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139146670|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
139146671|NCT02253550|Simeprevir|simeprevir|mesh-list
139146672|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
139146673|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139146674|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
139146675|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146676|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146677|NCT05203432|Atropine|atropine|mesh-list
139146678|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139146679|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139146680|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139146681|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
139146682|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146683|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146684|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139146685|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
139146686|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
139146687|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
139146688|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139146689|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139146690|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
139146691|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139146692|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146693|NCT03667053|Glucagon|glucagon|mesh-list
139146694|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139146695|NCT03667053|Hormones|hormones|mesh-ancestor
139146696|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139146697|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146698|NCT04589728|Venetoclax|venetoclax|mesh-list
139146699|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146700|NCT05557240|Poly I-C|poly i-c|mesh-list
139146701|NCT05557240|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139146702|NCT05557240|Vaccines|vaccines|mesh-list
139146703|NCT05557240|Poly ICLC|poly iclc|mesh-list
139146704|NCT05557240|Immunologic Factors|immunologic factors|mesh-ancestor
139146705|NCT05557240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146706|NCT05557240|Interferon Inducers|interferon inducers|mesh-ancestor
139146707|NCT05557240|Laxatives|laxatives|mesh-ancestor
139146708|NCT05557240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139146709|NCT05557240|Antiviral Agents|antiviral agents|mesh-ancestor
139146710|NCT05557240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139146711|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
139146712|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139146713|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146714|NCT03631407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139146715|NCT03631407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146716|NCT03547024|Midazolam|midazolam|mesh-list
139146717|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
139146718|NCT03547024|Omeprazole|omeprazole|mesh-list
139146719|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
139146720|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139146721|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139146723|NCT03547024|Estradiol|estradiol|mesh-list
139146724|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139146725|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139146726|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897235|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139146727|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146728|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139146729|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139146730|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139146731|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139146732|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
139146734|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
139146735|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
139146736|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139146737|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146738|NCT03547024|Estrogens|estrogens|mesh-ancestor
139146739|NCT03547024|Hormones|hormones|mesh-ancestor
139146740|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139146741|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139146742|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
139146743|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139146744|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139146745|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139146746|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139146747|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139146748|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146749|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139146750|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139146751|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139146752|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
139146753|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
139146754|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139146755|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139146756|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139146757|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
139146758|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139146759|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139146760|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
139146761|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
139146762|NCT04012996|Meloxicam|meloxicam|mesh-list
139146763|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139146764|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139146765|NCT04012996|Analgesics|analgesics|mesh-ancestor
139146766|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
139146767|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146768|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146769|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139146770|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146771|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139146772|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139146773|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146774|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146775|NCT02253784|Dexamethasone|dexamethasone|mesh-list
139146776|NCT02253784|Bupivacaine|bupivacaine|mesh-list
139146777|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139146778|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
139146779|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
139146780|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146781|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146782|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139146783|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
139146784|NCT02253784|Hormones|hormones|mesh-ancestor
139146785|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139146786|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139146787|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146788|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
139146789|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
139146790|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146791|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
139146792|NCT03734445|Vitamins|vitamins|mesh-list
139146793|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
139146794|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146795|NCT03546088|Anesthetics|anesthetics|mesh-list
139146796|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146797|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146799|NCT03866980|Pemetrexed|pemetrexed|mesh-list
139146800|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146801|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146802|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146803|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139146804|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139146805|NCT02253862|Ritonavir|ritonavir|mesh-list
139146806|NCT02253862|Tipranavir|tipranavir|mesh-list
139146807|NCT02253862|Tadalafil|tadalafil|mesh-list
139146808|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139146809|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139146810|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
139146811|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146812|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146813|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139146814|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139146815|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
139146816|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139146817|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139146818|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139146819|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
139146820|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139146821|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139146822|NCT02253862|Urological Agents|urological agents|mesh-ancestor
139146823|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139146824|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139146825|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139146826|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146827|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146828|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139146829|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139146830|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139146831|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139146832|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
139146833|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139146834|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146835|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139146836|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139146837|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
139146838|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139146839|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139146840|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
139146841|NCT03776656|Allopurinol|allopurinol|mesh-list
139146842|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
139146843|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146844|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146845|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
139146846|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146847|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139146848|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
139146849|NCT03776656|Protective Agents|protective agents|mesh-ancestor
139146850|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146851|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
139146852|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139146853|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
139146854|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146855|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146856|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139146857|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
139146858|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146859|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146860|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139146861|NCT00126581|Paclitaxel|paclitaxel|mesh-list
139146862|NCT00126581|Carboplatin|carboplatin|mesh-list
139146863|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139146864|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139146865|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139146866|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146867|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
139146868|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
139146869|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
139146870|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146871|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139146872|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146873|NCT03704584|Methylprednisolone|methylprednisolone|mesh-list
139146874|NCT03704584|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139146875|NCT03704584|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139146876|NCT03704584|Prednisolone|prednisolone|mesh-list
138897391|NCT02615912|Castor Oil|castor oil|mesh-list
139146877|NCT03704584|Prednisolone acetate|prednisolone acetate|mesh-list
139146878|NCT03704584|Lidocaine|lidocaine|mesh-list
139146879|NCT03704584|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139146880|NCT03704584|Prednisolone phosphate|prednisolone phosphate|mesh-list
139146881|NCT03704584|Anesthetics, Local|anesthetics, local|mesh-ancestor
139146882|NCT03704584|Anesthetics|anesthetics|mesh-ancestor
139146883|NCT03704584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146884|NCT03704584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146885|NCT03704584|Sensory System Agents|sensory system agents|mesh-ancestor
139146886|NCT03704584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146887|NCT03704584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139146888|NCT03704584|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139146889|NCT03704584|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139146890|NCT03704584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139146891|NCT03704584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146892|NCT03704584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139146893|NCT03704584|Antiemetics|antiemetics|mesh-ancestor
139146894|NCT03704584|Autonomic Agents|autonomic agents|mesh-ancestor
139146895|NCT03704584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139146896|NCT03704584|Glucocorticoids|glucocorticoids|mesh-ancestor
139146897|NCT03704584|Hormones|hormones|mesh-ancestor
139146898|NCT03704584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139146899|NCT03704584|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139146900|NCT03704584|Protective Agents|protective agents|mesh-ancestor
139146901|NCT03704584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139146902|NCT03704584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146903|NCT03737721|Avelumab|avelumab|mesh-list
139146904|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139146905|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146906|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
139146907|NCT03647709|Narcotics|narcotics|mesh-ancestor
139146908|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146909|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146910|NCT03647709|Analgesics|analgesics|mesh-ancestor
139146911|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
139146912|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146913|NCT03546634|Vaccines|vaccines|mesh-list
139146914|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
139146915|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146916|NCT03661983|Aripiprazole|aripiprazole|mesh-list
139146917|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
139146918|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139146919|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139146920|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139146921|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139146922|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146923|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
139146924|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
139146925|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139146926|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146927|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139146928|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139146929|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
139146930|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139146931|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139146932|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139146933|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139146934|NCT02783170|Vaccines|vaccines|mesh-list
139146935|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
139146936|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146937|NCT02254018|Maytansine|maytansine|mesh-list
139146938|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
139146939|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139146940|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146941|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
139146942|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
139146943|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
139146945|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139146946|NCT02254018|Immunotoxins|immunotoxins|mesh-ancestor
139146947|NCT02254018|Immunoconjugates|immunoconjugates|mesh-ancestor
139146948|NCT02254018|Immunologic Factors|immunologic factors|mesh-ancestor
139146949|NCT02254018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146950|NCT03396952|Aspirin|aspirin|mesh-list
139146951|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
139146952|NCT03396952|Ipilimumab|ipilimumab|mesh-list
139146953|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139146954|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146955|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139146956|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146957|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139146958|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139146959|NCT03396952|Analgesics|analgesics|mesh-ancestor
139146960|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
139146961|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139146962|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146963|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139146964|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146965|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139146966|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139146967|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139146968|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139146969|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146970|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
139146971|NCT03378934|Aspirin|aspirin|mesh-list
139146972|NCT03378934|Clopidogrel|clopidogrel|mesh-list
139146973|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139146974|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139146975|NCT03378934|Analgesics|analgesics|mesh-ancestor
139146976|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
138788016|NCT02683564|Infliximab|infliximab|mesh-list
139146977|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880324|NCT02650388|Chrysarobin|chrysarobin|mesh-list
139146978|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139146979|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139146980|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139146981|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139146982|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139146983|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139146984|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139146985|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139146986|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139146987|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
139146988|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139146989|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139146990|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139146991|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
139146992|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139146993|NCT00126503|Bevacizumab|bevacizumab|mesh-list
139146994|NCT00126503|Sorafenib|sorafenib|mesh-list
139146995|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139146996|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139146997|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139146998|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139146999|NCT00126503|Growth Substances|growth substances|mesh-ancestor
139147000|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147001|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
139147002|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147003|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147004|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147005|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139147006|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147007|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147008|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147009|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139147010|NCT00126191|Leucovorin|leucovorin|mesh-list
139147011|NCT00126191|Cytarabine|cytarabine|mesh-list
139147012|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
139147013|NCT00126191|Ifosfamide|ifosfamide|mesh-list
139147014|NCT00126191|Rituximab|rituximab|mesh-list
139147015|NCT00126191|Doxorubicin|doxorubicin|mesh-list
139147016|NCT00126191|Methotrexate|methotrexate|mesh-list
139147017|NCT00126191|Etoposide|etoposide|mesh-list
139147018|NCT00126191|Vincristine|vincristine|mesh-list
139147020|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
139147021|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147022|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138788028|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139147023|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139147024|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
139147025|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897527|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147026|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147027|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139147028|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139147029|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139147030|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139147031|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139147032|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147033|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139147034|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
139147035|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139147036|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139147037|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
139147038|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
139147039|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139147040|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139147041|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139147042|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
139147043|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139147044|NCT00126191|Antidotes|antidotes|mesh-ancestor
139147045|NCT00126191|Protective Agents|protective agents|mesh-ancestor
139147046|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
139147047|NCT00126191|Vitamins|vitamins|mesh-ancestor
139147048|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
139147049|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
139147050|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
139147051|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
139147052|NCT00124943|Paclitaxel|paclitaxel|mesh-list
139147053|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139147054|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139147055|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147056|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
139147057|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
139147058|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
139147059|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147060|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
139147061|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139147062|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139147063|NCT00124709|Analgesics|analgesics|mesh-ancestor
139147064|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
139147065|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147066|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147067|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139147068|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139147069|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
139147070|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139147071|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
139147072|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139147073|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147074|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147075|NCT04139434|Azacitidine|azacitidine|mesh-list
139147076|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139147077|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
139147078|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147079|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147080|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147081|NCT03058354|Propofol|propofol|mesh-list
139147082|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
138602840|NCT05807035|Vaccines|vaccines|mesh-list
139147083|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147084|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147085|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139147086|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139147087|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
139147088|NCT02143570|Darifenacin|darifenacin|mesh-list
139147089|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139147090|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139147091|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
139147093|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147094|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147095|NCT02143570|Urological Agents|urological agents|mesh-ancestor
139147096|NCT02143804|Molgramostim|molgramostim|mesh-list
139147097|NCT02143804|Sargramostim|sargramostim|mesh-list
139147098|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
139147099|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147100|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147101|NCT03544996|Insulin|insulin|mesh-list
139147102|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139147103|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147104|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139147105|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
139147106|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139147107|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
139147108|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139147109|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147110|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139147111|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139147112|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147113|NCT02144194|Docetaxel|docetaxel|mesh-list
139147114|NCT02144194|Vinorelbine|vinorelbine|mesh-list
139147115|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147116|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
139147117|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
139147118|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
139147119|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147120|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139147121|NCT02140840|Trametinib|trametinib|mesh-list
139147122|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147123|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147124|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147125|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147126|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
139147127|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139147128|NCT00108160|Mupirocin|mupirocin|mesh-list
139147129|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139147130|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139147131|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139147132|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147133|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147134|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
139147135|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139147136|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139147137|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
139147138|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147139|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147140|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139147141|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
139147142|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
139147143|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139147144|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
139147145|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139147146|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147147|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139147148|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139147149|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139147150|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
139147151|NCT03545308|Rocuronium|rocuronium|mesh-list
139147152|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139147153|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139147154|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139147155|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147156|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147157|NCT00108082|Atenolol|atenolol|mesh-list
139147159|NCT00108082|Lisinopril|lisinopril|mesh-list
139147160|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139147161|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139147162|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
139147163|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139147164|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923191|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
139147165|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147166|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139147168|NCT00108082|Protective Agents|protective agents|mesh-ancestor
139147169|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139147170|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139147171|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139147172|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
139147173|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139147174|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139147175|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139147176|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
139147177|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147178|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139147179|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139147180|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
139147181|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
139147182|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147183|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139147184|NCT02144662|Ranibizumab|ranibizumab|mesh-list
139147185|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139147186|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139147187|NCT02144662|Growth Substances|growth substances|mesh-ancestor
139147188|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147189|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
139147190|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147191|NCT02141698|Esomeprazole|esomeprazole|mesh-list
139147192|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139147193|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139147194|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139147195|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147196|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147197|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139147198|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
139147199|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139147200|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
139147201|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139147202|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147203|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139147204|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139147205|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147206|NCT02147938|Tacrolimus|tacrolimus|mesh-list
139147207|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139147208|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
139147209|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147210|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139147211|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147212|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147213|NCT02148016|Levofloxacin|levofloxacin|mesh-list
139147214|NCT02148016|Betamethasone|betamethasone|mesh-list
139147215|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139147216|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139147217|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138880386|NCT02765009|Furosemide|furosemide|mesh-list
139147218|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139147219|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139147220|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147221|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147222|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147223|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139147224|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139147225|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139147226|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
139147227|NCT02148016|Hormones|hormones|mesh-ancestor
139147228|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139147229|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147230|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139147231|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
139147232|NCT02148094|Tenofovir|tenofovir|mesh-list
139147233|NCT02148094|Emtricitabine|emtricitabine|mesh-list
139147234|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138923192|NCT02604095|Melatonin|melatonin|mesh-list
139147236|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139147237|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139147238|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139147239|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147240|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147241|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139147242|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139147243|NCT02148328|Vaccines|vaccines|mesh-list
139147244|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
139147245|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147246|NCT02142010|Paclitaxel|paclitaxel|mesh-list
139147247|NCT02142010|Cisplatin|cisplatin|mesh-list
139147248|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139147249|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147250|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
139147251|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
139147252|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
139147253|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147254|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
139147255|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139147256|NCT03543826|Rocuronium|rocuronium|mesh-list
139147257|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139147258|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139147259|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139147260|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147261|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147262|NCT02148640|Infliximab|infliximab|mesh-list
139147263|NCT02148640|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139147264|NCT02148640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139147265|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
139147266|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139147267|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139147268|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139147269|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
139147271|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139147272|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139147273|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147274|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147275|NCT02142634|Budesonide|budesonide|mesh-list
139147276|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139147277|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139147278|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
139147279|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147280|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147281|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139147282|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
139147283|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
139147284|NCT02142634|Hormones|hormones|mesh-ancestor
139147285|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139147286|NCT02142790|Paclitaxel|paclitaxel|mesh-list
139147287|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139147288|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147289|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
139147290|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
139147291|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
139147292|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147293|NCT02142868|Letrozole|letrozole|mesh-list
139147294|NCT02142868|Palbociclib|palbociclib|mesh-list
139147295|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147296|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139147297|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139147298|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147299|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147300|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139147301|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
139147302|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139147303|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147304|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147305|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
139147306|NCT02145520|Analgesics|analgesics|mesh-ancestor
139147307|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
139147308|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147309|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147311|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147312|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139147313|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
139147314|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139147315|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139147316|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147317|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139147318|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
139147319|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139147320|NCT02145598|Lenalidomide|lenalidomide|mesh-list
139147321|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
139147322|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147323|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139147324|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139147325|NCT02145598|Growth Substances|growth substances|mesh-ancestor
139147326|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
139147327|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147329|NCT02145832|Micafungin|micafungin|mesh-list
139147330|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
139147331|NCT02145832|Clotrimazole|clotrimazole|mesh-list
139147332|NCT02145832|Miconazole|miconazole|mesh-list
139147333|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139147334|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139147335|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139147336|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147337|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147338|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139147339|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
139147340|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139147341|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147342|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139147343|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139147344|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139147345|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139147347|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147348|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147349|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147350|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147351|NCT02145910|Vemurafenib|vemurafenib|mesh-list
139147352|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147353|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147354|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147355|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147356|NCT02146222|Docetaxel|docetaxel|mesh-list
139147357|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147358|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
139147359|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
139147360|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
139147361|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147362|NCT02146300|Xylometazoline|xylometazoline|mesh-list
139147363|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
139147364|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139147365|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
139147366|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
139147367|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139147368|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139147369|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147370|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
139147371|NCT02146456|Coagulants|coagulants|mesh-ancestor
139147372|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
139147373|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139147374|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139147375|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147376|NCT02151916|Fluorides|fluorides|mesh-list
139147377|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
139147378|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
139147379|NCT02151916|Protective Agents|protective agents|mesh-ancestor
139147380|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147381|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
139147382|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147383|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147384|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147385|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147386|NCT02152228|Teriparatide|teriparatide|mesh-list
139147387|NCT02152228|Hormones|hormones|mesh-list
139147388|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
139147389|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139147390|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147391|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139147392|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139147393|NCT02152306|Amlodipine|amlodipine|mesh-list
139147394|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139147395|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139147396|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139147397|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147398|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139147399|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147401|NCT02261116|Telmisartan|telmisartan|mesh-list
139147402|NCT02261116|Candesartan|candesartan|mesh-list
139147403|NCT02261116|Candesartan cilexetil|candesartan cilexetil|mesh-list
139147404|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139147405|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139147406|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139147407|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147408|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139147409|NCT02147548|Lorazepam|lorazepam|mesh-list
139147410|NCT02147548|Etifoxine|etifoxine|mesh-list
139147411|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
139147412|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
139147413|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
139147414|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147415|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147416|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139147417|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139147418|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147419|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139147420|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139147421|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139147422|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
139147423|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
139147424|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139147425|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147426|NCT00122681|Vaccines|vaccines|mesh-list
139147427|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
139147428|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147429|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139147430|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147431|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147432|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147433|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147434|NCT05666349|Niraparib|niraparib|mesh-list
139147435|NCT05666349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139147436|NCT05666349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147437|NCT05666349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147438|NCT05666349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147439|NCT03733275|Lidocaine|lidocaine|mesh-list
139147440|NCT03733275|Bupivacaine|bupivacaine|mesh-list
139147441|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
139147442|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
139147443|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147444|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147445|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
139147446|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147447|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139147448|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139147449|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139147450|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139147451|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147452|NCT03542422|Apatinib|apatinib|mesh-list
139147453|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147454|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147455|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147456|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147457|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139147458|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
139147459|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139147460|NCT02153866|Vaccines|vaccines|mesh-list
139147461|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
139147462|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147463|NCT03645057|Tacrolimus|tacrolimus|mesh-list
139147464|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139147465|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
139147466|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147467|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139147468|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147469|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897980|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
139147471|NCT04863430|Apatinib|apatinib|mesh-list
139147472|NCT04863430|Tegafur|tegafur|mesh-list
139147473|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147474|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147475|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147476|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147477|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139147478|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
139147479|NCT05665881|Phenylephrine|phenylephrine|mesh-list
139147480|NCT05665881|Oxymetazoline|oxymetazoline|mesh-list
139147481|NCT05665881|Norepinephrine|norepinephrine|mesh-list
139147482|NCT05665881|Ephedrine|ephedrine|mesh-list
139147483|NCT05665881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139147484|NCT05665881|Mydriatics|mydriatics|mesh-ancestor
139147485|NCT05665881|Autonomic Agents|autonomic agents|mesh-ancestor
139147486|NCT05665881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147487|NCT05665881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147488|NCT05665881|Sympathomimetics|sympathomimetics|mesh-ancestor
139147489|NCT05665881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139147490|NCT05665881|Nasal Decongestants|nasal decongestants|mesh-ancestor
139147491|NCT05665881|Respiratory System Agents|respiratory system agents|mesh-ancestor
139147492|NCT05665881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139147493|NCT05665881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139147494|NCT05665881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139147495|NCT05665881|Adrenergic Agents|adrenergic agents|mesh-ancestor
139147496|NCT05665881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139147497|NCT05665881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147498|NCT05665881|Protective Agents|protective agents|mesh-ancestor
139147499|NCT05665881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139147500|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
139147501|NCT03643575|Guaifenesin|guaifenesin|mesh-list
139147502|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139147503|NCT03643575|Expectorants|expectorants|mesh-ancestor
139147504|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
139147505|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139147506|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138788133|NCT04183192|Reslizumab|reslizumab|mesh-list
139147507|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
139147508|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880443|NCT04223219|Ketamine|ketamine|mesh-list
139147509|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147510|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147511|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
139147512|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139147513|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
139147514|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
139147515|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147516|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
139147517|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139147518|NCT02768194|Fluorides|fluorides|mesh-list
139147519|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
139147520|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
139147521|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
139147522|NCT02768194|Protective Agents|protective agents|mesh-ancestor
139147523|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147524|NCT02254954|Temozolomide|temozolomide|mesh-list
139147525|NCT02254954|Macitentan|macitentan|mesh-list
139147526|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139147527|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
139147528|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147529|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147530|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139147531|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139147532|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139147533|NCT00130793|Vaccines|vaccines|mesh-list
139147534|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
139147535|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147536|NCT03732105|Apatinib|apatinib|mesh-list
139147537|NCT03732105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
139147538|NCT03732105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147539|NCT03732105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147540|NCT03732105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147541|NCT03732105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147542|NCT03732105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139147543|NCT03732105|Growth Substances|growth substances|mesh-ancestor
139147544|NCT03732105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147545|NCT03732105|Growth Inhibitors|growth inhibitors|mesh-ancestor
139147546|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
139147547|NCT02154334|Phenylephrine|phenylephrine|mesh-list
139147548|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
139147549|NCT02154334|Esketamine|esketamine|mesh-list
139147550|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139147551|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
139147552|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139147553|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
139147554|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139147555|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139147556|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139147557|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
139147558|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139147559|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147560|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147561|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
139147562|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
139147563|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147564|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
139147565|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139147566|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
139147567|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139147568|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
139147569|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139147570|NCT02154334|Protective Agents|protective agents|mesh-ancestor
139147571|NCT01078961|Bortezomib|bortezomib|mesh-list
139147572|NCT01078961|Sorafenib|sorafenib|mesh-list
139147573|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147574|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147575|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147576|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147577|NCT03818399|Buprenorphine|buprenorphine|mesh-list
139147578|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139147579|NCT03818399|Narcotics|narcotics|mesh-ancestor
139147580|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147581|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147582|NCT03818399|Analgesics|analgesics|mesh-ancestor
139147583|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
139147584|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147585|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139147586|NCT02154646|Gemcitabine|gemcitabine|mesh-list
139147587|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139147588|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
139147589|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147590|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147591|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
139147592|NCT03642873|Hydrocodone|hydrocodone|mesh-list
139147593|NCT03642873|Guaifenesin|guaifenesin|mesh-list
139147594|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139147595|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139147596|NCT03642873|Narcotics|narcotics|mesh-ancestor
139147597|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147598|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147599|NCT03642873|Analgesics|analgesics|mesh-ancestor
139147600|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
139147601|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147602|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
139147603|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
139147604|NCT03642873|Expectorants|expectorants|mesh-ancestor
139147605|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139147606|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139147607|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
139147608|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139147609|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147610|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
139147611|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139147612|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
139147613|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
139147614|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
139147615|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139147617|NCT01079819|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139147618|NCT01079819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147619|NCT01079819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147620|NCT02156596|Ketoprofen|ketoprofen|mesh-list
139147621|NCT02156596|Morphine|morphine|mesh-list
138898130|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
139147622|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139147623|NCT02156596|Narcotics|narcotics|mesh-ancestor
139147624|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147625|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147626|NCT02156596|Analgesics|analgesics|mesh-ancestor
139147627|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
139147628|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147629|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139147630|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139147631|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139147632|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139147633|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139147634|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147635|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147636|NCT01079117|Morphine|morphine|mesh-list
139147637|NCT01079117|Methadone|methadone|mesh-list
139147638|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139147639|NCT01079117|Narcotics|narcotics|mesh-ancestor
139147640|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147641|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147642|NCT01079117|Analgesics|analgesics|mesh-ancestor
139147643|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
139147644|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147645|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
139147646|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
139147647|NCT03732963|Melatonin|melatonin|mesh-list
139147648|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
139147649|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147650|NCT03732963|Protective Agents|protective agents|mesh-ancestor
139147651|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147652|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147653|NCT03818321|Methenamine|methenamine|mesh-list
139147654|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
139147655|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
139147656|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139147657|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139147658|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139147659|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
139147660|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139147661|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147662|NCT04996719|Sirolimus|sirolimus|mesh-list
139147663|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139147664|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139147666|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147667|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
139147668|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139147669|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
139147670|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147671|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
139147672|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139147673|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147674|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
139147675|NCT02770612|Narcotics|narcotics|mesh-ancestor
139147676|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147677|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147678|NCT02770612|Analgesics|analgesics|mesh-ancestor
139147679|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
138610528|NCT00579475|Mifepristone|mifepristone|mesh-list
139147680|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147681|NCT03542110|Alirocumab|alirocumab|mesh-list
139147682|NCT03542110|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139147683|NCT03542110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139147684|NCT03542110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139147685|NCT03542110|Antimetabolites|antimetabolites|mesh-ancestor
139147686|NCT03542110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147687|NCT03542110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139147688|NCT03542110|Protease Inhibitors|protease inhibitors|mesh-ancestor
139147689|NCT03542110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147690|NCT03542110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139147691|NCT03575871|Abrocitinib|abrocitinib|mesh-list
139147692|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147693|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147694|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147695|NCT02155504|Itraconazole|itraconazole|mesh-list
139147696|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
139147697|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139147698|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139147699|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139147700|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147701|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147702|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139147703|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
139147704|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139147705|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147706|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139147707|NCT03642717|Empagliflozin|empagliflozin|mesh-list
139147708|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139147709|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147710|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139147711|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147712|NCT02766478|Genistein|genistein|mesh-list
139147713|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139147714|NCT02766478|Protective Agents|protective agents|mesh-ancestor
139147715|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147716|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147717|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147718|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147719|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147720|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
139147721|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139147722|NCT02766478|Estrogens|estrogens|mesh-ancestor
139147723|NCT02766478|Hormones|hormones|mesh-ancestor
139147724|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139147725|NCT03729375|Bupivacaine|bupivacaine|mesh-list
139147726|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
139147727|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
139147728|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147729|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147730|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
139147731|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147732|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139147733|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
139147734|NCT02159326|Riociguat|riociguat|mesh-list
139147735|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
139147736|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147737|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139147738|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
139147739|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139147740|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147741|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139147742|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139147743|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139147744|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139147745|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139147746|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
139147747|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139147748|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139147749|NCT02255266|Liraglutide|liraglutide|mesh-list
139147750|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139147751|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147752|NCT02255266|Incretins|incretins|mesh-ancestor
139147753|NCT02255266|Hormones|hormones|mesh-ancestor
139147754|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139147755|NCT00104650|Diphosphonates|diphosphonates|mesh-list
139147756|NCT00104650|Denosumab|denosumab|mesh-list
139147757|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139147758|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147759|NCT02158078|Insulin|insulin|mesh-list
139147760|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139147761|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147762|NCT00104416|Lamotrigine|lamotrigine|mesh-list
139147763|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
139147764|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139147765|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139147766|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147767|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139147768|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147769|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139147770|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139147771|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147772|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139147773|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139147774|NCT02149888|Tenofovir|tenofovir|mesh-list
139147775|NCT02149888|Emtricitabine|emtricitabine|mesh-list
139147776|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
139147777|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139147778|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139147779|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139147780|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880561|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147781|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147782|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139147783|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139147784|NCT03639675|Aflibercept|aflibercept|mesh-list
139147785|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139147786|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139147787|NCT03639675|Growth Substances|growth substances|mesh-ancestor
139147788|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147789|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
139147790|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147791|NCT03543436|Meropenem|meropenem|mesh-list
139147792|NCT03543436|Imipenem|imipenem|mesh-list
139147793|NCT03543436|Temocillin|temocillin|mesh-list
139147794|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139147795|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139147796|NCT02149966|Mitapivat|mitapivat|mesh-list
139147797|NCT02149966|Enzyme Activators|enzyme activators|mesh-ancestor
139147798|NCT02149966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147799|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
139147800|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
139147801|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188393|NCT00361959|Xhance|xhance|mesh-list
139147802|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
139147803|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139147804|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147805|NCT01310361|Amoxicillin|amoxicillin|mesh-list
139147806|NCT01310361|Penicillins|penicillins|mesh-list
139147807|NCT01310361|Penicillin G|penicillin g|mesh-list
139147808|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139147809|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
139147810|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139147811|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139147812|NCT03541798|Anesthetics|anesthetics|mesh-list
139147813|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147814|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147815|NCT02150122|Vitamin D|vitamin d|mesh-list
139147816|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
139147817|NCT02150122|Vitamins|vitamins|mesh-ancestor
139147818|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
139147819|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147820|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139147821|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139147822|NCT03728829|Carboplatin|carboplatin|mesh-list
139147823|NCT03728829|Docetaxel|docetaxel|mesh-list
139147825|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147826|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
139147827|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
139147828|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
139147829|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147830|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139147831|NCT00121667|Metformin|metformin|mesh-list
139147832|NCT00121667|Pioglitazone|pioglitazone|mesh-list
139147833|NCT00121667|Saxagliptin|saxagliptin|mesh-list
139147834|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139147835|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147836|NCT00121667|Incretins|incretins|mesh-ancestor
139147837|NCT00121667|Hormones|hormones|mesh-ancestor
139147838|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139147839|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139147840|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
139147841|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147842|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147843|NCT02954601|Insulin|insulin|mesh-list
139147844|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139147845|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139147846|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147848|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
139147849|NCT00121199|Bevacizumab|bevacizumab|mesh-list
139147850|NCT00121199|Rituximab|rituximab|mesh-list
139147851|NCT00121199|Doxorubicin|doxorubicin|mesh-list
139147852|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139147853|NCT00121199|Vincristine|vincristine|mesh-list
139147854|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139147855|NCT00121199|Antibodies|antibodies|mesh-list
139147856|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
139147857|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139147858|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139147859|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
139147860|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147861|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139147862|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139147863|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
139147864|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147865|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147866|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139147867|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139147868|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139147869|NCT00121199|Growth Substances|growth substances|mesh-ancestor
139147870|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
139147871|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139147872|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139147873|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139147874|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147875|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139147876|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
139147877|NCT00121199|Hormones|hormones|mesh-ancestor
139147878|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139147879|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139147880|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139147881|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
139147882|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
139147883|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
139147884|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
139147885|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139147886|NCT00119015|Fluticasone|fluticasone|mesh-list
139147888|NCT00119015|Montelukast|montelukast|mesh-list
139147889|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139147890|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139147891|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
139147892|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147893|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147894|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138880602|NCT00542425|Teriparatide|teriparatide|mesh-list
139147895|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
139147896|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
139147897|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139147898|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139147899|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
139147900|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139147901|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139147902|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139147903|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147905|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139147906|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
139147908|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
139147909|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
139147910|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139147911|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147912|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147913|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139147914|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139147915|NCT01079351|Analgesics|analgesics|mesh-ancestor
138615476|NCT00215514|Fluorouracil|fluorouracil|mesh-list
139147916|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
139147917|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147918|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139147919|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139147920|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147921|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139147922|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139147923|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
139147924|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139147925|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147926|NCT02158624|Ranibizumab|ranibizumab|mesh-list
139147927|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139147928|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139147929|NCT02158624|Growth Substances|growth substances|mesh-ancestor
139147930|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147931|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
139147932|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147933|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
139147934|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147935|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147936|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147937|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147938|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
139147939|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
139147940|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147941|NCT03639519|Protective Agents|protective agents|mesh-ancestor
139147942|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147943|NCT03639519|Vitamins|vitamins|mesh-ancestor
139147944|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
139147945|NCT02158702|Dexamethasone|dexamethasone|mesh-list
139147946|NCT02158702|Pomalidomide|pomalidomide|mesh-list
139147947|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139147948|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
139147949|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
139147950|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139147951|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147952|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139147953|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
139147954|NCT02158702|Hormones|hormones|mesh-ancestor
139147955|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139147956|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139147957|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147958|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
138817858|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
138887368|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
139147959|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139147960|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139147961|NCT02158702|Growth Substances|growth substances|mesh-ancestor
139147962|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
139147963|NCT03725709|Anesthetics|anesthetics|mesh-list
139147964|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147965|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147967|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147968|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147969|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147970|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147971|NCT02160028|Anesthetics|anesthetics|mesh-list
139147972|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139147973|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147974|NCT03246152|Bevacizumab|bevacizumab|mesh-list
139147975|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139147976|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147977|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139147978|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139147979|NCT03246152|Growth Substances|growth substances|mesh-ancestor
139147980|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139147981|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
139147982|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
139147983|NCT03541564|Deucravacitinib|deucravacitinib|mesh-list
139147984|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139147985|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139147986|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139147987|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139147988|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139147989|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147990|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139147991|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
139147992|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139147993|NCT00115349|Deferiprone|deferiprone|mesh-list
139147994|NCT00115349|Deferoxamine|deferoxamine|mesh-list
139147995|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139147996|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
139147997|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
139147998|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139147999|NCT00115349|Siderophores|siderophores|mesh-ancestor
139148000|NCT04804696|Paclitaxel|paclitaxel|mesh-list
139148001|NCT04804696|Cisplatin|cisplatin|mesh-list
139148002|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139148003|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148004|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
139148005|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
139148006|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
139148007|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148008|NCT00115037|Naltrexone|naltrexone|mesh-list
139148009|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139148010|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139148011|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148012|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
139148013|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148014|NCT02160106|Vactosertib|vactosertib|mesh-list
139148015|NCT02160106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139148016|NCT02160106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148017|NCT02160106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148019|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139148020|NCT03725553|Vasopressins|vasopressins|mesh-list
139148021|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
139148022|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
139148023|NCT03725553|Coagulants|coagulants|mesh-ancestor
139148024|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139148025|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139148026|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
139148027|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148028|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138887397|NCT00611195|Narcotics|narcotics|mesh-ancestor
139148029|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148030|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139148031|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148032|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148033|NCT03604341|Dronabinol|dronabinol|mesh-list
139148034|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
139148035|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148036|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139148037|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139148038|NCT03604341|Analgesics|analgesics|mesh-ancestor
139148039|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
139148040|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148041|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139148042|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139148043|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139148044|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148045|NCT03604341|Hormones|hormones|mesh-ancestor
139148046|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139148048|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139148049|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139148050|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148051|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
139148052|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
139148053|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
139148054|NCT01186640|Fludarabine|fludarabine|mesh-list
139148055|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
139148056|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
139148057|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
139148058|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139148059|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
139148060|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148061|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139148062|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139148063|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
139148064|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148065|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148066|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139148067|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139148068|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
139148069|NCT01186640|Analgesics|analgesics|mesh-ancestor
139148070|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
139148071|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148072|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139148073|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139148074|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148075|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139148076|NCT04949516|Aspirin|aspirin|mesh-list
139148077|NCT04949516|Colchicine|colchicine|mesh-list
139148078|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139148079|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139148080|NCT04949516|Analgesics|analgesics|mesh-ancestor
139148081|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
139148082|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148083|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148084|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139148085|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139148086|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139148087|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139148088|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148089|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139148090|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139148091|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148092|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
139148093|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
139148094|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
139148095|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
139148096|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
139148097|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148098|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
139148099|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
139148100|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148101|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139148102|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148103|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148104|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139148105|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139148106|NCT02778100|Phenylephrine|phenylephrine|mesh-list
139148107|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
139148108|NCT02778100|Glucagon|glucagon|mesh-list
139148109|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139148110|NCT02778100|Hormones|hormones|mesh-ancestor
139148111|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139148112|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148113|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139148114|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139148115|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
139148116|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139148117|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148118|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
139148119|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
139148120|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148121|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
139148122|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139148123|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
139148124|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139148125|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
139148126|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139148127|NCT02778100|Protective Agents|protective agents|mesh-ancestor
139148128|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
139148129|NCT02159248|Gemcitabine|gemcitabine|mesh-list
139148130|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139148131|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
139148132|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148133|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148134|NCT02159248|Analgesics|analgesics|mesh-ancestor
139148135|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
139148136|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148137|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148138|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139148139|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139148140|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139148141|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139148142|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139148143|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139148144|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139148145|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
139148146|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
139148147|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138617657|NCT00226980|Thalidomide|thalidomide|mesh-list
139148148|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139148149|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
139148150|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139148151|NCT00118157|Tamoxifen|tamoxifen|mesh-list
139148152|NCT00118157|Lapatinib|lapatinib|mesh-list
139148153|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148154|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139148155|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
139148156|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139148157|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148158|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139148159|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148160|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139148161|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139148162|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139148163|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139148164|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148165|NCT03543202|Anesthetics|anesthetics|mesh-list
139148166|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139148167|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148168|NCT03552549|Interferons|interferons|mesh-list
139148169|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
139148170|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
139148171|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139148172|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148173|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
139148174|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148175|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
139148176|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148177|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
139148178|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148179|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
139148180|NCT02761642|Hematinics|hematinics|mesh-ancestor
139148181|NCT03731403|Fluorides|fluorides|mesh-list
139148182|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
139148183|NCT03731403|Protective Agents|protective agents|mesh-ancestor
139148184|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148185|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
139148186|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148187|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139148188|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148189|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148190|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
139148191|NCT03600909|Busulfan|busulfan|mesh-list
139148192|NCT03600909|Fludarabine|fludarabine|mesh-list
139148193|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139148194|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
139148195|NCT03600909|Lenograstim|lenograstim|mesh-list
139148196|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139148198|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148199|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139148200|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139148201|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
139148202|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148203|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148204|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139148205|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139148206|NCT03189446|Paclitaxel|paclitaxel|mesh-list
139148207|NCT03189446|Carboplatin|carboplatin|mesh-list
139148208|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139148210|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
139148211|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
139148212|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
138619212|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
139148213|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148214|NCT01314482|Minocycline|minocycline|mesh-list
139148215|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139148216|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148217|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
139148218|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139148219|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
139148220|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148221|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148222|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139148223|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
139148224|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
139148225|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139148226|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
139148227|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139148228|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148229|NCT02895945|Factor VIII|factor viii|mesh-list
139148230|NCT02895945|Coagulants|coagulants|mesh-ancestor
139148231|NCT02777554|Thalidomide|thalidomide|mesh-list
139148232|NCT02777554|Apremilast|apremilast|mesh-list
139148233|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139148234|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139148235|NCT02777554|Analgesics|analgesics|mesh-ancestor
139148236|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
139148237|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148238|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148239|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139148240|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139148241|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139148242|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139148243|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148244|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148245|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139148246|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
139148247|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
139148248|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139148249|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148250|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139148251|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139148252|NCT02777554|Growth Substances|growth substances|mesh-ancestor
139148253|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
139148254|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148255|NCT03220178|Letrozole|letrozole|mesh-list
139148256|NCT03220178|Fulvestrant|fulvestrant|mesh-list
139148257|NCT03220178|Palbociclib|palbociclib|mesh-list
139148258|NCT03220178|Anastrozole|anastrozole|mesh-list
139148259|NCT03220178|Exemestane|exemestane|mesh-list
139148260|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148261|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139148262|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139148263|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148264|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148265|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139148266|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
139148267|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139148268|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148269|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139148270|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138620030|NCT00234858|Diuretics|diuretics|mesh-ancestor
139148271|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139148273|NCT03032510|Ertapenem|ertapenem|mesh-list
139148274|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139148275|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148276|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139148277|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139148278|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139148279|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148280|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148281|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148282|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139148283|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139148285|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139148286|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139148287|NCT03022292|Growth Substances|growth substances|mesh-ancestor
139148288|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148289|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
139148290|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148291|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
139148292|NCT03599193|Tazarotene|tazarotene|mesh-list
139148293|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
139148294|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
139148295|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
139148296|NCT03599193|Vitamins|vitamins|mesh-ancestor
139148297|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
139148298|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148299|NCT02161354|Buprenorphine|buprenorphine|mesh-list
139148300|NCT02161354|Naloxone|naloxone|mesh-list
139148301|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139148302|NCT02161354|Narcotics|narcotics|mesh-ancestor
139148303|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139148304|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148305|NCT02161354|Analgesics|analgesics|mesh-ancestor
139148306|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
139148307|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148308|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139148309|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
139148310|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139148311|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148312|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
139148313|NCT02777242|Testosterone|testosterone|mesh-list
139148314|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
139148315|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
138880682|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
139148316|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139148317|NCT02777242|Androgens|androgens|mesh-ancestor
139148318|NCT02777242|Hormones|hormones|mesh-ancestor
139148319|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139148320|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148321|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139148322|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148323|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
139148324|NCT02163070|Vitamins|vitamins|mesh-list
139148325|NCT02163070|Vitamin E|vitamin e|mesh-list
139148326|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
139148327|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148328|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
139148329|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148330|NCT02163070|Protective Agents|protective agents|mesh-ancestor
139148331|NCT03484520|Venetoclax|venetoclax|mesh-list
139148332|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148333|NCT03566979|Naproxen|naproxen|mesh-list
139148334|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139148335|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139148336|NCT03566979|Analgesics|analgesics|mesh-ancestor
139148337|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
139148338|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148339|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148340|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139148341|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139148342|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
139148343|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139148344|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148345|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148346|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
139148347|NCT00116831|Glipizide|glipizide|mesh-list
139148348|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139148349|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148350|NCT02784704|Meropenem|meropenem|mesh-list
139148351|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139148352|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148353|NCT03540472|Tacrolimus|tacrolimus|mesh-list
139148354|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139148355|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
139148356|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148357|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139148358|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148359|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148360|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139148361|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139148362|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139148363|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
139148364|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148365|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138887470|NCT01005199|Sorafenib|sorafenib|mesh-list
139148366|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139148367|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148368|NCT01310283|Fluorides|fluorides|mesh-list
139148369|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
139148370|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
139148371|NCT01310283|Protective Agents|protective agents|mesh-ancestor
139148372|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148373|NCT02161822|Simvastatin|simvastatin|mesh-list
139148374|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139148376|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
139148377|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148378|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139148379|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139148380|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148381|NCT03183908|Vaccines|vaccines|mesh-list
139148382|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
139148383|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148384|NCT03724851|Vactosertib|vactosertib|mesh-list
139148385|NCT03724851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139148386|NCT03724851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148387|NCT03724851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148388|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139148389|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139148390|NCT00113399|Paclitaxel|paclitaxel|mesh-list
139148391|NCT00113399|Docetaxel|docetaxel|mesh-list
139148392|NCT00113399|Fluorouracil|fluorouracil|mesh-list
139148393|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139148394|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148395|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
139148396|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
139148397|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
139148398|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148399|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
139148400|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139148401|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139148402|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
139148403|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148404|NCT01326611|Clarithromycin|clarithromycin|mesh-list
139148405|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139148406|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148407|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139148408|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148409|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148410|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139148411|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139148412|NCT00113087|Enalapril|enalapril|mesh-list
139148413|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139148414|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
139148415|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148416|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148417|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139148418|NCT00112463|Romidepsin|romidepsin|mesh-list
139148419|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139148420|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148421|NCT00112463|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139148422|NCT00112463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148423|NCT00112463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148424|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
139148425|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
139148426|NCT01083017|Diuretics|diuretics|mesh-ancestor
139148427|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
139148428|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148429|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139148430|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139148431|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148432|NCT00112385|Etanercept|etanercept|mesh-list
139148433|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139148434|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139148435|NCT00112385|Analgesics|analgesics|mesh-ancestor
139148436|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
139148437|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148438|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148439|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139148440|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139148441|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139148442|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139148443|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
139148444|NCT03731169|Voriconazole|voriconazole|mesh-list
139148445|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
139148446|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148447|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139148448|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139148449|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148450|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148451|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139148452|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
139148453|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139148454|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148455|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139148457|NCT03731091|Betamethasone|betamethasone|mesh-list
139148458|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
139148459|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139148460|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
139148461|NCT03731091|Calcipotriene|calcipotriene|mesh-list
139148462|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139148463|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139148464|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
139148465|NCT03731091|Hormones|hormones|mesh-ancestor
139148466|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139148467|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148468|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139148469|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
139148470|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
139148471|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139148472|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139148473|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139148474|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148475|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139148476|NCT03731091|Vitamins|vitamins|mesh-ancestor
139148477|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
139148478|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139148479|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139148480|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
139148481|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148482|NCT03560739|Ofatumumab|ofatumumab|mesh-list
139148483|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139148484|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148485|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
139148486|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148487|NCT01310673|Allopurinol|allopurinol|mesh-list
139148488|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
139148489|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148490|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148491|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
139148492|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139148493|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139148494|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
139148495|NCT01310673|Protective Agents|protective agents|mesh-ancestor
139148496|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148497|NCT00101686|Bevacizumab|bevacizumab|mesh-list
139148498|NCT00101686|Capecitabine|capecitabine|mesh-list
139148499|NCT00101686|Irinotecan|irinotecan|mesh-list
139148500|NCT00101686|Fluorouracil|fluorouracil|mesh-list
139148501|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139148502|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148503|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139148504|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139148505|NCT00101686|Growth Substances|growth substances|mesh-ancestor
139148506|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148507|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
139148508|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139148509|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
139148510|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148511|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139148512|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139148513|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148514|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139148515|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
139148516|NCT02163616|Misoprostol|misoprostol|mesh-list
139148517|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139148518|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
139148519|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139148520|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148521|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139148522|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138626607|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139148523|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
139148524|NCT00101452|Escitalopram|escitalopram|mesh-list
139148525|NCT00101452|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139148526|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139148527|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139148528|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148529|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139148530|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
139148531|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148532|NCT02162134|Cefuroxime|cefuroxime|mesh-list
139148533|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
139148534|NCT02162134|Ketorolac|ketorolac|mesh-list
139148535|NCT02162134|Midazolam|midazolam|mesh-list
139148536|NCT02162134|Propofol|propofol|mesh-list
139148537|NCT02162134|Sevoflurane|sevoflurane|mesh-list
139148538|NCT02162134|Atracurium|atracurium|mesh-list
139148539|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139148540|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139148541|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148542|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139148543|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
139148544|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
139148545|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139148546|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139148547|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139148548|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139148549|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
139148550|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
139148551|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139148552|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148553|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139148554|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139148555|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139148556|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139148557|NCT02162134|Analgesics|analgesics|mesh-ancestor
139148558|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
139148559|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148560|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139148561|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139148562|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139148563|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148564|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139148565|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148566|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139148567|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138818479|NCT04075201|Vaccines|vaccines|mesh-list
139148568|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139148569|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139148570|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139148571|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
139148572|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139148573|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139148574|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139148575|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148576|NCT02164006|Immunotoxins|immunotoxins|mesh-ancestor
139148577|NCT02164006|Immunoconjugates|immunoconjugates|mesh-ancestor
139148578|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
139148579|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148580|NCT02167360|Tisagenlecleucel|tisagenlecleucel|mesh-list
139148581|NCT02167360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139148582|NCT02167360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148583|NCT03546621|Tenofovir|tenofovir|mesh-list
139148584|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
139148585|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148586|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139148587|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139148588|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148589|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148590|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139148591|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139148592|NCT02761330|Ketamine|ketamine|mesh-list
138899109|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148593|NCT02761330|Analgesics|analgesics|mesh-ancestor
139148594|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
139148595|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148596|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148597|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139148598|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139148599|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
139148600|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
139148601|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139148602|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139148603|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139148604|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139148605|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148607|NCT03730857|Risperidone|risperidone|mesh-list
139148608|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139148609|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
139148610|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139148611|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
139148612|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139148613|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880842|NCT02761577|Antidotes|antidotes|mesh-ancestor
139148614|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148615|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139148616|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139148617|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139148618|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139148619|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
139148620|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
139148621|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
139148622|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148623|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139148624|NCT03730857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139148625|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139148626|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139148627|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139148628|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139148629|NCT03726177|Aspirin|aspirin|mesh-list
139148630|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139148631|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139148632|NCT03726177|Analgesics|analgesics|mesh-ancestor
139148633|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
139148634|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148635|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148636|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139148637|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139148638|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139148639|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139148640|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148641|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139148642|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139148643|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148644|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
139148645|NCT03726099|Amoxicillin|amoxicillin|mesh-list
139148646|NCT03726099|Tetracycline|tetracycline|mesh-list
139148647|NCT03726099|Furazolidone|furazolidone|mesh-list
139148648|NCT03726099|Esomeprazole|esomeprazole|mesh-list
139148649|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139148650|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148651|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139148652|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139148653|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139148654|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148655|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148656|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139148657|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139148658|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139148659|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139148660|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139148661|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139148662|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139148663|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
139148664|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
138880868|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139148665|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139148666|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139148667|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148668|NCT03558555|Acetaminophen|acetaminophen|mesh-list
139148669|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139148670|NCT03558555|Analgesics|analgesics|mesh-ancestor
139148671|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
139148672|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148673|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148674|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
139148675|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
139148677|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148678|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139148679|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139148680|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148681|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148682|NCT05665023|Bevacizumab|bevacizumab|mesh-list
139148683|NCT05665023|Folfirinox|folfirinox|mesh-list
139148684|NCT05665023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139148685|NCT05665023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148686|NCT05665023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139148687|NCT05665023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139148688|NCT05665023|Growth Substances|growth substances|mesh-ancestor
139148689|NCT05665023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148690|NCT05665023|Growth Inhibitors|growth inhibitors|mesh-ancestor
139148691|NCT03557931|Olanzapine|olanzapine|mesh-list
139148692|NCT03557931|Risperidone|risperidone|mesh-list
139148693|NCT03557931|Aripiprazole|aripiprazole|mesh-list
139148694|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139148695|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139148696|NCT03557931|Ziprasidone|ziprasidone|mesh-list
139148697|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139148698|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
139148699|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139148700|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
139148701|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139148702|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148703|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148704|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139148705|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139148706|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139148707|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139148708|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139148709|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
139148710|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
139148711|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
139148712|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148713|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139148714|NCT03557931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139148715|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139148716|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139148717|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
139148718|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
139148719|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139148720|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139148721|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139148722|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139148723|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139148724|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139148725|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139148726|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
139148727|NCT03977675|Ketamine|ketamine|mesh-list
139148728|NCT03977675|Analgesics|analgesics|mesh-ancestor
139148729|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
139148730|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148731|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148732|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139148733|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139148734|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
139148735|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
139148736|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139148737|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139148738|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139148739|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139148740|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148741|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
139148742|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
139148743|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139148744|NCT01066559|Protective Agents|protective agents|mesh-ancestor
139148745|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148746|NCT00293813|Denosumab|denosumab|mesh-list
139148747|NCT00293813|Alendronate|alendronate|mesh-list
139148748|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139148749|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148750|NCT00293579|Pemetrexed|pemetrexed|mesh-list
139148751|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148752|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148753|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148754|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139148755|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139148756|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
139148757|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139148758|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
139148759|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148760|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139148761|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148762|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
139148763|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148764|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
139148765|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139148766|NCT00293423|Protective Agents|protective agents|mesh-ancestor
139148767|NCT03521817|Ethanol|ethanol|mesh-list
139148768|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139148769|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148770|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139148771|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148772|NCT03538431|Buspirone|buspirone|mesh-list
139148773|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139148774|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139148775|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139148776|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148777|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139148778|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139148779|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
138880976|NCT00669786|Hormones|hormones|mesh-list
139148780|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139148781|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148782|NCT03521193|Aspirin|aspirin|mesh-list
139148783|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139148784|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139148785|NCT03521193|Analgesics|analgesics|mesh-ancestor
139148786|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
139148787|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148788|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148789|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139148790|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139148791|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139148792|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139148793|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148794|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139148795|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139148796|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148797|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
139148798|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
139148799|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139148800|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139148801|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
139148802|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148803|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139148804|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139148805|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881002|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
139148806|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148807|NCT03977441|Pramipexole|pramipexole|mesh-list
139148808|NCT03977441|Agomelatine|agomelatine|mesh-list
139148809|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
139148810|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148811|NCT03977441|Protective Agents|protective agents|mesh-ancestor
139148812|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148813|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139148814|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139148815|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
139148816|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
139148817|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139148818|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139148819|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139148820|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139148821|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139148822|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
139148823|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139148824|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148825|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139148826|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
139148827|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139148828|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148829|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148830|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148831|NCT00111917|Infliximab|infliximab|mesh-list
139148832|NCT00111917|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139148833|NCT00111917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139148834|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
139148835|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139148836|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139148837|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
139148838|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
139148839|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139148840|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139148841|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148842|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148843|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148844|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139148845|NCT03520569|Octreotide|octreotide|mesh-list
139148846|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139148847|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139148848|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148849|NCT00111839|Pemetrexed|pemetrexed|mesh-list
139148850|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148851|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148852|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148853|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139148854|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139148855|NCT03723291|Tocopherols|tocopherols|mesh-list
139148856|NCT03723291|Vitamin E|vitamin e|mesh-list
139148857|NCT03723291|Tocotrienols|tocotrienols|mesh-list
139148858|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
139148859|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
139148860|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139148861|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148862|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148863|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139148864|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139148865|NCT03723291|Protective Agents|protective agents|mesh-ancestor
139148866|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148867|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
139148868|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139148870|NCT03723291|Vitamins|vitamins|mesh-ancestor
139148871|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
139148872|NCT00111761|Leucovorin|leucovorin|mesh-list
139148873|NCT00111761|Fluorouracil|fluorouracil|mesh-list
139148874|NCT00111761|Irinotecan|irinotecan|mesh-list
139148875|NCT00111761|Panitumumab|panitumumab|mesh-list
139148876|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
139148877|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148878|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139148879|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148880|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139148881|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
139148882|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148883|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139148884|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139148885|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148886|NCT00111761|Antidotes|antidotes|mesh-ancestor
139148887|NCT00111761|Protective Agents|protective agents|mesh-ancestor
139148888|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
139148889|NCT00111761|Vitamins|vitamins|mesh-ancestor
139148890|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
139148891|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139148892|NCT03519867|Bromides|bromides|mesh-list
138899408|NCT04171739|Itraconazole|itraconazole|mesh-list
139148893|NCT03519867|Rocuronium|rocuronium|mesh-list
139148894|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
139148895|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139148896|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139148897|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139148898|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148899|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148900|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
139148901|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139148902|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148903|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
139148904|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
139148905|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139148906|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139148907|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
139148908|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148909|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139148910|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
139148911|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148912|NCT02164552|Vitamin D|vitamin d|mesh-list
139148913|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
139148914|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
139148915|NCT02164552|Vitamins|vitamins|mesh-list
139148916|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
139148917|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148918|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139148919|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139148920|NCT03723135|Azacitidine|azacitidine|mesh-list
139148921|NCT03723135|Cc-486|cc-486|mesh-list
139148922|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139148923|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
139148924|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148925|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139148926|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148927|NCT02762578|Insulin|insulin|mesh-list
139148928|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139148929|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
139148930|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
139148931|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139148932|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
139148933|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139148934|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148935|NCT03540628|Thiamine|thiamine|mesh-list
139148936|NCT03540628|Vitamins|vitamins|mesh-ancestor
139148937|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
139148938|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148939|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
139148940|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
139148941|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139148942|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139148943|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148945|NCT02170948|Analgesics|analgesics|mesh-ancestor
139148946|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
139148947|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148948|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139148949|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139148950|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139148951|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
139148952|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139148953|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148954|NCT02171026|Amiodarone|amiodarone|mesh-list
139148955|NCT02171026|Dabigatran|dabigatran|mesh-list
139148956|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
139148957|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139148958|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
139148959|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148960|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148961|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
139148962|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139148963|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
139148964|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139148965|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139148966|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139148967|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139148968|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139148969|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139148970|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139148971|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139148972|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
139148973|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139148974|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
139148975|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148977|NCT02165020|Protective Agents|protective agents|mesh-ancestor
139148979|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139148980|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148981|NCT03539224|Lamivudine|lamivudine|mesh-list
139148982|NCT03539224|Dolutegravir|dolutegravir|mesh-list
139148983|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139148984|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139148985|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139148986|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139148987|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
139148988|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139148989|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139148990|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139148991|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139148992|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139148993|NCT02171182|Capsaicin|capsaicin|mesh-list
139148994|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
139148995|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
139148996|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
139148997|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139148998|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139148999|NCT00100828|Irinotecan|irinotecan|mesh-list
139149000|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139149001|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139149002|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149003|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149004|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149005|NCT02165098|Cariprazine|cariprazine|mesh-list
139149006|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139149007|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139149008|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139149009|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149010|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139149011|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139149012|NCT02171338|Azithromycin|azithromycin|mesh-list
139149013|NCT02171338|Clarithromycin|clarithromycin|mesh-list
139149014|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
139149015|NCT02171338|Tazobactam|tazobactam|mesh-list
139149016|NCT02171338|Piperacillin|piperacillin|mesh-list
139149017|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139149018|NCT02171338|Penicillin G|penicillin g|mesh-list
139149019|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139149020|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139149021|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149022|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149023|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139149024|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139149025|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139149026|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139149027|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149028|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139149029|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139149031|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139149032|NCT02171494|Warfarin|warfarin|mesh-list
139149033|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
139149034|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
139149035|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139149036|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139149037|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139149038|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139149039|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139149040|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149041|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149042|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149043|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139149044|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
139149045|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139149046|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149047|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139149048|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139149049|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139149050|NCT02171572|Dabigatran|dabigatran|mesh-list
139149051|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
139149052|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139149053|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
139149054|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149055|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149056|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
139149057|NCT02255578|Clomiphene|clomiphene|mesh-list
139149058|NCT02255578|Enclomiphene|enclomiphene|mesh-list
139149059|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
139149060|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139149061|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
139149062|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139149063|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149064|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139149065|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
139149066|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139149067|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139149068|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139149069|NCT02169154|Diclofenac|diclofenac|mesh-list
139149070|NCT02169154|Menthol|menthol|mesh-list
139149071|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139149072|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139149073|NCT02169154|Analgesics|analgesics|mesh-ancestor
138887635|NCT01006057|Insulin|insulin|mesh-list
139149074|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
139149075|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149076|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149077|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139149078|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139149079|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139149080|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149081|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149082|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
139149083|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
139149084|NCT00100048|Tenofovir|tenofovir|mesh-list
139149085|NCT00100048|Lamivudine|lamivudine|mesh-list
139149086|NCT00100048|Efavirenz|efavirenz|mesh-list
139149087|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
139149088|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
139149089|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139149090|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139149091|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139149092|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149093|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149094|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139149095|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139149096|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139149097|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139149098|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139149099|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139149100|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139149101|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139149102|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139149103|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139149104|NCT02171650|Afatinib|afatinib|mesh-list
139149105|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149106|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139149107|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149108|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149109|NCT02165566|Insulin|insulin|mesh-list
139149110|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139149111|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
139149112|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139149113|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149114|NCT02171728|Afatinib|afatinib|mesh-list
139149115|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149116|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139149117|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149118|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149119|NCT02165644|Nimodipine|nimodipine|mesh-list
139149120|NCT02165644|Acetazolamide|acetazolamide|mesh-list
138899624|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
139149121|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
139149122|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139149123|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149124|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149125|NCT02165644|Diuretics|diuretics|mesh-ancestor
139149126|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
139149127|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149128|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139149129|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139149130|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139149131|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139149132|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
139149133|NCT02171806|Olodaterol|olodaterol|mesh-list
139149134|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139149135|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
139149136|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149137|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149138|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139149139|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
139149140|NCT02169544|Abatacept|abatacept|mesh-list
139149141|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139149142|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149143|NCT02169544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139149144|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149145|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139149146|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
139149147|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149148|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139149149|NCT02169856|Cefuroxime|cefuroxime|mesh-list
139149150|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
139149151|NCT02169856|Ketorolac|ketorolac|mesh-list
139149152|NCT02169856|Midazolam|midazolam|mesh-list
139149153|NCT02169856|Propofol|propofol|mesh-list
139149154|NCT02169856|Sevoflurane|sevoflurane|mesh-list
139149155|NCT02169856|Atracurium|atracurium|mesh-list
139149156|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139149157|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139149158|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149159|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139149160|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
139149161|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
139149162|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139149163|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139149164|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139149165|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139149166|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
139149167|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
139149168|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139149169|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149170|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139149171|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139149172|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139149173|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139149174|NCT02169856|Analgesics|analgesics|mesh-ancestor
139149175|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
139149176|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149177|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139149178|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139149179|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139149180|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149181|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139149182|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139149183|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139149184|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139149185|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139149186|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139149187|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139149188|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
139149189|NCT02170246|Telmisartan|telmisartan|mesh-list
139149190|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139149191|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139149192|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139149193|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149194|NCT02170324|Exenatide|exenatide|mesh-list
139149195|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139149196|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149197|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139149198|NCT02170324|Incretins|incretins|mesh-ancestor
138899706|NCT02654171|Ziresovir|ziresovir|mesh-list
139149199|NCT02170324|Hormones|hormones|mesh-ancestor
139149200|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139149201|NCT02170402|Factor VIII|factor viii|mesh-list
139149202|NCT02170402|Coagulants|coagulants|mesh-ancestor
139149203|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139149204|NCT02172196|Empagliflozin|empagliflozin|mesh-list
139149205|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139149206|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149207|NCT02172196|Incretins|incretins|mesh-ancestor
139149208|NCT02172196|Hormones|hormones|mesh-ancestor
139149209|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139149210|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139149211|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
139149212|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149213|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149214|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139149215|NCT02172274|Empagliflozin|empagliflozin|mesh-list
139149216|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139149217|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149218|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139149219|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149220|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
139149221|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139149222|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
139149223|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149224|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149225|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139149226|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
139149227|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
139149228|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139149229|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
139149230|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139149231|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149232|NCT02757352|Ixekizumab|ixekizumab|mesh-list
139149233|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
139149234|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
139149235|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139149236|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
139149237|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149239|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139149240|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
139149241|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
139149242|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139149243|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
139149244|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139149245|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149246|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
139149247|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139149248|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
139149249|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149250|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149251|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139149252|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
139149253|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
139149254|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139149255|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
139149256|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139149257|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149259|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139149260|NCT02172586|Telmisartan|telmisartan|mesh-list
139149261|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139149262|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139149263|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139149264|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139149265|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149266|NCT02172586|Diuretics|diuretics|mesh-ancestor
139149267|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
139149268|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149269|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139149270|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139149271|NCT02170636|Pantoprazole|pantoprazole|mesh-list
139149272|NCT02170636|Dabigatran|dabigatran|mesh-list
139149273|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139149274|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139149275|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139149276|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149277|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149278|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
139149279|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139149280|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
139149281|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
139149282|NCT02255734|Acyclovir|acyclovir|mesh-list
139149283|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
139149284|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139149285|NCT02170792|Ranitidine|ranitidine|mesh-list
139149286|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139149287|NCT02170792|Dabigatran|dabigatran|mesh-list
139149288|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139149289|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139149290|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139149291|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
139149292|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
139149293|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139149294|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149295|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149296|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
139149297|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139149298|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
139149299|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149300|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
139149301|NCT02172976|Gemcitabine|gemcitabine|mesh-list
139149302|NCT02172976|Fluorouracil|fluorouracil|mesh-list
139149303|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
139149304|NCT02172976|Irinotecan|irinotecan|mesh-list
139149305|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139149306|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
139149307|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149308|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149309|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139149310|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
139149311|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149313|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139149314|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149315|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
139149316|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
139149318|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
139149319|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149320|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
139149321|NCT02173288|Furosemide|furosemide|mesh-list
139149322|NCT02173288|Spironolactone|spironolactone|mesh-list
139149323|NCT02173288|Tolvaptan|tolvaptan|mesh-list
139149324|NCT02173288|Midodrine|midodrine|mesh-list
139149325|NCT02173288|Diuretics|diuretics|mesh-ancestor
139149326|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
139149327|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149328|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139149329|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139149330|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149331|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139149332|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
139149333|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881405|NCT02648906|Choline|choline|mesh-list
139149334|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139149335|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139149337|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
139149338|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149339|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139149340|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139149341|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139149342|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139149343|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
139149344|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139149345|NCT02175394|Linagliptin|linagliptin|mesh-list
139149346|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139149347|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
139149348|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139149349|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149350|NCT02175394|Incretins|incretins|mesh-ancestor
139149351|NCT02175394|Hormones|hormones|mesh-ancestor
139149352|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139149353|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139149354|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
139149355|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149356|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149357|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139149358|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
139149359|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139149360|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139149361|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139149362|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139149363|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139149364|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139149365|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
139149366|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139149367|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139149368|NCT02256124|Lamotrigine|lamotrigine|mesh-list
139149369|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
139149370|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139149371|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139149372|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149373|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139149374|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149375|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139149376|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139149377|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139149378|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139149379|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139149380|NCT02173756|Morphine|morphine|mesh-list
139149381|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139149382|NCT02173756|Narcotics|narcotics|mesh-ancestor
139149383|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139149384|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149385|NCT02173756|Analgesics|analgesics|mesh-ancestor
138887691|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
139149386|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
139149387|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149388|NCT00102466|Metformin|metformin|mesh-list
139149389|NCT00102466|Vildagliptin|vildagliptin|mesh-list
139149390|NCT00102466|Gliclazide|gliclazide|mesh-list
139149391|NCT00102466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139149392|NCT00102466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149393|NCT00102466|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139149394|NCT00102466|Protease Inhibitors|protease inhibitors|mesh-ancestor
139149395|NCT00102466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149396|NCT00102466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149397|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139149398|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139149399|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139149400|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149401|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149402|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149403|NCT02173912|Amlodipine|amlodipine|mesh-list
139149404|NCT02173912|Candesartan|candesartan|mesh-list
139149405|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
139149406|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139149407|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139149408|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138881467|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
139149409|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149410|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139149411|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149412|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
139149413|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139149414|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139149415|NCT02173990|Aflibercept|aflibercept|mesh-list
139149416|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139149417|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139149418|NCT02173990|Growth Substances|growth substances|mesh-ancestor
139149419|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149420|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
139149421|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149422|NCT02255812|Quinine|quinine|mesh-list
139149423|NCT02255812|Citric Acid|citric acid|mesh-list
139149424|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
139149425|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
139149426|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139149427|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139149428|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139149429|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139149430|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149431|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139149432|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149433|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139149434|NCT02255812|Analgesics|analgesics|mesh-ancestor
139149435|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
139149436|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
139149437|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139149438|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
139149439|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
139149440|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149441|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
139149442|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139149443|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149444|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139149445|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149446|NCT02256280|Neostigmine|neostigmine|mesh-list
139149447|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139149448|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149449|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149450|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
139149451|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139149452|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149453|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139149454|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
139149455|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149456|NCT02174068|Acetaminophen|acetaminophen|mesh-list
139149457|NCT02174068|Nefopam|nefopam|mesh-list
139149458|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139149459|NCT02174068|Analgesics|analgesics|mesh-ancestor
139149460|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
139149461|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149462|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149463|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
139149464|NCT02179294|Meperidine|meperidine|mesh-list
139149465|NCT02179294|Remifentanil|remifentanil|mesh-list
139149466|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139149467|NCT02179294|Narcotics|narcotics|mesh-ancestor
139149468|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139149469|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149470|NCT02179294|Analgesics|analgesics|mesh-ancestor
139149471|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
139149472|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149473|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139149474|NCT02179528|Etoposide|etoposide|mesh-list
139149475|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139149476|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149477|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139149478|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139149479|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149480|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149481|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
139149482|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
139149483|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149484|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149485|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139149486|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
139149487|NCT02182102|Pemetrexed|pemetrexed|mesh-list
139149488|NCT02182102|Nintedanib|nintedanib|mesh-list
139149489|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149490|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149491|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149492|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139149493|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139149494|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138900004|NCT02661191|Vitamin D|vitamin d|mesh-list
139149496|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
139149497|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
139149498|NCT02176720|Protective Agents|protective agents|mesh-ancestor
139149499|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149500|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
139149501|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139149502|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149503|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139149504|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
139149505|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149507|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149508|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139149509|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149510|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149511|NCT02182336|Vitamin K|vitamin k|mesh-list
139149512|NCT02182336|Digoxin|digoxin|mesh-list
139149513|NCT02182336|Midazolam|midazolam|mesh-list
139149514|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
139149515|NCT02182336|Caffeine|caffeine|mesh-list
139149516|NCT02182336|Omeprazole|omeprazole|mesh-list
139149517|NCT02182336|Warfarin|warfarin|mesh-list
139149518|NCT02182336|Vitamins|vitamins|mesh-ancestor
139149519|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
139149520|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149521|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139149522|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139149523|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139149524|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139149525|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139149526|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139149527|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139149528|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
139149529|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
139149530|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
139149531|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
139149532|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138923210|NCT04107779|Menthol|menthol|mesh-list
139149533|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149535|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139149536|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139149537|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149538|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139149539|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139149540|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
139149541|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139149542|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139149543|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139149544|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139149545|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139149546|NCT02182336|Protective Agents|protective agents|mesh-ancestor
139149547|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139149548|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139149549|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
139149550|NCT02182336|Coagulants|coagulants|mesh-ancestor
139149551|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
139149552|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
139149553|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139149554|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139149555|NCT02182570|Epinastine|epinastine|mesh-list
139149556|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139149557|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
139149558|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
139149559|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139149560|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149561|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149562|NCT02182648|Propofol|propofol|mesh-list
139149563|NCT02182648|Etomidate|etomidate|mesh-list
139149564|NCT02182648|Sevoflurane|sevoflurane|mesh-list
139149565|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139149566|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139149567|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149568|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138900075|NCT00748150|Vaccines|vaccines|mesh-list
139149569|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
139149570|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
139149571|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139149572|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139149573|NCT02179996|Vaccines|vaccines|mesh-list
139149574|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
139149575|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149576|NCT02177344|Bromides|bromides|mesh-list
139149577|NCT02177344|Ipratropium|ipratropium|mesh-list
139149578|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
139149579|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139149580|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
139149581|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149582|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149583|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139149584|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
139149585|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139149586|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
139149587|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139149588|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149589|NCT03536494|Mirabegron|mirabegron|mesh-list
139149590|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139149591|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139149592|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139149593|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
139149594|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139149595|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149596|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149597|NCT03536494|Urological Agents|urological agents|mesh-ancestor
139149598|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139149599|NCT02177422|Telmisartan|telmisartan|mesh-list
139149600|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139149601|NCT02177422|Diuretics|diuretics|mesh-ancestor
139149602|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
139149603|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149604|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139149605|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138923213|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
139149606|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149607|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139149608|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139149609|NCT02182960|Ibuprofen|ibuprofen|mesh-list
139149610|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139149611|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139149612|NCT02182960|Analgesics|analgesics|mesh-ancestor
139149613|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
139149614|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149615|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149616|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139149617|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139149618|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139149619|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149620|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149621|NCT05141968|Vitamin D|vitamin d|mesh-list
139149622|NCT05141968|Vitamins|vitamins|mesh-ancestor
139149623|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
139149624|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149625|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139149626|NCT00110357|Irinotecan|irinotecan|mesh-list
139149627|NCT00110357|Cetuximab|cetuximab|mesh-list
139149628|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139149629|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139149630|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149631|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149632|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149633|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139149634|NCT02183038|Naproxen|naproxen|mesh-list
139149635|NCT02183038|Meloxicam|meloxicam|mesh-list
139149636|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139149637|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139149638|NCT02183038|Analgesics|analgesics|mesh-ancestor
139149639|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
139149640|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149641|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149642|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139149643|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139149644|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
139149645|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139149646|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149647|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881670|NCT02644304|Cabergoline|cabergoline|mesh-list
139149648|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139149650|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
139149651|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149652|NCT00293033|Fentanyl|fentanyl|mesh-list
139149653|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139149654|NCT00293033|Narcotics|narcotics|mesh-ancestor
139149655|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139149656|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149657|NCT00293033|Analgesics|analgesics|mesh-ancestor
139149658|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
139149659|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149660|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139149661|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139149662|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
139149663|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
139149664|NCT02183116|Meloxicam|meloxicam|mesh-list
139149665|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139149666|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139149667|NCT02183116|Analgesics|analgesics|mesh-ancestor
139149668|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
139149669|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149670|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149671|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139149672|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139149673|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139149674|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139149675|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149676|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149677|NCT02183194|Paclitaxel|paclitaxel|mesh-list
139149678|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139149679|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149680|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
139149681|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
139149682|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
139149683|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149684|NCT02183272|Ketamine|ketamine|mesh-list
139149685|NCT02183272|Analgesics|analgesics|mesh-ancestor
139149686|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
139149687|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149688|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149689|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139149690|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139149691|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
139149692|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
139149693|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139149694|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139149695|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139149696|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139149697|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149698|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139149699|NCT02177500|Telmisartan|telmisartan|mesh-list
139149700|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
139149701|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139149702|NCT02177500|Diuretics|diuretics|mesh-ancestor
139149703|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
139149704|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149705|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139149706|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138881713|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
139149707|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149708|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139149709|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139149710|NCT02183350|Linagliptin|linagliptin|mesh-list
139149711|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139149712|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149713|NCT02183350|Incretins|incretins|mesh-ancestor
139149714|NCT02183350|Hormones|hormones|mesh-ancestor
139149715|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139149716|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139149717|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
139149718|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149719|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149720|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139149721|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
139149722|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139149723|NCT02183428|Glyburide|glyburide|mesh-list
139149724|NCT02183428|Linagliptin|linagliptin|mesh-list
139149725|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139149726|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149727|NCT02183428|Incretins|incretins|mesh-ancestor
139149728|NCT02183428|Hormones|hormones|mesh-ancestor
139149729|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139149730|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139149731|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
139149732|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149733|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149734|NCT01080911|Morphine|morphine|mesh-list
139149735|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
139149736|NCT01080911|Narcotics|narcotics|mesh-ancestor
139149737|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139149738|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149739|NCT01080911|Analgesics|analgesics|mesh-ancestor
139149740|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
139149741|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149742|NCT02183506|Metformin|metformin|mesh-list
139149743|NCT02183506|Linagliptin|linagliptin|mesh-list
139149744|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139149745|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149746|NCT02183506|Incretins|incretins|mesh-ancestor
139149747|NCT02183506|Hormones|hormones|mesh-ancestor
139149748|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139149749|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139149750|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
139149751|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149752|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149753|NCT02177734|Vaccines|vaccines|mesh-list
139149754|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
139149755|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149756|NCT02183584|Linagliptin|linagliptin|mesh-list
139149757|NCT02183584|Rifampin|rifampin|mesh-list
138881734|NCT00652808|Naproxen|naproxen|mesh-list
139149758|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139149759|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
139149760|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139149761|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139149762|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
139149763|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139149764|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149765|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149766|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139149767|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139149768|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139149769|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139149770|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139149771|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139149772|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139149773|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149774|NCT02183584|Incretins|incretins|mesh-ancestor
139149775|NCT02183584|Hormones|hormones|mesh-ancestor
139149776|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139149777|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139149778|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
139149779|NCT01068353|Etanercept|etanercept|mesh-list
139149780|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139149781|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139149782|NCT01068353|Analgesics|analgesics|mesh-ancestor
139149783|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
139149784|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149785|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149786|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139149787|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139149788|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139149789|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139149790|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
139149791|NCT01083251|Vitamin D|vitamin d|mesh-list
139149792|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
139149793|NCT01083251|Cholecalciferol|cholecalciferol|mesh-list
139149794|NCT01083251|Vitamins|vitamins|mesh-list
138900296|NCT02644499|Vitamins|vitamins|mesh-ancestor
139149795|NCT01083251|Entecavir|entecavir|mesh-list
139149796|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
139149797|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149798|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139149799|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139149801|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139149802|NCT02184052|Meloxicam|meloxicam|mesh-list
139149803|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139149804|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139149805|NCT02184052|Analgesics|analgesics|mesh-ancestor
139149806|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
139149807|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149808|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149809|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139149810|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139149811|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139149812|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139149813|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149814|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149815|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
139149816|NCT01083329|Niacin|niacin|mesh-list
139149817|NCT01083329|Niacinamide|niacinamide|mesh-list
139149818|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
139149819|NCT01083329|Vitamins|vitamins|mesh-ancestor
139149820|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
139149821|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149822|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139149823|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
139149824|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149825|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139149826|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
139149827|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
139149828|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139149829|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139149830|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139149832|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
139149833|NCT02181322|Meloxicam|meloxicam|mesh-list
139149834|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139149835|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139149836|NCT02181322|Analgesics|analgesics|mesh-ancestor
139149837|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
139149838|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149839|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149840|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139149841|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139149842|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139149843|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139149844|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149845|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149846|NCT02184286|Nevirapine|nevirapine|mesh-list
139149847|NCT02184286|Saquinavir|saquinavir|mesh-list
138881828|NCT02653196|Etoposide|etoposide|mesh-list
139149848|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139149849|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139149851|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149852|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
139149853|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139149854|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139149855|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139149856|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139149857|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139149858|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139149859|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139149860|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
139149861|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139149862|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139149863|NCT02178124|Donepezil|donepezil|mesh-list
139149864|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139149865|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149866|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149867|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
139149868|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138900373|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149869|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149871|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
139149872|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139149873|NCT02030314|Diuretics|diuretics|mesh-ancestor
139149874|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
139149875|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149876|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138881886|NCT02758691|Insulin|insulin|mesh-list
139149877|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139149878|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149879|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139149880|NCT02184364|Estrogens|estrogens|mesh-ancestor
139149881|NCT02184364|Hormones|hormones|mesh-ancestor
139149882|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139149884|NCT02181478|Cyclosporine|cyclosporine|mesh-list
139149885|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
139149886|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
139149887|NCT02181478|Fludarabine|fludarabine|mesh-list
139149888|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
139149889|NCT02181478|Cyclosporins|cyclosporins|mesh-list
139149890|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139149891|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
139149892|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149893|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139149894|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139149895|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
139149896|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149897|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149898|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139149899|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139149900|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
139149901|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149902|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
139149903|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139149904|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
139149905|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139149906|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139149907|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139149908|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
139149909|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139149910|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
139149911|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139149912|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
139149913|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
139149914|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139149915|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149916|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139149917|NCT02755090|Analgesics|analgesics|mesh-ancestor
139149918|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
139149919|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139149920|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139149921|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
139149922|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149923|NCT02185690|Carboplatin|carboplatin|mesh-list
139149924|NCT02185690|Pemetrexed|pemetrexed|mesh-list
139149925|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149926|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149927|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149928|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139149929|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139149930|NCT03536806|Canrenone|canrenone|mesh-list
139149931|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139149932|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
139149933|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139149934|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149935|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139149936|NCT03536806|Diuretics|diuretics|mesh-ancestor
139149937|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
139149938|NCT00108485|Niacin|niacin|mesh-list
139149939|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139149940|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
139149941|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149942|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139149943|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
139149944|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
139149945|NCT00108485|Vitamins|vitamins|mesh-ancestor
139149946|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
139149947|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149948|NCT02181946|Fluconazole|fluconazole|mesh-list
139149949|NCT02181946|Nevirapine|nevirapine|mesh-list
139149950|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
139149951|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139149952|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139149953|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139149954|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149955|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149956|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139149957|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
139149958|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139149959|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149960|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139149961|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139149962|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139149963|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139149964|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
139149965|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139149966|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139149967|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139149968|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139149969|NCT00107783|Nitisinone|nitisinone|mesh-list
139149970|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149971|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149973|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139149974|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139149975|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139149976|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139149977|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149978|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149979|NCT02182024|Dabigatran|dabigatran|mesh-list
139149980|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
139149981|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139149982|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
139149983|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139149984|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139149985|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
139149986|NCT02185846|Dirithromycin|dirithromycin|mesh-list
139149987|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139149988|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139149989|NCT02184832|Metformin|metformin|mesh-list
139149990|NCT02184832|Tryptophan|tryptophan|mesh-list
139149991|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139149992|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139149993|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139149994|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
139149995|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139149996|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
139149997|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
139149998|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139149999|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150000|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150001|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139150002|NCT01083797|Analgesics|analgesics|mesh-ancestor
139150003|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
139150004|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150005|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139150006|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139150007|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139150008|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
139150009|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150010|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150011|NCT01083875|Amlexanox|amlexanox|mesh-list
139150012|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139150013|NCT01068977|Bevacizumab|bevacizumab|mesh-list
139150014|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139150015|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139150016|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150017|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139150018|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139150019|NCT01068977|Growth Substances|growth substances|mesh-ancestor
139150020|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150021|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
139150022|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
139150024|NCT02184910|Hormones|hormones|mesh-ancestor
139150025|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150026|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150027|NCT02185924|Parecoxib|parecoxib|mesh-list
139150028|NCT02185924|Ropivacaine|ropivacaine|mesh-list
139150029|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
139150030|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
139150031|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150032|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150033|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
139150034|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150035|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139150036|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139150037|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150038|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150039|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139150040|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139150041|NCT02185924|Analgesics|analgesics|mesh-ancestor
139150042|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150043|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139150045|NCT02185066|Atorvastatin|atorvastatin|mesh-list
139150046|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139150047|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150048|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139150049|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139150050|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
139150051|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150052|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139150053|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139150054|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150055|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
139150056|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
139150057|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150058|NCT01069055|Acetaminophen|acetaminophen|mesh-list
139150059|NCT01069055|Lornoxicam|lornoxicam|mesh-list
139150060|NCT01069055|Piroxicam|piroxicam|mesh-list
139150061|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139150062|NCT01069055|Analgesics|analgesics|mesh-ancestor
139150063|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
139150064|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150065|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150066|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
139150067|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139150068|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150069|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139150070|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139150071|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150072|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150073|NCT01083953|Sevoflurane|sevoflurane|mesh-list
139150074|NCT01083953|Desflurane|desflurane|mesh-list
139150075|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139150076|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139150077|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
139150078|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
138887882|NCT00871494|Azithromycin|azithromycin|mesh-list
139150079|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150080|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150081|NCT02190526|Mesalamine|mesalamine|mesh-list
139150082|NCT02190526|Amitriptyline|amitriptyline|mesh-list
139150083|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139150084|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139150085|NCT02190526|Analgesics|analgesics|mesh-ancestor
139150086|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
139150087|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150088|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150089|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150090|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139150091|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139150092|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
139150093|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139150094|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139150095|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139150096|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139150097|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150098|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
139150099|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150100|NCT01084031|Propofol|propofol|mesh-list
139150101|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139150102|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150103|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150104|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139150105|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
139150106|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
139150107|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
139150108|NCT02185222|Vitamin D|vitamin d|mesh-list
139150109|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139150110|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150111|NCT02185222|Vitamins|vitamins|mesh-ancestor
139150112|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
139150113|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139150114|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139150115|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
139150116|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139150117|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139150118|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150119|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150120|NCT01084187|Urological Agents|urological agents|mesh-ancestor
139150121|NCT02185300|Dolutegravir|dolutegravir|mesh-list
139150122|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139150123|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139150124|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150125|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150126|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139150127|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139150128|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
139150129|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150130|NCT02190760|Dexamethasone|dexamethasone|mesh-list
139150131|NCT02190760|Bupivacaine|bupivacaine|mesh-list
139150132|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150133|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
139150134|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
139150135|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150136|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150137|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139150138|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
139150139|NCT02190760|Hormones|hormones|mesh-ancestor
139150140|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150141|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139150142|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150143|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
139150144|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
139150145|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150146|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
139150147|NCT02190838|Metformin|metformin|mesh-list
139150148|NCT02190838|Dacarbazine|dacarbazine|mesh-list
139150149|NCT02190838|Melatonin|melatonin|mesh-list
139150150|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139150151|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150152|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
139150153|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150154|NCT02190838|Protective Agents|protective agents|mesh-ancestor
139150155|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150156|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139150157|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
139150158|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150159|NCT02185456|Metronidazole|metronidazole|mesh-list
139150160|NCT02185456|Miconazole|miconazole|mesh-list
139150161|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150162|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139150163|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139150164|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139150165|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
139150166|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139150167|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139150168|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150169|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150170|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139150171|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
139150172|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150173|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150174|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139150175|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139150178|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150179|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
139150180|NCT02190994|Hormones|hormones|mesh-ancestor
139150181|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150182|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150183|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139150184|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150185|NCT02193568|Anesthetics|anesthetics|mesh-list
139150186|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150187|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150188|NCT02191072|Omalizumab|omalizumab|mesh-list
139150189|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139150190|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139150191|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
139150192|NCT02191228|Linagliptin|linagliptin|mesh-list
139150193|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139150194|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150195|NCT02191228|Incretins|incretins|mesh-ancestor
139150196|NCT02191228|Hormones|hormones|mesh-ancestor
139150197|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150198|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139150199|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
139150200|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150201|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150202|NCT02186782|Citric Acid|citric acid|mesh-list
139150203|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
139150204|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139150205|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139150206|NCT02186782|Clomiphene|clomiphene|mesh-list
139150207|NCT02186782|Enclomiphene|enclomiphene|mesh-list
139150208|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
139150209|NCT02186782|Estradiol|estradiol|mesh-list
139150210|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139150211|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
139150212|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139150213|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
139150214|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
139150215|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150216|NCT02186782|Estrogens|estrogens|mesh-ancestor
139150217|NCT02186782|Hormones|hormones|mesh-ancestor
139150218|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150219|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150220|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139150221|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
139150222|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139150223|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139150224|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139150225|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
139150226|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139150227|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
139150228|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139150229|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139150230|NCT02187250|Metformin|metformin|mesh-list
139150231|NCT02187250|Liraglutide|liraglutide|mesh-list
139150232|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138882089|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139150233|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150235|NCT02187250|Hormones|hormones|mesh-ancestor
139150236|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150237|NCT03535480|Lenograstim|lenograstim|mesh-list
139150238|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139150239|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
139150240|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900752|NCT00744406|Sertraline|sertraline|mesh-list
139150241|NCT02187484|Telmisartan|telmisartan|mesh-list
139150242|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139150243|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139150244|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139150245|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150247|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139150248|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139150249|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150250|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150251|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139150253|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139150254|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139150255|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
139150256|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
139150257|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
139150258|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
139150259|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150260|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150261|NCT02187562|Aspirin|aspirin|mesh-list
139150262|NCT02187562|Meloxicam|meloxicam|mesh-list
139150263|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139150264|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139150265|NCT02187562|Analgesics|analgesics|mesh-ancestor
139150266|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
139150267|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150268|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150269|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150270|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139150271|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139150272|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139150273|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150274|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139150275|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139150276|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150277|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
139150279|NCT02187718|Anesthetics|anesthetics|mesh-list
139150280|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150281|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150282|NCT03535168|Midazolam|midazolam|mesh-list
139150283|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139150284|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139150285|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150286|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150287|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139150288|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139150289|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139150290|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139150291|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
139150292|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
139150293|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
139150294|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
139150295|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150296|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150297|NCT02192320|Dexamethasone|dexamethasone|mesh-list
139150298|NCT02192320|Atorvastatin|atorvastatin|mesh-list
139150299|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150300|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
139150301|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
139150302|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150303|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150304|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139150305|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
139150306|NCT02192320|Hormones|hormones|mesh-ancestor
139150307|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150308|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139150309|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150310|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139150311|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139150312|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
139150313|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150314|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139150315|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139150316|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150317|NCT02187874|Oxytocin|oxytocin|mesh-list
139150318|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
139150319|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139150320|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150321|NCT04870138|Azithromycin|azithromycin|mesh-list
139150322|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
139150323|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
139150324|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139150325|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150326|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138520688|NCT00035295|Aprepitant|aprepitant|mesh-list
139150327|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139150328|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150329|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150330|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150331|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139150332|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139150334|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139150335|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139150336|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150337|NCT02188186|Incretins|incretins|mesh-ancestor
139150338|NCT02188186|Hormones|hormones|mesh-ancestor
139150339|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150340|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139150341|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
139150342|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150343|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150344|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
139150345|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139150346|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139150347|NCT02192632|Analgesics|analgesics|mesh-ancestor
139150348|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
139150349|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150350|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150351|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150352|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139150353|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
139150354|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
139150355|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139150356|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139150357|NCT03535090|Prednisolone|prednisolone|mesh-list
139150358|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
139150359|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139150360|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
139150361|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150362|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
139150363|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
139150364|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150365|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150366|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139150367|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
139150368|NCT03535090|Hormones|hormones|mesh-ancestor
139150369|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150370|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139150371|NCT03535090|Protective Agents|protective agents|mesh-ancestor
139150372|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139150373|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150374|NCT03535870|Fluticasone|fluticasone|mesh-list
139150375|NCT03535870|Xhance|xhance|mesh-list
139150376|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139150377|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139150378|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150379|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139150380|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
139150381|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150382|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150383|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139150384|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
139150385|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
138882163|NCT00539305|Hormones|hormones|mesh-ancestor
139150386|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139150387|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139150388|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139150389|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139150390|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
139150391|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150392|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150393|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
139150394|NCT03535870|Hormones|hormones|mesh-ancestor
139150395|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150396|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
139150397|NCT02192710|Midazolam|midazolam|mesh-list
139150398|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139150399|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139150400|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150401|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150402|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139150403|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139150404|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139150405|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139150406|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
139150407|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
139150408|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
139150409|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
139150410|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150411|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150412|NCT02188654|Metformin|metformin|mesh-list
139150413|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139150414|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150415|NCT02192944|Chloroquine|chloroquine|mesh-list
139150416|NCT02192944|Piperaquine|piperaquine|mesh-list
139150417|NCT02192944|Artenimol|artenimol|mesh-list
139150418|NCT02192944|Amebicides|amebicides|mesh-ancestor
139150419|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139150420|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139150421|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150422|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
139150423|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139150424|NCT02193022|Miltefosine|miltefosine|mesh-list
139150425|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
139150426|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150427|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150428|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139150429|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139150430|NCT02188810|Vaccines|vaccines|mesh-list
139150431|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
139150432|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150433|NCT02188888|Esmolol|esmolol|mesh-list
139150434|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139150435|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139150436|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139150437|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
139150438|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150439|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150440|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150441|NCT02256826|Ritonavir|ritonavir|mesh-list
139150442|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139150443|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139150444|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
139150445|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150446|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150447|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139150448|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139150449|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
139150450|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150451|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139150452|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139150453|NCT03535792|Fentanyl|fentanyl|mesh-list
139150454|NCT03535792|Nalbuphine|nalbuphine|mesh-list
139150455|NCT03535792|Bupivacaine|bupivacaine|mesh-list
139150456|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
139150457|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
139150458|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150459|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150460|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
139150461|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150462|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139150463|NCT03535792|Narcotics|narcotics|mesh-ancestor
139150464|NCT03535792|Analgesics|analgesics|mesh-ancestor
139150465|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139150466|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139150467|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
139150468|NCT02193256|Prazosin|prazosin|mesh-list
139150469|NCT02193256|Varenicline|varenicline|mesh-list
139150470|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139150471|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139150472|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
139150473|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150474|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150475|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150476|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139150477|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139150478|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139150479|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139150480|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
139150481|NCT03535558|Azithromycin|azithromycin|mesh-list
139150482|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
139150483|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139150484|NCT03535558|Trimethoprim|trimethoprim|mesh-list
139150485|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
139150486|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139150487|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150488|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139150490|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139150491|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139150492|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139150493|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150494|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150495|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139150496|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139150497|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139150498|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139150499|NCT02193334|Mitogens|mitogens|mesh-list
139150500|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
139150501|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150502|NCT02194192|Ephedrine|ephedrine|mesh-list
139150503|NCT02194192|Ondansetron|ondansetron|mesh-list
139150504|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
139150505|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
139150506|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150507|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150508|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139150509|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
139150510|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
139150511|NCT02194192|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139150512|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139150513|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
139150514|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150515|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150516|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139150517|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
139150518|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139150519|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
139150520|NCT02194270|Ambroxol|ambroxol|mesh-list
139150521|NCT02194270|Expectorants|expectorants|mesh-ancestor
139150522|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
139150523|NCT02190058|DS-1971a|ds-1971a|mesh-list
139150524|NCT02190058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139150525|NCT02190058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139150526|NCT02190058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139150527|NCT02190058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150528|NCT02194348|Olcegepant|olcegepant|mesh-list
139150529|NCT02194348|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139150530|NCT02194348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150531|NCT02194348|Analgesics|analgesics|mesh-ancestor
139150532|NCT02194348|Sensory System Agents|sensory system agents|mesh-ancestor
139150533|NCT02194348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150534|NCT02194348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150535|NCT02195908|Antiemetics|antiemetics|mesh-list
139150536|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
139150537|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150538|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150539|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139150540|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
138882229|NCT00715858|Rifampin|rifampin|mesh-list
139150541|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139150542|NCT02197000|Protective Agents|protective agents|mesh-ancestor
139150543|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150544|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150545|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
139150546|NCT02196142|Mannitol|mannitol|mesh-list
139150547|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139150548|NCT02196142|Diuretics|diuretics|mesh-ancestor
139150549|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
139150550|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150551|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150552|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139150553|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139150554|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139150555|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150556|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139150558|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
139150559|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150560|NCT04308694|Methadone|methadone|mesh-list
139150561|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139150562|NCT04308694|Narcotics|narcotics|mesh-ancestor
139150563|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150564|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150565|NCT04308694|Analgesics|analgesics|mesh-ancestor
139150566|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
139150567|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150568|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
139150569|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
139150570|NCT03534310|Liraglutide|liraglutide|mesh-list
139150571|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139150572|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150573|NCT03534310|Incretins|incretins|mesh-ancestor
139150574|NCT03534310|Hormones|hormones|mesh-ancestor
139150575|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150576|NCT02194894|Acetaminophen|acetaminophen|mesh-list
139150577|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139150578|NCT02194894|Analgesics|analgesics|mesh-ancestor
139150579|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
139150580|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150581|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150582|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
139150583|NCT03534622|Delafloxacin|delafloxacin|mesh-list
139150584|NCT03534622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150585|NCT02197702|Vitamin D|vitamin d|mesh-list
139150586|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
139150587|NCT02197702|Vitamins|vitamins|mesh-ancestor
139150588|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
139150589|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150590|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139150591|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139150593|NCT02031016|Remifentanil|remifentanil|mesh-list
139150594|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139150595|NCT02031016|Narcotics|narcotics|mesh-ancestor
139150596|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150597|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150598|NCT02031016|Analgesics|analgesics|mesh-ancestor
139150599|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
139150600|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150601|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139150602|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139150603|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
139150604|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
139150605|NCT00095147|Infliximab|infliximab|mesh-list
139150606|NCT00095147|Methotrexate|methotrexate|mesh-list
139150607|NCT00095147|Abatacept|abatacept|mesh-list
139150608|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139150609|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
139150610|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139150611|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150612|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139150613|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
139150614|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150615|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150616|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
139150617|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150618|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139150619|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139150620|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
139150621|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139150622|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139150623|NCT00095147|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139150624|NCT00095147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150625|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139150626|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139150627|NCT00095147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139150628|NCT02198170|Ketoconazole|ketoconazole|mesh-list
139150629|NCT02198170|Lenvatinib|lenvatinib|mesh-list
139150630|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
139150631|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150632|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139150633|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139150634|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150635|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150636|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139150637|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
139150638|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150639|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150640|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139150641|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150642|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139150643|NCT02198248|Prednisolone|prednisolone|mesh-list
139150644|NCT02198248|Rituximab|rituximab|mesh-list
139150645|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
139150646|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139150647|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150648|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
139150649|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150650|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139150651|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150652|NCT02198248|Hormones|hormones|mesh-ancestor
139150653|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150654|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139150655|NCT01069133|Rifaximin|rifaximin|mesh-list
139150656|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139150657|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150658|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139150659|NCT02198326|Olcegepant|olcegepant|mesh-list
139019564|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139150660|NCT02198326|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139150661|NCT02198326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150662|NCT02198326|Analgesics|analgesics|mesh-ancestor
139150663|NCT02198326|Sensory System Agents|sensory system agents|mesh-ancestor
139150664|NCT02198326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150665|NCT02198326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150666|NCT02198482|Cytarabine|cytarabine|mesh-list
139150667|NCT02198482|Daunorubicin|daunorubicin|mesh-list
139150668|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
139150669|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139150670|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
139150671|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150672|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150673|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
139150674|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150675|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139150676|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
139150677|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150678|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139150679|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139150680|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139150681|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150682|NCT02198482|Analgesics|analgesics|mesh-ancestor
139150683|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
139150684|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150685|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
139150686|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150687|NCT02201134|Sevoflurane|sevoflurane|mesh-list
139150688|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139150689|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139150690|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
139150691|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
139150692|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150693|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901191|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
139150694|NCT02201602|Gliclazide|gliclazide|mesh-list
139150695|NCT02201602|Glyburide|glyburide|mesh-list
139150696|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139150697|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150699|NCT02201914|Clomiphene|clomiphene|mesh-list
139150700|NCT02201914|Enclomiphene|enclomiphene|mesh-list
139150701|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
139150702|NCT02201914|Cetrorelix|cetrorelix|mesh-list
139150703|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
139150704|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139150705|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
139150706|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139150707|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150708|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139150709|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139150710|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150711|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139150712|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
139150713|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150714|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139150715|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
139150716|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139150717|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139150718|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139150719|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139150720|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139150721|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150722|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150723|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139150724|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138882351|NCT00716170|Glucagon|glucagon|mesh-list
139150725|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150726|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
139150727|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150728|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
139150729|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139150730|NCT02202304|Thymol|thymol|mesh-list
139150731|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139150732|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150733|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
139150734|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
139150735|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
139150736|NCT02207452|Albuterol|albuterol|mesh-list
139150737|NCT02207452|Ipratropium|ipratropium|mesh-list
139150738|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139150739|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
139150740|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150741|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150742|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139150743|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
139150744|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
139150745|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139150746|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139150747|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139150748|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139150749|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
139150750|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150751|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150752|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139150753|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
139150754|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
139150755|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139150756|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139150757|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139150758|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139150759|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139150760|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150761|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
139150762|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150763|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150764|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139150765|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150766|NCT02207920|Vaccines|vaccines|mesh-list
139150767|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
139150768|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150769|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
139150770|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139150772|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150773|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
139150774|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
139150775|NCT03532906|Bupivacaine|bupivacaine|mesh-list
139150776|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
139150777|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
139150778|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150779|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150780|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
139150781|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150782|NCT02199418|Paclitaxel|paclitaxel|mesh-list
139150783|NCT02199418|Cisplatin|cisplatin|mesh-list
139150784|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139150785|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150786|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
139150787|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
139150788|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
139150789|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150790|NCT02208778|Remifentanil|remifentanil|mesh-list
139150791|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139150792|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139150793|NCT02208778|Narcotics|narcotics|mesh-ancestor
139150794|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150795|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150796|NCT02208778|Analgesics|analgesics|mesh-ancestor
139150797|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
139150798|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150799|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139150800|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139150801|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139150802|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150803|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150804|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
139150805|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139150806|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
139150807|NCT02203396|Cyclosporine|cyclosporine|mesh-list
139150808|NCT02203396|Levamisole|levamisole|mesh-list
139150809|NCT02203396|Cyclosporins|cyclosporins|mesh-list
139150810|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
139150811|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150812|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150813|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139150814|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
139150815|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150816|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
139150817|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150818|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
139150819|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139150820|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139150821|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139150822|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
139150823|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
139150824|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139150826|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139150827|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150828|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139150829|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139150830|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
139150831|NCT02200354|Bevacizumab|bevacizumab|mesh-list
139150832|NCT02200354|Pemetrexed|pemetrexed|mesh-list
139150833|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139150834|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150835|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139150836|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139150837|NCT02200354|Growth Substances|growth substances|mesh-ancestor
139150838|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150839|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
139150840|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019565|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139150841|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150842|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139150843|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139150844|NCT02204020|Azacitidine|azacitidine|mesh-list
139150845|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139150847|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150848|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150849|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150850|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139150851|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139150852|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
139150853|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150854|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150855|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150856|NCT02220634|Regadenoson|regadenoson|mesh-list
139150857|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139150858|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139150859|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
139150860|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
139150861|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150862|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150863|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150864|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
139150865|NCT02204644|Flumatinib|flumatinib|mesh-list
139150866|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150867|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139150868|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150869|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150870|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
139150871|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150872|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139150873|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150874|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150875|NCT02204878|Parecoxib|parecoxib|mesh-list
139150876|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139150877|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139150878|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150879|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150880|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139150881|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139150882|NCT02204878|Analgesics|analgesics|mesh-ancestor
139150883|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
139150884|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150885|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150886|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150887|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139150888|NCT02210728|Methylphenidate|methylphenidate|mesh-list
139150889|NCT02210728|Amphetamine|amphetamine|mesh-list
139150890|NCT02210728|Adderall|adderall|mesh-list
139150891|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
139150892|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139150893|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150894|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139150895|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139150896|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139150897|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150898|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
139150899|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150900|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
139150901|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
139150902|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150903|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
139150904|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139150905|NCT02220868|Ribavirin|ribavirin|mesh-list
139150906|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
139150907|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139150908|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
139150909|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150910|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
139150911|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150912|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139150913|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139150914|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139150915|NCT02221102|Aspirin|aspirin|mesh-list
139150916|NCT02221102|Edoxaban|edoxaban|mesh-list
139150917|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139150918|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139150920|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
139150921|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139150922|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150923|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139150924|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139150925|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139150926|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139150927|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150928|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139150929|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139150930|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150931|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
139150932|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139150933|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
139150934|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139150935|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
139150936|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
139150937|NCT02213302|Midazolam|midazolam|mesh-list
139150938|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139150939|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139150940|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139150941|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150942|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139150943|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139150944|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139150945|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139150946|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
139150947|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
139150948|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
139150949|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
139150950|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139150951|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150952|NCT02221180|Metformin|metformin|mesh-list
139150953|NCT02221180|Canagliflozin|canagliflozin|mesh-list
139150954|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139150955|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150956|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139150957|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150958|NCT02205112|Levofloxacin|levofloxacin|mesh-list
139150959|NCT02205112|Nemonoxacin|nemonoxacin|mesh-list
139150960|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139150961|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150962|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138882477|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
139150963|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139150964|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139150965|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150966|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150967|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150968|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139150969|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139150970|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139150971|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139150972|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139150973|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
139150974|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150975|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139150976|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139150977|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150978|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
139150979|NCT02257918|Zoliflodacin|zoliflodacin|mesh-list
139150980|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139150981|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139150982|NCT02257918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139150983|NCT02257918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139150984|NCT02257918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150985|NCT02257918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150986|NCT02257918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139150988|NCT02221414|Linagliptin|linagliptin|mesh-list
139150989|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139150990|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139150991|NCT02221414|Incretins|incretins|mesh-ancestor
139150992|NCT02221414|Hormones|hormones|mesh-ancestor
138901489|NCT00834912|Analgesics|analgesics|mesh-ancestor
139150993|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139150994|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139150995|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
139150996|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139150997|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139150998|NCT02221492|Plerixafor|plerixafor|mesh-list
139150999|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139151000|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139151001|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
139151002|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139151003|NCT05164978|Antibodies|antibodies|mesh-list
139151004|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
139151005|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151006|NCT02221570|Baclofen|baclofen|mesh-list
139151007|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139151008|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151009|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139151010|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151011|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139151012|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
139151013|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
139151014|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151015|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151016|NCT02205502|Lidocaine|lidocaine|mesh-list
139151017|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
139151018|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
139151019|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151020|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151021|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
139151022|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151023|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139151024|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139151025|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139151026|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139151027|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151028|NCT02219698|Acetaminophen|acetaminophen|mesh-list
139151029|NCT02219698|Ibuprofen|ibuprofen|mesh-list
139151030|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139151031|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139151032|NCT02219698|Analgesics|analgesics|mesh-ancestor
139151033|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
139151034|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151035|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151036|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139151037|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139151038|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139151039|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151040|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151041|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
139151042|NCT02205580|Sufentanil|sufentanil|mesh-list
139151043|NCT02205580|Dsuvia|dsuvia|mesh-list
139151044|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139151045|NCT02205580|Narcotics|narcotics|mesh-ancestor
139151046|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151047|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151048|NCT02205580|Analgesics|analgesics|mesh-ancestor
139151049|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
139151050|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151051|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139151052|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139151053|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
139151054|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
139151055|NCT02221960|Durvalumab|durvalumab|mesh-list
139151056|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139151057|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151058|NCT02220088|Leucovorin|leucovorin|mesh-list
139151059|NCT02220088|Fluorouracil|fluorouracil|mesh-list
139151060|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
139151061|NCT02220088|Sorafenib|sorafenib|mesh-list
139151062|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
139151063|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151064|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139151065|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151066|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139151067|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
138901561|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139151068|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151069|NCT02220088|Antidotes|antidotes|mesh-ancestor
139151070|NCT02220088|Protective Agents|protective agents|mesh-ancestor
139151071|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
139151072|NCT02220088|Vitamins|vitamins|mesh-ancestor
139151073|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
139151074|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139151075|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151076|NCT02220400|Ketamine|ketamine|mesh-list
139151077|NCT02220400|Analgesics|analgesics|mesh-ancestor
139151078|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
139151079|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151080|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151081|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139151082|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139151083|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
139151084|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
139151085|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151086|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139151087|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139151088|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151089|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151091|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139151092|NCT02224768|Ipilimumab|ipilimumab|mesh-list
139151093|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139151094|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151095|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139151096|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151097|NCT05262166|Dexmedetomidine|dexmedetomidine|mesh-list
139151098|NCT05262166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139151099|NCT05262166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151100|NCT05262166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151101|NCT05262166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139151102|NCT05262166|Analgesics|analgesics|mesh-ancestor
139151103|NCT05262166|Sensory System Agents|sensory system agents|mesh-ancestor
139151104|NCT05262166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151105|NCT05262166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139151106|NCT05262166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139151107|NCT05262166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139151108|NCT05262166|Adrenergic Agents|adrenergic agents|mesh-ancestor
139151109|NCT05262166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151110|NCT05262166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151111|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
139151112|NCT02206204|Selexipag|selexipag|mesh-list
139151113|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139151114|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139151115|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139151116|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139151117|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139151118|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151119|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151120|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151121|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139151122|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
139151123|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139151124|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151125|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139151126|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139151127|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139151128|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139151129|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
139151130|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139151131|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139151132|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139151133|NCT02230930|Apomorphine|apomorphine|mesh-list
139151134|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139151135|NCT02230930|Emetics|emetics|mesh-ancestor
139151136|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151137|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
139151138|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151139|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139151140|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
139151141|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
139151142|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151143|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151145|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139151146|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151147|NCT02222428|Olodaterol|olodaterol|mesh-list
139151148|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139151149|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
139151150|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151151|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151152|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139151153|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
139151154|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139151155|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139151156|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
139151157|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151158|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151159|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139151160|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
139151161|NCT02225470|Vinorelbine|vinorelbine|mesh-list
139151162|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139151163|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151164|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
139151165|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
139151166|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
139151167|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151168|NCT02225548|Tadalafil|tadalafil|mesh-list
139151169|NCT02225548|Selegiline|selegiline|mesh-list
139151170|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
139151171|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139151172|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139151173|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151174|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151175|NCT02225548|Urological Agents|urological agents|mesh-ancestor
139151176|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
139151177|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139151178|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139151179|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139151180|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139151181|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139151182|NCT02225548|Protective Agents|protective agents|mesh-ancestor
139151183|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151184|NCT02223052|Azacitidine|azacitidine|mesh-list
139151185|NCT02223052|Cc-486|cc-486|mesh-list
139151186|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139151187|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
139151188|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151189|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151190|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151191|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139151192|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139151193|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139151194|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151195|NCT02231788|Amlodipine|amlodipine|mesh-list
139151196|NCT02231788|Telmisartan|telmisartan|mesh-list
139151197|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139151198|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139151199|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139151200|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151201|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139151202|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151203|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
139151204|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139151205|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139151206|NCT02258620|Isosorbide|isosorbide|mesh-list
139151207|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139151208|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139151209|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
139151210|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
139151211|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139151212|NCT02258620|Diuretics|diuretics|mesh-ancestor
139151213|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
138882602|NCT00681876|Growth Substances|growth substances|mesh-ancestor
139151214|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151215|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139151216|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151217|NCT02223598|Dexamethasone|dexamethasone|mesh-list
139151218|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139151219|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
139151220|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
139151221|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151222|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151223|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139151224|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
139151225|NCT02223598|Hormones|hormones|mesh-ancestor
139151226|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138888168|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139151227|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139151228|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151229|NCT00094835|Paclitaxel|paclitaxel|mesh-list
139151230|NCT00094835|Carboplatin|carboplatin|mesh-list
139151231|NCT00094835|Panitumumab|panitumumab|mesh-list
139151232|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
139151233|NCT00094835|Imetelstat|imetelstat|mesh-list
139151234|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139151235|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151236|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
139151237|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
139151238|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
139151239|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151240|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139151241|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139151242|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151243|NCT02226328|Midazolam|midazolam|mesh-list
139151244|NCT02226328|Fentanyl|fentanyl|mesh-list
139151245|NCT02226328|Propofol|propofol|mesh-list
139151246|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139151247|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151248|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151249|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139151250|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
139151251|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
139151252|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139151253|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139151254|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139151255|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139151256|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
139151257|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
139151258|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151259|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151260|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139151261|NCT02226328|Narcotics|narcotics|mesh-ancestor
139151262|NCT02226328|Analgesics|analgesics|mesh-ancestor
139151263|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
139151264|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151265|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
139151266|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139151267|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139151268|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
139151269|NCT02226484|Quercetin|quercetin|mesh-list
139151270|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
139151271|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151272|NCT02226484|Protective Agents|protective agents|mesh-ancestor
139151273|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151274|NCT04453852|Vaccines|vaccines|mesh-list
139151275|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
139151276|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151277|NCT00094757|Pioglitazone|pioglitazone|mesh-list
139151278|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139151279|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139151280|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151281|NCT00094757|Incretins|incretins|mesh-ancestor
139151282|NCT00094757|Hormones|hormones|mesh-ancestor
139151283|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139151284|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139151285|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
139151286|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151287|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151288|NCT02223832|Ponesimod|ponesimod|mesh-list
139151289|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139151290|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151291|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139151292|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
139151293|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151294|NCT02224066|Aspirin|aspirin|mesh-list
139151295|NCT02224066|Clopidogrel|clopidogrel|mesh-list
139151296|NCT02224066|Ticagrelor|ticagrelor|mesh-list
139151297|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139151298|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139151299|NCT02224066|Analgesics|analgesics|mesh-ancestor
139151300|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
139151301|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151302|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151303|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139151304|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139151305|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139151306|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139151307|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151308|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139151309|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139151310|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151311|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
139151312|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139151313|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139151314|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139151315|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
139151316|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151317|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139151318|NCT04378114|Acetaminophen|acetaminophen|mesh-list
139151319|NCT04378114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139151320|NCT04378114|Analgesics|analgesics|mesh-ancestor
139151321|NCT04378114|Sensory System Agents|sensory system agents|mesh-ancestor
139151322|NCT04378114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151323|NCT04378114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151324|NCT04378114|Antipyretics|antipyretics|mesh-ancestor
139151325|NCT00082433|Capecitabine|capecitabine|mesh-list
139151326|NCT00082433|Epothilones|epothilones|mesh-list
139151327|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139151328|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
139151329|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151330|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151331|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
139151332|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
139151333|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
139151334|NCT00094445|Curcumin|curcumin|mesh-list
139151335|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139151336|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139151337|NCT00094445|Analgesics|analgesics|mesh-ancestor
139151338|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
139151339|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151340|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888179|NCT00657488|Thalidomide|thalidomide|mesh-list
139151341|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139151342|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139151343|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151344|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151345|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151346|NCT01081535|Ketorolac|ketorolac|mesh-list
139151347|NCT01081535|Fentanyl|fentanyl|mesh-list
139151348|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139151349|NCT01081535|Narcotics|narcotics|mesh-ancestor
139151350|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151351|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151352|NCT01081535|Analgesics|analgesics|mesh-ancestor
139151353|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
139151354|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151355|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139151356|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139151357|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
139151358|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
139151359|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139151360|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139151361|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139151362|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139151363|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139151364|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151365|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151366|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
139151367|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139151369|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
139151370|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151371|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151372|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139151373|NCT01087229|Analgesics|analgesics|mesh-ancestor
139151374|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
139151375|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151376|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139151377|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139151378|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139151379|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151380|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139151381|NCT01084577|Laxatives|laxatives|mesh-ancestor
139151382|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139151383|NCT00094055|Axitinib|axitinib|mesh-list
139151384|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151385|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139151386|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151387|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151388|NCT02531165|Aspirin|aspirin|mesh-list
139151389|NCT02531165|Heparin|heparin|mesh-list
139151390|NCT02531165|Fentanyl|fentanyl|mesh-list
139151391|NCT02531165|Morphine|morphine|mesh-list
139151392|NCT02531165|Ticagrelor|ticagrelor|mesh-list
139151393|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139151394|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139151395|NCT02531165|Analgesics|analgesics|mesh-ancestor
139151396|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
139151397|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151398|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151399|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139151400|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139151401|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139151402|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139151403|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151404|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139151405|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139151406|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151407|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
139151408|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139151409|NCT02531165|Narcotics|narcotics|mesh-ancestor
139151410|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151411|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138888211|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
139151412|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139151413|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
139151414|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
139151415|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
139151416|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139151417|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139151418|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139151419|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
139151420|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151421|NCT00099983|Risperidone|risperidone|mesh-list
139151422|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139151423|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
139151424|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151425|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151426|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151427|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139151428|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139151429|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151430|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139151431|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139151432|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
139151433|NCT00099359|Lamivudine|lamivudine|mesh-list
139151434|NCT00099359|Zidovudine|zidovudine|mesh-list
139151435|NCT00099359|Nevirapine|nevirapine|mesh-list
139151436|NCT00099359|Nelfinavir|nelfinavir|mesh-list
139151437|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139151438|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139151439|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151440|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151442|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139151443|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139151444|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139151445|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
139151446|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139151447|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139151448|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139151449|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139151450|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
139151451|NCT00092417|Vaccines|vaccines|mesh-list
139151452|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
139151453|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151454|NCT00091949|Pioglitazone|pioglitazone|mesh-list
139151455|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139151456|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151457|NCT02258542|Benralizumab|benralizumab|mesh-list
139151458|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139151459|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
139151460|NCT00091793|Denosumab|denosumab|mesh-list
139151461|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139151462|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151463|NCT00098813|Romidepsin|romidepsin|mesh-list
139151464|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139151465|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151466|NCT00098813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139151467|NCT00098813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151468|NCT00098813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151469|NCT01081613|Bevacizumab|bevacizumab|mesh-list
139151470|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
139151471|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139151472|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151473|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139151474|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139151475|NCT01081613|Growth Substances|growth substances|mesh-ancestor
139151476|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151477|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
139151478|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139151479|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151480|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
139151481|NCT02227264|Cinacalcet|cinacalcet|mesh-list
139151482|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139151483|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151484|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139151485|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
139151486|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139151487|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139151488|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139151489|NCT04772248|Adalimumab|adalimumab|mesh-list
139151490|NCT04772248|Infliximab|infliximab|mesh-list
139151491|NCT04772248|Golimumab|golimumab|mesh-list
139151492|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
139151493|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139151494|NCT04772248|Etanercept|etanercept|mesh-list
139151495|NCT04772248|Tofacitinib|tofacitinib|mesh-list
139151496|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139151497|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139151498|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
139151499|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139151500|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139151501|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139151502|NCT04772248|Analgesics|analgesics|mesh-ancestor
139151503|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
139151504|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151505|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151506|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139151507|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
139151508|NCT04772248|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139151509|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139151510|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151511|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151512|NCT00090857|Letrozole|letrozole|mesh-list
138521887|NCT00275054|Rituximab|rituximab|mesh-list
139151513|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151514|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139151515|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139151516|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151517|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151518|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139151519|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
139151520|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139151521|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151522|NCT01775644|Bevacizumab|bevacizumab|mesh-list
139151523|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139151524|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151525|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139151526|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139151527|NCT01775644|Growth Substances|growth substances|mesh-ancestor
139151528|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151529|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
139151530|NCT04259086|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139151531|NCT04259086|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139151532|NCT04259086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139151533|NCT04259086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151534|NCT04259086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151535|NCT04259086|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139151536|NCT04259086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139151537|NCT04259086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151538|NCT04259086|Cholinergic Agents|cholinergic agents|mesh-ancestor
139151539|NCT04259086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151540|NCT00090779|Ritonavir|ritonavir|mesh-list
139151541|NCT00090779|Lopinavir|lopinavir|mesh-list
139151542|NCT00090779|Tenofovir|tenofovir|mesh-list
139151543|NCT00090779|Emtricitabine|emtricitabine|mesh-list
139151544|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139151545|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139151546|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139151547|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
139151548|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151549|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151550|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139151551|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139151552|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
139151553|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139151554|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139151555|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139151556|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139151557|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139151558|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139151559|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
139151560|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151561|NCT01081847|Mannitol|mannitol|mesh-list
139151562|NCT01081847|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139151563|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
139151564|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139151565|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
139151566|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151567|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139151568|NCT01081847|Diuretics|diuretics|mesh-ancestor
139151569|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
139151570|NCT02224456|Tenofovir|tenofovir|mesh-list
139151571|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
139151572|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139151573|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139151574|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139151575|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151576|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151577|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139151578|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139151579|NCT02224534|Clopidogrel|clopidogrel|mesh-list
139151580|NCT02224534|Ticagrelor|ticagrelor|mesh-list
139151581|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139151582|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139151583|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139151584|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139151585|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
139151586|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151587|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151588|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151590|NCT04174612|Daunorubicin|daunorubicin|mesh-list
139151591|NCT04174612|Midostaurin|midostaurin|mesh-list
138902103|NCT04142658|Warfarin|warfarin|mesh-list
139151592|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139151594|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151595|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151596|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
139151597|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139151598|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139151599|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
139151600|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882805|NCT00720538|Growth Substances|growth substances|mesh-ancestor
139151601|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139151602|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139151603|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139151604|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151605|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139151606|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
139151607|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139151608|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151609|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151610|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139151611|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139151612|NCT01082003|Protective Agents|protective agents|mesh-ancestor
139151613|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151614|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
139151615|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139151616|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
139151617|NCT01082237|Escitalopram|escitalopram|mesh-list
139151618|NCT01082237|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139151619|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139151620|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139151621|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151622|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151623|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
139151624|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151625|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139151626|NCT02228122|Laxatives|laxatives|mesh-ancestor
139151627|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139151628|NCT01082315|Cetuximab|cetuximab|mesh-list
139151629|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139151630|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151631|NCT01082471|Morphine|morphine|mesh-list
139151632|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139151633|NCT01082471|Narcotics|narcotics|mesh-ancestor
139151634|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151635|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151636|NCT01082471|Analgesics|analgesics|mesh-ancestor
139151637|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
139151638|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151639|NCT03553498|Acetaminophen|acetaminophen|mesh-list
139151640|NCT03553498|Hydromorphone|hydromorphone|mesh-list
139151641|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139151642|NCT03553498|Analgesics|analgesics|mesh-ancestor
139151643|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
138888261|NCT00695682|Infliximab|infliximab|mesh-list
139151644|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151645|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151646|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
139151647|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139151648|NCT03553498|Narcotics|narcotics|mesh-ancestor
139151649|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151650|NCT01589393|Enoxaparin|enoxaparin|mesh-list
139151651|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
139151652|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139151653|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139151654|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151655|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
139151656|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139151657|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139151658|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139151659|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138882833|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
139151660|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151661|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
139151662|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151663|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151664|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139151665|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151666|NCT00096941|Pertuzumab|pertuzumab|mesh-list
139151667|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139151668|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151669|NCT00096785|Entecavir|entecavir|mesh-list
139151670|NCT00096785|Adefovir|adefovir|mesh-list
139151671|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
139151672|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139151673|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139151674|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139151675|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151676|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151677|NCT01326767|Paclitaxel|paclitaxel|mesh-list
139151678|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139151679|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139151680|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151681|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
139151682|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
139151683|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
139151684|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151685|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
139151686|NCT03963479|Pyridoxal|pyridoxal|mesh-list
139151687|NCT03963479|Pyridoxine|pyridoxine|mesh-list
139151688|NCT03963479|Vitamins|vitamins|mesh-ancestor
139151689|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
139151690|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151691|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
139151692|NCT02228512|Prednisone|prednisone|mesh-list
139151693|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
139151694|NCT02228512|Rituximab|rituximab|mesh-list
139151695|NCT02228512|Doxorubicin|doxorubicin|mesh-list
139151696|NCT02228512|Etoposide|etoposide|mesh-list
139151697|NCT02228512|Vincristine|vincristine|mesh-list
139151698|NCT02228512|Pomalidomide|pomalidomide|mesh-list
139151699|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139151700|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
139151701|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151702|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139151703|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139151704|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
139151705|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151706|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151707|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139151708|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139151709|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139151710|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139151711|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139151712|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151713|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139151714|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
139151715|NCT02228512|Hormones|hormones|mesh-ancestor
139151716|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139151717|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139151718|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139151719|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
139151720|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
139151721|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
139151722|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139151723|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139151724|NCT02228512|Growth Substances|growth substances|mesh-ancestor
139151725|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
139151726|NCT01082627|Somatostatin|somatostatin|mesh-list
139151727|NCT01082627|Hormones|hormones|mesh-ancestor
139151728|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139151729|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151730|NCT03515044|Rifaximin|rifaximin|mesh-list
139151731|NCT03515044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139151732|NCT03515044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139151733|NCT03515044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139151735|NCT01082705|Artemether|artemether|mesh-list
139151736|NCT01082705|Piperaquine|piperaquine|mesh-list
139151737|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138902243|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139151738|NCT01082705|Artenimol|artenimol|mesh-list
139151739|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
139151740|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139151741|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139151742|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139151744|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151745|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139151746|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151747|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151748|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
139151749|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151750|NCT01085981|Niacin|niacin|mesh-list
139151751|NCT01085981|Niacinamide|niacinamide|mesh-list
139151752|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
139151753|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139151754|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
139151755|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151756|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139151757|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
139151758|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
139151759|NCT01085981|Vitamins|vitamins|mesh-ancestor
139151760|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
139151761|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151762|NCT03345082|Ranibizumab|ranibizumab|mesh-list
139151763|NCT03345082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139151764|NCT03345082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139151765|NCT03345082|Growth Substances|growth substances|mesh-ancestor
139151766|NCT03345082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151767|NCT03345082|Growth Inhibitors|growth inhibitors|mesh-ancestor
139151768|NCT03345082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151769|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
139151770|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
139151771|NCT02228902|Trace Elements|trace elements|mesh-ancestor
139151772|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
139151773|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151774|NCT02228902|Hematinics|hematinics|mesh-ancestor
139151775|NCT03288454|Apixaban|apixaban|mesh-list
139151776|NCT03288454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139151777|NCT03288454|Antithrombins|antithrombins|mesh-ancestor
139151778|NCT03288454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139151779|NCT03288454|Protease Inhibitors|protease inhibitors|mesh-ancestor
139151780|NCT03288454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151781|NCT03288454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151782|NCT03288454|Anticoagulants|anticoagulants|mesh-ancestor
139151783|NCT00090545|Sorafenib|sorafenib|mesh-list
139151784|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151785|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139151786|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151787|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151788|NCT02829814|Cyclobenzaprine|cyclobenzaprine|mesh-list
139151789|NCT02829814|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139151790|NCT02829814|Antidepressive Agents|antidepressive agents|mesh-ancestor
139151791|NCT02829814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139151792|NCT02829814|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139151793|NCT02829814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151794|NCT02829814|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139151795|NCT02829814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151796|NCT02829814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139151797|NCT02829814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151798|NCT03916042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139151799|NCT03916042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139151800|NCT02229058|Paclitaxel|paclitaxel|mesh-list
139151801|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139151802|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139151803|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151804|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
139151805|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
139151806|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
139151807|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151808|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
139151809|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139151810|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139151811|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151812|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
139151813|NCT02229292|Coagulants|coagulants|mesh-ancestor
139151814|NCT00070109|Trabectedin|trabectedin|mesh-list
139151815|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139151816|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
139151817|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151818|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151819|NCT00069953|Paclitaxel|paclitaxel|mesh-list
139151820|NCT00069953|Fluorouracil|fluorouracil|mesh-list
139151821|NCT00069953|Lenograstim|lenograstim|mesh-list
139151822|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139151823|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151824|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
139151825|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
139151826|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
139151827|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151828|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
139151829|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139151830|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139151831|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
139151832|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151833|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139151834|NCT02750800|Adalimumab|adalimumab|mesh-list
139151835|NCT02750800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139151836|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139151837|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139151838|NCT02229760|Ritonavir|ritonavir|mesh-list
139151839|NCT02229760|Tipranavir|tipranavir|mesh-list
139151840|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139151841|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139151842|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
139151843|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151844|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151845|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139151846|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139151847|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
139151848|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139151849|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139151850|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139151851|NCT01329562|Naproxen|naproxen|mesh-list
139151852|NCT01329562|Sumatriptan|sumatriptan|mesh-list
139151853|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139151854|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139151855|NCT01329562|Analgesics|analgesics|mesh-ancestor
139151856|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
139151857|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151858|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151859|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139151860|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139151861|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
139151862|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139151863|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151864|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151865|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139151866|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139151867|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139151868|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
139151869|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151870|NCT02230228|Vitamin A|vitamin a|mesh-list
139151871|NCT02230228|Retinol acetate|retinol acetate|mesh-list
139151873|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
139151874|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151875|NCT02230228|Protective Agents|protective agents|mesh-ancestor
139151876|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139151877|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151878|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139151879|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
139151880|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
139151881|NCT01090661|Mipomersen|mipomersen|mesh-list
139151882|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139151883|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139151884|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139151885|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139151886|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139151887|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151888|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151889|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151890|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139151891|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
139151892|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139151893|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151894|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139151895|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139151896|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139151897|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139151898|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139151900|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139151901|NCT05563480|Cisplatin|cisplatin|mesh-list
139151902|NCT05563480|Gemcitabine|gemcitabine|mesh-list
139151903|NCT05563480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139151904|NCT05563480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139151905|NCT05563480|Antimetabolites|antimetabolites|mesh-ancestor
139151906|NCT05563480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151907|NCT05546398|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139151908|NCT05546398|Ezetimibe|ezetimibe|mesh-list
139151909|NCT05546398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139151910|NCT05546398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139151911|NCT05546398|Antimetabolites|antimetabolites|mesh-ancestor
139151912|NCT05546398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151913|NCT05546398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139151914|NCT05546398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151915|NCT05546398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139151916|NCT05546398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151917|NCT05472766|Anticoagulants|anticoagulants|mesh-list
139151918|NCT05472766|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
139151919|NCT05472766|Antithrombins|antithrombins|mesh-ancestor
139151920|NCT05472766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138882948|NCT00679458|Buprenorphine|buprenorphine|mesh-list
139151921|NCT05472766|Protease Inhibitors|protease inhibitors|mesh-ancestor
139151922|NCT05472766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151923|NCT05472766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151924|NCT03653026|Upadacitinib|upadacitinib|mesh-list
139151925|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139151926|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139151927|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151928|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151929|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139151930|NCT02232724|Choline|choline|mesh-list
139151931|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
139151932|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139151933|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
139151934|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151935|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139151936|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139151937|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
139151938|NCT02234440|Metformin|metformin|mesh-list
139151939|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139151940|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151941|NCT02230618|Insulin|insulin|mesh-list
139151942|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
139151943|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139151944|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151945|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
139151946|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139151947|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139151948|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151949|NCT02262520|Digoxin|digoxin|mesh-list
139151950|NCT02262520|Apixaban|apixaban|mesh-list
139151951|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139151952|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
139151953|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139151954|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
139151955|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139151956|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151957|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
139151958|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139151959|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139151960|NCT02262520|Protective Agents|protective agents|mesh-ancestor
139151961|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151962|NCT02233504|Deferasirox|deferasirox|mesh-list
139151963|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139151964|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
139151965|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
139151966|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151967|NCT02262598|Telmisartan|telmisartan|mesh-list
138902465|NCT04157699|Tenofovir|tenofovir|mesh-list
139151968|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139151969|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139151970|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139151971|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139151972|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151974|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
139151975|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151976|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139151977|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139151978|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
139151979|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139151980|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139151981|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139151982|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139151983|NCT03723538|Analgesics|analgesics|mesh-ancestor
139151984|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
139151985|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139151986|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139151987|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139151988|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139151989|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
139151990|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139151991|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151992|NCT01337674|Metoprolol|metoprolol|mesh-list
139151993|NCT01337674|Amlodipine|amlodipine|mesh-list
139151994|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139151995|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139151996|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139151997|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139151998|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139151999|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152000|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
139152001|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139152002|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
139152003|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
139152004|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152005|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139152006|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139152007|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139152008|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
139152009|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152010|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
139152011|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139152012|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
139152013|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139152014|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
139152015|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883000|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
139152016|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152017|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
139152018|NCT02233582|Ibuprofen|ibuprofen|mesh-list
139152019|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139152020|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139152021|NCT02233582|Analgesics|analgesics|mesh-ancestor
139152022|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
139152023|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152024|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152025|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139152026|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139152027|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139152028|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152029|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152030|NCT02580370|Botulinum Toxins|botulinum toxins|mesh-list
139152031|NCT02580370|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139152033|NCT02580370|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139152034|NCT02580370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139152035|NCT02580370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152036|NCT02580370|Cholinergic Agents|cholinergic agents|mesh-ancestor
139152037|NCT02580370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152038|NCT02580370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152039|NCT02580370|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138902557|NCT00843492|PENTA|penta|mesh-list
139152040|NCT02580370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152041|NCT02233816|Vaccines|vaccines|mesh-list
139152042|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
139152043|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152044|NCT02750410|Dulaglutide|dulaglutide|mesh-list
139152045|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139152046|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152047|NCT02750332|Nitisinone|nitisinone|mesh-list
139152048|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152049|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152050|NCT02233894|Ipratropium|ipratropium|mesh-list
139152051|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139152052|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
139152053|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152054|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152055|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139152056|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
139152057|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139152058|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
139152059|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152060|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152061|NCT02233972|Midazolam|midazolam|mesh-list
139152062|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139152063|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139152064|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139152065|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152066|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139152067|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139152068|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139152069|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139152070|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
139152071|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
139152072|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
139152073|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
139152074|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152075|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152076|NCT02234050|Trabectedin|trabectedin|mesh-list
139152077|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139152078|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
139152079|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152080|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152081|NCT02263066|Factor VIII|factor viii|mesh-list
139152082|NCT02263066|Coagulants|coagulants|mesh-ancestor
139152083|NCT02235532|Fluorides|fluorides|mesh-list
139152084|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
139152085|NCT02235532|Protective Agents|protective agents|mesh-ancestor
139152086|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152087|NCT00069095|Leucovorin|leucovorin|mesh-list
139152088|NCT00069095|Bevacizumab|bevacizumab|mesh-list
139152089|NCT00069095|Capecitabine|capecitabine|mesh-list
139152090|NCT00069095|Fluorouracil|fluorouracil|mesh-list
139152091|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
139152092|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139152093|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152094|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139152095|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139152096|NCT00069095|Growth Substances|growth substances|mesh-ancestor
139152097|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152098|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
139152099|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139152100|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
139152101|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152102|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139152103|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
139152104|NCT00069095|Antidotes|antidotes|mesh-ancestor
138522473|NCT05258721|Fluorides|fluorides|mesh-list
139152105|NCT00069095|Protective Agents|protective agents|mesh-ancestor
139152106|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
139152107|NCT00069095|Vitamins|vitamins|mesh-ancestor
139152108|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
139152109|NCT00086411|Bupropion|bupropion|mesh-list
139152110|NCT00086411|Nicotine|nicotine|mesh-list
139152111|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139152112|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
139152113|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152114|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152115|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139152116|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139152117|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
139152118|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152119|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152120|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139152121|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
139152122|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139152123|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139152124|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139152125|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139152126|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
139152127|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139152128|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139152129|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152130|NCT01086527|Montelukast|montelukast|mesh-list
139152131|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138883044|NCT00679614|Tramadol|tramadol|mesh-list
139152132|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
139152133|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139152134|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
139152135|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152136|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152137|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139152138|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139152139|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152141|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139152142|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139152143|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
139152144|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152145|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152146|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152147|NCT01094015|Lidocaine|lidocaine|mesh-list
139152148|NCT01094015|Prilocaine|prilocaine|mesh-list
139152149|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139152150|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
139152151|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
139152152|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139152153|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152154|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
139152155|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152156|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139152157|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139152158|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139152159|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139152160|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152161|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139152162|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
139152163|NCT01090895|Vitamins|vitamins|mesh-ancestor
139152164|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
139152165|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152166|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
139152167|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152168|NCT01090895|Protective Agents|protective agents|mesh-ancestor
139152169|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
139152170|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
139152171|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
139152172|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139152173|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152174|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
139152175|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152176|NCT01094249|Valproic Acid|valproic acid|mesh-list
139152177|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139152178|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139152179|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139152180|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139152181|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152182|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139152183|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139152184|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139152185|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
139152186|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152187|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152188|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138902690|NCT00667433|Tenofovir|tenofovir|mesh-list
139152189|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139152190|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
139152191|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
139152192|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152193|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
139152194|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
139152195|NCT00055601|Paclitaxel|paclitaxel|mesh-list
139152196|NCT00055601|Gemcitabine|gemcitabine|mesh-list
139152197|NCT00055601|Fluorouracil|fluorouracil|mesh-list
139152198|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139152199|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152200|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
139152201|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
139152202|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
139152203|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152204|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139152205|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
139152206|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139152207|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
139152208|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152209|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
139152210|NCT01583621|Vitamin D|vitamin d|mesh-list
139152211|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139152212|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152213|NCT01583621|Vitamins|vitamins|mesh-ancestor
139152214|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
139152215|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139152216|NCT03806231|Dinoprostone|dinoprostone|mesh-list
139152217|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
139152218|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139152219|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152220|NCT01091051|Ustekinumab|ustekinumab|mesh-list
139152221|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
139152222|NCT01327079|Methadone|methadone|mesh-list
138888433|NCT04902859|Analgesics|analgesics|mesh-ancestor
139152223|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139152224|NCT01327079|Narcotics|narcotics|mesh-ancestor
139152225|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139152226|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152227|NCT01327079|Analgesics|analgesics|mesh-ancestor
139152228|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
139152229|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152230|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
139152231|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
139152232|NCT01091207|Sorafenib|sorafenib|mesh-list
139152233|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152234|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139152235|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152236|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152237|NCT00054275|Docetaxel|docetaxel|mesh-list
139152238|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139152239|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152240|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
139152241|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
139152242|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
139152243|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152244|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139152245|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152246|NCT01095185|Simvastatin|simvastatin|mesh-list
139152247|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139152248|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139152249|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
139152250|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152251|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139152252|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139152253|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152254|NCT01583777|Belinostat|belinostat|mesh-list
139152255|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152256|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139152257|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152258|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152259|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
139152260|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139152261|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138883121|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
139152262|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902760|NCT00662987|Amoxicillin|amoxicillin|mesh-list
139152263|NCT00052715|Poly ICLC|poly iclc|mesh-list
139152264|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
139152265|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
139152266|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152267|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
139152268|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139152269|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
139152270|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152271|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139152272|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139152273|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
139152274|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152275|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152276|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139152277|NCT00051311|Cyclosporine|cyclosporine|mesh-list
139152278|NCT00051311|Prednisone|prednisone|mesh-list
139152279|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
139152280|NCT00051311|Doxorubicin|doxorubicin|mesh-list
139152281|NCT00051311|Methotrexate|methotrexate|mesh-list
139152282|NCT00051311|Fludarabine|fludarabine|mesh-list
139152283|NCT00051311|Etoposide|etoposide|mesh-list
139152284|NCT00051311|Vincristine|vincristine|mesh-list
139152285|NCT00051311|Cyclosporins|cyclosporins|mesh-list
139152286|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139152287|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
139152288|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152289|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139152290|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139152291|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
139152292|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152293|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152294|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139152295|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139152296|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139152297|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139152298|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152299|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139152300|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
139152301|NCT00051311|Hormones|hormones|mesh-ancestor
139152302|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152303|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139152304|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139152306|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139152307|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139152308|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
139152309|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
139152310|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139152311|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139152312|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139152313|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
139152314|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
139152315|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
139152316|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
139152317|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152318|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139152319|NCT01091753|Amlodipine|amlodipine|mesh-list
139152320|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139152321|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139152322|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139152323|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152324|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139152325|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152326|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
139152327|NCT00049673|Thalidomide|thalidomide|mesh-list
139152328|NCT00049673|Prednisone|prednisone|mesh-list
139152329|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139152330|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
139152331|NCT00049673|Hormones|hormones|mesh-ancestor
139152332|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152333|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152334|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139152335|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152336|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139152337|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
139152338|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
139152339|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139152340|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152341|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139152342|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139152343|NCT00049673|Growth Substances|growth substances|mesh-ancestor
139152344|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
139152345|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
139152346|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152347|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139152348|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152349|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152351|NCT00066365|Sargramostim|sargramostim|mesh-list
139152352|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
139152353|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152354|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152355|NCT00048581|Abatacept|abatacept|mesh-list
139152356|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139152357|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152358|NCT00048581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139152359|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152360|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139152361|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
139152362|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152363|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139152364|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
139152365|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139152366|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
139152367|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152368|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152369|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
139152370|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152371|NCT03957629|Interferons|interferons|mesh-list
139152372|NCT03957629|Tenofovir|tenofovir|mesh-list
139152373|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
139152374|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
139152375|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139152376|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152377|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
139152378|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152379|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139152380|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139152381|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152382|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152383|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139152384|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139152385|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
139152386|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152387|NCT00065507|Entecavir|entecavir|mesh-list
139152388|NCT00065507|Adefovir|adefovir|mesh-list
139152389|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
139152390|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152391|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139152392|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139152393|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152394|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152395|NCT01095575|Morphine|morphine|mesh-list
139152396|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139152398|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139152399|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152400|NCT01095575|Analgesics|analgesics|mesh-ancestor
139152401|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
139152402|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152403|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
139152404|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139152405|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152406|NCT00065429|Immunotoxins|immunotoxins|mesh-ancestor
139152407|NCT00065429|Immunoconjugates|immunoconjugates|mesh-ancestor
139152408|NCT00065429|Immunologic Factors|immunologic factors|mesh-ancestor
139152409|NCT00065429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152410|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139152411|NCT01095731|Acetic Acid|acetic acid|mesh-list
139152412|NCT01095731|Retinol acetate|retinol acetate|mesh-list
139152413|NCT01095731|Glycine|glycine|mesh-list
139152414|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
139152415|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152416|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152417|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152418|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139152419|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152420|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139152421|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
139152422|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139152423|NCT01095731|Protective Agents|protective agents|mesh-ancestor
139152424|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152425|NCT01095809|Triamcinolone|triamcinolone|mesh-list
139152426|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139152427|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139152428|NCT01095809|Bevacizumab|bevacizumab|mesh-list
139152429|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139152430|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139152431|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152432|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139152433|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139152434|NCT01095809|Growth Substances|growth substances|mesh-ancestor
139152435|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152436|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
139152437|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139152438|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
139152439|NCT01095809|Hormones|hormones|mesh-ancestor
139152440|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152441|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139152442|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
139152443|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152444|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152445|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
139152446|NCT00048035|Hematinics|hematinics|mesh-ancestor
139152447|NCT01092221|Allopurinol|allopurinol|mesh-list
139152448|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
139152449|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883263|NCT02742467|Amlodipine|amlodipine|mesh-list
139152450|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152451|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
139152452|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139152453|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139152454|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
139152455|NCT01092221|Protective Agents|protective agents|mesh-ancestor
139152456|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152457|NCT00047879|Interferons|interferons|mesh-list
139152458|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
139152459|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
139152460|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139152461|NCT00047879|Thalidomide|thalidomide|mesh-list
139152462|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152463|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
139152464|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152465|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
139152466|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152467|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139152468|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
139152469|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139152470|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139152471|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139152472|NCT00047879|Growth Substances|growth substances|mesh-ancestor
139152473|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
139152475|NCT00064337|Dexamethasone|dexamethasone|mesh-list
139152476|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
139152478|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139152479|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
139152480|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152481|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139152482|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139152483|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
139152484|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152485|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152486|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139152487|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139152488|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
139152489|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
139152490|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152491|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139152492|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
139152493|NCT00064337|Hormones|hormones|mesh-ancestor
139152494|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152495|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139152496|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
139152497|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139152498|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152499|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139152500|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139152501|NCT00064337|Growth Substances|growth substances|mesh-ancestor
139152502|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
139152503|NCT01096121|Enalapril|enalapril|mesh-list
138883267|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139152504|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139152505|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
139152506|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152507|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152508|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139152509|NCT00064259|Fluorouracil|fluorouracil|mesh-list
139152510|NCT00064259|Oblimersen|oblimersen|mesh-list
139152511|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152512|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
139152513|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152514|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139152515|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139152516|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
139152517|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152518|NCT03954197|Hormones|hormones|mesh-list
139152519|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152520|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152521|NCT00044213|Vitamins|vitamins|mesh-list
139152522|NCT00044213|Edetic Acid|edetic acid|mesh-list
139152523|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
139152524|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
139152525|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152526|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
139152527|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139152528|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
139152529|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
139152530|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152531|NCT00044213|Antidotes|antidotes|mesh-ancestor
139152532|NCT00044213|Protective Agents|protective agents|mesh-ancestor
139152533|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139152534|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139152535|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
139152536|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139152537|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139152538|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139152539|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
139152540|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139152541|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152542|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139152543|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139152544|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139152545|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139152546|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152547|NCT01096199|Cisplatin|cisplatin|mesh-list
139152548|NCT01096199|Everolimus|everolimus|mesh-list
139152549|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152550|NCT01096199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139152551|NCT01096199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139152552|NCT01096199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152553|NCT01096199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152554|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139152555|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
139152556|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152557|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139152558|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139152559|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152561|NCT01096277|Hormones|hormones|mesh-ancestor
139152562|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152563|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139152564|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
139152565|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152566|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152567|NCT01096355|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139152568|NCT01096355|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139152569|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152570|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152572|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139152573|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139152574|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152575|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139152576|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139152577|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152578|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152579|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152580|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139152581|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
139152582|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139152583|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152584|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139152585|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139152586|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139152587|NCT01092455|Heparin|heparin|mesh-list
139152588|NCT01092455|Calcium heparin|calcium heparin|mesh-list
139152589|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
139152590|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139152591|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139152592|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152593|NCT02264938|Antioxidants|antioxidants|mesh-list
139152594|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152595|NCT02264938|Protective Agents|protective agents|mesh-ancestor
139152596|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152597|NCT02511886|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
138883332|NCT00991627|Anesthetics|anesthetics|mesh-list
139152598|NCT02511886|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139152599|NCT02511886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152600|NCT02511886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139152601|NCT02511886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152602|NCT02511886|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139152603|NCT02511886|GABA Agonists|gaba agonists|mesh-ancestor
139152604|NCT02511886|GABA Agents|gaba agents|mesh-ancestor
139152605|NCT02511886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152606|NCT02511886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152607|NCT00043979|Cyclosporine|cyclosporine|mesh-list
139152608|NCT00043979|Sirolimus|sirolimus|mesh-list
139152609|NCT00043979|Prednisone|prednisone|mesh-list
139152610|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
139152611|NCT00043979|Melphalan|melphalan|mesh-list
139152612|NCT00043979|Doxorubicin|doxorubicin|mesh-list
139152613|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139152614|NCT00043979|Fludarabine|fludarabine|mesh-list
139152615|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
139152616|NCT00043979|Etoposide|etoposide|mesh-list
139152617|NCT00043979|Vincristine|vincristine|mesh-list
139152618|NCT00043979|Tacrolimus|tacrolimus|mesh-list
139152619|NCT00043979|Cyclosporins|cyclosporins|mesh-list
139152620|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139152621|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139152622|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
139152623|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152624|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139152625|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139152626|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
139152627|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152628|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152629|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139152630|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139152631|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139152632|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139152633|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152634|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139152635|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
139152637|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152638|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139152639|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139152641|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139152642|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139152643|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
139152644|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
139152645|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
139152646|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
139152647|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152648|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
139152649|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139152650|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139152651|NCT01436032|Ketorolac|ketorolac|mesh-list
139152652|NCT01436032|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139152653|NCT01436032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139152654|NCT01436032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139152655|NCT01436032|Analgesics|analgesics|mesh-ancestor
139152656|NCT01436032|Sensory System Agents|sensory system agents|mesh-ancestor
139152657|NCT01436032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152658|NCT01436032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152659|NCT01436032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139152660|NCT01436032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139152661|NCT01436032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139152662|NCT01436032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152663|NCT01436032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152664|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
139152665|NCT01092533|Prednisolone|prednisolone|mesh-list
139152666|NCT01092533|Prednisone|prednisone|mesh-list
139152667|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139152668|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152669|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139152670|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
139152671|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139152672|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152673|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152674|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152675|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139152676|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
139152677|NCT01092533|Hormones|hormones|mesh-ancestor
139152678|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152679|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152680|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139152681|NCT01431820|Luliconazole|luliconazole|mesh-list
139152682|NCT01431820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139152683|NCT01431820|Antifungal Agents|antifungal agents|mesh-ancestor
139152684|NCT01431820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152685|NCT01425970|Interferons|interferons|mesh-list
139152686|NCT01425970|Ribavirin|ribavirin|mesh-list
139152687|NCT01425970|Interferon-alpha|interferon-alpha|mesh-list
139152688|NCT01425970|Interferon alpha-2|interferon alpha-2|mesh-list
139152689|NCT01425970|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139152690|NCT01425970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152691|NCT01425970|Antiviral Agents|antiviral agents|mesh-ancestor
139152692|NCT01425970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152693|NCT01425970|Antimetabolites|antimetabolites|mesh-ancestor
139152694|NCT01425970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152695|NCT01425970|Immunologic Factors|immunologic factors|mesh-ancestor
139152696|NCT01425970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152698|NCT01619332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139152699|NCT01619332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152700|NCT01619332|Incretins|incretins|mesh-ancestor
139152701|NCT01619332|Hormones|hormones|mesh-ancestor
139152702|NCT01619332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152703|NCT01619332|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139152704|NCT01619332|Protease Inhibitors|protease inhibitors|mesh-ancestor
139152705|NCT01619332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152706|NCT01619332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152707|NCT01616524|Interferons|interferons|mesh-list
139152708|NCT01616524|Ribavirin|ribavirin|mesh-list
139152709|NCT01616524|Interferon-alpha|interferon-alpha|mesh-list
139152710|NCT01616524|Interferon alpha-2|interferon alpha-2|mesh-list
139152711|NCT01616524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139152712|NCT01616524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152713|NCT01616524|Antiviral Agents|antiviral agents|mesh-ancestor
139152714|NCT01616524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152715|NCT01616524|Antimetabolites|antimetabolites|mesh-ancestor
139152716|NCT01616524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152718|NCT01616524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152719|NCT02265328|Prednisolone|prednisolone|mesh-list
139152720|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139152721|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
139152722|NCT02265328|Hormones|hormones|mesh-ancestor
139152723|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152724|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152725|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139152726|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152727|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
139152728|NCT01421056|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
139152729|NCT01421056|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139152730|NCT01421056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152731|NCT01421056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152733|NCT01416064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139152734|NCT01416064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139152735|NCT01416064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139152736|NCT01416064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152737|NCT01416064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139152738|NCT01594216|Exemestane|exemestane|mesh-list
139152739|NCT01594216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152740|NCT01594216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139152741|NCT01594216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139152742|NCT01594216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152743|NCT01594216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152744|NCT01594216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139152745|NCT01594216|Hormone Antagonists|hormone antagonists|mesh-ancestor
139152746|NCT01594216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152747|NCT01594216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152748|NCT02263690|Lidocaine|lidocaine|mesh-list
139152749|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
139152750|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
139152751|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139152752|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152753|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
139152754|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152755|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139152756|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139152757|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139152758|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139019566|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139152759|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152760|NCT02265562|Alprostadil|alprostadil|mesh-list
139152761|NCT02265562|Misoprostol|misoprostol|mesh-list
139152762|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139152763|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
139152764|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139152765|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152766|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139152767|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139152768|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
139152769|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139152771|NCT02265562|Urological Agents|urological agents|mesh-ancestor
139152772|NCT01399684|Leucovorin|leucovorin|mesh-list
139152773|NCT01399684|Folic Acid|folic acid|mesh-list
139152774|NCT01399684|Bevacizumab|bevacizumab|mesh-list
139152775|NCT01399684|Fluorouracil|fluorouracil|mesh-list
139152776|NCT01399684|Oxaliplatin|oxaliplatin|mesh-list
139152777|NCT01399684|Levoleucovorin|levoleucovorin|mesh-list
139152778|NCT01399684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139152779|NCT01399684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152780|NCT01399684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139152781|NCT01399684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139152782|NCT01399684|Growth Substances|growth substances|mesh-ancestor
139152783|NCT01399684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152784|NCT01399684|Growth Inhibitors|growth inhibitors|mesh-ancestor
139152785|NCT01399684|Antimetabolites|antimetabolites|mesh-ancestor
139152786|NCT01399684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903277|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139152787|NCT01399684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139152788|NCT01399684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139152789|NCT01399684|Immunologic Factors|immunologic factors|mesh-ancestor
139152790|NCT01399684|Antidotes|antidotes|mesh-ancestor
139152791|NCT01399684|Protective Agents|protective agents|mesh-ancestor
139152792|NCT01399684|Vitamin B Complex|vitamin b complex|mesh-ancestor
139152793|NCT01399684|Vitamins|vitamins|mesh-ancestor
139152794|NCT01399684|Micronutrients|micronutrients|mesh-ancestor
139152795|NCT01399684|Hematinics|hematinics|mesh-ancestor
139152796|NCT01397968|Cenobamate|cenobamate|mesh-list
139152797|NCT01397968|Anticonvulsants|anticonvulsants|mesh-ancestor
139152798|NCT01397578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139152799|NCT01397578|Immunologic Factors|immunologic factors|mesh-ancestor
139152800|NCT01397578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152801|NCT02265718|Methylphenidate|methylphenidate|mesh-list
139152802|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139152803|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152804|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139152805|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139152806|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139152807|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152808|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
138883573|NCT05295355|Anticonvulsants|anticonvulsants|mesh-ancestor
139152809|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152810|NCT01381666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139152811|NCT02266030|Aspirin|aspirin|mesh-list
139152812|NCT02266030|Cilostazol|cilostazol|mesh-list
139152813|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139152814|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139152815|NCT02266030|Analgesics|analgesics|mesh-ancestor
139152816|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
139152817|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152818|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152819|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139152820|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139152821|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139152822|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139152823|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152824|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139152825|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139152826|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152827|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
139152828|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139152829|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
139152830|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139152831|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
139152832|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
139152833|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139152834|NCT02266030|Protective Agents|protective agents|mesh-ancestor
139152835|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139152836|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139152837|NCT01527916|Donepezil|donepezil|mesh-list
139152838|NCT01527916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139152839|NCT01527916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139152840|NCT01527916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152841|NCT01527916|Cholinergic Agents|cholinergic agents|mesh-ancestor
139152842|NCT01527916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523211|NCT05772546|Maleic acid|maleic acid|mesh-list
139152843|NCT01527916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152845|NCT01373086|Eplerenone|eplerenone|mesh-list
139152846|NCT01373086|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139152847|NCT01373086|Hormone Antagonists|hormone antagonists|mesh-ancestor
139152848|NCT01373086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152849|NCT01373086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152850|NCT01373086|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139152851|NCT01373086|Diuretics|diuretics|mesh-ancestor
139152852|NCT01373086|Natriuretic Agents|natriuretic agents|mesh-ancestor
139152853|NCT01373086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139152854|NCT01519804|Paclitaxel|paclitaxel|mesh-list
139152855|NCT01519804|Carboplatin|carboplatin|mesh-list
139152856|NCT01519804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139152857|NCT01519804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152858|NCT01519804|Tubulin Modulators|tubulin modulators|mesh-ancestor
139152859|NCT01519804|Antimitotic Agents|antimitotic agents|mesh-ancestor
138883596|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
139152860|NCT01519804|Mitosis Modulators|mitosis modulators|mesh-ancestor
139152861|NCT01519804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152862|NCT02263924|Tocotrienols|tocotrienols|mesh-list
139152864|NCT02263924|Tocopherols|tocopherols|mesh-list
139152865|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
139152866|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152867|NCT02263924|Protective Agents|protective agents|mesh-ancestor
139152868|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152869|NCT02263924|Vitamins|vitamins|mesh-ancestor
139152870|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
139152871|NCT02264002|Metoprolol|metoprolol|mesh-list
139152872|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139152873|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139152874|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
139152875|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
139152876|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152877|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152878|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139152879|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139152880|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139152881|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
139152882|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152883|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152884|NCT01517776|Temozolomide|temozolomide|mesh-list
139152885|NCT01517776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139152886|NCT01517776|Alkylating Agents|alkylating agents|mesh-ancestor
139152887|NCT01517776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152888|NCT01517776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152889|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
139152890|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139152891|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139152892|NCT01516918|Ribavirin|ribavirin|mesh-list
139152893|NCT01516918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139152894|NCT01516918|Antimetabolites|antimetabolites|mesh-ancestor
139152895|NCT01516918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152896|NCT01516918|Antiviral Agents|antiviral agents|mesh-ancestor
139152897|NCT01516918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152898|NCT01508026|Valsartan|valsartan|mesh-list
139152899|NCT01508026|Nebivolol|nebivolol|mesh-list
139152900|NCT01508026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139152901|NCT01508026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139152902|NCT01508026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139152903|NCT01508026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152904|NCT01508026|Vasodilator Agents|vasodilator agents|mesh-ancestor
139152905|NCT01508026|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139152906|NCT01508026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139152907|NCT01508026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139152908|NCT01508026|Adrenergic Agents|adrenergic agents|mesh-ancestor
139152909|NCT01508026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152910|NCT01508026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152911|NCT01357642|Epinephrine|epinephrine|mesh-list
139152912|NCT01357642|Racepinephrine|racepinephrine|mesh-list
139152913|NCT01357642|Epinephryl borate|epinephryl borate|mesh-list
139152914|NCT01357642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139152915|NCT01357642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139152916|NCT01357642|Adrenergic Agents|adrenergic agents|mesh-ancestor
139152917|NCT01357642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152918|NCT01357642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152919|NCT01357642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152920|NCT01357642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139152921|NCT01357642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139152922|NCT01357642|Autonomic Agents|autonomic agents|mesh-ancestor
139152923|NCT01357642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152924|NCT01357642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139152925|NCT01357642|Respiratory System Agents|respiratory system agents|mesh-ancestor
139152927|NCT01357642|Sympathomimetics|sympathomimetics|mesh-ancestor
139152928|NCT01357642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139152929|NCT03135340|Anesthetics|anesthetics|mesh-list
139152930|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139152931|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152932|NCT01356160|Ribavirin|ribavirin|mesh-list
139152933|NCT01356160|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139152934|NCT01356160|Ledipasvir|ledipasvir|mesh-list
139152935|NCT01356160|Antimetabolites|antimetabolites|mesh-ancestor
139152936|NCT01356160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152937|NCT01356160|Antiviral Agents|antiviral agents|mesh-ancestor
139152938|NCT01356160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139152939|NCT02264158|Telmisartan|telmisartan|mesh-list
139152940|NCT02264158|Lacidipine|lacidipine|mesh-list
139152941|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139152942|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139152943|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139152944|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152945|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139152946|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139152947|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139152948|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152950|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
139152951|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152952|NCT01476904|Epinephrine|epinephrine|mesh-list
139152953|NCT01476904|Racepinephrine|racepinephrine|mesh-list
139152954|NCT01476904|Epinephryl borate|epinephryl borate|mesh-list
139152955|NCT01476904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139152956|NCT01476904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139152957|NCT01476904|Adrenergic Agents|adrenergic agents|mesh-ancestor
139152958|NCT01476904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139152959|NCT01476904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152960|NCT01476904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152961|NCT01476904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139152962|NCT01476904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139152963|NCT01476904|Autonomic Agents|autonomic agents|mesh-ancestor
139152964|NCT01476904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152965|NCT01476904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139152966|NCT01476904|Respiratory System Agents|respiratory system agents|mesh-ancestor
139152967|NCT01476904|Mydriatics|mydriatics|mesh-ancestor
139152968|NCT01476904|Sympathomimetics|sympathomimetics|mesh-ancestor
139152969|NCT01476904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139152970|NCT01337752|Dexamethasone|dexamethasone|mesh-list
139152971|NCT01337752|Bortezomib|bortezomib|mesh-list
139152972|NCT01337752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139152973|NCT01337752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139152974|NCT01337752|Antiemetics|antiemetics|mesh-ancestor
139152975|NCT01337752|Autonomic Agents|autonomic agents|mesh-ancestor
139152976|NCT01337752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152977|NCT01337752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152978|NCT01337752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139152979|NCT01337752|Glucocorticoids|glucocorticoids|mesh-ancestor
139152980|NCT01337752|Hormones|hormones|mesh-ancestor
139152981|NCT01337752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139152982|NCT01337752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139152983|NCT01337752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152984|NCT01337752|Immunologic Factors|immunologic factors|mesh-ancestor
139152985|NCT01318642|Gemcitabine|gemcitabine|mesh-list
139152986|NCT01318642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139152987|NCT01318642|Antimetabolites|antimetabolites|mesh-ancestor
139152988|NCT01318642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139152989|NCT01318642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139152990|NCT01318252|Latanoprost|latanoprost|mesh-list
139152991|NCT01318252|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139152992|NCT01318252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139152994|NCT01313572|Analgesics|analgesics|mesh-ancestor
139152995|NCT01313572|Sensory System Agents|sensory system agents|mesh-ancestor
139152996|NCT01313572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139152997|NCT01313572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139152998|NCT01313572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139152999|NCT01313572|Vasodilator Agents|vasodilator agents|mesh-ancestor
139153000|NCT01313572|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139153001|NCT01313572|Purinergic Agonists|purinergic agonists|mesh-ancestor
139153002|NCT01313572|Purinergic Agents|purinergic agents|mesh-ancestor
139153003|NCT01313572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153004|NCT01313572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153005|NCT02265484|Rifaximin|rifaximin|mesh-list
139153006|NCT02265484|Bromocriptine|bromocriptine|mesh-list
139153007|NCT02265484|Lactulose|lactulose|mesh-list
139153008|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139153009|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153010|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139153011|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139153012|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139153013|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
139153014|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139153015|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153016|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
139153017|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
139153018|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153019|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153021|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139153022|NCT02264626|Narcotics|narcotics|mesh-ancestor
139153023|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139153024|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153025|NCT02264626|Analgesics|analgesics|mesh-ancestor
139153026|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
139153027|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153028|NCT03993262|Bortezomib|bortezomib|mesh-list
139153029|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153030|NCT02267044|Ropivacaine|ropivacaine|mesh-list
139153031|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
139153032|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
139153033|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139153034|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153035|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
139153036|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153037|NCT02267122|Mupirocin|mupirocin|mesh-list
139153038|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139153039|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153040|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139153041|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153042|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153043|NCT01261312|Guadecitabine|guadecitabine|mesh-list
139153044|NCT01261312|Azacitidine|azacitidine|mesh-list
139153045|NCT01261312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153046|NCT01261312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139153047|NCT01261312|Antimetabolites|antimetabolites|mesh-ancestor
139153048|NCT01261312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153049|NCT01261312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153050|NCT01254370|Travoprost|travoprost|mesh-list
139153051|NCT01254370|Latanoprost|latanoprost|mesh-list
139153052|NCT01254370|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139153053|NCT01254370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139153054|NCT01254370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139153055|NCT01254136|Trastuzumab|trastuzumab|mesh-list
139153056|NCT01254136|Vinorelbine|vinorelbine|mesh-list
139153057|NCT01254136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139153058|NCT01254136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153059|NCT01254136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139153060|NCT01254136|Tubulin Modulators|tubulin modulators|mesh-ancestor
139153061|NCT01254136|Antimitotic Agents|antimitotic agents|mesh-ancestor
139153062|NCT01254136|Mitosis Modulators|mitosis modulators|mesh-ancestor
139153063|NCT01254136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153065|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153066|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139153067|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153068|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153071|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
139153072|NCT00039377|Methotrexate|methotrexate|mesh-list
139153073|NCT00039377|Etoposide|etoposide|mesh-list
139153074|NCT00039377|Vincristine|vincristine|mesh-list
139153075|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
139153076|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
139153077|NCT00039377|Tacrolimus|tacrolimus|mesh-list
139153078|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
139153079|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139153080|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
139153081|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153082|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139153083|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139153084|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
139153085|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153086|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153087|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139153088|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139153089|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
139153090|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139153091|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139153092|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
139153093|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
139153094|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153095|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139153096|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139153097|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139153098|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139153099|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139153100|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
139153101|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153102|NCT00039377|Antidotes|antidotes|mesh-ancestor
139153103|NCT00039377|Protective Agents|protective agents|mesh-ancestor
139153104|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
139153105|NCT00039377|Vitamins|vitamins|mesh-ancestor
139153106|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
139153107|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139153108|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
139153109|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
139153110|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
139153111|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139153112|NCT01096745|Cisplatin|cisplatin|mesh-list
139153113|NCT01096745|Gemcitabine|gemcitabine|mesh-list
139153114|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153115|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139153116|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
139153117|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153119|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139153120|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139153121|NCT03953729|Analgesics|analgesics|mesh-ancestor
139153122|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
139153123|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153124|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153125|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139153126|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139153127|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139153128|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153129|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153130|NCT01097213|Ethanol|ethanol|mesh-list
139153131|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139153132|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153133|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139153134|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153135|NCT00154102|Leucovorin|leucovorin|mesh-list
139153136|NCT00154102|Folic Acid|folic acid|mesh-list
139153137|NCT00154102|Fluorouracil|fluorouracil|mesh-list
139153138|NCT00154102|Irinotecan|irinotecan|mesh-list
139153139|NCT00154102|Cetuximab|cetuximab|mesh-list
139153140|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
139153141|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
139153142|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153143|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139153144|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153145|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139153146|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
139153147|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153148|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139153149|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139153150|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153151|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139153153|NCT00154102|Protective Agents|protective agents|mesh-ancestor
139153154|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
139153155|NCT00154102|Vitamins|vitamins|mesh-ancestor
139153156|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
139153157|NCT00154102|Hematinics|hematinics|mesh-ancestor
139153158|NCT01269658|Azithromycin|azithromycin|mesh-list
139153159|NCT01269658|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138883745|NCT02625168|Afatinib|afatinib|mesh-list
139153160|NCT01269658|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139153161|NCT01269658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139153162|NCT01269658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153163|NCT01229644|Crenolanib|crenolanib|mesh-list
139153164|NCT01229644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153165|NCT02267980|Ketamine|ketamine|mesh-list
139153166|NCT02267980|Sevoflurane|sevoflurane|mesh-list
139153167|NCT02267980|Analgesics|analgesics|mesh-ancestor
139153168|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
139153169|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153170|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153171|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139153172|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139153173|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
139153174|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
139153175|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139153176|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139153177|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139153178|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153179|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153180|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139153181|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139153182|NCT01224262|Vaccines|vaccines|mesh-list
139153183|NCT01224262|Immunologic Factors|immunologic factors|mesh-ancestor
139153184|NCT01224262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153185|NCT01222702|Vancomycin|vancomycin|mesh-list
139153186|NCT01222702|Oxazolidinones|oxazolidinones|mesh-list
139153187|NCT01222702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139153188|NCT01222702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153189|NCT01222702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139153190|NCT01222702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153191|NCT01222702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153192|NCT01204762|Entecavir|entecavir|mesh-list
139153193|NCT01204762|Antiviral Agents|antiviral agents|mesh-ancestor
139153194|NCT01204762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153195|NCT02236078|Isoniazid|isoniazid|mesh-list
139153196|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
139153197|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139153198|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153199|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139153200|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139153201|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
139153202|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153203|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139153204|NCT01198834|Etodolac|etodolac|mesh-list
139153205|NCT01198834|Lidocaine|lidocaine|mesh-list
139153206|NCT01198834|Anesthetics, Local|anesthetics, local|mesh-ancestor
139153207|NCT01198834|Anesthetics|anesthetics|mesh-ancestor
139153208|NCT01198834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139153209|NCT01198834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153210|NCT01198834|Sensory System Agents|sensory system agents|mesh-ancestor
139153211|NCT01198834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153212|NCT01198834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139153213|NCT01198834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139153214|NCT01198834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139153215|NCT01198834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138883774|NCT05407597|Immunologic Factors|immunologic factors|mesh-ancestor
139153216|NCT01198834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153217|NCT01198834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139153218|NCT01198834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139153219|NCT01198834|Analgesics|analgesics|mesh-ancestor
139153220|NCT01198834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138923264|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
139153222|NCT01198834|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139153223|NCT01198834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139153224|NCT01198834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153225|NCT01193140|Temozolomide|temozolomide|mesh-list
139153226|NCT01193140|Veliparib|veliparib|mesh-list
139153227|NCT01193140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139153228|NCT01193140|Alkylating Agents|alkylating agents|mesh-ancestor
139153229|NCT01193140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153230|NCT01193140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153231|NCT01193140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139153232|NCT01193140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153233|NCT01189396|Albuterol|albuterol|mesh-list
139153234|NCT01189396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139153235|NCT01189396|Autonomic Agents|autonomic agents|mesh-ancestor
139153236|NCT01189396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153237|NCT01189396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153238|NCT01189396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139153239|NCT01189396|Respiratory System Agents|respiratory system agents|mesh-ancestor
139153240|NCT01189396|Tocolytic Agents|tocolytic agents|mesh-ancestor
139153241|NCT01189396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139153242|NCT01189396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139153243|NCT01189396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139153245|NCT01189396|Adrenergic Agents|adrenergic agents|mesh-ancestor
139153246|NCT01189396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153247|NCT01189396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153248|NCT05626972|Tenecteplase|tenecteplase|mesh-list
139153249|NCT05626972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139153250|NCT05626972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139153251|NCT05626972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153252|NCT01174732|Albuterol|albuterol|mesh-list
139153253|NCT01174732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139153254|NCT01174732|Autonomic Agents|autonomic agents|mesh-ancestor
139153255|NCT01174732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153256|NCT01174732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153257|NCT01174732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139153258|NCT01174732|Respiratory System Agents|respiratory system agents|mesh-ancestor
139153259|NCT01174732|Tocolytic Agents|tocolytic agents|mesh-ancestor
139153260|NCT01174732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139153261|NCT01174732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138888710|NCT00851799|Ritonavir|ritonavir|mesh-list
139153262|NCT01174732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139153263|NCT01174732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139153264|NCT01174732|Adrenergic Agents|adrenergic agents|mesh-ancestor
139153265|NCT01174732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153266|NCT01174732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153267|NCT01076764|Heparin|heparin|mesh-list
139153268|NCT01076764|Calcium heparin|calcium heparin|mesh-list
139153269|NCT01076764|Otamixaban|otamixaban|mesh-list
139153270|NCT01076764|Eptifibatide|eptifibatide|mesh-list
139153271|NCT01076764|Anticoagulants|anticoagulants|mesh-ancestor
139153272|NCT01076764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139153273|NCT01076764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139153274|NCT01076764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153275|NCT01076764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139153276|NCT01076764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139153277|NCT01076764|Antithrombins|antithrombins|mesh-ancestor
139153278|NCT01076764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139153279|NCT01076764|Protease Inhibitors|protease inhibitors|mesh-ancestor
139153280|NCT01076764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153281|NCT02269072|Anastrozole|anastrozole|mesh-list
139153282|NCT02269072|Leuprolide|leuprolide|mesh-list
139153283|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139153284|NCT02269072|Testosterone|testosterone|mesh-list
139153285|NCT02269072|Androgens|androgens|mesh-ancestor
139153286|NCT02269072|Hormones|hormones|mesh-ancestor
139153287|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139153288|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153289|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139153290|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153291|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139153292|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139153293|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153294|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153295|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139153296|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
139153297|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139153298|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
139153299|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139153300|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
139153301|NCT01071850|Metformin|metformin|mesh-list
139153302|NCT01071850|Ipragliflozin|ipragliflozin|mesh-list
139153303|NCT01071850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139153304|NCT01071850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153305|NCT01071850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139153306|NCT01071850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153307|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
139153308|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139153309|NCT01037062|Entecavir|entecavir|mesh-list
139153310|NCT01037062|Antiviral Agents|antiviral agents|mesh-ancestor
139153311|NCT01037062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153312|NCT01167166|ON 01910|on 01910|mesh-list
139153313|NCT01167166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153314|NCT01167166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139153315|NCT01167166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153316|NCT01167166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153317|NCT01035502|Idarubicin|idarubicin|mesh-list
138883811|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139153318|NCT01035502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139153319|NCT01035502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153320|NCT01035502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139153321|NCT01035502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139153322|NCT01035502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153323|NCT01035502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153324|NCT01030432|Ribavirin|ribavirin|mesh-list
139153325|NCT01030432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139153326|NCT01030432|Interferon-alpha|interferon-alpha|mesh-list
139153327|NCT01030432|Asunaprevir|asunaprevir|mesh-list
139153328|NCT01030432|Antimetabolites|antimetabolites|mesh-ancestor
139153329|NCT01030432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153330|NCT01030432|Antiviral Agents|antiviral agents|mesh-ancestor
139153331|NCT01030432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153332|NCT01030432|Immunologic Factors|immunologic factors|mesh-ancestor
139153333|NCT01030432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153334|NCT01030432|Protease Inhibitors|protease inhibitors|mesh-ancestor
139153335|NCT01030432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153336|NCT02269462|Efavirenz|efavirenz|mesh-list
139153337|NCT02269462|Nevirapine|nevirapine|mesh-list
139153338|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139153339|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139153340|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153341|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153342|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
139153343|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153344|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139153345|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139153346|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139153347|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139153348|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139153349|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139153350|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139153351|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139153352|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139153353|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139153354|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153355|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
139153356|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
139153357|NCT02269540|Sertraline|sertraline|mesh-list
139153359|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139153360|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
139153361|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153362|NCT02269540|Expectorants|expectorants|mesh-ancestor
139153363|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
139153364|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139153365|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
139153366|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153367|NCT02269540|Protective Agents|protective agents|mesh-ancestor
139153368|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153369|NCT02269540|Antidotes|antidotes|mesh-ancestor
139153370|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
139153371|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139153372|NCT02269540|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139153373|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138888745|NCT00520975|Antibodies|antibodies|mesh-list
139153374|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139153375|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153376|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
139153377|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139153378|NCT01023880|Delanzomib|delanzomib|mesh-list
139153379|NCT01023880|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
139153380|NCT01023880|Protease Inhibitors|protease inhibitors|mesh-ancestor
139153381|NCT01023880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153382|NCT01023880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153383|NCT02650804|Coenzyme Q10|coenzyme q10|mesh-list
139153384|NCT02650804|Gemcitabine|gemcitabine|mesh-list
139153385|NCT02650804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139153386|NCT02650804|Antimetabolites|antimetabolites|mesh-ancestor
139153387|NCT02650804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153388|NCT02650804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153389|NCT02650804|Vitamins|vitamins|mesh-ancestor
139153390|NCT02650804|Micronutrients|micronutrients|mesh-ancestor
139153391|NCT02650804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903876|NCT00823212|Analgesics|analgesics|mesh-ancestor
139153392|NCT02269696|Metoprolol|metoprolol|mesh-list
139153393|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139153394|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139153395|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
139153396|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
139153397|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153398|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153399|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139153400|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139153401|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139153402|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
139153403|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153404|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153405|NCT03135184|Coal Tar|coal tar|mesh-list
139153406|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
139153407|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
139153408|NCT05613400|Simvastatin|simvastatin|mesh-list
139153409|NCT05613400|Ezetimibe|ezetimibe|mesh-list
139153410|NCT05613400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139153411|NCT05613400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139153412|NCT05613400|Antimetabolites|antimetabolites|mesh-ancestor
138888762|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139153413|NCT05613400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153414|NCT05613400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139153415|NCT05613400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139153416|NCT05613400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153418|NCT02261662|Betamethasone|betamethasone|mesh-list
139153419|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
139153420|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153421|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
139153422|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153423|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139153424|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
139153425|NCT02261662|Hormones|hormones|mesh-ancestor
139153426|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139153427|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153428|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139153429|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
139153430|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
139153431|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139153432|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153433|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139153434|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139153435|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153436|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153437|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153438|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139153439|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139153440|NCT00035555|Cyclosporine|cyclosporine|mesh-list
139153441|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
139153442|NCT00035555|Abatacept|abatacept|mesh-list
139153443|NCT00035555|Cyclosporins|cyclosporins|mesh-list
139153444|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153445|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153446|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139153447|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
139153448|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153449|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
139153450|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153451|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
139153452|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139153453|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139153454|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139153455|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153456|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139153457|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
139153458|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139153459|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139153460|NCT00035555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139153462|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139153463|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139153464|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883901|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
138903951|NCT05957913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153466|NCT01093235|Bevacizumab|bevacizumab|mesh-list
139153467|NCT01093235|Docetaxel|docetaxel|mesh-list
139153468|NCT01093235|Fluorouracil|fluorouracil|mesh-list
139153469|NCT01093235|Epirubicin|epirubicin|mesh-list
139153470|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139153471|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
139153472|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153473|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139153474|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139153475|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
139019567|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139153476|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153477|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153478|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139153479|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139153480|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139153481|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139153482|NCT01093235|Growth Substances|growth substances|mesh-ancestor
139153483|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
139153484|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
139153485|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
139153486|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
139153487|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
139153488|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139153489|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139153490|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139153491|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139153492|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153493|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
139153494|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139153495|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153496|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139153497|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153498|NCT01088009|Lamivudine|lamivudine|mesh-list
139153499|NCT01088009|Adefovir|adefovir|mesh-list
139153500|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139153501|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139153502|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153503|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153504|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
139153505|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153506|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139153507|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139153508|NCT03894046|Imipenem|imipenem|mesh-list
139153509|NCT03894046|Colistin|colistin|mesh-list
139153510|NCT03894046|Sulbactam|sulbactam|mesh-list
139153511|NCT03894046|Durlobactam|durlobactam|mesh-list
139153512|NCT03894046|Cilastatin|cilastatin|mesh-list
139153513|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139153514|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153515|NCT03894046|Protease Inhibitors|protease inhibitors|mesh-ancestor
139153516|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153517|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523884|NCT02575677|Oxycodone|oxycodone|mesh-list
139153518|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139153519|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
139153520|NCT04475614|Vitamins|vitamins|mesh-ancestor
139153521|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
139153522|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153523|NCT01143064|Progesterone|progesterone|mesh-list
139153524|NCT01143064|Progestins|progestins|mesh-ancestor
139153525|NCT01143064|Hormones|hormones|mesh-ancestor
139153526|NCT01143064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139153527|NCT01143064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153528|NCT00033371|Eflornithine|eflornithine|mesh-list
139153529|NCT00033371|Celecoxib|celecoxib|mesh-list
139153530|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139153531|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139153532|NCT00033371|Analgesics|analgesics|mesh-ancestor
139153533|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
139153534|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153535|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153536|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139153537|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139153538|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139153539|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139153540|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153541|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153542|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153543|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139153544|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139153545|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139153546|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153547|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
139153549|NCT01001338|Lesinurad|lesinurad|mesh-list
139153550|NCT01001338|Antimetabolites|antimetabolites|mesh-ancestor
139153551|NCT01001338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153552|NCT01001338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153553|NCT01001338|Gout Suppressants|gout suppressants|mesh-ancestor
139153554|NCT01001338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139153555|NCT01001338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139153556|NCT01001338|Antioxidants|antioxidants|mesh-ancestor
139153557|NCT01001338|Protective Agents|protective agents|mesh-ancestor
139153558|NCT01001338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153559|NCT01001338|Uricosuric Agents|uricosuric agents|mesh-ancestor
139153560|NCT03952715|Ibuprofen|ibuprofen|mesh-list
139153561|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139153562|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139153563|NCT03952715|Analgesics|analgesics|mesh-ancestor
139153564|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
139153565|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153566|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153567|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139153568|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139153569|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139153570|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153571|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153572|NCT01137526|Donepezil|donepezil|mesh-list
139153573|NCT01137526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139153574|NCT01137526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153575|NCT01137526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153576|NCT01137526|Cholinergic Agents|cholinergic agents|mesh-ancestor
139153577|NCT01137526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153578|NCT01137526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153579|NCT01137526|Nootropic Agents|nootropic agents|mesh-ancestor
139153580|NCT00993382|Amiodarone|amiodarone|mesh-list
139153581|NCT00993382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139153582|NCT00993382|Vasodilator Agents|vasodilator agents|mesh-ancestor
139153583|NCT00993382|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139153584|NCT00993382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139153585|NCT00993382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153586|NCT00993382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139153587|NCT00993382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139153588|NCT00993382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139153589|NCT00993382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153590|NCT00993382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139153591|NCT00993382|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138883981|NCT00718354|Enoxaparin|enoxaparin|mesh-list
139153592|NCT00993382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139153594|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139153595|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139153596|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139153597|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153598|NCT05628610|Paclitaxel|paclitaxel|mesh-list
139153599|NCT05628610|Carboplatin|carboplatin|mesh-list
139153600|NCT05628610|Tislelizumab|tislelizumab|mesh-list
139153601|NCT05628610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139153602|NCT05628610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153603|NCT05628610|Tubulin Modulators|tubulin modulators|mesh-ancestor
139153604|NCT05628610|Antimitotic Agents|antimitotic agents|mesh-ancestor
139153605|NCT05628610|Mitosis Modulators|mitosis modulators|mesh-ancestor
139153606|NCT05628610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153607|NCT05628610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139153608|NCT00079937|Fluticasone|fluticasone|mesh-list
139153609|NCT00079937|Omalizumab|omalizumab|mesh-list
139153610|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139153611|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139153612|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
139153613|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153614|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153615|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139153616|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
139153617|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
139153618|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139153619|NCT00909610|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139153620|NCT00909610|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139153621|NCT00909610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139153622|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139153623|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139153624|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
139153625|NCT03126110|Nivolumab|nivolumab|mesh-list
139153626|NCT03126110|Ipilimumab|ipilimumab|mesh-list
139153627|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139153628|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153629|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139153630|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153631|NCT00908128|Mycophenolic Acid|mycophenolic acid|mesh-list
139153632|NCT00908128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139153633|NCT00908128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153634|NCT00908128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139153635|NCT00908128|Antitubercular Agents|antitubercular agents|mesh-ancestor
139153636|NCT00908128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139153637|NCT00908128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153638|NCT00908128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153639|NCT00908128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153640|NCT00906334|ON 01910|on 01910|mesh-list
139153642|NCT00906334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153643|NCT00906334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139153644|NCT00906334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153645|NCT00906334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153646|NCT00906334|Glycine Agents|glycine agents|mesh-ancestor
139153647|NCT00906334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153648|NCT00906334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153649|NCT00905164|Topiramate|topiramate|mesh-list
139153650|NCT00905164|Anticonvulsants|anticonvulsants|mesh-ancestor
139153651|NCT00905164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139153652|NCT00905164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153653|NCT00978016|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
139153654|NCT00978016|Baclofen|baclofen|mesh-list
139153655|NCT00978016|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139153656|NCT00978016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153657|NCT00978016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153658|NCT00978016|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139153659|NCT00978016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153660|NCT00978016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139153661|NCT00978016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153662|NCT00978016|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139153663|NCT00978016|GABA Agonists|gaba agonists|mesh-ancestor
139153664|NCT00978016|GABA Agents|gaba agents|mesh-ancestor
139153665|NCT00978016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153667|NCT01129648|Antimetabolites|antimetabolites|mesh-ancestor
139153668|NCT01129648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153669|NCT01129648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153670|NCT01129648|Gout Suppressants|gout suppressants|mesh-ancestor
139153671|NCT01129648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139153672|NCT01129648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139153673|NCT01129648|Antioxidants|antioxidants|mesh-ancestor
139153674|NCT01129648|Protective Agents|protective agents|mesh-ancestor
139153675|NCT01129648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153676|NCT04438720|Nifedipine|nifedipine|mesh-list
139153677|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139153678|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139153679|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153680|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139153681|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153682|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
139153683|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
139153684|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139153685|NCT03176966|Vitamin E|vitamin e|mesh-list
139153686|NCT03176966|Ropinirole|ropinirole|mesh-list
139153687|NCT03176966|Vitamins|vitamins|mesh-ancestor
139153688|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
139153689|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153690|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
139153691|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153692|NCT03176966|Protective Agents|protective agents|mesh-ancestor
139153693|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139153694|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139153695|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
139153696|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
139153697|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153699|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
139153700|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
139153701|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139153702|NCT03209570|Protective Agents|protective agents|mesh-ancestor
139153703|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153704|NCT04405102|Ozanimod|ozanimod|mesh-list
139153705|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139153706|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153707|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139153708|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
139153709|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153710|NCT03209492|Leuprolide|leuprolide|mesh-list
139153711|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139153712|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
139153713|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139153714|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153715|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139153716|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153717|NCT00894868|Vildagliptin|vildagliptin|mesh-list
139153718|NCT00894868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139153719|NCT00894868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153720|NCT00894868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139153721|NCT00894868|Protease Inhibitors|protease inhibitors|mesh-ancestor
139153722|NCT00894868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153723|NCT00894868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153724|NCT01122784|Vaccines|vaccines|mesh-list
139153725|NCT01122784|Immunologic Factors|immunologic factors|mesh-ancestor
139153726|NCT01122784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153727|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
139153728|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153729|NCT01088165|Adalimumab|adalimumab|mesh-list
139153730|NCT01088165|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139153731|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139153732|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139153733|NCT00892762|Travoprost|travoprost|mesh-list
139153734|NCT00892762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139153735|NCT00892762|Latanoprost|latanoprost|mesh-list
139153736|NCT00892762|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139153737|NCT00892762|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139153738|NCT00890968|Triamcinolone|triamcinolone|mesh-list
139153739|NCT00890968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139153740|NCT00890968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139153741|NCT00890968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139153742|NCT00890968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139153744|NCT00890968|Hormones|hormones|mesh-ancestor
139153745|NCT00890968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139153746|NCT00890968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153747|NCT00890968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139153748|NCT00890968|Immunologic Factors|immunologic factors|mesh-ancestor
139153749|NCT00890968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153750|NCT00890968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153751|NCT01098383|Acetylcholine|acetylcholine|mesh-list
139153752|NCT01098383|Donepezil|donepezil|mesh-list
139153753|NCT01098383|Choline|choline|mesh-list
139153754|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139153755|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153756|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153757|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
139153758|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153759|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153760|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
139153761|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
139153762|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139153763|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
139153764|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139153765|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139153766|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
139153767|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139153768|NCT00890890|BMS 708163|bms 708163|mesh-list
139153769|NCT00890890|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139153770|NCT00890890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153771|NCT00890890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153772|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
139153773|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139153774|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153775|NCT03175172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139153776|NCT03175172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153777|NCT00961090|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139153778|NCT00961090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139153779|NCT00961090|Dermatologic Agents|dermatologic agents|mesh-ancestor
139153780|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139153781|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139153782|NCT01088477|Estradiol|estradiol|mesh-list
139153783|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139153784|NCT01088477|Estrogens|estrogens|mesh-ancestor
139153785|NCT01088477|Hormones|hormones|mesh-ancestor
139153786|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139153787|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153788|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139153789|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
139153790|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139153791|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139153792|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
139153793|NCT01088555|Antidotes|antidotes|mesh-ancestor
139153794|NCT01088555|Protective Agents|protective agents|mesh-ancestor
139153795|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153796|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
139153797|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153798|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
139153799|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139153800|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153801|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
139153802|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
139153803|NCT04474210|JNJ-56136379|jnj-56136379|mesh-list
139153804|NCT04474210|Antiviral Agents|antiviral agents|mesh-ancestor
139153805|NCT04474210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153806|NCT00078767|Sertraline|sertraline|mesh-list
139153807|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
139153808|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139153809|NCT00078767|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139153810|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139153811|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139153812|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153813|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153814|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
139153815|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153816|NCT04474288|Antibodies|antibodies|mesh-list
139153817|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
139153818|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153819|NCT00078377|Modafinil|modafinil|mesh-list
139153820|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139153821|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153822|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139153823|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139153824|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139153825|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153826|NCT01107496|Viloxazine|viloxazine|mesh-list
139153827|NCT01107496|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139153828|NCT01107496|Antidepressive Agents|antidepressive agents|mesh-ancestor
139153829|NCT01107496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139153830|NCT01107496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139153831|NCT01107496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139153832|NCT01107496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138884133|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
139153833|NCT01107496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153834|NCT01107496|Adrenergic Agents|adrenergic agents|mesh-ancestor
139153835|NCT01107496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153836|NCT01107496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904329|NCT05064319|Analgesics|analgesics|mesh-ancestor
139153838|NCT00886600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139153839|NCT00886600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139153840|NCT00886600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139153841|NCT00886600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139153842|NCT00886600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139153843|NCT00886600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153844|NCT00886600|Diuretics|diuretics|mesh-ancestor
139153845|NCT00886600|Natriuretic Agents|natriuretic agents|mesh-ancestor
139153846|NCT00886600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153847|NCT00886600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139153848|NCT00886600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139153849|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
139153850|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139153851|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153852|NCT02591654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139153853|NCT02591654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153854|NCT03134872|Carboplatin|carboplatin|mesh-list
139153855|NCT03134872|Pemetrexed|pemetrexed|mesh-list
139153856|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153857|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153858|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153859|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139153860|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139153861|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139153863|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139153864|NCT05135312|Etanercept|etanercept|mesh-list
139153865|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139153866|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139153867|NCT05135312|Analgesics|analgesics|mesh-ancestor
139153868|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
139153869|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153870|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153871|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139153872|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139153873|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139153874|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139153875|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
139153876|NCT00881452|Citric Acid|citric acid|mesh-list
139153877|NCT00881452|Anticoagulants|anticoagulants|mesh-ancestor
139153878|NCT00881452|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139153879|NCT00881452|Chelating Agents|chelating agents|mesh-ancestor
139153880|NCT00881452|Sequestering Agents|sequestering agents|mesh-ancestor
139153881|NCT00881452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153882|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
139153883|NCT03952325|Nivolumab|nivolumab|mesh-list
139153884|NCT03952325|Atezolizumab|atezolizumab|mesh-list
139153885|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139153886|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153887|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139153888|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153889|NCT00948142|Linezolid|linezolid|mesh-list
139153890|NCT00948142|Fusidic Acid|fusidic acid|mesh-list
139153891|NCT00948142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139153892|NCT00948142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153893|NCT00948142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139153894|NCT00948142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153895|NCT00948142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153896|NCT00947518|Chlorhexidine|chlorhexidine|mesh-list
138884203|NCT00636545|Oblimersen|oblimersen|mesh-list
139153897|NCT00947518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139153898|NCT00947518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153899|NCT00947518|Disinfectants|disinfectants|mesh-ancestor
139153900|NCT00945802|Ciprofloxacin|ciprofloxacin|mesh-list
139153901|NCT00945802|Dexamethasone|dexamethasone|mesh-list
139153902|NCT00945802|Dexamethasone acetate|dexamethasone acetate|mesh-list
139153903|NCT00945802|BB 1101|bb 1101|mesh-list
139153904|NCT00945802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139153905|NCT00945802|Antiemetics|antiemetics|mesh-ancestor
139153906|NCT00945802|Autonomic Agents|autonomic agents|mesh-ancestor
139153907|NCT00945802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153908|NCT00945802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153909|NCT00945802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139153910|NCT00945802|Glucocorticoids|glucocorticoids|mesh-ancestor
139153911|NCT00945802|Hormones|hormones|mesh-ancestor
139153912|NCT00945802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139153913|NCT00945802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139153914|NCT00945802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153915|NCT00945802|Protease Inhibitors|protease inhibitors|mesh-ancestor
139153916|NCT00945802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153917|NCT00945802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153918|NCT00945802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139153919|NCT00945802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153920|NCT00945802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139153921|NCT00945802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139153922|NCT00945802|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139153923|NCT00945802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139153924|NCT01105624|Azithromycin|azithromycin|mesh-list
139153925|NCT01105624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139153926|NCT01105624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139153927|NCT01105624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139153928|NCT01105624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153929|NCT01102660|Naproxen|naproxen|mesh-list
139153930|NCT01102660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139153931|NCT01102660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139153932|NCT01102660|Analgesics|analgesics|mesh-ancestor
139153933|NCT01102660|Sensory System Agents|sensory system agents|mesh-ancestor
139153934|NCT01102660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153935|NCT01102660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153936|NCT01102660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139153937|NCT01102660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139153938|NCT01102660|Gout Suppressants|gout suppressants|mesh-ancestor
139153939|NCT01102660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139153940|NCT01102660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153941|NCT01102660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153942|NCT03135106|Itraconazole|itraconazole|mesh-list
139153944|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
139153945|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139153946|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139153947|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139153948|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153949|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923279|NCT04070079|Tenofovir|tenofovir|mesh-list
139153950|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139153951|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
139153952|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139153953|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153954|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139153955|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139153956|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139153958|NCT00872014|Trebananib|trebananib|mesh-list
139153959|NCT00872014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139153960|NCT00872014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139153961|NCT00872014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153962|NCT00872014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153963|NCT00872014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139153964|NCT00872014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139153965|NCT00872014|Growth Substances|growth substances|mesh-ancestor
139153966|NCT00872014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153967|NCT00872014|Growth Inhibitors|growth inhibitors|mesh-ancestor
139153968|NCT00870688|Valproic Acid|valproic acid|mesh-list
139153969|NCT00870688|Anticonvulsants|anticonvulsants|mesh-ancestor
139153970|NCT00870688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139153971|NCT00870688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153972|NCT00870688|GABA Agents|gaba agents|mesh-ancestor
139153973|NCT00870688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139153974|NCT00870688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153975|NCT00870688|Antimanic Agents|antimanic agents|mesh-ancestor
139153976|NCT00870688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139153977|NCT00870688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139153978|NCT00870688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139153979|NCT00870454|Pregabalin|pregabalin|mesh-list
139153980|NCT00870454|Analgesics|analgesics|mesh-ancestor
139153981|NCT00870454|Sensory System Agents|sensory system agents|mesh-ancestor
139153982|NCT00870454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139153983|NCT00870454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153984|NCT00870454|Anticonvulsants|anticonvulsants|mesh-ancestor
139153985|NCT00870454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139153986|NCT00870454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138884261|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
139153987|NCT00870454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153988|NCT00870454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139153989|NCT00870454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139153990|NCT00870454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139153991|NCT00870454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139153992|NCT00870454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139153993|NCT05096962|Antibodies|antibodies|mesh-list
139153994|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
139153995|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139153996|NCT00869128|Melatonin|melatonin|mesh-list
139153997|NCT00869128|Antioxidants|antioxidants|mesh-ancestor
139153998|NCT00869128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139153999|NCT00869128|Protective Agents|protective agents|mesh-ancestor
139154000|NCT00869128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154001|NCT00869128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139154002|NCT00945646|Dexamethasone|dexamethasone|mesh-list
139154003|NCT00945646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139154004|NCT00945646|Antiemetics|antiemetics|mesh-ancestor
139154005|NCT00945646|Autonomic Agents|autonomic agents|mesh-ancestor
139154006|NCT00945646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154007|NCT00945646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154008|NCT00945646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139154009|NCT00945646|Glucocorticoids|glucocorticoids|mesh-ancestor
139154010|NCT00945646|Hormones|hormones|mesh-ancestor
139154011|NCT00945646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154012|NCT00945646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139154013|NCT00945646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154014|NCT00077675|Vancomycin|vancomycin|mesh-list
139154015|NCT00077675|Penicillins|penicillins|mesh-list
139154016|NCT00077675|Telavancin|telavancin|mesh-list
139154017|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139154018|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154019|NCT00934180|Ondansetron|ondansetron|mesh-list
139154020|NCT00934180|Antiemetics|antiemetics|mesh-ancestor
139154022|NCT00934180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154023|NCT00934180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154024|NCT00934180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139154025|NCT00934180|Antipruritics|antipruritics|mesh-ancestor
139154026|NCT00934180|Dermatologic Agents|dermatologic agents|mesh-ancestor
139154027|NCT00934180|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139154028|NCT00934180|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139154029|NCT00934180|Serotonin Agents|serotonin agents|mesh-ancestor
139154030|NCT00934180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154031|NCT00934180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154033|NCT02576444|Adavosertib|adavosertib|mesh-list
139154034|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139154035|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154036|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154037|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154038|NCT00929968|Fluticasone|fluticasone|mesh-list
139154039|NCT00929968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139154040|NCT00929968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139154041|NCT00929968|Autonomic Agents|autonomic agents|mesh-ancestor
139154042|NCT00929968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154043|NCT00929968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154044|NCT00929968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139154045|NCT00929968|Respiratory System Agents|respiratory system agents|mesh-ancestor
139154046|NCT00929968|Dermatologic Agents|dermatologic agents|mesh-ancestor
139154047|NCT00929968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139154048|NCT03957083|Oxytocin|oxytocin|mesh-list
139154049|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
139154050|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139154051|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154052|NCT04945616|Aspirin|aspirin|mesh-list
139154053|NCT04945616|Clopidogrel|clopidogrel|mesh-list
139154054|NCT04945616|Ticagrelor|ticagrelor|mesh-list
139154055|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139154056|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139154057|NCT04945616|Analgesics|analgesics|mesh-ancestor
139154058|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
139154059|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154060|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904561|NCT03554083|Atezolizumab|atezolizumab|mesh-list
139154061|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139154062|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139154063|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139154064|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139154065|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154066|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139154067|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139154068|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154069|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
139154070|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139154071|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138884348|NCT02571556|Hormones|hormones|mesh-ancestor
139154072|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139154073|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
139154074|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154075|NCT00855712|Cardioplegic Solutions|cardioplegic solutions|mesh-list
139154076|NCT00855712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139154077|NCT00850174|Oxcarbazepine|oxcarbazepine|mesh-list
139154078|NCT00850174|Anticonvulsants|anticonvulsants|mesh-ancestor
139154079|NCT00850174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139154080|NCT00850174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139154081|NCT00850174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139154082|NCT00850174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154083|NCT00850174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139154084|NCT00850174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139154085|NCT00849862|Levetiracetam|levetiracetam|mesh-list
139154086|NCT00849862|Anticonvulsants|anticonvulsants|mesh-ancestor
139154087|NCT00849862|Nootropic Agents|nootropic agents|mesh-ancestor
139154088|NCT00077207|Carboplatin|carboplatin|mesh-list
139154089|NCT00077207|Vincristine|vincristine|mesh-list
139154090|NCT00077207|Temozolomide|temozolomide|mesh-list
139154091|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923288|NCT00739934|Voriconazole|voriconazole|mesh-list
139154092|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139154093|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
139154095|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
139154096|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923733|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139154097|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139154098|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
139154099|NCT01099085|Simvastatin|simvastatin|mesh-list
138924040|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
139154100|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139154101|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139154102|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
139154103|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924785|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924862|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
138924937|NCT00741351|Sevoflurane|sevoflurane|mesh-list
139154104|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139154105|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139154106|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154107|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
138925389|NCT04088084|Hormones|hormones|mesh-ancestor
139154108|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925614|NCT00695565|Clonidine|clonidine|mesh-list
138925687|NCT00692913|Vitamin D|vitamin d|mesh-list
139154109|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139154110|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925910|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
138926208|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138926281|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
139154111|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926602|NCT00683787|Docetaxel|docetaxel|mesh-list
138926740|NCT00790205|Incretins|incretins|mesh-ancestor
139154113|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138927029|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138927102|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138927176|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
138927402|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139154114|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139154115|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927857|NCT02581826|Silodosin|silodosin|mesh-list
139154116|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154117|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154118|NCT03169244|Bupropion|bupropion|mesh-list
138928228|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139154119|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139154120|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
139154121|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139154122|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138928450|NCT05338502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154123|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138928669|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154124|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138928746|NCT02579564|Paclitaxel|paclitaxel|mesh-list
138928818|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
139154125|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154126|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
139154127|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154128|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929346|NCT00790881|Lumefantrine|lumefantrine|mesh-list
139154129|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138929638|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
138929711|NCT00791271|Decitabine|decitabine|mesh-list
138929787|NCT00783081|Cilostazol|cilostazol|mesh-list
139154130|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139154131|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904641|NCT03338920|Sumatriptan|sumatriptan|mesh-list
138930087|NCT00788931|Paclitaxel|paclitaxel|mesh-list
138930160|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139154132|NCT02486042|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138930307|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
139154133|NCT02486042|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139154134|NCT02486042|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139154135|NCT02486042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138930603|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138930779|NCT00581100|Etanercept|etanercept|mesh-list
138930830|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
138930904|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138930980|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
139154137|NCT00920764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154138|NCT00920764|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139154139|NCT00920764|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139154140|NCT00920764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154141|NCT05376046|Thrombin|thrombin|mesh-list
139154143|NCT05376046|Coagulants|coagulants|mesh-ancestor
139154145|NCT03034304|Gemcitabine|gemcitabine|mesh-list
139154147|NCT03034304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139154148|NCT03034304|Ifosfamide|ifosfamide|mesh-list
139154150|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
138931716|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
139154151|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154152|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931789|NCT00717470|Prednisone|prednisone|mesh-list
139154153|NCT03034304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139154154|NCT03034304|Antimetabolites|antimetabolites|mesh-ancestor
139154155|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154156|NCT03034304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139154157|NCT03034304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138884436|NCT02727881|Squalamine|squalamine|mesh-list
139154158|NCT03034304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139154159|NCT03034304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154160|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139154161|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
139154162|NCT00914602|Levodopa|levodopa|mesh-list
139154163|NCT00914602|Carbidopa|carbidopa|mesh-list
139154164|NCT00914602|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139154165|NCT00914602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139154166|NCT00914602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139154167|NCT00914602|Dopamine Agents|dopamine agents|mesh-ancestor
139154168|NCT00914602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154169|NCT00914602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154170|NCT00914602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154171|NCT00914602|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139154172|NCT00914602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154173|NCT00914602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139154174|NCT00914602|Immunologic Factors|immunologic factors|mesh-ancestor
139154175|NCT00914602|Dopamine Agonists|dopamine agonists|mesh-ancestor
139154176|NCT00914290|Baclofen|baclofen|mesh-list
139154177|NCT00914290|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139154178|NCT00914290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154179|NCT00914290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139154180|NCT00914290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154181|NCT00914290|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139154182|NCT00914290|GABA Agonists|gaba agonists|mesh-ancestor
139154183|NCT00914290|GABA Agents|gaba agents|mesh-ancestor
138931864|NCT01366092|Analgesics|analgesics|mesh-ancestor
138931978|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
138932056|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138932138|NCT02575248|Dienogest|dienogest|mesh-list
139154184|NCT00914290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138932355|NCT05610800|Incretins|incretins|mesh-ancestor
138932433|NCT05359835|Edetic Acid|edetic acid|mesh-list
138932651|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
139154185|NCT00914290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932876|NCT03720119|Lidocaine|lidocaine|mesh-list
139154187|NCT00057941|Anastrozole|anastrozole|mesh-list
138933026|NCT06062823|Afatinib|afatinib|mesh-list
139154188|NCT00057941|Gefitinib|gefitinib|mesh-list
139154189|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138933251|NCT05372354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933396|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
139154190|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933781|NCT01165632|Fluorides|fluorides|mesh-list
139154191|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138933929|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
138934006|NCT02078869|Progesterone|progesterone|mesh-list
139154192|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139154193|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
138934304|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934530|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138934604|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867743|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867744|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867745|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
138867746|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884463|NCT00723658|Cytarabine|cytarabine|mesh-list
138867747|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138867748|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
138936035|NCT00862108|Methylphenidate|methylphenidate|mesh-list
138867749|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867751|NCT03043547|Antidotes|antidotes|mesh-ancestor
138867752|NCT03043547|Protective Agents|protective agents|mesh-ancestor
138936338|NCT00654381|Vitamins|vitamins|mesh-ancestor
138936403|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
138936626|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
138936775|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
138867753|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867754|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
138867755|NCT03043547|Vitamins|vitamins|mesh-ancestor
138937610|NCT05896033|Menthol|menthol|mesh-list
139154194|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138590111|NCT00510367|Doxorubicin|doxorubicin|mesh-list
138938193|NCT05115838|Islatravir|islatravir|mesh-list
138938268|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938345|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
138938428|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
139154195|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154196|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139154197|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867759|NCT00905255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867761|NCT00905021|Exemestane|exemestane|mesh-list
138939244|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154198|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154199|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138939618|NCT01720563|Vitamins|vitamins|mesh-ancestor
139154202|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139154204|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
138940074|NCT00732576|Vitamin K|vitamin k|mesh-list
138940144|NCT00577460|Pramipexole|pramipexole|mesh-list
138940219|NCT00864058|Gabapentin|gabapentin|mesh-list
138889017|NCT00512707|Testosterone|testosterone|mesh-list
138940363|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
139154205|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940436|NCT00615550|Progesterone|progesterone|mesh-list
138940667|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
139154206|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154207|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139154208|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
138941337|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
138867763|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139154210|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138941496|NCT00811083|Succimer|succimer|mesh-list
138941706|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
139154211|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139154212|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154213|NCT02998736|Tadalafil|tadalafil|mesh-list
138942005|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
139154214|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
139154215|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139154216|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139154217|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867764|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139154218|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942820|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
139154219|NCT02998736|Urological Agents|urological agents|mesh-ancestor
139154221|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154222|NCT00838630|Cilostazol|cilostazol|mesh-list
139154223|NCT00838630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138943257|NCT00699608|Zopiclone|zopiclone|mesh-list
139154225|NCT00838630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154226|NCT00838630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154227|NCT00838630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139154228|NCT00838630|Respiratory System Agents|respiratory system agents|mesh-ancestor
139154229|NCT00838630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138943774|NCT02550327|Paclitaxel|paclitaxel|mesh-list
139154230|NCT00838630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138944001|NCT00901654|Vaccines|vaccines|mesh-list
138944088|NCT00908362|Hormones|hormones|mesh-ancestor
139154231|NCT00838630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154232|NCT00838630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139154234|NCT00838630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139154235|NCT00838630|Protective Agents|protective agents|mesh-ancestor
139154236|NCT00838630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139154237|NCT00838630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139154238|NCT00838630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154239|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
139154240|NCT02996474|Decitabine|decitabine|mesh-list
139154241|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139154242|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154243|NCT02996474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139154244|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154245|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139154247|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154248|NCT00821002|Latanoprost|latanoprost|mesh-list
139154249|NCT00821002|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139154250|NCT00821002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139154251|NCT00820924|Lapatinib|lapatinib|mesh-list
139154252|NCT00820924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154253|NCT00820924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139154254|NCT00820924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154255|NCT00820924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154256|NCT00820300|Latanoprost|latanoprost|mesh-list
139154257|NCT00820300|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139154258|NCT00820300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139154259|NCT00814372|Metformin|metformin|mesh-list
139154260|NCT00814372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139154261|NCT00814372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154263|NCT03134638|Fulvestrant|fulvestrant|mesh-list
139154264|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154265|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139154266|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139154268|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
138867765|NCT00905021|Growth Substances|growth substances|mesh-ancestor
139154269|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154270|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154271|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
139154272|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154273|NCT04855526|Dronabinol|dronabinol|mesh-list
139154274|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
139154275|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154276|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139154277|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139154278|NCT04855526|Analgesics|analgesics|mesh-ancestor
139154279|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
138904795|NCT00755950|Silymarin|silymarin|mesh-list
139154280|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154281|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139154282|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139154283|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154284|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154285|NCT04855526|Hormones|hormones|mesh-ancestor
139154286|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154287|NCT02339090|Hormones|hormones|mesh-list
139154288|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154289|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154290|NCT05442008|Erenumab|erenumab|mesh-list
139154291|NCT05442008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139154292|NCT05442008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154293|NCT05442008|Analgesics|analgesics|mesh-ancestor
139154294|NCT05442008|Sensory System Agents|sensory system agents|mesh-ancestor
138944680|NCT00396253|Tenecteplase|tenecteplase|mesh-list
139154295|NCT05442008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154296|NCT05442008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154298|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
139154299|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139154300|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154301|NCT03331562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139154302|NCT03331562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154303|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139154304|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154305|NCT03331562|Vitamins|vitamins|mesh-ancestor
139154306|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
139154308|NCT00814294|Insulin|insulin|mesh-list
139154309|NCT00814294|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139154310|NCT00814294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139154311|NCT00814294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154312|NCT02038634|Betamethasone|betamethasone|mesh-list
139154313|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139154314|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
139154315|NCT02038634|Hormones|hormones|mesh-ancestor
139154316|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154317|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154318|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139154319|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
139154320|NCT00808288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138944747|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154321|NCT00808288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139154322|NCT00808288|Autonomic Agents|autonomic agents|mesh-ancestor
139154323|NCT00808288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154324|NCT00808288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154325|NCT00808288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139154326|NCT00808288|Respiratory System Agents|respiratory system agents|mesh-ancestor
139154327|NCT00808288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139154328|NCT00808288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139154329|NCT00808288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139154330|NCT00808288|Adrenergic Agents|adrenergic agents|mesh-ancestor
139154331|NCT00808288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154332|NCT00808288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154333|NCT03636308|Paclitaxel|paclitaxel|mesh-list
139154334|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139154335|NCT03636308|Gemcitabine|gemcitabine|mesh-list
139154336|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139154337|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154338|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
139154339|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
138884636|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
139154341|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154342|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139154343|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
139154344|NCT00836056|Clindamycin|clindamycin|mesh-list
139154345|NCT00836056|Clindamycin palmitate|clindamycin palmitate|mesh-list
139154346|NCT00836056|Clindamycin phosphate|clindamycin phosphate|mesh-list
139154347|NCT00836056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139154348|NCT00836056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154349|NCT00836056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139154350|NCT00836056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154351|NCT00836056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154352|NCT00835666|Finasteride|finasteride|mesh-list
139154353|NCT00835666|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139154354|NCT00835666|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139154355|NCT00835666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154356|NCT00835666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154357|NCT00835666|Hormone Antagonists|hormone antagonists|mesh-ancestor
139154358|NCT00835666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154359|NCT00835666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154360|NCT00835666|Urological Agents|urological agents|mesh-ancestor
139154361|NCT00835588|Pantoprazole|pantoprazole|mesh-list
139154362|NCT00835588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139154363|NCT00835588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139154364|NCT00835588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139154365|NCT00835588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154366|NCT00835588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154367|NCT00713518|Ranibizumab|ranibizumab|mesh-list
139154368|NCT00713518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139154369|NCT00713518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138944910|NCT00566254|Zonisamide|zonisamide|mesh-list
139154370|NCT00713518|Growth Substances|growth substances|mesh-ancestor
139154371|NCT00713518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154372|NCT00713518|Growth Inhibitors|growth inhibitors|mesh-ancestor
139154373|NCT00713518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154374|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
138945033|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154375|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139154376|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
139154377|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154378|NCT00708292|Dexamethasone|dexamethasone|mesh-list
139154379|NCT00708292|Bortezomib|bortezomib|mesh-list
139154380|NCT00708292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139154381|NCT00708292|Antiemetics|antiemetics|mesh-ancestor
139154382|NCT00708292|Autonomic Agents|autonomic agents|mesh-ancestor
139154383|NCT00708292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154384|NCT00708292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154385|NCT00708292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139154386|NCT00708292|Glucocorticoids|glucocorticoids|mesh-ancestor
139154387|NCT00708292|Hormones|hormones|mesh-ancestor
138945177|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138867766|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867767|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
139154388|NCT00708292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154389|NCT00708292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139154390|NCT00708292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154392|NCT00790660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139154393|NCT00790660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154394|NCT00790660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139154395|NCT00790660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154396|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
138946136|NCT00844233|Irinotecan|irinotecan|mesh-list
138946514|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
139154399|NCT00835354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138946730|NCT02545959|Prednisolone|prednisolone|mesh-list
138946805|NCT05602064|Antipyretics|antipyretics|mesh-ancestor
139154400|NCT00835354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154401|NCT00698230|Metformin|metformin|mesh-list
138947052|NCT00852423|Artesunate|artesunate|mesh-list
138947180|NCT05300932|Cyclophosphamide|cyclophosphamide|mesh-list
138947265|NCT00946504|Glipizide|glipizide|mesh-list
138947563|NCT00944242|Sertraline|sertraline|mesh-list
138947637|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
138947706|NCT00865371|Bupropion|bupropion|mesh-list
138947779|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
138947929|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138948156|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
139154403|NCT00698230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154404|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
138948305|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154405|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138948450|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
139154406|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154407|NCT01330472|Alprazolam|alprazolam|mesh-list
139154408|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139154409|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139154410|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154411|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138949041|NCT05350384|Antiemetics|antiemetics|mesh-ancestor
139154413|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138949265|NCT00872235|Quinapril|quinapril|mesh-list
138949419|NCT00878865|Alprazolam|alprazolam|mesh-list
139154415|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
139154416|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949793|NCT00875745|Sorafenib|sorafenib|mesh-list
138950027|NCT00963274|Bortezomib|bortezomib|mesh-list
138950089|NCT00761670|Risperidone|risperidone|mesh-list
138950311|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
138867768|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138867769|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950909|NCT04657666|Analgesics|analgesics|mesh-ancestor
139154417|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154418|NCT00835276|Fexofenadine|fexofenadine|mesh-list
139154419|NCT00835276|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138951211|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
138951286|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
138951439|NCT02036372|Insulin|insulin|mesh-list
139154420|NCT00835276|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139154421|NCT00835276|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139154422|NCT00835276|Histamine Antagonists|histamine antagonists|mesh-ancestor
139154423|NCT00835276|Histamine Agents|histamine agents|mesh-ancestor
139154424|NCT00835276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154425|NCT00835276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154426|NCT00835276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154427|NCT03344536|Fulvestrant|fulvestrant|mesh-list
139154428|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139154429|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154430|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138603766|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
139154431|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139154432|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
138952097|NCT00674154|Vitamin D|vitamin d|mesh-list
138952246|NCT05227300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138952317|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138952390|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138952463|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
138867770|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867771|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138952764|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
138867772|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138867773|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138867774|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
138953285|NCT00901407|Lamotrigine|lamotrigine|mesh-list
138953662|NCT00895323|Antibodies|antibodies|mesh-list
138953804|NCT00905931|Lycopene|lycopene|mesh-list
138953951|NCT00905073|Cyclosporine|cyclosporine|mesh-list
138954028|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139154433|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154434|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154435|NCT01759238|Bevacizumab|bevacizumab|mesh-list
139154436|NCT01759238|Capecitabine|capecitabine|mesh-list
139154437|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139154438|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154439|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139154440|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139154441|NCT01759238|Growth Substances|growth substances|mesh-ancestor
139154442|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154443|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
139154444|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139154445|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
139154446|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154447|NCT00835042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139154448|NCT00835042|Moexipril|moexipril|mesh-list
139154449|NCT00835042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139154450|NCT00835042|Diuretics|diuretics|mesh-ancestor
139154451|NCT00835042|Natriuretic Agents|natriuretic agents|mesh-ancestor
139154452|NCT00835042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154453|NCT00835042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139154454|NCT00835042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139154455|NCT00835042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154456|NCT00835042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139154457|NCT00835042|Protease Inhibitors|protease inhibitors|mesh-ancestor
139154458|NCT00835042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154459|NCT00834964|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139154460|NCT00834964|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139154461|NCT00834964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139154462|NCT00834964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139154463|NCT00834964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154464|NCT00834964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154465|NCT00834964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154466|NCT00834964|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139154467|NCT00834964|Antidepressive Agents|antidepressive agents|mesh-ancestor
139154468|NCT00834964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139154469|NCT03070522|Prednisone|prednisone|mesh-list
139154470|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139154471|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
139154472|NCT03070522|Hormones|hormones|mesh-ancestor
139154473|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154474|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154475|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139154476|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154477|NCT00834574|Cefdinir|cefdinir|mesh-list
139154478|NCT00834574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139154479|NCT00834574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154480|NCT04879966|Infliximab|infliximab|mesh-list
139154481|NCT04879966|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139154482|NCT04879966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139154483|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
139154484|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139154485|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139154486|NCT00834418|Leflunomide|leflunomide|mesh-list
139154487|NCT00834418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154488|NCT00834418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154489|NCT00834418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139154490|NCT00834418|Immunologic Factors|immunologic factors|mesh-ancestor
139154491|NCT00834418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154492|NCT04621318|Denosumab|denosumab|mesh-list
139154493|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139154494|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154495|NCT00834340|Glimepiride|glimepiride|mesh-list
139154496|NCT00834340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139154497|NCT00834340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139154498|NCT00834340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905017|NCT00705822|Prednisone|prednisone|mesh-list
139154499|NCT00834340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139154500|NCT00834340|Immunologic Factors|immunologic factors|mesh-ancestor
139154501|NCT00683722|Remestemcel-l|remestemcel-l|mesh-list
139154502|NCT00683722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139154503|NCT00683722|Antiviral Agents|antiviral agents|mesh-ancestor
139154504|NCT00683722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154505|NCT04473274|Pioglitazone|pioglitazone|mesh-list
139154506|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139154507|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154509|NCT00679588|Semuloparin|semuloparin|mesh-list
139154510|NCT00679588|Enoxaparin sodium|enoxaparin sodium|mesh-list
138884884|NCT00692328|Levodopa|levodopa|mesh-list
139154511|NCT00679588|Anticoagulants|anticoagulants|mesh-ancestor
139154512|NCT00679588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139154513|NCT00679588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139154514|NCT00679588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154515|NCT00151996|Guanfacine|guanfacine|mesh-list
139154516|NCT00151996|Methylphenidate|methylphenidate|mesh-list
139154517|NCT00151996|Amphetamine|amphetamine|mesh-list
139154518|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139154519|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154520|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138889128|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139154521|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139154522|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139154523|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154524|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
139154525|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154526|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
139154527|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
139154528|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154529|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
139154530|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139154531|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139154532|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139154533|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139154534|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139154535|NCT00830206|Azithromycin|azithromycin|mesh-list
139154536|NCT00830206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139154537|NCT00830206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154539|NCT00829504|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139154540|NCT00829504|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139154541|NCT00829504|Dopamine Agonists|dopamine agonists|mesh-ancestor
139154542|NCT00829504|Dopamine Agents|dopamine agents|mesh-ancestor
139154543|NCT00829504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154544|NCT00829504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154545|NCT00829504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154546|NCT00829426|Alprazolam|alprazolam|mesh-list
139154547|NCT00829426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139154548|NCT00829426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139154549|NCT00829426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154550|NCT00829426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139154551|NCT00829426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139154552|NCT00829426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139154553|NCT00829426|GABA Modulators|gaba modulators|mesh-ancestor
139154554|NCT00829426|GABA Agents|gaba agents|mesh-ancestor
139154555|NCT00829426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154556|NCT00829426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154557|NCT00152464|Levocetirizine|levocetirizine|mesh-list
139154558|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139154559|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139154560|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
139154561|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
139154562|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154563|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154564|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154565|NCT04472806|Endostar protein|endostar protein|mesh-list
139154566|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139154567|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139154568|NCT04472806|Growth Substances|growth substances|mesh-ancestor
139154569|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154570|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
139154571|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154572|NCT00674440|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
139154573|NCT00674440|Dopamine Agents|dopamine agents|mesh-ancestor
139154574|NCT00674440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154575|NCT00674440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154576|NCT00674440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154577|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139154578|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
139154579|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139154580|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139154581|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139154582|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139154583|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154585|NCT00770848|Mitoxantrone|mitoxantrone|mesh-list
139154586|NCT00770848|Rilotumumab|rilotumumab|mesh-list
139154587|NCT00770848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139154588|NCT00770848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139154589|NCT00770848|Glucocorticoids|glucocorticoids|mesh-ancestor
139154590|NCT00770848|Hormones|hormones|mesh-ancestor
139154591|NCT00770848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154592|NCT00770848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154593|NCT00770848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139154594|NCT00770848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154595|NCT00770848|Analgesics|analgesics|mesh-ancestor
139154596|NCT00770848|Sensory System Agents|sensory system agents|mesh-ancestor
138885011|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
139154597|NCT00770848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154598|NCT00770848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139154599|NCT00770848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139154600|NCT00770848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154601|NCT00770848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154602|NCT00770848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139154603|NCT00770848|Immunologic Factors|immunologic factors|mesh-ancestor
139154604|NCT00672412|Lamivudine|lamivudine|mesh-list
139154605|NCT00672412|Zidovudine|zidovudine|mesh-list
139154606|NCT00672412|Nevirapine|nevirapine|mesh-list
139154607|NCT00672412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139154608|NCT00672412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139154609|NCT00672412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154610|NCT00672412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154611|NCT00672412|Antiviral Agents|antiviral agents|mesh-ancestor
139154612|NCT00672412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154613|NCT00672412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139154614|NCT00672412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139154615|NCT00672412|Antimetabolites|antimetabolites|mesh-ancestor
139154616|NCT00672412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139154617|NCT00672412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139154618|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
139154619|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
139154620|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139154621|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139154622|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154623|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154624|NCT01315262|Urological Agents|urological agents|mesh-ancestor
139154625|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
139154626|NCT03197324|Digoxin|digoxin|mesh-list
139154627|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139154628|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139154629|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154630|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154631|NCT03197324|Protective Agents|protective agents|mesh-ancestor
139154632|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154633|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139154634|NCT01330706|Polihexanide|polihexanide|mesh-list
139154635|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
139154636|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154637|NCT01156220|Furosemide|furosemide|mesh-list
139154638|NCT01156220|Diuretics|diuretics|mesh-ancestor
139154639|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
139154640|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154641|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139154642|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139154643|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154644|NCT03192488|Cetirizine|cetirizine|mesh-list
139154645|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139154646|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139154647|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138905156|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
139154648|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
139154649|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
139154650|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154651|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154652|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154653|NCT01642004|Docetaxel|docetaxel|mesh-list
139154654|NCT01642004|Nivolumab|nivolumab|mesh-list
139154655|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154656|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
139154657|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
139154658|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
139154659|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154660|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139154661|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139154662|NCT03907826|Antibodies|antibodies|mesh-list
139154663|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
139154664|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
139154665|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154666|NCT00042289|Ritonavir|ritonavir|mesh-list
139154667|NCT00042289|Lopinavir|lopinavir|mesh-list
139154668|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139154669|NCT00042289|Darunavir|darunavir|mesh-list
139154670|NCT00042289|Nelfinavir|nelfinavir|mesh-list
139154671|NCT00042289|Indinavir|indinavir|mesh-list
139154672|NCT00042289|Fosamprenavir|fosamprenavir|mesh-list
139154673|NCT00042289|Amprenavir|amprenavir|mesh-list
139154674|NCT00042289|Tenofovir|tenofovir|mesh-list
139154675|NCT00042289|Emtricitabine|emtricitabine|mesh-list
139154676|NCT00042289|Raltegravir Potassium|raltegravir potassium|mesh-list
139154677|NCT00042289|Nevirapine|nevirapine|mesh-list
139154678|NCT00042289|Dolutegravir|dolutegravir|mesh-list
139154679|NCT00042289|Maraviroc|maraviroc|mesh-list
139154680|NCT00042289|Abacavir|abacavir|mesh-list
139154681|NCT00042289|Didanosine|didanosine|mesh-list
139154682|NCT00042289|Cobicistat|cobicistat|mesh-list
139154683|NCT00042289|Rilpivirine|rilpivirine|mesh-list
139154684|NCT00042289|Tipranavir|tipranavir|mesh-list
139154685|NCT00042289|Elvitegravir|elvitegravir|mesh-list
139154686|NCT00042289|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139154687|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
139154688|NCT00042289|Efavirenz|efavirenz|mesh-list
139154689|NCT00042289|Rifampin|rifampin|mesh-list
139154690|NCT00042289|Isoniazid|isoniazid|mesh-list
139154691|NCT00042289|Linezolid|linezolid|mesh-list
139154692|NCT00042289|Cycloserine|cycloserine|mesh-list
139154693|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
139154694|NCT00042289|Amikacin|amikacin|mesh-list
139154695|NCT00042289|Ethambutol|ethambutol|mesh-list
139154696|NCT00042289|Bedaquiline|bedaquiline|mesh-list
139154697|NCT00042289|Etravirine|etravirine|mesh-list
139154698|NCT00042289|Clofazimine|clofazimine|mesh-list
139154699|NCT00042289|Ofloxacin|ofloxacin|mesh-list
139154700|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
139154701|NCT00042289|Ethionamide|ethionamide|mesh-list
139154702|NCT00042289|Kanamycin|kanamycin|mesh-list
139154703|NCT00042289|Prothionamide|prothionamide|mesh-list
139154704|NCT00042289|Capreomycin|capreomycin|mesh-list
139154705|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139154706|NCT00042289|Etonogestrel|etonogestrel|mesh-list
139154707|NCT00042289|Estradiol|estradiol|mesh-list
139154708|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139154709|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139154710|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
139154711|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154712|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154713|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139154714|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139154715|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
139154716|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154717|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139154718|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139154719|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139154720|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139154721|NCT00042289|Estrogens|estrogens|mesh-ancestor
139154722|NCT00042289|Hormones|hormones|mesh-ancestor
139154723|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154724|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154725|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139154726|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-ancestor
139154727|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139154728|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139154729|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139154730|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139154731|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139154732|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154733|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138885099|NCT00688194|Letrozole|letrozole|mesh-list
139154734|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139154735|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139154736|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139154737|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139154738|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139154739|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139154740|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139154741|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139154742|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
139154743|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
139154744|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139154745|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139154746|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139154747|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139154748|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139154749|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139154750|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
139154751|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139154752|NCT00042289|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139154753|NCT00042289|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139154754|NCT00042289|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139154755|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139154756|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139154757|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139154758|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139154760|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139154761|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
139154762|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
139154763|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154764|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
139154765|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154766|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
139154767|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154768|NCT01096693|Substance P|substance p|mesh-list
139154769|NCT01096693|Neurokinin A|neurokinin a|mesh-list
139154770|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154771|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154772|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154773|NCT00015457|Amlodipine|amlodipine|mesh-list
139154774|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
139154775|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139154776|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139154777|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154778|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
139154779|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154780|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154781|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139154782|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139154783|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139154784|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
139154785|NCT03564470|Dasatinib|dasatinib|mesh-list
139154786|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154787|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139154788|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154789|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154790|NCT03191396|Liraglutide|liraglutide|mesh-list
139154791|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139154792|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154793|NCT03191396|Incretins|incretins|mesh-ancestor
139154794|NCT03191396|Hormones|hormones|mesh-ancestor
139154795|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154796|NCT03509636|Fluzoparib|fluzoparib|mesh-list
139154797|NCT03509636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139154798|NCT03509636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154799|NCT03509636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154800|NCT03509636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154801|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139154802|NCT00007345|Romidepsin|romidepsin|mesh-list
139154803|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139154804|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154805|NCT00007345|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139154806|NCT00007345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154807|NCT00007345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154808|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139154809|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
139154810|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154811|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139154812|NCT00031447|Acyclovir|acyclovir|mesh-list
139154813|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
139154814|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154815|NCT00006289|Neurotropin|neurotropin|mesh-list
139154816|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139154817|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
139154818|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154819|NCT00006289|Analgesics|analgesics|mesh-ancestor
139154820|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
139154821|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154822|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
139154823|NCT05625841|Propolis|propolis|mesh-list
139154824|NCT05625841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154825|NCT01103401|Tobramycin|tobramycin|mesh-list
139154826|NCT01103401|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
139154827|NCT01103401|Dexamethasone|dexamethasone|mesh-list
139154828|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
139154829|NCT01103401|Ketorolac|ketorolac|mesh-list
139154830|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139154831|NCT01103401|BB 1101|bb 1101|mesh-list
139154832|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139154833|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
139154834|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
139154835|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154836|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154837|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139154838|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
139154839|NCT01103401|Hormones|hormones|mesh-ancestor
139154840|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154841|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139154842|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154843|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
139154844|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154845|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154846|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139154847|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139154848|NCT01103401|Analgesics|analgesics|mesh-ancestor
139154849|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
139154850|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138885209|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154851|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139154852|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139154853|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154854|NCT01103401|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139154855|NCT01103401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139154856|NCT00005047|Doxorubicin|doxorubicin|mesh-list
139154857|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139154858|NCT00005047|Methotrexate|methotrexate|mesh-list
139154859|NCT00005047|Vinblastine|vinblastine|mesh-list
139154860|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154861|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139154862|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139154863|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139154864|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154865|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154866|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139154867|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
139154868|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139154869|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154870|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139154871|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
139154872|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
139154873|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139154874|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138905381|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154875|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
139154876|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139154877|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139154878|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139154879|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
139154880|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
139154881|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
139154882|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139154884|NCT01103635|Tremelimumab|tremelimumab|mesh-list
139154885|NCT01103635|Antibodies|antibodies|mesh-list
139154886|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
139154887|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139154888|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
139154889|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154890|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154891|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139154892|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154893|NCT03949075|Enalapril|enalapril|mesh-list
139154894|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139154895|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
139154896|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154897|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154898|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139154899|NCT01101529|Aprepitant|aprepitant|mesh-list
139154900|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
139154901|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
138885256|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
139154902|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139154903|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154904|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139154905|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139154906|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154907|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154908|NCT01100125|Insulin|insulin|mesh-list
139154909|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139154910|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139154911|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
139154912|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139154913|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154914|NCT01100125|Incretins|incretins|mesh-ancestor
139154915|NCT01100125|Hormones|hormones|mesh-ancestor
139154916|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154917|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139154918|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
139154919|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154920|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154921|NCT01100203|Eplerenone|eplerenone|mesh-list
139154922|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139154923|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
139154924|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139154925|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154926|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139154927|NCT01100203|Diuretics|diuretics|mesh-ancestor
139154928|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
139154929|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139154930|NCT03948685|Carvedilol|carvedilol|mesh-list
139154931|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139154932|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139154933|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
139154934|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154935|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154936|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154937|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139154938|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
139154939|NCT03948685|Protective Agents|protective agents|mesh-ancestor
139154940|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139154941|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139154942|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139154943|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
139154944|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139154945|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139154946|NCT01585051|Vitamin D|vitamin d|mesh-list
139154947|NCT01585051|Vitamins|vitamins|mesh-ancestor
139154948|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
139154949|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154950|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139154951|NCT01103791|Docetaxel|docetaxel|mesh-list
139154952|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154953|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
139154954|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
139154955|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
139154956|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154957|NCT03800173|Galidesivir|galidesivir|mesh-list
139154958|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
139154959|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154960|NCT00003631|Cytarabine|cytarabine|mesh-list
139154961|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
139154962|NCT00003631|Melphalan|melphalan|mesh-list
139154963|NCT00003631|Ifosfamide|ifosfamide|mesh-list
139154964|NCT00003631|Carmustine|carmustine|mesh-list
139154965|NCT00003631|Carboplatin|carboplatin|mesh-list
139154966|NCT00003631|Etoposide|etoposide|mesh-list
139154967|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139154968|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
139154969|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154970|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139154971|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139154972|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
139154973|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154974|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139154975|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139154976|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139154977|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139154978|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139154979|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139154980|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139154981|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
139154982|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
139154983|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139154984|NCT01101685|Escitalopram|escitalopram|mesh-list
139154985|NCT01101685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139154986|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139154987|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139154988|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154989|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139154990|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
139154991|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154992|NCT00030901|Selenium|selenium|mesh-list
139154993|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
139154994|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139154995|NCT00030901|Protective Agents|protective agents|mesh-ancestor
139154996|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139154997|NCT00030901|Trace Elements|trace elements|mesh-ancestor
139154998|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
139154999|NCT01104259|Vinorelbine|vinorelbine|mesh-list
139155000|NCT01104259|Veliparib|veliparib|mesh-list
139155001|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155002|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139155003|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
139155004|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
139155005|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
139155006|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155007|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139155008|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155009|NCT01104337|Acetaminophen|acetaminophen|mesh-list
139155010|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139155012|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
139155013|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155014|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155015|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
139155016|NCT01100359|Carboplatin|carboplatin|mesh-list
139155017|NCT01100359|Doxorubicin|doxorubicin|mesh-list
139155018|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139155019|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155020|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139155021|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139155022|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139155023|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155024|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155025|NCT00003199|Tamoxifen|tamoxifen|mesh-list
139155026|NCT00003199|Aldesleukin|aldesleukin|mesh-list
138905544|NCT00764374|Z 338|z 338|mesh-list
139155027|NCT00003199|Melphalan|melphalan|mesh-list
139155028|NCT00003199|Busulfan|busulfan|mesh-list
139155029|NCT00003199|Thiotepa|thiotepa|mesh-list
139155030|NCT00003199|Interleukin-2|interleukin-2|mesh-list
139155031|NCT00003199|Sargramostim|sargramostim|mesh-list
139155032|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889223|NCT02638376|Riboflavin|riboflavin|mesh-list
139155033|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139155034|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
139155035|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155036|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139155037|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139155038|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
139155039|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155040|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139155041|NCT00003199|Analgesics|analgesics|mesh-ancestor
139155042|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
138885339|NCT04137432|Oxytocin|oxytocin|mesh-list
139155043|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155044|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139155045|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
139155046|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139155047|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139155048|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139155049|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139155050|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139155052|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139155053|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
139155054|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155055|NCT01327261|Levodopa|levodopa|mesh-list
139155056|NCT01327261|Benserazide|benserazide|mesh-list
139155057|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139155058|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139155059|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
139155060|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155061|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155062|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155063|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155064|NCT01101919|Tofacitinib|tofacitinib|mesh-list
139155065|NCT01101919|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139155066|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139155067|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155068|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155069|NCT03951415|Durvalumab|durvalumab|mesh-list
139155070|NCT03951415|Olaparib|olaparib|mesh-list
139155071|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139155072|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139155073|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155074|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155075|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155076|NCT00001849|Edetic Acid|edetic acid|mesh-list
139155077|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
139155078|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155079|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155080|NCT00001849|Antidotes|antidotes|mesh-ancestor
139155081|NCT00001849|Protective Agents|protective agents|mesh-ancestor
139155082|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
139155083|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
139155084|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139155085|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
138889231|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
139155086|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139155087|NCT01104571|Trastuzumab|trastuzumab|mesh-list
139155088|NCT01104571|Lapatinib|lapatinib|mesh-list
139155089|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139155090|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155091|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139155093|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155094|NCT01104649|Riluzole|riluzole|mesh-list
139155095|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
139155096|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139155097|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139155098|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155099|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155100|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155101|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139155102|NCT01104649|Protective Agents|protective agents|mesh-ancestor
139155104|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
139155105|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
139155106|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139155107|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155108|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
139155109|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155110|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
139155111|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155112|NCT01342952|Ambrisentan|ambrisentan|mesh-list
139155113|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139155114|NCT01104883|Iodine|iodine|mesh-list
139155115|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139155116|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155117|NCT01104883|Trace Elements|trace elements|mesh-ancestor
139155118|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
139155119|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155120|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139155121|NCT04371380|Rilpivirine|rilpivirine|mesh-list
139155122|NCT04371380|Cabotegravir|cabotegravir|mesh-list
139155123|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139155124|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139155125|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155126|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155127|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
139155128|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155129|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139155130|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139155131|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139155132|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139155133|NCT01341080|Varenicline|varenicline|mesh-list
139155134|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139155135|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139155136|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
139155137|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155138|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155139|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155140|NCT01333982|Amoxicillin|amoxicillin|mesh-list
138885404|NCT00656006|Ribavirin|ribavirin|mesh-list
139155142|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139155143|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155144|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139155145|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155146|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155147|NCT01334060|Vaccines|vaccines|mesh-list
139155148|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
139155149|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155150|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
139155151|NCT04130828|Trace Elements|trace elements|mesh-ancestor
139155152|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
139155153|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155154|NCT01332344|Fluticasone|fluticasone|mesh-list
139155155|NCT01332344|Xhance|xhance|mesh-list
139155156|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139155157|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139155158|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139155159|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
139155160|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155161|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155162|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139155163|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
139155164|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
139155165|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139155166|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139155167|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139155168|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139155169|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
139155170|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155171|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155172|NCT01332422|Fluticasone|fluticasone|mesh-list
139155173|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139155174|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139155175|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139155176|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139155177|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
139155178|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905689|NCT00820950|Hormones|hormones|mesh-ancestor
139155179|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155180|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139155181|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
139155182|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
139155183|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139155184|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139155185|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139155186|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139155187|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
139155188|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155189|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155190|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
139155191|NCT01332422|Hormones|hormones|mesh-ancestor
139155192|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139155193|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
139155194|NCT03162224|Durvalumab|durvalumab|mesh-list
139155195|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139155196|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155197|NCT00904046|Pioglitazone|pioglitazone|mesh-list
139155198|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
139155199|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139155200|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155201|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
139155202|NCT01332734|Analgesics|analgesics|mesh-ancestor
139155203|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
138885412|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139155204|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155205|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155206|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
139155207|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139155208|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139155209|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
139155210|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139155211|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139155212|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155213|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139155214|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
139155215|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139155216|NCT03326492|Antivenins|antivenins|mesh-list
139155217|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
139155218|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155219|NCT01524536|Prednisone|prednisone|mesh-list
139155220|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139155221|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
139155222|NCT01524536|Hormones|hormones|mesh-ancestor
139155223|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139155224|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155225|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139155226|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155227|NCT00533468|Lidocaine|lidocaine|mesh-list
139155228|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
139155229|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
139155230|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139155231|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155232|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
139155233|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155234|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139155235|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139155236|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139155237|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139155238|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155239|NCT01333124|Gemcitabine|gemcitabine|mesh-list
139155240|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139155241|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
139155242|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155243|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155244|NCT03035630|Sunitinib|sunitinib|mesh-list
139155245|NCT03035630|Avelumab|avelumab|mesh-list
139155246|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155247|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139155248|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139155249|NCT03035630|Growth Substances|growth substances|mesh-ancestor
139155250|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155251|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
139155252|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139155253|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155254|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155255|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139155256|NCT00004124|Prednisone|prednisone|mesh-list
139155257|NCT00004124|Goserelin|goserelin|mesh-list
139155258|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
139155259|NCT00004124|Bicalutamide|bicalutamide|mesh-list
139155260|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139155261|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
139155262|NCT00004124|Hormones|hormones|mesh-ancestor
139155263|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139155264|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155265|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139155266|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155267|NCT00004124|Analgesics|analgesics|mesh-ancestor
139155268|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
139155269|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155270|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139155271|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139155272|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155273|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155274|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
139155275|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
139155276|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
139155277|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139155278|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155279|NCT01334684|Metformin|metformin|mesh-list
139155280|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139155281|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155282|NCT01334762|Letrozole|letrozole|mesh-list
139155283|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155284|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139155285|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139155286|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155287|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155288|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139155289|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
139155290|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139155291|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155292|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
139155293|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
139155294|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139155295|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
139155296|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155297|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155298|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139155299|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
139155300|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139155301|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139155302|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139155303|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
139155304|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155305|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155306|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139155307|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
139155308|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139155309|NCT01335074|Sirolimus|sirolimus|mesh-list
139155310|NCT01335074|Sorafenib|sorafenib|mesh-list
139155311|NCT01335074|Temsirolimus|temsirolimus|mesh-list
139155312|NCT01335074|MTOR Inhibitors|mtor inhibitors|mesh-list
139155313|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155314|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139155316|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155317|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139155318|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
139155319|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155320|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139155321|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155322|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139155323|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
139155324|NCT01337492|Sorafenib|sorafenib|mesh-list
138905827|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
139155325|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155326|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139155327|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155328|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155330|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139155331|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139155332|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
139155333|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155334|NCT01337804|Omeprazole|omeprazole|mesh-list
139019568|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139155335|NCT01337804|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
139155336|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139155337|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139155338|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139155339|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155340|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155341|NCT01776424|Aspirin|aspirin|mesh-list
139155342|NCT01776424|Pantoprazole|pantoprazole|mesh-list
139155343|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
139155344|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139155345|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139155346|NCT01776424|Analgesics|analgesics|mesh-ancestor
139155347|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
139155348|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155349|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155350|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139155351|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139155352|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139155353|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139155354|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155355|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139155356|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139155357|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155358|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
139155359|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139155360|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
139155361|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139155362|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
139155363|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
139155364|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139155365|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139155366|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139155367|NCT00642148|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139155368|NCT00642148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139155369|NCT00642148|Autonomic Agents|autonomic agents|mesh-ancestor
139155370|NCT00642148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155371|NCT00642148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155372|NCT00642148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139155373|NCT00642148|Respiratory System Agents|respiratory system agents|mesh-ancestor
139155374|NCT00642148|Glucocorticoids|glucocorticoids|mesh-ancestor
139155375|NCT00642148|Hormones|hormones|mesh-ancestor
139155376|NCT00642148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139155377|NCT00642148|Sympathomimetics|sympathomimetics|mesh-ancestor
139155378|NCT00629980|Azithromycin|azithromycin|mesh-list
139155379|NCT00629980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139155380|NCT00629980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155381|NCT00629590|Azithromycin|azithromycin|mesh-list
139155383|NCT00629590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155384|NCT00626704|Doxorubicin|doxorubicin|mesh-list
139155385|NCT00626704|Conatumumab|conatumumab|mesh-list
139155386|NCT00626704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139155387|NCT00626704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155388|NCT00626704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139155389|NCT00626704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139155390|NCT00626704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155391|NCT00626704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155392|NCT00626704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139155393|NCT00765700|Ketoprofen|ketoprofen|mesh-list
139155394|NCT00765700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139155395|NCT00765700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139155396|NCT00765700|Analgesics|analgesics|mesh-ancestor
139155397|NCT00765700|Sensory System Agents|sensory system agents|mesh-ancestor
139155398|NCT00765700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155399|NCT00765700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155400|NCT00765700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905905|NCT00668746|Minocycline|minocycline|mesh-list
138889308|NCT00707187|Tadalafil|tadalafil|mesh-list
139155401|NCT00765700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139155402|NCT00765700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139155403|NCT00765700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155404|NCT00765700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155405|NCT02280694|Celecoxib|celecoxib|mesh-list
139155406|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
139155407|NCT02280694|Capecitabine|capecitabine|mesh-list
139155408|NCT02280694|Methotrexate|methotrexate|mesh-list
139155409|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139155410|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
139155411|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155412|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139155413|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139155414|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
139155415|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155416|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155417|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139155418|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139155419|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
139155420|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139155421|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
139155422|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139155423|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
139155424|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155425|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139155426|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139155427|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139155428|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139155429|NCT02280694|Analgesics|analgesics|mesh-ancestor
139155430|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
138885475|NCT02639858|Docetaxel|docetaxel|mesh-list
139155431|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155432|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139155433|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139155434|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139155435|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
139155437|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139155438|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
139155439|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
139155440|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
139155441|NCT02281006|Antidotes|antidotes|mesh-ancestor
139155442|NCT02281006|Protective Agents|protective agents|mesh-ancestor
139155443|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155444|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
139155445|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155446|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
139155447|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139155448|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155449|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
139155450|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
139155451|NCT00758290|Triclosan|triclosan|mesh-list
139155452|NCT00758290|Fluorides|fluorides|mesh-list
139155453|NCT00758290|Cariostatic Agents|cariostatic agents|mesh-ancestor
139155454|NCT00758290|Protective Agents|protective agents|mesh-ancestor
139155455|NCT00758290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155456|NCT00758290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139155457|NCT00758290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155458|NCT00758290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139155459|NCT00758290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139155460|NCT00758290|Antimetabolites|antimetabolites|mesh-ancestor
139155461|NCT00758290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155462|NCT00758290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139155463|NCT03799627|Epoetin Alfa|epoetin alfa|mesh-list
139155464|NCT03799627|Glycine|glycine|mesh-list
139155465|NCT03799627|Hematinics|hematinics|mesh-ancestor
139155466|NCT03799627|Glycine Agents|glycine agents|mesh-ancestor
139155467|NCT03799627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155468|NCT03799627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155469|NCT03799627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155470|NCT02274142|Methamphetamine|methamphetamine|mesh-list
139155471|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139155472|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155473|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
139155474|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
139155475|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155476|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
139155477|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155478|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155479|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
139155480|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139155481|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139155482|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139155483|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139155484|NCT00752050|Botulinum Toxins|botulinum toxins|mesh-list
139155485|NCT00752050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139155486|NCT00752050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139155487|NCT00752050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139155488|NCT00752050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139155489|NCT00752050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155490|NCT00752050|Cholinergic Agents|cholinergic agents|mesh-ancestor
139155491|NCT00752050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155492|NCT00752050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155493|NCT00752050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139155494|NCT00752050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155495|NCT02276014|Beta Carotene|beta carotene|mesh-list
139155496|NCT02276014|Carotenoids|carotenoids|mesh-list
139155497|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
139155498|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155499|NCT02276014|Protective Agents|protective agents|mesh-ancestor
139155500|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155501|NCT02276014|Provitamins|provitamins|mesh-ancestor
139155502|NCT02276014|Vitamins|vitamins|mesh-ancestor
139155503|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
139155504|NCT01102387|Octenidine|octenidine|mesh-list
139155505|NCT01102387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155506|NCT01102387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139155507|NCT02277808|Amikacin|amikacin|mesh-list
139155508|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139155509|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155510|NCT02281240|Oprelvekin|oprelvekin|mesh-list
139155511|NCT02281240|Heparin|heparin|mesh-list
139155512|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
139155513|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139155514|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139155515|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155516|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155517|NCT01102465|Losartan|losartan|mesh-list
139155518|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139155519|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139155520|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139155521|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139155522|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139155523|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155524|NCT01102465|Diuretics|diuretics|mesh-ancestor
139155525|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
139155526|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155527|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139155528|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139155529|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
139155530|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139155531|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155532|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
139155533|NCT00749632|Mandelic Acids|mandelic acids|mesh-list
139155534|NCT00749632|Oxybutynin|oxybutynin|mesh-list
139155535|NCT00749632|Parasympatholytics|parasympatholytics|mesh-ancestor
139155536|NCT00749632|Autonomic Agents|autonomic agents|mesh-ancestor
139155537|NCT00749632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155538|NCT00749632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155539|NCT00749632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139155540|NCT00749632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139155541|NCT00749632|Cholinergic Agents|cholinergic agents|mesh-ancestor
139155542|NCT00749632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155543|NCT00749632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155544|NCT00749632|Urological Agents|urological agents|mesh-ancestor
139155545|NCT00749632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139155546|NCT00749632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155547|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
139155548|NCT01105273|Fludarabine|fludarabine|mesh-list
139155549|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139155550|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139155551|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
139155552|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155553|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139155554|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139155555|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
138885508|NCT02694263|Pioglitazone|pioglitazone|mesh-list
139155556|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155557|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155558|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139155559|NCT00743938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139155560|NCT00743938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155561|NCT00743938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139155562|NCT00743938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155563|NCT00743938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155564|NCT01105351|Folic Acid|folic acid|mesh-list
139155565|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
139155566|NCT01105351|Hematinics|hematinics|mesh-ancestor
139155567|NCT01105351|Vitamins|vitamins|mesh-ancestor
139155568|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
139155569|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155570|NCT00662506|Deoxyglucose|deoxyglucose|mesh-list
139155571|NCT00662506|Temozolomide|temozolomide|mesh-list
139155572|NCT00662506|Cediranib|cediranib|mesh-list
139155573|NCT00662506|Maleic acid|maleic acid|mesh-list
139155574|NCT00662506|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139155575|NCT00662506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139155576|NCT00662506|Alkylating Agents|alkylating agents|mesh-ancestor
139155577|NCT00662506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155578|NCT00662506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155579|NCT00662506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155580|NCT00662506|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139155581|NCT00662506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139155582|NCT00662506|Antimetabolites|antimetabolites|mesh-ancestor
139155583|NCT00662506|Antiviral Agents|antiviral agents|mesh-ancestor
139155584|NCT00662506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155585|NCT03947125|Buprenorphine|buprenorphine|mesh-list
139155586|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139155587|NCT03947125|Narcotics|narcotics|mesh-ancestor
139155588|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139155589|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155590|NCT03947125|Analgesics|analgesics|mesh-ancestor
139155591|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
139155592|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155593|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139155594|NCT00658762|Paroxetine|paroxetine|mesh-list
139155595|NCT00658762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139155596|NCT00658762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139155597|NCT00658762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139155598|NCT00658762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155599|NCT00658762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155600|NCT00658762|Serotonin Agents|serotonin agents|mesh-ancestor
139155601|NCT00658762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155602|NCT00658762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139155603|NCT00658762|Antidepressive Agents|antidepressive agents|mesh-ancestor
139155604|NCT00658762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139155605|NCT00658762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139155606|NCT00658762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139155607|NCT00658762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155608|NCT00658372|Paroxetine|paroxetine|mesh-list
139155609|NCT00658372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138885523|NCT00693030|Sirolimus|sirolimus|mesh-list
139155610|NCT00658372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139155611|NCT00658372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139155612|NCT00658372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155613|NCT00658372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155614|NCT00658372|Serotonin Agents|serotonin agents|mesh-ancestor
139155615|NCT00658372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155616|NCT00658372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139155617|NCT00658372|Antidepressive Agents|antidepressive agents|mesh-ancestor
139155618|NCT00658372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139155619|NCT00658372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139155620|NCT00658372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139155621|NCT00658372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155622|NCT03946657|Anesthetics|anesthetics|mesh-list
139155623|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
139155624|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139155625|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155626|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
139155627|NCT00616798|Antipsychotic Agents|antipsychotic agents|mesh-list
139155628|NCT00616798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139155629|NCT00616798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139155630|NCT00616798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155631|NCT00616798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139155632|NCT01106053|Pramipexole|pramipexole|mesh-list
139155633|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
139155634|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155635|NCT01106053|Protective Agents|protective agents|mesh-ancestor
139155636|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155637|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139155638|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139155639|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
139155640|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
139155641|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155642|NCT00616330|Clindamycin|clindamycin|mesh-list
139155643|NCT00616330|Clindamycin palmitate|clindamycin palmitate|mesh-list
139155644|NCT00616330|Clindamycin phosphate|clindamycin phosphate|mesh-list
139155645|NCT00616330|Butoconazole|butoconazole|mesh-list
139155646|NCT00616330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139155647|NCT00616330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155648|NCT00616330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139155649|NCT00616330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155650|NCT00616330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155651|NCT00616330|Antifungal Agents|antifungal agents|mesh-ancestor
139155652|NCT00612820|Fluticasone|fluticasone|mesh-list
139155653|NCT00612820|Xhance|xhance|mesh-list
139155654|NCT00612820|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
139155655|NCT00612820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139155656|NCT00612820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139155657|NCT00612820|Autonomic Agents|autonomic agents|mesh-ancestor
139155658|NCT00612820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155659|NCT00612820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155660|NCT00612820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139155661|NCT00612820|Respiratory System Agents|respiratory system agents|mesh-ancestor
139155662|NCT00612820|Dermatologic Agents|dermatologic agents|mesh-ancestor
139155663|NCT00612820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139155664|NCT00612820|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138885543|NCT04137276|Thiamine|thiamine|mesh-list
139155665|NCT00612820|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139155666|NCT00612820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155667|NCT00612820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155668|NCT00612742|Testosterone|testosterone|mesh-list
139155669|NCT00612742|Androgens|androgens|mesh-ancestor
139155670|NCT00612742|Hormones|hormones|mesh-ancestor
139155671|NCT00612742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139155672|NCT00612742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155673|NCT01106131|Pioglitazone|pioglitazone|mesh-list
139155674|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139155675|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155676|NCT00612118|Azelastine|azelastine|mesh-list
139155677|NCT00612118|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
139155678|NCT00612118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139155679|NCT00612118|Autonomic Agents|autonomic agents|mesh-ancestor
139155680|NCT00612118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155681|NCT00612118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155682|NCT00612118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139155683|NCT00612118|Respiratory System Agents|respiratory system agents|mesh-ancestor
139155684|NCT00612118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139155685|NCT00612118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155686|NCT00612118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155687|NCT00612118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139155688|NCT00612118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139155689|NCT00612118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139155690|NCT00612118|Histamine Antagonists|histamine antagonists|mesh-ancestor
139155691|NCT00612118|Histamine Agents|histamine agents|mesh-ancestor
139155692|NCT00612118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155693|NCT00612118|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139155694|NCT00612118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139155695|NCT00743002|Metformin|metformin|mesh-list
138906195|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139155696|NCT00743002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139155697|NCT00743002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155698|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139155699|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155700|NCT01102699|Lenograstim|lenograstim|mesh-list
139155701|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139155702|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
139155703|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155704|NCT00603616|Rifaximin|rifaximin|mesh-list
139155705|NCT00603616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139155706|NCT00603616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155707|NCT00603616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139155708|NCT02280070|Leucovorin|leucovorin|mesh-list
139155709|NCT02280070|Fluorouracil|fluorouracil|mesh-list
139155710|NCT02280070|Tegafur|tegafur|mesh-list
139155711|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
139155712|NCT02280070|Antibodies|antibodies|mesh-list
139155713|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
139155714|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
139155715|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
139155716|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155717|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
139155718|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155719|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139155720|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155721|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139155722|NCT02280070|Antidotes|antidotes|mesh-ancestor
139155723|NCT02280070|Protective Agents|protective agents|mesh-ancestor
139155724|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
139155725|NCT02280070|Vitamins|vitamins|mesh-ancestor
139155726|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
139155727|NCT01108783|Desloratadine|desloratadine|mesh-list
139155729|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
139155730|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155731|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155732|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155733|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139155734|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139155735|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
139155736|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
139155737|NCT02743780|MGV354|mgv354|mesh-list
139155738|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
139155739|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155741|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
139155742|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139155743|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155744|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139155745|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139155746|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
139155747|NCT00602602|Bevacizumab|bevacizumab|mesh-list
139155748|NCT00602602|Gemcitabine|gemcitabine|mesh-list
139155749|NCT00602602|Fluorouracil|fluorouracil|mesh-list
139155750|NCT00602602|Oxaliplatin|oxaliplatin|mesh-list
139155751|NCT00602602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139155752|NCT00602602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155753|NCT00602602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139155754|NCT00602602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139155755|NCT00602602|Growth Substances|growth substances|mesh-ancestor
139155756|NCT00602602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155757|NCT00602602|Growth Inhibitors|growth inhibitors|mesh-ancestor
139155758|NCT00602602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139155759|NCT00602602|Antimetabolites|antimetabolites|mesh-ancestor
139155760|NCT00602602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155761|NCT00602602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139155762|NCT00602602|Immunologic Factors|immunologic factors|mesh-ancestor
139155763|NCT04177654|Albendazole|albendazole|mesh-list
139155764|NCT04177654|Mebendazole|mebendazole|mesh-list
139155765|NCT04177654|Benzimidazole|benzimidazole|mesh-list
139155766|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
139155767|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139155768|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155769|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
139155770|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139155771|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139155772|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
139155773|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
139155774|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
139155775|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155776|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155777|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
139155779|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
139155780|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155781|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139155782|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155783|NCT04471480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139155784|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155785|NCT02880956|Tilavonemab|tilavonemab|mesh-list
139155786|NCT02880956|Nootropic Agents|nootropic agents|mesh-ancestor
139155787|NCT01111513|Analgesics|analgesics|mesh-list
139155788|NCT01111513|Ropivacaine|ropivacaine|mesh-list
139155789|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
139155790|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
139155791|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138885573|NCT00912444|Doxorubicin|doxorubicin|mesh-list
139155792|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155793|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
139155794|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155795|NCT01111591|Celecoxib|celecoxib|mesh-list
139155796|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
139155797|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139155798|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139155799|NCT01111591|Analgesics|analgesics|mesh-ancestor
139155800|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
139155801|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155802|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155803|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139155804|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139155805|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139155806|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155807|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155808|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
139155809|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139155810|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139155811|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155813|NCT01111669|Coagulants|coagulants|mesh-ancestor
139155814|NCT01108939|Antimalarials|antimalarials|mesh-list
139155815|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139155816|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139155817|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155818|NCT00654706|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139155819|NCT00654706|Sertindole|sertindole|mesh-list
139155820|NCT00654706|Antidepressive Agents|antidepressive agents|mesh-ancestor
139155821|NCT00654706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139155822|NCT00654706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139155823|NCT00654706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139155824|NCT00654706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139155825|NCT00654706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155826|NCT03944473|Neostigmine|neostigmine|mesh-list
139155827|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139155828|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155829|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155830|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
139155831|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155832|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155833|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139155834|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
139155835|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155836|NCT03944317|Azithromycin|azithromycin|mesh-list
139155837|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
139155838|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
139155839|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139155840|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139155841|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155842|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
139155843|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139155844|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139155845|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139155846|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155847|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155848|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138906345|NCT00684827|Albuterol|albuterol|mesh-list
139155849|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
138885591|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
139155850|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139155851|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
139155852|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155853|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
139155854|NCT02280538|Protective Agents|protective agents|mesh-ancestor
139155855|NCT01111747|Mitogens|mitogens|mesh-list
139155856|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
139155857|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155858|NCT02281708|Cisplatin|cisplatin|mesh-list
139155859|NCT02281708|Vinorelbine|vinorelbine|mesh-list
139155860|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155861|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139155862|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
139155863|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
139155864|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
139155865|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155866|NCT01111903|Lenalidomide|lenalidomide|mesh-list
139155867|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
139155868|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155869|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139155870|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139155871|NCT01111903|Growth Substances|growth substances|mesh-ancestor
139155872|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
139155873|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155874|NCT02280616|Budesonide|budesonide|mesh-list
139155875|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139155876|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139155877|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
139155878|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155879|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155880|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139155881|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
139155882|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
139155883|NCT02280616|Hormones|hormones|mesh-ancestor
139155884|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139155885|NCT01111981|Clobetasol|clobetasol|mesh-list
139155886|NCT01111981|Emollients|emollients|mesh-list
139155887|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139155888|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
139155889|NCT01111981|Hormones|hormones|mesh-ancestor
139155890|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139155891|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155892|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
139155893|NCT02283424|Carboplatin|carboplatin|mesh-list
139155894|NCT02283424|Docetaxel|docetaxel|mesh-list
139155895|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155896|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
139155897|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
139155898|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
139155899|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155900|NCT03942601|Sirolimus|sirolimus|mesh-list
139155901|NCT03942601|Dexamethasone|dexamethasone|mesh-list
139155902|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
139155903|NCT03942601|Temsirolimus|temsirolimus|mesh-list
139155904|NCT03942601|MTOR Inhibitors|mtor inhibitors|mesh-list
139155905|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139155906|NCT03942601|BB 1101|bb 1101|mesh-list
139155907|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139155908|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
139155909|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
138885617|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
139155910|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155911|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155912|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139155913|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
139155914|NCT03942601|Hormones|hormones|mesh-ancestor
139155915|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139155916|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139155917|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155918|NCT03942601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139155919|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155920|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155921|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139155922|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
139155923|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139155924|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906429|NCT02626247|Vitamin A|vitamin a|mesh-list
139155925|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139155926|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
139155927|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
139155928|NCT00598312|Leuprolide|leuprolide|mesh-list
139155929|NCT00598312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139155930|NCT00598312|Fertility Agents|fertility agents|mesh-ancestor
139155931|NCT00598312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139155932|NCT00598312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155933|NCT00598312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139155934|NCT00598312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155935|NCT00595426|Warfarin|warfarin|mesh-list
139155936|NCT00595426|Anticoagulants|anticoagulants|mesh-ancestor
139155937|NCT01112137|Clopidogrel|clopidogrel|mesh-list
139155938|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139155939|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139155940|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139155941|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139155942|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
139155943|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155944|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155945|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155946|NCT02282098|Colchicine|colchicine|mesh-list
139155947|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
139155948|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139155949|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
139155950|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
139155951|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
139155952|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155953|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139155954|NCT01208935|Nicotine|nicotine|mesh-list
139155955|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139155956|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
139155957|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139155958|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155959|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139155960|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139155961|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
139155962|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155963|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155964|NCT00584974|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139155965|NCT00584974|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139155966|NCT00584974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139155967|NCT00584974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139155968|NCT00584974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155969|NCT00584974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139155970|NCT00584974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155971|NCT00584974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139155972|NCT00584974|Antidepressive Agents|antidepressive agents|mesh-ancestor
139155973|NCT00584974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139155974|NCT01107067|Testosterone|testosterone|mesh-list
139155975|NCT01107067|Androgens|androgens|mesh-ancestor
139155977|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139155978|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155979|NCT02282176|Azithromycin|azithromycin|mesh-list
139155980|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139155981|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139155983|NCT00580216|Warfarin|warfarin|mesh-list
139155984|NCT00580216|Idraparinux|idraparinux|mesh-list
139155985|NCT00580216|Idrabiotaparinux|idrabiotaparinux|mesh-list
139155986|NCT00580216|Anticoagulants|anticoagulants|mesh-ancestor
139155987|NCT00580216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139155988|NCT00580216|Antithrombins|antithrombins|mesh-ancestor
139155989|NCT00580216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139155990|NCT00580216|Protease Inhibitors|protease inhibitors|mesh-ancestor
139155991|NCT00580216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139155992|NCT00580216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139155993|NCT00580216|Vitamin B Complex|vitamin b complex|mesh-ancestor
139155994|NCT00580216|Vitamins|vitamins|mesh-ancestor
139155995|NCT00580216|Micronutrients|micronutrients|mesh-ancestor
139155996|NCT00580216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139155997|NCT01107145|Artesunate|artesunate|mesh-list
139155998|NCT01107145|Chloroquine|chloroquine|mesh-list
139155999|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139156000|NCT01107145|Lumefantrine|lumefantrine|mesh-list
139156001|NCT01107145|Artemether|artemether|mesh-list
139156002|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139156003|NCT01107145|Mefloquine|mefloquine|mesh-list
139156004|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
139156005|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139156006|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139156007|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156008|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156009|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
139156010|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
139156011|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139156012|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
139156013|NCT01107145|Amebicides|amebicides|mesh-ancestor
139156014|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139156015|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139156016|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139156017|NCT01107145|Analgesics|analgesics|mesh-ancestor
139156018|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
139156019|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156020|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156021|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139156022|NCT01107145|Filaricides|filaricides|mesh-ancestor
139156023|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
139156024|NCT03944005|Anesthetics|anesthetics|mesh-list
139156025|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139156026|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156027|NCT01209403|Insulin|insulin|mesh-list
139156028|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
139156029|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139156030|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156031|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
139156032|NCT01112215|Azathioprine|azathioprine|mesh-list
139156033|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139156034|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156035|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139156036|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
139156037|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139156038|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156039|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156040|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156041|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
139156042|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139156043|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139156044|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
139156045|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156046|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139156047|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139156048|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139156049|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156050|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
139156051|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139156052|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156053|NCT02286544|Atorvastatin|atorvastatin|mesh-list
139156054|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139156055|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139156056|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
139156057|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156058|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139156059|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139156060|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156061|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139156062|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156063|NCT00384904|Ritonavir|ritonavir|mesh-list
139156064|NCT00384904|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139156065|NCT00384904|Tenofovir|tenofovir|mesh-list
139156066|NCT00384904|Famotidine|famotidine|mesh-list
139156067|NCT00384904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139156068|NCT00384904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139156069|NCT00384904|Protease Inhibitors|protease inhibitors|mesh-ancestor
139156070|NCT00384904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156071|NCT00384904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156072|NCT00384904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139156073|NCT00384904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138906572|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
139156074|NCT00384904|Antiviral Agents|antiviral agents|mesh-ancestor
139156075|NCT00384904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156076|NCT00384904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139156077|NCT00384904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139156078|NCT00384904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139156079|NCT00384904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139156080|NCT00384904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139156081|NCT00384904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139156082|NCT00384904|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139156083|NCT00384904|Histamine Antagonists|histamine antagonists|mesh-ancestor
139156084|NCT00384904|Histamine Agents|histamine agents|mesh-ancestor
139156085|NCT00384904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156086|NCT00384904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156087|NCT01335386|Glycerol|glycerol|mesh-list
139156088|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139156089|NCT01335386|Protective Agents|protective agents|mesh-ancestor
139156090|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156091|NCT00383578|Metformin|metformin|mesh-list
139156092|NCT00383578|Vildagliptin|vildagliptin|mesh-list
139156093|NCT00383578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139156094|NCT00383578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156095|NCT00383578|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139156096|NCT00383578|Protease Inhibitors|protease inhibitors|mesh-ancestor
139156097|NCT00383578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156098|NCT00383578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156099|NCT00383422|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139156100|NCT00383422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139156101|NCT00383422|Hormone Antagonists|hormone antagonists|mesh-ancestor
139156102|NCT00383422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139156103|NCT00383422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156104|NCT00383422|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139156105|NCT00383422|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139156106|NCT00383422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139156107|NCT02286622|Deflazacort|deflazacort|mesh-list
139156108|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139156109|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139156110|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
139156111|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156112|NCT00564226|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139156113|NCT00564226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139156114|NCT00564226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139156115|NCT00564226|Cholinergic Agents|cholinergic agents|mesh-ancestor
139156116|NCT00564226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156117|NCT00564226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156118|NCT00564226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156119|NCT00564226|Urological Agents|urological agents|mesh-ancestor
139156120|NCT03635684|Acetaminophen|acetaminophen|mesh-list
139156121|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139156122|NCT03635684|Analgesics|analgesics|mesh-ancestor
139156123|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
139156124|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156125|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156126|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
139156127|NCT00092690|Atorvastatin|atorvastatin|mesh-list
139156128|NCT00092690|Simvastatin|simvastatin|mesh-list
139156129|NCT00092690|Ezetimibe|ezetimibe|mesh-list
139156130|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139156131|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139156132|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
139156133|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156134|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139156135|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139156136|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156137|NCT02286700|Desonide|desonide|mesh-list
139156138|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139156139|NCT01338896|Rotigotine|rotigotine|mesh-list
139156140|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
139156141|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
139156142|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156143|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156144|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156145|NCT05185544|Pemetrexed|pemetrexed|mesh-list
139156146|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156147|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156148|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156149|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139156150|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139156151|NCT00382096|Metformin|metformin|mesh-list
139156152|NCT00382096|Vildagliptin|vildagliptin|mesh-list
139156153|NCT00382096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139156154|NCT00382096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156155|NCT00382096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139156156|NCT00382096|Protease Inhibitors|protease inhibitors|mesh-ancestor
139156157|NCT00382096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156158|NCT00382096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156159|NCT00482092|Remestemcel-l|remestemcel-l|mesh-list
139156160|NCT00482092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139156161|NCT00482092|Antiviral Agents|antiviral agents|mesh-ancestor
139156162|NCT00482092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156163|NCT00379990|Prednisolone|prednisolone|mesh-list
139156164|NCT00379990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139156165|NCT00379990|Glucocorticoids|glucocorticoids|mesh-ancestor
139156166|NCT00379990|Hormones|hormones|mesh-ancestor
139156167|NCT00379990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139156168|NCT00379990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156169|NCT00379990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139156170|NCT00379990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156171|NCT00377182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139156172|NCT00377182|Antiviral Agents|antiviral agents|mesh-ancestor
139156173|NCT00377182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156174|NCT01341938|Nicotine|nicotine|mesh-list
139156175|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139156176|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
139156177|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156178|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156179|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139156180|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139156181|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
139156182|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156183|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156184|NCT02284048|Ticagrelor|ticagrelor|mesh-list
139156185|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139156186|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139156187|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139156188|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139156189|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
139019569|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
139156190|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156191|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156192|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156193|NCT00374296|Mocetinostat|mocetinostat|mesh-list
139156194|NCT00374296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139156195|NCT00374296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156196|NCT00374296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156197|NCT00547066|Veltuzumab|veltuzumab|mesh-list
139156198|NCT00547066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156199|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
139156200|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139156201|NCT01315496|Antibodies|antibodies|mesh-list
139156202|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
139156203|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
139156204|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156205|NCT00544960|Docetaxel|docetaxel|mesh-list
139156206|NCT00544960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156207|NCT00544960|Tubulin Modulators|tubulin modulators|mesh-ancestor
139156208|NCT00544960|Antimitotic Agents|antimitotic agents|mesh-ancestor
139156209|NCT00544960|Mitosis Modulators|mitosis modulators|mesh-ancestor
139156210|NCT00544960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156211|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139156212|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139156214|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139156215|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156216|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
139156217|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156218|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156219|NCT00468442|Sirolimus|sirolimus|mesh-list
139156220|NCT00468442|Rituximab|rituximab|mesh-list
139156221|NCT00468442|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139156222|NCT00468442|Daclizumab|daclizumab|mesh-list
139156223|NCT00468442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139156224|NCT00468442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156225|NCT00468442|Immunologic Factors|immunologic factors|mesh-ancestor
139156226|NCT00468442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156227|NCT00468442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139156228|NCT00468442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139156229|NCT00468442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156230|NCT00468442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139156231|NCT00468442|Antifungal Agents|antifungal agents|mesh-ancestor
139156232|NCT00468442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139156233|NCT01339442|Fulvestrant|fulvestrant|mesh-list
139156234|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139156235|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156236|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139156237|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139156238|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
139156239|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139156240|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156241|NCT02286934|Carvedilol|carvedilol|mesh-list
139156242|NCT02286934|Isoproterenol|isoproterenol|mesh-list
139156243|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139156244|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139156245|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
139156246|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156247|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156248|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156249|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139156250|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
139156251|NCT02286934|Protective Agents|protective agents|mesh-ancestor
139156252|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139156253|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139156254|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139156255|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
139156256|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139156257|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139156258|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139156259|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139156260|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139156261|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
139156262|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156263|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139156264|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
139156265|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139156267|NCT02282410|Factor VIII|factor viii|mesh-list
139156268|NCT02282410|Coagulants|coagulants|mesh-ancestor
139156269|NCT00092612|Ezetimibe|ezetimibe|mesh-list
139156270|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139156271|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139156272|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
139156273|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156274|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139156275|NCT00540358|Carboplatin|carboplatin|mesh-list
139156276|NCT00540358|Gemcitabine|gemcitabine|mesh-list
139156277|NCT00540358|Iniparib|iniparib|mesh-list
139156278|NCT00540358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156279|NCT00540358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139156280|NCT00540358|Antimetabolites|antimetabolites|mesh-ancestor
139156281|NCT00540358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156282|NCT00540358|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139156283|NCT00540358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156284|NCT00462202|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
139156285|NCT00462202|Anticoagulants|anticoagulants|mesh-ancestor
139156286|NCT00462202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139156287|NCT00462202|Antimetabolites|antimetabolites|mesh-ancestor
139156288|NCT00462202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156289|NCT00462202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139156290|NCT00462202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139156291|NCT00462202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139156292|NCT00462202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139156293|NCT00462202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156294|NCT02287246|Bupivacaine|bupivacaine|mesh-list
139156295|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
139156296|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
139156297|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139156298|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156299|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
139156300|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156301|NCT04470544|Camostat|camostat|mesh-list
139156302|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
139156303|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156304|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156305|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139156306|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139156307|NCT00535366|Fluticasone|fluticasone|mesh-list
139156308|NCT00535366|Ciclesonide|ciclesonide|mesh-list
139156309|NCT00535366|Tiotropium Bromide|tiotropium bromide|mesh-list
139156310|NCT00535366|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139156311|NCT00535366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139156312|NCT00535366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139156313|NCT00535366|Autonomic Agents|autonomic agents|mesh-ancestor
139156314|NCT00535366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156315|NCT00535366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156316|NCT00535366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139156317|NCT00535366|Respiratory System Agents|respiratory system agents|mesh-ancestor
139156318|NCT00535366|Dermatologic Agents|dermatologic agents|mesh-ancestor
139156319|NCT00535366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139156320|NCT00535366|Parasympatholytics|parasympatholytics|mesh-ancestor
139156321|NCT00535366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139156322|NCT00535366|Cholinergic Agents|cholinergic agents|mesh-ancestor
139156323|NCT00535366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156324|NCT00535366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156325|NCT00535366|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139156326|NCT00535366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139156327|NCT00535366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139156328|NCT00535366|Adrenergic Agents|adrenergic agents|mesh-ancestor
139156329|NCT00535366|Glucocorticoids|glucocorticoids|mesh-ancestor
139156330|NCT00535366|Hormones|hormones|mesh-ancestor
139156331|NCT00535366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139156332|NCT00369070|Paclitaxel|paclitaxel|mesh-list
139156333|NCT00369070|Bevacizumab|bevacizumab|mesh-list
139156334|NCT00369070|Carboplatin|carboplatin|mesh-list
139156335|NCT00369070|Motesanib diphosphate|motesanib diphosphate|mesh-list
139156336|NCT00369070|Imetelstat|imetelstat|mesh-list
139156337|NCT00369070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139156338|NCT00369070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156339|NCT00369070|Tubulin Modulators|tubulin modulators|mesh-ancestor
139156340|NCT00369070|Antimitotic Agents|antimitotic agents|mesh-ancestor
139156341|NCT00369070|Mitosis Modulators|mitosis modulators|mesh-ancestor
139156342|NCT00369070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156343|NCT00369070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139156344|NCT00369070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139156345|NCT00369070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139156346|NCT00369070|Growth Substances|growth substances|mesh-ancestor
139156347|NCT00369070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156348|NCT00369070|Growth Inhibitors|growth inhibitors|mesh-ancestor
139156349|NCT00369070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139156350|NCT00369070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156351|NCT02284204|Midazolam|midazolam|mesh-list
139156352|NCT02284204|Ketamine|ketamine|mesh-list
139156353|NCT02284204|Sevoflurane|sevoflurane|mesh-list
139156354|NCT02284204|Analgesics|analgesics|mesh-ancestor
139156355|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
139156356|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156357|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156358|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139156359|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139156360|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
139156361|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
139156362|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139156363|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139156364|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139156365|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156366|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156367|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139156368|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139156369|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139156370|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139156371|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139156372|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
139156373|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
139156374|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139156375|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139156376|NCT01352416|Ranolazine|ranolazine|mesh-list
139156377|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139156378|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139156379|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156380|NCT00531622|Escitalopram|escitalopram|mesh-list
139156381|NCT00531622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139156382|NCT00531622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139156383|NCT00531622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139156384|NCT00531622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156385|NCT00531622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156386|NCT00531622|Serotonin Agents|serotonin agents|mesh-ancestor
139156387|NCT00531622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156388|NCT00364546|Tapentadol|tapentadol|mesh-list
139156389|NCT00364546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139156390|NCT00364546|Narcotics|narcotics|mesh-ancestor
138423770|NCT05801133|Pirfenidone|pirfenidone|mesh-list
139156391|NCT00364546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139156392|NCT00364546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156393|NCT00364546|Analgesics|analgesics|mesh-ancestor
139156394|NCT00364546|Sensory System Agents|sensory system agents|mesh-ancestor
139156395|NCT00364546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156396|NCT00364546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139156397|NCT00364546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139156398|NCT00364546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139156399|NCT00364546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156400|NCT00364546|Adrenergic Agents|adrenergic agents|mesh-ancestor
139156401|NCT00364546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156402|NCT00361582|Tapentadol|tapentadol|mesh-list
139156403|NCT00361582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139156405|NCT00361582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139156406|NCT00361582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156407|NCT00361582|Analgesics|analgesics|mesh-ancestor
139156409|NCT00361582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156410|NCT00361582|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139156411|NCT00361582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139156412|NCT00361582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139156413|NCT00361582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156414|NCT00361582|Adrenergic Agents|adrenergic agents|mesh-ancestor
139156415|NCT00361582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156416|NCT00450970|Satraplatin|satraplatin|mesh-list
139156417|NCT00450970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156418|NCT02282800|Vitamin D|vitamin d|mesh-list
139156419|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
139156420|NCT02282800|Vitamins|vitamins|mesh-ancestor
139156421|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
139156422|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156423|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139156424|NCT05208034|Methotrexate|methotrexate|mesh-list
139156425|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139156426|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
139156427|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139156428|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156429|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139156430|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
139156431|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156432|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156433|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
139156434|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156435|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139156436|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139156437|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
139156438|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139156439|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139156440|NCT02284282|Lidocaine|lidocaine|mesh-list
139156441|NCT02284282|Morphine|morphine|mesh-list
139156442|NCT02284282|Bupivacaine|bupivacaine|mesh-list
139156443|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
139156444|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
139156445|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139156446|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156447|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
139156448|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156449|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139156450|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139156451|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139156452|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139156453|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156454|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139156455|NCT02284282|Narcotics|narcotics|mesh-ancestor
139156456|NCT02284282|Analgesics|analgesics|mesh-ancestor
139156457|NCT00359086|Mocetinostat|mocetinostat|mesh-list
139156458|NCT00359086|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139156459|NCT00359086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156460|NCT00359086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156461|NCT03133780|Midazolam|midazolam|mesh-list
139156462|NCT03133780|Ketamine|ketamine|mesh-list
139156463|NCT03133780|Analgesics|analgesics|mesh-ancestor
139156464|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
138885793|NCT00689520|Vitamin K|vitamin k|mesh-list
139156465|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156466|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156467|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139156468|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139156469|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
139156470|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
139156471|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139156472|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139156473|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139156474|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156475|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156477|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139156478|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139156479|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139156480|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139156481|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
139156482|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
139156483|NCT02282956|Droperidol|droperidol|mesh-list
139156484|NCT02282956|Morphine|morphine|mesh-list
139156485|NCT02282956|Ropivacaine|ropivacaine|mesh-list
139156486|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139156487|NCT02282956|Narcotics|narcotics|mesh-ancestor
139156488|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139156489|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156490|NCT02282956|Analgesics|analgesics|mesh-ancestor
139156491|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
139156492|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156493|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
139156494|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
139156495|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139156496|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
139156497|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
139156498|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139156499|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139156500|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139156501|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139156502|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139156503|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139156504|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
139156505|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156506|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156507|NCT02287558|Pomalidomide|pomalidomide|mesh-list
139156508|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
139156509|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156510|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139156511|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139156512|NCT02287558|Growth Substances|growth substances|mesh-ancestor
139156513|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
139156514|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156515|NCT04470076|Carboplatin|carboplatin|mesh-list
139156516|NCT04470076|Gemcitabine|gemcitabine|mesh-list
139156517|NCT04470076|Pemetrexed|pemetrexed|mesh-list
139156518|NCT04470076|Afatinib|afatinib|mesh-list
139156519|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156520|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139156521|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
139156522|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156523|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156524|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139156525|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139156526|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139156528|NCT00445198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156529|NCT00345748|Abatacept|abatacept|mesh-list
139156530|NCT00345748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139156531|NCT00345748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156532|NCT00345748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139156533|NCT00345748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156534|NCT00345748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139156536|NCT00345748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156537|NCT00345748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139156538|NCT00439738|Amlodipine|amlodipine|mesh-list
139156539|NCT00439738|Valsartan|valsartan|mesh-list
139156540|NCT00439738|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139156541|NCT00439738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139156542|NCT00439738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139156543|NCT00439738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139156544|NCT00439738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156545|NCT00439738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139156546|NCT00439738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156547|NCT00439738|Vasodilator Agents|vasodilator agents|mesh-ancestor
139156548|NCT00439738|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138889639|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
139156549|NCT00439738|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139156550|NCT00439738|Diuretics|diuretics|mesh-ancestor
139156551|NCT00439738|Natriuretic Agents|natriuretic agents|mesh-ancestor
139156552|NCT00439738|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139156553|NCT00435916|Dacetuzumab|dacetuzumab|mesh-list
139156554|NCT00435916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139156555|NCT00435916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156556|NCT00523042|Insulin|insulin|mesh-list
139156557|NCT00523042|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139156558|NCT00523042|Insulin Aspart|insulin aspart|mesh-list
139156559|NCT00523042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139156560|NCT00523042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156561|NCT00338104|Insulin|insulin|mesh-list
139156562|NCT00338104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139156563|NCT00338104|Insulin Glargine|insulin glargine|mesh-list
139156564|NCT00338104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139156565|NCT00338104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156566|NCT00519142|Mitiglinide|mitiglinide|mesh-list
139156567|NCT00519142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139156568|NCT00519142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156569|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
139156570|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139156571|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139156572|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156573|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139156574|NCT02284672|Analgesics|analgesics|mesh-ancestor
139156575|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
139156576|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156577|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139156578|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139156579|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139156580|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
139156581|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156582|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156583|NCT02283190|Asparaginase|asparaginase|mesh-list
139156584|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156585|NCT00333502|Camptothecin|camptothecin|mesh-list
139156586|NCT00333502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139156587|NCT00333502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885824|NCT02570230|Ketamine|ketamine|mesh-list
139156588|NCT00333502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139156589|NCT00333502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139156590|NCT00333502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156591|NCT00333502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156592|NCT05982704|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139156593|NCT05982704|Antiviral Agents|antiviral agents|mesh-ancestor
139156594|NCT05982704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156595|NCT05982678|Trastuzumab|trastuzumab|mesh-list
139156596|NCT05982678|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139156597|NCT05982678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139156598|NCT05982678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156599|NCT05982678|Immunoconjugates|immunoconjugates|mesh-ancestor
139156600|NCT05982678|Immunologic Factors|immunologic factors|mesh-ancestor
139156601|NCT05982678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156602|NCT05982587|Calcium Carbonate|calcium carbonate|mesh-list
139156603|NCT05982587|Antacids|antacids|mesh-ancestor
139156604|NCT05982587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156605|NCT05982587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139156606|NCT05982522|Paclitaxel|paclitaxel|mesh-list
139156607|NCT05982522|Tislelizumab|tislelizumab|mesh-list
139156608|NCT05982522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139156609|NCT05982522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156610|NCT05982522|Tubulin Modulators|tubulin modulators|mesh-ancestor
139156611|NCT05982522|Antimitotic Agents|antimitotic agents|mesh-ancestor
139156612|NCT05982522|Mitosis Modulators|mitosis modulators|mesh-ancestor
139156613|NCT05982522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156614|NCT05982522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139156615|NCT05982483|Bupivacaine|bupivacaine|mesh-list
139156616|NCT05982483|Anesthetics, Local|anesthetics, local|mesh-ancestor
139156617|NCT05982483|Anesthetics|anesthetics|mesh-ancestor
139156618|NCT05982483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139156619|NCT05982483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156620|NCT05982483|Sensory System Agents|sensory system agents|mesh-ancestor
139156621|NCT05982483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156622|NCT05982470|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138526898|NCT00028574|Gabapentin|gabapentin|mesh-list
139156623|NCT05982470|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139156624|NCT05982470|Estradiol|estradiol|mesh-list
139156625|NCT05982470|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139156626|NCT05982470|Progesterone|progesterone|mesh-list
139156627|NCT05982470|Estrogens|estrogens|mesh-ancestor
139156628|NCT05982470|Hormones|hormones|mesh-ancestor
139156629|NCT05982470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139156630|NCT05982470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156631|NCT05982470|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139156632|NCT05982470|Contraceptive Agents|contraceptive agents|mesh-ancestor
139156633|NCT05982470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139156634|NCT05982470|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139156635|NCT05982470|Progestins|progestins|mesh-ancestor
139156636|NCT05982314|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139156637|NCT05982314|Immunologic Factors|immunologic factors|mesh-ancestor
139156638|NCT05982314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156639|NCT05982301|Paclitaxel|paclitaxel|mesh-list
139156640|NCT05982301|Oxaliplatin|oxaliplatin|mesh-list
139156641|NCT05982301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139156642|NCT05982301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156643|NCT05982301|Tubulin Modulators|tubulin modulators|mesh-ancestor
139156644|NCT05982301|Antimitotic Agents|antimitotic agents|mesh-ancestor
139156645|NCT05982301|Mitosis Modulators|mitosis modulators|mesh-ancestor
139156646|NCT05982301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156648|NCT05982197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139156649|NCT05982197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139156650|NCT05982197|Analgesics|analgesics|mesh-ancestor
139156651|NCT05982197|Sensory System Agents|sensory system agents|mesh-ancestor
139156652|NCT05982197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156653|NCT05982197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156654|NCT05982197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139156655|NCT05982197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139156656|NCT05982197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156657|NCT05982197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156658|NCT05982197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156659|NCT05982093|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139156660|NCT05982093|Luteolytic Agents|luteolytic agents|mesh-ancestor
139156661|NCT05982093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139156662|NCT05982093|Contraceptive Agents|contraceptive agents|mesh-ancestor
139156663|NCT05982093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139156664|NCT05982093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156665|NCT05982093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139156666|NCT05982093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139156667|NCT05982093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156668|NCT05981976|Abatacept|abatacept|mesh-list
139156669|NCT05981976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139156670|NCT05981976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156671|NCT05981976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139156672|NCT05981976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156673|NCT05981976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139156674|NCT05981976|Immunologic Factors|immunologic factors|mesh-ancestor
139156675|NCT05981976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156676|NCT05981976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139156677|NCT05981742|Metformin|metformin|mesh-list
139156678|NCT05981742|Cabergoline|cabergoline|mesh-list
139156679|NCT05981742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139156680|NCT05981742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156681|NCT05981742|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139156682|NCT05981742|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139156683|NCT05981742|Dopamine Agonists|dopamine agonists|mesh-ancestor
139156684|NCT05981742|Dopamine Agents|dopamine agents|mesh-ancestor
139156685|NCT05981742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156686|NCT05981742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156687|NCT05981079|Tazobactam|tazobactam|mesh-list
139156688|NCT05981079|Piperacillin|piperacillin|mesh-list
139156689|NCT05981079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139156690|NCT05981079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139156691|NCT05981079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156692|NCT05981079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139156693|NCT05981079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156694|NCT05981079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156695|NCT05981053|Resveratrol|resveratrol|mesh-list
139156696|NCT05981053|Antioxidants|antioxidants|mesh-ancestor
139156697|NCT05981053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156698|NCT05981053|Protective Agents|protective agents|mesh-ancestor
139156699|NCT05981053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156700|NCT05981053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156701|NCT05981053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139156702|NCT05981014|Paclitaxel|paclitaxel|mesh-list
139156703|NCT05981014|Cyclophosphamide|cyclophosphamide|mesh-list
139156704|NCT05981014|Doxorubicin|doxorubicin|mesh-list
139156705|NCT05981014|Fludarabine|fludarabine|mesh-list
139156706|NCT05981014|Interleukin-2|interleukin-2|mesh-list
139156707|NCT05981014|Epirubicin|epirubicin|mesh-list
139156708|NCT05981014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139156709|NCT05981014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156710|NCT05981014|Tubulin Modulators|tubulin modulators|mesh-ancestor
139156711|NCT05981014|Antimitotic Agents|antimitotic agents|mesh-ancestor
139156712|NCT05981014|Mitosis Modulators|mitosis modulators|mesh-ancestor
139156713|NCT05981014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156714|NCT05981014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139156715|NCT05981014|Immunologic Factors|immunologic factors|mesh-ancestor
139156716|NCT05981014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156717|NCT05981014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139156718|NCT05981014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139156719|NCT05981014|Alkylating Agents|alkylating agents|mesh-ancestor
139156720|NCT05981014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139156721|NCT05981014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139156722|NCT05981014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139156723|NCT05981014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139156724|NCT05981014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156725|NCT05981014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139156726|NCT05981014|Analgesics|analgesics|mesh-ancestor
139156727|NCT05981014|Sensory System Agents|sensory system agents|mesh-ancestor
139156728|NCT05981014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156729|NCT05981001|Paclitaxel|paclitaxel|mesh-list
139156730|NCT05981001|Cyclophosphamide|cyclophosphamide|mesh-list
139156731|NCT05981001|Carboplatin|carboplatin|mesh-list
139156732|NCT05981001|Gemcitabine|gemcitabine|mesh-list
139156733|NCT05981001|Fludarabine|fludarabine|mesh-list
139156734|NCT05981001|Interleukin-2|interleukin-2|mesh-list
139156735|NCT05981001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139156736|NCT05981001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156737|NCT05981001|Tubulin Modulators|tubulin modulators|mesh-ancestor
139156738|NCT05981001|Antimitotic Agents|antimitotic agents|mesh-ancestor
139156739|NCT05981001|Mitosis Modulators|mitosis modulators|mesh-ancestor
139156740|NCT05981001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156741|NCT05981001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139156742|NCT05981001|Immunologic Factors|immunologic factors|mesh-ancestor
139156743|NCT05981001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156744|NCT05981001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139156745|NCT05981001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139156746|NCT05981001|Alkylating Agents|alkylating agents|mesh-ancestor
139156747|NCT05981001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139156748|NCT05981001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138907247|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
139156749|NCT05981001|Antimetabolites|antimetabolites|mesh-ancestor
139156750|NCT05981001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139156751|NCT05981001|Analgesics|analgesics|mesh-ancestor
139156752|NCT05981001|Sensory System Agents|sensory system agents|mesh-ancestor
139156753|NCT05981001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156754|NCT05980871|Doxycycline|doxycycline|mesh-list
139156755|NCT05980871|Ceftriaxone|ceftriaxone|mesh-list
139156756|NCT05980871|Penicillins|penicillins|mesh-list
139156757|NCT05980871|Penicillin G|penicillin g|mesh-list
139156758|NCT05980871|Penicillin G Benzathine|penicillin g benzathine|mesh-list
139156759|NCT05980871|Penicillin G Procaine|penicillin g procaine|mesh-list
139156760|NCT05980871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139156761|NCT05980871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885867|NCT00730288|Vaccines|vaccines|mesh-list
139156762|NCT05980871|Antimalarials|antimalarials|mesh-ancestor
139156763|NCT05980871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139156764|NCT05980871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139156765|NCT05980715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139156766|NCT05980715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156767|NCT05980715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139156768|NCT05980715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156769|NCT05979597|Dexamethasone|dexamethasone|mesh-list
139156770|NCT05979597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139156771|NCT05979597|Antiemetics|antiemetics|mesh-ancestor
139156772|NCT05979597|Autonomic Agents|autonomic agents|mesh-ancestor
139156773|NCT05979597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156774|NCT05979597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156775|NCT05979597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139156776|NCT05979597|Glucocorticoids|glucocorticoids|mesh-ancestor
139156777|NCT05979597|Hormones|hormones|mesh-ancestor
139156778|NCT05979597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139156779|NCT05979597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139156780|NCT05979597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156781|NCT05979038|Metformin|metformin|mesh-list
139156782|NCT05979038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139156783|NCT05979038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156784|NCT05978219|Mirtazapine|mirtazapine|mesh-list
139156785|NCT05978219|Antidepressive Agents|antidepressive agents|mesh-ancestor
139156786|NCT05978219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139156787|NCT05978219|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139156788|NCT05978219|Histamine Antagonists|histamine antagonists|mesh-ancestor
139156789|NCT05978219|Histamine Agents|histamine agents|mesh-ancestor
139156790|NCT05978219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156791|NCT05978219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156792|NCT05978219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156793|NCT05978219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139156794|NCT05978219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139156795|NCT05978219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139156796|NCT05978219|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139156797|NCT05978219|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139156798|NCT05978219|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139156799|NCT05978219|Adrenergic Agents|adrenergic agents|mesh-ancestor
138889678|NCT04161482|Diuretics|diuretics|mesh-ancestor
139156800|NCT05978219|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139156801|NCT05978219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139156802|NCT05978219|Serotonin Agents|serotonin agents|mesh-ancestor
139156803|NCT05978219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139156804|NCT05975489|Caffeine|caffeine|mesh-list
139156805|NCT05975489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139156806|NCT05975489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156807|NCT05975489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139156808|NCT05975489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156809|NCT05975489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156810|NCT05975489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139156811|NCT05975489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139156812|NCT05975489|Purinergic Agents|purinergic agents|mesh-ancestor
139156813|NCT05975489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156814|NCT05947201|Paclitaxel|paclitaxel|mesh-list
139156815|NCT05947201|Fluorouracil|fluorouracil|mesh-list
139156816|NCT05947201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139156817|NCT05947201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885888|NCT04132011|Oxycodone|oxycodone|mesh-list
139156818|NCT05947201|Tubulin Modulators|tubulin modulators|mesh-ancestor
139156819|NCT05947201|Antimitotic Agents|antimitotic agents|mesh-ancestor
139156820|NCT05947201|Mitosis Modulators|mitosis modulators|mesh-ancestor
139156821|NCT05947201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156822|NCT05947201|Antimetabolites|antimetabolites|mesh-ancestor
139156823|NCT05947201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139156824|NCT05947201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139156825|NCT05947201|Immunologic Factors|immunologic factors|mesh-ancestor
139156826|NCT05947201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156827|NCT05914389|Capecitabine|capecitabine|mesh-list
139156828|NCT05914389|Oxaliplatin|oxaliplatin|mesh-list
139156829|NCT05914389|Antibodies|antibodies|mesh-list
139156830|NCT05914389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139156831|NCT05914389|Immunologic Factors|immunologic factors|mesh-ancestor
139156832|NCT05914389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156833|NCT05914389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139156834|NCT05914389|Antimetabolites|antimetabolites|mesh-ancestor
139156835|NCT05914389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156836|NCT05914389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156837|NCT05909267|Carbidopa|carbidopa|mesh-list
139156838|NCT05909267|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139156839|NCT05909267|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139156840|NCT05909267|Dopamine Agents|dopamine agents|mesh-ancestor
139156841|NCT05909267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954311|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
139156842|NCT05909267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156843|NCT05909267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156844|NCT05909267|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139156846|NCT05906589|Psyllium|psyllium|mesh-list
139156847|NCT05906589|Cathartics|cathartics|mesh-ancestor
139156848|NCT05906589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139156849|NCT05886140|Paclitaxel|paclitaxel|mesh-list
139156850|NCT05886140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139156851|NCT05886140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156852|NCT05886140|Tubulin Modulators|tubulin modulators|mesh-ancestor
139156853|NCT05886140|Antimitotic Agents|antimitotic agents|mesh-ancestor
139156854|NCT05886140|Mitosis Modulators|mitosis modulators|mesh-ancestor
139156855|NCT05886140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156856|NCT05870319|Carboplatin|carboplatin|mesh-list
139156857|NCT05870319|Pemetrexed|pemetrexed|mesh-list
139156858|NCT05870319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156859|NCT05870319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156860|NCT05870319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156861|NCT05870319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139156862|NCT05870319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139156863|NCT05863364|Rifaximin|rifaximin|mesh-list
139156864|NCT05863364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139156865|NCT05863364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156866|NCT05863364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139156867|NCT05816252|Carboplatin|carboplatin|mesh-list
139156868|NCT05816252|Pembrolizumab|pembrolizumab|mesh-list
139156869|NCT05816252|Osimertinib|osimertinib|mesh-list
139156870|NCT05816252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156871|NCT05816252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139156872|NCT05816252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139156873|NCT05816252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156874|NCT05816252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139156875|NCT05816252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156876|NCT05801172|Ketoprofen|ketoprofen|mesh-list
139156877|NCT05801172|Lidocaine|lidocaine|mesh-list
139156878|NCT05801172|Anesthetics|anesthetics|mesh-list
139156879|NCT05801172|Anesthetics, Local|anesthetics, local|mesh-ancestor
139156880|NCT05801172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138885906|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156881|NCT05801172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156882|NCT05801172|Sensory System Agents|sensory system agents|mesh-ancestor
139156883|NCT05801172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156884|NCT05801172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139156885|NCT05801172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139156886|NCT05801172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139156887|NCT05801172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139156888|NCT05801172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156889|NCT05801172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139156890|NCT05801172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139156891|NCT05801172|Analgesics|analgesics|mesh-ancestor
139156892|NCT05801172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139156893|NCT05801172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139156894|NCT05801172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139156895|NCT05801172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156896|NCT05761223|Pembrolizumab|pembrolizumab|mesh-list
139156897|NCT05761223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139156898|NCT05761223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156899|NCT05761223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138907391|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
139156900|NCT05761223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156901|NCT05758818|Moxifloxacin|moxifloxacin|mesh-list
139156902|NCT05758818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139156903|NCT05758818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156904|NCT05758818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139156905|NCT05758818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139156906|NCT05758818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156907|NCT05758818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156908|NCT05758818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156909|NCT05757648|Anesthetics|anesthetics|mesh-list
139156910|NCT05757648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139156911|NCT05757648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156912|NCT05679258|Daratumumab|daratumumab|mesh-list
139156913|NCT05679258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139156914|NCT05679258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156915|NCT05679258|Immunologic Factors|immunologic factors|mesh-ancestor
139156916|NCT05679258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156917|NCT05674877|Dexmedetomidine|dexmedetomidine|mesh-list
139156918|NCT05674877|Ketamine|ketamine|mesh-list
139156919|NCT05674877|Analgesics, Opioid|analgesics, opioid|mesh-list
139156920|NCT05674877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139156921|NCT05674877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139156922|NCT05674877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156923|NCT05674877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139156924|NCT05674877|Analgesics|analgesics|mesh-ancestor
139156925|NCT05674877|Sensory System Agents|sensory system agents|mesh-ancestor
139156926|NCT05674877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139156927|NCT05674877|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139156928|NCT05674877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139156929|NCT05674877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139156930|NCT05674877|Adrenergic Agents|adrenergic agents|mesh-ancestor
139156931|NCT05674877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139156932|NCT05674877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156933|NCT05674877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139156934|NCT05674877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139156935|NCT05674877|Anesthetics, General|anesthetics, general|mesh-ancestor
139156936|NCT05674877|Anesthetics|anesthetics|mesh-ancestor
138885922|NCT00689598|Diuretics|diuretics|mesh-ancestor
139156937|NCT05674877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139156938|NCT05674877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139156939|NCT05674877|Narcotics|narcotics|mesh-ancestor
139156940|NCT06098625|Empagliflozin|empagliflozin|mesh-list
139156941|NCT06098625|Linagliptin|linagliptin|mesh-list
139156942|NCT06098625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139156943|NCT06098625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156944|NCT06098625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139156945|NCT06098625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156946|NCT06098625|Incretins|incretins|mesh-ancestor
139156948|NCT06098625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139156949|NCT06098625|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139156950|NCT06098625|Protease Inhibitors|protease inhibitors|mesh-ancestor
139156951|NCT06098625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156952|NCT06098599|Doxorubicin|doxorubicin|mesh-list
139156953|NCT06098599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139156954|NCT06098599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139156955|NCT06098599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156956|NCT06098599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139156957|NCT06098599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139156958|NCT06098599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139156959|NCT06098599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156960|NCT06098417|Liver Extracts|liver extracts|mesh-list
139156961|NCT06098417|Hematinics|hematinics|mesh-ancestor
139156962|NCT06098326|Cyclophosphamide|cyclophosphamide|mesh-list
139156963|NCT06098326|Fludarabine|fludarabine|mesh-list
139156964|NCT06098326|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139156965|NCT06098326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139156966|NCT06098326|Immunologic Factors|immunologic factors|mesh-ancestor
139156967|NCT06098326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156968|NCT06098326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139156969|NCT06098326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139156970|NCT06098326|Alkylating Agents|alkylating agents|mesh-ancestor
139156971|NCT06098326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156972|NCT06098326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889780|NCT00517699|Cytarabine|cytarabine|mesh-list
139156973|NCT06098326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139156974|NCT06098313|Cyclophosphamide|cyclophosphamide|mesh-list
139156975|NCT06098313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139156976|NCT06098313|Immunologic Factors|immunologic factors|mesh-ancestor
139156977|NCT06098313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156978|NCT06098313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139156979|NCT06098313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139156980|NCT06098313|Alkylating Agents|alkylating agents|mesh-ancestor
139156981|NCT06098313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139156982|NCT06098313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156983|NCT06098313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139156984|NCT06098014|Thalidomide|thalidomide|mesh-list
139156985|NCT06098014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139156986|NCT06098014|Immunologic Factors|immunologic factors|mesh-ancestor
139156987|NCT06098014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139156988|NCT06098014|Leprostatic Agents|leprostatic agents|mesh-ancestor
139156989|NCT06098014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139156990|NCT06098014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139156991|NCT06098014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139156992|NCT06098014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139156993|NCT06098014|Growth Substances|growth substances|mesh-ancestor
139156994|NCT06098014|Growth Inhibitors|growth inhibitors|mesh-ancestor
139156995|NCT06098014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156996|NCT06097975|Nivolumab|nivolumab|mesh-list
139156997|NCT06097975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139156998|NCT06097975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139156999|NCT06097975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139157000|NCT06097975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157001|NCT06097767|Amikacin|amikacin|mesh-list
139157002|NCT06097767|Caffeine|caffeine|mesh-list
139157003|NCT06097767|Caffeine citrate|caffeine citrate|mesh-list
138889845|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
139157004|NCT06097767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157005|NCT06097767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139157006|NCT06097767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157007|NCT06097767|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139157008|NCT06097767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157009|NCT06097767|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139157010|NCT06097767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139157011|NCT06097767|Purinergic Agents|purinergic agents|mesh-ancestor
139157012|NCT06097767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157013|NCT06097767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139157014|NCT06097767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139157015|NCT06097585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139157016|NCT06097585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157017|NCT06097585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139157018|NCT06097585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157019|NCT06097169|Fentanyl|fentanyl|mesh-list
139157020|NCT06097169|Dexmedetomidine|dexmedetomidine|mesh-list
139157021|NCT06097169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139157022|NCT06097169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157023|NCT06097169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157024|NCT06097169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139157025|NCT06097169|Analgesics|analgesics|mesh-ancestor
139157026|NCT06097169|Sensory System Agents|sensory system agents|mesh-ancestor
139157027|NCT06097169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157028|NCT06097169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139157029|NCT06097169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139157030|NCT06097169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139157031|NCT06097169|Adrenergic Agents|adrenergic agents|mesh-ancestor
139157032|NCT06097169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157033|NCT06097169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157034|NCT06097169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139157035|NCT06097169|Narcotics|narcotics|mesh-ancestor
139157036|NCT06097169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139157037|NCT06097169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139157038|NCT06097169|Anesthetics, General|anesthetics, general|mesh-ancestor
139157039|NCT06097169|Anesthetics|anesthetics|mesh-ancestor
139157040|NCT06097026|Nitric Oxide|nitric oxide|mesh-list
139157041|NCT06097026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139157042|NCT06097026|Autonomic Agents|autonomic agents|mesh-ancestor
139157043|NCT06097026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157044|NCT06097026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157045|NCT06097026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139157046|NCT06097026|Respiratory System Agents|respiratory system agents|mesh-ancestor
139157047|NCT06097026|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139157049|NCT06097026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157050|NCT06097026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157051|NCT06097026|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139157052|NCT06097026|Vasodilator Agents|vasodilator agents|mesh-ancestor
139157053|NCT06097026|Gasotransmitters|gasotransmitters|mesh-ancestor
139157054|NCT06097026|Protective Agents|protective agents|mesh-ancestor
139157055|NCT06093698|Antibodies|antibodies|mesh-list
139157056|NCT06093698|Immunologic Factors|immunologic factors|mesh-ancestor
139157057|NCT06093698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157058|NCT06093672|Hydroxyurea|hydroxyurea|mesh-list
139157059|NCT06093672|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
139157060|NCT06093672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157061|NCT06093672|Antisickling Agents|antisickling agents|mesh-ancestor
139157062|NCT06093672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157063|NCT06093672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157064|NCT06093672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139157065|NCT06093672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139157066|NCT06093659|Nicotine|nicotine|mesh-list
139157067|NCT06093659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139157068|NCT06093659|Autonomic Agents|autonomic agents|mesh-ancestor
139157069|NCT06093659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157070|NCT06093659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157071|NCT06093659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139157072|NCT06093659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139157073|NCT06093659|Cholinergic Agents|cholinergic agents|mesh-ancestor
139157074|NCT06093659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157075|NCT06093659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157076|NCT06093503|Carboplatin|carboplatin|mesh-list
139157077|NCT06093503|Pemetrexed|pemetrexed|mesh-list
139157078|NCT06093503|Osimertinib|osimertinib|mesh-list
139157079|NCT06093503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157080|NCT06093503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157081|NCT06093503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157082|NCT06093503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139157083|NCT06093503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139157084|NCT06093503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139157085|NCT06093477|Melatonin|melatonin|mesh-list
139157086|NCT06093477|Antioxidants|antioxidants|mesh-ancestor
139157087|NCT06093477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889935|NCT04713709|Naloxone|naloxone|mesh-list
139157088|NCT06093477|Protective Agents|protective agents|mesh-ancestor
139157089|NCT06093477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157090|NCT06093477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157091|NCT06093464|Corticosterone|corticosterone|mesh-list
139157092|NCT06093464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139157093|NCT06093451|Dexmedetomidine|dexmedetomidine|mesh-list
139157094|NCT06093451|Lorazepam|lorazepam|mesh-list
139157095|NCT06093451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139157096|NCT06093451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157097|NCT06093451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954318|NCT00986050|Abciximab|abciximab|mesh-list
139157098|NCT06093451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139157099|NCT06093451|Analgesics|analgesics|mesh-ancestor
139157100|NCT06093451|Sensory System Agents|sensory system agents|mesh-ancestor
139157101|NCT06093451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157102|NCT06093451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139157103|NCT06093451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139157104|NCT06093451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139157105|NCT06093451|Adrenergic Agents|adrenergic agents|mesh-ancestor
139157106|NCT06093451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157107|NCT06093451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157108|NCT06093451|Anticonvulsants|anticonvulsants|mesh-ancestor
139157109|NCT06093451|Antiemetics|antiemetics|mesh-ancestor
139157110|NCT06093451|Autonomic Agents|autonomic agents|mesh-ancestor
139157111|NCT06093451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139157112|NCT06093451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139157113|NCT06093451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139157114|NCT06093451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139157115|NCT06093451|GABA Modulators|gaba modulators|mesh-ancestor
139157116|NCT06093451|GABA Agents|gaba agents|mesh-ancestor
139157117|NCT06093425|Leucovorin|leucovorin|mesh-list
139157118|NCT06093425|Folic Acid|folic acid|mesh-list
139157119|NCT06093425|Capecitabine|capecitabine|mesh-list
139157120|NCT06093425|Fluorouracil|fluorouracil|mesh-list
139157121|NCT06093425|Oxaliplatin|oxaliplatin|mesh-list
139157122|NCT06093425|Nivolumab|nivolumab|mesh-list
139157123|NCT06093425|Levoleucovorin|levoleucovorin|mesh-list
138907617|NCT00662038|Pirfenidone|pirfenidone|mesh-list
139157124|NCT06093425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139157125|NCT06093425|Antimetabolites|antimetabolites|mesh-ancestor
139157126|NCT06093425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157127|NCT06093425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157128|NCT06093425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139157129|NCT06093425|Immunologic Factors|immunologic factors|mesh-ancestor
139157130|NCT06093425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157131|NCT06093425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157132|NCT06093425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139157133|NCT06093425|Antidotes|antidotes|mesh-ancestor
139157134|NCT06093425|Protective Agents|protective agents|mesh-ancestor
139157135|NCT06093425|Vitamin B Complex|vitamin b complex|mesh-ancestor
139157136|NCT06093425|Vitamins|vitamins|mesh-ancestor
139157137|NCT06093425|Micronutrients|micronutrients|mesh-ancestor
139157138|NCT06093425|Hematinics|hematinics|mesh-ancestor
139157139|NCT06093412|Anesthetics|anesthetics|mesh-list
139157140|NCT06093412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157141|NCT06093412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157142|NCT06093152|Albuterol|albuterol|mesh-list
139157143|NCT06093152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139157144|NCT06093152|Autonomic Agents|autonomic agents|mesh-ancestor
139157145|NCT06093152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157146|NCT06093152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157147|NCT06093152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139157148|NCT06093152|Respiratory System Agents|respiratory system agents|mesh-ancestor
139157149|NCT06093152|Tocolytic Agents|tocolytic agents|mesh-ancestor
139157150|NCT06093152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139157151|NCT06093152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139157152|NCT06093152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139157153|NCT06093152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139157154|NCT06093152|Adrenergic Agents|adrenergic agents|mesh-ancestor
139157155|NCT06093152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157156|NCT06093152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157157|NCT06093126|Lemborexant|lemborexant|mesh-list
139157158|NCT06093126|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139157159|NCT06093126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157160|NCT06093126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157161|NCT06093126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139157162|NCT06093126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139157163|NCT06093126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157164|NCT06093126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157165|NCT06093061|Capecitabine|capecitabine|mesh-list
139157166|NCT06093061|Tislelizumab|tislelizumab|mesh-list
139157167|NCT06093061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139157168|NCT06093061|Antimetabolites|antimetabolites|mesh-ancestor
138885986|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139157169|NCT06093061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157170|NCT06093061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157171|NCT06093061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157173|NCT06092684|Esketamine|esketamine|mesh-list
139157174|NCT06092684|Antidepressive Agents|antidepressive agents|mesh-ancestor
139157175|NCT06092684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139157176|NCT06092684|Analgesics|analgesics|mesh-ancestor
139157177|NCT06092684|Sensory System Agents|sensory system agents|mesh-ancestor
139157178|NCT06092684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157179|NCT06092684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157180|NCT06092684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139157181|NCT06092684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139157182|NCT06092684|Anesthetics, General|anesthetics, general|mesh-ancestor
139157183|NCT06092684|Anesthetics|anesthetics|mesh-ancestor
139157184|NCT06092684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157185|NCT06092684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139157186|NCT06092684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139157187|NCT06092684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157188|NCT06092684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157189|NCT06092671|Anesthetics|anesthetics|mesh-list
138889971|NCT03393611|Cytarabine|cytarabine|mesh-list
139157190|NCT06092671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157191|NCT06092671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157192|NCT06092541|Anesthetics|anesthetics|mesh-list
139157193|NCT06092541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157194|NCT06092541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157195|NCT06092515|Zinc|zinc|mesh-list
139157196|NCT06092515|Trace Elements|trace elements|mesh-ancestor
138907693|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157197|NCT06092515|Micronutrients|micronutrients|mesh-ancestor
139157198|NCT06092515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157200|NCT06092437|Natriuretic Agents|natriuretic agents|mesh-ancestor
139157201|NCT06092437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157202|NCT06092242|Bevacizumab|bevacizumab|mesh-list
139157203|NCT06092242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157204|NCT06092242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157205|NCT06092242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139157206|NCT06092242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139157207|NCT06092242|Growth Substances|growth substances|mesh-ancestor
139157208|NCT06092242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157209|NCT06092242|Growth Inhibitors|growth inhibitors|mesh-ancestor
139157210|NCT06092151|Fluorides|fluorides|mesh-list
139157211|NCT06092151|Cariostatic Agents|cariostatic agents|mesh-ancestor
139157212|NCT06092151|Protective Agents|protective agents|mesh-ancestor
139157213|NCT06092151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157214|NCT06092073|Bupivacaine|bupivacaine|mesh-list
139157215|NCT06092073|Anesthetics, Local|anesthetics, local|mesh-ancestor
139157216|NCT06092073|Anesthetics|anesthetics|mesh-ancestor
139157217|NCT06092073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157218|NCT06092073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157219|NCT06092073|Sensory System Agents|sensory system agents|mesh-ancestor
139157220|NCT06092073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157221|NCT06092047|Cyclophosphamide|cyclophosphamide|mesh-list
139157222|NCT06092047|Fludarabine|fludarabine|mesh-list
139157223|NCT06092047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139157224|NCT06092047|Immunologic Factors|immunologic factors|mesh-ancestor
139157225|NCT06092047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157226|NCT06092047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139157227|NCT06092047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139157228|NCT06092047|Alkylating Agents|alkylating agents|mesh-ancestor
139157229|NCT06092047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157230|NCT06092047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157231|NCT06092047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139157232|NCT06091657|Dexamethasone|dexamethasone|mesh-list
139157233|NCT06091657|Ketamine|ketamine|mesh-list
139157234|NCT06091657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139157235|NCT06091657|Antiemetics|antiemetics|mesh-ancestor
139157236|NCT06091657|Autonomic Agents|autonomic agents|mesh-ancestor
139157237|NCT06091657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157238|NCT06091657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157239|NCT06091657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139157240|NCT06091657|Glucocorticoids|glucocorticoids|mesh-ancestor
139157241|NCT06091657|Hormones|hormones|mesh-ancestor
139157242|NCT06091657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139157243|NCT06091657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139157244|NCT06091657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157245|NCT06091657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157246|NCT06091657|Analgesics|analgesics|mesh-ancestor
139157247|NCT06091657|Sensory System Agents|sensory system agents|mesh-ancestor
139157248|NCT06091657|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139157249|NCT06091657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139157250|NCT06091657|Anesthetics, General|anesthetics, general|mesh-ancestor
139157251|NCT06091657|Anesthetics|anesthetics|mesh-ancestor
139157252|NCT06091657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157253|NCT06091657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139157254|NCT06091657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139157255|NCT06091657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157256|NCT06091267|Decitabine|decitabine|mesh-list
139157257|NCT06091267|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139157258|NCT06091267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139157259|NCT06091267|Antimetabolites|antimetabolites|mesh-ancestor
139157260|NCT06091267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157261|NCT06091267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157262|NCT06091267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157263|NCT06085742|Cyclophosphamide|cyclophosphamide|mesh-list
139157264|NCT06085742|Capecitabine|capecitabine|mesh-list
139157265|NCT06085742|Methotrexate|methotrexate|mesh-list
139157266|NCT06085742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139157267|NCT06085742|Immunologic Factors|immunologic factors|mesh-ancestor
139157268|NCT06085742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157269|NCT06085742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139157270|NCT06085742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138907772|NCT00706680|Prednisone|prednisone|mesh-list
139157271|NCT06085742|Alkylating Agents|alkylating agents|mesh-ancestor
139157272|NCT06085742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157273|NCT06085742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157274|NCT06085742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139157275|NCT06085742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139157276|NCT06085742|Antimetabolites|antimetabolites|mesh-ancestor
139157277|NCT06085742|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139157278|NCT06085742|Abortifacient Agents|abortifacient agents|mesh-ancestor
139157279|NCT06085742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139157280|NCT06085742|Dermatologic Agents|dermatologic agents|mesh-ancestor
139157281|NCT06085742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157282|NCT06085742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139157283|NCT06085742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139157284|NCT06084897|Paclitaxel|paclitaxel|mesh-list
139157285|NCT06084897|Cisplatin|cisplatin|mesh-list
139157286|NCT06084897|Carboplatin|carboplatin|mesh-list
139157287|NCT06084897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139157288|NCT06084897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139157289|NCT06084897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157290|NCT06084897|Tubulin Modulators|tubulin modulators|mesh-ancestor
139157291|NCT06084897|Antimitotic Agents|antimitotic agents|mesh-ancestor
139157292|NCT06084897|Mitosis Modulators|mitosis modulators|mesh-ancestor
139157293|NCT06084897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157294|NCT06084897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157295|NCT06083662|Maleic acid|maleic acid|mesh-list
139157296|NCT06083662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157297|NCT06083662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157298|NCT06081348|Sertraline|sertraline|mesh-list
139157299|NCT06081348|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139157300|NCT06081348|Serotonin|serotonin|mesh-list
139157301|NCT06081348|Antidepressive Agents|antidepressive agents|mesh-ancestor
139157302|NCT06081348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139157303|NCT06081348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139157304|NCT06081348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139157305|NCT06081348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157306|NCT06081348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157307|NCT06081348|Serotonin Agents|serotonin agents|mesh-ancestor
139157308|NCT06081348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157309|NCT06081348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139157310|NCT06079645|Triamcinolone|triamcinolone|mesh-list
139157311|NCT06079645|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139157312|NCT06079645|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138954357|NCT04767256|Dexamethasone|dexamethasone|mesh-list
139157313|NCT06079645|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139157314|NCT06079645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139157315|NCT06079645|Glucocorticoids|glucocorticoids|mesh-ancestor
139157316|NCT06079645|Hormones|hormones|mesh-ancestor
139157317|NCT06079645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139157318|NCT06079645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157319|NCT06079645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139157320|NCT06079645|Immunologic Factors|immunologic factors|mesh-ancestor
139157321|NCT06079645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157322|NCT06079645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157323|NCT06075004|Anesthetics|anesthetics|mesh-list
139157324|NCT06075004|Anesthetics, Local|anesthetics, local|mesh-list
139157325|NCT06075004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157326|NCT06075004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157327|NCT06075004|Sensory System Agents|sensory system agents|mesh-ancestor
139157328|NCT06075004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019570|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139019571|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
139157329|NCT06072326|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139157330|NCT06072326|Ambrisentan|ambrisentan|mesh-list
139157331|NCT06072326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139157332|NCT06072326|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139157333|NCT06072326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157334|NCT06072326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139157335|NCT06072326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157336|NCT06056752|Cyclophosphamide|cyclophosphamide|mesh-list
139157337|NCT06056752|Fludarabine|fludarabine|mesh-list
139157338|NCT06056752|Fludarabine phosphate|fludarabine phosphate|mesh-list
139157339|NCT06056752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139157340|NCT06056752|Immunologic Factors|immunologic factors|mesh-ancestor
139157341|NCT06056752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157342|NCT06056752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139157343|NCT06056752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139157344|NCT06056752|Alkylating Agents|alkylating agents|mesh-ancestor
139157345|NCT06056752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157346|NCT06056752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157347|NCT06056752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139157348|NCT06056752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139157349|NCT06056752|Antimetabolites|antimetabolites|mesh-ancestor
139157350|NCT06048627|Fluorides|fluorides|mesh-list
139157351|NCT06048627|Cariostatic Agents|cariostatic agents|mesh-ancestor
139157352|NCT06048627|Protective Agents|protective agents|mesh-ancestor
139157353|NCT06048627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157354|NCT06039436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139157355|NCT06039436|Thymoglobulin|thymoglobulin|mesh-list
139157356|NCT06039436|Immunologic Factors|immunologic factors|mesh-ancestor
138886028|NCT02617290|Ticagrelor|ticagrelor|mesh-list
139157357|NCT06039436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157358|NCT06039436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139157359|NCT06022029|Cemiplimab|cemiplimab|mesh-list
139157360|NCT06022029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157361|NCT06022029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157362|NCT06010732|Listerine|listerine|mesh-list
139157363|NCT06010732|Fluorides|fluorides|mesh-list
139157364|NCT06010732|Sodium Fluoride|sodium fluoride|mesh-list
139157365|NCT06010732|Cariostatic Agents|cariostatic agents|mesh-ancestor
139157366|NCT06010732|Protective Agents|protective agents|mesh-ancestor
139157367|NCT06010732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157368|NCT06010732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139157369|NCT06010732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139157370|NCT06002438|Micronutrients|micronutrients|mesh-list
139157371|NCT06002438|Trace Elements|trace elements|mesh-list
139157372|NCT06002438|Pyrimethamine|pyrimethamine|mesh-list
139157373|NCT06002438|Sulfadoxine|sulfadoxine|mesh-list
139157374|NCT06002438|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139157375|NCT06002438|Antimalarials|antimalarials|mesh-ancestor
139157376|NCT06002438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139157377|NCT06002438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139157378|NCT06002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139157379|NCT06002438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139157380|NCT06002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157381|NCT06002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157382|NCT06002438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139157383|NCT06002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157384|NCT06001320|Letermovir|letermovir|mesh-list
139157385|NCT06001320|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139157386|NCT06001320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157387|NCT06001320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157388|NCT06001320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157389|NCT06001320|Antiviral Agents|antiviral agents|mesh-ancestor
139157390|NCT06001320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139157391|NCT05992922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139157392|NCT05992922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139157393|NCT05991908|Vidarabine|vidarabine|mesh-list
139157394|NCT05991908|Fludarabine|fludarabine|mesh-list
139157395|NCT05991908|Fludarabine phosphate|fludarabine phosphate|mesh-list
139157396|NCT05991908|Melphalan|melphalan|mesh-list
139157397|NCT05991908|Busulfan|busulfan|mesh-list
139157398|NCT05991908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157399|NCT05991908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139157400|NCT05991908|Antimetabolites|antimetabolites|mesh-ancestor
139157401|NCT05991908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157402|NCT05991908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139157403|NCT05991908|Immunologic Factors|immunologic factors|mesh-ancestor
139157404|NCT05991908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157405|NCT05991908|Antiviral Agents|antiviral agents|mesh-ancestor
139157406|NCT05991908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139157407|NCT05991908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139157408|NCT05991908|Alkylating Agents|alkylating agents|mesh-ancestor
139157409|NCT05991908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139157410|NCT05988983|Contraceptive Agents|contraceptive agents|mesh-list
139157411|NCT05988983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139157412|NCT05988983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157413|NCT05960656|Empagliflozin|empagliflozin|mesh-list
139157414|NCT05960656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138886032|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139157415|NCT05960656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157416|NCT05960656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139157417|NCT05960656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157418|NCT06217796|Phenylephrine|phenylephrine|mesh-list
139157419|NCT06217796|Oxymetazoline|oxymetazoline|mesh-list
139157420|NCT06217796|Tropicamide|tropicamide|mesh-list
139157421|NCT06217796|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139157422|NCT06217796|Mydriatics|mydriatics|mesh-ancestor
139157423|NCT06217796|Autonomic Agents|autonomic agents|mesh-ancestor
139157424|NCT06217796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157425|NCT06217796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157426|NCT06217796|Sympathomimetics|sympathomimetics|mesh-ancestor
139157427|NCT06217796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139157428|NCT06217796|Nasal Decongestants|nasal decongestants|mesh-ancestor
139157429|NCT06217796|Respiratory System Agents|respiratory system agents|mesh-ancestor
139157430|NCT06217796|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139157431|NCT06217796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139157432|NCT06217796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139157433|NCT06217796|Adrenergic Agents|adrenergic agents|mesh-ancestor
139157434|NCT06217796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157435|NCT06217796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157436|NCT06217796|Protective Agents|protective agents|mesh-ancestor
139157437|NCT06217796|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139157438|NCT06217796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139157439|NCT06217796|Cholinergic Agents|cholinergic agents|mesh-ancestor
139157440|NCT06217757|Etoposide|etoposide|mesh-list
139157441|NCT06217757|Olaparib|olaparib|mesh-list
139157442|NCT06217757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139157443|NCT06217757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139157444|NCT06217757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157445|NCT06217757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139157446|NCT06217757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139157447|NCT06217757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139157448|NCT06217757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157449|NCT06217757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157450|NCT06217757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157451|NCT06217562|Vasopressins|vasopressins|mesh-list
139157452|NCT06217562|Arginine Vasopressin|arginine vasopressin|mesh-list
139157453|NCT06217562|Hemostatics|hemostatics|mesh-ancestor
139157454|NCT06217562|Coagulants|coagulants|mesh-ancestor
139157455|NCT06217562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139157456|NCT06217562|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139157457|NCT06217562|Natriuretic Agents|natriuretic agents|mesh-ancestor
139157458|NCT06217562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157459|NCT06217406|Acyclovir|acyclovir|mesh-list
139157460|NCT06217406|Antiviral Agents|antiviral agents|mesh-ancestor
139157461|NCT06217406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139157462|NCT06217367|Diphenhydramine|diphenhydramine|mesh-list
139157463|NCT06217367|Promethazine|promethazine|mesh-list
139157464|NCT06217367|Loratadine|loratadine|mesh-list
139157465|NCT06217367|Desloratadine|desloratadine|mesh-list
139157466|NCT06217367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139157467|NCT06217367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139157468|NCT06217367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157469|NCT06217367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157470|NCT06217367|Anesthetics, Local|anesthetics, local|mesh-ancestor
139157471|NCT06217367|Anesthetics|anesthetics|mesh-ancestor
139157472|NCT06217367|Sensory System Agents|sensory system agents|mesh-ancestor
139157473|NCT06217367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157474|NCT06217367|Antiemetics|antiemetics|mesh-ancestor
139157475|NCT06217367|Autonomic Agents|autonomic agents|mesh-ancestor
139157476|NCT06217367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139157477|NCT06217367|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139157478|NCT06217367|Histamine Antagonists|histamine antagonists|mesh-ancestor
139157479|NCT06217367|Histamine Agents|histamine agents|mesh-ancestor
139157480|NCT06217367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157481|NCT06217367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157482|NCT06217367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139157483|NCT06217367|Antipruritics|antipruritics|mesh-ancestor
139157484|NCT06217367|Dermatologic Agents|dermatologic agents|mesh-ancestor
139157485|NCT06217367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139157486|NCT06217367|Cholinergic Agents|cholinergic agents|mesh-ancestor
139157487|NCT06217367|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139157488|NCT06217354|Carbetocin|carbetocin|mesh-list
139157489|NCT06217354|Oxytocics|oxytocics|mesh-ancestor
139157490|NCT06217354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139157491|NCT06217354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157492|NCT06217302|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139157493|NCT06217302|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139157494|NCT06217302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157495|NCT06217302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139157496|NCT06217302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157497|NCT06217185|Capecitabine|capecitabine|mesh-list
139157498|NCT06217185|Trastuzumab|trastuzumab|mesh-list
139157499|NCT06217185|Taxane|taxane|mesh-list
139157500|NCT06217185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139157501|NCT06217185|Antimetabolites|antimetabolites|mesh-ancestor
139157502|NCT06217185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157503|NCT06217185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157504|NCT06217185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157505|NCT06217055|Sevoflurane|sevoflurane|mesh-list
139157506|NCT06217055|Anesthetics|anesthetics|mesh-ancestor
139157507|NCT06217055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157508|NCT06217055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157509|NCT06217055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139157510|NCT06217055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139157511|NCT06217055|Anesthetics, General|anesthetics, general|mesh-ancestor
139157512|NCT06217042|Leucovorin|leucovorin|mesh-list
139157513|NCT06217042|Gemcitabine|gemcitabine|mesh-list
139157514|NCT06217042|Capecitabine|capecitabine|mesh-list
139157515|NCT06217042|Fluorouracil|fluorouracil|mesh-list
139157516|NCT06217042|Oxaliplatin|oxaliplatin|mesh-list
139157517|NCT06217042|Calcium|calcium|mesh-list
139157518|NCT06217042|Levoleucovorin|levoleucovorin|mesh-list
139157519|NCT06217042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139157520|NCT06217042|Antimetabolites|antimetabolites|mesh-ancestor
139157521|NCT06217042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157522|NCT06217042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157523|NCT06217042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139157524|NCT06217042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157525|NCT06217042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139157526|NCT06217042|Immunologic Factors|immunologic factors|mesh-ancestor
139157527|NCT06217042|Antidotes|antidotes|mesh-ancestor
139157528|NCT06217042|Protective Agents|protective agents|mesh-ancestor
139157529|NCT06217042|Vitamin B Complex|vitamin b complex|mesh-ancestor
139157530|NCT06217042|Vitamins|vitamins|mesh-ancestor
139157531|NCT06217042|Micronutrients|micronutrients|mesh-ancestor
139157532|NCT06216886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139157533|NCT06216886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139157534|NCT06216886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139157535|NCT06216886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157539|NCT06216886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157540|NCT06216886|Cholinergic Agents|cholinergic agents|mesh-ancestor
139157541|NCT06216886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157546|NCT06216639|Amoxicillin|amoxicillin|mesh-list
139157547|NCT06216639|Metronidazole|metronidazole|mesh-list
139157548|NCT06216639|Clarithromycin|clarithromycin|mesh-list
139157549|NCT06216639|Levofloxacin|levofloxacin|mesh-list
139157550|NCT06216639|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
139157551|NCT06216639|Esomeprazole|esomeprazole|mesh-list
139157552|NCT06216639|Bismuth|bismuth|mesh-list
139157553|NCT06216639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139157554|NCT06216639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139157555|NCT06216639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139157556|NCT06216639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139157557|NCT06216639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139157558|NCT06216639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139157559|NCT06216639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139157560|NCT06216639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157561|NCT06216639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157562|NCT06216639|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139157563|NCT06216639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139157564|NCT06216639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139157565|NCT06216639|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139157566|NCT06216639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139157567|NCT06216639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139157568|NCT06216639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157569|NCT06216639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139157570|NCT06216639|Antacids|antacids|mesh-ancestor
139157571|NCT06216535|Escitalopram|escitalopram|mesh-list
139157572|NCT06216535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139157573|NCT06216535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139157574|NCT06216535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139157575|NCT06216535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157576|NCT06216535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157577|NCT06216535|Serotonin Agents|serotonin agents|mesh-ancestor
139157578|NCT06216535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157579|NCT06216522|Mineral Oil|mineral oil|mesh-list
139157580|NCT06216522|Emollients|emollients|mesh-ancestor
139157581|NCT06216522|Dermatologic Agents|dermatologic agents|mesh-ancestor
139157582|NCT06216301|Pembrolizumab|pembrolizumab|mesh-list
139157583|NCT06216301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157584|NCT06216301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157585|NCT06216301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139157586|NCT06216301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157588|NCT06216262|Calcium|calcium|mesh-list
139157589|NCT06216262|Caseins|caseins|mesh-list
139157590|NCT06216262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139157591|NCT06216262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157592|NCT06216262|Chelating Agents|chelating agents|mesh-ancestor
139157593|NCT06216262|Sequestering Agents|sequestering agents|mesh-ancestor
139157594|NCT06216262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157595|NCT06216262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139157596|NCT06216249|Edetic Acid|edetic acid|mesh-list
139157597|NCT06216249|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
139157598|NCT06216249|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139157599|NCT06216249|177Lu-PSMA-617|177lu-psma-617|mesh-list
139157600|NCT06216249|Chelating Agents|chelating agents|mesh-ancestor
139157601|NCT06216249|Sequestering Agents|sequestering agents|mesh-ancestor
139157602|NCT06216249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157603|NCT06216249|Anticoagulants|anticoagulants|mesh-ancestor
139157604|NCT06216249|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139157605|NCT06216249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139157606|NCT06216210|Analgesics, Opioid|analgesics, opioid|mesh-list
139157607|NCT06216210|Anesthetics|anesthetics|mesh-list
139157608|NCT06216210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157609|NCT06216210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157610|NCT06216210|Narcotics|narcotics|mesh-ancestor
139157611|NCT06216210|Analgesics|analgesics|mesh-ancestor
139157612|NCT06216210|Sensory System Agents|sensory system agents|mesh-ancestor
139157613|NCT06216210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157614|NCT06216197|Fentanyl|fentanyl|mesh-list
139157615|NCT06216197|Dexmedetomidine|dexmedetomidine|mesh-list
139157616|NCT06216197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139157617|NCT06216197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157618|NCT06216197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157619|NCT06216197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139157620|NCT06216197|Analgesics|analgesics|mesh-ancestor
139157621|NCT06216197|Sensory System Agents|sensory system agents|mesh-ancestor
139157622|NCT06216197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157623|NCT06216197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139157624|NCT06216197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139157625|NCT06216197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139157626|NCT06216197|Adrenergic Agents|adrenergic agents|mesh-ancestor
139157627|NCT06216197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157628|NCT06216197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157629|NCT06216197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139157630|NCT06216197|Narcotics|narcotics|mesh-ancestor
139157631|NCT06216197|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139157632|NCT06216197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139157633|NCT06216197|Anesthetics, General|anesthetics, general|mesh-ancestor
139157634|NCT06216197|Anesthetics|anesthetics|mesh-ancestor
139157635|NCT06216158|Dexamethasone|dexamethasone|mesh-list
139157636|NCT06216158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139157637|NCT06216158|Antiemetics|antiemetics|mesh-ancestor
139157638|NCT06216158|Autonomic Agents|autonomic agents|mesh-ancestor
139157639|NCT06216158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157640|NCT06216158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157641|NCT06216158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139157642|NCT06216158|Glucocorticoids|glucocorticoids|mesh-ancestor
139157643|NCT06216158|Hormones|hormones|mesh-ancestor
139157644|NCT06216158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138908144|NCT02620631|Analgesics|analgesics|mesh-ancestor
139157645|NCT06216158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139157646|NCT06216158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157647|NCT06216132|Naltrexone|naltrexone|mesh-list
139157648|NCT06216132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139157649|NCT06216132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139157650|NCT06216132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157651|NCT06216132|Sensory System Agents|sensory system agents|mesh-ancestor
139157652|NCT06216132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157653|NCT06215989|Colchicine|colchicine|mesh-list
139157654|NCT06215989|Gout Suppressants|gout suppressants|mesh-ancestor
139157655|NCT06215989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139157656|NCT06215989|Tubulin Modulators|tubulin modulators|mesh-ancestor
139157657|NCT06215989|Antimitotic Agents|antimitotic agents|mesh-ancestor
138886098|NCT03903406|Hormones|hormones|mesh-ancestor
139157667|NCT06215859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157668|NCT06215859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157670|NCT06215859|Sensory System Agents|sensory system agents|mesh-ancestor
139157671|NCT06215859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157682|NCT06215820|Tramadol|tramadol|mesh-list
139157683|NCT06215820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139157684|NCT06215820|Narcotics|narcotics|mesh-ancestor
139157685|NCT06215820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157686|NCT06215820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157687|NCT06215820|Analgesics|analgesics|mesh-ancestor
139157688|NCT06215820|Sensory System Agents|sensory system agents|mesh-ancestor
139157689|NCT06215820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157690|NCT06215768|Midazolam|midazolam|mesh-list
139157691|NCT06215768|Dexmedetomidine|dexmedetomidine|mesh-list
138496138|NCT00108979|Escitalopram|escitalopram|mesh-list
139157692|NCT06215768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139157693|NCT06215768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157694|NCT06215768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157695|NCT06215768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139157696|NCT06215768|Analgesics|analgesics|mesh-ancestor
139157697|NCT06215768|Sensory System Agents|sensory system agents|mesh-ancestor
139157698|NCT06215768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157699|NCT06215768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139157700|NCT06215768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139157701|NCT06215768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139157702|NCT06215768|Adrenergic Agents|adrenergic agents|mesh-ancestor
139157703|NCT06215768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157704|NCT06215768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157705|NCT06215768|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139157706|NCT06215768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139157707|NCT06215768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139157708|NCT06215768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139157709|NCT06215768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138886118|NCT00999271|Hormones|hormones|mesh-list
139157710|NCT06215768|Anesthetics, General|anesthetics, general|mesh-ancestor
139157711|NCT06215768|Anesthetics|anesthetics|mesh-ancestor
139157712|NCT06215768|GABA Modulators|gaba modulators|mesh-ancestor
139157713|NCT06215768|GABA Agents|gaba agents|mesh-ancestor
139157715|NCT06215651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157716|NCT06215651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139157717|NCT06215651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157718|NCT06215651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157719|NCT06215638|Bortezomib|bortezomib|mesh-list
139157720|NCT06215638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157721|NCT06215573|Melatonin|melatonin|mesh-list
139157722|NCT06215573|Antioxidants|antioxidants|mesh-ancestor
139157723|NCT06215573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157724|NCT06215573|Protective Agents|protective agents|mesh-ancestor
139157725|NCT06215573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157726|NCT06215573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157727|NCT06215521|Moxifloxacin|moxifloxacin|mesh-list
139157728|NCT06215521|Pirtobrutinib|pirtobrutinib|mesh-list
139157729|NCT06215521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139157730|NCT06215521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139157731|NCT06215521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139157732|NCT06215521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139157733|NCT06215521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157734|NCT06215521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157735|NCT06215521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157736|NCT06215521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139157737|NCT06215430|Caffeine|caffeine|mesh-list
139157738|NCT06215430|Omeprazole|omeprazole|mesh-list
139157739|NCT06215430|Warfarin|warfarin|mesh-list
139157740|NCT06215430|Pirtobrutinib|pirtobrutinib|mesh-list
139157741|NCT06215430|Anticoagulants|anticoagulants|mesh-ancestor
139157742|NCT06215430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139157743|NCT06215430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157744|NCT06215430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139157745|NCT06215430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157746|NCT06215430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157747|NCT06215430|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139157748|NCT06215430|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139157749|NCT06215430|Purinergic Agents|purinergic agents|mesh-ancestor
139157750|NCT06215430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157751|NCT06215430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139157752|NCT06215430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139157753|NCT06215430|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139157754|NCT06215430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139157755|NCT06215378|Heparin|heparin|mesh-list
139157756|NCT06215378|Protamines|protamines|mesh-list
139157757|NCT06215378|Anticoagulants|anticoagulants|mesh-ancestor
139157758|NCT06215378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139157759|NCT06215378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139157760|NCT06215378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157761|NCT06215378|Heparin Antagonists|heparin antagonists|mesh-ancestor
139157762|NCT06215378|Coagulants|coagulants|mesh-ancestor
139157763|NCT06214728|Hyaluronic Acid|hyaluronic acid|mesh-list
139157764|NCT06214728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139157765|NCT06214728|Immunologic Factors|immunologic factors|mesh-ancestor
139157766|NCT06214728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157767|NCT06214728|Viscosupplements|viscosupplements|mesh-ancestor
139157768|NCT06214728|Protective Agents|protective agents|mesh-ancestor
139157769|NCT06213896|Tropicamide|tropicamide|mesh-list
139157770|NCT06213896|Mydriatics|mydriatics|mesh-list
139157771|NCT06213896|Autonomic Agents|autonomic agents|mesh-ancestor
139157772|NCT06213896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157773|NCT06213896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157774|NCT06213896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139157775|NCT06213896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139157776|NCT06213896|Cholinergic Agents|cholinergic agents|mesh-ancestor
139157777|NCT06213896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157778|NCT06213896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157779|NCT06213649|Biguanides|biguanides|mesh-list
139157780|NCT06213649|Polihexanide|polihexanide|mesh-list
139157781|NCT06213649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139157782|NCT06213649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157783|NCT06213649|Disinfectants|disinfectants|mesh-ancestor
139157784|NCT06213649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139157785|NCT06211283|Valproic Acid|valproic acid|mesh-list
139157786|NCT06211283|Anticonvulsants|anticonvulsants|mesh-ancestor
139157787|NCT06211283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157788|NCT06211283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157789|NCT06211283|GABA Agents|gaba agents|mesh-ancestor
139157790|NCT06211283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157791|NCT06211283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157792|NCT06211283|Antimanic Agents|antimanic agents|mesh-ancestor
139157793|NCT06211283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139157794|NCT06211283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157795|NCT06211283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139157796|NCT06206291|Cannabidiol|cannabidiol|mesh-list
139157797|NCT06206291|Anticonvulsants|anticonvulsants|mesh-ancestor
139157798|NCT06203912|Dexamethasone|dexamethasone|mesh-list
139157799|NCT06203912|Dexamethasone acetate|dexamethasone acetate|mesh-list
139157800|NCT06203912|Cyclophosphamide|cyclophosphamide|mesh-list
139157801|NCT06203912|Ichthammol|ichthammol|mesh-list
139157802|NCT06203912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139157803|NCT06203912|BB 1101|bb 1101|mesh-list
139157804|NCT06203912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139157805|NCT06203912|Immunologic Factors|immunologic factors|mesh-ancestor
139157806|NCT06203912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157807|NCT06203912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139157808|NCT06203912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139157809|NCT06203912|Alkylating Agents|alkylating agents|mesh-ancestor
139157810|NCT06203912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157811|NCT06203912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157812|NCT06203912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139157813|NCT06203912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139157814|NCT06203912|Antiemetics|antiemetics|mesh-ancestor
139157815|NCT06203912|Autonomic Agents|autonomic agents|mesh-ancestor
139019572|NCT04278404|Coagulants|coagulants|mesh-ancestor
139157816|NCT06203912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157817|NCT06203912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139157819|NCT06203912|Hormones|hormones|mesh-ancestor
139157820|NCT06203912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139157821|NCT06203912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139157822|NCT06203912|Protease Inhibitors|protease inhibitors|mesh-ancestor
139157823|NCT06203912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157824|NCT06203912|Dermatologic Agents|dermatologic agents|mesh-ancestor
139157825|NCT06192888|Lenalidomide|lenalidomide|mesh-list
139157826|NCT06192888|Obinutuzumab|obinutuzumab|mesh-list
139157827|NCT06192888|Immunologic Factors|immunologic factors|mesh-ancestor
139157828|NCT06192888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157829|NCT06192888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139157830|NCT06192888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139157831|NCT06192888|Growth Substances|growth substances|mesh-ancestor
139157832|NCT06192888|Growth Inhibitors|growth inhibitors|mesh-ancestor
139157833|NCT06192888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157834|NCT06192888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157835|NCT06128590|Epinephrine|epinephrine|mesh-list
139157836|NCT06128590|Anesthetics|anesthetics|mesh-list
139157837|NCT06128590|Mepivacaine|mepivacaine|mesh-list
139157838|NCT06128590|Anesthetics, Local|anesthetics, local|mesh-list
139157839|NCT06128590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157840|NCT06128590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157841|NCT06128590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139157842|NCT06128590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139157843|NCT06128590|Adrenergic Agents|adrenergic agents|mesh-ancestor
139157844|NCT06128590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139157845|NCT06128590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157846|NCT06128590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139157847|NCT06128590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139157848|NCT06128590|Autonomic Agents|autonomic agents|mesh-ancestor
139157849|NCT06128590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157850|NCT06128590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139157851|NCT06128590|Respiratory System Agents|respiratory system agents|mesh-ancestor
139157852|NCT06128590|Mydriatics|mydriatics|mesh-ancestor
139157853|NCT06128590|Sympathomimetics|sympathomimetics|mesh-ancestor
139157854|NCT06128590|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139157855|NCT06128590|Sensory System Agents|sensory system agents|mesh-ancestor
139157856|NCT06120075|Docetaxel|docetaxel|mesh-list
139157857|NCT06120075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157858|NCT06120075|Tubulin Modulators|tubulin modulators|mesh-ancestor
139157859|NCT06120075|Antimitotic Agents|antimitotic agents|mesh-ancestor
139157860|NCT06120075|Mitosis Modulators|mitosis modulators|mesh-ancestor
139157861|NCT06120075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157862|NCT06097364|Prednisone|prednisone|mesh-list
139157863|NCT06097364|Cyclophosphamide|cyclophosphamide|mesh-list
139157864|NCT06097364|Rituximab|rituximab|mesh-list
139157865|NCT06097364|Doxorubicin|doxorubicin|mesh-list
139157866|NCT06097364|Vincristine|vincristine|mesh-list
139157867|NCT06097364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139157868|NCT06097364|Immunologic Factors|immunologic factors|mesh-ancestor
139157869|NCT06097364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157870|NCT06097364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139157871|NCT06097364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138908366|NCT00814632|Apremilast|apremilast|mesh-list
139157872|NCT06097364|Alkylating Agents|alkylating agents|mesh-ancestor
139157873|NCT06097364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157874|NCT06097364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157875|NCT06097364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139157876|NCT06097364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157877|NCT06097364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139157878|NCT06097364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139157879|NCT06097364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139157880|NCT06097364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157881|NCT06097364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139157882|NCT06097364|Glucocorticoids|glucocorticoids|mesh-ancestor
139157883|NCT06097364|Hormones|hormones|mesh-ancestor
139157884|NCT06097364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139157885|NCT06097364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139157886|NCT06097364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139157887|NCT06097364|Tubulin Modulators|tubulin modulators|mesh-ancestor
139157888|NCT06097364|Antimitotic Agents|antimitotic agents|mesh-ancestor
138886169|NCT00994513|Vitamins|vitamins|mesh-ancestor
139157889|NCT06097364|Mitosis Modulators|mitosis modulators|mesh-ancestor
139157890|NCT06093191|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139157891|NCT06093191|Ciprofloxacin|ciprofloxacin|mesh-list
139157893|NCT06093191|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139157894|NCT06093191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139157895|NCT06093191|Antitubercular Agents|antitubercular agents|mesh-ancestor
139157896|NCT06093191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139157897|NCT06093191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139157898|NCT06093191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157899|NCT06093191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157900|NCT06093191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157901|NCT06093191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139157902|NCT06093191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139157903|NCT06091254|Prednisone|prednisone|mesh-list
139157904|NCT06091254|Prednisolone|prednisolone|mesh-list
139157905|NCT06091254|Cyclophosphamide|cyclophosphamide|mesh-list
139157906|NCT06091254|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139157907|NCT06091254|Rituximab|rituximab|mesh-list
139157908|NCT06091254|Doxorubicin|doxorubicin|mesh-list
139157909|NCT06091254|Vincristine|vincristine|mesh-list
139157910|NCT06091254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139157911|NCT06091254|Immunologic Factors|immunologic factors|mesh-ancestor
139157912|NCT06091254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157913|NCT06091254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139157914|NCT06091254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139157915|NCT06091254|Alkylating Agents|alkylating agents|mesh-ancestor
138890424|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157916|NCT06091254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157917|NCT06091254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157918|NCT06091254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139157919|NCT06091254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157920|NCT06091254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139157921|NCT06091254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139157922|NCT06091254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139157923|NCT06091254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157924|NCT06091254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139157925|NCT06091254|Glucocorticoids|glucocorticoids|mesh-ancestor
139157926|NCT06091254|Hormones|hormones|mesh-ancestor
139157927|NCT06091254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139157928|NCT06091254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139157929|NCT06091254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139157930|NCT06091254|Tubulin Modulators|tubulin modulators|mesh-ancestor
139157931|NCT06091254|Antimitotic Agents|antimitotic agents|mesh-ancestor
139157932|NCT06091254|Mitosis Modulators|mitosis modulators|mesh-ancestor
139157933|NCT06088732|Ibuprofen|ibuprofen|mesh-list
139157934|NCT06088732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139157935|NCT06088732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139157936|NCT06088732|Analgesics|analgesics|mesh-ancestor
139157937|NCT06088732|Sensory System Agents|sensory system agents|mesh-ancestor
139157938|NCT06088732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157939|NCT06088732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157940|NCT06088732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139157941|NCT06088732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139157942|NCT06088732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139157943|NCT06088732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139157944|NCT06088732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157945|NCT06077760|Pembrolizumab|pembrolizumab|mesh-list
139157946|NCT06077760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157947|NCT06077760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157948|NCT06077760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138908447|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
139157949|NCT06077760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157950|NCT06069791|Bupivacaine|bupivacaine|mesh-list
139157951|NCT06069791|Anesthetics, Local|anesthetics, local|mesh-ancestor
139157952|NCT06069791|Anesthetics|anesthetics|mesh-ancestor
139157953|NCT06069791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139157954|NCT06069791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157955|NCT06069791|Sensory System Agents|sensory system agents|mesh-ancestor
139157956|NCT06069791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157957|NCT06062420|Dostarlimab|dostarlimab|mesh-list
139157958|NCT06062420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157959|NCT06049212|Carboplatin|carboplatin|mesh-list
139157960|NCT06049212|Pembrolizumab|pembrolizumab|mesh-list
139157961|NCT06049212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157962|NCT06049212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157963|NCT06049212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139157964|NCT06049212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157965|NCT06038539|Carboplatin|carboplatin|mesh-list
139157967|NCT06038539|Trastuzumab|trastuzumab|mesh-list
139157968|NCT06038539|Pertuzumab|pertuzumab|mesh-list
138890482|NCT00615875|Naproxen|naproxen|mesh-list
139157969|NCT06038539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157970|NCT06038539|Tubulin Modulators|tubulin modulators|mesh-ancestor
139157971|NCT06038539|Antimitotic Agents|antimitotic agents|mesh-ancestor
139157972|NCT06038539|Mitosis Modulators|mitosis modulators|mesh-ancestor
139157973|NCT06038539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157974|NCT06038539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157975|NCT06023706|Capsaicin|capsaicin|mesh-list
139157976|NCT06023706|Antipruritics|antipruritics|mesh-ancestor
139157977|NCT06023706|Dermatologic Agents|dermatologic agents|mesh-ancestor
139157978|NCT06023706|Sensory System Agents|sensory system agents|mesh-ancestor
139157979|NCT06023706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139157980|NCT06023706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157981|NCT06016270|Paclitaxel|paclitaxel|mesh-list
139157982|NCT06016270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139157983|NCT06016270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139157984|NCT06016270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157985|NCT06016270|Tubulin Modulators|tubulin modulators|mesh-ancestor
139157986|NCT06016270|Antimitotic Agents|antimitotic agents|mesh-ancestor
139157987|NCT06016270|Mitosis Modulators|mitosis modulators|mesh-ancestor
139157988|NCT06016270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157989|NCT06016088|Tobramycin|tobramycin|mesh-list
139157990|NCT06016088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139157991|NCT06016088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139157992|NCT05958303|Antioxidants|antioxidants|mesh-list
139157993|NCT05958303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139157994|NCT05958303|Protective Agents|protective agents|mesh-ancestor
139157995|NCT05958303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139157996|NCT05909995|Ipilimumab|ipilimumab|mesh-list
139157997|NCT05909995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139157998|NCT05909995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139157999|NCT05909995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138886207|NCT04426240|Cyclosporine|cyclosporine|mesh-list
139158038|NCT05809830|LB100|lb100|mesh-list
139158039|NCT05809830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139158040|NCT05809830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158041|NCT05809830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139158042|NCT05809830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139158047|NCT05803382|Antimetabolites|antimetabolites|mesh-ancestor
139158048|NCT05803382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158049|NCT05803382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158054|NCT05705349|Islatravir|islatravir|mesh-list
139158055|NCT05705349|Antiviral Agents|antiviral agents|mesh-ancestor
139158056|NCT05705349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158057|NCT05705349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158058|NCT05705349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158059|NCT05705349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139158060|NCT05705349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139158061|NCT05705349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139158062|NCT05696626|Fulvestrant|fulvestrant|mesh-list
139158063|NCT05696626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139158064|NCT05696626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158065|NCT05696626|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139158066|NCT05696626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139158067|NCT05696626|Hormone Antagonists|hormone antagonists|mesh-ancestor
139158068|NCT05696626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139158069|NCT05696626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158070|NCT05687058|Empagliflozin|empagliflozin|mesh-list
139158071|NCT05687058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139158072|NCT05687058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158073|NCT05687058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139158074|NCT05687058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158075|NCT05646316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139158076|NCT05625724|Aspirin|aspirin|mesh-list
139158077|NCT05625724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139158078|NCT05625724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139158079|NCT05625724|Analgesics|analgesics|mesh-ancestor
139158080|NCT05625724|Sensory System Agents|sensory system agents|mesh-ancestor
139158081|NCT05625724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139158082|NCT05625724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158083|NCT05625724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139158084|NCT05625724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139158085|NCT05625724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139158086|NCT05625724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139158087|NCT05625724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158088|NCT05625724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139158089|NCT05625724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139158090|NCT05625724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158091|NCT05625724|Antipyretics|antipyretics|mesh-ancestor
139158092|NCT05612594|Ertugliflozin|ertugliflozin|mesh-list
139158093|NCT05612594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139158094|NCT05612594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158095|NCT05612594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139158096|NCT05612594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158097|NCT05607550|Aflutinib|aflutinib|mesh-list
139158098|NCT05607550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138886266|NCT00866307|BB 1101|bb 1101|mesh-list
139158106|NCT05605639|Sensory System Agents|sensory system agents|mesh-ancestor
139158107|NCT05605639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139158117|NCT05600426|Cyclophosphamide|cyclophosphamide|mesh-list
139158118|NCT05600426|Methotrexate|methotrexate|mesh-list
139158119|NCT05600426|Fludarabine|fludarabine|mesh-list
139158120|NCT05600426|Cyclosporins|cyclosporins|mesh-list
139158121|NCT05600426|Thymoglobulin|thymoglobulin|mesh-list
139158122|NCT05600426|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139158123|NCT05600426|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139158124|NCT05600426|Immunologic Factors|immunologic factors|mesh-ancestor
139158125|NCT05600426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158126|NCT05600426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139158127|NCT05600426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139158128|NCT05600426|Alkylating Agents|alkylating agents|mesh-ancestor
139158129|NCT05600426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158130|NCT05600426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158131|NCT05600426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139158132|NCT05600426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139158133|NCT05600426|Abortifacient Agents|abortifacient agents|mesh-ancestor
139158134|NCT05600426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139158135|NCT05600426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139158136|NCT05600426|Antimetabolites|antimetabolites|mesh-ancestor
139158137|NCT05600426|Dermatologic Agents|dermatologic agents|mesh-ancestor
139158138|NCT05600426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158139|NCT05600426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139158140|NCT05600426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139158141|NCT05600426|Antifungal Agents|antifungal agents|mesh-ancestor
139158142|NCT05600426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158143|NCT05600426|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139158144|NCT05592418|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
139158145|NCT05592418|Poly I-C|poly i-c|mesh-list
139158146|NCT05592418|Antiviral Agents|antiviral agents|mesh-ancestor
139158147|NCT05592418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158148|NCT05592418|Interferon Inducers|interferon inducers|mesh-ancestor
139158149|NCT05592418|Immunologic Factors|immunologic factors|mesh-ancestor
139158150|NCT05592418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158151|NCT05591677|Cycloserine|cycloserine|mesh-list
139158152|NCT05591677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139158153|NCT05591677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158154|NCT05591677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139158155|NCT05591677|Antitubercular Agents|antitubercular agents|mesh-ancestor
139158156|NCT05591677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139158157|NCT05591677|Antimetabolites|antimetabolites|mesh-ancestor
139158158|NCT05591677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886283|NCT00866307|Hormones|hormones|mesh-ancestor
139158161|NCT05591339|Immunologic Factors|immunologic factors|mesh-ancestor
139158162|NCT05591339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158207|NCT05556616|Lenalidomide|lenalidomide|mesh-list
139158208|NCT05556616|Pomalidomide|pomalidomide|mesh-list
139158210|NCT05556616|Daratumumab|daratumumab|mesh-list
139158211|NCT05556616|Immunologic Factors|immunologic factors|mesh-ancestor
139158212|NCT05556616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158213|NCT05556616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139158214|NCT05556616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139158215|NCT05556616|Growth Substances|growth substances|mesh-ancestor
139158216|NCT05556616|Growth Inhibitors|growth inhibitors|mesh-ancestor
139158217|NCT05556616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158218|NCT05554341|Paclitaxel|paclitaxel|mesh-list
139158219|NCT05554341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139158220|NCT05554341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139158221|NCT05554341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158222|NCT05554341|Tubulin Modulators|tubulin modulators|mesh-ancestor
139158223|NCT05554341|Antimitotic Agents|antimitotic agents|mesh-ancestor
139158224|NCT05554341|Mitosis Modulators|mitosis modulators|mesh-ancestor
139158225|NCT05554341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158226|NCT05552508|Benralizumab|benralizumab|mesh-list
139158227|NCT05552508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139158228|NCT05552508|Respiratory System Agents|respiratory system agents|mesh-ancestor
139158229|NCT05549505|Anastrozole|anastrozole|mesh-list
139158230|NCT05549505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139158231|NCT05549505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158232|NCT05549505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139158233|NCT05549505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139158234|NCT05549505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158235|NCT05549505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158236|NCT05549505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139158237|NCT05549505|Hormone Antagonists|hormone antagonists|mesh-ancestor
139158238|NCT05549505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139158239|NCT05549505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158240|NCT05542381|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139158241|NCT05542381|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139158242|NCT05542381|Lubricant Eye Drops|lubricant eye drops|mesh-list
139158243|NCT05542381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139158244|NCT05542381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139158245|NCT05542147|Fenofibrate|fenofibrate|mesh-list
139158246|NCT05542147|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139158247|NCT05542147|Antimetabolites|antimetabolites|mesh-ancestor
139158248|NCT05542147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158249|NCT05542147|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139158250|NCT05504291|Carboplatin|carboplatin|mesh-list
139158251|NCT05504291|Etoposide|etoposide|mesh-list
139158252|NCT05504291|Vincristine|vincristine|mesh-list
139158253|NCT05504291|Etoposide phosphate|etoposide phosphate|mesh-list
139158254|NCT05504291|Melphalan|melphalan|mesh-list
139158255|NCT05504291|Mechlorethamine|mechlorethamine|mesh-list
139158256|NCT05504291|Podophyllotoxin|podophyllotoxin|mesh-list
139158257|NCT05504291|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139158258|NCT05504291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158259|NCT05504291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158260|NCT05504291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139158261|NCT05504291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139158262|NCT05504291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139158263|NCT05504291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158264|NCT05504291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158265|NCT05504291|Tubulin Modulators|tubulin modulators|mesh-ancestor
139158266|NCT05504291|Antimitotic Agents|antimitotic agents|mesh-ancestor
139158267|NCT05504291|Mitosis Modulators|mitosis modulators|mesh-ancestor
139158268|NCT05504291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139158269|NCT05504291|Alkylating Agents|alkylating agents|mesh-ancestor
138890566|NCT00666770|Gabapentin|gabapentin|mesh-list
139158270|NCT05504291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139158271|NCT05504291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158272|NCT05504291|Immunologic Factors|immunologic factors|mesh-ancestor
139158273|NCT05504291|Keratolytic Agents|keratolytic agents|mesh-ancestor
139158274|NCT05504291|Dermatologic Agents|dermatologic agents|mesh-ancestor
139158275|NCT05501769|Everolimus|everolimus|mesh-list
139158276|NCT05501769|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139158277|NCT05501769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139158278|NCT05501769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158279|NCT05501769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158280|NCT05501769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158281|NCT05501769|Immunologic Factors|immunologic factors|mesh-ancestor
139158282|NCT05501769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158283|NCT05501769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158284|NCT05480306|Bevacizumab|bevacizumab|mesh-list
139158285|NCT05480306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158286|NCT05480306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158287|NCT05480306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139158288|NCT05480306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139158289|NCT05480306|Growth Substances|growth substances|mesh-ancestor
139158290|NCT05480306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158291|NCT05480306|Growth Inhibitors|growth inhibitors|mesh-ancestor
139158292|NCT05457556|Mycophenolic Acid|mycophenolic acid|mesh-list
139158293|NCT05457556|Cyclophosphamide|cyclophosphamide|mesh-list
139158294|NCT05457556|Melphalan|melphalan|mesh-list
139158295|NCT05457556|Busulfan|busulfan|mesh-list
139158296|NCT05457556|Mechlorethamine|mechlorethamine|mesh-list
139158297|NCT05457556|Thiotepa|thiotepa|mesh-list
139158298|NCT05457556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139158299|NCT05457556|Rituximab|rituximab|mesh-list
139158300|NCT05457556|Methotrexate|methotrexate|mesh-list
139158301|NCT05457556|Fludarabine|fludarabine|mesh-list
139158302|NCT05457556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139158303|NCT05457556|Tacrolimus|tacrolimus|mesh-list
139158304|NCT05457556|Thymoglobulin|thymoglobulin|mesh-list
139158305|NCT05457556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139158306|NCT05457556|Antibodies|antibodies|mesh-list
139158307|NCT05457556|Immunoglobulins|immunoglobulins|mesh-list
139158308|NCT05457556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139158309|NCT05457556|gamma-Globulins|gamma-globulins|mesh-list
139158310|NCT05457556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139158311|NCT05457556|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139158312|NCT05457556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158313|NCT05457556|Immunologic Factors|immunologic factors|mesh-ancestor
139158314|NCT05457556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158315|NCT05457556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139158316|NCT05457556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139158317|NCT05457556|Alkylating Agents|alkylating agents|mesh-ancestor
138890596|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158318|NCT05457556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158319|NCT05457556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158320|NCT05457556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139158321|NCT05457556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139158322|NCT05457556|Abortifacient Agents|abortifacient agents|mesh-ancestor
139158323|NCT05457556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139158324|NCT05457556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139158325|NCT05457556|Antimetabolites|antimetabolites|mesh-ancestor
139158326|NCT05457556|Dermatologic Agents|dermatologic agents|mesh-ancestor
139158327|NCT05457556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158328|NCT05457556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139158329|NCT05457556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139158330|NCT05457556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139158331|NCT05457556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139158332|NCT05457556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139158333|NCT05457556|Antitubercular Agents|antitubercular agents|mesh-ancestor
139158334|NCT05457556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139158335|NCT05457556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158336|NCT05425940|Atezolizumab|atezolizumab|mesh-list
139158337|NCT05425940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139158338|NCT05425940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158339|NCT05425940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158340|NCT05425940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158341|NCT05396742|Ravulizumab|ravulizumab|mesh-list
139158342|NCT05396742|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139158343|NCT05396742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158344|NCT05396742|Immunologic Factors|immunologic factors|mesh-ancestor
139158345|NCT05396742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158346|NCT05382338|Sodium thiosulfate|sodium thiosulfate|mesh-list
139158347|NCT05382338|Cyclophosphamide|cyclophosphamide|mesh-list
139158348|NCT05382338|Lomustine|lomustine|mesh-list
139158349|NCT05382338|Cisplatin|cisplatin|mesh-list
139158350|NCT05382338|Vincristine|vincristine|mesh-list
139158351|NCT05382338|Mesna|mesna|mesh-list
139158352|NCT05382338|Antidotes|antidotes|mesh-list
139158353|NCT05382338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158354|NCT05382338|Immunologic Factors|immunologic factors|mesh-ancestor
138890625|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139158355|NCT05382338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158356|NCT05382338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139158357|NCT05382338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139158358|NCT05382338|Alkylating Agents|alkylating agents|mesh-ancestor
139158359|NCT05382338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158360|NCT05382338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158361|NCT05382338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139158362|NCT05382338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139158363|NCT05382338|Tubulin Modulators|tubulin modulators|mesh-ancestor
139158364|NCT05382338|Antimitotic Agents|antimitotic agents|mesh-ancestor
139158365|NCT05382338|Mitosis Modulators|mitosis modulators|mesh-ancestor
139158366|NCT05382338|Protective Agents|protective agents|mesh-ancestor
139158367|NCT05382338|Antioxidants|antioxidants|mesh-ancestor
139158368|NCT05382338|Antitubercular Agents|antitubercular agents|mesh-ancestor
139158369|NCT05382338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139158370|NCT05382338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158371|NCT05382338|Chelating Agents|chelating agents|mesh-ancestor
139158372|NCT05382338|Sequestering Agents|sequestering agents|mesh-ancestor
139158373|NCT05380934|Methotrexate|methotrexate|mesh-list
139158374|NCT05380934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139158375|NCT05380934|Abortifacient Agents|abortifacient agents|mesh-ancestor
139158376|NCT05380934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139158377|NCT05380934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886330|NCT00531427|Buprenorphine|buprenorphine|mesh-list
139158378|NCT05380934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139158379|NCT05380934|Antimetabolites|antimetabolites|mesh-ancestor
139158380|NCT05380934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158381|NCT05380934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158382|NCT05380934|Dermatologic Agents|dermatologic agents|mesh-ancestor
139158383|NCT05380934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158384|NCT05380934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139158385|NCT05380934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158386|NCT05380934|Immunologic Factors|immunologic factors|mesh-ancestor
139158387|NCT05380934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139158388|NCT05380934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139158389|NCT05362058|Insulin|insulin|mesh-list
139158390|NCT05362058|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139158391|NCT05362058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139158392|NCT05362058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158393|NCT05312970|Polidocanol|polidocanol|mesh-list
139158394|NCT05312970|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
139158395|NCT05312970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139158396|NCT05304585|Dactinomycin|dactinomycin|mesh-list
139158397|NCT05304585|Cactinomycin|cactinomycin|mesh-list
139158398|NCT05304585|Cyclophosphamide|cyclophosphamide|mesh-list
139158399|NCT05304585|Vincristine|vincristine|mesh-list
139158400|NCT05304585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158401|NCT05304585|Immunologic Factors|immunologic factors|mesh-ancestor
139158402|NCT05304585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158403|NCT05304585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139158404|NCT05304585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139158405|NCT05304585|Alkylating Agents|alkylating agents|mesh-ancestor
139158406|NCT05304585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158407|NCT05304585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158408|NCT05304585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139158409|NCT05304585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139158410|NCT05304585|Tubulin Modulators|tubulin modulators|mesh-ancestor
139158411|NCT05304585|Antimitotic Agents|antimitotic agents|mesh-ancestor
138890708|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
139158412|NCT05304585|Mitosis Modulators|mitosis modulators|mesh-ancestor
139158413|NCT05304585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139158414|NCT05304585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158415|NCT05304585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139158416|NCT05304585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139158417|NCT05304585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158418|NCT05304585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139158419|NCT05302817|Xenon|xenon|mesh-list
139158420|NCT05302817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139158421|NCT05302817|Anesthetics, General|anesthetics, general|mesh-ancestor
139158422|NCT05302817|Anesthetics|anesthetics|mesh-ancestor
139158423|NCT05302817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139158424|NCT05302817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158425|NCT05286827|Olaparib|olaparib|mesh-list
139158426|NCT05286827|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139158427|NCT05286827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019573|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139158428|NCT05286827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158438|NCT05227677|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139158439|NCT05227677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158440|NCT05185947|Paclitaxel|paclitaxel|mesh-list
139158441|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139158442|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158443|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
139158444|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
139158445|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
139158446|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158447|NCT05178745|Fluorouracil|fluorouracil|mesh-list
139158448|NCT05178745|Irinotecan|irinotecan|mesh-list
139158449|NCT05178745|Aflibercept|aflibercept|mesh-list
139158450|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
139158451|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158452|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139158453|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158454|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158455|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
139158456|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158457|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139158458|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139158459|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158460|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139158461|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139158462|NCT05178745|Growth Substances|growth substances|mesh-ancestor
139158463|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
139158464|NCT05162131|Ticagrelor|ticagrelor|mesh-list
139158465|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139158466|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139158467|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139158468|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139158469|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
139158470|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139158471|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158472|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158473|NCT05108688|Sumatriptan|sumatriptan|mesh-list
139158474|NCT05108688|Mirtazapine|mirtazapine|mesh-list
139158475|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139158476|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139158477|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139158478|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
139158479|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139158480|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158481|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158482|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
139158483|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139158484|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139158485|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
139158486|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
139158487|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139158488|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139158489|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139158490|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139158491|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139158492|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139158493|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
139158494|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139158495|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139158496|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139158497|NCT05079841|Oxytocin|oxytocin|mesh-list
139158498|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
139158499|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139158500|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158502|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139158503|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139158504|NCT05074056|Analgesics|analgesics|mesh-ancestor
139158505|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
139158506|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139158507|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158508|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139158509|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139158510|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139158511|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886354|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158512|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158513|NCT05071183|Trametinib|trametinib|mesh-list
139158514|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158515|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139158516|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158517|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158518|NCT05047172|Aspirin|aspirin|mesh-list
139158519|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
139158520|NCT05047172|Clopidogrel|clopidogrel|mesh-list
139158521|NCT05047172|Ticagrelor|ticagrelor|mesh-list
139158522|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139158523|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139158524|NCT05047172|Analgesics|analgesics|mesh-ancestor
139158525|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
139158526|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139158527|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158528|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139158529|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139158530|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139158531|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139158532|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158533|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139158534|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139158535|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158536|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
139158537|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139158538|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139158539|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139158540|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
139158541|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139158542|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139158543|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
139158544|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139158545|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
139158546|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
139158547|NCT05007106|Docetaxel|docetaxel|mesh-list
139158548|NCT05007106|Bevacizumab|bevacizumab|mesh-list
139158549|NCT05007106|Carboplatin|carboplatin|mesh-list
139158550|NCT05007106|Gemcitabine|gemcitabine|mesh-list
139158551|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
139158552|NCT05007106|Capecitabine|capecitabine|mesh-list
139158553|NCT05007106|Fluorouracil|fluorouracil|mesh-list
138909037|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
139158554|NCT05007106|Oxaliplatin|oxaliplatin|mesh-list
139158555|NCT05007106|Lenvatinib|lenvatinib|mesh-list
139158556|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954448|NCT00333775|Bevacizumab|bevacizumab|mesh-list
139158557|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
139158558|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
139158559|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
139158560|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158561|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158562|NCT05007106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139158563|NCT05007106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139158564|NCT05007106|Growth Substances|growth substances|mesh-ancestor
139158565|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158566|NCT05007106|Growth Inhibitors|growth inhibitors|mesh-ancestor
139158567|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139158568|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
139158569|NCT05007106|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139158570|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158571|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
139158572|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139158573|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158574|NCT04994132|Dactinomycin|dactinomycin|mesh-list
139158575|NCT04994132|Cactinomycin|cactinomycin|mesh-list
139158576|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
139158577|NCT04994132|Vincristine|vincristine|mesh-list
139158578|NCT04994132|Vinorelbine|vinorelbine|mesh-list
139158579|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158580|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
139158581|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158582|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139158583|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139158584|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
139158585|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158586|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158587|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139158588|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139158589|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
139158590|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
139158591|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
139158592|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139158593|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158594|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139158595|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139158596|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158597|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139158598|NCT04990128|Triamcinolone|triamcinolone|mesh-list
139158599|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139158600|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
139158601|NCT04990128|Hormones|hormones|mesh-ancestor
139158602|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139158603|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158604|NCT04987931|Talazoparib|talazoparib|mesh-list
139158605|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139158606|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158607|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158608|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158609|NCT04981509|Listerine|listerine|mesh-list
139158610|NCT04981509|Bevacizumab|bevacizumab|mesh-list
139158611|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139158612|NCT04981509|Atezolizumab|atezolizumab|mesh-list
139158613|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
139158614|NCT04981509|Antibodies|antibodies|mesh-list
139158615|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
139158616|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139158617|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
139158618|NCT04981509|Fluorides|fluorides|mesh-list
139158620|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158621|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139158622|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139158623|NCT04981509|Growth Substances|growth substances|mesh-ancestor
139158624|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158625|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
139158626|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
139158627|NCT04981509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158628|NCT04981509|Cariostatic Agents|cariostatic agents|mesh-ancestor
139158629|NCT04981509|Protective Agents|protective agents|mesh-ancestor
139158630|NCT04981509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138890982|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
139158631|NCT04981509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139158632|NCT04981509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158633|NCT04980482|Interferons|interferons|mesh-list
139158634|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
139158635|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
139158636|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139158637|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158638|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
139158639|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158640|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
139158641|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158642|NCT04969263|Vaccines|vaccines|mesh-list
139158643|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
139158644|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158645|NCT04964063|Listerine|listerine|mesh-list
139158646|NCT04964063|Fluorides|fluorides|mesh-list
139158647|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
139158648|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
139158649|NCT04964063|Protective Agents|protective agents|mesh-ancestor
139158650|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158651|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139158652|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158653|NCT04959812|Sufentanil|sufentanil|mesh-list
139158654|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139158655|NCT04959812|Narcotics|narcotics|mesh-ancestor
139158656|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139158657|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158658|NCT04959812|Analgesics|analgesics|mesh-ancestor
139158659|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
139158660|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139158661|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139158662|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139158663|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
139158664|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
139158665|NCT04919395|Etonogestrel|etonogestrel|mesh-list
139158666|NCT04919395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139158667|NCT04919395|Contraceptive Agents|contraceptive agents|mesh-ancestor
139158668|NCT04919395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139158669|NCT04919395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158670|NCT04919395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139158671|NCT04914390|Paclitaxel|paclitaxel|mesh-list
139158672|NCT04914390|Tislelizumab|tislelizumab|mesh-list
139158673|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139158674|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158675|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
139158676|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
139158677|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
139158678|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158679|NCT04914390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158680|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
139158681|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139158682|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158683|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139158684|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158685|NCT04847453|Dexamethasone|dexamethasone|mesh-list
139158686|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
139158688|NCT04847453|Ixazomib|ixazomib|mesh-list
139158689|NCT04847453|Ichthammol|ichthammol|mesh-list
139158690|NCT04847453|BB 1101|bb 1101|mesh-list
139158691|NCT04847453|Glycine|glycine|mesh-list
139158692|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139158693|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
139158694|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
139158695|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139158696|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158697|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139158698|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
139158699|NCT04847453|Hormones|hormones|mesh-ancestor
139158700|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139158701|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139158702|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158703|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
139158704|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158705|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158706|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
139158707|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
139158708|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139158710|NCT04835805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138891045|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
139158711|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158712|NCT04835805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139158713|NCT04835805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158714|NCT04765059|Cisplatin|cisplatin|mesh-list
139158715|NCT04765059|Carboplatin|carboplatin|mesh-list
139158716|NCT04765059|Pemetrexed|pemetrexed|mesh-list
139158717|NCT04765059|Osimertinib|osimertinib|mesh-list
139158718|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158719|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158720|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158721|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139158722|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139158723|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139158724|NCT04744831|Camptothecin|camptothecin|mesh-list
139158725|NCT04744831|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139158726|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
139158727|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
139158728|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158729|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139158730|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158731|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139158732|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139158733|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158734|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158735|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
139158736|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139158737|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139158738|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158739|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
139158740|NCT04742205|Coagulants|coagulants|mesh-ancestor
139158741|NCT04724447|Valganciclovir|valganciclovir|mesh-list
139158742|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
139158743|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158744|NCT04712097|Rituximab|rituximab|mesh-list
139158745|NCT04712097|Lenalidomide|lenalidomide|mesh-list
139158746|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158747|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891079|NCT01009567|Cabergoline|cabergoline|mesh-list
139158748|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
139158749|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158750|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139158751|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139158752|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139158753|NCT04712097|Growth Substances|growth substances|mesh-ancestor
139158754|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
139158755|NCT04684368|Carboplatin|carboplatin|mesh-list
139158756|NCT04684368|Etoposide|etoposide|mesh-list
139158757|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
139158758|NCT04684368|Ifosfamide|ifosfamide|mesh-list
139158759|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
139158760|NCT04684368|Thiotepa|thiotepa|mesh-list
139158761|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
139158762|NCT04684368|Lenograstim|lenograstim|mesh-list
139158763|NCT04684368|Mesna|mesna|mesh-list
139158764|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158765|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139158766|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139158767|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139158768|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158769|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158770|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139158771|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
139158772|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158773|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139158774|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
139158775|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158776|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139158777|NCT04684368|Protective Agents|protective agents|mesh-ancestor
139158778|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
139158779|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
139158780|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
139158781|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
138909263|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139158782|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
139158783|NCT04678479|Ganaxolone|ganaxolone|mesh-list
139158784|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
139158786|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158787|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158788|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
139158789|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
139158790|NCT04671667|Cisplatin|cisplatin|mesh-list
139158791|NCT04671667|Carboplatin|carboplatin|mesh-list
139158792|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
139158793|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158794|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158795|NCT04671667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139158796|NCT04671667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158797|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
139158798|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
139158799|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
138886444|NCT02712671|Interferons|interferons|mesh-list
139158800|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158801|NCT04662710|Leucovorin|leucovorin|mesh-list
139158802|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
139158803|NCT04662710|Capecitabine|capecitabine|mesh-list
139158804|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
139158805|NCT04662710|Lenvatinib|lenvatinib|mesh-list
139158806|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
139158807|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158808|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158809|NCT04662710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139158810|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158811|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139158812|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
139158813|NCT04662710|Antidotes|antidotes|mesh-ancestor
139158814|NCT04662710|Protective Agents|protective agents|mesh-ancestor
139158815|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158816|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
139158817|NCT04662710|Vitamins|vitamins|mesh-ancestor
139158818|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
139158819|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139158820|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158821|NCT04660344|Atezolizumab|atezolizumab|mesh-list
139158822|NCT04660344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139158823|NCT04660344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158824|NCT04660344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158825|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158826|NCT04652960|Nivolumab|nivolumab|mesh-list
139158827|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158828|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158829|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139158830|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158844|NCT04629495|Sirolimus|sirolimus|mesh-list
139158845|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139158846|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139158847|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139158848|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158849|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
139158850|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158851|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
139158852|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158853|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139158854|NCT04616183|Cetuximab|cetuximab|mesh-list
139158855|NCT04616183|Antibodies|antibodies|mesh-list
139158856|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
139158857|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139158858|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
138909364|NCT00702260|Ramipril|ramipril|mesh-list
139158859|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891137|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139158861|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139158862|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139158863|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139158864|NCT04587687|Antibodies|antibodies|mesh-list
139158865|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
139158866|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139158867|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
139158868|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
139158869|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158870|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158871|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139158872|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
139158873|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158874|NCT04587687|Immunotoxins|immunotoxins|mesh-ancestor
139158880|NCT04572451|Nivolumab|nivolumab|mesh-list
139158881|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158882|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158883|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139158884|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158885|NCT04559048|Tacrolimus|tacrolimus|mesh-list
139158886|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158887|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
139158888|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158889|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139158890|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158891|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158892|NCT04495621|Cetuximab|cetuximab|mesh-list
139158893|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158894|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158895|NCT04468984|Navitoclax|navitoclax|mesh-list
139158896|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158897|NCT04458909|Cisplatin|cisplatin|mesh-list
139158898|NCT04458909|Carboplatin|carboplatin|mesh-list
139158899|NCT04458909|Gemcitabine|gemcitabine|mesh-list
139158900|NCT04458909|Nivolumab|nivolumab|mesh-list
139158901|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158902|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139158903|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
139158904|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954497|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139158905|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158906|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139158908|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
139158909|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158910|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158911|NCT04443348|Paclitaxel|paclitaxel|mesh-list
139158912|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
139158913|NCT04443348|Carboplatin|carboplatin|mesh-list
139158914|NCT04443348|Doxorubicin|doxorubicin|mesh-list
139158915|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
139158916|NCT04443348|Capecitabine|capecitabine|mesh-list
139158917|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139158918|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158919|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
139158920|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
139158921|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
139158922|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158923|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158924|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
139158925|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158926|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139158927|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139158928|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
139158929|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139158930|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139158931|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139158932|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139158933|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158934|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158935|NCT04443348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139158936|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139158937|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
139158938|NCT04420195|Tacrolimus|tacrolimus|mesh-list
139158939|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158940|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
139158941|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158942|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139158944|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158945|NCT04363801|Leucovorin|leucovorin|mesh-list
139158946|NCT04363801|Capecitabine|capecitabine|mesh-list
139158947|NCT04363801|Fluorouracil|fluorouracil|mesh-list
139158948|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
139158949|NCT04363801|Tislelizumab|tislelizumab|mesh-list
139158950|NCT04363801|Calcium|calcium|mesh-list
139158951|NCT04363801|Levoleucovorin|levoleucovorin|mesh-list
139158952|NCT04363801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139158953|NCT04363801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158954|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139158955|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
139158956|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158957|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158958|NCT04363801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158959|NCT04363801|Immunologic Factors|immunologic factors|mesh-ancestor
139158960|NCT04363801|Antidotes|antidotes|mesh-ancestor
139158961|NCT04363801|Protective Agents|protective agents|mesh-ancestor
139158962|NCT04363801|Vitamin B Complex|vitamin b complex|mesh-ancestor
139158963|NCT04363801|Vitamins|vitamins|mesh-ancestor
139158964|NCT04363801|Micronutrients|micronutrients|mesh-ancestor
139158965|NCT04363801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139158966|NCT04329494|Leucovorin|leucovorin|mesh-list
139158967|NCT04329494|Cisplatin|cisplatin|mesh-list
139158968|NCT04329494|Doxorubicin|doxorubicin|mesh-list
139158969|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139158970|NCT04329494|Fluorouracil|fluorouracil|mesh-list
139158971|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
139158972|NCT04329494|Irinotecan|irinotecan|mesh-list
139158973|NCT04329494|Daunorubicin|daunorubicin|mesh-list
139158974|NCT04329494|Mitomycins|mitomycins|mesh-list
139158975|NCT04329494|Mitomycin|mitomycin|mesh-list
139158976|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139158977|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139158978|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139158979|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139158980|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139158981|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139158982|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
139158983|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139158984|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139158985|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
139158986|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139158987|NCT04329494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139158988|NCT04329494|Antidotes|antidotes|mesh-ancestor
139158989|NCT04329494|Protective Agents|protective agents|mesh-ancestor
139158990|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
139158991|NCT04329494|Vitamins|vitamins|mesh-ancestor
139158992|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
139158993|NCT04329494|Alkylating Agents|alkylating agents|mesh-ancestor
139158994|NCT04329494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139158995|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
139158996|NCT04322318|Ifosfamide|ifosfamide|mesh-list
139158997|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
139158998|NCT04322318|Carboplatin|carboplatin|mesh-list
139158999|NCT04322318|Doxorubicin|doxorubicin|mesh-list
139159000|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139159001|NCT04322318|Irinotecan|irinotecan|mesh-list
139159002|NCT04322318|Etoposide|etoposide|mesh-list
139159003|NCT04322318|Vincristine|vincristine|mesh-list
139159004|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
139159005|NCT04322318|Daunorubicin|daunorubicin|mesh-list
139159006|NCT04322318|Topotecan|topotecan|mesh-list
139159007|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
139159008|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139159009|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
139159010|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159011|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139159012|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139159013|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
139159014|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159015|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159016|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139159017|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139159018|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139159019|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139159020|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159021|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139159022|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159023|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159024|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159025|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159026|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
139159027|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
139159028|NCT04294628|Trastuzumab|trastuzumab|mesh-list
139159029|NCT04294628|Camptothecin|camptothecin|mesh-list
139159030|NCT04294628|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139159031|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
139159032|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139159033|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159034|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
139159035|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159036|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159037|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139159038|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139159039|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159040|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159041|NCT04293562|Cytarabine|cytarabine|mesh-list
139159042|NCT04293562|Deoxyglucose|deoxyglucose|mesh-list
139159043|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
139159044|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139159045|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139159046|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139159047|NCT04293562|Methotrexate|methotrexate|mesh-list
139159048|NCT04293562|Etoposide|etoposide|mesh-list
139159049|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
139159050|NCT04293562|Daunorubicin|daunorubicin|mesh-list
139159051|NCT04293562|Asparaginase|asparaginase|mesh-list
139159052|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
139159053|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
139159054|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
139159055|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
139159056|NCT04293562|Razoxane|razoxane|mesh-list
139159057|NCT04293562|Calicheamicins|calicheamicins|mesh-list
139159058|NCT04293562|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
139159059|NCT04293562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139159060|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139159061|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
139159062|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139159063|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159064|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139159065|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
139159066|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159067|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159068|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
139159069|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159070|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139159071|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139159072|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
139159073|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139159074|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139159075|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159076|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139159077|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139159078|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
139159079|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139159080|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139159081|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139159082|NCT04293562|Analgesics|analgesics|mesh-ancestor
139159083|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
139159084|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139159085|NCT04293562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139159086|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
139159087|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159088|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159089|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159090|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139159091|NCT04293562|Immunotoxins|immunotoxins|mesh-ancestor
139159092|NCT04293562|Immunoconjugates|immunoconjugates|mesh-ancestor
139159093|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139159094|NCT04293562|Protective Agents|protective agents|mesh-ancestor
139159095|NCT04260464|PF-06700841|pf-06700841|mesh-list
139159096|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139159097|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159098|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159099|NCT04246372|Tofacitinib|tofacitinib|mesh-list
139159100|NCT04246372|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139159101|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139159102|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159103|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159104|NCT04204967|Fentanyl|fentanyl|mesh-list
139159105|NCT04204967|Remifentanil|remifentanil|mesh-list
139159106|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139159107|NCT04204967|Narcotics|narcotics|mesh-ancestor
139159108|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139159109|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159110|NCT04204967|Analgesics|analgesics|mesh-ancestor
139159111|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
139159112|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139159113|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139159114|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139159115|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
138886536|NCT00857259|Everolimus|everolimus|mesh-list
139159116|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
139159118|NCT04195399|Nirogacestat|nirogacestat|mesh-list
139159119|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159120|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159121|NCT04195399|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139159122|NCT04158362|Paclitaxel|paclitaxel|mesh-list
139159123|NCT04158362|Capecitabine|capecitabine|mesh-list
139159124|NCT04158362|Letrozole|letrozole|mesh-list
139159125|NCT04158362|Fulvestrant|fulvestrant|mesh-list
139159126|NCT04158362|Anastrozole|anastrozole|mesh-list
139159127|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159128|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159129|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159130|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159131|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159132|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159133|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139159134|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
139159135|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139159136|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139159137|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159138|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139159139|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
138891317|NCT02699645|Telmisartan|telmisartan|mesh-list
139159140|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139159141|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159142|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139159143|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139159144|NCT04145258|Aspirin|aspirin|mesh-list
139159145|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139159146|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139159147|NCT04145258|Analgesics|analgesics|mesh-ancestor
139159148|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
139159149|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139159150|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159151|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139159152|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139159153|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139159154|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139159155|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159156|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139159157|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139159158|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159159|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
139159160|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139159161|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
139159162|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139159163|NCT04030559|Niraparib|niraparib|mesh-list
139159164|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139159165|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909641|NCT00826280|Caffeine|caffeine|mesh-list
139159166|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159169|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139159170|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159171|NCT04000529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139159172|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159173|NCT03986034|Venetoclax|venetoclax|mesh-list
139159174|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159175|NCT03971253|Peficitinib|peficitinib|mesh-list
139159176|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159177|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159178|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139159179|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
139159180|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159181|NCT03970447|Temozolomide|temozolomide|mesh-list
139159182|NCT03970447|Lomustine|lomustine|mesh-list
139159183|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
139159184|NCT03970447|GDC-0084|gdc-0084|mesh-list
139159185|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139159186|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
139159187|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159188|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159189|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159190|NCT03969901|Relebactam|relebactam|mesh-list
139159191|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139159192|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159193|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159194|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139159195|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139159196|NCT03959085|Calcium, Dietary|calcium, dietary|mesh-list
139159197|NCT03959085|Leucovorin|leucovorin|mesh-list
139159198|NCT03959085|Folic Acid|folic acid|mesh-list
139159199|NCT03959085|Cytarabine|cytarabine|mesh-list
139159200|NCT03959085|Dexamethasone|dexamethasone|mesh-list
139159201|NCT03959085|Dexamethasone acetate|dexamethasone acetate|mesh-list
139159202|NCT03959085|Prednisolone|prednisolone|mesh-list
139159203|NCT03959085|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139159204|NCT03959085|Methylprednisolone|methylprednisolone|mesh-list
139159205|NCT03959085|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139159206|NCT03959085|Prednisolone acetate|prednisolone acetate|mesh-list
139159207|NCT03959085|Hydrocortisone|hydrocortisone|mesh-list
139159208|NCT03959085|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139159209|NCT03959085|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139159210|NCT03959085|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139159211|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
139159212|NCT03959085|Doxorubicin|doxorubicin|mesh-list
139159213|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139159214|NCT03959085|Methotrexate|methotrexate|mesh-list
139159215|NCT03959085|Vincristine|vincristine|mesh-list
139159216|NCT03959085|Daunorubicin|daunorubicin|mesh-list
139159217|NCT03959085|Asparaginase|asparaginase|mesh-list
139159218|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
138891416|NCT01009801|Everolimus|everolimus|mesh-list
139159219|NCT03959085|Pegaspargase|pegaspargase|mesh-list
139159220|NCT03959085|Thioguanine|thioguanine|mesh-list
139159221|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139159222|NCT03959085|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139159223|NCT03959085|Prednisolone phosphate|prednisolone phosphate|mesh-list
139159224|NCT03959085|BB 1101|bb 1101|mesh-list
139159225|NCT03959085|Calcium|calcium|mesh-list
139159226|NCT03959085|2-Aminopurine|2-aminopurine|mesh-list
139159227|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
139159228|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139159229|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
138829181|NCT00943124|Niacin|niacin|mesh-list
139159230|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159231|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139159232|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139159233|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
139159234|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159235|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159236|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139159237|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139159238|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
138909716|NCT02614937|Squalamine|squalamine|mesh-list
139159239|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
139159240|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139159241|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139159242|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
139159243|NCT03959085|Hormones|hormones|mesh-ancestor
139159244|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139159245|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139159246|NCT03959085|Protease Inhibitors|protease inhibitors|mesh-ancestor
139159247|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159248|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139159249|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139159250|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139159251|NCT03959085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139159252|NCT03959085|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139159253|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139159254|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
139159255|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139159256|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139159257|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
139159258|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
139159259|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139159260|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139159261|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
139159262|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139159263|NCT03959085|Antidotes|antidotes|mesh-ancestor
139159264|NCT03959085|Protective Agents|protective agents|mesh-ancestor
139159265|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
139159266|NCT03959085|Vitamins|vitamins|mesh-ancestor
139159267|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
139159268|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159269|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159270|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159271|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159272|NCT03959085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139159273|NCT03959085|Hematinics|hematinics|mesh-ancestor
139159274|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139159275|NCT03959085|Immunotoxins|immunotoxins|mesh-ancestor
139159276|NCT03959085|Immunoconjugates|immunoconjugates|mesh-ancestor
139159277|NCT03952637|Sirolimus|sirolimus|mesh-list
139159278|NCT03952637|Prednisone|prednisone|mesh-list
139159279|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
139159280|NCT03952637|Rituximab|rituximab|mesh-list
139159281|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139159282|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159283|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
139159284|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159285|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139159286|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139159287|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
139159288|NCT03952637|Hormones|hormones|mesh-ancestor
139159289|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139159290|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139159291|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139159292|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139159293|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139159294|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
139159295|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139159296|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
139159297|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
139159298|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139159299|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139159300|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139159301|NCT03952637|Protective Agents|protective agents|mesh-ancestor
139159315|NCT03896503|Topotecan|topotecan|mesh-list
139159316|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139159317|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138909792|NCT00657046|Droxidopa|droxidopa|mesh-list
139159318|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159319|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159320|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159321|NCT03885037|Infliximab|infliximab|mesh-list
139159322|NCT03885037|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139159323|NCT03885037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139159324|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
139159325|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139159326|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139159327|NCT03866239|Atezolizumab|atezolizumab|mesh-list
139159328|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
139159329|NCT03866239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139159330|NCT03866239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159331|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139159332|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159333|NCT03817398|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139159334|NCT03817398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139159335|NCT03817398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159336|NCT03817398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159357|NCT03771157|Vaccines|vaccines|mesh-list
139159358|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
139159359|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159360|NCT03705585|Vaccines|vaccines|mesh-list
139159361|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
139159362|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159363|NCT03643510|Fulvestrant|fulvestrant|mesh-list
139159364|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138886597|NCT02620800|Calcium|calcium|mesh-list
139159365|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159366|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139159367|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139159368|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
139159369|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139159370|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159372|NCT03533582|Carboplatin|carboplatin|mesh-list
139159373|NCT03533582|Gemcitabine|gemcitabine|mesh-list
139159374|NCT03533582|Doxorubicin|doxorubicin|mesh-list
139159375|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139159376|NCT03533582|Fluorouracil|fluorouracil|mesh-list
139159377|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
139159378|NCT03533582|Irinotecan|irinotecan|mesh-list
139159379|NCT03533582|Etoposide|etoposide|mesh-list
139159380|NCT03533582|Vincristine|vincristine|mesh-list
139159381|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
139159382|NCT03533582|Sorafenib|sorafenib|mesh-list
139159383|NCT03533582|Daunorubicin|daunorubicin|mesh-list
139159384|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
139159385|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159386|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139159387|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
139159388|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159389|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139159390|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139159391|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139159392|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159393|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139159394|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
139159395|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159396|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139159397|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159398|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159399|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159400|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159401|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139159402|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
139159403|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
139159404|NCT03529110|Trastuzumab|trastuzumab|mesh-list
139159405|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139159406|NCT03529110|Maytansine|maytansine|mesh-list
139159407|NCT03529110|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139159408|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138954533|NCT00983398|Diuretics|diuretics|mesh-ancestor
139159409|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159410|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138891525|NCT02622906|Hormones|hormones|mesh-ancestor
139159411|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159412|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159413|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159414|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159415|NCT03529110|Immunotoxins|immunotoxins|mesh-ancestor
139159416|NCT03529110|Immunoconjugates|immunoconjugates|mesh-ancestor
139159417|NCT03529110|Immunologic Factors|immunologic factors|mesh-ancestor
139159418|NCT03529110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159419|NCT03524092|Mirikizumab|mirikizumab|mesh-list
139159420|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139159421|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139159422|NCT03524092|Analgesics|analgesics|mesh-ancestor
139159423|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
139159424|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139159425|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159426|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139159427|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139159428|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139159429|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139159430|NCT03518086|Mirikizumab|mirikizumab|mesh-list
139159431|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139159432|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139159433|NCT03518086|Analgesics|analgesics|mesh-ancestor
139159434|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
139159435|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139159436|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159437|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139159438|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139159439|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139159440|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139159441|NCT03500874|Leucovorin|leucovorin|mesh-list
139159442|NCT03500874|Fluorouracil|fluorouracil|mesh-list
139159443|NCT03500874|Floxuridine|floxuridine|mesh-list
139159444|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
139159445|NCT03500874|Irinotecan|irinotecan|mesh-list
139159446|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
139159447|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159448|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139159449|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159450|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139159451|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
139159452|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159453|NCT03500874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139159454|NCT03500874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139159455|NCT03500874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159456|NCT03500874|Antidotes|antidotes|mesh-ancestor
139159457|NCT03500874|Protective Agents|protective agents|mesh-ancestor
139159458|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
139159459|NCT03500874|Vitamins|vitamins|mesh-ancestor
138891566|NCT04212533|Vitamin D|vitamin d|mesh-list
139159460|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
139159461|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
139159462|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139159463|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
139159464|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159465|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
139159466|NCT03460158|Protective Agents|protective agents|mesh-ancestor
139159467|NCT03358472|Carboplatin|carboplatin|mesh-list
139159468|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
139159469|NCT03358472|Fluorouracil|fluorouracil|mesh-list
139159470|NCT03358472|Cetuximab|cetuximab|mesh-list
139159471|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159472|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139159473|NCT03358472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139159474|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159475|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
139159476|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139159477|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139159478|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
139159479|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159480|NCT03294460|Ethanol|ethanol|mesh-list
139159481|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139159482|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139159483|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139159484|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159485|NCT03126916|Vitamin A|vitamin a|mesh-list
139159486|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
139159487|NCT03126916|Melphalan|melphalan|mesh-list
139159488|NCT03126916|Busulfan|busulfan|mesh-list
139159489|NCT03126916|Thiotepa|thiotepa|mesh-list
139159490|NCT03126916|Cisplatin|cisplatin|mesh-list
139159491|NCT03126916|Carboplatin|carboplatin|mesh-list
139159492|NCT03126916|Doxorubicin|doxorubicin|mesh-list
139159493|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139159494|NCT03126916|Etoposide|etoposide|mesh-list
139159495|NCT03126916|Vincristine|vincristine|mesh-list
139159496|NCT03126916|Topotecan|topotecan|mesh-list
139159497|NCT03126916|Tretinoin|tretinoin|mesh-list
139159498|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
139159499|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139159501|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
139159502|NCT03126916|Razoxane|razoxane|mesh-list
139159503|NCT03126916|Isotretinoin|isotretinoin|mesh-list
139159504|NCT03126916|Sargramostim|sargramostim|mesh-list
139159505|NCT03126916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139159506|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139159507|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
139159508|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159509|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139159510|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139159511|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
139159512|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159513|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159514|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139159515|NCT03126916|Vitamins|vitamins|mesh-ancestor
139159516|NCT03126916|Micronutrients|micronutrients|mesh-ancestor
139159517|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139159518|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139159519|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139159520|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159521|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159522|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159523|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159524|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159525|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139159526|NCT03126916|Keratolytic Agents|keratolytic agents|mesh-ancestor
139159527|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
139159528|NCT03126916|Protective Agents|protective agents|mesh-ancestor
139159529|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139159530|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139159531|NCT03099382|Docetaxel|docetaxel|mesh-list
139159532|NCT03099382|Irinotecan|irinotecan|mesh-list
139159533|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159534|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159535|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159536|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159537|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159538|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139159539|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139159540|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159541|NCT03067181|Cisplatin|cisplatin|mesh-list
139159542|NCT03067181|Carboplatin|carboplatin|mesh-list
139159543|NCT03067181|Etoposide|etoposide|mesh-list
139159544|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
139159545|NCT03067181|Bleomycin|bleomycin|mesh-list
139159546|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
139159547|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159548|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159549|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139159550|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139159551|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159552|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159553|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139159555|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
139159556|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159557|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159558|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159559|NCT03007147|Calcium, Dietary|calcium, dietary|mesh-list
139159560|NCT03007147|Leucovorin|leucovorin|mesh-list
139159561|NCT03007147|Folic Acid|folic acid|mesh-list
139159562|NCT03007147|Cytarabine|cytarabine|mesh-list
138886652|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
139159564|NCT03007147|Dexamethasone acetate|dexamethasone acetate|mesh-list
139159565|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
139159566|NCT03007147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139159567|NCT03007147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139159568|NCT03007147|Prednisolone|prednisolone|mesh-list
139159569|NCT03007147|Prednisolone acetate|prednisolone acetate|mesh-list
139159570|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
139159571|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139159572|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139159573|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139159574|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
139159575|NCT03007147|Ifosfamide|ifosfamide|mesh-list
138891663|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
139159576|NCT03007147|Isophosphamide mustard|isophosphamide mustard|mesh-list
139159577|NCT03007147|Doxorubicin|doxorubicin|mesh-list
139159578|NCT03007147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139159579|NCT03007147|Methotrexate|methotrexate|mesh-list
139159580|NCT03007147|Etoposide|etoposide|mesh-list
139159581|NCT03007147|Vincristine|vincristine|mesh-list
139159582|NCT03007147|Etoposide phosphate|etoposide phosphate|mesh-list
139159583|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
139159584|NCT03007147|Daunorubicin|daunorubicin|mesh-list
139159585|NCT03007147|Asparaginase|asparaginase|mesh-list
139159586|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
139159587|NCT03007147|Podophyllotoxin|podophyllotoxin|mesh-list
139159588|NCT03007147|Pegaspargase|pegaspargase|mesh-list
139159589|NCT03007147|Thioguanine|thioguanine|mesh-list
139159590|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
139159591|NCT03007147|Razoxane|razoxane|mesh-list
139159592|NCT03007147|Azathioprine|azathioprine|mesh-list
139159593|NCT03007147|Lenograstim|lenograstim|mesh-list
139159594|NCT03007147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139159595|NCT03007147|Prednisolone phosphate|prednisolone phosphate|mesh-list
139159596|NCT03007147|BB 1101|bb 1101|mesh-list
139159597|NCT03007147|Calcium|calcium|mesh-list
139159598|NCT03007147|2-Aminopurine|2-aminopurine|mesh-list
139159599|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
139159600|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139159601|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
139159602|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159603|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139159604|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139159605|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
139159606|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159607|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159608|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139159609|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139159610|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
139159611|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
139159612|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139159613|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139159614|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
139159615|NCT03007147|Hormones|hormones|mesh-ancestor
139159616|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139159617|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139159618|NCT03007147|Protease Inhibitors|protease inhibitors|mesh-ancestor
139159619|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159620|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139159621|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139159622|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138886662|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139159623|NCT03007147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139159624|NCT03007147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138910086|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139159625|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139159626|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
139159627|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139159628|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139159629|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
139159630|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
139159631|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139159632|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139159633|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159635|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139159636|NCT03007147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139159637|NCT03007147|Antidotes|antidotes|mesh-ancestor
139159638|NCT03007147|Protective Agents|protective agents|mesh-ancestor
139159639|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
139159641|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
139159642|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159643|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159644|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159645|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139159646|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139159647|NCT03007147|Hematinics|hematinics|mesh-ancestor
139159648|NCT03007147|Keratolytic Agents|keratolytic agents|mesh-ancestor
139159649|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139159650|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
139159652|NCT02981628|Folic Acid|folic acid|mesh-list
139159653|NCT02981628|Cytarabine|cytarabine|mesh-list
139159654|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
139159655|NCT02981628|Methotrexate|methotrexate|mesh-list
139159656|NCT02981628|Vincristine|vincristine|mesh-list
139159657|NCT02981628|Asparaginase|asparaginase|mesh-list
139159658|NCT02981628|Pegaspargase|pegaspargase|mesh-list
139159659|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139159660|NCT02981628|Calcium|calcium|mesh-list
139159661|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
139159662|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139159663|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
139159664|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159665|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139159666|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139159667|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
139159668|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159669|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159670|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139159671|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139159672|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139159673|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139159674|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
139159675|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139159676|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139159677|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
139159678|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
139159679|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159680|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139159681|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139159682|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
139159683|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139159684|NCT02981628|Antidotes|antidotes|mesh-ancestor
139159685|NCT02981628|Protective Agents|protective agents|mesh-ancestor
139159686|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
139159687|NCT02981628|Vitamins|vitamins|mesh-ancestor
139159688|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
138886688|NCT00856323|Tenofovir|tenofovir|mesh-list
139159689|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159690|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159691|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159692|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159693|NCT02981628|Hematinics|hematinics|mesh-ancestor
139159694|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139159695|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139159696|NCT02981628|Immunotoxins|immunotoxins|mesh-ancestor
139159697|NCT02981628|Immunoconjugates|immunoconjugates|mesh-ancestor
139159698|NCT02939287|Olanzapine|olanzapine|mesh-list
139159699|NCT02939287|Aprepitant|aprepitant|mesh-list
139159700|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
139159701|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
139159702|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
139159703|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139159704|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159705|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139159706|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139159707|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139159708|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139159709|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139159710|NCT02939287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139159711|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139159712|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139159713|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159714|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139159715|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
139159716|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139159718|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
139159719|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
139159720|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139159721|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159722|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139159723|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
139159724|NCT02748018|Insulin|insulin|mesh-list
139159725|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139159726|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159727|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
139159728|NCT02724579|Lomustine|lomustine|mesh-list
139159729|NCT02724579|Cisplatin|cisplatin|mesh-list
139159730|NCT02724579|Vincristine|vincristine|mesh-list
139159731|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139159732|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
139159733|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159734|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139159735|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139159736|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
139159737|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159738|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159739|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139159740|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159741|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159742|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159743|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159762|NCT02564900|Camptothecin|camptothecin|mesh-list
139159763|NCT02564900|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139159764|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
139159765|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
139159766|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159767|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159768|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159785|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159786|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139159787|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159788|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159789|NCT02163733|Osimertinib|osimertinib|mesh-list
139159790|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159791|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139159792|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159793|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159794|NCT01822314|Paclitaxel|paclitaxel|mesh-list
139159795|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139159796|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159797|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159798|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159799|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159800|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159801|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159802|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139159803|NCT01407263|Hemostatics|hemostatics|mesh-list
139159804|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139159805|NCT01407263|Coagulants|coagulants|mesh-ancestor
139159823|NCT00025935|Lithium Carbonate|lithium carbonate|mesh-list
139159824|NCT00025935|Antidepressive Agents|antidepressive agents|mesh-ancestor
139159825|NCT00025935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139159826|NCT00025935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159827|NCT00025935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159828|NCT00025935|Antimanic Agents|antimanic agents|mesh-ancestor
139159829|NCT00025935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139159830|NCT00025935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139159831|NCT00025935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159832|NCT05924776|Immunomodulating Agents|immunomodulating agents|mesh-list
139159833|NCT05924776|Immunologic Factors|immunologic factors|mesh-ancestor
139159834|NCT05924776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159835|NCT05922033|Insulin|insulin|mesh-list
139159836|NCT05922033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139159837|NCT05922033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139159838|NCT05922033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159839|NCT05901519|Prednisone|prednisone|mesh-list
139159840|NCT05901519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139159841|NCT05901519|Glucocorticoids|glucocorticoids|mesh-ancestor
139159842|NCT05901519|Hormones|hormones|mesh-ancestor
139159843|NCT05901519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139159844|NCT05901519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159845|NCT05901519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139159846|NCT05901519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159847|NCT05894057|Midazolam|midazolam|mesh-list
139159848|NCT05894057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139159849|NCT05894057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139159850|NCT05894057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139159851|NCT05894057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159852|NCT05894057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139159853|NCT05894057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139159854|NCT05894057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139159855|NCT05894057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139159856|NCT05894057|Anesthetics, General|anesthetics, general|mesh-ancestor
139159857|NCT05894057|Anesthetics|anesthetics|mesh-ancestor
139159858|NCT05894057|GABA Modulators|gaba modulators|mesh-ancestor
139159859|NCT05894057|GABA Agents|gaba agents|mesh-ancestor
139159860|NCT05894057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139159861|NCT05894057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159862|NCT05877807|Baclofen|baclofen|mesh-list
139159863|NCT05877807|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139159864|NCT05877807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159865|NCT05877807|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139159866|NCT05877807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139159867|NCT05877807|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139159868|NCT05877807|GABA Agonists|gaba agonists|mesh-ancestor
139159870|NCT05877807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139159871|NCT05877807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159872|NCT05874544|Amoxicillin|amoxicillin|mesh-list
139159873|NCT05874544|Metronidazole|metronidazole|mesh-list
139159874|NCT05874544|Tetracycline|tetracycline|mesh-list
139159875|NCT05874544|Rifabutin|rifabutin|mesh-list
139159876|NCT05874544|Potassium Citrate|potassium citrate|mesh-list
139159877|NCT05874544|Bismuth|bismuth|mesh-list
139159878|NCT05874544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159879|NCT05874544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139159880|NCT05874544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139159881|NCT05874544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139159882|NCT05874544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139159883|NCT05874544|Antacids|antacids|mesh-ancestor
139159884|NCT05874544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139159885|NCT05874544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139159886|NCT05874544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159887|NCT05874544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139159888|NCT05874544|Antitubercular Agents|antitubercular agents|mesh-ancestor
139159889|NCT05874544|Diuretics|diuretics|mesh-ancestor
139159890|NCT05874544|Natriuretic Agents|natriuretic agents|mesh-ancestor
139159891|NCT05874544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159892|NCT05874544|Expectorants|expectorants|mesh-ancestor
139159893|NCT05874544|Respiratory System Agents|respiratory system agents|mesh-ancestor
139159894|NCT05857059|Misoprostol|misoprostol|mesh-list
139159895|NCT05857059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139159896|NCT05857059|Abortifacient Agents|abortifacient agents|mesh-ancestor
139159897|NCT05857059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139159898|NCT05857059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159899|NCT05857059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139159900|NCT05857059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139159901|NCT05857059|Oxytocics|oxytocics|mesh-ancestor
139159902|NCT05847686|Psilocybin|psilocybin|mesh-list
139159903|NCT05847686|Hallucinogens|hallucinogens|mesh-ancestor
139159904|NCT05847686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159905|NCT05847686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139159906|NCT05846880|Vitamin D|vitamin d|mesh-list
139159907|NCT05846880|Ergocalciferols|ergocalciferols|mesh-list
139159908|NCT05846880|Cholecalciferol|cholecalciferol|mesh-list
139159909|NCT05846880|Vitamins|vitamins|mesh-list
139159910|NCT05846880|Lenalidomide|lenalidomide|mesh-list
139159911|NCT05846880|Micronutrients|micronutrients|mesh-ancestor
139159912|NCT05846880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159913|NCT05846880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139159914|NCT05846880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139159915|NCT05846880|Immunologic Factors|immunologic factors|mesh-ancestor
139159916|NCT05846880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139159917|NCT05846880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139159918|NCT05846880|Growth Substances|growth substances|mesh-ancestor
139159919|NCT05846880|Growth Inhibitors|growth inhibitors|mesh-ancestor
139159920|NCT05846880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159921|NCT05832827|Paclitaxel|paclitaxel|mesh-list
139159922|NCT05832827|Carboplatin|carboplatin|mesh-list
139159923|NCT05832827|Pembrolizumab|pembrolizumab|mesh-list
139159924|NCT05832827|Lenvatinib|lenvatinib|mesh-list
139159925|NCT05832827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139159926|NCT05832827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159927|NCT05832827|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159928|NCT05832827|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159929|NCT05832827|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159930|NCT05832827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159931|NCT05832827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139159932|NCT05832827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139159933|NCT05832827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139159934|NCT05832827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159935|NCT05822830|Tirzepatide|tirzepatide|mesh-list
139159936|NCT05822830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139159937|NCT05822830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159938|NCT05822830|Incretins|incretins|mesh-ancestor
139159940|NCT05822830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139159941|NCT05804162|Moxifloxacin|moxifloxacin|mesh-list
139159942|NCT05804162|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139159943|NCT05804162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139159944|NCT05804162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139159945|NCT05804162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139159946|NCT05804162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139159947|NCT05804162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159948|NCT05804162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159949|NCT05804162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159950|NCT05804162|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139159951|NCT05804162|Contraceptive Agents|contraceptive agents|mesh-ancestor
139159952|NCT05804162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139159953|NCT05804162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159954|NCT05804162|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139159955|NCT05804162|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139159956|NCT05804162|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139159957|NCT05798793|Cisplatin|cisplatin|mesh-list
139159958|NCT05798793|Docetaxel|docetaxel|mesh-list
139159959|NCT05798793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159960|NCT05798793|Tubulin Modulators|tubulin modulators|mesh-ancestor
139159961|NCT05798793|Antimitotic Agents|antimitotic agents|mesh-ancestor
139159962|NCT05798793|Mitosis Modulators|mitosis modulators|mesh-ancestor
139159963|NCT05798793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159964|NCT05748145|Metronidazole|metronidazole|mesh-list
139159965|NCT05748145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139159966|NCT05748145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139159967|NCT05748145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139159968|NCT05748145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139159969|NCT05718869|Zanubrutinib|zanubrutinib|mesh-list
139159970|NCT05718869|Immunoglobulins|immunoglobulins|mesh-list
139159971|NCT05718869|Immunologic Factors|immunologic factors|mesh-ancestor
138891885|NCT00855894|Pertuzumab|pertuzumab|mesh-list
139159972|NCT05718869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159973|NCT05718869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139159974|NCT05718869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139159975|NCT05718869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139159976|NCT05718869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159977|NCT05714631|Lidocaine|lidocaine|mesh-list
139159978|NCT05714631|Anesthetics, Local|anesthetics, local|mesh-ancestor
139159979|NCT05714631|Anesthetics|anesthetics|mesh-ancestor
139159980|NCT05714631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139159981|NCT05714631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159982|NCT05714631|Sensory System Agents|sensory system agents|mesh-ancestor
139159983|NCT05714631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139159984|NCT05714631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139159985|NCT05714631|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139159986|NCT05714631|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139159987|NCT05714631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139159988|NCT05714631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159989|NCT05701969|Melatonin|melatonin|mesh-list
139159990|NCT05701969|Antioxidants|antioxidants|mesh-ancestor
139159991|NCT05701969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139159992|NCT05701969|Protective Agents|protective agents|mesh-ancestor
139159993|NCT05701969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139159994|NCT05701969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139159995|NCT05699993|Itraconazole|itraconazole|mesh-list
139159996|NCT05699993|Dextromethorphan|dextromethorphan|mesh-list
139159997|NCT05699993|Antifungal Agents|antifungal agents|mesh-ancestor
139159998|NCT05699993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139159999|NCT05699993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139160000|NCT05699993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139160001|NCT05699993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160002|NCT05699993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160003|NCT05699993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139160004|NCT05699993|Hormone Antagonists|hormone antagonists|mesh-ancestor
138886759|NCT01000441|Adalimumab|adalimumab|mesh-list
139160005|NCT05699993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160006|NCT05699993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160007|NCT05699993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139160008|NCT05699993|Antitussive Agents|antitussive agents|mesh-ancestor
139160009|NCT05699993|Respiratory System Agents|respiratory system agents|mesh-ancestor
139160010|NCT05699993|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139160011|NCT05699993|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139160012|NCT05699993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160013|NCT05688124|Esomeprazole|esomeprazole|mesh-list
139160014|NCT05688124|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139160015|NCT05688124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139160016|NCT05688124|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139160017|NCT05688124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160018|NCT05688124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160019|NCT05681884|Faricimab|faricimab|mesh-list
139160020|NCT05681884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139160021|NCT05681884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139160022|NCT05681884|Growth Substances|growth substances|mesh-ancestor
139160023|NCT05681884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160024|NCT05681884|Growth Inhibitors|growth inhibitors|mesh-ancestor
139160025|NCT05681884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160026|NCT05677919|Venetoclax|venetoclax|mesh-list
139160027|NCT05677919|Pirtobrutinib|pirtobrutinib|mesh-list
139160028|NCT05677919|Pyrazole|pyrazole|mesh-list
139160029|NCT05677919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160030|NCT05677919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139160031|NCT05677919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160032|NCT05677919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160033|NCT05657613|Fluconazole|fluconazole|mesh-list
139160034|NCT05657613|Bosentan|bosentan|mesh-list
139160035|NCT05657613|Antifungal Agents|antifungal agents|mesh-ancestor
139160036|NCT05657613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160037|NCT05657613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139160038|NCT05657613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139160039|NCT05657613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160040|NCT05657613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160041|NCT05657613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139160042|NCT05657613|Hormone Antagonists|hormone antagonists|mesh-ancestor
139160043|NCT05657613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160044|NCT05657613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160045|NCT05657613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139160046|NCT05657613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139160047|NCT05657613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139160048|NCT05657613|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139160049|NCT05647057|Polygeline|polygeline|mesh-list
139160050|NCT05647057|Plasma Substitutes|plasma substitutes|mesh-ancestor
139160051|NCT05647057|Blood Substitutes|blood substitutes|mesh-ancestor
139160052|NCT05645406|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139160053|NCT05645406|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139160054|NCT05645406|Estradiol|estradiol|mesh-list
139160055|NCT05645406|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139160056|NCT05645406|Estrogens|estrogens|mesh-ancestor
139160057|NCT05645406|Hormones|hormones|mesh-ancestor
139160058|NCT05645406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160059|NCT05645406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160060|NCT05645406|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139160061|NCT05645406|Contraceptive Agents|contraceptive agents|mesh-ancestor
139160062|NCT05645406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139160063|NCT05645406|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139160064|NCT05645393|Estrogens|estrogens|mesh-list
139160065|NCT05645393|Hormones|hormones|mesh-ancestor
139160066|NCT05645393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160067|NCT05645393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160068|NCT05631262|Docetaxel|docetaxel|mesh-list
139160069|NCT05631262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160070|NCT05631262|Tubulin Modulators|tubulin modulators|mesh-ancestor
139160071|NCT05631262|Antimitotic Agents|antimitotic agents|mesh-ancestor
139160072|NCT05631262|Mitosis Modulators|mitosis modulators|mesh-ancestor
139160073|NCT05631262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160074|NCT05624853|Pregabalin|pregabalin|mesh-list
139160075|NCT05624853|Analgesics|analgesics|mesh-ancestor
139160076|NCT05624853|Sensory System Agents|sensory system agents|mesh-ancestor
139160077|NCT05624853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160078|NCT05624853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160079|NCT05624853|Anticonvulsants|anticonvulsants|mesh-ancestor
139160080|NCT05624853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139160081|NCT05624853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139160082|NCT05624853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160083|NCT05624853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139160084|NCT05624853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139160085|NCT05624853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139160086|NCT05624853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139160087|NCT05624853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139160088|NCT05608005|MF59 oil emulsion|mf59 oil emulsion|mesh-list
139160089|NCT05608005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139160090|NCT05608005|Immunologic Factors|immunologic factors|mesh-ancestor
139160091|NCT05608005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160092|NCT05594433|Lenograstim|lenograstim|mesh-list
139160093|NCT05594433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139160094|NCT05594433|Immunologic Factors|immunologic factors|mesh-ancestor
139160095|NCT05594433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160096|NCT05589597|Nivolumab|nivolumab|mesh-list
139160097|NCT05589597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160098|NCT05589597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160099|NCT05589597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139160100|NCT05589597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160101|NCT05573802|Dexamethasone|dexamethasone|mesh-list
139160102|NCT05573802|Lenalidomide|lenalidomide|mesh-list
139160103|NCT05573802|Nirogacestat|nirogacestat|mesh-list
139160104|NCT05573802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139160105|NCT05573802|Antiemetics|antiemetics|mesh-ancestor
139160106|NCT05573802|Autonomic Agents|autonomic agents|mesh-ancestor
139160107|NCT05573802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160108|NCT05573802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160109|NCT05573802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139160110|NCT05573802|Glucocorticoids|glucocorticoids|mesh-ancestor
139160111|NCT05573802|Hormones|hormones|mesh-ancestor
139160112|NCT05573802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160113|NCT05573802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139160114|NCT05573802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160115|NCT05573802|Immunologic Factors|immunologic factors|mesh-ancestor
139160116|NCT05573802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139160117|NCT05573802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139160118|NCT05573802|Growth Substances|growth substances|mesh-ancestor
139160119|NCT05573802|Growth Inhibitors|growth inhibitors|mesh-ancestor
139160120|NCT05573802|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139160121|NCT05573802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160122|NCT05573802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160123|NCT05546242|Dolutegravir|dolutegravir|mesh-list
139160124|NCT05546242|Cabotegravir|cabotegravir|mesh-list
139160125|NCT05546242|Rilpivirine|rilpivirine|mesh-list
139160126|NCT05546242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139160127|NCT05546242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139160128|NCT05546242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139160129|NCT05546242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160130|NCT05546242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160131|NCT05546242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139160132|NCT05546242|Antiviral Agents|antiviral agents|mesh-ancestor
139160133|NCT05546242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160134|NCT05546242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139160135|NCT05546242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139160137|NCT05544968|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139160138|NCT05544968|Immunologic Factors|immunologic factors|mesh-ancestor
139160139|NCT05544968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160140|NCT05543122|Fluconazole|fluconazole|mesh-list
139160141|NCT05543122|Methotrexate|methotrexate|mesh-list
139160142|NCT05543122|Atenolol|atenolol|mesh-list
139160143|NCT05543122|Lamotrigine|lamotrigine|mesh-list
139160144|NCT05543122|Lacosamide|lacosamide|mesh-list
139160145|NCT05543122|Levetiracetam|levetiracetam|mesh-list
139160146|NCT05543122|Brivaracetam|brivaracetam|mesh-list
139160147|NCT05543122|Bupropion|bupropion|mesh-list
139160148|NCT05543122|Ezetimibe|ezetimibe|mesh-list
139160149|NCT05543122|Escitalopram|escitalopram|mesh-list
139160150|NCT05543122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139160151|NCT05543122|Abortifacient Agents|abortifacient agents|mesh-ancestor
138530398|NCT00072150|Bortezomib|bortezomib|mesh-list
139160152|NCT05543122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139160153|NCT05543122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160154|NCT05543122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139160155|NCT05543122|Antimetabolites|antimetabolites|mesh-ancestor
139160156|NCT05543122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160157|NCT05543122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160158|NCT05543122|Dermatologic Agents|dermatologic agents|mesh-ancestor
139160159|NCT05543122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160160|NCT05543122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139160161|NCT05543122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139160162|NCT05543122|Immunologic Factors|immunologic factors|mesh-ancestor
139160163|NCT05543122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139160164|NCT05543122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139160165|NCT05543122|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139160166|NCT05543122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139160167|NCT05543122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139160168|NCT05543122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160169|NCT05543122|Serotonin Agents|serotonin agents|mesh-ancestor
139160170|NCT05543122|Autonomic Agents|autonomic agents|mesh-ancestor
139160171|NCT05543122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886817|NCT00997477|Budesonide|budesonide|mesh-list
139160172|NCT05543122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139160173|NCT05543122|Antidepressive Agents|antidepressive agents|mesh-ancestor
139160174|NCT05543122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139160175|NCT05543122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139160176|NCT05543122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139160177|NCT05543122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139160178|NCT05543122|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139160180|NCT05543122|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139160181|NCT05543122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139160182|NCT05543122|Anticonvulsants|anticonvulsants|mesh-ancestor
139160183|NCT05543122|Nootropic Agents|nootropic agents|mesh-ancestor
139160184|NCT05543122|Antifungal Agents|antifungal agents|mesh-ancestor
139160185|NCT05543122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160186|NCT05543122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139160187|NCT05543122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139160188|NCT05543122|Hormone Antagonists|hormone antagonists|mesh-ancestor
139160189|NCT05543122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160190|NCT05543122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139160191|NCT05543122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139160192|NCT05543122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139160193|NCT05543122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139160194|NCT05543122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139160195|NCT05543122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139160196|NCT05543122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139160197|NCT05543122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139160198|NCT05543122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139160199|NCT05543122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139160200|NCT05543122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139160201|NCT05543122|Sympatholytics|sympatholytics|mesh-ancestor
139160202|NCT05543122|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139160203|NCT05543122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139160204|NCT05543122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139160205|NCT05543122|Adrenergic Agents|adrenergic agents|mesh-ancestor
139160206|NCT05539365|Pembrolizumab|pembrolizumab|mesh-list
139160207|NCT05539365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160208|NCT05539365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160209|NCT05539365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139160210|NCT05539365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160211|NCT05499572|Minocycline|minocycline|mesh-list
139160212|NCT05499572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139160213|NCT05499572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160214|NCT05480566|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
139160215|NCT05480566|Autonomic Agents|autonomic agents|mesh-ancestor
139160216|NCT05480566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160217|NCT05480566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160218|NCT05480566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139160219|NCT05480566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139160220|NCT05480566|Respiratory System Agents|respiratory system agents|mesh-ancestor
139160221|NCT05480046|Risperidone|risperidone|mesh-list
139160222|NCT05480046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139160223|NCT05480046|Serotonin Agents|serotonin agents|mesh-ancestor
139160224|NCT05480046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160225|NCT05480046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160226|NCT05480046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160227|NCT05480046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139160228|NCT05480046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139160229|NCT05480046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139160230|NCT05480046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139160231|NCT05480046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139160232|NCT05480046|Dopamine Agents|dopamine agents|mesh-ancestor
139160233|NCT05466474|Tislelizumab|tislelizumab|mesh-list
139160234|NCT05466474|Dacarbazine|dacarbazine|mesh-list
139160235|NCT05466474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138910693|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
139160236|NCT05466474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160237|NCT05466474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139160238|NCT05466474|Alkylating Agents|alkylating agents|mesh-ancestor
139160239|NCT05466474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160240|NCT05465330|Propofol|propofol|mesh-list
139160241|NCT05465330|Desflurane|desflurane|mesh-list
139160242|NCT05465330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139160243|NCT05465330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139160244|NCT05465330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160245|NCT05465330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139160246|NCT05465330|Anesthetics, General|anesthetics, general|mesh-ancestor
139160247|NCT05465330|Anesthetics|anesthetics|mesh-ancestor
139160248|NCT05465330|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139160249|NCT05435573|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
139160250|NCT05435573|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139160251|NCT05435573|Plasma Substitutes|plasma substitutes|mesh-ancestor
138892067|NCT06156059|Melatonin|melatonin|mesh-list
139160252|NCT05435573|Blood Substitutes|blood substitutes|mesh-ancestor
139160253|NCT05403086|Ketamine|ketamine|mesh-list
139160254|NCT05403086|Psilocybin|psilocybin|mesh-list
139160255|NCT05403086|Hallucinogens|hallucinogens|mesh-list
139160256|NCT05403086|Analgesics|analgesics|mesh-ancestor
139160257|NCT05403086|Sensory System Agents|sensory system agents|mesh-ancestor
139160258|NCT05403086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160259|NCT05403086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160260|NCT05403086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139160261|NCT05403086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139160262|NCT05403086|Anesthetics, General|anesthetics, general|mesh-ancestor
139160263|NCT05403086|Anesthetics|anesthetics|mesh-ancestor
139160264|NCT05403086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139160265|NCT05403086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139160266|NCT05403086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139160267|NCT05403086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160268|NCT05403086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160269|NCT05403086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139160270|NCT05385367|Anesthetics|anesthetics|mesh-list
139160271|NCT05385367|Anesthetics, General|anesthetics, general|mesh-list
139160272|NCT05385367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139160273|NCT05385367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160274|NCT05347134|Gemcitabine|gemcitabine|mesh-list
139160275|NCT05347134|Capecitabine|capecitabine|mesh-list
139160276|NCT05347134|Vinorelbine|vinorelbine|mesh-list
139160277|NCT05347134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139160278|NCT05347134|Antimetabolites|antimetabolites|mesh-ancestor
139160279|NCT05347134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160280|NCT05347134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160281|NCT05347134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139160282|NCT05347134|Tubulin Modulators|tubulin modulators|mesh-ancestor
139160283|NCT05347134|Antimitotic Agents|antimitotic agents|mesh-ancestor
139160284|NCT05347134|Mitosis Modulators|mitosis modulators|mesh-ancestor
139160285|NCT05331651|Glycopyrrolate|glycopyrrolate|mesh-list
139160286|NCT05331651|Tropisetron|tropisetron|mesh-list
139160287|NCT05331651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139160288|NCT05331651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139160289|NCT05331651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139160290|NCT05331651|Cholinergic Agents|cholinergic agents|mesh-ancestor
139160291|NCT05331651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160292|NCT05331651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160293|NCT05331651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160294|NCT05331651|Antiemetics|antiemetics|mesh-ancestor
139160295|NCT05331651|Autonomic Agents|autonomic agents|mesh-ancestor
139160296|NCT05331651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160297|NCT05331651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139160298|NCT05331651|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139160299|NCT05331651|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139160300|NCT05331651|Serotonin Agents|serotonin agents|mesh-ancestor
139160301|NCT05304598|Dexmedetomidine|dexmedetomidine|mesh-list
139160302|NCT05304598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139160303|NCT05304598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139160304|NCT05304598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160305|NCT05304598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139160306|NCT05304598|Analgesics|analgesics|mesh-ancestor
139160307|NCT05304598|Sensory System Agents|sensory system agents|mesh-ancestor
139160308|NCT05304598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160309|NCT05304598|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139160310|NCT05304598|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139160311|NCT05304598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139160312|NCT05304598|Adrenergic Agents|adrenergic agents|mesh-ancestor
139160313|NCT05304598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160314|NCT05304598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160315|NCT05299125|Pemetrexed|pemetrexed|mesh-list
139160316|NCT05299125|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
139160317|NCT05299125|Lazertinib|lazertinib|mesh-list
139160318|NCT05299125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160319|NCT05299125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160320|NCT05299125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160321|NCT05299125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139160322|NCT05299125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139160323|NCT05299125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139160324|NCT05299125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160325|NCT05294172|Cisplatin|cisplatin|mesh-list
139160326|NCT05294172|Gemcitabine|gemcitabine|mesh-list
139160327|NCT05294172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160328|NCT05294172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139160329|NCT05294172|Antimetabolites|antimetabolites|mesh-ancestor
139160330|NCT05294172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160331|NCT05275010|Trastuzumab|trastuzumab|mesh-list
139160332|NCT05275010|Pertuzumab|pertuzumab|mesh-list
139160333|NCT05275010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160334|NCT05275010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160335|NCT05261321|Dronabinol|dronabinol|mesh-list
139160336|NCT05261321|Hallucinogens|hallucinogens|mesh-ancestor
139160337|NCT05261321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160338|NCT05261321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139160339|NCT05261321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139160340|NCT05261321|Analgesics|analgesics|mesh-ancestor
139160341|NCT05261321|Sensory System Agents|sensory system agents|mesh-ancestor
139160342|NCT05261321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160343|NCT05261321|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138892103|NCT06155916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139160344|NCT05261321|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139160345|NCT05261321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160346|NCT05261321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160347|NCT05261321|Hormones|hormones|mesh-ancestor
139160348|NCT05261321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160349|NCT05245292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139160350|NCT05245292|Antibodies|antibodies|mesh-list
139160351|NCT05245292|Immunoglobulins|immunoglobulins|mesh-list
139160352|NCT05245292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139160353|NCT05245292|Antibodies, Blocking|antibodies, blocking|mesh-list
139160354|NCT05245292|Immunologic Factors|immunologic factors|mesh-ancestor
139160355|NCT05245292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160356|NCT05245292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160357|NCT05234684|Prednisone|prednisone|mesh-list
139160358|NCT05234684|Cyclophosphamide|cyclophosphamide|mesh-list
139160359|NCT05234684|Vincristine|vincristine|mesh-list
139160360|NCT05234684|Rituximab|rituximab|mesh-list
139160361|NCT05234684|Doxorubicin|doxorubicin|mesh-list
139160362|NCT05234684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139160363|NCT05234684|Immunologic Factors|immunologic factors|mesh-ancestor
139160364|NCT05234684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160365|NCT05234684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139160366|NCT05234684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139160367|NCT05234684|Alkylating Agents|alkylating agents|mesh-ancestor
139160368|NCT05234684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160369|NCT05234684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160370|NCT05234684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139160371|NCT05234684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139160372|NCT05234684|Glucocorticoids|glucocorticoids|mesh-ancestor
139160373|NCT05234684|Hormones|hormones|mesh-ancestor
139160374|NCT05234684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160375|NCT05234684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139160376|NCT05234684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139160377|NCT05234684|Tubulin Modulators|tubulin modulators|mesh-ancestor
139160378|NCT05234684|Antimitotic Agents|antimitotic agents|mesh-ancestor
139160379|NCT05234684|Mitosis Modulators|mitosis modulators|mesh-ancestor
139160380|NCT05234684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160381|NCT05234684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139160382|NCT05234684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139160383|NCT05234684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139160384|NCT05234684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160385|NCT05172700|Pirtobrutinib|pirtobrutinib|mesh-list
139160386|NCT05172700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139160387|NCT05172700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160388|NCT05172700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160389|NCT05161338|Estradiol|estradiol|mesh-list
139160390|NCT05161338|Progesterone|progesterone|mesh-list
139160391|NCT05161338|Estrogens|estrogens|mesh-ancestor
139160392|NCT05161338|Hormones|hormones|mesh-ancestor
139160393|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160394|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160395|NCT05161338|Progestins|progestins|mesh-ancestor
139160396|NCT05153772|Octreotide|octreotide|mesh-list
139160397|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139160398|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139160399|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160400|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139160401|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160402|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
139160403|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139160404|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160405|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139160406|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
139160407|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139160408|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139160409|NCT05113901|Prednisolone|prednisolone|mesh-list
139160410|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
139160411|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139160412|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
139160413|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139160414|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
139160415|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
139160416|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160417|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160418|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139160419|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
139160420|NCT05113901|Hormones|hormones|mesh-ancestor
139160421|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160422|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138954567|NCT03984409|Diuretics|diuretics|mesh-ancestor
139160423|NCT05113901|Protective Agents|protective agents|mesh-ancestor
139160424|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139160425|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160426|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139160427|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139160428|NCT05085873|Midazolam|midazolam|mesh-list
139160429|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
139160430|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139160431|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139160432|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139160433|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160434|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139160435|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139160436|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139160437|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139160438|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
139160439|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
139160440|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
139160441|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
139160442|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160443|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160444|NCT05022758|Warfarin|warfarin|mesh-list
139160445|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
139160446|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
139160447|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139160448|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
139160449|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139160450|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
139160451|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160452|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160453|NCT05003258|Dexamethasone|dexamethasone|mesh-list
139160454|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139160455|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
139160456|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
139160457|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160458|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160459|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139160460|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
139160461|NCT05003258|Hormones|hormones|mesh-ancestor
139160462|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160463|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139160464|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160465|NCT04977986|Cannabidiol|cannabidiol|mesh-list
139160466|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
139160467|NCT04938232|Nivolumab|nivolumab|mesh-list
139160468|NCT04938232|Ipilimumab|ipilimumab|mesh-list
138886897|NCT02714699|Analgesics|analgesics|mesh-ancestor
139160469|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160470|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160471|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139160472|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160473|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139160474|NCT04931615|Thrombin|thrombin|mesh-list
139160475|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
139160476|NCT04931615|Coagulants|coagulants|mesh-ancestor
139160477|NCT04925973|Tofacitinib|tofacitinib|mesh-list
139160478|NCT04925973|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139160479|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139160480|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160481|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160482|NCT04907721|Glucagon|glucagon|mesh-list
139160483|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139160484|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139160485|NCT04907721|Hormones|hormones|mesh-ancestor
139160486|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160487|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160488|NCT04907721|Incretins|incretins|mesh-ancestor
139160489|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139160490|NCT04890873|Antacids|antacids|mesh-ancestor
139160491|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160492|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139160493|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
139160494|NCT04887805|Lenvatinib|lenvatinib|mesh-list
139160495|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160496|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160497|NCT04887805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139160498|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160499|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139160501|NCT04878432|Azacitidine|azacitidine|mesh-list
139160502|NCT04878432|Decitabine|decitabine|mesh-list
138892179|NCT06070116|Filaricides|filaricides|mesh-ancestor
139160503|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139160504|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
139160505|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160506|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160507|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160508|NCT04847557|Tirzepatide|tirzepatide|mesh-list
139160509|NCT04847557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139160510|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160511|NCT04847557|Incretins|incretins|mesh-ancestor
139160512|NCT04847557|Hormones|hormones|mesh-ancestor
139160513|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160514|NCT04834024|Antibodies|antibodies|mesh-list
139160515|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139160516|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
139160517|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160518|NCT04811014|Buprenorphine|buprenorphine|mesh-list
139160519|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139160520|NCT04811014|Naloxone|naloxone|mesh-list
139160521|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139160522|NCT04811014|Narcotics|narcotics|mesh-ancestor
139160523|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139160524|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160525|NCT04811014|Analgesics|analgesics|mesh-ancestor
139160526|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
139160527|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160528|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139160529|NCT04801303|Calcitriol|calcitriol|mesh-list
139160530|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139160531|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160532|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139160533|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139160534|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160535|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139160536|NCT04801303|Vitamins|vitamins|mesh-ancestor
139160537|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
139160538|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139160539|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139160540|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139160541|NCT04727684|Cetrorelix|cetrorelix|mesh-list
139160542|NCT04727684|Menotropins|menotropins|mesh-list
139160543|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
139160544|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139160545|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
139160546|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139160547|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160548|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139160549|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139160550|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160551|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139160552|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
139160553|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
139160554|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160555|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139160556|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139160557|NCT04727671|Cetrorelix|cetrorelix|mesh-list
139160558|NCT04727671|Menotropins|menotropins|mesh-list
139160559|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
139160560|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139160561|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
139160562|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139160563|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160564|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139160565|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139160566|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160567|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139160568|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
139160569|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
138954588|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
139160570|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160571|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139160572|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139160573|NCT04724486|Cetrorelix|cetrorelix|mesh-list
139160574|NCT04724486|Menotropins|menotropins|mesh-list
139160575|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
139160576|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139160577|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
139160578|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139160579|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160580|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139160581|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139160582|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160583|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139160584|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
139160585|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
139160586|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160587|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139160588|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139160589|NCT04724343|Cetrorelix|cetrorelix|mesh-list
139160590|NCT04724343|Menotropins|menotropins|mesh-list
139160591|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
139160592|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139160593|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
139160594|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139160595|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160596|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139160597|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139160598|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160599|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139160600|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
139160601|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
139160602|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160603|NCT04706013|Pyridoxal|pyridoxal|mesh-list
139160604|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
139160605|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
139160606|NCT04706013|Vitamins|vitamins|mesh-ancestor
139160607|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
139160608|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160609|NCT04704024|Tenofovir|tenofovir|mesh-list
139160610|NCT04704024|Lamivudine|lamivudine|mesh-list
139160611|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
139160612|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160613|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138911068|NCT03849313|Adalimumab|adalimumab|mesh-list
139160614|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139160615|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160616|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160617|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139160618|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139160620|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139160621|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160622|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160623|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160624|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160625|NCT04682522|Metronidazole|metronidazole|mesh-list
139160626|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160627|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139160628|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139160629|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139160630|NCT04675931|Artesunate|artesunate|mesh-list
139160631|NCT04675931|Lumefantrine|lumefantrine|mesh-list
139160632|NCT04675931|Artemether|artemether|mesh-list
139160633|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139160634|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
139160635|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139160636|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139160637|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954590|NCT00908817|Triamcinolone|triamcinolone|mesh-list
139160638|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160639|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
139160640|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
139160641|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139160642|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
139160655|NCT04642365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160656|NCT04642365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160657|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160658|NCT04634838|Copper|copper|mesh-list
139160659|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139160660|NCT04634838|Trace Elements|trace elements|mesh-ancestor
139160661|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
139160662|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160663|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160664|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
139160665|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139160666|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139160667|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160668|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139160669|NCT04628663|Analgesics|analgesics|mesh-ancestor
139160670|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
139160671|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160672|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139160673|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139160674|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139160675|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
139160676|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160677|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160678|NCT04626635|Cemiplimab|cemiplimab|mesh-list
139160679|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160680|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160681|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
139160682|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138892295|NCT05952557|Hormone Antagonists|hormone antagonists|mesh-ancestor
139160683|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160684|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139160685|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160686|NCT04547985|Naltrexone|naltrexone|mesh-list
139160687|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139160688|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139160689|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160690|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
139160691|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160693|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139160694|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
139160695|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
139160696|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139160697|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160698|NCT04467905|Etripamil|etripamil|mesh-list
139160699|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139160700|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139160701|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160702|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139160703|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160704|NCT04417621|Trametinib|trametinib|mesh-list
139160705|NCT04417621|Naporafenib|naporafenib|mesh-list
139160706|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160707|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138954600|NCT00908817|Hormones|hormones|mesh-ancestor
139160708|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160709|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160710|NCT04406272|Bevacizumab|bevacizumab|mesh-list
139160711|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160712|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160713|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139160714|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139160715|NCT04406272|Growth Substances|growth substances|mesh-ancestor
139160716|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160717|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
139160718|NCT04395222|Fludarabine|fludarabine|mesh-list
139160719|NCT04395222|Melphalan|melphalan|mesh-list
139160720|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
139160721|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139160722|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019574|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139160723|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160724|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139160725|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
139160726|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160727|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139160728|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
139160729|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139160730|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
139160731|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139160732|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
139160733|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160734|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
139160735|NCT04358055|Protective Agents|protective agents|mesh-ancestor
139160736|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
139160737|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
139160738|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139160739|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139160740|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160741|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160742|NCT04356716|Urological Agents|urological agents|mesh-ancestor
139160743|NCT04343235|Labetalol|labetalol|mesh-list
139160744|NCT04343235|Furosemide|furosemide|mesh-list
139160745|NCT04343235|Diuretics|diuretics|mesh-ancestor
139160746|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
139160747|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160748|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139160749|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139160750|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160751|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139160752|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139160753|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
139160754|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160755|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139160756|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
139160757|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
139160758|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160759|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138886980|NCT00532129|Rituximab|rituximab|mesh-list
139160760|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139160761|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139160762|NCT04338321|Esketamine|esketamine|mesh-list
139160763|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
139160764|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139160765|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139160766|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139160767|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139160768|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160769|NCT04322955|Nivolumab|nivolumab|mesh-list
139160770|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160771|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160772|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139160773|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160774|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
139160775|NCT04311632|Tacrolimus|tacrolimus|mesh-list
139160776|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139160777|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
139160778|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160779|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139160780|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160781|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160782|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139160783|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160784|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139160785|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
139160786|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139160787|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160789|NCT04303780|Sotorasib|sotorasib|mesh-list
139160790|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160791|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
139160792|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
139160793|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
139160794|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160795|NCT04303780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139160796|NCT04303780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160797|NCT04302168|Choline|choline|mesh-list
139160798|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
139160799|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139160800|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
139160801|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160802|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139160803|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139160804|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
139160805|NCT04299490|Analgesics|analgesics|mesh-list
139160806|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160807|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
139160808|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160809|NCT04294225|Letrozole|letrozole|mesh-list
139160810|NCT04294225|Anastrozole|anastrozole|mesh-list
139160811|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160812|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139160813|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139160814|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160815|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160816|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139160817|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
139160818|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160819|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160820|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139160821|NCT04259996|Estradiol|estradiol|mesh-list
139160822|NCT04259996|Progesterone|progesterone|mesh-list
139160823|NCT04259996|Estrogens|estrogens|mesh-ancestor
139160824|NCT04259996|Hormones|hormones|mesh-ancestor
139160825|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160826|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160827|NCT04259996|Progestins|progestins|mesh-ancestor
139160828|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
139160829|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139160830|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
139160831|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160832|NCT04226456|Expectorants|expectorants|mesh-ancestor
139160833|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
139160834|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139160835|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
139160836|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911289|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160837|NCT04226456|Protective Agents|protective agents|mesh-ancestor
139160838|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160839|NCT04226456|Antidotes|antidotes|mesh-ancestor
139160840|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139160841|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160842|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
139160843|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160844|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160845|NCT04157517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139160846|NCT04157517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160847|NCT04124432|Nicotine|nicotine|mesh-list
139160848|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139160849|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
139160850|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160851|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160852|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139160853|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139160854|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
139160855|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160856|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160858|NCT04110301|Antibodies|antibodies|mesh-list
139160859|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139160860|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
139160861|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160862|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139160863|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139160864|NCT04110301|Growth Substances|growth substances|mesh-ancestor
139160865|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
139160866|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160867|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
139160868|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139160869|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160870|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160871|NCT04068181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139160872|NCT04068181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160873|NCT04066881|Vaccines|vaccines|mesh-list
139160874|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
139160875|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160876|NCT04058717|Nicotine|nicotine|mesh-list
138892416|NCT05794230|Vaccines|vaccines|mesh-list
139160877|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139160878|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
139160879|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160880|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160881|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139160882|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139160883|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
139160884|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160885|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160886|NCT03972488|Octreotide|octreotide|mesh-list
139160887|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139160888|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139160889|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139160890|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160891|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139160892|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160893|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
139160894|NCT03970746|Pemetrexed|pemetrexed|mesh-list
139160895|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160896|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160897|NCT03970746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139160898|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160899|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160900|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139160901|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139160902|NCT03945019|Infliximab|infliximab|mesh-list
139160903|NCT03945019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139160904|NCT03945019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139160905|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
139160906|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139160907|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139160908|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
139160909|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139160910|NCT03910673|Fosfomycin|fosfomycin|mesh-list
139160911|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139160912|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160913|NCT03906071|Docetaxel|docetaxel|mesh-list
139160914|NCT03906071|Nivolumab|nivolumab|mesh-list
139160915|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160916|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
139160917|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
139160918|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
139160919|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160920|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139160921|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139160922|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
139160923|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139160924|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139160926|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
139160927|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139160928|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
139160929|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139160930|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
139160931|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
139160932|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139160933|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160934|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139160935|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
139160936|NCT03875690|Hormones|hormones|mesh-ancestor
139160937|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139160938|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139160939|NCT03875690|Protective Agents|protective agents|mesh-ancestor
139160940|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139160941|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160942|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
139160943|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139160944|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139160945|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160946|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
139160947|NCT03868956|Coagulants|coagulants|mesh-ancestor
139160948|NCT03866408|Pioglitazone|pioglitazone|mesh-list
139160949|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139160950|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160951|NCT03842085|Antibodies|antibodies|mesh-list
139160952|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139160953|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139160954|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
139160955|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160956|NCT03836209|Cytarabine|cytarabine|mesh-list
139160957|NCT03836209|Daunorubicin|daunorubicin|mesh-list
139160958|NCT03836209|Midostaurin|midostaurin|mesh-list
139160959|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139160960|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
139160961|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160962|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160963|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
139160964|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160965|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139160966|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
139160967|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160968|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139160969|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139160970|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139160971|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139160972|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139160973|NCT03829514|Fenofibrate|fenofibrate|mesh-list
139160974|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139160975|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
139160976|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160977|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139160978|NCT03780127|Fenfluramine|fenfluramine|mesh-list
139160979|NCT03780127|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139160980|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139160981|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139160982|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139160983|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139160984|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
139160985|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139160986|NCT03771313|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139160987|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139160988|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139160990|NCT03748134|Fluorouracil|fluorouracil|mesh-list
139160991|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139160992|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139160993|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
139160994|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
139160995|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
139160996|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892511|NCT05450042|Paclitaxel|paclitaxel|mesh-list
139160997|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
139160998|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139160999|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139161000|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
139161001|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161002|NCT03702582|Warfarin|warfarin|mesh-list
139161003|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
139161004|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
139161005|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139161006|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
139161007|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139161008|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
139161009|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161010|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161011|NCT03701711|Lenalidomide|lenalidomide|mesh-list
139161012|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
139161013|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161014|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139161015|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139161016|NCT03701711|Growth Substances|growth substances|mesh-ancestor
139161017|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
139161018|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161019|NCT03689712|Manganese|manganese|mesh-list
139161020|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
139161021|NCT03689712|Trace Elements|trace elements|mesh-ancestor
139161022|NCT03689712|Micronutrients|micronutrients|mesh-ancestor
139161023|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161024|NCT03689712|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139161025|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
139161026|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161027|NCT03689712|Protective Agents|protective agents|mesh-ancestor
139161028|NCT03680508|Dostarlimab|dostarlimab|mesh-list
139161029|NCT03680508|Antibodies|antibodies|mesh-list
139161030|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
139161031|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
139161032|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161033|NCT03680508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161034|NCT03679624|Daratumumab|daratumumab|mesh-list
139161035|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161036|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
139161037|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161038|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161039|NCT03658772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139019575|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
139161040|NCT03658772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161041|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
139161042|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161043|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161044|NCT03625323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139161045|NCT03625323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161046|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
139161047|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161048|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161049|NCT03602586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139161050|NCT03602586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161051|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
139161052|NCT03539900|Naltrexone|naltrexone|mesh-list
139161053|NCT03539900|Bupropion|bupropion|mesh-list
139161054|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139161055|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139161056|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161057|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
139161058|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161059|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139161060|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
138911516|NCT00810706|Exemestane|exemestane|mesh-list
139161061|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139161062|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139161063|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139161064|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139161065|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161066|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
139161067|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139161068|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139161069|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139161070|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161071|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139161072|NCT03535363|Osimertinib|osimertinib|mesh-list
139161073|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161074|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139161075|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892569|NCT05292664|Doxorubicin|doxorubicin|mesh-list
139161076|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161077|NCT03480191|Daptomycin|daptomycin|mesh-list
139161078|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139161079|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139161080|NCT03429543|Empagliflozin|empagliflozin|mesh-list
139161081|NCT03429543|Linagliptin|linagliptin|mesh-list
139161082|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139161083|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161084|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139161085|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161086|NCT03429543|Incretins|incretins|mesh-ancestor
139161087|NCT03429543|Hormones|hormones|mesh-ancestor
139161088|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139161089|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139161090|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
139161091|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161092|NCT03402945|Vancomycin|vancomycin|mesh-list
139161093|NCT03402945|Cefazolin|cefazolin|mesh-list
139161094|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139161095|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139161096|NCT03399552|Avelumab|avelumab|mesh-list
139161097|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161098|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161099|NCT03370276|Nivolumab|nivolumab|mesh-list
139161100|NCT03370276|Cetuximab|cetuximab|mesh-list
139161101|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161102|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161103|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139161104|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161105|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
139161106|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
139161107|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139161108|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
139161109|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139161110|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161111|NCT03292731|Progestins|progestins|mesh-ancestor
139161112|NCT03292731|Hormones|hormones|mesh-ancestor
139161113|NCT03239340|Osimertinib|osimertinib|mesh-list
139161114|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830998|NCT00605930|Niacin|niacin|mesh-list
139161115|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139161117|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161118|NCT03206073|Durvalumab|durvalumab|mesh-list
139161119|NCT03206073|Tremelimumab|tremelimumab|mesh-list
139161120|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161121|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161122|NCT03138603|Metoprolol|metoprolol|mesh-list
139161123|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139161124|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139161125|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
139161126|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
139161127|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161128|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161129|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139161130|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139161131|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139161132|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
139161133|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139161134|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161135|NCT03034356|Levetiracetam|levetiracetam|mesh-list
139161136|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
139161137|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
139161138|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
139161139|NCT02973997|Lenvatinib|lenvatinib|mesh-list
139161140|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161141|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161142|NCT02973997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139161143|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954607|NCT00332839|Cyclosporine|cyclosporine|mesh-list
139161144|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139161145|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161146|NCT02962063|Paclitaxel|paclitaxel|mesh-list
139161147|NCT02962063|Carboplatin|carboplatin|mesh-list
139161148|NCT02962063|Durvalumab|durvalumab|mesh-list
139161149|NCT02962063|Tremelimumab|tremelimumab|mesh-list
138892655|NCT05220462|Midazolam|midazolam|mesh-list
139161150|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139161151|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161152|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
139161153|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
139161154|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
139161155|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161156|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161157|NCT02941926|Letrozole|letrozole|mesh-list
139161158|NCT02941926|Leuprolide|leuprolide|mesh-list
139161159|NCT02941926|Goserelin|goserelin|mesh-list
139161160|NCT02941926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161161|NCT02941926|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139161162|NCT02941926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139161163|NCT02941926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161164|NCT02941926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161165|NCT02941926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139161166|NCT02941926|Hormone Antagonists|hormone antagonists|mesh-ancestor
139161167|NCT02941926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139161168|NCT02941926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161169|NCT02941926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139161170|NCT02941926|Fertility Agents|fertility agents|mesh-ancestor
139161171|NCT02941926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139161172|NCT02941926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139161173|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
139161174|NCT02905578|Paclitaxel|paclitaxel|mesh-list
139161175|NCT02905578|Gemcitabine|gemcitabine|mesh-list
139161176|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139161177|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161178|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
139161179|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
139161180|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
139161181|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161182|NCT02905578|Vitamins|vitamins|mesh-ancestor
139161183|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
139161184|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161185|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139161186|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
139161187|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
139161188|NCT02905578|Protective Agents|protective agents|mesh-ancestor
139161189|NCT02780024|Metformin|metformin|mesh-list
139161190|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139161191|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161192|NCT02688842|Sirolimus|sirolimus|mesh-list
139161193|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139161194|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139161195|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139161196|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161197|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
139161198|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139161199|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
139161200|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161201|NCT02671435|Bevacizumab|bevacizumab|mesh-list
139161202|NCT02671435|Cetuximab|cetuximab|mesh-list
139161203|NCT02671435|Durvalumab|durvalumab|mesh-list
139161204|NCT02671435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161205|NCT02671435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161206|NCT02671435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139161207|NCT02671435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139161208|NCT02671435|Growth Substances|growth substances|mesh-ancestor
139161209|NCT02671435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161210|NCT02671435|Growth Inhibitors|growth inhibitors|mesh-ancestor
139161211|NCT02640313|Choline|choline|mesh-list
139161212|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
139161213|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139161214|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
139161215|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161216|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139161217|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139161218|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
139161220|NCT02535312|Pemetrexed|pemetrexed|mesh-list
139161221|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161222|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161223|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161224|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139161225|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139161226|NCT02520180|Everolimus|everolimus|mesh-list
139161227|NCT02520180|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139161228|NCT02520180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139161229|NCT02520180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161230|NCT02520180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161231|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139161232|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
139161233|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161234|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161235|NCT02519348|Bevacizumab|bevacizumab|mesh-list
139161236|NCT02519348|Durvalumab|durvalumab|mesh-list
139161237|NCT02519348|Tremelimumab|tremelimumab|mesh-list
139161238|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161239|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161240|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139161241|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139161242|NCT02519348|Growth Substances|growth substances|mesh-ancestor
139161243|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161244|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
139161245|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
139161246|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
139161247|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
139161248|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139161249|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139161250|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
139161251|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
139161252|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139161253|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161254|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161255|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139161256|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
139161257|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139161258|NCT02383433|Gemcitabine|gemcitabine|mesh-list
139161259|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139161260|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
139161261|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161262|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161263|NCT02357797|Vortioxetine|vortioxetine|mesh-list
139161264|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
138892703|NCT05148715|Tacrolimus|tacrolimus|mesh-list
139161265|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139161266|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139161267|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139161268|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139161269|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161270|NCT02357797|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139161271|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139161272|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139161273|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161274|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139161275|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
139161276|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139161277|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139161278|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139161279|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139161280|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
139161281|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139161282|NCT02336074|Vorinostat|vorinostat|mesh-list
139161283|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161284|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139161285|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161286|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161287|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139161288|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
139161289|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139161290|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139161291|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139161292|NCT02313272|Bevacizumab|bevacizumab|mesh-list
139161293|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
139161294|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161295|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161296|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139161297|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139161298|NCT02313272|Growth Substances|growth substances|mesh-ancestor
139161299|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161300|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
139161301|NCT02313272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139161302|NCT02313272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161303|NCT02307812|Paclitaxel|paclitaxel|mesh-list
139161304|NCT02307812|Ramucirumab|ramucirumab|mesh-list
139161305|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139161306|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161307|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
139161308|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
139161309|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
139161310|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161311|NCT02303821|Cytarabine|cytarabine|mesh-list
139161312|NCT02303821|Dexamethasone|dexamethasone|mesh-list
139161313|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
139161314|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
139161315|NCT02303821|Methotrexate|methotrexate|mesh-list
139161316|NCT02303821|Vincristine|vincristine|mesh-list
139161317|NCT02303821|Daunorubicin|daunorubicin|mesh-list
139161318|NCT02303821|Asparaginase|asparaginase|mesh-list
139161319|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
139161320|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
139161321|NCT02303821|Pegaspargase|pegaspargase|mesh-list
139161322|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139161323|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
139161324|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161325|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139161326|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139161327|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
139161328|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161329|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161330|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139161331|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139161332|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
139161333|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
139161334|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161335|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139161336|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
139161337|NCT02303821|Hormones|hormones|mesh-ancestor
139161338|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139161339|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139161340|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139161341|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
139161342|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139161343|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139161344|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
139161345|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
139161346|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161347|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139161348|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139161349|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
139161350|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139161351|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139161352|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
139161353|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
139161354|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
139161355|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139161356|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139161357|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139161358|NCT02303821|Analgesics|analgesics|mesh-ancestor
139161359|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
139161360|NCT02254031|Maytansine|maytansine|mesh-list
139161361|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
139161362|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139161363|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161364|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
139161365|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
139161366|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
139161367|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161368|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161370|NCT02254031|Immunoconjugates|immunoconjugates|mesh-ancestor
139161371|NCT02254031|Immunologic Factors|immunologic factors|mesh-ancestor
139161372|NCT02254031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161373|NCT02254005|Maytansine|maytansine|mesh-list
139161374|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
139161375|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139161376|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161377|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
139161378|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
139161379|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
139161380|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161381|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161382|NCT02254005|Immunotoxins|immunotoxins|mesh-ancestor
139161383|NCT02254005|Immunoconjugates|immunoconjugates|mesh-ancestor
139161384|NCT02254005|Immunologic Factors|immunologic factors|mesh-ancestor
139161385|NCT02254005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161386|NCT02231931|Metformin|metformin|mesh-list
139161387|NCT02231931|Digoxin|digoxin|mesh-list
139161388|NCT02231931|Furosemide|furosemide|mesh-list
139161389|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139161390|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139161391|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161392|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139161393|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139161394|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
138892785|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
139161395|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161396|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139161397|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139161398|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161399|NCT02231931|Diuretics|diuretics|mesh-ancestor
139161400|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
139210425|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
139161401|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139161402|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139161403|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139161404|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139161405|NCT02231931|Protective Agents|protective agents|mesh-ancestor
139161406|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139161407|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139161408|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139161409|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139161410|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161411|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139161412|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161413|NCT02229825|Analgesics|analgesics|mesh-ancestor
139161414|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
139161415|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161416|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
139161417|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139161418|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
139161419|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
139161420|NCT02112916|Leucovorin|leucovorin|mesh-list
139161421|NCT02112916|Folic Acid|folic acid|mesh-list
139161422|NCT02112916|Cytarabine|cytarabine|mesh-list
139161423|NCT02112916|Dexamethasone|dexamethasone|mesh-list
139161424|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
139161425|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
139161426|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139161427|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139161428|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139161429|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
139161430|NCT02112916|Ifosfamide|ifosfamide|mesh-list
139161431|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
139161432|NCT02112916|Doxorubicin|doxorubicin|mesh-list
139161433|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139161434|NCT02112916|Methotrexate|methotrexate|mesh-list
139161435|NCT02112916|Etoposide|etoposide|mesh-list
139161436|NCT02112916|Vincristine|vincristine|mesh-list
139161437|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
139161438|NCT02112916|Bortezomib|bortezomib|mesh-list
139161439|NCT02112916|Daunorubicin|daunorubicin|mesh-list
139161440|NCT02112916|Asparaginase|asparaginase|mesh-list
139161441|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
139161442|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
139161443|NCT02112916|Pegaspargase|pegaspargase|mesh-list
139161444|NCT02112916|Thioguanine|thioguanine|mesh-list
139161445|NCT02112916|BB 1101|bb 1101|mesh-list
139161446|NCT02112916|Calcium|calcium|mesh-list
139161447|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
139161448|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
139161449|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139161450|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
139161451|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161452|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139161453|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139161454|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
139161455|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161456|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161457|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139161458|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139161459|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
139161460|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
139161461|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161462|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139161463|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
139161464|NCT02112916|Hormones|hormones|mesh-ancestor
139210468|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
139161465|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139161466|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139161467|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
139161468|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161469|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139161470|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139161471|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139161472|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139161473|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139161474|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139161475|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
139161476|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139161477|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139161478|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
139161479|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
139161480|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139161481|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139161482|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139161483|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
139161484|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139161485|NCT02112916|Antidotes|antidotes|mesh-ancestor
139161486|NCT02112916|Protective Agents|protective agents|mesh-ancestor
139161487|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
139161488|NCT02112916|Vitamins|vitamins|mesh-ancestor
139161489|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
139161490|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
139161491|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
139161492|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
139161493|NCT02112916|Hematinics|hematinics|mesh-ancestor
139161494|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
139161495|NCT02065765|Ramucirumab|ramucirumab|mesh-list
139161496|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161497|NCT01981551|Nirogacestat|nirogacestat|mesh-list
139161498|NCT01981551|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139161499|NCT01981551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161500|NCT01981551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161501|NCT01920737|Leucovorin|leucovorin|mesh-list
139161502|NCT01920737|Cytarabine|cytarabine|mesh-list
139161503|NCT01920737|Dexamethasone|dexamethasone|mesh-list
139161504|NCT01920737|Prednisone|prednisone|mesh-list
139161505|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
139161506|NCT01920737|Methotrexate|methotrexate|mesh-list
139161507|NCT01920737|Vincristine|vincristine|mesh-list
139161508|NCT01920737|Daunorubicin|daunorubicin|mesh-list
139161509|NCT01920737|Asparaginase|asparaginase|mesh-list
139161510|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
139161511|NCT01920737|Pegaspargase|pegaspargase|mesh-list
139161512|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138892842|NCT04915612|Immunotoxins|immunotoxins|mesh-ancestor
139161513|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
139161514|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161516|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139161517|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
139161518|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161519|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161520|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139161521|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139161523|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
139161524|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161525|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139161526|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
139161527|NCT01920737|Hormones|hormones|mesh-ancestor
139161528|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139161529|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139161530|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139161531|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
139161532|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139161533|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139161534|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
139161535|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
139161536|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161537|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139161538|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139161539|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
139161540|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139161541|NCT01920737|Antidotes|antidotes|mesh-ancestor
139161542|NCT01920737|Protective Agents|protective agents|mesh-ancestor
139161543|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
139161544|NCT01920737|Vitamins|vitamins|mesh-ancestor
139161545|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
139161546|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139161547|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
139161548|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
139161549|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
139161550|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139161551|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139161552|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139161553|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
139161554|NCT01852890|Gemcitabine|gemcitabine|mesh-list
139161555|NCT01852890|Vitamins|vitamins|mesh-ancestor
139161556|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
139161557|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161558|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139161559|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
139161560|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161561|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161562|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
139161563|NCT01852890|Protective Agents|protective agents|mesh-ancestor
139161564|NCT01788774|Risperidone|risperidone|mesh-list
139161565|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139161566|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
139161567|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139161568|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161569|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161570|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139161571|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139161572|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139161573|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139161574|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139161575|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
139161576|NCT01755975|Lenalidomide|lenalidomide|mesh-list
139161577|NCT01755975|Romidepsin|romidepsin|mesh-list
139161578|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
139161579|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161580|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139161581|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139161582|NCT01755975|Growth Substances|growth substances|mesh-ancestor
139161583|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
139161584|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161585|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139161586|NCT01755975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139161587|NCT01755975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161588|NCT01755975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161589|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
139161590|NCT01752491|Temozolomide|temozolomide|mesh-list
139161591|NCT01752491|Vitamins|vitamins|mesh-ancestor
139161592|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
139161593|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161594|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139161595|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
139161596|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161597|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161598|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
139161599|NCT01752491|Protective Agents|protective agents|mesh-ancestor
139161600|NCT01750281|Docetaxel|docetaxel|mesh-list
139161601|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161602|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
139161603|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
139161604|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
139161605|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161606|NCT01494662|Capecitabine|capecitabine|mesh-list
139161607|NCT01494662|Trastuzumab|trastuzumab|mesh-list
139161608|NCT01494662|Maytansine|maytansine|mesh-list
139161609|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139161610|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139161611|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
139161612|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161613|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161614|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161615|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139161616|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
139161617|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
139161618|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
139161619|NCT01494662|Immunotoxins|immunotoxins|mesh-ancestor
139161620|NCT01494662|Immunoconjugates|immunoconjugates|mesh-ancestor
139161621|NCT01494662|Immunologic Factors|immunologic factors|mesh-ancestor
139161622|NCT01494662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161623|NCT01205061|Lidocaine|lidocaine|mesh-list
139161624|NCT01205061|Anesthetics, Local|anesthetics, local|mesh-ancestor
139161625|NCT01205061|Anesthetics|anesthetics|mesh-ancestor
139161626|NCT01205061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139161627|NCT01205061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161628|NCT01205061|Sensory System Agents|sensory system agents|mesh-ancestor
139161629|NCT01205061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161630|NCT01205061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139161631|NCT01205061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139161632|NCT01205061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139161633|NCT01205061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139161634|NCT01205061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161636|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139161637|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
139161638|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161639|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161640|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139161641|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139161642|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
139161643|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139161644|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161645|NCT00736450|Prednisone|prednisone|mesh-list
139161646|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
139161647|NCT00736450|Rituximab|rituximab|mesh-list
139161648|NCT00736450|Doxorubicin|doxorubicin|mesh-list
139161649|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139161650|NCT00736450|Vincristine|vincristine|mesh-list
139161651|NCT00736450|Oblimersen|oblimersen|mesh-list
139161652|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139161653|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
139161654|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161655|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139161656|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139161657|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
139161658|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161659|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161660|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139161661|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138954624|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831548|NCT03393741|Taxane|taxane|mesh-list
139161662|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139161663|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139161664|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139161665|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161666|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139161667|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
139161668|NCT00736450|Hormones|hormones|mesh-ancestor
139161669|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139161670|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139161671|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139161672|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
139161673|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
139161674|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
139161675|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
139161676|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
139161677|NCT00611351|Busulfan|busulfan|mesh-list
139161678|NCT00611351|Tacrolimus|tacrolimus|mesh-list
139161679|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139161680|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139161681|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
139161682|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161683|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139161684|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139161685|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
139161686|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161687|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161688|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139161689|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139161690|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161691|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139161692|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139161693|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
139161694|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139161695|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139161696|NCT00572936|Timolol|timolol|mesh-list
139161697|NCT00572936|Dorzolamide|dorzolamide|mesh-list
139161698|NCT00572936|Latanoprost|latanoprost|mesh-list
139161699|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139161700|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139161701|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
139161702|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139161703|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161704|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161705|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139161706|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139161707|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139161708|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139161709|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139161710|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161711|NCT00571662|Cyclosporine|cyclosporine|mesh-list
139161712|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
139161713|NCT00571662|Pentostatin|pentostatin|mesh-list
139161714|NCT00571662|Cyclosporins|cyclosporins|mesh-list
139161715|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161716|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161717|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139161718|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
139161719|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161720|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
139161721|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139161722|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
139161723|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139161724|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139161725|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139161726|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161727|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139161728|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
139161729|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139161730|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139161731|NCT00436254|Molgramostim|molgramostim|mesh-list
139161732|NCT00436254|Sargramostim|sargramostim|mesh-list
139161733|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
139161734|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161735|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161736|NCT00383032|Mifepristone|mifepristone|mesh-list
139161737|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139161738|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
139161739|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139161740|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161741|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139161742|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139161743|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139161744|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
138892885|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139161745|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139161746|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139161747|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
139161748|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139161749|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
139161750|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139161751|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139161752|NCT00310765|Pregabalin|pregabalin|mesh-list
139161753|NCT00310765|Analgesics|analgesics|mesh-ancestor
139161754|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
139161755|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161756|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161757|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
139161758|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139161759|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139161760|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161761|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139161762|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139161763|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139161764|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139161765|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139161766|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139161767|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139161768|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139161769|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139161770|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161771|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139161772|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161773|NCT00071708|Analgesics|analgesics|mesh-ancestor
139161774|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
139161775|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161776|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
139161777|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139161778|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
139161779|NCT05534672|Sirolimus|sirolimus|mesh-list
139161780|NCT05534672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139161781|NCT05534672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139161782|NCT05534672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139161783|NCT05534672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161784|NCT05534672|Antifungal Agents|antifungal agents|mesh-ancestor
139161785|NCT05534672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139161786|NCT05534672|Immunologic Factors|immunologic factors|mesh-ancestor
139161787|NCT05534672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161788|NCT05527548|Alendronate|alendronate|mesh-list
139161789|NCT05527548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139161790|NCT05527548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161791|NCT05498675|Valsartan|valsartan|mesh-list
139161792|NCT05498675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139161793|NCT05498675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139161794|NCT05498675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139161795|NCT05498675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139161796|NCT05498675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161797|NCT05390528|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139161798|NCT05390528|Immunologic Factors|immunologic factors|mesh-ancestor
139161799|NCT05390528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161800|NCT05374057|Ibuprofen|ibuprofen|mesh-list
139161801|NCT05374057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139161802|NCT05374057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139161803|NCT05374057|Analgesics|analgesics|mesh-ancestor
139161804|NCT05374057|Sensory System Agents|sensory system agents|mesh-ancestor
139161805|NCT05374057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161806|NCT05374057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161807|NCT05374057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139161808|NCT05374057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139161809|NCT05374057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139161810|NCT05374057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161811|NCT05374057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161812|NCT05352516|Denosumab|denosumab|mesh-list
139161813|NCT05352516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139161814|NCT05352516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161815|NCT05345613|Epinephrine|epinephrine|mesh-list
139161816|NCT05345613|Tranexamic Acid|tranexamic acid|mesh-list
139161817|NCT05345613|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139161818|NCT05345613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138912260|NCT04111380|Paclitaxel|paclitaxel|mesh-list
139161819|NCT05345613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161820|NCT05345613|Hemostatics|hemostatics|mesh-ancestor
139161821|NCT05345613|Coagulants|coagulants|mesh-ancestor
139161822|NCT05345613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139161823|NCT05345613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139161824|NCT05345613|Adrenergic Agents|adrenergic agents|mesh-ancestor
139161825|NCT05345613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139161826|NCT05345613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161827|NCT05345613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139161828|NCT05345613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139161829|NCT05345613|Autonomic Agents|autonomic agents|mesh-ancestor
139161830|NCT05345613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161831|NCT05345613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138892953|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
139161832|NCT05345613|Respiratory System Agents|respiratory system agents|mesh-ancestor
139161833|NCT05345613|Mydriatics|mydriatics|mesh-ancestor
139161834|NCT05345613|Sympathomimetics|sympathomimetics|mesh-ancestor
139161835|NCT05345613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139161836|NCT05222516|Broncho-Vaxom|broncho-vaxom|mesh-list
139161837|NCT05222516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139161838|NCT05222516|Immunologic Factors|immunologic factors|mesh-ancestor
139161839|NCT05222516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161840|NCT05139043|Dexamethasone|dexamethasone|mesh-list
139161841|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
139161842|NCT05139043|Ichthammol|ichthammol|mesh-list
139161843|NCT05139043|BB 1101|bb 1101|mesh-list
139161844|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139161845|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
139161846|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
139161847|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161848|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161849|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139161850|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
139161851|NCT05139043|Hormones|hormones|mesh-ancestor
139161852|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139161853|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139161854|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161855|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
139161856|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161857|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161858|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
139161859|NCT05116293|Acetaminophen|acetaminophen|mesh-list
139161860|NCT05116293|Digoxin|digoxin|mesh-list
139161861|NCT05116293|Midazolam|midazolam|mesh-list
139161862|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139161863|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139161864|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139161865|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161866|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139161867|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139161868|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139161869|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139161870|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
139161871|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
139161872|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
139161873|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
139161874|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139161875|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161876|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139161877|NCT05116293|Analgesics|analgesics|mesh-ancestor
139161878|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
139161879|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161880|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
139161881|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139161882|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139161883|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161884|NCT05116293|Protective Agents|protective agents|mesh-ancestor
139161885|NCT05116189|Paclitaxel|paclitaxel|mesh-list
139161886|NCT05116189|Docetaxel|docetaxel|mesh-list
139161887|NCT05116189|Bevacizumab|bevacizumab|mesh-list
139161888|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
139161889|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139161890|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161891|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
139161892|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
139161893|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
139161894|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161895|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161896|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139161897|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139161898|NCT05116189|Growth Substances|growth substances|mesh-ancestor
139161899|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161900|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
139161901|NCT05116189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139161903|NCT05104567|Cetuximab|cetuximab|mesh-list
139161904|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139161905|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161906|NCT05104567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139161907|NCT05104567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161908|NCT05097651|Cannabidiol|cannabidiol|mesh-list
139161909|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
139161910|NCT05086224|Lidocaine|lidocaine|mesh-list
139161911|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
139161912|NCT05086224|Anesthetics|anesthetics|mesh-list
139161913|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139161914|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161915|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
139161916|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161917|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139161918|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139161919|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139161920|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139161921|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161922|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
139161923|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161924|NCT04996251|Bupivacaine|bupivacaine|mesh-list
139161925|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
139161926|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
139161927|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139161928|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161929|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
139161930|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161931|NCT04976387|Acetaminophen|acetaminophen|mesh-list
139161932|NCT04976387|Ibuprofen|ibuprofen|mesh-list
139161933|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139161934|NCT04976387|Hydrocodone|hydrocodone|mesh-list
139161935|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139161936|NCT04976387|Analgesics|analgesics|mesh-ancestor
139161937|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
139161938|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161939|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161940|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
139161941|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139161942|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139161943|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139161944|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139161945|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161946|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161947|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139161948|NCT04976387|Narcotics|narcotics|mesh-ancestor
139161949|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139161950|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
139161951|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
139161952|NCT04941872|FAPI-46|fapi-46|mesh-list
139161953|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139161954|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161955|NCT04915755|Niraparib|niraparib|mesh-list
139161956|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139161957|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161958|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161959|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161960|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
139161961|NCT04897321|Fludarabine|fludarabine|mesh-list
139161962|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139161963|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
139161964|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161965|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139161966|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139161967|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
139161968|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161969|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161970|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139161971|NCT04879823|Acetaminophen|acetaminophen|mesh-list
139161972|NCT04879823|Dexamethasone|dexamethasone|mesh-list
139161973|NCT04879823|Ibuprofen|ibuprofen|mesh-list
139161974|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139161975|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
139161976|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
139161977|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139161978|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139161979|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139161980|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
139161981|NCT04879823|Hormones|hormones|mesh-ancestor
139161982|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139161983|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139161984|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139161985|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139161986|NCT04879823|Analgesics|analgesics|mesh-ancestor
139161987|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
139161988|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
139161989|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139161990|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139161991|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139161992|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139161993|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161994|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
139161995|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139161996|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139161997|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139161998|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
138893092|NCT04469075|Hormones|hormones|mesh-ancestor
139161999|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162000|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162001|NCT04844918|Tirzepatide|tirzepatide|mesh-list
139162002|NCT04844918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139162003|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162004|NCT04844918|Incretins|incretins|mesh-ancestor
139162005|NCT04844918|Hormones|hormones|mesh-ancestor
139162006|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139162007|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139162008|NCT04826354|Ezetimibe|ezetimibe|mesh-list
139162009|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139162010|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139162011|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
139162012|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162013|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139162014|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139162015|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162016|NCT04781998|Liraglutide|liraglutide|mesh-list
139162017|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139162018|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162019|NCT04781998|Incretins|incretins|mesh-ancestor
139162020|NCT04781998|Hormones|hormones|mesh-ancestor
139162021|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139162022|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139162023|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139162024|NCT04708613|Corticosterone|corticosterone|mesh-list
139162025|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139162026|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139162027|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
139162028|NCT04664738|Coagulants|coagulants|mesh-ancestor
139162029|NCT04601402|Avelumab|avelumab|mesh-list
139162030|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139162031|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162032|NCT04562246|Antibodies|antibodies|mesh-list
139162033|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
139162034|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162035|NCT04545710|Osimertinib|osimertinib|mesh-list
139162036|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162037|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139162038|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162039|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162040|NCT04539938|Trastuzumab|trastuzumab|mesh-list
139162041|NCT04539938|Tucatinib|tucatinib|mesh-list
139162042|NCT04539938|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139162043|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139162044|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162045|NCT04539938|Immunoconjugates|immunoconjugates|mesh-ancestor
139162046|NCT04539938|Immunologic Factors|immunologic factors|mesh-ancestor
139162047|NCT04539938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162048|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139162049|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162050|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162051|NCT04530981|Repaglinide|repaglinide|mesh-list
139162052|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139162053|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162054|NCT04520178|Carbidopa|carbidopa|mesh-list
139162055|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
139162056|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139162057|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139162058|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
139162059|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162060|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162061|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162062|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139162063|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162064|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139162065|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
139162066|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139162067|NCT04418427|Aflibercept|aflibercept|mesh-list
139162068|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139162069|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139162070|NCT04418427|Growth Substances|growth substances|mesh-ancestor
139162071|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162072|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
139162073|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162074|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139162075|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139162076|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162077|NCT04398368|Gemcitabine|gemcitabine|mesh-list
138960841|NCT03903640|Ipilimumab|ipilimumab|mesh-list
139162078|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139162079|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
139162080|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162081|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162082|NCT04378959|Lidocaine|lidocaine|mesh-list
139162083|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
139162084|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
139162085|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139162086|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162088|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139162089|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139162090|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139162091|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139162092|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139162093|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162094|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
139162095|NCT04310930|Azithromycin|azithromycin|mesh-list
139162096|NCT04310930|Clarithromycin|clarithromycin|mesh-list
139162097|NCT04310930|Doxycycline|doxycycline|mesh-list
139162098|NCT04310930|Linezolid|linezolid|mesh-list
139162099|NCT04310930|Imipenem|imipenem|mesh-list
139162100|NCT04310930|Amikacin|amikacin|mesh-list
139162101|NCT04310930|Ethambutol|ethambutol|mesh-list
139162102|NCT04310930|Rifabutin|rifabutin|mesh-list
139162103|NCT04310930|Tigecycline|tigecycline|mesh-list
139162104|NCT04310930|Bedaquiline|bedaquiline|mesh-list
139162105|NCT04310930|Clofazimine|clofazimine|mesh-list
139162106|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139162107|NCT04310930|Cefoxitin|cefoxitin|mesh-list
139162108|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139162109|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139162110|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139162111|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139162112|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162113|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162114|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162115|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139162116|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139162117|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139162118|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
139162119|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139162120|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139162121|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
139162122|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139162123|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139162124|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
139162125|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139162126|NCT04297995|Carboplatin|carboplatin|mesh-list
139162127|NCT04297995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162128|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
139162129|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139162130|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
139162131|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162132|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
139162133|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139162134|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139162135|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139162136|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139162137|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162138|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162139|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162140|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
139162141|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139162142|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
139162143|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162144|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
139162145|NCT04196413|Fludarabine|fludarabine|mesh-list
139162146|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139162147|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
139162148|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162149|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139162150|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139162151|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
139162152|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162153|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162154|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139162155|NCT04164732|Valsartan|valsartan|mesh-list
139162156|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139162157|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139162158|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139162159|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139162160|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162161|NCT04117932|Ustekinumab|ustekinumab|mesh-list
139162162|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
139162163|NCT04033354|Paclitaxel|paclitaxel|mesh-list
139162164|NCT04033354|Carboplatin|carboplatin|mesh-list
139162165|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139162166|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162167|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
139162168|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
139162169|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
139162170|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162171|NCT03952403|Bevacizumab|bevacizumab|mesh-list
139162172|NCT03952403|Carboplatin|carboplatin|mesh-list
139162173|NCT03952403|Pemetrexed|pemetrexed|mesh-list
139162174|NCT03952403|Antibodies|antibodies|mesh-list
139162175|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139162176|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162177|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139162178|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139162179|NCT03952403|Growth Substances|growth substances|mesh-ancestor
139162180|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162181|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
139162182|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
139162183|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162184|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162185|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139162186|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139162187|NCT03918278|Paclitaxel|paclitaxel|mesh-list
139162188|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139162189|NCT03918278|Carboplatin|carboplatin|mesh-list
139162190|NCT03918278|Gemcitabine|gemcitabine|mesh-list
139162191|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
139162192|NCT03918278|Pemetrexed|pemetrexed|mesh-list
139162193|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139162194|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162195|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
139162196|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
139162197|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
139162198|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162199|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139162200|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
139162201|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139162202|NCT03918278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139162203|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162204|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138893184|NCT04269200|Paclitaxel|paclitaxel|mesh-list
139162205|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139162206|NCT03748784|Aflibercept|aflibercept|mesh-list
139162207|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139162208|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139162209|NCT03748784|Growth Substances|growth substances|mesh-ancestor
139162210|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162211|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
139162212|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162213|NCT03727776|Hormones|hormones|mesh-list
139162214|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139162215|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139162216|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
139162217|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139162218|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162219|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162220|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162221|NCT03654274|Norethindrone|norethindrone|mesh-list
139162222|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
139162223|NCT03654274|Estradiol|estradiol|mesh-list
139162224|NCT03654274|Relugolix|relugolix|mesh-list
139162225|NCT03654274|Estrogens|estrogens|mesh-ancestor
139162226|NCT03654274|Hormones|hormones|mesh-ancestor
139162227|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139162228|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162229|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139162230|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
139162231|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139162232|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138954650|NCT00983788|Bezafibrate|bezafibrate|mesh-list
139162233|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139162234|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139162235|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139162236|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
139162237|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
139162238|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
139162239|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139162240|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162241|NCT03417882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139019576|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139162242|NCT03417882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162243|NCT03330457|Betrixaban|betrixaban|mesh-list
139162244|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139162245|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
139162246|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139162247|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
139162248|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162249|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162250|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
139162251|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139162252|NCT03286556|Autoantibodies|autoantibodies|mesh-list
139162253|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139162254|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
139162255|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162256|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139162257|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139162259|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139162260|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162261|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
139162262|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162263|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162264|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
139162265|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139162266|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
139162267|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162268|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139162269|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138912709|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139162270|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
139162271|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162272|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162273|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139162275|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
139162276|NCT03083704|Apixaban|apixaban|mesh-list
139162277|NCT03083704|Edoxaban|edoxaban|mesh-list
139162278|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
139162279|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139162280|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
139162281|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139162282|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
139162283|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162284|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162285|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
139162286|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139162287|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139162288|NCT03059940|Nicotine|nicotine|mesh-list
139162289|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
139162290|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139162291|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
139162292|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139162293|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162294|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139162295|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139162296|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
139162297|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162298|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162299|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
139162300|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
139162301|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
139162302|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139162303|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162304|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
139162305|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139162307|NCT02596100|Betrixaban|betrixaban|mesh-list
139162308|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139162309|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
139162310|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139162311|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
139162312|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162313|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162314|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
139162315|NCT02319837|Leuprolide|leuprolide|mesh-list
139162316|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139162317|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
139162318|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139162319|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162320|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139162321|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162322|NCT01782352|Vitamin D|vitamin d|mesh-list
139162323|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
139162324|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
139162325|NCT01782352|Vitamins|vitamins|mesh-list
139162326|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
139162327|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162328|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139162329|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139162330|NCT01765868|Betrixaban|betrixaban|mesh-list
139162331|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139162332|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
139162333|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139162334|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
139162335|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162336|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162337|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
139162338|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139162339|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
139162340|NCT01641718|Coagulants|coagulants|mesh-ancestor
139162341|NCT00968799|Cisplatin|cisplatin|mesh-list
139162342|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162343|NCT00751231|Clopidogrel|clopidogrel|mesh-list
139162344|NCT00751231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139162345|NCT00751231|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139162346|NCT00751231|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139162347|NCT00751231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139162348|NCT00751231|Purinergic Agents|purinergic agents|mesh-ancestor
139162349|NCT00751231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162350|NCT00751231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162351|NCT00751231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162352|NCT00332956|Vaccines|vaccines|mesh-list
139162353|NCT00332956|Immunologic Factors|immunologic factors|mesh-ancestor
139162354|NCT00332956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162355|NCT00324220|Mocetinostat|mocetinostat|mesh-list
139162356|NCT00324220|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139162357|NCT00324220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162358|NCT00324220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162359|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139162360|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139162361|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162362|NCT00417118|Escitalopram|escitalopram|mesh-list
139162363|NCT00417118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139162364|NCT00417118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139162365|NCT00417118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139162366|NCT00417118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162367|NCT00417118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162368|NCT00417118|Serotonin Agents|serotonin agents|mesh-ancestor
139162369|NCT00417118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162370|NCT02883452|Infliximab|infliximab|mesh-list
139162371|NCT02883452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138960911|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
139162372|NCT02883452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139162373|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
139162374|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139162375|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139162376|NCT00508066|Bupivacaine|bupivacaine|mesh-list
139162377|NCT00508066|Anesthetics, Local|anesthetics, local|mesh-ancestor
139162378|NCT00508066|Anesthetics|anesthetics|mesh-ancestor
139162379|NCT00508066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139162380|NCT00508066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162381|NCT00508066|Sensory System Agents|sensory system agents|mesh-ancestor
139162382|NCT00508066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139162383|NCT01336010|Ribavirin|ribavirin|mesh-list
139162384|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139162385|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
139162386|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162387|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
139162388|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139162389|NCT02207504|Crizotinib|crizotinib|mesh-list
139162390|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162391|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139162392|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162393|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162394|NCT01342016|Prednisone|prednisone|mesh-list
139162395|NCT01342016|Tacrolimus|tacrolimus|mesh-list
139162396|NCT01342016|Leflunomide|leflunomide|mesh-list
139162397|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139162398|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
139162399|NCT01342016|Hormones|hormones|mesh-ancestor
139162400|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139162401|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162402|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139162403|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162404|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139162405|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
139162406|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139162407|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162408|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162409|NCT01336166|Vaccines|vaccines|mesh-list
139162410|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
139162411|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162412|NCT04470310|Pioglitazone|pioglitazone|mesh-list
139162413|NCT04470310|Glimepiride|glimepiride|mesh-list
139162414|NCT04470310|Alogliptin|alogliptin|mesh-list
139162415|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139162416|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162417|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139162418|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139162419|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
139162420|NCT04470310|Incretins|incretins|mesh-ancestor
139162421|NCT04470310|Hormones|hormones|mesh-ancestor
139162422|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139162423|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139162424|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
139162425|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162426|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162427|NCT02083250|Fludarabine|fludarabine|mesh-list
139162428|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
139162429|NCT02083250|Busulfan|busulfan|mesh-list
139162430|NCT02083250|Vorinostat|vorinostat|mesh-list
139162431|NCT02083250|Clofarabine|clofarabine|mesh-list
139162432|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
139162433|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139162434|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162435|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139162436|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
139162437|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162438|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139162439|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
139162440|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162441|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
139162442|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139162443|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139162444|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139162445|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162446|NCT00412828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
139162447|NCT00412828|Immunoconjugates|immunoconjugates|mesh-ancestor
139162448|NCT00412828|Immunologic Factors|immunologic factors|mesh-ancestor
139162449|NCT00412828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162450|NCT00412828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139162451|NCT00412828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162453|NCT00315640|Anecortave|anecortave|mesh-list
139162454|NCT00315640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139162455|NCT00315640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139162456|NCT00315640|Growth Substances|growth substances|mesh-ancestor
139162457|NCT00315640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162458|NCT00315640|Growth Inhibitors|growth inhibitors|mesh-ancestor
139162459|NCT00315640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162460|NCT00315640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139162461|NCT00411892|Insulin|insulin|mesh-list
139162462|NCT00411892|Pioglitazone|pioglitazone|mesh-list
139162463|NCT00411892|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139162464|NCT00411892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139162465|NCT00411892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162466|NCT01336322|Metformin|metformin|mesh-list
139162467|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139162468|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139162469|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162470|NCT01336322|Incretins|incretins|mesh-ancestor
139162471|NCT01336322|Hormones|hormones|mesh-ancestor
139162472|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139162473|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139162474|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
139162475|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162476|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162477|NCT01339676|Vitamin D|vitamin d|mesh-list
139162478|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
139162479|NCT01339676|Vitamins|vitamins|mesh-ancestor
139162480|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
139162481|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162482|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139162483|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139162484|NCT01339754|Trabectedin|trabectedin|mesh-list
139162485|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139162486|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
139162487|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162488|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162489|NCT00313768|Paclitaxel|paclitaxel|mesh-list
138960961|NCT00773630|Cilostazol|cilostazol|mesh-list
139162490|NCT00313768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139162491|NCT00313768|Bevacizumab|bevacizumab|mesh-list
139162492|NCT00313768|Carboplatin|carboplatin|mesh-list
139162493|NCT00313768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139162494|NCT00313768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912936|NCT00640510|Olanzapine|olanzapine|mesh-list
139162495|NCT00313768|Tubulin Modulators|tubulin modulators|mesh-ancestor
139162496|NCT00313768|Antimitotic Agents|antimitotic agents|mesh-ancestor
139162497|NCT00313768|Mitosis Modulators|mitosis modulators|mesh-ancestor
139162498|NCT00313768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162499|NCT00313768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139162500|NCT00313768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139162501|NCT00313768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139162502|NCT00313768|Growth Substances|growth substances|mesh-ancestor
139162503|NCT00313768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162504|NCT00313768|Growth Inhibitors|growth inhibitors|mesh-ancestor
139162505|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
139162506|NCT01339988|Busulfan|busulfan|mesh-list
139162507|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139162508|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
139162509|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162510|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139162511|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139162512|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
139162513|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162514|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162515|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139162516|NCT00406588|Levodopa|levodopa|mesh-list
139162517|NCT00406588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139162518|NCT00406588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139162519|NCT00406588|Dopamine Agents|dopamine agents|mesh-ancestor
139162520|NCT00406588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162521|NCT00406588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162522|NCT00406588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162523|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
139162524|NCT01342328|Propofol|propofol|mesh-list
138954660|NCT00983944|Etoposide|etoposide|mesh-list
139162525|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139162526|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139162527|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162528|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139162529|NCT01342328|Analgesics|analgesics|mesh-ancestor
139162530|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
139162531|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139162532|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139162533|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139162534|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138893367|NCT04179162|Gemcitabine|gemcitabine|mesh-list
139162535|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
139162536|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162537|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162538|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139162539|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
139162540|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
139162542|NCT00313222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139162543|NCT00313222|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139162544|NCT00313222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162545|NCT05184530|Evolocumab|evolocumab|mesh-list
139162546|NCT05184530|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139162547|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139162549|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
139162550|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162551|NCT05184530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139162552|NCT05184530|Protease Inhibitors|protease inhibitors|mesh-ancestor
139162553|NCT05184530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162554|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139162555|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139162556|NCT05184374|Hormones|hormones|mesh-ancestor
139162557|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139162558|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162559|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139162560|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
139162561|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
139162562|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139162563|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162564|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
139162565|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139162566|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139162567|NCT01342562|Anesthetics|anesthetics|mesh-list
139162568|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139162569|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162570|NCT00116116|Lamivudine|lamivudine|mesh-list
139162571|NCT00116116|Efavirenz|efavirenz|mesh-list
139162572|NCT00116116|Stavudine|stavudine|mesh-list
139162573|NCT00116116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139162574|NCT00116116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139162575|NCT00116116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162576|NCT00116116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162577|NCT00116116|Antiviral Agents|antiviral agents|mesh-ancestor
139162578|NCT00116116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139162579|NCT00116116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139162580|NCT00116116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139162581|NCT00116116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139162582|NCT00116116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139162583|NCT00116116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139162584|NCT00116116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139162585|NCT00116116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139162586|NCT00116116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139162587|NCT00116116|Antimetabolites|antimetabolites|mesh-ancestor
139162588|NCT02287870|Lidocaine|lidocaine|mesh-list
139162589|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
139162590|NCT02287870|Procaine|procaine|mesh-list
139162591|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
139162592|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
139162593|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139162594|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162595|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
139162596|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139162597|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139162598|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139162599|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139162600|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139162601|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162602|NCT01340456|Rifampin|rifampin|mesh-list
139162603|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139162604|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
139162605|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139162606|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139162607|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
139162608|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139162609|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162610|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162611|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139162612|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139162613|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139162614|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139162615|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139162616|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139162617|NCT00110422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139162619|NCT00110422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139162620|NCT00110422|Diuretics|diuretics|mesh-ancestor
139162621|NCT00110422|Natriuretic Agents|natriuretic agents|mesh-ancestor
139162622|NCT00110422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162623|NCT00110422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139162624|NCT00110422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139162625|NCT00110422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162626|NCT00110422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139162627|NCT00110422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139162628|NCT00305656|Cediranib|cediranib|mesh-list
139162629|NCT00305656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162630|NCT00305656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162631|NCT00305656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162632|NCT00305656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139162633|NCT02284984|Rituximab|rituximab|mesh-list
139162634|NCT02284984|Belimumab|belimumab|mesh-list
139162635|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139162636|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162637|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
139162638|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162639|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139162640|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139162641|NCT00305188|Leucovorin|leucovorin|mesh-list
139162642|NCT00305188|Fluorouracil|fluorouracil|mesh-list
139162643|NCT00305188|Oxaliplatin|oxaliplatin|mesh-list
139162644|NCT00305188|Xaliproden|xaliproden|mesh-list
139162645|NCT00305188|Antimetabolites|antimetabolites|mesh-ancestor
139162646|NCT00305188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162647|NCT00305188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139162648|NCT00305188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162649|NCT00305188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139162650|NCT00305188|Immunologic Factors|immunologic factors|mesh-ancestor
139162651|NCT00305188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162652|NCT00305188|Antidotes|antidotes|mesh-ancestor
139162653|NCT00305188|Protective Agents|protective agents|mesh-ancestor
139162654|NCT00305188|Vitamin B Complex|vitamin b complex|mesh-ancestor
139162655|NCT00305188|Vitamins|vitamins|mesh-ancestor
139162656|NCT00305188|Micronutrients|micronutrients|mesh-ancestor
139162657|NCT00305188|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139162658|NCT00305188|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139162659|NCT00305188|Serotonin Agents|serotonin agents|mesh-ancestor
139162660|NCT00305188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162661|NCT00297310|Tacrolimus|tacrolimus|mesh-list
139162662|NCT00297310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139162663|NCT00297310|Immunologic Factors|immunologic factors|mesh-ancestor
139162664|NCT00297310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162665|NCT00297310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139162666|NCT00297310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162667|NCT00297310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162668|NCT00095290|Ramipril|ramipril|mesh-list
139162669|NCT00095290|Irbesartan|irbesartan|mesh-list
138961003|NCT00307489|Tenofovir|tenofovir|mesh-list
139162670|NCT00095290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139162671|NCT00095290|Protease Inhibitors|protease inhibitors|mesh-ancestor
139162672|NCT00095290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162673|NCT00095290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162674|NCT00095290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139162675|NCT00095290|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139162676|NCT00095290|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139162677|NCT01340846|Ketoconazole|ketoconazole|mesh-list
139162678|NCT01340846|Dabrafenib|dabrafenib|mesh-list
139162679|NCT01340846|Warfarin|warfarin|mesh-list
139162680|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
139162681|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
139162682|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
139162683|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139162684|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139162685|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139162686|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162687|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162688|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139162689|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
139162690|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139162691|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162692|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139162693|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162694|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139162695|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139162696|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
139162697|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139162698|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139162699|NCT01342874|Inositol|inositol|mesh-list
139162700|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
139162701|NCT01342874|Vitamins|vitamins|mesh-ancestor
139162702|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
139162703|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162704|NCT01337258|Dutasteride|dutasteride|mesh-list
139162705|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139162706|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139162707|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162708|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162709|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
139162710|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139162711|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162712|NCT02603809|Lisinopril|lisinopril|mesh-list
139162713|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139162714|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
139162715|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162716|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162717|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139162718|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139162719|NCT02603809|Protective Agents|protective agents|mesh-ancestor
139162720|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162721|NCT01341158|Interferons|interferons|mesh-list
139162722|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162723|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
139162724|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139162725|NCT00393952|Fluticasone|fluticasone|mesh-list
139162727|NCT00393952|Formoterol Fumarate|formoterol fumarate|mesh-list
139162728|NCT00393952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139162729|NCT00393952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139162730|NCT00393952|Autonomic Agents|autonomic agents|mesh-ancestor
139162731|NCT00393952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139162732|NCT00393952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162733|NCT00393952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139162734|NCT00393952|Respiratory System Agents|respiratory system agents|mesh-ancestor
139162735|NCT00393952|Dermatologic Agents|dermatologic agents|mesh-ancestor
139162736|NCT00393952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139162737|NCT00393952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139162738|NCT00393952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139162739|NCT00393952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139162740|NCT00393952|Adrenergic Agents|adrenergic agents|mesh-ancestor
139162741|NCT00393952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162742|NCT00393952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162745|NCT02285374|Efavirenz|efavirenz|mesh-list
139162746|NCT02285374|Dolutegravir|dolutegravir|mesh-list
139019577|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139019578|NCT04278404|Narcotics|narcotics|mesh-ancestor
139162747|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139162748|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
139162749|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139162750|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139162751|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139162752|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162753|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162754|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139162755|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139162756|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139162757|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139162758|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139162759|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139162760|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139162761|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139162762|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139162763|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139162764|NCT01112449|Selenium|selenium|mesh-list
139162765|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
139162766|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162767|NCT01112449|Protective Agents|protective agents|mesh-ancestor
139162768|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162769|NCT01112449|Trace Elements|trace elements|mesh-ancestor
139162770|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
139162771|NCT01341392|Amlodipine|amlodipine|mesh-list
139162772|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139162773|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139162774|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139162775|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162776|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139162777|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162778|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
139162779|NCT04390958|Paclitaxel|paclitaxel|mesh-list
139162780|NCT04390958|Capecitabine|capecitabine|mesh-list
139162781|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139162782|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162783|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
139162784|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
139162785|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
139162786|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162787|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139162788|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
139162789|NCT03943459|Atorvastatin|atorvastatin|mesh-list
139162790|NCT03943459|Quercetin|quercetin|mesh-list
139162791|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139162792|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139162793|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
139162794|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162795|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139162796|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139162797|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162798|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
139162799|NCT03943459|Protective Agents|protective agents|mesh-ancestor
139162800|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162801|NCT04832438|Carboplatin|carboplatin|mesh-list
139162802|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162803|NCT05182970|Metformin|metformin|mesh-list
139162804|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139162805|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162806|NCT01315886|Fentanyl|fentanyl|mesh-list
139162807|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139162808|NCT01315886|Narcotics|narcotics|mesh-ancestor
139162809|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139162810|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162811|NCT01315886|Analgesics|analgesics|mesh-ancestor
139162812|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
139162813|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139162814|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139162815|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139162816|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
139162817|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
139162818|NCT00065728|Anecortave|anecortave|mesh-list
139162819|NCT00065728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139162820|NCT00065728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139162821|NCT00065728|Growth Substances|growth substances|mesh-ancestor
139162822|NCT00065728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162823|NCT00065728|Growth Inhibitors|growth inhibitors|mesh-ancestor
139162824|NCT00065728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162825|NCT00064714|Exenatide|exenatide|mesh-list
139162826|NCT00064714|Daclizumab|daclizumab|mesh-list
139162827|NCT00064714|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139162828|NCT00064714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139162829|NCT00064714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162830|NCT00064714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139162831|NCT00064714|Incretins|incretins|mesh-ancestor
139162832|NCT00064714|Hormones|hormones|mesh-ancestor
139162833|NCT00064714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139162834|NCT00064714|Immunologic Factors|immunologic factors|mesh-ancestor
139162835|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139162836|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139162837|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139162838|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139162839|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139162840|NCT01109485|Analgesics|analgesics|mesh-ancestor
139162841|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
139162842|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139162843|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162844|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139162845|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139162846|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139162847|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139162848|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139162849|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
139162850|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
139162851|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138893512|NCT03820193|Narcotics|narcotics|mesh-ancestor
139162852|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162853|NCT00292396|Antibodies|antibodies|mesh-list
139162854|NCT00292396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139162855|NCT00292396|Immunologic Factors|immunologic factors|mesh-ancestor
139162856|NCT00292396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162857|NCT03942289|Norepinephrine|norepinephrine|mesh-list
139162858|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139162859|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139162860|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
139162861|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162862|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162863|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162864|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
139162865|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
139162866|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139162867|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139162868|NCT00284128|Losartan|losartan|mesh-list
139162869|NCT00284128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139162870|NCT00284128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139162871|NCT00284128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139162872|NCT00284128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139162873|NCT00284128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162874|NCT00035542|Metformin|metformin|mesh-list
139162875|NCT00035542|Glyburide|glyburide|mesh-list
139162876|NCT00035542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139162877|NCT00035542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162878|NCT01209715|Fluticasone|fluticasone|mesh-list
139162879|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139162880|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139162881|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139162882|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139162883|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
139162884|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139162885|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162886|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139162887|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
139162888|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
139162889|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139162890|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139162891|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139162892|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139162893|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
139162894|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139162895|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162896|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
139162897|NCT01209715|Hormones|hormones|mesh-ancestor
139162898|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139162899|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
139162900|NCT03740893|Durvalumab|durvalumab|mesh-list
139162901|NCT03740893|Olaparib|olaparib|mesh-list
139162902|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139162903|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162904|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139162905|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162906|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162907|NCT00005788|Aldesleukin|aldesleukin|mesh-list
139162908|NCT00005788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162909|NCT00005788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139162910|NCT00005788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139162911|NCT00005788|Antiviral Agents|antiviral agents|mesh-ancestor
139162912|NCT00005788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139162913|NCT03945955|Melatonin|melatonin|mesh-list
139162914|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
139162915|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162916|NCT03945955|Protective Agents|protective agents|mesh-ancestor
139162917|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162918|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139162919|NCT00005608|Leucovorin|leucovorin|mesh-list
139162920|NCT00005608|Tegafur|tegafur|mesh-list
139162921|NCT00005608|Calcium|calcium|mesh-list
139162922|NCT00005608|Levoleucovorin|levoleucovorin|mesh-list
139162923|NCT00005608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139162924|NCT00005608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162925|NCT00005608|Antidotes|antidotes|mesh-ancestor
139162926|NCT00005608|Protective Agents|protective agents|mesh-ancestor
139162927|NCT00005608|Vitamin B Complex|vitamin b complex|mesh-ancestor
139162928|NCT00005608|Vitamins|vitamins|mesh-ancestor
139162929|NCT00005608|Micronutrients|micronutrients|mesh-ancestor
139162930|NCT00005608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139162931|NCT00005608|Antimetabolites|antimetabolites|mesh-ancestor
139162932|NCT00005608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162933|NCT00005608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162934|NCT02288338|Atorvastatin|atorvastatin|mesh-list
139162935|NCT02288338|Ezetimibe|ezetimibe|mesh-list
139162936|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139162937|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139162938|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
139162939|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162940|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139162941|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139162942|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162943|NCT00388960|Etoposide|etoposide|mesh-list
139162944|NCT00388960|Amrubicin|amrubicin|mesh-list
139162945|NCT00388960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162946|NCT00388960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139162947|NCT00388960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139162948|NCT00388960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139162949|NCT00388960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162950|NCT00388960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162952|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
139162953|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
138954674|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139162954|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139162955|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162956|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
139162957|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139162958|NCT00004912|Megestrol|megestrol|mesh-list
139162959|NCT00004912|Megestrol Acetate|megestrol acetate|mesh-list
139162960|NCT00004912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139162961|NCT00004912|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139162962|NCT00004912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139162963|NCT00004912|Contraceptive Agents|contraceptive agents|mesh-ancestor
139162964|NCT00004912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139162965|NCT00004912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162966|NCT00004912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139162967|NCT00004912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139162968|NCT00004912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139162969|NCT00004912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162970|NCT00004912|Appetite Stimulants|appetite stimulants|mesh-ancestor
139162971|NCT00004912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139162972|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
139162973|NCT02529787|Lansoprazole|lansoprazole|mesh-list
139162974|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139162975|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139162976|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139162977|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162978|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162979|NCT00267592|Temozolomide|temozolomide|mesh-list
139162980|NCT00267592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139162981|NCT00267592|Alkylating Agents|alkylating agents|mesh-ancestor
139162982|NCT00267592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162983|NCT00267592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139162984|NCT00267280|Atorvastatin|atorvastatin|mesh-list
139162985|NCT00267280|Simvastatin|simvastatin|mesh-list
139162986|NCT00267280|Torcetrapib|torcetrapib|mesh-list
139162987|NCT00267280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139162988|NCT00267280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139162989|NCT00267280|Antimetabolites|antimetabolites|mesh-ancestor
139162990|NCT00267280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139162991|NCT00267280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139162992|NCT00267280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139162993|NCT00267280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139162994|NCT03530488|Lidocaine|lidocaine|mesh-list
139162995|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
139162996|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
139162997|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139162998|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139162999|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
139163000|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163001|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139163002|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139163003|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139163004|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139163005|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163006|NCT00262990|Doxorubicin|doxorubicin|mesh-list
139163007|NCT00262990|Epothilone B|epothilone b|mesh-list
139163008|NCT00262990|Epothilones|epothilones|mesh-list
139163009|NCT00262990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139163010|NCT00262990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163011|NCT00262990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139163012|NCT00262990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139163013|NCT00262990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163014|NCT00262990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163015|NCT00262990|Tubulin Modulators|tubulin modulators|mesh-ancestor
139163016|NCT00262990|Antimitotic Agents|antimitotic agents|mesh-ancestor
138913454|NCT00823186|Paclitaxel|paclitaxel|mesh-list
139163017|NCT00262990|Mitosis Modulators|mitosis modulators|mesh-ancestor
139163018|NCT01110031|Ofatumumab|ofatumumab|mesh-list
139163019|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163020|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139163021|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
139163022|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163023|NCT01210339|Esomeprazole|esomeprazole|mesh-list
139163024|NCT01210339|Clopidogrel|clopidogrel|mesh-list
139163025|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139163026|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139163027|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139163028|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139163029|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
139163030|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163031|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163032|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163033|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139163034|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139163035|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139163036|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163037|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
138961153|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
139163038|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139163039|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163041|NCT03147248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139163042|NCT03147248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139163043|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
139163044|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139163045|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139163046|NCT00250822|Gemcitabine|gemcitabine|mesh-list
139163047|NCT00250822|Oxaliplatin|oxaliplatin|mesh-list
139163048|NCT00250822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139163049|NCT00250822|Antimetabolites|antimetabolites|mesh-ancestor
139163050|NCT00250822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163051|NCT00250822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163052|NCT00004096|Carboplatin|carboplatin|mesh-list
139163053|NCT00004096|Vinorelbine|vinorelbine|mesh-list
139163054|NCT00004096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163055|NCT00004096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139163056|NCT00004096|Tubulin Modulators|tubulin modulators|mesh-ancestor
139163057|NCT00004096|Antimitotic Agents|antimitotic agents|mesh-ancestor
139163058|NCT00004096|Mitosis Modulators|mitosis modulators|mesh-ancestor
139163059|NCT00004096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163060|NCT00002224|Nelfinavir|nelfinavir|mesh-list
139163061|NCT00002224|Didanosine|didanosine|mesh-list
139163062|NCT00002224|Stavudine|stavudine|mesh-list
139163063|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139163064|NCT00002224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139163065|NCT00002224|Protease Inhibitors|protease inhibitors|mesh-ancestor
139163066|NCT00002224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163067|NCT00002224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163068|NCT00002224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139163069|NCT00002224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139163070|NCT00002224|Antiviral Agents|antiviral agents|mesh-ancestor
139163071|NCT00002224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163072|NCT00002224|Antimetabolites|antimetabolites|mesh-ancestor
139163073|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139163074|NCT00002224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139163075|NCT01207921|Lenalidomide|lenalidomide|mesh-list
139163076|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
139163077|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163078|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139163079|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139163080|NCT01207921|Growth Substances|growth substances|mesh-ancestor
139163081|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
139163082|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163083|NCT01108393|Agomelatine|agomelatine|mesh-list
139163084|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139163085|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139019579|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
139163086|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163087|NCT01113229|Misoprostol|misoprostol|mesh-list
139163088|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138913529|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163089|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
139163090|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139163091|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163092|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139163093|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139163094|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
139163095|NCT03530176|Listerine|listerine|mesh-list
139163096|NCT03530176|Fluorides|fluorides|mesh-list
139163097|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
139163098|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
139163099|NCT03530176|Protective Agents|protective agents|mesh-ancestor
139163100|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163101|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138961170|NCT00321685|Vitamins|vitamins|mesh-ancestor
139163102|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163103|NCT03151304|Azacitidine|azacitidine|mesh-list
139163104|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139163105|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
139163106|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163107|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163108|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163109|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
139163110|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
139163111|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139163112|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163113|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163114|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
139163115|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139163116|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163117|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163118|NCT02288962|Cabergoline|cabergoline|mesh-list
139163119|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139163120|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139163121|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
139163122|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
139163123|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163124|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163125|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163126|NCT03942991|Carticaine|carticaine|mesh-list
139163127|NCT03942991|Mepivacaine|mepivacaine|mesh-list
139163128|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
139163129|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
139163130|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163131|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163132|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
139163133|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163134|NCT00162292|Methotrexate|methotrexate|mesh-list
139163135|NCT00162292|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139163136|NCT00162292|Abortifacient Agents|abortifacient agents|mesh-ancestor
139163137|NCT00162292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139019580|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139163138|NCT00162292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163139|NCT00162292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139163140|NCT00162292|Antimetabolites|antimetabolites|mesh-ancestor
139163141|NCT00162292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163142|NCT00162292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163143|NCT00162292|Dermatologic Agents|dermatologic agents|mesh-ancestor
139163144|NCT00162292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163145|NCT00162292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139163146|NCT00162292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139163147|NCT00162292|Immunologic Factors|immunologic factors|mesh-ancestor
139163148|NCT00162292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139163149|NCT00162292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139163150|NCT00135382|Efavirenz|efavirenz|mesh-list
139163151|NCT00135382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139163152|NCT00135382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139163153|NCT00135382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163154|NCT00135382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163155|NCT00135382|Antiviral Agents|antiviral agents|mesh-ancestor
139163156|NCT00135382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163157|NCT00135382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139163158|NCT00135382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139163159|NCT00135382|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139163160|NCT00135382|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139163161|NCT00135382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139163162|NCT00135382|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139163163|NCT03531970|Dexamethasone|dexamethasone|mesh-list
139163164|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
139163165|NCT03531970|Lidocaine|lidocaine|mesh-list
138913603|NCT04105023|Genistein|genistein|mesh-list
139163166|NCT03531970|Epinephrine|epinephrine|mesh-list
139163167|NCT03531970|BB 1101|bb 1101|mesh-list
139163168|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139163169|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
139163170|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
139163171|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163172|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163173|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139163174|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
139163175|NCT03531970|Hormones|hormones|mesh-ancestor
139163176|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139163177|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139163178|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163179|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
139163180|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163181|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163182|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
139163183|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
139163184|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163185|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
139163186|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139163187|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139163188|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139163189|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139163190|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139163191|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139163192|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
139163193|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163194|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139163195|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139163196|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139163197|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
139163198|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
139163199|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
139163200|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139163201|NCT01211821|Metoprolol|metoprolol|mesh-list
139163202|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139163203|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139163204|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
139163205|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
139163206|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163207|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163208|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139163209|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139163210|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139163211|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
139163212|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163213|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163214|NCT03527836|Lidocaine|lidocaine|mesh-list
139163215|NCT03527836|Bupivacaine|bupivacaine|mesh-list
139163216|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
139163217|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
139163218|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163219|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163220|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
138961195|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139163221|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163222|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139163223|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139163224|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139163225|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139163226|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163227|NCT05724862|Anesthetics|anesthetics|mesh-list
139163228|NCT05724862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163229|NCT05724862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163230|NCT03940651|Anesthetics|anesthetics|mesh-list
139163231|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
139163232|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163233|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163234|NCT03152552|Empagliflozin|empagliflozin|mesh-list
139163235|NCT03152552|Licogliflozin|licogliflozin|mesh-list
139163236|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139163237|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913679|NCT00829192|Afamelanotide|afamelanotide|mesh-list
139163239|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163240|NCT01211275|Cisplatin|cisplatin|mesh-list
139163241|NCT01211275|Pemetrexed|pemetrexed|mesh-list
139163242|NCT01211275|Axitinib|axitinib|mesh-list
139163243|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163244|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163245|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163246|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139163247|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139163248|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139163249|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139163250|NCT03529084|Gefitinib|gefitinib|mesh-list
139163251|NCT03529084|Nazartinib|nazartinib|mesh-list
139163252|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163253|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139163254|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163255|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163256|NCT03942757|Bilirubin|bilirubin|mesh-list
139163257|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
139163258|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163259|NCT03942757|Protective Agents|protective agents|mesh-ancestor
139163260|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163261|NCT05724628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139163262|NCT05724628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163263|NCT01208701|Atorvastatin|atorvastatin|mesh-list
139163264|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139163265|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139163266|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
139163267|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163268|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139163269|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139163270|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163271|NCT03528772|Minoxidil|minoxidil|mesh-list
139163272|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
139163273|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139163274|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
139163275|NCT01316744|Ketamine|ketamine|mesh-list
139163276|NCT01316744|Analgesics|analgesics|mesh-ancestor
139163277|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
139163278|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163279|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163280|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139163281|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139163282|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
139163283|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
139163284|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139019581|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139163285|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139163286|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139163287|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163288|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163289|NCT01213381|Carboplatin|carboplatin|mesh-list
139163290|NCT01213381|Gemcitabine|gemcitabine|mesh-list
139163291|NCT01213381|Iniparib|iniparib|mesh-list
139163292|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163293|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139163294|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
139163295|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163296|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139163297|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163298|NCT01316978|Ibuprofen|ibuprofen|mesh-list
139163299|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139163300|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139163301|NCT01316978|Analgesics|analgesics|mesh-ancestor
139163302|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
139163303|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163304|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163305|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139163306|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139163307|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139163308|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163309|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163310|NCT01317212|Carboplatin|carboplatin|mesh-list
139163311|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163312|NCT05250752|Dapagliflozin|dapagliflozin|mesh-list
139163313|NCT05250752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139163314|NCT05250752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163315|NCT05250752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139163316|NCT05250752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163317|NCT01211509|Montelukast|montelukast|mesh-list
139163318|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139163319|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
139163320|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139163321|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
139163322|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139163323|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163324|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139163325|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139163326|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163327|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
139163328|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139163329|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139163330|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163331|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163332|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
139163333|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138893693|NCT03595917|Prednisone|prednisone|mesh-list
139163334|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
139163335|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163336|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
139163337|NCT04441528|Protective Agents|protective agents|mesh-ancestor
139163338|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
139163339|NCT01344512|Ceftazidime|ceftazidime|mesh-list
139163340|NCT01344512|Voriconazole|voriconazole|mesh-list
139163341|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139163342|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163343|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139163344|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139163345|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961221|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139163346|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163348|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139163349|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139163350|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
139163351|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139163352|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139163353|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
139163354|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139163355|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163356|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139163357|NCT05064488|Metformin|metformin|mesh-list
139163358|NCT05064488|Digoxin|digoxin|mesh-list
139163359|NCT05064488|Sumatriptan|sumatriptan|mesh-list
139163360|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139163361|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139163362|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163363|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139163364|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139163365|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
139163366|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163367|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139163368|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139163369|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163370|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139163371|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139163372|NCT05064488|Protective Agents|protective agents|mesh-ancestor
139163373|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139163374|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139163375|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139163376|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
139163377|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163378|NCT01344590|Ethanol|ethanol|mesh-list
139163379|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139163380|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163381|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163382|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163383|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
139163384|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163385|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139163386|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163387|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163388|NCT01212133|Liraglutide|liraglutide|mesh-list
139163389|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139163390|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163391|NCT01212133|Incretins|incretins|mesh-ancestor
139163392|NCT01212133|Hormones|hormones|mesh-ancestor
139163393|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139163394|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
139163395|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139163396|NCT04269356|Antacids|antacids|mesh-ancestor
139163397|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163398|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139163399|NCT01118065|Everolimus|everolimus|mesh-list
139163400|NCT01118065|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139163401|NCT01118065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139163402|NCT01118065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163403|NCT01118065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163404|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139163405|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
138961237|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
139163406|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163407|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163408|NCT03528616|Propranolol|propranolol|mesh-list
139163409|NCT03528616|Digoxin|digoxin|mesh-list
139163410|NCT03528616|Adenosine|adenosine|mesh-list
139163411|NCT03528616|Amiodarone|amiodarone|mesh-list
139163412|NCT03528616|Flecainide|flecainide|mesh-list
139163413|NCT03528616|Procainamide|procainamide|mesh-list
139163414|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139163415|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139163416|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
139163417|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163418|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163419|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163420|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139163421|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139163422|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
139163423|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139163424|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163425|NCT03528616|Protective Agents|protective agents|mesh-ancestor
139163426|NCT03528616|Analgesics|analgesics|mesh-ancestor
139163427|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
139163428|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163429|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139163430|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
139163431|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
139163432|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139163433|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139163434|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139163435|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139163436|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139163437|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139163438|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139163439|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139163440|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139163441|NCT02529631|Orlistat|orlistat|mesh-list
139163442|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163443|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163444|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139163445|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139163446|NCT04469062|Mirikizumab|mirikizumab|mesh-list
139163447|NCT04469062|Vedolizumab|vedolizumab|mesh-list
139163448|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139163449|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139163450|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139163451|NCT04469062|Analgesics|analgesics|mesh-ancestor
139163452|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
139163453|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163454|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163455|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139163456|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139163457|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139163458|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
139163459|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139163460|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163461|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
139163462|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139163463|NCT03145766|Antibodies|antibodies|mesh-list
139163464|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
139163465|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163466|NCT01115179|Propofol|propofol|mesh-list
139163467|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
139163468|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139163469|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163470|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163471|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139163472|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
139163473|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
139163474|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
139163475|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139163476|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139163477|NCT04468438|Estrogens|estrogens|mesh-list
139163478|NCT04468438|Hormones|hormones|mesh-ancestor
139163479|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139163480|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163481|NCT04468282|Vigabatrin|vigabatrin|mesh-list
139163482|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
139163483|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163484|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163485|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
139163486|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163487|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163488|NCT01121731|Interferons|interferons|mesh-list
139163489|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
139163490|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163491|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
139163492|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163493|NCT01215799|Bafetinib|bafetinib|mesh-list
139163494|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139163495|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163496|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163497|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
139163498|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163499|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139163500|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163501|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163502|NCT03527134|Amantadine|amantadine|mesh-list
139163503|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139163504|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139163505|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
139163506|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163507|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
139163508|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163509|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163510|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163511|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139163512|NCT03527134|Analgesics|analgesics|mesh-ancestor
139163513|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
139163514|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163515|NCT01213693|Fluticasone|fluticasone|mesh-list
139163516|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139163517|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139163518|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139163519|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
139163520|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163521|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163522|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139163523|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
139163524|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
139163525|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139163526|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139163527|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139163528|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139163529|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
139163530|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163531|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163532|NCT01213849|Fluticasone|fluticasone|mesh-list
139163534|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139019582|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139163535|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138913978|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
139163536|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
139163537|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163538|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163539|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139163540|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
139163541|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
139163542|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139163543|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
139163544|NCT01121809|Etravirine|etravirine|mesh-list
139163545|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139163546|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139163547|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
139163548|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163549|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139163550|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139163551|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163552|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163553|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139163554|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139163555|NCT03937687|Caffeine|caffeine|mesh-list
139163556|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139163557|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163558|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139163559|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163560|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163561|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139163562|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139163563|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
139163564|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163565|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139163566|NCT05110144|Amitriptyline|amitriptyline|mesh-list
139163567|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139163568|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139163569|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139163570|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163571|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163572|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163573|NCT05110144|Analgesics|analgesics|mesh-ancestor
139163574|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
139163575|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163576|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
139163577|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139163578|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
138893815|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
139163579|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139163580|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139163581|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139163582|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
139163583|NCT01212367|Interferons|interferons|mesh-list
139163584|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
139163585|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
139163586|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139163587|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163588|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
139163589|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163590|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
139163591|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163592|NCT01216111|Paclitaxel|paclitaxel|mesh-list
139163593|NCT01216111|Docetaxel|docetaxel|mesh-list
139163594|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
139163595|NCT01216111|Fluorouracil|fluorouracil|mesh-list
139163596|NCT01216111|Epirubicin|epirubicin|mesh-list
139163597|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139163598|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163599|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
139163600|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
139163601|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
139163602|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163603|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139163604|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
139163605|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163606|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139163607|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139163608|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
139163609|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138914060|NCT00838240|Cytarabine|cytarabine|mesh-list
139163610|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
139163611|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139163612|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139163613|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139163614|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139163615|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163616|NCT01216267|Lansoprazole|lansoprazole|mesh-list
139163617|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
139163618|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139163619|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139163620|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139163621|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163622|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163623|NCT01216345|Gemcitabine|gemcitabine|mesh-list
139163624|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
139163625|NCT01216345|Cetuximab|cetuximab|mesh-list
139163626|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139163627|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
139163628|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163629|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163630|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139163631|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
139163632|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
139163633|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
139163634|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139163635|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139163636|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163637|NCT01212523|Propofol|propofol|mesh-list
139163638|NCT01212523|Isoflurane|isoflurane|mesh-list
139163639|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139163640|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163641|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163642|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139163643|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
139163644|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
139163645|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139163647|NCT01122121|Flutamide|flutamide|mesh-list
139163648|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139163649|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
139163650|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139163651|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163652|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139163653|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163654|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
139163655|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
139163656|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139163657|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139163658|NCT01115725|Hormones|hormones|mesh-ancestor
139163659|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139163660|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163661|NCT01122199|Everolimus|everolimus|mesh-list
139163662|NCT01122199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139163663|NCT01122199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139163664|NCT01122199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163665|NCT01122199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163666|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139163667|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
139163668|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163669|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163670|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139163671|NCT01118923|Antacids|antacids|mesh-ancestor
139163672|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163673|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139163674|NCT01119079|Anesthetics|anesthetics|mesh-list
139163675|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163676|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163677|NCT01119157|Vaccines|vaccines|mesh-list
139163678|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
139163679|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163680|NCT01120015|Diacerein|diacerein|mesh-list
139163681|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139163682|NCT01216579|Mannitol|mannitol|mesh-list
139163683|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139163684|NCT01216579|Diuretics|diuretics|mesh-ancestor
139163685|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
139163686|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163688|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139163689|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139163690|NCT03528070|Analgesics|analgesics|mesh-ancestor
139163691|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
139163692|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163693|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163695|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139163696|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139163697|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139163698|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163699|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139163700|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139163701|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
139163702|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
139163703|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163704|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139163705|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139163706|NCT03935815|Ropivacaine|ropivacaine|mesh-list
139163707|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
139163708|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
139163709|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163710|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163711|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
139163712|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163713|NCT01216657|Sunitinib|sunitinib|mesh-list
139163714|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163715|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139163716|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139163717|NCT01216657|Growth Substances|growth substances|mesh-ancestor
139163718|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163719|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
139163720|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139163721|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163722|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163723|NCT04400188|Temozolomide|temozolomide|mesh-list
139163724|NCT04400188|Fluzoparib|fluzoparib|mesh-list
139163725|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139163726|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
139163727|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163728|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163729|NCT04400188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139163730|NCT04400188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163731|NCT01115959|Valproic Acid|valproic acid|mesh-list
139163732|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
139163733|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163734|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163735|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
139163736|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163737|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163738|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
139163740|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163741|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139163742|NCT03936907|Nabiximols|nabiximols|mesh-list
139163743|NCT03936907|Analgesics|analgesics|mesh-ancestor
139163744|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
139163745|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163746|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163747|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
139163748|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163749|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163750|NCT01217203|Lenalidomide|lenalidomide|mesh-list
139163751|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
139163752|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163753|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139163754|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139163755|NCT01217203|Growth Substances|growth substances|mesh-ancestor
139163756|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
139163757|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163758|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
139163759|NCT01120171|Doxorubicin|doxorubicin|mesh-list
139163760|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139163761|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139163762|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
139163763|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163764|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139163765|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139163766|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
139163767|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163768|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163769|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139163770|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139163771|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139163772|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139163773|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163774|NCT01116193|Dexamethasone|dexamethasone|mesh-list
139163775|NCT01116193|Lenalidomide|lenalidomide|mesh-list
139163776|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139163777|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
139163778|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
139163779|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163780|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163781|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139163782|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
139163784|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139163785|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139163786|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163787|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
139163788|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139163789|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139163790|NCT01116193|Growth Substances|growth substances|mesh-ancestor
139163791|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
139163792|NCT01120327|Amlodipine|amlodipine|mesh-list
139163793|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139163794|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139163795|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139163796|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163797|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139163798|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163799|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
139163800|NCT01116271|Irinotecan|irinotecan|mesh-list
139163801|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139163802|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139163803|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163804|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163805|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163806|NCT01217359|Interferons|interferons|mesh-list
139163807|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
139163808|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
139163809|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163810|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
139163811|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163812|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
138534053|NCT00044135|Clevudine|clevudine|mesh-list
139163814|NCT01212679|Mitogens|mitogens|mesh-list
139163815|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
139163816|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163817|NCT03193684|Empagliflozin|empagliflozin|mesh-list
138961337|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139163818|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139163819|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163820|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139163821|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163822|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
139163823|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139163824|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163825|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163826|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139163827|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139163829|NCT01116583|Analgesics|analgesics|mesh-ancestor
139163830|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
139163831|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163832|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163833|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
139163834|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139163835|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139163836|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163837|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139163838|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139163839|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139163840|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163841|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163842|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
139163843|NCT03935347|Vidarabine|vidarabine|mesh-list
139163844|NCT03935347|Aldesleukin|aldesleukin|mesh-list
139163845|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
139163846|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
139163847|NCT03935347|Fludarabine|fludarabine|mesh-list
139163848|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
139163849|NCT03935347|Interleukin-2|interleukin-2|mesh-list
139163850|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
139163851|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
139163852|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139163853|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
139163854|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163855|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139163856|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139163857|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
139163858|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163859|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163860|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139163861|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139163862|NCT03935347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139163863|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139163864|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
139163865|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
139163866|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163867|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139163868|NCT03935347|Analgesics|analgesics|mesh-ancestor
139163869|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
139163870|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163871|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139163872|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139163873|NCT04467346|Temozolomide|temozolomide|mesh-list
139163874|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139163875|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
139163876|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163877|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163879|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139163881|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
139163882|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
139163883|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
139163884|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163885|NCT01122667|Anacetrapib|anacetrapib|mesh-list
139163886|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139163887|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139163888|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
139163889|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163890|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139163891|NCT01120561|Trastuzumab|trastuzumab|mesh-list
139163892|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139163893|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139163894|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163895|NCT01120561|Immunotoxins|immunotoxins|mesh-ancestor
139163896|NCT01120561|Immunoconjugates|immunoconjugates|mesh-ancestor
139163897|NCT01120561|Immunologic Factors|immunologic factors|mesh-ancestor
139163898|NCT01120561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163899|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
139163900|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
139163901|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
139163902|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163903|NCT01217125|Sirolimus|sirolimus|mesh-list
139163904|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139163905|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163906|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139163907|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163908|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
139163909|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139163910|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
139163911|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163912|NCT03635372|Sucralfate|sucralfate|mesh-list
139163913|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
139163914|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139163915|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139163916|NCT03635372|Antacids|antacids|mesh-ancestor
139163917|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163918|NCT01116817|Ritonavir|ritonavir|mesh-list
139163919|NCT01116817|Lopinavir|lopinavir|mesh-list
139163920|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139163921|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139163922|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
139163923|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139163924|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163925|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139163926|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139163927|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
139163928|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139163929|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139163930|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139163952|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139163953|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163954|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139163955|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
139163956|NCT04467892|Hormones|hormones|mesh-ancestor
139163957|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139163958|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139163959|NCT04467892|Protective Agents|protective agents|mesh-ancestor
139163960|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139163961|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163962|NCT01122979|Insulin|insulin|mesh-list
139163963|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139163964|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
139163965|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
139163966|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
139163967|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
139163968|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
139163969|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139163970|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163971|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
139163972|NCT04179110|Ramucirumab|ramucirumab|mesh-list
139163973|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139163974|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139163975|NCT04179110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139163976|NCT04179110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163977|NCT01123057|Riboflavin|riboflavin|mesh-list
139163978|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
139163979|NCT01123057|Vitamins|vitamins|mesh-ancestor
139163980|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
139163981|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163982|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139163983|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
139163984|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
139163985|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139163986|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139163987|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139163988|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138961391|NCT00768989|Ritonavir|ritonavir|mesh-list
139163994|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139163995|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
139163996|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139163997|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139163998|NCT03524872|Analgesics|analgesics|mesh-list
139163999|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164000|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
139164001|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164007|NCT01345370|Temozolomide|temozolomide|mesh-list
139164008|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139164009|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
139164010|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164011|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164012|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
139164013|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139164014|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
139164015|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164016|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
139164017|NCT04702802|Protective Agents|protective agents|mesh-ancestor
139164018|NCT01214941|Itraconazole|itraconazole|mesh-list
139164019|NCT01214941|Ticlopidine|ticlopidine|mesh-list
139164020|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
139164021|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139164022|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139164023|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139164024|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164025|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164026|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139164027|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
139164028|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139164029|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164030|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139164031|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139164032|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139164033|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139164034|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138534277|NCT00078975|Gemcitabine|gemcitabine|mesh-list
139164035|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139164036|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139164037|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
139164038|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164039|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139164040|NCT05301634|Bupivacaine|bupivacaine|mesh-list
139164041|NCT05301634|Anesthetics, Local|anesthetics, local|mesh-ancestor
139164042|NCT05301634|Anesthetics|anesthetics|mesh-ancestor
139164043|NCT05301634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138961411|NCT00779714|Cytarabine|cytarabine|mesh-list
139164044|NCT05301634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164045|NCT05301634|Sensory System Agents|sensory system agents|mesh-ancestor
139164046|NCT05301634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164048|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139164049|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164050|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164051|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139164052|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139164053|NCT01328821|Protective Agents|protective agents|mesh-ancestor
139164054|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164055|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
139164056|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139164057|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
139164058|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139164059|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139164060|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139164061|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139164062|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139164063|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
139164064|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164065|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164066|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164068|NCT04001894|Ticagrelor|ticagrelor|mesh-list
139164069|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139164070|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139164071|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139164072|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139164073|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
139164074|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894041|NCT01897454|Vitamins|vitamins|mesh-ancestor
139164075|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164076|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164077|NCT01212913|Insulin|insulin|mesh-list
139164078|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139164079|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
139164080|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
139164081|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
139164082|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139164083|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139164084|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164085|NCT01345604|Ropivacaine|ropivacaine|mesh-list
139164086|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
139164087|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
139164088|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164089|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164090|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
139164091|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164092|NCT01218217|Rifampin|rifampin|mesh-list
139164093|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139164094|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
139164095|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139164096|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139164097|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
139164098|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139164099|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164100|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164101|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139164102|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139164103|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139164104|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139164105|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139164106|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139164108|NCT03522532|Trace Elements|trace elements|mesh-ancestor
139164109|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
139164110|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164111|NCT01215019|Mannitol|mannitol|mesh-list
139164112|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139164113|NCT01215019|Diuretics|diuretics|mesh-ancestor
139164114|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
139164115|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164116|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
139164117|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
139164118|NCT01215331|Insulin|insulin|mesh-list
139164119|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139164120|NCT01215331|Metformin|metformin|mesh-list
139164121|NCT01215331|Glyburide|glyburide|mesh-list
139164122|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139164123|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164124|NCT03526276|Fluorides|fluorides|mesh-list
139164125|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
139164126|NCT03526276|Protective Agents|protective agents|mesh-ancestor
138894052|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164127|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164128|NCT04466254|Cetuximab|cetuximab|mesh-list
139164129|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139164130|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164131|NCT04466176|Fluticasone|fluticasone|mesh-list
139164132|NCT04466176|Xhance|xhance|mesh-list
139164133|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139164134|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139164135|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139164136|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139164138|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164139|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164140|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139164141|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
139164142|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
139164143|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139164144|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139164145|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139164146|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139164147|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
139164148|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164149|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164150|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
139164151|NCT04466176|Hormones|hormones|mesh-ancestor
139164152|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139164153|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
139164154|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139164155|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
139164156|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139164157|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139164158|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164159|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164160|NCT01215409|Urological Agents|urological agents|mesh-ancestor
139164161|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
139164162|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139164163|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164164|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164165|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139164167|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
139164168|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164169|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139164170|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139164171|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139164172|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
139164173|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164174|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164175|NCT04674020|Erenumab|erenumab|mesh-list
139164176|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139164177|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164178|NCT04674020|Analgesics|analgesics|mesh-ancestor
139164179|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
139164180|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164181|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164182|NCT01123525|Adenosine|adenosine|mesh-list
139164183|NCT01123525|Analgesics|analgesics|mesh-ancestor
139164184|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
139164185|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164186|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164187|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139164188|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
139164189|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139164190|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
139164191|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
139164192|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164193|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164194|NCT01215565|Sunitinib|sunitinib|mesh-list
139164195|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164196|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139164197|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139164198|NCT01215565|Growth Substances|growth substances|mesh-ancestor
139164199|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164200|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
139164201|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139164202|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164203|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164204|NCT01121497|Physostigmine|physostigmine|mesh-list
139164205|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139164206|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164207|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164208|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
139164209|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164210|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164211|NCT01121497|Miotics|miotics|mesh-ancestor
139164212|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
139164213|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164214|NCT01213147|Clomiphene|clomiphene|mesh-list
139164215|NCT01213147|Enclomiphene|enclomiphene|mesh-list
139164216|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
139164217|NCT01213147|Buserelin|buserelin|mesh-list
139164218|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139164219|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
139164220|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139164221|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164222|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139164223|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
139164224|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139164225|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138894090|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139164226|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139164227|NCT03143816|Insulin|insulin|mesh-list
139164228|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139164229|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164230|NCT01117129|Rituximab|rituximab|mesh-list
139164231|NCT01117129|Methotrexate|methotrexate|mesh-list
139164232|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139164233|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164234|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
139164235|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164236|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139164237|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139164238|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
139164239|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139164240|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139164241|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
139164242|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164243|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
139164244|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164245|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139164246|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139164247|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139164248|NCT03133988|Margetuximab|margetuximab|mesh-list
139164249|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164250|NCT03934411|Tramadol|tramadol|mesh-list
139164251|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139164252|NCT03934411|Narcotics|narcotics|mesh-ancestor
139164253|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164254|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164255|NCT03934411|Analgesics|analgesics|mesh-ancestor
139164256|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
139164257|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164258|NCT01218451|Vaccines|vaccines|mesh-list
139164259|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
139164260|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164261|NCT01346930|Macitentan|macitentan|mesh-list
139164262|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139164263|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139164264|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164265|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139164266|NCT01219153|Letrozole|letrozole|mesh-list
139164267|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
139164268|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139164269|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164270|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139164271|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139164272|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164273|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164274|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139164275|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
139164276|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139164277|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164278|NCT01219153|Hormones|hormones|mesh-ancestor
139164279|NCT03526042|Losartan|losartan|mesh-list
139164280|NCT03526042|Enalapril|enalapril|mesh-list
139164281|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139164282|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139164283|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139164284|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139164285|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139164286|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139164287|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164288|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
139164289|NCT01124539|Camptothecin|camptothecin|mesh-list
139164290|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
139164291|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139164292|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164293|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139164294|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139164295|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164296|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164297|NCT03781375|Etanercept|etanercept|mesh-list
139164298|NCT03781375|Methotrexate|methotrexate|mesh-list
139164299|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139164300|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
139164301|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139164302|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164303|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139164304|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
139164305|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164306|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164307|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
139164308|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164309|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139164310|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139164311|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
139164312|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139164313|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139164314|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139164315|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139164316|NCT03781375|Analgesics|analgesics|mesh-ancestor
139164317|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
139164318|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164319|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139164320|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139164321|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139164322|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139164323|NCT01123915|Protective Agents|protective agents|mesh-ancestor
139164324|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164325|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139164326|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
139164327|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164328|NCT01218529|Lapatinib|lapatinib|mesh-list
139164329|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164330|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139164331|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164332|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164333|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139164334|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139164335|NCT01218607|Bosentan|bosentan|mesh-list
139164336|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139164337|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139164338|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164339|NCT03933787|Saxagliptin|saxagliptin|mesh-list
139164340|NCT03933787|Incretins|incretins|mesh-ancestor
139164341|NCT03933787|Hormones|hormones|mesh-ancestor
139164342|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139164343|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164344|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139164345|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
139164346|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164347|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164348|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139164349|NCT03934333|Budesonide|budesonide|mesh-list
139164350|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139164351|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139164352|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
139164353|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164354|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164355|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139164356|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
139164357|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
139164358|NCT03934333|Hormones|hormones|mesh-ancestor
139164359|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139164360|NCT01124227|Icodextrin|icodextrin|mesh-list
139164361|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
139164362|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139164363|NCT03931915|Leuprolide|leuprolide|mesh-list
139164364|NCT03931915|Relugolix|relugolix|mesh-list
139164365|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139164366|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
139164367|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139164368|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164369|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139164370|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164371|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
139164372|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
139164373|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139164374|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
139164375|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139164376|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164377|NCT01124383|Lidocaine|lidocaine|mesh-list
139164378|NCT01124383|Ephedrine|ephedrine|mesh-list
139164379|NCT01124383|Midazolam|midazolam|mesh-list
139164380|NCT01124383|Sufentanil|sufentanil|mesh-list
139164381|NCT01124383|Dsuvia|dsuvia|mesh-list
139164382|NCT01124383|Anesthetics|anesthetics|mesh-list
139164383|NCT01124383|Propofol|propofol|mesh-list
139164384|NCT01124383|Sevoflurane|sevoflurane|mesh-list
139164385|NCT01124383|Rocuronium|rocuronium|mesh-list
139164386|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
139164387|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164388|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164389|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
139164390|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164391|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139164392|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139164393|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139164394|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139164395|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164397|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139164398|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
139164399|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139164400|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139164401|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139164402|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139164403|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
139164404|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
139164405|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164406|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139164407|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139164408|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139164409|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139164410|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139164411|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139164412|NCT01124383|Narcotics|narcotics|mesh-ancestor
139164413|NCT01124383|Analgesics|analgesics|mesh-ancestor
139164414|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139164415|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
139164416|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
139164417|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139164418|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
139164419|NCT01226017|Oxytocin|oxytocin|mesh-list
139164420|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
139164421|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139164422|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164423|NCT01222819|Lenograstim|lenograstim|mesh-list
139164424|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139164425|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
139164426|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164427|NCT01222897|Valacyclovir|valacyclovir|mesh-list
139164428|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
139164429|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139164430|NCT03150056|Prednisone|prednisone|mesh-list
139164431|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139164432|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
139164433|NCT03150056|Hormones|hormones|mesh-ancestor
139164434|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139164435|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164436|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139164437|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164438|NCT01329367|Antioxidants|antioxidants|mesh-list
139164439|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164440|NCT01329367|Protective Agents|protective agents|mesh-ancestor
139164441|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164442|NCT01222975|Risperidone|risperidone|mesh-list
139164443|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139164444|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
139164445|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164446|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894182|NCT02628080|Atovaquone|atovaquone|mesh-list
139164447|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164448|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139164449|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139164450|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164451|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139164452|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139164453|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
139164454|NCT01129063|Clopidogrel|clopidogrel|mesh-list
139164455|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139164456|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139164457|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139164458|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139164459|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
139164460|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961528|NCT00808392|Vaccines|vaccines|mesh-list
139164461|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164462|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164463|NCT01317368|Ropivacaine|ropivacaine|mesh-list
139164464|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
139164465|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
139164466|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164467|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164468|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
139164469|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164470|NCT01219699|Fulvestrant|fulvestrant|mesh-list
139164471|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139164472|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164473|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139164474|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139164475|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
139164476|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139164477|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164478|NCT03933319|Doxorubicin|doxorubicin|mesh-list
139164479|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139164480|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139164481|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164482|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139164483|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139164484|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164485|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164486|NCT01223053|Ketoprofen|ketoprofen|mesh-list
139164487|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139164488|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139164489|NCT01223053|Analgesics|analgesics|mesh-ancestor
139164490|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
139164491|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164492|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164493|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139164494|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139164495|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139164496|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164497|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164498|NCT01223131|Insulin|insulin|mesh-list
139164499|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139164500|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
139164501|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
139164502|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
138914935|NCT00703625|Sirolimus|sirolimus|mesh-list
139164503|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
139164504|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139164505|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164507|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
139164508|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139164509|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164510|NCT02640664|Ranibizumab|ranibizumab|mesh-list
139164511|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139164512|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139164513|NCT02640664|Growth Substances|growth substances|mesh-ancestor
139164514|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164515|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
139164516|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164517|NCT01317446|Fluorides|fluorides|mesh-list
139164518|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
139164519|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
139164520|NCT01317446|Protective Agents|protective agents|mesh-ancestor
138954738|NCT03990103|Bevacizumab|bevacizumab|mesh-list
139164521|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164523|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
138961535|NCT00780104|Cytarabine|cytarabine|mesh-list
139164524|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139164525|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139164526|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139164527|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164528|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164530|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139164531|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139164532|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139164533|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164534|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164535|NCT00812006|Rizatriptan|rizatriptan|mesh-list
139164536|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139164537|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
139164538|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164539|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164540|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164541|NCT03133234|Osimertinib|osimertinib|mesh-list
139164542|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164543|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139164544|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164545|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164546|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139164547|NCT01125787|Ofatumumab|ofatumumab|mesh-list
139164548|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139164549|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139164550|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
139164551|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164552|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164553|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
139164554|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164555|NCT03132038|Nivolumab|nivolumab|mesh-list
139164556|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139164557|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164558|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139164559|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164560|NCT01129375|Omeprazole|omeprazole|mesh-list
139164561|NCT01129375|Clopidogrel|clopidogrel|mesh-list
139164562|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138961547|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139164563|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139164564|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139164565|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139164566|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
139164567|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164568|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164569|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164570|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139164571|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139164572|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139164573|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164574|NCT06130072|Ethiodized Oil|ethiodized oil|mesh-list
139164575|NCT06130072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164576|NCT06130059|Colchicine|colchicine|mesh-list
138915015|NCT00771030|Brodalumab|brodalumab|mesh-list
139164577|NCT06130059|Gout Suppressants|gout suppressants|mesh-ancestor
139164578|NCT06130059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139164579|NCT06130059|Tubulin Modulators|tubulin modulators|mesh-ancestor
139164580|NCT06130059|Antimitotic Agents|antimitotic agents|mesh-ancestor
139164581|NCT06130059|Mitosis Modulators|mitosis modulators|mesh-ancestor
139164582|NCT06130059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164583|NCT06130059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164584|NCT06130007|Docetaxel|docetaxel|mesh-list
139164585|NCT06130007|Trastuzumab|trastuzumab|mesh-list
139164586|NCT06130007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164587|NCT06130007|Tubulin Modulators|tubulin modulators|mesh-ancestor
139164588|NCT06130007|Antimitotic Agents|antimitotic agents|mesh-ancestor
139164589|NCT06130007|Mitosis Modulators|mitosis modulators|mesh-ancestor
139164590|NCT06130007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954740|NCT03990103|Tegafur|tegafur|mesh-list
139164591|NCT06130007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139164592|NCT06129955|Lenvatinib|lenvatinib|mesh-list
139164593|NCT06129955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164594|NCT06129955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139164595|NCT06129955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164596|NCT06129955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164597|NCT06129851|Relugolix|relugolix|mesh-list
138961588|NCT00815256|Riboflavin|riboflavin|mesh-list
139164598|NCT06129851|Androgen Antagonists|androgen antagonists|mesh-ancestor
139164599|NCT06129851|Hormone Antagonists|hormone antagonists|mesh-ancestor
139164600|NCT06129851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139164601|NCT06129851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164602|NCT06129773|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139164603|NCT06129773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139164604|NCT06129734|Decitabine|decitabine|mesh-list
139164605|NCT06129734|Venetoclax|venetoclax|mesh-list
139164606|NCT06129734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139164607|NCT06129734|Antimetabolites|antimetabolites|mesh-ancestor
139164608|NCT06129734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164609|NCT06129734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164610|NCT06129734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164611|NCT06129474|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139164612|NCT06129474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164613|NCT06129474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164614|NCT06129162|Anesthetics|anesthetics|mesh-list
139164615|NCT06129162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164616|NCT06129162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164617|NCT06128967|Metformin|metformin|mesh-list
139164618|NCT06128967|Fluvoxamine|fluvoxamine|mesh-list
139164619|NCT06128967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139164620|NCT06128967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164621|NCT06128967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164622|NCT06128967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164623|NCT06128967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139164624|NCT06128967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139164625|NCT06128967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164626|NCT06128967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139164627|NCT06128967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139164628|NCT06128967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139164629|NCT06128967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139164630|NCT06128967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164631|NCT06128967|Serotonin Agents|serotonin agents|mesh-ancestor
139164632|NCT06128967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139164633|NCT06128967|Antidepressive Agents|antidepressive agents|mesh-ancestor
139164634|NCT06128967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139164635|NCT06128967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139164636|NCT06128967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139164637|NCT06128863|Pembrolizumab|pembrolizumab|mesh-list
139164638|NCT06128863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139164639|NCT06128863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164640|NCT06128863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139164641|NCT06128863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164642|NCT06128837|Irinotecan|irinotecan|mesh-list
139164643|NCT06128837|Topotecan|topotecan|mesh-list
139164644|NCT06128837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139164645|NCT06128837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139164646|NCT06128837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164647|NCT06128837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164648|NCT06128837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164649|NCT06128733|Vaccines|vaccines|mesh-list
139164650|NCT06128733|Immunologic Factors|immunologic factors|mesh-ancestor
139164651|NCT06128733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164653|NCT06128434|Cariostatic Agents|cariostatic agents|mesh-ancestor
139164654|NCT06128434|Protective Agents|protective agents|mesh-ancestor
139164655|NCT06128434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164656|NCT06128408|Olanzapine|olanzapine|mesh-list
139164657|NCT06128408|Risperidone|risperidone|mesh-list
139164658|NCT06128408|Aripiprazole|aripiprazole|mesh-list
139164659|NCT06128408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139164660|NCT06128408|Serotonin Agents|serotonin agents|mesh-ancestor
139164661|NCT06128408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954743|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
139164662|NCT06128408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164663|NCT06128408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164664|NCT06128408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139164665|NCT06128408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139164666|NCT06128408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164667|NCT06128408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139164668|NCT06128408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139164669|NCT06128408|Dopamine Agents|dopamine agents|mesh-ancestor
139164670|NCT06128408|Antiemetics|antiemetics|mesh-ancestor
139164671|NCT06128408|Autonomic Agents|autonomic agents|mesh-ancestor
139164672|NCT06128408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164673|NCT06128408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139164674|NCT06128408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139164675|NCT06128408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139164676|NCT06128408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139164677|NCT06128408|Antidepressive Agents|antidepressive agents|mesh-ancestor
139164678|NCT06128408|Dopamine Agonists|dopamine agonists|mesh-ancestor
139164679|NCT06128408|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139164680|NCT06128408|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139164681|NCT06128408|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139164682|NCT06128408|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139164683|NCT06128356|Dexmedetomidine|dexmedetomidine|mesh-list
139164684|NCT06128356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139164685|NCT06128356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164686|NCT06128356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164687|NCT06128356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139164688|NCT06128356|Analgesics|analgesics|mesh-ancestor
139164689|NCT06128356|Sensory System Agents|sensory system agents|mesh-ancestor
139164690|NCT06128356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164691|NCT06128356|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139164692|NCT06128356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139164693|NCT06128356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139164694|NCT06128356|Adrenergic Agents|adrenergic agents|mesh-ancestor
139164695|NCT06128356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164696|NCT06128356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164698|NCT06128278|Phytoestrogens|phytoestrogens|mesh-ancestor
139164699|NCT06128278|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139164700|NCT06128278|Estrogens|estrogens|mesh-ancestor
139164701|NCT06128278|Hormones|hormones|mesh-ancestor
139164702|NCT06128278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139164703|NCT06128278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164704|NCT06128213|Cycloserine|cycloserine|mesh-list
139164705|NCT06128213|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139164706|NCT06128213|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139164707|NCT06128213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139164708|NCT06128213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139164709|NCT06128213|Antitubercular Agents|antitubercular agents|mesh-ancestor
139164710|NCT06128213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139164711|NCT06128213|Antimetabolites|antimetabolites|mesh-ancestor
139164712|NCT06128213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164713|NCT06128213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139164714|NCT06128213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139164715|NCT06128213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164716|NCT06128213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164717|NCT06128213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139164718|NCT06128213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139164719|NCT06128213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139164720|NCT06128213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139164721|NCT06128213|Adrenergic Agents|adrenergic agents|mesh-ancestor
138915161|NCT05500092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139164722|NCT06128213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164723|NCT06128213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139164724|NCT06128213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139164725|NCT06128213|Serotonin Agents|serotonin agents|mesh-ancestor
139164726|NCT06128213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139164727|NCT06128213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139164728|NCT06128213|Dopamine Agents|dopamine agents|mesh-ancestor
139164729|NCT06128109|Lidocaine|lidocaine|mesh-list
139164730|NCT06128109|Anesthetics, Local|anesthetics, local|mesh-ancestor
139164731|NCT06128109|Anesthetics|anesthetics|mesh-ancestor
139164732|NCT06128109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164733|NCT06128109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164734|NCT06128109|Sensory System Agents|sensory system agents|mesh-ancestor
139164735|NCT06128109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164736|NCT06128109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139164737|NCT06128109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139164738|NCT06128109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139164739|NCT06128109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139164740|NCT06128109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164742|NCT06128070|Tacrolimus|tacrolimus|mesh-list
139164743|NCT06128070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139164744|NCT06128070|Abortifacient Agents|abortifacient agents|mesh-ancestor
139164745|NCT06128070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139164746|NCT06128070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164747|NCT06128070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139164748|NCT06128070|Antimetabolites|antimetabolites|mesh-ancestor
139164749|NCT06128070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164750|NCT06128070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164751|NCT06128070|Dermatologic Agents|dermatologic agents|mesh-ancestor
139164752|NCT06128070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164753|NCT06128070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139164754|NCT06128070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139164755|NCT06128070|Immunologic Factors|immunologic factors|mesh-ancestor
139164756|NCT06128070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139164757|NCT06128070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139164758|NCT06128070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139164759|NCT06126315|Acetylcarnitine|acetylcarnitine|mesh-list
139164760|NCT06126315|Vitamin B Complex|vitamin b complex|mesh-ancestor
139164761|NCT06126315|Vitamins|vitamins|mesh-ancestor
139164762|NCT06126315|Micronutrients|micronutrients|mesh-ancestor
139164763|NCT06126315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164764|NCT06126315|Nootropic Agents|nootropic agents|mesh-ancestor
139164765|NCT06126068|Magnesium Sulfate|magnesium sulfate|mesh-list
139164766|NCT06126068|Analgesics|analgesics|mesh-ancestor
139164767|NCT06126068|Sensory System Agents|sensory system agents|mesh-ancestor
139164768|NCT06126068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164769|NCT06126068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164770|NCT06126068|Anesthetics|anesthetics|mesh-ancestor
139164771|NCT06126068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164772|NCT06126068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139164773|NCT06126068|Anticonvulsants|anticonvulsants|mesh-ancestor
139164774|NCT06126068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139164775|NCT06126068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139164776|NCT06126068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164777|NCT06126068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139164779|NCT06126068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139164780|NCT06124378|Capecitabine|capecitabine|mesh-list
139164781|NCT06124378|Oxaliplatin|oxaliplatin|mesh-list
139164782|NCT06124378|Tislelizumab|tislelizumab|mesh-list
139164783|NCT06124378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139164784|NCT06124378|Antimetabolites|antimetabolites|mesh-ancestor
139164785|NCT06124378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164786|NCT06124378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164787|NCT06124378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139164788|NCT06123468|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139164789|NCT06123468|Immunoconjugates|immunoconjugates|mesh-ancestor
139164790|NCT06123468|Immunologic Factors|immunologic factors|mesh-ancestor
139164791|NCT06123468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164792|NCT06086691|Caffeine|caffeine|mesh-list
139164793|NCT06086691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139164794|NCT06086691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164795|NCT06086691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139164796|NCT06086691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164797|NCT06086691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164798|NCT06086691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139164799|NCT06086691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139164800|NCT06086691|Purinergic Agents|purinergic agents|mesh-ancestor
139164801|NCT06086691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164803|NCT06086171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139164805|NCT06086171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164806|NCT06086171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164807|NCT06086171|Analgesics|analgesics|mesh-ancestor
139164808|NCT06086171|Sensory System Agents|sensory system agents|mesh-ancestor
139164809|NCT06086171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164810|NCT06086171|Antitussive Agents|antitussive agents|mesh-ancestor
139164811|NCT06086171|Respiratory System Agents|respiratory system agents|mesh-ancestor
139164812|NCT06064500|AMG 757|amg 757|mesh-list
139164813|NCT06064500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164814|NCT06058650|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
139164815|NCT06058650|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139164816|NCT06058650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164817|NCT06054113|Blinatumomab|blinatumomab|mesh-list
139164818|NCT06054113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164819|NCT06022146|Rifampin|rifampin|mesh-list
139164820|NCT06022146|Rifapentine|rifapentine|mesh-list
139164821|NCT06022146|Isoniazid|isoniazid|mesh-list
139164822|NCT06022146|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139164823|NCT06022146|Antitubercular Agents|antitubercular agents|mesh-ancestor
139164824|NCT06022146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139164825|NCT06022146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139164826|NCT06022146|Leprostatic Agents|leprostatic agents|mesh-ancestor
139164827|NCT06022146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139164828|NCT06022146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164829|NCT06022146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164830|NCT06022146|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139164831|NCT06022146|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139164832|NCT06022146|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139164833|NCT06022146|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139164834|NCT06022146|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139164835|NCT06022146|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139164836|NCT06022146|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139164837|NCT06022146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139164838|NCT06022146|Antimetabolites|antimetabolites|mesh-ancestor
139164839|NCT06022146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139164840|NCT05998928|Cyclophosphamide|cyclophosphamide|mesh-list
139164841|NCT05998928|Fludarabine|fludarabine|mesh-list
139164842|NCT05998928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139164843|NCT05998928|Immunologic Factors|immunologic factors|mesh-ancestor
139164844|NCT05998928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164845|NCT05998928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139164846|NCT05998928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139164847|NCT05998928|Alkylating Agents|alkylating agents|mesh-ancestor
139164848|NCT05998928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164849|NCT05998928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164850|NCT05998928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139164851|NCT05995600|Warfarin|warfarin|mesh-list
139164852|NCT05995600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139164853|NCT05995600|Anticoagulants|anticoagulants|mesh-ancestor
139164854|NCT05968937|Baclofen|baclofen|mesh-list
139164855|NCT05968937|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139164856|NCT05968937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164857|NCT05968937|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139164858|NCT05968937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164859|NCT05968937|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139164860|NCT05968937|GABA Agonists|gaba agonists|mesh-ancestor
139164861|NCT05968937|GABA Agents|gaba agents|mesh-ancestor
139164862|NCT05968937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139164863|NCT05968937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164864|NCT05930561|Aflibercept|aflibercept|mesh-list
139164865|NCT05930561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139164866|NCT05930561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139164867|NCT05930561|Growth Substances|growth substances|mesh-ancestor
139164868|NCT05930561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164869|NCT05930561|Growth Inhibitors|growth inhibitors|mesh-ancestor
139164870|NCT05930561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164873|NCT05867329|Methylprednisolone|methylprednisolone|mesh-list
139164874|NCT05867329|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139164875|NCT05867329|Upadacitinib|upadacitinib|mesh-list
139164876|NCT05867329|Cyclosporins|cyclosporins|mesh-list
139164877|NCT05867329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139164878|NCT05867329|Glucocorticoids|glucocorticoids|mesh-ancestor
139164879|NCT05867329|Hormones|hormones|mesh-ancestor
139164880|NCT05867329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139164881|NCT05867329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164882|NCT05867329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139164883|NCT05867329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164884|NCT05867329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164885|NCT05867329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164886|NCT05867329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139164887|NCT05867329|Immunologic Factors|immunologic factors|mesh-ancestor
139164888|NCT05867329|Antifungal Agents|antifungal agents|mesh-ancestor
139164889|NCT05867329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139164890|NCT05867329|Dermatologic Agents|dermatologic agents|mesh-ancestor
139164891|NCT05867329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139164892|NCT05867329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139164893|NCT05867329|Antiemetics|antiemetics|mesh-ancestor
139164894|NCT05867329|Autonomic Agents|autonomic agents|mesh-ancestor
138894410|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
139164895|NCT05867329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164896|NCT05867329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139164897|NCT05867329|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139164898|NCT05867329|Protective Agents|protective agents|mesh-ancestor
138961681|NCT00813072|Docetaxel|docetaxel|mesh-list
139164915|NCT05733923|Eusol|eusol|mesh-list
139164916|NCT05733923|Disinfectants|disinfectants|mesh-ancestor
139164917|NCT05733923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139164918|NCT05694715|Irinotecan|irinotecan|mesh-list
139164919|NCT05694715|Niraparib|niraparib|mesh-list
139164920|NCT05694715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139164921|NCT05694715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139164922|NCT05694715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164923|NCT05694715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164924|NCT05694715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164925|NCT05694715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139164926|NCT05689047|Artesunate|artesunate|mesh-list
139164927|NCT05689047|Pyronaridine|pyronaridine|mesh-list
139164928|NCT05689047|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139164929|NCT05689047|Antimalarials|antimalarials|mesh-ancestor
139164930|NCT05689047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139164931|NCT05689047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139164932|NCT05689047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139164933|NCT05689047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164934|NCT05689047|Antiviral Agents|antiviral agents|mesh-ancestor
139164935|NCT05689047|Schistosomicides|schistosomicides|mesh-ancestor
139164936|NCT05689047|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139164937|NCT05689047|Anthelmintics|anthelmintics|mesh-ancestor
139164938|NCT05660538|Pregabalin|pregabalin|mesh-list
139164939|NCT05660538|Analgesics|analgesics|mesh-ancestor
139164940|NCT05660538|Sensory System Agents|sensory system agents|mesh-ancestor
139164941|NCT05660538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139164942|NCT05660538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164943|NCT05660538|Anticonvulsants|anticonvulsants|mesh-ancestor
139164944|NCT05660538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139164945|NCT05660538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139164946|NCT05660538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164947|NCT05660538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139164948|NCT05660538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139164949|NCT05660538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139164950|NCT05660538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139164951|NCT05660538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139164952|NCT05623995|Evolocumab|evolocumab|mesh-list
139164953|NCT05623995|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
139164954|NCT05623995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139164955|NCT05623995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139164956|NCT05623995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139164957|NCT05623995|Antimetabolites|antimetabolites|mesh-ancestor
139164958|NCT05623995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164959|NCT05623995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139164960|NCT05623995|Protease Inhibitors|protease inhibitors|mesh-ancestor
139164961|NCT05623995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139164962|NCT05623995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139164963|NCT05616013|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139164964|NCT05616013|Antibodies, Blocking|antibodies, blocking|mesh-list
139164965|NCT05616013|Immunologic Factors|immunologic factors|mesh-ancestor
139164966|NCT05616013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164968|NCT05608252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139164969|NCT05608252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164970|NCT05608252|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139164971|NCT05608252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139164972|NCT05608252|Hormone Antagonists|hormone antagonists|mesh-ancestor
139164973|NCT05608252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139164974|NCT05608252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164975|NCT05606913|Dulaglutide|dulaglutide|mesh-list
139164976|NCT05606913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139164977|NCT05606913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164978|NCT05528952|Bevacizumab|bevacizumab|mesh-list
139164979|NCT05528952|Atezolizumab|atezolizumab|mesh-list
139164980|NCT05528952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139164981|NCT05528952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139164982|NCT05528952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139164983|NCT05528952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139164984|NCT05528952|Growth Substances|growth substances|mesh-ancestor
139164985|NCT05528952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139164986|NCT05528952|Growth Inhibitors|growth inhibitors|mesh-ancestor
139164987|NCT05528952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139164988|NCT05528952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139164989|NCT05493111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139164990|NCT05493111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139164991|NCT05465876|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139164992|NCT05465876|Antiviral Agents|antiviral agents|mesh-ancestor
139164993|NCT05465876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139164994|NCT05442567|Vedolizumab|vedolizumab|mesh-list
139164995|NCT05442567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139164996|NCT05385887|Metronidazole|metronidazole|mesh-list
139164997|NCT05385887|Ciprofloxacin|ciprofloxacin|mesh-list
139164998|NCT05385887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139164999|NCT05385887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139165000|NCT05385887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139165001|NCT05385887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139165002|NCT05385887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139165003|NCT05385887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139165004|NCT05385887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165005|NCT05385887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165006|NCT05385887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165007|NCT05385887|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139165008|NCT05385887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139165009|NCT05382312|Bedaquiline|bedaquiline|mesh-list
139165011|NCT05382312|Antitubercular Agents|antitubercular agents|mesh-ancestor
139165012|NCT05382312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139165013|NCT05382312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165014|NCT05300035|Antibodies|antibodies|mesh-list
139165015|NCT05300035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139165016|NCT05300035|Immunologic Factors|immunologic factors|mesh-ancestor
139165017|NCT05300035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954758|NCT00987220|Donepezil|donepezil|mesh-list
139165018|NCT05264558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138915461|NCT00759915|Morphine|morphine|mesh-list
139165019|NCT05264558|Antiviral Agents|antiviral agents|mesh-ancestor
139165020|NCT05264558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165021|NCT05232344|Estradiol|estradiol|mesh-list
139165022|NCT05232344|Progesterone|progesterone|mesh-list
139165023|NCT05232344|Estrogens|estrogens|mesh-ancestor
139165024|NCT05232344|Hormones|hormones|mesh-ancestor
139165025|NCT05232344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165026|NCT05232344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165028|NCT05197257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139165029|NCT05197257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139165030|NCT05197257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165031|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139165032|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139165033|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139165034|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139165035|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165036|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139165037|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139165038|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165039|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
139165040|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165041|NCT05156905|Docetaxel|docetaxel|mesh-list
139165042|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165043|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
139165044|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
139165045|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
139165046|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165047|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139165048|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
139165049|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139165050|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
139165051|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139165052|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165053|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139165054|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139165055|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139165056|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139165057|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139165058|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
139165059|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139165060|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139165061|NCT05127304|Bromides|bromides|mesh-list
139165062|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
139165063|NCT05127304|Olodaterol|olodaterol|mesh-list
139165064|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139165065|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
139165066|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139165067|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165068|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139165069|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
139165070|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
139165071|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139165072|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
139165073|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165074|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165075|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
139165076|NCT05121909|Listerine|listerine|mesh-list
139165077|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139165078|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
139165079|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
139165080|NCT05121909|Protective Agents|protective agents|mesh-ancestor
139165081|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165082|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165083|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
139165084|NCT05016609|Velpatasvir|velpatasvir|mesh-list
139165085|NCT05016609|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139165086|NCT05016609|Antibodies|antibodies|mesh-list
139165087|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
139165088|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
139165089|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165090|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
139165091|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165092|NCT04988308|Adalimumab|adalimumab|mesh-list
139165093|NCT04988308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139165094|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139165095|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139165096|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
139165097|NCT04904562|Giapreza|giapreza|mesh-list
139165098|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
139165099|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139165100|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139165101|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
139165102|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165103|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165104|NCT04862663|Fulvestrant|fulvestrant|mesh-list
139165105|NCT04862663|Palbociclib|palbociclib|mesh-list
139165106|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139165107|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165108|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139165109|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139165110|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
139165111|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165112|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894476|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
139165113|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165114|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165115|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165116|NCT04849364|Pembrolizumab|pembrolizumab|mesh-list
139165117|NCT04849364|Capecitabine|capecitabine|mesh-list
139165118|NCT04849364|Talazoparib|talazoparib|mesh-list
139165119|NCT04849364|Inavolisib|inavolisib|mesh-list
139165120|NCT04849364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165121|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165122|NCT04849364|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139165123|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165124|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139165125|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
139165126|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139165127|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165128|NCT04849364|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139165129|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
139165130|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139165131|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139165132|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165133|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
139165134|NCT04797156|Coagulants|coagulants|mesh-ancestor
139165135|NCT04776148|Trifluridine|trifluridine|mesh-list
139165136|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
139165137|NCT04776148|Lenvatinib|lenvatinib|mesh-list
139165138|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165139|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165140|NCT04776148|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139165141|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165142|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165143|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165144|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
139165145|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
139165146|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165147|NCT04737109|Ipatasertib|ipatasertib|mesh-list
139165148|NCT04737109|Androgens|androgens|mesh-list
139165149|NCT04737109|Hormones|hormones|mesh-ancestor
139165150|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165151|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165152|NCT04737109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165153|NCT04737109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165154|NCT04737109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961723|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139165155|NCT04737109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165156|NCT04730258|Azacitidine|azacitidine|mesh-list
139165157|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139165158|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
139165159|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165160|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165161|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165162|NCT04661150|Capecitabine|capecitabine|mesh-list
139165163|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
139165164|NCT04661150|Trastuzumab|trastuzumab|mesh-list
139165165|NCT04661150|Atezolizumab|atezolizumab|mesh-list
139165166|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139165167|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
139165168|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165169|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165170|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165171|NCT04661150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139165172|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
139165173|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165174|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
139165175|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165176|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165177|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139165178|NCT04589325|Ixekizumab|ixekizumab|mesh-list
139165179|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
139165180|NCT04582669|Triamcinolone|triamcinolone|mesh-list
139165181|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139165182|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139165183|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139165184|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139165185|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
139165186|NCT04582669|Hormones|hormones|mesh-ancestor
139165187|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165188|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165189|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139165190|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
139165191|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165192|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165193|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
139165194|NCT04548661|Povidone|povidone|mesh-list
139165195|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
139165196|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
139165197|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139165198|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165199|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139165200|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165201|NCT04522323|Lenvatinib|lenvatinib|mesh-list
139165202|NCT04522323|Axitinib|axitinib|mesh-list
139165203|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165204|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165205|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165206|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165207|NCT04187196|Propofol|propofol|mesh-list
139165208|NCT04187196|Methohexital|methohexital|mesh-list
139165209|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139165210|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139165211|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165212|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139165213|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
139165214|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
139165215|NCT04166474|Dolutegravir|dolutegravir|mesh-list
139165216|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139165217|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139165218|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165219|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165220|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139165221|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139165222|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
139165223|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165224|NCT04091971|Ketamine|ketamine|mesh-list
139165225|NCT04091971|Analgesics|analgesics|mesh-ancestor
139165226|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
139165227|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139165228|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165229|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139165230|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139165231|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
139165232|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
139165233|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139165234|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139165235|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139165236|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165237|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165238|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
139165239|NCT04023669|Gemcitabine|gemcitabine|mesh-list
139165240|NCT04023669|Lenograstim|lenograstim|mesh-list
139165241|NCT04023669|Prexasertib|prexasertib|mesh-list
139165242|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139165243|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
139165244|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165245|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139165246|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139165247|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
139165248|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165249|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165250|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139165251|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139165252|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
139165253|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139165254|NCT04023669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165255|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165256|NCT04019873|Lamivudine|lamivudine|mesh-list
139165257|NCT04019873|Rilpivirine|rilpivirine|mesh-list
139165258|NCT04019873|Dolutegravir|dolutegravir|mesh-list
139165259|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139165260|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139165261|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165262|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165263|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
139165264|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165265|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139165266|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139165267|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139165268|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139165269|NCT03955887|Dimercaprol|dimercaprol|mesh-list
139165270|NCT03955887|Chelating Agents|chelating agents|mesh-ancestor
139165271|NCT03955887|Sequestering Agents|sequestering agents|mesh-ancestor
139165272|NCT03955887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165273|NCT03950609|Everolimus|everolimus|mesh-list
139165274|NCT03950609|Lenvatinib|lenvatinib|mesh-list
139165275|NCT03950609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139165276|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165277|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165278|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165279|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139165280|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
139165281|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165282|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165283|NCT03943901|Prednisone|prednisone|mesh-list
139165284|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
139165285|NCT03943901|Rituximab|rituximab|mesh-list
139165286|NCT03943901|Doxorubicin|doxorubicin|mesh-list
139165287|NCT03943901|Vincristine|vincristine|mesh-list
139165288|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139165289|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
139165290|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165291|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138894604|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
139165292|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139165293|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
138954779|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139165294|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165295|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165296|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139165297|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165298|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139165299|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139165300|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139165301|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165302|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139165303|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
139165304|NCT03943901|Hormones|hormones|mesh-ancestor
139165305|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165306|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139165307|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139165308|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
139165309|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
139165310|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
139165311|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139165312|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139165313|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139165314|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139165315|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165316|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139165317|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139165318|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139165319|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139165320|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
139165321|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165322|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165323|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139165324|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139165325|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
139165326|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139165327|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139165328|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
139165330|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
139165331|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
139165332|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139165333|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165334|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
139165335|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139165336|NCT03753919|Durvalumab|durvalumab|mesh-list
139165337|NCT03753919|Tremelimumab|tremelimumab|mesh-list
139165338|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165339|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165340|NCT03654768|Imatinib Mesylate|imatinib mesylate|mesh-list
139165341|NCT03654768|Dasatinib|dasatinib|mesh-list
139165342|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139165343|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165344|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165345|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165346|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165347|NCT03495232|Cimetidine|cimetidine|mesh-list
139165348|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139165349|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139165350|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139165351|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
139165352|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
139165353|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165354|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165355|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165356|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139165357|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139165358|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165359|NCT03422731|Alovudine|alovudine|mesh-list
139165360|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
139165361|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165362|NCT03299842|Fenfluramine|fenfluramine|mesh-list
139165363|NCT03299842|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139165364|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139165365|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139165366|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165367|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165368|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
139165369|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165370|NCT03249181|Dolutegravir|dolutegravir|mesh-list
139165371|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139165372|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139165373|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165374|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165375|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139165376|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139165377|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
139165378|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165379|NCT03237611|Dexamethasone|dexamethasone|mesh-list
139165380|NCT03237611|Ondansetron|ondansetron|mesh-list
139165381|NCT03237611|Aprepitant|aprepitant|mesh-list
139165382|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
139165383|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139165384|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
139165385|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
139165386|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139165387|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165388|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139165389|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
139165390|NCT03237611|Hormones|hormones|mesh-ancestor
139165391|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165392|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138915836|NCT00823823|Calpastatin|calpastatin|mesh-list
139165393|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165394|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
139165395|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
139165396|NCT03237611|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139165397|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139165398|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
139165399|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165400|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165401|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139165403|NCT03220022|Cortisone|cortisone|mesh-list
139165404|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
139165405|NCT03220022|Rituximab|rituximab|mesh-list
139165406|NCT03220022|Doxorubicin|doxorubicin|mesh-list
139165407|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139165408|NCT03220022|Etoposide|etoposide|mesh-list
139165409|NCT03220022|Vincristine|vincristine|mesh-list
139165410|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
139165411|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
139165412|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139165413|NCT03220022|Antibodies|antibodies|mesh-list
139165414|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
139165415|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139165416|NCT03220022|Lenograstim|lenograstim|mesh-list
139165417|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139165418|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
139165419|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165420|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139165421|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139165422|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
139165423|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165424|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165425|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139165426|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139165427|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139165428|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139165429|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165430|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139165431|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
139165432|NCT03220022|Hormones|hormones|mesh-ancestor
139165433|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165434|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139165435|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139165436|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138712630|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
139165437|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
139165438|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
139165439|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
139165440|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
139165441|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
139165442|NCT03104374|Upadacitinib|upadacitinib|mesh-list
139165443|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139165444|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165445|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165446|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165447|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139165448|NCT03073941|Cimetidine|cimetidine|mesh-list
139165449|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139165450|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139165451|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139165452|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
139165453|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
139165454|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165455|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165456|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165457|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139165458|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139165459|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165460|NCT03054363|Letrozole|letrozole|mesh-list
139165461|NCT03054363|Palbociclib|palbociclib|mesh-list
139165462|NCT03054363|Tucatinib|tucatinib|mesh-list
139165463|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165464|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139165465|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139165466|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546837|NCT00232531|Niacin|niacin|mesh-list
139165467|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165468|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139165469|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
139165470|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165471|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165472|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165474|NCT03043313|Tucatinib|tucatinib|mesh-list
139165475|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165476|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165477|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165478|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165479|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165480|NCT03016533|Lamivudine|lamivudine|mesh-list
139165481|NCT03016533|Dolutegravir|dolutegravir|mesh-list
139165482|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139165483|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139165484|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165485|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165486|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
139165487|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165488|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139165489|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139165490|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139165491|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139165492|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
139165493|NCT02829957|Apixaban|apixaban|mesh-list
139165494|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139165495|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
139165496|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139165497|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
139165498|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165499|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165500|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
139165501|NCT02817958|Paclitaxel|paclitaxel|mesh-list
139165502|NCT02817958|Ifosfamide|ifosfamide|mesh-list
139165503|NCT02817958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139165504|NCT02817958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165505|NCT02817958|Tubulin Modulators|tubulin modulators|mesh-ancestor
139165506|NCT02817958|Antimitotic Agents|antimitotic agents|mesh-ancestor
139165507|NCT02817958|Mitosis Modulators|mitosis modulators|mesh-ancestor
139165508|NCT02817958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165509|NCT02817958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139165510|NCT02817958|Alkylating Agents|alkylating agents|mesh-ancestor
139165511|NCT02342444|Enoxaparin|enoxaparin|mesh-list
139165512|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
139165513|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
139165514|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139165515|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139165516|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165517|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
139165518|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139165519|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
139165520|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
139165521|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
139165522|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139165523|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165524|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139165525|NCT01787409|Vitamin D|vitamin d|mesh-list
139165526|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
139165527|NCT01787409|Vitamins|vitamins|mesh-ancestor
139165528|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
139165529|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165530|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139165531|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139165532|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139165533|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
139165534|NCT00541047|Leuprolide|leuprolide|mesh-list
139165535|NCT00541047|Goserelin|goserelin|mesh-list
139165536|NCT00541047|Bicalutamide|bicalutamide|mesh-list
139165537|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139165538|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
139165539|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139165540|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165541|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139165542|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165543|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
139165544|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
139165545|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165546|NCT01352702|Dabigatran|dabigatran|mesh-list
139165547|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
139165548|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
139165549|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139165550|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
139165551|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165552|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165553|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
139165554|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
139165555|NCT03525730|Valproic Acid|valproic acid|mesh-list
139165556|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
139165557|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139165558|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139165559|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165560|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138894785|NCT00863304|Tanezumab|tanezumab|mesh-list
139165561|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165562|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165563|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
139165564|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
139165565|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165566|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165567|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
139165568|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139165569|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139165570|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139165571|NCT01223443|Paclitaxel|paclitaxel|mesh-list
139165572|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139165573|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165574|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
139165575|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
139165576|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
139165577|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165578|NCT03525652|Vaccines|vaccines|mesh-list
139165579|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
139165580|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165581|NCT02290054|Anesthetics|anesthetics|mesh-list
139165582|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139165583|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165584|NCT01347944|Lenalidomide|lenalidomide|mesh-list
139165585|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
139165586|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165587|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139165588|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139165589|NCT01347944|Growth Substances|growth substances|mesh-ancestor
139165590|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
139165591|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165592|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
139165593|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
139165594|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165595|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139165596|NCT01220245|Heparin|heparin|mesh-list
139165597|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
139165598|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139165599|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139165600|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165601|NCT03931135|Dexamethasone|dexamethasone|mesh-list
139165602|NCT03931135|Morphine|morphine|mesh-list
139165603|NCT03931135|Cyclizine|cyclizine|mesh-list
139165604|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139165605|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
139165606|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
139165607|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139165608|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165609|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139165610|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
139165611|NCT03931135|Hormones|hormones|mesh-ancestor
139165612|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165613|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139165614|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165615|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139165616|NCT03931135|Narcotics|narcotics|mesh-ancestor
139165617|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139165618|NCT03931135|Analgesics|analgesics|mesh-ancestor
139165619|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
139165620|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139165621|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
139165622|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
139165623|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165624|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165625|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
139165626|NCT01353170|Calcium|calcium|mesh-list
139165627|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139165628|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165629|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139165630|NCT03620318|Crenolanib|crenolanib|mesh-list
139165631|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165632|NCT01125943|Bevacizumab|bevacizumab|mesh-list
139165633|NCT01125943|Nitroprusside|nitroprusside|mesh-list
139165634|NCT01125943|Acetylcholine|acetylcholine|mesh-list
139165635|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165636|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165637|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139165638|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139165639|NCT01125943|Growth Substances|growth substances|mesh-ancestor
139165640|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165641|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
139165642|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139165643|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
139165644|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139165645|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165646|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139165647|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
139165648|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165649|NCT01223755|Sirolimus|sirolimus|mesh-list
139165650|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139165651|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165652|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139165653|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165654|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
139165655|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139165656|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
139165657|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165658|NCT01126177|Interferons|interferons|mesh-list
139165659|NCT01126177|Interferon-beta|interferon-beta|mesh-list
139165660|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
139165662|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
139165663|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165664|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
139165665|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165666|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139165667|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
139165669|NCT03680092|Abatacept|abatacept|mesh-list
139165670|NCT03680092|Tacrolimus|tacrolimus|mesh-list
139165671|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139165672|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
139165673|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165674|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139165675|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139165676|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
139165677|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165678|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165679|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139165680|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139165681|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
139165682|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139165683|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139165684|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
139165685|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
139165686|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165687|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139165688|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139165689|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139165690|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139165691|NCT03680092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165692|NCT03671044|Docetaxel|docetaxel|mesh-list
139165693|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165694|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
139165695|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
139165696|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
139165697|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165698|NCT05790070|Betaine|betaine|mesh-list
139165699|NCT05790070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139165700|NCT05790070|Lipotropic Agents|lipotropic agents|mesh-ancestor
139165701|NCT05790070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139165702|NCT05790070|Antimetabolites|antimetabolites|mesh-ancestor
139019583|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139165703|NCT05790070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165704|NCT05790070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139165705|NCT05789680|Parathyroid Hormone|parathyroid hormone|mesh-list
139165706|NCT05789680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139165707|NCT05789680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165708|NCT05789667|Lenvatinib|lenvatinib|mesh-list
139165709|NCT05789667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165710|NCT05789667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165711|NCT05789667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165712|NCT05789667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165713|NCT05789186|Fluoxetine|fluoxetine|mesh-list
139165714|NCT05789186|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139165715|NCT05789186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139165716|NCT05789186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139165717|NCT05789186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165718|NCT05789186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165719|NCT05789186|Serotonin Agents|serotonin agents|mesh-ancestor
139165720|NCT05789186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165721|NCT05789186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139165722|NCT05789186|Antidepressive Agents|antidepressive agents|mesh-ancestor
139165723|NCT05789186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139165724|NCT05789186|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139165725|NCT05789186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139165726|NCT05789186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165727|NCT05789030|Prednisone|prednisone|mesh-list
139165728|NCT05789030|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
139165729|NCT05789030|Betamethasone|betamethasone|mesh-list
139165730|NCT05789030|Leflunomide|leflunomide|mesh-list
139165731|NCT05789030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139165732|NCT05789030|Glucocorticoids|glucocorticoids|mesh-ancestor
139165733|NCT05789030|Hormones|hormones|mesh-ancestor
139165734|NCT05789030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165735|NCT05789030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165736|NCT05789030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139165737|NCT05789030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165738|NCT05789030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165739|NCT05789030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165740|NCT05789030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139165741|NCT05789030|Immunologic Factors|immunologic factors|mesh-ancestor
139165742|NCT05789030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139165743|NCT05789030|Respiratory System Agents|respiratory system agents|mesh-ancestor
139165744|NCT05789017|Mycophenolic Acid|mycophenolic acid|mesh-list
139165745|NCT05789017|Prednisone|prednisone|mesh-list
139165746|NCT05789017|Leflunomide|leflunomide|mesh-list
139165747|NCT05789017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139165748|NCT05789017|Glucocorticoids|glucocorticoids|mesh-ancestor
139165749|NCT05789017|Hormones|hormones|mesh-ancestor
139165750|NCT05789017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165751|NCT05789017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165752|NCT05789017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139165753|NCT05789017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165754|NCT05789017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139165755|NCT05789017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139165756|NCT05789017|Antitubercular Agents|antitubercular agents|mesh-ancestor
139165757|NCT05789017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139165758|NCT05789017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165759|NCT05789017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165760|NCT05789017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165761|NCT05789017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139165762|NCT05789017|Immunologic Factors|immunologic factors|mesh-ancestor
139165763|NCT05788991|Metronidazole|metronidazole|mesh-list
139165764|NCT05788991|Dequalinium|dequalinium|mesh-list
139165765|NCT05788991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165766|NCT05788991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139165767|NCT05788991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139165768|NCT05788991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139165769|NCT05788991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139165770|NCT05788913|Heparin|heparin|mesh-list
139165771|NCT05788913|Anticoagulants|anticoagulants|mesh-ancestor
139165772|NCT05788913|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139165773|NCT05788913|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139165774|NCT05788913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165775|NCT05788900|Heparin|heparin|mesh-list
139165776|NCT05788900|Anticoagulants|anticoagulants|mesh-ancestor
139165777|NCT05788900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139165778|NCT05788900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139165779|NCT05788900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165780|NCT05788835|Chlorotrianisene|chlorotrianisene|mesh-list
139165781|NCT05788835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139165782|NCT05788835|Estrogens|estrogens|mesh-ancestor
139165783|NCT05788835|Hormones|hormones|mesh-ancestor
139165784|NCT05788835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165785|NCT05788835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165786|NCT05788835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139165787|NCT05788835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165788|NCT05788705|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
139165789|NCT05788705|Boswellic acid|boswellic acid|mesh-list
139165790|NCT05788705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139165791|NCT05788705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139165792|NCT05788705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139165793|NCT05788705|Analgesics|analgesics|mesh-ancestor
139165794|NCT05788705|Sensory System Agents|sensory system agents|mesh-ancestor
139165795|NCT05788705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139165796|NCT05788705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165797|NCT05788705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139165798|NCT05755282|Hand Sanitizers|hand sanitizers|mesh-list
139165799|NCT05755282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139165800|NCT05755282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165801|NCT05755282|Disinfectants|disinfectants|mesh-ancestor
139165802|NCT05702905|Metformin|metformin|mesh-list
139165803|NCT05702905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139165804|NCT05702905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165805|NCT05697471|Dienogest|dienogest|mesh-list
139165806|NCT05697471|Danazol|danazol|mesh-list
139165807|NCT05697471|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139165808|NCT05697471|Contraceptive Agents|contraceptive agents|mesh-ancestor
139165809|NCT05697471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139165810|NCT05697471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165811|NCT05697471|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139165812|NCT05697471|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139165813|NCT05697471|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139165814|NCT05697471|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139165815|NCT05697471|Hormone Antagonists|hormone antagonists|mesh-ancestor
139165816|NCT05697471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139165817|NCT05697471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139165818|NCT05697471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165819|NCT05697471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139165820|NCT05670561|Sufentanil|sufentanil|mesh-list
139165821|NCT05670561|Esketamine|esketamine|mesh-list
139165822|NCT05670561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139165823|NCT05670561|Narcotics|narcotics|mesh-ancestor
139165824|NCT05670561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139165825|NCT05670561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165826|NCT05670561|Analgesics|analgesics|mesh-ancestor
139165827|NCT05670561|Sensory System Agents|sensory system agents|mesh-ancestor
139165828|NCT05670561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139165829|NCT05670561|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139165830|NCT05670561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139165831|NCT05670561|Anesthetics, General|anesthetics, general|mesh-ancestor
139165832|NCT05670561|Anesthetics|anesthetics|mesh-ancestor
139165833|NCT05670561|Antidepressive Agents|antidepressive agents|mesh-ancestor
139165834|NCT05670561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139165835|NCT05635877|Esmolol|esmolol|mesh-list
139165836|NCT05635877|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139165837|NCT05635877|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139165838|NCT05635877|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139165839|NCT05635877|Adrenergic Agents|adrenergic agents|mesh-ancestor
139165840|NCT05635877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165841|NCT05635877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165842|NCT05635877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165843|NCT05596006|Domperidone|domperidone|mesh-list
139165844|NCT05596006|Antiemetics|antiemetics|mesh-ancestor
139165845|NCT05596006|Autonomic Agents|autonomic agents|mesh-ancestor
138916286|NCT00749463|Nicotine|nicotine|mesh-list
139165846|NCT05596006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139165847|NCT05596006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165848|NCT05596006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139165849|NCT05596006|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139165850|NCT05596006|Dopamine Agents|dopamine agents|mesh-ancestor
139165851|NCT05596006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165852|NCT05596006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165853|NCT05586529|Cholecalciferol|cholecalciferol|mesh-list
139165854|NCT05586529|Vitamin D|vitamin d|mesh-list
139165855|NCT05586529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138895046|NCT00620165|Levetiracetam|levetiracetam|mesh-list
139165856|NCT05586529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165857|NCT05586529|Vitamins|vitamins|mesh-ancestor
139165858|NCT05586529|Micronutrients|micronutrients|mesh-ancestor
139165859|NCT05586529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139165860|NCT05555303|Amikacin|amikacin|mesh-list
139165861|NCT05555303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139165862|NCT05555303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165863|NCT05549752|Amiodarone|amiodarone|mesh-list
139165864|NCT05549752|Flecainide|flecainide|mesh-list
139165865|NCT05549752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139165866|NCT05549752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139165867|NCT05549752|Vasodilator Agents|vasodilator agents|mesh-ancestor
139165868|NCT05549752|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139165869|NCT05549752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139165870|NCT05549752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165871|NCT05549752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139165872|NCT05549752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139165873|NCT05549752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139165874|NCT05549752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165875|NCT05549752|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139165876|NCT05549752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139165877|NCT05549752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139165878|NCT05549752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139165880|NCT05499832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139165881|NCT05499832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139165882|NCT05499832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165883|NCT05461456|Fexofenadine|fexofenadine|mesh-list
139165884|NCT05461456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139165885|NCT05461456|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139165886|NCT05461456|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139165887|NCT05461456|Histamine Antagonists|histamine antagonists|mesh-ancestor
139165888|NCT05461456|Histamine Agents|histamine agents|mesh-ancestor
139165889|NCT05461456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961958|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
139165890|NCT05461456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165891|NCT05461456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165892|NCT05441930|Levofloxacin|levofloxacin|mesh-list
139165893|NCT05441930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139165894|NCT05441930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165895|NCT05441930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139165896|NCT05441930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139165897|NCT05441930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139165898|NCT05441930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165899|NCT05441930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165900|NCT05441930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165901|NCT05441930|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139165902|NCT05441930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139165903|NCT05394727|Insulin|insulin|mesh-list
139165904|NCT05394727|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139165905|NCT05394727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139165906|NCT05394727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165907|NCT05350501|Nivolumab|nivolumab|mesh-list
139165908|NCT05350501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165909|NCT05350501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165910|NCT05350501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139165911|NCT05350501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165912|NCT05268926|Dapagliflozin|dapagliflozin|mesh-list
139165913|NCT05268926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139165914|NCT05268926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165915|NCT05268926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139165916|NCT05268926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165917|NCT05267366|Bevacizumab|bevacizumab|mesh-list
139165919|NCT05267366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139165920|NCT05267366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165921|NCT05267366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165922|NCT05267366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139165923|NCT05267366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139165924|NCT05267366|Growth Substances|growth substances|mesh-ancestor
139165925|NCT05267366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165926|NCT05267366|Growth Inhibitors|growth inhibitors|mesh-ancestor
139165927|NCT05267366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165928|NCT05267288|Afatinib|afatinib|mesh-list
139165929|NCT05267288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165930|NCT05267288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165931|NCT05267288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165932|NCT05267288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165933|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139165934|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165935|NCT05218629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165936|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165937|NCT05191667|Paclitaxel|paclitaxel|mesh-list
139165938|NCT05191667|Carboplatin|carboplatin|mesh-list
139165939|NCT05191667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139165940|NCT05191667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165941|NCT05191667|Tubulin Modulators|tubulin modulators|mesh-ancestor
139165942|NCT05191667|Antimitotic Agents|antimitotic agents|mesh-ancestor
139165943|NCT05191667|Mitosis Modulators|mitosis modulators|mesh-ancestor
139165944|NCT05191667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165945|NCT05112263|Cyclosporine|cyclosporine|mesh-list
139165946|NCT05112263|Cyclosporins|cyclosporins|mesh-list
139165947|NCT05112263|Tofacitinib|tofacitinib|mesh-list
139165948|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165949|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165951|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
139165952|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165953|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
139165954|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139165955|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
139165956|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139165957|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139165958|NCT05112263|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139165959|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165960|NCT05104281|Osimertinib|osimertinib|mesh-list
139165961|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165962|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139165963|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139165964|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165966|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139165967|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165968|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
139165969|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139165970|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
139165971|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139165972|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165973|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165974|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165975|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
139165976|NCT05040984|Mirabegron|mirabegron|mesh-list
139165977|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139165978|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139165979|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
139165980|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139165981|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139165982|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165983|NCT05040984|Urological Agents|urological agents|mesh-ancestor
139165984|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139165985|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139165986|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139165987|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
139165988|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
139165989|NCT05017272|Narcotics|narcotics|mesh-ancestor
139165990|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139165991|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139165992|NCT05017272|Analgesics|analgesics|mesh-ancestor
139165993|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
139165994|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139165995|NCT04981912|Rituximab|rituximab|mesh-list
139165996|NCT04981912|Venetoclax|venetoclax|mesh-list
139165997|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139165998|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139165999|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
139166000|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166001|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139166002|NCT04974879|Osimertinib|osimertinib|mesh-list
139166003|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166004|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139166005|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166006|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166007|NCT04933058|Acetaminophen|acetaminophen|mesh-list
139166008|NCT04933058|Fentanyl|fentanyl|mesh-list
138961987|NCT00998920|Equol|equol|mesh-list
139166009|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139166010|NCT04933058|Narcotics|narcotics|mesh-ancestor
139166011|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139166012|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166013|NCT04933058|Analgesics|analgesics|mesh-ancestor
139166014|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
139166015|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166016|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139166017|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139166018|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
139166019|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
139166020|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139166021|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
139166022|NCT04918810|Docetaxel|docetaxel|mesh-list
139166023|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166024|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
139166025|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
139166026|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
139166027|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166028|NCT04880395|Lamivudine|lamivudine|mesh-list
139166029|NCT04880395|Emtricitabine|emtricitabine|mesh-list
139166030|NCT04880395|Dolutegravir|dolutegravir|mesh-list
139166031|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139166032|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139166033|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166034|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166035|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
139166036|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166037|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139166038|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139166039|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139166040|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139166041|NCT04849013|Ketanserin|ketanserin|mesh-list
139166042|NCT04849013|Mescaline|mescaline|mesh-list
139166043|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139166044|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139166045|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139166046|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
139166047|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139166048|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166049|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166050|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
138961999|NCT00641706|Bortezomib|bortezomib|mesh-list
139166051|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139166052|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139166053|NCT04808245|Atezolizumab|atezolizumab|mesh-list
139166055|NCT04808245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139166056|NCT04808245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166057|NCT04808245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166058|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166059|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139166060|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
139166061|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166062|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
139166063|NCT04790513|Evolocumab|evolocumab|mesh-list
139166064|NCT04790513|Alirocumab|alirocumab|mesh-list
139166065|NCT04790513|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139166066|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139166067|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139166068|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
139166069|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166070|NCT04790513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139166071|NCT04790513|Protease Inhibitors|protease inhibitors|mesh-ancestor
139166072|NCT04790513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166073|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139166075|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139166076|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
139166077|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
139166078|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166079|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
139166080|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139166081|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139166082|NCT04646837|Paclitaxel|paclitaxel|mesh-list
139166083|NCT04646837|Carboplatin|carboplatin|mesh-list
139166084|NCT04646837|Durvalumab|durvalumab|mesh-list
139166085|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139166086|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166087|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
139166088|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
139166089|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
139166090|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166091|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166092|NCT04600167|Isoniazid|isoniazid|mesh-list
139166093|NCT04600167|Rifapentine|rifapentine|mesh-list
139166094|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
139166095|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139166096|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166097|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139166098|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139166099|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
139166100|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895170|NCT01015729|Esomeprazole|esomeprazole|mesh-list
139166101|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139166102|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139166103|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
139166104|NCT04522284|Capecitabine|capecitabine|mesh-list
139166105|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139166106|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
139166107|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166108|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166109|NCT04489888|Paclitaxel|paclitaxel|mesh-list
139166110|NCT04489888|Carboplatin|carboplatin|mesh-list
139166111|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
139166112|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139166113|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166114|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
139166115|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
139166116|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
139166117|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166118|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166119|NCT04489888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139166121|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166122|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139166123|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166124|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166125|NCT04401800|Lenvatinib|lenvatinib|mesh-list
139166126|NCT04401800|Tislelizumab|tislelizumab|mesh-list
139166127|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166128|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139166129|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166130|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166131|NCT04401800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166132|NCT04400110|Amoxicillin|amoxicillin|mesh-list
139166133|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
139166134|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
139166135|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139166136|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166137|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166138|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166139|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139166140|NCT04368078|Lenvatinib|lenvatinib|mesh-list
139166141|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166142|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139166143|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166144|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166145|NCT04347616|Aldesleukin|aldesleukin|mesh-list
139166146|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166147|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139166148|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139166149|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
139166150|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166151|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
139166152|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139166153|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166154|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139166155|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166157|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139166158|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
139166159|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139166160|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166161|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139166162|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
139166163|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166164|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166165|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
139166166|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166167|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139166168|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139166169|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
139166170|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139166171|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139166172|NCT04227522|Rucaparib|rucaparib|mesh-list
139166173|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139166174|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166175|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166176|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166177|NCT04216953|Atezolizumab|atezolizumab|mesh-list
138962047|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166178|NCT04216953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139166179|NCT04216953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166180|NCT04216953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166181|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166183|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166184|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139166185|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166186|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166187|NCT04196257|Paclitaxel|paclitaxel|mesh-list
139166188|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139166189|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166190|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
139166191|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
139166192|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
139166193|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166194|NCT04193553|Lenvatinib|lenvatinib|mesh-list
139166195|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166196|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139166197|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166198|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166199|NCT04188548|Trastuzumab|trastuzumab|mesh-list
139166200|NCT04188548|Pertuzumab|pertuzumab|mesh-list
139166201|NCT04188548|Everolimus|everolimus|mesh-list
139166202|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139166203|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166204|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166205|NCT04188548|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139166206|NCT04188548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139166207|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166208|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166209|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139166210|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
139166211|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166212|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139166213|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139166214|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
139166215|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139166216|NCT04183101|Enalapril|enalapril|mesh-list
139166218|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139166219|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
139166220|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166221|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166222|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139166223|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
139166224|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139166225|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
139166226|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166227|NCT04155632|Expectorants|expectorants|mesh-ancestor
139166228|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
139166229|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139166230|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
139166231|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166232|NCT04155632|Protective Agents|protective agents|mesh-ancestor
139166240|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166241|NCT04073134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139166243|NCT04073134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166244|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139166245|NCT04034485|Evolocumab|evolocumab|mesh-list
139166246|NCT04034485|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139166247|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139166248|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139166249|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
139166250|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166251|NCT04034485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139166252|NCT04034485|Protease Inhibitors|protease inhibitors|mesh-ancestor
139166253|NCT04034485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166254|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139166255|NCT04010071|Axitinib|axitinib|mesh-list
139166256|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166257|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139166258|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166259|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166260|NCT03988920|Sevelamer|sevelamer|mesh-list
139166261|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
139166262|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
139166263|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166264|NCT03925402|Ertapenem|ertapenem|mesh-list
139166265|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139166266|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166267|NCT03892577|Immunomodulating Agents|immunomodulating agents|mesh-list
139166268|NCT03892577|Immunologic Factors|immunologic factors|mesh-ancestor
139166269|NCT03892577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166270|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
139166271|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166272|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166273|NCT03875079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139166274|NCT03875079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166275|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139166276|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
139166277|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166278|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139166279|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139166280|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
139166281|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139166282|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166283|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139166291|NCT03688451|Rituximab|rituximab|mesh-list
139166292|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166293|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166294|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
139166295|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166296|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139166298|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139166299|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
139166300|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166301|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166302|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139166303|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139166304|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
139166305|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139166306|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166307|NCT03593018|Gemcitabine|gemcitabine|mesh-list
139166308|NCT03593018|Azacitidine|azacitidine|mesh-list
139166309|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139166310|NCT03593018|Romidepsin|romidepsin|mesh-list
139166311|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139166312|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
139166313|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166314|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166315|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166316|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139166317|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
139166318|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139166319|NCT03593018|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139166320|NCT03570099|Naloxone|naloxone|mesh-list
139166321|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139166322|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166323|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
139166324|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166325|NCT03529396|Chloroquine|chloroquine|mesh-list
139166326|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139166327|NCT03529396|Primaquine|primaquine|mesh-list
139166328|NCT03529396|Amebicides|amebicides|mesh-ancestor
139166329|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139166330|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139166331|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962098|NCT00821496|Norinyl|norinyl|mesh-list
139166332|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
139166333|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139166334|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139166335|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139166336|NCT03529396|Analgesics|analgesics|mesh-ancestor
139166337|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
139166338|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166339|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166340|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139166341|NCT03529396|Filaricides|filaricides|mesh-ancestor
139166342|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
139166343|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
139166344|NCT03436563|Atezolizumab|atezolizumab|mesh-list
139166345|NCT03436563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139166346|NCT03436563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166347|NCT03436563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166348|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166349|NCT03426254|Talazoparib|talazoparib|mesh-list
139166350|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139166351|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166352|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166353|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166354|NCT03411031|Thalidomide|thalidomide|mesh-list
139166355|NCT03411031|Dexamethasone|dexamethasone|mesh-list
139166356|NCT03411031|Lenalidomide|lenalidomide|mesh-list
139166357|NCT03411031|Elotuzumab|elotuzumab|mesh-list
139166358|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139166359|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
139166360|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
139166361|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166362|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166363|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139166364|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
139166365|NCT03411031|Hormones|hormones|mesh-ancestor
139166366|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139166367|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139166368|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166369|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
139166370|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139166371|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139166372|NCT03411031|Growth Substances|growth substances|mesh-ancestor
139166373|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
139166374|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139166375|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
139166376|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139166377|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166378|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
139166379|NCT03358017|Atorvastatin|atorvastatin|mesh-list
139166380|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139166381|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139166382|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
139166383|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166384|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139166385|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139166386|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166387|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139166388|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166389|NCT03289351|Tazobactam|tazobactam|mesh-list
139166390|NCT03289351|Piperacillin|piperacillin|mesh-list
139166391|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139166392|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139166393|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166394|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139166395|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166396|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166397|NCT03280667|Denosumab|denosumab|mesh-list
139166398|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
139166399|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166400|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166401|NCT03280667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139166402|NCT03280667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166403|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139166404|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166405|NCT03272347|Tenofovir|tenofovir|mesh-list
139166406|NCT03272347|Lamivudine|lamivudine|mesh-list
139166407|NCT03272347|Islatravir|islatravir|mesh-list
139166408|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
139166409|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166410|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139166411|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139166412|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166413|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166414|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139166415|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139166416|NCT03251300|Mirabegron|mirabegron|mesh-list
139166417|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138895390|NCT04382885|Cariprazine|cariprazine|mesh-list
139166418|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139166419|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139166420|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
139166421|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954851|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
139166422|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166423|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166424|NCT03251300|Urological Agents|urological agents|mesh-ancestor
139166426|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139166427|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
139166428|NCT03228693|Hormones|hormones|mesh-ancestor
139166429|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139166430|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166431|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139166432|NCT03108690|Meropenem|meropenem|mesh-list
139166433|NCT03108690|Tazobactam|tazobactam|mesh-list
139166434|NCT03108690|Piperacillin|piperacillin|mesh-list
139166435|NCT03108690|Ampicillin|ampicillin|mesh-list
139166436|NCT03108690|Cefuroxime|cefuroxime|mesh-list
139166437|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139166438|NCT03108690|Lactams|lactams|mesh-list
139166439|NCT03108690|beta-Lactams|beta-lactams|mesh-list
139166440|NCT03108690|Penicillin G|penicillin g|mesh-list
139166441|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
139166442|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139166443|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166444|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
139166445|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139166446|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166447|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166449|NCT03103152|Vitamin D|vitamin d|mesh-list
139166450|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
139166451|NCT03103152|Cholecalciferol|cholecalciferol|mesh-list
139166452|NCT03103152|Vitamins|vitamins|mesh-list
139166453|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
139166454|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166455|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139166456|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139166457|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139166458|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139166459|NCT03103152|Analgesics|analgesics|mesh-ancestor
139166460|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
139166461|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166462|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139166463|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139166464|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139166465|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139166466|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166467|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139166468|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139166469|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166470|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
139166471|NCT02937285|Interferons|interferons|mesh-list
139166472|NCT02937285|Interferon-beta|interferon-beta|mesh-list
139166473|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
139166474|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
139166475|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166476|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
139166477|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166478|NCT02937285|Analgesics|analgesics|mesh-ancestor
139166479|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
139166480|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166481|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166482|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139166483|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139166484|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166485|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166487|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139166488|NCT02878785|Decitabine|decitabine|mesh-list
139166489|NCT02878785|Talazoparib|talazoparib|mesh-list
139166490|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139166491|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
139166492|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166493|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166494|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166495|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139166496|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
139166497|NCT02825576|Neostigmine|neostigmine|mesh-list
139166498|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139166499|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166500|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166501|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
139166502|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139166503|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166504|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139166505|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
139166506|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166507|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139166508|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139166509|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139166510|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139166511|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139166512|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
139166513|NCT02315196|Paclitaxel|paclitaxel|mesh-list
139166514|NCT02315196|Carboplatin|carboplatin|mesh-list
139166515|NCT02315196|Doxorubicin|doxorubicin|mesh-list
139166516|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139166517|NCT02315196|Epirubicin|epirubicin|mesh-list
138916948|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
139166518|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139166519|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166520|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
139166521|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
139166522|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
139166523|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166524|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139166525|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139166526|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139166527|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166528|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139166529|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139166530|NCT01917877|Dexamethasone|dexamethasone|mesh-list
139166531|NCT01917877|Bevacizumab|bevacizumab|mesh-list
139166532|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166533|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166534|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139166535|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139166536|NCT01917877|Growth Substances|growth substances|mesh-ancestor
139166537|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166538|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
139166539|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139166540|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
139166542|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166543|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139166544|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
139166545|NCT01917877|Hormones|hormones|mesh-ancestor
139166546|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139166547|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139166548|NCT01570296|Gefitinib|gefitinib|mesh-list
139166549|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166550|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139166551|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166552|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166553|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
139166554|NCT00496873|Rituximab|rituximab|mesh-list
139166555|NCT00496873|Pentostatin|pentostatin|mesh-list
139166556|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139166557|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
139166558|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166559|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139166560|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139166561|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
139166562|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166563|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166564|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139166565|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138962183|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
139166566|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139166567|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166568|NCT00492778|Cisplatin|cisplatin|mesh-list
139166569|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166570|NCT03931369|Tolvaptan|tolvaptan|mesh-list
139166571|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139166572|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166573|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
139166574|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166575|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
139166576|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139166577|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
139166578|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139166579|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
139166580|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139166581|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166582|NCT03721328|Vancomycin|vancomycin|mesh-list
139166583|NCT03721328|Tobramycin|tobramycin|mesh-list
139166584|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139166585|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166586|NCT01220791|Progesterone|progesterone|mesh-list
139166587|NCT01220791|Progestins|progestins|mesh-ancestor
139166588|NCT01220791|Hormones|hormones|mesh-ancestor
139166589|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139166590|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166591|NCT01353482|Pemetrexed|pemetrexed|mesh-list
139166592|NCT01353482|Vorinostat|vorinostat|mesh-list
139166593|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917024|NCT00742560|Dexamethasone|dexamethasone|mesh-list
139166594|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166595|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166596|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139166597|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139166598|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139166599|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
139166600|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139166601|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139166602|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139166603|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139166604|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166605|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
139166606|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139166607|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166608|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139166609|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166610|NCT01353716|Dolutegravir|dolutegravir|mesh-list
139166611|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139166612|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139166613|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166614|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166615|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139166616|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139166617|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
139166618|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166619|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
139166620|NCT04481672|Analgesics|analgesics|mesh-ancestor
139166621|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
139166622|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166623|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166624|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
139166625|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139166626|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139166627|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
139166628|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139166629|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139166630|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895535|NCT05368181|Prednisolone|prednisolone|mesh-list
139166631|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139166632|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
139166633|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139166634|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139166635|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
139166636|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139166637|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139166638|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139166639|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139166640|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166641|NCT04465942|Paclitaxel|paclitaxel|mesh-list
139166642|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
139166643|NCT04465942|Nivolumab|nivolumab|mesh-list
139166644|NCT04465942|Pemetrexed|pemetrexed|mesh-list
139166645|NCT04465942|Atezolizumab|atezolizumab|mesh-list
139166646|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139166647|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166648|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
139166649|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
139166650|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
139166651|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166652|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166653|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139166654|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166655|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139166656|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139166657|NCT01126645|Sorafenib|sorafenib|mesh-list
139166658|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166659|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139166660|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166661|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166662|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139166663|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
139166664|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
139166665|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166666|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
139166667|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166668|NCT01329289|Dexamethasone|dexamethasone|mesh-list
139166669|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
139166670|NCT01329289|Bortezomib|bortezomib|mesh-list
139166671|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139166672|NCT01329289|Pasireotide|pasireotide|mesh-list
139166673|NCT01329289|BB 1101|bb 1101|mesh-list
139166674|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139166675|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
139166676|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
139166677|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166678|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166679|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139166680|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
139166681|NCT01329289|Hormones|hormones|mesh-ancestor
139166682|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139166683|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139166684|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166685|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
139166686|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166687|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166689|NCT02291536|Cannabidiol|cannabidiol|mesh-list
139166690|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
139166691|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
139166692|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166693|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139166694|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139166695|NCT02291536|Analgesics|analgesics|mesh-ancestor
139166696|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
139166697|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166698|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139166699|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139166700|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139166701|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166702|NCT02291536|Hormones|hormones|mesh-ancestor
139166703|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139166704|NCT01317992|Ibudilast|ibudilast|mesh-list
139166705|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139166706|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
139166707|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166708|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166709|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139166710|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
139166711|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139166713|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166714|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139166715|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
139166716|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
139166717|NCT01348412|Raltitrexed|raltitrexed|mesh-list
139166718|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166719|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139166720|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
139166721|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166722|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139166723|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166724|NCT01353794|Sorafenib|sorafenib|mesh-list
138962245|NCT00319111|Bosentan|bosentan|mesh-list
139166726|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139166727|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166728|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166729|NCT01224301|Vaccines|vaccines|mesh-list
139166730|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
139166731|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166732|NCT01221025|Parecoxib|parecoxib|mesh-list
139166733|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139166734|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139166735|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166736|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166737|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139166738|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139166739|NCT01221025|Analgesics|analgesics|mesh-ancestor
139166740|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
139166741|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166742|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166743|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139166744|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139166746|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166747|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166748|NCT01221103|Dexamethasone|dexamethasone|mesh-list
139166749|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139166750|NCT01221103|Ofatumumab|ofatumumab|mesh-list
139166751|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139166752|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139166753|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
139166754|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
139166755|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166756|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166757|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139166758|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
139166759|NCT01221103|Hormones|hormones|mesh-ancestor
139166760|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139166761|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139166762|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166763|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139166764|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
139166765|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166766|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
139166767|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
139166768|NCT03706898|Dolutegravir|dolutegravir|mesh-list
139166769|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
139166770|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
139166771|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166772|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139166773|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139166774|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166775|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166776|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139166777|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139166778|NCT03927313|Aspirin|aspirin|mesh-list
139166779|NCT03927313|Rifampin|rifampin|mesh-list
139166780|NCT03927313|Linezolid|linezolid|mesh-list
139166781|NCT03927313|Dexamethasone|dexamethasone|mesh-list
139166782|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139166783|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
139166784|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
139166785|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962264|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139166786|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895678|NCT00819039|Aprepitant|aprepitant|mesh-list
139166787|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139166788|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
139166789|NCT03927313|Hormones|hormones|mesh-ancestor
139166790|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139166791|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139166792|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166793|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139166794|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139166795|NCT03927313|Analgesics|analgesics|mesh-ancestor
139166796|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
139166797|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139166798|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139166799|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139166800|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166801|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139166802|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139166803|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166804|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
139166805|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139166806|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
139166807|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139166808|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166809|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
139166810|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139166811|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139166812|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139166813|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139166814|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139166815|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139166816|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139166817|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139166818|NCT01224457|Phenobarbital|phenobarbital|mesh-list
139166819|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
139166820|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139166821|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139166822|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166823|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139166824|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139166825|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139166826|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166827|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
139166828|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
138954971|NCT01054105|Iloprost|iloprost|mesh-list
139166829|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138962279|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139166830|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139166831|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139166832|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
139166833|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139166834|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
139166835|NCT03133312|Povidone|povidone|mesh-list
139166836|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139166837|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166838|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
139166839|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
139166840|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
139166841|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
139166842|NCT01318148|Caspofungin|caspofungin|mesh-list
139166843|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
139166844|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139166845|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166846|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166847|NCT01354262|Vitamin D|vitamin d|mesh-list
139166848|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
139166849|NCT01354262|Cholecalciferol|cholecalciferol|mesh-list
139166850|NCT01354262|Vitamins|vitamins|mesh-list
139166851|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
139166852|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166853|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139166854|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139166855|NCT01343498|Dactolisib|dactolisib|mesh-list
139166856|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166857|NCT01221337|Heparin|heparin|mesh-list
139166858|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
139166859|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139166860|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139166861|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166862|NCT01354418|Phenylephrine|phenylephrine|mesh-list
139166863|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
139166864|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139166865|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
139166866|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
139166867|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166868|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166869|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
139166870|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139166871|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
139166872|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
139166873|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139166874|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139166875|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139166876|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
139166877|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139166878|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166879|NCT01354418|Protective Agents|protective agents|mesh-ancestor
139166880|NCT02818868|Apixaban|apixaban|mesh-list
139166881|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139166882|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
139166883|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139166884|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
139166885|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166886|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166887|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
139166888|NCT01224535|Micronutrients|micronutrients|mesh-list
139166889|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166890|NCT02289274|Aceclofenac|aceclofenac|mesh-list
139166891|NCT02289274|Eperisone|eperisone|mesh-list
139166892|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139166893|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139166894|NCT02289274|Analgesics|analgesics|mesh-ancestor
138954979|NCT00987766|Gemcitabine|gemcitabine|mesh-list
139166896|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166897|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166898|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139166899|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139166900|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
139166901|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139166902|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139166903|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166904|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139166905|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139166906|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139166907|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
139166908|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
139166909|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
139166910|NCT01224613|Vaccines|vaccines|mesh-list
139166911|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
139166912|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166913|NCT03930433|Nebivolol|nebivolol|mesh-list
139166914|NCT03930433|Diltiazem|diltiazem|mesh-list
139166915|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139166916|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
139166917|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139166918|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139166919|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139166920|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
139166921|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139166922|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166923|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166924|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139166925|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139166926|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139166927|NCT01224769|Rituximab|rituximab|mesh-list
139166928|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139166929|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139166930|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139166931|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
139166932|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166933|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139166934|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139166935|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
139166936|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166937|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139166938|NCT02289430|Ezetimibe|ezetimibe|mesh-list
139166939|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139166940|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139166941|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
139166942|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166943|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139166944|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139166945|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166946|NCT01224847|Lidocaine|lidocaine|mesh-list
139166947|NCT01224847|Cocaine|cocaine|mesh-list
139166948|NCT01224847|Tetracaine|tetracaine|mesh-list
139166949|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
139166950|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
139166951|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139166952|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166953|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
139166954|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166955|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139166956|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139166957|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138954987|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139166958|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139166959|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166961|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139166962|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139166963|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
139166964|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139166965|NCT02289586|Midazolam|midazolam|mesh-list
139166966|NCT02289586|Fentanyl|fentanyl|mesh-list
139166967|NCT02289586|Remifentanil|remifentanil|mesh-list
138917400|NCT04114526|Nicotine|nicotine|mesh-list
139166968|NCT02289586|Dezocine|dezocine|mesh-list
139166969|NCT02289586|Propofol|propofol|mesh-list
139166970|NCT02289586|Rocuronium|rocuronium|mesh-list
139166971|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
139166972|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139166973|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166974|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139166975|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139166976|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
139166977|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139166978|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139166979|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139166980|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139166981|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
139166982|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
139166983|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139166984|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139166985|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139166986|NCT02289586|Narcotics|narcotics|mesh-ancestor
139166987|NCT02289586|Analgesics|analgesics|mesh-ancestor
139166988|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
139166989|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139166990|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139166991|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139166992|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139166993|NCT03740581|Insulin|insulin|mesh-list
139166994|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139166995|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139166996|NCT03874897|Antibodies|antibodies|mesh-list
139166997|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139166998|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
139166999|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167000|NCT01127035|Immunomodulating Agents|immunomodulating agents|mesh-list
139167001|NCT01127035|Immunologic Factors|immunologic factors|mesh-ancestor
139167002|NCT01127035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167003|NCT02294266|Ethanol|ethanol|mesh-list
138962338|NCT01001260|Aspirin|aspirin|mesh-list
138895847|NCT04185857|Diuretics|diuretics|mesh-ancestor
139167004|NCT02294266|Methamphetamine|methamphetamine|mesh-list
139167005|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139167006|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167007|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167008|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167009|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139167010|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
139167011|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
139167012|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167013|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
139167014|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167015|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167016|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
139167017|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139167018|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139167019|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139167020|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139167021|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
139167022|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139167023|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
139167024|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167025|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139167026|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139167027|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
139167028|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167029|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167030|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139167032|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
139167033|NCT01130311|Vitamins|vitamins|mesh-ancestor
139167034|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
139167035|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167036|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139167037|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139167038|NCT03926377|Clobetasol|clobetasol|mesh-list
139167039|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139167040|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
139167041|NCT03926377|Hormones|hormones|mesh-ancestor
138917475|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139167042|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139167043|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167045|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139167046|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167047|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167048|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139167049|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
139167050|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
139167051|NCT01227811|Darifenacin|darifenacin|mesh-list
139167052|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
139167053|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
139167054|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139167055|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167056|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167057|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167058|NCT01227811|Urological Agents|urological agents|mesh-ancestor
139167059|NCT01225081|Pioglitazone|pioglitazone|mesh-list
139167060|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
139167061|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139167062|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167063|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139167064|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167065|NCT02298166|Cytarabine|cytarabine|mesh-list
139167066|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
139167067|NCT02298166|Crenolanib|crenolanib|mesh-list
139167068|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139167069|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
138955019|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
139167070|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167071|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167073|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895907|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
139167074|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139167075|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
139167076|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167077|NCT02298166|Analgesics|analgesics|mesh-ancestor
139167078|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
139167079|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167080|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139167081|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139167082|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167083|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
139167084|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139167085|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167086|NCT01221883|Diazepam|diazepam|mesh-list
139167087|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139167088|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
139167089|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
139167090|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
139167091|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167092|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167093|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139167094|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139167095|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895991|NCT00499603|Paclitaxel|paclitaxel|mesh-list
139167096|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139167097|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139167098|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139167099|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139167100|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139167101|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139167102|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
139167103|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
139167104|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
139167105|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
139167106|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167107|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167108|NCT02294656|Triamcinolone|triamcinolone|mesh-list
139167109|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139167110|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139167111|NCT02294656|Ranibizumab|ranibizumab|mesh-list
139167112|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139167113|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139167114|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139167115|NCT02294656|Growth Substances|growth substances|mesh-ancestor
139167116|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167117|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
139167118|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167119|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139167120|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
139167121|NCT02294656|Hormones|hormones|mesh-ancestor
139167122|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139167123|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139167124|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
139167125|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167126|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167127|NCT01225237|Ramosetron|ramosetron|mesh-list
139167128|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
139167129|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
139167130|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167131|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167132|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139167133|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139167134|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
139167135|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167136|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167137|NCT03517930|Loratadine|loratadine|mesh-list
139167138|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
139167139|NCT03517930|Ephedrine|ephedrine|mesh-list
139167140|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
139167141|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
139167142|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139167143|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139167144|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139167145|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
139167146|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
139167147|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167148|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167149|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167150|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139167151|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
139167152|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167153|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139167154|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
139167155|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
139167156|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139167157|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139167158|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
139167159|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
139167160|NCT01130467|Methylphenidate|methylphenidate|mesh-list
139167161|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139167162|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139167163|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167164|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139167165|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139167166|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139167167|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167168|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
139167169|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167170|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139167171|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
139167172|NCT02295046|Amlodipine|amlodipine|mesh-list
139167173|NCT02295046|Atorvastatin|atorvastatin|mesh-list
139167174|NCT02295046|Calcium|calcium|mesh-list
139167175|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139167176|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167177|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139167178|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139167179|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
139167180|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167181|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139167182|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139167183|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167184|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139167185|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139167186|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139167187|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
139167188|NCT03517618|Leucovorin|leucovorin|mesh-list
139167189|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167190|NCT03517618|Antidotes|antidotes|mesh-ancestor
139167191|NCT03517618|Protective Agents|protective agents|mesh-ancestor
139167192|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
139167193|NCT03517618|Vitamins|vitamins|mesh-ancestor
139167194|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
139167195|NCT02295124|Oxycodone|oxycodone|mesh-list
139167196|NCT02295124|Hydromorphone|hydromorphone|mesh-list
139167197|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139167198|NCT02295124|Narcotics|narcotics|mesh-ancestor
139167199|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167200|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167201|NCT02295124|Analgesics|analgesics|mesh-ancestor
139167202|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
139167203|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167204|NCT03925051|Denosumab|denosumab|mesh-list
139167205|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139167206|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167207|NCT03514576|Pasireotide|pasireotide|mesh-list
139167208|NCT03514576|Hormones|hormones|mesh-ancestor
139167209|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139167210|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167211|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
139167212|NCT02299024|Narcotics|narcotics|mesh-ancestor
139167213|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167214|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167215|NCT02299024|Analgesics|analgesics|mesh-ancestor
139167216|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
139167217|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167218|NCT03929419|Insulin|insulin|mesh-list
139167219|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139167220|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167221|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139167222|NCT01228279|Icodextrin|icodextrin|mesh-list
139167223|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
139167224|NCT03514342|Ropivacaine|ropivacaine|mesh-list
139167225|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
139167226|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
139167227|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167228|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167229|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
139167230|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167231|NCT01228045|Trastuzumab|trastuzumab|mesh-list
139167232|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167233|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139167234|NCT03514030|Antibodies|antibodies|mesh-list
139167235|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
139167236|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167237|NCT03517462|Ivermectin|ivermectin|mesh-list
139167238|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139167239|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167240|NCT06142708|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139167241|NCT06142708|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139167242|NCT06142708|Hormones|hormones|mesh-ancestor
139167243|NCT06142708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139167244|NCT06142708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167245|NCT06142708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139167246|NCT06142617|Pembrolizumab|pembrolizumab|mesh-list
139167247|NCT06142617|Pemetrexed|pemetrexed|mesh-list
139167248|NCT06142617|Osimertinib|osimertinib|mesh-list
139167249|NCT06142617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139167250|NCT06142617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167251|NCT06142617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139167252|NCT06142617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167253|NCT06142617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167254|NCT06142617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139167255|NCT06142617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139167256|NCT06142617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139167257|NCT06142604|Flecainide|flecainide|mesh-list
139167258|NCT06142604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139167259|NCT06142604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139167260|NCT06142604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139167261|NCT06142604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139167262|NCT06142604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167264|NCT06142591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139167265|NCT06142591|Narcotics|narcotics|mesh-ancestor
139167266|NCT06142591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167267|NCT06142591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917698|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139167268|NCT06142591|Analgesics|analgesics|mesh-ancestor
139167269|NCT06142591|Sensory System Agents|sensory system agents|mesh-ancestor
139167270|NCT06142591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167271|NCT06142474|Dapagliflozin|dapagliflozin|mesh-list
139167272|NCT06142474|Empagliflozin|empagliflozin|mesh-list
139167273|NCT06142474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139167274|NCT06142474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167275|NCT06142474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139167276|NCT06142474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167277|NCT06142318|Pirfenidone|pirfenidone|mesh-list
139167278|NCT06142318|Analgesics|analgesics|mesh-ancestor
139167279|NCT06142318|Sensory System Agents|sensory system agents|mesh-ancestor
139167280|NCT06142318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896104|NCT00693758|Adenosine|adenosine|mesh-list
139167281|NCT06142318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167282|NCT06142318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139167283|NCT06142318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139167284|NCT06142318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139167285|NCT06142318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139167286|NCT06142318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167287|NCT06142136|Vitamin D|vitamin d|mesh-list
139167288|NCT06142136|Ergocalciferols|ergocalciferols|mesh-list
139167289|NCT06142136|Cholecalciferol|cholecalciferol|mesh-list
139167290|NCT06142136|Vitamins|vitamins|mesh-list
139167291|NCT06142136|Micronutrients|micronutrients|mesh-ancestor
139167292|NCT06142136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167293|NCT06142136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139167294|NCT06142136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139167295|NCT06141447|Oxytocin|oxytocin|mesh-list
139167296|NCT06141447|Oxytocics|oxytocics|mesh-ancestor
139167297|NCT06141447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139167298|NCT06141447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167299|NCT06141330|Azithromycin|azithromycin|mesh-list
139167300|NCT06141330|Adapalene|adapalene|mesh-list
139167301|NCT06141330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139167302|NCT06141330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167303|NCT06141330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139167304|NCT06141330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139167305|NCT06141330|Analgesics|analgesics|mesh-ancestor
139167306|NCT06141330|Sensory System Agents|sensory system agents|mesh-ancestor
139167307|NCT06141330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167308|NCT06141330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167309|NCT06141330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139167310|NCT06141330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139167311|NCT06141330|Dermatologic Agents|dermatologic agents|mesh-ancestor
139167312|NCT06141304|Plerixafor|plerixafor|mesh-list
139167313|NCT06141304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139167314|NCT06141304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139167315|NCT06141304|Antiviral Agents|antiviral agents|mesh-ancestor
139167316|NCT06141304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167317|NCT06141265|Niraparib|niraparib|mesh-list
139167318|NCT06141265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139167319|NCT06141265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167320|NCT06141265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167321|NCT06141265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167322|NCT06141226|Docetaxel|docetaxel|mesh-list
139167323|NCT06141226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167324|NCT06141226|Tubulin Modulators|tubulin modulators|mesh-ancestor
139167325|NCT06141226|Antimitotic Agents|antimitotic agents|mesh-ancestor
139167326|NCT06141226|Mitosis Modulators|mitosis modulators|mesh-ancestor
139167327|NCT06141226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167328|NCT06141200|Captopril|captopril|mesh-list
139167329|NCT06141200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139167330|NCT06141200|Protease Inhibitors|protease inhibitors|mesh-ancestor
139167331|NCT06141200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167332|NCT06141200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167333|NCT06141200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139167334|NCT06141109|Cytarabine|cytarabine|mesh-list
139167335|NCT06141109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139167336|NCT06141109|Antimetabolites|antimetabolites|mesh-ancestor
139167337|NCT06141109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167338|NCT06141109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167339|NCT06141109|Antiviral Agents|antiviral agents|mesh-ancestor
139167340|NCT06141109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167341|NCT06141109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138917773|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167342|NCT06141109|Immunologic Factors|immunologic factors|mesh-ancestor
139167343|NCT06141109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167344|NCT06141018|Hyaluronic Acid|hyaluronic acid|mesh-list
139167345|NCT06141018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139167346|NCT06141018|Immunologic Factors|immunologic factors|mesh-ancestor
139167347|NCT06141018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167348|NCT06141018|Viscosupplements|viscosupplements|mesh-ancestor
139167349|NCT06141018|Protective Agents|protective agents|mesh-ancestor
139167351|NCT06140953|Nicotinic Acids|nicotinic acids|mesh-list
139167352|NCT06140953|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139167353|NCT06140953|Furosemide|furosemide|mesh-list
139167354|NCT06140953|Trimetazidine|trimetazidine|mesh-list
139167355|NCT06140953|Diuretics|diuretics|mesh-ancestor
139167356|NCT06140953|Natriuretic Agents|natriuretic agents|mesh-ancestor
139167357|NCT06140953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167358|NCT06140953|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139167359|NCT06140953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139167360|NCT06140953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167361|NCT06140953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139167362|NCT06140953|Antimetabolites|antimetabolites|mesh-ancestor
139167363|NCT06140953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139167364|NCT06140953|Vasodilator Agents|vasodilator agents|mesh-ancestor
139167365|NCT06140953|Vitamin B Complex|vitamin b complex|mesh-ancestor
139167366|NCT06140953|Vitamins|vitamins|mesh-ancestor
139167367|NCT06140953|Micronutrients|micronutrients|mesh-ancestor
139167368|NCT06140927|Ketamine|ketamine|mesh-list
139167369|NCT06140927|Analgesics|analgesics|mesh-ancestor
139167370|NCT06140927|Sensory System Agents|sensory system agents|mesh-ancestor
139167371|NCT06140927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167372|NCT06140927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167373|NCT06140927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139167374|NCT06140927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139167375|NCT06140927|Anesthetics, General|anesthetics, general|mesh-ancestor
139167376|NCT06140927|Anesthetics|anesthetics|mesh-ancestor
138896154|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
139167377|NCT06140927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167378|NCT06140927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139167379|NCT06140927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139167380|NCT06140927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167381|NCT06140927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167383|NCT06140914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139167384|NCT06140914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167385|NCT06140420|Naltrexone|naltrexone|mesh-list
139167386|NCT06140420|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139167387|NCT06140420|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139167388|NCT06140420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167389|NCT06140420|Sensory System Agents|sensory system agents|mesh-ancestor
139167390|NCT06140420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167391|NCT06139029|Beclomethasone|beclomethasone|mesh-list
139167392|NCT06139029|Albuterol|albuterol|mesh-list
139167393|NCT06139029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139167394|NCT06139029|Autonomic Agents|autonomic agents|mesh-ancestor
139167395|NCT06139029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167396|NCT06139029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167397|NCT06139029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139167398|NCT06139029|Respiratory System Agents|respiratory system agents|mesh-ancestor
139167399|NCT06139029|Tocolytic Agents|tocolytic agents|mesh-ancestor
139167400|NCT06139029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139167401|NCT06139029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139167402|NCT06139029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139167403|NCT06139029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139167404|NCT06139029|Adrenergic Agents|adrenergic agents|mesh-ancestor
139167405|NCT06139029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167406|NCT06139029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167407|NCT06139029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139167408|NCT06139029|Glucocorticoids|glucocorticoids|mesh-ancestor
139167409|NCT06139029|Hormones|hormones|mesh-ancestor
139167410|NCT06139029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139167411|NCT06137378|Pembrolizumab|pembrolizumab|mesh-list
139167412|NCT06137378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139167413|NCT06137378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167414|NCT06137378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139167415|NCT06137378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167416|NCT06134726|Rheumatoid Factor|rheumatoid factor|mesh-list
139167417|NCT06134726|Immunologic Factors|immunologic factors|mesh-ancestor
139167418|NCT06134726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167419|NCT06134037|Aminophylline|aminophylline|mesh-list
139167420|NCT06134037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139167421|NCT06134037|Autonomic Agents|autonomic agents|mesh-ancestor
139167422|NCT06134037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167423|NCT06134037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167424|NCT06134037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139167425|NCT06134037|Respiratory System Agents|respiratory system agents|mesh-ancestor
139167426|NCT06134037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139167427|NCT06134037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139167428|NCT06134037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167429|NCT06134037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167430|NCT06134037|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139167431|NCT06134037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139167432|NCT06134037|Purinergic Agents|purinergic agents|mesh-ancestor
139167433|NCT06134037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167434|NCT06134037|Protective Agents|protective agents|mesh-ancestor
139167435|NCT06112262|Heparin|heparin|mesh-list
139167436|NCT06112262|Hirudins|hirudins|mesh-list
138962513|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
139167437|NCT06112262|Anticoagulants|anticoagulants|mesh-ancestor
139167438|NCT06112262|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139167439|NCT06112262|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139167440|NCT06112262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167441|NCT06112262|Antithrombins|antithrombins|mesh-ancestor
138896229|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139167442|NCT06112262|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139167443|NCT06112262|Protease Inhibitors|protease inhibitors|mesh-ancestor
139167444|NCT06112262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167445|NCT06098196|Aminophylline|aminophylline|mesh-list
139167446|NCT06098196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139167447|NCT06098196|Autonomic Agents|autonomic agents|mesh-ancestor
139167448|NCT06098196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167449|NCT06098196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167450|NCT06098196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139167451|NCT06098196|Respiratory System Agents|respiratory system agents|mesh-ancestor
139167452|NCT06098196|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139167453|NCT06098196|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139167454|NCT06098196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167455|NCT06098196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167456|NCT06098196|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139167457|NCT06098196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139167458|NCT06098196|Purinergic Agents|purinergic agents|mesh-ancestor
139167459|NCT06098196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167460|NCT06098196|Protective Agents|protective agents|mesh-ancestor
139167461|NCT06056895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139167462|NCT06056895|Antibodies|antibodies|mesh-list
139167463|NCT06056895|Immunoglobulins|immunoglobulins|mesh-list
139167464|NCT06056895|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139167465|NCT06056895|Immunologic Factors|immunologic factors|mesh-ancestor
139167466|NCT06056895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167467|NCT06056895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167468|NCT06045026|Fluorides|fluorides|mesh-list
139167469|NCT06045026|Tin Fluorides|tin fluorides|mesh-list
139167470|NCT06045026|Cariostatic Agents|cariostatic agents|mesh-ancestor
139167471|NCT06045026|Protective Agents|protective agents|mesh-ancestor
139167472|NCT06045026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167473|NCT06030258|Carboplatin|carboplatin|mesh-list
139167474|NCT06030258|Etoposide|etoposide|mesh-list
139167475|NCT06030258|Tislelizumab|tislelizumab|mesh-list
139167476|NCT06030258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167477|NCT06030258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139167478|NCT06030258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139167479|NCT06030258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139167480|NCT06030258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167481|NCT06030258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167482|NCT06030258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139167483|NCT06021145|Empagliflozin|empagliflozin|mesh-list
139167484|NCT06021145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139167485|NCT06021145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167486|NCT06021145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139167487|NCT06021145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167488|NCT06017895|Doxepin|doxepin|mesh-list
139167489|NCT06017895|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139167490|NCT06017895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139167491|NCT06017895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167492|NCT06017895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167493|NCT06017895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139167494|NCT06017895|Antidepressive Agents|antidepressive agents|mesh-ancestor
139167495|NCT06017895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139167496|NCT06017895|Histamine Antagonists|histamine antagonists|mesh-ancestor
139167498|NCT06017895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167499|NCT06017895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167500|NCT06003114|Palbociclib|palbociclib|mesh-list
139167501|NCT06003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167502|NCT06003114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139167503|NCT06003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167504|NCT06003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167505|NCT05979818|Propranolol|propranolol|mesh-list
139167506|NCT05979818|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139167507|NCT05979818|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139167508|NCT05979818|Adrenergic Agents|adrenergic agents|mesh-ancestor
139167509|NCT05979818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167510|NCT05979818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167511|NCT05979818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167512|NCT05979818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139167513|NCT05979818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139167514|NCT05979818|Vasodilator Agents|vasodilator agents|mesh-ancestor
139167515|NCT05957978|Paromomycin|paromomycin|mesh-list
139167516|NCT05957978|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
139167517|NCT05957978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139167518|NCT05957978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167519|NCT05957978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139167520|NCT05957978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139167521|NCT05957978|Schistosomicides|schistosomicides|mesh-ancestor
139167522|NCT05957978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139167523|NCT05957978|Anthelmintics|anthelmintics|mesh-ancestor
139167524|NCT05918198|Venetoclax|venetoclax|mesh-list
139167525|NCT05918198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167526|NCT05914467|Teicoplanin|teicoplanin|mesh-list
139167527|NCT05914467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139167528|NCT05914467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167529|NCT05891613|Bupivacaine|bupivacaine|mesh-list
139167530|NCT05891613|Anesthetics, Local|anesthetics, local|mesh-ancestor
139167531|NCT05891613|Anesthetics|anesthetics|mesh-ancestor
139167532|NCT05891613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167533|NCT05891613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167534|NCT05891613|Sensory System Agents|sensory system agents|mesh-ancestor
139167535|NCT05891613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167536|NCT05883150|Midazolam|midazolam|mesh-list
139167537|NCT05883150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138896370|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
139167538|NCT05883150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139167539|NCT05883150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167540|NCT05883150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167541|NCT05883150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139167542|NCT05883150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139167543|NCT05883150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139167544|NCT05883150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139167545|NCT05883150|Anesthetics, General|anesthetics, general|mesh-ancestor
139167546|NCT05883150|Anesthetics|anesthetics|mesh-ancestor
139167547|NCT05883150|GABA Modulators|gaba modulators|mesh-ancestor
139167548|NCT05883150|GABA Agents|gaba agents|mesh-ancestor
139167549|NCT05883150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167550|NCT05883150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167551|NCT05880862|Mirabegron|mirabegron|mesh-list
139167552|NCT05880862|Trospium chloride|trospium chloride|mesh-list
139167553|NCT05880862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139167554|NCT05880862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139167555|NCT05880862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139167556|NCT05880862|Adrenergic Agents|adrenergic agents|mesh-ancestor
139167557|NCT05880862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167558|NCT05880862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167559|NCT05880862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167560|NCT05880862|Urological Agents|urological agents|mesh-ancestor
139167561|NCT05880862|Parasympatholytics|parasympatholytics|mesh-ancestor
139167562|NCT05880862|Autonomic Agents|autonomic agents|mesh-ancestor
139167563|NCT05880862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917996|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167564|NCT05880862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139167565|NCT05880862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139167566|NCT05880862|Cholinergic Agents|cholinergic agents|mesh-ancestor
139167567|NCT05853575|Adagrasib|adagrasib|mesh-list
139167568|NCT05853575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167569|NCT05851677|Disitamab vedotin|disitamab vedotin|mesh-list
139167570|NCT05851677|Immunoconjugates|immunoconjugates|mesh-ancestor
139167571|NCT05851677|Immunologic Factors|immunologic factors|mesh-ancestor
139167572|NCT05851677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167573|NCT05850091|Colchicine|colchicine|mesh-list
139167574|NCT05850091|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139167575|NCT05850091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139167576|NCT05850091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139167577|NCT05850091|Antimetabolites|antimetabolites|mesh-ancestor
139167578|NCT05850091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167579|NCT05850091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139167580|NCT05850091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139167581|NCT05850091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167582|NCT05850091|Gout Suppressants|gout suppressants|mesh-ancestor
139167583|NCT05850091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139167584|NCT05850091|Tubulin Modulators|tubulin modulators|mesh-ancestor
139167585|NCT05850091|Antimitotic Agents|antimitotic agents|mesh-ancestor
139167586|NCT05850091|Mitosis Modulators|mitosis modulators|mesh-ancestor
139167587|NCT05850091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167588|NCT05845671|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
139167589|NCT05845671|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139167590|NCT05845671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139167591|NCT05845671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167592|NCT05845671|Immunologic Factors|immunologic factors|mesh-ancestor
139167593|NCT05845671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167594|NCT05825924|Nicotine|nicotine|mesh-list
139167595|NCT05825924|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139167596|NCT05825924|Autonomic Agents|autonomic agents|mesh-ancestor
139167597|NCT05825924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167598|NCT05825924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167599|NCT05825924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139167600|NCT05825924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139167601|NCT05825924|Cholinergic Agents|cholinergic agents|mesh-ancestor
139167602|NCT05825924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167603|NCT05825924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167604|NCT05809271|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139167605|NCT05809271|Hallucinogens|hallucinogens|mesh-ancestor
139167606|NCT05809271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167607|NCT05809271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139167608|NCT05809271|Serotonin Agents|serotonin agents|mesh-ancestor
139167609|NCT05809271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167610|NCT05809271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167611|NCT05809271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139167612|NCT05809271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139167613|NCT05809271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139167614|NCT05809271|Adrenergic Agents|adrenergic agents|mesh-ancestor
139167615|NCT05790720|Propofol|propofol|mesh-list
139167616|NCT05790720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139167617|NCT05790720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167618|NCT05790720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167619|NCT05790720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139167620|NCT05790720|Anesthetics, General|anesthetics, general|mesh-ancestor
139167621|NCT05790720|Anesthetics|anesthetics|mesh-ancestor
139167622|NCT05734495|Venetoclax|venetoclax|mesh-list
139167623|NCT05734495|Pirtobrutinib|pirtobrutinib|mesh-list
139167624|NCT05734495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167625|NCT05734495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139167626|NCT05734495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167627|NCT05734495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167628|NCT05695495|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
139167629|NCT05695495|Hallucinogens|hallucinogens|mesh-ancestor
139167630|NCT05695495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167631|NCT05695495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139167632|NCT05695495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139167633|NCT05695495|Serotonin Agents|serotonin agents|mesh-ancestor
139167634|NCT05695495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167635|NCT05695495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167636|NCT05695495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139167637|NCT05685615|Polymyxins|polymyxins|mesh-list
139167638|NCT05685615|Polymyxin B|polymyxin b|mesh-list
139167639|NCT05685615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139167640|NCT05685615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167641|NCT05684718|Itraconazole|itraconazole|mesh-list
139167642|NCT05684718|Rifabutin|rifabutin|mesh-list
139167643|NCT05684718|Antifungal Agents|antifungal agents|mesh-ancestor
139167644|NCT05684718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167645|NCT05684718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139167646|NCT05684718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139167647|NCT05684718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167648|NCT05684718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167649|NCT05684718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139167650|NCT05684718|Hormone Antagonists|hormone antagonists|mesh-ancestor
139167651|NCT05684718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139167652|NCT05684718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167653|NCT05684718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139167654|NCT05684718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139167655|NCT05684718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139167656|NCT05684718|Antitubercular Agents|antitubercular agents|mesh-ancestor
139167657|NCT05684705|Rifabutin|rifabutin|mesh-list
139167658|NCT05684705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139167659|NCT05684705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167660|NCT05684705|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139167661|NCT05684705|Antitubercular Agents|antitubercular agents|mesh-ancestor
139167662|NCT05669339|Irinotecan|irinotecan|mesh-list
139167663|NCT05669339|Sorafenib|sorafenib|mesh-list
139167664|NCT05669339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139167665|NCT05669339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139167666|NCT05669339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167667|NCT05669339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167668|NCT05669339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167669|NCT05669339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139167670|NCT05665062|Cyclophosphamide|cyclophosphamide|mesh-list
139167671|NCT05665062|Fludarabine|fludarabine|mesh-list
139167672|NCT05665062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139167673|NCT05665062|Immunologic Factors|immunologic factors|mesh-ancestor
139167674|NCT05665062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167675|NCT05665062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139167676|NCT05665062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139167677|NCT05665062|Alkylating Agents|alkylating agents|mesh-ancestor
139167700|NCT05562492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139167701|NCT05562492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167702|NCT05553613|Clopidogrel|clopidogrel|mesh-list
139167703|NCT05553613|Ticagrelor|ticagrelor|mesh-list
139167704|NCT05553613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139167705|NCT05553613|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139167706|NCT05553613|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139167707|NCT05553613|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139167708|NCT05553613|Purinergic Agents|purinergic agents|mesh-ancestor
139167709|NCT05553613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167710|NCT05553613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167711|NCT05553613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167712|NCT05550662|Xenon|xenon|mesh-list
139167713|NCT05550662|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139167714|NCT05550662|Anesthetics, General|anesthetics, general|mesh-ancestor
139167715|NCT05550662|Anesthetics|anesthetics|mesh-ancestor
139167716|NCT05550662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167717|NCT05550662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167718|NCT05537090|Midazolam|midazolam|mesh-list
139167719|NCT05537090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139167720|NCT05537090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139167721|NCT05537090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167722|NCT05537090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167723|NCT05537090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139167724|NCT05537090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139167725|NCT05537090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139167726|NCT05537090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139167727|NCT05537090|Anesthetics, General|anesthetics, general|mesh-ancestor
139167728|NCT05537090|Anesthetics|anesthetics|mesh-ancestor
139167729|NCT05537090|GABA Modulators|gaba modulators|mesh-ancestor
139167730|NCT05537090|GABA Agents|gaba agents|mesh-ancestor
139167731|NCT05537090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955098|NCT00540046|Copper|copper|mesh-list
139167732|NCT05537090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167733|NCT05518903|FAPI-46|fapi-46|mesh-list
139167734|NCT05518903|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139167735|NCT05518903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167736|NCT05509933|Budesonide|budesonide|mesh-list
139167737|NCT05509933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139167738|NCT05509933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139167739|NCT05509933|Autonomic Agents|autonomic agents|mesh-ancestor
139167740|NCT05509933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167741|NCT05509933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167742|NCT05509933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139167743|NCT05509933|Respiratory System Agents|respiratory system agents|mesh-ancestor
138962600|NCT00530842|Hormones|hormones|mesh-ancestor
139167744|NCT05509933|Glucocorticoids|glucocorticoids|mesh-ancestor
139167745|NCT05509933|Hormones|hormones|mesh-ancestor
139167746|NCT05509933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139167747|NCT05500326|Ivermectin|ivermectin|mesh-list
139167748|NCT05500326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139167749|NCT05500326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167750|NCT05478174|Propofol|propofol|mesh-list
139167751|NCT05478174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139167752|NCT05478174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167753|NCT05478174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167754|NCT05478174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139167755|NCT05478174|Anesthetics, General|anesthetics, general|mesh-ancestor
139167756|NCT05478174|Anesthetics|anesthetics|mesh-ancestor
139167757|NCT05463419|Vaccines|vaccines|mesh-list
139167758|NCT05463419|Immunologic Factors|immunologic factors|mesh-ancestor
139167759|NCT05463419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167760|NCT05461573|Drospirenone|drospirenone|mesh-list
139167761|NCT05461573|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139167762|NCT05461573|Hormone Antagonists|hormone antagonists|mesh-ancestor
139167763|NCT05461573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139167764|NCT05461573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167765|NCT05461573|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139167766|NCT05461573|Diuretics|diuretics|mesh-ancestor
139167767|NCT05461573|Natriuretic Agents|natriuretic agents|mesh-ancestor
139167768|NCT05456334|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139167769|NCT05456334|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139167770|NCT05456334|Dermatologic Agents|dermatologic agents|mesh-ancestor
139167771|NCT05453916|Rifaximin|rifaximin|mesh-list
139167772|NCT05453916|Nitazoxanide|nitazoxanide|mesh-list
139167773|NCT05453916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139167774|NCT05453916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167775|NCT05453916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139167776|NCT05453916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139167777|NCT05443555|Gabapentin|gabapentin|mesh-list
139167778|NCT05443555|Analgesics|analgesics|mesh-ancestor
139167779|NCT05443555|Sensory System Agents|sensory system agents|mesh-ancestor
139167780|NCT05443555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167781|NCT05443555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167782|NCT05443555|Anticonvulsants|anticonvulsants|mesh-ancestor
139167783|NCT05443555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139167784|NCT05443555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139167785|NCT05443555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167786|NCT05443555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139167787|NCT05443555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139167788|NCT05443555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139167789|NCT05443555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167790|NCT05443555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167791|NCT05443555|Antimanic Agents|antimanic agents|mesh-ancestor
139167792|NCT05425056|Sirolimus|sirolimus|mesh-list
139167793|NCT05425056|Temsirolimus|temsirolimus|mesh-list
139167794|NCT05425056|MTOR Inhibitors|mtor inhibitors|mesh-list
139167795|NCT05425056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139167796|NCT05425056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139167797|NCT05425056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139167798|NCT05425056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167799|NCT05425056|Antifungal Agents|antifungal agents|mesh-ancestor
139167800|NCT05425056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139167801|NCT05425056|Immunologic Factors|immunologic factors|mesh-ancestor
139167802|NCT05425056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167803|NCT05425056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139167804|NCT05425056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167805|NCT05425056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167806|NCT05384678|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
139167807|NCT05384678|Hallucinogens|hallucinogens|mesh-ancestor
139167808|NCT05384678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167809|NCT05384678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139167810|NCT05384678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139167812|NCT05384678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167813|NCT05384678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167814|NCT05384678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139167815|NCT05384119|Fulvestrant|fulvestrant|mesh-list
139167816|NCT05384119|Palbociclib|palbociclib|mesh-list
139167817|NCT05384119|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139167818|NCT05384119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139167819|NCT05384119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167820|NCT05384119|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139167821|NCT05384119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139167822|NCT05384119|Hormone Antagonists|hormone antagonists|mesh-ancestor
139167823|NCT05384119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139167824|NCT05384119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167825|NCT05384119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139167826|NCT05384119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167827|NCT05384119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167828|NCT05384119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139167829|NCT05369234|Sucralfate|sucralfate|mesh-list
139167830|NCT05369234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139167831|NCT05369234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139167832|NCT05298761|Lidocaine|lidocaine|mesh-list
139167833|NCT05298761|Nalbuphine|nalbuphine|mesh-list
139167834|NCT05298761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139167835|NCT05298761|Narcotics|narcotics|mesh-ancestor
139167836|NCT05298761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139167837|NCT05298761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167838|NCT05298761|Analgesics|analgesics|mesh-ancestor
139167839|NCT05298761|Sensory System Agents|sensory system agents|mesh-ancestor
139167840|NCT05298761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167841|NCT05298761|Anesthetics, Local|anesthetics, local|mesh-ancestor
139167842|NCT05298761|Anesthetics|anesthetics|mesh-ancestor
139167843|NCT05298761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139167844|NCT05298761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139167845|NCT05298761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139167846|NCT05298761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139167847|NCT05298761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167848|NCT05275439|Azacitidine|azacitidine|mesh-list
139167849|NCT05275439|Venetoclax|venetoclax|mesh-list
139167850|NCT05275439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139167851|NCT05275439|Antimetabolites|antimetabolites|mesh-ancestor
139167852|NCT05275439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167853|NCT05275439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167855|NCT05219435|Nivolumab|nivolumab|mesh-list
139167856|NCT05219435|Ipilimumab|ipilimumab|mesh-list
139167857|NCT05219435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139167858|NCT05219435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896521|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
139167859|NCT05219435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139167860|NCT05219435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167861|NCT05211635|Vitamin D|vitamin d|mesh-list
139167862|NCT05211635|Vitamins|vitamins|mesh-ancestor
139167863|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
139167864|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167865|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139167866|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139167867|NCT05173597|Hormones|hormones|mesh-ancestor
139167868|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139167869|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167870|NCT05171816|Olaparib|olaparib|mesh-list
139167871|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
138962621|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167872|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139167873|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167874|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167875|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167876|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139167877|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
139167878|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139167879|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167880|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139167881|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
139167882|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139167883|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167884|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
139167885|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
139167886|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167887|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167888|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
139167889|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139167890|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167891|NCT05119296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139167892|NCT05119296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167893|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
139167894|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139167895|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167896|NCT05070247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139167897|NCT05070247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167898|NCT05065554|Rituximab|rituximab|mesh-list
139167899|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
139167900|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139167901|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167902|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
139167903|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167904|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139167905|NCT05061992|Lactulose|lactulose|mesh-list
139167906|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139167907|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
139167908|NCT05061420|Cetuximab|cetuximab|mesh-list
139167909|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139167910|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167911|NCT05061420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139167912|NCT05061420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167913|NCT05058417|Empagliflozin|empagliflozin|mesh-list
139167914|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138896609|NCT00696644|Teriparatide|teriparatide|mesh-list
139167915|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167916|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139167917|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167918|NCT05052957|Temozolomide|temozolomide|mesh-list
139167919|NCT05052957|Carmustine|carmustine|mesh-list
139167920|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
139167921|NCT05052957|Lenograstim|lenograstim|mesh-list
139167922|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139167923|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
139167924|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167925|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139167926|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
139167927|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167928|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167929|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167930|NCT05030623|Tadalafil|tadalafil|mesh-list
139167931|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
138962643|NCT03879772|Hormones|hormones|mesh-ancestor
139167932|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139167933|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139167934|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167935|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167936|NCT05030623|Urological Agents|urological agents|mesh-ancestor
139167937|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139167938|NCT05026736|Antibodies|antibodies|mesh-list
139167939|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
139167940|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139167941|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
139167942|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167943|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167944|NCT05014581|Norepinephrine|norepinephrine|mesh-list
139167945|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139167946|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139167947|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
139167948|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139167949|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167950|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167951|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
139167952|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
139167953|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139167954|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139167955|NCT05009082|Paclitaxel|paclitaxel|mesh-list
139167956|NCT05009082|Bevacizumab|bevacizumab|mesh-list
139167957|NCT05009082|Carboplatin|carboplatin|mesh-list
139167958|NCT05009082|Niraparib|niraparib|mesh-list
139167959|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139167960|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167961|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
139167962|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
139167963|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
139167964|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167965|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139167966|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139167967|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139167968|NCT05009082|Growth Substances|growth substances|mesh-ancestor
139167969|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167970|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
139167971|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139167972|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167973|NCT05004116|Irinotecan|irinotecan|mesh-list
139167974|NCT05004116|Temozolomide|temozolomide|mesh-list
139167975|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139167976|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139167977|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139167978|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139167979|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167980|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139167981|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
139167982|NCT05000710|Durvalumab|durvalumab|mesh-list
139167983|NCT05000710|Tremelimumab|tremelimumab|mesh-list
139167984|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139167985|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139167986|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
139167987|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139167988|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
139167989|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167990|NCT04992052|Bone wax|bone wax|mesh-list
139167991|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
139167992|NCT04992052|Coagulants|coagulants|mesh-ancestor
139167993|NCT04977908|Insulin|insulin|mesh-list
139167994|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139167995|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139167996|NCT04924322|Enoxaparin|enoxaparin|mesh-list
139167997|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
138962653|NCT01007500|Dexamethasone|dexamethasone|mesh-list
139167998|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139167999|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139168000|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168001|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
139168002|NCT04859946|Busulfan|busulfan|mesh-list
139168003|NCT04859946|Thiotepa|thiotepa|mesh-list
139168004|NCT04859946|Fludarabine|fludarabine|mesh-list
139168005|NCT04859946|Tacrolimus|tacrolimus|mesh-list
139168006|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139168007|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
139168008|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168009|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139168010|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168011|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
139168012|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168013|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168014|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139168015|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139168016|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168017|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
139168018|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
139168019|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168020|NCT04807517|Buspirone|buspirone|mesh-list
139168021|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139168022|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139168023|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139168024|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168025|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139168026|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139168027|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
139168028|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139168029|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168030|NCT04789837|Cilostazol|cilostazol|mesh-list
139168031|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139168032|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
139168033|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168034|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168035|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139168036|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
139168037|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139168038|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139168039|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168040|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139168041|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
139168042|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139168043|NCT04789837|Protective Agents|protective agents|mesh-ancestor
139168044|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139168045|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139168046|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168047|NCT04762160|Rituximab|rituximab|mesh-list
139168048|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168049|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168050|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
139168051|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168052|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139168053|NCT04726280|Ropivacaine|ropivacaine|mesh-list
139168054|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139168055|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
139168056|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
138955153|NCT05473234|Azithromycin|azithromycin|mesh-list
139168057|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139168058|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168059|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
139168060|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168062|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139168063|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139168064|NCT04677972|Analgesics|analgesics|mesh-ancestor
139168065|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
139168066|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168067|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168068|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139168069|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139168070|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139168071|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139168072|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
139168073|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168074|NCT04677972|Protective Agents|protective agents|mesh-ancestor
139168075|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139168076|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435427|NCT00217737|Vitamins|vitamins|mesh-ancestor
139168077|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139168078|NCT04663997|Docetaxel|docetaxel|mesh-list
139168079|NCT04663997|177Lu-PSMA-617|177lu-psma-617|mesh-list
139168080|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168081|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
139168082|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
139168083|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
139168084|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168085|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139168086|NCT04634877|Paclitaxel|paclitaxel|mesh-list
139168087|NCT04634877|Docetaxel|docetaxel|mesh-list
139168088|NCT04634877|Cisplatin|cisplatin|mesh-list
139168089|NCT04634877|Carboplatin|carboplatin|mesh-list
139168090|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
139168091|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139168092|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168093|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
139168094|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
139168095|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
139168096|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168097|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138962678|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
139168098|NCT04634877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139168099|NCT04625972|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139168101|NCT04625972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139168102|NCT04602078|Gemcitabine|gemcitabine|mesh-list
139168103|NCT04602078|Atezolizumab|atezolizumab|mesh-list
139168104|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168105|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139168106|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
139168107|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168108|NCT04602078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139168109|NCT04602078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168110|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
139168111|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168112|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
139168113|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139168114|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139168115|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168116|NCT04565925|Urological Agents|urological agents|mesh-ancestor
139168117|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
139168118|NCT04555603|Avelumab|avelumab|mesh-list
139168119|NCT04555603|Axitinib|axitinib|mesh-list
139168120|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168121|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896704|NCT01014793|Cabergoline|cabergoline|mesh-list
139168122|NCT04555603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139168123|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168124|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138607122|NCT02908126|Oxytocin|oxytocin|mesh-list
139168125|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168126|NCT04519645|Lacosamide|lacosamide|mesh-list
139168127|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
139168128|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139168129|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139168130|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139168131|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168132|NCT04491383|Tocovid|tocovid|mesh-list
139168133|NCT04491383|Vitamins|vitamins|mesh-ancestor
139168134|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
139168135|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168136|NCT04488315|Dexamethasone|dexamethasone|mesh-list
139168137|NCT04488315|Ropivacaine|ropivacaine|mesh-list
139168138|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139168139|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
139168140|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
139168141|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168142|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168143|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139168144|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
139168145|NCT04488315|Hormones|hormones|mesh-ancestor
139168146|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139168147|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139168148|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168149|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
139168150|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
139168151|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139168152|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
139168153|NCT04487067|Bevacizumab|bevacizumab|mesh-list
139168154|NCT04487067|Atezolizumab|atezolizumab|mesh-list
139168155|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168156|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168157|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139168158|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139168159|NCT04487067|Growth Substances|growth substances|mesh-ancestor
138896739|NCT00498433|Amlodipine|amlodipine|mesh-list
139168160|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168161|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
138962709|NCT00640146|Bromides|bromides|mesh-list
139168162|NCT04487067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139168163|NCT04487067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168164|NCT04478279|Temozolomide|temozolomide|mesh-list
139168165|NCT04478279|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168166|NCT04478279|Alkylating Agents|alkylating agents|mesh-ancestor
139168167|NCT04478279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168169|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
139168170|NCT04464005|Analgesics|analgesics|mesh-ancestor
139168171|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
139168172|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168173|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168174|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
139168175|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139168176|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139168177|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
139168178|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139168179|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139168180|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168181|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139168182|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
139168183|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139168184|NCT04429503|Aflibercept|aflibercept|mesh-list
139168185|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139168186|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139168187|NCT04429503|Growth Substances|growth substances|mesh-ancestor
139168188|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168189|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
139168190|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168191|NCT04385277|Vitamin A|vitamin a|mesh-list
139168192|NCT04385277|Irinotecan|irinotecan|mesh-list
139168193|NCT04385277|Temozolomide|temozolomide|mesh-list
139168194|NCT04385277|Tretinoin|tretinoin|mesh-list
139168195|NCT04385277|Dinutuximab|dinutuximab|mesh-list
139168196|NCT04385277|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139168197|NCT04385277|Isotretinoin|isotretinoin|mesh-list
139168198|NCT04385277|Sargramostim|sargramostim|mesh-list
139168199|NCT04385277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139168200|NCT04385277|Vitamins|vitamins|mesh-ancestor
139168201|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
139168202|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168203|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139168204|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139168205|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168206|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168207|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168208|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168209|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
139168210|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
139168211|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
139168212|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
139168213|NCT04385277|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139168214|NCT04379011|Brivaracetam|brivaracetam|mesh-list
139168215|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
139168216|NCT04342715|Paromomycin|paromomycin|mesh-list
139168217|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
139168218|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139168219|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139168220|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139168221|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139168222|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
139168223|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139168224|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
139168225|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
139168226|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139168227|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168228|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139168229|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168230|NCT04332393|Metformin|metformin|mesh-list
139168231|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139168232|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168233|NCT04240106|Niraparib|niraparib|mesh-list
139168234|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139168235|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139168236|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168237|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168238|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168239|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139168240|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139168241|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
139168242|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918673|NCT02604992|Hormones|hormones|mesh-ancestor
139168243|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168244|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
139168245|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139168246|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168247|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139168248|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168249|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139168250|NCT04205266|Hematinics|hematinics|mesh-ancestor
139168251|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139168252|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139168253|NCT04103645|Vactosertib|vactosertib|mesh-list
139168254|NCT04103645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139168255|NCT04103645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168256|NCT04103645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168257|NCT04100135|Clopidogrel|clopidogrel|mesh-list
139168258|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139168259|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139168260|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139168261|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139168262|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139168263|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
139168264|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139168265|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168266|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168267|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139168268|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139168270|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
139168271|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139168272|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139168273|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139168274|NCT04028479|Immunomodulating Agents|immunomodulating agents|mesh-list
139168275|NCT04028479|Immunologic Factors|immunologic factors|mesh-ancestor
139168276|NCT04028479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168277|NCT03944902|Niraparib|niraparib|mesh-list
139168278|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139168279|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168280|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168281|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168282|NCT03928093|Pregabalin|pregabalin|mesh-list
139168283|NCT03928093|Analgesics|analgesics|mesh-ancestor
139168284|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
139168285|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168286|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168287|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
139168288|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138962729|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168291|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139168293|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139168294|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139168295|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139168296|NCT03917186|Sevoflurane|sevoflurane|mesh-list
139168297|NCT03917186|Desflurane|desflurane|mesh-list
139168298|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139168299|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139168300|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
139168301|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
139168302|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139168303|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168304|NCT03916419|Paclitaxel|paclitaxel|mesh-list
139168305|NCT03916419|Carboplatin|carboplatin|mesh-list
139168306|NCT03916419|Durvalumab|durvalumab|mesh-list
139168307|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139168308|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168309|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
139168310|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
139168311|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
139168312|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168313|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168314|NCT03916003|Primaquine|primaquine|mesh-list
139168315|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
138918751|NCT04114643|Thrombin|thrombin|mesh-list
139168317|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139168318|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139168319|NCT03898986|Vaccines|vaccines|mesh-list
139168320|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
139168321|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168322|NCT03871348|Cemiplimab|cemiplimab|mesh-list
139168323|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168324|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168325|NCT03861299|Anesthetics|anesthetics|mesh-list
139168326|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139168327|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168331|NCT03825380|Bimatoprost|bimatoprost|mesh-list
139168332|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139168333|NCT03768414|Paclitaxel|paclitaxel|mesh-list
139168334|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139168335|NCT03768414|Cisplatin|cisplatin|mesh-list
139168336|NCT03768414|Gemcitabine|gemcitabine|mesh-list
139168337|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139168338|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168339|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
139168340|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
139168341|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
139168342|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168343|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139168344|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
139168345|NCT03759288|Adalimumab|adalimumab|mesh-list
139168346|NCT03759288|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139168347|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139168348|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139168349|NCT03679546|Infliximab|infliximab|mesh-list
139168350|NCT03679546|Vedolizumab|vedolizumab|mesh-list
139168351|NCT03679546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139168352|NCT03679546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139168353|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
139168354|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139168355|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139168356|NCT03653247|Plerixafor|plerixafor|mesh-list
139168357|NCT03653247|Busulfan|busulfan|mesh-list
139168358|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
139168359|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168360|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139168361|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
139168362|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168363|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168364|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168365|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139168366|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139168367|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139168368|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
139168369|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139168370|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
139168371|NCT03600649|Topotecan|topotecan|mesh-list
139168372|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139168373|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
139168374|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168375|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139168376|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168377|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
139168378|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168379|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168380|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139168381|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139168382|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139168383|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168384|NCT03600155|Nivolumab|nivolumab|mesh-list
139168385|NCT03600155|Ipilimumab|ipilimumab|mesh-list
139168386|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168387|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168388|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139168389|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168390|NCT03567434|Ethanol|ethanol|mesh-list
139168391|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139168392|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139168393|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139168394|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168396|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139168397|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
138896824|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139168398|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168399|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168400|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139168401|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139168402|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
139168403|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139168404|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168405|NCT03481998|Letrozole|letrozole|mesh-list
139168406|NCT03481998|Fulvestrant|fulvestrant|mesh-list
139168407|NCT03481998|Anastrozole|anastrozole|mesh-list
139168408|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168409|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139168410|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139168411|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168412|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168413|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139168414|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
139168415|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139168416|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168417|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139168418|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139168420|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168421|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168422|NCT03366844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139168423|NCT03366844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168424|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139168425|NCT03258554|Cetuximab|cetuximab|mesh-list
139168426|NCT03258554|Durvalumab|durvalumab|mesh-list
139168427|NCT03258554|Antibodies|antibodies|mesh-list
139168428|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
139168429|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139168430|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
139168431|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
139168432|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168433|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168434|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139168435|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139168436|NCT03238248|Azacitidine|azacitidine|mesh-list
139168437|NCT03238248|Pevonedistat|pevonedistat|mesh-list
139168438|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139168439|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
139019584|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139168440|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168441|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168442|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168443|NCT03196180|Fluorouracil|fluorouracil|mesh-list
139168444|NCT03196180|Imiquimod|imiquimod|mesh-list
139168445|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
139168446|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168447|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139168449|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139168450|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
139168451|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168452|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139168453|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
139168454|NCT03174197|Temozolomide|temozolomide|mesh-list
139168455|NCT03174197|Atezolizumab|atezolizumab|mesh-list
139168456|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139168457|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168458|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
139168459|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168460|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168461|NCT03174197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139168462|NCT03174197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168463|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
139168464|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168465|NCT03164980|Trabectedin|trabectedin|mesh-list
139168466|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168467|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
139168468|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168469|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168470|NCT03093155|Bevacizumab|bevacizumab|mesh-list
139168471|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168472|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168473|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139168474|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139168475|NCT03093155|Growth Substances|growth substances|mesh-ancestor
139168476|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168477|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
139168478|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
139168480|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168481|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168482|NCT03069378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139168483|NCT03069378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168484|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
139168485|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168486|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
139168487|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168488|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168489|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
139168490|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139168491|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168492|NCT02937571|Dexamethasone|dexamethasone|mesh-list
139168493|NCT02937571|Lenalidomide|lenalidomide|mesh-list
139168494|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139168495|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
139168496|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
139168497|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168498|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168499|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139168500|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
139168501|NCT02937571|Hormones|hormones|mesh-ancestor
139168502|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139168503|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139168504|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168505|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
139168506|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139168507|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139168508|NCT02937571|Growth Substances|growth substances|mesh-ancestor
139168509|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
139168510|NCT02919072|Ropivacaine|ropivacaine|mesh-list
139168511|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
139168512|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
139168513|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
139019585|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
139168514|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139168515|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168516|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
139168517|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168518|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
139168519|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
139168520|NCT02880293|Melphalan|melphalan|mesh-list
139168521|NCT02880293|Thiotepa|thiotepa|mesh-list
139168522|NCT02880293|Fludarabine|fludarabine|mesh-list
139168523|NCT02880293|Tacrolimus|tacrolimus|mesh-list
139168524|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139168525|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
139168526|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168527|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139168528|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168529|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
139168530|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168531|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168532|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139168533|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139168534|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168535|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139168536|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139168537|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
139168538|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139168539|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139168540|NCT02739035|Dexamethasone|dexamethasone|mesh-list
139168541|NCT02739035|Celecoxib|celecoxib|mesh-list
139168542|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139168543|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
139168544|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
139168545|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168546|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168547|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139168548|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
139168549|NCT02739035|Hormones|hormones|mesh-ancestor
139168550|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139168551|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139168552|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168553|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139168554|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139168555|NCT02739035|Analgesics|analgesics|mesh-ancestor
139168556|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
139168557|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139168558|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139168559|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139168560|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168561|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168567|NCT02657434|Carboplatin|carboplatin|mesh-list
139168568|NCT02657434|Pemetrexed|pemetrexed|mesh-list
139168569|NCT02657434|Atezolizumab|atezolizumab|mesh-list
139168570|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168571|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168572|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168573|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139168574|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139168575|NCT02657434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139168576|NCT02657434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168577|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
139168578|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168579|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168580|NCT02557321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139168581|NCT02557321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168583|NCT02555839|Dexamethasone|dexamethasone|mesh-list
139168584|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
139168585|NCT02555839|Bortezomib|bortezomib|mesh-list
139168586|NCT02555839|Pomalidomide|pomalidomide|mesh-list
139168587|NCT02555839|BB 1101|bb 1101|mesh-list
139168588|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139168589|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
139168590|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
139168591|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168592|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168593|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139168594|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
139168595|NCT02555839|Hormones|hormones|mesh-ancestor
139168596|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139168597|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139168598|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168599|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
139168600|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168601|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168602|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
139168603|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139168604|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139168605|NCT02555839|Growth Substances|growth substances|mesh-ancestor
139168606|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
139168607|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139168608|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
139168609|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139168610|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139168611|NCT02543879|Azacitidine|azacitidine|mesh-list
139168612|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139168613|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
139168614|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168615|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168616|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168617|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
139168618|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168619|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168620|NCT02504372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139168621|NCT02504372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168622|NCT02390284|Timolol|timolol|mesh-list
139168623|NCT02390284|Bimatoprost|bimatoprost|mesh-list
139168624|NCT02390284|Travoprost|travoprost|mesh-list
139168625|NCT02390284|Dorzolamide|dorzolamide|mesh-list
139168626|NCT02390284|Acetazolamide|acetazolamide|mesh-list
139168627|NCT02390284|Methazolamide|methazolamide|mesh-list
139168628|NCT02390284|Latanoprost|latanoprost|mesh-list
139168629|NCT02390284|Brinzolamide|brinzolamide|mesh-list
139168630|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139168631|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139168632|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
139168633|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139168634|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168635|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168636|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139168637|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139168638|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139168639|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139168640|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
139168641|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139168642|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168643|NCT02390284|Diuretics|diuretics|mesh-ancestor
139168644|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
139168645|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
139168646|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139168647|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
139168648|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139168649|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
139168650|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168651|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168652|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
139168653|NCT02180867|Doxorubicin|doxorubicin|mesh-list
139168654|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139168655|NCT02180867|Daunorubicin|daunorubicin|mesh-list
139168656|NCT02180867|Ifosfamide|ifosfamide|mesh-list
139168657|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
138962814|NCT01008358|Tremelimumab|tremelimumab|mesh-list
139168658|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139168659|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168660|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139168661|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139168662|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168663|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168664|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168665|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
139168666|NCT02112734|Vitamin D|vitamin d|mesh-list
139168667|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
139168668|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
139168669|NCT02112734|Vitamins|vitamins|mesh-list
139168670|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
139168671|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168672|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139168673|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139168674|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
139168675|NCT02101853|Leucovorin|leucovorin|mesh-list
139168676|NCT02101853|Folic Acid|folic acid|mesh-list
139168677|NCT02101853|Cytarabine|cytarabine|mesh-list
139168678|NCT02101853|Dexamethasone|dexamethasone|mesh-list
139168679|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
139168680|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
139168681|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139168682|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139168683|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139168684|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
139168685|NCT02101853|Methotrexate|methotrexate|mesh-list
139168686|NCT02101853|Etoposide|etoposide|mesh-list
139168687|NCT02101853|Vincristine|vincristine|mesh-list
139168688|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
139168689|NCT02101853|Asparaginase|asparaginase|mesh-list
139168690|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
138919125|NCT00735696|Paclitaxel|paclitaxel|mesh-list
139168691|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
139168692|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
139168693|NCT02101853|Pegaspargase|pegaspargase|mesh-list
139168694|NCT02101853|Thioguanine|thioguanine|mesh-list
139168695|NCT02101853|Blinatumomab|blinatumomab|mesh-list
139168696|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139168697|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
139168698|NCT02101853|Antibodies|antibodies|mesh-list
139168699|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
139168700|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139168701|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139168702|NCT02101853|BB 1101|bb 1101|mesh-list
139168703|NCT02101853|Calcium|calcium|mesh-list
139168704|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
139168705|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
139168706|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139168707|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
139168708|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168709|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139168710|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168711|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
139168712|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168713|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168714|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138955268|NCT00772356|Insulin|insulin|mesh-list
139168715|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139168716|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
139168717|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
139168718|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168719|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139168720|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
139168721|NCT02101853|Hormones|hormones|mesh-ancestor
139019586|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139168722|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139168723|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138962835|NCT00302731|Hormones|hormones|mesh-list
139168724|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
139168725|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168726|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139168727|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139168728|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139168729|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
139168730|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139168731|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139168732|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
139168733|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
139168734|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139168735|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139168736|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139168737|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139168738|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139168739|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
139168740|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139168741|NCT02101853|Antidotes|antidotes|mesh-ancestor
139168742|NCT02101853|Protective Agents|protective agents|mesh-ancestor
139168743|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
139168744|NCT02101853|Vitamins|vitamins|mesh-ancestor
139168745|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
139168746|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
139168747|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
139168748|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
139168749|NCT02101853|Hematinics|hematinics|mesh-ancestor
139168750|NCT02101853|Analgesics|analgesics|mesh-ancestor
139168751|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
139168752|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
139168753|NCT01990352|Doxorubicin|doxorubicin|mesh-list
139168754|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139168755|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139168756|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168757|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139168758|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139168759|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168760|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168761|NCT01473628|Rituximab|rituximab|mesh-list
139168762|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139168763|NCT01473628|Antibodies|antibodies|mesh-list
139168764|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
139168765|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139168766|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
139168767|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168768|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168769|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139168770|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
139168771|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
139168772|NCT01409200|Axitinib|axitinib|mesh-list
139168773|NCT01409200|Hormones|hormones|mesh-list
139168774|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139168775|NCT01409200|Androgens|androgens|mesh-list
139168776|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
139168777|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139168778|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168779|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
139168780|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962847|NCT00780143|Cytarabine|cytarabine|mesh-list
139168781|NCT01409200|Protective Agents|protective agents|mesh-ancestor
139168782|NCT01409200|Vitamins|vitamins|mesh-ancestor
139168783|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
139168784|NCT01409200|Estrogens|estrogens|mesh-ancestor
139168785|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139168786|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168787|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
139168788|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139168789|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168790|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
139168792|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139168793|NCT01236560|Temozolomide|temozolomide|mesh-list
139168794|NCT01236560|Vorinostat|vorinostat|mesh-list
139168795|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
139168796|NCT01236560|Antibodies|antibodies|mesh-list
139168797|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
139168798|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139168799|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
139168800|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168801|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139168802|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139168803|NCT01236560|Growth Substances|growth substances|mesh-ancestor
139168804|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168805|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
139168806|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
139168807|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168808|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
139019587|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
139168809|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168810|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139168811|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168812|NCT01193842|Prednisone|prednisone|mesh-list
139168813|NCT01193842|Cortisone|cortisone|mesh-list
139168814|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
139168815|NCT01193842|Rituximab|rituximab|mesh-list
139168816|NCT01193842|Doxorubicin|doxorubicin|mesh-list
139168817|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139168818|NCT01193842|Etoposide|etoposide|mesh-list
139168819|NCT01193842|Vincristine|vincristine|mesh-list
139168820|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
139168821|NCT01193842|Vorinostat|vorinostat|mesh-list
139168822|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
139168823|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139168824|NCT01193842|Antibodies|antibodies|mesh-list
139168825|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
139168826|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139168827|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139168828|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
139168829|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168830|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139168831|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168832|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
139168833|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168834|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168835|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139168836|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139168837|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139168838|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139168839|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168840|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139168841|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
139168842|NCT01193842|Hormones|hormones|mesh-ancestor
139168843|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139168844|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139168845|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139168846|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
139168847|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
139168848|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
139168849|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139168850|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
139168851|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
139168852|NCT00855465|Riociguat|riociguat|mesh-list
139168853|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
139168854|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168855|NCT00770809|Paclitaxel|paclitaxel|mesh-list
139168856|NCT00770809|Trastuzumab|trastuzumab|mesh-list
139168857|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139168858|NCT00770809|Lapatinib|lapatinib|mesh-list
138897132|NCT01012141|Docetaxel|docetaxel|mesh-list
139168859|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139168860|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139168861|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168862|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
139168863|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
138955277|NCT04394182|Piperacillin|piperacillin|mesh-list
139168864|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
139168865|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168866|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139168867|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139168868|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168869|NCT00602641|Thalidomide|thalidomide|mesh-list
139168870|NCT00602641|Prednisone|prednisone|mesh-list
139168871|NCT00602641|Cortisone|cortisone|mesh-list
139168872|NCT00602641|Lenalidomide|lenalidomide|mesh-list
139168873|NCT00602641|Melphalan|melphalan|mesh-list
139168874|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
139168875|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139168876|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139168877|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
139168878|NCT00602641|Hormones|hormones|mesh-ancestor
139168879|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139168880|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168881|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139168882|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168883|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
139168884|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139168885|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139168886|NCT00602641|Growth Substances|growth substances|mesh-ancestor
139168887|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
139168888|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168889|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
139168890|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168891|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139168892|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139168893|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
139168894|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139168895|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139168896|NCT00569127|Interferons|interferons|mesh-list
139168897|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
139168898|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
139168899|NCT00569127|Bevacizumab|bevacizumab|mesh-list
138962871|NCT05559112|Micronutrients|micronutrients|mesh-ancestor
139168900|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139168901|NCT00569127|Octreotide|octreotide|mesh-list
139168902|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
139168903|NCT00569127|Antibodies|antibodies|mesh-list
139168904|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
139168905|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139168906|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
139168907|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168908|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139168909|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139168910|NCT00569127|Growth Substances|growth substances|mesh-ancestor
139168911|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168912|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
139168913|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
139168914|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
139168915|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139168916|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139168917|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139168918|NCT00114101|Lenalidomide|lenalidomide|mesh-list
139168919|NCT00114101|Melphalan|melphalan|mesh-list
139168920|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
139168921|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139168922|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
139168923|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168924|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139168925|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139168926|NCT00114101|Growth Substances|growth substances|mesh-ancestor
139168927|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
139168928|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168929|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168930|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
139168931|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168932|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139168933|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139168935|NCT00098475|Dexamethasone|dexamethasone|mesh-list
139168936|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
139168937|NCT00098475|Lenalidomide|lenalidomide|mesh-list
139168938|NCT00098475|Ichthammol|ichthammol|mesh-list
139168939|NCT00098475|BB 1101|bb 1101|mesh-list
139168940|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139168941|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
139168942|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
139168943|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168944|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168945|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139168946|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
139168947|NCT00098475|Hormones|hormones|mesh-ancestor
139168948|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139168949|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139168950|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168951|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
139168952|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139168953|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168954|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
139168955|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138962898|NCT00316225|Pemetrexed|pemetrexed|mesh-list
139168956|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139168957|NCT00098475|Growth Substances|growth substances|mesh-ancestor
139168958|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
139168959|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139168960|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
139168961|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139168962|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139168963|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
139168964|NCT03929575|Calcium|calcium|mesh-list
139168965|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139168966|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168967|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
139168968|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139168969|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139168970|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139168971|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139168972|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168973|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
139168974|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139168975|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168976|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139168977|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139168978|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139168979|NCT01131247|Ofatumumab|ofatumumab|mesh-list
139168980|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139168981|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139168982|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
139168983|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139168984|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139168985|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
139168986|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168987|NCT03513874|Metformin|metformin|mesh-list
139168988|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139168989|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139168990|NCT01228357|Milnacipran|milnacipran|mesh-list
139168991|NCT01228357|Mirtazapine|mirtazapine|mesh-list
139168992|NCT01228357|Sertraline|sertraline|mesh-list
139168993|NCT01228357|Fluoxetine|fluoxetine|mesh-list
139168994|NCT01228357|Paroxetine|paroxetine|mesh-list
139168995|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139168996|NCT01228357|Nortriptyline|nortriptyline|mesh-list
139168997|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
139168998|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139168999|NCT01228357|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139169000|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139169001|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139169002|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169003|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169004|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
139169005|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169006|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139169007|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139169008|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139169009|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169010|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139169011|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139169014|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139169015|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139169016|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169017|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139169018|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139169019|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139169020|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
139169021|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139169022|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139169023|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139169024|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139169025|NCT01228357|Analgesics|analgesics|mesh-ancestor
139169026|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
139169027|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169028|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139169029|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139169030|NCT01130701|Capecitabine|capecitabine|mesh-list
139169031|NCT01130701|Panitumumab|panitumumab|mesh-list
139169032|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139169033|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
139169034|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169035|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169036|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139169037|NCT02292550|Ceritinib|ceritinib|mesh-list
139169038|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169039|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139169040|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169041|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169042|NCT03925285|Bevacizumab|bevacizumab|mesh-list
139169043|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139169044|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169045|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139169046|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139169047|NCT03925285|Growth Substances|growth substances|mesh-ancestor
139169048|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169049|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
139169050|NCT04464694|Ranibizumab|ranibizumab|mesh-list
139169051|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139169052|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139169053|NCT04464694|Growth Substances|growth substances|mesh-ancestor
139169054|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169055|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
139169056|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169057|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139169058|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169059|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138897206|NCT00860028|Varenicline|varenicline|mesh-list
139169060|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169061|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169062|NCT03519724|Neostigmine|neostigmine|mesh-list
139169063|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139169064|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169065|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169066|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
139169067|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169068|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169069|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139169070|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
139169071|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169072|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
139169073|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139169074|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139169075|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169076|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
139169077|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169078|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169079|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
139169080|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139169081|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169082|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139169083|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
139169084|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139169085|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169086|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169087|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169089|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139169090|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
139169091|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169092|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139169093|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169094|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169095|NCT03136484|Canagliflozin|canagliflozin|mesh-list
139169096|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139169097|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169098|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139169099|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169100|NCT01132183|Valproic Acid|valproic acid|mesh-list
139169101|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
139169102|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169103|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169104|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
139169105|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169106|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169107|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
139169108|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139169109|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169110|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139169111|NCT03923881|Cetuximab|cetuximab|mesh-list
139169112|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139169113|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169114|NCT02295748|Deflazacort|deflazacort|mesh-list
139169115|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139169116|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139169117|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
139169118|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169119|NCT03923803|Calcitonin|calcitonin|mesh-list
139169120|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
139169121|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139169123|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139169124|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169125|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139169126|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
139169127|NCT02295826|Aspirin|aspirin|mesh-list
139169128|NCT02295826|Dabigatran|dabigatran|mesh-list
139169129|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139169130|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139169131|NCT02295826|Analgesics|analgesics|mesh-ancestor
139169132|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
139169133|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169134|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169135|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139169136|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139169137|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139169138|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139169139|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169140|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139169141|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139169142|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169143|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
139169144|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
139169145|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139169146|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
139169147|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
139169148|NCT01348724|Naloxegol|naloxegol|mesh-list
139169149|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138919584|NCT04101578|Hormones|hormones|mesh-ancestor
139169150|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169151|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
139169152|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169153|NCT03519022|Cocaine|cocaine|mesh-list
139169154|NCT03519022|Methylphenidate|methylphenidate|mesh-list
139169155|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139169156|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169157|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139169158|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139169159|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139169160|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169161|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
139169162|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169163|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
139169164|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
139169165|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169166|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
139169167|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169168|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139169169|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139169170|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139169171|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169172|NCT03516526|Natalizumab|natalizumab|mesh-list
139169173|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
139169174|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169175|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
139169176|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
139169177|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
139169178|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169179|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169180|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
139169181|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169182|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139169183|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
138962972|NCT00293293|Taxane|taxane|mesh-list
139169184|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139169185|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139169186|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169187|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169188|NCT01348880|Urological Agents|urological agents|mesh-ancestor
139169189|NCT03923179|Etoposide|etoposide|mesh-list
139169190|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139169191|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169192|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139169193|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139169194|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169195|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169196|NCT01318460|Simendan|simendan|mesh-list
139169197|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139169198|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
139169199|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139169200|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139169201|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169202|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169203|NCT01318460|Protective Agents|protective agents|mesh-ancestor
139169204|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169205|NCT02299726|Spironolactone|spironolactone|mesh-list
139169206|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139169207|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
139169208|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139169209|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169210|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139169211|NCT02299726|Diuretics|diuretics|mesh-ancestor
139169212|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
139169213|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
139169214|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139169215|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139169216|NCT03647852|Prednisolone|prednisolone|mesh-list
139169217|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
139169218|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139169219|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
139169220|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139169221|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
139169222|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
139169223|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169224|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169226|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
139169227|NCT03647852|Hormones|hormones|mesh-ancestor
139169228|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139169229|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139169230|NCT03647852|Protective Agents|protective agents|mesh-ancestor
139169231|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139169232|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169233|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139169234|NCT01354886|Hormones|hormones|mesh-ancestor
139169235|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139169236|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169238|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139169239|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169240|NCT01355120|Ipilimumab|ipilimumab|mesh-list
139169241|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139169242|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169243|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139169244|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169245|NCT02300038|Lidocaine|lidocaine|mesh-list
139169246|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
139169247|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
139169248|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169249|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169250|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
139169251|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169252|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139169253|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139169254|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139169255|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139169256|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169257|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
139169258|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139169259|NCT01355198|Glycine|glycine|mesh-list
139169260|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
139169261|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169262|NCT01355198|Expectorants|expectorants|mesh-ancestor
139169263|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
139169264|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139169265|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
139169266|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169267|NCT01355198|Protective Agents|protective agents|mesh-ancestor
139169268|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169269|NCT01355198|Antidotes|antidotes|mesh-ancestor
139169270|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
139169271|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169272|NCT01355276|Domperidone|domperidone|mesh-list
139169273|NCT01355276|Cinitapride|cinitapride|mesh-list
139169274|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
139169275|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
139169276|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169277|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169278|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139169279|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139169280|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
139169281|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019588|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139169282|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169283|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139169284|NCT02589860|Melphalan|melphalan|mesh-list
139169285|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139169286|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
138963007|NCT05774028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139169287|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169288|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169289|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139169290|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139169291|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
139169292|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169294|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139169295|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139169296|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169297|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169298|NCT01355354|Protective Agents|protective agents|mesh-ancestor
139169299|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169300|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139169301|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139169302|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139169303|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139169304|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139169305|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
139169306|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169307|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169308|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169309|NCT01349270|Prednisone|prednisone|mesh-list
139169310|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
139169311|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139169312|NCT01349270|Antibodies|antibodies|mesh-list
139169313|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139169314|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
139169315|NCT01349270|Hormones|hormones|mesh-ancestor
139169316|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139169317|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169318|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139169319|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169320|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
139169321|NCT01132417|Tigecycline|tigecycline|mesh-list
139169322|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139169323|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169324|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139169325|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169326|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169327|NCT02300194|Morphine|morphine|mesh-list
139169328|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139169329|NCT02300194|Narcotics|narcotics|mesh-ancestor
139169330|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169331|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169332|NCT02300194|Analgesics|analgesics|mesh-ancestor
139169333|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
139169334|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169335|NCT01225705|Ritonavir|ritonavir|mesh-list
139169336|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139169337|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
139169338|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139169339|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139169340|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
139169341|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169342|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169343|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139169344|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139169345|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
139169346|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169347|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139169348|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139169349|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139169350|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139169351|NCT01128985|Canagliflozin|canagliflozin|mesh-list
139169352|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139169353|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169354|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139169355|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169356|NCT03922555|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
139169357|NCT03922555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139169358|NCT03922555|Antimetabolites|antimetabolites|mesh-ancestor
139169359|NCT03922555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169360|NCT03922555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169361|NCT03512860|Valproic Acid|valproic acid|mesh-list
139169362|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
139169363|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169364|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169365|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
139169366|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169367|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169368|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
138919801|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139169369|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139169370|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169371|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139169372|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
139169373|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139169374|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169375|NCT02296762|Sirolimus|sirolimus|mesh-list
139169376|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139169377|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169378|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139169379|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169380|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
139169381|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139169382|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
139019589|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139169383|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169384|NCT01132573|Clofarabine|clofarabine|mesh-list
139169385|NCT01132573|Entinostat|entinostat|mesh-list
139169386|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139169387|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139169388|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
139169389|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169390|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169391|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169392|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139169393|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139169394|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169395|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139169396|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139169397|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139169398|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169399|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
139169400|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169401|NCT03518320|Gemcitabine|gemcitabine|mesh-list
139169402|NCT03518320|Nivolumab|nivolumab|mesh-list
139169403|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139169405|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169406|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169407|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139169408|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139169409|NCT01134289|Bupivacaine|bupivacaine|mesh-list
139169410|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
139169411|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
139169412|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
139169413|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169414|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169415|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
139169416|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169417|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139169418|NCT02300350|Digoxin|digoxin|mesh-list
139169419|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139169420|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139169421|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169422|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169423|NCT02300350|Protective Agents|protective agents|mesh-ancestor
139169424|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169425|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139169426|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139169427|NCT01349348|Tolvaptan|tolvaptan|mesh-list
139169428|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138897429|NCT00868166|Riluzole|riluzole|mesh-list
139169429|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169430|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
139169431|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169432|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
139169433|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
139169434|NCT02300428|Trace Elements|trace elements|mesh-ancestor
139169435|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
139169436|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169437|NCT02300428|Hematinics|hematinics|mesh-ancestor
139169438|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138955290|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
139169439|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138919882|NCT04078659|Narcotics|narcotics|mesh-ancestor
139169441|NCT02296996|Dabrafenib|dabrafenib|mesh-list
139169442|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169443|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139169444|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169445|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169446|NCT01132729|Valacyclovir|valacyclovir|mesh-list
139169447|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
139169448|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169449|NCT02294110|Anesthetics|anesthetics|mesh-list
139169450|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169451|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169452|NCT03512548|Itraconazole|itraconazole|mesh-list
139169453|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
139169454|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169455|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139169456|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139169457|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169458|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169459|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139169460|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
139169461|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139169462|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169463|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139169464|NCT03515668|Methylphenidate|methylphenidate|mesh-list
139169465|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139169466|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169467|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139169468|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139169469|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139169470|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169471|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
139169472|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169474|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139169475|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139169476|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139169477|NCT01356212|Analgesics|analgesics|mesh-ancestor
139169478|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
139169479|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169480|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169481|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139169482|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139169483|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139169484|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169485|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169486|NCT02302378|Bupivacaine|bupivacaine|mesh-list
139169487|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
139169488|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
139169489|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897464|NCT00699062|Montelukast|montelukast|mesh-list
139169490|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169491|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
139169492|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169493|NCT01356368|Docetaxel|docetaxel|mesh-list
139169494|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169495|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
139169496|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
139169497|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
139169498|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169499|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
139169500|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139169501|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139169502|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169503|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
139169504|NCT02302456|Coagulants|coagulants|mesh-ancestor
139169505|NCT01356524|Progesterone|progesterone|mesh-list
139169506|NCT01356524|Progestins|progestins|mesh-ancestor
139169507|NCT01356524|Hormones|hormones|mesh-ancestor
139169508|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139169509|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169510|NCT01232023|Indobufen|indobufen|mesh-list
139169511|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139169512|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138919955|NCT02582307|Analgesics|analgesics|mesh-list
139169513|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169514|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169515|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138963084|NCT05667883|Hormones|hormones|mesh-ancestor
139169516|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139169517|NCT01232023|Analgesics|analgesics|mesh-ancestor
139169518|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
139169519|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169520|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169521|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139169522|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139169523|NCT02300740|Niacinamide|niacinamide|mesh-list
139169525|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
139169526|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
139169527|NCT02300740|Vitamins|vitamins|mesh-ancestor
139169528|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
139169529|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169530|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139169531|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
139169532|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169533|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139169534|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
139169535|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139169536|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139169537|NCT02297386|Testosterone|testosterone|mesh-list
139169538|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
139169539|NCT02297386|Androgens|androgens|mesh-ancestor
139169540|NCT02297386|Hormones|hormones|mesh-ancestor
139169541|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139169542|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169543|NCT04464616|Anesthetics|anesthetics|mesh-list
139169544|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169545|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169546|NCT01356680|Prednisone|prednisone|mesh-list
139169547|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
139169548|NCT01356680|Dacarbazine|dacarbazine|mesh-list
139169549|NCT01356680|Etoposide|etoposide|mesh-list
139169550|NCT01356680|Vincristine|vincristine|mesh-list
139169551|NCT01356680|Doxorubicin|doxorubicin|mesh-list
139169552|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139169553|NCT01356680|Bleomycin|bleomycin|mesh-list
139169554|NCT01356680|Vinblastine|vinblastine|mesh-list
139169555|NCT01356680|Procarbazine|procarbazine|mesh-list
139169556|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139169557|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
139169558|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169559|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139169560|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139169561|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
139169562|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169563|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169564|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139169565|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139169566|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
139169567|NCT01356680|Hormones|hormones|mesh-ancestor
139169568|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139169569|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139169570|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139169571|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139169572|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139169573|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169574|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
139169575|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
139169576|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
139169577|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139169579|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
139169580|NCT04464850|Folic Acid|folic acid|mesh-list
139169581|NCT04464850|Trace Elements|trace elements|mesh-ancestor
139169582|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
139169583|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169584|NCT04464850|Hematinics|hematinics|mesh-ancestor
139169586|NCT04464850|Vitamins|vitamins|mesh-ancestor
139169587|NCT01356758|Adalimumab|adalimumab|mesh-list
139169588|NCT01356758|Infliximab|infliximab|mesh-list
139169589|NCT01356758|Etanercept|etanercept|mesh-list
139169590|NCT01356758|Ustekinumab|ustekinumab|mesh-list
139169591|NCT01356758|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139169592|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139169593|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139169594|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
139169595|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139169596|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139169597|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139169598|NCT01356758|Analgesics|analgesics|mesh-ancestor
139169599|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
139169600|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169601|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169602|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139169603|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
139169604|NCT01134523|Paclitaxel|paclitaxel|mesh-list
139169605|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139169606|NCT01134523|Epirubicin|epirubicin|mesh-list
139169607|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139169608|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169609|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
139169610|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
139169611|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
139169612|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169613|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139169614|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139169615|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139169616|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169617|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139169618|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
139169619|NCT01349738|Levofloxacin|levofloxacin|mesh-list
139169620|NCT01349738|Ofloxacin|ofloxacin|mesh-list
139169621|NCT01349738|Gentamicins|gentamicins|mesh-list
139169622|NCT01349738|Cefazolin|cefazolin|mesh-list
139169623|NCT01349738|Tobramycin|tobramycin|mesh-list
139169624|NCT01349738|Ampicillin|ampicillin|mesh-list
139169625|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139169626|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
139169627|NCT01349738|Sulbactam|sulbactam|mesh-list
139169628|NCT01349738|Trimethoprim|trimethoprim|mesh-list
139169629|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
139169630|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169631|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139169632|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139169633|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169634|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169635|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169636|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139169637|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139169638|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139169639|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139169640|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
139169641|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139169642|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139169643|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139169644|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139169645|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139169646|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139169647|NCT02302768|Selenium|selenium|mesh-list
139169648|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
139169649|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169650|NCT02302768|Protective Agents|protective agents|mesh-ancestor
139169651|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169652|NCT02302768|Trace Elements|trace elements|mesh-ancestor
139169653|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
139169654|NCT03921775|Propofol|propofol|mesh-list
139169655|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139169656|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897575|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
139169657|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169658|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138955298|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
139169659|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
139169660|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
139169661|NCT01356992|Enoxaparin|enoxaparin|mesh-list
139169662|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
139169663|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139169664|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138920099|NCT04113551|Methylphenidate|methylphenidate|mesh-list
139169665|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169666|NCT01350050|Carticaine|carticaine|mesh-list
139169667|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
139169668|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
139169669|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169670|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169671|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
139169672|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169673|NCT03918889|Midazolam|midazolam|mesh-list
139169674|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
139169675|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139169676|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169677|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169678|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139169679|NCT03918889|Analgesics|analgesics|mesh-ancestor
139169680|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
139169681|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169682|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139169683|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139169684|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139169685|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
139169686|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169687|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169688|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139169689|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139169690|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139169691|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139169692|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139169693|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
139169694|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
139169695|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
139169696|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
139169697|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
139169698|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139169699|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169700|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139169701|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169702|NCT03739801|Irinotecan|irinotecan|mesh-list
139169703|NCT03739801|Ramucirumab|ramucirumab|mesh-list
139169704|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139169705|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139169706|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169707|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169708|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169709|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
139169710|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139169711|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169712|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
139169713|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139169714|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139169715|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139169716|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139169717|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169718|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
139169719|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169720|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169721|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139169722|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169723|NCT02297854|Valganciclovir|valganciclovir|mesh-list
139169724|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
139169725|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169726|NCT03511768|Octreotide|octreotide|mesh-list
139169727|NCT03511768|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
139169728|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139169729|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139169730|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169731|NCT03511768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139169732|NCT03511768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169733|NCT01134991|Minocycline|minocycline|mesh-list
139169734|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139169735|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169736|NCT03515200|Cytarabine|cytarabine|mesh-list
139169737|NCT03515200|Dexamethasone|dexamethasone|mesh-list
139169738|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
139169739|NCT03515200|Doxorubicin|doxorubicin|mesh-list
139169740|NCT03515200|Methotrexate|methotrexate|mesh-list
139169741|NCT03515200|Bortezomib|bortezomib|mesh-list
139169742|NCT03515200|Dasatinib|dasatinib|mesh-list
139169743|NCT03515200|Palbociclib|palbociclib|mesh-list
139169744|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139169745|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
139169746|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
139169747|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169748|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169749|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139169750|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
139169751|NCT03515200|Hormones|hormones|mesh-ancestor
139169752|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139169753|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139169754|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169755|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139169756|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139169757|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139169758|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169759|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169760|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139169761|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
139169762|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139169763|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139169764|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
139169765|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
139169766|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139169767|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139169768|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
139169769|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139169770|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139169771|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
139169772|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169773|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139169774|NCT03918265|Tacrolimus|tacrolimus|mesh-list
139169775|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139169776|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
139169777|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169778|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139169779|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169780|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169781|NCT03920839|Paclitaxel|paclitaxel|mesh-list
139169782|NCT03920839|Carboplatin|carboplatin|mesh-list
139169783|NCT03920839|Gemcitabine|gemcitabine|mesh-list
139169784|NCT03920839|Pemetrexed|pemetrexed|mesh-list
139169785|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139169786|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169787|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
139169788|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
139169789|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
139169790|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169791|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139169792|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
139169793|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169794|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139169795|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139169796|NCT02301130|Durvalumab|durvalumab|mesh-list
139169797|NCT02301130|Tremelimumab|tremelimumab|mesh-list
139169798|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
139169799|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139169800|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139169801|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169802|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
139169803|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169804|NCT03920605|Tenofovir|tenofovir|mesh-list
139169805|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139169806|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139169808|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169809|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139169810|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139169811|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169812|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169813|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139169814|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139169815|NCT02301208|Nedaplatin|nedaplatin|mesh-list
139169816|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897700|NCT02976935|Xenon|xenon|mesh-list
139169817|NCT02298010|Capecitabine|capecitabine|mesh-list
139169818|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
139169819|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138920252|NCT04115423|Analgesics|analgesics|mesh-ancestor
139169820|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
139169821|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169823|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
139169824|NCT01229605|Docetaxel|docetaxel|mesh-list
139169825|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139169826|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
139169827|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169828|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139169829|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139169830|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
139169831|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169832|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169833|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139169834|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
139169835|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
139169836|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
139169837|NCT01319006|Glycine|glycine|mesh-list
139169838|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
139169839|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169840|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169841|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169842|NCT01358240|Econazole|econazole|mesh-list
139169843|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
139169844|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169845|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139169846|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139169847|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169848|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169849|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139169850|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
139169851|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139169852|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169853|NCT01131949|Lamotrigine|lamotrigine|mesh-list
139169854|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
139169855|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139169856|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139169857|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169858|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139169859|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169860|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139169861|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139169862|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169863|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139169864|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139169865|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
139169866|NCT03511222|Nivolumab|nivolumab|mesh-list
139169867|NCT03511222|Vorolanib|vorolanib|mesh-list
139169868|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139169869|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139169870|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139169871|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019590|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
139169872|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139169873|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169875|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139169876|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139169877|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139169878|NCT01230463|Analgesics|analgesics|mesh-ancestor
139169879|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
139169880|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169881|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169882|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139169883|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139169884|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139169885|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169886|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169887|NCT01358396|Chrysarobin|chrysarobin|mesh-list
139169888|NCT01358396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139169889|NCT01358396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139169890|NCT01358396|Analgesics|analgesics|mesh-ancestor
139169891|NCT01358396|Sensory System Agents|sensory system agents|mesh-ancestor
139169892|NCT01358396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169893|NCT01358396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169895|NCT01358396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139169896|NCT01135615|Calcium|calcium|mesh-list
139169897|NCT01135615|Sevelamer|sevelamer|mesh-list
139169898|NCT01135615|Calcium acetate|calcium acetate|mesh-list
139169899|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139169900|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169901|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
139169902|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
139169903|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169904|NCT01361516|Anesthetics|anesthetics|mesh-list
139169905|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169906|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169907|NCT03920137|Nicotine|nicotine|mesh-list
139169908|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139169909|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
139169910|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169911|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169912|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139169913|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139169914|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
139169915|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169916|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169917|NCT03132610|Andrographolide|andrographolide|mesh-list
139169918|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139169919|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139169920|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139169921|NCT03132610|Analgesics|analgesics|mesh-ancestor
139169922|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
139169923|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169924|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169925|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139169926|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139169927|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139169928|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169929|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
139169930|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139169931|NCT02298088|Clopidogrel|clopidogrel|mesh-list
139169932|NCT02298088|Ticagrelor|ticagrelor|mesh-list
139169933|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139169934|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139169935|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139169936|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139169937|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
139169938|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169939|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169940|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169941|NCT01133119|Bupivacaine|bupivacaine|mesh-list
139169942|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
139169943|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
139169944|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169945|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169946|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
139169947|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169948|NCT01230541|Udenafil|udenafil|mesh-list
139169949|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139169951|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169952|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169953|NCT01229761|Trimethoprim|trimethoprim|mesh-list
139169954|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139169955|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
139169956|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139169957|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139169958|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
139169959|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139169960|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139169961|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139169962|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169963|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169964|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139169965|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139169966|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139169967|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139169968|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
139169969|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
139169971|NCT03514810|Sertraline|sertraline|mesh-list
139169972|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
139169973|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139169974|NCT03514810|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139169975|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139169976|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139169977|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139169978|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139169979|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
139169980|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169981|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139169982|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139169983|NCT03514810|Analgesics|analgesics|mesh-ancestor
139169984|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
139169985|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139169986|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139169987|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139169988|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139169989|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139169990|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
139169991|NCT02301676|Propofol|propofol|mesh-list
139169992|NCT02301676|Sevoflurane|sevoflurane|mesh-list
139169993|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139169994|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139169995|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139169996|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139169997|NCT02301676|Analgesics|analgesics|mesh-ancestor
139169998|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
139169999|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170000|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139170001|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139170002|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139170003|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
139170004|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139170005|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170006|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139170007|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
139170008|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
139170009|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139170010|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139170011|NCT01135771|Insulin|insulin|mesh-list
139170012|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139170013|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170014|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
139170015|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139170016|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139170017|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139170018|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170019|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
139170020|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139170021|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170022|NCT01135927|Insulin|insulin|mesh-list
139170023|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139170024|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
139170025|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139170026|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170027|NCT02301910|Tenecteplase|tenecteplase|mesh-list
139170028|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139170029|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139170030|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170031|NCT01585753|Maraviroc|maraviroc|mesh-list
139170032|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139170033|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139170034|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170035|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139170036|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139170037|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
139170038|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170039|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139170040|NCT01136005|Provitamins|provitamins|mesh-list
139170041|NCT01136005|Vitamins|vitamins|mesh-ancestor
139170042|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
139170043|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170044|NCT03509740|Acetaminophen|acetaminophen|mesh-list
139170045|NCT03509740|Tramadol|tramadol|mesh-list
139170046|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139170047|NCT03509740|Analgesics|analgesics|mesh-ancestor
139170048|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
139170049|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170050|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170051|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
139170052|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139170053|NCT03509740|Narcotics|narcotics|mesh-ancestor
139170054|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139170055|NCT03918187|Midazolam|midazolam|mesh-list
139170056|NCT03918187|Nalbuphine|nalbuphine|mesh-list
139170057|NCT03918187|Bupivacaine|bupivacaine|mesh-list
139170058|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
139170059|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
139170060|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139170061|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170062|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
139170063|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170064|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138963209|NCT05227716|Tocolytic Agents|tocolytic agents|mesh-ancestor
139170065|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139170066|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139170067|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139170068|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139170069|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139170070|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
139170071|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
139170072|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
139170073|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139170074|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170075|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139170076|NCT03918187|Narcotics|narcotics|mesh-ancestor
139170077|NCT03918187|Analgesics|analgesics|mesh-ancestor
139170078|NCT03507634|Lidocaine|lidocaine|mesh-list
139170079|NCT03507634|Fentanyl|fentanyl|mesh-list
139170080|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
139170081|NCT03507634|Remifentanil|remifentanil|mesh-list
139170082|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
139170083|NCT03507634|Anesthetics|anesthetics|mesh-list
139170084|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
139170085|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139170086|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170087|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
139170088|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170089|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139170090|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139170091|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139170092|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139170093|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170094|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139170095|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139170096|NCT03507634|Analgesics|analgesics|mesh-ancestor
139170097|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139170098|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139170099|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139170100|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
139170101|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139170102|NCT03507634|Narcotics|narcotics|mesh-ancestor
139170103|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139170104|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139170105|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
139170106|NCT03507556|Metronidazole|metronidazole|mesh-list
139170107|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
139170108|NCT03507556|Minocycline|minocycline|mesh-list
139170109|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
139170110|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170111|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139170112|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139170113|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139170114|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139170115|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138920551|NCT02604719|Coagulants|coagulants|mesh-ancestor
139170116|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170117|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170118|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170119|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139170120|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139170121|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
139170122|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
139170123|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139170124|NCT03507556|Protective Agents|protective agents|mesh-ancestor
139170125|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170126|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
139170127|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139170129|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170130|NCT01232257|Expectorants|expectorants|mesh-ancestor
139170131|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
139170132|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139170133|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
139170134|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170135|NCT01232257|Protective Agents|protective agents|mesh-ancestor
139170136|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170137|NCT01232257|Antidotes|antidotes|mesh-ancestor
139170138|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
139170139|NCT03509662|Thiamine|thiamine|mesh-list
139170140|NCT03509662|Vitamins|vitamins|mesh-ancestor
139170141|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
139170142|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170143|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
139170144|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170145|NCT03509662|Protective Agents|protective agents|mesh-ancestor
139170146|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
139170147|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
139170148|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139170149|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170150|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139170151|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139170152|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170153|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170154|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170155|NCT01133431|Glimepiride|glimepiride|mesh-list
139170156|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139170157|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139170158|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170159|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139170160|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
139170161|NCT05610007|Prilocaine|prilocaine|mesh-list
139170162|NCT05610007|Anesthetics, Local|anesthetics, local|mesh-ancestor
139170163|NCT05610007|Anesthetics|anesthetics|mesh-ancestor
139170164|NCT05610007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139170165|NCT05610007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170166|NCT05610007|Sensory System Agents|sensory system agents|mesh-ancestor
139170167|NCT05610007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170168|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
138897884|NCT02683733|Curcumin|curcumin|mesh-list
139170169|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
139170170|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139170171|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170172|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139170173|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139170174|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170175|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170176|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170177|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170178|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139170179|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139170180|NCT02303782|Azacitidine|azacitidine|mesh-list
139170181|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139170182|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
139170183|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170184|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170185|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170186|NCT01233505|Capecitabine|capecitabine|mesh-list
139170187|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
139170188|NCT01233505|Veliparib|veliparib|mesh-list
139170189|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139170190|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
139170191|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170192|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170193|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139170194|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170195|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
139170196|NCT04925180|Cyproterone|cyproterone|mesh-list
139170197|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
139170198|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
139170199|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139170200|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170201|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170202|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139170203|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
139170204|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139170205|NCT01133509|Vaccines|vaccines|mesh-list
139170206|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
139170207|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170208|NCT02306902|Fenofibrate|fenofibrate|mesh-list
139170209|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139170210|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
139170211|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170212|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139170213|NCT01230697|Sorafenib|sorafenib|mesh-list
139170214|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170215|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139170216|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170217|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170218|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139170219|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
139170220|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139170221|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
139170222|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170223|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170224|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139170225|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
139170226|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139170227|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139170228|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139170229|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
139170230|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963254|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
139170231|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170232|NCT01230775|Anagrelide|anagrelide|mesh-list
139170233|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139170234|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139170235|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170236|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139170237|NCT01136317|Omeprazole|omeprazole|mesh-list
139170238|NCT01136317|Rabeprazole|rabeprazole|mesh-list
139170239|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139170240|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139170241|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139170243|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170244|NCT03507244|Dexamethasone|dexamethasone|mesh-list
139170245|NCT03507244|Pemetrexed|pemetrexed|mesh-list
139170246|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170247|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
139170248|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
139170249|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170250|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170251|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139170252|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
139170253|NCT03507244|Hormones|hormones|mesh-ancestor
139170254|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139170255|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139170256|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170257|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170258|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170259|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139170260|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139170261|NCT01136395|Rituximab|rituximab|mesh-list
139170262|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139170263|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170264|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
138920705|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139170265|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170266|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139170267|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
139170268|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139170269|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139170270|NCT02304094|Prednisolone|prednisolone|mesh-list
139170271|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
139170272|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139170273|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
139170274|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170275|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
139170276|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
139170277|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170278|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170279|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139170280|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
139170281|NCT02304094|Hormones|hormones|mesh-ancestor
139170282|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139170283|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139170284|NCT02304094|Protective Agents|protective agents|mesh-ancestor
138963280|NCT04907539|Denosumab|denosumab|mesh-list
139170285|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139170286|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170287|NCT03507166|Trastuzumab|trastuzumab|mesh-list
139170288|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139170289|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170290|NCT01233583|Adalimumab|adalimumab|mesh-list
139170291|NCT01233583|Infliximab|infliximab|mesh-list
139170292|NCT01233583|Etanercept|etanercept|mesh-list
139170293|NCT01233583|Acitretin|acitretin|mesh-list
139170294|NCT01233583|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139170295|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170296|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139170297|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
139170298|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139170299|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139170300|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139170301|NCT01233583|Analgesics|analgesics|mesh-ancestor
139170302|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
139170303|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170304|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170305|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139170306|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
139170307|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
139170308|NCT02304250|Dexamethasone|dexamethasone|mesh-list
139170309|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170310|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
139170311|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
139170312|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897971|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
139170313|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540525|NCT00055523|Adalimumab|adalimumab|mesh-list
139170314|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139170315|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
139170316|NCT02304250|Hormones|hormones|mesh-ancestor
139170317|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139170318|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139170319|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170320|NCT01136551|Huperzine A|huperzine a|mesh-list
139170321|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139170322|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170323|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170324|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
139170325|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139170326|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170327|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139170328|NCT01136551|Protective Agents|protective agents|mesh-ancestor
139170329|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
139170330|NCT03132142|Capsaicin|capsaicin|mesh-list
139170331|NCT03132142|Menthol|menthol|mesh-list
139170332|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
139170333|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
139170334|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
139170335|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170336|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170337|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139170338|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170339|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139170340|NCT03132142|Protective Agents|protective agents|mesh-ancestor
139170341|NCT01232647|Vitamins|vitamins|mesh-list
138920798|NCT04033263|Fluorides|fluorides|mesh-list
139170342|NCT01232647|Vitamin K|vitamin k|mesh-list
139170343|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
139170345|NCT01232647|Menatetrenone|menatetrenone|mesh-list
139170346|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
139170347|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170348|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139170349|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139170350|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170351|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
139170352|NCT01232647|Coagulants|coagulants|mesh-ancestor
139170353|NCT03917095|Mesalamine|mesalamine|mesh-list
139170354|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139170355|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139170356|NCT03917095|Analgesics|analgesics|mesh-ancestor
139170357|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
139170358|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170359|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170360|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170361|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139170362|NCT01133743|Thalidomide|thalidomide|mesh-list
139170363|NCT01133743|Dexamethasone|dexamethasone|mesh-list
139170364|NCT01133743|Lenalidomide|lenalidomide|mesh-list
139170365|NCT01133743|Immunomodulating Agents|immunomodulating agents|mesh-list
139170366|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170367|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
139170368|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
139170369|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170370|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170371|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139170372|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
139170373|NCT01133743|Hormones|hormones|mesh-ancestor
139170374|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139170375|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139170376|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170377|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
139170378|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139170379|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139170380|NCT01133743|Growth Substances|growth substances|mesh-ancestor
139170381|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
139170382|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139170383|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
139170384|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139170385|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170386|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139170387|NCT01138423|Moxonidine|moxonidine|mesh-list
139170388|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139170389|NCT01138423|Diuretics|diuretics|mesh-ancestor
139170390|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
139170391|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170392|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139170393|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139170394|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170395|NCT01136863|Felodipine|felodipine|mesh-list
139170396|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139170397|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139170398|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139170399|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139170400|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170401|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139170402|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170403|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
139170404|NCT03961516|Pancrelipase|pancrelipase|mesh-list
139170405|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139170406|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
139170407|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139170408|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139170409|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139170410|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139170411|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170412|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
139170413|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139170414|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170415|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139170416|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170417|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
139170419|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139170420|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170421|NCT03504280|Vitamins|vitamins|mesh-ancestor
139170422|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
139170423|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139170424|NCT03504202|Trimetazidine|trimetazidine|mesh-list
139170425|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
139170426|NCT01136941|Zileuton|zileuton|mesh-list
139170427|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139170428|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139170429|NCT01136941|Analgesics|analgesics|mesh-ancestor
139170430|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
139170431|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170432|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170433|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170434|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139170435|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139170436|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170437|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170438|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139170439|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
139170440|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139170441|NCT01232803|Tenofovir|tenofovir|mesh-list
139170442|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
139170443|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170444|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139170445|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139170446|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170447|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170448|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139170449|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139170450|NCT03504046|Pancrelipase|pancrelipase|mesh-list
139170451|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139170452|NCT01139203|Lamivudine|lamivudine|mesh-list
139170453|NCT01139203|Adefovir|adefovir|mesh-list
139170454|NCT01139203|Entecavir|entecavir|mesh-list
139170455|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139170456|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139170457|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170458|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170459|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
139170460|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170461|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139170462|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139170463|NCT05187715|Simvastatin|simvastatin|mesh-list
139170464|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139170465|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139170466|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
139170467|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170468|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139170469|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139170470|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170471|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
139170472|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139170473|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139170474|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170476|NCT02312440|Coagulants|coagulants|mesh-ancestor
139170477|NCT01137019|Everolimus|everolimus|mesh-list
139170478|NCT01137019|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139170479|NCT01137019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139170480|NCT01137019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170481|NCT01137019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170482|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139170483|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
139170484|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170485|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170486|NCT03508804|Lidocaine|lidocaine|mesh-list
139170487|NCT03508804|Prilocaine|prilocaine|mesh-list
139170488|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139170489|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
139170490|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
139170491|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139170492|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170493|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
139170494|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170495|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139170496|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139170497|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139170498|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139170499|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170500|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139170501|NCT01231165|Aspirin|aspirin|mesh-list
139170502|NCT01231165|Amiloride|amiloride|mesh-list
139170503|NCT01231165|Clopidogrel|clopidogrel|mesh-list
139170504|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139170505|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139170506|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139170507|NCT01231165|Analgesics|analgesics|mesh-ancestor
139170508|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
139170509|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170510|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170511|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170512|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139170513|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139170514|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139170515|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170516|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139170517|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139170518|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170519|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
139170520|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139170521|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139170522|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139170523|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
139170524|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139170525|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139170526|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139170527|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
139170528|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139170529|NCT01231165|Diuretics|diuretics|mesh-ancestor
139170530|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
138955329|NCT04050436|Cemiplimab|cemiplimab|mesh-list
139170531|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139170532|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139170533|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139170534|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139170535|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139170536|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139170537|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139170538|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170539|NCT03503890|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
139170540|NCT03503890|Immunoconjugates|immunoconjugates|mesh-ancestor
139170541|NCT03503890|Immunologic Factors|immunologic factors|mesh-ancestor
139170542|NCT03503890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170544|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170545|NCT03506620|Ropivacaine|ropivacaine|mesh-list
139170546|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
139170547|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
139170548|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139170549|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170550|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
139170551|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170552|NCT02305030|Opicapone|opicapone|mesh-list
139170553|NCT02305030|Warfarin|warfarin|mesh-list
139170554|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
139170555|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139170556|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170557|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170558|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139170559|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139170560|NCT01139437|Vaccines|vaccines|mesh-list
139170561|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
139170562|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170563|NCT01137253|Trimethaphan|trimethaphan|mesh-list
139170564|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
139170565|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139170566|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139170567|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
139170568|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
139170569|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170570|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170571|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139170572|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139170573|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
139170574|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139170575|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170576|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
139170577|NCT05493163|Fibrinolytic Agents|fibrinolytic agents|mesh-list
139170578|NCT05493163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139170579|NCT05493163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170580|NCT03506542|Mitomycins|mitomycins|mesh-list
139170581|NCT03506542|Mitomycin|mitomycin|mesh-list
139170582|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139170583|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170584|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
139170585|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170586|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139170587|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170588|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
139170589|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139170590|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170591|NCT02305186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139170592|NCT02305186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170593|NCT02312908|Clonazepam|clonazepam|mesh-list
139170594|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
139170595|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
139170596|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
139170597|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139170598|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170599|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170600|NCT02308930|Vitamin D|vitamin d|mesh-list
139170601|NCT02308930|Vitamins|vitamins|mesh-list
139170602|NCT02308930|Vitamin A|vitamin a|mesh-list
139170603|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
139170604|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
139170605|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170606|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
139170607|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170608|NCT02308930|Protective Agents|protective agents|mesh-ancestor
139170609|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139170610|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170611|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139170612|NCT01139671|Remifentanil|remifentanil|mesh-list
139170613|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139170614|NCT01139671|Narcotics|narcotics|mesh-ancestor
139170615|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139170616|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170617|NCT01139671|Analgesics|analgesics|mesh-ancestor
139170618|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
139170619|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170620|NCT02313064|CXA-10|cxa-10|mesh-list
139170621|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170622|NCT01234051|Docetaxel|docetaxel|mesh-list
139170623|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
139170624|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170625|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
139170626|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
139170627|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
139170628|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170629|NCT03341962|Calcium|calcium|mesh-list
139170630|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139170631|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170632|NCT01234597|Insulin|insulin|mesh-list
139170633|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139170634|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
139170635|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
139170636|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139170637|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170638|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
139170639|NCT02313220|Exenatide|exenatide|mesh-list
139170640|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139170641|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170642|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139170643|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170644|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139170646|NCT02313220|Hormones|hormones|mesh-ancestor
139170647|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139170648|NCT02309320|Gontivimab|gontivimab|mesh-list
139170649|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
139170650|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170651|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
139170652|NCT01139749|Ciclopirox|ciclopirox|mesh-list
139170653|NCT01139749|Salicylates|salicylates|mesh-list
139170654|NCT01139749|Isotretinoin|isotretinoin|mesh-list
139170655|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
139170656|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170657|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
139170658|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
139170659|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139170660|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139170661|NCT01139749|Analgesics|analgesics|mesh-ancestor
139170662|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
139170663|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170664|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170665|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170666|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139170667|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139170668|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170669|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170670|NCT02305810|Everolimus|everolimus|mesh-list
139170671|NCT02305810|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139170672|NCT02305810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139170673|NCT02305810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170674|NCT02305810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170675|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139170676|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
139170677|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170678|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170680|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139170681|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170682|NCT01139905|Ritonavir|ritonavir|mesh-list
139170683|NCT01139905|Lopinavir|lopinavir|mesh-list
139170684|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139170685|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139170686|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
139170687|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170688|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170689|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139170690|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139170691|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
139170692|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170693|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139170694|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139170695|NCT05044429|Lidocaine|lidocaine|mesh-list
139170696|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
139170697|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
139170698|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139170699|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170700|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
139170701|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170702|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139170703|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139170704|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139170705|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139170706|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170707|NCT02309554|Nonoxynol|nonoxynol|mesh-list
139170708|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
139170709|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
139170710|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963387|NCT04030000|Paclitaxel|paclitaxel|mesh-list
139170711|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139170712|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
139170713|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139170714|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139170715|NCT01143025|Ropivacaine|ropivacaine|mesh-list
139170716|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
139170717|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
139170718|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139170719|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170720|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
139170721|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170723|NCT03502642|Ropivacaine|ropivacaine|mesh-list
139170724|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
139170725|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139170726|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170727|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139170728|NCT03502642|Narcotics|narcotics|mesh-ancestor
139170729|NCT03502642|Analgesics|analgesics|mesh-ancestor
139170730|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
139170731|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170732|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
139170734|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170735|NCT02306278|Analgesics|analgesics|mesh-ancestor
139170736|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
139170737|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170738|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
139170739|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139170740|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139170741|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139170742|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139170743|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139170744|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139170745|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139170746|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170747|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
139170748|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
139170749|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139170750|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170751|NCT02313922|Etanercept|etanercept|mesh-list
139170752|NCT02313922|Methotrexate|methotrexate|mesh-list
139170753|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139170754|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
139170755|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139170756|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170757|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139170758|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
139019591|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
139170759|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170760|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170761|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
139170762|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170763|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139170764|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139170765|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
139170766|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139170767|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139170768|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139170769|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139170770|NCT02313922|Analgesics|analgesics|mesh-ancestor
139170771|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
139170772|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170773|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170774|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139170775|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139170776|NCT03508102|Remifentanil|remifentanil|mesh-list
139170777|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139170778|NCT03508102|Narcotics|narcotics|mesh-ancestor
139170779|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139170780|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170781|NCT03508102|Analgesics|analgesics|mesh-ancestor
139170782|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
139170783|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170784|NCT03505528|Paclitaxel|paclitaxel|mesh-list
139170785|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139170786|NCT03505528|Phenelzine|phenelzine|mesh-list
139170787|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139170788|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170789|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
139170790|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
139170791|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
139170792|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170793|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
139170794|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139170795|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139170796|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170797|NCT01234285|Heparin|heparin|mesh-list
139170798|NCT01234285|Calcium heparin|calcium heparin|mesh-list
139170799|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
139170800|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139170801|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139170802|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170803|NCT02314312|Cyclosporine|cyclosporine|mesh-list
139170804|NCT02314312|Prednisolone|prednisolone|mesh-list
139170805|NCT02314312|Everolimus|everolimus|mesh-list
139170806|NCT02314312|Cyclosporins|cyclosporins|mesh-list
139170807|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170808|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170809|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139170810|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
139170811|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170812|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
139170813|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170814|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
139170815|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139170816|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139170817|NCT02314312|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139170818|NCT02314312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139170819|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170820|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170821|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
139170822|NCT02314312|Hormones|hormones|mesh-ancestor
139170823|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139170824|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139170825|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139170826|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139170827|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
139170828|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139170829|NCT02310490|Mannitol|mannitol|mesh-list
139170830|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139170831|NCT02310490|Diuretics|diuretics|mesh-ancestor
139170832|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
139170833|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170835|NCT02316496|Cetuximab|cetuximab|mesh-list
139170836|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139170837|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139170838|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170839|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170840|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170841|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139170842|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
139170843|NCT01140529|Haloperidol|haloperidol|mesh-list
139170844|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
139170845|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139170846|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139170847|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170848|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139170849|NCT01140529|Analgesics|analgesics|mesh-ancestor
139170850|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
139170851|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170852|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139170853|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139170854|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139170855|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
139170856|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139170857|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170858|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
139170859|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
139170860|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139170861|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139170862|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139170863|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139170864|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139170865|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
139170866|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139170867|NCT01141153|Aspirin|aspirin|mesh-list
139170868|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
139170869|NCT01141153|Clopidogrel|clopidogrel|mesh-list
139170870|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138921313|NCT00755846|Alogliptin|alogliptin|mesh-list
139170871|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139170872|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139170873|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139170874|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
139170875|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139170876|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170877|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170878|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139170879|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139170880|NCT01141153|Analgesics|analgesics|mesh-ancestor
139170881|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
139170882|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170883|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170884|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139170885|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139170887|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139170888|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170889|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
139170890|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
139170891|NCT01235143|Sevoflurane|sevoflurane|mesh-list
139170893|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139170894|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139170895|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
139170896|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
139170897|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138963437|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
139170898|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170899|NCT01238029|Capecitabine|capecitabine|mesh-list
139170900|NCT01238029|Vinorelbine|vinorelbine|mesh-list
139170901|NCT01238029|Lapatinib|lapatinib|mesh-list
139170902|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139170903|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
139170904|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170905|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170906|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139170907|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
139170908|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
139170909|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
139170910|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139170911|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170912|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
139170913|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139170914|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139170915|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170916|NCT03139604|Prednisone|prednisone|mesh-list
139170917|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
139170918|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138898360|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139170919|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139170920|NCT03139604|Prednisolone|prednisolone|mesh-list
139170921|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
139170922|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139170923|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
139170924|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170925|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
139170926|NCT03139604|Hormones|hormones|mesh-ancestor
139170927|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139170928|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170929|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139170930|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139170931|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
139170932|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
139170933|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170934|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139170935|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139170936|NCT03139604|Protective Agents|protective agents|mesh-ancestor
139170937|NCT01350596|Ibuprofen|ibuprofen|mesh-list
139170938|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139170939|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139170940|NCT01350596|Analgesics|analgesics|mesh-ancestor
139170941|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
139170942|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170943|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170944|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170945|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139170946|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139170947|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170948|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170950|NCT04462822|Xhance|xhance|mesh-list
139170951|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139170952|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139170953|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170954|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139170955|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
139170956|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170957|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170958|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138898378|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139170959|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
139170960|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
139170961|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138541161|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
139170962|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139170963|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139170965|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
139170966|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139170967|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170968|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
139170969|NCT04462822|Hormones|hormones|mesh-ancestor
139170970|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139170971|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
139170972|NCT01362218|Aspirin|aspirin|mesh-list
139170973|NCT01362218|Ramipril|ramipril|mesh-list
139170974|NCT01362218|Simvastatin|simvastatin|mesh-list
139170975|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139170976|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139170977|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
139170978|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139170979|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139170980|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139170981|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139170982|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139170983|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139170984|NCT01362218|Analgesics|analgesics|mesh-ancestor
139170985|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
139170986|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139170987|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139170988|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139170989|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139170990|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139170991|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139170992|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139170993|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139170994|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
138898410|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139170995|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139170996|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
139170997|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139170998|NCT02316964|Aldesleukin|aldesleukin|mesh-list
139170999|NCT02316964|Decitabine|decitabine|mesh-list
139171000|NCT02316964|Azacitidine|azacitidine|mesh-list
139171001|NCT02316964|Interleukin-2|interleukin-2|mesh-list
139171002|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139171003|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
139171004|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171005|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171006|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171007|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139171008|NCT02316964|Analgesics|analgesics|mesh-ancestor
139171009|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
139171010|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171011|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171012|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139171013|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139171014|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
139171015|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171016|NCT02875340|Risperidone|risperidone|mesh-list
139171017|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139171018|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
139171019|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921459|NCT00769184|Clobetasol|clobetasol|mesh-list
139171020|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171021|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171022|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139171023|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139171024|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171025|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139171026|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139171027|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
139171028|NCT04462666|Etoricoxib|etoricoxib|mesh-list
139171029|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139171030|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139171031|NCT04462666|Analgesics|analgesics|mesh-ancestor
139171032|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
139171033|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171034|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171035|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139171036|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139171037|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139171038|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139171039|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171040|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171041|NCT01359020|Acetaminophen|acetaminophen|mesh-list
139171043|NCT01359020|Ibuprofen|ibuprofen|mesh-list
139171044|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139171045|NCT01359020|Analgesics|analgesics|mesh-ancestor
139171046|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
139171047|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171048|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171049|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
139171050|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139171051|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139171052|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139171053|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139171054|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171055|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171056|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
139171057|NCT01359098|Dexamethasone|dexamethasone|mesh-list
139171058|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139171059|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
139171060|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
139171061|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171062|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171063|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139171064|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
139171065|NCT01359098|Hormones|hormones|mesh-ancestor
139171066|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139171067|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139171068|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171069|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171070|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171071|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139171072|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171073|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139171074|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139171075|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139171076|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139171077|NCT01319240|Insulin|insulin|mesh-list
139171078|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139171079|NCT01319240|Liraglutide|liraglutide|mesh-list
139171080|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
139171081|NCT01319240|Xultophy|xultophy|mesh-list
139171082|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139171083|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171084|NCT01319240|Incretins|incretins|mesh-ancestor
139171085|NCT01319240|Hormones|hormones|mesh-ancestor
139171086|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139171087|NCT04463056|Eculizumab|eculizumab|mesh-list
139171088|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139171089|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139171090|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
139171091|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171092|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
139171093|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139171094|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139171095|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171096|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
139171097|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171098|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171099|NCT03319316|Durvalumab|durvalumab|mesh-list
139171100|NCT03319316|Tremelimumab|tremelimumab|mesh-list
139171101|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139171102|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171103|NCT02316028|Decitabine|decitabine|mesh-list
139171104|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139171105|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
139171106|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171107|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171108|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171110|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
139171111|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139171112|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171113|NCT01141465|Fluticasone|fluticasone|mesh-list
139171114|NCT01141465|Xhance|xhance|mesh-list
139171115|NCT01141465|Budesonide|budesonide|mesh-list
139171116|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
139171117|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139171118|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139171119|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139171120|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139171121|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139171122|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
139171123|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171124|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171125|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139171126|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
139171127|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
139171128|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139171129|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
139171130|NCT01141465|Hormones|hormones|mesh-ancestor
139171131|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963488|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
139171132|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139171134|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139171135|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
139171136|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171137|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171138|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
139171139|NCT01141543|Plerixafor|plerixafor|mesh-list
139171140|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139171141|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139171142|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
139171143|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171144|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139171145|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139171146|NCT03300518|Estradiol|estradiol|mesh-list
139171147|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139171148|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139171149|NCT03300518|Ganirelix|ganirelix|mesh-list
139171150|NCT03300518|Estrogens|estrogens|mesh-ancestor
139171151|NCT03300518|Hormones|hormones|mesh-ancestor
139171152|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139171153|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171154|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139171155|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
139171156|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139171157|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139171158|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
139171159|NCT02317198|Clopidogrel|clopidogrel|mesh-list
139171160|NCT02317198|Ticagrelor|ticagrelor|mesh-list
139171161|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139171162|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139171163|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139171164|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139171165|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139171166|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
139171167|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171168|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171169|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921601|NCT00753506|Artemisinins|artemisinins|mesh-list
139171171|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139171172|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
139171173|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171174|NCT01359722|Expectorants|expectorants|mesh-ancestor
139171175|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
139171176|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139171177|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
139171178|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171179|NCT01359722|Protective Agents|protective agents|mesh-ancestor
139171180|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171181|NCT01359722|Antidotes|antidotes|mesh-ancestor
139171182|NCT01238185|Aspirin|aspirin|mesh-list
139171183|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139171184|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139171185|NCT01238185|Analgesics|analgesics|mesh-ancestor
139171186|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
139171187|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171188|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171189|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139171190|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139171191|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139171192|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139171193|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171194|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138963511|NCT03418649|Eplerenone|eplerenone|mesh-list
139171195|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139171196|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171197|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
139171198|NCT01143805|Tofacitinib|tofacitinib|mesh-list
139171199|NCT01143805|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139171200|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139171201|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171202|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171203|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
139171204|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171205|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139171206|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171207|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171208|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
139171209|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139171210|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171211|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139171212|NCT03498118|Bupivacaine|bupivacaine|mesh-list
139171213|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
139171214|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
139171215|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171216|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171217|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
139171218|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171219|NCT05188742|Mirabegron|mirabegron|mesh-list
139171220|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139171221|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139171222|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139171223|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
139171224|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171225|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171226|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171227|NCT05188742|Urological Agents|urological agents|mesh-ancestor
139171228|NCT02324452|Capecitabine|capecitabine|mesh-list
139171229|NCT02324452|Fluorouracil|fluorouracil|mesh-list
139171230|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139171231|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
139171232|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171233|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171234|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139171235|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
139171236|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171237|NCT02321176|Resveratrol|resveratrol|mesh-list
139171238|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
139171239|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171240|NCT02321176|Protective Agents|protective agents|mesh-ancestor
139171241|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171242|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171243|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139171244|NCT01351298|Lidocaine|lidocaine|mesh-list
139171245|NCT01351298|Xylometazoline|xylometazoline|mesh-list
139171246|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
139171247|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
139171248|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171249|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171250|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
139171251|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171252|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139171253|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139171254|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139171255|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139171256|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171257|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
139171258|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139171259|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
139171260|NCT02324686|Vitamin K|vitamin k|mesh-list
139171261|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
139171262|NCT02324686|Vitamins|vitamins|mesh-ancestor
139171263|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
139171264|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171265|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139171266|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139171267|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171268|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
139171269|NCT02324686|Coagulants|coagulants|mesh-ancestor
139171270|NCT01360034|Indomethacin|indomethacin|mesh-list
139171271|NCT01360034|Nifedipine|nifedipine|mesh-list
139171272|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139171273|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139171274|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171275|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139171276|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171277|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
139171278|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
139171279|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139171280|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139171281|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139171282|NCT01360034|Analgesics|analgesics|mesh-ancestor
139171283|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
139171284|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171285|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139171286|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139171287|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
139171288|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139171289|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171290|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139171291|NCT01363310|Escitalopram|escitalopram|mesh-list
139171292|NCT01363310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139171293|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139171294|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139171295|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171296|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171297|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
139171298|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171299|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
139171300|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139171301|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139171302|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139171303|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171304|NCT01363544|Methylphenidate|methylphenidate|mesh-list
139171305|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139171306|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171307|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139171308|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139171309|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139171310|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171311|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
139171313|NCT03257618|Temozolomide|temozolomide|mesh-list
139171314|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139171315|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
139171316|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171317|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171319|NCT01363778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139171320|NCT01363778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171321|NCT01363778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171322|NCT04175834|Cetirizine|cetirizine|mesh-list
139171323|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-list
139171324|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139171325|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139171326|NCT04175834|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139171327|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
139171328|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171329|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171330|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171331|NCT02324998|Olaparib|olaparib|mesh-list
139171332|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139171333|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171334|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171335|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171336|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
139171337|NCT03500848|Sirolimus|sirolimus|mesh-list
139171338|NCT03500848|Tacrolimus|tacrolimus|mesh-list
139171339|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139171340|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
139171341|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171342|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139171343|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171344|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171345|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139171346|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171347|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139171348|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
139171349|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139171350|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171351|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
139171352|NCT01360190|Fluoxetine|fluoxetine|mesh-list
139171353|NCT01360190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139171354|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139171355|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139171356|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171357|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171358|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
139171359|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171360|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139171361|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
139171362|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139171363|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139171364|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139171365|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171367|NCT01363934|Hematinics|hematinics|mesh-ancestor
139171368|NCT03132376|Caseins|caseins|mesh-list
139171369|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
139171370|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
139171371|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171372|NCT01364012|Paclitaxel|paclitaxel|mesh-list
139171373|NCT01364012|Bevacizumab|bevacizumab|mesh-list
139171374|NCT01364012|Carboplatin|carboplatin|mesh-list
139171375|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139171376|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171377|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
139171378|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
139171379|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
139171380|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171381|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139171382|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139171383|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139171384|NCT01364012|Growth Substances|growth substances|mesh-ancestor
139171385|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171386|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
139171387|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139171388|NCT02318056|Bacitracin|bacitracin|mesh-list
139171389|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139171390|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171391|NCT02318056|Laxatives|laxatives|mesh-ancestor
139171392|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139171393|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139171394|NCT01360424|Teriparatide|teriparatide|mesh-list
139171395|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139171396|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171397|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139171398|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
139171399|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139171400|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171401|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
139171402|NCT01364402|Hematinics|hematinics|mesh-ancestor
139171403|NCT03552380|Nivolumab|nivolumab|mesh-list
139171404|NCT03552380|Ipilimumab|ipilimumab|mesh-list
139171405|NCT03552380|Entinostat|entinostat|mesh-list
139171406|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139171407|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171408|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139171409|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171410|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139171411|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171412|NCT02318290|Analgesics|analgesics|mesh-list
139171413|NCT02318290|Narcotics|narcotics|mesh-list
139171414|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
139171415|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171416|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171417|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171418|NCT03467360|Etoposide|etoposide|mesh-list
139171419|NCT03467360|Acetazolamide|acetazolamide|mesh-list
139171420|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139171421|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171422|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139171423|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139171424|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171425|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171426|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
139171427|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139171429|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
139171430|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171431|NCT03452072|Timolol|timolol|mesh-list
139171432|NCT03452072|Petrolatum|petrolatum|mesh-list
139171433|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139171434|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139171435|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
139171436|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171437|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171438|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171439|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139171440|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139171441|NCT03452072|Emollients|emollients|mesh-ancestor
139171442|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
139171443|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
139171444|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
139171445|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139171446|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
139171447|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139171448|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171449|NCT03433040|Progestins|progestins|mesh-ancestor
139171450|NCT03433040|Hormones|hormones|mesh-ancestor
139171451|NCT02318446|Folic Acid|folic acid|mesh-list
139171452|NCT02318446|Hematinics|hematinics|mesh-ancestor
139171453|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
139171454|NCT02318446|Vitamins|vitamins|mesh-ancestor
139171455|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
139171456|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171457|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139171458|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139171459|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139171460|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
139171461|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171462|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
139171463|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139171464|NCT01360658|Antibodies|antibodies|mesh-list
139171465|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
139171466|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139171467|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
139171468|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171469|NCT02318758|Ethanol|ethanol|mesh-list
139171470|NCT02318758|Treprostinil|treprostinil|mesh-list
139171471|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139171472|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171473|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171474|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171475|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139171476|NCT02441686|Dexamethasone|dexamethasone|mesh-list
139171477|NCT02441686|Lenalidomide|lenalidomide|mesh-list
139171478|NCT02441686|Bortezomib|bortezomib|mesh-list
139171479|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139171480|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
139171481|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
139171482|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171483|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171484|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139171485|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
139171486|NCT02441686|Hormones|hormones|mesh-ancestor
139171487|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139171488|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139171489|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171490|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
139171491|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139171492|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139171493|NCT02441686|Growth Substances|growth substances|mesh-ancestor
139171494|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
138571179|NCT00101153|Cytarabine|cytarabine|mesh-list
139171495|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139171497|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171498|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171499|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171500|NCT01352234|Aspirin|aspirin|mesh-list
139171501|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139171502|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139171503|NCT01352234|Analgesics|analgesics|mesh-ancestor
139171504|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
139171505|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171506|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171507|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139171508|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139171509|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139171510|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139171511|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171512|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139171513|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139171514|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171515|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
139171516|NCT01364792|Valacyclovir|valacyclovir|mesh-list
139171517|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
139171518|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171519|NCT02318836|Lofexidine|lofexidine|mesh-list
139171520|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139171521|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139171522|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171523|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
139171524|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171525|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139171526|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139171527|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139171528|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
139171529|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171530|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171531|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139171532|NCT01352312|Ofatumumab|ofatumumab|mesh-list
139171533|NCT01352312|Pentostatin|pentostatin|mesh-list
139171534|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139171535|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
139171536|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171537|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171538|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139171539|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171541|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139171542|NCT02939209|Narcotics|narcotics|mesh-ancestor
139171543|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171544|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171545|NCT02939209|Analgesics|analgesics|mesh-ancestor
139171546|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
139171547|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171548|NCT01141855|Varenicline|varenicline|mesh-list
139171549|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139171550|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139171551|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
139171552|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171553|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171554|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171555|NCT01236859|Gabapentin|gabapentin|mesh-list
139171556|NCT01236859|Analgesics|analgesics|mesh-ancestor
139171557|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
139171558|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171559|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171560|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
139171561|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139171562|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139171563|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171564|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139171565|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139171566|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139171567|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171568|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171569|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
139171570|NCT01145365|Anesthetics|anesthetics|mesh-list
139171571|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171572|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171573|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
139171574|NCT01365104|Deferoxamine|deferoxamine|mesh-list
139171575|NCT01365104|Siderophores|siderophores|mesh-ancestor
139171576|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139171577|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
139171578|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
139171579|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171580|NCT03492970|Melatonin|melatonin|mesh-list
139171581|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
139171582|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171583|NCT03492970|Protective Agents|protective agents|mesh-ancestor
139171584|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171585|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171586|NCT01362374|Leucovorin|leucovorin|mesh-list
139171587|NCT01362374|Paclitaxel|paclitaxel|mesh-list
139171588|NCT01362374|Docetaxel|docetaxel|mesh-list
139171589|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
139171590|NCT01362374|Ipatasertib|ipatasertib|mesh-list
139171591|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139171592|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171593|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
139171594|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
139171595|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
139171596|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171597|NCT01362374|Antidotes|antidotes|mesh-ancestor
139171598|NCT01362374|Protective Agents|protective agents|mesh-ancestor
139171599|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171600|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
139171601|NCT01362374|Vitamins|vitamins|mesh-ancestor
139171602|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
139171603|NCT01362374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139171604|NCT01362374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171605|NCT01142011|Belimumab|belimumab|mesh-list
139171606|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139171607|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
139171608|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171609|NCT02319460|Thrombin|thrombin|mesh-list
139171610|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
139171611|NCT02319460|Coagulants|coagulants|mesh-ancestor
139171612|NCT04722952|Cytarabine|cytarabine|mesh-list
139171613|NCT04722952|Azacitidine|azacitidine|mesh-list
139171614|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
139171615|NCT04722952|Visilizumab|visilizumab|mesh-list
139171616|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139171617|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
139171618|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171619|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171620|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
139171621|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171622|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139171623|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
139171624|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171625|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171626|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139171627|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139171628|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
139171629|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139171630|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
139171631|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171632|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
139171633|NCT01365260|Protective Agents|protective agents|mesh-ancestor
139171634|NCT01235455|Interferons|interferons|mesh-list
139171635|NCT01235455|Interferon-beta|interferon-beta|mesh-list
139171636|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
139171637|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171638|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
139171639|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171640|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
139171641|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171642|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139171643|NCT01145677|Topiramate|topiramate|mesh-list
139171644|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
139171645|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139171646|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171647|NCT02319616|Clobetasol|clobetasol|mesh-list
139171648|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139171649|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
139171650|NCT02319616|Hormones|hormones|mesh-ancestor
139171651|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139171652|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171653|NCT01142245|Esomeprazole|esomeprazole|mesh-list
139171654|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139171655|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139171656|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139171657|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171658|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171659|NCT02319772|Galidesivir|galidesivir|mesh-list
139171660|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
139171661|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171662|NCT03499132|Anesthetics|anesthetics|mesh-list
139171663|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171664|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171665|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
139171666|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171667|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171668|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171669|NCT03498820|Remifentanil|remifentanil|mesh-list
139171670|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139171671|NCT03498820|Narcotics|narcotics|mesh-ancestor
139171672|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171673|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171674|NCT03498820|Analgesics|analgesics|mesh-ancestor
139171675|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
139171676|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171677|NCT05158309|Capsaicin|capsaicin|mesh-list
139171678|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
139171679|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
139171680|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
139171681|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171682|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171683|NCT02320084|Nitisinone|nitisinone|mesh-list
139171684|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171685|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171686|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139171687|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
139171689|NCT02320240|Fluoxetine|fluoxetine|mesh-list
139171690|NCT02320240|Paroxetine|paroxetine|mesh-list
139171691|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138922138|NCT05285358|Antimetabolites|antimetabolites|mesh-ancestor
139171692|NCT02320240|Sertraline|sertraline|mesh-list
139171693|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139171694|NCT02320240|Escitalopram|escitalopram|mesh-list
139171695|NCT02320240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139171696|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139171697|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139171698|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171699|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171700|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
139171701|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171702|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171703|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139171704|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
139171705|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139171706|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139171707|NCT02320240|Analgesics|analgesics|mesh-ancestor
139171708|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
139171709|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
139171710|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138898837|NCT02674295|Esketamine|esketamine|mesh-list
139171711|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139171712|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171713|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139171714|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139171715|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171716|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139171717|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139171718|NCT03492736|Melatonin|melatonin|mesh-list
139171719|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
139171720|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171721|NCT03492736|Protective Agents|protective agents|mesh-ancestor
139171722|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171723|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171724|NCT02320474|Aflibercept|aflibercept|mesh-list
139171725|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139171726|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139171727|NCT02320474|Growth Substances|growth substances|mesh-ancestor
139171728|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171729|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
139171730|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171731|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
139171732|NCT03492580|Empagliflozin|empagliflozin|mesh-list
139171733|NCT03492580|Canagliflozin|canagliflozin|mesh-list
139171734|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
139171735|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139171736|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139171737|NCT03492580|Glucagon|glucagon|mesh-list
139171738|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139171739|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171740|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139171741|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171742|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139171743|NCT03492580|Hormones|hormones|mesh-ancestor
139171744|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139171745|NCT03492580|Incretins|incretins|mesh-ancestor
139171746|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
139171747|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171748|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
139171750|NCT01238965|Fluorouracil|fluorouracil|mesh-list
139171751|NCT01238965|Panobinostat|panobinostat|mesh-list
139171752|NCT01238965|Calcium|calcium|mesh-list
139171753|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
139171754|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139171755|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139171756|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171757|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139171758|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
139171759|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171760|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139171761|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171762|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139171763|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
139171764|NCT01238965|Antidotes|antidotes|mesh-ancestor
139171765|NCT01238965|Protective Agents|protective agents|mesh-ancestor
139171766|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
139171767|NCT01238965|Vitamins|vitamins|mesh-ancestor
139171768|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
139171769|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171771|NCT01142557|Interferon-beta|interferon-beta|mesh-list
139171772|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
139171773|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171774|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
139171775|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171776|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
139171777|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171778|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139171779|NCT04496908|Misoprostol|misoprostol|mesh-list
139171780|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139171781|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
139171782|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139171783|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171784|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139171785|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139171786|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
139171787|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
139171788|NCT01144117|Hematinics|hematinics|mesh-ancestor
139171789|NCT04371640|Sirolimus|sirolimus|mesh-list
139171790|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139171791|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171792|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139171793|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171794|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
139171795|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139171796|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
139171797|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171798|NCT04356196|Verapamil|verapamil|mesh-list
139171799|NCT04356196|Bisoprolol|bisoprolol|mesh-list
139171800|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139171801|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139171802|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139171803|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171804|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139171805|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171806|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
139171807|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139171808|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
139171809|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
139171810|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171811|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139171812|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139171813|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139171814|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
139171815|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171816|NCT02115139|Ipilimumab|ipilimumab|mesh-list
139171817|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139171818|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171819|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139171820|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171821|NCT02047981|Azithromycin|azithromycin|mesh-list
139171822|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139171823|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171824|NCT04802356|Dexamethasone|dexamethasone|mesh-list
139171825|NCT04802356|Lenalidomide|lenalidomide|mesh-list
139171826|NCT04802356|Bortezomib|bortezomib|mesh-list
139171827|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139171828|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
139171829|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
139171830|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171831|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171832|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139171833|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
139171834|NCT04802356|Hormones|hormones|mesh-ancestor
139171835|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139171836|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139171837|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171838|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
139171839|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139171840|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139171841|NCT04802356|Growth Substances|growth substances|mesh-ancestor
139171842|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
138922288|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
139171843|NCT01142635|Bromides|bromides|mesh-list
139171844|NCT01142635|Rocuronium|rocuronium|mesh-list
139171845|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
139171846|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139171847|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139171848|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139171849|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171850|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171851|NCT01144195|Panitumumab|panitumumab|mesh-list
139171852|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139171853|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171854|NCT05631769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139171855|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139171856|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139171857|NCT02528383|Estradiol|estradiol|mesh-list
139171858|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139171859|NCT02528383|Estrogens|estrogens|mesh-ancestor
139171860|NCT02528383|Hormones|hormones|mesh-ancestor
139171861|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139171862|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171863|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139171864|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
139171865|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139171866|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139171867|NCT01146067|Rivastigmine|rivastigmine|mesh-list
139171868|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139171869|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171870|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171871|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
139171872|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171873|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171874|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139171875|NCT01146067|Protective Agents|protective agents|mesh-ancestor
139171876|NCT01237249|Dexamethasone|dexamethasone|mesh-list
139171877|NCT01237249|Prednisone|prednisone|mesh-list
139171878|NCT01237249|Melphalan|melphalan|mesh-list
139171879|NCT01237249|Lenalidomide|lenalidomide|mesh-list
139171880|NCT01237249|Bortezomib|bortezomib|mesh-list
139171881|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139171882|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
139171883|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
139171884|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171885|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171886|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139171887|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
139171888|NCT01237249|Hormones|hormones|mesh-ancestor
139171889|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139171890|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139171891|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171892|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139171893|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
139171894|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171895|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139171896|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139171897|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
139171898|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139171899|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139171900|NCT01237249|Growth Substances|growth substances|mesh-ancestor
139171901|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
139171902|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
139171903|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139171904|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
138955382|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
139171905|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139171907|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139171908|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
139171909|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139171910|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139171911|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139171912|NCT01244347|Folic Acid|folic acid|mesh-list
139171913|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
139171914|NCT01244347|Hematinics|hematinics|mesh-ancestor
139171915|NCT01244347|Vitamins|vitamins|mesh-ancestor
139171916|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
138898947|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
139171917|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171918|NCT01763827|Ezetimibe|ezetimibe|mesh-list
139171919|NCT01763827|Evolocumab|evolocumab|mesh-list
139171920|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139171921|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139171922|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139171923|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
139171924|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171925|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139171926|NCT01763827|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139171927|NCT01763827|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139171928|NCT01763827|Protease Inhibitors|protease inhibitors|mesh-ancestor
139171929|NCT01763827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963666|NCT00602459|Rituximab|rituximab|mesh-list
139171930|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
139171931|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171933|NCT01146145|Morphine|morphine|mesh-list
139171934|NCT01146145|Analgesics|analgesics|mesh-ancestor
139171935|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
139171936|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139171937|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171938|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139171939|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139171940|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
139171941|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
139171942|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139171943|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139171944|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139171945|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139171946|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171947|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139171948|NCT01146145|Narcotics|narcotics|mesh-ancestor
139171949|NCT01146535|Interferons|interferons|mesh-list
139171950|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
139171951|NCT01146535|Oseltamivir|oseltamivir|mesh-list
139171952|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171953|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
139171954|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171955|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
139171956|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171957|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171958|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171959|NCT01732783|Panitumumab|panitumumab|mesh-list
139171960|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139171961|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171962|NCT04355728|Heparin|heparin|mesh-list
139171963|NCT04355728|Calcium heparin|calcium heparin|mesh-list
139171964|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
139171965|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139171966|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139171967|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171968|NCT01693783|Ipilimumab|ipilimumab|mesh-list
139171969|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139171970|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171971|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139171972|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171973|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
139171974|NCT02528461|Liver Extracts|liver extracts|mesh-list
139171975|NCT02528461|Hematinics|hematinics|mesh-ancestor
139171976|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
139171977|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139171978|NCT01237483|Cetuximab|cetuximab|mesh-list
139171979|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139171980|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139171981|NCT01240213|Vitamin D|vitamin d|mesh-list
139171982|NCT01240213|Vitamins|vitamins|mesh-ancestor
139171983|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
139171984|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139171985|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139171986|NCT01375777|Ezetimibe|ezetimibe|mesh-list
139171987|NCT01375777|Evolocumab|evolocumab|mesh-list
139171988|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139171989|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139171990|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139171991|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
139171992|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139171993|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139171994|NCT01375777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139171995|NCT01375777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139171996|NCT01375777|Protease Inhibitors|protease inhibitors|mesh-ancestor
139171997|NCT01375777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139171998|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
139171999|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172000|NCT02431702|Haloperidol|haloperidol|mesh-list
139172001|NCT02431702|Olanzapine|olanzapine|mesh-list
139172002|NCT02431702|Risperidone|risperidone|mesh-list
139172003|NCT02431702|Aripiprazole|aripiprazole|mesh-list
139172004|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139172005|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139172006|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
139172007|NCT02431702|Perphenazine|perphenazine|mesh-list
139172008|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139172009|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
139172010|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172011|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172012|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172013|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139172014|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139172015|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139172016|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139172017|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139172018|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
139172019|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
139172020|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
139172021|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172022|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139172023|NCT02431702|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139172024|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139172025|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139172026|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
139172027|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
139172028|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139172029|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139172030|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139172031|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139172032|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139172033|NCT02086552|Lenalidomide|lenalidomide|mesh-list
139172034|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
139172035|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172036|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139172037|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139172038|NCT02086552|Growth Substances|growth substances|mesh-ancestor
139172039|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
139172040|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172041|NCT02321878|Liraglutide|liraglutide|mesh-list
139172042|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139172043|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172044|NCT02321878|Incretins|incretins|mesh-ancestor
139172045|NCT02321878|Hormones|hormones|mesh-ancestor
139172046|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172047|NCT03625141|Atezolizumab|atezolizumab|mesh-list
139172048|NCT03625141|Vemurafenib|vemurafenib|mesh-list
139172049|NCT03625141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139172050|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172051|NCT03625141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139172052|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172053|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139172054|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172055|NCT03491410|Aspirin|aspirin|mesh-list
139172056|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139172057|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139172058|NCT03491410|Analgesics|analgesics|mesh-ancestor
139172059|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
139172060|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172061|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172062|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139172063|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172064|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139172065|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139172066|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172067|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139172068|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139172069|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172070|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
138922509|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139172071|NCT00876031|Etoposide|etoposide|mesh-list
139172072|NCT00876031|Idarubicin|idarubicin|mesh-list
139172073|NCT00876031|Trofosfamide|trofosfamide|mesh-list
139172074|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139172075|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172076|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139172077|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139172078|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172079|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172080|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139172081|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139172082|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
139172083|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172084|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139172085|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
139172086|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
139172087|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
139172088|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
139172089|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139172090|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172091|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
139172092|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172093|NCT01146301|Clopidogrel|clopidogrel|mesh-list
139172094|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139172095|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139172096|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139172097|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139172098|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
139172099|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172100|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172101|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172102|NCT00807859|Paclitaxel|paclitaxel|mesh-list
139172103|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139172104|NCT00807859|Capecitabine|capecitabine|mesh-list
139172105|NCT00807859|Trastuzumab|trastuzumab|mesh-list
139172106|NCT00807859|Lapatinib|lapatinib|mesh-list
139172108|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139172109|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172110|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
139172111|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
139172112|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
139172113|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172114|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139172115|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
139172116|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139172117|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139172118|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172119|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139172120|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139172121|NCT00807859|Growth Substances|growth substances|mesh-ancestor
138955390|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139172122|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172123|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
139172124|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139172125|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139172126|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139172127|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172128|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
139172129|NCT03491098|Prednisolone|prednisolone|mesh-list
139172130|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139172131|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
139172132|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139172133|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
139172134|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139172135|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
139172136|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139172137|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
139172138|NCT03491098|Hormones|hormones|mesh-ancestor
138963733|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
139172139|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172140|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172141|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139172142|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172143|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
139172144|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
139172145|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172146|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139172147|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139172148|NCT03491098|Protective Agents|protective agents|mesh-ancestor
139172149|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
139172150|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139172151|NCT02322502|Propofol|propofol|mesh-list
139172152|NCT02322502|Sevoflurane|sevoflurane|mesh-list
139172153|NCT02322502|Desflurane|desflurane|mesh-list
139172154|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139172155|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139172156|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172157|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139172158|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
139172159|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
139172160|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139172161|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139172162|NCT02322580|Etanercept|etanercept|mesh-list
139172163|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139172164|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139172165|NCT02322580|Analgesics|analgesics|mesh-ancestor
139172166|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
139172167|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172168|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172169|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139172170|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172171|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139172172|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139172173|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
139172174|NCT03190174|Sirolimus|sirolimus|mesh-list
139172175|NCT03190174|Nivolumab|nivolumab|mesh-list
139172176|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139172177|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172178|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139172179|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172180|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139172181|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139172182|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139172183|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
139172184|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139172185|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
139172186|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172187|NCT03490708|Tranilast|tranilast|mesh-list
139172188|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139172189|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139172190|NCT03490708|Analgesics|analgesics|mesh-ancestor
139172191|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
139172192|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172193|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172194|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139172195|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963782|NCT01067365|Citric Acid|citric acid|mesh-list
139172196|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139172197|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139172198|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172199|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139172200|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139172201|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
139172202|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
138899095|NCT02671175|Piperaquine|piperaquine|mesh-list
139172203|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172204|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139172205|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139172206|NCT00924326|Vidarabine|vidarabine|mesh-list
139172207|NCT00924326|Aldesleukin|aldesleukin|mesh-list
139172208|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
139172209|NCT00924326|Fludarabine|fludarabine|mesh-list
139172210|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
139172211|NCT00924326|Interleukin-2|interleukin-2|mesh-list
139172212|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139172213|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
139172214|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172215|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172216|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139172217|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
139172218|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172219|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172220|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138922660|NCT00919776|Hormones|hormones|mesh-ancestor
139172221|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139172222|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
139172223|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
139172224|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139172225|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139172226|NCT00924326|Analgesics|analgesics|mesh-ancestor
139172227|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
139172228|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172229|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139172230|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139172231|NCT03496870|Levodopa|levodopa|mesh-list
139172232|NCT03496870|Carbidopa|carbidopa|mesh-list
139172233|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139172234|NCT03496870|Opicapone|opicapone|mesh-list
139172235|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139172236|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139172237|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
139172238|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172239|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172240|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172241|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139172242|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172243|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139172244|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
139172245|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
139172246|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139172247|NCT01370096|Epoprostenol|epoprostenol|mesh-list
139172248|NCT01370096|Vasopressins|vasopressins|mesh-list
139172249|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
139172250|NCT01370096|Tezosentan|tezosentan|mesh-list
139172251|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
139172252|NCT01370096|Coagulants|coagulants|mesh-ancestor
139172253|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139172254|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139172255|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
139172256|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172257|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139172258|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139172259|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
138963801|NCT00568776|Inositol|inositol|mesh-list
139172261|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
139172262|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172263|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
139172264|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172265|NCT02875028|Vorapaxar|vorapaxar|mesh-list
139172266|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139172267|NCT01371344|Tacrolimus|tacrolimus|mesh-list
139172268|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139172269|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
139172270|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172271|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139172272|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172273|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172274|NCT03631004|Olanzapine|olanzapine|mesh-list
139172275|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
139172276|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
139172277|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172278|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172279|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139172280|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139172281|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139172282|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139172283|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139172284|NCT03631004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139172285|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139172286|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139172287|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172288|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172289|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
139172290|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
139172291|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172292|NCT00943618|Bupropion|bupropion|mesh-list
139172293|NCT00943618|Varenicline|varenicline|mesh-list
139172294|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139172295|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
139172296|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139172297|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139172298|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139172299|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139172300|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172301|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
139172302|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172303|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172304|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139172305|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139172306|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172307|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139172308|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139172309|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
139172310|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
139172311|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
139172312|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
139172313|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139172314|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
139172315|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
138963803|NCT00568776|Vitamins|vitamins|mesh-ancestor
139172316|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172317|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172318|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172319|NCT02322658|Eszopiclone|eszopiclone|mesh-list
139172320|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139172321|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139172322|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172323|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
139172324|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139172325|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
139172326|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139172327|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
139172328|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172329|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172330|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
139172331|NCT02710084|Oxytocin|oxytocin|mesh-list
139172332|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
139172333|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139172334|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172335|NCT02849990|Prednisone|prednisone|mesh-list
139172336|NCT02849990|Cortisone|cortisone|mesh-list
139172337|NCT02849990|Indomethacin|indomethacin|mesh-list
139172338|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
139172339|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139172340|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
139172341|NCT02849990|Hormones|hormones|mesh-ancestor
139172342|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172343|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172344|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139172345|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172346|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139172347|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172348|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172349|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
139172350|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139172351|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139172352|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139172353|NCT02849990|Analgesics|analgesics|mesh-ancestor
139172354|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
139172355|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172356|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172357|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
139172358|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
139172359|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139172360|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139172361|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
139172362|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139172363|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172364|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
139172365|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172366|NCT03490396|Povidone|povidone|mesh-list
139172367|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
139172368|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139172369|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
139172370|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172371|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
138922811|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172372|NCT03490396|Protective Agents|protective agents|mesh-ancestor
139172373|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
139172374|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
139172375|NCT05136040|Bupivacaine|bupivacaine|mesh-list
139172376|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
139172377|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
139172378|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139172379|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172380|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
139172381|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172382|NCT03496246|Vitamin D|vitamin d|mesh-list
139172383|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139172384|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
139172385|NCT03496246|Calcifediol|calcifediol|mesh-list
139172386|NCT03496246|Calcium|calcium|mesh-list
139172387|NCT03496246|Vitamins|vitamins|mesh-ancestor
139172388|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
139172389|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172390|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139172391|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139172392|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
139172393|NCT02017964|Carboplatin|carboplatin|mesh-list
139172394|NCT02017964|Methotrexate|methotrexate|mesh-list
139172395|NCT02017964|Etoposide|etoposide|mesh-list
139172396|NCT02017964|Vincristine|vincristine|mesh-list
138899258|NCT01022749|Vaccines|vaccines|mesh-list
139172397|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
139172398|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
139172399|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139172400|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
139172401|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172402|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172403|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139172404|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
139172405|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172406|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172407|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139172408|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139172409|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
138955403|NCT00329641|Carboplatin|carboplatin|mesh-list
139172410|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139172411|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139172412|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
139172413|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
139172414|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172415|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139172416|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139172417|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139172418|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139172419|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139172420|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
139172421|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
139172422|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
139172423|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
139172424|NCT05121298|Upadacitinib|upadacitinib|mesh-list
139172425|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139172426|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139172427|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172428|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172429|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172430|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139172431|NCT01956110|Hormones|hormones|mesh-ancestor
139172432|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172433|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172434|NCT03489928|Misoprostol|misoprostol|mesh-list
139172435|NCT03489928|Dinoprostone|dinoprostone|mesh-list
139172436|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139172437|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
139172438|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139172439|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172440|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139172441|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139172442|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
139172443|NCT02323282|Ropivacaine|ropivacaine|mesh-list
139172444|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
139172445|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
138963832|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139172446|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138922887|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172447|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172448|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
139172449|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172450|NCT01802086|Lidocaine|lidocaine|mesh-list
139172451|NCT01802086|Prilocaine|prilocaine|mesh-list
139172452|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139172453|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
139172454|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
139172455|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139172456|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172457|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
139172458|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172459|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139172460|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139172461|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139172462|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139172463|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172464|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139172465|NCT05347316|Colchicine|colchicine|mesh-list
139172466|NCT05347316|Gout Suppressants|gout suppressants|mesh-ancestor
139172467|NCT05347316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172468|NCT05347316|Tubulin Modulators|tubulin modulators|mesh-ancestor
139172469|NCT05347316|Antimitotic Agents|antimitotic agents|mesh-ancestor
139172470|NCT05347316|Mitosis Modulators|mitosis modulators|mesh-ancestor
139172471|NCT05347316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172472|NCT05347316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172473|NCT03495466|Anesthetics|anesthetics|mesh-list
139172474|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139172475|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172476|NCT01372826|Naloxegol|naloxegol|mesh-list
139172477|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138899336|NCT00646607|Vitamins|vitamins|mesh-ancestor
139172478|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172479|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
139172480|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172481|NCT01371968|Alfentanil|alfentanil|mesh-list
139172482|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139172483|NCT01371968|Narcotics|narcotics|mesh-ancestor
139172484|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139172485|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172486|NCT01371968|Analgesics|analgesics|mesh-ancestor
139172487|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
139172488|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172489|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139172490|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
139172491|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
139172492|NCT04989322|Carboplatin|carboplatin|mesh-list
139172493|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
139172494|NCT04989322|Pemetrexed|pemetrexed|mesh-list
139172495|NCT04989322|Lenvatinib|lenvatinib|mesh-list
139172496|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172497|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139172498|NCT04989322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139172499|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172500|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172501|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139172502|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139172503|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139172504|NCT01367054|Metformin|metformin|mesh-list
138963849|NCT00816894|Olanzapine|olanzapine|mesh-list
139172505|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139172506|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172507|NCT03634514|Hormones|hormones|mesh-list
139172508|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172509|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172510|NCT02323438|Menthol|menthol|mesh-list
139172511|NCT02323438|Nicotine|nicotine|mesh-list
139172512|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139172513|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
139172514|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172515|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172516|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139172517|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139172518|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
139172519|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172520|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172521|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
139172522|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
139172523|NCT01372904|Dexamethasone|dexamethasone|mesh-list
139172524|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
139172525|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139172526|NCT01372904|BB 1101|bb 1101|mesh-list
139172527|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139172528|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
139172529|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
139172530|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172531|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172532|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139172533|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
139172534|NCT01372904|Hormones|hormones|mesh-ancestor
139172535|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172536|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139172537|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172538|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
139172539|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172540|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172541|NCT01372982|Letrozole|letrozole|mesh-list
139172542|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172543|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139172544|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139172545|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172546|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172547|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139172548|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
139172549|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172550|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172551|NCT02323516|Aspirin|aspirin|mesh-list
139172552|NCT02323516|Loperamide|loperamide|mesh-list
139172553|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
139172554|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139172555|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139172556|NCT02323516|Analgesics|analgesics|mesh-ancestor
139172557|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
139172558|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172559|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172560|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139172561|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172562|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139172563|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139172564|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172565|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139172566|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139172567|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172568|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
139172569|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139172570|NCT01367210|Maraviroc|maraviroc|mesh-list
139172571|NCT01367210|Darunavir|darunavir|mesh-list
139172572|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139172573|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139172574|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139172575|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172576|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139172577|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
139172578|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139172579|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139172580|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139172581|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139172582|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
139172583|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172584|NCT02323594|Asunaprevir|asunaprevir|mesh-list
139172585|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
139172586|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172587|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172588|NCT01372280|Galantamine|galantamine|mesh-list
139172589|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139172590|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172591|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172592|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
139172593|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172594|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172595|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139172596|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
139172597|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923037|NCT05683782|Coagulants|coagulants|mesh-ancestor
139172598|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
139172599|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
139172600|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139172601|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172602|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139172603|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899433|NCT02656121|Vitamin D|vitamin d|mesh-list
139172604|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
139172605|NCT04742140|Analgesics|analgesics|mesh-ancestor
139172606|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
139172607|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172608|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172609|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
139172610|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139172611|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139172612|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
139172613|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139172614|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139172615|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172616|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139172617|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
139172618|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139172619|NCT04580992|Ajmaline|ajmaline|mesh-list
139172620|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139172621|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139172622|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139172623|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139172624|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172625|NCT04590274|Azithromycin|azithromycin|mesh-list
139172626|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
139172627|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139172628|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139172629|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
139172630|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139172631|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139172632|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172633|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172634|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172635|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
139172636|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139172637|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172638|NCT04455178|Indapamide|indapamide|mesh-list
139172639|NCT04455178|Spironolactone|spironolactone|mesh-list
139172640|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139172641|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
139172642|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172643|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172644|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139172645|NCT04455178|Diuretics|diuretics|mesh-ancestor
139172646|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
139172647|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139172648|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139172649|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139172650|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172651|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
139172652|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139172653|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172654|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
139172655|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172656|NCT02446834|Metformin|metformin|mesh-list
139172657|NCT02446834|Acarbose|acarbose|mesh-list
139172658|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139172659|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172660|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139172661|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172662|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172663|NCT03489616|Pemetrexed|pemetrexed|mesh-list
139172664|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172665|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172666|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172667|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139172668|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139172669|NCT02323906|Sorafenib|sorafenib|mesh-list
139172670|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172671|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139172672|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172673|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172674|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139172675|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
139172676|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139172677|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139172678|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139172679|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172681|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172682|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139172683|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172684|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172685|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
139172686|NCT01373138|Ephedrine|ephedrine|mesh-list
139172687|NCT01373138|Desloratadine|desloratadine|mesh-list
139172688|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139172689|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
139172690|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172691|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955413|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
139172692|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172693|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139172694|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139172695|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
139172696|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
139172697|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139172698|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
139172699|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172700|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139172701|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
139172702|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
139172703|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139172704|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139172705|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
139172706|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
139172707|NCT01373216|Exenatide|exenatide|mesh-list
139172708|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139172709|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172710|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139172711|NCT01373216|Incretins|incretins|mesh-ancestor
139172712|NCT01373216|Hormones|hormones|mesh-ancestor
139172713|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172714|NCT03487354|Misoprostol|misoprostol|mesh-list
139172715|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139172716|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
139172717|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139172718|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172719|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139172720|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139172721|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
139172722|NCT04461340|Sirolimus|sirolimus|mesh-list
139172723|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139172724|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139172725|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139172726|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172727|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
139172728|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139172729|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
139172730|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172731|NCT05154968|Mannitol|mannitol|mesh-list
139172732|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139172733|NCT05154968|Diuretics|diuretics|mesh-ancestor
139172734|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
139172735|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172736|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
139172737|NCT01373372|Hormones|hormones|mesh-ancestor
139172738|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172739|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172740|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139172741|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139172742|NCT02324296|Cisplatin|cisplatin|mesh-list
139172743|NCT02324296|Etoposide|etoposide|mesh-list
139172744|NCT02324296|Ifosfamide|ifosfamide|mesh-list
139172745|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172746|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139172747|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139172748|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139172749|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172750|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172751|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139172752|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
139172753|NCT03494686|Anesthetics|anesthetics|mesh-list
139172754|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139172755|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172756|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
139172757|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
139172758|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172759|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172760|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172761|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
139172762|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
139172763|NCT03881020|Fluorides|fluorides|mesh-list
139172764|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
139172765|NCT03881020|Protective Agents|protective agents|mesh-ancestor
139172766|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172767|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
139172768|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139172769|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172770|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
139172771|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172772|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
139172773|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139172774|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139172775|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
139172776|NCT03487042|Bimatoprost|bimatoprost|mesh-list
139172777|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139172778|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139172779|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139172780|NCT03115294|Theophylline|theophylline|mesh-list
139172781|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139172782|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
139172783|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172784|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172785|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139172786|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
139172787|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139172788|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172789|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172790|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
139172791|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139172792|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139172793|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
139172794|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172795|NCT01367756|Citalopram|citalopram|mesh-list
139172796|NCT01367756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139172797|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139172798|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139172799|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172800|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172801|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
139172802|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172803|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139172804|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
139172805|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139172806|NCT04624958|Rituximab|rituximab|mesh-list
139172807|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
139172808|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139172809|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172810|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
139172811|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172812|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172813|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139172814|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172815|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172816|NCT03485482|Bisoprolol|bisoprolol|mesh-list
139172817|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139172818|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
139172819|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
139172820|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172821|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172822|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139172823|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139172824|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139172825|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
139172826|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172827|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172828|NCT02946424|Simvastatin|simvastatin|mesh-list
139172829|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139172830|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139172831|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
139172832|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172833|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139172834|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139172835|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172837|NCT00783536|Methotrexate|methotrexate|mesh-list
139172838|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139172839|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
139172840|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139172841|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172842|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139172843|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
139172844|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172845|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172846|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
139172847|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172848|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139172849|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139172850|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
139172851|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172852|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139172853|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139172854|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139172855|NCT00783536|Analgesics|analgesics|mesh-ancestor
139172856|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
139172857|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172858|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139172859|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139172860|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139172861|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139172862|NCT01367912|Estradiol|estradiol|mesh-list
139172863|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139172864|NCT01367912|Estrogens|estrogens|mesh-ancestor
139172865|NCT01367912|Hormones|hormones|mesh-ancestor
139172866|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172867|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172868|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139172869|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
139172870|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139172871|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139172872|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139172873|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
139172874|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139172875|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172876|NCT03115112|Incretins|incretins|mesh-ancestor
139172877|NCT03115112|Hormones|hormones|mesh-ancestor
139172878|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172879|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139172880|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
139172881|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172882|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172883|NCT01373528|Budesonide|budesonide|mesh-list
139172884|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139172885|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139172886|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
139172887|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172888|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172889|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139172890|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
139172891|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
138923339|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
139172893|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172894|NCT03634202|Capecitabine|capecitabine|mesh-list
139172895|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139172896|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
139172897|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172898|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172899|NCT05019560|Sevoflurane|sevoflurane|mesh-list
139172900|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139172901|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139172902|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
139172903|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
139172904|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139172905|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172906|NCT01373606|Terlipressin|terlipressin|mesh-list
138955423|NCT00743990|Emollients|emollients|mesh-ancestor
139172907|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139172908|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139172909|NCT01367990|Norepinephrine|norepinephrine|mesh-list
139172910|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139172911|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139172912|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
139172913|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172914|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899636|NCT00649415|Valdecoxib|valdecoxib|mesh-list
139172915|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172916|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
139172917|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
139172918|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172919|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139172920|NCT03556358|Paclitaxel|paclitaxel|mesh-list
139172921|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
139172922|NCT03556358|Trastuzumab|trastuzumab|mesh-list
139172923|NCT03556358|Epirubicin|epirubicin|mesh-list
139172924|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139172925|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172926|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
139172927|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
139172928|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
139172929|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172930|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139172931|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
139172932|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172933|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139172934|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139172935|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
139172936|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139172937|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139172938|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139172939|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139172940|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139172941|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172943|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
139172944|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
139172945|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139172946|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172947|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
139172948|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139172949|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
139172950|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172951|NCT01368068|Tibolone|tibolone|mesh-list
139172952|NCT01368068|Escitalopram|escitalopram|mesh-list
139172953|NCT01368068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139172954|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139172955|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139172956|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172957|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139172958|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
139172959|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172960|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
139172961|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
139172962|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172963|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139172964|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139172965|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172966|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139172967|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
139172968|NCT01368068|Hormones|hormones|mesh-ancestor
139172969|NCT01373684|Tenofovir|tenofovir|mesh-list
139172970|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139172971|NCT01373684|Entecavir|entecavir|mesh-list
139172972|NCT01373684|Adefovir|adefovir|mesh-list
139172973|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
139172974|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139172975|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139172976|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139172977|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139172978|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139172979|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139172980|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139172981|NCT02891798|Dexamethasone|dexamethasone|mesh-list
139172982|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
139172983|NCT02891798|Clonidine|clonidine|mesh-list
139172984|NCT02891798|Buprenorphine|buprenorphine|mesh-list
139172985|NCT02891798|Bupivacaine|bupivacaine|mesh-list
139172986|NCT02891798|BB 1101|bb 1101|mesh-list
139172987|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139172988|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
139172989|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
139172990|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139172991|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139172992|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139172993|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
139172994|NCT02891798|Hormones|hormones|mesh-ancestor
139172995|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139172996|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139172997|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139172998|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
139172999|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964017|NCT02600741|Asenapine|asenapine|mesh-list
139173000|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173001|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
139173002|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
139173003|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173004|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
139173005|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139173006|NCT02891798|Narcotics|narcotics|mesh-ancestor
139173007|NCT02891798|Analgesics|analgesics|mesh-ancestor
139173008|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139173009|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139173010|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
139173011|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139173012|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139173013|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139173014|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
139173015|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173016|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
139173017|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
139173018|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
139173019|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173020|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173021|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
139173022|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173023|NCT01374620|Paclitaxel|paclitaxel|mesh-list
139173024|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139173025|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
139173026|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139173027|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173028|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
139173029|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
139173030|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
139173031|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173032|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139173033|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
139173034|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173035|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173036|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139173037|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
139173038|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139173039|NCT01374698|Aspirin|aspirin|mesh-list
139173040|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139173041|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139173042|NCT01374698|Analgesics|analgesics|mesh-ancestor
139173043|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
139173044|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173045|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173046|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173047|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173048|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139173049|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139173050|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173051|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139173052|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139173053|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173055|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
139173056|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139173057|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173058|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173059|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139173060|NCT05197088|Tamsulosin|tamsulosin|mesh-list
139173061|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139173062|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139173063|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139173064|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
139173065|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173066|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173067|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173068|NCT05197088|Urological Agents|urological agents|mesh-ancestor
139173069|NCT01375088|Propolis|propolis|mesh-list
139173070|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173071|NCT01368848|Bevacizumab|bevacizumab|mesh-list
139173072|NCT01368848|Docetaxel|docetaxel|mesh-list
139173073|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139173074|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173075|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139173076|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139173077|NCT01368848|Growth Substances|growth substances|mesh-ancestor
139173078|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173079|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
139173080|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
139173081|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
139173082|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
139173083|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173084|NCT03604874|Oxytocin|oxytocin|mesh-list
139173085|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
139173086|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139173087|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173088|NCT01369082|Cyclosporine|cyclosporine|mesh-list
139173089|NCT01369082|Sirolimus|sirolimus|mesh-list
139173090|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
139173091|NCT01369082|Tacrolimus|tacrolimus|mesh-list
139173092|NCT01369082|Cyclosporins|cyclosporins|mesh-list
139173093|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139173094|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
139173095|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173096|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139173097|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173098|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173099|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
139173100|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173101|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
139173102|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173103|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139173104|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173105|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139173106|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
139173107|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139173108|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
139173109|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139173110|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139173111|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173112|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
139173113|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
139173115|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
139173116|NCT03135262|Venetoclax|venetoclax|mesh-list
139173117|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139173118|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173119|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
139173120|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173121|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173122|NCT01375244|Lisinopril|lisinopril|mesh-list
139173123|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139173124|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
139173125|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173126|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173127|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139173128|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139173129|NCT01375244|Protective Agents|protective agents|mesh-ancestor
139173130|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173131|NCT01375322|Amlodipine|amlodipine|mesh-list
139173132|NCT01375322|Valsartan|valsartan|mesh-list
139173133|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139173134|NCT01375322|Benazepril|benazepril|mesh-list
139173135|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139173136|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139173137|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139173138|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173139|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139173140|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173141|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
139173142|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139173143|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139173144|NCT01375322|Diuretics|diuretics|mesh-ancestor
139173145|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
139173146|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139173147|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139173148|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
139173149|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173150|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
139173151|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139173152|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139173153|NCT01369238|Analgesics|analgesics|mesh-ancestor
139173154|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
139173155|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173156|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173157|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173158|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173159|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
139173160|NCT03485404|Vitamins|vitamins|mesh-list
139173161|NCT03485404|Folic Acid|folic acid|mesh-list
139173162|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
139173163|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
139173164|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
139173165|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173166|NCT03485404|Hematinics|hematinics|mesh-ancestor
139173167|NCT05195294|Lenvatinib|lenvatinib|mesh-list
139173168|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173169|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139173170|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173171|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173172|NCT03535194|Mirikizumab|mirikizumab|mesh-list
139173173|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139173174|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139173175|NCT03535194|Analgesics|analgesics|mesh-ancestor
139173176|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
139173177|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173178|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173179|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173181|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139173182|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139173183|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139173184|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139173185|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
139173186|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173187|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173188|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173189|NCT05194904|Ketorolac|ketorolac|mesh-list
139173190|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
138955436|NCT01056835|Tezosentan|tezosentan|mesh-list
139173191|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139173192|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173193|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173194|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139173196|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
139173197|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173198|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139173199|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139173200|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139173201|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
139173202|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173203|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173204|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139173205|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173206|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173207|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139173208|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173209|NCT01375400|Aspirin|aspirin|mesh-list
139173210|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139173211|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139173212|NCT01375400|Analgesics|analgesics|mesh-ancestor
139173213|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
139173214|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173215|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173216|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173217|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173218|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139173219|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139173220|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173221|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139173222|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139173223|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173224|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
139173225|NCT01319864|Plerixafor|plerixafor|mesh-list
139173226|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139173227|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139173228|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
139173229|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173230|NCT05194046|Amoxicillin|amoxicillin|mesh-list
139173231|NCT05194046|Clarithromycin|clarithromycin|mesh-list
139173232|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139173233|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173234|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139173235|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173236|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173237|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139173238|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139173239|NCT01369472|Carvedilol|carvedilol|mesh-list
139173240|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139173241|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139173242|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
139173243|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173244|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173245|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173246|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139173247|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
139173248|NCT01369472|Protective Agents|protective agents|mesh-ancestor
139173249|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139173250|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139173251|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139173252|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
139173253|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139173254|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139173255|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
139173256|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139173257|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
139173258|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
139173259|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
139173260|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173261|NCT05193734|Coagulants|coagulants|mesh-ancestor
139173262|NCT01375556|Ethanol|ethanol|mesh-list
139173263|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139173264|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173265|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173266|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173267|NCT03486496|Gefitinib|gefitinib|mesh-list
139173268|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173269|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139173270|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173271|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173272|NCT02091934|Dipivefrin|dipivefrin|mesh-list
139173273|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139173274|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
139173275|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899794|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
139173276|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173277|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173278|NCT01375634|Midazolam|midazolam|mesh-list
139173279|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139173280|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139173281|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173282|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173283|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139173284|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139173285|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139173286|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139173287|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
139173288|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
139173289|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
139173290|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
139173291|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173292|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173293|NCT05388448|Amoxicillin|amoxicillin|mesh-list
139173294|NCT05388448|Rifampin|rifampin|mesh-list
139173295|NCT05388448|Clavulanic Acids|clavulanic acids|mesh-list
139173296|NCT05388448|Clavulanic Acid|clavulanic acid|mesh-list
138964097|NCT01067989|Pamidronate|pamidronate|mesh-list
139173297|NCT05388448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139173298|NCT05388448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173299|NCT05388448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139173300|NCT05388448|Antitubercular Agents|antitubercular agents|mesh-ancestor
139173301|NCT05388448|Leprostatic Agents|leprostatic agents|mesh-ancestor
139173302|NCT05388448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139173303|NCT05388448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173304|NCT05388448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173305|NCT05388448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139173306|NCT05388448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139173307|NCT05388448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139173308|NCT05388448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139173309|NCT05388448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139173310|NCT05388448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139173311|NCT05388448|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139173312|NCT05108740|Everolimus|everolimus|mesh-list
139173313|NCT05108740|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139173314|NCT05108740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139173315|NCT05108740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173316|NCT05108740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173317|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139173318|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
139173319|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173320|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173321|NCT05105750|Aspirin|aspirin|mesh-list
139173322|NCT05105750|Indobufen|indobufen|mesh-list
139173323|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139173324|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139173325|NCT05105750|Analgesics|analgesics|mesh-ancestor
139173326|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
139173327|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173328|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173329|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173330|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173331|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139173332|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139173333|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173334|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139173335|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139173336|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173337|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
139173338|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139173339|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139173340|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173341|NCT05152264|Analgesics|analgesics|mesh-list
139173342|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
139173343|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173344|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173345|NCT05152186|Disinfectants|disinfectants|mesh-list
139173346|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173347|NCT03485092|Empagliflozin|empagliflozin|mesh-list
139173348|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139173349|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173350|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139173351|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173352|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
139173353|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
139173354|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
139173355|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139173356|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173357|NCT05064800|Ritonavir|ritonavir|mesh-list
139173358|NCT05064800|Nirmatrelvir|nirmatrelvir|mesh-list
139173359|NCT05064800|Dabigatran|dabigatran|mesh-list
139173360|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139173361|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139173362|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
139173363|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173364|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173365|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139173366|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139173367|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
139173368|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173369|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139173370|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139173371|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
139173372|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139173373|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
139173374|NCT01376180|Lamotrigine|lamotrigine|mesh-list
139173375|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
139173376|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139173377|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139173378|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173379|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139173380|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173381|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139173382|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139173383|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173384|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139173385|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139173386|NCT03633734|Folfirinox|folfirinox|mesh-list
139173387|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173388|NCT01376258|Finasteride|finasteride|mesh-list
139173389|NCT01376258|Dutasteride|dutasteride|mesh-list
139173390|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139173391|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139173392|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173393|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173394|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
139173395|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139173396|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173397|NCT01376258|Urological Agents|urological agents|mesh-ancestor
139173398|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139173399|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139173400|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139173401|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139173402|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173403|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
139173404|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173405|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173407|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173409|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139173410|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173411|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173412|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173413|NCT05151796|Aspirin|aspirin|mesh-list
139173414|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139173415|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139173416|NCT05151796|Analgesics|analgesics|mesh-ancestor
139173417|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
139173418|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173419|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173420|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173421|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173422|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139173423|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139173424|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173425|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139173426|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139173427|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173428|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
139173429|NCT04460092|Insulin|insulin|mesh-list
139173430|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139173431|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139173432|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173433|NCT03110900|Lorazepam|lorazepam|mesh-list
139173434|NCT03110900|Haloperidol|haloperidol|mesh-list
139173435|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
139173436|NCT03110900|Loxapine|loxapine|mesh-list
139173437|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
139173438|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
139173439|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173440|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173441|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139173442|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139173443|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139173444|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173445|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139173446|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139173447|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
139173448|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173449|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173450|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139173451|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
139173452|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139173453|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139173454|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
139173455|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
139173456|NCT03486184|Cystatins|cystatins|mesh-list
139173457|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139173458|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
139173459|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173460|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173462|NCT03109756|Analgesics|analgesics|mesh-ancestor
139173463|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
139173464|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173465|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173466|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
139173467|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
139173468|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
139173469|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173470|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173471|NCT03867734|Aztreonam|aztreonam|mesh-list
139173472|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139173473|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173474|NCT05759546|Fulvestrant|fulvestrant|mesh-list
139173475|NCT05759546|Fluzoparib|fluzoparib|mesh-list
139173476|NCT05759546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139173477|NCT05759546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173478|NCT05759546|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139173479|NCT05759546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139173480|NCT05759546|Hormone Antagonists|hormone antagonists|mesh-ancestor
139173481|NCT05759546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139173482|NCT05759546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173483|NCT05759546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139173484|NCT05759546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173485|NCT05759546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173486|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139173487|NCT05151016|Mifepristone|mifepristone|mesh-list
139173488|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139173489|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
139173490|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139173491|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173492|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139173493|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139173494|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139173495|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
139173496|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139173497|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139173498|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
139173499|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139173500|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
138899874|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
139173501|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139173502|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139173503|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139173504|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173506|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
139173507|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173508|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139173509|NCT04871360|Laxatives|laxatives|mesh-ancestor
139173510|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139173511|NCT05153200|Adalimumab|adalimumab|mesh-list
139173512|NCT05153200|Upadacitinib|upadacitinib|mesh-list
139173513|NCT05153200|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139173514|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173515|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173516|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139173517|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139173518|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173519|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173520|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
139173521|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173522|NCT03477136|Vitamin D|vitamin d|mesh-list
139173523|NCT03477136|Vitamins|vitamins|mesh-ancestor
139173524|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
139173525|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173526|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139173527|NCT03552068|Clonidine|clonidine|mesh-list
139173528|NCT03552068|Analgesics|analgesics|mesh-ancestor
139173529|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
139173530|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173531|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173532|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139173533|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
139173534|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
139173535|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139173536|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139173537|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139173538|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
139173539|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173540|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173541|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139173542|NCT00702988|Hormones|hormones|mesh-ancestor
139173543|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139173544|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173545|NCT05759312|Metformin|metformin|mesh-list
139173546|NCT05759312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139173547|NCT05759312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173548|NCT03446456|Vasopressins|vasopressins|mesh-list
139173549|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
139173550|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
139173551|NCT03446456|Coagulants|coagulants|mesh-ancestor
139173552|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139173553|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139173554|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
139173555|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173556|NCT03396692|Morphine|morphine|mesh-list
139173557|NCT03396692|Ropivacaine|ropivacaine|mesh-list
139173558|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139173559|NCT03396692|Narcotics|narcotics|mesh-ancestor
139173560|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173561|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173562|NCT03396692|Analgesics|analgesics|mesh-ancestor
139173563|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
139173564|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173565|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
139173566|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
139173567|NCT03480958|Morphine|morphine|mesh-list
139173569|NCT03480958|Narcotics|narcotics|mesh-ancestor
139173570|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173571|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173572|NCT03480958|Analgesics|analgesics|mesh-ancestor
139173573|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
139173574|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173575|NCT03495102|Dulaglutide|dulaglutide|mesh-list
139173576|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139173577|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173578|NCT04859608|Eculizumab|eculizumab|mesh-list
138964191|NCT00631410|Sunitinib|sunitinib|mesh-list
139173579|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139173580|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139173581|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
139173582|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173583|NCT04754386|Antibodies|antibodies|mesh-list
139173584|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
139173585|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173586|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139173587|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139173588|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139173589|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173590|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
139173591|NCT03253172|Diuretics|diuretics|mesh-ancestor
139173592|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
139173593|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173594|NCT03253172|Expectorants|expectorants|mesh-ancestor
139173595|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
139173597|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139173598|NCT03480646|Prednisone|prednisone|mesh-list
139173599|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
138899935|NCT05298020|Paclitaxel|paclitaxel|mesh-list
139173600|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173601|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
139173602|NCT03480646|Hormones|hormones|mesh-ancestor
139173603|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139173604|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173605|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139173606|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173607|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173608|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173609|NCT03483142|Misoprostol|misoprostol|mesh-list
139173610|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139173611|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
139173612|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139173613|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173614|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139173615|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139173616|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
139173617|NCT03726372|Bromides|bromides|mesh-list
139173618|NCT03726372|Rocuronium|rocuronium|mesh-list
139173619|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
139173620|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139173621|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139173622|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139173623|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173624|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173625|NCT03104816|Acetaminophen|acetaminophen|mesh-list
139173626|NCT03104816|Hydromorphone|hydromorphone|mesh-list
139173627|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139173628|NCT03104816|Analgesics|analgesics|mesh-ancestor
138955843|NCT00925977|Insulin|insulin|mesh-list
139173629|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
139173630|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173631|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173633|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139173634|NCT03104816|Narcotics|narcotics|mesh-ancestor
139173635|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173636|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
139173637|NCT04720976|Sotorasib|sotorasib|mesh-list
139173638|NCT04720976|Osimertinib|osimertinib|mesh-list
139173639|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139173640|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173641|NCT04720976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139173642|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173643|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139173644|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173645|NCT03480568|Alirocumab|alirocumab|mesh-list
139173646|NCT03480568|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139173647|NCT03480568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139173648|NCT03480568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139173649|NCT03480568|Antimetabolites|antimetabolites|mesh-ancestor
139173650|NCT03480568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173651|NCT03480568|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139173652|NCT03480568|Protease Inhibitors|protease inhibitors|mesh-ancestor
139173653|NCT03480568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173654|NCT03480568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139173655|NCT04707326|Lamivudine|lamivudine|mesh-list
139173656|NCT04707326|Dolutegravir|dolutegravir|mesh-list
139173657|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139173658|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139173659|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173660|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173661|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
139173662|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173663|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139173664|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139173665|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139173666|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139173667|NCT03559062|Ivacaftor|ivacaftor|mesh-list
139173668|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139173669|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139173670|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173671|NCT05759000|Dapagliflozin|dapagliflozin|mesh-list
139173672|NCT05759000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139173673|NCT05759000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173674|NCT05759000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139173675|NCT05759000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173676|NCT03726216|Dalbavancin|dalbavancin|mesh-list
139173677|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139173678|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173679|NCT00089791|Denosumab|denosumab|mesh-list
139173680|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139173681|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173682|NCT02876510|Aldesleukin|aldesleukin|mesh-list
139173683|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
139173684|NCT02876510|Fludarabine|fludarabine|mesh-list
139173685|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
139173686|NCT02876510|Atezolizumab|atezolizumab|mesh-list
139173687|NCT02876510|Interleukin-2|interleukin-2|mesh-list
139173688|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139173689|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
139173690|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173691|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173692|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139173693|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
139173694|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173695|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173696|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139173697|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138964220|NCT00823290|Sorafenib|sorafenib|mesh-list
139173698|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
139173699|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
139173700|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173701|NCT02876510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139173702|NCT02876510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139173703|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139173704|NCT02876510|Analgesics|analgesics|mesh-ancestor
139173705|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
139173706|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955950|NCT00777738|Bortezomib|bortezomib|mesh-list
139173708|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139173709|NCT03380455|Cimetidine|cimetidine|mesh-list
139173710|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139173711|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139173712|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139173713|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
139173714|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
139173715|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173716|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173717|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173718|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139173719|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139173720|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173722|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139173723|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173724|NCT03482752|Molgramostim|molgramostim|mesh-list
139173725|NCT03482752|Sargramostim|sargramostim|mesh-list
139173726|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173727|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
139173728|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173729|NCT01310712|Oxybutynin|oxybutynin|mesh-list
139173730|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
139173731|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
139173732|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173733|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173734|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139173735|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139173736|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
139173737|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173738|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173739|NCT01310712|Urological Agents|urological agents|mesh-ancestor
139173740|NCT02737930|Fluoxetine|fluoxetine|mesh-list
139173741|NCT02737930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139173742|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139173743|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138956112|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
139173744|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173745|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173747|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173748|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139173749|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
139173750|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138899985|NCT00600353|Palonosetron|palonosetron|mesh-list
139173751|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139173752|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139173753|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173754|NCT01242787|Entecavir|entecavir|mesh-list
139173755|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
139173756|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173757|NCT03476356|Clomiphene|clomiphene|mesh-list
139173758|NCT03476356|Enclomiphene|enclomiphene|mesh-list
139173759|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
139173760|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139173761|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
139173762|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139173763|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173764|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139173765|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
139173766|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139173767|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139173768|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139173769|NCT03723096|Pomalidomide|pomalidomide|mesh-list
139173770|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
139173771|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173772|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139173773|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139173774|NCT03723096|Growth Substances|growth substances|mesh-ancestor
139173775|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
139173776|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173777|NCT02534012|Anesthetics|anesthetics|mesh-list
139173778|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173779|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173780|NCT05626387|Mycophenolic Acid|mycophenolic acid|mesh-list
139173781|NCT05626387|Prednisolone|prednisolone|mesh-list
139173782|NCT05626387|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139173783|NCT05626387|Methylprednisolone|methylprednisolone|mesh-list
139173784|NCT05626387|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139173785|NCT05626387|Prednisolone acetate|prednisolone acetate|mesh-list
139173786|NCT05626387|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139173787|NCT05626387|Prednisolone phosphate|prednisolone phosphate|mesh-list
139173788|NCT05626387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139173789|NCT05626387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173790|NCT05626387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139173791|NCT05626387|Antitubercular Agents|antitubercular agents|mesh-ancestor
139173792|NCT05626387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139173793|NCT05626387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139173795|NCT05626387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173796|NCT05626387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173797|NCT05626387|Glucocorticoids|glucocorticoids|mesh-ancestor
139173799|NCT05626387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139173800|NCT05626387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173801|NCT05626387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139173802|NCT05626387|Antiemetics|antiemetics|mesh-ancestor
139173803|NCT05626387|Autonomic Agents|autonomic agents|mesh-ancestor
138956356|NCT00688688|Urological Agents|urological agents|mesh-ancestor
139173804|NCT05626387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173805|NCT05626387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139173806|NCT05626387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139173807|NCT05626387|Protective Agents|protective agents|mesh-ancestor
139173808|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
139173809|NCT03722940|Analgesics|analgesics|mesh-ancestor
139173810|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
139173811|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173812|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173813|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
139173814|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173815|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139173816|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
139173818|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139173819|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173820|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139173822|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139173823|NCT01146925|Deferiprone|deferiprone|mesh-list
139173824|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139173825|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
139173826|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
139173827|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173828|NCT04635254|Histamine|histamine|mesh-list
139173829|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
139173830|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
139173831|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173832|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173833|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173834|NCT03476044|Selenium|selenium|mesh-list
139173835|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
139173836|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173837|NCT03476044|Protective Agents|protective agents|mesh-ancestor
138900064|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139173838|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173839|NCT03476044|Trace Elements|trace elements|mesh-ancestor
139173840|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
139173841|NCT01250821|Menotropins|menotropins|mesh-list
139173842|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139173843|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
139173844|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139173845|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173846|NCT03493698|Midazolam|midazolam|mesh-list
139173847|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139173848|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139173849|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173850|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173851|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139173852|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139173853|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138964301|NCT00820092|Hormones|hormones|mesh-ancestor
139173854|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139173855|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
139173856|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
139173857|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
139173858|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
139173859|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173860|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173862|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139173863|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
139173864|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173866|NCT01898312|Mifepristone|mifepristone|mesh-list
139173867|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139173868|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
139173869|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139173870|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173871|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139173872|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139173873|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139173874|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
139173875|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139173876|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139173877|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
139173878|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139173879|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
139173880|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139173881|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138900088|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
139173883|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139173884|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
139173885|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139173886|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139173887|NCT03482440|Analgesics|analgesics|mesh-ancestor
139173888|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
139173889|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173890|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173891|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173892|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173893|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
139173894|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
139173895|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173896|NCT01253473|Budesonide|budesonide|mesh-list
139173897|NCT01253473|Albuterol|albuterol|mesh-list
139173898|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
139173899|NCT01253473|Ipratropium|ipratropium|mesh-list
139173900|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173901|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139173902|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
139173903|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173904|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173905|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139173906|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
139173907|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
139173908|NCT01253473|Hormones|hormones|mesh-ancestor
139173909|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139173910|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139173911|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139173912|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139173913|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
139173914|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173915|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173916|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
139173917|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139173919|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
139173921|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139173922|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
139173923|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
139173924|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173925|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173926|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139173927|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139173928|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139173929|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
138900123|NCT02564536|Decitabine|decitabine|mesh-list
139173930|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173931|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173932|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139173933|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139173934|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173935|NCT03480100|Xylometazoline|xylometazoline|mesh-list
139173936|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
139173937|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139173938|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
139173939|NCT02348203|Aspirin|aspirin|mesh-list
139173940|NCT02348203|Zileuton|zileuton|mesh-list
139173941|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139173942|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139173943|NCT02348203|Analgesics|analgesics|mesh-ancestor
139173944|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
138957164|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173945|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173946|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173947|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173948|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173949|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139173950|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138957232|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173951|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173952|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139173953|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139173954|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173956|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139173957|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139173958|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
139173959|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139173960|NCT03482362|Vinorelbine|vinorelbine|mesh-list
139173961|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139173962|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173963|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
139173964|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
139173965|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
139173966|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173967|NCT04500470|Ketoprofen|ketoprofen|mesh-list
139173968|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139173969|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139173970|NCT04500470|Analgesics|analgesics|mesh-ancestor
139173971|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
139173972|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139173973|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173974|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139173975|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139173976|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139173977|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139173978|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173980|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
139173981|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139173982|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173983|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173984|NCT04937816|Empagliflozin|empagliflozin|mesh-list
139173985|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138957353|NCT00990496|Fludarabine|fludarabine|mesh-list
139173986|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173987|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139173988|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173989|NCT01366898|Methotrexate|methotrexate|mesh-list
139173990|NCT01366898|Idarubicin|idarubicin|mesh-list
138957425|NCT00792324|Efavirenz|efavirenz|mesh-list
139173991|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139173992|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
139173993|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139173994|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139173995|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139173996|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
139173997|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139173998|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139173999|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
139174000|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174001|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139174002|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139174003|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
139174004|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174005|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139174006|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139174007|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139174008|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139174009|NCT01248871|Sufentanil|sufentanil|mesh-list
139174010|NCT01248871|Remifentanil|remifentanil|mesh-list
139174011|NCT01248871|Dsuvia|dsuvia|mesh-list
139174012|NCT01248871|Propofol|propofol|mesh-list
139174013|NCT01248871|Sevoflurane|sevoflurane|mesh-list
139174014|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139174015|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139174016|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174017|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139174018|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
139174019|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
139174020|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139174021|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139174022|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139174023|NCT01248871|Narcotics|narcotics|mesh-ancestor
139174024|NCT01248871|Analgesics|analgesics|mesh-ancestor
139174025|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
139174026|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174027|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139174028|NCT01251133|Vaccines|vaccines|mesh-list
139174029|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
139174030|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174032|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
139174033|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139174034|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174035|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174036|NCT03720288|Diuretics|diuretics|mesh-ancestor
139174037|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
139174038|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174040|NCT03916393|Aversive Agents|aversive agents|mesh-ancestor
139174041|NCT03916393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174042|NCT03916393|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
139174043|NCT03916393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174044|NCT03916393|Sensory System Agents|sensory system agents|mesh-ancestor
139174045|NCT03916393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174046|NCT03907813|Bupivacaine|bupivacaine|mesh-list
139174047|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
139174048|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
139174049|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139174050|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174051|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
139174052|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174054|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
139174055|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139174057|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174058|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174059|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
138957956|NCT00685178|Topiramate|topiramate|mesh-list
139174060|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139174061|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139174062|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139174063|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174064|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174065|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
139174066|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139174067|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174068|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139174069|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174070|NCT03473340|Pirfenidone|pirfenidone|mesh-list
139174071|NCT03473340|Analgesics|analgesics|mesh-ancestor
139174072|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
139174073|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958019|NCT02560766|Analgesics|analgesics|mesh-ancestor
139174074|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174075|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139174076|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139174077|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139174078|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174079|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174080|NCT01147705|Allopurinol|allopurinol|mesh-list
139174082|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174083|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174084|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
139174085|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174086|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139174087|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
139174088|NCT01147705|Protective Agents|protective agents|mesh-ancestor
139174089|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174090|NCT03907111|Chitosan|chitosan|mesh-list
139174091|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139174092|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139174094|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174095|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139174096|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
139174097|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
139174098|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
139174099|NCT03907111|Coagulants|coagulants|mesh-ancestor
139174100|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
139174101|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
139174102|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174103|NCT03912727|Protective Agents|protective agents|mesh-ancestor
139174104|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174105|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
139174106|NCT03912727|Vitamins|vitamins|mesh-ancestor
139174107|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
139174108|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
139174109|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139174110|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139174111|NCT03661567|Prednisolone|prednisolone|mesh-list
139174112|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
139174113|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139174114|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
139174115|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139174116|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
139174117|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
139174118|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174119|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174120|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139174121|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
139174122|NCT03661567|Hormones|hormones|mesh-ancestor
138958350|NCT05408104|Tolvaptan|tolvaptan|mesh-list
139174123|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139174124|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139174125|NCT03661567|Protective Agents|protective agents|mesh-ancestor
139174126|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139174127|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174129|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139174130|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174131|NCT03739138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139174132|NCT03739138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174133|NCT03472326|GS-9131|gs-9131|mesh-list
139174134|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174135|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174136|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139174137|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139174138|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
139174139|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139174140|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139174141|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139174142|NCT03472014|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139174144|NCT03472014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139174145|NCT04182100|Aspirin|aspirin|mesh-list
139174146|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139174147|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139174148|NCT04182100|Analgesics|analgesics|mesh-ancestor
139174149|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
139174150|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174151|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174152|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139174153|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174154|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139174155|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139174156|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174157|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139174158|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139174159|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174161|NCT03479320|Lidocaine|lidocaine|mesh-list
139174162|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
139174163|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
138964362|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139174164|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139174165|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174166|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
139174167|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174168|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139174169|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139174170|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139174171|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174172|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174173|NCT03912415|Paclitaxel|paclitaxel|mesh-list
139174174|NCT03912415|Bevacizumab|bevacizumab|mesh-list
139174175|NCT03912415|Carboplatin|carboplatin|mesh-list
139174176|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139174177|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174178|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
139174179|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
139174180|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
138958596|NCT00803166|Halobetasol|halobetasol|mesh-list
139174181|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174182|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139174183|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139174184|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139174185|NCT03912415|Growth Substances|growth substances|mesh-ancestor
139174186|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174187|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
139174189|NCT03525834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139174190|NCT03525834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139174191|NCT03525834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174192|NCT03525834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174193|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139174194|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
139174195|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174196|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174197|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
139174198|NCT00925652|Bevacizumab|bevacizumab|mesh-list
139174199|NCT00925652|Methotrexate|methotrexate|mesh-list
139174200|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139174201|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
139174202|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174203|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174204|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139174205|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
139174206|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174207|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174208|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139174209|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139174210|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139174211|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139174212|NCT00925652|Growth Substances|growth substances|mesh-ancestor
139174213|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
139174214|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139174215|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
139174216|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139174217|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139174218|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
139174219|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
139174220|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174221|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139174222|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139174223|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
139174224|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139174225|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139174226|NCT03954106|Defibrotide|defibrotide|mesh-list
139174227|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139174228|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139174229|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174230|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139174231|NCT03525444|Ivacaftor|ivacaftor|mesh-list
139174232|NCT03525444|Elexacaftor|elexacaftor|mesh-list
139174233|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139174234|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174235|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174237|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
139174238|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139174239|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
139174240|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139174241|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139174242|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
139174243|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139174244|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174245|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958883|NCT00656136|Afatinib|afatinib|mesh-list
139174246|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139174247|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139174248|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138958948|NCT00575042|Fenofibrate|fenofibrate|mesh-list
139174249|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139174250|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139174251|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139174252|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139174253|NCT03632876|Vitamin A|vitamin a|mesh-list
139174254|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
139174255|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
138959101|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
139174256|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174257|NCT03632876|Protective Agents|protective agents|mesh-ancestor
139174258|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174259|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139174260|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174262|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
139174263|NCT03914755|Tucatinib|tucatinib|mesh-list
139174264|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174265|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139174266|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174267|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174268|NCT03905317|Bevacizumab|bevacizumab|mesh-list
139174269|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139174270|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174271|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139174272|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139174273|NCT03905317|Growth Substances|growth substances|mesh-ancestor
139174274|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174275|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
139174277|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
139174278|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139174279|NCT01251991|Psyllium|psyllium|mesh-list
139174280|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
139174281|NCT01251991|Cathartics|cathartics|mesh-ancestor
139174282|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139174283|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
139174284|NCT04458454|Methocarbamol|methocarbamol|mesh-list
139174285|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138959304|NCT02558816|Venetoclax|venetoclax|mesh-list
138964388|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139174286|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174287|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139174288|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174289|NCT03914677|Mecamylamine|mecamylamine|mesh-list
139174290|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139174291|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
139174292|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
139174293|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174294|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174295|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139174296|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139174297|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
139174298|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139174299|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174300|NCT03479086|Topiramate|topiramate|mesh-list
139174301|NCT03479086|Naltrexone|naltrexone|mesh-list
139174302|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139174303|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139174304|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174305|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
139174306|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174308|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139174309|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
139174310|NCT01252069|Progestins|progestins|mesh-list
139174311|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139174312|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
139174313|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139174314|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174315|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139174316|NCT01252069|Hormones|hormones|mesh-ancestor
139174317|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139174318|NCT01252225|Lidocaine|lidocaine|mesh-list
139174319|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
139174320|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
139174321|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139174322|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174323|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
139174324|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174325|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139174326|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139174327|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139174328|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174329|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174330|NCT04459702|Ritonavir|ritonavir|mesh-list
139174331|NCT04459702|Lopinavir|lopinavir|mesh-list
139174332|NCT04459702|Azithromycin|azithromycin|mesh-list
139174333|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
139174334|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139174335|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139174336|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
139174337|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174338|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174339|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139174340|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138959705|NCT00946335|Temozolomide|temozolomide|mesh-list
139174341|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
139174342|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139174343|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139174344|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139174345|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139174346|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
139174347|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139174348|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139174349|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174350|NCT03574792|Oxycodone|oxycodone|mesh-list
139174351|NCT03574792|Methadone|methadone|mesh-list
139174352|NCT03574792|Gabapentin|gabapentin|mesh-list
139174353|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139174354|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139174355|NCT03574792|Narcotics|narcotics|mesh-ancestor
139174356|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900302|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
139174357|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174358|NCT03574792|Analgesics|analgesics|mesh-ancestor
139174359|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
138959890|NCT00764972|Sorafenib|sorafenib|mesh-list
139174360|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174361|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
139174362|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139174363|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139174364|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139174365|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139174366|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139174367|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139174368|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174369|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
139174370|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
138960032|NCT00811200|Triamcinolone|triamcinolone|mesh-list
139174371|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
139174372|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139174373|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139174374|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174375|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139174376|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
139174378|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
139174379|NCT01250743|Vitamins|vitamins|mesh-list
139174380|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
139174381|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
139174382|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174383|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
139174384|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174385|NCT01250743|Protective Agents|protective agents|mesh-ancestor
138924851|NCT04366518|Rivastigmine|rivastigmine|mesh-list
139174386|NCT01254175|Vaccines|vaccines|mesh-list
139174387|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
139174388|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174389|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139174390|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139174391|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174392|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174393|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139174394|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
139174395|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139174396|NCT03903367|Fentanyl|fentanyl|mesh-list
139174397|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139174398|NCT03903367|Narcotics|narcotics|mesh-ancestor
138960096|NCT00655668|Lenalidomide|lenalidomide|mesh-list
139174399|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139174400|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174401|NCT03903367|Analgesics|analgesics|mesh-ancestor
139174402|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
139174403|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174404|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139174405|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139174406|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
139174407|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
139174408|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
139174409|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139174410|NCT03717168|Hormones|hormones|mesh-list
139174411|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138964450|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139174412|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174413|NCT00708448|Bevacizumab|bevacizumab|mesh-list
139174414|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139174415|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139174416|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174417|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139174418|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139174419|NCT00708448|Growth Substances|growth substances|mesh-ancestor
139174420|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174421|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
139174422|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139174423|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174424|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174426|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139174427|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174428|NCT03478306|Melatonin|melatonin|mesh-list
138960203|NCT00811980|Vancomycin|vancomycin|mesh-list
139174430|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174431|NCT03478306|Protective Agents|protective agents|mesh-ancestor
139174432|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174433|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139174435|NCT03103100|Bupivacaine|bupivacaine|mesh-list
139174436|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
139174437|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
139174438|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139174439|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174440|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
139174441|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174442|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139174443|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139174444|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139174445|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138960394|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
139174446|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174447|NCT03639168|Cisplatin|cisplatin|mesh-list
139174448|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174449|NCT03131050|Scopolamine|scopolamine|mesh-list
139174450|NCT03131050|Escitalopram|escitalopram|mesh-list
139174451|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139174452|NCT03131050|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139174453|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139174454|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174455|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174456|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139174457|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
139174458|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924927|NCT00732758|Vitamin D|vitamin d|mesh-list
139174460|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
139174461|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174462|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139174463|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139174464|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
139174465|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139174466|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
138960531|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
139174467|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139174468|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
139174469|NCT03719820|Clopidogrel|clopidogrel|mesh-list
139174470|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139174471|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174472|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960593|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139174473|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139174474|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174475|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139174476|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139174477|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139174478|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
139174479|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139174480|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139174481|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139174482|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
139174483|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139174484|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139174485|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139174486|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139174487|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139174488|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139174489|NCT01254799|Doxycycline|doxycycline|mesh-list
139174490|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139174491|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139174492|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
139174493|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139174494|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139174511|NCT03718806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174513|NCT03716856|Fludarabine|fludarabine|mesh-list
139174514|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139174515|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
139174516|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174517|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174518|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139174519|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
138706466|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174520|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174521|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174522|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139174523|NCT03910543|Tofacitinib|tofacitinib|mesh-list
139174524|NCT03910543|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139174525|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139174526|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706531|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174527|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174528|NCT03101462|Vaccines|vaccines|mesh-list
138964523|NCT00524680|Vitamin D|vitamin d|mesh-list
139174529|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
139174530|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174531|NCT03904537|Antibodies|antibodies|mesh-list
139174532|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
138925005|NCT00738530|Growth Substances|growth substances|mesh-ancestor
139174533|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964537|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174536|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
139174537|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174538|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174539|NCT03910231|Tolvaptan|tolvaptan|mesh-list
139174540|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139174541|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174542|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
139174543|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174544|NCT01149109|Temozolomide|temozolomide|mesh-list
139174545|NCT01149109|Lomustine|lomustine|mesh-list
139174546|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139174547|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
139174548|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174549|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174550|NCT05667415|Cisplatin|cisplatin|mesh-list
139174552|NCT05667415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174553|NCT05667415|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139174554|NCT05667415|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139174555|NCT05667415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174556|NCT05667415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174557|NCT01586143|Acetaminophen|acetaminophen|mesh-list
139174558|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138706859|NCT01818921|CKD732|ckd732|mesh-list
139174560|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
139174561|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174562|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174563|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
139174564|NCT01256359|Docetaxel|docetaxel|mesh-list
139174565|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174566|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
139174567|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
138964604|NCT00524134|Carvedilol|carvedilol|mesh-list
139174569|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174570|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139174571|NCT02527993|Liraglutide|liraglutide|mesh-list
139174572|NCT02527993|Acarbose|acarbose|mesh-list
139174573|NCT02527993|Verapamil|verapamil|mesh-list
139174574|NCT02527993|Pasireotide|pasireotide|mesh-list
139174575|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139174576|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174577|NCT02527993|Incretins|incretins|mesh-ancestor
139174578|NCT02527993|Hormones|hormones|mesh-ancestor
139174579|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139174580|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139174581|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
139174582|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174583|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174584|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139174585|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139174586|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174587|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139174588|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
139174589|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139174590|NCT01149499|Valacyclovir|valacyclovir|mesh-list
139174591|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
139174592|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139174593|NCT03900871|Aspirin|aspirin|mesh-list
139174594|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139174595|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139174596|NCT03900871|Analgesics|analgesics|mesh-ancestor
139174597|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
139174598|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174599|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174600|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139174602|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139174603|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139174604|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174605|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139174606|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139174607|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174608|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
139174610|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
139174611|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
139174612|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174613|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174614|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139174615|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139174616|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139174617|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139174618|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139174619|NCT01149577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139174620|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139174621|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138900401|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174622|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174623|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139174624|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
139174625|NCT03894007|Maytansine|maytansine|mesh-list
139174626|NCT03894007|Docetaxel|docetaxel|mesh-list
139174627|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139174628|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
139174629|NCT03894007|Carboplatin|carboplatin|mesh-list
139174630|NCT03894007|Trastuzumab|trastuzumab|mesh-list
139174631|NCT03894007|Atezolizumab|atezolizumab|mesh-list
139174632|NCT03894007|Epirubicin|epirubicin|mesh-list
139174633|NCT03894007|Pertuzumab|pertuzumab|mesh-list
139174634|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139174635|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174636|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
139174637|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
139174638|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
139174639|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174640|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139174641|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
139174642|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174643|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174644|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139174645|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
139174646|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139174647|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139174648|NCT03894007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139174649|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139174650|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139174651|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139174652|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174653|NCT03894007|Immunotoxins|immunotoxins|mesh-ancestor
139174654|NCT03894007|Immunoconjugates|immunoconjugates|mesh-ancestor
139174655|NCT01150747|Azithromycin|azithromycin|mesh-list
139174656|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
139174657|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139174658|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139174659|NCT03893695|Nivolumab|nivolumab|mesh-list
139174660|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139174661|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174662|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139174663|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174664|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139174665|NCT01258309|Ketorolac|ketorolac|mesh-list
139174666|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138900436|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174667|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139174668|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139174669|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139174670|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139174671|NCT01258309|Analgesics|analgesics|mesh-ancestor
139174672|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
139174673|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174674|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174675|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139174676|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174677|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139174678|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174679|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174680|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139174681|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139174682|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139174683|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
139174685|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139174686|NCT01256905|Modafinil|modafinil|mesh-list
139174687|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139174688|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174689|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139174690|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139174691|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139174692|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174693|NCT01586299|Acetaminophen|acetaminophen|mesh-list
139174694|NCT01586299|Ibuprofen|ibuprofen|mesh-list
139174695|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139174696|NCT01586299|Analgesics|analgesics|mesh-ancestor
139174697|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
139174698|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174699|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174700|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
139174701|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139174702|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139174703|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174704|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139174705|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174706|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174708|NCT02874794|Enalapril|enalapril|mesh-list
139174709|NCT02874794|Enalaprilat|enalaprilat|mesh-list
139174710|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139174711|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139174712|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139174713|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139174714|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174715|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139174716|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
139174717|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174718|NCT03102710|Lidocaine|lidocaine|mesh-list
139174719|NCT03102710|Capsaicin|capsaicin|mesh-list
139174720|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
138707251|NCT00533858|Losartan|losartan|mesh-list
139174722|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139174723|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174724|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
139174725|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174726|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139174727|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139174728|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139174729|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174730|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174731|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
139174732|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
139174733|NCT01149967|Dexetimide|dexetimide|mesh-list
139174734|NCT01149967|Citalopram|citalopram|mesh-list
139174735|NCT01149967|Escitalopram|escitalopram|mesh-list
139174736|NCT01149967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139174737|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139174738|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174739|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174740|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139174742|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174743|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139174744|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
139174745|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139174746|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139174747|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139174748|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
139174749|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
139174750|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174751|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139174752|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139174753|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
139174754|NCT05505409|Pirfenidone|pirfenidone|mesh-list
139174755|NCT05505409|Glucocorticoids|glucocorticoids|mesh-list
139174756|NCT05505409|Immunosuppressive Agents|immunosuppressive agents|mesh-list
139174757|NCT05505409|Hormones|hormones|mesh-ancestor
139174758|NCT05505409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139174759|NCT05505409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174760|NCT05505409|Analgesics|analgesics|mesh-ancestor
139174761|NCT05505409|Sensory System Agents|sensory system agents|mesh-ancestor
139174762|NCT05505409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174763|NCT05505409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139174764|NCT05505409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139174765|NCT05505409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139174766|NCT05505409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174767|NCT05505409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174768|NCT05505409|Immunologic Factors|immunologic factors|mesh-ancestor
139174769|NCT04770740|Vitamin K|vitamin k|mesh-list
139174770|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
139174771|NCT04770740|Menaquinone 7|menaquinone 7|mesh-list
139174772|NCT04770740|Vitamins|vitamins|mesh-ancestor
139174773|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
139174774|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174775|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139174776|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139174777|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174778|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
139174779|NCT04770740|Coagulants|coagulants|mesh-ancestor
139174780|NCT03896971|Cyclosporine|cyclosporine|mesh-list
139174781|NCT03896971|Cyclosporins|cyclosporins|mesh-list
139174782|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174783|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174784|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139174785|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
139174786|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174788|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139174789|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
139174790|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174791|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139174792|NCT01258777|Golimumab|golimumab|mesh-list
139174793|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139174794|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139174795|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139174796|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139174797|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
139174798|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174799|NCT03896893|Emollients|emollients|mesh-list
139174800|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
139174801|NCT01257373|Cobalt|cobalt|mesh-list
139174802|NCT01257373|Chromium|chromium|mesh-list
139174803|NCT01257373|Sirolimus|sirolimus|mesh-list
139174804|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139174805|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139174806|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139174807|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174808|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
139174809|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139174810|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
139174811|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174812|NCT01257373|Trace Elements|trace elements|mesh-ancestor
139174813|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
139174814|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
139174815|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139174816|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139174817|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174818|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
138900518|NCT02642861|Antacids|antacids|mesh-ancestor
139174819|NCT03899233|Coagulants|coagulants|mesh-ancestor
139174820|NCT03101150|Vitamin D|vitamin d|mesh-list
139174821|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
139174822|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
139174823|NCT03101150|Vitamins|vitamins|mesh-list
139174824|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
139174825|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174826|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139174827|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139174828|NCT03899077|Goserelin|goserelin|mesh-list
139174829|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139174830|NCT03899077|Leuprolide|leuprolide|mesh-list
139174831|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139174832|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174833|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
139174834|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139174835|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
139174836|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139174837|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174838|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139174839|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139174840|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
139174841|NCT01255579|Fluticasone|fluticasone|mesh-list
139174842|NCT01255579|Beclomethasone|beclomethasone|mesh-list
139174843|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
139174844|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139174845|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139174846|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139174847|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139174848|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
139174849|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174850|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174851|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139174852|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
139174853|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
139174854|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139174855|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139174856|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139174857|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139174858|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
139174860|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174861|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
139174862|NCT01255579|Hormones|hormones|mesh-ancestor
139174863|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139174864|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
139174865|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139174866|NCT03101930|Liraglutide|liraglutide|mesh-list
139174867|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139174868|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174869|NCT03101930|Incretins|incretins|mesh-ancestor
139174870|NCT03101930|Hormones|hormones|mesh-ancestor
138707615|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139174871|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139174872|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139174873|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
139174874|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174875|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174876|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139174877|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139174878|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139174879|NCT05415254|Calcitriol|calcitriol|mesh-list
139174880|NCT05415254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139174881|NCT05415254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174882|NCT05415254|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139174883|NCT05415254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174884|NCT05415254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174885|NCT05415254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139174886|NCT05415254|Vitamins|vitamins|mesh-ancestor
139174887|NCT05415254|Micronutrients|micronutrients|mesh-ancestor
139174888|NCT05415254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139174889|NCT01150201|Losartan|losartan|mesh-list
139174890|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139174891|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139174892|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139174893|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139174894|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174895|NCT01257451|Vildagliptin|vildagliptin|mesh-list
139174896|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139174897|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174898|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139174899|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
139174900|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174901|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174902|NCT01257529|Pregabalin|pregabalin|mesh-list
139174903|NCT01257529|Analgesics|analgesics|mesh-ancestor
139174904|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
139174905|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174906|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925380|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139174907|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
139174908|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139174909|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174910|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174911|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139174913|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139174914|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139174915|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139174916|NCT03896113|Celecoxib|celecoxib|mesh-list
138707792|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
139174917|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139174918|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139174920|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
139174921|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174922|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174923|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139174924|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174925|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139174926|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139174927|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174928|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174929|NCT03100838|Nifedipine|nifedipine|mesh-list
139174930|NCT03100838|Omeprazole|omeprazole|mesh-list
139174931|NCT03100838|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
139174932|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139174933|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139174934|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139174935|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174936|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174937|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139174938|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139174939|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139174940|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174941|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
139174943|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139174944|NCT01260025|Endostatins|endostatins|mesh-list
139174945|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174946|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139174947|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139174948|NCT01260025|Growth Substances|growth substances|mesh-ancestor
139174949|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174950|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
139174951|NCT03892525|Atezolizumab|atezolizumab|mesh-list
139174952|NCT03892525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139174953|NCT03892525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174954|NCT03892525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139174955|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174956|NCT05418452|Metformin|metformin|mesh-list
139174957|NCT05418452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139174958|NCT05418452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174959|NCT01260103|Temozolomide|temozolomide|mesh-list
139174960|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139174961|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
138707980|NCT00554346|Analgesics|analgesics|mesh-ancestor
139174962|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174963|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174965|NCT03480750|Doxorubicin|doxorubicin|mesh-list
139174966|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139174967|NCT03480750|Trientine|trientine|mesh-list
139174968|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139174969|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139174970|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139174971|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139174972|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139174973|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174974|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
139174975|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
139174976|NCT03892447|Ferulic acid|ferulic acid|mesh-list
139174977|NCT03892447|Dopamine|dopamine|mesh-list
139174978|NCT03892447|Alprostadil|alprostadil|mesh-list
139174979|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139174980|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
139174982|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139174983|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139174984|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
139174985|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139174986|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139174988|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139174989|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
139174990|NCT03892447|Urological Agents|urological agents|mesh-ancestor
139174991|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139174992|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139174993|NCT03892447|Analgesics|analgesics|mesh-ancestor
139174994|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
139174995|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139174996|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139174997|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
139174998|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139174999|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139175000|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139175001|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139175002|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
139175003|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
139175004|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
139175005|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139175006|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139175007|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
139175008|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175009|NCT05250596|Colchicine|colchicine|mesh-list
139175010|NCT05250596|Atorvastatin|atorvastatin|mesh-list
139175011|NCT05250596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139175012|NCT05250596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139175013|NCT05250596|Antimetabolites|antimetabolites|mesh-ancestor
139175014|NCT05250596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175015|NCT05250596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138900638|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
139175016|NCT05250596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139175017|NCT05250596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175018|NCT05250596|Gout Suppressants|gout suppressants|mesh-ancestor
139175019|NCT05250596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139175020|NCT05250596|Tubulin Modulators|tubulin modulators|mesh-ancestor
139175021|NCT05250596|Antimitotic Agents|antimitotic agents|mesh-ancestor
139175022|NCT05250596|Mitosis Modulators|mitosis modulators|mesh-ancestor
139175023|NCT05250596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175024|NCT04788914|Charcoal|charcoal|mesh-list
139175025|NCT04788914|Antidotes|antidotes|mesh-ancestor
139175026|NCT04788914|Protective Agents|protective agents|mesh-ancestor
139175027|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175028|NCT03716622|Clarithromycin|clarithromycin|mesh-list
139175029|NCT03716622|Furazolidone|furazolidone|mesh-list
139175030|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139175031|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175032|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139175033|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175034|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175035|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139175036|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139175037|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139175038|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139175039|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139175040|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139175041|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139175042|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139175043|NCT03892213|Benzonidazole|benzonidazole|mesh-list
139175044|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139175045|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
139175046|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175047|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139175048|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139175049|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139175050|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175051|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
139175052|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139175053|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175054|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
139175055|NCT04881032|Temozolomide|temozolomide|mesh-list
138925531|NCT04061655|Iron|iron|mesh-list
139175056|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139175057|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
139175058|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175059|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175060|NCT03891979|Metronidazole|metronidazole|mesh-list
139175062|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
139175063|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139175064|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175065|NCT03891979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139175066|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175067|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708398|NCT02301234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139175068|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138900653|NCT04164797|Endostar protein|endostar protein|mesh-list
139175069|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139175070|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139175071|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139175072|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139175073|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175074|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139175075|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139175076|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
139175077|NCT01260415|Panitumumab|panitumumab|mesh-list
139175078|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175079|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139175080|NCT04608344|Atorvastatin|atorvastatin|mesh-list
139175081|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139175082|NCT04608344|Pravastatin|pravastatin|mesh-list
139175083|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138708605|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
139175085|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
139175086|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175087|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139175088|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139175089|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175090|NCT03891433|Meropenem|meropenem|mesh-list
139175091|NCT03891433|Tazobactam|tazobactam|mesh-list
139175092|NCT03891433|Piperacillin|piperacillin|mesh-list
139175093|NCT03891433|Ertapenem|ertapenem|mesh-list
139175094|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139175095|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175096|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139175097|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175098|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175099|NCT03895411|Sotalol|sotalol|mesh-list
139175100|NCT03895411|Propafenone|propafenone|mesh-list
139175101|NCT03895411|Metoprolol|metoprolol|mesh-list
139175102|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139175103|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139175104|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
139175105|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138708740|NCT00544349|Calcium|calcium|mesh-list
139175106|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175107|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175108|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139175109|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
139175110|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
139175111|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175112|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139175113|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139175114|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139175115|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139175116|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139175117|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139175118|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
139175119|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175120|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
139175122|NCT03888157|Liraglutide|liraglutide|mesh-list
139175123|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139175124|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708804|NCT05824455|Irinotecan|irinotecan|mesh-list
139175126|NCT03888157|Hormones|hormones|mesh-ancestor
139175127|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139175128|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
139175129|NCT01154491|Hematinics|hematinics|mesh-ancestor
139175130|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139175131|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
139175132|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139175133|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139175135|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
139175136|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175137|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175138|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139175139|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139175140|NCT01259479|Satraplatin|satraplatin|mesh-list
139175141|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175143|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
139175144|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175145|NCT03890809|Deucravacitinib|deucravacitinib|mesh-list
139175146|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
139175147|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139175148|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175149|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175150|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
139175151|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139175152|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139175153|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139175154|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138965021|NCT01564810|Cetuximab|cetuximab|mesh-list
139175155|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175156|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
139175157|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175158|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175159|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139175160|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175161|NCT01154569|Azithromycin|azithromycin|mesh-list
139175162|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139175163|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175164|NCT03891043|Selenium|selenium|mesh-list
139175165|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
139175166|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175167|NCT03891043|Protective Agents|protective agents|mesh-ancestor
139175168|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175169|NCT03891043|Trace Elements|trace elements|mesh-ancestor
139175170|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
139175171|NCT03890341|Drospirenone|drospirenone|mesh-list
139175172|NCT03890341|Midazolam|midazolam|mesh-list
139175173|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139175174|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139175175|NCT03890341|Betadex|betadex|mesh-list
139175176|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139175177|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139175178|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139175179|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175180|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139175181|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139175182|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139175183|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139175184|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
139175185|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
139175186|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
139175187|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
139175188|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175189|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175190|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139175191|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139175192|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139175193|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
139175194|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139175195|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139175196|NCT03890341|Estrogens|estrogens|mesh-ancestor
139175197|NCT03890341|Hormones|hormones|mesh-ancestor
139175198|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139175199|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139175200|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
139175201|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139175202|NCT03890341|Diuretics|diuretics|mesh-ancestor
139175203|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
139175204|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
138925677|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175205|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
139175206|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139175208|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139175209|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139175210|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965043|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
139175211|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
139175212|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175213|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175214|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139175215|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175216|NCT03894085|Paroxetine|paroxetine|mesh-list
139175217|NCT03894085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139175218|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139175219|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139175220|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175221|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175222|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
139175223|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175224|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139175225|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
139175226|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139175227|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139175228|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139175229|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175230|NCT01152931|Vitamins|vitamins|mesh-list
139175231|NCT01152931|Vitamin E|vitamin e|mesh-list
139175232|NCT01152931|Tocopherols|tocopherols|mesh-list
139175233|NCT01152931|Tocotrienols|tocotrienols|mesh-list
139175234|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
139175235|NCT01152931|Vitamin A|vitamin a|mesh-list
139175236|NCT01152931|Zinc|zinc|mesh-list
139175237|NCT01152931|Selenium|selenium|mesh-list
139175238|NCT01152931|Artesunate|artesunate|mesh-list
139175239|NCT01152931|Lumefantrine|lumefantrine|mesh-list
139175240|NCT01152931|Artemether|artemether|mesh-list
139175241|NCT01152931|Amodiaquine|amodiaquine|mesh-list
139175242|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
139175243|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
139175244|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709498|NCT03456401|Sorafenib|sorafenib|mesh-list
139175245|NCT01152931|Trace Elements|trace elements|mesh-ancestor
139175246|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
139175247|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175248|NCT01152931|Protective Agents|protective agents|mesh-ancestor
139175249|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
139175250|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139175251|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139175252|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175253|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175254|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
139175255|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
138709563|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
139175256|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139175258|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139175259|NCT01261117|Ibuprofen|ibuprofen|mesh-list
139175260|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138709632|NCT00546533|Etanercept|etanercept|mesh-list
139175261|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139175262|NCT01261117|Analgesics|analgesics|mesh-ancestor
139175263|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
139175264|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175265|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175266|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139175267|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139175268|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139175269|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175270|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175271|NCT03889717|Vitamin D|vitamin d|mesh-list
139175272|NCT03889717|Vitamins|vitamins|mesh-ancestor
139175273|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
139175274|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709764|NCT00548483|Hormones|hormones|mesh-ancestor
139175275|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139175277|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139175278|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139175279|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175280|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
139175281|NCT03885895|Coagulants|coagulants|mesh-ancestor
139175282|NCT01154647|Citalopram|citalopram|mesh-list
139175283|NCT01154647|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139175284|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139175285|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139175286|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175287|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175288|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
139175289|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175290|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139175291|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
139175292|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139175293|NCT01153165|Citalopram|citalopram|mesh-list
139175294|NCT01153165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138709831|NCT00560586|Budesonide|budesonide|mesh-list
139175295|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139175296|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139175297|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175298|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175299|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
139175300|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175301|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139175302|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
139175303|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139175304|NCT01155505|Lenalidomide|lenalidomide|mesh-list
139175305|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
139175306|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175307|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139175308|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139175309|NCT01155505|Growth Substances|growth substances|mesh-ancestor
139175310|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
139175311|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175312|NCT01153243|Vitamin D|vitamin d|mesh-list
139175313|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
139175314|NCT01153243|Vitamins|vitamins|mesh-ancestor
139175315|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
139175316|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175317|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139175318|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139175319|NCT03432858|Vancomycin|vancomycin|mesh-list
139175320|NCT03432858|Cefazolin|cefazolin|mesh-list
139175321|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139175322|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175323|NCT01154803|Micronutrients|micronutrients|mesh-list
139175324|NCT01154803|Trace Elements|trace elements|mesh-list
139175325|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175326|NCT03885427|Ketamine|ketamine|mesh-list
139175327|NCT03885427|Analgesics|analgesics|mesh-ancestor
138900765|NCT00690820|Pancrelipase|pancrelipase|mesh-list
139175328|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
138709938|NCT00549887|Insulin|insulin|mesh-list
139175329|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175330|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175331|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139175332|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139175333|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
139175334|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
139175335|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139175336|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139175337|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139175338|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175339|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175340|NCT03456960|Aspirin|aspirin|mesh-list
139175341|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139175342|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139175343|NCT03456960|Analgesics|analgesics|mesh-ancestor
139175344|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
139175345|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709999|NCT00550433|Hormones|hormones|mesh-ancestor
139175346|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175347|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139175348|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139175349|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139175350|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139175351|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175352|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139175353|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139175355|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
139175356|NCT03716388|Mesalamine|mesalamine|mesh-list
139175357|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139175358|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139175360|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
139175361|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710125|NCT00553124|Vitamin E|vitamin e|mesh-list
139175362|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175364|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139175365|NCT01311336|Loratadine|loratadine|mesh-list
139175366|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
139175367|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
139175368|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139175369|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139175370|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139175371|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
139175372|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
139175373|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175374|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175375|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175376|NCT03430986|Lidocaine|lidocaine|mesh-list
139175377|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
139175378|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
139175379|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139175380|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175381|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
139175382|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175383|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139175384|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139175385|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139175386|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139175387|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175388|NCT01261741|Memantine|memantine|mesh-list
139175389|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139175390|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139175391|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
139175392|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710193|NCT00559689|Budesonide|budesonide|mesh-list
139175393|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175394|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175395|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139175396|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139175397|NCT01157455|Aspirin|aspirin|mesh-list
139175398|NCT01157455|Everolimus|everolimus|mesh-list
139175399|NCT01157455|Heparin|heparin|mesh-list
139175400|NCT01157455|Bivalirudin|bivalirudin|mesh-list
139175401|NCT01157455|Clopidogrel|clopidogrel|mesh-list
139175402|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139175403|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139175404|NCT01157455|Analgesics|analgesics|mesh-ancestor
139175405|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
139175406|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175407|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175408|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139175409|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139175410|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139175411|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139175412|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710386|NCT00561756|Vaccines|vaccines|mesh-list
139175413|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139175414|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139175415|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175416|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
139175417|NCT01157455|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138900825|NCT00883337|Interferons|interferons|mesh-list
139175418|NCT01157455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139175419|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139175420|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
139175421|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175422|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139175423|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139175424|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139175425|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
139175426|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175427|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
139175428|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
139175429|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139175430|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
139175431|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139175433|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175435|NCT03884881|Imipenem|imipenem|mesh-list
139175436|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139175437|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175438|NCT01154881|Insulin|insulin|mesh-list
139175439|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139175440|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175441|NCT03886441|Beclomethasone|beclomethasone|mesh-list
139175442|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139175443|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
139175444|NCT03886441|Hormones|hormones|mesh-ancestor
139175445|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139175446|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175447|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139175448|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
139175449|NCT03713346|Caseins|caseins|mesh-list
139175450|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
139175451|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
139175452|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175453|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
139175454|NCT01154959|Rifampin|rifampin|mesh-list
139175455|NCT01154959|Isoniazid|isoniazid|mesh-list
139175456|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
139175457|NCT01154959|Ethambutol|ethambutol|mesh-list
139175458|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139175459|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175460|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139175461|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139175462|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175463|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175464|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175465|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139175466|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
139175467|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
138710630|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138900843|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
139175468|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139175469|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139175470|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139175471|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139175472|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139175473|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139175474|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139175475|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139175476|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139175478|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139175479|NCT03881293|Lidocaine|lidocaine|mesh-list
139175480|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
139175481|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
139175482|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139175483|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175484|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
139175485|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175486|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139175487|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139175488|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139175489|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139175490|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175491|NCT01155037|Vaccines|vaccines|mesh-list
139175492|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
139175493|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175494|NCT01261897|Ropivacaine|ropivacaine|mesh-list
139175495|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
139175496|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
139175497|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139175498|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175499|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
139175500|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175501|NCT03448536|Acetaminophen|acetaminophen|mesh-list
139175502|NCT03448536|Naproxen|naproxen|mesh-list
139175503|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139175504|NCT03448536|Analgesics|analgesics|mesh-ancestor
138925985|NCT00723710|Interferons|interferons|mesh-list
139175505|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
139175506|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710688|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
139175507|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175509|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139175510|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139175511|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139175512|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
139175513|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139175514|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175515|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175516|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
139175517|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139175518|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
139175519|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175520|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175521|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139175522|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
139175523|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139175524|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
139175525|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175526|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175527|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139175528|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
139175529|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
139175530|NCT01155115|Protective Agents|protective agents|mesh-ancestor
139175531|NCT03713190|Empagliflozin|empagliflozin|mesh-list
138710717|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
139175532|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139175533|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175534|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139175535|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175536|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
139175537|NCT03718182|Vitamin D|vitamin d|mesh-list
139175538|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139175539|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175540|NCT03718182|Vitamins|vitamins|mesh-ancestor
139175541|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
139175542|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139175543|NCT03881449|Aripiprazole|aripiprazole|mesh-list
139175544|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
139175545|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139175546|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139175547|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139175548|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138710764|NCT00562068|Doxorubicin|doxorubicin|mesh-list
139175549|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175550|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
139175551|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
139175552|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175553|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175554|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139175555|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139175556|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
139175557|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139175558|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139175559|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139175560|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139175561|NCT03884491|Vortioxetine|vortioxetine|mesh-list
139175562|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
139175563|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139175564|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139175565|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139175566|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139175567|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175568|NCT03884491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139175569|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139175570|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139175571|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175572|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175573|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
139175574|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139175575|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139175576|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139175577|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139175579|NCT03880981|Ibuprofen|ibuprofen|mesh-list
139175580|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139175581|NCT03880981|Analgesics|analgesics|mesh-ancestor
139175582|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
139175583|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175584|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175585|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
139175586|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139175587|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139175588|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139175589|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139175590|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175591|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175592|NCT03424044|Glucagon|glucagon|mesh-list
139175593|NCT03424044|Pancrelipase|pancrelipase|mesh-list
139175594|NCT03424044|Pancreatin|pancreatin|mesh-list
139175595|NCT03424044|Hormones|hormones|mesh-list
139175596|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139175597|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175598|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139175599|NCT03880903|Albuterol|albuterol|mesh-list
139175600|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139175601|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
139175602|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175603|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175604|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139175605|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
139175606|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
139175607|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139175608|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139175609|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139175611|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
139175612|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711146|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175613|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175615|NCT01155895|Benazepril|benazepril|mesh-list
139175616|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139175617|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139175618|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139175619|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175620|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139175621|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175622|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
139175623|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139175624|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
139175625|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175626|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
139175627|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139175628|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175629|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139175630|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139175631|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175632|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175633|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175634|NCT01589809|Niacinamide|niacinamide|mesh-list
139175635|NCT01589809|Niacin|niacin|mesh-list
139175636|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
139175638|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
139175639|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175640|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
139175641|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139175642|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
138711322|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
139175643|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175644|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139175645|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
139175646|NCT01264237|Etoricoxib|etoricoxib|mesh-list
139175647|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139175648|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139175650|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
139175651|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711466|NCT04617561|Hormones|hormones|mesh-ancestor
139175652|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175653|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139175654|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139175655|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139175656|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139175657|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175658|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175659|NCT03880825|Metformin|metformin|mesh-list
139175660|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139175661|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175663|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139175664|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139175665|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139175666|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139175667|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
138711693|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
139175668|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175669|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175670|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175671|NCT03880357|Betamethasone|betamethasone|mesh-list
139175672|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
139175673|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139175674|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
139175675|NCT03880357|Calcipotriene|calcipotriene|mesh-list
139175676|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139175677|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139175678|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
139175679|NCT03880357|Hormones|hormones|mesh-ancestor
139175680|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139175681|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175682|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139175683|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
139175684|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
138668126|NCT02957630|Hormones|hormones|mesh-ancestor
139175685|NCT01266031|Bevacizumab|bevacizumab|mesh-list
139175686|NCT01266031|Vorinostat|vorinostat|mesh-list
139175687|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139175688|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175689|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139175690|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139175692|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175693|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
139175694|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139175695|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175696|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175697|NCT03880045|Vasopressins|vasopressins|mesh-list
139175698|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
139175699|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
139175700|NCT03880045|Coagulants|coagulants|mesh-ancestor
139175701|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139175702|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139175703|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
139175704|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175705|NCT03879889|Nicotine|nicotine|mesh-list
139175706|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139175708|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175709|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175710|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139175711|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139175712|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
139175713|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175714|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175716|NCT01266187|Cetuximab|cetuximab|mesh-list
139175717|NCT01266187|Fluorouracil|fluorouracil|mesh-list
139175718|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
139175719|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139175720|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175721|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
139175722|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175723|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139175724|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139175725|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
139175726|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175727|NCT01266187|Antidotes|antidotes|mesh-ancestor
139175728|NCT01266187|Protective Agents|protective agents|mesh-ancestor
139175729|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
139175730|NCT01266187|Vitamins|vitamins|mesh-ancestor
139175731|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
139175732|NCT01586533|Mesalamine|mesalamine|mesh-list
139175733|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139175734|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139175735|NCT01586533|Analgesics|analgesics|mesh-ancestor
139175736|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
139175737|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175738|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175739|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139175740|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139175741|NCT03880123|Ixazomib|ixazomib|mesh-list
139175742|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175743|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
139175744|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175745|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175746|NCT01266499|Colistin|colistin|mesh-list
139175747|NCT01266499|Polymyxins|polymyxins|mesh-list
139175748|NCT01266499|Gentamicins|gentamicins|mesh-list
138900951|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
139175749|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138712215|NCT01952990|Sympathomimetics|sympathomimetics|mesh-ancestor
139175750|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175751|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139175752|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175753|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175754|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
139175755|NCT00075725|Leucovorin|leucovorin|mesh-list
139175756|NCT00075725|Folic Acid|folic acid|mesh-list
139175757|NCT00075725|Cytarabine|cytarabine|mesh-list
139175758|NCT00075725|Dexamethasone|dexamethasone|mesh-list
139175759|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
139175760|NCT00075725|Prednisone|prednisone|mesh-list
139175761|NCT00075725|Cortisone|cortisone|mesh-list
139175762|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
139175763|NCT00075725|Doxorubicin|doxorubicin|mesh-list
139175764|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139175765|NCT00075725|Methotrexate|methotrexate|mesh-list
138712266|NCT01941836|Ezetimibe|ezetimibe|mesh-list
139175766|NCT00075725|Vincristine|vincristine|mesh-list
139175767|NCT00075725|Daunorubicin|daunorubicin|mesh-list
139175768|NCT00075725|Asparaginase|asparaginase|mesh-list
139175769|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
139175770|NCT00075725|Pegaspargase|pegaspargase|mesh-list
139175771|NCT00075725|Thioguanine|thioguanine|mesh-list
139175772|NCT00075725|BB 1101|bb 1101|mesh-list
139175773|NCT00075725|Calcium|calcium|mesh-list
139175774|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
139175775|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
139175776|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139175777|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
139175778|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175779|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139175780|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139175781|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
139175782|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175783|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175784|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139175785|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139175786|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
139175787|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
139175788|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175789|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139175790|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
139175792|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139175793|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139175794|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
138712523|NCT01779947|Estradiol|estradiol|mesh-list
139175796|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139175797|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139175798|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138900959|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175799|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138712622|NCT04600089|Ketamine|ketamine|mesh-list
139175800|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139175801|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139175802|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
139175803|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139175804|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139175805|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
139175806|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
139175807|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139175808|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139175809|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
139175810|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175812|NCT00075725|Protective Agents|protective agents|mesh-ancestor
139175813|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
139175814|NCT00075725|Vitamins|vitamins|mesh-ancestor
139175815|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
139175816|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139175817|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
139175818|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
139175819|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
139175820|NCT00075725|Hematinics|hematinics|mesh-ancestor
139175821|NCT02953782|Cetuximab|cetuximab|mesh-list
139175822|NCT02953782|Magrolimab|magrolimab|mesh-list
139175823|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139175824|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175825|NCT01264783|RNS60|rns60|mesh-list
139175826|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139175827|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139175828|NCT01264783|Analgesics|analgesics|mesh-ancestor
139175829|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
139175830|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175831|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175832|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139175833|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139175834|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139175835|NCT01160029|Nateglinide|nateglinide|mesh-list
139175836|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139175837|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175838|NCT00057863|Paclitaxel|paclitaxel|mesh-list
139175839|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
138713006|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175840|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139175841|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175842|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
139175843|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
139175844|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
139175845|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175846|NCT01266655|Baclofen|baclofen|mesh-list
139175847|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139175848|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175849|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139175850|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175851|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139175852|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
139175853|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
139175854|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175855|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175856|NCT00075023|Thalidomide|thalidomide|mesh-list
139175857|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139175858|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
139175859|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175860|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
139175861|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139175862|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175863|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139175864|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139175865|NCT00075023|Growth Substances|growth substances|mesh-ancestor
139175866|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
139175867|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175868|NCT01100801|Cisplatin|cisplatin|mesh-list
139175869|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
139175870|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175871|NCT01263145|Paclitaxel|paclitaxel|mesh-list
138713274|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
139175872|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139175873|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175874|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
139175875|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
139175876|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
139175877|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175878|NCT03717558|Ivermectin|ivermectin|mesh-list
139175879|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139175880|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175881|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
139175882|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
139175883|NCT00074711|Calcium|calcium|mesh-list
139175884|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139175885|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175886|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139175888|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175890|NCT03960905|Meropenem|meropenem|mesh-list
139175891|NCT03960905|Ceftazidime|ceftazidime|mesh-list
139175892|NCT03960905|Cefepime|cefepime|mesh-list
139175893|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
139175894|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139175895|NCT05619120|Mexiletine|mexiletine|mesh-list
139175896|NCT05619120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139175897|NCT05619120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139175898|NCT05619120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139175899|NCT05619120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139175900|NCT05619120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175901|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
139175902|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139175903|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139175904|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139175905|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139175906|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139175907|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139175908|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
139175909|NCT01265017|Estradiol|estradiol|mesh-list
139175910|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139175911|NCT01265017|Hormones|hormones|mesh-ancestor
139175912|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139175913|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175914|NCT01265017|Estrogens|estrogens|mesh-ancestor
139175915|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139175916|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
139175917|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139175918|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139175919|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139175920|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139175921|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139175922|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139175923|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139175924|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139175925|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175926|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139175927|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
139175928|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175929|NCT03879811|Nivolumab|nivolumab|mesh-list
139175930|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139175931|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175932|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139175933|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175934|NCT01158859|Pregabalin|pregabalin|mesh-list
139175935|NCT01158859|Analgesics|analgesics|mesh-ancestor
139175937|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175938|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175939|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
139175940|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138713805|NCT00567450|Ropivacaine|ropivacaine|mesh-list
139175941|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139175942|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175943|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139175944|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139175945|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138713877|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175946|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139175947|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139175948|NCT01100021|Doxazosin|doxazosin|mesh-list
139175949|NCT01100021|Tamsulosin|tamsulosin|mesh-list
139175950|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139175951|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139175952|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139175953|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
139175954|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139175955|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175956|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175957|NCT01100021|Urological Agents|urological agents|mesh-ancestor
138965269|NCT04043676|Ponatinib|ponatinib|mesh-list
139175958|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139175959|NCT03407430|Pregabalin|pregabalin|mesh-list
139175960|NCT03407430|Analgesics|analgesics|mesh-ancestor
138714012|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
139175961|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
139175962|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175963|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175964|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
139175965|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139175966|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139175967|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175968|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139175969|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139175970|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139175971|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139175972|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139175973|NCT01266811|Dexamethasone|dexamethasone|mesh-list
139175974|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
139175975|NCT01266811|Bortezomib|bortezomib|mesh-list
139175976|NCT01266811|Siltuximab|siltuximab|mesh-list
139175977|NCT01266811|BB 1101|bb 1101|mesh-list
139175978|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139175979|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
139175980|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
139175981|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139175982|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175983|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139175984|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
139175985|NCT01266811|Hormones|hormones|mesh-ancestor
139175986|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139175987|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139175988|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139175989|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
139175990|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139175991|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139175992|NCT01158937|Meropenem|meropenem|mesh-list
139175993|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139175994|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139175995|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
139175996|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139175997|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139175998|NCT01100177|Sunitinib|sunitinib|mesh-list
139175999|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176000|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139176001|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139176002|NCT01100177|Growth Substances|growth substances|mesh-ancestor
139176003|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176004|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
139176005|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139176006|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176007|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176008|NCT01100333|Hormones|hormones|mesh-list
139176009|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139176010|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138714199|NCT01151098|Buprenorphine|buprenorphine|mesh-list
139176011|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176012|NCT01327235|Cisplatin|cisplatin|mesh-list
139176013|NCT01327235|Endostar protein|endostar protein|mesh-list
139176014|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176015|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139176016|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139176017|NCT01327235|Growth Substances|growth substances|mesh-ancestor
139176018|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176019|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
139176021|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139176022|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
139176023|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139176024|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176025|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176026|NCT01089179|Metformin|metformin|mesh-list
139176027|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139176028|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176029|NCT01160185|Paclitaxel|paclitaxel|mesh-list
139176030|NCT01160185|Topotecan|topotecan|mesh-list
139176031|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139176032|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139176033|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
139176035|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
138714309|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
139176036|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139176037|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139176038|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139176039|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139176040|NCT03419364|Niacinamide|niacinamide|mesh-list
139176041|NCT03419364|Niacin|niacin|mesh-list
139176042|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
139176043|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
139176044|NCT03419364|Vitamins|vitamins|mesh-ancestor
139176045|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
139176046|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139176047|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139176048|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
139176049|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901085|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
139035569|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139035570|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
139035571|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139035572|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139035573|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139035574|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
139035575|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035576|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139035578|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
139035579|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035580|NCT01323374|Carbidopa|carbidopa|mesh-list
139035581|NCT01323374|Droxidopa|droxidopa|mesh-list
139035582|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139035583|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139035584|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
139035585|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035586|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035587|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035588|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139035589|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035590|NCT00431964|Azithromycin|azithromycin|mesh-list
139035591|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139035592|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035593|NCT00431496|Cinacalcet|cinacalcet|mesh-list
139035594|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139035595|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035596|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139035597|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
139035598|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035599|NCT00316173|Carboplatin|carboplatin|mesh-list
139035600|NCT00316173|Topotecan|topotecan|mesh-list
139035601|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035602|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139035603|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139035604|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035605|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035606|NCT00412542|Thalidomide|thalidomide|mesh-list
139035607|NCT00412542|Irinotecan|irinotecan|mesh-list
139035608|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139035609|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139035610|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035611|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035612|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035613|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139035614|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
139035615|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035616|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
139035617|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139035618|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035619|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139035620|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139035621|NCT00412542|Growth Substances|growth substances|mesh-ancestor
139035622|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
139035623|NCT00316017|Dextrans|dextrans|mesh-list
139035624|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
139035625|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
139035626|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
139035627|NCT00451178|Prednisone|prednisone|mesh-list
139035628|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
139035629|NCT00451178|Rituximab|rituximab|mesh-list
139035630|NCT00451178|Doxorubicin|doxorubicin|mesh-list
139035631|NCT00451178|Vincristine|vincristine|mesh-list
139035632|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139035633|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
138562302|NCT00425152|Leucovorin|leucovorin|mesh-list
139035634|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035635|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139035636|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139035637|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
139035638|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035639|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035640|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139035641|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139035642|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139035643|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139035644|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139035645|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035646|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139035648|NCT00451178|Hormones|hormones|mesh-ancestor
139035649|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035650|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139035651|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139035652|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
139035653|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
139035654|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
139035655|NCT00450866|Epothilones|epothilones|mesh-list
139035656|NCT00450866|Epothilone B|epothilone b|mesh-list
139035657|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
139035658|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
139035659|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
139035660|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035661|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035662|NCT01026584|Aripiprazole|aripiprazole|mesh-list
139035663|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
139035664|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139035665|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139035666|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139035667|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139035668|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035669|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
139035670|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
139035671|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035672|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035673|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139035674|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139035675|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
139035676|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139035677|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139035678|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139035679|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139035680|NCT01023464|Emollients|emollients|mesh-list
139035681|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139035682|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139035683|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
139035685|NCT01023542|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138703952|NCT06225440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138703953|NCT06225440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138703954|NCT06225440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138703955|NCT06225440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138703956|NCT06225440|Antiviral Agents|antiviral agents|mesh-ancestor
138703957|NCT06225440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703958|NCT06225440|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138703959|NCT06225440|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138990117|NCT05291403|Erythromycin stearate|erythromycin stearate|mesh-list
139035686|NCT01023542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139035687|NCT01023542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035688|NCT01023542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035689|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139035690|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
139035691|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035692|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035694|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
139035695|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139035696|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035697|NCT01028534|Olmesartan|olmesartan|mesh-list
139035698|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139035699|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
139035700|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
139035701|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
139035702|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139035703|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035704|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139035705|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139035706|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035707|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139035708|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139035710|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139035711|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
139035712|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035713|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139035714|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139035715|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035716|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035717|NCT00441584|Ribavirin|ribavirin|mesh-list
139035718|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139035719|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
139035720|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
139035721|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035722|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
138496654|NCT00112567|Fludarabine|fludarabine|mesh-list
139035723|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035724|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
139035725|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035726|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
139035727|NCT00430716|Citric Acid|citric acid|mesh-list
139035728|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
139035729|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
139035730|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139035731|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
139035732|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
139035733|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035734|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
139035735|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139035736|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139035737|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035738|NCT00430716|Urological Agents|urological agents|mesh-ancestor
139035739|NCT01028768|Teduglutide|teduglutide|mesh-list
139035740|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139035741|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139035742|NCT01028768|Protective Agents|protective agents|mesh-ancestor
139035743|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035744|NCT00441272|Pioglitazone|pioglitazone|mesh-list
139035745|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139035746|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035747|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139035748|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
139035749|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035750|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139035751|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139035752|NCT01028924|Teduglutide|teduglutide|mesh-list
139035753|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139035754|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139035755|NCT01028924|Protective Agents|protective agents|mesh-ancestor
139035756|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035757|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139035759|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139035760|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139035761|NCT00430638|Diuretics|diuretics|mesh-ancestor
139035762|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
139035763|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035764|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139035765|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139035766|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035767|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139035768|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139035769|NCT03671330|Letrozole|letrozole|mesh-list
139035770|NCT03671330|Goserelin|goserelin|mesh-list
139035771|NCT03671330|Anastrozole|anastrozole|mesh-list
139035772|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035773|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139035774|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139035775|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562638|NCT03975439|Chrysarobin|chrysarobin|mesh-list
139035776|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035778|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
139035779|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138496736|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035780|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035781|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139035782|NCT01038882|Midazolam|midazolam|mesh-list
139035783|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139035784|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139035785|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139035786|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035787|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139035788|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139035789|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139035790|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139035791|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
139035792|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
139035793|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
139035794|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
139035795|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035796|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035797|NCT00449930|Metformin|metformin|mesh-list
139035798|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139035799|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139035800|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035801|NCT00449930|Incretins|incretins|mesh-ancestor
139035802|NCT00449930|Hormones|hormones|mesh-ancestor
139035803|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562768|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
139035804|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139035805|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
139035806|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035807|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035809|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139035810|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139035811|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035812|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035813|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
139035814|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035815|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035816|NCT01024322|Diclofenac|diclofenac|mesh-list
139035817|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
139035818|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139035819|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
139035820|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139035821|NCT01024322|Prednisolone|prednisolone|mesh-list
139035822|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139035823|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
139035824|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139035825|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139035826|NCT01024322|Analgesics|analgesics|mesh-ancestor
139035827|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
139035828|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035829|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035830|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139035831|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138496834|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
139035832|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139035833|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035834|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035835|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
139035836|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
139035837|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139035838|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
139035839|NCT01024322|Hormones|hormones|mesh-ancestor
139035840|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035841|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139035842|NCT01024322|Protective Agents|protective agents|mesh-ancestor
139035843|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139035844|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035845|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139035846|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035847|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035848|NCT01566266|Amoxicillin|amoxicillin|mesh-list
139035849|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139035850|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035851|NCT00430248|Allopurinol|allopurinol|mesh-list
139035852|NCT00430248|Febuxostat|febuxostat|mesh-list
139035853|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
139035854|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035855|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035856|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
139035857|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139035858|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139035859|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
139035860|NCT00430248|Protective Agents|protective agents|mesh-ancestor
139035861|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035862|NCT00411762|Capecitabine|capecitabine|mesh-list
139035863|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139035864|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
138496869|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
139035865|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035866|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035867|NCT00429858|Gemcitabine|gemcitabine|mesh-list
139035868|NCT00429858|Tegafur|tegafur|mesh-list
139035869|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139035870|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
139035871|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035872|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035873|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
139035874|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139035875|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
139035876|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035877|NCT00449150|Cetrorelix|cetrorelix|mesh-list
139035878|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139035879|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
139035880|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139035881|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035882|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
139035883|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035884|NCT00428844|Vancomycin|vancomycin|mesh-list
139035885|NCT00428844|Daptomycin|daptomycin|mesh-list
139035886|NCT00428844|Teicoplanin|teicoplanin|mesh-list
139035887|NCT00428844|Floxacillin|floxacillin|mesh-list
139035889|NCT00428844|Nafcillin|nafcillin|mesh-list
139035890|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139035891|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035892|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139035893|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
139035894|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035895|NCT01039194|Galantamine|galantamine|mesh-list
139035896|NCT01039194|BMS 708163|bms 708163|mesh-list
139035897|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139035898|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035899|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035900|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
139035901|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035902|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035903|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139035904|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
139035905|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035906|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
139035907|NCT01039194|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139035908|NCT00449072|Loratadine|loratadine|mesh-list
139035909|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
139035910|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
139035911|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139035912|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139035913|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139035914|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
139035915|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
139035916|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035917|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035918|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035919|NCT00419094|Levetiracetam|levetiracetam|mesh-list
139035920|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
139035921|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
139035922|NCT00448916|Pregabalin|pregabalin|mesh-list
139035923|NCT00448916|Analgesics|analgesics|mesh-ancestor
139035924|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
139035925|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035926|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035927|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
139035928|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139035929|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139035930|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035931|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139035932|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139035933|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139035934|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139035935|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139035936|NCT00418938|Leucovorin|leucovorin|mesh-list
139035937|NCT00418938|Bevacizumab|bevacizumab|mesh-list
139035939|NCT00418938|Fluorouracil|fluorouracil|mesh-list
139035940|NCT00418938|Irinotecan|irinotecan|mesh-list
139035941|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139035942|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035943|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139035944|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139035945|NCT00418938|Growth Substances|growth substances|mesh-ancestor
139035946|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035947|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
139035948|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
139035949|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035950|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139035951|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139035952|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
139035953|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139035954|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139035955|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035956|NCT00418938|Antidotes|antidotes|mesh-ancestor
139035957|NCT00418938|Protective Agents|protective agents|mesh-ancestor
139035958|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
139035959|NCT00418938|Vitamins|vitamins|mesh-ancestor
139035960|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
139035961|NCT00448760|Leucovorin|leucovorin|mesh-list
139035962|NCT00448760|Docetaxel|docetaxel|mesh-list
139035963|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
139035964|NCT00448760|Floxuridine|floxuridine|mesh-list
139035966|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
139035967|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
139035968|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
139035969|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035970|NCT00448760|Antidotes|antidotes|mesh-ancestor
139035971|NCT00448760|Protective Agents|protective agents|mesh-ancestor
139035972|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035973|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
139035974|NCT00448760|Vitamins|vitamins|mesh-ancestor
139035975|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
139035976|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139035977|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
139035978|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
139035979|NCT01039350|Hematinics|hematinics|mesh-ancestor
139035980|NCT01039506|Irinotecan|irinotecan|mesh-list
139035981|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139035982|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139035983|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035984|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035985|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035986|NCT01033500|Abatacept|abatacept|mesh-list
139035987|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139035988|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035989|NCT01033500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139035990|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035991|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139035992|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
139035993|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035994|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139035995|NCT01035450|Sirolimus|sirolimus|mesh-list
139035996|NCT01035450|Everolimus|everolimus|mesh-list
139035997|NCT01035450|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139035998|NCT01035450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139035999|NCT01035450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036000|NCT01035450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036001|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036002|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
139036003|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036004|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036005|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139036006|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139036007|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139036008|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
139036009|NCT01035528|Metformin|metformin|mesh-list
139036010|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
139036011|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139036012|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036013|NCT01033656|Methotrexate|methotrexate|mesh-list
139036014|NCT01033656|Azathioprine|azathioprine|mesh-list
139036015|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139036016|NCT01033656|Leflunomide|leflunomide|mesh-list
139036017|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139036018|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
139036019|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139036020|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036021|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139036022|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
139036023|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036024|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036025|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
139036026|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036027|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139036028|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036029|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
139036030|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036031|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139036032|NCT01039740|Mirtazapine|mirtazapine|mesh-list
139036033|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
139036034|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139036035|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139036036|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
139036037|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
139036038|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036039|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036040|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036041|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139036042|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139036043|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139036044|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139036045|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139036046|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138497224|NCT00115609|Tenofovir|tenofovir|mesh-list
139036047|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
139036048|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139036049|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139036050|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
139036051|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139036052|NCT00448136|Bevacizumab|bevacizumab|mesh-list
139036053|NCT00448136|Streptozocin|streptozocin|mesh-list
139036054|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139036055|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036056|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139036057|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139036058|NCT00448136|Growth Substances|growth substances|mesh-ancestor
139036059|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036060|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
139036061|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139036062|NCT00447902|Ritonavir|ritonavir|mesh-list
139036063|NCT00447902|Tipranavir|tipranavir|mesh-list
139036064|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139036065|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139036066|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
139036067|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036068|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036069|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139036070|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139036071|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
139036072|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139036073|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139036074|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139036076|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
139036077|NCT00440726|Cytarabine|cytarabine|mesh-list
139036078|NCT00440726|Dexamethasone|dexamethasone|mesh-list
139036079|NCT00440726|Doxorubicin|doxorubicin|mesh-list
139036080|NCT00440726|Methotrexate|methotrexate|mesh-list
139036081|NCT00440726|Vincristine|vincristine|mesh-list
139036082|NCT00440726|Bortezomib|bortezomib|mesh-list
139036083|NCT00440726|Asparaginase|asparaginase|mesh-list
139036084|NCT00440726|Pegaspargase|pegaspargase|mesh-list
139036085|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139036086|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
139036087|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
139036088|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036089|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036090|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139036091|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
139036092|NCT00440726|Hormones|hormones|mesh-ancestor
139036093|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139036094|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139036095|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036096|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139036097|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139036098|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139036099|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036100|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036101|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139036102|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
139036103|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138497326|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036104|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139036105|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
139036106|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
139036107|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139036108|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036109|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
139036110|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036111|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139036112|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
139036113|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563446|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139036114|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139036115|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
139036116|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
139036117|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
139036119|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139036120|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139036121|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
138990296|NCT05004077|Amiodarone|amiodarone|mesh-list
139036122|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036123|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497371|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139036124|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036125|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139036126|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139036127|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
139036128|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
139036129|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036130|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139036131|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
139036132|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
139036133|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036134|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036135|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139036136|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139036137|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139036138|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139036139|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036140|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
139036141|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036142|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036144|NCT01030094|Carbamazepine|carbamazepine|mesh-list
139036145|NCT01030094|Valproic Acid|valproic acid|mesh-list
139036146|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
139036147|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139036148|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036149|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036150|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036151|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
139036152|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036153|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
139036154|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139036155|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139036156|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139036157|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139036158|NCT01030094|Analgesics|analgesics|mesh-ancestor
139036159|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
139036160|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036162|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138990316|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139036163|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139036164|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139036166|NCT01565798|Trace Elements|trace elements|mesh-ancestor
139036167|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
139036168|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036169|NCT01030328|Fenofibrate|fenofibrate|mesh-list
139036170|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139036171|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
139036172|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036173|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139036174|NCT00405756|Aspirin|aspirin|mesh-list
139036175|NCT00405756|Prednisone|prednisone|mesh-list
139036176|NCT00405756|Lenalidomide|lenalidomide|mesh-list
139036177|NCT00405756|Melphalan|melphalan|mesh-list
139036178|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139036179|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
139036180|NCT00405756|Hormones|hormones|mesh-ancestor
139036181|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139036182|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497473|NCT00117013|Topotecan|topotecan|mesh-list
139036183|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139036184|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036185|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139036186|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139036187|NCT00405756|Analgesics|analgesics|mesh-ancestor
139036188|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
138563815|NCT00084461|Romidepsin|romidepsin|mesh-list
139036189|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036190|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036191|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139036192|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139036193|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036194|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139036195|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139036196|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036197|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
139036198|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
139036199|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139036200|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139036201|NCT00405756|Growth Substances|growth substances|mesh-ancestor
139036202|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
139036203|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139036204|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
139036205|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139036206|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036207|NCT00456092|Apremilast|apremilast|mesh-list
139036208|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139036209|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139036210|NCT00456092|Analgesics|analgesics|mesh-ancestor
139036211|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
139036212|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036213|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036214|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139036215|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036216|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139036217|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139036218|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036219|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036220|NCT01030640|Tanezumab|tanezumab|mesh-list
139036221|NCT01030640|Analgesics|analgesics|mesh-ancestor
139036222|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
139036223|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036224|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036225|NCT00411450|Panitumumab|panitumumab|mesh-list
139036226|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139036227|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036228|NCT00404820|Vitamin D|vitamin d|mesh-list
139036229|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
139036230|NCT00404820|Alendronate|alendronate|mesh-list
139036231|NCT00404820|Calcium|calcium|mesh-list
139036232|NCT00404820|Vitamins|vitamins|mesh-ancestor
139036233|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
139036234|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036235|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139036236|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139036237|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
139036238|NCT00446030|Bevacizumab|bevacizumab|mesh-list
139036239|NCT00446030|Carboplatin|carboplatin|mesh-list
139036240|NCT00446030|Docetaxel|docetaxel|mesh-list
139036241|NCT00446030|Doxorubicin|doxorubicin|mesh-list
139036242|NCT00446030|Trastuzumab|trastuzumab|mesh-list
139036243|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036244|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
139036245|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036246|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036247|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139036248|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
139036249|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036250|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036251|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139036252|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139036253|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139036254|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139036255|NCT00446030|Growth Substances|growth substances|mesh-ancestor
139036256|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
139036257|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
139036258|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
139036259|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
139036260|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139036261|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139036262|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139036263|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036264|NCT00410514|Mirabegron|mirabegron|mesh-list
139036265|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139036266|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139036267|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139036269|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036270|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036271|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036272|NCT00410514|Urological Agents|urological agents|mesh-ancestor
139036274|NCT03847610|Penicillin V|penicillin v|mesh-list
139036275|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139036276|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139036277|NCT01036854|Ondansetron|ondansetron|mesh-list
139036278|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
139036279|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
139036280|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036281|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036282|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139036283|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
139036284|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
138497612|NCT00118183|Cetuximab|cetuximab|mesh-list
139036285|NCT01036854|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139036286|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139036287|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
139036288|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036289|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036290|NCT01030796|Caffeine|caffeine|mesh-list
139036291|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139036292|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036293|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138990361|NCT04957329|Latanoprost|latanoprost|mesh-list
139036294|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036295|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036296|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139036297|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139036298|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
139036299|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036300|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
138564096|NCT00325858|Narcotics|narcotics|mesh-ancestor
139036301|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139036302|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036304|NCT00439556|Rituximab|rituximab|mesh-list
139036305|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139036306|NCT00439556|Methotrexate|methotrexate|mesh-list
139036307|NCT00439556|Etoposide|etoposide|mesh-list
139036308|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
139036309|NCT00439556|Bortezomib|bortezomib|mesh-list
139036310|NCT00439556|Melphalan|melphalan|mesh-list
139036311|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
139036312|NCT00439556|Carmustine|carmustine|mesh-list
139036313|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
139036314|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139036315|NCT00439556|Antibodies|antibodies|mesh-list
139036316|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
138497648|NCT00118261|Calcium|calcium|mesh-list
139036317|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139036318|NCT00439556|Lenograstim|lenograstim|mesh-list
139036319|NCT00439556|Tacrolimus|tacrolimus|mesh-list
139036320|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
139036321|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139036322|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
139036323|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036324|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036325|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036326|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139036327|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
139036328|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139036329|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139036330|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
139036331|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036332|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
139036333|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036334|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139036335|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036336|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139036337|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139036338|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139036339|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139036340|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
138786963|NCT00621556|Secretin|secretin|mesh-list
138497693|NCT00402142|Vaccines|vaccines|mesh-list
139036341|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139036342|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139036343|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139036344|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139036347|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
139036348|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
139036349|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
139036350|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
139036351|NCT00410202|Tenofovir|tenofovir|mesh-list
139036352|NCT00410202|Lamivudine|lamivudine|mesh-list
139036353|NCT00410202|Entecavir|entecavir|mesh-list
139036354|NCT00410202|Adefovir|adefovir|mesh-list
139036355|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
139036356|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138564251|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036357|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139036358|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139036359|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036360|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036361|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139036362|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139036363|NCT03802058|Paclitaxel|paclitaxel|mesh-list
139036364|NCT03802058|Carboplatin|carboplatin|mesh-list
139036365|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139036366|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036367|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
139036368|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
139036369|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
139036370|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036371|NCT00445328|Heparin|heparin|mesh-list
139036372|NCT00445328|Calcium heparin|calcium heparin|mesh-list
139036373|NCT00445328|Dalteparin|dalteparin|mesh-list
139036374|NCT00445328|Tinzaparin|tinzaparin|mesh-list
139036375|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139036376|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
139036377|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139036378|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138497806|NCT00120172|Bevacizumab|bevacizumab|mesh-list
139036379|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036380|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
139036381|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
139036382|NCT00455312|Fludarabine|fludarabine|mesh-list
139036383|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
139036384|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
139036385|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139036386|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036387|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
139036388|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036389|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036390|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139036391|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
139036392|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036393|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036394|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139036395|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139036396|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
139036397|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
139036398|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036399|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139036400|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
139036401|NCT00455312|Hormones|hormones|mesh-ancestor
139036402|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139036403|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139036404|NCT00455312|Protective Agents|protective agents|mesh-ancestor
139036405|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139036406|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
139036407|NCT01031030|Fluorouracil|fluorouracil|mesh-list
139036408|NCT01031030|Methotrexate|methotrexate|mesh-list
139036409|NCT01031030|Epirubicin|epirubicin|mesh-list
139036410|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036411|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
139036412|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036413|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036414|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139036415|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
139036416|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036417|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036418|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139036419|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
139036420|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139036421|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139036422|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
139036423|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139036424|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
139036425|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036426|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139036427|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139036428|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139036429|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139036430|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139036431|NCT01024712|Paclitaxel|paclitaxel|mesh-list
139036432|NCT01024712|Carboplatin|carboplatin|mesh-list
139036433|NCT01024712|Gefitinib|gefitinib|mesh-list
139036434|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139036435|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036436|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
139036437|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
139036438|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
139036439|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036440|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139036441|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036442|NCT01323452|Entecavir|entecavir|mesh-list
139036443|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
139036444|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139036445|NCT00444626|Lidocaine|lidocaine|mesh-list
139036446|NCT00444626|Prilocaine|prilocaine|mesh-list
139036447|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139036448|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
139036449|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
139036450|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
139036451|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139036452|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036453|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
139036454|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036455|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139036456|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139036457|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139036458|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139036459|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036460|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139036461|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
139036462|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
139036463|NCT00444626|Protective Agents|protective agents|mesh-ancestor
139036464|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139036465|NCT01024868|Ropivacaine|ropivacaine|mesh-list
139036466|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
139036467|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
139036468|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139036469|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036470|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
139036471|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036472|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
139036473|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139036474|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
139036475|NCT03795194|Ampicillin|ampicillin|mesh-list
139036476|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139036477|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036478|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036479|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139036480|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139036481|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
139036482|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139036483|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
139036484|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497932|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
139036485|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036486|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
139036487|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139036488|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
139036489|NCT00439244|Teriparatide|teriparatide|mesh-list
139036490|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139036491|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036492|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139036493|NCT04844762|Menthol|menthol|mesh-list
139036494|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
139036495|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
139036496|NCT01323218|Vitamin D|vitamin d|mesh-list
139036497|NCT01323218|Vitamins|vitamins|mesh-ancestor
139036498|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
139036499|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036500|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139036501|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139036502|NCT01323296|Hematinics|hematinics|mesh-ancestor
139036503|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139036504|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139036505|NCT00438464|Finasteride|finasteride|mesh-list
139036506|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139036507|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139036508|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564507|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036509|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036510|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
139036511|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139036512|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036513|NCT00438464|Urological Agents|urological agents|mesh-ancestor
139036514|NCT00437294|Capecitabine|capecitabine|mesh-list
139036515|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139036516|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
139036517|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564537|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
139036518|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036519|NCT01033760|Ritonavir|ritonavir|mesh-list
139036520|NCT01033760|Darunavir|darunavir|mesh-list
139036521|NCT01033760|Tenofovir|tenofovir|mesh-list
139036522|NCT01033760|Emtricitabine|emtricitabine|mesh-list
139036523|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
139036524|NCT01033760|Maraviroc|maraviroc|mesh-list
139036525|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139036526|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139036527|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
139036528|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036529|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036530|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139036531|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139036532|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
139036533|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139036534|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139036535|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139036536|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138564601|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139036537|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139036538|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139036539|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139036540|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139036541|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139036542|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139036543|NCT01031732|Tacrine|tacrine|mesh-list
139036544|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139036545|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036546|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036547|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
139036548|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036549|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036550|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139036551|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
139036552|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036553|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
139036554|NCT01033994|Mitogens|mitogens|mesh-list
139036555|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
139036556|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036557|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139036558|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139036559|NCT00436826|Interferons|interferons|mesh-list
139036560|NCT00436826|Interferon-beta|interferon-beta|mesh-list
139036561|NCT00436826|Cladribine|cladribine|mesh-list
139036562|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
139036563|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036564|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
139036565|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139036566|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
139036567|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036568|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036569|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139036570|NCT00410124|Everolimus|everolimus|mesh-list
139036571|NCT00410124|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139036572|NCT00410124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139036573|NCT00410124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036574|NCT00410124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036575|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036576|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
139036577|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036578|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564712|NCT00094341|Etanercept|etanercept|mesh-list
139036579|NCT01036932|Lenograstim|lenograstim|mesh-list
139036580|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139036581|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
139036582|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036583|NCT00410046|Etanercept|etanercept|mesh-list
139036584|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139036585|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139036586|NCT00410046|Analgesics|analgesics|mesh-ancestor
139036587|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
139036588|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036589|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036590|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139036591|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036592|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139036593|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036594|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
139036595|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
139036596|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
139036597|NCT00416624|Hematinics|hematinics|mesh-ancestor
139036599|NCT00262600|Dabigatran|dabigatran|mesh-list
139036600|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
139036601|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
139036602|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139036603|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
139036604|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036605|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036606|NCT00409578|Valsartan|valsartan|mesh-list
139036607|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139036608|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139036609|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139036610|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036611|NCT01037322|Cannabidiol|cannabidiol|mesh-list
138564896|NCT00086840|Sirolimus|sirolimus|mesh-list
139036612|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
139036613|NCT01070758|Lanreotide|lanreotide|mesh-list
139036614|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036615|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
139036616|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139036617|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036618|NCT01031966|Thymalfasin|thymalfasin|mesh-list
139036619|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139036620|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
139036621|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036622|NCT00436436|Temozolomide|temozolomide|mesh-list
139036623|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
139036624|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139036625|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
139036626|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036627|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036628|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036629|NCT00262522|Ritonavir|ritonavir|mesh-list
139036630|NCT00262522|Lopinavir|lopinavir|mesh-list
139036631|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139036632|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139036633|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139036634|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
139036635|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036636|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036637|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139036638|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139036639|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
139036640|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139036641|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139036642|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139036643|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139036644|NCT00436280|Rituximab|rituximab|mesh-list
139036645|NCT00436280|Gemcitabine|gemcitabine|mesh-list
139036646|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
138787258|NCT01178138|Prazosin|prazosin|mesh-list
139036647|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139036648|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036649|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
139036650|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036651|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036652|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139036653|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
139036654|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036656|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139036657|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036658|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
139036659|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036660|NCT01040598|Omalizumab|omalizumab|mesh-list
139036661|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139036662|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139036663|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
139036664|NCT01039974|Ketoconazole|ketoconazole|mesh-list
139036665|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
139036666|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565130|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
139036667|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139036668|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139036669|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036670|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036671|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139036672|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
139036673|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139036674|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036675|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139036677|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139036678|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036679|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
139036680|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036681|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036683|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139036684|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036685|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
139036686|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139036687|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139036688|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036689|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139036690|NCT00409344|Analgesics|analgesics|mesh-ancestor
139036691|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
139036692|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036693|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139036694|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139036695|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139036696|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
139036697|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036698|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036700|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139036701|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139036702|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139036703|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036704|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139036705|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036706|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
139036707|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
139036708|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
139036709|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
139036710|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036711|NCT01722812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139036712|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139036713|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139036714|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
139036715|NCT00250432|Caspofungin|caspofungin|mesh-list
139036716|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
139036717|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139036718|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036719|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036720|NCT00249808|Antibodies|antibodies|mesh-list
139036721|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139036722|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
138498299|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
139036723|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036726|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
139036727|NCT00278512|Tacrolimus|tacrolimus|mesh-list
139036728|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
139036729|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036730|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
139036731|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036732|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036733|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139036734|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
139036735|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036736|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036737|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139036738|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139036739|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036740|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139036741|NCT01072240|Rituximab|rituximab|mesh-list
139036742|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139036743|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036744|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
139036745|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036746|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036748|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139036749|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139036750|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036751|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139036752|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139036753|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
139036754|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139036755|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139036757|NCT00427700|Clomiphene|clomiphene|mesh-list
139036758|NCT00427700|Enclomiphene|enclomiphene|mesh-list
139036759|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
139036760|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139036761|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
139036762|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139036763|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036764|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139036765|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
139036766|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139036767|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139036768|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139036769|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139036771|NCT01324076|Sorafenib|sorafenib|mesh-list
139036772|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139036773|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036774|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139036775|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139036776|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036777|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036778|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139036779|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
139036780|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036781|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
139036782|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036783|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139036784|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139036785|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
139036786|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036787|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036788|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139036789|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
139036790|NCT00434954|Exenatide|exenatide|mesh-list
138565700|NCT05254639|Donepezil|donepezil|mesh-list
139036791|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139036792|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036793|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139036794|NCT00434954|Incretins|incretins|mesh-ancestor
139036795|NCT00434954|Hormones|hormones|mesh-ancestor
138787395|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139036796|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139036797|NCT00276484|Atorvastatin|atorvastatin|mesh-list
138990534|NCT04715230|Lorazepam|lorazepam|mesh-list
139036799|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139036800|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139036801|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
139036802|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036803|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139036804|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139036805|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036806|NCT00426842|Midodrine|midodrine|mesh-list
139036807|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
139036808|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
139036809|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036810|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036811|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139036812|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139036813|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139036814|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139036815|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
139036816|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036817|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036818|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139036819|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
139036820|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139036821|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139036822|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139036823|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139036824|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036825|NCT01072318|Letrozole|letrozole|mesh-list
138498433|NCT00018694|Cathartics|cathartics|mesh-ancestor
139036826|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036827|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139036828|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139036829|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036830|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036831|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139036832|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
139036833|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139036834|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036835|NCT00276094|Tamoxifen|tamoxifen|mesh-list
139036836|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139036837|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
139036838|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139036839|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036840|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139036841|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036842|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139036843|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139036844|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139036845|NCT03975088|Ranibizumab|ranibizumab|mesh-list
139036846|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139036847|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139036848|NCT03975088|Growth Substances|growth substances|mesh-ancestor
139036849|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036850|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
139036851|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036852|NCT00276016|Phenylephrine|phenylephrine|mesh-list
139036853|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
139036854|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
139036855|NCT00276016|Ephedrine|ephedrine|mesh-list
139036856|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139036857|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
139036858|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
139036859|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036860|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036861|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
139036862|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139036863|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
139036864|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
139036865|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139036866|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139036867|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138887237|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139036868|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
139036869|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036870|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036871|NCT00276016|Protective Agents|protective agents|mesh-ancestor
139036872|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139036873|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139036874|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139036875|NCT00434642|Bevacizumab|bevacizumab|mesh-list
139036876|NCT00434642|Carboplatin|carboplatin|mesh-list
139036877|NCT00434642|Gemcitabine|gemcitabine|mesh-list
139036878|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139036879|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036880|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139036881|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139036882|NCT00434642|Growth Substances|growth substances|mesh-ancestor
139036883|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036884|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
138566066|NCT03063619|Tamoxifen|tamoxifen|mesh-list
139036885|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139036886|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
139036887|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036888|NCT01032434|Sertraline|sertraline|mesh-list
139036889|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
138498528|NCT00019240|Cidofovir|cidofovir|mesh-list
139036890|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139036891|NCT01032434|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139036892|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139036893|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139036894|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036895|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036896|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
139036897|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036898|NCT00426764|Romidepsin|romidepsin|mesh-list
139036899|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139036900|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036901|NCT00426764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139036902|NCT00426764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139036903|NCT00426764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036904|NCT01032668|Clopidogrel|clopidogrel|mesh-list
139036905|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139036906|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139036907|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139036908|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139036909|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
139036910|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036911|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036912|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036913|NCT00434252|Paclitaxel|paclitaxel|mesh-list
139036914|NCT00434252|Bevacizumab|bevacizumab|mesh-list
139036915|NCT00434252|Carboplatin|carboplatin|mesh-list
139036916|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139036917|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036918|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
139036919|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
139036920|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
139036921|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036922|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139036923|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139036924|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139036925|NCT00434252|Growth Substances|growth substances|mesh-ancestor
139036926|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036927|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
139036928|NCT00425750|Docetaxel|docetaxel|mesh-list
139036929|NCT00425750|Bortezomib|bortezomib|mesh-list
139036930|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036931|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
139036932|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
139036933|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
139036934|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036936|NCT00414908|Pancreatin|pancreatin|mesh-list
139036937|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139036938|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
139036939|NCT00242710|Estrogens|estrogens|mesh-list
139036940|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138887238|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
139036941|NCT00242710|Hormones|hormones|mesh-ancestor
139036942|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139036943|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036944|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139036945|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139036946|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
139036947|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139036948|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139036949|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139036950|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139036951|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139036952|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036953|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139036954|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036955|NCT00408876|Analgesics|analgesics|mesh-ancestor
139036956|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
139036957|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139036958|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
139036959|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139036960|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
139036961|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
139036962|NCT00240994|Sirolimus|sirolimus|mesh-list
139036963|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
139036964|NCT00240994|Tacrolimus|tacrolimus|mesh-list
139036965|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139036966|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
139036967|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036968|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139036969|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990588|NCT04672005|Irinotecan|irinotecan|mesh-list
139036970|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139036971|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139036972|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036973|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139036974|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
139036975|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139036976|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139036977|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
139036978|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139036979|NCT01070836|Natalizumab|natalizumab|mesh-list
139036980|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
139036981|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036982|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
139036983|NCT00239590|Testosterone|testosterone|mesh-list
139036984|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
139036985|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
139036986|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139036987|NCT00239590|Androgens|androgens|mesh-ancestor
139036988|NCT00239590|Hormones|hormones|mesh-ancestor
139036989|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139036990|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036991|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139036992|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139036993|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
139036994|NCT00433160|Teriparatide|teriparatide|mesh-list
139036995|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139036996|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139036997|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139036998|NCT00239356|Aripiprazole|aripiprazole|mesh-list
139036999|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
139037000|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139037001|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139037002|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139037003|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139037004|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037005|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
139037006|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
139037007|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139037008|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037009|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139037010|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139037011|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
139037012|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139037013|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139037014|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139037015|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139037016|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
139037017|NCT00425438|Prednisolone|prednisolone|mesh-list
139037018|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
139037019|NCT00425438|Azathioprine|azathioprine|mesh-list
139037020|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139037021|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
139037022|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037023|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139037024|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139037025|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
139037026|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037027|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037028|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139037029|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139037030|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139037031|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
139037032|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139037033|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037034|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037035|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139037036|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
139037038|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139037039|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139037040|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
139037041|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139037043|NCT01041066|Nicardipine|nicardipine|mesh-list
139037044|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139037045|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139037046|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
139037047|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566261|NCT05952505|Vaccines|vaccines|mesh-list
139037048|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037050|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139037051|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
139037052|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
139037053|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037054|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139037055|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139037056|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139037057|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139037058|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139037059|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
139037061|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
139037062|NCT01323608|Vitamins|vitamins|mesh-ancestor
139037063|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
139037064|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037065|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139037066|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139037067|NCT00275002|Temozolomide|temozolomide|mesh-list
139037068|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
139037069|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139037070|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
139037071|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037072|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037073|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037074|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
138498856|NCT00020761|Paclitaxel|paclitaxel|mesh-list
139037075|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139037076|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
139037077|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139037078|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037079|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139037080|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139037081|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139037082|NCT00393042|Amphetamine|amphetamine|mesh-list
139037083|NCT00393042|Adderall|adderall|mesh-list
139037084|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
139037085|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139037086|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037087|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
139037088|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
139037089|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037090|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
139037091|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566429|NCT05811390|Vasodilator Agents|vasodilator agents|mesh-ancestor
139037092|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037093|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
139037094|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139037095|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139037096|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139037097|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139037098|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
139037099|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
138498904|NCT00020878|Celecoxib|celecoxib|mesh-list
139037100|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139037101|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037102|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
139037103|NCT01040286|Analgesics|analgesics|mesh-ancestor
139037104|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
139037105|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037106|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037107|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139037108|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139037109|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139037110|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139037111|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139037112|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566492|NCT05635370|Cilostazol|cilostazol|mesh-list
139037113|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037115|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139037116|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
139037117|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
139037118|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037119|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566547|NCT05481112|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139037120|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139037121|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
139037122|NCT01041378|Hormones|hormones|mesh-ancestor
139037123|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139037124|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139037125|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037126|NCT03546192|Vaccines|vaccines|mesh-list
139037127|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
139037128|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037129|NCT01043952|Remifentanil|remifentanil|mesh-list
139037130|NCT01043952|Propofol|propofol|mesh-list
139037131|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139037132|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139037133|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037134|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139037135|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
139037136|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
139037137|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139037138|NCT01043952|Narcotics|narcotics|mesh-ancestor
139037140|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
139037141|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037142|NCT00274846|Aldesleukin|aldesleukin|mesh-list
139037143|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
139037144|NCT00274846|Fludarabine|fludarabine|mesh-list
139037145|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
139037146|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139037147|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
139037148|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037149|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139037150|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139037152|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990626|NCT04606446|Letrozole|letrozole|mesh-list
138990627|NCT04606446|Fulvestrant|fulvestrant|mesh-list
138990628|NCT04606446|Palbociclib|palbociclib|mesh-list
138990629|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990630|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138990631|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138990632|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037153|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037154|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139037155|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139037156|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
139037157|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139037158|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139037159|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
139037160|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037161|NCT01072786|Vaccines|vaccines|mesh-list
139037162|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
139037163|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037164|NCT03970798|Midazolam|midazolam|mesh-list
139037165|NCT03970798|Caffeine|caffeine|mesh-list
139037166|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139037167|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139037168|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139037169|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139037170|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037171|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139037172|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139037173|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139037174|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139037175|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
139037176|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
139037177|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
139037178|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
139037179|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139037180|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037181|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139037182|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139037183|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
139037184|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139037185|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139037186|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037187|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139037188|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139037189|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139037190|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139037191|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
139037193|NCT00414440|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139037194|NCT00414440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139037195|NCT00414440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566796|NCT04485039|Sevelamer|sevelamer|mesh-list
139037196|NCT00414440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037197|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139037198|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
139037199|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037200|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037201|NCT00209560|Fospropofol|fospropofol|mesh-list
139037202|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139037203|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139037204|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037205|NCT01073800|Atorvastatin|atorvastatin|mesh-list
139037206|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139037207|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139037208|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
139037209|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037210|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138990641|NCT04602117|Paclitaxel|paclitaxel|mesh-list
139037211|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139037212|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037214|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139037215|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037216|NCT00236080|Modafinil|modafinil|mesh-list
139037217|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139037218|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037219|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139037220|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139037221|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138499154|NCT00022126|Doxorubicin|doxorubicin|mesh-list
139037222|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037223|NCT01033058|Atorvastatin|atorvastatin|mesh-list
139037224|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139037225|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139037226|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
139037227|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037228|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139037229|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139037230|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037231|NCT03973138|Ranibizumab|ranibizumab|mesh-list
139037232|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139037233|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139037234|NCT03973138|Growth Substances|growth substances|mesh-ancestor
139037235|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037236|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
139037237|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037238|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
139037239|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139037240|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037241|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138566912|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
139037242|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139037243|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037244|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037245|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037246|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139037247|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139037248|NCT00234052|Bevacizumab|bevacizumab|mesh-list
139037249|NCT00234052|Carboplatin|carboplatin|mesh-list
139037250|NCT00234052|Pemetrexed|pemetrexed|mesh-list
139037251|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139037252|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037253|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139037254|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139037255|NCT00234052|Growth Substances|growth substances|mesh-ancestor
138566947|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
139037256|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037257|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
139037258|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037259|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037260|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139037261|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139037262|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
139037263|NCT00408408|Bevacizumab|bevacizumab|mesh-list
139037264|NCT00408408|Gemcitabine|gemcitabine|mesh-list
139037265|NCT00408408|Docetaxel|docetaxel|mesh-list
139037266|NCT00408408|Doxorubicin|doxorubicin|mesh-list
139037267|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139037268|NCT00408408|Capecitabine|capecitabine|mesh-list
139037269|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139037270|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
139037271|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037273|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139037274|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
139037275|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037276|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037277|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139037278|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139037279|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139037280|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139037281|NCT00408408|Growth Substances|growth substances|mesh-ancestor
139037282|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
139037283|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139037284|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
139037285|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
139037286|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
139037287|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
139037288|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139037289|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139037290|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139037291|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037292|NCT00414050|Vaccines|vaccines|mesh-list
139037293|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
139037294|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037295|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
139037296|NCT03973840|Testosterone|testosterone|mesh-list
139037297|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
139037298|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
139037299|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139037300|NCT03973840|Androgens|androgens|mesh-ancestor
139037301|NCT03973840|Hormones|hormones|mesh-ancestor
139037302|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139037303|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037304|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139037305|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037306|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
139037307|NCT00413972|Simvastatin|simvastatin|mesh-list
139037308|NCT00413972|Ezetimibe|ezetimibe|mesh-list
139037309|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139037310|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139037311|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
139037312|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037313|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139037314|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139037315|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037316|NCT00259012|Pantoprazole|pantoprazole|mesh-list
139037317|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139037318|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139037319|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139037320|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037321|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037322|NCT01044186|Deferasirox|deferasirox|mesh-list
139037323|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139037324|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
139037325|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
139037326|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037327|NCT00209170|Escitalopram|escitalopram|mesh-list
139037328|NCT00209170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139037329|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139037330|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139037331|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037332|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139037333|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
139037334|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037335|NCT01071694|Interferons|interferons|mesh-list
139037336|NCT01071694|Interferon-beta|interferon-beta|mesh-list
139037337|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
139037338|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037339|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
139037340|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037341|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
139037342|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037343|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139037344|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
139037345|NCT00413894|Hematinics|hematinics|mesh-ancestor
139037346|NCT03972748|Itraconazole|itraconazole|mesh-list
139037347|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
139037348|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037349|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139037350|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139037351|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037352|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037353|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138499415|NCT00023218|Ritonavir|ritonavir|mesh-list
139037354|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
139037355|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139037356|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037357|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139037358|NCT01581814|Metformin|metformin|mesh-list
139037359|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139037360|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139037361|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139037362|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037363|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139037364|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139037365|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139037366|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139037367|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
139037368|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139037369|NCT01581814|Estrogens|estrogens|mesh-ancestor
139037370|NCT01581814|Hormones|hormones|mesh-ancestor
139037371|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139037372|NCT00407550|Gemcitabine|gemcitabine|mesh-list
139037373|NCT00407550|Pemetrexed|pemetrexed|mesh-list
139037374|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139037375|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
139037376|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037377|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037378|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037379|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139037380|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139037381|NCT00209092|Docetaxel|docetaxel|mesh-list
138693845|NCT04356430|Prednisone|prednisone|mesh-list
139037382|NCT00209092|Capecitabine|capecitabine|mesh-list
139037383|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037384|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
139037385|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
139037386|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
138887239|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139037387|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037388|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139037389|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
139037391|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139037392|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139037393|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037395|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139037396|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139037397|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139037398|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037399|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139037400|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037401|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
139037402|NCT00403260|Artesunate|artesunate|mesh-list
139037403|NCT00403260|Mefloquine|mefloquine|mesh-list
139037404|NCT00403260|Pyronaridine|pyronaridine|mesh-list
139037405|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
139037406|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139037407|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139037408|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037409|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037410|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
139037411|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
139037412|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139037413|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
139037414|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139037415|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139037416|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139037417|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139037418|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037419|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139037420|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037422|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
139037423|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037424|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
139037425|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139037426|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
139037427|NCT00406692|Zonisamide|zonisamide|mesh-list
139037428|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
139037429|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139037430|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139037431|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037432|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139037433|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037434|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
139037435|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139037436|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
139037437|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139037438|NCT00004494|Protective Agents|protective agents|mesh-ancestor
139037439|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037440|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
139037441|NCT00315705|Etoposide|etoposide|mesh-list
139037442|NCT00315705|Clofarabine|clofarabine|mesh-list
139037443|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139037444|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
139037445|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037446|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138499598|NCT00023725|Growth Substances|growth substances|mesh-ancestor
139037447|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139037448|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
139037449|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037450|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037451|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139037452|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138990749|NCT04409873|Listerine|listerine|mesh-list
139037453|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139037454|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139037455|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037456|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139037457|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
139037458|NCT03982173|Durvalumab|durvalumab|mesh-list
139037459|NCT03982173|Tremelimumab|tremelimumab|mesh-list
138887240|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037460|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139037461|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037462|NCT01062633|Erythritol|erythritol|mesh-list
139037463|NCT01062633|Sorbitol|sorbitol|mesh-list
139037464|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
139037465|NCT01062633|Cathartics|cathartics|mesh-ancestor
139037466|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139037467|NCT00307125|Rituximab|rituximab|mesh-list
139037468|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139037469|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037470|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
139037471|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037472|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139037473|NCT01066299|Oxytocin|oxytocin|mesh-list
139037474|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
139037475|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139037476|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037477|NCT00307047|Paclitaxel|paclitaxel|mesh-list
139037478|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139037479|NCT00307047|Everolimus|everolimus|mesh-list
139037480|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139037481|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037482|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
139037483|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
139037484|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
138499646|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499647|NCT00023920|Cytarabine|cytarabine|mesh-list
139037485|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037486|NCT00307047|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139037487|NCT00307047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139037488|NCT00307047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037489|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139037490|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
139037491|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037492|NCT01066377|Sulfalene|sulfalene|mesh-list
139037493|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037494|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139037495|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
139037496|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139037497|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139037498|NCT00306891|Cediranib|cediranib|mesh-list
139037499|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037500|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139037501|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037502|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037503|NCT03980847|Alendronate|alendronate|mesh-list
139037504|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139037505|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037506|NCT00391872|Clopidogrel|clopidogrel|mesh-list
139037507|NCT00391872|Ticagrelor|ticagrelor|mesh-list
139037508|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139037509|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139037510|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139037511|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139037512|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
139037513|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139037514|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037515|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037516|NCT00391170|Dexamethasone|dexamethasone|mesh-list
139037517|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139037518|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
139037519|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
139037520|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037521|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037522|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139037523|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
139037524|NCT00391170|Hormones|hormones|mesh-ancestor
139037525|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139037526|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139037527|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037528|NCT00402324|Valproic Acid|valproic acid|mesh-list
139037529|NCT00402324|Olanzapine|olanzapine|mesh-list
139037530|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
139037531|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
139037532|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037533|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037534|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139037535|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139037536|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139037537|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139037538|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139037539|NCT00402324|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139037540|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139037541|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139037542|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037543|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139037544|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
139037545|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
139037546|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037547|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
139037548|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
139037549|NCT00294723|Liraglutide|liraglutide|mesh-list
139037550|NCT00294723|Glimepiride|glimepiride|mesh-list
139037551|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139037552|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037553|NCT00294723|Incretins|incretins|mesh-ancestor
139037554|NCT00294723|Hormones|hormones|mesh-ancestor
138499720|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139037555|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139037556|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139037557|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139037558|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
139037559|NCT00375492|Exenatide|exenatide|mesh-list
139037560|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139037561|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037562|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139037563|NCT00375492|Incretins|incretins|mesh-ancestor
139037564|NCT00375492|Hormones|hormones|mesh-ancestor
139037565|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139037566|NCT00306189|Denosumab|denosumab|mesh-list
139037567|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139037568|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037569|NCT00305877|Bevacizumab|bevacizumab|mesh-list
139037570|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139037571|NCT00305877|Cetuximab|cetuximab|mesh-list
139037572|NCT00305877|Gemcitabine|gemcitabine|mesh-list
139037573|NCT00305877|Capecitabine|capecitabine|mesh-list
139037574|NCT00305877|Antibodies|antibodies|mesh-list
139037575|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
139037576|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139037577|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037578|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139037579|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139037580|NCT00305877|Growth Substances|growth substances|mesh-ancestor
139037581|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037582|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
138499781|NCT00024232|Antibodies|antibodies|mesh-list
139037583|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
139037584|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139037585|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
139037586|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037587|NCT00312195|Buprenorphine|buprenorphine|mesh-list
139037588|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139037589|NCT00312195|Narcotics|narcotics|mesh-ancestor
139037590|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139037591|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037592|NCT00312195|Analgesics|analgesics|mesh-ancestor
139037593|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
139037594|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037595|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139037596|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
139037597|NCT02532777|Prednisone|prednisone|mesh-list
139037598|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
139037599|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
139037600|NCT02532777|Leflunomide|leflunomide|mesh-list
139037601|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139037602|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139037603|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139037604|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
139037605|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037606|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138990836|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037607|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139037608|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
139037609|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037610|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037611|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139037612|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139037613|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
139037614|NCT02532777|Hormones|hormones|mesh-ancestor
139037615|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139037616|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139037617|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139037618|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139037619|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
139037620|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139037621|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037622|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
139037623|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
139037624|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037625|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139037626|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139037627|NCT02532777|Protective Agents|protective agents|mesh-ancestor
139037628|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
139037629|NCT01062945|Doxazosin|doxazosin|mesh-list
138499867|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037630|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139037631|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139037632|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139037633|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139037634|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
139037635|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139037636|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037637|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037638|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
139037639|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139037640|NCT01063023|Asunaprevir|asunaprevir|mesh-list
139037641|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
139037642|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037643|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037644|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139037645|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
139037646|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139037647|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037648|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139037649|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139037650|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139037651|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139037652|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037653|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139037654|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139037655|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037656|NCT01063101|Fucoidan|fucoidan|mesh-list
139037657|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138990865|NCT04191096|Hormones|hormones|mesh-ancestor
139037659|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
139037660|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037661|NCT01066689|Rituximab|rituximab|mesh-list
139037662|NCT01066689|Citric Acid|citric acid|mesh-list
139037663|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
139037664|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139037665|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037666|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
138694165|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139037667|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037668|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139037669|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
139037670|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139037671|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
139037672|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
139037673|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037674|NCT00293709|Etanercept|etanercept|mesh-list
139037675|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139037676|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139037677|NCT00293709|Analgesics|analgesics|mesh-ancestor
139037678|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
139037679|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037680|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037681|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139037682|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139037683|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139037684|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139037685|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
139037686|NCT01063257|Clofarabine|clofarabine|mesh-list
139037687|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139037688|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
139037689|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037690|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037691|NCT03977649|Erenumab|erenumab|mesh-list
139037692|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139037693|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037694|NCT03977649|Analgesics|analgesics|mesh-ancestor
139037695|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
139037696|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037697|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037698|NCT01066767|Fexofenadine|fexofenadine|mesh-list
139037699|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139037700|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139037701|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139037702|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
139037703|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
139037704|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139037705|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037706|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037707|NCT03980379|Rituximab|rituximab|mesh-list
139037708|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139037709|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037710|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
138990884|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
139037711|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037712|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139037713|NCT01064271|Risperidone|risperidone|mesh-list
139037714|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139037715|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
139037716|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139037717|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037718|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037719|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139037720|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139037721|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139037722|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139037723|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139037724|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
139037725|NCT01066845|Tadalafil|tadalafil|mesh-list
139037726|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
139037727|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139037728|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139037729|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037730|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037731|NCT01066845|Urological Agents|urological agents|mesh-ancestor
139037732|NCT01064349|Trastuzumab|trastuzumab|mesh-list
138500075|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
138500080|NCT00000395|Folic Acid|folic acid|mesh-list
139037733|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139037734|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037735|NCT00293397|Doxorubicin|doxorubicin|mesh-list
139037736|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139037737|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139037738|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694248|NCT05119257|Antibodies|antibodies|mesh-list
139037739|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139037740|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139037741|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037742|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037743|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
139037744|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139037745|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037746|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139037747|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139037748|NCT01069263|Protective Agents|protective agents|mesh-ancestor
139037749|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037750|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139037751|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
139037752|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037753|NCT01067235|Modafinil|modafinil|mesh-list
139037754|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139037755|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037757|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139037758|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139037759|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037760|NCT00290745|Tamoxifen|tamoxifen|mesh-list
138788372|NCT02674906|Heparin|heparin|mesh-list
139037761|NCT00290745|Letrozole|letrozole|mesh-list
138694280|NCT01266148|Cyclosporins|cyclosporins|mesh-list
139037762|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037763|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037764|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139037765|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139037766|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037767|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139037768|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
139037769|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139037770|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037771|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139037772|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139037773|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139037774|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139037775|NCT03980223|Doxycycline|doxycycline|mesh-list
139037776|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139037777|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037778|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
139037779|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139037780|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139037781|NCT01067391|Tadalafil|tadalafil|mesh-list
139037782|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
139037783|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139037784|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139037785|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037786|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037787|NCT01067391|Urological Agents|urological agents|mesh-ancestor
139037788|NCT00402168|Cyclosporine|cyclosporine|mesh-list
139037789|NCT00402168|Abatacept|abatacept|mesh-list
139037790|NCT00402168|Tacrolimus|tacrolimus|mesh-list
139037791|NCT00402168|Cyclosporins|cyclosporins|mesh-list
139037792|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139037793|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
139037794|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037795|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139037796|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037797|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037798|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
139037799|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037800|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
139037801|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500172|NCT00025636|Cytarabine|cytarabine|mesh-list
139037802|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139037803|NCT00402168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139037804|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037805|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
139037806|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139037807|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139037809|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
139037810|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138694376|NCT00545961|Amoxicillin|amoxicillin|mesh-list
139037811|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
139037812|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139037813|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
139037814|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
139037815|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037816|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037817|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139037818|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
139037820|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139037821|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139037822|NCT00290589|Protective Agents|protective agents|mesh-ancestor
139037823|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139037824|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037825|NCT01067547|Iron|iron|mesh-list
139037826|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139037827|NCT01067547|Trace Elements|trace elements|mesh-ancestor
139037828|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
139037829|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037830|NCT01067547|Hematinics|hematinics|mesh-ancestor
139037831|NCT00290511|Dexamethasone|dexamethasone|mesh-list
139037832|NCT00290511|Rituximab|rituximab|mesh-list
139037833|NCT00290511|Fludarabine|fludarabine|mesh-list
139037834|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
139037835|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
139037836|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139037837|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
139037839|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037840|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037841|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139037842|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
139037843|NCT00290511|Hormones|hormones|mesh-ancestor
139037844|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139037845|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139037846|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037847|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139037848|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
139037849|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139037850|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139037851|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
139037852|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037853|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139037854|NCT00290511|Analgesics|analgesics|mesh-ancestor
139037855|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
139037856|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139037857|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139037858|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037859|NCT00290433|Cytarabine|cytarabine|mesh-list
139037860|NCT00290433|Dexamethasone|dexamethasone|mesh-list
139037861|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
139037862|NCT00290433|Doxorubicin|doxorubicin|mesh-list
139037863|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139037864|NCT00290433|Methotrexate|methotrexate|mesh-list
139037865|NCT00290433|Vincristine|vincristine|mesh-list
139037866|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139037867|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
139037868|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037869|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139037870|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139037871|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
139037872|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037873|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037874|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139037875|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139037876|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
139037877|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
139037878|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037879|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139037880|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
139037881|NCT00290433|Hormones|hormones|mesh-ancestor
139037882|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139037883|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139037884|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139037885|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139037886|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139037887|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037888|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139037889|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
139037890|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139037891|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139037892|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
139037893|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
139037894|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139037895|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139037896|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
139037897|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139037898|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139037899|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
139037900|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
139037901|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
139037902|NCT00304083|Doxorubicin|doxorubicin|mesh-list
139037903|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139037904|NCT00304083|Etoposide|etoposide|mesh-list
139037905|NCT00304083|Ifosfamide|ifosfamide|mesh-list
139037906|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139037907|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037908|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139037909|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139037910|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037911|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788552|NCT00644020|Mitomycins|mitomycins|mesh-list
139037912|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139037913|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139037914|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
139037916|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037917|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037918|NCT00391092|Bevacizumab|bevacizumab|mesh-list
139037919|NCT00391092|Trastuzumab|trastuzumab|mesh-list
139037920|NCT00391092|Docetaxel|docetaxel|mesh-list
139037921|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139037922|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037923|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139037924|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139037925|NCT00391092|Growth Substances|growth substances|mesh-ancestor
139037926|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037927|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
139037928|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
139037929|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
139037930|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
139037931|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037932|NCT00374868|Pemetrexed|pemetrexed|mesh-list
139037933|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037934|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037935|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037936|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139037937|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139037938|NCT01044342|Donepezil|donepezil|mesh-list
139037939|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139037940|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990957|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037941|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037942|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
139037943|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139037944|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037945|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
139037946|NCT00374556|Eszopiclone|eszopiclone|mesh-list
139037947|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139037948|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139037949|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037950|NCT01064973|Baclofen|baclofen|mesh-list
139037951|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139037952|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037953|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139037954|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139037955|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139037956|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
139037957|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
139037958|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139037959|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037960|NCT00374322|Lapatinib|lapatinib|mesh-list
139037961|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139037962|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139037963|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139037964|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037965|NCT00303459|Bosentan|bosentan|mesh-list
139037966|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139037967|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139037968|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037969|NCT00289887|Losartan|losartan|mesh-list
139037970|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139037971|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139037972|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139037973|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139037974|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037975|NCT01068093|Ezetimibe|ezetimibe|mesh-list
139037976|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139037977|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139037978|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
139037979|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037980|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139037981|NCT00401544|Dextrans|dextrans|mesh-list
139037982|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
139037983|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
139037984|NCT00401544|Hematinics|hematinics|mesh-ancestor
139037985|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
139037986|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
139037987|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
139037988|NCT00292461|Lamotrigine|lamotrigine|mesh-list
139037989|NCT00292461|Zonisamide|zonisamide|mesh-list
139037990|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
139037991|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139037992|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139037993|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139037994|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139037995|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139037996|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139037997|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139037998|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139037999|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139038000|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139038001|NCT00288639|Pregabalin|pregabalin|mesh-list
139038002|NCT00288639|Analgesics|analgesics|mesh-ancestor
138990971|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
139038003|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
138694586|NCT00546507|Diclofenac|diclofenac|mesh-list
139038004|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038005|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038006|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
139038007|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139038008|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139038009|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038010|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139038011|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139038012|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139038013|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139038014|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138694620|NCT00659711|Hormones|hormones|mesh-ancestor
139038015|NCT00390858|Deferasirox|deferasirox|mesh-list
139038016|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139038017|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
139038018|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
139038019|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038020|NCT00390780|Clotrimazole|clotrimazole|mesh-list
139038022|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139038023|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038024|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
139038025|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139038026|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139038027|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038028|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038029|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139038030|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
139038031|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139038032|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038033|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139038034|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139038035|NCT00390546|Propranolol|propranolol|mesh-list
139038036|NCT00390546|Digoxin|digoxin|mesh-list
139038037|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138694677|NCT04681937|Prednisolone|prednisolone|mesh-list
139038038|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139038039|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
139038040|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139038041|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038042|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038043|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139038044|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139038045|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
139038046|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139038047|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038048|NCT00390546|Protective Agents|protective agents|mesh-ancestor
139038049|NCT00400764|Rituximab|rituximab|mesh-list
139038050|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139038051|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038052|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
139038053|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038054|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038055|NCT00302211|Bosentan|bosentan|mesh-list
139038056|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
139038057|NCT00302211|Iloprost|iloprost|mesh-list
139038058|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
139038059|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139038060|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139038061|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038062|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038063|NCT00302211|Urological Agents|urological agents|mesh-ancestor
139038064|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139038065|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139038066|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139038067|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
139038068|NCT01045902|Ampicillin|ampicillin|mesh-list
139038069|NCT01045902|Sulbactam|sulbactam|mesh-list
139038070|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139038071|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139038072|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038073|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139038074|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139038075|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038076|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038077|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038078|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139038079|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
139038080|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139038081|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038082|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139038083|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139038084|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139038085|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139038086|NCT01041690|Bevacizumab|bevacizumab|mesh-list
139038087|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139038088|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038089|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139038090|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139038091|NCT01041690|Growth Substances|growth substances|mesh-ancestor
139038092|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038093|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
139038094|NCT00288015|Bevacizumab|bevacizumab|mesh-list
138694843|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
139038095|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139038096|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038097|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139038098|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139038099|NCT00288015|Growth Substances|growth substances|mesh-ancestor
139038100|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038101|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
139038102|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139038103|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
139038104|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139038105|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138991013|NCT03944954|Hormones|hormones|mesh-ancestor
139038106|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139038107|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139038108|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038110|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
139038111|NCT01045980|Cholecalciferol|cholecalciferol|mesh-list
139038112|NCT01045980|Vitamins|vitamins|mesh-list
139038113|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
139038114|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038115|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139038116|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139038117|NCT00388674|Entecavir|entecavir|mesh-list
139038118|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
139038119|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038120|NCT00388362|Sirolimus|sirolimus|mesh-list
139038121|NCT00388362|Prednisone|prednisone|mesh-list
139038122|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139038123|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
139038124|NCT00388362|Hormones|hormones|mesh-ancestor
139038125|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139038126|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038127|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139038128|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038129|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139038130|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038131|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139038132|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
139038133|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138788760|NCT04175002|Hormones|hormones|mesh-ancestor
139038134|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
139038136|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
139038137|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038138|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
139038139|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038140|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038141|NCT01046214|Bupropion|bupropion|mesh-list
139038142|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139038143|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
139038144|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139038145|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139038146|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139038147|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139038148|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038149|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
139038150|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139038151|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038152|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139038153|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139038154|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038155|NCT01324284|Lubiprostone|lubiprostone|mesh-list
139038156|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139038157|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139038158|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038159|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139038160|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038161|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139038162|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038163|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038164|NCT00387426|Sunitinib|sunitinib|mesh-list
139038165|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038166|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139038167|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139038168|NCT00387426|Growth Substances|growth substances|mesh-ancestor
139038169|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038170|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
139038171|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139038172|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038173|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038174|NCT00387348|Dexetimide|dexetimide|mesh-list
139038175|NCT00387348|Citalopram|citalopram|mesh-list
139038176|NCT00387348|Escitalopram|escitalopram|mesh-list
139038177|NCT00387348|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139038178|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139038179|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139038180|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038181|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139038182|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
139038183|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038184|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139038185|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139038186|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
139038188|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038189|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139038190|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139038191|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
139038192|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139038193|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
139038194|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139038195|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
139038196|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
139038197|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
139038198|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138500670|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139038199|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038200|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
139038201|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038202|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
139038204|NCT00413660|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138887241|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139038205|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139038206|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038207|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038209|NCT01234532|Entinostat|entinostat|mesh-list
139038210|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139038211|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038212|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139038213|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139038214|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038215|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038216|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139038217|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
139038218|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139038219|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038220|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139038221|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
139038222|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139038223|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139038224|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038225|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139038226|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
139038227|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138695159|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
139038228|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139038229|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139038231|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139038232|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038233|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
138695204|NCT02898779|Primaquine|primaquine|mesh-list
139038234|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038235|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038237|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139038238|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
139038239|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139038240|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038241|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139038242|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
139038243|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038244|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038245|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
139038246|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038247|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139038248|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139038249|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
139038250|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038251|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139038252|NCT00429572|Fludarabine|fludarabine|mesh-list
139038253|NCT00429572|Melphalan|melphalan|mesh-list
139038254|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038255|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038256|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139038257|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
139038258|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038259|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139038260|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
139038261|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139038262|NCT00429494|Leuprolide|leuprolide|mesh-list
139038263|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139038264|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
139038265|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139038266|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038267|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139038268|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038269|NCT00429416|Cytarabine|cytarabine|mesh-list
139038270|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
139038271|NCT00429416|Fludarabine|fludarabine|mesh-list
139038272|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
139038273|NCT00429416|Molgramostim|molgramostim|mesh-list
139038274|NCT00429416|Tacrolimus|tacrolimus|mesh-list
139038275|NCT00429416|Sargramostim|sargramostim|mesh-list
139038276|NCT00429416|Mesna|mesna|mesh-list
138500803|NCT00012129|Annamycin|annamycin|mesh-list
139038277|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138887242|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139038278|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
139038279|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038280|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038281|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139038282|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
139038283|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038284|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038285|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139038286|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139038287|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
139038288|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
139038289|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038290|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139038291|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038292|NCT00429416|Protective Agents|protective agents|mesh-ancestor
139038293|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
139038294|NCT00429182|Thiotepa|thiotepa|mesh-list
139038295|NCT00429182|Carboplatin|carboplatin|mesh-list
139038296|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139038297|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
139038298|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038299|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038300|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139038301|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
139038302|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038303|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038304|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139038305|NCT00429104|Trastuzumab|trastuzumab|mesh-list
139038306|NCT00429104|Sargramostim|sargramostim|mesh-list
139038307|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139038308|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038309|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
139038310|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038311|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
139038312|NCT00429026|Melphalan|melphalan|mesh-list
139038313|NCT00429026|Fludarabine|fludarabine|mesh-list
139038314|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139038315|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
138991098|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
139038316|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038317|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038318|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139038319|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
139038320|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038321|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038322|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139038323|NCT00301821|Prednisone|prednisone|mesh-list
139038324|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
139038325|NCT00301821|Rituximab|rituximab|mesh-list
139038326|NCT00301821|Doxorubicin|doxorubicin|mesh-list
139038327|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139038328|NCT00301821|Vincristine|vincristine|mesh-list
139038329|NCT00301821|Epratuzumab|epratuzumab|mesh-list
139038330|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139038331|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
139038332|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038333|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038334|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139038335|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
139038336|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038337|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038338|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139038339|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139038340|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139038341|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139038342|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139038343|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038344|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139038345|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
139038346|NCT00301821|Hormones|hormones|mesh-ancestor
139038347|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139038348|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139038349|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139038350|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
139038351|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
139038352|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
139038353|NCT03976713|Bromides|bromides|mesh-list
139038354|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
139038355|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139038356|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
139038357|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038358|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038359|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139038360|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
139038361|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
139038362|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139038363|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
139038364|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139038365|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038366|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
139038367|NCT00372996|Fulvestrant|fulvestrant|mesh-list
138500925|NCT00028600|Melphalan|melphalan|mesh-list
139038369|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139038370|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038371|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139038372|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139038373|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
139038374|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139038375|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038376|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139038377|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139038378|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038379|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038380|NCT00399360|Metformin|metformin|mesh-list
139038381|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139038382|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038383|NCT00428948|Tolvaptan|tolvaptan|mesh-list
139038384|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139038385|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038386|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
139038387|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038388|NCT00428792|Methylphenidate|methylphenidate|mesh-list
139038389|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139038390|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038391|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139038392|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139038393|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139038394|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038395|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
139038396|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139038397|NCT00300885|Paclitaxel|paclitaxel|mesh-list
139038398|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139038399|NCT00300885|Carboplatin|carboplatin|mesh-list
139038400|NCT00300885|Sorafenib|sorafenib|mesh-list
138500989|NCT00028756|Gemcitabine|gemcitabine|mesh-list
139038401|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139038402|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038403|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
139038404|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
139038405|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
139038406|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038407|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139038408|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038409|NCT00386334|Eszopiclone|eszopiclone|mesh-list
139038410|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139038412|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038413|NCT01143116|Silver Nitrate|silver nitrate|mesh-list
139038414|NCT01143116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139038415|NCT01143116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038416|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
139038417|NCT00292227|Rotigotine|rotigotine|mesh-list
139038418|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139038419|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695528|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
139038420|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139038421|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139038422|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038423|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038424|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038425|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038426|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
139038427|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
139038428|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139038430|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139038431|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038433|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139038434|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
139038435|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139038436|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139038437|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038438|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139038439|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138991122|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
139038440|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139038441|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038442|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139038443|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139038444|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139038445|NCT03979989|Tapentadol|tapentadol|mesh-list
139038446|NCT03979989|Omeprazole|omeprazole|mesh-list
139038447|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139038448|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139038449|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139038450|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038451|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038452|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139038453|NCT03979989|Narcotics|narcotics|mesh-ancestor
139038454|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139038455|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038456|NCT03979989|Analgesics|analgesics|mesh-ancestor
139038457|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
139038458|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038459|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139038460|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139038461|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139038462|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
139038463|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139038464|NCT01325571|Tacrolimus|tacrolimus|mesh-list
139038465|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139038466|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
139038467|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038468|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139038469|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038470|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038471|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139038472|NCT00386022|Estrogens|estrogens|mesh-list
139038473|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
139038474|NCT00386022|Hormones|hormones|mesh-ancestor
139038475|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139038476|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038477|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
139038478|NCT01068795|Enoxaparin|enoxaparin|mesh-list
139038479|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
139038480|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139038481|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139038482|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038483|NCT00286455|Alogliptin|alogliptin|mesh-list
139038484|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139038485|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038486|NCT00286455|Incretins|incretins|mesh-ancestor
139038487|NCT00286455|Hormones|hormones|mesh-ancestor
139038488|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139038489|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139038490|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
139038491|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501110|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038492|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038493|NCT00385944|Clopidogrel|clopidogrel|mesh-list
139038494|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139038495|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139038496|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139038497|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139038498|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139038499|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
139038500|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139038501|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038502|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038503|NCT00286221|Fentanyl|fentanyl|mesh-list
139038504|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139038505|NCT00286221|Narcotics|narcotics|mesh-ancestor
139038506|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139038507|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038508|NCT00286221|Analgesics|analgesics|mesh-ancestor
139038509|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
139038510|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038511|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139038512|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139038513|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
139038514|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
139038515|NCT00398112|Sunitinib|sunitinib|mesh-list
139038516|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038517|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138501159|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139038518|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139038519|NCT00398112|Growth Substances|growth substances|mesh-ancestor
139038520|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038521|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
139038522|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139038523|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038524|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038525|NCT01065129|Plerixafor|plerixafor|mesh-list
139038526|NCT01065129|Azacitidine|azacitidine|mesh-list
139038527|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139038528|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
139038529|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038530|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038531|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038532|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139038533|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139038534|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
139038535|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038536|NCT01042314|Donepezil|donepezil|mesh-list
139038537|NCT01042314|BMS 708163|bms 708163|mesh-list
139038538|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139038539|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038540|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038541|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
139038542|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139038543|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038544|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
139038545|NCT01042314|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139038546|NCT00372528|Pregabalin|pregabalin|mesh-list
139038547|NCT00372528|Analgesics|analgesics|mesh-ancestor
139038548|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
139038549|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038550|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647578|NCT03942328|Antibodies|antibodies|mesh-list
139038551|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
139038552|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139038553|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139038554|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038555|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139038556|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139038557|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139038558|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139038559|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139038560|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
139038561|NCT00283803|Hormones|hormones|mesh-list
139038562|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139038563|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
139038564|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139038565|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038566|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038567|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
139038568|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139038569|NCT00283803|Protective Agents|protective agents|mesh-ancestor
139038570|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139038571|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038572|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038573|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139038574|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139038576|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
139038577|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138647597|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138647598|NCT03929718|Diuretics|diuretics|mesh-ancestor
139038578|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139038579|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038580|NCT01044810|Efavirenz|efavirenz|mesh-list
139038581|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139038582|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139038583|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038584|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038585|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
139038586|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038587|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139038588|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139038589|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139038590|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139038591|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139038592|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139038593|NCT01033370|Clevidipine|clevidipine|mesh-list
139038594|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139038595|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139038596|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038597|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139038598|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038600|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
139038601|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139038602|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139038603|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038604|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
139038605|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139038606|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139038607|NCT03742466|Prednisolone|prednisolone|mesh-list
139038608|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
139038609|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139038610|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
139038611|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139038612|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
139038613|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
139038614|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038615|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038616|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139038617|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
139038618|NCT03742466|Hormones|hormones|mesh-ancestor
139038619|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139038620|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139038621|NCT03742466|Protective Agents|protective agents|mesh-ancestor
139038622|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139038623|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038624|NCT01065285|Vaccines|vaccines|mesh-list
139038625|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
139038626|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038627|NCT01033526|Aspirin|aspirin|mesh-list
139038628|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138695950|NCT01211197|Metformin|metformin|mesh-list
139038629|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139038630|NCT01033526|Analgesics|analgesics|mesh-ancestor
139038631|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
139038632|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038633|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038634|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139038635|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038636|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139038637|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139038638|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038639|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139038640|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139038642|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
139038643|NCT00397488|Sunitinib|sunitinib|mesh-list
139038644|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038645|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139038646|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139038647|NCT00397488|Growth Substances|growth substances|mesh-ancestor
139038648|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038649|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
139038650|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139038651|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038652|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038653|NCT01581411|Plasminogen|plasminogen|mesh-list
139038654|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139038655|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139038656|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139038657|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038658|NCT02900664|Trametinib|trametinib|mesh-list
139038659|NCT02900664|Spartalizumab|spartalizumab|mesh-list
139038660|NCT02900664|Nazartinib|nazartinib|mesh-list
139038661|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038662|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139038663|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038664|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038665|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139038666|NCT02900664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139038667|NCT01324596|Prednisolone|prednisolone|mesh-list
139038668|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139038669|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
139038670|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139038671|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
139038672|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
139038673|NCT01324596|Rituximab|rituximab|mesh-list
139038674|NCT01324596|Doxorubicin|doxorubicin|mesh-list
139038675|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139038676|NCT01324596|Vincristine|vincristine|mesh-list
139038677|NCT01324596|Bortezomib|bortezomib|mesh-list
139038678|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139038679|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
139038680|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139038681|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
139038682|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038683|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038684|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139038685|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
139038686|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038687|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038688|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139038689|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139038690|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139038691|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139038692|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139038693|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038694|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139038695|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
139038696|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
139038697|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
138696115|NCT03540758|Niacin|niacin|mesh-list
139038698|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139038699|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
139038701|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139038702|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139038703|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
139038704|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
139038705|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038706|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139038707|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139038708|NCT01324596|Protective Agents|protective agents|mesh-ancestor
139038709|NCT00424190|Vancomycin|vancomycin|mesh-list
139038710|NCT00424190|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139038711|NCT00424190|Aztreonam|aztreonam|mesh-list
139038712|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139038713|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038714|NCT02859012|Axitinib|axitinib|mesh-list
139038715|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038716|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139038717|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038718|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038719|NCT00274287|Sargramostim|sargramostim|mesh-list
139038720|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
139038721|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038722|NCT01045278|Interferons|interferons|mesh-list
139038723|NCT01045278|Ribavirin|ribavirin|mesh-list
139038724|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
139038725|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
139038726|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139038727|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038728|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
139038729|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038730|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
139038731|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038732|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
138991194|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
139038733|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038734|NCT00423800|Interferons|interferons|mesh-list
138647849|NCT03471624|Tenofovir|tenofovir|mesh-list
138647850|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
139038735|NCT00423800|Ribavirin|ribavirin|mesh-list
139038736|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
139038737|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
139038738|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139038739|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038740|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
139038741|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038742|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
139038743|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038744|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
139038745|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038746|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138395697|NCT05095571|Niacin|niacin|mesh-list
139038747|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
139038748|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038749|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
139038750|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139038751|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038752|NCT00282243|Tacrolimus|tacrolimus|mesh-list
139038753|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139038754|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
139038755|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038756|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139038757|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038758|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059138|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647895|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139038759|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
139038760|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139038761|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139038762|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038763|NCT00282087|Gemcitabine|gemcitabine|mesh-list
139038764|NCT00282087|Docetaxel|docetaxel|mesh-list
139038765|NCT00282087|Doxorubicin|doxorubicin|mesh-list
139038766|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139038767|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
139038768|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038769|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038770|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
139038771|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
139038772|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
139038773|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139038774|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139038775|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139038776|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038777|NCT00281697|Bevacizumab|bevacizumab|mesh-list
139038778|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139038779|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038780|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138991214|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
139038782|NCT00281697|Growth Substances|growth substances|mesh-ancestor
139038783|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038784|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
139038786|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139038787|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
138647943|NCT03272477|Pertuzumab|pertuzumab|mesh-list
138647944|NCT03272477|Anastrozole|anastrozole|mesh-list
139038788|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139038789|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038790|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139038792|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
139038793|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139038794|NCT01070277|Albendazole|albendazole|mesh-list
139038795|NCT01070277|Tinidazole|tinidazole|mesh-list
139038796|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
139038797|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139038798|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038799|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
139038800|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139038801|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139038802|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
139038803|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
139038804|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
139038805|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038806|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038807|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
139038808|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139038809|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139038810|NCT00270231|Naltrexone|naltrexone|mesh-list
139038811|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139038812|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139038813|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038814|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
138647988|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139038815|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038816|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139038817|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139038818|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139038819|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
139038820|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038821|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139038822|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139038823|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038824|NCT00258856|Vaccines|vaccines|mesh-list
139038825|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
139038826|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038827|NCT00269919|Risperidone|risperidone|mesh-list
138991250|NCT03581487|Durvalumab|durvalumab|mesh-list
139038828|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139038829|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
139038830|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139038831|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038832|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038833|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139038834|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139038835|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139038836|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139038837|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139038838|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
139038839|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
139038840|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038842|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
139038843|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139038844|NCT00268983|Iodine|iodine|mesh-list
139038845|NCT00268983|Rituximab|rituximab|mesh-list
139038847|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139038848|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139038849|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038850|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
139038851|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038852|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038853|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139038854|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038855|NCT00268983|Trace Elements|trace elements|mesh-ancestor
139038856|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
139038857|NCT01070511|Tadalafil|tadalafil|mesh-list
139038858|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
139038859|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139038860|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139038861|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038862|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038863|NCT01070511|Urological Agents|urological agents|mesh-ancestor
139038864|NCT01070667|Dronedarone|dronedarone|mesh-list
139038865|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139038866|NCT00257608|Bevacizumab|bevacizumab|mesh-list
139038867|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139038868|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139038869|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696593|NCT01230892|Atenolol|atenolol|mesh-list
139038870|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139038871|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139038872|NCT00257608|Growth Substances|growth substances|mesh-ancestor
139038873|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038874|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
139038875|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139038876|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038877|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038878|NCT00231478|Granisetron|granisetron|mesh-list
139038879|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
139038880|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
139038881|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038882|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038883|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139038884|NCT00231478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139038885|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139038886|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
139038887|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139038888|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038889|NCT00207142|Ritonavir|ritonavir|mesh-list
139038890|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139038891|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138991266|NCT03557619|Estradiol|estradiol|mesh-list
139038892|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139038893|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
139038894|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038895|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038896|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139038897|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139038898|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
139038899|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139038900|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139038901|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139038902|NCT00268905|Carboplatin|carboplatin|mesh-list
138648143|NCT02558010|Morphine|morphine|mesh-list
139038903|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038904|NCT00206518|Docetaxel|docetaxel|mesh-list
139038905|NCT00206518|Doxorubicin|doxorubicin|mesh-list
139038906|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139038907|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
139038908|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038909|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
139038910|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
139038911|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
139038912|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038913|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139038914|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138696693|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
139038915|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139038916|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038917|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139038918|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
139038919|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038920|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038921|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139038922|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
139038923|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139038924|NCT00206440|Esomeprazole|esomeprazole|mesh-list
139038925|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139038926|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139038927|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139038928|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038929|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038930|NCT00268437|Carboplatin|carboplatin|mesh-list
139038931|NCT00268437|Pemetrexed|pemetrexed|mesh-list
139038932|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038933|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038934|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038935|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139038936|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139038937|NCT00423488|Simvastatin|simvastatin|mesh-list
139038938|NCT00423488|Ezetimibe|ezetimibe|mesh-list
138648179|NCT02305238|Aflibercept|aflibercept|mesh-list
139038939|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139038940|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139038941|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
139038942|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696762|NCT04683237|Megestrol|megestrol|mesh-list
139038943|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139038944|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139038945|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038946|NCT00404066|Dexamethasone|dexamethasone|mesh-list
139038947|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
139038949|NCT00404066|Doxorubicin|doxorubicin|mesh-list
139038950|NCT00404066|Trastuzumab|trastuzumab|mesh-list
139038951|NCT00404066|Lapatinib|lapatinib|mesh-list
139038952|NCT00404066|Lenograstim|lenograstim|mesh-list
139038953|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139038954|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
139038955|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038956|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139038957|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139038958|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
139038959|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648213|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
139038960|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038961|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139038962|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139038963|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
139038964|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
139038965|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139038966|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139038967|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
139038968|NCT00404066|Hormones|hormones|mesh-ancestor
139038969|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139038970|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139038971|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
139038972|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
139038973|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
139038974|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139038975|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139038976|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139038977|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038978|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139038979|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139038980|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139038981|NCT00423332|Cediranib|cediranib|mesh-list
139038982|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038983|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139038984|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139038985|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038986|NCT00413036|Lenalidomide|lenalidomide|mesh-list
139038987|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
139038988|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139038989|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139038990|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139038991|NCT00413036|Growth Substances|growth substances|mesh-ancestor
139038992|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
139038993|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139038994|NCT00412958|Plasminogen|plasminogen|mesh-list
139038995|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
139038996|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139038997|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139038998|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139038999|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139039000|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139039001|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039002|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
139039003|NCT01040702|Methylphenidate|methylphenidate|mesh-list
139039004|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139039005|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039006|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139039007|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139039008|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139039009|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039010|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
139039011|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039012|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
139039013|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039015|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
139039016|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139039017|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139039018|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039019|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039020|NCT00384930|Urological Agents|urological agents|mesh-ancestor
139039021|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
139039022|NCT00423098|Prednisone|prednisone|mesh-list
139039023|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
139039024|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138696986|NCT06087211|Analgesics|analgesics|mesh-ancestor
139039025|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139039026|NCT00423098|Prednisolone|prednisolone|mesh-list
139039027|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
139039028|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139039029|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
139039030|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139039031|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
139039032|NCT00423098|Hormones|hormones|mesh-ancestor
139039033|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139039034|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039035|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139039036|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039037|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139039038|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139039039|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
139039040|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139039041|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039042|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039043|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039044|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
139039045|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
139039046|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039047|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139039048|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139039049|NCT00423098|Protective Agents|protective agents|mesh-ancestor
139039050|NCT01042704|Aspirin|aspirin|mesh-list
139039051|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139039052|NCT01042704|Dexamethasone|dexamethasone|mesh-list
139039053|NCT01042704|Lenalidomide|lenalidomide|mesh-list
138697077|NCT06085703|Metformin|metformin|mesh-list
139039055|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139039056|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
138648364|NCT00289445|Leucovorin|leucovorin|mesh-list
139039057|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
139039058|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039059|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991318|NCT03442569|Nivolumab|nivolumab|mesh-list
139039060|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139039061|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
139039062|NCT01042704|Hormones|hormones|mesh-ancestor
139039063|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139039064|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139039065|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039066|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139039067|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139039068|NCT01042704|Analgesics|analgesics|mesh-ancestor
139039069|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
139039070|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139039071|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139039072|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139039073|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039074|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139039075|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139039076|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039077|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
139039078|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
139039079|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139039080|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139039081|NCT01042704|Growth Substances|growth substances|mesh-ancestor
139039082|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
139039083|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039084|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139039085|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
139039086|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139039087|NCT00750698|Entinostat|entinostat|mesh-list
139039088|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039089|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139039090|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039091|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039092|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139039093|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
139039094|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
139039095|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139039096|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139039097|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039098|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039099|NCT01046838|Urological Agents|urological agents|mesh-ancestor
139039101|NCT01042782|Mitomycin|mitomycin|mesh-list
139039102|NCT01042782|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139039103|NCT01042782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139039104|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039105|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039106|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139039107|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
139039108|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039109|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039110|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
139039111|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139039112|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139039114|NCT00411788|Trastuzumab|trastuzumab|mesh-list
139039115|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139039116|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039117|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139039118|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039119|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139039120|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
139039121|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139039122|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
139039123|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648440|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039124|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139039125|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039126|NCT01040936|Atorvastatin|atorvastatin|mesh-list
139039127|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139039128|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139039129|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
138697374|NCT05788094|Artenimol|artenimol|mesh-list
139039130|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039131|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139039132|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139039133|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039134|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139039135|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139039136|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
139039137|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139039138|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039139|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139039140|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139039141|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139039142|NCT01041170|Rimonabant|rimonabant|mesh-list
139039143|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139039144|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
139039145|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139039146|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039147|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039148|NCT01041170|Hormones|hormones|mesh-ancestor
138991366|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
139039149|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139039150|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039151|NCT01041482|Sorafenib|sorafenib|mesh-list
139039152|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039153|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139039154|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039155|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039156|NCT00422942|Rituximab|rituximab|mesh-list
139039157|NCT00422942|Methotrexate|methotrexate|mesh-list
139039158|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139039159|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039160|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
139039161|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039162|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139039163|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139039164|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
139039165|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139039166|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139039167|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
139039168|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789793|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039169|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
139039170|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039171|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139039172|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138697549|NCT05275725|Vasodilator Agents|vasodilator agents|mesh-ancestor
139039173|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139039175|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
139039176|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
139039177|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139039178|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139039179|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139039180|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139039181|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039182|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039183|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039184|NCT00422162|Analgesics|analgesics|mesh-ancestor
138328875|NCT00472056|Cytarabine|cytarabine|mesh-list
139039185|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
139039186|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039187|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
139039188|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139039189|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
139039190|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139039191|NCT00411632|Bexarotene|bexarotene|mesh-list
139039192|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039193|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139039194|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039195|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039196|NCT00422084|Artesunate|artesunate|mesh-list
139039197|NCT00422084|Lumefantrine|lumefantrine|mesh-list
139039198|NCT00422084|Artemether|artemether|mesh-list
139039199|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139039200|NCT00422084|Pyronaridine|pyronaridine|mesh-list
139039201|NCT00422084|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139039202|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
139039203|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139039204|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139039205|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039206|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648567|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039207|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
139039208|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
138697669|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139039209|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139039210|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
139039211|NCT00421928|Oxycodone|oxycodone|mesh-list
139039212|NCT00421928|Tapentadol|tapentadol|mesh-list
139039213|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139039214|NCT00421928|Narcotics|narcotics|mesh-ancestor
139039215|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139039216|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039217|NCT00421928|Analgesics|analgesics|mesh-ancestor
139039218|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
139039219|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039220|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139039221|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139039222|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139039223|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039224|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
139039225|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039226|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
139039227|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
139039228|NCT01047072|Rituximab|rituximab|mesh-list
139039229|NCT01047072|Fludarabine|fludarabine|mesh-list
139039230|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
139039231|NCT01047072|Tacrolimus|tacrolimus|mesh-list
139039232|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139039233|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
139039234|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039235|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139039236|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139039237|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
139039238|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039239|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039240|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139039241|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139039242|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139039243|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
139039244|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139039245|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039246|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139039247|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139039248|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
139039249|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139039250|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039251|NCT00372060|Pioglitazone|pioglitazone|mesh-list
139039252|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139039253|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139039254|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039255|NCT00372060|Incretins|incretins|mesh-ancestor
139039256|NCT00372060|Hormones|hormones|mesh-ancestor
139039257|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139039258|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139039259|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
139039260|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648665|NCT00303771|Antidotes|antidotes|mesh-ancestor
139039261|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039262|NCT01043172|Gemcitabine|gemcitabine|mesh-list
139039263|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139039264|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
139039265|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039266|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039267|NCT01045434|Omeprazole|omeprazole|mesh-list
139039268|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138697904|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
139039269|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139039270|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139039271|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039272|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039273|NCT01043484|Bevacizumab|bevacizumab|mesh-list
139039274|NCT01043484|Capecitabine|capecitabine|mesh-list
139039275|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139039276|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039277|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138648715|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
139039278|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139039279|NCT01043484|Growth Substances|growth substances|mesh-ancestor
139039280|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039281|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
139039282|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139039283|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
139039284|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039285|NCT00396318|Tenecteplase|tenecteplase|mesh-list
139039286|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139039287|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139039288|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039289|NCT00381888|PENTA|penta|mesh-list
139039290|NCT00381888|Fondaparinux|fondaparinux|mesh-list
139039291|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139039292|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
139039293|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139039294|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
139039295|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039296|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039298|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139039299|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139039300|NCT00267969|Ustekinumab|ustekinumab|mesh-list
139039301|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
139039302|NCT00280293|Lamotrigine|lamotrigine|mesh-list
139039303|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
139039304|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139039305|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139039306|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039307|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139039308|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039309|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139039310|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139039311|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139039312|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138648761|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
139039313|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139039314|NCT00421148|Bromides|bromides|mesh-list
139039315|NCT00421148|Rocuronium|rocuronium|mesh-list
139039316|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
139039317|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138789941|NCT01169558|Bevacizumab|bevacizumab|mesh-list
139039318|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139039319|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139039320|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039321|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648807|NCT00304317|Celecoxib|celecoxib|mesh-list
139039322|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139039323|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139039324|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
139039325|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039326|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039327|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139039328|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
139039329|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139039330|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139039331|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139039332|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
139039333|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698284|NCT01933932|Docetaxel|docetaxel|mesh-list
139039334|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039335|NCT00280059|Pregabalin|pregabalin|mesh-list
139039336|NCT00280059|Lamotrigine|lamotrigine|mesh-list
139039337|NCT00280059|Analgesics|analgesics|mesh-ancestor
139039338|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
139039339|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039340|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039341|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
139039342|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139039343|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139039344|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039345|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139039346|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139039347|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139039348|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139039349|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139039350|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139039351|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139039352|NCT00403130|Paclitaxel|paclitaxel|mesh-list
139039354|NCT00403130|Gemcitabine|gemcitabine|mesh-list
139039355|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139039356|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039357|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
139039358|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
139039359|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
139039360|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039361|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139039362|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139039363|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139039364|NCT00403130|Growth Substances|growth substances|mesh-ancestor
139039365|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039366|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
139039367|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139039368|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
139039369|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
139039370|NCT01039610|Linezolid|linezolid|mesh-list
139039371|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139039372|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039373|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139039374|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139039375|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039376|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039377|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039378|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139039379|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139039380|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139039381|NCT00267189|Cyclosporine|cyclosporine|mesh-list
139039382|NCT00267189|Everolimus|everolimus|mesh-list
139039383|NCT00267189|Azathioprine|azathioprine|mesh-list
139039384|NCT00267189|Tacrolimus|tacrolimus|mesh-list
139039385|NCT00267189|Cyclosporins|cyclosporins|mesh-list
139039386|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139039387|NCT00267189|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139039388|NCT00267189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139039389|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648919|NCT00324948|Alprostadil|alprostadil|mesh-list
139039390|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039391|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139039392|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
139039393|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039394|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039395|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039396|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
139039397|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139039398|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139039399|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
139039400|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
139039401|NCT00402116|Temozolomide|temozolomide|mesh-list
139039402|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139039403|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
138698540|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
139039404|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039405|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039407|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139039408|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039409|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139039410|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138698582|NCT00541086|Tamoxifen|tamoxifen|mesh-list
139039411|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139039412|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139039413|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039414|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039415|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039416|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139039417|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
139039419|NCT00371826|Cyclosporine|cyclosporine|mesh-list
139039420|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
139039421|NCT00371826|Prednisone|prednisone|mesh-list
139039422|NCT00371826|Everolimus|everolimus|mesh-list
139039423|NCT00371826|Cyclosporins|cyclosporins|mesh-list
139039424|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139039425|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139039426|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
139039427|NCT00371826|Hormones|hormones|mesh-ancestor
139039428|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139039429|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039430|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139039431|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039432|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039433|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039435|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
139039436|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
139039437|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039438|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
139039439|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139039440|NCT00371826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139039441|NCT00371826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139039442|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139039443|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139039444|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
139039445|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139039446|NCT03993366|Pramlintide|pramlintide|mesh-list
139039447|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
139039448|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139039449|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039450|NCT02457702|Glycerol|glycerol|mesh-list
139039451|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139039452|NCT02457702|Protective Agents|protective agents|mesh-ancestor
139039453|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039454|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
139039455|NCT00396084|Levofloxacin|levofloxacin|mesh-list
139039456|NCT00396084|Isoniazid|isoniazid|mesh-list
139039457|NCT00396084|Linezolid|linezolid|mesh-list
138698837|NCT04653506|Ibuprofen|ibuprofen|mesh-list
139039458|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
139039459|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139039460|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039461|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139039462|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139039463|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039464|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039465|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039466|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139039467|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139039468|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139039469|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
138698925|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
138254385|NCT00002715|Etoposide|etoposide|mesh-list
138649054|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
139039470|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139039472|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
139039473|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139039474|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139039475|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139039476|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139039477|NCT00395850|Disulfiram|disulfiram|mesh-list
139039478|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139039479|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139039480|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039481|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039482|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139039483|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
139039484|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139039485|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
139039486|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039487|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139039488|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139039489|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139039490|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139039491|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039492|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039493|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039494|NCT00401258|Analgesics|analgesics|mesh-ancestor
138649096|NCT00293696|Goserelin|goserelin|mesh-list
139039495|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
139039496|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039497|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
139039498|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139039499|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
139039500|NCT00380874|Pregabalin|pregabalin|mesh-list
139039501|NCT00380874|Analgesics|analgesics|mesh-ancestor
139039502|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
139039503|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699030|NCT00557921|Analgesics|analgesics|mesh-ancestor
139039504|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039505|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
139039506|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139039507|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139039508|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039509|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139039510|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139039511|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139039512|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139039513|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139039514|NCT00420056|Palbociclib|palbociclib|mesh-list
139039515|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039516|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139039517|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039518|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039519|NCT00411554|Inositol|inositol|mesh-list
139039520|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139039521|NCT00411554|Voglibose|voglibose|mesh-list
139039522|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139039523|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039524|NCT00411554|Incretins|incretins|mesh-ancestor
139039525|NCT00411554|Hormones|hormones|mesh-ancestor
139039526|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139039527|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139039528|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
139039529|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039530|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991509|NCT03056001|Doxorubicin|doxorubicin|mesh-list
139039531|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139039532|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
139039533|NCT00411554|Vitamins|vitamins|mesh-ancestor
139039534|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
139039535|NCT00380718|Pemetrexed|pemetrexed|mesh-list
139039536|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039537|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039538|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039539|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139039540|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139039541|NCT00380250|Lubiprostone|lubiprostone|mesh-list
139039542|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138375973|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
138867775|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138867776|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
138867777|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138867778|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867779|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138867780|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867781|NCT02677805|Botulinum Toxins|botulinum toxins|mesh-list
138867782|NCT02677805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138867783|NCT02677805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138867784|NCT02677805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138867785|NCT02677805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138519902|NCT00031746|Caseins|caseins|mesh-list
138867786|NCT02677805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867787|NCT02677805|Cholinergic Agents|cholinergic agents|mesh-ancestor
138867788|NCT02677805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867789|NCT02677805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867790|NCT02677805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138867791|NCT02677805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867792|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138867793|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138867794|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
138867795|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138867796|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138867797|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
138867798|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
138867799|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867800|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867801|NCT00632645|Olanzapine|olanzapine|mesh-list
138867802|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
138867803|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
138867804|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
138867805|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
138991519|NCT03043599|Nivolumab|nivolumab|mesh-list
138991520|NCT03043599|Ipilimumab|ipilimumab|mesh-list
138991521|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991522|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991523|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991530|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
138867806|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867807|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867808|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138867809|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138699326|NCT06022276|Nimotuzumab|nimotuzumab|mesh-list
138867810|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138867811|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867812|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138867813|NCT00632645|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138867814|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138867815|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138867816|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867817|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867818|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
138867819|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138867820|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
138867821|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138867822|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
138867824|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
138867825|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
138867826|NCT02849483|Ramosetron|ramosetron|mesh-list
138867827|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
138867828|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
138867829|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867830|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867831|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138867832|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138867833|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
138867834|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867835|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649273|NCT00305370|Aripiprazole|aripiprazole|mesh-list
138867836|NCT02849327|Immunomodulating Agents|immunomodulating agents|mesh-list
138867837|NCT02849327|Immunologic Factors|immunologic factors|mesh-ancestor
138867838|NCT02849327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867839|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138867841|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
138867842|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138867843|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
138867844|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867845|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867846|NCT00618852|Furosemide|furosemide|mesh-list
138867847|NCT00618852|Diuretics|diuretics|mesh-ancestor
138867848|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
138867849|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867850|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138867851|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138699425|NCT06021015|Irinotecan|irinotecan|mesh-list
138867852|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867853|NCT02073474|Nabiximols|nabiximols|mesh-list
138867854|NCT02073474|Analgesics|analgesics|mesh-ancestor
138867855|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
138867856|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867857|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867858|NCT00637104|Chromium|chromium|mesh-list
138867859|NCT00637104|Trace Elements|trace elements|mesh-ancestor
138867860|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
138867861|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867863|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138867864|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
138867865|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867866|NCT00620490|Ropivacaine|ropivacaine|mesh-list
138867867|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
138867868|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
138867869|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138867870|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867871|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
138867872|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867873|NCT04212078|Levofloxacin|levofloxacin|mesh-list
138867874|NCT04212078|Cefuroxime|cefuroxime|mesh-list
138649320|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138867875|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
138867876|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138867877|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138867878|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138867879|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138867880|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138867881|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867882|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867883|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867884|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138867885|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138867886|NCT01898520|Nabiximols|nabiximols|mesh-list
138867887|NCT01898520|Analgesics|analgesics|mesh-ancestor
138867888|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
138867889|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867890|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867891|NCT00903617|Niacin|niacin|mesh-list
138867892|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
138867893|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138867894|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
138867895|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649355|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138649364|NCT00326235|Buspirone|buspirone|mesh-list
138867896|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138867897|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
138867898|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
138867899|NCT00903617|Vitamins|vitamins|mesh-ancestor
138867900|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
138867901|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867902|NCT02848937|Citric Acid|citric acid|mesh-list
138867903|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
138867904|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
138867905|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138867906|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
138867907|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
138867908|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867909|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138867910|NCT00343824|Laxatives|laxatives|mesh-ancestor
138867911|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138867912|NCT02849015|Immunomodulating Agents|immunomodulating agents|mesh-list
138867913|NCT02849015|Immunologic Factors|immunologic factors|mesh-ancestor
138867914|NCT02849015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867915|NCT04212000|Ketoconazole|ketoconazole|mesh-list
138867916|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
138867917|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138867918|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138867919|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138867920|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867921|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867922|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138867923|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
138867924|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138867925|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867926|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138867928|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138867929|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
138867930|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867931|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138867932|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867933|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867935|NCT00620646|Cilostazol|cilostazol|mesh-list
138867936|NCT00620646|Clopidogrel|clopidogrel|mesh-list
138867937|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138867938|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138867939|NCT00620646|Analgesics|analgesics|mesh-ancestor
138867940|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
138867941|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867942|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867943|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138867944|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138867945|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138867946|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138867947|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867948|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138867949|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138867950|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867951|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
138867952|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138867953|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138867954|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138867955|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
138867956|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867957|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138867958|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
138867959|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138867960|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
138867961|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
138991599|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
138867962|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138867963|NCT00620646|Protective Agents|protective agents|mesh-ancestor
138867964|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138867965|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138867966|NCT00810017|Trastuzumab|trastuzumab|mesh-list
138867967|NCT00810017|Etoposide|etoposide|mesh-list
138867968|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138867969|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138867970|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138867971|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138867972|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138867973|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867974|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867975|NCT00620724|Nifedipine|nifedipine|mesh-list
138867976|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138867977|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138867978|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867979|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138867980|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867981|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
138867982|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
138867983|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138867985|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138867986|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138867987|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138867988|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
138867989|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138867990|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138867991|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138867992|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
138867993|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138867994|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
138867995|NCT00620802|Clopidogrel|clopidogrel|mesh-list
138867996|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138867997|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138867998|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138867999|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138868000|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
138868001|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868002|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868003|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868004|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
138868005|NCT02848157|Ropivacaine|ropivacaine|mesh-list
138868006|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138868007|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138868008|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868009|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138868011|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
138868012|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868014|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138868015|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138868016|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
138868017|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649543|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138868018|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868019|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
138868020|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
138868021|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
138868022|NCT04211844|Ledipasvir|ledipasvir|mesh-list
138868023|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
138868024|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868025|NCT00619710|Meropenem|meropenem|mesh-list
138868026|NCT00619710|Imipenem|imipenem|mesh-list
138868027|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
138868028|NCT00619710|Cilastatin|cilastatin|mesh-list
138868029|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138868030|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138699844|NCT04953910|Decitabine|decitabine|mesh-list
138868031|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
138868032|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868033|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868035|NCT02846909|Progestins|progestins|mesh-ancestor
138868036|NCT02846909|Hormones|hormones|mesh-ancestor
138868037|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138868038|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868039|NCT00632723|Gefitinib|gefitinib|mesh-list
138649584|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868040|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868041|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138868042|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868043|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868044|NCT02847143|Oxytocin|oxytocin|mesh-list
138868045|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
138868046|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138868047|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868048|NCT02847455|Rabeprazole|rabeprazole|mesh-list
138868049|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138868050|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138868051|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138868052|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868053|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868054|NCT03897335|Aminophylline|aminophylline|mesh-list
138868055|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138868056|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
138868057|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868058|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868060|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
138868061|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138868062|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138868063|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868064|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868065|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138868066|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138868067|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
138868068|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868069|NCT03897335|Protective Agents|protective agents|mesh-ancestor
138868070|NCT01617096|Dapivirine|dapivirine|mesh-list
138868071|NCT01617096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138868072|NCT01617096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138868073|NCT01617096|Antiviral Agents|antiviral agents|mesh-ancestor
138868074|NCT01617096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868075|NCT00619944|Ritonavir|ritonavir|mesh-list
138868076|NCT00619944|Lopinavir|lopinavir|mesh-list
138868077|NCT00619944|Lumefantrine|lumefantrine|mesh-list
138868078|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138868079|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138868080|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138868081|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
138868082|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868083|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868084|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138868085|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138868086|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
138868087|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868088|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138868089|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138868090|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
138868091|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138868092|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138868093|NCT00621036|Methotrexate|methotrexate|mesh-list
138868094|NCT00621036|Thiotepa|thiotepa|mesh-list
138868095|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
138868096|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138868097|NCT00621036|Antibodies|antibodies|mesh-list
138868098|NCT00621036|Sargramostim|sargramostim|mesh-list
138868099|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138868100|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138868101|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
138868102|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138868103|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868104|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138868105|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
138700066|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
138868106|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868107|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868108|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
138868109|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868110|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138868111|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138868112|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
138868113|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138868114|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138868115|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138868116|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
138868117|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138868118|NCT02846831|Insulin|insulin|mesh-list
138868119|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138868120|NCT02846831|Hormones|hormones|mesh-list
138868121|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138868122|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700111|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
138868123|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138868125|NCT01497509|Racepinephrine|racepinephrine|mesh-list
138868126|NCT01497509|Fentanyl|fentanyl|mesh-list
138868127|NCT01497509|Bupivacaine|bupivacaine|mesh-list
138868128|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
138868129|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
138868130|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
138868131|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138868132|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868133|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
138868134|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868135|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138868137|NCT01497509|Analgesics|analgesics|mesh-ancestor
138868138|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138868139|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138868140|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
138868141|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138868142|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138868143|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
138868144|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868145|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868146|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138868147|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138868148|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
138868149|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138868150|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
138868151|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
138868152|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
138868153|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138868154|NCT02844881|Apatinib|apatinib|mesh-list
138868155|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868156|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138868157|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520274|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868158|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868159|NCT02846519|Rifampin|rifampin|mesh-list
138868160|NCT02846519|Esketamine|esketamine|mesh-list
138868161|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138868162|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
138868163|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138868164|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700229|NCT03261830|Cefazolin|cefazolin|mesh-list
138868165|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
138868166|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138868167|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868168|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868169|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138868170|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138868171|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138868172|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138868173|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138868174|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138868176|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138868177|NCT00618228|Balsalazide|balsalazide|mesh-list
138868178|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138868179|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138868180|NCT00618228|Analgesics|analgesics|mesh-ancestor
138868181|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
138868182|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868183|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868184|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138868185|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138868186|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138868187|NCT03711305|Carboplatin|carboplatin|mesh-list
138868188|NCT03711305|Etoposide|etoposide|mesh-list
138868189|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868190|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138868191|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138868192|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138700349|NCT01316523|Rituximab|rituximab|mesh-list
138868194|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868195|NCT00618384|Sorafenib|sorafenib|mesh-list
138868196|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868197|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138868198|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868199|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868200|NCT05000658|Dexamethasone|dexamethasone|mesh-list
138868201|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138868202|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138868203|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
138868204|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
138868205|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868206|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868207|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138868208|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
138868209|NCT05000658|Hormones|hormones|mesh-ancestor
138868210|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138868211|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138868212|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868213|NCT02844803|Metformin|metformin|mesh-list
138868214|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138868215|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868216|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
138868217|NCT04211298|Propofol|propofol|mesh-list
138868218|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138868219|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138868220|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868221|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138868222|NCT04211298|Analgesics|analgesics|mesh-ancestor
138868223|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
138868224|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868225|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138868226|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138868227|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138868228|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
138868229|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868230|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991713|NCT02673931|Exenatide|exenatide|mesh-list
138868231|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138868232|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
138868233|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
138868234|NCT04212702|Everolimus|everolimus|mesh-list
138868235|NCT04212702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138868236|NCT04212702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138868237|NCT04212702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868238|NCT04212702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868239|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138868240|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
138868241|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868242|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868243|NCT02691780|Sorafenib|sorafenib|mesh-list
138868244|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868245|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138868246|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868247|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868248|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
138868249|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138868250|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138770568|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138868251|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700535|NCT01229371|Vaccines|vaccines|mesh-list
138868252|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138868253|NCT02845661|Analgesics|analgesics|mesh-ancestor
138868254|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
138868255|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868256|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138868257|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138868258|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138868259|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
138868260|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868261|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868262|NCT02844335|Immunomodulating Agents|immunomodulating agents|mesh-list
138868263|NCT02844335|Immunologic Factors|immunologic factors|mesh-ancestor
138868264|NCT02844335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868265|NCT00880074|Alovudine|alovudine|mesh-list
138868266|NCT00880074|Antiviral Agents|antiviral agents|mesh-ancestor
138868267|NCT00880074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868268|NCT04375787|Atorvastatin|atorvastatin|mesh-list
138868269|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138868270|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138868271|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
138868272|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868273|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138868274|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138868275|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868276|NCT00825630|Esomeprazole|esomeprazole|mesh-list
138868277|NCT00825630|Pantoprazole|pantoprazole|mesh-list
138868278|NCT00825630|Lansoprazole|lansoprazole|mesh-list
138868279|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
138868280|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138868281|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139210391|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138868282|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138868283|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991726|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
138868284|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868285|NCT00620100|Docetaxel|docetaxel|mesh-list
138868286|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868287|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
138868288|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
138868289|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
138868290|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868291|NCT02845349|Vortioxetine|vortioxetine|mesh-list
138868292|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
138868293|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138868294|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138868295|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138868296|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138868297|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770747|NCT01139580|Calcipotriene|calcipotriene|mesh-list
138868298|NCT02845349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138868299|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138868300|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138868301|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868302|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868303|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
138868304|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138868305|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138868306|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138868307|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138868308|NCT03852251|Capecitabine|capecitabine|mesh-list
138868309|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
138868310|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138868311|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
138868312|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868313|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868314|NCT00620178|Losartan|losartan|mesh-list
138868315|NCT00620178|Candesartan|candesartan|mesh-list
138868316|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
138868317|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138868318|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138868319|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138868320|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138868321|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868322|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
138868323|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138868324|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138868325|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868326|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
138868327|NCT04349982|Coagulants|coagulants|mesh-ancestor
138868328|NCT04315350|Prednisolone|prednisolone|mesh-list
138868329|NCT04315350|Curcumin|curcumin|mesh-list
138868330|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138770945|NCT01168973|Docetaxel|docetaxel|mesh-list
138868331|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
138868332|NCT04315350|Hormones|hormones|mesh-ancestor
139039543|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138868333|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138868334|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868335|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138868336|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868337|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868338|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138868339|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138868341|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
138868342|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138868343|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868344|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868345|NCT04288206|Cefazolin|cefazolin|mesh-list
138868346|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138868347|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868348|NCT04958772|Lenograstim|lenograstim|mesh-list
138868349|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138868350|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
138770987|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138868351|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868352|NCT02771249|Pyridoxine|pyridoxine|mesh-list
138868353|NCT02771249|Isoniazid|isoniazid|mesh-list
138868354|NCT02771249|Darunavir|darunavir|mesh-list
138868355|NCT02771249|Cobicistat|cobicistat|mesh-list
139210392|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
138868356|NCT02771249|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139210393|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
138868357|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
138868358|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138868359|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868360|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138868361|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138868362|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
138868363|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868364|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138868365|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138868366|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138868367|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
138868368|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868369|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138868370|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138868371|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
138868372|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138771039|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138868373|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138868374|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
138868375|NCT02771249|Vitamins|vitamins|mesh-ancestor
138868376|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
138868377|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868378|NCT02697318|Timolol|timolol|mesh-list
138868379|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138868380|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138700903|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868381|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868382|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138868383|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138868384|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
138868385|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868386|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868387|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138868388|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138868389|NCT05242133|Interferons|interferons|mesh-list
138868390|NCT05242133|Interferon-beta|interferon-beta|mesh-list
138868391|NCT05242133|Interferon beta-1a|interferon beta-1a|mesh-list
138868392|NCT05242133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868393|NCT05242133|Antiviral Agents|antiviral agents|mesh-ancestor
138868394|NCT05242133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868395|NCT05242133|Immunologic Factors|immunologic factors|mesh-ancestor
138868396|NCT05242133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868397|NCT05242133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138868398|NCT00621816|Nitroprusside|nitroprusside|mesh-list
138868399|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138868400|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
138868401|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138868402|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868403|NCT05368974|Antiviral Agents|antiviral agents|mesh-list
138868404|NCT05368974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868405|NCT04186026|Glucagon|glucagon|mesh-list
138868406|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138868407|NCT04186026|Incretins|incretins|mesh-ancestor
138868408|NCT04186026|Hormones|hormones|mesh-ancestor
138700957|NCT04640324|Vitamin D|vitamin d|mesh-list
138868409|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138868410|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868411|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138868413|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138868414|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
138868415|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868416|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868417|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138868418|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
138868419|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
138701006|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
138868420|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138868422|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868423|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868424|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138868425|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868426|NCT05241821|Fibrinolytic Agents|fibrinolytic agents|mesh-list
138868427|NCT05241821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138868428|NCT05241821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868429|NCT00650819|Simvastatin|simvastatin|mesh-list
138868430|NCT00650819|Ezetimibe|ezetimibe|mesh-list
138868431|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138868432|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138868433|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
138771281|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
138868434|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868435|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138868436|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138868437|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868438|NCT05662410|Aflibercept|aflibercept|mesh-list
138868439|NCT05662410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138868440|NCT05662410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138868441|NCT05662410|Growth Substances|growth substances|mesh-ancestor
138868442|NCT05662410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868443|NCT05662410|Growth Inhibitors|growth inhibitors|mesh-ancestor
138868444|NCT05662410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868445|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138868446|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138868447|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868448|NCT02689362|Incretins|incretins|mesh-ancestor
138868449|NCT02689362|Hormones|hormones|mesh-ancestor
138868450|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991790|NCT02586831|Incretins|incretins|mesh-ancestor
138868451|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138868452|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
138868453|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868454|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868456|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
138868457|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138868458|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138868459|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868460|NCT00622206|Ritonavir|ritonavir|mesh-list
138868462|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138868463|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138868464|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
138868465|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868466|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868467|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138868468|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138868469|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
138868470|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868471|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138868472|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138868473|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
138868474|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138868475|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138868476|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868477|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
138868479|NCT03574337|Neostigmine|neostigmine|mesh-list
138868480|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138868481|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868482|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868483|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
138868484|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868485|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868486|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138868487|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
138868488|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868489|NCT02689596|Oxytocin|oxytocin|mesh-list
138868490|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
138868491|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138868492|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868493|NCT00423995|Loratadine|loratadine|mesh-list
138868494|NCT00423995|Montelukast|montelukast|mesh-list
138868495|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138868496|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
138868497|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138868498|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
138868499|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138868500|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868501|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138868502|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138868503|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868505|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
138868506|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138868507|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138868508|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138868509|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
138868510|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
138868511|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868512|NCT00380627|Etoricoxib|etoricoxib|mesh-list
138868513|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138868514|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138868515|NCT00380627|Analgesics|analgesics|mesh-ancestor
138868516|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
138868517|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868518|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868519|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138868520|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138868521|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138868522|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138868523|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868524|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868525|NCT00212771|Olanzapine|olanzapine|mesh-list
138868526|NCT00212771|Asenapine|asenapine|mesh-list
138868527|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
138868528|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
138868529|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868530|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520643|NCT00393497|Bevacizumab|bevacizumab|mesh-list
138868531|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138868532|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138868533|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138868534|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138868535|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138868536|NCT00212771|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138868537|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138868538|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138868539|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868540|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868541|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
138868542|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138868543|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138868544|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138868545|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868546|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868547|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
138868548|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868549|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138868550|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138868551|NCT03829722|Paclitaxel|paclitaxel|mesh-list
138868552|NCT03829722|Carboplatin|carboplatin|mesh-list
138868553|NCT03829722|Nivolumab|nivolumab|mesh-list
138868554|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138868555|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868556|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
138868557|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
138868558|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
138868559|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868560|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138868561|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138868562|NCT03822312|Tobramycin|tobramycin|mesh-list
138868563|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138868564|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868565|NCT02687178|Canrenone|canrenone|mesh-list
138868566|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138868567|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
138868568|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138868569|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868570|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138868571|NCT02687178|Diuretics|diuretics|mesh-ancestor
138868572|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
138868573|NCT03711318|Buprenorphine|buprenorphine|mesh-list
138868574|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138868576|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138868577|NCT03711318|Narcotics|narcotics|mesh-ancestor
138868578|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138868579|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868580|NCT03711318|Analgesics|analgesics|mesh-ancestor
138701525|NCT05427942|Adalimumab|adalimumab|mesh-list
138868581|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
138868582|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868583|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138868584|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
138868585|NCT03704298|Fludarabine|fludarabine|mesh-list
138868586|NCT03704298|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138868587|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138868588|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
138868589|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868590|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138868591|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138868592|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
138868593|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868594|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868595|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138868596|NCT03704298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138868597|NCT02687100|Beclomethasone|beclomethasone|mesh-list
138868598|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138868599|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
138868600|NCT02687100|Hormones|hormones|mesh-ancestor
138868601|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138868602|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868603|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138520715|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138868604|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
138868605|NCT02153645|Amantadine|amantadine|mesh-list
138868606|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138868607|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138868608|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
138868609|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868610|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
138868611|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868612|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868613|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868614|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138868615|NCT02153645|Analgesics|analgesics|mesh-ancestor
138868616|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
138868617|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868618|NCT02688738|Doxycycline|doxycycline|mesh-list
138868619|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138868620|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868621|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
138868622|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138868623|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138868624|NCT00639366|Trastuzumab|trastuzumab|mesh-list
138868625|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138868626|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868627|NCT02686788|Tarenflurbil|tarenflurbil|mesh-list
138868628|NCT02686788|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138868629|NCT02686788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868630|NCT02686788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868631|NCT02686710|Propofol|propofol|mesh-list
138868632|NCT02686710|Sevoflurane|sevoflurane|mesh-list
138868633|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138868634|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138868635|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868636|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138868637|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
138868638|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
138868639|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138868640|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138868641|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138868642|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
138868643|NCT01773083|Heparin|heparin|mesh-list
138868644|NCT01773083|Calcium heparin|calcium heparin|mesh-list
138868645|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
138868646|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138868647|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138868648|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868649|NCT02354898|Sorafenib|sorafenib|mesh-list
138868650|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868651|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138868652|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868653|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868655|NCT00110435|Simvastatin|simvastatin|mesh-list
138868656|NCT00110435|Ezetimibe|ezetimibe|mesh-list
138868657|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138868658|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138868659|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
138868660|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868661|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138868662|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138868663|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868664|NCT00093899|Simvastatin|simvastatin|mesh-list
138868665|NCT00093899|Ezetimibe|ezetimibe|mesh-list
138868666|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138868667|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138868668|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
138868669|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868670|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138868671|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138868672|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868674|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138520796|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
138868675|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138868676|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
138868677|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868678|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138868679|NCT00092729|Naproxen|naproxen|mesh-list
138868680|NCT00092729|Etoricoxib|etoricoxib|mesh-list
138868681|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138868682|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138868683|NCT00092729|Analgesics|analgesics|mesh-ancestor
138868684|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
138868685|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868686|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868687|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138868688|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138868689|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
138868690|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138868691|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868692|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868693|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138868694|NCT02686476|Empagliflozin|empagliflozin|mesh-list
138868695|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138868696|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868697|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138868698|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868699|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
138868700|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138868701|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868702|NCT00616382|Indomethacin|indomethacin|mesh-list
138868703|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
138868704|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138868705|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868706|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868707|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138868708|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138868709|NCT00616382|Protective Agents|protective agents|mesh-ancestor
138868710|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868711|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
138868712|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138868713|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
138771757|NCT02731729|Nivolumab|nivolumab|mesh-list
138868714|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138868715|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138868716|NCT00616382|Analgesics|analgesics|mesh-ancestor
138868717|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
138868718|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868719|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138868720|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138868721|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
138868722|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
138868723|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138868724|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138868726|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138868727|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
138868728|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138868729|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
138868730|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868731|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868732|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
138868734|NCT02574728|Celecoxib|celecoxib|mesh-list
138868735|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
138868736|NCT02574728|Etoposide|etoposide|mesh-list
138868737|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138868738|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
138868739|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868740|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138868741|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138868742|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
138868743|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868744|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868745|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138868746|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138868747|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138868748|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138868749|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868750|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138868751|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868752|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138868753|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
138868754|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138868755|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138868756|NCT02574728|Analgesics|analgesics|mesh-ancestor
138868757|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
138868758|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868759|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138868760|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138868761|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138868762|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
138868763|NCT00617474|Hematinics|hematinics|mesh-ancestor
138868765|NCT00619034|Dorzolamide|dorzolamide|mesh-list
138868766|NCT00619034|Latanoprost|latanoprost|mesh-list
138868767|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138868768|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138701945|NCT05425368|Fluorides|fluorides|mesh-list
138868769|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138868770|NCT00619034|Analgesics|analgesics|mesh-ancestor
138868771|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
138868772|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868773|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868774|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138868775|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138868776|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138868777|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868778|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868779|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138868780|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138868781|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138868782|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138868783|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138868784|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138868785|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138868786|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868787|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138868788|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138868789|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138868790|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138868791|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
138868792|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868793|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868794|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138868795|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138868796|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
138868797|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138868798|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138868799|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
138868800|NCT00638742|Latanoprost|latanoprost|mesh-list
138868801|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138868802|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138868803|NCT02686242|Anesthetics|anesthetics|mesh-list
138868804|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138868805|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868806|NCT05661786|Antiviral Agents|antiviral agents|mesh-list
138771961|NCT01123356|Lenalidomide|lenalidomide|mesh-list
138868807|NCT05661786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868808|NCT00639522|Paclitaxel|paclitaxel|mesh-list
138868809|NCT00639522|Capecitabine|capecitabine|mesh-list
138868810|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138868811|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868812|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
138868813|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
138868814|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
138868815|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868816|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138868817|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
138868818|NCT02686086|Albuterol|albuterol|mesh-list
138868819|NCT02686086|Ipratropium|ipratropium|mesh-list
138868820|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138868821|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
138868822|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868823|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868824|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138868825|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
138868826|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
138868827|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138868828|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138868829|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138868830|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138868831|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
138868832|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868833|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868834|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138868835|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
138868836|NCT02685852|Exenatide|exenatide|mesh-list
138868837|NCT02685852|Acarbose|acarbose|mesh-list
138868838|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138868839|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868840|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138868841|NCT02685852|Incretins|incretins|mesh-ancestor
138868842|NCT02685852|Hormones|hormones|mesh-ancestor
138868843|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138868844|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138868845|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868846|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868847|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138868849|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868850|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138868851|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138868852|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138868853|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
138868854|NCT00622674|Cetuximab|cetuximab|mesh-list
138868855|NCT00622674|Bortezomib|bortezomib|mesh-list
138868856|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138868857|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868858|NCT02687724|Golimumab|golimumab|mesh-list
138868859|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138868860|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138868861|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138868862|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
138868863|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868864|NCT02685774|Metformin|metformin|mesh-list
138868865|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138868866|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868867|NCT00638976|Eptifibatide|eptifibatide|mesh-list
138868868|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138868869|NCT00639756|Allopurinol|allopurinol|mesh-list
138868870|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
138868871|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868872|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868873|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
138991892|NCT01500473|Progestins|progestins|mesh-ancestor
138868874|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138868875|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138868877|NCT00639756|Protective Agents|protective agents|mesh-ancestor
138868878|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868879|NCT00622752|Nicotine|nicotine|mesh-list
138868880|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138868881|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
138868882|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868883|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868884|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138868885|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138868886|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
138868887|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868888|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868889|NCT03451578|alpha-MSH|alpha-msh|mesh-list
138788223|NCT00996996|Iodine|iodine|mesh-list
138868891|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138868892|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868893|NCT02686008|Olaparib|olaparib|mesh-list
138868894|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138868895|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868896|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868897|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868898|NCT02685618|Iloprost|iloprost|mesh-list
138772094|NCT04164355|Tadalafil|tadalafil|mesh-list
138868899|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138868900|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
138868901|NCT00602472|Linagliptin|linagliptin|mesh-list
138868902|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138868903|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868905|NCT00602472|Hormones|hormones|mesh-ancestor
138868906|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138868907|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138868908|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
138868909|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868910|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868911|NCT02685462|Digoxin|digoxin|mesh-list
138868912|NCT02685462|Caffeine|caffeine|mesh-list
138868913|NCT02685462|Atorvastatin|atorvastatin|mesh-list
138868914|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138868915|NCT02685462|Simvastatin|simvastatin|mesh-list
138868916|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138868917|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138868918|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
138868919|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868920|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138868921|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138868922|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868923|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138868924|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868925|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138868926|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138868927|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138868928|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
138868929|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138868930|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138868931|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138868932|NCT02685462|Protective Agents|protective agents|mesh-ancestor
138868934|NCT02685306|Taxane|taxane|mesh-list
138868935|NCT02685306|Bavituximab|bavituximab|mesh-list
138868936|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138868937|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868938|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
138868939|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
138868940|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
138868941|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868942|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138868944|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
138868945|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138868946|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868947|NCT05663892|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138868948|NCT05663892|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138868949|NCT05663892|Estradiol|estradiol|mesh-list
138868950|NCT05663892|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138868952|NCT05663892|Hormones|hormones|mesh-ancestor
138868953|NCT05663892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138868954|NCT05663892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868955|NCT05663892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138868956|NCT05663892|Contraceptive Agents|contraceptive agents|mesh-ancestor
138868957|NCT05663892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138868958|NCT05663892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138868959|NCT02685228|Gemcitabine|gemcitabine|mesh-list
138868960|NCT02685228|Decitabine|decitabine|mesh-list
138868961|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138868962|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
138868963|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772195|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
138868964|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868965|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868966|NCT00616460|Bivalirudin|bivalirudin|mesh-list
138868967|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
138868968|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138868969|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
138868970|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138868971|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138868972|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
138868973|NCT00616538|Fluticasone|fluticasone|mesh-list
138868974|NCT00616538|Xhance|xhance|mesh-list
138868975|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138868976|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138868977|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
138788508|NCT01158950|Tolcapone|tolcapone|mesh-list
138868978|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772233|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138868979|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868980|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138868981|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
138868982|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
138868983|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138868984|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
138868985|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138868986|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138868987|NCT02680548|Prednisolone|prednisolone|mesh-list
138868988|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
138868989|NCT02680548|Bupivacaine|bupivacaine|mesh-list
138868990|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138868991|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
138868992|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
138868993|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
138868994|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138868995|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138868996|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
138868997|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138868998|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138868999|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
138869000|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
138869001|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138869002|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
138869004|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138869005|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138869006|NCT02680548|Protective Agents|protective agents|mesh-ancestor
138869007|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138869008|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869009|NCT05663736|Glimepiride|glimepiride|mesh-list
138869010|NCT05663736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138869011|NCT05663736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138869012|NCT05663736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869013|NCT05663736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138869014|NCT05663736|Immunologic Factors|immunologic factors|mesh-ancestor
138869015|NCT02685150|Omeprazole|omeprazole|mesh-list
138869016|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138869017|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138869018|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138869019|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869020|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869021|NCT02682186|Ropivacaine|ropivacaine|mesh-list
138869022|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
138869023|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
138869024|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869025|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869026|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
138869027|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869029|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
138869030|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
138869031|NCT00619268|Sirolimus|sirolimus|mesh-list
138869032|NCT00619268|Bevacizumab|bevacizumab|mesh-list
138869033|NCT00619268|Sunitinib|sunitinib|mesh-list
138869034|NCT00619268|Temsirolimus|temsirolimus|mesh-list
138869035|NCT00619268|MTOR Inhibitors|mtor inhibitors|mesh-list
138869036|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138869037|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869038|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138869039|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138869040|NCT00619268|Growth Substances|growth substances|mesh-ancestor
138869041|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869042|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
138869043|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
138869044|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869045|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
138869046|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138869047|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869048|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869049|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138869050|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138869051|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138869052|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
138869053|NCT00619346|Pafuramidine|pafuramidine|mesh-list
138869054|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138869055|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138869056|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138521159|NCT00037596|Cytarabine|cytarabine|mesh-list
138869057|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869058|NCT04182828|Lidocaine|lidocaine|mesh-list
138869059|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
138869060|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
138869061|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869062|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869063|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
138869064|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869065|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138869066|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138869067|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138869068|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138869069|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869070|NCT00619424|Pemetrexed|pemetrexed|mesh-list
138869071|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138869072|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869073|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869074|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869075|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138869076|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138869077|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138869078|NCT00641004|Esomeprazole|esomeprazole|mesh-list
138869079|NCT00641004|Rebamipide|rebamipide|mesh-list
138869080|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138869081|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138772376|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
138869082|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138869083|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869084|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869085|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
138869086|NCT00641004|Protective Agents|protective agents|mesh-ancestor
138869087|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869088|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
138869089|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138869090|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869091|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138869092|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138869093|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869094|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869095|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869096|NCT04183608|Adalimumab|adalimumab|mesh-list
138788751|NCT00644956|Tadalafil|tadalafil|mesh-list
138869097|NCT04183608|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138869098|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138869099|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138869100|NCT00641082|Adefovir|adefovir|mesh-list
138869102|NCT00641082|Clevudine|clevudine|mesh-list
138869103|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
138869104|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869105|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138869106|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138869107|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869108|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869109|NCT00641160|Vinorelbine|vinorelbine|mesh-list
138869110|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138869111|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869112|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
138869113|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
138869114|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
138869115|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869117|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138869118|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
138869119|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869120|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
138869121|NCT02679924|Protective Agents|protective agents|mesh-ancestor
138869122|NCT00618176|Lamivudine|lamivudine|mesh-list
138869123|NCT00618176|Zidovudine|zidovudine|mesh-list
138869124|NCT00618176|Nevirapine|nevirapine|mesh-list
138869125|NCT00618176|Didanosine|didanosine|mesh-list
138869126|NCT00618176|Stavudine|stavudine|mesh-list
138869127|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138869128|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138869129|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869130|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869131|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
138869132|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869133|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138869134|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138869135|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
138869136|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138869137|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138869138|NCT04211558|Ozanimod|ozanimod|mesh-list
138869139|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138869140|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772471|NCT04235062|Furosemide|furosemide|mesh-list
138869141|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138869142|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
138869143|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869144|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138869145|NCT00901901|Sorafenib|sorafenib|mesh-list
138869146|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869147|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138869148|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869149|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869150|NCT00618254|Granisetron|granisetron|mesh-list
138869151|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
138869152|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
138869153|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869154|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869155|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138869156|NCT00618254|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138869157|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138869158|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
138869159|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869160|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869161|NCT04184466|Insulin|insulin|mesh-list
138788935|NCT00645658|Hormones|hormones|mesh-ancestor
138869162|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138869163|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
138869164|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
138772506|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
138869165|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138869166|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138869167|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869168|NCT04201769|Dexamethasone|dexamethasone|mesh-list
138869169|NCT04201769|Palonosetron|palonosetron|mesh-list
138869170|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138869173|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869174|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869175|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138869176|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
138869177|NCT04201769|Hormones|hormones|mesh-ancestor
138869178|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138869179|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138869180|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869181|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138869182|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138789044|NCT04292886|Tamoxifen|tamoxifen|mesh-list
138869183|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
138869184|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869185|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869186|NCT05336825|Lidocaine|lidocaine|mesh-list
138869187|NCT05336825|Anesthetics, Local|anesthetics, local|mesh-ancestor
138869188|NCT05336825|Anesthetics|anesthetics|mesh-ancestor
138869189|NCT05336825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869190|NCT05336825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869191|NCT05336825|Sensory System Agents|sensory system agents|mesh-ancestor
138869192|NCT05336825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869193|NCT05336825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138869194|NCT05336825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138869195|NCT05336825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138869196|NCT05336825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138869197|NCT05336825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869198|NCT04748783|Listerine|listerine|mesh-list
138869199|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
138869200|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138869201|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138869202|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
138869203|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
138869204|NCT04748783|Protective Agents|protective agents|mesh-ancestor
138869205|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869206|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138869207|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869208|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
138869209|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
138869210|NCT02777580|Tenecteplase|tenecteplase|mesh-list
138869211|NCT02777580|Clopidogrel|clopidogrel|mesh-list
138869212|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138869213|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138869214|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138869215|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138869216|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
138869217|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869218|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869219|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869220|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138869221|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138869222|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
138869223|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138869224|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138869225|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
138869226|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869227|NCT00642096|Metoprolol|metoprolol|mesh-list
138789277|NCT00994422|Ivermectin|ivermectin|mesh-list
138869228|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138869229|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138869230|NCT00642096|Diuretics|diuretics|mesh-ancestor
138869231|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
138869232|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869233|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138869234|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138869235|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869236|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138166773|NCT04193852|Estradiol|estradiol|mesh-list
138869237|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
138869238|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
138869239|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772644|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
138869240|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138869241|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138869242|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138869243|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
138869244|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869245|NCT05336513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138869246|NCT02679456|Fluconazole|fluconazole|mesh-list
138869247|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
138869248|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
138869249|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789404|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138869251|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138869253|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869254|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138869255|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
138869256|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138869257|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869258|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138869259|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138869260|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
138869261|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
138869262|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138869263|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138869264|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869265|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869266|NCT00640458|Urological Agents|urological agents|mesh-ancestor
138869267|NCT00909948|Fludarabine|fludarabine|mesh-list
138869268|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869269|NCT02681562|Olaparib|olaparib|mesh-list
138869270|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138789539|NCT00994110|Hormones|hormones|mesh-ancestor
138869271|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869272|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869273|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869274|NCT00633035|Esomeprazole|esomeprazole|mesh-list
138869275|NCT00633035|Famotidine|famotidine|mesh-list
138869276|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138869277|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138869278|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138789596|NCT04170790|Incretins|incretins|mesh-ancestor
138869279|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869280|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869282|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
138869283|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
138869284|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869285|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869286|NCT02511132|Gemcitabine|gemcitabine|mesh-list
138869287|NCT02511132|Docetaxel|docetaxel|mesh-list
138869288|NCT02511132|Irinotecan|irinotecan|mesh-list
138869289|NCT02511132|Temozolomide|temozolomide|mesh-list
138869290|NCT02511132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138869291|NCT02511132|Antimetabolites|antimetabolites|mesh-ancestor
138869292|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869293|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869294|NCT02511132|Tubulin Modulators|tubulin modulators|mesh-ancestor
138869295|NCT02511132|Antimitotic Agents|antimitotic agents|mesh-ancestor
138869296|NCT02511132|Mitosis Modulators|mitosis modulators|mesh-ancestor
138869297|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138869298|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138869299|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869300|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138869301|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
138869302|NCT02678520|Goserelin|goserelin|mesh-list
138869303|NCT02678520|Bicalutamide|bicalutamide|mesh-list
138869304|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138869305|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869306|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138869307|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869308|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
138869309|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
138869310|NCT00642252|Fluorides|fluorides|mesh-list
138869311|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
138869312|NCT00642252|Protective Agents|protective agents|mesh-ancestor
138869313|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869314|NCT00642330|Ibuprofen|ibuprofen|mesh-list
138869315|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138869316|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138869317|NCT00642330|Analgesics|analgesics|mesh-ancestor
138869318|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
138869319|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869320|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869321|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138869322|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138869323|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138869324|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869325|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869326|NCT02681796|Bupivacaine|bupivacaine|mesh-list
138869327|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
138869328|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
138869329|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869330|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869331|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
138869332|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869334|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
138869335|NCT02842931|Doxorubicin|doxorubicin|mesh-list
138869336|NCT02842931|Etoposide|etoposide|mesh-list
138869337|NCT02842931|Vincristine|vincristine|mesh-list
138869338|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138869339|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
138869340|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869341|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138869342|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138869343|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
138869344|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869345|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869346|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138869347|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138869348|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138869349|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138869350|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789906|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
138869351|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138869352|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138869353|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
138869354|NCT02842931|Hormones|hormones|mesh-ancestor
138869355|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138869356|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138869357|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
138869358|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
138869359|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
138869361|NCT04183296|Sevoflurane|sevoflurane|mesh-list
138869362|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138869363|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869364|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869365|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138869366|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
138869367|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
138869368|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138869369|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138869370|NCT00642408|Micronutrients|micronutrients|mesh-list
138869371|NCT00642408|Trace Elements|trace elements|mesh-list
138869372|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869374|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
138869375|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869376|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
138869377|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138869378|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869379|NCT02359019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138869380|NCT02359019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869381|NCT02678364|Vitamin D|vitamin d|mesh-list
138869382|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
138869383|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138869384|NCT02678364|Calcifediol|calcifediol|mesh-list
138869385|NCT02678364|Vitamins|vitamins|mesh-ancestor
138869386|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
138869387|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869388|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138869389|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138869390|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
138869391|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138869392|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138869393|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869394|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
138869395|NCT02678208|Coagulants|coagulants|mesh-ancestor
138869396|NCT05551182|Nicergoline|nicergoline|mesh-list
138869397|NCT05551182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138869398|NCT05551182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138869399|NCT05551182|Adrenergic Agents|adrenergic agents|mesh-ancestor
138869400|NCT05551182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869401|NCT05551182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869402|NCT05551182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869403|NCT05551182|Vasodilator Agents|vasodilator agents|mesh-ancestor
138869404|NCT05551182|Nootropic Agents|nootropic agents|mesh-ancestor
138869405|NCT02677584|Caffeine|caffeine|mesh-list
138869406|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
138869407|NCT02677584|Citric Acid|citric acid|mesh-list
138869408|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
138869409|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
138869410|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138869411|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
138869412|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
138869413|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742829|NCT01235949|Ibuprofen|ibuprofen|mesh-list
138869414|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138869415|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869416|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138869417|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869418|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138869419|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138772865|NCT04782700|Hormones|hormones|mesh-ancestor
138869420|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
138869421|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869422|NCT05662956|Azacitidine|azacitidine|mesh-list
138869423|NCT05662956|Venetoclax|venetoclax|mesh-list
138869424|NCT05662956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138869425|NCT05662956|Antimetabolites|antimetabolites|mesh-ancestor
138869426|NCT05662956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790125|NCT02536690|Narcotics|narcotics|mesh-ancestor
138869428|NCT05662956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869429|NCT02838173|Ropivacaine|ropivacaine|mesh-list
138869430|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
138869431|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
138521537|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
138869432|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869433|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869434|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
138869435|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869436|NCT00641472|Budesonide|budesonide|mesh-list
138869437|NCT00641472|Montelukast|montelukast|mesh-list
138869438|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138869439|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138869440|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
138869441|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869442|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869443|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138869444|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
138869445|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
138869446|NCT00641472|Hormones|hormones|mesh-ancestor
138869447|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138869448|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138869449|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
138869450|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138772903|NCT02642419|Aspirin|aspirin|mesh-list
138869451|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138869452|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869453|NCT00896051|Ritonavir|ritonavir|mesh-list
138869454|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138869455|NCT00896051|Tenofovir|tenofovir|mesh-list
138869456|NCT00896051|Etravirine|etravirine|mesh-list
138869457|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138869458|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138869459|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138869460|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
138869461|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869462|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869463|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138869464|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138869465|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
138869466|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869467|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138869468|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138790298|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
138869469|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138869470|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138869471|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138869472|NCT02673606|Estradiol|estradiol|mesh-list
138869473|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138869474|NCT02673606|Estrogens|estrogens|mesh-ancestor
138869475|NCT02673606|Hormones|hormones|mesh-ancestor
138869476|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138869478|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138869479|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
138869480|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138869481|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138869482|NCT02675400|Methylphenidate|methylphenidate|mesh-list
138869483|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138869484|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138869485|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869486|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138869487|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138869488|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138869489|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869490|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
138869491|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869492|NCT00894647|Imiquimod|imiquimod|mesh-list
138869493|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138869494|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
138869495|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869496|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869497|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
138869498|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
138869499|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138869500|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869501|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138869502|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138869503|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869504|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869506|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
138869507|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138869508|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
138869509|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869510|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869511|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138869512|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
138869513|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138869515|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869516|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869517|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138790402|NCT02650102|Olanzapine|olanzapine|mesh-list
138869518|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
138869519|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
138869520|NCT04179942|Protective Agents|protective agents|mesh-ancestor
138869522|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
138869523|NCT04250831|Trace Elements|trace elements|mesh-ancestor
138869524|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
138869525|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869526|NCT04250831|Cathartics|cathartics|mesh-ancestor
138869527|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138869528|NCT00633191|Immunomodulating Agents|immunomodulating agents|mesh-list
138869529|NCT00633191|Immunologic Factors|immunologic factors|mesh-ancestor
138869530|NCT00633191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869531|NCT00643500|Levetiracetam|levetiracetam|mesh-list
138869532|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
138869533|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
138869534|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
138869535|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138869536|NCT00633269|Olaparib|olaparib|mesh-list
138869537|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138869538|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869539|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869540|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869541|NCT04181346|Pregabalin|pregabalin|mesh-list
138869542|NCT04181346|Analgesics|analgesics|mesh-ancestor
138790465|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
138869543|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
138869544|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869545|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869546|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
138869547|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138869548|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138869549|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869550|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138869552|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138869553|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869554|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138869555|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138869556|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138869557|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869558|NCT00642798|Incretins|incretins|mesh-ancestor
138869559|NCT00642798|Hormones|hormones|mesh-ancestor
138869560|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138869561|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138869562|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
138869563|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869564|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869565|NCT05364996|Dimercaprol|dimercaprol|mesh-list
138869566|NCT05364996|Chelating Agents|chelating agents|mesh-ancestor
138869567|NCT05364996|Sequestering Agents|sequestering agents|mesh-ancestor
138869568|NCT05364996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869569|NCT00643734|Azithromycin|azithromycin|mesh-list
138869570|NCT00643734|Levofloxacin|levofloxacin|mesh-list
138869571|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138869572|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869573|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138869574|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138869575|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138869576|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869577|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869578|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869579|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138869580|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138869581|NCT02674308|Vedolizumab|vedolizumab|mesh-list
138869582|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138869583|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
138869584|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138869585|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138869586|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138869588|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
138869589|NCT04178850|Infliximab|infliximab|mesh-list
138869590|NCT04178850|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138869591|NCT04178850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138869592|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
138869593|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138869594|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138869595|NCT04178850|Hematinics|hematinics|mesh-ancestor
138869596|NCT04178850|Vitamins|vitamins|mesh-ancestor
138869597|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
138869598|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869599|NCT02676336|Iodine|iodine|mesh-list
138869600|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
138869601|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138869602|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869603|NCT02676336|Trace Elements|trace elements|mesh-ancestor
138869604|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
138869605|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869606|NCT02672358|Trametinib|trametinib|mesh-list
138869607|NCT02672358|Dabrafenib|dabrafenib|mesh-list
138869608|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869609|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138869610|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869611|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869612|NCT02675868|Phenylephrine|phenylephrine|mesh-list
138869613|NCT02675868|Vasopressins|vasopressins|mesh-list
138992130|NCT00936962|Vaccines|vaccines|mesh-list
138773113|NCT00882115|Sulforaphane|sulforaphane|mesh-list
138869614|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
138869615|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
138869616|NCT02675868|Norepinephrine|norepinephrine|mesh-list
138869617|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138869618|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
138869619|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
138869620|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869621|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869622|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
138790757|NCT02535910|Vitamin D|vitamin d|mesh-list
138869623|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138869624|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
138869625|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
138869626|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138869628|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138869629|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
138869630|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869631|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869632|NCT02675868|Protective Agents|protective agents|mesh-ancestor
138869633|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
138869634|NCT02675868|Coagulants|coagulants|mesh-ancestor
138869635|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138869636|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
138869637|NCT05279742|Valsartan|valsartan|mesh-list
138869638|NCT05279742|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138869639|NCT05279742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138869640|NCT05279742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138869641|NCT05279742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138869642|NCT05279742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869643|NCT02673840|Ketotifen|ketotifen|mesh-list
138869644|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
138869645|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
138869646|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138869647|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
138869648|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
138869649|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869650|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869651|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869652|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138869653|NCT00644124|Aflibercept|aflibercept|mesh-list
138869654|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138869655|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138869656|NCT00644124|Growth Substances|growth substances|mesh-ancestor
138869657|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869658|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
138869659|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869660|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
138869661|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
138869662|NCT02670954|Tramadol|tramadol|mesh-list
138869663|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138869664|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869665|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869666|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138869667|NCT02670954|Analgesics|analgesics|mesh-ancestor
138869668|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
138869669|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869670|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138869671|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138790864|NCT02643550|Cetuximab|cetuximab|mesh-list
138869672|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138869673|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
138869674|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869675|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869676|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138869677|NCT02670954|Narcotics|narcotics|mesh-ancestor
138869678|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138869679|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138869680|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138869681|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138869682|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869683|NCT00644904|Vitamin D|vitamin d|mesh-list
138869684|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
138869685|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
138869686|NCT00644904|Vitamins|vitamins|mesh-list
138869687|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
138869688|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869689|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138869690|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138869691|NCT02670564|Busulfan|busulfan|mesh-list
138869692|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
138869693|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869694|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138869695|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
138869696|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869697|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138790970|NCT00848965|Fluticasone|fluticasone|mesh-list
138869698|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869699|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138869700|NCT02672202|Pregabalin|pregabalin|mesh-list
138869702|NCT02672202|Analgesics|analgesics|mesh-ancestor
138869703|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
138869704|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869705|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869706|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
138869707|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138869708|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138869709|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869710|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138869711|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138791039|NCT00816595|Pentostatin|pentostatin|mesh-list
138869712|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138869713|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869714|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138869715|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138869716|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138869717|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869718|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
138869719|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
138869720|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
138869721|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138869722|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
138869723|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
138869724|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869725|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869726|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138869727|NCT02671578|Analgesics|analgesics|mesh-ancestor
138869728|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
138869729|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869730|NCT00644982|Sertraline|sertraline|mesh-list
138869731|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138869732|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
138869733|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138869734|NCT00644982|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138869735|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138869736|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138869737|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869738|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869739|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
138869740|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869741|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138869742|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138869743|NCT02670642|Esomeprazole|esomeprazole|mesh-list
138869744|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138869745|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138869746|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138869747|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869748|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869749|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138869750|NCT02670018|Metformin|metformin|mesh-list
138869751|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138869752|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869753|NCT02670096|Acetazolamide|acetazolamide|mesh-list
138869754|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
138869755|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138869756|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791109|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
138869757|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869758|NCT02670096|Diuretics|diuretics|mesh-ancestor
138869759|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
138869760|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869761|NCT00645060|Antibodies|antibodies|mesh-list
138869762|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138869763|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
138869764|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869765|NCT00644670|Atorvastatin|atorvastatin|mesh-list
138869766|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138869767|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138869768|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
138869769|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869771|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138869772|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869773|NCT02669706|Pentamidine|pentamidine|mesh-list
138869774|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
138869775|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869776|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138869777|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138869778|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138869779|NCT00645138|Anesthetics|anesthetics|mesh-list
138869780|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869781|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869782|NCT00895895|Donepezil|donepezil|mesh-list
138869783|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138869784|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869785|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869786|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
138869787|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869788|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869789|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
138869790|NCT00644748|Gabapentin|gabapentin|mesh-list
138869791|NCT00644748|Analgesics|analgesics|mesh-ancestor
138869792|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
138869793|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869794|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869795|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
138869796|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138869797|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138869798|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869799|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138869800|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138869801|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138869802|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869803|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869804|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
138869805|NCT00910416|Remifentanil|remifentanil|mesh-list
138869806|NCT00910416|Propofol|propofol|mesh-list
138869807|NCT00910416|Sevoflurane|sevoflurane|mesh-list
138869808|NCT00910416|Atracurium|atracurium|mesh-list
138869809|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138869810|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869811|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869812|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138869813|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
138869814|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
138869816|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138869817|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138869818|NCT00910416|Narcotics|narcotics|mesh-ancestor
138869819|NCT00910416|Analgesics|analgesics|mesh-ancestor
138869820|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
138869821|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869822|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138869823|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138869824|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138869825|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138869826|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138869827|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
138869828|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869829|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869830|NCT02669238|Etonogestrel|etonogestrel|mesh-list
138869831|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138869832|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
138869833|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138869834|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869835|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138869836|NCT02669004|Morphine|morphine|mesh-list
138869837|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138869838|NCT02669004|Narcotics|narcotics|mesh-ancestor
138869839|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138992204|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
138869840|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869841|NCT02669004|Analgesics|analgesics|mesh-ancestor
138869842|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
138869843|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869844|NCT00895661|Rituximab|rituximab|mesh-list
138869845|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138869846|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869847|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
138869848|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869849|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138869850|NCT00645294|Adefovir|adefovir|mesh-list
138869851|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138869852|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
138869853|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869854|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138869855|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138869856|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869857|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869858|NCT02837003|Aspirin|aspirin|mesh-list
138869859|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138869860|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138869861|NCT02837003|Analgesics|analgesics|mesh-ancestor
138869862|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
138869863|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869864|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869865|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138869866|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138869867|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138869868|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138773391|NCT00657007|Belimumab|belimumab|mesh-list
138869869|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791448|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
138869870|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138869871|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138869872|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869873|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
138869874|NCT02668926|Amphetamine|amphetamine|mesh-list
138869875|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138869876|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
138869877|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138869878|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521985|NCT00130364|Analgesics|analgesics|mesh-ancestor
138869879|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
138869880|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
138869881|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869882|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
138869883|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869884|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869885|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
138869886|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138869887|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138869888|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138791531|NCT00599326|Deferasirox|deferasirox|mesh-list
138869889|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138869890|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
138869891|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138869892|NCT02668536|Protective Agents|protective agents|mesh-ancestor
138869893|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869894|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
138869896|NCT00645372|Ziprasidone|ziprasidone|mesh-list
138869897|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138869898|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
138869899|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869900|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869901|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869902|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138869903|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138869904|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869905|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138869906|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138869907|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
138869908|NCT00645918|Clopidogrel|clopidogrel|mesh-list
138869909|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138869910|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138869911|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138869912|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138773487|NCT02633839|Carbidopa|carbidopa|mesh-list
138869913|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
138869914|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138869915|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869916|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869917|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
138869918|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
138869919|NCT00646854|Doxorubicin|doxorubicin|mesh-list
138869920|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138869921|NCT00646854|Vincristine|vincristine|mesh-list
138869922|NCT00646854|Lenograstim|lenograstim|mesh-list
138869923|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138869924|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
138869925|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869926|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138869927|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138869929|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869930|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869931|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138869932|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138869933|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138869934|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138869935|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138869936|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138869937|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791710|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138869938|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138869939|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
138869940|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
138869941|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
138869943|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138992233|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138869944|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869945|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
138869946|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773524|NCT04161001|Amlodipine|amlodipine|mesh-list
138869948|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138869949|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869950|NCT00646932|Vitamins|vitamins|mesh-ancestor
138869951|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
138869952|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138869953|NCT00646152|Poly ICLC|poly iclc|mesh-list
138869954|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
138869955|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
138869956|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869957|NCT00647166|Azathioprine|azathioprine|mesh-list
138869958|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
138791776|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
138869959|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869960|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138869961|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869962|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138869963|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
138869964|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869965|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138869966|NCT00647244|Tenofovir|tenofovir|mesh-list
138869967|NCT00647244|Abacavir|abacavir|mesh-list
138869968|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
138869969|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791842|NCT02637700|Antibodies|antibodies|mesh-list
138869970|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138869971|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138869972|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869973|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869974|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138869975|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138869976|NCT00895583|Sirolimus|sirolimus|mesh-list
138869977|NCT00895583|Tacrolimus|tacrolimus|mesh-list
138869978|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138869979|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
138869980|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869981|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138869982|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138869983|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138869984|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138869985|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138869986|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138869987|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138869988|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
138869989|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
138869990|NCT04174872|Midazolam|midazolam|mesh-list
138869991|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
138869992|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138869993|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138869994|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138869995|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138869996|NCT04174872|Analgesics|analgesics|mesh-ancestor
138869997|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
138645578|NCT00319293|Metformin|metformin|mesh-list
138869998|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138869999|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138870000|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138870001|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138870002|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
138870003|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870004|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870005|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138870006|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138870007|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138870008|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138870009|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138870010|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
138870013|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
138870014|NCT02841137|Progesterone|progesterone|mesh-list
138870015|NCT02841137|Progestins|progestins|mesh-ancestor
138870016|NCT02841137|Hormones|hormones|mesh-ancestor
138870017|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138870018|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870019|NCT00645606|Rituximab|rituximab|mesh-list
138870020|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138870021|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870022|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
138870023|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870024|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138870025|NCT02836847|Trastuzumab|trastuzumab|mesh-list
138870026|NCT02836847|Cetuximab|cetuximab|mesh-list
138870027|NCT02836847|Everolimus|everolimus|mesh-list
138870028|NCT02836847|Sorafenib|sorafenib|mesh-list
138870029|NCT02836847|Gefitinib|gefitinib|mesh-list
138870030|NCT02836847|Lapatinib|lapatinib|mesh-list
138870031|NCT02836847|Crizotinib|crizotinib|mesh-list
138870032|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138870033|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870035|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138870036|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870037|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870038|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138870039|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
138870040|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870041|NCT02666040|Anesthetics|anesthetics|mesh-list
138870042|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870043|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870044|NCT00894413|Tadalafil|tadalafil|mesh-list
138870045|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
138870046|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138870047|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138870048|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059139|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870049|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870050|NCT00894413|Urological Agents|urological agents|mesh-ancestor
138870051|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138870052|NCT04250519|Eusol|eusol|mesh-list
138870053|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
138870054|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870055|NCT02665806|Fluticasone|fluticasone|mesh-list
138870056|NCT02665806|Ciclesonide|ciclesonide|mesh-list
138870057|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138992276|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
138870058|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138870060|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870061|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870062|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138870063|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
138870064|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
138870065|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138870066|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
138870067|NCT02665806|Hormones|hormones|mesh-ancestor
138870068|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138870069|NCT00646386|Adalimumab|adalimumab|mesh-list
138870070|NCT00646386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138870071|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138870072|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138870073|NCT00647634|Alprazolam|alprazolam|mesh-list
138870074|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138870075|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870076|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870077|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138870078|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138870079|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138870080|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
138870081|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
138870082|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870083|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870084|NCT04172064|Dobutamine|dobutamine|mesh-list
138870085|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138870086|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
138870087|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
138870088|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870089|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870090|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138792092|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
138870091|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138870092|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138870093|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
138870094|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870095|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870096|NCT04172064|Protective Agents|protective agents|mesh-ancestor
138870098|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
138870099|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870100|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870101|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
138870102|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870103|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870104|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
138870105|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138870106|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870107|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138870108|NCT04173390|Pregabalin|pregabalin|mesh-list
138870109|NCT04173390|Analgesics|analgesics|mesh-ancestor
138870110|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
138870111|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870112|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870113|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
138870114|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138870115|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138870116|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870117|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138870118|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138792144|NCT00657982|Everolimus|everolimus|mesh-list
138870119|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138870120|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870121|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138870122|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
138870123|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138870124|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870125|NCT02665650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138870126|NCT02665650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870127|NCT00647868|Testosterone|testosterone|mesh-list
138870128|NCT00647868|Androgens|androgens|mesh-ancestor
138870129|NCT00647868|Hormones|hormones|mesh-ancestor
138792192|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
138870130|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138870131|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870132|NCT00647946|Tenofovir|tenofovir|mesh-list
138870133|NCT00647946|Abacavir|abacavir|mesh-list
138870134|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
138870135|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870136|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138870137|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138870138|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870139|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870140|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138870141|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138870142|NCT00648024|Anagrelide|anagrelide|mesh-list
138870143|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138870144|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138870145|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870146|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138870147|NCT02665416|Bevacizumab|bevacizumab|mesh-list
138870148|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138870149|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870150|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138870151|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138870152|NCT02665416|Growth Substances|growth substances|mesh-ancestor
138870153|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870154|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
138870155|NCT00646620|Fluticasone|fluticasone|mesh-list
138870156|NCT00646620|Budesonide|budesonide|mesh-list
138870157|NCT00646620|Albuterol|albuterol|mesh-list
138870158|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
138773830|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
138870159|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138870160|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138870161|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138870162|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138870163|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138870164|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
138870165|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870166|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992313|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
138870167|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138870168|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
138870169|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
138870170|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138870171|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
138870172|NCT00646620|Hormones|hormones|mesh-ancestor
138870173|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138870174|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138870175|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138870176|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138870177|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
138870178|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870179|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522288|NCT05765305|Chromium|chromium|mesh-list
138870180|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
138870181|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138870182|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
138870183|NCT00648180|Doxycycline|doxycycline|mesh-list
138870184|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138870185|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870186|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
138870187|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138870188|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138870189|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138870190|NCT02664168|Laxatives|laxatives|mesh-ancestor
138792315|NCT01076075|Metformin|metformin|mesh-list
138870191|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138870193|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138870194|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870195|NCT00648570|Dexetimide|dexetimide|mesh-list
138870196|NCT00648570|Citalopram|citalopram|mesh-list
138870197|NCT00648570|Escitalopram|escitalopram|mesh-list
138870198|NCT00648570|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138870199|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138870200|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138792346|NCT00881530|Incretins|incretins|mesh-ancestor
138870201|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870202|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870203|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
138870204|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870205|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138870206|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138870207|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
138870208|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
138870209|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870210|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138870211|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138870212|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
138870213|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138870214|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
138870215|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138870216|NCT00648258|Naproxen|naproxen|mesh-list
138870217|NCT00648258|Valdecoxib|valdecoxib|mesh-list
138870218|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138870219|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138870220|NCT00648258|Analgesics|analgesics|mesh-ancestor
138992339|NCT00447694|Deferasirox|deferasirox|mesh-list
138870221|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
138870222|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870223|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870224|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138870225|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138870226|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
138870227|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138870228|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870229|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870230|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138870232|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
138792466|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138870233|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870234|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138870235|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870236|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138870237|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
138870239|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138870240|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870241|NCT00648414|Fentanyl|fentanyl|mesh-list
138870242|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138870243|NCT00648414|Narcotics|narcotics|mesh-ancestor
138870244|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870245|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870246|NCT00648414|Analgesics|analgesics|mesh-ancestor
138870247|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
138870248|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870249|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138870250|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138870251|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
138870253|NCT02663700|Artesunate|artesunate|mesh-list
138870254|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
138870255|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138870256|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138870257|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870258|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870259|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
138870260|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
138870261|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138870262|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
138870263|NCT00648726|Azithromycin|azithromycin|mesh-list
138870264|NCT00648726|Erythromycin|erythromycin|mesh-list
138870265|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
138870266|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138870267|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
138870268|NCT00648726|Cefuroxime|cefuroxime|mesh-list
138870269|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
138870270|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138870271|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870272|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138870273|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138870274|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773956|NCT01208402|Esmolol|esmolol|mesh-list
138870275|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870277|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
138870278|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138870279|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870280|NCT00648804|Ondansetron|ondansetron|mesh-list
138870281|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
138870282|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
138870283|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870284|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870285|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138870286|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
138870287|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
138870288|NCT00648804|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138870289|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138870290|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
138870291|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870292|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870293|NCT02664012|Menthol|menthol|mesh-list
138870294|NCT02664012|Nicotine|nicotine|mesh-list
138870295|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138870296|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
138870297|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870298|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870299|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138870300|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138870301|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
138870302|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870303|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870304|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
138870305|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
138870306|NCT00895037|Factor VIII|factor viii|mesh-list
138870307|NCT00895037|Coagulants|coagulants|mesh-ancestor
138870308|NCT04170504|Methotrexate|methotrexate|mesh-list
138870309|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138870310|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
138870311|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138870312|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870313|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138792758|NCT06199102|Vitamins|vitamins|mesh-ancestor
138870314|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
138870315|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870316|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870317|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
138870318|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870319|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138870320|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138870321|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
138870322|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138870323|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138870324|NCT04170270|Omeprazole|omeprazole|mesh-list
138870325|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138870326|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138870327|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138870328|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059140|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138870329|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870330|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138870331|NCT00633347|Cetrorelix|cetrorelix|mesh-list
138870332|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138870333|NCT00633347|Hormones|hormones|mesh-ancestor
138792820|NCT06174961|Heparin|heparin|mesh-list
138870334|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138870335|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870336|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138870337|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
138870338|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138870339|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
138870340|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
138870341|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138870342|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
138870343|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138870344|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138870345|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870346|NCT02838719|Dexamethasone|dexamethasone|mesh-list
138870347|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
138870348|NCT02838719|BB 1101|bb 1101|mesh-list
138870349|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138870350|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
138870351|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
138774075|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
138870352|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870353|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870354|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138870355|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
138870356|NCT02838719|Hormones|hormones|mesh-ancestor
138870357|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138870358|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138870359|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870360|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
138870361|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870362|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870363|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138870364|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138870365|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870366|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138870367|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138870368|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138870369|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870370|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
138870371|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870372|NCT00649194|Rabeprazole|rabeprazole|mesh-list
138870373|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138870374|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138870375|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138870376|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870377|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870378|NCT02658864|Lafutidine|lafutidine|mesh-list
138870379|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138870380|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138870381|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138774133|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
138870382|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
138870383|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
138870384|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870385|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870386|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870387|NCT02835833|Bevacizumab|bevacizumab|mesh-list
138870388|NCT02835833|Nintedanib|nintedanib|mesh-list
138870389|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138870390|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870391|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138870392|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138870393|NCT02835833|Growth Substances|growth substances|mesh-ancestor
138992398|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138870394|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870395|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
138870396|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138870397|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870398|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870399|NCT04171284|Docetaxel|docetaxel|mesh-list
138870400|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870401|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
138870402|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
138870403|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
138870404|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870405|NCT02838329|Ropivacaine|ropivacaine|mesh-list
138870406|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
138870407|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
138870408|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870409|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870410|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
138870411|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870412|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
138870413|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138870414|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138870415|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138870416|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138870417|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870418|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
138870419|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870420|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870421|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138870422|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870423|NCT02835521|Triamcinolone|triamcinolone|mesh-list
138870424|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138870425|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138870426|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138870427|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138870428|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
138870429|NCT02835521|Hormones|hormones|mesh-ancestor
138870430|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138870431|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870432|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138870433|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
138870434|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870435|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870436|NCT00649272|Oxybutynin|oxybutynin|mesh-list
138870437|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
138870438|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
138870439|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870440|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870441|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138870442|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138870443|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
138870444|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870445|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870446|NCT00649272|Urological Agents|urological agents|mesh-ancestor
138774212|NCT00669643|Rifampin|rifampin|mesh-list
138870447|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
138870448|NCT02666898|Fludarabine|fludarabine|mesh-list
138870449|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
138870450|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138870451|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
138870452|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870453|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138870454|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138870455|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
138992410|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
138870456|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870457|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870458|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138870459|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138870461|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138870462|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138870463|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870464|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138870467|NCT02840279|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138870468|NCT02840279|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138870469|NCT02840279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870470|NCT02840279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870471|NCT00648960|Clarithromycin|clarithromycin|mesh-list
138870472|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138870473|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870474|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138870475|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870476|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870477|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138870478|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138522598|NCT04771520|Piperazine|piperazine|mesh-list
138870479|NCT04437329|Cisplatin|cisplatin|mesh-list
138870480|NCT04437329|Docetaxel|docetaxel|mesh-list
138870481|NCT04437329|Fluorouracil|fluorouracil|mesh-list
138870482|NCT04437329|Nedaplatin|nedaplatin|mesh-list
138870483|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870484|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
138870485|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
138870486|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
138870487|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870488|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
138870489|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138870490|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138870491|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
138870492|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870494|NCT02834507|Carbidopa|carbidopa|mesh-list
138870495|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138870496|NCT02834507|Entacapone|entacapone|mesh-list
138870497|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138870498|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138992423|NCT01012011|Sorafenib|sorafenib|mesh-list
138870499|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
138870500|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870501|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870502|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870503|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138870504|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870505|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138870506|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
138870507|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
138870508|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138870509|NCT02831543|Mosapride|mosapride|mesh-list
139059141|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138870510|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870511|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138870512|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138870513|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
138870514|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870515|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870516|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138870517|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
138870518|NCT02667054|Anesthetics|anesthetics|mesh-list
138870519|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
138870520|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870521|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870522|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
138870523|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870524|NCT02662296|Idelalisib|idelalisib|mesh-list
138870525|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870526|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870527|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870528|NCT02662374|Nystatin|nystatin|mesh-list
138870529|NCT02662374|Calcium|calcium|mesh-list
138870530|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138870531|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870532|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138774344|NCT02887313|Fluorouracil|fluorouracil|mesh-list
138870533|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870534|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
138870535|NCT02662374|Ionophores|ionophores|mesh-ancestor
138870536|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138870537|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870538|NCT05334251|Anesthetics|anesthetics|mesh-list
138870539|NCT05334251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870540|NCT05334251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870541|NCT00649350|Metformin|metformin|mesh-list
138870542|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138870543|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870544|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
138870545|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138870546|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870547|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138870548|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138870549|NCT00649038|Benazepril|benazepril|mesh-list
138870550|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138870551|NCT00649038|Diuretics|diuretics|mesh-ancestor
138870552|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
138870553|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870554|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138870556|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870557|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138870558|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
138870559|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870560|NCT04169256|Bupivacaine|bupivacaine|mesh-list
138870561|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
138870562|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
138870563|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870564|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870565|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
138870566|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870567|NCT02658396|Bortezomib|bortezomib|mesh-list
138870568|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870569|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
138870570|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138870571|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870572|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138870573|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138870574|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870575|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870576|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870577|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138870578|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138870579|NCT00894803|Eptifibatide|eptifibatide|mesh-list
138870580|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138870581|NCT00601458|Naproxen|naproxen|mesh-list
138870582|NCT00601458|Pregabalin|pregabalin|mesh-list
138870583|NCT00601458|Analgesics|analgesics|mesh-ancestor
138870584|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
138870585|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774456|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870586|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870587|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
138870588|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138870589|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138870590|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870591|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138870592|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138870593|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138870594|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870595|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138870596|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138870597|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138870598|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138870599|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138870600|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
138870601|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138870602|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870603|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
138870604|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138870605|NCT02660736|Incretins|incretins|mesh-ancestor
138870606|NCT02660736|Hormones|hormones|mesh-ancestor
138870607|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138870608|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870609|NCT00649584|Gemcitabine|gemcitabine|mesh-list
138870610|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138870611|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138870612|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
138870613|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870614|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870615|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138870616|NCT00649584|Immunotoxins|immunotoxins|mesh-ancestor
138870617|NCT00649584|Immunoconjugates|immunoconjugates|mesh-ancestor
138870618|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
138870619|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870620|NCT02141282|Venetoclax|venetoclax|mesh-list
138870621|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870622|NCT02657616|Vitamin K|vitamin k|mesh-list
138870624|NCT02657616|Vitamins|vitamins|mesh-ancestor
138870625|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
138870626|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870627|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138870628|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138774489|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870629|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870630|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
138870631|NCT02657616|Coagulants|coagulants|mesh-ancestor
138870632|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
138870633|NCT02657694|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138870634|NCT02657694|Ledipasvir|ledipasvir|mesh-list
138870635|NCT02657694|Velpatasvir|velpatasvir|mesh-list
138870636|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
138870637|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870638|NCT02657460|Cisplatin|cisplatin|mesh-list
138870639|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870640|NCT00649896|Estradiol|estradiol|mesh-list
138870641|NCT00649896|Estrogens|estrogens|mesh-ancestor
138870642|NCT00649896|Hormones|hormones|mesh-ancestor
138870643|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138870644|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870645|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
138870646|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138870647|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870648|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138870649|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138870650|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870651|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870652|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870653|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138870654|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138870655|NCT04188158|Capecitabine|capecitabine|mesh-list
138870656|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
138870657|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138870658|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
138870659|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870660|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870661|NCT02831231|Xanomeline|xanomeline|mesh-list
138870662|NCT02831231|Trospium chloride|trospium chloride|mesh-list
138870663|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
138870664|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
138870665|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870666|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870667|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138870668|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138870669|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
138870670|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138793828|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
138870671|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870672|NCT02831231|Urological Agents|urological agents|mesh-ancestor
138870673|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138870674|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138870675|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138870676|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138870677|NCT05234606|Pembrolizumab|pembrolizumab|mesh-list
138870678|NCT05234606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138870679|NCT05234606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870680|NCT05234606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138870681|NCT05234606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870682|NCT00649740|Topiramate|topiramate|mesh-list
138870683|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
138870684|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138870685|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870686|NCT04209920|Chromium|chromium|mesh-list
138870688|NCT04209920|Trace Elements|trace elements|mesh-ancestor
138870689|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
138870690|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870691|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
138870692|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138870693|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138870694|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870695|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138870696|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870697|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138870698|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
138870699|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138870700|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870701|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870702|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138870704|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
138870705|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138794022|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870706|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138870707|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138870708|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138870709|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
138870710|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870711|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870712|NCT02660502|Insulin|insulin|mesh-list
138870713|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138870714|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
138870715|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138870716|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870717|NCT02660346|Vancomycin|vancomycin|mesh-list
138870718|NCT02660346|Daptomycin|daptomycin|mesh-list
138870719|NCT02660346|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138870720|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138870721|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870722|NCT00620438|Efavirenz|efavirenz|mesh-list
138870723|NCT00620438|Nevirapine|nevirapine|mesh-list
138870724|NCT00620438|Rifampin|rifampin|mesh-list
138870725|NCT00620438|Lumefantrine|lumefantrine|mesh-list
138870726|NCT00620438|Artemether|artemether|mesh-list
138870727|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138870728|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138870729|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138870730|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870731|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870732|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
138870733|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138794077|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870734|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138870735|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138870736|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138870737|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138870738|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138992557|NCT00492531|Urological Agents|urological agents|mesh-ancestor
138870739|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138870740|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138870741|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
138870742|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138870743|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
138870744|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138870745|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138870746|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138870747|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138870748|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138870749|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
138870750|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138870751|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138870752|NCT00891839|Rituximab|rituximab|mesh-list
138870753|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138870754|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138870755|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870756|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
138870757|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774639|NCT02832778|Zidovudine|zidovudine|mesh-list
138870758|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138870759|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138870760|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
138870761|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870762|NCT00600756|Risperidone|risperidone|mesh-list
138870763|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138870764|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138870765|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
138870766|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138794251|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138870767|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870768|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870769|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138870770|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138870771|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870772|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138870773|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138870774|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
138870775|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
138870776|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
138870777|NCT02657148|Etonogestrel|etonogestrel|mesh-list
138870778|NCT02657148|Desogestrel|desogestrel|mesh-list
138870779|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138794316|NCT03237780|Atezolizumab|atezolizumab|mesh-list
138870780|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870781|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138870782|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138870783|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138870785|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138870786|NCT02657148|Progestins|progestins|mesh-ancestor
138870787|NCT02657148|Hormones|hormones|mesh-ancestor
138870788|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138870789|NCT04247087|Vitamin K|vitamin k|mesh-list
138870790|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
138870791|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138870792|NCT04247087|Vitamins|vitamins|mesh-ancestor
138870793|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
138870794|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870795|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138870796|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138870797|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870798|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
138870799|NCT04247087|Coagulants|coagulants|mesh-ancestor
138870800|NCT00649116|Metoprolol|metoprolol|mesh-list
138870801|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138870802|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138870803|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
138870804|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
138870805|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870806|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870807|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138870808|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138870809|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138870810|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
138870811|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870812|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870813|NCT02652234|Endostar protein|endostar protein|mesh-list
138870814|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138870815|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138870816|NCT02652234|Growth Substances|growth substances|mesh-ancestor
138870817|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870818|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
138870819|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870820|NCT04211012|Paclitaxel|paclitaxel|mesh-list
138870821|NCT04211012|Cisplatin|cisplatin|mesh-list
138870822|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138870823|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870824|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
138870825|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
138870826|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
138870827|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870829|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
138870830|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870831|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138870832|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870833|NCT00620594|Dactolisib|dactolisib|mesh-list
138870834|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870835|NCT02655822|Atezolizumab|atezolizumab|mesh-list
138870836|NCT02655822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138870837|NCT02655822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794560|NCT02844816|Atezolizumab|atezolizumab|mesh-list
138992609|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138870838|NCT02655822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138870839|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870840|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138870841|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138870843|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138870844|NCT00650442|Estrogens|estrogens|mesh-ancestor
138870845|NCT00650442|Hormones|hormones|mesh-ancestor
138870846|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138870847|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870848|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138870849|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
138870850|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138774775|NCT04243954|Morphine|morphine|mesh-list
138870851|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138870852|NCT00890825|Docetaxel|docetaxel|mesh-list
138870853|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870854|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
138870855|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
138870856|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
138870857|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870858|NCT04760132|Vaccines|vaccines|mesh-list
138870859|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
138870860|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870861|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
138870862|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138870863|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138870864|NCT00649818|Lorazepam|lorazepam|mesh-list
138870865|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
138870866|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
138870867|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
138870868|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870869|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870870|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138870871|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138870872|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870873|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138870874|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138870875|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138870876|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
138870877|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
138870878|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870879|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870880|NCT02830139|Capecitabine|capecitabine|mesh-list
138870881|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
138870882|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870883|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138870884|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
138870885|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870886|NCT02833025|Thrombin|thrombin|mesh-list
138870887|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
138870888|NCT02833025|Coagulants|coagulants|mesh-ancestor
138870889|NCT02651610|Paclitaxel|paclitaxel|mesh-list
138870890|NCT02651610|Docetaxel|docetaxel|mesh-list
138870892|NCT02651610|Bavituximab|bavituximab|mesh-list
138870893|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138870894|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870895|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
138870896|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
138870897|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
138870898|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870899|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138870900|NCT04208594|Propranolol|propranolol|mesh-list
138870901|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138870902|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138870903|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
138870904|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870905|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870906|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870907|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138870908|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138870909|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
138870910|NCT04733144|Dexamethasone|dexamethasone|mesh-list
138870911|NCT04733144|Prednisolone|prednisolone|mesh-list
138870912|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138870913|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
138870914|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
138870915|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870916|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870917|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138870918|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
138870919|NCT04733144|Hormones|hormones|mesh-ancestor
138870920|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138870921|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138870922|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870923|NCT04724720|Famotidine|famotidine|mesh-list
138870924|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138870925|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138870926|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138870927|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
138774876|NCT04155697|Ethanol|ethanol|mesh-list
138870928|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
138870929|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523045|NCT02471430|Interferons|interferons|mesh-list
138870930|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870931|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870932|NCT02833103|Pinaverium|pinaverium|mesh-list
138870933|NCT02833103|Bromides|bromides|mesh-list
138794797|NCT02299999|Docetaxel|docetaxel|mesh-list
138870935|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138870936|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138870937|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870938|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138870939|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870940|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
138870941|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
138870942|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870943|NCT02648490|Acetaminophen|acetaminophen|mesh-list
138870944|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
138870945|NCT02648490|Promethazine|promethazine|mesh-list
138870946|NCT02648490|Dexamethasone|dexamethasone|mesh-list
138870947|NCT02648490|Ondansetron|ondansetron|mesh-list
138870948|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138870949|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
138870950|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
138870951|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870952|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870953|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138870954|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
138870955|NCT02648490|Hormones|hormones|mesh-ancestor
138870956|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138870957|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138870958|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138870959|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138870960|NCT02648490|Analgesics|analgesics|mesh-ancestor
138870961|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
138870962|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
138870963|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
138870964|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
138870965|NCT02648490|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138870966|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138870967|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
138870968|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870969|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870970|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138870971|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138870972|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870973|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
138870974|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
138870975|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138870976|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
139210394|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870977|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
138870978|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138870979|NCT04965272|Cariprazine|cariprazine|mesh-list
138870980|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138870981|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138870982|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870983|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870984|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138870985|NCT02648412|Ketamine|ketamine|mesh-list
138870986|NCT02648412|Analgesics|analgesics|mesh-ancestor
138774944|NCT04157959|Febuxostat|febuxostat|mesh-list
138870987|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
138870988|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138870989|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138870990|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138870991|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138870992|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
138870993|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
138870994|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138870995|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138870996|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138870997|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138870998|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138870999|NCT00650520|Bromocriptine|bromocriptine|mesh-list
138992681|NCT02565719|Interferons|interferons|mesh-list
138871000|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138871001|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138871002|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
138871003|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138871004|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871005|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
138871006|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
138871007|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871008|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871009|NCT00621218|Tretinoin|tretinoin|mesh-list
138871010|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871011|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
138871012|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
138871013|NCT02655276|Glycine|glycine|mesh-list
138871014|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
138871015|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871016|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871017|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871018|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
138871019|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138871020|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
138871021|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138871022|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
138871023|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871024|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871026|NCT00651300|Parecoxib|parecoxib|mesh-list
138871027|NCT00651300|Valdecoxib|valdecoxib|mesh-list
138871028|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138871029|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138871030|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871031|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871032|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138871033|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138871034|NCT00651300|Analgesics|analgesics|mesh-ancestor
138871035|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
138871036|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871037|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871038|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138871039|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138871041|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138871042|NCT00621998|Olanzapine|olanzapine|mesh-list
138871043|NCT00621998|Risperidone|risperidone|mesh-list
138871044|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138871045|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
138871046|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871047|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871048|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871049|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138871050|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138871051|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871052|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138871053|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138871054|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
138871055|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
138871056|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
138871057|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871058|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138871059|NCT00621998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138871060|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138871061|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138871062|NCT02655198|Fenfluramine|fenfluramine|mesh-list
138871063|NCT02655198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138871064|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138871065|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138871066|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871067|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871068|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
138871069|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871070|NCT00650052|Zonisamide|zonisamide|mesh-list
138871071|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
138871072|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138871073|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138871074|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871075|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138871076|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871077|NCT00891527|Bevacizumab|bevacizumab|mesh-list
138871078|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
138775074|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
138871079|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138871080|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523197|NCT05772676|Aprepitant|aprepitant|mesh-list
138871081|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138871082|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138871083|NCT00891527|Growth Substances|growth substances|mesh-ancestor
138871084|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871085|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
138871086|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138871087|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992743|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871088|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871089|NCT03861078|Nicotine|nicotine|mesh-list
138871090|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138871091|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
138871092|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871093|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871094|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138871095|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138871096|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
138871097|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871098|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871099|NCT02829359|Entecavir|entecavir|mesh-list
138871100|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
138871101|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138871102|NCT02650752|Capecitabine|capecitabine|mesh-list
138871103|NCT02650752|Lapatinib|lapatinib|mesh-list
138871104|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138871105|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
138871106|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871107|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871108|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138871109|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871110|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
138871111|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138871112|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138871113|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
138871114|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138871115|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138871116|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871117|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
138871118|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871119|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871120|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138871121|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
138871122|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
138871123|NCT02832713|Protective Agents|protective agents|mesh-ancestor
138871124|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138871125|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871127|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138871128|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
138871129|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871130|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871131|NCT00650598|Diclofenac|diclofenac|mesh-list
138871132|NCT00650598|Valdecoxib|valdecoxib|mesh-list
138871133|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138871134|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138871135|NCT00650598|Analgesics|analgesics|mesh-ancestor
138871136|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
138871137|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871138|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871139|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138871140|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138871141|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138871142|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871143|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871144|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138871146|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138871147|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138871148|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
138775157|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871149|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871150|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138871151|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138871152|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871153|NCT06096558|Melatonin|melatonin|mesh-list
138871154|NCT06096558|Antioxidants|antioxidants|mesh-ancestor
138523267|NCT05770960|Codeine|codeine|mesh-list
138871155|NCT06096558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871156|NCT06096558|Protective Agents|protective agents|mesh-ancestor
138871157|NCT06096558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871158|NCT06096558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871159|NCT06096480|Gabapentin|gabapentin|mesh-list
138871160|NCT06096480|Analgesics|analgesics|mesh-ancestor
138871161|NCT06096480|Sensory System Agents|sensory system agents|mesh-ancestor
138871162|NCT06096480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871163|NCT06096480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871164|NCT06096480|Anticonvulsants|anticonvulsants|mesh-ancestor
138871165|NCT06096480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138871166|NCT06096480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138871167|NCT06096480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871168|NCT06096480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138871169|NCT06096480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138871170|NCT06096480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138871171|NCT06096480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059142|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871172|NCT06096480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871173|NCT06096480|Antimanic Agents|antimanic agents|mesh-ancestor
138871174|NCT06096454|Metformin|metformin|mesh-list
138871175|NCT06096454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138871176|NCT06096454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871177|NCT06096259|Metformin|metformin|mesh-list
138871178|NCT06096259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138871179|NCT06096259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871180|NCT06096220|Fluorouracil|fluorouracil|mesh-list
138871181|NCT06096220|Antimetabolites|antimetabolites|mesh-ancestor
138871182|NCT06096220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871183|NCT06096220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138871184|NCT06096220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871185|NCT06096220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138871186|NCT06096220|Immunologic Factors|immunologic factors|mesh-ancestor
138871187|NCT06096220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871188|NCT06096194|Vitamin D|vitamin d|mesh-list
138871189|NCT06096194|Vitamins|vitamins|mesh-ancestor
138795501|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
138871198|NCT06096181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871199|NCT06096181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138871201|NCT06096181|Sensory System Agents|sensory system agents|mesh-ancestor
138871202|NCT06096181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871203|NCT06096181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138871204|NCT06096181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138871205|NCT06096181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138871206|NCT06096181|Adrenergic Agents|adrenergic agents|mesh-ancestor
138871207|NCT06096181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871208|NCT06096181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871209|NCT06096181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138871210|NCT06096181|Anesthetics, General|anesthetics, general|mesh-ancestor
138871211|NCT06096181|Anesthetics|anesthetics|mesh-ancestor
138871212|NCT06096181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138871213|NCT06096181|Narcotics|narcotics|mesh-ancestor
138871214|NCT06096116|Antithrombins|antithrombins|mesh-list
138871215|NCT06096116|Antithrombin III|antithrombin iii|mesh-list
138871216|NCT06096116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138871217|NCT06096116|Protease Inhibitors|protease inhibitors|mesh-ancestor
138871218|NCT06096116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871219|NCT06096116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871220|NCT06096116|Anticoagulants|anticoagulants|mesh-ancestor
138871221|NCT06096012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138871222|NCT06096012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138871223|NCT06095791|Immunologic Factors|immunologic factors|mesh-list
138871224|NCT06095791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
138871225|NCT06095791|Immunomodulating Agents|immunomodulating agents|mesh-list
138871226|NCT06095791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871235|NCT06095674|Antibodies|antibodies|mesh-list
138871236|NCT06095674|Immunoglobulins|immunoglobulins|mesh-list
138871237|NCT06095674|Immunologic Factors|immunologic factors|mesh-ancestor
138871238|NCT06095674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871239|NCT06095635|Resveratrol|resveratrol|mesh-list
138871240|NCT06095635|Antioxidants|antioxidants|mesh-ancestor
138795620|NCT00470223|Methotrexate|methotrexate|mesh-list
138871241|NCT06095635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871242|NCT06095635|Protective Agents|protective agents|mesh-ancestor
138871243|NCT06095635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871244|NCT06095635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871245|NCT06095635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138871246|NCT06095622|Fenugreek seed meal|fenugreek seed meal|mesh-list
138871247|NCT06095622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138871248|NCT06095622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871249|NCT06095518|Thrombin|thrombin|mesh-list
138871250|NCT06095518|Hemostatics|hemostatics|mesh-ancestor
138871251|NCT06095518|Coagulants|coagulants|mesh-ancestor
138871252|NCT06095453|Narcotics|narcotics|mesh-list
138871253|NCT06095453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871254|NCT06095453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871255|NCT06095453|Analgesics|analgesics|mesh-ancestor
138871256|NCT06095453|Sensory System Agents|sensory system agents|mesh-ancestor
138795679|NCT00408005|Leucovorin|leucovorin|mesh-list
138871257|NCT06095453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871258|NCT06095427|Denosumab|denosumab|mesh-list
138871259|NCT06095427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138871260|NCT06095427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871261|NCT06095375|Temozolomide|temozolomide|mesh-list
138871262|NCT06095375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138871263|NCT06095375|Alkylating Agents|alkylating agents|mesh-ancestor
138871264|NCT06095375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871265|NCT06095375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871266|NCT06095362|Bevacizumab|bevacizumab|mesh-list
138871267|NCT06095362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138871268|NCT06095362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871269|NCT06095362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138871270|NCT06095362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138871271|NCT06095362|Growth Substances|growth substances|mesh-ancestor
138871272|NCT06095362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871273|NCT06095362|Growth Inhibitors|growth inhibitors|mesh-ancestor
138871274|NCT06095167|Cisplatin|cisplatin|mesh-list
138871275|NCT06095167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871277|NCT06094946|Ropivacaine|ropivacaine|mesh-list
138871278|NCT06094946|Anesthetics, Local|anesthetics, local|mesh-ancestor
138871279|NCT06094946|Anesthetics|anesthetics|mesh-ancestor
138871280|NCT06094946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871281|NCT06094946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871282|NCT06094946|Sensory System Agents|sensory system agents|mesh-ancestor
138871283|NCT06094946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871284|NCT06094946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138871285|NCT06094946|Narcotics|narcotics|mesh-ancestor
138871286|NCT06094946|Analgesics|analgesics|mesh-ancestor
138871287|NCT06094946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138871288|NCT06094946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138871289|NCT06094946|Anesthetics, General|anesthetics, general|mesh-ancestor
138871290|NCT06094920|Empagliflozin|empagliflozin|mesh-list
138871291|NCT06094920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138871292|NCT06094920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871293|NCT06094920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138871294|NCT06094920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871296|NCT06094907|Hallucinogens|hallucinogens|mesh-ancestor
138871297|NCT06094907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871298|NCT06094907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138871299|NCT06094907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138871300|NCT06094907|Serotonin Agents|serotonin agents|mesh-ancestor
138871301|NCT06094907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138992830|NCT00940550|Protective Agents|protective agents|mesh-ancestor
138871302|NCT06094907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871303|NCT06094907|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138871305|NCT06094868|Oxaliplatin|oxaliplatin|mesh-list
138871306|NCT06094868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138871307|NCT06094868|Antimetabolites|antimetabolites|mesh-ancestor
138871308|NCT06094868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871309|NCT06094868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871310|NCT06094790|Cortisone|cortisone|mesh-list
138871311|NCT06094790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138871312|NCT06094738|Cortisone|cortisone|mesh-list
138871313|NCT06094738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138871314|NCT06094478|Methamphetamine|methamphetamine|mesh-list
138871315|NCT06094478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138871316|NCT06094478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871317|NCT06094478|Sympathomimetics|sympathomimetics|mesh-ancestor
138871318|NCT06094478|Autonomic Agents|autonomic agents|mesh-ancestor
138871319|NCT06094478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871320|NCT06094478|Dopamine Agents|dopamine agents|mesh-ancestor
138871321|NCT06094478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059143|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138871322|NCT06094478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871323|NCT06094478|Adrenergic Agents|adrenergic agents|mesh-ancestor
138871324|NCT06094478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138871325|NCT06094478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138871326|NCT06094478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138871327|NCT06094478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138871328|NCT06094309|Botulinum Toxins|botulinum toxins|mesh-list
138871329|NCT06094309|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138871330|NCT06094309|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138871331|NCT06094309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138871332|NCT06094309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138871333|NCT06094309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871334|NCT06094309|Cholinergic Agents|cholinergic agents|mesh-ancestor
138871335|NCT06094309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871336|NCT06094309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871337|NCT06094309|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138871338|NCT06094309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871339|NCT06094244|Atorvastatin|atorvastatin|mesh-list
138871340|NCT06094244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138871341|NCT06094244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138871342|NCT06094244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138871343|NCT06094244|Antimetabolites|antimetabolites|mesh-ancestor
138871344|NCT06094244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871345|NCT06094244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138871346|NCT06094244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138871347|NCT06094244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210395|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871348|NCT06094231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138871349|NCT06094231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871350|NCT06094231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138871351|NCT06094231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871352|NCT06094140|Leucovorin|leucovorin|mesh-list
138871353|NCT06094140|Fluorouracil|fluorouracil|mesh-list
138871354|NCT06094140|Oxaliplatin|oxaliplatin|mesh-list
138871355|NCT06094140|Irinotecan|irinotecan|mesh-list
138871356|NCT06094140|Durvalumab|durvalumab|mesh-list
138871357|NCT06094140|Calcium|calcium|mesh-list
138871358|NCT06094140|Levoleucovorin|levoleucovorin|mesh-list
138871359|NCT06094140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138871360|NCT06094140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871362|NCT06094140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871363|NCT06094140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138871364|NCT06094140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871365|NCT06094140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138871366|NCT06094140|Immunologic Factors|immunologic factors|mesh-ancestor
138871367|NCT06094140|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138871368|NCT06094140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138871369|NCT06094140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871370|NCT06094140|Antidotes|antidotes|mesh-ancestor
138871371|NCT06094140|Protective Agents|protective agents|mesh-ancestor
138871372|NCT06094140|Vitamin B Complex|vitamin b complex|mesh-ancestor
138871373|NCT06094140|Vitamins|vitamins|mesh-ancestor
138871374|NCT06094140|Micronutrients|micronutrients|mesh-ancestor
138871375|NCT06094140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138871376|NCT06093971|Propofol|propofol|mesh-list
138871377|NCT06093971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138871378|NCT06093971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871379|NCT06093971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871380|NCT06093971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138871381|NCT06093971|Anesthetics, General|anesthetics, general|mesh-ancestor
138871382|NCT06093971|Anesthetics|anesthetics|mesh-ancestor
138871383|NCT06091735|Interferons|interferons|mesh-list
138871384|NCT06091735|Interferon-alpha|interferon-alpha|mesh-list
138871385|NCT06091735|Magnesium Sulfate|magnesium sulfate|mesh-list
138871386|NCT06091735|Linaclotide|linaclotide|mesh-list
138871387|NCT06091735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138871388|NCT06091735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871389|NCT06091735|Antiviral Agents|antiviral agents|mesh-ancestor
138871390|NCT06091735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138871391|NCT06091735|Immunologic Factors|immunologic factors|mesh-ancestor
138871392|NCT06091735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871393|NCT06091735|Analgesics|analgesics|mesh-ancestor
138871394|NCT06091735|Sensory System Agents|sensory system agents|mesh-ancestor
138871395|NCT06091735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871396|NCT06091735|Anesthetics|anesthetics|mesh-ancestor
138871397|NCT06091735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871398|NCT06091735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138871399|NCT06091735|Anticonvulsants|anticonvulsants|mesh-ancestor
138871400|NCT06091735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138871401|NCT06091735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138871402|NCT06091735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871403|NCT06091735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138871404|NCT06091735|Tocolytic Agents|tocolytic agents|mesh-ancestor
138871405|NCT06091735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138871406|NCT06091735|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138871407|NCT06091735|Enzyme Activators|enzyme activators|mesh-ancestor
138871408|NCT06091735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138871409|NCT06090565|Azithromycin|azithromycin|mesh-list
138871410|NCT06090565|Doxycycline|doxycycline|mesh-list
138871411|NCT06090565|Ceftriaxone|ceftriaxone|mesh-list
138871412|NCT06090565|Cefixime|cefixime|mesh-list
138871413|NCT06090565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138871414|NCT06090565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138871415|NCT06090565|Antimalarials|antimalarials|mesh-ancestor
138871417|NCT06090565|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138871418|NCT06087614|Cisplatin|cisplatin|mesh-list
138871419|NCT06087614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871420|NCT06081257|Vitamins|vitamins|mesh-list
138871421|NCT06081257|Vitamin E|vitamin e|mesh-list
138871422|NCT06081257|Tocopherols|tocopherols|mesh-list
138871423|NCT06081257|Tocotrienols|tocotrienols|mesh-list
138871424|NCT06081257|alpha-Tocopherol|alpha-tocopherol|mesh-list
138871425|NCT06081257|Micronutrients|micronutrients|mesh-ancestor
138646977|NCT05649956|Letrozole|letrozole|mesh-list
139210396|NCT03400826|Simvastatin|simvastatin|mesh-list
138871426|NCT06081257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871428|NCT06081257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871429|NCT06081257|Protective Agents|protective agents|mesh-ancestor
138871430|NCT06059118|Eflornithine|eflornithine|mesh-list
138871431|NCT06059118|Methyltestosterone|methyltestosterone|mesh-list
138871432|NCT06059118|Hormones|hormones|mesh-list
138871433|NCT06059118|Testosterone|testosterone|mesh-list
138871434|NCT06059118|Testosterone undecanoate|testosterone undecanoate|mesh-list
138871435|NCT06059118|Testosterone enanthate|testosterone enanthate|mesh-list
138871436|NCT06059118|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138871437|NCT06059118|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138871438|NCT06059118|Relugolix|relugolix|mesh-list
138796101|NCT05780489|Estradiol|estradiol|mesh-list
138871439|NCT06059118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138871440|NCT06059118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871441|NCT06059118|Androgens|androgens|mesh-ancestor
138871442|NCT06059118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138871443|NCT06059118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871444|NCT06059118|Anabolic Agents|anabolic agents|mesh-ancestor
138871445|NCT06059118|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138871446|NCT06059118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138871447|NCT06059118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138871448|NCT06059118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138871449|NCT06059118|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138871450|NCT06059118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871451|NCT06059118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871452|NCT06059118|Androgen Antagonists|androgen antagonists|mesh-ancestor
138871453|NCT06059118|Hormone Antagonists|hormone antagonists|mesh-ancestor
138871454|NCT06051513|Colistin|colistin|mesh-list
139059144|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138871455|NCT06051513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138871456|NCT06051513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138871457|NCT06006598|Midazolam|midazolam|mesh-list
138871458|NCT06006598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138992888|NCT00940784|Aspirin|aspirin|mesh-list
138871459|NCT06006598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138871460|NCT06006598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871461|NCT06006598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871462|NCT06006598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138871463|NCT06006598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138871464|NCT06006598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138871465|NCT06006598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138871466|NCT06006598|Anesthetics, General|anesthetics, general|mesh-ancestor
138871467|NCT06006598|Anesthetics|anesthetics|mesh-ancestor
138871468|NCT06006598|GABA Modulators|gaba modulators|mesh-ancestor
138871469|NCT06006598|GABA Agents|gaba agents|mesh-ancestor
138871470|NCT06006598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871471|NCT06006598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871472|NCT05994703|Cycloserine|cycloserine|mesh-list
138871473|NCT05994703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138871474|NCT05994703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138871475|NCT05994703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138871476|NCT05994703|Antitubercular Agents|antitubercular agents|mesh-ancestor
138871477|NCT05994703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138871478|NCT05994703|Antimetabolites|antimetabolites|mesh-ancestor
138871479|NCT05994703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059145|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
138871480|NCT05989503|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138871482|NCT05989503|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138871483|NCT05989503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138871484|NCT05989503|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138871485|NCT05989503|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138871486|NCT05989503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871487|NCT05989503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138871488|NCT05989503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871489|NCT05972018|Bupivacaine|bupivacaine|mesh-list
138871490|NCT05972018|Ropivacaine|ropivacaine|mesh-list
138871491|NCT05972018|Anesthetics, Local|anesthetics, local|mesh-ancestor
138871492|NCT05972018|Anesthetics|anesthetics|mesh-ancestor
138871493|NCT05972018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871494|NCT05972018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871495|NCT05972018|Sensory System Agents|sensory system agents|mesh-ancestor
138871496|NCT05972018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871497|NCT05952882|Metformin|metformin|mesh-list
138871498|NCT05952882|Liraglutide|liraglutide|mesh-list
138871499|NCT05952882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138647040|NCT05435547|Dexamethasone|dexamethasone|mesh-list
138871500|NCT05952882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871502|NCT05952882|Hormones|hormones|mesh-ancestor
138871503|NCT05952882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138871504|NCT05927649|Moxifloxacin|moxifloxacin|mesh-list
138871505|NCT05927649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138871506|NCT05927649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138871507|NCT05927649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138871508|NCT05927649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138871509|NCT05927649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871510|NCT05927649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871511|NCT05927649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871512|NCT05909644|Efavirenz|efavirenz|mesh-list
138871513|NCT05909644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138871514|NCT05909644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138992918|NCT00698009|Interleukin-2|interleukin-2|mesh-list
138871515|NCT05909644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871516|NCT05909644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871517|NCT05909644|Antiviral Agents|antiviral agents|mesh-ancestor
138871518|NCT05909644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138871519|NCT05909644|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138871520|NCT05909644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138871521|NCT05909644|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138871522|NCT05909644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138871523|NCT05909644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138871524|NCT05909644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138871525|NCT05881265|Venetoclax|venetoclax|mesh-list
138871526|NCT05881265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871527|NCT05879107|Vaccines|vaccines|mesh-list
138871528|NCT05879107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138871529|NCT05879107|Immunologic Factors|immunologic factors|mesh-ancestor
138871530|NCT05879107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871531|NCT05808972|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138871532|NCT05804123|Acetylcysteine|acetylcysteine|mesh-list
138871533|NCT05804123|Ciprofloxacin|ciprofloxacin|mesh-list
138871534|NCT05804123|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138871535|NCT05804123|Cefotaxime|cefotaxime|mesh-list
138871536|NCT05804123|Cefoxitin|cefoxitin|mesh-list
138871537|NCT05804123|Xylometazoline|xylometazoline|mesh-list
138871538|NCT05804123|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138871539|NCT05804123|Antiviral Agents|antiviral agents|mesh-ancestor
138871540|NCT05804123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138871541|NCT05804123|Expectorants|expectorants|mesh-ancestor
138871542|NCT05804123|Respiratory System Agents|respiratory system agents|mesh-ancestor
138871543|NCT05804123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138871544|NCT05804123|Antioxidants|antioxidants|mesh-ancestor
138871545|NCT05804123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871546|NCT05804123|Protective Agents|protective agents|mesh-ancestor
138871547|NCT05804123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871548|NCT05804123|Antidotes|antidotes|mesh-ancestor
138871549|NCT05804123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138871550|NCT05804123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138871551|NCT05804123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138871552|NCT05804123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871553|NCT05804123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871554|NCT05804123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138871555|NCT05804123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138871556|NCT05804123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138871558|NCT05804123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138871559|NCT05735834|Rituximab|rituximab|mesh-list
138871560|NCT05735834|Zanubrutinib|zanubrutinib|mesh-list
138871561|NCT05735834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138871562|NCT05735834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871563|NCT05735834|Immunologic Factors|immunologic factors|mesh-ancestor
138871564|NCT05735834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871565|NCT05735834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138871566|NCT05735834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138871567|NCT05735834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871568|NCT05735834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871570|NCT05733403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138871571|NCT05733403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138871572|NCT05733403|Adrenergic Agents|adrenergic agents|mesh-ancestor
138871573|NCT05733403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871574|NCT05733403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871575|NCT05733403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871576|NCT05733403|Sympathomimetics|sympathomimetics|mesh-ancestor
138871577|NCT05733403|Autonomic Agents|autonomic agents|mesh-ancestor
138871578|NCT05733403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871579|NCT05733403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138871580|NCT05657873|Immunomodulating Agents|immunomodulating agents|mesh-list
138871581|NCT05657873|Immunologic Factors|immunologic factors|mesh-ancestor
138871582|NCT05657873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871583|NCT05647551|Lidocaine|lidocaine|mesh-list
138775778|NCT04240834|Ticagrelor|ticagrelor|mesh-list
138871584|NCT05647551|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138871585|NCT05647551|Anesthetics, Local|anesthetics, local|mesh-ancestor
138871586|NCT05647551|Anesthetics|anesthetics|mesh-ancestor
138871587|NCT05647551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871588|NCT05647551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871589|NCT05647551|Sensory System Agents|sensory system agents|mesh-ancestor
138871590|NCT05647551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871591|NCT05647551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138796333|NCT05276596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871592|NCT05647551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138871593|NCT05647551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138871594|NCT05647551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138871595|NCT05647551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871596|NCT05647551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138871597|NCT05647551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138871598|NCT05647551|Cholinergic Agents|cholinergic agents|mesh-ancestor
138871599|NCT05647551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871600|NCT05642182|Vitamin D|vitamin d|mesh-list
138871601|NCT05642182|Ergocalciferols|ergocalciferols|mesh-list
138871602|NCT05642182|Cholecalciferol|cholecalciferol|mesh-list
138871603|NCT05642182|Vitamins|vitamins|mesh-list
138871604|NCT05642182|Micronutrients|micronutrients|mesh-ancestor
138871605|NCT05642182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871606|NCT05642182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138871607|NCT05642182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138871608|NCT05625802|Ropivacaine|ropivacaine|mesh-list
138871609|NCT05625802|Anesthetics, Local|anesthetics, local|mesh-ancestor
138871610|NCT05625802|Anesthetics|anesthetics|mesh-ancestor
138992960|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138871611|NCT05625802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871612|NCT05625802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871613|NCT05625802|Sensory System Agents|sensory system agents|mesh-ancestor
138871614|NCT05625802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871615|NCT05609942|Azacitidine|azacitidine|mesh-list
138871616|NCT05609942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138871617|NCT05609942|Antimetabolites|antimetabolites|mesh-ancestor
138871618|NCT05609942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871619|NCT05609942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871620|NCT05609942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871622|NCT05593731|Antioxidants|antioxidants|mesh-ancestor
138871623|NCT05593731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871624|NCT05593731|Protective Agents|protective agents|mesh-ancestor
138871625|NCT05593731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871626|NCT05593731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871627|NCT05565430|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138871628|NCT05565430|Cholinergic Agents|cholinergic agents|mesh-ancestor
138871629|NCT05565430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871630|NCT05565430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796373|NCT05023070|Cannabidiol|cannabidiol|mesh-list
138871631|NCT05565430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871632|NCT05556798|Pomalidomide|pomalidomide|mesh-list
138871633|NCT05556798|Nirogacestat|nirogacestat|mesh-list
138871634|NCT05556798|Immunologic Factors|immunologic factors|mesh-ancestor
138871635|NCT05556798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871636|NCT05556798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138871637|NCT05556798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138871638|NCT05556798|Growth Substances|growth substances|mesh-ancestor
138871639|NCT05556798|Growth Inhibitors|growth inhibitors|mesh-ancestor
138871640|NCT05556798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871641|NCT05556798|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138871642|NCT05556798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871643|NCT05556798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871644|NCT05546710|Anesthetics|anesthetics|mesh-list
138871645|NCT05546710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871646|NCT05546710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871647|NCT05509777|Mirikizumab|mirikizumab|mesh-list
138871648|NCT05509777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138871650|NCT05509777|Analgesics|analgesics|mesh-ancestor
138871651|NCT05509777|Sensory System Agents|sensory system agents|mesh-ancestor
138871652|NCT05509777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871653|NCT05509777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796418|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
138871654|NCT05509777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138871655|NCT05509777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138871656|NCT05509777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138871657|NCT05509777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138871659|NCT05443932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138871660|NCT05443932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138871661|NCT05443932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871662|NCT05443932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138871663|NCT05443932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871664|NCT05443932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138871665|NCT05443932|Diuretics|diuretics|mesh-ancestor
138871666|NCT05443932|Natriuretic Agents|natriuretic agents|mesh-ancestor
138871667|NCT05443932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138796462|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
138871668|NCT05443932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138871669|NCT05440786|Irinotecan|irinotecan|mesh-list
138871670|NCT05440786|Temozolomide|temozolomide|mesh-list
138871671|NCT05440786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138871672|NCT05440786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138775908|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
138871673|NCT05440786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871674|NCT05440786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871675|NCT05440786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871676|NCT05440786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138871677|NCT05440786|Alkylating Agents|alkylating agents|mesh-ancestor
138871678|NCT05429502|Temozolomide|temozolomide|mesh-list
138871679|NCT05429502|Topotecan|topotecan|mesh-list
138871680|NCT05429502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138871681|NCT05429502|Alkylating Agents|alkylating agents|mesh-ancestor
138796522|NCT04084171|Pancrelipase|pancrelipase|mesh-list
138871682|NCT05429502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871683|NCT05429502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871684|NCT05429502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138871685|NCT05429502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138871686|NCT05429502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871687|NCT05426434|Pyrimethamine|pyrimethamine|mesh-list
138871688|NCT05426434|Piperaquine|piperaquine|mesh-list
138871689|NCT05426434|Sulfadoxine|sulfadoxine|mesh-list
138871690|NCT05426434|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138871691|NCT05426434|Artenimol|artenimol|mesh-list
138871692|NCT05426434|Antimalarials|antimalarials|mesh-ancestor
138871693|NCT05426434|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138796583|NCT03657810|Acetaminophen|acetaminophen|mesh-list
138871694|NCT05426434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138871695|NCT05426434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138871696|NCT05426434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138871697|NCT05426434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871698|NCT05426434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871699|NCT05426434|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138871700|NCT05413915|Imatinib Mesylate|imatinib mesylate|mesh-list
138871701|NCT05413915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871702|NCT05413915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138871703|NCT05413915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871704|NCT05413915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871705|NCT05412004|Tirzepatide|tirzepatide|mesh-list
138871706|NCT05412004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138871707|NCT05412004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871708|NCT05412004|Incretins|incretins|mesh-ancestor
138871709|NCT05412004|Hormones|hormones|mesh-ancestor
138871710|NCT05412004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138871711|NCT05377333|Dulaglutide|dulaglutide|mesh-list
138871712|NCT05377333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138871713|NCT05377333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871714|NCT05366816|Sunitinib|sunitinib|mesh-list
138796653|NCT03321656|Tacrolimus|tacrolimus|mesh-list
138871715|NCT05366816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871716|NCT05366816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138871717|NCT05366816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138871719|NCT05366816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871720|NCT05366816|Growth Inhibitors|growth inhibitors|mesh-ancestor
138871721|NCT05366816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138871722|NCT05366816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993008|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138871723|NCT05366816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871725|NCT05364762|Tacrolimus|tacrolimus|mesh-list
138871726|NCT05364762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138871727|NCT05364762|Immunologic Factors|immunologic factors|mesh-ancestor
138871728|NCT05364762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871729|NCT05364762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138871730|NCT05364762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138871731|NCT05364762|Alkylating Agents|alkylating agents|mesh-ancestor
138871732|NCT05364762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871733|NCT05364762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871734|NCT05364762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138871735|NCT05364762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138871736|NCT05364762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871737|NCT05287256|Dronabinol|dronabinol|mesh-list
138871738|NCT05287256|Hallucinogens|hallucinogens|mesh-ancestor
138871739|NCT05287256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871740|NCT05287256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138871741|NCT05287256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138871742|NCT05287256|Analgesics|analgesics|mesh-ancestor
138871743|NCT05287256|Sensory System Agents|sensory system agents|mesh-ancestor
138871744|NCT05287256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871745|NCT05287256|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138871746|NCT05287256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138871747|NCT05287256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871748|NCT05287256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871749|NCT05287256|Hormones|hormones|mesh-ancestor
138871750|NCT05287256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138871751|NCT05252390|Olaparib|olaparib|mesh-list
138871752|NCT05252390|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138871753|NCT05252390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871754|NCT05252390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871755|NCT05252390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871756|NCT05239182|Gemcitabine|gemcitabine|mesh-list
138871757|NCT05239182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138871758|NCT05239182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138871759|NCT05239182|Antimetabolites|antimetabolites|mesh-ancestor
138871760|NCT05239182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871761|NCT05239182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871762|NCT05204667|Acetaminophen|acetaminophen|mesh-list
138871763|NCT05204667|Aspirin|aspirin|mesh-list
138796777|NCT01993836|Propofol|propofol|mesh-list
138871765|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138871766|NCT05204667|Analgesics|analgesics|mesh-ancestor
138871767|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
138871768|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871769|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871770|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
138871771|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138871772|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138871773|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138871774|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138871775|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138871776|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138871777|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138871778|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871779|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138871780|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138871781|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871782|NCT05180240|Cannabidiol|cannabidiol|mesh-list
138871783|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
138871784|NCT05163561|Vaccines|vaccines|mesh-list
138776023|NCT02821312|DA-8010|da-8010|mesh-list
138871785|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
138871786|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871787|NCT05142696|Carboplatin|carboplatin|mesh-list
138871788|NCT05142696|Etoposide|etoposide|mesh-list
138871789|NCT05142696|Tislelizumab|tislelizumab|mesh-list
138871790|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138871791|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138871792|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871793|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138871794|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138871795|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138871796|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871797|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871798|NCT05142696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138871799|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
138871800|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
138871801|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138871803|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138871804|NCT04993352|Mitogens|mitogens|mesh-list
138871805|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
138871806|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
138871807|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871808|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
138871809|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871810|NCT04993352|Growth Substances|growth substances|mesh-ancestor
138871811|NCT04977401|Glycerol|glycerol|mesh-list
138871812|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138871813|NCT04977401|Protective Agents|protective agents|mesh-ancestor
138871814|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871815|NCT04950465|Fluorides|fluorides|mesh-list
138871816|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
138871817|NCT04950465|Protective Agents|protective agents|mesh-ancestor
138871818|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871819|NCT04907825|Warfarin|warfarin|mesh-list
138871820|NCT04907825|Anticoagulants|anticoagulants|mesh-list
138871821|NCT04889547|Dexamethasone|dexamethasone|mesh-list
138871822|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
138871823|NCT04889547|BB 1101|bb 1101|mesh-list
138871824|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138871825|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
138871826|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
138871827|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871828|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871829|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138871830|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
138871831|NCT04889547|Hormones|hormones|mesh-ancestor
138871832|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138871833|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138871834|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871835|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
138871836|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993036|NCT00696137|Fentanyl|fentanyl|mesh-list
138871837|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871838|NCT04887285|Anesthetics|anesthetics|mesh-list
138871839|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
138871840|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796881|NCT01131104|Tadalafil|tadalafil|mesh-list
138871841|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871842|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
138871843|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871845|NCT04887194|Digoxin|digoxin|mesh-list
138871846|NCT04887194|Midazolam|midazolam|mesh-list
138871847|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
138871848|NCT04887194|Warfarin|warfarin|mesh-list
138871849|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138871850|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138871851|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871852|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138871853|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871854|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138871855|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138871856|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871857|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871858|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138871859|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138871860|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138871861|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138871862|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
138871863|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
138871864|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
138871865|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
138871866|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871867|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138871868|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138871869|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
138871870|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138871871|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138647409|NCT04405167|Hormones|hormones|mesh-ancestor
138871872|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871873|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
138871874|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138871875|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138871876|NCT04887194|Protective Agents|protective agents|mesh-ancestor
138871877|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
138871878|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
138871879|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138871880|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138871881|NCT04857320|Insulin|insulin|mesh-list
138871882|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138871883|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138871884|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871885|NCT04807894|Testosterone|testosterone|mesh-list
138871886|NCT04807894|Androgens|androgens|mesh-ancestor
138871887|NCT04807894|Hormones|hormones|mesh-ancestor
138871888|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138871889|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871890|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138871891|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
138871892|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138797015|NCT01129622|Letrozole|letrozole|mesh-list
138871893|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
138871894|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871896|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138871897|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
138871898|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871899|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871900|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138871901|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138871902|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
138871903|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138871904|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871905|NCT04735185|Anesthetics|anesthetics|mesh-list
138871906|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
138871907|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138871908|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871909|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
138871910|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138871911|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
138871912|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871914|NCT04518046|Ipilimumab|ipilimumab|mesh-list
138871915|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138871916|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871917|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138871918|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871919|NCT04485052|Azacitidine|azacitidine|mesh-list
138871920|NCT04485052|Decitabine|decitabine|mesh-list
138871921|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138871922|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
138871923|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871924|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871925|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871926|NCT04447183|Iodine|iodine|mesh-list
138871927|NCT04447183|Hormones|hormones|mesh-list
138871928|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138871929|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871930|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138871931|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138871932|NCT04447183|Trace Elements|trace elements|mesh-ancestor
138871933|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
138871934|NCT04432831|Faricimab|faricimab|mesh-list
138871935|NCT04432831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138871936|NCT04432831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138871937|NCT04432831|Growth Substances|growth substances|mesh-ancestor
138871938|NCT04432831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871939|NCT04432831|Growth Inhibitors|growth inhibitors|mesh-ancestor
138871940|NCT04432831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871941|NCT04392479|Aflibercept|aflibercept|mesh-list
138871942|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138871943|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138871945|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871946|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
138871947|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871948|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
138871949|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138871950|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871951|NCT04344795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138871952|NCT04344795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871953|NCT04308785|Atezolizumab|atezolizumab|mesh-list
138871954|NCT04308785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138871955|NCT04308785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871956|NCT04308785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138871957|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871959|NCT04277858|Docetaxel|docetaxel|mesh-list
138871960|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871961|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
138871962|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
138871963|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
138871964|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871965|NCT04265950|Vaccines|vaccines|mesh-list
138871966|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
138871967|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871968|NCT04166773|Tirzepatide|tirzepatide|mesh-list
138871969|NCT04166773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138871970|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871971|NCT04166773|Incretins|incretins|mesh-ancestor
138871972|NCT04166773|Hormones|hormones|mesh-ancestor
138776287|NCT00678769|Temsirolimus|temsirolimus|mesh-list
138871973|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138871974|NCT04104672|Paclitaxel|paclitaxel|mesh-list
138871975|NCT04104672|Gemcitabine|gemcitabine|mesh-list
138871976|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138871977|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871978|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
138871979|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
138871980|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
138871981|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871982|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138524100|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
138871983|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
138871984|NCT04091217|Bevacizumab|bevacizumab|mesh-list
138871985|NCT04091217|Atezolizumab|atezolizumab|mesh-list
138871986|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138871987|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871988|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138871989|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138871990|NCT04091217|Growth Substances|growth substances|mesh-ancestor
138993089|NCT00458302|Darunavir|darunavir|mesh-list
138871991|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138871992|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
138871993|NCT04091217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138871994|NCT04091217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138871996|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138871997|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138871998|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138871999|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872000|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
138872001|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138872002|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138872003|NCT04051203|Prednisolone|prednisolone|mesh-list
138872004|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
138872005|NCT04051203|Lidocaine|lidocaine|mesh-list
138872006|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138872007|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
138872008|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
138872009|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
138872010|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872011|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872012|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
138872013|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872014|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138872015|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138872016|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138872017|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138872018|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872019|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138872020|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
138872022|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138872023|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
138872024|NCT04051203|Hormones|hormones|mesh-ancestor
138872025|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872026|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138872027|NCT04051203|Protective Agents|protective agents|mesh-ancestor
138776382|NCT05652400|Antiviral Agents|antiviral agents|mesh-ancestor
138872028|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138872029|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872030|NCT04015869|Pregnanolone|pregnanolone|mesh-list
138872031|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
138872032|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872033|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872034|NCT04008186|Metformin|metformin|mesh-list
138872035|NCT04008186|Repaglinide|repaglinide|mesh-list
138872036|NCT04008186|Itraconazole|itraconazole|mesh-list
138872037|NCT04008186|Digoxin|digoxin|mesh-list
138872038|NCT04008186|Verapamil|verapamil|mesh-list
138872039|NCT04008186|Midazolam|midazolam|mesh-list
138872040|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138872041|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
138872042|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138872043|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872044|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138872045|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138872046|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872047|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138872048|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138872049|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138872050|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138872051|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
138872052|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
138872053|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
138872054|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
138872055|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872056|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872057|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138872058|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138872059|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
138872060|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138872061|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138872062|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872063|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
138872064|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872065|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138872066|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138872067|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138872068|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
138872069|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872070|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138872071|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138872072|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138872073|NCT04008186|Protective Agents|protective agents|mesh-ancestor
138872074|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138872075|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138872076|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138872077|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
138872078|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138872079|NCT03891901|Isoniazid|isoniazid|mesh-list
138872080|NCT03891901|Rifabutin|rifabutin|mesh-list
138872081|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
138872082|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872083|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138872084|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872085|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872086|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
138872087|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138872088|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872089|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138872090|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138872091|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
138872092|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138872093|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138872094|NCT03887936|Testosterone|testosterone|mesh-list
138872095|NCT03887936|Androgens|androgens|mesh-ancestor
138872096|NCT03887936|Hormones|hormones|mesh-ancestor
138872097|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872098|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872099|NCT03872388|Capecitabine|capecitabine|mesh-list
138872100|NCT03872388|Atorvastatin|atorvastatin|mesh-list
138993161|NCT03034642|Chelating Agents|chelating agents|mesh-ancestor
138872101|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138872102|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
138872103|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872104|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872105|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138872106|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138872107|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138872108|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138872109|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872110|NCT03827018|Prednisone|prednisone|mesh-list
138872111|NCT03827018|Mavrilimumab|mavrilimumab|mesh-list
138872112|NCT03827018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138872113|NCT03827018|Glucocorticoids|glucocorticoids|mesh-ancestor
138872114|NCT03827018|Hormones|hormones|mesh-ancestor
138872115|NCT03827018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872116|NCT03827018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872117|NCT03827018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138872118|NCT03827018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872119|NCT03827018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872120|NCT03777319|Prednisolone|prednisolone|mesh-list
138872121|NCT03777319|Spironolactone|spironolactone|mesh-list
138872122|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138872123|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
138872124|NCT03777319|Hormones|hormones|mesh-ancestor
138872125|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872126|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872127|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138872128|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872129|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138872130|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
138872131|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138872132|NCT03777319|Diuretics|diuretics|mesh-ancestor
138872133|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
138872134|NCT03747484|Interferons|interferons|mesh-list
138872136|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
138872137|NCT03747484|Avelumab|avelumab|mesh-list
138872138|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
138872139|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
138872140|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138872141|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138872142|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872143|NCT03747484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138872144|NCT03747484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872145|NCT03747484|Antiviral Agents|antiviral agents|mesh-ancestor
138872146|NCT03747484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872147|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
138776567|NCT02811484|Exenatide|exenatide|mesh-list
138872148|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872149|NCT03575325|Cytarabine|cytarabine|mesh-list
138872150|NCT03575325|Daunorubicin|daunorubicin|mesh-list
138872151|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138872152|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
138872153|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872154|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872155|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
138872156|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872157|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138872158|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
138872159|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872160|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138872161|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138872162|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138872163|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872164|NCT03532295|Bevacizumab|bevacizumab|mesh-list
138872165|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138872166|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872167|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138872168|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138872169|NCT03532295|Growth Substances|growth substances|mesh-ancestor
138872170|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872171|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
138872173|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138872174|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138872175|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
138872176|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872177|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872178|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872179|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872180|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138872181|NCT03439254|Cathartics|cathartics|mesh-ancestor
138872182|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138872183|NCT03434379|Bevacizumab|bevacizumab|mesh-list
138872184|NCT03434379|Atezolizumab|atezolizumab|mesh-list
138872185|NCT03434379|Sorafenib|sorafenib|mesh-list
139059146|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
138872186|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138872187|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872188|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138872189|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138872190|NCT03434379|Growth Substances|growth substances|mesh-ancestor
138872191|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872192|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
138872193|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138872194|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872195|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872196|NCT03434379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138872197|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138872198|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872199|NCT03228186|Docetaxel|docetaxel|mesh-list
138872200|NCT03228186|Pevonedistat|pevonedistat|mesh-list
138872201|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872202|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
138872203|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
138872204|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
138872205|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872206|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872207|NCT03139916|Temozolomide|temozolomide|mesh-list
138872208|NCT03139916|Bavituximab|bavituximab|mesh-list
138524332|NCT00039390|Capecitabine|capecitabine|mesh-list
138872209|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138872210|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
138872211|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872212|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872213|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138872215|NCT03088540|Carboplatin|carboplatin|mesh-list
138872216|NCT03088540|Gemcitabine|gemcitabine|mesh-list
138872217|NCT03088540|Pemetrexed|pemetrexed|mesh-list
138872218|NCT03088540|Cemiplimab|cemiplimab|mesh-list
138872219|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138872220|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872221|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
138776652|NCT04237480|Vitamin D|vitamin d|mesh-list
138872222|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
138872223|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
138872224|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872225|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138872226|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
138872227|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872228|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138872229|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138872230|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138872231|NCT03003637|Nivolumab|nivolumab|mesh-list
138872232|NCT03003637|Ipilimumab|ipilimumab|mesh-list
138872233|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138872234|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872235|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138872236|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872237|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
138872238|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138872239|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
138872240|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872241|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872242|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138872243|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
138872244|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872245|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872246|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138872248|NCT02937272|Gemcitabine|gemcitabine|mesh-list
138872249|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138872250|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872251|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
138872252|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
138872253|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
138872254|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872255|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138872256|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
138872258|NCT02888067|Rocuronium|rocuronium|mesh-list
138872259|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
138872260|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138872261|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138872262|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138872263|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872264|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872265|NCT02848820|Amoxicillin|amoxicillin|mesh-list
138872266|NCT02848820|Gentamicins|gentamicins|mesh-list
138872267|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138872268|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
138872269|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
138872270|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138872271|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872272|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138872273|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872274|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872275|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138872276|NCT02668770|Ipilimumab|ipilimumab|mesh-list
138993197|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872277|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138872278|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872279|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138872280|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872317|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872318|NCT00476515|Rituximab|rituximab|mesh-list
138872319|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138872320|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872321|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
138872322|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872323|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872324|NCT00261547|Rituximab|rituximab|mesh-list
138872325|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138872326|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872327|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
138872328|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872329|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872330|NCT02650596|Liraglutide|liraglutide|mesh-list
138872331|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138872332|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872333|NCT02650596|Incretins|incretins|mesh-ancestor
138872334|NCT02650596|Hormones|hormones|mesh-ancestor
138872335|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872336|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138872337|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872338|NCT02832089|Carvedilol|carvedilol|mesh-list
138872339|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138872340|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138872341|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
138872342|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872343|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872344|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872345|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138872346|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
138872347|NCT02832089|Protective Agents|protective agents|mesh-ancestor
138872348|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138872349|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138872350|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138872351|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
138872352|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138872353|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138872354|NCT04247633|Palbociclib|palbociclib|mesh-list
138872355|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872356|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138776776|NCT02809378|Remifentanil|remifentanil|mesh-list
138872357|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872358|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872360|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872361|NCT02829281|Triamcinolone|triamcinolone|mesh-list
138872362|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138872363|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138872364|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
138872365|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138872366|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138872367|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138872368|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138872369|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138872370|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872371|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
138872372|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872373|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872374|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138872375|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
138872376|NCT02829281|Hormones|hormones|mesh-ancestor
138872377|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872378|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138872379|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
138872380|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872381|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138872382|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872384|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
138872385|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
138872386|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872387|NCT04168944|Lenvatinib|lenvatinib|mesh-list
138872388|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138872389|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872390|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138872391|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872392|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776812|NCT01185353|Methotrexate|methotrexate|mesh-list
138872393|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
138872394|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872395|NCT02697032|Bicalutamide|bicalutamide|mesh-list
138872396|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
138872397|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
138872398|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872399|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993277|NCT00439270|Docetaxel|docetaxel|mesh-list
138872400|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872401|NCT02647632|Ribavirin|ribavirin|mesh-list
138872402|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
138872403|NCT02647632|Grazoprevir|grazoprevir|mesh-list
138872404|NCT02647632|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138872405|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
138872406|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872407|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
138872408|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872409|NCT00621452|Aldesleukin|aldesleukin|mesh-list
138872410|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
138872411|NCT00621452|Interleukin-2|interleukin-2|mesh-list
138872412|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138872413|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
138797943|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
138872414|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872415|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872416|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138872417|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
138872418|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872419|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872420|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138872421|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138872422|NCT00621452|Analgesics|analgesics|mesh-ancestor
138872423|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
138798012|NCT00958074|Vorinostat|vorinostat|mesh-list
138872424|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872426|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138872427|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
138872428|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872429|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
138872430|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
138872431|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138872432|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138872433|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872434|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872435|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872436|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872437|NCT00651612|Timolol|timolol|mesh-list
138872438|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138872439|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138872440|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138872441|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138872442|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138872443|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
138872444|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872445|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872446|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872447|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138872448|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138872449|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138872450|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138872451|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138872452|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138872453|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138872454|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
138872455|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872456|NCT02650206|Liraglutide|liraglutide|mesh-list
138872457|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138872458|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872459|NCT02650206|Incretins|incretins|mesh-ancestor
138872461|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872462|NCT05368766|Diuretics|diuretics|mesh-list
138872463|NCT05368766|Natriuretic Agents|natriuretic agents|mesh-ancestor
138872464|NCT05368766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872465|NCT00891293|Fenofibrate|fenofibrate|mesh-list
138872466|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138872467|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
138872468|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872469|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138872470|NCT05368142|Cell Wall Skeleton|cell wall skeleton|mesh-list
138872471|NCT05368142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138872472|NCT05368142|Immunologic Factors|immunologic factors|mesh-ancestor
138872473|NCT05368142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872475|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138872476|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138872477|NCT00889421|Analgesics|analgesics|mesh-ancestor
138872478|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
138872479|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872480|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872481|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138872482|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872483|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138872484|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138872485|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872486|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872487|NCT02827643|Vitamin D|vitamin d|mesh-list
138872488|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
138872489|NCT02827643|Lamivudine|lamivudine|mesh-list
138872490|NCT02827643|Calcium|calcium|mesh-list
138872491|NCT02827643|Vitamins|vitamins|mesh-ancestor
138872492|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
138872493|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872494|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138872495|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138872496|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138872497|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138872498|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872499|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872500|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
138872501|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872502|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138872503|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138872504|NCT02646774|Micafungin|micafungin|mesh-list
138872505|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
138872506|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872507|NCT02647086|Metoprolol|metoprolol|mesh-list
138524639|NCT00020735|Toremifene|toremifene|mesh-list
138872509|NCT02647086|Caffeine|caffeine|mesh-list
138872510|NCT02647086|Omeprazole|omeprazole|mesh-list
138872511|NCT02647086|Warfarin|warfarin|mesh-list
138872512|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138798259|NCT00910299|Clopidogrel|clopidogrel|mesh-list
138872513|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138872514|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872515|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872516|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138872517|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138872518|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138872519|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138872520|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
138872521|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
138872522|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
138872523|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
138872524|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872525|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872526|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
138872527|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138872528|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138872529|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872530|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138872531|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138872532|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
138872533|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138872534|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138872535|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138872536|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138872537|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138872539|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
138872540|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872541|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138872542|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138872543|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138872544|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
138872545|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
138872546|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138872547|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138872548|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138872549|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138872550|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872552|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872553|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872554|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138872555|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872556|NCT00651768|Budesonide|budesonide|mesh-list
138872557|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
138872558|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138872559|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138798363|NCT00676702|Vitamin K|vitamin k|mesh-list
138872560|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138872561|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
139059147|NCT01107808|Vitamin D|vitamin d|mesh-list
138872562|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872563|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872564|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138872565|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
138872566|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
138872567|NCT00651768|Hormones|hormones|mesh-ancestor
138798390|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
138872568|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872569|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138872570|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138872571|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138872572|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
138872573|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872574|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872575|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138872576|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138872577|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138872578|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872579|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138524707|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
138872580|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
138872581|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138872582|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138872583|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138872584|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138872585|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138872586|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138872587|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138872588|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138872589|NCT04167306|Bupropion|bupropion|mesh-list
138872590|NCT04167306|Varenicline|varenicline|mesh-list
138872591|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138872592|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
138872593|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138872594|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138872595|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138872596|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138872597|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872598|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
138872599|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872600|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872601|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138872602|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138872603|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872604|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138872605|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138872606|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
138872607|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
138872608|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138872609|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138872610|NCT04244591|Prednisolone|prednisolone|mesh-list
138872611|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
138872612|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138872613|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
139059148|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
138872614|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138872615|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
138872616|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
138648162|NCT02484404|Durvalumab|durvalumab|mesh-list
138872619|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138872620|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
138872621|NCT04244591|Hormones|hormones|mesh-ancestor
138872622|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872623|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138872624|NCT04244591|Protective Agents|protective agents|mesh-ancestor
138872625|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138872626|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872627|NCT02649582|Temozolomide|temozolomide|mesh-list
138872628|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138872629|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
138872630|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872631|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872632|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
138872633|NCT04167696|Fludarabine|fludarabine|mesh-list
138872634|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
138872635|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138872636|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
138872637|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872638|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872639|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138872640|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
138872641|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872642|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872643|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138872644|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138872645|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
138872646|NCT02827487|Celecoxib|celecoxib|mesh-list
138872647|NCT02827487|Tramadol|tramadol|mesh-list
138872648|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138872649|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138872650|NCT02827487|Analgesics|analgesics|mesh-ancestor
138872651|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
138872652|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138524795|NCT00041223|Procyanidin|procyanidin|mesh-list
138872653|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872654|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138872655|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872656|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138872657|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138872658|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872659|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872660|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138872661|NCT02827487|Narcotics|narcotics|mesh-ancestor
138872662|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872663|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
138872664|NCT02649504|Dexamethasone|dexamethasone|mesh-list
138872665|NCT02649504|Rituximab|rituximab|mesh-list
138872666|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138872667|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
138872668|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
138872669|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872670|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872671|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138872672|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
138872673|NCT02649504|Hormones|hormones|mesh-ancestor
138872674|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872675|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138872676|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798745|NCT00912262|Capsaicin|capsaicin|mesh-list
138872677|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138872678|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
138872679|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872680|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138872681|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138872682|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
138872683|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138872684|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872685|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872686|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872688|NCT00650910|Digoxin|digoxin|mesh-list
138872689|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872690|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138872691|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872692|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872693|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138872694|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138872695|NCT00650910|Protective Agents|protective agents|mesh-ancestor
138872696|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872697|NCT02654730|Piperaquine|piperaquine|mesh-list
138872698|NCT02654730|Primaquine|primaquine|mesh-list
138872699|NCT02654730|Artenimol|artenimol|mesh-list
138872700|NCT02654730|Artemisinins|artemisinins|mesh-list
138872702|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138872703|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138872704|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872705|NCT00888329|Aprepitant|aprepitant|mesh-list
138872706|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
138872707|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
138993343|NCT01024192|Zolpidem|zolpidem|mesh-list
138872708|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872709|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872711|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138872712|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872713|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872714|NCT00652002|Budesonide|budesonide|mesh-list
138872715|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
138872716|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138872717|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138872718|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
138872719|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872720|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872721|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138777230|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
138872722|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
138872723|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
138872724|NCT00652002|Hormones|hormones|mesh-ancestor
138799009|NCT02857842|Hormones|hormones|mesh-ancestor
138872725|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872726|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138872727|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138872728|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138872730|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872731|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872732|NCT02646540|Metolazone|metolazone|mesh-list
138872733|NCT02646540|Furosemide|furosemide|mesh-list
138872734|NCT02646540|Tolvaptan|tolvaptan|mesh-list
138872735|NCT02646540|Diuretics|diuretics|mesh-list
138872736|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
138872737|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872738|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138872739|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138799041|NCT02606539|Methotrexate|methotrexate|mesh-list
138872740|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872741|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138872742|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138872743|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138872744|NCT00651066|Ritonavir|ritonavir|mesh-list
138872745|NCT00651066|Lopinavir|lopinavir|mesh-list
138872746|NCT00651066|Rifabutin|rifabutin|mesh-list
138872747|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138872748|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138872749|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
138872750|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872751|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872752|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138872753|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138872754|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
138872755|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872756|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138872757|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138872758|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138872759|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138872760|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
138872761|NCT02646072|Ketorolac|ketorolac|mesh-list
138872762|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138872763|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138872764|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138993353|NCT01024270|Misoprostol|misoprostol|mesh-list
138872765|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138872766|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138872767|NCT02646072|Analgesics|analgesics|mesh-ancestor
138872768|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
138872769|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872770|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872771|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138872772|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872773|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138872774|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872775|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872776|NCT02654106|Temozolomide|temozolomide|mesh-list
138872777|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138872778|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
138872779|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872780|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872782|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872783|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872784|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872785|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138872786|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138872787|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
138872788|NCT03434366|Ketamine|ketamine|mesh-list
138872789|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138872790|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872791|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872792|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138872793|NCT03434366|Analgesics|analgesics|mesh-ancestor
138872794|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
138872795|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872796|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138872797|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138872798|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138872799|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
138872800|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138524940|NCT00394745|Valsartan|valsartan|mesh-list
138872801|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872802|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138799290|NCT03198741|Aspirin|aspirin|mesh-list
138872803|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138872804|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
138872806|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138872807|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138872808|NCT04167228|Ceftazidime|ceftazidime|mesh-list
138872809|NCT04167228|Avibactam|avibactam|mesh-list
138872810|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
138872811|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138872812|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872813|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138872814|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872815|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872816|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
138872817|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138872818|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
138872819|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138872820|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
138872821|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138872822|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872823|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138872824|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872825|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
138872826|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138993370|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138872827|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777403|NCT00694759|Metformin|metformin|mesh-list
138872828|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872829|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138872830|NCT02648958|Analgesics|analgesics|mesh-ancestor
138799401|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
138872831|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
138872832|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872833|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138872834|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138872835|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138872836|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
138872837|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872838|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872839|NCT00887549|Pemetrexed|pemetrexed|mesh-list
138872840|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872841|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872842|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872843|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138872844|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138872845|NCT04243811|Anesthetics|anesthetics|mesh-list
138872846|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872847|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872848|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
138872849|NCT00638300|Calcium|calcium|mesh-list
138872850|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138872851|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872852|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138872853|NCT00887315|Cisplatin|cisplatin|mesh-list
138872854|NCT00887315|Docetaxel|docetaxel|mesh-list
138872855|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872856|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
138872857|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
138872858|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
138872859|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872860|NCT02645994|Anesthetics|anesthetics|mesh-list
138872861|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872862|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872863|NCT02645058|Analgesics|analgesics|mesh-list
138872864|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872865|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
138872866|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872867|NCT02644980|Anesthetics|anesthetics|mesh-list
138872868|NCT02644980|Propofol|propofol|mesh-list
138872869|NCT02644980|Etomidate|etomidate|mesh-list
138872870|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872871|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872872|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138872873|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138799523|NCT00680134|Tavaborole|tavaborole|mesh-list
138872874|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
138872876|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138872877|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138872878|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872879|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872880|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138872881|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138872882|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138872883|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138872884|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
138872885|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
138872886|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
138872887|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
138872888|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993376|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
138872889|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872890|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138872891|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
138872892|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
138872893|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138872894|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872895|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872896|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138872897|NCT02687204|Enoxaparin|enoxaparin|mesh-list
138872898|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
138872899|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
138872900|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138872901|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138872902|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872903|NCT00650208|Lamotrigine|lamotrigine|mesh-list
138872904|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
138872905|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138872906|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138872907|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872908|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138872909|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872910|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138872911|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138872912|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872913|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138872914|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138872916|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
138872917|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138872918|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872919|NCT00652392|Budesonide|budesonide|mesh-list
138872920|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
138872921|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138872922|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138872923|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
138872924|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872925|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872926|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138872927|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
138872928|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
138872929|NCT00652392|Hormones|hormones|mesh-ancestor
138872930|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138872931|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138872932|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138872933|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138777597|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138872934|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
138872935|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872936|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872937|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138872938|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872939|NCT02653638|Indomethacin|indomethacin|mesh-list
138872940|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138872941|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138872942|NCT02653638|Analgesics|analgesics|mesh-ancestor
138872943|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
138872944|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138872945|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872946|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138872947|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138872948|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
138872950|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138872951|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138872952|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872953|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872954|NCT02644590|Melatonin|melatonin|mesh-list
138872955|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
138777643|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
138872956|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872957|NCT02644590|Protective Agents|protective agents|mesh-ancestor
138872958|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872959|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872960|NCT00910806|Nevirapine|nevirapine|mesh-list
138872961|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138872962|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138872963|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138872964|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872965|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
138872966|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872967|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138872968|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138872969|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138872970|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138872971|NCT00652704|Doxycycline|doxycycline|mesh-list
138872972|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138872973|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138872974|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
138872975|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138872977|NCT00652782|Rolofylline|rolofylline|mesh-list
138872978|NCT00652782|Diuretics|diuretics|mesh-ancestor
138872979|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
138872980|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872981|NCT00653562|Zolpidem|zolpidem|mesh-list
138872982|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138872983|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138872984|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138872985|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138872986|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138872987|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
138872988|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
138872989|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138872990|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138872992|NCT00887159|Etoposide|etoposide|mesh-list
138872993|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
138872994|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
138872995|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138872996|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138872997|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138872998|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138872999|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138873000|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873001|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873002|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
138873003|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
138873004|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
138993408|NCT01024348|Acetaminophen|acetaminophen|mesh-list
138873005|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
138873006|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
138799836|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
138873008|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873010|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138873011|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873012|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138873013|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138873014|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138873015|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873016|NCT02640846|Simendan|simendan|mesh-list
138873017|NCT02640846|Milrinone|milrinone|mesh-list
138873018|NCT02640846|Norepinephrine|norepinephrine|mesh-list
138873019|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138873020|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138873021|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
138873022|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873023|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873024|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873026|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
138873027|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873028|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138873029|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138873030|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
138873031|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138873032|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138873033|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873034|NCT02640846|Protective Agents|protective agents|mesh-ancestor
138873035|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138873036|NCT02644044|Methotrexate|methotrexate|mesh-list
138873037|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138873038|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
138873039|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138873040|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873041|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138873042|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
138873043|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873044|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873045|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
138873046|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873047|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138873048|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138873049|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
138873050|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138873051|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138873052|NCT00652860|Doxorubicin|doxorubicin|mesh-list
138873053|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138873054|NCT00652860|Ifosfamide|ifosfamide|mesh-list
138873055|NCT00652860|Molgramostim|molgramostim|mesh-list
138873056|NCT00652860|Mitomycins|mitomycins|mesh-list
138873057|NCT00652860|Mitomycin|mitomycin|mesh-list
138873058|NCT00652860|Sargramostim|sargramostim|mesh-list
138993426|NCT00950222|Imipenem|imipenem|mesh-list
138873059|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873060|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138873061|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138648619|NCT00291122|Celecoxib|celecoxib|mesh-list
138873062|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138873064|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873065|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138873066|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
138873067|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
138777845|NCT01149473|Diuretics|diuretics|mesh-ancestor
138873068|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873069|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138873070|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
138873071|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138873072|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873073|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873074|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138873075|NCT02536014|Analgesics|analgesics|mesh-ancestor
138873076|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
138873077|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873078|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138873079|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138873080|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138873081|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
138873082|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873083|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873084|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
138873085|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138873086|NCT02653014|Hormones|hormones|mesh-ancestor
138873087|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138873088|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873089|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
138873090|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138873091|NCT02653014|Diuretics|diuretics|mesh-ancestor
138873092|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
138873093|NCT00886613|Vaccines|vaccines|mesh-list
138873094|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
139059149|NCT01107808|Metformin|metformin|mesh-list
138873095|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873096|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138873097|NCT00653016|Norelgestromin|norelgestromin|mesh-list
138873098|NCT00653016|Estradiol|estradiol|mesh-list
138873099|NCT00653016|Estrogens|estrogens|mesh-ancestor
138873100|NCT00653016|Hormones|hormones|mesh-ancestor
138873101|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138873102|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873103|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138873104|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
138873105|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138873106|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138873107|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138873108|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138873109|NCT00886379|Vitamin D|vitamin d|mesh-list
138873110|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
138873111|NCT00886379|Cholecalciferol|cholecalciferol|mesh-list
138873112|NCT00886379|Vitamins|vitamins|mesh-list
138873113|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
138873114|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873115|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138873116|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138873117|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
138873118|NCT00633581|Vitamins|vitamins|mesh-ancestor
138873119|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
138873120|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873121|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
138873122|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873123|NCT00633581|Protective Agents|protective agents|mesh-ancestor
138873124|NCT02825147|Dexamethasone|dexamethasone|mesh-list
138873125|NCT02825147|Methotrexate|methotrexate|mesh-list
138873126|NCT02825147|Etoposide|etoposide|mesh-list
138873127|NCT02825147|Pegaspargase|pegaspargase|mesh-list
138800082|NCT02844621|Omeprazole|omeprazole|mesh-list
138873129|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
138873130|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
138873131|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873132|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873133|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138873134|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
138873135|NCT02825147|Hormones|hormones|mesh-ancestor
138873136|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138873138|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873139|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138873140|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
138873141|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138873142|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138873143|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
138873144|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873145|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
138873146|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873147|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138873148|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138873149|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
138873150|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138873151|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139059150|NCT01107808|Calcium|calcium|mesh-list
138873152|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138873153|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138873154|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138873155|NCT02825225|Anesthetics|anesthetics|mesh-list
138873156|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873157|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873158|NCT00637949|Rofecoxib|rofecoxib|mesh-list
138873159|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
138873160|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138873161|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138873162|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873163|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873164|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138873165|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138873166|NCT00637949|Analgesics|analgesics|mesh-ancestor
138873167|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
138873168|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873169|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873170|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138873171|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138873172|NCT00599196|Rotigotine|rotigotine|mesh-list
138873173|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
138873174|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
138873175|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873176|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873177|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873178|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
138873179|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138873180|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873181|NCT04201145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138873182|NCT04201145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873183|NCT02824601|Calcium|calcium|mesh-list
138873184|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138873185|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873186|NCT02643732|Methylphenidate|methylphenidate|mesh-list
138873187|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138873188|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873189|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138873190|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138873191|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138873192|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873193|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
138873194|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873195|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
138873196|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138873197|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873198|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873199|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138873201|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
138873202|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873203|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138873204|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138873205|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138873206|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
138873207|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873208|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873209|NCT04165590|Immunomodulating Agents|immunomodulating agents|mesh-list
138873210|NCT04165590|Immunologic Factors|immunologic factors|mesh-ancestor
138873211|NCT04165590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873213|NCT05660993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138873214|NCT05660993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873215|NCT05660993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138873216|NCT05660993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873217|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138873218|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138873219|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
138873220|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
138873221|NCT04241705|Lumefantrine|lumefantrine|mesh-list
138873222|NCT04241705|Artemether|artemether|mesh-list
138873223|NCT04241705|Primaquine|primaquine|mesh-list
138873224|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138873225|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
138873226|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138873227|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138873228|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873229|NCT04243109|Dexamethasone|dexamethasone|mesh-list
138873230|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
138873231|NCT04243109|Pomalidomide|pomalidomide|mesh-list
138873232|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138993463|NCT01031368|Cytarabine|cytarabine|mesh-list
138873233|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
138873234|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873235|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138873236|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138873237|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
138873238|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873239|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873240|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138873241|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138873243|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
138873244|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873245|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138873246|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
138873247|NCT04243109|Hormones|hormones|mesh-ancestor
138873248|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138873249|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138873250|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138873251|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138873252|NCT04243109|Growth Substances|growth substances|mesh-ancestor
138873253|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
138873254|NCT04861181|Niraparib|niraparib|mesh-list
138873255|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138873256|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873257|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873258|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873259|NCT00603512|Tofacitinib|tofacitinib|mesh-list
138873260|NCT00603512|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138873261|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138873262|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873263|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873264|NCT04167774|Paclitaxel|paclitaxel|mesh-list
138873265|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138873266|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138873267|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873268|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
138873269|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
138873270|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
138873271|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873272|NCT02640300|Clozapine|clozapine|mesh-list
138873273|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138873274|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
138873275|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873276|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873277|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873278|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138873279|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139059151|NCT01107808|Vitamins|vitamins|mesh-ancestor
138873280|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873281|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138873282|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
138873283|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
138873284|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
138873285|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138873286|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
138873287|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873288|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
138873289|NCT02640144|Protective Agents|protective agents|mesh-ancestor
138873290|NCT02643186|Misoprostol|misoprostol|mesh-list
138873291|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138873292|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
138873293|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138873294|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873295|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138873296|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138873298|NCT02652312|Diclofenac|diclofenac|mesh-list
138873299|NCT02652312|Fentanyl|fentanyl|mesh-list
138873300|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
138873301|NCT02652312|Ondansetron|ondansetron|mesh-list
138873302|NCT02652312|Propofol|propofol|mesh-list
138873303|NCT02652312|Desflurane|desflurane|mesh-list
138873304|NCT02652312|Atracurium|atracurium|mesh-list
138873305|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138873306|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873307|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873308|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138873309|NCT02652312|Analgesics|analgesics|mesh-ancestor
138873310|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
138873311|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873312|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138873313|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138873314|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138873315|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
138873316|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873317|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873318|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138873319|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
138873321|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138873322|NCT02652312|Narcotics|narcotics|mesh-ancestor
138873323|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138873324|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138873325|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138800476|NCT00602706|Melphalan|melphalan|mesh-list
138873326|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138873327|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138873328|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873329|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
138873330|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
138873331|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138873332|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
138873333|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
138873334|NCT02652312|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138873335|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138873336|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
138873337|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138873338|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138873339|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138873340|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138873341|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138873342|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138873343|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
138873344|NCT04165512|Triamcinolone|triamcinolone|mesh-list
138873345|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138873346|NCT04165512|Bupivacaine|bupivacaine|mesh-list
138873347|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
138873348|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
138873349|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873350|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873351|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
138873352|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873353|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138873354|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
138873355|NCT04165512|Hormones|hormones|mesh-ancestor
138873356|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138873357|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138873358|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
138873359|NCT02642874|Methocarbamol|methocarbamol|mesh-list
138873360|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
138873361|NCT02642874|Calcium|calcium|mesh-list
138873362|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138873363|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873364|NCT02642874|Antacids|antacids|mesh-ancestor
138873365|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873366|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138873367|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138873368|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138873369|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873370|NCT00653874|Bilirubin|bilirubin|mesh-list
138873371|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
138873372|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873373|NCT00653874|Protective Agents|protective agents|mesh-ancestor
138873374|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873375|NCT04224701|Vaccines|vaccines|mesh-list
138873376|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
138873377|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873378|NCT00653952|Paclitaxel|paclitaxel|mesh-list
139059152|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
138873379|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138873380|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873381|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
138873382|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
138873383|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
138873384|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873385|NCT00650364|Midodrine|midodrine|mesh-list
138873386|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
138873387|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
138873388|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873389|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873390|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138873391|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138873392|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138873393|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138873394|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
138873395|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873396|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873397|NCT04909697|Sivelestat|sivelestat|mesh-list
138873398|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138873399|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
138873400|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873401|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873402|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
138873403|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
138873404|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138873405|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873406|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138873407|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138873408|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993517|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138873409|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873410|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873411|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138873412|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138873413|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
138873414|NCT00654108|Protective Agents|protective agents|mesh-ancestor
138873415|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873416|NCT00654108|Vitamins|vitamins|mesh-ancestor
138873417|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
138873418|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
138800624|NCT04268394|Rifampin|rifampin|mesh-list
138873419|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138873420|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
138873421|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873422|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
138873423|NCT04165902|Protective Agents|protective agents|mesh-ancestor
138873424|NCT02639598|Topiramate|topiramate|mesh-list
138873425|NCT02639598|Flunarizine|flunarizine|mesh-list
138873426|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
138873427|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138873428|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873429|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138873430|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138873431|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873432|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138873433|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138873434|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
138873435|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
138873436|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873437|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
138873438|NCT04907279|Aripiprazole|aripiprazole|mesh-list
138873439|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
138873440|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138873441|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138873442|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138873443|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873444|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873445|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
138873446|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
138873447|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873448|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873449|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138873450|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138873451|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
138873452|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138873453|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138873454|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138873455|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138873457|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138873458|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138873459|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138873460|NCT02642718|Analgesics|analgesics|mesh-ancestor
138873461|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
138873462|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873463|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873464|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138873465|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138873466|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138873467|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873468|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873469|NCT02642484|Gabapentin|gabapentin|mesh-list
138873471|NCT02642484|Calcium|calcium|mesh-list
138525620|NCT00024089|Gefitinib|gefitinib|mesh-list
138873472|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138873473|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873475|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
138873476|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873477|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
138873478|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138873479|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138873480|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873481|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138873482|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138873483|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138873484|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800762|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873485|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873486|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
138873487|NCT02642484|Antacids|antacids|mesh-ancestor
138873488|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138873489|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
138873490|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138873491|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873492|NCT04185350|Exenatide|exenatide|mesh-list
138873493|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138873494|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993567|NCT02917564|Triamcinolone|triamcinolone|mesh-list
138873495|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138873496|NCT04185350|Incretins|incretins|mesh-ancestor
138873497|NCT04185350|Hormones|hormones|mesh-ancestor
138873498|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138873499|NCT00653172|Streptogramin A|streptogramin a|mesh-list
138873500|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138873501|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873502|NCT02639520|Fosfomycin|fosfomycin|mesh-list
138873503|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138873504|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873506|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138873507|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138873508|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138873509|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138873510|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
138873511|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873512|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873513|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873514|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138873515|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138873517|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873518|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138873519|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138873520|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138873521|NCT00653250|Celecoxib|celecoxib|mesh-list
138873522|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138873523|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138873524|NCT00653250|Analgesics|analgesics|mesh-ancestor
138873525|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
138873526|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873527|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873528|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138873530|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138873531|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138873532|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873533|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873534|NCT00638534|Telithromycin|telithromycin|mesh-list
138873535|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138873536|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873537|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138873538|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138873539|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138873540|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873541|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873542|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138873543|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138778589|NCT00868231|Bromides|bromides|mesh-list
138800929|NCT00874120|Protective Agents|protective agents|mesh-ancestor
138873544|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525696|NCT00024323|Cisplatin|cisplatin|mesh-list
138873545|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
138873546|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873547|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
138873548|NCT02638896|Celecoxib|celecoxib|mesh-list
138873549|NCT02638896|Etanercept|etanercept|mesh-list
138873550|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138873551|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138873552|NCT02638896|Analgesics|analgesics|mesh-ancestor
138873553|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
138873554|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873555|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873556|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138873557|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138873558|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138873559|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138873560|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873561|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873562|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138873563|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138873564|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
138873565|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873566|NCT04240223|Brilacidin|brilacidin|mesh-list
138873567|NCT04240223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873568|NCT00653406|Risperidone|risperidone|mesh-list
138873569|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138873570|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
138873571|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873572|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873573|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873574|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138873575|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138778619|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138873576|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873577|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138873578|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138873579|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
138873580|NCT04239755|Doxycycline|doxycycline|mesh-list
138873581|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138873582|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873583|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
138873584|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138873585|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138873587|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
138873588|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
138873589|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873590|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873591|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
138993653|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138873593|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138873594|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138873595|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138873596|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138873597|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873598|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
138873599|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138873600|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138873601|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138873602|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138873603|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873604|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
138873605|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873606|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873607|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138873608|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873609|NCT04239833|Gefitinib|gefitinib|mesh-list
138873610|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873611|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138873612|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873613|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873614|NCT03513770|Ketorolac|ketorolac|mesh-list
138873615|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138873616|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138873617|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138873618|NCT03513770|Analgesics|analgesics|mesh-ancestor
138873619|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
138801086|NCT04266132|Bupivacaine|bupivacaine|mesh-list
138873620|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873621|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873622|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138873624|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138873625|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873626|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873627|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
138873628|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
138873629|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873630|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138873631|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873632|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
138873633|NCT02823977|Ketamine|ketamine|mesh-list
138873634|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138873635|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873636|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873637|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138873638|NCT02823977|Analgesics|analgesics|mesh-ancestor
138873639|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
138873640|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873641|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138873642|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138873643|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138873644|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
138873645|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873646|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873647|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138873648|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138873649|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
138873650|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
138873651|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138873652|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138873653|NCT00680511|Methamphetamine|methamphetamine|mesh-list
138873654|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138873655|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649220|NCT00305292|Modafinil|modafinil|mesh-list
138873656|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
138873657|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
138873658|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873659|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
138873660|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873661|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873662|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
138873663|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138873664|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138873665|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138873666|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138873667|NCT00654576|Olanzapine|olanzapine|mesh-list
138873668|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
138873669|NCT00654576|Risperidone|risperidone|mesh-list
138873670|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138873671|NCT00654576|Clozapine|clozapine|mesh-list
138873672|NCT00654576|Sulpiride|sulpiride|mesh-list
138873673|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138873674|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
138873675|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873676|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873677|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873678|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138873679|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138873680|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873681|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138873682|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138873683|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
138873684|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
138873685|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
138873686|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873687|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138873688|NCT00654576|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138873689|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138873690|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138873691|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
138873692|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
138873693|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
138873694|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138873695|NCT00622622|Gemcitabine|gemcitabine|mesh-list
138873696|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138873697|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
138873698|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873699|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873700|NCT00598650|Donepezil|donepezil|mesh-list
138873701|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138873702|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801205|NCT00873730|Etanercept|etanercept|mesh-list
138873703|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873705|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873706|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873707|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
138873708|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
138873709|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138873710|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873711|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801267|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
138873712|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138873713|NCT02641938|Analgesics|analgesics|mesh-ancestor
138778853|NCT05342272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873714|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
138873715|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873716|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138873717|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138873718|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138873719|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
138873720|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873721|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873722|NCT04249076|Clobetasol|clobetasol|mesh-list
138873723|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138873724|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
138873725|NCT04249076|Hormones|hormones|mesh-ancestor
138873726|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138873727|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873728|NCT00681135|Olaflur|olaflur|mesh-list
138873729|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
138873730|NCT00681135|Protective Agents|protective agents|mesh-ancestor
138873731|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873733|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
138873734|NCT02821559|Raltitrexed|raltitrexed|mesh-list
138873735|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138873736|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873737|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138873738|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138873739|NCT02821559|Growth Substances|growth substances|mesh-ancestor
138873740|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873741|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
138873742|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138873743|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
138873744|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873745|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138873746|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873748|NCT00681213|Temsirolimus|temsirolimus|mesh-list
138873749|NCT00681213|MTOR Inhibitors|mtor inhibitors|mesh-list
138873750|NCT00681213|Tacrolimus|tacrolimus|mesh-list
138873751|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138873752|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
138873753|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873754|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138873755|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873756|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873757|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138873758|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873759|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138873760|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873761|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
138873762|NCT00681213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138873763|NCT02638506|Fentanyl|fentanyl|mesh-list
138873764|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138873765|NCT02638506|Narcotics|narcotics|mesh-ancestor
138873766|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873767|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873769|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
138873770|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873771|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138873772|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138873773|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
138873774|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
138873775|NCT04745975|Paclitaxel|paclitaxel|mesh-list
138873776|NCT04745975|Vinorelbine|vinorelbine|mesh-list
138873777|NCT04745975|Gemcitabine|gemcitabine|mesh-list
138873778|NCT04745975|Capecitabine|capecitabine|mesh-list
138873779|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138873780|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873781|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
138801451|NCT00673426|Enoxaparin|enoxaparin|mesh-list
138873782|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
138873783|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
138873784|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873785|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138873786|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
138873787|NCT04150107|Insulin|insulin|mesh-list
138873788|NCT04150107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138873789|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138873790|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873791|NCT02638428|Cytarabine|cytarabine|mesh-list
138873792|NCT02638428|Carboplatin|carboplatin|mesh-list
138873793|NCT02638428|Trastuzumab|trastuzumab|mesh-list
138873794|NCT02638428|Fludarabine|fludarabine|mesh-list
138873795|NCT02638428|Etoposide|etoposide|mesh-list
138873796|NCT02638428|Everolimus|everolimus|mesh-list
138873797|NCT02638428|Sorafenib|sorafenib|mesh-list
138873798|NCT02638428|Dasatinib|dasatinib|mesh-list
138873799|NCT02638428|Ifosfamide|ifosfamide|mesh-list
138873800|NCT02638428|Axitinib|axitinib|mesh-list
138873801|NCT02638428|Vemurafenib|vemurafenib|mesh-list
138873802|NCT02638428|Crizotinib|crizotinib|mesh-list
138873803|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873804|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138873806|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
138873807|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873808|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138873809|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
138873810|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873811|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138873812|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138873813|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138873814|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873815|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
138873816|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873817|NCT02638428|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138873818|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138873819|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138873820|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
138873821|NCT01003964|Cisplatin|cisplatin|mesh-list
138873822|NCT01003964|Gemcitabine|gemcitabine|mesh-list
138873823|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873824|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138873825|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
138873826|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873827|NCT02823743|Aspirin|aspirin|mesh-list
138873828|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138873829|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138873830|NCT02823743|Analgesics|analgesics|mesh-ancestor
138873831|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
138873832|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873833|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873834|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138873835|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138873836|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138873837|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138873838|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873839|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138873840|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138801607|NCT00936702|Paclitaxel|paclitaxel|mesh-list
138873841|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873842|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
138873843|NCT00654888|Mitomycins|mitomycins|mesh-list
138526016|NCT00025142|Leucovorin|leucovorin|mesh-list
138873844|NCT00654888|Mitomycin|mitomycin|mesh-list
138873845|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138873846|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873847|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
138873848|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873849|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138873850|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873851|NCT05299203|Verapamil|verapamil|mesh-list
138873852|NCT05299203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138873853|NCT05299203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138873854|NCT05299203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138873855|NCT05299203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873856|NCT05299203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138873857|NCT05299203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873858|NCT05299203|Vasodilator Agents|vasodilator agents|mesh-ancestor
138873859|NCT02638584|Rabeprazole|rabeprazole|mesh-list
138873860|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138873861|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138873862|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138873863|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873864|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873865|NCT02821169|Ropivacaine|ropivacaine|mesh-list
138873866|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
138873867|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
138873868|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138873869|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873870|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
138873871|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138873872|NCT02820935|Itraconazole|itraconazole|mesh-list
138873873|NCT02820935|Rifampin|rifampin|mesh-list
138873874|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
138873875|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138873876|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138873877|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138873878|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873879|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873880|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138873881|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
138887301|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873882|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138779208|NCT02781064|Atorvastatin|atorvastatin|mesh-list
138873883|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873884|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138873885|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138873886|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
138873887|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138873888|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
138873889|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138873890|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138873891|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138179251|NCT05664971|Paclitaxel|paclitaxel|mesh-list
138873892|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138873893|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138873894|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138873895|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138873896|NCT02626845|Rituximab|rituximab|mesh-list
138873897|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138873898|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873899|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
138873900|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873901|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138873902|NCT02821247|Aflibercept|aflibercept|mesh-list
138873903|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138873904|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138873905|NCT02821247|Growth Substances|growth substances|mesh-ancestor
138873906|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873907|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
138873908|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873909|NCT00681525|Atorvastatin|atorvastatin|mesh-list
138873910|NCT00681525|Ezetimibe|ezetimibe|mesh-list
138873911|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
138873912|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138873913|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138873914|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
138873915|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873916|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138526073|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873917|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138873918|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873919|NCT00681603|Bevacizumab|bevacizumab|mesh-list
138873920|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138873921|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873922|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138873923|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138873924|NCT00681603|Growth Substances|growth substances|mesh-ancestor
138873925|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873926|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
138873928|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138873929|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873930|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138873931|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873932|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873933|NCT04239443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138873935|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
138873936|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138873937|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873938|NCT02820077|Hemostatics|hemostatics|mesh-list
138873939|NCT02820077|Coagulants|coagulants|mesh-ancestor
138873940|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
138873941|NCT00681993|Carboplatin|carboplatin|mesh-list
138873942|NCT00681993|Docetaxel|docetaxel|mesh-list
138873943|NCT00681993|Trastuzumab|trastuzumab|mesh-list
138873944|NCT00681993|Doxorubicin|doxorubicin|mesh-list
138873945|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138873946|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138873947|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
138873948|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873949|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138873950|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138873951|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
138873952|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873953|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873954|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138873955|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
138873956|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
138873957|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
138873958|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138873959|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138802013|NCT05321576|Analgesics|analgesics|mesh-ancestor
138873960|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138873961|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138873962|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873964|NCT02819999|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
138873965|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873966|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138873967|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138873968|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138873969|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138873970|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873971|NCT02819999|Immunoconjugates|immunoconjugates|mesh-ancestor
138873972|NCT02819999|Immunologic Factors|immunologic factors|mesh-ancestor
138873973|NCT02819999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873974|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138873975|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138873976|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138873977|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138873978|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873979|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138873980|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873981|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
138873982|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138873984|NCT00875979|Pertuzumab|pertuzumab|mesh-list
138873985|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138873986|NCT00875979|Maytansine|maytansine|mesh-list
138873987|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138873988|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138873989|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138873990|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
138873991|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
138873992|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
138873993|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138873994|NCT00875979|Immunotoxins|immunotoxins|mesh-ancestor
138873995|NCT00875979|Immunoconjugates|immunoconjugates|mesh-ancestor
138873996|NCT00875979|Immunologic Factors|immunologic factors|mesh-ancestor
138873997|NCT00875979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138873998|NCT02818751|Escitalopram|escitalopram|mesh-list
138873999|NCT02818751|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138874000|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138874001|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138874002|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874004|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
138874005|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874006|NCT04238975|Vaccines|vaccines|mesh-list
138874007|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
138874008|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874009|NCT00602420|Naproxen|naproxen|mesh-list
138874010|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138874011|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138874012|NCT00602420|Analgesics|analgesics|mesh-ancestor
138874013|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
138874014|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874015|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874016|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874017|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138874018|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
138874019|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138874020|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874021|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874022|NCT04635605|Methylene Blue|methylene blue|mesh-list
138874023|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874024|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874025|NCT02688374|Nicotine|nicotine|mesh-list
138874026|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138874027|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
138874028|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874029|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874030|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138874031|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138874032|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
138874033|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874034|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874035|NCT02819375|Ketamine|ketamine|mesh-list
138874036|NCT02819375|Remifentanil|remifentanil|mesh-list
138874037|NCT02819375|Propofol|propofol|mesh-list
138874038|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138874039|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874040|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874041|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138874042|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
138874043|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
138874044|NCT02819375|Analgesics|analgesics|mesh-ancestor
138874045|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
138874046|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874047|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138874048|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138874049|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138874050|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874051|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874052|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138874053|NCT02819375|Narcotics|narcotics|mesh-ancestor
138874054|NCT02818985|Dexamethasone|dexamethasone|mesh-list
138874055|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
138874056|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874057|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
138874058|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
138874059|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874060|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874061|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138874062|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
138874063|NCT02818985|Hormones|hormones|mesh-ancestor
138874064|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138526229|NCT00025727|Ritonavir|ritonavir|mesh-list
138874065|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138874066|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874067|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138874068|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874069|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138874070|NCT02818985|Analgesics|analgesics|mesh-ancestor
138874071|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
138874072|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138874073|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138874074|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138874075|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
138874076|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874077|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874078|NCT02815787|Glyburide|glyburide|mesh-list
138874079|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138874080|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874081|NCT00639938|Nevirapine|nevirapine|mesh-list
138874082|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
138874083|NCT00639938|Antibodies|antibodies|mesh-list
138874084|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
138874085|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138874086|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138874087|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
138874088|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874089|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138874090|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138874091|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874092|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874093|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
138874094|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874095|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138874096|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138874097|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138874098|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138874099|NCT02815319|Dexamethasone|dexamethasone|mesh-list
138874100|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874101|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
138874102|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
138874103|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874104|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874105|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138874107|NCT02815319|Hormones|hormones|mesh-ancestor
138874108|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138874109|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138874110|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874111|NCT02815475|Curcumin|curcumin|mesh-list
138874112|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138874113|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138874114|NCT02815475|Analgesics|analgesics|mesh-ancestor
138874115|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
138874116|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779565|NCT02777866|Bupivacaine|bupivacaine|mesh-list
138874117|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874118|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874119|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138874120|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874121|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874122|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874123|NCT00640796|Aldesleukin|aldesleukin|mesh-list
138874124|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
138874125|NCT00640796|Fludarabine|fludarabine|mesh-list
138874126|NCT00640796|Interleukin-2|interleukin-2|mesh-list
138874127|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138874128|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
138874129|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874130|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138874131|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138874132|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
138874133|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874134|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874135|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138874136|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138874137|NCT00640796|Analgesics|analgesics|mesh-ancestor
138874138|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
138526301|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
138874139|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874140|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138874141|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138874142|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
138874143|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874145|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138874146|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
138779610|NCT02777710|Durvalumab|durvalumab|mesh-list
138874147|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874148|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874149|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874150|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138874151|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138874152|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874153|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138874154|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138874155|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
138874156|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138874157|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138993821|NCT00110617|Deferasirox|deferasirox|mesh-list
138874158|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
138874159|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874160|NCT02684786|Lidocaine|lidocaine|mesh-list
138874161|NCT02684786|Reserpine|reserpine|mesh-list
138874162|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
138874163|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
138874164|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874165|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874166|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
138874167|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874168|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138874169|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138874170|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138874171|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138874172|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874173|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138874174|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138874175|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138874176|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138779652|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779653|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
138779654|NCT01193348|Eculizumab|eculizumab|mesh-list
138779655|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138779656|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138874177|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138874178|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138874179|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
138874180|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874181|NCT02683070|Tramadol|tramadol|mesh-list
138874182|NCT02683070|Ropivacaine|ropivacaine|mesh-list
138874183|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
138874184|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
138874185|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874186|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874187|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
138874188|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874189|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138874190|NCT02683070|Narcotics|narcotics|mesh-ancestor
138874191|NCT02683070|Analgesics|analgesics|mesh-ancestor
138874192|NCT02685176|Charcoal|charcoal|mesh-list
138874193|NCT02685176|Antidotes|antidotes|mesh-ancestor
138874194|NCT02685176|Protective Agents|protective agents|mesh-ancestor
138874195|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874196|NCT05664074|Ketorolac|ketorolac|mesh-list
138874197|NCT05664074|Indomethacin|indomethacin|mesh-list
138874198|NCT05664074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138874199|NCT05664074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138874200|NCT05664074|Analgesics|analgesics|mesh-ancestor
138874201|NCT05664074|Sensory System Agents|sensory system agents|mesh-ancestor
138874202|NCT05664074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874203|NCT05664074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874204|NCT05664074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874205|NCT05664074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138874206|NCT05664074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138874207|NCT05664074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874208|NCT05664074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874209|NCT05664074|Gout Suppressants|gout suppressants|mesh-ancestor
138874210|NCT05664074|Tocolytic Agents|tocolytic agents|mesh-ancestor
138874211|NCT05664074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138874212|NCT00634205|Doxorubicin|doxorubicin|mesh-list
138874213|NCT00634205|Valproic Acid|valproic acid|mesh-list
138874214|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138874215|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993837|NCT00550238|Pimavanserin|pimavanserin|mesh-list
138874216|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138779701|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
138874217|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138874218|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874219|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874220|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
138874221|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
138874222|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874223|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874224|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
138874225|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138874226|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874227|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138874228|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
138874229|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138874230|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874231|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138874232|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138874233|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874234|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874235|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874236|NCT02818049|Dimercaprol|dimercaprol|mesh-list
138874237|NCT02818049|Chelating Agents|chelating agents|mesh-ancestor
138874238|NCT02818049|Sequestering Agents|sequestering agents|mesh-ancestor
138874239|NCT02818049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874240|NCT02684708|Prednisone|prednisone|mesh-list
138874241|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
138874242|NCT02684708|Dacarbazine|dacarbazine|mesh-list
138874243|NCT02684708|Vincristine|vincristine|mesh-list
138874244|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138874245|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
138874246|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874247|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138874248|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138874249|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
138779734|NCT01075152|Lamivudine|lamivudine|mesh-list
138874250|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874251|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874252|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138874253|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874254|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
138874256|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138874257|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138874258|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138874259|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
138874260|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
138874261|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
138874262|NCT02817503|Folic Acid|folic acid|mesh-list
138874263|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
138874264|NCT02817503|Amlodipine|amlodipine|mesh-list
138874265|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138874266|NCT02817503|Enalapril|enalapril|mesh-list
138874267|NCT02817503|Enalaprilat|enalaprilat|mesh-list
138874268|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138874269|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138874270|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138874271|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874272|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138874273|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874274|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
138874275|NCT02817503|Hematinics|hematinics|mesh-ancestor
138874276|NCT02817503|Vitamins|vitamins|mesh-ancestor
138874277|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
138874278|NCT02817503|Diuretics|diuretics|mesh-ancestor
138874279|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
138874280|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138993862|NCT00946946|Analgesics|analgesics|mesh-ancestor
138874281|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138874282|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
138874283|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874284|NCT02814461|Axitinib|axitinib|mesh-list
138874285|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874286|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138874287|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874288|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874289|NCT00875667|Fludarabine|fludarabine|mesh-list
138874290|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
138874291|NCT00875667|Lenalidomide|lenalidomide|mesh-list
138874292|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874293|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138874294|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
138874295|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874296|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138874297|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
138874298|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874299|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138874300|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138874301|NCT00875667|Growth Substances|growth substances|mesh-ancestor
138874302|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
138874303|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138874304|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138874305|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874306|NCT02811341|Scopolamine|scopolamine|mesh-list
138874307|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138874308|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138874309|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
138874310|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
138874311|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874312|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874313|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138874314|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
138874315|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138874316|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
138874317|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874318|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874319|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138874320|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
138874321|NCT00682383|Docetaxel|docetaxel|mesh-list
138874322|NCT00682383|Etoposide|etoposide|mesh-list
138874323|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874324|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
138874325|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
138874326|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
138874327|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802473|NCT00867490|Amlodipine|amlodipine|mesh-list
138874328|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138874329|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138874330|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138874331|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874332|NCT04237493|Insulin|insulin|mesh-list
138874333|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138874334|NCT04237493|Metformin|metformin|mesh-list
138874335|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
138874336|NCT04237493|Glimepiride|glimepiride|mesh-list
138874337|NCT04237493|Vildagliptin|vildagliptin|mesh-list
138874338|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138874339|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874340|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138874341|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138874342|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
138874343|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138874344|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
138874345|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874346|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874347|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
138874348|NCT00683319|Carboplatin|carboplatin|mesh-list
138874349|NCT00683319|Methotrexate|methotrexate|mesh-list
138874350|NCT00683319|Vincristine|vincristine|mesh-list
138874351|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138874352|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
138874353|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874354|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138874355|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138874356|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
138874357|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874358|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874359|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138874360|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138874361|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
138874362|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138874363|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138874364|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
138874365|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
138874366|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874367|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138874368|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138874369|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138874370|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
138874371|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
138874372|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
138874373|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138874374|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138874375|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138874377|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
138874378|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138874379|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874381|NCT00683865|Ofloxacin|ofloxacin|mesh-list
138874382|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138874383|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138874384|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874385|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138874386|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138874387|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874388|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874389|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874390|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138874391|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
138874392|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138874393|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802621|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
138874394|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138874395|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138874396|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138874397|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138874398|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138874399|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138874400|NCT02813369|Naloxegol|naloxegol|mesh-list
138874401|NCT02813369|Laxatives|laxatives|mesh-list
138874402|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138874403|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210397|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138874404|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
138874405|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874406|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138874407|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
138874408|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
138874409|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138874410|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874411|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874412|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
138874413|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138874414|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874415|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874416|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
138874417|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138874418|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138874419|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138874420|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138874421|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874422|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
138874423|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874424|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874425|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138874426|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874428|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138874429|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138874430|NCT02809781|Analgesics|analgesics|mesh-ancestor
138874431|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
138874432|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874433|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874434|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874435|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138874436|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138874437|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138874438|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
138526610|NCT00055614|Topotecan|topotecan|mesh-list
138874439|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
138874440|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138874441|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874442|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874443|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138874444|NCT02809937|Analgesics|analgesics|mesh-ancestor
138874445|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
138874446|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874447|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138874448|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138874449|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138874450|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
138874451|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874452|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874453|NCT02812979|Albuterol|albuterol|mesh-list
138993910|NCT01032304|Erdosteine|erdosteine|mesh-list
138874454|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138874455|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
138874456|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874457|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874458|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138874459|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
138874460|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
138874461|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138874462|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138874463|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138874464|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138874465|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
138874466|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874467|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874468|NCT02809469|Apixaban|apixaban|mesh-list
138874469|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138874470|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
138874471|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138874472|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
138874473|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874474|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874475|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
138874476|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
138874477|NCT02809079|Prednisone|prednisone|mesh-list
138874478|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874479|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
138874480|NCT02809079|Hormones|hormones|mesh-ancestor
138874481|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138874482|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874483|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138874484|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874485|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138874486|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138874487|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
138874488|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138874489|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874490|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874491|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874492|NCT02812199|Lidocaine|lidocaine|mesh-list
138874493|NCT02812199|Epinephrine|epinephrine|mesh-list
138874494|NCT02812199|Racepinephrine|racepinephrine|mesh-list
138874495|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
138874496|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
138874497|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
138780097|NCT00943917|Exenatide|exenatide|mesh-list
138802889|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
138874498|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874499|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874500|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
138874501|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874502|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138874503|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138874504|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138874505|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138874506|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874507|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138874509|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
138874510|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874511|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138526691|NCT00055809|Antibodies|antibodies|mesh-list
138874512|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138874513|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
138874514|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138874515|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
138874516|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
138874517|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
138874518|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138874519|NCT02812043|Amorolfine|amorolfine|mesh-list
138874520|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
138874521|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874522|NCT02808767|Ticagrelor|ticagrelor|mesh-list
138874523|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138874524|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138874525|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138802943|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
138874526|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138874527|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138874528|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
138874529|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874530|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874531|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874532|NCT02812355|Heparin|heparin|mesh-list
138874533|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
138874534|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138874535|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138874536|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874537|NCT02811731|Amlodipine|amlodipine|mesh-list
138874538|NCT02811731|Candesartan|candesartan|mesh-list
138874539|NCT02811731|Candesartan cilexetil|candesartan cilexetil|mesh-list
138874540|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138874541|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138874542|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138874543|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874544|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138874545|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874546|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
138874547|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138874548|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138874550|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138874551|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
138874552|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138874553|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874554|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138874555|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874556|NCT05569421|Budesonide|budesonide|mesh-list
138874557|NCT05569421|Formoterol Fumarate|formoterol fumarate|mesh-list
138874558|NCT05569421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874559|NCT05569421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138874560|NCT05569421|Autonomic Agents|autonomic agents|mesh-ancestor
138874561|NCT05569421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874562|NCT05569421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874563|NCT05569421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138874564|NCT05569421|Respiratory System Agents|respiratory system agents|mesh-ancestor
138874565|NCT05569421|Glucocorticoids|glucocorticoids|mesh-ancestor
138874566|NCT05569421|Hormones|hormones|mesh-ancestor
138874567|NCT05569421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138993924|NCT00954642|Growth Substances|growth substances|mesh-ancestor
138874568|NCT05569421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138874569|NCT05569421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138874570|NCT05569421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138874571|NCT05569421|Adrenergic Agents|adrenergic agents|mesh-ancestor
138874572|NCT05569421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874573|NCT05569421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874574|NCT02808611|Propranolol|propranolol|mesh-list
138874575|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138874576|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138874577|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
138874578|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874579|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874580|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874581|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138874582|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138874583|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
138874584|NCT02808533|Topiramate|topiramate|mesh-list
138874585|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
138874586|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138874587|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874589|NCT02811497|Durvalumab|durvalumab|mesh-list
138874590|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138874591|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
138874592|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874593|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803090|NCT04132102|Afatinib|afatinib|mesh-list
138874594|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874595|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138874596|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138874597|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138874598|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138874599|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138874600|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874601|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
138874602|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874603|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874604|NCT02807909|Itraconazole|itraconazole|mesh-list
138874605|NCT02807909|Diltiazem|diltiazem|mesh-list
138874606|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
138874607|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874608|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138874609|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138874610|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874611|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874612|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138874613|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
138874614|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138874615|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874616|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138874617|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138874618|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138874619|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138874620|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138874621|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
138874622|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
138874623|NCT02808065|Tacrolimus|tacrolimus|mesh-list
138874624|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138874625|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
138874626|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874627|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138874628|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874629|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874630|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138874631|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874632|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138874633|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
138874634|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138874635|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874636|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138874638|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874639|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138874640|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874641|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874642|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138874643|NCT02804711|Vaccines|vaccines|mesh-list
138874644|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
138874645|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874646|NCT00640094|Melatonin|melatonin|mesh-list
138874647|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
138874648|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874649|NCT00640094|Protective Agents|protective agents|mesh-ancestor
138180741|NCT02697292|Antibodies|antibodies|mesh-list
138874650|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874651|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874652|NCT04183634|Rotigotine|rotigotine|mesh-list
138874653|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
138874654|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
138874655|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874656|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526841|NCT04730973|Evolocumab|evolocumab|mesh-list
138874657|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874658|NCT02804633|Acetaminophen|acetaminophen|mesh-list
138874659|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138874660|NCT02804633|Analgesics|analgesics|mesh-ancestor
138874661|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
138874662|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874663|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874664|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
138874665|NCT02807441|Aspirin|aspirin|mesh-list
138874666|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138874667|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138874668|NCT02807441|Analgesics|analgesics|mesh-ancestor
138874669|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
138874670|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874671|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874672|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874673|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138874674|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138874675|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138874676|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874677|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138874678|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138874679|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874680|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
138874681|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
138874682|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
138874683|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874684|NCT02682680|Ezetimibe|ezetimibe|mesh-list
138874685|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138874686|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138874687|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138874688|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
138874689|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874690|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138874692|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138874693|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
138874694|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
138874695|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874696|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874697|NCT02682524|Aceclofenac|aceclofenac|mesh-list
138874698|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138874699|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138874700|NCT02682524|Analgesics|analgesics|mesh-ancestor
138874701|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
138874702|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874703|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874704|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874705|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138874706|NCT04183556|Naproxen|naproxen|mesh-list
138874707|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138874708|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138874709|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138874710|NCT04183556|Analgesics|analgesics|mesh-ancestor
138874711|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
138780458|NCT00940485|Entecavir|entecavir|mesh-list
138874712|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874713|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874714|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138874715|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
138874716|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138874717|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874718|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874719|NCT00640952|Acamprosate|acamprosate|mesh-list
138874720|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138874721|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
138874722|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138874723|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874724|NCT02807051|Clarithromycin|clarithromycin|mesh-list
138874725|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138874726|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874727|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138874728|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874729|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874730|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138874731|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138874732|NCT02684084|Dexamethasone|dexamethasone|mesh-list
138874733|NCT02684084|Ranibizumab|ranibizumab|mesh-list
138874734|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874736|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
138874737|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874738|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874739|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138874740|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
138874741|NCT02684084|Hormones|hormones|mesh-ancestor
138780501|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138874742|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138874743|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138874744|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874745|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138874746|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138874747|NCT02684084|Growth Substances|growth substances|mesh-ancestor
138874748|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
138874750|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138874751|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874752|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874753|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874754|NCT02806817|Bevacizumab|bevacizumab|mesh-list
138874755|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138874756|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874757|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138874758|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138874759|NCT02806817|Growth Substances|growth substances|mesh-ancestor
138874760|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874761|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
138874762|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138874763|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138874765|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
138874766|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874767|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138874768|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138994019|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
138874769|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874770|NCT02680808|Olorofim|olorofim|mesh-list
139210398|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138874771|NCT02680808|Midazolam|midazolam|mesh-list
138874772|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138874773|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138874774|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874775|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874776|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138874777|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138874778|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138874779|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138874780|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
138874781|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
138874782|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
138874783|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
138874784|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874785|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874786|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
138874787|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874788|NCT05663684|Proxymetacaine|proxymetacaine|mesh-list
138874789|NCT05663684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138874790|NCT05663684|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138874791|NCT05663684|Anesthetics, Local|anesthetics, local|mesh-ancestor
138874792|NCT05663684|Anesthetics|anesthetics|mesh-ancestor
138874793|NCT05663684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874794|NCT05663684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874795|NCT05663684|Sensory System Agents|sensory system agents|mesh-ancestor
138874796|NCT05663684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874797|NCT04004819|Rituximab|rituximab|mesh-list
138874798|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138874799|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874800|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
138874801|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874802|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780606|NCT01130051|Colchicine|colchicine|mesh-list
138874803|NCT00641654|Interferons|interferons|mesh-list
138874804|NCT00641654|Ribavirin|ribavirin|mesh-list
138526985|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
138874805|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
138874806|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
138874807|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138874808|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874809|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
138874810|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874811|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
138874812|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874813|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
138874814|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874815|NCT00549601|Rivastigmine|rivastigmine|mesh-list
138874816|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138874817|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874818|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874819|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
138874820|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874821|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874822|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138874823|NCT00549601|Protective Agents|protective agents|mesh-ancestor
138874824|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
138874825|NCT02806349|Cathartics|cathartics|mesh-ancestor
138874826|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138874827|NCT04184492|Insulin|insulin|mesh-list
138874828|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138874829|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
138874830|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
138874831|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138874832|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
138874833|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138874834|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
138874835|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138874836|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874837|NCT02806115|Acetic Acid|acetic acid|mesh-list
138874838|NCT02806115|Retinol acetate|retinol acetate|mesh-list
138874839|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138874840|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874841|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138874842|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
138874843|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874844|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138874845|NCT02806115|Protective Agents|protective agents|mesh-ancestor
138874846|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874848|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
138874849|NCT02682134|Lidocaine|lidocaine|mesh-list
138874850|NCT02682134|BB 1101|bb 1101|mesh-list
138874851|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874852|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
138874853|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
138874854|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874855|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874856|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138874857|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
138874858|NCT02682134|Hormones|hormones|mesh-ancestor
138874859|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138874860|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138874861|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874862|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
138874863|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874864|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874865|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
138874866|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
138874867|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138874868|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
138874869|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138874870|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138874871|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138874872|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138874873|NCT04236323|Remifentanil|remifentanil|mesh-list
138874874|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138874875|NCT04236323|Narcotics|narcotics|mesh-ancestor
138874876|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803718|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
138874877|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874878|NCT04236323|Analgesics|analgesics|mesh-ancestor
138874879|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
138874880|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874881|NCT04206163|Edotreotide|edotreotide|mesh-list
138527058|NCT00029003|Gefitinib|gefitinib|mesh-list
138874882|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138874883|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874884|NCT00909974|Micronutrients|micronutrients|mesh-list
138874885|NCT00909974|Trace Elements|trace elements|mesh-list
138874886|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874887|NCT05300347|Adenosine|adenosine|mesh-list
138874889|NCT05300347|Sensory System Agents|sensory system agents|mesh-ancestor
138874890|NCT05300347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874891|NCT05300347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874892|NCT05300347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138874893|NCT05300347|Vasodilator Agents|vasodilator agents|mesh-ancestor
138874894|NCT05300347|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138874895|NCT05300347|Purinergic Agonists|purinergic agonists|mesh-ancestor
138874896|NCT05300347|Purinergic Agents|purinergic agents|mesh-ancestor
138874897|NCT05300347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059153|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874898|NCT05300347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874899|NCT04011241|Itraconazole|itraconazole|mesh-list
138874900|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
138874901|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874902|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138874903|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138874904|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874905|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874906|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138874907|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
138874908|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138874909|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874910|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138874911|NCT00956059|Prednisone|prednisone|mesh-list
138874912|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874913|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
138874915|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138874916|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874917|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138874918|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874919|NCT04010929|Pemetrexed|pemetrexed|mesh-list
138874920|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874921|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138874922|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874923|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138874924|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138874925|NCT00956215|Aprepitant|aprepitant|mesh-list
138874926|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
138874927|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
138874928|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
138874929|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874930|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874931|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138874932|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138874933|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138874934|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874935|NCT00640640|Bevacizumab|bevacizumab|mesh-list
138874936|NCT00640640|Ranibizumab|ranibizumab|mesh-list
138874937|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138874938|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874939|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138803792|NCT02839785|Ibuprofen|ibuprofen|mesh-list
138874940|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138874942|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874943|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
138874944|NCT03973177|Phenol|phenol|mesh-list
138874945|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
138874946|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138874947|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138874948|NCT03973177|Prednisolone|prednisolone|mesh-list
138874949|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
138874950|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138874951|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
138874952|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138874953|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
138874954|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
138874955|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874956|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874957|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138874958|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
138874959|NCT03973177|Hormones|hormones|mesh-ancestor
138874960|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138874961|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138874962|NCT03973177|Protective Agents|protective agents|mesh-ancestor
138874963|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138874964|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138874965|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138874966|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874967|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
138874968|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138874969|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138874970|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
138874971|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138874972|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874974|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138874975|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874976|NCT04115189|Sunitinib|sunitinib|mesh-list
138874977|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780798|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
138874978|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138874979|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138874980|NCT04115189|Growth Substances|growth substances|mesh-ancestor
138874981|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874982|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
138874983|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138874984|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803888|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138874985|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138874987|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138874988|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138874989|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
138874990|NCT02678234|Acetaminophen|acetaminophen|mesh-list
138874991|NCT02678234|Phenylephrine|phenylephrine|mesh-list
138874992|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
138874993|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138874994|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138874995|NCT02678234|Analgesics|analgesics|mesh-ancestor
138874996|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
138874997|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138874999|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875000|NCT02678234|Protective Agents|protective agents|mesh-ancestor
138875001|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138875002|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
138875003|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
138875004|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
138994098|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875005|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138875006|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
138875007|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
138875008|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138875009|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138875010|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138875011|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
138875012|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875013|NCT00601640|Eflornithine|eflornithine|mesh-list
138875014|NCT00601640|Diclofenac|diclofenac|mesh-list
138875015|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138875016|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138875017|NCT00601640|Analgesics|analgesics|mesh-ancestor
138875018|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
138875019|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875020|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875021|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138875022|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138875023|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138875024|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875025|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875026|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875027|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138875028|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138875029|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138804064|NCT01067144|Gabapentin|gabapentin|mesh-list
138875030|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875031|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138875032|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
138875033|NCT02805725|Trabectedin|trabectedin|mesh-list
138875034|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138875035|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
138875036|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875037|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138875038|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138875039|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
138875040|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875041|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804124|NCT00793819|Silodosin|silodosin|mesh-list
138875042|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138875044|NCT03549715|Tremelimumab|tremelimumab|mesh-list
138875045|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138875046|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875047|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
138875048|NCT02803385|Anesthetics|anesthetics|mesh-list
138875049|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
138875050|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875051|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875052|NCT02803385|Narcotics|narcotics|mesh-ancestor
138875053|NCT02803385|Analgesics|analgesics|mesh-ancestor
138875054|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
138875055|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804179|NCT00892437|Cobicistat|cobicistat|mesh-list
138875057|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138875058|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875059|NCT05352373|Calcium|calcium|mesh-list
138875060|NCT05352373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138875061|NCT05352373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875062|NCT02677532|Acetaminophen|acetaminophen|mesh-list
138875063|NCT02677532|Sufentanil|sufentanil|mesh-list
138875064|NCT02677532|Morphine|morphine|mesh-list
138875065|NCT02677532|Dsuvia|dsuvia|mesh-list
138875066|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
138875067|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138875068|NCT02677532|Narcotics|narcotics|mesh-ancestor
138875069|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875070|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875071|NCT02677532|Analgesics|analgesics|mesh-ancestor
138875072|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
138875073|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875074|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138875075|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
138875076|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138875077|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138875078|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
138875079|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
138875080|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
138875081|NCT00641810|Caffeine|caffeine|mesh-list
138875082|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138875083|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875084|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138875085|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875086|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875087|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138875088|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138875089|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
138875090|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875091|NCT02802995|Thrombin|thrombin|mesh-list
138875092|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
138875093|NCT02802995|Coagulants|coagulants|mesh-ancestor
138875094|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138875095|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
138875096|NCT00910052|Coagulants|coagulants|mesh-ancestor
138875097|NCT02677376|Listerine|listerine|mesh-list
138875098|NCT02677376|Fluorides|fluorides|mesh-list
138875099|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
138875100|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
138875101|NCT02677376|Protective Agents|protective agents|mesh-ancestor
138875102|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875103|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138875104|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875105|NCT02800889|Pixantrone|pixantrone|mesh-list
138875106|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138875107|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138875108|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875109|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875110|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875111|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
138875112|NCT02803073|Testosterone|testosterone|mesh-list
138875113|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
138875114|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
138875115|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138875116|NCT02803073|Androgens|androgens|mesh-ancestor
138875117|NCT02803073|Hormones|hormones|mesh-ancestor
138875118|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875119|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875120|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138875121|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875122|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
138875123|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
138875124|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138875125|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
138875126|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875127|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875128|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138875129|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
138875130|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138875131|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
138875132|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875133|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875134|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138875135|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
138875136|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
138875137|NCT00922532|Protective Agents|protective agents|mesh-ancestor
138875139|NCT05662904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138875140|NCT05662904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875141|NCT05662904|Immunotoxins|immunotoxins|mesh-ancestor
138875142|NCT05662904|Immunoconjugates|immunoconjugates|mesh-ancestor
138875143|NCT05662904|Immunologic Factors|immunologic factors|mesh-ancestor
138875144|NCT05662904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875145|NCT00642512|Dronabinol|dronabinol|mesh-list
138875146|NCT00642512|Ondansetron|ondansetron|mesh-list
138875147|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
138875148|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
138875149|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875150|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875151|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138875152|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
138875153|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
138875154|NCT00642512|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138875155|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138875156|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
138875157|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875158|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875159|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
138875160|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138804330|NCT00787267|Dasatinib|dasatinib|mesh-list
138875161|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138875163|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
138875164|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138875165|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138875166|NCT00642512|Hormones|hormones|mesh-ancestor
138875167|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875168|NCT02802683|Phenylephrine|phenylephrine|mesh-list
138875169|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
138875170|NCT02802683|Bupivacaine|bupivacaine|mesh-list
138875171|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
138875172|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
138875173|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
138875174|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875175|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875176|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
138875177|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875178|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138875179|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
138875180|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
138875181|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
138875182|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138875183|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
138875184|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
138875185|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138875186|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138875187|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138875188|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
138875189|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875190|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875191|NCT02802683|Protective Agents|protective agents|mesh-ancestor
138875192|NCT00641264|Omeprazole|omeprazole|mesh-list
138875193|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138875194|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138875195|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138875196|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875197|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875198|NCT05484167|Methyltestosterone|methyltestosterone|mesh-list
138875199|NCT05484167|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138875200|NCT05484167|Testosterone|testosterone|mesh-list
138875201|NCT05484167|Testosterone undecanoate|testosterone undecanoate|mesh-list
138875202|NCT05484167|Testosterone enanthate|testosterone enanthate|mesh-list
138875203|NCT05484167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138875204|NCT05484167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875205|NCT05484167|Anabolic Agents|anabolic agents|mesh-ancestor
138875206|NCT05484167|Hormones|hormones|mesh-ancestor
138875207|NCT05484167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875208|NCT05484167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875209|NCT05484167|Androgens|androgens|mesh-ancestor
138804470|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138875210|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138875211|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
138875212|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875213|NCT04180982|Febuxostat|febuxostat|mesh-list
138875214|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
138875215|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138875216|NCT02802605|Bemiparin|bemiparin|mesh-list
138875217|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
138875218|NCT02800265|Sulforaphane|sulforaphane|mesh-list
138875219|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138875220|NCT02800265|Protective Agents|protective agents|mesh-ancestor
138875221|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875222|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875224|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875225|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138875226|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138875227|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875228|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875229|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138875230|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
138875231|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875232|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875234|NCT02802215|Metformin|metformin|mesh-list
138875235|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138875236|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875237|NCT02802215|Hematinics|hematinics|mesh-ancestor
138875238|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
138875239|NCT02802215|Vitamins|vitamins|mesh-ancestor
138994153|NCT00956046|Vaccines|vaccines|mesh-list
138875240|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
138875241|NCT02799797|Sufentanil|sufentanil|mesh-list
138875242|NCT02799797|Dsuvia|dsuvia|mesh-list
138875243|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138875244|NCT02799797|Narcotics|narcotics|mesh-ancestor
138875245|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875246|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875247|NCT02799797|Analgesics|analgesics|mesh-ancestor
138875248|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
138875249|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875250|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138875251|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138875252|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
138875253|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
138875254|NCT05663372|Eplerenone|eplerenone|mesh-list
138875255|NCT05663372|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138875256|NCT05663372|Hormone Antagonists|hormone antagonists|mesh-ancestor
138804596|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
138875257|NCT05663372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875258|NCT05663372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875259|NCT05663372|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138875260|NCT05663372|Diuretics|diuretics|mesh-ancestor
138875261|NCT05663372|Natriuretic Agents|natriuretic agents|mesh-ancestor
138875262|NCT05663372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138875264|NCT02802137|Dorzolamide|dorzolamide|mesh-list
138875265|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138875266|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138875267|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
138875268|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138804636|NCT00706888|Pyridoxal|pyridoxal|mesh-list
138875269|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875270|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875271|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138875272|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138875273|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138781184|NCT02756728|Melphalan|melphalan|mesh-list
138875274|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875275|NCT04033562|Lidocaine|lidocaine|mesh-list
138875276|NCT04033562|Bupivacaine|bupivacaine|mesh-list
138875277|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
138875278|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
138875279|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875280|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875281|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
138875282|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875283|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138875284|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138875285|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138875286|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138875287|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875288|NCT04032834|Budesonide|budesonide|mesh-list
138875289|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138875290|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138875291|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
138875292|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875293|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875294|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138875295|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
138875296|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
138875298|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875299|NCT02817191|Tobramycin|tobramycin|mesh-list
138875300|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
138875301|NCT02817191|Dexamethasone|dexamethasone|mesh-list
138650852|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
138875302|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
138875303|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138875304|NCT02817191|BB 1101|bb 1101|mesh-list
138875305|NCT02817191|Dipivefrin|dipivefrin|mesh-list
138875306|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138875307|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
138875308|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
138875309|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875310|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875311|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138875312|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
138875313|NCT02817191|Hormones|hormones|mesh-ancestor
138875314|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875315|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138875316|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875317|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
138875318|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875319|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875320|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138875321|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138875322|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875323|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138875324|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
138875325|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875326|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
138875327|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138875328|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875329|NCT02636010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138875330|NCT02636010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875331|NCT00642824|Bevacizumab|bevacizumab|mesh-list
138875332|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138875333|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875334|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138875335|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138527513|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
138875336|NCT00642824|Growth Substances|growth substances|mesh-ancestor
138875337|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875338|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
138875339|NCT02679014|Petesicatib|petesicatib|mesh-list
138875340|NCT02679014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875341|NCT02679014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875342|NCT02801357|Lofexidine|lofexidine|mesh-list
138875343|NCT02801357|Buprenorphine|buprenorphine|mesh-list
138875344|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138875345|NCT02801357|Narcotics|narcotics|mesh-ancestor
138875346|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875347|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875348|NCT02801357|Analgesics|analgesics|mesh-ancestor
138875349|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
138875350|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875351|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138875352|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138875353|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138875354|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138875355|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138875356|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
138875357|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875358|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875359|NCT02676674|Vitamin D|vitamin d|mesh-list
138875360|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
138875361|NCT02676674|Vitamins|vitamins|mesh-ancestor
138875362|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
138875363|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875364|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138875365|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138875367|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138875368|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
138875369|NCT00962299|Hormones|hormones|mesh-ancestor
138875370|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875371|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875372|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138875373|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
138875374|NCT02679092|Misoprostol|misoprostol|mesh-list
138875375|NCT02679092|Mifepristone|mifepristone|mesh-list
139210399|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
138875376|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138875377|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
138875378|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138875379|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875380|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138875381|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138805053|NCT00826540|Sorafenib|sorafenib|mesh-list
138875383|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138875384|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138875385|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138875386|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138875387|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
138875388|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138875389|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138875390|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
138875391|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875392|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
138875393|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138875394|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138875395|NCT04183088|Tislelizumab|tislelizumab|mesh-list
138875396|NCT04183088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138875397|NCT04183088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875398|NCT00642122|Budesonide|budesonide|mesh-list
138875399|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138875400|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138875401|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
138875402|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875403|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875404|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138875405|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
138875406|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
138875407|NCT00642122|Hormones|hormones|mesh-ancestor
138875408|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875409|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
138875410|NCT00546871|Antibodies|antibodies|mesh-list
138875411|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
138875412|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138875413|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138875414|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
138994214|NCT03717623|Posaconazole|posaconazole|mesh-list
138875415|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875416|NCT02817113|Fluorouracil|fluorouracil|mesh-list
138875417|NCT02817113|Cetuximab|cetuximab|mesh-list
138875418|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
138875419|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875420|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138875421|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875422|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138875423|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
138805158|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138875424|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875425|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138875427|NCT02801201|Bupivacaine|bupivacaine|mesh-list
138875428|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
138875429|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
138875430|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875431|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875432|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
138875433|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875434|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138875435|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138875436|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138875437|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138875438|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138875439|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138875440|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
138875441|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
138875442|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
138875443|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875444|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875446|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
138875447|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875448|NCT03951805|Insulin|insulin|mesh-list
138875449|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138875450|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
138875451|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138875452|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875454|NCT02681198|Paroxetine|paroxetine|mesh-list
138875455|NCT02681198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138875456|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138875457|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138875458|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875459|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875460|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
138875461|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875462|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138875463|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
138875464|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138875465|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138875466|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138875467|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875468|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138875469|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138875470|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
138875471|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875472|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138875473|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138875474|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138875475|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
138875476|NCT00962533|Telbivudine|telbivudine|mesh-list
138875477|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
138875478|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875479|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138805328|NCT04203342|Ketoconazole|ketoconazole|mesh-list
138875480|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875481|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875482|NCT00642980|Clindamycin|clindamycin|mesh-list
138875483|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
138875484|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
138875485|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138875486|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875487|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138875488|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875489|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875490|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
138875491|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875492|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
138875493|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138875494|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138875495|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875496|NCT02798159|Urological Agents|urological agents|mesh-ancestor
138875498|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138875499|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875500|NCT00962767|Immunotoxins|immunotoxins|mesh-ancestor
138875501|NCT00962767|Immunoconjugates|immunoconjugates|mesh-ancestor
138875502|NCT00962767|Immunologic Factors|immunologic factors|mesh-ancestor
138875503|NCT00962767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875504|NCT02678780|Lenvatinib|lenvatinib|mesh-list
138875505|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875506|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138875507|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875508|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875509|NCT00963001|Treprostinil|treprostinil|mesh-list
138994237|NCT03704753|Ropivacaine|ropivacaine|mesh-list
138875510|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138875511|NCT00643136|Pregabalin|pregabalin|mesh-list
138875512|NCT00643136|Analgesics|analgesics|mesh-ancestor
138875513|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
138875514|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875515|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875516|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
138875517|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138875518|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138875519|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875520|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138875521|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138875522|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138651085|NCT00333294|Vinorelbine|vinorelbine|mesh-list
138875523|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875524|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138875525|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138875526|NCT01563367|Hematinics|hematinics|mesh-ancestor
138875528|NCT00963313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138875529|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138875530|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138875531|NCT02797145|Digoxin|digoxin|mesh-list
138875532|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138875533|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138875534|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875535|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875536|NCT02797145|Protective Agents|protective agents|mesh-ancestor
138875537|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875538|NCT02690129|Progesterone|progesterone|mesh-list
138875539|NCT02690129|Progestins|progestins|mesh-ancestor
138875540|NCT02690129|Hormones|hormones|mesh-ancestor
138875541|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875542|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875543|NCT00883116|Paclitaxel|paclitaxel|mesh-list
138875544|NCT00883116|Doxorubicin|doxorubicin|mesh-list
138875545|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138875546|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138875547|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875548|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
138875549|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
138875550|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
138875551|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875552|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138875553|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138875554|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138875555|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875556|NCT00643292|Amoxicillin|amoxicillin|mesh-list
138875557|NCT00643292|Azithromycin|azithromycin|mesh-list
138875558|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
138875559|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
138875560|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138875561|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138875562|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875563|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138875564|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875565|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875566|NCT02797067|Indomethacin|indomethacin|mesh-list
138875567|NCT02797067|Glycerol|glycerol|mesh-list
138875568|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138875569|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138875570|NCT02797067|Analgesics|analgesics|mesh-ancestor
138875571|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
138875572|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875573|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875574|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138875575|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138875576|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
138875578|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138875579|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138875580|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875581|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875582|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138875583|NCT02797067|Protective Agents|protective agents|mesh-ancestor
138875584|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
138875585|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138875586|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875587|NCT00963703|Rituximab|rituximab|mesh-list
138875588|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138875589|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875590|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
138875591|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875592|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138875593|NCT00655122|Dalteparin|dalteparin|mesh-list
138875594|NCT00655122|Tinzaparin|tinzaparin|mesh-list
138875595|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138875596|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
138875597|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138875598|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138875599|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875600|NCT02638116|Omeprazole|omeprazole|mesh-list
138875601|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138875602|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138875603|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138875604|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875605|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875606|NCT04164264|Propofol|propofol|mesh-list
138875607|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138875608|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875609|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875610|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138875611|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
138875612|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
138875613|NCT02795039|Fulvestrant|fulvestrant|mesh-list
138875614|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138875615|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875616|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138875617|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138875618|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
138994299|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
138875619|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875620|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875621|NCT02796833|SMOFlipid|smoflipid|mesh-list
138875622|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138875623|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138875624|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138875625|NCT04009603|Metformin|metformin|mesh-list
138875626|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138875627|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875628|NCT02635230|Aspirin|aspirin|mesh-list
138875629|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138875630|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138875631|NCT02635230|Analgesics|analgesics|mesh-ancestor
138875632|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
138875633|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059154|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138875634|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875635|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138805652|NCT00888381|Vaccines|vaccines|mesh-list
138875636|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138875637|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138875638|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138875639|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875640|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138805677|NCT04242927|Niacin|niacin|mesh-list
138875641|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138875642|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875643|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
138875644|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138875645|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
138875646|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
138875647|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138875648|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
138875649|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138875650|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
138875651|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138875652|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875653|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138875654|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138875655|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875656|NCT04009525|Cyclosporine|cyclosporine|mesh-list
138875657|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
138875658|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
138875659|NCT04009525|Busulfan|busulfan|mesh-list
138875660|NCT04009525|Methotrexate|methotrexate|mesh-list
138875661|NCT04009525|Fludarabine|fludarabine|mesh-list
138875662|NCT04009525|Tacrolimus|tacrolimus|mesh-list
138875663|NCT04009525|Cyclosporins|cyclosporins|mesh-list
138875664|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
138875665|NCT04009525|Basiliximab|basiliximab|mesh-list
138875666|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138875667|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
138875668|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875669|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138875670|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138875671|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
138875672|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875673|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875674|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138875675|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138875676|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
138875677|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138875678|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138875679|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
138875680|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
138875681|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875682|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138875683|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138875684|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138875685|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
138875686|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875687|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138875688|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138875689|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
138875690|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138875691|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
138875692|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138875693|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
138781647|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138875694|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875695|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875696|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138875697|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
138875698|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138875699|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
138875700|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875701|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875702|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138875703|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
138875704|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
138875705|NCT04032366|Protective Agents|protective agents|mesh-ancestor
138875706|NCT02537600|Vemurafenib|vemurafenib|mesh-list
138875707|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875708|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138875709|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875710|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875713|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875714|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
138875715|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
138875716|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
138875717|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875718|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875719|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138875720|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138875721|NCT04159896|Nivolumab|nivolumab|mesh-list
138875722|NCT04159896|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138875723|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138875724|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875725|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138875726|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805865|NCT02825121|Iodine|iodine|mesh-list
138875727|NCT04159896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138875728|NCT04159896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875729|NCT02635074|Cytarabine|cytarabine|mesh-list
138875730|NCT02635074|Idarubicin|idarubicin|mesh-list
138875731|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138875732|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
138875733|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875734|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875735|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
138875736|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875737|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138875738|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
138875739|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875740|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138875741|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138875742|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138875743|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875744|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
138875745|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138875746|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875747|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875748|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138875749|NCT02537366|Analgesics|analgesics|mesh-ancestor
138875750|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
138875751|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875752|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138875753|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138875754|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138875755|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
138875756|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805881|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
138875757|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875758|NCT00690417|Vitamin D|vitamin d|mesh-list
138875759|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
138875760|NCT00690417|Vitamins|vitamins|mesh-ancestor
138875761|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
138875762|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875763|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138875764|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138875765|NCT05434559|Insulin|insulin|mesh-list
138875766|NCT05434559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138875767|NCT05434559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875768|NCT00546637|Fesoterodine|fesoterodine|mesh-list
138875769|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138875770|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138875771|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
138875772|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875773|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875774|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875775|NCT00546637|Urological Agents|urological agents|mesh-ancestor
138875776|NCT00690885|Interferons|interferons|mesh-list
138875777|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
138875778|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
138875779|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138875780|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875781|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
138875782|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875783|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
138875784|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875785|NCT04138719|Paclitaxel|paclitaxel|mesh-list
138527961|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
138875786|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138875787|NCT04138719|Carboplatin|carboplatin|mesh-list
138875788|NCT04138719|Epirubicin|epirubicin|mesh-list
138875789|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138875790|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875791|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
138875792|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
138875793|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
138875794|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875795|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138781770|NCT02749162|Acetaminophen|acetaminophen|mesh-list
138875796|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138875797|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138875798|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875799|NCT02790203|Celecoxib|celecoxib|mesh-list
138875800|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138875801|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138805930|NCT02823249|Erythritol|erythritol|mesh-list
138875802|NCT02790203|Analgesics|analgesics|mesh-ancestor
138875803|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
138875804|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875805|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875806|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138875807|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138875808|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138875809|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138875810|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875811|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875812|NCT02816567|Sufentanil|sufentanil|mesh-list
138875813|NCT02816567|Propofol|propofol|mesh-list
138875814|NCT02816567|Cisatracurium|cisatracurium|mesh-list
138875815|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138875816|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875817|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875818|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138875819|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
138875820|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
138875821|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138875822|NCT02816567|Narcotics|narcotics|mesh-ancestor
138875823|NCT02816567|Analgesics|analgesics|mesh-ancestor
138875824|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
138875825|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875826|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138875827|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138875828|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138875830|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138875831|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
138875832|NCT00657774|Hormones|hormones|mesh-ancestor
138875833|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875834|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875835|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138875836|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875837|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
138875838|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
138875839|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875840|NCT02789969|Fentanyl|fentanyl|mesh-list
138875841|NCT02789969|Hydromorphone|hydromorphone|mesh-list
138875842|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138875843|NCT02789969|Narcotics|narcotics|mesh-ancestor
138875844|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875845|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875846|NCT02789969|Analgesics|analgesics|mesh-ancestor
138875847|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
138875848|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875849|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138875850|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138875851|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
138875852|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
138875853|NCT00657852|Pamidronate|pamidronate|mesh-list
138875854|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138875855|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875856|NCT00691275|Ondansetron|ondansetron|mesh-list
138875857|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
138875858|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
138528039|NCT00060684|Hormones|hormones|mesh-ancestor
138875859|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875860|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875861|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138875862|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
138875863|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
138875864|NCT00691275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138875865|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138875866|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
138875867|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875868|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875869|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
138875870|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138875871|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875872|NCT00655512|Clobetasol|clobetasol|mesh-list
138875873|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
138875874|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138875875|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
138875876|NCT00655512|Hormones|hormones|mesh-ancestor
138781870|NCT02746744|Rituximab|rituximab|mesh-list
138875877|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138806016|NCT04200885|Hormones|hormones|mesh-ancestor
138875878|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875879|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138875880|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138875881|NCT00655512|Analgesics|analgesics|mesh-ancestor
138875882|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
138875883|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138875884|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138875885|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
138875886|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138875887|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
138875888|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138806051|NCT02821533|Cisplatin|cisplatin|mesh-list
138875889|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875890|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875891|NCT00644306|Thalidomide|thalidomide|mesh-list
138875892|NCT00644306|Prednisone|prednisone|mesh-list
138875893|NCT00644306|Melphalan|melphalan|mesh-list
138875894|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138875895|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
138875896|NCT00644306|Hormones|hormones|mesh-ancestor
138875897|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138875898|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875899|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138875900|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138875901|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138875902|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
138875903|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875904|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138875905|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138875906|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
138875907|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
138875908|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138875909|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875910|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138875911|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138875912|NCT00644306|Growth Substances|growth substances|mesh-ancestor
138875913|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
138994369|NCT00427648|Lidocaine|lidocaine|mesh-list
138875915|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138875916|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
138875917|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
138875918|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
138875919|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138875920|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875921|NCT02816411|Caseins|caseins|mesh-list
138875922|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
138875923|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
138875924|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875925|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
138875926|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138875927|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
138875928|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138875929|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138875930|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875931|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875932|NCT00655590|Urological Agents|urological agents|mesh-ancestor
138875933|NCT02794025|Esmolol|esmolol|mesh-list
138875934|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138875935|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138528108|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875936|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138875938|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875939|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875940|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875941|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
138875942|NCT00546481|Hematinics|hematinics|mesh-ancestor
138875943|NCT02789813|Valproic Acid|valproic acid|mesh-list
138875944|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
138875945|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875946|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875947|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
138875948|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138875949|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875950|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
138875951|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138875952|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875953|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138875954|NCT02632578|Vaccines|vaccines|mesh-list
138875955|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
138875956|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875957|NCT04138251|Empagliflozin|empagliflozin|mesh-list
138994394|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138875958|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138875959|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875960|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138875961|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875962|NCT00964171|Efavirenz|efavirenz|mesh-list
138875963|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138875964|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138875965|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875966|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875967|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
138875968|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875969|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138875970|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138875971|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138875972|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138875973|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138875975|NCT04016246|Propofol|propofol|mesh-list
138875976|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138875977|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875978|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875979|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138875980|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
138875981|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
138875982|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138875983|NCT04178876|Ethanol|ethanol|mesh-list
138875984|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138875985|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875986|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138875987|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138875989|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
138875990|NCT02789579|Cefuroxime|cefuroxime|mesh-list
138875991|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
138875992|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138875993|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138875994|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138875995|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138875996|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138875997|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138875998|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138875999|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876000|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138876001|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138876002|NCT04233203|Insulin|insulin|mesh-list
138876003|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138876004|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138876005|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876006|NCT00959101|Metformin|metformin|mesh-list
138876007|NCT00959101|Repaglinide|repaglinide|mesh-list
138876008|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138528184|NCT00033410|Paclitaxel|paclitaxel|mesh-list
138876009|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876010|NCT04233359|Anesthetics|anesthetics|mesh-list
138876011|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
138876012|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876013|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876014|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
138876015|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876016|NCT00964327|Darunavir|darunavir|mesh-list
138876017|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138876018|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138876019|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
138876020|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876021|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876022|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138876023|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138876024|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
138876025|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876026|NCT05252546|Loperamide|loperamide|mesh-list
138876027|NCT05252546|Antidiarrheals|antidiarrheals|mesh-list
138876028|NCT05252546|Bentonite|bentonite|mesh-list
138876029|NCT05252546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138876030|NCT05252546|Antidotes|antidotes|mesh-ancestor
138876031|NCT05252546|Protective Agents|protective agents|mesh-ancestor
138876032|NCT05252546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876033|NCT00644384|Acitretin|acitretin|mesh-list
138876034|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
138876035|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
138876036|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
138876037|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138876038|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138876039|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
138876040|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
138876041|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876042|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876043|NCT02815865|Oxytocin|oxytocin|mesh-list
138876044|NCT02815865|Dinoprostone|dinoprostone|mesh-list
138876045|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
138876046|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138876047|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876048|NCT02673866|Pregabalin|pregabalin|mesh-list
138876049|NCT02673866|DS-1971a|ds-1971a|mesh-list
138876050|NCT02673866|Analgesics|analgesics|mesh-ancestor
138876051|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
138806259|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138876052|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876053|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876055|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138876056|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138876057|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876058|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138876059|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138876060|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138876061|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876062|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138876063|NCT02673866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138876064|NCT02673866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138876065|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138876066|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
138876067|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138876068|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876069|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
138876070|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138876071|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138876072|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876073|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876074|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876075|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138876076|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138876077|NCT02793323|Anesthetics|anesthetics|mesh-list
138876078|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876079|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876080|NCT00964639|Ropivacaine|ropivacaine|mesh-list
138876081|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
138876082|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
138876083|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876084|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876085|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
138876086|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876087|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138876089|NCT00880620|Levodopa|levodopa|mesh-list
138876090|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138876091|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
138806372|NCT00705562|Caseins|caseins|mesh-list
138876092|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876093|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138876094|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138876095|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
138876096|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
138876097|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138876098|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876099|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138876100|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876101|NCT00959335|Bicalutamide|bicalutamide|mesh-list
138876102|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
138876103|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
138876104|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876105|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876106|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876107|NCT00644618|Gemcitabine|gemcitabine|mesh-list
138876108|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138876109|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
138876110|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876111|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876112|NCT03967847|Ketorolac|ketorolac|mesh-list
138876113|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138876114|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138876115|NCT03967847|Analgesics|analgesics|mesh-ancestor
138876116|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
138876117|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782078|NCT00856375|Irinotecan|irinotecan|mesh-list
138876118|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876119|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876120|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138876121|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138876122|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876123|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876125|NCT04175990|Progestins|progestins|mesh-ancestor
138876126|NCT04175990|Hormones|hormones|mesh-ancestor
138876127|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876128|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806419|NCT05631249|Sotorasib|sotorasib|mesh-list
138876129|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138876130|NCT00959569|Esmolol|esmolol|mesh-list
138876131|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138876132|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
138876133|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138876134|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876135|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876136|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138876137|NCT00881868|Clobetasol|clobetasol|mesh-list
138876138|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876139|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
138876140|NCT00881868|Hormones|hormones|mesh-ancestor
138876141|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876142|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876143|NCT04176068|Calcium|calcium|mesh-list
138876144|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138876145|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876146|NCT00959725|Infliximab|infliximab|mesh-list
138876147|NCT00959725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138876148|NCT00959725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876149|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
138876150|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138876151|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138876152|NCT02789189|Gemcitabine|gemcitabine|mesh-list
138876153|NCT02789189|Nedaplatin|nedaplatin|mesh-list
138876154|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138876155|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
138876156|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876157|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876158|NCT04234607|Carboplatin|carboplatin|mesh-list
138876159|NCT04234607|Etoposide|etoposide|mesh-list
138876160|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876161|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138876162|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138876163|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138806523|NCT02874326|Octreotide|octreotide|mesh-list
138876164|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876165|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876166|NCT03955471|Niraparib|niraparib|mesh-list
138876167|NCT03955471|Dostarlimab|dostarlimab|mesh-list
138876168|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138876169|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876170|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876171|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876172|NCT02637726|Remifentanil|remifentanil|mesh-list
138876173|NCT02637726|Propofol|propofol|mesh-list
138876174|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138876175|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876176|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876177|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138876178|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
138876179|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
138876180|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138876181|NCT02637726|Narcotics|narcotics|mesh-ancestor
138876182|NCT02637726|Analgesics|analgesics|mesh-ancestor
138876183|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
138876184|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876185|NCT04161768|Norfloxacin|norfloxacin|mesh-list
138876186|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138876187|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876188|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138876189|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138876190|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876191|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876192|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876193|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138876194|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138876195|NCT02793011|Dexamethasone|dexamethasone|mesh-list
138876196|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876197|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
138782132|NCT00848107|Treprostinil|treprostinil|mesh-list
138876198|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
138876199|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876200|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876201|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138876202|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
138876203|NCT02793011|Hormones|hormones|mesh-ancestor
138876204|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876205|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138876206|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876207|NCT00965107|Thiopental|thiopental|mesh-list
138876208|NCT00965107|Propofol|propofol|mesh-list
138876209|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138876210|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876211|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876212|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138876213|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
138876214|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
138876215|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
138876216|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
138876217|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
138876218|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138876219|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876220|NCT02788877|Aflibercept|aflibercept|mesh-list
138876221|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138876222|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138876223|NCT02788877|Growth Substances|growth substances|mesh-ancestor
138876224|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876225|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
138876226|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876227|NCT00959881|Donepezil|donepezil|mesh-list
138876228|NCT00959881|Begacestat|begacestat|mesh-list
138876229|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138876230|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876231|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876232|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
138876233|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528413|NCT00034502|Irinotecan|irinotecan|mesh-list
138876234|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876235|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
138876236|NCT00959881|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138876237|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
138876238|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876239|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876240|NCT03651011|Aflibercept|aflibercept|mesh-list
138876241|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138876242|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138876243|NCT03651011|Growth Substances|growth substances|mesh-ancestor
138876244|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876245|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
138876246|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876247|NCT00880542|Sorafenib|sorafenib|mesh-list
138876248|NCT00880542|Ifosfamide|ifosfamide|mesh-list
138876249|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876250|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138876251|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876252|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806791|NCT02804373|Oxytocin|oxytocin|mesh-list
138876253|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138876254|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
138876256|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
138876257|NCT00960037|Vitamins|vitamins|mesh-ancestor
138876258|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
138876259|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876260|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138876261|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138876262|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138876263|NCT04161690|Ropivacaine|ropivacaine|mesh-list
138876264|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
138876265|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
138876266|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876267|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876268|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
138876269|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876270|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138876271|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138876272|NCT04161690|Analgesics|analgesics|mesh-ancestor
138876273|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876274|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138876275|NCT00885534|Temozolomide|temozolomide|mesh-list
138876276|NCT00885534|Vinblastine|vinblastine|mesh-list
138876277|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876278|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138876279|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
138876280|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876281|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138876282|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
138876283|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
138806916|NCT00908232|Hormones|hormones|mesh-ancestor
138876284|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
138876286|NCT05277038|Zopiclone|zopiclone|mesh-list
138876287|NCT05277038|Analgesics|analgesics|mesh-ancestor
138876288|NCT05277038|Sensory System Agents|sensory system agents|mesh-ancestor
138876289|NCT05277038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876290|NCT05277038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876291|NCT05277038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138876292|NCT05277038|Sympatholytics|sympatholytics|mesh-ancestor
138876293|NCT05277038|Autonomic Agents|autonomic agents|mesh-ancestor
138876294|NCT05277038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138806974|NCT00762463|Analgesics|analgesics|mesh-ancestor
138876295|NCT05277038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138876296|NCT05277038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138876297|NCT05277038|Adrenergic Agents|adrenergic agents|mesh-ancestor
138876298|NCT05277038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138876299|NCT05277038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876300|NCT05277038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138876301|NCT05277038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876303|NCT00960349|Capecitabine|capecitabine|mesh-list
138876304|NCT00960349|Cediranib|cediranib|mesh-list
138876305|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876306|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138528484|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
138876307|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
138876308|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876309|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138876310|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876311|NCT02670434|Pitavastatin|pitavastatin|mesh-list
138876312|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138876313|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138876314|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138876315|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
138876316|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876317|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876318|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138876319|NCT00965653|Folic Acid|folic acid|mesh-list
138876320|NCT00965653|Methotrexate|methotrexate|mesh-list
138876321|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138876322|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
138876323|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138876324|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876325|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138876326|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
138876327|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876328|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876329|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
138876330|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876331|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138876332|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138876333|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
138876334|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138876335|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138876336|NCT00965653|Hematinics|hematinics|mesh-ancestor
138876337|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
138876338|NCT00965653|Vitamins|vitamins|mesh-ancestor
138876339|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
138876340|NCT00644696|Cefixime|cefixime|mesh-list
138876341|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
138876342|NCT00644696|Irinotecan|irinotecan|mesh-list
138876343|NCT00644696|Bortezomib|bortezomib|mesh-list
138876344|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138876345|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138651894|NCT00230477|Lamivudine|lamivudine|mesh-list
138876346|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876347|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876348|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876349|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138876350|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876351|NCT00960739|Topotecan|topotecan|mesh-list
138876352|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138876353|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138876354|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138876355|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994601|NCT04011098|Analgesics|analgesics|mesh-ancestor
138876356|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876357|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876358|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138876359|NCT00659022|Bevacizumab|bevacizumab|mesh-list
138876360|NCT00659022|Capecitabine|capecitabine|mesh-list
138876361|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
138876362|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138876363|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876364|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138876365|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138876366|NCT00659022|Growth Substances|growth substances|mesh-ancestor
138876367|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876368|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
138876369|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138876370|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
138876371|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876372|NCT02788643|Dimercaprol|dimercaprol|mesh-list
138876373|NCT02788643|Chelating Agents|chelating agents|mesh-ancestor
138876374|NCT02788643|Sequestering Agents|sequestering agents|mesh-ancestor
138876375|NCT02788643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876376|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
138876377|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138876378|NCT04175522|Antibodies|antibodies|mesh-list
138876380|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
138782316|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138528560|NCT00034853|Analgesics|analgesics|mesh-ancestor
138876381|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876382|NCT00960817|Aspirin|aspirin|mesh-list
138876383|NCT00960817|Dipyridamole|dipyridamole|mesh-list
138876384|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138876385|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138876386|NCT00960817|Analgesics|analgesics|mesh-ancestor
138876387|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
138876388|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876389|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876390|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876391|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138876392|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138876393|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138876394|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876395|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138876396|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138876397|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876398|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
138876399|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138876400|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
138876401|NCT00965809|Dronabinol|dronabinol|mesh-list
138994648|NCT00653159|Copper|copper|mesh-list
138876403|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876404|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138807185|NCT05804903|Histamine Agents|histamine agents|mesh-ancestor
138876405|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138876406|NCT00965809|Analgesics|analgesics|mesh-ancestor
138876407|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
138876408|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876409|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138876410|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138876411|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138876412|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876413|NCT00965809|Hormones|hormones|mesh-ancestor
138876414|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876415|NCT00885378|Metformin|metformin|mesh-list
138876416|NCT00885378|Saxagliptin|saxagliptin|mesh-list
138876417|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138876418|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876419|NCT00885378|Incretins|incretins|mesh-ancestor
138876420|NCT00885378|Hormones|hormones|mesh-ancestor
138876421|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876422|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138876424|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876425|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876426|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
138876427|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138876428|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
138876429|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
138876430|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876431|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876432|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138876433|NCT04095494|Analgesics|analgesics|mesh-ancestor
138876434|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
138876435|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876436|NCT02537210|Mesalamine|mesalamine|mesh-list
138876437|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138876438|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138876439|NCT02537210|Analgesics|analgesics|mesh-ancestor
138876440|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
138876441|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876442|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876443|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876444|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138876445|NCT01563289|Ibuprofen|ibuprofen|mesh-list
138876446|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138876447|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138876448|NCT01563289|Analgesics|analgesics|mesh-ancestor
138876449|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
138876450|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876451|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876452|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876453|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138876454|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138876455|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876456|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528633|NCT00035087|Epothilones|epothilones|mesh-list
138876457|NCT00960973|Menatetrenone|menatetrenone|mesh-list
138876458|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
138876459|NCT00960973|Coagulants|coagulants|mesh-ancestor
138876460|NCT04099849|Zinc|zinc|mesh-list
138994659|NCT03047070|Lidocaine|lidocaine|mesh-list
138876461|NCT04099849|Trace Elements|trace elements|mesh-ancestor
138876462|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
138876463|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876464|NCT00659100|Gabapentin|gabapentin|mesh-list
138876465|NCT00659100|Analgesics|analgesics|mesh-ancestor
138876466|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
138876467|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876468|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876469|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
138876470|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138876471|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138876472|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876473|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138876474|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138876475|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138876476|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138876477|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876478|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
138876479|NCT00659178|Doxorubicin|doxorubicin|mesh-list
138876480|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138782438|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138876481|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138876482|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876483|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138876484|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138876485|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876486|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876487|NCT02792621|Acipimox|acipimox|mesh-list
138876488|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138876489|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
138876490|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876491|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138876492|NCT04009759|Ketamine|ketamine|mesh-list
138876493|NCT04009759|Morphine|morphine|mesh-list
138876494|NCT04009759|Analgesics|analgesics|mesh-ancestor
138876495|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
138876496|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876497|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876498|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138876499|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138876501|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
138876502|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876503|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138876504|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138876505|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138876506|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876507|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138876508|NCT04009759|Narcotics|narcotics|mesh-ancestor
138876509|NCT00645086|Clarithromycin|clarithromycin|mesh-list
138876510|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138876511|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876512|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138876513|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876514|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876515|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138876516|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138876517|NCT05238649|Vaccines|vaccines|mesh-list
138876518|NCT05238649|Immunologic Factors|immunologic factors|mesh-ancestor
138876519|NCT05238649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876520|NCT02792153|Estradiol|estradiol|mesh-list
138876521|NCT02792153|Estrogens|estrogens|mesh-ancestor
138876522|NCT02792153|Hormones|hormones|mesh-ancestor
138876523|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876524|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876525|NCT00644540|Vaccines|vaccines|mesh-list
138876526|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
138876527|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876528|NCT02669732|Firuglipel|firuglipel|mesh-list
138994715|NCT02897778|Entinostat|entinostat|mesh-list
138876529|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138528710|NCT00035321|Olanzapine|olanzapine|mesh-list
138876530|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876531|NCT05003245|Ranibizumab|ranibizumab|mesh-list
138876532|NCT05003245|Antibodies|antibodies|mesh-list
138876533|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138876535|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
138876536|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
138876537|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876538|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
138876539|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876540|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138876541|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138876542|NCT05003245|Growth Substances|growth substances|mesh-ancestor
138807411|NCT05728775|Propofol|propofol|mesh-list
138876543|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
138876544|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876545|NCT05367089|Fluconazole|fluconazole|mesh-list
138876546|NCT05367089|Antifungal Agents|antifungal agents|mesh-ancestor
138876547|NCT05367089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876548|NCT05367089|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138876549|NCT05367089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138876550|NCT05367089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876551|NCT05367089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876552|NCT05367089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138876553|NCT05367089|Hormone Antagonists|hormone antagonists|mesh-ancestor
138876554|NCT05367089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876555|NCT05367089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876556|NCT05367089|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138876557|NCT05367089|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138876558|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
138876559|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138876560|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138876561|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138876562|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876563|NCT02791919|Cytarabine|cytarabine|mesh-list
138876564|NCT02791919|Fludarabine|fludarabine|mesh-list
138876565|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
138876566|NCT02791919|Lenograstim|lenograstim|mesh-list
138876567|NCT02791919|Adavosertib|adavosertib|mesh-list
138652123|NCT00337545|Everolimus|everolimus|mesh-list
138876568|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876569|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138876571|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876572|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138876573|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
138876574|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876575|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
138876576|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876577|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138876578|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876579|NCT00966121|Propranolol|propranolol|mesh-list
138876580|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138876581|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138876582|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
138876583|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994750|NCT00746447|Mesalamine|mesalamine|mesh-list
138876584|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876585|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876586|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138876587|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138876588|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
138876589|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
138876590|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138876591|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876592|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138876593|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138876594|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876595|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876596|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876597|NCT00659412|Methotrexate|methotrexate|mesh-list
138782537|NCT00847015|Sunitinib|sunitinib|mesh-list
138876599|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138876600|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
138876601|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138876602|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876603|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138876604|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
138876605|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876606|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876607|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
138876608|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876609|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138876610|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138876611|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
138876612|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138876613|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138876614|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
138876615|NCT04158102|Bupivacaine|bupivacaine|mesh-list
138876616|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
138876617|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
138876618|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876619|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876620|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
138876621|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876622|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138876623|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
138876624|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876625|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138876626|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138876627|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876628|NCT00961363|Incretins|incretins|mesh-ancestor
138876629|NCT00961363|Hormones|hormones|mesh-ancestor
138876630|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876631|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138876632|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
138876633|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876634|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876635|NCT02633202|Cisplatin|cisplatin|mesh-list
138876636|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876637|NCT00645242|Fluconazole|fluconazole|mesh-list
138876638|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
138876639|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876640|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138876641|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138876642|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876643|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876644|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138876645|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
138876646|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876647|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876648|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138876649|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138876650|NCT00659568|Metformin|metformin|mesh-list
138876651|NCT00659568|Sirolimus|sirolimus|mesh-list
138876652|NCT00659568|Temsirolimus|temsirolimus|mesh-list
138876653|NCT00659568|MTOR Inhibitors|mtor inhibitors|mesh-list
138876654|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138876655|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876656|NCT00659568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138876657|NCT00659568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876658|NCT00659568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876659|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138876660|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
138876661|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876662|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138876663|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876664|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138876665|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
138876666|NCT00961753|Ibuprofen|ibuprofen|mesh-list
138807743|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876668|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138876669|NCT00961753|Analgesics|analgesics|mesh-ancestor
138876670|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
138876671|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876672|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876673|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876674|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138876675|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138876676|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876677|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876678|NCT04232813|Estradiol|estradiol|mesh-list
138528855|NCT00063453|Selenium|selenium|mesh-list
138876680|NCT04232813|Hormones|hormones|mesh-ancestor
138782665|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
138876681|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876682|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876683|NCT00659958|Zonisamide|zonisamide|mesh-list
138876684|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
138876685|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138876686|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138876687|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876688|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138876689|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876690|NCT00644774|Azithromycin|azithromycin|mesh-list
138876691|NCT00644774|Cefdinir|cefdinir|mesh-list
138876692|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138876693|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876694|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
138876695|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138876696|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876697|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
138876698|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138876699|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
138876700|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876701|NCT00910442|Expectorants|expectorants|mesh-ancestor
138876702|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
138876703|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138876704|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
138876705|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876706|NCT00910442|Protective Agents|protective agents|mesh-ancestor
138782721|NCT00701857|Pemetrexed|pemetrexed|mesh-list
138876707|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876708|NCT00910442|Antidotes|antidotes|mesh-ancestor
138876709|NCT00660036|Etoposide|etoposide|mesh-list
138876710|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
138876711|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
138876712|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138876713|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876714|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138876715|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138876716|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876717|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876718|NCT00660036|Analgesics|analgesics|mesh-ancestor
138876719|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
138876720|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876721|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876722|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138876723|NCT00660036|Immunotoxins|immunotoxins|mesh-ancestor
138876724|NCT00660036|Immunoconjugates|immunoconjugates|mesh-ancestor
138876725|NCT00660036|Immunologic Factors|immunologic factors|mesh-ancestor
138994830|NCT00948740|Vitamin D|vitamin d|mesh-list
138876726|NCT02791373|Gemcitabine|gemcitabine|mesh-list
138876727|NCT02791373|Vinorelbine|vinorelbine|mesh-list
138876728|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138876729|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
138876730|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876731|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876732|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138876733|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
138876734|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
138876735|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
138876736|NCT03102047|Durvalumab|durvalumab|mesh-list
138876737|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138876738|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876739|NCT00966745|Milrinone|milrinone|mesh-list
138876740|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138876741|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138876742|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
138876743|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138876744|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138876745|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876746|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876747|NCT00966745|Protective Agents|protective agents|mesh-ancestor
138876748|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876749|NCT02669030|Suvorexant|suvorexant|mesh-list
138876750|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138876751|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138876752|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138528931|NCT00063687|Oxypurinol|oxypurinol|mesh-list
138876753|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876754|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138876755|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138876756|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994849|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
138876757|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138876758|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138876759|NCT02668796|Estradiol|estradiol|mesh-list
138876760|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138876761|NCT02668796|Estrogens|estrogens|mesh-ancestor
138876762|NCT02668796|Hormones|hormones|mesh-ancestor
138876763|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876764|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876765|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138876766|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
138876767|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138876768|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138876769|NCT00645320|Ziprasidone|ziprasidone|mesh-list
138876770|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138876771|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
138876772|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138876773|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876774|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807850|NCT03197077|Hormones|hormones|mesh-ancestor
138876775|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138876776|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138876777|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876778|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138876779|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138876780|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
138876781|NCT03938857|Fentanyl|fentanyl|mesh-list
138876782|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
138876783|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138876784|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876785|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994889|NCT00963222|Vitamin A|vitamin a|mesh-list
138876786|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138876787|NCT03938857|Analgesics|analgesics|mesh-ancestor
138876788|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
138876789|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807906|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
138876790|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138876791|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138876792|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138876793|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
138876794|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138876795|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876796|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138876797|NCT03938857|Narcotics|narcotics|mesh-ancestor
138876798|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138876799|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138876800|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
138876801|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
138876802|NCT04160598|Fentanyl|fentanyl|mesh-list
138876803|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138876804|NCT04160598|Narcotics|narcotics|mesh-ancestor
138876805|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876806|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876807|NCT04160598|Analgesics|analgesics|mesh-ancestor
138876808|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
138876809|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876810|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138876811|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138876812|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
138876813|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
138876814|NCT00967837|Insulin|insulin|mesh-list
138876815|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138876816|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138876817|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876818|NCT02668016|Atorvastatin|atorvastatin|mesh-list
138876819|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138876820|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138876821|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138876822|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
138876823|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876824|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138876825|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876826|NCT00966901|Nicotine|nicotine|mesh-list
138876827|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138782890|NCT02719756|Metformin|metformin|mesh-list
138876828|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
138876829|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876830|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876831|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138876832|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138876833|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
138876834|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138876835|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876836|NCT02668172|Pasireotide|pasireotide|mesh-list
138876837|NCT02668172|Hormones|hormones|mesh-ancestor
138876838|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876839|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876840|NCT00660270|Interferons|interferons|mesh-list
138876841|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
138876842|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138876843|NCT00660270|Gemcitabine|gemcitabine|mesh-list
138876844|NCT00660270|Fluorouracil|fluorouracil|mesh-list
138876845|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876846|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138876847|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
138876848|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876849|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138876850|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
138876851|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876852|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
138876853|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876854|NCT04032132|Curcumin|curcumin|mesh-list
138876855|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138876856|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138876857|NCT04032132|Analgesics|analgesics|mesh-ancestor
138876858|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
138876859|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876860|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876861|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876862|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138876863|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876864|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876865|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876866|NCT00967057|Dexamethasone|dexamethasone|mesh-list
138876867|NCT00967057|Methotrexate|methotrexate|mesh-list
138876868|NCT00967057|Vincristine|vincristine|mesh-list
138876869|NCT00967057|Asparaginase|asparaginase|mesh-list
138876870|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
138876871|NCT00967057|Idarubicin|idarubicin|mesh-list
138876872|NCT00967057|Pegaspargase|pegaspargase|mesh-list
138876873|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876874|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
138876875|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
138876876|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876877|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876878|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138876879|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
138876880|NCT00967057|Hormones|hormones|mesh-ancestor
138876881|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876882|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138876883|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876884|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138876885|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
138876886|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138876887|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138876888|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
138876889|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876890|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
138876891|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876892|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138876893|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138876894|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
138876895|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138876896|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138876897|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138876898|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
138876899|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
138876900|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
138876901|NCT00967057|Analgesics|analgesics|mesh-ancestor
138876902|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
138876903|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138529080|NCT00064623|Capsaicin|capsaicin|mesh-list
138808245|NCT02789865|Ertapenem|ertapenem|mesh-list
138876904|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138876905|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138876907|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876908|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138876909|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138876910|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138876911|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876912|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876913|NCT00656214|Lycopene|lycopene|mesh-list
138876914|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876915|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
138876916|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876917|NCT00656214|Protective Agents|protective agents|mesh-ancestor
138876918|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876919|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138876920|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138876921|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876922|NCT02790671|Firuglipel|firuglipel|mesh-list
138876923|NCT02790671|Itraconazole|itraconazole|mesh-list
138876924|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
138876925|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138876926|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138876927|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138876928|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138876929|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876930|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138876931|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
138783093|NCT02715232|Cyproterone|cyproterone|mesh-list
138876932|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138876933|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876934|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138876935|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138876936|NCT02668094|Lidocaine|lidocaine|mesh-list
138876937|NCT02668094|Pregabalin|pregabalin|mesh-list
138876938|NCT02668094|Propofol|propofol|mesh-list
138876939|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
138876940|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
138808387|NCT00816166|Aspirin|aspirin|mesh-list
138876941|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876942|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876943|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
138876944|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876945|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138876946|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138876947|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138876948|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138876949|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876950|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138876951|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138876952|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
138876954|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
138876955|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138808421|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
138876956|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138876958|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138876959|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138876960|NCT00967135|Pregabalin|pregabalin|mesh-list
138876961|NCT00967135|Analgesics|analgesics|mesh-ancestor
138876962|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
138876963|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138876964|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876965|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
138876966|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138876967|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138876968|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876969|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138876970|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138876971|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138876972|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138876973|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138876974|NCT00967213|Ranibizumab|ranibizumab|mesh-list
138876975|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138876976|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138876977|NCT00967213|Growth Substances|growth substances|mesh-ancestor
138876978|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876979|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
138876980|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876982|NCT04160676|Thiamine|thiamine|mesh-list
138876983|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
138876984|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138876985|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
138876986|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876987|NCT04160676|Protective Agents|protective agents|mesh-ancestor
138876988|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138876989|NCT04160676|Vitamins|vitamins|mesh-ancestor
138876990|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
138876991|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
138876992|NCT00660426|Gemcitabine|gemcitabine|mesh-list
138876993|NCT00660426|Capecitabine|capecitabine|mesh-list
138876994|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
138876995|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138876996|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
138876997|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138876998|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138876999|NCT00967291|Ifosfamide|ifosfamide|mesh-list
138877000|NCT00967291|Mitomycins|mitomycins|mesh-list
138877001|NCT00967291|Mitomycin|mitomycin|mesh-list
138877002|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138877003|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
138877004|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877005|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877006|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138877007|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138877008|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877009|NCT00645398|Pregabalin|pregabalin|mesh-list
138877010|NCT00645398|Analgesics|analgesics|mesh-ancestor
138877011|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
138877012|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457585|NCT01918917|Narcotics|narcotics|mesh-ancestor
138877013|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877014|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
138877015|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138877016|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138877017|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877018|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138877019|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138877020|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138877021|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138877022|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138877024|NCT00884832|Analgesics|analgesics|mesh-ancestor
138877025|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
138877026|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877027|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877028|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138877029|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
138877030|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
138877031|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138877032|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138877033|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138877034|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
138877035|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877036|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877037|NCT00660582|Leucovorin|leucovorin|mesh-list
138877038|NCT00660582|Folic Acid|folic acid|mesh-list
138877039|NCT00660582|Fluorouracil|fluorouracil|mesh-list
138877040|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
138877041|NCT00660582|Cetuximab|cetuximab|mesh-list
138877042|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
138877044|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877045|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138877046|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877047|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138877048|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
138877049|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877050|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138877051|NCT00660582|Antidotes|antidotes|mesh-ancestor
138877052|NCT00660582|Protective Agents|protective agents|mesh-ancestor
138877053|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
138877054|NCT00660582|Vitamins|vitamins|mesh-ancestor
138877055|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
138877056|NCT00660582|Hematinics|hematinics|mesh-ancestor
138877057|NCT00646802|Progesterone|progesterone|mesh-list
138877058|NCT00646802|Progestins|progestins|mesh-ancestor
138877059|NCT00646802|Hormones|hormones|mesh-ancestor
138877060|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138877061|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877062|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138877063|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138877064|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
138877065|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
138877066|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138877067|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
138877068|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877069|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877070|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808629|NCT00703144|Piperacillin|piperacillin|mesh-list
138877071|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877072|NCT00657228|Heparin|heparin|mesh-list
138877073|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
138877074|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138877075|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138877076|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877077|NCT02666534|Lidocaine|lidocaine|mesh-list
138877078|NCT02666534|Prilocaine|prilocaine|mesh-list
138877079|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138877080|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138877081|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138877082|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
138877083|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
138877084|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138877085|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877086|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
138877087|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877088|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138877089|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138877090|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138877091|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138877092|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877093|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138877094|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
138877095|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138877096|NCT02787473|Docetaxel|docetaxel|mesh-list
138877097|NCT02787473|Pemetrexed|pemetrexed|mesh-list
138877098|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877099|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
138877100|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
138877101|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
138808667|NCT05758012|Oxytocin|oxytocin|mesh-list
138995052|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
138877102|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877104|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138877105|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138877107|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138877108|NCT00967603|Sunitinib|sunitinib|mesh-list
138877109|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877110|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138877111|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138877112|NCT00967603|Growth Substances|growth substances|mesh-ancestor
138877113|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877114|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
138877115|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138877116|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877117|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877118|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
138877119|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138877120|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138877121|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877122|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
138877123|NCT00657384|Coagulants|coagulants|mesh-ancestor
138877124|NCT00973453|Immunomodulating Agents|immunomodulating agents|mesh-list
138877125|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
138877126|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877127|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138877128|NCT00646880|Propiverine|propiverine|mesh-list
138877129|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138877130|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138877131|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
138877132|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877133|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877134|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877135|NCT00646880|Urological Agents|urological agents|mesh-ancestor
138877136|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
138877137|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
138783261|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138877138|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877139|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
138877140|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
138877141|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138877142|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
138877143|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877144|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138877145|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138877146|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
138877147|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877148|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877149|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138877150|NCT00968461|Protective Agents|protective agents|mesh-ancestor
138877151|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877152|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877154|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138877155|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
138877156|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138877157|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877158|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138877159|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
138877160|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877161|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877162|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
138877163|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877164|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138877165|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138877166|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
138877167|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138877168|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138877169|NCT02632032|Insulin|insulin|mesh-list
138877170|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138877171|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138877172|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877173|NCT00973609|Folic Acid|folic acid|mesh-list
138877174|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
138877175|NCT00973609|Bevacizumab|bevacizumab|mesh-list
138877176|NCT00973609|Capecitabine|capecitabine|mesh-list
138877177|NCT00973609|Fluorouracil|fluorouracil|mesh-list
138877178|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138877179|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877180|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138877181|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138877182|NCT00973609|Growth Substances|growth substances|mesh-ancestor
138877183|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877184|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
138877185|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138877186|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
138877187|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877188|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138877189|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
138877190|NCT00973609|Hematinics|hematinics|mesh-ancestor
138877191|NCT00973609|Vitamins|vitamins|mesh-ancestor
138877192|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
138877193|NCT02537054|Aflibercept|aflibercept|mesh-list
138877194|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138877195|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138877196|NCT02537054|Growth Substances|growth substances|mesh-ancestor
138877197|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877198|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
138877199|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877200|NCT00973687|Dexamethasone|dexamethasone|mesh-list
138877201|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138877202|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
138877204|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877205|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877206|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138877208|NCT00973687|Hormones|hormones|mesh-ancestor
138877209|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138877210|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138877211|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877212|NCT02785757|Thrombin|thrombin|mesh-list
138877213|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
138877214|NCT02785757|Coagulants|coagulants|mesh-ancestor
138877215|NCT00645554|Galantamine|galantamine|mesh-list
138877216|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138877217|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877218|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877219|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
138877220|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877221|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877222|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138877223|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
138783405|NCT05378919|Folic Acid|folic acid|mesh-list
138877224|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877225|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
138877226|NCT02785601|Trazodone|trazodone|mesh-list
138877227|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138877228|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138877229|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138877230|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877231|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138877232|NCT02785601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138877233|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138877234|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138877235|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877236|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877237|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
138877238|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138877240|NCT05299567|Azithromycin|azithromycin|mesh-list
138877241|NCT05299567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138877242|NCT05299567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138877244|NCT00660894|Tegafur|tegafur|mesh-list
138877245|NCT00660894|Calcium|calcium|mesh-list
138877246|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
138877247|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138877248|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877249|NCT00660894|Antidotes|antidotes|mesh-ancestor
138877250|NCT00660894|Protective Agents|protective agents|mesh-ancestor
138877251|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
138877252|NCT00660894|Vitamins|vitamins|mesh-ancestor
138877253|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
138877254|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138877255|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
138877256|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877257|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877259|NCT00660972|Emtricitabine|emtricitabine|mesh-list
138877260|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
138877261|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138877262|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
138877263|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138877264|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138877265|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138877267|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877268|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138877269|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138877270|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138877271|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138877272|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
138877273|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138877274|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138877275|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
138877276|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877277|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877278|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877279|NCT02667470|Urological Agents|urological agents|mesh-ancestor
138877280|NCT04157478|Temozolomide|temozolomide|mesh-list
138877281|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138877282|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
138877283|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877284|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877285|NCT00647192|Eplerenone|eplerenone|mesh-list
138877286|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138877287|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
138877288|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138877289|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877290|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138877291|NCT00647192|Diuretics|diuretics|mesh-ancestor
138877292|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
138877293|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138877294|NCT00661206|Clopidogrel|clopidogrel|mesh-list
138877295|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138877296|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138877297|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138877298|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138877299|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
138877300|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809056|NCT02848794|Irinotecan|irinotecan|mesh-list
138877301|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877302|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877303|NCT05276960|Cholecalciferol|cholecalciferol|mesh-list
138877304|NCT05276960|Vitamin D|vitamin d|mesh-list
138877305|NCT05276960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138877306|NCT05276960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877307|NCT05276960|Vitamins|vitamins|mesh-ancestor
138877308|NCT05276960|Micronutrients|micronutrients|mesh-ancestor
138877309|NCT05276960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138877310|NCT02787317|Heparin|heparin|mesh-list
138877311|NCT02787317|Bivalirudin|bivalirudin|mesh-list
138877312|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
138877313|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138877314|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138877315|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877316|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
138877317|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138877318|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
138877319|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877320|NCT00645632|Doxorubicin|doxorubicin|mesh-list
138877321|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138877322|NCT00645632|Methotrexate|methotrexate|mesh-list
138877323|NCT00645632|Ifosfamide|ifosfamide|mesh-list
138877324|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877325|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138877326|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138877327|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138877328|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877329|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877330|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138877331|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
138877332|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138877333|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877334|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138877335|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
138877336|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
138877337|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138877338|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138877340|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138877341|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138877342|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138877343|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
138877344|NCT04156464|Lorazepam|lorazepam|mesh-list
138877345|NCT04156464|Phenobarbital|phenobarbital|mesh-list
138877346|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
138877347|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
138877348|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
138877349|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877350|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877351|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138877352|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138877353|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138529543|NCT00066417|Cyclosporine|cyclosporine|mesh-list
138877354|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138877355|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138877356|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138877357|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
138877358|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
138877359|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877360|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877361|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138877362|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138877363|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138877364|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138877365|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138809152|NCT02784015|Melphalan|melphalan|mesh-list
138877367|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138877368|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877369|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
138877370|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
138877371|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
138877372|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877373|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
138877374|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138877375|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138877376|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877377|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
138877378|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877379|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877380|NCT00968929|Streptokinase|streptokinase|mesh-list
138877381|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138877382|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138877383|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877384|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138877385|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
138877386|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138877387|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138877388|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783679|NCT00605397|Trastuzumab|trastuzumab|mesh-list
139210400|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877389|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877390|NCT00661596|Urological Agents|urological agents|mesh-ancestor
138877391|NCT00969085|Curcumin|curcumin|mesh-list
138877392|NCT00969085|Turmeric extract|turmeric extract|mesh-list
138877393|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138877394|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138877395|NCT00969085|Analgesics|analgesics|mesh-ancestor
138877396|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
138877397|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877398|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877399|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138877400|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138877401|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877402|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877403|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877404|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
138877405|NCT00969085|Protective Agents|protective agents|mesh-ancestor
138877406|NCT00974155|Dexetimide|dexetimide|mesh-list
138877407|NCT00974155|Citalopram|citalopram|mesh-list
138877408|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138877409|NCT00974155|Escitalopram|escitalopram|mesh-list
138877410|NCT00974155|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138877411|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138877412|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138877413|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877414|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877415|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
138877416|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877417|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138877418|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138877419|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
138877420|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
138877421|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877422|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138877423|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138809388|NCT00903006|Dasatinib|dasatinib|mesh-list
138877425|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138877426|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
138877427|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138877428|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138877429|NCT00879996|Buprenorphine|buprenorphine|mesh-list
138877430|NCT00879996|Methadone|methadone|mesh-list
138877431|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138877432|NCT00879996|Naloxone|naloxone|mesh-list
138877433|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138877434|NCT00879996|Narcotics|narcotics|mesh-ancestor
138877435|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138877436|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877437|NCT00879996|Analgesics|analgesics|mesh-ancestor
138877438|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
138877439|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877440|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138877441|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
138877442|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
138877443|NCT00969163|Testosterone|testosterone|mesh-list
138877444|NCT00969163|Androgens|androgens|mesh-ancestor
138877445|NCT00969163|Hormones|hormones|mesh-ancestor
138877446|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138877447|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877448|NCT00873093|Leucovorin|leucovorin|mesh-list
138877449|NCT00873093|Cytarabine|cytarabine|mesh-list
138877451|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
138877452|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138877453|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138877454|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138877455|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
138877456|NCT00873093|Doxorubicin|doxorubicin|mesh-list
138877457|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138877458|NCT00873093|Methotrexate|methotrexate|mesh-list
138877459|NCT00873093|Etoposide|etoposide|mesh-list
138877460|NCT00873093|Vincristine|vincristine|mesh-list
138877461|NCT00873093|Bortezomib|bortezomib|mesh-list
138877463|NCT00873093|Pegaspargase|pegaspargase|mesh-list
138877464|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
138877465|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
138877466|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138877467|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
138877468|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877469|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138877470|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138877471|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
138877472|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877473|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877474|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138877475|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138877476|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138877477|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138877478|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877479|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138783812|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
138877480|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
138877481|NCT00873093|Hormones|hormones|mesh-ancestor
138877482|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138877483|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138877484|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138877485|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
138877486|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138877487|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138877488|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
138877489|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
138877490|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138877491|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138877492|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138877493|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
138877494|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138877495|NCT00873093|Antidotes|antidotes|mesh-ancestor
138877496|NCT00873093|Protective Agents|protective agents|mesh-ancestor
138877497|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
138877498|NCT00873093|Vitamins|vitamins|mesh-ancestor
138877499|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
138877500|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
138877501|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
138877502|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
138877503|NCT00969319|Factor VIII|factor viii|mesh-list
138877504|NCT00969319|Coagulants|coagulants|mesh-ancestor
138877505|NCT02784899|Iloprost|iloprost|mesh-list
138877506|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138877507|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
138877508|NCT00974389|Bevacizumab|bevacizumab|mesh-list
138877509|NCT00974389|Tegafur|tegafur|mesh-list
138877510|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138877511|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877512|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138877513|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138877514|NCT00974389|Growth Substances|growth substances|mesh-ancestor
138877515|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877516|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
138877517|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138877518|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
138877519|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877520|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
138877521|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138877522|NCT00969397|Growth Substances|growth substances|mesh-ancestor
138877523|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877524|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
138877525|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877526|NCT02783885|Immunomodulating Agents|immunomodulating agents|mesh-list
138877527|NCT02783885|Immunologic Factors|immunologic factors|mesh-ancestor
138877528|NCT02783885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877529|NCT00647660|Nadolol|nadolol|mesh-list
138877530|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
138877531|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138877532|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138877533|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
138877534|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877535|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877536|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877537|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138877538|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138877539|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
138877540|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
138877541|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877542|NCT00647660|Diuretics|diuretics|mesh-ancestor
138877543|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
138877544|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138877545|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138877547|NCT00634595|Cisplatin|cisplatin|mesh-list
138877548|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138877549|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877550|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
138877551|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
138877552|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
138877553|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877554|NCT00647738|Baclofen|baclofen|mesh-list
138877555|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138877556|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877557|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138877558|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877559|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138877560|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
138877561|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
138877562|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877563|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877564|NCT04008511|Capecitabine|capecitabine|mesh-list
138877565|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
138877566|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138877567|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
138877568|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877569|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877570|NCT00979537|Nisoldipine|nisoldipine|mesh-list
138877571|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138877572|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138877573|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138877574|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877575|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138877576|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877577|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
138877578|NCT00692055|Naproxen|naproxen|mesh-list
138877579|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138877580|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138877581|NCT00692055|Analgesics|analgesics|mesh-ancestor
138877582|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
138877583|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877584|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877585|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138877586|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138877587|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
138877588|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138877589|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783936|NCT04862962|Ezetimibe|ezetimibe|mesh-list
138877590|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877591|NCT04033250|Bisacodyl|bisacodyl|mesh-list
138877592|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
138877593|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
138877594|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
138877595|NCT04033250|Citric Acid|citric acid|mesh-list
138877596|NCT04033250|Cathartics|cathartics|mesh-ancestor
138877597|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138877598|NCT04033250|Laxatives|laxatives|mesh-ancestor
138877599|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
138877600|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138877601|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
138877602|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
138877603|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877604|NCT04033250|Antacids|antacids|mesh-ancestor
138877605|NCT02624973|Tamoxifen|tamoxifen|mesh-list
138877606|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
138877607|NCT02624973|Docetaxel|docetaxel|mesh-list
138877608|NCT02624973|Trastuzumab|trastuzumab|mesh-list
138877609|NCT02624973|Letrozole|letrozole|mesh-list
138877610|NCT02624973|Epirubicin|epirubicin|mesh-list
138877611|NCT02624973|Olaparib|olaparib|mesh-list
138877612|NCT02624973|Palbociclib|palbociclib|mesh-list
138877613|NCT02624973|Pertuzumab|pertuzumab|mesh-list
138877614|NCT02624973|Goserelin|goserelin|mesh-list
138877615|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138877616|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
138877617|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877618|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138877619|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138877621|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877622|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877623|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138877624|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
138877625|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
138877626|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
138877627|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138877628|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138877629|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138877630|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877631|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138877632|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
138877633|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138877634|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138877635|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138877636|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138877637|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138877638|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138877639|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138877640|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138809843|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
138877641|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138877642|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138877643|NCT00647816|Propranolol|propranolol|mesh-list
138877644|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138877645|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138877646|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
138877647|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877648|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877649|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877650|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138877651|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138877652|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
138877653|NCT00647894|Alprazolam|alprazolam|mesh-list
138877654|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138877655|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138529842|NCT00067431|Valproic Acid|valproic acid|mesh-list
138877656|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877657|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138877658|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138877659|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138877660|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
138877661|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
138877662|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877663|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877664|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
138877665|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
138877666|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138877667|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138877668|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877669|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877670|NCT02782559|Urological Agents|urological agents|mesh-ancestor
138877671|NCT00647972|Olanzapine|olanzapine|mesh-list
138877672|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
138877673|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
138877674|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877675|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877676|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138877677|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138877678|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138877679|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138877680|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138877681|NCT00647972|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138877682|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138877683|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138877684|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877685|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877686|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
138877687|NCT02782403|Axitinib|axitinib|mesh-list
138877688|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877689|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138877690|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877691|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877692|NCT00646178|Adalimumab|adalimumab|mesh-list
138877693|NCT00646178|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138877694|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138877695|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138877696|NCT02624817|Glyburide|glyburide|mesh-list
138877697|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138877698|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877699|NCT02664116|Diclofenac|diclofenac|mesh-list
138877700|NCT02664116|Ketorolac|ketorolac|mesh-list
138877701|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138877702|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138877703|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138877704|NCT02664116|Analgesics|analgesics|mesh-ancestor
138877705|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
138877706|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877707|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877708|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138877709|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138877710|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138877711|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877712|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877713|NCT00692601|Capsaicin|capsaicin|mesh-list
138877714|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
138877715|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
138877716|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
138877717|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877718|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877719|NCT02785055|Hydromorphone|hydromorphone|mesh-list
138877720|NCT02785055|Bupivacaine|bupivacaine|mesh-list
138877721|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
138877722|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
138877723|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138877724|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877725|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
138877726|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877727|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138877728|NCT02785055|Narcotics|narcotics|mesh-ancestor
138877729|NCT02785055|Analgesics|analgesics|mesh-ancestor
138877730|NCT02624661|Glycerol|glycerol|mesh-list
138877731|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138877732|NCT02624661|Protective Agents|protective agents|mesh-ancestor
138809969|NCT00774930|Lanreotide|lanreotide|mesh-list
138877733|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877734|NCT00648050|Verapamil|verapamil|mesh-list
138877735|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138877736|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138877737|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138877738|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877739|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138877740|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877741|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
138877742|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
138877743|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138877744|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138877746|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138877747|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
138877748|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877749|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877750|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138877752|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
138877753|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138877754|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138877755|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138877756|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138877757|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
138877758|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877759|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877760|NCT00969631|Metformin|metformin|mesh-list
138877761|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138877762|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877763|NCT02782481|Levodopa|levodopa|mesh-list
138877764|NCT02782481|Carbidopa|carbidopa|mesh-list
138877765|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139210401|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138877766|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138877767|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138877768|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
138877769|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877770|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877771|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877772|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138877773|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877774|NCT00648128|Clarithromycin|clarithromycin|mesh-list
138877775|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138877776|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138877777|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138877778|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877779|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877780|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138877781|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138877782|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138877783|NCT02784821|Gentamicins|gentamicins|mesh-list
138877784|NCT02784821|Ampicillin|ampicillin|mesh-list
138877785|NCT02784821|Cefotaxime|cefotaxime|mesh-list
138877786|NCT02784821|Cefoxitin|cefoxitin|mesh-list
138877787|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138877788|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138877789|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
138877790|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138877791|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877792|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877793|NCT00693069|Clopidogrel|clopidogrel|mesh-list
138877794|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138877795|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138877796|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138877797|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138877798|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
138877799|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138995330|NCT00688103|Etanercept|etanercept|mesh-list
138877800|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877801|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877802|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138877803|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138877804|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877805|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138877806|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138877807|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
138877808|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877809|NCT00974935|Antacids|antacids|mesh-ancestor
138877810|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877811|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138877812|NCT00665808|Insulin|insulin|mesh-list
138877813|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138877814|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
138877815|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
138877816|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
138877817|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
138877818|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138877819|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877821|NCT04230083|Nandrolone|nandrolone|mesh-list
138877822|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138877823|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
138877824|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138877825|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877826|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138877827|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138877828|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138877829|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138877830|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
138877831|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138877832|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138877833|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877834|NCT04230083|Androgens|androgens|mesh-ancestor
138877835|NCT04230083|Hormones|hormones|mesh-ancestor
138877836|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
138877837|NCT00645866|Docetaxel|docetaxel|mesh-list
138877838|NCT00645866|Capecitabine|capecitabine|mesh-list
138877839|NCT00645866|Epirubicin|epirubicin|mesh-list
138877840|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877842|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
138877843|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
138784409|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877844|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877845|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138877846|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
138877847|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138877848|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138877849|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138877850|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877851|NCT05221151|Pregabalin|pregabalin|mesh-list
138877852|NCT05221151|Ondansetron|ondansetron|mesh-list
138877853|NCT05221151|Melatonin|melatonin|mesh-list
138877854|NCT05221151|Analgesics|analgesics|mesh-ancestor
138877855|NCT05221151|Sensory System Agents|sensory system agents|mesh-ancestor
138877856|NCT05221151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877857|NCT05221151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877858|NCT05221151|Anticonvulsants|anticonvulsants|mesh-ancestor
138877859|NCT05221151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138810240|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877860|NCT05221151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138995347|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138877861|NCT05221151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877862|NCT05221151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138877863|NCT05221151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138877864|NCT05221151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138877865|NCT05221151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138877866|NCT05221151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138877867|NCT05221151|Antioxidants|antioxidants|mesh-ancestor
138877868|NCT05221151|Protective Agents|protective agents|mesh-ancestor
138877869|NCT05221151|Antiemetics|antiemetics|mesh-ancestor
138877870|NCT05221151|Autonomic Agents|autonomic agents|mesh-ancestor
138877871|NCT05221151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138877872|NCT05221151|Antipruritics|antipruritics|mesh-ancestor
138877873|NCT05221151|Dermatologic Agents|dermatologic agents|mesh-ancestor
138877874|NCT05221151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138877875|NCT05221151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138877876|NCT05221151|Serotonin Agents|serotonin agents|mesh-ancestor
138877877|NCT05221151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877878|NCT04008043|Acetaminophen|acetaminophen|mesh-list
138530067|NCT00202462|Androgens|androgens|mesh-ancestor
138877879|NCT04008043|Dexamethasone|dexamethasone|mesh-list
138877880|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138877881|NCT04008043|Hydrocodone|hydrocodone|mesh-list
138877882|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138877883|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
138877884|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
138877885|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877886|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877887|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138877888|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
138877889|NCT04008043|Hormones|hormones|mesh-ancestor
138877890|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138877891|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138877892|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877893|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138877894|NCT04008043|Analgesics|analgesics|mesh-ancestor
138877895|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
138877896|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
138877897|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138877898|NCT04008043|Narcotics|narcotics|mesh-ancestor
138877899|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138877900|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
138877901|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
138877902|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138877903|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138877904|NCT02783183|Pregabalin|pregabalin|mesh-list
138877905|NCT02783183|Analgesics|analgesics|mesh-ancestor
138877906|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
138877907|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877908|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877909|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
138877910|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138877911|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138877912|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877913|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138877914|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138877915|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138877916|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138877917|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138877919|NCT00693381|Prednisone|prednisone|mesh-list
138877920|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
138877921|NCT00693381|Tacrolimus|tacrolimus|mesh-list
138877922|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138877923|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
138877924|NCT00693381|Hormones|hormones|mesh-ancestor
138877925|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138877926|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877927|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138877928|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877929|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138877930|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
138877931|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138877932|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138877933|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877934|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138877935|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138877936|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
138877937|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138877938|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138642925|NCT00297219|Calcium|calcium|mesh-list
138877940|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
138877941|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877942|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138877943|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138877944|NCT00693381|Protective Agents|protective agents|mesh-ancestor
138877945|NCT00693615|Vaccines|vaccines|mesh-list
138877946|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
138877947|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877948|NCT02663960|Citric Acid|citric acid|mesh-list
138877949|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
138877950|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
138877951|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138877952|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
138877953|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
138877954|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877955|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
138877956|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138877957|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877958|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138877959|NCT00693849|Sertraline|sertraline|mesh-list
138877960|NCT00693849|Escitalopram|escitalopram|mesh-list
138877961|NCT00693849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138877962|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138877963|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138877964|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877965|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138877966|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
138877967|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877968|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138877969|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
138877970|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138877971|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138877972|NCT00693927|Fludarabine|fludarabine|mesh-list
138877973|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138877974|NCT00648362|Glimepiride|glimepiride|mesh-list
138877975|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138877976|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138877977|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877978|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138877979|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
138877981|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
138877982|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
138877983|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138877984|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138877985|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138877986|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138877987|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138877988|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138877989|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
138877991|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138877992|NCT00694005|Sirolimus|sirolimus|mesh-list
138877993|NCT00694005|Paclitaxel|paclitaxel|mesh-list
138877994|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138877995|NCT00694005|Everolimus|everolimus|mesh-list
138877996|NCT00694005|Temsirolimus|temsirolimus|mesh-list
138877997|NCT00694005|MTOR Inhibitors|mtor inhibitors|mesh-list
138877998|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138877999|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878000|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
138878001|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
138878002|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138878003|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878004|NCT00694005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138878005|NCT00694005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878006|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138878007|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
138878008|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878009|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138878010|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878011|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138878012|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
138878014|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
138878015|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
138878016|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878017|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878018|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138878019|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138878020|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138878021|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
138878022|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878023|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878024|NCT00975325|Urological Agents|urological agents|mesh-ancestor
138878025|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138878026|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138878028|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138784690|NCT00608673|Hormones|hormones|mesh-ancestor
138878029|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878030|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
138878031|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
138530218|NCT00038831|Melphalan|melphalan|mesh-list
138878032|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138878033|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138878034|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878035|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878036|NCT00648596|Urological Agents|urological agents|mesh-ancestor
138878037|NCT03921151|Mirtazapine|mirtazapine|mesh-list
138878038|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
138878039|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138878040|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138878041|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
138878042|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
138878043|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878044|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878045|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878046|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138878047|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138878048|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878049|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138878050|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138878051|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138878052|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
138878053|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138878054|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138878055|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
138878056|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138878057|NCT04171388|Micronutrients|micronutrients|mesh-list
138878058|NCT04171388|Trace Elements|trace elements|mesh-list
138878059|NCT04171388|Azithromycin|azithromycin|mesh-list
138878060|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138878061|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878062|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878063|NCT00970411|Tivozanib|tivozanib|mesh-list
138878064|NCT00970411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138878065|NCT00970411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878066|NCT00970411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878067|NCT05341193|Bevacizumab|bevacizumab|mesh-list
138878068|NCT05341193|Gemcitabine|gemcitabine|mesh-list
138878069|NCT05341193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138878070|NCT05341193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878071|NCT05341193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138878072|NCT05341193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138810411|NCT04532463|Flucytosine|flucytosine|mesh-list
138878073|NCT05341193|Growth Substances|growth substances|mesh-ancestor
138878074|NCT05341193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878075|NCT05341193|Growth Inhibitors|growth inhibitors|mesh-ancestor
138878076|NCT05341193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138878077|NCT05341193|Antimetabolites|antimetabolites|mesh-ancestor
138878078|NCT05341193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878079|NCT04229459|Nivolumab|nivolumab|mesh-list
138878080|NCT04229459|Cetuximab|cetuximab|mesh-list
138878081|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878082|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138878083|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138784764|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784765|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138784766|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
138784767|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138784768|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784769|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138878084|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878085|NCT00980239|Bevacizumab|bevacizumab|mesh-list
138878086|NCT00980239|Cetuximab|cetuximab|mesh-list
138878087|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
138878088|NCT00980239|Irinotecan|irinotecan|mesh-list
138878089|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138878090|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810452|NCT04090021|Rifabutin|rifabutin|mesh-list
138878091|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138878092|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138878093|NCT00980239|Growth Substances|growth substances|mesh-ancestor
138878094|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878095|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
138878096|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138878097|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138878098|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878099|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878100|NCT02665832|Amlodipine|amlodipine|mesh-list
138878101|NCT02665832|Olmesartan|olmesartan|mesh-list
138878102|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138878104|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138878105|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138530299|NCT00072072|Analgesics|analgesics|mesh-ancestor
138878106|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878107|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138878108|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878109|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
138878110|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138784797|NCT03172780|Analgesics|analgesics|mesh-ancestor
138878111|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138878112|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
138878113|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138878114|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138878115|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878116|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138878117|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138878118|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
138878120|NCT02781467|Interleukin-2|interleukin-2|mesh-list
138878121|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138878122|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
138878123|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878124|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138878125|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138878126|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
138878127|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878128|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878129|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138878130|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138995597|NCT00105235|Tacrolimus|tacrolimus|mesh-list
138878132|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
138878133|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878134|NCT00648830|Clarithromycin|clarithromycin|mesh-list
138878135|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138878136|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878137|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138878138|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878139|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878140|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138878141|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138878142|NCT00970567|Insulin|insulin|mesh-list
138878143|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138878144|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878145|NCT02663570|Melatonin|melatonin|mesh-list
138878146|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
138878147|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810675|NCT02759991|Vaccines|vaccines|mesh-list
138878148|NCT02663570|Protective Agents|protective agents|mesh-ancestor
138878149|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878150|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878152|NCT00980473|Travoprost|travoprost|mesh-list
138878153|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138878154|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138878155|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
138810721|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
138878156|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878157|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878158|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878159|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138878160|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138878161|NCT02784743|Ivermectin|ivermectin|mesh-list
138878162|NCT02784743|Albendazole|albendazole|mesh-list
138878163|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138878164|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878165|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
138878166|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
138878167|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138878168|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138878169|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
138878170|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
138878171|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
138878172|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878173|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878175|NCT00980551|Vincristine|vincristine|mesh-list
138878176|NCT00980551|Topotecan|topotecan|mesh-list
138878177|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878178|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138878179|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
138878180|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
138878181|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
138878182|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878183|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138878184|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138878185|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878186|NCT02660060|Pramipexole|pramipexole|mesh-list
138878187|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
138878188|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878189|NCT02660060|Protective Agents|protective agents|mesh-ancestor
138878190|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878191|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138878192|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138878193|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
138878194|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
138878195|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878196|NCT04008979|Aspirin|aspirin|mesh-list
138878197|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138878198|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138878199|NCT04008979|Analgesics|analgesics|mesh-ancestor
138878200|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
138878201|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878202|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878203|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138878204|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138878205|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138878206|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138878207|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878208|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138878209|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138878210|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878213|NCT05263583|Anticonvulsants|anticonvulsants|mesh-ancestor
138878214|NCT00970879|Mefloquine|mefloquine|mesh-list
138878215|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138878216|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
138878217|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138878218|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138878219|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878220|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138878221|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138878222|NCT05340803|Magnesium Sulfate|magnesium sulfate|mesh-list
138878224|NCT05340803|Dexmedetomidine|dexmedetomidine|mesh-list
138878225|NCT05340803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138878226|NCT05340803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878227|NCT05340803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878228|NCT05340803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138878229|NCT05340803|Analgesics|analgesics|mesh-ancestor
138878230|NCT05340803|Sensory System Agents|sensory system agents|mesh-ancestor
138878231|NCT05340803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878232|NCT05340803|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138878233|NCT05340803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138878234|NCT05340803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138878235|NCT05340803|Adrenergic Agents|adrenergic agents|mesh-ancestor
138878236|NCT05340803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878237|NCT05340803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878238|NCT05340803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138878239|NCT05340803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138878240|NCT05340803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138878241|NCT05340803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138878242|NCT05340803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138878243|NCT05340803|Anesthetics, General|anesthetics, general|mesh-ancestor
138878244|NCT05340803|Anesthetics|anesthetics|mesh-ancestor
138878245|NCT05340803|GABA Modulators|gaba modulators|mesh-ancestor
138878246|NCT05340803|GABA Agents|gaba agents|mesh-ancestor
138878247|NCT05340803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138878248|NCT05340803|Anticonvulsants|anticonvulsants|mesh-ancestor
138878250|NCT05340803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138878251|NCT05340803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138878252|NCT05340803|Tocolytic Agents|tocolytic agents|mesh-ancestor
138878253|NCT05340803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138878254|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
138878255|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138878256|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878257|NCT02663258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138878258|NCT02663258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878259|NCT04033172|Fulvestrant|fulvestrant|mesh-list
138878260|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138878261|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878262|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138878263|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138878264|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
138811084|NCT04217265|Letrozole|letrozole|mesh-list
138878265|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138878266|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878268|NCT00980707|Xhance|xhance|mesh-list
138878269|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138878270|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138878271|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
138878272|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878273|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878274|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138878275|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
138878276|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
138878277|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138878278|NCT05340725|Dexmedetomidine|dexmedetomidine|mesh-list
138878279|NCT05340725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138878280|NCT05340725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878281|NCT05340725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878282|NCT05340725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138878283|NCT05340725|Analgesics|analgesics|mesh-ancestor
138811195|NCT04138875|Immunotoxins|immunotoxins|mesh-ancestor
138878284|NCT05340725|Sensory System Agents|sensory system agents|mesh-ancestor
138878285|NCT05340725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653851|NCT06024174|Cetuximab|cetuximab|mesh-list
138878286|NCT05340725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138878287|NCT05340725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138878288|NCT05340725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138878289|NCT05340725|Adrenergic Agents|adrenergic agents|mesh-ancestor
138878290|NCT05340725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878291|NCT05340725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878292|NCT00970957|Bevacizumab|bevacizumab|mesh-list
138878293|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138878294|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878295|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138878296|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138878297|NCT00970957|Growth Substances|growth substances|mesh-ancestor
138878298|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878299|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
138878300|NCT00976105|Zolpidem|zolpidem|mesh-list
138878301|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138878302|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138878303|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878304|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878305|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138878306|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
138878307|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
138878308|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878309|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878310|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138878311|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138878312|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878313|NCT00976261|Incretins|incretins|mesh-ancestor
138878314|NCT00976261|Hormones|hormones|mesh-ancestor
138878315|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138878316|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138878317|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
138995686|NCT00502203|Paclitaxel|paclitaxel|mesh-list
138878318|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878319|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878320|NCT02662712|JNJ-56136379|jnj-56136379|mesh-list
138878321|NCT02662712|Antiviral Agents|antiviral agents|mesh-ancestor
138878322|NCT02662712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878323|NCT00976651|Menotropins|menotropins|mesh-list
138878324|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138878325|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
138878326|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138878327|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878328|NCT00971581|Ketoprofen|ketoprofen|mesh-list
138878329|NCT00971581|Omeprazole|omeprazole|mesh-list
138878330|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138878331|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138878332|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138811353|NCT00839254|Vaccines|vaccines|mesh-list
138878334|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878335|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138878336|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138878337|NCT00971581|Analgesics|analgesics|mesh-ancestor
138878338|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
138878339|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878340|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878341|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138878342|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138878343|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138878344|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138878345|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878346|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878347|NCT00971659|Insulin|insulin|mesh-list
138878348|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138878349|NCT00971659|Metformin|metformin|mesh-list
138878350|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
138878351|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138878352|NCT00971659|Exenatide|exenatide|mesh-list
138878353|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138811426|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
138878354|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878355|NCT00971659|Incretins|incretins|mesh-ancestor
138878356|NCT00971659|Hormones|hormones|mesh-ancestor
138878357|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138878358|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138878359|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
138878360|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878361|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878363|NCT00648986|Tazarotene|tazarotene|mesh-list
138878364|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
138878365|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
138878366|NCT00971815|Dexetimide|dexetimide|mesh-list
138878367|NCT00971815|Citalopram|citalopram|mesh-list
138878368|NCT00971815|Escitalopram|escitalopram|mesh-list
138878369|NCT00971815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138878370|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138878371|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138878372|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878373|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878374|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
138878375|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878376|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138878377|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138878378|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
138878379|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
138878380|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878381|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138878382|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138878383|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
138878384|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138878385|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
138878386|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138878387|NCT00981487|Ondansetron|ondansetron|mesh-list
138878388|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
138878389|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
138878390|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878391|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878392|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138878393|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
138878394|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
138878395|NCT00981487|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138878396|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138878397|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
138878398|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878399|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878400|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138878401|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138878402|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878403|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
138878404|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138878405|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138878407|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
138878408|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138878409|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
138878410|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138878411|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
138878412|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
138878413|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878414|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878415|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138878416|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
138878417|NCT00971893|Hormones|hormones|mesh-ancestor
138878418|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138878419|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138878420|NCT00971893|Protective Agents|protective agents|mesh-ancestor
138878421|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138878422|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878424|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138878425|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
138785389|NCT02699710|Hematinics|hematinics|mesh-ancestor
138878426|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878427|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878428|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138878429|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138878430|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
138878431|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878432|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878434|NCT00977353|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138878435|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138995752|NCT00501969|Rotigotine|rotigotine|mesh-list
138878436|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138878437|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878438|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878439|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
138878440|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878441|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138878442|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
138878443|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138878444|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138878445|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878446|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138878447|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878448|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878449|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
138878450|NCT04170530|Irinotecan|irinotecan|mesh-list
138878451|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878452|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138878453|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138878454|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878455|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878456|NCT02617017|Buspirone|buspirone|mesh-list
138811799|NCT05917340|Antipyretics|antipyretics|mesh-ancestor
138878457|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138878458|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138878459|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878460|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878461|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138878462|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138878463|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
138878464|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138811844|NCT05827055|Antimitotic Agents|antimitotic agents|mesh-ancestor
138878465|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878466|NCT02616861|Praliciguat|praliciguat|mesh-list
138878467|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138878468|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
138878469|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878470|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138878471|NCT00981721|Cediranib|cediranib|mesh-list
138878472|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878473|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138878474|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878475|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878476|NCT04133337|Apatinib|apatinib|mesh-list
138878477|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878478|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138878479|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878480|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878481|NCT04133259|Tenofovir|tenofovir|mesh-list
138878482|NCT04133259|Entecavir|entecavir|mesh-list
138878483|NCT04133259|Antibodies|antibodies|mesh-list
138878484|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138878485|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
138878486|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878487|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
138878488|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878489|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138878490|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138878491|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878492|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878493|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138878494|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138878495|NCT02616315|Naltrexone|naltrexone|mesh-list
138878496|NCT02616315|Bupropion|bupropion|mesh-list
138878497|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138878498|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138878499|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878500|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
138878501|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878502|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138878503|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
138878504|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138878505|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138878506|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138878507|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138878508|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878510|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878511|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138878512|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138878513|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878514|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
138878515|NCT02779283|Leucovorin|leucovorin|mesh-list
138878516|NCT02779283|Folic Acid|folic acid|mesh-list
138878517|NCT02779283|Cytarabine|cytarabine|mesh-list
138878518|NCT02779283|Dexamethasone|dexamethasone|mesh-list
138878519|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
138878520|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138878521|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138878522|NCT02779283|Prednisolone|prednisolone|mesh-list
138878523|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
138878524|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
138878525|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
138878526|NCT02779283|Rituximab|rituximab|mesh-list
138878527|NCT02779283|Doxorubicin|doxorubicin|mesh-list
138878528|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138878529|NCT02779283|Methotrexate|methotrexate|mesh-list
138878530|NCT02779283|Vincristine|vincristine|mesh-list
138878531|NCT02779283|Sorafenib|sorafenib|mesh-list
138878532|NCT02779283|Sunitinib|sunitinib|mesh-list
138878533|NCT02779283|Dasatinib|dasatinib|mesh-list
138878534|NCT02779283|Idarubicin|idarubicin|mesh-list
138878535|NCT02779283|Ponatinib|ponatinib|mesh-list
138878536|NCT02779283|Idelalisib|idelalisib|mesh-list
138878537|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138878538|NCT02779283|Antibodies|antibodies|mesh-list
138878539|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
138878540|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138878541|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138878542|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
138878543|NCT02779283|BB 1101|bb 1101|mesh-list
138878544|NCT02779283|Calcium|calcium|mesh-list
138878545|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
138878546|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138878547|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
138878548|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878549|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138878550|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138878551|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
138878552|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878553|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878554|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138878555|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138878556|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
138878557|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
138878558|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878559|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138878560|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
138878562|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138878563|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138878564|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138878565|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138878566|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138878567|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878568|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138995769|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
138878569|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138878570|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138878571|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
138878572|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138878573|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138878575|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
138878576|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138878577|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138878578|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
138878579|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878580|NCT02779283|Antidotes|antidotes|mesh-ancestor
138878581|NCT02779283|Protective Agents|protective agents|mesh-ancestor
138878582|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
138878583|NCT02779283|Vitamins|vitamins|mesh-ancestor
138878584|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
138878585|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138878586|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
138878587|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
138878588|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
138878589|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138878591|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138878592|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138878593|NCT02779283|Growth Substances|growth substances|mesh-ancestor
138878594|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
138878595|NCT02779283|Hematinics|hematinics|mesh-ancestor
138878596|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
138878597|NCT02616003|Liraglutide|liraglutide|mesh-list
138878598|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138878599|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878600|NCT02616003|Incretins|incretins|mesh-ancestor
138878601|NCT02616003|Hormones|hormones|mesh-ancestor
138878602|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138878603|NCT02661152|Nimorazole|nimorazole|mesh-list
138878604|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138878605|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138878606|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138878607|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878608|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
138878609|NCT00697671|Etoposide|etoposide|mesh-list
138878610|NCT00697671|Interleukin-2|interleukin-2|mesh-list
138878611|NCT00697671|Clofarabine|clofarabine|mesh-list
138878612|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138878613|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
138878614|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878615|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138878616|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138878617|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
138878618|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878619|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878620|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138878621|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138878622|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138878623|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138878624|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878625|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138878626|NCT00697671|Analgesics|analgesics|mesh-ancestor
138878627|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
138785796|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
138878628|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878629|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138878630|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
138878631|NCT03922945|Topiramate|topiramate|mesh-list
138878632|NCT03922945|Phentermine|phentermine|mesh-list
138878633|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
138878634|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138878635|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878636|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138878637|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
138878638|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138878639|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
138878640|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
138878641|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878642|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
138878643|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878644|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878646|NCT05236985|Oxytocics|oxytocics|mesh-ancestor
138878647|NCT05236985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138878648|NCT05236985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878649|NCT03922477|Atezolizumab|atezolizumab|mesh-list
138878650|NCT03922477|Magrolimab|magrolimab|mesh-list
138878651|NCT03922477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138878652|NCT03922477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878653|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138878654|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878655|NCT00978211|Octreotide|octreotide|mesh-list
138878656|NCT00978211|Somatostatin|somatostatin|mesh-list
138878657|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138878658|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138878659|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878660|NCT00978211|Hormones|hormones|mesh-ancestor
138878661|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138878662|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878663|NCT00867165|Ezetimibe|ezetimibe|mesh-list
138878664|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138878665|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138878666|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
138878667|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878669|NCT00981955|Caffeine|caffeine|mesh-list
138878670|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138878671|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878672|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138878673|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812571|NCT03642509|Apixaban|apixaban|mesh-list
138878674|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878675|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138878676|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138878677|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
138878678|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878679|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138878680|NCT00972829|Ezetimibe|ezetimibe|mesh-list
138878681|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138878682|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138878683|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
138878684|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878685|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138878686|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138878687|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878688|NCT00972907|Nifedipine|nifedipine|mesh-list
138878689|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138878690|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138878691|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812615|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
138878692|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138878693|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878694|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
138878695|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
138878696|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138878697|NCT04008433|Lidocaine|lidocaine|mesh-list
138878698|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
138878699|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
138878700|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878701|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878702|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
138878703|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878704|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138878705|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138530899|NCT00040391|Antidotes|antidotes|mesh-ancestor
138878706|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138878707|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138878708|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878709|NCT04132479|Amoxicillin|amoxicillin|mesh-list
138878710|NCT04132479|Clarithromycin|clarithromycin|mesh-list
138878712|NCT04132479|Rabeprazole|rabeprazole|mesh-list
138878713|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138878714|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878715|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138878716|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878717|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878718|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138878719|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138878720|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138878721|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138878722|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138878723|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
138878724|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138878725|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138878726|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138878727|NCT00972985|Lorazepam|lorazepam|mesh-list
138878728|NCT00972985|Methylphenidate|methylphenidate|mesh-list
138878729|NCT00972985|Modafinil|modafinil|mesh-list
138812724|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
138878730|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138878731|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878732|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138878733|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138878734|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138878735|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878737|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878738|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138878739|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138878740|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138878741|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
138878742|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
138878743|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
138878744|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878745|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138878746|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138878747|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878748|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138878749|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138878750|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138878751|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
138878752|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
138878753|NCT00867087|Rituximab|rituximab|mesh-list
138878754|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138878755|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138878756|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878757|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
138878758|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878759|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138786095|NCT04252443|Narcotics|narcotics|mesh-ancestor
138878760|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138878762|NCT00867087|Immunoconjugates|immunoconjugates|mesh-ancestor
138878763|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138878764|NCT02778425|Somatostatin|somatostatin|mesh-list
138878765|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138878766|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
138878767|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878768|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878769|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878770|NCT02778425|Hormones|hormones|mesh-ancestor
138878771|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138878772|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
138878773|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138878774|NCT04228757|Estrogens|estrogens|mesh-ancestor
138878775|NCT04228757|Hormones|hormones|mesh-ancestor
138878776|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138878777|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878778|NCT04227431|Insulin|insulin|mesh-list
138878779|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138878780|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878782|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138878783|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
138878784|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995930|NCT00492063|Vaccines|vaccines|mesh-list
138878786|NCT00545233|Pioglitazone|pioglitazone|mesh-list
138878787|NCT00545233|Ribavirin|ribavirin|mesh-list
138878788|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138878789|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
138812835|NCT02631746|Nivolumab|nivolumab|mesh-list
138878790|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878791|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
138878792|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878793|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138878794|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878795|NCT02393248|Gemcitabine|gemcitabine|mesh-list
138878796|NCT02393248|Docetaxel|docetaxel|mesh-list
138878797|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
138878798|NCT02393248|Trastuzumab|trastuzumab|mesh-list
138878799|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878800|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138878801|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
138878802|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878803|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
138878804|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
138878805|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
138878806|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138878807|NCT02393248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138878808|NCT00601484|Tanezumab|tanezumab|mesh-list
138878809|NCT00601484|Analgesics|analgesics|mesh-ancestor
138878810|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
138878811|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878812|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878813|NCT04228601|Fluzoparib|fluzoparib|mesh-list
139210402|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138878814|NCT04228601|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138878815|NCT04228601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878816|NCT04228601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878817|NCT04228601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878819|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
138878820|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878821|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878822|NCT00883896|Fezakinumab|fezakinumab|mesh-list
138878823|NCT00883896|Dermatologic Agents|dermatologic agents|mesh-ancestor
138878824|NCT02778191|Carboplatin|carboplatin|mesh-list
138878825|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878826|NCT05170685|Nivolumab|nivolumab|mesh-list
138878827|NCT05170685|Relatlimab|relatlimab|mesh-list
138878828|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138878829|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878830|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138878831|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878832|NCT02778893|Thalidomide|thalidomide|mesh-list
138878833|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138878834|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
138878835|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878836|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
138878837|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138878838|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878839|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138878840|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138878841|NCT02778893|Growth Substances|growth substances|mesh-ancestor
138878842|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
138878843|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878844|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138878845|NCT02671864|Incretins|incretins|mesh-list
138878846|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878847|NCT02671864|Hormones|hormones|mesh-ancestor
138878848|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138878849|NCT00867009|Pemetrexed|pemetrexed|mesh-list
138878850|NCT00867009|Cetuximab|cetuximab|mesh-list
138878851|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878852|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878853|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878854|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138878855|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138878856|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138878858|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138878859|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138878860|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138878861|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138878862|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878863|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138878864|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138878865|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878866|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878867|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878868|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138878869|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
138878870|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138878871|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878872|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138878873|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138878874|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138878875|NCT02660840|Flupenthixol|flupenthixol|mesh-list
138878876|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
138878877|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138878878|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138878879|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878880|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878881|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138878882|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138878883|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
138878884|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878885|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878886|NCT02777801|Entecavir|entecavir|mesh-list
138878887|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
138878888|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138878889|NCT00649064|Ziprasidone|ziprasidone|mesh-list
138878890|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138878891|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
138878892|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878893|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878894|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878895|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138878896|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138878897|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878898|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138878899|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138878900|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
138878901|NCT04132713|Capecitabine|capecitabine|mesh-list
138878902|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138878903|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
138878904|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878905|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138878906|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
138878907|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138878908|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878909|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878910|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138878911|NCT04007341|Analgesics|analgesics|mesh-ancestor
138878912|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
138878913|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878914|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138878915|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138878916|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138878917|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
138878918|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813063|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
138878919|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878920|NCT02656082|Etanercept|etanercept|mesh-list
138878921|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138878922|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138878923|NCT02656082|Analgesics|analgesics|mesh-ancestor
138878924|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
138878925|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878926|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878927|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138813115|NCT00744055|Prazosin|prazosin|mesh-list
138878928|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138878929|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138878930|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138878931|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
138878932|NCT04132635|Mitogens|mitogens|mesh-list
138878933|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
138878934|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878935|NCT02623504|Carbamazepine|carbamazepine|mesh-list
138878936|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
138878937|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
138878938|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138878939|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878940|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786502|NCT02996110|Nivolumab|nivolumab|mesh-list
138878941|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138878942|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138878943|NCT02623504|Analgesics|analgesics|mesh-ancestor
138878944|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
138878945|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878946|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138878947|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138878948|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878949|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138878950|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138878951|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
138878952|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138813194|NCT00734929|Dexamethasone|dexamethasone|mesh-list
138878953|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
138878954|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878955|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
138878956|NCT02777723|Protective Agents|protective agents|mesh-ancestor
138878957|NCT00601250|Linagliptin|linagliptin|mesh-list
138878958|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138878959|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878960|NCT00601250|Incretins|incretins|mesh-ancestor
138878961|NCT00601250|Hormones|hormones|mesh-ancestor
139210403|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878962|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138878963|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138878965|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138878966|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878967|NCT04226885|Midazolam|midazolam|mesh-list
138878968|NCT04226885|Fentanyl|fentanyl|mesh-list
138878969|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
138878970|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138878971|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138878972|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138878973|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138878974|NCT04226885|Analgesics|analgesics|mesh-ancestor
138878975|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
138878976|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138878977|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138878978|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138786561|NCT04213924|Analgesics|analgesics|mesh-ancestor
138878979|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138878980|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
138878981|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138878982|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138878983|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138878984|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138878985|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138878986|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138878987|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138878988|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
138878990|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
138878991|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
138878992|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138878993|NCT04226885|Narcotics|narcotics|mesh-ancestor
138878994|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138878995|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
138878996|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138878997|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138878998|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138878999|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879000|NCT02777411|Vaccines|vaccines|mesh-list
138879001|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
138879002|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531198|NCT00041015|Etoposide|etoposide|mesh-list
138879003|NCT02777489|Perindopril|perindopril|mesh-list
138879004|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138879005|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
138879007|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879008|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138879009|NCT02660762|Cytarabine|cytarabine|mesh-list
138879010|NCT02660762|Dexamethasone|dexamethasone|mesh-list
138879011|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
138879012|NCT02660762|Prednisone|prednisone|mesh-list
138879013|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
138879014|NCT02660762|Methotrexate|methotrexate|mesh-list
138879015|NCT02660762|Etoposide|etoposide|mesh-list
138879016|NCT02660762|Vincristine|vincristine|mesh-list
138879017|NCT02660762|Daunorubicin|daunorubicin|mesh-list
138879018|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
138879019|NCT02660762|Pegaspargase|pegaspargase|mesh-list
138879020|NCT02660762|Thioguanine|thioguanine|mesh-list
138879021|NCT02660762|BB 1101|bb 1101|mesh-list
138879022|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138786646|NCT00918333|Everolimus|everolimus|mesh-list
138879023|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
138879024|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879025|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138879026|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138879027|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
138879028|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879029|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879030|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138879031|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138879032|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
138879033|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
138879034|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879035|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138879036|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
138879037|NCT02660762|Hormones|hormones|mesh-ancestor
138879038|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138879039|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138879040|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
138879041|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879042|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138879043|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
138879044|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138879045|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138879046|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
138879047|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
138879048|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138879049|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138879050|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138879051|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138879052|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138879053|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
138879054|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138879055|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
138879056|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
138879057|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
138879058|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138879059|NCT02660684|Cyclosporine|cyclosporine|mesh-list
138879060|NCT02660684|Methotrexate|methotrexate|mesh-list
138879061|NCT02660684|Tacrolimus|tacrolimus|mesh-list
138879062|NCT02660684|Cyclosporins|cyclosporins|mesh-list
138879063|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138879064|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
138879065|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138879066|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879067|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138879068|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
138879069|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879070|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879071|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
138879072|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879073|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138879074|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138879075|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
138879076|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138879077|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138879078|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138879079|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
138786803|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
138786804|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138786805|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138786806|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786807|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138786808|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786809|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138786810|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138786811|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138879080|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138879082|NCT00982891|Hydromorphone|hydromorphone|mesh-list
138879083|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138879084|NCT00982891|Narcotics|narcotics|mesh-ancestor
138879085|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138879086|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879087|NCT00982891|Analgesics|analgesics|mesh-ancestor
138879088|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
138879089|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879090|NCT02615223|Bicalutamide|bicalutamide|mesh-list
138879091|NCT02615223|Hormones|hormones|mesh-list
138879092|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138813481|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
138879093|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138879094|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879095|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
138879096|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
138879097|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879098|NCT04132557|Methylphenidate|methylphenidate|mesh-list
138879099|NCT04132557|Amphetamine|amphetamine|mesh-list
138879100|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138879101|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
138879102|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138879103|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138879104|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879105|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138879106|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138879107|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138879108|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879109|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
138879110|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879111|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138879112|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
138879113|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
138879114|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
138879115|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879116|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
138879118|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
138879119|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879120|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138879122|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138879123|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
138879124|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879125|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879126|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138879127|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
138879128|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138879129|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879130|NCT04227509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138879131|NCT04227509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879133|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138879134|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138879135|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138879136|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879137|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138879138|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
138879139|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
138879140|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879141|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879142|NCT04072900|Imiquimod|imiquimod|mesh-list
138879143|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138879144|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
138879145|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879146|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879147|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
138879148|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138879149|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138879150|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
138879151|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879152|NCT00984763|Antacids|antacids|mesh-ancestor
138879153|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531348|NCT00209677|Gemcitabine|gemcitabine|mesh-list
138879154|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138879155|NCT02578108|Lidocaine|lidocaine|mesh-list
138879156|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
138879157|NCT02578108|Anesthetics|anesthetics|mesh-list
138879158|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138879159|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879160|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
138879161|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879162|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138879163|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138879164|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138879165|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138879166|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879167|NCT02776163|Docetaxel|docetaxel|mesh-list
138879168|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879169|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
138879170|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
138879171|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
138879172|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879173|NCT05325346|Argatroban|argatroban|mesh-list
138879174|NCT05325346|Antithrombins|antithrombins|mesh-ancestor
138879175|NCT05325346|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138879176|NCT05325346|Protease Inhibitors|protease inhibitors|mesh-ancestor
138879177|NCT05325346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879178|NCT05325346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879179|NCT05325346|Anticoagulants|anticoagulants|mesh-ancestor
138879180|NCT05325346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138879181|NCT00984997|Etoposide|etoposide|mesh-list
138879182|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879183|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138879184|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138879185|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138879187|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879188|NCT00973219|Interferons|interferons|mesh-list
138879190|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
138879191|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
138879192|NCT00973219|Adefovir|adefovir|mesh-list
138879193|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138879194|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138879195|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879196|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
138813894|NCT02720601|Capecitabine|capecitabine|mesh-list
138879198|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138879199|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138879200|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879201|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879202|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138879203|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138879204|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
138879205|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996096|NCT00972660|Prednisone|prednisone|mesh-list
138879206|NCT04194125|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
138879207|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138787136|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879208|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879209|NCT04973891|Metformin|metformin|mesh-list
138879210|NCT04973891|Canagliflozin|canagliflozin|mesh-list
138879211|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138879212|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879213|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138879214|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879215|NCT00983047|Docetaxel|docetaxel|mesh-list
138879216|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
138879217|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879218|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
138879219|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
138879220|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
138879221|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879222|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138879223|NCT00983125|Clonidine|clonidine|mesh-list
138879224|NCT00983125|Analgesics|analgesics|mesh-ancestor
138879225|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
138879226|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879227|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879228|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138879229|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
138879230|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
138879231|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138879232|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138879233|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138879234|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
138879235|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879236|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879237|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
138879238|NCT00988039|Lopinavir|lopinavir|mesh-list
138879239|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138879240|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138879241|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
138879242|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138879243|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138879244|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138879245|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879246|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879247|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138879248|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138879249|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
138879250|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138879251|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138879253|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138879254|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879255|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
138879257|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
138879258|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138879259|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879260|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138879261|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138879262|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879263|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
138879264|NCT02775773|Coagulants|coagulants|mesh-ancestor
138879265|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138879266|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
138879267|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138879268|NCT00988195|Doxorubicin|doxorubicin|mesh-list
138879269|NCT00988195|BCT-100|bct-100|mesh-list
138879270|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138879271|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879272|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138879273|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138814184|NCT02716233|Asparaginase|asparaginase|mesh-list
138879274|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879275|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879276|NCT00634985|Eletriptan|eletriptan|mesh-list
138879277|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138879278|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
138879279|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879280|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879281|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879282|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
138879283|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138879284|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138879285|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
138879286|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879287|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879288|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879289|NCT00985387|Urological Agents|urological agents|mesh-ancestor
138996172|NCT00966576|Timolol|timolol|mesh-list
138879290|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
138879291|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138879292|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
138879293|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879294|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
138879295|NCT02776943|Protective Agents|protective agents|mesh-ancestor
138879296|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
138879297|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
138879298|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138879299|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138879300|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138879301|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879302|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879303|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138879304|NCT04654351|Icatibant|icatibant|mesh-list
138879306|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138879307|NCT04654351|Analgesics|analgesics|mesh-ancestor
138879308|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
138814306|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879309|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879310|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879311|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138879312|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138879313|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138879314|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138879315|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879316|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138879317|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138879318|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
138879319|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
138879320|NCT00582556|Leuprolide|leuprolide|mesh-list
138879321|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138879322|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879323|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138879324|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
138879325|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138879326|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138879327|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879328|NCT02776397|Vitamin E|vitamin e|mesh-list
138879329|NCT02776397|Tocopherols|tocopherols|mesh-list
138879330|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
138879331|NCT02776397|Vitamins|vitamins|mesh-ancestor
138879332|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
138879333|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879334|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
138879335|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879336|NCT02776397|Protective Agents|protective agents|mesh-ancestor
138879337|NCT00985777|Vitamin E|vitamin e|mesh-list
138879338|NCT00985777|Tocopherols|tocopherols|mesh-list
138879339|NCT00985777|Tocotrienols|tocotrienols|mesh-list
138879340|NCT00985777|Vitamins|vitamins|mesh-ancestor
138879341|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
138879342|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879343|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
138879344|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879345|NCT00985777|Protective Agents|protective agents|mesh-ancestor
138879346|NCT01563601|Carboplatin|carboplatin|mesh-list
138879347|NCT01563601|Etoposide|etoposide|mesh-list
138879348|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
138879349|NCT01563601|Obatoclax|obatoclax|mesh-list
138787313|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
138879350|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879351|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138879352|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138879353|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138879354|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879355|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879356|NCT00988507|Artesunate|artesunate|mesh-list
138879357|NCT00988507|Ferroquine|ferroquine|mesh-list
138879358|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
138879359|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138879360|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138879361|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138879362|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879363|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
138879364|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
138879365|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138879366|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
138879367|NCT00985855|Etoposide|etoposide|mesh-list
138879368|NCT00985855|Cetuximab|cetuximab|mesh-list
138879369|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879370|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138814414|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
138879371|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138879372|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138879373|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879374|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879375|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138879376|NCT04226105|Insulin|insulin|mesh-list
138879377|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138879378|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
138879379|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
138879380|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138787401|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138879381|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138879382|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138879383|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879385|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
138879386|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
138879387|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138879388|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879389|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
138879390|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879391|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138879392|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138879393|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138879394|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138879395|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879396|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138879397|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
138814454|NCT02609698|Aspirin|aspirin|mesh-list
138879398|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879399|NCT00542269|Amlodipine|amlodipine|mesh-list
138879400|NCT00542269|Ramipril|ramipril|mesh-list
138879401|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138879402|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138879403|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138996205|NCT04008888|Dexamethasone|dexamethasone|mesh-list
138879404|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879405|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138879406|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879407|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
138879408|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138879409|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
138879410|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879411|NCT02579434|Midazolam|midazolam|mesh-list
138879412|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138879413|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138879414|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138879415|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879416|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138879417|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138879418|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138879419|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138814510|NCT00611169|Tirofiban|tirofiban|mesh-list
138879420|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
138879422|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
138879423|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
138879424|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879425|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879426|NCT00542191|Paclitaxel|paclitaxel|mesh-list
138879427|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
138879428|NCT00542191|Carboplatin|carboplatin|mesh-list
138879429|NCT00542191|Doxorubicin|doxorubicin|mesh-list
138879430|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138879431|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879432|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
138879433|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
138879434|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
138879435|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879436|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138879437|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
138879438|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879439|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138879440|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138879441|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
138879442|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138879443|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138879444|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138879445|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138879446|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879447|NCT00600938|Deferasirox|deferasirox|mesh-list
138879448|NCT00600938|Deferoxamine|deferoxamine|mesh-list
138879449|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138879450|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
138879451|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
138879452|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879453|NCT00600938|Siderophores|siderophores|mesh-ancestor
138879454|NCT00988663|Memantine|memantine|mesh-list
138879455|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138879456|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138879457|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
138879458|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879459|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879460|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879461|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138879462|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138879463|NCT04072198|Leucovorin|leucovorin|mesh-list
138879464|NCT04072198|Bevacizumab|bevacizumab|mesh-list
138879465|NCT04072198|Nivolumab|nivolumab|mesh-list
138879466|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
138879467|NCT04072198|Irinotecan|irinotecan|mesh-list
138879468|NCT04072198|Fluorouracil|fluorouracil|mesh-list
138879469|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138879470|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879471|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138879472|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138879473|NCT04072198|Growth Substances|growth substances|mesh-ancestor
138879474|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879475|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
138879476|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138879477|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879478|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138879479|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138879480|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879482|NCT04072198|Protective Agents|protective agents|mesh-ancestor
138879483|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
138879484|NCT04072198|Vitamins|vitamins|mesh-ancestor
138879485|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
138879486|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
138879487|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138879488|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138879489|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
138879490|NCT02772419|Benralizumab|benralizumab|mesh-list
138879491|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138879492|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
138879493|NCT00543439|Factor VIII|factor viii|mesh-list
138879494|NCT00543439|Coagulants|coagulants|mesh-ancestor
138879495|NCT02772497|Aflibercept|aflibercept|mesh-list
138879496|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138879497|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138879498|NCT02772497|Growth Substances|growth substances|mesh-ancestor
138879499|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879501|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879502|NCT00582166|Rituximab|rituximab|mesh-list
138879503|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138879504|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138879505|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879506|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
138879507|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879508|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138879509|NCT02775539|Mirabegron|mirabegron|mesh-list
138879510|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138879511|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138879512|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138879513|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
138879514|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501226|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138879515|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879516|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879517|NCT02775539|Urological Agents|urological agents|mesh-ancestor
138879518|NCT04840459|Bamlanivimab|bamlanivimab|mesh-list
138879519|NCT04840459|Antiviral Agents|antiviral agents|mesh-ancestor
138879520|NCT04840459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138879521|NCT04666961|Tamoxifen|tamoxifen|mesh-list
138996247|NCT00545064|Timolol|timolol|mesh-list
138879523|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138879524|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
138879525|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138879526|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879527|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138879528|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531737|NCT00211432|Anecortave|anecortave|mesh-list
138879529|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138879530|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138879531|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138879532|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138879533|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138879534|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879535|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879536|NCT04006639|Analgesics|analgesics|mesh-list
138879537|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
138879538|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879539|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879540|NCT00601172|Dexamethasone|dexamethasone|mesh-list
138879541|NCT00601172|Ondansetron|ondansetron|mesh-list
138879542|NCT00601172|Casopitant|casopitant|mesh-list
138879543|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138879544|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
138879545|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
138879546|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879547|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879548|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138879549|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
138879550|NCT00601172|Hormones|hormones|mesh-ancestor
138501271|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138879551|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138879552|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138879553|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879555|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
138879556|NCT00601172|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138879557|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138879558|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
138879559|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996251|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138879560|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879561|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138879562|NCT02772107|Temozolomide|temozolomide|mesh-list
138879563|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138814804|NCT00726895|Analgesics|analgesics|mesh-ancestor
138879564|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
138879565|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879567|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138879568|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
138879569|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138879570|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138879571|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138879572|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814863|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
138879573|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879575|NCT00988897|Bevacizumab|bevacizumab|mesh-list
138879576|NCT00988897|Fluorouracil|fluorouracil|mesh-list
138879577|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
138879578|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138879579|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879580|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138879581|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138879582|NCT00988897|Growth Substances|growth substances|mesh-ancestor
138879583|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879584|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
138879585|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
138814929|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
138879586|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879587|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138879588|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138879590|NCT00988897|Antidotes|antidotes|mesh-ancestor
138879591|NCT00988897|Protective Agents|protective agents|mesh-ancestor
138879592|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
138879593|NCT00988897|Vitamins|vitamins|mesh-ancestor
138879594|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
138879595|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
138879596|NCT02775227|Pasireotide|pasireotide|mesh-list
138879597|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138879598|NCT02775227|Hormones|hormones|mesh-ancestor
138879599|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138879600|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879601|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
138879602|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138879603|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814991|NCT02607982|Paclitaxel|paclitaxel|mesh-list
138879604|NCT02875132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138879605|NCT02875132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879607|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138879608|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879609|NCT00989053|Escitalopram|escitalopram|mesh-list
138879610|NCT00989053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138879611|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138879612|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138815046|NCT00803452|Azithromycin|azithromycin|mesh-list
138879613|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879615|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
138879616|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879617|NCT04614493|Temozolomide|temozolomide|mesh-list
138879618|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138879619|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
138879620|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879621|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879623|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138879624|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879625|NCT02841748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138879626|NCT02841748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879627|NCT04033094|Morphine|morphine|mesh-list
138879628|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138879629|NCT04033094|Narcotics|narcotics|mesh-ancestor
138879630|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138879631|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879632|NCT04033094|Analgesics|analgesics|mesh-ancestor
138879633|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
138879634|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501577|NCT00000563|Hormones|hormones|mesh-ancestor
138879635|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
138879636|NCT04073758|Remifentanil|remifentanil|mesh-list
138879637|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138879638|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138879639|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879640|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138879642|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
138879643|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879644|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138879645|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138879646|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138879647|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
138879648|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879649|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879650|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138879651|NCT04073758|Narcotics|narcotics|mesh-ancestor
138815183|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
138879652|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
138879653|NCT02660606|Narcotics|narcotics|mesh-ancestor
138879654|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138879655|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879656|NCT02660606|Analgesics|analgesics|mesh-ancestor
138879657|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
138879658|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879659|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
138879660|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138879661|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
138879662|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879663|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879664|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138879665|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
138879666|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138879667|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
138879668|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879669|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879670|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138879671|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
138879672|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
138879673|NCT00582010|Protective Agents|protective agents|mesh-ancestor
138879674|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
138879675|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138879676|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138879677|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138815300|NCT00589420|Docetaxel|docetaxel|mesh-list
138531871|NCT00212875|Hematinics|hematinics|mesh-ancestor
138879678|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138879679|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879680|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
138879681|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879682|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879683|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138879684|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879686|NCT00649922|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138879687|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138879688|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138879689|NCT00986557|Ganciclovir|ganciclovir|mesh-list
138879690|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138879691|NCT00986557|Foscarnet|foscarnet|mesh-list
138879692|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138879693|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
138879694|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138879695|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879696|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
138879697|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138879698|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138879699|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879700|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501710|NCT00000575|Hormones|hormones|mesh-ancestor
138879701|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138879702|NCT00910754|Prednisone|prednisone|mesh-list
138879703|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
138879704|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138879705|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
138879706|NCT00910754|Hormones|hormones|mesh-ancestor
138879707|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138879708|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879709|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138879710|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879711|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138879712|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815396|NCT01024946|Everolimus|everolimus|mesh-list
138879713|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879714|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
138879715|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138879716|NCT00649376|Fexofenadine|fexofenadine|mesh-list
138879717|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138879718|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138879719|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138879720|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
138879721|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
138879722|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879723|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879724|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879725|NCT02340676|Interleukin-2|interleukin-2|mesh-list
138879726|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879727|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138879728|NCT02340676|Analgesics|analgesics|mesh-ancestor
138879729|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
138879730|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879731|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879732|NCT00649454|Metformin|metformin|mesh-list
138879733|NCT00649454|Glipizide|glipizide|mesh-list
138879734|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138879735|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879736|NCT02655770|Liraglutide|liraglutide|mesh-list
138879737|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138879738|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879739|NCT02655770|Incretins|incretins|mesh-ancestor
138879740|NCT02655770|Hormones|hormones|mesh-ancestor
138879741|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138879742|NCT00986713|Amphotericin B|amphotericin b|mesh-list
138879743|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138879744|NCT00986713|Amebicides|amebicides|mesh-ancestor
138879745|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138879746|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138879747|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138879748|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138879749|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
138879750|NCT02651870|Amlodipine|amlodipine|mesh-list
138879751|NCT02651870|Candesartan|candesartan|mesh-list
138531945|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879752|NCT02651870|Candesartan cilexetil|candesartan cilexetil|mesh-list
138879753|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138879754|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138879755|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138879756|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879757|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138879758|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879759|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
138879760|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138879761|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138879762|NCT02766803|Resveratrol|resveratrol|mesh-list
138879763|NCT02766803|Simvastatin|simvastatin|mesh-list
138879764|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138879765|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138879766|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
138879767|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879768|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138879769|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138879770|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879771|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
138879772|NCT02766803|Protective Agents|protective agents|mesh-ancestor
138879773|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879774|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138879775|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
138879776|NCT00650468|Prednisone|prednisone|mesh-list
138879777|NCT00650468|Tacrolimus|tacrolimus|mesh-list
138879778|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138879779|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
138879780|NCT00650468|Hormones|hormones|mesh-ancestor
138879781|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138815507|NCT03462069|Empagliflozin|empagliflozin|mesh-list
138879782|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879783|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138879785|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138879786|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
138879787|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138879788|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879789|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879790|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138879791|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138879792|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
138879793|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138879794|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138879795|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
138879796|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879797|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138879798|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879799|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879800|NCT02651792|Meperidine|meperidine|mesh-list
138879801|NCT02651792|Ketamine|ketamine|mesh-list
138879802|NCT02651792|Propofol|propofol|mesh-list
138879803|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138879804|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138879805|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178432|NCT02352363|Levodopa|levodopa|mesh-list
138879806|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138879807|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
138879808|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
138879809|NCT02651792|Analgesics|analgesics|mesh-ancestor
138879810|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
138879811|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879812|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138879813|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138879814|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138879815|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879816|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879817|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138879818|NCT02651792|Narcotics|narcotics|mesh-ancestor
138879819|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138879820|NCT04754815|Paclitaxel|paclitaxel|mesh-list
138879821|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138879822|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
138879823|NCT04754815|Pemetrexed|pemetrexed|mesh-list
138815585|NCT00720109|Prednisolone|prednisolone|mesh-list
138879824|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138879825|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879826|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
138879827|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
138879828|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
138879829|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879830|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138879831|NCT04754815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138879832|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879833|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138879834|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138879835|NCT00649532|Ondansetron|ondansetron|mesh-list
138879836|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
138879837|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
138815644|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
138879838|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879839|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879840|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138879841|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
138879842|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
138879843|NCT00649532|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138879844|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138879845|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
138879846|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879847|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879849|NCT02655614|Caffeine|caffeine|mesh-list
138879850|NCT02655614|Rabeprazole|rabeprazole|mesh-list
138879851|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138879852|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138879853|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138879854|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879855|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138879856|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138879857|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138879858|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138879859|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
138879860|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
138879861|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
138879862|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
138879863|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879864|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879865|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138879866|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138879867|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879868|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138879869|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138879870|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
138879871|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138879872|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138879873|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138879874|NCT02772029|Apatinib|apatinib|mesh-list
138879875|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879876|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138879877|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879878|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879879|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
138879880|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
138815768|NCT00722761|Estradiol|estradiol|mesh-list
138502076|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138879881|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138879882|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138879883|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879884|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879885|NCT02766725|Urological Agents|urological agents|mesh-ancestor
138879886|NCT02658422|Montelukast|montelukast|mesh-list
138879887|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138879888|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
138879889|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138879890|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
138879891|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138879892|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879893|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138879894|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138879895|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879896|NCT02771795|Trastuzumab|trastuzumab|mesh-list
138879897|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138879898|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879899|NCT02655536|Bevacizumab|bevacizumab|mesh-list
138879900|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138879901|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138879902|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138879903|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138879904|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138879905|NCT02655536|Growth Substances|growth substances|mesh-ancestor
138879906|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879907|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
138879908|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138879909|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879910|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879911|NCT02766647|Lenograstim|lenograstim|mesh-list
138879912|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138879913|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
138879914|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879915|NCT02651636|Folic Acid|folic acid|mesh-list
138879916|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
138879917|NCT02651636|Inositol|inositol|mesh-list
138879918|NCT02651636|Hematinics|hematinics|mesh-ancestor
138879919|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
138502152|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138879920|NCT02651636|Vitamins|vitamins|mesh-ancestor
138879921|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
138879922|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879923|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
138879924|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879925|NCT02651636|Protective Agents|protective agents|mesh-ancestor
138879926|NCT02774993|Doxycycline|doxycycline|mesh-list
138879927|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138996353|NCT00980382|Docetaxel|docetaxel|mesh-list
138879928|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138879929|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
138879930|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138879931|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138879932|NCT02774837|Tenofovir|tenofovir|mesh-list
138879933|NCT02774837|Telbivudine|telbivudine|mesh-list
138879934|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
138879935|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138879936|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138879937|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138879938|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879939|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879940|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138879941|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138879942|NCT02658188|Gabapentin|gabapentin|mesh-list
138879943|NCT02658188|Analgesics|analgesics|mesh-ancestor
138879944|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
138879945|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879946|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879947|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
138879948|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138879949|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138879950|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138879951|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138879952|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138879953|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138879954|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879955|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879956|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
138879957|NCT02771717|Budesonide|budesonide|mesh-list
138879958|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138879959|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138879960|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
138879961|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879962|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879963|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138879964|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
138879965|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
138879966|NCT02771717|Hormones|hormones|mesh-ancestor
138879967|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138879968|NCT02655380|Ketamine|ketamine|mesh-list
138879969|NCT02655380|Remifentanil|remifentanil|mesh-list
138879970|NCT02655380|Analgesics|analgesics|mesh-ancestor
138879971|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
138879972|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138879973|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879974|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138879975|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138879976|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
138879977|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
138815957|NCT00722371|Pioglitazone|pioglitazone|mesh-list
138879978|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138879979|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138879980|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138879981|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138879982|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879983|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138879984|NCT02655380|Narcotics|narcotics|mesh-ancestor
138879985|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
138879986|NCT00580840|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138879987|NCT00580840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138879988|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138879989|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
138879990|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879991|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138879992|NCT00987103|Tacrolimus|tacrolimus|mesh-list
138502323|NCT02971540|Narcotics|narcotics|mesh-ancestor
138879993|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138879994|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
138879995|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138879996|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138879997|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138879998|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138879999|NCT02655458|Lenalidomide|lenalidomide|mesh-list
138880000|NCT02655458|Elotuzumab|elotuzumab|mesh-list
138880001|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
138880002|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880003|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138880004|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138880005|NCT02655458|Growth Substances|growth substances|mesh-ancestor
138880006|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
138880007|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880008|NCT04006093|Apixaban|apixaban|mesh-list
138880009|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138880010|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
139210404|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138880011|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138880012|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
138880013|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880014|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502359|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138880015|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
138880016|NCT02766257|Anesthetics|anesthetics|mesh-list
138880017|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880018|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880019|NCT04005469|Treprostinil|treprostinil|mesh-list
138880020|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138880021|NCT02651324|Ketamine|ketamine|mesh-list
138880022|NCT02651324|Analgesics|analgesics|mesh-ancestor
138880023|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
138880024|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880025|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880026|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138880027|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138880028|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
138880029|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
138880030|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880031|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138880032|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138880033|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880034|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880035|NCT00662220|Ribavirin|ribavirin|mesh-list
138502412|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880036|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138880037|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
138880038|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
138880039|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880040|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
138880041|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880042|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
138880043|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880044|NCT02575924|Imidacloprid|imidacloprid|mesh-list
138880045|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
138880046|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880047|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880048|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880050|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138880051|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138880052|NCT02651168|Growth Substances|growth substances|mesh-ancestor
138880053|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880054|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
138880055|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880056|NCT00650000|Modafinil|modafinil|mesh-list
138880057|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138880058|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880059|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138880060|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138880061|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138880062|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880064|NCT02630862|Dipyridamole|dipyridamole|mesh-list
138880065|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138880066|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138880067|NCT02630862|Analgesics|analgesics|mesh-ancestor
138880068|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
138816088|NCT04115410|Gefitinib|gefitinib|mesh-list
138880069|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880070|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502467|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138880071|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138880072|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880073|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138880074|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138880075|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880076|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138880077|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138880078|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880079|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
138880080|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138880081|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
138880082|NCT02536430|Ketorolac|ketorolac|mesh-list
138880083|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138880084|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138880085|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138880086|NCT02536430|Analgesics|analgesics|mesh-ancestor
138880087|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
138880088|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880089|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880090|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138880091|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138502508|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
138880092|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138880093|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880094|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880095|NCT02631174|Antithrombins|antithrombins|mesh-list
138880096|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
138880097|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138880098|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
138880099|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880100|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880101|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
138880103|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138880104|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880105|NCT04686929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138880106|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816154|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
138880107|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138880108|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
138880109|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880110|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880111|NCT02765633|Cangrelor|cangrelor|mesh-list
138880112|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138880113|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138880114|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138880115|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138880116|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
138880117|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880118|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880119|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880121|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
138880122|NCT00581776|Rituximab|rituximab|mesh-list
138880123|NCT00581776|Doxorubicin|doxorubicin|mesh-list
138880124|NCT00581776|Vincristine|vincristine|mesh-list
138880125|NCT00581776|Bortezomib|bortezomib|mesh-list
138880126|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138880127|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
138880128|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880129|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880130|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138880131|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
138880132|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880133|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816247|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
138880134|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138880135|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138880136|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
138880137|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
138880138|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880139|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138880140|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
138880141|NCT00581776|Hormones|hormones|mesh-ancestor
138880142|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138880143|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138880144|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138880145|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138880146|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138880147|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138880148|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880149|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138880150|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
138880151|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
138880152|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
138880153|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138880154|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138880155|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
138880156|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138880157|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138880158|NCT00662454|Estradiol|estradiol|mesh-list
138880159|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138880160|NCT00662454|Estrogens|estrogens|mesh-ancestor
138880161|NCT00662454|Hormones|hormones|mesh-ancestor
138880162|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138880163|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880164|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138880165|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
138880166|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138880167|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138880168|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138880169|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138880170|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138880171|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138880172|NCT04156152|Listerine|listerine|mesh-list
138880173|NCT04156152|Fluorides|fluorides|mesh-list
138880174|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
138880175|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
138880176|NCT04156152|Protective Agents|protective agents|mesh-ancestor
138880177|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880178|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138880179|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880180|NCT00662610|Naproxen|naproxen|mesh-list
138880181|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
138880182|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138880183|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138880184|NCT00662610|Analgesics|analgesics|mesh-ancestor
138880185|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
138880186|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880187|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880188|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138880189|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880190|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
138880191|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138880192|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880193|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880194|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138880195|NCT04225325|Dolutegravir|dolutegravir|mesh-list
138880196|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138880197|NCT04225325|Emtricitabine|emtricitabine|mesh-list
138880198|NCT04225325|Darunavir|darunavir|mesh-list
138880199|NCT04225325|Cobicistat|cobicistat|mesh-list
138880200|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138880201|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138880202|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880203|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880205|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138880206|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
138880207|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880208|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138880209|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138880210|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138880211|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138880212|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
138880213|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138880214|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138880215|NCT00649610|Diclofenac|diclofenac|mesh-list
138880216|NCT00649610|Valdecoxib|valdecoxib|mesh-list
138880217|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138880218|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138880220|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
138880221|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880222|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880223|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138880224|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880225|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138880226|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880227|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816599|NCT02706015|Analgesics|analgesics|mesh-ancestor
138880228|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138880229|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138880230|NCT02655146|Progesterone|progesterone|mesh-list
138880231|NCT02655146|Estradiol|estradiol|mesh-list
138880232|NCT02655146|Progestins|progestins|mesh-ancestor
138880233|NCT02655146|Hormones|hormones|mesh-ancestor
139210405|NCT03384238|Panitumumab|panitumumab|mesh-list
138880234|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138880235|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880236|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
138880237|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138880238|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
138880239|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138880240|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138880241|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138880242|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880243|NCT02655146|Estrogens|estrogens|mesh-ancestor
138880244|NCT02774525|Ethanol|ethanol|mesh-list
138880245|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138880246|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880247|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880248|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880249|NCT04167566|Artemisinins|artemisinins|mesh-list
138880250|NCT04167566|Artemisinin|artemisinin|mesh-list
138880251|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
138880252|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138816719|NCT02704923|Atropine|atropine|mesh-list
138880253|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138880254|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880255|NCT00650624|Valdecoxib|valdecoxib|mesh-list
138880256|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138880257|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138880258|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880259|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880260|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138880261|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138880262|NCT00650624|Analgesics|analgesics|mesh-ancestor
138880263|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
138880264|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880265|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880266|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138880267|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880268|NCT00666354|Methotrexate|methotrexate|mesh-list
138880269|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138880270|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
138880271|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138880272|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880273|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138880274|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
138880275|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880276|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880277|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
138880278|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880279|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138880280|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138880281|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
138880282|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138502938|NCT02971345|Iodine|iodine|mesh-list
138880283|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138880285|NCT02536352|Fluorides|fluorides|mesh-list
138880286|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
138880287|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880288|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
138880289|NCT02536352|Protective Agents|protective agents|mesh-ancestor
138880290|NCT02773979|Chloroquine|chloroquine|mesh-list
138880291|NCT02773979|Amebicides|amebicides|mesh-ancestor
138880292|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138880293|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138880294|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880295|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
138880296|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880297|NCT00662844|Vitamin D|vitamin d|mesh-list
138880298|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
138880299|NCT00662844|Vitamins|vitamins|mesh-ancestor
138880300|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
138880301|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880302|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138880303|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138880304|NCT02650544|Mirtazapine|mirtazapine|mesh-list
138880305|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
138880306|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138996467|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
138880307|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138880308|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
138880309|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
138880310|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880311|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880312|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880313|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138880314|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138880315|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880316|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138880317|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138880318|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138880319|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
138880320|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138880321|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138880322|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
138816821|NCT04805073|Promethazine|promethazine|mesh-list
138880323|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138880325|NCT02650388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138880326|NCT02650388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138880327|NCT02650388|Analgesics|analgesics|mesh-ancestor
138503033|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
138880328|NCT02650388|Sensory System Agents|sensory system agents|mesh-ancestor
138880329|NCT02650388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880330|NCT02650388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880331|NCT02650388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138816870|NCT02702817|Naproxen|naproxen|mesh-list
138880332|NCT02650388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880333|NCT00883740|Pregabalin|pregabalin|mesh-list
138880334|NCT00883740|Analgesics|analgesics|mesh-ancestor
138880335|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
138880336|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880337|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880338|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
138880339|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138880340|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138880341|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880342|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138880343|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138880344|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138503079|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880345|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880346|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138880347|NCT04183712|Gemcitabine|gemcitabine|mesh-list
138880348|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
138880349|NCT04183712|Afatinib|afatinib|mesh-list
138880350|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138880351|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
138880352|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880353|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880354|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138880355|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880356|NCT02773199|Bupivacaine|bupivacaine|mesh-list
138880357|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
138880358|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
138503136|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138880359|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880360|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880361|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
138880362|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880363|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
138880364|NCT02654834|Anesthetics|anesthetics|mesh-list
138880365|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880366|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880367|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138880368|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
138880369|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138880370|NCT02654834|Analgesics|analgesics|mesh-ancestor
138880371|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
138880372|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880373|NCT00656526|Lidocaine|lidocaine|mesh-list
138880374|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
138880375|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
138880376|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880377|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817051|NCT02586259|Hormones|hormones|mesh-ancestor
138880378|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
138503202|NCT00037063|Vitamin E|vitamin e|mesh-list
138880379|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880380|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138880381|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138880382|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139210407|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
138880383|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138880384|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880385|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138880387|NCT02765009|Bumetanide|bumetanide|mesh-list
138880388|NCT02765009|Diuretics|diuretics|mesh-list
138880389|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138880390|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
138880391|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880392|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138880393|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138880394|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880395|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138880396|NCT02649920|Dinoprostone|dinoprostone|mesh-list
138880397|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
138880398|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138880399|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880400|NCT00649688|Metoprolol|metoprolol|mesh-list
138880401|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138880402|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138880403|NCT00649688|Diuretics|diuretics|mesh-ancestor
138880404|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
138880405|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880406|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138880407|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138880408|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880409|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138880410|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
138880411|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
138880412|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880413|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138880414|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138880415|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138503319|NCT00037570|Pantoprazole|pantoprazole|mesh-list
138880416|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
138880417|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880418|NCT00667056|Tacrolimus|tacrolimus|mesh-list
138880419|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138880420|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
138880421|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880422|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138880423|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880424|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880425|NCT02764619|Spironolactone|spironolactone|mesh-list
138880427|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
138880428|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138880429|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880430|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138880431|NCT02764619|Diuretics|diuretics|mesh-ancestor
138880432|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
138880434|NCT04032210|Fluorides|fluorides|mesh-list
138880435|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
138880436|NCT04032210|Protective Agents|protective agents|mesh-ancestor
138880437|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880438|NCT04032210|Trace Elements|trace elements|mesh-ancestor
138880439|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
138880440|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
138880441|NCT04223219|Fentanyl|fentanyl|mesh-list
138880442|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
138880444|NCT04223219|Propofol|propofol|mesh-list
138880445|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138880446|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880447|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880448|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138880449|NCT04223219|Analgesics|analgesics|mesh-ancestor
138880450|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
138880451|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880452|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138880453|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138880454|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138880455|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
138880456|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880457|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880458|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139210408|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138880459|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
138880461|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138880462|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138880463|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138880464|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138880465|NCT04223219|Narcotics|narcotics|mesh-ancestor
138880466|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138880467|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138880468|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
138880469|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138880470|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138817411|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
138880471|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138880472|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
138880473|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138880474|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
138880475|NCT02631252|Etoposide|etoposide|mesh-list
138880476|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
138880477|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138880478|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880479|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138880480|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138880481|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880482|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880483|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
138880484|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138880485|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138880486|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880487|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880488|NCT02631252|Analgesics|analgesics|mesh-ancestor
138880489|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
138880490|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880491|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880492|NCT02631408|Vancomycin|vancomycin|mesh-list
138880493|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138880494|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880495|NCT02630394|Azithromycin|azithromycin|mesh-list
138880496|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138880497|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880498|NCT02771405|Ribavirin|ribavirin|mesh-list
138880499|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
138880500|NCT02771405|Simeprevir|simeprevir|mesh-list
138880501|NCT02771405|Ledipasvir|ledipasvir|mesh-list
138880502|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
138880503|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880505|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880506|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
138880507|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880508|NCT00667758|Cetrorelix|cetrorelix|mesh-list
138880509|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138880510|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
138880511|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138880512|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880513|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
138880514|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138880515|NCT00542815|Sevelamer|sevelamer|mesh-list
138880516|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
138880517|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
138880518|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880519|NCT02762591|Pimavanserin|pimavanserin|mesh-list
138880520|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138880521|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138880522|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138880523|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138880524|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880525|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880526|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138880527|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138996572|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
138880528|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138880529|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
138880530|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880531|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880532|NCT02696369|Lidocaine|lidocaine|mesh-list
138880533|NCT02696369|Epinephrine|epinephrine|mesh-list
138880534|NCT02696369|Racepinephrine|racepinephrine|mesh-list
138880535|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
138880536|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
138880538|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880539|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880540|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
138880541|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880542|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138880543|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138880544|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138880545|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138880546|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880547|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138880548|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138880549|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
138880550|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880551|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138880552|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138880553|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
138880554|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138880555|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
138880556|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
138880557|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
138880558|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138880559|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138880560|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880562|NCT02636088|Cetuximab|cetuximab|mesh-list
138880563|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138880564|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880565|NCT02630160|Epinephrine|epinephrine|mesh-list
138880566|NCT02630160|Bupivacaine|bupivacaine|mesh-list
138880567|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
138880568|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
138880569|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880570|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880571|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
138880572|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880573|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138817678|NCT01072175|Trametinib|trametinib|mesh-list
138880574|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138880575|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
138880576|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880577|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880578|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138880579|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138880580|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
138880581|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138880582|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
138880583|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
138880584|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
138880585|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138880586|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
138880587|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138880588|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138880589|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880590|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138880591|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138880592|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880593|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880594|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880595|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138880596|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
138880597|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138880598|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880599|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138880600|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138880601|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138880603|NCT00542425|Abaloparatide|abaloparatide|mesh-list
138880604|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
138880605|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138880606|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880607|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138880608|NCT00668538|Miconazole|miconazole|mesh-list
138880609|NCT00668538|Clotrimazole|clotrimazole|mesh-list
138880610|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
138880611|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880612|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138880613|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138880614|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880615|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880616|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138880617|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
138880618|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138880619|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880620|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138503711|NCT05076877|Lazertinib|lazertinib|mesh-list
138503746|NCT00396760|Aprotinin|aprotinin|mesh-list
138880621|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138880622|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138880623|NCT00668616|Paclitaxel|paclitaxel|mesh-list
138880624|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138880625|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
138880626|NCT00668616|Epirubicin|epirubicin|mesh-list
138880627|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138880628|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880629|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
138880630|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
138880631|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
138880632|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880633|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138880634|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
138880635|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880636|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880637|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138880638|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
138817916|NCT01071083|Hormones|hormones|mesh-ancestor
138503767|NCT00396799|Estrogens|estrogens|mesh-list
138880639|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138880640|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138880641|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138880642|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138880643|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880644|NCT02763761|Prednisone|prednisone|mesh-list
138880645|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
138880646|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138880647|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138880648|NCT02763761|Prednisolone|prednisolone|mesh-list
138532840|NCT00073593|Heparin|heparin|mesh-list
138312127|NCT02246920|Xhance|xhance|mesh-list
138880649|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
138880650|NCT02763761|Infliximab|infliximab|mesh-list
138880651|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138880652|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
138880653|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138880654|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
138880655|NCT02763761|Hormones|hormones|mesh-ancestor
138880656|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138880657|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880658|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138880659|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880660|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
138880661|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
138880662|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880663|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138880664|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138880665|NCT02763761|Protective Agents|protective agents|mesh-ancestor
138503820|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880666|NCT02763761|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138880667|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
138880668|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880669|NCT04155918|Allopurinol|allopurinol|mesh-list
138880670|NCT04155918|Febuxostat|febuxostat|mesh-list
138880671|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
138880672|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880673|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880674|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
138880675|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880676|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138880677|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
138880678|NCT04155918|Protective Agents|protective agents|mesh-ancestor
138880679|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880680|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138880681|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138880683|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880684|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138880685|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138880686|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
138880688|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880689|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880690|NCT00541099|Bevacizumab|bevacizumab|mesh-list
138880691|NCT00541099|Docetaxel|docetaxel|mesh-list
138880692|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138880693|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880694|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138880695|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138880696|NCT00541099|Growth Substances|growth substances|mesh-ancestor
138880697|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880698|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
138880699|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
138880700|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
138880701|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
138880702|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880703|NCT00580606|Glycerol|glycerol|mesh-list
138880704|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138880705|NCT00580606|Protective Agents|protective agents|mesh-ancestor
138880706|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880707|NCT02575768|Adenosine|adenosine|mesh-list
138880708|NCT02575768|Analgesics|analgesics|mesh-ancestor
138996620|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
138880709|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
138880710|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880711|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880712|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138880713|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
138880714|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138880715|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
138880716|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
138880717|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880718|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880719|NCT00987493|Rituximab|rituximab|mesh-list
138880720|NCT00987493|Lenalidomide|lenalidomide|mesh-list
138880721|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138880722|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138880723|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880724|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
138880725|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880726|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880727|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138880728|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138880729|NCT00987493|Growth Substances|growth substances|mesh-ancestor
138880730|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
138880731|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138880732|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
138880733|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880734|NCT02579356|Telmisartan|telmisartan|mesh-list
138880735|NCT02579356|Atorvastatin|atorvastatin|mesh-list
138880736|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138880737|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138880738|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
138880739|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880740|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138818270|NCT00618501|Etoposide|etoposide|mesh-list
138880741|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138880742|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880743|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138880744|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138880745|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138880746|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
138880747|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138880748|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880749|NCT02577250|Ketamine|ketamine|mesh-list
138880750|NCT02577250|Analgesics|analgesics|mesh-ancestor
138880751|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
138880752|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880753|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503965|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
138880754|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138880755|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138656325|NCT00323804|Ribavirin|ribavirin|mesh-list
138880756|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
138880757|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
138880758|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880759|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138880760|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138880761|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880762|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880763|NCT00668850|Insulin|insulin|mesh-list
138880764|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138880765|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138880766|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880767|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
138880768|NCT02762123|Digoxin|digoxin|mesh-list
138880769|NCT02762123|Midazolam|midazolam|mesh-list
138880770|NCT02762123|Omeprazole|omeprazole|mesh-list
138880771|NCT02762123|Montelukast|montelukast|mesh-list
138880772|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138880773|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138880774|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880775|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880776|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138880777|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138880778|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138880779|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138880780|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
138880781|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
138880782|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
138880783|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
138880784|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880785|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880786|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138880787|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138880788|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138880789|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880790|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138880791|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
138880792|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138880793|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
138880794|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138880795|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138880796|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138880797|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138880798|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138880799|NCT02762123|Protective Agents|protective agents|mesh-ancestor
138880800|NCT02762123|Analgesics|analgesics|mesh-ancestor
138880801|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
138880802|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880803|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138880804|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138880805|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138880806|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880807|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138880808|NCT04153734|Paclitaxel|paclitaxel|mesh-list
138880809|NCT04153734|Carboplatin|carboplatin|mesh-list
138880810|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
138880811|NCT04153734|Pemetrexed|pemetrexed|mesh-list
138880812|NCT04153734|Cisplatin|cisplatin|mesh-list
138880813|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138880814|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880815|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
138880816|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
138880817|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
138504049|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880818|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880819|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138880820|NCT04153734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138880821|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880822|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138880823|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138880825|NCT04073680|Serabelisib|serabelisib|mesh-list
138880826|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138880827|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880828|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138880829|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880830|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880831|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
138880832|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138880833|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
138880834|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880835|NCT02761577|Expectorants|expectorants|mesh-ancestor
138880836|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
138880837|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138880838|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
138880839|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880840|NCT02761577|Protective Agents|protective agents|mesh-ancestor
138880841|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880843|NCT00579982|Lamotrigine|lamotrigine|mesh-list
138880844|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
138880845|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138880846|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138880847|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880848|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138880849|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880850|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138880851|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138880852|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880853|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138880854|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138880855|NCT00596466|Pregabalin|pregabalin|mesh-list
138880856|NCT00596466|Analgesics|analgesics|mesh-ancestor
138880857|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
138880858|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880859|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880860|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
138880861|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138880862|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138880863|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880864|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138880865|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138880866|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138880867|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880869|NCT02763059|Acetaminophen|acetaminophen|mesh-list
138880870|NCT02763059|Dexamethasone|dexamethasone|mesh-list
138880871|NCT02763059|Ibuprofen|ibuprofen|mesh-list
138504141|NCT00016302|Vitamins|vitamins|mesh-ancestor
138880872|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138880873|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
138880874|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
138209384|NCT01791608|Zinc|zinc|mesh-list
138880875|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880876|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880877|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138880878|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
138880880|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138880881|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138880882|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880883|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138880884|NCT02763059|Analgesics|analgesics|mesh-ancestor
138880885|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
138880886|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
138880887|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138880888|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138880889|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138818602|NCT06183892|Tacrolimus|tacrolimus|mesh-list
138880890|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880891|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880892|NCT04222517|Hemostatics|hemostatics|mesh-list
138880893|NCT04222517|Coagulants|coagulants|mesh-ancestor
138880894|NCT00671112|Everolimus|everolimus|mesh-list
138880895|NCT00671112|Bortezomib|bortezomib|mesh-list
138880896|NCT00671112|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138880897|NCT00671112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138880898|NCT00671112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880899|NCT00671112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880900|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138880901|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
138880902|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880903|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880904|NCT04857385|Hemostatics|hemostatics|mesh-list
138880905|NCT04857385|Coagulants|coagulants|mesh-ancestor
138880906|NCT00664014|Tolvaptan|tolvaptan|mesh-list
138880907|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138504201|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
138880908|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880909|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
138880910|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880911|NCT02696915|Fentanyl|fentanyl|mesh-list
138880912|NCT02696915|Bupivacaine|bupivacaine|mesh-list
138880913|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
138880914|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
138880915|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880916|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880917|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
138880918|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138880919|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138880920|NCT02696915|Narcotics|narcotics|mesh-ancestor
138880921|NCT02696915|Analgesics|analgesics|mesh-ancestor
138880922|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138880923|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138880924|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
138880925|NCT00911664|Vitamin D|vitamin d|mesh-list
138880926|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
138880927|NCT00911664|Cholecalciferol|cholecalciferol|mesh-list
138880928|NCT00911664|Vitamins|vitamins|mesh-list
138880929|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
138880930|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880931|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138880932|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138880933|NCT00664170|Docetaxel|docetaxel|mesh-list
138880934|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880935|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
138880936|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
138880937|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
138880938|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880939|NCT02758067|Risperidone|risperidone|mesh-list
138880940|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
138880941|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138880942|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
138880943|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880944|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880945|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880946|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138880947|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138880948|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880949|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138880950|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138880951|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
138880952|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
138880953|NCT00664248|Clindamycin|clindamycin|mesh-list
138880954|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
138880955|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
138880956|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138880957|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138880958|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138880959|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138880960|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818676|NCT06166628|Phenol|phenol|mesh-list
138880961|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504276|NCT00016887|Interferons|interferons|mesh-list
138880962|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
138880963|NCT00579670|Ziprasidone|ziprasidone|mesh-list
138880964|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138880965|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
138880966|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138880967|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880968|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880969|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138880970|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138880971|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880972|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138880973|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138880974|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
138880975|NCT00669786|Menotropins|menotropins|mesh-list
138880977|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138880978|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138880979|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880980|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138880981|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
138880982|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138880983|NCT02760953|Epirubicin|epirubicin|mesh-list
139210409|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
138880985|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138880986|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138880987|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138880988|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138880989|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880990|NCT02630004|Melatonin|melatonin|mesh-list
138880991|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
138504330|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138880992|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138880993|NCT02630004|Protective Agents|protective agents|mesh-ancestor
138880994|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138880995|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138880996|NCT00129922|Paclitaxel|paclitaxel|mesh-list
138880997|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
138880998|NCT00129922|Fluorouracil|fluorouracil|mesh-list
138880999|NCT00129922|Epirubicin|epirubicin|mesh-list
138881000|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138881001|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881003|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
138881004|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
138881005|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881006|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138881007|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
138881008|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881009|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138881010|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138881011|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
138881012|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138881013|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
138881014|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138881015|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138881016|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138881017|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138881018|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881019|NCT03909295|Valsartan|valsartan|mesh-list
138881020|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138881021|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138881022|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138881023|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138881024|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881025|NCT04153968|Retinol acetate|retinol acetate|mesh-list
138881026|NCT04153968|Protective Agents|protective agents|mesh-ancestor
138881027|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881028|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138881029|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
138881030|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138881031|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881032|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
138881033|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138881034|NCT00671424|Furosemide|furosemide|mesh-list
138881035|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138881036|NCT00671424|Diuretics|diuretics|mesh-ancestor
138881037|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
138881038|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881039|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138881040|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138881041|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881042|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138881043|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138881044|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138881045|NCT00599924|Leucovorin|leucovorin|mesh-list
138881046|NCT00599924|Sunitinib|sunitinib|mesh-list
138881047|NCT00599924|Fluorouracil|fluorouracil|mesh-list
138881048|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
138881049|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881050|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138881051|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138881052|NCT00599924|Growth Substances|growth substances|mesh-ancestor
138881053|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881054|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
138881055|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138881056|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881057|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881059|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138881060|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138881061|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
138881062|NCT00599924|Antidotes|antidotes|mesh-ancestor
138881063|NCT00599924|Protective Agents|protective agents|mesh-ancestor
138881064|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
138881065|NCT00599924|Vitamins|vitamins|mesh-ancestor
138881066|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
138881067|NCT02757209|Fluticasone|fluticasone|mesh-list
138881068|NCT02757209|Xhance|xhance|mesh-list
138881069|NCT02757209|Budesonide|budesonide|mesh-list
138881070|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
138881071|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138881072|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138881073|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138881074|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138881075|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
138881076|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881077|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881078|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138881079|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
138881080|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
138881081|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138881082|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
138881083|NCT02757209|Hormones|hormones|mesh-ancestor
138881084|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881085|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138881086|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138881087|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138881088|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
138881089|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138881090|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881091|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
138881092|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138881093|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
138881094|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138881095|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881096|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138881097|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138533288|NCT00043121|Leucovorin|leucovorin|mesh-list
138881098|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881099|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881100|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881101|NCT05338801|Menthol|menthol|mesh-list
138881102|NCT05338801|Antipruritics|antipruritics|mesh-ancestor
138881103|NCT05338801|Dermatologic Agents|dermatologic agents|mesh-ancestor
138881104|NCT02757287|Desogestrel|desogestrel|mesh-list
138881105|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138881106|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138504659|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
138881107|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138818881|NCT05738291|Anesthetics|anesthetics|mesh-ancestor
138881108|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
138881109|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138881110|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881111|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138881112|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138881113|NCT02757287|Progestins|progestins|mesh-ancestor
138881114|NCT02757287|Hormones|hormones|mesh-ancestor
138881115|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881116|NCT02757365|Aspirin|aspirin|mesh-list
138881117|NCT02757365|Levofloxacin|levofloxacin|mesh-list
138881118|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138881119|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138881120|NCT02757365|Analgesics|analgesics|mesh-ancestor
138881121|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
138881122|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881123|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881124|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138881125|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138881126|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138881127|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138881128|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881129|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138881130|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138881131|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881132|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
138881133|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138881134|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996861|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
138881135|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138881136|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138881137|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138881138|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881139|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138504782|NCT00041275|Megestrol|megestrol|mesh-list
138881140|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138881142|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881143|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881144|NCT02575534|Procainamide|procainamide|mesh-list
138881145|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138881146|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138881147|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138881148|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138881149|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881150|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
138881151|NCT02757443|Anesthetics|anesthetics|mesh-list
138881152|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138881153|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881154|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138881155|NCT02757443|Protective Agents|protective agents|mesh-ancestor
138881156|NCT04071262|Prednisolone|prednisolone|mesh-list
138881157|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
138881158|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138881159|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
138881160|NCT04071262|Hormones|hormones|mesh-ancestor
138881161|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881162|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881163|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138881164|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881165|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138881166|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881167|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881168|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
138881169|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138881170|NCT04154748|Omeprazole|omeprazole|mesh-list
138881171|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138881172|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138881173|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138881174|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881175|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881176|NCT02657096|Hybenx|hybenx|mesh-list
138881177|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
138881178|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
138881179|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881180|NCT02536742|Fulvestrant|fulvestrant|mesh-list
138881181|NCT02536742|Palbociclib|palbociclib|mesh-list
138881182|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138881183|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881184|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138881185|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138881186|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
138881187|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881188|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881189|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138881190|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881191|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881192|NCT00670410|Fludarabine|fludarabine|mesh-list
138881193|NCT00670410|Busulfan|busulfan|mesh-list
138881194|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
138881195|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881196|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881197|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138881198|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
138881199|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881200|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
138881201|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138881202|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138881203|NCT02756663|Dexamethasone|dexamethasone|mesh-list
138881204|NCT02756663|Panobinostat|panobinostat|mesh-list
138881206|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
138881207|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
138819009|NCT05323149|Hemostatics|hemostatics|mesh-ancestor
138881208|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881209|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881210|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138881211|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
138881212|NCT02756663|Hormones|hormones|mesh-ancestor
138881213|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881214|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138881215|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881216|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138881217|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881218|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881219|NCT02654678|Enalapril|enalapril|mesh-list
138881220|NCT02654678|Enalaprilat|enalaprilat|mesh-list
138881221|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138881222|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
138881223|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881224|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881225|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138881226|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138881227|NCT00670566|Irbesartan|irbesartan|mesh-list
138881228|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138881229|NCT00670566|Diuretics|diuretics|mesh-ancestor
138881230|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
138881231|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881232|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138881233|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138881234|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881235|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138881236|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138881237|NCT02629848|Paclitaxel|paclitaxel|mesh-list
138881238|NCT02629848|Carboplatin|carboplatin|mesh-list
138881239|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
138881240|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138881241|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881242|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
138881243|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
138881244|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
138881245|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881246|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138881247|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881249|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138881250|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881251|NCT03912337|Analgesics|analgesics|mesh-ancestor
138881252|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
138881253|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881254|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881255|NCT00650156|Adalimumab|adalimumab|mesh-list
138881256|NCT00650156|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138881257|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138881258|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138881259|NCT02576782|Dexamethasone|dexamethasone|mesh-list
138881260|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
138881261|NCT02576782|Bupivacaine|bupivacaine|mesh-list
138881262|NCT02576782|BB 1101|bb 1101|mesh-list
138881263|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138455198|NCT01903824|Modafinil|modafinil|mesh-list
138881264|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
138881265|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
138881266|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881267|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881268|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138881269|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
138881270|NCT02576782|Hormones|hormones|mesh-ancestor
138881271|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881272|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138881273|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881274|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
138881275|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881276|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881277|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
138881278|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
138881279|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138881280|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
138881281|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138881282|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881283|NCT02577094|Fludarabine|fludarabine|mesh-list
138881284|NCT02577094|Busulfan|busulfan|mesh-list
138881285|NCT02577094|Epratuzumab|epratuzumab|mesh-list
138881286|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
138881287|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505002|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138881288|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881289|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138881290|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
138881291|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881292|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
138881293|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138881294|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138881295|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138881296|NCT00649844|Ziprasidone|ziprasidone|mesh-list
138881297|NCT00649844|Clozapine|clozapine|mesh-list
138881298|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138881299|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
138881300|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138881301|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881302|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881303|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138881304|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138881305|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138881306|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138881307|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138881308|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
138881309|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
138881310|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
138881311|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
138881312|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
138881313|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138881314|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138881315|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881316|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
138881317|NCT02656472|Coagulants|coagulants|mesh-ancestor
138881318|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138881319|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
138881320|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138881321|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138881322|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533520|NCT00125905|Bupropion|bupropion|mesh-list
138881323|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881324|NCT00665340|Urological Agents|urological agents|mesh-ancestor
138881325|NCT00665418|Sevoflurane|sevoflurane|mesh-list
138881326|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138881327|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138881328|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
138881329|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
138881330|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138881331|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881332|NCT00595920|Vaccines|vaccines|mesh-list
138881333|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
138881334|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881335|NCT02654288|Gemcitabine|gemcitabine|mesh-list
138881336|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138881337|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
138881338|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881339|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881340|NCT02649140|Acetic Acid|acetic acid|mesh-list
138881341|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138881342|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881343|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138881344|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
138881345|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138881346|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138881347|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881348|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881349|NCT00665496|Urological Agents|urological agents|mesh-ancestor
138881351|NCT02653898|Piperaquine|piperaquine|mesh-list
138881352|NCT02653898|Primaquine|primaquine|mesh-list
138881353|NCT02653898|Artenimol|artenimol|mesh-list
138881354|NCT02653898|Mefloquine|mefloquine|mesh-list
139210410|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881355|NCT02653898|Permethrin|permethrin|mesh-list
138881356|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
138881357|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138881358|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138881359|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881360|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881361|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
138881362|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
138881363|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138881364|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
138881365|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819177|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
138881366|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881367|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
138881368|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138881369|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
138881370|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881371|NCT02629536|Expectorants|expectorants|mesh-ancestor
138881372|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
138881373|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138881374|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
138881375|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881376|NCT02629536|Protective Agents|protective agents|mesh-ancestor
138881377|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881378|NCT02629536|Antidotes|antidotes|mesh-ancestor
138881379|NCT04071106|Betamethasone|betamethasone|mesh-list
138881380|NCT04071106|Calcipotriene|calcipotriene|mesh-list
138881381|NCT04071106|Petrolatum|petrolatum|mesh-list
138881382|NCT04071106|Turmeric extract|turmeric extract|mesh-list
138881383|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138881384|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
138881385|NCT04071106|Hormones|hormones|mesh-ancestor
138881386|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881387|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881388|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138881389|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
138881390|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
138881391|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
138881392|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881393|NCT04071106|Protective Agents|protective agents|mesh-ancestor
138881394|NCT04071106|Emollients|emollients|mesh-ancestor
138881395|NCT00670722|Insulin|insulin|mesh-list
138881396|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138881397|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
138881398|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
138881399|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138881400|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
138881401|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
138819197|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059155|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138881402|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138996974|NCT00424372|Pregabalin|pregabalin|mesh-list
138881403|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138881404|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881406|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
138881407|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138881408|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
138881409|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881410|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138881411|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138881412|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
138881413|NCT00670878|Gemcitabine|gemcitabine|mesh-list
138881414|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138881415|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
138881416|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881417|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881418|NCT02760095|Vitamin A|vitamin a|mesh-list
138881419|NCT02760095|Acetic Acid|acetic acid|mesh-list
138881420|NCT02760095|Retinol acetate|retinol acetate|mesh-list
138881421|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
138881422|NCT02760095|Vitamins|vitamins|mesh-ancestor
138881423|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
138881424|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881425|NCT02760095|Protective Agents|protective agents|mesh-ancestor
138881426|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138819243|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
138881427|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881428|NCT02760095|Astringents|astringents|mesh-ancestor
138881429|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
138881430|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138881431|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
138881432|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138881433|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881434|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
138881435|NCT02576626|Albuterol|albuterol|mesh-list
138881436|NCT02576626|Ipratropium|ipratropium|mesh-list
138881437|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138881438|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
138881439|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881440|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881441|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138881442|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
138881443|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
138881444|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138881445|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138881446|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138881447|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138881448|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
138881449|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138881450|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881451|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138881452|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138881453|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138881454|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
138881455|NCT00877890|Exenatide|exenatide|mesh-list
138881456|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138881457|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881458|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138881459|NCT00877890|Incretins|incretins|mesh-ancestor
138881460|NCT00877890|Hormones|hormones|mesh-ancestor
138881461|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881462|NCT02648672|BPN14770|bpn14770|mesh-list
138881463|NCT02648672|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138881464|NCT02648672|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138881465|NCT02648672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881466|NCT02648672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881468|NCT04221971|Fludarabine|fludarabine|mesh-list
138881469|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138881470|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
138881471|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881472|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138881473|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138881474|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
138881475|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881476|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881477|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138881478|NCT02644694|Dexamethasone|dexamethasone|mesh-list
138881479|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138881480|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138881481|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138881482|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
138881483|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
138505335|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138881484|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881485|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881486|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138881487|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
138881488|NCT02644694|Hormones|hormones|mesh-ancestor
138881489|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881490|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138881491|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881492|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138881493|NCT02653742|Ketorolac|ketorolac|mesh-list
138881494|NCT02653742|Fentanyl|fentanyl|mesh-list
138881495|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138881496|NCT02653742|Narcotics|narcotics|mesh-ancestor
138881497|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138881498|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881499|NCT02653742|Analgesics|analgesics|mesh-ancestor
138881500|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
138881501|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881502|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138881503|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138881504|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
138881505|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
138881506|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138881507|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138881509|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138881510|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138881511|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881512|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881513|NCT02755259|Acetazolamide|acetazolamide|mesh-list
138881514|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
138881515|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138881516|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881517|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881518|NCT02755259|Diuretics|diuretics|mesh-ancestor
138881519|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
138881520|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881521|NCT02575222|Nivolumab|nivolumab|mesh-list
138881522|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138881523|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881524|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138881525|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881526|NCT00680394|Misoprostol|misoprostol|mesh-list
138881527|NCT00680394|Mifepristone|mifepristone|mesh-list
138881528|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138505432|NCT00397501|Carboplatin|carboplatin|mesh-list
138881529|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
138881530|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138881531|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881532|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138881533|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138881534|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
138881535|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138881536|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138881537|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138881538|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138881539|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
138881540|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138881541|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138881542|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
138881543|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881544|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
138881545|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138881546|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138881548|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138881549|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881550|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881551|NCT00671814|Linezolid|linezolid|mesh-list
138881552|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138881553|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881554|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138881555|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881556|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881557|NCT02627430|Talazoparib|talazoparib|mesh-list
138881558|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138881559|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881560|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819414|NCT04192981|GDC-0084|gdc-0084|mesh-list
138881561|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881562|NCT02759393|Lansoprazole|lansoprazole|mesh-list
138881563|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
138881564|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138881565|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138881566|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138881567|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881568|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881569|NCT02576548|MEDI4276|medi4276|mesh-list
138881570|NCT02576548|Immunoconjugates|immunoconjugates|mesh-ancestor
138881571|NCT02576548|Immunologic Factors|immunologic factors|mesh-ancestor
138881572|NCT02576548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881573|NCT02758925|Cytarabine|cytarabine|mesh-list
138881574|NCT02758925|Rituximab|rituximab|mesh-list
138881575|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138881576|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138881577|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881578|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
138881579|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881580|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138505548|NCT00045136|Melphalan|melphalan|mesh-list
138881581|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138881582|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
138881583|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881584|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
138881585|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881586|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138881587|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138881588|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
138881589|NCT00676260|Pioglitazone|pioglitazone|mesh-list
138881590|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138881591|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881592|NCT00652652|Furosemide|furosemide|mesh-list
138881593|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138881594|NCT00652652|Diuretics|diuretics|mesh-ancestor
138881595|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
138881596|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881597|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138881598|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138881599|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881600|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
138881601|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138881602|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881603|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138881604|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138881605|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138881606|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881607|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
138881608|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138881609|NCT02644616|Torsemide|torsemide|mesh-list
138881610|NCT02644616|Tolvaptan|tolvaptan|mesh-list
139059156|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138505582|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138881611|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138881612|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881613|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
138881614|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881615|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138881616|NCT02644616|Diuretics|diuretics|mesh-ancestor
138881617|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138881618|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138881619|NCT02648048|Pirfenidone|pirfenidone|mesh-list
138881620|NCT02648048|Analgesics|analgesics|mesh-ancestor
138881621|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
138881622|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881623|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881624|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138881625|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138881626|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138881627|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138881628|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881630|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138881631|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059157|NCT01104844|Acetaminophen|acetaminophen|mesh-list
138881632|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881633|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138881634|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
138881636|NCT04150536|Lidocaine|lidocaine|mesh-list
138881637|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
138881638|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
138881639|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138881640|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881641|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
138881642|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881643|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138881644|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138881645|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138881646|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138881647|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881648|NCT05167123|Calcium|calcium|mesh-list
138881649|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138881650|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881651|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138881652|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
138505683|NCT00001688|Ritonavir|ritonavir|mesh-list
138881653|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881654|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
138881655|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138881656|NCT02576314|Ledipasvir|ledipasvir|mesh-list
138881657|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
138881658|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881659|NCT00650234|Metformin|metformin|mesh-list
138881660|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138881661|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881662|NCT00680940|Paclitaxel|paclitaxel|mesh-list
138881663|NCT00680940|Cisplatin|cisplatin|mesh-list
138881664|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138881665|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881666|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
138881667|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
138881668|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
138881669|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881671|NCT02644304|Clomiphene|clomiphene|mesh-list
138881672|NCT02644304|Enclomiphene|enclomiphene|mesh-list
138881673|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
138881674|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881675|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138881676|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
138881677|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881678|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881679|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138881680|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
138881681|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138881682|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138881683|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138881684|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138881685|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138881686|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
138881687|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
138881688|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138881689|NCT00681174|Acetaminophen|acetaminophen|mesh-list
138881690|NCT00681174|Morphine|morphine|mesh-list
138881691|NCT00681174|Remifentanil|remifentanil|mesh-list
138881692|NCT00681174|Oxycodone|oxycodone|mesh-list
138881693|NCT00681174|Propofol|propofol|mesh-list
138881694|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138881695|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138881696|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881697|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138881698|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
138881699|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
138881700|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138881701|NCT00681174|Narcotics|narcotics|mesh-ancestor
138881702|NCT00681174|Analgesics|analgesics|mesh-ancestor
138881703|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
138881704|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881705|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138881706|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
138881707|NCT02758769|Abatacept|abatacept|mesh-list
138881708|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138881709|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819575|NCT03337087|Fluorouracil|fluorouracil|mesh-list
138881710|NCT02758769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138881711|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881712|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138881714|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881715|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138881716|NCT04150146|Rebamipide|rebamipide|mesh-list
138881717|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138881718|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138881719|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
138881720|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881721|NCT04150146|Protective Agents|protective agents|mesh-ancestor
138881722|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881723|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881724|NCT00652730|Buspirone|buspirone|mesh-list
138881725|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138881726|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138881727|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138881728|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881729|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138881730|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138881731|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
138881732|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138881733|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881735|NCT00652808|Valdecoxib|valdecoxib|mesh-list
138997080|NCT00979056|Rifaximin|rifaximin|mesh-list
138881750|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138881751|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138881752|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881753|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138881754|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138881755|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138881756|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
139059158|NCT01104844|Ibuprofen|ibuprofen|mesh-list
138881758|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138881759|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881760|NCT02535156|Risperidone|risperidone|mesh-list
138881761|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138881762|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
138881763|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138881764|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881765|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881766|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138881767|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138881768|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138881769|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138881770|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138881771|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
138881772|NCT03417895|Apatinib|apatinib|mesh-list
138881773|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533957|NCT04726657|Insulin|insulin|mesh-list
138881774|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138881775|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881776|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881805|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138881806|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881807|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
138881808|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881811|NCT01563835|Analgesics|analgesics|mesh-ancestor
138881812|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138881813|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138881814|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
138881815|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
138881816|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138881817|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
138881818|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
138881819|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881820|NCT02768207|Vemurafenib|vemurafenib|mesh-list
138881821|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881822|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138881823|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881824|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881825|NCT02653196|Cyclosporine|cyclosporine|mesh-list
138881826|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
138881827|NCT02653196|Fludarabine|fludarabine|mesh-list
138881830|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
138881831|NCT02653196|Thiotepa|thiotepa|mesh-list
138881832|NCT02653196|Tacrolimus|tacrolimus|mesh-list
138881833|NCT02653196|Cyclosporins|cyclosporins|mesh-list
138881834|NCT02653196|Mitogens|mitogens|mesh-list
138881835|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881836|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881837|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138881838|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
138881839|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881840|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138881841|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138881842|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138881843|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881844|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138881845|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
138881846|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881847|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
138881848|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138881849|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138881850|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138881851|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
138881852|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138881853|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138881854|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
138881855|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138881856|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
138881857|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138881858|NCT05135845|Spartalizumab|spartalizumab|mesh-list
138881859|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138881860|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881861|NCT05135845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138881862|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881863|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
138881864|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138881865|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881866|NCT00677118|Cisplatin|cisplatin|mesh-list
138881867|NCT00677118|Fluorouracil|fluorouracil|mesh-list
138881868|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881869|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
138997168|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
138881870|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881871|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138881872|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138881873|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
138881874|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881875|NCT02644226|Sevoflurane|sevoflurane|mesh-list
138881876|NCT02644226|Desflurane|desflurane|mesh-list
138881877|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138881878|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138881879|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
138881880|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
138881881|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138506031|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
138881882|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881884|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138881885|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881887|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138881888|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881889|NCT00714376|Docetaxel|docetaxel|mesh-list
138881890|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881891|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
138881892|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
138881893|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
138881894|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881895|NCT04068766|Bupivacaine|bupivacaine|mesh-list
138881896|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
138881897|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
138881898|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138881899|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881900|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
138997192|NCT00987870|Calcipotriene|calcipotriene|mesh-list
138881901|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881902|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
138881903|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138881904|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881905|NCT04725695|Lidocaine|lidocaine|mesh-list
138881906|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
138881907|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
138881908|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138881909|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881910|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
138881911|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881912|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138881913|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138881914|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138881915|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138881916|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881917|NCT04070794|Metformin|metformin|mesh-list
138881918|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138881919|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881920|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
138881921|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138881922|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138881923|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881924|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
138881925|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
138881926|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
138534112|NCT00078390|S 3304|s 3304|mesh-list
138881928|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
138997237|NCT04005612|Vitamins|vitamins|mesh-list
138881929|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138881930|NCT00677664|Diuretics|diuretics|mesh-ancestor
138506128|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138881931|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
138881932|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881933|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138881934|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
138881935|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138881936|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138881937|NCT02572492|Dexamethasone|dexamethasone|mesh-list
138881938|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
138881939|NCT02572492|Melphalan|melphalan|mesh-list
138881940|NCT02572492|BB 1101|bb 1101|mesh-list
138881941|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138881942|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
138881943|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
138881944|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138881945|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881946|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138881947|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
138881948|NCT02572492|Hormones|hormones|mesh-ancestor
138506184|NCT05641337|Insulin|insulin|mesh-list
138881949|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881950|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138881951|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881952|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
138881953|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881954|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881955|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138881956|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
138881957|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138881958|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138881959|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
138881960|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
138881961|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138881962|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881963|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
138881964|NCT00672282|Bicalutamide|bicalutamide|mesh-list
138881965|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
138881966|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
138881967|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138881968|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881969|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881970|NCT02753309|Sirolimus|sirolimus|mesh-list
138881971|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138881972|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138881973|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138881974|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881975|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
138881976|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138881977|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
138881978|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881979|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
138881980|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138881981|NCT04147728|Growth Substances|growth substances|mesh-ancestor
138881982|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881983|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
138881984|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881986|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138881987|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138881988|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138881989|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138881990|NCT00672360|Folic Acid|folic acid|mesh-list
138881991|NCT00672360|Hematinics|hematinics|mesh-ancestor
138881992|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
138881993|NCT00672360|Vitamins|vitamins|mesh-ancestor
138881994|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
138881995|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138881996|NCT02628522|Lidocaine|lidocaine|mesh-list
138881997|NCT02628522|Epinephrine|epinephrine|mesh-list
138881998|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
138881999|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
138882000|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882001|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882002|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
138882003|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882004|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138882005|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138882006|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138882007|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138882008|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882009|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138882010|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138882011|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
138882012|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882013|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138882014|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138882015|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
138882016|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138882017|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
138882018|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
138882019|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
138882020|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138882021|NCT02572336|Plasminogen|plasminogen|mesh-list
138882022|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138882023|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138882024|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138882025|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882026|NCT02750969|Lidocaine|lidocaine|mesh-list
138882027|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
138882028|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
138882029|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882030|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882031|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
138882032|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882033|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138887302|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138882034|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138882036|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138882037|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882038|NCT04067011|Doxycycline|doxycycline|mesh-list
138882039|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
138882040|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138882041|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882042|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
138882043|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138882044|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138882045|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138882046|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138882047|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882048|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882049|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882050|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138882051|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138882052|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
138882053|NCT00719056|Lactams|lactams|mesh-list
138882054|NCT00719056|Cephalosporins|cephalosporins|mesh-list
138882055|NCT00719056|Teicoplanin|teicoplanin|mesh-list
138882056|NCT00719056|beta-Lactams|beta-lactams|mesh-list
138882057|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138882058|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882059|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138882060|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138882061|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882062|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882063|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882064|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138882065|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138882066|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138820032|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
138882067|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138882068|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
138882069|NCT03475004|Bevacizumab|bevacizumab|mesh-list
138882070|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
138882071|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138882072|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882073|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138997332|NCT05919550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138882074|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138882075|NCT03475004|Growth Substances|growth substances|mesh-ancestor
138882076|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882077|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
138882078|NCT03475004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138882079|NCT03475004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882081|NCT02695745|Capsaicin|capsaicin|mesh-list
138882082|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138882083|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138882084|NCT02695745|Analgesics|analgesics|mesh-ancestor
138882085|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
138882086|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882087|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882088|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138882090|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138882091|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138882093|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882094|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
138882095|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
138882096|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138882097|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138882098|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138253596|NCT05751044|Antimetabolites|antimetabolites|mesh-ancestor
138882099|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138882100|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138882101|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882102|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882103|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882104|NCT00990067|Analgesics|analgesics|mesh-ancestor
138882105|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
138882106|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882107|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
138882108|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138882109|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
138882110|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
138882111|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
138882112|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138882113|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
138882114|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
138882115|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138882116|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
138882117|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882118|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
138882119|NCT00719290|Protective Agents|protective agents|mesh-ancestor
138882120|NCT00635921|Ziprasidone|ziprasidone|mesh-list
138882121|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138882122|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
138882123|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882124|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882125|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882126|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138882127|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138882128|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882129|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138882130|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138882131|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
138882132|NCT04166006|Interleukin-2|interleukin-2|mesh-list
138820192|NCT00770224|Doxorubicin|doxorubicin|mesh-list
138882133|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882134|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138882135|NCT04166006|Analgesics|analgesics|mesh-ancestor
138882136|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
138882137|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882138|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882140|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
138882141|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882142|NCT00710086|Remifentanil|remifentanil|mesh-list
138882143|NCT00710086|Hydromorphone|hydromorphone|mesh-list
138882144|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138882145|NCT00710086|Narcotics|narcotics|mesh-ancestor
138882146|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882147|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882148|NCT00710086|Analgesics|analgesics|mesh-ancestor
138882149|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
138882150|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882151|NCT00652886|Oxandrolone|oxandrolone|mesh-list
138882152|NCT00652886|Androgens|androgens|mesh-ancestor
138882153|NCT00652886|Hormones|hormones|mesh-ancestor
138882154|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820249|NCT01057589|Folic Acid|folic acid|mesh-list
138882155|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882156|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
138882157|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
138882158|NCT00539305|Testosterone|testosterone|mesh-list
138882159|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
138882160|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
138882161|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138882162|NCT00539305|Androgens|androgens|mesh-ancestor
138882164|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138882165|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882166|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138882167|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882168|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
138882169|NCT02643914|Nicotine|nicotine|mesh-list
138882170|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138882171|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
138882172|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882173|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882174|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138882175|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138882176|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
138882177|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882178|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882179|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
138882180|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138882181|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882182|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138882183|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138882184|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
138882185|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882186|NCT00990223|Eplerenone|eplerenone|mesh-list
138882187|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138882188|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
138882189|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138882190|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882191|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138882192|NCT00990223|Diuretics|diuretics|mesh-ancestor
138882193|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
138882194|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138882195|NCT00715780|Insulin|insulin|mesh-list
138882196|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138882197|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
138882198|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
138882199|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138882200|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
138882201|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
138882202|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
138882203|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
138882204|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
138882205|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138997491|NCT05664568|Amoxicillin|amoxicillin|mesh-list
138882206|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882207|NCT02652884|Betamethasone|betamethasone|mesh-list
138882208|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
138882209|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138882210|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
138882211|NCT02652884|Hormones|hormones|mesh-ancestor
138882212|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138882213|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882214|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138882215|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
138882216|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138882217|NCT00990301|Moexipril|moexipril|mesh-list
138882218|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138882219|NCT00990301|Diuretics|diuretics|mesh-ancestor
138882220|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
138882221|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882222|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138882223|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138882224|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882225|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138882226|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
138882227|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882228|NCT00715858|Doxycycline|doxycycline|mesh-list
138882230|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138882231|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882232|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
138882233|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138882234|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138882235|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138882236|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
138882237|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
138882238|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138882239|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882240|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882241|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138882242|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138820448|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
138882243|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138882244|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138882245|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138882246|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138882247|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
138882248|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138882249|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882250|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
138882251|NCT04696445|Morphine|morphine|mesh-list
138882252|NCT04696445|Oxycodone|oxycodone|mesh-list
138882253|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138882254|NCT04696445|Narcotics|narcotics|mesh-ancestor
138882255|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882256|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882257|NCT04696445|Analgesics|analgesics|mesh-ancestor
138882258|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
138882259|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882260|NCT05360953|Clonidine|clonidine|mesh-list
138882261|NCT05360953|Doxazosin|doxazosin|mesh-list
138882262|NCT05360953|Analgesics|analgesics|mesh-ancestor
138882263|NCT05360953|Sensory System Agents|sensory system agents|mesh-ancestor
138882264|NCT05360953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882265|NCT05360953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882266|NCT05360953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138882267|NCT05360953|Sympatholytics|sympatholytics|mesh-ancestor
138882268|NCT05360953|Autonomic Agents|autonomic agents|mesh-ancestor
138882269|NCT05360953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138882270|NCT05360953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138882271|NCT05360953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138882272|NCT05360953|Adrenergic Agents|adrenergic agents|mesh-ancestor
138882273|NCT05360953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882274|NCT05360953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882275|NCT05360953|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138882276|NCT05360953|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138882277|NCT05360953|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138882278|NCT02647424|Letrozole|letrozole|mesh-list
138882279|NCT02647424|Clomiphene|clomiphene|mesh-list
138882280|NCT02647424|Enclomiphene|enclomiphene|mesh-list
138882281|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
138882282|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882283|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138882284|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138882285|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882286|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882287|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138882288|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
138882289|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138882290|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882291|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138882292|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
138882293|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138882294|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138882295|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138882296|NCT02574754|Warfarin|warfarin|mesh-list
138882297|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
138882298|NCT00719602|Ritonavir|ritonavir|mesh-list
138882299|NCT00719602|Lopinavir|lopinavir|mesh-list
138882300|NCT00719602|Lamivudine|lamivudine|mesh-list
138882301|NCT00719602|Zidovudine|zidovudine|mesh-list
138882302|NCT00719602|Nevirapine|nevirapine|mesh-list
138882304|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138882305|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
138882306|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506949|NCT00053872|Vincristine|vincristine|mesh-list
138882307|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882308|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138882309|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138882310|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
138882311|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882312|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138882313|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138882314|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138882315|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138882316|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
138882317|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138882318|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138882319|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138882320|NCT02652650|Norethindrone|norethindrone|mesh-list
138882321|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
138882322|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138882323|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138882324|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138882325|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
138328022|NCT03984240|Midazolam|midazolam|mesh-list
138882326|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138882327|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882328|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138882329|NCT02652650|Estrogens|estrogens|mesh-ancestor
138882330|NCT02652650|Hormones|hormones|mesh-ancestor
138882331|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887303|NCT04219865|Protective Agents|protective agents|mesh-ancestor
138882332|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138882334|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138882335|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
138882336|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882337|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882338|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138882339|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
138882340|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138882341|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882342|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882343|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
138882344|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138882345|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138882346|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
138882347|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882348|NCT00710320|Anesthetics|anesthetics|mesh-list
138882349|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882350|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882352|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
138882353|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138882354|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138882355|NCT00716170|Hormones|hormones|mesh-ancestor
138882356|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138882357|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882358|NCT00716170|Incretins|incretins|mesh-ancestor
138882359|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
138882360|NCT02652806|Hematinics|hematinics|mesh-ancestor
138882361|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
138882362|NCT04529135|Remifentanil|remifentanil|mesh-list
138882363|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138882364|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882365|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882366|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138882367|NCT04529135|Analgesics|analgesics|mesh-ancestor
138882368|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
138882369|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882370|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138882371|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138882372|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138882373|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
138997624|NCT05219929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997626|NCT05205382|Nicotine|nicotine|mesh-list
138882374|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138534548|NCT00403312|Nicotine|nicotine|mesh-list
138882375|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882376|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138882377|NCT04529135|Narcotics|narcotics|mesh-ancestor
138882378|NCT02647190|Asparaginase|asparaginase|mesh-list
138882379|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882380|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138882381|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
138882382|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882383|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
138882384|NCT04165850|Celecoxib|celecoxib|mesh-list
138882385|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138882386|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138882387|NCT04165850|Analgesics|analgesics|mesh-ancestor
138882388|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
138882389|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882390|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882391|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138882392|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138507159|NCT00055393|Bupropion|bupropion|mesh-list
138882393|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138882394|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138882395|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882396|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882397|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138882398|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882399|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138882400|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138882401|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882402|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138882403|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138882404|NCT00719758|Beraprost|beraprost|mesh-list
138882405|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138882406|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
138882407|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
138882408|NCT02647268|Oxytocin|oxytocin|mesh-list
138882409|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
138882410|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138882411|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882412|NCT02647268|Analgesics|analgesics|mesh-ancestor
138882413|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
138882414|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882415|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
138882416|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882417|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138882418|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
138882419|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138882420|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138882421|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882422|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138882423|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
138882424|NCT04218149|Bupivacaine|bupivacaine|mesh-list
138882425|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
138882426|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
138882427|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882428|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882429|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
138882430|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882431|NCT04032860|Tenofovir|tenofovir|mesh-list
138882432|NCT04032860|Entecavir|entecavir|mesh-list
138882433|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
138882434|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882435|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138882436|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138882437|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882438|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882439|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138882440|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138882441|NCT00716248|Bucillamine|bucillamine|mesh-list
138882442|NCT00716248|Methotrexate|methotrexate|mesh-list
138882443|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138882444|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
138882445|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138882446|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882447|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138882448|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
138534627|NCT03399838|Midazolam|midazolam|mesh-list
138882449|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882450|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882451|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
138882452|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882453|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138882454|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138882455|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
138882456|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138882457|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138882458|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138882459|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138882460|NCT00716248|Analgesics|analgesics|mesh-ancestor
138882461|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
138882462|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882463|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138882464|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
138882465|NCT00716248|Protective Agents|protective agents|mesh-ancestor
138882466|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
138882467|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138882468|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
138882469|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138882470|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
138882471|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882472|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882473|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
138882474|NCT02642900|Nystatin|nystatin|mesh-list
138820828|NCT00998738|Calcium|calcium|mesh-list
138882475|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138882476|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882478|NCT02642900|Ionophores|ionophores|mesh-ancestor
138882479|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138882480|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882482|NCT02652728|Enalaprilat|enalaprilat|mesh-list
138882483|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138882484|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
138882485|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882486|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882487|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138882488|NCT00720148|Bortezomib|bortezomib|mesh-list
138882489|NCT00720148|Sunitinib|sunitinib|mesh-list
138882490|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882491|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138882492|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138882493|NCT00720148|Growth Substances|growth substances|mesh-ancestor
138882494|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882495|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
138882496|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138882497|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882498|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882499|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
138882500|NCT00710788|Calcium|calcium|mesh-list
138882501|NCT00710788|Sevelamer|sevelamer|mesh-list
138882502|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138882503|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882504|NCT00710788|Antacids|antacids|mesh-ancestor
138882505|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882506|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138882507|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
138882508|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
138882509|NCT02646800|Micafungin|micafungin|mesh-list
138882510|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
138882511|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882512|NCT02749409|Parecoxib|parecoxib|mesh-list
138882513|NCT02749409|Morphine|morphine|mesh-list
138882514|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138882515|NCT02749409|Narcotics|narcotics|mesh-ancestor
138820931|NCT04299971|Methotrexate|methotrexate|mesh-list
138507367|NCT05495321|Aldesleukin|aldesleukin|mesh-list
138882516|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882517|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882518|NCT02749409|Analgesics|analgesics|mesh-ancestor
138882519|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
138882520|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882521|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138882522|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138882523|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882524|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882525|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138882526|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138882527|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138882528|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138882529|NCT03449459|Amikacin|amikacin|mesh-list
138882530|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138882531|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882532|NCT00653120|Propranolol|propranolol|mesh-list
138882533|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138882534|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138882535|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
138882536|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882537|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882538|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882539|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138882540|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138882541|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
138882542|NCT00678132|Gemcitabine|gemcitabine|mesh-list
138882543|NCT00678132|Olaparib|olaparib|mesh-list
138882544|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882545|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138882546|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
138882547|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882548|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138882549|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882550|NCT02789345|Osimertinib|osimertinib|mesh-list
138882551|NCT02789345|Ramucirumab|ramucirumab|mesh-list
138882552|NCT02789345|Necitumumab|necitumumab|mesh-list
138882553|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882554|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138882555|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882556|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882557|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138882558|NCT02772965|Methotrexate|methotrexate|mesh-list
138882559|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138882560|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
138882561|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138882562|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882563|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138882564|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
138882565|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882566|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882567|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
138882568|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882569|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138882570|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138882571|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
138882572|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138882573|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138882574|NCT00681720|Flumazenil|flumazenil|mesh-list
138882575|NCT00681720|Antidotes|antidotes|mesh-ancestor
138882576|NCT00681720|Protective Agents|protective agents|mesh-ancestor
138882577|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882578|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
138882579|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
138882580|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882581|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882582|NCT00650312|Metformin|metformin|mesh-list
138882583|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138882584|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882585|NCT00538681|Pemetrexed|pemetrexed|mesh-list
138882586|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882587|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882588|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507431|NCT00057421|Hormones|hormones|mesh-ancestor
138882589|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138882590|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138882591|NCT00650390|Adalimumab|adalimumab|mesh-list
138882592|NCT00650390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138882593|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138882594|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138882595|NCT00681876|Bevacizumab|bevacizumab|mesh-list
138882596|NCT00681876|Cetuximab|cetuximab|mesh-list
138882597|NCT00681876|Irinotecan|irinotecan|mesh-list
138882598|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138882599|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534802|NCT00130546|Sirolimus|sirolimus|mesh-list
138821109|NCT00769132|Niacin|niacin|mesh-list
138882600|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138882601|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138882603|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882604|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
138882605|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138882606|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138882607|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882608|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882609|NCT02226367|Prazosin|prazosin|mesh-list
138882610|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138882611|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138882612|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138882613|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138882614|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
138882615|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882616|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882617|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882618|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138882619|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
138882620|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882621|NCT02628132|Paclitaxel|paclitaxel|mesh-list
138882622|NCT02628132|Durvalumab|durvalumab|mesh-list
138882623|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138882624|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882625|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
138882626|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
138882627|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
138882628|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882629|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138882630|NCT02695355|Methylphenidate|methylphenidate|mesh-list
138882631|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138882632|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882633|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138882634|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138882635|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138882636|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882637|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
138882638|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882639|NCT02573038|Aflibercept|aflibercept|mesh-list
138882640|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138882641|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138821185|NCT00994448|Bupropion|bupropion|mesh-list
138882642|NCT02573038|Growth Substances|growth substances|mesh-ancestor
138882643|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882644|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
138882645|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882646|NCT01822015|Cytarabine|cytarabine|mesh-list
138882647|NCT01822015|Sirolimus|sirolimus|mesh-list
138882648|NCT01822015|Idarubicin|idarubicin|mesh-list
138882649|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138882650|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
138882651|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882652|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882653|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
138882654|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882655|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138882656|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
138882657|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882658|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138882659|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138882660|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
138882661|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882662|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138882663|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138882664|NCT00990535|Octreotide|octreotide|mesh-list
138882665|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138882666|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138882667|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882668|NCT05590897|Anti-Infective Agents|anti-infective agents|mesh-list
138882669|NCT05590897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138882670|NCT00720304|Docetaxel|docetaxel|mesh-list
138882671|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138882672|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882673|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
138882675|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
138882676|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882677|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138882678|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882679|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
138882680|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
138882681|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
138882682|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882683|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882684|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
138882685|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882686|NCT00990691|Desipramine|desipramine|mesh-list
138882687|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138882688|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
138882689|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138882690|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882691|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882692|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138882693|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138882694|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138882695|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
138882696|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882697|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882698|NCT00678522|Atorvastatin|atorvastatin|mesh-list
138882699|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138882700|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138882701|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
138882702|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882703|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138882704|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138882705|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882706|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
138882707|NCT04391855|Tramadol|tramadol|mesh-list
138882708|NCT04391855|Ropivacaine|ropivacaine|mesh-list
138882709|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138882710|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882711|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882712|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138882713|NCT04391855|Analgesics|analgesics|mesh-ancestor
138882714|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
138882715|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882716|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138882717|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138882718|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138882719|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
138882720|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882721|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882722|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
138882723|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
138882724|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138882725|NCT04391855|Narcotics|narcotics|mesh-ancestor
138882726|NCT00716950|Losartan|losartan|mesh-list
138882727|NCT00716950|Valsartan|valsartan|mesh-list
138882728|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138882729|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138882730|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138882731|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882732|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138882733|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138882734|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138882735|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138882736|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
138882737|NCT00678756|Ketoconazole|ketoconazole|mesh-list
138882738|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
138882739|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882740|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138882741|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138882742|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882743|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882744|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138882745|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
138534929|NCT00131053|Hormones|hormones|mesh-ancestor
138882746|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138882747|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882748|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138882749|NCT02748395|Triamcinolone|triamcinolone|mesh-list
138882751|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
138882752|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
138882753|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882754|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882755|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
138882756|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821385|NCT00714883|Sirolimus|sirolimus|mesh-list
138882757|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138882758|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138882759|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138882760|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138882761|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507763|NCT00060385|Prednisone|prednisone|mesh-list
138882762|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138882763|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
138882764|NCT02748395|Hormones|hormones|mesh-ancestor
138882765|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138882766|NCT02629224|Gabapentin|gabapentin|mesh-list
138882767|NCT02629224|Analgesics|analgesics|mesh-ancestor
138882768|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
138882769|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882770|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882771|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
138882772|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138882774|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882775|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138882776|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138882777|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138882778|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821408|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
138882779|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882781|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
138882782|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138882783|NCT00711256|Protective Agents|protective agents|mesh-ancestor
138882784|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882785|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
138882786|NCT04069234|Clopidogrel|clopidogrel|mesh-list
138882787|NCT04069234|Ticagrelor|ticagrelor|mesh-list
138882788|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138882789|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138882790|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138882791|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138882792|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
138882793|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882794|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882795|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882796|NCT00720538|Thalidomide|thalidomide|mesh-list
138882797|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138882798|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
138507819|NCT05312372|Paclitaxel|paclitaxel|mesh-list
138882799|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882800|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
138882801|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138882802|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882803|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138882804|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138882806|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
138882807|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882808|NCT00678990|Heparin|heparin|mesh-list
138882809|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
138882810|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138882811|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138882812|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882813|NCT00679068|Bosentan|bosentan|mesh-list
138882814|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138882815|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138882816|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882817|NCT00679146|Ketoprofen|ketoprofen|mesh-list
138882818|NCT00679146|Colchicine|colchicine|mesh-list
138882819|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138882820|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138882822|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
138882823|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882824|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882825|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138882826|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138882827|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138882828|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882829|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882830|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
138882831|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
138882832|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
138882834|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882836|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138882837|NCT02748005|Fenugreek seed meal|fenugreek seed meal|mesh-list
138882838|NCT02748005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138882839|NCT02748005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882840|NCT00990847|Procaterol|procaterol|mesh-list
138882841|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138882842|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
138882843|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882844|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882845|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138882846|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
138882847|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
138882848|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138882849|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138882850|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138882851|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
138882852|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882853|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882854|NCT00594516|Tapentadol|tapentadol|mesh-list
138882855|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138882856|NCT00594516|Narcotics|narcotics|mesh-ancestor
138882857|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882858|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882859|NCT00594516|Analgesics|analgesics|mesh-ancestor
138882860|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
138882861|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882862|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138882863|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138882864|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138882865|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882866|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
138882867|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138882868|NCT00682500|Calfactant|calfactant|mesh-list
138882869|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138882870|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
138882871|NCT00538291|Capecitabine|capecitabine|mesh-list
138882872|NCT00538291|Cetuximab|cetuximab|mesh-list
138882873|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138882874|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
138882875|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882876|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821618|NCT00715273|Vitamins|vitamins|mesh-ancestor
138882877|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138882878|NCT00682578|Artesunate|artesunate|mesh-list
138882879|NCT00682578|Chloroquine|chloroquine|mesh-list
138882880|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
138882881|NCT00682578|Piperaquine|piperaquine|mesh-list
138507952|NCT06197529|Antipruritics|antipruritics|mesh-ancestor
138507953|NCT06197529|Dermatologic Agents|dermatologic agents|mesh-ancestor
138507954|NCT06197529|Sensory System Agents|sensory system agents|mesh-ancestor
138507955|NCT06197529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882882|NCT00682578|Artenimol|artenimol|mesh-list
138882883|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
138882885|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138882886|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882887|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882888|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
138882889|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
138882890|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138882891|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
138882892|NCT00682578|Amebicides|amebicides|mesh-ancestor
138882893|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138508000|NCT06197022|Immunologic Factors|immunologic factors|mesh-ancestor
138882894|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138882895|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882896|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882897|NCT00594906|Teriparatide|teriparatide|mesh-list
138882898|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138882899|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882900|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138882901|NCT02745431|Oxytocin|oxytocin|mesh-list
138882902|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
138882903|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138882904|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882905|NCT00682656|Azithromycin|azithromycin|mesh-list
138882906|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138882907|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138882908|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138882909|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138882910|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138882911|NCT05590117|Leucovorin|leucovorin|mesh-list
138882912|NCT05590117|Fluorouracil|fluorouracil|mesh-list
138882913|NCT05590117|Oxaliplatin|oxaliplatin|mesh-list
138882914|NCT05590117|Pentoxifylline|pentoxifylline|mesh-list
138882915|NCT05590117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882916|NCT05590117|Antimetabolites|antimetabolites|mesh-ancestor
138882917|NCT05590117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882918|NCT05590117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138882919|NCT05590117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882920|NCT05590117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138882921|NCT05590117|Immunologic Factors|immunologic factors|mesh-ancestor
138882922|NCT05590117|Antidotes|antidotes|mesh-ancestor
138882923|NCT05590117|Protective Agents|protective agents|mesh-ancestor
138882924|NCT05590117|Vitamin B Complex|vitamin b complex|mesh-ancestor
138882925|NCT05590117|Vitamins|vitamins|mesh-ancestor
138882926|NCT05590117|Micronutrients|micronutrients|mesh-ancestor
138882927|NCT05590117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138882928|NCT05590117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882929|NCT05590117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138882931|NCT05590117|Vasodilator Agents|vasodilator agents|mesh-ancestor
138882932|NCT05590117|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138882933|NCT05590117|Antioxidants|antioxidants|mesh-ancestor
138882934|NCT00636311|Gemcitabine|gemcitabine|mesh-list
138882935|NCT00636311|Bortezomib|bortezomib|mesh-list
138882936|NCT00636311|Vinorelbine|vinorelbine|mesh-list
138882937|NCT00636311|Ifosfamide|ifosfamide|mesh-list
138882938|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138882939|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
138882940|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882941|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882942|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138882943|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
138882944|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
138882945|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
138821777|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
138882946|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138882947|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
138882950|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138882951|NCT00679458|Narcotics|narcotics|mesh-ancestor
138882952|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138882953|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882954|NCT00679458|Analgesics|analgesics|mesh-ancestor
138882955|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
138882956|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138882957|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138882958|NCT04216511|Autoantibodies|autoantibodies|mesh-list
138882959|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
138882960|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882961|NCT02747537|Irinotecan|irinotecan|mesh-list
138882962|NCT02747537|Sorafenib|sorafenib|mesh-list
138882963|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138882964|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138882965|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882966|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882967|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882968|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138882969|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
138882970|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138709291|NCT03416179|Cytarabine|cytarabine|mesh-list
138882971|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138882972|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882973|NCT02747381|Vitamins|vitamins|mesh-ancestor
138882974|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
138882975|NCT00673218|Omalizumab|omalizumab|mesh-list
138882976|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138882977|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138882978|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
138882979|NCT00673296|Bevacizumab|bevacizumab|mesh-list
138997847|NCT04162873|Celecoxib|celecoxib|mesh-list
138882980|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138882981|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882982|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138882983|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138882984|NCT00673296|Growth Substances|growth substances|mesh-ancestor
138882985|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138882986|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
138882987|NCT04216355|Azacitidine|azacitidine|mesh-list
138882988|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138882989|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
138882990|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138882991|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138882992|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138882993|NCT00683124|Losartan|losartan|mesh-list
138882994|NCT00683124|Nebivolol|nebivolol|mesh-list
138882995|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138821872|NCT02686827|Vitamin D|vitamin d|mesh-list
138882996|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138882997|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138882998|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138882999|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883001|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138883002|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138883003|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138883004|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
138883005|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883006|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883007|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
138883008|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138883009|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883010|NCT00683202|Aspirin|aspirin|mesh-list
138883011|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138883012|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138883013|NCT00683202|Analgesics|analgesics|mesh-ancestor
138883014|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
138883015|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883016|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883017|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138883018|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138883019|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138883020|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138709383|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138709384|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138709385|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
138709386|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709387|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138709388|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138709389|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709390|NCT01549587|Listerine|listerine|mesh-list
138709391|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
138709392|NCT01549587|Fluorides|fluorides|mesh-list
138709393|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
138709394|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
138709395|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
138709396|NCT01549587|Protective Agents|protective agents|mesh-ancestor
138709397|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709398|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138709399|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138665735|NCT03737994|Ceritinib|ceritinib|mesh-list
138883021|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883022|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138883023|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138883024|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883025|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
138883026|NCT00679536|Fludarabine|fludarabine|mesh-list
138883027|NCT00679536|Busulfan|busulfan|mesh-list
138883028|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
138883029|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883030|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883031|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138883032|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
138883033|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883034|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
138883035|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138709443|NCT01047540|Pritelivir|pritelivir|mesh-list
138709444|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
138709445|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138709446|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709447|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709448|NCT00521222|Fluticasone|fluticasone|mesh-list
138709449|NCT00521222|Xhance|xhance|mesh-list
138709450|NCT00521222|Albuterol|albuterol|mesh-list
138709451|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138709452|NCT00521222|Ipratropium|ipratropium|mesh-list
138883036|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138883037|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
138883038|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138883039|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883041|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
138883042|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138883043|NCT00679614|Acetaminophen|acetaminophen|mesh-list
138883045|NCT00679614|Naloxone|naloxone|mesh-list
138883046|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138883047|NCT00679614|Analgesics|analgesics|mesh-ancestor
138883048|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
138883049|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883050|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883051|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
138883052|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138883053|NCT00679614|Narcotics|narcotics|mesh-ancestor
138883054|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138883055|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138883056|NCT02744417|Bupropion|bupropion|mesh-list
138883057|NCT02744417|Nicotine|nicotine|mesh-list
138883058|NCT02744417|Varenicline|varenicline|mesh-list
138883059|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138883060|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
138822027|NCT02573935|Clarithromycin|clarithromycin|mesh-list
138883061|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883062|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883063|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138883064|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138883065|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
138883066|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883067|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883068|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138709499|NCT03456401|Sunitinib|sunitinib|mesh-list
138883069|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
138883070|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138883071|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138883072|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138883073|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138883074|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
138883075|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138883076|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138883077|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883078|NCT02629146|Midazolam|midazolam|mesh-list
138883079|NCT02629146|Fentanyl|fentanyl|mesh-list
138883080|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139210411|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883081|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138883082|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138883083|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883084|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138883085|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138883086|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138883087|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138883088|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
138883089|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
138883090|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
138883091|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
138883092|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883093|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883094|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138883095|NCT02629146|Narcotics|narcotics|mesh-ancestor
138883096|NCT02629146|Analgesics|analgesics|mesh-ancestor
138883097|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
138883098|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883100|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
138883101|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883102|NCT00991159|Bococizumab|bococizumab|mesh-list
138883103|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138883104|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138883105|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
138883106|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883107|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138883108|NCT00679770|Tavaborole|tavaborole|mesh-list
138883109|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
138883110|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883111|NCT02744495|Betamethasone|betamethasone|mesh-list
138883112|NCT02744495|Droperidol|droperidol|mesh-list
138883113|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138883114|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
138883115|NCT02744495|Hormones|hormones|mesh-ancestor
138883116|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138883117|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883118|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138883119|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
138883120|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138883122|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
138883123|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883124|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138883125|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138883126|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138883127|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138883128|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138883129|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138883130|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138883132|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883133|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883134|NCT00683358|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138883135|NCT00683358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138883136|NCT00683358|Immunologic Factors|immunologic factors|mesh-ancestor
138709583|NCT04645914|Nicotine|nicotine|mesh-list
138883137|NCT00683358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883138|NCT00683436|Adipiplon|adipiplon|mesh-list
138883139|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138883140|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883141|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
138883142|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
138883143|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883144|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883145|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138883146|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138883147|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138883148|NCT00989443|Cidofovir|cidofovir|mesh-list
138883149|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
138883150|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883151|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883152|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883153|NCT00683514|Cisplatin|cisplatin|mesh-list
138883154|NCT00683514|Vinorelbine|vinorelbine|mesh-list
138883155|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883156|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138883157|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
138883158|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
138883159|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
138883160|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883161|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
138883162|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138883163|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
138883164|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883165|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138883166|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138883167|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
138883168|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883169|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883170|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138883171|NCT05629325|Buspirone|buspirone|mesh-list
138883172|NCT05629325|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138883173|NCT05629325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138883174|NCT05629325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138883175|NCT05629325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883176|NCT05629325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138883177|NCT05629325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138883178|NCT05629325|Serotonin Agents|serotonin agents|mesh-ancestor
138883179|NCT05629325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883180|NCT05629325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883181|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
138883182|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138883183|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
138883184|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883185|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
138883186|NCT02629380|Protective Agents|protective agents|mesh-ancestor
138883187|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
138883188|NCT02743247|Tacrolimus|tacrolimus|mesh-list
138883189|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138883190|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
138883191|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883192|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138883193|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883194|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883195|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138883196|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883197|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138883198|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
138535376|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138883199|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138883200|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883201|NCT00680160|Tavaborole|tavaborole|mesh-list
138883202|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
138883203|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883204|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
138883205|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138883206|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883207|NCT00537823|Leucovorin|leucovorin|mesh-list
138883208|NCT00537823|Bevacizumab|bevacizumab|mesh-list
138883209|NCT00537823|Cetuximab|cetuximab|mesh-list
138883210|NCT00537823|Fluorouracil|fluorouracil|mesh-list
138883211|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
138883212|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138883213|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883214|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138883215|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138883216|NCT00537823|Growth Substances|growth substances|mesh-ancestor
138883217|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883218|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
138883219|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
138883220|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883221|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138709720|NCT00547664|Morphine|morphine|mesh-list
138883222|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138883223|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
138883224|NCT00537823|Antidotes|antidotes|mesh-ancestor
138883225|NCT00537823|Protective Agents|protective agents|mesh-ancestor
138883226|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
138883227|NCT00537823|Vitamins|vitamins|mesh-ancestor
138883228|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
138883229|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
139210412|NCT03375242|Crizotinib|crizotinib|mesh-list
138883230|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
138883231|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883232|NCT04139928|Cathartics|cathartics|mesh-ancestor
138883233|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138883234|NCT04139928|Antacids|antacids|mesh-ancestor
138883235|NCT05589025|Eugenol|eugenol|mesh-list
138883236|NCT05589025|Zinc Oxide|zinc oxide|mesh-list
138883237|NCT05589025|Dermatologic Agents|dermatologic agents|mesh-ancestor
138883238|NCT05589025|Sunscreening Agents|sunscreening agents|mesh-ancestor
138883239|NCT05589025|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138883240|NCT05589025|Protective Agents|protective agents|mesh-ancestor
138883241|NCT05589025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883242|NCT05589025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883243|NCT02742233|Saxagliptin|saxagliptin|mesh-list
138883244|NCT02742233|Incretins|incretins|mesh-ancestor
138883245|NCT02742233|Hormones|hormones|mesh-ancestor
138822304|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
138883246|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138883247|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883248|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138883249|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
138883250|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883251|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883252|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138883253|NCT00673608|Deferasirox|deferasirox|mesh-list
138883254|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138883255|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
138883256|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
138709761|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883257|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883258|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
138883259|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
138883260|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138883261|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138883262|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883264|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138883265|NCT02742467|Perindopril|perindopril|mesh-list
138883266|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138883268|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138883269|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883270|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138883271|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883272|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
138883273|NCT02742467|Diuretics|diuretics|mesh-ancestor
138883274|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
138883275|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138883276|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138883278|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883279|NCT00684216|Tamoxifen|tamoxifen|mesh-list
138883280|NCT00684216|Capecitabine|capecitabine|mesh-list
138883281|NCT00684216|Letrozole|letrozole|mesh-list
138883282|NCT00684216|Anastrozole|anastrozole|mesh-list
138883283|NCT00684216|Exemestane|exemestane|mesh-list
138883284|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138883286|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883287|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883288|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138883289|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138883290|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883291|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138883292|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
138883293|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138883294|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883295|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138883296|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138883297|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138883298|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138883299|NCT00684450|Protamines|protamines|mesh-list
138883300|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
138883301|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883302|NCT00684450|Coagulants|coagulants|mesh-ancestor
138883303|NCT00684528|Metformin|metformin|mesh-list
138883304|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138883305|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883306|NCT00684606|Oxytocin|oxytocin|mesh-list
138883307|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
138883308|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138883309|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883311|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883312|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883313|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138883314|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
138883315|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883316|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138883317|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138883318|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883319|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
138883320|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138883321|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883322|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138883323|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138883324|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
138883325|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883326|NCT00991627|Atropine|atropine|mesh-list
138883327|NCT00991627|Ephedrine|ephedrine|mesh-list
138883328|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
138883329|NCT00991627|Morphine|morphine|mesh-list
138883330|NCT00991627|Bupivacaine|bupivacaine|mesh-list
138883331|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
138709918|NCT04643691|Diuretics|diuretics|mesh-ancestor
138883333|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138883334|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883335|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
138883336|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883337|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138883338|NCT00991627|Narcotics|narcotics|mesh-ancestor
138883339|NCT00991627|Analgesics|analgesics|mesh-ancestor
138883340|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138883341|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138883342|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138883343|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
138822493|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138883344|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138883345|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
138883346|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
138883347|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
138883348|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138883349|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138883350|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
138883351|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883352|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883353|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138883354|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
138883355|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138883356|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
138883357|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
138883358|NCT03562871|Carboplatin|carboplatin|mesh-list
138883359|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
138883361|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883362|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138883363|NCT03562871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138883364|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883365|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883366|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138883367|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138883368|NCT00690222|Mydriatics|mydriatics|mesh-list
138883369|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
138883370|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883371|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883372|NCT02736071|Celecoxib|celecoxib|mesh-list
138883373|NCT02736071|Tramadol|tramadol|mesh-list
138883374|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138883375|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138883376|NCT02736071|Analgesics|analgesics|mesh-ancestor
138883377|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
138883378|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883379|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883380|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138883381|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138883382|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138883383|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138658927|NCT00436761|Melphalan|melphalan|mesh-list
138883384|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883385|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883386|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138883388|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138883389|NCT00690300|Docetaxel|docetaxel|mesh-list
138883390|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
138883391|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883392|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
138883393|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
138883394|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
138883395|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883396|NCT02741219|Sufentanil|sufentanil|mesh-list
138883397|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
138883398|NCT02741219|Dsuvia|dsuvia|mesh-list
138883399|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138883400|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138883401|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883402|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138883403|NCT02741219|Analgesics|analgesics|mesh-ancestor
138883404|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
138883405|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883406|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138883407|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138883408|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138883409|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
138883410|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059159|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138883411|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883412|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138883413|NCT02741219|Narcotics|narcotics|mesh-ancestor
138883414|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138883415|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138883416|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
138883417|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
138883418|NCT00690534|Insulin|insulin|mesh-list
138883419|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138883420|NCT00690534|Nitroprusside|nitroprusside|mesh-list
138883421|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138883422|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883423|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138883424|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
138883425|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138883426|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883427|NCT00991705|Atorvastatin|atorvastatin|mesh-list
138883428|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138883429|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138883430|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
138883431|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883432|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138883433|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138883434|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883435|NCT02735837|Doxycycline|doxycycline|mesh-list
138883436|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138883437|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883438|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
138883439|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138883440|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138883441|NCT02625558|Riociguat|riociguat|mesh-list
138883442|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
138883443|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883444|NCT00685230|Antivenins|antivenins|mesh-list
138883445|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
138883446|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883447|NCT05455879|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138883448|NCT05455879|Respiratory System Agents|respiratory system agents|mesh-ancestor
138883449|NCT00991783|Digoxin|digoxin|mesh-list
138883450|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138883451|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138883452|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059160|NCT01104844|Analgesics|analgesics|mesh-ancestor
138883453|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883454|NCT00991783|Protective Agents|protective agents|mesh-ancestor
138883455|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883456|NCT00690768|Bevacizumab|bevacizumab|mesh-list
138998003|NCT03395314|Midazolam|midazolam|mesh-list
138883457|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138883458|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883459|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138883460|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138883461|NCT00690768|Growth Substances|growth substances|mesh-ancestor
138883462|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883463|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
138883465|NCT00690846|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138883466|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138883467|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138883468|NCT00685464|Abciximab|abciximab|mesh-list
138883469|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
138883470|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138883471|NCT02740829|Glucagon|glucagon|mesh-list
138883472|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138883473|NCT02740829|Hormones|hormones|mesh-ancestor
138883474|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138883475|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883476|NCT00685542|Diacerein|diacerein|mesh-list
138883477|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138883478|NCT02741063|Oxytocin|oxytocin|mesh-list
138883479|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
138883480|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138883481|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883482|NCT04138836|Itraconazole|itraconazole|mesh-list
138883483|NCT04138836|Midazolam|midazolam|mesh-list
138883484|NCT04138836|Esomeprazole|esomeprazole|mesh-list
138883485|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138883486|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138883487|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138883488|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883489|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138883490|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138883491|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138883492|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138883493|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
138883494|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
138883495|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
138883496|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
138883497|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883498|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883499|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138883500|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138883501|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138883502|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883503|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
138883504|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883505|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138883506|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138883507|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138883508|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
138883509|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138883510|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138883512|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883513|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138883514|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883515|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883516|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
138883517|NCT02735603|Naltrexone|naltrexone|mesh-list
138883518|NCT02735603|Bupropion|bupropion|mesh-list
138883519|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138883520|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883521|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138883522|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138883523|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883524|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883525|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883526|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883527|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138883528|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138883529|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
138883530|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883531|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138883532|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
138883533|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138883534|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138883535|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138883536|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138883538|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883539|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138883540|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138883542|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138883543|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138883544|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
138883545|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883546|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138883547|NCT00685854|Ranibizumab|ranibizumab|mesh-list
138883548|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138883549|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138883550|NCT00685854|Growth Substances|growth substances|mesh-ancestor
138883551|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883552|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
138883553|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883554|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
138883555|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
138883556|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138883557|NCT04003207|Hormones|hormones|mesh-list
138883558|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138883559|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883560|NCT05295355|Bromides|bromides|mesh-list
138883561|NCT05295355|Tiotropium Bromide|tiotropium bromide|mesh-list
138883562|NCT05295355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138883563|NCT05295355|Autonomic Agents|autonomic agents|mesh-ancestor
138883564|NCT05295355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883565|NCT05295355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883566|NCT05295355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138883567|NCT05295355|Respiratory System Agents|respiratory system agents|mesh-ancestor
138822700|NCT02865668|Metformin|metformin|mesh-list
138883568|NCT05295355|Parasympatholytics|parasympatholytics|mesh-ancestor
138883569|NCT05295355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138883570|NCT05295355|Cholinergic Agents|cholinergic agents|mesh-ancestor
138883571|NCT05295355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883572|NCT05295355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883574|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
138883575|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138883576|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
138535751|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
138883577|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
138883578|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883579|NCT01564303|Expectorants|expectorants|mesh-ancestor
138883580|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
138883581|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138883583|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883584|NCT01564303|Protective Agents|protective agents|mesh-ancestor
138883585|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883586|NCT01564303|Antidotes|antidotes|mesh-ancestor
138883587|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138883588|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883589|NCT00674232|Misoprostol|misoprostol|mesh-list
138883590|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138883591|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
138883592|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138883593|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883594|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138883595|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138883597|NCT00674310|Ropinirole|ropinirole|mesh-list
138883598|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138883599|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138883600|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
138883601|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
138883602|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883603|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883604|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883605|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
138883606|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138883607|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138883608|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
138883609|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883610|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138883612|NCT05265247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138883613|NCT05265247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138822771|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
138883614|NCT05265247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138883615|NCT05265247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883616|NCT05265247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883617|NCT03823300|Aflibercept|aflibercept|mesh-list
138883618|NCT03823300|Faricimab|faricimab|mesh-list
138883619|NCT03823300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138883620|NCT03823300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138883621|NCT03823300|Growth Substances|growth substances|mesh-ancestor
138883622|NCT03823300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883623|NCT03823300|Growth Inhibitors|growth inhibitors|mesh-ancestor
138883624|NCT03823300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883625|NCT00537745|Naltrexone|naltrexone|mesh-list
138883626|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138883627|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138883628|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883629|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
138883630|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883631|NCT00686322|Paclitaxel|paclitaxel|mesh-list
138883632|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138883633|NCT00686322|Cisplatin|cisplatin|mesh-list
138883634|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138883635|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883636|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
138883637|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
138883638|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
138883639|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883640|NCT02734511|Propofol|propofol|mesh-list
138883641|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138883642|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138883643|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998046|NCT03172975|Antacids|antacids|mesh-ancestor
138883644|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138883645|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
138883646|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
138883647|NCT04003441|Fexuprazan|fexuprazan|mesh-list
138883648|NCT04003441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138883649|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138883650|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
138883651|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883652|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138883653|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138883654|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883655|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
138883656|NCT02739815|Coagulants|coagulants|mesh-ancestor
138883657|NCT00720616|Insulin|insulin|mesh-list
138883658|NCT00720616|Hormones|hormones|mesh-list
138883659|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138883660|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883661|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138883662|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
138883663|NCT00720772|Antidotes|antidotes|mesh-ancestor
138883664|NCT00720772|Protective Agents|protective agents|mesh-ancestor
138883665|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883666|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
138883667|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883668|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
138883669|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138883670|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883671|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
138710492|NCT04655508|Hormones|hormones|mesh-ancestor
138883672|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
138883673|NCT00720850|Lenalidomide|lenalidomide|mesh-list
138883674|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
138883675|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883676|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138883677|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138883678|NCT00720850|Growth Substances|growth substances|mesh-ancestor
138883679|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
138883680|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883681|NCT03785158|Melatonin|melatonin|mesh-list
138883682|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
138883683|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883684|NCT03785158|Protective Agents|protective agents|mesh-ancestor
138883685|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883686|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138883687|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138883688|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138883689|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
138883690|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883691|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883692|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883693|NCT02733809|Sorafenib|sorafenib|mesh-list
138883694|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883695|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138883696|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883697|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883698|NCT00717340|Paclitaxel|paclitaxel|mesh-list
138883699|NCT00717340|Tivozanib|tivozanib|mesh-list
138883700|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138883701|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883702|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
138998067|NCT03020589|Tacrolimus|tacrolimus|mesh-list
138883704|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
138883705|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883706|NCT00717340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138883707|NCT00717340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883708|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138883709|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138883710|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883711|NCT00874848|Paclitaxel|paclitaxel|mesh-list
138883712|NCT00874848|Carboplatin|carboplatin|mesh-list
138883713|NCT00874848|Cetuximab|cetuximab|mesh-list
138883714|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138883715|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138883716|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883717|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
138883718|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
138883719|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
138883720|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883721|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138883722|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
138883723|NCT00691236|Doxorubicin|doxorubicin|mesh-list
138883724|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138883725|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883726|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138883727|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138883728|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883729|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883730|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138883731|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883732|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
138883733|NCT04137978|Diuretics|diuretics|mesh-ancestor
138883734|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
138883735|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883736|NCT04137978|Expectorants|expectorants|mesh-ancestor
138883737|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
138883738|NCT00691392|Linezolid|linezolid|mesh-list
138883739|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138823011|NCT00640575|Triamcinolone|triamcinolone|mesh-list
138883740|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883741|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138883742|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883743|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883744|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138883746|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883747|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138883748|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883749|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883750|NCT00717730|Vitamins|vitamins|mesh-list
138883751|NCT00717730|Folic Acid|folic acid|mesh-list
138883752|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
138883753|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
138883754|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
138883755|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
138883756|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883757|NCT00717730|Hematinics|hematinics|mesh-ancestor
138883758|NCT00691470|Warfarin|warfarin|mesh-list
138883759|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
138883760|NCT05407597|Icatibant|icatibant|mesh-list
138883761|NCT05407597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138883762|NCT05407597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138883763|NCT05407597|Analgesics|analgesics|mesh-ancestor
138883764|NCT05407597|Sensory System Agents|sensory system agents|mesh-ancestor
138883765|NCT05407597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883766|NCT05407597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883767|NCT05407597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138883768|NCT05407597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138883769|NCT05407597|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138883770|NCT05407597|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138883771|NCT05407597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883772|NCT05407597|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138883773|NCT05407597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138883775|NCT05407207|Immunologic Factors|immunologic factors|mesh-list
138883776|NCT05407207|Immunomodulating Agents|immunomodulating agents|mesh-list
138883777|NCT05407207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883779|NCT05493995|Gemcitabine|gemcitabine|mesh-list
138883780|NCT05493995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138883781|NCT05493995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883782|NCT05493995|Tubulin Modulators|tubulin modulators|mesh-ancestor
138883783|NCT05493995|Antimitotic Agents|antimitotic agents|mesh-ancestor
138883784|NCT05493995|Mitosis Modulators|mitosis modulators|mesh-ancestor
138883785|NCT05493995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883786|NCT05493995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138883787|NCT05493995|Antimetabolites|antimetabolites|mesh-ancestor
138883788|NCT00717808|Tranilast|tranilast|mesh-list
138883789|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
138883790|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138883791|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138883792|NCT00717808|Analgesics|analgesics|mesh-ancestor
138823108|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883793|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
138883794|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883795|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883796|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138883797|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138883798|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138710726|NCT04652739|Lycopene|lycopene|mesh-list
138883799|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138883800|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883801|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138883802|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138883803|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
138883804|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
138883805|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883806|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138883807|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138883808|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
138883809|NCT02738177|Isosorbide|isosorbide|mesh-list
138883810|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138883812|NCT02738177|Misoprostol|misoprostol|mesh-list
138883813|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138883814|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
138883815|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138883816|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883817|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138883818|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138883819|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
138883820|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138883821|NCT02738177|Diuretics|diuretics|mesh-ancestor
138883822|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
138710787|NCT00562068|Hormones|hormones|mesh-ancestor
138883823|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
138883824|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138883825|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883826|NCT04043806|Ivacaftor|ivacaftor|mesh-list
138883827|NCT04043806|Elexacaftor|elexacaftor|mesh-list
138883828|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138883829|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138883830|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883831|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138883833|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883834|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
138883835|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883836|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883837|NCT05290753|Erythromycin|erythromycin|mesh-list
138883838|NCT05290753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138883839|NCT05290753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823232|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
138883840|NCT05290753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138883841|NCT05290753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138883842|NCT05290753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883843|NCT05290753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883844|NCT02737709|Paclitaxel|paclitaxel|mesh-list
138883845|NCT02737709|Carboplatin|carboplatin|mesh-list
138883846|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138883847|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883848|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
138883849|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
138883850|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
138883851|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883852|NCT02572960|Vitamin D|vitamin d|mesh-list
138883853|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
138883854|NCT02572960|Valsartan|valsartan|mesh-list
138883855|NCT02572960|Vitamins|vitamins|mesh-ancestor
138883856|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
138883857|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883858|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138883859|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138883860|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138883861|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138883862|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138883863|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883864|NCT04001959|Fluorides|fluorides|mesh-list
138883865|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
138883866|NCT04001959|Protective Agents|protective agents|mesh-ancestor
138883867|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883868|NCT00721240|Montelukast|montelukast|mesh-list
138883869|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138883870|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
138883871|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138883872|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
138883873|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138883874|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883875|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138883876|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138883877|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883878|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138883879|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138883880|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138883881|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
138883882|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883883|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138883884|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138883885|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883886|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138710860|NCT02902289|Ibuprofen|ibuprofen|mesh-list
138883887|NCT00721552|Prednisolone|prednisolone|mesh-list
138883888|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138883889|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
138883890|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138883891|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
138883892|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138883893|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
138883894|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138883895|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
138883896|NCT00721552|Hormones|hormones|mesh-ancestor
138883897|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138883898|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883899|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138883900|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883902|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
138883903|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883904|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138883905|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138883906|NCT00721552|Protective Agents|protective agents|mesh-ancestor
138883907|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138883908|NCT00721552|Incretins|incretins|mesh-ancestor
138883909|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138883910|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
138883911|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883912|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883914|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138883915|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138883916|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
138883917|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
138883918|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883919|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883920|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138883921|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
138883922|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138883923|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
138883924|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138883925|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883926|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138883927|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
138883928|NCT02732249|Metronidazole|metronidazole|mesh-list
138883929|NCT02732249|Clarithromycin|clarithromycin|mesh-list
138883930|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
138883931|NCT02732249|Esomeprazole|esomeprazole|mesh-list
138883932|NCT02732249|Bismuth|bismuth|mesh-list
138883933|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883934|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883935|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138883936|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138883937|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138883938|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138883939|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138883940|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138883941|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883942|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138883943|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138883944|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138883945|NCT02732249|Antacids|antacids|mesh-ancestor
138883946|NCT02732249|Diuretics|diuretics|mesh-ancestor
138883947|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
138883948|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883949|NCT02732249|Expectorants|expectorants|mesh-ancestor
138883950|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
138883951|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
138883952|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
138883953|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
138883954|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138883955|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138883956|NCT02732093|Lidocaine|lidocaine|mesh-list
138883957|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
138883958|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
138883959|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138883960|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883961|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
138883962|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138883963|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138883964|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138883965|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138883966|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138883967|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883968|NCT00718276|Vitamin D|vitamin d|mesh-list
138883969|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
138883970|NCT00718276|Vitamins|vitamins|mesh-ancestor
138883971|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
138883972|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883973|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138711002|NCT01212757|Apremilast|apremilast|mesh-list
138883974|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138883975|NCT00718354|Cisplatin|cisplatin|mesh-list
138883976|NCT00718354|Carboplatin|carboplatin|mesh-list
138883977|NCT00718354|Capecitabine|capecitabine|mesh-list
138883978|NCT00718354|Fluorouracil|fluorouracil|mesh-list
138883979|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
138883980|NCT00718354|Epirubicin|epirubicin|mesh-list
138883982|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138883983|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138883984|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
138883985|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138883986|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138883987|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
138883988|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138883989|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138883990|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138883991|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138883992|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138883993|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
138883994|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138883995|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138883996|NCT00536809|Capecitabine|capecitabine|mesh-list
138883997|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
138883998|NCT00536809|Lapatinib|lapatinib|mesh-list
138883999|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138884000|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
138884001|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884002|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884003|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138884004|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884005|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
138884006|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
138884007|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884009|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884010|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138884011|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884012|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884013|NCT00536731|Budesonide|budesonide|mesh-list
138884014|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138884015|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138884016|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
138884017|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138884018|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138884019|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
138884020|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884021|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884022|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
138884023|NCT00536731|Hormones|hormones|mesh-ancestor
138884024|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138884025|NCT02571712|Timolol|timolol|mesh-list
138884026|NCT02571712|Bimatoprost|bimatoprost|mesh-list
138884027|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138884028|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138884029|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
138884030|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884031|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884032|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884033|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138884034|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138884036|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138884037|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138884038|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884039|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138884040|NCT02730845|Analgesics|analgesics|mesh-ancestor
138884041|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
138884042|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884043|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138884044|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138884045|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138884046|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
138884047|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884048|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998152|NCT01265030|Sirolimus|sirolimus|mesh-list
138884050|NCT02730689|Ezetimibe|ezetimibe|mesh-list
138884051|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138884052|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138884053|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
138884054|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884055|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139059161|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
138711080|NCT04621110|Midazolam|midazolam|mesh-list
138884056|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138884057|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884058|NCT02730533|Esomeprazole|esomeprazole|mesh-list
138884059|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138884060|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138884061|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138884062|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884063|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884064|NCT00536575|Bortezomib|bortezomib|mesh-list
138884065|NCT00536575|Sorafenib|sorafenib|mesh-list
138884066|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884067|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138884068|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884069|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884070|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138884071|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138884072|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
138884073|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884074|NCT03214250|Paclitaxel|paclitaxel|mesh-list
138884075|NCT03214250|Gemcitabine|gemcitabine|mesh-list
138884076|NCT03214250|Nivolumab|nivolumab|mesh-list
138884077|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138823596|NCT00734383|Propofol|propofol|mesh-list
138884078|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884079|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
138884080|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
138884081|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
138884082|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884083|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138884084|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
138884085|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138884086|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138884087|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
138884088|NCT00722098|Vaccines|vaccines|mesh-list
138884089|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
138884090|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884091|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138884092|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138711110|NCT04621110|Narcotics|narcotics|mesh-ancestor
138884093|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138884094|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
138884095|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884096|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884097|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138884098|NCT05245591|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
138884099|NCT05245591|Anticoagulants|anticoagulants|mesh-ancestor
138884100|NCT00992095|Buprenorphine|buprenorphine|mesh-list
138884101|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138884102|NCT00992095|Narcotics|narcotics|mesh-ancestor
138884103|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138884104|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884105|NCT00992095|Analgesics|analgesics|mesh-ancestor
138884106|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
138823633|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
138884107|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884108|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138884109|NCT00653354|Valdecoxib|valdecoxib|mesh-list
138884110|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138884111|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138884112|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884113|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884114|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138884115|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138884116|NCT00653354|Analgesics|analgesics|mesh-ancestor
138884117|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
138884118|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884119|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884120|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138884121|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138884122|NCT00712504|Docetaxel|docetaxel|mesh-list
138884123|NCT00712504|Sunitinib|sunitinib|mesh-list
138884124|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884125|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
138884126|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
138884127|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
138884128|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884129|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138884130|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138884131|NCT00712504|Growth Substances|growth substances|mesh-ancestor
138823678|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884132|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884134|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138884135|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884137|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138884138|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138884139|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884140|NCT02694653|Acetaminophen|acetaminophen|mesh-list
138884141|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138884142|NCT02694653|Analgesics|analgesics|mesh-ancestor
138884143|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
138884144|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884145|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884146|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
138884147|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
138884148|NCT00722956|Atorvastatin|atorvastatin|mesh-list
138884149|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138884150|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138884151|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
138667534|NCT02957435|Eplerenone|eplerenone|mesh-list
138884152|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884153|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138884154|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138884155|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884156|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138884157|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138884158|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138884159|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
138884160|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884161|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138884162|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884163|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884164|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884165|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138884166|NCT02729285|Ketorolac|ketorolac|mesh-list
138884167|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138884168|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138884169|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138884170|NCT02729285|Analgesics|analgesics|mesh-ancestor
138884171|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
138884172|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884173|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884174|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138884175|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138884176|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138884177|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536357|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138884178|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884180|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138884181|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
138884182|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711236|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
138884183|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884184|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884185|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138884186|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138884187|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138884188|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138884189|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138998293|NCT00490971|Olanzapine|olanzapine|mesh-list
138884190|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
138884191|NCT02729441|Ramipril|ramipril|mesh-list
138884192|NCT02729441|Perindopril|perindopril|mesh-list
138823791|NCT00752206|Saracatinib|saracatinib|mesh-list
138884193|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138884194|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
138884195|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884196|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884197|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138884198|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
138884199|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138884200|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138884201|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884202|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138884204|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884205|NCT00722488|Pevonedistat|pevonedistat|mesh-list
138884206|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884207|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884208|NCT00652106|Timolol|timolol|mesh-list
138884209|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138884210|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138884211|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138884212|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138884213|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138884214|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
138884215|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884216|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884217|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884218|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138884219|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138884220|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138884221|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138884222|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138884223|NCT00723268|Prednisolone|prednisolone|mesh-list
138884224|NCT00723268|Colchicine|colchicine|mesh-list
138884225|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138884226|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
138884227|NCT00723268|Hormones|hormones|mesh-ancestor
138884228|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138884229|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884230|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138823815|NCT00642135|Phenylephrine|phenylephrine|mesh-list
138884231|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884232|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
138884233|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138884234|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
138884235|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
138884236|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
138711315|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
138884237|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884238|NCT00874770|Ribavirin|ribavirin|mesh-list
138884239|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138884240|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
138884241|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884242|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
138884243|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884244|NCT00536263|Interferons|interferons|mesh-list
138884245|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
138884246|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
138884247|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138884248|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536434|NCT00148330|Triamcinolone|triamcinolone|mesh-list
138884249|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
138884250|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884251|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
138884252|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884253|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
138884254|NCT00578344|Busulfan|busulfan|mesh-list
138884255|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
138884256|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138884257|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
138884258|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884259|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823854|NCT02537379|Ribavirin|ribavirin|mesh-list
138884260|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138884262|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884263|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884264|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138884265|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138884266|NCT00653588|Atorvastatin|atorvastatin|mesh-list
138884267|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138884268|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138884269|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138884270|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
138884271|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884272|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138884273|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138884274|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884275|NCT00723346|Asparaginase|asparaginase|mesh-list
138884276|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884277|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
138884278|NCT02571400|Analgesics|analgesics|mesh-list
138884279|NCT02571400|Narcotics|narcotics|mesh-ancestor
138884280|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138998419|NCT01019109|Cobalt|cobalt|mesh-list
138884281|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884282|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
138884283|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884285|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
138884286|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138884287|NCT02641652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138823899|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884288|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138884289|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138884290|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884291|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884292|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
138884293|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884294|NCT02626104|Lactoferrin|lactoferrin|mesh-list
138884295|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884296|NCT02571166|Valacyclovir|valacyclovir|mesh-list
138884297|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
138884298|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884299|NCT00686478|Interferons|interferons|mesh-list
138884300|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
138884301|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
138884302|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884303|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
138884304|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884305|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
138884306|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986500|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998477|NCT01016223|Beclomethasone|beclomethasone|mesh-list
138884307|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
138884308|NCT00723424|Digoxin|digoxin|mesh-list
138884309|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138884310|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138884311|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884312|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884313|NCT00723424|Protective Agents|protective agents|mesh-ancestor
138884314|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884315|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138884316|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138884317|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138884318|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
138884319|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884320|NCT02641340|Fentanyl|fentanyl|mesh-list
138884321|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138884322|NCT02641340|Narcotics|narcotics|mesh-ancestor
138884323|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138536525|NCT00148681|Paclitaxel|paclitaxel|mesh-list
138884324|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884325|NCT02641340|Analgesics|analgesics|mesh-ancestor
138884326|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
138884327|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884328|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138884329|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138884330|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
138884331|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
138884332|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
138884333|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138884334|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138884335|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884336|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
138884337|NCT02625948|Coagulants|coagulants|mesh-ancestor
138884338|NCT02571556|Dexamethasone|dexamethasone|mesh-list
138884339|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138884340|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138884341|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138884342|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
138884343|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
138884344|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884345|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884346|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138884347|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
138884349|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138884350|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138884351|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711510|NCT00558090|Analgesics|analgesics|mesh-ancestor
138884352|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138884353|NCT00691548|Cetuximab|cetuximab|mesh-list
138884354|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138884355|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884356|NCT00712738|Nifedipine|nifedipine|mesh-list
138884357|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138884358|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138884359|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884360|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138884361|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884362|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
138884363|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
138884364|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138884366|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
138884367|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
138884368|NCT00686556|Fludarabine|fludarabine|mesh-list
138884369|NCT00686556|Cyclosporins|cyclosporins|mesh-list
138884370|NCT00686556|Lenograstim|lenograstim|mesh-list
138884371|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138884372|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
138884373|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884374|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138884375|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138884376|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
138884377|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884378|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884379|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138884380|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998560|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
138884381|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
138884382|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884383|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
138884384|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138884385|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138884386|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138884387|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
138884388|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138884389|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138884390|NCT04070482|Tenofovir|tenofovir|mesh-list
138884391|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
138884392|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884393|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138884394|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138884395|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884396|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884397|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138884398|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138884399|NCT04166786|Ethanol|ethanol|mesh-list
138884400|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
138884401|NCT04166786|Petrolatum|petrolatum|mesh-list
138884402|NCT04166786|Testosterone|testosterone|mesh-list
138884403|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
138884404|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
138884405|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138884406|NCT04166786|Androgens|androgens|mesh-ancestor
138884407|NCT04166786|Hormones|hormones|mesh-ancestor
138884408|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138884409|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884410|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138884411|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884412|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
138884413|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138884414|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884415|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138884416|NCT04166786|Emollients|emollients|mesh-ancestor
138884417|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
138884418|NCT02727647|Factor VIII|factor viii|mesh-list
138884419|NCT02727647|Coagulants|coagulants|mesh-ancestor
138884420|NCT00723502|Amoxicillin|amoxicillin|mesh-list
138884421|NCT00723502|Finafloxacin|finafloxacin|mesh-list
138884422|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
138884423|NCT00723502|Esomeprazole|esomeprazole|mesh-list
138884424|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138884425|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884426|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138884427|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138884428|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138884429|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884430|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884431|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138884432|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138659964|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138884433|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138884434|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884435|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138884437|NCT02727881|Ranibizumab|ranibizumab|mesh-list
138884438|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138884439|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138884440|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138884441|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138884442|NCT02727881|Growth Substances|growth substances|mesh-ancestor
138884443|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884444|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
138884445|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884446|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138884447|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884448|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138884449|NCT02727881|Protective Agents|protective agents|mesh-ancestor
138884450|NCT01564381|Resveratrol|resveratrol|mesh-list
138884451|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
138884452|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884453|NCT01564381|Protective Agents|protective agents|mesh-ancestor
138884454|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884455|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884456|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138884457|NCT04164524|Gentamicins|gentamicins|mesh-list
138884458|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138884459|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884460|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138884461|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884462|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884465|NCT00723658|Dexamethasone|dexamethasone|mesh-list
138884466|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
138884467|NCT00723658|Melphalan|melphalan|mesh-list
138884468|NCT00723658|Carmustine|carmustine|mesh-list
138884469|NCT00723658|Rituximab|rituximab|mesh-list
138884470|NCT00723658|Doxorubicin|doxorubicin|mesh-list
138884471|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138884472|NCT00723658|Etoposide|etoposide|mesh-list
138884473|NCT00723658|Bortezomib|bortezomib|mesh-list
138884474|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138884475|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
138884476|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884477|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138884478|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138884479|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
138884480|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884481|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884482|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138884483|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138884484|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
138884485|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
138884486|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884487|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138884488|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
138884489|NCT00723658|Hormones|hormones|mesh-ancestor
138884490|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138884491|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138884492|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138884493|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138884494|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138884495|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138884496|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884497|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138884498|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138884499|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
138884500|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
138884501|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884502|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
138884503|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138884504|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138884505|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138884506|NCT00723658|Growth Substances|growth substances|mesh-ancestor
138884507|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
138884508|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
138660040|NCT00453609|Naltrexone|naltrexone|mesh-list
138884509|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884510|NCT02638142|Furosemide|furosemide|mesh-list
138884511|NCT02638142|Diuretics|diuretics|mesh-ancestor
138884512|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
138884513|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884514|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138884515|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138884516|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884517|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
138884518|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
138884519|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
138884520|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138884521|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138884522|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884523|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884524|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884526|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138884527|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
138884528|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884529|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884530|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138884531|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
138884532|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
138884533|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138884534|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138884535|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138884536|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138791691|NCT04164238|Paclitaxel|paclitaxel|mesh-list
138884537|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
138884538|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884539|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884540|NCT00686868|Ofatumumab|ofatumumab|mesh-list
138884541|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884542|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
138884543|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138884544|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884545|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138884546|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138884547|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884548|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884549|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884550|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138884551|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138884552|NCT02645864|Irinotecan|irinotecan|mesh-list
138884554|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138884555|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138884556|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884557|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884558|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884559|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138884560|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
138884561|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138884562|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884563|NCT02574130|Amikacin|amikacin|mesh-list
138884564|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138884565|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884566|NCT00652184|Valacyclovir|valacyclovir|mesh-list
138884567|NCT00652184|Sorivudine|sorivudine|mesh-list
138884568|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
138884569|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884570|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884571|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884572|NCT02726867|Lacosamide|lacosamide|mesh-list
138884573|NCT02726867|Ketamine|ketamine|mesh-list
138884574|NCT02726867|Levetiracetam|levetiracetam|mesh-list
138884575|NCT02726867|Phenobarbital|phenobarbital|mesh-list
138884576|NCT02726867|Analgesics|analgesics|mesh-ancestor
138791745|NCT01132820|Cediranib|cediranib|mesh-list
138884577|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
138884578|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884579|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884580|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138884581|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138884582|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
139210413|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884583|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
138884584|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138884585|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138884586|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138884587|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884588|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884589|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
138884590|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
138884591|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138884592|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138884593|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138884594|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138884595|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
138884596|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
138884597|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138884598|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138884599|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138884600|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138884601|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
138884602|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138884603|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138884604|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138884605|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138884606|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884607|NCT00873366|Tamoxifen|tamoxifen|mesh-list
138884608|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
138884609|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884610|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138884611|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
138884612|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138884613|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884614|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138884615|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884616|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138884617|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138884618|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138884619|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
138884620|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
138884621|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138884622|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138884623|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884624|NCT00712894|Verapamil|verapamil|mesh-list
138884625|NCT00712894|Diltiazem|diltiazem|mesh-list
138884626|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
138884627|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
138884628|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138884629|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138884630|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138884631|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884632|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138884633|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884634|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138884635|NCT04164368|Lenalidomide|lenalidomide|mesh-list
138884637|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884638|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138884639|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138884640|NCT04164368|Growth Substances|growth substances|mesh-ancestor
138884641|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
138884642|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884643|NCT02726555|Atorvastatin|atorvastatin|mesh-list
138884644|NCT02726555|Red yeast rice|red yeast rice|mesh-list
138884645|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138884646|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138884647|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
138884648|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884649|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138884650|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138884651|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884652|NCT00536107|Docetaxel|docetaxel|mesh-list
138884653|NCT00536107|Gefitinib|gefitinib|mesh-list
138884654|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210414|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138884655|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
138884656|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
138884657|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
138884658|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884659|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138884660|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884661|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
138884662|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138884663|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
138884664|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884665|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138884666|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138884667|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
138884668|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884669|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884670|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138884671|NCT00724360|Trastuzumab|trastuzumab|mesh-list
138884672|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138884673|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884674|NCT02637830|Fluorides|fluorides|mesh-list
138884675|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
138884676|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
138884677|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
138884678|NCT02637830|Protective Agents|protective agents|mesh-ancestor
138884679|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884680|NCT00687258|Vitamin E|vitamin e|mesh-list
138884681|NCT00687258|Vitamins|vitamins|mesh-ancestor
138884682|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
138884683|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884684|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
138884685|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884686|NCT00687258|Protective Agents|protective agents|mesh-ancestor
138884688|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138884689|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884690|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
138884691|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
138884692|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
138884693|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884694|NCT00692016|Naproxen|naproxen|mesh-list
138884695|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138884696|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138884697|NCT00692016|Analgesics|analgesics|mesh-ancestor
138884698|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
138884699|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884700|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824393|NCT02667561|Hormones|hormones|mesh-ancestor
138536874|NCT00049361|Growth Substances|growth substances|mesh-ancestor
138884701|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138884702|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138884703|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
138791967|NCT04159870|Rifaximin|rifaximin|mesh-list
138884704|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138884705|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884706|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884707|NCT02733107|Etoposide|etoposide|mesh-list
138884708|NCT02733107|Apatinib|apatinib|mesh-list
138884709|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138884710|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884711|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138884712|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138884713|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884714|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884715|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138884716|NCT00675012|Capecitabine|capecitabine|mesh-list
138884717|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
138884718|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138884719|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
138884720|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884721|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884722|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138884723|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
138884724|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138792025|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
138884725|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138884726|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884727|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884728|NCT00652262|Urological Agents|urological agents|mesh-ancestor
138884730|NCT02640794|Clopidogrel|clopidogrel|mesh-list
138884731|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138884732|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138884733|NCT02640794|Analgesics|analgesics|mesh-ancestor
138884734|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
138884735|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884736|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884737|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138884738|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138884739|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138884740|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138884741|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884742|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138884743|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138884744|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884745|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
138884746|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138884747|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138884748|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138884749|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
138884750|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884751|NCT00724672|Adalimumab|adalimumab|mesh-list
138884752|NCT00724672|Infliximab|infliximab|mesh-list
138884753|NCT00724672|Etanercept|etanercept|mesh-list
138884754|NCT00724672|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138884755|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138884756|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138884757|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
138884758|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138884759|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138884760|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138884761|NCT00724672|Analgesics|analgesics|mesh-ancestor
138884762|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
138884763|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884764|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884765|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138884766|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
138884767|NCT02624856|Dexamethasone|dexamethasone|mesh-list
138884768|NCT02624856|Bupivacaine|bupivacaine|mesh-list
138884769|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138884770|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
138884771|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
138884772|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884773|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884774|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138884775|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
138884776|NCT02624856|Hormones|hormones|mesh-ancestor
138884777|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138884778|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138884779|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884780|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
138884781|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
138884782|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138884783|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
138884784|NCT02646020|Loratadine|loratadine|mesh-list
138884785|NCT02646020|Aprepitant|aprepitant|mesh-list
138884786|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
138884787|NCT02646020|Desloratadine|desloratadine|mesh-list
138884788|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
138884789|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
138884790|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884791|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884792|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138792114|NCT02633878|Progestins|progestins|mesh-ancestor
138884793|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138884794|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884795|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884796|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138884797|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
138884798|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138884799|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138884800|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
138884801|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
138884802|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
138884803|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
138884804|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138884805|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138884806|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
138884807|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
138884808|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138884809|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138884810|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138884811|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884812|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138884813|NCT00992797|Vitamin D|vitamin d|mesh-list
138884814|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
138884815|NCT00992797|Vitamins|vitamins|mesh-ancestor
138884816|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
138185866|NCT03490825|Melatonin|melatonin|mesh-list
138884817|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998743|NCT01037842|Mitiglinide|mitiglinide|mesh-list
138884818|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138884819|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138884821|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138884822|NCT02725541|Maytansine|maytansine|mesh-list
138884823|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138884824|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884825|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138884826|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
138884827|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
138884828|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
138884829|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884830|NCT02725541|Immunotoxins|immunotoxins|mesh-ancestor
138884831|NCT02725541|Immunoconjugates|immunoconjugates|mesh-ancestor
138884832|NCT02725541|Immunologic Factors|immunologic factors|mesh-ancestor
138884833|NCT02725541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884834|NCT00911066|Azacitidine|azacitidine|mesh-list
138884835|NCT00911066|Pevonedistat|pevonedistat|mesh-list
138884836|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138884837|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
138884838|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884839|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884840|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884841|NCT02733341|Ticagrelor|ticagrelor|mesh-list
138884842|NCT02733341|Cangrelor|cangrelor|mesh-list
138884843|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138884844|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138884845|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138884846|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138884847|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
138884848|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884849|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884850|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884851|NCT00692172|Alefacept|alefacept|mesh-list
138884852|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
138884853|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
138884854|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884855|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138884856|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138884857|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138884858|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
138884859|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884860|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138884861|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138884862|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
138884863|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
138884864|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138884865|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138884866|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138884867|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
138884868|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138884869|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884870|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138884871|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138884872|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138884873|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138884874|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884875|NCT03675139|Progestins|progestins|mesh-ancestor
138884877|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138884878|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
139210415|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884879|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138884880|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138884881|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884882|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
138884883|NCT02645552|Coagulants|coagulants|mesh-ancestor
138884885|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138884886|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138884887|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
138884888|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884889|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884890|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884891|NCT00687648|Prednisolone|prednisolone|mesh-list
138884892|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
138884893|NCT00687648|Methotrexate|methotrexate|mesh-list
138884894|NCT00687648|Letrozole|letrozole|mesh-list
138884895|NCT00687648|Anastrozole|anastrozole|mesh-list
138884896|NCT00687648|Exemestane|exemestane|mesh-list
138884897|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138884898|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
138884899|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884900|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138792307|NCT01076153|Clarithromycin|clarithromycin|mesh-list
138884901|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138884902|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
138884903|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884904|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884905|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138884906|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138884907|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
138884908|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138884909|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138884910|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
138884911|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
138884912|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884913|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138884914|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138884915|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138884917|NCT00687648|Hormones|hormones|mesh-ancestor
138884918|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138884919|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138884920|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138884921|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138884922|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138884923|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
138884924|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
138884925|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
138884926|NCT00725218|Analgesics|analgesics|mesh-ancestor
138884927|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
138884928|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884929|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884930|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138884931|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138884932|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138884933|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138884934|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138884935|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138884936|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884937|NCT02732795|Morphine|morphine|mesh-list
138884938|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138884939|NCT02732795|Narcotics|narcotics|mesh-ancestor
138884940|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138884941|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884942|NCT02732795|Analgesics|analgesics|mesh-ancestor
138884943|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
138884944|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884945|NCT05373004|Empagliflozin|empagliflozin|mesh-list
138884946|NCT05373004|Enalapril|enalapril|mesh-list
138884947|NCT05373004|Enalaprilat|enalaprilat|mesh-list
138884948|NCT05373004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138884949|NCT05373004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884950|NCT05373004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138884951|NCT05373004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884952|NCT05373004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210416|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884953|NCT05373004|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139210417|NCT03368963|Trifluridine|trifluridine|mesh-list
138884954|NCT05373004|Protease Inhibitors|protease inhibitors|mesh-ancestor
138884955|NCT05373004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138884956|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138884957|NCT00655616|Montelukast|montelukast|mesh-list
138884958|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138884959|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
138792397|NCT04160416|Capecitabine|capecitabine|mesh-list
138884960|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884961|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884962|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138884963|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
138884964|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138884965|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138884966|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138884967|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
138884968|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138884969|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138884970|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138884971|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
138884972|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138884973|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138884974|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138884975|NCT00713440|Acetaminophen|acetaminophen|mesh-list
138884976|NCT00713440|Prednisolone|prednisolone|mesh-list
138884977|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138884978|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
138884979|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138884980|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
138884981|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138884982|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
138884983|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138884984|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
138884985|NCT00713440|Hormones|hormones|mesh-ancestor
138884986|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138884987|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138884988|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138884989|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138884990|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
138884991|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
138884992|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138884993|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138884994|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138884995|NCT00713440|Protective Agents|protective agents|mesh-ancestor
138884996|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138884997|NCT00713440|Analgesics|analgesics|mesh-ancestor
138884998|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
138884999|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
138885000|NCT00993109|Valsartan|valsartan|mesh-list
138885001|NCT00993109|Nifedipine|nifedipine|mesh-list
138885002|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138885003|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138885004|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138824618|NCT00646659|Cetuximab|cetuximab|mesh-list
138885005|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885006|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138885007|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138885008|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138885009|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885010|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
138885012|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138885013|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
138885014|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
138885015|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
138885016|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138885017|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885018|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
138885019|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885020|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
138885021|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
138885022|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
138885023|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885024|NCT00675246|Betamethasone|betamethasone|mesh-list
138885025|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
139210418|NCT03368963|Irinotecan|irinotecan|mesh-list
138885026|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138885027|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
138885029|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138885030|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885031|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138885032|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
138885033|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138885034|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
138885035|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885036|NCT02732405|Grazoprevir|grazoprevir|mesh-list
138885037|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
138885038|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885039|NCT04001725|Metformin|metformin|mesh-list
138885040|NCT04001725|Dexamethasone|dexamethasone|mesh-list
138885041|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138885042|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
138885043|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
138885044|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885045|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885046|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138885047|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
138885048|NCT04001725|Hormones|hormones|mesh-ancestor
138824652|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
138885049|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138885050|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138885051|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885052|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138885053|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138885054|NCT00713674|Mupirocin|mupirocin|mesh-list
138885055|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885056|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138885057|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885058|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885059|NCT00885482|Ritonavir|ritonavir|mesh-list
138885060|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138885061|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138885062|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138885063|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
138885064|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885065|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885066|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138885067|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138885068|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
138885069|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885070|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138885071|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138885072|NCT04139226|CC-11050|cc-11050|mesh-list
138885073|NCT04139226|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138885074|NCT04139226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138885075|NCT04139226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885076|NCT04139226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885078|NCT05366062|Pembrolizumab|pembrolizumab|mesh-list
138885079|NCT05366062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138885080|NCT05366062|Immunologic Factors|immunologic factors|mesh-ancestor
138885081|NCT05366062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792556|NCT04287426|Analgesics|analgesics|mesh-ancestor
138885082|NCT05366062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138885083|NCT05366062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138885084|NCT05366062|Alkylating Agents|alkylating agents|mesh-ancestor
138885085|NCT05366062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885086|NCT05366062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885087|NCT05366062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138885088|NCT05366062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138885089|NCT05366062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138885090|NCT02645240|Heparin|heparin|mesh-list
138885091|NCT02645240|Calcium heparin|calcium heparin|mesh-list
138885092|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138885093|NCT02645240|Tinzaparin|tinzaparin|mesh-list
138885094|NCT02645240|Dalteparin|dalteparin|mesh-list
138885095|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
138885096|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138885097|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138885098|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885100|NCT00688194|Fulvestrant|fulvestrant|mesh-list
138885101|NCT00688194|Lapatinib|lapatinib|mesh-list
138660639|NCT00347087|Irbesartan|irbesartan|mesh-list
138885102|NCT00688194|Anastrozole|anastrozole|mesh-list
138885103|NCT00688194|Exemestane|exemestane|mesh-list
138885104|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885105|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138885106|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138885107|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885108|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885109|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138885110|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
138885111|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138885112|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885113|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138885114|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138885115|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138885116|NCT00653744|Atorvastatin|atorvastatin|mesh-list
138792641|NCT06199895|Paclitaxel|paclitaxel|mesh-list
138885117|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138885118|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138885119|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138885120|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
138885121|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885122|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138885123|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138885124|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885125|NCT03322267|Cisplatin|cisplatin|mesh-list
138885126|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
138885127|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885128|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138885129|NCT03322267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138885130|NCT03322267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885131|NCT00652496|Bimatoprost|bimatoprost|mesh-list
138885132|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138885133|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138885134|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138885135|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
138885136|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138885137|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885138|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138885139|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138885140|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885141|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885142|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885143|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138792643|NCT06199895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792644|NCT06199895|Tubulin Modulators|tubulin modulators|mesh-ancestor
138792645|NCT06199895|Antimitotic Agents|antimitotic agents|mesh-ancestor
138792646|NCT06199895|Mitosis Modulators|mitosis modulators|mesh-ancestor
138792647|NCT06199895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792648|NCT06199882|Immunomodulating Agents|immunomodulating agents|mesh-list
138792649|NCT06199882|Immunologic Factors|immunologic factors|mesh-ancestor
138792650|NCT06199882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792651|NCT06199843|Rifaximin|rifaximin|mesh-list
138792652|NCT06199843|Norfloxacin|norfloxacin|mesh-list
138792653|NCT06199843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138792654|NCT06199843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792655|NCT06199843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138792656|NCT06199843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138885144|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138885146|NCT00993343|Sirolimus|sirolimus|mesh-list
138885147|NCT00993343|Methotrexate|methotrexate|mesh-list
138885148|NCT00993343|Tacrolimus|tacrolimus|mesh-list
138537323|NCT00152191|Methotrexate|methotrexate|mesh-list
138885149|NCT00993343|Cyclosporins|cyclosporins|mesh-list
138885150|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138885151|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
138885152|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138885153|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885154|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138885155|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
138885156|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885157|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885158|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
138885159|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885160|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138885161|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138885162|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
138885163|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138885164|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138885165|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138885166|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
138885167|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885168|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138885169|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138885171|NCT02974049|Albendazole|albendazole|mesh-list
138885172|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
138885173|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138885174|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885175|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
138885176|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
138885177|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138885178|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138792698|NCT06199700|Esketamine|esketamine|mesh-list
138170133|NCT03779048|Phentermine|phentermine|mesh-list
138792699|NCT06199700|Antidepressive Agents|antidepressive agents|mesh-ancestor
138792700|NCT06199700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138792701|NCT06199596|Caseins|caseins|mesh-list
138792702|NCT06199596|Chelating Agents|chelating agents|mesh-ancestor
138792703|NCT06199596|Sequestering Agents|sequestering agents|mesh-ancestor
138792704|NCT06199596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792705|NCT06199557|Mercaptopurine|mercaptopurine|mesh-list
138792706|NCT06199557|Hydroxyurea|hydroxyurea|mesh-list
138792707|NCT06199557|Valproic Acid|valproic acid|mesh-list
138885179|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
138885180|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
138885181|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
138885182|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885183|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885184|NCT02974049|Filaricides|filaricides|mesh-ancestor
138885185|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
138885186|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138885187|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885188|NCT02637284|BPC 157|bpc 157|mesh-list
138885189|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138885190|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138885191|NCT04138992|Bevacizumab|bevacizumab|mesh-list
138885192|NCT04138992|Cisplatin|cisplatin|mesh-list
138885193|NCT04138992|Docetaxel|docetaxel|mesh-list
138885194|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138885195|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885196|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138885197|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138885198|NCT04138992|Growth Substances|growth substances|mesh-ancestor
138885199|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885200|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
138885201|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
138885202|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
138885203|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
138885204|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885205|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138885206|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
138885207|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885208|NCT04137588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138885210|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138885211|NCT04137588|Growth Substances|growth substances|mesh-ancestor
138885212|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885213|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
138885214|NCT02721329|Acetaminophen|acetaminophen|mesh-list
138885215|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138885216|NCT02721329|Analgesics|analgesics|mesh-ancestor
138885217|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
138885218|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885219|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885220|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
138885221|NCT02637128|Artesunate|artesunate|mesh-list
138885222|NCT02637128|Lumefantrine|lumefantrine|mesh-list
138885223|NCT02637128|Artemether|artemether|mesh-list
138885224|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138885225|NCT02637128|Amodiaquine|amodiaquine|mesh-list
138885226|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
138885227|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138885228|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138885229|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885230|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885231|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
138885232|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
138885233|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138885234|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
138885235|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
138885236|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138885237|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138885238|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885239|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
138885240|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
138885241|NCT00585247|Imiquimod|imiquimod|mesh-list
138885242|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138885243|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
138885244|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885245|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885246|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
138885247|NCT04002349|Budesonide|budesonide|mesh-list
138885248|NCT04002349|Levocabastine|levocabastine|mesh-list
138885249|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138885250|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138885251|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
138885252|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885253|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885254|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139210419|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138885255|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
138885257|NCT04002349|Hormones|hormones|mesh-ancestor
138885258|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138885259|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138885260|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138885261|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
138885262|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
138885263|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138885264|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885265|NCT00688428|Aspirin|aspirin|mesh-list
138885266|NCT00688428|Esomeprazole|esomeprazole|mesh-list
138885267|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138885268|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138885269|NCT00688428|Analgesics|analgesics|mesh-ancestor
138885270|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
138885271|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885272|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885273|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138885274|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138885275|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138885276|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138885277|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885278|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138885279|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138885280|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885281|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
138885282|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138885283|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138885284|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138885285|NCT02724761|Epinephrine|epinephrine|mesh-list
138885286|NCT02724761|Racepinephrine|racepinephrine|mesh-list
138885287|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
138885288|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138885289|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138885290|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
138885291|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138885292|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885293|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885294|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138885295|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138885296|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
138885297|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885298|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138885299|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
138885300|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
138537482|NCT00152815|Vitamin E|vitamin e|mesh-list
138885301|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
138885302|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138885303|NCT04350190|Apatinib|apatinib|mesh-list
138885304|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885305|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138885306|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885307|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885308|NCT02721173|Clindamycin|clindamycin|mesh-list
138885309|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
138885310|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
138885311|NCT02721173|Adapalene|adapalene|mesh-list
138885312|NCT02721173|Tazarotene|tazarotene|mesh-list
138885313|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138885314|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885315|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138885316|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885317|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885318|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138885319|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138885320|NCT02721173|Analgesics|analgesics|mesh-ancestor
138885321|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
138885322|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885323|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885324|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138885325|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138792923|NCT06054776|Acalabrutinib|acalabrutinib|mesh-list
138885326|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
138885327|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
138885328|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
138885329|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
138885330|NCT00713986|Protective Agents|protective agents|mesh-ancestor
138885331|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885332|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
138885333|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138885334|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138885335|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885336|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138885337|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885338|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885340|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
138885341|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138885342|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885344|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
138885345|NCT00885170|Calcium|calcium|mesh-list
138885346|NCT00885170|Vitamins|vitamins|mesh-ancestor
138885347|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
138885348|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885349|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138885350|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138885351|NCT02720783|Econazole|econazole|mesh-list
138885352|NCT02720783|Benzydamine|benzydamine|mesh-list
138885353|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138885354|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
138885355|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885356|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138885357|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138885358|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885359|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885360|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138885361|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
138885362|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138885363|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885364|NCT00714064|Edetic Acid|edetic acid|mesh-list
138885365|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138885366|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
138885367|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
138885368|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885369|NCT00714064|Antidotes|antidotes|mesh-ancestor
138885370|NCT00714064|Protective Agents|protective agents|mesh-ancestor
138885371|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
138792963|NCT06043323|Antipyretics|antipyretics|mesh-ancestor
138885372|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
138885373|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885374|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138885375|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
138885376|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138885377|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
138885378|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138885379|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138885380|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885381|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138885382|NCT02720705|Analgesics|analgesics|mesh-ancestor
138885383|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
138885384|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885385|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138885386|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138885387|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138885388|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
138885389|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998969|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138885390|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885391|NCT02720471|Anesthetics|anesthetics|mesh-list
138885392|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
138885393|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138885394|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885395|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
138885396|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885397|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138885398|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
138885399|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138885400|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138885401|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138885402|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138885403|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885405|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
138885406|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885407|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
138885408|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885409|NCT00688896|Pravastatin|pravastatin|mesh-list
138885410|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
138885411|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138885413|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
138885414|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885415|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138885416|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138885417|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885419|NCT02724293|Analgesics|analgesics|mesh-ancestor
138885420|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
138885421|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885422|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885423|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
138885424|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138885425|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138885426|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059162|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793045|NCT06011772|Oxaliplatin|oxaliplatin|mesh-list
138885427|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138885428|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138885429|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138885430|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138885431|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138885432|NCT05092828|Morphine|morphine|mesh-list
138885433|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138885434|NCT05092828|Narcotics|narcotics|mesh-ancestor
138885435|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138885436|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885437|NCT05092828|Analgesics|analgesics|mesh-ancestor
138825283|NCT05740657|Fentanyl|fentanyl|mesh-list
138885438|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
138885439|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885440|NCT04137198|Sufentanil|sufentanil|mesh-list
138885441|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138885442|NCT04137198|Narcotics|narcotics|mesh-ancestor
138885443|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138885444|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885445|NCT04137198|Analgesics|analgesics|mesh-ancestor
138885446|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
138885447|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885448|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138885449|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138885450|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
138885451|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
138537630|NCT00153283|Gabapentin|gabapentin|mesh-list
138885453|NCT00995293|Fluorouracil|fluorouracil|mesh-list
138885454|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885455|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
138885456|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
138885457|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
138885458|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885459|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
138825345|NCT02645565|Hormones|hormones|mesh-ancestor
138885460|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138885461|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138885462|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
138885463|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885464|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
138885465|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
138885466|NCT00692952|Nonoxynol|nonoxynol|mesh-list
138885467|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138885468|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885469|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138885470|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885471|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138885472|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138885473|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138885474|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138885476|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885477|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
138885478|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
138885479|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
138885480|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885481|NCT00689208|Atropine|atropine|mesh-list
138885482|NCT00689208|Physostigmine|physostigmine|mesh-list
138885483|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138885484|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138885485|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138885486|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
138885487|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885488|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885489|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138885490|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
138885491|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
138885492|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
138885493|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138885494|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138885495|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
138999008|NCT01324180|Vincristine|vincristine|mesh-list
138885496|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138885497|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885498|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138885499|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885500|NCT00689208|Miotics|miotics|mesh-ancestor
138885501|NCT00726466|Ranibizumab|ranibizumab|mesh-list
138885502|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138885503|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138885504|NCT00726466|Growth Substances|growth substances|mesh-ancestor
138885505|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885506|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
138885507|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885509|NCT02694263|Glimepiride|glimepiride|mesh-list
138885510|NCT02694263|Canagliflozin|canagliflozin|mesh-list
138885511|NCT02694263|Repaglinide|repaglinide|mesh-list
138885512|NCT02694263|Gliclazide|gliclazide|mesh-list
138885513|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138885514|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885515|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138885516|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138885517|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
138885518|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138885519|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885520|NCT04139070|Bleomycin|bleomycin|mesh-list
138885521|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138885522|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885524|NCT00693030|Paclitaxel|paclitaxel|mesh-list
138885525|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138885526|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885527|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
138885528|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
138885529|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
138885530|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885531|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138885532|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885533|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138885534|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
138885535|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138885536|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
138885537|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885539|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
138885540|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
138885541|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885542|NCT04137276|Vitamins|vitamins|mesh-list
138885544|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
138885545|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
138999049|NCT00754403|Metformin|metformin|mesh-list
138885546|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885547|NCT02723981|Vitamins|vitamins|mesh-list
138885548|NCT02723981|Vitamin K|vitamin k|mesh-list
138885549|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
138885550|NCT02723981|Dabigatran|dabigatran|mesh-list
138885551|NCT02723981|Anticoagulants|anticoagulants|mesh-list
138885552|NCT02723981|Clopidogrel|clopidogrel|mesh-list
138885553|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
138885554|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885555|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138885556|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138885557|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138885558|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138885559|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
138885560|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059163|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885561|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885562|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138885563|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
138885564|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138885565|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
138885566|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885567|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138885568|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138885569|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
138885570|NCT02723981|Coagulants|coagulants|mesh-ancestor
138885571|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
138885572|NCT00912444|Docetaxel|docetaxel|mesh-list
138885574|NCT00912444|Epirubicin|epirubicin|mesh-list
138885575|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138885576|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
138885577|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885578|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138885579|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138885580|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
138885581|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885582|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885583|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138885584|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
138885585|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
138885586|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
138885587|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138885588|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138885589|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138885590|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885592|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885593|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138885594|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885595|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885596|NCT00726700|Prednisone|prednisone|mesh-list
138885597|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
138885598|NCT00726700|Rituximab|rituximab|mesh-list
138885599|NCT00726700|Doxorubicin|doxorubicin|mesh-list
138885600|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138885601|NCT00726700|Vincristine|vincristine|mesh-list
138885602|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138825875|NCT00751114|Incretins|incretins|mesh-ancestor
138885603|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
138885604|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885605|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138885606|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138885607|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
138885608|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885609|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885610|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138885611|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138885612|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138885613|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138885614|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138885615|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885616|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138885618|NCT00726700|Hormones|hormones|mesh-ancestor
138825931|NCT05972967|Ravulizumab|ravulizumab|mesh-list
138999125|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138885619|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138885620|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138885621|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138885622|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
138885623|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
138885624|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
138885625|NCT02723903|Fluoxetine|fluoxetine|mesh-list
138885626|NCT02723903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138885627|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138885628|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138885629|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885630|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138885631|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
138885632|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885633|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138885634|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
138885635|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138885636|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138885637|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138885638|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885639|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
138885640|NCT00675714|Itraconazole|itraconazole|mesh-list
138885641|NCT00675714|Fluconazole|fluconazole|mesh-list
138885642|NCT00675714|Ketoconazole|ketoconazole|mesh-list
138826064|NCT05924256|Leuprolide|leuprolide|mesh-list
138885643|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
138885644|NCT00675714|Propranolol|propranolol|mesh-list
138885645|NCT00675714|Metoprolol|metoprolol|mesh-list
138885646|NCT00675714|Hormones|hormones|mesh-list
138885647|NCT00675714|Testosterone|testosterone|mesh-list
138885648|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
138885649|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
138885650|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138885651|NCT00675714|Oxandrolone|oxandrolone|mesh-list
138885652|NCT00675714|Nandrolone|nandrolone|mesh-list
138885653|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
138885654|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138885655|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885656|NCT00675714|Androgens|androgens|mesh-ancestor
138885657|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138885658|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885659|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
138885660|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
138885661|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885662|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138885663|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138885664|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885665|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885666|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138885667|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
138885668|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138885669|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138885670|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138885671|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
138885672|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138885673|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138885674|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138885675|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
138885676|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
138885677|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
138885678|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885679|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138826171|NCT05327686|Immunologic Factors|immunologic factors|mesh-ancestor
138885680|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138885681|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138885682|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138885683|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138885684|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138885685|NCT00729976|Ibuprofen|ibuprofen|mesh-list
138885686|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138826249|NCT05007392|Febuxostat|febuxostat|mesh-list
138885687|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138885688|NCT00729976|Analgesics|analgesics|mesh-ancestor
138885689|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
138885690|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885691|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885692|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138885693|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138885694|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138885695|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885696|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885697|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
138885698|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
138885699|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138885700|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138885701|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885702|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138885703|NCT02451553|Capecitabine|capecitabine|mesh-list
138885704|NCT02451553|Afatinib|afatinib|mesh-list
138885705|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138885706|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
138887304|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210420|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138826298|NCT04683939|Antimetabolites|antimetabolites|mesh-ancestor
138885707|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885708|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885709|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138885710|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885712|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
138885713|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138885714|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885715|NCT00730054|Clonidine|clonidine|mesh-list
138885716|NCT00730054|Remifentanil|remifentanil|mesh-list
138885717|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138885718|NCT00730054|Narcotics|narcotics|mesh-ancestor
138885719|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138885720|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885721|NCT00730054|Analgesics|analgesics|mesh-ancestor
138885722|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
138885723|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885724|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138885725|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
138885726|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
138885727|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138885728|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138885729|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138885730|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
138885731|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138885732|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885734|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
138885735|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885736|NCT00693108|Testosterone|testosterone|mesh-list
138885737|NCT00693108|Androgens|androgens|mesh-ancestor
138885738|NCT00693108|Hormones|hormones|mesh-ancestor
138885739|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138885740|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885741|NCT00884390|Factor VIII|factor viii|mesh-list
138885742|NCT00884390|Coagulants|coagulants|mesh-ancestor
138885743|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
138885744|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138885745|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
138885746|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885747|NCT02723669|Expectorants|expectorants|mesh-ancestor
138885748|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
138885749|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138885750|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
138885751|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826346|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
138885752|NCT02723669|Protective Agents|protective agents|mesh-ancestor
138885753|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885754|NCT02723669|Antidotes|antidotes|mesh-ancestor
138885755|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138885756|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
138885757|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885758|NCT00689442|Atorvastatin|atorvastatin|mesh-list
138885759|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
138885760|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138885761|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138885762|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
138885763|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885764|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138885765|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138885766|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885767|NCT02625636|Glucagon|glucagon|mesh-list
138885768|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138885769|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138885770|NCT02625636|Hormones|hormones|mesh-ancestor
138885771|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138885772|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885773|NCT02625636|Incretins|incretins|mesh-ancestor
138885774|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
138885775|NCT03012100|Vaccines|vaccines|mesh-list
138885776|NCT03012100|Sargramostim|sargramostim|mesh-list
138885777|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
138826386|NCT04040231|Nivolumab|nivolumab|mesh-list
138885778|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885779|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138885780|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138885781|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138885782|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
138999184|NCT00496197|Voriconazole|voriconazole|mesh-list
138885783|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885784|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885785|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138885786|NCT02379247|Paclitaxel|paclitaxel|mesh-list
138885787|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138885788|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826431|NCT03602859|Niraparib|niraparib|mesh-list
138885789|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
138885790|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
138885791|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
138885792|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885794|NCT00689520|Tinzaparin|tinzaparin|mesh-list
138885795|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138885796|NCT00689520|Dalteparin|dalteparin|mesh-list
138885797|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
138885798|NCT00689520|Vitamins|vitamins|mesh-ancestor
138885799|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
138885800|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885801|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138885802|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138885803|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885804|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
138885805|NCT00689520|Coagulants|coagulants|mesh-ancestor
138885806|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
138885807|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138885808|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138885809|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138885810|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138885811|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
138885812|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138885813|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885814|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885815|NCT02723279|Urological Agents|urological agents|mesh-ancestor
138885816|NCT02615301|Vitamin D|vitamin d|mesh-list
138885817|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
138793414|NCT05273320|Dronabinol|dronabinol|mesh-list
138885818|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
138885819|NCT02615301|Vitamins|vitamins|mesh-list
138885820|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
138826558|NCT02632175|Adalimumab|adalimumab|mesh-list
138885821|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885822|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138885823|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138885825|NCT02570230|Analgesics|analgesics|mesh-ancestor
138885826|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
138885827|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885828|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885829|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138885830|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138885831|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
138885832|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
138885833|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138885835|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138885836|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138885837|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885838|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
138885839|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
138885840|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885841|NCT00697905|Carboplatin|carboplatin|mesh-list
138885842|NCT00697905|Gemcitabine|gemcitabine|mesh-list
138885843|NCT00697905|Fluorouracil|fluorouracil|mesh-list
138885844|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885845|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138885846|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
138885847|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885848|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138885849|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
138885850|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885851|NCT02718755|Cytarabine|cytarabine|mesh-list
138885852|NCT02718755|Fludarabine|fludarabine|mesh-list
138885853|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
138885854|NCT02718755|Asparaginase|asparaginase|mesh-list
138885855|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885856|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138885857|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
139210421|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885858|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885859|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138885860|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
138885861|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885862|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
138885863|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885864|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
138885865|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138885866|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885868|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
138885869|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885870|NCT00872898|Memantine|memantine|mesh-list
138885871|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138885872|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138885873|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
138885874|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138885875|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885876|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885877|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138885878|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138885879|NCT02723435|Midostaurin|midostaurin|mesh-list
138885880|NCT02723435|Staurosporine|staurosporine|mesh-list
138885881|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885882|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138885883|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885884|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885885|NCT02718677|Factor VIII|factor viii|mesh-list
138885886|NCT02718677|Coagulants|coagulants|mesh-ancestor
138885887|NCT04132011|Morphine|morphine|mesh-list
138885889|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
138885890|NCT04132011|Hydromorphone|hydromorphone|mesh-list
138885891|NCT04132011|Narcotics|narcotics|mesh-ancestor
138885892|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138885893|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885894|NCT04132011|Analgesics|analgesics|mesh-ancestor
138885895|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
138885896|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885897|NCT00693576|Simvastatin|simvastatin|mesh-list
138885898|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138885899|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138885900|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
138885901|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885902|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138885903|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138885904|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885905|NCT04116047|Durvalumab|durvalumab|mesh-list
138885907|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138885908|NCT00693732|Escitalopram|escitalopram|mesh-list
138885909|NCT00693732|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138885910|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138885911|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138885912|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885913|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138885915|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885916|NCT00689598|Spironolactone|spironolactone|mesh-list
138885917|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138885918|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
138885919|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138885920|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885921|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138885923|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
138885924|NCT04163354|Listerine|listerine|mesh-list
138885925|NCT04163354|Fluorides|fluorides|mesh-list
138885926|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
138885927|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
138885928|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
138885929|NCT04163354|Protective Agents|protective agents|mesh-ancestor
138885930|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885931|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138885932|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138885933|NCT04131621|Nivolumab|nivolumab|mesh-list
138885934|NCT04131621|Ipilimumab|ipilimumab|mesh-list
138887305|NCT01002703|Prednisone|prednisone|mesh-list
138885935|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138885936|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885937|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138885938|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885940|NCT00689832|Tacrolimus|tacrolimus|mesh-list
138885941|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138885942|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
138885943|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885944|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138885945|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138885946|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885947|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138885948|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138885949|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
138885950|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885951|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138885952|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
138885953|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
138885954|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138885955|NCT02718521|Isosorbide|isosorbide|mesh-list
138885956|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138885957|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138885958|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138885959|NCT02718521|Diuretics|diuretics|mesh-ancestor
138885960|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
138885961|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885962|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
138885963|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138885964|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885965|NCT02718599|Terlipressin|terlipressin|mesh-list
138885966|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138885967|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138885968|NCT00693966|Vaccines|vaccines|mesh-list
138885969|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
138885970|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885971|NCT00694044|Varenicline|varenicline|mesh-list
138885972|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138885973|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138885974|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
138885975|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138885976|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885977|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885978|NCT02722811|Etanercept|etanercept|mesh-list
138885979|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138885980|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138538153|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
138885981|NCT02722811|Analgesics|analgesics|mesh-ancestor
138885982|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
138885983|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138885984|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138885985|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138885987|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138885988|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138885989|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
138885990|NCT04136886|Cisplatin|cisplatin|mesh-list
138885991|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885992|NCT00534313|Abatacept|abatacept|mesh-list
138885993|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139059164|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
138885994|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138885995|NCT00534313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138885996|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138885997|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138885998|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
138885999|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886000|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138886001|NCT00694200|Bevacizumab|bevacizumab|mesh-list
138886002|NCT00694200|Vinorelbine|vinorelbine|mesh-list
138886003|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138886004|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886005|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138886006|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138886007|NCT00694200|Growth Substances|growth substances|mesh-ancestor
138886008|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886010|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138886011|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
138886012|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
138886013|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
138886014|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886015|NCT02722733|Cytarabine|cytarabine|mesh-list
138886016|NCT02722733|Lenograstim|lenograstim|mesh-list
138886017|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138886018|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
138886019|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827328|NCT00696787|Analgesics|analgesics|mesh-ancestor
138886020|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138886021|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
138886022|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886023|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886024|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
138886025|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886026|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138886027|NCT02617290|Clopidogrel|clopidogrel|mesh-list
138886029|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138886030|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138886031|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138827394|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
138886033|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
138886034|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138886035|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886036|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886037|NCT02717819|Vitamin D|vitamin d|mesh-list
138886038|NCT02717819|Vitamins|vitamins|mesh-ancestor
138886039|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
138886040|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886041|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138886042|NCT02007655|Apixaban|apixaban|mesh-list
138886043|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138886044|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
138886045|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138886046|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
138886047|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793776|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
138793777|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138793778|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793779|NCT04551430|Nivolumab|nivolumab|mesh-list
138793780|NCT04551430|Ipilimumab|ipilimumab|mesh-list
138793781|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793782|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793783|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138886048|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827493|NCT00962390|Equol|equol|mesh-list
138886049|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
138886050|NCT05298462|Antibodies|antibodies|mesh-list
138886051|NCT05298462|Immunologic Factors|immunologic factors|mesh-ancestor
138886052|NCT05298462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886053|NCT00730366|Chloroquine|chloroquine|mesh-list
138886054|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
138886055|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
138886056|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138886057|NCT00730366|Amebicides|amebicides|mesh-ancestor
138538219|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138886058|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138886059|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138886060|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886061|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
138886062|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138886063|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138886064|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886065|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886066|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138886068|NCT02722343|Emtricitabine|emtricitabine|mesh-list
138886069|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138886070|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
138886071|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886072|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138886073|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138886074|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886075|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886076|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138886077|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138886078|NCT00694590|Plerixafor|plerixafor|mesh-list
138886079|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138886080|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138886081|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
138886082|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886083|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138886085|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886086|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886087|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138886088|NCT03903406|Dexamethasone|dexamethasone|mesh-list
138886089|NCT03903406|Lenalidomide|lenalidomide|mesh-list
138886090|NCT03903406|Ixazomib|ixazomib|mesh-list
138886091|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886092|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
138886093|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
138886094|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886095|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886096|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138886097|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
138886099|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138886100|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138886101|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886102|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
138886103|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138886104|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138886105|NCT03903406|Growth Substances|growth substances|mesh-ancestor
138886106|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
138886107|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
138886108|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827686|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886109|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886110|NCT00594204|Varenicline|varenicline|mesh-list
138886111|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138886112|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138886113|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
138886114|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138886115|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886116|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886117|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
138886119|NCT00999271|Incretins|incretins|mesh-list
138886120|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138886121|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793848|NCT04340843|Belinostat|belinostat|mesh-list
138793849|NCT04340843|Guadecitabine|guadecitabine|mesh-list
138886122|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138886123|NCT02716961|Gemcitabine|gemcitabine|mesh-list
138886124|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886125|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138886126|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
138886127|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886128|NCT02704156|Gemcitabine|gemcitabine|mesh-list
138886129|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
138886130|NCT02704156|Trametinib|trametinib|mesh-list
138886131|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138538263|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
138886132|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
138886133|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886134|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886135|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138886136|NCT02704156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138886137|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138886138|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886139|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
138886140|NCT00912678|Tacrolimus|tacrolimus|mesh-list
138886141|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138886142|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
138886143|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886144|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138886145|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793890|NCT04190550|Cytarabine|cytarabine|mesh-list
138793891|NCT04190550|Idarubicin|idarubicin|mesh-list
138793892|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793893|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
138793895|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999284|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
138886146|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886147|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138886148|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886149|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138886150|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
138886151|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138886152|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886153|NCT00995839|Terlipressin|terlipressin|mesh-list
138886154|NCT00995839|Vasopressins|vasopressins|mesh-list
138886155|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
138886156|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
138886157|NCT00995839|Coagulants|coagulants|mesh-ancestor
138886158|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138886159|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138886160|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
138886161|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886162|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138886163|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
138886164|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
138886165|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886166|NCT00994513|Protective Agents|protective agents|mesh-ancestor
138886167|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886168|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
138886170|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
138886171|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
138886172|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138886173|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886174|NCT00995917|Vitamin K|vitamin k|mesh-list
138886175|NCT00995917|Vitamins|vitamins|mesh-ancestor
138886176|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
138886177|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886178|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138886179|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138886180|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886181|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
138886182|NCT00995917|Coagulants|coagulants|mesh-ancestor
138886183|NCT02616822|Resveratrol|resveratrol|mesh-list
138886184|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
138886185|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886186|NCT02616822|Protective Agents|protective agents|mesh-ancestor
138886187|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886188|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886189|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138886190|NCT00912756|Cilostazol|cilostazol|mesh-list
138886191|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138886192|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
138886193|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886194|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886195|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138886196|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
138886197|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138886198|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138886199|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886200|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138886201|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
138827975|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
138886202|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138886203|NCT00912756|Protective Agents|protective agents|mesh-ancestor
138886204|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138886205|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138886206|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886208|NCT04426240|Cyclosporins|cyclosporins|mesh-list
138886209|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886210|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886211|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138886212|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
138886213|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886214|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
138886215|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886216|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
138886217|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138886218|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138886219|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
138886220|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138886221|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886223|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
138886224|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886225|NCT00999349|Protective Agents|protective agents|mesh-ancestor
138886226|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886227|NCT02621112|Imiquimod|imiquimod|mesh-list
138886228|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138886229|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
138886230|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886231|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886232|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
138886233|NCT04000789|Vitamins|vitamins|mesh-list
138886234|NCT04000789|Vitamin E|vitamin e|mesh-list
138886235|NCT04000789|Vitamin A|vitamin a|mesh-list
138886236|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
138886237|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
138886238|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886239|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
138886240|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886241|NCT04000789|Protective Agents|protective agents|mesh-ancestor
138886242|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138886243|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
138886244|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
138886245|NCT00697554|Vaccines|vaccines|mesh-list
138886246|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
138886247|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886248|NCT00731068|Mitogens|mitogens|mesh-list
138886249|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
138886250|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886251|NCT00866307|Cytarabine|cytarabine|mesh-list
138886252|NCT00866307|Dexamethasone|dexamethasone|mesh-list
138886253|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
138886254|NCT00866307|Prednisone|prednisone|mesh-list
138886255|NCT00866307|Cortisone|cortisone|mesh-list
138886256|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
138886257|NCT00866307|Doxorubicin|doxorubicin|mesh-list
138886258|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138886259|NCT00866307|Methotrexate|methotrexate|mesh-list
138886260|NCT00866307|Vincristine|vincristine|mesh-list
138886261|NCT00866307|Daunorubicin|daunorubicin|mesh-list
138886262|NCT00866307|Asparaginase|asparaginase|mesh-list
138886263|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
138886264|NCT00866307|Pegaspargase|pegaspargase|mesh-list
138886265|NCT00866307|Thioguanine|thioguanine|mesh-list
138886267|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
138886268|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138886269|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
138886270|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886271|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138886272|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138886273|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
138828126|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
138886274|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886275|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886276|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138886277|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886278|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
138886279|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
138886280|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886281|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138886282|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
138886284|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138886285|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138886286|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
138886287|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828186|NCT04204382|Levofloxacin|levofloxacin|mesh-list
138886288|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138886289|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138886290|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138886291|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138886292|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
138886293|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138886294|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138886295|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
138886296|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
138886297|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138886298|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138886299|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
138886300|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886301|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138886302|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
138886303|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
138886304|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
138886305|NCT00731146|Anesthetics|anesthetics|mesh-list
138886306|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138886307|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886309|NCT02716415|Petrolatum|petrolatum|mesh-list
138886310|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
138886311|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
138886312|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
138886313|NCT02716415|Emollients|emollients|mesh-ancestor
138886314|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
138886315|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138886316|NCT02716415|Protective Agents|protective agents|mesh-ancestor
138886317|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886318|NCT02616354|Imipenem|imipenem|mesh-list
138886319|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138886320|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886321|NCT00731224|Rivastigmine|rivastigmine|mesh-list
138886322|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138886323|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886324|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886325|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
138886326|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138886327|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886328|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138886329|NCT00731224|Protective Agents|protective agents|mesh-ancestor
138886331|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138886332|NCT00531427|Narcotics|narcotics|mesh-ancestor
138886333|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138886334|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886335|NCT00531427|Analgesics|analgesics|mesh-ancestor
138886336|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
138886337|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886338|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138886339|NCT00731302|Aspirin|aspirin|mesh-list
138886340|NCT00731302|Meloxicam|meloxicam|mesh-list
138886341|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138886342|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138886343|NCT00731302|Analgesics|analgesics|mesh-ancestor
138886344|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
138886345|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886346|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886347|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886348|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138886349|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138886350|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138886351|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886352|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138886353|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138886355|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
138886356|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138886357|NCT00871728|Itraconazole|itraconazole|mesh-list
138886358|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
138886359|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886360|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138886361|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138886362|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886363|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886364|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138886366|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138886367|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886368|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138886369|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138886370|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886371|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
138886372|NCT00999427|Povidone|povidone|mesh-list
138886373|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
138886374|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
138886375|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138886376|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886377|NCT04189211|Trastuzumab|trastuzumab|mesh-list
138886378|NCT04189211|Maytansine|maytansine|mesh-list
138886379|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138886380|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886381|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138886382|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
138886383|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
138886384|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
138999344|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886385|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886386|NCT00364780|XL647|xl647|mesh-list
138886387|NCT00364780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886388|NCT00364780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138886389|NCT00364780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887306|NCT01002703|Lenalidomide|lenalidomide|mesh-list
138886390|NCT00364780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886391|NCT00868998|Gemcitabine|gemcitabine|mesh-list
138886392|NCT00868998|Capecitabine|capecitabine|mesh-list
138886393|NCT00868998|Docetaxel|docetaxel|mesh-list
138886394|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138886395|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
138886396|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886397|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886398|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
138886399|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
138886400|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
138886401|NCT00996151|Testosterone|testosterone|mesh-list
138886402|NCT00996151|Androgens|androgens|mesh-ancestor
138886403|NCT00996151|Hormones|hormones|mesh-ancestor
138886404|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138886405|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886406|NCT04131231|Aldesleukin|aldesleukin|mesh-list
138886407|NCT04131231|Methotrexate|methotrexate|mesh-list
138886408|NCT04131231|Interleukin-2|interleukin-2|mesh-list
138886409|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138886410|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
138886411|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138886412|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886413|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138886414|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
138886415|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886416|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886417|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
138886418|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886419|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138886420|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138886421|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
138886422|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138828646|NCT00586066|Memantine|memantine|mesh-list
138886423|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138886424|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138886425|NCT04131231|Analgesics|analgesics|mesh-ancestor
138886426|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
138886427|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886428|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138886429|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138886430|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
138886431|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886432|NCT02716259|Fluorides|fluorides|mesh-list
138886433|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
138886434|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
138886435|NCT02716259|Protective Agents|protective agents|mesh-ancestor
138886436|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886437|NCT00996229|Resveratrol|resveratrol|mesh-list
138538570|NCT00159484|Celecoxib|celecoxib|mesh-list
138886438|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
138886439|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886440|NCT00996229|Protective Agents|protective agents|mesh-ancestor
138886441|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886442|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886443|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138886445|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
138886446|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886447|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
138886448|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886449|NCT02614833|Paclitaxel|paclitaxel|mesh-list
138886450|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138886451|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886452|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
138886453|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
138886454|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
138886455|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886456|NCT00999505|Amantadine|amantadine|mesh-list
138886457|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138886458|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138886459|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
138886460|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886461|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
138886462|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138886463|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886464|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886465|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138886467|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
138886468|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886469|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
138886470|NCT00996385|Bortezomib|bortezomib|mesh-list
138886471|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886472|NCT00533845|Bupivacaine|bupivacaine|mesh-list
138886473|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
138886474|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
138886475|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138886476|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886477|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
138886478|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886480|NCT02752763|Povidone|povidone|mesh-list
138886481|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138828893|NCT02592772|Menthol|menthol|mesh-list
138886482|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
138886483|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138886484|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
138886485|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
138886486|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
138886487|NCT00857649|Memantine|memantine|mesh-list
138886488|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138886489|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138886490|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
138886491|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138886492|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886493|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886494|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138886495|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138886496|NCT02752841|Vitamin D|vitamin d|mesh-list
138886497|NCT02752841|Vitamins|vitamins|mesh-ancestor
138886498|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
138886499|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886500|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138886501|NCT02715869|Sevoflurane|sevoflurane|mesh-list
138886502|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138886503|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138886504|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
138886505|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
138886506|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138886507|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886508|NCT00532441|Docetaxel|docetaxel|mesh-list
138886509|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138886510|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886511|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
138886512|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
138886513|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
138886514|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538643|NCT00052169|Docetaxel|docetaxel|mesh-list
138886515|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138886516|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886517|NCT00999739|Vaccines|vaccines|mesh-list
138886518|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138886519|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
138886520|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886521|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138886522|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138886523|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138886524|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886525|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
138886526|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138886527|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
138886528|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
138886529|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
138886530|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
138886531|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138886532|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138886533|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138886534|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886535|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886537|NCT00857259|Ranibizumab|ranibizumab|mesh-list
138886538|NCT00857259|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138886539|NCT00857259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138886540|NCT00857259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138662058|NCT00426647|Buprenorphine|buprenorphine|mesh-list
138886541|NCT00857259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886542|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138886543|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
138886544|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886545|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886546|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138886547|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138886548|NCT00857259|Growth Substances|growth substances|mesh-ancestor
138886549|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
138886550|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138886551|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138886552|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886553|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138886554|NCT00868608|Immunotoxins|immunotoxins|mesh-ancestor
138886555|NCT00868608|Immunoconjugates|immunoconjugates|mesh-ancestor
138886556|NCT00868608|Immunologic Factors|immunologic factors|mesh-ancestor
138886557|NCT00868608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886558|NCT04000633|Lidocaine|lidocaine|mesh-list
138886559|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
138886560|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
138886561|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138886562|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886563|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
138886564|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886565|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138886566|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138886567|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138886568|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138886569|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886570|NCT00994825|Simendan|simendan|mesh-list
138886571|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138886572|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
138886573|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138886574|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138886575|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886576|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886577|NCT00994825|Protective Agents|protective agents|mesh-ancestor
138886578|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886579|NCT02752529|Tacrolimus|tacrolimus|mesh-list
138886580|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138886581|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
138886582|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886583|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138886584|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886585|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886586|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
138886587|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
138538709|NCT05567484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138886588|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138886589|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
138886590|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886591|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138886592|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138886593|NCT02620800|Leucovorin|leucovorin|mesh-list
138886594|NCT02620800|Paclitaxel|paclitaxel|mesh-list
138886595|NCT02620800|Bevacizumab|bevacizumab|mesh-list
138886596|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
138886598|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
138886599|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138886600|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886601|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
138886602|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
138886603|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
138886604|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886605|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138886606|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138886607|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138886608|NCT02620800|Growth Substances|growth substances|mesh-ancestor
138886609|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886610|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
138886611|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138886612|NCT02620800|Antidotes|antidotes|mesh-ancestor
138886613|NCT02620800|Protective Agents|protective agents|mesh-ancestor
138886614|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
138794481|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
139210422|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886615|NCT02620800|Vitamins|vitamins|mesh-ancestor
138886616|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
138886617|NCT04135014|Midazolam|midazolam|mesh-list
138886618|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
138886619|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138886620|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138886621|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886622|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138886623|NCT04135014|Analgesics|analgesics|mesh-ancestor
138886624|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
138829290|NCT00752401|Vitamin D|vitamin d|mesh-list
138886625|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886626|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138886627|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138886628|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138886629|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
138886630|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138886631|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886632|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138886633|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138886634|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138886635|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138886636|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138886637|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
138886638|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
138886639|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
138886640|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
138886641|NCT00996697|Budesonide|budesonide|mesh-list
138886642|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
138886643|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
138886644|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138886645|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886646|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138886647|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
138886648|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886649|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886650|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138886651|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
138886654|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138886655|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138886656|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138886657|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138886658|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
138886659|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138886660|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886661|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
138829474|NCT00750997|Dextrans|dextrans|mesh-list
138886663|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
138886664|NCT00999973|Mitomycins|mitomycins|mesh-list
138886665|NCT00999973|Mitomycin|mitomycin|mesh-list
138886666|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138886667|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886668|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
138886669|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886670|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138886671|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886672|NCT02715947|Methotrexate|methotrexate|mesh-list
138886673|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138886674|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
138886675|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138886676|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886677|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138886678|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
138886679|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886680|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829520|NCT00687271|Calcium|calcium|mesh-list
138886681|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
138886682|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886683|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138886684|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138886685|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
138886686|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138886687|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138886690|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138886691|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
138886692|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138829579|NCT00751699|Mesalamine|mesalamine|mesh-list
138886693|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138886694|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138886695|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886696|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886697|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138886698|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138886699|NCT00856245|Rituximab|rituximab|mesh-list
138886700|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138886701|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886702|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
138886703|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886704|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138886705|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
138794625|NCT02513563|Adavosertib|adavosertib|mesh-list
138886706|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138886707|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886708|NCT00994903|Simvastatin|simvastatin|mesh-list
138886709|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138886710|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138886711|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
138886712|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886713|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138886714|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138886715|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886716|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
138886717|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
138886718|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138886719|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138886720|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886721|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138886722|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886723|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138886724|NCT02712125|Isosorbide|isosorbide|mesh-list
138886725|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138886726|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138886727|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138886728|NCT02712125|Diuretics|diuretics|mesh-ancestor
138886729|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
138886730|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886731|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
138886732|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138886733|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886734|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
138886735|NCT00994981|Analgesics|analgesics|mesh-ancestor
138886736|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
138886737|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886738|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829752|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138886740|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138886741|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138886742|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
138886743|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138886744|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138886745|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886746|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138886747|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
138886748|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138886749|NCT02715479|Dolutegravir|dolutegravir|mesh-list
138886750|NCT02715479|BMS-955176|bms-955176|mesh-list
138886751|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138886752|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138886753|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886754|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886755|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138886756|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138886757|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
138886758|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886760|NCT01000441|Infliximab|infliximab|mesh-list
138886761|NCT01000441|Etanercept|etanercept|mesh-list
138886762|NCT01000441|Rituximab|rituximab|mesh-list
138886763|NCT01000441|Abatacept|abatacept|mesh-list
138886764|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138886765|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886766|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
138886767|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886768|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138886769|NCT01000441|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138886770|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886771|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
138886772|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138886773|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138886774|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138886775|NCT01000441|Analgesics|analgesics|mesh-ancestor
138886776|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
138886777|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886778|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138794764|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
138886779|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138886780|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886781|NCT00997087|Flumazenil|flumazenil|mesh-list
138886782|NCT00997087|Antidotes|antidotes|mesh-ancestor
138886783|NCT00997087|Protective Agents|protective agents|mesh-ancestor
138886784|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886785|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
138886786|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
138886787|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138886788|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886789|NCT01000597|Fluticasone|fluticasone|mesh-list
138886791|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886792|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138886793|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
138886794|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886795|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886796|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138886797|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
138886798|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
138886799|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138886800|NCT02751593|Dexamethasone|dexamethasone|mesh-list
138886801|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886802|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
138886803|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
138886804|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886805|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886806|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138886807|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
138886808|NCT02751593|Hormones|hormones|mesh-ancestor
138886809|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138886810|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138886811|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886812|NCT00997399|Panobinostat|panobinostat|mesh-list
138886813|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886814|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138886815|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886816|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886818|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
138886819|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886820|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138886821|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
138886822|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886823|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886824|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138886825|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
138886826|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
138886827|NCT00997477|Hormones|hormones|mesh-ancestor
138886828|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138886829|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138886830|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138830060|NCT00716092|Hormones|hormones|mesh-ancestor
138886831|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138886832|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
138886833|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138886834|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886835|NCT01000831|Vaccines|vaccines|mesh-list
138886836|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
138886837|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886838|NCT05170789|Dexamethasone|dexamethasone|mesh-list
138886840|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886841|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
138886842|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
138830094|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
138886843|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886844|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886845|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138886846|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
138886847|NCT05170789|Hormones|hormones|mesh-ancestor
138886848|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138886849|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138794924|NCT02101788|Tamoxifen|tamoxifen|mesh-list
138886850|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886851|NCT02693951|Cefotiam|cefotiam|mesh-list
138886852|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138886853|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886854|NCT00997711|Sirolimus|sirolimus|mesh-list
138886855|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138886856|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886857|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138886858|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886859|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
138886860|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138886861|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
138886862|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886863|NCT01001143|Decitabine|decitabine|mesh-list
138886864|NCT01001143|Bexarotene|bexarotene|mesh-list
138886865|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138886866|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
138886867|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886868|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886869|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886870|NCT02715167|Budesonide|budesonide|mesh-list
138886871|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886872|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138886873|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
138886874|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886875|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886876|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138886877|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
138886878|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
138886879|NCT02715167|Hormones|hormones|mesh-ancestor
138886880|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138886881|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138886882|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138886883|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138999535|NCT02559791|Reslizumab|reslizumab|mesh-list
138886884|NCT02620566|Bupivacaine|bupivacaine|mesh-list
138886885|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
138886886|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
138886887|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138886888|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886889|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
138886890|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886891|NCT02714699|Diclofenac|diclofenac|mesh-list
138886892|NCT02714699|Scopolamine|scopolamine|mesh-list
138886893|NCT02714699|Bromides|bromides|mesh-list
138886894|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138886895|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138886896|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138830285|NCT00680407|Silymarin|silymarin|mesh-list
138886898|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
138886899|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886900|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886901|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886902|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138886903|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138886904|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886905|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886906|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
138886907|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138886908|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
138886909|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
138886910|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138886911|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
138886912|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138886913|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
138886914|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138886915|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138886916|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
138886917|NCT01004419|Fulvestrant|fulvestrant|mesh-list
138886918|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138886919|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886920|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138886921|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138886922|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
138886923|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138886924|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886925|NCT02714855|Apixaban|apixaban|mesh-list
138886926|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138886927|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
138886928|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138886929|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
138886930|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886931|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886932|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
138886933|NCT02712203|Vaccines|vaccines|mesh-list
138886934|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
138886935|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886936|NCT00696930|Edotreotide|edotreotide|mesh-list
138886937|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138886938|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886939|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
138886940|NCT00598442|Hematinics|hematinics|mesh-ancestor
138886941|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
138886942|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
138886943|NCT02714543|Antioxidants|antioxidants|mesh-list
138886944|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886945|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138886946|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
138886947|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886948|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
138886950|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886951|NCT02714231|Diclofenac|diclofenac|mesh-list
138886952|NCT02714231|Scopolamine|scopolamine|mesh-list
138886953|NCT02714231|Bromides|bromides|mesh-list
138886954|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138886955|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138886956|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138886957|NCT02714231|Analgesics|analgesics|mesh-ancestor
138886958|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
138886959|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138886960|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886961|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138886962|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138539100|NCT00162526|Vitamin E|vitamin e|mesh-list
138886963|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138886964|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138886965|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886966|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
138886967|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138886968|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
138886969|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
138886970|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138886971|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
138886972|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138886973|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
138886974|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138886975|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138886976|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
138886978|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
138886979|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138886981|NCT00532129|Chlorambucil|chlorambucil|mesh-list
138886982|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138886983|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138886984|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
138886985|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886986|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138886987|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138886988|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
138886989|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886990|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138886991|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138795164|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
138886992|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138886993|NCT04163588|Metolazone|metolazone|mesh-list
138886994|NCT04163588|Diuretics|diuretics|mesh-list
138886995|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138886996|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
138886997|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138886998|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138886999|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887000|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138887001|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138887002|NCT05167513|Metformin|metformin|mesh-list
138887003|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138887004|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138887005|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887006|NCT05167513|Incretins|incretins|mesh-ancestor
138887007|NCT05167513|Hormones|hormones|mesh-ancestor
138887008|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887009|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138887010|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
138887011|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887012|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887013|NCT00654056|Insulin|insulin|mesh-list
138887014|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138887015|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138887016|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887017|NCT00854373|Hormones|hormones|mesh-list
138887018|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138887019|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887020|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887021|NCT00611507|Fluorouracil|fluorouracil|mesh-list
138887022|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
138887023|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
138830771|NCT00919984|Paclitaxel|paclitaxel|mesh-list
138887024|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795213|NCT01199575|Rituximab|rituximab|mesh-list
138887025|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138887026|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887027|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138887028|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
138887029|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887030|NCT01001845|Vitamin E|vitamin e|mesh-list
138887031|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
138887032|NCT01001845|Tocopherols|tocopherols|mesh-list
138887033|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
138887034|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887035|NCT01001845|Protective Agents|protective agents|mesh-ancestor
138887036|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887037|NCT01001845|Vitamins|vitamins|mesh-ancestor
138887038|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
138887039|NCT02635334|Montelukast|montelukast|mesh-list
138887040|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138887041|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
138887042|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138887043|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
138887044|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887045|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887046|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138887047|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138887048|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887049|NCT00853905|Triamcinolone|triamcinolone|mesh-list
138887050|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138887051|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138887052|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138887053|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138887054|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138887055|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
138887056|NCT00853905|Hormones|hormones|mesh-ancestor
138887057|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887058|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887059|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138887060|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
138887061|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887062|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887063|NCT00998101|Carboplatin|carboplatin|mesh-list
138887065|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887066|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138887067|NCT04234217|Niacin|niacin|mesh-list
138887068|NCT04234217|Niacinamide|niacinamide|mesh-list
138887069|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
138795262|NCT01081262|Paclitaxel|paclitaxel|mesh-list
138887070|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138887071|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
138887072|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887073|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138887074|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
138830929|NCT04080388|Diuretics|diuretics|mesh-list
138887075|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
138887076|NCT04234217|Vitamins|vitamins|mesh-ancestor
138887078|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887079|NCT01002079|Rifampin|rifampin|mesh-list
138887080|NCT01002079|BMS 708163|bms 708163|mesh-list
138887081|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138887082|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
138887083|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138887084|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138887085|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
138887086|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138887087|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887088|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887089|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138887090|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138887091|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138887092|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138887093|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138887094|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138887095|NCT01002079|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138887096|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
138887097|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138887098|NCT05429567|Fentanyl|fentanyl|mesh-list
138887099|NCT05429567|Bupivacaine|bupivacaine|mesh-list
138887100|NCT05429567|Anesthetics, Local|anesthetics, local|mesh-ancestor
138795282|NCT01081262|Growth Substances|growth substances|mesh-ancestor
138795283|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795284|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
138795285|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
138795286|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138795288|NCT01064648|Cisplatin|cisplatin|mesh-list
138795289|NCT01064648|Pemetrexed|pemetrexed|mesh-list
138795290|NCT01064648|Cediranib|cediranib|mesh-list
138795291|NCT01064648|Maleic acid|maleic acid|mesh-list
138795292|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795293|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795294|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452042|NCT01873443|Folic Acid|folic acid|mesh-list
138887101|NCT05429567|Anesthetics|anesthetics|mesh-ancestor
138887102|NCT05429567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887103|NCT05429567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887104|NCT05429567|Sensory System Agents|sensory system agents|mesh-ancestor
138887105|NCT05429567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887106|NCT05429567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138887107|NCT05429567|Narcotics|narcotics|mesh-ancestor
138887108|NCT05429567|Analgesics|analgesics|mesh-ancestor
138887109|NCT05429567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138887110|NCT05429567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138887111|NCT05429567|Anesthetics, General|anesthetics, general|mesh-ancestor
138887112|NCT00868296|Pantoprazole|pantoprazole|mesh-list
138887113|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138887114|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138887115|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138831046|NCT05857267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887117|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887118|NCT01002157|Vitamin K|vitamin k|mesh-list
138887119|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
138887120|NCT01002157|Menaquinone 7|menaquinone 7|mesh-list
138887121|NCT01002157|Vitamins|vitamins|mesh-ancestor
138887122|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
138887123|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887124|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138887125|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138887126|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887127|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
138887128|NCT01002157|Coagulants|coagulants|mesh-ancestor
138887129|NCT01004497|Cytarabine|cytarabine|mesh-list
138887130|NCT01004497|Dexamethasone|dexamethasone|mesh-list
138887131|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
138887132|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
138887133|NCT01004497|Vincristine|vincristine|mesh-list
138887134|NCT01004497|Daunorubicin|daunorubicin|mesh-list
138887135|NCT01004497|Dasatinib|dasatinib|mesh-list
138887136|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
138887137|NCT01004497|BB 1101|bb 1101|mesh-list
138887138|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138887139|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
138887140|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887141|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138887142|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138887144|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887145|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887146|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138887147|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138887148|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
138887149|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
138887150|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887151|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138887152|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
138887153|NCT01004497|Hormones|hormones|mesh-ancestor
138887154|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887155|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138887156|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
138887157|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887158|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138887159|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
138887160|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
138887161|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138887162|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138887163|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
138887164|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
138887165|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
138887166|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138887167|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138887168|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138887169|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138887170|NCT01004497|Analgesics|analgesics|mesh-ancestor
138887171|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
138887172|NCT02713841|Insulin|insulin|mesh-list
138887173|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138887174|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
138887175|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138887176|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887177|NCT01004575|Cobalt|cobalt|mesh-list
138887178|NCT01004575|Chromium|chromium|mesh-list
138887179|NCT01004575|Trace Elements|trace elements|mesh-ancestor
138887180|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
138887181|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887182|NCT02615730|Paclitaxel|paclitaxel|mesh-list
138887183|NCT02615730|GSK2636771|gsk2636771|mesh-list
138887184|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138887185|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887186|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
138887187|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
138887188|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
138887189|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887190|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138887191|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887192|NCT02711891|Loperamide|loperamide|mesh-list
138887193|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
138887194|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138887195|NCT02615496|Aflibercept|aflibercept|mesh-list
138887196|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138887197|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138887198|NCT02615496|Growth Substances|growth substances|mesh-ancestor
138887199|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887200|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
138887201|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887202|NCT02714075|Zinc|zinc|mesh-list
138887203|NCT02714075|Iron|iron|mesh-list
138887204|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
138887205|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
138887206|NCT02714075|Citric Acid|citric acid|mesh-list
138887207|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
138887208|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
138887209|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138887210|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
138887211|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
138887212|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887213|NCT02714075|Trace Elements|trace elements|mesh-ancestor
138887214|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
138887215|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887216|NCT02714075|Astringents|astringents|mesh-ancestor
138887217|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
138887218|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
138887219|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138887220|NCT02714075|Protective Agents|protective agents|mesh-ancestor
138887221|NCT02636426|Sorafenib|sorafenib|mesh-list
139210423|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210424|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
139210426|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139210427|NCT03365622|Acetaminophen|acetaminophen|mesh-list
139210428|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139210429|NCT03365622|Analgesics|analgesics|mesh-ancestor
139210430|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
139210431|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210432|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210433|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
139210434|NCT03361306|Elotuzumab|elotuzumab|mesh-list
139210435|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210436|NCT03325439|Brivaracetam|brivaracetam|mesh-list
139210437|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
139210438|NCT03324425|Simvastatin|simvastatin|mesh-list
139210439|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139210440|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139210441|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
139210442|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210443|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139210444|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139210445|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210446|NCT03291899|Folfirinox|folfirinox|mesh-list
139210447|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210448|NCT03246347|Docetaxel|docetaxel|mesh-list
139210449|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210450|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
139210451|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210452|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
139210453|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210454|NCT03221426|Leucovorin|leucovorin|mesh-list
139210455|NCT03221426|Docetaxel|docetaxel|mesh-list
139210456|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
139210457|NCT03221426|Capecitabine|capecitabine|mesh-list
139210458|NCT03221426|Fluorouracil|fluorouracil|mesh-list
139210459|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
139210460|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210461|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
139210462|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210463|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
139210464|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210465|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138831296|NCT05041270|Narcotics|narcotics|mesh-ancestor
139210466|NCT03221426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210467|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139210469|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139210470|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
139210471|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210472|NCT03221426|Antidotes|antidotes|mesh-ancestor
139210473|NCT03221426|Protective Agents|protective agents|mesh-ancestor
139210474|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
139210475|NCT03221426|Vitamins|vitamins|mesh-ancestor
139210476|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
139210477|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
139210478|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210479|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
139210480|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831326|NCT04806906|Cc-486|cc-486|mesh-list
139210481|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210482|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139210483|NCT03147612|Cytarabine|cytarabine|mesh-list
139210484|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
139210485|NCT03147612|Rituximab|rituximab|mesh-list
139210486|NCT03147612|Methotrexate|methotrexate|mesh-list
139210487|NCT03147612|Vincristine|vincristine|mesh-list
139210488|NCT03147612|Blinatumomab|blinatumomab|mesh-list
139210489|NCT03147612|Ponatinib|ponatinib|mesh-list
139210490|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139210491|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
139210492|NCT03147612|Antibodies|antibodies|mesh-list
139210493|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
139210494|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139210495|NCT03147612|Lenograstim|lenograstim|mesh-list
139210496|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139210497|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139210498|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
138706421|NCT04676997|Paclitaxel|paclitaxel|mesh-list
139210499|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210500|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139210501|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139210502|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
139210503|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210504|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210505|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139210506|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139210507|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
139210508|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139210509|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139210510|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
138999653|NCT00964574|Insulin|insulin|mesh-list
138795488|NCT00792948|BB 1101|bb 1101|mesh-list
139210511|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
139210512|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210513|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139210514|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139210515|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
139210516|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139210517|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139210518|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139210519|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
139210520|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210521|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
139210522|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139210523|NCT03141177|Nivolumab|nivolumab|mesh-list
139210524|NCT03141177|Ipilimumab|ipilimumab|mesh-list
139210525|NCT03141177|Sunitinib|sunitinib|mesh-list
139210526|NCT03141177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210527|NCT03141177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210528|NCT03141177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210529|NCT03141177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210530|NCT03141177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139210531|NCT03141177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139210532|NCT03141177|Growth Substances|growth substances|mesh-ancestor
139210533|NCT03141177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210534|NCT03141177|Growth Inhibitors|growth inhibitors|mesh-ancestor
139210535|NCT03141177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139210536|NCT03141177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210537|NCT03118986|Olanzapine|olanzapine|mesh-list
139210538|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
139210539|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
139210540|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210541|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210542|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139210543|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139210544|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139210545|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139210546|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139210547|NCT03118986|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139210548|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139210549|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139210550|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210551|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139210552|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
139210553|NCT03109288|Pioglitazone|pioglitazone|mesh-list
139210554|NCT03109288|Clemastine|clemastine|mesh-list
139210555|NCT03109288|Pirfenidone|pirfenidone|mesh-list
139210556|NCT03109288|Dantrolene|dantrolene|mesh-list
139210557|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139210558|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210559|NCT03109288|Analgesics|analgesics|mesh-ancestor
139210560|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
139210561|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139210562|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139210563|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139210564|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139210565|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139210566|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210567|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
139210568|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
139210569|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139210570|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
139210571|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
139210572|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139210573|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210574|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139210575|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139210576|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139210577|NCT03099499|TIC10 compound|tic10 compound|mesh-list
139210578|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210579|NCT03098836|Prednisone|prednisone|mesh-list
139210580|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
139210581|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139210582|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
139210583|NCT03098836|Hormones|hormones|mesh-ancestor
139210584|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139210585|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210586|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139210587|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210588|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139210589|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210590|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210591|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
138268381|NCT00338377|Mesna|mesna|mesh-list
139210592|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139210593|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
139210594|NCT03092518|Mitomycins|mitomycins|mesh-list
139210595|NCT03092518|Mitomycin|mitomycin|mesh-list
139210596|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210597|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139210598|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
139210599|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210600|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139210602|NCT03092518|Antidotes|antidotes|mesh-ancestor
139210603|NCT03092518|Protective Agents|protective agents|mesh-ancestor
139210604|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210605|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
139210606|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
139210607|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139210608|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139210609|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
139210610|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
139210611|NCT03083691|Nivolumab|nivolumab|mesh-list
139210612|NCT03083691|Ipilimumab|ipilimumab|mesh-list
139210613|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139210614|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210615|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139210616|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210617|NCT03071536|Furosemide|furosemide|mesh-list
139210618|NCT03071536|Diuretics|diuretics|mesh-ancestor
139210619|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
139210620|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210621|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139210622|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139210623|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210624|NCT03069937|Docetaxel|docetaxel|mesh-list
139210625|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139210626|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
139210627|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
139210628|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
139210629|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210630|NCT03065387|Everolimus|everolimus|mesh-list
139210631|NCT03065387|Palbociclib|palbociclib|mesh-list
139210632|NCT03065387|Trametinib|trametinib|mesh-list
139210633|NCT03065387|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139210634|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139210635|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139210636|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139210637|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139210638|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
139210639|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139210640|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706722|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
138887222|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707068|NCT01712451|Xhance|xhance|mesh-list
138707704|NCT04678791|Cisplatin|cisplatin|mesh-list
138707780|NCT00557232|Bevacizumab|bevacizumab|mesh-list
138709053|NCT04813653|Cyclosporine|cyclosporine|mesh-list
138999727|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
138709352|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709672|NCT00547001|Estradiol|estradiol|mesh-list
138831769|NCT04080310|Ezetimibe|ezetimibe|mesh-list
138709872|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138709945|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138887223|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138710405|NCT04800302|Morphine|morphine|mesh-list
138887224|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887307|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138710989|NCT04621617|Midodrine|midodrine|mesh-list
138887308|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138887309|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
138887310|NCT01002703|Hormones|hormones|mesh-ancestor
138960817|NCT02556866|Rituximab|rituximab|mesh-list
138960818|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138960819|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960820|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
138960821|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960822|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138960823|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138960824|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
138960825|NCT02556866|Hormones|hormones|mesh-ancestor
138960826|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138960827|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138960828|NCT00308113|Ubiquinone|ubiquinone|mesh-list
138960829|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
138960830|NCT00308113|Prednisone|prednisone|mesh-list
138960831|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138960832|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
138960833|NCT00308113|Hormones|hormones|mesh-ancestor
138960834|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138960835|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960836|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138960837|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960838|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
138960839|NCT00308113|Vitamins|vitamins|mesh-ancestor
138960840|NCT03903640|Nivolumab|nivolumab|mesh-list
138795627|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960842|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138960843|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960844|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138960845|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960846|NCT03982849|Silymarin|silymarin|mesh-list
138960847|NCT03982849|Hydroquinone|hydroquinone|mesh-list
138960848|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
138960849|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960850|NCT03982849|Protective Agents|protective agents|mesh-ancestor
138960851|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960852|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138960853|NCT05357872|Anesthetics|anesthetics|mesh-list
138960854|NCT05357872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831938|NCT00764725|Analgesics|analgesics|mesh-ancestor
138960855|NCT05357872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960856|NCT00777218|Topiramate|topiramate|mesh-list
138960857|NCT00777218|Propranolol|propranolol|mesh-list
138960858|NCT00777218|Zonisamide|zonisamide|mesh-list
138960859|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138960860|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138960861|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
138960862|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960863|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960864|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960865|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138960866|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138960867|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
138960868|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
138960869|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138960870|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138960871|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138960872|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138960873|NCT04047758|Letrozole|letrozole|mesh-list
138960874|NCT04047758|Palbociclib|palbociclib|mesh-list
138960875|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960876|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138960877|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138960878|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795648|NCT00433511|Doxorubicin|doxorubicin|mesh-list
138960879|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960880|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138960881|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
138960882|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138960883|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960884|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138960885|NCT00307801|Dienogest|dienogest|mesh-list
138960886|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138960887|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138960888|NCT00307801|Estradiol|estradiol|mesh-list
138960889|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138960890|NCT00307801|Estrogens|estrogens|mesh-ancestor
138960891|NCT00307801|Hormones|hormones|mesh-ancestor
138960892|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138960893|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960894|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138960895|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
138960896|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138960897|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138960898|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138960899|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138960900|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138960901|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
138960902|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138960903|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960905|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138960906|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
138795688|NCT00408005|Doxorubicin|doxorubicin|mesh-list
138960907|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138960908|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960909|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138960910|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138960912|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
138960913|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138960914|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138960915|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
138960916|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960917|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960918|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960919|NCT00773552|Urological Agents|urological agents|mesh-ancestor
138960920|NCT04002700|Haloperidol|haloperidol|mesh-list
138960921|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
138960922|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
138960923|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
138960924|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
138960925|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960926|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960927|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138960928|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138960929|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960930|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138960931|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138960932|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
138960933|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960934|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960935|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138960936|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
138960937|NCT04098653|Busulfan|busulfan|mesh-list
138960938|NCT04098653|Decitabine|decitabine|mesh-list
138960939|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138960940|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
138960941|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960942|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138960943|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138960944|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
138960945|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960946|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960947|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138960948|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138960949|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
138960950|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960951|NCT05297123|Tretinoin|tretinoin|mesh-list
138960952|NCT05297123|Arsenic Trioxide|arsenic trioxide|mesh-list
138960953|NCT05297123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960954|NCT05297123|Keratolytic Agents|keratolytic agents|mesh-ancestor
138960955|NCT05297123|Dermatologic Agents|dermatologic agents|mesh-ancestor
138960956|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138960957|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960958|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138960959|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960960|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960962|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138960963|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
138960964|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960965|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960966|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138960967|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
138960968|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138960969|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138960970|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960971|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138960972|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
138960973|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138960974|NCT00773630|Protective Agents|protective agents|mesh-ancestor
138960975|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138960976|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138960977|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960978|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138960979|NCT04016922|Hematinics|hematinics|mesh-ancestor
138960980|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
138960981|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138960982|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138960983|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960984|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
138960985|NCT03646474|Coagulants|coagulants|mesh-ancestor
138960987|NCT00808002|Emtricitabine|emtricitabine|mesh-list
138960988|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
138960989|NCT00808002|Maraviroc|maraviroc|mesh-list
138960990|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
138960991|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960992|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138960993|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138960994|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960995|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960996|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138960997|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138960998|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138960999|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138961000|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138961001|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138961002|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138961004|NCT00307489|Emtricitabine|emtricitabine|mesh-list
138961005|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
138961006|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961007|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138961008|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138961009|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961010|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961011|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138961012|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138961013|NCT00812292|Rilpivirine|rilpivirine|mesh-list
138961014|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138832534|NCT00776503|Vorinostat|vorinostat|mesh-list
138961015|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138961016|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961017|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961018|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
138961019|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961020|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138961021|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138961022|NCT00812370|Bivalirudin|bivalirudin|mesh-list
138961023|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
138961024|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138961025|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
138961026|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961027|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961028|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
138961029|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138961030|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138961031|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
138961032|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138961033|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138961034|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
138961035|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961036|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138961037|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138961038|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961039|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711881|NCT02137343|Capecitabine|capecitabine|mesh-list
138961041|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
138961042|NCT00762359|Gefarnate|gefarnate|mesh-list
138961043|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138961044|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138961045|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138961046|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961047|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961048|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138961049|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
138961050|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138961051|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
138961052|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961053|NCT00770042|Ritonavir|ritonavir|mesh-list
138961054|NCT00770042|Ketoconazole|ketoconazole|mesh-list
138961055|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138961056|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138961057|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
138961058|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961059|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961060|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138961061|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138961062|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
138961063|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961064|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138961065|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138961066|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
138961067|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138961068|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138961069|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
138961070|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138795904|NCT00878800|Doxorubicin|doxorubicin|mesh-list
138961071|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961072|NCT00654186|Lenalidomide|lenalidomide|mesh-list
138961073|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
138961074|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961075|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138961076|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138961077|NCT00654186|Growth Substances|growth substances|mesh-ancestor
138961078|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
138961079|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961080|NCT03275818|Paclitaxel|paclitaxel|mesh-list
138961081|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138961082|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961083|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
138961084|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
138961085|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
138961086|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961087|NCT03979105|Ketamine|ketamine|mesh-list
138961088|NCT03979105|Analgesics|analgesics|mesh-ancestor
138961089|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
138961090|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138961091|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961092|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138961093|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138961094|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
138961095|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
138961096|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138961097|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138961098|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138961099|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961100|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961101|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
138961102|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138961103|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961104|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
138961105|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138961106|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138961107|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961108|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
138961109|NCT04100447|Coagulants|coagulants|mesh-ancestor
138961110|NCT03274804|Maraviroc|maraviroc|mesh-list
138961111|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
138961112|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138961113|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961114|NCT03274804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138961115|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961116|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138961117|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138961118|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138961119|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138961120|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
138961121|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961122|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138961123|NCT00761891|Aspirin|aspirin|mesh-list
138961124|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138961125|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138961126|NCT00761891|Analgesics|analgesics|mesh-ancestor
138961127|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
138961128|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138961129|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961130|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138961131|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138961132|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138961133|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138961134|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961135|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138961136|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138961137|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961138|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
138961139|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
138961140|NCT00321685|Leucovorin|leucovorin|mesh-list
138961141|NCT00321685|Folic Acid|folic acid|mesh-list
138961142|NCT00321685|Bevacizumab|bevacizumab|mesh-list
138961143|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138961144|NCT00321685|Capecitabine|capecitabine|mesh-list
138961145|NCT00321685|Fluorouracil|fluorouracil|mesh-list
138961146|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
138961147|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
138961148|NCT00321685|Antibodies|antibodies|mesh-list
138961149|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
138961150|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138961151|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
138961152|NCT00321685|Calcium|calcium|mesh-list
138961154|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961155|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138961156|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138961157|NCT00321685|Growth Substances|growth substances|mesh-ancestor
138961158|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961159|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
138961160|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
138961161|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138961162|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138961163|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138961164|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
138961165|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961166|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138961167|NCT00321685|Antidotes|antidotes|mesh-ancestor
138961168|NCT00321685|Protective Agents|protective agents|mesh-ancestor
138832928|NCT02579590|Hormones|hormones|mesh-ancestor
138961169|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
138961171|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
138961172|NCT00321685|Hematinics|hematinics|mesh-ancestor
138961173|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
138961174|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138961175|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
138961176|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961177|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
138961178|NCT00778076|Protective Agents|protective agents|mesh-ancestor
138961179|NCT00306787|Valacyclovir|valacyclovir|mesh-list
138961180|NCT00306787|Famciclovir|famciclovir|mesh-list
138961181|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
138961182|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961183|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138961184|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961185|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961186|NCT00778232|Gabapentin|gabapentin|mesh-list
138961187|NCT00778232|Analgesics|analgesics|mesh-ancestor
138961188|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
138961189|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138961190|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961191|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
138961192|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138961193|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138961194|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833032|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
138961196|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138961197|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138961198|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961199|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961200|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
138961201|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
138961202|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138961203|NCT00774488|Incretins|incretins|mesh-ancestor
138961204|NCT00774488|Hormones|hormones|mesh-ancestor
138961205|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138961206|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961207|NCT01066195|Pemetrexed|pemetrexed|mesh-list
138961208|NCT01066195|Gefitinib|gefitinib|mesh-list
138961209|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961210|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961211|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961212|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138961213|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138961214|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138961215|NCT00774644|Clarithromycin|clarithromycin|mesh-list
138961216|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138961217|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961218|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138961219|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961220|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833157|NCT00779389|Dasatinib|dasatinib|mesh-list
138961222|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138961223|NCT05123092|Morphine|morphine|mesh-list
138961224|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138961225|NCT05123092|Narcotics|narcotics|mesh-ancestor
138961226|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138961227|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961228|NCT05123092|Analgesics|analgesics|mesh-ancestor
138961229|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
138961230|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138961231|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138961232|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138961233|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961234|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138961235|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961236|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961238|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
138961239|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961240|NCT00667394|Bevacizumab|bevacizumab|mesh-list
138833284|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961241|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138961242|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961243|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138961244|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138961245|NCT00667394|Growth Substances|growth substances|mesh-ancestor
138961246|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961247|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
138961248|NCT05357326|Atropine|atropine|mesh-list
138961249|NCT05357326|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138961250|NCT05357326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138961251|NCT05357326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138961252|NCT05357326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138961253|NCT05357326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138961254|NCT05357326|Autonomic Agents|autonomic agents|mesh-ancestor
138961255|NCT05357326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138961256|NCT05357326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961257|NCT05357326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138961258|NCT05357326|Respiratory System Agents|respiratory system agents|mesh-ancestor
138961259|NCT05357326|Mydriatics|mydriatics|mesh-ancestor
138961260|NCT05357326|Parasympatholytics|parasympatholytics|mesh-ancestor
138961261|NCT05357326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138961262|NCT05357326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138961263|NCT05357326|Cholinergic Agents|cholinergic agents|mesh-ancestor
138961264|NCT05357326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833404|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
138999892|NCT04008290|Incretins|incretins|mesh-ancestor
138961265|NCT05357326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961266|NCT00778466|Metformin|metformin|mesh-list
138961267|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138961268|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961269|NCT00761735|Ribavirin|ribavirin|mesh-list
138961270|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138961271|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
138961272|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961273|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
138961274|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961275|NCT00569946|Axitinib|axitinib|mesh-list
138833469|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
138961276|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961277|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138961278|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961279|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961280|NCT00778544|Amoxicillin|amoxicillin|mesh-list
138961281|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
138961282|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
138961283|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138961284|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138961285|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961286|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961287|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961288|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138961289|NCT04001374|Ticagrelor|ticagrelor|mesh-list
138961290|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138961291|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138961292|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138961293|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138961294|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
138961295|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961296|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961297|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961298|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
138961299|NCT05265910|Loratadine|loratadine|mesh-list
138961300|NCT05265910|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138961301|NCT05265910|Dextrans|dextrans|mesh-list
138961302|NCT05265910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138961303|NCT05265910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138961304|NCT05265910|Antipruritics|antipruritics|mesh-ancestor
138961305|NCT05265910|Dermatologic Agents|dermatologic agents|mesh-ancestor
138961306|NCT05265910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138961307|NCT05265910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138961308|NCT05265910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138961309|NCT05265910|Histamine Antagonists|histamine antagonists|mesh-ancestor
138961310|NCT05265910|Histamine Agents|histamine agents|mesh-ancestor
138961311|NCT05265910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961312|NCT05265910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961313|NCT05265910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961314|NCT05265910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138961315|NCT05265910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138961316|NCT05265910|Analgesics|analgesics|mesh-ancestor
138961317|NCT05265910|Sensory System Agents|sensory system agents|mesh-ancestor
138961318|NCT05265910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138961319|NCT05265910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138961320|NCT05265910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138961321|NCT05265910|Anticoagulants|anticoagulants|mesh-ancestor
138961322|NCT05265910|Plasma Substitutes|plasma substitutes|mesh-ancestor
138961323|NCT05265910|Blood Substitutes|blood substitutes|mesh-ancestor
138961324|NCT00814866|Adalimumab|adalimumab|mesh-list
138961325|NCT00814866|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138961326|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138961327|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138961328|NCT00991978|Bevacizumab|bevacizumab|mesh-list
138961329|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
138961330|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138187190|NCT02245295|Anesthetics|anesthetics|mesh-list
138961331|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961332|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138961333|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138961334|NCT00991978|Growth Substances|growth substances|mesh-ancestor
138961335|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961336|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
138961338|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961339|NCT00645528|Insulin|insulin|mesh-list
138961340|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138961341|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961342|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138961343|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
138961344|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961345|NCT00812448|Protective Agents|protective agents|mesh-ancestor
138961346|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961347|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138961348|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138961349|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961350|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138961351|NCT00295633|Metformin|metformin|mesh-list
138961352|NCT00295633|Pioglitazone|pioglitazone|mesh-list
138833709|NCT00664287|Niacin|niacin|mesh-list
138961353|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
138961354|NCT00295633|Saxagliptin|saxagliptin|mesh-list
138961355|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138796206|NCT05712265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961356|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961357|NCT00295633|Incretins|incretins|mesh-ancestor
138961358|NCT00295633|Hormones|hormones|mesh-ancestor
138961359|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138961360|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138961361|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
138961362|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961363|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961364|NCT00570674|Paclitaxel|paclitaxel|mesh-list
138961365|NCT00570674|Carboplatin|carboplatin|mesh-list
138961366|NCT00570674|Cetuximab|cetuximab|mesh-list
138961367|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138485736|NCT00000652|Didanosine|didanosine|mesh-list
138961368|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138961369|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961370|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
138961371|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
138961372|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
138961373|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961374|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138961376|NCT00808314|Regadenoson|regadenoson|mesh-list
138961377|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138961378|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961379|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961380|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138961381|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
138961382|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138961383|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138961384|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
138961385|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
138961386|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961387|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961388|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138961389|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138961390|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
138961392|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138961393|NCT00768989|Tenofovir|tenofovir|mesh-list
138961394|NCT00768989|Emtricitabine|emtricitabine|mesh-list
138961395|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
138961396|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138961397|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138961398|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
138961399|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961400|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961401|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138961402|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138961403|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
138961404|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961405|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138961406|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138961407|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138961408|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138961409|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138961410|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138961412|NCT00779714|Paclitaxel|paclitaxel|mesh-list
138961413|NCT00779714|Cisplatin|cisplatin|mesh-list
138961414|NCT00779714|Dacarbazine|dacarbazine|mesh-list
138961415|NCT00779714|Treosulfan|treosulfan|mesh-list
138961416|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138961417|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961418|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
138961419|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
138961420|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
138961421|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961422|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138961423|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
138961424|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
138833922|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138961425|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961426|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138961427|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
138961428|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961429|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138961430|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
138961431|NCT00812760|Levodopa|levodopa|mesh-list
138961432|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138961433|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138961434|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
138961435|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961436|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961437|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961438|NCT00814944|Sirolimus|sirolimus|mesh-list
138961439|NCT00814944|Temsirolimus|temsirolimus|mesh-list
138961440|NCT00814944|MTOR Inhibitors|mtor inhibitors|mesh-list
138961441|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138961442|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961443|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138961444|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961445|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
138961446|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138961447|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
138961448|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961449|NCT00814944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138961450|NCT00814944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961451|NCT00814944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961452|NCT00779792|Triamcinolone|triamcinolone|mesh-list
138961453|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138961454|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138961455|NCT00779792|Clobetasol|clobetasol|mesh-list
138961456|NCT00779792|Mineral Oil|mineral oil|mesh-list
138961457|NCT00779792|Tacrolimus|tacrolimus|mesh-list
138961458|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138961459|NCT00779792|Glycerol|glycerol|mesh-list
138961460|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138961461|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
138961462|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961463|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138961464|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961465|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961466|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138961467|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
138961468|NCT00779792|Hormones|hormones|mesh-ancestor
138961469|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138961470|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138961471|NCT00779792|Protective Agents|protective agents|mesh-ancestor
138961472|NCT00779792|Emollients|emollients|mesh-ancestor
138961473|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
138961474|NCT00992134|Cytarabine|cytarabine|mesh-list
138961475|NCT00992134|Rituximab|rituximab|mesh-list
138961476|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138961477|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138961478|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961479|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
138961480|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961481|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138961482|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138961483|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
138961484|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961485|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
138961486|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961487|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138961488|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138961489|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
138961490|NCT02551536|Fexofenadine|fexofenadine|mesh-list
138961491|NCT02551536|Montelukast|montelukast|mesh-list
138961492|NCT02551536|Levocetirizine|levocetirizine|mesh-list
138834158|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
138999955|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138961493|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138796311|NCT05355311|Vitamins|vitamins|mesh-ancestor
138961494|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
138961495|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138961496|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
138961497|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138961498|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961499|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138961500|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138961501|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961502|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138961503|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138961504|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138961505|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
138961506|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
138961507|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961508|NCT00815022|Fentanyl|fentanyl|mesh-list
138961509|NCT00815022|Morphine|morphine|mesh-list
138961510|NCT00815022|Bupivacaine|bupivacaine|mesh-list
138961511|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
138961512|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
138961513|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138961514|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961515|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
138961516|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138961517|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138961518|NCT00815022|Narcotics|narcotics|mesh-ancestor
138961519|NCT00815022|Analgesics|analgesics|mesh-ancestor
138961520|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138961521|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138961522|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
138961523|NCT00774722|Metronidazole|metronidazole|mesh-list
138961524|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961525|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138961526|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138961527|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138961529|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
138961530|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961531|NCT04045548|Dinoprostone|dinoprostone|mesh-list
138961532|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
138961533|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138961534|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961536|NCT00780104|Sirolimus|sirolimus|mesh-list
138961537|NCT00780104|Etoposide|etoposide|mesh-list
138961538|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
138961539|NCT00780104|Temsirolimus|temsirolimus|mesh-list
138961540|NCT00780104|MTOR Inhibitors|mtor inhibitors|mesh-list
138961541|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138961542|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961543|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138961544|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138961545|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961546|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961548|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
138961549|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
138961550|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961551|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138961552|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
138999967|NCT00972842|Growth Substances|growth substances|mesh-ancestor
138961553|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961554|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138961555|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138961556|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
138796376|NCT05003713|Cortisone|cortisone|mesh-list
138961557|NCT00780104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138961559|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
138961560|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138961561|NCT04047680|Ritonavir|ritonavir|mesh-list
138961562|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
138961563|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138961564|NCT04047680|Grazoprevir|grazoprevir|mesh-list
138961565|NCT04047680|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138961566|NCT04047680|Ledipasvir|ledipasvir|mesh-list
138961567|NCT04047680|Velpatasvir|velpatasvir|mesh-list
138961568|NCT04047680|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138961569|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138961570|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138961571|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
138961572|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961573|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961574|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138961575|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138961576|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
138961577|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961578|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138834462|NCT04046653|Sulforaphane|sulforaphane|mesh-list
138961579|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138961580|NCT00774878|Fulvestrant|fulvestrant|mesh-list
138961581|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138961582|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961583|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138961584|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138961585|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
138961586|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138796436|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961587|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961589|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
138961590|NCT00815256|Vitamins|vitamins|mesh-ancestor
138961591|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
138961592|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961593|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138961594|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
138961595|NCT00778778|Cefprozil|cefprozil|mesh-list
138999986|NCT00965666|Analgesics|analgesics|mesh-ancestor
138961596|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138961597|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961598|NCT00305773|Vorinostat|vorinostat|mesh-list
138961599|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961600|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138961601|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961602|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961603|NCT00780182|Brincidofovir|brincidofovir|mesh-list
138961604|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
138961605|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961606|NCT00812994|Escitalopram|escitalopram|mesh-list
138961607|NCT00812994|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138961608|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138961609|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138961610|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961611|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961612|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
138961613|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961614|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
138961615|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138834499|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
138961616|NCT00784394|Protective Agents|protective agents|mesh-ancestor
138961617|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961618|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961619|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
138961620|NCT00305695|Imidazole|imidazole|mesh-list
138961621|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138961622|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961623|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961624|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961625|NCT00784472|Morphine|morphine|mesh-list
138961626|NCT00784472|Oxycodone|oxycodone|mesh-list
138961627|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138961628|NCT00784472|Narcotics|narcotics|mesh-ancestor
138961629|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138961630|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961631|NCT00784472|Analgesics|analgesics|mesh-ancestor
138961632|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
138961633|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138961634|NCT00779012|Infliximab|infliximab|mesh-list
138961635|NCT00779012|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138961636|NCT00779012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138961637|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
138961638|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138961639|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138961640|NCT00647556|Adapalene|adapalene|mesh-list
138961641|NCT00647556|Tretinoin|tretinoin|mesh-list
138961642|NCT00647556|Emollients|emollients|mesh-list
138961643|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961644|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
138961645|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
138961646|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138961647|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138961648|NCT00647556|Analgesics|analgesics|mesh-ancestor
138961649|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
138961650|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138961651|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961652|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138961653|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138961654|NCT03978559|Trimethoprim|trimethoprim|mesh-list
138961655|NCT03978559|Caspofungin|caspofungin|mesh-list
138961656|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
138961657|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
138961658|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138961659|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
138961660|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
138961661|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138961662|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961663|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138961664|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
138961665|NCT03978559|Hormones|hormones|mesh-ancestor
138961666|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138961667|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138961668|NCT03978559|Protective Agents|protective agents|mesh-ancestor
138961669|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138961670|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961671|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
138961672|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138834718|NCT04031703|Docetaxel|docetaxel|mesh-list
138961673|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138961674|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138961675|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961676|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961677|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138961678|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138961679|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138961680|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
138961682|NCT00813072|Irinotecan|irinotecan|mesh-list
138961683|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961684|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
138961685|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
138961686|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
138961687|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961688|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138961689|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138961690|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961691|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138961692|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138961693|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961694|NCT00813228|Incretins|incretins|mesh-ancestor
138961695|NCT00813228|Hormones|hormones|mesh-ancestor
138961696|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138961697|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138961698|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
138961699|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961700|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961701|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
138961702|NCT00808704|Hematinics|hematinics|mesh-ancestor
138961703|NCT00320515|Pemetrexed|pemetrexed|mesh-list
138961704|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961705|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961706|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961707|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138961708|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138961709|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138961710|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138961711|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138961712|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961713|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
138961714|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138961715|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
138961716|NCT00815568|Fludarabine|fludarabine|mesh-list
138961717|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
138961718|NCT00815568|Busulfan|busulfan|mesh-list
138961719|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961720|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138961721|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
138834966|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138961722|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961724|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
138961725|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961726|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
138961727|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138961728|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139000089|NCT00979862|Cediranib|cediranib|mesh-list
138961730|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
138961731|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138961732|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138961733|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961734|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961735|NCT00815646|Urological Agents|urological agents|mesh-ancestor
138961736|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
138961737|NCT01066351|Hematinics|hematinics|mesh-ancestor
138961738|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138961739|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138961740|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961741|NCT00661778|Bevacizumab|bevacizumab|mesh-list
138961742|NCT00661778|Docetaxel|docetaxel|mesh-list
138961743|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138961744|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961745|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138961746|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138961747|NCT00661778|Growth Substances|growth substances|mesh-ancestor
138961748|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961749|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
138961750|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
138961751|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
138961752|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
138961753|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961754|NCT01062139|Cetirizine|cetirizine|mesh-list
138961755|NCT01062139|Levocetirizine|levocetirizine|mesh-list
138835101|NCT00912327|Cetuximab|cetuximab|mesh-list
138961756|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138961757|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138961758|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
138796662|NCT03236987|Rifampin|rifampin|mesh-list
138961759|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
138961760|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961761|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961762|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961763|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138961764|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138961765|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138961766|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138961767|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138961768|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835143|NCT00991289|Ribavirin|ribavirin|mesh-list
138961769|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
138961770|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961771|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961772|NCT00653328|Doxorubicin|doxorubicin|mesh-list
138961773|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138961774|NCT00653328|Atrasentan|atrasentan|mesh-list
138961775|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138961776|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961777|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138961778|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138961779|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961780|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961781|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138961782|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138961783|NCT01664182|Bevacizumab|bevacizumab|mesh-list
138961784|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138961785|NCT01664182|Sunitinib|sunitinib|mesh-list
138961786|NCT01664182|Trebananib|trebananib|mesh-list
138961787|NCT01664182|Sorafenib|sorafenib|mesh-list
138961788|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
138961789|NCT01664182|Antibodies|antibodies|mesh-list
138961790|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
138961791|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138961792|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
138961793|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961794|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138961795|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138961796|NCT01664182|Growth Substances|growth substances|mesh-ancestor
138961797|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961798|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
138961799|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
138961800|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138961801|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961802|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961803|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
138961804|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
138961805|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138961806|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138961807|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961808|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961809|NCT00780728|Urological Agents|urological agents|mesh-ancestor
138961810|NCT00809172|Cyclosporine|cyclosporine|mesh-list
138961811|NCT00809172|Methotrexate|methotrexate|mesh-list
138961812|NCT00809172|Cyclosporins|cyclosporins|mesh-list
138961813|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138961814|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
138961815|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138961816|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961817|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138961818|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
138961819|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961820|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835330|NCT00685347|Albuterol|albuterol|mesh-list
138961821|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
138961822|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961823|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138961824|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138961825|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
138961826|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138961827|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138961828|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
138961829|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961830|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138961831|NCT00784862|Tamoxifen|tamoxifen|mesh-list
138961832|NCT00784862|Anastrozole|anastrozole|mesh-list
138961833|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138961834|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
138961835|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138961836|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835379|NCT00802009|Hormones|hormones|mesh-ancestor
138961837|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139000133|NCT00989898|Insulin|insulin|mesh-list
138961838|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961839|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138961840|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138796708|NCT03038256|Capecitabine|capecitabine|mesh-list
138961841|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138961842|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138961843|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138961844|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961845|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961847|NCT00784940|Anastrozole|anastrozole|mesh-list
138961848|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138961849|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
138961850|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138961851|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961852|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138961853|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961854|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138961855|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138961856|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138961857|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138961858|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138961859|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961860|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961861|NCT00790244|Doxorubicin|doxorubicin|mesh-list
138961862|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138961863|NCT00790244|Ifosfamide|ifosfamide|mesh-list
138961864|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
138961865|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138961866|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961867|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138961868|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138961869|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961870|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961871|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138961872|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
138961873|NCT00785018|Complement C1s|complement c1s|mesh-list
138961874|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138961875|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138961876|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
138961877|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961878|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138961879|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138961880|NCT00534352|Ritonavir|ritonavir|mesh-list
138961881|NCT00534352|Darunavir|darunavir|mesh-list
138961882|NCT00534352|Etravirine|etravirine|mesh-list
138961883|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138961884|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138961885|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
138796745|NCT02582008|Bupropion|bupropion|mesh-list
138961886|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961887|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961888|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138961889|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138961890|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
138961891|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138961892|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138961893|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138961894|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138961895|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138961896|NCT00642174|Clopidogrel|clopidogrel|mesh-list
138961897|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138961898|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138961899|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138961900|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138961901|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138961903|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961904|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961905|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961906|NCT02550444|Clonidine|clonidine|mesh-list
138961907|NCT02550444|Analgesics|analgesics|mesh-ancestor
138961908|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
138961909|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138961910|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961911|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138961912|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
138961913|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
138961914|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138961915|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138961916|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138961917|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
138961918|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961919|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961920|NCT00665366|Valproic Acid|valproic acid|mesh-list
138961921|NCT00665366|Aripiprazole|aripiprazole|mesh-list
138961922|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
138961923|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138961924|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138961925|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138961926|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138961927|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835603|NCT00687999|Ribavirin|ribavirin|mesh-list
138961928|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
138961929|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
138961930|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138961931|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961932|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138961933|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138961934|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
138961935|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138961936|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138961937|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138961938|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138961939|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961940|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
138961941|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
138961942|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
138712781|NCT01563731|Atorvastatin|atorvastatin|mesh-list
138961943|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138961944|NCT00775684|Exenatide|exenatide|mesh-list
138961945|NCT00775684|Glimepiride|glimepiride|mesh-list
138961946|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138961947|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961948|NCT00775684|Incretins|incretins|mesh-ancestor
138961949|NCT00775684|Hormones|hormones|mesh-ancestor
138961950|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138961951|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138961952|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
138961953|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138961954|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961955|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138961956|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138961957|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138961959|NCT02556008|Cannabidiol|cannabidiol|mesh-list
138961960|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
138961961|NCT00992524|Misoprostol|misoprostol|mesh-list
138961962|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138961963|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
138961964|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138961965|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961966|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138961967|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138961968|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
138961969|NCT00642018|Prednisone|prednisone|mesh-list
138961970|NCT00642018|Docetaxel|docetaxel|mesh-list
138961971|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961972|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
138961973|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
138961974|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
138961975|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961976|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138961977|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
138961978|NCT00642018|Hormones|hormones|mesh-ancestor
138961979|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138961980|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961981|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138961982|NCT00532948|Capecitabine|capecitabine|mesh-list
138961983|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138961984|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
138961985|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138961986|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138961988|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
138961989|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138961990|NCT00998920|Estrogens|estrogens|mesh-ancestor
138961991|NCT00998920|Hormones|hormones|mesh-ancestor
138961992|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138961993|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961994|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
138961995|NCT00992758|Antibodies|antibodies|mesh-list
138961996|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
138961997|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138961998|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962000|NCT00641706|Vorinostat|vorinostat|mesh-list
138962001|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962002|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138962003|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962004|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962005|NCT00995332|Cytarabine|cytarabine|mesh-list
138962006|NCT00995332|Tretinoin|tretinoin|mesh-list
138962007|NCT00995332|Valproic Acid|valproic acid|mesh-list
138962008|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138962009|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
138962010|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962011|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962012|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
138962013|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962014|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138962015|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
138962016|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962017|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
138962018|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
138962019|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
138962020|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962022|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962023|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
138962024|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138962025|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138962026|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138962027|NCT00992914|Lidocaine|lidocaine|mesh-list
138962028|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
138962029|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
138962030|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138962031|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962032|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
138962033|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962034|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138962035|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138962036|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138962037|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138962038|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962039|NCT00999232|Erythromycin|erythromycin|mesh-list
138962040|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
138962041|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138962042|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
138962043|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138962044|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962045|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138962046|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138962048|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962049|NCT00993070|Capsaicin|capsaicin|mesh-list
138962050|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
138962051|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
138962052|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
138962053|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962054|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962055|NCT00993304|Liraglutide|liraglutide|mesh-list
138962056|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138836062|NCT05737069|Ibuprofen|ibuprofen|mesh-list
138962057|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962058|NCT00993304|Incretins|incretins|mesh-ancestor
138962059|NCT00993304|Hormones|hormones|mesh-ancestor
138962060|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138962061|NCT05189002|Dalteparin|dalteparin|mesh-list
138962062|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
138962063|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138962064|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138962065|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962066|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138962067|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
138962068|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138962069|NCT00644358|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138962070|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138962071|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138962072|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962073|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962074|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
138836123|NCT05594602|Itraconazole|itraconazole|mesh-list
138962075|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962076|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138962077|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138962078|NCT00993694|Dapsone|dapsone|mesh-list
138962079|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962080|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
138962081|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138962082|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138962083|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138962084|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962085|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962086|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
138962087|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138962088|NCT00640926|Radezolid|radezolid|mesh-list
138962089|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
138962090|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138962091|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962092|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138962093|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962094|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962095|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138962096|NCT00821496|Norethindrone|norethindrone|mesh-list
138962097|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
138962099|NCT00821496|Estradiol|estradiol|mesh-list
138962100|NCT00821496|Estrogens|estrogens|mesh-ancestor
138962101|NCT00821496|Hormones|hormones|mesh-ancestor
138962102|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138962103|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962104|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138962105|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
138962106|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138962107|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138962108|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138962109|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138962110|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138962111|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138962113|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
138962114|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
138962115|NCT02550912|Vitamins|vitamins|mesh-list
138962116|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
138962117|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962118|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138962119|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138962120|NCT00999700|Cisplatin|cisplatin|mesh-list
138962121|NCT00999700|Docetaxel|docetaxel|mesh-list
138962122|NCT00999700|Fluorouracil|fluorouracil|mesh-list
138962123|NCT00999700|Cetuximab|cetuximab|mesh-list
138962124|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962125|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
138962126|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
138962127|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
138836233|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962128|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962129|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
138962130|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138962131|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138962132|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
138962133|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962134|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138962135|NCT00818298|Ziprasidone|ziprasidone|mesh-list
138962136|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138962137|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
138962138|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962139|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962140|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962141|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138962142|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138962143|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138962144|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138962145|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138962146|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
138962147|NCT00821574|Valsartan|valsartan|mesh-list
138962148|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138962149|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138962150|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138962151|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138962152|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962153|NCT00821574|Diuretics|diuretics|mesh-ancestor
138962154|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
138962155|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962156|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138962157|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138962158|NCT00995800|Fluticasone|fluticasone|mesh-list
138962159|NCT00995800|Xhance|xhance|mesh-list
138962160|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
138962161|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138962162|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138962163|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
138836333|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
138962164|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962165|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962166|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138962167|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
138962168|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
138962169|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138962170|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138962171|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138962172|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138962173|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
138962174|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962175|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962176|NCT00821652|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138962177|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
138962178|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138962179|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
138962180|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962181|NCT00319501|Diazepam|diazepam|mesh-list
138962182|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138962184|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
138962185|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
138962186|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962187|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962188|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138962189|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138962190|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138962191|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138962192|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138962193|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139000283|NCT00090259|Losartan|losartan|mesh-list
138962194|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138962195|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138962196|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138962197|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
138962198|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
138962199|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
138962200|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
138962201|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962202|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962203|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
138962204|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
138962205|NCT00994006|Levulinic acid|levulinic acid|mesh-list
138962206|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962207|NCT00994006|Cathartics|cathartics|mesh-ancestor
138962208|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138962210|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962211|NCT00818610|Amoxicillin|amoxicillin|mesh-list
138962212|NCT00818610|Clarithromycin|clarithromycin|mesh-list
138962213|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138962214|NCT00818610|Cefuroxime|cefuroxime|mesh-list
138962215|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
138962216|NCT00818610|Lactams|lactams|mesh-list
138962217|NCT00818610|beta-Lactams|beta-lactams|mesh-list
138962218|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138962219|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962220|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138962221|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962222|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962223|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138962224|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138962225|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138962226|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138962227|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138962228|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138962229|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138962230|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962231|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138962232|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138962233|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138962234|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
138962235|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962236|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962237|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138962238|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138962239|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
138962240|NCT00627042|Ramucirumab|ramucirumab|mesh-list
138962241|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138962242|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962243|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
138962244|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713079|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138962246|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138962247|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138962248|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962249|NCT00994396|Vitamin D|vitamin d|mesh-list
138962250|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
138962251|NCT00994396|Vitamins|vitamins|mesh-ancestor
138962252|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
138962253|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962254|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138962255|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138962256|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
138962257|NCT00816426|Rifampin|rifampin|mesh-list
138962258|NCT00816426|Isoniazid|isoniazid|mesh-list
138962259|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
138962260|NCT00816426|Kanamycin|kanamycin|mesh-list
138962261|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138962262|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962263|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138962265|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962266|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962267|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962268|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138962269|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
138962270|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
138962271|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138797051|NCT04669041|Ezetimibe|ezetimibe|mesh-list
138962272|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138962273|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138962274|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138962275|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138962276|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138962277|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138962278|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138962280|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
138962281|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138962282|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138962283|NCT00996190|Phenylephrine|phenylephrine|mesh-list
138962284|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
138962285|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138962286|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
138962287|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
138962288|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962289|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962290|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
138962291|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138962292|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
138962293|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
138962294|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138962295|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138962296|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138962297|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
138962298|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962299|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962300|NCT00996190|Protective Agents|protective agents|mesh-ancestor
138962301|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
138962302|NCT00640224|Drospirenone|drospirenone|mesh-list
138962303|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138962304|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138962305|NCT00640224|Estradiol|estradiol|mesh-list
138962306|NCT00640224|Estrogens|estrogens|mesh-ancestor
138962307|NCT00640224|Hormones|hormones|mesh-ancestor
138962308|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138962309|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962310|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138962311|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
138962312|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138962313|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138962314|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138962315|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138962316|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138836762|NCT00928070|Fesoterodine|fesoterodine|mesh-list
138962317|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138962318|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
138962319|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138962320|NCT00640224|Diuretics|diuretics|mesh-ancestor
138962321|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
138962322|NCT01000792|Cetirizine|cetirizine|mesh-list
138962323|NCT01000792|Levocetirizine|levocetirizine|mesh-list
138962324|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138962325|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138962326|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
138962327|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
138962328|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962329|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962330|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962331|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138962332|NCT02550756|Capsaicin|capsaicin|mesh-list
138962333|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
138962334|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
138962335|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
138962336|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962337|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962339|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138962340|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138962341|NCT01001260|Analgesics|analgesics|mesh-ancestor
138962342|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
138962343|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962344|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962345|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138962346|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138962347|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138962348|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138962349|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962350|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138962351|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138962352|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962353|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
138962354|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
138962355|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138962356|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
138962357|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962358|NCT00996424|Expectorants|expectorants|mesh-ancestor
138836884|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
138962359|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
138962360|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138962361|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
138962362|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962363|NCT00996424|Protective Agents|protective agents|mesh-ancestor
138962364|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962365|NCT00996424|Antidotes|antidotes|mesh-ancestor
138962366|NCT05220280|Infliximab|infliximab|mesh-list
138962367|NCT05220280|Imatinib Mesylate|imatinib mesylate|mesh-list
138962368|NCT05220280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962369|NCT05220280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138962370|NCT05220280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962371|NCT05220280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962372|NCT05220280|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138962373|NCT05220280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138962374|NCT05220280|Dermatologic Agents|dermatologic agents|mesh-ancestor
138962375|NCT05220280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138962376|NCT05220280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138962377|NCT00318643|Mitomycins|mitomycins|mesh-list
138962378|NCT00318643|Mitomycin|mitomycin|mesh-list
138962379|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138962380|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962381|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
138962382|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962383|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138962384|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962385|NCT00994708|Esomeprazole|esomeprazole|mesh-list
138962386|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138962387|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138962388|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138962389|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962390|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962391|NCT01064557|Tretinoin|tretinoin|mesh-list
138962392|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962393|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
138962394|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
138962395|NCT01001962|Metformin|metformin|mesh-list
138713231|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
138962397|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138962398|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962399|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138962400|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962401|NCT01066429|Dexamethasone|dexamethasone|mesh-list
138962402|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
138962403|NCT01066429|BB 1101|bb 1101|mesh-list
138962404|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138962405|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
138962406|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
138962407|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962408|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962409|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138962410|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
138962411|NCT01066429|Hormones|hormones|mesh-ancestor
138962412|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138962413|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138962414|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962415|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
138962416|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962417|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962418|NCT00994786|Pregabalin|pregabalin|mesh-list
138962419|NCT00994786|Analgesics|analgesics|mesh-ancestor
138962420|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
138962421|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962422|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962423|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
138962424|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138962425|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138962426|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962427|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138962428|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138962429|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138797168|NCT00632073|Maleic acid|maleic acid|mesh-list
138962430|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138962431|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138962432|NCT00994942|Morphine|morphine|mesh-list
138962433|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138962434|NCT00994942|Narcotics|narcotics|mesh-ancestor
138962435|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138962436|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962437|NCT00994942|Analgesics|analgesics|mesh-ancestor
138962438|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
138962439|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962440|NCT01002898|Ritonavir|ritonavir|mesh-list
138962441|NCT01002898|Lopinavir|lopinavir|mesh-list
138962442|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138962443|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138962444|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
138962445|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962446|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962447|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138962448|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138962449|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
138962450|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962451|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138962452|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138962453|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
138962454|NCT01003054|Busulfan|busulfan|mesh-list
138962455|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
138962456|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138962457|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
138962458|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962459|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138962460|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138962461|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
138962462|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962463|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962464|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138837076|NCT03853187|Durvalumab|durvalumab|mesh-list
138962465|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138962466|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962467|NCT01004068|Clomiphene|clomiphene|mesh-list
138962468|NCT01004068|Enclomiphene|enclomiphene|mesh-list
138962469|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
138713311|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
138962470|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138962471|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
138962472|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138962473|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962474|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138962475|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
138962476|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138962477|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138962478|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138962479|NCT01004224|Infigratinib|infigratinib|mesh-list
138962480|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962481|NCT00530920|Ritonavir|ritonavir|mesh-list
138962482|NCT00530920|Tipranavir|tipranavir|mesh-list
138962483|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138962484|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138962485|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
138962486|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566959|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962487|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962488|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138962489|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138962490|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
138962491|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962492|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138962493|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138962494|NCT01004380|Carboplatin|carboplatin|mesh-list
138962495|NCT01004380|Farletuzumab|farletuzumab|mesh-list
138962496|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962497|NCT01003522|Anesthetics|anesthetics|mesh-list
138962498|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
138962499|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138962500|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962501|NCT01003678|Clofarabine|clofarabine|mesh-list
138962502|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138962503|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
138962504|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962505|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962506|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
138962507|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962508|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
138962509|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
138962510|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
138962511|NCT04000126|Lidocaine|lidocaine|mesh-list
138567076|NCT02633397|Riociguat|riociguat|mesh-list
138962512|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
138797239|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138962514|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138962515|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962516|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
138962517|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962518|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138962519|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138962520|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138962521|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138962522|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962523|NCT01008982|Belimumab|belimumab|mesh-list
138962524|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567140|NCT01176474|Nivolumab|nivolumab|mesh-list
138962525|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
138962526|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962527|NCT01005160|Metformin|metformin|mesh-list
138962528|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138962529|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962530|NCT01005238|Lamivudine|lamivudine|mesh-list
138962531|NCT01005238|Telbivudine|telbivudine|mesh-list
138962532|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138962533|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138962534|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962535|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962536|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
138962537|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962538|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138962539|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138962540|NCT01005472|Temozolomide|temozolomide|mesh-list
138962541|NCT01005472|Sunitinib|sunitinib|mesh-list
138962542|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138962543|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
138962544|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962545|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962546|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138962547|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138962548|NCT01005472|Growth Substances|growth substances|mesh-ancestor
138962549|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962550|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
138962551|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138962552|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962553|NCT01005550|Ropivacaine|ropivacaine|mesh-list
138962554|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
138962555|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
138962556|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138962557|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962558|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
138567250|NCT00087815|Hormones|hormones|mesh-ancestor
138962559|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962561|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
138962562|NCT03999580|Vitamins|vitamins|mesh-ancestor
138962563|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
138962564|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962565|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138962566|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138962567|NCT00768755|Pemetrexed|pemetrexed|mesh-list
138962568|NCT00768755|Axitinib|axitinib|mesh-list
138962569|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962570|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962571|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962572|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138962573|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138962574|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138962575|NCT01005628|Bortezomib|bortezomib|mesh-list
138962576|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962577|NCT00530842|Fluticasone|fluticasone|mesh-list
138962578|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
138962579|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138962580|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138962581|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138962582|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138567321|NCT00127023|Vaccines|vaccines|mesh-list
138962583|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
138962584|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962585|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962586|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138962587|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
138962588|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
138962589|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138962590|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
138962591|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138962592|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
138962593|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962594|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962595|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138962596|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138962597|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138962598|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
138962599|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
138962601|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138962602|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
138962603|NCT01005784|Cetrorelix|cetrorelix|mesh-list
138962604|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138962605|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
138962606|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138962607|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962608|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
138962609|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138962610|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138962611|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962612|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138962613|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962614|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962615|NCT01006720|Neostigmine|neostigmine|mesh-list
138962616|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138962617|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962618|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962619|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
138962620|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567488|NCT00421096|Gemcitabine|gemcitabine|mesh-list
138962622|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138962623|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
138962624|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962625|NCT01006876|Warfarin|warfarin|mesh-list
138962626|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
138962627|NCT03882424|Bevacizumab|bevacizumab|mesh-list
138962628|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138962629|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962630|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138962631|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138962632|NCT03882424|Growth Substances|growth substances|mesh-ancestor
138962633|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962634|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
138962635|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
138962636|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
138962637|NCT03879772|Beclomethasone|beclomethasone|mesh-list
138962638|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962639|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138962640|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
138962641|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138962642|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
138962644|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138962645|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962646|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138962647|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
138962648|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
138962649|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138962650|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
138962651|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
138962652|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962654|NCT01007500|Ondansetron|ondansetron|mesh-list
138962655|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138962656|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
138962657|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
138962658|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962659|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962660|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138962661|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
138962663|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138962664|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138962665|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962666|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
138962667|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
138962668|NCT01007500|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138962669|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138962670|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
138962671|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962672|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962673|NCT00642954|Dexamethasone|dexamethasone|mesh-list
138962674|NCT00642954|Lenalidomide|lenalidomide|mesh-list
138962675|NCT00642954|Vorinostat|vorinostat|mesh-list
138962676|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138962677|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
138567750|NCT04715152|Dexamethasone|dexamethasone|mesh-list
138962679|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962680|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962681|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138962682|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
138962683|NCT00642954|Hormones|hormones|mesh-ancestor
138797358|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138962684|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138962685|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138962686|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962687|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
138962688|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138962689|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138962690|NCT00642954|Growth Substances|growth substances|mesh-ancestor
138962691|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
138962692|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138962693|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962694|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962695|NCT00816660|Factor VIII|factor viii|mesh-list
138962696|NCT00816660|Coagulants|coagulants|mesh-ancestor
138962697|NCT00819000|Interferon-beta|interferon-beta|mesh-list
138962698|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
138962699|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
138962700|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
138962701|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138962702|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
138962703|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962704|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138962705|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138962706|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962707|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
138962708|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962710|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
138962711|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
138962712|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138962713|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962714|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
138962715|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962716|NCT00819078|Bupropion|bupropion|mesh-list
138962717|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138962718|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
138962719|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138962720|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138962721|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138962722|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138962723|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962724|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
138962725|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962726|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962727|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138962728|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138962730|NCT01008046|Metformin|metformin|mesh-list
138962731|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
138962732|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138962733|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138962734|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962735|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
138962736|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962737|NCT01008046|Expectorants|expectorants|mesh-ancestor
138962738|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
138962739|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138962740|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
138567987|NCT00343876|Aspirin|aspirin|mesh-list
138962741|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962742|NCT01008046|Protective Agents|protective agents|mesh-ancestor
138962743|NCT01008046|Antidotes|antidotes|mesh-ancestor
138962744|NCT00317473|Vaccines|vaccines|mesh-list
138962745|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
138962746|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962747|NCT00530218|Ganciclovir|ganciclovir|mesh-list
138962748|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138962749|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
138962750|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568034|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138962751|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138962752|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962753|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962754|NCT00761267|Fluconazole|fluconazole|mesh-list
138962755|NCT00761267|Anidulafungin|anidulafungin|mesh-list
138962756|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
138962757|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962758|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138962759|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138962760|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962761|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962762|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138962763|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
138962764|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138568100|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
138962765|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962766|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138962767|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138713607|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962769|NCT00303667|Aldesleukin|aldesleukin|mesh-list
138962771|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
138962772|NCT00303667|Fludarabine|fludarabine|mesh-list
138962773|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
138962774|NCT00303667|Interleukin-2|interleukin-2|mesh-list
138962775|NCT00303667|Cyclosporins|cyclosporins|mesh-list
138568172|NCT00420589|Hormones|hormones|mesh-ancestor
138962776|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
138962777|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138962778|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
138962779|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962780|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138962781|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138962782|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
138962783|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797407|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
138797408|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797409|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797410|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138962784|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962785|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138962786|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138962787|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
138962788|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
138962789|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962790|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962791|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
138962792|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
138962793|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138962794|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138962795|NCT00303667|Analgesics|analgesics|mesh-ancestor
138962796|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
138962797|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962798|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138962799|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138962800|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138962801|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138962802|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138962803|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138962804|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962805|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138962806|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138962807|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138962808|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
138962809|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962810|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962811|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138962812|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138962813|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
138962815|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962816|NCT01008592|Levocetirizine|levocetirizine|mesh-list
138962817|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138962818|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138962819|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
138962820|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
138962821|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962822|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962823|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962824|NCT01062529|Somatostatin|somatostatin|mesh-list
138962825|NCT01062529|Hormones|hormones|mesh-ancestor
138962826|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138962827|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962828|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
138962829|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962830|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138962831|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962832|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962833|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138962834|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138962836|NCT00302731|Estradiol|estradiol|mesh-list
138962837|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138962838|NCT00302731|Progesterone|progesterone|mesh-list
138962839|NCT00302731|Estrogens|estrogens|mesh-list
138962840|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138962841|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962842|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138962843|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
138962844|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138962845|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138962848|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138962849|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
138962850|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962851|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962852|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
138962853|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962854|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138962855|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
138962856|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962857|NCT01007968|Panobinostat|panobinostat|mesh-list
138962858|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962859|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138962860|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962861|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962862|NCT00779909|Vitamin D|vitamin d|mesh-list
138962863|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
138962864|NCT00779909|Vitamins|vitamins|mesh-ancestor
138962865|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
138962866|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962867|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138797466|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
138962868|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138962869|NCT05559112|Vitamin D|vitamin d|mesh-list
138962870|NCT05559112|Vitamins|vitamins|mesh-ancestor
138962872|NCT05559112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962873|NCT05559112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138962874|NCT00302107|Mirtazapine|mirtazapine|mesh-list
138962875|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
138962876|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138962877|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138962878|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
138962879|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
138962880|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962881|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962882|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962883|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138962884|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138962885|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138962886|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138962887|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138962888|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138962889|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
138962890|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138962891|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138962892|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
138962893|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138962894|NCT02602301|Oxytocin|oxytocin|mesh-list
138962895|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
138962896|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138962897|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962899|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962900|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962901|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962902|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138962903|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138962904|NCT04988152|Sotrovimab|sotrovimab|mesh-list
138962905|NCT04988152|Antiviral Agents|antiviral agents|mesh-ancestor
138962906|NCT04988152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138962907|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
138962908|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138962909|NCT00636168|Ipilimumab|ipilimumab|mesh-list
138962910|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138962911|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962912|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138962913|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962914|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138962915|NCT00759941|Latanoprost|latanoprost|mesh-list
138962916|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138962917|NCT00759941|Brinzolamide|brinzolamide|mesh-list
138962918|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138962919|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962920|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962921|NCT00315445|Acetaminophen|acetaminophen|mesh-list
138962922|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138962923|NCT00315445|Oxycodone|oxycodone|mesh-list
138962924|NCT00315445|Buprenorphine|buprenorphine|mesh-list
138962925|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138962926|NCT00315445|Analgesics|analgesics|mesh-ancestor
138962927|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
138962928|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962929|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962930|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
138962931|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138962932|NCT00315445|Narcotics|narcotics|mesh-ancestor
138962933|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138962934|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138962935|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138962936|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138962937|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138962938|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138962939|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138962940|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138962941|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139000600|NCT00982436|Carboplatin|carboplatin|mesh-list
138568685|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962942|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962943|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
138962944|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138962945|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962946|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138962947|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962948|NCT00779675|Infliximab|infliximab|mesh-list
138962949|NCT00779675|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138962950|NCT00779675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138962951|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
138962952|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138962953|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138962954|NCT04102943|Tacrolimus|tacrolimus|mesh-list
138962955|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138962956|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
138962957|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962958|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138962959|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962960|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962961|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138962962|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
138962963|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962964|NCT00315055|Vaccines|vaccines|mesh-list
138797520|NCT00912015|Analgesics|analgesics|mesh-ancestor
138962965|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
138568734|NCT00126204|Doxycycline|doxycycline|mesh-list
138962966|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962967|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
138962968|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138962969|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962970|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
138568793|NCT00126282|Cycloserine|cycloserine|mesh-list
138962971|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962973|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962974|NCT05774574|Cannabidiol|cannabidiol|mesh-list
138962975|NCT05774574|Anticonvulsants|anticonvulsants|mesh-ancestor
138962976|NCT05774275|Doxorubicin|doxorubicin|mesh-list
138962977|NCT05774275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138962978|NCT05774275|Antibodies|antibodies|mesh-list
138962979|NCT05774275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138962980|NCT05774275|Immunologic Factors|immunologic factors|mesh-ancestor
138962981|NCT05774275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962982|NCT05774275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138962983|NCT05774275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138962984|NCT05774275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138962985|NCT05774275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138962986|NCT05774275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138962987|NCT05774275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138962988|NCT05774028|Dexamethasone|dexamethasone|mesh-list
138962989|NCT05774028|Gemcitabine|gemcitabine|mesh-list
138962990|NCT05774028|Etoposide|etoposide|mesh-list
138962991|NCT05774028|Mitoxantrone|mitoxantrone|mesh-list
138962992|NCT05774028|Pegaspargase|pegaspargase|mesh-list
138962993|NCT05774028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138962994|NCT05774028|Antiemetics|antiemetics|mesh-ancestor
138962995|NCT05774028|Autonomic Agents|autonomic agents|mesh-ancestor
138962996|NCT05774028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138962997|NCT05774028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138962998|NCT05774028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138962999|NCT05774028|Glucocorticoids|glucocorticoids|mesh-ancestor
138963000|NCT05774028|Hormones|hormones|mesh-ancestor
138963001|NCT05774028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963002|NCT05774028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138963004|NCT05774028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138963005|NCT05774028|Antimetabolites|antimetabolites|mesh-ancestor
138963006|NCT05774028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963008|NCT05774028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138963009|NCT05774028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138963010|NCT05774028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963011|NCT05774028|Analgesics|analgesics|mesh-ancestor
138963012|NCT05774028|Sensory System Agents|sensory system agents|mesh-ancestor
138963013|NCT05773911|Chitosan|chitosan|mesh-list
138963014|NCT05773911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138963015|NCT05773911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138963016|NCT05773911|Antimetabolites|antimetabolites|mesh-ancestor
138963017|NCT05773911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963018|NCT05773911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138963019|NCT05773911|Chelating Agents|chelating agents|mesh-ancestor
138963020|NCT05773911|Sequestering Agents|sequestering agents|mesh-ancestor
138963021|NCT05773911|Hemostatics|hemostatics|mesh-ancestor
138963022|NCT05773911|Coagulants|coagulants|mesh-ancestor
138963023|NCT05773859|Vaccines|vaccines|mesh-list
138963024|NCT05773859|Immunologic Factors|immunologic factors|mesh-ancestor
138963025|NCT05773859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963026|NCT05773807|Propofol|propofol|mesh-list
138963027|NCT05773807|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138963028|NCT05773807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138963029|NCT05773807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963030|NCT05773807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138963031|NCT05773807|Anesthetics, General|anesthetics, general|mesh-ancestor
138963032|NCT05773807|Anesthetics|anesthetics|mesh-ancestor
138963033|NCT05773183|Testosterone|testosterone|mesh-list
138963034|NCT05773183|Androgens|androgens|mesh-ancestor
138963035|NCT05773183|Hormones|hormones|mesh-ancestor
138963036|NCT05773183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963037|NCT05773183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963038|NCT05732051|Niacinamide|niacinamide|mesh-list
138963039|NCT05732051|Niacin|niacin|mesh-list
138963040|NCT05732051|Nicotinic Acids|nicotinic acids|mesh-list
138963041|NCT05732051|Vitamin B Complex|vitamin b complex|mesh-ancestor
138963042|NCT05732051|Vitamins|vitamins|mesh-ancestor
138963043|NCT05732051|Micronutrients|micronutrients|mesh-ancestor
138963044|NCT05732051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963045|NCT05732051|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138963046|NCT05732051|Antimetabolites|antimetabolites|mesh-ancestor
138963047|NCT05732051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963048|NCT05732051|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138569028|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
138963049|NCT05732051|Vasodilator Agents|vasodilator agents|mesh-ancestor
138963050|NCT05667922|Tacrolimus|tacrolimus|mesh-list
138963051|NCT05667922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138963052|NCT05667922|Immunologic Factors|immunologic factors|mesh-ancestor
138963053|NCT05667922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963054|NCT05667922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138963055|NCT05667922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963056|NCT05667922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963057|NCT05667909|Rituximab|rituximab|mesh-list
138963058|NCT05667909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963059|NCT05667909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963060|NCT05667909|Immunologic Factors|immunologic factors|mesh-ancestor
138569088|NCT00092300|Analgesics|analgesics|mesh-ancestor
138963061|NCT05667909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963062|NCT05667909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963063|NCT05667896|Tacrolimus|tacrolimus|mesh-list
138963064|NCT05667896|Glucocorticoids|glucocorticoids|mesh-list
138963065|NCT05667896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138963066|NCT05667896|Immunologic Factors|immunologic factors|mesh-ancestor
138963067|NCT05667896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963068|NCT05667896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138963069|NCT05667896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963070|NCT05667896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963071|NCT05667896|Hormones|hormones|mesh-ancestor
138963072|NCT05667896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963073|NCT05667883|Cyclophosphamide|cyclophosphamide|mesh-list
138963074|NCT05667883|Glucocorticoids|glucocorticoids|mesh-list
138963075|NCT05667883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138963076|NCT05667883|Immunologic Factors|immunologic factors|mesh-ancestor
138245467|NCT04499573|Cytarabine|cytarabine|mesh-list
138963077|NCT05667883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963078|NCT05667883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963079|NCT05667883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138797621|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
138963080|NCT05667883|Alkylating Agents|alkylating agents|mesh-ancestor
138963081|NCT05667883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963082|NCT05667883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963083|NCT05667883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138963085|NCT05667883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963086|NCT05667805|Thrombin|thrombin|mesh-list
138963087|NCT05667805|Hemostatics|hemostatics|mesh-ancestor
138963088|NCT05667805|Coagulants|coagulants|mesh-ancestor
138963089|NCT05644496|Meloxicam|meloxicam|mesh-list
138963090|NCT05644496|Bupivacaine|bupivacaine|mesh-list
138963091|NCT05644496|Anesthetics, Local|anesthetics, local|mesh-ancestor
138963092|NCT05644496|Anesthetics|anesthetics|mesh-ancestor
138963093|NCT05644496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138963094|NCT05644496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963095|NCT05644496|Sensory System Agents|sensory system agents|mesh-ancestor
138963096|NCT05644496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963097|NCT05644496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138963098|NCT05644496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138963099|NCT05644496|Analgesics|analgesics|mesh-ancestor
138963100|NCT05644496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138963101|NCT05644496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963102|NCT05644496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138963103|NCT05644496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138963104|NCT05644496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963105|NCT05644496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963106|NCT05554978|Landiolol|landiolol|mesh-list
138963107|NCT05554978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138963108|NCT05554978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138963109|NCT05554978|Adrenergic Agents|adrenergic agents|mesh-ancestor
138963110|NCT05554978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963111|NCT05554978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963112|NCT05554978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963113|NCT05554978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138963114|NCT05438888|Warfarin|warfarin|mesh-list
138963115|NCT05438888|Apixaban|apixaban|mesh-list
138963116|NCT05438888|Anticoagulants|anticoagulants|mesh-ancestor
138963117|NCT05438888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138963118|NCT05438888|Antithrombins|antithrombins|mesh-ancestor
138963119|NCT05438888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138963120|NCT05438888|Protease Inhibitors|protease inhibitors|mesh-ancestor
138963121|NCT05438888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963122|NCT05438888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963123|NCT05430074|Calpastatin|calpastatin|mesh-list
138963124|NCT05430074|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138963125|NCT05430074|Protease Inhibitors|protease inhibitors|mesh-ancestor
138963126|NCT05430074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963127|NCT05430074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963128|NCT05351736|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138963129|NCT05351736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138963130|NCT05351736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138963131|NCT05351736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138963132|NCT05351736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963133|NCT05351736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138963134|NCT05351736|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138963135|NCT05351736|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138963136|NCT05351736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138963137|NCT05351736|Adrenergic Agents|adrenergic agents|mesh-ancestor
138963138|NCT05351736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963139|NCT05351736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963140|NCT05351736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138963141|NCT05351736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138963142|NCT05351736|Serotonin Agents|serotonin agents|mesh-ancestor
138963143|NCT05351736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138963144|NCT05351736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138713984|NCT01153009|Vortioxetine|vortioxetine|mesh-list
138963145|NCT05351736|Dopamine Agents|dopamine agents|mesh-ancestor
138963146|NCT05335928|Abatacept|abatacept|mesh-list
138963147|NCT05335928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138963148|NCT05335928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963149|NCT05335928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963150|NCT05335928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963151|NCT05335928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138963152|NCT05335928|Immunologic Factors|immunologic factors|mesh-ancestor
138963153|NCT05335928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963154|NCT05335928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963155|NCT05319561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138963156|NCT05319561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138963157|NCT05286957|Tislelizumab|tislelizumab|mesh-list
138963158|NCT05286957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963159|NCT05286957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963160|NCT05282108|Imatinib Mesylate|imatinib mesylate|mesh-list
138963161|NCT05282108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963162|NCT05282108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138963163|NCT05282108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963164|NCT05282108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963165|NCT05255276|Itraconazole|itraconazole|mesh-list
138963166|NCT05255276|Rifampin|rifampin|mesh-list
138569484|NCT00094640|Olanzapine|olanzapine|mesh-list
138963167|NCT05255276|Antifungal Agents|antifungal agents|mesh-ancestor
138963168|NCT05255276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138963169|NCT05255276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138963170|NCT05255276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138963171|NCT05255276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963172|NCT05255276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963173|NCT05255276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138963174|NCT05255276|Hormone Antagonists|hormone antagonists|mesh-ancestor
138963175|NCT05255276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963176|NCT05255276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963177|NCT05255276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138963178|NCT05255276|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138963179|NCT05255276|Antitubercular Agents|antitubercular agents|mesh-ancestor
138963180|NCT05255276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138963181|NCT05255276|Leprostatic Agents|leprostatic agents|mesh-ancestor
138963182|NCT05255276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138963183|NCT05255276|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138963184|NCT05255276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138963185|NCT05255276|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138963186|NCT05255276|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138963187|NCT05255276|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138569559|NCT01990911|Diuretics|diuretics|mesh-list
138963188|NCT05255276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138963189|NCT05243199|Valsartan|valsartan|mesh-list
138963190|NCT05243199|Irbesartan|irbesartan|mesh-list
138963191|NCT05243199|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138963192|NCT05243199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138963193|NCT05243199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138963194|NCT05243199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138569634|NCT00429559|Gemcitabine|gemcitabine|mesh-list
138963195|NCT05243199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963196|NCT05227716|Magnesium Sulfate|magnesium sulfate|mesh-list
138963197|NCT05227716|Analgesics|analgesics|mesh-ancestor
138963198|NCT05227716|Sensory System Agents|sensory system agents|mesh-ancestor
138963199|NCT05227716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963200|NCT05227716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963201|NCT05227716|Anesthetics|anesthetics|mesh-ancestor
138963202|NCT05227716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138963203|NCT05227716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138963204|NCT05227716|Anticonvulsants|anticonvulsants|mesh-ancestor
138963205|NCT05227716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138963206|NCT05227716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138963207|NCT05227716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963208|NCT05227716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138963210|NCT05227716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138963211|NCT05195996|Propranolol|propranolol|mesh-list
138963212|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138963213|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138963214|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
138714053|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138963215|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963216|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963217|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963218|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138963219|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138963220|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
138963221|NCT05113966|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138963222|NCT05113966|Immunoconjugates|immunoconjugates|mesh-ancestor
138963223|NCT05113966|Immunologic Factors|immunologic factors|mesh-ancestor
138963224|NCT05113966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963225|NCT05101564|Tamoxifen|tamoxifen|mesh-list
138963226|NCT05101564|Fulvestrant|fulvestrant|mesh-list
138963227|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138963228|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
138963229|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963230|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963231|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138963232|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963233|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138963234|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138963235|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138963236|NCT05101564|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138963237|NCT05005741|Dulaglutide|dulaglutide|mesh-list
138963238|NCT05005741|Glucagon|glucagon|mesh-list
138963239|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138963240|NCT05005741|Incretins|incretins|mesh-ancestor
138963241|NCT05005741|Hormones|hormones|mesh-ancestor
138963242|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963243|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963244|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138963245|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138963246|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138963247|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138963248|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138963249|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
138963250|NCT04974216|Rituximab|rituximab|mesh-list
138963251|NCT04974216|Lenalidomide|lenalidomide|mesh-list
138963252|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963253|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963255|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963256|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963257|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138963258|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138963259|NCT04974216|Growth Substances|growth substances|mesh-ancestor
138963260|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
138963261|NCT04972552|Ubiquinone|ubiquinone|mesh-list
138963262|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
138963263|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
138963264|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963265|NCT04972552|Vitamins|vitamins|mesh-ancestor
138963266|NCT04924699|Trastuzumab|trastuzumab|mesh-list
138963267|NCT04924699|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138963268|NCT04924699|Maytansine|maytansine|mesh-list
138963269|NCT04924699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963270|NCT04924699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963271|NCT04924699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138963272|NCT04924699|Tubulin Modulators|tubulin modulators|mesh-ancestor
138963273|NCT04924699|Antimitotic Agents|antimitotic agents|mesh-ancestor
138963274|NCT04924699|Mitosis Modulators|mitosis modulators|mesh-ancestor
138963275|NCT04924699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963276|NCT04924699|Immunotoxins|immunotoxins|mesh-ancestor
138963277|NCT04924699|Immunoconjugates|immunoconjugates|mesh-ancestor
138963278|NCT04924699|Immunologic Factors|immunologic factors|mesh-ancestor
138963279|NCT04924699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963281|NCT04907539|Nivolumab|nivolumab|mesh-list
138963282|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963283|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963284|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138963285|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963286|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138963287|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963288|NCT04830397|Timolol|timolol|mesh-list
138963289|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963290|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138963291|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138963292|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
138963293|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963294|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963295|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138963296|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138963297|NCT04802590|Venetoclax|venetoclax|mesh-list
138963298|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963299|NCT04776993|Methimazole|methimazole|mesh-list
138963300|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
138963301|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
138963302|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963303|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963304|NCT04671875|Antibodies|antibodies|mesh-list
138963305|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138963306|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
138963307|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963308|NCT04545944|Midazolam|midazolam|mesh-list
138963309|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138963310|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138963311|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138570033|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963312|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963313|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138963314|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138963315|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138963316|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138963317|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
138963318|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
138963319|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
138963320|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
138963321|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963322|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963323|NCT04522804|Psilocybin|psilocybin|mesh-list
138963324|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
138963325|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963326|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138963327|NCT04393285|Letrozole|letrozole|mesh-list
138963328|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963329|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138963330|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138963331|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963332|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963333|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138963334|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
138963335|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963336|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963337|NCT04391283|Osimertinib|osimertinib|mesh-list
138963338|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963339|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138963340|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963341|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963342|NCT04374799|Heparin|heparin|mesh-list
138963343|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
138963344|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138963345|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138963346|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963347|NCT04266275|Curcumin|curcumin|mesh-list
138963348|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138570221|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
138963349|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138963350|NCT04266275|Analgesics|analgesics|mesh-ancestor
138963351|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
138963352|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963353|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963354|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138963355|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963356|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963357|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963358|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963359|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
138963360|NCT04207086|Lenvatinib|lenvatinib|mesh-list
138570281|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
138797874|NCT02858622|Narcotics|narcotics|mesh-ancestor
138963361|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963362|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963363|NCT04207086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138963364|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963366|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963367|NCT04194359|Bevacizumab|bevacizumab|mesh-list
138963368|NCT04194359|Capecitabine|capecitabine|mesh-list
138963369|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
138963370|NCT04194359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963371|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963372|NCT04194359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138963373|NCT04194359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138963374|NCT04194359|Growth Substances|growth substances|mesh-ancestor
138963375|NCT04194359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963376|NCT04194359|Growth Inhibitors|growth inhibitors|mesh-ancestor
138963377|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138963378|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
138963379|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963380|NCT04053491|Anesthetics|anesthetics|mesh-list
138963381|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138963382|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963383|NCT04041232|Glycerol|glycerol|mesh-list
138963384|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138963385|NCT04041232|Protective Agents|protective agents|mesh-ancestor
138963386|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963388|NCT04030000|Carboplatin|carboplatin|mesh-list
138963389|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138963390|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963391|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
138963392|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
138963393|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
138963394|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963395|NCT03957590|Paclitaxel|paclitaxel|mesh-list
138963396|NCT03957590|Tislelizumab|tislelizumab|mesh-list
138963397|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138963398|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963399|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
138963400|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
138963401|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
138963402|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963403|NCT03957590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963404|NCT03921866|Palbociclib|palbociclib|mesh-list
138963405|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963406|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138963407|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963408|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963409|NCT03760588|Valsartan|valsartan|mesh-list
138963410|NCT03760588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138570458|NCT00433225|Analgesics|analgesics|mesh-ancestor
138963411|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138963412|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138963413|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138963414|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963415|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138963416|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
138963417|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963418|NCT03649048|Cisplatin|cisplatin|mesh-list
138963419|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963420|NCT03642626|Vidarabine|vidarabine|mesh-list
138963421|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
138963422|NCT03642626|Fludarabine|fludarabine|mesh-list
138963423|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
138963424|NCT03642626|Tisagenlecleucel|tisagenlecleucel|mesh-list
138963425|NCT03642626|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138963426|NCT03642626|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
138963427|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138963428|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
138963429|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963430|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963431|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138963432|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
138963433|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963434|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963435|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138963436|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138963438|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
138963439|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138963440|NCT03642626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963441|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
138963442|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963443|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963444|NCT03621982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138963445|NCT03621982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963446|NCT03608163|Diazoxide|diazoxide|mesh-list
138963447|NCT03608163|Naloxone|naloxone|mesh-list
138963448|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138963449|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963450|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
138963451|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963452|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138963453|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
138963454|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
138963455|NCT03573700|Fludarabine|fludarabine|mesh-list
138963456|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138963457|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
138963458|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963459|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963460|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138963461|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
138963462|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963463|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963464|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138963465|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
138963466|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138963467|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138963468|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963469|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138963471|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
138963472|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963473|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138963474|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138963475|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138963476|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
138963477|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963478|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963479|NCT03521830|Nivolumab|nivolumab|mesh-list
138963480|NCT03521830|Ipilimumab|ipilimumab|mesh-list
138963481|NCT03521830|Relatlimab|relatlimab|mesh-list
138963482|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963483|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963484|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138963485|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963486|NCT03496610|Bupivacaine|bupivacaine|mesh-list
138963487|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
138963489|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138963490|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963491|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
138963492|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963493|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
138963494|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138963495|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138963496|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138963497|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963498|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138963499|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138963500|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
138963501|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797952|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138963502|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963503|NCT03448783|Apixaban|apixaban|mesh-list
138963504|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138963505|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
138963506|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138963507|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
138963508|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963509|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963510|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
139000754|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
138963512|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138963513|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
138963514|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963515|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570873|NCT00403806|Hormones|hormones|mesh-ancestor
138963516|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138963517|NCT03418649|Diuretics|diuretics|mesh-ancestor
138963518|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
138963519|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138963520|NCT03315832|Valsartan|valsartan|mesh-list
138963521|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138963522|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138963523|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138963524|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963525|NCT03124355|Bromides|bromides|mesh-list
138963526|NCT03124355|Galantamine|galantamine|mesh-list
138963527|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138963528|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
138570933|NCT00132093|Diuretics|diuretics|mesh-ancestor
138963529|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138963530|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963531|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963532|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
138963533|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963534|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963535|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138963536|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
138963537|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963538|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
138963539|NCT03122652|Teriflunomide|teriflunomide|mesh-list
138963540|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138963541|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138963542|NCT03122652|Analgesics|analgesics|mesh-ancestor
138963543|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
138963544|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963545|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963546|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138963547|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963548|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138963549|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
138963550|NCT03011268|Adalimumab|adalimumab|mesh-list
138963551|NCT03011268|Infliximab|infliximab|mesh-list
138963552|NCT03011268|Golimumab|golimumab|mesh-list
138963553|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138963554|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138963555|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138963556|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963557|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
138963558|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138963559|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138963560|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
138963561|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963562|NCT02944578|Curcumin|curcumin|mesh-list
138963563|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138963564|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138963565|NCT02944578|Analgesics|analgesics|mesh-ancestor
138963566|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
138963567|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963568|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963569|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138963570|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963571|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963572|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963573|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963574|NCT02889523|Prednisolone|prednisolone|mesh-list
138963575|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
138963576|NCT02889523|Rituximab|rituximab|mesh-list
138963577|NCT02889523|Doxorubicin|doxorubicin|mesh-list
138963578|NCT02889523|Vincristine|vincristine|mesh-list
138571111|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138963579|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138963580|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
138963581|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963582|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963583|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138963584|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
138963585|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963586|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963587|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138963588|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963589|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138963590|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138963591|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138963592|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963593|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138963594|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
138963595|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
138963596|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
138963597|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138963598|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
138963600|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963601|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138963602|NCT02771626|Nivolumab|nivolumab|mesh-list
138963603|NCT02771626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963604|NCT02771626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963605|NCT02771626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138571241|NCT00101309|Aldesleukin|aldesleukin|mesh-list
138963606|NCT02771626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963607|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
138963608|NCT02616302|Lansoprazole|lansoprazole|mesh-list
138963609|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138963610|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138963611|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138963612|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963613|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963614|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138963615|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138963616|NCT02469753|Analgesics|analgesics|mesh-ancestor
138963617|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
138963618|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963619|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963620|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138963621|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963622|NCT02374242|Nivolumab|nivolumab|mesh-list
138963623|NCT02374242|Ipilimumab|ipilimumab|mesh-list
138963624|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963625|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963626|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138963627|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963628|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
138963629|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138963630|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138963631|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963632|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
138963633|NCT02314988|Coagulants|coagulants|mesh-ancestor
138963634|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
138963635|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138963636|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138963638|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138963639|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138963640|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138963641|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963642|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138963643|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138963644|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
138963645|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963646|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963647|NCT01582776|Lenalidomide|lenalidomide|mesh-list
138963648|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
138963649|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
138963650|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963651|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138571491|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
138963652|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138963653|NCT01582776|Growth Substances|growth substances|mesh-ancestor
138963654|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
138963655|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963656|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963657|NCT01464164|Prednisone|prednisone|mesh-list
138963658|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138963659|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
138963660|NCT01464164|Hormones|hormones|mesh-ancestor
138714514|NCT00568074|Acarbose|acarbose|mesh-list
138963661|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963662|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963663|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138247870|NCT02338362|Xhance|xhance|mesh-list
138963664|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963665|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
138963667|NCT00602459|Fludarabine|fludarabine|mesh-list
138963668|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
138963669|NCT00602459|Lenalidomide|lenalidomide|mesh-list
138963670|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138963671|NCT00602459|Antibodies|antibodies|mesh-list
138963672|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
138963673|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138963674|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138963675|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
138963676|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963677|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963678|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138963679|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
138963680|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963681|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963682|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138963683|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138963684|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
138963685|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138963686|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138963687|NCT00602459|Growth Substances|growth substances|mesh-ancestor
138963688|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
138963689|NCT00199069|Cytarabine|cytarabine|mesh-list
138963690|NCT00199069|Dexamethasone|dexamethasone|mesh-list
138963691|NCT00199069|Prednisolone|prednisolone|mesh-list
138963692|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
138963693|NCT00199069|Ifosfamide|ifosfamide|mesh-list
138963694|NCT00199069|Methotrexate|methotrexate|mesh-list
138963695|NCT00199069|Vincristine|vincristine|mesh-list
138963696|NCT00199069|Doxorubicin|doxorubicin|mesh-list
138963697|NCT00199069|Daunorubicin|daunorubicin|mesh-list
138963698|NCT00199069|Asparaginase|asparaginase|mesh-list
138963699|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
138963700|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
138963701|NCT00199069|Thioguanine|thioguanine|mesh-list
138963702|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138963703|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
138963704|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963705|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138571738|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
138963706|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138963707|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
138963708|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963709|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963710|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138963711|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138963712|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
138963713|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
138963714|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963715|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138963716|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
138963717|NCT00199069|Hormones|hormones|mesh-ancestor
138963718|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963719|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138963720|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138963721|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
138963722|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138963723|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138963724|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
138963725|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
138963726|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963727|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138963728|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138963729|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
138963730|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138963731|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138963732|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
138963734|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
138963735|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138963736|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138963737|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138963738|NCT00199069|Analgesics|analgesics|mesh-ancestor
138963739|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
138963740|NCT00199043|Allopurinol|allopurinol|mesh-list
138963741|NCT00199043|Rasburicase|rasburicase|mesh-list
138963742|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
138963743|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963744|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000830|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
138963745|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
138963746|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963747|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138963748|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
138963749|NCT00199043|Protective Agents|protective agents|mesh-ancestor
138963750|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963751|NCT02601989|Tadalafil|tadalafil|mesh-list
138963752|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
138963753|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138963754|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138963755|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963756|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963757|NCT02601989|Urological Agents|urological agents|mesh-ancestor
138963758|NCT01067053|Bevacizumab|bevacizumab|mesh-list
138963759|NCT01067053|Capecitabine|capecitabine|mesh-list
138963760|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
138963761|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138963762|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963763|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138963764|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138963765|NCT01067053|Growth Substances|growth substances|mesh-ancestor
138963766|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963767|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
138963768|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138963769|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
138963770|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963771|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
138963772|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138963773|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138571822|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138963774|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138963775|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138963776|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963777|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
138963778|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963779|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963780|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138963781|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963783|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
138963784|NCT01067365|Enclomiphene|enclomiphene|mesh-list
138963785|NCT01067365|Clomiphene|clomiphene|mesh-list
138963786|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
138963787|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
138963788|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138963789|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
138963790|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
138963791|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963792|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138963793|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
138963794|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963795|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963796|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138963797|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
138963798|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138963799|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138963800|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138571912|NCT00136773|Amlodipine|amlodipine|mesh-list
138963802|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
138963804|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
138963805|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963806|NCT01067443|Amphotericin B|amphotericin b|mesh-list
138963807|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138963808|NCT01067443|Miltefosine|miltefosine|mesh-list
138963809|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138963810|NCT01067443|Amebicides|amebicides|mesh-ancestor
138963811|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138963812|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138963813|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138963814|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138963815|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
138963816|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963817|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
138963818|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138963819|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
138963820|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138963821|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138963822|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138963823|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138963824|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963825|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
138963826|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963827|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963828|NCT00822666|Clopidogrel|clopidogrel|mesh-list
138963829|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138963830|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138963831|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138963833|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
138963834|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963835|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963836|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963837|NCT00816816|Docetaxel|docetaxel|mesh-list
138963838|NCT00816816|Fluorouracil|fluorouracil|mesh-list
138963839|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963840|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
138963841|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
138963842|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
138963843|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963844|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
138963845|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138963846|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138963847|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
138963848|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963850|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
138963851|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
138963852|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963853|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963854|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138572158|NCT00105209|Aspirin|aspirin|mesh-list
138963855|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138963856|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138963857|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138963858|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138963859|NCT00816894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138963860|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138963861|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138963862|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963863|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963864|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
138963865|NCT00635154|Dexamethasone|dexamethasone|mesh-list
138963866|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
139000860|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138963867|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138963868|NCT00635154|BB 1101|bb 1101|mesh-list
138963869|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138963870|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
138963871|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
138963872|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963873|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963874|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138963875|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
138963876|NCT00635154|Hormones|hormones|mesh-ancestor
138963877|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963878|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138963879|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963880|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138963881|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
138963882|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963883|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963884|NCT00822744|Escitalopram|escitalopram|mesh-list
138963885|NCT00822744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138963886|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138714750|NCT00563615|Tegaserod|tegaserod|mesh-list
138963887|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138963888|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963889|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963891|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963892|NCT00819468|Teduglutide|teduglutide|mesh-list
138963893|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138963894|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138798226|NCT00879970|Vitamin D|vitamin d|mesh-list
138963895|NCT00819468|Protective Agents|protective agents|mesh-ancestor
138963896|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963897|NCT01067599|Nicotine|nicotine|mesh-list
138963898|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138963899|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
138963900|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963901|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963902|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138963903|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138963904|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
138963905|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963906|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963907|NCT00778817|Mitotane|mitotane|mesh-list
138963908|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138963909|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963910|NCT00293059|Dienogest|dienogest|mesh-list
138963911|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138963912|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138963913|NCT00293059|Estradiol|estradiol|mesh-list
138963914|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138963915|NCT00293059|Estrogens|estrogens|mesh-ancestor
138963916|NCT00293059|Hormones|hormones|mesh-ancestor
138963917|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963918|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963919|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138963920|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
138963921|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138963922|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138963923|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138963924|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138963925|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138963926|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
138963927|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138963928|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138963929|NCT00756275|Nicotine|nicotine|mesh-list
138963930|NCT00756275|Varenicline|varenicline|mesh-list
138963931|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138963932|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
138963933|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963934|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963935|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138963936|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138963937|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
138963938|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963939|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963940|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
138963941|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138963942|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
138963943|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138963944|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
138963945|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963946|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963947|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
138963948|NCT00298831|Rocuronium|rocuronium|mesh-list
138798270|NCT03007329|Exenatide|exenatide|mesh-list
138963949|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138963950|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138963951|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138963952|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963953|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963954|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138963955|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138963956|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963957|NCT00758069|Incretins|incretins|mesh-ancestor
138963958|NCT00758069|Hormones|hormones|mesh-ancestor
138963959|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138963960|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138963961|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
138963962|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138963963|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963964|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
138963965|NCT01067677|Promethazine|promethazine|mesh-list
138963966|NCT01067677|Ondansetron|ondansetron|mesh-list
138963967|NCT01067677|Metoclopramide|metoclopramide|mesh-list
138963968|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
138963969|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
138963970|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138963971|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138963972|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138963973|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
138963974|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
138963975|NCT01067677|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138963976|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138963977|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
138963978|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138963979|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138963980|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138963981|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138963982|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138963983|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
138963984|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
138963985|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
138963986|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138963987|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
138963989|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138963990|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138963991|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138963992|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
138963993|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
138963994|NCT03979651|Trametinib|trametinib|mesh-list
138963995|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
138963996|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138963997|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138963998|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138963999|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572543|NCT04702360|Ivacaftor|ivacaftor|mesh-list
138964000|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964001|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138964002|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964003|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138964004|NCT02600741|Droperidol|droperidol|mesh-list
138964005|NCT02600741|Haloperidol|haloperidol|mesh-list
138964006|NCT02600741|Pimozide|pimozide|mesh-list
138964007|NCT02600741|Olanzapine|olanzapine|mesh-list
138964008|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
138964009|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
138964010|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
138964011|NCT02600741|Risperidone|risperidone|mesh-list
138964012|NCT02600741|Aripiprazole|aripiprazole|mesh-list
138964013|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138964014|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138964015|NCT02600741|Ziprasidone|ziprasidone|mesh-list
138964016|NCT02600741|Clozapine|clozapine|mesh-list
138964018|NCT02600741|Loxapine|loxapine|mesh-list
138964019|NCT02600741|Iloperidone|iloperidone|mesh-list
138964020|NCT02600741|Perphenazine|perphenazine|mesh-list
138964021|NCT02600741|Fluphenazine|fluphenazine|mesh-list
138964022|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
138964023|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
138964024|NCT02600741|Thioridazine|thioridazine|mesh-list
138964025|NCT02600741|Thiothixene|thiothixene|mesh-list
138964026|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138964027|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
138964028|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964029|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964030|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964031|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138964032|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138964033|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138964034|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138964035|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138964036|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
138964037|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
138964038|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
138964039|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964040|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138964041|NCT02600741|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138964042|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139000898|NCT04003350|Tramadol|tramadol|mesh-list
138964043|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138964044|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
138964045|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
138964046|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138964047|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138964048|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138964049|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138964050|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138798305|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
138964051|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
138964052|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
138964053|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138964054|NCT01065649|Nortriptyline|nortriptyline|mesh-list
138964055|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138964056|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
138964057|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138964058|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138964059|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138964060|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138964061|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964062|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
138964063|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964064|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964065|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
138964066|NCT01065727|Natalizumab|natalizumab|mesh-list
138964067|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
138964068|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
138964069|NCT01065727|Immunomodulating Agents|immunomodulating agents|mesh-list
138964070|NCT01065727|Analgesics|analgesics|mesh-ancestor
138964071|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
138964072|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964073|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964074|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964075|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138964076|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138964077|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964078|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964079|NCT01065805|Alovudine|alovudine|mesh-list
138964080|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
138964081|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138964082|NCT00311623|Sirolimus|sirolimus|mesh-list
138964083|NCT00311623|Temsirolimus|temsirolimus|mesh-list
138964084|NCT00311623|MTOR Inhibitors|mtor inhibitors|mesh-list
138964085|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138964086|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138964087|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138964088|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798325|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
138964089|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
138964090|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138964091|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
138964092|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964093|NCT00311623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138964094|NCT00311623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964095|NCT00311623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964096|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
138964098|NCT01067989|Celecoxib|celecoxib|mesh-list
138964099|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
138964100|NCT01067989|Capecitabine|capecitabine|mesh-list
138964101|NCT01067989|Methotrexate|methotrexate|mesh-list
138964102|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138964103|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
138964104|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964105|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138964106|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138964107|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
138964108|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964109|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964110|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138964111|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138964112|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
138964113|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138964114|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
138964115|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138964116|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
138964117|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964118|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138964119|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138964120|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138964121|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138964122|NCT01067989|Analgesics|analgesics|mesh-ancestor
138964123|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
138964124|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964125|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138964126|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138964127|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138964128|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138964129|NCT00633594|Rituximab|rituximab|mesh-list
138964130|NCT00633594|Lenalidomide|lenalidomide|mesh-list
138964131|NCT00633594|Bortezomib|bortezomib|mesh-list
138964132|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138964133|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964134|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
138964135|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964136|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138964137|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138964138|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138964139|NCT00633594|Growth Substances|growth substances|mesh-ancestor
138964140|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
138964141|NCT04840888|Itraconazole|itraconazole|mesh-list
138964142|NCT04840888|Carbamazepine|carbamazepine|mesh-list
138964143|NCT04840888|Omeprazole|omeprazole|mesh-list
138964144|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138964145|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138964146|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138964147|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964148|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964149|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
138964150|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138964151|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138964152|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138964153|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138964154|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
138964155|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138964156|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964157|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138964158|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
138964159|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
138964160|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138964161|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138964162|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138964163|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138964164|NCT04840888|Analgesics|analgesics|mesh-ancestor
138964165|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
138964166|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964167|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138964168|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138964169|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139000944|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
138964171|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138964172|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138573126|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138964173|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138964174|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138964175|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964176|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964177|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964178|NCT00755807|Analgesics|analgesics|mesh-ancestor
138964179|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
138964180|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964181|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
138964182|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138964183|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
138964184|NCT05372224|Cholecalciferol|cholecalciferol|mesh-list
138964185|NCT05372224|Vitamin D|vitamin d|mesh-list
138964186|NCT05372224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138964187|NCT05372224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964188|NCT05372224|Vitamins|vitamins|mesh-ancestor
138964189|NCT05372224|Micronutrients|micronutrients|mesh-ancestor
138964190|NCT05372224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138964192|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964193|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138964194|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138964195|NCT00631410|Growth Substances|growth substances|mesh-ancestor
138964196|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964197|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
138964198|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138964199|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964200|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964201|NCT00817284|Bevacizumab|bevacizumab|mesh-list
138964202|NCT00817284|Irinotecan|irinotecan|mesh-list
138964203|NCT00817284|Temozolomide|temozolomide|mesh-list
138964204|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138964205|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964206|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138964207|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138964208|NCT00817284|Growth Substances|growth substances|mesh-ancestor
138964209|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964210|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
138964211|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138964212|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138964213|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964214|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964215|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138964216|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
138964217|NCT04096157|Isavuconazole|isavuconazole|mesh-list
138573298|NCT00441961|Methotrexate|methotrexate|mesh-list
138964218|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
138964219|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138964221|NCT00823290|Panobinostat|panobinostat|mesh-list
138964222|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964223|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138964224|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964225|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964226|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138964227|NCT00755417|Gabapentin|gabapentin|mesh-list
138964228|NCT00755417|Analgesics|analgesics|mesh-ancestor
138964229|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
138964230|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964231|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964232|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
138964233|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138964234|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138964235|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138964236|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138964237|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138964238|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138964239|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964240|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964241|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
138964242|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
138964243|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138964244|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138964245|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138964246|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138964247|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138964248|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964249|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
138964250|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964251|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964252|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138964253|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964254|NCT00825864|Dexamethasone|dexamethasone|mesh-list
138964255|NCT00825864|Diclofenac|diclofenac|mesh-list
138964256|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
138964257|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138964258|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138964259|NCT00825864|BB 1101|bb 1101|mesh-list
138964260|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138964261|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
138964262|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
138964263|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964264|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964265|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138964266|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
138964267|NCT00825864|Hormones|hormones|mesh-ancestor
138964268|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138964269|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138964270|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964271|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138964272|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138964273|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138964274|NCT00825864|Analgesics|analgesics|mesh-ancestor
138964275|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
138573409|NCT00404586|Xhance|xhance|mesh-list
138964276|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138964277|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138964278|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964279|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964280|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
138964281|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138964282|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138964283|NCT00527332|Fentanyl|fentanyl|mesh-list
138964284|NCT00527332|Morphine|morphine|mesh-list
138798464|NCT01125566|Afatinib|afatinib|mesh-list
138964285|NCT00527332|Bupivacaine|bupivacaine|mesh-list
138964286|NCT00527332|Propofol|propofol|mesh-list
138964287|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
138964288|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
138964289|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138964290|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964291|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
138964292|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964293|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138964294|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138964295|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
138964296|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138964297|NCT00527332|Narcotics|narcotics|mesh-ancestor
138964298|NCT00527332|Analgesics|analgesics|mesh-ancestor
138964299|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138964300|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
138964302|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138964303|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964304|NCT00823602|Buserelin|buserelin|mesh-list
138964305|NCT00823602|Ganirelix|ganirelix|mesh-list
138964306|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
138964307|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138964308|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964309|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138964310|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
138964311|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138964312|NCT00820326|Dolasetron|dolasetron|mesh-list
138964313|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
138964314|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
138964315|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964316|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964317|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138964318|NCT00820326|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138964319|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138964320|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
138964321|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964322|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964323|NCT00916097|Docetaxel|docetaxel|mesh-list
138964324|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964325|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
138964326|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
138964327|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
138964328|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964329|NCT00629772|Infliximab|infliximab|mesh-list
138964330|NCT00629772|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138964331|NCT00629772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138964332|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
138964333|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138964334|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138964335|NCT00526630|Methylphenidate|methylphenidate|mesh-list
138964336|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138964337|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964338|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138964339|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138964340|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138964341|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964342|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
138964343|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964345|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138964346|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138964347|NCT00755183|Testosterone|testosterone|mesh-list
138964348|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
138964349|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
138964350|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138964351|NCT00755183|Androgens|androgens|mesh-ancestor
138964352|NCT00755183|Hormones|hormones|mesh-ancestor
138964353|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138964354|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964355|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138964356|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964357|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
138964358|NCT00826254|Vitamins|vitamins|mesh-list
138964359|NCT00826254|Vitamin K|vitamin k|mesh-list
138964360|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
138964361|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964363|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138964364|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964365|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
138964366|NCT00826254|Coagulants|coagulants|mesh-ancestor
138964367|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138964368|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
138964369|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964370|NCT00820404|BLI-489|bli-489|mesh-list
138964371|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138964372|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573813|NCT00452062|Hormones|hormones|mesh-ancestor
138964373|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964374|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138964375|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138964376|NCT00820482|Menotropins|menotropins|mesh-list
138964377|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138964378|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
138964379|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138964380|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964381|NCT00754793|Dexetimide|dexetimide|mesh-list
138964382|NCT00754793|Citalopram|citalopram|mesh-list
138964383|NCT00754793|Escitalopram|escitalopram|mesh-list
138798498|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138964384|NCT00754793|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138573874|NCT03275116|Bromides|bromides|mesh-list
138964385|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138964386|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139000997|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
138964387|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964389|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
138964390|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964391|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138964392|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138964393|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
138964394|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
138964395|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964396|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138964397|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138964398|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
138964399|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138964400|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
138964401|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138964402|NCT00826566|Caffeine|caffeine|mesh-list
138964403|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138964404|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964405|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138964406|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964407|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964408|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138964409|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138964410|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
138964411|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964412|NCT03999190|Raclopride|raclopride|mesh-list
138964413|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
138964414|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138964415|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964416|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138964417|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138964418|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138964419|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964420|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
138964421|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964422|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138964423|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138964424|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138964425|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138964426|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138964427|NCT05244694|Insulin|insulin|mesh-list
138964428|NCT05244694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138964429|NCT05244694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964430|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
138964431|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138964432|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
138964433|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964434|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964435|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138964436|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
138964437|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138964438|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
138964439|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964440|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964441|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138964442|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
138964443|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
138964444|NCT00626028|Protective Agents|protective agents|mesh-ancestor
138964445|NCT00826644|Etoposide|etoposide|mesh-list
138964446|NCT00826644|Belotecan|belotecan|mesh-list
138964447|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964448|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138964449|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138964451|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964452|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964453|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138964454|NCT00826722|Levetiracetam|levetiracetam|mesh-list
138964455|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
138964456|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
138964457|NCT04922944|Vaccines|vaccines|mesh-list
138964458|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
138964459|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964460|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
138964461|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
138964462|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138964463|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964464|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964465|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
138964466|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138964467|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138964468|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964469|NCT04044378|Ifosfamide|ifosfamide|mesh-list
138964470|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138964471|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
138964472|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964473|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964474|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138964475|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
138964476|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138964477|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138964478|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
138964479|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138964480|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
138964481|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964482|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964483|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138964484|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138964485|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138964486|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
138964487|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964488|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964489|NCT00821028|Paclitaxel|paclitaxel|mesh-list
138964490|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138964491|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964492|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
138964493|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
138964494|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
138964495|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964496|NCT00826878|Tivozanib|tivozanib|mesh-list
138964497|NCT00826878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138964498|NCT00826878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964499|NCT00826878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964500|NCT00827034|Warfarin|warfarin|mesh-list
138964501|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
138964502|NCT02600585|Vaccines|vaccines|mesh-list
138964503|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
138964504|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964506|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964507|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138964508|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964509|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964510|NCT00754325|Dasatinib|dasatinib|mesh-list
138964511|NCT00754325|Fulvestrant|fulvestrant|mesh-list
138964512|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964513|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138964514|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964515|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964516|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138964517|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138964518|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138964519|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
138964520|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138964521|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964522|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
138964524|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138964525|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964526|NCT00524680|Vitamins|vitamins|mesh-ancestor
138964527|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
138964528|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138964529|NCT00298363|Tenofovir|tenofovir|mesh-list
138964530|NCT00298363|Emtricitabine|emtricitabine|mesh-list
138964531|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138964532|NCT00298363|Entecavir|entecavir|mesh-list
138964533|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
138964534|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138964535|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138574173|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138964536|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138964538|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964539|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138964540|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138964541|NCT00821262|Propofol|propofol|mesh-list
138964542|NCT00821262|Sevoflurane|sevoflurane|mesh-list
138964543|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138964544|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138964545|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964546|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138964547|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
138964548|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
138964549|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138964550|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138964551|NCT00524368|Ritonavir|ritonavir|mesh-list
138964552|NCT00524368|Darunavir|darunavir|mesh-list
138964553|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138964554|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138964555|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
138964556|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964557|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964558|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138964559|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138964560|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
138964561|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715402|NCT00577980|Testosterone|testosterone|mesh-list
138964562|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138964563|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138964564|NCT00777101|Capecitabine|capecitabine|mesh-list
138964565|NCT00777101|Lapatinib|lapatinib|mesh-list
138964566|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138964567|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
138964568|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964569|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964570|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138964571|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964572|NCT00830856|Lamivudine|lamivudine|mesh-list
138964573|NCT00830856|Nevirapine|nevirapine|mesh-list
138964574|NCT00830856|Stavudine|stavudine|mesh-list
138964575|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
138964576|NCT00830856|Fluconazole|fluconazole|mesh-list
138964577|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138964578|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138964579|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964580|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964581|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
138964582|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138964583|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138798589|NCT00678106|Dalbavancin|dalbavancin|mesh-list
138964584|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138964585|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
138964586|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138964587|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138964588|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138964589|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
138964590|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138964591|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964592|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138964593|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138964594|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138964595|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138964596|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
138964597|NCT01068067|Tacrolimus|tacrolimus|mesh-list
138964598|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138964599|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
138964600|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964601|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138964602|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964603|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964605|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138964606|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138964607|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
138964608|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964609|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964610|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964611|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138964612|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
138964613|NCT00524134|Protective Agents|protective agents|mesh-ancestor
138964614|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138964615|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138964616|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138964617|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
138964618|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138964619|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138964620|NCT00777023|Gabapentin|gabapentin|mesh-list
138964621|NCT00777023|Analgesics|analgesics|mesh-ancestor
138964622|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
138964623|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964624|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964625|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
138798612|NCT00877006|Doxorubicin|doxorubicin|mesh-list
138964626|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138964627|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138964628|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138964629|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138964630|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138964631|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138964632|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964633|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964634|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
138964635|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138964636|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138964637|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
138964638|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138964639|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138964640|NCT00297037|Analgesics|analgesics|mesh-ancestor
138964641|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
138964642|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964643|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964644|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138964645|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138964646|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
138964647|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138964648|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
138964649|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138964650|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964651|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964652|NCT00292981|Complement C1s|complement c1s|mesh-list
138964653|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138964654|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138964655|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
138964656|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964657|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138964658|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138964659|NCT02598869|Triamcinolone|triamcinolone|mesh-list
138964660|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138964661|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138964662|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138964663|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138964664|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
138964665|NCT02598869|Hormones|hormones|mesh-ancestor
138964666|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138964667|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964668|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138964669|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
138964670|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798642|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138964671|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964672|NCT04095455|Ketamine|ketamine|mesh-list
138964673|NCT04095455|Analgesics|analgesics|mesh-ancestor
138964674|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
138964675|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001093|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138964676|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964677|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138964678|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138964679|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
138964681|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138964682|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138964683|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138964684|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964685|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964686|NCT04095299|Capecitabine|capecitabine|mesh-list
138964687|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138964688|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
138964689|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964690|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964691|NCT00296725|Fluoxetine|fluoxetine|mesh-list
138964692|NCT00296725|Imipramine|imipramine|mesh-list
138964693|NCT00296725|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138964694|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138964695|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138964696|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964697|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964698|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
138964699|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964700|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138964701|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
138964702|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138964703|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138964704|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138964705|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964706|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138964707|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138964708|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
138964709|NCT00523978|Sotalol|sotalol|mesh-list
138964710|NCT00523978|Flecainide|flecainide|mesh-list
138964711|NCT00523978|Propafenone|propafenone|mesh-list
138964712|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138964713|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138964714|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
138964715|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964716|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964717|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964718|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138964719|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
138964720|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
138964721|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964722|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138964723|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138964724|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138964725|NCT00296647|Bupropion|bupropion|mesh-list
138964726|NCT00296647|Nicotine|nicotine|mesh-list
138964727|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138964728|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
138964729|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964730|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964731|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139001120|NCT00987038|Midazolam|midazolam|mesh-list
138964732|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138964733|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
138964734|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964735|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964736|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138964737|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
138964738|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138964739|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138964740|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138964741|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138964742|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
138964743|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138964744|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138964745|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964746|NCT00754013|Donepezil|donepezil|mesh-list
138964747|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138964748|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964749|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964750|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
138964751|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964752|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964753|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
138964754|NCT00523744|Amlodipine|amlodipine|mesh-list
138964755|NCT00523744|Valsartan|valsartan|mesh-list
138964756|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138964757|NCT00523744|Olmesartan|olmesartan|mesh-list
138964758|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138964759|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138964760|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138574290|NCT00455416|Selenium|selenium|mesh-list
138964761|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138964762|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964763|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138964764|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964765|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
138964766|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138964767|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138964768|NCT00523744|Diuretics|diuretics|mesh-ancestor
138964769|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
138964770|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138964771|NCT03979625|Heparin|heparin|mesh-list
138964772|NCT03979625|Antibodies|antibodies|mesh-list
138964773|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
138964774|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964775|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
138964776|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138964777|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138964778|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964780|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
138964781|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138964782|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964783|NCT00752219|Metronidazole|metronidazole|mesh-list
138964784|NCT00752219|Meropenem|meropenem|mesh-list
138964785|NCT00752219|Ceftazidime|ceftazidime|mesh-list
138964786|NCT00752219|Avibactam|avibactam|mesh-list
138964787|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138964788|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138964789|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138964790|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138964791|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138964792|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964793|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964794|NCT02598791|Glucagon|glucagon|mesh-list
138964795|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138964796|NCT02598791|Incretins|incretins|mesh-ancestor
138964797|NCT02598791|Hormones|hormones|mesh-ancestor
138964798|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138964799|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964800|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138964801|NCT00827346|Clopidogrel|clopidogrel|mesh-list
138964802|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138964803|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138964804|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138964805|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138964806|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
138964807|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964808|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964809|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964810|NCT00997750|Lornoxicam|lornoxicam|mesh-list
138964811|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138964812|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138964813|NCT00997750|Analgesics|analgesics|mesh-ancestor
138964814|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
138964815|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964816|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964817|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138964818|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138964819|NCT00622908|Besifloxacin|besifloxacin|mesh-list
138964820|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138964821|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138964822|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138964823|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138964824|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964825|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964826|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964827|NCT00997828|Everolimus|everolimus|mesh-list
138964828|NCT00997828|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138964829|NCT00997828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138964830|NCT00997828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964831|NCT00997828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964832|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138964833|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
138964834|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964835|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964836|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
138964837|NCT02598635|Vitamin D|vitamin d|mesh-list
138964838|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138964839|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964840|NCT02598635|Vitamins|vitamins|mesh-ancestor
138964841|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
138964842|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138964843|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
138964844|NCT04093271|Promethazine|promethazine|mesh-list
138964845|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138964846|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138964847|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138964848|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964849|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
138964850|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
138964851|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
138964852|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964853|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
138964854|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
138964855|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138715711|NCT04589429|Morphine|morphine|mesh-list
138964856|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138964857|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
138964858|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
138964859|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964860|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964861|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138964862|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
138964863|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
138964864|NCT00827580|Eniluracil|eniluracil|mesh-list
138964865|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964866|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964867|NCT04094909|Paclitaxel|paclitaxel|mesh-list
138964868|NCT04094909|Cisplatin|cisplatin|mesh-list
138964869|NCT04094909|Carboplatin|carboplatin|mesh-list
138964870|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
138964871|NCT04094909|Pemetrexed|pemetrexed|mesh-list
138964872|NCT04094909|Endostatins|endostatins|mesh-list
138964873|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138964874|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964875|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
138964876|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
138964877|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
138964878|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964879|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138964880|NCT04094909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138964881|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964882|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138964883|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138964884|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138964885|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138964886|NCT04094909|Growth Substances|growth substances|mesh-ancestor
138964887|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964888|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
138964889|NCT02599571|Nicotine|nicotine|mesh-list
138964890|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138964891|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
138964892|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964893|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964894|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138964895|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138964896|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
138574331|NCT00455806|Amoxicillin|amoxicillin|mesh-list
138964897|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964898|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964899|NCT00296491|Fluticasone|fluticasone|mesh-list
138964901|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138964902|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138964903|NCT00296491|Montelukast|montelukast|mesh-list
138964904|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138964905|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138964906|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
138964907|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964908|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964909|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138964910|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
138964911|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
138964912|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138964913|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138964914|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138964915|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138964916|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
138964917|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574384|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964918|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964919|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138964920|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
138964921|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138964922|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138964923|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138964924|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
138964925|NCT00296491|Hormones|hormones|mesh-ancestor
138964926|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
138964927|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138964928|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138964929|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715778|NCT00581685|Celecoxib|celecoxib|mesh-list
138964930|NCT02599493|Rifampin|rifampin|mesh-list
138964931|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138964932|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
138964933|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138964934|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138964935|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
138964936|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138964937|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964938|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964939|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138964940|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138574437|NCT00456586|Istradefylline|istradefylline|mesh-list
138964941|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138964942|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138964943|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138964944|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138964946|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
138964947|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138964948|NCT00296335|Mitomycins|mitomycins|mesh-list
138964949|NCT00296335|Mitomycin|mitomycin|mesh-list
138964950|NCT00296335|Doxifluridine|doxifluridine|mesh-list
138964951|NCT00296335|Floxuridine|floxuridine|mesh-list
138964952|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964953|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138964954|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
138964955|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964956|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138964957|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964958|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138964959|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
138964960|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138964961|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
138964962|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964963|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
138964964|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138964965|NCT04094597|Lactoferrin|lactoferrin|mesh-list
138964966|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138964967|NCT01065961|Dexamethasone|dexamethasone|mesh-list
138964968|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
138964969|NCT01065961|BB 1101|bb 1101|mesh-list
138964970|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138964971|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
138964972|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
138964973|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964974|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964975|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138964976|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
138964977|NCT01065961|Hormones|hormones|mesh-ancestor
138964978|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138964979|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138964980|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138964981|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
138574607|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
138964982|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138964983|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964984|NCT01068223|Cetirizine|cetirizine|mesh-list
138964985|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138964986|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138964987|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138964988|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
138964989|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
138964990|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138964991|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138964992|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964993|NCT02600273|Nicotine|nicotine|mesh-list
138964994|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138964995|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
138964996|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138964997|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138964998|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138964999|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138965000|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
138965001|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138965002|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965003|NCT01068301|Plerixafor|plerixafor|mesh-list
138965004|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138965005|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138965006|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
138965007|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138965008|NCT04999228|Infliximab|infliximab|mesh-list
138965009|NCT04999228|Mesalamine|mesalamine|mesh-list
138965010|NCT04999228|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138965011|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138965012|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
138965013|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138965014|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138965015|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138965016|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138965017|NCT04999228|Analgesics|analgesics|mesh-ancestor
138965018|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
138965019|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965020|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965022|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138965023|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965024|NCT04093895|Taurolidine|taurolidine|mesh-list
138965025|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138965026|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138965027|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965028|NCT00624780|Pregabalin|pregabalin|mesh-list
138965029|NCT00624780|Lorazepam|lorazepam|mesh-list
138965030|NCT00624780|Analgesics|analgesics|mesh-ancestor
138965031|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
138965032|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965033|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965034|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
138965035|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138965036|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138965037|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965038|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138965039|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138965040|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138965041|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138965042|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138965044|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
138965045|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138965046|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138965047|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
138965048|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
138965049|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138965050|NCT02599337|Sorafenib|sorafenib|mesh-list
138965051|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965052|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138965053|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574897|NCT00348361|Xhance|xhance|mesh-list
138965054|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965055|NCT00831636|Cytarabine|cytarabine|mesh-list
138965056|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138965057|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
138965058|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965059|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965060|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
138965061|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138965062|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138965063|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
138965064|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965065|NCT00750737|Amphotericin B|amphotericin b|mesh-list
138965066|NCT00750737|Posaconazole|posaconazole|mesh-list
138965067|NCT00750737|Amebicides|amebicides|mesh-ancestor
138965068|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138965069|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138965070|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138965071|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138965072|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
138965073|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138965074|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138965076|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965077|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965078|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138965079|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
138965080|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138965081|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965083|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138965084|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965085|NCT04093505|Immunotoxins|immunotoxins|mesh-ancestor
138965086|NCT04093505|Immunoconjugates|immunoconjugates|mesh-ancestor
138965087|NCT04093505|Immunologic Factors|immunologic factors|mesh-ancestor
138965088|NCT04093505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965089|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
138965090|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138965091|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
138965092|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138965093|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
138965094|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965095|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965096|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
138965097|NCT02597699|Lidocaine|lidocaine|mesh-list
138965098|NCT02597699|Sufentanil|sufentanil|mesh-list
138965099|NCT02597699|Remifentanil|remifentanil|mesh-list
138965100|NCT02597699|Dsuvia|dsuvia|mesh-list
138965101|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
138965102|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
138965103|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138965104|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965105|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
138965106|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965107|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138965108|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138965109|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138965110|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138965111|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965112|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138965113|NCT02597699|Narcotics|narcotics|mesh-ancestor
138965114|NCT02597699|Analgesics|analgesics|mesh-ancestor
138965115|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138965116|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138965117|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
138965118|NCT00744653|Bleomycin|bleomycin|mesh-list
138965119|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138965120|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965121|NCT00998218|Ranolazine|ranolazine|mesh-list
138965122|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138965123|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138965124|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965125|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138965126|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138965127|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
138965128|NCT00311311|Sirolimus|sirolimus|mesh-list
138965129|NCT00311311|Prednisone|prednisone|mesh-list
138965130|NCT00311311|Tacrolimus|tacrolimus|mesh-list
138965131|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138965132|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
138965133|NCT00311311|Hormones|hormones|mesh-ancestor
138965134|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138965135|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965136|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138965137|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965138|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138965139|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
138965140|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138965141|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965142|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965143|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138965144|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138965145|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
138965146|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138965147|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138965148|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
138965149|NCT04089605|Dexamethasone|dexamethasone|mesh-list
138965150|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
138965151|NCT04089605|Ranibizumab|ranibizumab|mesh-list
138965152|NCT04089605|BB 1101|bb 1101|mesh-list
138965153|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138965154|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
138965155|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
138965156|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965157|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965158|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138965160|NCT04089605|Hormones|hormones|mesh-ancestor
138965161|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138965162|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138965163|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965164|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
138965165|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965166|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965167|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138965168|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138965169|NCT04089605|Growth Substances|growth substances|mesh-ancestor
138965170|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
138965171|NCT00521404|Gemcitabine|gemcitabine|mesh-list
138965172|NCT00521404|Antibodies|antibodies|mesh-list
138965173|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
138965174|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965175|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138965176|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
138965177|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575254|NCT00111956|Analgesics|analgesics|mesh-ancestor
138965178|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965179|NCT00311155|Amlodipine|amlodipine|mesh-list
138965180|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138965181|NCT00311155|Olmesartan|olmesartan|mesh-list
138965182|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138965183|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138965184|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138965185|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138965186|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965187|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138965188|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965189|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
138965190|NCT00311155|Diuretics|diuretics|mesh-ancestor
138965191|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
138965192|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138965193|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138965194|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138965195|NCT03981601|Lovastatin|lovastatin|mesh-list
138965196|NCT03981601|L 647318|l 647318|mesh-list
138965197|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
138965198|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138965199|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138575314|NCT00351130|Amlodipine|amlodipine|mesh-list
138965200|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
138965201|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965202|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138965203|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138965204|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965205|NCT00274651|Belinostat|belinostat|mesh-list
138965206|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965207|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138965208|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965209|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965210|NCT00274261|Nonoxynol|nonoxynol|mesh-list
138965211|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138965212|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138965213|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575362|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
138965214|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138965215|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
138965216|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138965217|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138965218|NCT00827814|Dutasteride|dutasteride|mesh-list
138965219|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138965220|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138965221|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965222|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965223|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
138965224|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138965225|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965226|NCT01068847|Cycloserine|cycloserine|mesh-list
138965227|NCT01068847|Verapamil|verapamil|mesh-list
138965228|NCT01068847|Nifedipine|nifedipine|mesh-list
138965229|NCT01068847|Tizanidine|tizanidine|mesh-list
138965230|NCT01068847|Naloxone|naloxone|mesh-list
138965231|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138965232|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965233|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
138965234|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965235|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138965236|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138965237|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965238|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138965239|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
138798970|NCT02856750|Gabapentin|gabapentin|mesh-list
138965240|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
138965241|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138965242|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138965243|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138965244|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138965245|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
138965246|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138965247|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
138965248|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138965249|NCT01068847|Analgesics|analgesics|mesh-ancestor
138965250|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
138965251|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138965252|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138965253|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
138965254|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
138965255|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138965256|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138965257|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138965258|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
138965259|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138965260|NCT00827892|Pioglitazone|pioglitazone|mesh-list
138965261|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138965262|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965263|NCT01070875|Heparin|heparin|mesh-list
138965264|NCT01070875|Calcium heparin|calcium heparin|mesh-list
138965265|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
138965266|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138965267|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138965268|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965270|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965271|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139001251|NCT00987116|Hormones|hormones|mesh-ancestor
138965272|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965273|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965274|NCT01325935|Clopidogrel|clopidogrel|mesh-list
138965275|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138965276|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138965277|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138965278|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138965279|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
138965280|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575591|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
138965281|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965282|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965284|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138965285|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965286|NCT00521014|Cytarabine|cytarabine|mesh-list
138965287|NCT00521014|Rituximab|rituximab|mesh-list
138965288|NCT00521014|Etoposide|etoposide|mesh-list
138965289|NCT00521014|Melphalan|melphalan|mesh-list
138965290|NCT00521014|Carmustine|carmustine|mesh-list
138965291|NCT00521014|Sargramostim|sargramostim|mesh-list
138965292|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138965293|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965294|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
138965295|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965296|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138965297|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138965298|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138965299|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138965300|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575709|NCT00112892|Selenium|selenium|mesh-list
138965301|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965302|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138965303|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
138965304|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
138965305|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138965306|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138965307|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138965308|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
138965309|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138965310|NCT00825552|Risperidone|risperidone|mesh-list
138965311|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138965312|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
138965313|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138965314|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965315|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965316|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138965317|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138965318|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138965319|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138965320|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138965321|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
138965322|NCT00291577|Docetaxel|docetaxel|mesh-list
138965323|NCT00291577|Sunitinib|sunitinib|mesh-list
138965324|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965325|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
138965326|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
138965327|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
138965328|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965329|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138965330|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138965331|NCT00291577|Growth Substances|growth substances|mesh-ancestor
138799022|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
138965332|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965333|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
138965334|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138965335|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965336|NCT00520936|Pemetrexed|pemetrexed|mesh-list
138965337|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965338|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965339|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965340|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138965341|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138965342|NCT02549430|Letrozole|letrozole|mesh-list
138965343|NCT02549430|Fulvestrant|fulvestrant|mesh-list
138965344|NCT02549430|Palbociclib|palbociclib|mesh-list
138965345|NCT02549430|Anastrozole|anastrozole|mesh-list
138965346|NCT02549430|Exemestane|exemestane|mesh-list
138965347|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965348|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138965349|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138965350|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965351|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965352|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138965353|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
138965354|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138965355|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965356|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138965357|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138965358|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138965359|NCT00943839|Sunitinib|sunitinib|mesh-list
138965360|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965361|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138965362|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138965363|NCT00943839|Growth Substances|growth substances|mesh-ancestor
138965364|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965365|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
138965366|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138965367|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965368|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965369|NCT00832182|Insulin|insulin|mesh-list
138965370|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138965371|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
138965372|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
138965373|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
138965374|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
138965375|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138965376|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965377|NCT00952497|Capecitabine|capecitabine|mesh-list
138965378|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965379|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138965380|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
138799046|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965381|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965382|NCT00828282|Simvastatin|simvastatin|mesh-list
138965383|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138965384|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138965385|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
138965386|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965387|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138965388|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138965389|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965390|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
138965391|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138965393|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138965394|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
138965395|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
138965396|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965397|NCT03865732|Pregnanolone|pregnanolone|mesh-list
138965398|NCT03865732|Ganaxolone|ganaxolone|mesh-list
138965399|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
138965400|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138965401|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965402|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965403|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
138965404|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
138965405|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
138965406|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138965407|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
138965408|NCT00944307|Antacids|antacids|mesh-list
138965409|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
138965410|NCT00944307|TEMPO|tempo|mesh-list
138965411|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138965412|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138965413|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
138965414|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138965415|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138965416|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138965417|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965418|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965419|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138965420|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
138965421|NCT00944307|Protective Agents|protective agents|mesh-ancestor
138575989|NCT05594121|Buprenorphine|buprenorphine|mesh-list
138965422|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965423|NCT00944385|Urinastatin|urinastatin|mesh-list
138965424|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138965425|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138965426|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
138965427|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965428|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965429|NCT00953355|Metformin|metformin|mesh-list
138965430|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138965431|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965432|NCT00944463|Gemcitabine|gemcitabine|mesh-list
138965433|NCT00944463|Simvastatin|simvastatin|mesh-list
138965434|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138965435|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
138965436|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965437|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965438|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138965439|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138965440|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138965441|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138965442|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965443|NCT00956397|Rifaximin|rifaximin|mesh-list
138965444|NCT00956397|Lactulose|lactulose|mesh-list
138965445|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138965446|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138965447|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138965448|NCT05300373|Adenosine|adenosine|mesh-list
138965449|NCT05300373|Analgesics|analgesics|mesh-ancestor
138965450|NCT05300373|Sensory System Agents|sensory system agents|mesh-ancestor
138965451|NCT05300373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965452|NCT05300373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965453|NCT05300373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138965454|NCT05300373|Vasodilator Agents|vasodilator agents|mesh-ancestor
138965455|NCT05300373|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138965456|NCT05300373|Purinergic Agonists|purinergic agonists|mesh-ancestor
138716296|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
138965457|NCT05300373|Purinergic Agents|purinergic agents|mesh-ancestor
138965458|NCT05300373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138965459|NCT05300373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965460|NCT00953589|Ribavirin|ribavirin|mesh-list
138965461|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
138965462|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965463|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
138965464|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138965465|NCT00947739|Camptothecin|camptothecin|mesh-list
138965466|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138965467|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965468|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138965469|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138965470|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965471|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965472|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
138965473|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138965474|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965475|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
138965476|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138965477|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138965478|NCT00947895|Prednisolone|prednisolone|mesh-list
138965479|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
138965480|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138965481|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
138965482|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138965483|NCT00947895|Hormones|hormones|mesh-ancestor
138965484|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138965485|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965486|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138965487|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
138965488|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
138965489|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965490|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138965491|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
138965492|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138965493|NCT00947895|Protective Agents|protective agents|mesh-ancestor
138965494|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138965495|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965496|NCT00623766|Dexamethasone|dexamethasone|mesh-list
138965497|NCT00623766|Prednisone|prednisone|mesh-list
138965498|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
138965499|NCT00623766|Prednisolone|prednisolone|mesh-list
138965500|NCT00623766|Triamcinolone|triamcinolone|mesh-list
138965501|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
138965502|NCT00623766|Betamethasone|betamethasone|mesh-list
138965503|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
138965504|NCT00623766|Ipilimumab|ipilimumab|mesh-list
138965505|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138965506|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
138965507|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
138965508|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965509|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965510|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138965511|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
138965512|NCT00623766|Hormones|hormones|mesh-ancestor
138576321|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138965513|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138965514|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138965515|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965516|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138965517|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138965518|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965519|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138965521|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138965522|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
138965523|NCT00832494|Paclitaxel|paclitaxel|mesh-list
138965524|NCT00832494|Carboplatin|carboplatin|mesh-list
138965525|NCT00832494|Vadimezan|vadimezan|mesh-list
138965526|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138965527|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965528|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
138965529|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
138965530|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
138965531|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965532|NCT00837564|Escitalopram|escitalopram|mesh-list
138965533|NCT00837564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138965534|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138965535|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138965536|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965537|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138965538|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
138965539|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965540|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
138965542|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138965543|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
138965544|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965545|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138965546|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138965548|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965549|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965550|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138965551|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138965552|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965553|NCT00832806|Varenicline|varenicline|mesh-list
138965554|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138965555|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138965556|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
138965557|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138965558|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965559|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965560|NCT00832884|Lacosamide|lacosamide|mesh-list
138965561|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
138965562|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138965563|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138965564|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139001327|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
138965565|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965566|NCT02549118|Tenoxicam|tenoxicam|mesh-list
138965567|NCT02549118|Meperidine|meperidine|mesh-list
138965568|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138965569|NCT02549118|Narcotics|narcotics|mesh-ancestor
138965570|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138965571|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965572|NCT02549118|Analgesics|analgesics|mesh-ancestor
138965573|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
138965574|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965575|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138965576|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138965577|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138965578|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138965579|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138965580|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138965581|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965582|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965583|NCT00957177|Pregabalin|pregabalin|mesh-list
138965584|NCT00957177|Analgesics|analgesics|mesh-ancestor
138965585|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
138965586|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965587|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965588|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
138965589|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138965590|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138965591|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965592|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138965593|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138965594|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138965595|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138965596|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138965597|NCT00828594|Sorafenib|sorafenib|mesh-list
138965598|NCT00828594|Everolimus|everolimus|mesh-list
138965599|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576557|NCT00449449|Lidocaine|lidocaine|mesh-list
138965600|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138965601|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965602|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965603|NCT00828594|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138965604|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138965605|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
138716444|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965606|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965607|NCT00550407|Lamotrigine|lamotrigine|mesh-list
138965608|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
138965609|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138965610|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138965611|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965612|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138965613|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965614|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138965615|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138965616|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138965617|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138965618|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138965619|NCT00957411|Cetuximab|cetuximab|mesh-list
138965620|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965621|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138965622|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
138965623|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
138965624|NCT00837954|Coagulants|coagulants|mesh-ancestor
138965625|NCT00954525|Gemcitabine|gemcitabine|mesh-list
139001341|NCT01088815|Paclitaxel|paclitaxel|mesh-list
138965626|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138965627|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138965628|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
138965629|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965630|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965631|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138965632|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965633|NCT00838032|Haloperidol|haloperidol|mesh-list
138965634|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138965635|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
138965636|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
138965637|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138965638|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138965639|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138965640|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138965641|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965642|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
138965643|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
138965644|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965645|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138965646|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138965647|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
138965648|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576797|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965649|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965650|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138965651|NCT00954603|Haloperidol|haloperidol|mesh-list
138965652|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138965653|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
138965654|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
138965655|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138965656|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138965657|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138965658|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138965659|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965660|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
138965661|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
138965662|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965663|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138965664|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138965665|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
138965666|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138965667|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965668|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138965669|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138965670|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965671|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138965672|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965673|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965674|NCT02548806|Clonidine|clonidine|mesh-list
138965675|NCT02548806|Analgesics|analgesics|mesh-ancestor
138965676|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
138965677|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965678|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965679|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138965680|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
138965682|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138965683|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138965684|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138965685|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
138965686|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138965687|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965688|NCT00549939|Alfuzosin|alfuzosin|mesh-list
138965689|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138576899|NCT00460252|Insulin|insulin|mesh-list
138965690|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138965691|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138965692|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
138965693|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138965694|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965695|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965696|NCT00549939|Urological Agents|urological agents|mesh-ancestor
138965698|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138965699|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
138965700|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138965701|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138965702|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138965703|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965704|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965705|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138965706|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138965707|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138965708|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138965709|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
138965710|NCT00957879|Calcitriol|calcitriol|mesh-list
138965711|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
138965712|NCT00957879|Vitamin D|vitamin d|mesh-list
138577026|NCT03273595|Paclitaxel|paclitaxel|mesh-list
138965713|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138965714|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965715|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138965716|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138965717|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965718|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138965719|NCT00957879|Vitamins|vitamins|mesh-ancestor
138965720|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
138965721|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138965722|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
138965723|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138965724|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965725|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
138965726|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965727|NCT00838266|Protective Agents|protective agents|mesh-ancestor
138965728|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965729|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
138965730|NCT04011033|Interleukin-2|interleukin-2|mesh-list
138965731|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138965732|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
138965733|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965734|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138965735|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138965736|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
138965737|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965738|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965739|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138965740|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138965741|NCT04011033|Analgesics|analgesics|mesh-ancestor
138965742|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
138965743|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965744|NCT00998608|Risperidone|risperidone|mesh-list
138965745|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138965746|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
138965747|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138965748|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965749|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965750|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138965751|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138965752|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138965753|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138965754|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138965755|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
138965756|NCT04011813|Antioxidants|antioxidants|mesh-list
138965757|NCT04011813|Hypotaurine|hypotaurine|mesh-list
138965758|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965759|NCT04011813|Protective Agents|protective agents|mesh-ancestor
138965760|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965761|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138965762|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138965763|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965764|NCT00998686|Incretins|incretins|mesh-ancestor
138965765|NCT00998686|Hormones|hormones|mesh-ancestor
138965766|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138965767|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138965768|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
138965769|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965770|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965771|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138965772|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138965773|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965774|NCT00958269|Incretins|incretins|mesh-ancestor
138965775|NCT00958269|Hormones|hormones|mesh-ancestor
138965776|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138965777|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138965778|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
138965779|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965780|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965782|NCT02547402|Simvastatin|simvastatin|mesh-list
138965783|NCT02547402|Ezetimibe|ezetimibe|mesh-list
138965784|NCT02547402|Pravastatin|pravastatin|mesh-list
138965785|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138965786|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138965787|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138965788|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
138965789|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965790|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138965791|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138965792|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965793|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138965794|NCT01068925|Dolutegravir|dolutegravir|mesh-list
138965795|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138965796|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138965797|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577319|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965798|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965799|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138965800|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138965801|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
138965802|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138965803|NCT00834600|Amlodipine|amlodipine|mesh-list
138965804|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138965805|NCT00834600|Olmesartan|olmesartan|mesh-list
138965806|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138577378|NCT00464347|Growth Substances|growth substances|mesh-ancestor
138965807|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138965808|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138965809|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138965810|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965811|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138965812|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965813|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
138965814|NCT00834600|Diuretics|diuretics|mesh-ancestor
138965815|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
138965816|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138965817|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138965818|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138965819|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
138965820|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138965821|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
138965822|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965823|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
138965824|NCT00958425|Protective Agents|protective agents|mesh-ancestor
138965826|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138965827|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138965828|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965829|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965830|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965831|NCT00838656|Paclitaxel|paclitaxel|mesh-list
138965832|NCT00838656|Carboplatin|carboplatin|mesh-list
138965833|NCT00838656|Gemcitabine|gemcitabine|mesh-list
138965834|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138965835|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965836|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
138577519|NCT00465439|Lidocaine|lidocaine|mesh-list
138965837|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
138965838|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
138965839|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965840|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138965841|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
138965842|NCT00829608|Vaccines|vaccines|mesh-list
138965843|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
138965844|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965845|NCT00553605|Ketoprofen|ketoprofen|mesh-list
138965846|NCT00553605|Parecoxib|parecoxib|mesh-list
138965847|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138799326|NCT00946998|Sertraline|sertraline|mesh-list
138965848|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138965849|NCT00553605|Analgesics|analgesics|mesh-ancestor
138965850|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
138577579|NCT00117026|Benphothiamine|benphothiamine|mesh-list
138965851|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965852|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965853|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138965854|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138965855|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138965856|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965857|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965858|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138965860|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
138965861|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965862|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
138965863|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138577628|NCT00117104|Hematinics|hematinics|mesh-ancestor
138965865|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965866|NCT04010955|Edoxaban|edoxaban|mesh-list
138965867|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138965868|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
138965869|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138965870|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
138965871|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965872|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965873|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
138965874|NCT00948987|Aspirin|aspirin|mesh-list
138965875|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138965876|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138965877|NCT00948987|Analgesics|analgesics|mesh-ancestor
138965878|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
138965879|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965880|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965881|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138965882|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138965883|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138965884|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138965885|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965886|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138965887|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138965888|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965889|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
138965890|NCT00744497|Prednisone|prednisone|mesh-list
138965891|NCT00744497|Docetaxel|docetaxel|mesh-list
138965892|NCT00744497|Dasatinib|dasatinib|mesh-list
138965893|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965894|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
138965895|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
138965896|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
138965897|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965898|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138965899|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
138965900|NCT00744497|Hormones|hormones|mesh-ancestor
138965901|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138965902|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965903|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138965904|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138799344|NCT00906087|Timolol|timolol|mesh-list
138965905|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965906|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
138965907|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138965908|NCT00949065|Antibodies|antibodies|mesh-list
138965909|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
138965910|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138965911|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
138965912|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965914|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965915|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138965916|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965917|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965918|NCT00955227|Ezetimibe|ezetimibe|mesh-list
138965919|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138965920|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138965921|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
138965922|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577794|NCT02964195|Rifaximin|rifaximin|mesh-list
138965923|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138965924|NCT00949299|Buprenorphine|buprenorphine|mesh-list
138965925|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138965926|NCT00949299|Narcotics|narcotics|mesh-ancestor
138965927|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138965928|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965929|NCT00949299|Analgesics|analgesics|mesh-ancestor
138965930|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
138965931|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965932|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138965933|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138965934|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138965935|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138965936|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
138965937|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965938|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138965939|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138965940|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965941|NCT00271609|Bevacizumab|bevacizumab|mesh-list
138965942|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138965943|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965944|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138965945|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138965946|NCT00271609|Growth Substances|growth substances|mesh-ancestor
138965947|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965948|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
138965949|NCT00548847|Interferons|interferons|mesh-list
138965950|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
138965951|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
138965952|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138965953|NCT00548847|Molgramostim|molgramostim|mesh-list
138965954|NCT00548847|Sargramostim|sargramostim|mesh-list
138965955|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965956|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
138965957|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138965958|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
138965959|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965961|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
138965962|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
138965963|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138965964|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965965|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
138965966|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965968|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138965969|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965970|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
138965971|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965972|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138965973|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
138965974|NCT02597387|Analgesics|analgesics|mesh-ancestor
138965975|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
138965976|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138965977|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138965978|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965979|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138965980|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138965981|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001428|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138965982|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965984|NCT01069081|Docetaxel|docetaxel|mesh-list
138965985|NCT01069081|Esomeprazole|esomeprazole|mesh-list
138965986|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965987|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
138965988|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
138965989|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
138965990|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138965991|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138965992|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138965993|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138577963|NCT00117689|Tacrolimus|tacrolimus|mesh-list
138965994|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965996|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138965997|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138965998|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138965999|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966000|NCT05296161|Ocrelizumab|ocrelizumab|mesh-list
138966001|NCT05296161|Immunologic Factors|immunologic factors|mesh-ancestor
138966002|NCT05296161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966003|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138966004|NCT00955695|Gefitinib|gefitinib|mesh-list
138966005|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966006|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138966007|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799385|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
138966008|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966009|NCT00955773|Everolimus|everolimus|mesh-list
138966010|NCT00955773|Trametinib|trametinib|mesh-list
138966011|NCT00955773|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138966012|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138966013|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966014|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966015|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966016|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
138966017|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966018|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966019|NCT00549549|Celecoxib|celecoxib|mesh-list
138966020|NCT00549549|Indomethacin|indomethacin|mesh-list
138966021|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138966022|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138966023|NCT00549549|Analgesics|analgesics|mesh-ancestor
138966024|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
138966025|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966026|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966027|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138966028|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966029|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138966030|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138966031|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966032|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966033|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
138966034|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
138966035|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138966036|NCT00622284|Glimepiride|glimepiride|mesh-list
138966037|NCT00622284|Linagliptin|linagliptin|mesh-list
138966038|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138966039|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138966040|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966041|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966042|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
138966043|NCT00622284|Incretins|incretins|mesh-ancestor
138966044|NCT00622284|Hormones|hormones|mesh-ancestor
138966045|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966046|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138966047|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
138966048|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966049|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966051|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138966052|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966053|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
138966054|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966055|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966056|NCT01069159|Propranolol|propranolol|mesh-list
138716914|NCT00574964|Carmustine|carmustine|mesh-list
138966057|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138966058|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138966059|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
138966060|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138966061|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966062|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966063|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138966064|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138966065|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
138966066|NCT03975205|Doxorubicin|doxorubicin|mesh-list
138966067|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138966068|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966069|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138578267|NCT00119132|Artesunate|artesunate|mesh-list
138966070|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138966071|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966072|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966073|NCT01325779|Heparin|heparin|mesh-list
138966074|NCT01325779|Enoxaparin|enoxaparin|mesh-list
138966075|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
138966076|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138966077|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138966078|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966079|NCT05170659|Relatlimab|relatlimab|mesh-list
138966080|NCT05170659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138966081|NCT05170659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966082|NCT05170659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138966083|NCT05170659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966084|NCT05352165|Pembrolizumab|pembrolizumab|mesh-list
138966085|NCT05352165|Fluorouracil|fluorouracil|mesh-list
138966086|NCT05352165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138966087|NCT05352165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966088|NCT05352165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138966089|NCT05352165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966090|NCT05352165|Antimetabolites|antimetabolites|mesh-ancestor
138966091|NCT05352165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138966092|NCT05352165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966093|NCT05352165|Immunologic Factors|immunologic factors|mesh-ancestor
138966094|NCT05352165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966095|NCT00956163|Diphosphonates|diphosphonates|mesh-list
138966096|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
138966097|NCT00956163|Listerine|listerine|mesh-list
138966098|NCT00956163|Fluorides|fluorides|mesh-list
138966099|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
138966100|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
138966101|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
138966102|NCT00956163|Protective Agents|protective agents|mesh-ancestor
138966103|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966104|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138966105|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966106|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138966107|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966108|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138966109|NCT00956319|Estazolam|estazolam|mesh-list
138966110|NCT00956319|Zolpidem|zolpidem|mesh-list
138966111|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138966112|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138966113|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138966114|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966115|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138966116|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
138966117|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
138578470|NCT00480649|Xhance|xhance|mesh-list
138966118|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138966119|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966121|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138966122|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138966123|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138966124|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
138966125|NCT00835848|Exenatide|exenatide|mesh-list
138966126|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138966127|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966128|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138966129|NCT00835848|Incretins|incretins|mesh-ancestor
138966131|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966132|NCT00961857|Metformin|metformin|mesh-list
138966133|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138966134|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138966135|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966136|NCT00961857|Incretins|incretins|mesh-ancestor
138966137|NCT00961857|Hormones|hormones|mesh-ancestor
138966138|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966139|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138966140|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
138966141|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966142|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966144|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
138966145|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966146|NCT00830466|Sirolimus|sirolimus|mesh-list
138966147|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138966148|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966149|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138966150|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966151|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
138966152|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966153|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
138966154|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966155|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138966156|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138966157|NCT00843570|Nafarelin|nafarelin|mesh-list
138966158|NCT00843570|Estradiol|estradiol|mesh-list
138966159|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138966160|NCT00843570|Progesterone|progesterone|mesh-list
138966161|NCT00843570|Estrogens|estrogens|mesh-ancestor
138966162|NCT00843570|Hormones|hormones|mesh-ancestor
138966163|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966164|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966165|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138966166|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
138966167|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138966168|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138966169|NCT00843570|Progestins|progestins|mesh-ancestor
138966170|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138966171|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
138966172|NCT02547870|Rilpivirine|rilpivirine|mesh-list
138966173|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138966174|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138966175|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966176|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966177|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
138966178|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966179|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138966180|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138966181|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
138966182|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
138966183|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
138966184|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138966185|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966186|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
138966187|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966188|NCT00621504|Clarithromycin|clarithromycin|mesh-list
138966189|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
138966190|NCT00621504|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138966191|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138966192|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966193|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138966194|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966195|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966196|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138966197|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138966199|NCT00548145|Pitavastatin|pitavastatin|mesh-list
138966200|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138966201|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138966202|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
138966203|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966204|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138966205|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138966206|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966207|NCT00547911|Carbidopa|carbidopa|mesh-list
138966208|NCT00547911|Entacapone|entacapone|mesh-list
138966209|NCT00547911|Droxidopa|droxidopa|mesh-list
138966210|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138966211|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138966212|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
138966213|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138966214|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578756|NCT00482716|Iron|iron|mesh-list
138966216|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138966217|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966218|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138966219|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
138966220|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
138966221|NCT00839280|Vitamins|vitamins|mesh-ancestor
138966222|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
138966223|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966224|NCT00836628|Busulfan|busulfan|mesh-list
138966225|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
138966226|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966227|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966228|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
138966229|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966230|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138966231|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966232|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138966233|NCT00962637|Citric Acid|citric acid|mesh-list
138966234|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
138966235|NCT00962637|Enclomiphene|enclomiphene|mesh-list
138966236|NCT00962637|Clomiphene|clomiphene|mesh-list
138966237|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
138966238|NCT00962637|Testosterone|testosterone|mesh-list
138966239|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
138966240|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138966241|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
138966242|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
138966243|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966244|NCT00962637|Androgens|androgens|mesh-ancestor
138966245|NCT00962637|Hormones|hormones|mesh-ancestor
138966246|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578830|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966247|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966248|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138966249|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
138966250|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138966251|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
138966252|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138966253|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138966254|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138966255|NCT00839358|Midodrine|midodrine|mesh-list
138966256|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
138966257|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
138966258|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966259|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966260|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138966261|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138966262|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138966263|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138966264|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
138966265|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138966266|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966267|NCT00962715|Interferons|interferons|mesh-list
138966268|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
138966269|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
138966271|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966272|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
138966273|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966274|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
138966275|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966276|NCT00963027|Treprostinil|treprostinil|mesh-list
138966277|NCT00963027|Esomeprazole|esomeprazole|mesh-list
138966278|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138966279|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138966280|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138966281|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578940|NCT01241110|Ofloxacin|ofloxacin|mesh-list
138717121|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
138966282|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966283|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138966285|NCT00837174|Vorinostat|vorinostat|mesh-list
138966286|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966287|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138966288|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966289|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966290|NCT04042974|Dinoprostone|dinoprostone|mesh-list
138966291|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
138966292|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138966293|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966294|NCT00844350|Letrozole|letrozole|mesh-list
138966295|NCT00844350|Oxytocin|oxytocin|mesh-list
138966296|NCT00844350|Clomiphene|clomiphene|mesh-list
138966297|NCT00844350|Enclomiphene|enclomiphene|mesh-list
138966298|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
138966299|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966300|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
138966301|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138966302|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966303|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966304|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138966305|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138966306|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966307|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138966308|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
138966309|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966310|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138966311|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
138966312|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138966313|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138966314|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
138966315|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966316|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
138966317|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579003|NCT00120731|Acetazolamide|acetazolamide|mesh-list
138966318|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966319|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138966320|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
138966321|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966322|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966323|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138966324|NCT00839826|Enoxaparin|enoxaparin|mesh-list
138966325|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
138966326|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138966327|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
138966328|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138966329|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
138966330|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799574|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
138966331|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966332|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
138966333|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138966334|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138966335|NCT00844662|Sevelamer|sevelamer|mesh-list
138966336|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
138966337|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
138966338|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966339|NCT04678089|Bortezomib|bortezomib|mesh-list
138966340|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966341|NCT00963573|Loratadine|loratadine|mesh-list
138966342|NCT00963573|Betamethasone|betamethasone|mesh-list
138966343|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138966344|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
138966345|NCT00963573|Hormones|hormones|mesh-ancestor
138579060|NCT01241383|Bosentan|bosentan|mesh-list
138966346|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966347|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966348|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138966349|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
138966350|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
138966351|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
138966352|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138966353|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138966354|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138966355|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
138966356|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
138966357|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138966358|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966359|NCT05299593|Timolol|timolol|mesh-list
138966360|NCT05299593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138966361|NCT05299593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138966362|NCT05299593|Adrenergic Agents|adrenergic agents|mesh-ancestor
138966363|NCT05299593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138966364|NCT05299593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966365|NCT05299593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966366|NCT05299593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138966367|NCT05299593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138966369|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138966370|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001572|NCT05361278|Eusol|eusol|mesh-list
138966372|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
138966373|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966374|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
138966375|NCT00963729|Docetaxel|docetaxel|mesh-list
138966376|NCT00963729|Fluorouracil|fluorouracil|mesh-list
138966377|NCT00963729|Letrozole|letrozole|mesh-list
138966378|NCT00963729|Epirubicin|epirubicin|mesh-list
138966379|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966380|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
138966381|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966382|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966383|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138966384|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
138966385|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966386|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966387|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138966388|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
138966389|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
138966390|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
138966391|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
138966392|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138966393|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138966394|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138966395|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966396|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138966397|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
138966398|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966399|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138966400|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138966401|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138966403|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138966404|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966405|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138966406|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
138966407|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138966408|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
138966409|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966410|NCT04009317|Crizotinib|crizotinib|mesh-list
138966411|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966412|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138966413|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966414|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966416|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966417|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138966418|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
138966419|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966420|NCT00851370|Omalizumab|omalizumab|mesh-list
138966421|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138966422|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138966423|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
138966424|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
138966425|NCT00967629|Calcium|calcium|mesh-list
138966426|NCT00967629|Sevelamer|sevelamer|mesh-list
138966427|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138966428|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966429|NCT00967629|Antacids|antacids|mesh-ancestor
138966430|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966431|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138966432|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
139001584|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
138966433|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
138966434|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138966435|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
138966436|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966437|NCT00840606|Buspirone|buspirone|mesh-list
138966438|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138966439|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138966440|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138966441|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966442|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138966443|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138966444|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
138966445|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138966446|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966447|NCT00840684|Cytarabine|cytarabine|mesh-list
138966448|NCT00840684|Melphalan|melphalan|mesh-list
138966449|NCT00840684|Busulfan|busulfan|mesh-list
138966450|NCT00840684|Daunorubicin|daunorubicin|mesh-list
138966451|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
138966452|NCT00840684|Amsacrine|amsacrine|mesh-list
138966453|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138966454|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
138966455|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966456|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966457|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
138966458|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966459|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966460|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
138966461|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966462|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138966463|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
138966464|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138966465|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138966466|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138966467|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138966468|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966469|NCT00840684|Analgesics|analgesics|mesh-ancestor
138966470|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
138966471|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966472|NCT00574080|Cytarabine|cytarabine|mesh-list
138966473|NCT00574080|Thalidomide|thalidomide|mesh-list
138966474|NCT00574080|Dexamethasone|dexamethasone|mesh-list
138966475|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
138966476|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
138966477|NCT00574080|Melphalan|melphalan|mesh-list
138966478|NCT00574080|Carmustine|carmustine|mesh-list
138966479|NCT00574080|Cisplatin|cisplatin|mesh-list
138966480|NCT00574080|Etoposide|etoposide|mesh-list
138966481|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
138966482|NCT00574080|Doxorubicin|doxorubicin|mesh-list
138966483|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138966484|NCT00574080|Bortezomib|bortezomib|mesh-list
138966485|NCT00574080|BB 1101|bb 1101|mesh-list
138966486|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966487|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
138966488|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966489|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138799655|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966490|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138966491|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
138966492|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966493|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966494|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138966495|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138966496|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
138966497|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
138966498|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966499|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139001596|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
138966500|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
138966502|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966503|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138966504|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
138966505|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966506|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138966507|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138966508|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138966509|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138966510|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
138966511|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
138966512|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966513|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138966514|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
138966515|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138966516|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138966517|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138966518|NCT00574080|Growth Substances|growth substances|mesh-ancestor
138966519|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
138966520|NCT00845364|Perhexiline|perhexiline|mesh-list
138966521|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138966522|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138966523|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966524|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138966525|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966526|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
138966527|NCT00267865|Leucovorin|leucovorin|mesh-list
138966528|NCT00267865|Rituximab|rituximab|mesh-list
138966529|NCT00267865|Methotrexate|methotrexate|mesh-list
138966530|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138966531|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966532|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
138966533|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966534|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966535|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138966536|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
138966537|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138966538|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138966539|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
138966540|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966541|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
138966542|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966543|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138966544|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966545|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138966546|NCT00267865|Antidotes|antidotes|mesh-ancestor
138966547|NCT00267865|Protective Agents|protective agents|mesh-ancestor
138966548|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
138966549|NCT00267865|Vitamins|vitamins|mesh-ancestor
138966550|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
138966551|NCT00840918|Lidocaine|lidocaine|mesh-list
138966552|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
138966553|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
138966554|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138966555|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579644|NCT00122096|Valdecoxib|valdecoxib|mesh-list
138966556|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
138966557|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966558|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138966559|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138966560|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138966561|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138966562|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966563|NCT00546117|Lansoprazole|lansoprazole|mesh-list
138966564|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
138966565|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138966566|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138966567|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138966568|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966569|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966570|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138966571|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138966572|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138966573|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
138966574|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966575|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138966576|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138966577|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966578|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
138966579|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138966580|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138966581|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966582|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
138966583|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
138966584|NCT00967707|Gabapentin|gabapentin|mesh-list
138966585|NCT00967707|Donepezil|donepezil|mesh-list
138966586|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138966587|NCT00967707|Analgesics|analgesics|mesh-ancestor
138966588|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
138966589|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966590|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966591|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
138966592|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138966593|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138799700|NCT00954174|Paclitaxel|paclitaxel|mesh-list
138966594|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138966595|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138966596|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138966597|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138966599|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966600|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
138966601|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138966602|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966603|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
138966604|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
138966605|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138966606|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138966607|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138579895|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
138966608|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138966610|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138966611|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138966612|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966613|NCT00845598|Fluticasone|fluticasone|mesh-list
138966614|NCT00845598|Xhance|xhance|mesh-list
138966615|NCT00845598|Azelastine|azelastine|mesh-list
138966616|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138966617|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138966618|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
138966619|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579948|NCT00126542|Bevacizumab|bevacizumab|mesh-list
138966620|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966621|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138966622|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
138966623|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
138966624|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138799723|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
138966625|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138966626|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966627|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966628|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138966629|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138966630|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
138966631|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
138966632|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138966633|NCT00251719|Lansoprazole|lansoprazole|mesh-list
138966634|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
138966635|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138966636|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138966637|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138966638|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966639|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966640|NCT00845754|Ketorolac|ketorolac|mesh-list
138966641|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138966642|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138966643|NCT00845754|Analgesics|analgesics|mesh-ancestor
138966644|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
138966645|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966646|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966647|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138966648|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966649|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138966650|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966651|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966652|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138966653|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
138966654|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
138966655|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966656|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
138966657|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966658|NCT00841386|Riboflavin|riboflavin|mesh-list
138966659|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
138887225|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966660|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
138966661|NCT00841386|Vitamins|vitamins|mesh-ancestor
138966662|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
138966663|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966664|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138966665|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
138966666|NCT03952143|Insulin|insulin|mesh-list
138966667|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138966668|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
138966669|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
138966670|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138966671|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966672|NCT00968331|Rituximab|rituximab|mesh-list
138966673|NCT00968331|Lenalidomide|lenalidomide|mesh-list
138966674|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138966675|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966676|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
138966677|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966678|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966679|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138966680|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138966681|NCT00968331|Growth Substances|growth substances|mesh-ancestor
138966682|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
138966684|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
138966685|NCT00852228|Irinotecan|irinotecan|mesh-list
138966686|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138966687|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966688|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138966689|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138966690|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966691|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966692|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
138966693|NCT00267007|Hematinics|hematinics|mesh-ancestor
138966694|NCT00841854|Metronidazole|metronidazole|mesh-list
138966695|NCT00841854|Tetracycline|tetracycline|mesh-list
138966696|NCT00841854|Pantoprazole|pantoprazole|mesh-list
138966697|NCT00841854|Bismuth|bismuth|mesh-list
138966698|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966699|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138966700|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138966701|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138966702|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138966703|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138966704|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138966705|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966706|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966707|NCT00841854|Antacids|antacids|mesh-ancestor
138966708|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138966709|NCT00848562|Nicorandil|nicorandil|mesh-list
138966710|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138966711|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138966712|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
138966713|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
138966714|NCT00848562|Vitamins|vitamins|mesh-ancestor
138966715|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
138966716|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966717|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138966718|NCT02546154|Hematinics|hematinics|mesh-ancestor
138966719|NCT03943095|Fluorides|fluorides|mesh-list
138966720|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
138966721|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
138966722|NCT03943095|Protective Agents|protective agents|mesh-ancestor
138966723|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966724|NCT00848640|Sorafenib|sorafenib|mesh-list
138966725|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966726|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138580225|NCT01244659|Tacrolimus|tacrolimus|mesh-list
138966727|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966728|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966729|NCT00968565|Citric Acid|citric acid|mesh-list
138966730|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
138966731|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
138887226|NCT02713763|Sunitinib|sunitinib|mesh-list
138966732|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138966733|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
138966734|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
138966735|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966737|NCT00848796|Calcium heparin|calcium heparin|mesh-list
138966738|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
138966739|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138966740|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138966741|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966742|NCT00965289|Rituximab|rituximab|mesh-list
138966743|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138966744|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966745|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
138966746|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966747|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966748|NCT04042506|Nivolumab|nivolumab|mesh-list
138580360|NCT00496600|Everolimus|everolimus|mesh-list
138966749|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138966750|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966751|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138966752|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966753|NCT00251641|Infliximab|infliximab|mesh-list
138966754|NCT00251641|Methotrexate|methotrexate|mesh-list
138966755|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138966756|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
138966757|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138966758|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966759|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138966760|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
138966761|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966762|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966763|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
138966764|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966765|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138966766|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966767|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
138966768|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966769|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138966770|NCT00251641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138966771|NCT00251641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138966772|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138966773|NCT00250705|Aripiprazole|aripiprazole|mesh-list
138966774|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
138966775|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138966776|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138966777|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138966778|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138966779|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966780|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
138966781|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
138966782|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138966783|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966784|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138966785|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138966786|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
138966787|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138966788|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138966789|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138966790|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138966791|NCT00849030|Tamoxifen|tamoxifen|mesh-list
138966792|NCT00849030|Anastrozole|anastrozole|mesh-list
138966793|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138966794|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
138580525|NCT00402584|Sibutramine|sibutramine|mesh-list
138966795|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966796|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966797|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138966798|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966799|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138966800|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138966801|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138966802|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138966803|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138966804|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966805|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966806|NCT00842400|Metformin|metformin|mesh-list
138966807|NCT00842400|Probenecid|probenecid|mesh-list
138966808|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138966809|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966810|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
138966811|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
138717647|NCT00564941|Deferasirox|deferasirox|mesh-list
138966812|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966814|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966815|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966816|NCT00849264|Fluorouracil|fluorouracil|mesh-list
138966817|NCT00849264|Endostar protein|endostar protein|mesh-list
138966818|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
138966819|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966820|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138966821|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966822|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966824|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966825|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138966826|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138966827|NCT00849264|Growth Substances|growth substances|mesh-ancestor
138966828|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
138966829|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
138966830|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138966831|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966832|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
138966833|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138966834|NCT00842556|Glimepiride|glimepiride|mesh-list
138966835|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138966836|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966837|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138966838|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966839|NCT00842556|Incretins|incretins|mesh-ancestor
138966840|NCT00842556|Hormones|hormones|mesh-ancestor
138966841|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966842|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138966843|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
138966844|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966845|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138966846|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966847|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
138966848|NCT00849966|Celecoxib|celecoxib|mesh-list
138966849|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138966850|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138966851|NCT00849966|Analgesics|analgesics|mesh-ancestor
138966852|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
138966853|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966854|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966855|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138966856|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966857|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138966858|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138966859|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966860|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966861|NCT00853008|Cytarabine|cytarabine|mesh-list
138966862|NCT00853008|Dexamethasone|dexamethasone|mesh-list
138966863|NCT00853008|Prednisone|prednisone|mesh-list
138966864|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
138966865|NCT00853008|Methotrexate|methotrexate|mesh-list
138966866|NCT00853008|Vincristine|vincristine|mesh-list
138966868|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
138966869|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
138966870|NCT00853008|Teniposide|teniposide|mesh-list
138966871|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138966872|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
138966873|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
138966874|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966875|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966876|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138966877|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
138966878|NCT00853008|Hormones|hormones|mesh-ancestor
138966879|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138966880|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138966881|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966882|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138717725|NCT00477165|Citalopram|citalopram|mesh-list
138966883|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
138966884|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138966885|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138966886|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
138966887|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966888|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
138966889|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966890|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138966891|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966892|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
138966893|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966894|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138966895|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
138966896|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966897|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138966898|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
138966899|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
138966900|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
138966901|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138966902|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138966903|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138580755|NCT00127985|Hormones|hormones|mesh-ancestor
138966904|NCT00853008|Analgesics|analgesics|mesh-ancestor
138966905|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
138966906|NCT02545530|Clonidine|clonidine|mesh-list
138966907|NCT02545530|Analgesics|analgesics|mesh-ancestor
138966908|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
138966909|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966910|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966911|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138966912|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
138966913|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
138966914|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138966915|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138966916|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138966917|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
138966918|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138966919|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966920|NCT00853320|Oxycodone|oxycodone|mesh-list
138966922|NCT00853320|Narcotics|narcotics|mesh-ancestor
138799975|NCT04202367|Bupivacaine|bupivacaine|mesh-list
138966923|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138966924|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966925|NCT00853320|Analgesics|analgesics|mesh-ancestor
138966926|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
138966927|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966928|NCT00547521|Methotrexate|methotrexate|mesh-list
138966929|NCT00547521|Abatacept|abatacept|mesh-list
138966930|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138966931|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
138966932|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138966933|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966934|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138966935|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
138966936|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966937|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966938|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
138966939|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966940|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138966941|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138966942|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
138966943|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966944|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138966945|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138966946|NCT00547521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138966947|NCT00850044|Ritonavir|ritonavir|mesh-list
138966948|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138966949|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138966950|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
138966951|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966952|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966953|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138966954|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138966955|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
138966956|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966957|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138966958|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138966959|NCT00266227|Rituximab|rituximab|mesh-list
138966960|NCT00266227|Methotrexate|methotrexate|mesh-list
138580830|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
138966961|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138966963|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
138966964|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966965|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138966966|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138966967|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
138966968|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138966969|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138966970|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
138966971|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138966972|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
138966973|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138966974|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138966975|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138580869|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799994|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138966976|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138966977|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
138966978|NCT00968877|Vitamin D|vitamin d|mesh-list
138966979|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138966980|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966981|NCT00968877|Vitamins|vitamins|mesh-ancestor
138966982|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
138966983|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138966984|NCT00850122|Cefazolin|cefazolin|mesh-list
138966985|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138966986|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138966987|NCT00968955|Ropivacaine|ropivacaine|mesh-list
138966988|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
138966989|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
138966990|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138966991|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966992|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
138966993|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138966994|NCT00853554|Hydromorphone|hydromorphone|mesh-list
138966995|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138966996|NCT00853554|Narcotics|narcotics|mesh-ancestor
138966997|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138966998|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138966999|NCT00853554|Analgesics|analgesics|mesh-ancestor
138967000|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
138967001|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967002|NCT00969033|Irinotecan|irinotecan|mesh-list
138967003|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138967004|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138967005|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967006|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967007|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967008|NCT00573768|Diclofenac|diclofenac|mesh-list
138967009|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138967010|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138967011|NCT00573768|Analgesics|analgesics|mesh-ancestor
138967012|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
138967013|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967014|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967015|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138967016|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138967017|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138967018|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967019|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967021|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138967022|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
139001721|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138967023|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967024|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967025|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138967026|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138967027|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
138581037|NCT00502060|Cediranib|cediranib|mesh-list
138967028|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967029|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967031|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
138967032|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138967033|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138967034|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138717868|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138967035|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138967036|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967037|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
138967038|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967039|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967041|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
138967042|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967043|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138967044|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138967045|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138967046|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967047|NCT00853944|Incretins|incretins|mesh-ancestor
138967048|NCT00853944|Hormones|hormones|mesh-ancestor
138967049|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967050|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
138967051|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581110|NCT00502567|Antidotes|antidotes|mesh-ancestor
138967052|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967053|NCT02545452|Anastrozole|anastrozole|mesh-list
138967054|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
138967055|NCT02545452|Nonoxynol|nonoxynol|mesh-list
138967056|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138967057|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967058|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138967059|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138967060|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967061|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967062|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138967063|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
138967064|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967065|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967066|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138967067|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
138967068|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139001758|NCT00766181|Lidocaine|lidocaine|mesh-list
138967069|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138967070|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138967071|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138967072|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138967073|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138967074|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138967075|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
138967076|NCT00547365|Antibodies|antibodies|mesh-list
138967077|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
138967078|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138967079|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138967080|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
138967081|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967082|NCT00854178|Anesthetics|anesthetics|mesh-list
138967083|NCT00854178|Isoflurane|isoflurane|mesh-list
138967084|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967085|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967086|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
138967087|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138967088|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
138967089|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
138967090|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138967091|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
138967092|NCT00850746|Z 338|z 338|mesh-list
138967093|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138967094|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138967095|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138967096|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138967097|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967098|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967099|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967100|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967101|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138967102|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
138967103|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967104|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138967105|NCT00969813|Tofacitinib|tofacitinib|mesh-list
138967106|NCT00969813|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138967107|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138967108|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967109|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967111|NCT00854256|Mitomycin|mitomycin|mesh-list
138967112|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138967113|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967114|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
138967115|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967116|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139001779|NCT00418522|Insulin|insulin|mesh-list
138967117|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967119|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138967120|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138967121|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967122|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
138967123|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967125|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138967126|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967127|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967128|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138967129|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
138967130|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
138967131|NCT00861276|Nicotine|nicotine|mesh-list
138967132|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138967133|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
138967134|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967135|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967136|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138967137|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138967138|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
138967139|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967140|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967141|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138967142|NCT02544828|Hematinics|hematinics|mesh-ancestor
138967143|NCT00861510|ON 01910|on 01910|mesh-list
138967144|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967145|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138967146|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967147|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967148|NCT01095003|Capecitabine|capecitabine|mesh-list
138967149|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138967150|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
138967151|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967152|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967153|NCT00854646|ON 01910|on 01910|mesh-list
138967154|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967155|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138967156|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967157|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967159|NCT00856362|Midazolam|midazolam|mesh-list
138967160|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138967161|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138967162|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967163|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967164|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138967165|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138967166|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138967167|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138967168|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
138967169|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
138967170|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
139001819|NCT00762671|Ebselen|ebselen|mesh-list
138967172|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967173|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967174|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
138967175|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138967176|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138967177|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
138967178|NCT00854802|Ribavirin|ribavirin|mesh-list
138967179|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138967180|NCT00854802|Cyclosporine|cyclosporine|mesh-list
138967181|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
138967182|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718018|NCT00583193|Analgesics|analgesics|mesh-ancestor
138967183|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
138967185|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
138967186|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
138967187|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967188|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138967189|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
138967190|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967191|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138967192|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138967193|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
138967194|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138967195|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138967196|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
138967197|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138967198|NCT00966771|Copper|copper|mesh-list
138967199|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
138967200|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138967201|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
138967202|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138967203|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967204|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138967205|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138967206|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138967207|NCT00966771|Trace Elements|trace elements|mesh-ancestor
138967208|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
138967209|NCT00856596|Sertaconazole|sertaconazole|mesh-list
138967210|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
138967211|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138967212|NCT00855114|Everolimus|everolimus|mesh-list
138967213|NCT00855114|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138967214|NCT00855114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138967215|NCT00855114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967216|NCT00855114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967217|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138967218|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
138967219|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967220|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967221|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
138967222|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138967223|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
138967224|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138967225|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
138967226|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001836|NCT02558387|Nintedanib|nintedanib|mesh-list
138967227|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967228|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138967229|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
138967230|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
138967231|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138967232|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
138967233|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967234|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967235|NCT00970905|Ondansetron|ondansetron|mesh-list
138967236|NCT00970905|Aprepitant|aprepitant|mesh-list
138967237|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
138967238|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
138967239|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967240|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967241|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138967242|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
138967243|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
138967244|NCT00970905|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138967245|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138967246|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
138967247|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967248|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967249|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138967250|NCT00619476|Gabapentin|gabapentin|mesh-list
138967251|NCT00619476|Analgesics|analgesics|mesh-ancestor
138967252|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
138967253|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967254|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967255|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
138967256|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138967257|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138967258|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967259|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138967260|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138967261|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138967262|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138581780|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
138967263|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967264|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
138967265|NCT00973713|Everolimus|everolimus|mesh-list
138967266|NCT00973713|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138967267|NCT00973713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138967268|NCT00973713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967269|NCT00973713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967270|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138967271|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
138967272|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967273|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967274|NCT00857142|Oxymorphone|oxymorphone|mesh-list
138967275|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138967276|NCT00857142|Narcotics|narcotics|mesh-ancestor
138967277|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967278|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967279|NCT00857142|Analgesics|analgesics|mesh-ancestor
138967280|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
138967281|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967282|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138967283|NCT00865176|Eplerenone|eplerenone|mesh-list
138967284|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138967285|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
138967286|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967287|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967288|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138967289|NCT00865176|Diuretics|diuretics|mesh-ancestor
138967290|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
138967291|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138967292|NCT00973869|Curcumin|curcumin|mesh-list
138967293|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138967294|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138967295|NCT00973869|Analgesics|analgesics|mesh-ancestor
138967296|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
138967297|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967298|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967299|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138800191|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
138967302|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967303|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967304|NCT00959439|Naproxen|naproxen|mesh-list
138967305|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138967306|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138967307|NCT00959439|Analgesics|analgesics|mesh-ancestor
138967308|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
138967309|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967310|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967311|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138967312|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138967313|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
138967314|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138967315|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581902|NCT00139815|PENTA|penta|mesh-list
138967316|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967317|NCT04041492|Vitamin D|vitamin d|mesh-list
138967318|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
138967319|NCT04041492|Vitamins|vitamins|mesh-ancestor
138967320|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
138967321|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967322|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138967323|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138967324|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
138967325|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
138967326|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967327|NCT00857376|Protective Agents|protective agents|mesh-ancestor
138967328|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967329|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
138967330|NCT00857376|Vitamins|vitamins|mesh-ancestor
138967331|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
138967332|NCT00618072|Metformin|metformin|mesh-list
138967333|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
138967334|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138967335|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967337|NCT00959517|Chloroquine|chloroquine|mesh-list
138967338|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
138967339|NCT00959517|Primaquine|primaquine|mesh-list
138967340|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
138967341|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138967342|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
138967343|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138967344|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138967345|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138967346|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967348|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
138967349|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138967350|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
138967352|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138967353|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138967354|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967355|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967356|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138967357|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138967358|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
138967359|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
138967360|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967361|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967362|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
138967363|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967364|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138967365|NCT00865410|Bupropion|bupropion|mesh-list
138967366|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138967367|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
138967368|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138967369|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138967370|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138967371|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138967372|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967373|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
138967374|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967375|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967376|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138967377|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138967378|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967379|NCT00974181|Paclitaxel|paclitaxel|mesh-list
138967380|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138967381|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138967382|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967383|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
138967384|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
138967385|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
138967386|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967387|NCT00971607|Sevoflurane|sevoflurane|mesh-list
138967388|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138967389|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138967390|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
138967391|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
138967392|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967393|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967394|NCT00971685|Dexamethasone|dexamethasone|mesh-list
138967395|NCT00971685|Lenalidomide|lenalidomide|mesh-list
138967396|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138967397|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
138967398|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
138967399|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800249|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
138967400|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967401|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138967402|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
138967403|NCT00971685|Hormones|hormones|mesh-ancestor
138967404|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967405|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138967406|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967407|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
138967408|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138718239|NCT00479817|Paclitaxel|paclitaxel|mesh-list
138967409|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138967410|NCT00971685|Growth Substances|growth substances|mesh-ancestor
138967411|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
138967413|NCT03861052|Tirzepatide|tirzepatide|mesh-list
138967414|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138967415|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967416|NCT03861052|Incretins|incretins|mesh-ancestor
138967417|NCT03861052|Hormones|hormones|mesh-ancestor
138967418|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967419|NCT00971763|Prednisolone|prednisolone|mesh-list
138967420|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
138967421|NCT00971763|Rituximab|rituximab|mesh-list
138967422|NCT00971763|Gemcitabine|gemcitabine|mesh-list
138967423|NCT00971763|Vincristine|vincristine|mesh-list
138967424|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138967425|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
138967426|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967427|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138582020|NCT00131300|Hylan|hylan|mesh-list
138967428|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138967429|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
138967430|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967431|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967432|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138967433|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138967434|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138967435|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
138967436|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138967437|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
138967438|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
138967439|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
138967440|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138967441|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
138967442|NCT00971763|Hormones|hormones|mesh-ancestor
138967443|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967444|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138967445|NCT00781196|Folic Acid|folic acid|mesh-list
138967446|NCT00781196|Hematinics|hematinics|mesh-ancestor
138967447|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
138967448|NCT00781196|Vitamins|vitamins|mesh-ancestor
138967449|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
138967450|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967451|NCT00865644|Imiquimod|imiquimod|mesh-list
138967452|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138967453|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
138967454|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967455|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967456|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
138967457|NCT00785330|Rituximab|rituximab|mesh-list
138967458|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138967459|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967460|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
138967461|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967462|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138967463|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138967464|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138967465|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967466|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138967467|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138967468|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138967469|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967470|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
138967471|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967472|NCT05279469|Fibrin fragment D|fibrin fragment d|mesh-list
138967473|NCT05279469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138582060|NCT03117309|Ipilimumab|ipilimumab|mesh-list
138967474|NCT05279469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138967475|NCT05279469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967476|NCT05279469|Hemostatics|hemostatics|mesh-ancestor
138967477|NCT05279469|Coagulants|coagulants|mesh-ancestor
138967478|NCT00790946|Valsartan|valsartan|mesh-list
138967479|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138967480|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138967481|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138967482|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967483|NCT05179239|Paclitaxel|paclitaxel|mesh-list
138967484|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138967486|NCT05179239|Carboplatin|carboplatin|mesh-list
138967487|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138967488|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967489|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
138967490|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
138967491|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
138967492|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967493|NCT00972075|Melatonin|melatonin|mesh-list
138967494|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
138967495|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967496|NCT00972075|Protective Agents|protective agents|mesh-ancestor
138967497|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582084|NCT00131768|Protective Agents|protective agents|mesh-ancestor
138967498|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967499|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138967500|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138967501|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
138967502|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967503|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967504|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138967505|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
138967506|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
138967507|NCT00974805|Hormones|hormones|mesh-ancestor
138967508|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967509|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
138967510|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
138967511|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138967512|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
138967513|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
138967514|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967515|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967516|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138967517|NCT00781352|Analgesics|analgesics|mesh-ancestor
138967518|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
138967519|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967520|NCT00791024|Lidocaine|lidocaine|mesh-list
138967521|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
138967522|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
138967523|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967524|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967525|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
138967526|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967527|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138967528|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138967529|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138967530|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138967531|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967532|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138967533|NCT03897244|Amoxicillin|amoxicillin|mesh-list
138967534|NCT03897244|Metronidazole|metronidazole|mesh-list
138967535|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138967536|NCT03897244|Rabeprazole|rabeprazole|mesh-list
138967537|NCT03897244|Bismuth|bismuth|mesh-list
138967538|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138967539|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138967540|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
138967541|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138967542|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138967543|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138967544|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138967545|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967546|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967547|NCT03897244|Antacids|antacids|mesh-ancestor
138967548|NCT00666536|Amlodipine|amlodipine|mesh-list
138967549|NCT00666536|Valsartan|valsartan|mesh-list
138967550|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
138967551|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138967552|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138967553|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138967554|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967555|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138967556|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967557|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
138967558|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138967559|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138967560|NCT00519532|Rotigotine|rotigotine|mesh-list
138967561|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
138967562|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
138967563|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582185|NCT00140478|Mifepristone|mifepristone|mesh-list
138967564|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967565|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967566|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138967567|NCT00666458|Saxagliptin|saxagliptin|mesh-list
138967568|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138967569|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967570|NCT00666458|Incretins|incretins|mesh-ancestor
138967571|NCT00666458|Hormones|hormones|mesh-ancestor
138967572|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967573|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138967574|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
138967575|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967576|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967577|NCT00974961|Bupivacaine|bupivacaine|mesh-list
138967578|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
138967579|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
138967580|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
138967581|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967582|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967583|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
138967584|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967585|NCT00511108|Pioglitazone|pioglitazone|mesh-list
138967586|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138967587|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138967588|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967589|NCT00511108|Incretins|incretins|mesh-ancestor
138967590|NCT00511108|Hormones|hormones|mesh-ancestor
138967591|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967592|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138967593|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
138967594|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967595|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967596|NCT00781586|Caffeine|caffeine|mesh-list
138967597|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967598|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138967599|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138967600|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582217|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
138967601|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967602|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138967603|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138967604|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
138967605|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967606|NCT00510952|Insulin|insulin|mesh-list
138967607|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138967608|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
138967609|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
138967610|NCT00510952|Protamines|protamines|mesh-list
138967611|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138967612|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967613|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
138967614|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967615|NCT00510952|Coagulants|coagulants|mesh-ancestor
138967616|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
138967617|NCT00617604|Alefacept|alefacept|mesh-list
138967618|NCT00617604|Tacrolimus|tacrolimus|mesh-list
138967619|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138967620|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
138967621|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967622|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138967623|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967624|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967625|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138967626|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967627|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138967628|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
138967629|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138967630|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138967631|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
138967632|NCT01012570|Adalimumab|adalimumab|mesh-list
138967633|NCT01012570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138967634|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138967635|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138967636|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138967637|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138967638|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
138967639|NCT00661622|Molgramostim|molgramostim|mesh-list
138967640|NCT00661622|Sargramostim|sargramostim|mesh-list
138967641|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
138967642|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967643|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967644|NCT00781820|Bifonazole|bifonazole|mesh-list
138967645|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
138967646|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138967648|NCT00786110|Sorafenib|sorafenib|mesh-list
138967649|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138967650|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967651|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
138967652|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
138967653|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
138967654|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967655|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138967656|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967657|NCT00791804|Fentanyl|fentanyl|mesh-list
138967658|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138967659|NCT00791804|Narcotics|narcotics|mesh-ancestor
138967660|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967661|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967662|NCT00791804|Analgesics|analgesics|mesh-ancestor
138967663|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
138967664|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967665|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138967666|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138967667|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
138967668|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
138967669|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
138967670|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
138967671|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
138967672|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967673|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967674|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138967675|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138967676|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
138967677|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
138967678|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967679|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967680|NCT00792350|Sorafenib|sorafenib|mesh-list
138967681|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967682|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138967683|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967684|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967685|NCT00792584|Efavirenz|efavirenz|mesh-list
138967686|NCT00792584|Etravirine|etravirine|mesh-list
138582285|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138967687|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138967688|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138967689|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967690|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967691|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
138967692|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138967693|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138967694|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138967695|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138967696|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139001969|NCT01035580|Curcumin|curcumin|mesh-list
138967697|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138967698|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138967699|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
138967700|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
138967701|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138967702|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
138967703|NCT04093752|Tirzepatide|tirzepatide|mesh-list
138967704|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138967705|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967706|NCT04093752|Incretins|incretins|mesh-ancestor
138967707|NCT04093752|Hormones|hormones|mesh-ancestor
138967708|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967709|NCT02544282|Acetaminophen|acetaminophen|mesh-list
138967710|NCT02544282|Sufentanil|sufentanil|mesh-list
138967711|NCT02544282|Tramadol|tramadol|mesh-list
138967712|NCT02544282|Pirinitramide|pirinitramide|mesh-list
138967713|NCT02544282|Propofol|propofol|mesh-list
138967714|NCT02544282|Sevoflurane|sevoflurane|mesh-list
138967715|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
138967716|NCT02544282|Atracurium|atracurium|mesh-list
138967717|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138967718|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967719|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967720|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138967721|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
138967722|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
138967723|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138967724|NCT02544282|Analgesics|analgesics|mesh-ancestor
138967725|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
138967726|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967727|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
138582372|NCT01244815|Asenapine|asenapine|mesh-list
138967728|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138967729|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138967730|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138967731|NCT02544282|Narcotics|narcotics|mesh-ancestor
138967732|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138967733|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
138800551|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
138967734|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138967735|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138967736|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138967737|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138967738|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138967739|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
138967740|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967741|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967742|NCT04041648|Treprostinil|treprostinil|mesh-list
138967743|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138967744|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138967745|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
138967746|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
138967747|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138967748|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
138967749|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967750|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138967751|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138967752|NCT00663962|Pregabalin|pregabalin|mesh-list
138967753|NCT00663962|Analgesics|analgesics|mesh-ancestor
138967754|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
138967755|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967756|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967757|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
138967758|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138967759|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138967760|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967761|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138967762|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138967763|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138967764|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967765|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138967766|NCT00858624|Ketamine|ketamine|mesh-list
138967767|NCT00858624|Analgesics|analgesics|mesh-ancestor
138967768|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
138967769|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967770|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967771|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138967772|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138967773|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
138967774|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
138967775|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967776|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138967777|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138967778|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967779|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967780|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138967781|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138967782|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967783|NCT00960453|Incretins|incretins|mesh-ancestor
138967784|NCT00960453|Hormones|hormones|mesh-ancestor
138967785|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967786|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138967787|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
138967788|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967789|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967790|NCT00265759|Letrozole|letrozole|mesh-list
138967791|NCT00265759|Anastrozole|anastrozole|mesh-list
138967792|NCT00265759|Exemestane|exemestane|mesh-list
138967793|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967794|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138967795|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138967796|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967797|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967798|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138967799|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
138967800|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967801|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967802|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138967803|NCT00972387|Prednisone|prednisone|mesh-list
138967804|NCT00972387|Prednisolone|prednisolone|mesh-list
138967805|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
138967806|NCT00972387|Doxorubicin|doxorubicin|mesh-list
138967807|NCT00972387|Vincristine|vincristine|mesh-list
138967808|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138967809|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
138967810|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967811|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138967812|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138967813|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
138967814|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967815|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967816|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138967817|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138967818|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138967819|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138967820|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967821|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138967822|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
138967824|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967825|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138967826|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138967827|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
138967828|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
138967829|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
138967830|NCT00744263|Vaccines|vaccines|mesh-list
138967831|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138967832|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
138967833|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967834|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
138967835|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138967836|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138967837|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
138967838|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967839|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967840|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967841|NCT00866736|Dasatinib|dasatinib|mesh-list
138967842|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967843|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138967844|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967845|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967846|NCT00792818|Ibuprofen|ibuprofen|mesh-list
138967847|NCT00792818|Curcumin|curcumin|mesh-list
138967848|NCT00792818|Turmeric extract|turmeric extract|mesh-list
138967849|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138582638|NCT00404508|Hydralazine|hydralazine|mesh-list
138967850|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138967851|NCT00792818|Analgesics|analgesics|mesh-ancestor
138967852|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
138967853|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188222|NCT03140722|Hematinics|hematinics|mesh-ancestor
138967854|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967855|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138967856|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138967857|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138718704|NCT04568265|Entecavir|entecavir|mesh-list
138967858|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967859|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967860|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967861|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
138967862|NCT00792818|Protective Agents|protective agents|mesh-ancestor
138967863|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
138967864|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138967865|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967866|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
138967867|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967868|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
138967869|NCT00975351|Vitamins|vitamins|mesh-ancestor
138967870|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
138967871|NCT01071187|Varenicline|varenicline|mesh-list
138967872|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138967873|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138967874|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
138967875|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967876|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967877|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967878|NCT00618774|Amlodipine|amlodipine|mesh-list
138967879|NCT00618774|Telmisartan|telmisartan|mesh-list
138967880|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138967881|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138967882|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138967883|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967884|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138967885|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967886|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
138967887|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138967888|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138967889|NCT00917345|Captopril|captopril|mesh-list
138967890|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138800703|NCT00682630|Artesunate|artesunate|mesh-list
138967892|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967893|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967894|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138967895|NCT00793052|Dexamethasone|dexamethasone|mesh-list
138967896|NCT00793052|Etoricoxib|etoricoxib|mesh-list
138967897|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138967898|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
138967899|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
138967900|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967901|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967902|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138967903|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
138967904|NCT00793052|Hormones|hormones|mesh-ancestor
138967905|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138967906|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138967907|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967908|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138967909|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138967910|NCT00793052|Analgesics|analgesics|mesh-ancestor
138967911|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
138967912|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138967913|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138967914|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138967915|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967916|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967917|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138967918|NCT02555852|Esomeprazole|esomeprazole|mesh-list
138967919|NCT02555852|Omeprazole|omeprazole|mesh-list
138967920|NCT02555852|Rabeprazole|rabeprazole|mesh-list
138967921|NCT02555852|Pantoprazole|pantoprazole|mesh-list
138967922|NCT02555852|Lansoprazole|lansoprazole|mesh-list
138967923|NCT02555852|Famotidine|famotidine|mesh-list
138967924|NCT02555852|Ranitidine|ranitidine|mesh-list
138967925|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138967926|NCT02555852|Cimetidine|cimetidine|mesh-list
138967927|NCT02555852|Nizatidine|nizatidine|mesh-list
138967928|NCT02555852|Lafutidine|lafutidine|mesh-list
138967929|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
138967930|NCT02555852|Bismuth|bismuth|mesh-list
138967931|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138967932|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
138718766|NCT00590408|Ubiquinone|ubiquinone|mesh-list
138967933|NCT02555852|Histamine|histamine|mesh-list
138967934|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
138967935|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967936|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138582755|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
138967937|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138967938|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967939|NCT02555852|Antacids|antacids|mesh-ancestor
138967940|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
138967941|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
138967942|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138967943|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800745|NCT00683176|Choline|choline|mesh-list
138967944|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
138967945|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138967946|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138967947|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138967948|NCT04091009|Buprenorphine|buprenorphine|mesh-list
138967949|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138967950|NCT04091009|Naloxone|naloxone|mesh-list
138967951|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138967952|NCT04091009|Narcotics|narcotics|mesh-ancestor
139002016|NCT00401830|Lacosamide|lacosamide|mesh-list
138967953|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967954|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967955|NCT04091009|Analgesics|analgesics|mesh-ancestor
138967956|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
138967957|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138967958|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138967959|NCT02597231|Melatonin|melatonin|mesh-list
138967960|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
138967961|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967962|NCT02597231|Protective Agents|protective agents|mesh-ancestor
138967963|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967964|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138967965|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
138967966|NCT00545571|Hematinics|hematinics|mesh-ancestor
138967967|NCT00783380|Vaccines|vaccines|mesh-list
138967968|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
138967969|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967970|NCT04008225|Dimercaprol|dimercaprol|mesh-list
138967972|NCT04008225|Sequestering Agents|sequestering agents|mesh-ancestor
138967973|NCT04008225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967974|NCT00748709|Afatinib|afatinib|mesh-list
138967975|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967976|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138967977|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138967978|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967979|NCT02597309|Canagliflozin|canagliflozin|mesh-list
138967980|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138967981|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967982|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138967983|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967984|NCT00863148|Busulfan|busulfan|mesh-list
138967985|NCT00863148|Clofarabine|clofarabine|mesh-list
138967986|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
138967987|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138967988|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138967989|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
138967990|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138967991|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138967992|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138967993|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138967994|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138967995|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
138967996|NCT00786734|Pitavastatin|pitavastatin|mesh-list
138967997|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138967998|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138967999|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138968000|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
138968001|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968002|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968003|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138968004|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
138968005|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138968006|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968007|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968008|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138968009|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138968010|NCT00867126|Pioglitazone|pioglitazone|mesh-list
138968011|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138968012|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968013|NCT00748553|Paclitaxel|paclitaxel|mesh-list
138968014|NCT00748553|Azacitidine|azacitidine|mesh-list
138968015|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138968016|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138968017|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968018|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
138968019|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
138968020|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
138968021|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968022|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138968023|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
138968024|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968025|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
138968026|NCT00661388|Hematinics|hematinics|mesh-ancestor
138968027|NCT00972855|Bicalutamide|bicalutamide|mesh-list
138968028|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
138968029|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
139039544|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968030|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968031|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968032|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968033|NCT00972933|Ipilimumab|ipilimumab|mesh-list
138968034|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138968035|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968036|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138968037|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968038|NCT00263575|Fentanyl|fentanyl|mesh-list
138968039|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138968040|NCT00263575|Narcotics|narcotics|mesh-ancestor
138968041|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138968042|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968043|NCT00263575|Analgesics|analgesics|mesh-ancestor
138968044|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
138968045|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968046|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138968047|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138968048|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
138968049|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
138968050|NCT00975663|Tacrolimus|tacrolimus|mesh-list
138968051|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968052|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
138968053|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968054|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138968055|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968056|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968057|NCT00570128|Donepezil|donepezil|mesh-list
138968058|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138968059|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968060|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968061|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
138968062|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968063|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968064|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
138968065|NCT00960921|Iron|iron|mesh-list
138968066|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138968067|NCT00960921|Trace Elements|trace elements|mesh-ancestor
138968068|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
138968069|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968070|NCT00960921|Hematinics|hematinics|mesh-ancestor
138968071|NCT00863460|Cytarabine|cytarabine|mesh-list
138968072|NCT00863460|Prednisone|prednisone|mesh-list
138968073|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
138968074|NCT00863460|Busulfan|busulfan|mesh-list
138968075|NCT00863460|Thiotepa|thiotepa|mesh-list
138968076|NCT00863460|Carmustine|carmustine|mesh-list
138968077|NCT00863460|Methotrexate|methotrexate|mesh-list
138968078|NCT00863460|Etoposide|etoposide|mesh-list
138968079|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968080|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
138968081|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968082|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138968083|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139002037|NCT00401752|Ranitidine|ranitidine|mesh-list
138968084|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
138968085|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968086|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968087|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138968088|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138968090|NCT00863460|Hormones|hormones|mesh-ancestor
138968091|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968092|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138968093|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138968094|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
138968095|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138968096|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138968097|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
138968098|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
138968099|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968100|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138968101|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138968102|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138968103|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138968104|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138968105|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
138968106|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968107|NCT00262951|Interferons|interferons|mesh-list
138968108|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
138968109|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
138968110|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138968111|NCT00262951|Cisplatin|cisplatin|mesh-list
138968112|NCT00262951|Fluorouracil|fluorouracil|mesh-list
138968113|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968114|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
138968115|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968116|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138968117|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968118|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
138968119|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968120|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
138968121|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968122|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
138968123|NCT02597153|Analgesics|analgesics|mesh-ancestor
138968124|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
138968125|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968126|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968127|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968128|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138968129|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138968130|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968131|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968132|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
138968133|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138968134|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
138968135|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138968136|NCT00262873|Bortezomib|bortezomib|mesh-list
138968137|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968138|NCT00975819|Sirolimus|sirolimus|mesh-list
138968139|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138968140|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968141|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138968142|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968143|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
138968144|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968145|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
138968146|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968147|NCT00859872|Haloperidol|haloperidol|mesh-list
138968148|NCT00859872|Risperidone|risperidone|mesh-list
138968149|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
138968150|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138968151|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
138968152|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968153|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968154|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968155|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138968156|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138968157|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138968158|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138968159|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138968160|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
138968161|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
138968162|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
138968163|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968164|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138968165|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138968167|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138968168|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968169|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
138968170|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
138968171|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
139002090|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138968172|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968173|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
138968174|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968175|NCT05147493|Dexamethasone|dexamethasone|mesh-list
138968176|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
138968177|NCT05147493|Lenalidomide|lenalidomide|mesh-list
138968178|NCT05147493|Bortezomib|bortezomib|mesh-list
138968179|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968180|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
138968181|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968182|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138968183|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138968184|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
138968185|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968186|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968187|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138968188|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138968189|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
138968190|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
138968191|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968192|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138968193|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
138968194|NCT05147493|Hormones|hormones|mesh-ancestor
138968195|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968196|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138968197|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138968198|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138968199|NCT05147493|Growth Substances|growth substances|mesh-ancestor
138968200|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
138968201|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138968202|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138968203|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968204|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138968205|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138968206|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138968207|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968208|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
138968209|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968210|NCT03974425|Aflibercept|aflibercept|mesh-list
138968211|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138968212|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138968213|NCT03974425|Growth Substances|growth substances|mesh-ancestor
138968214|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968215|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
138968216|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968217|NCT00975897|Leucovorin|leucovorin|mesh-list
138968218|NCT00975897|Bevacizumab|bevacizumab|mesh-list
138968219|NCT00975897|Cetuximab|cetuximab|mesh-list
138968220|NCT00975897|Fluorouracil|fluorouracil|mesh-list
138968221|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
138968222|NCT00975897|Irinotecan|irinotecan|mesh-list
138968223|NCT00975897|Calcium|calcium|mesh-list
138968224|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
138968225|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138968226|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968227|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138968228|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138968229|NCT00975897|Growth Substances|growth substances|mesh-ancestor
138968230|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968231|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
138968232|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138582956|NCT04725357|Meloxicam|meloxicam|mesh-list
138968233|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
138968234|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968235|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138968236|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968237|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
138968238|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138968239|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138968240|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968241|NCT00975897|Antidotes|antidotes|mesh-ancestor
138968242|NCT00975897|Protective Agents|protective agents|mesh-ancestor
138968243|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
138968245|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
138968246|NCT00867672|Decitabine|decitabine|mesh-list
138968247|NCT00867672|Tretinoin|tretinoin|mesh-list
138968248|NCT00867672|Valproic Acid|valproic acid|mesh-list
138968249|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138968250|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
138968251|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968252|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968253|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968254|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
138968255|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
138968256|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
138968257|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
138968258|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968259|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968260|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
138968261|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138968262|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138968263|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138968264|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
138968265|NCT00783926|Vaccines|vaccines|mesh-list
138968266|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
138968267|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968268|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
138968269|NCT00783926|Coagulants|coagulants|mesh-ancestor
138968270|NCT01071499|Morphine|morphine|mesh-list
138968271|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138968272|NCT01071499|Narcotics|narcotics|mesh-ancestor
138968273|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138968274|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968275|NCT01071499|Analgesics|analgesics|mesh-ancestor
138968276|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
138968277|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968278|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
138968279|NCT00961155|Montelukast|montelukast|mesh-list
138968280|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138968281|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
138968282|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968283|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968284|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138968285|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
138968286|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138968287|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138968288|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138968289|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
138968290|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968291|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968292|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138968293|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
138968294|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968295|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138968296|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138968297|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138968298|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138968299|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138968300|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138968301|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968302|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
138968303|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968304|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968305|NCT00973245|Warfarin|warfarin|mesh-list
138968306|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
138968307|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
138968308|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138968309|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
138968310|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138968311|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
138968312|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968313|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968314|NCT00793754|Aspirin|aspirin|mesh-list
138968315|NCT00793754|Atorvastatin|atorvastatin|mesh-list
138968316|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138968317|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138968318|NCT00793754|Analgesics|analgesics|mesh-ancestor
138968319|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
138968320|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968321|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968322|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138968323|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138968324|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138968325|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138968326|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968327|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138968328|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138968329|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968330|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
138968331|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138968332|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138968333|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
138968334|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138968335|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138968336|NCT02596763|Baclofen|baclofen|mesh-list
138968337|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138968338|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968339|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138968340|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968341|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138968342|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
138968343|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
138968344|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968345|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968346|NCT00973323|Warfarin|warfarin|mesh-list
138968347|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
138968348|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
138968349|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138968350|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
138968351|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138968352|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
138968353|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968354|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968355|NCT00793988|Anesthetics|anesthetics|mesh-list
138968356|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138968357|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968358|NCT00973401|Insulin|insulin|mesh-list
138968359|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138968360|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968361|NCT04040322|Iloprost|iloprost|mesh-list
138968362|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138968363|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
138968364|NCT00787436|Thalidomide|thalidomide|mesh-list
138968365|NCT00787436|Timolol|timolol|mesh-list
138968366|NCT00787436|Propranolol|propranolol|mesh-list
138968367|NCT00787436|Nadolol|nadolol|mesh-list
138968368|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968369|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
138968370|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968371|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
138968372|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139039545|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
138968373|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968374|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138968375|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138968376|NCT00787436|Growth Substances|growth substances|mesh-ancestor
138968377|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
138968378|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800979|NCT00939510|Lenalidomide|lenalidomide|mesh-list
138968379|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138968380|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138968381|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
138968382|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968383|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968384|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138968385|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138968386|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
138968387|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
138968388|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
138583139|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
138968389|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968390|NCT03945981|Lamivudine|lamivudine|mesh-list
138968391|NCT03945981|Dolutegravir|dolutegravir|mesh-list
138968392|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138968393|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138968394|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968395|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968396|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
138968397|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138968398|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138968399|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138968400|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138968401|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138968402|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
138968403|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968404|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
138968405|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968406|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968407|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138968408|NCT00979563|Irinotecan|irinotecan|mesh-list
138968409|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138968410|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138968411|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968412|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968413|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968414|NCT00745901|Drospirenone|drospirenone|mesh-list
138968415|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138968416|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138968417|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138968418|NCT00745901|Norgestimate|norgestimate|mesh-list
138968419|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138968420|NCT00745901|Estradiol|estradiol|mesh-list
138968421|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138968422|NCT00745901|Estrogens|estrogens|mesh-ancestor
138968423|NCT00745901|Hormones|hormones|mesh-ancestor
138968424|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968425|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968426|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138968427|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
138968428|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138968429|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138968430|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138583199|NCT00406146|Artesunate|artesunate|mesh-list
138968431|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138968432|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138968433|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
138968434|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138968435|NCT00745901|Diuretics|diuretics|mesh-ancestor
138968436|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
138968437|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138968438|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138968439|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138968440|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
138968441|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968442|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138968443|NCT00860340|Spironolactone|spironolactone|mesh-list
138968444|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138968445|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
138968446|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968447|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968448|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138968449|NCT00860340|Diuretics|diuretics|mesh-ancestor
138968450|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
138968451|NCT00784316|Metoprolol|metoprolol|mesh-list
138968452|NCT00784316|Amiodarone|amiodarone|mesh-list
138968453|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138968454|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138968455|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
138968456|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
138968457|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138968458|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968459|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138968460|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138968461|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138968462|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
138968463|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968464|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968465|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
139002164|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138968466|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138968467|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138968468|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138968469|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138968470|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138968472|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138968473|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138583230|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968474|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138968475|NCT00286429|Insulin|insulin|mesh-list
138968476|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138968477|NCT00286429|Alogliptin|alogliptin|mesh-list
138968478|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138968479|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968480|NCT00286429|Incretins|incretins|mesh-ancestor
138968481|NCT00286429|Hormones|hormones|mesh-ancestor
138968482|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138968483|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138968484|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
138968485|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968486|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968487|NCT00665444|Aripiprazole|aripiprazole|mesh-list
138968488|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
138968489|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138968490|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138968491|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138968492|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138968493|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968494|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
138968495|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
138968496|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968497|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968498|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138968499|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138968500|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
138968501|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138968502|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138968503|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138968504|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138968505|NCT00864006|Valproic Acid|valproic acid|mesh-list
138968506|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
138583294|NCT00136448|Cytarabine|cytarabine|mesh-list
138968507|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968508|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968509|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
138968510|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138968511|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968512|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
138968513|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138968514|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138968515|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138968516|NCT00860496|Cyclosporine|cyclosporine|mesh-list
138968517|NCT00860496|Tacrolimus|tacrolimus|mesh-list
138968518|NCT00860496|Cyclosporins|cyclosporins|mesh-list
138968519|NCT00860496|Tofacitinib|tofacitinib|mesh-list
138968520|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138968521|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
138968522|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138968523|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138968524|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138968525|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138968526|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
139002190|NCT01037140|Vitamin D|vitamin d|mesh-list
138711750|NCT00563472|Progesterone|progesterone|mesh-list
138711751|NCT00563472|Progestins|progestins|mesh-ancestor
138711752|NCT00563472|Hormones|hormones|mesh-ancestor
138711753|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138711754|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711755|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138711756|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138711757|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138711758|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
138711759|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138711760|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138711761|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138711762|NCT04679597|Capecitabine|capecitabine|mesh-list
138711763|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
138711764|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138711765|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
138711766|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711767|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711768|NCT04609397|Hemay005|hemay005|mesh-list
138711769|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
138711770|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138711771|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138711772|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711773|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711774|NCT04587947|Valsartan|valsartan|mesh-list
138711775|NCT04587947|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138711776|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138711777|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138711778|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138711793|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138711794|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138711795|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
138711796|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711797|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711798|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
138711799|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138711800|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138711801|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138711802|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
138711803|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138711804|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
138711805|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138711806|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
138711807|NCT00563589|Cyclosporine|cyclosporine|mesh-list
138711808|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
138711809|NCT00563589|Methotrexate|methotrexate|mesh-list
138711810|NCT00563589|Cyclosporins|cyclosporins|mesh-list
138711811|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138711812|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
138711813|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138711814|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711815|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138711816|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
138711817|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711818|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711819|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
138711820|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711821|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138711822|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079011|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139079012|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139079013|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
139079014|NCT00071396|Rituximab|rituximab|mesh-list
139079015|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
139079016|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139079017|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079018|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
139079019|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079020|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139079021|NCT03472534|Diacerein|diacerein|mesh-list
139079022|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079023|NCT03725020|Fluorides|fluorides|mesh-list
139079024|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
139079025|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
139079026|NCT03725020|Protective Agents|protective agents|mesh-ancestor
138711823|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
138711824|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138711825|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138711826|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
138711827|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711828|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138711829|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138711830|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138711831|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
138711832|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138711833|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
138711834|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138711835|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
138711836|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711837|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711838|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711839|NCT02204345|Paclitaxel|paclitaxel|mesh-list
138711840|NCT02204345|Carboplatin|carboplatin|mesh-list
138711841|NCT02204345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138711842|NCT02204345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711843|NCT02204345|Tubulin Modulators|tubulin modulators|mesh-ancestor
138711844|NCT02204345|Antimitotic Agents|antimitotic agents|mesh-ancestor
138711845|NCT02204345|Mitosis Modulators|mitosis modulators|mesh-ancestor
138711846|NCT02204345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711847|NCT02187302|Bevacizumab|bevacizumab|mesh-list
138711848|NCT02187302|Sunitinib|sunitinib|mesh-list
138711849|NCT02187302|Everolimus|everolimus|mesh-list
138711850|NCT02187302|Sorafenib|sorafenib|mesh-list
138711851|NCT02187302|Axitinib|axitinib|mesh-list
138711852|NCT02187302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138711853|NCT02187302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711854|NCT02187302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138711855|NCT02187302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138711856|NCT02187302|Growth Substances|growth substances|mesh-ancestor
139079027|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079028|NCT03721432|Pregabalin|pregabalin|mesh-list
139079029|NCT03721432|Analgesics|analgesics|mesh-ancestor
139079030|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
139079031|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079032|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079033|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
139079034|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139079035|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138711857|NCT02187302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711858|NCT02187302|Growth Inhibitors|growth inhibitors|mesh-ancestor
138711859|NCT02187302|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138711860|NCT02187302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138711861|NCT02187302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711862|NCT02187302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711863|NCT02187302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138711864|NCT02187302|Immunologic Factors|immunologic factors|mesh-ancestor
138711865|NCT02179151|CKD732|ckd732|mesh-list
138711866|NCT02179151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138711867|NCT02179151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138711868|NCT02179151|Growth Substances|growth substances|mesh-ancestor
138711869|NCT02179151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711870|NCT02179151|Growth Inhibitors|growth inhibitors|mesh-ancestor
138711871|NCT02179151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711872|NCT02160665|Tazarotene|tazarotene|mesh-list
138711873|NCT02160665|Dermatologic Agents|dermatologic agents|mesh-ancestor
138711874|NCT02160665|Keratolytic Agents|keratolytic agents|mesh-ancestor
138711875|NCT02138630|Capsaicin|capsaicin|mesh-list
138711876|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
138711877|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
138711878|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
138711879|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711880|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711882|NCT02137343|Rilotumumab|rilotumumab|mesh-list
138711883|NCT02137343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711884|NCT02137343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138711885|NCT02137343|Antimetabolites|antimetabolites|mesh-ancestor
138711886|NCT02137343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711887|NCT02137343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138711888|NCT02125253|Mometasone Furoate|mometasone furoate|mesh-list
138711889|NCT02125253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138711890|NCT02125253|Dermatologic Agents|dermatologic agents|mesh-ancestor
138711891|NCT02125253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138711901|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138711902|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
138711903|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711904|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138711905|NCT04611438|Cannabidiol|cannabidiol|mesh-list
138711906|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
138711907|NCT00563823|Vatalanib|vatalanib|mesh-list
138711908|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138711909|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711910|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711911|NCT00563862|Fluorouracil|fluorouracil|mesh-list
138711912|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711913|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
138711914|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711915|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138711916|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138711917|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
138711918|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711919|NCT04611711|Decitabine|decitabine|mesh-list
138711920|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138711921|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
138711922|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711923|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711924|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711925|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
138711926|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138711927|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
138711928|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711929|NCT02092922|Filanesib|filanesib|mesh-list
138711930|NCT02092922|Lenograstim|lenograstim|mesh-list
138711931|NCT02092922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138711932|NCT02092922|Immunologic Factors|immunologic factors|mesh-ancestor
138711933|NCT02092922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647723|NCT03784677|SOR-C13|sor-c13|mesh-list
139079036|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079037|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139079038|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139079039|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139079040|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139079041|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138711934|NCT02092922|Antimitotic Agents|antimitotic agents|mesh-ancestor
138711935|NCT02092922|Mitosis Modulators|mitosis modulators|mesh-ancestor
138711936|NCT02092922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711937|NCT02092922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711938|NCT02092454|Benzocaine|benzocaine|mesh-list
138711939|NCT02092454|Anesthetics, Local|anesthetics, local|mesh-ancestor
138711940|NCT02092454|Anesthetics|anesthetics|mesh-ancestor
138711941|NCT02092454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711942|NCT02092454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545844|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138711943|NCT02092454|Sensory System Agents|sensory system agents|mesh-ancestor
138711944|NCT02092454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711945|NCT02083289|Latanoprost|latanoprost|mesh-list
138711946|NCT02083289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138711947|NCT02083289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138711948|NCT02081300|Methyltestosterone|methyltestosterone|mesh-list
138711949|NCT02081300|Testosterone|testosterone|mesh-list
138711950|NCT02081300|Testosterone undecanoate|testosterone undecanoate|mesh-list
138711951|NCT02081300|Testosterone enanthate|testosterone enanthate|mesh-list
138711952|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138711953|NCT02081300|Androgens|androgens|mesh-ancestor
138711954|NCT02081300|Hormones|hormones|mesh-ancestor
138711955|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138711956|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711957|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138711958|NCT02081300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711959|NCT02081300|Anabolic Agents|anabolic agents|mesh-ancestor
139079042|NCT03469336|Betamethasone|betamethasone|mesh-list
139079043|NCT03469336|Calcipotriene|calcipotriene|mesh-list
139079044|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079045|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
139079046|NCT03469336|Hormones|hormones|mesh-ancestor
139079047|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139079048|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079049|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139079050|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
139079051|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
139079052|NCT03719560|Cytarabine|cytarabine|mesh-list
139079053|NCT03719560|Methotrexate|methotrexate|mesh-list
139079054|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139079055|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
139079056|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139079057|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079058|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139079059|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
139079060|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079061|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079062|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
139079063|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711960|NCT02074007|Benzocaine|benzocaine|mesh-list
138711961|NCT02074007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711962|NCT02074007|Anesthetics, Local|anesthetics, local|mesh-ancestor
138711963|NCT02074007|Anesthetics|anesthetics|mesh-ancestor
138711964|NCT02074007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711965|NCT02074007|Sensory System Agents|sensory system agents|mesh-ancestor
138711966|NCT02074007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711967|NCT02072954|Asenapine|asenapine|mesh-list
138711968|NCT02072954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138711969|NCT02072954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138711970|NCT02072954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711971|NCT02072954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711972|NCT02072954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138711973|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
138711974|NCT00554918|Prednisolone|prednisolone|mesh-list
138711975|NCT00554918|Docetaxel|docetaxel|mesh-list
138711976|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711977|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
138711978|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
138711979|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
138711980|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711981|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138711982|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
138711983|NCT00554918|Hormones|hormones|mesh-ancestor
138711984|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138711985|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711986|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138711987|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138711988|NCT04631874|Varenicline|varenicline|mesh-list
138711989|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138711990|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138711991|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
138711992|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139079064|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139079065|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079066|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
139079067|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139079068|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139079069|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
139079070|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139079071|NCT03469258|Pancrelipase|pancrelipase|mesh-list
139079073|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139079074|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
139079075|NCT00066170|Modafinil|modafinil|mesh-list
138711993|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711994|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711995|NCT02057315|Ketoprofen|ketoprofen|mesh-list
138711996|NCT02057315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138711997|NCT02057315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138711998|NCT02057315|Analgesics|analgesics|mesh-ancestor
138711999|NCT02057315|Sensory System Agents|sensory system agents|mesh-ancestor
138712000|NCT02057315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712001|NCT02057315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712002|NCT02057315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138712003|NCT02057315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138712004|NCT02057315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138801190|NCT04153084|Cathartics|cathartics|mesh-ancestor
138712005|NCT02057315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712006|NCT02057315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712007|NCT02047214|Bevacizumab|bevacizumab|mesh-list
138712008|NCT02047214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138712009|NCT02047214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712010|NCT02047214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138545851|NCT00413296|Levetiracetam|levetiracetam|mesh-list
138712011|NCT02047214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138712012|NCT02047214|Growth Substances|growth substances|mesh-ancestor
138712013|NCT02047214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712014|NCT02047214|Growth Inhibitors|growth inhibitors|mesh-ancestor
138712015|NCT02032277|Paclitaxel|paclitaxel|mesh-list
138712016|NCT02032277|Cyclophosphamide|cyclophosphamide|mesh-list
138712017|NCT02032277|Carboplatin|carboplatin|mesh-list
138712018|NCT02032277|Doxorubicin|doxorubicin|mesh-list
138712019|NCT02032277|Veliparib|veliparib|mesh-list
138712020|NCT02032277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138712021|NCT02032277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712022|NCT02032277|Tubulin Modulators|tubulin modulators|mesh-ancestor
138712023|NCT02032277|Antimitotic Agents|antimitotic agents|mesh-ancestor
138712024|NCT02032277|Mitosis Modulators|mitosis modulators|mesh-ancestor
138712025|NCT02032277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079076|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139079077|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079078|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139079079|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139079080|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138712026|NCT02032277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138712027|NCT02032277|Immunologic Factors|immunologic factors|mesh-ancestor
138712028|NCT02032277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712029|NCT02032277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138712030|NCT02032277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138712031|NCT02032277|Alkylating Agents|alkylating agents|mesh-ancestor
138712032|NCT02032277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138712033|NCT02032277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138712034|NCT02032277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138712035|NCT02032277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138712036|NCT02032277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712037|NCT02032277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138712038|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138712039|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
138712040|NCT00560976|Hematinics|hematinics|mesh-ancestor
138712041|NCT02026349|Favipiravir|favipiravir|mesh-list
138712042|NCT02026349|Antiviral Agents|antiviral agents|mesh-ancestor
138712043|NCT02026349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138712044|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
138712045|NCT04611126|Nivolumab|nivolumab|mesh-list
138712046|NCT04611126|Fludarabine|fludarabine|mesh-list
138712047|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
138712048|NCT04611126|Ipilimumab|ipilimumab|mesh-list
138712049|NCT04611126|Relatlimab|relatlimab|mesh-list
138712050|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138712051|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
138712052|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079081|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079082|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139079083|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139079084|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
139079086|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139079087|NCT00065468|Interferons|interferons|mesh-list
139079088|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
139079089|NCT00065468|Sirolimus|sirolimus|mesh-list
139079090|NCT00065468|Temsirolimus|temsirolimus|mesh-list
139079091|NCT00065468|MTOR Inhibitors|mtor inhibitors|mesh-list
139079092|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079093|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
139079094|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139079095|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
139079096|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079097|NCT00065468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139079098|NCT00065468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079099|NCT00065468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079100|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079101|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139079102|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139079103|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
139079104|NCT00071006|Axitinib|axitinib|mesh-list
139079105|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712053|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138712054|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138712055|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
138712056|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712057|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712058|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138712059|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138712060|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138712061|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138712062|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
138712063|NCT04611165|Nivolumab|nivolumab|mesh-list
138712064|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138712065|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712066|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138712067|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712068|NCT02014649|Laninamivir|laninamivir|mesh-list
138712069|NCT02014649|Zanamivir|zanamivir|mesh-list
138712070|NCT02014649|Antiviral Agents|antiviral agents|mesh-ancestor
138712071|NCT02014649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138712072|NCT02014649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712073|NCT02014649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712074|NCT02014142|Latanoprost|latanoprost|mesh-list
138712075|NCT02014142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138712076|NCT02014142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138712077|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138712078|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139079106|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139079107|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079108|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079109|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139079110|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139079111|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079112|NCT00094107|Axitinib|axitinib|mesh-list
139079113|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079114|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139079115|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079116|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079117|NCT00102063|Aripiprazole|aripiprazole|mesh-list
139079118|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
139079119|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138273274|NCT03557333|Analgesics|analgesics|mesh-ancestor
139079120|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139079121|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139079122|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139079123|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079124|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
139079125|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
139079126|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712079|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
138712080|NCT01998035|Azacitidine|azacitidine|mesh-list
138712081|NCT01998035|Romidepsin|romidepsin|mesh-list
138712082|NCT01998035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138712083|NCT01998035|Antimetabolites|antimetabolites|mesh-ancestor
138712084|NCT01998035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712085|NCT01998035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712086|NCT01998035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712087|NCT01998035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138712088|NCT01998035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138712089|NCT04611243|Vaccines|vaccines|mesh-list
138712090|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
138712091|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712092|NCT00564057|Candesartan|candesartan|mesh-list
138712093|NCT00564057|Candesartan cilexetil|candesartan cilexetil|mesh-list
138712094|NCT00564057|Lercanidipine|lercanidipine|mesh-list
138712095|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138712096|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138712097|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138712098|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712099|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138712100|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138801263|NCT00691912|Doxorubicin|doxorubicin|mesh-list
138712101|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139079127|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079128|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139079129|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139079130|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
139079131|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139079132|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139079133|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139079134|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139079135|NCT00065156|Lenalidomide|lenalidomide|mesh-list
139079136|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
139079137|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079138|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139079139|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139079140|NCT00065156|Growth Substances|growth substances|mesh-ancestor
139079141|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
139079142|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079143|NCT01094210|Fluorides|fluorides|mesh-list
139079144|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
139079145|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
139079146|NCT01094210|Protective Agents|protective agents|mesh-ancestor
139079147|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079148|NCT01094444|Vitamin K|vitamin k|mesh-list
139079149|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
139079150|NCT01094444|Vitamins|vitamins|mesh-ancestor
139079151|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
139079152|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079153|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139079154|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138712102|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712103|NCT04610541|Remdesivir|remdesivir|mesh-list
138712104|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
138712105|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712106|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
138712107|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138712108|NCT04677335|Lovastatin|lovastatin|mesh-list
138712109|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138712110|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138712111|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
138712112|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712113|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138712114|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138712115|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712116|NCT04630548|Copper|copper|mesh-list
138712117|NCT04630548|Trace Elements|trace elements|mesh-ancestor
138712118|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
138712119|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712120|NCT01975610|Spebrutinib|spebrutinib|mesh-list
138712121|NCT01975610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138712122|NCT01975610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712123|NCT01975610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712124|NCT01969838|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
138712125|NCT01969838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138712126|NCT01969838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712127|NCT01969838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712128|NCT01967810|Bevacizumab|bevacizumab|mesh-list
138712129|NCT01967810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138712130|NCT01967810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712131|NCT01967810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138712132|NCT01967810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138712133|NCT01967810|Growth Substances|growth substances|mesh-ancestor
138712134|NCT01967810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712135|NCT01967810|Growth Inhibitors|growth inhibitors|mesh-ancestor
138712136|NCT01165138|Fluticasone|fluticasone|mesh-list
138712137|NCT01165138|Xhance|xhance|mesh-list
138712139|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138712141|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712142|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712143|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138712144|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
138712145|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
138712146|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138712147|NCT00561054|Cetuximab|cetuximab|mesh-list
138712148|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138712149|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712150|NCT04206358|Molgramostim|molgramostim|mesh-list
138712151|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712152|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138712200|NCT01956812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712201|NCT01952990|Phenylephrine|phenylephrine|mesh-list
138712202|NCT01952990|Oxymetazoline|oxymetazoline|mesh-list
138712203|NCT01952990|Tetracaine|tetracaine|mesh-list
138712204|NCT01952990|Anesthetics, Local|anesthetics, local|mesh-ancestor
138712205|NCT01952990|Anesthetics|anesthetics|mesh-ancestor
138712206|NCT01952990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138712207|NCT01952990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712208|NCT01952990|Sensory System Agents|sensory system agents|mesh-ancestor
138712209|NCT01952990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712210|NCT01952990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138712211|NCT01952990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138712212|NCT01952990|Adrenergic Agents|adrenergic agents|mesh-ancestor
138712213|NCT01952990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712214|NCT01952990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712216|NCT01952990|Autonomic Agents|autonomic agents|mesh-ancestor
138712221|NCT01952990|Mydriatics|mydriatics|mesh-ancestor
138712261|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
138545889|NCT00226564|Analgesics|analgesics|mesh-ancestor
138712262|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138712263|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
138712264|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712265|NCT01941836|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138712267|NCT01941836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138712268|NCT01941836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138712269|NCT01941836|Antimetabolites|antimetabolites|mesh-ancestor
138712270|NCT01941836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712271|NCT01941836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138712272|NCT01941836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712273|NCT01941836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138712274|NCT01941836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712275|NCT04629885|Oxytocin|oxytocin|mesh-list
138712276|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
138712277|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138712278|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712279|NCT01163851|Bococizumab|bococizumab|mesh-list
138712280|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138712281|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138712282|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
138712283|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712313|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712314|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138712315|NCT01909427|Methotrexate|methotrexate|mesh-list
138712316|NCT01909427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138712317|NCT01909427|Abortifacient Agents|abortifacient agents|mesh-ancestor
138712318|NCT01909427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138712319|NCT01909427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712320|NCT01909427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138712321|NCT01909427|Antimetabolites|antimetabolites|mesh-ancestor
138545907|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
138712322|NCT01909427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712323|NCT01909427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712324|NCT01909427|Dermatologic Agents|dermatologic agents|mesh-ancestor
138712325|NCT01909427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712326|NCT01909427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138712327|NCT01909427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138712328|NCT01909427|Immunologic Factors|immunologic factors|mesh-ancestor
138712329|NCT01909427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138712330|NCT01909427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138712331|NCT04629573|Anesthetics|anesthetics|mesh-list
138801351|NCT00871780|Natalizumab|natalizumab|mesh-list
138712332|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138668644|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
138712333|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712334|NCT00564174|Aspirin|aspirin|mesh-list
138712335|NCT00564174|Heparin|heparin|mesh-list
138712336|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138712337|NCT00564174|Tinzaparin|tinzaparin|mesh-list
138712338|NCT00564174|Dalteparin|dalteparin|mesh-list
138712339|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138712340|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138712341|NCT00564174|Analgesics|analgesics|mesh-ancestor
138712354|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
138712355|NCT01163266|Vortioxetine|vortioxetine|mesh-list
138712356|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
138712357|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138712358|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138712359|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138712360|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138712361|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712362|NCT01163266|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138712363|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138712364|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138712365|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712366|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712367|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
138712368|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138712369|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138712370|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138712371|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138712372|NCT01873703|Azacitidine|azacitidine|mesh-list
138712373|NCT01873703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138712374|NCT01873703|Antimetabolites|antimetabolites|mesh-ancestor
138712375|NCT01873703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712376|NCT01873703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712377|NCT01873703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712379|NCT01870505|Exemestane|exemestane|mesh-list
138712380|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712381|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138712382|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138712383|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712384|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712385|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138712386|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
138712394|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138712395|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712396|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
138712397|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712398|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138712399|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712400|NCT01861847|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138712401|NCT01861847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138712402|NCT01861847|Immunologic Factors|immunologic factors|mesh-ancestor
138712403|NCT01861847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712404|NCT00564252|Finasteride|finasteride|mesh-list
138712405|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138712406|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138712407|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712408|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712409|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
138712410|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138712411|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712412|NCT00564252|Urological Agents|urological agents|mesh-ancestor
138712413|NCT04629144|Belimumab|belimumab|mesh-list
138712414|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138712415|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
138712416|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712417|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138712418|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
138712419|NCT01847573|Halofuginone|halofuginone|mesh-list
138712420|NCT01847573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712421|NCT01847573|Coccidiostats|coccidiostats|mesh-ancestor
138712422|NCT01847573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138712423|NCT01847573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138712424|NCT01847573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138712425|NCT01847573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138712426|NCT01847573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712427|NCT01847573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712428|NCT01847573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138712431|NCT01847573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712432|NCT01847573|Growth Inhibitors|growth inhibitors|mesh-ancestor
138712433|NCT04609254|Acetaminophen|acetaminophen|mesh-list
138712434|NCT04609254|Ibuprofen|ibuprofen|mesh-list
138712435|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138712436|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138712437|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138712438|NCT04609254|Analgesics|analgesics|mesh-ancestor
138712439|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
138712440|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712441|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712442|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138712443|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138712444|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138712445|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712446|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712447|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
138712448|NCT01846481|Cocaine|cocaine|mesh-list
138712449|NCT01846481|Anesthetics, Local|anesthetics, local|mesh-ancestor
138712450|NCT01846481|Anesthetics|anesthetics|mesh-ancestor
138712451|NCT01846481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138712452|NCT01846481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712453|NCT01846481|Sensory System Agents|sensory system agents|mesh-ancestor
139079155|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079157|NCT01094444|Coagulants|coagulants|mesh-ancestor
139079158|NCT00078819|Etanercept|etanercept|mesh-list
139079159|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139079160|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139079161|NCT00078819|Analgesics|analgesics|mesh-ancestor
139079162|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
139079163|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079164|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079165|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079166|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139079167|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139079168|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079169|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
139079170|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139079171|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139079172|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139079173|NCT00098865|Thalidomide|thalidomide|mesh-list
139079174|NCT00098865|Temozolomide|temozolomide|mesh-list
139079175|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139079177|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079178|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079179|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079180|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
139079181|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079182|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
139079183|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139079184|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139079185|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138712461|NCT01846481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712463|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712464|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138712465|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712466|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712467|NCT04676789|Pegaspargase|pegaspargase|mesh-list
138712468|NCT04676789|Antibodies|antibodies|mesh-list
138712469|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138712470|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
138712471|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712472|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712473|NCT01811576|Hormones|hormones|mesh-list
138712474|NCT01811576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138801436|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
138712475|NCT01811576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668790|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138712484|NCT01804829|Immunoglobulins|immunoglobulins|mesh-list
138712494|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138712495|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138712496|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712497|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712498|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
138712499|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712500|NCT01802723|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138712501|NCT01802723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138712502|NCT01802723|Autonomic Agents|autonomic agents|mesh-ancestor
138712503|NCT01802723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712504|NCT01802723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712505|NCT01802723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138712506|NCT01802723|Respiratory System Agents|respiratory system agents|mesh-ancestor
138712507|NCT01802723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138712508|NCT01802723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138712509|NCT01802723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138712510|NCT01802723|Adrenergic Agents|adrenergic agents|mesh-ancestor
138712511|NCT01802723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712512|NCT01802723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712513|NCT01789736|Travoprost|travoprost|mesh-list
138712514|NCT01789736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138712515|NCT01789736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138712516|NCT01789736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138712517|NCT00564330|Esomeprazole|esomeprazole|mesh-list
138712518|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138712519|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138712520|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138712521|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712522|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712524|NCT01779947|Estrogens|estrogens|mesh-ancestor
138712525|NCT01779947|Hormones|hormones|mesh-ancestor
138712526|NCT01779947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138712527|NCT01779947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712528|NCT00564408|Carbachol|carbachol|mesh-list
138712529|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138712533|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712534|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138712535|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
138712536|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712537|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712538|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138712540|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
138712541|NCT00564408|Protective Agents|protective agents|mesh-ancestor
138712542|NCT01773785|Docetaxel|docetaxel|mesh-list
138712543|NCT01773785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712544|NCT01773785|Tubulin Modulators|tubulin modulators|mesh-ancestor
138712545|NCT01773785|Antimitotic Agents|antimitotic agents|mesh-ancestor
138712546|NCT01773785|Mitosis Modulators|mitosis modulators|mesh-ancestor
138712547|NCT01773785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712548|NCT01758458|Interferons|interferons|mesh-list
138712549|NCT01758458|Aldesleukin|aldesleukin|mesh-list
138712550|NCT01758458|Interferon-beta|interferon-beta|mesh-list
138712551|NCT01758458|Interleukin-2|interleukin-2|mesh-list
138712552|NCT01758458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712553|NCT01758458|Antiviral Agents|antiviral agents|mesh-ancestor
138712554|NCT01758458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138712555|NCT01758458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138712556|NCT01758458|Analgesics|analgesics|mesh-ancestor
138712557|NCT01758458|Sensory System Agents|sensory system agents|mesh-ancestor
138712558|NCT01758458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712559|NCT01758458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712560|NCT01758458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138712561|NCT01758458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138712562|NCT01758458|Immunologic Factors|immunologic factors|mesh-ancestor
138712563|NCT04608981|Prednisolone|prednisolone|mesh-list
138712564|NCT04608981|Diclofenac|diclofenac|mesh-list
138712565|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079186|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139079187|NCT00098865|Growth Substances|growth substances|mesh-ancestor
139079188|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
139079189|NCT01084863|Paclitaxel|paclitaxel|mesh-list
139079190|NCT01084863|Trastuzumab|trastuzumab|mesh-list
139079191|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139079192|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079193|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
139079194|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
139079195|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
139079196|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079197|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138712566|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
138712567|NCT04608981|Hormones|hormones|mesh-ancestor
138712568|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138712569|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712570|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138712571|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712572|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712573|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138712574|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138712575|NCT04608981|Analgesics|analgesics|mesh-ancestor
138712576|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
138712577|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138712578|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138712579|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712580|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712581|NCT01737905|Epinephrine|epinephrine|mesh-list
138712582|NCT01737905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138712583|NCT01737905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138712584|NCT01737905|Adrenergic Agents|adrenergic agents|mesh-ancestor
138712585|NCT01737905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712586|NCT01737905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712587|NCT01737905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712588|NCT01737905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138712589|NCT01737905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138712590|NCT01737905|Autonomic Agents|autonomic agents|mesh-ancestor
138712591|NCT01737905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712592|NCT01737905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138712593|NCT01737905|Respiratory System Agents|respiratory system agents|mesh-ancestor
138712594|NCT01737905|Mydriatics|mydriatics|mesh-ancestor
138712595|NCT01737905|Sympathomimetics|sympathomimetics|mesh-ancestor
138712608|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138712609|NCT04608669|Analgesics|analgesics|mesh-ancestor
138712610|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
138712611|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712612|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712613|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
138712614|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138712615|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138712616|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138712617|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
138712618|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712619|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138712620|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138712621|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712623|NCT04600089|Analgesics|analgesics|mesh-ancestor
138712624|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
138712625|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712626|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712627|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138712628|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138712629|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
138712631|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138712632|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138712633|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138712634|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712635|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712636|NCT01704365|Vaccines|vaccines|mesh-list
138712656|NCT01698281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712657|NCT00565461|Vaccines|vaccines|mesh-list
138712658|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
138712659|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712660|NCT01858883|Paclitaxel|paclitaxel|mesh-list
138712661|NCT01858883|Gemcitabine|gemcitabine|mesh-list
138712662|NCT01858883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138712663|NCT01858883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712664|NCT01858883|Tubulin Modulators|tubulin modulators|mesh-ancestor
138712665|NCT01858883|Antimitotic Agents|antimitotic agents|mesh-ancestor
138712666|NCT01858883|Mitosis Modulators|mitosis modulators|mesh-ancestor
138712667|NCT01858883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712668|NCT01858883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138712669|NCT01858883|Antimetabolites|antimetabolites|mesh-ancestor
138712670|NCT01697072|Cisplatin|cisplatin|mesh-list
138712671|NCT01697072|Capecitabine|capecitabine|mesh-list
138712672|NCT01697072|Epirubicin|epirubicin|mesh-list
138712673|NCT01697072|Rilotumumab|rilotumumab|mesh-list
138712674|NCT01697072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712675|NCT01697072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138712676|NCT01697072|Antimetabolites|antimetabolites|mesh-ancestor
138712677|NCT01697072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712678|NCT01697072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138712679|NCT01697072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138712680|NCT01697072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138712681|NCT01697072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712682|NCT01697072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138712683|NCT00565500|Ibuprofen|ibuprofen|mesh-list
138712684|NCT00565500|Celecoxib|celecoxib|mesh-list
138712685|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138712686|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138712687|NCT00565500|Analgesics|analgesics|mesh-ancestor
138712688|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
138712689|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712697|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138712698|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138712699|NCT01691846|Metformin|metformin|mesh-list
138712700|NCT01691846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138712701|NCT01691846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712702|NCT01658501|Metformin|metformin|mesh-list
138712703|NCT01658501|Liraglutide|liraglutide|mesh-list
138712704|NCT01658501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138712705|NCT01658501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712706|NCT01658501|Incretins|incretins|mesh-ancestor
138712707|NCT01658501|Hormones|hormones|mesh-ancestor
138712708|NCT01658501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138712709|NCT01651871|Cetirizine|cetirizine|mesh-list
138712710|NCT01651871|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138712711|NCT01651871|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138712712|NCT01651871|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138712713|NCT01651871|Histamine Antagonists|histamine antagonists|mesh-ancestor
138712714|NCT01651871|Histamine Agents|histamine agents|mesh-ancestor
138712715|NCT01651871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712716|NCT01651871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712717|NCT01651871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712718|NCT04608006|Fentanyl|fentanyl|mesh-list
138712719|NCT04608006|Bupivacaine|bupivacaine|mesh-list
138712720|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
138712721|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
138712722|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138712723|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712724|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
138712725|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801546|NCT02624440|Clarithromycin|clarithromycin|mesh-list
138712726|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138712727|NCT04608006|Narcotics|narcotics|mesh-ancestor
138712728|NCT04608006|Analgesics|analgesics|mesh-ancestor
138712729|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138712730|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138712731|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
138712732|NCT04599621|Uric Acid|uric acid|mesh-list
138712733|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
138712734|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712736|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712738|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138712739|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
138712740|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138712741|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138712742|NCT00564525|Analgesics|analgesics|mesh-ancestor
138712743|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
138712744|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712745|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712746|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138712747|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138712748|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138712749|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712750|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
138712751|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712752|NCT04607733|Mirikizumab|mirikizumab|mesh-list
138712753|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138712754|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138712755|NCT04607733|Analgesics|analgesics|mesh-ancestor
138712756|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
138712757|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712758|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712759|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079198|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
139079199|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139079200|NCT03719404|Eusol|eusol|mesh-list
139079201|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139079202|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139079203|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
139079204|NCT03720886|Teriparatide|teriparatide|mesh-list
139079205|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139079206|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079207|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139079208|NCT00077649|Ribavirin|ribavirin|mesh-list
139079209|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139079210|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
139079211|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
139079212|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139079213|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
139079214|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079215|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
139079216|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139079217|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
138273402|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138801558|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
139079218|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079219|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079220|NCT00038948|Cyclosporine|cyclosporine|mesh-list
138829794|NCT00756847|Paclitaxel|paclitaxel|mesh-list
139079221|NCT00038948|Sirolimus|sirolimus|mesh-list
139079222|NCT00038948|Tacrolimus|tacrolimus|mesh-list
138712761|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138712762|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138712763|NCT01632137|Rebamipide|rebamipide|mesh-list
138712764|NCT01632137|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138712765|NCT01632137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138712766|NCT01632137|Antioxidants|antioxidants|mesh-ancestor
138712767|NCT01632137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712768|NCT01632137|Protective Agents|protective agents|mesh-ancestor
138712769|NCT01632137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712770|NCT01632137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712771|NCT00565539|Interferons|interferons|mesh-list
138712772|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712773|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
138712774|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138712775|NCT04599699|Androgens|androgens|mesh-list
138712776|NCT04599699|Hormones|hormones|mesh-ancestor
138712777|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138712778|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712779|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
138712780|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
138712782|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138712783|NCT01563731|Simvastatin|simvastatin|mesh-list
138712784|NCT01563731|Pravastatin|pravastatin|mesh-list
138712785|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138712786|NCT01563731|Diuretics|diuretics|mesh-list
138712787|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138712788|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138712789|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138712790|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
138712791|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138712792|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712793|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138712803|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138712804|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138712805|NCT01516346|Hydralazine|hydralazine|mesh-list
138712807|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138712808|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138712809|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138712810|NCT01516346|Diuretics|diuretics|mesh-ancestor
138712811|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
138712812|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712813|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
138712814|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138712815|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712816|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138712817|NCT01303796|Decitabine|decitabine|mesh-list
138712818|NCT01303796|Sapacitabine|sapacitabine|mesh-list
138712819|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138712820|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
138712821|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712822|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712823|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712824|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
138712825|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
138712826|NCT04598880|Cathartics|cathartics|mesh-ancestor
138712827|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138712828|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138712829|NCT00564564|Clomipramine|clomipramine|mesh-list
138712830|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
138712831|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138712832|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138712833|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138712834|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138712835|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712836|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138712837|NCT00564564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138712838|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138712842|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
138712843|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138712844|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138712845|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138712846|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712847|NCT00565656|Bevacizumab|bevacizumab|mesh-list
138712848|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138712849|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712850|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138712851|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138712852|NCT00565656|Growth Substances|growth substances|mesh-ancestor
138712853|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712854|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
138712855|NCT00564603|Dexamethasone|dexamethasone|mesh-list
138712856|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
138712857|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138712858|NCT00564603|BB 1101|bb 1101|mesh-list
138712859|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138712860|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
138712861|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
138712862|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712863|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712864|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138712865|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
138712866|NCT00564603|Hormones|hormones|mesh-ancestor
138712867|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138545964|NCT00227110|Pioglitazone|pioglitazone|mesh-list
138712868|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138712869|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712870|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
138712871|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712872|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712873|NCT00555347|Modafinil|modafinil|mesh-list
138712880|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
138712882|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
138712883|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138712884|NCT00564642|Expectorants|expectorants|mesh-ancestor
138712885|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
138712886|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138712887|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
138712888|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712889|NCT00564642|Protective Agents|protective agents|mesh-ancestor
138712890|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712891|NCT00564642|Antidotes|antidotes|mesh-ancestor
138712892|NCT00555386|Selenium|selenium|mesh-list
138712893|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
138712894|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712895|NCT00555386|Protective Agents|protective agents|mesh-ancestor
138712896|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712897|NCT00555386|Trace Elements|trace elements|mesh-ancestor
138712898|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
138712899|NCT00565929|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138712900|NCT00565929|Antiviral Agents|antiviral agents|mesh-ancestor
138712901|NCT00565929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138712902|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
138712903|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712904|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712905|NCT04675697|Etoposide|etoposide|mesh-list
138712906|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138712907|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712908|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138712909|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138712910|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712911|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712912|NCT04606836|Bupivacaine|bupivacaine|mesh-list
138712913|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
138712914|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
139079223|NCT00038948|Cyclosporins|cyclosporins|mesh-list
139079224|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079225|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
139079226|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079227|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139079228|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079229|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079230|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
139079231|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138712915|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138712916|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712917|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
138712918|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712919|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
138712920|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
138712921|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712922|NCT04676126|Dorzolamide|dorzolamide|mesh-list
138712923|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138712924|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138712925|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712926|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712927|NCT04675619|Pirfenidone|pirfenidone|mesh-list
138712928|NCT04675619|Analgesics|analgesics|mesh-ancestor
138712929|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
138712930|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712931|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712932|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138712933|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138712934|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138712935|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138712936|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712937|NCT05305300|Vaccines|vaccines|mesh-list
138712938|NCT05305300|Somatomedin B|somatomedin b|mesh-list
138712939|NCT05305300|Immunologic Factors|immunologic factors|mesh-ancestor
138712940|NCT05305300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712941|NCT05305300|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138712942|NCT05305300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138712943|NCT05305300|Protease Inhibitors|protease inhibitors|mesh-ancestor
138712944|NCT05305300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712945|NCT05305300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712946|NCT04187755|Ceftazidime|ceftazidime|mesh-list
138712947|NCT04187755|Cefepime|cefepime|mesh-list
138712948|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139079232|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
139079233|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139079234|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139079235|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139079236|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079237|NCT01096940|Simvastatin|simvastatin|mesh-list
139079238|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138712949|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138712951|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138712952|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712953|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
138712954|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712955|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138712956|NCT04606563|Losartan|losartan|mesh-list
138712957|NCT04606563|Valsartan|valsartan|mesh-list
138712958|NCT04606563|Telmisartan|telmisartan|mesh-list
138712959|NCT04606563|Candesartan|candesartan|mesh-list
138712960|NCT04606563|Candesartan cilexetil|candesartan cilexetil|mesh-list
138712961|NCT04606563|Olmesartan|olmesartan|mesh-list
138712962|NCT04606563|Irbesartan|irbesartan|mesh-list
138712963|NCT04606563|Eprosartan|eprosartan|mesh-list
138712964|NCT04606563|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138712965|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138712966|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138712967|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138712968|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712969|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138712970|NCT04606563|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
138712971|NCT00565968|Sorafenib|sorafenib|mesh-list
138712972|NCT00565968|Melphalan|melphalan|mesh-list
138712973|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712974|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138712975|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712976|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712977|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138712978|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
138712997|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
138712998|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712999|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713000|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138669310|NCT00438984|Aldesleukin|aldesleukin|mesh-list
138713001|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
138713002|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138713003|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138713004|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
138713005|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138713007|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138713008|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138713009|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138713010|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138713011|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138713012|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138713013|NCT01162135|Digoxin|digoxin|mesh-list
138713014|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138713015|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138713016|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713017|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713018|NCT01162135|Protective Agents|protective agents|mesh-ancestor
138713019|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713020|NCT00555776|Gabapentin|gabapentin|mesh-list
138713021|NCT00555776|Analgesics|analgesics|mesh-ancestor
138713022|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
138713023|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713024|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713025|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
138713026|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138713027|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138713028|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138713029|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138713030|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139079239|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139079240|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
139079241|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079242|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138713031|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138713032|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713033|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713034|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
138713035|NCT01161628|Rituximab|rituximab|mesh-list
138713036|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138713037|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713038|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
138713039|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713040|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713041|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
138713042|NCT04314505|Narcotics|narcotics|mesh-ancestor
138713043|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138713044|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713045|NCT04314505|Analgesics|analgesics|mesh-ancestor
138713046|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
138713047|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713048|NCT02885545|Anticoagulants|anticoagulants|mesh-list
138713049|NCT01161472|Alprazolam|alprazolam|mesh-list
138713050|NCT01161472|Fesoterodine|fesoterodine|mesh-list
138713051|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138713052|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138713053|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713054|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138713083|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713084|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713085|NCT04674956|Paclitaxel|paclitaxel|mesh-list
138713086|NCT04674956|Gemcitabine|gemcitabine|mesh-list
138713087|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138713088|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713089|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
138713090|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
138713091|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
138713092|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713093|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138713094|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
138713095|NCT00564720|Gemcitabine|gemcitabine|mesh-list
138713096|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
138713097|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138713098|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138713099|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
138713100|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713101|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713102|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138713103|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713104|NCT01160770|Clobazam|clobazam|mesh-list
138713105|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
138713106|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138713107|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138713108|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138713109|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713113|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
138713133|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
138713134|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138713135|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713136|NCT01159912|Fluticasone|fluticasone|mesh-list
138713137|NCT01159912|Xhance|xhance|mesh-list
138713138|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713139|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138713140|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
138713141|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713142|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545993|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713143|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138713144|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
138713145|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
138713146|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138713147|NCT04606212|Losartan|losartan|mesh-list
138713148|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138713149|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138713150|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138713151|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138713152|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713153|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
138713154|NCT04606017|Antacids|antacids|mesh-ancestor
138713155|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713156|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138713157|NCT04631822|Dexamethasone|dexamethasone|mesh-list
138713158|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713159|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
138713160|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
138713161|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713162|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713163|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138713164|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
138713165|NCT04631822|Hormones|hormones|mesh-ancestor
138648889|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
139079243|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139079244|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079245|NCT02530424|Trastuzumab|trastuzumab|mesh-list
139079246|NCT02530424|Pertuzumab|pertuzumab|mesh-list
139079247|NCT02530424|Fulvestrant|fulvestrant|mesh-list
139079248|NCT02530424|Palbociclib|palbociclib|mesh-list
138713166|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138713167|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138713168|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713169|NCT04605705|Chrysarobin|chrysarobin|mesh-list
138713170|NCT04605705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138713171|NCT04605705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138713172|NCT04605705|Analgesics|analgesics|mesh-ancestor
138713173|NCT04605705|Sensory System Agents|sensory system agents|mesh-ancestor
138713174|NCT04605705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713175|NCT04605705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713176|NCT04605705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713177|NCT04605705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713179|NCT00560924|Estrogens|estrogens|mesh-ancestor
138713180|NCT00560924|Hormones|hormones|mesh-ancestor
138713181|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138713182|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713183|NCT00560963|Everolimus|everolimus|mesh-list
138713184|NCT00560963|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138713185|NCT00560963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138713186|NCT00560963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713187|NCT00560963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713188|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138713189|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
138713190|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713191|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713192|NCT01159600|Empagliflozin|empagliflozin|mesh-list
138713193|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138713194|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713195|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138713208|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713209|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138713210|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138713211|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713212|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
138713213|NCT04314193|Prednisolone|prednisolone|mesh-list
138713214|NCT04314193|Methotrexate|methotrexate|mesh-list
138713215|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138713216|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
138713217|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138713218|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713219|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138713220|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
138713221|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713222|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713223|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
138713224|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713225|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138713226|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138713227|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
138713228|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713229|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138713230|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713232|NCT04314193|Hormones|hormones|mesh-ancestor
138713233|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138713234|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138713235|NCT01159171|Bevacizumab|bevacizumab|mesh-list
138713236|NCT01159171|Capecitabine|capecitabine|mesh-list
138713237|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
138713238|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138713239|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713240|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138713241|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138713242|NCT01159171|Growth Substances|growth substances|mesh-ancestor
138713248|NCT04631315|Prednisolone|prednisolone|mesh-list
138713249|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138713250|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
138713251|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138713252|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
138713253|NCT04631315|Phenylephrine|phenylephrine|mesh-list
138713254|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
138713255|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138713256|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138713257|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
138713258|NCT04631315|Difluprednate|difluprednate|mesh-list
138713259|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138713260|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713261|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
138713262|NCT04631315|Hormones|hormones|mesh-ancestor
138713263|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138713264|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713265|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138713266|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713267|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
138713268|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
138713269|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713270|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138713271|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138713272|NCT04631315|Protective Agents|protective agents|mesh-ancestor
138713273|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138713275|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
138713276|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138713277|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
138713281|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138713296|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138713297|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
138713298|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138713299|NCT00566241|Mecasermin|mecasermin|mesh-list
138713300|NCT00566241|Growth Substances|growth substances|mesh-ancestor
138713301|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713302|NCT00561119|Paclitaxel|paclitaxel|mesh-list
138713303|NCT00561119|Gemcitabine|gemcitabine|mesh-list
138713304|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138713305|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713306|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
138713307|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
138713308|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
138713309|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713310|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138713312|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
138713313|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138713314|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713315|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138713316|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
138713317|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138713318|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713319|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138713320|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138713321|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138713322|NCT00564993|Dobutamine|dobutamine|mesh-list
138713323|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138713324|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
138713325|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
138713344|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713345|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713346|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138713347|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138713348|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138713349|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
138713350|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713351|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713352|NCT04604886|Protective Agents|protective agents|mesh-ancestor
138713353|NCT04595877|Dipyrone|dipyrone|mesh-list
138713354|NCT04595877|Endorphins|endorphins|mesh-list
138713355|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
138713356|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138713357|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138713358|NCT04595877|Analgesics|analgesics|mesh-ancestor
138713359|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
138713360|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713361|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713362|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713363|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713364|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
138713365|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713366|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713367|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
138713368|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138713369|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
138713370|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138649053|NCT00293150|Diuretics|diuretics|mesh-ancestor
139079249|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139079250|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079251|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139079252|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139079253|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139079254|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
139079255|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139079256|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079257|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139079258|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079259|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079260|NCT01088763|Dexamethasone|dexamethasone|mesh-list
139079261|NCT01088763|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139079262|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079263|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
139079264|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
138713371|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713372|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
138713373|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713374|NCT00566553|Protective Agents|protective agents|mesh-ancestor
138713375|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713376|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138713377|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138713378|NCT01157182|Norethindrone|norethindrone|mesh-list
138713379|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
138713380|NCT01157182|Estradiol|estradiol|mesh-list
138713381|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138713382|NCT01157182|Estrogens|estrogens|mesh-ancestor
138713383|NCT01157182|Hormones|hormones|mesh-ancestor
138801774|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
138713384|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138713385|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713386|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138713387|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
138713388|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138713389|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138713390|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138713391|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138713392|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138713393|NCT01157065|Ranibizumab|ranibizumab|mesh-list
138713394|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138713395|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138713396|NCT01157065|Growth Substances|growth substances|mesh-ancestor
138713397|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713398|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
138713399|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713400|NCT00566592|Ethanol|ethanol|mesh-list
138713401|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138713402|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138713403|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139079265|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079266|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079267|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139079268|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
139079269|NCT01088763|Hormones|hormones|mesh-ancestor
139079270|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139079271|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139079272|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713404|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713406|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138713407|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
138713408|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138713409|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
138713410|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138713411|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713412|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138713413|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138713414|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801818|NCT00932646|Olodaterol|olodaterol|mesh-list
138713415|NCT04604223|Pioglitazone|pioglitazone|mesh-list
138713416|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138713417|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713418|NCT04628624|Antioxidants|antioxidants|mesh-list
138713419|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713420|NCT04628624|Protective Agents|protective agents|mesh-ancestor
138713421|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713422|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
138713423|NCT04604028|Lenalidomide|lenalidomide|mesh-list
138713424|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138713425|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
138713426|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713427|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713428|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138713429|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
138713430|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713431|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713432|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138713433|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138713434|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138713435|NCT04604028|Growth Substances|growth substances|mesh-ancestor
138713436|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
138713437|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
138713438|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138649138|NCT00293930|Tacrolimus|tacrolimus|mesh-list
138713440|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
138713441|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138713442|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138713443|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138713444|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138713445|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713446|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
138713447|NCT01156363|Hematinics|hematinics|mesh-ancestor
138713448|NCT02884921|Acetaminophen|acetaminophen|mesh-list
138713449|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138713450|NCT02884921|Analgesics|analgesics|mesh-ancestor
138713451|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
138713452|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713453|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713454|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
138713455|NCT00561704|Losartan|losartan|mesh-list
138713456|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138713457|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138713458|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138713459|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138713460|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713461|NCT01156051|Guanfacine|guanfacine|mesh-list
138713462|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138713463|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138713464|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138713465|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138713466|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
138713467|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713468|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713469|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713470|NCT04595409|Ustekinumab|ustekinumab|mesh-list
138713471|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
138713472|NCT04628000|Vitamin D|vitamin d|mesh-list
138713473|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
138546041|NCT00063011|Calcium|calcium|mesh-list
138713474|NCT04628000|Cholecalciferol|cholecalciferol|mesh-list
138713475|NCT04628000|Vitamins|vitamins|mesh-list
139079273|NCT01088763|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139079274|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079275|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713476|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
138713477|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713478|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138713479|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138713480|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
138713481|NCT01155661|Serotonin|serotonin|mesh-list
138713482|NCT01155661|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138713483|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138713484|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
138713485|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713486|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713487|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713488|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138713489|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138713490|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138713491|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138713492|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
138713493|NCT00565188|Adenosine|adenosine|mesh-list
138713494|NCT00565188|Analgesics|analgesics|mesh-ancestor
138713495|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
138713496|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713497|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713498|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138713499|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
138713500|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138713501|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
138713502|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
138713503|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801855|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138713504|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713505|NCT04603833|Docetaxel|docetaxel|mesh-list
138713506|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713507|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
138713508|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
138713509|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
138649212|NCT00417872|Metronidazole|metronidazole|mesh-list
139079276|NCT01094600|Secretin|secretin|mesh-list
139079277|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139079278|NCT01094600|Hormones|hormones|mesh-ancestor
139079279|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138713510|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713511|NCT04603872|Dasatinib|dasatinib|mesh-list
138713512|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713513|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138713514|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713515|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713516|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
138713517|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138713518|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
138713519|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138713520|NCT04603794|Povidone|povidone|mesh-list
138713521|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138713522|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138713523|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
138713524|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
138713525|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
138713526|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
138713527|NCT01155583|Dexamethasone|dexamethasone|mesh-list
138713528|NCT01155583|Lenalidomide|lenalidomide|mesh-list
138713529|NCT01155583|Azacitidine|azacitidine|mesh-list
138713530|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713531|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
138713532|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
138713533|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713534|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713535|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138713536|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
138713537|NCT01155583|Hormones|hormones|mesh-ancestor
138713538|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138713539|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138713540|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713541|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
138713542|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138713543|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138713544|NCT01155583|Growth Substances|growth substances|mesh-ancestor
138713545|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
138713546|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138649254|NCT00294359|Mitomycins|mitomycins|mesh-list
139079280|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079281|NCT01097252|Cisplatin|cisplatin|mesh-list
138713547|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
138713548|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713549|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713550|NCT04603131|Vaccines|vaccines|mesh-list
138713551|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
138713552|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713553|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
138713554|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
138713555|NCT04627181|Hematinics|hematinics|mesh-ancestor
138713556|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
138713557|NCT04627181|Vitamins|vitamins|mesh-ancestor
138713558|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
138713559|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713560|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
138713561|NCT04626752|Fludarabine|fludarabine|mesh-list
138713562|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138713563|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
138713564|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713565|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713566|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138713567|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
138713568|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713569|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713570|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138713571|NCT01155466|Rasagiline|rasagiline|mesh-list
138713572|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138713573|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713574|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713575|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138713576|NCT01155466|Protective Agents|protective agents|mesh-ancestor
138713577|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713578|NCT00561899|Piperaquine|piperaquine|mesh-list
138713579|NCT00561899|Amodiaquine|amodiaquine|mesh-list
139079282|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079283|NCT00054704|Riluzole|riluzole|mesh-list
139079284|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
139079285|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139079286|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139079287|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139079288|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079289|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079290|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139079291|NCT00054704|Protective Agents|protective agents|mesh-ancestor
139079292|NCT01092572|Simvastatin|simvastatin|mesh-list
138713580|NCT00561899|Artenimol|artenimol|mesh-list
138713581|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
138713582|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138713583|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138713584|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138713585|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
138713586|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138713587|NCT01155388|Hematinics|hematinics|mesh-ancestor
138713588|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138713589|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138713590|NCT01155388|Trace Elements|trace elements|mesh-ancestor
138713591|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
138713592|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713593|NCT00565227|Docetaxel|docetaxel|mesh-list
138713594|NCT00565227|Vorinostat|vorinostat|mesh-list
138713595|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713596|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
138713597|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
138713598|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
138713599|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713600|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138713601|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713602|NCT04602273|Azacitidine|azacitidine|mesh-list
138713603|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138713604|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
138713605|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713606|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713608|NCT04313764|Bupivacaine|bupivacaine|mesh-list
138713609|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
139079293|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139079294|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139079295|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
139079296|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079297|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139079298|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139079299|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079301|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
139079302|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139079303|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079304|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
139079305|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
139079306|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
139079307|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079308|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139079309|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
139079310|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079311|NCT03953066|Melatonin|melatonin|mesh-list
139079312|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
138713611|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138713612|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713613|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
138713614|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713615|NCT04626089|Metformin|metformin|mesh-list
138713616|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138713617|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713618|NCT04601688|Dexamethasone|dexamethasone|mesh-list
138713619|NCT04601688|Bevacizumab|bevacizumab|mesh-list
138713620|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138713621|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713622|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138713623|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138713624|NCT04601688|Growth Substances|growth substances|mesh-ancestor
138713625|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713626|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
138713627|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713628|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
138713629|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
138713630|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713631|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138713632|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
138713633|NCT04601688|Hormones|hormones|mesh-ancestor
138713634|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138713635|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138713636|NCT01154452|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
138713637|NCT01154452|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
138713640|NCT04313452|Insulin|insulin|mesh-list
138713652|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
138713653|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138713654|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
138713655|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713656|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
138713657|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
138713658|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713659|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713660|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138713661|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
138713662|NCT04601142|Hormones|hormones|mesh-ancestor
138713663|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138713664|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138713665|NCT04601142|Protective Agents|protective agents|mesh-ancestor
138713666|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138713667|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713668|NCT04625543|Paclitaxel|paclitaxel|mesh-list
138713669|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138713670|NCT04625543|Cisplatin|cisplatin|mesh-list
138713671|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138713672|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713673|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
138649410|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
139079313|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079314|NCT03953066|Protective Agents|protective agents|mesh-ancestor
139079315|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079316|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139079317|NCT00093795|Paclitaxel|paclitaxel|mesh-list
139079318|NCT00093795|Docetaxel|docetaxel|mesh-list
139079319|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
139079320|NCT00093795|Gemcitabine|gemcitabine|mesh-list
139079321|NCT00093795|Doxorubicin|doxorubicin|mesh-list
139079322|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139079323|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079324|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
139079325|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
139079326|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
139079327|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079328|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079329|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
139079330|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079331|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139079332|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139079333|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
139079334|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139079335|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139079336|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
139079337|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139079338|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139079339|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139079340|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079341|NCT01092806|Tacrolimus|tacrolimus|mesh-list
139079342|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079343|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
138713674|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
138713675|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
138713676|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713677|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
138713678|NCT04601259|Salicylates|salicylates|mesh-list
138669981|NCT00479739|Xhance|xhance|mesh-list
138713679|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138713680|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
138713681|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
138713682|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
138713683|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138713684|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138713685|NCT04601259|Analgesics|analgesics|mesh-ancestor
138713686|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
138713687|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713688|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713689|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713690|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713691|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138713692|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713693|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713694|NCT00565383|Fentanyl|fentanyl|mesh-list
138713695|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138713696|NCT00565383|Narcotics|narcotics|mesh-ancestor
138713697|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138713698|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713699|NCT00565383|Analgesics|analgesics|mesh-ancestor
138713700|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
138713701|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713702|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138713703|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138713704|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
138713705|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
138713706|NCT04625426|Protective Agents|protective agents|mesh-list
138713707|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713715|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
138713716|NCT00567099|Aripiprazole|aripiprazole|mesh-list
138713717|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
138713718|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138713719|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138713720|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138713721|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138713722|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713723|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
138713724|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
138713725|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713726|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713727|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138713728|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138713729|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
138713730|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138713731|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138713732|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138713733|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138713734|NCT00567177|Cyclosporine|cyclosporine|mesh-list
138713735|NCT00567177|Cyclosporins|cyclosporins|mesh-list
138713736|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713737|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713738|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138713739|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
138713740|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713741|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
138713742|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138713743|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
138713744|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713745|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138713746|NCT00567216|Nadolol|nadolol|mesh-list
138713747|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138713748|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139079344|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079345|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139079346|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079347|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079348|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
139079349|NCT01094912|Narcotics|narcotics|mesh-ancestor
139079350|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138713749|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
138713750|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713751|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713752|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713753|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138713754|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138713755|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
138713756|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
138713757|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713758|NCT00562055|Reboxetine|reboxetine|mesh-list
138713759|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138713760|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138713761|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138713762|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138713763|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713764|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
138713765|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713766|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713767|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
138713768|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138713769|NCT04623866|Valsartan|valsartan|mesh-list
138713770|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138713801|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713802|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138713803|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138713804|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
138713806|NCT00567450|Mepivacaine|mepivacaine|mesh-list
138713807|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
138713808|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
138713809|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138713810|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713811|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
138713812|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713813|NCT00567528|Ibuprofen|ibuprofen|mesh-list
138713814|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138713815|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138713816|NCT00567528|Analgesics|analgesics|mesh-ancestor
138713817|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
138713818|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713819|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713820|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713821|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713822|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138713823|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713824|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713825|NCT04590612|Levodopa|levodopa|mesh-list
138713826|NCT04590612|Carbidopa|carbidopa|mesh-list
138713827|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138713828|NCT04590612|Citalopram|citalopram|mesh-list
138713829|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
138713849|NCT00562250|Glimepiride|glimepiride|mesh-list
138713850|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138713851|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713852|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138713853|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713854|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138713855|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138713856|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
138713857|NCT00562289|Aspirin|aspirin|mesh-list
138713858|NCT00562289|Dipyridamole|dipyridamole|mesh-list
138713859|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
138713860|NCT00562289|Apixaban|apixaban|mesh-list
138713861|NCT00562289|Dabigatran|dabigatran|mesh-list
138713862|NCT00562289|Antivitamins K|antivitamins k|mesh-list
138713863|NCT00562289|Clopidogrel|clopidogrel|mesh-list
138713864|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138713865|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138713866|NCT00562289|Analgesics|analgesics|mesh-ancestor
138713867|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
138713868|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713869|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713870|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713871|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713872|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138713873|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138546086|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713874|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713875|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138713876|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138713878|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
138713879|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138713880|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138713881|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138713882|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
138713883|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713884|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138713885|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
138713886|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138713887|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
138713889|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138713890|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
138713891|NCT04313218|Misoprostol|misoprostol|mesh-list
138713892|NCT04313218|Carbetocin|carbetocin|mesh-list
138713893|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138713894|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
138713895|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138713896|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713897|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138713898|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138713899|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
138713900|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
138713901|NCT00624871|Ibuprofen|ibuprofen|mesh-list
138713902|NCT00624871|Vitamins|vitamins|mesh-ancestor
138713903|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
138713904|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713905|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138713906|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138713907|NCT00624871|Analgesics|analgesics|mesh-ancestor
138713908|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
138713909|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713910|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713911|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713912|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138713913|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713914|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713936|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713937|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
138713938|NCT04590183|Hormones|hormones|mesh-ancestor
138713939|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138713940|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138713941|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713942|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
138713943|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
138713944|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713945|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138713946|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138713947|NCT04590183|Protective Agents|protective agents|mesh-ancestor
138713948|NCT04622618|Gabapentin|gabapentin|mesh-list
138713949|NCT04622618|Analgesics|analgesics|mesh-ancestor
138713950|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
138713951|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713952|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713953|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
138713954|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138713955|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138713956|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138713957|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138713958|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138713959|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138713960|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713961|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713962|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
138713963|NCT04622891|Azithromycin|azithromycin|mesh-list
138713964|NCT04622891|Clarithromycin|clarithromycin|mesh-list
138713965|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138713966|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138713967|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138649649|NCT00296777|Escitalopram|escitalopram|mesh-list
139079351|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079352|NCT01094912|Analgesics|analgesics|mesh-ancestor
139079353|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
139079354|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079355|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
139079356|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
139079357|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079358|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
139079359|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079360|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713968|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713969|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713970|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138713971|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138713972|NCT04622579|Rituximab|rituximab|mesh-list
138713973|NCT04622579|Lenalidomide|lenalidomide|mesh-list
138639447|NCT00270426|Benazepril|benazepril|mesh-list
138713974|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138713975|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713976|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
138713977|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713978|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713979|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138713980|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138713981|NCT04622579|Growth Substances|growth substances|mesh-ancestor
138713982|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
138714028|NCT04621487|Metronidazole|metronidazole|mesh-list
138714029|NCT04621487|Clarithromycin|clarithromycin|mesh-list
138714030|NCT04621487|Pantoprazole|pantoprazole|mesh-list
138714031|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138714032|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138714033|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138714034|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138714035|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138714036|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714037|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714038|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138714039|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138714040|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138714041|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138714042|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138714043|NCT01152190|Tadalafil|tadalafil|mesh-list
138714044|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
138714045|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138714046|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138714047|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714048|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714049|NCT01152190|Urological Agents|urological agents|mesh-ancestor
138714050|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
138714051|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138714052|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138714054|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714055|NCT01151410|Enalapril|enalapril|mesh-list
138714056|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138714057|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
138714058|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714060|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138714074|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
138714075|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714076|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714077|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138714078|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138546103|NCT00096330|Vitamins|vitamins|mesh-ancestor
138714079|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138714080|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
138714081|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714082|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714083|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138714084|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
138714085|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714086|NCT00562523|Sorafenib|sorafenib|mesh-list
138714087|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714088|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138714089|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714090|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714091|NCT04649697|Clobetasol|clobetasol|mesh-list
138714092|NCT04649697|Rebamipide|rebamipide|mesh-list
138714093|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714094|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
138714095|NCT04649697|Hormones|hormones|mesh-ancestor
138714096|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138714097|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714098|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138714099|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138714100|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
138714101|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714102|NCT04649697|Protective Agents|protective agents|mesh-ancestor
138714103|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714104|NCT04621253|Dipyrone|dipyrone|mesh-list
138714105|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138714106|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138714107|NCT04621253|Analgesics|analgesics|mesh-ancestor
138714108|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
138714109|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714110|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714111|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714112|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138714113|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
138714114|NCT00567762|Tacrolimus|tacrolimus|mesh-list
138714115|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138714116|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
138714117|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714118|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138714119|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714120|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714121|NCT04620785|Methylene Blue|methylene blue|mesh-list
138802209|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
138714122|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714123|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714124|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
138670433|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
138714125|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138714126|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714127|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138714128|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714129|NCT04691063|Carboplatin|carboplatin|mesh-list
138714130|NCT04691063|Etoposide|etoposide|mesh-list
138714131|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
138714132|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714133|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138714134|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138714135|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138714136|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714137|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714138|NCT01151215|Anastrozole|anastrozole|mesh-list
138714139|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138714140|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714141|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138714142|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138714143|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649771|NCT00327288|Docetaxel|docetaxel|mesh-list
139079361|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139079362|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
138714144|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714145|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138714146|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
138714147|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138714148|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714149|NCT04588389|Lidocaine|lidocaine|mesh-list
138714150|NCT04588389|Ropivacaine|ropivacaine|mesh-list
138714151|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
138714152|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
138714153|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138714154|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714155|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
138714156|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714157|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138714158|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138714159|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138802231|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
138714160|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138714161|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714162|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
138714163|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
138714164|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138714165|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138714166|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138714167|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714190|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714191|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714192|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714193|NCT02940314|Urological Agents|urological agents|mesh-ancestor
138714195|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138714196|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714197|NCT01151137|Dronedarone|dronedarone|mesh-list
138714198|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138714200|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138714201|NCT01151098|Narcotics|narcotics|mesh-ancestor
138714202|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138714203|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714204|NCT01151098|Analgesics|analgesics|mesh-ancestor
138714205|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
138714206|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714207|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138714208|NCT04619303|Dexamethasone|dexamethasone|mesh-list
138714209|NCT04619303|Bevacizumab|bevacizumab|mesh-list
138714210|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138714211|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714212|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138714213|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138714214|NCT04619303|Growth Substances|growth substances|mesh-ancestor
138714215|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714216|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
138714217|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714218|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
138714219|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
138714220|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714221|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138714222|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
138714223|NCT04619303|Hormones|hormones|mesh-ancestor
138714224|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138714225|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138714231|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714232|NCT04619381|Clopidogrel|clopidogrel|mesh-list
138714233|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138714234|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138714235|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138714236|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138714237|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
138714238|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714239|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714240|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714241|NCT00568503|Bromides|bromides|mesh-list
138714242|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
138714243|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138714244|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
138714245|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714246|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714247|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138714248|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
138714249|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
138714250|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138714251|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
138714252|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714253|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714254|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
138714255|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
138714256|NCT00568542|Hematinics|hematinics|mesh-ancestor
138714257|NCT00562835|Thiamine|thiamine|mesh-list
138714258|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
138714259|NCT00562835|Vitamins|vitamins|mesh-ancestor
138714260|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
138714261|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714262|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714263|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
138714264|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
138714265|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714266|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138714268|NCT00562835|Hormones|hormones|mesh-ancestor
138714270|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138714272|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
138714273|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138714274|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138714275|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
138714276|NCT04587141|Hematinics|hematinics|mesh-ancestor
138714277|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138714278|NCT04586790|Epinephrine|epinephrine|mesh-list
138714279|NCT04586790|Racepinephrine|racepinephrine|mesh-list
138714280|NCT04586790|Midodrine|midodrine|mesh-list
138714281|NCT04586790|Norepinephrine|norepinephrine|mesh-list
138714282|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
138714283|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138714284|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138714285|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
138714286|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802302|NCT00609570|Calcium|calcium|mesh-list
138714287|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714288|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714289|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138714290|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138714291|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
138714292|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714293|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138714294|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
138714295|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
138714296|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
138714297|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138714298|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138714299|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
138714300|NCT04586790|Coagulants|coagulants|mesh-ancestor
138714319|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138714320|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714321|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714322|NCT00569088|Mannitol|mannitol|mesh-list
138714323|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138714324|NCT00569088|Diuretics|diuretics|mesh-ancestor
138714325|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
138714326|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714327|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138714328|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138714329|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714330|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
138714331|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138714332|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
138714333|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714334|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
138714335|NCT04586361|Protective Agents|protective agents|mesh-ancestor
138714336|NCT04618952|Calcium|calcium|mesh-list
138714337|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138714338|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714339|NCT04619069|Hormones|hormones|mesh-list
138714340|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138714341|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714342|NCT04585932|Leuprolide|leuprolide|mesh-list
138714343|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138714344|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
138714345|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138714346|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714347|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138714348|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714363|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802327|NCT00926328|Triclosan|triclosan|mesh-list
138714364|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
138714365|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
138714366|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714367|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714368|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138714369|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138714370|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138714371|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
138714372|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714373|NCT04618601|Spironolactone|spironolactone|mesh-list
138714374|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138714375|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
138546181|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138714376|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138714377|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714378|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138714379|NCT04618601|Diuretics|diuretics|mesh-ancestor
138714380|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
138714381|NCT00567918|Tacrolimus|tacrolimus|mesh-list
138714382|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138714383|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
138714384|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714385|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138714386|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714387|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714388|NCT00569712|Budesonide|budesonide|mesh-list
138714389|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
138714390|NCT00569712|Dimercaprol|dimercaprol|mesh-list
138714391|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714392|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138714393|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
138802345|NCT00863512|Vinorelbine|vinorelbine|mesh-list
138714394|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714395|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649976|NCT00299351|Romidepsin|romidepsin|mesh-list
139079363|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079364|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079365|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138714396|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138714397|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
138714398|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
138714399|NCT00569712|Hormones|hormones|mesh-ancestor
138714400|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138714401|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138714402|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138714403|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138714404|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
138714405|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714406|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714407|NCT00569712|Chelating Agents|chelating agents|mesh-ancestor
138714408|NCT00569712|Sequestering Agents|sequestering agents|mesh-ancestor
138714409|NCT00569751|Paclitaxel|paclitaxel|mesh-list
138714410|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138714411|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714412|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
138714413|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
138714414|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
138714415|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714416|NCT00569790|Bevacizumab|bevacizumab|mesh-list
138714417|NCT00569790|Irinotecan|irinotecan|mesh-list
138714418|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138714419|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714420|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138714421|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138714422|NCT00569790|Growth Substances|growth substances|mesh-ancestor
138714423|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670733|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
138714424|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
138714425|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138714427|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714438|NCT02940002|Clobetasol|clobetasol|mesh-list
138714439|NCT02940002|Calcipotriene|calcipotriene|mesh-list
138714440|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714441|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
138714442|NCT02940002|Hormones|hormones|mesh-ancestor
138714443|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138714444|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714445|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138714446|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
138714447|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
138714448|NCT04618328|Tretinoin|tretinoin|mesh-list
138714449|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714450|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
138802392|NCT00868192|Bevacizumab|bevacizumab|mesh-list
138714451|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
138714452|NCT04617782|Donepezil|donepezil|mesh-list
138714453|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138714454|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714455|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714456|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
138714457|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714458|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714459|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
138714460|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
138714461|NCT00569985|Carmustine|carmustine|mesh-list
138714462|NCT00569985|Etoposide|etoposide|mesh-list
138714463|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
138714465|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
138714489|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714491|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
138714492|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138714493|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138714494|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714495|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714496|NCT02939495|Urological Agents|urological agents|mesh-ancestor
138670806|NCT00488670|Escitalopram|escitalopram|mesh-list
138714497|NCT00570219|Valproic Acid|valproic acid|mesh-list
138714498|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
138714499|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714500|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714501|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
138714502|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714503|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714504|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
138714505|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138714506|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138714507|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138714508|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138714509|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714510|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138714511|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714512|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714513|NCT00568074|Repaglinide|repaglinide|mesh-list
138714515|NCT00568074|Gliquidone|gliquidone|mesh-list
138714516|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138714517|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714518|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138714534|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138714535|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138714536|NCT00568152|Analgesics|analgesics|mesh-ancestor
138714537|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
138714538|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714539|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714540|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714541|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138714542|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138714543|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138714544|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714545|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138714546|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138714547|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714548|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
138714549|NCT04610879|Carbamazepine|carbamazepine|mesh-list
138714550|NCT04610879|Levetiracetam|levetiracetam|mesh-list
138714551|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
138714552|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
138714553|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
138714554|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138714555|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138714556|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714557|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138714558|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138714559|NCT04610879|Analgesics|analgesics|mesh-ancestor
138714560|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
138714561|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714562|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138714563|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138714564|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714565|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138714566|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138714575|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138714576|NCT00570726|Growth Substances|growth substances|mesh-ancestor
138714578|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
138714579|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714580|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
138714581|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138714582|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138714583|NCT00563069|Midazolam|midazolam|mesh-list
138714584|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138714585|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138714586|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138714587|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714588|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138714589|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138714590|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138714591|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138714592|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
138714593|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
138714594|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
138714595|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
138714596|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714597|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714598|NCT04580355|Amoxicillin|amoxicillin|mesh-list
138714599|NCT04580355|Metronidazole|metronidazole|mesh-list
138714600|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138714601|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138714602|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138714603|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138714604|NCT00563108|Basiliximab|basiliximab|mesh-list
138714605|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138714606|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
138714607|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714608|NCT00570882|Sunitinib|sunitinib|mesh-list
138714609|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714610|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138714611|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138714612|NCT00570882|Growth Substances|growth substances|mesh-ancestor
138714613|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714614|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
138714615|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138714616|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714617|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714619|NCT00563147|Temsirolimus|temsirolimus|mesh-list
138714620|NCT00563147|MTOR Inhibitors|mtor inhibitors|mesh-list
138714621|NCT00563147|Tivozanib|tivozanib|mesh-list
138714622|NCT00563147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138714623|NCT00563147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714624|NCT00563147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714625|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138714626|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
138714627|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714628|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714629|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138714630|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138714631|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138714632|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
138714633|NCT00570999|Mitogens|mitogens|mesh-list
138714634|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
138714635|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714636|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
138546219|NCT00228358|Analgesics|analgesics|mesh-ancestor
138714637|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138714638|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
138714639|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714645|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138714662|NCT04615481|Metronidazole|metronidazole|mesh-list
138714663|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138714664|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138714665|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138714666|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138714667|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
138714668|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714669|NCT00571506|Pioglitazone|pioglitazone|mesh-list
138714670|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
138714671|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138714672|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714673|NCT04613609|Nicotine|nicotine|mesh-list
138714674|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138714675|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
138714676|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714677|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714678|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138714679|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138714680|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
138714681|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714682|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714683|NCT00571740|Leucovorin|leucovorin|mesh-list
138714684|NCT00571740|Bevacizumab|bevacizumab|mesh-list
138714685|NCT00571740|Cetuximab|cetuximab|mesh-list
138714686|NCT00571740|Fluorouracil|fluorouracil|mesh-list
138714687|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
138714688|NCT00571740|Calcium|calcium|mesh-list
138714689|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
138714690|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138714691|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714692|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138714693|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138714694|NCT00571740|Growth Substances|growth substances|mesh-ancestor
138714695|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714696|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
138714697|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138714705|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
138714706|NCT00571740|Vitamins|vitamins|mesh-ancestor
138714707|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
138714708|NCT00563342|Ethanol|ethanol|mesh-list
138714709|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138714710|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138714711|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138714712|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714714|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138714715|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
138714716|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138714717|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138714718|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714719|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714720|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138714721|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138714722|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714723|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
138714724|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714725|NCT04613726|Ondansetron|ondansetron|mesh-list
138714726|NCT04613726|Granisetron|granisetron|mesh-list
138714727|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
138714728|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
138714729|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714730|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714731|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138714755|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714756|NCT00563654|Alfuzosin|alfuzosin|mesh-list
138714757|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138714758|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138714759|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138714760|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
138714761|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714762|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714763|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714764|NCT00563654|Urological Agents|urological agents|mesh-ancestor
138714765|NCT04613180|Montelukast|montelukast|mesh-list
138714766|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138714767|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
138714768|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138714769|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
138546232|NCT00075543|Docetaxel|docetaxel|mesh-list
138714770|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138714771|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714772|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138714773|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138714774|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714775|NCT00571935|Insulin|insulin|mesh-list
138714776|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138714777|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
138714778|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138714779|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714780|NCT04612634|Vaccines|vaccines|mesh-list
138714781|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
138714782|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714783|NCT04612556|Vaccines|vaccines|mesh-list
138714784|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
138714785|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714786|NCT04580199|Ethanol|ethanol|mesh-list
138714787|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138714788|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138714794|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138714795|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714796|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138714798|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714799|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671111|NCT00461825|Cyclosporine|cyclosporine|mesh-list
138714800|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138714801|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
138714802|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
138714803|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138714804|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138714805|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138714806|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138714807|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
138714808|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714809|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714810|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
138714811|NCT00568347|Hormones|hormones|mesh-ancestor
138714812|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138714813|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
138714814|NCT04611971|Belimumab|belimumab|mesh-list
138714815|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138714816|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
138714817|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714818|NCT00572208|Gabapentin|gabapentin|mesh-list
138714819|NCT00572208|Analgesics|analgesics|mesh-ancestor
138714820|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
138714821|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714822|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714823|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
138714824|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138714825|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138714826|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138714827|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138714828|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138650289|NCT00301925|Epirubicin|epirubicin|mesh-list
139079366|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138714829|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138714830|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546248|NCT00228475|Hormones|hormones|mesh-ancestor
138714831|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714832|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
138714833|NCT00572364|Olaparib|olaparib|mesh-list
138714834|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138714835|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714836|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714837|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714838|NCT00563771|Rasburicase|rasburicase|mesh-list
138714839|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
138714840|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138714841|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138714842|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138714843|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138714844|NCT04582032|Analgesics|analgesics|mesh-ancestor
138714845|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
138714846|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714847|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714848|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714849|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138714850|NCT00563849|Leflunomide|leflunomide|mesh-list
138714851|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714852|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714853|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138714854|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
138714855|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714856|NCT04581876|Paclitaxel|paclitaxel|mesh-list
138714857|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138714858|NCT04581876|Raltitrexed|raltitrexed|mesh-list
138714859|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138714870|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714871|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
138714872|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714873|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138714874|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138714875|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
138714876|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714877|NCT01150123|Vaccines|vaccines|mesh-list
138714878|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
138714879|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714880|NCT00572559|Vancomycin|vancomycin|mesh-list
138714881|NCT00572559|Linezolid|linezolid|mesh-list
138714882|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138714883|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138714884|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138714885|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714886|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714887|NCT04611464|Misoprostol|misoprostol|mesh-list
138714888|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138714889|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
138714890|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138714891|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714892|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138714893|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138714894|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
138714895|NCT04611776|Paclitaxel|paclitaxel|mesh-list
138714896|NCT04611776|Carboplatin|carboplatin|mesh-list
138714897|NCT04611776|Gemcitabine|gemcitabine|mesh-list
138714898|NCT04611776|Pemetrexed|pemetrexed|mesh-list
138714899|NCT04611776|Atezolizumab|atezolizumab|mesh-list
138714900|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138714901|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714902|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
138714903|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
138714904|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
138714905|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714911|NCT04611776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138714912|NCT04611776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138714913|NCT00572637|Delanzomib|delanzomib|mesh-list
138714914|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
138714915|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
138714916|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714917|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714918|NCT01149655|Aripiprazole|aripiprazole|mesh-list
138714919|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
138714920|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138714921|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138714922|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138714923|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138714924|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714925|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
138714926|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
138714927|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714928|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714929|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138714930|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138714931|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
138714932|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138714933|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138714934|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138714935|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138714936|NCT00575406|Prednisolone|prednisolone|mesh-list
138714937|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
138714938|NCT00575406|Rituximab|rituximab|mesh-list
138714939|NCT00575406|Doxorubicin|doxorubicin|mesh-list
138714940|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138714941|NCT00575406|Vincristine|vincristine|mesh-list
138714942|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138714943|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
138714944|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714945|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138714946|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139079367|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139079368|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
139079369|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138714947|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
138714948|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714949|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714950|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138714951|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138714952|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138714953|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138714954|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138714955|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714956|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714957|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
138714958|NCT00575406|Hormones|hormones|mesh-ancestor
138714959|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138714960|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138714961|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138714962|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
138714963|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
138714964|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
138714965|NCT01149538|Choline|choline|mesh-list
138714966|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
138714967|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138546265|NCT00075621|Melphalan|melphalan|mesh-list
138714968|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
138714969|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714970|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138714971|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138714972|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
138714973|NCT01149460|Valacyclovir|valacyclovir|mesh-list
138714974|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
138714975|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138714976|NCT00575523|Atropine|atropine|mesh-list
138714977|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138714978|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138714979|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138714980|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
138714987|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138714988|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138714989|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
138714990|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714991|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714992|NCT01149421|Dulaglutide|dulaglutide|mesh-list
138714993|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138714994|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714995|NCT00575601|Simvastatin|simvastatin|mesh-list
138714996|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138714997|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138714998|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
138714999|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715000|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138715001|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138715002|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715003|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138715004|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138715005|NCT04600271|Norepinephrine|norepinephrine|mesh-list
138715006|NCT04600271|Analgesics|analgesics|mesh-list
138715007|NCT04600271|Diuretics|diuretics|mesh-list
138715008|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
138715009|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715010|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715011|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
138715012|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138715013|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138715014|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
138715015|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715034|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715035|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715036|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138715037|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715039|NCT04600115|Regadenoson|regadenoson|mesh-list
138715040|NCT04600115|Analgesics|analgesics|mesh-ancestor
138715041|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
138715042|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715043|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715044|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138715045|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
138715046|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138715047|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
138802677|NCT00860470|Iron|iron|mesh-list
138715048|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
138715049|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715050|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715051|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138715052|NCT04600037|Pregabalin|pregabalin|mesh-list
138715053|NCT04600037|Analgesics|analgesics|mesh-ancestor
138715054|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
138715055|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715056|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715057|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
138715058|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138715059|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138715062|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138715081|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138715082|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138715083|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
138715085|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138715086|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715087|NCT03454217|Oxycodone|oxycodone|mesh-list
138715088|NCT03454217|Tramadol|tramadol|mesh-list
138715089|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138715090|NCT03454217|Narcotics|narcotics|mesh-ancestor
138715091|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138715092|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715093|NCT03454217|Analgesics|analgesics|mesh-ancestor
138715094|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
138715095|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715096|NCT00575913|Alfuzosin|alfuzosin|mesh-list
138715097|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138715098|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138715099|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138715100|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
138715101|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715102|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715103|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715104|NCT00575913|Urological Agents|urological agents|mesh-ancestor
138715105|NCT04579302|Bupivacaine|bupivacaine|mesh-list
138715106|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
138715107|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
138715108|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139079370|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139079371|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079373|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139079374|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
139079375|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079376|NCT01088919|Pioglitazone|pioglitazone|mesh-list
139079377|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
138273532|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079378|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139079379|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079380|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139079381|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079382|NCT03802916|Deferiprone|deferiprone|mesh-list
139079383|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139079384|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
139079385|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
139079386|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079387|NCT03720340|Oprelvekin|oprelvekin|mesh-list
139079388|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715109|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715110|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
138715111|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715113|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138715114|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138715115|NCT00565682|Analgesics|analgesics|mesh-ancestor
138715116|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
138715117|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715118|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715119|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138715120|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138715121|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138715122|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138715123|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715124|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715125|NCT00575952|Paclitaxel|paclitaxel|mesh-list
138715126|NCT00575952|Doxorubicin|doxorubicin|mesh-list
138715127|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138715128|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138715129|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715130|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
138715131|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
138715132|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
138715133|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715134|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138802739|NCT04134052|Ketamine|ketamine|mesh-list
138715135|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138715136|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138715153|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138715154|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
138715155|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138715156|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715157|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138715158|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138715159|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715160|NCT04598594|Nicotine|nicotine|mesh-list
138715161|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138715162|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
138546293|NCT00229138|Tacrolimus|tacrolimus|mesh-list
138715163|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715164|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715165|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138715166|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138715167|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
138715168|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715169|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715171|NCT00573690|Etoposide|etoposide|mesh-list
138715172|NCT00573690|Pemetrexed|pemetrexed|mesh-list
138715173|NCT00573690|Sorafenib|sorafenib|mesh-list
138715174|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715175|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138715176|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138715177|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138715178|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715179|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715180|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138715197|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
138715198|NCT00576459|Hormones|hormones|mesh-ancestor
138715199|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138715200|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715201|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
138715202|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
138715203|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138715204|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138715205|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715206|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715207|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715208|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138715209|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138715210|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
138715211|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715212|NCT00573885|Protective Agents|protective agents|mesh-ancestor
138715213|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715214|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138715215|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138715216|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715217|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138715218|NCT00573924|Lansoprazole|lansoprazole|mesh-list
138715219|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
138715220|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138715221|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138715222|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138715223|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715224|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715225|NCT00573963|Ropivacaine|ropivacaine|mesh-list
138715226|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
138715227|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
138715228|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138715229|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715230|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
138715238|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
138715239|NCT00574041|Interferons|interferons|mesh-list
138715240|NCT00574041|Interferon-beta|interferon-beta|mesh-list
138715241|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
138802807|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
138715242|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715243|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
138715244|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715245|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
138715246|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715247|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138715248|NCT00566267|Simvastatin|simvastatin|mesh-list
138715249|NCT00566267|Ezetimibe|ezetimibe|mesh-list
138715250|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138715251|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138715252|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
138715253|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715300|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715301|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
138715302|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715303|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138715304|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138546303|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138715305|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138715306|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138715307|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138715308|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138715309|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
138715310|NCT04595942|Midodrine|midodrine|mesh-list
138715311|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
138715312|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
138715313|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715314|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715315|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138715316|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138715317|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138715318|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138715319|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
138715320|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715321|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715322|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138715323|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138715324|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138715325|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
138715326|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715327|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
138715328|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138715341|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715342|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715343|NCT00577668|Thalidomide|thalidomide|mesh-list
138715344|NCT00577668|Dexamethasone|dexamethasone|mesh-list
138715345|NCT00577668|Melphalan|melphalan|mesh-list
138715346|NCT00577668|Bortezomib|bortezomib|mesh-list
138715347|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138715348|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
138715349|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
138715350|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715351|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715352|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138715353|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
138715354|NCT00577668|Hormones|hormones|mesh-ancestor
138715355|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138715356|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138715357|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715358|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138715359|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
138715360|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715361|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138715362|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138715363|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
138715364|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
138715365|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138715366|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715367|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138715368|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138715387|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138715388|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715389|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138715390|NCT04313374|Morphine|morphine|mesh-list
138715391|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138715392|NCT04313374|Narcotics|narcotics|mesh-ancestor
138715393|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138715394|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715395|NCT04313374|Analgesics|analgesics|mesh-ancestor
138715396|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
138715397|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715398|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138715399|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138715400|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138715401|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138715403|NCT00577980|Androgens|androgens|mesh-ancestor
138715404|NCT00577980|Hormones|hormones|mesh-ancestor
138715405|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138715406|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715407|NCT04594343|Disulfiram|disulfiram|mesh-list
138715408|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138715409|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138715410|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715411|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715412|NCT01147393|Epratuzumab|epratuzumab|mesh-list
138715413|NCT01147393|Veltuzumab|veltuzumab|mesh-list
138715414|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138715431|NCT00578370|Cyclosporine|cyclosporine|mesh-list
138715433|NCT00578370|Calcipotriene|calcipotriene|mesh-list
138715434|NCT00578370|Cyclosporins|cyclosporins|mesh-list
138715435|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715436|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715437|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138715438|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
138715439|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715440|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
138546313|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715441|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715442|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
138715443|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138715444|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138715445|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138715446|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
138715447|NCT00578370|Hormones|hormones|mesh-ancestor
138715448|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138715449|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138715450|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
138715451|NCT04593836|Peppermint oil|peppermint oil|mesh-list
138715452|NCT04593836|Menthol|menthol|mesh-list
138715453|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
138715454|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
138715455|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
138715456|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
138715457|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715458|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715459|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138715460|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
138715461|NCT04593524|Vitamin D|vitamin d|mesh-list
138715462|NCT04593524|Vitamins|vitamins|mesh-ancestor
138715479|NCT00566891|Tirofiban|tirofiban|mesh-list
138715480|NCT00566891|Clopidogrel|clopidogrel|mesh-list
138715481|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138715482|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138715483|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138715484|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138715485|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
138715486|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715487|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715488|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715489|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138715490|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138715491|NCT00578760|Aspirin|aspirin|mesh-list
138715492|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138715493|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138715494|NCT00578760|Analgesics|analgesics|mesh-ancestor
138715495|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
138715496|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715497|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715498|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138715499|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138715500|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138715501|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138715502|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715503|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138715504|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138715506|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
138715507|NCT04592822|Dabigatran|dabigatran|mesh-list
138715508|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
138715509|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138715510|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
138715511|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079389|NCT01094990|Dexamethasone|dexamethasone|mesh-list
139079390|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079391|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
139079392|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
139079393|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079394|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079395|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139079396|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
139079397|NCT01094990|Hormones|hormones|mesh-ancestor
139079398|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138715512|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715514|NCT00567047|Vildagliptin|vildagliptin|mesh-list
138715515|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138715516|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715517|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138715518|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
138715519|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715520|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715521|NCT04592666|Carboplatin|carboplatin|mesh-list
138715522|NCT04592666|Pemetrexed|pemetrexed|mesh-list
138715523|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715524|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715525|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715526|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138802936|NCT00626834|Vigabatrin|vigabatrin|mesh-list
138715527|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138715528|NCT04592198|Palonosetron|palonosetron|mesh-list
138715529|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
138715530|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
138715531|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715532|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715533|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138715534|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138715535|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138715536|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
138715537|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715538|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715539|NCT04592081|Dexamethasone|dexamethasone|mesh-list
138715557|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
138715558|NCT04591847|Vitamins|vitamins|mesh-ancestor
138715559|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
138715560|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715561|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138715562|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138715563|NCT04591535|Levodopa|levodopa|mesh-list
138715564|NCT04591535|Carbidopa|carbidopa|mesh-list
138715565|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138715566|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138715567|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138715568|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
138715569|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138222640|NCT01393457|Levodopa|levodopa|mesh-list
138715570|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715571|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715572|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138715573|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715574|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138715575|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
138715576|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
138715578|NCT00580242|Bortezomib|bortezomib|mesh-list
138715579|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
138715580|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715581|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138715582|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138715583|NCT00580242|Growth Substances|growth substances|mesh-ancestor
138715584|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
138715585|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715586|NCT04591457|Insulin|insulin|mesh-list
138715603|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138715604|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
138715605|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
138715606|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715607|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715608|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138715609|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138715610|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138715611|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
138715612|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802958|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138715613|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715614|NCT00580437|Protective Agents|protective agents|mesh-ancestor
138715615|NCT00580827|Disulfiram|disulfiram|mesh-list
138715616|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138715617|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138715618|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715619|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715620|NCT00580905|Adenosine|adenosine|mesh-list
138715621|NCT00580905|Nitroprusside|nitroprusside|mesh-list
138715622|NCT00580905|Analgesics|analgesics|mesh-ancestor
138715623|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
138715624|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715625|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715626|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138715627|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
138715628|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138715629|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
138715630|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
138715631|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715632|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715635|NCT04590638|Epinephrine|epinephrine|mesh-list
138715646|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
138715647|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715648|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138715649|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
138715650|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
138715651|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
138715652|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138715653|NCT00567554|Paclitaxel|paclitaxel|mesh-list
138715654|NCT00567554|Docetaxel|docetaxel|mesh-list
138715655|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138715656|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
138715657|NCT00567554|Bevacizumab|bevacizumab|mesh-list
138715658|NCT00567554|Trastuzumab|trastuzumab|mesh-list
138715659|NCT00567554|Everolimus|everolimus|mesh-list
138715660|NCT00567554|Epirubicin|epirubicin|mesh-list
138715661|NCT00567554|Lapatinib|lapatinib|mesh-list
138715662|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138715663|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715664|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
138715665|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
138715666|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
138715667|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715668|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138715669|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
138715670|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715686|NCT04590482|Letrozole|letrozole|mesh-list
138715698|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138715699|NCT00567710|Risperidone|risperidone|mesh-list
138715700|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138715701|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
138715702|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715703|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715704|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715705|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138715706|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138802986|NCT01070888|Hormones|hormones|mesh-ancestor
138715707|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138715708|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546342|NCT00229528|Paroxetine|paroxetine|mesh-list
138715709|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138715710|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
138715712|NCT04589429|Nalbuphine|nalbuphine|mesh-list
138715713|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138715714|NCT04589429|Narcotics|narcotics|mesh-ancestor
138715715|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138715716|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715717|NCT04589429|Analgesics|analgesics|mesh-ancestor
138715718|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
138715719|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715720|NCT04589390|Selexipag|selexipag|mesh-list
138715721|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138715722|NCT04577040|Tadalafil|tadalafil|mesh-list
138715723|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
138715724|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138715725|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138715726|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715729|NCT04589234|Gemcitabine|gemcitabine|mesh-list
138715746|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715747|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715748|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138715749|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138715750|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138715751|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138715752|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
138715753|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138715754|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
138715755|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
138715756|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138715757|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138715758|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715759|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138715760|NCT04577430|Analgesics|analgesics|mesh-ancestor
138715761|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
138715762|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715763|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138715764|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138715765|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138715766|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
138715767|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715768|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715769|NCT00567788|Bimatoprost|bimatoprost|mesh-list
138715770|NCT00567788|Latanoprost|latanoprost|mesh-list
138715793|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138715794|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138715795|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138715796|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138715797|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138715798|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138715799|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715800|NCT04588220|Plasminogen|plasminogen|mesh-list
138715801|NCT04588220|Melatonin|melatonin|mesh-list
138715802|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
138715803|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715804|NCT04588220|Protective Agents|protective agents|mesh-ancestor
138715805|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715806|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138715807|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138715808|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138715809|NCT04586543|Docetaxel|docetaxel|mesh-list
138715810|NCT04586543|Selegiline|selegiline|mesh-list
138715811|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715812|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
138715813|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
138715814|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
138715815|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715816|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
138715817|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138715818|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138715819|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138715820|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138715821|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715822|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138715823|NCT04586543|Protective Agents|protective agents|mesh-ancestor
138715824|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715825|NCT04586465|Carboplatin|carboplatin|mesh-list
138715826|NCT04586465|Gemcitabine|gemcitabine|mesh-list
138715827|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
138715828|NCT04586465|Pemetrexed|pemetrexed|mesh-list
138715829|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715830|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139079399|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138715832|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715833|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138715834|NCT04586465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138715835|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715836|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138715837|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138715838|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
138715839|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138715840|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
138715841|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715842|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138715843|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138715844|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138715845|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715846|NCT04585997|Omalizumab|omalizumab|mesh-list
138715847|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138715848|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138672155|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715849|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
138715851|NCT04593108|Misoprostol|misoprostol|mesh-list
138715852|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715853|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138715854|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138715855|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715856|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715857|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138715858|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
138715859|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138715860|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715861|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138715862|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
138715863|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138715864|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138715865|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138715866|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
138715867|NCT04585412|Palonosetron|palonosetron|mesh-list
138715868|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
138715869|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
138715870|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715871|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715872|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138715873|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138715874|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138715875|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
138715876|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715877|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715878|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138715879|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
138715880|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138715881|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138715882|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138715883|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138715884|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715885|NCT00567983|Cyclosporine|cyclosporine|mesh-list
138715886|NCT00567983|Cyclosporins|cyclosporins|mesh-list
138715887|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715888|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715889|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138715890|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
138715891|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715892|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
138715893|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715894|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
138715895|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138715896|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138715897|NCT00582582|Vitamin D|vitamin d|mesh-list
138715898|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138715899|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139079400|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079401|NCT01584050|Folic Acid|folic acid|mesh-list
139079402|NCT01584050|Hematinics|hematinics|mesh-ancestor
139079403|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
139079404|NCT01584050|Vitamins|vitamins|mesh-ancestor
139079405|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
139079406|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079407|NCT03952832|Leflunomide|leflunomide|mesh-list
139079408|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079409|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715900|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138715901|NCT00582582|Docetaxel|docetaxel|mesh-list
138715902|NCT00582582|Vitamins|vitamins|mesh-ancestor
138715903|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
138715904|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715905|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715906|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
138715907|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
138715908|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
138715909|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715910|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138715911|NCT00566904|Aspirin|aspirin|mesh-list
138715912|NCT00566904|Lidocaine|lidocaine|mesh-list
138715913|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
138715914|NCT00566904|Anesthetics|anesthetics|mesh-list
138715915|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138715916|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715917|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
138715918|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715919|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138715920|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138715921|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138715922|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138715923|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715924|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138715925|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138715926|NCT00566904|Analgesics|analgesics|mesh-ancestor
138715927|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138715928|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138715929|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139079410|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079411|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
139079412|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079413|NCT01311076|Insulin|insulin|mesh-list
139079414|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139079415|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
139079416|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139079417|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079418|NCT01098344|Gemcitabine|gemcitabine|mesh-list
139079419|NCT01098344|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
139079420|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139079421|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
139079422|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079423|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715931|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138715932|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138715933|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715934|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
138715935|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138715936|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138715937|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138715938|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138715939|NCT04584515|Itraconazole|itraconazole|mesh-list
138715940|NCT04584515|Rifampin|rifampin|mesh-list
138715941|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
138715942|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715943|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138715944|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138715945|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715946|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715947|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138715948|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
138715949|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138715950|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715951|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138715952|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138715953|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
138715954|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138715955|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
138715956|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138715957|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138715958|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138715959|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138715960|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138715970|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715971|NCT04592211|Paclitaxel|paclitaxel|mesh-list
138715972|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
138715973|NCT04592211|Olaparib|olaparib|mesh-list
138715974|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138715975|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715976|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
138715977|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
138715978|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
138715979|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715980|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138715981|NCT04592211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138715982|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138715983|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715984|NCT04583813|Empagliflozin|empagliflozin|mesh-list
138803083|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715985|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138715986|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715987|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138715988|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715989|NCT04576143|Paclitaxel|paclitaxel|mesh-list
138715990|NCT04576143|Docetaxel|docetaxel|mesh-list
138715991|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
138715992|NCT04576143|Epirubicin|epirubicin|mesh-list
138715995|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
138716020|NCT04583111|Domperidone|domperidone|mesh-list
138716022|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
138716023|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
138716024|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716025|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716026|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716027|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138716028|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
138716029|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716030|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716031|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138716032|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138716033|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716034|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138716035|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138716036|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
138716037|NCT01146613|Varenicline|varenicline|mesh-list
138716038|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138716039|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138716040|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
138716041|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716042|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716043|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716044|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138716045|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138716046|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138716047|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138716048|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716049|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716050|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716051|NCT01145755|Analgesics|analgesics|mesh-ancestor
138716062|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138716063|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138716064|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
138716065|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716066|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180659|NCT00867451|Melatonin|melatonin|mesh-list
138716068|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138716069|NCT00567060|Protective Agents|protective agents|mesh-ancestor
138716070|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716071|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
138716072|NCT00568217|Acetaminophen|acetaminophen|mesh-list
138716073|NCT00568217|Ibuprofen|ibuprofen|mesh-list
138716074|NCT00568217|Diclofenac|diclofenac|mesh-list
138716075|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138716076|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138716077|NCT00568217|Analgesics|analgesics|mesh-ancestor
138716078|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
138716079|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716080|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716081|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138716082|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716083|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138716084|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716085|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716086|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
138716087|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
138716088|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716089|NCT04582604|Decitabine|decitabine|mesh-list
138716090|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138716091|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
138716092|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716093|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716094|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716095|NCT00590928|Esomeprazole|esomeprazole|mesh-list
138716096|NCT00590928|Ranitidine|ranitidine|mesh-list
138716097|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138716102|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716103|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138716104|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
138716105|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
138716106|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716107|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716108|NCT01145482|Insulin|insulin|mesh-list
138716109|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
138716110|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138716111|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716112|NCT00568295|Acetaminophen|acetaminophen|mesh-list
138716113|NCT00568295|Rofecoxib|rofecoxib|mesh-list
138716114|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138716115|NCT00568295|Analgesics|analgesics|mesh-ancestor
138716116|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
138716117|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716118|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716160|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
138716161|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716162|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
138716163|NCT04575675|Valsartan|valsartan|mesh-list
138716164|NCT04575675|Carvedilol|carvedilol|mesh-list
138803140|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138716165|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138716166|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138716167|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
138716168|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138716169|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138716170|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716171|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138716172|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716173|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138716174|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138716175|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138716176|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138716177|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
138716178|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716179|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
138716180|NCT04575675|Protective Agents|protective agents|mesh-ancestor
138716181|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138716182|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138716183|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138716184|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
138716185|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138716186|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138716187|NCT04575675|Hormones|hormones|mesh-ancestor
138716204|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
138716205|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138716206|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716207|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716208|NCT00568529|Capecitabine|capecitabine|mesh-list
138716209|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
138716210|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138716211|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
138716212|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716213|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716215|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138716216|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716217|NCT04575558|Azithromycin|azithromycin|mesh-list
138716218|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
138716219|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138716220|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716221|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
138716222|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138716223|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138716224|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716225|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716226|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716227|NCT00568763|Sargramostim|sargramostim|mesh-list
138716228|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
138716229|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716230|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138716231|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716232|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138716233|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716234|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716235|NCT00583869|Pregabalin|pregabalin|mesh-list
138716236|NCT00583869|Analgesics|analgesics|mesh-ancestor
138716237|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
138716238|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651323|NCT00451568|Metformin|metformin|mesh-list
139079424|NCT01098344|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139079426|NCT01098656|Lenalidomide|lenalidomide|mesh-list
139079427|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
139079428|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716239|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716240|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
138716241|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138716242|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138716243|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716244|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138716245|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138716246|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138716247|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716248|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138716249|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
138716250|NCT00568880|Bortezomib|bortezomib|mesh-list
138716251|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716252|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
138716253|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138716254|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138716255|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716256|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716257|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716295|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
138716297|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716298|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716299|NCT00569699|Bevacizumab|bevacizumab|mesh-list
138716300|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138716301|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716302|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138716303|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138716304|NCT00569699|Growth Substances|growth substances|mesh-ancestor
138716305|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716306|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
138716307|NCT00569816|Sevoflurane|sevoflurane|mesh-list
138716308|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138716309|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138716310|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
138716311|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
138716312|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716313|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716314|NCT00570050|Insulin|insulin|mesh-list
138716315|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138716316|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138716317|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716318|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
138716319|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138716320|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
138716321|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716322|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716323|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138716324|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
138716342|NCT00570440|Estradiol|estradiol|mesh-list
138716343|NCT00570440|Estrogens|estrogens|mesh-ancestor
138716344|NCT00570440|Hormones|hormones|mesh-ancestor
138716345|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138716346|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716347|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138716348|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138716349|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138716350|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138716351|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138716352|NCT00570479|Anecortave|anecortave|mesh-list
138716353|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138716354|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138716355|NCT00570479|Growth Substances|growth substances|mesh-ancestor
138716356|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716357|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
138716358|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716359|NCT00584298|Octreotide|octreotide|mesh-list
138716360|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716361|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138716362|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716363|NCT00584376|Pregabalin|pregabalin|mesh-list
138716364|NCT00584376|Analgesics|analgesics|mesh-ancestor
138716365|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
138716366|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716367|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716368|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
138716369|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138716370|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138716371|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716372|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138716385|NCT04580342|Propranolol|propranolol|mesh-list
138716386|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138716387|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138716388|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
138716389|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716390|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716391|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716392|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138716393|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138716394|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
138716395|NCT00571142|Bevacizumab|bevacizumab|mesh-list
138716396|NCT00571142|Temazepam|temazepam|mesh-list
138716397|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138716398|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716399|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138716400|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138716401|NCT00571142|Growth Substances|growth substances|mesh-ancestor
138716402|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716403|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
138716404|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138716405|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716406|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138716407|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138716408|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138716409|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
138716433|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138716435|NCT03451500|Carbidopa|carbidopa|mesh-list
138716436|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138716437|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138716438|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138716439|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
138716440|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716441|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716442|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672760|NCT00500565|Bupivacaine|bupivacaine|mesh-list
138716443|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138716445|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138716446|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
138716447|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
138716448|NCT00584610|Copper|copper|mesh-list
138803272|NCT02605213|Vancomycin|vancomycin|mesh-list
138716449|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
138716450|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138716451|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
138651466|NCT00334347|Valproic Acid|valproic acid|mesh-list
139079429|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139079430|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139079431|NCT01098656|Growth Substances|growth substances|mesh-ancestor
139079432|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
139079433|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079434|NCT00076011|Mitogens|mitogens|mesh-list
139079435|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
139079436|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
139079437|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079438|NCT00076011|Growth Substances|growth substances|mesh-ancestor
139079439|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079440|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
139079441|NCT03465436|Lasmiditan|lasmiditan|mesh-list
139079442|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139079443|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139079444|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139079445|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139079446|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079447|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079448|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079449|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079450|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139079451|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
139079452|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139079453|NCT01098890|Plasminogen|plasminogen|mesh-list
139079454|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139079455|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139079456|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139079457|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079458|NCT00053846|Buspirone|buspirone|mesh-list
139079459|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139079460|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139079461|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139079462|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079463|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139079464|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139079465|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
138716452|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138716453|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716454|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138716455|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138716456|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138716457|NCT00584610|Trace Elements|trace elements|mesh-ancestor
138716458|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
138716459|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
138716460|NCT00571298|Gemcitabine|gemcitabine|mesh-list
138716461|NCT00571298|Amifostine|amifostine|mesh-list
138716462|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716463|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138716464|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
138716465|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716466|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138716467|NCT00571298|Protective Agents|protective agents|mesh-ancestor
138716468|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716469|NCT00571298|Antidotes|antidotes|mesh-ancestor
138716470|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
138716471|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
138716472|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138716473|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716474|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
138716475|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
138716476|NCT00571337|Infliximab|infliximab|mesh-list
138716477|NCT00571337|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138716478|NCT00571337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138716479|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
138716480|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716481|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716482|NCT04575519|Aspirin|aspirin|mesh-list
138716483|NCT04575519|Ibuprofen|ibuprofen|mesh-list
138716484|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138716486|NCT04575519|Analgesics|analgesics|mesh-ancestor
138716496|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138716497|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138716498|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
138716500|NCT04573803|Levetiracetam|levetiracetam|mesh-list
138716501|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
138716502|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
138716503|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138716504|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138716505|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138716506|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716507|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138716508|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138716509|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138716510|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
138716511|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138716512|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138716513|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138716514|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716515|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716516|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
138716517|NCT04573686|Hematinics|hematinics|mesh-ancestor
138716518|NCT01143337|Methotrexate|methotrexate|mesh-list
138716519|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138716520|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
138716521|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138716522|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716545|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
138716546|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716547|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716548|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716549|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
138716550|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138716551|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716552|NCT02883556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138716553|NCT02883556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716554|NCT00585000|Tremelimumab|tremelimumab|mesh-list
138716555|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716556|NCT00572078|Sorafenib|sorafenib|mesh-list
138716557|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716558|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138716559|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716560|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716561|NCT00572312|Atorvastatin|atorvastatin|mesh-list
138716562|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138716563|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138716564|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
138716565|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716567|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138716568|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716569|NCT00585156|Celecoxib|celecoxib|mesh-list
138716570|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138716571|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138716572|NCT00585156|Analgesics|analgesics|mesh-ancestor
138716573|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
138716590|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138716591|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716592|NCT01142128|Esomeprazole|esomeprazole|mesh-list
138716593|NCT01142128|Pancrelipase|pancrelipase|mesh-list
138716594|NCT01142128|Pancreatin|pancreatin|mesh-list
138716595|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138716596|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716597|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138716598|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716599|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716600|NCT04572867|Diuretics|diuretics|mesh-list
138716601|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
138716602|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716603|NCT01142089|Rifamycins|rifamycins|mesh-list
138716604|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
138716605|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138716606|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716607|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716608|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
138716609|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138716610|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
138716611|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716612|NCT00572663|Expectorants|expectorants|mesh-ancestor
138716613|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
138716614|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138716615|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
138716616|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716617|NCT00572663|Protective Agents|protective agents|mesh-ancestor
138716618|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716619|NCT00572663|Antidotes|antidotes|mesh-ancestor
138716620|NCT01140880|Tenofovir|tenofovir|mesh-list
138716621|NCT01140880|Emtricitabine|emtricitabine|mesh-list
138716622|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138716623|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
138716624|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651609|NCT00452855|Remifentanil|remifentanil|mesh-list
138716629|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138716630|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138716632|NCT00572741|Vitamins|vitamins|mesh-ancestor
138716633|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
138716634|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716635|NCT00572819|Misoprostol|misoprostol|mesh-list
138716636|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138716637|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
138716638|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138716639|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716641|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716642|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
138716643|NCT03451110|Fluconazole|fluconazole|mesh-list
138716644|NCT03451110|Lemborexant|lemborexant|mesh-list
138716645|NCT03451110|Famotidine|famotidine|mesh-list
138716646|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
138716647|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
138716648|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716649|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138716650|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138716651|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716652|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716653|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138716654|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
138716655|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138716656|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716657|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138716658|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138716659|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138716660|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716661|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138716662|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
139079466|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139079467|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079468|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
139079469|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139079470|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139079471|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138716663|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
138716664|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716665|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138716666|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138716667|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138716668|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716669|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138716670|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138716671|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138716672|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
138716673|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138716674|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138716675|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138716676|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
138716677|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138716678|NCT00585741|Alovudine|alovudine|mesh-list
138716679|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
138716680|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716681|NCT03450798|Anesthetics|anesthetics|mesh-list
138716682|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716683|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716684|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
138716685|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716686|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138716687|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716688|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716689|NCT01140061|MK 0873|mk 0873|mesh-list
138716690|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138716691|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138716707|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
138716708|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716709|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138716710|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138716711|NCT00573404|Growth Substances|growth substances|mesh-ancestor
138716712|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716713|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
138716714|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138716715|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716716|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716718|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138716719|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716720|NCT01139047|Metronidazole|metronidazole|mesh-list
138716721|NCT01139047|Azelaic acid|azelaic acid|mesh-list
138716722|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716723|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138716724|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138716725|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138716726|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716727|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
138716728|NCT01139008|Metronidazole|metronidazole|mesh-list
138716729|NCT01139008|Azelaic acid|azelaic acid|mesh-list
138716730|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716731|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138716732|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138716733|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138716734|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716735|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
138716736|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
138716737|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
138716738|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138716739|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138716740|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716741|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716742|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
138716743|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
138716744|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
138716745|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716746|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
138716747|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
138716748|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716749|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138716750|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
138716751|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
138716752|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716753|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716754|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138716755|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138716756|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138716757|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138716758|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138716759|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
138716760|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138716761|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138716762|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138716763|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716764|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716765|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138716766|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138716767|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716768|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
138546463|NCT00230035|Rituximab|rituximab|mesh-list
138716769|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716770|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138716771|NCT00573638|Latanoprost|latanoprost|mesh-list
138716772|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138716774|NCT01138657|Adalimumab|adalimumab|mesh-list
138716775|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138716776|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
138716777|NCT01138657|Hormones|hormones|mesh-ancestor
138716778|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138716779|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716780|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138716785|NCT01138501|Coagulants|coagulants|mesh-ancestor
138716786|NCT01138150|Naproxen|naproxen|mesh-list
138716787|NCT01138150|Sumatriptan|sumatriptan|mesh-list
138716788|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138716789|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138716790|NCT01138150|Analgesics|analgesics|mesh-ancestor
138716791|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
138716792|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716793|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716794|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138716795|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716796|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
138716797|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138716798|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716799|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716800|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138803445|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
138716801|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138716802|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138716803|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
138716804|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716805|NCT00586092|Bevacizumab|bevacizumab|mesh-list
138716806|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138716807|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716808|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138716809|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138716810|NCT00586092|Growth Substances|growth substances|mesh-ancestor
138716811|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716812|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
138716813|NCT01137955|Rifaximin|rifaximin|mesh-list
138716814|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138716815|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716816|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716817|NCT00573950|Cilostazol|cilostazol|mesh-list
138716818|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138716819|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
138716820|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651787|NCT00336375|Artemether|artemether|mesh-list
139079472|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079473|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
139079474|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716821|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716822|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138716823|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
138716824|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138716825|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138716826|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716827|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138716828|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
138716829|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138716830|NCT00573950|Protective Agents|protective agents|mesh-ancestor
138716831|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138716832|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138716833|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716834|NCT00586131|Citric Acid|citric acid|mesh-list
138716835|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
138716836|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
138716837|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138716838|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
138716839|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
138716878|NCT00574769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716879|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138716880|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
138716881|NCT00586443|Bevacizumab|bevacizumab|mesh-list
138716882|NCT00586443|Panitumumab|panitumumab|mesh-list
138716883|NCT00586443|Everolimus|everolimus|mesh-list
138716884|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138716885|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716946|NCT00586911|Betaine|betaine|mesh-list
138716947|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716948|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
138716949|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138716950|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
138716951|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716952|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138716953|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
138716954|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138717014|NCT01137604|Bevacizumab|bevacizumab|mesh-list
138717015|NCT01137604|Lenvatinib|lenvatinib|mesh-list
138717016|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138717017|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717018|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138717019|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138717020|NCT01137604|Growth Substances|growth substances|mesh-ancestor
138717021|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717022|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
138717023|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138717024|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717025|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717026|NCT03454919|Palbociclib|palbociclib|mesh-list
138717027|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717028|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138717029|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717030|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717031|NCT00198822|Vitamin A|vitamin a|mesh-list
138717032|NCT00198822|Beta Carotene|beta carotene|mesh-list
138717033|NCT00198822|Carotenoids|carotenoids|mesh-list
138717034|NCT00198822|Vitamins|vitamins|mesh-ancestor
138717035|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
138717036|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717068|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
138717069|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138717070|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717071|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138717072|NCT02883478|Riboflavin|riboflavin|mesh-list
138717073|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
138717074|NCT02883478|Vitamins|vitamins|mesh-ancestor
138717075|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
138717076|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717077|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138717078|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
138717079|NCT00197145|Aplaviroc|aplaviroc|mesh-list
138717080|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138717081|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138717082|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717083|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138717084|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138717085|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
138717086|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138717087|NCT04674137|Histamine|histamine|mesh-list
138717088|NCT04674137|Glutarimide|glutarimide|mesh-list
138717089|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
138717090|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
138717091|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717092|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717093|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717094|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138717095|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717096|NCT04312438|Caseins|caseins|mesh-list
138717097|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
138717098|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
138717099|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717111|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138717112|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138717113|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138717114|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138717115|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
138717116|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717117|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717118|NCT01136746|Insulin|insulin|mesh-list
138717119|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138717120|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
138717122|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138717123|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717124|NCT01136356|Morphine|morphine|mesh-list
138717125|NCT01136356|Buprenorphine|buprenorphine|mesh-list
138717126|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138717174|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138717175|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717176|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138717177|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138717178|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717179|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
138717180|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
138717181|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138717182|NCT00195663|Adalimumab|adalimumab|mesh-list
138717183|NCT00195663|Methotrexate|methotrexate|mesh-list
138717184|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138717185|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
138717186|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138717187|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717188|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138717233|NCT02883439|Fluticasone|fluticasone|mesh-list
138717234|NCT02883439|Xhance|xhance|mesh-list
138717235|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138717236|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138717237|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
138717238|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717239|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717240|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138717241|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
138717242|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
138717302|NCT00564200|Bortezomib|bortezomib|mesh-list
138717303|NCT00564200|Melphalan|melphalan|mesh-list
138717304|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138717305|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
138717306|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
138717307|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717308|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717309|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138717310|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
138717311|NCT00564200|Hormones|hormones|mesh-ancestor
138717312|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138717313|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138717314|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717315|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717316|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138717317|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
138717318|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138717319|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
138717360|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717361|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138717362|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
138717363|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138717364|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138717365|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138717366|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717367|NCT00193050|Gemcitabine|gemcitabine|mesh-list
138717368|NCT00193050|Docetaxel|docetaxel|mesh-list
138717369|NCT00193050|Epirubicin|epirubicin|mesh-list
138717370|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138717371|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
138717372|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717424|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138717426|NCT00191646|Carboplatin|carboplatin|mesh-list
138717427|NCT00191646|Gemcitabine|gemcitabine|mesh-list
138717428|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138717429|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717430|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
138717431|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
138717432|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
138717433|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717434|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138717435|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
138717436|NCT00191451|Carboplatin|carboplatin|mesh-list
138717437|NCT00191451|Gemcitabine|gemcitabine|mesh-list
138717486|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717487|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717488|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138717489|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138717491|NCT00190749|Risperidone|risperidone|mesh-list
138717492|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138717493|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
138717494|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717495|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717496|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717497|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138717498|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138717499|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138717500|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138717501|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138717502|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
138717503|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
138717504|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
138717505|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717506|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138717507|NCT00190749|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138717508|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138717509|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138717510|NCT04607447|Dexamethasone|dexamethasone|mesh-list
138717511|NCT04607447|Atorvastatin|atorvastatin|mesh-list
138717512|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138717513|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
138717514|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
138717519|NCT04607447|Hormones|hormones|mesh-ancestor
138717531|NCT00190671|Pemetrexed|pemetrexed|mesh-list
138717532|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138717533|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
138717534|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717535|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138717536|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138717537|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
138717538|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717539|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717540|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138717541|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717542|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138717543|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138717544|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
138717545|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138717546|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138717547|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717587|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138717589|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
138717590|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
138717591|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138717592|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717593|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
138717594|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138717595|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138717596|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138717597|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138717598|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717599|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
138717600|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717601|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717602|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138717603|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717604|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138717605|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138717606|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717607|NCT04605770|Pemetrexed|pemetrexed|mesh-list
138717608|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717616|NCT04605419|Calcium|calcium|mesh-list
138717638|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717639|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138717640|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138717641|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
138717642|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717643|NCT00589485|Cobalt|cobalt|mesh-list
138717644|NCT00589485|Trace Elements|trace elements|mesh-ancestor
138717645|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
138673950|NCT01246557|Dexamethasone|dexamethasone|mesh-list
138717646|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717705|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
138717706|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717707|NCT04604327|Bemiparin|bemiparin|mesh-list
138717708|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
138717709|NCT00590694|Ranibizumab|ranibizumab|mesh-list
138717710|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138717711|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138717712|NCT00590694|Growth Substances|growth substances|mesh-ancestor
138717713|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717714|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
138717715|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717716|NCT00565175|Famotidine|famotidine|mesh-list
138717717|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138717718|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138717719|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138717720|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
138717721|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
138717722|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717723|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717724|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717726|NCT00477165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138717760|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717761|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138717762|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138717763|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
138717765|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138717766|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138717767|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138717768|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717769|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717770|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138717771|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
138717772|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138717773|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138717774|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138717775|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138717776|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138717777|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
138717778|NCT04603664|Cystatins|cystatins|mesh-list
138717779|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138717780|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
138717781|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717782|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717783|NCT00474903|Aspirin|aspirin|mesh-list
138717784|NCT00474903|Esomeprazole|esomeprazole|mesh-list
138717808|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717809|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
138717810|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717811|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138717878|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138717879|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138717880|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138717882|NCT04602143|Androgens|androgens|mesh-ancestor
138717883|NCT04602143|Hormones|hormones|mesh-ancestor
138717884|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138717885|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717886|NCT02277678|Morphine|morphine|mesh-list
138717887|NCT02277678|Oxycodone|oxycodone|mesh-list
138717888|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
138717889|NCT02277678|Narcotics|narcotics|mesh-ancestor
138717890|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138717891|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717892|NCT02277678|Analgesics|analgesics|mesh-ancestor
138717893|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
138717894|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717895|NCT04601675|Dexamethasone|dexamethasone|mesh-list
138717896|NCT04601675|Ranibizumab|ranibizumab|mesh-list
138717897|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138717898|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
138717899|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
138717900|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803637|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
138717901|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717902|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138717904|NCT04601675|Hormones|hormones|mesh-ancestor
138717929|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
138717930|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138717931|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138717932|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
138717933|NCT00473694|Rocuronium|rocuronium|mesh-list
138717934|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
138717935|NCT00473694|Neostigmine|neostigmine|mesh-list
138717936|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138717937|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138717938|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138717939|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717940|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717941|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138717942|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717943|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717945|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717946|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138717947|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
138717948|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138717949|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138717950|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138717951|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138717952|NCT00565331|Rituximab|rituximab|mesh-list
138717953|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138717954|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717955|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
138717956|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717978|NCT02210325|Solithromycin|solithromycin|mesh-list
138717979|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138717980|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138717981|NCT00473265|Teriparatide|teriparatide|mesh-list
138717982|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138717983|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717984|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138717985|NCT00472641|Ziprasidone|ziprasidone|mesh-list
138717986|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138717987|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
138717988|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717989|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718042|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138718043|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718044|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
138718045|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
138718046|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
138718047|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718048|NCT01133665|Lenalidomide|lenalidomide|mesh-list
138718049|NCT01133665|Cetuximab|cetuximab|mesh-list
138718050|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
138718051|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718052|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138718053|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138718054|NCT01133665|Growth Substances|growth substances|mesh-ancestor
138718055|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
138718056|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718057|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138718058|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
138718059|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
138718060|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138718061|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
138718062|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718063|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138718064|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138718065|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138718066|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138718090|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247953|NCT02271698|Dexamethasone|dexamethasone|mesh-list
138718091|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718093|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138718094|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138718095|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718096|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718097|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138718098|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138718099|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718100|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
138718101|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718102|NCT02210364|Capecitabine|capecitabine|mesh-list
138718103|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138718104|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
138718105|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718106|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718107|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138718108|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138803708|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138718109|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138718110|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138718111|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718112|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718113|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718114|NCT00471315|Analgesics|analgesics|mesh-ancestor
138718115|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
138718116|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718117|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
138718118|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138718119|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
138718120|NCT00471237|Alendronate|alendronate|mesh-list
138718121|NCT00471237|Teriparatide|teriparatide|mesh-list
138718122|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138652222|NCT00308360|Risperidone|risperidone|mesh-list
139079475|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139079476|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079477|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079478|NCT03489304|Zaleplon|zaleplon|mesh-list
138718123|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718124|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138718125|NCT04570683|Nivolumab|nivolumab|mesh-list
138718126|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138718127|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718128|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138718129|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718130|NCT04570449|Fluoxetine|fluoxetine|mesh-list
138718131|NCT04570449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138718132|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138718133|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138718134|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718135|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718181|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718182|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718183|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138718184|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718185|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
138718186|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138718187|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138718188|NCT01133275|Growth Substances|growth substances|mesh-ancestor
138718189|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
138718190|NCT00470184|Capecitabine|capecitabine|mesh-list
138718191|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
138718192|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138718193|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
138718194|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718195|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718196|NCT04570254|Vitamins|vitamins|mesh-list
138718197|NCT04570254|Vitamin E|vitamin e|mesh-list
138718198|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
138718199|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
138718200|NCT04570254|Melatonin|melatonin|mesh-list
138718201|NCT04570254|Antioxidants|antioxidants|mesh-list
138718202|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138718203|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
138652276|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139079479|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
139079480|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139079481|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139079482|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079483|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
139079484|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
139079485|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139079486|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079487|NCT03718624|Paclitaxel|paclitaxel|mesh-list
139079488|NCT03718624|Apatinib|apatinib|mesh-list
139079489|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139079490|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079491|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
139079492|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
139079493|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
139079494|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079495|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139079496|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079497|NCT03543358|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
139079498|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
139079499|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
139079500|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079501|NCT03485950|Meropenem|meropenem|mesh-list
139079502|NCT03485950|Tazobactam|tazobactam|mesh-list
139079503|NCT03485950|Piperacillin|piperacillin|mesh-list
139079504|NCT03485950|Cefepime|cefepime|mesh-list
139079505|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139079506|NCT03485950|Ceftolozane|ceftolozane|mesh-list
139079507|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139079508|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138718204|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718205|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718206|NCT04570254|Protective Agents|protective agents|mesh-ancestor
138718207|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718208|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138718209|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718210|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138718211|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138718212|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
138718213|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138718214|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
138718215|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138718216|NCT04570254|Expectorants|expectorants|mesh-ancestor
138718217|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
138718264|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138718265|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
138718266|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138718267|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138718268|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138718269|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138718270|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718271|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
138718272|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718273|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138718274|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138718275|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718276|NCT00478179|Bupivacaine|bupivacaine|mesh-list
138718277|NCT00478179|Anesthetics, Local|anesthetics, local|mesh-ancestor
138718278|NCT00478179|Anesthetics|anesthetics|mesh-ancestor
138718279|NCT00478179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718280|NCT00478179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718281|NCT00478179|Sensory System Agents|sensory system agents|mesh-ancestor
138718282|NCT00478179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718283|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138718284|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138718285|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138718286|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
138718287|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718288|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138718289|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138718290|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718291|NCT00585260|Mannitol|mannitol|mesh-list
138718308|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
138718309|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138718310|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138718312|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
138718313|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138718314|NCT00585455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138718315|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138718316|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138718317|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718318|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718319|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
138718320|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718321|NCT01132807|Prednisone|prednisone|mesh-list
138718323|NCT01132807|Dacarbazine|dacarbazine|mesh-list
138718369|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718370|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718371|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138718372|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138718373|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718374|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718375|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
138718376|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
138718377|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138718378|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138718379|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138718380|NCT03452696|Calcium|calcium|mesh-list
138718431|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718432|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138718433|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138718434|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718436|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138718437|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138718438|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
138718439|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
138718440|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718441|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718442|NCT04569279|Warfarin|warfarin|mesh-list
138718443|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
138718490|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718491|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
138718492|NCT01087788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138803825|NCT02839161|Antacids|antacids|mesh-ancestor
138718493|NCT01087788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138718494|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138718495|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
138718496|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718497|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138718498|NCT00586976|Ropivacaine|ropivacaine|mesh-list
138718499|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
138718500|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
138718501|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718502|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718503|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
138718504|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718505|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
138718506|NCT00587015|Immunotoxins|immunotoxins|mesh-ancestor
138718507|NCT00587015|Immunoconjugates|immunoconjugates|mesh-ancestor
138718508|NCT00587015|Immunologic Factors|immunologic factors|mesh-ancestor
138718509|NCT00587015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718510|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718511|NCT04568772|Atovaquone|atovaquone|mesh-list
138718512|NCT04568772|Proguanil|proguanil|mesh-list
138718514|NCT04568772|Esomeprazole|esomeprazole|mesh-list
138718542|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138718543|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138718544|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
138718545|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718546|NCT00587249|Antacids|antacids|mesh-ancestor
138718547|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718548|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138718549|NCT00587327|Atosiban|atosiban|mesh-list
138718550|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
138718551|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718552|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718553|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
138718605|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138718606|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
138718607|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718608|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718610|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
138718611|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138718612|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718613|NCT03452657|Ranibizumab|ranibizumab|mesh-list
138718614|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138718615|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138718616|NCT03452657|Growth Substances|growth substances|mesh-ancestor
138803851|NCT04260828|Aspirin|aspirin|mesh-list
138718617|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718618|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
138718619|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718620|NCT03452501|Infliximab|infliximab|mesh-list
138718621|NCT03452501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138718622|NCT03452501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138718623|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
138718624|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138718625|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138718626|NCT00588302|Moexipril|moexipril|mesh-list
138718627|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138718628|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
138718657|NCT00588926|Narcotics|narcotics|mesh-ancestor
138718658|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718659|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718660|NCT00588926|Analgesics|analgesics|mesh-ancestor
138718661|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
138718662|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718663|NCT00589082|Daunorubicin|daunorubicin|mesh-list
138718664|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138718665|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718666|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138718667|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138718668|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718669|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718670|NCT00589238|Paclitaxel|paclitaxel|mesh-list
138718671|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
138718672|NCT00589238|Carboplatin|carboplatin|mesh-list
138718673|NCT00589238|Doxorubicin|doxorubicin|mesh-list
138718674|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138718675|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138718676|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718677|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
138718678|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
138718679|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
138718680|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718681|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138718682|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
138718683|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718684|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138718685|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139079509|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139079510|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079511|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079512|NCT00060944|Dexamethasone|dexamethasone|mesh-list
139079513|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
139079514|NCT00060944|Trabectedin|trabectedin|mesh-list
139079515|NCT00060944|BB 1101|bb 1101|mesh-list
139079516|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079517|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
139079518|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
139079519|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079520|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079521|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139079522|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
139079523|NCT00060944|Hormones|hormones|mesh-ancestor
139079524|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139079525|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138718686|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
138803881|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138718687|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138718688|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138718689|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138718690|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138718691|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718692|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138718693|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
138718694|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718695|NCT01083576|Gentamicins|gentamicins|mesh-list
138718696|NCT01083576|Paromomycin|paromomycin|mesh-list
138718697|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138718698|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138718699|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138718700|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718702|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138718745|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718746|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138718747|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138718748|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138718749|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138718750|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718751|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138718752|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138718753|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718755|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138718756|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138718757|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138718758|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
138718759|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718760|NCT00590213|Bicalutamide|bicalutamide|mesh-list
138718761|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
138718762|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
138718763|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718764|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718765|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718767|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
138718768|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
138718769|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718770|NCT00590408|Vitamins|vitamins|mesh-ancestor
138718795|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718797|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718798|NCT03452306|Metformin|metformin|mesh-list
138718799|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138718800|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718801|NCT01080300|Gabapentin|gabapentin|mesh-list
138718802|NCT01080300|Analgesics|analgesics|mesh-ancestor
138718803|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
138718804|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718805|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718806|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
138718807|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138718808|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138718809|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718856|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138718857|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
138718858|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718859|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718860|NCT01086267|Cetuximab|cetuximab|mesh-list
138718861|NCT01086267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138718862|NCT01086267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718863|NCT00590915|Asparaginase|asparaginase|mesh-list
138718864|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718865|NCT04567290|Ticagrelor|ticagrelor|mesh-list
138718866|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138718867|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138718868|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138718869|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138718870|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
138718871|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718873|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718912|NCT01081782|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138718913|NCT01081782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718914|NCT01081782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138718915|NCT01081782|Immunologic Factors|immunologic factors|mesh-ancestor
138718916|NCT01081782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718918|NCT01080222|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138718919|NCT01080222|Antimetabolites|antimetabolites|mesh-ancestor
138718920|NCT01080222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718921|NCT01080222|Antiviral Agents|antiviral agents|mesh-ancestor
138803928|NCT00848536|Travoprost|travoprost|mesh-list
138718922|NCT01080222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138718923|NCT03452267|Metformin|metformin|mesh-list
138718924|NCT03452267|Pioglitazone|pioglitazone|mesh-list
138718925|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138718926|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718972|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718974|NCT04572542|Apatinib|apatinib|mesh-list
138718975|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138718976|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718977|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
138718978|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
138718979|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
138718980|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718981|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138718982|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718983|NCT04572620|Rituximab|rituximab|mesh-list
138718984|NCT04572620|Abatacept|abatacept|mesh-list
138718985|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138718986|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718987|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
138718988|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718989|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138719030|NCT04565496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719031|NCT03450161|Fentanyl|fentanyl|mesh-list
138719032|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138719033|NCT03450161|Narcotics|narcotics|mesh-ancestor
138719034|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138719035|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719036|NCT03450161|Analgesics|analgesics|mesh-ancestor
138719037|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
138719038|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719039|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138719043|NCT04565184|Artesunate|artesunate|mesh-list
138719093|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719094|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138719095|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138719096|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138719097|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138719098|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138719099|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
138719100|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719101|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719102|NCT04564638|Cyclosporine|cyclosporine|mesh-list
138719103|NCT04564638|Cyclosporins|cyclosporins|mesh-list
138719104|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719105|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719106|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138719107|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
138719108|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719150|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
138719151|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
138719152|NCT02215122|Hormones|hormones|mesh-ancestor
138719153|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719154|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
138719155|NCT00196976|Edetic Acid|edetic acid|mesh-list
138719156|NCT00196976|Vaccines|vaccines|mesh-list
138719157|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
138719158|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
138719159|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719160|NCT00196976|Antidotes|antidotes|mesh-ancestor
138719161|NCT00196976|Protective Agents|protective agents|mesh-ancestor
138719162|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
138719163|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
138719164|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719212|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
138719213|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719214|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719215|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
138719216|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719217|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138719218|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138719219|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
138719220|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138719221|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138719222|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138719223|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138719224|NCT00195494|Analgesics|analgesics|mesh-ancestor
138719225|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
138719226|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719227|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138719228|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138719270|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138719271|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
138719272|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719273|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
138719274|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138719275|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
138719276|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138719277|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138719278|NCT02486367|Clopidogrel|clopidogrel|mesh-list
138719279|NCT02486367|Ticagrelor|ticagrelor|mesh-list
138719280|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138719281|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138719330|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719331|NCT04563429|Vitamin A|vitamin a|mesh-list
138719332|NCT04563429|Vitamins|vitamins|mesh-ancestor
138719333|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
138719334|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719335|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138719336|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138719337|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138719338|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138719339|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719340|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
138719341|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719342|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719343|NCT00191984|Irinotecan|irinotecan|mesh-list
138719391|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719392|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
138719393|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719394|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719395|NCT00198263|Bleomycin|bleomycin|mesh-list
138719396|NCT00198263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138719397|NCT00198263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719398|NCT00198107|Cycloserine|cycloserine|mesh-list
138719399|NCT00198107|Aripiprazole|aripiprazole|mesh-list
138719400|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
138719401|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138719402|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138719403|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138719404|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138719423|NCT00179660|Lenalidomide|lenalidomide|mesh-list
138719452|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719453|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719454|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138719455|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138719456|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138719457|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138719458|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
138719459|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
138719460|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
138719461|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719462|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138719463|NCT00177164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138719464|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138719465|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138719466|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
138719467|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
138719468|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138719469|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138719470|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138719471|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138719472|NCT04559841|Simvastatin|simvastatin|mesh-list
138719473|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138719474|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138719476|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719477|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138719478|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138719479|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719480|NCT02489942|Empagliflozin|empagliflozin|mesh-list
138719481|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138719482|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719483|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138719484|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719491|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138719492|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138719493|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138719494|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
138719495|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
138719496|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
138719497|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
138719498|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719499|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719500|NCT00176462|Leucovorin|leucovorin|mesh-list
138719501|NCT00176462|Cytarabine|cytarabine|mesh-list
138719502|NCT00176462|Dexamethasone|dexamethasone|mesh-list
138719503|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
138719504|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
138719505|NCT00176462|Methotrexate|methotrexate|mesh-list
138719506|NCT00176462|Vincristine|vincristine|mesh-list
138719507|NCT00176462|Asparaginase|asparaginase|mesh-list
138719509|NCT00176462|Thioguanine|thioguanine|mesh-list
138719510|NCT00176462|Daunorubicin|daunorubicin|mesh-list
138719511|NCT00176462|Aminopterin|aminopterin|mesh-list
138719554|NCT00175019|Febuxostat|febuxostat|mesh-list
138719555|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
138719556|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719557|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719558|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
138719559|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138719560|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138719561|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
138719562|NCT00175019|Protective Agents|protective agents|mesh-ancestor
138719563|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719564|NCT00174941|Febuxostat|febuxostat|mesh-list
138719565|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
138719566|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138719567|NCT00171704|Tamoxifen|tamoxifen|mesh-list
138719568|NCT00171704|Letrozole|letrozole|mesh-list
138719569|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719615|NCT00476606|Indinavir|indinavir|mesh-list
138719616|NCT00476606|Saquinavir|saquinavir|mesh-list
138719617|NCT00476606|Lamivudine|lamivudine|mesh-list
138719618|NCT00476606|Zidovudine|zidovudine|mesh-list
138719619|NCT00476606|Nevirapine|nevirapine|mesh-list
138719620|NCT00476606|Didanosine|didanosine|mesh-list
138719621|NCT00476606|Stavudine|stavudine|mesh-list
138719622|NCT00476606|Efavirenz|efavirenz|mesh-list
138719623|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138719624|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138719625|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
138719626|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719627|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719628|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138719629|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138719630|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
138719678|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
138719679|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
138719680|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719681|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
138719682|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138719683|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
138719684|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719685|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
138719686|NCT00479687|Protective Agents|protective agents|mesh-ancestor
138719687|NCT00479336|Tolvaptan|tolvaptan|mesh-list
138719690|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
138719742|NCT00477386|Decitabine|decitabine|mesh-list
138719743|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138719744|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
138719745|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719746|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719747|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719748|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
138719749|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719750|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138546543|NCT00230542|Pemetrexed|pemetrexed|mesh-list
138719809|NCT04556760|Hormones|hormones|mesh-ancestor
138719810|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719811|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719812|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138719813|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719815|NCT00474929|Sorafenib|sorafenib|mesh-list
138719878|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
138719879|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
138719880|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
138719881|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719882|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138719883|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
138719884|NCT02212431|Cysteamine|cysteamine|mesh-list
138719885|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138719886|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719887|NCT00470093|Interferons|interferons|mesh-list
138719888|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719889|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
138719890|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138719939|NCT00474188|Glucocorticoids|glucocorticoids|mesh-ancestor
138719940|NCT00474188|Hormones|hormones|mesh-ancestor
138719941|NCT00474188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719942|NCT00474188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138719943|NCT00474188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719944|NCT00474188|Immunologic Factors|immunologic factors|mesh-ancestor
138719945|NCT00474188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138719946|NCT00474188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138719947|NCT00474188|Growth Substances|growth substances|mesh-ancestor
138719948|NCT00474188|Growth Inhibitors|growth inhibitors|mesh-ancestor
138719949|NCT01089647|Budesonide|budesonide|mesh-list
138719950|NCT01089647|Montelukast|montelukast|mesh-list
138719951|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138720001|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720002|NCT02212782|Incretins|incretins|mesh-ancestor
138720003|NCT02212782|Hormones|hormones|mesh-ancestor
138720004|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720005|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138720006|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
138720007|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720008|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720009|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138720010|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138720011|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
138720012|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720013|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720014|NCT02212821|Erythromycin|erythromycin|mesh-list
138720015|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
138720016|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138720017|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
138720058|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138720059|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138720060|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138720061|NCT01088048|Growth Substances|growth substances|mesh-ancestor
138720062|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
138720063|NCT01088048|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138720064|NCT01088048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138720065|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720066|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138720067|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
138720068|NCT01087970|Carboplatin|carboplatin|mesh-list
138720069|NCT01087970|Pemetrexed|pemetrexed|mesh-list
138720070|NCT01087970|Cetuximab|cetuximab|mesh-list
138720071|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720072|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720073|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720074|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138720075|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138720076|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138720077|NCT01087814|Efavirenz|efavirenz|mesh-list
138720080|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720111|NCT02213211|Artemisinin|artemisinin|mesh-list
138720112|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
138720113|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138720114|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138720115|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720116|NCT01086410|Fluticasone|fluticasone|mesh-list
138720117|NCT01086410|Xhance|xhance|mesh-list
138720118|NCT01086410|Prednisolone|prednisolone|mesh-list
138720119|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138720120|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138720121|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
138720122|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720123|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720124|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138720125|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
138720126|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
138720127|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138720128|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
138720172|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720173|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138720174|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138720175|NCT01085045|Bromides|bromides|mesh-list
138720176|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
138720177|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
138720178|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138720179|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
138676471|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
138720180|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720181|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720182|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138720234|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720235|NCT04552431|Urological Agents|urological agents|mesh-ancestor
138720236|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
138720237|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138720238|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720239|NCT01084538|Vitamins|vitamins|mesh-ancestor
138720240|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
138720241|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138720242|NCT00179517|Anastrozole|anastrozole|mesh-list
138720300|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138720301|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720302|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
138720303|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
138720304|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138720305|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
138720306|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720307|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
138720308|NCT04671914|Protective Agents|protective agents|mesh-ancestor
138720309|NCT01083485|Oxycodone|oxycodone|mesh-list
138720310|NCT01083485|Naloxone|naloxone|mesh-list
138720311|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138720312|NCT01083485|Narcotics|narcotics|mesh-ancestor
138720313|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138720364|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720365|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720366|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
138720367|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720368|NCT01082081|Acetaminophen|acetaminophen|mesh-list
138720369|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138720370|NCT01082081|Analgesics|analgesics|mesh-ancestor
138720371|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
138720430|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138720431|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138720432|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138720433|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138720434|NCT01081145|Guanfacine|guanfacine|mesh-list
138720435|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138720436|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138720443|NCT00174915|Allopurinol|allopurinol|mesh-list
138720498|NCT01087151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138720499|NCT01087151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720500|NCT01087151|Immunologic Factors|immunologic factors|mesh-ancestor
138720501|NCT01087151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720502|NCT01087151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138720504|NCT00171834|Epothilone B|epothilone b|mesh-list
138720505|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
138720565|NCT00179400|Pioglitazone|pioglitazone|mesh-list
138720566|NCT00179400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138720567|NCT00179400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720568|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
138720569|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138720570|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138720571|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720572|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
138720573|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720574|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720576|NCT00479856|Docetaxel|docetaxel|mesh-list
138720577|NCT00479856|Capecitabine|capecitabine|mesh-list
138720578|NCT00479856|Lapatinib|lapatinib|mesh-list
138720579|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138720580|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720581|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
138720627|NCT00479232|Vorinostat|vorinostat|mesh-list
138720628|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138720629|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
138720630|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720631|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720632|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720633|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138720634|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138720635|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
138720636|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138720692|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138720694|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720695|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
138720696|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138720697|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720698|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720699|NCT00478608|Sirolimus|sirolimus|mesh-list
138720700|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138720701|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720758|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720759|NCT04549935|Prednisolone|prednisolone|mesh-list
138720760|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138720761|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
138720762|NCT04549935|Hormones|hormones|mesh-ancestor
138720763|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720764|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720765|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138720766|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720767|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138720768|NCT00477633|Norethindrone|norethindrone|mesh-list
138720769|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
138720770|NCT00477633|Estradiol|estradiol|mesh-list
138720771|NCT00477633|Estrogens|estrogens|mesh-ancestor
138720772|NCT00477633|Hormones|hormones|mesh-ancestor
138720773|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720819|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
138720820|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720821|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720822|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
138720823|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720824|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138720825|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
138720826|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720827|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720884|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720885|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138720886|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138720887|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138720888|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138720889|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138720890|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
138720891|NCT02215434|Testosterone|testosterone|mesh-list
138720892|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
138720893|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
138804175|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720894|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138720895|NCT02215434|Androgens|androgens|mesh-ancestor
138720948|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720949|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138720950|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
138720951|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720952|NCT04560218|Misoprostol|misoprostol|mesh-list
138720953|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138720954|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
138720955|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138720956|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720957|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138720958|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138720959|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
138720960|NCT05135104|Palbociclib|palbociclib|mesh-list
138720961|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720962|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138720963|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720965|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
138721007|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721008|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721009|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138721010|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138721011|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
138721012|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138721013|NCT04311697|Protective Agents|protective agents|mesh-ancestor
138721015|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138721016|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138721017|NCT00575861|Analgesics|analgesics|mesh-ancestor
138721018|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
138721019|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721020|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721021|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138804200|NCT02836509|Ibuprofen|ibuprofen|mesh-list
138721022|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138721023|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138721024|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721025|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721026|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138721027|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
138721028|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138721029|NCT04547088|Apatinib|apatinib|mesh-list
138721030|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721031|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138721034|NCT01129882|Aripiprazole|aripiprazole|mesh-list
138721055|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721056|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
138721057|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721058|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721059|NCT02882737|Glucagon|glucagon|mesh-list
138721060|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138721061|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138721062|NCT02882737|Hormones|hormones|mesh-ancestor
138721065|NCT02882737|Incretins|incretins|mesh-ancestor
138721122|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138721123|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138721124|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721125|NCT02278458|Gemcitabine|gemcitabine|mesh-list
138721126|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138721127|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
138721128|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721129|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721130|NCT01128595|Fluticasone|fluticasone|mesh-list
138721131|NCT01128595|Xhance|xhance|mesh-list
138721132|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138721133|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138721134|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
138721135|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721136|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721137|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138721138|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
138721139|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
138721140|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138721141|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
138721142|NCT01129336|Diphosphonates|diphosphonates|mesh-list
138721143|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138721144|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721145|NCT01128244|Pyridoxine|pyridoxine|mesh-list
138721146|NCT01128244|Pyridoxal|pyridoxal|mesh-list
138721147|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
138721148|NCT01128244|Vitamins|vitamins|mesh-ancestor
138721173|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721174|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
138721175|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721176|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138721177|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138721178|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138721242|NCT02882347|Somatostatin|somatostatin|mesh-list
138721243|NCT02882347|Hormones|hormones|mesh-ancestor
138721244|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138721245|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721246|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
138721247|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138721248|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721249|NCT00637468|Aspirin|aspirin|mesh-list
138721250|NCT00637468|Heparin|heparin|mesh-list
138721251|NCT00637468|Acetazolamide|acetazolamide|mesh-list
138721252|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138721253|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
138721254|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138721255|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138721256|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721257|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138721258|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138721259|NCT00637468|Analgesics|analgesics|mesh-ancestor
138721260|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
138721261|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721262|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721263|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138721264|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138721296|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138721297|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721298|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138721299|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721301|NCT04558268|Hematinics|hematinics|mesh-ancestor
138721302|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
138721303|NCT04558268|Vitamins|vitamins|mesh-ancestor
138721304|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
138721305|NCT01125514|Furosemide|furosemide|mesh-list
138721306|NCT01125514|Diuretics|diuretics|mesh-ancestor
138677596|NCT00494156|Analgesics|analgesics|mesh-ancestor
138721307|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
138721308|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721309|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138721310|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138721353|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721354|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
138721355|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
138721356|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721357|NCT04558424|Protective Agents|protective agents|mesh-ancestor
138721358|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721359|NCT04558424|Vitamins|vitamins|mesh-ancestor
138721360|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
138721361|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
138721362|NCT00576602|Hematinics|hematinics|mesh-ancestor
138721363|NCT02212223|Vitamin D|vitamin d|mesh-list
138721418|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721419|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138721420|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721421|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
138721422|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138804264|NCT05326425|Lazertinib|lazertinib|mesh-list
138721423|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138721424|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721425|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721426|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
138721427|NCT04579133|Durvalumab|durvalumab|mesh-list
138721428|NCT04579133|Olaparib|olaparib|mesh-list
138721429|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138721430|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721431|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138721432|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721434|NCT00576914|Endostatins|endostatins|mesh-list
138721477|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
138721478|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
138721479|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721480|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138721481|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138721482|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721483|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721484|NCT00577109|Leucovorin|leucovorin|mesh-list
138721485|NCT00577109|Bevacizumab|bevacizumab|mesh-list
138721486|NCT00577109|Cetuximab|cetuximab|mesh-list
138721487|NCT00577109|Irinotecan|irinotecan|mesh-list
138721488|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138721489|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721490|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138721491|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138721539|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138721540|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138721541|NCT01124149|Analgesics|analgesics|mesh-ancestor
138721542|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
138721543|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804282|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
138721544|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721545|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138721546|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138721547|NCT04545099|Neostigmine|neostigmine|mesh-list
138721548|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138721549|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721550|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721551|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
138721552|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721553|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721595|NCT00577694|Clofarabine|clofarabine|mesh-list
138721596|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
138721597|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138721598|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
138721599|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721600|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721601|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138721602|NCT00577694|Immunotoxins|immunotoxins|mesh-ancestor
138721603|NCT00577694|Immunoconjugates|immunoconjugates|mesh-ancestor
138721604|NCT00577694|Immunologic Factors|immunologic factors|mesh-ancestor
138721605|NCT00577694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721606|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
138721607|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138721608|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138721609|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721610|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
138721611|NCT04537533|Coagulants|coagulants|mesh-ancestor
138721612|NCT02216058|Sirolimus|sirolimus|mesh-list
138721613|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138721614|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721615|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138721616|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721617|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
138721618|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138721619|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
138721620|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721621|NCT00577850|Alendronate|alendronate|mesh-list
138721629|NCT00577967|Gabapentin|gabapentin|mesh-list
138721643|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
138721645|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138721646|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721647|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
138721648|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138721649|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721650|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138721651|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721652|NCT04578470|Vitamin D|vitamin d|mesh-list
138721653|NCT04578470|Vitamins|vitamins|mesh-ancestor
138721654|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
138721655|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721656|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138721706|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
138721707|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138721708|NCT04543890|Etoposide|etoposide|mesh-list
138721709|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721710|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138721711|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138721712|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138721713|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721714|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721715|NCT04536831|Vitamin D|vitamin d|mesh-list
138721716|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
138721717|NCT04536831|Cholecalciferol|cholecalciferol|mesh-list
138721718|NCT04536831|Vitamins|vitamins|mesh-list
138721719|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
138721720|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721721|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138721722|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138721723|NCT02214966|Telmisartan|telmisartan|mesh-list
138721724|NCT02214966|Ramipril|ramipril|mesh-list
138721725|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138721726|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138721759|NCT00578825|Ribavirin|ribavirin|mesh-list
138721760|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138721761|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138721762|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
138721763|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721764|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721765|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138721766|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138721767|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
138721768|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721769|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138721770|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138721771|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
138721772|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
138721820|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138721821|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138721822|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138721823|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138721824|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138721825|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138721826|NCT04535817|Omalizumab|omalizumab|mesh-list
138721827|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138721828|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138721886|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721887|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721888|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
138804367|NCT00928434|Leuprolide|leuprolide|mesh-list
138721889|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721890|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138721891|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
138721892|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
138721893|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138721894|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
138721895|NCT04532775|Hormones|hormones|mesh-ancestor
138721896|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138721897|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138721898|NCT04532775|Protective Agents|protective agents|mesh-ancestor
138721899|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138721900|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721944|NCT04555733|Lemborexant|lemborexant|mesh-list
138721945|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138721946|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721947|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721948|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138721949|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138721950|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721951|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721952|NCT02216994|Mineral Oil|mineral oil|mesh-list
138721953|NCT02216994|Lactulose|lactulose|mesh-list
138721954|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138722008|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722009|NCT00580112|Dexamethasone|dexamethasone|mesh-list
138722010|NCT00580112|Trabectedin|trabectedin|mesh-list
138722011|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138722012|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
138722013|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
138722014|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722015|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722074|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
138722075|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
138722076|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138722077|NCT04530474|Ivermectin|ivermectin|mesh-list
138722078|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138722079|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722080|NCT04554680|Trametinib|trametinib|mesh-list
138722081|NCT04554680|Dabrafenib|dabrafenib|mesh-list
138722082|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722083|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138722084|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722085|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722086|NCT00580424|Norethindrone|norethindrone|mesh-list
138722087|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
138722088|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138722089|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138722090|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138722091|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
138722092|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138722093|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722129|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
138722130|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
138722131|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722132|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722133|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138722134|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138722135|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138722144|NCT04554524|Paclitaxel|paclitaxel|mesh-list
138722195|NCT02217930|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138722196|NCT04577846|Cephalexin|cephalexin|mesh-list
138722197|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138722198|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722199|NCT04529811|Rifaximin|rifaximin|mesh-list
138722200|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138722201|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722203|NCT02218047|Interferons|interferons|mesh-list
138722264|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722265|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138722266|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
138722267|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138722268|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138722269|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138722270|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
138722271|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722272|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722273|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
138722274|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
138722275|NCT00581009|Sertraline|sertraline|mesh-list
138722326|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722327|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138722328|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
138722329|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
138722330|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138722331|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
138722332|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722333|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722334|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138722335|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138722337|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138722338|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138722339|NCT01119898|Analgesics|analgesics|mesh-ancestor
138722340|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
138722341|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722342|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722348|NCT01119859|Adalimumab|adalimumab|mesh-list
138722382|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
138722383|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722384|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138722386|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
138722387|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722388|NCT01118962|Lacosamide|lacosamide|mesh-list
138722389|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
138722390|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138722391|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138722392|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138722393|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722394|NCT00581165|Etanercept|etanercept|mesh-list
138722395|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138722396|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138722397|NCT00581165|Analgesics|analgesics|mesh-ancestor
138722398|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
138722439|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138722440|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
138722441|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138722442|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138722443|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
138722444|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138722445|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
138722446|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138722447|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138722448|NCT01118377|Capecitabine|capecitabine|mesh-list
138722449|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138722450|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
138722451|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722452|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722453|NCT02219178|Dexamethasone|dexamethasone|mesh-list
138722454|NCT02219178|Lenalidomide|lenalidomide|mesh-list
138722455|NCT02219178|Bortezomib|bortezomib|mesh-list
138722456|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138722457|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
138722458|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
138722459|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722460|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722461|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138722491|NCT04577378|Tretinoin|tretinoin|mesh-list
138722492|NCT04577378|Isotretinoin|isotretinoin|mesh-list
138722493|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
138722494|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722495|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138722496|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138722497|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722498|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722499|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138722500|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
138804434|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
138722501|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138722502|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722552|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138722553|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138722554|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
138722555|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722556|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722557|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722558|NCT02211846|Urological Agents|urological agents|mesh-ancestor
138722559|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138722560|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
138722561|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138722562|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138722563|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722564|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722565|NCT02219646|Urological Agents|urological agents|mesh-ancestor
138722610|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138722611|NCT00581789|Growth Substances|growth substances|mesh-ancestor
138722612|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722613|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
138722614|NCT02213588|Antioxidants|antioxidants|mesh-list
138722615|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722616|NCT02213588|Protective Agents|protective agents|mesh-ancestor
138722617|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722618|NCT01642524|Dextrans|dextrans|mesh-list
138722619|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
138722620|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
138722621|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
138722622|NCT02213783|Imipenem|imipenem|mesh-list
138722623|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138722624|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722625|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
138722626|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722627|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138722628|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722629|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722630|NCT02219490|Ritonavir|ritonavir|mesh-list
138722631|NCT02219490|Ribavirin|ribavirin|mesh-list
138722632|NCT02219490|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138722663|NCT02211417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138722665|NCT02211417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722666|NCT02211417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138722667|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
138722668|NCT02211417|Emollients|emollients|mesh-ancestor
138722669|NCT02279121|Taurolidine|taurolidine|mesh-list
138722670|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138722671|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722672|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138722673|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722674|NCT02218164|Interferons|interferons|mesh-list
138722675|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
138722676|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
138722728|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
138722729|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138722730|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138722731|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722732|NCT01643499|Antidotes|antidotes|mesh-ancestor
138722733|NCT01643499|Protective Agents|protective agents|mesh-ancestor
138722734|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
138722735|NCT01643499|Vitamins|vitamins|mesh-ancestor
138722736|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
138722737|NCT01117012|Ivacaftor|ivacaftor|mesh-list
138722738|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138722739|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138722740|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722741|NCT01116739|Fluorides|fluorides|mesh-list
138722742|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
138722743|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
138722744|NCT01116739|Protective Agents|protective agents|mesh-ancestor
138722745|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722746|NCT01640496|Vitamin D|vitamin d|mesh-list
138722747|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
138722748|NCT01640496|Vitamins|vitamins|mesh-ancestor
138722749|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
138722750|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722751|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138722752|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138722753|NCT04551248|Vaccines|vaccines|mesh-list
138722754|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138722755|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
138722756|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722776|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
138722777|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722778|NCT04550858|Rebamipide|rebamipide|mesh-list
138722779|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138722780|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138722781|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
138722782|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722783|NCT04550858|Protective Agents|protective agents|mesh-ancestor
138722784|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722785|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722786|NCT01640574|Chloroquine|chloroquine|mesh-list
138722787|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138722788|NCT01640574|Piperaquine|piperaquine|mesh-list
138722789|NCT01640574|Artenimol|artenimol|mesh-list
138722790|NCT01640574|Artemisinins|artemisinins|mesh-list
138722791|NCT01640574|Amebicides|amebicides|mesh-ancestor
138722792|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138722793|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138722794|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722795|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
138722796|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138722797|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138722832|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138722833|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
138722834|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
138722835|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
138722836|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722837|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138722838|NCT04529226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138722839|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138722840|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138722841|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138722842|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
138722843|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
138722844|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138722845|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
138722846|NCT04310683|Hormones|hormones|mesh-list
138722847|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138722848|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722849|NCT04550702|Mirabegron|mirabegron|mesh-list
138722850|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138804536|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
138722888|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722889|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722890|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722891|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722892|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
138722894|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722895|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138722896|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138722897|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
138722898|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722899|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
138722900|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
138722901|NCT04550078|Calcium|calcium|mesh-list
138722902|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138722903|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722904|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138722905|NCT04550078|Antacids|antacids|mesh-ancestor
138722906|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722907|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138722945|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722946|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138722947|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
138722949|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138722950|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138722951|NCT04528797|Protective Agents|protective agents|mesh-ancestor
138722952|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138722953|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722954|NCT00624481|Teriparatide|teriparatide|mesh-list
138722955|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138722956|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722957|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138722958|NCT04529187|Midazolam|midazolam|mesh-list
138722959|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
138722960|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138722961|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138722962|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722963|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138722964|NCT04529187|Analgesics|analgesics|mesh-ancestor
138722965|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
138722966|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722967|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138722968|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138722969|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138722970|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
138722971|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722972|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722973|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138722989|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138722990|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
138722992|NCT01204294|Metformin|metformin|mesh-list
138722993|NCT01204294|Linagliptin|linagliptin|mesh-list
138722994|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138722995|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722996|NCT01204294|Incretins|incretins|mesh-ancestor
138722997|NCT01204294|Hormones|hormones|mesh-ancestor
138723000|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
138723058|NCT04547894|Protease Inhibitors|protease inhibitors|mesh-ancestor
138723059|NCT04547894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723060|NCT04547894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723061|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
138723062|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
138723063|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723064|NCT01644825|Paclitaxel|paclitaxel|mesh-list
138723065|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138723066|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723067|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
138723068|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
138723069|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
138723071|NCT01644864|Ropivacaine|ropivacaine|mesh-list
138723118|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723119|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
138723120|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723121|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
138723122|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723124|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723125|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138723126|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723127|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723128|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
138723129|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138723130|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723131|NCT04547504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138723132|NCT04547504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723133|NCT01645254|Antimalarials|antimalarials|mesh-list
138723134|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138723135|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138723136|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723137|NCT01181011|Amlodipine|amlodipine|mesh-list
138723138|NCT01181011|Telmisartan|telmisartan|mesh-list
138723171|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723173|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
138723174|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723175|NCT04546373|Niraparib|niraparib|mesh-list
138723176|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138804590|NCT02613130|Fluorides|fluorides|mesh-list
138723177|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723178|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723179|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723180|NCT01645410|Atorvastatin|atorvastatin|mesh-list
138723182|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138723183|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723234|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138723235|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
138723236|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723237|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138723238|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138723239|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723240|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138723241|NCT01645800|Muramidase|muramidase|mesh-list
138723299|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138723300|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
138723301|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
138723302|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723303|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723304|NCT01646307|Atorvastatin|atorvastatin|mesh-list
138723305|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138723306|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138723307|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138723308|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
138723309|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723310|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138723311|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138723312|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723313|NCT04544969|Cisplatin|cisplatin|mesh-list
138723315|NCT04544969|Docetaxel|docetaxel|mesh-list
138723360|NCT04544228|Neostigmine|neostigmine|mesh-list
138723361|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
138723362|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
138723363|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723364|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723365|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
138723366|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723367|NCT04544228|Analgesics|analgesics|mesh-ancestor
138723368|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138723369|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138723370|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
138723371|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138723372|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138723373|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723374|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723375|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138723376|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723377|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
138723417|NCT01646853|Fluorouracil|fluorouracil|mesh-list
138723418|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723419|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
138723420|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723421|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138723422|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138723423|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
138723424|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723425|NCT01647165|Dexamethasone|dexamethasone|mesh-list
138723426|NCT01647165|Lenalidomide|lenalidomide|mesh-list
138723427|NCT01647165|Bortezomib|bortezomib|mesh-list
138723481|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138723482|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138723483|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723484|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138723485|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
138723486|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723487|NCT04528095|Clozapine|clozapine|mesh-list
138723488|NCT04528095|Amisulpride|amisulpride|mesh-list
138723489|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138723490|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
138723491|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723492|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723493|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723543|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
138723544|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723545|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723546|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138723547|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138723548|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
138723549|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
138723550|NCT01681563|Ofatumumab|ofatumumab|mesh-list
138723551|NCT01681563|Pentostatin|pentostatin|mesh-list
138723552|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138723553|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
138723554|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723555|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138723556|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138723557|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
138723558|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723604|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723605|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
138723606|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723607|NCT01682343|Calcium|calcium|mesh-list
138723608|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138723609|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723610|NCT01648257|Cabotegravir|cabotegravir|mesh-list
138723611|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138723612|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138723613|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723614|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546654|NCT00097071|Insulin|insulin|mesh-list
138723665|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138723666|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138723667|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723668|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
138723669|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723670|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
138723671|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
138723672|NCT01682499|Calcium|calcium|mesh-list
138723673|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138723674|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723675|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138723676|NCT01682499|Analgesics|analgesics|mesh-ancestor
138723677|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
138723678|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723679|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
138723680|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723681|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138723682|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
138723683|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138723684|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138723685|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804700|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
138723686|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
138723687|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138723688|NCT04540055|Anesthetics|anesthetics|mesh-list
138723689|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723690|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723691|NCT01180660|Lidocaine|lidocaine|mesh-list
138723692|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
138723693|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
138723694|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723695|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723696|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
138723697|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723698|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138723699|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138723700|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139079526|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723701|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138723702|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723703|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138723704|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138723705|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723707|NCT01202227|Analgesics|analgesics|mesh-ancestor
138723708|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
138680018|NCT02274974|Lidocaine|lidocaine|mesh-list
138723765|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
138723766|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723767|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723768|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138723769|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
138723770|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138723771|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
138723772|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
138723773|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723774|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723776|NCT02279628|Ropivacaine|ropivacaine|mesh-list
138723777|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138723829|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138723830|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138723831|NCT01179919|Oseltamivir|oseltamivir|mesh-list
138723832|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
138723833|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723834|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723835|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723836|NCT01201798|Prednisolone|prednisolone|mesh-list
138723837|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138723838|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
138723894|NCT01200589|Rituximab|rituximab|mesh-list
138723895|NCT01200589|Ofatumumab|ofatumumab|mesh-list
138723896|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138723897|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138723898|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723899|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
138723900|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723901|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138723902|NCT01683552|Fexofenadine|fexofenadine|mesh-list
138723903|NCT01683552|Prednisone|prednisone|mesh-list
138723904|NCT01683552|Aprepitant|aprepitant|mesh-list
138804714|NCT00781885|Beraprost|beraprost|mesh-list
138723905|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138723906|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
138723907|NCT01683552|Hormones|hormones|mesh-ancestor
138723908|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138723909|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723952|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138723953|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138723954|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
138723955|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723956|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723957|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
138723958|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138723959|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138723960|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724015|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
138724016|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138724018|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724019|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138724020|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
138724021|NCT01649505|Coagulants|coagulants|mesh-ancestor
138724022|NCT01178086|Rituximab|rituximab|mesh-list
138724023|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138724024|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724025|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
138724026|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724027|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138724028|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
138724029|NCT04531865|Rituximab|rituximab|mesh-list
138724075|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724076|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724077|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138680393|NCT00510081|Calcium|calcium|mesh-list
138724078|NCT04315831|Buprenorphine|buprenorphine|mesh-list
138724079|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138724080|NCT04315831|Narcotics|narcotics|mesh-ancestor
138724081|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138724082|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724083|NCT04315831|Analgesics|analgesics|mesh-ancestor
138724084|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
138724085|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724086|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138724087|NCT02216045|Ribavirin|ribavirin|mesh-list
138724088|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138724089|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
138724090|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
138724132|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724133|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138724134|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
138724135|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138804732|NCT00918684|Escitalopram|escitalopram|mesh-list
138724136|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724201|NCT01685658|Acetaminophen|acetaminophen|mesh-list
138724202|NCT01685658|Ketoprofen|ketoprofen|mesh-list
138724203|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138724204|NCT01685658|Analgesics|analgesics|mesh-ancestor
138724205|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
138724206|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724207|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724208|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
138724209|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138724210|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138724211|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138724212|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138724213|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724214|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724215|NCT04530578|Heparin|heparin|mesh-list
138724216|NCT04530578|Calcium heparin|calcium heparin|mesh-list
138724264|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138724265|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138724266|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138724267|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
138724268|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138724269|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724270|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138724271|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138724272|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138724273|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138724274|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724275|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138724326|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724327|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138724328|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138724329|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
138724330|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724332|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138724333|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138724334|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724336|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
138724392|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138724393|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
138724394|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138724395|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
138724396|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724397|NCT04535960|Liraglutide|liraglutide|mesh-list
138724398|NCT04535960|Empagliflozin|empagliflozin|mesh-list
138724399|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138724400|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724401|NCT04535960|Incretins|incretins|mesh-ancestor
138724402|NCT04535960|Hormones|hormones|mesh-ancestor
138724404|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138724456|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
138724457|NCT01688154|Procyanidin|procyanidin|mesh-list
138724458|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
138804761|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
138724459|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724460|NCT01688154|Protective Agents|protective agents|mesh-ancestor
138724461|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724462|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138724463|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138724464|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724524|NCT02218658|Brotizolam|brotizolam|mesh-list
138724525|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138724526|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138724527|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724528|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138724529|NCT01199068|Efatutazone|efatutazone|mesh-list
138724530|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724531|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138680847|NCT00512928|Vitamin K|vitamin k|mesh-list
138724532|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724533|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724534|NCT01198873|Dronedarone|dronedarone|mesh-list
138724536|NCT01198795|Escitalopram|escitalopram|mesh-list
138724586|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724587|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
138724588|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138724589|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
138724590|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724591|NCT01198132|Vitamin D|vitamin d|mesh-list
138724592|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
138724593|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
138724594|NCT01198132|Vitamins|vitamins|mesh-list
138724595|NCT01198132|Interferons|interferons|mesh-list
138724596|NCT01198132|Interferon-beta|interferon-beta|mesh-list
138724597|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
138724598|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
138724599|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724600|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138724601|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138724602|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724603|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
138724604|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724605|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
138724606|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138724640|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724641|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138724642|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
138724643|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
138724644|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
138724645|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724646|NCT01196104|Insulin|insulin|mesh-list
138724647|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138724648|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
138724649|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
138724650|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138724651|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724652|NCT04534322|Dexamethasone|dexamethasone|mesh-list
138724653|NCT04534322|Melphalan|melphalan|mesh-list
138724654|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138724655|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
138724656|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
138724657|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724658|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724697|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138724698|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
138724699|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138724700|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
138724701|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724703|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138724765|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138724766|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138724767|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724768|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
138724769|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138724770|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724771|NCT02219906|Resveratrol|resveratrol|mesh-list
138724772|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
138724773|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724774|NCT02219906|Protective Agents|protective agents|mesh-ancestor
138724831|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138724832|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
138724833|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138724834|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
138724835|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138724836|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138724837|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138724838|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138724840|NCT01195090|Pioglitazone|pioglitazone|mesh-list
138724898|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138724899|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724900|NCT02216786|Everolimus|everolimus|mesh-list
138724901|NCT02216786|Fulvestrant|fulvestrant|mesh-list
138724902|NCT02216786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138724903|NCT02216786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138724904|NCT02216786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724905|NCT02216786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724906|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138724907|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
138724908|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724909|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724910|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138724911|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138724912|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138724913|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
138724914|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724915|NCT02279147|Neostigmine|neostigmine|mesh-list
138724954|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804812|NCT04246905|Sulforaphane|sulforaphane|mesh-list
138724955|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138724956|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724957|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724958|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
138724959|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724960|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724962|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
138725019|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
138725020|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725021|NCT01642745|Miotics|miotics|mesh-ancestor
138725022|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
138725023|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725024|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138725025|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138725026|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
138725027|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138725028|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138725029|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
138725030|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725031|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725032|NCT01640990|GW 328267|gw 328267|mesh-list
138725033|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138725034|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138725035|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
138725036|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
138725037|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725038|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725039|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725040|NCT01642862|Simvastatin|simvastatin|mesh-list
138725070|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138725071|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725072|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
138725073|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
138725074|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725075|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
138725076|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
138725077|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138725078|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138725079|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725080|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
138725081|NCT01643135|Coagulants|coagulants|mesh-ancestor
138725133|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
138725134|NCT01643447|Urinastatin|urinastatin|mesh-list
138725135|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138725136|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138725137|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
138725138|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725139|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725140|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725142|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725143|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138725144|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725145|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725146|NCT02755844|Metformin|metformin|mesh-list
138725147|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
138725193|NCT06031688|Ramucirumab|ramucirumab|mesh-list
138725194|NCT06031688|Tepotinib|tepotinib|mesh-list
138725195|NCT06031688|Antibodies|antibodies|mesh-list
138725196|NCT06031688|Immunoglobulins|immunoglobulins|mesh-list
138725197|NCT06031688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138725198|NCT06031688|Lexatumumab|lexatumumab|mesh-list
138725199|NCT06031688|Immunologic Factors|immunologic factors|mesh-ancestor
138725200|NCT06031688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725201|NCT06031688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725202|NCT06048926|Paclitaxel|paclitaxel|mesh-list
138725203|NCT06048926|Cisplatin|cisplatin|mesh-list
138725204|NCT06048926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138725205|NCT06048926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681562|NCT00505427|Vitamins|vitamins|mesh-ancestor
138725206|NCT06048926|Tubulin Modulators|tubulin modulators|mesh-ancestor
138725207|NCT06048926|Antimitotic Agents|antimitotic agents|mesh-ancestor
138725208|NCT06048926|Mitosis Modulators|mitosis modulators|mesh-ancestor
138725209|NCT06048926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725210|NCT06048913|Nimotuzumab|nimotuzumab|mesh-list
138725214|NCT06048705|Cyclophosphamide|cyclophosphamide|mesh-list
138725253|NCT06047860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725254|NCT06047860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725255|NCT06047860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138725256|NCT06047860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138725258|NCT06047860|Growth Inhibitors|growth inhibitors|mesh-ancestor
138725259|NCT06047860|Immunologic Factors|immunologic factors|mesh-ancestor
138725260|NCT06047860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725261|NCT06047860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138725262|NCT06047535|Isotretinoin|isotretinoin|mesh-list
138725263|NCT06047535|Dermatologic Agents|dermatologic agents|mesh-ancestor
138725264|NCT06047483|Loxoprofen|loxoprofen|mesh-list
138725265|NCT06047483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138725266|NCT06047483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138725267|NCT06047483|Analgesics|analgesics|mesh-ancestor
138725268|NCT06047483|Sensory System Agents|sensory system agents|mesh-ancestor
138725269|NCT06047483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725270|NCT06047483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725271|NCT06047483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725272|NCT06047483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138725273|NCT06047327|Liver Extracts|liver extracts|mesh-list
138725274|NCT06047327|Hematinics|hematinics|mesh-ancestor
138725275|NCT06047184|Letrozole|letrozole|mesh-list
138725276|NCT06047184|Fulvestrant|fulvestrant|mesh-list
138546717|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
138725277|NCT06047184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725278|NCT06047184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138725279|NCT06047184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138725280|NCT06047184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079527|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
139079528|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079529|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079530|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139079531|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
139079532|NCT03956732|Vitamin D|vitamin d|mesh-list
139079533|NCT03956732|Caseins|caseins|mesh-list
139079534|NCT03956732|Vitamins|vitamins|mesh-ancestor
139079535|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
139079536|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079537|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139079538|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
139079539|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
139079540|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079541|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
139079542|NCT01093274|Cathartics|cathartics|mesh-ancestor
139079543|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139079544|NCT01584206|Ezetimibe|ezetimibe|mesh-list
139079545|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138681609|NCT02949765|Iron|iron|mesh-list
138725281|NCT06047184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725282|NCT06047184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138725283|NCT06047184|Hormone Antagonists|hormone antagonists|mesh-ancestor
138725284|NCT06047184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138725285|NCT06047184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725286|NCT06047184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138725287|NCT06047184|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138725288|NCT06047015|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
138725289|NCT06047015|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138725290|NCT06047015|Immunologic Factors|immunologic factors|mesh-ancestor
138725291|NCT06047015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725292|NCT06046963|Paclitaxel|paclitaxel|mesh-list
138725293|NCT06046963|Oxaliplatin|oxaliplatin|mesh-list
138725294|NCT06046963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138725295|NCT06046963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725296|NCT06046963|Tubulin Modulators|tubulin modulators|mesh-ancestor
138725334|NCT06046313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725335|NCT06046313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725336|NCT06046196|Sarpogrelate|sarpogrelate|mesh-list
138725337|NCT06046196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138725338|NCT06046196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138725339|NCT06046196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725340|NCT06046196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138725341|NCT06046196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138725342|NCT06046196|Serotonin Agents|serotonin agents|mesh-ancestor
138546726|NCT00231829|Celecoxib|celecoxib|mesh-list
138725343|NCT06046196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725344|NCT06046196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725345|NCT06046105|Ibuprofen|ibuprofen|mesh-list
138725346|NCT06046105|Dexmedetomidine|dexmedetomidine|mesh-list
138725347|NCT06046105|Bupivacaine|bupivacaine|mesh-list
138725348|NCT06046105|Anesthetics, Local|anesthetics, local|mesh-ancestor
138725349|NCT06046105|Anesthetics|anesthetics|mesh-ancestor
138725350|NCT06046105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138725351|NCT06046105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725352|NCT06046105|Sensory System Agents|sensory system agents|mesh-ancestor
138725353|NCT06046105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725355|NCT06046105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138725356|NCT06046105|Analgesics|analgesics|mesh-ancestor
138725359|NCT06046105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138725386|NCT06045832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725387|NCT06045429|Chlorhexidine|chlorhexidine|mesh-list
138725388|NCT06045429|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138725389|NCT06045429|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138725390|NCT06045429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138725391|NCT06045429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725392|NCT06045429|Disinfectants|disinfectants|mesh-ancestor
138725393|NCT06045429|Dermatologic Agents|dermatologic agents|mesh-ancestor
138725394|NCT06045364|Anisodamine|anisodamine|mesh-list
138725395|NCT06045364|Glycopyrrolate|glycopyrrolate|mesh-list
138725396|NCT06045364|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138725397|NCT06045364|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138725398|NCT06045364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138725399|NCT06045364|Cholinergic Agents|cholinergic agents|mesh-ancestor
138725400|NCT06045364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725401|NCT06045364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725402|NCT06045364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725403|NCT06045364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138725404|NCT06045364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138725405|NCT06045364|Adrenergic Agents|adrenergic agents|mesh-ancestor
138725406|NCT06045364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138725407|NCT06045364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138725408|NCT06045364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138725438|NCT06045156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138725439|NCT06045013|Methylprednisolone|methylprednisolone|mesh-list
138725440|NCT06045013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138725441|NCT06045013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138725442|NCT06045013|Prednisolone|prednisolone|mesh-list
138725443|NCT06045013|Prednisolone acetate|prednisolone acetate|mesh-list
138725444|NCT06045013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138725445|NCT06045013|Prednisolone phosphate|prednisolone phosphate|mesh-list
138725446|NCT06045013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725447|NCT06045013|Antiemetics|antiemetics|mesh-ancestor
138725448|NCT06045013|Autonomic Agents|autonomic agents|mesh-ancestor
138725449|NCT06045013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725450|NCT06045013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725451|NCT06045013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138725452|NCT06045013|Glucocorticoids|glucocorticoids|mesh-ancestor
138725453|NCT06045013|Hormones|hormones|mesh-ancestor
138725455|NCT06045013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138725496|NCT06044480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725497|NCT06044467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138725498|NCT06044467|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
138725500|NCT06044467|Immunoglobulins|immunoglobulins|mesh-list
138725501|NCT06044467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138725502|NCT06044467|Immunologic Factors|immunologic factors|mesh-ancestor
138725503|NCT06044467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725504|NCT06044467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725505|NCT06044090|Minocycline|minocycline|mesh-list
138725506|NCT06044090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138725507|NCT06044090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725508|NCT06044077|Vaccines|vaccines|mesh-list
138725509|NCT06044077|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138725510|NCT06044077|Immunologic Factors|immunologic factors|mesh-ancestor
138725511|NCT06044077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725512|NCT06043908|Cyclosporine|cyclosporine|mesh-list
138725513|NCT06043908|Lubricant Eye Drops|lubricant eye drops|mesh-list
138725514|NCT06043908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138725555|NCT06043336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138725556|NCT06043336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138725557|NCT06043336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725558|NCT06043336|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138725559|NCT06043336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138725560|NCT06043336|Serotonin Agents|serotonin agents|mesh-ancestor
138725561|NCT06043336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725562|NCT06043336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725563|NCT06043310|Nitroprusside|nitroprusside|mesh-list
138725564|NCT06043310|Acetylcholine|acetylcholine|mesh-list
138725565|NCT06043310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138725566|NCT06043310|Vasodilator Agents|vasodilator agents|mesh-ancestor
138725567|NCT06043310|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138725569|NCT06043310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138725616|NCT06038682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725617|NCT06038682|Antithrombins|antithrombins|mesh-ancestor
138725618|NCT06038682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138725619|NCT06038682|Protease Inhibitors|protease inhibitors|mesh-ancestor
138725620|NCT06038682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725621|NCT06038682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138725623|NCT06037993|Analgesics|analgesics|mesh-ancestor
138725624|NCT06037993|Sensory System Agents|sensory system agents|mesh-ancestor
138725625|NCT06037993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725626|NCT06037993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725627|NCT06037993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138725628|NCT06037993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138725629|NCT06037993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725630|NCT06037993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138725631|NCT06037993|Antiviral Agents|antiviral agents|mesh-ancestor
138725632|NCT06037993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725633|NCT06037993|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138725634|NCT06037993|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138725635|NCT06037993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725636|NCT06037993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725637|NCT06037993|Hormones|hormones|mesh-ancestor
138725639|NCT06034873|Fentanyl|fentanyl|mesh-list
138725667|NCT06034379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138725668|NCT06034379|Cholinergic Agents|cholinergic agents|mesh-ancestor
138725669|NCT06034379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725670|NCT06034379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725671|NCT06034158|Propranolol|propranolol|mesh-list
138725672|NCT06034158|Benserazide|benserazide|mesh-list
138725673|NCT06034158|Levodopa|levodopa|mesh-list
138725674|NCT06034158|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
138725675|NCT06034158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138725676|NCT06034158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138725677|NCT06034158|Adrenergic Agents|adrenergic agents|mesh-ancestor
138725731|NCT06009107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138725732|NCT06009107|Antimetabolites|antimetabolites|mesh-ancestor
138725733|NCT06007846|Memantine|memantine|mesh-list
138725734|NCT06007846|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138725735|NCT06007846|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138725736|NCT06007846|Dopamine Agents|dopamine agents|mesh-ancestor
138725737|NCT06007846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725738|NCT06007846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725739|NCT06007846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725740|NCT06007846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138725741|NCT06007846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138725742|NCT05986331|Pembrolizumab|pembrolizumab|mesh-list
138725743|NCT05986331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138725744|NCT05986331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725745|NCT05986331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138725786|NCT05944510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725787|NCT05938907|Mitogens|mitogens|mesh-list
138725788|NCT05938907|Mitosis Modulators|mitosis modulators|mesh-ancestor
138725789|NCT05938907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725790|NCT05934253|Chloroprocaine|chloroprocaine|mesh-list
138725791|NCT05934253|Anesthetics, Local|anesthetics, local|mesh-ancestor
138725792|NCT05934253|Anesthetics|anesthetics|mesh-ancestor
138725793|NCT05934253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138725794|NCT05934253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725795|NCT05934253|Sensory System Agents|sensory system agents|mesh-ancestor
138725796|NCT05934253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725797|NCT05918822|Maribavir|maribavir|mesh-list
138725798|NCT05918822|Rabeprazole|rabeprazole|mesh-list
138725799|NCT05918822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138725800|NCT05918822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138725801|NCT05918822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138725807|NCT05895838|Olanzapine|olanzapine|mesh-list
138725845|NCT05886582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725846|NCT05886582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725847|NCT05885932|Aspirin|aspirin|mesh-list
138725848|NCT05885932|Sirolimus|sirolimus|mesh-list
138725849|NCT05885932|Clopidogrel|clopidogrel|mesh-list
138725850|NCT05885932|Ticagrelor|ticagrelor|mesh-list
138725851|NCT05885932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138725852|NCT05885932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138725854|NCT05885932|Sensory System Agents|sensory system agents|mesh-ancestor
138725855|NCT05885932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725911|NCT05842213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138725912|NCT05842213|Immunologic Factors|immunologic factors|mesh-ancestor
138725913|NCT05842213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725914|NCT05811377|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138725915|NCT05811377|Hematinics|hematinics|mesh-ancestor
138725916|NCT05811377|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138725917|NCT05811377|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138725918|NCT05802225|Pertuzumab|pertuzumab|mesh-list
138725920|NCT05802225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725980|NCT05741905|Ofloxacin|ofloxacin|mesh-list
138725981|NCT05741905|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138725982|NCT05741905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725983|NCT05741905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138725984|NCT05741905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138725985|NCT05741905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138725986|NCT05741905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725987|NCT05741905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725988|NCT05741905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725989|NCT05741905|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138725990|NCT05741905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138725991|NCT05719883|Sirolimus|sirolimus|mesh-list
138725992|NCT05719883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138725993|NCT05719883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725994|NCT05719883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138725995|NCT05719883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725996|NCT05719883|Antifungal Agents|antifungal agents|mesh-ancestor
138725997|NCT05719883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138725998|NCT05719883|Immunologic Factors|immunologic factors|mesh-ancestor
138725999|NCT05719883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726001|NCT05717049|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138726002|NCT05717049|Autonomic Agents|autonomic agents|mesh-ancestor
138726031|NCT05698147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138726032|NCT05698147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138726033|NCT05696236|Tin Fluorides|tin fluorides|mesh-list
138726034|NCT05696236|Cariostatic Agents|cariostatic agents|mesh-ancestor
138726035|NCT05696236|Protective Agents|protective agents|mesh-ancestor
138726036|NCT05696236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726037|NCT05672550|Enoxaparin|enoxaparin|mesh-list
138726038|NCT05672550|Enoxaparin sodium|enoxaparin sodium|mesh-list
138726039|NCT05672550|Anticoagulants|anticoagulants|mesh-ancestor
138726040|NCT05672550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138726041|NCT05672550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138726042|NCT05672550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726043|NCT05672407|Tranexamic Acid|tranexamic acid|mesh-list
138726044|NCT05672407|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138726045|NCT05672407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138726046|NCT05672407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726047|NCT05672407|Hemostatics|hemostatics|mesh-ancestor
138726048|NCT05672407|Coagulants|coagulants|mesh-ancestor
138726049|NCT05663515|Insulin|insulin|mesh-list
138726050|NCT05663515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138726051|NCT05663515|Exenatide|exenatide|mesh-list
138726052|NCT05663515|Biguanides|biguanides|mesh-list
138726053|NCT05663515|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
138726054|NCT05663515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138726086|NCT05653401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138726087|NCT05653401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138726088|NCT05653401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138726089|NCT05653401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726090|NCT05653401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138726091|NCT05653401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138726092|NCT05653401|Analgesics|analgesics|mesh-ancestor
138726093|NCT05653401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138726094|NCT05653401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138726095|NCT05653401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138726150|NCT05599841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138726151|NCT05589220|Nicotine|nicotine|mesh-list
138726152|NCT05589220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138726153|NCT05589220|Autonomic Agents|autonomic agents|mesh-ancestor
138726154|NCT05589220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726155|NCT05589220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726156|NCT05589220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138726157|NCT05589220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138726158|NCT05589220|Cholinergic Agents|cholinergic agents|mesh-ancestor
138726159|NCT05589220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138726160|NCT05589220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726212|NCT05509569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726214|NCT05509569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138726215|NCT05509569|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138726216|NCT05509569|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138726217|NCT05509569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726218|NCT05509569|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138726219|NCT05509569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138726220|NCT05509569|Immunologic Factors|immunologic factors|mesh-ancestor
138805018|NCT00704314|Simvastatin|simvastatin|mesh-list
138726221|NCT05506566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138726222|NCT05506566|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138726230|NCT05500170|Niacin|niacin|mesh-list
138726277|NCT05431920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726278|NCT05431920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138726279|NCT05431920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138726280|NCT05418244|Ondansetron|ondansetron|mesh-list
138726281|NCT05418244|Antiemetics|antiemetics|mesh-ancestor
138726282|NCT05418244|Autonomic Agents|autonomic agents|mesh-ancestor
138726283|NCT05418244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726284|NCT05418244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726285|NCT05418244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138726286|NCT05418244|Antipruritics|antipruritics|mesh-ancestor
138726287|NCT05418244|Dermatologic Agents|dermatologic agents|mesh-ancestor
138726288|NCT05418244|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138726289|NCT05418244|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138726290|NCT05418244|Serotonin Agents|serotonin agents|mesh-ancestor
138726291|NCT05418244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138726292|NCT05418244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726293|NCT05411991|Chlorthalidone|chlorthalidone|mesh-list
138726294|NCT05411991|Acetazolamide|acetazolamide|mesh-list
138726295|NCT05411991|Bumetanide|bumetanide|mesh-list
138726296|NCT05411991|Diuretics|diuretics|mesh-list
138726297|NCT05411991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138726298|NCT05411991|Natriuretic Agents|natriuretic agents|mesh-ancestor
138726299|NCT05411991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726300|NCT05411991|Anticonvulsants|anticonvulsants|mesh-ancestor
138726301|NCT05411991|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138726302|NCT05411991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726303|NCT05411991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726304|NCT05411991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138726307|NCT05410860|Etripamil|etripamil|mesh-list
138682668|NCT00524199|Mesna|mesna|mesh-list
138726323|NCT05408845|Immunologic Factors|immunologic factors|mesh-ancestor
138726324|NCT05408845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726325|NCT05408845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726326|NCT05408845|Tubulin Modulators|tubulin modulators|mesh-ancestor
138726327|NCT05408845|Antimitotic Agents|antimitotic agents|mesh-ancestor
138726328|NCT05408845|Mitosis Modulators|mitosis modulators|mesh-ancestor
138726329|NCT05408845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726330|NCT05408845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138726391|NCT05389423|Etoposide|etoposide|mesh-list
138726392|NCT05389423|Vincristine|vincristine|mesh-list
138726393|NCT05389423|Pomalidomide|pomalidomide|mesh-list
138726394|NCT05389423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138726395|NCT05389423|Immunologic Factors|immunologic factors|mesh-ancestor
138726396|NCT05389423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726397|NCT05389423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138726398|NCT05389423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138726399|NCT05389423|Alkylating Agents|alkylating agents|mesh-ancestor
138726400|NCT05389423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726401|NCT05389423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726402|NCT05389423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138726403|NCT05389423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726404|NCT05389423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138726405|NCT05389423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138726406|NCT05389423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138726407|NCT05389423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726408|NCT05389423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138726409|NCT05389423|Glucocorticoids|glucocorticoids|mesh-ancestor
138726410|NCT05389423|Hormones|hormones|mesh-ancestor
138726411|NCT05389423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726412|NCT05389423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138726444|NCT05358704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138726445|NCT05358704|Antimetabolites|antimetabolites|mesh-ancestor
138726446|NCT05358704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726447|NCT05358704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726448|NCT05358704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138726449|NCT05358704|Immunologic Factors|immunologic factors|mesh-ancestor
138726450|NCT05358704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726451|NCT05358704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138726452|NCT05358704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138726453|NCT05358704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726454|NCT05358704|Antidotes|antidotes|mesh-ancestor
138726455|NCT05358704|Protective Agents|protective agents|mesh-ancestor
138726456|NCT05358704|Vitamin B Complex|vitamin b complex|mesh-ancestor
138726457|NCT05358704|Vitamins|vitamins|mesh-ancestor
138726458|NCT05358704|Micronutrients|micronutrients|mesh-ancestor
138726459|NCT05358249|Cetuximab|cetuximab|mesh-list
138726460|NCT05358249|Trametinib|trametinib|mesh-list
138726461|NCT05358249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726462|NCT05358249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726463|NCT05358249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138726464|NCT05358249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726465|NCT05358249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726466|NCT05347238|Dopamine|dopamine|mesh-list
138726467|NCT05347238|Norepinephrine|norepinephrine|mesh-list
138726468|NCT05347238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138726469|NCT05347238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138726470|NCT05347238|Adrenergic Agents|adrenergic agents|mesh-ancestor
138726471|NCT05347238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138726472|NCT05347238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726473|NCT05347238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726489|NCT05316168|Glucocorticoids|glucocorticoids|mesh-ancestor
138726490|NCT05316168|Hormones|hormones|mesh-ancestor
138726491|NCT05316168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726492|NCT05316168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138726493|NCT05316168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726494|NCT05316168|Anesthetics, Local|anesthetics, local|mesh-ancestor
138726495|NCT05316168|Anesthetics|anesthetics|mesh-ancestor
138726496|NCT05316168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138726497|NCT05316168|Sensory System Agents|sensory system agents|mesh-ancestor
138726498|NCT05300191|Dialysis Solutions|dialysis solutions|mesh-list
138726499|NCT05300191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138726500|NCT05293509|Cyclosporine|cyclosporine|mesh-list
138726501|NCT05293509|Mycophenolic Acid|mycophenolic acid|mesh-list
138726553|NCT05263206|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138726554|NCT05263206|Histamine Antagonists|histamine antagonists|mesh-ancestor
138726555|NCT05263206|Histamine Agents|histamine agents|mesh-ancestor
138726556|NCT05263206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138726557|NCT05263206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726558|NCT05263206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726560|NCT05256472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726561|NCT05256472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138726562|NCT05256472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726563|NCT05256472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726564|NCT05227937|Amikacin|amikacin|mesh-list
138726565|NCT05227937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138726566|NCT05227937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138726567|NCT05208879|Carotenoids|carotenoids|mesh-list
138726568|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
138726569|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726611|NCT05195918|Analgesics|analgesics|mesh-ancestor
138726612|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
138726613|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726614|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726615|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138726616|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138726617|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138726618|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138726619|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
138726620|NCT05195918|Protective Agents|protective agents|mesh-ancestor
138726621|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138726622|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138726623|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138726625|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
138726626|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
138726671|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726672|NCT05095376|Temozolomide|temozolomide|mesh-list
138726673|NCT05095376|Lomustine|lomustine|mesh-list
138726674|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138726675|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
138726678|NCT05090358|Canagliflozin|canagliflozin|mesh-list
138726738|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138726739|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138726740|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726741|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
138726742|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138726743|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726744|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
138726745|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138726746|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726805|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138726806|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138726807|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726808|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726809|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726810|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138726811|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
138726812|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138726813|NCT05010434|Bevacizumab|bevacizumab|mesh-list
138726814|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726815|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726816|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138726817|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138726818|NCT05010434|Growth Substances|growth substances|mesh-ancestor
138726819|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726820|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
138726821|NCT04984993|Tadalafil|tadalafil|mesh-list
138726822|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
138726823|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138726824|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138726825|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726826|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726827|NCT04984993|Urological Agents|urological agents|mesh-ancestor
138726828|NCT04982848|Talazoparib|talazoparib|mesh-list
138726833|NCT04979611|Exenatide|exenatide|mesh-list
138726852|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138726853|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
138726854|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726855|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726857|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138726858|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
138726859|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138726860|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
138726861|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726862|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726863|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
138726864|NCT04952389|Budesonide|budesonide|mesh-list
138726873|NCT04952389|Hormones|hormones|mesh-ancestor
138726914|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
138726915|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726916|NCT04891757|Cytarabine|cytarabine|mesh-list
138726917|NCT04891757|Decitabine|decitabine|mesh-list
138726918|NCT04891757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138726919|NCT04891757|Antimetabolites|antimetabolites|mesh-ancestor
138726920|NCT04891757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726921|NCT04891757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726922|NCT04891757|Antiviral Agents|antiviral agents|mesh-ancestor
138726923|NCT04891757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138726924|NCT04891757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138726981|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726982|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138726983|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
138726984|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726985|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726986|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
138726987|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726988|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138726989|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138726990|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
138726991|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138726992|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138726993|NCT04798755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138726994|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138726995|NCT04775550|Dexamethasone|dexamethasone|mesh-list
138726996|NCT04775550|Lenalidomide|lenalidomide|mesh-list
138726997|NCT04775550|Bortezomib|bortezomib|mesh-list
138726998|NCT04775550|Daratumumab|daratumumab|mesh-list
138726999|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138727000|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
138727001|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
138727036|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727037|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
138727038|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727040|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138727041|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
138727042|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727043|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727044|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138727045|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727046|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138727047|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138727048|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138727096|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138727097|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138727098|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
138727099|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727100|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727101|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138727102|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
138805134|NCT00707824|Analgesics|analgesics|mesh-ancestor
138727103|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727104|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
138727105|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727106|NCT04593927|Siponimod|siponimod|mesh-list
138727159|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727160|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727162|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
138727163|NCT04545242|Hormones|hormones|mesh-ancestor
138727164|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727165|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138727166|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727167|NCT04516447|Paclitaxel|paclitaxel|mesh-list
138727168|NCT04516447|Carboplatin|carboplatin|mesh-list
138727169|NCT04516447|Gemcitabine|gemcitabine|mesh-list
138727170|NCT04516447|Doxorubicin|doxorubicin|mesh-list
138727171|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138547162|NCT00076206|Temsirolimus|temsirolimus|mesh-list
138727172|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138727173|NCT04516447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727174|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
138727219|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727220|NCT04505254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138727221|NCT04505254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727222|NCT04505254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727224|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
138727225|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727226|NCT04485559|Everolimus|everolimus|mesh-list
138727227|NCT04485559|Trametinib|trametinib|mesh-list
138727228|NCT04485559|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138727229|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138727230|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727231|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727232|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727233|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
138727234|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547320|NCT00234910|Ritonavir|ritonavir|mesh-list
138727235|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727236|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
138727274|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138727275|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
138727276|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727277|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727278|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138727279|NCT04432506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727280|NCT04417062|Olaparib|olaparib|mesh-list
138727281|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138727282|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727283|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727285|NCT04406389|Heparin|heparin|mesh-list
138727337|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
138727338|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138727339|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727340|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
138727341|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727342|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138727343|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138727344|NCT04264208|Bombesin|bombesin|mesh-list
138547804|NCT00398684|Nevirapine|nevirapine|mesh-list
138727346|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727347|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727348|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727349|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
138727350|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138727351|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138727352|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727353|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138727354|NCT04251910|Analgesics|analgesics|mesh-ancestor
138727355|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
138727356|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727357|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138727358|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138727359|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138727387|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
138727388|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727389|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138727390|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138727391|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138727392|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
138727393|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727394|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727395|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
138727396|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138727397|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727398|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727399|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727400|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
138727401|NCT04171843|Fludarabine|fludarabine|mesh-list
138727402|NCT04171843|Nirogacestat|nirogacestat|mesh-list
138727403|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727404|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
138727405|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727406|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138727407|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138727408|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
138727409|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727436|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138727437|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727438|NCT04082780|Rifamycins|rifamycins|mesh-list
138727439|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
138727440|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138727441|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727442|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138727503|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138727504|NCT03994055|Antioxidants|antioxidants|mesh-list
138727505|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727506|NCT03994055|Protective Agents|protective agents|mesh-ancestor
138727507|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727508|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
138727509|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727510|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138727511|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138727512|NCT03959488|Palivizumab|palivizumab|mesh-list
138727513|NCT03959488|Antiviral Agents|antiviral agents|mesh-ancestor
138727514|NCT03959488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727515|NCT03950817|Ketamine|ketamine|mesh-list
138727516|NCT03950817|Analgesics|analgesics|mesh-ancestor
138727517|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
138727518|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727519|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727520|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138727521|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138727522|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
138727523|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
138727524|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138727525|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138727526|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138727527|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727528|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727529|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138727530|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
138727532|NCT03913195|Ibalizumab|ibalizumab|mesh-list
138727549|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727550|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138727551|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727553|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
138727554|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727555|NCT03801876|Paclitaxel|paclitaxel|mesh-list
138727556|NCT03801876|Docetaxel|docetaxel|mesh-list
138727557|NCT03801876|Carboplatin|carboplatin|mesh-list
138727558|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138727560|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138727561|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727562|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
138727563|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
138727564|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
138727565|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727566|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
138727567|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138727568|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727569|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
138727571|NCT03765541|Cytarabine|cytarabine|mesh-list
138727606|NCT03712098|Hormones|hormones|mesh-ancestor
138727607|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727608|NCT03710772|Cytarabine|cytarabine|mesh-list
138727609|NCT03710772|Dexamethasone|dexamethasone|mesh-list
138727610|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
138727611|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
138727612|NCT03710772|Rituximab|rituximab|mesh-list
138727613|NCT03710772|Doxorubicin|doxorubicin|mesh-list
138727614|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138727615|NCT03710772|Methotrexate|methotrexate|mesh-list
138727616|NCT03710772|Vincristine|vincristine|mesh-list
138727617|NCT03710772|Venetoclax|venetoclax|mesh-list
138727618|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138727619|NCT03710772|Antibodies|antibodies|mesh-list
138727620|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
138727621|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138727622|NCT03710772|BB 1101|bb 1101|mesh-list
138727623|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727668|NCT03686332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138727669|NCT03686332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727670|NCT03686332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727671|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727672|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
138727673|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727674|NCT03671746|Ketorolac|ketorolac|mesh-list
138727675|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138727676|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138727677|NCT03671746|Analgesics|analgesics|mesh-ancestor
138727678|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
138727679|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727680|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727681|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138727683|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138727728|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727730|NCT03601897|Rebastinib|rebastinib|mesh-list
138727731|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138727732|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727733|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
138727734|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
138727735|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
138727736|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727737|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138727738|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727739|NCT03573349|Ketamine|ketamine|mesh-list
138727740|NCT03573349|Analgesics|analgesics|mesh-ancestor
138727741|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
138727742|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727743|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727744|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138727787|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138727788|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138727789|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
138727790|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727791|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727792|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138727793|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
138727794|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
138727795|NCT03487809|Hormones|hormones|mesh-ancestor
138727796|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727797|NCT03470922|Nivolumab|nivolumab|mesh-list
138727798|NCT03470922|Relatlimab|relatlimab|mesh-list
138727799|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727800|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727801|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138727802|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727846|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138727847|NCT03368664|Protective Agents|protective agents|mesh-ancestor
138727848|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138727849|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727850|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138727851|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
138727852|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727853|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138727854|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138727913|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138727914|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
138727915|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727916|NCT03202628|Dexamethasone|dexamethasone|mesh-list
138727917|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
138727918|NCT03202628|Pomalidomide|pomalidomide|mesh-list
138727919|NCT03202628|Ixazomib|ixazomib|mesh-list
138727920|NCT03202628|Ichthammol|ichthammol|mesh-list
138727921|NCT03202628|BB 1101|bb 1101|mesh-list
138727922|NCT03202628|Glycine|glycine|mesh-list
138727923|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138727924|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
138727925|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
138727980|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138727981|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138727982|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138727983|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138727984|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
138727985|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727986|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138727987|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138727988|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138727989|NCT03164057|Analgesics|analgesics|mesh-ancestor
138727990|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
138727991|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727992|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138727993|NCT03164057|Protective Agents|protective agents|mesh-ancestor
138727994|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
138727995|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
138727996|NCT03136146|Dexamethasone|dexamethasone|mesh-list
138727997|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
138727998|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
138728000|NCT03136146|Etoposide|etoposide|mesh-list
138728001|NCT03136146|Vincristine|vincristine|mesh-list
138728002|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
138728003|NCT03136146|Bortezomib|bortezomib|mesh-list
138728004|NCT03136146|Clofarabine|clofarabine|mesh-list
138728034|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138728035|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138728036|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138728037|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
138728038|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
138728039|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
138728040|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138728041|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
138728042|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
138728043|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
138728044|NCT03129828|Bortezomib|bortezomib|mesh-list
138805311|NCT00784927|Hormones|hormones|mesh-ancestor
138728045|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728046|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
138728047|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138728048|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138728049|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728050|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
138728051|NCT03128866|Coagulants|coagulants|mesh-ancestor
138728052|NCT03127631|Atorvastatin|atorvastatin|mesh-list
138728093|NCT06081101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138728095|NCT06081101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728096|NCT06080880|Dexamethasone|dexamethasone|mesh-list
138728097|NCT06080880|Ondansetron|ondansetron|mesh-list
138728098|NCT06080880|Aprepitant|aprepitant|mesh-list
138728099|NCT06080880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138728100|NCT06080880|Antiemetics|antiemetics|mesh-ancestor
138728101|NCT06080880|Autonomic Agents|autonomic agents|mesh-ancestor
138728102|NCT06080880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728103|NCT06080880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728157|NCT06080724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728158|NCT06080724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138728159|NCT06080490|Tacrolimus|tacrolimus|mesh-list
138728160|NCT06080490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138728161|NCT06080490|Immunologic Factors|immunologic factors|mesh-ancestor
138728162|NCT06080490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728163|NCT06080490|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138728164|NCT06080490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728165|NCT06080490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728166|NCT06080438|Botulinum Toxins|botulinum toxins|mesh-list
138728167|NCT06080438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138728168|NCT06080438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138728169|NCT06080438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728170|NCT06080438|Cholinergic Agents|cholinergic agents|mesh-ancestor
138728171|NCT06080438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138728172|NCT06080438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728173|NCT06080256|Atorvastatin|atorvastatin|mesh-list
138728174|NCT06080256|Alirocumab|alirocumab|mesh-list
138728175|NCT06080256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138728176|NCT06080256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138728177|NCT06080256|Antimetabolites|antimetabolites|mesh-ancestor
138728178|NCT06080256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728179|NCT06080256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138728180|NCT06080256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138728181|NCT06080256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728182|NCT06080256|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138728183|NCT06080256|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138728184|NCT06080256|Protease Inhibitors|protease inhibitors|mesh-ancestor
138728185|NCT06080100|Hydroxyzine|hydroxyzine|mesh-list
138728186|NCT06080100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728187|NCT06080100|Antipruritics|antipruritics|mesh-ancestor
138728188|NCT06080100|Dermatologic Agents|dermatologic agents|mesh-ancestor
138728189|NCT06080100|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138728190|NCT06080100|Histamine Antagonists|histamine antagonists|mesh-ancestor
138728191|NCT06080100|Histamine Agents|histamine agents|mesh-ancestor
138728192|NCT06080100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139079546|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139079547|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
138728193|NCT06080100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728194|NCT06079996|Caffeine|caffeine|mesh-list
138728195|NCT06079996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138728196|NCT06079996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728197|NCT06079996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138728198|NCT06079996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728199|NCT06079996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728200|NCT06079996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138728201|NCT06079996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138728202|NCT06079996|Purinergic Agents|purinergic agents|mesh-ancestor
138728203|NCT06079996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138728204|NCT06079983|Paclitaxel|paclitaxel|mesh-list
138728205|NCT06079983|Vinorelbine|vinorelbine|mesh-list
138728206|NCT06079983|Docetaxel|docetaxel|mesh-list
138728207|NCT06079983|Gemcitabine|gemcitabine|mesh-list
138728208|NCT06079983|Capecitabine|capecitabine|mesh-list
138728209|NCT06079983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138728210|NCT06079983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728211|NCT06079983|Tubulin Modulators|tubulin modulators|mesh-ancestor
138728212|NCT06079983|Antimitotic Agents|antimitotic agents|mesh-ancestor
138728213|NCT06079983|Mitosis Modulators|mitosis modulators|mesh-ancestor
138728214|NCT06079983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728215|NCT06079983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138728216|NCT06079983|Antimetabolites|antimetabolites|mesh-ancestor
138728244|NCT06079047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138728245|NCT06079047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138728246|NCT06079047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728247|NCT06078995|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138728248|NCT06078995|Tenecteplase|tenecteplase|mesh-list
138728249|NCT06078995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138728250|NCT06078995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138728251|NCT06078995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728252|NCT06078982|Disitamab vedotin|disitamab vedotin|mesh-list
138728253|NCT06078982|Immunoconjugates|immunoconjugates|mesh-ancestor
138728254|NCT06078982|Immunologic Factors|immunologic factors|mesh-ancestor
138728255|NCT06078982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728256|NCT06078891|BCG Vaccine|bcg vaccine|mesh-list
138728257|NCT06078891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138728258|NCT06078891|Immunologic Factors|immunologic factors|mesh-ancestor
138728259|NCT06078891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728260|NCT06078839|Nafamostat|nafamostat|mesh-list
138728299|NCT06078696|Antifungal Agents|antifungal agents|mesh-ancestor
138464808|NCT05790161|Caffeine|caffeine|mesh-list
138728301|NCT06078670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138728302|NCT06078670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728303|NCT06078670|Tubulin Modulators|tubulin modulators|mesh-ancestor
138728304|NCT06078670|Antimitotic Agents|antimitotic agents|mesh-ancestor
138728305|NCT06078670|Mitosis Modulators|mitosis modulators|mesh-ancestor
138728306|NCT06078670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728307|NCT06078605|Niacinamide|niacinamide|mesh-list
138728308|NCT06078605|Niacin|niacin|mesh-list
138728309|NCT06078605|Nicotinic Acids|nicotinic acids|mesh-list
138728310|NCT06078605|Vitamin B Complex|vitamin b complex|mesh-ancestor
138728311|NCT06078605|Vitamins|vitamins|mesh-ancestor
138728312|NCT06078605|Micronutrients|micronutrients|mesh-ancestor
138728313|NCT06078605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728314|NCT06078605|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138728315|NCT06078605|Antimetabolites|antimetabolites|mesh-ancestor
138728316|NCT06078605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728317|NCT06078605|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138728318|NCT06078605|Vasodilator Agents|vasodilator agents|mesh-ancestor
138728319|NCT06078592|Timolol|timolol|mesh-list
138728357|NCT06064448|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138728358|NCT06064448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138728359|NCT06064448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728360|NCT06064448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728361|NCT06064448|Urological Agents|urological agents|mesh-ancestor
138728362|NCT06061250|Anesthetics|anesthetics|mesh-list
138728363|NCT06061250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138728364|NCT06061250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728365|NCT06026254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138728366|NCT06026254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728367|NCT06026254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728368|NCT06026254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728369|NCT05988697|Trametinib|trametinib|mesh-list
138728370|NCT05988697|Dabrafenib|dabrafenib|mesh-list
138728415|NCT05877027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138728416|NCT05877027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138728417|NCT05877027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138728418|NCT05877027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728419|NCT05877027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728420|NCT05837806|Tislelizumab|tislelizumab|mesh-list
138728421|NCT05837806|Disitamab vedotin|disitamab vedotin|mesh-list
138728422|NCT05837806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728423|NCT05837806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728424|NCT05837806|Immunoconjugates|immunoconjugates|mesh-ancestor
138728425|NCT05837806|Immunologic Factors|immunologic factors|mesh-ancestor
138805409|NCT00778921|Amlodipine|amlodipine|mesh-list
138728426|NCT05837806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728427|NCT05827874|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138728430|NCT05824728|Levetiracetam|levetiracetam|mesh-list
138728476|NCT05789173|Anticonvulsants|anticonvulsants|mesh-ancestor
138728477|NCT05789173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138728478|NCT05789173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138728479|NCT05789173|Parasympatholytics|parasympatholytics|mesh-ancestor
138728480|NCT05789173|Autonomic Agents|autonomic agents|mesh-ancestor
138728481|NCT05789173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138728482|NCT05789173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138728483|NCT05789173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138728484|NCT05789173|Adrenergic Agents|adrenergic agents|mesh-ancestor
138728485|NCT05789173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138728486|NCT05789173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138728487|NCT05789173|Sympatholytics|sympatholytics|mesh-ancestor
138728489|NCT05721755|Cisplatin|cisplatin|mesh-list
138728490|NCT05721755|Carboplatin|carboplatin|mesh-list
138728491|NCT05721755|Pembrolizumab|pembrolizumab|mesh-list
138728492|NCT05721755|Fluorouracil|fluorouracil|mesh-list
138728493|NCT05721755|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138728494|NCT05721755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138728534|NCT05656443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138728535|NCT05656443|Antiviral Agents|antiviral agents|mesh-ancestor
138728536|NCT05656443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138728537|NCT05656443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138728538|NCT05656443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138728539|NCT05630755|Islatravir|islatravir|mesh-list
138728540|NCT05630755|Antiviral Agents|antiviral agents|mesh-ancestor
138728541|NCT05630755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138728542|NCT05630755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728543|NCT05630755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728544|NCT05630755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138728596|NCT05387759|Aticaprant|aticaprant|mesh-list
138728597|NCT05387759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138728598|NCT05387759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138728599|NCT05387759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138728600|NCT05387759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138728601|NCT05387759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728602|NCT05387759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728603|NCT05387759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728604|NCT05387759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728605|NCT05387759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138728606|NCT05387759|Sensory System Agents|sensory system agents|mesh-ancestor
138728607|NCT05387759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728608|NCT05373186|Insulin Lispro|insulin lispro|mesh-list
138728609|NCT05373186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138728610|NCT05373186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728611|NCT05321758|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138728612|NCT05321758|Immunologic Factors|immunologic factors|mesh-ancestor
138728613|NCT05321758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728615|NCT05314933|Antimetabolites|antimetabolites|mesh-ancestor
138728653|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138728654|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138728655|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
138728656|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
138805424|NCT00776659|Exemestane|exemestane|mesh-list
138728657|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138728658|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138728659|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138728660|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138728661|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138684981|NCT00520247|Folic Acid|folic acid|mesh-list
138728662|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138728716|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728717|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728718|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
138728719|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
138728720|NCT05054348|Cemiplimab|cemiplimab|mesh-list
138728721|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728722|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728723|NCT05054348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138728724|NCT05054348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728725|NCT05046431|Golimumab|golimumab|mesh-list
138728726|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138728727|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138728728|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138728729|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
138728730|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728731|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
138728732|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138728733|NCT04995497|Lidocaine|lidocaine|mesh-list
138728734|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
138728735|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
138728772|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728773|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
138728774|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
138728775|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138728776|NCT04867798|Tenofovir|tenofovir|mesh-list
138728777|NCT04867798|Lamivudine|lamivudine|mesh-list
138728778|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
138728779|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138728780|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138728781|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138728782|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728783|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728834|NCT04725331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728835|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138728836|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138728837|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728838|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
138728839|NCT04715191|Fludarabine|fludarabine|mesh-list
138728840|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
138728841|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138728842|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
138728843|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728844|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138728845|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138728846|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
138728847|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728848|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728849|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138728850|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138728851|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
138728852|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
138728853|NCT04660799|Promethazine|promethazine|mesh-list
138728854|NCT04660799|Prednisone|prednisone|mesh-list
138728855|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
138728856|NCT04660799|Rituximab|rituximab|mesh-list
138728857|NCT04660799|Doxorubicin|doxorubicin|mesh-list
138728858|NCT04660799|Vincristine|vincristine|mesh-list
138728859|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138728884|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
138728885|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728886|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138728887|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138728888|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138728889|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
138728891|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
138728892|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
138728893|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138728894|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
138728895|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138728896|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138728897|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
138728898|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
138728899|NCT04648033|Atovaquone|atovaquone|mesh-list
138728900|NCT04648033|Cisplatin|cisplatin|mesh-list
138728901|NCT04648033|Vinorelbine|vinorelbine|mesh-list
138728902|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728903|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138728904|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
138728905|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
138728942|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138728943|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138728944|NCT04564898|Growth Substances|growth substances|mesh-ancestor
138728945|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728946|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
138728947|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138728948|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
138728949|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728950|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
138729009|NCT04218539|Psilocybin|psilocybin|mesh-list
138729010|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
138729011|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729012|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138729013|NCT04211675|Irinotecan|irinotecan|mesh-list
138729014|NCT04211675|Temozolomide|temozolomide|mesh-list
138729015|NCT04211675|Dinutuximab|dinutuximab|mesh-list
138729016|NCT04211675|Sargramostim|sargramostim|mesh-list
138729017|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138729018|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138729019|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729020|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729030|NCT04116112|Labetalol|labetalol|mesh-list
138729075|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729076|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729077|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138729078|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729080|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138729081|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138729082|NCT03927690|Growth Substances|growth substances|mesh-ancestor
138805510|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138729083|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729084|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
138729085|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729086|NCT03864068|Inositol|inositol|mesh-list
138729087|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
138729088|NCT03864068|Vitamins|vitamins|mesh-ancestor
138729089|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
138729091|NCT03833921|Prednisone|prednisone|mesh-list
138729135|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
138729136|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
138729137|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729138|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138729139|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138729140|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
138729141|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138729142|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138729143|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729202|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
138729203|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
138729204|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729205|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729206|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138729207|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
138729208|NCT03287908|Hormones|hormones|mesh-ancestor
138729209|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138729217|NCT03266991|Isoniazid|isoniazid|mesh-list
138729270|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138729271|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
138729272|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138729273|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
138729274|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729275|NCT02921256|Antidotes|antidotes|mesh-ancestor
138729276|NCT02921256|Protective Agents|protective agents|mesh-ancestor
138729277|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
138729278|NCT02921256|Vitamins|vitamins|mesh-ancestor
138729279|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
138729280|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138729281|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729282|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
138729283|NCT02757885|Thiotepa|thiotepa|mesh-list
138729333|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
138729334|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
138729335|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729336|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138685644|NCT00525239|Lopinavir|lopinavir|mesh-list
138729337|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
138729338|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729339|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138729340|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138729341|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
138729342|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138729343|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
138729344|NCT02635867|Calcium|calcium|mesh-list
138729345|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138729346|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729347|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138729348|NCT02426658|Pemetrexed|pemetrexed|mesh-list
138729349|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729350|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729351|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729352|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138729353|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138729354|NCT02400242|Dexamethasone|dexamethasone|mesh-list
138729355|NCT02400242|Pomalidomide|pomalidomide|mesh-list
138729356|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138729357|NCT02400242|Immunomodulating Agents|immunomodulating agents|mesh-list
138729358|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138729380|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729381|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138729382|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729383|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138729384|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
138729385|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729386|NCT02338687|Calcium|calcium|mesh-list
138729387|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138729388|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729446|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
138729447|NCT01460654|Testosterone|testosterone|mesh-list
138729448|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
138729449|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
138729450|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138729451|NCT01460654|Androgens|androgens|mesh-ancestor
138729452|NCT01460654|Hormones|hormones|mesh-ancestor
138729453|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138729454|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729455|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138729456|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729457|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
138729458|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138729459|NCT01093326|Ponesimod|ponesimod|mesh-list
138729460|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138729461|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729462|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138729463|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
138729464|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729465|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
138729466|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729467|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729498|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
138729499|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729502|NCT02872259|Dabrafenib|dabrafenib|mesh-list
138729503|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729504|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729505|NCT02872259|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138729507|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138729567|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729568|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
138729569|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
138729570|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
138729571|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729572|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138729573|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729574|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
138729575|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138729576|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729577|NCT02703610|Acetaminophen|acetaminophen|mesh-list
138729578|NCT02703610|Ibuprofen|ibuprofen|mesh-list
138729579|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138729580|NCT02703610|Oxycodone|oxycodone|mesh-list
138729628|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138729629|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
138729630|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138729631|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
138729632|NCT02661035|Protective Agents|protective agents|mesh-ancestor
138729633|NCT02627846|Lidocaine|lidocaine|mesh-list
138729634|NCT02627846|Epinephrine|epinephrine|mesh-list
138729635|NCT02627846|Racepinephrine|racepinephrine|mesh-list
138729636|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138729637|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
138729638|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
138729639|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
138729640|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
138729641|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138729642|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729643|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
138729644|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729645|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138729646|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138729647|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138729648|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138729649|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729650|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138729651|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138729652|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
138729653|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138729654|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138729677|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138729678|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
138729679|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138729680|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729681|NCT02542293|Paclitaxel|paclitaxel|mesh-list
138729682|NCT02542293|Cisplatin|cisplatin|mesh-list
138729683|NCT02542293|Carboplatin|carboplatin|mesh-list
138729684|NCT02542293|Gemcitabine|gemcitabine|mesh-list
138729685|NCT02542293|Pemetrexed|pemetrexed|mesh-list
138729686|NCT02542293|Durvalumab|durvalumab|mesh-list
138729687|NCT02542293|Tremelimumab|tremelimumab|mesh-list
138729688|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138729689|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729700|NCT02535988|Thymalfasin|thymalfasin|mesh-list
138729741|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138548246|NCT00239980|Dalteparin|dalteparin|mesh-list
138729742|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729743|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729744|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138729745|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138729746|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
138729747|NCT02437136|Entinostat|entinostat|mesh-list
138729748|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138805659|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
138729749|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729750|NCT02437136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138729751|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729804|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138729805|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
138729806|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729807|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729808|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138729809|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138729810|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138729811|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138729812|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729813|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138729814|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
138729816|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138729817|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138729818|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138729819|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
138729820|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
138729821|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
138729822|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
138729823|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
138729860|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729862|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729863|NCT02046460|Aspirin|aspirin|mesh-list
138729864|NCT02046460|Vitamin K|vitamin k|mesh-list
138729865|NCT02046460|Warfarin|warfarin|mesh-list
138729866|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
138729867|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
138729868|NCT02046460|Vitamins|vitamins|mesh-ancestor
138729869|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
138729870|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729871|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
138729872|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138729873|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138729874|NCT02046460|Analgesics|analgesics|mesh-ancestor
138729875|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
138729876|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729877|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138729878|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138729879|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138729880|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138729881|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729882|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138729883|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138729917|NCT01752049|Timolol|timolol|mesh-list
138729918|NCT01752049|Maleic acid|maleic acid|mesh-list
138805696|NCT04241523|Lenvatinib|lenvatinib|mesh-list
138729919|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729920|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729921|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138729922|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138729923|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
138729924|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138729925|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729926|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138729927|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138729928|NCT01747447|Vitamin D|vitamin d|mesh-list
138729929|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
138729930|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
138729931|NCT01747447|Vitamins|vitamins|mesh-list
138729932|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
138729980|NCT01523977|Pegaspargase|pegaspargase|mesh-list
138729981|NCT01523977|Razoxane|razoxane|mesh-list
138729982|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138729983|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729984|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138729985|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138729986|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729987|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729988|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138729989|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
138729990|NCT01523977|Hormones|hormones|mesh-ancestor
138729991|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138805721|NCT00845182|Pioglitazone|pioglitazone|mesh-list
138729992|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729993|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138729994|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138729995|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
138729996|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
138729997|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
138729998|NCT01523977|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138729999|NCT01523977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138730000|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730001|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
138730002|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138730003|NCT01523977|Protective Agents|protective agents|mesh-ancestor
138730004|NCT01517243|Sirolimus|sirolimus|mesh-list
138730005|NCT01517243|Sunitinib|sunitinib|mesh-list
138730006|NCT01517243|Temsirolimus|temsirolimus|mesh-list
138730007|NCT01517243|MTOR Inhibitors|mtor inhibitors|mesh-list
138730030|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
138730031|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730032|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730033|NCT01321073|Treprostinil|treprostinil|mesh-list
138730034|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138730035|NCT01308203|Niacin|niacin|mesh-list
138730036|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138730037|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
138730038|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730039|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138730040|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
138730041|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
138730042|NCT01308203|Vitamins|vitamins|mesh-ancestor
138730043|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
138730044|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730045|NCT01289171|Glycolic acid|glycolic acid|mesh-list
138730046|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
138730047|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
138730048|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
138730049|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
138730050|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138730051|NCT01276704|Estrogens|estrogens|mesh-ancestor
138730052|NCT01276704|Hormones|hormones|mesh-ancestor
138730053|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138730054|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730055|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
138730056|NCT01190930|Leucovorin|leucovorin|mesh-list
138730057|NCT01190930|Folic Acid|folic acid|mesh-list
138730058|NCT01190930|Cytarabine|cytarabine|mesh-list
138730059|NCT01190930|Dexamethasone|dexamethasone|mesh-list
138730060|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
138730061|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
138730062|NCT01190930|Doxorubicin|doxorubicin|mesh-list
138730064|NCT01190930|Methotrexate|methotrexate|mesh-list
138730080|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730081|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805768|NCT02612272|Ketorolac|ketorolac|mesh-list
138730082|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138730083|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138730084|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
138730085|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
138730086|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730087|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138730088|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
138730089|NCT01190930|Hormones|hormones|mesh-ancestor
138730090|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138730091|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138730092|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
138730093|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730094|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138730095|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138730096|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138730097|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138730098|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138730099|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138730100|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
138730101|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138730102|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138730103|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
138730104|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
138730105|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138730106|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138730107|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
138730126|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138730127|NCT01047007|Cisplatin|cisplatin|mesh-list
138730128|NCT01047007|Adavosertib|adavosertib|mesh-list
138730129|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730130|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805792|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138730131|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730196|NCT00003838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730197|NCT00003838|Dermatologic Agents|dermatologic agents|mesh-ancestor
138730198|NCT00003838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730199|NCT00003838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138730200|NCT00003838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730201|NCT00003838|Immunologic Factors|immunologic factors|mesh-ancestor
138548321|NCT00240409|Pramipexole|pramipexole|mesh-list
138730202|NCT00003838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138730203|NCT00003838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138730204|NCT00003838|Antifungal Agents|antifungal agents|mesh-ancestor
138730205|NCT00003838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730206|NCT00003838|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138730207|NCT00003838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138730208|NCT06031376|Trifluridine|trifluridine|mesh-list
138730209|NCT06031376|Bevacizumab|bevacizumab|mesh-list
138730210|NCT06031376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138730211|NCT06031376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138730212|NCT06031376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730213|NCT06031376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138730214|NCT06031376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138730215|NCT06031376|Growth Substances|growth substances|mesh-ancestor
138730216|NCT06031376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730217|NCT06031376|Growth Inhibitors|growth inhibitors|mesh-ancestor
138730218|NCT06031376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730219|NCT06031376|Antimetabolites|antimetabolites|mesh-ancestor
138730220|NCT06031376|Antiviral Agents|antiviral agents|mesh-ancestor
138730245|NCT06031233|Bevacizumab|bevacizumab|mesh-list
138730246|NCT06031233|Pembrolizumab|pembrolizumab|mesh-list
138730247|NCT06031233|Nivolumab|nivolumab|mesh-list
138730248|NCT06031233|Trastuzumab|trastuzumab|mesh-list
138730249|NCT06031233|Ipilimumab|ipilimumab|mesh-list
138730250|NCT06031233|Atezolizumab|atezolizumab|mesh-list
138730251|NCT06031233|Durvalumab|durvalumab|mesh-list
138730252|NCT06031233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138730253|NCT06031233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730254|NCT06031233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138730255|NCT06031233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138730256|NCT06031233|Growth Substances|growth substances|mesh-ancestor
138686568|NCT00531167|Lamivudine|lamivudine|mesh-list
138730257|NCT06031233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730258|NCT06031233|Growth Inhibitors|growth inhibitors|mesh-ancestor
138730259|NCT06031233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138730305|NCT06031012|Growth Inhibitors|growth inhibitors|mesh-ancestor
138730306|NCT06031012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730307|NCT06030934|Paclitaxel|paclitaxel|mesh-list
138730308|NCT06030934|Lenvatinib|lenvatinib|mesh-list
138730309|NCT06030934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138730310|NCT06030934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730311|NCT06030934|Tubulin Modulators|tubulin modulators|mesh-ancestor
138730312|NCT06030934|Antimitotic Agents|antimitotic agents|mesh-ancestor
138730313|NCT06030934|Mitosis Modulators|mitosis modulators|mesh-ancestor
138730314|NCT06030934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730315|NCT06030934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138730316|NCT06030934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730317|NCT06030895|Sorafenib|sorafenib|mesh-list
138730318|NCT06030895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730319|NCT06030895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138730320|NCT06030895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730321|NCT06030895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730322|NCT06030557|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138730360|NCT06027099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730361|NCT06027099|Analgesics|analgesics|mesh-ancestor
138730362|NCT06027099|Sensory System Agents|sensory system agents|mesh-ancestor
138730363|NCT06027099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730364|NCT06027099|Anticonvulsants|anticonvulsants|mesh-ancestor
138730365|NCT06027099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138730366|NCT06027099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138730367|NCT06027099|Parasympatholytics|parasympatholytics|mesh-ancestor
138730368|NCT06027099|Autonomic Agents|autonomic agents|mesh-ancestor
138730369|NCT06027099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138730370|NCT06027099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138730371|NCT06027099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138730372|NCT06027099|Adrenergic Agents|adrenergic agents|mesh-ancestor
138730422|NCT05898672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138805886|NCT00886743|Oprelvekin|oprelvekin|mesh-list
138730423|NCT05898672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138730424|NCT05898672|Protease Inhibitors|protease inhibitors|mesh-ancestor
138730425|NCT05898672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730426|NCT05898672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730427|NCT05898672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138730428|NCT05898672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138730429|NCT05898672|Antiviral Agents|antiviral agents|mesh-ancestor
138730430|NCT05898672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730431|NCT05898672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138730433|NCT05898672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138730485|NCT05842759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138730486|NCT05779007|Pirfenidone|pirfenidone|mesh-list
138730487|NCT05779007|Nintedanib|nintedanib|mesh-list
138730488|NCT05779007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730489|NCT05779007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138730490|NCT05779007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730491|NCT05779007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730492|NCT05779007|Analgesics|analgesics|mesh-ancestor
138730493|NCT05779007|Sensory System Agents|sensory system agents|mesh-ancestor
138730494|NCT05779007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730495|NCT05779007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730499|NCT05779007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138730548|NCT05615012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138730549|NCT05615012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138730550|NCT05615012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138730551|NCT05615012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138730552|NCT05609240|Cefuroxime|cefuroxime|mesh-list
138730553|NCT05609240|Cefuroxime axetil|cefuroxime axetil|mesh-list
138730554|NCT05609240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138730555|NCT05609240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730561|NCT05465317|Glucagon|glucagon|mesh-list
138730615|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
138730616|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
138730617|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138730618|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138730619|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138730620|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730621|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730622|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
138730623|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138730624|NCT05201001|Carboplatin|carboplatin|mesh-list
138730625|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730626|NCT05198050|Letrozole|letrozole|mesh-list
138730627|NCT05198050|Alprostadil|alprostadil|mesh-list
138730628|NCT05198050|Misoprostol|misoprostol|mesh-list
138730629|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730630|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138730631|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138730675|NCT05114486|Miotics|miotics|mesh-ancestor
138730676|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
138730677|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730678|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730679|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138730680|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138730681|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
138730682|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730683|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730743|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730744|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
138730745|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730746|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138730747|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138730748|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138730749|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138730750|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730752|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138730753|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138730754|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
138730755|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138730756|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138730757|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730758|NCT04670471|Remifentanil|remifentanil|mesh-list
138730759|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138730760|NCT04670471|Narcotics|narcotics|mesh-ancestor
138730761|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138730763|NCT04670471|Analgesics|analgesics|mesh-ancestor
138730797|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730798|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
138730799|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138730800|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138730801|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730802|NCT04607421|Antidotes|antidotes|mesh-ancestor
138730803|NCT04607421|Protective Agents|protective agents|mesh-ancestor
138730804|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
138730805|NCT04607421|Vitamins|vitamins|mesh-ancestor
138730866|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730867|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730868|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138730869|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138730870|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
138730871|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
138730872|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138730873|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138730874|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138730875|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730876|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730877|NCT04441138|Durvalumab|durvalumab|mesh-list
138730878|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138730880|NCT04311502|Pyridoxine|pyridoxine|mesh-list
138730927|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138730928|NCT04276883|Analgesics|analgesics|mesh-ancestor
138730929|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
138730930|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730931|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138730932|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138730933|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138730934|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
138730935|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730936|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730937|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
138730991|NCT04081389|Daunorubicin|daunorubicin|mesh-list
138730992|NCT04081389|Benzenesulfonamide|benzenesulfonamide|mesh-list
138730993|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138730994|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730995|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
138730996|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
138730997|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
138730998|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730999|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138731000|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
138731001|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731002|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731003|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138731004|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
138731005|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138731006|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138731007|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138731008|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138731009|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731010|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
138731011|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731012|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138731013|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138731014|NCT04081389|Analgesics|analgesics|mesh-ancestor
138731015|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
138731016|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731017|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138731018|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138731019|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138731020|NCT04081389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138731022|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138731035|NCT04075396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731036|NCT04075396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731037|NCT04032080|Prexasertib|prexasertib|mesh-list
138731038|NCT04032080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138731039|NCT04032080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731040|NCT04032080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731041|NCT04022005|Rituximab|rituximab|mesh-list
138731042|NCT04022005|Gemcitabine|gemcitabine|mesh-list
138731043|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
138731044|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138731045|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731046|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
138731047|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731048|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731049|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138806022|NCT04200885|Analgesics|analgesics|mesh-ancestor
138731050|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
138731051|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731052|NCT04016142|Paclitaxel|paclitaxel|mesh-list
138731053|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138731054|NCT04016142|Carboplatin|carboplatin|mesh-list
138731055|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138731056|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731057|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
138731058|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
138731059|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
138731060|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731083|NCT03912818|Durvalumab|durvalumab|mesh-list
138731084|NCT03912818|Daunorubicin|daunorubicin|mesh-list
138731085|NCT03912818|Vinblastine|vinblastine|mesh-list
138731086|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731087|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138731088|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
138731089|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731090|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138731091|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138731092|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138731093|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731094|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138731146|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138731147|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
138731148|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138731149|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138731150|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
138731151|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
138731152|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731153|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138731154|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138731212|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731213|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
138731214|NCT03340766|Blinatumomab|blinatumomab|mesh-list
138731215|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138731216|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731217|NCT03340766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138731218|NCT03340766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731219|NCT03267589|Durvalumab|durvalumab|mesh-list
138731220|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138731221|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731222|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
138731223|NCT03208452|Analgesics|analgesics|mesh-ancestor
138731224|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
138731225|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731273|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138731275|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138731276|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731277|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138731278|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
138731279|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731280|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
138731281|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138731282|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138731283|NCT02429570|Analgesics|analgesics|mesh-ancestor
138731284|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
138731285|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731286|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731332|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138731333|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731334|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
138731335|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138731336|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
138731337|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138731338|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138731339|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138731340|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
138731341|NCT01951885|Methotrexate|methotrexate|mesh-list
138731342|NCT01951885|Tacrolimus|tacrolimus|mesh-list
138731343|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138731344|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
138731345|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138806084|NCT02820987|Tazobactam|tazobactam|mesh-list
138806085|NCT02820987|Piperacillin|piperacillin|mesh-list
138731346|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731347|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138731348|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
138731349|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731350|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731351|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
138731352|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731353|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138731354|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138731355|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
138731356|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731357|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138731358|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138731359|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138731360|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138731361|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
138731362|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138731363|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731364|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
139079548|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079549|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139079550|NCT03541252|Cisplatin|cisplatin|mesh-list
139079551|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806119|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139079552|NCT00031460|Acyclovir|acyclovir|mesh-list
139079553|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
139079554|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731365|NCT01810588|Rituximab|rituximab|mesh-list
138806120|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
138806121|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138806122|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138806123|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806124|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731366|NCT01810588|Fludarabine|fludarabine|mesh-list
138731367|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
138731368|NCT01810588|Melphalan|melphalan|mesh-list
138731369|NCT01810588|Tacrolimus|tacrolimus|mesh-list
138731370|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138731371|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
138731372|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138731373|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731374|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
138731375|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731376|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731377|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138731378|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
138731379|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261281|NCT00370097|Xhance|xhance|mesh-list
138731425|NCT00709865|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138731426|NCT00709865|Purinergic Agents|purinergic agents|mesh-ancestor
138731427|NCT00709865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731428|NCT00709865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731429|NCT00709865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731430|NCT00682318|Ethanol|ethanol|mesh-list
138731431|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138731432|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731433|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138731434|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731488|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731489|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731490|NCT01643759|Buprenorphine|buprenorphine|mesh-list
138731491|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138731492|NCT01643759|Narcotics|narcotics|mesh-ancestor
138731493|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138731494|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731495|NCT01643759|Analgesics|analgesics|mesh-ancestor
138731496|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
138731497|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731498|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138731499|NCT04488237|Vitamin D|vitamin d|mesh-list
138731500|NCT04488237|Vitamins|vitamins|mesh-ancestor
138731501|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
138731504|NCT04528628|Norepinephrine|norepinephrine|mesh-list
138731550|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138731551|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138731552|NCT01680263|Analgesics|analgesics|mesh-ancestor
138731553|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
138731554|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731555|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731556|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731557|NCT01601730|Dexetimide|dexetimide|mesh-list
138731558|NCT01601730|Modafinil|modafinil|mesh-list
138731559|NCT01601730|Citalopram|citalopram|mesh-list
138731560|NCT01601730|Escitalopram|escitalopram|mesh-list
138731561|NCT01601730|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138731562|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138731583|NCT01644071|Dexetimide|dexetimide|mesh-list
138731611|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731612|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138731613|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138731614|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138731615|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731616|NCT01602003|Incretins|incretins|mesh-ancestor
138731679|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138731680|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138731682|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731683|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138806195|NCT00766363|Rivastigmine|rivastigmine|mesh-list
138731684|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731685|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731686|NCT01602900|Rolipram|rolipram|mesh-list
138731687|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
138731688|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138731689|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138731690|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138731691|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731692|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731693|NCT01645241|Ganirelix|ganirelix|mesh-list
138731694|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
138731695|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138731696|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731697|NCT01602939|Cladribine|cladribine|mesh-list
138731698|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731699|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138731701|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731702|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
138731703|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138731704|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
138731705|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731706|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731707|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731708|NCT01603134|Allopurinol|allopurinol|mesh-list
138731709|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
138731710|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731711|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731722|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138731723|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138731724|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731725|NCT01603212|Interferons|interferons|mesh-list
138731726|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
138731727|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
138731728|NCT01603212|Aldesleukin|aldesleukin|mesh-list
138731729|NCT01603212|Interleukin-2|interleukin-2|mesh-list
138731730|NCT01603212|Vemurafenib|vemurafenib|mesh-list
138731731|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731732|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
138731733|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731734|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
138731735|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731783|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138731784|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138731785|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731786|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
138731787|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138731788|NCT01646294|Mirabegron|mirabegron|mesh-list
138731789|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138731790|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138731791|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138731792|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
138731793|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731794|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731795|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731796|NCT01646294|Urological Agents|urological agents|mesh-ancestor
138731797|NCT01603758|Ezetimibe|ezetimibe|mesh-list
138731798|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138731799|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138731800|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
138731801|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731802|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138731803|NCT01177228|Vedolizumab|vedolizumab|mesh-list
138731804|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138731805|NCT02279342|Febuxostat|febuxostat|mesh-list
138731806|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
138731836|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
138731837|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
138731838|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138731839|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138731840|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138731841|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138731842|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
138731843|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731844|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731845|NCT01646684|Pasireotide|pasireotide|mesh-list
138731846|NCT01646684|Hormones|hormones|mesh-ancestor
138731847|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138731848|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731849|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
138731898|NCT01682408|Mannitol|mannitol|mesh-list
138731899|NCT01682408|Ranitidine|ranitidine|mesh-list
138731900|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138731901|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138731902|NCT01682408|Diuretics|diuretics|mesh-ancestor
138731903|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
138731967|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138731968|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731969|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138731970|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138731971|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138731972|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731973|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
138731974|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731975|NCT01604928|Mirabegron|mirabegron|mesh-list
138731976|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138731977|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138731978|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138731979|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138731980|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
138731981|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731982|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731984|NCT01604928|Urological Agents|urological agents|mesh-ancestor
138732025|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138732026|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732027|NCT01608750|Folic Acid|folic acid|mesh-list
138732028|NCT01608750|Hematinics|hematinics|mesh-ancestor
138732029|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
138732030|NCT01608750|Vitamins|vitamins|mesh-ancestor
138732031|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
138732032|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732033|NCT01605513|Interferons|interferons|mesh-list
138732034|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732035|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
138732093|NCT01609101|Cobalt|cobalt|mesh-list
138732094|NCT01609101|Trace Elements|trace elements|mesh-ancestor
138732095|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
138732096|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732097|NCT01648556|Prednisone|prednisone|mesh-list
138732098|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138732099|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
138732100|NCT01648556|Hormones|hormones|mesh-ancestor
138732101|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138732102|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732103|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138732104|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732105|NCT01648595|Fentanyl|fentanyl|mesh-list
138732106|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138732107|NCT01648595|Narcotics|narcotics|mesh-ancestor
138732110|NCT01648595|Analgesics|analgesics|mesh-ancestor
138732155|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138732156|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138732157|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
138732158|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
138732159|NCT01648829|Atorvastatin|atorvastatin|mesh-list
138732160|NCT01648829|Pitavastatin|pitavastatin|mesh-list
138732161|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138732162|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138732163|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
138732164|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732165|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138732166|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138732167|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732218|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
138732219|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
138732220|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732222|NCT02279615|Mirabegron|mirabegron|mesh-list
138732223|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138732224|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138732225|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138732226|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
138732227|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732228|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732229|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732230|NCT02279615|Urological Agents|urological agents|mesh-ancestor
138732231|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138732232|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138732233|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138732234|NCT01689051|Glucagon|glucagon|mesh-list
138732235|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138732236|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138732237|NCT01689051|Hormones|hormones|mesh-ancestor
138732238|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138732239|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732240|NCT01689051|Incretins|incretins|mesh-ancestor
138732241|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
138732242|NCT01689090|Citric Acid|citric acid|mesh-list
138732243|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
138732244|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138732245|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
138732246|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138732247|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
138732248|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
138732249|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732250|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138732261|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
138732262|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138732263|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732264|NCT01689285|Valacyclovir|valacyclovir|mesh-list
138732265|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
138732266|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732267|NCT01606527|Ibuprofen|ibuprofen|mesh-list
138806401|NCT00705796|Testosterone|testosterone|mesh-list
138732268|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138732269|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138732270|NCT01606527|Analgesics|analgesics|mesh-ancestor
138732271|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
138732272|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732273|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732274|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138732275|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138732276|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138732277|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732278|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732316|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732317|NCT01649258|Granisetron|granisetron|mesh-list
138732318|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
138732319|NCT01649258|Aprepitant|aprepitant|mesh-list
138732320|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
138732321|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
138732322|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732323|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732324|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138732325|NCT01649258|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138732326|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138732327|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
138732378|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138732379|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
138732380|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732381|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732382|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732384|NCT01580202|Entecavir|entecavir|mesh-list
138732385|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138732386|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138732387|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732388|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732389|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
138732390|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732391|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138732392|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138732393|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
138732394|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138732395|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732396|NCT01609881|Ketorolac|ketorolac|mesh-list
138732397|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138732398|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138732399|NCT01609881|Analgesics|analgesics|mesh-ancestor
138732400|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
138732401|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732402|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732403|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138732404|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138732405|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138732406|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732407|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732424|NCT01606566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732425|NCT01605162|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
138732426|NCT01605162|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138732427|NCT01605162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806471|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
138732428|NCT01605162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732429|NCT01605162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732430|NCT01649999|Peficitinib|peficitinib|mesh-list
138732436|NCT01604889|Ipilimumab|ipilimumab|mesh-list
138548581|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138732484|NCT01602393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732486|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138732487|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138732488|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732489|NCT02270034|Crizotinib|crizotinib|mesh-list
138732490|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732491|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138732492|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732493|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732494|NCT02273271|Alovudine|alovudine|mesh-list
138732495|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
138732496|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732497|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
138732498|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138732499|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
138732500|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732501|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138732502|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138732503|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
138732507|NCT02270424|Fluticasone|fluticasone|mesh-list
138732536|NCT05140655|Fulvestrant|fulvestrant|mesh-list
138732537|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138732538|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732539|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138732540|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138732541|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
138732542|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138732543|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732544|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
138732545|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138732546|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138732547|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138732548|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138732596|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138732597|NCT01688648|Analgesics|analgesics|mesh-ancestor
138732598|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138732599|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138732600|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138732601|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
138732602|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732603|NCT01686659|Chrysarobin|chrysarobin|mesh-list
138732604|NCT01686659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138732605|NCT01686659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138732606|NCT01686659|Analgesics|analgesics|mesh-ancestor
138732607|NCT01686659|Sensory System Agents|sensory system agents|mesh-ancestor
138732608|NCT01686659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732609|NCT01686659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732610|NCT01686659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138732611|NCT01686659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138732612|NCT02271126|Heparin|heparin|mesh-list
138732613|NCT02271126|Thromboplastin|thromboplastin|mesh-list
138732614|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
138732615|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138732616|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138732617|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732618|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
138732649|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138732650|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138732651|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
138732652|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
138732653|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732654|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732655|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
138688927|NCT03866499|Gefitinib|gefitinib|mesh-list
138732656|NCT02271360|Coagulants|coagulants|mesh-ancestor
138732657|NCT01687049|Red yeast rice|red yeast rice|mesh-list
138732658|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138732659|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138732660|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138732661|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
138732662|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732707|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
138732708|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
138732709|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732710|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732711|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138732712|NCT02271555|Narcotics|narcotics|mesh-ancestor
138732713|NCT02271555|Analgesics|analgesics|mesh-ancestor
138732714|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
138732715|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732717|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
138732718|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732719|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138732720|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138732721|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732722|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732723|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138732724|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138732725|NCT01689194|genexol-PM|genexol-pm|mesh-list
138732726|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732727|NCT01689194|Tubulin Modulators|tubulin modulators|mesh-ancestor
138732728|NCT01689194|Antimitotic Agents|antimitotic agents|mesh-ancestor
138732729|NCT01689194|Mitosis Modulators|mitosis modulators|mesh-ancestor
138732730|NCT01689194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732759|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732760|NCT01689311|Alprostadil|alprostadil|mesh-list
138732761|NCT01689311|Misoprostol|misoprostol|mesh-list
138732762|NCT01689311|Oxytocin|oxytocin|mesh-list
138732763|NCT01689311|Ergonovine|ergonovine|mesh-list
138732764|NCT01689311|Dinoprost|dinoprost|mesh-list
138732765|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
138732766|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
138732767|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138732768|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732769|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138732770|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
138732771|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138732772|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138732773|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138732774|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
138732775|NCT01689311|Urological Agents|urological agents|mesh-ancestor
138732776|NCT01588782|Ketoconazole|ketoconazole|mesh-list
138732777|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
138732778|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732779|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138732780|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138732781|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732782|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732812|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138732813|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732814|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
138732815|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732816|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138732817|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732818|NCT01689623|Simeprevir|simeprevir|mesh-list
138732819|NCT01689623|Atorvastatin|atorvastatin|mesh-list
138732820|NCT01689623|Simvastatin|simvastatin|mesh-list
138732821|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138732822|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138732823|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
138548622|NCT00066638|Romidepsin|romidepsin|mesh-list
138732824|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732825|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138732831|NCT04055142|Cidofovir|cidofovir|mesh-list
138732870|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138732871|NCT01689896|Testosterone|testosterone|mesh-list
138732872|NCT01689896|Androgens|androgens|mesh-ancestor
138732873|NCT01689896|Hormones|hormones|mesh-ancestor
138732874|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138732875|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732876|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
138732877|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138732878|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732880|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732881|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138732882|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138732883|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
138732884|NCT01316133|Tacrolimus|tacrolimus|mesh-list
138732885|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138732886|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
138732887|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732888|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138732889|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732890|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732892|NCT05654064|Dexmedetomidine|dexmedetomidine|mesh-list
138732893|NCT05654064|Remifentanil|remifentanil|mesh-list
138732898|NCT05654064|Analgesics|analgesics|mesh-ancestor
138732923|NCT01685255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732924|NCT01685255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138732925|NCT01685255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732926|NCT01685255|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138732927|NCT01685255|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138732928|NCT01685255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138732929|NCT01680965|Ofatumumab|ofatumumab|mesh-list
138732930|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732931|NCT01683188|Vemurafenib|vemurafenib|mesh-list
138732932|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732933|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138732936|NCT01339923|Vaccines|vaccines|mesh-list
138732985|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138732986|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
138732987|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138732988|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732989|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138732990|NCT01371747|Diuretics|diuretics|mesh-ancestor
138732991|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
138732992|NCT01335399|Dexamethasone|dexamethasone|mesh-list
138732993|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
138732994|NCT01335399|Lenalidomide|lenalidomide|mesh-list
138733051|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733052|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733053|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138733054|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138733055|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138733056|NCT01366209|Pirfenidone|pirfenidone|mesh-list
138733057|NCT01366209|Analgesics|analgesics|mesh-ancestor
138733058|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
138733059|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733060|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733061|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138733062|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138733063|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138733064|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806745|NCT04236453|Tenofovir|tenofovir|mesh-list
138733065|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733066|NCT01365507|Insulin|insulin|mesh-list
138733067|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
138733068|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138733069|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733070|NCT02995694|Estradiol|estradiol|mesh-list
138733109|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733110|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
138733111|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138733112|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138733113|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138733114|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138733115|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138733116|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138733117|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733118|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733119|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
138733120|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138733121|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138733171|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138733172|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733173|NCT01350804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138733174|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733175|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138733176|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
138733177|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733178|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138733180|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138733181|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733182|NCT02270957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138733183|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733184|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138733185|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
138733186|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733187|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138733227|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733228|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
138733229|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138733230|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138733231|NCT01342887|Analgesics|analgesics|mesh-ancestor
138733232|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
138733233|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733234|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138733235|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138733236|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
138733237|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138733238|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138733240|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
138733241|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733242|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
138733243|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138733244|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733245|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138733246|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733247|NCT01340664|Metformin|metformin|mesh-list
138733248|NCT01340664|Canagliflozin|canagliflozin|mesh-list
138733249|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138733279|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733280|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138733281|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138733282|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138733283|NCT02893332|Gefitinib|gefitinib|mesh-list
138733284|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733285|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138733286|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733287|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733288|NCT04328493|Chloroquine|chloroquine|mesh-list
138733289|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138733290|NCT04328493|Amebicides|amebicides|mesh-ancestor
138733291|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138733292|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138733293|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733294|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
138733295|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138733296|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138733339|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138733340|NCT02893371|Ziprasidone|ziprasidone|mesh-list
138733341|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138733342|NCT02893371|Clozapine|clozapine|mesh-list
138733343|NCT02893371|Asenapine|asenapine|mesh-list
138733344|NCT02893371|Perphenazine|perphenazine|mesh-list
138733345|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
138733346|NCT02893371|Mirtazapine|mirtazapine|mesh-list
138733347|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
138733348|NCT02893371|Doxepin|doxepin|mesh-list
138733349|NCT02893371|Citalopram|citalopram|mesh-list
138733350|NCT02893371|Bupropion|bupropion|mesh-list
138733406|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138733407|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138733408|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138733409|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
138733410|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138733411|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138733412|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138733413|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138733414|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138733416|NCT05138978|Listerine|listerine|mesh-list
138733468|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
138733469|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138733470|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733471|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138733472|NCT02894268|Doxycycline|doxycycline|mesh-list
138733473|NCT02894268|Furazolidone|furazolidone|mesh-list
138733474|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138733475|NCT02894268|Esomeprazole|esomeprazole|mesh-list
138733476|NCT02894268|Bismuth|bismuth|mesh-list
138733477|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733478|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138733486|NCT02894268|Antacids|antacids|mesh-ancestor
138733533|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138733534|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733535|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
138733536|NCT01600235|Phenylephrine|phenylephrine|mesh-list
138733537|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
138733538|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138733539|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
138733540|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
138733541|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733542|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733543|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
138733544|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138733598|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138733599|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138733600|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138733601|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138733602|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
138733603|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138733604|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138733605|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
138733606|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138733607|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
138733608|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138733609|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138733610|NCT00592332|Alprazolam|alprazolam|mesh-list
138733611|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138733613|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733657|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
138733658|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
138733659|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733660|NCT01113541|Ziprasidone|ziprasidone|mesh-list
138733661|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138733662|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
138733663|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733664|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733665|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733666|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138733720|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138733721|NCT01607333|Lamotrigine|lamotrigine|mesh-list
138733722|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
138733723|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138733724|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138733725|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733726|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138733727|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733728|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138733729|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138733730|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138733731|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138806878|NCT05549115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733784|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138733785|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138733786|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
138733787|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
138733788|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138733789|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138733790|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138733791|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
138733792|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138733793|NCT01601327|Testosterone|testosterone|mesh-list
138733794|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
138733795|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
138733796|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138733847|NCT01607918|Metronidazole|metronidazole|mesh-list
138733848|NCT01607918|Clarithromycin|clarithromycin|mesh-list
138733849|NCT01607918|Lansoprazole|lansoprazole|mesh-list
138733850|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
138733851|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138733852|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733853|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138733854|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138733855|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138733856|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733857|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733858|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138733863|NCT01607996|Anesthetics|anesthetics|mesh-list
138733909|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
138733910|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733911|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733912|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138733913|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733914|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138733915|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
138733916|NCT01175590|Besifloxacin|besifloxacin|mesh-list
138733917|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138733918|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733919|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138733920|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138733921|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733922|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733923|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733924|NCT01175473|Metformin|metformin|mesh-list
138733925|NCT01175473|Liraglutide|liraglutide|mesh-list
138733926|NCT01175473|Lixisenatide|lixisenatide|mesh-list
138733927|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138733928|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733929|NCT01175473|Incretins|incretins|mesh-ancestor
138733930|NCT01175473|Hormones|hormones|mesh-ancestor
138733931|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138733961|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733962|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733963|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138733964|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138733965|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
138733966|NCT01602302|Adalimumab|adalimumab|mesh-list
138733967|NCT01602302|Infliximab|infliximab|mesh-list
138733968|NCT01602302|Golimumab|golimumab|mesh-list
138733969|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
138733970|NCT01602302|Etanercept|etanercept|mesh-list
138733971|NCT01602302|Abatacept|abatacept|mesh-list
138733972|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138734025|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138734026|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138734027|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
138734028|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734029|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138734096|NCT01609166|Protective Agents|protective agents|mesh-ancestor
138734097|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734099|NCT01609205|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138734100|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138734101|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138734102|NCT01604057|Teriparatide|teriparatide|mesh-list
138734103|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138734104|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734105|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138734106|NCT00592566|Dexamethasone|dexamethasone|mesh-list
138734107|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138806953|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
138734108|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138734161|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
138734162|NCT01110382|Doripenem|doripenem|mesh-list
138734170|NCT00592917|Vitamin D|vitamin d|mesh-list
138734233|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734234|NCT01609907|Valsartan|valsartan|mesh-list
138734235|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138734236|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138734237|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138734238|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
138548778|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
138734239|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734240|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138734259|NCT00593619|Iron|iron|mesh-list
138734298|NCT01601522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138734299|NCT01601522|Histamine Agents|histamine agents|mesh-ancestor
138734300|NCT01601522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138734301|NCT01601522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138734302|NCT01601522|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138734303|NCT00593853|Methylphenidate|methylphenidate|mesh-list
138734304|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138734305|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734306|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138734307|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138734308|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138734309|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734310|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
138734311|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734312|NCT01607294|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138734358|NCT00593463|Naloxone|naloxone|mesh-list
138734359|NCT00593463|Analgesics|analgesics|mesh-ancestor
138734360|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
138734361|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806989|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138734362|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734363|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
138734364|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138734365|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138734366|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138734367|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138734368|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138734369|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138734370|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734371|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734372|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
138734373|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138734374|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138734375|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138734376|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138734377|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
138734378|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
138734410|NCT01605734|Estrogens|estrogens|mesh-ancestor
138734411|NCT01605734|Hormones|hormones|mesh-ancestor
138734412|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138734413|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734414|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138734415|NCT01605773|Glyburide|glyburide|mesh-list
138734416|NCT01605773|Repaglinide|repaglinide|mesh-list
138734417|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138734419|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
138734479|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
138734480|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138734481|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734482|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
138734483|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734550|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138734551|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
138734552|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138734553|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
138734554|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734555|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
138734621|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734622|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734623|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138734624|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138734625|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138734626|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138734686|NCT02271971|Vitamin D|vitamin d|mesh-list
138734687|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
138734688|NCT02271971|Vitamins|vitamins|mesh-ancestor
138734689|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
138734690|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734691|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138734692|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138734693|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
138734756|NCT02272478|Immunologic Factors|immunologic factors|mesh-ancestor
138734757|NCT02272478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734758|NCT02272517|Vortioxetine|vortioxetine|mesh-list
138734759|NCT02272517|Escitalopram|escitalopram|mesh-list
138734760|NCT02272517|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138734761|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138734762|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138734763|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734764|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734765|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
138734766|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734767|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
138734768|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138734769|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138734770|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138734771|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138734775|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138734813|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734814|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734815|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138734816|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138734817|NCT01108510|Cobicistat|cobicistat|mesh-list
138734818|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138734822|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
138734879|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734880|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734881|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734882|NCT04310293|Hormones|hormones|mesh-list
138734883|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138734884|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734885|NCT01339559|Brivaracetam|brivaracetam|mesh-list
138734949|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138734950|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138734951|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138734952|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
138734953|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734954|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734955|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138734956|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138734957|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
138734958|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734959|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138734960|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138734961|NCT00107120|Escitalopram|escitalopram|mesh-list
138734962|NCT00107120|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138734963|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138734964|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138734965|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734966|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734967|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
138735001|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
138735002|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
138735003|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735004|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735005|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735006|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138735007|NCT00598962|Azithromycin|azithromycin|mesh-list
138735008|NCT00598962|Rifampin|rifampin|mesh-list
138735009|NCT00598962|Rifabutin|rifabutin|mesh-list
138735010|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138735011|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735012|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138735063|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735064|NCT00599235|Urological Agents|urological agents|mesh-ancestor
138735065|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138735066|NCT00599274|Interferons|interferons|mesh-list
138735067|NCT00599274|Interferon-beta|interferon-beta|mesh-list
138735068|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
138735069|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735070|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
138735071|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735072|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
138735073|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735074|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138735075|NCT01332227|Ritonavir|ritonavir|mesh-list
138735125|NCT00599625|Pravastatin|pravastatin|mesh-list
138735126|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138735127|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138735128|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
138735129|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735130|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138691429|NCT01283464|Vitamin A|vitamin a|mesh-list
138735131|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138735132|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735133|NCT05649878|Methylprednisolone|methylprednisolone|mesh-list
138735134|NCT05649878|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138735135|NCT05649878|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138735186|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
138735187|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138735188|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
138735189|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
138735190|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138735191|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138735192|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735193|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735194|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735249|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138735250|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138735251|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735252|NCT01351025|Atorvastatin|atorvastatin|mesh-list
138735253|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138735254|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138735255|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
138735256|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735257|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138735258|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138735259|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735260|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138735261|NCT01348763|Maraviroc|maraviroc|mesh-list
138735310|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735311|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138735312|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
138735313|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735314|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735315|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138735316|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138735317|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735318|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138807189|NCT05804734|Vitamin K|vitamin k|mesh-list
138735319|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138735320|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735321|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735322|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
138735323|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735325|NCT01342211|Bococizumab|bococizumab|mesh-list
138735366|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
138735367|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735368|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138735369|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735370|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
138735371|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138735372|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138735373|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138735374|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735375|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735376|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
138735377|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735378|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735379|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138735381|NCT00598338|Prucalopride|prucalopride|mesh-list
138735425|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138735426|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735427|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138735428|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138735429|NCT00600210|Growth Substances|growth substances|mesh-ancestor
138735430|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735431|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
138735433|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
138735434|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138735435|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138735436|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735487|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138735488|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138735489|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735491|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138735492|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
138735493|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735495|NCT00601692|Docetaxel|docetaxel|mesh-list
138735496|NCT00601692|Irinotecan|irinotecan|mesh-list
138735497|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735498|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
138735499|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
138735550|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735551|NCT01169701|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138735552|NCT01169701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138735553|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735554|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138735555|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138735556|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
138735557|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138735558|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735559|NCT01167907|Ropivacaine|ropivacaine|mesh-list
138735560|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
138735561|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
138735562|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138735563|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735564|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
138735565|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735566|NCT01115491|Bevacizumab|bevacizumab|mesh-list
138735567|NCT01115491|Temozolomide|temozolomide|mesh-list
138691877|NCT00532584|Beclomethasone|beclomethasone|mesh-list
138735568|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138735604|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735605|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735606|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138548901|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138735607|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138735608|NCT04309357|Plasminogen|plasminogen|mesh-list
138548906|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138735670|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735671|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138735673|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
138735674|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138735675|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138735676|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735677|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138735678|NCT02878837|Analgesics|analgesics|mesh-ancestor
138735679|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
138735680|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735681|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138735682|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138735683|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138735684|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
138735685|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735687|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138735726|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
138735727|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735728|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735729|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
138735730|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138735731|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138735732|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
138735733|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138735734|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735735|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735736|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138735737|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
138735738|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138735739|NCT02893826|Nimodipine|nimodipine|mesh-list
138735740|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138548914|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
138735782|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735783|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138735784|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138735785|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
138735786|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735787|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138735788|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
138735789|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735790|NCT00592670|Fluoxetine|fluoxetine|mesh-list
138735791|NCT00592670|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138807281|NCT05803642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138807282|NCT05803642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138807283|NCT05803642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138807284|NCT05803642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138807285|NCT05803642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138807286|NCT05803642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138807287|NCT05803642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138807288|NCT05803642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735792|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138735793|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735842|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
138735843|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735844|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138735845|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138735846|NCT00595322|Bevacizumab|bevacizumab|mesh-list
138735847|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138735848|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735910|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735911|NCT00598676|Sirolimus|sirolimus|mesh-list
138735912|NCT00598676|Everolimus|everolimus|mesh-list
138735913|NCT00598676|MTOR Inhibitors|mtor inhibitors|mesh-list
138735914|NCT00598676|Temsirolimus|temsirolimus|mesh-list
138735915|NCT00598676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138735982|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
138735983|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138735984|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
138735985|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
138735986|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
138735987|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
138735988|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138735989|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735991|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
138735992|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735993|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
138735994|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735995|NCT00601016|Imiquimod|imiquimod|mesh-list
138736043|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736044|NCT04308031|Digoxin|digoxin|mesh-list
138736045|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138736046|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138736047|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736048|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736049|NCT04308031|Protective Agents|protective agents|mesh-ancestor
138736050|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736051|NCT01096849|Levofloxacin|levofloxacin|mesh-list
138736052|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138736053|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736104|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138736105|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736106|NCT01324310|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138736107|NCT01102231|Cetuximab|cetuximab|mesh-list
138736108|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138736109|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736110|NCT01095835|Interferons|interferons|mesh-list
138736111|NCT01095835|Lamivudine|lamivudine|mesh-list
138736171|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736172|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
138736173|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736174|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138736175|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138736176|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
138736177|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138736178|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138736179|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138736180|NCT01093885|Ambrisentan|ambrisentan|mesh-list
138736181|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138736182|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138736183|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736184|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138736185|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736186|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736230|NCT00600093|Analgesics|analgesics|mesh-ancestor
138736231|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
138736232|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736233|NCT00600249|Docetaxel|docetaxel|mesh-list
138736234|NCT00600249|Cetuximab|cetuximab|mesh-list
138736235|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692555|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736236|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
138736237|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
138736297|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
138736298|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736299|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736300|NCT00600873|Pramipexole|pramipexole|mesh-list
138736301|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
138736302|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736303|NCT00600873|Protective Agents|protective agents|mesh-ancestor
138736304|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736305|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138736306|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138736307|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
138736308|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
138736309|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736310|NCT00598611|Loratadine|loratadine|mesh-list
138736311|NCT00598611|Desloratadine|desloratadine|mesh-list
138736312|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138736313|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
138736314|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736315|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736316|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736317|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138736318|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138736319|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
138736320|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
138736347|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736348|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736349|NCT01325493|Ketamine|ketamine|mesh-list
138736350|NCT01325493|Analgesics|analgesics|mesh-ancestor
138736351|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
138736352|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736353|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736354|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138736355|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138736356|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
138736357|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
138736358|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138736359|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138736364|NCT01325337|Minoxidil|minoxidil|mesh-list
138736405|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138736406|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138736407|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138736408|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138736409|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138736410|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138736411|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138736412|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736413|NCT01324323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138736414|NCT05344963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138736415|NCT05344963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736416|NCT05344963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138736417|NCT05344963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736418|NCT02879227|Cisplatin|cisplatin|mesh-list
138736464|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736465|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
138736466|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138736467|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138736468|NCT05644743|Gemcitabine|gemcitabine|mesh-list
138736469|NCT05644743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736470|NCT05644743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138736471|NCT05644743|Antimetabolites|antimetabolites|mesh-ancestor
138736472|NCT05644743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736474|NCT01317615|Carboplatin|carboplatin|mesh-list
138736475|NCT01317615|Everolimus|everolimus|mesh-list
138736476|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138736477|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736478|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
138736479|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
138736480|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
138736525|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138736526|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736528|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138736529|NCT01321710|Analgesics|analgesics|mesh-ancestor
138736530|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
138736531|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692860|NCT00624130|Dacuronium|dacuronium|mesh-list
138736594|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736595|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736596|NCT01313559|Hormones|hormones|mesh-ancestor
138736597|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138736598|NCT02890875|Ethanol|ethanol|mesh-list
138736599|NCT02890875|Heparin|heparin|mesh-list
138736600|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
138736601|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138736602|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138736603|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736658|NCT01313780|Oxycodone|oxycodone|mesh-list
138736659|NCT01313780|Naloxone|naloxone|mesh-list
138736660|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138736661|NCT01313780|Narcotics|narcotics|mesh-ancestor
138736662|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138736663|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736664|NCT01313780|Analgesics|analgesics|mesh-ancestor
138736665|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
138736666|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736667|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138736668|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138736720|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736721|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138736722|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
138736723|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
138736724|NCT00624754|Hormones|hormones|mesh-ancestor
138736725|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138807634|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138736726|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138736727|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138736728|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138736729|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
138736730|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736731|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736732|NCT01114828|Tolvaptan|tolvaptan|mesh-list
138736733|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138736734|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736735|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
138736736|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736749|NCT01114672|Vitamin D|vitamin d|mesh-list
138736775|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138736776|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138736777|NCT01313078|Asparaginase|asparaginase|mesh-list
138736778|NCT01313078|Pegaspargase|pegaspargase|mesh-list
138736779|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736780|NCT01114360|Melatonin|melatonin|mesh-list
138736781|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
138736782|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736783|NCT01114360|Protective Agents|protective agents|mesh-ancestor
138736784|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736785|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138736786|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138736839|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138736840|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138736841|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138736842|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138736843|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736845|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
138736846|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138736847|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138736848|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736859|NCT00623402|Sorafenib|sorafenib|mesh-list
138736905|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138736906|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
138736907|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693232|NCT00537173|Paclitaxel|paclitaxel|mesh-list
138736908|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736909|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736910|NCT02877901|Urological Agents|urological agents|mesh-ancestor
138736911|NCT04306159|Anesthetics|anesthetics|mesh-list
138736912|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138736971|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
138736972|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
138736973|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736974|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736975|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138736976|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138736977|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138736978|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
138736979|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736980|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736981|NCT01076335|Docetaxel|docetaxel|mesh-list
138736982|NCT01076335|Leuprolide|leuprolide|mesh-list
138736983|NCT01076335|Goserelin|goserelin|mesh-list
138736984|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737034|NCT05320705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138737035|NCT05320705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138737036|NCT05320705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737037|NCT05320705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138737038|NCT05320705|Analgesics|analgesics|mesh-ancestor
138737039|NCT05320705|Sensory System Agents|sensory system agents|mesh-ancestor
138737040|NCT05320705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737041|NCT05320705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138737042|NCT05320705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138737043|NCT05320705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138737044|NCT05320705|Adrenergic Agents|adrenergic agents|mesh-ancestor
138737095|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138737096|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737097|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
138737098|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
138737099|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737100|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
138737165|NCT04972396|Estrogens|estrogens|mesh-ancestor
138737166|NCT04972396|Hormones|hormones|mesh-ancestor
138737167|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138737168|NCT01089361|Ketamine|ketamine|mesh-list
138737169|NCT01089361|Analgesics|analgesics|mesh-ancestor
138737170|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
138737171|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737172|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737173|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138737175|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
138737228|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138737229|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
138737230|NCT04306471|Evolocumab|evolocumab|mesh-list
138737231|NCT04306471|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138737232|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138737233|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138737234|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
138737235|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737236|NCT04306471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138737294|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138737295|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737296|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138737297|NCT00592241|Insulin|insulin|mesh-list
138737298|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138737299|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138737300|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737301|NCT02890719|Ribavirin|ribavirin|mesh-list
138737302|NCT02890719|Grazoprevir|grazoprevir|mesh-list
138737303|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
138737304|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737305|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
138737307|NCT04325061|Dexamethasone|dexamethasone|mesh-list
138737355|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138737356|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138737357|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138737358|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138807878|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138737359|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737360|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737361|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737362|NCT01070329|Analgesics|analgesics|mesh-ancestor
138737363|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
138737364|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737365|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
138737366|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138737367|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
138737368|NCT04327427|Aspirin|aspirin|mesh-list
138737371|NCT04327427|Analgesics|analgesics|mesh-ancestor
138737415|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138737416|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737417|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
138737418|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737419|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737420|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138737421|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138737422|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737423|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
138737424|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138693748|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
138737425|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737427|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138737429|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
138737430|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
138737434|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
138737472|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138737473|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138737474|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138737475|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
138737476|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138737477|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138737478|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737479|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138737480|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
138737481|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737483|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138737484|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138737485|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138737486|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737487|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
138737488|NCT04326959|Hormones|hormones|mesh-ancestor
138737489|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138737490|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737491|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138737492|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
138737493|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737494|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737495|NCT00594737|Memantine|memantine|mesh-list
138737496|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138737497|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138737498|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
138737499|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693824|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
138737500|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737501|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737502|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138737503|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138737510|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138737511|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737512|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737513|NCT00596063|Insulin|insulin|mesh-list
138737514|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138737515|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737516|NCT00596219|Celecoxib|celecoxib|mesh-list
138737517|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138737518|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138737519|NCT00596219|Analgesics|analgesics|mesh-ancestor
138737520|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
138737521|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737522|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737523|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737524|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138737525|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138737526|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138737527|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737528|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737529|NCT00596297|Bevacizumab|bevacizumab|mesh-list
138737530|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138737531|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737532|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138737533|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138737534|NCT00596297|Growth Substances|growth substances|mesh-ancestor
138737537|NCT00596375|Lidocaine|lidocaine|mesh-list
138737558|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737559|NCT04326803|Vaccines|vaccines|mesh-list
138737560|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
138737561|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737562|NCT00597233|Insulin|insulin|mesh-list
138737563|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138737564|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
138737565|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
138737628|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138737629|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737630|NCT00623415|Flupirtine|flupirtine|mesh-list
138737631|NCT00623415|Analgesics|analgesics|mesh-ancestor
138737632|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
138737633|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737634|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737635|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
138737636|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
138737650|NCT00598169|Etoposide|etoposide|mesh-list
138737695|NCT00598637|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138737696|NCT00598637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138737697|NCT00598637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737698|NCT00598637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737699|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138737700|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
138737701|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737702|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737703|NCT00598715|Sirolimus|sirolimus|mesh-list
138737704|NCT00598715|Paclitaxel|paclitaxel|mesh-list
138737705|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138737706|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737707|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
138737708|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
138737709|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
138737710|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737711|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138737712|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737713|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138737752|NCT00599573|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138737753|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138737754|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
138737755|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737756|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737757|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138737758|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
138737759|NCT01048099|Trastuzumab|trastuzumab|mesh-list
138737761|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138737762|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737763|NCT00599807|Vitamin D|vitamin d|mesh-list
138737818|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737819|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138737820|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
138737821|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737822|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138737823|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737824|NCT01045447|Insulin|insulin|mesh-list
138737825|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138737826|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
138737827|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
138737828|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138737829|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737830|NCT00623207|Atropine|atropine|mesh-list
138737831|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138737832|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138737833|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138737834|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
138737835|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737836|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737837|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138737838|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
138737839|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
138737840|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
138737841|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138737842|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138737843|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
138737844|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737845|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737846|NCT00600977|Doxorubicin|doxorubicin|mesh-list
138737847|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138737848|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138737863|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737864|NCT00601289|Temozolomide|temozolomide|mesh-list
138737865|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138737866|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
138737867|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737868|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737869|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138737870|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737871|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138737872|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737873|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737874|NCT00601991|Aflibercept|aflibercept|mesh-list
138737875|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
138737876|NCT00601991|Growth Substances|growth substances|mesh-ancestor
138737877|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737882|NCT01301391|Maleic acid|maleic acid|mesh-list
138737920|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
138737921|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
138737922|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138737923|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737924|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
138737925|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737926|NCT00626977|Analgesics|analgesics|mesh-ancestor
138737927|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138737928|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
138737929|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
138737930|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138737931|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138737932|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138737936|NCT04303819|Exenatide|exenatide|mesh-list
138737981|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138737982|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138737983|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138737984|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138737985|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138737986|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549274|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138737987|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738046|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138738047|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
138738048|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738049|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138738050|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138738051|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
138738052|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738053|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738111|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138738112|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
138738113|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138738114|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738115|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138738116|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738122|NCT01106092|Vaccines|vaccines|mesh-list
138738179|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138738181|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738182|NCT01322009|Expectorants|expectorants|mesh-ancestor
138738183|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
138738184|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138738185|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
138738186|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738250|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738251|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738252|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738253|NCT01093534|Urological Agents|urological agents|mesh-ancestor
138738254|NCT01314911|Oseltamivir|oseltamivir|mesh-list
138738256|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738257|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738258|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738260|NCT01093222|Sorafenib|sorafenib|mesh-list
138738315|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
138738316|NCT01313273|Estrogens|estrogens|mesh-ancestor
138738317|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138738318|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738319|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
138738320|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
138738321|NCT01091974|Modafinil|modafinil|mesh-list
138738322|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138738323|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738382|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138738383|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138738384|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
138738385|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738386|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738387|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738388|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138738389|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738390|NCT01309997|Rituximab|rituximab|mesh-list
138738391|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
138738392|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138738393|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738394|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
138738395|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738396|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138738397|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138738398|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738399|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738437|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738439|NCT01307579|Caspofungin|caspofungin|mesh-list
138738440|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
138738441|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738442|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138738443|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138738444|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738445|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738446|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138738447|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
138738448|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138738495|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138738496|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138738497|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138738498|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138738499|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738500|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738501|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738502|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
138738503|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138738504|NCT02875093|Cytarabine|cytarabine|mesh-list
138738514|NCT01033825|Ciclesonide|ciclesonide|mesh-list
138808201|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138738558|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
138738559|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138738560|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738561|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738562|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138738563|NCT01096186|Carbidopa|carbidopa|mesh-list
138738564|NCT01096186|Levodopa|levodopa|mesh-list
138738565|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138738566|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
138738567|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738622|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738623|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
138738624|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738625|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138738626|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138738628|NCT01023061|Leuprolide|leuprolide|mesh-list
138738629|NCT01023061|Goserelin|goserelin|mesh-list
138738630|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
138738631|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138738632|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
138738633|NCT01023061|Hormones|hormones|mesh-ancestor
138738634|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138738635|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738636|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138738637|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738638|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138738639|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
138738640|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138738641|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138738642|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738643|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738644|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
138738645|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138738646|NCT01027897|Doripenem|doripenem|mesh-list
138738647|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138738648|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738649|NCT01027351|Vaccines|vaccines|mesh-list
138738650|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
138738651|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808279|NCT02791737|Coal Tar|coal tar|mesh-list
138738652|NCT05661045|Anesthetics|anesthetics|mesh-list
138738653|NCT05661045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138738669|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
138738670|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738671|NCT01294449|Cytarabine|cytarabine|mesh-list
138738672|NCT01294449|Dexamethasone|dexamethasone|mesh-list
138738673|NCT01294449|Methotrexate|methotrexate|mesh-list
138738674|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138738675|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
138738676|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738677|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738678|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
138738679|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738680|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138738681|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
138738682|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738683|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138738684|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
138738685|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
138738686|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738689|NCT01294449|Hormones|hormones|mesh-ancestor
138738725|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738726|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138738727|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
138738729|NCT01026493|Veliparib|veliparib|mesh-list
138738793|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738794|NCT02872597|Dexamethasone|dexamethasone|mesh-list
138738795|NCT02872597|Prednisone|prednisone|mesh-list
138738796|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
138738797|NCT02872597|Prednisolone|prednisolone|mesh-list
138738798|NCT02872597|Albuterol|albuterol|mesh-list
138738799|NCT02872597|Ipratropium|ipratropium|mesh-list
138738800|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138738801|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
138738802|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
138738803|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738804|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738805|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138738806|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
138738807|NCT02872597|Hormones|hormones|mesh-ancestor
138738809|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138738855|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138738856|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
138738857|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138738858|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138738859|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138738860|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138738861|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
138738862|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138738863|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138738864|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738865|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
138738866|NCT01014013|Ertapenem|ertapenem|mesh-list
138738867|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138738868|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738869|NCT01013701|Fluticasone|fluticasone|mesh-list
138738871|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138738872|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138738873|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
138738874|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738875|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738876|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138738877|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
138738878|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
138738879|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138738880|NCT01020019|Lofexidine|lofexidine|mesh-list
138738881|NCT01020019|Dronabinol|dronabinol|mesh-list
138738882|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
138738883|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738884|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138738885|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138738886|NCT01020019|Analgesics|analgesics|mesh-ancestor
138738887|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
138738888|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738889|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138738890|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138738891|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738894|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138738895|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138738896|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138738897|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138738898|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138738899|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138738900|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
138738901|NCT00627835|Cisplatin|cisplatin|mesh-list
138738902|NCT00627835|Sorafenib|sorafenib|mesh-list
138738903|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738904|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138738905|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738906|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738907|NCT01019317|Cytarabine|cytarabine|mesh-list
138738908|NCT01019317|Fludarabine|fludarabine|mesh-list
138738909|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
138738910|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738911|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138738912|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
138738933|NCT01288443|Alirocumab|alirocumab|mesh-list
138738948|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138738949|NCT01288209|Simeprevir|simeprevir|mesh-list
138738950|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
138738951|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738952|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
138738953|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738954|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
138738955|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738956|NCT01287195|Omeprazole|omeprazole|mesh-list
138738957|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
138738958|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138738959|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138738960|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138738961|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738962|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739012|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138739013|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138739014|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
138808369|NCT00632580|Ropivacaine|ropivacaine|mesh-list
138739015|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739016|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739017|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138739018|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138739019|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
138739020|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739021|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138739023|NCT01090414|Idelalisib|idelalisib|mesh-list
138739075|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138739076|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
138739077|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138739078|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739079|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138739080|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138739081|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138739082|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138739083|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
138739084|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138739085|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138739086|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739137|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
138739138|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739139|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739140|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138739141|NCT01079962|Atenolol|atenolol|mesh-list
138739142|NCT01079962|Bisoprolol|bisoprolol|mesh-list
138739143|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138808409|NCT02788851|Guanfacine|guanfacine|mesh-list
138739144|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138739145|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
138739146|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
138739147|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739148|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739149|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138739150|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138739151|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138739152|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
138739153|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739154|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739155|NCT01274637|Dalteparin|dalteparin|mesh-list
138739156|NCT01274637|Tinzaparin|tinzaparin|mesh-list
138739157|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138739192|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138739193|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739194|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138739196|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138739197|NCT00623376|Analgesics|analgesics|mesh-ancestor
138739198|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
138739200|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138739201|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739202|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739203|NCT00623376|Hormones|hormones|mesh-ancestor
138739204|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138739205|NCT01313286|Globalagliatin|globalagliatin|mesh-list
138739206|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
138739207|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739208|NCT01313208|Etanercept|etanercept|mesh-list
138739209|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138739210|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138739211|NCT01313208|Analgesics|analgesics|mesh-ancestor
138739212|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
138739213|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739214|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739215|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739216|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739217|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138739218|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138739219|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
138739239|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739240|NCT01012999|Sufentanil|sufentanil|mesh-list
138549562|NCT00249574|Narcotics|narcotics|mesh-ancestor
138739241|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138739242|NCT01012999|Narcotics|narcotics|mesh-ancestor
138739243|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739244|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739245|NCT01012999|Analgesics|analgesics|mesh-ancestor
138739246|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
138739247|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739248|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138739249|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138739250|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
138739251|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
138739252|NCT00637663|Lamivudine|lamivudine|mesh-list
138739253|NCT00637663|Entecavir|entecavir|mesh-list
138739254|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138739255|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138739256|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739257|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739258|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
138739259|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739260|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138739261|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138739262|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
138739263|NCT01016977|Clindamycin|clindamycin|mesh-list
138739264|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
138739265|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
138739266|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138739267|NCT01016977|Tazarotene|tazarotene|mesh-list
138739268|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138739269|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739270|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138739271|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739272|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739273|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
138739280|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138739281|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
138739282|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138739283|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138739284|NCT02871661|Analgesics|analgesics|mesh-ancestor
138739285|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
138739286|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808540|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
138739287|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739288|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138739289|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138739290|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138739291|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739292|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
138739293|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739294|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
138739295|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138739296|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
138739297|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739298|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739299|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138739300|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
138739301|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
138739302|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138739303|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
138739304|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739305|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739307|NCT00628459|Trace Elements|trace elements|mesh-list
138739308|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739309|NCT00627913|Anesthetics|anesthetics|mesh-list
138739324|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138739325|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138739326|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
138739327|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739328|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739329|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739330|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138739331|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138739332|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
138739333|NCT01012609|Irinotecan|irinotecan|mesh-list
138739334|NCT01012609|Cetuximab|cetuximab|mesh-list
138739335|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138739336|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138739337|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739338|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739339|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739340|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138739341|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138739342|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
138739343|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739344|NCT01012219|Aspirin|aspirin|mesh-list
138739345|NCT01012219|Niacin|niacin|mesh-list
138739346|NCT01012219|Clopidogrel|clopidogrel|mesh-list
138739347|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138739348|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138739349|NCT01012219|Analgesics|analgesics|mesh-ancestor
138739350|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
138739351|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739352|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739353|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739354|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739355|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138739356|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138657796|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139079555|NCT03540160|Serlopitant|serlopitant|mesh-list
139079556|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139079557|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139079558|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079559|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079560|NCT01095302|Docetaxel|docetaxel|mesh-list
139079561|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739357|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739358|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138739359|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138739360|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739361|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
138739362|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138739363|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138739364|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138739365|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
138739366|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739367|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138739368|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
138739369|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138695710|NCT00551109|SA 4503|sa 4503|mesh-list
138549609|NCT00249964|Paclitaxel|paclitaxel|mesh-list
138739370|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
138739371|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
138739372|NCT01012219|Vitamins|vitamins|mesh-ancestor
138739373|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
138739374|NCT01011907|Varenicline|varenicline|mesh-list
138739375|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138739376|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138739377|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
138739378|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739379|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739380|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739381|NCT01011673|Ketorolac|ketorolac|mesh-list
138739382|NCT01011673|Metoclopramide|metoclopramide|mesh-list
138739383|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138739384|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138739385|NCT01011673|Analgesics|analgesics|mesh-ancestor
138739386|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
138739400|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739401|NCT01011439|Maleic acid|maleic acid|mesh-list
138739402|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739403|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739404|NCT01311024|Vaccines|vaccines|mesh-list
138739405|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
138739406|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739407|NCT02871193|Dexamethasone|dexamethasone|mesh-list
138739408|NCT02871193|Ropivacaine|ropivacaine|mesh-list
138739409|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739410|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
138739411|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
138739412|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739413|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739414|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138739415|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
138739416|NCT02871193|Hormones|hormones|mesh-ancestor
138739417|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138739418|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138739419|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739420|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
138739421|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
138739422|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739423|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
138739424|NCT01310868|Carmustine|carmustine|mesh-list
138739425|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138739426|NCT01310868|Levulinic acid|levulinic acid|mesh-list
138739427|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138739428|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
138657880|NCT00329498|Vitamins|vitamins|mesh-ancestor
139079562|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
139079563|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
139079564|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
139079565|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079566|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139079567|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
139079568|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139079569|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139079570|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
139079571|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079572|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079573|NCT03457636|Doxycycline|doxycycline|mesh-list
139079574|NCT03457636|Adapalene|adapalene|mesh-list
139079575|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
139079576|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139079577|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139079578|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739429|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739430|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739431|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739432|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138739433|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
138739434|NCT01273155|Belinostat|belinostat|mesh-list
138739435|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739436|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138739437|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739438|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739439|NCT05557851|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
138739440|NCT05557851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138739441|NCT05557851|Alkylating Agents|alkylating agents|mesh-ancestor
138695769|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
138739442|NCT05557851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739443|NCT05557851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739445|NCT01005901|Bromides|bromides|mesh-list
138739446|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
138739447|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138739448|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138739449|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138739450|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
138739451|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739452|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739453|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739454|NCT02889549|Clopidogrel|clopidogrel|mesh-list
138739455|NCT02889549|Ticagrelor|ticagrelor|mesh-list
138739456|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138739457|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138739458|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138739459|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138739460|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
138739461|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739464|NCT01309386|Morphine|morphine|mesh-list
138739468|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739469|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739470|NCT01309386|Analgesics|analgesics|mesh-ancestor
138739471|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
138739472|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739473|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138739474|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138739475|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138739476|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739477|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
138739478|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739479|NCT04295317|Capecitabine|capecitabine|mesh-list
138739480|NCT04295317|Antibodies|antibodies|mesh-list
138739481|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
138739482|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
138739483|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739484|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138739485|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
138739486|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739487|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739488|NCT01266603|Aldesleukin|aldesleukin|mesh-list
138739489|NCT01266603|Interleukin-2|interleukin-2|mesh-list
138739490|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739491|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138739492|NCT01266603|Analgesics|analgesics|mesh-ancestor
138739493|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
138739494|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739516|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739517|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
138739518|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739519|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739520|NCT01004263|Rizatriptan|rizatriptan|mesh-list
138739521|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138739522|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
138739523|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739524|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739525|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739526|NCT01265823|Adalimumab|adalimumab|mesh-list
138739527|NCT01265823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138739528|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739529|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739530|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
138739531|NCT01004185|Mesalamine|mesalamine|mesh-list
138739532|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138739533|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138739534|NCT01004185|Analgesics|analgesics|mesh-ancestor
138739535|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
138739536|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739537|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739538|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739539|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739540|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
138739541|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138739542|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739543|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138739544|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
138739545|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739562|NCT01264887|Analgesics|analgesics|mesh-ancestor
138739563|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
138739564|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739565|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138739566|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138549620|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
138739567|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138739568|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739569|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
138739570|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739571|NCT01011283|Azacitidine|azacitidine|mesh-list
138739572|NCT01011283|Decitabine|decitabine|mesh-list
138739573|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138739574|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
138739575|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739576|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739577|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739578|NCT01263483|Inositol|inositol|mesh-list
138739579|NCT01263483|Alogliptin|alogliptin|mesh-list
138739580|NCT01263483|Voglibose|voglibose|mesh-list
138739581|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138739582|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739583|NCT01263483|Incretins|incretins|mesh-ancestor
138739584|NCT01263483|Hormones|hormones|mesh-ancestor
138739585|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138739586|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138739587|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
138739588|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739589|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695917|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138739590|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138739591|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
138739592|NCT01263483|Vitamins|vitamins|mesh-ancestor
138739593|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
138739602|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
138739603|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739604|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739605|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739607|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
138739608|NCT01010971|Hormones|hormones|mesh-ancestor
138739609|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138739610|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739611|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138739612|NCT01306656|Vitamin D|vitamin d|mesh-list
138739613|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
138739614|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
138739615|NCT01306656|Vitamins|vitamins|mesh-list
138739616|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
138739617|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739618|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138739619|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138739620|NCT01003639|Aspirin|aspirin|mesh-list
138739621|NCT01003639|Acetaminophen|acetaminophen|mesh-list
138739622|NCT01003639|Ibuprofen|ibuprofen|mesh-list
138739623|NCT01003639|Naproxen|naproxen|mesh-list
138739624|NCT01003639|Acetazolamide|acetazolamide|mesh-list
138739625|NCT01003639|Codeine|codeine|mesh-list
138739626|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138739627|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138739628|NCT01003639|Analgesics|analgesics|mesh-ancestor
138739629|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
138739630|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739631|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739632|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739633|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739634|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138809072|NCT04216134|Edetic Acid|edetic acid|mesh-list
138739635|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138739636|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739644|NCT01003639|Diuretics|diuretics|mesh-ancestor
138739645|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
138739646|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138739647|NCT01003639|Narcotics|narcotics|mesh-ancestor
138739648|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739649|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
138739650|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
138739651|NCT01003249|Baclofen|baclofen|mesh-list
138739652|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138739653|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739654|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138739655|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739656|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138739657|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
138739658|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
138739659|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739660|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739661|NCT04297033|Lovastatin|lovastatin|mesh-list
138739662|NCT04297033|L 647318|l 647318|mesh-list
138739663|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
138739664|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138739665|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138739666|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
138739667|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739668|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138739669|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138739670|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739671|NCT04294537|Anesthetics|anesthetics|mesh-list
138739672|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739674|NCT04295629|Anesthetics|anesthetics|mesh-list
138739690|NCT01263015|Lamivudine|lamivudine|mesh-list
138739691|NCT01263015|Abacavir|abacavir|mesh-list
138739692|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
138739693|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138739694|NCT01263015|Dolutegravir|dolutegravir|mesh-list
138739695|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138739696|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138739697|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739698|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739699|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
138739700|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739701|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138739702|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138739703|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138739704|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138739705|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
138739706|NCT04322175|Meloxicam|meloxicam|mesh-list
138739707|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138739708|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138739709|NCT04322175|Analgesics|analgesics|mesh-ancestor
138739710|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
138739711|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739712|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739713|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739714|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739715|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138739716|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138739717|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739718|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739719|NCT04321785|Caffeine|caffeine|mesh-list
138739729|NCT01305408|Modafinil|modafinil|mesh-list
138739733|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138739734|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138739735|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739736|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
138739737|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138739738|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138739739|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138739740|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138549675|NCT00068432|Celecoxib|celecoxib|mesh-list
138739741|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739743|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739744|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739745|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138739746|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739747|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
138739748|NCT04320693|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138739749|NCT04320693|Immunoconjugates|immunoconjugates|mesh-ancestor
138739750|NCT04320693|Immunologic Factors|immunologic factors|mesh-ancestor
138739751|NCT04320693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739752|NCT00624039|Pilocarpine|pilocarpine|mesh-list
138739753|NCT00624039|Miotics|miotics|mesh-ancestor
138739754|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
138739755|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739756|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739757|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138739758|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138739759|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
138739760|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658131|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
139079579|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
139079580|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139079581|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139079582|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
139079583|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139079584|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139079585|NCT03457636|Analgesics|analgesics|mesh-ancestor
139079586|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
139079587|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079588|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079589|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079590|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139079591|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
139079592|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
139079593|NCT01099436|Docetaxel|docetaxel|mesh-list
139079594|NCT01099436|Doxorubicin|doxorubicin|mesh-list
139079595|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139079596|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138739761|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739762|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138739763|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739764|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
138739765|NCT01304706|Hormones|hormones|mesh-ancestor
138739766|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138739767|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739768|NCT05661240|Docetaxel|docetaxel|mesh-list
138739769|NCT05661240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739770|NCT05661240|Tubulin Modulators|tubulin modulators|mesh-ancestor
138739771|NCT05661240|Antimitotic Agents|antimitotic agents|mesh-ancestor
138739772|NCT05661240|Mitosis Modulators|mitosis modulators|mesh-ancestor
138739773|NCT05661240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739774|NCT02889003|Pioglitazone|pioglitazone|mesh-list
138739775|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138739776|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739777|NCT01008553|Fentanyl|fentanyl|mesh-list
138739778|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138739779|NCT01008553|Narcotics|narcotics|mesh-ancestor
138739780|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739781|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739782|NCT01008553|Analgesics|analgesics|mesh-ancestor
138739783|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
138739784|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739785|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138739786|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138739787|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
138739788|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
138739789|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
138739790|NCT04901169|Giapreza|giapreza|mesh-list
138739791|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
138739792|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138739793|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138739794|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
138739795|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739797|NCT04479267|Prednisone|prednisone|mesh-list
138739802|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
138739803|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
138739804|NCT04479267|Cortisone|cortisone|mesh-list
138739805|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
138739806|NCT04479267|Rituximab|rituximab|mesh-list
138739807|NCT04479267|Doxorubicin|doxorubicin|mesh-list
138739808|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138739809|NCT04479267|Antibodies|antibodies|mesh-list
138739810|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
138739811|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138739812|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138739813|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
138739814|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
138739815|NCT04479267|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138739816|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138739817|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
138739818|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739819|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739820|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138739821|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
138739822|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739823|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739824|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138739825|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138739826|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138739827|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138739828|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138739829|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739830|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739831|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
138739832|NCT04479267|Hormones|hormones|mesh-ancestor
138739833|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138739834|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138739847|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138739848|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739849|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138739850|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
138739851|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138739852|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138739854|NCT03764553|Carboplatin|carboplatin|mesh-list
138739855|NCT03764553|Capecitabine|capecitabine|mesh-list
138739856|NCT03764553|Fluorouracil|fluorouracil|mesh-list
138739857|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
138739858|NCT03764553|Irinotecan|irinotecan|mesh-list
138549692|NCT00250237|Haloperidol|haloperidol|mesh-list
138739859|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739860|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138739861|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
138739862|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739863|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138739864|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
138739865|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739866|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138739867|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138739868|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739869|NCT03764553|Antidotes|antidotes|mesh-ancestor
138739870|NCT03764553|Protective Agents|protective agents|mesh-ancestor
138739871|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
138739872|NCT03764553|Vitamins|vitamins|mesh-ancestor
138739896|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739897|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739898|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138739899|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138739900|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
138739901|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
138739902|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739903|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138739904|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138739905|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739906|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739907|NCT02890602|Prednisolone|prednisolone|mesh-list
138739908|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
138739909|NCT02890602|Vincristine|vincristine|mesh-list
138739910|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
138739911|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138739912|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
138739913|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739914|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739915|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138739916|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
138739917|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739918|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549728|NCT00068471|Anidulafungin|anidulafungin|mesh-list
138739919|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138739920|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138739921|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
138739922|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
138739923|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
138658283|NCT00331838|Enoxaparin|enoxaparin|mesh-list
139079597|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
139079598|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079599|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139079600|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139079601|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
139079602|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079603|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079604|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139079605|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
139079606|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
139079607|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
139079608|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139079609|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139079611|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739924|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739925|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
138739926|NCT02890602|Hormones|hormones|mesh-ancestor
138739927|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138739928|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138739929|NCT02890602|Hematinics|hematinics|mesh-ancestor
138739930|NCT01259115|Ketoconazole|ketoconazole|mesh-list
138739931|NCT01259115|Buprenorphine|buprenorphine|mesh-list
138739932|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138739933|NCT01259115|Narcotics|narcotics|mesh-ancestor
138739934|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739935|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739936|NCT01259115|Analgesics|analgesics|mesh-ancestor
138739937|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
138739938|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739939|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138739940|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
139079612|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139079613|NCT01099592|Citalopram|citalopram|mesh-list
139079614|NCT01099592|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139079615|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139079616|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139079617|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079618|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139079619|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
139079620|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079621|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139079622|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
139079623|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139079624|NCT01099748|Methadone|methadone|mesh-list
139079625|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139079626|NCT01099748|Narcotics|narcotics|mesh-ancestor
139079627|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139079628|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079629|NCT01099748|Analgesics|analgesics|mesh-ancestor
139079630|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
139079631|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079632|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
138809396|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139079633|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
139079634|NCT03481816|Vaccines|vaccines|mesh-list
139079635|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
139079636|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079637|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
139079638|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139079639|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
139079640|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139079641|NCT03956888|Expectorants|expectorants|mesh-ancestor
139079642|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
139079643|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139079644|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
139079645|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079646|NCT03956888|Protective Agents|protective agents|mesh-ancestor
139079647|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079648|NCT03956888|Antidotes|antidotes|mesh-ancestor
139079649|NCT03955406|Anesthetics|anesthetics|mesh-list
139079650|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139079651|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079652|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
139079653|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
138739941|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739942|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138739943|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138739944|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739945|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809432|NCT04229355|Sorafenib|sorafenib|mesh-list
138739946|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138739947|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
138739948|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138739949|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138739950|NCT01302054|Fesoterodine|fesoterodine|mesh-list
138739951|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138739952|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138739953|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
138739954|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739955|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739956|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739957|NCT01302054|Urological Agents|urological agents|mesh-ancestor
138739958|NCT05642910|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
138739959|NCT05642910|Antiviral Agents|antiviral agents|mesh-ancestor
138739960|NCT05642910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739961|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138739962|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739963|NCT01300572|Cyclosporine|cyclosporine|mesh-list
138739964|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
138658370|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079654|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
139079655|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139079656|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139079657|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139079658|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079659|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079660|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139079661|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
139079662|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079664|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139079665|NCT00050960|Carboplatin|carboplatin|mesh-list
139079666|NCT00050960|Bexarotene|bexarotene|mesh-list
139079667|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139079668|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079669|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
139079670|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
139079672|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079673|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
139079674|NCT00097773|Tobramycin|tobramycin|mesh-list
139079675|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139079676|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739965|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138739966|NCT01300572|Fludarabine|fludarabine|mesh-list
138739967|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
138739968|NCT01300572|Antibodies|antibodies|mesh-list
138739969|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
138739970|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138739971|NCT01300572|Cyclosporins|cyclosporins|mesh-list
138739972|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
138739973|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739974|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739975|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138739976|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
138739977|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739978|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138739979|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739980|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
138739981|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739982|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
138739983|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739984|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138739985|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138739986|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138739987|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
138739988|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138739989|NCT01077154|Denosumab|denosumab|mesh-list
138739990|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138739991|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739992|NCT01258101|Ribavirin|ribavirin|mesh-list
138739993|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138739994|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
138739995|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
138739996|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739997|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
138740009|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740010|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740011|NCT01300260|Dulaglutide|dulaglutide|mesh-list
138740013|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138740014|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138740015|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740016|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138740017|NCT01300260|Hormones|hormones|mesh-ancestor
138740018|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740019|NCT01300260|Incretins|incretins|mesh-ancestor
138740020|NCT01256385|Sirolimus|sirolimus|mesh-list
138740021|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138740022|NCT01256385|Cetuximab|cetuximab|mesh-list
138740023|NCT01256385|Temsirolimus|temsirolimus|mesh-list
138740024|NCT01256385|MTOR Inhibitors|mtor inhibitors|mesh-list
138740025|NCT01256385|Antibodies|antibodies|mesh-list
138740026|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
138740027|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138740028|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
138740029|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740030|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740031|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138740032|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740033|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138740034|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
138740035|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138740036|NCT01256385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138740037|NCT01256385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740038|NCT01256385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740039|NCT00637182|Anastrozole|anastrozole|mesh-list
138740040|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138740041|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740042|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138740043|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139079677|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139079678|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139079679|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079680|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079681|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696362|NCT02342249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740044|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740045|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740046|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138740047|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
138740048|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740049|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740050|NCT01298778|Acetaminophen|acetaminophen|mesh-list
138740051|NCT01298778|Morphine|morphine|mesh-list
138549742|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
138740052|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138740053|NCT01298778|Analgesics|analgesics|mesh-ancestor
138740054|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
138740055|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138740056|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740057|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
138740058|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138740059|NCT01298778|Narcotics|narcotics|mesh-ancestor
138740060|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138740061|NCT01298700|Bimatoprost|bimatoprost|mesh-list
138740062|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138740063|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138740064|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138740065|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138740066|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138740067|NCT01297920|Brinzolamide|brinzolamide|mesh-list
138740068|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138740069|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138740070|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138740071|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138740072|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138740073|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
139079682|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139079683|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139079684|NCT03480022|Liraglutide|liraglutide|mesh-list
139079685|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139079686|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079687|NCT03480022|Incretins|incretins|mesh-ancestor
139079688|NCT03480022|Hormones|hormones|mesh-ancestor
139079689|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139079690|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
139079691|NCT01093820|Hematinics|hematinics|mesh-ancestor
139079692|NCT00049322|Bevacizumab|bevacizumab|mesh-list
139079693|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138740075|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740076|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740077|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138740078|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740079|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
138740080|NCT01255761|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138740081|NCT01255761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138740082|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138740083|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
138740084|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740085|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138740086|NCT01297062|Exenatide|exenatide|mesh-list
138740087|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
138740088|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138740089|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740090|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138740091|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138740092|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740093|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740094|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740095|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740096|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138740097|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138740098|NCT01297062|Incretins|incretins|mesh-ancestor
138740099|NCT01297062|Hormones|hormones|mesh-ancestor
138740100|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740101|NCT01296672|Finasteride|finasteride|mesh-list
138740102|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139079694|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079695|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139079696|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139079697|NCT00049322|Growth Substances|growth substances|mesh-ancestor
139079698|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079699|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
139079700|NCT00008138|Paclitaxel|paclitaxel|mesh-list
139079701|NCT00008138|Carboplatin|carboplatin|mesh-list
139079702|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139079703|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079704|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
139079705|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
139079706|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
139079707|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079708|NCT03436732|LMB-100|lmb-100|mesh-list
139079709|NCT03436732|Immunoconjugates|immunoconjugates|mesh-ancestor
139079710|NCT03436732|Immunologic Factors|immunologic factors|mesh-ancestor
138740103|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138740104|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740105|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740106|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
138740107|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740108|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740109|NCT01296672|Urological Agents|urological agents|mesh-ancestor
138740111|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
138740112|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740113|NCT04324476|Bevacizumab|bevacizumab|mesh-list
138740114|NCT04324476|Capecitabine|capecitabine|mesh-list
138740115|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
138740116|NCT04324476|Irinotecan|irinotecan|mesh-list
138740117|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138740118|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740119|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138740120|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138740121|NCT04324476|Growth Substances|growth substances|mesh-ancestor
138740122|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740123|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
138740124|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138740125|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
138740126|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740129|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740154|NCT01295034|Cholecalciferol|cholecalciferol|mesh-list
138740156|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
138740157|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740158|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138740159|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138740160|NCT01253421|Amisulpride|amisulpride|mesh-list
138740161|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138740162|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138740163|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138740164|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740165|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138740166|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138740167|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
138740168|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740169|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740170|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138740171|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
138740172|NCT01077076|Omeprazole|omeprazole|mesh-list
138809924|NCT01028222|Dacarbazine|dacarbazine|mesh-list
138740173|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
138740174|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138740175|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138740176|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138740177|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740178|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740179|NCT02876224|Bevacizumab|bevacizumab|mesh-list
138740180|NCT02876224|Atezolizumab|atezolizumab|mesh-list
138740201|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740202|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740203|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
138740204|NCT01253187|Drospirenone|drospirenone|mesh-list
138740205|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138740206|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
138740207|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740208|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740209|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138740210|NCT01253187|Diuretics|diuretics|mesh-ancestor
138740211|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
138740212|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
138740213|NCT01253187|Vitamins|vitamins|mesh-ancestor
138740214|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
138740215|NCT01252563|Amlodipine|amlodipine|mesh-list
138740216|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138740217|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138740218|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138740219|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740220|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138740221|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740222|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
138740223|NCT01292226|Cyclosporine|cyclosporine|mesh-list
138740224|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
138740225|NCT01292226|Antibodies|antibodies|mesh-list
138740226|NCT01292226|Cyclosporins|cyclosporins|mesh-list
138740227|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
138740228|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740229|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740230|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740231|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138740232|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
138740233|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740234|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
139079711|NCT03436732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079712|NCT01100060|Azithromycin|azithromycin|mesh-list
139079713|NCT01100060|Chloroquine|chloroquine|mesh-list
139079714|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139079715|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138273800|NCT05716945|Antiemetics|antiemetics|mesh-ancestor
139079716|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740235|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138740236|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138810023|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740237|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138740238|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740239|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138740240|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
138740241|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138740243|NCT01075048|Cetuximab|cetuximab|mesh-list
138740244|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138740245|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138740246|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740247|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740248|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740249|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138740250|NCT01252251|Everolimus|everolimus|mesh-list
138740251|NCT01252251|Pasireotide|pasireotide|mesh-list
138740252|NCT01252251|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138740253|NCT01252251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138740254|NCT01252251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740255|NCT01252251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740256|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138740257|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
138740258|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740259|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740260|NCT01252251|Hormones|hormones|mesh-ancestor
138549761|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138658665|NCT00432120|Clopidogrel|clopidogrel|mesh-list
139079717|NCT01100060|Amebicides|amebicides|mesh-ancestor
139079718|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139079719|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139079720|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
139079721|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139079722|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139079723|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139079724|NCT01100060|Analgesics|analgesics|mesh-ancestor
139079725|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
139079726|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079727|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079728|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079729|NCT01100060|Filaricides|filaricides|mesh-ancestor
139079730|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
139079731|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
139079732|NCT01100216|Nicotine|nicotine|mesh-list
139079733|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139079734|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
139079735|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079736|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079737|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138740261|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740263|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138740264|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
138740265|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740266|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740267|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
138740268|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
138740269|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138740270|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138740271|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740272|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740273|NCT00624273|Urological Agents|urological agents|mesh-ancestor
138740274|NCT04305964|Silicon|silicon|mesh-list
138740275|NCT04305964|Trace Elements|trace elements|mesh-ancestor
138740276|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
138740277|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740278|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
138740279|NCT04306042|Nivolumab|nivolumab|mesh-list
138740280|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138740281|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740282|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138740283|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740284|NCT01074502|Apremilast|apremilast|mesh-list
138740285|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138740286|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138740287|NCT01074502|Analgesics|analgesics|mesh-ancestor
138740288|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
138740289|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079738|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139079739|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
139079740|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139079741|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830312|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079742|NCT01100294|Vaccines|vaccines|mesh-list
139079743|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
139079744|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079745|NCT03436420|Calcium|calcium|mesh-list
139079746|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139079747|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079749|NCT01100372|Doxorubicin|doxorubicin|mesh-list
139079750|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139079751|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139079752|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
138273837|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138740290|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740291|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138740292|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138740293|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138740294|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138740295|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740296|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740297|NCT04303312|Benzydamine|benzydamine|mesh-list
138740298|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138740299|NCT01285908|Norepinephrine|norepinephrine|mesh-list
138740300|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138740301|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138740302|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
138740303|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740304|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740305|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740306|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
138740307|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
138740308|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138740309|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138740310|NCT01074268|Insulin|insulin|mesh-list
138740311|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138740312|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
138740313|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
138740314|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138740315|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740316|NCT01074190|Fentanyl|fentanyl|mesh-list
138740317|NCT01074190|Bupivacaine|bupivacaine|mesh-list
138740318|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
138740319|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
138740320|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138740321|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740322|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
138740323|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138740324|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139079753|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079754|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079755|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139079756|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139079757|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138740325|NCT01074190|Narcotics|narcotics|mesh-ancestor
138740326|NCT01074190|Analgesics|analgesics|mesh-ancestor
138740327|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138740328|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138740329|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
138740330|NCT01073566|Insulin|insulin|mesh-list
138740331|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138740332|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138740333|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740334|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
138740335|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138740336|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
138740337|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138740338|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740339|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138740340|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
138740341|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
138740342|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138740343|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
138740344|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740345|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696660|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
138740346|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
138740347|NCT01045096|Lansoprazole|lansoprazole|mesh-list
138740348|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138740349|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138740350|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138740351|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740370|NCT02875756|Selamectin|selamectin|mesh-list
138740374|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138740375|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138740376|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138740377|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
138740378|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740379|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740380|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740382|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
138740383|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138740384|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138740385|NCT04305028|Analgesics|analgesics|mesh-ancestor
138740386|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
138740387|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138740388|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740389|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138740390|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138549791|NCT00250861|Aldesleukin|aldesleukin|mesh-list
138549862|NCT00068744|Fluorouracil|fluorouracil|mesh-list
138740391|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138549943|NCT00068861|Metformin|metformin|mesh-list
138740392|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138740393|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740394|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138740395|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138740396|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740397|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
138740398|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138740399|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
138740400|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138740401|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
138740402|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
138740403|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
138740404|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
138740405|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740406|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740407|NCT02874664|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
138740409|NCT02874664|Immunologic Factors|immunologic factors|mesh-ancestor
138740410|NCT02874664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740411|NCT01284114|Renin Inhibitors|renin inhibitors|mesh-list
138740412|NCT01284114|Protease Inhibitors|protease inhibitors|mesh-ancestor
138740413|NCT01284114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740414|NCT01284114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740415|NCT01283334|Carboplatin|carboplatin|mesh-list
138740416|NCT01283334|Cetuximab|cetuximab|mesh-list
138740417|NCT01283334|Everolimus|everolimus|mesh-list
138740418|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740419|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138740420|NCT01283334|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138696734|NCT04721457|Protective Agents|protective agents|mesh-ancestor
138740421|NCT01283334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138740422|NCT01283334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740423|NCT01283334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740424|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138740425|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
138740426|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740427|NCT04304716|Anesthetics|anesthetics|mesh-list
138740428|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138740429|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740430|NCT01282476|Rituximab|rituximab|mesh-list
138740431|NCT01282476|Panobinostat|panobinostat|mesh-list
138740432|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138740433|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740434|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
138810416|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740435|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740436|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138740437|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138740438|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550157|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740439|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740440|NCT02889822|Alprostadil|alprostadil|mesh-list
138740441|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138740442|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
139079758|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740443|NCT02889822|Urological Agents|urological agents|mesh-ancestor
138740444|NCT01282164|Insulin|insulin|mesh-list
138740445|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138740446|NCT01282164|Glucagon|glucagon|mesh-list
138740447|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138740448|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138740449|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740450|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138740451|NCT01282164|Hormones|hormones|mesh-ancestor
138740452|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740453|NCT01282164|Incretins|incretins|mesh-ancestor
138740454|NCT01250379|Bevacizumab|bevacizumab|mesh-list
138740455|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138740456|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740457|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138740458|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138740459|NCT01250379|Growth Substances|growth substances|mesh-ancestor
138740460|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740461|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
138740462|NCT01072630|Modafinil|modafinil|mesh-list
138740463|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138740464|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740465|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138740466|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138740467|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138740468|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740469|NCT04302532|Ubiquinone|ubiquinone|mesh-list
138740470|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
138740471|NCT04302532|Clomiphene|clomiphene|mesh-list
138740472|NCT04302532|Enclomiphene|enclomiphene|mesh-list
139079759|NCT00027560|Cyclosporine|cyclosporine|mesh-list
139079760|NCT00027560|Fludarabine|fludarabine|mesh-list
139079761|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
139079762|NCT00027560|Melphalan|melphalan|mesh-list
139079763|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
139079764|NCT00027560|Cyclosporins|cyclosporins|mesh-list
139079765|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079766|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139079767|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
139079768|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079769|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079770|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
139079771|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079772|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079773|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
139079774|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139079775|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
138740473|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
138740474|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138740475|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
138740476|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740477|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740478|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138740479|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
138740480|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138740481|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138740482|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138740483|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
138740484|NCT04302532|Vitamins|vitamins|mesh-ancestor
138740485|NCT01281306|Valsartan|valsartan|mesh-list
138740486|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138740487|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138740488|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138740489|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138740490|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740491|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
138810485|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138740492|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138740493|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740494|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138740495|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740496|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
138740497|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740498|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139079776|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139079777|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139079778|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139079779|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
139079780|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139079781|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139079782|NCT02529878|Paclitaxel|paclitaxel|mesh-list
139079783|NCT02529878|Apatinib|apatinib|mesh-list
139079784|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139079785|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079786|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
139079787|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
139079788|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
139079789|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079790|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139079791|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079792|NCT03451006|Metformin|metformin|mesh-list
139079793|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139079794|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079795|NCT05625854|Cocaine|cocaine|mesh-list
138740499|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740500|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740501|NCT01250145|Teriparatide|teriparatide|mesh-list
138740502|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138740503|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740504|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138740505|NCT04319601|Rituximab|rituximab|mesh-list
138550184|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
138740506|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138740507|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740508|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
138740509|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740510|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138740511|NCT04640896|Lidocaine|lidocaine|mesh-list
138740512|NCT04640896|Bupivacaine|bupivacaine|mesh-list
138740513|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
138740514|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
138740515|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138740516|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740517|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
138740518|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138740519|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138740520|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138740521|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138740522|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138740523|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740524|NCT01273818|Gentamicins|gentamicins|mesh-list
138740525|NCT01273818|Cefazolin|cefazolin|mesh-list
138740543|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138740544|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138740545|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740546|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138740547|NCT01269918|Analgesics|analgesics|mesh-ancestor
138740548|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
138740549|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138740550|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138740551|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138740552|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138740553|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
138740554|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740555|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740556|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138740557|NCT01269918|Narcotics|narcotics|mesh-ancestor
138740558|NCT01036594|Ketoconazole|ketoconazole|mesh-list
138740559|NCT01036594|Dexamethasone|dexamethasone|mesh-list
138740560|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
138740561|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
138740562|NCT01036594|BB 1101|bb 1101|mesh-list
138740563|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138740564|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
138740565|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
138740566|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810619|NCT02760459|Dexamethasone|dexamethasone|mesh-list
138740567|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740568|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138740569|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
138740570|NCT01036594|Hormones|hormones|mesh-ancestor
138740571|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740572|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139079796|NCT05625854|Anesthetics, Local|anesthetics, local|mesh-ancestor
139079797|NCT05625854|Anesthetics|anesthetics|mesh-ancestor
139079798|NCT05625854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139079799|NCT05625854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079800|NCT05625854|Sensory System Agents|sensory system agents|mesh-ancestor
139079801|NCT05625854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079802|NCT05625854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139079803|NCT05625854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139079804|NCT05625854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139079805|NCT05625854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139079806|NCT05625854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079807|NCT05625854|Dopamine Agents|dopamine agents|mesh-ancestor
139079808|NCT05625854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139079809|NCT01327118|Dinoprost|dinoprost|mesh-list
139079810|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
138740573|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740574|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
138740575|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740576|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740577|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
138740578|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740579|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138740580|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138740581|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138740582|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
138740583|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138740584|NCT04301908|Interferons|interferons|mesh-list
138740585|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740586|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
138740587|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740588|NCT04304248|Paclitaxel|paclitaxel|mesh-list
138740589|NCT04304248|Carboplatin|carboplatin|mesh-list
138740590|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138740591|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138740592|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740593|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
138740594|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
138740595|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
138740596|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740597|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138740598|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138740599|NCT01268046|Estradiol|estradiol|mesh-list
138740600|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138740601|NCT01268046|Estrogens|estrogens|mesh-list
138740602|NCT01268046|Hormones|hormones|mesh-ancestor
138740603|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139079811|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139079812|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
139079813|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139079814|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079815|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
139079816|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
139079817|NCT03449758|Chloroquine|chloroquine|mesh-list
139079818|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
139079819|NCT03449758|Methotrexate|methotrexate|mesh-list
139079820|NCT03449758|Azathioprine|azathioprine|mesh-list
139079821|NCT03449758|Leflunomide|leflunomide|mesh-list
139079822|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139079823|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
139079824|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138740604|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740605|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138740607|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138740608|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138740609|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
138740610|NCT01267266|Saracatinib|saracatinib|mesh-list
138740611|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138740612|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740613|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740614|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740615|NCT01034176|Levofloxacin|levofloxacin|mesh-list
138740616|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138740617|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740618|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138740619|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138740620|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138740621|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740622|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740623|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740624|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138740625|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138740626|NCT02889432|Melatonin|melatonin|mesh-list
138740627|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
138740628|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740629|NCT02889432|Protective Agents|protective agents|mesh-ancestor
138740630|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740631|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138740632|NCT01033942|Tenofovir|tenofovir|mesh-list
138740633|NCT01033942|Emtricitabine|emtricitabine|mesh-list
138740634|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
138740635|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740636|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138740637|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139079825|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079826|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138810804|NCT02758509|Interferons|interferons|mesh-list
139079828|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079829|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740638|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740639|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740640|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138740641|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138740642|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
138740643|NCT01062256|Guaifenesin|guaifenesin|mesh-list
138740644|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
138740645|NCT01062256|Expectorants|expectorants|mesh-ancestor
138740646|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
138740647|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138740648|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138740649|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
138740650|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740651|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740652|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740653|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
138740654|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138740655|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
138740656|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
138740657|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138740658|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
138740659|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138740660|NCT01029886|Liraglutide|liraglutide|mesh-list
138740661|NCT01029886|Exenatide|exenatide|mesh-list
138740662|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138740663|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740664|NCT01029886|Incretins|incretins|mesh-ancestor
138740665|NCT01029886|Hormones|hormones|mesh-ancestor
138740666|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740667|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138740668|NCT01244061|Varenicline|varenicline|mesh-list
138740669|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138740681|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740682|NCT01266876|Alirocumab|alirocumab|mesh-list
138740683|NCT01266876|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138740684|NCT01266876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138740685|NCT01266876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138740686|NCT01266876|Antimetabolites|antimetabolites|mesh-ancestor
138740687|NCT01266876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740688|NCT01266876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138740689|NCT01266876|Protease Inhibitors|protease inhibitors|mesh-ancestor
138740690|NCT01266876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740691|NCT01266876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138740692|NCT01033240|Sorafenib|sorafenib|mesh-list
138740693|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740694|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138740695|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740696|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740697|NCT01032382|Gentamicins|gentamicins|mesh-list
138740698|NCT01032382|Paromomycin|paromomycin|mesh-list
138740699|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138740700|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740701|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138740702|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740703|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740704|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138740705|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138740706|NCT01029652|Triamcinolone|triamcinolone|mesh-list
138740707|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138740708|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138740709|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138740710|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138740711|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079830|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
139079831|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079832|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139079833|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079834|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
139079835|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139079836|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139079837|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
139079838|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139079839|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139079840|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139079841|NCT03449758|Amebicides|amebicides|mesh-ancestor
139079842|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139079843|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139079844|NCT03449758|Analgesics|analgesics|mesh-ancestor
138740712|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
138740713|NCT01029652|Hormones|hormones|mesh-ancestor
138697034|NCT06086483|Sensory System Agents|sensory system agents|mesh-ancestor
138740714|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740715|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740716|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138740717|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
138740718|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740719|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740720|NCT01029340|Factor VIII|factor viii|mesh-list
138740721|NCT01029340|Coagulants|coagulants|mesh-ancestor
138740722|NCT01265550|Baclofen|baclofen|mesh-list
138740723|NCT01265550|Desipramine|desipramine|mesh-list
138740724|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138740725|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740726|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138740727|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138740728|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138740729|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
138740730|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
138740731|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740732|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740733|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138740734|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
138740735|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138740736|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659226|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
139079845|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
138273915|NCT05346601|Chiauranib|chiauranib|mesh-list
139079846|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079847|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079848|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139079850|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079851|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079852|NCT03716596|Antibodies|antibodies|mesh-list
139079853|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
139079854|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079855|NCT05650840|Calcium Carbonate|calcium carbonate|mesh-list
139079856|NCT05650840|Calcium|calcium|mesh-list
139079857|NCT05650840|Charcoal|charcoal|mesh-list
139079858|NCT05650840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139079859|NCT05650840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079860|NCT05650840|Antacids|antacids|mesh-ancestor
139079861|NCT05650840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079862|NCT05650840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139079863|NCT05650840|Antidotes|antidotes|mesh-ancestor
139079864|NCT05650840|Protective Agents|protective agents|mesh-ancestor
139079865|NCT03722914|Benzonatate|benzonatate|mesh-list
139079866|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
138740737|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138740738|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138810971|NCT04090801|Ethanol|ethanol|mesh-list
138740739|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138740741|NCT01265394|Flutemetamol|flutemetamol|mesh-list
138740742|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138740743|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740744|NCT01029262|Lenalidomide|lenalidomide|mesh-list
138740745|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
138740746|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740747|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138740748|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138740749|NCT01029262|Growth Substances|growth substances|mesh-ancestor
138740750|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
138740751|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740752|NCT01061710|Varenicline|varenicline|mesh-list
138740753|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138740754|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138740755|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
138740756|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740757|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740758|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740759|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
138740760|NCT01028014|Ephedrine|ephedrine|mesh-list
138740761|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
138740762|NCT01028014|Imipramine|imipramine|mesh-list
138740763|NCT01028014|Tamsulosin|tamsulosin|mesh-list
138740764|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
138740765|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138740766|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138740782|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138740783|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138740784|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
138740785|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138740786|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
138740787|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138740788|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138740789|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138740790|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138740791|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138740792|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138740793|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138740794|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138740795|NCT01264770|Adalimumab|adalimumab|mesh-list
138740796|NCT01264770|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138740797|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138740798|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138740799|NCT02873650|Dabrafenib|dabrafenib|mesh-list
138740800|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740801|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138740802|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740803|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740804|NCT01302080|Sertraline|sertraline|mesh-list
138740805|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
138740806|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138740807|NCT01302080|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138740808|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138740809|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138740810|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740811|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740824|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138740825|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
138740826|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740827|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740828|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138740829|NCT01237899|Diuretics|diuretics|mesh-ancestor
138740830|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
138740831|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138740832|NCT01263444|Timolol|timolol|mesh-list
138740833|NCT01263444|Bimatoprost|bimatoprost|mesh-list
138740834|NCT01263444|Travoprost|travoprost|mesh-list
138740835|NCT01263444|Latanoprost|latanoprost|mesh-list
138740836|NCT01263444|Brinzolamide|brinzolamide|mesh-list
138740837|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138740838|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138811062|NCT02753205|Analgesics|analgesics|mesh-ancestor
138740839|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
138740840|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740841|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740842|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740843|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138740844|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138740845|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138740846|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138740847|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138740848|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740849|NCT01031836|Sifalimumab|sifalimumab|mesh-list
138740850|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138740851|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
138226528|NCT04370288|Antidotes|antidotes|mesh-ancestor
138740852|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740854|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138740858|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740867|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138740868|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740869|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138740870|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740871|NCT01031446|Paclitaxel|paclitaxel|mesh-list
138740872|NCT01031446|Everolimus|everolimus|mesh-list
138740873|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138740874|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740875|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
138740876|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
138740877|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
138740878|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740879|NCT01031446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138740880|NCT01031446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138740881|NCT01031446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740882|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138740883|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
138740884|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740885|NCT01030900|Prednisone|prednisone|mesh-list
138740886|NCT01030900|Cyclophosphamide|cyclophosphamide|mesh-list
138740887|NCT01030900|Rituximab|rituximab|mesh-list
138740888|NCT01030900|Doxorubicin|doxorubicin|mesh-list
138740889|NCT01030900|Etoposide|etoposide|mesh-list
138740890|NCT01030900|Vincristine|vincristine|mesh-list
138740891|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
138740892|NCT01030900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138740893|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
138740894|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740895|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138740896|NCT01030900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138740897|NCT01030900|Alkylating Agents|alkylating agents|mesh-ancestor
138740898|NCT01030900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740899|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740900|NCT01030900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138740901|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138740902|NCT01030900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138740903|NCT01030900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138740905|NCT01030900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740906|NCT01030900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138740907|NCT01030900|Glucocorticoids|glucocorticoids|mesh-ancestor
138740908|NCT01030900|Hormones|hormones|mesh-ancestor
138740909|NCT01030900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740910|NCT01030900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138811144|NCT04036929|Estrogens|estrogens|mesh-list
138740911|NCT01030900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138740912|NCT01030900|Tubulin Modulators|tubulin modulators|mesh-ancestor
138740913|NCT01030900|Antimitotic Agents|antimitotic agents|mesh-ancestor
138740914|NCT01030900|Mitosis Modulators|mitosis modulators|mesh-ancestor
138740915|NCT01030822|Vaccines|vaccines|mesh-list
138740916|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138740917|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
138740918|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740919|NCT01026454|Valacyclovir|valacyclovir|mesh-list
138740967|NCT06055465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138740968|NCT06055465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740969|NCT06055465|Immunoconjugates|immunoconjugates|mesh-ancestor
138740970|NCT06055465|Immunologic Factors|immunologic factors|mesh-ancestor
138740971|NCT06055465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740972|NCT06055348|Paclitaxel|paclitaxel|mesh-list
138740973|NCT06055348|Gemcitabine|gemcitabine|mesh-list
138740974|NCT06055348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138740975|NCT06055348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740976|NCT06055348|Tubulin Modulators|tubulin modulators|mesh-ancestor
138740977|NCT06055348|Antimitotic Agents|antimitotic agents|mesh-ancestor
138740978|NCT06055348|Mitosis Modulators|mitosis modulators|mesh-ancestor
138740979|NCT06055348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740980|NCT06055348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138740981|NCT06055348|Antimetabolites|antimetabolites|mesh-ancestor
138740982|NCT06055335|Anesthetics|anesthetics|mesh-list
138740983|NCT06055335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138740984|NCT06055335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740985|NCT06055257|Clodronic Acid|clodronic acid|mesh-list
138740986|NCT06055257|Tocopherols|tocopherols|mesh-list
138740987|NCT06055257|Pentoxifylline|pentoxifylline|mesh-list
138740988|NCT06055257|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138740989|NCT06055257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740990|NCT06055257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740991|NCT06055257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138811184|NCT04138875|Rituximab|rituximab|mesh-list
138740992|NCT06055257|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138740993|NCT06055257|Protective Agents|protective agents|mesh-ancestor
138740994|NCT06055257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740995|NCT06055257|Vasodilator Agents|vasodilator agents|mesh-ancestor
138740996|NCT06055257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138740997|NCT06055257|Antioxidants|antioxidants|mesh-ancestor
138740998|NCT06055257|Vitamins|vitamins|mesh-ancestor
138740999|NCT06055257|Micronutrients|micronutrients|mesh-ancestor
138741001|NCT06055244|Amantadine|amantadine|mesh-list
138741009|NCT06055244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741010|NCT06055244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138741012|NCT06055244|Sensory System Agents|sensory system agents|mesh-ancestor
138741013|NCT06055244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741014|NCT06055166|Capecitabine|capecitabine|mesh-list
138741015|NCT06055166|Fluzoparib|fluzoparib|mesh-list
138741016|NCT06055166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138741017|NCT06055166|Antimetabolites|antimetabolites|mesh-ancestor
138741018|NCT06055166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741019|NCT06055166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741020|NCT06055166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138741021|NCT06055166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741022|NCT06055153|Disitamab vedotin|disitamab vedotin|mesh-list
138741023|NCT06055153|Immunoconjugates|immunoconjugates|mesh-ancestor
138741024|NCT06055153|Immunologic Factors|immunologic factors|mesh-ancestor
138741025|NCT06055153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741026|NCT06055101|Dexmedetomidine|dexmedetomidine|mesh-list
138741027|NCT06055101|Bupivacaine|bupivacaine|mesh-list
138741028|NCT06055101|Neostigmine|neostigmine|mesh-list
138741029|NCT06055101|Anesthetics, Local|anesthetics, local|mesh-ancestor
138741030|NCT06055101|Anesthetics|anesthetics|mesh-ancestor
138741031|NCT06055101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741032|NCT06055101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741033|NCT06055101|Sensory System Agents|sensory system agents|mesh-ancestor
138741034|NCT06055101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741035|NCT06055101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138741058|NCT06054789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741059|NCT06054321|Dexetimide|dexetimide|mesh-list
138741060|NCT06054321|Aripiprazole|aripiprazole|mesh-list
138741061|NCT06054321|Mirtazapine|mirtazapine|mesh-list
138741062|NCT06054321|Citalopram|citalopram|mesh-list
138741063|NCT06054321|Antidepressive Agents|antidepressive agents|mesh-list
138741064|NCT06054321|Escitalopram|escitalopram|mesh-list
138741065|NCT06054321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138741066|NCT06054321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138741067|NCT06054321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138741068|NCT06054321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741069|NCT06054321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741070|NCT06054321|Serotonin Agents|serotonin agents|mesh-ancestor
138741071|NCT06054321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741072|NCT06054321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138741073|NCT06054321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138741074|NCT06054321|Parasympatholytics|parasympatholytics|mesh-ancestor
138741075|NCT06054321|Autonomic Agents|autonomic agents|mesh-ancestor
138741076|NCT06054321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741077|NCT06054321|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138741078|NCT06054321|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138741079|NCT06054321|Cholinergic Agents|cholinergic agents|mesh-ancestor
138741080|NCT06054321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138741081|NCT06054321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138741082|NCT06054321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138741083|NCT06054321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138741084|NCT06054321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741085|NCT06054321|Dopamine Agonists|dopamine agonists|mesh-ancestor
138741086|NCT06054321|Dopamine Agents|dopamine agents|mesh-ancestor
138741087|NCT06054321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138741088|NCT06054321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138741102|NCT06054152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138741103|NCT06054152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741104|NCT06054152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138741105|NCT06054152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741106|NCT06054100|Colchicine|colchicine|mesh-list
138741107|NCT06054100|Gout Suppressants|gout suppressants|mesh-ancestor
138741108|NCT06054100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138741109|NCT06054100|Tubulin Modulators|tubulin modulators|mesh-ancestor
138741110|NCT06054100|Antimitotic Agents|antimitotic agents|mesh-ancestor
138741111|NCT06054100|Mitosis Modulators|mitosis modulators|mesh-ancestor
138741112|NCT06054100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741113|NCT06054100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741115|NCT06054035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138741116|NCT06054035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741117|NCT06054035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138741118|NCT06054035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741119|NCT06050824|Metronidazole|metronidazole|mesh-list
138741120|NCT06050824|Clarithromycin|clarithromycin|mesh-list
138741121|NCT06050824|Pantoprazole|pantoprazole|mesh-list
138741122|NCT06050824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138741123|NCT06050824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138741124|NCT06050824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138741125|NCT06050824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138741126|NCT06050824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138741127|NCT06050824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741128|NCT06050824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811316|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
138741129|NCT06050824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138741149|NCT05983354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138741151|NCT05983354|Sensory System Agents|sensory system agents|mesh-ancestor
138741152|NCT05983354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741153|NCT05983354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741154|NCT05983354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138741155|NCT05983354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138741156|NCT05983354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138741157|NCT05983354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741158|NCT05983354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741159|NCT05983354|Antiemetics|antiemetics|mesh-ancestor
138741160|NCT05983354|Autonomic Agents|autonomic agents|mesh-ancestor
138741161|NCT05983354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138741162|NCT05983354|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138741163|NCT05983354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138741164|NCT05983354|Dopamine Agents|dopamine agents|mesh-ancestor
138741165|NCT05983354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741166|NCT05960708|Omalizumab|omalizumab|mesh-list
138741167|NCT05960708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138741168|NCT05960708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138741169|NCT05960708|Respiratory System Agents|respiratory system agents|mesh-ancestor
138741170|NCT05959044|Folic Acid|folic acid|mesh-list
138741171|NCT05959044|Vitamins|vitamins|mesh-ancestor
138741172|NCT05959044|Micronutrients|micronutrients|mesh-ancestor
138741173|NCT05959044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741174|NCT05959044|Hematinics|hematinics|mesh-ancestor
138741175|NCT05959044|Vitamin B Complex|vitamin b complex|mesh-ancestor
138741176|NCT05955924|Niacinamide|niacinamide|mesh-list
138741177|NCT05955924|Niacin|niacin|mesh-list
138741178|NCT05955924|Nicotinic Acids|nicotinic acids|mesh-list
138741179|NCT05955924|Vitamin B Complex|vitamin b complex|mesh-ancestor
138741198|NCT05943691|Autonomic Agents|autonomic agents|mesh-ancestor
138741199|NCT05943691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741200|NCT05943691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741201|NCT05943691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138741202|NCT05943691|Glucocorticoids|glucocorticoids|mesh-ancestor
138741203|NCT05943691|Hormones|hormones|mesh-ancestor
138741204|NCT05943691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138741205|NCT05943691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138741206|NCT05943691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741207|NCT05935930|Propofol|propofol|mesh-list
138741208|NCT05935930|Sevoflurane|sevoflurane|mesh-list
138741209|NCT05935930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138741210|NCT05935930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741211|NCT05935930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741212|NCT05935930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138741213|NCT05935930|Anesthetics, General|anesthetics, general|mesh-ancestor
138741214|NCT05935930|Anesthetics|anesthetics|mesh-ancestor
138741215|NCT05935930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138741216|NCT05935930|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138741217|NCT05931575|Quinine|quinine|mesh-list
138741218|NCT05931575|Fasudil|fasudil|mesh-list
138741219|NCT05931575|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
138741220|NCT05931575|Antimalarials|antimalarials|mesh-ancestor
138741221|NCT05931575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138741222|NCT05931575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138741223|NCT05931575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138741224|NCT05931575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138741225|NCT05931575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741226|NCT05931575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138741227|NCT05931575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741228|NCT05931575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138741229|NCT05931575|Analgesics|analgesics|mesh-ancestor
138741230|NCT05931575|Sensory System Agents|sensory system agents|mesh-ancestor
138741231|NCT05931575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138741232|NCT05931575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138741233|NCT05931575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741234|NCT05931575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138741235|NCT05931575|Vasodilator Agents|vasodilator agents|mesh-ancestor
138741236|NCT05931575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138741237|NCT05931575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741238|NCT05927714|Hemostatics|hemostatics|mesh-list
138741239|NCT05927714|Coagulants|coagulants|mesh-ancestor
138741240|NCT05907525|Propofol|propofol|mesh-list
138741241|NCT05907525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138741242|NCT05907525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741243|NCT05907525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741244|NCT05907525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138741245|NCT05907525|Anesthetics, General|anesthetics, general|mesh-ancestor
138741246|NCT05907525|Anesthetics|anesthetics|mesh-ancestor
139079867|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
139079868|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
139079869|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139079870|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139079871|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079872|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
139079873|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139079874|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079875|NCT03444766|Nivolumab|nivolumab|mesh-list
139079876|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139079877|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079878|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139079879|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079880|NCT03526432|Bevacizumab|bevacizumab|mesh-list
139079881|NCT03526432|Atezolizumab|atezolizumab|mesh-list
138741293|NCT05890586|Fluvoxamine|fluvoxamine|mesh-list
138741294|NCT05890586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741295|NCT05890586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741296|NCT05890586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138741297|NCT05890586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138741298|NCT05890586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741299|NCT05890586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741300|NCT05890586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138741301|NCT05890586|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138741302|NCT05890586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138741303|NCT05890586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138741304|NCT05890586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741305|NCT05890586|Serotonin Agents|serotonin agents|mesh-ancestor
138741306|NCT05890586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138741307|NCT05890586|Antidepressive Agents|antidepressive agents|mesh-ancestor
138741308|NCT05890586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138741309|NCT05890586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138741310|NCT05890586|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138741312|NCT05873881|Colchicine|colchicine|mesh-list
138741313|NCT05873881|Gout Suppressants|gout suppressants|mesh-ancestor
138741314|NCT05873881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138741315|NCT05873881|Tubulin Modulators|tubulin modulators|mesh-ancestor
138741316|NCT05873881|Antimitotic Agents|antimitotic agents|mesh-ancestor
138741317|NCT05873881|Mitosis Modulators|mitosis modulators|mesh-ancestor
138741318|NCT05873881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741319|NCT05873881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697634|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741320|NCT05873881|Vitamin B Complex|vitamin b complex|mesh-ancestor
139079882|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139079883|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079884|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139079885|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139079886|NCT03526432|Growth Substances|growth substances|mesh-ancestor
139079887|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079888|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
138811494|NCT06179056|Azithromycin|azithromycin|mesh-list
139079889|NCT03526432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138741322|NCT05873881|Micronutrients|micronutrients|mesh-ancestor
138741323|NCT05873881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741324|NCT05866055|Midazolam|midazolam|mesh-list
138741325|NCT05866055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138741326|NCT05866055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138741327|NCT05866055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741328|NCT05866055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741329|NCT05866055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138741330|NCT05866055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138741331|NCT05866055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138741332|NCT05866055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138741333|NCT05866055|Anesthetics, General|anesthetics, general|mesh-ancestor
138741334|NCT05866055|Anesthetics|anesthetics|mesh-ancestor
138741335|NCT05866055|GABA Modulators|gaba modulators|mesh-ancestor
138741336|NCT05866055|GABA Agents|gaba agents|mesh-ancestor
138741337|NCT05866055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741338|NCT05866055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741339|NCT05864625|Propofol|propofol|mesh-list
138741340|NCT05864625|Sevoflurane|sevoflurane|mesh-list
138741341|NCT05864625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138811534|NCT06178926|Propofol|propofol|mesh-list
138741342|NCT05864625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741343|NCT05864625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741344|NCT05864625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138741345|NCT05864625|Anesthetics, General|anesthetics, general|mesh-ancestor
138741346|NCT05864625|Anesthetics|anesthetics|mesh-ancestor
138741347|NCT05864625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138741348|NCT05864625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138741349|NCT05852769|Flurbiprofen|flurbiprofen|mesh-list
138741350|NCT05852769|Digoxin|digoxin|mesh-list
138741370|NCT05852769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138741371|NCT05852769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138741372|NCT05852769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741373|NCT05852769|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138741374|NCT05852769|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138741375|NCT05852769|Purinergic Agents|purinergic agents|mesh-ancestor
138741376|NCT05852769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138741377|NCT05852769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138741378|NCT05852769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138741379|NCT05852769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138741380|NCT05852769|Respiratory System Agents|respiratory system agents|mesh-ancestor
138741381|NCT05852769|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138741382|NCT05852769|Hormone Antagonists|hormone antagonists|mesh-ancestor
138741383|NCT05852769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138741384|NCT05852769|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138741385|NCT05852769|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138811618|NCT06173466|Hormones|hormones|mesh-ancestor
138741386|NCT05852769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138741387|NCT05852769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138741388|NCT05852769|Protective Agents|protective agents|mesh-ancestor
138741389|NCT05852769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138741390|NCT05852769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138741391|NCT05852769|Antimetabolites|antimetabolites|mesh-ancestor
138741392|NCT05852769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138741393|NCT05852769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138741394|NCT05852769|Analgesics|analgesics|mesh-ancestor
138741395|NCT05852769|Sensory System Agents|sensory system agents|mesh-ancestor
138741396|NCT05852769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741397|NCT05852769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138741416|NCT05793060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741417|NCT05793060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741418|NCT05793060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138741419|NCT05793060|Glucocorticoids|glucocorticoids|mesh-ancestor
138741420|NCT05793060|Hormones|hormones|mesh-ancestor
138741421|NCT05793060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138741422|NCT05793060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138741423|NCT05793060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741424|NCT05793060|Protease Inhibitors|protease inhibitors|mesh-ancestor
138741425|NCT05793060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741426|NCT05793060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741427|NCT05793060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138741428|NCT05793060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741429|NCT05793060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138741430|NCT05793060|Analgesics|analgesics|mesh-ancestor
138741431|NCT05793060|Sensory System Agents|sensory system agents|mesh-ancestor
138741432|NCT05793060|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138741433|NCT05793060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138741434|NCT05793060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138741435|NCT05793060|Adrenergic Agents|adrenergic agents|mesh-ancestor
138741436|NCT05793060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741437|NCT05773092|Osimertinib|osimertinib|mesh-list
138741438|NCT05773092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741439|NCT05773092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138741440|NCT05773092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741441|NCT05773092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741442|NCT05734443|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138741451|NCT05707455|Chrysarobin|chrysarobin|mesh-list
138741461|NCT05615051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138741462|NCT05615051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138741464|NCT05613842|Bombesin|bombesin|mesh-list
138741465|NCT05613842|Trace Elements|trace elements|mesh-ancestor
138741466|NCT05613842|Micronutrients|micronutrients|mesh-ancestor
138741467|NCT05613842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741468|NCT05613842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741469|NCT05613842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741470|NCT05592951|Methamphetamine|methamphetamine|mesh-list
138741471|NCT05592951|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138741472|NCT05592951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741473|NCT05592951|Sympathomimetics|sympathomimetics|mesh-ancestor
138741474|NCT05592951|Autonomic Agents|autonomic agents|mesh-ancestor
138741475|NCT05592951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741476|NCT05592951|Dopamine Agents|dopamine agents|mesh-ancestor
138741477|NCT05592951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741478|NCT05592951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741479|NCT05592951|Adrenergic Agents|adrenergic agents|mesh-ancestor
138741480|NCT05592951|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138741481|NCT05592951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138741482|NCT05592951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138741483|NCT05592951|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138741484|NCT05579119|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138741485|NCT05579119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138741486|NCT05579119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741487|NCT05579119|Incretins|incretins|mesh-ancestor
138741488|NCT05579119|Hormones|hormones|mesh-ancestor
138741494|NCT05575180|Acetazolamide|acetazolamide|mesh-list
138741507|NCT05518929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138741508|NCT05518929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741509|NCT05518929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741510|NCT05518929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138741511|NCT05518929|Anesthetics, General|anesthetics, general|mesh-ancestor
138741513|NCT05477004|Ketamine|ketamine|mesh-list
138741514|NCT05477004|Analgesics|analgesics|mesh-ancestor
138741515|NCT05477004|Sensory System Agents|sensory system agents|mesh-ancestor
138741516|NCT05477004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741517|NCT05477004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741518|NCT05477004|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138741519|NCT05477004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138741520|NCT05477004|Anesthetics, General|anesthetics, general|mesh-ancestor
138741521|NCT05477004|Anesthetics|anesthetics|mesh-ancestor
138741522|NCT05477004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741523|NCT05477004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138741524|NCT05477004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138741525|NCT05477004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741526|NCT05477004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741527|NCT05450029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138811676|NCT06151847|Cyclophosphamide|cyclophosphamide|mesh-list
138741528|NCT05450029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741529|NCT05450029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138741530|NCT05450029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741531|NCT05422001|Ketamine|ketamine|mesh-list
138741532|NCT05422001|Analgesics|analgesics|mesh-ancestor
138741533|NCT05422001|Sensory System Agents|sensory system agents|mesh-ancestor
138741534|NCT05422001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741535|NCT05422001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741536|NCT05422001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138741537|NCT05422001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138741538|NCT05422001|Anesthetics, General|anesthetics, general|mesh-ancestor
138741548|NCT05363631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138741549|NCT05363631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741550|NCT05363631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138741551|NCT05363631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741552|NCT05363631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138741553|NCT05363631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741554|NCT05363631|Antioxidants|antioxidants|mesh-ancestor
138741555|NCT05363631|Protective Agents|protective agents|mesh-ancestor
138811699|NCT06150014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138811700|NCT06150014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811702|NCT06150014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138741556|NCT05363631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741557|NCT05363631|Trace Elements|trace elements|mesh-ancestor
138741558|NCT05363631|Micronutrients|micronutrients|mesh-ancestor
138741559|NCT05357833|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138741560|NCT05357833|Hematinics|hematinics|mesh-ancestor
138741561|NCT05357833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138741562|NCT05357833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138741563|NCT05295589|Paclitaxel|paclitaxel|mesh-list
138741564|NCT05295589|Doxorubicin|doxorubicin|mesh-list
138741565|NCT05295589|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138741566|NCT05295589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138741567|NCT05295589|Topotecan|topotecan|mesh-list
138741568|NCT05295589|Olaparib|olaparib|mesh-list
138741569|NCT05295589|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138741570|NCT05295589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138741571|NCT05295589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741572|NCT05295589|Tubulin Modulators|tubulin modulators|mesh-ancestor
138741573|NCT05295589|Antimitotic Agents|antimitotic agents|mesh-ancestor
138741574|NCT05295589|Mitosis Modulators|mitosis modulators|mesh-ancestor
138741575|NCT05295589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741576|NCT05295589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138741577|NCT05295589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138741578|NCT05295589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138741579|NCT05295589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741592|NCT05294965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138741593|NCT05294965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138741594|NCT05294965|Adrenergic Agents|adrenergic agents|mesh-ancestor
138741595|NCT05294965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550287|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138741596|NCT05294965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741597|NCT05280743|Oxycodone|oxycodone|mesh-list
138741598|NCT05280743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138741599|NCT05280743|Narcotics|narcotics|mesh-ancestor
138741600|NCT05280743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741601|NCT05280743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741602|NCT05280743|Analgesics|analgesics|mesh-ancestor
138741603|NCT05280743|Sensory System Agents|sensory system agents|mesh-ancestor
138741604|NCT05280743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741605|NCT05255913|Fluorides|fluorides|mesh-list
138741606|NCT05255913|Cariostatic Agents|cariostatic agents|mesh-ancestor
138741607|NCT05255913|Protective Agents|protective agents|mesh-ancestor
138811816|NCT05917340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138741608|NCT05255913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741609|NCT05247320|Sotalol|sotalol|mesh-list
138741610|NCT05247320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138741611|NCT05247320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138741612|NCT05247320|Adrenergic Agents|adrenergic agents|mesh-ancestor
138741613|NCT05247320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741614|NCT05247320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741643|NCT05179603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138741644|NCT05179603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741646|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
138741647|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138741648|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138741649|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741650|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741651|NCT05163249|Osimertinib|osimertinib|mesh-list
138741652|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741653|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138741654|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741655|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741656|NCT05155293|Aflibercept|aflibercept|mesh-list
138741657|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138741658|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138741659|NCT05155293|Growth Substances|growth substances|mesh-ancestor
138741660|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741661|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
138811863|NCT05774899|Lenvatinib|lenvatinib|mesh-list
138741662|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741663|NCT05151263|Salicylates|salicylates|mesh-list
138741664|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138741665|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138741666|NCT05151263|Analgesics|analgesics|mesh-ancestor
138741667|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
138741668|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741669|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741670|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138741671|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138741672|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741673|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138741674|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741675|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
138741676|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138741684|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
138741685|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
138741686|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
138741687|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138741688|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741689|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
138741690|NCT05096195|Vitamin D|vitamin d|mesh-list
138741691|NCT05096195|Denosumab|denosumab|mesh-list
138741692|NCT05096195|Calcium|calcium|mesh-list
138741693|NCT05096195|Vitamins|vitamins|mesh-ancestor
138741694|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
138741695|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741696|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138741697|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138741698|NCT05093959|Metformin|metformin|mesh-list
138741699|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138741700|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741701|NCT05044468|Lidocaine|lidocaine|mesh-list
138741702|NCT05044468|Bupivacaine|bupivacaine|mesh-list
138741703|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
138741704|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
138741705|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741706|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741707|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
138741708|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741709|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138741710|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138741711|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138741712|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138741713|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741714|NCT04989283|Paclitaxel|paclitaxel|mesh-list
138741715|NCT04989283|Etoposide|etoposide|mesh-list
138741716|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
138741717|NCT04989283|Cisplatin|cisplatin|mesh-list
138741718|NCT04989283|Carboplatin|carboplatin|mesh-list
138741719|NCT04989283|Pemetrexed|pemetrexed|mesh-list
138741720|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138741721|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
138741726|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
138741727|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
138741728|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
138741729|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741730|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138741731|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138741732|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741733|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138741734|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138812038|NCT05153668|Everolimus|everolimus|mesh-list
138741735|NCT04989283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138741736|NCT04989283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138741737|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
138741738|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741739|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
138741740|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
138741741|NCT04988841|Nivolumab|nivolumab|mesh-list
138741742|NCT04988841|Ipilimumab|ipilimumab|mesh-list
138741743|NCT04988841|Laxatives|laxatives|mesh-list
138741744|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138741745|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138741746|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741747|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138741748|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741749|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138741750|NCT04977778|Fluorides|fluorides|mesh-list
138741751|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
138741752|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
138741753|NCT04977778|Protective Agents|protective agents|mesh-ancestor
138741754|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741755|NCT04973254|Rilpivirine|rilpivirine|mesh-list
138741772|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698087|NCT03434418|Osimertinib|osimertinib|mesh-list
138741773|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741775|NCT04873895|Axitinib|axitinib|mesh-list
138741776|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
138741777|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138741778|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138741779|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138741780|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741781|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741782|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138741783|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741784|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138741785|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138741786|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
138741787|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741788|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
138741789|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138741831|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741832|NCT04356326|Aspirin|aspirin|mesh-list
138741833|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138741834|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138741835|NCT04356326|Analgesics|analgesics|mesh-ancestor
138741836|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
138741837|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741838|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741839|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138741840|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138741841|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138741842|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138741843|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741844|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138741845|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138741846|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741848|NCT04300049|Glucagon|glucagon|mesh-list
138812174|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812175|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812176|NCT04833907|Prednisone|prednisone|mesh-list
138812177|NCT04833907|Levetiracetam|levetiracetam|mesh-list
138812178|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138812179|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
138812180|NCT04833907|Hormones|hormones|mesh-ancestor
138812185|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
138741849|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138698161|NCT03061474|Vitamins|vitamins|mesh-ancestor
138741850|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138741851|NCT04300049|Hormones|hormones|mesh-ancestor
138741855|NCT04278729|Apixaban|apixaban|mesh-list
138741884|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741886|NCT04191421|Siltuximab|siltuximab|mesh-list
138741887|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138741888|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741889|NCT04191421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138741890|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741891|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
138741892|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741893|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741894|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138741895|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
138741896|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138741897|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
138741898|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
138741899|NCT04133194|Mesalamine|mesalamine|mesh-list
138741900|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138741901|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138741902|NCT04133194|Analgesics|analgesics|mesh-ancestor
138741903|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
138741904|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741905|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741906|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138741907|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138741908|NCT04123379|Nivolumab|nivolumab|mesh-list
138741909|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138741910|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741911|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138741912|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741913|NCT04084769|Vaccines|vaccines|mesh-list
138741914|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
138741916|NCT04059224|Trametinib|trametinib|mesh-list
138741926|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
138741928|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741929|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741930|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741931|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138741932|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138741933|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741934|NCT03918850|Buprenorphine|buprenorphine|mesh-list
138741935|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138741936|NCT03918850|Narcotics|narcotics|mesh-ancestor
138741937|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741938|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741939|NCT03918850|Analgesics|analgesics|mesh-ancestor
138741940|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
138741941|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741942|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138741943|NCT03914170|Cetuximab|cetuximab|mesh-list
138741944|NCT03914170|Folfirinox|folfirinox|mesh-list
138741945|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138741946|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741947|NCT03911739|Buprenorphine|buprenorphine|mesh-list
138741948|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138741949|NCT03911739|Narcotics|narcotics|mesh-ancestor
138741952|NCT03911739|Analgesics|analgesics|mesh-ancestor
138741979|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741980|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138741982|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
138741983|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741984|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741985|NCT03701321|Dexamethasone|dexamethasone|mesh-list
138741986|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
138741987|NCT03701321|Bortezomib|bortezomib|mesh-list
138741988|NCT03701321|Venetoclax|venetoclax|mesh-list
138741989|NCT03701321|Daratumumab|daratumumab|mesh-list
138741990|NCT03701321|Ichthammol|ichthammol|mesh-list
138741991|NCT03701321|BB 1101|bb 1101|mesh-list
138741992|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138741993|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
138741994|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
138741995|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741996|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741997|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138741998|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
138741999|NCT03701321|Hormones|hormones|mesh-ancestor
138742000|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138742001|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138742002|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742003|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
138742004|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742005|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742006|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
138742007|NCT03678129|Clobazam|clobazam|mesh-list
138742008|NCT03678129|Anticonvulsants|anticonvulsants|mesh-ancestor
138742009|NCT03678129|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138742029|NCT03561376|Emollients|emollients|mesh-ancestor
138742030|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
138742031|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
138742032|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138742033|NCT03561376|Protective Agents|protective agents|mesh-ancestor
138742034|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742035|NCT03469271|Calcitriol|calcitriol|mesh-list
138742036|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138742037|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138742038|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742039|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138742040|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138742041|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742042|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138742043|NCT03469271|Vitamins|vitamins|mesh-ancestor
138742044|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
138742045|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138742046|NCT03458260|Rituximab|rituximab|mesh-list
138742047|NCT03458260|Etoposide|etoposide|mesh-list
138742048|NCT03458260|Ifosfamide|ifosfamide|mesh-list
138742049|NCT03458260|Pixantrone|pixantrone|mesh-list
138742050|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742051|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742052|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
138742053|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742054|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138742055|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138742056|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138742057|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138742058|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742059|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742072|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742073|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742074|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138742075|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
138742076|NCT03376672|Hormones|hormones|mesh-ancestor
138742077|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138742078|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138742079|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742080|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
138742081|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138742082|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138742083|NCT03376672|Growth Substances|growth substances|mesh-ancestor
138742084|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
138742085|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
138742086|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742087|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742088|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
138742090|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742091|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742092|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138742093|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742094|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138742095|NCT03290937|Cetuximab|cetuximab|mesh-list
138742096|NCT03290937|Irinotecan|irinotecan|mesh-list
138742097|NCT03290937|Camptothecin|camptothecin|mesh-list
138742098|NCT03290937|Antibodies|antibodies|mesh-list
138742099|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
138742100|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138742101|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
138742102|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
138742103|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742104|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742105|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138742107|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742114|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138742115|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742116|NCT03245892|Paclitaxel|paclitaxel|mesh-list
138742117|NCT03245892|Carboplatin|carboplatin|mesh-list
138742118|NCT03245892|Nivolumab|nivolumab|mesh-list
138742119|NCT03245892|Ipilimumab|ipilimumab|mesh-list
138742120|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138742121|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742122|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
138742123|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
138742124|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
138550367|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
138742125|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742126|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742127|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138742128|NCT03228537|Cisplatin|cisplatin|mesh-list
138742129|NCT03228537|Pemetrexed|pemetrexed|mesh-list
138742130|NCT03228537|Atezolizumab|atezolizumab|mesh-list
138742131|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138742132|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742133|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742134|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742135|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138742136|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138742137|NCT03228537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138742138|NCT03228537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742139|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
138742140|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742141|NCT03218137|Adenosine|adenosine|mesh-list
138742142|NCT03218137|Verapamil|verapamil|mesh-list
138742143|NCT03218137|Analgesics|analgesics|mesh-ancestor
138742144|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
138742145|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742146|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742147|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138742148|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
138660150|NCT00344006|Proguanil|proguanil|mesh-list
138273946|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139079890|NCT03526432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079891|NCT01310842|Nicotine|nicotine|mesh-list
138742149|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138742150|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
138742151|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
138742153|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742154|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138742155|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138742156|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138742157|NCT03161522|Capecitabine|capecitabine|mesh-list
138742158|NCT03161522|Fluorouracil|fluorouracil|mesh-list
138742159|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138742160|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
138742161|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742162|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742163|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138742164|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
138742165|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742166|NCT03155100|Dexamethasone|dexamethasone|mesh-list
138742167|NCT03155100|Elotuzumab|elotuzumab|mesh-list
138742168|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
138742169|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138742170|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
138742171|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
138742172|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742173|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742174|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138742175|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
138742176|NCT03155100|Hormones|hormones|mesh-ancestor
138742177|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138742178|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138742179|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742180|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
138742181|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742182|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742184|NCT03126630|Maytansine|maytansine|mesh-list
138742190|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138742191|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
138742192|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
138742193|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
138742194|NCT03126630|Immunoconjugates|immunoconjugates|mesh-ancestor
138742195|NCT03126630|Immunologic Factors|immunologic factors|mesh-ancestor
138742196|NCT03126630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742197|NCT03060473|Amoxicillin|amoxicillin|mesh-list
138742198|NCT03060473|Azithromycin|azithromycin|mesh-list
138742199|NCT03060473|Erythromycin|erythromycin|mesh-list
138742200|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
138742201|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138742202|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
138742203|NCT03060473|Ampicillin|ampicillin|mesh-list
138742204|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138742205|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138742206|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138742207|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138742208|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742209|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742210|NCT02983578|Durvalumab|durvalumab|mesh-list
138742211|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
138742212|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138742213|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
138742214|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742215|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742216|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
138742217|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742218|NCT02949284|Prednisone|prednisone|mesh-list
138742219|NCT02949284|Cortisone|cortisone|mesh-list
138742220|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
138742221|NCT02949284|Hormones|hormones|mesh-list
138742222|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138742223|NCT02949284|Androgens|androgens|mesh-list
138742224|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
138742225|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138742226|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
138698538|NCT04658420|Ketamine|ketamine|mesh-list
138812454|NCT04070287|Antibodies|antibodies|mesh-list
138742227|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138742229|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138742230|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742231|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138742232|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742233|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742234|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
138742235|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138742236|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
138742237|NCT02891954|Canagliflozin|canagliflozin|mesh-list
138742238|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138742239|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742240|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138742241|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742242|NCT02754596|Timolol|timolol|mesh-list
138742243|NCT02754596|Travoprost|travoprost|mesh-list
138742244|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138812489|NCT03964532|Avelumab|avelumab|mesh-list
138742245|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138742246|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742247|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138742248|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138742249|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
138742250|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742251|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742254|NCT02744898|Paclitaxel|paclitaxel|mesh-list
138742279|NCT02095132|Adavosertib|adavosertib|mesh-list
138742280|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138742281|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138742282|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742283|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742284|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742285|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138742286|NCT01919086|Dexamethasone|dexamethasone|mesh-list
138742287|NCT01919086|Lenalidomide|lenalidomide|mesh-list
138742288|NCT01919086|Bortezomib|bortezomib|mesh-list
138742289|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138742290|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
138742291|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
138742292|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742293|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742294|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138742295|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
138742296|NCT01919086|Hormones|hormones|mesh-ancestor
138742297|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138742298|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138742299|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742300|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
138742301|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138742303|NCT01919086|Growth Substances|growth substances|mesh-ancestor
138742333|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138742334|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
138742335|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742336|NCT01534494|Psilocybin|psilocybin|mesh-list
138742337|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
138742338|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742339|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138742340|NCT01273441|Amoxicillin|amoxicillin|mesh-list
138742341|NCT01273441|Metronidazole|metronidazole|mesh-list
138742342|NCT01273441|Clarithromycin|clarithromycin|mesh-list
138742343|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138742344|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138742345|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138742346|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138742347|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138742348|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742349|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742350|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138742351|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138742352|NCT00856037|Doxorubicin|doxorubicin|mesh-list
138742353|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138742354|NCT00856037|Topotecan|topotecan|mesh-list
138742355|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138742356|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742357|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138742358|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138742359|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742360|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742361|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138742362|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
138742363|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138742375|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
138698685|NCT03199794|Factor VIII|factor viii|mesh-list
138742376|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
138742377|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
138742378|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742380|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742381|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138742382|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742383|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742384|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
138742385|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138742386|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
138742387|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742388|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138742389|NCT00006721|Prednisone|prednisone|mesh-list
138742390|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
138742391|NCT00006721|Rituximab|rituximab|mesh-list
138742392|NCT00006721|Doxorubicin|doxorubicin|mesh-list
138742393|NCT00006721|Vincristine|vincristine|mesh-list
138742394|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138742395|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
138742396|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742397|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138742398|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138742399|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
138742400|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742401|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742402|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138742403|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138550390|NCT00254878|Methylphenidate|methylphenidate|mesh-list
138742404|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138742405|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138742406|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138742407|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742408|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138742409|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
138742410|NCT00006721|Hormones|hormones|mesh-ancestor
138742411|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138742412|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138742413|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138742414|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
138742415|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
138812639|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
138742416|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
138742417|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
138742418|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138742419|NCT01030666|Doxycycline|doxycycline|mesh-list
138742420|NCT01030666|Ibuprofen|ibuprofen|mesh-list
138742421|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138742422|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138742423|NCT01030666|Analgesics|analgesics|mesh-ancestor
138742424|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
138742425|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742426|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742427|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138742428|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138742429|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138742430|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742431|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742432|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138742433|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138742434|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
138742435|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
138742436|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138742437|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
138742438|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139079892|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139079893|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
139079894|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830461|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
139079895|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079896|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139079897|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139079898|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
139079899|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139079900|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079901|NCT03722290|Metformin|metformin|mesh-list
139079902|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139079903|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079904|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139079905|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139079906|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139079907|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139079908|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742439|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138742440|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138742441|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
138742442|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742443|NCT01058668|Cariprazine|cariprazine|mesh-list
138742444|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138742445|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138742446|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138742447|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742448|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138742449|NCT00623558|Docetaxel|docetaxel|mesh-list
138742450|NCT00623558|Cetuximab|cetuximab|mesh-list
138742451|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742452|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
138742453|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
138742454|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
138742455|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742456|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742457|NCT01301066|Pravastatin|pravastatin|mesh-list
138742458|NCT01301066|Pitavastatin|pitavastatin|mesh-list
138742459|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138742460|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138742461|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
138660423|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139079909|NCT03717688|Incretins|incretins|mesh-ancestor
139079910|NCT03717688|Hormones|hormones|mesh-ancestor
139079911|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139079912|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
139079913|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079914|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079915|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139079916|NCT02953678|Prednisone|prednisone|mesh-list
139079917|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
139079918|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139079919|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139079920|NCT02953678|Prednisolone|prednisolone|mesh-list
139079921|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
139079922|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139079923|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
139079924|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139079925|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
139079926|NCT02953678|Hormones|hormones|mesh-ancestor
139079927|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139079928|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079929|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139079930|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079931|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
139079932|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
139079933|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079934|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139079935|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139079936|NCT02953678|Protective Agents|protective agents|mesh-ancestor
139079937|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
139079938|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
138742462|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742463|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138742464|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138742465|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742467|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
138742468|NCT01022398|Vitamins|vitamins|mesh-ancestor
138742469|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
138812736|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
138742470|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742471|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138742472|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138742473|NCT05642624|Amphotericin B|amphotericin b|mesh-list
138742474|NCT05642624|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138742475|NCT05642624|Deoxycholic Acid|deoxycholic acid|mesh-list
138742476|NCT05642624|Amebicides|amebicides|mesh-ancestor
138742477|NCT05642624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138742478|NCT05642624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138742479|NCT05642624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138742480|NCT05642624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138742481|NCT05642624|Antifungal Agents|antifungal agents|mesh-ancestor
138742482|NCT05642624|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138742483|NCT05642624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138742484|NCT04324346|Paclitaxel|paclitaxel|mesh-list
138742485|NCT04324346|Docetaxel|docetaxel|mesh-list
138742486|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138742487|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742488|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
138742489|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
138742490|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
138742491|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742492|NCT04300114|Fluzoparib|fluzoparib|mesh-list
138742493|NCT04300114|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138742494|NCT04300114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742495|NCT04300114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742496|NCT04300114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742497|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
138742498|NCT02890238|Citric Acid|citric acid|mesh-list
138742499|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
138742501|NCT02890238|Enclomiphene|enclomiphene|mesh-list
138742502|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
138742503|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
138742504|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138742505|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
138742506|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
138742507|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742508|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
138742509|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138742510|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138742511|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742512|NCT02890238|Urological Agents|urological agents|mesh-ancestor
138742513|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138742514|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
138742515|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138742516|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742517|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138742518|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
138742519|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138742520|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138742521|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138742522|NCT00627796|Lanreotide|lanreotide|mesh-list
138742523|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742524|NCT01299896|Bupropion|bupropion|mesh-list
138742525|NCT01299896|Nicotine|nicotine|mesh-list
138742526|NCT01299896|Varenicline|varenicline|mesh-list
138742527|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138742528|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
138742529|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742548|NCT01299584|Narcotics|narcotics|mesh-ancestor
138742549|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138742550|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742551|NCT01299584|Analgesics|analgesics|mesh-ancestor
138742552|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
138742553|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742554|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
138742555|NCT01236573|Fludarabine|fludarabine|mesh-list
138742556|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138742557|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
138742558|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742559|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138742560|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138742561|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
138742562|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742563|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742564|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138742565|NCT04323228|Antioxidants|antioxidants|mesh-list
138742566|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742567|NCT04323228|Protective Agents|protective agents|mesh-ancestor
138742568|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742569|NCT04322760|Lidocaine|lidocaine|mesh-list
138742570|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
138742571|NCT04322760|Bupivacaine|bupivacaine|mesh-list
138742572|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
138742573|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
138812884|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742574|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138742575|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742576|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
138742577|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742578|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138742579|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138742580|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138742583|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138742588|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138742589|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
138742590|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742591|NCT04322214|Cobicistat|cobicistat|mesh-list
138742592|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138742593|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138742594|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
138742595|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138742596|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138742597|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138742598|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742599|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742600|NCT01057810|Ipilimumab|ipilimumab|mesh-list
138742601|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698909|NCT00542802|Analgesics|analgesics|mesh-ancestor
138742602|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742603|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138742604|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742605|NCT01262352|Ivacaftor|ivacaftor|mesh-list
138742606|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138550407|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138742607|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138742608|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742635|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742636|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138742637|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138742638|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742639|NCT04321278|Azithromycin|azithromycin|mesh-list
138742640|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
138742641|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138742642|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138742643|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
138742644|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138742645|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138742646|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742647|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742648|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138742649|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
138742650|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138742651|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138742652|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
138742653|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742654|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138742655|NCT01260948|Donepezil|donepezil|mesh-list
138742656|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138742657|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742658|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742659|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
138742660|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742661|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742662|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
138742663|NCT01025284|Lenograstim|lenograstim|mesh-list
138742664|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138742665|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
138742666|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742667|NCT02873026|Triamcinolone|triamcinolone|mesh-list
138742668|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138742669|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138742675|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742676|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138742677|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
138742678|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742679|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742680|NCT01056718|Nebivolol|nebivolol|mesh-list
138742681|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138742682|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
138742683|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138742684|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138742685|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138742686|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
138742687|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742688|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742689|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742690|NCT01298570|Leucovorin|leucovorin|mesh-list
138742691|NCT01298570|Fluorouracil|fluorouracil|mesh-list
138742692|NCT01298570|Irinotecan|irinotecan|mesh-list
138742693|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
138742694|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
138742695|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742696|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138742697|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742698|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138742699|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
138742700|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742701|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138742702|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138742703|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742704|NCT01298570|Antidotes|antidotes|mesh-ancestor
138742705|NCT01298570|Protective Agents|protective agents|mesh-ancestor
138742706|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
138742707|NCT01298570|Vitamins|vitamins|mesh-ancestor
138742719|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138742720|NCT01259856|Analgesics|analgesics|mesh-ancestor
138742721|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
138813009|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
138742722|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742723|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742724|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138742725|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138742726|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138742727|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138742728|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742729|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138742730|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138742731|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742732|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
138742733|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
138742734|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
138742735|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138742736|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138742737|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138742738|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138742739|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742741|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138742742|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
138742743|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742744|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742745|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138742746|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138742747|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
138742748|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742749|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699060|NCT00557960|Amphetamine|amphetamine|mesh-list
138742760|NCT05525910|Nirmatrelvir|nirmatrelvir|mesh-list
138742761|NCT05525910|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
138742762|NCT05525910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138742763|NCT05525910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138742764|NCT05525910|Protease Inhibitors|protease inhibitors|mesh-ancestor
138742765|NCT05525910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742766|NCT05525910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742767|NCT05525910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138742768|NCT05525910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138742769|NCT05525910|Antiviral Agents|antiviral agents|mesh-ancestor
138742770|NCT05525910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138742771|NCT05525910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138742772|NCT05525910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138742774|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
138742775|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742776|NCT01297244|Tivozanib|tivozanib|mesh-list
138742777|NCT01297244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138742778|NCT01297244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742779|NCT01297244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742780|NCT04554732|Mitogens|mitogens|mesh-list
138742781|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
138742782|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742783|NCT04481256|Paclitaxel|paclitaxel|mesh-list
138742784|NCT04481256|Carboplatin|carboplatin|mesh-list
138742785|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139079939|NCT00090753|Hematinics|hematinics|mesh-ancestor
139079940|NCT00048932|Abatacept|abatacept|mesh-list
139079941|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139079942|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079943|NCT00048932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139079944|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079945|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079946|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
139079947|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079948|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139079949|NCT00073983|Gemcitabine|gemcitabine|mesh-list
139079950|NCT00073983|Docetaxel|docetaxel|mesh-list
139079951|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139079952|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
139079953|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079954|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079955|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
139079956|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
139079957|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
139079958|NCT02952820|Lemborexant|lemborexant|mesh-list
139079959|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139079960|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742786|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742787|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
138742788|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
138742789|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
138742790|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742791|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
138742792|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
138742793|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742794|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
138813154|NCT00735475|Vaccines|vaccines|mesh-list
138742795|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138742796|NCT03377478|Velpatasvir|velpatasvir|mesh-list
138742797|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
138742798|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138742799|NCT03181932|Vancomycin|vancomycin|mesh-list
138742800|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138742801|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138742802|NCT02888730|Tobramycin|tobramycin|mesh-list
138742803|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138742804|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138742805|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138742806|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138742807|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138742808|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138742809|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742810|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742811|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742812|NCT01598298|Analgesics|analgesics|mesh-ancestor
138742813|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
138742814|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742815|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
138742816|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138742817|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
139079961|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079962|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139079963|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139079964|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139079965|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079966|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
139079967|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079968|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
139079970|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139079971|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
138742818|NCT02888652|Clopidogrel|clopidogrel|mesh-list
138742819|NCT02888652|Ticagrelor|ticagrelor|mesh-list
138742820|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138742821|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138742822|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138742823|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138742824|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
138742825|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742826|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742827|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742828|NCT01235949|Acetaminophen|acetaminophen|mesh-list
138742830|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138742831|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138742832|NCT01235949|Analgesics|analgesics|mesh-ancestor
138742833|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
138742834|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742835|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742836|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138742837|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138742838|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138742839|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742840|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742841|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
138742869|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742870|NCT01234467|Rituximab|rituximab|mesh-list
138742871|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138742872|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742873|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742874|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
138742875|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742876|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138742877|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138742878|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
138742879|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742880|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
138742881|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138742882|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138742883|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138742884|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138550427|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
138742885|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742886|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
138742887|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742888|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742889|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138742890|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742891|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138742892|NCT01233687|Rilotumumab|rilotumumab|mesh-list
138660812|NCT00348023|Timolol|timolol|mesh-list
139079972|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139079973|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079974|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139079975|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139079976|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139079977|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139079978|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079979|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
139079980|NCT01085487|Coagulants|coagulants|mesh-ancestor
139079981|NCT01089309|Spironolactone|spironolactone|mesh-list
139079982|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139079983|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
139079984|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139079985|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079986|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139079987|NCT01089309|Diuretics|diuretics|mesh-ancestor
139079988|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
139079989|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
139079990|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
139079991|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
139079993|NCT01085721|Guaifenesin|guaifenesin|mesh-list
138742893|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742894|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138742895|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742896|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742897|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742898|NCT01233609|Valproic Acid|valproic acid|mesh-list
138742899|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
138742900|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742901|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742902|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
138742903|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742904|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742905|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
138742906|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138742907|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138742908|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138742909|NCT01232283|Apremilast|apremilast|mesh-list
138742910|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138742911|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138742912|NCT01232283|Analgesics|analgesics|mesh-ancestor
138742913|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
138742914|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742915|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813261|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138742916|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138742917|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138742918|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138742919|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138742920|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742921|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742922|NCT01232127|Ritonavir|ritonavir|mesh-list
138742923|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138742924|NCT01232127|Tenofovir|tenofovir|mesh-list
138742925|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138742926|NCT01232127|Famotidine|famotidine|mesh-list
138742927|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138742928|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139079994|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139079995|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
138742929|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
138742930|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742931|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742932|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138742933|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138742934|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
138742935|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138742936|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138742937|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138742938|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138742939|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138742940|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138742941|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138742942|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
138742943|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
138742944|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742945|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742946|NCT01258608|Sorafenib|sorafenib|mesh-list
138742947|NCT01258608|Mapatumumab|mapatumumab|mesh-list
138742948|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742949|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138742950|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742951|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742952|NCT01231659|Everolimus|everolimus|mesh-list
138742953|NCT01231659|Letrozole|letrozole|mesh-list
138742954|NCT01231659|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138742979|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742980|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742981|NCT01054222|Urological Agents|urological agents|mesh-ancestor
138742982|NCT01052428|Metoprolol|metoprolol|mesh-list
138742983|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138742984|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138742985|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
138742986|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
138742987|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742988|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742989|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138742990|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138742991|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138742992|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
138742993|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742994|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742995|NCT01052272|Allopurinol|allopurinol|mesh-list
138742996|NCT01052272|Candesartan|candesartan|mesh-list
138742997|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
138742998|NCT01052272|Ramipril|ramipril|mesh-list
138742999|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138743000|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138743001|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138743002|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743003|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
138743004|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743005|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
138743006|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138743007|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138743008|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
138743009|NCT01052272|Protective Agents|protective agents|mesh-ancestor
138743010|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743011|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138743012|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
139079996|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139079997|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
139079998|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139079999|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080000|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138743013|NCT01257204|Interferons|interferons|mesh-list
138743015|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
138743016|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
138743017|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138743018|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743019|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
138743020|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743021|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
138550433|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743022|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743023|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
138743024|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743026|NCT01231581|Trametinib|trametinib|mesh-list
138743027|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138743028|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
138813364|NCT02735343|Ketamine|ketamine|mesh-list
138743029|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743030|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743031|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138743032|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743033|NCT01050634|Exemestane|exemestane|mesh-list
138743034|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743035|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138743036|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138743037|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743038|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743039|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138743040|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
138743041|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138743042|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743043|NCT01020526|Pregabalin|pregabalin|mesh-list
138743057|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138743058|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
138743059|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138743060|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
138743061|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138743062|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743063|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138743064|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138743065|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743066|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138743067|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138743068|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743069|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
138743070|NCT01256658|Lumefantrine|lumefantrine|mesh-list
138743071|NCT01256658|Artemether|artemether|mesh-list
138743072|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138743073|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
138743074|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138743075|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138743076|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743077|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138743078|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
138743079|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
138743080|NCT01256190|Coagulants|coagulants|mesh-ancestor
138743081|NCT02888574|Oxytocin|oxytocin|mesh-list
138743082|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
138743083|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138743084|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743085|NCT01231503|Vaccines|vaccines|mesh-list
138743106|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743107|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743108|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138743109|NCT01226745|Ceralifimod|ceralifimod|mesh-list
138813405|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138743110|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138743111|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743112|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138743113|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
138743114|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743115|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138743116|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138743117|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138743118|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138743119|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743120|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743121|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743122|NCT01226511|Analgesics|analgesics|mesh-ancestor
138743123|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
138743124|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743125|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
138743126|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138743127|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
138743128|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
138743129|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138743130|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743131|NCT01001377|Cetuximab|cetuximab|mesh-list
138743132|NCT01001377|Panitumumab|panitumumab|mesh-list
138743133|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138743134|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743135|NCT01225887|Nintedanib|nintedanib|mesh-list
138743136|NCT01225887|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138743137|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743138|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138743145|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138743146|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
138743147|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138550447|NCT00069992|Fludarabine|fludarabine|mesh-list
138743148|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743149|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138743150|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138743151|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
138743152|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743153|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743154|NCT01001221|Gemcitabine|gemcitabine|mesh-list
138743155|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138743156|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
138743157|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743158|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743159|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138743160|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
138743161|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138743162|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138743163|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138743164|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
138743165|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138743166|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743167|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138743168|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138743169|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138743170|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138743171|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743172|NCT01002547|Vitamins|vitamins|mesh-list
139080001|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
139080002|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
139080003|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139080004|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139080005|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
139080006|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
139080007|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080008|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080009|NCT01085721|Expectorants|expectorants|mesh-ancestor
139080010|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139080011|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139080012|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
139080013|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139080014|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138743173|NCT01002547|Vitamin E|vitamin e|mesh-list
138743174|NCT01002547|Tocopherols|tocopherols|mesh-list
138743175|NCT01002547|Tocotrienols|tocotrienols|mesh-list
138743176|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
138743177|NCT01002547|Pioglitazone|pioglitazone|mesh-list
138743178|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
138743179|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743180|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138743181|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
138743182|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743183|NCT01002547|Protective Agents|protective agents|mesh-ancestor
138743184|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
138743185|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743186|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138743187|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743188|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743189|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
138743190|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138743191|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743192|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138743193|NCT01007149|Omalizumab|omalizumab|mesh-list
138743194|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138743195|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138743196|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
138743197|NCT00998335|Insulin|insulin|mesh-list
138743198|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138743199|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
138743200|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
138743221|NCT01006603|Saxagliptin|saxagliptin|mesh-list
138743222|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138743223|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138743224|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743225|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138743226|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
138743227|NCT01006603|Incretins|incretins|mesh-ancestor
138743228|NCT01006603|Hormones|hormones|mesh-ancestor
138743229|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138743230|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138743231|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
138743232|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743233|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743234|NCT00997321|Ketamine|ketamine|mesh-list
138743235|NCT00997321|Propofol|propofol|mesh-list
138743236|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138743237|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138743238|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743239|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138743240|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
138743241|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
138743242|NCT00997321|Analgesics|analgesics|mesh-ancestor
138743243|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
138743244|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743245|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138743246|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138743247|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138743248|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743249|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743250|NCT01294592|Tamsulosin|tamsulosin|mesh-list
138743251|NCT01294592|Dutasteride|dutasteride|mesh-list
138743252|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138743253|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138743254|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138743255|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
138743260|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138743261|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138743262|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743263|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
138743264|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138743265|NCT00997243|Azacitidine|azacitidine|mesh-list
138743266|NCT00997243|Lintuzumab|lintuzumab|mesh-list
138743267|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138743268|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
138743269|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743270|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743271|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743272|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138743274|NCT02869321|Morphine|morphine|mesh-list
138743275|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138743276|NCT02869321|Narcotics|narcotics|mesh-ancestor
138743277|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138743278|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743279|NCT02869321|Analgesics|analgesics|mesh-ancestor
138743280|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
138743281|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743282|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138743283|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138743284|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
138743285|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
138743286|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
138743287|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138743288|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743289|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138743290|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743291|NCT01294358|Gemcitabine|gemcitabine|mesh-list
138743292|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138743293|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
138743294|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743295|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743300|NCT01293968|Promethazine|promethazine|mesh-list
138743301|NCT01293968|Ibuprofen|ibuprofen|mesh-list
138743302|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138743303|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138743304|NCT01293968|Analgesics|analgesics|mesh-ancestor
138743305|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
138743306|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743307|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743308|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138743309|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138743310|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138743311|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743312|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743313|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138743314|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138743315|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138743316|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
138743317|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
138743318|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
138743319|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
138743320|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138743321|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138743322|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
138743323|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
138743324|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743325|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138743326|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
138743327|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
138743328|NCT01293032|Tamoxifen|tamoxifen|mesh-list
138743329|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138743330|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743331|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138743332|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
138743333|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138743334|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743335|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139080015|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
139080016|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
139080017|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
138743336|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743337|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138743338|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138743339|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138743340|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138743341|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743342|NCT01224171|Vedolizumab|vedolizumab|mesh-list
138743343|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138743344|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138743345|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
138743346|NCT01223937|Coagulants|coagulants|mesh-ancestor
138743347|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138743348|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
138743349|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743350|NCT01223235|Bevacizumab|bevacizumab|mesh-list
138743351|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138743352|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743353|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138743354|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138743355|NCT01223235|Growth Substances|growth substances|mesh-ancestor
138743356|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743357|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
138743359|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
138743360|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743361|NCT00993967|Protective Agents|protective agents|mesh-ancestor
138743362|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743363|NCT04204603|CKD-506|ckd-506|mesh-list
138743364|NCT04204603|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138743365|NCT04204603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743366|NCT04204603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080018|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
139080019|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139080020|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
139080021|NCT00006392|Vitamins|vitamins|mesh-list
139080022|NCT00006392|Vitamin E|vitamin e|mesh-list
139080023|NCT00006392|Tocopherols|tocopherols|mesh-list
139080024|NCT00006392|Tocotrienols|tocotrienols|mesh-list
139080025|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
139080026|NCT00006392|Selenium|selenium|mesh-list
139080027|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
139080028|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080029|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
138813608|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139080030|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080031|NCT00006392|Protective Agents|protective agents|mesh-ancestor
139080032|NCT00006392|Trace Elements|trace elements|mesh-ancestor
138274070|NCT05648916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138743367|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
138743368|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138743369|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
138743370|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743371|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743372|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138743373|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
138743374|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
138743375|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138743376|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
138743377|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743378|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743379|NCT01221753|Carboplatin|carboplatin|mesh-list
138743380|NCT01221753|Docetaxel|docetaxel|mesh-list
138743381|NCT01221753|Fluorouracil|fluorouracil|mesh-list
138743382|NCT01221753|Cetuximab|cetuximab|mesh-list
138743383|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743384|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
138743385|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
138743386|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
138743387|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743388|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
138743389|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138743390|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138743391|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
138743392|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743393|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138743394|NCT02888223|Factor VIII|factor viii|mesh-list
138743395|NCT02888223|Coagulants|coagulants|mesh-ancestor
138743396|NCT01014988|Zanamivir|zanamivir|mesh-list
138743397|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
138661281|NCT00457119|Everolimus|everolimus|mesh-list
139080033|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139080034|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139080035|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139080036|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139080037|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080038|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080039|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080040|NCT01089621|Analgesics|analgesics|mesh-ancestor
139080041|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
139080042|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080043|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
139080044|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139080045|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
138743398|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743399|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743400|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743401|NCT01019980|Acetaminophen|acetaminophen|mesh-list
138743402|NCT01019980|Diclofenac|diclofenac|mesh-list
138743403|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138743404|NCT01019980|Analgesics|analgesics|mesh-ancestor
138743405|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
138743406|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743407|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743408|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
138743409|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138743410|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138743411|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138813665|NCT02728869|Vaccines|vaccines|mesh-list
138743412|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138743413|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743414|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743415|NCT00993499|Sirolimus|sirolimus|mesh-list
138743416|NCT00993499|Afatinib|afatinib|mesh-list
138743417|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138743418|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743419|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138743420|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743421|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
138743422|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138743423|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
138743424|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743425|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138743426|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080046|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139080047|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139080048|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139080049|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139080050|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080051|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080052|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080053|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
139080054|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139080055|NCT00379769|Metformin|metformin|mesh-list
139080056|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
139080057|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139080058|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080059|NCT00006164|Ribavirin|ribavirin|mesh-list
139080060|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139080061|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
139080062|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
138743427|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743428|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
138743429|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138743430|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743431|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138743432|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
138743433|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138743434|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743435|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743436|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743437|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
138743438|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138743439|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
138743440|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743442|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138743443|NCT02869165|Hormones|hormones|mesh-ancestor
138743444|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138743445|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743446|NCT01219959|Icodextrin|icodextrin|mesh-list
138743447|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
138743448|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138743449|NCT00993421|Sibutramine|sibutramine|mesh-list
138743450|NCT00993421|Metoprolol|metoprolol|mesh-list
138743451|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138743452|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138743453|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
138743454|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
138743455|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743456|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743457|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138743458|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138743459|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138743460|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
138743461|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661368|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080063|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080064|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
138743462|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743463|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
138743464|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138743465|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
138743466|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138743467|NCT01014208|Rituximab|rituximab|mesh-list
138743468|NCT01014208|Ofatumumab|ofatumumab|mesh-list
138743469|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138743470|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743471|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
138743472|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743473|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138743474|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
138743475|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138743476|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138743477|NCT04205578|Protective Agents|protective agents|mesh-ancestor
138743478|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743479|NCT00991939|Dexamethasone|dexamethasone|mesh-list
138743480|NCT00991939|Prednisone|prednisone|mesh-list
138743481|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138743482|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
138743483|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
138743484|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743485|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743486|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138743487|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
138743488|NCT00991939|Hormones|hormones|mesh-ancestor
138743489|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138743490|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138743491|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743492|NCT02868385|Praziquantel|praziquantel|mesh-list
138743493|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
138743494|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139080065|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080066|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
139080067|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080068|NCT00378599|Interferons|interferons|mesh-list
139080069|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
139080070|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
139080071|NCT00378599|Ribavirin|ribavirin|mesh-list
139080072|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139080073|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080074|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
139080075|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080076|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
138743496|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
138743497|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138743498|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
138743499|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743500|NCT00993265|Expectorants|expectorants|mesh-ancestor
138743501|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
138743502|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138743503|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
138743504|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743505|NCT00993265|Protective Agents|protective agents|mesh-ancestor
138743506|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743507|NCT00993265|Antidotes|antidotes|mesh-ancestor
138743508|NCT00993031|Ritonavir|ritonavir|mesh-list
138743509|NCT00993031|Lopinavir|lopinavir|mesh-list
138743510|NCT00993031|Lamivudine|lamivudine|mesh-list
138743511|NCT00993031|Zidovudine|zidovudine|mesh-list
138743512|NCT00993031|Efavirenz|efavirenz|mesh-list
138743513|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138743514|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138743515|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
138743516|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743517|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743518|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138743519|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138743520|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
138743521|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743522|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138743523|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138743524|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138743525|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138743526|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
138743527|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138743528|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139080077|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080078|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
139080079|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080080|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139080081|NCT01046981|Metronidazole|metronidazole|mesh-list
139080082|NCT01046981|Cefazolin|cefazolin|mesh-list
139080083|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139080084|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080085|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
138743529|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138743530|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138743531|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138743532|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138743533|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138743534|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138743535|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138743536|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743537|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138743538|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138743539|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138743540|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
138743541|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743542|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743543|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138743544|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138743545|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
138743546|NCT04291729|Interferons|interferons|mesh-list
138743547|NCT04291729|Ritonavir|ritonavir|mesh-list
138743548|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743549|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
138743550|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743551|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138743552|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138743553|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
138743554|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743555|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743556|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138743557|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138743558|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138743559|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138743560|NCT02868931|Insulin|insulin|mesh-list
138743561|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138743562|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743563|NCT01018810|Interleukin-23|interleukin-23|mesh-list
138743564|NCT01018810|Antibodies|antibodies|mesh-list
138743565|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
139080086|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138743566|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
138743567|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743568|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138743569|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138743570|NCT01018810|Growth Substances|growth substances|mesh-ancestor
138743571|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
138743572|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743573|NCT02867917|Psyllium|psyllium|mesh-list
138743574|NCT02867917|Cathartics|cathartics|mesh-ancestor
138743575|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138743577|NCT01018732|Cathartics|cathartics|mesh-ancestor
138743578|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138743579|NCT01218867|Aldesleukin|aldesleukin|mesh-list
138743580|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
138743581|NCT01218867|Fludarabine|fludarabine|mesh-list
138743582|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138743583|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
138743584|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743585|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138743586|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138743587|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
138743588|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743589|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743590|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138743591|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138743592|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138743593|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
138743594|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743595|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
138743596|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138743597|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138743598|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
138743599|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743600|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743604|NCT01018186|Xhance|xhance|mesh-list
138743609|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743610|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138743611|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
138743613|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138743614|NCT00992407|Risperidone|risperidone|mesh-list
138743615|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138743616|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
138743617|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743618|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743619|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743620|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138743621|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138743622|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138743623|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138743624|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138743625|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
138743626|NCT00986245|Ropinirole|ropinirole|mesh-list
138743627|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138743628|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138743629|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
138743630|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
138743634|NCT00989833|Budesonide|budesonide|mesh-list
138743663|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138743664|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743665|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743666|NCT01218009|Albuterol|albuterol|mesh-list
138743667|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138743668|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
138743669|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743670|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743671|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138743672|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
138743673|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
138743674|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138743675|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138743676|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138743677|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138743678|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
138743679|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743680|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743681|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
138743682|NCT02868151|Vitamins|vitamins|mesh-ancestor
138743683|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
138743684|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743685|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
138743686|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743687|NCT02868151|Protective Agents|protective agents|mesh-ancestor
138743688|NCT01217307|Metformin|metformin|mesh-list
138743689|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138743690|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743691|NCT02868073|Vaccines|vaccines|mesh-list
138743692|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
138743709|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138743710|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743711|NCT00985621|Oxycodone|oxycodone|mesh-list
138743712|NCT00985621|Tanezumab|tanezumab|mesh-list
138743713|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138743714|NCT00985621|Narcotics|narcotics|mesh-ancestor
138743715|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138743716|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743717|NCT00985621|Analgesics|analgesics|mesh-ancestor
138743718|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
138743719|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814029|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138743720|NCT01215981|Vaccines|vaccines|mesh-list
138743721|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
138743722|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743723|NCT01215435|Insulin|insulin|mesh-list
138743724|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138743725|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
138743726|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
138743727|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138743728|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
138743729|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138743730|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
138743731|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138743732|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080087|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139080088|NCT00378209|Dexamethasone|dexamethasone|mesh-list
139080089|NCT00378209|Lenalidomide|lenalidomide|mesh-list
139080090|NCT00378209|Bortezomib|bortezomib|mesh-list
139080091|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139080092|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
139080093|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
139080094|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080095|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080096|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139080097|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
139080098|NCT00378209|Hormones|hormones|mesh-ancestor
139080099|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139080100|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139080101|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274166|NCT00358813|Casopitant|casopitant|mesh-list
139080102|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
139080103|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139080104|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139080105|NCT00378209|Growth Substances|growth substances|mesh-ancestor
139080106|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
139080107|NCT01047059|Bevacizumab|bevacizumab|mesh-list
139080108|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139080109|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139080110|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080111|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139080112|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139080113|NCT01047059|Growth Substances|growth substances|mesh-ancestor
139080114|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743733|NCT01215357|Ecopipam|ecopipam|mesh-list
138743734|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138743735|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138743736|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138743737|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743738|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138743739|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138743740|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
138743741|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814148|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
138743742|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743743|NCT01017874|Pemetrexed|pemetrexed|mesh-list
138743744|NCT01017874|Gefitinib|gefitinib|mesh-list
138743745|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743746|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743747|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743748|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138743749|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138743750|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138743751|NCT00627952|Amlodipine|amlodipine|mesh-list
138743752|NCT00627952|Manidipine|manidipine|mesh-list
138743753|NCT00627952|Delapril|delapril|mesh-list
138743754|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138743755|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138743756|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138743757|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743758|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138743759|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743760|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
138743761|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138743762|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
138743763|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080115|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
139080116|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139080117|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080118|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080120|NCT00377819|Alendronate|alendronate|mesh-list
139080121|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139080122|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080123|NCT00377429|Catumaxomab|catumaxomab|mesh-list
139080124|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139080125|NCT01047215|Aripiprazole|aripiprazole|mesh-list
139080126|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139080127|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
139080128|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138743764|NCT01009840|Bortezomib|bortezomib|mesh-list
138743765|NCT01009840|Busulfan|busulfan|mesh-list
138743766|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743767|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
138743768|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743769|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138743770|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
138743771|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743772|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138743773|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138743774|NCT04420936|Benzocaine|benzocaine|mesh-list
138743775|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
138743776|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
138743777|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138743778|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743779|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
138743780|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743781|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
138743782|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
138743783|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138743784|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
138743785|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661722|NCT00354185|Belinostat|belinostat|mesh-list
139080129|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139080130|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139080131|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139080132|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080133|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
139080134|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
139080135|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080136|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080137|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139080138|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139080139|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
139080140|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139080141|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139080142|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139080143|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139080144|NCT03715582|Trimetazidine|trimetazidine|mesh-list
139080145|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
139080146|NCT00376961|Prednisone|prednisone|mesh-list
139080147|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
139080148|NCT00376961|Rituximab|rituximab|mesh-list
139080149|NCT00376961|Doxorubicin|doxorubicin|mesh-list
139080150|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139080151|NCT00376961|Vincristine|vincristine|mesh-list
139080152|NCT00376961|Bortezomib|bortezomib|mesh-list
138274203|NCT04500613|Dexamethasone|dexamethasone|mesh-list
139080153|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139080154|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
139080155|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080156|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139080157|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139080158|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
138743786|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743787|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138743788|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
138743789|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
138743790|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138743791|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
138743792|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743793|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743794|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138743795|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138743796|NCT00982657|Sunitinib|sunitinib|mesh-list
138743797|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743798|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138743799|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138743800|NCT00982657|Growth Substances|growth substances|mesh-ancestor
138743801|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743803|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138743804|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743805|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743806|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
138743807|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743808|NCT02867293|Anesthetics|anesthetics|mesh-list
138743809|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138743810|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743811|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
138743812|NCT01005316|Prednisone|prednisone|mesh-list
138743813|NCT01005316|Tacrolimus|tacrolimus|mesh-list
138743814|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
139080159|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080160|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080161|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139080162|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139080163|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139080164|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139080165|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139080166|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080167|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139080168|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
139080169|NCT00376961|Hormones|hormones|mesh-ancestor
139080170|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139080171|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139080172|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139080173|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
139080174|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
139080175|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
139080176|NCT00376259|Adefovir|adefovir|mesh-list
139080177|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138743815|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138743816|NCT01005316|Antibodies|antibodies|mesh-list
138743817|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
138743818|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138743819|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138743820|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
138743821|NCT01005316|Hormones|hormones|mesh-ancestor
138743822|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138743823|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743824|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138743825|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743826|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138743827|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
138743828|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138743829|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743830|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743831|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138743832|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138743833|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
138743834|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138743835|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743836|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
139080178|NCT00376259|Telbivudine|telbivudine|mesh-list
139080179|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
139080180|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080181|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139080182|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139080183|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080184|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080185|NCT03715348|Thrombin|thrombin|mesh-list
139080186|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
139080187|NCT03715348|Coagulants|coagulants|mesh-ancestor
139080188|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
139080189|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
139080190|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139080191|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080192|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080193|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080194|NCT00365105|Vitamin D|vitamin d|mesh-list
139080195|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
139080196|NCT00365105|Calcium|calcium|mesh-list
139080197|NCT00365105|Vitamins|vitamins|mesh-ancestor
139080198|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
139080199|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080200|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139080201|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139080203|NCT01049633|Sirolimus|sirolimus|mesh-list
139080204|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139080205|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
139080206|NCT01049633|Clotrimazole|clotrimazole|mesh-list
139080207|NCT01049633|Miconazole|miconazole|mesh-list
139080208|NCT01049633|Trimethoprim|trimethoprim|mesh-list
139080209|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
139080210|NCT01049633|Valganciclovir|valganciclovir|mesh-list
138743838|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138743839|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138743840|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138743841|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743842|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
138743843|NCT01008904|Antacids|antacids|mesh-ancestor
138743844|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743845|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138743846|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
138743847|NCT04290793|Trastuzumab|trastuzumab|mesh-list
138743848|NCT04290793|Epirubicin|epirubicin|mesh-list
138743850|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138743851|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
138743852|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743853|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138743854|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138743855|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
138743856|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743857|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743858|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138743859|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138743860|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138743861|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138743862|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138743863|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743864|NCT01004614|Amlodipine|amlodipine|mesh-list
138743865|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138743866|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138743867|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138743868|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743869|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138743870|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080211|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
139080212|NCT01049633|Heparin|heparin|mesh-list
139080213|NCT01049633|Enoxaparin|enoxaparin|mesh-list
139080214|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
139080215|NCT01049633|Tacrolimus|tacrolimus|mesh-list
139080216|NCT01049633|Basiliximab|basiliximab|mesh-list
139080217|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138743871|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
138743872|NCT04297462|Oseltamivir|oseltamivir|mesh-list
138743873|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
138743874|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743875|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743876|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743877|NCT00981409|Heparin|heparin|mesh-list
138743878|NCT00981409|Calcium heparin|calcium heparin|mesh-list
138743879|NCT00981409|PENTA|penta|mesh-list
138743880|NCT00981409|Fondaparinux|fondaparinux|mesh-list
138743881|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
138743882|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138743883|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138743884|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743885|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138743886|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
138743887|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138743888|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
138743889|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743890|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
138743891|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138743892|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
138743893|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138814517|NCT05754502|Maytansine|maytansine|mesh-list
138743894|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
138743895|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743896|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080218|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139080219|NCT01049633|Analgesics|analgesics|mesh-ancestor
139080220|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
139080221|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080222|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080223|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139080224|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139080225|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139080226|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139080227|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080228|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139080229|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139080230|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080231|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
139080232|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139080233|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
139080234|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139080235|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080236|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139080237|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080238|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
139080239|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139080240|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139080241|NCT01049633|Protective Agents|protective agents|mesh-ancestor
139080242|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
139080243|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138743897|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
138743898|NCT01008748|Nicotine|nicotine|mesh-list
138743899|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138743900|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
138743901|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743902|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743903|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138743904|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138743905|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
138743906|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743907|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743908|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
138743909|NCT00628732|Topotecan|topotecan|mesh-list
138743910|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138743911|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
138743912|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743913|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138743914|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138743915|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
138743916|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743917|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743918|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138743919|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138743920|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138743922|NCT04205344|Bupivacaine|bupivacaine|mesh-list
139080244|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
139080245|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139080246|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
139080247|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139080248|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139080249|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139080250|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139080251|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139080252|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139080253|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139080254|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139080255|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139080256|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
139080257|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139080258|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139080259|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139080260|NCT00399893|Octreotide|octreotide|mesh-list
139080261|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139080262|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139080263|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080264|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
139080265|NCT01049711|Hematinics|hematinics|mesh-ancestor
139080266|NCT00048542|Adalimumab|adalimumab|mesh-list
139080267|NCT00048542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139080268|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138743923|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
138743924|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
138743925|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138743926|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743927|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
138743928|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743929|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138743930|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138743931|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138743932|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
138743933|NCT00978757|Ketamine|ketamine|mesh-list
138743934|NCT00978757|Analgesics|analgesics|mesh-ancestor
138743935|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
138743936|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743937|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080269|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138830843|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080270|NCT03814590|Vaccines|vaccines|mesh-list
139080271|NCT03814590|Immunologic Factors|immunologic factors|mesh-ancestor
139080272|NCT03814590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080273|NCT01583244|Abatacept|abatacept|mesh-list
139080274|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139080275|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274299|NCT04010305|Analgesics|analgesics|mesh-ancestor
139080276|NCT01583244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139080277|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080278|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139080279|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
139080280|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080281|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139080282|NCT01085526|Immunomodulating Agents|immunomodulating agents|mesh-list
139080283|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
139080284|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080285|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
139080286|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139080287|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080288|NCT01102946|Ranibizumab|ranibizumab|mesh-list
139080289|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139080290|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139080291|NCT01102946|Growth Substances|growth substances|mesh-ancestor
139080292|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080293|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
139080294|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080295|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139080296|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
139080297|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080298|NCT01101386|Voriconazole|voriconazole|mesh-list
139080299|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
139080300|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080301|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139080302|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139080303|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080304|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080305|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139080306|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
139080307|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139080308|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080309|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139080310|NCT00005906|Octreotide|octreotide|mesh-list
138743938|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138743939|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138743940|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
138743941|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
138743942|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138743943|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138743944|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138743945|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743946|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743947|NCT01214421|Tolvaptan|tolvaptan|mesh-list
138743948|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138743949|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743950|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
138743951|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743952|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
138743953|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
138743954|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743955|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
138743956|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743957|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743958|NCT02866903|Bevacizumab|bevacizumab|mesh-list
138743959|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
138743960|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138743961|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743962|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138743963|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138743964|NCT02866903|Growth Substances|growth substances|mesh-ancestor
138743965|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743966|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
138743967|NCT01003990|Ritonavir|ritonavir|mesh-list
139080311|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139080312|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139080313|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080314|NCT01103336|Nicorandil|nicorandil|mesh-list
139080315|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139080316|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139080317|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
139080318|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
139080319|NCT01103336|Vitamins|vitamins|mesh-ancestor
139080320|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
139080321|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080322|NCT03950960|Itraconazole|itraconazole|mesh-list
139080323|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
139080324|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743968|NCT01003990|Lopinavir|lopinavir|mesh-list
138743969|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138743970|NCT01003990|Tenofovir|tenofovir|mesh-list
138743971|NCT01003990|Emtricitabine|emtricitabine|mesh-list
138743972|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138743973|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138743974|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
138743975|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743976|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743977|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138743978|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138743979|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
138743980|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743981|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138743982|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138743983|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138743984|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138743985|NCT01002820|Ganaxolone|ganaxolone|mesh-list
138743986|NCT01002820|Neurosteroids|neurosteroids|mesh-ancestor
138743987|NCT01002820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743988|NCT01002820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550520|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
138743989|NCT01002820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743990|NCT01002820|GABA Modulators|gaba modulators|mesh-ancestor
138743991|NCT01002820|GABA Agents|gaba agents|mesh-ancestor
138743992|NCT01012258|Cetuximab|cetuximab|mesh-list
138743993|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138743994|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743995|NCT00628810|Leucovorin|leucovorin|mesh-list
138743996|NCT00628810|Bevacizumab|bevacizumab|mesh-list
138743997|NCT00628810|Fluorouracil|fluorouracil|mesh-list
138743998|NCT00628810|Irinotecan|irinotecan|mesh-list
138743999|NCT00628810|Calcium|calcium|mesh-list
138744000|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
138744001|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138744002|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744009|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
138744010|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744011|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138744012|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138744013|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
138744014|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138744015|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138744016|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744017|NCT00628810|Antidotes|antidotes|mesh-ancestor
138744018|NCT00628810|Protective Agents|protective agents|mesh-ancestor
138744019|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
138744020|NCT00628810|Vitamins|vitamins|mesh-ancestor
138744021|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
138744022|NCT00975481|Alprazolam|alprazolam|mesh-list
138744023|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138744024|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138744025|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744026|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138744027|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138744028|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138744029|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
138744030|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
138744031|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744032|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744033|NCT01011868|Empagliflozin|empagliflozin|mesh-list
138744034|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138744035|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744036|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138744037|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744038|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
138744039|NCT04290013|Norethindrone|norethindrone|mesh-list
138744040|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
138744041|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138744042|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138744043|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744044|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
138744049|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
138744050|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138744051|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744052|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138744053|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138744054|NCT04288999|Capecitabine|capecitabine|mesh-list
138744055|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138744056|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
138744057|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744058|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744059|NCT01213173|Metoprolol|metoprolol|mesh-list
138744060|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138744061|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138744062|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
138744063|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
139080325|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139080326|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138814838|NCT02716857|Oxycodone|oxycodone|mesh-list
139080327|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080328|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080329|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139080330|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
139080331|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139080332|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080333|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139080335|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139080336|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139080337|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080338|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
139080339|NCT03954860|Coagulants|coagulants|mesh-ancestor
139080340|NCT03409276|Vaccines|vaccines|mesh-list
139080341|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
139080342|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080343|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139080344|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139080345|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138830918|NCT00920296|Etravirine|etravirine|mesh-list
139080346|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139080347|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
139080348|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
139080349|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080350|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080351|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080352|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
139080353|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
139080354|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080355|NCT00004088|Pamidronate|pamidronate|mesh-list
139080356|NCT00004088|Interferons|interferons|mesh-list
139080357|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
139080358|NCT00004088|Thalidomide|thalidomide|mesh-list
139080359|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
139080360|NCT00004088|Melphalan|melphalan|mesh-list
139080361|NCT00004088|Busulfan|busulfan|mesh-list
139080362|NCT00004088|Lenograstim|lenograstim|mesh-list
139080363|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139080364|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
139080365|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080366|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139080367|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139080368|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
138744064|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744065|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744066|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138744067|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138744068|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138744069|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
138744070|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744071|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744072|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
138744073|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744074|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
138744075|NCT02866435|Protective Agents|protective agents|mesh-ancestor
138744076|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138744077|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138744078|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744079|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138744080|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
138744081|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138744082|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138744084|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138744085|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138744086|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744087|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
138744088|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744089|NCT04288765|Dexamethasone|dexamethasone|mesh-list
138744090|NCT04288765|Lenalidomide|lenalidomide|mesh-list
138744091|NCT04288765|Daratumumab|daratumumab|mesh-list
138744092|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138744093|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
138744094|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
138744095|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744096|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744097|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138744098|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
138744099|NCT04288765|Hormones|hormones|mesh-ancestor
138744100|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138744102|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744103|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
138744104|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138744105|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138744106|NCT04288765|Growth Substances|growth substances|mesh-ancestor
138744107|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
138744108|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138744109|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
138744110|NCT02863861|Ketamine|ketamine|mesh-list
138744111|NCT02863861|Propofol|propofol|mesh-list
138744112|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138744113|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138744114|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744115|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138744116|NCT02863861|Analgesics|analgesics|mesh-ancestor
138744117|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
138744118|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744119|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138744120|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138744121|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138744122|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
138744123|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744124|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744125|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138744126|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
138744127|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
138744128|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138744129|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138744130|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138744131|NCT05406765|Bupivacaine|bupivacaine|mesh-list
138744132|NCT05406765|Anesthetics, Local|anesthetics, local|mesh-ancestor
138744133|NCT05406765|Anesthetics|anesthetics|mesh-ancestor
138744139|NCT01011556|Hormones|hormones|mesh-list
138744144|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138744145|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
138744146|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
138744147|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138744148|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138744149|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
138744150|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744151|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744152|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744153|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744154|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138744155|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744157|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138744158|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744159|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080369|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080370|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080371|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139080373|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080374|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139080375|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
139080376|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139080377|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138466912|NCT01963559|Lidocaine|lidocaine|mesh-list
139080378|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139080379|NCT00004088|Growth Substances|growth substances|mesh-ancestor
139080380|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
139080381|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139080382|NCT03439072|Glucagon|glucagon|mesh-list
139080383|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139080384|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139080385|NCT03439072|Hormones|hormones|mesh-ancestor
139080386|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139080387|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080388|NCT03439072|Incretins|incretins|mesh-ancestor
139080389|NCT00078312|Modafinil|modafinil|mesh-list
139080390|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139080391|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080392|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139080393|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139080394|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139080395|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080396|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139080397|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080398|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139080399|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080400|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080401|NCT00003896|Paclitaxel|paclitaxel|mesh-list
139080402|NCT00003896|Doxorubicin|doxorubicin|mesh-list
139080403|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139080404|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139080405|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080406|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
139080407|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
139080408|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
139080409|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744160|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138744161|NCT00977665|Protective Agents|protective agents|mesh-ancestor
138744162|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744163|NCT04298008|Durvalumab|durvalumab|mesh-list
138744164|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138744165|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744166|NCT00628342|Esomeprazole|esomeprazole|mesh-list
138744167|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138744168|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138744169|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138744170|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744171|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744172|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
138744173|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138744174|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744175|NCT04287361|Clonazepam|clonazepam|mesh-list
138744177|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
138744178|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
138744179|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744180|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744181|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744182|NCT00624429|Budesonide|budesonide|mesh-list
138744183|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138744184|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138744185|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
138744186|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744187|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662399|NCT00460707|Casopitant|casopitant|mesh-list
139080410|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139080411|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139080412|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139080413|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080414|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139080415|NCT03712540|Rifampin|rifampin|mesh-list
139080416|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139080417|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
139080418|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139080419|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830993|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
139080420|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
139080421|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139080422|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080423|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080424|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139080425|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139080426|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138744188|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138744189|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
138744190|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
138744191|NCT00624429|Hormones|hormones|mesh-ancestor
138744192|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138744193|NCT01001572|Amlodipine|amlodipine|mesh-list
138744194|NCT01001572|Valsartan|valsartan|mesh-list
138744195|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138744196|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138744197|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138744198|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744199|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138744200|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744201|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
138744202|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138744203|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138744204|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
138744206|NCT04287205|Hormones|hormones|mesh-ancestor
138744207|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138744208|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744209|NCT00628576|Heparin|heparin|mesh-list
138744210|NCT00628576|Calcium heparin|calcium heparin|mesh-list
138744211|NCT00628576|Tinzaparin|tinzaparin|mesh-list
138744212|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138744213|NCT00628576|Dalteparin|dalteparin|mesh-list
138744214|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
138815077|NCT04188483|Selenium|selenium|mesh-list
138744215|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138744216|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139080427|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139080428|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139080429|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139080430|NCT05472220|Carboplatin|carboplatin|mesh-list
139080431|NCT05472220|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
139080432|NCT05472220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080433|NCT05472220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080434|NCT05472220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080435|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
139080436|NCT00003782|Docetaxel|docetaxel|mesh-list
139080437|NCT00003782|Doxorubicin|doxorubicin|mesh-list
139080438|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139080439|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
139080440|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080441|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139080442|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139080443|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
139080444|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744217|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744219|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138744220|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744221|NCT04370548|Clindamycin|clindamycin|mesh-list
138744222|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
138744223|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
138744224|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138744225|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744226|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138744227|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744228|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744229|NCT01208181|Etoricoxib|etoricoxib|mesh-list
138744230|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138744231|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138744232|NCT01208181|Analgesics|analgesics|mesh-ancestor
138744233|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
138744234|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744235|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744236|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138744237|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138744238|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138744239|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138744240|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815087|NCT00717067|Ritonavir|ritonavir|mesh-list
139080445|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080446|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139080447|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
139080448|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
139080449|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
139080450|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139080451|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139080452|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139080453|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080454|NCT03389308|Diacerein|diacerein|mesh-list
139080455|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139080456|NCT03714490|Capecitabine|capecitabine|mesh-list
139080457|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
139080458|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139080459|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
139080460|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080461|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080463|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139080464|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080465|NCT03407170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139080466|NCT03407170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080467|NCT01103648|Simvastatin|simvastatin|mesh-list
139080468|NCT01103648|Ezetimibe|ezetimibe|mesh-list
139080469|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
139080470|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139080471|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138744241|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744242|NCT01208103|Bevacizumab|bevacizumab|mesh-list
138744243|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138744244|NCT01208103|Capecitabine|capecitabine|mesh-list
138744245|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
138744246|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
138744247|NCT01208103|Antibodies|antibodies|mesh-list
138744248|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
138744249|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138744250|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
138744251|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744252|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138744253|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138744254|NCT01208103|Growth Substances|growth substances|mesh-ancestor
138744255|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744256|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
138744257|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
138744258|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138744259|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
138744260|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744261|NCT01206777|Rituximab|rituximab|mesh-list
138744262|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138744263|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744264|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
138744265|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744266|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138744267|NCT01001494|Bromides|bromides|mesh-list
138744268|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
138744269|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138744270|NCT01205685|Letrozole|letrozole|mesh-list
138744271|NCT01205685|Goserelin|goserelin|mesh-list
138744272|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662512|NCT06189404|Autonomic Agents|autonomic agents|mesh-ancestor
139080472|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
139080473|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080474|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139080475|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080476|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
139080477|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139080478|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139080479|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080480|NCT03406858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139080481|NCT03406858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080482|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
138744273|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138744274|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744275|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744276|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138744277|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138744278|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138744279|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
138744280|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138744281|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744282|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138744283|NCT01205529|Procainamide|procainamide|mesh-list
138744284|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138744285|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138744286|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138744287|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138744288|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744289|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
138744290|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138744291|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138744292|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138744293|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138744294|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744295|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
138744296|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744297|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744298|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138744299|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744300|NCT04294732|Bupivacaine|bupivacaine|mesh-list
138744301|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
138744302|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
138662557|NCT06188676|Doxorubicin|doxorubicin|mesh-list
139080483|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080484|NCT01095848|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139080485|NCT01095848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139080486|NCT01095848|Immunologic Factors|immunologic factors|mesh-ancestor
139080487|NCT01095848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080488|NCT01095926|Doxorubicin|doxorubicin|mesh-list
139080489|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139080490|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080491|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139080492|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138744303|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138744304|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744305|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
138744306|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744307|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
138744308|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138744309|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744310|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138744311|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744312|NCT01001104|Dulaglutide|dulaglutide|mesh-list
138744313|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138744314|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744315|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
138744316|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
138744317|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138744318|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744319|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138744320|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138744321|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744322|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700633|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
138744323|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744324|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138815169|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
139080493|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080494|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080495|NCT00003656|Interferons|interferons|mesh-list
139080496|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
139080498|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080499|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
139080500|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080501|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
139080502|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080503|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
139080504|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
139080505|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
139080506|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080507|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
139080508|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274437|NCT05444101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139080509|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080510|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139080512|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139080513|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080514|NCT03416374|Dexamethasone|dexamethasone|mesh-list
139080515|NCT03416374|Lenalidomide|lenalidomide|mesh-list
139080516|NCT03416374|Bortezomib|bortezomib|mesh-list
139080517|NCT03416374|Ixazomib|ixazomib|mesh-list
139080518|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139080519|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
139080520|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
138744325|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138744326|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138744327|NCT01204671|Vaccines|vaccines|mesh-list
138744328|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
138744329|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744330|NCT01202955|Tolcapone|tolcapone|mesh-list
138744331|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138744332|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138815199|NCT00802360|Progesterone|progesterone|mesh-list
138744333|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138744334|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744335|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744336|NCT01202877|Azacitidine|azacitidine|mesh-list
138744337|NCT01202877|Midostaurin|midostaurin|mesh-list
138744338|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138744339|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
138744340|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744341|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744342|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744343|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138744344|NCT01202409|Panitumumab|panitumumab|mesh-list
138744345|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138744346|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744347|NCT01202175|Nebivolol|nebivolol|mesh-list
138744348|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138744349|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
138744350|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138744351|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138744352|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138744353|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
138744354|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080521|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080522|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080523|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139080524|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
139080525|NCT03416374|Hormones|hormones|mesh-ancestor
139080526|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139080527|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139080528|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080529|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
139080530|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139080531|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139080532|NCT03416374|Growth Substances|growth substances|mesh-ancestor
139080533|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
139080534|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
139080535|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744355|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744356|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744357|NCT01201785|Aspirin|aspirin|mesh-list
138744358|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138744359|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138744360|NCT01201785|Analgesics|analgesics|mesh-ancestor
138744361|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
138744362|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744363|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744364|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138744365|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138744366|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138744367|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138744368|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744369|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138744370|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139080536|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080537|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
139080538|NCT00077766|Hematinics|hematinics|mesh-ancestor
139080539|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
139080540|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
139080541|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139080542|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080543|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080544|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
139080545|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139080546|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139080547|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080548|NCT03388138|Ketotifen|ketotifen|mesh-list
139080549|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
139080550|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
139080551|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139080552|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
139080553|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
139080554|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080555|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080556|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080557|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139080558|NCT01101620|Simendan|simendan|mesh-list
139080559|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139080560|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
139080561|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139080562|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139080563|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080564|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080565|NCT01101620|Protective Agents|protective agents|mesh-ancestor
139080566|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080567|NCT02952898|Diclofenac|diclofenac|mesh-list
139080568|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139080569|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139080570|NCT02952898|Analgesics|analgesics|mesh-ancestor
139080571|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
139080572|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080573|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080574|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139080575|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138744372|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
138744373|NCT01200069|Ibuprofen|ibuprofen|mesh-list
138744374|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138744375|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138744376|NCT01200069|Analgesics|analgesics|mesh-ancestor
138744377|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
138744378|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744379|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744380|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138744381|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138744382|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138744383|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744384|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744385|NCT01199289|Brodalumab|brodalumab|mesh-list
138744386|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
138744387|NCT01199055|Paclitaxel|paclitaxel|mesh-list
138744388|NCT01199055|Carboplatin|carboplatin|mesh-list
138744389|NCT01199055|Efatutazone|efatutazone|mesh-list
138744390|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138744391|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744392|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
138744393|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
138744394|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
138744395|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744396|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
138700710|NCT00558623|Calcium|calcium|mesh-list
138744397|NCT01198587|Astringents|astringents|mesh-ancestor
138744398|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744399|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
138744400|NCT01198509|Vancomycin|vancomycin|mesh-list
138744401|NCT01198509|Doxycycline|doxycycline|mesh-list
138815309|NCT04114630|Erenumab|erenumab|mesh-list
139080576|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139080577|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080578|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080579|NCT01101698|Vitamin D|vitamin d|mesh-list
139080580|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
139080581|NCT01101698|Vitamins|vitamins|mesh-list
139080582|NCT01101698|Vitamin K|vitamin k|mesh-list
139080583|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
139080584|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
139080585|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080586|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139080587|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139080588|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139080589|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138744402|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138744403|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744404|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
138744405|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138744406|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138744408|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138744409|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
138744410|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138744411|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138744412|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744413|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138744414|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138744415|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138744416|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744417|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138815343|NCT00613665|Vaccines|vaccines|mesh-list
138744418|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138744419|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138744420|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
138744421|NCT01197417|Analgesics|analgesics|mesh-ancestor
138744422|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
138744423|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744424|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744425|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
138744426|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138744427|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138744428|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
138744429|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138744435|NCT00977431|Temozolomide|temozolomide|mesh-list
138744447|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138744448|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744449|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
138744450|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744451|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744452|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138744453|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744454|NCT02864095|Epinephrine|epinephrine|mesh-list
138744455|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
138744456|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138744457|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138744458|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744459|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
138744460|NCT02864095|Coagulants|coagulants|mesh-ancestor
138744461|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138744462|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138744463|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
138744464|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744465|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744466|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138744467|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138744468|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
138744469|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700795|NCT04644185|Paraproteins|paraproteins|mesh-list
138744470|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138744471|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
138744472|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
138744473|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
138744474|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138744475|NCT00977197|Pregabalin|pregabalin|mesh-list
138744476|NCT00977197|Analgesics|analgesics|mesh-ancestor
138744477|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
138744478|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744479|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662828|NCT06186921|Analgesics|analgesics|mesh-ancestor
138744486|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138744487|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138744488|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138744490|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138744491|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138744492|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744493|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138744494|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744495|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
138744496|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
138744497|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138744498|NCT00974233|Rituximab|rituximab|mesh-list
138744499|NCT00974233|Lenalidomide|lenalidomide|mesh-list
138744500|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138815430|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138744501|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138744502|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744503|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
138744504|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744505|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138744506|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138744507|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138744508|NCT00974233|Growth Substances|growth substances|mesh-ancestor
138744509|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
138744510|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138744511|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
138744534|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744535|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138744536|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
138744537|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138744538|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138744539|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744540|NCT00972283|Insulin|insulin|mesh-list
138744541|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138744542|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
138744543|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
138744544|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138744545|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744547|NCT05366049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138744548|NCT05366049|Analgesics|analgesics|mesh-ancestor
138744549|NCT05366049|Sensory System Agents|sensory system agents|mesh-ancestor
138744550|NCT05366049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744551|NCT05366049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744552|NCT05366049|Antipyretics|antipyretics|mesh-ancestor
138744553|NCT00969709|Milnacipran|milnacipran|mesh-list
138744554|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
138744555|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138744556|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138744557|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138744558|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744559|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744560|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744561|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
138744562|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138744563|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138744564|NCT00969709|Analgesics|analgesics|mesh-ancestor
138744565|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
138744566|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744567|NCT01193517|Capecitabine|capecitabine|mesh-list
138744568|NCT01193517|Azacitidine|azacitidine|mesh-list
138744577|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138744578|NCT02863705|Bimatoprost|bimatoprost|mesh-list
138744579|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138744580|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138744581|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138744582|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138744583|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
138744584|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744585|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744586|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744587|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138744588|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138744589|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138744590|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138744591|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138744592|NCT01193283|Cyclosporine|cyclosporine|mesh-list
138744593|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
138744594|NCT01193283|Cyclosporins|cyclosporins|mesh-list
138744595|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138744596|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
138744597|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744598|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138744599|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138744600|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
138744601|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744602|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744603|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138744604|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744605|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
138744606|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744607|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
138744608|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138744609|NCT02863471|Gemcitabine|gemcitabine|mesh-list
138815514|NCT03414723|Ramipril|ramipril|mesh-list
138744610|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138744611|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
138744612|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080590|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080591|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
138744613|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744614|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138744615|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138744616|NCT01193127|Mydriatics|mydriatics|mesh-list
138744617|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
138744618|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744619|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744620|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138744621|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744622|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138744623|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744624|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744625|NCT01192191|Fluticasone|fluticasone|mesh-list
138744627|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138744628|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138744629|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
138744630|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744631|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744632|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138744633|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
138744634|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
138744635|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138744636|NCT01307267|Rituximab|rituximab|mesh-list
138744637|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138744638|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
138744639|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138744640|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744641|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
138744642|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080592|NCT01101698|Coagulants|coagulants|mesh-ancestor
139080593|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
139080594|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080595|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139080596|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080597|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080598|NCT05513768|Protein C|protein c|mesh-list
139080599|NCT05513768|Anticoagulants|anticoagulants|mesh-ancestor
139080600|NCT05513768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139080601|NCT05513768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139080602|NCT05513768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080603|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
139080604|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139080605|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139080606|NCT03387046|Prednisolone|prednisolone|mesh-list
139080607|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
139080608|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139080609|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
138744643|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138744644|NCT01307111|Misoprostol|misoprostol|mesh-list
138744645|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138744646|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
138744647|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138744648|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744649|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138744650|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138744651|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
138744652|NCT01191801|Cytarabine|cytarabine|mesh-list
138744653|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138744654|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
138744655|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744656|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744657|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
138744658|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744659|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138744660|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
138744661|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744662|NCT01306643|Idelalisib|idelalisib|mesh-list
138744663|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815576|NCT00720109|Leucovorin|leucovorin|mesh-list
138744664|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744665|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744666|NCT05656833|Cysteamine|cysteamine|mesh-list
138744667|NCT05656833|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138744668|NCT05656833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744669|NCT01306331|Nonoxynol|nonoxynol|mesh-list
138744670|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138744671|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138744672|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744673|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138744674|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
138744675|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139080610|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139080611|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
139080612|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
139080613|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080614|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080615|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139080616|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
139080617|NCT03387046|Hormones|hormones|mesh-ancestor
139080618|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138744676|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138744677|NCT00624663|Rivastigmine|rivastigmine|mesh-list
138744678|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138744679|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744680|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744681|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
138744682|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744683|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744684|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138744685|NCT00624663|Protective Agents|protective agents|mesh-ancestor
138744686|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
138744687|NCT02890823|Vitamin D|vitamin d|mesh-list
138744688|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138550566|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
138744689|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744691|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
138744692|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138744693|NCT02887443|Midazolam|midazolam|mesh-list
138744694|NCT02887443|Idebenone|idebenone|mesh-list
138744695|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138744696|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138744697|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138744698|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744699|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138744700|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138744701|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138744702|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138744703|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
138744704|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
138744705|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
138744706|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
139080619|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139080620|NCT03387046|Protective Agents|protective agents|mesh-ancestor
139080621|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139080622|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080623|NCT01101776|Interferons|interferons|mesh-list
139080624|NCT01101776|Interferon-beta|interferon-beta|mesh-list
139080625|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
139080626|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080627|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
139080628|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080629|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
139080630|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080631|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139080632|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139080633|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080634|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138744707|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744708|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744710|NCT02887443|Protective Agents|protective agents|mesh-ancestor
138744711|NCT05359263|Dapagliflozin|dapagliflozin|mesh-list
138744712|NCT05359263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138744713|NCT05359263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744714|NCT05359263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138744715|NCT05359263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744716|NCT01305941|Trastuzumab|trastuzumab|mesh-list
138744717|NCT01305941|Everolimus|everolimus|mesh-list
138744718|NCT01305941|Vinorelbine|vinorelbine|mesh-list
138744719|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138744720|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744721|NCT01305941|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138744722|NCT01305941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138744723|NCT01305941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744724|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744725|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138744726|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
138744727|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744728|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138744729|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
138744730|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
138744731|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
138744732|NCT05658549|Acetylcysteine|acetylcysteine|mesh-list
138744733|NCT05658549|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138744755|NCT05658159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138744756|NCT05658159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138744757|NCT01305239|Exemestane|exemestane|mesh-list
138744758|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744759|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138744760|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138744762|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744763|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138744764|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
138744765|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138744766|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744767|NCT04317183|Miconazole|miconazole|mesh-list
138744768|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
138744769|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744770|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138701090|NCT01235728|Vitamins|vitamins|mesh-ancestor
138744771|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138744772|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744773|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744774|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138744775|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
138744776|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138744777|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744778|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138744779|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138744780|NCT01194219|Apremilast|apremilast|mesh-list
138744781|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138744782|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138744783|NCT01194219|Analgesics|analgesics|mesh-ancestor
138744784|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
138744785|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744786|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663121|NCT06101173|Vaccines|vaccines|mesh-list
138744792|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744793|NCT01304693|Ranibizumab|ranibizumab|mesh-list
138744794|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138744795|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138744796|NCT01304693|Growth Substances|growth substances|mesh-ancestor
138744797|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744798|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
138744799|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744800|NCT01304147|Ketamine|ketamine|mesh-list
138744801|NCT01304147|Analgesics|analgesics|mesh-ancestor
138744802|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
138744803|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815812|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744804|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744805|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138744806|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138744807|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
138744808|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
138744809|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138744810|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138744811|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138744812|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744813|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744814|NCT05661227|Dexmedetomidine|dexmedetomidine|mesh-list
138744815|NCT05661227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138744816|NCT05661227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138744817|NCT05661227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744818|NCT05661227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138744819|NCT05661227|Analgesics|analgesics|mesh-ancestor
138744820|NCT05661227|Sensory System Agents|sensory system agents|mesh-ancestor
139080635|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080636|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080637|NCT03353740|Edetic Acid|edetic acid|mesh-list
139080638|NCT03353740|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139080639|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
139080640|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
138815857|NCT01018862|Azelastine|azelastine|mesh-list
139080641|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080642|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
139080643|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139080644|NCT03353740|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139080646|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139080647|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139080648|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
138274515|NCT01634100|Empagliflozin|empagliflozin|mesh-list
139080649|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139080650|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138744821|NCT05661227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744822|NCT05661227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138550579|NCT00070187|Analgesics|analgesics|mesh-ancestor
138744823|NCT05661227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138744824|NCT05661227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138744825|NCT05661227|Adrenergic Agents|adrenergic agents|mesh-ancestor
138744826|NCT05661227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744827|NCT05661227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744828|NCT01303445|Omeprazole|omeprazole|mesh-list
138744829|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138744830|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138744831|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138744832|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138744833|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744834|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744835|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138744836|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138744837|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
138744838|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138744839|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
138744840|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080651|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080653|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
139080654|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139080655|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139080656|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080657|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139080658|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080659|NCT00399035|Leucovorin|leucovorin|mesh-list
139080660|NCT00399035|Capecitabine|capecitabine|mesh-list
139080661|NCT00399035|Fluorouracil|fluorouracil|mesh-list
139080662|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
139080663|NCT00399035|Cediranib|cediranib|mesh-list
139080664|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
139080665|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139080666|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
138815961|NCT00722371|Incretins|incretins|mesh-ancestor
139080667|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080668|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080669|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139080670|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
139080671|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080672|NCT00399035|Antidotes|antidotes|mesh-ancestor
139080673|NCT00399035|Protective Agents|protective agents|mesh-ancestor
139080674|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
139080675|NCT00399035|Vitamins|vitamins|mesh-ancestor
139080676|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
139080677|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139080678|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080679|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139080680|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139080681|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701161|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
138744841|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744842|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
138744843|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744844|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138744845|NCT01302899|Ramipril|ramipril|mesh-list
138744846|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138744847|NCT01302899|Diuretics|diuretics|mesh-ancestor
138744848|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
138744849|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744850|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138744851|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138744852|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744853|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138744854|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
138744855|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744856|NCT01187901|Sulindac|sulindac|mesh-list
138744857|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138744858|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744859|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138744860|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744861|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744862|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138744863|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138744864|NCT01187901|Analgesics|analgesics|mesh-ancestor
138744865|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
138744866|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744867|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744868|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138744869|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138744870|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138744871|NCT01302119|Tavaborole|tavaborole|mesh-list
138744872|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138744881|NCT05927922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744882|NCT05927922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138744883|NCT05927922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138744884|NCT05927922|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138744885|NCT05927922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744886|NCT05927922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744887|NCT05927857|Trifluridine|trifluridine|mesh-list
138744888|NCT05927857|Ramucirumab|ramucirumab|mesh-list
138744889|NCT05927857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744890|NCT05927857|Antimetabolites|antimetabolites|mesh-ancestor
138744891|NCT05927857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744892|NCT05927857|Antiviral Agents|antiviral agents|mesh-ancestor
138744893|NCT05927857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744894|NCT05927831|Grape Seed Extract|grape seed extract|mesh-list
138744895|NCT05927831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138744896|NCT05927831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744897|NCT05927831|Antioxidants|antioxidants|mesh-ancestor
138744898|NCT05927831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744899|NCT05927831|Protective Agents|protective agents|mesh-ancestor
138744900|NCT05927831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744902|NCT05927818|Antidotes|antidotes|mesh-ancestor
138744903|NCT05927818|Protective Agents|protective agents|mesh-ancestor
138744904|NCT05927818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744905|NCT05927428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138744906|NCT05927428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138744907|NCT05927259|Acetylcysteine|acetylcysteine|mesh-list
138744908|NCT05927259|Atropine|atropine|mesh-list
138744909|NCT05927259|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138744910|NCT05927259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138744911|NCT05927259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138744912|NCT05927259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138744913|NCT05927259|Autonomic Agents|autonomic agents|mesh-ancestor
138744914|NCT05927259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663279|NCT05931601|Norepinephrine|norepinephrine|mesh-list
139080682|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139080683|NCT00073749|Immunotoxins|immunotoxins|mesh-ancestor
139080684|NCT00073749|Immunoconjugates|immunoconjugates|mesh-ancestor
139080685|NCT00073749|Immunologic Factors|immunologic factors|mesh-ancestor
139080686|NCT00073749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080687|NCT03960801|Remifentanil|remifentanil|mesh-list
139080688|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139080689|NCT03960801|Narcotics|narcotics|mesh-ancestor
139080690|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138744915|NCT05927259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744916|NCT05927259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138744917|NCT05927259|Respiratory System Agents|respiratory system agents|mesh-ancestor
138744918|NCT05927259|Mydriatics|mydriatics|mesh-ancestor
138744919|NCT05927259|Parasympatholytics|parasympatholytics|mesh-ancestor
138744920|NCT05927259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138744921|NCT05927259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138744922|NCT05927259|Cholinergic Agents|cholinergic agents|mesh-ancestor
138744923|NCT05927259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744924|NCT05927259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744925|NCT05927259|Antiviral Agents|antiviral agents|mesh-ancestor
138744926|NCT05927259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744927|NCT05927259|Expectorants|expectorants|mesh-ancestor
138744928|NCT05927259|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138744929|NCT05927259|Antioxidants|antioxidants|mesh-ancestor
138744930|NCT05927259|Protective Agents|protective agents|mesh-ancestor
138744931|NCT05927259|Antidotes|antidotes|mesh-ancestor
138744932|NCT05927155|Tiotropium Bromide|tiotropium bromide|mesh-list
138744933|NCT05927155|Olodaterol|olodaterol|mesh-list
138744934|NCT05927155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138744935|NCT05927155|Autonomic Agents|autonomic agents|mesh-ancestor
138744936|NCT05927155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744937|NCT05927155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744938|NCT05927155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138744939|NCT05927155|Respiratory System Agents|respiratory system agents|mesh-ancestor
138744940|NCT05927155|Parasympatholytics|parasympatholytics|mesh-ancestor
138744941|NCT05927155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138744942|NCT05927155|Cholinergic Agents|cholinergic agents|mesh-ancestor
138744943|NCT05927155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816151|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744944|NCT05927155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744945|NCT05927129|Antidepressive Agents|antidepressive agents|mesh-list
139080691|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080692|NCT03960801|Analgesics|analgesics|mesh-ancestor
139080693|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
139080694|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080695|NCT01583439|Ritonavir|ritonavir|mesh-list
139080696|NCT01583439|Lopinavir|lopinavir|mesh-list
139080697|NCT01583439|Tenofovir|tenofovir|mesh-list
139080698|NCT01583439|Lamivudine|lamivudine|mesh-list
139080699|NCT01583439|Emtricitabine|emtricitabine|mesh-list
139080700|NCT01583439|Zidovudine|zidovudine|mesh-list
139080701|NCT01583439|Efavirenz|efavirenz|mesh-list
139080702|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139080703|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139080704|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139080705|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
139080706|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744946|NCT05927129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138744947|NCT05926895|Betamethasone|betamethasone|mesh-list
138744948|NCT05926895|Betamethasone Valerate|betamethasone valerate|mesh-list
138744949|NCT05926895|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138744950|NCT05926895|Betamethasone benzoate|betamethasone benzoate|mesh-list
138744951|NCT05926895|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
138744952|NCT05926895|Prilocaine|prilocaine|mesh-list
138744953|NCT05926895|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138744954|NCT05926895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138744955|NCT05926895|Glucocorticoids|glucocorticoids|mesh-ancestor
138744956|NCT05926895|Hormones|hormones|mesh-ancestor
138744957|NCT05926895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138744958|NCT05926895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744959|NCT05926895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138744960|NCT05926895|Respiratory System Agents|respiratory system agents|mesh-ancestor
138744961|NCT05926895|Anesthetics, Local|anesthetics, local|mesh-ancestor
138744962|NCT05926895|Anesthetics|anesthetics|mesh-ancestor
138744963|NCT05926895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138744964|NCT05926895|Sensory System Agents|sensory system agents|mesh-ancestor
138744965|NCT05926895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744966|NCT05926882|Apremilast|apremilast|mesh-list
138744967|NCT05926882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138744968|NCT05926882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138744969|NCT05926882|Analgesics|analgesics|mesh-ancestor
138744970|NCT05926882|Sensory System Agents|sensory system agents|mesh-ancestor
138744971|NCT05926882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744972|NCT05926882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744973|NCT05926882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138744974|NCT05926882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138744975|NCT05926882|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138744976|NCT05926882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138744977|NCT05926882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744978|NCT05926882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744979|NCT05926869|Clindamycin|clindamycin|mesh-list
138744985|NCT05926869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138744986|NCT05926869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744987|NCT05926869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744988|NCT05926869|Antimalarials|antimalarials|mesh-ancestor
138744989|NCT05926869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138744990|NCT05926869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138744991|NCT05926869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138744992|NCT05926869|Leprostatic Agents|leprostatic agents|mesh-ancestor
138744993|NCT05926271|Clopidogrel|clopidogrel|mesh-list
138744994|NCT05926271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138744995|NCT05926271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138744996|NCT05926271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138744997|NCT05926271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138744998|NCT05926271|Purinergic Agents|purinergic agents|mesh-ancestor
138744999|NCT05926271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138745000|NCT05926271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745001|NCT05926271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816298|NCT00793546|Exemestane|exemestane|mesh-list
138745002|NCT05926245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138745003|NCT05926206|Folfirinox|folfirinox|mesh-list
138745004|NCT05926206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745005|NCT05926128|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138745006|NCT05926128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138745007|NCT05926128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745008|NCT05926128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745009|NCT05924152|Adagrasib|adagrasib|mesh-list
138745010|NCT05924152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745011|NCT05922176|Immunomodulating Agents|immunomodulating agents|mesh-list
138745012|NCT05922176|Immunologic Factors|immunologic factors|mesh-list
138745013|NCT05922176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745014|NCT05876182|Vancomycin|vancomycin|mesh-list
138745015|NCT05876182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138745016|NCT05876182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745017|NCT05736341|Midazolam|midazolam|mesh-list
138745018|NCT05736341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138663405|NCT05850546|Prednisone|prednisone|mesh-list
139080707|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080708|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139080709|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
139080710|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745019|NCT05736341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138745020|NCT05736341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138745021|NCT05736341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745022|NCT05736341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138745023|NCT05736341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138745024|NCT05736341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138745025|NCT05736341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138745026|NCT05736341|Anesthetics, General|anesthetics, general|mesh-ancestor
138745028|NCT05736341|GABA Modulators|gaba modulators|mesh-ancestor
138745030|NCT05736341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138745031|NCT05736341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745032|NCT05690984|Dexamethasone|dexamethasone|mesh-list
138745033|NCT05690984|Lenalidomide|lenalidomide|mesh-list
138745034|NCT05690984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138745035|NCT05690984|Antiemetics|antiemetics|mesh-ancestor
138745036|NCT05690984|Autonomic Agents|autonomic agents|mesh-ancestor
138745037|NCT05690984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745038|NCT05690984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745039|NCT05690984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138745040|NCT05690984|Glucocorticoids|glucocorticoids|mesh-ancestor
138745041|NCT05690984|Hormones|hormones|mesh-ancestor
138745042|NCT05690984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139080711|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139080712|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139080713|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139080714|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139080715|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
139080716|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139080717|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139080718|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138816465|NCT00915616|Protective Agents|protective agents|mesh-ancestor
139080719|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138831297|NCT05039736|Nivolumab|nivolumab|mesh-list
139080720|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139080721|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
139080722|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
139080723|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080724|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139080725|NCT00398567|Trastuzumab|trastuzumab|mesh-list
139080726|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139080727|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080728|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139080729|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139080730|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139080731|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139080732|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080733|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139080734|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139080735|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139080736|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139080737|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
138745048|NCT05690984|Growth Substances|growth substances|mesh-ancestor
138745049|NCT05690984|Growth Inhibitors|growth inhibitors|mesh-ancestor
138745050|NCT05688332|Metformin|metformin|mesh-list
138745051|NCT05688332|Glyburide|glyburide|mesh-list
138745052|NCT05688332|Voglibose|voglibose|mesh-list
138745053|NCT05688332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138745054|NCT05688332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745055|NCT05688332|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138745056|NCT05688332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745057|NCT05688332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745058|NCT05642962|Pancrelipase|pancrelipase|mesh-list
138745059|NCT05642962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138745060|NCT05597735|Tecovirimat|tecovirimat|mesh-list
138745061|NCT05597735|Antiviral Agents|antiviral agents|mesh-ancestor
138745062|NCT05597735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745063|NCT05488431|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138745064|NCT05488431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138745065|NCT05488431|Antimetabolites|antimetabolites|mesh-ancestor
138745066|NCT05488431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745067|NCT05488431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138745068|NCT05488431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745069|NCT05488431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138745070|NCT05488431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745076|NCT05382208|Doxycycline|doxycycline|mesh-list
138745077|NCT05382208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138745086|NCT05354453|Protective Agents|protective agents|mesh-ancestor
138745087|NCT05354453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745088|NCT05354453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745094|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
138745095|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
138745096|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138745097|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745098|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
138745099|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745100|NCT05038982|Abrocitinib|abrocitinib|mesh-list
138745101|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138745102|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745103|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745104|NCT04983966|Desflurane|desflurane|mesh-list
138745105|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138745106|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
138745107|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
138745108|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138745109|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745110|NCT04972942|Daratumumab|daratumumab|mesh-list
138745111|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745112|NCT04953897|Decitabine|decitabine|mesh-list
138745113|NCT04953897|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138745119|NCT04917406|Dexamethasone|dexamethasone|mesh-list
138745127|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
138745128|NCT04917406|Hormones|hormones|mesh-ancestor
138745129|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138745130|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138745131|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745132|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
138745133|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
138745134|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138745135|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
138745136|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138745137|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138745138|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138745139|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138745140|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745141|NCT04867785|Dulaglutide|dulaglutide|mesh-list
138745142|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138745143|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745145|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138745146|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745147|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138550619|NCT00104598|Bupropion|bupropion|mesh-list
138745148|NCT04706507|Ganciclovir|ganciclovir|mesh-list
138745149|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138745150|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
138745151|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745152|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138745174|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138745175|NCT04466917|Growth Substances|growth substances|mesh-ancestor
138745176|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745177|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
138745178|NCT04462471|Vemurafenib|vemurafenib|mesh-list
138745179|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745180|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138745181|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745182|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745183|NCT04370483|Leflunomide|leflunomide|mesh-list
138745184|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745185|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745186|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138745187|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
138745188|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745189|NCT04283656|Tenofovir|tenofovir|mesh-list
138745190|NCT04283656|Lamivudine|lamivudine|mesh-list
138745191|NCT04283656|Spironolactone|spironolactone|mesh-list
138745192|NCT04283656|Estradiol|estradiol|mesh-list
138745193|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
138745194|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745195|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138745196|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138745197|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745198|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745199|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138745200|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138745201|NCT04283656|Estrogens|estrogens|mesh-ancestor
138745202|NCT04283656|Hormones|hormones|mesh-ancestor
138745221|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745223|NCT04063267|Nicotine|nicotine|mesh-list
138745224|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138745225|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
138745226|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745227|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745228|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138745229|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138745230|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
138745231|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138745232|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745233|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-list
138745234|NCT04047914|Mupirocin|mupirocin|mesh-list
138745235|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138745236|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138745237|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745238|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745239|NCT04042753|Nivolumab|nivolumab|mesh-list
138745240|NCT04042753|Ipilimumab|ipilimumab|mesh-list
138745241|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745242|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745243|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138745244|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745245|NCT03995355|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138745246|NCT03995355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138745247|NCT03942211|Selexipag|selexipag|mesh-list
138745248|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138745249|NCT03933397|Morphine|morphine|mesh-list
138745250|NCT03933397|Hydromorphone|hydromorphone|mesh-list
138745251|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138745252|NCT03933397|Narcotics|narcotics|mesh-ancestor
139080738|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080739|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080740|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139080741|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139080742|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
139080743|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139080744|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139080745|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
139080746|NCT05842174|Hydroxychloroquine|hydroxychloroquine|mesh-list
139080747|NCT05842174|Ethiodized Oil|ethiodized oil|mesh-list
139080748|NCT05842174|Antimalarials|antimalarials|mesh-ancestor
139080749|NCT05842174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139080750|NCT05842174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138745253|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138745254|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745255|NCT03933397|Analgesics|analgesics|mesh-ancestor
138745256|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
138745257|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745258|NCT03925090|Cisplatin|cisplatin|mesh-list
138745259|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745260|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138745261|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745262|NCT03829436|Nivolumab|nivolumab|mesh-list
138745263|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745264|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745265|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138745266|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745267|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138745268|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745269|NCT03790488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745270|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745271|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138745272|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138745273|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138745274|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
138745275|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745276|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138745277|NCT03576690|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
138745278|NCT03576690|Atoltivimab|atoltivimab|mesh-list
138745279|NCT03576690|Odesivimab|odesivimab|mesh-list
138745280|NCT03576690|Maftivimab|maftivimab|mesh-list
138745299|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138745300|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745301|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745302|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138745303|NCT03532880|Olaparib|olaparib|mesh-list
138745304|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138745305|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745306|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745307|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745308|NCT03420508|Ensartinib|ensartinib|mesh-list
138745309|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745310|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138745311|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745312|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745313|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
138745314|NCT03410875|Vemurafenib|vemurafenib|mesh-list
138745315|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745316|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745317|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138745318|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745319|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745320|NCT03207945|Alirocumab|alirocumab|mesh-list
138745321|NCT03207945|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138745322|NCT03207945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138745323|NCT03207945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138745324|NCT03207945|Antimetabolites|antimetabolites|mesh-ancestor
138745325|NCT03207945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080751|NCT05842174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080752|NCT05842174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080753|NCT05842174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080754|NCT05842174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139080755|NCT05842174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080756|NCT05841992|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139080757|NCT05841992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139080758|NCT05841992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080759|NCT05841849|Aprepitant|aprepitant|mesh-list
139080760|NCT05841849|Fosaprepitant|fosaprepitant|mesh-list
139080761|NCT05841849|Palonosetron|palonosetron|mesh-list
139080762|NCT05841849|Antiemetics|antiemetics|mesh-ancestor
139080763|NCT05841849|Autonomic Agents|autonomic agents|mesh-ancestor
139080764|NCT05841849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080765|NCT05841849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080766|NCT05841849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139080767|NCT05841849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139080768|NCT05841849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080769|NCT05841849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745326|NCT03207945|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138745328|NCT03207945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745329|NCT03207945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138745330|NCT03134703|Morphine|morphine|mesh-list
138745331|NCT03134703|Methadone|methadone|mesh-list
138745332|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138745333|NCT03134703|Narcotics|narcotics|mesh-ancestor
138745334|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138745335|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745336|NCT03134703|Analgesics|analgesics|mesh-ancestor
138745337|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
138745338|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745339|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
138745340|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
138745341|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
138745342|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138745343|NCT03118674|Ledipasvir|ledipasvir|mesh-list
138745344|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
138745345|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745346|NCT03085056|Paclitaxel|paclitaxel|mesh-list
138745347|NCT03085056|Trametinib|trametinib|mesh-list
138745348|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138745349|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745350|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
138745351|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
138745352|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
138745353|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745354|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138745355|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745374|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138745375|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138745376|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745377|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138745378|NCT03036488|Paclitaxel|paclitaxel|mesh-list
138745379|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
138745380|NCT03036488|Carboplatin|carboplatin|mesh-list
138745381|NCT03036488|Doxorubicin|doxorubicin|mesh-list
138745382|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
138745383|NCT03036488|Epirubicin|epirubicin|mesh-list
138745384|NCT03036488|Lenograstim|lenograstim|mesh-list
138745385|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138745386|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745387|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
138745388|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
138745389|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
138745390|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745391|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138745392|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
138745393|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745394|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138745395|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138745396|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
138745397|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138745405|NCT02993523|Azacitidine|azacitidine|mesh-list
138745428|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745429|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138745430|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138745431|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745432|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745433|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
138745434|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
138745435|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138745436|NCT02795429|Spartalizumab|spartalizumab|mesh-list
138745437|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138745438|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745439|NCT02795429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745440|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745441|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
138745442|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138745443|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
138745444|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745445|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138745446|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138745447|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
138745448|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745449|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745450|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138745451|NCT02783625|Bortezomib|bortezomib|mesh-list
138745452|NCT02783625|Romidepsin|romidepsin|mesh-list
138745453|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663795|NCT05582434|Adapalene|adapalene|mesh-list
139080770|NCT05841849|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139080771|NCT05841849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139080772|NCT05841849|Serotonin Agents|serotonin agents|mesh-ancestor
139080773|NCT05841771|Azacitidine|azacitidine|mesh-list
139080774|NCT05841771|Decitabine|decitabine|mesh-list
139080775|NCT05841771|Venetoclax|venetoclax|mesh-list
139080776|NCT05841771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139080777|NCT05841771|Antimetabolites|antimetabolites|mesh-ancestor
139080778|NCT05841771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080779|NCT05841771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080780|NCT05841771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080781|NCT05841758|Hydroxychloroquine|hydroxychloroquine|mesh-list
139080782|NCT05841758|Antimalarials|antimalarials|mesh-ancestor
139080783|NCT05841758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139080784|NCT05841758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139080785|NCT05841758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080786|NCT05841758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274604|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080787|NCT05841758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080788|NCT05841758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139080789|NCT05841654|Antihypertensive Agents|antihypertensive agents|mesh-list
138745454|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138745455|NCT02783625|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138745456|NCT02783625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745457|NCT02783625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745459|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745460|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745461|NCT02632344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138745462|NCT02632344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745463|NCT02605486|Palbociclib|palbociclib|mesh-list
138745464|NCT02605486|Bicalutamide|bicalutamide|mesh-list
138745465|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745466|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138745467|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745468|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745469|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
138745470|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
138745471|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138745472|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745473|NCT02538198|Lenalidomide|lenalidomide|mesh-list
139080790|NCT05841654|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139080791|NCT05841654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139080792|NCT05841654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139080793|NCT05841654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080794|NCT05841641|Hemostatics|hemostatics|mesh-list
139080795|NCT05841641|Coagulants|coagulants|mesh-ancestor
139080796|NCT05841589|Chlorhexidine|chlorhexidine|mesh-list
139080797|NCT05841589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139080798|NCT05841589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080799|NCT05841589|Disinfectants|disinfectants|mesh-ancestor
139080800|NCT05841446|Apixaban|apixaban|mesh-list
139080801|NCT05841446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139080802|NCT05841446|Antithrombins|antithrombins|mesh-ancestor
139080803|NCT05841446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139080804|NCT05841446|Protease Inhibitors|protease inhibitors|mesh-ancestor
139080805|NCT05841446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080806|NCT05841446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080807|NCT05841446|Anticoagulants|anticoagulants|mesh-ancestor
139080808|NCT05841394|Esomeprazole|esomeprazole|mesh-list
139080809|NCT05841394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139080810|NCT05841394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139080811|NCT05841394|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139080812|NCT05841394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080813|NCT05841394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080814|NCT05841381|Paclitaxel|paclitaxel|mesh-list
139080815|NCT05841381|Trastuzumab|trastuzumab|mesh-list
139080816|NCT05841381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139080817|NCT05841381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080818|NCT05841381|Tubulin Modulators|tubulin modulators|mesh-ancestor
139080819|NCT05841381|Antimitotic Agents|antimitotic agents|mesh-ancestor
139080820|NCT05841381|Mitosis Modulators|mitosis modulators|mesh-ancestor
139080821|NCT05841381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745474|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
138745475|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745476|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138745477|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138745478|NCT02538198|Growth Substances|growth substances|mesh-ancestor
138745479|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
138745480|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745481|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138745482|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745483|NCT02341144|Ropivacaine|ropivacaine|mesh-list
138745484|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
138745485|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
138745486|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138745487|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745488|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
138745489|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745490|NCT02213328|Tenofovir|tenofovir|mesh-list
138745491|NCT02213328|Emtricitabine|emtricitabine|mesh-list
138745492|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138745493|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
138745494|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745495|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138745496|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138745497|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745498|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745499|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138745500|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138745501|NCT02204241|Dexamethasone|dexamethasone|mesh-list
138745502|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
138663894|NCT05550532|Aticaprant|aticaprant|mesh-list
139080822|NCT05841381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139080823|NCT05841303|Ascorbic Acid|ascorbic acid|mesh-list
139080824|NCT05841303|Antioxidants|antioxidants|mesh-ancestor
139080825|NCT05841303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817239|NCT00775138|Amikacin|amikacin|mesh-list
139080826|NCT05841303|Protective Agents|protective agents|mesh-ancestor
139080827|NCT05841303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080828|NCT05841303|Vitamins|vitamins|mesh-ancestor
139080829|NCT05841303|Micronutrients|micronutrients|mesh-ancestor
139080830|NCT05841251|Phenylephrine|phenylephrine|mesh-list
139080831|NCT05841251|Oxymetazoline|oxymetazoline|mesh-list
139080832|NCT05841251|Tranexamic Acid|tranexamic acid|mesh-list
139080833|NCT05841251|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139080834|NCT05841251|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139080835|NCT05841251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080836|NCT05841251|Hemostatics|hemostatics|mesh-ancestor
139080837|NCT05841251|Coagulants|coagulants|mesh-ancestor
138745503|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138745504|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
138745505|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745506|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138745507|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138745508|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
138745509|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745510|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745511|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138745512|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138745513|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
138745514|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
138745515|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745516|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138745517|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
138745518|NCT02204241|Hormones|hormones|mesh-ancestor
138745519|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138745520|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138745521|NCT02185820|Dexamethasone|dexamethasone|mesh-list
138745522|NCT02185820|Pomalidomide|pomalidomide|mesh-list
138745523|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138745524|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
138745525|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
138745526|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745527|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745528|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138745529|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
138745530|NCT02185820|Hormones|hormones|mesh-ancestor
138745539|NCT02150967|Infigratinib|infigratinib|mesh-list
138745550|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
138745551|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745552|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138745553|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
138745554|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745555|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138745556|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138745557|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138745558|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745559|NCT02004782|Prednisolone|prednisolone|mesh-list
138745560|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138745561|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
138745562|NCT02004782|Hormones|hormones|mesh-ancestor
138745563|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138745564|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745565|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138745566|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745567|NCT01908777|Cytarabine|cytarabine|mesh-list
138745568|NCT01908777|Etoposide|etoposide|mesh-list
138745569|NCT01908777|Melphalan|melphalan|mesh-list
138745570|NCT01908777|Carmustine|carmustine|mesh-list
138745571|NCT01908777|Romidepsin|romidepsin|mesh-list
138745572|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138745573|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745574|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138745575|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138745576|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745577|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745578|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138745579|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
138745580|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
138745581|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745582|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138745583|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
138745584|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745585|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138745591|NCT01873326|Etoposide|etoposide|mesh-list
138745592|NCT01873326|Ifosfamide|ifosfamide|mesh-list
138745593|NCT01873326|Bleomycin|bleomycin|mesh-list
138745594|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138745595|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745596|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
138745597|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
138745598|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
138745599|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745600|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138745601|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138745602|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745603|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138745604|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
138745605|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138745606|NCT01862315|Dexamethasone|dexamethasone|mesh-list
138745607|NCT01862315|Gemcitabine|gemcitabine|mesh-list
138745608|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
138745609|NCT01862315|Floxuridine|floxuridine|mesh-list
138745610|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138745611|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
138745612|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
138745613|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745614|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745615|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138745616|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
138745617|NCT01862315|Hormones|hormones|mesh-ancestor
138745618|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138745619|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139080838|NCT05841251|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139080839|NCT05841251|Mydriatics|mydriatics|mesh-ancestor
139080840|NCT05841251|Autonomic Agents|autonomic agents|mesh-ancestor
139080841|NCT05841251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080842|NCT05841251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080843|NCT05841251|Sympathomimetics|sympathomimetics|mesh-ancestor
139080844|NCT05841251|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139080845|NCT05841251|Nasal Decongestants|nasal decongestants|mesh-ancestor
139080846|NCT05841251|Respiratory System Agents|respiratory system agents|mesh-ancestor
139080847|NCT05841251|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139080848|NCT05841251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139080849|NCT05841251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139080850|NCT05841251|Adrenergic Agents|adrenergic agents|mesh-ancestor
139080851|NCT05841251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080852|NCT05841251|Protective Agents|protective agents|mesh-ancestor
139080853|NCT05841147|Tirofiban|tirofiban|mesh-list
139080854|NCT05841147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139080855|NCT05841147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138745620|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745621|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138745622|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
138745623|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745625|NCT01745588|Dexamethasone|dexamethasone|mesh-list
138745626|NCT01745588|Pomalidomide|pomalidomide|mesh-list
138745627|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138745628|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
138745629|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
138745630|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745631|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745632|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138745633|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
138745634|NCT01745588|Hormones|hormones|mesh-ancestor
138745635|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138817557|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138745636|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138745637|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745638|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138745639|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745640|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138745641|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745642|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745643|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138745644|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138745645|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
138745646|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138745647|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138745648|NCT01745588|Growth Substances|growth substances|mesh-ancestor
138664060|NCT05444530|Ipilimumab|ipilimumab|mesh-list
139080856|NCT05841147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080857|NCT05841147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139080858|NCT05841121|Dexamethasone|dexamethasone|mesh-list
139080859|NCT05841121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139080861|NCT05841121|Autonomic Agents|autonomic agents|mesh-ancestor
139080862|NCT05841121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080863|NCT05841121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080864|NCT05841121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139080865|NCT05841121|Glucocorticoids|glucocorticoids|mesh-ancestor
139080866|NCT05841121|Hormones|hormones|mesh-ancestor
139080867|NCT05841121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139080868|NCT05841121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139080869|NCT05841121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745649|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
138745650|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
138745651|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
138745652|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745653|NCT00996866|Vitamin D|vitamin d|mesh-list
138745654|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
138745655|NCT00996866|Vitamins|vitamins|mesh-ancestor
138745656|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
138745657|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745658|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138745659|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138745660|NCT00876993|Bevacizumab|bevacizumab|mesh-list
138745661|NCT00876993|Irinotecan|irinotecan|mesh-list
138745662|NCT00876993|Temozolomide|temozolomide|mesh-list
138745663|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745664|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745665|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138745666|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138745668|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745669|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
138745670|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138745671|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138745672|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817658|NCT00583219|Protective Agents|protective agents|mesh-ancestor
138745673|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745674|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138745675|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
138745676|NCT00700882|Dasatinib|dasatinib|mesh-list
138745677|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745678|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138745679|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745680|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745681|NCT00673309|Insulin|insulin|mesh-list
138745682|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138745683|NCT00673309|Itraconazole|itraconazole|mesh-list
138745691|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745692|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
138745693|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745694|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138745695|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138745696|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745697|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138745698|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
138745699|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138745700|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138745701|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138745702|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
138745703|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138745704|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138745705|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138745706|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
138745707|NCT00673309|Androgens|androgens|mesh-ancestor
138745708|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
138745709|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
138745710|NCT00666835|Hematinics|hematinics|mesh-ancestor
138745711|NCT00551759|Docetaxel|docetaxel|mesh-list
138745712|NCT00551759|Fluorouracil|fluorouracil|mesh-list
138745713|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
138745714|NCT00551759|Cetuximab|cetuximab|mesh-list
138745715|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745716|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
138745717|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
138745718|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
138745719|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745720|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
138745721|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139080870|NCT05841043|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139080871|NCT05841043|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139080872|NCT05840913|Epinephrine|epinephrine|mesh-list
139080873|NCT05840913|Carticaine|carticaine|mesh-list
139080874|NCT05840913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139080875|NCT05840913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139080876|NCT05840913|Adrenergic Agents|adrenergic agents|mesh-ancestor
139080877|NCT05840913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080878|NCT05840913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080879|NCT05840913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080880|NCT05840913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139080881|NCT05840913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139080882|NCT05840913|Autonomic Agents|autonomic agents|mesh-ancestor
139080883|NCT05840913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080884|NCT05840913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138745722|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138745723|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
138745724|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745725|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745726|NCT00335140|Leucovorin|leucovorin|mesh-list
138745727|NCT00335140|Cytarabine|cytarabine|mesh-list
138745728|NCT00335140|Dexamethasone|dexamethasone|mesh-list
138745729|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
138745730|NCT00335140|Rituximab|rituximab|mesh-list
138745731|NCT00335140|Methotrexate|methotrexate|mesh-list
138745732|NCT00335140|Vincristine|vincristine|mesh-list
138745733|NCT00335140|Procarbazine|procarbazine|mesh-list
138745734|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138745735|NCT00335140|BB 1101|bb 1101|mesh-list
138745736|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
138745737|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138702067|NCT02901288|Isoniazid|isoniazid|mesh-list
138745738|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
138745739|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
138745740|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745741|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745742|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138745743|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
138745744|NCT00335140|Hormones|hormones|mesh-ancestor
138745745|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138745746|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138745747|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745748|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
138745749|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745750|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745751|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745752|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
138664173|NCT05252533|Ustekinumab|ustekinumab|mesh-list
139080885|NCT05840913|Respiratory System Agents|respiratory system agents|mesh-ancestor
139080886|NCT05840913|Mydriatics|mydriatics|mesh-ancestor
139080887|NCT05840913|Sympathomimetics|sympathomimetics|mesh-ancestor
139080888|NCT05840913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139080889|NCT05840913|Anesthetics, Local|anesthetics, local|mesh-ancestor
139080890|NCT05840913|Anesthetics|anesthetics|mesh-ancestor
139080891|NCT05840913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139080892|NCT05840913|Sensory System Agents|sensory system agents|mesh-ancestor
139080893|NCT05840822|Cannabidiol|cannabidiol|mesh-list
139080894|NCT05840822|Anticonvulsants|anticonvulsants|mesh-ancestor
139080895|NCT05840796|Caseins|caseins|mesh-list
139080896|NCT05840796|Chelating Agents|chelating agents|mesh-ancestor
139080897|NCT05840796|Sequestering Agents|sequestering agents|mesh-ancestor
139080898|NCT05840796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745753|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138745754|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138745755|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
138745756|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138745757|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138745758|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
138745759|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
138745760|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138745761|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138745762|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138745763|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
138745764|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745765|NCT00335140|Antidotes|antidotes|mesh-ancestor
138817904|NCT01071083|Natalizumab|natalizumab|mesh-list
138745766|NCT00335140|Protective Agents|protective agents|mesh-ancestor
138745767|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
138745768|NCT00335140|Vitamins|vitamins|mesh-ancestor
138745769|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
138745770|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138745771|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
138745772|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
138745773|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
138745774|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138745775|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138745776|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
138745777|NCT00101283|Carboplatin|carboplatin|mesh-list
138745778|NCT00101283|Gemcitabine|gemcitabine|mesh-list
138745779|NCT00101283|Pemetrexed|pemetrexed|mesh-list
138745780|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745781|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138745782|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
138745800|NCT05643677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745801|NCT05643677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745802|NCT05643677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745803|NCT02890589|Chromium|chromium|mesh-list
138745804|NCT02890589|Everolimus|everolimus|mesh-list
138745805|NCT02890589|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138745806|NCT02890589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138745807|NCT02890589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745808|NCT02890589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745809|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138745810|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
138745811|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745812|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745813|NCT02890589|Trace Elements|trace elements|mesh-ancestor
138745814|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
138745815|NCT01301027|Pioglitazone|pioglitazone|mesh-list
138745816|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138745817|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745818|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138745819|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138745820|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138745821|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138745822|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745823|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138745824|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818011|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
138745825|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138745826|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
138745828|NCT05641883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138745829|NCT02886897|Antibodies|antibodies|mesh-list
138745830|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
138745831|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745832|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138745833|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
138745834|NCT01184859|Coagulants|coagulants|mesh-ancestor
138745841|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
138745842|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
138745843|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
138745844|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745845|NCT01184079|Vaccines|vaccines|mesh-list
138745846|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
138745847|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745848|NCT05333289|Vaccines|vaccines|mesh-list
138745849|NCT05333289|Immunologic Factors|immunologic factors|mesh-ancestor
138745850|NCT05333289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745851|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138745852|NCT01289990|Empagliflozin|empagliflozin|mesh-list
138745853|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138745854|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745855|NCT01289990|Incretins|incretins|mesh-ancestor
138745856|NCT01289990|Hormones|hormones|mesh-ancestor
138745857|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138745858|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138745859|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
138745860|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745861|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745862|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138745863|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
138745864|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138745865|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138745866|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
138745867|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745868|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138745869|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138745870|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138745884|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138745885|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
138745886|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745887|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745888|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138702240|NCT00449657|Paclitaxel|paclitaxel|mesh-list
138745889|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745890|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
138745891|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138745892|NCT02890277|Chitosan|chitosan|mesh-list
138745893|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138745894|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138745895|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
138745896|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745897|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138745898|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
138745899|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
138745900|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
138745901|NCT02890277|Coagulants|coagulants|mesh-ancestor
138745902|NCT01289678|Interleukin-2|interleukin-2|mesh-list
138745903|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745905|NCT01289678|Analgesics|analgesics|mesh-ancestor
138745906|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
138745907|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745908|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745909|NCT01183221|Oxytocin|oxytocin|mesh-list
138745910|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
138745911|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138745912|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745913|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138745914|NCT01183143|Hormones|hormones|mesh-ancestor
138745915|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138745916|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745917|NCT01183065|Folic Acid|folic acid|mesh-list
139080899|NCT05840068|Metformin|metformin|mesh-list
139080900|NCT05840068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139080901|NCT05840068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080902|NCT05782816|Oxytocin|oxytocin|mesh-list
139080903|NCT05782816|Oxytocics|oxytocics|mesh-ancestor
139080904|NCT05782816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138274717|NCT00003279|Antibodies|antibodies|mesh-list
139080905|NCT05782816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080907|NCT05768932|Carboplatin|carboplatin|mesh-list
138745918|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
138745919|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
138745920|NCT01183065|Vitamins|vitamins|mesh-ancestor
138745921|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
138745922|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745923|NCT01183065|Hematinics|hematinics|mesh-ancestor
138745924|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
138745925|NCT01182441|Warfarin|warfarin|mesh-list
138745926|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
138745927|NCT01182285|Valproic Acid|valproic acid|mesh-list
138745928|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
138745929|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745930|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745931|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
138745932|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138745933|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745934|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
139080908|NCT05768932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139080909|NCT05768932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080910|NCT05768932|Tubulin Modulators|tubulin modulators|mesh-ancestor
139080911|NCT05768932|Antimitotic Agents|antimitotic agents|mesh-ancestor
139080912|NCT05768932|Mitosis Modulators|mitosis modulators|mesh-ancestor
139080913|NCT05768932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080914|NCT05726318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139080915|NCT05726318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080916|NCT05637398|Colchicine|colchicine|mesh-list
139080917|NCT05637398|Gout Suppressants|gout suppressants|mesh-ancestor
139080918|NCT05637398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139080919|NCT05637398|Tubulin Modulators|tubulin modulators|mesh-ancestor
139080920|NCT05637398|Antimitotic Agents|antimitotic agents|mesh-ancestor
139080921|NCT05637398|Mitosis Modulators|mitosis modulators|mesh-ancestor
139080922|NCT05637398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080923|NCT05637398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080924|NCT05604729|Botulinum Toxins|botulinum toxins|mesh-list
139080925|NCT05604729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139080926|NCT05604729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139080927|NCT05604729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139080928|NCT05604729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139080929|NCT05604729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080930|NCT05604729|Cholinergic Agents|cholinergic agents|mesh-ancestor
139080931|NCT05604729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080932|NCT05604729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080933|NCT05604729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139080934|NCT05604729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080935|NCT05583071|Rituximab|rituximab|mesh-list
139080936|NCT05583071|Methotrexate|methotrexate|mesh-list
139080937|NCT05583071|Lenalidomide|lenalidomide|mesh-list
139080938|NCT05583071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139080939|NCT05583071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139080940|NCT05583071|Immunologic Factors|immunologic factors|mesh-ancestor
139080941|NCT05583071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080942|NCT05583071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139080943|NCT05583071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139080944|NCT05583071|Abortifacient Agents|abortifacient agents|mesh-ancestor
139080945|NCT05583071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139080946|NCT05583071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139080947|NCT05583071|Antimetabolites|antimetabolites|mesh-ancestor
139080948|NCT05583071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818332|NCT05322603|Narcotics|narcotics|mesh-ancestor
139080949|NCT05583071|Dermatologic Agents|dermatologic agents|mesh-ancestor
139080950|NCT05583071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080951|NCT05583071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138745936|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138745937|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138745938|NCT04315935|Fentanyl|fentanyl|mesh-list
138745939|NCT04315935|Butorphanol|butorphanol|mesh-list
138745940|NCT04315935|Propofol|propofol|mesh-list
138745941|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138745942|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138745943|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745944|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138745945|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
138745946|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
138745947|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138745948|NCT04315935|Narcotics|narcotics|mesh-ancestor
138745949|NCT04315935|Analgesics|analgesics|mesh-ancestor
138745950|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
138745951|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745952|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138745953|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
138745954|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
138745955|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138745956|NCT01182207|Drospirenone|drospirenone|mesh-list
138745957|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138745958|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138745959|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138745960|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138745961|NCT01182207|Estradiol|estradiol|mesh-list
138745962|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138745963|NCT01182207|Estrogens|estrogens|mesh-ancestor
138745964|NCT01182207|Hormones|hormones|mesh-ancestor
138745965|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138745966|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745967|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138745968|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
138745969|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138664410|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080952|NCT05583071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139080953|NCT05583071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139080954|NCT05583071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139080955|NCT05583071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139080956|NCT05583071|Growth Substances|growth substances|mesh-ancestor
138745970|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138745971|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138745973|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138745974|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
138745975|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138745976|NCT01182207|Diuretics|diuretics|mesh-ancestor
138745978|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138745979|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138745980|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
138745981|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745982|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745983|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138745984|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
138745985|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138745986|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138745987|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138745988|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
138745989|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138745990|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745991|NCT01181271|Sirolimus|sirolimus|mesh-list
138745992|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
138745993|NCT01181271|Busulfan|busulfan|mesh-list
139080957|NCT05583071|Growth Inhibitors|growth inhibitors|mesh-ancestor
139080959|NCT05417113|Anesthetics, Local|anesthetics, local|mesh-ancestor
139080960|NCT05417113|Anesthetics|anesthetics|mesh-ancestor
139080961|NCT05417113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139080962|NCT05417113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080963|NCT05417113|Sensory System Agents|sensory system agents|mesh-ancestor
139080964|NCT05417113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080965|NCT05394298|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139080966|NCT05394298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139080967|NCT05394298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080968|NCT05394298|Antitubercular Agents|antitubercular agents|mesh-ancestor
139080969|NCT05390359|Oxymetazoline|oxymetazoline|mesh-list
139080970|NCT05390359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139080971|NCT05390359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139080972|NCT05390359|Adrenergic Agents|adrenergic agents|mesh-ancestor
139080973|NCT05390359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080974|NCT05390359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080975|NCT05390359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080976|NCT05390359|Sympathomimetics|sympathomimetics|mesh-ancestor
139080977|NCT05390359|Autonomic Agents|autonomic agents|mesh-ancestor
139080978|NCT05390359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080979|NCT05390359|Nasal Decongestants|nasal decongestants|mesh-ancestor
139080980|NCT05390359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139080981|NCT05390359|Respiratory System Agents|respiratory system agents|mesh-ancestor
139080982|NCT05330078|Botulinum Toxins|botulinum toxins|mesh-list
139080983|NCT05330078|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139080984|NCT05330078|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139080985|NCT05330078|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139080986|NCT05330078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138745994|NCT01181271|Methotrexate|methotrexate|mesh-list
138745995|NCT01181271|Fludarabine|fludarabine|mesh-list
138745996|NCT01181271|Etoposide|etoposide|mesh-list
138745997|NCT01181271|Tacrolimus|tacrolimus|mesh-list
138745998|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138745999|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
138746000|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746001|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138746002|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138746003|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
138746004|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746005|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746006|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138746007|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138746008|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
138746009|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138746010|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138746011|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
138746012|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
138746013|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746014|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138746015|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138746016|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138746017|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138746018|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138746019|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138746020|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138746021|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138746022|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138746023|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
138746024|NCT00624741|Pergolide|pergolide|mesh-list
138818612|NCT06182592|Cytarabine|cytarabine|mesh-list
138746025|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
138746026|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
138746027|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746028|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746029|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746030|NCT01180647|Naltrexone|naltrexone|mesh-list
139080987|NCT05330078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746031|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138746032|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138746033|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746034|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
138746035|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746037|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138746038|NCT01178853|Pitavastatin|pitavastatin|mesh-list
138746039|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138746040|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138746041|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
138702369|NCT00450164|Diuretics|diuretics|mesh-ancestor
138746042|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746043|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138746044|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138746045|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746046|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
138746047|NCT04286035|Bupivacaine|bupivacaine|mesh-list
138746048|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
138746049|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
138818693|NCT06154447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818694|NCT06154447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818695|NCT06154447|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138818696|NCT06154447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138468832|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
138818697|NCT06154447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138818698|NCT06154447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138818699|NCT06154447|Anesthetics, General|anesthetics, general|mesh-ancestor
138818700|NCT06154447|Anesthetics|anesthetics|mesh-ancestor
138818701|NCT06154447|GABA Modulators|gaba modulators|mesh-ancestor
138818702|NCT06154447|GABA Agents|gaba agents|mesh-ancestor
138818703|NCT06154447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818719|NCT06149507|Ibuprofen|ibuprofen|mesh-list
138746050|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746051|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746052|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
138746053|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746054|NCT00629473|Dexamethasone|dexamethasone|mesh-list
138746055|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
138746056|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138746057|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
138746058|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
138664553|NCT04923893|Dexamethasone|dexamethasone|mesh-list
139080988|NCT05330078|Cholinergic Agents|cholinergic agents|mesh-ancestor
139080989|NCT05330078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274786|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139080990|NCT05330078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080991|NCT05330078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139080992|NCT05330078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080993|NCT05309564|Botulinum Toxins|botulinum toxins|mesh-list
139080994|NCT05309564|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139080995|NCT05309564|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139080996|NCT05309564|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138468854|NCT01976078|Midazolam|midazolam|mesh-list
139080997|NCT05309564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139080998|NCT05309564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080999|NCT05309564|Cholinergic Agents|cholinergic agents|mesh-ancestor
139081000|NCT05309564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081001|NCT05309564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081002|NCT05309564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139081003|NCT05309564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746059|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746060|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746061|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138746063|NCT00629473|Hormones|hormones|mesh-ancestor
138746064|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138746065|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138818812|NCT05930171|Antipyretics|antipyretics|mesh-ancestor
138746066|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746067|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
138746068|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746069|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746070|NCT04286503|Ritonavir|ritonavir|mesh-list
138746071|NCT04286503|Lopinavir|lopinavir|mesh-list
138746072|NCT04286503|Chloroquine|chloroquine|mesh-list
138746073|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138746074|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138746075|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138746076|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
138746077|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746078|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746079|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138746080|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138746081|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
138746082|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138746083|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138746084|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138746085|NCT04286503|Amebicides|amebicides|mesh-ancestor
138746086|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138746087|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138746088|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
138746089|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138746090|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138818895|NCT05718882|Lenvatinib|lenvatinib|mesh-list
138746091|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138746092|NCT04286503|Analgesics|analgesics|mesh-ancestor
138746093|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
138746094|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746095|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081005|NCT05249569|Bavituximab|bavituximab|mesh-list
138746096|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138746097|NCT04286503|Filaricides|filaricides|mesh-ancestor
138746098|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
138746099|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
138746100|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
138746101|NCT00968617|Hematinics|hematinics|mesh-ancestor
138746102|NCT00968539|Vaccines|vaccines|mesh-list
138746103|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
138746104|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746105|NCT00976573|Paclitaxel|paclitaxel|mesh-list
138746106|NCT00976573|Bevacizumab|bevacizumab|mesh-list
138746107|NCT00976573|Carboplatin|carboplatin|mesh-list
138746108|NCT00976573|Everolimus|everolimus|mesh-list
138746109|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138746110|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746111|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
138746112|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
138746113|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
138746114|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746115|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138746116|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138276051|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
138746117|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138746118|NCT00976573|Growth Substances|growth substances|mesh-ancestor
138702452|NCT00450827|Antibodies|antibodies|mesh-list
139081006|NCT05249569|Axitinib|axitinib|mesh-list
139081007|NCT05249569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139081008|NCT05249569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081009|NCT05249569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139081010|NCT05249569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081011|NCT05249569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081012|NCT05212662|Cysteamine|cysteamine|mesh-list
139081013|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
139081014|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081015|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
139081016|NCT05182073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139081017|NCT05182073|Fludarabine|fludarabine|mesh-list
139081018|NCT05182073|Daratumumab|daratumumab|mesh-list
139081019|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139081020|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138831586|NCT03158688|Hormones|hormones|mesh-ancestor
139081021|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
139081022|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081023|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138818968|NCT05545280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138818969|NCT05545280|Autonomic Agents|autonomic agents|mesh-ancestor
138818970|NCT05545280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818971|NCT05545280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138818972|NCT05545280|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138818973|NCT05545280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138818975|NCT05526157|Glucagon|glucagon|mesh-list
139081024|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139081025|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
139081026|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081027|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081028|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139081029|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139081030|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081031|NCT05096663|Vitamins|vitamins|mesh-list
139081032|NCT05096663|Folic Acid|folic acid|mesh-list
139081033|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
138819025|NCT05262400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138746119|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746120|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
138746121|NCT00976573|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138746122|NCT00976573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138746123|NCT00976573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746124|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138746125|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
138746126|NCT00629863|Fluorouracil|fluorouracil|mesh-list
138746127|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746128|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
138746129|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746130|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138746131|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138746132|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
138746133|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746134|NCT02865733|Treprostinil|treprostinil|mesh-list
138746135|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138746136|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
138746137|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138746138|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138746139|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746140|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138746141|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746142|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138746143|NCT00976495|Diuretics|diuretics|mesh-ancestor
138746144|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
138746145|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138746146|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746147|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
138746148|NCT00630019|Levofloxacin|levofloxacin|mesh-list
138664672|NCT04778527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139081034|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
139081035|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
139081036|NCT05096663|Dexamethasone|dexamethasone|mesh-list
139081037|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
139081038|NCT05096663|Gemcitabine|gemcitabine|mesh-list
139081039|NCT05096663|Docetaxel|docetaxel|mesh-list
139081040|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
139081041|NCT05096663|Pemetrexed|pemetrexed|mesh-list
139081042|NCT05096663|Ramucirumab|ramucirumab|mesh-list
139081043|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139081045|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
139081046|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139081047|NCT05096663|Lexatumumab|lexatumumab|mesh-list
139081048|NCT05096663|BB 1101|bb 1101|mesh-list
139081049|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
139081050|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746149|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138746150|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138746151|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138746152|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138746153|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138746154|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138819155|NCT04884035|Prednisone|prednisone|mesh-list
138746155|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138746156|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746157|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746158|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746159|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138746160|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
138746161|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138746162|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746163|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138746164|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138746165|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138746166|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138746167|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138746168|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138746169|NCT00998296|Nintedanib|nintedanib|mesh-list
138746170|NCT00998296|Afatinib|afatinib|mesh-list
138746171|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746172|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138746173|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664718|NCT04706715|Cemiplimab|cemiplimab|mesh-list
139081051|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
139081052|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139081053|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
139081054|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
139081055|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081056|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139081057|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
139081058|NCT05096663|Hormones|hormones|mesh-ancestor
139081059|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139081060|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139081061|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081062|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
139081063|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819257|NCT04550260|Cisplatin|cisplatin|mesh-list
139081064|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081065|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139081066|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
139081067|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
139081068|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
139081069|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
139081070|NCT05096663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139081071|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138746174|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746176|NCT01178073|Tadalafil|tadalafil|mesh-list
138746177|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
138746178|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138746179|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138746180|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746181|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819304|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
138746182|NCT01178073|Urological Agents|urological agents|mesh-ancestor
138746184|NCT00997984|Guanfacine|guanfacine|mesh-list
138746185|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138746186|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138746187|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138746188|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138746189|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
138746190|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746191|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746192|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746193|NCT01177293|Amlodipine|amlodipine|mesh-list
138746194|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138746195|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138746196|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139081072|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139081073|NCT05096663|Hematinics|hematinics|mesh-ancestor
139081074|NCT04982796|Psilocybin|psilocybin|mesh-list
139081075|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
139081076|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081077|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139081078|NCT04941911|Octreotide|octreotide|mesh-list
139081079|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139081080|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139081081|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081082|NCT04858490|Diazepam|diazepam|mesh-list
139081083|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139081084|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
139081085|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
139081086|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
139081087|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081088|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274836|NCT00003315|Amebicides|amebicides|mesh-ancestor
139081089|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139081090|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139081091|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139081092|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139081093|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138831658|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081094|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139081095|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139081096|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139081097|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139081098|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
139081099|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
138746197|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746198|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138746199|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746200|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
138746201|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
138746202|NCT02886429|Bupivacaine|bupivacaine|mesh-list
138746203|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
138746204|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
138746205|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746206|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746207|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
138746208|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746209|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138746210|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138746211|NCT02886429|Analgesics|analgesics|mesh-ancestor
138746212|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138746213|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138746214|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138746215|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
138746216|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746217|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746218|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138746219|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138746220|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138746221|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746222|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746223|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138746224|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138746225|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138746226|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
139081100|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
139081101|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
139081102|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081103|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081104|NCT04790032|Cangrelor|cangrelor|mesh-list
139081105|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139081106|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139081107|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139081108|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139081109|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
139081110|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081111|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746227|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746228|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746229|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138746230|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138746232|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
138746233|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138746234|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
138746235|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
138746236|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746237|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746238|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138746239|NCT02886351|Analgesics|analgesics|mesh-ancestor
138746240|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
138746241|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746242|NCT00976027|Vaccines|vaccines|mesh-list
138746243|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
138746244|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746245|NCT01298765|Buprenorphine|buprenorphine|mesh-list
138746246|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138746247|NCT01298765|Narcotics|narcotics|mesh-ancestor
138746248|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746249|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746250|NCT01298765|Analgesics|analgesics|mesh-ancestor
138746251|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
138550725|NCT00100776|Olanzapine|olanzapine|mesh-list
138746252|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746253|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138746254|NCT04296214|Azacitidine|azacitidine|mesh-list
138746255|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138746256|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
138746257|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746258|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746259|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746260|NCT04296370|Apatinib|apatinib|mesh-list
138746261|NCT04296370|Fluzoparib|fluzoparib|mesh-list
138746266|NCT04296370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138746267|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
138746268|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
138746269|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746270|NCT00997438|Protective Agents|protective agents|mesh-ancestor
138746271|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746272|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
138746273|NCT00997438|Vitamins|vitamins|mesh-ancestor
138746274|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
138746275|NCT00997126|Alfentanil|alfentanil|mesh-list
138746276|NCT00997126|Propofol|propofol|mesh-list
138746277|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138746278|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746279|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746280|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138746281|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
138746282|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
138746283|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138746284|NCT00997126|Narcotics|narcotics|mesh-ancestor
138746285|NCT00997126|Analgesics|analgesics|mesh-ancestor
138746286|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
138746287|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746288|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138746289|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138746290|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
138746291|NCT04433494|Tamoxifen|tamoxifen|mesh-list
138746292|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138746293|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
138746294|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138819769|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
138746295|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746296|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138746297|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664898|NCT04623541|Growth Inhibitors|growth inhibitors|mesh-ancestor
139081112|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081113|NCT04779879|Sotrovimab|sotrovimab|mesh-list
139081114|NCT04779879|Antiviral Agents|antiviral agents|mesh-ancestor
139081115|NCT04779879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081116|NCT04768101|Corticosterone|corticosterone|mesh-list
139081117|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139081118|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
139081119|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139081120|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
139081121|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
139081122|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746298|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138746299|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138746300|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138746301|NCT01000480|Pemetrexed|pemetrexed|mesh-list
138746302|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746303|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746304|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746305|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138746306|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138746307|NCT02862691|Acetaminophen|acetaminophen|mesh-list
138746308|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138746309|NCT02862691|Oxycodone|oxycodone|mesh-list
138746310|NCT02862691|Analgesics|analgesics|mesh-list
138746311|NCT02862691|Bupivacaine|bupivacaine|mesh-list
138746312|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
138746313|NCT02862691|Anesthetics|anesthetics|mesh-list
138819882|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
138746314|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746315|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746316|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
138746317|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746318|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138746319|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
138746320|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138746321|NCT02862691|Narcotics|narcotics|mesh-ancestor
138746322|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138746323|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138746324|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138746325|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
138746326|NCT00965341|Testosterone|testosterone|mesh-list
138746327|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
138746328|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
139081123|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081124|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081125|NCT04599075|Insulin|insulin|mesh-list
139081126|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139081127|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139081128|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081129|NCT04574583|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139081130|NCT04574583|Antiviral Agents|antiviral agents|mesh-ancestor
138274885|NCT00361621|Hormones|hormones|mesh-ancestor
139081131|NCT04574583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081132|NCT04523363|Metformin|metformin|mesh-list
138819945|NCT00628706|Hormones|hormones|mesh-ancestor
139081133|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139081134|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081135|NCT04495894|Ketorolac|ketorolac|mesh-list
138746330|NCT00965341|Androgens|androgens|mesh-ancestor
138746331|NCT00965341|Hormones|hormones|mesh-ancestor
138746332|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138746333|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746334|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138746335|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746336|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
138746337|NCT01175811|Insulin|insulin|mesh-list
138746338|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138746339|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
138746340|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
138746341|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
138746342|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
138746343|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
138746344|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138746345|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746346|NCT00965263|Cocaine|cocaine|mesh-list
138746347|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
138746348|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
138746349|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746350|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746351|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
138746352|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746353|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138746354|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138746355|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138746356|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746357|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746358|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
139081136|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139081137|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139081138|NCT04495894|Analgesics|analgesics|mesh-ancestor
139081139|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
139081140|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081141|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081142|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139081143|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081144|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139081145|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081146|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081147|NCT04478721|Meropenem|meropenem|mesh-list
138746359|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746361|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138746362|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746363|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746364|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746365|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138746366|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138746367|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138746368|NCT02862769|Lidocaine|lidocaine|mesh-list
138746369|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
138746370|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
138746371|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746372|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746373|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
138746374|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746375|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138746376|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138746377|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138746378|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746379|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746380|NCT00965185|Atorvastatin|atorvastatin|mesh-list
138746381|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138746382|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138746383|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
138746384|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746385|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138665031|NCT04542824|Glucocorticoids|glucocorticoids|mesh-ancestor
139081148|NCT04478721|Temocillin|temocillin|mesh-list
139081149|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139081150|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081151|NCT04283500|Buprenorphine|buprenorphine|mesh-list
139081152|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139081153|NCT04283500|Naloxone|naloxone|mesh-list
139081154|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139081155|NCT04283500|Narcotics|narcotics|mesh-ancestor
139081156|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139081157|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081158|NCT04283500|Analgesics|analgesics|mesh-ancestor
139081159|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
139081160|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081161|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139081162|NCT04223791|Islatravir|islatravir|mesh-list
139081163|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
139081164|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081165|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820024|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138746386|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138746387|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746388|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138746389|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746390|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138746391|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746392|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746393|NCT01298531|Etanercept|etanercept|mesh-list
138746394|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138746395|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138746396|NCT01298531|Analgesics|analgesics|mesh-ancestor
138746397|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
138746398|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746399|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746400|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138746401|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138746402|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138746403|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138746404|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
138746405|NCT02862145|Dexamethasone|dexamethasone|mesh-list
138746406|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138746407|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
138746408|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
138746409|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746410|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746411|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138746412|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
138746413|NCT02862145|Hormones|hormones|mesh-ancestor
139081166|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081167|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139081168|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139081169|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139081170|NCT03982030|Dalbavancin|dalbavancin|mesh-list
139081171|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139081172|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081173|NCT03915067|Botulinum Toxins|botulinum toxins|mesh-list
139081174|NCT03915067|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139081175|NCT03915067|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139081176|NCT03915067|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139081177|NCT03915067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139081178|NCT03915067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081179|NCT03915067|Cholinergic Agents|cholinergic agents|mesh-ancestor
139081180|NCT03915067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081181|NCT03915067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081182|NCT03915067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139081183|NCT03915067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820112|NCT00580801|Ribavirin|ribavirin|mesh-list
138746414|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138746415|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138746416|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746418|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138746419|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746420|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746421|NCT00964795|Aflibercept|aflibercept|mesh-list
138746422|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138746423|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138746424|NCT00964795|Growth Substances|growth substances|mesh-ancestor
138746425|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746426|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
138746427|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746428|NCT01173471|Niacinamide|niacinamide|mesh-list
138746429|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
138746430|NCT01173471|Vitamins|vitamins|mesh-ancestor
138746431|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
138746432|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746433|NCT01172847|Oseltamivir|oseltamivir|mesh-list
138746434|NCT01172847|Rimantadine|rimantadine|mesh-list
138746435|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
138746436|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138746437|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746438|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746439|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138746440|NCT00966355|Octreotide|octreotide|mesh-list
138746441|NCT00966355|Terlipressin|terlipressin|mesh-list
138746442|NCT00966355|Somatostatin|somatostatin|mesh-list
138746443|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138746460|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
138746461|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138746462|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138746463|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138746464|NCT05160493|Pregabalin|pregabalin|mesh-list
138746465|NCT05160493|Ketamine|ketamine|mesh-list
138746466|NCT05160493|Esketamine|esketamine|mesh-list
138746467|NCT05160493|Analgesics|analgesics|mesh-ancestor
138746468|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
138746469|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746470|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746471|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138746472|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138746473|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
138746474|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
138746475|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746476|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138746477|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138746478|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746479|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746480|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
138746481|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138746482|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746483|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138746484|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138746485|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138746486|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138746487|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
138746488|NCT00966277|Dalteparin|dalteparin|mesh-list
138746489|NCT00966277|Tinzaparin|tinzaparin|mesh-list
138746490|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138746491|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
138746492|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138746493|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138746494|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081185|NCT03903133|Antioxidants|antioxidants|mesh-list
139081186|NCT03903133|Vitamins|vitamins|mesh-ancestor
139081187|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
139081188|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081189|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746495|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138746496|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138746498|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138746499|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138746500|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138746501|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138746502|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138746503|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
138746504|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746505|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746506|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746507|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138746508|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746509|NCT01296347|Ketamine|ketamine|mesh-list
138746510|NCT01296347|Analgesics|analgesics|mesh-ancestor
138746511|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
138746512|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746513|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746514|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138746515|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138746516|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
138746517|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
138746518|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746519|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138746520|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138746521|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820169|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
138746522|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746523|NCT01296035|Panitumumab|panitumumab|mesh-list
138746524|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139081190|NCT03903133|Protective Agents|protective agents|mesh-ancestor
139081191|NCT03841305|Liver Extracts|liver extracts|mesh-list
139081192|NCT03841305|Hematinics|hematinics|mesh-ancestor
139081193|NCT03727633|Idarubicin|idarubicin|mesh-list
139081194|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
139081195|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139081196|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081197|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139081198|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139081199|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081200|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081201|NCT03694002|Paclitaxel|paclitaxel|mesh-list
139081202|NCT03694002|Carboplatin|carboplatin|mesh-list
139081203|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139081204|NCT03694002|Ramucirumab|ramucirumab|mesh-list
139081205|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138746525|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746526|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
138746527|NCT01294787|Bromides|bromides|mesh-list
138746528|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
138746529|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138746530|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
138746531|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746532|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746533|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138746534|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
138746535|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
138746536|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138746537|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
138746538|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746539|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746540|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
138746541|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138746542|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138746544|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
138746545|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138746546|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746547|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138746548|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746549|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746550|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746551|NCT01294397|Denosumab|denosumab|mesh-list
138746552|NCT01294397|Etanercept|etanercept|mesh-list
138746553|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138746554|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138746555|NCT01294397|Analgesics|analgesics|mesh-ancestor
139081206|NCT03694002|Antibodies|antibodies|mesh-list
139081207|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
139081208|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139081209|NCT03694002|Lexatumumab|lexatumumab|mesh-list
139081210|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139081211|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081212|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
139081213|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
139081214|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
139081215|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081216|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
139081217|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081218|NCT03623321|Pimavanserin|pimavanserin|mesh-list
139081219|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139081220|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139081221|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139081222|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138820251|NCT01057589|Pemetrexed|pemetrexed|mesh-list
138746556|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
138746557|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746558|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746559|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138746560|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138746561|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138746562|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138746563|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
138746564|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138746565|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138746566|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746567|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746568|NCT01293539|Melphalan|melphalan|mesh-list
138746569|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138746570|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
138746571|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746572|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746573|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138746574|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138746575|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
138746576|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746577|NCT01292837|Levetiracetam|levetiracetam|mesh-list
138746578|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
138746579|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
138746580|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138746581|NCT00965731|Crizotinib|crizotinib|mesh-list
138746582|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746583|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138274928|NCT03614221|Tacrolimus|tacrolimus|mesh-list
139081223|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139081224|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081225|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139081226|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139081227|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139081228|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
139081229|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081230|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081231|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
139081232|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139081233|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081234|NCT03447314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139081235|NCT03447314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081236|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
139081237|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
139081238|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081239|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138746584|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746585|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746586|NCT00630175|Zolpidem|zolpidem|mesh-list
138746587|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138746588|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138746589|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746590|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746591|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138746592|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
138746593|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
138746594|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746595|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746596|NCT00965575|Melatonin|melatonin|mesh-list
138746597|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
138746598|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746599|NCT00965575|Protective Agents|protective agents|mesh-ancestor
138665327|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139081240|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139081241|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139081242|NCT03365882|Trastuzumab|trastuzumab|mesh-list
139081243|NCT03365882|Cetuximab|cetuximab|mesh-list
139081244|NCT03365882|Pertuzumab|pertuzumab|mesh-list
139081245|NCT03365882|Irinotecan|irinotecan|mesh-list
139081246|NCT03365882|Camptothecin|camptothecin|mesh-list
139081247|NCT03365882|Antibodies|antibodies|mesh-list
139081248|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
139081249|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139081250|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
139081251|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081252|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081253|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139081254|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139081255|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081256|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081257|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139081258|NCT03364530|Gemcitabine|gemcitabine|mesh-list
139081259|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
139081260|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139081261|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
139081262|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081263|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081264|NCT03289910|Carboplatin|carboplatin|mesh-list
139081265|NCT03289910|Topotecan|topotecan|mesh-list
139081266|NCT03289910|Veliparib|veliparib|mesh-list
139081267|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081268|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139081269|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139081270|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081271|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081272|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139081273|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
139081274|NCT03253133|Oxycodone|oxycodone|mesh-list
139081275|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081276|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139081277|NCT03253133|Narcotics|narcotics|mesh-ancestor
139081278|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139081279|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081280|NCT03253133|Analgesics|analgesics|mesh-ancestor
139081281|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
138746600|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746601|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746602|NCT00965497|Escitalopram|escitalopram|mesh-list
138746603|NCT00965497|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138550746|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
138746604|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138746605|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746606|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746607|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746608|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
138746609|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746610|NCT00963937|Sumatriptan|sumatriptan|mesh-list
138746611|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138746612|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138746613|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138746614|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
138746615|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746616|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746617|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746618|NCT01170663|Paclitaxel|paclitaxel|mesh-list
138746619|NCT01170663|Ramucirumab|ramucirumab|mesh-list
138746620|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138746621|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746622|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
138746623|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
138746624|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
138820355|NCT02334865|Growth Substances|growth substances|mesh-ancestor
139081282|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081283|NCT03252756|Cannabidiol|cannabidiol|mesh-list
139081284|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
139081285|NCT03225417|Sirolimus|sirolimus|mesh-list
139081286|NCT03225417|Cyclophosphamide|cyclophosphamide|mesh-list
139081287|NCT03225417|Ixazomib|ixazomib|mesh-list
139081288|NCT03225417|Tacrolimus|tacrolimus|mesh-list
139081289|NCT03225417|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139081290|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139081291|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
139081292|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081293|NCT03225417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081294|NCT03225417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139081295|NCT03225417|Alkylating Agents|alkylating agents|mesh-ancestor
139081296|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081297|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081298|NCT03225417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139081299|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139081300|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081301|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139081302|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081303|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138746625|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746626|NCT04315155|Nivolumab|nivolumab|mesh-list
138746627|NCT04315155|Ipilimumab|ipilimumab|mesh-list
138746628|NCT04315155|Belinostat|belinostat|mesh-list
138746629|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138746630|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746631|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138746632|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746633|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138746634|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746635|NCT01170273|Vitamin D|vitamin d|mesh-list
138746636|NCT01170273|Vitamins|vitamins|mesh-ancestor
138746637|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
138746638|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746639|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138746640|NCT01170039|Lubiprostone|lubiprostone|mesh-list
138746641|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138746642|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746643|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746644|NCT01286558|Amlodipine|amlodipine|mesh-list
138746645|NCT01286558|Telmisartan|telmisartan|mesh-list
138746646|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138746647|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138746648|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746649|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081304|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
139081305|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
139081306|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139081307|NCT03091660|Vaccines|vaccines|mesh-list
139081308|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
139081309|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
139081310|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081311|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139081312|NCT03091595|Drospirenone|drospirenone|mesh-list
139081313|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139081314|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139081315|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139081316|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139081317|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
139081318|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139081319|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081320|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139081321|NCT03091595|Estrogens|estrogens|mesh-ancestor
139081322|NCT03091595|Hormones|hormones|mesh-ancestor
139081323|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139081324|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139081325|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
139081326|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139081327|NCT03091595|Diuretics|diuretics|mesh-ancestor
139081328|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
138746650|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138746651|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746652|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
138746653|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138746654|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138746655|NCT01169103|Hormones|hormones|mesh-list
138746656|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138746657|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746658|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
138746659|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138746660|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138746661|NCT01286168|Eusol|eusol|mesh-list
138746662|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138746663|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138746664|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138746665|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
138746666|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
138746667|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138746668|NCT02889692|Gefitinib|gefitinib|mesh-list
138746669|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746670|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138746671|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550751|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138746672|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746673|NCT05569382|Verapamil|verapamil|mesh-list
138746674|NCT05569382|Bisoprolol|bisoprolol|mesh-list
138746675|NCT05569382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138746676|NCT05569382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138746677|NCT05569382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746678|NCT05569382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746679|NCT05569382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138746680|NCT05569382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081329|NCT01925131|Prednisone|prednisone|mesh-list
139081330|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
139081331|NCT01925131|Vincristine|vincristine|mesh-list
139081332|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139081333|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139081334|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
139081335|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081336|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081337|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139081338|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
138746681|NCT05569382|Vasodilator Agents|vasodilator agents|mesh-ancestor
138746682|NCT05569382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138746683|NCT05569382|Sympatholytics|sympatholytics|mesh-ancestor
138746684|NCT05569382|Autonomic Agents|autonomic agents|mesh-ancestor
138746685|NCT05569382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746686|NCT05569382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138746687|NCT05569382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138746688|NCT05569382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138746689|NCT05569382|Adrenergic Agents|adrenergic agents|mesh-ancestor
138746690|NCT05569382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746691|NCT00963547|Trastuzumab|trastuzumab|mesh-list
138746692|NCT00963547|Lapatinib|lapatinib|mesh-list
138746693|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138746694|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746695|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138746696|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746697|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746698|NCT01285310|Thalidomide|thalidomide|mesh-list
138746699|NCT01285310|Apremilast|apremilast|mesh-list
138746700|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138746701|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138746702|NCT01285310|Analgesics|analgesics|mesh-ancestor
138746703|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
138746704|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746705|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746706|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138746707|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138746708|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139081339|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081340|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081341|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139081342|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139081343|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
139081344|NCT01925131|Hormones|hormones|mesh-ancestor
139081345|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139081346|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139081347|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139081348|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
139081349|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
139081350|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
139081351|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139081352|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139081353|NCT01925131|Immunotoxins|immunotoxins|mesh-ancestor
139081354|NCT01925131|Immunoconjugates|immunoconjugates|mesh-ancestor
139081355|NCT01698918|Dexamethasone|dexamethasone|mesh-list
139081356|NCT01698918|Everolimus|everolimus|mesh-list
139081357|NCT01698918|Letrozole|letrozole|mesh-list
138746709|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138746710|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746711|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746712|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138746713|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
138746714|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
138746715|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138746716|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138746717|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138746718|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138746719|NCT01285310|Growth Substances|growth substances|mesh-ancestor
138746720|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
138746721|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746723|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
138746724|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746725|NCT01253304|Dulaglutide|dulaglutide|mesh-list
138746726|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138746727|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746728|NCT04319484|Lenvatinib|lenvatinib|mesh-list
138746729|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665600|NCT03899467|Androgens|androgens|mesh-list
139081358|NCT01698918|Exemestane|exemestane|mesh-list
139081359|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139081360|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
139081361|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
139081362|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081363|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081364|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139081365|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
139081366|NCT01698918|Hormones|hormones|mesh-ancestor
139081367|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139081368|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139081369|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081370|NCT01698918|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139081371|NCT01698918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139081372|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081373|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081374|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139081375|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
139081376|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139081377|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139081378|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139081379|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
139081380|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
139081381|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
139081382|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139081383|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139081384|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081385|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081386|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081387|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081388|NCT00840177|Cytarabine|cytarabine|mesh-list
139081389|NCT00840177|Idarubicin|idarubicin|mesh-list
139081390|NCT00840177|Pravastatin|pravastatin|mesh-list
139081391|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139081392|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
138746730|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138746731|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746732|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746733|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138746734|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
138746735|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746736|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138746737|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
138746738|NCT00624312|Hematinics|hematinics|mesh-ancestor
138746739|NCT01250418|Ketamine|ketamine|mesh-list
138746740|NCT01250418|Analgesics|analgesics|mesh-ancestor
138746741|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
138820521|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
138550756|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138746742|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746743|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746744|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138746745|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138746746|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
138746747|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
138665637|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139081393|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081394|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081395|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
139081396|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081397|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139081398|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
139081399|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081400|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139081401|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139081402|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139081403|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081404|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139081405|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139081406|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139081407|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139081408|NCT01347580|Ticagrelor|ticagrelor|mesh-list
139081409|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139081410|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139081411|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139081412|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139081413|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
139081414|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081415|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081416|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081417|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
139081418|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139081419|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081420|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139081421|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139081422|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081423|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081424|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081425|NCT03352414|Alvimopan|alvimopan|mesh-list
139081426|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139081427|NCT00364793|Emtricitabine|emtricitabine|mesh-list
138746748|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746749|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138746750|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138746751|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746752|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746753|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
138746754|NCT01292603|Rituximab|rituximab|mesh-list
138746755|NCT01292603|Fludarabine|fludarabine|mesh-list
138746756|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138746757|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
138746758|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746759|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138746760|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138746761|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
138746762|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746763|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746764|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138746765|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138746766|NCT01292057|Aripiprazole|aripiprazole|mesh-list
138746767|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
138746768|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138746769|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138746770|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139081428|NCT00364793|Efavirenz|efavirenz|mesh-list
139081429|NCT00364793|Didanosine|didanosine|mesh-list
139081430|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
139081431|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138275040|NCT03576001|Androgens|androgens|mesh-ancestor
139081432|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139081433|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139081434|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081435|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081436|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139081437|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139081438|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139081439|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139081440|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139081441|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139081442|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139081443|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139081444|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
139081445|NCT03351478|Empagliflozin|empagliflozin|mesh-list
139081446|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139081447|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139081448|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081449|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139081450|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081451|NCT00363545|Vaccines|vaccines|mesh-list
139081452|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
138746771|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746772|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746773|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
138746774|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
138746775|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746776|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746777|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138746778|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138746779|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
138746780|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138746781|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138746782|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138746783|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138746784|NCT01290887|Reslizumab|reslizumab|mesh-list
138665744|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
139081453|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081454|NCT03351244|BI 409306|bi 409306|mesh-list
139081455|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139081456|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081457|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081458|NCT03386032|Desonide|desonide|mesh-list
139081459|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139081460|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
139081461|NCT00077610|Hematinics|hematinics|mesh-ancestor
139081462|NCT00066222|Etoposide|etoposide|mesh-list
139081463|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820549|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081464|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139081465|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139081466|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139081467|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081468|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081469|NCT00397943|Vaccines|vaccines|mesh-list
139081470|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
139081471|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081472|NCT00066066|Amoxicillin|amoxicillin|mesh-list
139081473|NCT00066066|Metronidazole|metronidazole|mesh-list
139081474|NCT00066066|Doxycycline|doxycycline|mesh-list
139081475|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138832034|NCT00770497|Pioglitazone|pioglitazone|mesh-list
139081477|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139081478|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139081479|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
139081480|NCT00363467|Busulfan|busulfan|mesh-list
139081481|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
139081482|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081483|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139081484|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
139081485|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081486|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139081487|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081488|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139081490|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139081491|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139081492|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081493|NCT00397631|Incretins|incretins|mesh-ancestor
139081494|NCT00397631|Hormones|hormones|mesh-ancestor
139081495|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139081496|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139081497|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
139081498|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746785|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138746786|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
138746787|NCT01290731|Interferons|interferons|mesh-list
138746788|NCT01290731|Ribavirin|ribavirin|mesh-list
138746789|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138746790|NCT01290731|Simeprevir|simeprevir|mesh-list
138746791|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746792|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
138746793|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138746794|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
138746795|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746796|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
138746797|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746798|NCT01290341|Naftifine|naftifine|mesh-list
138746799|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
138746800|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138746801|NCT01290263|Bevacizumab|bevacizumab|mesh-list
138746802|NCT01290263|Trebananib|trebananib|mesh-list
138746803|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138746804|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746805|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138746806|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138746807|NCT01290263|Growth Substances|growth substances|mesh-ancestor
138746808|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746809|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
138746810|NCT01290029|Cinacalcet|cinacalcet|mesh-list
138746811|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138469220|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
138746812|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746814|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
138746815|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138746816|NCT02890199|Lidocaine|lidocaine|mesh-list
139081499|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081500|NCT00077376|Carboplatin|carboplatin|mesh-list
139081501|NCT00077376|Trastuzumab|trastuzumab|mesh-list
139081502|NCT00077376|Epothilone B|epothilone b|mesh-list
139081503|NCT00077376|Epothilones|epothilones|mesh-list
139081504|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081505|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139081506|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
139081507|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
139081508|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
139081509|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081510|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
139081511|NCT01088724|Rituximab|rituximab|mesh-list
139081512|NCT01088724|Doxorubicin|doxorubicin|mesh-list
139081513|NCT01088724|Fludarabine|fludarabine|mesh-list
138746817|NCT02890199|Bupivacaine|bupivacaine|mesh-list
138746818|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
138746819|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
138746820|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746821|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746822|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
138746823|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746824|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138746825|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138746826|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138746827|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746828|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746829|NCT01289639|Pioglitazone|pioglitazone|mesh-list
138746830|NCT01289639|Fenofibrate|fenofibrate|mesh-list
138746831|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138746832|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746833|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138746834|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
138746835|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746836|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138746837|NCT01288937|Milnacipran|milnacipran|mesh-list
138746838|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
138746839|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138746840|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138746841|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746842|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746843|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746844|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746862|NCT01288469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138746863|NCT01288469|Protease Inhibitors|protease inhibitors|mesh-ancestor
138746864|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
138746865|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746866|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138746867|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138746868|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138746869|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746870|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746871|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138746872|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746873|NCT01288079|Analgesics|analgesics|mesh-ancestor
138746874|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
138746875|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746876|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
138746877|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138746878|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
138746879|NCT01287221|Riboflavin|riboflavin|mesh-list
138746880|NCT01287221|Rifampin|rifampin|mesh-list
138746881|NCT01287221|Vitamins|vitamins|mesh-ancestor
138746882|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
138746883|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081514|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139081515|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
139081516|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275086|NCT00002865|Hormones|hormones|mesh-ancestor
139081517|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081518|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139081519|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
139081520|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081521|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081522|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139081523|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139081524|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139081525|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139081526|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139081527|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081528|NCT03957174|Rivastigmine|rivastigmine|mesh-list
139081529|NCT03957174|Reboxetine|reboxetine|mesh-list
139081530|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139081531|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081532|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081533|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
139081534|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081535|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081536|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139081537|NCT03957174|Protective Agents|protective agents|mesh-ancestor
139081538|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
139081539|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139081540|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139081541|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139081542|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746884|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
138746885|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138746886|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
138746887|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138746888|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138746889|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
138746890|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138746891|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746892|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746893|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138746894|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138746895|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138746896|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138746897|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138746898|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138746899|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138746900|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
138746901|NCT01167153|Amlodipine|amlodipine|mesh-list
138746902|NCT01167153|Valsartan|valsartan|mesh-list
138746903|NCT01167153|Nifedipine|nifedipine|mesh-list
138746904|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138746905|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138746906|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138746907|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746908|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138746909|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746910|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
138746911|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138746912|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138746913|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
139081543|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
139081544|NCT00363311|Dutasteride|dutasteride|mesh-list
139081545|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139081546|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139081547|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081548|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081549|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
139081550|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139081551|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081552|NCT00362609|Pantoprazole|pantoprazole|mesh-list
139081553|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138746914|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138746916|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
138746917|NCT01166763|Vitamins|vitamins|mesh-ancestor
138746918|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
138746919|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746920|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138746921|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138746922|NCT02885961|Dabigatran|dabigatran|mesh-list
138746923|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
138746924|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138746925|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
138746926|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746927|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746928|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
138746929|NCT02885727|Durvalumab|durvalumab|mesh-list
138746930|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138746931|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746932|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138746933|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
138746934|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746936|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138746937|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746938|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138746939|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138746940|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139081554|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139081555|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139081556|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081557|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081558|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
139081559|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
139081560|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275126|NCT00361387|Methylphenidate|methylphenidate|mesh-list
139081561|NCT02534753|Protective Agents|protective agents|mesh-ancestor
139081562|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081563|NCT02534753|Vitamins|vitamins|mesh-ancestor
139081564|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
139081565|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
139081566|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139081567|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081568|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139081569|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
139081570|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139081571|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081572|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081573|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081574|NCT00362297|Valacyclovir|valacyclovir|mesh-list
138746941|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746942|NCT01165281|Oxycodone|oxycodone|mesh-list
138746943|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138746944|NCT01165281|Narcotics|narcotics|mesh-ancestor
138746945|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746946|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746947|NCT01165281|Analgesics|analgesics|mesh-ancestor
138746948|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
138746949|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746950|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138746951|NCT02860897|Estrogens|estrogens|mesh-ancestor
138746952|NCT02860897|Hormones|hormones|mesh-ancestor
138746953|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138746954|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746955|NCT02860819|Carboplatin|carboplatin|mesh-list
138746956|NCT02860819|Gemcitabine|gemcitabine|mesh-list
138746957|NCT02860819|Veliparib|veliparib|mesh-list
138746958|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746959|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138746960|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
138746961|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746962|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138746963|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746964|NCT04284007|Dexamethasone|dexamethasone|mesh-list
138746965|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
138746966|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
138746967|NCT04284007|BB 1101|bb 1101|mesh-list
138746968|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138746969|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
139081575|NCT00362297|Acyclovir|acyclovir|mesh-list
139081576|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
139081577|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081578|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
139081579|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081580|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
139081581|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
139081582|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081583|NCT00090402|Protective Agents|protective agents|mesh-ancestor
139081584|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081585|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
139081586|NCT00090402|Vitamins|vitamins|mesh-ancestor
139081587|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
139081588|NCT00361283|Atorvastatin|atorvastatin|mesh-list
139081589|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139081590|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139081591|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
139081592|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081593|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138746970|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
138746971|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746972|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746973|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138746974|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
138746975|NCT04284007|Hormones|hormones|mesh-ancestor
138746976|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138746977|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138746978|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746979|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
138746980|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746981|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746982|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
138746983|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
138746984|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138746985|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
138746986|NCT01165203|Vaccines|vaccines|mesh-list
138746987|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
138746988|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746989|NCT00960661|Insulin|insulin|mesh-list
138746990|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138746991|NCT00960661|Metformin|metformin|mesh-list
138746992|NCT00960661|Exenatide|exenatide|mesh-list
138746993|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
138746994|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138746995|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746996|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138746997|NCT00960661|Incretins|incretins|mesh-ancestor
138746998|NCT00960661|Hormones|hormones|mesh-ancestor
139081594|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139081595|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081596|NCT00077064|Captopril|captopril|mesh-list
139081597|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139081598|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
139081599|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081600|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081601|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139081602|NCT00396383|Plerixafor|plerixafor|mesh-list
139081603|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139081604|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139081605|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
139081606|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081607|NCT02534363|Aripiprazole|aripiprazole|mesh-list
139081608|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139081609|NCT02534363|Ziprasidone|ziprasidone|mesh-list
139081610|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
139081611|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139081612|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139081613|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138746999|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138747000|NCT00960193|Colchicine|colchicine|mesh-list
138747001|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
138747002|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138747003|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
138747004|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
138747005|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
138747006|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747007|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747008|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
138747009|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
138747010|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747011|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747012|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138747013|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138747014|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
138747015|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081614|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139081615|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081616|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
139081617|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
139081618|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081619|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081620|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139081621|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139081622|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
139081623|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139081624|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138832202|NCT00766441|Hormones|hormones|mesh-ancestor
139081625|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139081626|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139081628|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139081629|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081630|NCT01088958|Micronutrients|micronutrients|mesh-list
139081631|NCT01088958|Trace Elements|trace elements|mesh-list
139081632|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081633|NCT03404518|Acetaminophen|acetaminophen|mesh-list
139081634|NCT03404518|Ibuprofen|ibuprofen|mesh-list
139081635|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139081636|NCT03404518|Hydrocodone|hydrocodone|mesh-list
139081637|NCT03404518|Narcotics|narcotics|mesh-list
139081638|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139081639|NCT03404518|Analgesics|analgesics|mesh-ancestor
139081640|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
139081641|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081642|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081644|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139081645|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139081646|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081647|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139081648|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081649|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081650|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139081651|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139081652|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
138747016|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747017|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138747018|NCT00959647|Bevacizumab|bevacizumab|mesh-list
138550776|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138747019|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138747020|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747021|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138747022|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138747023|NCT00959647|Growth Substances|growth substances|mesh-ancestor
138747024|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747025|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
138747026|NCT00957853|Cetuximab|cetuximab|mesh-list
138747027|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138747028|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747029|NCT02859571|Oxytocin|oxytocin|mesh-list
138747030|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
138747031|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138747032|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747033|NCT00956839|Vitamin D|vitamin d|mesh-list
138747034|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
138747035|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
138747036|NCT00956839|Vitamins|vitamins|mesh-list
138747037|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
138747038|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747039|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138747040|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138747041|NCT00956293|Cyclosporine|cyclosporine|mesh-list
138747042|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
138747043|NCT00956293|Everolimus|everolimus|mesh-list
138747044|NCT00956293|Cyclosporins|cyclosporins|mesh-list
138747045|NCT00956293|Basiliximab|basiliximab|mesh-list
138747046|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081653|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
139081654|NCT03404206|Ibuprofen|ibuprofen|mesh-list
139081655|NCT03404206|Naproxen|naproxen|mesh-list
139081656|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139081657|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139081658|NCT03404206|Analgesics|analgesics|mesh-ancestor
139081659|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
139081660|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081661|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081662|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139081663|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081664|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139081665|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081666|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081667|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
138747047|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747048|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747049|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
138747050|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747051|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
138747052|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747053|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
138747054|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138747055|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138747057|NCT00956293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138747058|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747059|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138747060|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138747061|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
138747062|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138747063|NCT04282291|Morphine|morphine|mesh-list
138747064|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138747065|NCT04282291|Narcotics|narcotics|mesh-ancestor
138747066|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138747067|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747068|NCT04282291|Analgesics|analgesics|mesh-ancestor
138747069|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
138747070|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747071|NCT00955825|Immunomodulating Agents|immunomodulating agents|mesh-list
138666222|NCT03011567|Ibuprofen|ibuprofen|mesh-list
139081668|NCT00394901|Pregabalin|pregabalin|mesh-list
139081669|NCT00394901|Analgesics|analgesics|mesh-ancestor
139081670|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
139081671|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081672|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081673|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
139081674|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139081675|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139081676|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081677|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139081678|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139081679|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139081680|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139081681|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139081682|NCT03349060|Abrocitinib|abrocitinib|mesh-list
139081683|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139081684|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081685|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081686|NCT03348904|Paclitaxel|paclitaxel|mesh-list
139081687|NCT03348904|Carboplatin|carboplatin|mesh-list
139081688|NCT03348904|Gemcitabine|gemcitabine|mesh-list
139081689|NCT03348904|Nivolumab|nivolumab|mesh-list
139081690|NCT03348904|Pemetrexed|pemetrexed|mesh-list
139081691|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138747072|NCT00955825|Immunologic Factors|immunologic factors|mesh-ancestor
138747073|NCT00955825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747074|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138747075|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138747076|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138747077|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138747078|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747079|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747080|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747081|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
138747082|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138747083|NCT02869009|Aspirin|aspirin|mesh-list
138703414|NCT02052648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138747084|NCT02869009|Clopidogrel|clopidogrel|mesh-list
138747085|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138747086|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138747087|NCT02869009|Analgesics|analgesics|mesh-ancestor
138747088|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
138747089|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747090|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747091|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138747092|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138747093|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138747094|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138747095|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747096|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138747097|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138747098|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747099|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
138747100|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138747101|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138747102|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139081692|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081693|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
139081694|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
139081695|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
139081696|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081697|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139081698|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
138832297|NCT04264286|Esmolol|esmolol|mesh-list
138747103|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
138747104|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747105|NCT01164579|Methotrexate|methotrexate|mesh-list
138747106|NCT01164579|Tofacitinib|tofacitinib|mesh-list
138747107|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138747108|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
138747109|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138747110|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747111|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138747112|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
138747113|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747114|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747115|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
138747116|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747117|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138747118|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747119|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
138747120|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138747121|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138747122|NCT01164579|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138747123|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138747124|NCT02859259|Fostemsavir|fostemsavir|mesh-list
138747125|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138747126|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138343119|NCT01811940|Topiramate|topiramate|mesh-list
139081699|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139081700|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139081701|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081702|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139081703|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139081704|NCT00359021|Etravirine|etravirine|mesh-list
139081705|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139081706|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139081707|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081708|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081709|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
139081710|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081711|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139081712|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139081713|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139081714|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139081715|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081716|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
139081717|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081718|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081719|NCT01052597|Curcumin|curcumin|mesh-list
139081720|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139081721|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139081722|NCT01052597|Analgesics|analgesics|mesh-ancestor
138747127|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
138747128|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747129|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138747130|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138747131|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747132|NCT02857777|Esketamine|esketamine|mesh-list
138747133|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
138747134|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138747135|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
138747136|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
138747137|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747138|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747139|NCT03202849|Vitamin D|vitamin d|mesh-list
138747140|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
138747141|NCT03202849|Cholecalciferol|cholecalciferol|mesh-list
138747142|NCT03202849|Vitamins|vitamins|mesh-list
138747143|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
138747144|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747145|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138747146|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138747147|NCT04277533|Calcium|calcium|mesh-list
138747148|NCT04277533|Bilirubin|bilirubin|mesh-list
138747149|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138747150|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747151|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
139081723|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
139081724|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081725|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081726|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139081727|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081728|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081729|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081730|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081731|NCT01051115|Dasatinib|dasatinib|mesh-list
139081732|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081733|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139081734|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081735|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081736|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
139081737|NCT00076752|Promethazine|promethazine|mesh-list
139081738|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
139081739|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
139081740|NCT00076752|Rituximab|rituximab|mesh-list
139081741|NCT00076752|Fludarabine|fludarabine|mesh-list
139081742|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
139081743|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139081744|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
139081745|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081746|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081747|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139081748|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
139081749|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747152|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747153|NCT04277533|Protective Agents|protective agents|mesh-ancestor
138747154|NCT02445391|Cisplatin|cisplatin|mesh-list
138703533|NCT02912234|Apixaban|apixaban|mesh-list
138747155|NCT02445391|Carboplatin|carboplatin|mesh-list
138747156|NCT02445391|Capecitabine|capecitabine|mesh-list
138747157|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747158|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138747159|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
138747160|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747161|NCT01246986|Sorafenib|sorafenib|mesh-list
138747162|NCT01246986|Ramucirumab|ramucirumab|mesh-list
138747163|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747164|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138747165|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747166|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747167|NCT01164501|Empagliflozin|empagliflozin|mesh-list
138747168|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138747169|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747170|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138747171|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747172|NCT01163721|Ranolazine|ranolazine|mesh-list
139081750|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081751|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139081752|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139081753|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139081754|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
139081755|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139081756|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
139081757|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
139081758|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081759|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139081760|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
139081761|NCT00076752|Hormones|hormones|mesh-ancestor
139081762|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139081763|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139081764|NCT00076752|Protective Agents|protective agents|mesh-ancestor
139081765|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139081766|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139081767|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139081768|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
139081769|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
139081770|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
139081771|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138832340|NCT00668395|Efavirenz|efavirenz|mesh-list
139081772|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
139081774|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081775|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139081776|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
139081777|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
139081778|NCT03384940|Trastuzumab|trastuzumab|mesh-list
139081779|NCT03384940|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139081780|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139081781|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747173|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138747174|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138747175|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747176|NCT00958243|Vaccines|vaccines|mesh-list
138747177|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
138747178|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747179|NCT01241760|Interferons|interferons|mesh-list
138747180|NCT01241760|Ribavirin|ribavirin|mesh-list
138747181|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
138747182|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
138747183|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138747184|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747185|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
138747186|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747187|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
138747188|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747189|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
138747190|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747191|NCT04280263|Caffeine|caffeine|mesh-list
138747192|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138666467|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
139081782|NCT03384940|Immunoconjugates|immunoconjugates|mesh-ancestor
138275313|NCT00004833|Antibodies|antibodies|mesh-list
139081783|NCT03384940|Immunologic Factors|immunologic factors|mesh-ancestor
139081784|NCT03384940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081785|NCT00075582|Dactinomycin|dactinomycin|mesh-list
139081786|NCT00075582|Cactinomycin|cactinomycin|mesh-list
139081787|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
139081788|NCT00075582|Vincristine|vincristine|mesh-list
139081789|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139081790|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
139081791|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081792|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081793|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139081794|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
139081795|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081796|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081797|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139081798|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139081799|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
139081800|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
139081801|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
139081802|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139081803|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081804|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139081805|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139081806|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081807|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139081808|NCT00063258|Paclitaxel|paclitaxel|mesh-list
139081809|NCT00063258|Carboplatin|carboplatin|mesh-list
139081810|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139081811|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139081812|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081813|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
139081814|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
139081815|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
138747193|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747194|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138747195|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747196|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747197|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138747198|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138747199|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
138747200|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747201|NCT00953329|Alefacept|alefacept|mesh-list
138747202|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
138747203|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
138747204|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747205|NCT02857153|Urapidil|urapidil|mesh-list
138747206|NCT02857153|Phenylephrine|phenylephrine|mesh-list
138747207|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
138747208|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138747209|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
138747210|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
138747211|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747212|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747213|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
138747214|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138747215|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
138747216|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
138747217|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138747218|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138747219|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138747220|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
139081816|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081817|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139081818|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081819|NCT00088530|Prednisone|prednisone|mesh-list
139081820|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
139081821|NCT00088530|Rituximab|rituximab|mesh-list
139081822|NCT00088530|Gemcitabine|gemcitabine|mesh-list
139081823|NCT00088530|Etoposide|etoposide|mesh-list
139081824|NCT00088530|Vincristine|vincristine|mesh-list
139081825|NCT00088530|Vinorelbine|vinorelbine|mesh-list
139081826|NCT00088530|Pixantrone|pixantrone|mesh-list
139081827|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139081828|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
139081829|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081830|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081831|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139081832|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
139081833|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081834|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081835|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139081836|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138747221|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747222|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747223|NCT02857153|Protective Agents|protective agents|mesh-ancestor
138747224|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138747225|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
138747226|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138747227|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
138747228|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138747229|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138747230|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138747231|NCT00953017|Bisacodyl|bisacodyl|mesh-list
138747232|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138747233|NCT00953017|Lubiprostone|lubiprostone|mesh-list
138747234|NCT00953017|Cathartics|cathartics|mesh-ancestor
138747235|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138747237|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138747238|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138747239|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747240|NCT00955357|Lacosamide|lacosamide|mesh-list
138747241|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
138747242|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138747243|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138747244|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139081837|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139081838|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
139081839|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139081840|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
139081841|NCT00088530|Hormones|hormones|mesh-ancestor
139081842|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139081843|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139081844|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139081845|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139081846|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139081847|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081848|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
139081849|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
139081850|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
139081851|NCT00359801|Insulin|insulin|mesh-list
139081852|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139081853|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139081854|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081855|NCT03990701|Metomidate|metomidate|mesh-list
139081856|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139081857|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139081858|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081859|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
139081860|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
139081861|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139081862|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139081863|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139081864|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747245|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747246|NCT00955279|Golimumab|golimumab|mesh-list
138747247|NCT00955279|Ustekinumab|ustekinumab|mesh-list
138747248|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
138747249|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138747250|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138747251|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747252|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
138747253|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747254|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138747255|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
138747256|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138747257|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747258|NCT02857309|Hormones|hormones|mesh-ancestor
138747259|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138747260|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747261|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
138747262|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138747263|NCT02857309|Diuretics|diuretics|mesh-ancestor
138747264|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
138747265|NCT04261231|Anesthetics|anesthetics|mesh-list
138747266|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138747267|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747268|NCT02857465|Dexamethasone|dexamethasone|mesh-list
138747269|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
138747270|NCT02857465|Sufentanil|sufentanil|mesh-list
138747271|NCT02857465|Dsuvia|dsuvia|mesh-list
138747272|NCT02857465|Ropivacaine|ropivacaine|mesh-list
138747273|NCT02857465|BB 1101|bb 1101|mesh-list
139081865|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139081866|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139081867|NCT01051271|Midazolam|midazolam|mesh-list
139081868|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139081869|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139081870|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139081871|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081872|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139081873|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139081874|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138275363|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
139081875|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139081876|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
139081877|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
139081878|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
139081879|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
139081880|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081881|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081882|NCT01051427|Hemostatics|hemostatics|mesh-list
138747274|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138747275|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
138820932|NCT04299971|Tofacitinib|tofacitinib|mesh-list
138747276|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
138747277|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747278|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820942|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747279|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138747280|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
138747281|NCT02857465|Hormones|hormones|mesh-ancestor
138747282|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138747283|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138747284|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747285|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
138747286|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747287|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747288|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
138747289|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
138747290|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138747291|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
138747292|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138747293|NCT02857465|Narcotics|narcotics|mesh-ancestor
138747294|NCT02857465|Analgesics|analgesics|mesh-ancestor
138747295|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138747296|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138747297|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
138747298|NCT04260139|Metronidazole|metronidazole|mesh-list
138747299|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747300|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138747301|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138747302|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138747303|NCT04206618|Denosumab|denosumab|mesh-list
138747304|NCT04206618|Teriparatide|teriparatide|mesh-list
139081883|NCT01051427|Surgiflo|surgiflo|mesh-list
139081884|NCT01051427|Coagulants|coagulants|mesh-ancestor
139081885|NCT01052909|Glimepiride|glimepiride|mesh-list
139081886|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139081887|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139081888|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081889|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139081890|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
139081891|NCT00045032|Trastuzumab|trastuzumab|mesh-list
139081892|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139081893|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081894|NCT01052987|Tranilast|tranilast|mesh-list
139081895|NCT01052987|Allopurinol|allopurinol|mesh-list
139081896|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
139081897|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081898|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747305|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138747306|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747307|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138747308|NCT01239732|Paclitaxel|paclitaxel|mesh-list
138747309|NCT01239732|Bevacizumab|bevacizumab|mesh-list
138747310|NCT01239732|Carboplatin|carboplatin|mesh-list
138747311|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138747312|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747313|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
138747314|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
138747315|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
138747316|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747317|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138747318|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138747319|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138747320|NCT01239732|Growth Substances|growth substances|mesh-ancestor
138747321|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747322|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
138747323|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138747324|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138821013|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138747325|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138747326|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138747327|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138747328|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
138747329|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081899|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
139081900|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139081901|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139081902|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
139081903|NCT01052987|Protective Agents|protective agents|mesh-ancestor
139081904|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081905|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139081906|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139081907|NCT01052987|Analgesics|analgesics|mesh-ancestor
139081908|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
139081909|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139081910|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139081911|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139081912|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139081913|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139081914|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139081915|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
139081916|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
139081917|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139081918|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139081919|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139081920|NCT02533973|Calcipotriene|calcipotriene|mesh-list
139081921|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
139081922|NCT01053065|Atorvastatin|atorvastatin|mesh-list
138747330|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747331|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747332|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138747333|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138747334|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747335|NCT00947011|Incretins|incretins|mesh-ancestor
138747336|NCT00947011|Hormones|hormones|mesh-ancestor
138747337|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138747338|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138747339|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
138747340|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747341|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747342|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
138747343|NCT02856685|Analgesics|analgesics|mesh-ancestor
138747344|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
138747345|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747346|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747347|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747348|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138747349|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138747350|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747351|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747352|NCT02860663|Vitamin D|vitamin d|mesh-list
138747353|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
138747354|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
138747355|NCT02860663|Vitamins|vitamins|mesh-list
138747356|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
138666768|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
139081923|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
139081924|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
139081925|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139081926|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139081927|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
139081928|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081929|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139081930|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139081931|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081933|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139081934|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081935|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139081936|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139081937|NCT01051583|Growth Substances|growth substances|mesh-ancestor
139081938|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081939|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
139081940|NCT03950804|Eculizumab|eculizumab|mesh-list
139081941|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138747357|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747358|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138747359|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138747360|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
138747361|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138747362|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747363|NCT01239342|Everolimus|everolimus|mesh-list
138747364|NCT01239342|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138747365|NCT01239342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138747366|NCT01239342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747367|NCT01239342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747368|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747369|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
138747370|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747371|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747372|NCT00946309|Sulforaphane|sulforaphane|mesh-list
138747373|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138747374|NCT00946309|Protective Agents|protective agents|mesh-ancestor
138747375|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747376|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747377|NCT02853799|Insulin|insulin|mesh-list
138747378|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138747379|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747380|NCT01236534|Lubiprostone|lubiprostone|mesh-list
138747381|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138747382|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138747383|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747384|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
138747385|NCT01235598|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138747386|NCT01235598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138747387|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747388|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
138747389|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747405|NCT01235442|Hormones|hormones|mesh-ancestor
138747406|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138747407|NCT01163253|Tofacitinib|tofacitinib|mesh-list
138747408|NCT01163253|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138747409|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138747410|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747411|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747412|NCT01162863|Lubiprostone|lubiprostone|mesh-list
138747413|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138747414|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138747415|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081942|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139081943|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
139081944|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081945|NCT00356915|Itraconazole|itraconazole|mesh-list
139081946|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
139081947|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
139081948|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139081949|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139081950|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139081951|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081952|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081953|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139081954|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
139081955|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139081956|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081957|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139081958|NCT00356759|Warfarin|warfarin|mesh-list
139081959|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
139081960|NCT00356603|Sumatriptan|sumatriptan|mesh-list
139081961|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139081962|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139081963|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139081964|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
139081969|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
139081970|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
139081971|NCT01052051|Calcium|calcium|mesh-list
139081972|NCT01052051|Vitamins|vitamins|mesh-ancestor
139081973|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
139081974|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081975|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139081976|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139081977|NCT01052051|Antacids|antacids|mesh-ancestor
139081978|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081979|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139081980|NCT00002558|Paclitaxel|paclitaxel|mesh-list
139081981|NCT00002558|Etoposide|etoposide|mesh-list
139081982|NCT00002558|Carboplatin|carboplatin|mesh-list
139081983|NCT00002558|Ifosfamide|ifosfamide|mesh-list
139081984|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139081985|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139081986|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
139081987|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
139081988|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
139081989|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081990|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139081991|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139081992|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139081993|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139081994|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
139081995|NCT00001880|Cyclosporine|cyclosporine|mesh-list
139081996|NCT00001880|Methotrexate|methotrexate|mesh-list
139081997|NCT00001880|Cyclosporins|cyclosporins|mesh-list
139081998|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139081999|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
139082000|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138821058|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139082001|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082002|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139082004|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082005|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082006|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
139082007|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082008|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139082009|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139082010|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
139082011|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139082012|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139082013|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
139082014|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082015|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139082016|NCT01096472|Octenidine|octenidine|mesh-list
138747434|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747436|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138747437|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138747438|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
138747439|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747440|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747441|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747442|NCT01161537|Ivacaftor|ivacaftor|mesh-list
138747443|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138747444|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138747445|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747446|NCT04314297|Durvalumab|durvalumab|mesh-list
138747447|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138747448|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747449|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
138747450|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138747451|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
138747452|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747453|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
138747454|NCT04124133|Protective Agents|protective agents|mesh-ancestor
138747455|NCT01233258|Factor VIII|factor viii|mesh-list
138747456|NCT01233258|Coagulants|coagulants|mesh-ancestor
138747457|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
138747458|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138747459|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
138747460|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747461|NCT01232790|Expectorants|expectorants|mesh-ancestor
138747462|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
138747463|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138747464|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
138747465|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747466|NCT01232790|Protective Agents|protective agents|mesh-ancestor
138747467|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747468|NCT01232790|Antidotes|antidotes|mesh-ancestor
138747469|NCT01232556|Rituximab|rituximab|mesh-list
138747470|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139082017|NCT01096472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747472|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138747473|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138747474|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747475|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
138747476|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747477|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138747478|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138747479|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
138747480|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747481|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138747482|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
138747483|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138747484|NCT01232556|Immunotoxins|immunotoxins|mesh-ancestor
138747485|NCT01232556|Immunoconjugates|immunoconjugates|mesh-ancestor
138747486|NCT00946153|Lenvatinib|lenvatinib|mesh-list
138747487|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747488|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138747489|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747490|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747491|NCT01914367|Vaccines|vaccines|mesh-list
138747492|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
138747493|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747494|NCT01160289|Tadalafil|tadalafil|mesh-list
138747495|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
139082018|NCT01096472|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139082019|NCT05627648|Mitogens|mitogens|mesh-list
139082020|NCT05627648|Mitosis Modulators|mitosis modulators|mesh-ancestor
139082021|NCT05627648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082022|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
139082023|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139082024|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139082025|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082026|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139082027|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139082028|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
139082029|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082030|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082031|NCT01104896|Nicotine|nicotine|mesh-list
139082032|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139082033|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
139082034|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082035|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082036|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139082037|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139082038|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
139082039|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082040|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082041|NCT00043550|Sertraline|sertraline|mesh-list
139082042|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138747496|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138747497|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138821110|NCT00769132|Niacinamide|niacinamide|mesh-list
138747499|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747500|NCT01160289|Urological Agents|urological agents|mesh-ancestor
138821124|NCT04100434|Evolocumab|evolocumab|mesh-list
138747501|NCT01159665|Plasminogen|plasminogen|mesh-list
138747502|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
138747503|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138747504|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138747505|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747506|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138747507|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
138747508|NCT01158261|Coagulants|coagulants|mesh-ancestor
138747509|NCT01157169|Buprenorphine|buprenorphine|mesh-list
138747510|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138747511|NCT01157169|Narcotics|narcotics|mesh-ancestor
138747512|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138747513|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747514|NCT01157169|Analgesics|analgesics|mesh-ancestor
138747515|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
138667048|NCT00430079|Etanidazole|etanidazole|mesh-list
139082043|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
139082044|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139082045|NCT00043550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139082046|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139082047|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139082048|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082049|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082051|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082052|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139082053|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139082054|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
139082055|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139082056|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139082057|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082058|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
139082059|NCT01102244|Hormones|hormones|mesh-ancestor
139082060|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082061|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082062|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139082063|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139082064|NCT01105208|Cephalexin|cephalexin|mesh-list
139082065|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139082066|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082067|NCT01105286|Vitamin D|vitamin d|mesh-list
139082068|NCT01105286|Calcipotriene|calcipotriene|mesh-list
139082069|NCT01105286|Vitamins|vitamins|mesh-ancestor
139082070|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
139082071|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832632|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
139082072|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139082073|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
139082074|NCT00041132|Leucovorin|leucovorin|mesh-list
139082075|NCT00041132|Cytarabine|cytarabine|mesh-list
139082076|NCT00041132|Dexamethasone|dexamethasone|mesh-list
139082077|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
139082078|NCT00041132|Rituximab|rituximab|mesh-list
138747516|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747517|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138747518|NCT04313907|Clonazepam|clonazepam|mesh-list
138747519|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
138747520|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
138747521|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
138747522|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821196|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138747523|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747524|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747525|NCT01231620|Oseltamivir|oseltamivir|mesh-list
138747526|NCT01231620|Zanamivir|zanamivir|mesh-list
138747527|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
138747528|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747529|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747530|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747531|NCT01231464|Fluticasone|fluticasone|mesh-list
138747532|NCT01231464|Xhance|xhance|mesh-list
138747533|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138747534|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138747535|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
138747536|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747537|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747538|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138747539|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
138747540|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
138747541|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138747542|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138747543|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
138747544|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747545|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
138747546|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747547|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
138747548|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138747549|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138747550|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138747551|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138747553|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
138747556|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138747557|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747558|NCT01155531|Sertraline|sertraline|mesh-list
138747559|NCT01155531|Telenzepine|telenzepine|mesh-list
138747560|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
138747561|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138747562|NCT01155531|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138747563|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138747564|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138747565|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747566|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747567|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
138747568|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747569|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
138747570|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
138747571|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747572|NCT01155219|Latanoprost|latanoprost|mesh-list
138747573|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138747574|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138747575|NCT00631033|Metformin|metformin|mesh-list
138747576|NCT00631033|Diazoxide|diazoxide|mesh-list
138747577|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138747578|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747579|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138747580|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
138747581|NCT01155063|Exemestane|exemestane|mesh-list
138747582|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747583|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138747605|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747606|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138747607|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138421799|NCT01682577|Perindopril|perindopril|mesh-list
138747608|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138747609|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138747610|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138747611|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138747612|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138747613|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138747614|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138747615|NCT02884713|Doxycycline|doxycycline|mesh-list
138747616|NCT02884713|Levofloxacin|levofloxacin|mesh-list
138747617|NCT02884713|Esomeprazole|esomeprazole|mesh-list
138747618|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138747619|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138747620|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138747621|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747622|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747623|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138747624|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747625|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
138747626|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138747627|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138747628|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138747629|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138747630|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138747631|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747632|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138747634|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
138747649|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747650|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138747651|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747652|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747653|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
138747654|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747655|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138747656|NCT01228734|Antidotes|antidotes|mesh-ancestor
138747657|NCT01228734|Protective Agents|protective agents|mesh-ancestor
138747658|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
138747659|NCT01228734|Vitamins|vitamins|mesh-ancestor
138747660|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
138747661|NCT01228734|Hematinics|hematinics|mesh-ancestor
138747662|NCT01153971|Rituximab|rituximab|mesh-list
138747663|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138747664|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747665|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
138747666|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747667|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138747668|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138747669|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
138747670|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747671|NCT00951379|Pioglitazone|pioglitazone|mesh-list
138747672|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138747673|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747674|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
138747675|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138747676|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138747677|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138747678|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138747679|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747680|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
138747681|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747682|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747683|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139082079|NCT00041132|Doxorubicin|doxorubicin|mesh-list
139082080|NCT00041132|Methotrexate|methotrexate|mesh-list
139082081|NCT00041132|Vincristine|vincristine|mesh-list
139082082|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
139082083|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747684|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138421874|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747685|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
138747686|NCT01153425|Teriparatide|teriparatide|mesh-list
138747687|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138747688|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747689|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138747691|NCT01153269|Lopinavir|lopinavir|mesh-list
138747692|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138747693|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138747694|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
138747695|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747696|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747697|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138747698|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138747699|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
138747700|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747701|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138747702|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138747703|NCT02884635|Methotrexate|methotrexate|mesh-list
138747704|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138747705|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
138747706|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138747707|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747708|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138747710|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082084|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
139082085|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082086|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139082087|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139082088|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
139082089|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082090|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275536|NCT00003603|Hormones|hormones|mesh-ancestor
139082091|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139082092|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139082093|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
139082094|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
139082095|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082096|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139082097|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
139082098|NCT00041132|Hormones|hormones|mesh-ancestor
139082099|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082100|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138747711|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747712|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
138747713|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747714|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138747715|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747716|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
138747717|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138747718|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138747719|NCT02884479|Docetaxel|docetaxel|mesh-list
138747720|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747721|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
138747722|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
138747723|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
138747724|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747725|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
138747726|NCT01152021|Propofol|propofol|mesh-list
138747727|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138747728|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138747729|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747730|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138747731|NCT01152021|Analgesics|analgesics|mesh-ancestor
138747732|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
138747733|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747734|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138747735|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138747736|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138747737|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
138747738|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747739|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747740|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138747741|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
139082101|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139082102|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139082103|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139082104|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139082105|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082106|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139082107|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
139082108|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139082109|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139082110|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
139082111|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
139082112|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138747742|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
138747743|NCT01151085|Voriconazole|voriconazole|mesh-list
138747744|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
138747745|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747746|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138747747|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138747748|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747749|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747750|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138747751|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
138747752|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138747753|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747754|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138747756|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
138747757|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
138747758|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747759|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747760|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138747761|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138747762|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747763|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747764|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
138747765|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138747766|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138747768|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
138821328|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
138747769|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138747770|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
138747771|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138747772|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
138747773|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
138747774|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747775|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747776|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138747777|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
138747778|NCT00879931|Hormones|hormones|mesh-ancestor
139082113|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138747779|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138747780|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138747781|NCT00879931|Protective Agents|protective agents|mesh-ancestor
138747782|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138747783|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747784|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
138747785|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138747786|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
138747787|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747788|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
138747789|NCT00739141|Thiotepa|thiotepa|mesh-list
138747790|NCT00739141|Fludarabine|fludarabine|mesh-list
138747791|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747792|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
138747793|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747794|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138747795|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138747796|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
138747797|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667361|NCT00462540|Bromides|bromides|mesh-list
139082114|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
139082115|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082116|NCT00041132|Antidotes|antidotes|mesh-ancestor
139082117|NCT00041132|Protective Agents|protective agents|mesh-ancestor
139082118|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
139082119|NCT00041132|Vitamins|vitamins|mesh-ancestor
139082120|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
139082121|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139082122|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
139082123|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
139082124|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
139082125|NCT00040664|Ritonavir|ritonavir|mesh-list
139082126|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
139082127|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139082128|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139082129|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
139082130|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082131|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082132|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139082133|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139082134|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
139082135|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082136|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139082137|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139082139|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139082140|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082141|NCT01096706|Aspirin|aspirin|mesh-list
139082142|NCT01096706|Fluconazole|fluconazole|mesh-list
139082143|NCT01096706|Substance P|substance p|mesh-list
139082144|NCT01096706|Neurokinin A|neurokinin a|mesh-list
139082145|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139082146|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139082147|NCT01096706|Analgesics|analgesics|mesh-ancestor
139082148|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
139082149|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082150|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747798|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747799|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138747800|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138747801|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138747802|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747803|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138747804|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138747805|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138747806|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747807|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
138747808|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747809|NCT01735825|Paclitaxel|paclitaxel|mesh-list
138747810|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138747811|NCT01735825|Everolimus|everolimus|mesh-list
138747812|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138747813|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747814|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
138747815|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
138747816|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
138747817|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747818|NCT01735825|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138747819|NCT01735825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138747820|NCT01735825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747821|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747822|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
138747823|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747824|NCT01148511|Ranibizumab|ranibizumab|mesh-list
138747825|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138747826|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139082151|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139082152|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139082153|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139082154|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139082155|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082156|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139082157|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139082158|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082160|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
139082161|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082162|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139082163|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139082164|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139082165|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
138747827|NCT01148511|Growth Substances|growth substances|mesh-ancestor
138821360|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
138747828|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747829|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
138747830|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747831|NCT02860117|Ketamine|ketamine|mesh-list
138747832|NCT02860117|Analgesics|analgesics|mesh-ancestor
138747833|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
138747834|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747835|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747836|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138747837|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138747838|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
138747839|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
138747840|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138747841|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138747842|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138747843|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747844|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747845|NCT02853253|SMOFlipid|smoflipid|mesh-list
138747846|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138747847|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138747848|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138747849|NCT04269187|Theophylline|theophylline|mesh-list
138747850|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138747851|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
138747852|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747853|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747854|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138747855|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
138747856|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138747871|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
138747872|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747873|NCT04268563|Metformin|metformin|mesh-list
138747874|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138747875|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138747876|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747877|NCT04268563|Incretins|incretins|mesh-ancestor
138747878|NCT04268563|Hormones|hormones|mesh-ancestor
138747879|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138747880|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138747881|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
138747882|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747883|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747884|NCT01225146|Ranibizumab|ranibizumab|mesh-list
138747885|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138747886|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138747887|NCT01225146|Growth Substances|growth substances|mesh-ancestor
138747888|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747889|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
138747890|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747891|NCT01223196|Pioglitazone|pioglitazone|mesh-list
138747892|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138747893|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747894|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138747895|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747896|NCT00950911|Denosumab|denosumab|mesh-list
138747897|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138747898|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747899|NCT02855515|Anesthetics|anesthetics|mesh-list
139082166|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082167|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139082168|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139082169|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082170|NCT01102478|Losartan|losartan|mesh-list
139082171|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139082172|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139082173|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139082174|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139082175|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139082176|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082177|NCT01102478|Diuretics|diuretics|mesh-ancestor
139082178|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
139082179|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082180|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138747900|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138747901|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747902|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138747903|NCT04206228|Hematinics|hematinics|mesh-ancestor
138747904|NCT01218594|Endostatins|endostatins|mesh-list
138747905|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138747906|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138747907|NCT01218594|Growth Substances|growth substances|mesh-ancestor
138747908|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747909|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
138747910|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747912|NCT01610557|Ranibizumab|ranibizumab|mesh-list
138747913|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138747914|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747915|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138747916|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138747917|NCT01610557|Growth Substances|growth substances|mesh-ancestor
138747918|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747919|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
138747921|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138747922|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138747923|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
138747924|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747925|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747926|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747927|NCT00943735|Urological Agents|urological agents|mesh-ancestor
138747929|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747930|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747931|NCT01147497|Misoprostol|misoprostol|mesh-list
138747932|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138747933|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
138747934|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138747935|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747936|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138747940|NCT01147341|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138747941|NCT01147341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138747942|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138747943|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
138747944|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747945|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138747946|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
138747947|NCT00950755|Antibodies|antibodies|mesh-list
138821406|NCT01014767|Leucovorin|leucovorin|mesh-list
138747948|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
138747949|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747950|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747951|NCT01147107|Efavirenz|efavirenz|mesh-list
138747952|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
138747953|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138747954|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138747955|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747956|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747957|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
138747958|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747959|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138747960|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138747961|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138747962|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139082181|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138275571|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139082182|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
139082183|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139082184|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
139082185|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082186|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139082187|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082188|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139082189|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082190|NCT03384316|Vaccines|vaccines|mesh-list
139082191|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
139082192|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082193|NCT01105832|Teriparatide|teriparatide|mesh-list
139082194|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139082195|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082196|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139082197|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139082198|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
139082199|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139082200|NCT00356525|Carboplatin|carboplatin|mesh-list
139082201|NCT00356525|Gemcitabine|gemcitabine|mesh-list
139082202|NCT00356525|Pemetrexed|pemetrexed|mesh-list
139082203|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082204|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139082205|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
139082206|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747963|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138747964|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138747965|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138747966|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138747967|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138747968|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138747969|NCT01146951|Rufinamide|rufinamide|mesh-list
138747970|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
138747971|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138747972|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138747973|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138747974|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747975|NCT01146873|Ritonavir|ritonavir|mesh-list
138747976|NCT01146873|Lopinavir|lopinavir|mesh-list
138747977|NCT01146873|Abacavir|abacavir|mesh-list
138747978|NCT01146873|Stavudine|stavudine|mesh-list
138747979|NCT01146873|Efavirenz|efavirenz|mesh-list
138747980|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138747981|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138747982|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
138747983|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747984|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747985|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138747986|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138747988|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138747989|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138747990|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138747991|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138747992|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139082207|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082208|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139082209|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139082210|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
139082211|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082212|NCT01052129|Naproxen|naproxen|mesh-list
139082213|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139082214|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139082215|NCT01052129|Analgesics|analgesics|mesh-ancestor
139082216|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
139082217|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082218|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082219|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139082220|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139082221|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
139082222|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139082223|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747993|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138747994|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138747995|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138747996|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138747997|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138747998|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
138747999|NCT01146795|Paclitaxel|paclitaxel|mesh-list
138748000|NCT01146795|Bevacizumab|bevacizumab|mesh-list
138748001|NCT01146795|Carboplatin|carboplatin|mesh-list
138748002|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138748003|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748004|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
138748005|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
138748006|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
138748007|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748008|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138748009|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138748010|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138748011|NCT01146795|Growth Substances|growth substances|mesh-ancestor
138748012|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748013|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
138748014|NCT01146561|Tanezumab|tanezumab|mesh-list
138748015|NCT01146561|Analgesics|analgesics|mesh-ancestor
138748016|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
138748017|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748018|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748019|NCT00942175|Esomeprazole|esomeprazole|mesh-list
138748020|NCT00942175|Omeprazole|omeprazole|mesh-list
138748021|NCT00942175|Lansoprazole|lansoprazole|mesh-list
138748022|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
138748023|NCT00942175|Clopidogrel|clopidogrel|mesh-list
138748024|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138748025|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138748035|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748037|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138748038|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
138748039|NCT02852083|Pioglitazone|pioglitazone|mesh-list
138748040|NCT02852083|Clarithromycin|clarithromycin|mesh-list
138748041|NCT02852083|Nivolumab|nivolumab|mesh-list
138748042|NCT02852083|Treosulfan|treosulfan|mesh-list
138748043|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138748044|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748045|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138748046|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748047|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138748048|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748049|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138748050|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138748051|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138748052|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748053|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138748054|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138748055|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138748056|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
138748058|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138748059|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
138748060|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748061|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748062|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138748063|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
138748064|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139082224|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082225|NCT01053377|Oseltamivir|oseltamivir|mesh-list
139082226|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
139082227|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082228|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082229|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082230|NCT03991559|Manganese|manganese|mesh-list
138821464|NCT01014533|Gabapentin|gabapentin|mesh-list
139082231|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139082232|NCT03991559|Antibodies|antibodies|mesh-list
139082233|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
139082234|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
139082235|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082236|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082237|NCT03991559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139082238|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082239|NCT03991559|Trace Elements|trace elements|mesh-ancestor
139082240|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
138748065|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138748066|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748067|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138748068|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
138748069|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138748070|NCT00602407|Protective Agents|protective agents|mesh-ancestor
138748071|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138748072|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138748073|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748074|NCT00950599|Saxagliptin|saxagliptin|mesh-list
138748075|NCT00950599|Incretins|incretins|mesh-ancestor
138748076|NCT00950599|Hormones|hormones|mesh-ancestor
138748077|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138748078|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748079|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138748080|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
138748081|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748082|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748083|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138748084|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138748085|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
138748086|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138748087|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138748088|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138748089|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
138748090|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138748091|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748092|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138748093|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138748094|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138748106|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138748107|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138748108|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
138748109|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748110|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138748111|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
138748112|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
138748113|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
138748114|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138748115|NCT05199597|Atropine|atropine|mesh-list
138748116|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138748117|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138748118|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138748119|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
138748120|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748121|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748122|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138748123|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
138748124|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
138748125|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
138748126|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138748127|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138748128|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
138748129|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748130|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748131|NCT01142193|Topiramate|topiramate|mesh-list
138748132|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
138748133|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138748134|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748135|NCT01139775|Pemetrexed|pemetrexed|mesh-list
138748151|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
138748152|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748153|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748154|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748155|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138748156|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138748157|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138748158|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138748159|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748160|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748161|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748162|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138748163|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
138748164|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138748165|NCT00941863|Sorafenib|sorafenib|mesh-list
138748166|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748167|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138748168|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748169|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748170|NCT00602173|Cilostazol|cilostazol|mesh-list
138748171|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138748172|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
138748173|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748174|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748175|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138748176|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
138748177|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138748178|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138748179|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748180|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139082241|NCT03949634|Paclitaxel|paclitaxel|mesh-list
139082242|NCT03949634|Docetaxel|docetaxel|mesh-list
139082243|NCT03949634|Doxorubicin|doxorubicin|mesh-list
139082244|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139082245|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082246|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
139082247|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
139082248|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
139082249|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082250|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138748181|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
138748182|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138748183|NCT00602173|Protective Agents|protective agents|mesh-ancestor
138748184|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138748185|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138748186|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748187|NCT02852239|Dabrafenib|dabrafenib|mesh-list
138748188|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748189|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138748190|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748191|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748193|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748194|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748195|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748196|NCT00602251|Terbinafine|terbinafine|mesh-list
138748197|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
138748198|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138748199|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748200|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748201|NCT01281956|Naluzotan|naluzotan|mesh-list
138748202|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138748203|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139082251|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139082252|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139082253|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082254|NCT01108874|Metaraminol|metaraminol|mesh-list
139082255|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
139082256|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
139082257|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082258|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082259|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139082260|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139082261|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139082262|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139082263|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
139082264|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082265|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082266|NCT03383614|Emodepside|emodepside|mesh-list
139082267|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139082268|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082269|NCT03403036|Brodalumab|brodalumab|mesh-list
139082271|NCT00356135|Clopidogrel|clopidogrel|mesh-list
139082272|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139082273|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139082274|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139082275|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139082276|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139082277|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
139082278|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082279|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082280|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082281|NCT01052363|Bevacizumab|bevacizumab|mesh-list
138748204|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
138748205|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748206|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748207|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748209|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138748210|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138748211|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138748212|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748213|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
138748214|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138748215|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
138748216|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748217|NCT00602719|Zolpidem|zolpidem|mesh-list
138748218|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138748219|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138748220|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138748221|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748222|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138748223|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
138748224|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
138748225|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748226|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748227|NCT00604435|Docetaxel|docetaxel|mesh-list
138748228|NCT00604435|Epirubicin|epirubicin|mesh-list
138748229|NCT00604435|Endostatins|endostatins|mesh-list
138748230|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748231|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
138748232|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
138748233|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
138748234|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082282|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139082283|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082284|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139082285|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139082286|NCT01052363|Growth Substances|growth substances|mesh-ancestor
139082287|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082288|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
139082289|NCT01053611|Remifentanil|remifentanil|mesh-list
139082290|NCT01053611|Propofol|propofol|mesh-list
139082291|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139082292|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139082293|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082294|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138748235|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138748236|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138748237|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138748238|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748239|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138748240|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138748241|NCT00604435|Growth Substances|growth substances|mesh-ancestor
138748242|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748243|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
138748244|NCT01136967|Lenvatinib|lenvatinib|mesh-list
138748245|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748246|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138748247|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748248|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748249|NCT01218516|Paclitaxel|paclitaxel|mesh-list
138748250|NCT01218516|Carboplatin|carboplatin|mesh-list
138748251|NCT01218516|Pemetrexed|pemetrexed|mesh-list
138748252|NCT01218516|Farletuzumab|farletuzumab|mesh-list
139082295|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
139082296|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
139082297|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139082298|NCT01053611|Narcotics|narcotics|mesh-ancestor
139082299|NCT01053611|Analgesics|analgesics|mesh-ancestor
139082300|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
139082301|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082302|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
139082303|NCT00350519|Hematinics|hematinics|mesh-ancestor
139082304|NCT01053689|Glimepiride|glimepiride|mesh-list
139082305|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139082306|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139082307|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082308|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139082309|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
139082310|NCT01111448|Sirolimus|sirolimus|mesh-list
138821604|NCT00715273|Niacin|niacin|mesh-list
139082311|NCT01111448|Temsirolimus|temsirolimus|mesh-list
139082312|NCT01111448|MTOR Inhibitors|mtor inhibitors|mesh-list
139082313|NCT01111448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139082314|NCT01111448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082315|NCT01111448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082316|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139082317|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
139082318|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082319|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082320|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139082321|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082322|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139082324|NCT03382912|Nivolumab|nivolumab|mesh-list
139082325|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139082326|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082327|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139082328|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082329|NCT03942926|Sirolimus|sirolimus|mesh-list
139082330|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139082331|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082332|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139082333|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082334|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
139082335|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139082336|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
139082337|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748253|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138550881|NCT00257803|Oxytocin|oxytocin|mesh-list
138748255|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
138748256|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
138748257|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
138748258|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748259|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748260|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138748261|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138748262|NCT00938431|Lacosamide|lacosamide|mesh-list
138748263|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
138748264|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138748265|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138748266|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138748267|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748268|NCT05381389|Bupivacaine|bupivacaine|mesh-list
138748269|NCT05381389|Anesthetics, Local|anesthetics, local|mesh-ancestor
138748270|NCT05381389|Anesthetics|anesthetics|mesh-ancestor
138748271|NCT05381389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138748272|NCT05381389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748273|NCT05381389|Sensory System Agents|sensory system agents|mesh-ancestor
138748274|NCT05381389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748275|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
138748276|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
138748277|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
138748278|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138748279|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138748280|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
138748281|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
138748282|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748283|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748284|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748285|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138748286|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
138748287|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138748288|NCT04312347|Tamoxifen|tamoxifen|mesh-list
138748289|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139082338|NCT00350207|Bromides|bromides|mesh-list
138748291|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138748292|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748293|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138748294|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748295|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138748296|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138748297|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138748298|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
138748299|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748300|NCT05379283|Lidocaine|lidocaine|mesh-list
138748301|NCT05379283|Anesthetics, Local|anesthetics, local|mesh-ancestor
138748302|NCT05379283|Anesthetics|anesthetics|mesh-ancestor
138748303|NCT05379283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138748304|NCT05379283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748305|NCT05379283|Sensory System Agents|sensory system agents|mesh-ancestor
138748306|NCT05379283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748307|NCT05379283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138748308|NCT05379283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138748309|NCT05379283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138748310|NCT05379283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138748311|NCT05379283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748312|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139082339|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
139082340|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139082341|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139082342|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
139082343|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082344|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082345|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139082346|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
139082347|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
139082348|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139082349|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
139082350|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082351|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275696|NCT00003639|Hormones|hormones|mesh-ancestor
139082352|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139082353|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139082354|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139082355|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
139082356|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
139082357|NCT03946826|Halometasone|halometasone|mesh-list
139082358|NCT03946826|Petrolatum|petrolatum|mesh-list
139082359|NCT03946826|Emollients|emollients|mesh-ancestor
139082360|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
139082361|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139082362|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
139082363|NCT03946826|Hormones|hormones|mesh-ancestor
138748313|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
138748314|NCT01218438|Antibodies|antibodies|mesh-list
138748315|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
138748316|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138748317|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138748318|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
138748319|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
138748320|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748321|NCT00604591|Tolcapone|tolcapone|mesh-list
138748322|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138748323|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138748324|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138748325|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748326|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748327|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
138748329|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
138748330|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748331|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
138748332|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748333|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748334|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
138748335|NCT02691156|Protective Agents|protective agents|mesh-ancestor
138748336|NCT00603031|Glucagon|glucagon|mesh-list
138748337|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
138748338|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138748339|NCT00603031|Hormones|hormones|mesh-ancestor
139082364|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082365|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082366|NCT01311622|Warfarin|warfarin|mesh-list
139082367|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
139082368|NCT00349973|Dipyridamole|dipyridamole|mesh-list
139082369|NCT00349973|Olanzapine|olanzapine|mesh-list
139082370|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
139082371|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
139082372|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082373|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082374|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139082375|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139082376|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139082377|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139082378|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139082379|NCT00349973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139082380|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139082381|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139082382|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082383|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082385|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139082386|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082387|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139082388|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
139082389|NCT01111682|Mannitol|mannitol|mesh-list
138748340|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138748341|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748342|NCT00603031|Incretins|incretins|mesh-ancestor
138748343|NCT05379049|Adalimumab|adalimumab|mesh-list
138748344|NCT05379049|Infliximab|infliximab|mesh-list
138748345|NCT05379049|Etanercept|etanercept|mesh-list
138748346|NCT05379049|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138748347|NCT05379049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138748348|NCT05379049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138748349|NCT05379049|Dermatologic Agents|dermatologic agents|mesh-ancestor
138748350|NCT05379049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138748351|NCT05379049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138748352|NCT05379049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138748353|NCT05379049|Analgesics|analgesics|mesh-ancestor
138748354|NCT05379049|Sensory System Agents|sensory system agents|mesh-ancestor
138748355|NCT05379049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748356|NCT05379049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748357|NCT05379049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138748358|NCT05379049|Immunologic Factors|immunologic factors|mesh-ancestor
138748359|NCT02851459|Vaccines|vaccines|mesh-list
138748360|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
138748361|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748362|NCT00603343|Propiverine|propiverine|mesh-list
138748363|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
138748364|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
138748365|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748366|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748388|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138748389|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
138748390|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138748391|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138748392|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138748393|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138748394|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748395|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138748396|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138748397|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138748399|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748400|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
138748401|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138748402|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138748403|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138748404|NCT05378503|Topiramate|topiramate|mesh-list
138748405|NCT05378503|Phentermine|phentermine|mesh-list
138748406|NCT05378503|Anticonvulsants|anticonvulsants|mesh-ancestor
138748407|NCT05378503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138748408|NCT05378503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748409|NCT05378503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138748410|NCT05378503|Appetite Depressants|appetite depressants|mesh-ancestor
138748411|NCT05378503|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138748412|NCT05378503|Sympathomimetics|sympathomimetics|mesh-ancestor
138748413|NCT05378503|Autonomic Agents|autonomic agents|mesh-ancestor
138748414|NCT05378503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748415|NCT05378503|Adrenergic Agents|adrenergic agents|mesh-ancestor
139082390|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139082391|NCT01111682|Diuretics|diuretics|mesh-ancestor
139082392|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
139082393|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082394|NCT04464122|Somatostatin|somatostatin|mesh-list
139082395|NCT04464122|Hormones|hormones|mesh-ancestor
139082396|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082397|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082398|NCT01111994|Clindamycin|clindamycin|mesh-list
139082399|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
139082400|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
139082401|NCT01111994|Tretinoin|tretinoin|mesh-list
139082402|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139082403|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082404|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139082405|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082406|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082407|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082408|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
139082409|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
139082410|NCT03187262|Daratumumab|daratumumab|mesh-list
138748416|NCT05378503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748417|NCT05378503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748418|NCT05378191|Vaccines|vaccines|mesh-list
138748419|NCT05378191|Immunologic Factors|immunologic factors|mesh-ancestor
138748420|NCT05378191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748421|NCT00605137|Insulin|insulin|mesh-list
138748422|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138748423|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
138748424|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
138748425|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
138422616|NCT05288127|Talazoparib|talazoparib|mesh-list
138748426|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
138748427|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138748428|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748430|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138748431|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138748432|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
138748433|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748434|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748435|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748436|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138748437|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
138748438|NCT00606775|Protective Agents|protective agents|mesh-ancestor
138748439|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138668217|NCT00435305|Linezolid|linezolid|mesh-list
139082411|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082412|NCT03944252|Cetuximab|cetuximab|mesh-list
139082413|NCT03944252|Avelumab|avelumab|mesh-list
139082414|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139082415|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082416|NCT01209026|Fluticasone|fluticasone|mesh-list
139082417|NCT01209026|Xhance|xhance|mesh-list
139082418|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
139082419|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139082420|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139082421|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139082422|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
139082423|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082424|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082425|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139082426|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
139082427|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
139082428|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139082429|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139082430|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082431|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139082432|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139082433|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082434|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082435|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082436|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139082437|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
138748440|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138748441|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138748442|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
138748443|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138748444|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138748445|NCT00605371|Lamotrigine|lamotrigine|mesh-list
138748446|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
138748447|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138748448|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138748449|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748450|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138748451|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748452|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138748453|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138748454|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138748455|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139082438|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139082439|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139082440|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139082441|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139082442|NCT01107470|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139082443|NCT01107470|Hormones|hormones|mesh-ancestor
139082444|NCT01107470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082445|NCT01107470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082446|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139082447|NCT01109264|Chlorambucil|chlorambucil|mesh-list
139082448|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139082449|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
139082450|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082451|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082453|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139082454|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139082455|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
139082456|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
139082457|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082458|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082459|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139082460|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139082461|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139082462|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
139082463|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082464|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082465|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
139082466|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
139082467|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139082468|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139082469|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082470|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082471|NCT01107782|Urological Agents|urological agents|mesh-ancestor
139082472|NCT01107938|Esomeprazole|esomeprazole|mesh-list
139082473|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139082474|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139082475|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139082476|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748457|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138748458|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138748459|NCT02850913|Doxycycline|doxycycline|mesh-list
138748460|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138748461|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138748462|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
138748463|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138748464|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138748465|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
138748466|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138748467|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138748469|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
138748470|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138748471|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
138748472|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
138748473|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138748474|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
138748475|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
138748476|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748477|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748478|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138748479|NCT00934843|Hormones|hormones|mesh-ancestor
138748480|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138748481|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139082477|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082478|NCT02950558|Ropivacaine|ropivacaine|mesh-list
139082479|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
139082480|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
139082481|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139082482|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082483|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
139082484|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082485|NCT02791334|Ramucirumab|ramucirumab|mesh-list
139082486|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082487|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
139082488|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139082489|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
139082490|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082491|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082492|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139082493|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
139082494|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
139082495|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139082496|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
139082497|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082498|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082499|NCT01209416|Acipimox|acipimox|mesh-list
139082500|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139082501|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
138748483|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138748484|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748485|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
138748486|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
138748487|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
138748488|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138748489|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138748490|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748491|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748492|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748493|NCT04267237|Atezolizumab|atezolizumab|mesh-list
138748494|NCT04267237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138821778|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748495|NCT04267237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748496|NCT04267237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138748497|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748498|NCT00605995|Simvastatin|simvastatin|mesh-list
138748499|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138748500|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138748501|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
138748502|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748503|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138748504|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138748505|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748506|NCT00605683|Cabergoline|cabergoline|mesh-list
139082502|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082503|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139082504|NCT00349349|Ofatumumab|ofatumumab|mesh-list
139082505|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082506|NCT01112462|Acetaminophen|acetaminophen|mesh-list
139082507|NCT01112462|Phenylephrine|phenylephrine|mesh-list
138275757|NCT00004941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139082509|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139082510|NCT01112462|Analgesics|analgesics|mesh-ancestor
139082511|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
139082512|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082513|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082514|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
139082515|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139082516|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
139082517|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
139082518|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
139082519|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139082520|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
139082521|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
139082522|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139082523|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139082524|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138748507|NCT00605683|Pramipexole|pramipexole|mesh-list
138748508|NCT00605683|Ropinirole|ropinirole|mesh-list
138748509|NCT00605683|Bromocriptine|bromocriptine|mesh-list
138748510|NCT00605683|Lisuride|lisuride|mesh-list
138748511|NCT00605683|Apomorphine|apomorphine|mesh-list
138748512|NCT00605683|Pergolide|pergolide|mesh-list
138748513|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138748514|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138748515|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
138748516|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
138748517|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748518|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748519|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748520|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
138748521|NCT00605683|Protective Agents|protective agents|mesh-ancestor
138748522|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
138748523|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138748524|NCT00605683|Emetics|emetics|mesh-ancestor
138748525|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
138748526|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748527|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138748528|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138668438|NCT00481884|Petrolatum|petrolatum|mesh-list
139082525|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
139082526|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082527|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082528|NCT01112462|Protective Agents|protective agents|mesh-ancestor
139082530|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139082531|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
139082532|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139082533|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
139082534|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082535|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082536|NCT01109030|Pioglitazone|pioglitazone|mesh-list
139082537|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
139082538|NCT01109030|Dexetimide|dexetimide|mesh-list
139082539|NCT01109030|Citalopram|citalopram|mesh-list
139082540|NCT01109030|Escitalopram|escitalopram|mesh-list
139082541|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139082542|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082543|NCT01109030|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139082544|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139082545|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139082546|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082547|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082548|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
139082549|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139082550|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
139082551|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139082552|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139082553|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139082554|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
139082555|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
139082556|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748529|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
138748530|NCT01266902|Rilpivirine|rilpivirine|mesh-list
138748531|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138748532|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138748533|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550899|NCT00257959|Amiodarone|amiodarone|mesh-list
138748534|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748535|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
138748536|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138748537|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138748538|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138748539|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
138748540|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138748541|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138748542|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
138748543|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
138748544|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138748545|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748546|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
138821822|NCT02686983|Betamethasone|betamethasone|mesh-list
138748547|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748548|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138748549|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
138748550|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082557|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139082558|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139082559|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
139082560|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139082561|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139082562|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139082563|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139082564|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139082565|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
139082566|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
139082567|NCT05494528|Entecavir|entecavir|mesh-list
139082568|NCT05494528|Antiviral Agents|antiviral agents|mesh-ancestor
139082569|NCT05494528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082570|NCT03987815|Nivolumab|nivolumab|mesh-list
139082571|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139082572|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082573|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139082574|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082575|NCT00348881|Vaccines|vaccines|mesh-list
139082576|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
139082577|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082578|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
139082579|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139082580|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139082581|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082582|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
139082583|NCT02257580|Coagulants|coagulants|mesh-ancestor
139082584|NCT01055795|Bevacizumab|bevacizumab|mesh-list
139082585|NCT01055795|Everolimus|everolimus|mesh-list
139082586|NCT01055795|Panobinostat|panobinostat|mesh-list
139082587|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138748552|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138748553|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138748554|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748555|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748556|NCT01266590|Protective Agents|protective agents|mesh-ancestor
138748557|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748558|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138748559|NCT01265498|Cathartics|cathartics|mesh-ancestor
138748560|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138748561|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
138748562|NCT00607711|Ifosfamide|ifosfamide|mesh-list
138748563|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138748564|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
138748565|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748566|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748567|NCT01263782|Bevacizumab|bevacizumab|mesh-list
138748568|NCT01263782|Carboplatin|carboplatin|mesh-list
138748569|NCT01263782|Pemetrexed|pemetrexed|mesh-list
138748570|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138748571|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748572|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138748573|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138748574|NCT01263782|Growth Substances|growth substances|mesh-ancestor
138748575|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748576|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
138748577|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748578|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748579|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138668529|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139082588|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082589|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139082590|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139082591|NCT01055795|Growth Substances|growth substances|mesh-ancestor
139082592|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082593|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
139082594|NCT01055795|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139082595|NCT01055795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139082596|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275827|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
139082597|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833165|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
139082598|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139082599|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
139082600|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138748580|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138748583|NCT01263704|Fludarabine|fludarabine|mesh-list
138748584|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138748585|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
138748586|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748587|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138748588|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138748589|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
138748590|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748591|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748592|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138748593|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138748594|NCT01263470|Alogliptin|alogliptin|mesh-list
138748595|NCT01263470|Voglibose|voglibose|mesh-list
138748596|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138748597|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748598|NCT01263470|Incretins|incretins|mesh-ancestor
138748599|NCT01263470|Hormones|hormones|mesh-ancestor
138748600|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138748601|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138748602|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
138748603|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550904|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082601|NCT03943784|Propranolol|propranolol|mesh-list
139082602|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139082603|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139082604|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
139082605|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082606|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082607|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082608|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139082609|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139082610|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
139082611|NCT00347009|Adefovir|adefovir|mesh-list
139082612|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139082613|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
139082614|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082615|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139082616|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139082617|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082618|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082619|NCT01209650|Afatinib|afatinib|mesh-list
139082620|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082621|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139082622|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082623|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082624|NCT01947140|Romidepsin|romidepsin|mesh-list
139082625|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139082626|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748604|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748605|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138821902|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138748606|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138748608|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748609|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748610|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
138748611|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
138748612|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748613|NCT04322240|Protective Agents|protective agents|mesh-ancestor
138748614|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748615|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
138748616|NCT04322240|Vitamins|vitamins|mesh-ancestor
138748617|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
138748618|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138748619|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
138748620|NCT01262456|Coagulants|coagulants|mesh-ancestor
138748621|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138748622|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
138748623|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748624|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
138748625|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748626|NCT04321850|Zinc|zinc|mesh-list
138748627|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
138748628|NCT04321850|Trace Elements|trace elements|mesh-ancestor
138748629|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
138748630|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748631|NCT04321850|Astringents|astringents|mesh-ancestor
138748632|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
138668635|NCT00438113|Terazosin|terazosin|mesh-list
139082627|NCT01947140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139082628|NCT01947140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082629|NCT01947140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082630|NCT00346775|Beclomethasone|beclomethasone|mesh-list
139082631|NCT00346775|Flunisolide|flunisolide|mesh-list
139082632|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139082633|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
139082634|NCT00346775|Hormones|hormones|mesh-ancestor
139082635|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082636|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082637|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139082638|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
139082639|NCT01108562|Lidocaine|lidocaine|mesh-list
139082640|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
139082641|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
139082642|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139082643|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748633|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
138748634|NCT04321616|Remdesivir|remdesivir|mesh-list
138748635|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
138748636|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138748637|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138748638|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138748639|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748640|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748641|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138748642|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
138748643|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
138748644|NCT00932893|Docetaxel|docetaxel|mesh-list
138748645|NCT00932893|Pemetrexed|pemetrexed|mesh-list
138748646|NCT00932893|Crizotinib|crizotinib|mesh-list
138748647|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748648|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
138748649|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
138422841|NCT05294406|Artenimol|artenimol|mesh-list
138748650|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
138748651|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748652|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668673|NCT00438269|Meropenem|meropenem|mesh-list
139082644|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
139082645|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082646|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139082647|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139082648|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139082649|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139082650|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082652|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139082653|NCT01112540|Narcotics|narcotics|mesh-ancestor
139082654|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139082655|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082656|NCT01112540|Analgesics|analgesics|mesh-ancestor
139082657|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
139082658|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082659|NCT03400852|Cosyntropin|cosyntropin|mesh-list
139082660|NCT03400852|Hormones|hormones|mesh-ancestor
139082661|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082662|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082663|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
139082664|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
139082665|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082666|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
139082667|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
139082668|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082669|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082670|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
139082671|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
139082672|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082673|NCT01056497|Protective Agents|protective agents|mesh-ancestor
139082674|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082675|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
139082676|NCT01056497|Vitamins|vitamins|mesh-ancestor
138821953|NCT02572375|Guaifenesin|guaifenesin|mesh-list
139082677|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
139082678|NCT03398356|Metformin|metformin|mesh-list
138748653|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138748654|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138748655|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138748657|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
138748658|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
138748659|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138748660|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138748661|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138748662|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748663|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748664|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
138748665|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138748666|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138748667|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138748668|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138748669|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138748670|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748671|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748672|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748673|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138748674|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
138748675|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138748676|NCT00939523|Lapatinib|lapatinib|mesh-list
138748677|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748678|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138748679|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668730|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
139082679|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139082680|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082681|NCT00346151|Sirolimus|sirolimus|mesh-list
139082682|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
139082683|NCT00346151|Abatacept|abatacept|mesh-list
139082684|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
139082685|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139082686|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
139082688|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139082689|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082690|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139082691|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082692|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
139082693|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139082694|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
139082695|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082696|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748680|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748681|NCT01260584|Clopidogrel|clopidogrel|mesh-list
138748682|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138748683|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138748684|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138748685|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138748686|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138748687|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
138748688|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748689|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748690|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748691|NCT04262635|Capecitabine|capecitabine|mesh-list
138748692|NCT04262635|Cetuximab|cetuximab|mesh-list
138748693|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138748694|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
138748695|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748696|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748697|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138748698|NCT00608101|Dexamethasone|dexamethasone|mesh-list
138748699|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
138748700|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138748701|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
138748702|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
138748703|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748704|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748705|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138748706|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
138748707|NCT00608101|Hormones|hormones|mesh-ancestor
138748708|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138748709|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138748710|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748711|NCT04264039|Fludarabine|fludarabine|mesh-list
138748712|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
138748713|NCT04264039|Melphalan|melphalan|mesh-list
138748714|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668771|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139082697|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139082698|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
138748715|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748716|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138748717|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
138748718|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748719|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138748720|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138748721|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
138748722|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138748723|NCT00608179|Glimepiride|glimepiride|mesh-list
138748725|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138748726|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138748727|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748728|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138748729|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
138748730|NCT00608335|Micafungin|micafungin|mesh-list
138748731|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
138748732|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138748733|NCT00927589|Carboplatin|carboplatin|mesh-list
138748734|NCT00927589|Docetaxel|docetaxel|mesh-list
139082699|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
139082700|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082701|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139082702|NCT00346151|Hormones|hormones|mesh-ancestor
139082703|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082704|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139082705|NCT00346151|Protective Agents|protective agents|mesh-ancestor
139082706|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139082707|NCT00346151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139082708|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139082709|NCT03940976|Afatinib|afatinib|mesh-list
139082710|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082711|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139082712|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082713|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082714|NCT01109498|Cyclosporine|cyclosporine|mesh-list
139082715|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
139082716|NCT01109498|Cyclosporins|cyclosporins|mesh-list
139082717|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082718|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082719|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139082720|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
139082721|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082722|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
139082723|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082724|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
139082725|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139082726|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139082727|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139082728|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082729|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139082730|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
139082731|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139082732|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
139082733|NCT00130286|Hormones|hormones|mesh-list
139082734|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138275916|NCT00004179|Vincristine|vincristine|mesh-list
138748735|NCT00927589|Trastuzumab|trastuzumab|mesh-list
138550922|NCT00070733|Testosterone|testosterone|mesh-list
138748736|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748737|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
138748738|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
138748739|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
138748740|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748741|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138748742|NCT05938374|Fluzoparib|fluzoparib|mesh-list
138748743|NCT05938374|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138748744|NCT05938374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748745|NCT05938374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748746|NCT05938374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748747|NCT05938140|Ritonavir|ritonavir|mesh-list
138748748|NCT05938140|Nirmatrelvir|nirmatrelvir|mesh-list
138748749|NCT05938140|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
138748750|NCT05938140|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138748751|NCT05938140|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138748752|NCT05938140|Protease Inhibitors|protease inhibitors|mesh-ancestor
138748753|NCT05938140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138668867|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
139082735|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082736|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139082737|NCT03940664|Formaldehyde|formaldehyde|mesh-list
139082738|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
139082739|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082740|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
139082741|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
139082742|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139082743|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
139082744|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
139082745|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139082746|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082747|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139082748|NCT03941990|Analgesics|analgesics|mesh-ancestor
139082749|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
139082750|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082751|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
139082752|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139082753|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082754|NCT03374488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139082755|NCT03374488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082756|NCT01209728|Ethanol|ethanol|mesh-list
139082757|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139082758|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082759|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139082760|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082761|NCT00345683|Vaccines|vaccines|mesh-list
139082762|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
139082763|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082764|NCT01211912|Acetaminophen|acetaminophen|mesh-list
139082765|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139082766|NCT01211912|Analgesics|analgesics|mesh-ancestor
139082767|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
139082768|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748754|NCT05938140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748755|NCT05938140|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138748756|NCT05938140|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138748757|NCT05938140|Antiviral Agents|antiviral agents|mesh-ancestor
138748758|NCT05938140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138748759|NCT05938140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138748760|NCT05938140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138748762|NCT05937880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748763|NCT05937880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748764|NCT05937880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138748765|NCT05937880|Immunologic Factors|immunologic factors|mesh-ancestor
138748766|NCT05937880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748767|NCT05937841|Compound 21|compound 21|mesh-list
138748768|NCT05937841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138748769|NCT05937789|Vitamin D|vitamin d|mesh-list
138748770|NCT05937789|Vitamins|vitamins|mesh-ancestor
138748771|NCT05937789|Micronutrients|micronutrients|mesh-ancestor
138748772|NCT05937789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748773|NCT05937789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138748774|NCT05937711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138748775|NCT05937711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138748776|NCT05937711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138748777|NCT05937711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138748778|NCT05937711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822045|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
138748779|NCT05937711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748780|NCT05937711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748781|NCT05937711|Analgesics|analgesics|mesh-ancestor
139082769|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082770|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
139082771|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
139082772|NCT03943472|Fludarabine|fludarabine|mesh-list
139082773|NCT03943472|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
139082774|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139082775|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
139082776|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082777|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139082778|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139082779|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
139082780|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082781|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082782|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139082783|NCT03943472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138275940|NCT00003687|Morphine|morphine|mesh-list
138748782|NCT05937711|Sensory System Agents|sensory system agents|mesh-ancestor
138748783|NCT05937711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748784|NCT05937711|Antidepressive Agents|antidepressive agents|mesh-ancestor
138748785|NCT05937711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138748787|NCT05937568|Imetelstat|imetelstat|mesh-list
138748788|NCT05937568|Motesanib diphosphate|motesanib diphosphate|mesh-list
138748789|NCT05937568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748790|NCT05937568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748791|NCT05937568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138748792|NCT05937490|Leuprolide|leuprolide|mesh-list
138748793|NCT05937490|Dienogest|dienogest|mesh-list
138748794|NCT05937490|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138748795|NCT05937490|Fertility Agents|fertility agents|mesh-ancestor
138748796|NCT05937490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138748797|NCT05937490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748798|NCT05937490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138748799|NCT05937490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748800|NCT05937490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138748801|NCT05937490|Contraceptive Agents|contraceptive agents|mesh-ancestor
138748802|NCT05937490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139082785|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139082786|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139082787|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
139082788|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082789|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139082790|NCT01209806|Simethicone|simethicone|mesh-list
139082791|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
139082792|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139082793|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139082794|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
139082796|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
139082797|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082798|NCT01209806|Emollients|emollients|mesh-ancestor
139082799|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
139082800|NCT01209806|Antacids|antacids|mesh-ancestor
139082801|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139082802|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139082803|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
139082804|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082805|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
139082806|NCT01209806|Protective Agents|protective agents|mesh-ancestor
139082807|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
139082808|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139082809|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082810|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139082811|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082812|NCT01109654|Cetrorelix|cetrorelix|mesh-list
139082813|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139082814|NCT01109654|Hormones|hormones|mesh-ancestor
139082815|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082816|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082817|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138748803|NCT05937490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138748804|NCT05937490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138748805|NCT05937490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138748806|NCT05937490|Hormone Antagonists|hormone antagonists|mesh-ancestor
138550926|NCT00070733|Androgens|androgens|mesh-ancestor
138748807|NCT05937490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138748808|NCT05937438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138748809|NCT05937438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748810|NCT05937438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138748811|NCT05937438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748812|NCT05937191|Leflunomide|leflunomide|mesh-list
138748813|NCT05937191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748814|NCT05937191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748815|NCT05937191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138748816|NCT05937191|Immunologic Factors|immunologic factors|mesh-ancestor
138748817|NCT05937191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748818|NCT05937126|Anti-Infective Agents|anti-infective agents|mesh-list
138748819|NCT05937126|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138748820|NCT05937100|Hyaluronic Acid|hyaluronic acid|mesh-list
138748821|NCT05937100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138748822|NCT05937100|Immunologic Factors|immunologic factors|mesh-ancestor
138748823|NCT05937100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748824|NCT05937100|Viscosupplements|viscosupplements|mesh-ancestor
138748825|NCT05937100|Protective Agents|protective agents|mesh-ancestor
138748826|NCT05936853|Anesthetics|anesthetics|mesh-list
138748827|NCT05936853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138748828|NCT05936853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748829|NCT05935059|Pregabalin|pregabalin|mesh-list
138748830|NCT05935059|Anticonvulsants|anticonvulsants|mesh-list
138748831|NCT05935059|Tianeptine|tianeptine|mesh-list
138748832|NCT05935059|Antidepressive Agents|antidepressive agents|mesh-list
138748833|NCT05935059|Analgesics|analgesics|mesh-ancestor
138748834|NCT05935059|Sensory System Agents|sensory system agents|mesh-ancestor
138748835|NCT05935059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748836|NCT05935059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082818|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
139082819|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139082820|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
138833396|NCT00780637|Bradykinin|bradykinin|mesh-list
139082821|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
138748837|NCT05935059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138748838|NCT05935059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138748839|NCT05935059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748840|NCT05935059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138748841|NCT05935059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138748842|NCT05935059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138748843|NCT05935059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138748844|NCT05935059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138748845|NCT05935059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138748846|NCT05928962|Tremelimumab|tremelimumab|mesh-list
138748847|NCT05928962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748848|NCT05924997|Apatinib|apatinib|mesh-list
138748849|NCT05924997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748850|NCT05924997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138748851|NCT05924997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748852|NCT05924997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748853|NCT05910190|Buprenorphine|buprenorphine|mesh-list
138748854|NCT05910190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138748855|NCT05910190|Narcotics|narcotics|mesh-ancestor
138748856|NCT05910190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138748857|NCT05910190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748858|NCT05910190|Analgesics|analgesics|mesh-ancestor
139082822|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
139082823|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138822121|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
139082824|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139082825|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082826|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082827|NCT01054001|Urological Agents|urological agents|mesh-ancestor
139082829|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139082830|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082831|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139082832|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082833|NCT01057511|Progesterone|progesterone|mesh-list
139082834|NCT01057511|Progestins|progestins|mesh-ancestor
139082835|NCT01057511|Hormones|hormones|mesh-ancestor
139082836|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082837|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082838|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139082839|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082840|NCT01210040|Folic Acid|folic acid|mesh-list
139082841|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
139082842|NCT01210040|Hematinics|hematinics|mesh-ancestor
139082843|NCT01210040|Vitamins|vitamins|mesh-ancestor
139082844|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
139082845|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082846|NCT01054313|Sirolimus|sirolimus|mesh-list
139082847|NCT01054313|Prednisone|prednisone|mesh-list
139082848|NCT01054313|Docetaxel|docetaxel|mesh-list
139082849|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082850|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
139082851|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
139082852|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
139082853|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748859|NCT05910190|Sensory System Agents|sensory system agents|mesh-ancestor
138748860|NCT05910190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748861|NCT05910190|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138748862|NCT05898919|Neostigmine|neostigmine|mesh-list
138748863|NCT05898919|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138748864|NCT05898919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748865|NCT05898919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748866|NCT05898919|Cholinergic Agents|cholinergic agents|mesh-ancestor
138748867|NCT05898919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748868|NCT05898919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748869|NCT05898919|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138748870|NCT05898919|Autonomic Agents|autonomic agents|mesh-ancestor
138748871|NCT05898919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748872|NCT05881291|Alfentanil|alfentanil|mesh-list
138748873|NCT05881291|Propofol|propofol|mesh-list
138748874|NCT05881291|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138748875|NCT05881291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138748876|NCT05881291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748877|NCT05881291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138748878|NCT05881291|Anesthetics, General|anesthetics, general|mesh-ancestor
138748879|NCT05881291|Anesthetics|anesthetics|mesh-ancestor
138748880|NCT05881291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138748881|NCT05881291|Narcotics|narcotics|mesh-ancestor
138748882|NCT05881291|Analgesics|analgesics|mesh-ancestor
138748883|NCT05881291|Sensory System Agents|sensory system agents|mesh-ancestor
138748884|NCT05881291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082854|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139082855|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
139082856|NCT01054313|Hormones|hormones|mesh-ancestor
139082857|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082858|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082859|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139082860|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139082861|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082862|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139082863|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
139082864|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139082865|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
139082866|NCT01114958|Cisplatin|cisplatin|mesh-list
139082867|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082868|NCT03742115|Dexamethasone|dexamethasone|mesh-list
139082869|NCT03742115|Etoposide|etoposide|mesh-list
139082870|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
139082871|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139082872|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
139082873|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
139082874|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082875|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082876|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139082877|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
139082878|NCT03742115|Hormones|hormones|mesh-ancestor
138748885|NCT05867342|Lidocaine|lidocaine|mesh-list
138748886|NCT05867342|Epinephrine|epinephrine|mesh-list
138748887|NCT05867342|Racepinephrine|racepinephrine|mesh-list
138748888|NCT05867342|Epinephryl borate|epinephryl borate|mesh-list
138748889|NCT05867342|Anesthetics, Local|anesthetics, local|mesh-ancestor
138748890|NCT05867342|Anesthetics|anesthetics|mesh-ancestor
138748891|NCT05867342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138748892|NCT05867342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748893|NCT05867342|Sensory System Agents|sensory system agents|mesh-ancestor
138748894|NCT05867342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138748895|NCT05867342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138748896|NCT05867342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138748897|NCT05867342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138748898|NCT05867342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138822191|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
138748899|NCT05867342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822205|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
138748900|NCT05867342|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138748901|NCT05867342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138748902|NCT05867342|Adrenergic Agents|adrenergic agents|mesh-ancestor
138748903|NCT05867342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748904|NCT05867342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138748905|NCT05867342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138748906|NCT05867342|Autonomic Agents|autonomic agents|mesh-ancestor
138748907|NCT05867342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138748908|NCT05867342|Respiratory System Agents|respiratory system agents|mesh-ancestor
139082879|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082880|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139082881|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275993|NCT00004215|Daunorubicin|daunorubicin|mesh-list
139082882|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139082883|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139082884|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139082885|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082886|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082887|NCT01115036|Panobinostat|panobinostat|mesh-list
139082888|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082889|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139082890|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082891|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082892|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139082893|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139082894|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139082895|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139082896|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082897|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
139082898|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082899|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082900|NCT03942068|Paclitaxel|paclitaxel|mesh-list
139082901|NCT03942068|Apatinib|apatinib|mesh-list
139082902|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138748909|NCT05867342|Mydriatics|mydriatics|mesh-ancestor
138748910|NCT05867342|Sympathomimetics|sympathomimetics|mesh-ancestor
138748911|NCT05867342|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138748912|NCT05843448|Pembrolizumab|pembrolizumab|mesh-list
138748913|NCT05843448|Vaccines|vaccines|mesh-list
138748914|NCT05843448|Immunologic Factors|immunologic factors|mesh-ancestor
138748915|NCT05843448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748916|NCT05843448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138748917|NCT05843448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748918|NCT05843448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138748919|NCT05843448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748920|NCT05810480|Immunoglobulins|immunoglobulins|mesh-list
138748921|NCT05810480|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138748922|NCT05810480|Antibodies|antibodies|mesh-list
138748923|NCT05810480|Immunoglobulin G|immunoglobulin g|mesh-list
138748924|NCT05810480|Autoantibodies|autoantibodies|mesh-list
138748925|NCT05810480|Immunologic Factors|immunologic factors|mesh-ancestor
138748926|NCT05810480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748927|NCT05798533|Tislelizumab|tislelizumab|mesh-list
138748928|NCT05798533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138748929|NCT05798533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748930|NCT05793632|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138748931|NCT05793632|Antidepressive Agents|antidepressive agents|mesh-ancestor
138748932|NCT05793632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138748933|NCT05793632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138748934|NCT05793632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138748935|NCT05793632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138748936|NCT05793632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748937|NCT05768191|Insulin|insulin|mesh-list
138748938|NCT05768191|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138748939|NCT05768191|Isophane Insulin, Human|isophane insulin, human|mesh-list
138748940|NCT05768191|Insulin, Isophane|insulin, isophane|mesh-list
138748941|NCT05768191|Isophane insulin, beef|isophane insulin, beef|mesh-list
138748942|NCT05768191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138748943|NCT05768191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748944|NCT05759481|Propofol|propofol|mesh-list
138748945|NCT05759481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138748946|NCT05759481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139082903|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138748947|NCT05759481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748948|NCT05759481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138748949|NCT05759481|Anesthetics, General|anesthetics, general|mesh-ancestor
138748950|NCT05759481|Anesthetics|anesthetics|mesh-ancestor
138748951|NCT05635110|Rifampin|rifampin|mesh-list
138748952|NCT05635110|Omeprazole|omeprazole|mesh-list
138748953|NCT05635110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138748954|NCT05635110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138748955|NCT05635110|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138748956|NCT05635110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748957|NCT05635110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748958|NCT05635110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138748959|NCT05635110|Antitubercular Agents|antitubercular agents|mesh-ancestor
138748960|NCT05635110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138748961|NCT05635110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138748962|NCT05635110|Leprostatic Agents|leprostatic agents|mesh-ancestor
138748963|NCT05635110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138748964|NCT05635110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138748965|NCT05635110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138748966|NCT05635110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138748967|NCT05635110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138748968|NCT05635110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138748969|NCT05635110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138748970|NCT05615025|Propofol|propofol|mesh-list
138748971|NCT05615025|Sevoflurane|sevoflurane|mesh-list
138748972|NCT05615025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138748973|NCT05615025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138748974|NCT05615025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748975|NCT05615025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138748976|NCT05615025|Anesthetics, General|anesthetics, general|mesh-ancestor
138748977|NCT05615025|Anesthetics|anesthetics|mesh-ancestor
138748978|NCT05615025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138748979|NCT05615025|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138748980|NCT05408065|Triamcinolone|triamcinolone|mesh-list
138748981|NCT05408065|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138748982|NCT05408065|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138748986|NCT05408065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138748987|NCT05408065|Glucocorticoids|glucocorticoids|mesh-ancestor
138748989|NCT05408065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138748990|NCT05408065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748991|NCT05408065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138748992|NCT05408065|Immunologic Factors|immunologic factors|mesh-ancestor
138748993|NCT05408065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748994|NCT05408065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748995|NCT05408065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138748996|NCT05408065|Viscosupplements|viscosupplements|mesh-ancestor
138748997|NCT05408065|Protective Agents|protective agents|mesh-ancestor
138748998|NCT05381753|Sunitinib|sunitinib|mesh-list
138748999|NCT05381753|Imatinib Mesylate|imatinib mesylate|mesh-list
138749000|NCT05381753|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138749001|NCT05381753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749002|NCT05381753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138749003|NCT05381753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138749004|NCT05381753|Growth Substances|growth substances|mesh-ancestor
138749005|NCT05381753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749006|NCT05381753|Growth Inhibitors|growth inhibitors|mesh-ancestor
138749007|NCT05381753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138749008|NCT05381753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749009|NCT05381753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749010|NCT05276206|Anesthetics|anesthetics|mesh-list
138749011|NCT05276206|Anesthetics, Local|anesthetics, local|mesh-list
138749012|NCT05276206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138749013|NCT05276206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749014|NCT05276206|Sensory System Agents|sensory system agents|mesh-ancestor
138749015|NCT05276206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749016|NCT05246111|Topotecan|topotecan|mesh-list
138749017|NCT05246111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138749018|NCT05246111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138749019|NCT05246111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749020|NCT05246111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749021|NCT05246111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749024|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138423223|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138749025|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749026|NCT05141305|Clopidogrel|clopidogrel|mesh-list
138749027|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749028|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749029|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138749030|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138749031|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138749032|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138749033|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
138749034|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749035|NCT05054842|Metformin|metformin|mesh-list
138749036|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138749037|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749038|NCT05022927|Bevacizumab|bevacizumab|mesh-list
138749039|NCT05022927|Atezolizumab|atezolizumab|mesh-list
138749040|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749041|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749042|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138749043|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138749044|NCT05022927|Growth Substances|growth substances|mesh-ancestor
138749045|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749046|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
138749047|NCT05022927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138749048|NCT05022927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749049|NCT04915508|Hormones|hormones|mesh-list
138749050|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138669336|NCT00441662|Hormones|hormones|mesh-ancestor
139082904|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082905|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
139082906|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
139082907|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
139082908|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082909|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139082910|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082911|NCT01112852|Terlipressin|terlipressin|mesh-list
139082912|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139082913|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139082914|NCT01112852|Somatostatin|somatostatin|mesh-list
139082915|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082916|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082917|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139082918|NCT01112852|Hormones|hormones|mesh-ancestor
138749051|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749053|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138749054|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
138749055|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
138749056|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138749057|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749058|NCT04520490|Exenatide|exenatide|mesh-list
138749059|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138749060|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749061|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138749062|NCT04520490|Incretins|incretins|mesh-ancestor
138749063|NCT04520490|Hormones|hormones|mesh-ancestor
138749064|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749065|NCT04483778|Pembrolizumab|pembrolizumab|mesh-list
138749066|NCT04483778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749067|NCT04483778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749068|NCT04483778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138749069|NCT04483778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082919|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082920|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082921|NCT01054469|Ropivacaine|ropivacaine|mesh-list
139082922|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
139082923|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
138276014|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082924|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139082925|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082926|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
139082927|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082929|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139082930|NCT00355121|Vaccines|vaccines|mesh-list
139082931|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
139082932|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082933|NCT02533349|Pantoprazole|pantoprazole|mesh-list
139082934|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139082935|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139082936|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139082937|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082938|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082939|NCT01115426|Losartan|losartan|mesh-list
139082940|NCT01115426|Ramipril|ramipril|mesh-list
139082941|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139082942|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139082943|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139082944|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139082945|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082946|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139082947|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
139082948|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082949|NCT03942458|Clopidogrel|clopidogrel|mesh-list
139082950|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139082951|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139082952|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139082953|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138749070|NCT04482309|Trastuzumab|trastuzumab|mesh-list
138749071|NCT04482309|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138749072|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749073|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749074|NCT04482309|Immunoconjugates|immunoconjugates|mesh-ancestor
138749075|NCT04482309|Immunologic Factors|immunologic factors|mesh-ancestor
138749076|NCT04482309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749077|NCT04480554|Naltrexone|naltrexone|mesh-list
138749078|NCT04480554|Buprenorphine|buprenorphine|mesh-list
138749079|NCT04480554|Methadone|methadone|mesh-list
138749080|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138749081|NCT04480554|Naloxone|naloxone|mesh-list
138749082|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138749083|NCT04480554|Narcotics|narcotics|mesh-ancestor
138749084|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138749085|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749086|NCT04480554|Analgesics|analgesics|mesh-ancestor
138749087|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
138749088|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749089|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138749090|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138749091|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
138749092|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
138749093|NCT04268498|Acetaminophen|acetaminophen|mesh-list
139082954|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
139082955|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139082956|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082957|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082958|NCT01115504|Thiamine|thiamine|mesh-list
139082959|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
139082960|NCT01115504|Vitamins|vitamins|mesh-ancestor
139082961|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
139082962|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082963|NCT00343889|Vaccines|vaccines|mesh-list
139082964|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
139082965|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082966|NCT03939884|Diclofenac|diclofenac|mesh-list
139082967|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139082968|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139082970|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
139082971|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082972|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082973|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139082974|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139082975|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139082976|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139082977|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082979|NCT01054547|Ropivacaine|ropivacaine|mesh-list
139082980|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139082981|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082982|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
139082983|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
139082984|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082985|NCT01115894|Naltrexone|naltrexone|mesh-list
138749094|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
138749095|NCT04268498|Promethazine|promethazine|mesh-list
138749096|NCT04268498|Dexamethasone|dexamethasone|mesh-list
138749097|NCT04268498|Lenalidomide|lenalidomide|mesh-list
138749098|NCT04268498|Bortezomib|bortezomib|mesh-list
138749099|NCT04268498|Daratumumab|daratumumab|mesh-list
138423299|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138749101|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138749102|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
138749103|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
138749104|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749105|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749106|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138749107|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
138749108|NCT04268498|Hormones|hormones|mesh-ancestor
138749109|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749110|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138749111|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749112|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
138749113|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138749114|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138749115|NCT04268498|Growth Substances|growth substances|mesh-ancestor
138749116|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
138749117|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139082986|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139082987|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139082988|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139082989|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
139082990|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139082991|NCT01115972|Valsartan|valsartan|mesh-list
139082992|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139082993|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139082994|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139082995|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139082996|NCT01116050|Misoprostol|misoprostol|mesh-list
139082997|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139082998|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
139082999|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139083000|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083001|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139083002|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083003|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
139083004|NCT01054781|Rituximab|rituximab|mesh-list
139083005|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139083006|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083007|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
139083008|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083009|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139083010|NCT05282290|Antihypertensive Agents|antihypertensive agents|mesh-list
139083011|NCT01311778|Fentanyl|fentanyl|mesh-list
139083012|NCT01311778|Cannabidiol|cannabidiol|mesh-list
139083013|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139083014|NCT01311778|Narcotics|narcotics|mesh-ancestor
138749118|NCT04268498|Analgesics|analgesics|mesh-ancestor
138749119|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
138749120|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
138749121|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138749122|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
138749123|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138749124|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
138749125|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138749126|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138749127|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749128|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138749129|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138749130|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138749131|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
138749132|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
138749133|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138749134|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
138749135|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
138749136|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749137|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138276078|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
139083015|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139083016|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083018|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
139083019|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083020|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139083021|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139083022|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
139083023|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
139083024|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
139083025|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
139083026|NCT00354341|Hematinics|hematinics|mesh-ancestor
139083027|NCT03708718|Prednisolone|prednisolone|mesh-list
139083028|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139083029|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
139083030|NCT03708718|Hormones|hormones|mesh-ancestor
139083031|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139083032|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083033|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139083034|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083035|NCT00354107|Cytarabine|cytarabine|mesh-list
139083036|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
139083037|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139083038|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139083039|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139083040|NCT00354107|Carboplatin|carboplatin|mesh-list
139083041|NCT00354107|Methotrexate|methotrexate|mesh-list
139083042|NCT00354107|Etoposide|etoposide|mesh-list
139083043|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
138833610|NCT00781105|Telbivudine|telbivudine|mesh-list
139083044|NCT00354107|Ifosfamide|ifosfamide|mesh-list
139083045|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139083046|NCT00354107|Antibodies|antibodies|mesh-list
139083047|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139083048|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
139083049|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083050|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749138|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
138749139|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
138749140|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
138749141|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138749142|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138749143|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749144|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
138749145|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749146|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749147|NCT04194775|Lenvatinib|lenvatinib|mesh-list
138749148|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749149|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138749150|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749151|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749152|NCT04098432|Nivolumab|nivolumab|mesh-list
138749153|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749154|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138669579|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
139083051|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139083052|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
139083053|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139083054|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139083055|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
139083056|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276108|NCT00004245|Salicylates|salicylates|mesh-list
139083057|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
139083058|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083059|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139083060|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139083061|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139083062|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139083063|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139083064|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139083065|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139083066|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
139083067|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083068|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139083069|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139083070|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
139083071|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139083072|NCT00354107|Immunotoxins|immunotoxins|mesh-ancestor
139083073|NCT00354107|Immunoconjugates|immunoconjugates|mesh-ancestor
139083074|NCT00354029|Ketamine|ketamine|mesh-list
139083075|NCT00354029|Analgesics|analgesics|mesh-ancestor
139083076|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
139083077|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083078|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083079|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139083080|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139083081|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
139083082|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
139083083|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139083084|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139083085|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139083086|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749155|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138749156|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749157|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138749158|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138749159|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749160|NCT03920007|Trimethoprim|trimethoprim|mesh-list
138749162|NCT03920007|Polymyxin B|polymyxin b|mesh-list
138749163|NCT03920007|Prednisone|prednisone|mesh-list
138749164|NCT03920007|Prednisolone|prednisolone|mesh-list
138749165|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138749166|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
138749167|NCT03920007|Hormones|hormones|mesh-ancestor
138749168|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749169|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749170|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138749171|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749172|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138749173|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138749174|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
138749175|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138749176|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138749177|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138749178|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083087|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083088|NCT00353873|Fluticasone|fluticasone|mesh-list
139083090|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139083091|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139083092|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139083093|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
139083094|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083095|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083096|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139083097|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
139083098|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
139083099|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139083100|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139083101|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139083102|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139083103|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
139083104|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083105|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083106|NCT01058057|Atorvastatin|atorvastatin|mesh-list
139083107|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139083108|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139083109|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
139083110|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083111|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139083112|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139083113|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749179|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749180|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138749181|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138749182|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138749183|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138749185|NCT03906136|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138749186|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138749187|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138749188|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
138749189|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
138749190|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138749191|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138749192|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138749194|NCT03695744|Bortezomib|bortezomib|mesh-list
138749195|NCT03695744|Daratumumab|daratumumab|mesh-list
138749196|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138749197|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
138749198|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
138749199|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138669689|NCT00478764|Triamcinolone|triamcinolone|mesh-list
139083114|NCT03796676|Abrocitinib|abrocitinib|mesh-list
139083115|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139083116|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083117|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083118|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138833685|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139083119|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139083120|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139083121|NCT00339833|Analgesics|analgesics|mesh-ancestor
139083122|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
139083123|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083124|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083125|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139083126|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139083127|NCT01058291|Apomorphine|apomorphine|mesh-list
139083128|NCT01058291|Emetics|emetics|mesh-ancestor
139083129|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083130|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
139083131|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083132|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083133|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
139083134|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
139083135|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083136|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083137|NCT01055249|Ibuprofen|ibuprofen|mesh-list
139083138|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
139083139|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139083140|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138822526|NCT00720265|Tacrolimus|tacrolimus|mesh-list
139083141|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139083142|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139083143|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139083144|NCT01055249|Analgesics|analgesics|mesh-ancestor
139083145|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
139083146|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749200|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749201|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138749202|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
138749203|NCT03695744|Hormones|hormones|mesh-ancestor
138749204|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749205|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138749206|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749207|NCT03690869|Cemiplimab|cemiplimab|mesh-list
138749208|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749209|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749210|NCT03637764|Atezolizumab|atezolizumab|mesh-list
138749211|NCT03637764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138749212|NCT03637764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749213|NCT03637764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749214|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749215|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138749216|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138749217|NCT03401853|Rituximab|rituximab|mesh-list
138749218|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138749219|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
138749220|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
138749221|NCT03401853|Antibodies|antibodies|mesh-list
138749222|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
138749223|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138550953|NCT00258232|Celecoxib|celecoxib|mesh-list
138749224|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
138749225|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749226|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749227|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138749228|NCT03401853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138669743|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139083147|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083148|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139083149|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139083150|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139083151|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083152|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083153|NCT01055327|Lamotrigine|lamotrigine|mesh-list
139083154|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
139083155|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139083156|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139083157|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083158|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139083159|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749229|NCT03401853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749231|NCT03222076|Ipilimumab|ipilimumab|mesh-list
138749232|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749233|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749234|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138749235|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749236|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138749237|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138749238|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138749239|NCT02936843|Analgesics|analgesics|mesh-ancestor
138749240|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
138749241|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749242|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749243|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138749244|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138749245|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
138749246|NCT02811861|Everolimus|everolimus|mesh-list
138749247|NCT02811861|Sunitinib|sunitinib|mesh-list
138749248|NCT02811861|Lenvatinib|lenvatinib|mesh-list
138669787|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
139083160|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139083161|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139083162|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139083163|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139083164|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139083165|NCT03793556|Omeprazole|omeprazole|mesh-list
139083166|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139083167|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083168|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139083169|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083170|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083171|NCT01113164|Ondansetron|ondansetron|mesh-list
139083172|NCT01113164|Sertraline|sertraline|mesh-list
139083173|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
139083174|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
139083175|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083176|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083177|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083178|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
139083179|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
139083180|NCT01113164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139083181|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139083182|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
139083183|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083184|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083185|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
139083186|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139083187|NCT01113164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139083188|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139083189|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138833760|NCT00664677|Analgesics|analgesics|mesh-ancestor
139083191|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
139083192|NCT01210430|Losartan|losartan|mesh-list
139083193|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
138749249|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749250|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749251|NCT02811861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138749252|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749253|NCT02811861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138749254|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138749255|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749256|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138749257|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
138749258|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749259|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138749260|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138749261|NCT02811861|Growth Substances|growth substances|mesh-ancestor
138749262|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
138749263|NCT02700451|Acetaminophen|acetaminophen|mesh-list
138749264|NCT02700451|Ketorolac|ketorolac|mesh-list
138749265|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138749266|NCT02700451|Analgesics|analgesics|mesh-ancestor
138749267|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
138749268|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749269|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749270|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
138749271|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139083194|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083195|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139083196|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139083197|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139083198|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139083199|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083200|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
139083201|NCT01210430|Protective Agents|protective agents|mesh-ancestor
139083202|NCT01210742|Hylan|hylan|mesh-list
139083203|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
139083204|NCT01210742|Protective Agents|protective agents|mesh-ancestor
139083205|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083206|NCT01116128|Prednisone|prednisone|mesh-list
139083207|NCT01116128|Melphalan|melphalan|mesh-list
139083208|NCT01116128|Dasatinib|dasatinib|mesh-list
139083209|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139083210|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
139083211|NCT01116128|Hormones|hormones|mesh-ancestor
139083212|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139083213|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083214|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139083215|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083216|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139083217|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
139083218|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083219|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139083220|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139083221|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
138749272|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138749274|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138749275|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749276|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749277|NCT02697344|Acetic Acid|acetic acid|mesh-list
138749278|NCT02697344|Dexamethasone|dexamethasone|mesh-list
138749279|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
138749280|NCT02697344|Lenalidomide|lenalidomide|mesh-list
138749281|NCT02697344|Retinol acetate|retinol acetate|mesh-list
138749282|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
138749283|NCT02697344|Gossypol|gossypol|mesh-list
138749284|NCT02697344|BB 1101|bb 1101|mesh-list
138749285|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138749286|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
138749287|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
138749288|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749289|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749290|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138749291|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
138749292|NCT02697344|Hormones|hormones|mesh-ancestor
138749293|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749294|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138749295|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749296|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
138749297|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138749298|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138749299|NCT02697344|Growth Substances|growth substances|mesh-ancestor
139083222|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139083223|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083224|NCT03390166|Vaccines|vaccines|mesh-list
139083225|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
139083226|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083227|NCT01116206|Prucalopride|prucalopride|mesh-list
139083228|NCT01116206|Laxatives|laxatives|mesh-ancestor
139083229|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083230|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139083231|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139083232|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
139083233|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083234|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083235|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083236|NCT01210976|Simendan|simendan|mesh-list
139083237|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139083238|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
139083239|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139083240|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139083241|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083242|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749300|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
138749301|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
138749302|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749303|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749304|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138749305|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138749306|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138749307|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138749308|NCT02697344|Protective Agents|protective agents|mesh-ancestor
138749309|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138749310|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
138749311|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138749312|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138749313|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138749314|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138749315|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138749316|NCT02667418|Vancomycin|vancomycin|mesh-list
138749317|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
138749318|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138749319|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138749320|NCT02623426|Dexamethasone|dexamethasone|mesh-list
138749321|NCT02623426|Methotrexate|methotrexate|mesh-list
138749322|NCT02623426|Ranibizumab|ranibizumab|mesh-list
138749323|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138749324|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
138749325|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
138749326|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749327|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749328|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138749329|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
138749330|NCT02623426|Hormones|hormones|mesh-ancestor
138749331|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749344|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
138749345|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138749346|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138749347|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138749348|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138749349|NCT02623426|Growth Substances|growth substances|mesh-ancestor
138749350|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
138749351|NCT02580058|Doxorubicin|doxorubicin|mesh-list
138749352|NCT02580058|Avelumab|avelumab|mesh-list
138749353|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138749354|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749355|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138749356|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138749357|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749358|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749359|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138669982|NCT00479739|Budesonide|budesonide|mesh-list
139083243|NCT01210976|Protective Agents|protective agents|mesh-ancestor
139083244|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083245|NCT03828539|Topiramate|topiramate|mesh-list
139083246|NCT03828539|Erenumab|erenumab|mesh-list
139083247|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139083248|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
139083249|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139083250|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083251|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139083252|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083253|NCT03828539|Analgesics|analgesics|mesh-ancestor
139083254|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
139083255|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083256|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
139083257|NCT01109888|Cetrorelix|cetrorelix|mesh-list
139083258|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139083259|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
139083260|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139083261|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083262|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
139083263|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139083264|NCT03336502|Posaconazole|posaconazole|mesh-list
139083265|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
138276236|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
139083267|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139083268|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139083269|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139083270|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139083271|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139083272|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083273|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083274|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139083275|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
139083276|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139083277|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083278|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
139083279|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138276279|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083280|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139083281|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
138822621|NCT02601508|Rocuronium|rocuronium|mesh-list
138749361|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138749362|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138749363|NCT02539394|Prednisolone|prednisolone|mesh-list
138749364|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
138749365|NCT02539394|Hemostatics|hemostatics|mesh-list
138550965|NCT00258232|Analgesics|analgesics|mesh-ancestor
138749366|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138749367|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
138749368|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138749369|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
138749370|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
138749371|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749372|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749373|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138749374|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
138749375|NCT02539394|Hormones|hormones|mesh-ancestor
138749376|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749377|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138749378|NCT02539394|Protective Agents|protective agents|mesh-ancestor
138749379|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138749380|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749381|NCT02539394|Coagulants|coagulants|mesh-ancestor
138749382|NCT02530437|Paclitaxel|paclitaxel|mesh-list
138749383|NCT02530437|Carboplatin|carboplatin|mesh-list
138749384|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138749385|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138749386|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083282|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083283|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139083284|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139083285|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083286|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083287|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
139083288|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
139083289|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139083290|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139083291|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083292|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083293|NCT01055405|Urological Agents|urological agents|mesh-ancestor
139083295|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083296|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139083297|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083298|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083299|NCT03370510|Oxytocin|oxytocin|mesh-list
139083300|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
139083301|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139083302|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083303|NCT03985865|Quinine|quinine|mesh-list
138749387|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
138749388|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
138749389|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
138749390|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749391|NCT02412670|Cisplatin|cisplatin|mesh-list
138749392|NCT02412670|Carboplatin|carboplatin|mesh-list
138749393|NCT02412670|Gemcitabine|gemcitabine|mesh-list
138749394|NCT02412670|Doxorubicin|doxorubicin|mesh-list
138749395|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138749396|NCT02412670|Methotrexate|methotrexate|mesh-list
138749397|NCT02412670|Vinblastine|vinblastine|mesh-list
138749398|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749399|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138749400|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
138749401|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749402|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138749403|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138749404|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138749405|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749406|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138749407|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
138749408|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138749409|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749410|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
138749411|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138749412|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138749413|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
138749414|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138670082|NCT00442221|Naproxen|naproxen|mesh-list
139083304|NCT03985865|Denatonium|denatonium|mesh-list
139083305|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
139083306|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139083307|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139083308|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083309|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139083310|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083311|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139083312|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083313|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139083314|NCT03985865|Analgesics|analgesics|mesh-ancestor
139083315|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
139083316|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
139083317|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083318|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
139083319|NCT01116596|Acetaminophen|acetaminophen|mesh-list
139083320|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139083321|NCT01116596|Analgesics|analgesics|mesh-ancestor
139083322|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
138749415|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138749416|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138749417|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
138749418|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
138749419|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
138749420|NCT01889199|Flutamide|flutamide|mesh-list
138749421|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
138749422|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
138749423|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749424|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749425|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138749426|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749427|NCT01737502|Sirolimus|sirolimus|mesh-list
138749428|NCT01737502|Auranofin|auranofin|mesh-list
138749429|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138749430|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138749431|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138749432|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749433|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
138749434|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138749435|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
138749436|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749437|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138670139|NCT00480090|Cytarabine|cytarabine|mesh-list
139083323|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083324|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083325|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
139083326|NCT00351611|Pregabalin|pregabalin|mesh-list
139083327|NCT00351611|Analgesics|analgesics|mesh-ancestor
139083328|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
139083329|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138276398|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
139083330|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083331|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
139083332|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138822679|NCT00640263|Ritonavir|ritonavir|mesh-list
139083333|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139083334|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083335|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139083336|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139083337|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139083338|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139083339|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139083340|NCT01211210|Fluorouracil|fluorouracil|mesh-list
139083341|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
139083342|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
139083343|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083344|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139083345|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083346|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139083347|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
139083348|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749439|NCT01666080|Busulfan|busulfan|mesh-list
138749440|NCT01666080|Levetiracetam|levetiracetam|mesh-list
138749441|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749442|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749443|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138749444|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
138749445|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749446|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
138749447|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138749448|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138749449|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
138749450|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
138749451|NCT00992238|Flavoxate|flavoxate|mesh-list
138749452|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
138749453|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
138749454|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749455|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749456|NCT00992238|Urological Agents|urological agents|mesh-ancestor
138749457|NCT00858897|Insulin|insulin|mesh-list
138749458|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138749459|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138749460|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083349|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
139083350|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138276441|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139083351|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139083352|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083353|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139083354|NCT01208012|Liraglutide|liraglutide|mesh-list
139083355|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139083356|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083357|NCT01208012|Incretins|incretins|mesh-ancestor
139083358|NCT01208012|Hormones|hormones|mesh-ancestor
139083359|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139083360|NCT03939806|Oxytocin|oxytocin|mesh-list
139083361|NCT03939806|Carbetocin|carbetocin|mesh-list
139083362|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
139083363|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139083364|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083365|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
139083366|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139083367|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083368|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139083369|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
139083370|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138276493|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
139083371|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083372|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083373|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083375|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
139083376|NCT00337727|Ondansetron|ondansetron|mesh-list
139083377|NCT00337727|Aprepitant|aprepitant|mesh-list
139083378|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
139083379|NCT00337727|BB 1101|bb 1101|mesh-list
138749461|NCT05940909|Amlodipine|amlodipine|mesh-list
138749462|NCT05940909|Perindopril|perindopril|mesh-list
138749463|NCT05940909|Indapamide|indapamide|mesh-list
138749464|NCT05940909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138749465|NCT05940909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138749466|NCT05940909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138749467|NCT05940909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749468|NCT05940909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138749469|NCT05940909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749470|NCT05940909|Vasodilator Agents|vasodilator agents|mesh-ancestor
138749471|NCT05940909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138822822|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
138749472|NCT05940909|Protease Inhibitors|protease inhibitors|mesh-ancestor
138749473|NCT05940909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749474|NCT05940909|Diuretics|diuretics|mesh-ancestor
138749475|NCT05940909|Natriuretic Agents|natriuretic agents|mesh-ancestor
138749476|NCT05940909|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138749477|NCT05940701|Listerine|listerine|mesh-list
138749478|NCT05940701|Sodium Fluoride|sodium fluoride|mesh-list
138749479|NCT05940701|Cariostatic Agents|cariostatic agents|mesh-ancestor
138749480|NCT05940701|Protective Agents|protective agents|mesh-ancestor
138749481|NCT05940701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749482|NCT05940701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138749483|NCT05940701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138749485|NCT05940441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138749486|NCT05940441|Antimetabolites|antimetabolites|mesh-ancestor
138749487|NCT05940441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749488|NCT05940441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749489|NCT05940376|Insulin, Short-Acting|insulin, short-acting|mesh-list
138749490|NCT05940376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138749491|NCT05940376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083380|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139083381|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
139083382|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
139083383|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083384|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083385|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083386|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
139083387|NCT00337727|Hormones|hormones|mesh-ancestor
139083388|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139083389|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139083390|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083391|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
139083392|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083393|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749492|NCT05940233|Letrozole|letrozole|mesh-list
138749493|NCT05940233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749494|NCT05940233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138749495|NCT05940233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138749496|NCT05940233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749497|NCT05940233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749498|NCT05940233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138749499|NCT05940233|Hormone Antagonists|hormone antagonists|mesh-ancestor
138749500|NCT05940233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749501|NCT05940233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749502|NCT05940064|Rituximab|rituximab|mesh-list
138749503|NCT05940064|Zanubrutinib|zanubrutinib|mesh-list
138749504|NCT05940064|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138749505|NCT05940064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749506|NCT05940064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749507|NCT05940064|Immunologic Factors|immunologic factors|mesh-ancestor
138749508|NCT05940064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749509|NCT05940064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138749510|NCT05940064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138749511|NCT05940064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749512|NCT05940064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749513|NCT05940064|Immunoconjugates|immunoconjugates|mesh-ancestor
138749514|NCT05940051|Rituximab|rituximab|mesh-list
138749515|NCT05940051|Zanubrutinib|zanubrutinib|mesh-list
139083394|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
139083395|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
139083396|NCT00337727|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139083397|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139083398|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
139083399|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822928|NCT00978068|Ritonavir|ritonavir|mesh-list
139083400|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139083402|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139083403|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083404|NCT03987893|Laxatives|laxatives|mesh-ancestor
139083405|NCT01208480|Carboplatin|carboplatin|mesh-list
139083406|NCT01208480|Docetaxel|docetaxel|mesh-list
139083408|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083409|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
139083410|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
139083411|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
139083412|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083413|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139083414|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139083415|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139083416|NCT01208480|Growth Substances|growth substances|mesh-ancestor
139083417|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083418|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
139083419|NCT04774120|Propofol|propofol|mesh-list
139083420|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139083421|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139083422|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749516|NCT05940051|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138749517|NCT05940051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749518|NCT05940051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749519|NCT05940051|Immunologic Factors|immunologic factors|mesh-ancestor
138749520|NCT05940051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749521|NCT05940051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138749522|NCT05940051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138749523|NCT05940051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749524|NCT05940051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749525|NCT05940051|Immunoconjugates|immunoconjugates|mesh-ancestor
138749526|NCT05939882|Atropine|atropine|mesh-list
138749527|NCT05939882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138749528|NCT05939882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138749529|NCT05939882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138749530|NCT05939882|Autonomic Agents|autonomic agents|mesh-ancestor
138749531|NCT05939882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749532|NCT05939882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749533|NCT05939882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138749534|NCT05939882|Respiratory System Agents|respiratory system agents|mesh-ancestor
138749535|NCT05939882|Mydriatics|mydriatics|mesh-ancestor
138749536|NCT05939882|Parasympatholytics|parasympatholytics|mesh-ancestor
138749537|NCT05939882|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138749538|NCT05939882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138749539|NCT05939882|Cholinergic Agents|cholinergic agents|mesh-ancestor
138749540|NCT05939882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749541|NCT05939882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749542|NCT05939817|Triamcinolone|triamcinolone|mesh-list
138749543|NCT05939817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138749544|NCT05939817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138749545|NCT05939817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138749546|NCT05939817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138749547|NCT05939817|Glucocorticoids|glucocorticoids|mesh-ancestor
138749548|NCT05939817|Hormones|hormones|mesh-ancestor
139083423|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139083424|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
139083425|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
139083426|NCT01117220|Ziprasidone|ziprasidone|mesh-list
139083427|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139083428|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
139083429|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083430|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083431|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083432|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138749549|NCT05939817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749550|NCT05939817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749551|NCT05939817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138749552|NCT05939817|Immunologic Factors|immunologic factors|mesh-ancestor
138749553|NCT05939817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749554|NCT05939817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749556|NCT05939284|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138749557|NCT05939284|Fertility Agents|fertility agents|mesh-ancestor
138749558|NCT05939284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138749559|NCT05939284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749560|NCT05939284|Hormone Antagonists|hormone antagonists|mesh-ancestor
138749561|NCT05939284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749562|NCT05939180|Cytarabine|cytarabine|mesh-list
138749563|NCT05939180|Azacitidine|azacitidine|mesh-list
138749564|NCT05939180|Daunorubicin|daunorubicin|mesh-list
138749565|NCT05939180|Venetoclax|venetoclax|mesh-list
138749566|NCT05939180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138749567|NCT05939180|Antimetabolites|antimetabolites|mesh-ancestor
139083433|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139083434|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139083435|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139083436|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139083437|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
139083438|NCT05236972|Capecitabine|capecitabine|mesh-list
139083439|NCT05236972|Oxaliplatin|oxaliplatin|mesh-list
139083440|NCT05236972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139083441|NCT05236972|Antimetabolites|antimetabolites|mesh-ancestor
139083442|NCT05236972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083443|NCT05236972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083444|NCT01114100|Sertraline|sertraline|mesh-list
139083445|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
139083446|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139083447|NCT01114100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139083448|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138276712|NCT00004785|Dexamethasone|dexamethasone|mesh-list
139083449|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139083450|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083451|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083452|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
139083453|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083454|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139083455|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
139083456|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139083457|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139083458|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083459|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083460|NCT01110590|Urological Agents|urological agents|mesh-ancestor
139083461|NCT01117298|Tadalafil|tadalafil|mesh-list
139083462|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
139083463|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139083464|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139083465|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083466|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083467|NCT01117298|Urological Agents|urological agents|mesh-ancestor
139083468|NCT01117376|Erythromycin|erythromycin|mesh-list
138749568|NCT05939180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749569|NCT05939180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749570|NCT05939180|Antiviral Agents|antiviral agents|mesh-ancestor
138749571|NCT05939180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138749572|NCT05939180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138749573|NCT05939180|Immunologic Factors|immunologic factors|mesh-ancestor
138749574|NCT05939180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749575|NCT05939180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749576|NCT05939180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138749577|NCT05939180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138749578|NCT05939180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138749579|NCT05939076|Sotalol|sotalol|mesh-list
138749580|NCT05939076|Flecainide|flecainide|mesh-list
138749581|NCT05939076|Dronedarone|dronedarone|mesh-list
138749582|NCT05939076|Propafenone|propafenone|mesh-list
138749583|NCT05939076|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138749584|NCT05939076|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138749585|NCT05939076|Adrenergic Agents|adrenergic agents|mesh-ancestor
138749586|NCT05939076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749587|NCT05939076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749588|NCT05939076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749589|NCT05939076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139083469|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
139083470|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139083471|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
139083472|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
139083473|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139083474|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083475|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083476|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139083477|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083478|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083479|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139083480|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083481|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
139083482|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083484|NCT01213238|Capecitabine|capecitabine|mesh-list
139083485|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
139083486|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139083487|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083488|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139083489|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139083490|NCT01213238|Growth Substances|growth substances|mesh-ancestor
139083491|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083492|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
139083493|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139083494|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
138823140|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083495|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083496|NCT01110824|Carvedilol|carvedilol|mesh-list
139083497|NCT01110824|Enalapril|enalapril|mesh-list
139083498|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139083499|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139083500|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
138749590|NCT05939076|Sympatholytics|sympatholytics|mesh-ancestor
138749591|NCT05939076|Autonomic Agents|autonomic agents|mesh-ancestor
138749592|NCT05939076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749593|NCT05939076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138749594|NCT05939076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138749595|NCT05939076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138749596|NCT05939037|Zanubrutinib|zanubrutinib|mesh-list
138749597|NCT05939037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749598|NCT05939037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138749599|NCT05939037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749600|NCT05939037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749601|NCT05938972|Omalizumab|omalizumab|mesh-list
138749602|NCT05938972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138749603|NCT05938972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138749604|NCT05938972|Respiratory System Agents|respiratory system agents|mesh-ancestor
138749605|NCT05937282|Lidocaine|lidocaine|mesh-list
138749606|NCT05937282|Dexmedetomidine|dexmedetomidine|mesh-list
138749607|NCT05937282|Propofol|propofol|mesh-list
138749608|NCT05937282|Anesthetics, Local|anesthetics, local|mesh-ancestor
138749609|NCT05937282|Anesthetics|anesthetics|mesh-ancestor
138749610|NCT05937282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138749611|NCT05937282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749612|NCT05937282|Sensory System Agents|sensory system agents|mesh-ancestor
138749613|NCT05937282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083501|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823165|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083502|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083503|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083504|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139083505|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
139083506|NCT01110824|Protective Agents|protective agents|mesh-ancestor
139083507|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139083508|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139083509|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139083510|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
139083511|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139083512|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139083513|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139083514|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
139083515|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083516|NCT03936140|Iloprost|iloprost|mesh-list
139083517|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139083518|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
139083519|NCT01117610|Ropivacaine|ropivacaine|mesh-list
139083520|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
139083521|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
139083522|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139083523|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083524|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
139083525|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083526|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
139083527|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138749615|NCT05937282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138749616|NCT05937282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138749617|NCT05937282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138749618|NCT05937282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749619|NCT05937282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138749620|NCT05937282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138749621|NCT05937282|Analgesics|analgesics|mesh-ancestor
138749622|NCT05937282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138749623|NCT05937282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138423837|NCT05797597|Aspirin|aspirin|mesh-list
138749624|NCT05937282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138749625|NCT05937282|Adrenergic Agents|adrenergic agents|mesh-ancestor
138749626|NCT05937282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749627|NCT05937282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138749628|NCT05937282|Anesthetics, General|anesthetics, general|mesh-ancestor
138749629|NCT05936268|Colchicine|colchicine|mesh-list
138749630|NCT05936268|Gout Suppressants|gout suppressants|mesh-ancestor
138749631|NCT05936268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138749632|NCT05936268|Tubulin Modulators|tubulin modulators|mesh-ancestor
138749633|NCT05936268|Antimitotic Agents|antimitotic agents|mesh-ancestor
138749634|NCT05936268|Mitosis Modulators|mitosis modulators|mesh-ancestor
138749635|NCT05936268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749636|NCT05936268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749637|NCT05935787|Niacinamide|niacinamide|mesh-list
138749638|NCT05935787|Niacin|niacin|mesh-list
138749639|NCT05935787|Nicotinic Acids|nicotinic acids|mesh-list
138749640|NCT05935787|Riboflavin|riboflavin|mesh-list
138749641|NCT05935787|Vitamin B Complex|vitamin b complex|mesh-ancestor
138749642|NCT05935787|Vitamins|vitamins|mesh-ancestor
139083528|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139083529|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083530|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139083531|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083532|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139083533|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
139083534|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139083535|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083536|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139083537|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
139083538|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139083539|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083540|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083541|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083542|NCT03368170|Mesdopetam|mesdopetam|mesh-list
139083543|NCT03368170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138749643|NCT05935787|Micronutrients|micronutrients|mesh-ancestor
138749644|NCT05935787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749645|NCT05935787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138749646|NCT05935787|Antimetabolites|antimetabolites|mesh-ancestor
138749647|NCT05935787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749648|NCT05935787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138749649|NCT05935787|Vasodilator Agents|vasodilator agents|mesh-ancestor
138749650|NCT05935787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138749651|NCT05935787|Dermatologic Agents|dermatologic agents|mesh-ancestor
138749653|NCT05933642|Furosemide|furosemide|mesh-list
138749654|NCT05933642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138749655|NCT05933642|Autonomic Agents|autonomic agents|mesh-ancestor
138749656|NCT05933642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749657|NCT05933642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749658|NCT05933642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138749659|NCT05933642|Respiratory System Agents|respiratory system agents|mesh-ancestor
138749660|NCT05933642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138749661|NCT05933642|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138749662|NCT05933642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749663|NCT05933642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749664|NCT05933642|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138749665|NCT05933642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138749666|NCT05933642|Purinergic Agents|purinergic agents|mesh-ancestor
138749667|NCT05933642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749668|NCT05933642|Protective Agents|protective agents|mesh-ancestor
138749669|NCT05933642|Diuretics|diuretics|mesh-ancestor
138749670|NCT05933642|Natriuretic Agents|natriuretic agents|mesh-ancestor
138749671|NCT05933642|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138749672|NCT05933642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138749673|NCT05932251|Metformin|metformin|mesh-list
139083544|NCT03368170|Dopamine Agents|dopamine agents|mesh-ancestor
139083545|NCT03368170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083546|NCT03368170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083547|NCT03368170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083548|NCT01121744|Sirolimus|sirolimus|mesh-list
139083549|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139083550|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083551|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139083552|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083553|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
139083554|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139083555|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
138749674|NCT05932251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138749675|NCT05932251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749676|NCT05928520|Lidocaine|lidocaine|mesh-list
138749677|NCT05928520|Tramadol|tramadol|mesh-list
138749678|NCT05928520|Anesthetics, Local|anesthetics, local|mesh-ancestor
138749679|NCT05928520|Anesthetics|anesthetics|mesh-ancestor
138749680|NCT05928520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138749681|NCT05928520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749682|NCT05928520|Sensory System Agents|sensory system agents|mesh-ancestor
138749683|NCT05928520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749684|NCT05928520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138749685|NCT05928520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138749686|NCT05928520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138749687|NCT05928520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138749688|NCT05928520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749689|NCT05928520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138749690|NCT05928520|Narcotics|narcotics|mesh-ancestor
138749691|NCT05928520|Analgesics|analgesics|mesh-ancestor
138749692|NCT05923411|Rabeprazole|rabeprazole|mesh-list
138749693|NCT05923411|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138749694|NCT05923411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138749695|NCT05923411|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138749696|NCT05923411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749697|NCT05923411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749698|NCT05923190|Pembrolizumab|pembrolizumab|mesh-list
138749699|NCT05923190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749700|NCT05923190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749701|NCT05923190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139083556|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083557|NCT01121822|Vaccines|vaccines|mesh-list
139083558|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
139083559|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083560|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
139083561|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139083562|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139083563|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083564|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
139083565|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
139083567|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083568|NCT01216046|Ivacaftor|ivacaftor|mesh-list
139083569|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139083570|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139083571|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083572|NCT01216124|Docetaxel|docetaxel|mesh-list
139083573|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
139083574|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083575|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
138749702|NCT05923190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749703|NCT05919173|Dexmedetomidine|dexmedetomidine|mesh-list
138749704|NCT05919173|Bupivacaine|bupivacaine|mesh-list
138749705|NCT05919173|Anesthetics, Local|anesthetics, local|mesh-ancestor
138749706|NCT05919173|Anesthetics|anesthetics|mesh-ancestor
138749707|NCT05919173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138749708|NCT05919173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749709|NCT05919173|Sensory System Agents|sensory system agents|mesh-ancestor
138749710|NCT05919173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749711|NCT05919173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138749712|NCT05919173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138749713|NCT05919173|Analgesics|analgesics|mesh-ancestor
138749714|NCT05919173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138749715|NCT05919173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138749716|NCT05919173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138749717|NCT05919173|Adrenergic Agents|adrenergic agents|mesh-ancestor
138749718|NCT05919173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749719|NCT05919173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749720|NCT05911776|Dexmedetomidine|dexmedetomidine|mesh-list
138749721|NCT05911776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138749722|NCT05911776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138749723|NCT05911776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749724|NCT05911776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138749725|NCT05911776|Analgesics|analgesics|mesh-ancestor
138749726|NCT05911776|Sensory System Agents|sensory system agents|mesh-ancestor
138749727|NCT05911776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749728|NCT05911776|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138749729|NCT05911776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138749730|NCT05911776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139083576|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
139083577|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
138823352|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083578|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083579|NCT01219010|Siltuximab|siltuximab|mesh-list
139083580|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083581|NCT01118234|Rituximab|rituximab|mesh-list
139083582|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139083583|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083584|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
139083585|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083586|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139083587|NCT00324155|Ipilimumab|ipilimumab|mesh-list
139083588|NCT00324155|Dacarbazine|dacarbazine|mesh-list
139083589|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139083590|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749732|NCT05911776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749733|NCT05911776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749734|NCT05908747|Paclitaxel|paclitaxel|mesh-list
138749735|NCT05908747|Gemcitabine|gemcitabine|mesh-list
138749736|NCT05908747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138749737|NCT05908747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749738|NCT05908747|Tubulin Modulators|tubulin modulators|mesh-ancestor
138749739|NCT05908747|Antimitotic Agents|antimitotic agents|mesh-ancestor
138749740|NCT05908747|Mitosis Modulators|mitosis modulators|mesh-ancestor
138749741|NCT05908747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749742|NCT05908747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138749743|NCT05908747|Antimetabolites|antimetabolites|mesh-ancestor
138749744|NCT05904808|Metolazone|metolazone|mesh-list
138749745|NCT05904808|Furosemide|furosemide|mesh-list
138749746|NCT05904808|Acetazolamide|acetazolamide|mesh-list
138749747|NCT05904808|Magnesium citrate|magnesium citrate|mesh-list
138749748|NCT05904808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749749|NCT05904808|Diuretics|diuretics|mesh-ancestor
138749750|NCT05904808|Natriuretic Agents|natriuretic agents|mesh-ancestor
138749751|NCT05904808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749752|NCT05904808|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138749753|NCT05904808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138749754|NCT05904808|Anticonvulsants|anticonvulsants|mesh-ancestor
138749755|NCT05904808|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138749756|NCT05904808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749757|NCT05904808|Cathartics|cathartics|mesh-ancestor
138749758|NCT05904808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138749759|NCT05904808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138749760|NCT05904808|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138749761|NCT05888350|Beclomethasone|beclomethasone|mesh-list
138749762|NCT05888350|Formoterol Fumarate|formoterol fumarate|mesh-list
138749763|NCT05888350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139083591|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139083592|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083593|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139083594|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
139083595|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
139083596|NCT03937544|Fludarabine|fludarabine|mesh-list
139083597|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139083598|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
139083599|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749764|NCT05888350|Autonomic Agents|autonomic agents|mesh-ancestor
138749765|NCT05888350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749766|NCT05888350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749767|NCT05888350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138749768|NCT05888350|Respiratory System Agents|respiratory system agents|mesh-ancestor
138749769|NCT05888350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138749770|NCT05888350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138749771|NCT05888350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138749772|NCT05888350|Adrenergic Agents|adrenergic agents|mesh-ancestor
138749773|NCT05888350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749774|NCT05888350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749775|NCT05888350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138749776|NCT05888350|Glucocorticoids|glucocorticoids|mesh-ancestor
138749777|NCT05888350|Hormones|hormones|mesh-ancestor
138749778|NCT05888350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749779|NCT05881083|Nicotine|nicotine|mesh-list
138670752|NCT00459563|Vitamin D|vitamin d|mesh-list
139083600|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139083601|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139083602|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
139083603|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083604|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083605|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139083606|NCT01122056|Interferons|interferons|mesh-list
139083607|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
139083608|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083609|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
139083610|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083611|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139083612|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
139083613|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083614|NCT01219088|Morphine|morphine|mesh-list
139083615|NCT01219088|Bupivacaine|bupivacaine|mesh-list
139083616|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
139083617|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
139083618|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139083619|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083620|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
139083621|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083622|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139083623|NCT01219088|Narcotics|narcotics|mesh-ancestor
139083624|NCT01219088|Analgesics|analgesics|mesh-ancestor
139083625|NCT01122134|Artesunate|artesunate|mesh-list
139083626|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
139083627|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139083628|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139083629|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083630|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083631|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
139083632|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
139083633|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139083634|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
139083635|NCT01118702|Methylphenidate|methylphenidate|mesh-list
139083636|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139083637|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083638|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139083639|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138834204|NCT00927758|Xhance|xhance|mesh-list
139083640|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138749781|NCT05881083|Autonomic Agents|autonomic agents|mesh-ancestor
138749782|NCT05881083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749783|NCT05881083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749784|NCT05881083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138749785|NCT05881083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138749786|NCT05881083|Cholinergic Agents|cholinergic agents|mesh-ancestor
138749787|NCT05881083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749788|NCT05881083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749789|NCT05870683|Amoxicillin|amoxicillin|mesh-list
138749790|NCT05870683|Esomeprazole|esomeprazole|mesh-list
138749791|NCT05870683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138749792|NCT05870683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138749793|NCT05870683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138749794|NCT05870683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138749795|NCT05870683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138749796|NCT05870683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749797|NCT05870683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749798|NCT05860400|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138749799|NCT05860400|Immunologic Factors|immunologic factors|mesh-ancestor
138749800|NCT05860400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749801|NCT05847452|Benralizumab|benralizumab|mesh-list
138749802|NCT05847452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138749803|NCT05847452|Respiratory System Agents|respiratory system agents|mesh-ancestor
138749804|NCT05833776|Fentanyl|fentanyl|mesh-list
138749805|NCT05833776|Bupivacaine|bupivacaine|mesh-list
138749806|NCT05833776|Anesthetics, Local|anesthetics, local|mesh-ancestor
138749807|NCT05833776|Anesthetics|anesthetics|mesh-ancestor
139083641|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083643|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083644|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
139083645|NCT01118936|Antacids|antacids|mesh-ancestor
139083646|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083647|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083648|NCT01119014|Aripiprazole|aripiprazole|mesh-list
139083649|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139083650|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
138277136|NCT04829799|Analgesics|analgesics|mesh-ancestor
139083651|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139083652|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139083653|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139083654|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139083655|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083656|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
139083657|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
139083658|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083659|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083660|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138749808|NCT05833776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138749809|NCT05833776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749810|NCT05833776|Sensory System Agents|sensory system agents|mesh-ancestor
138823485|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138749811|NCT05833776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749812|NCT05833776|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138749813|NCT05833776|Narcotics|narcotics|mesh-ancestor
138749814|NCT05833776|Analgesics|analgesics|mesh-ancestor
138749815|NCT05833776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138749816|NCT05833776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138749817|NCT05833776|Anesthetics, General|anesthetics, general|mesh-ancestor
138749818|NCT05823441|Oxytocin|oxytocin|mesh-list
138749819|NCT05823441|Oxytocics|oxytocics|mesh-ancestor
138749820|NCT05823441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138749821|NCT05823441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749822|NCT05816616|Xenon|xenon|mesh-list
138749823|NCT05816616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138749824|NCT05816616|Anesthetics, General|anesthetics, general|mesh-ancestor
138749825|NCT05816616|Anesthetics|anesthetics|mesh-ancestor
138749826|NCT05816616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138749827|NCT05816616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749828|NCT05760261|Midazolam|midazolam|mesh-list
138749829|NCT05760261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138749830|NCT05760261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138749831|NCT05760261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139083661|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139083662|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
139083663|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138277161|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139083664|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139083665|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139083666|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139083667|NCT01219244|Resveratrol|resveratrol|mesh-list
139083668|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
139083669|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083670|NCT01219244|Protective Agents|protective agents|mesh-ancestor
139083671|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083672|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823531|NCT00727831|Antidotes|antidotes|mesh-ancestor
139083673|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139083674|NCT01119482|Vaccines|vaccines|mesh-list
139083675|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
139083676|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083678|NCT01119638|Escitalopram|escitalopram|mesh-list
139083679|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139083680|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
139083681|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083682|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083683|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083684|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139083685|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139083686|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139083687|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139083688|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138749832|NCT05760261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749833|NCT05760261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138749834|NCT05760261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138749835|NCT05760261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138749836|NCT05760261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138749837|NCT05760261|Anesthetics, General|anesthetics, general|mesh-ancestor
138749838|NCT05760261|Anesthetics|anesthetics|mesh-ancestor
138749839|NCT05760261|GABA Modulators|gaba modulators|mesh-ancestor
138749840|NCT05760261|GABA Agents|gaba agents|mesh-ancestor
138749841|NCT05760261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749842|NCT05760261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749843|NCT05746377|Metoclopramide|metoclopramide|mesh-list
138749844|NCT05746377|Antiemetics|antiemetics|mesh-ancestor
138749845|NCT05746377|Autonomic Agents|autonomic agents|mesh-ancestor
138749846|NCT05746377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749847|NCT05746377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749848|NCT05746377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138749849|NCT05746377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138749850|NCT05746377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138749851|NCT05746377|Dopamine Agents|dopamine agents|mesh-ancestor
138749852|NCT05746377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749853|NCT05746377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749854|NCT05725798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138749855|NCT05725798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138551004|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
139083689|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
139083690|NCT01119638|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139083691|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138277288|NCT02420041|Triamcinolone|triamcinolone|mesh-list
139083692|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139083693|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139083695|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139083696|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083697|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139083698|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
139083699|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083700|NCT03935984|Calcitonin|calcitonin|mesh-list
139083701|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
139083702|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139083703|NCT03935984|Katacalcin|katacalcin|mesh-list
139083704|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139083705|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083706|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139083707|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
139083708|NCT01219400|Vildagliptin|vildagliptin|mesh-list
139083709|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139083710|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083711|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139083712|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
139083713|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749856|NCT05725798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749857|NCT05725798|Incretins|incretins|mesh-ancestor
138749858|NCT05725798|Hormones|hormones|mesh-ancestor
138749859|NCT05725798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749860|NCT05725798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138749861|NCT05725798|Protease Inhibitors|protease inhibitors|mesh-ancestor
138749862|NCT05725798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749863|NCT05725798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749864|NCT05699252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138749865|NCT05699252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138749866|NCT05699252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749867|NCT05625594|Cyclophosphamide|cyclophosphamide|mesh-list
138749868|NCT05625594|Fludarabine|fludarabine|mesh-list
138749869|NCT05625594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138749870|NCT05625594|Immunologic Factors|immunologic factors|mesh-ancestor
138749871|NCT05625594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749872|NCT05625594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138749873|NCT05625594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138749874|NCT05625594|Alkylating Agents|alkylating agents|mesh-ancestor
138749875|NCT05625594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749876|NCT05625594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749877|NCT05625594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138749878|NCT05618301|Natalizumab|natalizumab|mesh-list
138749879|NCT05618301|Immunologic Factors|immunologic factors|mesh-ancestor
138749880|NCT05618301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749881|NCT05549778|Polaprezinc|polaprezinc|mesh-list
138749882|NCT05549778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138670955|NCT00460733|Calcium|calcium|mesh-list
139083714|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083716|NCT01124630|Fluorouracil|fluorouracil|mesh-list
139083717|NCT01124630|Irinotecan|irinotecan|mesh-list
139083718|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
139083719|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083720|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139083721|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083722|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139083723|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
139083724|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083725|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139083726|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139083727|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083728|NCT01124630|Antidotes|antidotes|mesh-ancestor
139083729|NCT01124630|Protective Agents|protective agents|mesh-ancestor
139083730|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
139083731|NCT01124630|Vitamins|vitamins|mesh-ancestor
139083732|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
139083733|NCT05683054|Adalimumab|adalimumab|mesh-list
138749883|NCT05549778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138749884|NCT05513924|Fluorouracil|fluorouracil|mesh-list
138749885|NCT05513924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138749886|NCT05513924|Latanoprost|latanoprost|mesh-list
138749887|NCT05513924|Antimetabolites|antimetabolites|mesh-ancestor
138749888|NCT05513924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749889|NCT05513924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138749890|NCT05513924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749891|NCT05513924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138749892|NCT05513924|Immunologic Factors|immunologic factors|mesh-ancestor
138749893|NCT05513924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749894|NCT05513924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138749896|NCT05444777|Analgesics|analgesics|mesh-ancestor
138749897|NCT05444777|Sensory System Agents|sensory system agents|mesh-ancestor
138749898|NCT05444777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138749899|NCT05444777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749900|NCT05444777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138749901|NCT05444777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138749902|NCT05444777|Anesthetics, General|anesthetics, general|mesh-ancestor
138749903|NCT05444777|Anesthetics|anesthetics|mesh-ancestor
138749904|NCT05444777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138749905|NCT05444777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138749906|NCT05444777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138749907|NCT05444777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749908|NCT05444777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749909|NCT05433961|Xenon|xenon|mesh-list
138749910|NCT05433961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138749911|NCT05433961|Anesthetics, General|anesthetics, general|mesh-ancestor
138749912|NCT05433961|Anesthetics|anesthetics|mesh-ancestor
138749913|NCT05433961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138749914|NCT05433961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749915|NCT05410821|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138749916|NCT05410821|Chelating Agents|chelating agents|mesh-ancestor
138749924|NCT05355168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749925|NCT05355168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749926|NCT05330130|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138749928|NCT05330130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138749929|NCT05330130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749931|NCT05323981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749932|NCT05323981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749933|NCT05311475|Mometasone Furoate|mometasone furoate|mesh-list
138749934|NCT05311475|Azelastine|azelastine|mesh-list
138749935|NCT05311475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138749936|NCT05311475|Dermatologic Agents|dermatologic agents|mesh-ancestor
138749937|NCT05311475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138749938|NCT05311475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138749939|NCT05311475|Autonomic Agents|autonomic agents|mesh-ancestor
138749940|NCT05311475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083734|NCT05683054|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139083735|NCT05683054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139083736|NCT05683054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139083737|NCT01120106|Simendan|simendan|mesh-list
139083738|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139083739|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
139083740|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139083741|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139083742|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083743|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083744|NCT01120106|Protective Agents|protective agents|mesh-ancestor
139083745|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083746|NCT01122368|Micafungin|micafungin|mesh-list
139083747|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
139083748|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083749|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
139083750|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
139083751|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
139083752|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083753|NCT01216826|Everolimus|everolimus|mesh-list
139083754|NCT01216826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139083755|NCT01216826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139083756|NCT01216826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083757|NCT01216826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083758|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139083759|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
139083760|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083761|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083762|NCT01120340|Mesalamine|mesalamine|mesh-list
139083763|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139083764|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139083765|NCT01120340|Analgesics|analgesics|mesh-ancestor
139083766|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
139083767|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083768|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083769|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139083770|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139083771|NCT01214408|Pantoprazole|pantoprazole|mesh-list
139083772|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138749941|NCT05311475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749942|NCT05311475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138749943|NCT05311475|Respiratory System Agents|respiratory system agents|mesh-ancestor
138749944|NCT05311475|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138749945|NCT05311475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749946|NCT05311475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749947|NCT05311475|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138749948|NCT05311475|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138749949|NCT05311475|Histamine Antagonists|histamine antagonists|mesh-ancestor
138749950|NCT05311475|Histamine Agents|histamine agents|mesh-ancestor
138749951|NCT05311475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138749952|NCT05311176|Paclitaxel|paclitaxel|mesh-list
138749953|NCT05311176|Pembrolizumab|pembrolizumab|mesh-list
138749954|NCT05311176|Ramucirumab|ramucirumab|mesh-list
138749955|NCT05311176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138749956|NCT05311176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749957|NCT05311176|Tubulin Modulators|tubulin modulators|mesh-ancestor
138749958|NCT05311176|Antimitotic Agents|antimitotic agents|mesh-ancestor
138749959|NCT05311176|Mitosis Modulators|mitosis modulators|mesh-ancestor
138749960|NCT05311176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749961|NCT05311176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138749962|NCT05311176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138749963|NCT05289492|Dexamethasone|dexamethasone|mesh-list
139083773|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083774|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139083775|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083776|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083777|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
139083778|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139083779|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139083780|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
139083781|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083782|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139083783|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139083784|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277440|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139083785|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083786|NCT01216904|Nicotine|nicotine|mesh-list
139083787|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139083788|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
139083789|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083790|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083792|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139083793|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
139083794|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083795|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083796|NCT01125020|Gemcitabine|gemcitabine|mesh-list
139083797|NCT01125020|Doxorubicin|doxorubicin|mesh-list
139083798|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
139083799|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083800|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139083801|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
139083802|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083803|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139083804|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139083805|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139083806|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083807|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
139083808|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083810|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139083811|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139083812|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139083813|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083814|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139083815|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083816|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
139083817|NCT03710434|Lansoprazole|lansoprazole|mesh-list
139083818|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
139083819|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139083820|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083821|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139083822|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277472|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138277474|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
139083823|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083824|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139083825|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
139083826|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138749994|NCT05255666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138749995|NCT05255666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749996|NCT05255666|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138749997|NCT05255666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138749998|NCT05255666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750000|NCT05255146|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138750001|NCT05255146|Anesthetics, General|anesthetics, general|mesh-ancestor
138750002|NCT05255146|Anesthetics|anesthetics|mesh-ancestor
138750004|NCT05255146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750005|NCT05255146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138750006|NCT05255146|Analgesics|analgesics|mesh-ancestor
138750007|NCT05255146|Sensory System Agents|sensory system agents|mesh-ancestor
138750008|NCT05255146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750009|NCT05198609|Apatinib|apatinib|mesh-list
138750010|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750011|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138750012|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750013|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750014|NCT05191004|Fulvestrant|fulvestrant|mesh-list
138750015|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139083827|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139083828|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083829|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083830|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
139083831|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083832|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139083833|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139083834|NCT05682586|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139083835|NCT05682586|Antiviral Agents|antiviral agents|mesh-ancestor
139083836|NCT05682586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083837|NCT01217138|Epinephrine|epinephrine|mesh-list
138277510|NCT02519023|Acetaminophen|acetaminophen|mesh-list
139083838|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139083839|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139083840|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
139083841|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083842|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083843|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083844|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139083845|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139083846|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
138750016|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750017|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138750018|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138750019|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
138750020|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750021|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750022|NCT05111145|Ivacaftor|ivacaftor|mesh-list
138750023|NCT05111145|Elexacaftor|elexacaftor|mesh-list
138750024|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138750025|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138750026|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750027|NCT05023980|Rituximab|rituximab|mesh-list
138750028|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138750029|NCT05023980|Pirtobrutinib|pirtobrutinib|mesh-list
138750030|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138750031|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750032|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
138750033|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750034|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138750035|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138750036|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
139083847|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083848|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139083849|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
139083851|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
139083852|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139083853|NCT03710356|Danazol|danazol|mesh-list
139083854|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139083855|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
139083856|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139083857|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083858|NCT01217294|Morphine|morphine|mesh-list
139083859|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139083860|NCT01217294|Narcotics|narcotics|mesh-ancestor
139083861|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138834435|NCT00929708|AZD-3199|azd-3199|mesh-list
139083862|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083864|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
139083865|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083866|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
139083867|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139083868|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083869|NCT03361228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139083870|NCT03361228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083871|NCT01121042|Ondansetron|ondansetron|mesh-list
139083872|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
139083873|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
139083874|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083875|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083876|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083877|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
139083878|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
138750037|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750039|NCT05023980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750040|NCT05007522|Ketotifen|ketotifen|mesh-list
138750041|NCT05007522|Indomethacin|indomethacin|mesh-list
138750042|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138750043|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138750044|NCT05007522|Analgesics|analgesics|mesh-ancestor
138750045|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
138750046|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750047|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750048|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750049|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138750050|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
138750051|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
138750052|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138750053|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138750054|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671306|NCT00489723|Tamsulosin|tamsulosin|mesh-list
139083879|NCT01121042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139083880|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139083881|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
139083882|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139083883|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083884|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
139083885|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139083886|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
139083887|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139083888|NCT01217450|Cetuximab|cetuximab|mesh-list
139083889|NCT01217450|Antibodies|antibodies|mesh-list
139083890|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
139083891|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139083892|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
139083893|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083894|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083895|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139083896|NCT01219556|Olmesartan|olmesartan|mesh-list
139083897|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139083898|NCT01219556|Diuretics|diuretics|mesh-ancestor
139083899|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
139083900|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083901|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139083902|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139083903|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083904|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139083905|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139083906|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
138277612|NCT02461693|Caffeine|caffeine|mesh-list
139083907|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139083908|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083909|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139083910|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083911|NCT01121276|Insulin|insulin|mesh-list
139083912|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139083913|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
139083914|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
138750055|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750056|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
138750057|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
138750058|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138750059|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
138750060|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
138750061|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138750062|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138750063|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
138750064|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138750065|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
138750066|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
138750067|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
138750068|NCT04952779|Insulin|insulin|mesh-list
138750069|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138750070|NCT04952779|Liraglutide|liraglutide|mesh-list
138750071|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
138750072|NCT04952779|Xultophy|xultophy|mesh-list
138750073|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138750074|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750076|NCT04952779|Hormones|hormones|mesh-ancestor
138424273|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138750077|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750079|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138750080|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
138750081|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
138750082|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138750083|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750084|NCT04900623|Paclitaxel|paclitaxel|mesh-list
138750085|NCT04900623|Cisplatin|cisplatin|mesh-list
138750086|NCT04900623|Carboplatin|carboplatin|mesh-list
138750087|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138750088|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083915|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139083916|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139083917|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083918|NCT05175508|Azacitidine|azacitidine|mesh-list
139083919|NCT05175508|Tretinoin|tretinoin|mesh-list
139083920|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139083921|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
139083922|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083923|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083924|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083925|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
139083926|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
138750089|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
138750090|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
138750091|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
138750092|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750093|NCT04899050|Cannabidiol|cannabidiol|mesh-list
138750094|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
138750095|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
138750096|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
138750097|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750098|NCT04808622|Protective Agents|protective agents|mesh-ancestor
138750099|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750100|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138750101|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750102|NCT04783675|Rituximab|rituximab|mesh-list
138750103|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138750104|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750105|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
138750106|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750107|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138750108|NCT04695080|Cladribine|cladribine|mesh-list
138750109|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750110|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138750111|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
138824154|NCT05273775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138750112|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750113|NCT04591353|Lidocaine|lidocaine|mesh-list
138750114|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
139083927|NCT01125410|Clindamycin|clindamycin|mesh-list
139083928|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
139083929|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
139083930|NCT01125410|Dequalinium|dequalinium|mesh-list
139083931|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139083932|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083933|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139083934|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083935|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083936|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139083937|NCT01328834|Tacrolimus|tacrolimus|mesh-list
139083938|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139083939|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
139083940|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083941|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139083942|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083943|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083944|NCT01121354|Cefazolin|cefazolin|mesh-list
138277649|NCT02535806|Cytarabine|cytarabine|mesh-list
139083945|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139083946|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139083947|NCT01122602|Aspirin|aspirin|mesh-list
139083948|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139083949|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139083950|NCT01122602|Analgesics|analgesics|mesh-ancestor
138750115|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
138750116|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138750117|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750118|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
138750119|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750120|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138750121|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138750122|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138750123|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138750124|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750125|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
138750126|NCT04499950|Naltrexone|naltrexone|mesh-list
138750127|NCT04499950|Bupropion|bupropion|mesh-list
138750128|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138750129|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138750130|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750131|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
138750132|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750133|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139083951|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
139083952|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083953|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083954|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139083955|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139083956|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139083957|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139083958|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083959|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139083960|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139083961|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083962|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
139083963|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139083964|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139083965|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083966|NCT03359590|Incretins|incretins|mesh-ancestor
139083967|NCT03359590|Hormones|hormones|mesh-ancestor
139083968|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139083969|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139083970|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
139083971|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083972|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083973|NCT01219712|Simendan|simendan|mesh-list
139083974|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139083975|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
139083976|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139083977|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139083978|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083979|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083980|NCT01219712|Protective Agents|protective agents|mesh-ancestor
139083981|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083982|NCT01215266|Sorafenib|sorafenib|mesh-list
138750134|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
138750135|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138750136|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138750137|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138824303|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750138|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138750139|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750140|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
138750141|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138750142|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138750143|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138750144|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750145|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138750146|NCT04402385|Aspirin|aspirin|mesh-list
138750147|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138750148|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138750149|NCT04402385|Analgesics|analgesics|mesh-ancestor
138750151|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750152|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750153|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750154|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139083983|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083984|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139083985|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083986|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139083987|NCT05682196|Rituximab|rituximab|mesh-list
139083988|NCT05682196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139083989|NCT05682196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139083990|NCT05682196|Immunologic Factors|immunologic factors|mesh-ancestor
138824345|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
139083991|NCT05682196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083992|NCT05682196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139083993|NCT03936374|Omeprazole|omeprazole|mesh-list
139083994|NCT03936374|Linrodostat|linrodostat|mesh-list
139083995|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139083996|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139083997|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139083998|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083999|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084000|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139084001|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
139084002|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139084003|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
139084004|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139084005|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084006|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139084007|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138834576|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
139084008|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084009|NCT01215578|Sunitinib|sunitinib|mesh-list
139084010|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084011|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139084012|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139084013|NCT01215578|Growth Substances|growth substances|mesh-ancestor
139084014|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750155|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138750156|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138750157|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750158|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138750159|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138750160|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750161|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
138750162|NCT04396730|Cannabidiol|cannabidiol|mesh-list
138750163|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
138750164|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
138750165|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138824399|NCT00732511|Metoprolol|metoprolol|mesh-list
138750166|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
138750167|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138750168|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750169|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138750170|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138750171|NCT04378868|Metronidazole|metronidazole|mesh-list
138750172|NCT04378868|Cefuroxime|cefuroxime|mesh-list
138750173|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
139084015|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
139084016|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139084017|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084018|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084019|NCT01120418|Besifloxacin|besifloxacin|mesh-list
139084020|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139084021|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084022|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139084023|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139084024|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084025|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084026|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084027|NCT05577988|Aspirin|aspirin|mesh-list
139084028|NCT05577988|Clopidogrel|clopidogrel|mesh-list
139084029|NCT05577988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139084030|NCT05577988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139084031|NCT05577988|Analgesics|analgesics|mesh-ancestor
139084032|NCT05577988|Sensory System Agents|sensory system agents|mesh-ancestor
139084033|NCT05577988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084034|NCT05577988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084035|NCT05577988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139084036|NCT05577988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139084037|NCT05577988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139084038|NCT05577988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139084039|NCT05577988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824429|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
139084040|NCT05577988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139084041|NCT05577988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139084042|NCT05577988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084043|NCT05577988|Antipyretics|antipyretics|mesh-ancestor
139084044|NCT05577988|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139084045|NCT05577988|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139084046|NCT05577988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139084047|NCT05577988|Purinergic Agents|purinergic agents|mesh-ancestor
139084048|NCT05577988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084049|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
139084051|NCT01222052|Fluorouracil|fluorouracil|mesh-list
139084052|NCT01222052|Epirubicin|epirubicin|mesh-list
139084053|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138750175|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138750176|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
138750177|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138750178|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138750179|NCT04218357|Probenecid|probenecid|mesh-list
138750180|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
138750181|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
138750182|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138750183|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
138750184|NCT04166877|Analgesics|analgesics|mesh-ancestor
138750185|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
138750186|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750187|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750188|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
138750189|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138750190|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138750191|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
138750192|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138750193|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138750194|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750195|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138750196|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
138824470|NCT00645879|Citric Acid|citric acid|mesh-list
138750197|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138750198|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
138750199|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138750200|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750201|NCT04164979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138750202|NCT04164979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750203|NCT04135846|Doxazosin|doxazosin|mesh-list
138750204|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138750205|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139084054|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
139084055|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084056|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139084057|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139084058|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
139084059|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084060|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084061|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139084062|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
139084063|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
138750206|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138750207|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138750208|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
138750209|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138750210|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750212|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138750213|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
138750214|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138750215|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
138750216|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750217|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
138750218|NCT04117893|Protective Agents|protective agents|mesh-ancestor
138750219|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138750220|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138750221|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138424426|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750222|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750223|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084064|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
139084065|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
139084066|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139084067|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139084068|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139084069|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139084070|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084071|NCT03710044|Cyclosporine|cyclosporine|mesh-list
139084072|NCT03710044|Cyclosporins|cyclosporins|mesh-list
139084073|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084074|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084075|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139084076|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
139084077|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084078|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
139084079|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084080|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
139084081|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139084082|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139084083|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
139084084|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
139084086|NCT03706300|Guaifenesin|guaifenesin|mesh-list
139084087|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139084088|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139084089|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
139084090|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084091|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084092|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139084093|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
139084094|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
139084095|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139084096|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139084097|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
139084098|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
139084099|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084100|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750225|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
138750226|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750227|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
138750228|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138750229|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
138750230|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138750231|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138750232|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138750233|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
138750234|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750235|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138750236|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138750237|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750238|NCT04049851|Ivermectin|ivermectin|mesh-list
138750239|NCT04049851|Moxidectin|moxidectin|mesh-list
138671721|NCT00591994|Piribedil|piribedil|mesh-list
139084101|NCT03706300|Expectorants|expectorants|mesh-ancestor
139084102|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139084103|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139084104|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
139084105|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139084106|NCT05155540|Plasminogen|plasminogen|mesh-list
139084107|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139084108|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139084109|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139084110|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084111|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139084112|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139084113|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
139084114|NCT01222442|AZD-3199|azd-3199|mesh-list
139084115|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139084116|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084117|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139084118|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139084119|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084120|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084121|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084122|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084123|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139084124|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139084125|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139084126|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
139084127|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084128|NCT03706222|Grazoprevir|grazoprevir|mesh-list
139084129|NCT03706222|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
139084130|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
139084131|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084132|NCT01222676|Gemcitabine|gemcitabine|mesh-list
139084133|NCT01222676|Sorafenib|sorafenib|mesh-list
139084134|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139084135|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084136|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139084137|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
139084138|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084139|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139084140|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084141|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139084142|NCT05681728|Paclitaxel|paclitaxel|mesh-list
139084143|NCT05681728|Cyclophosphamide|cyclophosphamide|mesh-list
139084144|NCT05681728|Pembrolizumab|pembrolizumab|mesh-list
139084145|NCT05681728|Epirubicin|epirubicin|mesh-list
138750240|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138750241|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138750242|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
138750243|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
138750244|NCT03970954|Interleukin-2|interleukin-2|mesh-list
138750245|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750246|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138750247|NCT03970954|Analgesics|analgesics|mesh-ancestor
138750248|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
138750249|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750250|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750251|NCT03963375|Cladribine|cladribine|mesh-list
138750252|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750253|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138750254|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
138750255|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750256|NCT03810105|Durvalumab|durvalumab|mesh-list
138750257|NCT03810105|Olaparib|olaparib|mesh-list
138824691|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138750258|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138750259|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750260|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138750261|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671768|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
138277752|NCT02531971|Narcotics|narcotics|mesh-ancestor
139084146|NCT05681728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139084147|NCT05681728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084148|NCT05681728|Tubulin Modulators|tubulin modulators|mesh-ancestor
139084149|NCT05681728|Antimitotic Agents|antimitotic agents|mesh-ancestor
139084150|NCT05681728|Mitosis Modulators|mitosis modulators|mesh-ancestor
139084151|NCT05681728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084152|NCT05681728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139084153|NCT05681728|Immunologic Factors|immunologic factors|mesh-ancestor
139084154|NCT05681728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084155|NCT05681728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139084156|NCT05681728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139084157|NCT05681728|Alkylating Agents|alkylating agents|mesh-ancestor
139084158|NCT05681728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139084159|NCT05681728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139084160|NCT05681728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139084161|NCT05681728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139084162|NCT05681728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139084163|NCT05681728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139084164|NCT05681728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084165|NCT03931928|Tamoxifen|tamoxifen|mesh-list
139084166|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139084167|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
139084168|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139084169|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084170|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139084171|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084172|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139084173|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138750262|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750263|NCT03785210|Vancomycin|vancomycin|mesh-list
138750264|NCT03785210|Nivolumab|nivolumab|mesh-list
138750265|NCT03785210|Tadalafil|tadalafil|mesh-list
138750266|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138750267|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750268|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138750269|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750270|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138750271|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138750272|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
138750273|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138750274|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138750275|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750276|NCT03785210|Urological Agents|urological agents|mesh-ancestor
138750277|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
138750278|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138750279|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750280|NCT03757689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138227362|NCT04355468|Anesthetics|anesthetics|mesh-list
139084174|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139084175|NCT01220102|Adapalene|adapalene|mesh-list
139084176|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139084177|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
139084178|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139084179|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139084180|NCT01220102|Analgesics|analgesics|mesh-ancestor
139084181|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
139084182|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084183|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277788|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
139084184|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139084185|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139084187|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139084188|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139084189|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
139084190|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084191|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139084192|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139084193|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084194|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139084195|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139084196|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084197|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084198|NCT01222910|Valacyclovir|valacyclovir|mesh-list
139084199|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
139084200|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084201|NCT04533568|Ibuprofen|ibuprofen|mesh-list
139084202|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
139084203|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139084204|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139084205|NCT04533568|Analgesics|analgesics|mesh-ancestor
139084206|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
139084207|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750281|NCT03757689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750283|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
138750284|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750285|NCT03750968|Protective Agents|protective agents|mesh-ancestor
138750286|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750287|NCT03722498|Leucovorin|leucovorin|mesh-list
138750288|NCT03722498|Fluorouracil|fluorouracil|mesh-list
138750289|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
138750290|NCT03722498|Sorafenib|sorafenib|mesh-list
138750291|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
138750292|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750293|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138750294|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750295|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138424498|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750297|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750298|NCT03722498|Antidotes|antidotes|mesh-ancestor
138750299|NCT03722498|Protective Agents|protective agents|mesh-ancestor
138750300|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
139084208|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084209|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139084210|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139084211|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139084212|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084213|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084214|NCT01312324|Docetaxel|docetaxel|mesh-list
139084215|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084216|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
139084217|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
139084218|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
139084219|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084220|NCT01127594|Temozolomide|temozolomide|mesh-list
139084221|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139084222|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
139084223|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084224|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084225|NCT01127672|Betamethasone|betamethasone|mesh-list
139084226|NCT01127672|Lidocaine|lidocaine|mesh-list
139084227|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139084228|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
139084230|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139084231|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084232|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139084233|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
139084234|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
139084235|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
139084236|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139084237|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
139084238|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084239|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139084240|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139084241|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139084242|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139084243|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750301|NCT03722498|Vitamins|vitamins|mesh-ancestor
138750302|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
138750303|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138750304|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750305|NCT03710824|Nintedanib|nintedanib|mesh-list
138750306|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750307|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138750308|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750309|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750310|NCT03648892|Raclopride|raclopride|mesh-list
138750311|NCT03648892|Fallypride|fallypride|mesh-list
138750312|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138750313|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138750314|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138750315|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750316|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138750317|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138750318|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
138750319|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138750320|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750321|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138750322|NCT03626831|Evolocumab|evolocumab|mesh-list
138750323|NCT03626831|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138750324|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139084244|NCT01220258|Azithromycin|azithromycin|mesh-list
139084245|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139084246|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139084247|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139084248|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084249|NCT01223534|Isoniazid|isoniazid|mesh-list
139084250|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
139084251|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139084252|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084253|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139084254|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139084255|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
139084256|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084257|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139084258|NCT01223612|Ranibizumab|ranibizumab|mesh-list
139084259|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139084260|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139084261|NCT01223612|Growth Substances|growth substances|mesh-ancestor
139084262|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084263|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
139084264|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084265|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139084266|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139084267|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084268|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139084269|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
139084270|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084271|NCT02946580|Naloxegol|naloxegol|mesh-list
139084272|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138750325|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138750326|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
138750327|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750328|NCT03626831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138750329|NCT03626831|Protease Inhibitors|protease inhibitors|mesh-ancestor
138750330|NCT03626831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750331|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138750332|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
138824963|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
138750333|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138750334|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750335|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138750336|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750337|NCT03445949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138750338|NCT03342690|Eplerenone|eplerenone|mesh-list
138750339|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138750340|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
138750341|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750342|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750343|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138750344|NCT03342690|Diuretics|diuretics|mesh-ancestor
138750345|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
138750346|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138750347|NCT03333616|Nivolumab|nivolumab|mesh-list
139084273|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084274|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
139084275|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084276|NCT01223690|Clarithromycin|clarithromycin|mesh-list
139084277|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139084278|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084279|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139084280|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084281|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084282|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139084283|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139084284|NCT05381350|Vaccines|vaccines|mesh-list
139084285|NCT05381350|Immunologic Factors|immunologic factors|mesh-ancestor
139084286|NCT05381350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084287|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
139084288|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
139084289|NCT01223768|Vitamins|vitamins|mesh-ancestor
139084290|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
139084291|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084292|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
139084293|NCT01126112|Panitumumab|panitumumab|mesh-list
139084294|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139084295|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084296|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
139084297|NCT01123538|Progesterone|progesterone|mesh-list
139084298|NCT01123538|Progestins|progestins|mesh-ancestor
139084299|NCT01123538|Hormones|hormones|mesh-ancestor
138750349|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138750350|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750351|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138750352|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750354|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138750355|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138750356|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
138750357|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138750358|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750359|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750360|NCT03257267|Cemiplimab|cemiplimab|mesh-list
138750361|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138750362|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750363|NCT03190668|Cefazolin|cefazolin|mesh-list
138750364|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
138750365|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138750366|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138750367|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138750368|NCT03162653|Allopurinol|allopurinol|mesh-list
139084300|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139084301|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084302|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
139084303|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
139084304|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138834874|NCT00801151|Vorinostat|vorinostat|mesh-list
139084306|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139084307|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
139084308|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139084309|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139084310|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139084311|NCT01220570|Sirolimus|sirolimus|mesh-list
139084312|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139084313|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139084314|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084315|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139084316|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084317|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
139084318|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139084319|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
139084320|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084321|NCT04682860|Scopolamine|scopolamine|mesh-list
139084322|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139084323|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139084324|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
139084325|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
139084326|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084327|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084328|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139084329|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
139084330|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139084331|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
139084332|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084333|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084334|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138750370|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
138750371|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750372|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750373|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
138750374|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138750375|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138750376|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
138750377|NCT03162653|Protective Agents|protective agents|mesh-ancestor
138750378|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750379|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138750380|NCT03162653|Diuretics|diuretics|mesh-ancestor
138750381|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
138750382|NCT02991456|Ondansetron|ondansetron|mesh-list
138750384|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
138750385|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
138750386|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084335|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
139084336|NCT01127906|Oxycodone|oxycodone|mesh-list
139084337|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139084338|NCT01127906|Narcotics|narcotics|mesh-ancestor
139084339|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139084340|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084341|NCT01127906|Analgesics|analgesics|mesh-ancestor
139084342|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
139084343|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084344|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139084345|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
139084346|NCT01127984|Coagulants|coagulants|mesh-ancestor
139084347|NCT01220648|Interferons|interferons|mesh-list
139084348|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
139084349|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084350|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
139084351|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084352|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
139084353|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084354|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139084355|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139084356|NCT01218386|Estradiol|estradiol|mesh-list
139084357|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139084358|NCT01218386|Estrogens|estrogens|mesh-ancestor
139084359|NCT01218386|Hormones|hormones|mesh-ancestor
139084360|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139084361|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084362|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139084363|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
139084364|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139084365|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139084366|NCT03933098|Vaccines|vaccines|mesh-list
139084367|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
139084368|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084369|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
139084370|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139084371|NCT01224392|Capecitabine|capecitabine|mesh-list
139084372|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139084373|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
139084374|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084375|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084376|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
139084377|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139084378|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138834949|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
138825013|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
138750387|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750388|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138750389|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
138750390|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
138750391|NCT02991456|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138750392|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138750393|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
138750394|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138750395|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750396|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138750397|NCT02842827|Tretinoin|tretinoin|mesh-list
138750398|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750399|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
138750400|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
138750401|NCT02503774|Durvalumab|durvalumab|mesh-list
138750402|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138750403|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750404|NCT02432274|Etoposide|etoposide|mesh-list
138750405|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
138750406|NCT02432274|Lenvatinib|lenvatinib|mesh-list
138750407|NCT02432274|Ifosfamide|ifosfamide|mesh-list
138750408|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
138750409|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138750410|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750411|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139084379|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084382|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
139084383|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084384|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139084385|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139084386|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139084387|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
139084388|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084389|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084390|NCT03740516|Apremilast|apremilast|mesh-list
139084391|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138825047|NCT00650325|Sertraline|sertraline|mesh-list
139084392|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139084393|NCT03740516|Analgesics|analgesics|mesh-ancestor
139084394|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
139084395|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084396|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084397|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139084398|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139084399|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139084400|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139084401|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084402|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084403|NCT03933956|Empagliflozin|empagliflozin|mesh-list
139084404|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138750412|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138750413|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750414|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750415|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138750416|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138750417|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
138551029|NCT00104910|Cetuximab|cetuximab|mesh-list
138750418|NCT02393859|Dexamethasone|dexamethasone|mesh-list
138750419|NCT02393859|Methotrexate|methotrexate|mesh-list
138750420|NCT02393859|Daunorubicin|daunorubicin|mesh-list
138750421|NCT02393859|Asparaginase|asparaginase|mesh-list
138750422|NCT02393859|Ifosfamide|ifosfamide|mesh-list
138750423|NCT02393859|Blinatumomab|blinatumomab|mesh-list
138750424|NCT02393859|Pegaspargase|pegaspargase|mesh-list
138750425|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750426|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
138750427|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
138750428|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750429|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750430|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138750431|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
138750432|NCT02393859|Hormones|hormones|mesh-ancestor
138750433|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750434|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138750435|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750436|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138750437|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
138750438|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138750439|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139084405|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084406|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139084407|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084408|NCT01218620|Tolbutamide|tolbutamide|mesh-list
139084409|NCT01218620|Rifampin|rifampin|mesh-list
139084410|NCT01218620|Ketoconazole|ketoconazole|mesh-list
139084411|NCT01218620|Midazolam|midazolam|mesh-list
139084412|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
139084413|NCT01218620|Omeprazole|omeprazole|mesh-list
139084414|NCT01218620|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139084415|NCT01218620|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139084416|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139084417|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139084418|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139084419|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084420|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139084421|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139084422|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138750440|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
138750441|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750442|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
138750443|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750444|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138750445|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138750446|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
138750447|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138750448|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138750449|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138750450|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138750451|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138750452|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138750453|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
138750454|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
138750455|NCT02096588|Doxorubicin|doxorubicin|mesh-list
138750456|NCT02096588|Simvastatin|simvastatin|mesh-list
138750457|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138750458|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
138750459|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750460|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138750461|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138750462|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
138750463|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084423|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139084424|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
139084425|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
139084426|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
139084427|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
139084428|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084429|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084430|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139084431|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139084432|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139084433|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084434|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139084435|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
139084436|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139084437|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084438|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
139084439|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139084440|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139084441|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139084442|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139084443|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139084444|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139084445|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139084446|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
139084447|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138750464|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750465|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138750466|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138750467|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138825223|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
138750468|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138750469|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750470|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138750471|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138750472|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
138750473|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138750474|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138750475|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
138750476|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
138750477|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138750478|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750479|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138750480|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
138750481|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139084448|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139084449|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139084450|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
139084451|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139084452|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139084453|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
139084454|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
139084455|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139084456|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139084457|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139084458|NCT00323297|Bosentan|bosentan|mesh-list
139084459|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
139084460|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084461|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
139084462|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139084463|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139084464|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084465|NCT00323297|Urological Agents|urological agents|mesh-ancestor
139084466|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139084467|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139084468|NCT01218698|Losartan|losartan|mesh-list
139084469|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139084470|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139084471|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139084472|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139084473|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084474|NCT01224860|Losartan|losartan|mesh-list
139084475|NCT01224860|Telmisartan|telmisartan|mesh-list
139084476|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139084477|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139084478|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139084479|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139084480|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084481|NCT00323063|Gemcitabine|gemcitabine|mesh-list
139084482|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
139084483|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139084484|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
138750483|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
138750484|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750485|NCT01359592|Prednisone|prednisone|mesh-list
138750486|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
138750487|NCT01359592|Rituximab|rituximab|mesh-list
138750488|NCT01359592|Doxorubicin|doxorubicin|mesh-list
138750489|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138750491|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138750492|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138750493|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
138750494|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750495|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138750496|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138750497|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
138750498|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750499|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750500|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138750501|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138750502|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138750503|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138750504|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138750505|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750506|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750507|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
138750508|NCT01359592|Hormones|hormones|mesh-ancestor
138750509|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750510|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138750511|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138750512|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
138750513|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
138750514|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
138750515|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138750516|NCT01331018|Plerixafor|plerixafor|mesh-list
138750517|NCT01331018|Prednisone|prednisone|mesh-list
138750518|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
139084485|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084486|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084487|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139084488|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084489|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
138750519|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138750520|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138424728|NCT03523520|Naloxegol|naloxegol|mesh-list
138750521|NCT01331018|Prednisolone|prednisolone|mesh-list
138750522|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
138750523|NCT01331018|Cortisone|cortisone|mesh-list
138750524|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138750525|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
138750526|NCT01331018|Lenograstim|lenograstim|mesh-list
138750527|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750528|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
138750529|NCT01331018|Hormones|hormones|mesh-ancestor
138750530|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750531|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750532|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138750533|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750534|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138750535|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
138750536|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
138750537|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
138750538|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825340|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
138750539|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138750540|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138750541|NCT01331018|Protective Agents|protective agents|mesh-ancestor
138750542|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139084490|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
139084491|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139084492|NCT01328990|Amodiaquine|amodiaquine|mesh-list
139084493|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
139084494|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139084495|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139084496|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084497|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139084498|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084499|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084500|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139084501|NCT01225094|Curcumin|curcumin|mesh-list
139084502|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139084503|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139084504|NCT01225094|Analgesics|analgesics|mesh-ancestor
139084505|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
139084506|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084507|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084508|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139084509|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139084510|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084511|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084512|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084513|NCT00322049|Vaccines|vaccines|mesh-list
139084514|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
139084515|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084516|NCT01124240|Temozolomide|temozolomide|mesh-list
139084517|NCT01124240|Procarbazine|procarbazine|mesh-list
138750543|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138750544|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
138750545|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138750546|NCT00840853|Acetaminophen|acetaminophen|mesh-list
138750547|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
138750548|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138750549|NCT00840853|Analgesics|analgesics|mesh-ancestor
138750550|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
138750551|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750552|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750553|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
138750554|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138750555|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138750556|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138750557|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
138750558|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
138750559|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
138750560|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
138750561|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138750562|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138750563|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
138750564|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
138750565|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138750566|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750567|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138750568|NCT00697073|Idebenone|idebenone|mesh-list
138750569|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
138750570|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750571|NCT00697073|Protective Agents|protective agents|mesh-ancestor
138750572|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750573|NCT00656331|Amlodipine|amlodipine|mesh-list
138750574|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138672459|NCT00499707|Metformin|metformin|mesh-list
139084518|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139084519|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
139084520|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084521|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084522|NCT01124318|Lactulose|lactulose|mesh-list
138278027|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139084523|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139084525|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139084526|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
139084527|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139084528|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139084529|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750575|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138750576|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138750577|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750578|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138750579|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750580|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
138750581|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
138750582|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138750583|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
138750584|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750585|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
138750586|NCT00653432|Protective Agents|protective agents|mesh-ancestor
138750588|NCT00537680|Idebenone|idebenone|mesh-list
138750589|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
138750590|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750591|NCT00537680|Protective Agents|protective agents|mesh-ancestor
138750592|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750593|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
139084530|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084531|NCT01221116|Protective Agents|protective agents|mesh-ancestor
139084532|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084533|NCT03929744|Midazolam|midazolam|mesh-list
139084534|NCT03929744|Atorvastatin|atorvastatin|mesh-list
139084535|NCT03929744|Simvastatin|simvastatin|mesh-list
139084536|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139084537|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139084538|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139084539|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084540|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139084541|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139084542|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139084543|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139084544|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
139084546|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
139084547|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
139084548|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084549|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084550|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139084551|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139084552|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
139084553|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139084554|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139084555|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084556|NCT01225406|Tenofovir|tenofovir|mesh-list
139084557|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
138825508|NCT02640495|Artesunate|artesunate|mesh-list
139084558|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278134|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
139084559|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139084560|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139084561|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084562|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084563|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139084564|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139084565|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
139084566|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750594|NCT00446043|Adapalene|adapalene|mesh-list
138750595|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
138750596|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138750597|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
138750598|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138750599|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138750601|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
138750602|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750603|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750604|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750605|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138750606|NCT00400725|Clobetasol|clobetasol|mesh-list
138750607|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750608|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
138750609|NCT00400725|Hormones|hormones|mesh-ancestor
138750610|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750611|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750612|NCT00932113|Folic Acid|folic acid|mesh-list
138750613|NCT00932113|Adalimumab|adalimumab|mesh-list
138750614|NCT00932113|Methotrexate|methotrexate|mesh-list
138750615|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138750616|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
138672553|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
139084567|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139084568|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084569|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084570|NCT01225484|Ropivacaine|ropivacaine|mesh-list
139084571|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
139084572|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
139084573|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139084574|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084575|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
138278194|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139084576|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084578|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139084579|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139084580|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139084581|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084582|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
139084583|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084584|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084585|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139084586|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084587|NCT01128998|Sorafenib|sorafenib|mesh-list
139084588|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084589|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138278254|NCT00422240|Adapalene|adapalene|mesh-list
139084590|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084591|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084592|NCT00321893|Budesonide|budesonide|mesh-list
139084593|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139084594|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138750617|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138750618|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750619|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138750620|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
138750621|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750622|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750623|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
138750624|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750625|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138750626|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138750627|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
138750628|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138750629|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138750630|NCT00932113|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138750631|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750632|NCT00932113|Hematinics|hematinics|mesh-ancestor
138750633|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
138750634|NCT00932113|Vitamins|vitamins|mesh-ancestor
138750635|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
138750636|NCT00931801|Tenofovir|tenofovir|mesh-list
138750637|NCT00931801|Emtricitabine|emtricitabine|mesh-list
138750638|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
138750639|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138750640|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
138750641|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138750642|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138750643|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138750644|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750645|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750646|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139084595|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
139084596|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084597|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084599|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
139084600|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
139084601|NCT00321893|Hormones|hormones|mesh-ancestor
139084602|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139084603|NCT01225874|Cytarabine|cytarabine|mesh-list
139084604|NCT01225874|Dexamethasone|dexamethasone|mesh-list
139084605|NCT01225874|Prednisone|prednisone|mesh-list
139084606|NCT01225874|Methotrexate|methotrexate|mesh-list
139084607|NCT01225874|Vincristine|vincristine|mesh-list
139084608|NCT01225874|Daunorubicin|daunorubicin|mesh-list
139084609|NCT01225874|Asparaginase|asparaginase|mesh-list
139084610|NCT01225874|Pegaspargase|pegaspargase|mesh-list
139084611|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139084612|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
139084613|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
138825704|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
138750648|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138750649|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138750650|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138750651|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138750652|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
138750653|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138750654|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
138750655|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138750656|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138750657|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138750658|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138750659|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750660|NCT05025397|Propofol|propofol|mesh-list
138750661|NCT05025397|Sevoflurane|sevoflurane|mesh-list
138750662|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138750663|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139084614|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084615|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084616|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139084617|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
139084618|NCT01225874|Hormones|hormones|mesh-ancestor
139084619|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139084620|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138825748|NCT00705757|Bimatoprost|bimatoprost|mesh-list
139084621|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084622|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139084623|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
139084624|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139084625|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139084626|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
139084627|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084628|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
138278310|NCT00365612|Tenofovir|tenofovir|mesh-list
139084629|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084630|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139084631|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139084632|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
139084633|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139084634|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139084635|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
139084636|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084637|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139084638|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
139084639|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
139084640|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
139084641|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139084642|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139084643|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139084644|NCT03928340|Metformin|metformin|mesh-list
139084645|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139084646|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084647|NCT00371345|Dasatinib|dasatinib|mesh-list
139084648|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825801|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
139084649|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139084650|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084651|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084652|NCT01226186|Morphine|morphine|mesh-list
138750664|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750665|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138750666|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
138750667|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
138750668|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138750669|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138750670|NCT00608803|Doxorubicin|doxorubicin|mesh-list
138750671|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138750672|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750673|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138750674|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138750675|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750676|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750677|NCT00931255|Sirolimus|sirolimus|mesh-list
138750678|NCT00931255|Tacrolimus|tacrolimus|mesh-list
138750679|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138750680|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
138750681|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750682|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138750683|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750684|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750685|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138750686|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138750687|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139084653|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139084654|NCT01226186|Narcotics|narcotics|mesh-ancestor
139084655|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139084656|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084657|NCT01226186|Analgesics|analgesics|mesh-ancestor
139084658|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
139084659|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084660|NCT01228214|Aspirin|aspirin|mesh-list
139084661|NCT01228214|Amiloride|amiloride|mesh-list
139084662|NCT01228214|Clopidogrel|clopidogrel|mesh-list
139084663|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139084664|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139084665|NCT01228214|Analgesics|analgesics|mesh-ancestor
139084666|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
139084667|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084668|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084669|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139084670|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139084671|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139084672|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139084673|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084674|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139084675|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139084676|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084677|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
139084678|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138750688|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750689|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
138750690|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138750691|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
138750692|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138750693|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138750694|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138750695|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138750696|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750697|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
138750698|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138750699|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750700|NCT00609817|Dexamethasone|dexamethasone|mesh-list
138750701|NCT00609817|Bortezomib|bortezomib|mesh-list
138750702|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750703|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
138750704|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
138750705|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750706|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750707|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138750708|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
138750710|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750711|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138750712|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750713|NCT00929695|Prednisone|prednisone|mesh-list
138750714|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
138750715|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138750716|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138750717|NCT00929695|Prednisolone|prednisolone|mesh-list
138750718|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
139084679|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138278396|NCT05360030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139084680|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139084681|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
139084682|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084683|NCT01228214|Diuretics|diuretics|mesh-ancestor
139084684|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
139084685|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138825870|NCT00751114|Metformin|metformin|mesh-list
139084686|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139084687|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139084688|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139084689|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139084690|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
139084691|NCT00321737|Lansoprazole|lansoprazole|mesh-list
139084692|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139084693|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138750719|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138750720|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
138750721|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750722|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
138750723|NCT00929695|Hormones|hormones|mesh-ancestor
138750724|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750725|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750726|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138750727|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750728|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
138750729|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
138750730|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750731|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138750732|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138750733|NCT00929695|Protective Agents|protective agents|mesh-ancestor
138750734|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
138750735|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139084694|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138278445|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
139084695|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084696|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084698|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139084699|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
139084700|NCT03740438|Chrysarobin|chrysarobin|mesh-list
139084701|NCT03740438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139084702|NCT03740438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139084703|NCT03740438|Analgesics|analgesics|mesh-ancestor
139084704|NCT03740438|Sensory System Agents|sensory system agents|mesh-ancestor
139084705|NCT03740438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084706|NCT03740438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084707|NCT03740438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139084708|NCT03740438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139084709|NCT01129154|Panitumumab|panitumumab|mesh-list
139084710|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139084711|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084712|NCT01047995|Ritonavir|ritonavir|mesh-list
139084713|NCT01047995|Darunavir|darunavir|mesh-list
139084714|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
139084715|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139084716|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139084717|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
139084718|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084719|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084720|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139084721|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138278504|NCT04740554|Prednisone|prednisone|mesh-list
139084723|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084724|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138825961|NCT05972902|Progestins|progestins|mesh-ancestor
139084725|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139084726|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139084727|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139084728|NCT01129310|Capecitabine|capecitabine|mesh-list
139084729|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
139084730|NCT01129310|Irinotecan|irinotecan|mesh-list
139084731|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139084732|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
139084733|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084734|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084735|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138750736|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750737|NCT04261465|Paclitaxel|paclitaxel|mesh-list
138750738|NCT04261465|Carboplatin|carboplatin|mesh-list
138750739|NCT04261465|Olaparib|olaparib|mesh-list
138750740|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138750741|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750742|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
138750743|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
138750744|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
138750745|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750746|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138750747|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750748|NCT00927355|Pioglitazone|pioglitazone|mesh-list
138750749|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138750750|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424952|NCT04312009|Losartan|losartan|mesh-list
138750751|NCT00923845|Sirolimus|sirolimus|mesh-list
138750753|NCT00923845|Pentostatin|pentostatin|mesh-list
138750754|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138750755|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
138672866|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139084736|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139084737|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084738|NCT01129388|Omeprazole|omeprazole|mesh-list
138324295|NCT04124094|Xhance|xhance|mesh-list
139084740|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139084741|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139084742|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139084743|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139084744|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
139084745|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084746|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084747|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084748|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139084749|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139084750|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139084751|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084753|NCT01228292|Calcium heparin|calcium heparin|mesh-list
139084754|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
139084755|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139084756|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139084757|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084758|NCT03924596|Boswellic acid|boswellic acid|mesh-list
139084759|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139084760|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139084761|NCT03924596|Analgesics|analgesics|mesh-ancestor
139084762|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
139084763|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084764|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084765|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139084767|NCT00320801|Buprenorphine|buprenorphine|mesh-list
139084768|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139084769|NCT00320801|Narcotics|narcotics|mesh-ancestor
139084770|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139084771|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084772|NCT00320801|Analgesics|analgesics|mesh-ancestor
138750756|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750757|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138750758|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138750759|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
138750760|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750761|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750762|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138750763|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138750764|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138750765|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138750766|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
138750767|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750768|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138750769|NCT05052541|Dronabinol|dronabinol|mesh-list
138750770|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
138750771|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826046|NCT05971004|Hormones|hormones|mesh-ancestor
138750772|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138750773|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138750774|NCT05052541|Analgesics|analgesics|mesh-ancestor
138551062|NCT00259129|Sorafenib|sorafenib|mesh-list
138750775|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
138672923|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139084773|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
139084774|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084775|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139084776|NCT01127204|Lamivudine|lamivudine|mesh-list
139084777|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139084778|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139084779|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084780|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084781|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
139084782|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084783|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139084784|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139084786|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139084787|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139084788|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139084789|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
139084790|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084791|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084792|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084793|NCT01228370|Urological Agents|urological agents|mesh-ancestor
139084794|NCT01221740|Milnacipran|milnacipran|mesh-list
139084795|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
139084796|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139084797|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138826071|NCT05916352|Caffeine|caffeine|mesh-list
139084798|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139084799|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084800|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084801|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084802|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139084803|NCT01221740|Analgesics|analgesics|mesh-ancestor
138750776|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750777|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138750778|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138750779|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138750780|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750781|NCT05052541|Hormones|hormones|mesh-ancestor
138750782|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750783|NCT04260685|Lidocaine|lidocaine|mesh-list
138750784|NCT04260685|Esmolol|esmolol|mesh-list
138750785|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
138750786|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
138750787|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138750788|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750789|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
138750790|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750791|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138750792|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138750793|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138750794|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138750795|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750796|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138750797|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138750798|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138750799|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
138750800|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138750801|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
138750802|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139084804|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
139084805|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084806|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
139084807|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139084808|NCT00320489|Olanzapine|olanzapine|mesh-list
139084809|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
139084810|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
138278716|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139084811|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084812|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084813|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139084814|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139084815|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139084816|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139084817|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139084818|NCT00320489|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139084819|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138750803|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
138750804|NCT05013463|Indapamide|indapamide|mesh-list
138750805|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
138750806|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138750807|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138750808|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138750809|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750810|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750811|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138750812|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138750813|NCT05013463|Diuretics|diuretics|mesh-ancestor
138750814|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
138750815|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750816|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138750817|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138750818|NCT00922987|Pregabalin|pregabalin|mesh-list
138750819|NCT00922987|Analgesics|analgesics|mesh-ancestor
138750820|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
138750821|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750822|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750823|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
138750824|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138750825|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138750826|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750827|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138750829|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138750830|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138750831|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138750832|NCT00610909|Paroxetine|paroxetine|mesh-list
138750833|NCT00610909|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138750834|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138826159|NCT05327686|Nivolumab|nivolumab|mesh-list
138750835|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138750836|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750837|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084820|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138278757|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084821|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750839|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750840|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138750841|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
138750842|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138750843|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138750844|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138750845|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750846|NCT00927901|Maleic acid|maleic acid|mesh-list
138750847|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750848|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750849|NCT04255771|Cisplatin|cisplatin|mesh-list
138750850|NCT04255771|Gemcitabine|gemcitabine|mesh-list
138750851|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750852|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138750853|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
138750854|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750855|NCT01218204|Atorvastatin|atorvastatin|mesh-list
138750856|NCT01218204|Ezetimibe|ezetimibe|mesh-list
138750857|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138750858|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138750859|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
138750860|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084822|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084823|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
139084825|NCT01127282|Vitamin A|vitamin a|mesh-list
139084826|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
139084827|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084828|NCT01127360|Bevacizumab|bevacizumab|mesh-list
139084829|NCT01127360|Ranibizumab|ranibizumab|mesh-list
139084830|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139084831|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084832|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139084833|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139084834|NCT01127360|Growth Substances|growth substances|mesh-ancestor
139084835|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084836|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
139084837|NCT01228604|Methylphenidate|methylphenidate|mesh-list
139084838|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139084839|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084840|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139084841|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139084842|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139084843|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084844|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
139084845|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084846|NCT01228682|Tolvaptan|tolvaptan|mesh-list
139084847|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139084848|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084849|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
138750861|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138750862|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138750863|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750864|NCT00926575|Beclomethasone|beclomethasone|mesh-list
138750865|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750866|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
138750867|NCT00926575|Hormones|hormones|mesh-ancestor
138750868|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750869|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750870|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138750871|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
138750872|NCT05456412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138750873|NCT05456412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138750874|NCT05456412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750875|NCT05456412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750876|NCT01217892|Metformin|metformin|mesh-list
138750877|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
138750878|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138750879|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826268|NCT04733534|Quercetin|quercetin|mesh-list
139084850|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084851|NCT01221896|Choline|choline|mesh-list
139084852|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
139084853|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139084854|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
139084855|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084856|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139084857|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139084858|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
139084859|NCT03923114|Exenatide|exenatide|mesh-list
139084860|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139084861|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084862|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139084863|NCT03923114|Incretins|incretins|mesh-ancestor
139084864|NCT03923114|Hormones|hormones|mesh-ancestor
139084865|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139084866|NCT00320411|Lapatinib|lapatinib|mesh-list
139084867|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084868|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139084869|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084870|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084871|NCT01132040|Primidone|primidone|mesh-list
139084872|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
139084873|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
139084874|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
139084875|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084876|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826324|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139084877|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084878|NCT01226966|Liraglutide|liraglutide|mesh-list
139084879|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139084880|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084881|NCT01226966|Incretins|incretins|mesh-ancestor
139084882|NCT01226966|Hormones|hormones|mesh-ancestor
139084883|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139084884|NCT03923036|Cetuximab|cetuximab|mesh-list
139084885|NCT03923036|Panitumumab|panitumumab|mesh-list
139084886|NCT03923036|Aflibercept|aflibercept|mesh-list
139084887|NCT03923036|Capecitabine|capecitabine|mesh-list
138750880|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138750881|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750882|NCT01217814|Leucovorin|leucovorin|mesh-list
138750883|NCT01217814|Folic Acid|folic acid|mesh-list
138750884|NCT01217814|Golimumab|golimumab|mesh-list
138750885|NCT01217814|Methotrexate|methotrexate|mesh-list
138750886|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
138750887|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138750888|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
138750889|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138750890|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750891|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138750892|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
138750893|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750894|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673173|NCT00600301|Triamcinolone|triamcinolone|mesh-list
139084888|NCT03923036|Irinotecan|irinotecan|mesh-list
139084889|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
139084890|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139084891|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139084892|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139084893|NCT03923036|Growth Substances|growth substances|mesh-ancestor
139084894|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084895|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
139084896|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139084897|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
138826371|NCT04154982|Protective Agents|protective agents|mesh-ancestor
139084898|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084899|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139084900|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139084901|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084902|NCT01129856|Dexamethasone|dexamethasone|mesh-list
139084903|NCT01129856|Citric Acid|citric acid|mesh-list
139084904|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
139084905|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139084906|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139084907|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139084908|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139084909|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
139084910|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
139084911|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084912|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084913|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139084914|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
139084915|NCT01129856|Hormones|hormones|mesh-ancestor
139084916|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139084917|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139084918|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139084919|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
139084920|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139084921|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
139084922|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
138826408|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139084923|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084924|NCT01129934|Promethazine|promethazine|mesh-list
139084925|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
139084926|NCT01129934|Morphine|morphine|mesh-list
139084927|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139084928|NCT01129934|Narcotics|narcotics|mesh-ancestor
139084929|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139084930|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084931|NCT01129934|Analgesics|analgesics|mesh-ancestor
138750896|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750897|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138750898|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138750899|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
138750900|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138750901|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138750902|NCT01217814|Antidotes|antidotes|mesh-ancestor
138750903|NCT01217814|Protective Agents|protective agents|mesh-ancestor
138750904|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
138750905|NCT01217814|Vitamins|vitamins|mesh-ancestor
138750906|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
138750907|NCT01217814|Hematinics|hematinics|mesh-ancestor
138750908|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138750909|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139084932|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
139084933|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084934|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
139084935|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
139084936|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139084937|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
139084938|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
139084939|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084940|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084941|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139084942|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139084943|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139084944|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
139084945|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
139084946|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
139084947|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
139084948|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139084949|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
139084950|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139084951|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
139084952|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139084953|NCT01131572|Expectorants|expectorants|mesh-ancestor
139084954|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
139084955|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139084956|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
139084957|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084958|NCT01131572|Protective Agents|protective agents|mesh-ancestor
139084959|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826520|NCT02914405|Nivolumab|nivolumab|mesh-list
139084960|NCT01131572|Antidotes|antidotes|mesh-ancestor
139084961|NCT01132196|Valproic Acid|valproic acid|mesh-list
139084962|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
139084963|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084964|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084965|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
139084966|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084967|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084968|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
139084969|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139084970|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139084971|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139084973|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139084974|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084975|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139084976|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139084977|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138826594|NCT01946529|Ifosfamide|ifosfamide|mesh-list
139084978|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
139084979|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
139084980|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138750911|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
138750912|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
138750913|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750914|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750915|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138750916|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
138750917|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
138750918|NCT01217190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138750919|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138750920|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
138750921|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138750922|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750923|NCT01136733|Everolimus|everolimus|mesh-list
138750924|NCT01136733|Lenvatinib|lenvatinib|mesh-list
138750925|NCT01136733|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138750926|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138673286|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
139084981|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084982|NCT03927170|Metformin|metformin|mesh-list
139084983|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139084984|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139084985|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084986|NCT03927170|Incretins|incretins|mesh-ancestor
139084987|NCT03927170|Hormones|hormones|mesh-ancestor
138826635|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
139084988|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139084989|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139084990|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
139084991|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084992|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084993|NCT01227200|Tramadol|tramadol|mesh-list
139084994|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139084995|NCT01227200|Narcotics|narcotics|mesh-ancestor
138279126|NCT00422396|Fenofibrate|fenofibrate|mesh-list
139084996|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139084997|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139084998|NCT01227200|Analgesics|analgesics|mesh-ancestor
139084999|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
139085000|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085001|NCT01227356|Interferons|interferons|mesh-list
139085002|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
139085003|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085004|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
139085005|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085006|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139085007|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085008|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085009|NCT01132352|Levetiracetam|levetiracetam|mesh-list
139085010|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
139085011|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
139085012|NCT01131728|Naproxen|naproxen|mesh-list
139085013|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
139085014|NCT01131728|Ephedrine|ephedrine|mesh-list
139085015|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139085016|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139085017|NCT01131728|Analgesics|analgesics|mesh-ancestor
139085018|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
139085019|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085020|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085021|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750927|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138750928|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750929|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138750930|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
138750931|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750932|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750933|NCT05178693|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138750934|NCT05178693|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138750935|NCT05178693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138750936|NCT05178693|Antimetabolites|antimetabolites|mesh-ancestor
138750937|NCT05178693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750938|NCT05178693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138750939|NCT05178693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138750940|NCT01136655|Budesonide|budesonide|mesh-list
138750941|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
138750942|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138750943|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750944|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138750945|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
139085022|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139085023|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
139085024|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139085025|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085026|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085027|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139085028|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
139085029|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139085030|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
139085031|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
139085032|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139085033|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139085034|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
139085035|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
139085036|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085037|NCT01132586|Cytarabine|cytarabine|mesh-list
139085038|NCT01132586|Lenalidomide|lenalidomide|mesh-list
139085039|NCT01132586|Idarubicin|idarubicin|mesh-list
139085040|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139085041|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
139085042|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085043|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085044|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
139085045|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085046|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139085047|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
139085048|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085049|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139085050|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139085051|NCT01132586|Growth Substances|growth substances|mesh-ancestor
139085052|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
139085053|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139085054|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139085055|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139085057|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
138750946|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138750947|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750948|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138750949|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
138750950|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
138750951|NCT01136655|Hormones|hormones|mesh-ancestor
138750952|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750953|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138750954|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138750955|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138750956|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
138750957|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138750958|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750959|NCT01135017|Dronedarone|dronedarone|mesh-list
138750960|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138750961|NCT01134705|Beclomethasone|beclomethasone|mesh-list
138750962|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139085058|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
139085059|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085060|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085061|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
139085062|NCT01227590|Ritonavir|ritonavir|mesh-list
139085063|NCT01227590|Lopinavir|lopinavir|mesh-list
139085064|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139085065|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139085066|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
139085067|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085068|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085069|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139085070|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139085071|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
139085072|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085073|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139085074|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139085075|NCT03927248|Nivolumab|nivolumab|mesh-list
139085076|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139085077|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085078|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139085079|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085080|NCT03926780|Warfarin|warfarin|mesh-list
139085081|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
139085082|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
139085083|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139085084|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
139085085|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139085086|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
139085087|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085088|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085089|NCT03926936|Fulvestrant|fulvestrant|mesh-list
139085090|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139085091|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085092|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139085093|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139085094|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
139085095|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139085096|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750963|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
138750964|NCT01134705|Hormones|hormones|mesh-ancestor
138826885|NCT00749398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138750965|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750966|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750967|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138750968|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
138750969|NCT01134627|Minocycline|minocycline|mesh-list
138750970|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138425181|NCT03001011|Sevelamer|sevelamer|mesh-list
138750971|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138750973|NCT01134393|Telmisartan|telmisartan|mesh-list
138750974|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138750975|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138750976|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138551073|NCT00104988|Temozolomide|temozolomide|mesh-list
138750977|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138750978|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750979|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138750980|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750981|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
138750982|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138750983|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138750984|NCT05331469|Insulin|insulin|mesh-list
138750985|NCT05331469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138750986|NCT05331469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750987|NCT00922441|Valsartan|valsartan|mesh-list
138750988|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138750989|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138750990|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138750991|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138750992|NCT01217112|Cannabidiol|cannabidiol|mesh-list
138750993|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
138750994|NCT01216332|Vaccines|vaccines|mesh-list
138750995|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
139085097|NCT03920618|Tenofovir|tenofovir|mesh-list
139085098|NCT03920618|Entecavir|entecavir|mesh-list
139085099|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
139085100|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085101|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139085102|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138750996|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138750997|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138750998|NCT00922207|Entecavir|entecavir|mesh-list
138750999|NCT00922207|Adefovir|adefovir|mesh-list
138751000|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
138751001|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751002|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138826908|NCT00742924|Methotrexate|methotrexate|mesh-list
138751003|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138751004|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751005|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751006|NCT01134315|Calcitriol|calcitriol|mesh-list
138751007|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138751008|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751009|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138751010|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138673489|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
139085103|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085104|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085105|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139085106|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139085107|NCT01131806|Fluticasone|fluticasone|mesh-list
139085108|NCT01131806|Xhance|xhance|mesh-list
139085109|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139085110|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139085111|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139085112|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139085113|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
139085114|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085115|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085116|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139085117|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
139085118|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
139085119|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139085120|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139085121|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139085122|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139085123|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
139085124|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835700|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139085125|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085126|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
139085127|NCT01131806|Hormones|hormones|mesh-ancestor
139085128|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139085129|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
139085130|NCT01229930|Paclitaxel|paclitaxel|mesh-list
139085131|NCT01229930|Carboplatin|carboplatin|mesh-list
139085132|NCT01229930|Cediranib|cediranib|mesh-list
139085133|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139085134|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085135|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
139085136|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
139085137|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
139085138|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085139|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085140|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139085141|NCT03920150|Vitamin D|vitamin d|mesh-list
139085142|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
139085143|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
139085144|NCT03920150|Vitamins|vitamins|mesh-list
139085145|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
138751011|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751012|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138751014|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
138751015|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138751016|NCT01216176|Anastrozole|anastrozole|mesh-list
138751017|NCT01216176|Saracatinib|saracatinib|mesh-list
138751018|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138751019|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751020|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138751021|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138751022|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751023|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751024|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138751025|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
138751026|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138751027|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751028|NCT01133847|Guanfacine|guanfacine|mesh-list
138751029|NCT01133847|Methylphenidate|methylphenidate|mesh-list
138751030|NCT01133847|Amphetamine|amphetamine|mesh-list
138751031|NCT01133847|Adderall|adderall|mesh-list
138751032|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138751033|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138751034|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751035|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138751036|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138751037|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139085146|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085147|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139085148|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139085149|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
139085150|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139085151|NCT01130324|Telavancin|telavancin|mesh-list
139085152|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139085153|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085154|NCT01229774|Diclofenac|diclofenac|mesh-list
139085155|NCT01229774|Etoricoxib|etoricoxib|mesh-list
139085156|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139085157|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139085158|NCT01229774|Analgesics|analgesics|mesh-ancestor
139085159|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
139085160|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085161|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085162|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139085163|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139085164|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139085165|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751038|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751040|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751041|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138751042|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
138751045|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751046|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138751047|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138751048|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138751049|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138751050|NCT01133379|Fluorides|fluorides|mesh-list
138751051|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
138751052|NCT01133379|Protective Agents|protective agents|mesh-ancestor
138751053|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751054|NCT00637455|Fexofenadine|fexofenadine|mesh-list
138751055|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138751056|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138751057|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138751058|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
138751059|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
138751060|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751061|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751062|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751063|NCT00919711|Denosumab|denosumab|mesh-list
138751064|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
138751065|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138751066|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751067|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138751068|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138751069|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751070|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138751071|NCT01131585|Ranibizumab|ranibizumab|mesh-list
139085166|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085167|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139085168|NCT03918590|Nepafenac|nepafenac|mesh-list
139085169|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139085170|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138827050|NCT02567383|Docetaxel|docetaxel|mesh-list
139085171|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139085172|NCT03918590|Analgesics|analgesics|mesh-ancestor
139085173|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
138751072|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138751073|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138751074|NCT01131585|Growth Substances|growth substances|mesh-ancestor
138751075|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751076|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
138751077|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751078|NCT01131507|Pancrelipase|pancrelipase|mesh-list
138751079|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138751080|NCT00919633|Interferons|interferons|mesh-list
138751082|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
138751083|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
138751084|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138751085|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751086|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751087|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
138751088|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751089|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
138751090|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751091|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
138751092|NCT00926029|Listerine|listerine|mesh-list
138751093|NCT00926029|Triclosan|triclosan|mesh-list
138751094|NCT00926029|Fluorides|fluorides|mesh-list
138751095|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
138673635|NCT00476099|Budesonide|budesonide|mesh-list
139085174|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085175|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085176|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139085177|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139085178|NCT03918590|Laxatives|laxatives|mesh-ancestor
139085179|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139085180|NCT00320255|Apixaban|apixaban|mesh-list
139085181|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139085182|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
139085183|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139085184|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
139085185|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085186|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085187|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
139085188|NCT01231802|Leucovorin|leucovorin|mesh-list
139085189|NCT01231802|Capecitabine|capecitabine|mesh-list
139085190|NCT01231802|Fluorouracil|fluorouracil|mesh-list
139085191|NCT01231802|Eniluracil|eniluracil|mesh-list
139085192|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139085193|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
139085194|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085195|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085196|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139085197|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
139085198|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085199|NCT01231802|Antidotes|antidotes|mesh-ancestor
139085200|NCT01231802|Protective Agents|protective agents|mesh-ancestor
138835776|NCT04256642|Analgesics|analgesics|mesh-ancestor
139085201|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
139085202|NCT01231802|Vitamins|vitamins|mesh-ancestor
139085203|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
138751096|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
138751097|NCT00926029|Protective Agents|protective agents|mesh-ancestor
138751098|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751099|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138751100|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751101|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138751102|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138751103|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
138751104|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751105|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138751106|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
138751107|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138751108|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751109|NCT01130493|Levodopa|levodopa|mesh-list
138751110|NCT01130493|Carbidopa|carbidopa|mesh-list
138751111|NCT01130493|Entacapone|entacapone|mesh-list
138751112|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138751113|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138751114|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138751115|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
138751116|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751117|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751118|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827135|NCT04063189|Clarithromycin|clarithromycin|mesh-list
138751119|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138751121|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138751122|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138751123|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
138751124|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
139085204|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085205|NCT01329614|Nicotine|nicotine|mesh-list
139085206|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139085207|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
139085208|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085209|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085210|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139085211|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139085212|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
139085213|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085214|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085215|NCT01231880|Piperaquine|piperaquine|mesh-list
139085216|NCT01231880|Artenimol|artenimol|mesh-list
139085217|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
139085218|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139085219|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139085220|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085221|NCT01232036|Metformin|metformin|mesh-list
138751125|NCT01130337|Capecitabine|capecitabine|mesh-list
138751126|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
138751127|NCT01130337|Trastuzumab|trastuzumab|mesh-list
138751128|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138751129|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
138751130|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751131|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751132|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138751133|NCT04901689|Leronlimab|leronlimab|mesh-list
138751134|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138751135|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138751136|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751137|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138751138|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138751139|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
138751140|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751141|NCT04252963|Streptokinase|streptokinase|mesh-list
138751142|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138751143|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138751144|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751145|NCT04258657|Paclitaxel|paclitaxel|mesh-list
138751146|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138751147|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751148|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
138751149|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
138751150|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
138751151|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751171|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751172|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
138751173|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751174|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138751176|NCT04254523|Analgesics|analgesics|mesh-ancestor
138751177|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138751178|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
138227424|NCT01656629|Vitamin D|vitamin d|mesh-list
138751179|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138751181|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138751182|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
138751183|NCT00625209|Protein C|protein c|mesh-list
138751184|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138751185|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
138751186|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138751187|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138751188|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751189|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751190|NCT04254601|Erythromycin|erythromycin|mesh-list
138751191|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
138425412|NCT02363998|Lofexidine|lofexidine|mesh-list
138751193|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
138751224|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751225|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751226|NCT04252885|Ritonavir|ritonavir|mesh-list
138751227|NCT04252885|Lopinavir|lopinavir|mesh-list
138751228|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138751229|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138751230|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
138751231|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751232|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751233|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138827211|NCT04644289|Durvalumab|durvalumab|mesh-list
138751234|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138751235|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
138751236|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751237|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138751238|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138751239|NCT04962841|Metformin|metformin|mesh-list
138751240|NCT04962841|Amlodipine|amlodipine|mesh-list
138751281|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138751282|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138751283|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138751284|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
138751286|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138751287|NCT04252261|Protective Agents|protective agents|mesh-ancestor
138751288|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751289|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751290|NCT04251871|Interferons|interferons|mesh-list
138751291|NCT04251871|Ritonavir|ritonavir|mesh-list
138751292|NCT04251871|Lopinavir|lopinavir|mesh-list
138751293|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
138751294|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138751295|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751343|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751344|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
138751345|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
138751346|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
138751347|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751348|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138751349|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751350|NCT01128387|Panitumumab|panitumumab|mesh-list
138751351|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138751352|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751407|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751408|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138751409|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751410|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138751411|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
138751412|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138751413|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138751417|NCT01213524|Nicotine|nicotine|mesh-list
138751473|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751474|NCT04782037|Calcium|calcium|mesh-list
138751475|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138751476|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751477|NCT00924469|Prednisone|prednisone|mesh-list
138751478|NCT00924469|Leuprolide|leuprolide|mesh-list
138751479|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138751480|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
138751481|NCT00924469|Hormones|hormones|mesh-ancestor
138751482|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138751483|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751484|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138751485|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751486|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138751488|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138751489|NCT00631579|Rasburicase|rasburicase|mesh-list
138751490|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
138751491|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138751492|NCT00916357|Insulin|insulin|mesh-list
138751493|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138751494|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
138751495|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138751496|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751497|NCT00916279|Paclitaxel|paclitaxel|mesh-list
138751504|NCT01209078|Linezolid|linezolid|mesh-list
138751527|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751528|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138751529|NCT04318158|Narcotics|narcotics|mesh-ancestor
138751530|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138751531|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138751532|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
138751533|NCT01207596|Hydromorphone|hydromorphone|mesh-list
138751534|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138751535|NCT01207596|Narcotics|narcotics|mesh-ancestor
138751594|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751595|NCT04816513|Ustekinumab|ustekinumab|mesh-list
138751596|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
138751597|NCT04203511|Paclitaxel|paclitaxel|mesh-list
138751598|NCT04203511|Etoposide|etoposide|mesh-list
138751599|NCT04203511|Carboplatin|carboplatin|mesh-list
138751600|NCT04203511|Pemetrexed|pemetrexed|mesh-list
138751601|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138751602|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751603|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
138751604|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
138751605|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
138751606|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751607|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138751608|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138751609|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751610|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138751611|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138751612|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
138751613|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138751614|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138751615|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751616|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
138751617|NCT03690037|Coagulants|coagulants|mesh-ancestor
138751618|NCT00910273|Etanercept|etanercept|mesh-list
138751619|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138751620|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138751621|NCT00910273|Analgesics|analgesics|mesh-ancestor
138751622|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
138751623|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751624|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751625|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138751626|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138751627|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138751628|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138751629|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
138751630|NCT00910039|Sunitinib|sunitinib|mesh-list
138751631|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085222|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138751632|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138751633|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138751634|NCT00910039|Growth Substances|growth substances|mesh-ancestor
138751635|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751636|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
138751701|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751702|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
138751703|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
138751704|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
138751705|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751706|NCT01281917|Sirolimus|sirolimus|mesh-list
138751707|NCT01281917|Bortezomib|bortezomib|mesh-list
138751708|NCT01281917|Temsirolimus|temsirolimus|mesh-list
138751709|NCT01281917|MTOR Inhibitors|mtor inhibitors|mesh-list
138751710|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751711|NCT01281917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138751712|NCT01281917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751713|NCT01281917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751714|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138751715|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
138751716|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751717|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138751718|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827361|NCT00734032|Darapladib|darapladib|mesh-list
138751719|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138751720|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
138751721|NCT01281839|Ribavirin|ribavirin|mesh-list
138751756|NCT05566223|Pembrolizumab|pembrolizumab|mesh-list
138751757|NCT05566223|Fludarabine|fludarabine|mesh-list
138751758|NCT05566223|Interleukin-2|interleukin-2|mesh-list
138751759|NCT05566223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138751760|NCT05566223|Immunologic Factors|immunologic factors|mesh-ancestor
138751761|NCT05566223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751762|NCT05566223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138751763|NCT05566223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138751764|NCT05566223|Alkylating Agents|alkylating agents|mesh-ancestor
138751765|NCT05566223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751766|NCT05566223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751767|NCT05566223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138751768|NCT05566223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138751769|NCT05566223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138751770|NCT05566223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138751771|NCT05566223|Analgesics|analgesics|mesh-ancestor
138751772|NCT05566223|Sensory System Agents|sensory system agents|mesh-ancestor
138751773|NCT05566223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751774|NCT05566223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138751775|NCT05566223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138751776|NCT05566223|Antiviral Agents|antiviral agents|mesh-ancestor
138751778|NCT01271933|Pregabalin|pregabalin|mesh-list
138751811|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751812|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
138751813|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138751814|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138751815|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138751816|NCT04323527|Analgesics|analgesics|mesh-ancestor
138751817|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
138751818|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751819|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751820|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138751821|NCT04323527|Filaricides|filaricides|mesh-ancestor
138751822|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
138751823|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
138751824|NCT02889497|Vaccines|vaccines|mesh-list
138751825|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
138751870|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138751871|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751872|NCT01265615|Vitamins|vitamins|mesh-ancestor
138751873|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
138751874|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138751875|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138751876|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138751877|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751878|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138751937|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138751938|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138751939|NCT04321655|Analgesics|analgesics|mesh-ancestor
138751940|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
138751941|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751942|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751943|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138751948|NCT01261325|Brivaracetam|brivaracetam|mesh-list
138752004|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752005|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138752006|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138752007|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138752008|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752009|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752010|NCT04321733|Amoxicillin|amoxicillin|mesh-list
138752011|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
138752012|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
138752013|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138752014|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138752067|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
138752068|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138752069|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
138752070|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752071|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752072|NCT01258595|Vaccines|vaccines|mesh-list
138752073|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
138752074|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752075|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138752076|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752130|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138752131|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752132|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
138752133|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
138752134|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
138752135|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752136|NCT04293172|Ticagrelor|ticagrelor|mesh-list
138752137|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138752138|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138752139|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138752140|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138752141|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
138752142|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752143|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752190|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752191|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138752192|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138752193|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138752194|NCT00996658|Linagliptin|linagliptin|mesh-list
138752195|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138827488|NCT00576823|Urological Agents|urological agents|mesh-ancestor
138752196|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752197|NCT00996658|Incretins|incretins|mesh-ancestor
138752198|NCT00996658|Hormones|hormones|mesh-ancestor
138752199|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138752200|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138752201|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
138752202|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752203|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752204|NCT04310631|Ranibizumab|ranibizumab|mesh-list
138752205|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138752206|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138752207|NCT04310631|Growth Substances|growth substances|mesh-ancestor
138752208|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752209|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
138752210|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752211|NCT01256411|Amlodipine|amlodipine|mesh-list
138752242|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138752243|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138752244|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752245|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138752246|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
138752247|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138752248|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138752249|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138752250|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138827530|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138752251|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752252|NCT02882451|Pinaverium|pinaverium|mesh-list
138752253|NCT02882451|Bromides|bromides|mesh-list
138752254|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752255|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752301|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752302|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752303|NCT01255787|Vortioxetine|vortioxetine|mesh-list
138752304|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
138752305|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138752306|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138752307|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138752308|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138752309|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752310|NCT01255787|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138752311|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138752363|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
138752364|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138752365|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138752366|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138752367|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138752368|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752369|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
138752370|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
138752371|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752372|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752373|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138752374|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138752375|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
138752376|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138752377|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138752378|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138752379|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138752380|NCT01254227|Deferasirox|deferasirox|mesh-list
138752381|NCT01254227|Deferoxamine|deferoxamine|mesh-list
138752382|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138752384|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
138752385|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752386|NCT01254227|Siderophores|siderophores|mesh-ancestor
138752416|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138752417|NCT01121913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138752418|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138752419|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752420|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752421|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752483|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138752484|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752485|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752486|NCT01120899|Minocycline|minocycline|mesh-list
138752487|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138752488|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139059165|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138651014|NCT00305630|Hormones|hormones|mesh-ancestor
138752489|NCT01120275|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
138752550|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
138752551|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752552|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138752553|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752554|NCT01119105|Vancomycin|vancomycin|mesh-list
138752555|NCT01119105|Lefamulin|lefamulin|mesh-list
138752556|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138752557|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752613|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138752614|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138752615|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138752616|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138752617|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138752618|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
138752619|NCT00991276|Protective Agents|protective agents|mesh-ancestor
138752620|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138752621|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138752622|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
138752623|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
138752676|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
138752678|NCT02867800|Cyclosporine|cyclosporine|mesh-list
138752679|NCT02867800|Sirolimus|sirolimus|mesh-list
138752680|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
138752681|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
138752753|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752754|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
138752755|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752756|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138752757|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138752758|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
138752759|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138752760|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
138752761|NCT02867176|Ketorolac|ketorolac|mesh-list
138752762|NCT02867176|Gabapentin|gabapentin|mesh-list
138752763|NCT02867176|Analgesics|analgesics|mesh-ancestor
138752764|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
138752765|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752766|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752768|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138752769|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138752770|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138752771|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138752772|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138752773|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138752774|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752775|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752776|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
138752777|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138752778|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138752779|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138752804|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
138752806|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
138827719|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
138752807|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752808|NCT04291066|Protective Agents|protective agents|mesh-ancestor
138752809|NCT04291066|Antidotes|antidotes|mesh-ancestor
138752810|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
138752811|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
138752812|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752813|NCT01260194|Trastuzumab|trastuzumab|mesh-list
138752870|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752871|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138752872|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138752873|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752874|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752875|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
138752876|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752877|NCT00624026|Memantine|memantine|mesh-list
138752878|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138752879|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138752880|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
138752933|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
138752934|NCT04291664|Hormones|hormones|mesh-ancestor
138752935|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138752936|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752937|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138752938|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752939|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138752940|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752941|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752942|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
138752943|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138752944|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
138752992|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
138752993|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
138752994|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752995|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752996|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138752997|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
138752998|NCT04319978|Hormones|hormones|mesh-ancestor
138753000|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138753060|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
138753061|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138753062|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
138753063|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753064|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
138753065|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753066|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753129|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138753130|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753131|NCT01259102|Analgesics|analgesics|mesh-ancestor
138753132|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
138753133|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753134|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138753135|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
138753136|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
138753137|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753138|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
138753139|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138753140|NCT01259024|Estrogens|estrogens|mesh-ancestor
138753142|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138753143|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753144|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138753145|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753146|NCT04319900|Chloroquine|chloroquine|mesh-list
138753147|NCT04319900|Favipiravir|favipiravir|mesh-list
138753185|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138753186|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
138753187|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753188|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753189|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138753190|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138753191|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
138753192|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753193|NCT01204710|Prednisone|prednisone|mesh-list
138753194|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
138753195|NCT01204710|Olaratumab|olaratumab|mesh-list
138753251|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
138753252|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
138753253|NCT01111851|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138753254|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138753255|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
138753256|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753257|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138753258|NCT01256294|Tacrolimus|tacrolimus|mesh-list
138753259|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138753260|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
138753261|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753262|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138753263|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753264|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753265|NCT01256060|Oxytocin|oxytocin|mesh-list
138753266|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
138753267|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138753268|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753269|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
138753270|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
138753271|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138753272|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138753273|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753274|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138753275|NCT01255904|Analgesics|analgesics|mesh-ancestor
138753290|NCT01203930|Rituximab|rituximab|mesh-list
138753301|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138753302|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
138753303|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753304|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753305|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753306|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138753308|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
138753309|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138753310|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138753311|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
138753312|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
138753363|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138753364|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
138753365|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
138753366|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138753367|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138753368|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138753428|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753429|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
138753430|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138753431|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138753432|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138753433|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138753434|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138753435|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138753436|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138753437|NCT01254344|Metronidazole|metronidazole|mesh-list
138753438|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
138753490|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138753491|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138753492|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753493|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138753494|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
138753495|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138753496|NCT01109979|Diuretics|diuretics|mesh-ancestor
138753497|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
138753498|NCT01102491|Ramosetron|ramosetron|mesh-list
138753499|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
138753501|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753502|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753503|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138753504|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138753505|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
138753548|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138753549|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753550|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138753551|NCT01253174|Diuretics|diuretics|mesh-ancestor
138753552|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
138753553|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
138753554|NCT01253174|Vitamins|vitamins|mesh-ancestor
138753555|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
138753612|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
138753613|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753614|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753616|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138753617|NCT01101165|Narcotics|narcotics|mesh-ancestor
138753618|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138753619|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753620|NCT01101165|Analgesics|analgesics|mesh-ancestor
138753621|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
138753622|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753623|NCT01100853|Naltrexone|naltrexone|mesh-list
138753624|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138753675|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138753676|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138753678|NCT01097577|Analgesics|analgesics|mesh-ancestor
138753679|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
138753680|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753681|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753682|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
138753683|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138753684|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138753685|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753739|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138753740|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138753741|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
138753742|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
138753743|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753810|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753811|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138753812|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827914|NCT02857946|Incretins|incretins|mesh-ancestor
138753813|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138753814|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
138753815|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138753816|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138753817|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
138753818|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753819|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
138753820|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753872|NCT01092507|Vaccines|vaccines|mesh-list
138753873|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
138753874|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753875|NCT01078545|Leuprolide|leuprolide|mesh-list
138753876|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138753877|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
138753878|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138753879|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753880|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138753881|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753882|NCT01091259|Bevacizumab|bevacizumab|mesh-list
138753883|NCT01091259|Irinotecan|irinotecan|mesh-list
138753885|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753933|NCT01200810|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
138753934|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
138753935|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
138753936|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138753937|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827958|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753938|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753939|NCT01200810|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138753999|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138754000|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138754001|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
138754002|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754003|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138754004|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754067|NCT01077375|Analgesics|analgesics|mesh-ancestor
138754068|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
138754069|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754070|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
138754071|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138754073|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138754074|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754075|NCT04306653|Betamethasone|betamethasone|mesh-list
138754076|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138754135|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
138754136|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754137|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754138|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138754139|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138754140|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754141|NCT02888327|Protective Agents|protective agents|mesh-ancestor
138754142|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
138754143|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754144|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138754145|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138754199|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754200|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138754202|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138754203|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138754204|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138754206|NCT01087203|Analgesics|analgesics|mesh-ancestor
138754207|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
138754208|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754209|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754210|NCT01246583|Tofacitinib|tofacitinib|mesh-list
138754211|NCT01246583|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138754261|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754262|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138754263|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138754264|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754265|NCT04083157|Imiquimod|imiquimod|mesh-list
138754266|NCT04083157|Vaccines|vaccines|mesh-list
138754267|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
138754268|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754269|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138754270|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754271|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
138754272|NCT00975286|Metformin|metformin|mesh-list
138754273|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
138754274|NCT00975286|Lixisenatide|lixisenatide|mesh-list
138754278|NCT00907777|Vaccines|vaccines|mesh-list
138754323|NCT01711021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138754324|NCT01711021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754325|NCT01711021|Sympathomimetics|sympathomimetics|mesh-ancestor
138754326|NCT01711021|Autonomic Agents|autonomic agents|mesh-ancestor
138754327|NCT01711021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754328|NCT01711021|Dopamine Agents|dopamine agents|mesh-ancestor
138754329|NCT01711021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754330|NCT01711021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754331|NCT01711021|Adrenergic Agents|adrenergic agents|mesh-ancestor
138754332|NCT01711021|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138754333|NCT01711021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138551376|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
138754337|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
138754384|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
138754385|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138754386|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
138754387|NCT05175625|Paraproteins|paraproteins|mesh-list
138754388|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
138754389|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428652|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138754390|NCT01241591|Etanercept|etanercept|mesh-list
138754391|NCT01241591|Tofacitinib|tofacitinib|mesh-list
138754392|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138754393|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138754394|NCT01241591|Analgesics|analgesics|mesh-ancestor
138754395|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
138754447|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138754448|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138754450|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
138754451|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754452|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754453|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138754454|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138754460|NCT02850211|Narcotics|narcotics|mesh-ancestor
138754515|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
138754516|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754517|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
138754518|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
138754519|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
138754520|NCT01238861|Benralizumab|benralizumab|mesh-list
138754521|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138754522|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
138754523|NCT02888561|Dobutamine|dobutamine|mesh-list
138754524|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138754525|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
138754526|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
138754527|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754528|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754529|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138754530|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138754531|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138754532|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
138754533|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059166|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138754534|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754535|NCT02888561|Protective Agents|protective agents|mesh-ancestor
138754536|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138754537|NCT04319549|Eusol|eusol|mesh-list
138754538|NCT04319549|Ketorolac|ketorolac|mesh-list
138754539|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138754542|NCT04319549|Analgesics|analgesics|mesh-ancestor
138754564|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138754565|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754566|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138754567|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754568|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
138754569|NCT01236365|Atorvastatin|atorvastatin|mesh-list
138754570|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138754571|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138754572|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
138754573|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754574|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138754575|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138754576|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754577|NCT00903331|Macitentan|macitentan|mesh-list
138754578|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138754579|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138754580|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754581|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138754582|NCT01235741|Pramlintide|pramlintide|mesh-list
138754583|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138754584|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754585|NCT02849353|Immunomodulating Agents|immunomodulating agents|mesh-list
138754586|NCT02849353|Immunologic Factors|immunologic factors|mesh-ancestor
138754587|NCT02849353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754588|NCT01235507|Methotrexate|methotrexate|mesh-list
138754589|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138754590|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
138754591|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138754607|NCT01868269|Rituximab|rituximab|mesh-list
138754608|NCT01868269|BB 1101|bb 1101|mesh-list
138754609|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138754610|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
138754611|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754612|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138754613|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138828120|NCT00948428|Imiquimod|imiquimod|mesh-list
138754614|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
138428876|NCT01713361|Enoxaparin|enoxaparin|mesh-list
138754615|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754616|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754617|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138754618|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138754669|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138754670|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
138754671|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138754672|NCT01075815|Hormones|hormones|mesh-list
138754673|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138551400|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138754674|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754675|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754737|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138754738|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138754739|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754740|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138754741|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754742|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138754743|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138754744|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754745|NCT04778787|Protective Agents|protective agents|mesh-ancestor
138754746|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
138754747|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138754748|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
138754749|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138754750|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138754751|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754752|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138754753|NCT04304157|Analgesics|analgesics|mesh-ancestor
138754754|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
138754789|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754790|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754791|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138754792|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754794|NCT02848963|Propofol|propofol|mesh-list
138754795|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138754796|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138754797|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754798|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138754799|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
138754800|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
138754801|NCT02848963|Analgesics|analgesics|mesh-ancestor
138754802|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
138754804|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138754848|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754849|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754851|NCT04697485|Bumetanide|bumetanide|mesh-list
138754852|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138754853|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
138754912|NCT02875821|Metformin|metformin|mesh-list
138754913|NCT02875821|Pioglitazone|pioglitazone|mesh-list
138754914|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
138754915|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138754916|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754917|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138754918|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754919|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
138754920|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754976|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138754978|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138754979|NCT01230749|Pioglitazone|pioglitazone|mesh-list
138754980|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138754981|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755046|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138755047|NCT02848417|Analgesics|analgesics|mesh-ancestor
138755048|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
138755049|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755050|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755051|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755052|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755053|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755054|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755055|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429320|NCT01715597|Vitamins|vitamins|mesh-ancestor
138755056|NCT02847403|Exenatide|exenatide|mesh-list
138755057|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138755058|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755059|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138755060|NCT02847403|Incretins|incretins|mesh-ancestor
138755061|NCT02847403|Hormones|hormones|mesh-ancestor
138828251|NCT02855294|Diuretics|diuretics|mesh-ancestor
138755103|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755104|NCT02846935|Decitabine|decitabine|mesh-list
138755105|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
138755106|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138755107|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
138755108|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755109|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755110|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755111|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
138755112|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755113|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
138755114|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755116|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138755165|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138755166|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138755167|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
138755168|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138755169|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755170|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755171|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138755172|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138755173|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138755232|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755233|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138755234|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138755235|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138755236|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138755237|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
138755238|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138755239|NCT02863120|Bupivacaine|bupivacaine|mesh-list
138755240|NCT02863120|Ropivacaine|ropivacaine|mesh-list
138755241|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
138755242|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
138755243|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059167|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755244|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755245|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
138755246|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755288|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755289|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755290|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755291|NCT00900757|Palonosetron|palonosetron|mesh-list
138755292|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
138755293|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
138755294|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755359|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
138755360|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755361|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755362|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138755363|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
138755364|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755365|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755366|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138755367|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138755368|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138755369|NCT02845999|Analgesics|analgesics|mesh-ancestor
138755370|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
138755371|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755373|NCT05337085|Dexmedetomidine|dexmedetomidine|mesh-list
138755374|NCT05337085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138755375|NCT05337085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138755378|NCT05337085|Analgesics|analgesics|mesh-ancestor
138755415|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755416|NCT00901927|Analgesics|analgesics|mesh-ancestor
138755417|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
138755418|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755419|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138755420|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138755421|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755423|NCT05335837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138755424|NCT05335837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755480|NCT02842567|Tocopherols|tocopherols|mesh-list
138755481|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
138755482|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
138755483|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
138755484|NCT02842567|Vitamins|vitamins|mesh-ancestor
138755485|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
138755486|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755487|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
138755488|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755489|NCT02842567|Protective Agents|protective agents|mesh-ancestor
138755490|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138755491|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138755544|NCT00156091|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138755545|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138755546|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138755547|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755548|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755549|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
138755550|NCT00140959|Losartan|losartan|mesh-list
138755551|NCT00140959|Atenolol|atenolol|mesh-list
138755552|NCT00140959|Amlodipine|amlodipine|mesh-list
138755553|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138755609|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755610|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755611|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138755612|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
138755613|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755614|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138755624|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
138755680|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138755681|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
138755682|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755683|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138755684|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
138755685|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
138755686|NCT01228019|Vitamins|vitamins|mesh-ancestor
138755687|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
138755688|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755689|NCT01227707|Leucovorin|leucovorin|mesh-list
138755690|NCT01227707|Bevacizumab|bevacizumab|mesh-list
138755691|NCT01227707|Capecitabine|capecitabine|mesh-list
138755692|NCT01227707|Fluorouracil|fluorouracil|mesh-list
138755693|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138755694|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755695|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138755744|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755745|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138755746|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
138755747|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138755748|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
138755749|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755750|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755751|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138755811|NCT00895453|Trace Elements|trace elements|mesh-ancestor
138755812|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
138755814|NCT00893737|Sumatriptan|sumatriptan|mesh-list
138755815|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138755816|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138755817|NCT00893737|Analgesics|analgesics|mesh-ancestor
138755818|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
138755819|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755820|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755821|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755822|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755823|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
138755824|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138755825|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755826|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755871|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755872|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138755873|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138755874|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138755875|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
138755876|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138755877|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138755878|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138755879|NCT00892957|Thrombin|thrombin|mesh-list
138755880|NCT00892957|Aprotinin|aprotinin|mesh-list
138755881|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
138755882|NCT00892957|Coagulants|coagulants|mesh-ancestor
138755883|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138755884|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138755885|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
138755886|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755887|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755888|NCT05322733|Cyclophosphamide|cyclophosphamide|mesh-list
138755889|NCT05322733|Fludarabine|fludarabine|mesh-list
138755890|NCT05322733|Obinutuzumab|obinutuzumab|mesh-list
138755891|NCT05322733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138755892|NCT05322733|Immunologic Factors|immunologic factors|mesh-ancestor
138755901|NCT00968812|Metformin|metformin|mesh-list
138755927|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138828394|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
138755928|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138755929|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138755930|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
138755931|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755932|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755933|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
138755934|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138755935|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138755990|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755992|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138755993|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138755994|NCT02836639|Etoposide|etoposide|mesh-list
138755995|NCT02836639|Busulfan|busulfan|mesh-list
138755996|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138755997|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138755998|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755999|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138756000|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138756001|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756002|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756003|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
138828431|NCT00917878|Calcium|calcium|mesh-list
138756004|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138756005|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
138756006|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756007|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138756047|NCT00971932|Cetuximab|cetuximab|mesh-list
138756048|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756049|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
138551534|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138756050|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756115|NCT00966940|Travoprost|travoprost|mesh-list
138756116|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138756117|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138756118|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138756119|NCT00965848|Doripenem|doripenem|mesh-list
138756120|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138756121|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138756122|NCT03447574|Ethanol|ethanol|mesh-list
138756123|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138756124|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138756125|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756126|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756127|NCT04284826|Mitomycins|mitomycins|mesh-list
138756128|NCT04284826|Mitomycin|mitomycin|mesh-list
138756129|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138756130|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756131|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
138756132|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756133|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138756134|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756135|NCT04285528|Lidocaine|lidocaine|mesh-list
138756136|NCT04285528|Fentanyl|fentanyl|mesh-list
138756137|NCT04285528|Ketamine|ketamine|mesh-list
138756138|NCT04285528|Propofol|propofol|mesh-list
138756167|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138756168|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
138756169|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756170|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
138756171|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756173|NCT00961636|Niacinamide|niacinamide|mesh-list
138756174|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
138756181|NCT00961636|Vitamins|vitamins|mesh-ancestor
138756237|NCT02860858|Aflibercept|aflibercept|mesh-list
138756238|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138756239|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138756240|NCT02860858|Growth Substances|growth substances|mesh-ancestor
138756241|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756244|NCT00960076|Metformin|metformin|mesh-list
138756306|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756307|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138756308|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138756309|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138756310|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138756311|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
138756312|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
138756313|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
138756314|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
138756375|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756376|NCT02861716|Fentanyl|fentanyl|mesh-list
138756377|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
138756378|NCT02861716|Bupivacaine|bupivacaine|mesh-list
138756379|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
138756380|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
138756381|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756382|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756383|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
138756384|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756385|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138551577|NCT00072332|Cisplatin|cisplatin|mesh-list
138756387|NCT02861716|Analgesics|analgesics|mesh-ancestor
138756437|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138756438|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138756439|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138756440|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756441|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756442|NCT00892099|Vitamin D|vitamin d|mesh-list
138756443|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
138756444|NCT00892099|Cholecalciferol|cholecalciferol|mesh-list
138756445|NCT00892099|Vitamins|vitamins|mesh-list
138756446|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
138756451|NCT00960856|Fenofibrate|fenofibrate|mesh-list
138756503|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138756504|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
138756505|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756506|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756507|NCT00630370|ATI 7505|ati 7505|mesh-list
138756508|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138756509|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138756510|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
138756511|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828515|NCT00686959|Paclitaxel|paclitaxel|mesh-list
138756512|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756513|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756514|NCT02835391|Surgiflo|surgiflo|mesh-list
138756515|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
138756516|NCT02835391|Coagulants|coagulants|mesh-ancestor
138756517|NCT02831101|Sufentanil|sufentanil|mesh-list
138756518|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138756519|NCT02831101|Narcotics|narcotics|mesh-ancestor
138756520|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756521|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756522|NCT02831101|Analgesics|analgesics|mesh-ancestor
138756523|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
138756524|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756525|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138756526|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138756527|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
138756529|NCT04245787|Fluorides|fluorides|mesh-list
138756530|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
138756531|NCT04245787|Protective Agents|protective agents|mesh-ancestor
138756532|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756533|NCT02831179|Capecitabine|capecitabine|mesh-list
138756534|NCT02831179|Temozolomide|temozolomide|mesh-list
138756535|NCT02831179|Veliparib|veliparib|mesh-list
138756536|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138756548|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756549|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138756550|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756551|NCT02830789|Antacids|antacids|mesh-ancestor
138756552|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138756553|NCT04243993|Calcium|calcium|mesh-list
138756554|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138756555|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756556|NCT04245319|Acitretin|acitretin|mesh-list
138756557|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
138756558|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
138756559|NCT02828059|Ropivacaine|ropivacaine|mesh-list
138756560|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
138756561|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
138756562|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756563|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756564|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
138756565|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756567|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138756568|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138756569|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756604|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756605|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756606|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138756607|NCT04244695|Dexamethasone|dexamethasone|mesh-list
138756608|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138756609|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
138756610|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
138756611|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756612|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756613|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138756614|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
138756615|NCT04244695|Hormones|hormones|mesh-ancestor
138756616|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138756617|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138756618|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756619|NCT00887809|Bevacizumab|bevacizumab|mesh-list
138756620|NCT00887809|Gemcitabine|gemcitabine|mesh-list
138756621|NCT00887809|Docetaxel|docetaxel|mesh-list
138756622|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138756623|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756624|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138756625|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138756626|NCT00887809|Growth Substances|growth substances|mesh-ancestor
138756627|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756628|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
138756629|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138756630|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
138756631|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756635|NCT02827747|Vitamin A|vitamin a|mesh-list
138756647|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138756648|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138756649|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
138756650|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
138756651|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756652|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138756653|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138756654|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756655|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756656|NCT00886795|Abatacept|abatacept|mesh-list
138756657|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138756658|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756659|NCT00886795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138828631|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
138756660|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756661|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138756662|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
138551596|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138756703|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756704|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138756705|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138756706|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
138756707|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
138756708|NCT02830243|Sevoflurane|sevoflurane|mesh-list
138756710|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138756711|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138756712|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
138756713|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
138756714|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756715|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756717|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138756718|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756719|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756720|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
138756721|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756722|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756723|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
138756724|NCT02829385|Apatinib|apatinib|mesh-list
138756725|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756726|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138756727|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756729|NCT02826343|Xenon|xenon|mesh-list
138756754|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138756755|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138756756|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756757|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138756758|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
138756759|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
138756760|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138756761|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
138756762|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138756763|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
138756764|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756817|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
138756818|NCT02825719|Coagulants|coagulants|mesh-ancestor
138756819|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138756820|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
138756821|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138756822|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756823|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138756824|NCT04241653|Sevoflurane|sevoflurane|mesh-list
138756885|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138756886|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138756887|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756888|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756889|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
138756890|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756891|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138756892|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
138756893|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138756894|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138756895|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138756896|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756897|NCT02823691|Metformin|metformin|mesh-list
138756898|NCT02823691|Lanreotide|lanreotide|mesh-list
138756899|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138756900|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756901|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756902|NCT02825095|Lidocaine|lidocaine|mesh-list
138756903|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
138756904|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
138756905|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756906|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756935|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756936|NCT00633763|Fallypride|fallypride|mesh-list
138756937|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138756938|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138756939|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
138756940|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756941|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756942|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756943|NCT02820025|Doxapram|doxapram|mesh-list
138756944|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138756945|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756999|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138757000|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757001|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757002|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138757003|NCT02818621|Analgesics|analgesics|mesh-ancestor
138757004|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
138757005|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757006|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138431278|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
138757007|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138757008|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138757009|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
138757010|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757011|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757012|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
138757013|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138757014|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757015|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757027|NCT01061151|Lopinavir|lopinavir|mesh-list
138757052|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
138757053|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
138757054|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757055|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757056|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138757057|NCT04472143|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138757058|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138757059|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
138757060|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138551622|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
138757061|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757062|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138757063|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
138757064|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757065|NCT04748523|Mirtazapine|mirtazapine|mesh-list
138757066|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
138757067|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138757068|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138757069|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
138757105|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138757106|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757108|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138757109|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
138757110|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757111|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138757112|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
138757113|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
138757114|NCT01239992|Vitamins|vitamins|mesh-ancestor
138757115|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
138757116|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757171|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138757172|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757173|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757174|NCT02874963|Antifungal Agents|antifungal agents|mesh-ancestor
138757175|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
138757176|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
138757177|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
138757178|NCT02818309|Lesogaberan|lesogaberan|mesh-list
138757179|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138757180|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138757236|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
138757237|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
138757238|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138757239|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
138757240|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757241|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757242|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138757243|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138757244|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757245|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757246|NCT01047501|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138757247|NCT01047501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138757248|NCT01047501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138757249|NCT01238120|Ibuprofen|ibuprofen|mesh-list
138828788|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
138757250|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138757251|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138757252|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138757253|NCT01238120|Analgesics|analgesics|mesh-ancestor
138757254|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
138757255|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757290|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
138757291|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138757292|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757293|NCT02874807|Empagliflozin|empagliflozin|mesh-list
138757294|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138757295|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757296|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138757297|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757298|NCT01054599|Memantine|memantine|mesh-list
138757299|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138757300|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138757301|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
138757302|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757310|NCT02874729|Dimercaprol|dimercaprol|mesh-list
138757351|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757352|NCT01235546|Azithromycin|azithromycin|mesh-list
138757353|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138757354|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138757355|NCT01053429|Ziprasidone|ziprasidone|mesh-list
138757356|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138757357|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
138757358|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757359|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551705|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138757360|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757361|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138757362|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138757363|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757364|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138757365|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138757366|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
138757367|NCT01233284|Bromides|bromides|mesh-list
138757368|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
138757369|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138757370|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
138757380|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
138757404|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757405|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757406|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
138757407|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138757408|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138757409|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757410|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138757411|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138757412|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138757413|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757414|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138757415|NCT01232738|Rasagiline|rasagiline|mesh-list
138757416|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138757417|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757418|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757419|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138757420|NCT01232738|Protective Agents|protective agents|mesh-ancestor
138757421|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757422|NCT00957268|Alogliptin|alogliptin|mesh-list
138757457|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757458|NCT02888054|Allopurinol|allopurinol|mesh-list
138757459|NCT02888054|Lesinurad|lesinurad|mesh-list
138757460|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
138757461|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757462|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757466|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
138757525|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138757526|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138757527|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
138757528|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138757529|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
138757530|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138757531|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757532|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138757591|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
138757592|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
138757593|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138757594|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138757595|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138757596|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
138757597|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
138757598|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138757599|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757600|NCT02809729|Cefazolin|cefazolin|mesh-list
138757601|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138757603|NCT04303377|Evolocumab|evolocumab|mesh-list
138757657|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757658|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757659|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138757660|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
138757661|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
138757662|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138757663|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
138757723|NCT04303065|Dexamethasone|dexamethasone|mesh-list
138757724|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138757725|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
138757726|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
138757727|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757729|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138757794|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138757795|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757796|NCT02808091|Bortezomib|bortezomib|mesh-list
138757797|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757798|NCT02811991|Acetaminophen|acetaminophen|mesh-list
138757799|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138757800|NCT02811991|Analgesics|analgesics|mesh-ancestor
138757801|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
138757802|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757803|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757804|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
138757805|NCT04237675|Anesthetics|anesthetics|mesh-list
138757859|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138757860|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138757861|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757862|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757863|NCT00946114|Urological Agents|urological agents|mesh-ancestor
138757864|NCT00627471|Insulin|insulin|mesh-list
138757865|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138757866|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
138757867|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138757868|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757869|NCT04302441|Capecitabine|capecitabine|mesh-list
138757870|NCT04302441|Vinorelbine|vinorelbine|mesh-list
138757871|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138757872|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
138757921|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
138757922|NCT01038609|Acetaminophen|acetaminophen|mesh-list
138757923|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138757924|NCT01038609|Morphine|morphine|mesh-list
138757925|NCT01038609|Hydrocodone|hydrocodone|mesh-list
138757926|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138757927|NCT01038609|Narcotics|narcotics|mesh-ancestor
138757928|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757930|NCT01038609|Analgesics|analgesics|mesh-ancestor
138757989|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757990|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138757991|NCT02853370|Rituximab|rituximab|mesh-list
138757992|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138828899|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138757993|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138757994|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757995|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
138757996|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757997|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138757998|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138757999|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
138758054|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138758055|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
138758056|NCT02853136|BI 409306|bi 409306|mesh-list
138758057|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138758058|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138758059|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758060|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758061|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138758067|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
138758121|NCT02805049|Echinocandins|echinocandins|mesh-list
138758122|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
138758123|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758124|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758125|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758126|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
138758127|NCT02799589|Remifentanil|remifentanil|mesh-list
138758128|NCT02799589|Ropivacaine|ropivacaine|mesh-list
138758129|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138758130|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758131|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758132|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138758133|NCT02799589|Analgesics|analgesics|mesh-ancestor
138758134|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
138758135|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758136|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138758137|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138758138|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138758153|NCT02799355|Ribavirin|ribavirin|mesh-list
138758179|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138758180|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138758181|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758182|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138758183|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138758184|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138758249|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138758250|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758251|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758252|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758253|NCT02798653|Progesterone|progesterone|mesh-list
138758254|NCT02798653|Progestins|progestins|mesh-ancestor
138758255|NCT02798653|Hormones|hormones|mesh-ancestor
138758258|NCT03863587|Ramucirumab|ramucirumab|mesh-list
138758319|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138758320|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138758321|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758322|NCT01197378|Cysteamine|cysteamine|mesh-list
138758323|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138758324|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758325|NCT02792491|Prednisone|prednisone|mesh-list
138758326|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
138758327|NCT02792491|Rituximab|rituximab|mesh-list
138758328|NCT02792491|Doxorubicin|doxorubicin|mesh-list
138758329|NCT02792491|Vincristine|vincristine|mesh-list
138758330|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138758331|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
138758332|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758333|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138758334|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138758346|NCT02792491|Hormones|hormones|mesh-ancestor
138758381|NCT02792335|Apixaban|apixaban|mesh-list
138758382|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
138758383|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138758384|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
138758385|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138758386|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
138758387|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758388|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758389|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
138758392|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
138758444|NCT02796157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138758445|NCT02796157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551900|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138758446|NCT02796157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758447|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138758448|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
138758449|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758450|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758451|NCT01196052|Trastuzumab|trastuzumab|mesh-list
138758452|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138758453|NCT01196052|Maytansine|maytansine|mesh-list
138758461|NCT01196052|Immunotoxins|immunotoxins|mesh-ancestor
138758506|NCT03028519|Vitamin D|vitamin d|mesh-list
138758507|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
138758508|NCT03028519|Vitamins|vitamins|mesh-ancestor
138758509|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
138758510|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758511|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138758512|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138758513|NCT02786641|Cisplatin|cisplatin|mesh-list
138758514|NCT02786641|Docetaxel|docetaxel|mesh-list
138758515|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758516|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
138758517|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
138758573|NCT02785705|Vaccines|vaccines|mesh-list
138758574|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
138758575|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758576|NCT02821507|Sirolimus|sirolimus|mesh-list
138758577|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
138758578|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138758579|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
138758580|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758581|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138758582|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138758637|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138758638|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138758639|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138758640|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138758641|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758642|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758643|NCT05342389|Apatinib|apatinib|mesh-list
138758644|NCT05342389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758645|NCT05342389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138758646|NCT05342389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758647|NCT05342389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758648|NCT02268175|Prednisone|prednisone|mesh-list
138758649|NCT02268175|Leuprolide|leuprolide|mesh-list
138758650|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
138758651|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138758652|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
138758653|NCT02268175|Hormones|hormones|mesh-ancestor
138758694|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
138758695|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758696|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138758697|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138758698|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758699|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758700|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138758701|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138758702|NCT02689843|Metformin|metformin|mesh-list
138758703|NCT02689843|Pioglitazone|pioglitazone|mesh-list
138758704|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
138758705|NCT02689843|Spironolactone|spironolactone|mesh-list
138758706|NCT02689843|Cyproterone|cyproterone|mesh-list
138758707|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138758708|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758709|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138758710|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
138758711|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758712|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138758713|NCT02689843|Diuretics|diuretics|mesh-ancestor
138758714|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
138758715|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
138758746|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758747|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138758748|NCT02781415|Morphine|morphine|mesh-list
138758749|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138758750|NCT02781415|Narcotics|narcotics|mesh-ancestor
138758751|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758752|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758753|NCT02781415|Analgesics|analgesics|mesh-ancestor
138758754|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
138758755|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758756|NCT02785003|Acetaminophen|acetaminophen|mesh-list
138758757|NCT02785003|Ketamine|ketamine|mesh-list
138758758|NCT02785003|Morphine|morphine|mesh-list
138758759|NCT02785003|Narcotics|narcotics|mesh-list
138758760|NCT02785003|Alvimopan|alvimopan|mesh-list
138758761|NCT02785003|Analgesics|analgesics|mesh-ancestor
138758762|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
138758763|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758764|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758765|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138758766|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138758767|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
138758768|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
138758771|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138758799|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
138758800|NCT02780245|Coagulants|coagulants|mesh-ancestor
138758802|NCT05340985|Ergocalciferols|ergocalciferols|mesh-list
138758803|NCT05340985|Cholecalciferol|cholecalciferol|mesh-list
138758804|NCT05340985|Calcifediol|calcifediol|mesh-list
138758805|NCT05340985|Vitamins|vitamins|mesh-list
138758870|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138758871|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138758872|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758873|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
138758874|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138758875|NCT05322031|Aripiprazole|aripiprazole|mesh-list
138758876|NCT05322031|Antidepressive Agents|antidepressive agents|mesh-ancestor
138758877|NCT05322031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138758878|NCT05322031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138758879|NCT05322031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138758880|NCT05322031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758931|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758932|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138758933|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758935|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138758936|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758937|NCT04228315|Primaquine|primaquine|mesh-list
138758938|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
138758939|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138758940|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138758941|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758942|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
138758943|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
138758944|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758945|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138758946|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758947|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138758948|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
138758949|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758950|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138758951|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758952|NCT02779777|Tipifarnib|tipifarnib|mesh-list
138758953|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758954|NCT01880359|Nimorazole|nimorazole|mesh-list
138758955|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138758956|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138758958|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758959|NCT05338489|Itraconazole|itraconazole|mesh-list
138758960|NCT05338489|Rifampin|rifampin|mesh-list
138758979|NCT05338489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138758980|NCT05338489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138758981|NCT05338489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138758982|NCT05338489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138758983|NCT05266417|Insulin|insulin|mesh-list
138758984|NCT05266417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138758985|NCT05266417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758986|NCT02779465|Vitamin D|vitamin d|mesh-list
138758987|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
138758988|NCT02779465|Vitamins|vitamins|mesh-ancestor
138758989|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
138758990|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758991|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138758992|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138758993|NCT02776189|Midazolam|midazolam|mesh-list
138758994|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
138758995|NCT02776189|Propofol|propofol|mesh-list
138758996|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138758997|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138829182|NCT00943124|Niacinamide|niacinamide|mesh-list
138758998|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758999|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138759000|NCT02776189|Analgesics|analgesics|mesh-ancestor
138759001|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
138759002|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759003|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138759031|NCT04883437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138759033|NCT04883437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759034|NCT02775877|Letrozole|letrozole|mesh-list
138759035|NCT02775877|Clomiphene|clomiphene|mesh-list
138759036|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759037|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138759038|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138759039|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759040|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759041|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138759042|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
138759043|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138759044|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759045|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138759088|NCT04226443|Analgesics|analgesics|mesh-ancestor
138759089|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
138759090|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759091|NCT02776891|Citric Acid|citric acid|mesh-list
138759092|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
138759093|NCT02776891|Gallium citrate|gallium citrate|mesh-list
138759094|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
138759095|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138759096|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
138759097|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
138759098|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759099|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138759100|NCT02776813|Rituximab|rituximab|mesh-list
138759101|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138759102|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829212|NCT05381168|Calcium|calcium|mesh-list
138759103|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
138759104|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759105|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138759149|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
138759151|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
138759152|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759153|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759154|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
138759155|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138759156|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138759157|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552094|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138759159|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138759160|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138759161|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759162|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138759163|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138759164|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138759165|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138759166|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138759167|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138759168|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759169|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
138759170|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138759171|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138759172|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
138759173|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138759174|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138759175|NCT02772601|Metoprolol|metoprolol|mesh-list
138759176|NCT02772601|Midazolam|midazolam|mesh-list
138759196|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138759197|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759198|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138759199|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138759200|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
138759201|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138759202|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138759203|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138759204|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138759205|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138759206|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
138759207|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
138759208|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759209|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138759257|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759258|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759260|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
138759261|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
138759262|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759263|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138759264|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759265|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138759266|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
138759267|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759268|NCT02767219|Dexamethasone|dexamethasone|mesh-list
138759269|NCT02767219|Bevacizumab|bevacizumab|mesh-list
138759270|NCT02767219|Fluorouracil|fluorouracil|mesh-list
138759271|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138759272|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759315|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138759316|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829300|NCT00750451|Tinzaparin|tinzaparin|mesh-list
138759317|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138759318|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138759319|NCT02771743|Analgesics|analgesics|mesh-ancestor
138759320|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
138759321|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759322|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
138759323|NCT02762851|Vaccines|vaccines|mesh-list
138759324|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
138759325|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759326|NCT02767063|Pioglitazone|pioglitazone|mesh-list
138759327|NCT02767063|Avelumab|avelumab|mesh-list
138759328|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138759347|NCT02766439|Etanercept|etanercept|mesh-list
138759381|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759382|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138759383|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138759384|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
138759385|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138759386|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
138759387|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
138759388|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
138759389|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138759390|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138759391|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138759392|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138759393|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138759394|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138759395|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759396|NCT02765347|Metformin|metformin|mesh-list
138759397|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138759398|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759399|NCT02770885|Dulaglutide|dulaglutide|mesh-list
138759400|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138759401|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759402|NCT02770651|Everolimus|everolimus|mesh-list
138759403|NCT02770651|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138759404|NCT02770651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138759405|NCT02770651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759406|NCT02770651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759407|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138433696|NCT06168214|Bismuth|bismuth|mesh-list
138759408|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
138759409|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759410|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759413|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138759423|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759424|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138759425|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138759426|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138759427|NCT02770105|Caffeine|caffeine|mesh-list
138759428|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138759429|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759430|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138759431|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759432|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759433|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138759434|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138759435|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
138759436|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138759437|NCT02769793|Levodopa|levodopa|mesh-list
138759438|NCT02769793|Benserazide|benserazide|mesh-list
138759481|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
138759483|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
138759484|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138759485|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138759486|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
138759487|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138759488|NCT02770261|Candesartan|candesartan|mesh-list
138759489|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
138759490|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138759491|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138759492|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138759493|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
138759544|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138759545|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759547|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138759548|NCT00951496|Bevacizumab|bevacizumab|mesh-list
138759549|NCT00951496|Cisplatin|cisplatin|mesh-list
138759550|NCT00951496|Carboplatin|carboplatin|mesh-list
138759551|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138759611|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759612|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759613|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138759614|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138759615|NCT01192152|Metformin|metformin|mesh-list
138759616|NCT01192152|Saxagliptin|saxagliptin|mesh-list
138759617|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138759618|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759619|NCT01192152|Incretins|incretins|mesh-ancestor
138759620|NCT01192152|Hormones|hormones|mesh-ancestor
138759621|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138759622|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138759623|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
138759624|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759625|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759627|NCT02758249|Sevoflurane|sevoflurane|mesh-list
138759628|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138759629|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759630|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759631|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138759632|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
138759633|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
138759634|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138759635|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138759636|NCT02758405|Fentanyl|fentanyl|mesh-list
138759637|NCT02758405|Bupivacaine|bupivacaine|mesh-list
138759638|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
138759639|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
138759640|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759641|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759642|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
138759643|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759644|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138759645|NCT02758405|Narcotics|narcotics|mesh-ancestor
138759646|NCT02758405|Analgesics|analgesics|mesh-ancestor
138759647|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138759648|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138675642|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
138759649|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
138759650|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138759651|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138759652|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
138759653|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138759654|NCT02758327|Laxatives|laxatives|mesh-ancestor
138759655|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138759656|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
138759657|NCT02763475|Fludarabine|fludarabine|mesh-list
138759658|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138759659|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
138759660|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759716|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138759717|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759718|NCT02752555|Antioxidants|antioxidants|mesh-list
138759719|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759720|NCT02752555|Protective Agents|protective agents|mesh-ancestor
138759721|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759722|NCT00624546|Lansoprazole|lansoprazole|mesh-list
138759723|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
138759783|NCT02768389|Bevacizumab|bevacizumab|mesh-list
138434084|NCT05574101|Cemiplimab|cemiplimab|mesh-list
138759784|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138759785|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759786|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138759787|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138759788|NCT02768389|Growth Substances|growth substances|mesh-ancestor
138759789|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759790|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
138759791|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
138759792|NCT04529005|Giapreza|giapreza|mesh-list
138759793|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
138759794|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138759795|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138759796|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
138759797|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759798|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759799|NCT05357040|Nitrous Oxide|nitrous oxide|mesh-list
138759800|NCT05357040|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138759801|NCT05357040|Anesthetics, General|anesthetics, general|mesh-ancestor
138759802|NCT05357040|Anesthetics|anesthetics|mesh-ancestor
138759803|NCT05357040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759804|NCT05357040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759805|NCT05357040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138759806|NCT05357040|Analgesics|analgesics|mesh-ancestor
138759807|NCT05357040|Sensory System Agents|sensory system agents|mesh-ancestor
138759808|NCT05357040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759809|NCT00943072|Aflibercept|aflibercept|mesh-list
138759810|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138759811|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139085223|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085224|NCT01130636|Oseltamivir|oseltamivir|mesh-list
139085225|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
139085226|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085227|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059168|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139085228|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085229|NCT03926156|Warfarin|warfarin|mesh-list
138279579|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
139085230|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
139085231|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
139085232|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139085233|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
139085234|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139085235|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
139085236|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085237|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085238|NCT01134536|Tapentadol|tapentadol|mesh-list
139085239|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138759812|NCT00943072|Growth Substances|growth substances|mesh-ancestor
138759813|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759814|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
138759815|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759816|NCT04222855|Diltiazem|diltiazem|mesh-list
138759817|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138759818|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138759819|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138759820|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759861|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759862|NCT05376852|Decitabine|decitabine|mesh-list
138759863|NCT05376852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138759864|NCT05376852|Antimetabolites|antimetabolites|mesh-ancestor
138759865|NCT05376852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759866|NCT05376852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759867|NCT05376852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759868|NCT00061282|Clotrimazole|clotrimazole|mesh-list
138759869|NCT00061282|Miconazole|miconazole|mesh-list
138759870|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138759871|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759872|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
138759873|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138759874|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138759875|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759876|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759877|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138759878|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
138759879|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138759880|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759881|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138759882|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138759883|NCT04268524|Miltefosine|miltefosine|mesh-list
138759912|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
138759913|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759914|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138434218|NCT05295784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138759915|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138759916|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138759917|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138759918|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759919|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
138759920|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138759921|NCT02751541|Protective Agents|protective agents|mesh-ancestor
138759922|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759923|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
138759925|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
138759926|NCT02755753|Rebamipide|rebamipide|mesh-list
138759927|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138759928|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138759929|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138759930|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759931|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759932|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
138759933|NCT02755753|Protective Agents|protective agents|mesh-ancestor
138759934|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759935|NCT02755909|Anesthetics|anesthetics|mesh-list
138759936|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759937|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759959|NCT02855866|Acetaminophen|acetaminophen|mesh-list
138759960|NCT02855866|Dexamethasone|dexamethasone|mesh-list
138759961|NCT02855866|Cortisone|cortisone|mesh-list
138759962|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
138759963|NCT02855866|BB 1101|bb 1101|mesh-list
138759964|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138759965|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
138759966|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
138759967|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759968|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759969|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138759970|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
138759971|NCT02855866|Hormones|hormones|mesh-ancestor
138759972|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138759976|NCT02855866|Analgesics|analgesics|mesh-ancestor
138760023|NCT01186458|Bortezomib|bortezomib|mesh-list
138760024|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138760025|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760026|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
138760027|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760028|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138760029|NCT01185366|Everolimus|everolimus|mesh-list
138760030|NCT01185366|Sunitinib|sunitinib|mesh-list
138760031|NCT01185366|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138760032|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138760033|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760034|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760035|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138760036|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
138760037|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760038|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760039|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138760040|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138760041|NCT01185366|Growth Substances|growth substances|mesh-ancestor
138760042|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
138760043|NCT01185288|Adalimumab|adalimumab|mesh-list
138760044|NCT01185288|Methotrexate|methotrexate|mesh-list
138760045|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138760046|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
138760047|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138760048|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760049|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138760050|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
138760052|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760070|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
138760071|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138760072|NCT01183884|Tretinoin|tretinoin|mesh-list
138760073|NCT01183884|Isotretinoin|isotretinoin|mesh-list
138760074|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760075|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
138760076|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
138760077|NCT05344248|Antibodies|antibodies|mesh-list
138760078|NCT05344248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138760079|NCT05344248|Immunologic Factors|immunologic factors|mesh-ancestor
138760080|NCT05344248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760081|NCT01191762|Sevelamer|sevelamer|mesh-list
138760082|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
138760083|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
138760084|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760085|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
138760086|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138760087|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
138760088|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138760177|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138760178|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760179|NCT01189812|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138760180|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138760181|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138760182|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138760183|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
138760184|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138760186|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138760187|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138760188|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
138760189|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139059169|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760190|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760191|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138760192|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760193|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138760194|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138760195|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138760196|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138760197|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138760198|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138760199|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760200|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138760201|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
138760202|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138760203|NCT00938860|Cyclosporine|cyclosporine|mesh-list
138760204|NCT00938860|Tacrolimus|tacrolimus|mesh-list
138760221|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
138760222|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138760223|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760224|NCT00938470|Docetaxel|docetaxel|mesh-list
138760225|NCT00938470|Capecitabine|capecitabine|mesh-list
138760226|NCT00938470|Fluorouracil|fluorouracil|mesh-list
138760227|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
138760228|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760229|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
138760230|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
138760231|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
138760232|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760233|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138760234|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
138760235|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138760236|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
138760237|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760238|NCT00602680|Donepezil|donepezil|mesh-list
138760239|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138760240|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760241|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760242|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
138760243|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138760244|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760245|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
138760246|NCT00938392|Vaccines|vaccines|mesh-list
138760247|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
138760248|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760249|NCT02851888|Ropivacaine|ropivacaine|mesh-list
138760250|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
138434590|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138434591|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434592|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
138434593|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
138434594|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
138434595|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829749|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138434596|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434597|NCT04632992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138760268|NCT05381428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138760325|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138760326|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
138760327|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138760328|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760329|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138760330|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
138760331|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760332|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760333|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
138760334|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760335|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138760336|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138760337|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
138760338|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138760339|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138760340|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138760341|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138760342|NCT01183104|Glimepiride|glimepiride|mesh-list
138760343|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138760381|NCT00950170|Factor VIII|factor viii|mesh-list
138760382|NCT00950170|Coagulants|coagulants|mesh-ancestor
138760383|NCT00604864|Infliximab|infliximab|mesh-list
138760384|NCT00604864|Antibodies|antibodies|mesh-list
138760385|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138760386|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
138760387|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760388|NCT00604864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138760389|NCT00604864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138760390|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
138760391|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138760392|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138760393|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
138760394|NCT01227824|Dolutegravir|dolutegravir|mesh-list
138760395|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138760397|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
138760431|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138760432|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138760433|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138760434|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138760435|NCT01227512|Tolvaptan|tolvaptan|mesh-list
138760436|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138760437|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760438|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
138760439|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760440|NCT01227278|Benralizumab|benralizumab|mesh-list
138760441|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138760442|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
138760443|NCT01227044|Naltrexone|naltrexone|mesh-list
138760492|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138760493|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
138760494|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138760495|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760496|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138760497|NCT02885454|Estrogens|estrogens|mesh-ancestor
138760498|NCT02885454|Hormones|hormones|mesh-ancestor
138760557|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138290607|NCT03189433|Dantrolene|dantrolene|mesh-list
138760558|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760559|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
138760560|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
138760561|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
138760563|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138760622|NCT02760901|Mannitol|mannitol|mesh-list
138760623|NCT02760901|Acetazolamide|acetazolamide|mesh-list
138760624|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138760625|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
138760626|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138760627|NCT02760901|Expectorants|expectorants|mesh-ancestor
138760628|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
138760629|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138760630|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
138760631|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760632|NCT02760901|Protective Agents|protective agents|mesh-ancestor
138760633|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760634|NCT02760901|Antidotes|antidotes|mesh-ancestor
138760635|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138760636|NCT02760901|Diuretics|diuretics|mesh-ancestor
138760637|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
138760638|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
138760639|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138760640|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760641|NCT00635713|Fulvestrant|fulvestrant|mesh-list
138760642|NCT00635713|Anastrozole|anastrozole|mesh-list
138760643|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138760644|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760645|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138760646|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138760647|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
138760648|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760649|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760650|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138760651|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138760652|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760654|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
138760667|NCT01020747|Growth Substances|growth substances|mesh-ancestor
138760668|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760669|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
138760670|NCT02754739|Pravastatin|pravastatin|mesh-list
138760671|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138760672|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138760673|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
138760674|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760675|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138760676|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138760677|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760678|NCT01031979|Yohimbine|yohimbine|mesh-list
138760679|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
138760680|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
138760730|NCT02760355|Ledipasvir|ledipasvir|mesh-list
138760731|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
138760732|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760733|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
138760734|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138760735|NCT01028391|Metformin|metformin|mesh-list
138760736|NCT01028391|Pioglitazone|pioglitazone|mesh-list
138760737|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138760738|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138760739|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760740|NCT01028391|Incretins|incretins|mesh-ancestor
138760741|NCT01028391|Hormones|hormones|mesh-ancestor
138760742|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760743|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138760744|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
138760745|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760746|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760787|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760788|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138760789|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
138760790|NCT02753647|Hormones|hormones|mesh-ancestor
138760791|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760792|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138760793|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138760854|NCT02750917|Analgesics|analgesics|mesh-ancestor
138760855|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
138760856|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760857|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760858|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138760859|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138760860|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138760861|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138760862|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760863|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760864|NCT02750995|Azacitidine|azacitidine|mesh-list
138760865|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138760866|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
138760879|NCT04299633|Calcium|calcium|mesh-list
138760915|NCT02750293|Vitamins|vitamins|mesh-ancestor
138760916|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
138760917|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138760918|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138760919|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138760920|NCT01026831|Timolol|timolol|mesh-list
138760921|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138760922|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138760923|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
138760924|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138760925|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760944|NCT02760043|Hormones|hormones|mesh-ancestor
138760979|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138760981|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138760982|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
138760983|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760984|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760985|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138760989|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138761043|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138761045|NCT04116775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138761046|NCT04116775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761047|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
138761048|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138761049|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761106|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761107|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138761108|NCT03523273|Liraglutide|liraglutide|mesh-list
138761109|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138761110|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761111|NCT03523273|Incretins|incretins|mesh-ancestor
138761112|NCT03523273|Hormones|hormones|mesh-ancestor
138761113|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138761114|NCT02695381|Etodolac|etodolac|mesh-list
138761115|NCT02695381|Lidocaine|lidocaine|mesh-list
138761116|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
138761117|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
138761118|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761119|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761120|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
138761121|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761122|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138761123|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138761124|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138761125|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138761126|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761129|NCT02695381|Analgesics|analgesics|mesh-ancestor
138761158|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138761159|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
138761160|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138761161|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
138761162|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761163|NCT02735239|Antidotes|antidotes|mesh-ancestor
138761164|NCT02735239|Protective Agents|protective agents|mesh-ancestor
138761165|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
138761166|NCT02735239|Vitamins|vitamins|mesh-ancestor
138761167|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
138761168|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138761169|NCT02655523|Dexamethasone|dexamethasone|mesh-list
138761170|NCT02655523|Triamcinolone|triamcinolone|mesh-list
138761171|NCT02655523|Bupivacaine|bupivacaine|mesh-list
138761172|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138761173|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
138761174|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
138761175|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761176|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761177|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138761178|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
138761179|NCT02655523|Hormones|hormones|mesh-ancestor
138761180|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138761181|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138761182|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761183|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
138761184|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
138761186|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
138761209|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138761210|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
138761211|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138761212|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138761213|NCT02281981|Curcumin|curcumin|mesh-list
138761214|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138761215|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138761216|NCT02281981|Analgesics|analgesics|mesh-ancestor
138761217|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
138761218|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761219|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761220|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138761221|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138761222|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761223|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761224|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761226|NCT04297839|Calcium heparin|calcium heparin|mesh-list
138761227|NCT04297839|Citric Acid|citric acid|mesh-list
138761228|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
138761229|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
138761230|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138761231|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
138761232|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
138761264|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
138761265|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
138761266|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138761267|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761268|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761269|NCT02736019|Celecoxib|celecoxib|mesh-list
138761270|NCT02736019|Tramadol|tramadol|mesh-list
138761271|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138761272|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138761273|NCT02736019|Analgesics|analgesics|mesh-ancestor
138761274|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
138761275|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761276|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761277|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138761278|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138761279|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138761280|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138761281|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761321|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761322|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761323|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761324|NCT02740933|Demeclocycline|demeclocycline|mesh-list
138761325|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138761326|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761327|NCT02739685|Everolimus|everolimus|mesh-list
138761328|NCT02739685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138761329|NCT02739685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138761330|NCT02739685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761331|NCT02739685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761332|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138761333|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
138761334|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761335|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761336|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
138761337|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
138761338|NCT02735317|Gentamicins|gentamicins|mesh-list
138761339|NCT02735317|Dexamethasone|dexamethasone|mesh-list
138761340|NCT02735317|Procaine|procaine|mesh-list
138761341|NCT02735317|Vitamins|vitamins|mesh-ancestor
138761342|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
138761343|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761375|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761377|NCT02739061|Sertraline|sertraline|mesh-list
138761378|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
138761379|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138761380|NCT02739061|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138761381|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138761382|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138761383|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761384|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761385|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
138761386|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761387|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138761388|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138761389|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761390|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138761391|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138761432|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761433|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761434|NCT00636415|Analgesics|analgesics|mesh-ancestor
138761435|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
138761436|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761437|NCT02733835|Remifentanil|remifentanil|mesh-list
138761438|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138761439|NCT02733835|Narcotics|narcotics|mesh-ancestor
138761442|NCT02733835|Analgesics|analgesics|mesh-ancestor
138761501|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761502|NCT02731105|Clindamycin|clindamycin|mesh-list
138761503|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
138761504|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
138761505|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
138761506|NCT02731105|Tretinoin|tretinoin|mesh-list
138761507|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138761508|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761509|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138761510|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761511|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761512|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761513|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
138761514|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
138761515|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138761516|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138761517|NCT02731105|Analgesics|analgesics|mesh-ancestor
138761518|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
138761519|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761520|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761521|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138761522|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138761523|NCT02743429|Dinutuximab|dinutuximab|mesh-list
138761524|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761525|NCT02730949|Folic Acid|folic acid|mesh-list
138761526|NCT02730949|Inositol|inositol|mesh-list
138761527|NCT02730949|Hematinics|hematinics|mesh-ancestor
138761528|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
138761529|NCT02730949|Vitamins|vitamins|mesh-ancestor
138761548|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138761549|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761550|NCT02730481|Paclitaxel|paclitaxel|mesh-list
138761551|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138761552|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761553|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
138761554|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
138761555|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
138761556|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761557|NCT02730091|Letrozole|letrozole|mesh-list
138761558|NCT02730091|Vinorelbine|vinorelbine|mesh-list
138761559|NCT02730091|Anastrozole|anastrozole|mesh-list
138761560|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761561|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138761562|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138761563|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761564|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761565|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138761566|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
138761604|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761605|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761606|NCT02729935|Parecoxib|parecoxib|mesh-list
138761607|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138761608|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138761609|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761671|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761672|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138761673|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761674|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761675|NCT02720965|Anesthetics|anesthetics|mesh-list
138761676|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
138761677|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761678|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761679|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
138761680|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761681|NCT02726737|Lidocaine|lidocaine|mesh-list
138761682|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
138761732|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138761733|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138761735|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138761736|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761737|NCT02719795|Ropivacaine|ropivacaine|mesh-list
138761738|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
138761739|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
138761740|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761741|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761742|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
138761743|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761744|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138761745|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
138761746|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761747|NCT02726035|Naltrexone|naltrexone|mesh-list
138761788|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138761789|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138761790|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138761791|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138761792|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138761794|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138761795|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138761796|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138761797|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138761798|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
138761802|NCT01225211|Ivacaftor|ivacaftor|mesh-list
138830244|NCT05340205|Oxytocics|oxytocics|mesh-ancestor
138761852|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761853|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138761854|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138761855|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138761856|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138761857|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761859|NCT02716129|Nalbuphine|nalbuphine|mesh-list
138761860|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138761861|NCT02716129|Narcotics|narcotics|mesh-ancestor
138761862|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761863|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761864|NCT02716129|Analgesics|analgesics|mesh-ancestor
138761865|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
138761866|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761867|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138761868|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
138761869|NCT02718079|Mannitol|mannitol|mesh-list
138761870|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138761871|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761872|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138761873|NCT02718079|Diuretics|diuretics|mesh-ancestor
138761874|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
138761876|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
138761906|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138761907|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138761908|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
138761909|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
138761910|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761911|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138761912|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138761913|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138761914|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761915|NCT02724163|Analgesics|analgesics|mesh-ancestor
138761921|NCT02723461|Oxytocin|oxytocin|mesh-list
138761973|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761974|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138761975|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
138761976|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
138761977|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761978|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761979|NCT05269537|Ephedrine|ephedrine|mesh-list
138762044|NCT02722759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138762045|NCT02722759|Analgesics|analgesics|mesh-ancestor
138762046|NCT02722759|Sensory System Agents|sensory system agents|mesh-ancestor
138762047|NCT02722759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762048|NCT02722759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762049|NCT02722759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138762050|NCT02722759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138762115|NCT02713477|Lixisenatide|lixisenatide|mesh-list
138762116|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138762117|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762118|NCT01014585|Milnacipran|milnacipran|mesh-list
138762119|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
138762120|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138762121|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138762122|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138762182|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762183|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762184|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
138762185|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138762186|NCT02722603|Narcotics|narcotics|mesh-ancestor
138762187|NCT02712697|Prednisone|prednisone|mesh-list
138762188|NCT02712697|Hormones|hormones|mesh-list
138762189|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138762190|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
138762191|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138762192|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762193|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138762194|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762243|NCT02712307|Penicillins|penicillins|mesh-list
138762244|NCT02712307|Penicillin V|penicillin v|mesh-list
138762245|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138762246|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762247|NCT02708251|Lidocaine|lidocaine|mesh-list
138762248|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
138762249|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
138762250|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
138762251|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138830316|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138762252|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762253|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
138762254|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762255|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138762261|NCT02708173|Vaccines|vaccines|mesh-list
138762306|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762307|NCT00612079|Sertindole|sertindole|mesh-list
138762308|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138762309|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138762310|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138762311|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762312|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138762313|NCT00940498|Gedatolisib|gedatolisib|mesh-list
138762314|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138762315|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762316|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762317|NCT03820531|Pancrelipase|pancrelipase|mesh-list
138762318|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138762319|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
138762320|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
138762321|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138762322|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138762323|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762324|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762325|NCT02850718|Urological Agents|urological agents|mesh-ancestor
138762326|NCT02707393|Cyclosporine|cyclosporine|mesh-list
138762327|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
138762328|NCT02707393|Fludarabine|fludarabine|mesh-list
138762329|NCT02707393|Melphalan|melphalan|mesh-list
138762330|NCT02707393|Thiotepa|thiotepa|mesh-list
138830354|NCT02560207|Cefotaxime|cefotaxime|mesh-list
138762331|NCT02707393|Cyclosporins|cyclosporins|mesh-list
138762332|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
138762333|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762334|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762335|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138762336|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
138762353|NCT00940342|Sargramostim|sargramostim|mesh-list
138762354|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138762355|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762356|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
138762357|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762358|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138762359|NCT00936910|Amphotericin B|amphotericin b|mesh-list
138762360|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138762361|NCT00936910|Amebicides|amebicides|mesh-ancestor
138762362|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138762363|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138762364|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762365|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138762366|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
138762367|NCT02707315|Gemcitabine|gemcitabine|mesh-list
138762368|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138762413|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138762414|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762415|NCT02707081|Lidocaine|lidocaine|mesh-list
138762416|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
138762417|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
138762418|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138762419|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762420|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
138762421|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762422|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138762423|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138762476|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
138762477|NCT02706769|Acetaminophen|acetaminophen|mesh-list
138762478|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138762479|NCT02706769|Analgesics|analgesics|mesh-ancestor
138762480|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
138762481|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762482|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762483|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
138762484|NCT05044117|Capecitabine|capecitabine|mesh-list
138762485|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138762486|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
138762487|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762488|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762489|NCT03961165|Scopolamine|scopolamine|mesh-list
138762490|NCT03961165|Bromides|bromides|mesh-list
138762491|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138762492|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
138762493|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
138762494|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
138762503|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
138762532|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762533|NCT00612157|Eszopiclone|eszopiclone|mesh-list
138762534|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138762535|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138762536|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762537|NCT00936598|Zolpidem|zolpidem|mesh-list
138762538|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138762539|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138762540|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138762541|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762542|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138762543|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
138762544|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
138762545|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762546|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762547|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
138762548|NCT01025817|Everolimus|everolimus|mesh-list
138762549|NCT01025817|Tacrolimus|tacrolimus|mesh-list
138762550|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138762587|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762588|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138762589|NCT04300881|Diuretics|diuretics|mesh-ancestor
138762590|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
138762591|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138762592|NCT03873493|Venetoclax|venetoclax|mesh-list
138762593|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762594|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
138762595|NCT00611689|Vatalanib|vatalanib|mesh-list
138552950|NCT00273481|Dorzolamide|dorzolamide|mesh-list
138762597|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138762598|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762599|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762600|NCT05264077|Midazolam|midazolam|mesh-list
138762601|NCT05264077|Dexmedetomidine|dexmedetomidine|mesh-list
138762602|NCT05264077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138762603|NCT05264077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138762604|NCT05264077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762605|NCT05264077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138762606|NCT05264077|Analgesics|analgesics|mesh-ancestor
138762607|NCT05264077|Sensory System Agents|sensory system agents|mesh-ancestor
138762608|NCT05264077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762609|NCT05264077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138762610|NCT05264077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138762611|NCT05264077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138762612|NCT05264077|Adrenergic Agents|adrenergic agents|mesh-ancestor
138762613|NCT05264077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762614|NCT05264077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762615|NCT05264077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138762616|NCT05264077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138762636|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
138762637|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762638|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138762639|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138762640|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
138762641|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762642|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762643|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138762644|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138762645|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138762646|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
138762647|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762648|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138762649|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762695|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762696|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
138762697|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138762698|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138762699|NCT01217957|Growth Substances|growth substances|mesh-ancestor
138762700|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
138762701|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
138762702|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762703|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762704|NCT01217801|Ondansetron|ondansetron|mesh-list
138762705|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
138762706|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
138762707|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762708|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762709|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138762710|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
138830552|NCT00762775|Vitamin D|vitamin d|mesh-list
138762711|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
138762712|NCT01217801|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138762713|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138986501|NCT01022632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138986502|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138986503|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138986504|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138986505|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
138986506|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138986507|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
138986508|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138986509|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138986510|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138986511|NCT01026376|Decitabine|decitabine|mesh-list
138986513|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
138986514|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986515|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986516|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986517|NCT00716573|Everolimus|everolimus|mesh-list
138986518|NCT00716573|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138986519|NCT00716573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138986520|NCT00716573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986521|NCT00716573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986522|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138986523|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
138762817|NCT04712071|Ketamine|ketamine|mesh-list
138986524|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986525|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986526|NCT02539706|Rocuronium|rocuronium|mesh-list
138986527|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138986528|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138986529|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138986530|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986531|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986532|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
138986533|NCT00451204|Estrogens|estrogens|mesh-list
138986535|NCT00451204|Hormones|hormones|mesh-ancestor
138986536|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138612353|NCT00185510|Hormones|hormones|mesh-ancestor
138986537|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986538|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138986539|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
138830571|NCT04049227|Letrozole|letrozole|mesh-list
138986540|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138986541|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138986542|NCT00721877|Resveratrol|resveratrol|mesh-list
138986543|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
138986544|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986545|NCT00721877|Protective Agents|protective agents|mesh-ancestor
138986546|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986547|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986548|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138986549|NCT03537586|Adenosine|adenosine|mesh-list
138986550|NCT03537586|Heparin|heparin|mesh-list
138986551|NCT03537586|Bivalirudin|bivalirudin|mesh-list
138986552|NCT03537586|Anticoagulants|anticoagulants|mesh-ancestor
138986553|NCT03537586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138986554|NCT03537586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138762945|NCT00607984|Melphalan|melphalan|mesh-list
138986555|NCT03537586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986557|NCT03537586|Sensory System Agents|sensory system agents|mesh-ancestor
138986558|NCT03537586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986559|NCT03537586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986560|NCT03537586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138986561|NCT03537586|Vasodilator Agents|vasodilator agents|mesh-ancestor
138986562|NCT03537586|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138986563|NCT03537586|Purinergic Agonists|purinergic agonists|mesh-ancestor
138986564|NCT03537586|Purinergic Agents|purinergic agents|mesh-ancestor
138986565|NCT03537586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138986566|NCT03537586|Antithrombins|antithrombins|mesh-ancestor
138986567|NCT03537586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138986568|NCT03537586|Protease Inhibitors|protease inhibitors|mesh-ancestor
138986569|NCT03537586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986570|NCT00722033|Indomethacin|indomethacin|mesh-list
138986571|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138986572|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138986573|NCT00722033|Analgesics|analgesics|mesh-ancestor
138986574|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
138986575|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986576|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986577|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138986578|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138830608|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
138986579|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
138986580|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
138986581|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138986582|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138986583|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986584|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986585|NCT00894374|Artesunate|artesunate|mesh-list
138986586|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
138986587|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138986588|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138986589|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986590|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986591|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
138986592|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
138986593|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138986594|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
138986595|NCT04920149|Mesalamine|mesalamine|mesh-list
138986596|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138986597|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138986599|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
138986600|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986601|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986602|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138986603|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138986604|NCT01026610|Entecavir|entecavir|mesh-list
138986605|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
138986606|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737426|NCT00593255|Insulin|insulin|mesh-list
138986607|NCT00901550|Infliximab|infliximab|mesh-list
138986608|NCT00901550|Methotrexate|methotrexate|mesh-list
138612476|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
138986609|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138986610|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
138986611|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138986612|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986613|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138986614|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
138986615|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986616|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986617|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
138986618|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986619|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138986620|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138986621|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
138986622|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138612541|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
138986623|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138986624|NCT00901550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138986625|NCT00901550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138986626|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138986628|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138986629|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138986630|NCT02573051|Misoprostol|misoprostol|mesh-list
138986631|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138986632|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
138986633|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138986634|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986635|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138986636|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138986637|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
138986638|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138986639|NCT02573051|Diuretics|diuretics|mesh-ancestor
138986640|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
138986641|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
138986642|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138986643|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986645|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138986646|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986647|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
138986648|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
138986649|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
138986650|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986651|NCT01028092|Cyclosporine|cyclosporine|mesh-list
138986652|NCT01028092|Everolimus|everolimus|mesh-list
138986653|NCT01028092|Interleukin-2|interleukin-2|mesh-list
138986654|NCT01028092|Cyclosporins|cyclosporins|mesh-list
138986655|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
138612661|NCT00188045|Diuretics|diuretics|mesh-ancestor
138986656|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986657|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986658|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138986659|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
138986660|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986661|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
138986662|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986663|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
138986664|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138986665|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138986666|NCT01028092|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138986667|NCT01028092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138986668|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986669|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138986670|NCT01028092|Analgesics|analgesics|mesh-ancestor
138986671|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
138986672|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986673|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
138986674|NCT00605306|Maleic acid|maleic acid|mesh-list
138986675|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986676|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986677|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138986678|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
138986679|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138986680|NCT00905918|Vitamin E|vitamin e|mesh-list
138986681|NCT00905918|Vitamins|vitamins|mesh-ancestor
138986682|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
138986683|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986684|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
138986685|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986686|NCT00905918|Protective Agents|protective agents|mesh-ancestor
138986687|NCT00894608|Letrozole|letrozole|mesh-list
138986688|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986689|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138986690|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138986691|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763365|NCT02699281|Hormones|hormones|mesh-ancestor
138986692|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986693|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138986694|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
138986695|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138986696|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986697|NCT00901784|Topiramate|topiramate|mesh-list
138986698|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
138986699|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138986700|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986701|NCT00905996|Propranolol|propranolol|mesh-list
138986702|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138986703|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138986704|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
138986705|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138986706|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986707|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986708|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138986709|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138986710|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
138986712|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
138986713|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
138986714|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138986715|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986716|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
138986717|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986718|NCT02573987|Lidocaine|lidocaine|mesh-list
138986719|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
138830772|NCT00919984|Carboplatin|carboplatin|mesh-list
138986720|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
138986721|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
138986722|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138986723|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986724|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
138986725|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986726|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138986727|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138986728|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138986729|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138986730|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986731|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138986732|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
138986733|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138986734|NCT02573987|Analgesics|analgesics|mesh-ancestor
138986735|NCT00906386|Varenicline|varenicline|mesh-list
138986736|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138986737|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138986738|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
138986739|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138986740|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986741|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986743|NCT00722579|Chromium|chromium|mesh-list
138986744|NCT00722579|Trace Elements|trace elements|mesh-ancestor
138986745|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
138986746|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986747|NCT00713687|Gemcitabine|gemcitabine|mesh-list
138986748|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
138986749|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138986750|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
138986751|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986752|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986753|NCT02540876|Ilorasertib|ilorasertib|mesh-list
138986754|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986755|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138986756|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986757|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986758|NCT00894920|Biotin|biotin|mesh-list
138986759|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
138986760|NCT00894920|Vitamins|vitamins|mesh-ancestor
138986761|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
138986762|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986763|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
138986764|NCT00722735|Finafloxacin|finafloxacin|mesh-list
138986765|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138986766|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986767|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138986768|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138986769|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986770|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986771|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986772|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138986773|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138986774|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138986775|NCT04067531|Clindamycin|clindamycin|mesh-list
138986776|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
138986777|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
138986778|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138986779|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986780|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138986781|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986782|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986783|NCT00713765|Donepezil|donepezil|mesh-list
138986784|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138986785|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986786|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986787|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
138986788|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612999|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
138986789|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986790|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
138986791|NCT00717587|Sunitinib|sunitinib|mesh-list
138986792|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
138986793|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986794|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138986795|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138986796|NCT00717587|Growth Substances|growth substances|mesh-ancestor
138986797|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986798|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
138830840|NCT00942266|Vitamins|vitamins|mesh-ancestor
138986799|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138986800|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986801|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986802|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138986803|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
138986804|NCT00894998|Heparin|heparin|mesh-list
138986805|NCT00894998|Calcium heparin|calcium heparin|mesh-list
138986806|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
138986807|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138986808|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138986809|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986810|NCT00713921|Fesoterodine|fesoterodine|mesh-list
138986811|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138986812|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138986813|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
138986814|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138289428|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
138986815|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986816|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986817|NCT00713921|Urological Agents|urological agents|mesh-ancestor
138986818|NCT00713999|Praziquantel|praziquantel|mesh-list
138986819|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
138986820|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138986821|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986822|NCT04072601|Atorvastatin|atorvastatin|mesh-list
138986823|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138830873|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986824|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138986825|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
138986826|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986827|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138986828|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138986829|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986830|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
138986831|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
138986832|NCT00717821|Hematinics|hematinics|mesh-ancestor
138986833|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138986834|NCT00722969|Sorafenib|sorafenib|mesh-list
138986835|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986836|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138986837|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986838|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986839|NCT04069325|Febuxostat|febuxostat|mesh-list
138986840|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
138986841|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138986842|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138986843|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
138986844|NCT00723047|Coagulants|coagulants|mesh-ancestor
138986845|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
138986846|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138986847|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
138986848|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986849|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138986850|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138986851|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
138986852|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986853|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986854|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138986856|NCT02571491|Morphine|morphine|mesh-list
138986857|NCT02571491|Remifentanil|remifentanil|mesh-list
138986858|NCT02571491|Analgesics|analgesics|mesh-ancestor
138986859|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
138986860|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986861|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986862|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138986863|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138986864|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
138986865|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
138986866|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138986867|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138986868|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138986869|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138986870|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986871|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138986872|NCT02571491|Narcotics|narcotics|mesh-ancestor
138986873|NCT00723437|Acitretin|acitretin|mesh-list
138986874|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
138986875|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
138986876|NCT00723515|Listerine|listerine|mesh-list
138986877|NCT00723515|Calcium|calcium|mesh-list
138986878|NCT00723515|Fluorides|fluorides|mesh-list
138986879|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
138986880|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138613126|NCT00189995|Haloperidol|haloperidol|mesh-list
138986881|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986882|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
138986883|NCT00723515|Protective Agents|protective agents|mesh-ancestor
138986884|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138986885|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986886|NCT01028170|Furosemide|furosemide|mesh-list
138986887|NCT01028170|Diuretics|diuretics|mesh-ancestor
138986888|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
138986889|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986890|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138986891|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138986892|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986893|NCT00518115|Exenatide|exenatide|mesh-list
138986894|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
138986895|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138986896|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986897|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138986898|NCT00518115|Incretins|incretins|mesh-ancestor
138986899|NCT00518115|Hormones|hormones|mesh-ancestor
138986900|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138986901|NCT00723983|Sumatriptan|sumatriptan|mesh-list
138986902|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138986903|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138986904|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138986905|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
138986906|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138986907|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986908|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986910|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138986911|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138737760|NCT01048099|Pertuzumab|pertuzumab|mesh-list
138986912|NCT00450658|Analgesics|analgesics|mesh-ancestor
138986913|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
138986914|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986915|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986916|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138986917|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138986918|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138986919|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986920|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986921|NCT02572505|Tenofovir|tenofovir|mesh-list
138986922|NCT02572505|Emtricitabine|emtricitabine|mesh-list
138763508|NCT02703649|Letrozole|letrozole|mesh-list
138763510|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138986923|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138986924|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
138986925|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986926|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138986927|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138986928|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986929|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986930|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138986931|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138986932|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
138986933|NCT00517881|Hematinics|hematinics|mesh-ancestor
138986934|NCT01010139|Codeine|codeine|mesh-list
138986935|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138986936|NCT01010139|Narcotics|narcotics|mesh-ancestor
138986937|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138986938|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986939|NCT01010139|Analgesics|analgesics|mesh-ancestor
138986940|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
138986941|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986942|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
138986943|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
138986945|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138986946|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
138986947|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986948|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
138986949|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986950|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
138986951|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138986952|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
138986953|NCT00517413|Hematinics|hematinics|mesh-ancestor
138986954|NCT00724529|Infliximab|infliximab|mesh-list
138986955|NCT00724529|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138986956|NCT00724529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138986957|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
138986958|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138986959|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138986960|NCT01012869|Everolimus|everolimus|mesh-list
138986961|NCT01012869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138986962|NCT01012869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138986963|NCT01012869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986964|NCT01012869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986965|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138986966|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
138986967|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986968|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986969|NCT01010295|Doxycycline|doxycycline|mesh-list
138986970|NCT01010295|Tetracycline|tetracycline|mesh-list
138986971|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138986972|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986973|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
138986974|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138763532|NCT02703415|Narcotics|narcotics|mesh-ancestor
138986975|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138986976|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138986977|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986978|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986979|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
138986980|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138986981|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
138986982|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986983|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986984|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138986985|NCT01010373|Protective Agents|protective agents|mesh-ancestor
138986986|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138986987|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138986988|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986989|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986990|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
138986991|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138986992|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
138986993|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138986995|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138986996|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986997|NCT02570789|Sunitinib|sunitinib|mesh-list
138986998|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138986999|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138987000|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138987001|NCT02570789|Growth Substances|growth substances|mesh-ancestor
138987002|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987003|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
138987004|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138987005|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987006|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987007|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138987008|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987009|NCT00450580|Ritonavir|ritonavir|mesh-list
138987010|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
138987011|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138987012|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138987013|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
138987014|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987015|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987016|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138987017|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138987018|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
138987019|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987020|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138987021|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138987022|NCT00724685|Ropivacaine|ropivacaine|mesh-list
138987023|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
138987024|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
138987025|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138987026|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987027|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
138987028|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987029|NCT00123487|Dasatinib|dasatinib|mesh-list
138987030|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987031|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138987032|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987033|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987034|NCT00509925|Insulin|insulin|mesh-list
138987035|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138987036|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
138987037|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
138987038|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
138987039|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
138987040|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
138987041|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138987042|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987043|NCT05277974|Dexamethasone|dexamethasone|mesh-list
138987044|NCT05277974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138987045|NCT05277974|Antiemetics|antiemetics|mesh-ancestor
138987046|NCT05277974|Autonomic Agents|autonomic agents|mesh-ancestor
138987047|NCT05277974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987048|NCT05277974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987049|NCT05277974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138987050|NCT05277974|Glucocorticoids|glucocorticoids|mesh-ancestor
138987051|NCT05277974|Hormones|hormones|mesh-ancestor
138987052|NCT05277974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138987053|NCT05277974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138987054|NCT05277974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987055|NCT00504777|Rituximab|rituximab|mesh-list
138987056|NCT00504777|Methotrexate|methotrexate|mesh-list
138987057|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138987058|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987059|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
138987060|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987061|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138987062|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138987063|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
138987064|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138987065|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138987066|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
138987067|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987068|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
138987069|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987070|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138987071|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138987072|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138987073|NCT03968263|Hydrocodone|hydrocodone|mesh-list
138987074|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138987075|NCT03968263|Narcotics|narcotics|mesh-ancestor
138987077|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987078|NCT03968263|Analgesics|analgesics|mesh-ancestor
138987079|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
138987080|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987081|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
138987082|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
138987083|NCT00895076|Dexamethasone|dexamethasone|mesh-list
138987084|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138987085|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
138987086|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
138831139|NCT05766540|Serotonin Agents|serotonin agents|mesh-ancestor
138987087|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987088|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987089|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138188422|NCT03096730|Dsuvia|dsuvia|mesh-list
138987090|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
138987091|NCT00895076|Hormones|hormones|mesh-ancestor
138987092|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138987093|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138987094|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987095|NCT01078519|Anesthetics|anesthetics|mesh-list
138987096|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
138987097|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138987098|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987099|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
138987100|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987101|NCT02539316|SMOFlipid|smoflipid|mesh-list
138987102|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138987103|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138987104|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138987105|NCT03968185|Analgesics|analgesics|mesh-list
138987106|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
138987107|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987108|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987109|NCT00509769|Trastuzumab|trastuzumab|mesh-list
138987110|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138987111|NCT00509769|Maytansine|maytansine|mesh-list
138987112|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138987113|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987114|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138987115|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
138987116|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
138987117|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
138987118|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987119|NCT00509769|Immunotoxins|immunotoxins|mesh-ancestor
138987120|NCT00509769|Immunoconjugates|immunoconjugates|mesh-ancestor
138987121|NCT00509769|Immunologic Factors|immunologic factors|mesh-ancestor
138987122|NCT00509769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059170|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987123|NCT02977715|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138987124|NCT02977715|Antiviral Agents|antiviral agents|mesh-ancestor
138987125|NCT02977715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987126|NCT01074697|Dexamethasone|dexamethasone|mesh-list
138987127|NCT01074697|Palonosetron|palonosetron|mesh-list
138987128|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
138987129|NCT01074697|Aprepitant|aprepitant|mesh-list
138987130|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138987131|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
138987132|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
138987133|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987134|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987135|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138987136|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
138987137|NCT01074697|Hormones|hormones|mesh-ancestor
138987138|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138987139|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138987140|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987141|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831224|NCT05286996|Anesthetics|anesthetics|mesh-list
138987142|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138987143|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138987144|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
138987145|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987146|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138987147|NCT01080079|Terbinafine|terbinafine|mesh-list
138987148|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
138987149|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987150|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613449|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138987151|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987152|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
138987153|NCT00725231|Doxorubicin|doxorubicin|mesh-list
138987154|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138987155|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138987156|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987157|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138987158|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138987159|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138987160|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987161|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987162|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138987163|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138987164|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138987165|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138987166|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987167|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987168|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987169|NCT00114127|Analgesics|analgesics|mesh-ancestor
138987170|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
138987171|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987172|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
138987173|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138987174|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
138987176|NCT00902954|Anastrozole|anastrozole|mesh-list
138987177|NCT00902954|Exemestane|exemestane|mesh-list
138987178|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987179|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138987180|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138987181|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987182|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987183|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138987184|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
138613489|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
138987185|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138987186|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987187|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138987189|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
138987190|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138987191|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138987192|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138987193|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
138987194|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
138987195|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987196|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987197|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138987198|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
138987199|NCT02540720|Hormones|hormones|mesh-ancestor
138987200|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138987201|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138987202|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987203|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
138987204|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
138987205|NCT02540642|Vitamins|vitamins|mesh-ancestor
138987206|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
138987207|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987208|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
138987209|NCT00122317|Eculizumab|eculizumab|mesh-list
138987210|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138987211|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138987212|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
138987213|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613529|NCT06116890|Aflibercept|aflibercept|mesh-list
138987215|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138987216|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987217|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
138987218|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
138987219|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
138987220|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987221|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138987222|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987223|NCT00908414|TMC-310911|tmc-310911|mesh-list
138987224|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
138987225|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987226|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987227|NCT01074853|Propranolol|propranolol|mesh-list
138987228|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138987229|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138987230|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
138987231|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763650|NCT04214977|Anesthetics|anesthetics|mesh-list
138987232|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987233|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987234|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138987235|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138987236|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
138987237|NCT00725777|Lumefantrine|lumefantrine|mesh-list
138987238|NCT00725777|Artemether|artemether|mesh-list
138987239|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138987240|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
138987241|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138987242|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138987243|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987244|NCT00165841|Rabeprazole|rabeprazole|mesh-list
138987245|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138987246|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138987247|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138987248|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987249|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987250|NCT00907166|Gemcitabine|gemcitabine|mesh-list
138987251|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138987252|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
138987253|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987254|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987255|NCT00460798|Sunitinib|sunitinib|mesh-list
138987256|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987257|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138987258|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138987259|NCT00460798|Growth Substances|growth substances|mesh-ancestor
138987260|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987261|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
138987262|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138987263|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987264|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987265|NCT00726869|Elotuzumab|elotuzumab|mesh-list
138987266|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987267|NCT01028248|Ranibizumab|ranibizumab|mesh-list
138987268|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138987269|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138987270|NCT01028248|Growth Substances|growth substances|mesh-ancestor
138987271|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987272|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
138987273|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987274|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
138987275|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
138987276|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
138987277|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138987278|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987279|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
138987280|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987281|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138987282|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138987283|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987284|NCT00603980|Alprazolam|alprazolam|mesh-list
138987285|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138987286|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138987287|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987288|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138987289|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138987290|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138987291|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
138987292|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
138987293|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987294|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987295|NCT01028404|Insulin|insulin|mesh-list
138987296|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138987297|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
138987298|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
138987299|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138987300|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138987301|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987302|NCT00727103|Varenicline|varenicline|mesh-list
138987303|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138987304|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138987305|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
138987306|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987307|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987308|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987309|NCT01028482|Sertraline|sertraline|mesh-list
138987310|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
138987311|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138987312|NCT01028482|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138831440|NCT03955172|Everolimus|everolimus|mesh-list
138987313|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138987314|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138987315|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613666|NCT05981365|Anesthetics|anesthetics|mesh-ancestor
138987316|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987317|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
138987318|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987319|NCT00903188|Cyclosporine|cyclosporine|mesh-list
138987320|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
138987321|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
138987322|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138987323|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138987324|NCT00903188|Prednisolone|prednisolone|mesh-list
138987325|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
138987326|NCT00903188|Everolimus|everolimus|mesh-list
138987327|NCT00903188|Cyclosporins|cyclosporins|mesh-list
138987328|NCT00903188|Basiliximab|basiliximab|mesh-list
138987329|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138987330|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
138987331|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987332|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987333|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138987334|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
138987335|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987336|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
138987337|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987338|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
138987339|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138987340|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138987341|NCT00903188|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138987342|NCT00903188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138987343|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987344|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138987346|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
138987347|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987348|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138987349|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
138987350|NCT00903188|Hormones|hormones|mesh-ancestor
138987351|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138987352|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138987353|NCT00903188|Protective Agents|protective agents|mesh-ancestor
138987354|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138987355|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138987356|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138987357|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
138987358|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138987359|NCT00908726|Propofol|propofol|mesh-list
138987360|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138987361|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138987362|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987363|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138987364|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
138987365|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
138987367|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987368|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138831516|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
138831517|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831518|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831519|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138831520|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
138831521|NCT03617731|Hormones|hormones|mesh-ancestor
138987369|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138987370|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
138987371|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987372|NCT00449956|Timolol|timolol|mesh-list
138987373|NCT00449956|Dorzolamide|dorzolamide|mesh-list
138987374|NCT00449956|Maleic acid|maleic acid|mesh-list
138987375|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987376|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987377|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138987378|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138987379|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
138987380|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987381|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987382|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138987383|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138987384|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138987385|NCT00907400|Naproxen|naproxen|mesh-list
138987386|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138987387|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138987388|NCT00907400|Analgesics|analgesics|mesh-ancestor
138987389|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
138987390|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987391|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987392|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138987393|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138987394|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
138987395|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138987396|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987397|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987398|NCT00727493|Alendronate|alendronate|mesh-list
138987399|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138987400|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987401|NCT00727727|Piribedil|piribedil|mesh-list
138987402|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138987403|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138987404|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
138987405|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
138987406|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987407|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763774|NCT02701309|Iron|iron|mesh-list
138987408|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987410|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987411|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138987412|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987413|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987414|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
138987415|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
138987416|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138987417|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138987418|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987419|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987420|NCT00730067|Urological Agents|urological agents|mesh-ancestor
138987421|NCT02538224|Doxycycline|doxycycline|mesh-list
138987422|NCT02538224|Ketoprofen|ketoprofen|mesh-list
138987423|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138987424|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987425|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
138987426|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138987427|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138987428|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138987430|NCT02538224|Analgesics|analgesics|mesh-ancestor
138987431|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
138987432|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987433|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738255|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
138987434|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138987435|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138987436|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138987437|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987438|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987439|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138987440|NCT02538302|Oxybutynin|oxybutynin|mesh-list
138987441|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
138987442|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
138987443|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987444|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614034|NCT05206955|Tadalafil|tadalafil|mesh-list
138987445|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138987446|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138987447|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
138987448|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987449|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987450|NCT02538302|Urological Agents|urological agents|mesh-ancestor
138987451|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
138987452|NCT02538302|Coagulants|coagulants|mesh-ancestor
138987453|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138987454|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
138987455|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138987456|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987457|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138987458|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987459|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987460|NCT00509067|Olanzapine|olanzapine|mesh-list
138987461|NCT00509067|Risperidone|risperidone|mesh-list
138987462|NCT00509067|Aripiprazole|aripiprazole|mesh-list
138987463|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138987464|NCT00509067|Ziprasidone|ziprasidone|mesh-list
138987465|NCT00509067|Choline|choline|mesh-list
138987466|NCT00509067|Galantamine|galantamine|mesh-list
138987467|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138987468|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138987469|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
138987470|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987471|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987472|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987473|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138987474|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138987475|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138987476|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138987477|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138987478|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
138987479|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
138987480|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
138987481|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987482|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138987483|NCT00509067|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138987484|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138987485|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138987486|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
138987487|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
138987488|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138987489|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138987490|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138987491|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138987492|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
138987493|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138987494|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
138987495|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138831711|NCT00572169|Hormones|hormones|mesh-ancestor
138987496|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
138987497|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138987498|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987499|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
138987500|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138987501|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
138987502|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
138987503|NCT02538146|Vitamins|vitamins|mesh-ancestor
138987504|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
138987505|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987506|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
138987507|NCT00908024|Cetuximab|cetuximab|mesh-list
138987508|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138987509|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987510|NCT00730223|Efavirenz|efavirenz|mesh-list
138987511|NCT00730223|Nevirapine|nevirapine|mesh-list
138738328|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
138987512|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138987513|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138987514|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987515|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987516|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
138987517|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987518|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138987519|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138987520|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138987521|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138987522|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138987523|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138987524|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138987525|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138987526|NCT00908180|Cytarabine|cytarabine|mesh-list
138987527|NCT00908180|Cyclosporine|cyclosporine|mesh-list
138987528|NCT00908180|Etoposide|etoposide|mesh-list
138987529|NCT00908180|Melphalan|melphalan|mesh-list
138987530|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
138987531|NCT00908180|Carmustine|carmustine|mesh-list
138987532|NCT00908180|Cyclosporins|cyclosporins|mesh-list
138987533|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138987534|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987535|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138987536|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138987537|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987538|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987539|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138987540|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
138987541|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
138987542|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987543|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138987544|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
138987545|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987546|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
138987547|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
138987548|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138987549|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138987550|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138987551|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
138987552|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138987553|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138987554|NCT00909506|Metformin|metformin|mesh-list
138987555|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138987556|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987557|NCT03997539|Vinorelbine|vinorelbine|mesh-list
138987558|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138987559|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987560|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
138987561|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
138987562|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
138987563|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987564|NCT02570243|Heparin|heparin|mesh-list
138987565|NCT02570243|Calcium heparin|calcium heparin|mesh-list
138987566|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
138987567|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138987568|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138987569|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987570|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
138987571|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138987572|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
138987573|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987574|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987575|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138987576|NCT00927212|Protective Agents|protective agents|mesh-ancestor
138987577|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138987578|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138831777|NCT04078048|Vitamins|vitamins|mesh-list
138987579|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987580|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987581|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
138987582|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987583|NCT00927290|Pioglitazone|pioglitazone|mesh-list
138987584|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138987585|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987586|NCT00728195|Olanzapine|olanzapine|mesh-list
138987587|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
138987588|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
138987589|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
138987590|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987591|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987592|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138987594|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138987595|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138987596|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138987597|NCT00728195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138987598|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138987599|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138987600|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987601|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987602|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
138987603|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138987604|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138987605|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
138987606|NCT00927524|Insulin|insulin|mesh-list
138987607|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138987608|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
138987609|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138614389|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
138987610|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987611|NCT00728273|Micronutrients|micronutrients|mesh-list
138987612|NCT00728273|Trace Elements|trace elements|mesh-list
138987613|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987614|NCT00927602|PENTA|penta|mesh-list
138987615|NCT00927602|Fondaparinux|fondaparinux|mesh-list
138987616|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138987617|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
138987618|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138987619|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
138987620|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987621|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987622|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
138987623|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138987624|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138987625|NCT04286867|Ethanol|ethanol|mesh-list
138987626|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138987627|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987628|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138987629|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987630|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138987631|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138987632|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138987633|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
138987634|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987635|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987636|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987637|NCT00730535|Urological Agents|urological agents|mesh-ancestor
138987638|NCT00927836|Lenograstim|lenograstim|mesh-list
138987639|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138987640|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
138987641|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987642|NCT00904280|Oxymorphone|oxymorphone|mesh-list
138987643|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138987644|NCT00904280|Narcotics|narcotics|mesh-ancestor
138987645|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138987646|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987647|NCT00904280|Analgesics|analgesics|mesh-ancestor
138987648|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
138987649|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987650|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138987651|NCT00928148|Amphetamine|amphetamine|mesh-list
138987652|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138987653|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987654|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
138987655|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
138987656|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987657|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
138987658|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987659|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987660|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
138987661|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138987662|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138987663|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138987664|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138987665|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138987667|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138987668|NCT00904436|Ipratropium|ipratropium|mesh-list
138987669|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138987670|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
138987671|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987672|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987673|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138987674|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
138987675|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138987676|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
138987677|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987678|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987679|NCT00728585|Mitogens|mitogens|mesh-list
138987680|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
138987681|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987682|NCT00730769|Valganciclovir|valganciclovir|mesh-list
138987683|NCT00730769|Ganciclovir|ganciclovir|mesh-list
138987684|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138987685|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
138987686|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987687|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138987688|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987689|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987690|NCT00728663|Docetaxel|docetaxel|mesh-list
138987691|NCT00728663|Cetuximab|cetuximab|mesh-list
138987692|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987693|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
138987694|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
138987695|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
138987696|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614542|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987697|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138987698|NCT00731003|Tryptophan|tryptophan|mesh-list
138987699|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
139059171|NCT03750136|Furosemide|furosemide|mesh-list
138987700|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138987701|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
138987702|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138987703|NCT00729131|Etanercept|etanercept|mesh-list
138987704|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138987705|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138987706|NCT00729131|Analgesics|analgesics|mesh-ancestor
138987707|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
138987708|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987709|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987710|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138987711|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138987712|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138987713|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138987714|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
138987715|NCT00729287|Selenium|selenium|mesh-list
138987716|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
138987717|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987718|NCT00729287|Protective Agents|protective agents|mesh-ancestor
138987719|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987720|NCT00729287|Trace Elements|trace elements|mesh-ancestor
138987721|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
138987722|NCT00731393|Vaccines|vaccines|mesh-list
138987723|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
138987724|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987725|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
138987726|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138987727|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138987728|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987729|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
138987730|NCT04390217|Coagulants|coagulants|mesh-ancestor
138987731|NCT02569463|Aldesleukin|aldesleukin|mesh-list
138987732|NCT02569463|Interleukin-2|interleukin-2|mesh-list
138987733|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987734|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138738548|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138987735|NCT02569463|Analgesics|analgesics|mesh-ancestor
138987736|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
138987737|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987738|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987739|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138987740|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138987741|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
138987742|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987744|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138987745|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138987746|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
139059172|NCT03750136|Diuretics|diuretics|mesh-ancestor
138987747|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987748|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138987749|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138987750|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987751|NCT00568178|Losartan|losartan|mesh-list
138987752|NCT00568178|Amlodipine|amlodipine|mesh-list
138987753|NCT00568178|Enalapril|enalapril|mesh-list
138987754|NCT00568178|Enalaprilat|enalaprilat|mesh-list
138987755|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138987756|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138987757|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138987758|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987759|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138987760|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987761|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
138987762|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138987763|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138987764|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138987765|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987766|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138987767|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
138987768|NCT00577889|Gemcitabine|gemcitabine|mesh-list
138987769|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138987770|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
138987771|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987772|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987773|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
138987774|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138987775|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987776|NCT02538926|Prednisone|prednisone|mesh-list
138987777|NCT02538926|Cortisone|cortisone|mesh-list
138987778|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
138987779|NCT02538926|Rituximab|rituximab|mesh-list
138987780|NCT02538926|Doxorubicin|doxorubicin|mesh-list
138987781|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138987782|NCT02538926|Etoposide|etoposide|mesh-list
138987783|NCT02538926|Vincristine|vincristine|mesh-list
138987784|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
138987785|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
138987786|NCT02538926|Asparaginase|asparaginase|mesh-list
138987787|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
138987788|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138987789|NCT02538926|Antibodies|antibodies|mesh-list
138987790|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
138987791|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138987792|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138987793|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
138987794|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987795|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138987796|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138987797|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
138987798|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987799|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987800|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138987801|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138987802|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138987803|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138987804|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763976|NCT01208051|Lenalidomide|lenalidomide|mesh-list
138987805|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138987806|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
138987807|NCT02538926|Hormones|hormones|mesh-ancestor
138987808|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138987809|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138987810|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138987811|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
138987812|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
138738627|NCT01023061|Prednisone|prednisone|mesh-list
138987813|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
138987814|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138832044|NCT02581696|Lafutidine|lafutidine|mesh-list
138987815|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
138987816|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
138987818|NCT00904904|Indomethacin|indomethacin|mesh-list
138987819|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138987820|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138987821|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138987822|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138987823|NCT00904904|Analgesics|analgesics|mesh-ancestor
138987824|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
138987825|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987826|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987827|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138987828|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138987829|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138987830|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987831|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987832|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
138987833|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
138987834|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138987835|NCT00731861|Paclitaxel|paclitaxel|mesh-list
138987836|NCT00731861|Vatalanib|vatalanib|mesh-list
138987837|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138987838|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987839|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
138987840|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
138763994|NCT00616915|Bupropion|bupropion|mesh-list
138987841|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
138987842|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987843|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138987844|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987846|NCT00567476|Terbutaline|terbutaline|mesh-list
138987847|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
138987848|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
138987849|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138987850|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
138987851|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987852|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987853|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138987854|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
138987855|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
138987856|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138987857|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138987858|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138987859|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987860|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987861|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138987862|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
138987863|NCT00729911|Amiodarone|amiodarone|mesh-list
138987864|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138987865|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
138987866|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138987867|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138987868|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987869|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138987870|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138987871|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138987872|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987873|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138987874|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138987875|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138987876|NCT04018703|Midazolam|midazolam|mesh-list
138987877|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
138987878|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138987879|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138987880|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987881|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138987882|NCT04018703|Analgesics|analgesics|mesh-ancestor
138987883|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
138987884|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987885|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138738695|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
138987886|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138987887|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138987888|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
138987889|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987890|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987891|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138987892|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138987893|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138987894|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138987895|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138987896|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
138987898|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
138987899|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
138987900|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138987901|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138987902|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987903|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138987904|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
138987905|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987906|NCT04065581|Metformin|metformin|mesh-list
138987907|NCT04065581|Acarbose|acarbose|mesh-list
138987908|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138987909|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987910|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138987911|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987912|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987913|NCT00733889|Docetaxel|docetaxel|mesh-list
138987914|NCT00733889|Fluorouracil|fluorouracil|mesh-list
138987915|NCT00733889|Cetuximab|cetuximab|mesh-list
138987916|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138987917|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
138987918|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
138987919|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
138832179|NCT00668863|Vitamins|vitamins|mesh-ancestor
138987920|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987921|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
138987922|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138987923|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138987924|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
138987925|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987926|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138987927|NCT00733967|Varenicline|varenicline|mesh-list
138987928|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138987929|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138987930|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
138987931|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987932|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987933|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987934|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138987935|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138987936|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138987937|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
138987938|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138987939|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138987940|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
138987941|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987942|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138987943|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138987944|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987945|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987946|NCT04644627|Gentamicins|gentamicins|mesh-list
138987947|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138987948|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987949|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138987950|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987951|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987952|NCT00732407|Losartan|losartan|mesh-list
138987953|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138987954|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138987955|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138987956|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138987957|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987958|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
138987959|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
138987960|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138987961|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138987962|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987963|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987964|NCT00507819|Urological Agents|urological agents|mesh-ancestor
138987965|NCT02569307|Minocycline|minocycline|mesh-list
138987966|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138987967|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138987968|NCT01013103|Atorvastatin|atorvastatin|mesh-list
138987969|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138987970|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138987971|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
138987972|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987973|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138987974|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138987975|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443997|NCT01818856|Ritonavir|ritonavir|mesh-list
138987976|NCT00732485|Fenofibrate|fenofibrate|mesh-list
138987977|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138987978|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
138987979|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987980|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138987981|NCT02569073|Dronabinol|dronabinol|mesh-list
138987982|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
138987983|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138987984|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138987985|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138987986|NCT02569073|Analgesics|analgesics|mesh-ancestor
138987987|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
138987988|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138987989|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138987990|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138987991|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987992|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987993|NCT02569073|Hormones|hormones|mesh-ancestor
138987994|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138987995|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138987996|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138987997|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138987998|NCT00734123|Aspirin|aspirin|mesh-list
138987999|NCT00734123|Rimonabant|rimonabant|mesh-list
138988000|NCT00734123|Enalapril|enalapril|mesh-list
138988001|NCT00734123|Clopidogrel|clopidogrel|mesh-list
138988002|NCT00734123|Atorvastatin|atorvastatin|mesh-list
138988003|NCT00734123|Simvastatin|simvastatin|mesh-list
138988004|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138988005|NCT00734123|Diuretics|diuretics|mesh-list
138988006|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138988007|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138988008|NCT00734123|Analgesics|analgesics|mesh-ancestor
138988009|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
138988010|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988011|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988012|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988013|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138988014|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138988015|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138614913|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138988016|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988017|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138988018|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138988019|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988021|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138988022|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138988023|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
138988024|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138988025|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138988026|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138988027|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138988028|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138988029|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
138988030|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138988031|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
138988032|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138988033|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
138988035|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138988036|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138988037|NCT00734123|Hormones|hormones|mesh-ancestor
138988038|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138988039|NCT00734279|Leuprolide|leuprolide|mesh-list
138988040|NCT00734279|Ganirelix|ganirelix|mesh-list
138988041|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138988042|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
138988043|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138988044|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988045|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138988046|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988047|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
138988048|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138988049|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
138988050|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
138988051|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138988052|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138988053|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
138988054|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138988055|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988056|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988057|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988058|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138988059|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988060|NCT00732953|Paclitaxel|paclitaxel|mesh-list
138988061|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138614959|NCT00191555|Olanzapine|olanzapine|mesh-list
138988062|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988063|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
138988064|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
138988065|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
138988066|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988067|NCT00577655|Albuterol|albuterol|mesh-list
138988068|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138988069|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
138988070|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988071|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988072|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138988073|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
138988074|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
138988075|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138988076|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138988077|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138988078|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138988079|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
138988080|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138988081|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988082|NCT00733031|Gemcitabine|gemcitabine|mesh-list
138988083|NCT00733031|Pemetrexed|pemetrexed|mesh-list
138988084|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138988085|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
138988086|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988087|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988088|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988089|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138988090|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138988091|NCT00734669|Glyburide|glyburide|mesh-list
138988092|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138988093|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988094|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
138988095|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
138988096|NCT00113269|Tacrolimus|tacrolimus|mesh-list
138988097|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
138988098|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138988099|NCT00113269|Basiliximab|basiliximab|mesh-list
138988100|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138988101|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
138988102|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988103|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138988104|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988105|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988106|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138988107|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988108|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138988109|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
138832424|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832425|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
138832426|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832427|NCT02557789|Lefamulin|lefamulin|mesh-list
138832428|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138832429|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832430|NCT00771823|Maraviroc|maraviroc|mesh-list
138832431|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138832434|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138988110|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138988111|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988112|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138988113|NCT04065269|Olaparib|olaparib|mesh-list
138988114|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138988115|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988116|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988117|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988118|NCT00515619|Lacosamide|lacosamide|mesh-list
138988119|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
138988120|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138988121|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138988122|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138988123|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988124|NCT00449644|Bedaquiline|bedaquiline|mesh-list
138988125|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
138988126|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138988127|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988128|NCT00733265|Ticagrelor|ticagrelor|mesh-list
138988129|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138988130|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138988131|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138988132|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138988133|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
138988134|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138988135|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764140|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988136|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988137|NCT00112489|Paclitaxel|paclitaxel|mesh-list
138988138|NCT00112489|Carboplatin|carboplatin|mesh-list
138988139|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138988140|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988141|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
138988142|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
138988143|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
138988144|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988145|NCT01023100|Tofacitinib|tofacitinib|mesh-list
138988146|NCT01023100|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138988147|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138988148|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988149|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988150|NCT00515463|Denosumab|denosumab|mesh-list
138988151|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138988152|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988153|NCT01082731|Artesunate|artesunate|mesh-list
138988154|NCT01082731|Lumefantrine|lumefantrine|mesh-list
138988155|NCT01082731|Artemether|artemether|mesh-list
138988156|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138988157|NCT01082731|Mefloquine|mefloquine|mesh-list
138988158|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
138988159|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138988160|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138988161|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988162|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988163|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
138988164|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
138988165|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138988166|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
138988167|NCT00739193|Amiodarone|amiodarone|mesh-list
138988168|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138988169|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
138988170|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138988171|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138988172|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988173|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138988174|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138988175|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138988176|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988177|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138988178|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138988179|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138988180|NCT01011543|Dimercaprol|dimercaprol|mesh-list
138988181|NCT01011543|Chelating Agents|chelating agents|mesh-ancestor
138988182|NCT01011543|Sequestering Agents|sequestering agents|mesh-ancestor
138988183|NCT01011543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988184|NCT00733811|Deferiprone|deferiprone|mesh-list
138988185|NCT00733811|Deferoxamine|deferoxamine|mesh-list
138988186|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138988187|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
138988188|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
138988189|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988190|NCT00733811|Siderophores|siderophores|mesh-ancestor
138988191|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
138988192|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
138988193|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988194|NCT00507507|Tenofovir|tenofovir|mesh-list
138988195|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
138988196|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988197|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138988198|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138988199|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988200|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988201|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138988202|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138988203|NCT00459706|Etanercept|etanercept|mesh-list
138988204|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138988205|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138988206|NCT00459706|Analgesics|analgesics|mesh-ancestor
138988207|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
138988208|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988209|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988210|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988211|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138988212|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138988213|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138988214|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
138988215|NCT00735527|Lorazepam|lorazepam|mesh-list
138988216|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
138988217|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
138988218|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
138988219|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988220|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988221|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138988222|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138988223|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138988224|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138988225|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138988226|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138988227|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
138988228|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
138988229|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138988230|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988231|NCT00735761|Acyclovir|acyclovir|mesh-list
138988232|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
138988233|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
138988234|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988235|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988236|NCT00740285|Lidocaine|lidocaine|mesh-list
138988237|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
138988238|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
138988239|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138988240|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988241|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
138988242|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988243|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138988244|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138988245|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138988246|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138988247|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988249|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
138988250|NCT00507429|Combretastatin|combretastatin|mesh-list
138988251|NCT00507429|Carboplatin|carboplatin|mesh-list
138988252|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138988253|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988254|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
138988255|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
138988256|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
138988257|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988258|NCT01011621|Prednisolone|prednisolone|mesh-list
138988259|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138988260|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
138988261|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138988262|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
138988263|NCT01011621|Betamethasone|betamethasone|mesh-list
138764231|NCT01887301|Nabiximols|nabiximols|mesh-list
138988264|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
138988265|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138988266|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
138988267|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138988268|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
138988269|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138988270|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988271|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
138988273|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138988274|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988275|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138988276|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988277|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
138988278|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
138988279|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988280|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138988281|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138988282|NCT01011621|Protective Agents|protective agents|mesh-ancestor
138988283|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138988284|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
138988285|NCT00449176|Oxycodone|oxycodone|mesh-list
138988286|NCT00449176|Tapentadol|tapentadol|mesh-list
138988287|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138988288|NCT00449176|Narcotics|narcotics|mesh-ancestor
138988289|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138988290|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988291|NCT00449176|Analgesics|analgesics|mesh-ancestor
138988292|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
138988293|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988294|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138988295|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138988296|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138988297|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832561|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
138988298|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
138988299|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138988300|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
138988301|NCT00515073|Promethazine|promethazine|mesh-list
138988302|NCT00515073|Dexamethasone|dexamethasone|mesh-list
138988303|NCT00515073|Paclitaxel|paclitaxel|mesh-list
138988304|NCT00515073|Cimetidine|cimetidine|mesh-list
138988305|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138988306|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988307|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
138988308|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
138988309|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
138988310|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988311|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988312|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
138988313|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
138764276|NCT04924621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138988314|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988315|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988316|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138988318|NCT00515073|Hormones|hormones|mesh-ancestor
138988319|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138988320|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138988321|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138988322|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138988323|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138988324|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
138988325|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
138988326|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
138988327|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138988328|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
138988329|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
138988330|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138988331|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138832585|NCT00669955|Antacids|antacids|mesh-ancestor
138988332|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
138988333|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
138988334|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138988335|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138988336|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138988337|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138988338|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988339|NCT00710021|Vitamin D|vitamin d|mesh-list
138988340|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
138988341|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
138988342|NCT00710021|Vitamins|vitamins|mesh-list
138988343|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
138988344|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988345|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138988346|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138988347|NCT00504153|Dasatinib|dasatinib|mesh-list
138988348|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988349|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138988350|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988351|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988352|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138988353|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138988354|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988355|NCT00740363|Incretins|incretins|mesh-ancestor
138988357|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138988358|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138988359|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
138988360|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988361|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988362|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
138988363|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138988364|NCT04065035|Protective Agents|protective agents|mesh-ancestor
138988365|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988366|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
138988367|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
138988368|NCT00442702|Hematinics|hematinics|mesh-ancestor
138988369|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
138988370|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138832625|NCT00671749|Adapalene|adapalene|mesh-list
138988371|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988372|NCT00514917|Docetaxel|docetaxel|mesh-list
138988373|NCT00514917|Leuprolide|leuprolide|mesh-list
138988374|NCT00514917|Bicalutamide|bicalutamide|mesh-list
138988375|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988376|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
138988377|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
138988378|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
138988379|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988380|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138988381|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
138988382|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138988383|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988384|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138988385|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
138988386|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
138988387|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138988388|NCT01011699|Niacinamide|niacinamide|mesh-list
138988389|NCT01011699|Niacin|niacin|mesh-list
138988390|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
138988391|NCT01011699|Sevelamer|sevelamer|mesh-list
138988392|NCT01011699|Cinacalcet|cinacalcet|mesh-list
138988393|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
138988394|NCT01011699|Vitamins|vitamins|mesh-ancestor
138988395|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
138988396|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988397|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138988398|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
138988399|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988400|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138988401|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
138988402|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
138988403|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
138988404|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138988405|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138988406|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
138988407|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138988408|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
138988409|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138988411|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
138988412|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138988413|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
138615469|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
138988414|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988415|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
138988416|NCT00503997|Pemetrexed|pemetrexed|mesh-list
138988417|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988418|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988419|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988420|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138988421|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138988422|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
138988423|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138988424|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
138988425|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
138988426|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988427|NCT00736463|Atorvastatin|atorvastatin|mesh-list
138988428|NCT00736463|Simvastatin|simvastatin|mesh-list
138988429|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138988430|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138988431|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
138988432|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988433|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138988434|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138988435|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988436|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
138988437|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138988438|NCT00736541|Cystatins|cystatins|mesh-list
138988439|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
138988440|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988441|NCT00736541|Expectorants|expectorants|mesh-ancestor
138988442|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
138988443|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138988444|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
138988445|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988446|NCT00736541|Protective Agents|protective agents|mesh-ancestor
138988447|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988448|NCT00736541|Antidotes|antidotes|mesh-ancestor
138988449|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138988450|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
138988451|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988452|NCT00096265|Temozolomide|temozolomide|mesh-list
138988453|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138988454|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138988455|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
138988456|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988457|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988458|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138988459|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988460|NCT01082809|Sunitinib|sunitinib|mesh-list
138988461|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988462|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138988463|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138988464|NCT01082809|Growth Substances|growth substances|mesh-ancestor
138988465|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832746|NCT00768937|Sorafenib|sorafenib|mesh-list
138988466|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
138988467|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138988468|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988469|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988470|NCT01080469|Tacrolimus|tacrolimus|mesh-list
138988471|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138988472|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
138988473|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988474|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138988475|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988476|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988477|NCT01079065|Famotidine|famotidine|mesh-list
138988478|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138988479|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138988480|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138988481|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
138988482|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
138988483|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138988484|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988485|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988487|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138988488|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
138988489|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988490|NCT00741221|Bevacizumab|bevacizumab|mesh-list
138988491|NCT00741221|Pemetrexed|pemetrexed|mesh-list
138988492|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138988493|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988494|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138988495|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138988496|NCT00741221|Growth Substances|growth substances|mesh-ancestor
138988497|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988498|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
138988499|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988500|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988501|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138988502|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138988503|NCT00736619|Paclitaxel|paclitaxel|mesh-list
138988504|NCT00736619|Cetuximab|cetuximab|mesh-list
138988505|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138988506|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138988507|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988508|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
138988509|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
138988510|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
138615617|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988511|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988512|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138988513|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
138988514|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138988515|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988516|NCT00448864|Ecallantide|ecallantide|mesh-list
138988517|NCT00448864|Analgesics|analgesics|mesh-ancestor
138988518|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
138988519|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988520|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988521|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138988522|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138988523|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988524|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138988525|NCT00567398|Icodextrin|icodextrin|mesh-list
138988526|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
138988527|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138988528|NCT00448708|Paclitaxel|paclitaxel|mesh-list
138832836|NCT02829502|Incretins|incretins|mesh-ancestor
138988529|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138988530|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138988531|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988532|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
138988533|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
138988534|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
138988535|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988536|NCT00925028|Warfarin|warfarin|mesh-list
138988537|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
138988538|NCT00905216|Heparin|heparin|mesh-list
138988539|NCT00905216|Calcium heparin|calcium heparin|mesh-list
138988540|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
138988541|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138988542|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138988543|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988544|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138988545|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
138988546|NCT00929630|Coagulants|coagulants|mesh-ancestor
138988547|NCT00925106|Celecoxib|celecoxib|mesh-list
138988548|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138988549|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138988550|NCT00925106|Analgesics|analgesics|mesh-ancestor
138988551|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
138988552|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988553|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988554|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988555|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138988556|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138988557|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138615712|NCT00193310|Paclitaxel|paclitaxel|mesh-list
138988558|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988559|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902177|NCT03851159|Mannitol|mannitol|mesh-list
138988562|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138988563|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138988564|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138988565|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988566|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138988567|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
138988568|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988569|NCT00736697|Moxidectin|moxidectin|mesh-list
138988570|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
138988571|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138988572|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988573|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
138988574|NCT02568995|Ketorolac|ketorolac|mesh-list
138988575|NCT02568995|Epinephrine|epinephrine|mesh-list
138988576|NCT02568995|Racepinephrine|racepinephrine|mesh-list
138988577|NCT02568995|Ropivacaine|ropivacaine|mesh-list
138988578|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
138988579|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
138988580|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
138988581|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138988582|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988583|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
138988584|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988585|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138988586|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138988587|NCT02568995|Analgesics|analgesics|mesh-ancestor
138988588|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988589|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138832917|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138988590|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138988591|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988592|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988593|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138988594|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138988595|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
138988596|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138988597|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138988598|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138988599|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
138988600|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138988601|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
138988602|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
138988603|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
138988604|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138988605|NCT00930020|Minocycline|minocycline|mesh-list
138988606|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138988607|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988608|NCT00930098|Clofarabine|clofarabine|mesh-list
138615813|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
138988609|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138988611|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988612|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988613|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138988614|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138988615|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988616|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
138988617|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
138988618|NCT00905762|Besifloxacin|besifloxacin|mesh-list
138988619|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138988620|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988621|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138988622|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138988623|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988624|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988625|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988626|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138988627|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138988628|NCT02568839|Docetaxel|docetaxel|mesh-list
138988629|NCT02568839|Trastuzumab|trastuzumab|mesh-list
138988630|NCT02568839|Pertuzumab|pertuzumab|mesh-list
138988631|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988632|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
138988633|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
138739444|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
138988635|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988636|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138988637|NCT06140784|Fluorides|fluorides|mesh-list
138988638|NCT06140784|Tin Fluorides|tin fluorides|mesh-list
138988639|NCT06140784|Fluorophosphate|fluorophosphate|mesh-list
138988640|NCT06140784|Cariostatic Agents|cariostatic agents|mesh-ancestor
138988641|NCT06140784|Protective Agents|protective agents|mesh-ancestor
138988642|NCT06140784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988643|NCT06140771|Fluorides|fluorides|mesh-list
138988644|NCT06140771|Tin Fluorides|tin fluorides|mesh-list
138988645|NCT06140771|Fluorophosphate|fluorophosphate|mesh-list
138988646|NCT06140771|Cariostatic Agents|cariostatic agents|mesh-ancestor
138988647|NCT06140771|Protective Agents|protective agents|mesh-ancestor
138988648|NCT06140771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988649|NCT06140758|Listerine|listerine|mesh-list
138988650|NCT06140758|Fluorides|fluorides|mesh-list
138988651|NCT06140758|Sodium Fluoride|sodium fluoride|mesh-list
138988652|NCT06140758|Tin Fluorides|tin fluorides|mesh-list
138988653|NCT06140758|Fluorophosphate|fluorophosphate|mesh-list
138988654|NCT06140758|Cariostatic Agents|cariostatic agents|mesh-ancestor
138988655|NCT06140758|Protective Agents|protective agents|mesh-ancestor
138988656|NCT06140758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988657|NCT06140758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138988658|NCT06140758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988659|NCT06140745|Fluorides|fluorides|mesh-list
138988660|NCT06140745|Cariostatic Agents|cariostatic agents|mesh-ancestor
138764391|NCT01000155|Vorinostat|vorinostat|mesh-list
138988661|NCT06140745|Protective Agents|protective agents|mesh-ancestor
138988662|NCT06140745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988663|NCT06140732|Apatinib|apatinib|mesh-list
138988664|NCT06140732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988665|NCT06140732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138988666|NCT06140732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988667|NCT06140732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988668|NCT06140576|Paclitaxel|paclitaxel|mesh-list
138988669|NCT06140576|Lenvatinib|lenvatinib|mesh-list
138988670|NCT06140576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138988671|NCT06140576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988672|NCT06140576|Tubulin Modulators|tubulin modulators|mesh-ancestor
138988673|NCT06140576|Antimitotic Agents|antimitotic agents|mesh-ancestor
138988674|NCT06140576|Mitosis Modulators|mitosis modulators|mesh-ancestor
138988675|NCT06140576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988676|NCT06140576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138988677|NCT06140576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988678|NCT06140407|Carboplatin|carboplatin|mesh-list
138988679|NCT06140407|Pembrolizumab|pembrolizumab|mesh-list
138988680|NCT06140407|Etoposide|etoposide|mesh-list
138988681|NCT06140407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988682|NCT06140407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138988683|NCT06140407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138988684|NCT06140407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988685|NCT06140407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138988686|NCT06140407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138988687|NCT06140407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138988688|NCT06140407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988689|NCT06138041|Lidocaine|lidocaine|mesh-list
138988690|NCT06138041|Anesthetics, Local|anesthetics, local|mesh-ancestor
138988691|NCT06138041|Anesthetics|anesthetics|mesh-ancestor
138988692|NCT06138041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138988693|NCT06138041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988694|NCT06138041|Sensory System Agents|sensory system agents|mesh-ancestor
138988695|NCT06138041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988696|NCT06138041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138988697|NCT06138041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138988698|NCT06138041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138988699|NCT06138041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138988700|NCT06138041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988701|NCT06138028|Cisplatin|cisplatin|mesh-list
138988702|NCT06138028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138988703|NCT06138028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988704|NCT06138028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988705|NCT06138028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138988706|NCT06137950|Interferons|interferons|mesh-list
138988707|NCT06137950|Interferon-alpha|interferon-alpha|mesh-list
138988708|NCT06137950|Interferon alpha-2|interferon alpha-2|mesh-list
138988709|NCT06137950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988710|NCT06137950|Antiviral Agents|antiviral agents|mesh-ancestor
138988711|NCT06137950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988712|NCT06137950|Immunologic Factors|immunologic factors|mesh-ancestor
138988713|NCT06137950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988715|NCT06137924|Dexamethasone acetate|dexamethasone acetate|mesh-list
138988716|NCT06137924|Clonidine|clonidine|mesh-list
138988717|NCT06137924|Bupivacaine|bupivacaine|mesh-list
138988718|NCT06137924|Anesthetics, Local|anesthetics, local|mesh-list
138988719|NCT06137924|Anesthetics|anesthetics|mesh-list
138988720|NCT06137924|BB 1101|bb 1101|mesh-list
138988721|NCT06137924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988722|NCT06137924|Antiemetics|antiemetics|mesh-ancestor
138988723|NCT06137924|Autonomic Agents|autonomic agents|mesh-ancestor
138988724|NCT06137924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988725|NCT06137924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988726|NCT06137924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138988727|NCT06137924|Glucocorticoids|glucocorticoids|mesh-ancestor
138988728|NCT06137924|Hormones|hormones|mesh-ancestor
138988729|NCT06137924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138988730|NCT06137924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138988731|NCT06137924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988732|NCT06137924|Protease Inhibitors|protease inhibitors|mesh-ancestor
138988733|NCT06137924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988734|NCT06137924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988735|NCT06137924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138988736|NCT06137924|Sensory System Agents|sensory system agents|mesh-ancestor
138988737|NCT06137924|Analgesics|analgesics|mesh-ancestor
138988738|NCT06137924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138988739|NCT06137924|Sympatholytics|sympatholytics|mesh-ancestor
138988740|NCT06137924|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138988741|NCT06137924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138988742|NCT06137924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138988743|NCT06137924|Adrenergic Agents|adrenergic agents|mesh-ancestor
138988744|NCT06137924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138988745|NCT06137664|Vaccines|vaccines|mesh-list
138988746|NCT06137664|Immunologic Factors|immunologic factors|mesh-ancestor
138988747|NCT06137664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988748|NCT06137651|Vinorelbine|vinorelbine|mesh-list
138988749|NCT06137651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138988750|NCT06137651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988751|NCT06137651|Tubulin Modulators|tubulin modulators|mesh-ancestor
138988752|NCT06137651|Antimitotic Agents|antimitotic agents|mesh-ancestor
138988753|NCT06137651|Mitosis Modulators|mitosis modulators|mesh-ancestor
138988754|NCT06137651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988755|NCT06137430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138988756|NCT06137430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988757|NCT06137430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138988758|NCT06137430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988759|NCT06137300|Kallikreins|kallikreins|mesh-list
138988760|NCT06137300|Coagulants|coagulants|mesh-ancestor
138988761|NCT06137300|Fertility Agents, Male|fertility agents, male|mesh-ancestor
138988762|NCT06137300|Fertility Agents|fertility agents|mesh-ancestor
138988763|NCT06137300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138988764|NCT06137300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988765|NCT06137092|Factor VIII|factor viii|mesh-list
138988766|NCT06137092|Coagulants|coagulants|mesh-ancestor
138988767|NCT06137040|Magnesium Sulfate|magnesium sulfate|mesh-list
138988768|NCT06137040|Analgesics|analgesics|mesh-ancestor
138988769|NCT06137040|Sensory System Agents|sensory system agents|mesh-ancestor
138988770|NCT06137040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988771|NCT06137040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988772|NCT06137040|Anesthetics|anesthetics|mesh-ancestor
138988773|NCT06137040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138988774|NCT06137040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138988775|NCT06137040|Anticonvulsants|anticonvulsants|mesh-ancestor
138988776|NCT06137040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138988777|NCT06137040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138988778|NCT06137040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988779|NCT06137040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138988780|NCT06137040|Tocolytic Agents|tocolytic agents|mesh-ancestor
138988781|NCT06137040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138988782|NCT06137027|Cannabidiol|cannabidiol|mesh-list
138988783|NCT06137027|Anticonvulsants|anticonvulsants|mesh-ancestor
138988784|NCT06136988|Paclitaxel|paclitaxel|mesh-list
138988785|NCT06136988|Docetaxel|docetaxel|mesh-list
138988786|NCT06136988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138988787|NCT06136988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739594|NCT01011049|Vaccines|vaccines|mesh-list
138988788|NCT06136988|Tubulin Modulators|tubulin modulators|mesh-ancestor
138988789|NCT06136988|Antimitotic Agents|antimitotic agents|mesh-ancestor
138988790|NCT06136988|Mitosis Modulators|mitosis modulators|mesh-ancestor
138988791|NCT06136988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988792|NCT06136897|Trastuzumab|trastuzumab|mesh-list
138988794|NCT06136897|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
138988795|NCT06136897|Antibodies|antibodies|mesh-list
138988796|NCT06136897|Immunoglobulins|immunoglobulins|mesh-list
138988797|NCT06136897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138988798|NCT06136897|Immunologic Factors|immunologic factors|mesh-ancestor
138988799|NCT06136897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988800|NCT06136897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138988801|NCT06136897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988802|NCT06136806|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138988803|NCT06136806|Hematinics|hematinics|mesh-ancestor
138988804|NCT06136806|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138988805|NCT06136806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138988806|NCT06136676|Complement Factor H|complement factor h|mesh-list
138988807|NCT06136676|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138988808|NCT06136676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138988809|NCT06136676|Immunologic Factors|immunologic factors|mesh-ancestor
138988810|NCT06136676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988811|NCT06136390|Oxytocin|oxytocin|mesh-list
138988812|NCT06136390|Oxytocics|oxytocics|mesh-ancestor
138988813|NCT06136390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138988814|NCT06136390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988815|NCT06136377|177Lu-PSMA-617|177lu-psma-617|mesh-list
138988816|NCT06136377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138988817|NCT06136377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988818|NCT06136208|Estradiol|estradiol|mesh-list
138988819|NCT06136208|Estrogens|estrogens|mesh-ancestor
138988820|NCT06136208|Hormones|hormones|mesh-ancestor
138988821|NCT06136208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138988822|NCT06136208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988823|NCT06135974|Metronidazole|metronidazole|mesh-list
138988824|NCT06135974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988825|NCT06135974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138988826|NCT06135974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138988827|NCT06135974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138988828|NCT06135844|Hand Sanitizers|hand sanitizers|mesh-list
138988829|NCT06135844|Mineral Oil|mineral oil|mesh-list
138988830|NCT06135844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138988831|NCT06135844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988832|NCT06135844|Disinfectants|disinfectants|mesh-ancestor
138988833|NCT06135844|Emollients|emollients|mesh-ancestor
138616114|NCT00125294|Methadone|methadone|mesh-list
138988834|NCT06135844|Dermatologic Agents|dermatologic agents|mesh-ancestor
138988835|NCT06135805|Fluocinonide|fluocinonide|mesh-list
138988836|NCT06135805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988837|NCT06135805|Glucocorticoids|glucocorticoids|mesh-ancestor
138988838|NCT06135805|Hormones|hormones|mesh-ancestor
138988839|NCT06135805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138988840|NCT06135805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988841|NCT06135805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138988842|NCT06135675|Rifamycins|rifamycins|mesh-list
138988843|NCT06135675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138988844|NCT06135675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988845|NCT06135584|Metformin|metformin|mesh-list
138988846|NCT06135584|Pioglitazone|pioglitazone|mesh-list
138988847|NCT06135584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138988848|NCT06135584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988849|NCT06135545|Bupivacaine|bupivacaine|mesh-list
138988850|NCT06135545|Anesthetics, Local|anesthetics, local|mesh-ancestor
138988851|NCT06135545|Anesthetics|anesthetics|mesh-ancestor
138988852|NCT06135545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138988853|NCT06135545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988854|NCT06135545|Sensory System Agents|sensory system agents|mesh-ancestor
138988855|NCT06135545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988856|NCT06135415|Tirbanibulin|tirbanibulin|mesh-list
138988857|NCT06135415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988858|NCT06135415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988859|NCT06135402|Clobetasol|clobetasol|mesh-list
138988860|NCT06135402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988861|NCT06135402|Glucocorticoids|glucocorticoids|mesh-ancestor
138988862|NCT06135402|Hormones|hormones|mesh-ancestor
138988863|NCT06135402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138988864|NCT06135402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988865|NCT06135194|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138988866|NCT06135194|Immunoconjugates|immunoconjugates|mesh-ancestor
138988867|NCT06135194|Immunologic Factors|immunologic factors|mesh-ancestor
138988868|NCT06135194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988869|NCT06134895|Ketamine|ketamine|mesh-list
138988870|NCT06134895|Tramadol|tramadol|mesh-list
138988871|NCT06134895|Analgesics|analgesics|mesh-ancestor
138988872|NCT06134895|Sensory System Agents|sensory system agents|mesh-ancestor
138988873|NCT06134895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988874|NCT06134895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988875|NCT06134895|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138988876|NCT06134895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138988877|NCT06134895|Anesthetics, General|anesthetics, general|mesh-ancestor
138988878|NCT06134895|Anesthetics|anesthetics|mesh-ancestor
138988879|NCT06134895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138988880|NCT06134895|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138988881|NCT06134895|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138988882|NCT06134895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138988883|NCT06134895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988884|NCT06134895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138988885|NCT06134895|Narcotics|narcotics|mesh-ancestor
138988886|NCT06134648|Vaccines|vaccines|mesh-list
138988887|NCT06134648|Immunologic Factors|immunologic factors|mesh-ancestor
138988888|NCT06134648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988889|NCT06134635|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138988890|NCT06134635|Evolocumab|evolocumab|mesh-list
138988891|NCT06134635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138988892|NCT06134635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138988893|NCT06134635|Antimetabolites|antimetabolites|mesh-ancestor
138988894|NCT06134635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988895|NCT06134635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988896|NCT06134635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138988897|NCT06134635|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138988898|NCT06134635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138988899|NCT06134635|Protease Inhibitors|protease inhibitors|mesh-ancestor
138988900|NCT06134622|Tirofiban|tirofiban|mesh-list
138988901|NCT06134622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138988902|NCT06134622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138988903|NCT06134622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988904|NCT06134622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138988905|NCT06134531|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138988906|NCT06134531|Immunologic Factors|immunologic factors|mesh-ancestor
138988907|NCT06134531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988908|NCT06134492|Acyclovir|acyclovir|mesh-list
138988909|NCT06134492|Antiviral Agents|antiviral agents|mesh-ancestor
138988910|NCT06134492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988911|NCT06134466|Caseins|caseins|mesh-list
138988912|NCT06134466|Chelating Agents|chelating agents|mesh-ancestor
138988913|NCT06134466|Sequestering Agents|sequestering agents|mesh-ancestor
138988914|NCT06134466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988915|NCT06134388|Sulfasalazine|sulfasalazine|mesh-list
138988916|NCT06134388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138988917|NCT06134388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138988918|NCT06134388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138988919|NCT06134388|Analgesics|analgesics|mesh-ancestor
138988920|NCT06134388|Sensory System Agents|sensory system agents|mesh-ancestor
138988921|NCT06134388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988922|NCT06134388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988923|NCT06134388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988924|NCT06134388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138988925|NCT06134388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138988926|NCT06134349|Lithium Carbonate|lithium carbonate|mesh-list
138988927|NCT06134349|Antidepressive Agents|antidepressive agents|mesh-ancestor
138988928|NCT06134349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138988929|NCT06134349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988930|NCT06134349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988931|NCT06134349|Antimanic Agents|antimanic agents|mesh-ancestor
138988932|NCT06134349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138988933|NCT06134349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138988934|NCT06134349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988935|NCT06134193|Tislelizumab|tislelizumab|mesh-list
138988936|NCT06134193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138988937|NCT06134193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988938|NCT06133881|Bupivacaine|bupivacaine|mesh-list
138988939|NCT06133881|Prilocaine|prilocaine|mesh-list
138988940|NCT06133881|Anesthetics, Local|anesthetics, local|mesh-ancestor
138988941|NCT06133881|Anesthetics|anesthetics|mesh-ancestor
138988943|NCT06133881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764491|NCT00620971|Bevacizumab|bevacizumab|mesh-list
138988944|NCT06133881|Sensory System Agents|sensory system agents|mesh-ancestor
138988945|NCT06133881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988946|NCT06133803|Aspirin|aspirin|mesh-list
138988947|NCT06133803|Enoxaparin|enoxaparin|mesh-list
138988948|NCT06133803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138988949|NCT06133803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138988950|NCT06133803|Analgesics|analgesics|mesh-ancestor
138988951|NCT06133803|Sensory System Agents|sensory system agents|mesh-ancestor
138988952|NCT06133803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988953|NCT06133803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988954|NCT06133803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988955|NCT06133803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138988956|NCT06133803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138988957|NCT06133803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138988958|NCT06133803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988959|NCT06133803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138988960|NCT06133803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138988961|NCT06133803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988962|NCT06133803|Antipyretics|antipyretics|mesh-ancestor
138988963|NCT06133803|Anticoagulants|anticoagulants|mesh-ancestor
138988964|NCT06133712|Dexamethasone|dexamethasone|mesh-list
138988965|NCT06133712|Dexmedetomidine|dexmedetomidine|mesh-list
138988966|NCT06133712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138988967|NCT06133712|Antiemetics|antiemetics|mesh-ancestor
138988968|NCT06133712|Autonomic Agents|autonomic agents|mesh-ancestor
138988969|NCT06133712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138988970|NCT06133712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988971|NCT06133712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138988972|NCT06133712|Glucocorticoids|glucocorticoids|mesh-ancestor
138988973|NCT06133712|Hormones|hormones|mesh-ancestor
138764502|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
138988974|NCT06133712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138988975|NCT06133712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138988976|NCT06133712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138988977|NCT06133712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138988978|NCT06133712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138988979|NCT06133712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138988980|NCT06133712|Analgesics|analgesics|mesh-ancestor
138988981|NCT06133712|Sensory System Agents|sensory system agents|mesh-ancestor
138988982|NCT06133712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138988983|NCT06133712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138988984|NCT06133712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138988985|NCT06133712|Adrenergic Agents|adrenergic agents|mesh-ancestor
138988986|NCT06133712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138988987|NCT06133712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988988|NCT06133465|Hormones|hormones|mesh-list
138988989|NCT06133465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138988990|NCT06133465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988991|NCT06133075|Mirabegron|mirabegron|mesh-list
138988992|NCT06133075|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138988993|NCT06133075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138988994|NCT06133075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138988995|NCT06133075|Adrenergic Agents|adrenergic agents|mesh-ancestor
138988996|NCT06133075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138988997|NCT06133075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988998|NCT06133075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138988999|NCT06133075|Urological Agents|urological agents|mesh-ancestor
138989000|NCT06132178|Psilocybin|psilocybin|mesh-list
138989001|NCT06132178|Hallucinogens|hallucinogens|mesh-ancestor
138989002|NCT06132178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989003|NCT06132178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138989004|NCT06130254|Olaparib|olaparib|mesh-list
138989005|NCT06130254|Adagrasib|adagrasib|mesh-list
138989006|NCT06130254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138989007|NCT06130254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989008|NCT06130254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989009|NCT06130254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989010|NCT06128616|Botulinum Toxins|botulinum toxins|mesh-list
138989011|NCT06128616|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138989012|NCT06128616|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138989013|NCT06128616|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138989014|NCT06128616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138989015|NCT06128616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989016|NCT06128616|Cholinergic Agents|cholinergic agents|mesh-ancestor
138616407|NCT00194753|Paclitaxel|paclitaxel|mesh-list
138989017|NCT06128616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138989018|NCT06128616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989019|NCT06128616|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138989020|NCT06128616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989021|NCT06127069|Chitosan|chitosan|mesh-list
138989022|NCT06127069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138989023|NCT06127069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138989024|NCT06127069|Antimetabolites|antimetabolites|mesh-ancestor
138989025|NCT06127069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989026|NCT06127069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138989027|NCT06127069|Chelating Agents|chelating agents|mesh-ancestor
138989028|NCT06127069|Sequestering Agents|sequestering agents|mesh-ancestor
138989029|NCT06127069|Hemostatics|hemostatics|mesh-ancestor
138989030|NCT06127069|Coagulants|coagulants|mesh-ancestor
138989031|NCT06126614|Chlorhexidine|chlorhexidine|mesh-list
138764592|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
138989032|NCT06126614|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138989033|NCT06126614|Povidone-Iodine|povidone-iodine|mesh-list
138989034|NCT06126614|Vancomycin|vancomycin|mesh-list
138989035|NCT06126614|Povidone|povidone|mesh-list
138989036|NCT06126614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138989037|NCT06126614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989038|NCT06126614|Disinfectants|disinfectants|mesh-ancestor
138989039|NCT06126614|Dermatologic Agents|dermatologic agents|mesh-ancestor
138989040|NCT06126614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138989041|NCT06126614|Plasma Substitutes|plasma substitutes|mesh-ancestor
138989042|NCT06126614|Blood Substitutes|blood substitutes|mesh-ancestor
138989043|NCT06110572|Carboplatin|carboplatin|mesh-list
138989044|NCT06110572|Etoposide|etoposide|mesh-list
138989045|NCT06110572|Atezolizumab|atezolizumab|mesh-list
138989046|NCT06110572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989047|NCT06110572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138989048|NCT06110572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138989049|NCT06110572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138989050|NCT06110572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989051|NCT06110572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989052|NCT06110572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138989053|NCT06110572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989054|NCT06107725|Minocycline|minocycline|mesh-list
138989055|NCT06107725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138989056|NCT06107725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989057|NCT06095492|Empagliflozin|empagliflozin|mesh-list
138989058|NCT06095492|Linagliptin|linagliptin|mesh-list
138989059|NCT06095492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138989060|NCT06095492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989061|NCT06095492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138989062|NCT06095492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989063|NCT06095492|Incretins|incretins|mesh-ancestor
138989064|NCT06095492|Hormones|hormones|mesh-ancestor
138989065|NCT06095492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138989066|NCT06095492|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138989067|NCT06095492|Protease Inhibitors|protease inhibitors|mesh-ancestor
138989068|NCT06095492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989069|NCT06091995|Abatacept|abatacept|mesh-list
138989070|NCT06091995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138989071|NCT06091995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989072|NCT06091995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989073|NCT06091995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989074|NCT06091995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138989075|NCT06091995|Immunologic Factors|immunologic factors|mesh-ancestor
138989076|NCT06091995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989077|NCT06091995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138989078|NCT06091124|Cisplatin|cisplatin|mesh-list
138989079|NCT06091124|Etoposide|etoposide|mesh-list
138989080|NCT06091124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989081|NCT06091124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138989082|NCT06091124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138989083|NCT06091124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138989084|NCT06091124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989085|NCT06091124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989086|NCT06085755|Trastuzumab|trastuzumab|mesh-list
138989087|NCT06085755|Afatinib|afatinib|mesh-list
138989088|NCT06085755|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138989089|NCT06085755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989090|NCT06085755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989091|NCT06085755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138989092|NCT06085755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989093|NCT06085755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989094|NCT06085755|Immunoconjugates|immunoconjugates|mesh-ancestor
138989095|NCT06085755|Immunologic Factors|immunologic factors|mesh-ancestor
138989096|NCT06085755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989098|NCT06078241|Anesthetics, Local|anesthetics, local|mesh-ancestor
138989099|NCT06078241|Anesthetics|anesthetics|mesh-ancestor
138989100|NCT06078241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138989101|NCT06078241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989102|NCT06078241|Sensory System Agents|sensory system agents|mesh-ancestor
138989103|NCT06078241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989104|NCT06078241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138989105|NCT06078241|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138989106|NCT06078241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138989107|NCT06078241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138764695|NCT02868801|Pregabalin|pregabalin|mesh-list
138989108|NCT06078241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989111|NCT06069180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989112|NCT06069180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138989113|NCT06069180|Immunologic Factors|immunologic factors|mesh-ancestor
138989114|NCT06069180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989115|NCT06069180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138989116|NCT06069180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989117|NCT06069180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138989118|NCT06067217|Tranexamic Acid|tranexamic acid|mesh-list
138989119|NCT06067217|Estradiol|estradiol|mesh-list
138989120|NCT06067217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138989121|NCT06067217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138989122|NCT06067217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989123|NCT06067217|Hemostatics|hemostatics|mesh-ancestor
138989124|NCT06067217|Coagulants|coagulants|mesh-ancestor
138989125|NCT06067217|Estrogens|estrogens|mesh-ancestor
138989126|NCT06067217|Hormones|hormones|mesh-ancestor
138989127|NCT06067217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138989128|NCT06067217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989129|NCT06061523|Sotorasib|sotorasib|mesh-list
138989130|NCT06061523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138989131|NCT06061523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989132|NCT06061523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989133|NCT06061523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989134|NCT06056804|Capecitabine|capecitabine|mesh-list
138989135|NCT06056804|Tislelizumab|tislelizumab|mesh-list
138989136|NCT06056804|Thymalfasin|thymalfasin|mesh-list
138989137|NCT06056804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138989138|NCT06056804|Antimetabolites|antimetabolites|mesh-ancestor
138989139|NCT06056804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989140|NCT06056804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989141|NCT06056804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989142|NCT06056804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138989143|NCT06056804|Immunologic Factors|immunologic factors|mesh-ancestor
138989144|NCT06056804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989145|NCT06042920|Deucravacitinib|deucravacitinib|mesh-list
138989146|NCT06042920|Dermatologic Agents|dermatologic agents|mesh-ancestor
138989147|NCT06042920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138833634|NCT00664105|Carboplatin|carboplatin|mesh-list
138989148|NCT06042920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989149|NCT06042920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989150|NCT06042647|Clobetasol|clobetasol|mesh-list
138989151|NCT06042647|Halobetasol|halobetasol|mesh-list
138989152|NCT06042647|Tazarotene|tazarotene|mesh-list
138989153|NCT06042647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138989155|NCT06042647|Hormones|hormones|mesh-ancestor
138989156|NCT06042647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138989157|NCT06042647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989158|NCT06042647|Dermatologic Agents|dermatologic agents|mesh-ancestor
138989159|NCT06042647|Keratolytic Agents|keratolytic agents|mesh-ancestor
138989160|NCT06042647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138989161|NCT06037889|Aspirin|aspirin|mesh-list
138989162|NCT06037889|Tirofiban|tirofiban|mesh-list
138989163|NCT06037889|Clopidogrel|clopidogrel|mesh-list
138989164|NCT06037889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138989165|NCT06037889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138989166|NCT06037889|Analgesics|analgesics|mesh-ancestor
138989167|NCT06037889|Sensory System Agents|sensory system agents|mesh-ancestor
138989168|NCT06037889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989169|NCT06037889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989170|NCT06037889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138989171|NCT06037889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138989172|NCT06037889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138989173|NCT06037889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138989174|NCT06037889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989175|NCT06037889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138989176|NCT06037889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138989177|NCT06037889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989178|NCT06037889|Antipyretics|antipyretics|mesh-ancestor
138989179|NCT06037889|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138989180|NCT06037889|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138989181|NCT06037889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138989182|NCT06037889|Purinergic Agents|purinergic agents|mesh-ancestor
138989183|NCT06037889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138989184|NCT06034340|Lidocaine|lidocaine|mesh-list
138989185|NCT06034340|Anesthetics, Local|anesthetics, local|mesh-ancestor
138989186|NCT06034340|Anesthetics|anesthetics|mesh-ancestor
138989187|NCT06034340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138989188|NCT06034340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989189|NCT06034340|Sensory System Agents|sensory system agents|mesh-ancestor
138989190|NCT06034340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989191|NCT06034340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138989192|NCT06034340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138989193|NCT06034340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138989194|NCT06034340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138989195|NCT06034340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989196|NCT06023368|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138989197|NCT06023368|Anesthetics, Local|anesthetics, local|mesh-ancestor
138989198|NCT06023368|Anesthetics|anesthetics|mesh-ancestor
138989199|NCT06023368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138989200|NCT06023368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989201|NCT06023368|Sensory System Agents|sensory system agents|mesh-ancestor
138989202|NCT06023368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989203|NCT06023368|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138989204|NCT06007911|Cytarabine|cytarabine|mesh-list
138989205|NCT06007911|Venetoclax|venetoclax|mesh-list
138989206|NCT06007911|Mitoxantrone|mitoxantrone|mesh-list
138989207|NCT06007911|Cladribine|cladribine|mesh-list
138989208|NCT06007911|Navitoclax|navitoclax|mesh-list
138989209|NCT06007911|Lenograstim|lenograstim|mesh-list
138989210|NCT06007911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138989211|NCT06007911|Antimetabolites|antimetabolites|mesh-ancestor
138989212|NCT06007911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989213|NCT06007911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989214|NCT06007911|Antiviral Agents|antiviral agents|mesh-ancestor
138989215|NCT06007911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989216|NCT06007911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138989217|NCT06007911|Immunologic Factors|immunologic factors|mesh-ancestor
138989218|NCT06007911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989220|NCT06007911|Sensory System Agents|sensory system agents|mesh-ancestor
138989221|NCT06007911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989222|NCT06007911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138989223|NCT06007911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138989224|NCT06007911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989225|NCT06007911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138989226|NCT05981209|Dexamethasone|dexamethasone|mesh-list
138989227|NCT05981209|Dexamethasone acetate|dexamethasone acetate|mesh-list
138989228|NCT05981209|Elotuzumab|elotuzumab|mesh-list
138989229|NCT05981209|Ichthammol|ichthammol|mesh-list
138989230|NCT05981209|BB 1101|bb 1101|mesh-list
138989231|NCT05981209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138989232|NCT05981209|Antiemetics|antiemetics|mesh-ancestor
138989233|NCT05981209|Autonomic Agents|autonomic agents|mesh-ancestor
138989234|NCT05981209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989235|NCT05981209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764791|NCT00622375|Mesalamine|mesalamine|mesh-list
138989236|NCT05981209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138989237|NCT05981209|Glucocorticoids|glucocorticoids|mesh-ancestor
138989238|NCT05981209|Hormones|hormones|mesh-ancestor
138989239|NCT05981209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138989240|NCT05981209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138989241|NCT05981209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989242|NCT05981209|Protease Inhibitors|protease inhibitors|mesh-ancestor
138989243|NCT05981209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989244|NCT05981209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989245|NCT05981209|Dermatologic Agents|dermatologic agents|mesh-ancestor
138989246|NCT05974969|Daratumumab|daratumumab|mesh-list
138989247|NCT05974969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989248|NCT05974293|Nabiximols|nabiximols|mesh-list
138989249|NCT05974293|Analgesics|analgesics|mesh-ancestor
138989250|NCT05974293|Sensory System Agents|sensory system agents|mesh-ancestor
138989251|NCT05974293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989252|NCT05974293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989253|NCT05966727|Cholestyramine Resin|cholestyramine resin|mesh-list
138989254|NCT05966727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138989255|NCT05966727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138989256|NCT05966727|Antimetabolites|antimetabolites|mesh-ancestor
138989257|NCT05966727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989258|NCT05966727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138989259|NCT05961527|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138989260|NCT05961527|Hallucinogens|hallucinogens|mesh-ancestor
138989261|NCT05961527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989262|NCT05961527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138989263|NCT05961527|Serotonin Agents|serotonin agents|mesh-ancestor
138989264|NCT05961527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138989265|NCT05961527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989266|NCT05961527|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138989267|NCT05961527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138989268|NCT05961527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138989269|NCT05961527|Adrenergic Agents|adrenergic agents|mesh-ancestor
138989270|NCT05960955|Docetaxel|docetaxel|mesh-list
138989271|NCT05960955|Fluorouracil|fluorouracil|mesh-list
138989272|NCT05960955|Oxaliplatin|oxaliplatin|mesh-list
138989273|NCT05960955|Tegafur|tegafur|mesh-list
138989274|NCT05960955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989275|NCT05960955|Tubulin Modulators|tubulin modulators|mesh-ancestor
138989276|NCT05960955|Antimitotic Agents|antimitotic agents|mesh-ancestor
138989277|NCT05960955|Mitosis Modulators|mitosis modulators|mesh-ancestor
138989278|NCT05960955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989279|NCT05960955|Antimetabolites|antimetabolites|mesh-ancestor
138989280|NCT05960955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138989281|NCT05960955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138989282|NCT05960955|Immunologic Factors|immunologic factors|mesh-ancestor
138616953|NCT00477529|Antimitotic Agents|antimitotic agents|mesh-ancestor
138989283|NCT05960955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989284|NCT05953038|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
138989285|NCT05953038|Hallucinogens|hallucinogens|mesh-ancestor
138989286|NCT05953038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989287|NCT05953038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138989288|NCT05953038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138989289|NCT05953038|Serotonin Agents|serotonin agents|mesh-ancestor
138989290|NCT05953038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138989291|NCT05953038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833801|NCT00671151|Theophylline|theophylline|mesh-list
138989292|NCT05953038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138989293|NCT05952089|Midazolam|midazolam|mesh-list
138989294|NCT05952089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138989295|NCT05952089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138989296|NCT05952089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138764821|NCT02689141|Ofatumumab|ofatumumab|mesh-list
138989297|NCT05952089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989298|NCT05952089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138989299|NCT05952089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138989300|NCT05952089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138989301|NCT05952089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138989302|NCT05952089|Anesthetics, General|anesthetics, general|mesh-ancestor
138989303|NCT05952089|Anesthetics|anesthetics|mesh-ancestor
138989304|NCT05952089|GABA Modulators|gaba modulators|mesh-ancestor
138989305|NCT05952089|GABA Agents|gaba agents|mesh-ancestor
138989306|NCT05952089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138989307|NCT05952089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989308|NCT05949281|Colchicine|colchicine|mesh-list
138989309|NCT05949281|Gout Suppressants|gout suppressants|mesh-ancestor
138989310|NCT05949281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138989311|NCT05949281|Tubulin Modulators|tubulin modulators|mesh-ancestor
138989312|NCT05949281|Antimitotic Agents|antimitotic agents|mesh-ancestor
138989313|NCT05949281|Mitosis Modulators|mitosis modulators|mesh-ancestor
138617067|NCT00202787|Vitamins|vitamins|mesh-ancestor
138989314|NCT05949281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989315|NCT05949281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989316|NCT05949021|Doxorubicin|doxorubicin|mesh-list
138989317|NCT05949021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138989318|NCT05949021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138989319|NCT05949021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989320|NCT05949021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138989321|NCT05949021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138989322|NCT05949021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989323|NCT05949021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989324|NCT05946655|Metronidazole|metronidazole|mesh-list
138989325|NCT05946655|Ofloxacin|ofloxacin|mesh-list
138989326|NCT05946655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989327|NCT05946655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138989328|NCT05946655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138989329|NCT05946655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138989330|NCT05946655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138989331|NCT05946655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138989332|NCT05946655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138989333|NCT05946655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989334|NCT05946655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989335|NCT05946655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989336|NCT05946655|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138989337|NCT05946655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138989338|NCT05939726|Vitamins|vitamins|mesh-list
138989339|NCT05939726|Vitamin E|vitamin e|mesh-list
138989340|NCT05939726|Tocopherols|tocopherols|mesh-list
138989341|NCT05939726|Tocotrienols|tocotrienols|mesh-list
138989342|NCT05939726|alpha-Tocopherol|alpha-tocopherol|mesh-list
138989343|NCT05939726|Micronutrients|micronutrients|mesh-ancestor
138617119|NCT00196391|Hormones|hormones|mesh-ancestor
138989344|NCT05939726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989345|NCT05939726|Antioxidants|antioxidants|mesh-ancestor
138989346|NCT05939726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989347|NCT05939726|Protective Agents|protective agents|mesh-ancestor
138989348|NCT05939193|Furosemide|furosemide|mesh-list
138989349|NCT05939193|Diuretics|diuretics|mesh-ancestor
138989350|NCT05939193|Natriuretic Agents|natriuretic agents|mesh-ancestor
138989351|NCT05939193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989352|NCT05939193|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138989353|NCT05939193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138989354|NCT05939193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989355|NCT05926466|Moxifloxacin|moxifloxacin|mesh-list
138989356|NCT05926466|Bedaquiline|bedaquiline|mesh-list
138989357|NCT05926466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138989358|NCT05926466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989359|NCT05926466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138989360|NCT05926466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138989361|NCT05926466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617161|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
138989362|NCT05926466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989363|NCT05926466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989365|NCT05925127|Vaccines|vaccines|mesh-list
138989366|NCT05925127|Immunologic Factors|immunologic factors|mesh-ancestor
138989367|NCT05925127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989368|NCT05922124|Meropenem|meropenem|mesh-list
138989369|NCT05922124|Colistin|colistin|mesh-list
138989370|NCT05922124|Ampicillin|ampicillin|mesh-list
138989371|NCT05922124|Sulbactam|sulbactam|mesh-list
138989372|NCT05922124|Sultamicillin|sultamicillin|mesh-list
138989373|NCT05922124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138989374|NCT05922124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989375|NCT05922124|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138989376|NCT05922124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989377|NCT05922124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989378|NCT05919888|Povidone-Iodine|povidone-iodine|mesh-list
138989379|NCT05919888|Povidone|povidone|mesh-list
138989380|NCT05919888|Plasma Substitutes|plasma substitutes|mesh-ancestor
138989381|NCT05919888|Blood Substitutes|blood substitutes|mesh-ancestor
138989382|NCT05919888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138989383|NCT05919888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989384|NCT05914779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138617216|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
138989385|NCT05914779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138989386|NCT05914779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989387|NCT05914779|Antitubercular Agents|antitubercular agents|mesh-ancestor
138989388|NCT05888597|Menthol|menthol|mesh-list
138989389|NCT05888597|Antipruritics|antipruritics|mesh-ancestor
138989390|NCT05888597|Dermatologic Agents|dermatologic agents|mesh-ancestor
138989391|NCT05885542|Cannabidiol|cannabidiol|mesh-list
138989392|NCT05885542|Anticonvulsants|anticonvulsants|mesh-ancestor
138989393|NCT05884320|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138989394|NCT05884320|Immunoconjugates|immunoconjugates|mesh-ancestor
138989396|NCT05884320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989397|NCT05872256|Halobetasol|halobetasol|mesh-list
138989398|NCT05872256|Tazarotene|tazarotene|mesh-list
138989399|NCT05872256|Dermatologic Agents|dermatologic agents|mesh-ancestor
138989400|NCT05872256|Keratolytic Agents|keratolytic agents|mesh-ancestor
138989401|NCT05872256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138989402|NCT05868226|Trastuzumab|trastuzumab|mesh-list
138989403|NCT05868226|Tucatinib|tucatinib|mesh-list
138989404|NCT05868226|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138989405|NCT05868226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989406|NCT05868226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989407|NCT05868226|Immunoconjugates|immunoconjugates|mesh-ancestor
138989408|NCT05868226|Immunologic Factors|immunologic factors|mesh-ancestor
138989409|NCT05868226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989410|NCT05868226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138989411|NCT05868226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989412|NCT05868226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989413|NCT05851976|Naproxen|naproxen|mesh-list
138989414|NCT05851976|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138989415|NCT05851976|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138989416|NCT05851976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138989417|NCT05851976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138989418|NCT05851976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989419|NCT05851976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138989420|NCT05851976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989421|NCT05851976|Analgesics|analgesics|mesh-ancestor
138989422|NCT05851976|Sensory System Agents|sensory system agents|mesh-ancestor
138989423|NCT05851976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989424|NCT05851976|Antidepressive Agents|antidepressive agents|mesh-ancestor
138989425|NCT05851976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138989426|NCT05851976|Dopamine Agents|dopamine agents|mesh-ancestor
138989427|NCT05851976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138989428|NCT05851976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138989429|NCT05851976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138989430|NCT05851976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138989431|NCT05851976|Gout Suppressants|gout suppressants|mesh-ancestor
138989432|NCT05851976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138989433|NCT05851976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989434|NCT05842096|Antibodies|antibodies|mesh-list
138989435|NCT05842096|Immunologic Factors|immunologic factors|mesh-ancestor
138989436|NCT05842096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989437|NCT05839574|Letrozole|letrozole|mesh-list
138989438|NCT05839574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989439|NCT05839574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138989440|NCT05839574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138989441|NCT05839574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989442|NCT05839574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989443|NCT05839574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138989444|NCT05839574|Hormone Antagonists|hormone antagonists|mesh-ancestor
138989445|NCT05839574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138989446|NCT05839574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989448|NCT05839561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989449|NCT05839561|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138989450|NCT05839561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138989451|NCT05839561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989452|NCT05839561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989453|NCT05839561|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138989454|NCT05839561|Hormone Antagonists|hormone antagonists|mesh-ancestor
138989455|NCT05839561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138989456|NCT05839561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989457|NCT05829317|Magnesium Sulfate|magnesium sulfate|mesh-list
138989458|NCT05829317|Analgesics|analgesics|mesh-ancestor
138989459|NCT05829317|Sensory System Agents|sensory system agents|mesh-ancestor
138989460|NCT05829317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989461|NCT05829317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989462|NCT05829317|Anesthetics|anesthetics|mesh-ancestor
138989463|NCT05829317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138989464|NCT05829317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138989465|NCT05829317|Anticonvulsants|anticonvulsants|mesh-ancestor
138989466|NCT05829317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138989467|NCT05829317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138989468|NCT05829317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989469|NCT05829317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138989470|NCT05829317|Tocolytic Agents|tocolytic agents|mesh-ancestor
138989471|NCT05829317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138989472|NCT05825391|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138989473|NCT05823311|Cisplatin|cisplatin|mesh-list
138989474|NCT05823311|Gemcitabine|gemcitabine|mesh-list
138989475|NCT05823311|Lenvatinib|lenvatinib|mesh-list
138989476|NCT05823311|Tislelizumab|tislelizumab|mesh-list
138989477|NCT05823311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989478|NCT05823311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138989479|NCT05823311|Antimetabolites|antimetabolites|mesh-ancestor
138989480|NCT05823311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989481|NCT05823311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138989482|NCT05823311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989483|NCT05823311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989484|NCT05807932|Mycophenolic Acid|mycophenolic acid|mesh-list
138989485|NCT05807932|Venetoclax|venetoclax|mesh-list
138989486|NCT05807932|Amsacrine|amsacrine|mesh-list
138989487|NCT05807932|Tacrolimus|tacrolimus|mesh-list
138989488|NCT05807932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138989489|NCT05807932|Immunologic Factors|immunologic factors|mesh-ancestor
138989490|NCT05807932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989491|NCT05807932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138989492|NCT05807932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989493|NCT05807932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989494|NCT05807932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138989495|NCT05807932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989496|NCT05807932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138989497|NCT05807932|Antitubercular Agents|antitubercular agents|mesh-ancestor
138989498|NCT05807932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138989499|NCT05807932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989500|NCT05803941|177Lu-PSMA-617|177lu-psma-617|mesh-list
138989501|NCT05803941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138989502|NCT05803941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989503|NCT05797376|Rivaroxaban|rivaroxaban|mesh-list
138989504|NCT05797376|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138989505|NCT05797376|Antithrombins|antithrombins|mesh-ancestor
138989506|NCT05797376|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138989507|NCT05797376|Protease Inhibitors|protease inhibitors|mesh-ancestor
138989508|NCT05797376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989509|NCT05797376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989510|NCT05797376|Anticoagulants|anticoagulants|mesh-ancestor
138989511|NCT05776758|Cisplatin|cisplatin|mesh-list
138989512|NCT05776758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989513|NCT05766514|Cytarabine|cytarabine|mesh-list
138989514|NCT05766514|Decitabine|decitabine|mesh-list
138989515|NCT05766514|Venetoclax|venetoclax|mesh-list
138989516|NCT05766514|Cladribine|cladribine|mesh-list
138989517|NCT05766514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138989518|NCT05766514|Antimetabolites|antimetabolites|mesh-ancestor
138989519|NCT05766514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989520|NCT05766514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989521|NCT05766514|Antiviral Agents|antiviral agents|mesh-ancestor
138989522|NCT05766514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989523|NCT05766514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138989525|NCT05766514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989526|NCT05766514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989527|NCT05757310|Vidarabine|vidarabine|mesh-list
138989528|NCT05757310|Cyclophosphamide|cyclophosphamide|mesh-list
138989529|NCT05757310|Pentostatin|pentostatin|mesh-list
138989530|NCT05757310|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138989531|NCT05757310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138989532|NCT05757310|Immunologic Factors|immunologic factors|mesh-ancestor
138989533|NCT05757310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989534|NCT05757310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138989535|NCT05757310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138989536|NCT05757310|Alkylating Agents|alkylating agents|mesh-ancestor
138989537|NCT05757310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989538|NCT05757310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989539|NCT05757310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138989540|NCT05757310|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138989541|NCT05757310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989542|NCT05757310|Antimetabolites|antimetabolites|mesh-ancestor
138989543|NCT05757310|Antiviral Agents|antiviral agents|mesh-ancestor
138740369|NCT02875756|Ivermectin|ivermectin|mesh-list
138989544|NCT05757310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989545|NCT05735639|Enoxaparin|enoxaparin|mesh-list
138989546|NCT05735639|Dalteparin|dalteparin|mesh-list
138989547|NCT05735639|Tinzaparin|tinzaparin|mesh-list
138989548|NCT05735639|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138989549|NCT05735639|Rivaroxaban|rivaroxaban|mesh-list
138989550|NCT05735639|Apixaban|apixaban|mesh-list
138989551|NCT05735639|Enoxaparin sodium|enoxaparin sodium|mesh-list
138989552|NCT05735639|Dabigatran|dabigatran|mesh-list
138989553|NCT05735639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138989554|NCT05735639|Antithrombins|antithrombins|mesh-ancestor
138989555|NCT05735639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138989556|NCT05735639|Protease Inhibitors|protease inhibitors|mesh-ancestor
138989557|NCT05735639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989558|NCT05735639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989559|NCT05735639|Anticoagulants|anticoagulants|mesh-ancestor
138989560|NCT05735639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138989561|NCT05735639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138989562|NCT05733611|Bevacizumab|bevacizumab|mesh-list
138989563|NCT05733611|Atezolizumab|atezolizumab|mesh-list
138989564|NCT05733611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989565|NCT05733611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989566|NCT05733611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138989567|NCT05733611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138834134|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
138989568|NCT05733611|Growth Substances|growth substances|mesh-ancestor
138989569|NCT05733611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989570|NCT05733611|Growth Inhibitors|growth inhibitors|mesh-ancestor
138989571|NCT05733611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138989572|NCT05733611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989573|NCT05733598|Bevacizumab|bevacizumab|mesh-list
138989574|NCT05733598|Atezolizumab|atezolizumab|mesh-list
138989575|NCT05733598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989576|NCT05733598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989577|NCT05733598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138989578|NCT05733598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138989579|NCT05733598|Growth Substances|growth substances|mesh-ancestor
138989580|NCT05733598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989581|NCT05733598|Growth Inhibitors|growth inhibitors|mesh-ancestor
138989582|NCT05733598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138989583|NCT05733598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989584|NCT05719714|Dapagliflozin|dapagliflozin|mesh-list
138989585|NCT05719714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138989586|NCT05719714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989587|NCT05719714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138989588|NCT05719714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989589|NCT05718258|Venglustat|venglustat|mesh-list
138989590|NCT05718258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989591|NCT05718258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989592|NCT05706402|Acetylcysteine|acetylcysteine|mesh-list
138989593|NCT05706402|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138989594|NCT05706402|Antiviral Agents|antiviral agents|mesh-ancestor
138989595|NCT05706402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989596|NCT05706402|Expectorants|expectorants|mesh-ancestor
138989597|NCT05706402|Respiratory System Agents|respiratory system agents|mesh-ancestor
138989598|NCT05706402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138989599|NCT05706402|Antioxidants|antioxidants|mesh-ancestor
138989600|NCT05706402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989601|NCT05706402|Protective Agents|protective agents|mesh-ancestor
138989602|NCT05706402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989603|NCT05706402|Antidotes|antidotes|mesh-ancestor
138989604|NCT05704725|Aflibercept|aflibercept|mesh-list
138989605|NCT05704725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138989606|NCT05704725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138989607|NCT05704725|Growth Substances|growth substances|mesh-ancestor
138989608|NCT05704725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989609|NCT05704725|Growth Inhibitors|growth inhibitors|mesh-ancestor
138989610|NCT05704725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989611|NCT05700903|Leuprolide|leuprolide|mesh-list
138989612|NCT05700903|Goserelin|goserelin|mesh-list
138989613|NCT05700903|Flutamide|flutamide|mesh-list
138989614|NCT05700903|Bicalutamide|bicalutamide|mesh-list
138989615|NCT05700903|Hormones|hormones|mesh-list
138989616|NCT05700903|Androgens|androgens|mesh-list
138989617|NCT05700903|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
138989618|NCT05700903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138989619|NCT05700903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989620|NCT05700903|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138989622|NCT05700903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138989623|NCT05700903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138834254|NCT04261634|Mitogens|mitogens|mesh-list
138989624|NCT05700903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989625|NCT05700903|Androgen Antagonists|androgen antagonists|mesh-ancestor
138989626|NCT05700903|Hormone Antagonists|hormone antagonists|mesh-ancestor
138989627|NCT05697029|Tetrandrine|tetrandrine|mesh-list
138989628|NCT05697029|Antimalarials|antimalarials|mesh-ancestor
138989629|NCT05697029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138989630|NCT05697029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138989631|NCT05697029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989632|NCT05697029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138989633|NCT05697029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989634|NCT05697029|Antiviral Agents|antiviral agents|mesh-ancestor
138989635|NCT05697029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138989636|NCT05697029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138989637|NCT05697029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989638|NCT05697029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138989639|NCT05697029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989640|NCT05697029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138989641|NCT05697029|Immunologic Factors|immunologic factors|mesh-ancestor
138989642|NCT05689710|Inositol|inositol|mesh-list
138989643|NCT05689710|Vitamin B Complex|vitamin b complex|mesh-ancestor
138989644|NCT05689710|Vitamins|vitamins|mesh-ancestor
138989645|NCT05689710|Micronutrients|micronutrients|mesh-ancestor
138989646|NCT05689710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989647|NCT05669352|Pembrolizumab|pembrolizumab|mesh-list
138989648|NCT05669352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989649|NCT05669352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989650|NCT05669352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138989651|NCT05669352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989652|NCT05659563|Tamoxifen|tamoxifen|mesh-list
138989653|NCT05659563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138989654|NCT05659563|Hormone Antagonists|hormone antagonists|mesh-ancestor
138989655|NCT05659563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138617553|NCT00208611|Vitamins|vitamins|mesh-list
138989656|NCT05659563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989657|NCT05659563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138989658|NCT05659563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989659|NCT05659563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138989660|NCT05659563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138989661|NCT05659563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138989662|NCT05655949|Cisplatin|cisplatin|mesh-list
138989663|NCT05655949|Gemcitabine|gemcitabine|mesh-list
138989664|NCT05655949|Durvalumab|durvalumab|mesh-list
138989665|NCT05655949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989666|NCT05655949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138989667|NCT05655949|Antimetabolites|antimetabolites|mesh-ancestor
138989668|NCT05655949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989669|NCT05655949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989670|NCT05647512|Dexamethasone|dexamethasone|mesh-list
138989671|NCT05647512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138989672|NCT05647512|Antiemetics|antiemetics|mesh-ancestor
138989673|NCT05647512|Autonomic Agents|autonomic agents|mesh-ancestor
138989674|NCT05647512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989675|NCT05647512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989676|NCT05647512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138989677|NCT05647512|Glucocorticoids|glucocorticoids|mesh-ancestor
138989678|NCT05647512|Hormones|hormones|mesh-ancestor
138989679|NCT05647512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138989681|NCT05647512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989682|NCT05644561|Ravulizumab|ravulizumab|mesh-list
138989683|NCT05644561|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138989684|NCT05644561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138989685|NCT05644561|Immunologic Factors|immunologic factors|mesh-ancestor
138765019|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989686|NCT05644561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989688|NCT05640245|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138989689|NCT05640245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138989690|NCT05640245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138989691|NCT05631093|Islatravir|islatravir|mesh-list
138989692|NCT05631093|Antiviral Agents|antiviral agents|mesh-ancestor
138989693|NCT05631093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989694|NCT05631093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989695|NCT05631093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617730|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138989696|NCT05631093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138989697|NCT05631093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138989698|NCT05631093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138989700|NCT05615974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989701|NCT05615974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989702|NCT05615974|Immunologic Factors|immunologic factors|mesh-ancestor
138989703|NCT05615974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989704|NCT05615974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138989705|NCT05615818|Gemcitabine|gemcitabine|mesh-list
138989706|NCT05615818|Trastuzumab|trastuzumab|mesh-list
138989707|NCT05615818|Niraparib|niraparib|mesh-list
138989708|NCT05615818|Ivosidenib|ivosidenib|mesh-list
138989709|NCT05615818|Futibatinib|futibatinib|mesh-list
138989710|NCT05615818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617786|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
138989711|NCT05615818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138989712|NCT05615818|Antimetabolites|antimetabolites|mesh-ancestor
138989713|NCT05615818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989714|NCT05615818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989715|NCT05615818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138989716|NCT05615818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989717|NCT05612880|Androgens|androgens|mesh-list
138989718|NCT05612880|Hormones|hormones|mesh-ancestor
138989719|NCT05612880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138989720|NCT05612880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989721|NCT05609682|Gabapentin|gabapentin|mesh-list
138989722|NCT05609682|Analgesics|analgesics|mesh-ancestor
138989723|NCT05609682|Sensory System Agents|sensory system agents|mesh-ancestor
138989724|NCT05609682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989725|NCT05609682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989726|NCT05609682|Anticonvulsants|anticonvulsants|mesh-ancestor
138989727|NCT05609682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138989728|NCT05609682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138989729|NCT05609682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138989730|NCT05609682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138989731|NCT05609682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138989732|NCT05609682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138989733|NCT05609682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138989734|NCT05609682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989735|NCT05609682|Antimanic Agents|antimanic agents|mesh-ancestor
138989736|NCT05600322|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138989737|NCT05600322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138989738|NCT05600322|Dermatologic Agents|dermatologic agents|mesh-ancestor
138989739|NCT05600062|Racecadotril|racecadotril|mesh-list
138989740|NCT05600062|Antidiarrheals|antidiarrheals|mesh-ancestor
138989741|NCT05600062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138989742|NCT05600062|Protease Inhibitors|protease inhibitors|mesh-ancestor
138989743|NCT05600062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989744|NCT05600062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989746|NCT05593055|Chlorthalidone|chlorthalidone|mesh-list
138989747|NCT05593055|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138989748|NCT05593055|Hormone Antagonists|hormone antagonists|mesh-ancestor
138989749|NCT05593055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138989750|NCT05593055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989751|NCT05593055|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138989752|NCT05593055|Diuretics|diuretics|mesh-ancestor
138989753|NCT05593055|Natriuretic Agents|natriuretic agents|mesh-ancestor
138989754|NCT05593055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138989755|NCT05593055|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138989756|NCT05593055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138989757|NCT05593055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989758|NCT05589688|Acyclovir|acyclovir|mesh-list
138989759|NCT05589688|Antiviral Agents|antiviral agents|mesh-ancestor
138989760|NCT05589688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989761|NCT05584735|Vaccines|vaccines|mesh-list
138989762|NCT05584735|Immunologic Factors|immunologic factors|mesh-ancestor
138989763|NCT05584735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989764|NCT05565729|Levocetirizine|levocetirizine|mesh-list
138989765|NCT05565729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138989766|NCT05565729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138989767|NCT05565729|Histamine Antagonists|histamine antagonists|mesh-ancestor
138989768|NCT05565729|Histamine Agents|histamine agents|mesh-ancestor
138989769|NCT05565729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138989770|NCT05565729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989771|NCT05565729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989772|NCT05564416|Atezolizumab|atezolizumab|mesh-list
138989773|NCT05564416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138989774|NCT05564416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138989775|NCT05564416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617970|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138989776|NCT05564416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989777|NCT05564416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989778|NCT05564416|Immunologic Factors|immunologic factors|mesh-ancestor
138989779|NCT05564416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989780|NCT05558280|Dinutuximab|dinutuximab|mesh-list
138989781|NCT05558280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989782|NCT05538897|Megestrol|megestrol|mesh-list
138989783|NCT05538897|Megestrol Acetate|megestrol acetate|mesh-list
138989784|NCT05538897|Ipatasertib|ipatasertib|mesh-list
138989785|NCT05538897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138989786|NCT05538897|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138989787|NCT05538897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138989788|NCT05538897|Contraceptive Agents|contraceptive agents|mesh-ancestor
138989789|NCT05538897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138989790|NCT05538897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989791|NCT05538897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138989792|NCT05538897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138989793|NCT05538897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138989794|NCT05538897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989795|NCT05538897|Appetite Stimulants|appetite stimulants|mesh-ancestor
138989796|NCT05538897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138989797|NCT05538897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138989798|NCT05538897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989799|NCT05538897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989800|NCT05536414|Escitalopram|escitalopram|mesh-list
138989801|NCT05536414|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138989802|NCT05536414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138989803|NCT05536414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138989804|NCT05536414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989805|NCT05536414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138989806|NCT05536414|Serotonin Agents|serotonin agents|mesh-ancestor
138989807|NCT05536414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989808|NCT05536349|Valacyclovir|valacyclovir|mesh-list
138989809|NCT05536349|Venetoclax|venetoclax|mesh-list
138989810|NCT05536349|Obinutuzumab|obinutuzumab|mesh-list
138989811|NCT05536349|Allopurinol|allopurinol|mesh-list
138989812|NCT05536349|Pirtobrutinib|pirtobrutinib|mesh-list
138765096|NCT02685085|Misoprostol|misoprostol|mesh-list
138989813|NCT05536349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989814|NCT05536349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989815|NCT05536349|Antimetabolites|antimetabolites|mesh-ancestor
138989816|NCT05536349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618139|NCT00409994|Sirolimus|sirolimus|mesh-list
138989817|NCT05536349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989818|NCT05536349|Gout Suppressants|gout suppressants|mesh-ancestor
138989819|NCT05536349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138989820|NCT05536349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138989821|NCT05536349|Antioxidants|antioxidants|mesh-ancestor
138989822|NCT05536349|Protective Agents|protective agents|mesh-ancestor
138989823|NCT05536349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989824|NCT05536349|Antiviral Agents|antiviral agents|mesh-ancestor
138989825|NCT05536349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989826|NCT05536349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138989827|NCT05535309|Sulbactam|sulbactam|mesh-list
138989828|NCT05535309|Cefoperazone|cefoperazone|mesh-list
138989829|NCT05535309|Sulperazone|sulperazone|mesh-list
138989830|NCT05535309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138989831|NCT05535309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989832|NCT05535309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138989833|NCT05535309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989834|NCT05535309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989835|NCT05535309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138989836|NCT05533619|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138989837|NCT05533619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989838|NCT05533619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989839|NCT05533606|Lactams|lactams|mesh-list
138989840|NCT05533606|beta-Lactams|beta-lactams|mesh-list
138989841|NCT05533606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138989842|NCT05533606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989843|NCT05532059|Cisplatin|cisplatin|mesh-list
138989844|NCT05532059|Gemcitabine|gemcitabine|mesh-list
138989845|NCT05532059|Lenvatinib|lenvatinib|mesh-list
138989846|NCT05532059|Tislelizumab|tislelizumab|mesh-list
138989847|NCT05532059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989848|NCT05532059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138989849|NCT05532059|Antimetabolites|antimetabolites|mesh-ancestor
138989850|NCT05532059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989851|NCT05532059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138989852|NCT05532059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989853|NCT05532059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989854|NCT05529927|Dextroamphetamine|dextroamphetamine|mesh-list
138989855|NCT05529927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138989856|NCT05529927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989857|NCT05529927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138989858|NCT05529927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138989859|NCT05529927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138618192|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
138989860|NCT05529927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989861|NCT05529927|Dopamine Agents|dopamine agents|mesh-ancestor
138989862|NCT05529927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138989863|NCT05527444|Thalidomide|thalidomide|mesh-list
138989864|NCT05527444|Adalimumab|adalimumab|mesh-list
138989865|NCT05527444|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138989866|NCT05527444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138989867|NCT05527444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138989868|NCT05527444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138989869|NCT05527444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138989870|NCT05527444|Immunologic Factors|immunologic factors|mesh-ancestor
138989871|NCT05527444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989872|NCT05527444|Leprostatic Agents|leprostatic agents|mesh-ancestor
138989873|NCT05527444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138989874|NCT05527444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989875|NCT05527444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138989876|NCT05527444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138989877|NCT05527444|Growth Substances|growth substances|mesh-ancestor
138989878|NCT05527444|Growth Inhibitors|growth inhibitors|mesh-ancestor
138989879|NCT05527444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989880|NCT05527054|Diuretics|diuretics|mesh-list
138989881|NCT05527054|Natriuretic Agents|natriuretic agents|mesh-ancestor
138989882|NCT05527054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989883|NCT05521997|Cisplatin|cisplatin|mesh-list
138989884|NCT05521997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989885|NCT05520619|Paclitaxel|paclitaxel|mesh-list
138989886|NCT05520619|Tislelizumab|tislelizumab|mesh-list
138989887|NCT05520619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138989888|NCT05520619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989889|NCT05520619|Tubulin Modulators|tubulin modulators|mesh-ancestor
138989890|NCT05520619|Antimitotic Agents|antimitotic agents|mesh-ancestor
138989891|NCT05520619|Mitosis Modulators|mitosis modulators|mesh-ancestor
138989892|NCT05520619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989893|NCT05520619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989894|NCT05514990|Dexamethasone|dexamethasone|mesh-list
138989895|NCT05514990|Dexamethasone acetate|dexamethasone acetate|mesh-list
138989896|NCT05514990|Pembrolizumab|pembrolizumab|mesh-list
138989897|NCT05514990|Bortezomib|bortezomib|mesh-list
138989898|NCT05514990|Ichthammol|ichthammol|mesh-list
138989899|NCT05514990|BB 1101|bb 1101|mesh-list
138989900|NCT05514990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138989901|NCT05514990|Antiemetics|antiemetics|mesh-ancestor
138989902|NCT05514990|Autonomic Agents|autonomic agents|mesh-ancestor
138989903|NCT05514990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989904|NCT05514990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989905|NCT05514990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138989906|NCT05514990|Glucocorticoids|glucocorticoids|mesh-ancestor
138989907|NCT05514990|Hormones|hormones|mesh-ancestor
138989908|NCT05514990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138989909|NCT05514990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138989910|NCT05514990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989911|NCT05514990|Protease Inhibitors|protease inhibitors|mesh-ancestor
138989912|NCT05514990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989913|NCT05514990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834527|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
138989914|NCT05514990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989915|NCT05514990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138989916|NCT05514990|Dermatologic Agents|dermatologic agents|mesh-ancestor
138989918|NCT05512520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138989919|NCT05512520|Antimetabolites|antimetabolites|mesh-ancestor
138989920|NCT05512520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989921|NCT05512520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989922|NCT05505279|Nicotine|nicotine|mesh-list
138989923|NCT05505279|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138989924|NCT05505279|Autonomic Agents|autonomic agents|mesh-ancestor
138989925|NCT05505279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989926|NCT05505279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989927|NCT05505279|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138989928|NCT05505279|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138989929|NCT05505279|Cholinergic Agents|cholinergic agents|mesh-ancestor
138989930|NCT05505279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138989931|NCT05505279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989932|NCT05498220|Dexamethasone|dexamethasone|mesh-list
138989933|NCT05498220|Rituximab|rituximab|mesh-list
138989934|NCT05498220|Gemcitabine|gemcitabine|mesh-list
138989935|NCT05498220|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138989936|NCT05498220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138989937|NCT05498220|Antiemetics|antiemetics|mesh-ancestor
138989938|NCT05498220|Autonomic Agents|autonomic agents|mesh-ancestor
138989939|NCT05498220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834573|NCT00800761|Deferiprone|deferiprone|mesh-list
138989940|NCT05498220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618321|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138989941|NCT05498220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138989942|NCT05498220|Glucocorticoids|glucocorticoids|mesh-ancestor
138989943|NCT05498220|Hormones|hormones|mesh-ancestor
138989944|NCT05498220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138989945|NCT05498220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138989946|NCT05498220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989947|NCT05498220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138989948|NCT05498220|Immunologic Factors|immunologic factors|mesh-ancestor
138989949|NCT05498220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138989950|NCT05498220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138989951|NCT05498220|Antimetabolites|antimetabolites|mesh-ancestor
138989952|NCT05498220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989953|NCT05498220|Immunoconjugates|immunoconjugates|mesh-ancestor
138989954|NCT05486416|Propofol|propofol|mesh-list
138989955|NCT05486416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138989956|NCT05486416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138989957|NCT05486416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989958|NCT05486416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138989959|NCT05486416|Anesthetics, General|anesthetics, general|mesh-ancestor
138989960|NCT05486416|Anesthetics|anesthetics|mesh-ancestor
138989961|NCT05476770|Cytarabine|cytarabine|mesh-list
138989962|NCT05476770|Dexamethasone|dexamethasone|mesh-list
138989963|NCT05476770|Hydrocortisone|hydrocortisone|mesh-list
138989964|NCT05476770|Methotrexate|methotrexate|mesh-list
138989965|NCT05476770|Fludarabine|fludarabine|mesh-list
138989967|NCT05476770|Azacitidine|azacitidine|mesh-list
138989968|NCT05476770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138989969|NCT05476770|Antiemetics|antiemetics|mesh-ancestor
138989970|NCT05476770|Autonomic Agents|autonomic agents|mesh-ancestor
138989971|NCT05476770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138989972|NCT05476770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989973|NCT05476770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138989974|NCT05476770|Glucocorticoids|glucocorticoids|mesh-ancestor
138989975|NCT05476770|Hormones|hormones|mesh-ancestor
138989976|NCT05476770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138989977|NCT05476770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138989978|NCT05476770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138989979|NCT05476770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138989980|NCT05476770|Abortifacient Agents|abortifacient agents|mesh-ancestor
138989981|NCT05476770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138989982|NCT05476770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138989983|NCT05476770|Antimetabolites|antimetabolites|mesh-ancestor
138989984|NCT05476770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989985|NCT05476770|Dermatologic Agents|dermatologic agents|mesh-ancestor
138989986|NCT05476770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989987|NCT05476770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138989988|NCT05476770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138989989|NCT05476770|Immunologic Factors|immunologic factors|mesh-ancestor
138989990|NCT05476770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138989991|NCT05476770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138989992|NCT05476770|Antiviral Agents|antiviral agents|mesh-ancestor
138989993|NCT05476770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138989994|NCT05476770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138989995|NCT05476770|Tubulin Modulators|tubulin modulators|mesh-ancestor
138989996|NCT05476770|Antimitotic Agents|antimitotic agents|mesh-ancestor
138989997|NCT05476770|Mitosis Modulators|mitosis modulators|mesh-ancestor
138989998|NCT05472337|Colchicine|colchicine|mesh-list
138989999|NCT05472337|Gout Suppressants|gout suppressants|mesh-ancestor
138990000|NCT05472337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138990001|NCT05472337|Tubulin Modulators|tubulin modulators|mesh-ancestor
138990002|NCT05472337|Antimitotic Agents|antimitotic agents|mesh-ancestor
138990003|NCT05472337|Mitosis Modulators|mitosis modulators|mesh-ancestor
138765236|NCT02686177|Metformin|metformin|mesh-list
138990004|NCT05472337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990005|NCT05472337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990006|NCT05463133|Sirolimus|sirolimus|mesh-list
138990007|NCT05463133|Cyclophosphamide|cyclophosphamide|mesh-list
138990008|NCT05463133|Busulfan|busulfan|mesh-list
138990009|NCT05463133|Alemtuzumab|alemtuzumab|mesh-list
138990010|NCT05463133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138990011|NCT05463133|Immunologic Factors|immunologic factors|mesh-ancestor
138990012|NCT05463133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990013|NCT05463133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138990014|NCT05463133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138990015|NCT05463133|Alkylating Agents|alkylating agents|mesh-ancestor
138990016|NCT05463133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990017|NCT05463133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990018|NCT05463133|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138990019|NCT05463133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138990020|NCT05463133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990021|NCT05463133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138990022|NCT05463133|Antifungal Agents|antifungal agents|mesh-ancestor
138990023|NCT05463133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990024|NCT05462496|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138990025|NCT05462496|Metronidazole|metronidazole|mesh-list
138990026|NCT05462496|Ciprofloxacin|ciprofloxacin|mesh-list
138990027|NCT05462496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138990028|NCT05462496|Pembrolizumab|pembrolizumab|mesh-list
138990029|NCT05462496|Folfirinox|folfirinox|mesh-list
138990030|NCT05462496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990031|NCT05462496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990032|NCT05462496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990033|NCT05462496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990034|NCT05462496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990035|NCT05462496|Antitubercular Agents|antitubercular agents|mesh-ancestor
138990036|NCT05462496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138990037|NCT05462496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138990038|NCT05462496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138990039|NCT05462496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138990040|NCT05462496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990041|NCT05462496|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138990042|NCT05462496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138990043|NCT05447910|Letrozole|letrozole|mesh-list
138990044|NCT05447910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990045|NCT05447910|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138990046|NCT05447910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138990047|NCT05447910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990048|NCT05447910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990049|NCT05447910|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138990050|NCT05447910|Hormone Antagonists|hormone antagonists|mesh-ancestor
138990051|NCT05447910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138990052|NCT05447910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990053|NCT05415709|Paclitaxel|paclitaxel|mesh-list
138990054|NCT05415709|Cisplatin|cisplatin|mesh-list
138990055|NCT05415709|Carboplatin|carboplatin|mesh-list
138990056|NCT05415709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138990057|NCT05415709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138990058|NCT05415709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990059|NCT05415709|Tubulin Modulators|tubulin modulators|mesh-ancestor
138990060|NCT05415709|Antimitotic Agents|antimitotic agents|mesh-ancestor
138990061|NCT05415709|Mitosis Modulators|mitosis modulators|mesh-ancestor
138990062|NCT05415709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990063|NCT05409872|Vitamin D|vitamin d|mesh-list
138990064|NCT05409872|Vitamins|vitamins|mesh-list
138990065|NCT05409872|Inositol|inositol|mesh-list
138990066|NCT05409872|Vitamin B 6|vitamin b 6|mesh-list
138990067|NCT05409872|Pyridoxal|pyridoxal|mesh-list
138990068|NCT05409872|Pyridoxine|pyridoxine|mesh-list
138990069|NCT05409872|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138990070|NCT05409872|Micronutrients|micronutrients|mesh-ancestor
138990071|NCT05409872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990072|NCT05409872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138990073|NCT05409872|Vitamin B Complex|vitamin b complex|mesh-ancestor
138990074|NCT05409872|Antioxidants|antioxidants|mesh-ancestor
138990075|NCT05409872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990076|NCT05409872|Protective Agents|protective agents|mesh-ancestor
138990077|NCT05409872|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138990078|NCT05409872|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138990079|NCT05409872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990080|NCT05409872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138990081|NCT05383456|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138990082|NCT05383456|Antiviral Agents|antiviral agents|mesh-ancestor
138990083|NCT05383456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990085|NCT05351229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138990086|NCT05351229|Narcotics|narcotics|mesh-ancestor
138990087|NCT05351229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138990088|NCT05351229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990089|NCT05351229|Analgesics|analgesics|mesh-ancestor
138990090|NCT05351229|Sensory System Agents|sensory system agents|mesh-ancestor
138990091|NCT05351229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990092|NCT05346484|Pembrolizumab|pembrolizumab|mesh-list
138990093|NCT05346484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990094|NCT05346484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990095|NCT05346484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990096|NCT05346484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990097|NCT05319587|Cytarabine|cytarabine|mesh-list
138990098|NCT05319587|Annamycin|annamycin|mesh-list
138990099|NCT05319587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138990100|NCT05319587|Antimetabolites|antimetabolites|mesh-ancestor
138618549|NCT00205751|Hormones|hormones|mesh-ancestor
138990101|NCT05319587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990102|NCT05319587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990103|NCT05319587|Antiviral Agents|antiviral agents|mesh-ancestor
138990104|NCT05319587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990105|NCT05319587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138990106|NCT05319587|Immunologic Factors|immunologic factors|mesh-ancestor
138990107|NCT05319587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990108|NCT05319587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138990109|NCT05318755|Testosterone|testosterone|mesh-list
138990110|NCT05318755|Androgens|androgens|mesh-ancestor
138990111|NCT05318755|Hormones|hormones|mesh-ancestor
138990112|NCT05318755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138990113|NCT05318755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990114|NCT05291403|Erythromycin|erythromycin|mesh-list
138990115|NCT05291403|Erythromycin Estolate|erythromycin estolate|mesh-list
138990116|NCT05291403|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138990118|NCT05291403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138990119|NCT05291403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990120|NCT05291403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138990121|NCT05291403|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138990122|NCT05291403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765263|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990123|NCT05291403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990124|NCT05269459|Cannabidiol|cannabidiol|mesh-list
138990125|NCT05269459|Anticonvulsants|anticonvulsants|mesh-ancestor
138990126|NCT05261672|Midazolam|midazolam|mesh-list
138990127|NCT05261672|Bupivacaine|bupivacaine|mesh-list
138990128|NCT05261672|Anesthetics, Local|anesthetics, local|mesh-ancestor
138990129|NCT05261672|Anesthetics|anesthetics|mesh-ancestor
138990130|NCT05261672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138990131|NCT05261672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990132|NCT05261672|Sensory System Agents|sensory system agents|mesh-ancestor
138990133|NCT05261672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990134|NCT05261672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138990135|NCT05261672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138990136|NCT05261672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138990137|NCT05261672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138990138|NCT05261672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138990139|NCT05261672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138990140|NCT05261672|Anesthetics, General|anesthetics, general|mesh-ancestor
138990141|NCT05261672|GABA Modulators|gaba modulators|mesh-ancestor
138990142|NCT05261672|GABA Agents|gaba agents|mesh-ancestor
138990143|NCT05261672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138990144|NCT05261672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990145|NCT05259527|Vitamin D|vitamin d|mesh-list
138740943|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138990146|NCT05259527|Ergocalciferols|ergocalciferols|mesh-list
138990147|NCT05259527|Cholecalciferol|cholecalciferol|mesh-list
138990148|NCT05259527|Vitamins|vitamins|mesh-list
138990149|NCT05259527|Micronutrients|micronutrients|mesh-ancestor
138990150|NCT05259527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990151|NCT05259527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138990152|NCT05259527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138990153|NCT05232851|Pembrolizumab|pembrolizumab|mesh-list
138990154|NCT05232851|Vaccines|vaccines|mesh-list
138990155|NCT05232851|Immunologic Factors|immunologic factors|mesh-ancestor
138990156|NCT05232851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990157|NCT05232851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990158|NCT05232851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990159|NCT05232851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990160|NCT05232851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990161|NCT05226871|Cetuximab|cetuximab|mesh-list
138990162|NCT05226871|Letrozole|letrozole|mesh-list
138990163|NCT05226871|Fulvestrant|fulvestrant|mesh-list
138990164|NCT05226871|Palbociclib|palbociclib|mesh-list
138990165|NCT05226871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990166|NCT05226871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834951|NCT00793663|Dexamethasone|dexamethasone|mesh-list
138990167|NCT05226871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138990168|NCT05226871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138990169|NCT05226871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990170|NCT05226871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990171|NCT05226871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138990172|NCT05226871|Hormone Antagonists|hormone antagonists|mesh-ancestor
138990173|NCT05226871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138990174|NCT05226871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990175|NCT05226871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138990176|NCT05226871|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138990177|NCT05226871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138990178|NCT05205486|Cefazolin|cefazolin|mesh-list
138990179|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138990180|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990181|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
138990182|NCT05188508|Temozolomide|temozolomide|mesh-list
138990183|NCT05188508|Olaparib|olaparib|mesh-list
138990184|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990185|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990186|NCT05188508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990187|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990188|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138990189|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
138990190|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138990191|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990192|NCT05184816|Deferoxamine|deferoxamine|mesh-list
138990193|NCT05184816|Siderophores|siderophores|mesh-ancestor
138990194|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138990195|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
138990196|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
138990197|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990198|NCT05178862|Fluconazole|fluconazole|mesh-list
138990199|NCT05178862|Caspofungin|caspofungin|mesh-list
138990200|NCT05178862|Micafungin|micafungin|mesh-list
138990201|NCT05178862|Anidulafungin|anidulafungin|mesh-list
138990202|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
138990203|NCT05178862|Echinocandins|echinocandins|mesh-list
138990204|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
138990205|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990206|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138990207|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138990208|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990209|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990210|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138990211|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
138990212|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138990213|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990214|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138765314|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
138990215|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138990216|NCT05152147|Capecitabine|capecitabine|mesh-list
138990217|NCT05152147|Fluorouracil|fluorouracil|mesh-list
138990218|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
138990219|NCT05152147|Trastuzumab|trastuzumab|mesh-list
138990220|NCT05152147|Tislelizumab|tislelizumab|mesh-list
138990221|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990222|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138990223|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
138990224|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990225|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138990226|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
138990227|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990228|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990229|NCT05139563|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138990230|NCT05139563|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138990231|NCT05139563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138990232|NCT05139563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138990233|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
138990234|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138990235|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990236|NCT05138549|Beta Carotene|beta carotene|mesh-list
138990237|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990238|NCT05138549|Provitamins|provitamins|mesh-ancestor
138990239|NCT05138549|Vitamins|vitamins|mesh-ancestor
138990240|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
138990241|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138990242|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
138990243|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
138990244|NCT05084378|Povidone|povidone|mesh-list
138990245|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138990246|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990247|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138990248|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
138990249|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
138990250|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
138990251|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
138990252|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138990253|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138990254|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138990255|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138990256|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990257|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
138990258|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138990259|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990260|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138990261|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990262|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
138990263|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990264|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990265|NCT05067166|Ansuvimab|ansuvimab|mesh-list
138990266|NCT05067166|Antiviral Agents|antiviral agents|mesh-ancestor
138990267|NCT05067166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990268|NCT05059535|Acetaminophen|acetaminophen|mesh-list
138990269|NCT05059535|Analgesics|analgesics|mesh-list
138990270|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138990271|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
138990272|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990273|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990274|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
138990275|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
138990276|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138618887|NCT00230217|Rasburicase|rasburicase|mesh-list
138990277|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138990278|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990279|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
138990280|NCT05053867|Coagulants|coagulants|mesh-ancestor
138990281|NCT05020574|Cephalexin|cephalexin|mesh-list
138990282|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138990283|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990284|NCT05013632|Antiviral Agents|antiviral agents|mesh-list
138990285|NCT05013632|Remdesivir|remdesivir|mesh-list
138990286|NCT05013632|Sotrovimab|sotrovimab|mesh-list
138990287|NCT05013632|Molnupiravir|molnupiravir|mesh-list
138990288|NCT05013632|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
138990289|NCT05013632|Antibodies|antibodies|mesh-list
138990290|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138990291|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
138619007|NCT01089556|Pregabalin|pregabalin|mesh-list
138990292|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990293|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990294|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
138990295|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741095|NCT06054321|Histamine Agents|histamine agents|mesh-ancestor
138990297|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138990298|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
138990299|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138990300|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138990301|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990302|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138990303|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138990304|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138990305|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990306|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138990307|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138990308|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138990309|NCT05003453|Palmidrol|palmidrol|mesh-list
138990310|NCT05003453|Analgesics|analgesics|mesh-ancestor
138990311|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
138990312|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990313|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990314|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138990315|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138990317|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138990318|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
138990319|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990320|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138990321|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138990322|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138990323|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990324|NCT05003453|Hormones|hormones|mesh-ancestor
138990325|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138990326|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
138990327|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138990328|NCT04991493|Tramadol|tramadol|mesh-list
138990329|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138990330|NCT04991493|Narcotics|narcotics|mesh-ancestor
138990331|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138990332|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990333|NCT04991493|Analgesics|analgesics|mesh-ancestor
138990334|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
138990335|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990336|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
138990337|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990338|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990339|NCT04986852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990340|NCT04986852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990341|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
138990342|NCT04959175|Sirolimus|sirolimus|mesh-list
138990343|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
138990344|NCT04959175|Fludarabine|fludarabine|mesh-list
138990345|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138990346|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
138990347|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990348|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138990349|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138990350|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
138990351|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990352|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990353|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138990354|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138990355|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138990356|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
138990357|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138990358|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990359|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990360|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
138619182|NCT01084603|Nicotine|nicotine|mesh-list
138990362|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138990363|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138990364|NCT04932096|Melatonin|melatonin|mesh-list
138990365|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
138990366|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990367|NCT04932096|Protective Agents|protective agents|mesh-ancestor
138990368|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990369|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138990370|NCT04928586|Pirfenidone|pirfenidone|mesh-list
138990371|NCT04928586|Analgesics|analgesics|mesh-ancestor
138990372|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
138990373|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990374|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990375|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138990376|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138990377|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138990378|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138990379|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990380|NCT04928066|Prednisone|prednisone|mesh-list
138990381|NCT04928066|Tofacitinib|tofacitinib|mesh-list
138990382|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138990383|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
138990384|NCT04928066|Hormones|hormones|mesh-ancestor
138990385|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138990386|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990387|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138990388|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990389|NCT04928066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138990390|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138990391|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619287|NCT00208715|Modafinil|modafinil|mesh-list
138990392|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990393|NCT04918524|Aspirin|aspirin|mesh-list
138990394|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
138990395|NCT04918524|Prednisone|prednisone|mesh-list
138990396|NCT04918524|Heparin|heparin|mesh-list
138990397|NCT04918524|Enoxaparin|enoxaparin|mesh-list
138990398|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138990399|NCT04918524|Tinzaparin|tinzaparin|mesh-list
138990400|NCT04918524|Dalteparin|dalteparin|mesh-list
138990401|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138990402|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
138990403|NCT04918524|Hormones|hormones|mesh-ancestor
138990404|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138990405|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990406|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138990407|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990408|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138990409|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138990410|NCT04918524|Analgesics|analgesics|mesh-ancestor
138990411|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
138990412|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990413|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138990414|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138990415|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138990416|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990417|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138990418|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138990419|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990420|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
138990421|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
138990422|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
138990423|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138990424|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138990425|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990427|NCT04912115|Ketamine|ketamine|mesh-list
138990428|NCT04912115|Analgesics|analgesics|mesh-ancestor
138990429|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
138990430|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990431|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990432|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138990433|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138990434|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
138990435|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
138990436|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138990437|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138990438|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138990439|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138990440|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990441|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138990442|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138835287|NCT00875433|Afatinib|afatinib|mesh-list
138990443|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138990444|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138619453|NCT00234312|Sertraline|sertraline|mesh-list
138990445|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138990446|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
138990447|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
138990448|NCT04896645|Albuterol|albuterol|mesh-list
138990449|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138990450|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
138990451|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990452|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990453|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138990454|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
138990455|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
138990456|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138990457|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138990458|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138990459|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138990460|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
138990461|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138990462|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990463|NCT04854395|Bupivacaine|bupivacaine|mesh-list
138990464|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
138990465|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
138990466|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138990467|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990468|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
138765433|NCT02680951|Cytarabine|cytarabine|mesh-list
138990469|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990470|NCT04827537|Metronidazole|metronidazole|mesh-list
138990471|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990472|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138990473|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138990474|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138990475|NCT04820179|Atezolizumab|atezolizumab|mesh-list
138990476|NCT04820179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990477|NCT04820179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990478|NCT04820179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990479|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990480|NCT04820036|Insulin|insulin|mesh-list
138990481|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138990482|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990483|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138990484|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990485|NCT04800692|Verapamil|verapamil|mesh-list
138990486|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138990487|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138990488|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138990489|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990490|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138990491|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990492|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
138990493|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
138990494|NCT04783415|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138990495|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990496|NCT04783415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138835370|NCT00802009|Dexamethasone|dexamethasone|mesh-list
138990497|NCT04783415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990498|NCT04783415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990499|NCT04777357|Cariprazine|cariprazine|mesh-list
138990500|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138990501|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138990502|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138990503|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990504|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138990505|NCT04772196|Vitamin D|vitamin d|mesh-list
138990506|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
138990507|NCT04772196|Vitamins|vitamins|mesh-ancestor
138990508|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
138765462|NCT02680717|Hormones|hormones|mesh-ancestor
138990509|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990510|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138990511|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138990512|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
138990513|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138990514|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
138990515|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
138990516|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138990517|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990518|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138990519|NCT04749043|Analgesics|analgesics|mesh-ancestor
138990520|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
138990521|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990522|NCT04716933|Carboplatin|carboplatin|mesh-list
138990523|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
138990525|NCT04716933|Lenvatinib|lenvatinib|mesh-list
138990526|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990527|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990528|NCT04716933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990529|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990530|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619665|NCT01084330|Docetaxel|docetaxel|mesh-list
138990531|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138990532|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138835421|NCT00797017|Fentanyl|fentanyl|mesh-list
138990533|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138990535|NCT04715230|Haloperidol|haloperidol|mesh-list
138990536|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
138990537|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
138990538|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
138990539|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990540|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990541|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138990542|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138990543|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138990544|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138990545|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138990546|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138990547|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
138990548|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619720|NCT00237705|Metoclopramide|metoclopramide|mesh-list
138990549|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990550|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138990551|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
138990552|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138990553|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138990555|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
138990556|NCT04710368|Evolocumab|evolocumab|mesh-list
138990557|NCT04710368|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138990558|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138990559|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138990560|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
138990561|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990562|NCT04710368|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138990563|NCT04710368|Protease Inhibitors|protease inhibitors|mesh-ancestor
138990564|NCT04710368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990565|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138990566|NCT04707872|Antibodies|antibodies|mesh-list
138990567|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
138990568|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990569|NCT04702880|Carboplatin|carboplatin|mesh-list
138990570|NCT04702880|Nivolumab|nivolumab|mesh-list
138990571|NCT04702880|Etoposide|etoposide|mesh-list
138990572|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990573|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990574|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990575|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990576|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138990577|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138990578|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138990579|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990580|NCT04695340|Psyllium|psyllium|mesh-list
138990581|NCT04695340|Cathartics|cathartics|mesh-ancestor
138990582|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138990583|NCT04672005|Leucovorin|leucovorin|mesh-list
138990584|NCT04672005|Paclitaxel|paclitaxel|mesh-list
138990585|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138990586|NCT04672005|Gemcitabine|gemcitabine|mesh-list
138990587|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
138990589|NCT04672005|Folfirinox|folfirinox|mesh-list
138990590|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138990591|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990592|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
138990593|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
138990594|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138990595|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990596|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138990597|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
138619890|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
138990598|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138990599|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138990601|NCT04672005|Antidotes|antidotes|mesh-ancestor
138990602|NCT04672005|Protective Agents|protective agents|mesh-ancestor
138990603|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990604|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
138990605|NCT04672005|Vitamins|vitamins|mesh-ancestor
138990606|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
138990607|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138990608|NCT04643379|Carboplatin|carboplatin|mesh-list
138990609|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
138990610|NCT04643379|Olaparib|olaparib|mesh-list
138990611|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619956|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
138990612|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990613|NCT04643379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990614|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765575|NCT00642577|Vitamins|vitamins|mesh-ancestor
138990615|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138990616|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990617|NCT04638751|Immunomodulating Agents|immunomodulating agents|mesh-list
138990618|NCT04638751|Immunologic Factors|immunologic factors|mesh-ancestor
138990619|NCT04638751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990633|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990634|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138990635|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
138990636|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138990637|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990638|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138620083|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
138990639|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138990640|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138990642|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138990643|NCT04602117|Trastuzumab|trastuzumab|mesh-list
138990644|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138990645|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990646|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
138990647|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
138990648|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
138990649|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990650|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990651|NCT04590963|Cetuximab|cetuximab|mesh-list
138990652|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990653|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990654|NCT04583488|Docetaxel|docetaxel|mesh-list
138990655|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990656|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
138990657|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
138990658|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
138990659|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990660|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
138990662|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990663|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990664|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990665|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990666|NCT04559646|Hemostatics|hemostatics|mesh-list
138990667|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138990668|NCT04559646|Coagulants|coagulants|mesh-ancestor
138990669|NCT04546009|Letrozole|letrozole|mesh-list
138990670|NCT04546009|Palbociclib|palbociclib|mesh-list
138990671|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990672|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138990673|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138990674|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835506|NCT00988637|Hormones|hormones|mesh-ancestor
138990675|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990676|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138990677|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
138990678|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138990679|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990680|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138990681|NCT04545151|Verapamil|verapamil|mesh-list
138765660|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990682|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138990683|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138990684|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138990685|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990686|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138990687|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990688|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
138990689|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138990690|NCT04538092|Analgesics|analgesics|mesh-list
138990691|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990692|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
138990693|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990694|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990695|NCT04524689|Carboplatin|carboplatin|mesh-list
138990696|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
138990697|NCT04524689|Pemetrexed|pemetrexed|mesh-list
138990698|NCT04524689|Maytansine|maytansine|mesh-list
138990699|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990700|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990701|NCT04524689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990702|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990703|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990704|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138990705|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138990706|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138990707|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
138990708|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
138990709|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
138990710|NCT04502849|Vitamin E|vitamin e|mesh-list
138990711|NCT04502849|Tocopherols|tocopherols|mesh-list
138990712|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
138990713|NCT04502849|Vitamins|vitamins|mesh-ancestor
138990714|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
138835544|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
138990715|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990716|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
138990717|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990718|NCT04502849|Protective Agents|protective agents|mesh-ancestor
138990719|NCT04502602|Niraparib|niraparib|mesh-list
138990720|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138990721|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990722|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990723|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990724|NCT04493216|Dolutegravir|dolutegravir|mesh-list
138990725|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138990726|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138990727|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990728|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990729|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138765709|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
138990730|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138990731|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
138990732|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990733|NCT04462328|Durvalumab|durvalumab|mesh-list
138990734|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
138990735|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990736|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990737|NCT04434092|Eculizumab|eculizumab|mesh-list
138990738|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138990739|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138990740|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
138990741|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990742|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
138835577|NCT02625753|Acetaminophen|acetaminophen|mesh-list
138990743|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138990744|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138990745|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990746|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
138990747|NCT04410042|Coagulants|coagulants|mesh-ancestor
138990748|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138741546|NCT05363631|Pembrolizumab|pembrolizumab|mesh-list
138990750|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
138990751|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
138990752|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138990753|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990754|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
138990755|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
138990756|NCT04392297|Antibodies|antibodies|mesh-list
138990757|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
138990758|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
138990759|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990760|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138990761|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138990762|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990763|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
138990764|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
138990765|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990766|NCT04345341|Bupivacaine|bupivacaine|mesh-list
138990767|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
138990768|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
138990769|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138990770|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990771|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
138990772|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990773|NCT04329949|Paclitaxel|paclitaxel|mesh-list
138990774|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138990775|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990776|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
138990777|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
138990778|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
138990779|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990780|NCT04329065|Paclitaxel|paclitaxel|mesh-list
138990781|NCT04329065|Trastuzumab|trastuzumab|mesh-list
138990782|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138990783|NCT04329065|Pertuzumab|pertuzumab|mesh-list
138990784|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
138620424|NCT00211484|Anecortave|anecortave|mesh-list
138990785|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138990786|NCT04329065|Vaccines|vaccines|mesh-list
138990787|NCT04329065|Antibodies|antibodies|mesh-list
138990788|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
138990789|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138990790|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
138990791|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
138990792|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990793|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138990794|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990795|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
138990796|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
138990797|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
138990798|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990799|NCT04300647|Atezolizumab|atezolizumab|mesh-list
138990800|NCT04300647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990801|NCT04300647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990802|NCT04300647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990803|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990804|NCT04290624|Listerine|listerine|mesh-list
138990805|NCT04290624|Fluorides|fluorides|mesh-list
138990806|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
138990807|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
138990808|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
138990809|NCT04290624|Protective Agents|protective agents|mesh-ancestor
138990810|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990811|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138990812|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990813|NCT04262193|Suvorexant|suvorexant|mesh-list
138990814|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138990815|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138990816|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138990817|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990818|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138990819|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138990820|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990821|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138990822|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
138990823|NCT04248452|Leucovorin|leucovorin|mesh-list
138990824|NCT04248452|Folic Acid|folic acid|mesh-list
138990825|NCT04248452|Capecitabine|capecitabine|mesh-list
138990826|NCT04248452|Fluorouracil|fluorouracil|mesh-list
138990828|NCT04248452|Calcium|calcium|mesh-list
138990829|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
138990830|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138990831|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990832|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138990833|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138990834|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
138990835|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990837|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138990838|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
138990839|NCT04248452|Antidotes|antidotes|mesh-ancestor
138990840|NCT04248452|Protective Agents|protective agents|mesh-ancestor
138990841|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
138990842|NCT04248452|Vitamins|vitamins|mesh-ancestor
138990843|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
138990844|NCT04248452|Hematinics|hematinics|mesh-ancestor
138990845|NCT04238637|Durvalumab|durvalumab|mesh-list
138990846|NCT04238637|Tremelimumab|tremelimumab|mesh-list
138990847|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990848|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990849|NCT04198623|Montelukast|montelukast|mesh-list
138765823|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990850|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138990851|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
138990852|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138990853|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
138990854|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138990855|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990856|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138990857|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138990858|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990859|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
138990860|NCT04191096|Androgens|androgens|mesh-list
138990861|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990862|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990863|NCT04191096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990864|NCT04191096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990866|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138990867|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990868|NCT04187833|Nivolumab|nivolumab|mesh-list
138990869|NCT04187833|Talazoparib|talazoparib|mesh-list
138990870|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990871|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990872|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990873|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990874|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138990875|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990876|NCT04157335|Benralizumab|benralizumab|mesh-list
138990877|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138990878|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
138990879|NCT04146493|Heparin|heparin|mesh-list
138990880|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
138990881|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138990882|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138990883|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990885|NCT04123795|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138990886|NCT04123795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138990887|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138990888|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
138990889|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990890|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138990891|NCT04092894|Suvorexant|suvorexant|mesh-list
138990892|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138990893|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138990894|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138990895|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990896|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138990897|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138990898|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990899|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138990900|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138990901|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138835726|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990902|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990903|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
138990904|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138990905|NCT04083495|Fludarabine|fludarabine|mesh-list
138990906|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138990907|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
138990908|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990909|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138990910|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138990911|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
138990912|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990913|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990914|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138990915|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138990916|NCT04039750|Clindamycin|clindamycin|mesh-list
138990917|NCT04039750|Gentamicins|gentamicins|mesh-list
138990918|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990919|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138990920|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990921|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990922|NCT04035486|Carboplatin|carboplatin|mesh-list
138990923|NCT04035486|Pemetrexed|pemetrexed|mesh-list
138990924|NCT04035486|Osimertinib|osimertinib|mesh-list
138990925|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990926|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990927|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990928|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138990929|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138990930|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138990931|NCT04028596|Acetaminophen|acetaminophen|mesh-list
138990932|NCT04028596|Nimodipine|nimodipine|mesh-list
138990933|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138990934|NCT04028596|Analgesics|analgesics|mesh-ancestor
138990935|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
138990936|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138990937|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990938|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
138990939|NCT04028596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138990940|NCT04028596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138990941|NCT04028596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138990942|NCT04028596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990943|NCT04028596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138990945|NCT04006483|Fluorides|fluorides|mesh-list
138990946|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
138990947|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
138990948|NCT04006483|Protective Agents|protective agents|mesh-ancestor
138990949|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990950|NCT04003649|Nivolumab|nivolumab|mesh-list
138990951|NCT04003649|Ipilimumab|ipilimumab|mesh-list
138990952|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990953|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990954|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138990955|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990956|NCT04002141|Letrozole|letrozole|mesh-list
138620873|NCT00239421|Xhance|xhance|mesh-list
138990958|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138990959|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138990960|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990961|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990962|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138990963|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
138990964|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138990965|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990966|NCT03999710|Durvalumab|durvalumab|mesh-list
138990967|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138990968|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990969|NCT03970096|Cyclosporine|cyclosporine|mesh-list
138990970|NCT03970096|Sirolimus|sirolimus|mesh-list
138990972|NCT03970096|Busulfan|busulfan|mesh-list
138990973|NCT03970096|Thiotepa|thiotepa|mesh-list
138990974|NCT03970096|Methotrexate|methotrexate|mesh-list
138741774|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
138990975|NCT03970096|Fludarabine|fludarabine|mesh-list
138990976|NCT03970096|Tacrolimus|tacrolimus|mesh-list
138990977|NCT03970096|Cyclosporins|cyclosporins|mesh-list
138990978|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138990979|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
138990980|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138990981|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138990982|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138990983|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
138990984|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138990985|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138990986|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138990987|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138990988|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
138990989|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138990990|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138990991|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
138990992|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
138990993|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138990994|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138990995|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138990996|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138990997|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
138990998|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138990999|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138991000|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138991001|NCT03944954|Dronabinol|dronabinol|mesh-list
138991002|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
138991003|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991004|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138991005|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138991006|NCT03944954|Analgesics|analgesics|mesh-ancestor
138991007|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
138991008|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991009|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138991010|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138991011|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138991012|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991014|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991015|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
138991016|NCT03927989|Nicotine|nicotine|mesh-list
138991017|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138991018|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
138991019|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991020|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991021|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138991022|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138991023|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
138991024|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138991025|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991026|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
138991027|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991028|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991029|NCT03899805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991030|NCT03899805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991031|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138991032|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138991033|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
138991034|NCT03897127|Cytarabine|cytarabine|mesh-list
138991035|NCT03897127|Daunorubicin|daunorubicin|mesh-list
138991036|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138991037|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
138991038|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991039|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991040|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
138621115|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
138991041|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991042|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991043|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
138991044|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991045|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138991046|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138991047|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138991048|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991049|NCT03895203|Adalimumab|adalimumab|mesh-list
138991050|NCT03895203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138991051|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138991052|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991053|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
138991054|NCT03855007|Prednisone|prednisone|mesh-list
138991055|NCT03855007|Methotrexate|methotrexate|mesh-list
138991056|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138991057|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
138991058|NCT03855007|Hormones|hormones|mesh-ancestor
138991059|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991060|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991061|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138991062|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991063|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138991064|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
138991065|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138991066|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138991067|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
138991068|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991069|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
138991070|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991071|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138991072|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991073|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
138991074|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991075|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138991076|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
138991077|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138991078|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138991079|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991080|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
138991081|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991082|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991083|NCT03854474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991084|NCT03854474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991085|NCT03836287|Bromides|bromides|mesh-list
138991086|NCT03836287|Anticonvulsants|anticonvulsants|mesh-ancestor
138991087|NCT03828019|Cyclosporine|cyclosporine|mesh-list
138991088|NCT03828019|Adalimumab|adalimumab|mesh-list
138991089|NCT03828019|Methotrexate|methotrexate|mesh-list
138991090|NCT03828019|Azathioprine|azathioprine|mesh-list
138991091|NCT03828019|Tacrolimus|tacrolimus|mesh-list
138991092|NCT03828019|Cyclosporins|cyclosporins|mesh-list
138991093|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138991094|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
138991095|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138991096|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991097|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138621233|NCT00244023|Hormones|hormones|mesh-ancestor
138991099|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991100|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991101|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
138991102|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991103|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138991104|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991105|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
138991106|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991107|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138991108|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138991109|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
138621266|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
138991110|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991111|NCT03828019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138991112|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138991113|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
138991114|NCT03819322|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138991115|NCT03819322|Velpatasvir|velpatasvir|mesh-list
138991116|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
138991117|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991118|NCT03817970|Ondansetron|ondansetron|mesh-list
138991119|NCT03817970|Palonosetron|palonosetron|mesh-list
138991120|NCT03817970|Granisetron|granisetron|mesh-list
138991121|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
138991123|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991124|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741927|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
138991125|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138991126|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
138991127|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
138991128|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138991129|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138991130|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
138991131|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138991132|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991133|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
138991134|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991135|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991136|NCT03815058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138766117|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991137|NCT03815058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991138|NCT03810742|Irinotecan|irinotecan|mesh-list
138991139|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138991140|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138991141|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991142|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991143|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991144|NCT03790670|Sargramostim|sargramostim|mesh-list
138991145|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
138991146|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991147|NCT03783494|Propofol|propofol|mesh-list
138991148|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138991149|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138991150|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991151|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138991152|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
138991153|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
138991154|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
138991155|NCT03774472|Letrozole|letrozole|mesh-list
138991156|NCT03774472|Palbociclib|palbociclib|mesh-list
138991157|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991158|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138991159|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138991160|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991161|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991162|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138991163|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
138991164|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991165|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991166|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
138991167|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138991168|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138991169|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991170|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621514|NCT00411866|Ketoconazole|ketoconazole|mesh-list
138991171|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138991178|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138991179|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138991180|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
138991181|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
138991182|NCT03666000|Fludarabine|fludarabine|mesh-list
138991183|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991184|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
138991185|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991186|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991187|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138991188|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
138991189|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991190|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991191|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138991192|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138991193|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138991195|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991196|NCT03641209|Acetaminophen|acetaminophen|mesh-list
138991197|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138991198|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138991199|NCT03641209|Analgesics|analgesics|mesh-ancestor
138991200|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
138991201|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991202|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991203|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
138991204|NCT03637062|Progesterone|progesterone|mesh-list
138991205|NCT03637062|Progestins|progestins|mesh-ancestor
138991206|NCT03637062|Hormones|hormones|mesh-ancestor
138991207|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991208|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991215|NCT03624036|Fludarabine|fludarabine|mesh-list
138991216|NCT03624036|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
138991217|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991218|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
138991219|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991220|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991221|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138991222|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
138991223|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991224|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991225|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138991226|NCT03624036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991227|NCT03618134|Durvalumab|durvalumab|mesh-list
138991228|NCT03618134|Ipilimumab|ipilimumab|mesh-list
138991229|NCT03618134|Tremelimumab|tremelimumab|mesh-list
138991230|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
138991231|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138991232|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
138991233|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991234|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991235|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
138991236|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991237|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138621751|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
138991238|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991239|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
138991240|NCT03602612|Fludarabine|fludarabine|mesh-list
138991241|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991242|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
138991243|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991244|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991245|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138991246|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
138991247|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991248|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991249|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138991251|NCT03581487|Ipilimumab|ipilimumab|mesh-list
138991252|NCT03581487|Tremelimumab|tremelimumab|mesh-list
138991253|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
138991254|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138991255|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
138991256|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991257|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991258|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
138991259|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991260|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991261|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991262|NCT03557619|Venetoclax|venetoclax|mesh-list
138991263|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
138991264|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138991265|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138991267|NCT03557619|Estrogens|estrogens|mesh-ancestor
138991268|NCT03557619|Hormones|hormones|mesh-ancestor
138991269|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991270|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991271|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138991272|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
138991273|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138742089|NCT03302234|Ipilimumab|ipilimumab|mesh-list
138991274|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138991275|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991276|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138991277|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138991278|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138991279|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138991280|NCT03498521|Bevacizumab|bevacizumab|mesh-list
138991281|NCT03498521|Carboplatin|carboplatin|mesh-list
138991282|NCT03498521|Gemcitabine|gemcitabine|mesh-list
138991283|NCT03498521|Trastuzumab|trastuzumab|mesh-list
138991284|NCT03498521|Atezolizumab|atezolizumab|mesh-list
138991285|NCT03498521|Olaparib|olaparib|mesh-list
138991286|NCT03498521|Pertuzumab|pertuzumab|mesh-list
138991287|NCT03498521|Vemurafenib|vemurafenib|mesh-list
138991288|NCT03498521|Ipatasertib|ipatasertib|mesh-list
138991289|NCT03498521|Ivosidenib|ivosidenib|mesh-list
138991290|NCT03498521|Entrectinib|entrectinib|mesh-list
138991291|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991292|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991293|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991294|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138991295|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138991296|NCT03498521|Growth Substances|growth substances|mesh-ancestor
138621907|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138991297|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991298|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
138991299|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138991300|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
138991301|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138991302|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991303|NCT03498521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991304|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138991305|NCT03483038|Irinotecan|irinotecan|mesh-list
138991306|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138991307|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138991308|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991309|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991310|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991311|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
138991312|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138991313|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991314|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621972|NCT04662385|Listerine|listerine|mesh-list
138991315|NCT03457948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991316|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991317|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138991319|NCT03442569|Ipilimumab|ipilimumab|mesh-list
138991320|NCT03442569|Panitumumab|panitumumab|mesh-list
138991321|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991323|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991324|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991325|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
138991326|NCT03420963|Etoposide|etoposide|mesh-list
138991327|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
138991328|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
138991329|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991330|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
138622022|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
138991331|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991332|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991333|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138991334|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
138991335|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991336|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991337|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138991338|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138991339|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138991340|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138991341|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991342|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
138991343|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
138991344|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
138991345|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
138991346|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
138991347|NCT03409458|Avelumab|avelumab|mesh-list
138991348|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742152|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138991349|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991350|NCT03406897|Vitamin D|vitamin d|mesh-list
138991351|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
138991352|NCT03406897|Vitamins|vitamins|mesh-ancestor
138991353|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
138991354|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991355|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138991356|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138991357|NCT03383458|Nivolumab|nivolumab|mesh-list
138991358|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991359|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991360|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991361|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991362|NCT03361852|Rituximab|rituximab|mesh-list
138991363|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
138991364|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991365|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622091|NCT04648813|Bromides|bromides|mesh-list
138766346|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
138991367|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991368|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991369|NCT03361852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991370|NCT03361852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991371|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
138991372|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991373|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991374|NCT03319745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991375|NCT03319745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991376|NCT03309150|Paclitaxel|paclitaxel|mesh-list
138991377|NCT03309150|Carboplatin|carboplatin|mesh-list
138991378|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138991379|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991380|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
138991381|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
138991382|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
138991383|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991384|NCT03263572|Cytarabine|cytarabine|mesh-list
138622126|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
138991385|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138991386|NCT03263572|Methotrexate|methotrexate|mesh-list
138991387|NCT03263572|Blinatumomab|blinatumomab|mesh-list
138991388|NCT03263572|Ponatinib|ponatinib|mesh-list
138991389|NCT03263572|Antibodies|antibodies|mesh-list
138991390|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
138991391|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138991392|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
138991393|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138991394|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
138991395|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991396|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991397|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138991398|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
138991399|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138991400|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138991401|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
138991402|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991403|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
138991404|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991405|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138991406|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991407|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991408|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138991409|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
138991410|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991411|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138991412|NCT03243058|Aldesleukin|aldesleukin|mesh-list
138991413|NCT03243058|Interleukin-2|interleukin-2|mesh-list
138991414|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991415|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138991416|NCT03243058|Analgesics|analgesics|mesh-ancestor
138766375|NCT02683369|Iron|iron|mesh-list
138991418|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991419|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991420|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138991421|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138991422|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
138991423|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991424|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138991425|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138991426|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991427|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138991428|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138991429|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138991430|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991431|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
138991432|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138991433|NCT03187080|Bupivacaine|bupivacaine|mesh-list
138991434|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
138991435|NCT03187080|Anesthetics|anesthetics|mesh-list
138991436|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138991437|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991438|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
138991439|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991440|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
138991441|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138991442|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991443|NCT03176693|Doxazosin|doxazosin|mesh-list
138991444|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
138991445|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138991446|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138991447|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138991448|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138991449|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
138991450|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138991451|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991452|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991453|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
138991454|NCT03148418|Bevacizumab|bevacizumab|mesh-list
138991455|NCT03148418|Atezolizumab|atezolizumab|mesh-list
138991456|NCT03148418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991457|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991458|NCT03148418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138991459|NCT03148418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138991460|NCT03148418|Growth Substances|growth substances|mesh-ancestor
138991461|NCT03148418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991462|NCT03148418|Growth Inhibitors|growth inhibitors|mesh-ancestor
138991463|NCT03148418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991464|NCT03148418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991465|NCT03141034|Irinotecan|irinotecan|mesh-list
138991466|NCT03141034|Ramucirumab|ramucirumab|mesh-list
138991467|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138991468|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138991469|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991470|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991471|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991472|NCT03094052|Trastuzumab|trastuzumab|mesh-list
138991473|NCT03094052|Atropine|atropine|mesh-list
138991474|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
138991475|NCT03094052|Loperamide|loperamide|mesh-list
138991476|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
138991477|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
138991478|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991479|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991480|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138991481|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138991482|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138991483|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
138991484|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991485|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991486|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138991487|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
138991488|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
138991489|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
138836213|NCT05246293|Tofacitinib|tofacitinib|mesh-list
138991490|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138991491|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138991492|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
138991493|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138991494|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991495|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138991496|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138991497|NCT03094052|Narcotics|narcotics|mesh-ancestor
138991498|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138991499|NCT03094052|Analgesics|analgesics|mesh-ancestor
138991500|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
138991501|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
138991502|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991503|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991504|NCT03092323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991505|NCT03092323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991506|NCT03083821|Entecavir|entecavir|mesh-list
138991507|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
138991508|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991510|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
138991511|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138991512|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991513|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138991514|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138991515|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991516|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991517|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991518|NCT03056001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991524|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991531|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138991532|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
138991533|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991534|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991535|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138991536|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
138991537|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138991539|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991540|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836252|NCT05114590|Lixisenatide|lixisenatide|mesh-list
138991541|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138991542|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
138991543|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
138991544|NCT03023449|Protective Agents|protective agents|mesh-ancestor
138991545|NCT02998918|Curcumin|curcumin|mesh-list
138991546|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138991547|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138991548|NCT02998918|Analgesics|analgesics|mesh-ancestor
138991549|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
138991550|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991551|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991552|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138991553|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991554|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991555|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991556|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991557|NCT02990338|Dexamethasone|dexamethasone|mesh-list
138991558|NCT02990338|Pomalidomide|pomalidomide|mesh-list
138991559|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138991560|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
138991561|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
138991562|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991563|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991564|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138991566|NCT02990338|Hormones|hormones|mesh-ancestor
138991567|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991568|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138991569|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991570|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
138991571|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138991572|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138991573|NCT02990338|Growth Substances|growth substances|mesh-ancestor
138991574|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
138991575|NCT02964182|Nicotine|nicotine|mesh-list
138991576|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138991577|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
138991578|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991579|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991580|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138991581|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138991582|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
138991583|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138991584|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991585|NCT02950766|Ipilimumab|ipilimumab|mesh-list
138991586|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991587|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991588|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991589|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991590|NCT02907983|Bupivacaine|bupivacaine|mesh-list
138991591|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
138991592|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
138991593|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138991594|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991595|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
138991596|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991597|NCT02877303|Cytarabine|cytarabine|mesh-list
138991598|NCT02877303|Dexamethasone|dexamethasone|mesh-list
138991600|NCT02877303|Prednisone|prednisone|mesh-list
138991601|NCT02877303|Cortisone|cortisone|mesh-list
138991602|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
138991603|NCT02877303|Rituximab|rituximab|mesh-list
138991604|NCT02877303|Doxorubicin|doxorubicin|mesh-list
138991605|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138991606|NCT02877303|Methotrexate|methotrexate|mesh-list
138991607|NCT02877303|Vincristine|vincristine|mesh-list
138991608|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
138991609|NCT02877303|Ofatumumab|ofatumumab|mesh-list
138991610|NCT02877303|Blinatumomab|blinatumomab|mesh-list
138991611|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138991612|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138991613|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
138991614|NCT02877303|Antibodies|antibodies|mesh-list
138991615|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
138991616|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138622721|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
138991617|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138991618|NCT02877303|BB 1101|bb 1101|mesh-list
138991619|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991620|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
138991621|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991622|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991623|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138991624|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
138991625|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991626|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991627|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138991628|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138991629|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
138991630|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
138991631|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991632|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138991633|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
138991634|NCT02877303|Hormones|hormones|mesh-ancestor
138991635|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991636|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138991637|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
138991638|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991639|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138991640|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138991641|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138991642|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138991643|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
138991644|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138991645|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138991646|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
138991647|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
138991648|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138991649|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138991650|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
138991651|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991652|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138991653|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
138991654|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
138991655|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
138991656|NCT02877303|Immunotoxins|immunotoxins|mesh-ancestor
138991657|NCT02877303|Immunoconjugates|immunoconjugates|mesh-ancestor
138991658|NCT02822378|Vitamin D|vitamin d|mesh-list
138991659|NCT02822378|Calcium|calcium|mesh-list
138991660|NCT02822378|Vitamins|vitamins|mesh-ancestor
138991661|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
138991662|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991663|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138991664|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138991665|NCT02813655|Cosyntropin|cosyntropin|mesh-list
138991666|NCT02813655|Hormones|hormones|mesh-ancestor
138991667|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991668|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991669|NCT02733042|Rituximab|rituximab|mesh-list
138991670|NCT02733042|Durvalumab|durvalumab|mesh-list
138991671|NCT02733042|Lenalidomide|lenalidomide|mesh-list
138991672|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138622885|NCT04625608|Acetaminophen|acetaminophen|mesh-list
138991673|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991674|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991675|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
138991676|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991677|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991678|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138991679|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138991680|NCT02733042|Growth Substances|growth substances|mesh-ancestor
138991681|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
138991682|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138991683|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
138991684|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991685|NCT02719574|Cytarabine|cytarabine|mesh-list
138991686|NCT02719574|Azacitidine|azacitidine|mesh-list
138991687|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138991688|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
138991689|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766629|NCT02678767|Hematinics|hematinics|mesh-ancestor
138991690|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991691|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
138991692|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991693|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991694|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
138991695|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991696|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991697|NCT02690558|Gemcitabine|gemcitabine|mesh-list
138991698|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
138991699|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991700|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138991701|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
138991702|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991703|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991704|NCT02690558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991705|NCT02689427|Paclitaxel|paclitaxel|mesh-list
138991706|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138991707|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138622946|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
138991708|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991709|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
138991710|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
138991711|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
138991712|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991714|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138991715|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991716|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138991717|NCT02673931|Incretins|incretins|mesh-ancestor
138991718|NCT02673931|Hormones|hormones|mesh-ancestor
138991719|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991720|NCT02654561|Heparin|heparin|mesh-list
138991721|NCT02654561|Calcium heparin|calcium heparin|mesh-list
138991722|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
138991723|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138991724|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138991725|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991727|NCT02614066|Fludarabine|fludarabine|mesh-list
138991728|NCT02614066|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
138488374|NCT00001011|Zidovudine|zidovudine|mesh-list
138991729|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991730|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
138991731|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991732|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991733|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138991734|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
138991735|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991736|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991737|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138766663|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
138991738|NCT02614066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991740|NCT02600949|Imiquimod|imiquimod|mesh-list
138991741|NCT02600949|Vaccines|vaccines|mesh-list
138991742|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991743|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991744|NCT02600949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991745|NCT02600949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991746|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138991747|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
138991748|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991749|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
138991750|NCT02599324|Paclitaxel|paclitaxel|mesh-list
138991751|NCT02599324|Docetaxel|docetaxel|mesh-list
138991752|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
138991753|NCT02599324|Cetuximab|cetuximab|mesh-list
138991754|NCT02599324|Everolimus|everolimus|mesh-list
138991755|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138991756|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991757|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
138991758|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
138991759|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
138991760|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991761|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138991762|NCT02599324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138991763|NCT02599324|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138991764|NCT02599324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138991765|NCT02599324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991766|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991767|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
138991768|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991769|NCT02586831|Exenatide|exenatide|mesh-list
138991770|NCT02586831|Aldesleukin|aldesleukin|mesh-list
138991771|NCT02586831|Adalimumab|adalimumab|mesh-list
138991772|NCT02586831|Interleukin-2|interleukin-2|mesh-list
138991773|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
138991774|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138991775|NCT02586831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138991777|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991778|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991779|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138991780|NCT02586831|Analgesics|analgesics|mesh-ancestor
138991781|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
138623150|NCT00220298|Testosterone|testosterone|mesh-list
138991782|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991783|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991784|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138991785|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138991786|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
138991787|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991788|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138991789|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138991791|NCT02586831|Hormones|hormones|mesh-ancestor
138991792|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991793|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
138991794|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991795|NCT02434744|Metformin|metformin|mesh-list
138991796|NCT02434744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138991797|NCT02434744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991798|NCT02432417|Chloroquine|chloroquine|mesh-list
138991799|NCT02432417|Amebicides|amebicides|mesh-ancestor
138991800|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138991801|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138991802|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991803|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
138991804|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991805|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
138991806|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138991807|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138991808|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991809|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
138991810|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
138991811|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991812|NCT02345265|Olaparib|olaparib|mesh-list
138991813|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138991814|NCT02345265|Cediranib|cediranib|mesh-list
138991815|NCT02345265|Maleic acid|maleic acid|mesh-list
138991816|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991817|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991818|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991819|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138991820|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
138991821|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991822|NCT02274155|Antibodies|antibodies|mesh-list
138991823|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
138991824|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991825|NCT02231723|Leucovorin|leucovorin|mesh-list
138991826|NCT02231723|Paclitaxel|paclitaxel|mesh-list
138991827|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138991828|NCT02231723|Gemcitabine|gemcitabine|mesh-list
138991829|NCT02231723|Fluorouracil|fluorouracil|mesh-list
138991830|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
138991831|NCT02231723|Irinotecan|irinotecan|mesh-list
138991832|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138991833|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991834|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
138991835|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
138991836|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
138991837|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991838|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138623406|NCT00562939|Vaccines|vaccines|mesh-list
138991839|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
138991840|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991841|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
138991842|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991843|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138991844|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138991845|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991846|NCT02231723|Antidotes|antidotes|mesh-ancestor
138991847|NCT02231723|Protective Agents|protective agents|mesh-ancestor
138991848|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
138991849|NCT02231723|Vitamins|vitamins|mesh-ancestor
138991850|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
138991851|NCT02198404|Propofol|propofol|mesh-list
138991852|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138991853|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138991854|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991855|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138991856|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
138991857|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
138991858|NCT02131597|Guadecitabine|guadecitabine|mesh-list
138991859|NCT02131597|Azacitidine|azacitidine|mesh-list
138991860|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991861|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138991862|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
138991863|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991864|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991865|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138991866|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138991867|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991868|NCT01824875|Capecitabine|capecitabine|mesh-list
138991869|NCT01824875|Temozolomide|temozolomide|mesh-list
138991870|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138991871|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
138991872|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991873|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991874|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138991876|NCT01765218|Topiramate|topiramate|mesh-list
138836452|NCT02859896|Vitamins|vitamins|mesh-ancestor
138991877|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
138991878|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138623517|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
138991879|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991880|NCT01756040|Lactulose|lactulose|mesh-list
138991881|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138991882|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138991883|NCT01500473|Desogestrel|desogestrel|mesh-list
138991884|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138991885|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138991886|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138991887|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
138991888|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138991889|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991890|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138991891|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138991893|NCT01500473|Hormones|hormones|mesh-ancestor
138991894|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991895|NCT01306357|Hormones|hormones|mesh-list
138991896|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991897|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991898|NCT01294020|Tacrolimus|tacrolimus|mesh-list
138991899|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991900|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
138991901|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991902|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138991903|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623632|NCT06177964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991904|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991905|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
138991906|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138991907|NCT01219075|Estrogens|estrogens|mesh-ancestor
138991908|NCT01219075|Hormones|hormones|mesh-ancestor
138991909|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991910|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991911|NCT00871936|Metformin|metformin|mesh-list
138991912|NCT00871936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138991913|NCT00871936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991915|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138991916|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138991917|NCT00741910|Analgesics|analgesics|mesh-ancestor
138991918|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
138991919|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836479|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991920|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991921|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138991922|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991923|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991924|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
138991925|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
138991926|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138991927|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138991928|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138991929|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138991930|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138991931|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991932|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991933|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991934|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138991935|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
138623757|NCT06176911|Hormone Antagonists|hormone antagonists|mesh-ancestor
138991936|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138991937|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991938|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138991939|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138991940|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138991941|NCT00736931|Levetiracetam|levetiracetam|mesh-list
138991942|NCT00736931|Lorazepam|lorazepam|mesh-list
138991943|NCT00736931|Brivaracetam|brivaracetam|mesh-list
138991944|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
138991945|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
138991946|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
138991947|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
138991948|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991949|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991950|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138766819|NCT00928486|Dexamethasone|dexamethasone|mesh-list
138991951|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138991952|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138623817|NCT06167057|Gemcitabine|gemcitabine|mesh-list
138991953|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138991954|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138991955|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138991956|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
138991957|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
138991958|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138991959|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991960|NCT00567164|Drospirenone|drospirenone|mesh-list
138991961|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138991962|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
138991963|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991964|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991965|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138991966|NCT00567164|Diuretics|diuretics|mesh-ancestor
138991967|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
138991968|NCT00920933|Prednisolone|prednisolone|mesh-list
138991969|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138991970|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
138991971|NCT00920933|Hormones|hormones|mesh-ancestor
138991972|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138991973|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991974|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138991975|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991976|NCT00930566|Methoxsalen|methoxsalen|mesh-list
138991977|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138991978|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
138991979|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
138991980|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138991981|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138991982|NCT00925730|Analgesics|analgesics|mesh-ancestor
138991983|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
138991984|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138991985|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138991986|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138991987|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138991988|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
138991989|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138991990|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
138991991|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138991992|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138991993|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138991994|NCT00713219|Docetaxel|docetaxel|mesh-list
138991995|NCT00713219|Cetuximab|cetuximab|mesh-list
138991996|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138991997|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
138991998|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
138991999|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
138623983|NCT06015659|Antimetabolites|antimetabolites|mesh-ancestor
138992000|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992001|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138992002|NCT00931580|Vitamin D|vitamin d|mesh-list
138992003|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
138992004|NCT00931580|Vitamins|vitamins|mesh-ancestor
138992005|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
138992006|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992007|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138992008|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138992009|NCT00931736|Rifampin|rifampin|mesh-list
138992010|NCT00931736|Isoniazid|isoniazid|mesh-list
138992011|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138992012|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
138992013|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138992014|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992015|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
138624048|NCT05988671|Hormones|hormones|mesh-ancestor
138992016|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138992017|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992018|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992019|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138992020|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138992021|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138992022|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138992023|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138992024|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138992025|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138992026|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138992027|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
138992028|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138992029|NCT02567981|Vitamin A|vitamin a|mesh-list
138992030|NCT02567981|Micronutrients|micronutrients|mesh-list
138992031|NCT02567981|Trace Elements|trace elements|mesh-list
138992032|NCT02567981|Vitamins|vitamins|mesh-ancestor
138766878|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
138992033|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992035|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992036|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992037|NCT00932048|Atorvastatin|atorvastatin|mesh-list
138992038|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138992039|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138992040|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
138992041|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992042|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138992043|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138992044|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992045|NCT04015778|Paclitaxel|paclitaxel|mesh-list
138992046|NCT04015778|Carboplatin|carboplatin|mesh-list
138992047|NCT04015778|Nivolumab|nivolumab|mesh-list
138992048|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138992049|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992050|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
138992051|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
138992052|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
138992053|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992054|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138992055|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138992056|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
138992057|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138992058|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
138992059|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992060|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992061|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138992062|NCT00926354|Protective Agents|protective agents|mesh-ancestor
138992063|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138992064|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138992065|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992066|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992067|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
138992068|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992069|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
138992070|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138992071|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992072|NCT00737789|Mesalamine|mesalamine|mesh-list
138992073|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138992074|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138992075|NCT00737789|Analgesics|analgesics|mesh-ancestor
138992076|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
138836614|NCT00106587|Paclitaxel|paclitaxel|mesh-list
138992077|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992078|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992079|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138992080|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138992081|NCT00700115|Ritonavir|ritonavir|mesh-list
138992082|NCT00700115|Lopinavir|lopinavir|mesh-list
138992083|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
138992084|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138992085|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138992086|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138992087|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
138992088|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992089|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992090|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138992091|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
138992092|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992093|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138992094|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138992096|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138992097|NCT05556473|Tryptophan|tryptophan|mesh-list
138992098|NCT05556473|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138992099|NCT05556473|Antidepressive Agents|antidepressive agents|mesh-ancestor
138992100|NCT05556473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138992101|NCT00566852|Memantine|memantine|mesh-list
138992102|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138992103|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138992104|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
138992105|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138992106|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992107|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992108|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138992109|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138992110|NCT00936650|Cinacalcet|cinacalcet|mesh-list
138992111|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138992112|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992113|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138992114|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
138992115|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138992116|NCT00442546|Pregabalin|pregabalin|mesh-list
138992117|NCT00442546|Analgesics|analgesics|mesh-ancestor
138992118|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
138992119|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992120|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992121|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
138992122|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138992123|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138624335|NCT05351554|Prednisone|prednisone|mesh-list
138992124|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992125|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138297105|NCT00002665|Vitamins|vitamins|mesh-ancestor
138992126|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138992127|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138992128|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138992129|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138992131|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
138992132|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992133|NCT00514683|Nintedanib|nintedanib|mesh-list
138992134|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992135|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138992136|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992137|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992138|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
138992139|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
138992140|NCT00566696|Melphalan|melphalan|mesh-list
138992141|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
138992142|NCT00566696|Thiotepa|thiotepa|mesh-list
138992143|NCT00566696|Rituximab|rituximab|mesh-list
138992144|NCT00566696|Fludarabine|fludarabine|mesh-list
138992145|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
138992146|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
138992147|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138992148|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
138992149|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138992150|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
138992151|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992152|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138992153|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138992154|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
138992155|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992156|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992157|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138992158|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138992159|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138992160|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138992161|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
138992162|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138992163|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992164|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992165|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
138992166|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
138992167|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
138992168|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138624437|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
138992169|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992170|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
138992171|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992172|NCT00926900|Cycloserine|cycloserine|mesh-list
138992173|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138992174|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992175|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138992176|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
138992177|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138992178|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
138992179|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992180|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138992181|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992182|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138992183|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992184|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992185|NCT00937508|Varenicline|varenicline|mesh-list
138992186|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138992187|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138992188|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
138992189|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138992190|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992191|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624489|NCT05088980|Lidocaine|lidocaine|mesh-list
138992192|NCT00937664|Gemcitabine|gemcitabine|mesh-list
138992193|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138992194|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
138992195|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992196|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992197|NCT00937820|Darexaban|darexaban|mesh-list
138992198|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138992199|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
138992200|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138992201|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
138992202|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992203|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992205|NCT00506883|Colchicine|colchicine|mesh-list
138992207|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138992208|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
138992209|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
138992210|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
138992211|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992212|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992213|NCT01028638|Bevacizumab|bevacizumab|mesh-list
138992214|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
138992215|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138992216|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992217|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138992218|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138992219|NCT01028638|Growth Substances|growth substances|mesh-ancestor
138992220|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992221|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
138992222|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138992223|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992224|NCT00938132|Warfarin|warfarin|mesh-list
138992225|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
138992226|NCT01023334|Lidocaine|lidocaine|mesh-list
138992227|NCT01023334|Anesthetics|anesthetics|mesh-list
138992228|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
138992229|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138992230|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992231|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
138992232|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992234|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138992235|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138992236|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138992237|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992238|NCT00938522|Cilostazol|cilostazol|mesh-list
138992239|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138992240|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
138992241|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992242|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992243|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138992244|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
138992245|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138992246|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138992247|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992248|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138992249|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
138992250|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138992251|NCT00938522|Protective Agents|protective agents|mesh-ancestor
138992252|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138992253|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138992254|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992255|NCT00938600|Vitamin D|vitamin d|mesh-list
138992256|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
138992257|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
138992259|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
138992260|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992261|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138992262|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138992263|NCT00503685|Cetuximab|cetuximab|mesh-list
138992264|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138992265|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992266|NCT00712673|Metformin|metformin|mesh-list
138992267|NCT00712673|Lixisenatide|lixisenatide|mesh-list
138992268|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138992269|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992270|NCT01562990|Rituximab|rituximab|mesh-list
138992271|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138992272|NCT01562990|Gemcitabine|gemcitabine|mesh-list
138992273|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
138992274|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138992275|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624776|NCT04151667|Dexamethasone|dexamethasone|mesh-list
138992277|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992278|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138992279|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138992280|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
138836775|NCT00976937|Metformin|metformin|mesh-list
138992281|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992282|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138992283|NCT01562990|Immunotoxins|immunotoxins|mesh-ancestor
138992284|NCT01562990|Immunoconjugates|immunoconjugates|mesh-ancestor
138992285|NCT00737867|Carboplatin|carboplatin|mesh-list
138992286|NCT00737867|Gemcitabine|gemcitabine|mesh-list
138992287|NCT00737867|Vinorelbine|vinorelbine|mesh-list
138992288|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992289|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138992290|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
138992291|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992292|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138992293|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
138992294|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
138992295|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
138992296|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138992297|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138992298|NCT03976466|Calcium|calcium|mesh-list
138992299|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138992300|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992301|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992302|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
138992303|NCT02536755|Eliglustat|eliglustat|mesh-list
138992304|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992305|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992306|NCT02567279|Denosumab|denosumab|mesh-list
138992307|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138992308|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992309|NCT00933374|Paclitaxel|paclitaxel|mesh-list
138992310|NCT00933374|Everolimus|everolimus|mesh-list
138992311|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138992312|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992314|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
138992315|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
138992316|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992317|NCT00933374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138992318|NCT00933374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138992319|NCT00933374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992320|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138992321|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
138767198|NCT05906576|Infliximab|infliximab|mesh-list
138992322|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992323|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138992324|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
138992325|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992326|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138992327|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138992328|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138992329|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138992330|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992332|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992334|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
138992335|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992336|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
138992337|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138992338|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
138992340|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138992341|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
138992342|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
138992343|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992344|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
138992345|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138992346|NCT00938990|Midazolam|midazolam|mesh-list
138992347|NCT00938990|Etomidate|etomidate|mesh-list
138992348|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138992349|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138992350|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138992351|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992352|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138992353|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138992354|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138992355|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138992356|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
138992357|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
138992358|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
138992359|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
138992360|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138992361|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992362|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
138992363|NCT00933998|Pyridoxal|pyridoxal|mesh-list
138992364|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
138992365|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
138992366|NCT00933998|Vitamins|vitamins|mesh-ancestor
138767250|NCT05879835|Heparin|heparin|mesh-list
138992367|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
138992368|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992369|NCT00447226|Lapatinib|lapatinib|mesh-list
138992370|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992371|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138992372|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992373|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992374|NCT00446992|Olanzapine|olanzapine|mesh-list
138992375|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
138992376|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
138992377|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992378|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992379|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138992380|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138992381|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138992382|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138992383|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138992384|NCT00446992|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138992385|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138992386|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138992387|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992388|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138992389|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
138992390|NCT00503139|Etanercept|etanercept|mesh-list
138992391|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138992392|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138992393|NCT00503139|Analgesics|analgesics|mesh-ancestor
138992394|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
138992395|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992396|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992397|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138992399|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138992400|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138992401|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
138992403|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
138992404|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138992405|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992406|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138992407|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138992408|NCT00577031|Growth Substances|growth substances|mesh-ancestor
138992409|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992411|NCT00565448|Docetaxel|docetaxel|mesh-list
138992412|NCT00565448|Fluorouracil|fluorouracil|mesh-list
138992413|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992414|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
138992415|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
138992416|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
138992417|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992418|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
138992419|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138992420|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138992421|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
138992422|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992424|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992425|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138992426|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992427|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992428|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138992429|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992430|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138992431|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992432|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992433|NCT00934154|Thalidomide|thalidomide|mesh-list
138992434|NCT00934154|Prednisolone|prednisolone|mesh-list
138992435|NCT00934154|Melphalan|melphalan|mesh-list
138992436|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138992437|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
138992438|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992439|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992440|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138992441|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138992442|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
138992443|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992444|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138992445|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
138992447|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138992448|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138992449|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
138992450|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138992451|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992452|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138836904|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
138992453|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138625291|NCT02727803|Antibodies|antibodies|mesh-list
138992454|NCT00934154|Growth Substances|growth substances|mesh-ancestor
138992455|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
138992456|NCT00446446|Panitumumab|panitumumab|mesh-list
138992457|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138992458|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992459|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
138992460|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138992461|NCT05078255|Incretins|incretins|mesh-ancestor
138992462|NCT05078255|Hormones|hormones|mesh-ancestor
138992463|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138992464|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992465|NCT00939458|Lamotrigine|lamotrigine|mesh-list
138992466|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
138992467|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138992468|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138992469|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992470|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138992471|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992472|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138992473|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138992474|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138992475|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138992476|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138992477|NCT02566967|Tofacitinib|tofacitinib|mesh-list
138992478|NCT02566967|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138992479|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138743273|NCT02869321|Fentanyl|fentanyl|mesh-list
138625344|NCT02626338|Analgesics|analgesics|mesh-ancestor
138992480|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992481|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992482|NCT00939068|Telbivudine|telbivudine|mesh-list
138992483|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
138992484|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992485|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138992486|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992487|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992488|NCT00934232|Busulfan|busulfan|mesh-list
138992489|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
138992490|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992491|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138992492|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
138992493|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992494|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138992495|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992496|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138992497|NCT01013571|Insulin|insulin|mesh-list
138992498|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138992499|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
138992500|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
138625382|NCT02379520|Nivolumab|nivolumab|mesh-list
138992501|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138992502|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992503|NCT00514449|Valacyclovir|valacyclovir|mesh-list
138992504|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
138992505|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992506|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
138992507|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138992508|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
138992509|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992510|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138992511|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138992512|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
138992513|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992514|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992515|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138992516|NCT00738257|Pamidronate|pamidronate|mesh-list
138992517|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138992518|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992519|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138992520|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992521|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138992522|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992523|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992524|NCT00502671|Capecitabine|capecitabine|mesh-list
138992525|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138992526|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
138992527|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992528|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992529|NCT00738413|Deferasirox|deferasirox|mesh-list
138992530|NCT00738413|Deferoxamine|deferoxamine|mesh-list
138992531|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138992532|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
138992533|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
138992534|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992535|NCT00738413|Siderophores|siderophores|mesh-ancestor
138992536|NCT00697463|Teriparatide|teriparatide|mesh-list
138992537|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138992538|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992539|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138992540|NCT04409795|Metformin|metformin|mesh-list
138992541|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138992542|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138992543|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992544|NCT04409795|Incretins|incretins|mesh-ancestor
138992545|NCT04409795|Hormones|hormones|mesh-ancestor
138992546|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138992547|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138992548|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
138992549|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992550|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992551|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
138992552|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
138992553|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
138992554|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138992555|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625479|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138992556|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992559|NCT01015209|Chitosan|chitosan|mesh-list
138992560|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138992561|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138992562|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138992563|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
138992564|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992565|NCT01015209|Expectorants|expectorants|mesh-ancestor
138992566|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
138992567|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138992568|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
138992569|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992570|NCT01015209|Protective Agents|protective agents|mesh-ancestor
138837015|NCT02619669|Letrozole|letrozole|mesh-list
138992571|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992572|NCT01015209|Antidotes|antidotes|mesh-ancestor
138992573|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138992574|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138992575|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
138992576|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138992577|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
138992578|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
138992579|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
138992580|NCT01015209|Coagulants|coagulants|mesh-ancestor
138992582|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
138992583|NCT04948463|Tazobactam|tazobactam|mesh-list
138992584|NCT04948463|Piperacillin|piperacillin|mesh-list
138992585|NCT04948463|Amikacin|amikacin|mesh-list
138992586|NCT04948463|Ceftazidime|ceftazidime|mesh-list
138992587|NCT04948463|Cefepime|cefepime|mesh-list
138992588|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138992589|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992590|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138992591|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138992592|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992593|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992594|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992595|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138992596|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138992597|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138992598|NCT01080547|Capecitabine|capecitabine|mesh-list
138992599|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
138992600|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138992601|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
138992602|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992603|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992605|NCT00111241|Anastrozole|anastrozole|mesh-list
138992606|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138992607|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992608|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138992610|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992611|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138992612|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
138992613|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138992614|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992615|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138992616|NCT00492297|Sorafenib|sorafenib|mesh-list
138992617|NCT00492297|Dacarbazine|dacarbazine|mesh-list
138992618|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992619|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138992620|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059174|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992621|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992622|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138992623|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
138992624|NCT00446134|Ribavirin|ribavirin|mesh-list
138992625|NCT00446134|Taribavirin|taribavirin|mesh-list
138992626|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
138992627|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992628|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
138992629|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992630|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
138992631|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
138992632|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
138992633|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138992634|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138992635|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138992636|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992637|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992638|NCT00921245|Darifenacin|darifenacin|mesh-list
138992639|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138992640|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138992641|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
138992642|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138992643|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992644|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992645|NCT00921245|Urological Agents|urological agents|mesh-ancestor
138992647|NCT00940238|Citalopram|citalopram|mesh-list
138992648|NCT00940238|Escitalopram|escitalopram|mesh-list
138992649|NCT00940238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138992650|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138992651|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138992652|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992653|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138992654|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
138992655|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992656|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138992657|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
138992658|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138992659|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138992660|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138992661|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
138992662|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
138992663|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992664|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138992665|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138992666|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
138992667|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138992668|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138992669|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
138992670|NCT04013438|Estradiol|estradiol|mesh-list
138992671|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138992672|NCT04013438|Estrogens|estrogens|mesh-ancestor
138992673|NCT04013438|Hormones|hormones|mesh-ancestor
138992674|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138992675|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992676|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138992677|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
138992678|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138992679|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138992680|NCT04013438|Urological Agents|urological agents|mesh-ancestor
138992682|NCT02565719|Tenofovir|tenofovir|mesh-list
138992683|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
138992684|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
138992685|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138992686|NCT02565719|REP 2139|rep 2139|mesh-list
138992687|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992688|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
138992689|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992690|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138992691|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138992692|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992693|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992694|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138992695|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138992696|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
138992697|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992698|NCT00111007|Paclitaxel|paclitaxel|mesh-list
138992699|NCT00111007|Carboplatin|carboplatin|mesh-list
138992700|NCT00111007|Sorafenib|sorafenib|mesh-list
138992701|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138992702|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992703|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
138992704|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
138992705|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
138992706|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992707|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138992708|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992709|NCT00699335|Fentanyl|fentanyl|mesh-list
138992710|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138992711|NCT00699335|Narcotics|narcotics|mesh-ancestor
138992712|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138992713|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992714|NCT00699335|Analgesics|analgesics|mesh-ancestor
138992715|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
138992716|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992717|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138992718|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138992719|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
138992720|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
138992721|NCT00939614|Lamotrigine|lamotrigine|mesh-list
138992722|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
138992723|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138992724|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138992725|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992726|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138992727|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992728|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138992729|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138992730|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138992731|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138992732|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138992733|NCT03962881|Vaccines|vaccines|mesh-list
138992734|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
138992735|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992736|NCT00935246|Dexetimide|dexetimide|mesh-list
138992737|NCT00935246|Citalopram|citalopram|mesh-list
138992738|NCT00935246|Escitalopram|escitalopram|mesh-list
138566970|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
138992739|NCT00935246|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138992740|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138992741|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138992742|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992744|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
138767684|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
138992745|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992746|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138992747|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138992748|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
138992749|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
138992750|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992751|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138992752|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138992753|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
138992754|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138992755|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
138992756|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138992757|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
138992758|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138992759|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138992760|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
138992761|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992762|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138992763|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138992764|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992765|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992767|NCT00939848|Gemcitabine|gemcitabine|mesh-list
138992768|NCT00939848|Cediranib|cediranib|mesh-list
138992769|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992770|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138992771|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
138992772|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992773|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138992774|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992775|NCT04013048|Fluzoparib|fluzoparib|mesh-list
138992776|NCT04013048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138992777|NCT04013048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767723|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
138992778|NCT04013048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992779|NCT04013048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743576|NCT01018732|Lactitol|lactitol|mesh-list
138992780|NCT00935558|Interleukin-2|interleukin-2|mesh-list
138992781|NCT00935558|Exemestane|exemestane|mesh-list
138992782|NCT00935558|Anastrozole|anastrozole|mesh-list
138992783|NCT00935558|Letrozole|letrozole|mesh-list
138992784|NCT00935558|Lactitol|lactitol|mesh-list
138992785|NCT00935558|Vaccines|vaccines|mesh-list
138992786|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138992787|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
138992788|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992789|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992790|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138992791|NCT00935558|Analgesics|analgesics|mesh-ancestor
138992792|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
138992793|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992794|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138992795|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992796|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992797|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138992798|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
138992799|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138992800|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138992801|NCT00935558|Cathartics|cathartics|mesh-ancestor
138992802|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138992803|NCT05280236|Propofol|propofol|mesh-list
138992804|NCT05280236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138992805|NCT05280236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138992806|NCT05280236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625982|NCT00222482|Valproic Acid|valproic acid|mesh-list
138992807|NCT05280236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138992808|NCT05280236|Anesthetics, General|anesthetics, general|mesh-ancestor
138992809|NCT05280236|Anesthetics|anesthetics|mesh-ancestor
138992810|NCT00940472|Metformin|metformin|mesh-list
138992811|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138992812|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992813|NCT00939926|Risperidone|risperidone|mesh-list
138992814|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138992815|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
138992816|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138992817|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992818|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992819|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138992820|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138767776|NCT02547987|Carboplatin|carboplatin|mesh-list
138992821|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138992822|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138992823|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138992825|NCT00940550|Melatonin|melatonin|mesh-list
138992826|NCT00940550|Zolpidem|zolpidem|mesh-list
138992827|NCT00940550|Temazepam|temazepam|mesh-list
138992828|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
138992829|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992831|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992832|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138992833|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138992834|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138992835|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138992836|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
138992837|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
138992838|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138992839|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138992840|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138992841|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138992842|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
138992843|NCT00940628|Orlistat|orlistat|mesh-list
138992844|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992845|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992846|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138992847|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138992848|NCT00936182|Fluconazole|fluconazole|mesh-list
138992849|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
138992850|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992851|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138992852|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138992853|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992854|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992855|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138992856|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
138992857|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138992858|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992859|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138992860|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138992861|NCT00936260|Alendronate|alendronate|mesh-list
138992862|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138992863|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992864|NCT00445978|Verapamil|verapamil|mesh-list
138992865|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138992866|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138992867|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138992868|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992869|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138992870|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992871|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
138992872|NCT02566733|Remifentanil|remifentanil|mesh-list
138992873|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138992874|NCT02566733|Narcotics|narcotics|mesh-ancestor
138992875|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138992876|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992877|NCT02566733|Analgesics|analgesics|mesh-ancestor
138992878|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
138767846|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
138992879|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992880|NCT01028950|Darexaban|darexaban|mesh-list
138992881|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138992882|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
138992883|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138992884|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
138626221|NCT04606537|Rifampin|rifampin|mesh-list
138992885|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992886|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992887|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
138992889|NCT00940784|Clopidogrel|clopidogrel|mesh-list
138992890|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138992891|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138992892|NCT00940784|Analgesics|analgesics|mesh-ancestor
138992893|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
138992894|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992895|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992896|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138992897|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138992898|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138992899|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138992900|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992901|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138992902|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138992903|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992904|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
138992905|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138992906|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138992907|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138992908|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
138992909|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138992910|NCT01023490|Vitamin D|vitamin d|mesh-list
138992911|NCT01023490|Vitamins|vitamins|mesh-ancestor
138992912|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
138992913|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992914|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138992915|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
138992916|NCT00698009|Fludarabine|fludarabine|mesh-list
138992917|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
138992919|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138992920|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
138992921|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992922|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138992923|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138992924|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
138992925|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992926|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992927|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138992928|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138992929|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
138992930|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138992931|NCT00698009|Analgesics|analgesics|mesh-ancestor
138992932|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
138992933|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992934|NCT00944606|Vitamin D|vitamin d|mesh-list
138992935|NCT00944606|Vitamins|vitamins|mesh-ancestor
138992936|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
138992937|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992938|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138992939|NCT00944684|Ribavirin|ribavirin|mesh-list
138992940|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
138992941|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992942|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
138992943|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992944|NCT04061057|Lidocaine|lidocaine|mesh-list
138992945|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
138992946|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
138992947|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138992948|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992949|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
138992950|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138992951|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138992952|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138992953|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138992954|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138992955|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992956|NCT00921167|Bevacizumab|bevacizumab|mesh-list
138992957|NCT00921167|Irinotecan|irinotecan|mesh-list
138992958|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138992959|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992961|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138992962|NCT00921167|Growth Substances|growth substances|mesh-ancestor
138992963|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992964|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
138992965|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138992966|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138992967|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992968|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992969|NCT04061447|Clarithromycin|clarithromycin|mesh-list
138992970|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138992971|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138992972|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138992973|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138992974|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992975|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138992976|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138992977|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138992978|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
138992979|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992980|NCT02565953|Paclitaxel|paclitaxel|mesh-list
138767975|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992981|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138992982|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992983|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
138992984|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
138992985|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
138626398|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138992986|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992987|NCT00562718|Capecitabine|capecitabine|mesh-list
138992988|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138992989|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
138992990|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138992991|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992992|NCT05222165|Infigratinib|infigratinib|mesh-list
138992993|NCT05222165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992994|NCT04555811|Rituximab|rituximab|mesh-list
138992995|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138992996|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138992997|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
138992998|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138992999|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138993000|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
138993001|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138993002|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993003|NCT02566187|Atorvastatin|atorvastatin|mesh-list
138743802|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
138993004|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138993005|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138993006|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
138993007|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993009|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138993010|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993012|NCT05324891|Dexmedetomidine|dexmedetomidine|mesh-list
138993013|NCT05324891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138993014|NCT05324891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138993015|NCT05324891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993016|NCT05324891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138993017|NCT05324891|Analgesics|analgesics|mesh-ancestor
138993018|NCT05324891|Sensory System Agents|sensory system agents|mesh-ancestor
138626500|NCT04601116|Atorvastatin|atorvastatin|mesh-list
138993019|NCT05324891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993020|NCT05324891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138993021|NCT05324891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138993022|NCT05324891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138993023|NCT05324891|Adrenergic Agents|adrenergic agents|mesh-ancestor
138993024|NCT05324891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993025|NCT05324891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993026|NCT05324891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138993027|NCT05324891|Narcotics|narcotics|mesh-ancestor
138993028|NCT05324891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138993029|NCT05324891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138993030|NCT05324891|Anesthetics, General|anesthetics, general|mesh-ancestor
138993031|NCT05324891|Anesthetics|anesthetics|mesh-ancestor
138993032|NCT00445432|Adalimumab|adalimumab|mesh-list
138993033|NCT00445432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138993034|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993035|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138993037|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138993038|NCT00696137|Narcotics|narcotics|mesh-ancestor
138567218|NCT00567580|Leuprolide|leuprolide|mesh-list
138993039|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138993040|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993041|NCT00696137|Analgesics|analgesics|mesh-ancestor
138993042|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
138993043|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993044|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138993045|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138993046|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
138993047|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
138993048|NCT02565641|Gemcitabine|gemcitabine|mesh-list
138993049|NCT02565641|Capecitabine|capecitabine|mesh-list
138993050|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138993051|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
138993052|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993053|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993054|NCT04036721|Prednisone|prednisone|mesh-list
138993055|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993056|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
138993057|NCT04036721|Hormones|hormones|mesh-ancestor
138993058|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138993059|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993060|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138993061|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993062|NCT00441142|Temozolomide|temozolomide|mesh-list
138993063|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138993064|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
138993065|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993066|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993067|NCT03848416|Ixekizumab|ixekizumab|mesh-list
138993068|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
138993069|NCT01029418|Sorafenib|sorafenib|mesh-list
138993070|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993071|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138993072|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993073|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993074|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
138993075|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138993076|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
138993077|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993078|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993079|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138993080|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
138993081|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138993082|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
138993083|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993084|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993085|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138993086|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
138993087|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
138993088|NCT04060979|Protective Agents|protective agents|mesh-ancestor
138993090|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138993091|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138993092|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
138993093|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993094|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993095|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138993096|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138993097|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
138993098|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993100|NCT00444106|Lumefantrine|lumefantrine|mesh-list
138993101|NCT00444106|Artemether|artemether|mesh-list
138993102|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138993103|NCT00444106|Mefloquine|mefloquine|mesh-list
138993104|NCT00444106|Atovaquone|atovaquone|mesh-list
138993105|NCT00444106|Proguanil|proguanil|mesh-list
138993106|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138993107|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
138993108|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138993109|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138993110|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993111|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993112|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
138993113|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
138993114|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138993115|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
138993116|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993117|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993118|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
138993119|NCT00561470|Leucovorin|leucovorin|mesh-list
138993120|NCT00561470|Fluorouracil|fluorouracil|mesh-list
138993121|NCT00561470|Irinotecan|irinotecan|mesh-list
138993122|NCT00561470|Aflibercept|aflibercept|mesh-list
138993123|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
138993124|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
138993125|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993126|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138993127|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993128|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138993129|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
138993130|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993131|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138993132|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138993133|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993134|NCT00561470|Antidotes|antidotes|mesh-ancestor
138993135|NCT00561470|Protective Agents|protective agents|mesh-ancestor
138993136|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
138993137|NCT00561470|Vitamins|vitamins|mesh-ancestor
138993138|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
138993139|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138993140|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138567280|NCT00088049|Olanzapine|olanzapine|mesh-list
138993141|NCT00561470|Growth Substances|growth substances|mesh-ancestor
138993142|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
138993143|NCT00443872|Selegiline|selegiline|mesh-list
138993144|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
138993145|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138993146|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138993147|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138993148|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138993149|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993150|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993151|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138993152|NCT00443872|Protective Agents|protective agents|mesh-ancestor
138993153|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993154|NCT01323244|Simeprevir|simeprevir|mesh-list
138993155|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
138993156|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993157|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
138993158|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993159|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993160|NCT03034642|Dimercaprol|dimercaprol|mesh-list
138993162|NCT03034642|Sequestering Agents|sequestering agents|mesh-ancestor
138993163|NCT03034642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993164|NCT03962738|Lasmiditan|lasmiditan|mesh-list
138993165|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138993166|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
138993167|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993168|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993169|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993170|NCT00561392|Rivastigmine|rivastigmine|mesh-list
138993171|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138993172|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626875|NCT00566761|Triamcinolone|triamcinolone|mesh-list
138993173|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993174|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
138993175|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993176|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993177|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138993178|NCT00561392|Protective Agents|protective agents|mesh-ancestor
138993179|NCT00694109|Mipomersen|mipomersen|mesh-list
138626940|NCT04593160|Diclofenac|diclofenac|mesh-list
138993180|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138993181|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138993182|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
138993183|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993184|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138993185|NCT03070301|Everolimus|everolimus|mesh-list
138993186|NCT03070301|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138993187|NCT03070301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138993188|NCT03070301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993189|NCT03070301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993190|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138993191|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
138993192|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993193|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993194|NCT00940862|Adalimumab|adalimumab|mesh-list
138993195|NCT00940862|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138993196|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993198|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
138993199|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138993200|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993201|NCT00561080|Vaccines|vaccines|mesh-list
138993202|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
138993203|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993204|NCT01307306|Metformin|metformin|mesh-list
138993205|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138993206|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993207|NCT00941096|Timolol|timolol|mesh-list
138993208|NCT00941096|Bimatoprost|bimatoprost|mesh-list
138993209|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138993210|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138993211|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
138993212|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993213|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993214|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993215|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138993216|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138993217|NCT04012424|Curcumin|curcumin|mesh-list
138993218|NCT04012424|Analgesics|analgesics|mesh-list
138993219|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138567336|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993220|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138993221|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
138993222|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993223|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993224|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993225|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138993226|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993227|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993228|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993229|NCT00562094|Pantoprazole|pantoprazole|mesh-list
138993230|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138993231|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138993232|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138993233|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993234|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993235|NCT03817853|Prednisone|prednisone|mesh-list
138993236|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
138993237|NCT03817853|Prednisolone|prednisolone|mesh-list
138993238|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
138993239|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138993240|NCT03817853|Doxorubicin|doxorubicin|mesh-list
138993241|NCT03817853|Vincristine|vincristine|mesh-list
138993242|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
138993243|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138993244|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
138993245|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993246|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138993247|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138993248|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
138993249|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993250|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993251|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138993252|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138993253|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138993254|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138993255|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993256|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993257|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
138993258|NCT03817853|Hormones|hormones|mesh-ancestor
138768101|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993259|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138993260|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138993261|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138993262|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
138993263|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
138993264|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
138993266|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
138993267|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993268|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138993269|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138993270|NCT03817853|Protective Agents|protective agents|mesh-ancestor
138993271|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138993272|NCT00944840|Amodiaquine|amodiaquine|mesh-list
138993273|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
138993274|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138993275|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138993276|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993278|NCT00439270|Dasatinib|dasatinib|mesh-list
138993279|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993280|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
138993281|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
138993282|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
138993283|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993284|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138993285|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993286|NCT00944918|Fulvestrant|fulvestrant|mesh-list
138993287|NCT00944918|Anastrozole|anastrozole|mesh-list
138993288|NCT00944918|Exemestane|exemestane|mesh-list
138993289|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138993290|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993291|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138993292|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138993293|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
138993294|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138993295|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993296|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138993297|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138993298|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993299|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993300|NCT04012268|Aspirin|aspirin|mesh-list
138993301|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138993302|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138993303|NCT04012268|Analgesics|analgesics|mesh-ancestor
138993304|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
138993305|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993306|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993307|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993308|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138993310|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138993311|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993312|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138993313|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138993314|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993315|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
138627255|NCT00253617|Trioxsalen|trioxsalen|mesh-list
138993316|NCT03995134|Remifentanil|remifentanil|mesh-list
138993317|NCT03995134|Propofol|propofol|mesh-list
138993318|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138993319|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138993320|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993321|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138993322|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
138993323|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
138993324|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138683224|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
138993326|NCT03995134|Analgesics|analgesics|mesh-ancestor
138993327|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
138993328|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993329|NCT00553280|Pregabalin|pregabalin|mesh-list
138993330|NCT00553280|Analgesics|analgesics|mesh-ancestor
138627317|NCT00253773|Analgesics|analgesics|mesh-ancestor
138993331|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
138993332|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993333|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993334|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
138993335|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138993336|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138993337|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993338|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138993339|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138993340|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138993341|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627378|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
138993342|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138993344|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138993345|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138993346|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138993347|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993348|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138993349|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
138993350|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
138993351|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627440|NCT00568048|Growth Substances|growth substances|mesh-ancestor
138993352|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993354|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138993355|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
138993356|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138993357|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993358|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138993359|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138993360|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
138993361|NCT00944996|Citalopram|citalopram|mesh-list
138993362|NCT00944996|Fluoxetine|fluoxetine|mesh-list
138993363|NCT00944996|Paroxetine|paroxetine|mesh-list
138993364|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138993365|NCT00944996|Sertraline|sertraline|mesh-list
138993366|NCT00944996|Clomipramine|clomipramine|mesh-list
138993367|NCT00944996|Escitalopram|escitalopram|mesh-list
138993368|NCT00944996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138993369|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138993371|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993372|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993374|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993375|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138993377|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138993378|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138993379|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138993380|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993381|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138744176|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
138993382|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138993383|NCT00950066|Amlodipine|amlodipine|mesh-list
138993384|NCT00950066|Irbesartan|irbesartan|mesh-list
138993385|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138627653|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
138993386|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138993387|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138993388|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993389|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138993390|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993391|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
138993392|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138993393|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138993394|NCT01031212|Acetic Acid|acetic acid|mesh-list
138993395|NCT01031212|Paclitaxel|paclitaxel|mesh-list
138993396|NCT01031212|Carboplatin|carboplatin|mesh-list
138993397|NCT01031212|Cetuximab|cetuximab|mesh-list
138993398|NCT01031212|Vadimezan|vadimezan|mesh-list
138993399|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138627703|NCT00254046|Etravirine|etravirine|mesh-list
138993400|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993401|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
138993402|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
138993403|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
138993404|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993405|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138993406|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138993407|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993409|NCT01024348|Tramadol|tramadol|mesh-list
138993410|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138993411|NCT01024348|Analgesics|analgesics|mesh-ancestor
138993412|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
138993413|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993414|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993415|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
138993416|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138993417|NCT01024348|Narcotics|narcotics|mesh-ancestor
138993418|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138993419|NCT03994744|Metformin|metformin|mesh-list
138993420|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138993421|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138567502|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138993422|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993423|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993424|NCT03994744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138993425|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993427|NCT00950222|Amikacin|amikacin|mesh-list
138993428|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138993429|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993430|NCT05301530|Docetaxel|docetaxel|mesh-list
138993431|NCT05301530|Trastuzumab|trastuzumab|mesh-list
138993432|NCT05301530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993433|NCT05301530|Tubulin Modulators|tubulin modulators|mesh-ancestor
138993434|NCT05301530|Antimitotic Agents|antimitotic agents|mesh-ancestor
138993435|NCT05301530|Mitosis Modulators|mitosis modulators|mesh-ancestor
138993436|NCT05301530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993437|NCT05301530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138993438|NCT00941174|Leucovorin|leucovorin|mesh-list
138993439|NCT00941174|Calcium|calcium|mesh-list
138993440|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
138993441|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138993442|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993443|NCT00941174|Antidotes|antidotes|mesh-ancestor
138993444|NCT00941174|Protective Agents|protective agents|mesh-ancestor
138993445|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
138993446|NCT00941174|Vitamins|vitamins|mesh-ancestor
138993447|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
138993448|NCT00440518|Lacosamide|lacosamide|mesh-list
138993449|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
138993450|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138993451|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138993452|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138627869|NCT00569335|Irinotecan|irinotecan|mesh-list
138993453|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993454|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
138993455|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138993456|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993457|NCT00941252|Imiquimod|imiquimod|mesh-list
138993458|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138993459|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
138993460|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993461|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993462|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
138993464|NCT01031368|Clofarabine|clofarabine|mesh-list
138993465|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138993466|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
138993467|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993468|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993469|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
138993470|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993471|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138993472|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
138993473|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993474|NCT00945308|Eptifibatide|eptifibatide|mesh-list
138993475|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138993476|NCT03172936|Spartalizumab|spartalizumab|mesh-list
138993477|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138993478|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993479|NCT03172936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138993480|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993482|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
138993483|NCT01030042|Irinotecan|irinotecan|mesh-list
138993484|NCT01030042|Cetuximab|cetuximab|mesh-list
138993485|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993486|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138993487|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138993488|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993489|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993490|NCT01030042|Antidotes|antidotes|mesh-ancestor
138993491|NCT01030042|Protective Agents|protective agents|mesh-ancestor
138993492|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993493|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
138993494|NCT01030042|Vitamins|vitamins|mesh-ancestor
138993495|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
138628004|NCT00570856|Folic Acid|folic acid|mesh-list
138993496|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138993497|NCT01024504|Bevacizumab|bevacizumab|mesh-list
138993498|NCT01024504|Capecitabine|capecitabine|mesh-list
138993499|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
138993500|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138567575|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
138993501|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993502|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138993503|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138993504|NCT01024504|Growth Substances|growth substances|mesh-ancestor
138993505|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993506|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
138993507|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138993508|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
138993509|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993510|NCT01030120|Etanercept|etanercept|mesh-list
138993511|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138993512|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138993513|NCT01030120|Analgesics|analgesics|mesh-ancestor
138993514|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
138993515|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993516|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993518|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138993519|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138993520|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138993521|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
138993522|NCT00951236|Cortisone|cortisone|mesh-list
138993523|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993524|NCT00945542|Hemostatics|hemostatics|mesh-list
138993525|NCT00945542|Coagulants|coagulants|mesh-ancestor
138993526|NCT00438256|Capecitabine|capecitabine|mesh-list
138993527|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138993528|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
138768217|NCT00976677|Paclitaxel|paclitaxel|mesh-list
138993529|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993530|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993531|NCT01031524|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138993532|NCT01031524|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138993533|NCT01031524|Immunologic Factors|immunologic factors|mesh-ancestor
138993534|NCT01031524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993535|NCT00945620|Ropivacaine|ropivacaine|mesh-list
138993536|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
138993537|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
138993538|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138993539|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993540|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
138993541|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993542|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138993543|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993544|NCT01030510|Rocuronium|rocuronium|mesh-list
138993545|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138993546|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138993547|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138993548|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993549|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993550|NCT04813822|Miconazole|miconazole|mesh-list
138993551|NCT04813822|Clotrimazole|clotrimazole|mesh-list
138993552|NCT04813822|Bromides|bromides|mesh-list
138993553|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
138993554|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
138993555|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993556|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138993557|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138993558|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993559|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993560|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138993561|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
138993562|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138993563|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993564|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138993565|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138993566|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138993568|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138993569|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138993570|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138993571|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993572|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
138993573|NCT02917564|Hormones|hormones|mesh-ancestor
138993574|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138993575|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993576|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138993577|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
138993578|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993579|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993580|NCT00952016|Methotrexate|methotrexate|mesh-list
138993581|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138993582|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
138993583|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138993584|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993585|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138993586|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
138993587|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993588|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993589|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
138993590|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993591|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138993592|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138993593|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
138993594|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138993595|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138993597|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138993598|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993599|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138993600|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
138993601|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138993602|NCT00942344|Losartan|losartan|mesh-list
138993603|NCT00942344|Amlodipine|amlodipine|mesh-list
138993604|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138993605|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138993606|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138993607|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993608|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138993609|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993610|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
138993611|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138993612|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138993613|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138993614|NCT00946166|Simvastatin|simvastatin|mesh-list
138993615|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138993616|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138993617|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
138993618|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993619|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138993620|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138993621|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993622|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
138993623|NCT00952562|Vitamin D|vitamin d|mesh-list
138993624|NCT00952562|Vitamins|vitamins|mesh-ancestor
138993625|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
138993626|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993627|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138993628|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138993629|NCT00952640|Vitamin A|vitamin a|mesh-list
138993630|NCT00952640|Vitamins|vitamins|mesh-ancestor
138993631|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
138993632|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993633|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
138993634|NCT00952796|Ampicillin|ampicillin|mesh-list
138993635|NCT00952796|Sulbactam|sulbactam|mesh-list
138993636|NCT00952796|Sultamicillin|sultamicillin|mesh-list
138993637|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138993638|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993639|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138993640|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138993641|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993642|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993643|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993644|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138993645|NCT00952952|Mesalamine|mesalamine|mesh-list
138993646|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138993647|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138993648|NCT00952952|Analgesics|analgesics|mesh-ancestor
138993649|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
138993650|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993651|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993652|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993654|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138993655|NCT00953108|Escitalopram|escitalopram|mesh-list
138993656|NCT00953108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138993657|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138993658|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138993659|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993660|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993661|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
138993662|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993663|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
138993664|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138993665|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138993666|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138993667|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138993668|NCT00953498|Pioglitazone|pioglitazone|mesh-list
138993669|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
138993670|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138993671|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993672|NCT00943358|Vaccines|vaccines|mesh-list
138993673|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
138993674|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993676|NCT00120289|Simvastatin|simvastatin|mesh-list
138993677|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138993678|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138993679|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
138993680|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768277|NCT02865681|Letrozole|letrozole|mesh-list
138993681|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138993682|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138993683|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993684|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
138993685|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
138993687|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
138993688|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993689|NCT00946556|Valacyclovir|valacyclovir|mesh-list
138993690|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
138993691|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993692|NCT00943748|Deferiprone|deferiprone|mesh-list
138628482|NCT00574483|Quinacrine|quinacrine|mesh-list
138993693|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138993694|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
138993695|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
138993696|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993697|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
138993698|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
138993699|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138993700|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138993701|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993702|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993703|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993704|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138993705|NCT00954200|Ibuprofen|ibuprofen|mesh-list
138993706|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138993707|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138993708|NCT00954200|Analgesics|analgesics|mesh-ancestor
138993709|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
138993710|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993711|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993712|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993713|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138993714|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138993715|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993716|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993717|NCT00954278|Sorafenib|sorafenib|mesh-list
138993718|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993719|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138993720|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993721|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993722|NCT00550446|Adalimumab|adalimumab|mesh-list
138993723|NCT00550446|Tofacitinib|tofacitinib|mesh-list
138993724|NCT00550446|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138993725|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993726|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138993727|NCT00550446|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138993728|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138993729|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993730|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993731|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138993732|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
138993733|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993734|NCT00953550|Rocuronium|rocuronium|mesh-list
138993735|NCT00953550|Succinylcholine|succinylcholine|mesh-list
138993736|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138993737|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138993738|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138993739|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993740|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993741|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138993742|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138993743|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138993744|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993745|NCT00949026|Sirolimus|sirolimus|mesh-list
138993746|NCT00949026|Temsirolimus|temsirolimus|mesh-list
138567804|NCT00127764|Hormones|hormones|mesh-ancestor
138993747|NCT00949026|MTOR Inhibitors|mtor inhibitors|mesh-list
138993748|NCT00949026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138628581|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
138993749|NCT00949026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993750|NCT00949026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993751|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138993752|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
138993753|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993754|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993755|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138993756|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993757|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138993758|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
138993759|NCT00436618|Everolimus|everolimus|mesh-list
138993760|NCT00436618|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138993761|NCT00436618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138993762|NCT00436618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993763|NCT00436618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993764|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138993765|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
138993766|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993767|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993768|NCT01024660|Donepezil|donepezil|mesh-list
138993769|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138993770|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993771|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993772|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
138993773|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993774|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993775|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
138993776|NCT01751126|Cyclosporine|cyclosporine|mesh-list
138628687|NCT00255489|Gefitinib|gefitinib|mesh-list
138993777|NCT01751126|Cyclosporins|cyclosporins|mesh-list
138993778|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768328|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
138993779|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993780|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138993781|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
138993782|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993783|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
138993784|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993785|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
138993786|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138993787|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138993788|NCT00943982|Interferons|interferons|mesh-list
138993789|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
138993790|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993791|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
138993792|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993793|NCT00548808|Insulin|insulin|mesh-list
138993794|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138993795|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
138993796|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
138993797|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138993798|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993799|NCT04011878|Mitomycins|mitomycins|mesh-list
138993800|NCT04011878|Mitomycin|mitomycin|mesh-list
138993801|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138993802|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993803|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
138993804|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993805|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138993806|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993807|NCT00954096|Nicotine|nicotine|mesh-list
138993808|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138993809|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
138993810|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993811|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993812|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138993813|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138993814|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
138993815|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993816|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993817|NCT00954252|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
138993818|NCT00954252|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138993819|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993820|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993822|NCT00110617|Deferoxamine|deferoxamine|mesh-list
138993823|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138993824|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
138993825|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
138768355|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
138993826|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993827|NCT00110617|Siderophores|siderophores|mesh-ancestor
138993828|NCT00949494|Hylan|hylan|mesh-list
138993829|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
138993830|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
138993831|NCT00949494|Protective Agents|protective agents|mesh-ancestor
138993832|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993833|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138993834|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
138993835|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
138993836|NCT00954486|Hematinics|hematinics|mesh-ancestor
138993838|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138993839|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138993840|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138993841|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138993842|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138993843|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993844|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138993845|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138993846|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138993847|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
138993848|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993849|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993851|NCT00946946|Azathioprine|azathioprine|mesh-list
138993852|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
138993853|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993854|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138993855|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993856|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138993857|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
138993858|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993859|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138993860|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138993861|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138993863|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
138993864|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993865|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138993866|NCT00947024|Glipizide|glipizide|mesh-list
138993867|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138993868|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993869|NCT00949572|Vaccines|vaccines|mesh-list
138993870|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
138993871|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
138993872|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993873|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138993874|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
138993875|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138993876|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138567893|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138993877|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993878|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
138993879|NCT01031992|Coagulants|coagulants|mesh-ancestor
138993880|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138993881|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138993882|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993883|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993884|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138993885|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
138993886|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138993887|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993888|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138993889|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
138993890|NCT00949728|Coagulants|coagulants|mesh-ancestor
138993891|NCT00954902|Antioxidants|antioxidants|mesh-list
138993892|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993893|NCT00954902|Protective Agents|protective agents|mesh-ancestor
138993894|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993895|NCT01034020|Nicotine|nicotine|mesh-list
138993896|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138993897|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
138993898|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993899|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993900|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138993901|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138993902|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
138993903|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993904|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993905|NCT01032148|Panobinostat|panobinostat|mesh-list
138993906|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993907|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138993908|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993909|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993911|NCT01032304|Expectorants|expectorants|mesh-ancestor
138993912|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
138993913|NCT00954642|Paclitaxel|paclitaxel|mesh-list
138993914|NCT00954642|Bevacizumab|bevacizumab|mesh-list
138629220|NCT00236067|Tiagabine|tiagabine|mesh-list
138993915|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138993916|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993917|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
138993918|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
138993919|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
138993920|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993921|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138993922|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138993923|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138629272|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
138993925|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993926|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
138993927|NCT00954798|Vaccines|vaccines|mesh-list
138993928|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
138993929|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993930|NCT00110305|Efavirenz|efavirenz|mesh-list
138993931|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138993932|NCT00110305|Rilpivirine|rilpivirine|mesh-list
138993933|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138993934|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138993935|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993936|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
138993937|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138993938|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138993939|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138993940|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138993941|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138993942|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138993943|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138993944|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138629339|NCT00228605|Analgesics|analgesics|mesh-ancestor
138993945|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138993946|NCT00560066|Vaccines|vaccines|mesh-list
138993947|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
138993948|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993949|NCT00549900|Vaccines|vaccines|mesh-list
138993950|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
138993951|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993952|NCT00435994|Epinephrine|epinephrine|mesh-list
138993953|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138993954|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138993955|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
138993956|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993957|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993958|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993959|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138993960|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138993961|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
138993962|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993963|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138993964|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
138993965|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
138993966|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
138993967|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138993968|NCT01563120|Metformin|metformin|mesh-list
138993969|NCT01563120|Glyburide|glyburide|mesh-list
138629393|NCT00256737|Omeprazole|omeprazole|mesh-list
138993970|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138993971|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993972|NCT00435370|Tropisetron|tropisetron|mesh-list
138993973|NCT00435370|Risperidone|risperidone|mesh-list
138993974|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138993975|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
138993976|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138993977|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138993978|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138993979|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138993980|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138993981|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138993982|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138993983|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138993984|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
138993985|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
138993986|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
138993987|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138993988|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138993989|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138993990|NCT00096031|Cetuximab|cetuximab|mesh-list
138993991|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138993992|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138993993|NCT00118417|Clonazepam|clonazepam|mesh-list
138993994|NCT00118417|Sertraline|sertraline|mesh-list
138993995|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
138993996|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138629443|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138993997|NCT00118417|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138993998|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138993999|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138994000|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994001|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994002|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
138994003|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994004|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
138994005|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
138994006|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
138994007|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138994008|NCT01079455|Corticosterone|corticosterone|mesh-list
138994009|NCT01079455|Bupivacaine|bupivacaine|mesh-list
138994010|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
138994011|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
138994012|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
138994013|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138994014|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994015|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
138994016|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994017|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138994018|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
138994020|NCT01079455|Protective Agents|protective agents|mesh-ancestor
138994021|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138994022|NCT00549848|Cytarabine|cytarabine|mesh-list
138994023|NCT00549848|Dexamethasone|dexamethasone|mesh-list
138994024|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
138994025|NCT00549848|Prednisone|prednisone|mesh-list
138994026|NCT00549848|Prednisolone|prednisolone|mesh-list
138994027|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
138994028|NCT00549848|Doxorubicin|doxorubicin|mesh-list
138994029|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138994030|NCT00549848|Methotrexate|methotrexate|mesh-list
138994031|NCT00549848|Etoposide|etoposide|mesh-list
138994032|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
138994033|NCT00549848|Vincristine|vincristine|mesh-list
138994034|NCT00549848|Daunorubicin|daunorubicin|mesh-list
138994035|NCT00549848|Asparaginase|asparaginase|mesh-list
138994036|NCT00549848|Dasatinib|dasatinib|mesh-list
138994037|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
138994038|NCT00549848|Clofarabine|clofarabine|mesh-list
138994039|NCT00549848|Pegaspargase|pegaspargase|mesh-list
138994040|NCT00549848|Thioguanine|thioguanine|mesh-list
138994041|NCT00549848|BB 1101|bb 1101|mesh-list
138994042|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138994043|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
138629548|NCT00229775|Chloroquine|chloroquine|mesh-list
138994044|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994045|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138994046|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138994047|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
138994048|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994049|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994050|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138994051|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138994052|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
138994053|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
138994054|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994055|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138994056|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
138994057|NCT00549848|Hormones|hormones|mesh-ancestor
138994058|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138994059|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138994060|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
138994061|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994062|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138994063|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138994064|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138994065|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138994066|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
138994067|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138994068|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138994069|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
138994070|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
138994071|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138994072|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138629673|NCT00179959|Eusol|eusol|mesh-list
138994073|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138994074|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
138994075|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994076|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
138994077|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
138994078|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
138994079|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138994081|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
138994082|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994083|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
138994084|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
138994085|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
138994086|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994087|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138994088|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994089|NCT00949182|Doxorubicin|doxorubicin|mesh-list
138994090|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138994091|NCT00949182|Mitomycins|mitomycins|mesh-list
138994092|NCT00949182|Mitomycin|mitomycin|mesh-list
138994093|NCT00949182|Sorafenib|sorafenib|mesh-list
138994094|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138629720|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138994095|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994096|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138994097|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138994099|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994100|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138994101|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
138994102|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138994103|NCT00549770|Valsartan|valsartan|mesh-list
138994104|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138994105|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138994106|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138994107|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138994108|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994109|NCT00548184|Trastuzumab|trastuzumab|mesh-list
138994110|NCT00548184|Lapatinib|lapatinib|mesh-list
138994111|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138994112|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994113|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138994114|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629836|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994115|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994116|NCT00454636|Cisplatin|cisplatin|mesh-list
138994117|NCT00454636|Docetaxel|docetaxel|mesh-list
138994118|NCT00454636|Capecitabine|capecitabine|mesh-list
138994119|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
138994120|NCT00454636|Epirubicin|epirubicin|mesh-list
138994121|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994122|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
138994123|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
138994124|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
138994125|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994126|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138994127|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
138994128|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138994129|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138994130|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138994131|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994132|NCT00427960|Atorvastatin|atorvastatin|mesh-list
138994133|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138994134|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138994135|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138994136|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
138994137|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994138|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138994139|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138994140|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994141|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
138994142|NCT00955890|Razoxane|razoxane|mesh-list
138994143|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994144|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138994145|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138994146|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138994147|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994148|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994149|NCT00955890|Protective Agents|protective agents|mesh-ancestor
138994150|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994151|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
138629966|NCT00257868|Rivastigmine|rivastigmine|mesh-list
138994152|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
138994154|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
138994155|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994156|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
138994157|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
138994158|NCT00454246|Hematinics|hematinics|mesh-ancestor
138994159|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
138994160|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138994161|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994162|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138994163|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
138994164|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138994165|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994166|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994167|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994168|NCT00956202|Vaccines|vaccines|mesh-list
138994169|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
138994170|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994171|NCT00695903|Vancomycin|vancomycin|mesh-list
138994172|NCT00695903|Daptomycin|daptomycin|mesh-list
138994173|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138994174|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994175|NCT00548262|Voriconazole|voriconazole|mesh-list
138994176|NCT00548262|Anidulafungin|anidulafungin|mesh-list
138994177|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
138994178|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994179|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138994180|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138994181|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994182|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994183|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138994184|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
138768538|NCT02670109|Busulfan|busulfan|mesh-list
138994185|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138994186|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994187|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138994189|NCT02565173|Adenosine|adenosine|mesh-list
138994190|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138994191|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138994192|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
138994193|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994194|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994195|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994196|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138994197|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138994198|NCT02565173|Analgesics|analgesics|mesh-ancestor
138994199|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
138994200|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994201|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
138994202|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138994203|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
138994204|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
138994205|NCT04619082|Tenofovir|tenofovir|mesh-list
138994206|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
138994207|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994208|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138630128|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994209|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138994210|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994211|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994212|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138887233|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138994213|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138994215|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
138994216|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994217|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138994218|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138994219|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138994220|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138994221|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138994222|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994223|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994224|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138994225|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
138994226|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138994227|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994228|NCT00095173|Abatacept|abatacept|mesh-list
138994229|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138994230|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994231|NCT00095173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138994232|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994233|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138994234|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
138994235|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994236|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138994238|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
138994239|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
138994240|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138994241|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994242|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
138994243|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994244|NCT00690443|Atorvastatin|atorvastatin|mesh-list
138994245|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138994246|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138994247|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
138994248|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994249|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138994250|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138994251|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994253|NCT03954834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138994254|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994255|NCT03954834|Incretins|incretins|mesh-ancestor
138994256|NCT03954834|Hormones|hormones|mesh-ancestor
138994257|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138994258|NCT00693017|Zonisamide|zonisamide|mesh-list
138994259|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
138994260|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138994261|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138994262|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994263|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138994264|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994265|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
138994266|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
138994267|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138994268|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138568175|NCT00344695|Bupropion|bupropion|mesh-list
138994269|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994270|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994271|NCT00692237|Urological Agents|urological agents|mesh-ancestor
138994272|NCT00110149|Rituximab|rituximab|mesh-list
138994273|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138994274|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994275|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
138994276|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994277|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138994278|NCT01084057|Vorinostat|vorinostat|mesh-list
138994279|NCT01084057|Epothilone B|epothilone b|mesh-list
138994280|NCT01084057|Epothilones|epothilones|mesh-list
138994281|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994282|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138994283|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994284|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994285|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
138994286|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
138994287|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
138994288|NCT03954444|Phenylephrine|phenylephrine|mesh-list
138994289|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
138994290|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138994291|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138994292|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
138994293|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994294|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994295|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994296|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
138994297|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
138994298|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994300|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138994301|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
138994302|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138994303|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
138994304|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138994305|NCT03954444|Protective Agents|protective agents|mesh-ancestor
138994306|NCT03953820|Diazepam|diazepam|mesh-list
138994307|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138994308|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
138994309|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
138994310|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
138994311|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994312|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994313|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138994314|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138994315|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138994316|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138994317|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138630410|NCT00202124|Tryptophan|tryptophan|mesh-list
138994318|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138994319|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138994320|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138994321|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138994322|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
138994323|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
138994324|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
138994325|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
138994326|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994327|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994328|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
138994329|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138994330|NCT04492956|Ecopipam|ecopipam|mesh-list
138994331|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138994332|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138994333|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138994334|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994335|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138994336|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138994337|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
138994338|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994339|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994340|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138994341|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
138994342|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138994343|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138994344|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994345|NCT00742937|Vitamin A|vitamin a|mesh-list
138994346|NCT00742937|Vitamins|vitamins|mesh-ancestor
138994347|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
138994348|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994349|NCT00692003|Zonisamide|zonisamide|mesh-list
138994350|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
138994351|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138994352|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138994353|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994354|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138994355|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994356|NCT02564315|Nicotine|nicotine|mesh-list
138994357|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138994358|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
138994359|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745144|NCT04812912|Hormones|hormones|mesh-list
138630576|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138994360|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994361|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138994362|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138994363|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
138994364|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994365|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994366|NCT02564237|Vaccines|vaccines|mesh-list
138630631|NCT00231335|Escitalopram|escitalopram|mesh-list
138994367|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
138994368|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994370|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
138994371|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
138994372|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138994373|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994374|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
138994375|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994376|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138994377|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138994378|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138994379|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138994380|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994381|NCT02153177|Acetaminophen|acetaminophen|mesh-list
138994382|NCT02153177|Ibuprofen|ibuprofen|mesh-list
138994383|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138994384|NCT02153177|Hydrocodone|hydrocodone|mesh-list
138994385|NCT02153177|Oxycodone|oxycodone|mesh-list
138994386|NCT02153177|Omeprazole|omeprazole|mesh-list
138994387|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138994388|NCT02153177|Analgesics|analgesics|mesh-ancestor
138994389|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
138994390|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994391|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994392|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
138630701|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138994393|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138994395|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138994396|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138994397|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994398|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994399|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138994400|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138994401|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138994402|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138994403|NCT02153177|Narcotics|narcotics|mesh-ancestor
138994404|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138994405|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
138994406|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
138994407|NCT00743327|Pioglitazone|pioglitazone|mesh-list
138994408|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138994409|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994410|NCT02564861|DS-1971a|ds-1971a|mesh-list
138994411|NCT02564861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138994412|NCT02564861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138994413|NCT02564861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138994414|NCT02564861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994415|NCT00416884|Fludarabine|fludarabine|mesh-list
138994416|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
138994417|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994418|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138994419|NCT00555620|Capecitabine|capecitabine|mesh-list
138994420|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
138994421|NCT00555620|Sunitinib|sunitinib|mesh-list
138994422|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994423|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138994424|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
138994425|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994426|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138994427|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138994428|NCT00555620|Growth Substances|growth substances|mesh-ancestor
138994429|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994430|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
138994431|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138994432|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994433|NCT00433966|Paclitaxel|paclitaxel|mesh-list
138994434|NCT00433966|Heparin|heparin|mesh-list
138994435|NCT00433966|Calcium heparin|calcium heparin|mesh-list
138994436|NCT00433966|Bivalirudin|bivalirudin|mesh-list
138745216|NCT04106414|Nivolumab|nivolumab|mesh-list
138994437|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138994438|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994439|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
138994440|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
138994441|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
138994442|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994443|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
138994444|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138994445|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138994446|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
138994447|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138994448|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
138994449|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994450|NCT00947336|Norfloxacin|norfloxacin|mesh-list
138994451|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138994452|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994453|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138994454|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138994455|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630794|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
138994456|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994457|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994458|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138994459|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138994460|NCT00955214|Paclitaxel|paclitaxel|mesh-list
138994461|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138994462|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994463|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
138994464|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
138994465|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
138994466|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994467|NCT00956462|Dexamethasone|dexamethasone|mesh-list
138994468|NCT00956462|Ketorolac|ketorolac|mesh-list
138994469|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138994470|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138994471|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
138994472|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
138994473|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994474|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994475|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138994476|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
138994477|NCT00956462|Hormones|hormones|mesh-ancestor
138994478|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138994479|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138994480|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994481|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138994483|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
138994484|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138994485|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138994486|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994487|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994488|NCT05300360|Adenosine|adenosine|mesh-list
138994489|NCT05300360|Analgesics|analgesics|mesh-ancestor
138994490|NCT05300360|Sensory System Agents|sensory system agents|mesh-ancestor
138568321|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
138994491|NCT05300360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994492|NCT05300360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994493|NCT05300360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138994494|NCT05300360|Vasodilator Agents|vasodilator agents|mesh-ancestor
138994495|NCT05300360|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138994496|NCT05300360|Purinergic Agonists|purinergic agonists|mesh-ancestor
138994497|NCT05300360|Purinergic Agents|purinergic agents|mesh-ancestor
138994498|NCT05300360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994499|NCT05300360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994500|NCT00956696|Topiramate|topiramate|mesh-list
138994501|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
138994502|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138994503|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994504|NCT03952650|Chloroquine|chloroquine|mesh-list
138994505|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138994506|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
138994507|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138994508|NCT03952650|Ibuprofen|ibuprofen|mesh-list
138994509|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138994510|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138745294|NCT03567642|Etoposide|etoposide|mesh-list
138994512|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
138994513|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994514|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994515|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138994516|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138994517|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138994518|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994519|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994520|NCT03952650|Amebicides|amebicides|mesh-ancestor
138994521|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138994522|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138994523|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994524|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
138994525|NCT03952650|Filaricides|filaricides|mesh-ancestor
138994526|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
138994527|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
138994528|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138994529|NCT00955526|Istradefylline|istradefylline|mesh-list
138994530|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138994531|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138994532|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138994533|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
138994534|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994535|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994536|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994537|NCT00955604|Rasagiline|rasagiline|mesh-list
138994538|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
138994539|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138994540|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138994541|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994542|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994543|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138994544|NCT00955604|Protective Agents|protective agents|mesh-ancestor
138994545|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994546|NCT03623646|Immunomodulating Agents|immunomodulating agents|mesh-list
138994547|NCT03623646|Immunologic Factors|immunologic factors|mesh-ancestor
138994548|NCT03623646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994549|NCT00962286|Furosemide|furosemide|mesh-list
138994550|NCT00962286|Diuretics|diuretics|mesh-ancestor
138631084|NCT00232661|Tamoxifen|tamoxifen|mesh-list
138994551|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
138994552|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994553|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138994554|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138994555|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994556|NCT00691301|Pemetrexed|pemetrexed|mesh-list
138994557|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994558|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994559|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994560|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138994561|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138994562|NCT05277480|Apatinib|apatinib|mesh-list
138994563|NCT05277480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994564|NCT05277480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138994565|NCT05277480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994566|NCT05277480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994567|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
138994568|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994569|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138994570|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994571|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994572|NCT02564003|Oxycodone|oxycodone|mesh-list
138994573|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138994574|NCT02564003|Narcotics|narcotics|mesh-ancestor
138994575|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138994576|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994577|NCT02564003|Analgesics|analgesics|mesh-ancestor
138994578|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
138994579|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994580|NCT00956150|Rifaximin|rifaximin|mesh-list
138994581|NCT00956150|Lactulose|lactulose|mesh-list
138568389|NCT00346255|Immunotoxins|immunotoxins|mesh-ancestor
138994582|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138994583|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138887234|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994584|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138994585|NCT00923663|Lenalidomide|lenalidomide|mesh-list
138994586|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
138994587|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994588|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138994589|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138994590|NCT00923663|Growth Substances|growth substances|mesh-ancestor
138994591|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
138994592|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994593|NCT00743873|Mitogens|mitogens|mesh-list
138994594|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
138994595|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994596|NCT04011098|Fentanyl|fentanyl|mesh-list
138994597|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138994598|NCT04011098|Narcotics|narcotics|mesh-ancestor
138631120|NCT00232700|Escitalopram|escitalopram|mesh-list
138994599|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138994600|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994602|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
138994603|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994604|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138994605|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138994606|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
138994607|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
138994608|NCT00927563|Tolcapone|tolcapone|mesh-list
138994609|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138994610|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138994611|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138994612|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994613|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994614|NCT00956306|Udenafil|udenafil|mesh-list
138994615|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138994616|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138994617|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994618|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994619|NCT00775229|Naltrexone|naltrexone|mesh-list
138994620|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138994621|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138994622|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994623|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
138994624|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994625|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
138994626|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138994627|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
138994628|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994629|NCT00962442|Expectorants|expectorants|mesh-ancestor
138994630|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
138994631|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138994632|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
138994633|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568420|NCT00125814|Interferons|interferons|mesh-list
138994634|NCT00962442|Protective Agents|protective agents|mesh-ancestor
138994635|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994636|NCT00962442|Antidotes|antidotes|mesh-ancestor
138994637|NCT00957320|Sirolimus|sirolimus|mesh-list
138994638|NCT00957320|Asparaginase|asparaginase|mesh-list
138994639|NCT00957320|Pegaspargase|pegaspargase|mesh-list
138994640|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138994641|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994642|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138994643|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994644|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
138994645|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138994646|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
138994647|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994649|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
138631200|NCT00267384|Antidotes|antidotes|mesh-ancestor
138994650|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138994651|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
138994652|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138994653|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994654|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138994655|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138994656|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138994657|NCT00653159|Trace Elements|trace elements|mesh-ancestor
138768712|NCT02886299|Simvastatin|simvastatin|mesh-list
138994658|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
138994660|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
138994661|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
138994662|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138994663|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994664|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
138994665|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994666|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138994667|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138994668|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138994669|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138994670|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994671|NCT00948272|Vaccines|vaccines|mesh-list
138994672|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
138994673|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994674|NCT00957554|Amlodipine|amlodipine|mesh-list
138994675|NCT00957554|Irbesartan|irbesartan|mesh-list
138994676|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138994677|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138994678|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138994679|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994680|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138994681|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994682|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
138994683|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138994684|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138994685|NCT03024684|Atorvastatin|atorvastatin|mesh-list
138994686|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138994687|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138994688|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
138994689|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994690|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138994691|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138994692|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994694|NCT00744107|Trace Elements|trace elements|mesh-ancestor
138994695|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
138994696|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994697|NCT00117637|Interferons|interferons|mesh-list
138994698|NCT00117637|Sorafenib|sorafenib|mesh-list
138994699|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994700|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
138568479|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
138994701|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994702|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138994703|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994704|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994705|NCT00744185|Propranolol|propranolol|mesh-list
138994706|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138994707|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138994708|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
138994709|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994710|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994711|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994712|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138994713|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138994714|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
138994716|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994717|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138994718|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994719|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994720|NCT01084291|Vaccines|vaccines|mesh-list
138994721|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
138994722|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994723|NCT00741767|Fluticasone|fluticasone|mesh-list
138994724|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138994725|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138994726|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138994727|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138994728|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
138994729|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994730|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994731|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138994732|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
138994733|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
138994734|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138994735|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138994736|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138994737|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138994738|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
138994739|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994740|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994741|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
138994742|NCT00741767|Hormones|hormones|mesh-ancestor
138994743|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138994744|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
138994745|NCT00741845|Metronidazole|metronidazole|mesh-list
138631342|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138994746|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994747|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138994748|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138994749|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138994751|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138994752|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138994753|NCT00746447|Analgesics|analgesics|mesh-ancestor
138994754|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
138994755|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994756|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994757|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138994758|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138994759|NCT00744419|Pantoprazole|pantoprazole|mesh-list
138994760|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138994761|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138994762|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138994763|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994764|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994766|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
138994767|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138994768|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138994769|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994770|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994771|NCT00549302|Urological Agents|urological agents|mesh-ancestor
138994772|NCT00957866|Interferons|interferons|mesh-list
138994773|NCT00957866|Ribavirin|ribavirin|mesh-list
138994774|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994775|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
138994776|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994777|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
138994778|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994779|NCT00958022|Carboplatin|carboplatin|mesh-list
138994780|NCT00958022|Etoposide|etoposide|mesh-list
138994781|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
138994782|NCT00958022|Panobinostat|panobinostat|mesh-list
138994783|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
138994784|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994785|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138994786|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138994787|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138994788|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994789|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994790|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138994791|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
138994792|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
138994793|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
138994794|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
138994795|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
138994796|NCT00958100|Tenofovir|tenofovir|mesh-list
138994797|NCT00958100|Lamivudine|lamivudine|mesh-list
138994798|NCT00958100|Emtricitabine|emtricitabine|mesh-list
138994799|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
138994800|NCT00958100|Abacavir|abacavir|mesh-list
138994801|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
138994802|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
138994803|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994804|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138994805|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138994806|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994807|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994808|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138994809|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138994810|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138994811|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138994812|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
138994813|NCT00948584|Insulin|insulin|mesh-list
138994814|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138994815|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
138994816|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138994817|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994818|NCT00948662|Ketoconazole|ketoconazole|mesh-list
138994819|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
138994820|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994821|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138994822|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138994823|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994824|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994825|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138994826|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
138994827|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138994828|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994829|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138994831|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
138994832|NCT00948740|Vitamins|vitamins|mesh-ancestor
138994833|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
138994834|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994835|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138994836|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138994837|NCT00108433|Vancomycin|vancomycin|mesh-list
138994838|NCT00108433|Cefazolin|cefazolin|mesh-list
138994839|NCT00108433|Linezolid|linezolid|mesh-list
138994840|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138994841|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994842|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138994843|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994844|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994845|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
138994846|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138994847|NCT01084369|Testosterone|testosterone|mesh-list
138994848|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
138994850|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138994851|NCT01084369|Androgens|androgens|mesh-ancestor
138994852|NCT01084369|Hormones|hormones|mesh-ancestor
138994853|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138994854|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994855|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138994856|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994857|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
138994858|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
138994859|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138994860|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138994861|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994862|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994863|NCT01084369|Urological Agents|urological agents|mesh-ancestor
138994864|NCT00949130|Linezolid|linezolid|mesh-list
138994865|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138994866|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994867|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138994868|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994869|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994870|NCT04010318|Anesthetics|anesthetics|mesh-list
138994871|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138994872|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994873|NCT00108355|Octreotide|octreotide|mesh-list
138994874|NCT00108355|Midodrine|midodrine|mesh-list
138994875|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138994876|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138994877|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994878|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
138994879|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
138994880|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994881|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994882|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138994883|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138994884|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138994885|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138745667|NCT00876993|Growth Substances|growth substances|mesh-ancestor
138994886|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
138994887|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994888|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994890|NCT00963222|Vitamins|vitamins|mesh-ancestor
138994891|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
138994892|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994893|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138994894|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138994895|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994896|NCT00968682|Trastuzumab|trastuzumab|mesh-list
138994897|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138994898|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994899|NCT02465138|Ketorolac|ketorolac|mesh-list
138994900|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138994901|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138994902|NCT02465138|Analgesics|analgesics|mesh-ancestor
138994903|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
138994904|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994905|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994906|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138994907|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138994908|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138994909|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994910|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994911|NCT00968994|Petrolatum|petrolatum|mesh-list
138994912|NCT00968994|Emollients|emollients|mesh-ancestor
138994913|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
138994914|NCT00969072|Dutasteride|dutasteride|mesh-list
138994915|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138994916|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138994917|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994918|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994919|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
138994920|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138994921|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994922|NCT00094861|Paclitaxel|paclitaxel|mesh-list
138994923|NCT00094861|Carboplatin|carboplatin|mesh-list
138994924|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138994925|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994926|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
138994927|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
138994928|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
138994929|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994930|NCT00963534|Rituximab|rituximab|mesh-list
138994931|NCT00963534|Lenalidomide|lenalidomide|mesh-list
138994932|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138994933|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138994934|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994935|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
138994936|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994937|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138994938|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138994939|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138768836|NCT00646087|Ketamine|ketamine|mesh-list
138994940|NCT00963534|Growth Substances|growth substances|mesh-ancestor
138994941|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
138994942|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138994943|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
138568691|NCT00347503|Bromfenac|bromfenac|mesh-list
138994944|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994945|NCT00963690|Hemostatics|hemostatics|mesh-list
138994946|NCT00963690|Coagulants|coagulants|mesh-ancestor
138994947|NCT01079767|Sirolimus|sirolimus|mesh-list
138994948|NCT01079767|Temsirolimus|temsirolimus|mesh-list
138994949|NCT01079767|MTOR Inhibitors|mtor inhibitors|mesh-list
138994950|NCT01079767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138994951|NCT01079767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994952|NCT01079767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994953|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138994954|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
138994955|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994956|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994957|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138994958|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994959|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138994960|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
138994961|NCT00969306|Chloroquine|chloroquine|mesh-list
138994962|NCT00969306|Amebicides|amebicides|mesh-ancestor
138994963|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138994964|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138994965|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138994966|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
138994967|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138994968|NCT00963768|Canagliflozin|canagliflozin|mesh-list
138994969|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138994970|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994971|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138994972|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994973|NCT00969462|Doxorubicin|doxorubicin|mesh-list
138994974|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138994975|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138994976|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138994977|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138994978|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994979|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994980|NCT00963846|Huperzine A|huperzine a|mesh-list
138994981|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138994982|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994983|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994984|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
138994985|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994986|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994987|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138994988|NCT00963846|Protective Agents|protective agents|mesh-ancestor
138994989|NCT00969696|Galantamine|galantamine|mesh-list
138568740|NCT04705402|Mannitol|mannitol|mesh-list
138994990|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138994991|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138994992|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138994993|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
138994994|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138994995|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138994996|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138994997|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
138994998|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138994999|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
138995000|NCT00958854|Thalidomide|thalidomide|mesh-list
138995001|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
138995002|NCT00958854|Fludarabine|fludarabine|mesh-list
138995003|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
138995004|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995005|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
138995006|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995007|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138995008|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138995009|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
138995010|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995011|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995012|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138995013|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138995014|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
138995015|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
138631730|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995016|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138995017|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995018|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138995019|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138995020|NCT00958854|Growth Substances|growth substances|mesh-ancestor
138995021|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
138995022|NCT00964080|Leucovorin|leucovorin|mesh-list
138995023|NCT00964080|Fluorouracil|fluorouracil|mesh-list
138995024|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
138995025|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
138995026|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995027|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138995028|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995029|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995030|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
138995031|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745827|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138995032|NCT00964080|Antidotes|antidotes|mesh-ancestor
138995033|NCT00964080|Protective Agents|protective agents|mesh-ancestor
138995034|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
138995035|NCT00964080|Vitamins|vitamins|mesh-ancestor
138995036|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
138995037|NCT00969852|Sertraline|sertraline|mesh-list
138995038|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
138995039|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138995040|NCT00969852|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138995041|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138631779|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
138995042|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138995043|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995044|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138995045|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
138995046|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995047|NCT00426556|Paclitaxel|paclitaxel|mesh-list
138995048|NCT00426556|Trastuzumab|trastuzumab|mesh-list
138995049|NCT00426556|Everolimus|everolimus|mesh-list
138995050|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138995051|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995053|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
138995054|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
138995055|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995056|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138995057|NCT00426556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138995058|NCT00426556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138995059|NCT00426556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995060|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995061|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
138995062|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995063|NCT00107653|Ribavirin|ribavirin|mesh-list
138995064|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138995065|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
138995066|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
138995067|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995068|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
138995069|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995070|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
138995071|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995072|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138995073|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
138995074|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995075|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
138995076|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138995077|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995078|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
138995079|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995080|NCT00970086|Bupivacaine|bupivacaine|mesh-list
138995081|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
138995082|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
138995083|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
138995084|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138995085|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995086|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
138995087|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138995088|NCT00689351|Vaccines|vaccines|mesh-list
138995089|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138995090|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
138995091|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995092|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138995093|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
138995094|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995096|NCT02563847|Tryptophan|tryptophan|mesh-list
138995097|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138995098|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
138995099|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138995100|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
138995101|NCT00746681|Pregabalin|pregabalin|mesh-list
138995102|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138995103|NCT00746681|Analgesics|analgesics|mesh-ancestor
138995104|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
138995105|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138995106|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995107|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
138995108|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138995109|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138995110|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995111|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138995112|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138995113|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138995114|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138995115|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138995116|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138995117|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138995118|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
138995119|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138995120|NCT00746681|Urological Agents|urological agents|mesh-ancestor
138995121|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
138995122|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138995123|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995124|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138995125|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138995126|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
138995127|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995128|NCT00749099|Pancrelipase|pancrelipase|mesh-list
138995129|NCT00749099|Pancreatin|pancreatin|mesh-list
138995130|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138995131|NCT00959400|Fentanyl|fentanyl|mesh-list
138995132|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138995133|NCT00959400|Narcotics|narcotics|mesh-ancestor
138995134|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138995135|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995136|NCT00959400|Analgesics|analgesics|mesh-ancestor
138995137|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
138995138|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138995139|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138995140|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138995141|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
138995142|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
138995143|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
138995144|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
138768917|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
138995145|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995146|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
138995147|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138995148|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995150|NCT00964626|Cisplatin|cisplatin|mesh-list
138995151|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138995152|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995153|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
138995154|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
138995155|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
138995156|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995157|NCT02562287|Olanzapine|olanzapine|mesh-list
138995158|NCT02562287|Risperidone|risperidone|mesh-list
138995159|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138995160|NCT02562287|Clozapine|clozapine|mesh-list
138995161|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138995162|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
138995163|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138995164|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995165|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995166|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138995167|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138995168|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138995169|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138995170|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138995171|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
138995172|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
138995173|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
138995174|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138995175|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138995176|NCT02562287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138632237|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
138995177|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138995178|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138995179|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
138995180|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
138995181|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
138995182|NCT02562053|Fluoxetine|fluoxetine|mesh-list
138995183|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
138995184|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
138995185|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138995186|NCT02562053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138995187|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138995188|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138995189|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995191|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
138995192|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995193|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138995194|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
138995195|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138995196|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138995197|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138995198|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995199|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138995200|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138768935|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
138568881|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
138995201|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
138995202|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138995203|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995204|NCT04060043|Goserelin|goserelin|mesh-list
138995205|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138995206|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995207|NCT00553358|Paclitaxel|paclitaxel|mesh-list
138995208|NCT00553358|Trastuzumab|trastuzumab|mesh-list
138995209|NCT00553358|Lapatinib|lapatinib|mesh-list
138995210|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138995211|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995212|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
138995213|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
138995214|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
138995215|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995216|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138995217|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138995218|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995219|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
138995220|NCT00744809|Efavirenz|efavirenz|mesh-list
138995221|NCT00744809|Rilpivirine|rilpivirine|mesh-list
138995222|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138995223|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995224|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138995225|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138995226|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995227|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995228|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995229|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138995230|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138995231|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
138995232|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138995233|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138995234|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138995235|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138995236|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138995237|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138995238|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138995239|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138995240|NCT00744887|Darunavir|darunavir|mesh-list
138995241|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138995242|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138995243|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
138995244|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995245|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995246|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138995247|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138995248|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
138995249|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995250|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
138995251|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138995252|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995253|NCT00749567|Bevacizumab|bevacizumab|mesh-list
138995254|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138768956|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
138995255|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138995256|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995257|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138995258|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138995260|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995261|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
138995262|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138995263|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995264|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995266|NCT04010942|Clomiphene|clomiphene|mesh-list
138995267|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138995268|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995269|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138995270|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
138995271|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138995272|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138995273|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
138995274|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138995275|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138995276|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138995277|NCT00949364|Pomalidomide|pomalidomide|mesh-list
138995278|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
138995279|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995280|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138995281|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138995282|NCT00949364|Growth Substances|growth substances|mesh-ancestor
138995283|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
138995284|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995285|NCT00689117|Clindamycin|clindamycin|mesh-list
138995286|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
138995287|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
138995288|NCT00689117|Tretinoin|tretinoin|mesh-list
138995289|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138995290|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995291|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138995292|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995293|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995294|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995295|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
138995296|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
138995297|NCT00949442|Insulin|insulin|mesh-list
138995298|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138995299|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
138995300|NCT00949442|Glimepiride|glimepiride|mesh-list
138995301|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138568944|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995302|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995303|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138995304|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995305|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
138995306|NCT00749723|Carboplatin|carboplatin|mesh-list
138995307|NCT00749723|Etoposide|etoposide|mesh-list
138995308|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
138995309|NCT00749723|Temozolomide|temozolomide|mesh-list
138995310|NCT00749723|Thiotepa|thiotepa|mesh-list
138995311|NCT00749723|Trofosfamide|trofosfamide|mesh-list
138995312|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
138995313|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995314|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138995315|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138995316|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138995317|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995318|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995319|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138995320|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
138995321|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138768978|NCT00646711|Valproic Acid|valproic acid|mesh-list
138995322|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995323|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
138995324|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995325|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138995326|NCT00547248|Vaccines|vaccines|mesh-list
138995327|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138995328|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
138995329|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995331|NCT00688103|Methotrexate|methotrexate|mesh-list
138995332|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138995333|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
138995334|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138995335|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995336|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138995337|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
138995338|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995339|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995340|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
138995341|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995342|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138995343|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995344|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
138995345|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138995346|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138995348|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138995349|NCT00688103|Analgesics|analgesics|mesh-ancestor
138995350|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
138995351|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138995352|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138995353|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138995354|NCT00949598|Tamoxifen|tamoxifen|mesh-list
138995355|NCT00949598|Letrozole|letrozole|mesh-list
138995356|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995357|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995358|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138995359|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138995360|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995361|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138995362|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
138995363|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138995364|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995365|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138995366|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138995367|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138995368|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138995369|NCT00964704|Bevacizumab|bevacizumab|mesh-list
138995370|NCT00964704|Trastuzumab|trastuzumab|mesh-list
138995371|NCT00964704|Docetaxel|docetaxel|mesh-list
138995372|NCT00964704|Capecitabine|capecitabine|mesh-list
138995373|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138995374|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995375|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138995376|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138995377|NCT00964704|Growth Substances|growth substances|mesh-ancestor
138995378|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768985|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
138995379|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
138995380|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
138995381|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
138995382|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
138995383|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995384|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138995386|NCT00686855|Dexamethasone|dexamethasone|mesh-list
138995387|NCT00686855|Tacrolimus|tacrolimus|mesh-list
138995388|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138995389|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
138995390|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
138995391|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138995392|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995393|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138568995|NCT04704622|Midazolam|midazolam|mesh-list
138995394|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
138995395|NCT00686855|Hormones|hormones|mesh-ancestor
138995396|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138995397|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138995398|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995399|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995400|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
138995401|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138995402|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995403|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995404|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
138995405|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
138995406|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138995407|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995408|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138995409|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
138995410|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
138995411|NCT00949832|Vitamin D|vitamin d|mesh-list
138995412|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
138995413|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
138995414|NCT00949832|Vitamins|vitamins|mesh-list
138995415|NCT00949832|Calcium|calcium|mesh-list
138995416|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
138995417|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995418|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138995419|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138995420|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
138995421|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
138995422|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
138995423|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995424|NCT00745199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138995425|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138995426|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138995427|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
138995428|NCT00961844|Temozolomide|temozolomide|mesh-list
138995429|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138995430|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
138995431|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995432|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995433|NCT00686777|Interferons|interferons|mesh-list
138995434|NCT00686777|Ribavirin|ribavirin|mesh-list
138995435|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
138995436|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
138995437|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138995438|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995439|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
138995440|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995441|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
138995442|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995443|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
138632745|NCT00236756|Topiramate|topiramate|mesh-list
138995444|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995445|NCT04009772|Metronidazole|metronidazole|mesh-list
138995446|NCT04009772|Cefepime|cefepime|mesh-list
138995447|NCT04009772|Cefuroxime|cefuroxime|mesh-list
138995448|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
138995449|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995450|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138995451|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138995452|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138995453|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138995454|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138995455|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995456|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138995457|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
138995458|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
138995459|NCT01563068|Calcipotriene|calcipotriene|mesh-list
138995460|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
138995461|NCT00747305|Sunitinib|sunitinib|mesh-list
138995462|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995463|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138995464|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138995465|NCT00747305|Growth Substances|growth substances|mesh-ancestor
138995466|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995467|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
138995468|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138995469|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995470|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995471|NCT05254106|Paclitaxel|paclitaxel|mesh-list
138995472|NCT05254106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138995473|NCT05254106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995474|NCT05254106|Tubulin Modulators|tubulin modulators|mesh-ancestor
138995475|NCT05254106|Antimitotic Agents|antimitotic agents|mesh-ancestor
138995476|NCT05254106|Mitosis Modulators|mitosis modulators|mesh-ancestor
138995477|NCT05254106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995478|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138995479|NCT00747383|Glimepiride|glimepiride|mesh-list
138995480|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138995481|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995482|NCT00747383|Incretins|incretins|mesh-ancestor
138995483|NCT00747383|Hormones|hormones|mesh-ancestor
138569057|NCT01580254|Latanoprost|latanoprost|mesh-list
138995484|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138995485|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138995486|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
138995487|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995488|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995489|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138995490|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995491|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
138995493|NCT00106639|Tofacitinib|tofacitinib|mesh-list
138995494|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995495|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
138995496|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995497|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138995498|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995499|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995500|NCT00106639|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138995501|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138995502|NCT00747539|Interferons|interferons|mesh-list
138995503|NCT00747539|Ribavirin|ribavirin|mesh-list
138995504|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
138995505|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995506|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
138995507|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995508|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
138995509|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995510|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
138995511|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995512|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
138995513|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995514|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138995515|NCT00962234|Protective Agents|protective agents|mesh-ancestor
138995516|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995517|NCT00747695|Rabeprazole|rabeprazole|mesh-list
138995518|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138995519|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138995520|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138995521|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995522|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995523|NCT00959972|Nicotine|nicotine|mesh-list
138995524|NCT00959972|Varenicline|varenicline|mesh-list
138995525|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138995526|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
138995527|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138995528|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995529|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138995530|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138995531|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
138995532|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138995533|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995534|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
138995535|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138995536|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995537|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
138995538|NCT00960284|Gemcitabine|gemcitabine|mesh-list
138995539|NCT00960284|Capecitabine|capecitabine|mesh-list
138995540|NCT00960284|Fluorouracil|fluorouracil|mesh-list
138995541|NCT00960284|Epirubicin|epirubicin|mesh-list
138995542|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995543|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138995544|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
138995545|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995546|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995547|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
138995548|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995549|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138995550|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138995551|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138995552|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995554|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138995555|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995556|NCT00962312|Capecitabine|capecitabine|mesh-list
138995557|NCT00962312|Lapatinib|lapatinib|mesh-list
138995558|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138995559|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
138995560|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995561|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995562|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138995563|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995564|NCT00960518|Adefovir|adefovir|mesh-list
138995565|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
138995566|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995567|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138995568|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138995569|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995570|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995571|NCT00960830|Mirtazapine|mirtazapine|mesh-list
138995572|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
138995573|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138995574|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138995575|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
138995576|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
138995577|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138995578|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995579|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995580|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138995581|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138995582|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138995583|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138995584|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138995585|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138995586|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
138995587|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138995588|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138995589|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
138995590|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138995592|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
138995593|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995594|NCT00105235|Cyclosporine|cyclosporine|mesh-list
138995595|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
138995596|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
138995598|NCT00105235|Cyclosporins|cyclosporins|mesh-list
138995599|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995600|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
138995601|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995602|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138995603|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995604|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995605|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
138995606|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995607|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
138995608|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138995609|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138995610|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995611|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138995612|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
138995613|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138995614|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138995615|NCT03962803|Vaccines|vaccines|mesh-list
138995616|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
138995617|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995618|NCT00547118|Rimonabant|rimonabant|mesh-list
138995619|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138995620|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138995621|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138995622|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138995623|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995624|NCT00547118|Hormones|hormones|mesh-ancestor
138995625|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138995626|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995627|NCT00962936|Pidilizumab|pidilizumab|mesh-list
138995628|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138995629|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995630|NCT01087099|Albendazole|albendazole|mesh-list
138995631|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
138995632|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138995633|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995634|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
138995635|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138769107|NCT01143402|Temozolomide|temozolomide|mesh-list
138995636|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138995637|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
138995638|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
138995639|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
138569196|NCT05561049|Hormones|hormones|mesh-ancestor
138995640|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995641|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995642|NCT00686543|Posaconazole|posaconazole|mesh-list
138995643|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
138995644|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995645|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138995646|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138995647|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138995648|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138995649|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138995650|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995651|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995652|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138995653|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
138995654|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138995655|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995656|NCT00750113|Telmisartan|telmisartan|mesh-list
138995658|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138995659|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138633024|NCT04539418|Vitamin K|vitamin k|mesh-list
138995660|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138995661|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995662|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138995663|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138995664|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138995665|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995666|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
138995667|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
138995668|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138995669|NCT00745511|Bevacizumab|bevacizumab|mesh-list
138995670|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138995671|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995672|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138995673|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138995674|NCT00745511|Growth Substances|growth substances|mesh-ancestor
138995675|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995676|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
138995677|NCT00545688|Docetaxel|docetaxel|mesh-list
138995678|NCT00545688|Trastuzumab|trastuzumab|mesh-list
138995679|NCT00545688|Pertuzumab|pertuzumab|mesh-list
138995680|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995681|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
138995682|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
138995683|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
138995684|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995685|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138995687|NCT00502203|Carboplatin|carboplatin|mesh-list
138995688|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138995689|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995690|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
138995691|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
138995692|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
138995693|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995695|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
138995696|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995697|NCT00967772|Naftopidil|naftopidil|mesh-list
138995698|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138995699|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138995700|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
138995701|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138995702|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995703|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995704|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138995705|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138995706|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138995707|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138746497|NCT01297517|Brinzolamide|brinzolamide|mesh-list
138995708|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138995710|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138995711|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
138995712|NCT00967928|Everolimus|everolimus|mesh-list
138995713|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995714|NCT00967928|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138995715|NCT00967928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138995716|NCT00967928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995717|NCT00967928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995718|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995719|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
138995720|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995721|NCT00546000|Fluticasone|fluticasone|mesh-list
138995722|NCT00546000|Xhance|xhance|mesh-list
138995723|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138995724|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138995725|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
138995726|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569294|NCT00093626|Sorafenib|sorafenib|mesh-list
138995727|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995728|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138687035|NCT02941016|Evolocumab|evolocumab|mesh-list
138995729|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
138995730|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
138995731|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138995732|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138995733|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138995734|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995735|NCT00968006|Incretins|incretins|mesh-ancestor
138995736|NCT00968006|Hormones|hormones|mesh-ancestor
138769144|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138995737|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138995738|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138633172|NCT00414245|Metformin|metformin|mesh-list
138995739|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
138995740|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995741|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995742|NCT00968162|Fludarabine|fludarabine|mesh-list
138995743|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995744|NCT00968240|Bevacizumab|bevacizumab|mesh-list
138995745|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138995746|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995747|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138995748|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138995749|NCT00968240|Growth Substances|growth substances|mesh-ancestor
138995750|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995751|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
138995753|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
138995754|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
138995755|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138995756|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995757|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995758|NCT03942042|Ixekizumab|ixekizumab|mesh-list
138995759|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
138995760|NCT00968396|Melphalan|melphalan|mesh-list
138995761|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138633243|NCT02216149|Capecitabine|capecitabine|mesh-list
138995762|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
138995763|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995764|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995765|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138995766|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995767|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
138995768|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995770|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
138569305|NCT05543109|Sevoflurane|sevoflurane|mesh-list
138995771|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
138995772|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138995773|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995774|NCT01013805|Leucovorin|leucovorin|mesh-list
138995775|NCT01013805|Fluorouracil|fluorouracil|mesh-list
138995776|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
138995777|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
138995778|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995779|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138995780|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995781|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995782|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
138995783|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995785|NCT01013805|Protective Agents|protective agents|mesh-ancestor
138995786|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
138995787|NCT01013805|Vitamins|vitamins|mesh-ancestor
138995788|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
138995789|NCT00104299|Prednisone|prednisone|mesh-list
138995790|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
138995791|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
138995792|NCT00104299|Rituximab|rituximab|mesh-list
138995793|NCT00104299|Azathioprine|azathioprine|mesh-list
138995794|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
138995795|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138995796|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
138995797|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995798|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138995799|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138995800|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
138995801|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995802|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995803|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138995804|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138995805|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138995806|NCT00104299|Hormones|hormones|mesh-ancestor
138995807|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138995808|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138995809|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
138995810|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
138995811|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138995812|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138995813|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138995814|NCT00104299|Protective Agents|protective agents|mesh-ancestor
138995815|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
138995816|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138995817|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
138995818|NCT00082381|Exenatide|exenatide|mesh-list
138995819|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138995820|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995821|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138995822|NCT00082381|Incretins|incretins|mesh-ancestor
138995823|NCT00082381|Hormones|hormones|mesh-ancestor
138995824|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138995825|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
138995826|NCT00964106|Rifampin|rifampin|mesh-list
138995827|NCT00964106|Fluconazole|fluconazole|mesh-list
138995828|NCT00964106|Ketoconazole|ketoconazole|mesh-list
138995829|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
138995830|NCT00964106|Midazolam|midazolam|mesh-list
138995831|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
138995832|NCT00964106|Caffeine|caffeine|mesh-list
138995833|NCT00964106|Omeprazole|omeprazole|mesh-list
138995834|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138995835|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138995836|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138995837|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138995838|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995839|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138995840|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138995841|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138995842|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138995843|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
138995844|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
138995845|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
138995846|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
138995847|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138995848|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995849|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138995850|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138569377|NCT00093743|Cyclosporine|cyclosporine|mesh-list
138995851|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
138995852|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138995853|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138995854|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995855|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138995856|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138995857|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138995858|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138995859|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
138995860|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138995861|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138995862|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138995863|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138995864|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
138995865|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138995866|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138995867|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
138995868|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138995869|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138995870|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138995871|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138995872|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138995873|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138995874|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138995875|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
138995876|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138995877|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138995878|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138995879|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
138995880|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138995881|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138995882|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138995883|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138995884|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138995885|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
138633489|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138995886|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
138995887|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138995888|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138995889|NCT00964106|Analgesics|analgesics|mesh-ancestor
138995890|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
138995891|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138995892|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138995893|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138995894|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138995895|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138995896|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138995897|NCT00960336|Doxorubicin|doxorubicin|mesh-list
138995898|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138995899|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138995900|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995901|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138995902|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138995903|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569412|NCT00402909|Nateglinide|nateglinide|mesh-list
138995904|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995905|NCT00965172|Calcium|calcium|mesh-list
138995906|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138995907|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995908|NCT01084837|Bortezomib|bortezomib|mesh-list
138995909|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995910|NCT00545844|Montelukast|montelukast|mesh-list
138995911|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138995912|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
138995913|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138995914|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
138995915|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138995916|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995917|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138995918|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138995919|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995920|NCT01084993|Heparin|heparin|mesh-list
138995921|NCT01084993|Bivalirudin|bivalirudin|mesh-list
138995922|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
138995923|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138995924|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138995925|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995926|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
138995927|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138995928|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
138995929|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995931|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
138746722|NCT01254630|Vaccines|vaccines|mesh-list
138995932|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995933|NCT00960492|Temozolomide|temozolomide|mesh-list
138995934|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138995935|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
138995936|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995937|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995938|NCT00971724|Prednisolone|prednisolone|mesh-list
138995939|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138995940|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
138995941|NCT00971724|Hormones|hormones|mesh-ancestor
138995942|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138995943|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995944|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138995945|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995946|NCT02976909|Paclitaxel|paclitaxel|mesh-list
138995947|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138995948|NCT02976909|Cisplatin|cisplatin|mesh-list
138995949|NCT02976909|Fluorouracil|fluorouracil|mesh-list
138995950|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138995951|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995952|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
138995953|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
138995954|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
138569431|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138995955|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995956|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
138995957|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138995958|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138633688|NCT04532671|Ether|ether|mesh-list
138995959|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
138995960|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995961|NCT02878083|Adalimumab|adalimumab|mesh-list
138995962|NCT02878083|Vedolizumab|vedolizumab|mesh-list
138995963|NCT02878083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138995964|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138995965|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138995966|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138995967|NCT00093145|Paclitaxel|paclitaxel|mesh-list
138995968|NCT00093145|Carboplatin|carboplatin|mesh-list
138995969|NCT00093145|Trastuzumab|trastuzumab|mesh-list
138995970|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138995971|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138995972|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769274|NCT01166178|Calcium|calcium|mesh-list
138995973|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
138995974|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
138995975|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
138995976|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995977|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138995978|NCT00965406|Insulin|insulin|mesh-list
138995979|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138995980|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995981|NCT00513357|Melatonin|melatonin|mesh-list
138995982|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
138995983|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995984|NCT00513357|Protective Agents|protective agents|mesh-ancestor
138995985|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138995986|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138995987|NCT00960960|Paclitaxel|paclitaxel|mesh-list
138995988|NCT00960960|Bevacizumab|bevacizumab|mesh-list
138995989|NCT00960960|Trastuzumab|trastuzumab|mesh-list
138995990|NCT00960960|Letrozole|letrozole|mesh-list
138995991|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138995992|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138995993|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
138995994|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
138995995|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
138995996|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138995997|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138995998|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138995999|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138996000|NCT00960960|Growth Substances|growth substances|mesh-ancestor
138996001|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996002|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
138996003|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138996004|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138996005|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996006|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138996007|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
138996008|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996009|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
138996010|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138996011|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138996012|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996013|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
138996014|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633798|NCT05896449|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138996015|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996016|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
138996017|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138996018|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996019|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138996020|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138996021|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996022|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996023|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996024|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138996025|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138996026|NCT00961194|Ketamine|ketamine|mesh-list
138996027|NCT00961194|Analgesics|analgesics|mesh-ancestor
138996028|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
138996029|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996030|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996031|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138996032|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138996033|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
138996034|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
138996035|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138996036|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138996037|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138996038|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996039|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996040|NCT05279586|Colistin|colistin|mesh-list
138996041|NCT05279586|Lactulose|lactulose|mesh-list
138996042|NCT05279586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138996043|NCT05279586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138996044|NCT05279586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996045|NCT00965796|Lidocaine|lidocaine|mesh-list
138996046|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
138996047|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
138996048|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138996049|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996050|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
138996051|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996052|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138996053|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138996054|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138996055|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138996056|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996057|NCT00415636|Pemetrexed|pemetrexed|mesh-list
138996058|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996059|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996060|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996061|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138996062|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138996063|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
138996064|NCT00965874|Analgesics|analgesics|mesh-ancestor
138996065|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
138996066|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996067|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996068|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
138996069|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138996070|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138996071|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
138996072|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138996073|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138996074|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996075|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138996076|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
138996077|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138996078|NCT00972426|Timolol|timolol|mesh-list
138746861|NCT01288469|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138996080|NCT00972426|Latanoprost|latanoprost|mesh-list
138996081|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138996082|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138996083|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
138996084|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996085|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996086|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996087|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138996088|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138996089|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138996090|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138996091|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
138996092|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
138996093|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996094|NCT00972660|Cyclosporine|cyclosporine|mesh-list
138996095|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
138996097|NCT00972660|Cyclosporins|cyclosporins|mesh-list
138996098|NCT00972660|Tacrolimus|tacrolimus|mesh-list
138996099|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138996100|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
138996101|NCT00972660|Hormones|hormones|mesh-ancestor
138996102|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996103|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996104|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138996105|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996106|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996107|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996108|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138996109|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
138996110|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
138996111|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996112|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
138996113|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138996114|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138996115|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138634012|NCT04381143|Aspirin|aspirin|mesh-list
138996116|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138996117|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
138996118|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138996119|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138996120|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138996121|NCT04008966|Cetrorelix|cetrorelix|mesh-list
138996122|NCT04008966|Progesterone|progesterone|mesh-list
138996123|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138996124|NCT04008966|Progestins|progestins|mesh-ancestor
138996125|NCT04008966|Hormones|hormones|mesh-ancestor
138996126|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996127|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996128|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
138996129|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138996130|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
138996131|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138996132|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138996133|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138996134|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996135|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138996136|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
138996137|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
138996138|NCT00425854|Afatinib|afatinib|mesh-list
138996139|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996140|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138996141|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996142|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996143|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
138996144|NCT00425698|Hematinics|hematinics|mesh-ancestor
138996145|NCT01037530|Ramipril|ramipril|mesh-list
138996146|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138996147|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
138996148|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996149|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996150|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138569515|NCT00095069|Gaboxadol|gaboxadol|mesh-list
138996151|NCT00973050|Bicalutamide|bicalutamide|mesh-list
138996152|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
138996153|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
138746935|NCT00630097|Modafinil|modafinil|mesh-list
138996154|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996155|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996156|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996157|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138996158|NCT00973128|Sargramostim|sargramostim|mesh-list
138996159|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
138996160|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996161|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138996162|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138996163|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996164|NCT00973986|Atorvastatin|atorvastatin|mesh-list
138996165|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138996166|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138996167|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
138996168|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996169|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138996170|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138996171|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996173|NCT00966576|Brinzolamide|brinzolamide|mesh-list
138996174|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996175|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996176|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138996177|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138996178|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
138996179|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634092|NCT03939182|Abexinostat|abexinostat|mesh-list
138996180|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996181|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138996182|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138996183|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138996184|NCT00425308|Cyclosporine|cyclosporine|mesh-list
138996185|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
138996186|NCT00425308|Everolimus|everolimus|mesh-list
138996187|NCT00425308|Cyclosporins|cyclosporins|mesh-list
138996188|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996189|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996190|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138996191|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
138996192|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996193|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
138996194|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996195|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
138996196|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138996197|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138996198|NCT00425308|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138996199|NCT00425308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138996200|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996201|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138996202|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138996203|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
138996204|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138996206|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
138996207|NCT04008888|Fludarabine|fludarabine|mesh-list
138996208|NCT04008888|Melphalan|melphalan|mesh-list
138996209|NCT04008888|BB 1101|bb 1101|mesh-list
138996210|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138996211|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
138996212|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
138996213|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996214|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996215|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138996216|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
138996217|NCT04008888|Hormones|hormones|mesh-ancestor
138634198|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
138996218|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996219|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138996220|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996221|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
138996222|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996223|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996224|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138996225|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
138996226|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138996227|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
138996228|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138996229|NCT01033084|Sertraline|sertraline|mesh-list
138996230|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
138996231|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138996232|NCT01033084|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138569582|NCT00429208|Nicotine|nicotine|mesh-list
138996233|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138996234|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138996235|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996236|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996237|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
138996238|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996239|NCT00979758|Atorvastatin|atorvastatin|mesh-list
138996240|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138996241|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138634264|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
138996242|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
138996243|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996244|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138996245|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138996246|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996248|NCT00545064|Dorzolamide|dorzolamide|mesh-list
138996249|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996250|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634307|NCT02229578|Lidocaine|lidocaine|mesh-list
138996252|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138996253|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
138996254|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996255|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996256|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138996257|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138996258|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138996259|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
138996260|NCT00979836|Calcium|calcium|mesh-list
138996261|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138996262|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996263|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
138996264|NCT00979836|Coagulants|coagulants|mesh-ancestor
138996265|NCT01588912|Tenofovir|tenofovir|mesh-list
138996266|NCT01588912|Entecavir|entecavir|mesh-list
138996267|NCT01588912|Telbivudine|telbivudine|mesh-list
138996268|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
138996269|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996270|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138996271|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138996272|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996273|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996274|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138996275|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138996276|NCT00432562|Vinorelbine|vinorelbine|mesh-list
138996277|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138569620|NCT00429442|Simvastatin|simvastatin|mesh-list
138996278|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996279|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
138996280|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
138996281|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
138996282|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996283|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
138996284|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138996285|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
138996286|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996287|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138996288|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138996289|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138996290|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996291|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
138996293|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138996294|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996295|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138996296|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
138996297|NCT00432172|Carboplatin|carboplatin|mesh-list
138996298|NCT00432172|Docetaxel|docetaxel|mesh-list
138996299|NCT00432172|Epirubicin|epirubicin|mesh-list
138996300|NCT00432172|Exemestane|exemestane|mesh-list
138996301|NCT00432172|Goserelin|goserelin|mesh-list
138996302|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138996303|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
138996304|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996305|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138996306|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138996307|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
138996308|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996309|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996310|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138996311|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
138996312|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
138996313|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
138569643|NCT00095810|Aripiprazole|aripiprazole|mesh-list
138569651|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
138996314|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138996315|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138996316|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138996317|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996318|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138996319|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138996320|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138996321|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
138634532|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
138996322|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996323|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138996324|NCT01034410|Cytarabine|cytarabine|mesh-list
138996325|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138996326|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
138769446|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138996327|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996328|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996329|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
138996330|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996331|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138996332|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
138996333|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996335|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996336|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996337|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996338|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138996339|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138996340|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
138996341|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138996342|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996343|NCT00980304|Rituximab|rituximab|mesh-list
138996344|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138996345|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996346|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
138996347|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996348|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138996349|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
138996350|NCT00974766|Hormones|hormones|mesh-ancestor
138634658|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
138996351|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996352|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996354|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996355|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
138996356|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
138996357|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
138996358|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996359|NCT00967434|Atorvastatin|atorvastatin|mesh-list
138996360|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138996361|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138996362|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
138996363|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996364|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138996365|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138996366|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996367|NCT00967512|Cytarabine|cytarabine|mesh-list
138996368|NCT00967512|Idarubicin|idarubicin|mesh-list
138996369|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138996370|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
138996371|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996372|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996373|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
138996374|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996375|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138996376|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
138996377|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996378|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138996380|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138996381|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996382|NCT04082910|Infliximab|infliximab|mesh-list
138996383|NCT04082910|Etanercept|etanercept|mesh-list
138996384|NCT04082910|Metoprolol|metoprolol|mesh-list
138996385|NCT04082910|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138996386|NCT04082910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138996387|NCT04082910|Dermatologic Agents|dermatologic agents|mesh-ancestor
138996388|NCT04082910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138996389|NCT04082910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138996390|NCT04082910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138996391|NCT04082910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138996392|NCT04082910|Analgesics|analgesics|mesh-ancestor
138996393|NCT04082910|Sensory System Agents|sensory system agents|mesh-ancestor
138996394|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996395|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996396|NCT04082910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138996397|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
138996398|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138996399|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138996400|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
138996401|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
138996402|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138996403|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138996404|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138996405|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
138996406|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996407|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996408|NCT00975078|Prednisone|prednisone|mesh-list
138996409|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138996410|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
138996411|NCT00975078|Hormones|hormones|mesh-ancestor
138996412|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996413|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996414|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138996415|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996416|NCT00980616|Ropivacaine|ropivacaine|mesh-list
138996417|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
138996418|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
138996419|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138996420|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996421|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
138996422|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996423|NCT00980850|Vaccines|vaccines|mesh-list
138996424|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
138996425|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996426|NCT00414466|Gabapentin|gabapentin|mesh-list
138996427|NCT00414466|Analgesics|analgesics|mesh-ancestor
138996428|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
138996429|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996430|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996431|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
138996432|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138996433|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138996434|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138996435|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138996436|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138996437|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138996438|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996439|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996440|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
138996441|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
138996442|NCT00984750|Simvastatin|simvastatin|mesh-list
138996443|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138996444|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138996445|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
138996446|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996447|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138996448|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138996449|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996450|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
138996451|NCT00984750|Vitamins|vitamins|mesh-ancestor
138569738|NCT00429871|Capecitabine|capecitabine|mesh-list
138996452|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
138747236|NCT00953017|Laxatives|laxatives|mesh-ancestor
138996453|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996454|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
138996456|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996457|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
138996458|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
138996459|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
138996460|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
138996461|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138996462|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
138996463|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996464|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996465|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138996466|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
138996468|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138996469|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
138996470|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996471|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996472|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138996473|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138996474|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138996475|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
138996477|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
138996478|NCT04974996|Rituximab|rituximab|mesh-list
138996479|NCT04974996|Doxorubicin|doxorubicin|mesh-list
138996480|NCT04974996|Vincristine|vincristine|mesh-list
138996481|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
138996482|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138996483|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
138996484|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996485|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138996486|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138996487|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
138996488|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996489|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996490|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138996491|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138996492|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138996493|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138996494|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138996495|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996496|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138996497|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
138996498|NCT04974996|Hormones|hormones|mesh-ancestor
138769559|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138996499|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996500|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138996501|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138996502|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
138996503|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
138996504|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
138996505|NCT00981006|Mitogens|mitogens|mesh-list
138996506|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
138996507|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996508|NCT00975390|Caffeine|caffeine|mesh-list
138996509|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138996510|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996511|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138996512|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996513|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996514|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138996515|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138996516|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
138996517|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996518|NCT00981318|Ritonavir|ritonavir|mesh-list
138996519|NCT00981318|Lopinavir|lopinavir|mesh-list
138996520|NCT00981318|Maraviroc|maraviroc|mesh-list
138996521|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138996522|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138996523|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
138996524|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996525|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996526|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138996527|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138996528|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
138996529|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996530|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138996531|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138996532|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138996533|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138996534|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138996535|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
138996536|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138996537|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138996538|NCT00984984|Prednisolone|prednisolone|mesh-list
138996539|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
138996540|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138996541|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
138996542|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138996543|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
138996544|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
138996545|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996546|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996547|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138996548|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
138996549|NCT00984984|Hormones|hormones|mesh-ancestor
138996550|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996551|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138996552|NCT00984984|Protective Agents|protective agents|mesh-ancestor
138996553|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138996554|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996555|NCT00545532|Oseltamivir|oseltamivir|mesh-list
138996556|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
138635229|NCT04720248|Dipyrone|dipyrone|mesh-list
138996557|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996558|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996559|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996560|NCT00544440|Prednisone|prednisone|mesh-list
138996561|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
138569853|NCT00096395|Gemcitabine|gemcitabine|mesh-list
138996562|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138996563|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
138996564|NCT00544440|Hormones|hormones|mesh-ancestor
138996565|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996566|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996567|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138996568|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996569|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138996570|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996571|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996573|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138996574|NCT00981708|Dexamethasone|dexamethasone|mesh-list
138996575|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
138996576|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
138996577|NCT00981708|Lenalidomide|lenalidomide|mesh-list
138996578|NCT00981708|BB 1101|bb 1101|mesh-list
138996579|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138996580|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
138996581|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996582|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138996583|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138996584|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
138996585|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996586|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996587|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138996588|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138996589|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
138996590|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
138996591|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996592|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138996593|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
138996594|NCT00981708|Hormones|hormones|mesh-ancestor
138996595|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996596|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138996597|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
138996598|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996599|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138996600|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138996601|NCT00981708|Growth Substances|growth substances|mesh-ancestor
138747391|NCT01235442|Etanercept|etanercept|mesh-list
138996602|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
138996603|NCT00981786|Timolol|timolol|mesh-list
138996604|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138996605|NCT00981786|Travoprost|travoprost|mesh-list
138996606|NCT00981786|Brinzolamide|brinzolamide|mesh-list
138996607|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138996608|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138996609|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
138996610|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996611|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996612|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996613|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138996614|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138996615|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138996616|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138996617|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138769681|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138996618|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138996619|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996621|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
138996622|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138996623|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138996624|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996625|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996626|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635508|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
138996627|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138996628|NCT00985374|Everolimus|everolimus|mesh-list
138996629|NCT00985374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138996630|NCT00985374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138996631|NCT00985374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996632|NCT00985374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996633|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138996634|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
138996635|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996636|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996637|NCT00975936|Ketoconazole|ketoconazole|mesh-list
138996638|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
138996639|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996640|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138996641|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138996642|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996643|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996644|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138996645|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
138996646|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996647|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996648|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138996649|NCT00976092|Heparin|heparin|mesh-list
138996650|NCT00976092|Calcium heparin|calcium heparin|mesh-list
138996651|NCT00976092|Bivalirudin|bivalirudin|mesh-list
138996652|NCT00976092|Clopidogrel|clopidogrel|mesh-list
138996653|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138996654|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138996655|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138996656|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138996657|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138996658|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
138996659|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996660|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996661|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996662|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
138996663|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138996664|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138996665|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
138996666|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138996667|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
138996668|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996669|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
138996670|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996671|NCT04006470|Fluorides|fluorides|mesh-list
138996672|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
138996673|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
138996674|NCT04006470|Protective Agents|protective agents|mesh-ancestor
138996675|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996676|NCT01323712|Vitamin D|vitamin d|mesh-list
138996677|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
138996678|NCT01323712|Vitamins|vitamins|mesh-ancestor
138996679|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
138996680|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996681|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138569948|NCT00430924|Diuretics|diuretics|mesh-ancestor
138996682|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138996683|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
138996684|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996685|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138996686|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996687|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996688|NCT00976170|Sorafenib|sorafenib|mesh-list
138996689|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996690|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138996691|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996692|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996693|NCT00982254|Insulin|insulin|mesh-list
138996694|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138996695|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138996696|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996697|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138996698|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138996699|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996700|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
138996701|NCT00976326|Insulin|insulin|mesh-list
138996702|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138996703|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996704|NCT00982332|Betamethasone|betamethasone|mesh-list
138996705|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
138996706|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138996707|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
138996708|NCT00982332|Hormones|hormones|mesh-ancestor
138996709|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996710|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996711|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138996712|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
138996714|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138996715|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138996716|NCT04007328|Prednisolone|prednisolone|mesh-list
138996717|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
138996718|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138996719|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
138996720|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138996721|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
138996722|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
138996723|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996724|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996725|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138996726|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
138996727|NCT04007328|Hormones|hormones|mesh-ancestor
138996728|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138996729|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138996730|NCT04007328|Protective Agents|protective agents|mesh-ancestor
138996731|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138996732|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996733|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
138996734|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138996735|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138996736|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996737|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
138996738|NCT00985920|Coagulants|coagulants|mesh-ancestor
138996739|NCT00976794|Carbamazepine|carbamazepine|mesh-list
138996740|NCT00976794|Valproic Acid|valproic acid|mesh-list
138996741|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
138996742|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
138996743|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138996744|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996745|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996746|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
138996747|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138996748|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138996749|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996750|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
138996751|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
138996752|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635727|NCT00264927|Satavaptan|satavaptan|mesh-list
138996753|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138996754|NCT00976794|Analgesics|analgesics|mesh-ancestor
138996755|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
138996756|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996757|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138996758|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138996759|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138996760|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138996761|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
138996762|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138996763|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996765|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996766|NCT00977028|Lidocaine|lidocaine|mesh-list
138996767|NCT00977028|Epinephrine|epinephrine|mesh-list
138996768|NCT00977028|Racepinephrine|racepinephrine|mesh-list
138996769|NCT00977028|Anesthetics|anesthetics|mesh-list
138996770|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
138996771|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
138996772|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138996773|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996774|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
138996775|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996776|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138996777|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138996778|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138996779|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138996780|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996781|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138996782|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138996783|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
138996784|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996785|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138996786|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138996787|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
138996788|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138996789|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
138996790|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
138635739|NCT00242411|Budesonide|budesonide|mesh-list
138996791|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
138996792|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138996793|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
138996794|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
138996795|NCT00982722|Vitamin D|vitamin d|mesh-list
138996796|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
138996797|NCT00982722|Calcium|calcium|mesh-list
138996798|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138996799|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996800|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138996801|NCT00982722|Vitamins|vitamins|mesh-ancestor
138996802|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
138996803|NCT00982722|Antacids|antacids|mesh-ancestor
138996804|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996805|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138996806|NCT00982800|Gabapentin|gabapentin|mesh-list
138996807|NCT00982800|Analgesics|analgesics|mesh-ancestor
138996808|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
138996809|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996810|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996811|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
138769783|NCT04285281|Gabapentin|gabapentin|mesh-list
138996812|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138996813|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138996814|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138996815|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138996816|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138635771|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
138996817|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138996818|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996819|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996820|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
138996821|NCT00986076|Enoxaparin|enoxaparin|mesh-list
138996822|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
138996823|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138996824|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138996825|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996826|NCT00984828|Bortezomib|bortezomib|mesh-list
138996827|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996828|NCT00983034|Amoxicillin|amoxicillin|mesh-list
138996829|NCT00983034|Clarithromycin|clarithromycin|mesh-list
138996830|NCT00983034|Lansoprazole|lansoprazole|mesh-list
138996831|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
138996832|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138996833|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138635825|NCT00242879|Ritonavir|ritonavir|mesh-list
138996834|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138996835|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996836|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996837|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138996838|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138996839|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138996840|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138996841|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138996842|NCT00983112|Thrombin|thrombin|mesh-list
138996843|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
138996844|NCT00983112|Coagulants|coagulants|mesh-ancestor
138996845|NCT00986466|Vitamin D|vitamin d|mesh-list
138570092|NCT00431275|Ipilimumab|ipilimumab|mesh-list
138996846|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
138996847|NCT00986466|Cholecalciferol|cholecalciferol|mesh-list
138996848|NCT00986466|Vitamins|vitamins|mesh-list
138996849|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
138996850|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996851|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138996852|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138996853|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
138996854|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138996855|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
138996856|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996857|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996858|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138996859|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
138996860|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138996862|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996863|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996864|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138769808|NCT00648193|Paroxetine|paroxetine|mesh-list
138996865|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
138996866|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
138996867|NCT00545298|Protective Agents|protective agents|mesh-ancestor
138996868|NCT00983268|Capecitabine|capecitabine|mesh-list
138996869|NCT00983268|Vorinostat|vorinostat|mesh-list
138996870|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138996871|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
138996872|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996873|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996874|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138635938|NCT00282945|Metformin|metformin|mesh-list
138996875|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996876|NCT00977964|Caseins|caseins|mesh-list
138996877|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
138996878|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
138996879|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996880|NCT00983424|Cyclosporine|cyclosporine|mesh-list
138996881|NCT00983424|Paclitaxel|paclitaxel|mesh-list
138996882|NCT00983424|Cyclosporins|cyclosporins|mesh-list
138996883|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138996884|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996885|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
138996886|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
138996887|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
138996888|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996889|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996890|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138996891|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
138996892|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996893|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
138996894|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996895|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
138996896|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138996897|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138996898|NCT00983736|Tramadol|tramadol|mesh-list
138996899|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138996900|NCT00983736|Narcotics|narcotics|mesh-ancestor
138996901|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138996902|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996903|NCT00983736|Analgesics|analgesics|mesh-ancestor
138996904|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
138996905|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996906|NCT00986778|Lamivudine|lamivudine|mesh-list
138996907|NCT00986778|Adefovir|adefovir|mesh-list
138996908|NCT00986778|Entecavir|entecavir|mesh-list
138996909|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138996910|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138996911|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996912|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996913|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
138996914|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138996915|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138996916|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138996917|NCT00429364|Losartan|losartan|mesh-list
138996918|NCT00429364|Atenolol|atenolol|mesh-list
138570165|NCT00431665|Heparin|heparin|mesh-list
138996919|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138996920|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138996921|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138769823|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138996922|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138996923|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996924|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
138996925|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
138996926|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996927|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996928|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138996929|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138996930|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138996931|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
138996932|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138996933|NCT00978354|Furosemide|furosemide|mesh-list
138996934|NCT00978354|Diuretics|diuretics|mesh-ancestor
138996935|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
138996936|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996937|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138996938|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138996939|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996940|NCT00984360|Naltrexone|naltrexone|mesh-list
138996941|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138996942|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138996943|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996944|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
138996945|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996946|NCT00414388|Sorafenib|sorafenib|mesh-list
138996947|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996948|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138996949|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996950|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996951|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138996952|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
138996953|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
138996954|NCT01037608|Nabiximols|nabiximols|mesh-list
138996955|NCT01037608|Analgesics|analgesics|mesh-ancestor
138996956|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
138570196|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996957|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769842|NCT00648271|Metoprolol|metoprolol|mesh-list
138996958|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996959|NCT04006080|Vedolizumab|vedolizumab|mesh-list
138996960|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138996961|NCT00984438|Bevacizumab|bevacizumab|mesh-list
138996962|NCT00984438|Irinotecan|irinotecan|mesh-list
138996963|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138996964|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996965|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138996966|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138996967|NCT00984438|Growth Substances|growth substances|mesh-ancestor
138996968|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996969|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
138996970|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138996971|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138996972|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138996973|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996975|NCT00424372|Analgesics|analgesics|mesh-ancestor
138996976|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
138996977|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138996978|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747767|NCT00879931|Prednisolone|prednisolone|mesh-list
138636211|NCT00244556|Analgesics|analgesics|mesh-ancestor
138996979|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
138996980|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138996981|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138996982|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138996983|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138996984|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138996985|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138996986|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138996987|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138996988|NCT00987168|Octreotide|octreotide|mesh-list
138996989|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138996990|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138996991|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138996992|NCT00978978|Midazolam|midazolam|mesh-list
138996993|NCT00978978|Fentanyl|fentanyl|mesh-list
138996994|NCT00978978|Propofol|propofol|mesh-list
138996995|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138996996|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138996997|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138996998|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138996999|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
138997000|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
138997001|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138997002|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138997003|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138997004|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138997005|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
138997006|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
138997007|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997008|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997009|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138997010|NCT00978978|Narcotics|narcotics|mesh-ancestor
138997011|NCT00978978|Analgesics|analgesics|mesh-ancestor
138997012|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
138997013|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997014|NCT00414310|Decitabine|decitabine|mesh-list
138997015|NCT00414310|Valproic Acid|valproic acid|mesh-list
138997016|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138997017|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
138997018|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997019|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997020|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997021|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
138997022|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
138997023|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997024|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997025|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
138997026|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138997027|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138997028|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138997029|NCT00542880|Fluticasone|fluticasone|mesh-list
138997030|NCT00542880|Budesonide|budesonide|mesh-list
138997031|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
138997032|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138997033|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138997034|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138997035|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138997036|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138997037|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
138997038|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997039|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570269|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
138997040|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138997041|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
138997042|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
138997043|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138997044|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
138997045|NCT00542880|Hormones|hormones|mesh-ancestor
138997046|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138997047|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138997048|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138997049|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138997050|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
138997051|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997052|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997053|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
138997054|NCT00414076|Letrozole|letrozole|mesh-list
138997055|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997056|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138997057|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138997058|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997059|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997060|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138997061|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
138997062|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138997063|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997065|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138997066|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138997067|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138997068|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138570298|NCT00097799|Ritonavir|ritonavir|mesh-list
138997069|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997070|NCT01033396|Fexofenadine|fexofenadine|mesh-list
138997071|NCT01033396|Terfenadine|terfenadine|mesh-list
138997072|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138997073|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138997074|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138997075|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
138997076|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
138997077|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997078|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636471|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
138997079|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997081|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138997082|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997083|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138997084|NCT00092677|Simvastatin|simvastatin|mesh-list
138997085|NCT00092677|Ezetimibe|ezetimibe|mesh-list
138997086|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138997087|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138997088|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
138997089|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997090|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138997091|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138997092|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997093|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138997094|NCT00542178|Simvastatin|simvastatin|mesh-list
138997095|NCT00542178|Fenofibrate|fenofibrate|mesh-list
138997096|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138997097|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138997098|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
138997099|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997100|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138997101|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138997102|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997103|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997104|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
138997105|NCT00987636|Diphosphonates|diphosphonates|mesh-list
138997106|NCT00987636|Busulfan|busulfan|mesh-list
138997107|NCT00987636|Treosulfan|treosulfan|mesh-list
138997108|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
138997109|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997110|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138654921|NCT01697527|Vaccines|vaccines|mesh-list
138997111|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
138997112|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997113|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138997114|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997115|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138997116|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138997117|NCT00424294|Celecoxib|celecoxib|mesh-list
138997118|NCT00424294|Methotrexate|methotrexate|mesh-list
138997119|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138997120|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
138997121|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138997122|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997123|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138997124|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
138997125|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997126|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747911|NCT01610557|Bevacizumab|bevacizumab|mesh-list
138997127|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
138997128|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997129|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138997130|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138997131|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
138997132|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138997133|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138997134|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138997135|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138997136|NCT00424294|Analgesics|analgesics|mesh-ancestor
138997137|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
138769960|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
138997138|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997139|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138997140|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138997141|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138997142|NCT00988728|Olanzapine|olanzapine|mesh-list
138997143|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
138997144|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
138997145|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997146|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997147|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138997148|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138997149|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138997150|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138997151|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138997152|NCT00988728|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138997153|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138997154|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138997155|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997156|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997157|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
138997158|NCT00988806|Simendan|simendan|mesh-list
138997159|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138997160|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
138997161|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138997162|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138997163|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997164|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997165|NCT00988806|Protective Agents|protective agents|mesh-ancestor
138997166|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997167|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
138997169|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138997170|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138997171|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997172|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997173|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997174|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138997175|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
138997176|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138997177|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138997178|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997179|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138997180|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138997181|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997182|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997183|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997184|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138997185|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
138997186|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138997187|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997188|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138997189|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138997190|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138997193|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138997194|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
138997195|NCT00987870|Hormones|hormones|mesh-ancestor
138997196|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138997197|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997198|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138997199|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
138997200|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
138997201|NCT00988026|Minocycline|minocycline|mesh-list
138997202|NCT00988026|Lymecycline|lymecycline|mesh-list
138997203|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138997204|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997205|NCT05578170|Pembrolizumab|pembrolizumab|mesh-list
138997206|NCT05578170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138997207|NCT05578170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997208|NCT05578170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138997209|NCT05578170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997210|NCT00989274|Vaccines|vaccines|mesh-list
138997211|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
138997212|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997213|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138997214|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138997215|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997216|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138997217|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997218|NCT05712642|Bevacizumab|bevacizumab|mesh-list
138997219|NCT05712642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138997220|NCT05712642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997221|NCT05712642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138997222|NCT05712642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138997223|NCT05712642|Growth Substances|growth substances|mesh-ancestor
138997224|NCT05712642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997225|NCT05712642|Growth Inhibitors|growth inhibitors|mesh-ancestor
138997226|NCT01085149|Simvastatin|simvastatin|mesh-list
138997227|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138997228|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138997229|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
138997230|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997231|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138997232|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138997233|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997235|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
138997236|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
138997238|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
138997239|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997240|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138997241|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138997242|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
138997243|NCT00413920|Prednisone|prednisone|mesh-list
138997244|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138997245|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
138997246|NCT00413920|Hormones|hormones|mesh-ancestor
138997247|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138997248|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997249|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138997250|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997251|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138997252|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138997253|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
138997254|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138997255|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997256|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997257|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997258|NCT00091819|Vancomycin|vancomycin|mesh-list
138997259|NCT00091819|Telavancin|telavancin|mesh-list
138997260|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138997261|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997262|NCT01326871|Gemcitabine|gemcitabine|mesh-list
138997263|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997264|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138997265|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
138997266|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997267|NCT01081561|Riboflavin|riboflavin|mesh-list
138997268|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
138997269|NCT01081561|Vitamins|vitamins|mesh-ancestor
138997270|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
138997271|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997272|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138748057|NCT00602407|Cilostazol|cilostazol|mesh-list
138997273|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
138997274|NCT04004754|Miltefosine|miltefosine|mesh-list
138997275|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
138997276|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997277|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997278|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138997279|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138997280|NCT05919797|Naltrexone|naltrexone|mesh-list
138997281|NCT05919797|Bupropion|bupropion|mesh-list
138997282|NCT05919797|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138997283|NCT05919797|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138997284|NCT05919797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997285|NCT05919797|Sensory System Agents|sensory system agents|mesh-ancestor
138997286|NCT05919797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997287|NCT05919797|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138997288|NCT05919797|Antidepressive Agents|antidepressive agents|mesh-ancestor
138997289|NCT05919797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138997290|NCT05919797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138997291|NCT05919797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138997292|NCT05919797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138997293|NCT05919797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997294|NCT05919797|Dopamine Agents|dopamine agents|mesh-ancestor
138997295|NCT05919797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997296|NCT05919797|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138997297|NCT05919797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138997298|NCT05919797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997299|NCT05919732|Epinephrine|epinephrine|mesh-list
138997300|NCT05919732|Bupivacaine|bupivacaine|mesh-list
138997301|NCT05919732|Anesthetics, Local|anesthetics, local|mesh-ancestor
138997302|NCT05919732|Anesthetics|anesthetics|mesh-ancestor
138997303|NCT05919732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138997304|NCT05919732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997305|NCT05919732|Sensory System Agents|sensory system agents|mesh-ancestor
138997306|NCT05919732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997307|NCT05919732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138997308|NCT05919732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138997309|NCT05919732|Adrenergic Agents|adrenergic agents|mesh-ancestor
138997310|NCT05919732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997311|NCT05919732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997312|NCT05919732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138997313|NCT05919732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138997314|NCT05919732|Autonomic Agents|autonomic agents|mesh-ancestor
138997315|NCT05919732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138997316|NCT05919732|Respiratory System Agents|respiratory system agents|mesh-ancestor
138997317|NCT05919732|Mydriatics|mydriatics|mesh-ancestor
138997318|NCT05919732|Sympathomimetics|sympathomimetics|mesh-ancestor
138997319|NCT05919732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138997320|NCT05919615|Tranexamic Acid|tranexamic acid|mesh-list
138997321|NCT05919615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138997322|NCT05919615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138997323|NCT05919615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997324|NCT05919615|Hemostatics|hemostatics|mesh-ancestor
138997325|NCT05919615|Coagulants|coagulants|mesh-ancestor
138997326|NCT05919550|Clozapine|clozapine|mesh-list
138997327|NCT05919550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138997328|NCT05919550|Serotonin Agents|serotonin agents|mesh-ancestor
138997329|NCT05919550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997330|NCT05919550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997331|NCT05919550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997333|NCT05919550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138997334|NCT05919550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138997335|NCT05919550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138997336|NCT05919550|GABA Antagonists|gaba antagonists|mesh-ancestor
138997337|NCT05919550|GABA Agents|gaba agents|mesh-ancestor
138997338|NCT05919407|Amifampridine|amifampridine|mesh-list
138997339|NCT05919407|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138997340|NCT05919407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138997341|NCT05919407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997342|NCT05919407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997343|NCT05919407|Cholinergic Agents|cholinergic agents|mesh-ancestor
138997344|NCT05919407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997345|NCT05919407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997346|NCT05919407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138997347|NCT05919407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997348|NCT05919407|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138997349|NCT05919407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138997351|NCT05919121|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138997353|NCT05919121|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138997354|NCT05919121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138997355|NCT05919017|Naltrexone|naltrexone|mesh-list
138997356|NCT05919017|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138997357|NCT05919017|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138997358|NCT05919017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997359|NCT05919017|Sensory System Agents|sensory system agents|mesh-ancestor
138997360|NCT05919017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997361|NCT05918718|Methotrexate|methotrexate|mesh-list
138997362|NCT05918718|Letrozole|letrozole|mesh-list
138997363|NCT05918718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138997364|NCT05918718|Abortifacient Agents|abortifacient agents|mesh-ancestor
138997365|NCT05918718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138997366|NCT05918718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997367|NCT05918718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138997368|NCT05918718|Antimetabolites|antimetabolites|mesh-ancestor
138997369|NCT05918718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997370|NCT05918718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997371|NCT05918718|Dermatologic Agents|dermatologic agents|mesh-ancestor
138997372|NCT05918718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997373|NCT05918718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138997374|NCT05918718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138997375|NCT05918718|Immunologic Factors|immunologic factors|mesh-ancestor
138997376|NCT05918718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138997377|NCT05918718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138997378|NCT05918718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138997379|NCT05918718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138997380|NCT05918718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138997381|NCT05918718|Hormone Antagonists|hormone antagonists|mesh-ancestor
138997382|NCT05918718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138997383|NCT05918627|Belumosudil|belumosudil|mesh-list
138997384|NCT05918627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138997385|NCT05918627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997386|NCT05918627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997387|NCT05918614|Belumosudil|belumosudil|mesh-list
138997388|NCT05918614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138997389|NCT05918614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997390|NCT05918614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997391|NCT05918588|Belumosudil|belumosudil|mesh-list
138997392|NCT05918588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138997393|NCT05918588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997394|NCT05918588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997395|NCT05918341|Piracetam|piracetam|mesh-list
138997396|NCT05918341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138997397|NCT05918341|Protective Agents|protective agents|mesh-ancestor
138997398|NCT05918341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997399|NCT05918341|Nootropic Agents|nootropic agents|mesh-ancestor
138997400|NCT05918068|Vitamin B 6|vitamin b 6|mesh-list
138997401|NCT05918068|Pyridoxal|pyridoxal|mesh-list
138997402|NCT05918068|Pyridoxine|pyridoxine|mesh-list
138997403|NCT05918068|Metformin|metformin|mesh-list
138997404|NCT05918068|Vitamins|vitamins|mesh-ancestor
138997405|NCT05918068|Micronutrients|micronutrients|mesh-ancestor
138997406|NCT05918068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997407|NCT05918068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138997408|NCT05918068|Vitamin B Complex|vitamin b complex|mesh-ancestor
138997410|NCT05917691|Anesthetics, General|anesthetics, general|mesh-list
138997411|NCT05917691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138997412|NCT05917691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997413|NCT05914506|Xenon|xenon|mesh-list
138997414|NCT05914506|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138997415|NCT05914506|Anesthetics, General|anesthetics, general|mesh-ancestor
138997416|NCT05914506|Anesthetics|anesthetics|mesh-ancestor
138997417|NCT05914506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138570554|NCT00098423|Cytarabine|cytarabine|mesh-list
138997418|NCT05914506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997419|NCT05913817|Adalimumab|adalimumab|mesh-list
138997420|NCT05913817|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138997421|NCT05913817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138997422|NCT05913817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138997423|NCT05883241|Diclofenac|diclofenac|mesh-list
138997424|NCT05883241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138997425|NCT05883241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138997426|NCT05883241|Analgesics|analgesics|mesh-ancestor
138997427|NCT05883241|Sensory System Agents|sensory system agents|mesh-ancestor
138997428|NCT05883241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997429|NCT05883241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997430|NCT05883241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138997431|NCT05883241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138997432|NCT05883241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138997433|NCT05883241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997434|NCT05883241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997436|NCT05882812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138997437|NCT05882812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138997438|NCT05882812|Analgesics|analgesics|mesh-ancestor
138997439|NCT05882812|Sensory System Agents|sensory system agents|mesh-ancestor
138997440|NCT05882812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997441|NCT05882812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997442|NCT05882812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138997443|NCT05882812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138997444|NCT05882812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138997445|NCT05882812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997446|NCT05882812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997447|NCT05874245|Midazolam|midazolam|mesh-list
138997448|NCT05874245|Dexmedetomidine|dexmedetomidine|mesh-list
138997449|NCT05874245|Ketamine|ketamine|mesh-list
138997450|NCT05874245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138770102|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
138997451|NCT05874245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138997452|NCT05874245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997453|NCT05874245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138997454|NCT05874245|Analgesics|analgesics|mesh-ancestor
138997455|NCT05874245|Sensory System Agents|sensory system agents|mesh-ancestor
138997456|NCT05874245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997457|NCT05874245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138997458|NCT05874245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138997459|NCT05874245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138997460|NCT05874245|Adrenergic Agents|adrenergic agents|mesh-ancestor
138997461|NCT05874245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997462|NCT05874245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997463|NCT05874245|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138997464|NCT05874245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138997465|NCT05874245|Anesthetics, General|anesthetics, general|mesh-ancestor
138997466|NCT05874245|Anesthetics|anesthetics|mesh-ancestor
138997467|NCT05874245|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138997468|NCT05874245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138997469|NCT05874245|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138997470|NCT05874245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138997471|NCT05874245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138997472|NCT05874245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138997473|NCT05874245|GABA Modulators|gaba modulators|mesh-ancestor
138997474|NCT05874245|GABA Agents|gaba agents|mesh-ancestor
138997475|NCT05824143|Carbamazepine|carbamazepine|mesh-list
138997476|NCT05824143|Anticonvulsants|anticonvulsants|mesh-ancestor
138997477|NCT05824143|Antimanic Agents|antimanic agents|mesh-ancestor
138997478|NCT05824143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138997479|NCT05824143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138997480|NCT05824143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997481|NCT05824143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138997482|NCT05824143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138997483|NCT05824143|Analgesics|analgesics|mesh-ancestor
138997484|NCT05824143|Sensory System Agents|sensory system agents|mesh-ancestor
138997485|NCT05824143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997486|NCT05824143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138997487|NCT05824143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138997488|NCT05824143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997489|NCT05824143|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138997490|NCT05824143|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138997492|NCT05664568|Clavulanic Acid|clavulanic acid|mesh-list
138997493|NCT05664568|Clavulanic Acids|clavulanic acids|mesh-list
138997494|NCT05664568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138997495|NCT05664568|Cephalexin|cephalexin|mesh-list
138997496|NCT05664568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138997497|NCT05664568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997498|NCT05664568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138997499|NCT05664568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997500|NCT05664568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997501|NCT05525858|Bevacizumab|bevacizumab|mesh-list
138997502|NCT05525858|Trastuzumab|trastuzumab|mesh-list
138997503|NCT05525858|Atezolizumab|atezolizumab|mesh-list
138997504|NCT05525858|Pertuzumab|pertuzumab|mesh-list
138997505|NCT05525858|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138997506|NCT05525858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138997507|NCT05525858|Vemurafenib|vemurafenib|mesh-list
138997508|NCT05525858|Maytansine|maytansine|mesh-list
138997509|NCT05525858|Pralsetinib|pralsetinib|mesh-list
138997510|NCT05525858|Entrectinib|entrectinib|mesh-list
138997511|NCT05525858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138997512|NCT05525858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997513|NCT05525858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138997514|NCT05525858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138997515|NCT05525858|Growth Substances|growth substances|mesh-ancestor
138997516|NCT05525858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997517|NCT05525858|Growth Inhibitors|growth inhibitors|mesh-ancestor
138997518|NCT05525858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138997519|NCT05525858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997520|NCT05525858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997521|NCT05525858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138997522|NCT05525858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138997523|NCT05525858|Tubulin Modulators|tubulin modulators|mesh-ancestor
138997524|NCT05525858|Antimitotic Agents|antimitotic agents|mesh-ancestor
138997525|NCT05525858|Mitosis Modulators|mitosis modulators|mesh-ancestor
138997526|NCT05525858|Immunotoxins|immunotoxins|mesh-ancestor
138997527|NCT05525858|Immunoconjugates|immunoconjugates|mesh-ancestor
138997528|NCT05525858|Immunologic Factors|immunologic factors|mesh-ancestor
138997529|NCT05524584|Fulvestrant|fulvestrant|mesh-list
138997530|NCT05524584|Anastrozole|anastrozole|mesh-list
138637018|NCT00248963|Estrogens|estrogens|mesh-ancestor
138997531|NCT05524584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138997532|NCT05524584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997533|NCT05524584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138997534|NCT05524584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138997535|NCT05524584|Hormone Antagonists|hormone antagonists|mesh-ancestor
138997536|NCT05524584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138997537|NCT05524584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997538|NCT05524584|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138997539|NCT05524584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138997540|NCT05524584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997541|NCT05524584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997542|NCT05494437|Gabapentin|gabapentin|mesh-list
138997543|NCT05494437|Nabilone|nabilone|mesh-list
138997544|NCT05494437|Analgesics|analgesics|mesh-ancestor
138997545|NCT05494437|Sensory System Agents|sensory system agents|mesh-ancestor
138997546|NCT05494437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997547|NCT05494437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997548|NCT05494437|Anticonvulsants|anticonvulsants|mesh-ancestor
138997549|NCT05494437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138997550|NCT05494437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138997551|NCT05494437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138997552|NCT05494437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138997553|NCT05494437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138997554|NCT05494437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138997555|NCT05494437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997556|NCT05494437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997557|NCT05494437|Antimanic Agents|antimanic agents|mesh-ancestor
138997558|NCT05494437|Antiemetics|antiemetics|mesh-ancestor
138997559|NCT05494437|Autonomic Agents|autonomic agents|mesh-ancestor
138997560|NCT05494437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138997561|NCT05405309|Olaparib|olaparib|mesh-list
138997562|NCT05405309|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138997563|NCT05405309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997564|NCT05405309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997565|NCT05405309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997566|NCT05387187|Pentoxifylline|pentoxifylline|mesh-list
138997567|NCT05387187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138997568|NCT05387187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997569|NCT05387187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997570|NCT05387187|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138997571|NCT05387187|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138997572|NCT05387187|Protective Agents|protective agents|mesh-ancestor
138997573|NCT05387187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997574|NCT05387187|Vasodilator Agents|vasodilator agents|mesh-ancestor
138997575|NCT05387187|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138997576|NCT05387187|Antioxidants|antioxidants|mesh-ancestor
138997577|NCT05365893|Hydroxychloroquine|hydroxychloroquine|mesh-list
138997578|NCT05365893|Losartan|losartan|mesh-list
138997579|NCT05365893|Antimalarials|antimalarials|mesh-ancestor
138997580|NCT05365893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138637050|NCT00278772|Valproic Acid|valproic acid|mesh-list
138997581|NCT05365893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138997582|NCT05365893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997583|NCT05365893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997584|NCT05365893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997585|NCT05365893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138997586|NCT05365893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138997587|NCT05365893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138997588|NCT05365893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138997589|NCT05365893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138997590|NCT05312671|Cisplatin|cisplatin|mesh-list
138997591|NCT05312671|Carboplatin|carboplatin|mesh-list
138997592|NCT05312671|Etoposide|etoposide|mesh-list
138997593|NCT05312671|Atezolizumab|atezolizumab|mesh-list
138997594|NCT05312671|Podophyllotoxin|podophyllotoxin|mesh-list
138997595|NCT05312671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997596|NCT05312671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138997597|NCT05312671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138997598|NCT05312671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138997599|NCT05312671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997600|NCT05312671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997601|NCT05312671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138997602|NCT05312671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138997603|NCT05312671|Keratolytic Agents|keratolytic agents|mesh-ancestor
138770175|NCT00649441|Quinapril|quinapril|mesh-list
138997604|NCT05312671|Dermatologic Agents|dermatologic agents|mesh-ancestor
138997605|NCT05312671|Tubulin Modulators|tubulin modulators|mesh-ancestor
138997606|NCT05312671|Antimitotic Agents|antimitotic agents|mesh-ancestor
138997607|NCT05312671|Mitosis Modulators|mitosis modulators|mesh-ancestor
138997609|NCT05254574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138997610|NCT05254574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138997611|NCT05254574|Analgesics|analgesics|mesh-ancestor
138997612|NCT05254574|Sensory System Agents|sensory system agents|mesh-ancestor
138997613|NCT05254574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997614|NCT05254574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997615|NCT05254574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138997616|NCT05254574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138997617|NCT05254574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138997618|NCT05254574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997619|NCT05254574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997620|NCT05219929|Tetracycline|tetracycline|mesh-list
138997621|NCT05219929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138997622|NCT05219929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997623|NCT05219929|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138997625|NCT05219929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997627|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138997628|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
138997629|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997630|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997631|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138997632|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138997633|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
138997634|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997635|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997638|NCT05132829|Azithromycin|azithromycin|mesh-list
138997639|NCT05132829|Cefazolin|cefazolin|mesh-list
138997640|NCT05132829|Indomethacin|indomethacin|mesh-list
138570789|NCT01051414|Asunaprevir|asunaprevir|mesh-list
138997641|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138997642|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997643|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138997644|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138997645|NCT05132829|Analgesics|analgesics|mesh-ancestor
138748429|NCT00606775|Carvedilol|carvedilol|mesh-list
138997646|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
138997647|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997649|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138997650|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138997651|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
138997652|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
138997653|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138997654|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138997655|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997656|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997657|NCT05117450|Heparin|heparin|mesh-list
138997658|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
138997659|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138997660|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139039579|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138997661|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997662|NCT05102669|Antibodies|antibodies|mesh-list
138997663|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
138997664|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997665|NCT05050448|Diclofenac|diclofenac|mesh-list
138997666|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138997667|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138997668|NCT05050448|Analgesics|analgesics|mesh-ancestor
138997669|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
138997670|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997671|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997672|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138997673|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138997674|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138997675|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997676|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997677|NCT04899388|Fentanyl|fentanyl|mesh-list
138997678|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138997679|NCT04899388|Narcotics|narcotics|mesh-ancestor
138570876|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997680|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138997681|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997682|NCT04899388|Analgesics|analgesics|mesh-ancestor
138997683|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
138997684|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997685|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138997686|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138997687|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
138997688|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
138997689|NCT04880785|Lamivudine|lamivudine|mesh-list
138997690|NCT04880785|Dolutegravir|dolutegravir|mesh-list
138997691|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138997692|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138997693|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997694|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997695|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
138997696|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997697|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138997698|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138997699|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138997700|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138997701|NCT04874246|Vasopressins|vasopressins|mesh-list
138997702|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
138997703|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
138997704|NCT04874246|Coagulants|coagulants|mesh-ancestor
138997705|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139039614|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
138997706|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138997707|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
138997708|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997709|NCT04865731|Esomeprazole|esomeprazole|mesh-list
138997710|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138997711|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138997712|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138997713|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997714|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997715|NCT04781088|Paclitaxel|paclitaxel|mesh-list
138997716|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
138997717|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138997718|NCT04781088|Lenvatinib|lenvatinib|mesh-list
138997719|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138997720|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997721|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
138997722|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
138997723|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
138997724|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997725|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138997726|NCT04781088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138997727|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138997728|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997729|NCT04777006|Amitriptyline|amitriptyline|mesh-list
138997730|NCT04777006|Fluoxetine|fluoxetine|mesh-list
138997731|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
138997732|NCT04777006|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138997733|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138997734|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138997735|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997736|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997737|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
138997738|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997739|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138997740|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138637385|NCT00286416|Omalizumab|omalizumab|mesh-list
138997741|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138997742|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138997743|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997744|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138997745|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138997746|NCT04777006|Analgesics|analgesics|mesh-ancestor
138997747|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
138997748|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997749|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138997750|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
138997751|NCT04766086|Vaccines|vaccines|mesh-list
138997752|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
138997753|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997754|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
138997755|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139039629|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997756|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997757|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138997758|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997759|NCT04678102|PHI-101|phi-101|mesh-list
138997760|NCT04678102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138997761|NCT04678102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997762|NCT04678102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138997763|NCT04678102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997764|NCT04643106|Hemostatics|hemostatics|mesh-list
138997765|NCT04643106|Coagulants|coagulants|mesh-ancestor
138997766|NCT04636437|Tenofovir|tenofovir|mesh-list
138997767|NCT04636437|Lamivudine|lamivudine|mesh-list
138997768|NCT04636437|Emtricitabine|emtricitabine|mesh-list
138997769|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
138997770|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
138997771|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997772|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138997773|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138997774|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997775|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997776|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138997777|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138997778|NCT04600648|Insulin|insulin|mesh-list
138997779|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138997780|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997781|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138997782|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138997783|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138997784|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138997785|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997786|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997787|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997788|NCT04504812|Analgesics|analgesics|mesh-ancestor
138571010|NCT04244058|Amantadine|amantadine|mesh-list
138997789|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
138997790|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997791|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
138997792|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138997793|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
138997794|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138997795|NCT04469595|Aflibercept|aflibercept|mesh-list
138748581|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
138997796|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138997797|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138997798|NCT04469595|Growth Substances|growth substances|mesh-ancestor
138997799|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997800|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
138997801|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997802|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138997803|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
138997804|NCT04469595|Hormones|hormones|mesh-ancestor
139039653|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997805|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138997806|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138997808|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
138997809|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138997810|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
138997811|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997812|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997813|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
138997814|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138997815|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138997816|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997817|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
138997818|NCT04233749|Coagulants|coagulants|mesh-ancestor
138997819|NCT04231851|Cytarabine|cytarabine|mesh-list
138997820|NCT04231851|Daunorubicin|daunorubicin|mesh-list
138997821|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138997822|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
138637680|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997823|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997824|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997825|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
138997826|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997827|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138997828|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
138997829|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997830|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138997831|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138997832|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138997833|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997834|NCT04201561|Selenious Acid|selenious acid|mesh-list
138997835|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
138997836|NCT04201561|Paclitaxel|paclitaxel|mesh-list
138997837|NCT04201561|Carboplatin|carboplatin|mesh-list
138997838|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138997839|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997840|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
138997841|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
138997842|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
138997843|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997844|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997845|NCT04201561|Trace Elements|trace elements|mesh-ancestor
138997846|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
138997848|NCT04162873|Benzenesulfonamide|benzenesulfonamide|mesh-list
138997849|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138997850|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138997851|NCT04162873|Analgesics|analgesics|mesh-ancestor
138997852|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
138997853|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997854|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997855|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138997856|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138997857|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138997858|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138997859|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997860|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997861|NCT04162873|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138997863|NCT04061421|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138997864|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138997865|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
138997866|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997867|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997868|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997869|NCT04046900|Metronidazole|metronidazole|mesh-list
138997870|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138997871|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138997872|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138997873|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138997874|NCT03989115|Osimertinib|osimertinib|mesh-list
138997875|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997876|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138997877|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997878|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997879|NCT03971071|Erenumab|erenumab|mesh-list
138997880|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138637794|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
138571120|NCT00100685|Volociximab|volociximab|mesh-list
138997881|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138997882|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997883|NCT03971071|Analgesics|analgesics|mesh-ancestor
138997884|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
138997885|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997886|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997887|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
138997888|NCT03937843|Carboplatin|carboplatin|mesh-list
138997889|NCT03937843|Etoposide|etoposide|mesh-list
138997890|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997891|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138997892|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138997893|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138997894|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997895|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997896|NCT03839823|Paclitaxel|paclitaxel|mesh-list
138997897|NCT03839823|Vinorelbine|vinorelbine|mesh-list
138997898|NCT03839823|Docetaxel|docetaxel|mesh-list
138997899|NCT03839823|Gemcitabine|gemcitabine|mesh-list
138997900|NCT03839823|Capecitabine|capecitabine|mesh-list
138997901|NCT03839823|Letrozole|letrozole|mesh-list
138997902|NCT03839823|Anastrozole|anastrozole|mesh-list
138997903|NCT03839823|Goserelin|goserelin|mesh-list
138997904|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138997905|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997906|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
138571180|NCT00101153|Daunorubicin|daunorubicin|mesh-list
138997907|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
138997908|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
138997909|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997910|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138997911|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
138997912|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138997913|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138997914|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997915|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138997916|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
138997917|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138997918|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997919|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138997921|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138997922|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997923|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997924|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997925|NCT03743636|Niacinamide|niacinamide|mesh-list
138997926|NCT03743636|Niacin|niacin|mesh-list
138997927|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
138997928|NCT03743636|Resveratrol|resveratrol|mesh-list
138997929|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
138997930|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997931|NCT03743636|Protective Agents|protective agents|mesh-ancestor
138997932|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997933|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997934|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138997935|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
138997936|NCT03743636|Vitamins|vitamins|mesh-ancestor
138997937|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
138997938|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138997939|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
138997940|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138997941|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
138997942|NCT03726775|Durvalumab|durvalumab|mesh-list
138997943|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138997944|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997945|NCT03718039|Aprepitant|aprepitant|mesh-list
138997946|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
138997947|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
138997948|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997949|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997950|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138997951|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138997952|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138997953|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997955|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138997956|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997957|NCT03602014|Droxidopa|droxidopa|mesh-list
138997958|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138489274|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
138997959|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138997960|NCT03559192|Aticaprant|aticaprant|mesh-list
138997961|NCT03559192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138997962|NCT03559192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997963|NCT03559192|Sensory System Agents|sensory system agents|mesh-ancestor
138997964|NCT03559192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138997965|NCT03552471|Rucaparib|rucaparib|mesh-list
138997966|NCT03552471|Maytansine|maytansine|mesh-list
138997967|NCT03552471|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
138997968|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138997969|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997970|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997971|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571275|NCT00133185|Diuretics|diuretics|mesh-ancestor
138997972|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138997973|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
138997974|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
138997975|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
138997976|NCT03552471|Immunoconjugates|immunoconjugates|mesh-ancestor
138997977|NCT03552471|Immunologic Factors|immunologic factors|mesh-ancestor
138997978|NCT03552471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997980|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138997981|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997982|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997983|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997984|NCT03523585|Capecitabine|capecitabine|mesh-list
138997985|NCT03523585|Trastuzumab|trastuzumab|mesh-list
138997986|NCT03523585|Lapatinib|lapatinib|mesh-list
138997987|NCT03523585|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138997988|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138997989|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
138997990|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138997991|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138997992|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138997993|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138997994|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997995|NCT03523585|Immunoconjugates|immunoconjugates|mesh-ancestor
138997996|NCT03523585|Immunologic Factors|immunologic factors|mesh-ancestor
138571309|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138997997|NCT03523585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138997998|NCT03485911|Berotralstat|berotralstat|mesh-list
138997999|NCT03485911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138998000|NCT03485911|Protease Inhibitors|protease inhibitors|mesh-ancestor
138998001|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489398|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
138998002|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998004|NCT03395314|Ketamine|ketamine|mesh-list
138998005|NCT03395314|Analgesics|analgesics|mesh-ancestor
138998006|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
138998007|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998008|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998009|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138998010|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138998011|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
138998012|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
138998013|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138998014|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138998015|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138998016|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039732|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998017|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998018|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138998019|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138998020|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138998021|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138998022|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138998024|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
138998025|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
138998026|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138998027|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998028|NCT03293680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138998029|NCT03293680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998030|NCT03172975|Albendazole|albendazole|mesh-list
138998031|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138998032|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
138998033|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138998034|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571431|NCT00135525|Paroxetine|paroxetine|mesh-list
138998035|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
138998036|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138998037|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138998038|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
138489582|NCT00001332|Cisplatin|cisplatin|mesh-list
138998039|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
138998040|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
138998041|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998042|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998043|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138998044|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
138998045|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998047|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138998048|NCT03028103|Repaglinide|repaglinide|mesh-list
138998049|NCT03028103|Fluconazole|fluconazole|mesh-list
138998050|NCT03028103|Omeprazole|omeprazole|mesh-list
138998051|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138998052|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138998053|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138998054|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998055|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998056|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
138998057|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138998058|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138998059|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138998060|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138998061|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
138998062|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998063|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998064|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138998065|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138998066|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138998068|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138998069|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
138998071|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138998072|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998073|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998074|NCT02932475|Metformin|metformin|mesh-list
138998075|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138571474|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
138998076|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998077|NCT02919917|Midodrine|midodrine|mesh-list
138998078|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
138998079|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
138998080|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998081|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998082|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138998083|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138998084|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138998085|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138998086|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
138998087|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998088|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998089|NCT02893553|Midodrine|midodrine|mesh-list
138998090|NCT02893553|Bromides|bromides|mesh-list
138998091|NCT02893553|Mirabegron|mirabegron|mesh-list
138998092|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138998093|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
138998094|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138998095|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138998096|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138998097|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
138998098|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998099|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998100|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998101|NCT02893553|Urological Agents|urological agents|mesh-ancestor
138998102|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
138998103|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
138998104|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571513|NCT00133419|Zinc|zinc|mesh-list
138998105|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138998106|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138998107|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138998108|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138998109|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998110|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
138998111|NCT02507687|Bimatoprost|bimatoprost|mesh-list
138998112|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138998113|NCT02321501|Everolimus|everolimus|mesh-list
138998114|NCT02321501|Ceritinib|ceritinib|mesh-list
138998115|NCT02321501|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138998116|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138998117|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998118|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998119|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138998120|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
138998121|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998122|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998123|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
138998124|NCT02237079|Estrogens|estrogens|mesh-list
138998125|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138998127|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998128|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998129|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138998130|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138998131|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
138998132|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138998133|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
138998134|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138998135|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138998136|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998137|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
138998138|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
138998139|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138998140|NCT01267448|Metformin|metformin|mesh-list
138998141|NCT01267448|Saxagliptin|saxagliptin|mesh-list
138998142|NCT01267448|Glipizide|glipizide|mesh-list
138998143|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138998144|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998145|NCT01267448|Incretins|incretins|mesh-ancestor
138998146|NCT01267448|Hormones|hormones|mesh-ancestor
138998147|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489988|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
138998148|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138998149|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
138998150|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998151|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998153|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138998154|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138998155|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138998156|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998157|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
138998158|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138998159|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
138998160|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998161|NCT00901511|Sargramostim|sargramostim|mesh-list
138998162|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
138998163|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998164|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
138998165|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138998166|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
138998167|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138998168|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998169|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138998170|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138998171|NCT00539994|Retapamulin|retapamulin|mesh-list
138998172|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138998173|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138998174|NCT04005222|Selenium|selenium|mesh-list
138998175|NCT04005222|Melatonin|melatonin|mesh-list
138998176|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
138998177|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998178|NCT04005222|Protective Agents|protective agents|mesh-ancestor
138998179|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998180|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138998181|NCT04005222|Trace Elements|trace elements|mesh-ancestor
138998182|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
138998183|NCT00098839|Leucovorin|leucovorin|mesh-list
138998184|NCT00098839|Cytarabine|cytarabine|mesh-list
138998185|NCT00098839|Prednisone|prednisone|mesh-list
138998186|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
138998187|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138998188|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138998189|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138998190|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
138998191|NCT00098839|Doxorubicin|doxorubicin|mesh-list
138998192|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138998193|NCT00098839|Methotrexate|methotrexate|mesh-list
138998194|NCT00098839|Etoposide|etoposide|mesh-list
138998195|NCT00098839|Vincristine|vincristine|mesh-list
138998196|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
138998197|NCT00098839|Asparaginase|asparaginase|mesh-list
138998198|NCT00098839|Pegaspargase|pegaspargase|mesh-list
138998199|NCT00098839|Epratuzumab|epratuzumab|mesh-list
138998200|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
138998201|NCT00098839|Razoxane|razoxane|mesh-list
138998202|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
138998203|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138998204|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
138998205|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998206|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138998207|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138998208|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
138998209|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998210|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998211|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138998212|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138998213|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138998214|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138998215|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998216|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998217|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
138998218|NCT00098839|Hormones|hormones|mesh-ancestor
138998219|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998220|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138998221|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138998222|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
138998223|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138998224|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138998225|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
138998226|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
138998227|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138998228|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138998229|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138998230|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
138998231|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138998232|NCT00098839|Antidotes|antidotes|mesh-ancestor
138998233|NCT00098839|Protective Agents|protective agents|mesh-ancestor
138998234|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
138998235|NCT00098839|Vitamins|vitamins|mesh-ancestor
138998236|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
138998237|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
138998238|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
138998239|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
138998240|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138998241|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138998242|NCT02531191|Peficitinib|peficitinib|mesh-list
138998243|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998244|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998245|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138998246|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
138998247|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998248|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138998249|NCT01081639|Hormones|hormones|mesh-ancestor
138998250|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998251|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998253|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138998254|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998255|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138998256|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
138998257|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998258|NCT01085383|Aripiprazole|aripiprazole|mesh-list
138998259|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
138998260|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138998261|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138998262|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138998263|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138998264|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998265|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
138998266|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
138998267|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998268|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998269|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138998270|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138998271|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
138998272|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138998273|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138998274|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138571662|NCT00103103|Leucovorin|leucovorin|mesh-list
138998275|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138998276|NCT00485589|Methotrexate|methotrexate|mesh-list
138998277|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
138998278|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138998279|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
138998280|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138998281|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998282|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138998283|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
138998284|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998285|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998286|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
138998287|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998288|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138998289|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138998290|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
138998291|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138998292|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138998294|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138998295|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
138998296|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
138998297|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998298|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998299|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138998300|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138998301|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138998302|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138998303|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138998304|NCT00490971|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138998305|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138998306|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138998307|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998308|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998309|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
138998310|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138998311|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138998312|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138998313|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138998314|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
138998315|NCT00750347|Acetaminophen|acetaminophen|mesh-list
138998317|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138998318|NCT00750347|Analgesics|analgesics|mesh-ancestor
138998319|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
138998320|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998321|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998322|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
138998323|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138998324|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138749100|NCT04268498|Montelukast|montelukast|mesh-list
138998325|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138998326|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998327|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998328|NCT00750347|Hormones|hormones|mesh-ancestor
138998329|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998330|NCT00750425|Cediranib|cediranib|mesh-list
138998331|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998332|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138571740|NCT00136461|Tretinoin|tretinoin|mesh-list
138998333|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490206|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138998334|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998335|NCT00745589|Sevelamer|sevelamer|mesh-list
138998336|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
138998337|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
138998338|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998339|NCT00750581|Indomethacin|indomethacin|mesh-list
138998340|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138998341|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138998342|NCT00750581|Analgesics|analgesics|mesh-ancestor
138998343|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
138998344|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998345|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998346|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998347|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138998348|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
138998349|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
138998350|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138998351|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138998352|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998353|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998354|NCT00685763|Gemcitabine|gemcitabine|mesh-list
138998355|NCT00685763|Capecitabine|capecitabine|mesh-list
138998356|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138998357|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
138998358|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998359|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998360|NCT00098293|Lamivudine|lamivudine|mesh-list
138998361|NCT00098293|Zidovudine|zidovudine|mesh-list
138998362|NCT00098293|Efavirenz|efavirenz|mesh-list
138998363|NCT00098293|Maraviroc|maraviroc|mesh-list
138998364|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138998365|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138998366|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998367|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998368|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
138998369|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138998370|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138998371|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138998372|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
138998373|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138998374|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138998375|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138998376|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138998377|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138998378|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138998379|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138998380|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138998381|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138998382|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
138998383|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998384|NCT00685685|Lovastatin|lovastatin|mesh-list
138998385|NCT00685685|L 647318|l 647318|mesh-list
138998386|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
138998387|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138998388|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138998389|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
138998390|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998391|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138998392|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138998394|NCT01087567|Insulin|insulin|mesh-list
138998395|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138998396|NCT01087567|Metformin|metformin|mesh-list
138998397|NCT01087567|Pioglitazone|pioglitazone|mesh-list
138998398|NCT01087567|Glimepiride|glimepiride|mesh-list
138749184|NCT03906136|Adalimumab|adalimumab|mesh-list
138998399|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138998400|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998401|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138998402|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138998403|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
138998404|NCT00751049|Timolol|timolol|mesh-list
138998405|NCT00751049|Latanoprost|latanoprost|mesh-list
138998406|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138998407|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138998408|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
138998409|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998410|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998411|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998412|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138571790|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998413|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138998414|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138998415|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138998416|NCT00500331|Pioglitazone|pioglitazone|mesh-list
138998417|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138490282|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
138998418|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998420|NCT01019109|Trace Elements|trace elements|mesh-ancestor
138998421|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
138998422|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998423|NCT00499863|Methylphenidate|methylphenidate|mesh-list
138998424|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138998425|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998426|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138998427|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138998428|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138998429|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998430|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
138998431|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998432|NCT04475835|Heparin|heparin|mesh-list
138998433|NCT04475835|Bivalirudin|bivalirudin|mesh-list
138998434|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
138998435|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138998436|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138998437|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998438|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
138998439|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138998440|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
138998441|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998442|NCT01014507|Goserelin|goserelin|mesh-list
138998443|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
138998444|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
138998445|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138998446|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998447|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139039921|NCT00408434|Efatutazone|efatutazone|mesh-list
138998448|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998449|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138998450|NCT00097981|Thalidomide|thalidomide|mesh-list
138998451|NCT00097981|Dexamethasone|dexamethasone|mesh-list
138998452|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998453|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
138998454|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
138998455|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998456|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998457|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138998458|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
138998459|NCT00097981|Hormones|hormones|mesh-ancestor
138998460|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998461|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138998462|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998463|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138998464|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
138998465|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
138490306|NCT00017368|Carboplatin|carboplatin|mesh-list
138998466|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138998467|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138998468|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138998469|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138998470|NCT00097981|Growth Substances|growth substances|mesh-ancestor
138998471|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
138998472|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
138998473|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138998474|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138998475|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138998476|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998478|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998479|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
138998480|NCT01016223|Hormones|hormones|mesh-ancestor
138998481|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998482|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998483|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138998484|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
138998485|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138998486|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
138998487|NCT04151017|Coagulants|coagulants|mesh-ancestor
138998488|NCT01019265|Buprenorphine|buprenorphine|mesh-list
138998489|NCT01019265|Tramadol|tramadol|mesh-list
138998490|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138998491|NCT01019265|Narcotics|narcotics|mesh-ancestor
138998492|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138998493|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998494|NCT01019265|Analgesics|analgesics|mesh-ancestor
138998495|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
138998496|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998497|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138998498|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138998499|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138998500|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138998501|NCT01087879|Etonogestrel|etonogestrel|mesh-list
138998502|NCT01087879|Desogestrel|desogestrel|mesh-list
138998503|NCT01087879|NuvaRing|nuvaring|mesh-list
138998504|NCT01087879|Norelgestromin|norelgestromin|mesh-list
138998505|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
138998506|NCT01087879|Estradiol|estradiol|mesh-list
138998507|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138998508|NCT01087879|Estrogens|estrogens|mesh-ancestor
138998509|NCT01087879|Hormones|hormones|mesh-ancestor
138998510|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998511|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998512|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138998513|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138998514|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138998515|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138998516|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138998517|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138998518|NCT01087879|Progestins|progestins|mesh-ancestor
138998519|NCT01019421|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
138998520|NCT01019421|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138998521|NCT01019421|Serotonin Agents|serotonin agents|mesh-ancestor
138571913|NCT00136773|Benazepril|benazepril|mesh-list
138998522|NCT01019421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998523|NCT01019421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998524|NCT01019421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998525|NCT01085695|Rabeprazole|rabeprazole|mesh-list
138998526|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138998527|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138998528|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138998529|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998530|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998531|NCT01088035|Carboplatin|carboplatin|mesh-list
138998532|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998533|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
138998534|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
138998535|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138998536|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
138998537|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
138998538|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998539|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998540|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998541|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
138998542|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
138998543|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138998544|NCT00751127|Timolol|timolol|mesh-list
138998545|NCT00751127|Latanoprost|latanoprost|mesh-list
138998546|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138998547|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138998548|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
138998549|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998550|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998551|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998552|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138998553|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138998554|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138998555|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138998556|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
138998557|NCT00751205|Prednisone|prednisone|mesh-list
138998558|NCT00751205|Prednisolone|prednisolone|mesh-list
138998559|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138998561|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138998562|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
138998563|NCT00751205|Sagopilone|sagopilone|mesh-list
138998564|NCT00751205|Epothilones|epothilones|mesh-list
138998565|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138998566|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
138998567|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998568|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
138998569|NCT00751205|Hormones|hormones|mesh-ancestor
138998570|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998571|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998572|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138998573|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998574|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
138998575|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
138571946|NCT00134355|Vatalanib|vatalanib|mesh-list
138998576|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998577|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138998578|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138998579|NCT00751205|Protective Agents|protective agents|mesh-ancestor
138998580|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
138998581|NCT00751205|Vitamins|vitamins|mesh-ancestor
138998582|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
138998583|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
138998584|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
138998585|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
138998586|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
138998587|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998588|NCT00752063|Capecitabine|capecitabine|mesh-list
138998589|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
138998590|NCT00752063|Sorafenib|sorafenib|mesh-list
138998591|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138998592|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
138998593|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998594|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998595|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138998596|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998597|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
138998598|NCT00752141|Oxybutynin|oxybutynin|mesh-list
138998599|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
138998600|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
138998601|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998602|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998603|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138998604|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138998605|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
138998606|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998607|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998608|NCT00752141|Urological Agents|urological agents|mesh-ancestor
138998609|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138998610|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138998611|NCT00752375|Trimethoprim|trimethoprim|mesh-list
138998612|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138998613|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
138998614|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138998615|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138998616|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
138998617|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138998618|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138998619|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138998620|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998621|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998622|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138998623|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138998624|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138998625|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138998626|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
138998627|NCT00751517|Methotrexate|methotrexate|mesh-list
138998628|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138998629|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
138998630|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998631|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138998632|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138998633|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
138998634|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998635|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998636|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138998637|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138998638|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
138998639|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138998640|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138998641|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
138998642|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
138998643|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998644|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138998645|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138998646|NCT02561117|Metronidazole|metronidazole|mesh-list
138998647|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138998648|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138998649|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138998650|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138998651|NCT00684515|Aspirin|aspirin|mesh-list
138998652|NCT00684515|Vorapaxar|vorapaxar|mesh-list
138998653|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138998654|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138998655|NCT00684515|Analgesics|analgesics|mesh-ancestor
138998656|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
138998657|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998658|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998659|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998660|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138998661|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138998662|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138998663|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998664|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138998665|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138998666|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998667|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
138998668|NCT00751751|Losartan|losartan|mesh-list
138998669|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138998670|NCT00751751|Olmesartan|olmesartan|mesh-list
138998671|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138998672|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138998673|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138998674|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138998675|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138998676|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998677|NCT00751751|Diuretics|diuretics|mesh-ancestor
138998678|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
138998679|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998680|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138998681|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138998682|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138998683|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998684|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
138998685|NCT00490815|Hormones|hormones|mesh-ancestor
138490577|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138998686|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998687|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998688|NCT04453137|Adalimumab|adalimumab|mesh-list
138998689|NCT04453137|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138998690|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998691|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138998692|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
138998693|NCT03855189|Beclomethasone|beclomethasone|mesh-list
138998694|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998695|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
138998696|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138998697|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
138998698|NCT03855189|Hormones|hormones|mesh-ancestor
138998699|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998700|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998701|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138749484|NCT05940441|Capecitabine|capecitabine|mesh-list
138998702|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
138998704|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998705|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138998706|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998707|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998708|NCT00423670|Ribavirin|ribavirin|mesh-list
138998709|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138998710|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
138998711|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998712|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
138998713|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138998714|NCT01019655|Nadroparin|nadroparin|mesh-list
138998715|NCT01019655|Calcium|calcium|mesh-list
138998716|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138998717|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998718|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
138998719|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138998720|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138998721|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998722|NCT00483717|Ketorolac|ketorolac|mesh-list
138998723|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138490647|NCT05573191|Lidocaine|lidocaine|mesh-list
138998724|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138998725|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138998726|NCT00483717|Analgesics|analgesics|mesh-ancestor
138998727|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
138998728|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998729|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998730|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998731|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138998732|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138998733|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998734|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998735|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138998736|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138998737|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138998738|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138998739|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998740|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
138998741|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998742|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998744|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138998745|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998746|NCT00483405|Capecitabine|capecitabine|mesh-list
138998747|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
138998748|NCT00483405|Cetuximab|cetuximab|mesh-list
138998749|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138998750|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
138998751|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998752|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998753|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138998754|NCT00483327|Megestrol|megestrol|mesh-list
138998755|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
138998756|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138998757|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138998758|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138998759|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
138998760|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138998761|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998762|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138998763|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138998764|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138998765|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998766|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
138998767|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138998768|NCT00684203|Aspirin|aspirin|mesh-list
138998769|NCT00684203|Clopidogrel|clopidogrel|mesh-list
138998770|NCT00684203|Vorapaxar|vorapaxar|mesh-list
138998771|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138998772|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138998773|NCT00684203|Analgesics|analgesics|mesh-ancestor
138998774|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
138749555|NCT05939284|Cetrorelix|cetrorelix|mesh-list
138998775|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998776|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998777|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998778|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138490868|NCT00392470|Cetuximab|cetuximab|mesh-list
138998779|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138998780|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138998781|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998782|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138998783|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138998784|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998785|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
138998786|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138998787|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138998788|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138998789|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
138998790|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998791|NCT00423592|Ambrisentan|ambrisentan|mesh-list
138998792|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138998793|NCT01037998|Gefitinib|gefitinib|mesh-list
138998794|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998795|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138998796|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998797|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998798|NCT00751907|Atorvastatin|atorvastatin|mesh-list
138998799|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138998800|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138998801|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
138998802|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998803|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138490914|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998804|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138998805|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998806|NCT00752843|Mifepristone|mifepristone|mesh-list
138998807|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138998808|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
138998809|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138998810|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998811|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138998812|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138998813|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138998814|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
138998815|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138998816|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138998817|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
138998818|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998819|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
138998820|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138490963|NCT05640726|Vitamin B Complex|vitamin b complex|mesh-ancestor
138998821|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138998822|NCT00752921|Etoricoxib|etoricoxib|mesh-list
138998823|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138998824|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138998825|NCT00752921|Analgesics|analgesics|mesh-ancestor
138998826|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
138998827|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998828|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998829|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998830|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138998831|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138998832|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138998833|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998834|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998835|NCT00683657|Saxagliptin|saxagliptin|mesh-list
138998836|NCT00683657|Incretins|incretins|mesh-ancestor
138998837|NCT00683657|Hormones|hormones|mesh-ancestor
138998838|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998839|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998840|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138998841|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
138998842|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998843|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998844|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138998845|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
138998846|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998847|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138998848|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998849|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998850|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
139039553|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998851|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998852|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998853|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138998854|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138572180|NCT00105287|Fentanyl|fentanyl|mesh-list
138998855|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138998856|NCT00755963|Estradiol|estradiol|mesh-list
138998857|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138998858|NCT00755963|Progesterone|progesterone|mesh-list
138998859|NCT00755963|Estrogens|estrogens|mesh-ancestor
138998860|NCT00755963|Hormones|hormones|mesh-ancestor
138998861|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138998862|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998863|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138998864|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
138998865|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138998866|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138998867|NCT00755963|Progestins|progestins|mesh-ancestor
138998868|NCT00753311|Rizatriptan|rizatriptan|mesh-list
138998869|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138998870|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
138998871|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998872|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998873|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491080|NCT00392899|Tegafur|tegafur|mesh-list
138998874|NCT00753389|Anesthetics|anesthetics|mesh-list
138998875|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138998876|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998877|NCT00753467|Interferons|interferons|mesh-list
138998878|NCT00753467|Adefovir|adefovir|mesh-list
138998879|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138998880|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
138998881|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998882|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
138998883|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138998884|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138998885|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138998886|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998887|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998888|NCT00482703|Dasatinib|dasatinib|mesh-list
138998889|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998890|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138998891|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998892|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998893|NCT04052867|Lidocaine|lidocaine|mesh-list
138998894|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
138998895|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
138998896|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138998897|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998898|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
138998899|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998900|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138998901|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138998902|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138998903|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138998904|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998905|NCT00482391|Paclitaxel|paclitaxel|mesh-list
138998906|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
138998907|NCT00482391|Doxorubicin|doxorubicin|mesh-list
138998908|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138998909|NCT00482391|Trastuzumab|trastuzumab|mesh-list
138998910|NCT00482391|Lapatinib|lapatinib|mesh-list
138998911|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138998912|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998913|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
138998914|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
139040104|NCT03972358|Misoprostol|misoprostol|mesh-list
138998916|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998917|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138998918|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
138998919|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998920|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138998921|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138998922|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
138998923|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138998924|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138998925|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138998926|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138998927|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998928|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138998929|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138998930|NCT00753779|Simvastatin|simvastatin|mesh-list
138998931|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138998932|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138998933|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138998934|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
138998935|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998936|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138998937|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138998938|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998939|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
138998940|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138998941|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138998942|NCT00757523|Analgesics|analgesics|mesh-ancestor
138998943|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
138998944|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572289|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138998945|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998946|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138998947|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138998948|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
138998949|NCT00757679|Milnacipran|milnacipran|mesh-list
138998950|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
138998951|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138998952|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138998953|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138998954|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998955|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998956|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998957|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138998958|NCT00757679|Analgesics|analgesics|mesh-ancestor
138998959|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
138998960|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138998961|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
138998962|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138998963|NCT00496587|Bevacizumab|bevacizumab|mesh-list
138998964|NCT00496587|Gemcitabine|gemcitabine|mesh-list
138998965|NCT00496587|Capecitabine|capecitabine|mesh-list
138998966|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138998967|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998970|NCT00496587|Growth Substances|growth substances|mesh-ancestor
138998971|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998972|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
138998973|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138998974|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
138998975|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998976|NCT00757835|Timolol|timolol|mesh-list
138998977|NCT00757835|Latanoprost|latanoprost|mesh-list
138998978|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138998979|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138998980|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
138998981|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138998982|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998983|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138998984|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138572326|NCT00434668|Cisplatin|cisplatin|mesh-list
138998985|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138998986|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138998987|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138998988|NCT01038154|Pravastatin|pravastatin|mesh-list
138998989|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138998990|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138998991|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
138998992|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138998993|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138998994|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138998995|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138998996|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
138998997|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138998998|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138998999|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138999000|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
138999001|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138999002|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999003|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999004|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999005|NCT01324180|Metformin|metformin|mesh-list
138999006|NCT01324180|Dexamethasone|dexamethasone|mesh-list
138999007|NCT01324180|Doxorubicin|doxorubicin|mesh-list
138999009|NCT01324180|Asparaginase|asparaginase|mesh-list
138999010|NCT01324180|Pegaspargase|pegaspargase|mesh-list
138999011|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138999012|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
138999013|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
138999014|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999015|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999016|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138999017|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
138999018|NCT01324180|Hormones|hormones|mesh-ancestor
138999019|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138999020|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138999021|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999022|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138999023|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138999024|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138999025|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138999026|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572364|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999027|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999028|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138999029|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
138999030|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
138999031|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
138999032|NCT02560649|Tenofovir|tenofovir|mesh-list
138999033|NCT02560649|Lamivudine|lamivudine|mesh-list
138999034|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138999035|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
138999036|NCT02560649|Entecavir|entecavir|mesh-list
138999037|NCT02560649|Adefovir|adefovir|mesh-list
138999038|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138999039|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
138999040|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999041|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139039554|NCT00395694|Lamotrigine|lamotrigine|mesh-list
138999042|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138999043|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999044|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999045|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138999046|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138999047|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
138999048|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999050|NCT00754403|Pioglitazone|pioglitazone|mesh-list
138999051|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138999052|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999053|NCT00758225|Idebenone|idebenone|mesh-list
138999054|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
138999055|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999056|NCT00758225|Protective Agents|protective agents|mesh-ancestor
138999057|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999058|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
138999059|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138999060|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999061|NCT00422734|Tadalafil|tadalafil|mesh-list
138999062|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
138999063|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138999064|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138999065|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999066|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999067|NCT00422734|Urological Agents|urological agents|mesh-ancestor
138999068|NCT00422422|Brivaracetam|brivaracetam|mesh-list
138999069|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
138999070|NCT00413374|Enoxaparin|enoxaparin|mesh-list
138999071|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
138999072|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138999073|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138999074|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999075|NCT00682643|Fluticasone|fluticasone|mesh-list
138999077|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138999078|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138999079|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
138999080|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999081|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999082|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138999083|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
138999084|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
138999085|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138999086|NCT00758381|Sorafenib|sorafenib|mesh-list
138999087|NCT00758381|Cisplatin|cisplatin|mesh-list
138999088|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999089|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138999090|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572452|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999091|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999092|NCT00754871|Dienogest|dienogest|mesh-list
138999093|NCT00754871|Nandrolone|nandrolone|mesh-list
138999094|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138999095|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
138999096|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138999097|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999098|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138999099|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138999100|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138999101|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138999102|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
138999103|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138999104|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138999105|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999106|NCT00754871|Androgens|androgens|mesh-ancestor
138999107|NCT00754871|Hormones|hormones|mesh-ancestor
138999108|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
138999109|NCT00755027|Rasagiline|rasagiline|mesh-list
138999110|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138999111|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999112|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999113|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138999114|NCT00755027|Protective Agents|protective agents|mesh-ancestor
138999115|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999116|NCT01038388|Dexamethasone|dexamethasone|mesh-list
138999117|NCT01038388|Lenalidomide|lenalidomide|mesh-list
138999118|NCT01038388|Bortezomib|bortezomib|mesh-list
138999119|NCT01038388|Vorinostat|vorinostat|mesh-list
138999120|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138999121|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
138999122|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
138999123|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999124|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999126|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
138999127|NCT01038388|Hormones|hormones|mesh-ancestor
138999128|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138999129|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138999130|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999131|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
138999132|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138999133|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138999134|NCT01038388|Growth Substances|growth substances|mesh-ancestor
138999135|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
138999136|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138999137|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999138|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999139|NCT04050059|Lidocaine|lidocaine|mesh-list
138999140|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138999141|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
138999142|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
138999143|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138999144|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999145|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
138999146|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999147|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138999148|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138999149|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138999150|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138491616|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
138999151|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999152|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138999154|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138999155|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999156|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999157|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
138999158|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138999159|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999160|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
138999161|NCT00490035|Brivaracetam|brivaracetam|mesh-list
138999162|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
138999163|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
138999164|NCT00421174|Etanercept|etanercept|mesh-list
138999165|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138999166|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
138999167|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
138999168|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999169|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999170|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138999171|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
138999172|NCT00421174|Hormones|hormones|mesh-ancestor
138999173|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138999174|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138999175|NCT00421174|Protective Agents|protective agents|mesh-ancestor
138999176|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138999177|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138999178|NCT00421174|Analgesics|analgesics|mesh-ancestor
138999179|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
138999180|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138999181|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138999182|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
138999183|NCT00496197|Fluconazole|fluconazole|mesh-list
138999185|NCT00496197|Anidulafungin|anidulafungin|mesh-list
138999186|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
138999187|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999188|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138999189|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138999190|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999191|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999192|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138999193|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
138999194|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138999195|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999196|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138999197|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138999198|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138999199|NCT03996993|Bicalutamide|bicalutamide|mesh-list
138999200|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
138999201|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
138999202|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138999203|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999204|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999205|NCT01015053|Ropivacaine|ropivacaine|mesh-list
138999206|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
138999207|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
138999208|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138999209|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999210|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
138999211|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999212|NCT00404092|Caspofungin|caspofungin|mesh-list
138999213|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
138999214|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139040257|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
138999215|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999216|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999217|NCT00481767|Vaccines|vaccines|mesh-list
138999218|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
138750003|NCT05255146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138999219|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999220|NCT00489489|Interferons|interferons|mesh-list
138999221|NCT00489489|Interferon-beta|interferon-beta|mesh-list
138999222|NCT00489489|Teriflunomide|teriflunomide|mesh-list
138999223|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
138999224|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999225|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
138999226|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999227|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138999228|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138999229|NCT00489489|Analgesics|analgesics|mesh-ancestor
138999230|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
138999231|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999232|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999233|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138999234|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138999235|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138999236|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
138999237|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138999238|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138999239|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138999240|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138999241|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138999242|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999243|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138999244|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999245|NCT00489411|Analgesics|analgesics|mesh-ancestor
138999246|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
138999247|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999248|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
138999249|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138999250|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
138999251|NCT00420784|Interferons|interferons|mesh-list
138999252|NCT00420784|Ribavirin|ribavirin|mesh-list
138999253|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
138999254|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
138999255|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138999256|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999257|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
138999259|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
138999260|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999261|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
138999262|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999263|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138999264|NCT00420628|Tobramycin|tobramycin|mesh-list
138999265|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138999266|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999267|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138999268|NCT00413218|Voriconazole|voriconazole|mesh-list
138999269|NCT00413218|Caspofungin|caspofungin|mesh-list
138999270|NCT00413218|Isavuconazole|isavuconazole|mesh-list
138999271|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
138999272|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999273|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138999274|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138999275|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999276|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999277|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138999278|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
138999279|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138999280|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999281|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138999282|NCT00494871|Warfarin|warfarin|mesh-list
138999283|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
138999285|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138999286|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
138999287|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138999288|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
138999289|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999290|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999291|NCT00420238|Etanercept|etanercept|mesh-list
138750078|NCT04941573|Xenon|xenon|mesh-list
138999292|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138999293|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138999295|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
138999296|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999297|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999298|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138999299|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138999300|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138999301|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138999302|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
138999303|NCT00420004|Escitalopram|escitalopram|mesh-list
138999304|NCT00420004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138999305|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138999306|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138999307|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999308|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138999309|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
139039555|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
138999310|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999311|NCT00494481|Docetaxel|docetaxel|mesh-list
138999312|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999313|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
138999314|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
138999315|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
138999316|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999317|NCT00097591|Clopidogrel|clopidogrel|mesh-list
138999318|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138999319|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138999320|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138999321|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138999322|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138999323|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
138999324|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138999325|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999326|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999327|NCT01082029|Lansoprazole|lansoprazole|mesh-list
138999328|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
138999329|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138999330|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138999331|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138999332|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999333|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999334|NCT00419926|Cyclosporine|cyclosporine|mesh-list
138572651|NCT00437086|Bortezomib|bortezomib|mesh-list
138999335|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
138999336|NCT00419926|Prednisone|prednisone|mesh-list
138999337|NCT00419926|Cyclosporins|cyclosporins|mesh-list
138999338|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138999339|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
138999340|NCT00419926|Hormones|hormones|mesh-ancestor
138999341|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139040356|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138999342|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999343|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138999345|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999346|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999347|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138999348|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
138999349|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
138999350|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999351|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
138999352|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138999353|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138999354|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138999355|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138999356|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
138999357|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138999358|NCT00080119|Isoniazid|isoniazid|mesh-list
138999359|NCT00080119|Trimethoprim|trimethoprim|mesh-list
138999360|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
138999361|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
138999362|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138999363|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999364|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138750150|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
138999365|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138999366|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
138999367|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999368|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138999369|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138999371|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138999372|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138999373|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138999374|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999375|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138572687|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
138999376|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138999377|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138999378|NCT01034878|Sunitinib|sunitinib|mesh-list
138999379|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999380|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138999381|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138999382|NCT01034878|Growth Substances|growth substances|mesh-ancestor
138999383|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999384|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
138999385|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138999386|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999387|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999388|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138999389|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138999390|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138999391|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138999392|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999393|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138999394|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138999395|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138999396|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138999397|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
138999398|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138999399|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999400|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138999401|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138999402|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
138999403|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138999404|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138492437|NCT04729465|Propofol|propofol|mesh-list
138999405|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
138999406|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138999407|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138999408|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999409|NCT00494091|Sirolimus|sirolimus|mesh-list
138999410|NCT00494091|Temsirolimus|temsirolimus|mesh-list
138999411|NCT00494091|MTOR Inhibitors|mtor inhibitors|mesh-list
138999412|NCT00494091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138999413|NCT00494091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999414|NCT00494091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999415|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138999416|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
138999417|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999418|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999419|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138999420|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999421|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138999422|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
138999423|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
138999424|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138999425|NCT01017159|Antibodies|antibodies|mesh-list
138999426|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
138999427|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999428|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
138999429|NCT00494013|Protamines|protamines|mesh-list
138999430|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138999431|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999432|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
138999433|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999434|NCT00494013|Coagulants|coagulants|mesh-ancestor
138999435|NCT00079339|Tipifarnib|tipifarnib|mesh-list
138999436|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999437|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
138999438|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138999439|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
138750224|NCT04117893|Analgesics|analgesics|mesh-ancestor
138999440|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999442|NCT01088191|Protective Agents|protective agents|mesh-ancestor
138999443|NCT01082341|Vaccines|vaccines|mesh-list
138999444|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
138999445|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999446|NCT00541866|Cytarabine|cytarabine|mesh-list
138999447|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138999448|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
138999449|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999450|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999451|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
138999452|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999453|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492577|NCT00084019|Ritonavir|ritonavir|mesh-list
138999454|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
138999455|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999456|NCT00493467|Rituximab|rituximab|mesh-list
138999457|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138999458|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999459|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
138999460|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999461|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138999462|NCT00090493|Immunomodulating Agents|immunomodulating agents|mesh-list
138999463|NCT00090493|Immunologic Factors|immunologic factors|mesh-ancestor
138999464|NCT00090493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999465|NCT01088347|Mapatumumab|mapatumumab|mesh-list
138999466|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999467|NCT04221828|Paclitaxel|paclitaxel|mesh-list
138999468|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138999469|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138999470|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999471|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
138999472|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
138999473|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
138999474|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999475|NCT04221750|Metformin|metformin|mesh-list
138999476|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138999477|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999478|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
138999479|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138999480|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
138999481|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999482|NCT01017393|Ketamine|ketamine|mesh-list
138999483|NCT01017393|Analgesics|analgesics|mesh-ancestor
138999484|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
138999485|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999486|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999487|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138999488|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138999489|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
138999490|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
138999491|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138999492|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138999493|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138999494|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138999495|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999496|NCT00493311|Acetaminophen|acetaminophen|mesh-list
138999497|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138999498|NCT00493311|Analgesics|analgesics|mesh-ancestor
138999499|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
138999500|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999501|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999502|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
138999503|NCT00571649|Enoxaparin|enoxaparin|mesh-list
138999504|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
138999505|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
138999506|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138999507|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
138999508|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138999509|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
138999510|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999511|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999512|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
138999513|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138750296|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
138999514|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138999515|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138999516|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
138999517|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999518|NCT03917472|Aflibercept|aflibercept|mesh-list
138999519|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138999520|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138999521|NCT03917472|Growth Substances|growth substances|mesh-ancestor
138999522|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999523|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
138999524|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999525|NCT00681863|Pramipexole|pramipexole|mesh-list
138999526|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
138999527|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999528|NCT00681863|Protective Agents|protective agents|mesh-ancestor
138999529|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999530|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138999531|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138999532|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
138999533|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
138999534|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138999536|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138999537|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
138999538|NCT05677620|Propofol|propofol|mesh-list
138999539|NCT05677620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138999540|NCT05677620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138999541|NCT05677620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999542|NCT05677620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138999543|NCT05677620|Anesthetics, General|anesthetics, general|mesh-ancestor
138999544|NCT05677620|Anesthetics|anesthetics|mesh-ancestor
138999545|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138999546|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
138999547|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138999548|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138999549|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138999550|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138999551|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999552|NCT00969176|Acetaminophen|acetaminophen|mesh-list
138999553|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138999554|NCT00969176|Analgesics|analgesics|mesh-ancestor
138999555|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
138999556|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999557|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999558|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
138999559|NCT04503252|Cefazolin|cefazolin|mesh-list
138999560|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138999561|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999562|NCT00679367|Dexamethasone|dexamethasone|mesh-list
138999563|NCT00679367|Lenalidomide|lenalidomide|mesh-list
138999564|NCT00679367|Melphalan|melphalan|mesh-list
138999565|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138999566|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
138999567|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
138999568|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999569|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999570|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138999571|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
138999572|NCT00679367|Hormones|hormones|mesh-ancestor
138999573|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138999574|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138999575|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999576|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
138999577|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138999578|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138999579|NCT00679367|Growth Substances|growth substances|mesh-ancestor
138999580|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
138572869|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138999581|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138999582|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
138999583|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999584|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138999585|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138999586|NCT00969566|Metformin|metformin|mesh-list
138999587|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138999588|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138999589|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999590|NCT00969566|Incretins|incretins|mesh-ancestor
138750383|NCT02991456|Rolapitant|rolapitant|mesh-list
138999592|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138999593|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138999594|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
138999595|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999596|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999597|NCT00755495|Doxepin|doxepin|mesh-list
138999598|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138999599|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138999600|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138999601|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999602|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138999603|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
138999604|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138999605|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
138999606|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
138999607|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138999608|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999609|NCT00964184|Metformin|metformin|mesh-list
138999610|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138572891|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
138999611|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999612|NCT00969800|Chlorine dioxide|chlorine dioxide|mesh-list
138999613|NCT00969800|Dental Disinfectants|dental disinfectants|mesh-ancestor
138999614|NCT00969800|Disinfectants|disinfectants|mesh-ancestor
138999615|NCT00969800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999616|NCT00964262|Exenatide|exenatide|mesh-list
138999617|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138999618|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999619|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138999620|NCT00964262|Incretins|incretins|mesh-ancestor
138999621|NCT00964262|Hormones|hormones|mesh-ancestor
138999622|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138999623|NCT00973778|Capecitabine|capecitabine|mesh-list
138999624|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138999625|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
138999626|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999627|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999628|NCT05623410|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138999629|NCT05623410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138999630|NCT05623410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999631|NCT05623410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999632|NCT05623410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138999633|NCT05623410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138999634|NCT05623410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999635|NCT05623410|Cholinergic Agents|cholinergic agents|mesh-ancestor
138999636|NCT05623410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138999637|NCT00964418|Insulin|insulin|mesh-list
138999638|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138999639|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
138999640|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138999641|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999642|NCT00974012|Valproic Acid|valproic acid|mesh-list
138999643|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
138999644|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999645|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999646|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
138999647|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572935|NCT00439855|Heparin|heparin|mesh-list
138999648|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999649|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
138999650|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138999651|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138999652|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138999654|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138999655|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
138999656|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
138999657|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138999658|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999659|NCT00970580|Paclitaxel|paclitaxel|mesh-list
138999660|NCT00970580|Carboplatin|carboplatin|mesh-list
138999661|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
138999662|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138999663|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999664|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
138999665|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
138999666|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
138999667|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999668|NCT00974324|Endostar protein|endostar protein|mesh-list
138999669|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138999670|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138999671|NCT00974324|Growth Substances|growth substances|mesh-ancestor
138999672|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999673|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
138999674|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999675|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
138999676|NCT00545714|Rituximab|rituximab|mesh-list
138999677|NCT00545714|Fludarabine|fludarabine|mesh-list
138999678|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138999679|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
138999680|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999681|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138999682|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138999683|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
138999684|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999685|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999686|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138999687|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138999688|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
138999689|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138999690|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999691|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138999692|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138999693|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999694|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999695|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999696|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
138999697|NCT00539838|Prednisone|prednisone|mesh-list
138999698|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
138999699|NCT00539838|Methotrexate|methotrexate|mesh-list
138999700|NCT00539838|Azathioprine|azathioprine|mesh-list
138999701|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138999702|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
138999703|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138999704|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
138999705|NCT00539838|Hormones|hormones|mesh-ancestor
138999706|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138999707|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999708|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138999709|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999710|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138999711|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
138999712|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138999713|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138999714|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
138999715|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999716|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
138999717|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999718|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138999719|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
138999720|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138999721|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138999722|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138999723|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138999724|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
138999725|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138999726|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999728|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
138999729|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999730|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138999731|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138999732|NCT00539838|Protective Agents|protective agents|mesh-ancestor
138999733|NCT00970892|Warfarin|warfarin|mesh-list
138999734|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
138999735|NCT00964808|Oxycodone|oxycodone|mesh-list
138999736|NCT00964808|Buprenorphine|buprenorphine|mesh-list
138999737|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138999738|NCT00964808|Narcotics|narcotics|mesh-ancestor
138999739|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138999740|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999741|NCT00964808|Analgesics|analgesics|mesh-ancestor
138999742|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
138999743|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999744|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138999745|NCT00970970|Bevacizumab|bevacizumab|mesh-list
138999746|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
138999747|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138999748|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999749|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138999750|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138999751|NCT00970970|Growth Substances|growth substances|mesh-ancestor
138999752|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999753|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
138999754|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138572989|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
138999755|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999756|NCT03765450|Infliximab|infliximab|mesh-list
138999757|NCT03765450|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138999758|NCT03765450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138999759|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
138999760|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138999761|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138999762|NCT00971126|Thalidomide|thalidomide|mesh-list
138999763|NCT00971126|Sorafenib|sorafenib|mesh-list
138999764|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999765|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138999766|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999767|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999768|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138999769|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
138999770|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999771|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
138999772|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138999773|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999774|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138999775|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138999776|NCT00971126|Growth Substances|growth substances|mesh-ancestor
138999777|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
138999778|NCT00964964|Insulin|insulin|mesh-list
138999779|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138999780|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
138999781|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138999782|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999784|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
138999785|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138999786|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999787|NCT00974792|Leucovorin|leucovorin|mesh-list
138999788|NCT00974792|Cytarabine|cytarabine|mesh-list
138999789|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
138999790|NCT00974792|Ifosfamide|ifosfamide|mesh-list
138999791|NCT00974792|Rituximab|rituximab|mesh-list
138999792|NCT00974792|Doxorubicin|doxorubicin|mesh-list
138999793|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138999794|NCT00974792|Methotrexate|methotrexate|mesh-list
138999795|NCT00974792|Etoposide|etoposide|mesh-list
138999796|NCT00974792|Vincristine|vincristine|mesh-list
138999797|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
138999798|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
138999799|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138999800|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
138999801|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999802|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138999803|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138999804|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
138999805|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999806|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999807|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138999808|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138999809|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138999810|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138999811|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138999812|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573014|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
138493585|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
138999813|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138999814|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
138999815|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138999816|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138750600|NCT00446043|Analgesics|analgesics|mesh-ancestor
138999817|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
138999818|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
138999819|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138999820|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138999821|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138999822|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
138999823|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999824|NCT00974792|Antidotes|antidotes|mesh-ancestor
138999825|NCT00974792|Protective Agents|protective agents|mesh-ancestor
138999826|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
138999827|NCT00974792|Vitamins|vitamins|mesh-ancestor
138999828|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
138999829|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
138999830|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
138493642|NCT00006167|Hormones|hormones|mesh-ancestor
138999831|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
138999832|NCT00965120|Bradykinin|bradykinin|mesh-list
138999833|NCT00965120|Kininogens|kininogens|mesh-list
138999834|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
138999835|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
138999836|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138999837|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
138999838|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999839|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999840|NCT00679289|Interferons|interferons|mesh-list
138999841|NCT00679289|Ecromeximab|ecromeximab|mesh-list
138999842|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999843|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
138999844|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999845|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138999846|NCT00679211|Trastuzumab|trastuzumab|mesh-list
138999847|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138999848|NCT00679211|Maytansine|maytansine|mesh-list
138999849|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138999850|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999851|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138999852|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
138999853|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
138999854|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
138999855|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999856|NCT00679211|Immunotoxins|immunotoxins|mesh-ancestor
138999857|NCT00679211|Immunoconjugates|immunoconjugates|mesh-ancestor
138999858|NCT00679211|Immunologic Factors|immunologic factors|mesh-ancestor
138999859|NCT00679211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999860|NCT00545948|Cisplatin|cisplatin|mesh-list
138999861|NCT00545948|Pemetrexed|pemetrexed|mesh-list
138999862|NCT00545948|Vinorelbine|vinorelbine|mesh-list
138999863|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999864|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999865|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999866|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138999867|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139040727|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999868|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138999869|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
138999870|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
138999871|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
138999872|NCT00755573|Pregabalin|pregabalin|mesh-list
138999873|NCT00755573|Analgesics|analgesics|mesh-ancestor
138999874|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
138999875|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999876|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999877|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
138999878|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138999879|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138999880|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999881|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138999882|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138999883|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138999884|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138999885|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138999886|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
138999887|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
138999888|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999889|NCT04008290|Liraglutide|liraglutide|mesh-list
138999890|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138999891|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999893|NCT04008290|Hormones|hormones|mesh-ancestor
138999894|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138999895|NCT02559167|Cannabidiol|cannabidiol|mesh-list
138999896|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
138999897|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138999898|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493864|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138999899|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138999900|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999901|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999902|NCT05271071|Lidocaine|lidocaine|mesh-list
138999903|NCT05271071|Anesthetics, Local|anesthetics, local|mesh-ancestor
138999904|NCT05271071|Anesthetics|anesthetics|mesh-ancestor
138999905|NCT05271071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138999906|NCT05271071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999907|NCT05271071|Sensory System Agents|sensory system agents|mesh-ancestor
138999908|NCT05271071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999909|NCT05271071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138999910|NCT05271071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138999911|NCT05271071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138999912|NCT05271071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138999913|NCT05271071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999914|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
138999915|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138999916|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
138999917|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999918|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040756|NCT01048632|Oxandrolone|oxandrolone|mesh-list
138999919|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138999920|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
138999921|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138999922|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138999923|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138999924|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
138999925|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138999926|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999927|NCT00972218|Adalimumab|adalimumab|mesh-list
138999928|NCT00972218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138999929|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138999930|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138999931|NCT05230901|Dihydralazine|dihydralazine|mesh-list
138999932|NCT05230901|Spironolactone|spironolactone|mesh-list
138999933|NCT05230901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138999934|NCT05230901|Hormone Antagonists|hormone antagonists|mesh-ancestor
138999935|NCT05230901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138999936|NCT05230901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999937|NCT05230901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138999938|NCT05230901|Diuretics|diuretics|mesh-ancestor
138999939|NCT05230901|Natriuretic Agents|natriuretic agents|mesh-ancestor
138999940|NCT05230901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138999941|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
138999942|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138999943|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138999944|NCT03927950|Bupropion|bupropion|mesh-list
138999945|NCT03927950|Escitalopram|escitalopram|mesh-list
138999946|NCT03927950|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138999947|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138999948|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138999949|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999950|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138999951|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
138999952|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999953|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138999954|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
138494041|NCT00006233|Cyclosporine|cyclosporine|mesh-list
138999956|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138999957|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
138999958|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138999959|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138999960|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999961|NCT00972842|Lenalidomide|lenalidomide|mesh-list
138999962|NCT00972842|Vorinostat|vorinostat|mesh-list
138999963|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
138999964|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999965|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138999966|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138750752|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
138999968|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
138999969|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138999970|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138999971|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999972|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999973|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
138999974|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
138999975|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138999976|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138999977|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138999978|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573070|NCT02957266|Gemcitabine|gemcitabine|mesh-list
138999979|NCT00975494|Urological Agents|urological agents|mesh-ancestor
138999981|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
138999982|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999983|NCT00965666|Etanercept|etanercept|mesh-list
138999984|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138999985|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138999987|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
138999988|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138999989|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999990|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138999991|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138999992|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138999993|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138999994|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
138999995|NCT00975728|Antioxidants|antioxidants|mesh-list
138999996|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138999997|NCT00975728|Protective Agents|protective agents|mesh-ancestor
138999998|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138999999|NCT04049747|Bicalutamide|bicalutamide|mesh-list
139000000|NCT04049747|Finasteride|finasteride|mesh-list
139000001|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
139000002|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
139000003|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139000004|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000005|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000006|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139000007|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139000008|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000009|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000010|NCT04049747|Urological Agents|urological agents|mesh-ancestor
139000011|NCT00973154|Prednisone|prednisone|mesh-list
139000012|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139000013|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
139000014|NCT00973154|Hormones|hormones|mesh-ancestor
139000015|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139000016|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000017|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139000018|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000019|NCT00965900|Propranolol|propranolol|mesh-list
139000020|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139000021|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139000022|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
139000023|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573086|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
139000024|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000025|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000026|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139000027|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139000028|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
139000029|NCT00973232|Acetaminophen|acetaminophen|mesh-list
139000030|NCT00973232|Tramadol|tramadol|mesh-list
139000031|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139000032|NCT00973232|Analgesics|analgesics|mesh-ancestor
139000033|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
139000034|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139000035|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000036|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
139000037|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139000038|NCT00973232|Narcotics|narcotics|mesh-ancestor
138750828|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139000039|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139000040|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139000041|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000042|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139000043|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000044|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000045|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
139000046|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139000047|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000048|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139000049|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139000050|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000051|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000052|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000053|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139000054|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139000055|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139000056|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000057|NCT00966056|Mitomycins|mitomycins|mesh-list
139000058|NCT00966056|Mitomycin|mitomycin|mesh-list
139000059|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139000060|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000061|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
139000062|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000063|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139000064|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000065|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139000066|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
139000067|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000068|NCT03523728|Venglustat|venglustat|mesh-list
139000069|NCT03523728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000070|NCT03523728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000071|NCT00979706|Cyclosporine|cyclosporine|mesh-list
139000072|NCT00979706|Interleukin-2|interleukin-2|mesh-list
139000073|NCT00979706|Cyclosporins|cyclosporins|mesh-list
139000074|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000075|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000076|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139000077|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
139000078|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000079|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
139000080|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000081|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
139000082|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139000083|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139000084|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000085|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139000086|NCT00979706|Analgesics|analgesics|mesh-ancestor
139000087|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
139000088|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139000090|NCT00979862|Maleic acid|maleic acid|mesh-list
139000091|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000092|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000093|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000094|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139000095|NCT00966290|Warfarin|warfarin|mesh-list
139000096|NCT00966290|Anticoagulants|anticoagulants|mesh-list
139000097|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
139000098|NCT00966290|Fluindione|fluindione|mesh-list
139000099|NCT00966290|Phenindione|phenindione|mesh-list
139000100|NCT00966368|Insulin|insulin|mesh-list
139000101|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139000102|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
139000103|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139000104|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000105|NCT00980408|Cycloserine|cycloserine|mesh-list
139000106|NCT00980408|Memantine|memantine|mesh-list
139000107|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139000108|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139000109|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
139000110|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139000111|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000112|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000113|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139000114|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139000115|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139000116|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000117|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139000118|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
139000119|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139000120|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
139000121|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
139000122|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
139000123|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139000124|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139000125|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000126|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139000127|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139000128|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000129|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000130|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000131|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139000132|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139000134|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139000135|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000136|NCT00990054|Plerixafor|plerixafor|mesh-list
139000137|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139000138|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139000139|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
139000140|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000141|NCT05361408|Zoledronic Acid|zoledronic acid|mesh-list
139000142|NCT05361408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139000143|NCT05361408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000144|NCT05590572|Etoposide|etoposide|mesh-list
139000145|NCT05590572|Ifosfamide|ifosfamide|mesh-list
139000146|NCT05590572|Isophosphamide mustard|isophosphamide mustard|mesh-list
138494450|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
139000147|NCT05590572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139000148|NCT05590572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000149|NCT05590572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139000150|NCT05590572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139000151|NCT05590572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000152|NCT05590572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000153|NCT05590572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139000154|NCT05590572|Alkylating Agents|alkylating agents|mesh-ancestor
139000155|NCT00990444|Insulin|insulin|mesh-list
139000156|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139000157|NCT00990444|Dextrans|dextrans|mesh-list
139000158|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139000159|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040883|NCT00361218|Serotonin|serotonin|mesh-list
139000160|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
139000161|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
139000162|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
139000163|NCT00990600|Tenofovir|tenofovir|mesh-list
139000164|NCT00990600|Emtricitabine|emtricitabine|mesh-list
139000165|NCT00990600|Efavirenz|efavirenz|mesh-list
139000166|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
139000167|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000168|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139000169|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139000170|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000171|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000172|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139000173|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138494564|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
139000174|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139000175|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139000176|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139000177|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139000178|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139000179|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139000180|NCT02897076|Betamethasone|betamethasone|mesh-list
139000181|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
139000182|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139000183|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
139000184|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139000185|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139000186|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
139000187|NCT02897076|Hormones|hormones|mesh-ancestor
138494629|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139000188|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138750972|NCT01134393|Amlodipine|amlodipine|mesh-list
139000189|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000190|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139000191|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
139000192|NCT00990678|Vitamin D|vitamin d|mesh-list
139000193|NCT00990678|Calcitriol|calcitriol|mesh-list
139000194|NCT00990678|Calcium|calcium|mesh-list
139000195|NCT00990678|Vitamins|vitamins|mesh-ancestor
139000196|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
139000197|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000198|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139000199|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139000200|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139000201|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139000202|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000203|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139000204|NCT00538590|Mitomycins|mitomycins|mesh-list
139000205|NCT00538590|Mitomycin|mitomycin|mesh-list
139000206|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138494691|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000207|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000208|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
139000209|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000210|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139000211|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000212|NCT00990834|Simvastatin|simvastatin|mesh-list
139000213|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139000214|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139000215|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
139000216|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000217|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139000218|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139000219|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000220|NCT00990990|Linezolid|linezolid|mesh-list
139000221|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
139000222|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139000223|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000224|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139000225|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000226|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000227|NCT00466947|Vaccines|vaccines|mesh-list
139000228|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139000229|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
139000230|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041144|NCT00183196|Naltrexone|naltrexone|mesh-list
139000231|NCT00537810|Sibutramine|sibutramine|mesh-list
139000232|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
139000233|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139000234|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
139000235|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139000236|NCT00989352|Rituximab|rituximab|mesh-list
139000237|NCT00989352|Methotrexate|methotrexate|mesh-list
139000238|NCT00989352|Lomustine|lomustine|mesh-list
139000239|NCT00989352|Procarbazine|procarbazine|mesh-list
139000240|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139000242|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
139000243|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000244|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139000245|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139000246|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
138494743|NCT00098683|Amifostine|amifostine|mesh-list
139000247|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139000248|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139000249|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
139000250|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000251|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
139000252|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000253|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139000254|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139000255|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139000256|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139000257|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
139000258|NCT05566626|Tropicamide|tropicamide|mesh-list
139000259|NCT05566626|Mydriatics|mydriatics|mesh-ancestor
139000260|NCT05566626|Autonomic Agents|autonomic agents|mesh-ancestor
139000261|NCT05566626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139000262|NCT05566626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000263|NCT05566626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139000264|NCT05566626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138751044|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
139000265|NCT05566626|Cholinergic Agents|cholinergic agents|mesh-ancestor
139000266|NCT05566626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139000267|NCT05566626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000268|NCT00989508|Perhexiline|perhexiline|mesh-list
139000269|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139000270|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139000271|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000272|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139000273|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000274|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
139000276|NCT05360394|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139000277|NCT05360394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139000278|NCT05360394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000279|NCT05360394|Tubulin Modulators|tubulin modulators|mesh-ancestor
139000280|NCT05360394|Antimitotic Agents|antimitotic agents|mesh-ancestor
139000281|NCT05360394|Mitosis Modulators|mitosis modulators|mesh-ancestor
139000282|NCT05360394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000284|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139000285|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139000286|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139000287|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139000288|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000289|NCT00079183|Sirolimus|sirolimus|mesh-list
139000290|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139000291|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000292|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139000293|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000294|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
139000295|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139000296|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
139000297|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000298|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139000299|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
139000300|NCT01086085|Adefovir|adefovir|mesh-list
139000301|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
139000302|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000303|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
139000304|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000305|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139000306|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139000307|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039556|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139000308|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000309|NCT01589419|Capecitabine|capecitabine|mesh-list
139000310|NCT01589419|Veliparib|veliparib|mesh-list
139000311|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139000312|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
139000313|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000314|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000315|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139000316|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000317|NCT00676403|Pregabalin|pregabalin|mesh-list
139000318|NCT00676403|Analgesics|analgesics|mesh-ancestor
139000319|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
139000320|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139000321|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000322|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
139000323|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139000324|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139000325|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000326|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139000327|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139000328|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139000329|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139000330|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139000331|NCT00078325|Modafinil|modafinil|mesh-list
139000332|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139000333|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000334|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139000335|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138573225|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
139000336|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138751120|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000337|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000338|NCT03963193|Cisplatin|cisplatin|mesh-list
139000339|NCT03963193|Irinotecan|irinotecan|mesh-list
139000340|NCT03963193|Etoposide|etoposide|mesh-list
139000341|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000342|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139000343|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139000344|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000345|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000346|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139000347|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139000348|NCT03961867|Docetaxel|docetaxel|mesh-list
139000349|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
139000350|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000351|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
139000352|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
139000353|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
139000354|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000355|NCT00077857|Docetaxel|docetaxel|mesh-list
139000356|NCT00077857|Capecitabine|capecitabine|mesh-list
139000357|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000358|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
139000359|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
139000360|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
139000361|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000362|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139000363|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
139000364|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
139000365|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139000366|NCT00545402|Tacrolimus|tacrolimus|mesh-list
139000367|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139000368|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
139000369|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000370|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139000371|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000372|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000373|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139000374|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000375|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139000376|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
139000377|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139000378|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000379|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139000380|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
139000381|NCT00545402|Hormones|hormones|mesh-ancestor
139000382|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139000383|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139000384|NCT00545402|Protective Agents|protective agents|mesh-ancestor
139000385|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139000386|NCT03963115|Epinephrine|epinephrine|mesh-list
139000387|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139000388|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139000389|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
139000390|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139000391|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000392|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000393|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139000394|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139000395|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
139000396|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139000397|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139000398|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
139000399|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
139000400|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
139000401|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139000402|NCT01583023|Bupropion|bupropion|mesh-list
139000403|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139000404|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
139000405|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139000406|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139000407|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139000408|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139000409|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751200|NCT01129557|Valsartan|valsartan|mesh-list
139000410|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
139000411|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139000412|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000413|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139000414|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139000415|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000417|NCT00976976|Docetaxel|docetaxel|mesh-list
139000418|NCT00976976|Capecitabine|capecitabine|mesh-list
139041646|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
139000419|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000420|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
139000421|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
139000422|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
139000423|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000424|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139000425|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
139000426|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139000427|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
139000428|NCT00977054|Ribavirin|ribavirin|mesh-list
139000429|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
139000430|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139000431|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
139000432|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000433|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
139000434|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000435|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
139000436|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000437|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000438|NCT00977132|Lenalidomide|lenalidomide|mesh-list
139000439|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
139000440|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000441|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139000442|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139000443|NCT00977132|Growth Substances|growth substances|mesh-ancestor
139000444|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
139000445|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000446|NCT00545792|Bevacizumab|bevacizumab|mesh-list
139000447|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139000449|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139000450|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139000451|NCT00545792|Growth Substances|growth substances|mesh-ancestor
139000452|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000453|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
139000454|NCT00977288|Atorvastatin|atorvastatin|mesh-list
139000455|NCT00977288|Anacetrapib|anacetrapib|mesh-list
139000456|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139000457|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139000458|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
139000459|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000460|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139000461|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139000462|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000464|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139000465|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139000466|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000467|NCT00966680|Anesthetics|anesthetics|mesh-list
139000468|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139000469|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000470|NCT00977444|Prednisolone|prednisolone|mesh-list
138495245|NCT00101842|Pemetrexed|pemetrexed|mesh-list
139000471|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139000472|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
139000473|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139000474|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
139000475|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139000476|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
139000477|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139000478|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
139000479|NCT00977444|Hormones|hormones|mesh-ancestor
139000480|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139000481|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000482|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138751265|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
139000483|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000484|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
139000485|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
139000486|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139000487|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139000488|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139000489|NCT00977444|Protective Agents|protective agents|mesh-ancestor
139000490|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139000491|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000492|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
139000493|NCT00966836|Valganciclovir|valganciclovir|mesh-list
139000494|NCT00966836|Everolimus|everolimus|mesh-list
139000495|NCT00966836|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139000496|NCT00966836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139000497|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000498|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000499|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139000500|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
139000501|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000502|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000503|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139000504|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139000505|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
139000506|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139000507|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000508|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
139000509|NCT00967070|Nicotine|nicotine|mesh-list
139000510|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139000511|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
139000512|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495303|NCT00102622|Paclitaxel|paclitaxel|mesh-list
139000513|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000514|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139000515|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139000516|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
139000517|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139000518|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000519|NCT00977756|Ritonavir|ritonavir|mesh-list
139000520|NCT00977756|Lopinavir|lopinavir|mesh-list
139000521|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139000522|NCT00977756|Darunavir|darunavir|mesh-list
139000523|NCT00977756|Tenofovir|tenofovir|mesh-list
139000524|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
139000525|NCT00977756|Maraviroc|maraviroc|mesh-list
139000526|NCT00977756|Etravirine|etravirine|mesh-list
139000527|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139000528|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139000529|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
139000530|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000531|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000532|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139000533|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139000534|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
139000535|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000536|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139000537|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139000538|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139000539|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139000540|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139000541|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139000542|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139000543|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139000544|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139000545|NCT00967148|Tinzaparin|tinzaparin|mesh-list
139000546|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139000547|NCT00967148|Dalteparin|dalteparin|mesh-list
139000548|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
139000549|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139000550|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139000551|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000552|NCT04007588|Nivolumab|nivolumab|mesh-list
139000553|NCT04007588|Ipilimumab|ipilimumab|mesh-list
139000554|NCT04007588|Linrodostat|linrodostat|mesh-list
139000555|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139000556|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000557|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139041942|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138573314|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
139000558|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000559|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000560|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
139000561|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041994|NCT00262041|Vaccines|vaccines|mesh-list
139000562|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
139000563|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000564|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000565|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139000566|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
139000567|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139000568|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000569|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139000570|NCT00967382|Dalteparin|dalteparin|mesh-list
139000571|NCT00967382|Tinzaparin|tinzaparin|mesh-list
139000572|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139000573|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
139000574|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139000575|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139000576|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000577|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
139000578|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139000579|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000580|NCT00982202|Pioglitazone|pioglitazone|mesh-list
139000581|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139000582|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000583|NCT00967538|Etanercept|etanercept|mesh-list
139000584|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139000585|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139000586|NCT00967538|Analgesics|analgesics|mesh-ancestor
139000587|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
139000588|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139000589|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000590|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139000591|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139000592|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139000593|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139000594|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
139000595|NCT00982358|Valsartan|valsartan|mesh-list
139000596|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139000597|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139000598|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139000599|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000601|NCT00982436|Docetaxel|docetaxel|mesh-list
139000602|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000603|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
139000605|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
139000606|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000607|NCT00545168|Permethrin|permethrin|mesh-list
139000608|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000609|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000610|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139000611|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139000612|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139000613|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
139000614|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000615|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139000616|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139000617|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000618|NCT00983138|Asparaginase|asparaginase|mesh-list
139000619|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000620|NCT00544544|Riluzole|riluzole|mesh-list
139000621|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
139000622|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139000623|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139000624|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139000625|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000626|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495603|NCT00104806|Vitamin D|vitamin d|mesh-list
139000627|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139000628|NCT00544544|Protective Agents|protective agents|mesh-ancestor
139000629|NCT00979160|Dasatinib|dasatinib|mesh-list
139042152|NCT01049672|Alfentanil|alfentanil|mesh-list
139000631|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139000632|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000633|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000634|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
139000635|NCT00979316|BMS 708163|bms 708163|mesh-list
139000636|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139000637|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000638|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139000639|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139000640|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000641|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000642|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000643|NCT00979316|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139000644|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139000645|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
139000646|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
139000648|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139000649|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000650|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139000651|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000652|NCT00983996|Alendronate|alendronate|mesh-list
139000653|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139000654|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000655|NCT00985244|Azithromycin|azithromycin|mesh-list
139000656|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139000657|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000658|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
139000659|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139000660|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139000661|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
139000662|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139000663|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000664|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000665|NCT00979472|Urological Agents|urological agents|mesh-ancestor
139000666|NCT00984152|Efavirenz|efavirenz|mesh-list
139000667|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139000668|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
139000669|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139000670|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139000671|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042407|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139000672|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000674|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000675|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139000676|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139000677|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139000678|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138495849|NCT00401206|Analgesics|analgesics|mesh-ancestor
139000679|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139000680|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139000681|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139000682|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139000683|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139000684|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139000686|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
139000687|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139000688|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
139000689|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000690|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000691|NCT00984230|Lactoferrin|lactoferrin|mesh-list
139000692|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000693|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139000694|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139000695|NCT00984386|Estradiol|estradiol|mesh-list
139000696|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139000697|NCT00984386|Estrogens|estrogens|mesh-ancestor
139000698|NCT00984386|Hormones|hormones|mesh-ancestor
139000699|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138495979|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139000700|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000701|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139000702|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
139000703|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139000704|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139000705|NCT00984464|Paclitaxel|paclitaxel|mesh-list
138751487|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
139000706|NCT00984464|Carboplatin|carboplatin|mesh-list
139000707|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139000708|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000709|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
139000710|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
139000711|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
139000712|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000713|NCT00985556|Capecitabine|capecitabine|mesh-list
139000714|NCT00985556|Tegafur|tegafur|mesh-list
139000715|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
138496040|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
139000716|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139000717|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
139000718|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000719|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000720|NCT04445246|Iloprost|iloprost|mesh-list
139042736|NCT00114244|Gemcitabine|gemcitabine|mesh-list
139000721|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139000722|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
139000723|NCT00541346|Methylphenidate|methylphenidate|mesh-list
139000724|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139000725|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000726|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139000727|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139000728|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139000729|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000730|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
139000731|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139000732|NCT00988520|Bromides|bromides|mesh-list
139000733|NCT00988520|Propofol|propofol|mesh-list
139000734|NCT00988520|Sevoflurane|sevoflurane|mesh-list
139000735|NCT00988520|Rocuronium|rocuronium|mesh-list
139000736|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139000737|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139000738|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000739|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139000740|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
139000741|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
139000742|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139000743|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139000744|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
139042851|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
139000746|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139000747|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139000748|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139000749|NCT05498090|Fenofibrate|fenofibrate|mesh-list
139000750|NCT05498090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139000751|NCT05498090|Antimetabolites|antimetabolites|mesh-ancestor
139000752|NCT05498090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000753|NCT05498090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139000755|NCT00077623|Hematinics|hematinics|mesh-ancestor
139000756|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
139000757|NCT00541034|Rituximab|rituximab|mesh-list
139000758|NCT00541034|Pentostatin|pentostatin|mesh-list
139000759|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139000760|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
139000761|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000762|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139000763|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139000764|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
139000765|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000766|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000767|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139000768|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139000769|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139000770|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000771|NCT00540644|Prednisone|prednisone|mesh-list
139000772|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
139000773|NCT00540644|Lenalidomide|lenalidomide|mesh-list
139000774|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139000775|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
139000776|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000777|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139000778|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139000779|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
139000780|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751569|NCT04404049|UB-421|ub-421|mesh-list
139000781|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000782|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139000783|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139000784|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
139000785|NCT00540644|Hormones|hormones|mesh-ancestor
139000786|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138496182|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000787|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139000788|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139000789|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139000790|NCT00540644|Growth Substances|growth substances|mesh-ancestor
139000791|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
139000793|NCT05450900|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139000794|NCT05450900|Vitamins|vitamins|mesh-ancestor
139000795|NCT05450900|Micronutrients|micronutrients|mesh-ancestor
139000796|NCT05450900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000797|NCT05450900|Vitamin B Complex|vitamin b complex|mesh-ancestor
139000798|NCT05450900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139000799|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
139000800|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
139000801|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139000802|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139000803|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000804|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139000805|NCT00986336|Topiramate|topiramate|mesh-list
139000806|NCT00986336|Risperidone|risperidone|mesh-list
139000807|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139000808|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
139000809|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139000810|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000811|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000812|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139000813|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139000814|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139000815|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139000816|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139000817|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
139000818|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
139000819|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139000820|NCT00989300|Omeprazole|omeprazole|mesh-list
139000821|NCT00989300|Rabeprazole|rabeprazole|mesh-list
139000822|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139000823|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139000824|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139000825|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000826|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000827|NCT01563614|Cytarabine|cytarabine|mesh-list
139000829|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139000831|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000832|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000833|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
139000834|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000835|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139000836|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
139000837|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000838|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139000839|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
139000840|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138496362|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
139000841|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139000842|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
139000843|NCT00543296|Hormones|hormones|mesh-ancestor
139000844|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139000845|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000846|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
139000847|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
139000848|NCT00543062|Loxapine|loxapine|mesh-list
139000849|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139000850|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043380|NCT00335322|Ritonavir|ritonavir|mesh-list
139000851|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139000852|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139000853|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000854|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000855|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000856|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000857|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
139000858|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
139000859|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139000861|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139000862|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139000863|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139000864|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139000865|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139000866|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
139000867|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139000868|NCT00986804|Decitabine|decitabine|mesh-list
139000869|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139000870|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
139000871|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000872|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000873|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000874|NCT00676091|Vaccines|vaccines|mesh-list
139000875|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139000876|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
139000877|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000878|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139000879|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
139000880|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496556|NCT00401674|Paclitaxel|paclitaxel|mesh-list
139000881|NCT02558933|Protective Agents|protective agents|mesh-ancestor
139043551|NCT03741621|Psyllium|psyllium|mesh-list
139000882|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000884|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139000885|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000886|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139000887|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
139000888|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139000889|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139000890|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139000891|NCT03903822|PF-06700841|pf-06700841|mesh-list
139000892|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139000893|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000894|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000895|NCT04003350|Acetaminophen|acetaminophen|mesh-list
139000896|NCT04003350|Meloxicam|meloxicam|mesh-list
139000897|NCT04003350|Oxycodone|oxycodone|mesh-list
139000899|NCT04003350|Gabapentin|gabapentin|mesh-list
139000900|NCT04003350|Esomeprazole|esomeprazole|mesh-list
139000901|NCT04003350|Metaxalone|metaxalone|mesh-list
139000902|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139000903|NCT04003350|Narcotics|narcotics|mesh-ancestor
139000904|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139000905|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000906|NCT04003350|Analgesics|analgesics|mesh-ancestor
139000907|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
139000908|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139000909|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
139000910|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139000911|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139000912|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139043679|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139000913|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139000914|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139000915|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139000916|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000918|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139000919|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139000920|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139000921|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000922|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139000923|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
139000924|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139000925|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139000926|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139000927|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139000928|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139000929|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139000930|NCT00748007|Rivastigmine|rivastigmine|mesh-list
139000931|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
139000932|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000933|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000934|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
139000935|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139000936|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000937|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139000938|NCT00748007|Protective Agents|protective agents|mesh-ancestor
139000939|NCT00748163|Paclitaxel|paclitaxel|mesh-list
139000940|NCT00748163|Sunitinib|sunitinib|mesh-list
139000941|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139000942|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139000943|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000945|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
139000946|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
139000947|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000948|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139000949|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139000950|NCT00748163|Growth Substances|growth substances|mesh-ancestor
139000951|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000952|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
139000953|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139000954|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139000955|NCT00687401|Infliximab|infliximab|mesh-list
139000956|NCT00687401|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139000957|NCT00687401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139000958|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
139000959|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139000960|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139000961|NCT00485693|Epinephrine|epinephrine|mesh-list
139000962|NCT00485693|Bupivacaine|bupivacaine|mesh-list
139000964|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
139000965|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139000966|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000967|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
139000968|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139000969|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139000970|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139043994|NCT06108544|Apremilast|apremilast|mesh-list
139000972|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573474|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000973|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000974|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139000975|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139000976|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
139000977|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139000978|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
139000979|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
139000980|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
139000981|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139000983|NCT00538902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139000984|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139000985|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139000986|NCT00541970|Vaccines|vaccines|mesh-list
139000987|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
139000988|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139000990|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139000991|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
139000992|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139000993|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139000994|NCT00989742|Doxycycline|doxycycline|mesh-list
139000995|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139000996|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496907|NCT00113815|Topiramate|topiramate|mesh-list
139000998|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139000999|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139001000|NCT05408208|Triamcinolone|triamcinolone|mesh-list
139001001|NCT05408208|Methotrexate|methotrexate|mesh-list
139001002|NCT05408208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139001003|NCT05408208|Abortifacient Agents|abortifacient agents|mesh-ancestor
139001004|NCT05408208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139001005|NCT05408208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001006|NCT05408208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139001007|NCT05408208|Antimetabolites|antimetabolites|mesh-ancestor
139001008|NCT05408208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001009|NCT05408208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001010|NCT05408208|Dermatologic Agents|dermatologic agents|mesh-ancestor
139001011|NCT05408208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001012|NCT05408208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139001013|NCT05408208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139001014|NCT05408208|Immunologic Factors|immunologic factors|mesh-ancestor
139001015|NCT05408208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139001016|NCT05408208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139044257|NCT05776862|Ursolic acid|ursolic acid|mesh-list
139001017|NCT05408208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139001018|NCT05408208|Glucocorticoids|glucocorticoids|mesh-ancestor
139001019|NCT05408208|Hormones|hormones|mesh-ancestor
139001020|NCT05408208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139001021|NCT00758693|Rituximab|rituximab|mesh-list
139001022|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139001023|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139001024|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001025|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
139001026|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001027|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138496959|NCT00114361|Ribavirin|ribavirin|mesh-list
139001028|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139001029|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
139001030|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001031|NCT00989820|Coal Tar|coal tar|mesh-list
139001032|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
139001033|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
139001034|NCT05357820|Itraconazole|itraconazole|mesh-list
139001035|NCT05357820|Rifampin|rifampin|mesh-list
139001036|NCT05357820|Antifungal Agents|antifungal agents|mesh-ancestor
139001037|NCT05357820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001038|NCT05357820|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139001039|NCT05357820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139001040|NCT05357820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001041|NCT05357820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496998|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
139001042|NCT05357820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139001043|NCT05357820|Hormone Antagonists|hormone antagonists|mesh-ancestor
139001044|NCT05357820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139001045|NCT05357820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001046|NCT05357820|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139001047|NCT05357820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139001048|NCT05357820|Antitubercular Agents|antitubercular agents|mesh-ancestor
139001049|NCT05357820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139001050|NCT05357820|Leprostatic Agents|leprostatic agents|mesh-ancestor
139001051|NCT05357820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139001052|NCT05357820|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139001053|NCT05357820|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139001054|NCT05357820|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139001055|NCT05357820|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139001056|NCT05357820|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138497059|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
139001057|NCT05357820|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139001058|NCT00748787|Psyllium|psyllium|mesh-list
139001059|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
139001060|NCT00748787|Cathartics|cathartics|mesh-ancestor
139001061|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139001062|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
139001063|NCT05712044|Folic Acid|folic acid|mesh-list
139001064|NCT05712044|Vitamin B Complex|vitamin b complex|mesh-list
139001065|NCT05712044|Hematinics|hematinics|mesh-ancestor
139001066|NCT05712044|Vitamins|vitamins|mesh-ancestor
139001067|NCT05712044|Micronutrients|micronutrients|mesh-ancestor
139001068|NCT05712044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001069|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139001070|NCT00986960|Hormones|hormones|mesh-ancestor
139001071|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139001072|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001073|NCT05711966|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139001074|NCT05711966|Respiratory System Agents|respiratory system agents|mesh-ancestor
139001075|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
138497120|NCT00115102|Ketamine|ketamine|mesh-list
139001077|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139001078|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139001079|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
139001080|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001081|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001082|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001083|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139001084|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139001086|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139001087|NCT04360070|Ketamine|ketamine|mesh-list
139001088|NCT04360070|Analgesics|analgesics|mesh-ancestor
139001089|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
139001090|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001091|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001092|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138497179|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001094|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
139001095|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
139001096|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139001097|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139001098|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139001099|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001100|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001101|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
139001102|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
139001103|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
139001104|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001105|NCT00749021|Ranibizumab|ranibizumab|mesh-list
139001106|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139001107|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139001108|NCT00749021|Growth Substances|growth substances|mesh-ancestor
139001109|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001110|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
139001111|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001112|NCT04048889|Ropivacaine|ropivacaine|mesh-list
139001113|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139001114|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
139001115|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
139001116|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139001117|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001118|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
139001119|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001121|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139001122|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139001123|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139001124|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001125|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139001126|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139001127|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139001128|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139001129|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
139001130|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
139001131|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
139001132|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
139001133|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001134|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001135|NCT05711810|Ubiquinone|ubiquinone|mesh-list
139001136|NCT05711810|Coenzyme Q10|coenzyme q10|mesh-list
139001137|NCT05711810|Tocopherols|tocopherols|mesh-list
139001138|NCT05711810|Vitamin E|vitamin e|mesh-list
139001139|NCT05711810|alpha-Tocopherol|alpha-tocopherol|mesh-list
139001140|NCT05711810|Metoprolol|metoprolol|mesh-list
139001141|NCT05711810|Enalapril|enalapril|mesh-list
139001142|NCT05711810|Enalaprilat|enalaprilat|mesh-list
139001143|NCT05711810|Nifedipine|nifedipine|mesh-list
139001144|NCT05711810|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139001145|NCT05711810|Lansoprazole|lansoprazole|mesh-list
139001146|NCT05711810|Superoxide Dismutase|superoxide dismutase|mesh-list
139001147|NCT05711810|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139001148|NCT05711810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139001149|NCT05711810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139001150|NCT05711810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001151|NCT05711810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001152|NCT05711810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001153|NCT05711810|Analgesics|analgesics|mesh-ancestor
139001154|NCT05711810|Sensory System Agents|sensory system agents|mesh-ancestor
139001155|NCT05711810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001156|NCT05711810|Antidepressive Agents|antidepressive agents|mesh-ancestor
138751944|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139001157|NCT05711810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139001158|NCT05711810|Dopamine Agents|dopamine agents|mesh-ancestor
139001159|NCT05711810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001160|NCT05711810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139001161|NCT05711810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139001162|NCT05711810|Sympatholytics|sympatholytics|mesh-ancestor
139001163|NCT05711810|Autonomic Agents|autonomic agents|mesh-ancestor
139001164|NCT05711810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139001165|NCT05711810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139045002|NCT03789110|Nivolumab|nivolumab|mesh-list
139001166|NCT05711810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139001167|NCT05711810|Adrenergic Agents|adrenergic agents|mesh-ancestor
139001168|NCT05711810|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139001169|NCT05711810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139001170|NCT05711810|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139001171|NCT05711810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139001172|NCT05711810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139001173|NCT05711810|Vasodilator Agents|vasodilator agents|mesh-ancestor
139001174|NCT05711810|Tocolytic Agents|tocolytic agents|mesh-ancestor
139001175|NCT05711810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139001176|NCT05711810|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139001177|NCT05711810|Protease Inhibitors|protease inhibitors|mesh-ancestor
139001178|NCT05711810|Micronutrients|micronutrients|mesh-ancestor
139001179|NCT05711810|Vitamins|vitamins|mesh-ancestor
139001180|NCT05711810|Antioxidants|antioxidants|mesh-ancestor
139001181|NCT05711810|Protective Agents|protective agents|mesh-ancestor
139001182|NCT05711810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139001183|NCT00759083|Bivalirudin|bivalirudin|mesh-list
139001184|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
138497463|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139045074|NCT03545464|Prednisone|prednisone|mesh-list
139001185|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139001186|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
139001187|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001188|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001189|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
139001190|NCT00759239|Timolol|timolol|mesh-list
139001191|NCT00759239|Travoprost|travoprost|mesh-list
139001192|NCT00759239|Maleic acid|maleic acid|mesh-list
139001193|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001194|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001195|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139001196|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139001197|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
139001198|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001199|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001200|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139001201|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139001202|NCT03742908|Clindamycin|clindamycin|mesh-list
139001203|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
139001204|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
139001205|NCT03742908|Cefazolin|cefazolin|mesh-list
139001206|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139001207|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001208|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139001209|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001210|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001211|NCT05357196|Gemcitabine|gemcitabine|mesh-list
139001212|NCT05357196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139001213|NCT05357196|Antimetabolites|antimetabolites|mesh-ancestor
139001214|NCT05357196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001215|NCT05357196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045245|NCT02861417|Fludarabine|fludarabine|mesh-list
139001217|NCT05232630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139001218|NCT05232630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139001219|NCT05232630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139001220|NCT05232630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001221|NCT05232630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001222|NCT05232630|Serotonin Agents|serotonin agents|mesh-ancestor
139001223|NCT05232630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001224|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
139001225|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
139001226|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001227|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045321|NCT02561273|Hormones|hormones|mesh-ancestor
139001228|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001229|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
139001230|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
139001231|NCT01004874|Bevacizumab|bevacizumab|mesh-list
139001232|NCT01004874|Temozolomide|temozolomide|mesh-list
139001233|NCT01004874|Topotecan|topotecan|mesh-list
139001234|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139001235|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001236|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139001237|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139001238|NCT01004874|Growth Substances|growth substances|mesh-ancestor
139001239|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001240|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
139001241|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139001242|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
139001243|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001244|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139001245|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139001246|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001248|NCT00987116|Azathioprine|azathioprine|mesh-list
139001249|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139001250|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
139001252|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139001253|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001254|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139001255|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001256|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
139001257|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001258|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139001259|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139001260|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
139001261|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139001262|NCT05711732|Busulfan|busulfan|mesh-list
139001263|NCT05711732|Alkylating Agents|alkylating agents|mesh-ancestor
139001264|NCT05711732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001265|NCT05711732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139001266|NCT05711732|Immunologic Factors|immunologic factors|mesh-ancestor
139001267|NCT05711732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001268|NCT05711732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139001269|NCT05711732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001270|NCT05711732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139001271|NCT04004702|Levetiracetam|levetiracetam|mesh-list
139045509|NCT01088750|Hormones|hormones|mesh-ancestor
139001272|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
139001273|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
139001274|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
139001275|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
139001276|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139001277|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
139001278|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001279|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139001281|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
139001282|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001283|NCT04731974|Protective Agents|protective agents|mesh-ancestor
139001284|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001285|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139001286|NCT00987662|Amlodipine|amlodipine|mesh-list
139001287|NCT00987662|Irbesartan|irbesartan|mesh-list
139001288|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139001289|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139001290|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139045628|NCT00182637|Bortezomib|bortezomib|mesh-list
139001291|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001292|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139001293|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001294|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
139001295|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139001296|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139001297|NCT00090103|Tamsulosin|tamsulosin|mesh-list
139001298|NCT00090103|Dutasteride|dutasteride|mesh-list
139001299|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139001300|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139001301|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139001302|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
139001303|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001304|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001305|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001306|NCT00090103|Urological Agents|urological agents|mesh-ancestor
139001307|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139045689|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
139001308|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139001310|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
139001311|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139001313|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139001314|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
139001315|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001316|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139001317|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139001318|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001319|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001320|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139001321|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139001322|NCT00087607|Ribavirin|ribavirin|mesh-list
139001323|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139001324|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139001325|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
139001326|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001329|NCT01088737|Imiquimod|imiquimod|mesh-list
139001330|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139001331|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
139001332|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001333|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001334|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
139001335|NCT00069823|Esomeprazole|esomeprazole|mesh-list
139001336|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139001337|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139001338|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138498147|NCT00122629|Interferons|interferons|mesh-list
139001339|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001340|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001342|NCT01088815|Gemcitabine|gemcitabine|mesh-list
139001343|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139001344|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001345|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
139001346|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
139001347|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
139045875|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001348|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001349|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139001350|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
139001351|NCT00086515|Metformin|metformin|mesh-list
139001352|NCT00086515|Pioglitazone|pioglitazone|mesh-list
139001353|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139001354|NCT00086515|Glipizide|glipizide|mesh-list
139001355|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139001356|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001357|NCT00086515|Incretins|incretins|mesh-ancestor
139001358|NCT00086515|Hormones|hormones|mesh-ancestor
139001359|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045978|NCT00104572|Vitamin D|vitamin d|mesh-list
139001360|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139001361|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
139001362|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498283|NCT05638763|Dasatinib|dasatinib|mesh-list
139045994|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001363|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001364|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
139001365|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
139001366|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139001367|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139001368|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001369|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139001370|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001371|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139001372|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139001373|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139001374|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001376|NCT04334174|Immunoconjugates|immunoconjugates|mesh-ancestor
139001377|NCT04334174|Immunologic Factors|immunologic factors|mesh-ancestor
139001378|NCT04334174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001379|NCT00987974|Atorvastatin|atorvastatin|mesh-list
139001380|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139001381|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139001382|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138498350|NCT00394537|Labetalol|labetalol|mesh-list
139001383|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
139001384|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001385|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139001386|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139001387|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001389|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001390|NCT03905642|Amikacin|amikacin|mesh-list
139001391|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139001392|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001393|NCT04126538|Pirfenidone|pirfenidone|mesh-list
139001394|NCT04126538|Analgesics|analgesics|mesh-ancestor
139001395|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
139001396|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001397|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001398|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139001399|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139001400|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139001402|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001403|NCT04004234|Manganese|manganese|mesh-list
139001404|NCT04004234|Paclitaxel|paclitaxel|mesh-list
139001405|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139001406|NCT04004234|Gemcitabine|gemcitabine|mesh-list
139001407|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139001408|NCT04004234|Antibodies|antibodies|mesh-list
139001409|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
139001410|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139001411|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001412|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
139001413|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
139001414|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
139001415|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001416|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
138573696|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139001417|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001418|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139001419|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
139001420|NCT04004234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139001421|NCT04004234|Trace Elements|trace elements|mesh-ancestor
139001422|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
139001423|NCT00990158|Vitamin K|vitamin k|mesh-list
139001425|NCT00990158|Vitamins|vitamins|mesh-ancestor
139001426|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
138498506|NCT00019084|Aldesleukin|aldesleukin|mesh-list
139001427|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001429|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139001430|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001431|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
139001432|NCT00990158|Coagulants|coagulants|mesh-ancestor
139001433|NCT00412984|Warfarin|warfarin|mesh-list
139001434|NCT00412984|Apixaban|apixaban|mesh-list
139001435|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
139001436|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139001437|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
139001438|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139001439|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
139001440|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001441|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001442|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
138498586|NCT00019513|Leucovorin|leucovorin|mesh-list
139001443|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
139001444|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
139001445|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001446|NCT00539864|Coagulants|coagulants|mesh-ancestor
139001447|NCT04003376|Vitamin D|vitamin d|mesh-list
139001448|NCT04003376|Triamcinolone|triamcinolone|mesh-list
139001449|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139001450|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139001451|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139001452|NCT04003376|Vitamins|vitamins|mesh-ancestor
139001453|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
139001454|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001455|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139046463|NCT01052792|Naproxen|naproxen|mesh-list
139001456|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139001457|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
138752239|NCT01124175|Losartan|losartan|mesh-list
139001458|NCT04003376|Hormones|hormones|mesh-ancestor
139001459|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139001460|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139001462|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001463|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001464|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139001465|NCT04086212|Icodextrin|icodextrin|mesh-list
139046492|NCT01045538|Capecitabine|capecitabine|mesh-list
139001466|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
139001467|NCT05404490|Bupivacaine|bupivacaine|mesh-list
139001468|NCT05404490|Anesthetics, Local|anesthetics, local|mesh-ancestor
139001469|NCT05404490|Anesthetics|anesthetics|mesh-ancestor
139001470|NCT05404490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139001471|NCT05404490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001472|NCT05404490|Sensory System Agents|sensory system agents|mesh-ancestor
139001473|NCT05404490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001474|NCT05359874|Bevacizumab|bevacizumab|mesh-list
139001475|NCT05359874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139001476|NCT05359874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001477|NCT05359874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139001478|NCT05359874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139001479|NCT05359874|Growth Substances|growth substances|mesh-ancestor
139001480|NCT05359874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001481|NCT05359874|Growth Inhibitors|growth inhibitors|mesh-ancestor
139001482|NCT00990392|Polymyxins|polymyxins|mesh-list
139001483|NCT00990392|Bacitracin|bacitracin|mesh-list
139001484|NCT00990392|Polymyxin B|polymyxin b|mesh-list
139001485|NCT00990392|Gramicidin|gramicidin|mesh-list
139001486|NCT00990392|Petrolatum|petrolatum|mesh-list
139001487|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139001488|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001489|NCT00990392|Emollients|emollients|mesh-ancestor
139001490|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
139001491|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139001492|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
139001493|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139001494|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001495|NCT03367754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139001496|NCT03367754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001498|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139001499|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001500|NCT01034956|Calcium|calcium|mesh-list
139001501|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
139046603|NCT00095056|Hormones|hormones|mesh-ancestor
139001502|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139001503|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001504|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139001505|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
139001506|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
139001507|NCT01034956|Protective Agents|protective agents|mesh-ancestor
139001508|NCT01580878|Butenafine|butenafine|mesh-list
139001509|NCT01580878|Clotrimazole|clotrimazole|mesh-list
139001510|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
139001511|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498739|NCT00020332|Alvocidib|alvocidib|mesh-list
139001512|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139001513|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139001514|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139001515|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001516|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001517|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139001518|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
139046675|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
139001519|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139001520|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001521|NCT05589974|Verteporfin|verteporfin|mesh-list
139001522|NCT05589974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139001523|NCT05589974|Dermatologic Agents|dermatologic agents|mesh-ancestor
139001524|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139001525|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001526|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139001527|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001528|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001530|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
139001531|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139001532|NCT04003844|Antibodies|antibodies|mesh-list
139001533|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
138752315|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
138498784|NCT00020488|Leucovorin|leucovorin|mesh-list
139001534|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
139001535|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001536|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139001538|NCT04003844|Analgesics|analgesics|mesh-ancestor
139001539|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
139001540|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001541|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139001542|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139001543|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139001544|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139001545|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001546|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139001547|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139001548|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001550|NCT05589584|Acetylcysteine|acetylcysteine|mesh-list
139001551|NCT05589584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139001552|NCT05589584|Antiviral Agents|antiviral agents|mesh-ancestor
139001553|NCT05589584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001555|NCT05589584|Respiratory System Agents|respiratory system agents|mesh-ancestor
139001556|NCT05589584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139001557|NCT05589584|Antioxidants|antioxidants|mesh-ancestor
139001558|NCT05589584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001559|NCT05589584|Protective Agents|protective agents|mesh-ancestor
139001560|NCT05589584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001561|NCT05589584|Antidotes|antidotes|mesh-ancestor
139001562|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139001563|NCT00412750|Telbivudine|telbivudine|mesh-list
139001564|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
139001565|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001566|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139001567|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001568|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001569|NCT05361278|Chlorhexidine|chlorhexidine|mesh-list
139001570|NCT05361278|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139001571|NCT05361278|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139001573|NCT05361278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139001574|NCT05361278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139001575|NCT05361278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001576|NCT05361278|Disinfectants|disinfectants|mesh-ancestor
139001577|NCT05361278|Dermatologic Agents|dermatologic agents|mesh-ancestor
139001579|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139001580|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139001581|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498966|NCT00021073|Vitamins|vitamins|mesh-ancestor
139001582|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139001583|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
139001585|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139001586|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139001587|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139001588|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139001589|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001590|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001591|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001592|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139001593|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
138499017|NCT00021463|Lamivudine|lamivudine|mesh-list
139001594|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139001595|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139001597|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139001598|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001599|NCT01041040|Immunotoxins|immunotoxins|mesh-ancestor
139001600|NCT01041040|Immunoconjugates|immunoconjugates|mesh-ancestor
139001601|NCT01041040|Immunologic Factors|immunologic factors|mesh-ancestor
139001602|NCT01041040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001603|NCT00765011|Cetuximab|cetuximab|mesh-list
139001604|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138499079|NCT00021814|Doxazosin|doxazosin|mesh-list
139001605|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001606|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
139001607|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139001608|NCT00765167|Triclosan|triclosan|mesh-list
138752383|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
139001609|NCT00765167|Fluorides|fluorides|mesh-list
139001610|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
139001611|NCT00765167|Protective Agents|protective agents|mesh-ancestor
139001612|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001613|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139001614|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001615|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
139001616|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
139001617|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139001618|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139001619|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
139001620|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001621|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139001622|NCT00759551|Olmesartan|olmesartan|mesh-list
139001623|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139001624|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139001625|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139001626|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139001627|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001628|NCT03905096|Donepezil|donepezil|mesh-list
139001629|NCT03905096|BI 425809|bi 425809|mesh-list
139001630|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139001631|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001632|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001633|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
139001634|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001635|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001636|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
139001637|NCT00412360|Cyclosporine|cyclosporine|mesh-list
139001638|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
139001639|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
139001640|NCT00412360|Fludarabine|fludarabine|mesh-list
139001641|NCT00412360|Cyclosporins|cyclosporins|mesh-list
139001642|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139001644|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001645|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139001646|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139001647|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
139001648|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001649|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001650|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139001651|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001652|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
139001653|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001654|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
139001655|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139001656|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139001657|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139001658|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
139001659|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139001660|NCT00761501|Naproxen|naproxen|mesh-list
139001661|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139001662|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139001663|NCT00761501|Analgesics|analgesics|mesh-ancestor
139001664|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
139001666|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001667|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139001668|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139001669|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
139001670|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139001671|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499408|NCT00022945|Hormones|hormones|mesh-ancestor
139001672|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001673|NCT01088893|Everolimus|everolimus|mesh-list
139001674|NCT01088893|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139001675|NCT01088893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139001676|NCT01088893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001677|NCT01088893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001678|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139001679|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
139001680|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001681|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001682|NCT03026036|Raclopride|raclopride|mesh-list
139001683|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139001684|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139001685|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139001686|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001687|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139001688|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139001689|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
139001690|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001691|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001692|NCT00990860|Doxorubicin|doxorubicin|mesh-list
139001693|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139001694|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001695|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139001696|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139001697|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001698|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001699|NCT01035190|Budesonide|budesonide|mesh-list
139001700|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139001701|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139001702|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
139001703|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001704|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001705|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139001706|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
139001707|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
139001708|NCT01035190|Hormones|hormones|mesh-ancestor
139001709|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139001710|NCT00571103|Acamprosate|acamprosate|mesh-list
139001711|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139001712|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139001713|NCT00765557|Laxatives|laxatives|mesh-ancestor
139001714|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139001715|NCT01086553|Budesonide|budesonide|mesh-list
139001716|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139001717|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139001718|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
139001719|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001720|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001722|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
139001723|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
139001724|NCT01086553|Hormones|hormones|mesh-ancestor
139001725|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139001726|NCT01041508|Cyclosporine|cyclosporine|mesh-list
139001727|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
139001728|NCT01041508|Clofarabine|clofarabine|mesh-list
139001729|NCT01041508|Cyclosporins|cyclosporins|mesh-list
139001730|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001731|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001732|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139001734|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001735|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
139001736|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001737|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
139001738|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139001739|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139001740|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139001741|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001742|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139001743|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
139001744|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139001745|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139001746|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
139001747|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139001748|NCT00766025|Calcium|calcium|mesh-list
139001749|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139001750|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001751|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139001752|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139001753|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
139001754|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001755|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139001756|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139001757|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752535|NCT02868580|Lamivudine|lamivudine|mesh-list
139001759|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
139001760|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
139001761|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139001762|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001763|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
139001764|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001765|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139001766|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139001767|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139001768|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139001769|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001771|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
139001772|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001773|NCT00991250|Temozolomide|temozolomide|mesh-list
139001774|NCT00991250|Dacarbazine|dacarbazine|mesh-list
139001775|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139001776|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
139001777|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001778|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001780|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139001781|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
139001782|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139001783|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001784|NCT00760175|Vaccines|vaccines|mesh-list
139001785|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
139001786|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001787|NCT00766337|Sirolimus|sirolimus|mesh-list
139001788|NCT00766337|Temsirolimus|temsirolimus|mesh-list
139001789|NCT00766337|Ranibizumab|ranibizumab|mesh-list
139001790|NCT00766337|MTOR Inhibitors|mtor inhibitors|mesh-list
139001791|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139001792|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001793|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139001794|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001795|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
139001796|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139001797|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
139001798|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001799|NCT00766337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139001800|NCT00766337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001801|NCT00766337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001802|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139001803|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139001804|NCT00766337|Growth Substances|growth substances|mesh-ancestor
139001805|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
139001806|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
139001807|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
139001808|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139001809|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001810|NCT00991562|Immunotoxins|immunotoxins|mesh-ancestor
139001811|NCT00991562|Immunoconjugates|immunoconjugates|mesh-ancestor
139001812|NCT00991562|Immunologic Factors|immunologic factors|mesh-ancestor
139001813|NCT00991562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001814|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139001815|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
139001816|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
139001817|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
139001818|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001820|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139001821|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139001822|NCT00762671|Analgesics|analgesics|mesh-ancestor
139001823|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
139001824|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001825|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001826|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139001827|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139001828|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139001829|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139001830|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
139001831|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001832|NCT00762671|Protective Agents|protective agents|mesh-ancestor
139001833|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139001834|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001835|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139001837|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001838|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139001839|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001840|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001841|NCT00766805|Propranolol|propranolol|mesh-list
139001842|NCT00766805|Isosorbide|isosorbide|mesh-list
139001843|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139001844|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139001845|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139001847|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
139001848|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001849|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001850|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001851|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139001852|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139001853|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
139001854|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139001855|NCT00766805|Diuretics|diuretics|mesh-ancestor
139001856|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
139001857|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139001858|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
139001859|NCT00762749|Promethazine|promethazine|mesh-list
139001860|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139001861|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139001862|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139001863|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001864|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
139001865|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
139001866|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
139047587|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
139001867|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001868|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
139001869|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
138499884|NCT00395239|Budesonide|budesonide|mesh-list
139001870|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139001871|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139001872|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
139001873|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
139001874|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001875|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001876|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139001877|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
139001878|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
139001879|NCT00403546|Ziprasidone|ziprasidone|mesh-list
139001880|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139001881|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
139001882|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001883|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499940|NCT00025168|Gemcitabine|gemcitabine|mesh-list
139001884|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001885|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139001886|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139001887|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139001888|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139001889|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139001890|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
139001891|NCT00767117|Ritonavir|ritonavir|mesh-list
139001892|NCT00767117|Lopinavir|lopinavir|mesh-list
139001893|NCT00767117|Etravirine|etravirine|mesh-list
139001894|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139001895|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139001896|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
139001897|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001898|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001899|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139001900|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139001901|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
139001902|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001903|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139001904|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139001905|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139001906|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139001908|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
139001909|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
139001910|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138752677|NCT02867800|Promethazine|promethazine|mesh-list
139001911|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139001912|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139001913|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
139001914|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
139001915|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001916|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001917|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001919|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139001920|NCT00403234|Narcotics|narcotics|mesh-ancestor
139047983|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
139001921|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139001922|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001924|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
138574108|NCT00454402|Urological Agents|urological agents|mesh-ancestor
139001925|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001926|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139001927|NCT04049201|Midazolam|midazolam|mesh-list
139001928|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139001929|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139001930|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139001931|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001932|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139001933|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139001934|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139001935|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139001936|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
139001937|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
139001938|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
139001939|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
139048187|NCT01056614|Methotrexate|methotrexate|mesh-list
139001940|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139001941|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001942|NCT00767663|Dipyridamole|dipyridamole|mesh-list
139001943|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139001944|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001945|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001946|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139001947|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
139001948|NCT00402688|Levofloxacin|levofloxacin|mesh-list
139001949|NCT00402688|Ofloxacin|ofloxacin|mesh-list
139001950|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139001951|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001952|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139001953|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139001954|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139001955|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001956|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001957|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001958|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139001959|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139001960|NCT04049045|Empagliflozin|empagliflozin|mesh-list
139001961|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139001962|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001963|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139001964|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001965|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139001966|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139001967|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001968|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
139001970|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139001972|NCT01035580|Analgesics|analgesics|mesh-ancestor
139001973|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
139001974|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001975|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001976|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139001977|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139001978|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139001979|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001980|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001981|NCT00671879|Carisoprodol|carisoprodol|mesh-list
139001982|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139001983|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139001984|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139001985|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139001987|NCT00767975|Isoniazid|isoniazid|mesh-list
139001988|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139001989|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
139001990|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139048515|NCT01064154|Carvedilol|carvedilol|mesh-list
139001991|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139001992|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
139001993|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139001994|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139001995|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139001996|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139001997|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139001998|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139001999|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139002000|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139002001|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139002002|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139002003|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139002004|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
139002005|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139002006|NCT00768131|Paclitaxel|paclitaxel|mesh-list
139002007|NCT00768131|Carboplatin|carboplatin|mesh-list
139002008|NCT00768131|Cetuximab|cetuximab|mesh-list
139002009|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139002010|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002011|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
139002012|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
139002013|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
139048758|NCT00156819|Xhance|xhance|mesh-list
139002014|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002015|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139002017|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
139002018|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139002019|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139002020|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139048781|NCT00224133|Silodosin|silodosin|mesh-list
139002021|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002022|NCT00768209|Topiramate|topiramate|mesh-list
139002023|NCT00768209|Phentermine|phentermine|mesh-list
139002024|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
139002025|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139002026|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002027|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139002028|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
139002029|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139002030|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
139002031|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
139002032|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002033|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
139002034|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138500623|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
139002035|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002036|NCT00401752|Esomeprazole|esomeprazole|mesh-list
139002038|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139002039|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139002040|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139002041|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139002042|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002043|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002044|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139002045|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
139002046|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
139002047|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002048|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002049|NCT00770471|Temozolomide|temozolomide|mesh-list
139002050|NCT00770471|Veliparib|veliparib|mesh-list
139002051|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139048979|NCT00481871|Vitamins|vitamins|mesh-list
139002052|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
139002053|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002054|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752853|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
139002055|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139002056|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002057|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
139002058|NCT00539240|Nortriptyline|nortriptyline|mesh-list
139002059|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
139002060|NCT00539240|Rabeprazole|rabeprazole|mesh-list
139002061|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139002062|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139002063|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139002064|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002065|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002066|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139002067|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139002068|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139002069|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139002070|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
139002071|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002072|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002073|NCT00417976|Bevacizumab|bevacizumab|mesh-list
139002074|NCT00417976|Gemcitabine|gemcitabine|mesh-list
139002075|NCT00417976|Fluorouracil|fluorouracil|mesh-list
139002076|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139002077|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002078|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139002079|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139002080|NCT00417976|Growth Substances|growth substances|mesh-ancestor
139002081|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002082|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
139002083|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139002084|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
139002085|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002086|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139002087|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
139002088|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
138500758|NCT00028171|Tacrolimus|tacrolimus|mesh-list
139002089|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139002092|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002093|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002094|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002095|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139002096|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
139002097|NCT00991796|Paclitaxel|paclitaxel|mesh-list
139002099|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139002100|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002101|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
139002102|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
139002103|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
138500781|NCT00395434|Bevacizumab|bevacizumab|mesh-list
139002104|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002105|NCT00673673|Bevacizumab|bevacizumab|mesh-list
139002106|NCT00673673|Fluorouracil|fluorouracil|mesh-list
139049219|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
139002107|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139002108|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002109|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139002110|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139002111|NCT00673673|Growth Substances|growth substances|mesh-ancestor
139049288|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
139002112|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002113|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
139002114|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
139002115|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002116|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139002117|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139002118|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
139002119|NCT00763685|Etoricoxib|etoricoxib|mesh-list
139002120|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139002122|NCT00763685|Analgesics|analgesics|mesh-ancestor
139002123|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
139002124|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002125|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002126|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139002127|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139002128|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139002129|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139002130|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002131|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002132|NCT04048655|Neostigmine|neostigmine|mesh-list
139002133|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139002134|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002135|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500916|NCT00028561|Carboplatin|carboplatin|mesh-list
139002136|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
139002137|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139002138|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002139|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139002140|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
139002141|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574171|NCT00110006|Hormones|hormones|mesh-ancestor
139002143|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
139002144|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139002145|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002146|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
139002147|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139002149|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002150|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
139002151|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002152|NCT05408936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139002153|NCT05408936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002154|NCT05408936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139002155|NCT05408936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002156|NCT02558153|Paclitaxel|paclitaxel|mesh-list
139002157|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139002158|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002159|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
139002160|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
139002161|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
139002162|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002163|NCT00763763|Interferons|interferons|mesh-list
139002165|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
139002166|NCT00763763|Dexamethasone|dexamethasone|mesh-list
139002167|NCT00763763|Vincristine|vincristine|mesh-list
139002168|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
139002169|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139002170|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
139002171|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
139049678|NCT00303108|Carboplatin|carboplatin|mesh-list
139002172|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139002173|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139002174|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139002175|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
139002176|NCT00763763|Hormones|hormones|mesh-ancestor
139002177|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139002178|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139002179|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139002180|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
139002181|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139002182|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139002183|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
139002184|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
139002185|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
139002186|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139002187|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139002188|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139002189|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
139002191|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
138711779|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711780|NCT04612998|Atropine|atropine|mesh-list
138711781|NCT04612998|Ephedrine|ephedrine|mesh-list
138711782|NCT04612998|Metoclopramide|metoclopramide|mesh-list
138711783|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138711784|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138711785|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138711786|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
138711787|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711788|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711789|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138711790|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
138711791|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
138711792|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
138647577|NCT03942328|Vaccines|vaccines|mesh-list
138711892|NCT02114060|Vaccines|vaccines|mesh-list
138711893|NCT02114060|Immunologic Factors|immunologic factors|mesh-ancestor
138711894|NCT02114060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711895|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138711896|NCT02104388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138711897|NCT02104388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138711898|NCT04633044|Betaine|betaine|mesh-list
138711899|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138712138|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138712153|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
139049865|NCT03982784|Morphine|morphine|mesh-list
138712154|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138712156|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712157|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138712158|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138712159|NCT00561093|Protective Agents|protective agents|mesh-ancestor
138712160|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712161|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
138712162|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138712163|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
138712164|NCT01960010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138712165|NCT01960010|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138712166|NCT01165021|Folic Acid|folic acid|mesh-list
138712167|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
138712168|NCT01165021|Dexamethasone|dexamethasone|mesh-list
138712169|NCT01165021|Pemetrexed|pemetrexed|mesh-list
138712170|NCT01165021|Vitamins|vitamins|mesh-ancestor
138712171|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
138712172|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712173|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138712174|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
138712176|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712177|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138712178|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
138712179|NCT01165021|Hormones|hormones|mesh-ancestor
138712180|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138712181|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138712182|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668489|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
138712183|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712184|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712185|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138712186|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138712187|NCT01165021|Hematinics|hematinics|mesh-ancestor
138712188|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
138712189|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
138574230|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138712190|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
138712192|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712193|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138712194|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138712195|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712196|NCT01956812|Gemcitabine|gemcitabine|mesh-list
138712197|NCT01956812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138712198|NCT01956812|Antimetabolites|antimetabolites|mesh-ancestor
138712199|NCT01956812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648080|NCT02986659|Metformin|metformin|mesh-list
138712217|NCT01952990|Nasal Decongestants|nasal decongestants|mesh-ancestor
138712218|NCT01952990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138712219|NCT01952990|Respiratory System Agents|respiratory system agents|mesh-ancestor
138712220|NCT01952990|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138712222|NCT01952990|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138712223|NCT01952990|Protective Agents|protective agents|mesh-ancestor
138712224|NCT04314310|Tenoxicam|tenoxicam|mesh-list
138712225|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138712226|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138712227|NCT04314310|Analgesics|analgesics|mesh-ancestor
138712228|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
138712229|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712230|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712231|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138712232|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138712233|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138712234|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712235|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712236|NCT04610307|Anesthetics|anesthetics|mesh-list
138712237|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138712238|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712239|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
138712240|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138712241|NCT04610502|Antibodies|antibodies|mesh-list
138712242|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
138712243|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712244|NCT01164475|Plerixafor|plerixafor|mesh-list
138712245|NCT01164475|Lenograstim|lenograstim|mesh-list
138712246|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139050246|NCT00283062|Docetaxel|docetaxel|mesh-list
138712247|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
138712248|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712249|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138712250|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138712251|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
138712252|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138712253|NCT01164007|Bevacizumab|bevacizumab|mesh-list
138712254|NCT01164007|Dacarbazine|dacarbazine|mesh-list
138712255|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138712256|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712257|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138712258|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138712259|NCT01164007|Growth Substances|growth substances|mesh-ancestor
138712260|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712284|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138712285|NCT01917383|Timolol|timolol|mesh-list
138712286|NCT01917383|Latanoprost|latanoprost|mesh-list
138712287|NCT01917383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138712288|NCT01917383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138712289|NCT01917383|Adrenergic Agents|adrenergic agents|mesh-ancestor
138712290|NCT01917383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139050299|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138712291|NCT01917383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712292|NCT01917383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712293|NCT01917383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138712294|NCT01917383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138712295|NCT01917383|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138712296|NCT01917383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138712297|NCT01163617|Adalimumab|adalimumab|mesh-list
138712298|NCT01163617|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138712299|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138712300|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138712301|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139050353|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
138712302|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
138712303|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138712304|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
138712305|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712306|NCT04629846|Docetaxel|docetaxel|mesh-list
138712307|NCT04629846|Trastuzumab|trastuzumab|mesh-list
138712308|NCT04629846|Pertuzumab|pertuzumab|mesh-list
138712309|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712310|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
138712311|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
138712312|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
138712342|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
138712343|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712344|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712345|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138712346|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138712347|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138712348|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138712349|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712350|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138712351|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138712352|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712353|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
138648125|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
138712387|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138712388|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712389|NCT04629612|Anesthetics|anesthetics|mesh-list
138712390|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138712391|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712392|NCT00564213|Mitomycins|mitomycins|mesh-list
138712393|NCT00564213|Mitomycin|mitomycin|mesh-list
138712429|NCT01847573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138712430|NCT01847573|Growth Substances|growth substances|mesh-ancestor
138648193|NCT02143050|Metformin|metformin|mesh-list
138712485|NCT01804829|Antibodies|antibodies|mesh-list
138712486|NCT01804829|gamma-Globulins|gamma-globulins|mesh-list
138712487|NCT01804829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138712488|NCT01804829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138712489|NCT01804829|Immunoglobulin G|immunoglobulin g|mesh-list
138712490|NCT01804829|Immunologic Factors|immunologic factors|mesh-ancestor
138712491|NCT01804829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712492|NCT00565422|Escitalopram|escitalopram|mesh-list
138712493|NCT00565422|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138648309|NCT00323154|Nalbuphine|nalbuphine|mesh-list
138712530|NCT00564408|Miotics|miotics|mesh-ancestor
138712531|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
138712532|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648317|NCT00289250|Artesunate|artesunate|mesh-list
138712596|NCT01737905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138712597|NCT01730027|Montelukast|montelukast|mesh-list
138712598|NCT01730027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138712599|NCT01730027|Respiratory System Agents|respiratory system agents|mesh-ancestor
138712600|NCT01730027|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138712601|NCT01730027|Hormone Antagonists|hormone antagonists|mesh-ancestor
138712602|NCT01730027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138712603|NCT01730027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712604|NCT01730027|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138712605|NCT01730027|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138712606|NCT01730027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712607|NCT04608669|Acetaminophen|acetaminophen|mesh-list
138712637|NCT01704365|Immunologic Factors|immunologic factors|mesh-ancestor
138712638|NCT01704365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712639|NCT01698281|Dexamethasone|dexamethasone|mesh-list
138712640|NCT01698281|Doxorubicin|doxorubicin|mesh-list
138712641|NCT01698281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138712642|NCT01698281|Antiemetics|antiemetics|mesh-ancestor
138712643|NCT01698281|Autonomic Agents|autonomic agents|mesh-ancestor
139050662|NCT00294398|Fluticasone|fluticasone|mesh-list
138712644|NCT01698281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138712645|NCT01698281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712646|NCT01698281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138712648|NCT01698281|Hormones|hormones|mesh-ancestor
138712649|NCT01698281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138712650|NCT01698281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138712651|NCT01698281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138712652|NCT01698281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138712653|NCT01698281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138712654|NCT01698281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138712655|NCT01698281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712690|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712691|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138712692|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138712693|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138712694|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138712695|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712696|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138648463|NCT04718259|Midazolam|midazolam|mesh-list
138712735|NCT04599621|Protective Agents|protective agents|mesh-ancestor
138648489|NCT00323973|Bisoprolol|bisoprolol|mesh-list
138712794|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138712795|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
138712796|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712797|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138712798|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138712799|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
138712800|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
138712801|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138712802|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
138712839|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138712840|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712841|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138712874|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138712875|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712876|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138712877|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138712878|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138712879|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138712881|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138712979|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138712980|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138712981|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
138712982|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712984|NCT01162486|Rifapentine|rifapentine|mesh-list
138712985|NCT01162486|Midazolam|midazolam|mesh-list
138712986|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138712987|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138712988|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138712989|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138712990|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138712991|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138712992|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139050841|NCT00276744|Sirolimus|sirolimus|mesh-list
138712993|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138712994|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
138712995|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
138712996|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
138713055|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138713056|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138713057|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
138713058|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
138713059|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713060|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713062|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138713063|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
138713064|NCT01161472|Urological Agents|urological agents|mesh-ancestor
138713065|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
138713066|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138713067|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
138713068|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713070|NCT04675385|Protective Agents|protective agents|mesh-ancestor
138713071|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
138713072|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138713073|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138713074|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713075|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138713076|NCT04598061|Analgesics|analgesics|mesh-ancestor
138713077|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
138713078|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051025|NCT00293384|Hormones|hormones|mesh-ancestor
138713080|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138713081|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138713082|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
138713110|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138713111|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138713112|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
138713114|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713115|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713116|NCT00566046|Levetiracetam|levetiracetam|mesh-list
138713117|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
138713118|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
138713119|NCT01160614|Oxycodone|oxycodone|mesh-list
138713120|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138713121|NCT01160614|Narcotics|narcotics|mesh-ancestor
138713122|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138713124|NCT01160614|Analgesics|analgesics|mesh-ancestor
138713125|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
138713126|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713127|NCT00566124|Insulin|insulin|mesh-list
138713128|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138713129|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
139051148|NCT00275028|Cediranib|cediranib|mesh-list
138713130|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
138713131|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
138713196|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713197|NCT04631627|Aspirin|aspirin|mesh-list
138713198|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138713199|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138713200|NCT04631627|Analgesics|analgesics|mesh-ancestor
138713201|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
138713202|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713203|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713204|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138713205|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138713206|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138713207|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138648932|NCT00325026|Misoprostol|misoprostol|mesh-list
138713243|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713244|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
138713245|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138713246|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
138713247|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051215|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138713278|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
138713279|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138713280|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138713282|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
138713283|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713284|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713285|NCT04597203|Hydroquinone|hydroquinone|mesh-list
138713286|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
138713287|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713288|NCT04597203|Protective Agents|protective agents|mesh-ancestor
138713289|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713290|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138713291|NCT01158118|Plerixafor|plerixafor|mesh-list
138713292|NCT01158118|Sargramostim|sargramostim|mesh-list
138713293|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
138713294|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713295|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138648994|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138713326|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713327|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713328|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138713329|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138713330|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138713331|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
138713332|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713333|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713334|NCT00564993|Protective Agents|protective agents|mesh-ancestor
138713335|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
138713336|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138713337|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
138713338|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713339|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138713340|NCT04604886|Dobutamine|dobutamine|mesh-list
138713341|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138713342|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
138713343|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
138713439|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138713638|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713639|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713641|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139051336|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138713643|NCT01154218|Crizotinib|crizotinib|mesh-list
138713644|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713645|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138713646|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713647|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713648|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
138713649|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138713650|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138713651|NCT04601142|Prednisolone|prednisolone|mesh-list
138649379|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138713708|NCT04625114|Gabexate|gabexate|mesh-list
138713709|NCT04625114|Camostat|camostat|mesh-list
138713710|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
138713711|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713712|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713713|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138713714|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138713771|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138713772|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138713773|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713774|NCT00567372|Bevacizumab|bevacizumab|mesh-list
138713775|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138713776|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713777|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138713778|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138713779|NCT00567372|Growth Substances|growth substances|mesh-ancestor
138713780|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713781|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
138713782|NCT00562133|Insulin|insulin|mesh-list
138713783|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138713784|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
138713785|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138713786|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713787|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138713788|NCT00567411|Apraclonidine|apraclonidine|mesh-list
138713789|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138713790|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138713791|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138713792|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138713793|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
138713794|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713795|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713796|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713797|NCT00562172|Metformin|metformin|mesh-list
138713798|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
138713799|NCT00562172|Glimepiride|glimepiride|mesh-list
138713800|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138713830|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138713831|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138713832|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
138713833|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713834|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713835|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713836|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138713837|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713838|NCT04590612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138713839|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138713840|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138713841|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
138713842|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138713843|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
138713844|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138713845|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138713846|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
138713847|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
138713848|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
138713915|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
138713916|NCT00624871|Protective Agents|protective agents|mesh-ancestor
138713917|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138574453|NCT00454558|Riociguat|riociguat|mesh-list
138713918|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138713919|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138713920|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713921|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713922|NCT04590183|Prednisolone|prednisolone|mesh-list
138713923|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138713924|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
138713925|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138713926|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
138713928|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138713929|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
138713930|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138713931|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
138713932|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713933|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138713934|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138713935|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649647|NCT00296777|Bupropion|bupropion|mesh-list
138713983|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138713985|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138713986|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138713987|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138713988|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138713989|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138713990|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138713991|NCT01153009|Analgesics|analgesics|mesh-ancestor
138713992|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
138713993|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138713994|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
138713995|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138713996|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
138713997|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138713998|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138713999|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138714000|NCT01153009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138714001|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
138714002|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138714003|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138714004|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138714005|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138714006|NCT04622111|Metformin|metformin|mesh-list
138714007|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138714008|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714009|NCT04622033|Brodalumab|brodalumab|mesh-list
138714010|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
138714011|NCT01152580|Melatonin|melatonin|mesh-list
138714013|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714014|NCT01152580|Protective Agents|protective agents|mesh-ancestor
138714015|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714016|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138714017|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138714018|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
138714019|NCT04621799|Coagulants|coagulants|mesh-ancestor
138714020|NCT04621370|Capecitabine|capecitabine|mesh-list
138714021|NCT04621370|Durvalumab|durvalumab|mesh-list
138714022|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138714023|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
138714024|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714025|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714026|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138714027|NCT04621487|Amoxicillin|amoxicillin|mesh-list
138714059|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714061|NCT00562406|Ranibizumab|ranibizumab|mesh-list
138714062|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138714063|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138714064|NCT00562406|Growth Substances|growth substances|mesh-ancestor
138714065|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714066|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
138714067|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714068|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
138714069|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138714070|NCT04588935|Bisoprolol|bisoprolol|mesh-list
138714071|NCT04588935|Perindopril|perindopril|mesh-list
138714072|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138714073|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
138714168|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138714169|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138714170|NCT04588194|Dexamethasone|dexamethasone|mesh-list
138714171|NCT04588194|Rituximab|rituximab|mesh-list
138714172|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138714173|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
138714174|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
138714175|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714176|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714177|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138714178|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
138714179|NCT04588194|Hormones|hormones|mesh-ancestor
138714180|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138714181|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138714182|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714183|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138714184|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
138714185|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138714186|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
138714187|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138714188|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138714189|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
138714226|NCT04619537|Docetaxel|docetaxel|mesh-list
138714227|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714228|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
138714229|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
138714230|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
138714267|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
138714269|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138714301|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138714302|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
138714303|NCT00568815|Rituximab|rituximab|mesh-list
138714304|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138714305|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714306|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
138714307|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714308|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138714310|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138714311|NCT00568971|Docetaxel|docetaxel|mesh-list
138714312|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714313|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
138714314|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
138714315|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
138714316|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714317|NCT00562913|Sorafenib|sorafenib|mesh-list
138714318|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714349|NCT00569400|Insulin|insulin|mesh-list
138714350|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138714351|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138714352|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714353|NCT04618367|Lenvatinib|lenvatinib|mesh-list
138714354|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714355|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138714356|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714357|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714358|NCT00562952|Telmisartan|telmisartan|mesh-list
138714359|NCT00562952|Bisoprolol|bisoprolol|mesh-list
138714360|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138714361|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138714362|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138714426|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138714428|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714429|NCT00567957|Remifentanil|remifentanil|mesh-list
138714430|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138714431|NCT00567957|Narcotics|narcotics|mesh-ancestor
138714432|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138714433|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714434|NCT00567957|Analgesics|analgesics|mesh-ancestor
138714435|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
138714436|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714464|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138714466|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714467|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138574503|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
138714468|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138714469|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
138714470|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714471|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714472|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138714473|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138714474|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138714475|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138714476|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714477|NCT04617626|Azithromycin|azithromycin|mesh-list
138714478|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138714479|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138714481|NCT04585230|Emollients|emollients|mesh-ancestor
138714482|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
138714483|NCT00570180|Bortezomib|bortezomib|mesh-list
138714484|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714485|NCT02939846|Trametinib|trametinib|mesh-list
138714486|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714487|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138714488|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650039|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714519|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714520|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714521|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
138714522|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138714523|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
138714524|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138714525|NCT00568113|Expectorants|expectorants|mesh-ancestor
138714526|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
138714527|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138714528|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
138714529|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714530|NCT00568113|Protective Agents|protective agents|mesh-ancestor
138714531|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714532|NCT00568113|Antidotes|antidotes|mesh-ancestor
138714533|NCT00568152|Aspirin|aspirin|mesh-list
138714567|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
138714568|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138714569|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
138714570|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714571|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
138714572|NCT00570648|Protective Agents|protective agents|mesh-ancestor
138714573|NCT00570726|Ranibizumab|ranibizumab|mesh-list
138714574|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138714640|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714641|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138714642|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
138714643|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138714644|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138714646|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
138714647|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714648|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714649|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
138670951|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
138714650|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138714651|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714652|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
138714653|NCT00571116|Disulfiram|disulfiram|mesh-list
138714654|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714655|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138714656|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138714657|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714658|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714659|NCT00571155|Levetiracetam|levetiracetam|mesh-list
138714660|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
138714661|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
138714698|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
138714699|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714700|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138714701|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138714702|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
138714703|NCT00571740|Antidotes|antidotes|mesh-ancestor
138714704|NCT00571740|Protective Agents|protective agents|mesh-ancestor
138714732|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
138714733|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
138714734|NCT04613726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138714735|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138714736|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
138714737|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714738|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714739|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138714740|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714741|NCT04613804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138714742|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714743|NCT04613102|Cannabidiol|cannabidiol|mesh-list
138714744|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
138714745|NCT04613219|Tofacitinib|tofacitinib|mesh-list
138714746|NCT04613219|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138714747|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138714748|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714749|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714751|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138714752|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
138714753|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138714754|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138714789|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138714790|NCT04580199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714791|NCT00568347|Fluticasone|fluticasone|mesh-list
138714793|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138714860|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138714861|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
138714862|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
138714863|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
138714864|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574564|NCT00457483|Valsartan|valsartan|mesh-list
138714865|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138714866|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
138714867|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138714868|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714869|NCT00563927|Fluorouracil|fluorouracil|mesh-list
138650338|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
138714906|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138714907|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
138714908|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138714909|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138714910|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138714981|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138714982|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138714983|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138714984|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
138714985|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
138714986|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
138715016|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715017|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
138715018|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
138715019|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138715020|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138715021|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138715022|NCT00575640|Hydralazine|hydralazine|mesh-list
138715023|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138715024|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
138715025|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
138715026|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138715027|NCT04579731|Lactitol|lactitol|mesh-list
138715028|NCT04579731|Cathartics|cathartics|mesh-ancestor
138715029|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138715030|NCT00565487|Capecitabine|capecitabine|mesh-list
138715031|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138715032|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138650469|NCT00303056|Icatibant|icatibant|mesh-list
138715060|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715061|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138715063|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138715064|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138715066|NCT00575796|Vinblastine|vinblastine|mesh-list
138715067|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138715068|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715069|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
138715070|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
138715071|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
138715072|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715073|NCT00575835|Vitamin D|vitamin d|mesh-list
138715074|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
138715075|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
138715076|NCT00575835|Vitamins|vitamins|mesh-list
138715077|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
138715078|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715079|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138715080|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138715137|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715138|NCT00573417|Modafinil|modafinil|mesh-list
139052742|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
138715140|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715141|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138715142|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138715143|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138715144|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715145|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
138715146|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139052797|NCT01023347|Paclitaxel|paclitaxel|mesh-list
138715147|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
138715148|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715149|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715150|NCT00565955|Montelukast|montelukast|mesh-list
138715151|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138715152|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
138650562|NCT00303758|Gemcitabine|gemcitabine|mesh-list
138715181|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138715182|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138715183|NCT00576225|Paclitaxel|paclitaxel|mesh-list
138715184|NCT00576225|Carboplatin|carboplatin|mesh-list
138715185|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
139052871|NCT06202001|Irinotecan|irinotecan|mesh-list
138715187|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715188|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
138715189|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
138715190|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
138715191|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715192|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
138715193|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138715194|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715195|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138715196|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138715231|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715232|NCT00576615|Propofol|propofol|mesh-list
138715233|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138715234|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138715235|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715236|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138715237|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
138715254|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139052926|NCT06201611|Vitamin B Complex|vitamin b complex|mesh-ancestor
138715255|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138715256|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715257|NCT00574353|Misonidazole|misonidazole|mesh-list
138715258|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715259|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138715260|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138715261|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715263|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
138715264|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715265|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
138715266|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715267|NCT00574470|Infliximab|infliximab|mesh-list
138715268|NCT00574470|Daclizumab|daclizumab|mesh-list
138715269|NCT00574470|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138715270|NCT00574470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138715271|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
138715272|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138715273|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138715274|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138715275|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
138715276|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715277|NCT00577161|Vidarabine|vidarabine|mesh-list
138715278|NCT00577161|Rituximab|rituximab|mesh-list
138715279|NCT00577161|Fludarabine|fludarabine|mesh-list
138715280|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
138715281|NCT00577161|Pixantrone|pixantrone|mesh-list
138715282|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138715283|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715284|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
138715285|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715286|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138715287|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138715288|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
138715289|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715290|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138715291|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
138715292|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053212|NCT06081153|Evolocumab|evolocumab|mesh-list
138715293|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138715294|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138715295|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715296|NCT04596488|Efavirenz|efavirenz|mesh-list
138715297|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138715298|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138715299|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650655|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138715329|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715330|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138715331|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
138715332|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138715333|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715334|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715335|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715336|NCT04595318|Varenicline|varenicline|mesh-list
138715337|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138715338|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139053253|NCT06060665|Seladelpar|seladelpar|mesh-list
138715339|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
138715340|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650670|NCT00304499|Oxybutynin|oxybutynin|mesh-list
138715369|NCT00577668|Growth Substances|growth substances|mesh-ancestor
138715370|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
138715371|NCT01147744|Fluticasone|fluticasone|mesh-list
138715372|NCT01147744|Xhance|xhance|mesh-list
138715373|NCT01147744|Montelukast|montelukast|mesh-list
138715374|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138715375|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138715376|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
138715377|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715378|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715379|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138715380|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
138715382|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138715383|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138715384|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
138715385|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138715386|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138650701|NCT00304616|Olanzapine|olanzapine|mesh-list
138715415|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138715416|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715417|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
138715418|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
139053371|NCT05941767|Anesthetics, Local|anesthetics, local|mesh-ancestor
139053372|NCT05941767|Anesthetics|anesthetics|mesh-ancestor
139053373|NCT05941767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139053374|NCT05941767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053375|NCT05941767|Sensory System Agents|sensory system agents|mesh-ancestor
139053384|NCT05941767|Analgesics|analgesics|mesh-ancestor
138715419|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715420|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
138715421|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138715422|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138715423|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138715424|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138715425|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715426|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
138715427|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715428|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715429|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139053436|NCT05882214|Niacin|niacin|mesh-list
138715430|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715432|NCT00578370|Betamethasone|betamethasone|mesh-list
138715463|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
138715464|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715465|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138715466|NCT00578526|Sunitinib|sunitinib|mesh-list
138715467|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715468|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138715469|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138715470|NCT00578526|Growth Substances|growth substances|mesh-ancestor
138715471|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715472|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
138715473|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138715474|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715475|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715476|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
138715477|NCT04593446|Cathartics|cathartics|mesh-ancestor
138715478|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138715540|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
138715541|NCT04592081|BB 1101|bb 1101|mesh-list
138715542|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138715543|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
138715544|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
138715545|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715546|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715547|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138671854|NCT01327339|Ropinirole|ropinirole|mesh-list
138715548|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
138715549|NCT04592081|Hormones|hormones|mesh-ancestor
138715550|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138715551|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138715552|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715554|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715555|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715556|NCT04591847|Vitamin D|vitamin d|mesh-list
138715587|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138715588|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
138715589|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138715590|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715591|NCT00580320|Bortezomib|bortezomib|mesh-list
138715592|NCT00580320|Dacarbazine|dacarbazine|mesh-list
138715593|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715594|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138715595|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
138715596|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715597|NCT00580359|Capecitabine|capecitabine|mesh-list
139053616|NCT05603754|Lorecivivint|lorecivivint|mesh-list
138715598|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138715599|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
138715600|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715601|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715602|NCT00580437|Dobutamine|dobutamine|mesh-list
138650858|NCT00329316|Progesterone|progesterone|mesh-list
138715633|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138715634|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138715636|NCT04590638|Racepinephrine|racepinephrine|mesh-list
138715637|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
138715638|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138715639|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138715640|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
138715641|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138715642|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715643|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715644|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138715645|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138650893|NCT00332904|Propranolol|propranolol|mesh-list
139053671|NCT05508867|Alkylating Agents|alkylating agents|mesh-ancestor
139053672|NCT05468489|Carboplatin|carboplatin|mesh-list
139053674|NCT05468489|Etoposide phosphate|etoposide phosphate|mesh-list
139053675|NCT05468489|Atezolizumab|atezolizumab|mesh-list
139053676|NCT05468489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053677|NCT05468489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139053678|NCT05468489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139053679|NCT05468489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139053684|NCT05445128|Plerixafor|plerixafor|mesh-list
138715671|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138715672|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138715673|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
138715674|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138715675|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138715676|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138715677|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138715678|NCT00567554|Growth Substances|growth substances|mesh-ancestor
138715679|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
138715680|NCT00567554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138715681|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138715682|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053735|NCT05352815|Insulin|insulin|mesh-list
138715683|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138715684|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138574790|NCT00111137|Hematinics|hematinics|mesh-ancestor
138715685|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138715687|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715689|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138715690|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138715691|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715692|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138715693|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
138715694|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138715695|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053794|NCT05317364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139053795|NCT05317364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053796|NCT05277051|Dostarlimab|dostarlimab|mesh-list
139053797|NCT05277051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053798|NCT05188170|Niclosamide|niclosamide|mesh-list
139053799|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
139053808|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
138715696|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138715697|NCT00581217|Laxatives|laxatives|mesh-ancestor
138650908|NCT00332904|Diuretics|diuretics|mesh-ancestor
138715727|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715728|NCT04577040|Urological Agents|urological agents|mesh-ancestor
138715730|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138715731|NCT04589234|Folfirinox|folfirinox|mesh-list
138715732|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138715733|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
138715734|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715735|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715736|NCT03453177|Fosfomycin|fosfomycin|mesh-list
138715737|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138715738|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138715739|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
138715740|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
138715741|NCT04588532|Doxepin|doxepin|mesh-list
138715742|NCT04588532|Histamine|histamine|mesh-list
138715743|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
138715744|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
138715745|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650932|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715771|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138715772|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138715773|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138715775|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138715776|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138715777|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715779|NCT00581685|Pregabalin|pregabalin|mesh-list
138715780|NCT00581685|Analgesics|analgesics|mesh-ancestor
138715781|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
138715782|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138715783|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138715784|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
138715785|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138715786|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138715787|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715788|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138715789|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138715790|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138715791|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138715792|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138650976|NCT00333021|Fondaparinux|fondaparinux|mesh-list
138715961|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138715962|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138715963|NCT04584710|Dactolisib|dactolisib|mesh-list
138715964|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715966|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138715967|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
138715968|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
138715969|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139054111|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
139054113|NCT04632069|Protective Agents|protective agents|mesh-ancestor
138651151|NCT00333372|Z 338|z 338|mesh-list
138715993|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138715994|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138715996|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
138672312|NCT01379521|Everolimus|everolimus|mesh-list
138715997|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
138715998|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138715999|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138716000|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
138716001|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716002|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716003|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138716004|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
138716005|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138716006|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138716007|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138716008|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138716009|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716010|NCT04583267|Tenofovir|tenofovir|mesh-list
138716011|NCT04583267|Emtricitabine|emtricitabine|mesh-list
138716012|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
138716013|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716014|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138716015|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138716016|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716017|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716018|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138716019|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138651188|NCT03275558|Sunitinib|sunitinib|mesh-list
138716052|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
138716053|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716054|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
138716056|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
138716058|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138716059|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
138716060|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716061|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651210|NCT00333567|Analgesics|analgesics|mesh-ancestor
138716098|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138716099|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716100|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138716101|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716119|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
138716120|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138716121|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138716122|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716123|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054306|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
138716124|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138716125|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138716126|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716127|NCT00591162|Tetracycline|tetracycline|mesh-list
138716128|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138716129|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716130|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138716131|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716132|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716134|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
138574888|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
138716135|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138716136|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716137|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138716138|NCT04582136|Sirolimus|sirolimus|mesh-list
138716139|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138716140|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716141|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138716142|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716143|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
138672455|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
138716144|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138716145|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
138716146|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716147|NCT00591201|Infliximab|infliximab|mesh-list
138716148|NCT00591201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138716149|NCT00591201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138716150|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
138716151|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716152|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716153|NCT04582097|Ramipril|ramipril|mesh-list
138716154|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138716155|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
138716156|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716157|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716158|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138716159|NCT00591357|Loperamide|loperamide|mesh-list
138716188|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138716189|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
138716190|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138716192|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
138716193|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
138716194|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138716195|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138716196|NCT00568412|Analgesics|analgesics|mesh-ancestor
138716197|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
138716198|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716199|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716200|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138716201|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716202|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
138716203|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138651293|NCT00451412|Heparin|heparin|mesh-list
138716258|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716259|NCT03451695|Morphine|morphine|mesh-list
138716260|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138716261|NCT03451695|Narcotics|narcotics|mesh-ancestor
138716262|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716263|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716264|NCT03451695|Analgesics|analgesics|mesh-ancestor
138716265|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
138716266|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716267|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
138716268|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138716269|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
138716270|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716271|NCT00569465|Expectorants|expectorants|mesh-ancestor
138716272|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
138716273|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138716274|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
138716275|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716276|NCT00569465|Protective Agents|protective agents|mesh-ancestor
138716277|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716278|NCT00569465|Antidotes|antidotes|mesh-ancestor
138716279|NCT00583986|Albuterol|albuterol|mesh-list
138716280|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138716281|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
138716282|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716283|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716284|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139054540|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716285|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
138716287|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138716288|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138716289|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138716290|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138716291|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
138716292|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716293|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716294|NCT00569621|Moxaverine|moxaverine|mesh-list
138716325|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138716326|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
138716327|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716328|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716329|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138716330|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
138716331|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
138716332|NCT00570245|Protective Agents|protective agents|mesh-ancestor
138716333|NCT00570284|Panobinostat|panobinostat|mesh-list
138716334|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716335|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138716336|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054666|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
138716337|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716338|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
138716339|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138716340|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
138716341|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
138716373|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138716374|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138716375|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716376|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138716377|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138716378|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138716379|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
138716380|NCT00570830|Hormones|hormones|mesh-ancestor
138716381|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138716382|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716383|NCT00584493|Tremelimumab|tremelimumab|mesh-list
138651414|NCT00331071|Ortho Evra|ortho evra|mesh-list
138716410|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
138716411|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716412|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716413|NCT00584571|Dexetimide|dexetimide|mesh-list
138716414|NCT00584571|Citalopram|citalopram|mesh-list
138716415|NCT00584571|Escitalopram|escitalopram|mesh-list
138716416|NCT00584571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138716417|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138716418|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138546452|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
138716419|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716420|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716422|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716423|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138716424|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138716425|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
138716426|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
139054785|NCT01517100|Hallucinogens|hallucinogens|mesh-ancestor
139054786|NCT01517100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139054787|NCT01517100|Analgesics|analgesics|mesh-ancestor
139054788|NCT01517100|Sensory System Agents|sensory system agents|mesh-ancestor
139054789|NCT01517100|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139054790|NCT01517100|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139054791|NCT01517100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138716427|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574985|NCT00421369|Sertraline|sertraline|mesh-list
138716428|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138716429|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138716430|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
138716431|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138716432|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
138716485|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138716487|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
138716488|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716489|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716490|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138716491|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716492|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138716493|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716494|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716495|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138716523|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138716524|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
138716525|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716526|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716527|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
138716528|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716529|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138716530|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138716531|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
138716532|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716533|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138716534|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
138716535|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
138716536|NCT02883595|Thymalfasin|thymalfasin|mesh-list
138716537|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138716538|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
138716539|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716540|NCT01143259|Alvimopan|alvimopan|mesh-list
138716541|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716542|NCT00571805|Varenicline|varenicline|mesh-list
138716543|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138716574|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716575|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716576|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138716577|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716578|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138716579|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138716580|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575007|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138716581|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716582|NCT01142596|Asenapine|asenapine|mesh-list
138716583|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138716584|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139054970|NCT00457691|Leucovorin|leucovorin|mesh-list
138716585|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716586|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716588|NCT00572390|Estrogens|estrogens|mesh-list
138716625|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138716626|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138716627|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716628|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716692|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716693|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716694|NCT04312750|Lidocaine|lidocaine|mesh-list
138716695|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
138716696|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
138716697|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716698|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716699|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
139055088|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
138716700|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716701|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138716702|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138716703|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138716704|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138716705|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716781|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716782|NCT01138657|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138716784|NCT01138501|Factor VIII|factor viii|mesh-list
138716840|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716841|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
138716842|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
138716843|NCT00586365|Naproxen|naproxen|mesh-list
138716844|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138716846|NCT00586365|Analgesics|analgesics|mesh-ancestor
138716847|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
138716848|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716849|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716850|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138716851|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716852|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
138716853|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138716854|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716855|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055285|NCT00281528|Paclitaxel|paclitaxel|mesh-list
138716857|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716858|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138716859|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138716860|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
138716861|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716862|NCT00574769|Bevacizumab|bevacizumab|mesh-list
138716863|NCT00574769|Docetaxel|docetaxel|mesh-list
138716864|NCT00574769|Everolimus|everolimus|mesh-list
138716865|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138716866|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716867|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138716868|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138716869|NCT00574769|Growth Substances|growth substances|mesh-ancestor
138716870|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716871|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
138716872|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
139055422|NCT00233064|Palivizumab|palivizumab|mesh-list
138716873|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
138716874|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
138716875|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716877|NCT00574769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138651835|NCT00322062|Vitamins|vitamins|mesh-ancestor
138716886|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138716887|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138716888|NCT00586443|Growth Substances|growth substances|mesh-ancestor
138716889|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716890|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
138716891|NCT00586443|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138716892|NCT00586443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138716893|NCT00586443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716894|NCT00586443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716895|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138716896|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
138716897|NCT00574925|Esomeprazole|esomeprazole|mesh-list
138716898|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138716899|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716900|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138716901|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716902|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716903|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
139055546|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
138716904|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138716905|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
138716906|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716907|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138716908|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138716909|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
138716910|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716911|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716912|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138716913|NCT00574964|Temozolomide|temozolomide|mesh-list
138716915|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138716916|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
138716917|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716918|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716919|NCT01137682|Octreotide|octreotide|mesh-list
138716920|NCT01137682|Lanreotide|lanreotide|mesh-list
138716921|NCT01137682|Pasireotide|pasireotide|mesh-list
138716922|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716923|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138716924|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716925|NCT01137682|Hormones|hormones|mesh-ancestor
139055672|NCT06185400|Immunoconjugates|immunoconjugates|mesh-ancestor
138716926|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138716927|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716928|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
138716929|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
138716930|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138716931|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138716932|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138716933|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716934|NCT00586794|Urological Agents|urological agents|mesh-ancestor
138716935|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
138716936|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716937|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716938|NCT00575354|Sevoflurane|sevoflurane|mesh-list
138716939|NCT00575354|Isoflurane|isoflurane|mesh-list
139055735|NCT06184958|Anesthetics|anesthetics|mesh-ancestor
138716940|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138716941|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138716942|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
138716944|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716945|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716955|NCT03453684|Vancomycin|vancomycin|mesh-list
138716956|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138716957|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716958|NCT00575627|Interferons|interferons|mesh-list
138716959|NCT00575627|Ribavirin|ribavirin|mesh-list
138716960|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
138716961|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
138716962|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138716963|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716964|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
138716965|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716966|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
138716967|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716968|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
138716969|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716970|NCT00555854|Benzocaine|benzocaine|mesh-list
138716971|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
138716972|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
138716973|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138716974|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716975|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
138716976|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138716977|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
138716978|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138716979|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716980|NCT00587145|Docetaxel|docetaxel|mesh-list
138716981|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716982|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
138716983|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
138716984|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
138716985|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716986|NCT04674176|Rifaximin|rifaximin|mesh-list
138716987|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138716988|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138716989|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138716990|NCT04674527|Temozolomide|temozolomide|mesh-list
138546480|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
138716991|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138716992|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
138716993|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138716994|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138716995|NCT00199836|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138716996|NCT00199836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138716997|NCT00199836|Immunologic Factors|immunologic factors|mesh-ancestor
138716998|NCT00199836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138716999|NCT00199797|Leucovorin|leucovorin|mesh-list
138717000|NCT00199797|Fluorouracil|fluorouracil|mesh-list
138717001|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
138717002|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
138717003|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717004|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138717005|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717006|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138717007|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
138717008|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717009|NCT00199797|Antidotes|antidotes|mesh-ancestor
138717010|NCT00199797|Protective Agents|protective agents|mesh-ancestor
138717011|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
138717012|NCT00199797|Vitamins|vitamins|mesh-ancestor
138717013|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
138717037|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
138717038|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717039|NCT00198822|Protective Agents|protective agents|mesh-ancestor
138717040|NCT00198822|Provitamins|provitamins|mesh-ancestor
138717041|NCT05214976|Paclitaxel|paclitaxel|mesh-list
138717042|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138717043|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717044|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
138717045|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
138717046|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
138717047|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717048|NCT05204134|Insulin|insulin|mesh-list
138717049|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138575119|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
138717050|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717051|NCT05181436|Chrysarobin|chrysarobin|mesh-list
138717052|NCT05181436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138717053|NCT05181436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138717054|NCT05181436|Analgesics|analgesics|mesh-ancestor
138717055|NCT05181436|Sensory System Agents|sensory system agents|mesh-ancestor
138717056|NCT05181436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717057|NCT05181436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717058|NCT05181436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138717060|NCT01137292|Voriconazole|voriconazole|mesh-list
138717061|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
138717062|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138717063|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138717064|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139056235|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138717066|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717067|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138717102|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138717103|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138717104|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138717105|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
138717106|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139056299|NCT04538352|Insulin|insulin|mesh-list
138717108|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138717109|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
138717110|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
138651889|NCT00336765|XL647|xl647|mesh-list
138717127|NCT01136356|Narcotics|narcotics|mesh-ancestor
138717128|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138717129|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717130|NCT01136356|Analgesics|analgesics|mesh-ancestor
138717131|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
138717132|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717133|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138717134|NCT00587379|Atorvastatin|atorvastatin|mesh-list
139056372|NCT04244552|Doxorubicin|doxorubicin|mesh-list
138717135|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138717136|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138717137|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
138717138|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717139|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138717140|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138717142|NCT04673396|Norcantharidin|norcantharidin|mesh-list
138717143|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717144|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717145|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717146|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
138717147|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138717148|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717149|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
138717150|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138717151|NCT00196326|Estradiol|estradiol|mesh-list
138717152|NCT00196326|Estrogens|estrogens|mesh-ancestor
138717153|NCT00196326|Hormones|hormones|mesh-ancestor
138717154|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138717155|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717156|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138717157|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
138717158|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138717159|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138717160|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139056490|NCT02550028|Levetiracetam|levetiracetam|mesh-list
138717161|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138717162|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138717164|NCT00587496|Valacyclovir|valacyclovir|mesh-list
138717165|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138717166|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138717167|NCT00587496|Analgesics|analgesics|mesh-ancestor
138717168|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
138717169|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717170|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717171|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138717172|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138717173|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138717189|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
138717190|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717191|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717192|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
138717193|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717194|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138717195|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138717196|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
138717197|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138717198|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138717199|NCT00195663|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138717200|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138717201|NCT01135498|Bevacizumab|bevacizumab|mesh-list
138717202|NCT01135498|Capecitabine|capecitabine|mesh-list
138717203|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138717204|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
138717205|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138717206|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717207|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138717208|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138717209|NCT01135498|Growth Substances|growth substances|mesh-ancestor
138717210|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717211|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
138717212|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138717213|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
138717214|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717215|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138717216|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717217|NCT04610567|Methotrexate|methotrexate|mesh-list
138717218|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138717219|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
138575173|NCT00350311|Nicotine|nicotine|mesh-list
138717220|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138717221|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717222|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138717224|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717225|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717226|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
138717228|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138717229|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138717230|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
138717231|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138717232|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138717243|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138717244|NCT00195507|Etanercept|etanercept|mesh-list
138717245|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138717246|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138717247|NCT00195507|Analgesics|analgesics|mesh-ancestor
138717248|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
138717249|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717250|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717251|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138717252|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138717253|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138717254|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138717255|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
138717256|NCT00195351|Metronidazole|metronidazole|mesh-list
138717257|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
138717258|NCT00195351|Tigecycline|tigecycline|mesh-list
138717259|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138717260|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138717261|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138717262|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138717263|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138717264|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056873|NCT00145509|Asenapine|asenapine|mesh-list
138717265|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717266|NCT04609748|Nimesulide|nimesulide|mesh-list
138717267|NCT04609748|Cannabidiol|cannabidiol|mesh-list
138717268|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
138717269|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138717270|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138717271|NCT04609748|Analgesics|analgesics|mesh-ancestor
138717272|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
138717274|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717275|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138717276|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138717277|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138717278|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717279|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717280|NCT00195273|Cyclosporine|cyclosporine|mesh-list
138717281|NCT00195273|Sirolimus|sirolimus|mesh-list
138717282|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
138717283|NCT00195273|Cyclosporins|cyclosporins|mesh-list
138717284|NCT00195273|Daclizumab|daclizumab|mesh-list
138717285|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807597|NCT05048901|Lanreotide|lanreotide|mesh-list
138717286|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717288|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
138717289|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717290|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
138717291|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138717292|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
138717293|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138717294|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138717295|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138717296|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717297|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138717298|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
138717299|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138717301|NCT00564200|Fludarabine|fludarabine|mesh-list
138717320|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138717321|NCT00193479|Prednisone|prednisone|mesh-list
138717322|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
138717323|NCT00193479|Rituximab|rituximab|mesh-list
138717324|NCT00193479|Vincristine|vincristine|mesh-list
138717325|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
138717326|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138717327|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
138717328|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717329|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138717330|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138717331|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
138717332|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057121|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
138717333|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717334|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138717335|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138717336|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138717338|NCT00193479|Hormones|hormones|mesh-ancestor
138717339|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138717340|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138717341|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138717342|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
138717343|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
138717344|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
138673646|NCT00476099|Hormones|hormones|mesh-ancestor
138717345|NCT00193479|Analgesics|analgesics|mesh-ancestor
138717346|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
138717347|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717348|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138717349|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138717350|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717351|NCT00193206|Paclitaxel|paclitaxel|mesh-list
138717352|NCT00193206|Gemcitabine|gemcitabine|mesh-list
138717353|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138717354|NCT00193206|Epirubicin|epirubicin|mesh-list
138717355|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138717356|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717357|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
138717359|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
138717373|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717374|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
138717375|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
138717376|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
138717378|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138717379|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138717380|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717381|NCT04608734|Midazolam|midazolam|mesh-list
138717382|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138717383|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138717384|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138717385|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717386|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138717387|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138717388|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138717389|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138717390|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
138717391|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
138717392|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
138717393|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
138717394|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139057298|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138717395|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717396|NCT00192075|Leucovorin|leucovorin|mesh-list
138717397|NCT00192075|Folic Acid|folic acid|mesh-list
138717398|NCT00192075|Gemcitabine|gemcitabine|mesh-list
138717399|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
138717400|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
138717401|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138717402|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
138717403|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717404|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717405|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717406|NCT00192075|Antidotes|antidotes|mesh-ancestor
138717407|NCT00192075|Protective Agents|protective agents|mesh-ancestor
138717408|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
138717409|NCT00192075|Vitamins|vitamins|mesh-ancestor
138717410|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
139057356|NCT00437645|Amlodipine|amlodipine|mesh-list
139057357|NCT00437645|Valsartan|valsartan|mesh-list
139057358|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139057359|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139057360|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575235|NCT00350857|Carbamazepine|carbamazepine|mesh-list
139057361|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057362|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139057363|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057364|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
139057365|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139057366|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139057396|NCT00437489|Insulin|insulin|mesh-list
139057397|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139057398|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139057399|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057400|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139057401|NCT01028573|Laxatives|laxatives|mesh-ancestor
139057402|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139057403|NCT04683575|Selenium|selenium|mesh-list
139057404|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
139057405|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057406|NCT04683575|Protective Agents|protective agents|mesh-ancestor
139057407|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057408|NCT04683575|Trace Elements|trace elements|mesh-ancestor
139057409|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
139057410|NCT00442559|Montelukast|montelukast|mesh-list
139057411|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138717412|NCT00192036|Gemcitabine|gemcitabine|mesh-list
138717413|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717414|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138717415|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
138717416|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717417|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138717418|NCT00191724|Enoxaparin|enoxaparin|mesh-list
138717419|NCT00191724|Protein C|protein c|mesh-list
138717420|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
138717421|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138717422|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138717423|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717438|NCT00191451|Trastuzumab|trastuzumab|mesh-list
138717439|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717440|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138717441|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
138717442|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717443|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138717444|NCT00191334|Gemcitabine|gemcitabine|mesh-list
138717445|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717446|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138717447|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
138717448|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717449|NCT00191139|Cisplatin|cisplatin|mesh-list
138717450|NCT00191139|Gemcitabine|gemcitabine|mesh-list
138717451|NCT00191139|Docetaxel|docetaxel|mesh-list
138717452|NCT00191139|Etoposide|etoposide|mesh-list
138717453|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
138717454|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717455|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138717456|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
138717457|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575264|NCT00114270|Letrozole|letrozole|mesh-list
138717458|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
138717459|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
138717460|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
138717461|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138717462|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138717463|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138717464|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717465|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
138717466|NCT00564512|Rituximab|rituximab|mesh-list
138717467|NCT00564512|Fludarabine|fludarabine|mesh-list
138717468|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
138717469|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138717470|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
138717471|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717472|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138717473|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138717474|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
138717475|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717476|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717477|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138717478|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138717479|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
138717480|NCT00564551|Calcium|calcium|mesh-list
138717481|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138717482|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717483|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138717484|NCT00190983|Pemetrexed|pemetrexed|mesh-list
138717485|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651983|NCT00306722|Fospropofol|fospropofol|mesh-list
138717515|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717516|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717517|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138717518|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
138717520|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138717521|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138717522|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717523|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138717524|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138717525|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
138717526|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717527|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139057593|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138717528|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138717529|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717530|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
138717548|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138717549|NCT04607525|Analgesics|analgesics|mesh-ancestor
138717550|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
138717551|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717552|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138717553|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138717554|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138717555|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
138717556|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717557|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717558|NCT00198276|Bleomycin|bleomycin|mesh-list
138717559|NCT00198276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138717561|NCT04607642|Manganese|manganese|mesh-list
138717562|NCT04607642|Trace Elements|trace elements|mesh-ancestor
138717563|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
138717564|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717565|NCT00588003|Anastrozole|anastrozole|mesh-list
138717566|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138717567|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717568|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138717569|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138717570|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717571|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717572|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138717573|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
138717574|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138717575|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717576|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
138717577|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138717578|NCT00564590|Melatonin|melatonin|mesh-list
138717579|NCT00564590|Omeprazole|omeprazole|mesh-list
138717580|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
138717581|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717582|NCT00564590|Protective Agents|protective agents|mesh-ancestor
138717583|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717584|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138717585|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138717586|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138717609|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717610|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717611|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138717612|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138717613|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138717614|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138717615|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
138717617|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138717618|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717619|NCT04605575|Vinorelbine|vinorelbine|mesh-list
138717620|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138717621|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057822|NCT01033097|Betamethasone|betamethasone|mesh-list
138717622|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
138717623|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
138717624|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
138717625|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717626|NCT00589134|Ganirelix|ganirelix|mesh-list
138717627|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
138808513|NCT02611804|Diclofenac|diclofenac|mesh-list
138717628|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138717629|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717630|NCT00589251|Penicillins|penicillins|mesh-list
138717631|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138717632|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138575295|NCT00401609|Vinorelbine|vinorelbine|mesh-list
138717634|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138717635|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717636|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138717637|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652050|NCT00337623|Hormones|hormones|mesh-ancestor
138717648|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138717649|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
138717650|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
138717651|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717653|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138717654|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717655|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
138717656|NCT00589953|Hematinics|hematinics|mesh-ancestor
138717657|NCT00589992|Ibutilide|ibutilide|mesh-list
138717658|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138717659|NCT00590070|Adenosine|adenosine|mesh-list
138717660|NCT00590070|Nitroprusside|nitroprusside|mesh-list
138717661|NCT00590070|Analgesics|analgesics|mesh-ancestor
138717662|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
138717663|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717664|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717665|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138717666|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
138717667|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138717668|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
138717669|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
138717670|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717671|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717672|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138717673|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138717674|NCT00565019|Triamcinolone|triamcinolone|mesh-list
138717675|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138717676|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138717677|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138717678|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138717679|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
138717680|NCT00565019|Hormones|hormones|mesh-ancestor
138717681|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138717682|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717683|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138717684|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
138717685|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717686|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717687|NCT00565097|Lanreotide|lanreotide|mesh-list
138717688|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717689|NCT04604756|Losartan|losartan|mesh-list
138717690|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138717691|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138717692|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138575317|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138717693|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138717694|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717695|NCT00590343|Vatalanib|vatalanib|mesh-list
138717696|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138717697|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717698|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717699|NCT04604678|Metformin|metformin|mesh-list
138717700|NCT04604678|Naltrexone|naltrexone|mesh-list
138717701|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138717702|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717703|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138717704|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138717727|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138717728|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138717729|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717731|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
138717732|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717733|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138717734|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
138717735|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138717736|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138717737|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138717738|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717739|NCT00476229|Rituximab|rituximab|mesh-list
138717740|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
138717741|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138717742|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138717743|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717744|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
138717745|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717746|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138717747|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138717748|NCT04603976|Erenumab|erenumab|mesh-list
138717749|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138717750|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717751|NCT04603976|Analgesics|analgesics|mesh-ancestor
138717752|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
138717753|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717754|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717755|NCT00476151|Ketamine|ketamine|mesh-list
138717756|NCT00476151|Amitriptyline|amitriptyline|mesh-list
138717757|NCT00476151|Analgesics|analgesics|mesh-ancestor
138717758|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
138717759|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717785|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138717786|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138575343|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138717787|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138717788|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717789|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717790|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138717791|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138717792|NCT00474903|Analgesics|analgesics|mesh-ancestor
138674100|NCT00472355|Apomorphine|apomorphine|mesh-list
138717793|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
138717794|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717795|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717796|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138717798|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138717799|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138717800|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138717801|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138717802|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
138717803|NCT01134055|Ranibizumab|ranibizumab|mesh-list
138717804|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138717805|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138717806|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138717807|NCT01134055|Growth Substances|growth substances|mesh-ancestor
138717812|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138717813|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138717814|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138717815|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138717816|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717817|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717818|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717819|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138717820|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
138717821|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138717822|NCT00474240|Atorvastatin|atorvastatin|mesh-list
138717823|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138717824|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138717825|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
138717826|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717827|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138717828|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138717829|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717830|NCT00473889|Paclitaxel|paclitaxel|mesh-list
138717831|NCT00473889|Carboplatin|carboplatin|mesh-list
138717832|NCT00473889|Vorinostat|vorinostat|mesh-list
138717833|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138717834|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717835|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
138717836|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
138717837|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
138717838|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717839|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138717840|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717841|NCT00565214|Vitamins|vitamins|mesh-list
138717842|NCT00565214|Vitamin E|vitamin e|mesh-list
138717843|NCT00565214|Selenium|selenium|mesh-list
138717844|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
138717845|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717846|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
138717847|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717848|NCT00565214|Protective Agents|protective agents|mesh-ancestor
138717849|NCT00565214|Trace Elements|trace elements|mesh-ancestor
138717850|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
138717851|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138717852|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
138717853|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138717854|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717855|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138717856|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
138717857|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138717858|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
138717859|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717860|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138717861|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138717862|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
138717863|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
138717864|NCT00565253|Protective Agents|protective agents|mesh-ancestor
138717865|NCT02277600|Darunavir|darunavir|mesh-list
138717866|NCT02277600|Cobicistat|cobicistat|mesh-list
138717867|NCT02277600|Fostemsavir|fostemsavir|mesh-list
138717869|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138717870|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
138717871|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247732|NCT03357393|Midazolam|midazolam|mesh-list
138717872|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717873|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138717874|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138717875|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
138717876|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138717877|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138652126|NCT00337545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717903|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
138717905|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138717906|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138717907|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717908|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138717909|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138717910|NCT04601675|Growth Substances|growth substances|mesh-ancestor
138717911|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
138717912|NCT00565292|Anacetrapib|anacetrapib|mesh-list
138717913|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138717914|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138717915|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
138717916|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717917|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138717918|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
138717919|NCT01580865|Tacrolimus|tacrolimus|mesh-list
138717920|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138717921|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
138717922|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717923|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138717924|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717925|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717926|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138717927|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717928|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138717957|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138717958|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138717959|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138575439|NCT00351871|Ribavirin|ribavirin|mesh-list
138717960|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138717961|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
138717962|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138717963|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138717964|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138717965|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138717966|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
138717967|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138717968|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058510|NCT03974360|Erenumab|erenumab|mesh-list
138717969|NCT00473382|Ranibizumab|ranibizumab|mesh-list
138717970|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138717971|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138717972|NCT00473382|Growth Substances|growth substances|mesh-ancestor
138717973|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717974|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
138717975|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138717976|NCT02210325|Azithromycin|azithromycin|mesh-list
138717977|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
138717990|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138717991|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138717992|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138717993|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138717994|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138717995|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138717996|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
138717997|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
138717998|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138717999|NCT04571151|Halobetasol|halobetasol|mesh-list
138718000|NCT04571151|Calcipotriene|calcipotriene|mesh-list
138718001|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
138718002|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138718004|NCT01133977|Dacarbazine|dacarbazine|mesh-list
138718005|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718006|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138718007|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718008|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718009|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138718010|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
138718011|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138718012|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138718013|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138718014|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138718015|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718016|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718017|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718020|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718021|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
138718022|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138718023|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
138718024|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138718025|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
138718026|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138718027|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138718028|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138718029|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718030|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718031|NCT00583271|Ethanol|ethanol|mesh-list
138718032|NCT00583271|Triamcinolone|triamcinolone|mesh-list
138718033|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138718034|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
138718035|NCT00583271|Hormones|hormones|mesh-ancestor
138718036|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718037|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718038|NCT00583271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138718039|NCT00583271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138718040|NCT00583271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718041|NCT00583349|Paclitaxel|paclitaxel|mesh-list
138652186|NCT00308165|Topotecan|topotecan|mesh-list
138718067|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718068|NCT01133626|Prednisone|prednisone|mesh-list
138718069|NCT01133626|Beclomethasone|beclomethasone|mesh-list
138718070|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138718071|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
138718072|NCT01133626|Hormones|hormones|mesh-ancestor
138718073|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718074|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718075|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138718076|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718077|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138718078|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
138718079|NCT01133392|Insulin|insulin|mesh-list
138718080|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138718081|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
138718082|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138718083|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718084|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138718085|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138718086|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138718087|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138718088|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718089|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
138652196|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
138718136|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
138718137|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718138|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138718139|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
138718140|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138718141|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138718142|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138718143|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718144|NCT00470847|Trastuzumab|trastuzumab|mesh-list
138718146|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138718147|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718148|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138718149|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718150|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718151|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
138718152|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138718153|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139058922|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
138718154|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
138718155|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718156|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718157|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718158|NCT00584090|Urological Agents|urological agents|mesh-ancestor
138718160|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138718161|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
138718162|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
138718163|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718164|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718165|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138718166|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
138718167|NCT00584168|Hormones|hormones|mesh-ancestor
138718168|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718169|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138718170|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718171|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138718172|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718173|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138718174|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718175|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718176|NCT01133275|Prednisone|prednisone|mesh-list
138718177|NCT01133275|Lenalidomide|lenalidomide|mesh-list
139058982|NCT01106872|Bevacizumab|bevacizumab|mesh-list
138718178|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138718179|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
138718218|NCT04570254|Antidotes|antidotes|mesh-ancestor
138718219|NCT00470067|Carboplatin|carboplatin|mesh-list
138718220|NCT00470067|Doxorubicin|doxorubicin|mesh-list
138718221|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138718222|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718223|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138718224|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138718225|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138718226|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059030|NCT00259610|Etanercept|etanercept|mesh-list
138718227|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718229|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138718230|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138718231|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
138718232|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718233|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546506|NCT00063401|Cetuximab|cetuximab|mesh-list
138718234|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138718235|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
138674561|NCT01315249|Xhance|xhance|mesh-list
138718236|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
138718237|NCT00584636|Hormones|hormones|mesh-ancestor
138718238|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718240|NCT00479817|Trebananib|trebananib|mesh-list
138718241|NCT00479817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138718242|NCT00479817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718243|NCT00479817|Tubulin Modulators|tubulin modulators|mesh-ancestor
138718244|NCT00479817|Antimitotic Agents|antimitotic agents|mesh-ancestor
138718245|NCT00479817|Mitosis Modulators|mitosis modulators|mesh-ancestor
138718246|NCT00479817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718247|NCT00479817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138718248|NCT00479817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138718249|NCT00479817|Growth Substances|growth substances|mesh-ancestor
138718250|NCT00479817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718251|NCT00479817|Growth Inhibitors|growth inhibitors|mesh-ancestor
138718252|NCT04575194|Liraglutide|liraglutide|mesh-list
138718253|NCT04575194|Naltrexone|naltrexone|mesh-list
138718254|NCT04575194|Bupropion|bupropion|mesh-list
138718255|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138718256|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138718257|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718258|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
138718259|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718260|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138718261|NCT04575194|Incretins|incretins|mesh-ancestor
138718262|NCT04575194|Hormones|hormones|mesh-ancestor
138718263|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718292|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138718293|NCT00585260|Diuretics|diuretics|mesh-ancestor
138718294|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
138718295|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718296|NCT00475020|Fludarabine|fludarabine|mesh-list
138718297|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
138718298|NCT00475020|Busulfan|busulfan|mesh-list
138718299|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
138718300|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138718301|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718302|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138718303|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
138718304|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718305|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138718306|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
138718307|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652354|NCT00309530|Fluorouracil|fluorouracil|mesh-list
138718322|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
138718324|NCT01132807|Doxorubicin|doxorubicin|mesh-list
138718325|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138718326|NCT01132807|Etoposide|etoposide|mesh-list
138718327|NCT01132807|Bleomycin|bleomycin|mesh-list
138718328|NCT01132807|Vinblastine|vinblastine|mesh-list
138718329|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
138718330|NCT01132807|Procarbazine|procarbazine|mesh-list
138718331|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138718332|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138718333|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
138718334|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718335|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138718336|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138718338|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575607|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
138718339|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718340|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138718341|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138718342|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138718343|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138718344|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059414|NCT03940378|Levamisole|levamisole|mesh-list
138718345|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138718346|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
138718347|NCT01132807|Hormones|hormones|mesh-ancestor
138718348|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718349|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138718350|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138718351|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138718352|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
138718353|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
138718354|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
138718355|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
138718356|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138718357|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718359|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138718360|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139059543|NCT01212406|Vitamin D|vitamin d|mesh-list
138718361|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138718362|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718363|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718364|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138718365|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718366|NCT01089504|Phenobarbital|phenobarbital|mesh-list
138718367|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
138718368|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138652377|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
138718381|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138718382|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718383|NCT01088997|Milrinone|milrinone|mesh-list
138718384|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138718385|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138718386|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
138718387|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138718388|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138575641|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
138718389|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718390|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718391|NCT01088997|Protective Agents|protective agents|mesh-ancestor
138718392|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718393|NCT00586118|Propofol|propofol|mesh-list
138718394|NCT00586118|Sevoflurane|sevoflurane|mesh-list
138718395|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138718396|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718397|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718398|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139059609|NCT01210456|Antidotes|antidotes|mesh-ancestor
138718399|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
138718400|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
138718401|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138718402|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138718403|NCT01088529|Prednisone|prednisone|mesh-list
138718404|NCT01088529|Leuprolide|leuprolide|mesh-list
138718405|NCT01088529|Goserelin|goserelin|mesh-list
138718406|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
138718407|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138718408|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
138718409|NCT01088529|Hormones|hormones|mesh-ancestor
138718410|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718411|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718412|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138718413|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718414|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138718415|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
138718416|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138718417|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138718418|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718419|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059714|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
138718420|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
138718421|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138718423|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
138718424|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718425|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138718426|NCT00586430|Lorazepam|lorazepam|mesh-list
138718427|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
138718428|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
138718429|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
139059779|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138718430|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718444|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
138718445|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138718446|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
138718447|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139059849|NCT01121848|Leucovorin|leucovorin|mesh-list
138718448|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
138718449|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718450|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718451|NCT04312204|Carboplatin|carboplatin|mesh-list
138718452|NCT04312204|Gemcitabine|gemcitabine|mesh-list
138718453|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718454|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138718455|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
138718456|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718457|NCT04312282|Itraconazole|itraconazole|mesh-list
138718458|NCT04312282|Rifampin|rifampin|mesh-list
138718459|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
138674768|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138718460|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138718461|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138718462|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138718463|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718464|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718465|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139060007|NCT01214122|Warfarin|warfarin|mesh-list
138718466|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
138718467|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718468|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718469|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138718470|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138718471|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
138718472|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138718473|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
138718474|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138718475|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138718476|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138718477|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138718478|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138718479|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138718480|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138718481|NCT01087905|Nicotine|nicotine|mesh-list
139060044|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138718482|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138718483|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
138718484|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718485|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718486|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138718487|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138718488|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
138718489|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652398|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718513|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138718515|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138718516|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138718517|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138718518|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718519|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718520|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138718522|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138718523|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138718524|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
138718525|NCT04575389|Uric Acid|uric acid|mesh-list
138718526|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
138718527|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718528|NCT04575389|Protective Agents|protective agents|mesh-ancestor
138718529|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718530|NCT01086150|Lidocaine|lidocaine|mesh-list
138718531|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
138718532|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
138718533|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718534|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718535|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
138718536|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718537|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138718538|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138718539|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138718540|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138718541|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060242|NCT03932266|Growth Substances|growth substances|mesh-ancestor
138718554|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138718555|NCT00587444|Heparin|heparin|mesh-list
138718556|NCT00587444|Calcium heparin|calcium heparin|mesh-list
138718557|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
138718558|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138718559|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138718560|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718561|NCT02278302|Ethanol|ethanol|mesh-list
138718562|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138718563|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138718564|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138718565|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718566|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718567|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138718568|NCT01085136|Afatinib|afatinib|mesh-list
139060288|NCT01222936|Panobinostat|panobinostat|mesh-list
138718569|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718570|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138718571|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718572|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718573|NCT00587873|Leucovorin|leucovorin|mesh-list
138718574|NCT00587873|Methotrexate|methotrexate|mesh-list
138718575|NCT00587873|Thioguanine|thioguanine|mesh-list
138718576|NCT00587873|Calcium|calcium|mesh-list
138718577|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
138718578|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138718579|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718580|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138718581|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
138718582|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138718583|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138718584|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
138718585|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718586|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718587|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
138718588|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718589|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138718590|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138718591|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
138718592|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138718593|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138718594|NCT00587873|Antidotes|antidotes|mesh-ancestor
138718595|NCT00587873|Protective Agents|protective agents|mesh-ancestor
138718596|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
138718597|NCT00587873|Vitamins|vitamins|mesh-ancestor
138718598|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
138718599|NCT01084707|Nicotine|nicotine|mesh-list
138718600|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138718601|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
138718602|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718603|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718604|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138652440|NCT00309881|Prednisone|prednisone|mesh-list
138718629|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718630|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718631|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138718632|NCT01084005|Linagliptin|linagliptin|mesh-list
138718633|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138718634|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718635|NCT01084005|Incretins|incretins|mesh-ancestor
138718636|NCT01084005|Hormones|hormones|mesh-ancestor
138718637|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718638|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138718639|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
138718640|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718641|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718642|NCT01083810|Ritonavir|ritonavir|mesh-list
138718643|NCT01083810|Lopinavir|lopinavir|mesh-list
138718644|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138718645|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138718646|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
138718647|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718648|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718649|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138718650|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138718651|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
138718652|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138718653|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138718654|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138718656|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138718701|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718703|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138718705|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
138718706|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138718707|NCT04568304|Carboplatin|carboplatin|mesh-list
138718708|NCT04568304|Gemcitabine|gemcitabine|mesh-list
138718709|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718710|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138718711|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
138718712|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718713|NCT01082640|Febuxostat|febuxostat|mesh-list
138718714|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
138718716|NCT00589862|Clopidogrel|clopidogrel|mesh-list
138718717|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138718718|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138718719|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138718720|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138718721|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
138718722|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718723|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718724|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718725|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
138718726|NCT00589901|Capecitabine|capecitabine|mesh-list
138718727|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138718728|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
138718729|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718730|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138718731|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138718732|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
138718733|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718734|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718735|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138718736|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138718737|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
138718738|NCT00590174|Aspirin|aspirin|mesh-list
138718739|NCT00590174|Clopidogrel|clopidogrel|mesh-list
138718740|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138718741|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138718742|NCT00590174|Analgesics|analgesics|mesh-ancestor
138718743|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
138718744|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138163798|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
138718772|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138718773|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718774|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
139060775|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
138718775|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718776|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138718777|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138718778|NCT01081626|Hormones|hormones|mesh-ancestor
138718779|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718780|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718781|NCT01080768|Amlodipine|amlodipine|mesh-list
138718782|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138718783|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138718784|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138718785|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718786|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138718787|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718788|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
138718789|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138718790|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138718791|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718792|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718793|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138718794|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575822|NCT00426010|Caffeine|caffeine|mesh-list
138718810|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138718811|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138718812|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138718813|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718814|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718816|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
138718817|NCT00590603|Bortezomib|bortezomib|mesh-list
138718818|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
138718819|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718820|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
138718821|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718822|NCT00590603|Protective Agents|protective agents|mesh-ancestor
138718823|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718824|NCT00590603|Vitamins|vitamins|mesh-ancestor
138718825|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
138718826|NCT01085097|Mycophenolic Acid|mycophenolic acid|mesh-list
138718827|NCT01085097|Prednisone|prednisone|mesh-list
138718828|NCT01085097|Methylprednisolone|methylprednisolone|mesh-list
138718829|NCT01085097|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138718830|NCT01085097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138718831|NCT01085097|Prednisolone|prednisolone|mesh-list
138718832|NCT01085097|Prednisolone acetate|prednisolone acetate|mesh-list
138718833|NCT01085097|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138718834|NCT01085097|Prednisolone phosphate|prednisolone phosphate|mesh-list
138718835|NCT01085097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138718836|NCT01085097|Glucocorticoids|glucocorticoids|mesh-ancestor
138718837|NCT01085097|Hormones|hormones|mesh-ancestor
138718838|NCT01085097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718839|NCT01085097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718840|NCT01085097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138718841|NCT01085097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718842|NCT01085097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138718843|NCT01085097|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138718844|NCT01085097|Antitubercular Agents|antitubercular agents|mesh-ancestor
138718845|NCT01085097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138718846|NCT01085097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138718847|NCT01085097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718848|NCT01085097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718849|NCT01085097|Antiemetics|antiemetics|mesh-ancestor
138718850|NCT01085097|Autonomic Agents|autonomic agents|mesh-ancestor
138718851|NCT01085097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718852|NCT01085097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138718853|NCT01085097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138718854|NCT01085097|Protective Agents|protective agents|mesh-ancestor
138718855|NCT00590837|Lomustine|lomustine|mesh-list
138718872|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718874|NCT01084161|Morphine|morphine|mesh-list
138718875|NCT01084161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138718876|NCT01084161|Narcotics|narcotics|mesh-ancestor
138718877|NCT01084161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718878|NCT01084161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718879|NCT01084161|Analgesics|analgesics|mesh-ancestor
138718880|NCT01084161|Sensory System Agents|sensory system agents|mesh-ancestor
138718881|NCT01084161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718882|NCT01083615|Prednisone|prednisone|mesh-list
138718883|NCT01083615|Docetaxel|docetaxel|mesh-list
138718884|NCT01083615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718885|NCT01083615|Tubulin Modulators|tubulin modulators|mesh-ancestor
138718886|NCT01083615|Antimitotic Agents|antimitotic agents|mesh-ancestor
139060962|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
138718887|NCT01083615|Mitosis Modulators|mitosis modulators|mesh-ancestor
138718888|NCT01083615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718889|NCT01083615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138718890|NCT01083615|Glucocorticoids|glucocorticoids|mesh-ancestor
138718891|NCT01083615|Hormones|hormones|mesh-ancestor
138718892|NCT01083615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138718893|NCT01083615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718894|NCT01083615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138718895|NCT00591188|Interferons|interferons|mesh-list
138718896|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
138718897|NCT00591188|Capecitabine|capecitabine|mesh-list
138718898|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138718899|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
138718900|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718901|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718902|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
138718903|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138718904|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
138675215|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
138718905|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718906|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138718907|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718908|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138718909|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718910|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718911|NCT01081782|Ceralifimod|ceralifimod|mesh-list
138718927|NCT01088802|Carboplatin|carboplatin|mesh-list
138718928|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138718929|NCT03451682|Procyanidin|procyanidin|mesh-list
138718930|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
139061043|NCT01230034|Imidapril|imidapril|mesh-list
138718931|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718932|NCT03451682|Protective Agents|protective agents|mesh-ancestor
138718933|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718934|NCT02210754|Menthol|menthol|mesh-list
138718935|NCT02210754|Nicotine|nicotine|mesh-list
138718936|NCT02210754|Glycerol|glycerol|mesh-list
138718937|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138718938|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
138718939|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138718940|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718941|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138718942|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138718943|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
138718944|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138718945|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718946|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
138718947|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
138718948|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138718949|NCT02210754|Protective Agents|protective agents|mesh-ancestor
138718950|NCT04574141|Melatonin|melatonin|mesh-list
138718951|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
138718952|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718953|NCT04574141|Protective Agents|protective agents|mesh-ancestor
138718954|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718955|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138718956|NCT04998981|Fenofibrate|fenofibrate|mesh-list
138718957|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138718958|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
138718959|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718960|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138718961|NCT04573049|Simendan|simendan|mesh-list
138718962|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138248865|NCT00553202|Hormones|hormones|mesh-ancestor
138718963|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
138718964|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138718965|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138718966|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138718967|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718968|NCT04573049|Protective Agents|protective agents|mesh-ancestor
138718969|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138718970|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
138718971|NCT04572698|Growth Substances|growth substances|mesh-ancestor
138718990|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138718991|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718992|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138718993|NCT03451019|Sevelamer|sevelamer|mesh-list
138718994|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
138718995|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
138718996|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138718997|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
138718998|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138718999|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719000|NCT02211066|Clopidogrel|clopidogrel|mesh-list
138719001|NCT02211066|Ticagrelor|ticagrelor|mesh-list
138719002|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138719003|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138719004|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138719005|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138719006|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
138719007|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719008|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719009|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719010|NCT03450317|Aspirin|aspirin|mesh-list
138719011|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138719012|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138719013|NCT03450317|Analgesics|analgesics|mesh-ancestor
138719014|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
138719015|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719016|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719017|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138719018|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138719019|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138719020|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138719021|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719022|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138719023|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138719024|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719025|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
138719026|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
138719027|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138719028|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719040|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138719041|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
138719042|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
138719044|NCT04565184|Lumefantrine|lumefantrine|mesh-list
138719045|NCT04565184|Artemether|artemether|mesh-list
138719046|NCT04565184|Amodiaquine|amodiaquine|mesh-list
138719047|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138719048|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
138719049|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
138719050|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138719051|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138719052|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138719053|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719054|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
138719055|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
138719056|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138719057|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
138719059|NCT03452579|Nivolumab|nivolumab|mesh-list
138719060|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138719061|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719062|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138719063|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138719064|NCT03452579|Growth Substances|growth substances|mesh-ancestor
138719065|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719066|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
138719067|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138719068|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719069|NCT04997850|Lenvatinib|lenvatinib|mesh-list
138719070|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719071|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138719072|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719073|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719074|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138719075|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138719076|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138719077|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138719078|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138719079|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138719080|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138719081|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
138719082|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719083|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719084|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719085|NCT03456947|Pregabalin|pregabalin|mesh-list
138719086|NCT03456947|Analgesics|analgesics|mesh-ancestor
138719087|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
138719088|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719089|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719090|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
138719091|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138719092|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138719109|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
138719110|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138719111|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
138719112|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138719113|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138719114|NCT04564326|Fentanyl|fentanyl|mesh-list
138719115|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138719116|NCT04564326|Narcotics|narcotics|mesh-ancestor
138719117|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138719118|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719119|NCT04564326|Analgesics|analgesics|mesh-ancestor
138719120|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
138719121|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719122|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138719123|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138719124|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
138719125|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
138719126|NCT03453164|Nivolumab|nivolumab|mesh-list
138719127|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138719128|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719129|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138719130|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719131|NCT03450434|Histamine|histamine|mesh-list
138719132|NCT03450434|Glutarimide|glutarimide|mesh-list
138719133|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
138719134|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
138719135|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719136|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719137|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719138|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138719139|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719140|NCT00198029|Hylan|hylan|mesh-list
138719141|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
138719142|NCT00198029|Protective Agents|protective agents|mesh-ancestor
138719143|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719144|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138719145|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138719146|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
138719147|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719148|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719149|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138652628|NCT00310934|Narcotics|narcotics|mesh-ancestor
138719165|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138719166|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
138719167|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138719168|NCT04563936|Goserelin|goserelin|mesh-list
138719169|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138719170|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719171|NCT04563975|Paclitaxel|paclitaxel|mesh-list
138719172|NCT04563975|Docetaxel|docetaxel|mesh-list
138719173|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138719174|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719175|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
138719176|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
138719177|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
139061828|NCT00112905|Sorafenib|sorafenib|mesh-list
138719178|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719179|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
138719180|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138719181|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
138719182|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139061889|NCT01763866|Simvastatin|simvastatin|mesh-list
138719183|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719184|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138719185|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138719186|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138719188|NCT00195650|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138719189|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138719190|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138719191|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
138719192|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138719193|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719194|NCT04560894|Sorafenib|sorafenib|mesh-list
138719195|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719196|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138719197|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719198|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719199|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
138719200|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138719201|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138719202|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719203|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
138719204|NCT04560465|Coagulants|coagulants|mesh-ancestor
138719205|NCT00195494|Etanercept|etanercept|mesh-list
138719206|NCT00195494|Methotrexate|methotrexate|mesh-list
138719207|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138719208|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
138719209|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138719210|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719211|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138719229|NCT00194987|Prednisone|prednisone|mesh-list
138719230|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
138719231|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138719232|NCT00194987|Antibodies|antibodies|mesh-list
138719233|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
138719234|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138719235|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138719236|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
138719237|NCT00194987|Hormones|hormones|mesh-ancestor
138719238|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719239|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719240|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139062075|NCT00423917|Growth Substances|growth substances|mesh-ancestor
138719241|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719242|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
138719243|NCT00194792|Paclitaxel|paclitaxel|mesh-list
138719244|NCT00194792|Vinorelbine|vinorelbine|mesh-list
138719245|NCT00194792|Capecitabine|capecitabine|mesh-list
138719246|NCT00194792|Methotrexate|methotrexate|mesh-list
138719247|NCT00194792|Exemestane|exemestane|mesh-list
138719248|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138719249|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138719250|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719251|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
138719252|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
138719253|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
138719254|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719255|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138719256|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
138719257|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138719258|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
138719259|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138719260|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719261|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
138719262|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719263|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138719264|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138719265|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
138719266|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138719267|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138719268|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138719269|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138652660|NCT00311051|Ramatroban|ramatroban|mesh-list
138719282|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138719283|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138719284|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
138719285|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719286|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719287|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719288|NCT00194675|Testosterone|testosterone|mesh-list
138719289|NCT00194675|Dutasteride|dutasteride|mesh-list
138719290|NCT00194675|Androgens|androgens|mesh-ancestor
138719291|NCT00194675|Hormones|hormones|mesh-ancestor
138719292|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719293|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719294|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138719295|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138719296|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719297|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719298|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
138719299|NCT00194012|Aripiprazole|aripiprazole|mesh-list
138719300|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
138719301|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138719302|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138719303|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138719304|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138719305|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719306|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
138719307|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
138719308|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719309|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719310|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138719311|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138719312|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
138576022|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719313|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138719314|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138719315|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138719316|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138719317|NCT04563351|Anesthetics|anesthetics|mesh-list
138719318|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
138719319|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138719320|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719321|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
138719322|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719323|NCT00192647|Ribavirin|ribavirin|mesh-list
138719324|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138719325|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
138719326|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
138719327|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719328|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
138719329|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652684|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
138719344|NCT00191984|Pemetrexed|pemetrexed|mesh-list
138719345|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138719346|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138719347|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719348|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719349|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719350|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138719351|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138719352|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
138719353|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139062586|NCT01251328|Anesthetics|anesthetics|mesh-list
138719354|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719355|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138719356|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138719357|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138719359|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719360|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
138719361|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719362|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719363|NCT00191789|Gemcitabine|gemcitabine|mesh-list
138719364|NCT00191789|Doxorubicin|doxorubicin|mesh-list
138719365|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719366|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138719367|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
138719368|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719369|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139062713|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
138719370|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138719371|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138719372|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719373|NCT00191282|Insulin|insulin|mesh-list
138719374|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138719376|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
138476794|NCT02014714|Narcotics|narcotics|mesh-ancestor
138719377|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
138719378|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
138719379|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
138719380|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138719381|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719382|NCT04560231|Remdesivir|remdesivir|mesh-list
138719383|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
138719384|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719385|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
138719386|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138719387|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138719388|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138719389|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138719390|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138719405|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719406|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
138719408|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719409|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719410|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138719411|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138719412|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
138719413|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138719414|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138719415|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138719416|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138719417|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138719418|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138719419|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138719420|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
138719421|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138719422|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
138719424|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
138719425|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719426|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138719427|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138719428|NCT00179660|Growth Substances|growth substances|mesh-ancestor
138719429|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
138719430|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719431|NCT00178256|Paclitaxel|paclitaxel|mesh-list
139062978|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
138719432|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138719433|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719434|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
138719435|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
138719436|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
138719437|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719438|NCT02211222|Lenvatinib|lenvatinib|mesh-list
138719439|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719440|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138719441|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719442|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719443|NCT00177164|Olanzapine|olanzapine|mesh-list
138719444|NCT00177164|Risperidone|risperidone|mesh-list
138719445|NCT00177164|Aripiprazole|aripiprazole|mesh-list
138719446|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138719447|NCT00177164|Ziprasidone|ziprasidone|mesh-list
138719448|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
138719449|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138719450|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
138719451|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652701|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719485|NCT04559568|Midazolam|midazolam|mesh-list
138719486|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138719487|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138719488|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063049|NCT03908944|Methadone|methadone|mesh-list
138719489|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719490|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138719512|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138719513|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
138719514|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719515|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138719516|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138719517|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
138719518|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719519|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719520|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138719521|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138719522|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
138719523|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
138719524|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719525|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138719526|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
138719527|NCT00176462|Hormones|hormones|mesh-ancestor
138719528|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719529|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138719530|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138719531|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
138719532|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138719533|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138719534|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
138719535|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
138719536|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719537|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138719538|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138719539|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
138719540|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138719541|NCT00176462|Antidotes|antidotes|mesh-ancestor
138719542|NCT00176462|Protective Agents|protective agents|mesh-ancestor
138719543|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
138719544|NCT00176462|Vitamins|vitamins|mesh-ancestor
138719545|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
138719546|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138719547|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
138719549|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
138719550|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138719551|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138719552|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138719553|NCT00175019|Allopurinol|allopurinol|mesh-list
138719570|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138719571|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138719572|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719573|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719574|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138719575|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
139063269|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719576|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719577|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719578|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138719579|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138719580|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138719581|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138719582|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
138719584|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719585|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138719586|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138719587|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719588|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719589|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138719590|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
138719591|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719592|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719593|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138719595|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719596|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138719597|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719598|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719599|NCT00170846|Everolimus|everolimus|mesh-list
138719600|NCT00170846|Azathioprine|azathioprine|mesh-list
138719601|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138719602|NCT00170846|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138719603|NCT00170846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138719604|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719605|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719606|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138719607|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
138719608|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719609|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719610|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
138719611|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138719612|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138719613|NCT00476606|Ritonavir|ritonavir|mesh-list
138719614|NCT00476606|Nelfinavir|nelfinavir|mesh-list
138719631|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138719632|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138719633|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138719634|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138719635|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138719636|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
138719637|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138719638|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138719639|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138719640|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138719641|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138719642|NCT04562103|Epinephrine|epinephrine|mesh-list
138719643|NCT04562103|Ropivacaine|ropivacaine|mesh-list
138719644|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
138719645|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
138719646|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063585|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719647|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719649|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719650|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138719651|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138719652|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
138719653|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719654|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719655|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138719656|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138719657|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
138719658|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138719659|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
138719660|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
138719661|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
138719662|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138719663|NCT04561635|Micronutrients|micronutrients|mesh-list
138719664|NCT04561635|Trace Elements|trace elements|mesh-list
138719665|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719666|NCT00479882|Simvastatin|simvastatin|mesh-list
138719667|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138719668|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138719669|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
138719670|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719671|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138719672|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138719673|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719674|NCT00479765|Paclitaxel|paclitaxel|mesh-list
138719675|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138719676|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719677|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
138719688|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138719689|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719691|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719692|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
138719694|NCT00478244|Fludarabine|fludarabine|mesh-list
138719695|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
138719696|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138719697|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
138719698|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719699|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138719700|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138719701|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
138719702|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719703|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719704|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138719705|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138719706|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
138719708|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138719709|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719710|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719711|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
138719712|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719713|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719714|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
138719715|NCT00477971|Dexamethasone|dexamethasone|mesh-list
138719716|NCT00477971|Melphalan|melphalan|mesh-list
138719717|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138719718|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
138719719|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
138719720|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719721|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719722|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138719723|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
138719724|NCT00477971|Hormones|hormones|mesh-ancestor
138719725|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719726|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138719727|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719728|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
138719729|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138719730|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
138719731|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719732|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138676036|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
138719733|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138719735|NCT00477464|Lapatinib|lapatinib|mesh-list
138719736|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138719737|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
138719738|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719739|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719740|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138719741|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719751|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719752|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719753|NCT00476996|Methotrexate|methotrexate|mesh-list
138719754|NCT00476996|Leflunomide|leflunomide|mesh-list
138719755|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
138719756|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138719757|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
138719758|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138719759|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719760|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138719761|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
138719762|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719763|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719764|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
138719765|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719766|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138719767|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138719768|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
138719769|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139063876|NCT01259830|Etoricoxib|etoricoxib|mesh-list
138719770|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138719772|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138719773|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138719774|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138719775|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719777|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138719778|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
138719779|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719780|NCT00475865|Teriflunomide|teriflunomide|mesh-list
138719781|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
138719782|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
138719783|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138719784|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
139063919|NCT01074372|Antimetabolites|antimetabolites|mesh-ancestor
138719785|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719786|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138719787|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138719788|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138719789|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138719790|NCT00475865|Analgesics|analgesics|mesh-ancestor
138719791|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
138719792|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719793|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138719794|NCT00475670|Paclitaxel|paclitaxel|mesh-list
138719795|NCT00475670|Docetaxel|docetaxel|mesh-list
138719796|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138719797|NCT00475670|Trastuzumab|trastuzumab|mesh-list
138719798|NCT00475670|Taxane|taxane|mesh-list
138719799|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138719800|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719801|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
138719802|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
138719803|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
138719804|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719805|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138719806|NCT04556760|Prednisolone|prednisolone|mesh-list
138719807|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138719808|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
138719816|NCT00474929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138719817|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138719818|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719819|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719820|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138719821|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
138719822|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719823|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719824|NCT00474812|Dasatinib|dasatinib|mesh-list
138719825|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719826|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138719827|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719828|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719829|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
138719830|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
138719831|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719832|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138719833|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719834|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719835|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
138719836|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719837|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719838|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138719839|NCT00474383|Hormones|hormones|mesh-ancestor
138719841|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
138719842|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719843|NCT00472199|Protective Agents|protective agents|mesh-ancestor
138719844|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719845|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138719846|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138719847|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
138719848|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
138719849|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719850|NCT04556136|Vitamin D|vitamin d|mesh-list
138719851|NCT04556136|Vitamins|vitamins|mesh-ancestor
138719852|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
138719853|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719854|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138719855|NCT00471887|Tremelimumab|tremelimumab|mesh-list
138719856|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719857|NCT04556058|Perindopril|perindopril|mesh-list
138719858|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138719859|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
138719860|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719861|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719862|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138719863|NCT00470834|Bicalutamide|bicalutamide|mesh-list
138719864|NCT00470834|Dutasteride|dutasteride|mesh-list
138719865|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
138719866|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
138719867|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719868|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719869|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719870|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138719871|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138719872|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719873|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719874|NCT00470366|Paclitaxel|paclitaxel|mesh-list
138719875|NCT00470366|Ifosfamide|ifosfamide|mesh-list
138719876|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139064020|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
138719877|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719891|NCT00470054|Dasatinib|dasatinib|mesh-list
138719892|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719893|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138719894|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719895|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719896|NCT00478595|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138719897|NCT00478595|Rimonabant|rimonabant|mesh-list
138719898|NCT00478595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138719899|NCT00478595|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138719900|NCT00478595|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138719901|NCT00478595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719902|NCT00478595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719903|NCT00478595|Hormones|hormones|mesh-ancestor
138719904|NCT00478595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719905|NCT00478595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719906|NCT04555707|Betamethasone|betamethasone|mesh-list
138719907|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
138719908|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138719909|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
138719910|NCT04555707|Apremilast|apremilast|mesh-list
138719911|NCT04555707|Calcipotriene|calcipotriene|mesh-list
138719912|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138719913|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138719914|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
138719915|NCT04555707|Hormones|hormones|mesh-ancestor
138719916|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719917|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719918|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138719919|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
138719920|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138719921|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138719922|NCT04555707|Analgesics|analgesics|mesh-ancestor
138719923|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
138719924|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719925|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138719926|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138719927|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138719928|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138719929|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719930|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
138719931|NCT00474188|Dexamethasone|dexamethasone|mesh-list
138719932|NCT00474188|Lenalidomide|lenalidomide|mesh-list
138719933|NCT00474188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138719934|NCT00474188|Antiemetics|antiemetics|mesh-ancestor
138719935|NCT00474188|Autonomic Agents|autonomic agents|mesh-ancestor
138719936|NCT00474188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719937|NCT00474188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719938|NCT00474188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138719952|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138719953|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
138719954|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719955|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719956|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138719957|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
138719958|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
138719960|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719961|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138719962|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
138719963|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138719964|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138719965|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719966|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
138719967|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138719968|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138719969|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138719970|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138719971|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138719972|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
138719973|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138719974|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719975|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138719976|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138719977|NCT01089608|Azithromycin|azithromycin|mesh-list
138719978|NCT01089608|Povidone|povidone|mesh-list
138719979|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138719980|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138719981|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
138719982|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
138719983|NCT04554654|Progesterone|progesterone|mesh-list
138719984|NCT04554654|Progestins|progestins|mesh-ancestor
138719985|NCT04554654|Hormones|hormones|mesh-ancestor
138546547|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138719986|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138719987|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719989|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138719990|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719991|NCT01089413|Bevacizumab|bevacizumab|mesh-list
138719992|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138719993|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138719994|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138719995|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138719996|NCT01089413|Growth Substances|growth substances|mesh-ancestor
138719997|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138719998|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
138719999|NCT02212782|Linagliptin|linagliptin|mesh-list
138720000|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138652833|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138720018|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138720019|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720020|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138720021|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138720022|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720023|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720024|NCT01088243|Mesalamine|mesalamine|mesh-list
138720025|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138720026|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138720027|NCT01088243|Analgesics|analgesics|mesh-ancestor
138720028|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
138720029|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720030|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720031|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138720032|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138720033|NCT04672499|Cortisone|cortisone|mesh-list
138720034|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138720035|NCT04554303|Amlodipine|amlodipine|mesh-list
138720036|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138720037|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138720038|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138720039|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720040|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138720041|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720042|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
138720043|NCT01088048|Rituximab|rituximab|mesh-list
138720044|NCT01088048|Fludarabine|fludarabine|mesh-list
138720045|NCT01088048|Lenalidomide|lenalidomide|mesh-list
138720046|NCT01088048|Everolimus|everolimus|mesh-list
138720047|NCT01088048|Bortezomib|bortezomib|mesh-list
138720048|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138720049|NCT01088048|Ofatumumab|ofatumumab|mesh-list
138720050|NCT01088048|Idelalisib|idelalisib|mesh-list
138720051|NCT01088048|Chlorambucil|chlorambucil|mesh-list
138576223|NCT00446680|Mannitol|mannitol|mesh-list
138720052|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138720053|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720054|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
138720055|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720056|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138720057|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720078|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138720079|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138720081|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720082|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
138720083|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720084|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138720085|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138720086|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138720087|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138720088|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138720089|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138720090|NCT04554030|Immunomodulating Agents|immunomodulating agents|mesh-list
138720091|NCT04554030|Immunologic Factors|immunologic factors|mesh-ancestor
138720092|NCT04554030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720093|NCT01087502|Glimepiride|glimepiride|mesh-list
138720094|NCT01087502|Linagliptin|linagliptin|mesh-list
138720095|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138720096|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138720097|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720098|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138720099|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
138720100|NCT01087502|Incretins|incretins|mesh-ancestor
138720101|NCT01087502|Hormones|hormones|mesh-ancestor
138720102|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720103|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138720104|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
138720105|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720106|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720107|NCT02213211|Lumefantrine|lumefantrine|mesh-list
138720108|NCT02213211|Artemether|artemether|mesh-list
138720109|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138720110|NCT02213211|Artemisinins|artemisinins|mesh-list
138652875|NCT00339768|Omeprazole|omeprazole|mesh-list
138720129|NCT01086410|Hormones|hormones|mesh-ancestor
138720130|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720131|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138720132|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720133|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138720135|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720136|NCT04553328|Bupivacaine|bupivacaine|mesh-list
138720137|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
138720138|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
138720139|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138720140|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720141|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
138720142|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720143|NCT01085591|Vancomycin|vancomycin|mesh-list
138720144|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138720145|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720146|NCT04552977|Temozolomide|temozolomide|mesh-list
138720147|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138720148|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
138720149|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720150|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720151|NCT01085201|Regadenoson|regadenoson|mesh-list
138720152|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138720153|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138720154|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
138720155|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
138720156|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720157|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720158|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720159|NCT02213718|Sufentanil|sufentanil|mesh-list
138720160|NCT02213718|Propofol|propofol|mesh-list
138720161|NCT02213718|Desflurane|desflurane|mesh-list
138720162|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138720163|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138720164|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720165|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138720166|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
138720167|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
138720168|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138720169|NCT02213718|Narcotics|narcotics|mesh-ancestor
138720170|NCT02213718|Analgesics|analgesics|mesh-ancestor
138720171|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
138720183|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
138720184|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138720185|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138720186|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138720187|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
138720188|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720189|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720190|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
138720191|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138720192|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
138720194|NCT02213796|Meropenem|meropenem|mesh-list
138720195|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139064162|NCT01267396|Sertraline|sertraline|mesh-list
138720196|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720197|NCT00179673|Lenalidomide|lenalidomide|mesh-list
138720198|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
138720199|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720200|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138720201|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138720202|NCT00179673|Growth Substances|growth substances|mesh-ancestor
138720203|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
138720204|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720205|NCT01084655|Prednisone|prednisone|mesh-list
138720206|NCT01084655|Docetaxel|docetaxel|mesh-list
138720207|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720208|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
138720209|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
138720210|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
138720211|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720212|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138720213|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
138720214|NCT01084655|Hormones|hormones|mesh-ancestor
138720215|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720216|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720217|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138720218|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
138720219|NCT04552431|Tamsulosin|tamsulosin|mesh-list
138720220|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138720221|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720222|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138720223|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138720224|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720225|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720226|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720227|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138720228|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138720229|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138720230|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138720231|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138720232|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
138720233|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652900|NCT00312650|Doxorubicin|doxorubicin|mesh-list
138720243|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138720244|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720245|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138720246|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138720247|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720248|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720249|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138720250|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
138720251|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720252|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720253|NCT01083641|Estradiol|estradiol|mesh-list
138720254|NCT01083641|Estrogens|estrogens|mesh-ancestor
138720255|NCT01083641|Hormones|hormones|mesh-ancestor
138720256|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720257|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720259|NCT00179010|Analgesics|analgesics|mesh-ancestor
138720260|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
138720261|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720262|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720263|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138720264|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
138720265|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138720266|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
138720267|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
138576285|NCT00447031|Hormones|hormones|mesh-ancestor
138720268|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720269|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720270|NCT01083602|Dexamethasone|dexamethasone|mesh-list
138720271|NCT01083602|Bortezomib|bortezomib|mesh-list
138720272|NCT01083602|Panobinostat|panobinostat|mesh-list
138720273|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138720274|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
138720275|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
138720276|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720277|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720278|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138720279|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
138720280|NCT01083602|Hormones|hormones|mesh-ancestor
138720281|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720282|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138720283|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720284|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138720285|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720286|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720288|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138720289|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138720290|NCT00178464|Analgesics|analgesics|mesh-ancestor
138720291|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
138720292|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720293|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720294|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138720295|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138720296|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138720297|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138720298|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720299|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138720314|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720315|NCT01083485|Analgesics|analgesics|mesh-ancestor
138720316|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
138720317|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720318|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138720319|NCT04551924|Ropivacaine|ropivacaine|mesh-list
138720320|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
138720321|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
138720322|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138720323|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720324|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
138720325|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720326|NCT04671836|Lorazepam|lorazepam|mesh-list
138720327|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
138720328|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
138720329|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
138720330|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720331|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720332|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138720333|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138720334|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138720335|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138720336|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138720337|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138720338|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
138720339|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
138720340|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720341|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720342|NCT00556088|Paclitaxel|paclitaxel|mesh-list
138720343|NCT00556088|Bevacizumab|bevacizumab|mesh-list
138720344|NCT00556088|Carboplatin|carboplatin|mesh-list
138720345|NCT00556088|Panobinostat|panobinostat|mesh-list
138720346|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138720347|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720348|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
138720349|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
138720350|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
138720351|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720352|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138720353|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138546552|NCT00097032|Risperidone|risperidone|mesh-list
138720354|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138720356|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720357|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
138720358|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138720359|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720361|NCT00177294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138720362|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138720363|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138720372|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720373|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720374|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
138720375|NCT00177216|Zolpidem|zolpidem|mesh-list
138720376|NCT00177216|Escitalopram|escitalopram|mesh-list
138720377|NCT00177216|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138720378|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138720379|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138720380|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720381|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720382|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
138720383|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720384|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138720385|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138720386|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138720387|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138720388|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
138720389|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
138720390|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138720391|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
138720392|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138720393|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138720394|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720395|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138720396|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138720397|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138720398|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
138720399|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720400|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720401|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138720402|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138720403|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
138720404|NCT04551768|Ribavirin|ribavirin|mesh-list
138720406|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720407|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
138720408|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720409|NCT04671563|Tenofovir|tenofovir|mesh-list
138720410|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
138720411|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720412|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138720413|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138720414|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720415|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720416|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138720417|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138720418|NCT04551573|Rifapentine|rifapentine|mesh-list
138720419|NCT04551573|Rifampin|rifampin|mesh-list
138720420|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138720421|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
138720422|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138720423|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720424|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
138720425|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138720426|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720427|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720428|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138720429|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138652932|NCT00343239|Fluorouracil|fluorouracil|mesh-list
138720437|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138720438|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138720439|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
138720440|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720441|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720442|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720444|NCT00174915|Febuxostat|febuxostat|mesh-list
138720445|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
138720446|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720447|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720448|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
138720449|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138720450|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138720451|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
138720452|NCT00174915|Protective Agents|protective agents|mesh-ancestor
138720453|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720454|NCT01080716|Vaccines|vaccines|mesh-list
138720455|NCT01080716|Complement Factor H|complement factor h|mesh-list
138720456|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
138720457|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720458|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138720459|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138720460|NCT04671446|Autoantibodies|autoantibodies|mesh-list
138720461|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
138720462|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720463|NCT04571489|Gemcitabine|gemcitabine|mesh-list
138720464|NCT04571489|Tegafur|tegafur|mesh-list
138720465|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138720466|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
138720467|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720468|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720469|NCT00172185|Teduglutide|teduglutide|mesh-list
139064315|NCT01165372|Artesunate|artesunate|mesh-list
138720470|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138720471|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138720472|NCT00172185|Protective Agents|protective agents|mesh-ancestor
138720473|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720474|NCT00171951|Pasireotide|pasireotide|mesh-list
138720475|NCT00171951|Hormones|hormones|mesh-ancestor
138720476|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720477|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720478|NCT01080131|Triamcinolone|triamcinolone|mesh-list
138720479|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138720480|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138720481|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138720482|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138720483|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138720484|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
138720485|NCT01080131|Hormones|hormones|mesh-ancestor
138720486|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720487|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720488|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138720489|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
138720490|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720491|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720492|NCT00171873|Octreotide|octreotide|mesh-list
138720493|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138720494|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138720495|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720496|NCT01087151|Rituximab|rituximab|mesh-list
138720506|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
138720507|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
138720508|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720509|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720510|NCT04571996|Acetaminophen|acetaminophen|mesh-list
138720511|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138720512|NCT04571996|Analgesics|analgesics|mesh-ancestor
138720513|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
138720514|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720515|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720516|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
138720517|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
138720518|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720519|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138720520|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720521|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720522|NCT04671056|Pioglitazone|pioglitazone|mesh-list
138720523|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138720524|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720525|NCT01082549|Carboplatin|carboplatin|mesh-list
138720526|NCT01082549|Gemcitabine|gemcitabine|mesh-list
138720527|NCT01082549|Iniparib|iniparib|mesh-list
138720528|NCT01082549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720529|NCT01082549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138720530|NCT01082549|Antimetabolites|antimetabolites|mesh-ancestor
138720531|NCT01082549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720532|NCT01082549|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138720533|NCT01082549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720534|NCT04550949|Denosumab|denosumab|mesh-list
138720535|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138720536|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720537|NCT01085630|Pemetrexed|pemetrexed|mesh-list
138720538|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720539|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720540|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720541|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138720542|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138720543|NCT00171210|Deferasirox|deferasirox|mesh-list
138720544|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138720545|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
138720546|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
138720547|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720548|NCT00171054|Amlodipine|amlodipine|mesh-list
138720549|NCT00171054|Valsartan|valsartan|mesh-list
138720550|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138576355|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
138720551|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138720552|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138720553|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138720554|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720555|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138720556|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720557|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
138720558|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138720559|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138720560|NCT00171054|Diuretics|diuretics|mesh-ancestor
138720561|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
138720562|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138720563|NCT00174837|Tirapazamine|tirapazamine|mesh-list
138720564|NCT00174837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720582|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
138720583|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
138720584|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720585|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138720586|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
138720587|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138720588|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720589|NCT04997759|Neostigmine|neostigmine|mesh-list
138720590|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138720591|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720592|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720593|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
138720594|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720595|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720596|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138720597|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
138720598|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720599|NCT00479466|Metformin|metformin|mesh-list
138720600|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138720601|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720602|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
138720603|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138720604|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720605|NCT04991948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138720606|NCT04991948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720607|NCT04990778|Venetoclax|venetoclax|mesh-list
138720608|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720609|NCT00479388|Niacin|niacin|mesh-list
138720610|NCT00479388|Atorvastatin|atorvastatin|mesh-list
138720611|NCT00479388|Simvastatin|simvastatin|mesh-list
138720612|NCT00479388|Calcium|calcium|mesh-list
138720613|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138720614|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720615|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138720616|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138720617|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
138720618|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720619|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138720620|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138720621|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720622|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
138720623|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
138720624|NCT00479388|Vitamins|vitamins|mesh-ancestor
138720625|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
138720637|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138720638|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064402|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720639|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720640|NCT00478881|Urological Agents|urological agents|mesh-ancestor
138720642|NCT00556127|Dexamethasone|dexamethasone|mesh-list
138720643|NCT00556127|Prednisone|prednisone|mesh-list
138720644|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
138720645|NCT00556127|Melphalan|melphalan|mesh-list
138720646|NCT00556127|Carmustine|carmustine|mesh-list
138720647|NCT00556127|Rituximab|rituximab|mesh-list
138720648|NCT00556127|Etoposide|etoposide|mesh-list
138720649|NCT00556127|Vincristine|vincristine|mesh-list
138720650|NCT00556127|Epirubicin|epirubicin|mesh-list
138720651|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
138720652|NCT00556127|Lenograstim|lenograstim|mesh-list
138720653|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138720654|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
138720655|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720656|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138720657|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138720658|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
138720659|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720660|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720661|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138720662|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138720663|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
138720664|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
138720665|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720666|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138720667|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
138720668|NCT00556127|Hormones|hormones|mesh-ancestor
138720669|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720670|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138720671|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138720672|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138720673|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138720674|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138720675|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720676|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138720677|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
138720678|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
138720679|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720680|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
138720681|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
138720682|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
138720683|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138720684|NCT00556127|Analgesics|analgesics|mesh-ancestor
138720685|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
138720686|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138720688|NCT00556205|Sunitinib|sunitinib|mesh-list
138720689|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138720690|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720691|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138652974|NCT00313157|Verapamil|verapamil|mesh-list
138720702|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138720703|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720704|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
138720705|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138720706|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
138720707|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720708|NCT00478140|Trastuzumab|trastuzumab|mesh-list
138720709|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138720710|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720712|NCT00478023|Tapentadol|tapentadol|mesh-list
138720713|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138720714|NCT00478023|Narcotics|narcotics|mesh-ancestor
138720715|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138720716|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720717|NCT00478023|Analgesics|analgesics|mesh-ancestor
138720718|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
138720719|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720720|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138720721|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138720722|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138720723|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720724|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
138720725|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720727|NCT00477750|Lenalidomide|lenalidomide|mesh-list
138720728|NCT00477750|Melphalan|melphalan|mesh-list
138720729|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138720730|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
138720731|NCT00477750|Hormones|hormones|mesh-ancestor
138720732|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720733|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720734|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138720735|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720736|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
138720737|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138720738|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138720739|NCT00477750|Growth Substances|growth substances|mesh-ancestor
138720740|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
138720741|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138720742|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
138720743|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720744|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138720745|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138720746|NCT00477672|Pimavanserin|pimavanserin|mesh-list
138720747|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138720748|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138720749|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138720750|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138720751|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138720752|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720753|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138720754|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138720755|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138720756|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
138720757|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720774|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720775|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138720776|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
138720777|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138720778|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138720779|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138720780|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138720781|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138720782|NCT04541823|Propofol|propofol|mesh-list
138720783|NCT04541823|Desflurane|desflurane|mesh-list
138720784|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138720785|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138720786|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720787|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138720788|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
138720789|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
138720790|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138720792|NCT00556361|Analgesics|analgesics|mesh-ancestor
138720793|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
138720794|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720795|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064484|NCT00220740|Antibodies|antibodies|mesh-list
138720796|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138720797|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138720798|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
138720799|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
138720800|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138720801|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138720802|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138720803|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720804|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720805|NCT04571606|Bupivacaine|bupivacaine|mesh-list
138720806|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
138720807|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
138720808|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138720809|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720810|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
138720811|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720812|NCT04541277|Cytarabine|cytarabine|mesh-list
138720813|NCT04541277|Azacitidine|azacitidine|mesh-list
138720814|NCT04541277|Decitabine|decitabine|mesh-list
138720815|NCT04541277|Tislelizumab|tislelizumab|mesh-list
138720816|NCT04541277|Idarubicin|idarubicin|mesh-list
138720817|NCT04541277|Lenograstim|lenograstim|mesh-list
138720818|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138720828|NCT04541277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138720829|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138720830|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138720831|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138720832|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138720833|NCT04540926|Cyclosporine|cyclosporine|mesh-list
138720834|NCT04540926|Cyclosporins|cyclosporins|mesh-list
138720835|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138720836|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720837|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138720838|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
138720839|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720840|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
138720841|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720842|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
138720843|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138720844|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138720845|NCT04540965|Famotidine|famotidine|mesh-list
138720846|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138720847|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138720848|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139064530|NCT00184002|Hormones|hormones|mesh-ancestor
138720849|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
138720850|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
138720851|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720852|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720853|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720854|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
138720855|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138720856|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720857|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138720858|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720859|NCT04570592|Dexamethasone|dexamethasone|mesh-list
138720860|NCT04570592|Granisetron|granisetron|mesh-list
138720861|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138546568|NCT02962336|Olmesartan|olmesartan|mesh-list
138720862|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138720864|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
138720865|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720866|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720867|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138720868|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
138720869|NCT04570592|Hormones|hormones|mesh-ancestor
138720870|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720871|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138720872|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720873|NCT04570592|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138720874|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138720875|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
138720876|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720877|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720878|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138720879|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
138720880|NCT02215395|Estradiol|estradiol|mesh-list
138720881|NCT02215395|Estrogens|estrogens|mesh-ancestor
138720882|NCT02215395|Hormones|hormones|mesh-ancestor
138720883|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720896|NCT02215434|Hormones|hormones|mesh-ancestor
138720897|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138720898|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720899|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138720900|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138720901|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
138720902|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
138720903|NCT04561076|Paraproteins|paraproteins|mesh-list
138720904|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
139064558|NCT01275508|Adalimumab|adalimumab|mesh-list
138720905|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720907|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138720908|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138720909|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720910|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
138720911|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
138720912|NCT04547829|Lenograstim|lenograstim|mesh-list
138720913|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138720914|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
138720915|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720916|NCT02211911|Bisacodyl|bisacodyl|mesh-list
138720917|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
138720918|NCT02211911|Cathartics|cathartics|mesh-ancestor
138720919|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138576435|NCT03276520|Ethanol|ethanol|mesh-list
138720920|NCT02211911|Laxatives|laxatives|mesh-ancestor
138720921|NCT01131676|Empagliflozin|empagliflozin|mesh-list
138720922|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138720923|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720924|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138720925|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720926|NCT04560569|Antibodies|antibodies|mesh-list
138720927|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
138720928|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720929|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
138720930|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138720931|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138720932|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138720933|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138546571|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138720934|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720936|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138720937|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720938|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138720939|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138720940|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138720941|NCT02214498|Enalapril|enalapril|mesh-list
138720942|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138720943|NCT02214498|Diuretics|diuretics|mesh-ancestor
138720944|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
138720945|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720946|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138720947|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138720964|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720966|NCT04540185|Vaccines|vaccines|mesh-list
138720967|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
138720968|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720969|NCT04540185|Protective Agents|protective agents|mesh-ancestor
138720970|NCT01130272|Eluxadoline|eluxadoline|mesh-list
138720971|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138720972|NCT04546815|Daptomycin|daptomycin|mesh-list
138720973|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138720974|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138720975|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138720976|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
138720977|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138720978|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138720979|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138720980|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720981|NCT04559165|Chitosan|chitosan|mesh-list
138720982|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138720983|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138720984|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
138720985|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138720986|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138720987|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
138720988|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
138720989|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
138720990|NCT04559165|Coagulants|coagulants|mesh-ancestor
138720991|NCT04312048|Isosorbide|isosorbide|mesh-list
138720992|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138720993|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138720994|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138720995|NCT04312048|Diuretics|diuretics|mesh-ancestor
138720996|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
138720997|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138720998|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
138720999|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138721000|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721001|NCT04311697|Phentolamine|phentolamine|mesh-list
138721002|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
138721003|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138721004|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138721005|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
138721006|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721032|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721033|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721035|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
138721036|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138721037|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138721038|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138721039|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721040|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721041|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
138721042|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
138721043|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721044|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721045|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138721046|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138721047|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
138721048|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138721049|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138721050|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138721051|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138721052|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
138721053|NCT02278419|Simeprevir|simeprevir|mesh-list
138721054|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
138653051|NCT00343707|Paroxetine|paroxetine|mesh-list
138721063|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138721064|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721066|NCT02211950|Acarbose|acarbose|mesh-list
138721067|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138721068|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721069|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721070|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138721071|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721072|NCT04538820|Dexamethasone|dexamethasone|mesh-list
138721073|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
138721074|NCT04538820|BB 1101|bb 1101|mesh-list
138721075|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138721076|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
138721077|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
138546577|NCT02962336|Diuretics|diuretics|mesh-ancestor
138721078|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721079|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721080|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138721082|NCT04538820|Hormones|hormones|mesh-ancestor
138721083|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138721084|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138721085|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721086|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
138576462|NCT00448825|Topiramate|topiramate|mesh-list
138721087|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721088|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721089|NCT00575978|Hydralazine|hydralazine|mesh-list
138721090|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138721091|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
138721092|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138721093|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138721094|NCT04539054|Caffeine|caffeine|mesh-list
138721095|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138721096|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721097|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138721098|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721099|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721100|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138721101|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138721102|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
138721103|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721104|NCT00576017|Fentanyl|fentanyl|mesh-list
138721105|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138721106|NCT00576017|Narcotics|narcotics|mesh-ancestor
138721107|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721108|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721109|NCT00576017|Analgesics|analgesics|mesh-ancestor
138721110|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
138721111|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721112|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138721113|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138721114|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
138721115|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
138721116|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
138721117|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138721118|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721119|NCT04558580|Rufinamide|rufinamide|mesh-list
138721120|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
138721121|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138721149|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
138721150|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721151|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
138721153|NCT01127893|Analgesics|analgesics|mesh-ancestor
138721154|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
138721155|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677445|NCT00493610|Expectorants|expectorants|mesh-ancestor
138721156|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721157|NCT00576173|Acetaminophen|acetaminophen|mesh-list
138721158|NCT00576173|Tramadol|tramadol|mesh-list
138721159|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138721160|NCT00576173|Analgesics|analgesics|mesh-ancestor
138721161|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
138721162|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721163|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721164|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
138721165|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138721166|NCT00576173|Narcotics|narcotics|mesh-ancestor
138721167|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721168|NCT00625339|Lamivudine|lamivudine|mesh-list
138721169|NCT00625339|Entecavir|entecavir|mesh-list
138721170|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138721171|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138721172|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721179|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
138721180|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721181|NCT04558463|Oseltamivir|oseltamivir|mesh-list
138721182|NCT04558463|Favipiravir|favipiravir|mesh-list
138721183|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
138721184|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721185|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721186|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721187|NCT01126879|Genistein|genistein|mesh-list
138721188|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138721189|NCT01126879|Protective Agents|protective agents|mesh-ancestor
138721190|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721191|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721192|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138721193|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721194|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721195|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
138721196|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138721197|NCT01126879|Estrogens|estrogens|mesh-ancestor
138721198|NCT01126879|Hormones|hormones|mesh-ancestor
138721199|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138721200|NCT04311658|Isosorbide|isosorbide|mesh-list
138721201|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138721202|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138721203|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138721204|NCT04311658|Diuretics|diuretics|mesh-ancestor
138721205|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
138721206|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721207|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
138721208|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138721209|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721210|NCT02882308|Durvalumab|durvalumab|mesh-list
138721211|NCT02882308|Olaparib|olaparib|mesh-list
138721212|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721213|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138721214|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138721215|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721216|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721217|NCT00625456|Molgramostim|molgramostim|mesh-list
138721218|NCT00625456|Sargramostim|sargramostim|mesh-list
138721219|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
138721220|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721221|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721222|NCT04539444|Tislelizumab|tislelizumab|mesh-list
138721223|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138721224|NCT04539444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138721225|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721226|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721228|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138721229|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138721230|NCT00576329|Analgesics|analgesics|mesh-ancestor
138721231|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
138721232|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721233|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721234|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138721235|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138721236|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138721237|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721238|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721239|NCT02882581|Metformin|metformin|mesh-list
138721240|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138721241|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721265|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138721266|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138721267|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721268|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
138721269|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
138721270|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138721271|NCT00637468|Diuretics|diuretics|mesh-ancestor
138721272|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
138721273|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138721274|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
138721275|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721276|NCT02278575|Antithrombins|antithrombins|mesh-list
138721277|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
138721278|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138721279|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
138721280|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721281|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721282|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
138721283|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138721284|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
138721285|NCT01126060|Coagulants|coagulants|mesh-ancestor
138721286|NCT01125748|Omalizumab|omalizumab|mesh-list
138721287|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138721288|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138721289|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
138721290|NCT04558268|Folic Acid|folic acid|mesh-list
138721291|NCT04558268|Prednisone|prednisone|mesh-list
138721292|NCT04558268|Progesterone|progesterone|mesh-list
138721293|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138721294|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
138721295|NCT04558268|Hormones|hormones|mesh-ancestor
138653115|NCT00313625|Methotrexate|methotrexate|mesh-list
138721311|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721312|NCT04545879|Allicin|allicin|mesh-list
138721313|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721314|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138721315|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
138721316|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721317|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138721318|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
138721319|NCT04545879|Protective Agents|protective agents|mesh-ancestor
138721320|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721321|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138721322|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138721323|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138721324|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138721325|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138721326|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721327|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721328|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138721329|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138721330|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721331|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
138721332|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721333|NCT04538391|Bupivacaine|bupivacaine|mesh-list
138721334|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
138721335|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
138576519|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138721336|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721337|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721338|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
138721339|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721341|NCT04545801|Analgesics|analgesics|mesh-ancestor
138721342|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
138721343|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721344|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721345|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138721346|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138721347|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
138721348|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
138721349|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721350|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138721351|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138721352|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653136|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
138721364|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
138721365|NCT02212223|Vitamins|vitamins|mesh-ancestor
138721366|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
139064743|NCT01282840|Urological Agents|urological agents|mesh-ancestor
138721367|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721368|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138721369|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138721370|NCT00637585|Fexofenadine|fexofenadine|mesh-list
138721371|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138721372|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138721373|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138251259|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
138721374|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
138721375|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
138721376|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721377|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721378|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721379|NCT02214810|Bupivacaine|bupivacaine|mesh-list
138721380|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
138721381|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
138721382|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721383|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721384|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
138721385|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721387|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138721388|NCT01125046|Antibodies|antibodies|mesh-list
138721389|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
138721390|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138721391|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721392|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138721393|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138721394|NCT01125046|Growth Substances|growth substances|mesh-ancestor
138721395|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721396|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
138721397|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
138721398|NCT01124734|Temozolomide|temozolomide|mesh-list
138721399|NCT01124734|Interleukin-2|interleukin-2|mesh-list
138721400|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138721401|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
138721402|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721403|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721404|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138721405|NCT01124734|Analgesics|analgesics|mesh-ancestor
138576536|NCT00449137|Antidotes|antidotes|mesh-ancestor
138721406|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
138721407|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721408|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721409|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
138721410|NCT04545450|Testosterone|testosterone|mesh-list
138721411|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
138721412|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
138721413|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138721414|NCT04545450|Dutasteride|dutasteride|mesh-list
138721415|NCT04545450|Androgens|androgens|mesh-ancestor
138721416|NCT04545450|Hormones|hormones|mesh-ancestor
138721417|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138653152|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138721433|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721435|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138721436|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138721437|NCT00576914|Growth Substances|growth substances|mesh-ancestor
138721438|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721439|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
138721440|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721441|NCT02212340|Remifentanil|remifentanil|mesh-list
138721442|NCT02212340|Desflurane|desflurane|mesh-list
138721443|NCT02212340|Propofol|propofol|mesh-list
138721444|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138721445|NCT02212340|Narcotics|narcotics|mesh-ancestor
138721446|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721447|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721448|NCT02212340|Analgesics|analgesics|mesh-ancestor
138721449|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
138721450|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721451|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138721452|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
138721453|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
138721454|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138721455|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138721457|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138721458|NCT01124617|Narcotics|narcotics|mesh-ancestor
138721459|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721460|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721461|NCT01124617|Analgesics|analgesics|mesh-ancestor
138721462|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
138721463|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721464|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138721465|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138721466|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138721467|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721468|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
138721469|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721470|NCT04205890|Ketamine|ketamine|mesh-list
138721471|NCT04205890|Analgesics|analgesics|mesh-ancestor
138721472|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
138721473|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721474|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721475|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138721476|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138721492|NCT00577109|Growth Substances|growth substances|mesh-ancestor
138721493|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721494|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
138721495|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138721496|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138721497|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721498|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721499|NCT00577109|Antidotes|antidotes|mesh-ancestor
138721500|NCT00577109|Protective Agents|protective agents|mesh-ancestor
138576549|NCT00449410|Ezetimibe|ezetimibe|mesh-list
138721501|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
138721502|NCT00577109|Vitamins|vitamins|mesh-ancestor
138721503|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
138721504|NCT01124422|Fluticasone|fluticasone|mesh-list
138721505|NCT01124422|Xhance|xhance|mesh-list
138721506|NCT01124422|Bromides|bromides|mesh-list
138721507|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
138721508|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138721509|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138721510|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138721511|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
138721512|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721513|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721514|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138721515|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
138721516|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
138721517|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138721518|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
138721519|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138721520|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
138721521|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546582|NCT00075738|Leucovorin|leucovorin|mesh-list
139064854|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721522|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721523|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138721524|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138721525|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138721526|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
138721528|NCT00625495|Esomeprazole|esomeprazole|mesh-list
138721529|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138721530|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138721531|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138721532|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721533|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677829|NCT05148546|Nivolumab|nivolumab|mesh-list
138721534|NCT02882425|Selexipag|selexipag|mesh-list
138721535|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138721536|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
138721537|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
138721538|NCT01124149|Mesalamine|mesalamine|mesh-list
138721554|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138721555|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
138721556|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721557|NCT02882269|Capecitabine|capecitabine|mesh-list
138721558|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138721559|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
138721560|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721561|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721562|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
138721563|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138721564|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721565|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
138721566|NCT04537767|Esmolol|esmolol|mesh-list
138721567|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138721568|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138721569|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138721570|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
138721571|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721572|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721573|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721574|NCT01121926|Trazodone|trazodone|mesh-list
138721575|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138721576|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138721577|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721578|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721579|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138721580|NCT01121926|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138721581|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138721582|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138721583|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721584|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721585|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
138721586|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138721587|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
138721588|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
138721589|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138721590|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138546586|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
138721591|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721592|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138721593|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721594|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138721622|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
138721623|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138721624|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721625|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138721626|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138721627|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721628|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138721630|NCT00577967|Analgesics|analgesics|mesh-ancestor
138721631|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
138721632|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721633|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721634|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
138721635|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138721636|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138721637|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721638|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138721639|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138721640|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138721641|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721642|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721657|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
138721658|NCT00578435|Busulfan|busulfan|mesh-list
138721659|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138721660|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
138721661|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721662|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138721663|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138721664|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
138721665|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721666|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721667|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138721668|NCT04537065|Mydriatics|mydriatics|mesh-list
138721669|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
138721670|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721671|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721672|NCT04544163|Lidocaine|lidocaine|mesh-list
138721673|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
138721674|NCT04544163|Fentanyl|fentanyl|mesh-list
138721675|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
138721676|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
138721677|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721678|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721679|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
138721680|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721681|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138721682|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138721683|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138721684|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138721685|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721686|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138721687|NCT04544163|Narcotics|narcotics|mesh-ancestor
138721688|NCT04544163|Analgesics|analgesics|mesh-ancestor
138721689|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138721690|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138721691|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
138721692|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
138721693|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138721694|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138721695|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
138721696|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138721697|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
138721698|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138721699|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721700|NCT00578591|Rituximab|rituximab|mesh-list
138721701|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138721702|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721703|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
138721704|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721727|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138721728|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721729|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138721730|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
138721731|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721732|NCT04536558|Olanzapine|olanzapine|mesh-list
138721733|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
138721734|NCT04536558|Aprepitant|aprepitant|mesh-list
138721735|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
138721736|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
138721737|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721738|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721739|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138721740|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138721741|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138721742|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721743|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138721744|NCT04536558|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138721745|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138721746|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138721747|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721748|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721749|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
138721750|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138721752|NCT04557137|Hormones|hormones|mesh-ancestor
138721753|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138721754|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721755|NCT04536675|Bromides|bromides|mesh-list
138721756|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
138721757|NCT00578825|Ritonavir|ritonavir|mesh-list
138721758|NCT00578825|Lopinavir|lopinavir|mesh-list
138721773|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138721774|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
138721775|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138721776|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721777|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
138721778|NCT04535973|Hormones|hormones|mesh-list
138721779|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138721780|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721781|NCT04536051|Acetaminophen|acetaminophen|mesh-list
138721782|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138721783|NCT04536051|Analgesics|analgesics|mesh-ancestor
138721784|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
138721785|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721786|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721787|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
138721788|NCT02215005|Telmisartan|telmisartan|mesh-list
138721789|NCT02215005|Ramipril|ramipril|mesh-list
138721790|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138721791|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138721792|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138721793|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721794|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138721795|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
138721796|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721797|NCT02215044|Gemcitabine|gemcitabine|mesh-list
138721798|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138721799|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
139064958|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
138721800|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721801|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721802|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138721803|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
138721804|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138721805|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721806|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138721807|NCT04556279|Diuretics|diuretics|mesh-ancestor
138251703|NCT02294058|Interferons|interferons|mesh-list
138721809|NCT02216331|Rifampin|rifampin|mesh-list
138721810|NCT02216331|Rifapentine|rifapentine|mesh-list
138721811|NCT02216331|Bedaquiline|bedaquiline|mesh-list
138721812|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138721813|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
138721814|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138721815|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721816|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
138721817|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138721818|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721819|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721829|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
138721830|NCT04578236|Tretinoin|tretinoin|mesh-list
138721831|NCT04578236|Captopril|captopril|mesh-list
138721832|NCT04578236|Isotretinoin|isotretinoin|mesh-list
138721833|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721834|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
138721835|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
138721836|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138721837|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
138721838|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721839|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721840|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138721841|NCT04542759|Besifloxacin|besifloxacin|mesh-list
138721842|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138721843|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138721844|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138721845|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721846|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138721847|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138721848|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721849|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721850|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721851|NCT04542213|Insulin|insulin|mesh-list
138721852|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138721853|NCT04542213|Linagliptin|linagliptin|mesh-list
138721854|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138721855|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721856|NCT04542213|Incretins|incretins|mesh-ancestor
138721858|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138721859|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138721860|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
138721861|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721862|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721863|NCT04542252|Cyclosporine|cyclosporine|mesh-list
138721864|NCT04542252|Cyclosporins|cyclosporins|mesh-list
138721865|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721866|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721867|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138721868|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
138721869|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721870|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
138721871|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721872|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
138721873|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138721874|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138721875|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
138721876|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138721877|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138721878|NCT04532775|Prednisolone|prednisolone|mesh-list
138721879|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
138721880|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
138721881|NCT04532775|Bupivacaine|bupivacaine|mesh-list
139065025|NCT01074996|Antidotes|antidotes|mesh-ancestor
138721882|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138721883|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
138721884|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
138721885|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
138653283|NCT00314639|Modafinil|modafinil|mesh-list
138721901|NCT04532775|Analgesics|analgesics|mesh-ancestor
138721902|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138721903|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
138721904|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138678196|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
138721905|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138721906|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721907|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138721908|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
138721909|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138721910|NCT04578158|Quercetin|quercetin|mesh-list
138721911|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
138721912|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721913|NCT04578158|Protective Agents|protective agents|mesh-ancestor
138721914|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721915|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
138721916|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
138721917|NCT04532736|Methotrexate|methotrexate|mesh-list
138721918|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138721919|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
138721920|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138721921|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721922|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138721923|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
138721924|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721925|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721926|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
138721927|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138721928|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138721929|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138721930|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
138721931|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138721932|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138721933|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138721934|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
138721935|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
138721936|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138721937|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138721938|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
138721939|NCT04532736|Hormones|hormones|mesh-ancestor
138721940|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138721941|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138721942|NCT04532736|Protective Agents|protective agents|mesh-ancestor
138721943|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138721955|NCT02216994|Emollients|emollients|mesh-ancestor
138721956|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
138721957|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
138721958|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
138721959|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138721960|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721961|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721962|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
138721963|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
138576655|NCT00450307|Antibodies|antibodies|mesh-list
138721964|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
138721965|NCT02217189|Astringents|astringents|mesh-ancestor
138721966|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721967|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
138721968|NCT00579956|Meropenem|meropenem|mesh-list
138721969|NCT00579956|Ceftazidime|ceftazidime|mesh-list
138721970|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138721971|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721972|NCT04555304|Paclitaxel|paclitaxel|mesh-list
138721973|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138721974|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139065123|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
138721975|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138721976|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
138721977|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
138721978|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
138721979|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721980|NCT04531800|Mitogens|mitogens|mesh-list
138721981|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
138721982|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721983|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
138721984|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138721985|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
138721986|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138721987|NCT00579995|Expectorants|expectorants|mesh-ancestor
138721988|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
138721989|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138721990|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
138721991|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138721992|NCT00579995|Protective Agents|protective agents|mesh-ancestor
138721993|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721994|NCT00579995|Antidotes|antidotes|mesh-ancestor
138721995|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
138721996|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138721997|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138721998|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138721999|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138722000|NCT04531371|Analgesics|analgesics|mesh-ancestor
138722001|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
138722002|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722003|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138722004|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138722005|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138722006|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
138722007|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138653309|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
138722016|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138722017|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
138722018|NCT00580112|Hormones|hormones|mesh-ancestor
138722019|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138722020|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138722021|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722022|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138722023|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
138722024|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722025|NCT04531332|Linezolid|linezolid|mesh-list
138576668|NCT00450736|Analgesics|analgesics|mesh-ancestor
138722026|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138722027|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722028|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138722029|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546594|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
138722030|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722031|NCT04530864|Dexamethasone|dexamethasone|mesh-list
138722032|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
138722033|NCT04530864|BB 1101|bb 1101|mesh-list
138722034|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138722035|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
138722036|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
138722037|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722038|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722039|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138722040|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
138722041|NCT04530864|Hormones|hormones|mesh-ancestor
138722042|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138722043|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138722044|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722045|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
138722046|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722047|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722048|NCT00580190|Alprazolam|alprazolam|mesh-list
138722049|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138722050|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138722051|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722052|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138722053|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138722054|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138722055|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
138722056|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
138722057|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722058|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722059|NCT04530903|Clonidine|clonidine|mesh-list
138722060|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
138722061|NCT04530903|Analgesics|analgesics|mesh-ancestor
138722062|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
138722063|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722064|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722065|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138722066|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
138722067|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
138722068|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138722069|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138722070|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138722071|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
138722072|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722073|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722094|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138722095|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138722096|NCT01121575|Crizotinib|crizotinib|mesh-list
138722097|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722098|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138722099|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722100|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722101|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138252012|NCT00002097|Nystatin|nystatin|mesh-list
138722102|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722103|NCT04205851|Gimsilumab|gimsilumab|mesh-list
138722104|NCT04205851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138722105|NCT04205851|Antiviral Agents|antiviral agents|mesh-ancestor
138722106|NCT04205851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722107|NCT02882113|Tacrolimus|tacrolimus|mesh-list
138722108|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138722109|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
138722110|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722111|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138722112|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722113|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722114|NCT04530045|Piperacillin|piperacillin|mesh-list
138722115|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138722116|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722117|NCT01121536|Modafinil|modafinil|mesh-list
138722118|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138722119|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722120|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138722121|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138722122|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138722123|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722124|NCT00580619|Methyldopa|methyldopa|mesh-list
138722125|NCT00580619|Trimethaphan|trimethaphan|mesh-list
138722126|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
138722127|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722128|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138722136|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
138722137|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722138|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138722139|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138722140|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138722141|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138722142|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
138722143|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
138722145|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
138722146|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138722147|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722148|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
138722149|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
138722150|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
138722151|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722152|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138722153|NCT04554524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138722154|NCT02212652|Vitamin D|vitamin d|mesh-list
138722155|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
138722156|NCT02212652|Cholecalciferol|cholecalciferol|mesh-list
138722157|NCT02212652|Vitamins|vitamins|mesh-list
138722158|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
138722159|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722160|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138722161|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138722162|NCT02212769|Losartan|losartan|mesh-list
138722163|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138722164|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138722165|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138722166|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138722167|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722168|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
138722169|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138722170|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138722171|NCT02217852|Captopril|captopril|mesh-list
138722172|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
138722173|NCT02217852|Nitrendipine|nitrendipine|mesh-list
138722174|NCT02217852|Diuretics|diuretics|mesh-ancestor
138722175|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
138722176|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722177|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139065191|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
138722178|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138722179|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722180|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138722181|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
138722182|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722183|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138722184|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138722185|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
138722186|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
138722187|NCT02217930|Levonadifloxacin|levonadifloxacin|mesh-list
138722188|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138722189|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722190|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138722191|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138722192|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722193|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722194|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653344|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
138722202|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138722204|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
138722205|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
138722206|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678497|NCT05844436|Pritelivir|pritelivir|mesh-list
138722207|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
138722208|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722209|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
138722210|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722211|NCT00580814|Methylphenidate|methylphenidate|mesh-list
138722212|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138722213|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722214|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138722215|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138722216|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138722217|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722218|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
138722219|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722221|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
138722222|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
138722223|NCT01120600|Calcium|calcium|mesh-list
138722224|NCT01120600|Vitamins|vitamins|mesh-ancestor
138722225|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
138722226|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722227|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138722228|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138722229|NCT01120600|Antacids|antacids|mesh-ancestor
138722230|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722231|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138722232|NCT04577885|Rifampin|rifampin|mesh-list
138722233|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138722234|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
138722235|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138722236|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722237|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
138722238|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138722239|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722240|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722241|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138722242|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138722243|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138722244|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138722245|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138722246|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138722247|NCT00580931|Niacinamide|niacinamide|mesh-list
138722249|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
138722250|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
138722251|NCT00580931|Vitamins|vitamins|mesh-ancestor
138722252|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
138722253|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722254|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138722255|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
138722256|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722257|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138722258|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
138722259|NCT01120093|Bromides|bromides|mesh-list
138722260|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
138722261|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138722262|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
138722263|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065258|NCT01177852|Ephedrine|ephedrine|mesh-list
138722276|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
138722277|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138722278|NCT00581009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138722279|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138722280|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138722281|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722282|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722283|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
138722284|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722285|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722286|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
138722287|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138722288|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138722289|NCT02218359|Amikacin|amikacin|mesh-list
138722290|NCT02218359|Fosfomycin|fosfomycin|mesh-list
138722291|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138722292|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138722293|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722294|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
138722295|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138722296|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
138722297|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138722298|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722299|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138722300|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138722301|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138722302|NCT02218398|Albuterol|albuterol|mesh-list
138722303|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138722304|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
138722305|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722306|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722307|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138722308|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
138722309|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
138722310|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138722311|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138722312|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138722313|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138722314|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
138722315|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722316|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722317|NCT02218671|Brotizolam|brotizolam|mesh-list
138722318|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138722319|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138722320|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722321|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
138722322|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
138722323|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138722324|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
138722325|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722343|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138722344|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138722345|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138722346|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722347|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722349|NCT01119859|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138722350|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138722352|NCT02278926|Insulin|insulin|mesh-list
138722353|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138722354|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722355|NCT01119703|Vaccines|vaccines|mesh-list
138722356|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
138722357|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722358|NCT02882230|Dolutegravir|dolutegravir|mesh-list
138722359|NCT02882230|Rilpivirine|rilpivirine|mesh-list
138722360|NCT02882230|Elvitegravir|elvitegravir|mesh-list
138722361|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138722362|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138722363|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722364|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722365|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138722366|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138722367|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
138722368|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722369|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138722370|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138722371|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138722372|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
138722373|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722374|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138722375|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138722376|NCT02881762|Maraviroc|maraviroc|mesh-list
138722377|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138722378|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138722379|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576751|NCT00458419|Naloxone|naloxone|mesh-list
138722380|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138722381|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138653372|NCT00315185|Cetuximab|cetuximab|mesh-list
138722399|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722400|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722401|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138722402|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138722403|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138722404|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138722405|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
138722406|NCT05092984|Spironolactone|spironolactone|mesh-list
138722407|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138722408|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
138722409|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138722410|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722411|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138722412|NCT05092984|Diuretics|diuretics|mesh-ancestor
138722413|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
138722414|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
138722415|NCT02213159|Morphine|morphine|mesh-list
138722416|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138722417|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138722418|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722419|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138722420|NCT02213159|Analgesics|analgesics|mesh-ancestor
138722421|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
138722422|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722423|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138722424|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138722425|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138722426|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
138722427|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722428|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722429|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138722431|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
138722432|NCT02219100|Mifepristone|mifepristone|mesh-list
138722433|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138722434|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
138722435|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138722436|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722437|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138722438|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138653395|NCT00348894|Reboxetine|reboxetine|mesh-list
138722462|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
138722463|NCT02219178|Hormones|hormones|mesh-ancestor
138576764|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722464|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138722465|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138722466|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722467|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
138722468|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138722469|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138722470|NCT02219178|Growth Substances|growth substances|mesh-ancestor
138722471|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
138722472|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
138722473|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138722474|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138722475|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
138722476|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722477|NCT02219217|Dolutegravir|dolutegravir|mesh-list
138722478|NCT02219217|Cobicistat|cobicistat|mesh-list
138722479|NCT02219217|Elvitegravir|elvitegravir|mesh-list
138722480|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138722481|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138722482|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722483|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065332|NCT01178320|Vitamins|vitamins|mesh-ancestor
138722485|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138722486|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
138722487|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722488|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138722489|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138722490|NCT04577378|Itraconazole|itraconazole|mesh-list
138722503|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138722504|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722505|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
138722506|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
138722507|NCT02219412|Aspirin|aspirin|mesh-list
138722508|NCT02219412|Ticagrelor|ticagrelor|mesh-list
138722509|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138722510|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138722511|NCT02219412|Analgesics|analgesics|mesh-ancestor
138722512|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
138722513|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722514|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722515|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138722516|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138722517|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138722518|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138722519|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576795|NCT03274024|Mitomycin|mitomycin|mesh-list
138722520|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138722521|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138252440|NCT00002379|Stavudine|stavudine|mesh-list
138722522|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722523|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
138722524|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138722525|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138722526|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138722527|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
138722528|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722529|NCT04577027|Travoprost|travoprost|mesh-list
138722530|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138722531|NCT02211690|Tenofovir|tenofovir|mesh-list
138722532|NCT02211690|Emtricitabine|emtricitabine|mesh-list
138722533|NCT02211690|Dolutegravir|dolutegravir|mesh-list
138722534|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
138722535|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722536|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138722537|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138722538|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065351|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
138722539|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722540|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138722541|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138722542|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138722543|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138722544|NCT04553393|Decitabine|decitabine|mesh-list
138722545|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138722546|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
138722547|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722548|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722549|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722550|NCT02211846|Mirabegron|mirabegron|mesh-list
138722551|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138722566|NCT04553510|Bevacizumab|bevacizumab|mesh-list
138722567|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138722568|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722569|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138722570|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138722571|NCT04553510|Growth Substances|growth substances|mesh-ancestor
138722572|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722573|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
138722574|NCT03453281|Aflibercept|aflibercept|mesh-list
138722575|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138722576|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138722577|NCT03453281|Growth Substances|growth substances|mesh-ancestor
138722578|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722579|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
138722580|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722581|NCT01642134|Aspirin|aspirin|mesh-list
138722582|NCT01642134|Clopidogrel|clopidogrel|mesh-list
138722583|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138722584|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138722585|NCT01642134|Analgesics|analgesics|mesh-ancestor
138722586|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
138722587|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722588|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722589|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138722590|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138722591|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138722592|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138722593|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722594|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138722595|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138722596|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065394|NCT01174810|Exenatide|exenatide|mesh-list
138722597|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
138722598|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138722599|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138722600|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138722601|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
138722602|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722603|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138722604|NCT00581789|Sunitinib|sunitinib|mesh-list
138722605|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722606|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138722607|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722608|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722609|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138653443|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138722633|NCT02219490|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138722634|NCT02219490|Protease Inhibitors|protease inhibitors|mesh-ancestor
138722635|NCT02219490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722636|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722637|NCT02219490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138722638|NCT02219490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138722639|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
138722640|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722641|NCT02219490|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138722642|NCT02219490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138722643|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
138722644|NCT01117051|Prucalopride|prucalopride|mesh-list
138722645|NCT01117051|Laxatives|laxatives|mesh-ancestor
138722646|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138722647|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138722648|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138722649|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
138722650|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722651|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722652|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722653|NCT02211417|Evening primrose oil|evening primrose oil|mesh-list
138722654|NCT02211417|Mineral Oil|mineral oil|mesh-list
138722655|NCT02211417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138722656|NCT02211417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138722657|NCT02211417|Analgesics|analgesics|mesh-ancestor
138722658|NCT02211417|Sensory System Agents|sensory system agents|mesh-ancestor
138722659|NCT02211417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722660|NCT02211417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722661|NCT02211417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138722662|NCT02211417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138722677|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138576855|NCT00401804|Bortezomib|bortezomib|mesh-list
138722678|NCT02218164|Capecitabine|capecitabine|mesh-list
138722679|NCT02218164|Fluorouracil|fluorouracil|mesh-list
138722680|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138722681|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
138722682|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722683|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722684|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138722685|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
138722686|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722687|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
138722688|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722690|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
138722691|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138722692|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138722693|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722694|NCT01643187|Vitamins|vitamins|mesh-list
138722695|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
138722696|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722697|NCT01643265|Caseins|caseins|mesh-list
138722698|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
138722699|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
138722700|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722701|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
138722702|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
138722703|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
138722704|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138722705|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722706|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
138722707|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722708|NCT04551755|Doxycycline|doxycycline|mesh-list
138722709|NCT04551755|Ivermectin|ivermectin|mesh-list
138722710|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138722711|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722712|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
138722713|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138722714|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138722715|NCT01643499|Leucovorin|leucovorin|mesh-list
138722716|NCT01643499|Fluorouracil|fluorouracil|mesh-list
138722717|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
138722718|NCT01643499|Irinotecan|irinotecan|mesh-list
138722719|NCT01643499|Calcium|calcium|mesh-list
138722720|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
138722721|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138722722|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722723|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
138722724|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722725|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138722726|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722727|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138722757|NCT01640535|Cetirizine|cetirizine|mesh-list
138722758|NCT01640535|Montelukast|montelukast|mesh-list
138722759|NCT01640535|Levocetirizine|levocetirizine|mesh-list
138722760|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138722761|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
138722762|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138722763|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
138576866|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722764|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138722765|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722766|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138722767|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138722768|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722769|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138722770|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138722771|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
138722772|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
138722773|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722774|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138722775|NCT04550936|Isavuconazole|isavuconazole|mesh-list
138722798|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138722799|NCT01640574|Analgesics|analgesics|mesh-ancestor
138722800|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
138722801|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722802|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722803|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138722804|NCT01640574|Filaricides|filaricides|mesh-ancestor
138722805|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
138722806|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
138679110|NCT04069273|Paclitaxel|paclitaxel|mesh-list
138722807|NCT01116427|Abatacept|abatacept|mesh-list
138722808|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138722809|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722810|NCT01116427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138722811|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722812|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138722813|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
138722814|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722815|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138722816|NCT04529226|Haloperidol|haloperidol|mesh-list
138722817|NCT04529226|Pimozide|pimozide|mesh-list
138722818|NCT04529226|Olanzapine|olanzapine|mesh-list
138722819|NCT04529226|Risperidone|risperidone|mesh-list
138252721|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
138722820|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
138722821|NCT04529226|Clozapine|clozapine|mesh-list
138722822|NCT04529226|Amisulpride|amisulpride|mesh-list
138722823|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138722824|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
138722825|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722826|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722827|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722828|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138722829|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138722830|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138722831|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138722851|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138722852|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138722853|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
138722854|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722855|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722856|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722857|NCT04550702|Urological Agents|urological agents|mesh-ancestor
138722858|NCT01116232|Sirolimus|sirolimus|mesh-list
138722859|NCT01116232|Rituximab|rituximab|mesh-list
138722860|NCT01116232|Tacrolimus|tacrolimus|mesh-list
138722861|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138722862|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138722863|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722864|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
138722865|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722866|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138722867|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138722868|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138722869|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138722870|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722871|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138722872|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722873|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138722874|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
138722875|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138722876|NCT04550351|Vaccines|vaccines|mesh-list
138722877|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
138722878|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722879|NCT01640691|Vaccines|vaccines|mesh-list
138722880|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
138722881|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722882|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
138722883|NCT01643889|Domperidone|domperidone|mesh-list
138722884|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138722885|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138722886|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138722887|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138722908|NCT01205035|Ranibizumab|ranibizumab|mesh-list
138722909|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138722910|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138722911|NCT01205035|Growth Substances|growth substances|mesh-ancestor
138722912|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722913|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
138722914|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722915|NCT04549844|Bupivacaine|bupivacaine|mesh-list
138722916|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
138722917|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
138722918|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138722919|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722920|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
138722921|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722922|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138722923|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
138722924|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
138722925|NCT01204918|Riluzole|riluzole|mesh-list
138722926|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
138722927|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139065487|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138722928|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138722929|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138722930|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138722931|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722932|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138722933|NCT01204918|Protective Agents|protective agents|mesh-ancestor
138722934|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
138722935|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138722936|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138722937|NCT04528797|Prednisolone|prednisolone|mesh-list
138722938|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
138722939|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138722940|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
138722941|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138722942|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
138722943|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
138722944|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138722974|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138722975|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138722976|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138722977|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138722978|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
138722979|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
138722980|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
138722981|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
138722982|NCT04549415|Metformin|metformin|mesh-list
138722983|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138722984|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138722985|NCT02214368|Propofol|propofol|mesh-list
139065525|NCT01179256|Curcumin|curcumin|mesh-list
138722986|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138722987|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138722988|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653582|NCT06164834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138722998|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138722999|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138723001|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723002|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723003|NCT01182181|Anastrozole|anastrozole|mesh-list
138723004|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138723005|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723006|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138723007|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138723008|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723009|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723010|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138723011|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
138723012|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138723013|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723015|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138723016|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723017|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138723018|NCT01181986|Incretins|incretins|mesh-ancestor
138723019|NCT01181986|Hormones|hormones|mesh-ancestor
138723020|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138723021|NCT04315909|Vitamin E|vitamin e|mesh-list
138723022|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138723023|NCT04315909|Vitamins|vitamins|mesh-ancestor
138723024|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
138723025|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723026|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
138723027|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723028|NCT04315909|Protective Agents|protective agents|mesh-ancestor
138723029|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
138723030|NCT04315909|Coagulants|coagulants|mesh-ancestor
138723031|NCT01181167|Enoxaparin|enoxaparin|mesh-list
138723032|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
138723033|NCT01181167|Edoxaban|edoxaban|mesh-list
138723034|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
138723035|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138723036|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138723037|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723038|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138723039|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
138723040|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138723041|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
138723042|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723043|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
138723044|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138723046|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
138723047|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138723048|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
138723049|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723050|NCT01181128|Factor VIII|factor viii|mesh-list
138723051|NCT01181128|Coagulants|coagulants|mesh-ancestor
138723052|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138723053|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
138723054|NCT04548284|Hormones|hormones|mesh-ancestor
138723055|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138723056|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723057|NCT04547894|TMC-310911|tmc-310911|mesh-list
138723070|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723072|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
138723073|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
138723074|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723075|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723076|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
138723077|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723078|NCT04547855|Temozolomide|temozolomide|mesh-list
138723079|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138723080|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
138723081|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723082|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723083|NCT01641510|Clopidogrel|clopidogrel|mesh-list
138723084|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138723085|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138723086|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138723087|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138723088|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138723089|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
138723090|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723091|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723092|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723093|NCT04547621|Temozolomide|temozolomide|mesh-list
138723094|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138723095|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
138723096|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723097|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723098|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
138723099|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138723100|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723101|NCT04547348|Denosumab|denosumab|mesh-list
138723102|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138723103|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723104|NCT04547426|Nicotine|nicotine|mesh-list
138723105|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138723106|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
138723107|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723108|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723109|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138723110|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138723111|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
138723112|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723113|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723114|NCT01641666|Ribavirin|ribavirin|mesh-list
138723115|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138723116|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
138723117|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
138653626|NCT06164275|Daunorubicin|daunorubicin|mesh-list
138723139|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138723140|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138723141|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138723142|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138723143|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723144|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138723145|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723146|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
138723147|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138723148|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138723149|NCT01641783|Paclitaxel|paclitaxel|mesh-list
138723150|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138723151|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138723152|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723153|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
138723154|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
138723155|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
138723156|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723157|NCT02214602|Doxorubicin|doxorubicin|mesh-list
138723158|NCT02214602|Epirubicin|epirubicin|mesh-list
138723159|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138723160|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723161|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138723162|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138723163|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723164|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723165|NCT01646580|Ciclopirox|ciclopirox|mesh-list
138723166|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
138723167|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723168|NCT04546802|Grazoprevir|grazoprevir|mesh-list
138576970|NCT00460915|Amlodipine|amlodipine|mesh-list
138723169|NCT04546802|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138723170|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
138723184|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138723185|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138723186|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
138723187|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723188|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138723189|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138723190|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723191|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
138723192|NCT04546334|Analgesics|analgesics|mesh-ancestor
138723193|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
138723194|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723195|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723196|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
138723197|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723198|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138723199|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
138723200|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138723201|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138723202|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723203|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138723204|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
138723205|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138723206|NCT04546256|Fluticasone|fluticasone|mesh-list
138723208|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138723209|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138723210|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138723211|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138723212|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
138723213|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723214|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723215|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138723216|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
138723217|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
138723218|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138723219|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138723220|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138723221|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138723222|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
138723223|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723224|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723225|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
138723226|NCT04546256|Hormones|hormones|mesh-ancestor
138723227|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138723228|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
138723229|NCT01645449|Atorvastatin|atorvastatin|mesh-list
138723230|NCT01645449|Calcium|calcium|mesh-list
138723231|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138723232|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723242|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723243|NCT02214680|Timolol|timolol|mesh-list
138723244|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138723245|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
138723246|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138723247|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138723248|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
138723249|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723250|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723251|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723252|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138723254|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138723255|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138723256|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138723257|NCT02756208|Vaccines|vaccines|mesh-list
138723258|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
138723259|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723260|NCT04545788|Linezolid|linezolid|mesh-list
138723261|NCT04545788|Cycloserine|cycloserine|mesh-list
138723262|NCT04545788|Bedaquiline|bedaquiline|mesh-list
138723263|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138723264|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723265|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138723266|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723267|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723268|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138723269|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138723270|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
138723271|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
138723272|NCT02756013|Paclitaxel|paclitaxel|mesh-list
138723273|NCT02756013|Carboplatin|carboplatin|mesh-list
138723274|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138723275|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723276|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
138723277|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
138723278|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
138723279|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723280|NCT01680042|Phenytoin|phenytoin|mesh-list
138723281|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
138723282|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138723283|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138723284|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138723285|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723286|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138723287|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138723288|NCT01646229|Polymyxins|polymyxins|mesh-list
138723289|NCT01646229|Polymyxin B|polymyxin b|mesh-list
138723290|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138723291|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723292|NCT01680081|Adenosine|adenosine|mesh-list
138723293|NCT01680081|Analgesics|analgesics|mesh-ancestor
138723294|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
138723295|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723296|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723297|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138723298|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
138723314|NCT04544969|Gemcitabine|gemcitabine|mesh-list
138723316|NCT04544969|Fluorouracil|fluorouracil|mesh-list
138723317|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723318|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138723319|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
138723320|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723321|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
138723322|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
138723323|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
138723324|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138723325|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
138723326|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723327|NCT04541732|Anesthetics|anesthetics|mesh-list
138723328|NCT04541732|Propofol|propofol|mesh-list
138723329|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723330|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723331|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138723332|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138723333|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
138723334|NCT01680471|Midazolam|midazolam|mesh-list
138723335|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138723336|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138723337|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723338|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723339|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138723340|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138723341|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138723342|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138723343|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
138723344|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
138723345|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
138723346|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
138723347|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723348|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723349|NCT02279316|Vitamin D|vitamin d|mesh-list
138723350|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
138723351|NCT02279316|Vitamins|vitamins|mesh-ancestor
138723352|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
138723353|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723354|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138723355|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138723356|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
138723357|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138723358|NCT04544228|Ketamine|ketamine|mesh-list
138723359|NCT04544228|Bupivacaine|bupivacaine|mesh-list
138723378|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138723379|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
138723380|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
138723381|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138723382|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
138723383|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723384|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138723385|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138723386|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
138253448|NCT05806476|Caffeine|caffeine|mesh-list
138723387|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723388|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723389|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138723390|NCT04542005|Albuterol|albuterol|mesh-list
138723391|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138723392|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
138723393|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723394|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723395|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138723396|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
138723397|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
138723398|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138723399|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138723400|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138723401|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138723402|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
138723403|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723404|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723405|NCT01646775|Fentanyl|fentanyl|mesh-list
138723406|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138723407|NCT01646775|Narcotics|narcotics|mesh-ancestor
138723408|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723409|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723410|NCT01646775|Analgesics|analgesics|mesh-ancestor
138723411|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
138723412|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723413|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138723414|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138723415|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
138723428|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138723429|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
138723430|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
138723431|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723432|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723433|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138723434|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
138723435|NCT01647165|Hormones|hormones|mesh-ancestor
139065714|NCT00149214|Pemetrexed|pemetrexed|mesh-list
138723436|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138723437|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138723438|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723439|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
138723440|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138723441|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138723442|NCT01647165|Growth Substances|growth substances|mesh-ancestor
138723443|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
138723444|NCT01681134|Tacrolimus|tacrolimus|mesh-list
138723445|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138723446|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
138723447|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723448|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138723449|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723450|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723451|NCT04543916|Irinotecan|irinotecan|mesh-list
138723452|NCT04543916|Venetoclax|venetoclax|mesh-list
138723453|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138723454|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138723455|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723456|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723457|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723458|NCT04541147|Dexamethasone|dexamethasone|mesh-list
138723459|NCT04541147|Analgesics|analgesics|mesh-list
138723460|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138723461|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
138723462|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
138723463|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723464|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723465|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138723466|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
138723467|NCT04541147|Hormones|hormones|mesh-ancestor
138723468|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138723469|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138723470|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723471|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
138723472|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
138723473|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138723474|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138723475|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723476|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
138723477|NCT04541303|Coagulants|coagulants|mesh-ancestor
138723478|NCT02214992|Telmisartan|telmisartan|mesh-list
138723479|NCT02214992|Ramipril|ramipril|mesh-list
138723480|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138653711|NCT06158412|Tretinoin|tretinoin|mesh-list
138723494|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138723495|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138723496|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723497|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138723498|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
138723500|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138723501|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
138723502|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138723503|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
138723504|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
138723505|NCT04528056|Ambrisentan|ambrisentan|mesh-list
138723506|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723507|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138723508|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138723509|NCT04528056|Analgesics|analgesics|mesh-ancestor
138723510|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
138723511|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723512|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723513|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138723514|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138723515|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138723516|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138723517|NCT04543565|Tenofovir|tenofovir|mesh-list
138723518|NCT04543565|Pradefovir|pradefovir|mesh-list
138723519|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
138723520|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723521|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138723522|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138723523|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723524|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723525|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138723526|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138723527|NCT01647555|Cetuximab|cetuximab|mesh-list
138723528|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138723529|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723530|NCT04543370|Deflazacort|deflazacort|mesh-list
138723531|NCT04543370|Midazolam|midazolam|mesh-list
138723532|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138723533|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138723534|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723535|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723536|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138723537|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138723538|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138723539|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138723540|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
138723541|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
138723542|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
138723559|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723560|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138723561|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138723562|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723564|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138723565|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723566|NCT01647633|Calcium|calcium|mesh-list
138723567|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138723568|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723569|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138723570|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723571|NCT01647984|Vitamins|vitamins|mesh-list
138723572|NCT01647984|Vitamin E|vitamin e|mesh-list
138723573|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
138723574|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
138723575|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723576|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
138723577|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723578|NCT01647984|Protective Agents|protective agents|mesh-ancestor
138723579|NCT02215382|Atropine|atropine|mesh-list
138723580|NCT02215382|Neostigmine|neostigmine|mesh-list
138723581|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138723582|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138723583|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138723584|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
138723585|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723586|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723587|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138723588|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
138723589|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
138723590|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
138723591|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138723592|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138723593|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
138723594|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723595|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723596|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138723597|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723598|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138723599|NCT01682109|Valacyclovir|valacyclovir|mesh-list
138723600|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
138723601|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723602|NCT02215148|Tolvaptan|tolvaptan|mesh-list
138723603|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138723615|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138723616|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138577085|NCT05483634|Estrogens|estrogens|mesh-list
138723617|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
138723618|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723619|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
138723620|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138723621|NCT02215460|Azithromycin|azithromycin|mesh-list
138723622|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138723623|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723624|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
138723625|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
138723626|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138723627|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
138723628|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138723629|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138723630|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
138723631|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
138723632|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723633|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723634|NCT01648608|Exemestane|exemestane|mesh-list
138723635|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723636|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138679940|NCT01248260|Hematinics|hematinics|mesh-ancestor
138723637|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138723638|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723639|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723640|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138723641|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
138723642|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138723643|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723644|NCT02215538|Methylphenidate|methylphenidate|mesh-list
138723645|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138723646|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723647|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138723648|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138723649|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138723650|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723651|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
138723652|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723653|NCT01682421|Dexamethasone|dexamethasone|mesh-list
138723654|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
138723655|NCT01682421|BB 1101|bb 1101|mesh-list
138723656|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723657|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723658|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138723659|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
138723660|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
138723661|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723662|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138723663|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
138723664|NCT01682421|Hormones|hormones|mesh-ancestor
138723709|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723710|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723711|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
138723712|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138723713|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138723714|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723715|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138723716|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138723717|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138723718|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723719|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138723720|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
138723721|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138723722|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138723723|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723724|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
138723725|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723726|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723728|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138723729|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723730|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723731|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723732|NCT01649037|Terlipressin|terlipressin|mesh-list
138723733|NCT01649037|Epinephrine|epinephrine|mesh-list
138723734|NCT01649037|Racepinephrine|racepinephrine|mesh-list
138723735|NCT01649037|Norepinephrine|norepinephrine|mesh-list
138723736|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
138723737|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138723738|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138723739|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
138723740|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723741|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723742|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723743|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138723744|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138723745|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
138723746|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723747|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138723748|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
138723749|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
138723750|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
138723751|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138723752|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138723753|NCT04539119|Tenofovir|tenofovir|mesh-list
138723754|NCT04539119|Entecavir|entecavir|mesh-list
138723755|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
138723756|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138723757|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138723758|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138723759|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723760|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723761|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138723762|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138723763|NCT02279511|Adenosine|adenosine|mesh-list
138723764|NCT02279511|Analgesics|analgesics|mesh-ancestor
138653803|NCT06050252|Antimetabolites|antimetabolites|mesh-ancestor
138723778|NCT02279628|Narcotics|narcotics|mesh-ancestor
138723779|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723780|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723782|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
138723783|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723784|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
138723786|NCT04542629|Trace Elements|trace elements|mesh-list
138723787|NCT04542629|Rituximab|rituximab|mesh-list
138723788|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138723789|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723790|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
138723791|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723792|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138723793|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
138723794|NCT01683006|Rocuronium|rocuronium|mesh-list
138723795|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138723796|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138723797|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138723798|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723799|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723800|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138723801|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138723802|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138723803|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138723804|NCT02215733|Telmisartan|telmisartan|mesh-list
138723805|NCT02215733|Diuretics|diuretics|mesh-list
138723806|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138723807|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138723808|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138723809|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138723810|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723811|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
138723812|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723813|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138723814|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
138723815|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723816|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
138723817|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
138723818|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138723819|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
138723820|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723821|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723822|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138723823|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
138723824|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
138723825|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138723826|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
138723827|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723828|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723839|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138723840|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
138723841|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138723842|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
138723843|NCT01201798|Difluprednate|difluprednate|mesh-list
138723844|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138723845|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
138723846|NCT01201798|Hormones|hormones|mesh-ancestor
138723847|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138577147|NCT00116103|Tacrolimus|tacrolimus|mesh-list
138723848|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723849|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138723850|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723851|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
138723852|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
138723853|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723854|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138723855|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138723856|NCT01201798|Protective Agents|protective agents|mesh-ancestor
138723857|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138723858|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
138680165|NCT01248494|Letrozole|letrozole|mesh-list
138723859|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138723860|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138723862|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
138723863|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723864|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723865|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138723866|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138723867|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138723868|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723869|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723870|NCT04532684|Pregabalin|pregabalin|mesh-list
138723871|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138723872|NCT04532684|Analgesics|analgesics|mesh-ancestor
138723873|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
138723874|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723875|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723876|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
138723877|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138723878|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138723879|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723880|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138723881|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138723882|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138723883|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723884|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138723885|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138723886|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138723887|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723888|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
138723889|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
138723890|NCT01649466|Insulin|insulin|mesh-list
138723891|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138723892|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138723893|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723910|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138723911|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138723912|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
138723913|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
138723914|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138723915|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138723916|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138723917|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723918|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723919|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138723920|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138723921|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138723922|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
138723923|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
138723924|NCT01649544|Amiodarone|amiodarone|mesh-list
138723925|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138723926|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
138723927|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138723928|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138723929|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723930|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138723931|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138723932|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138723933|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723934|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138723935|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138723936|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138723938|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138723939|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723940|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138723941|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
138723942|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723943|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
138723944|NCT01179334|Riociguat|riociguat|mesh-list
138723945|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
138723946|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138723947|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138723948|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723949|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723950|NCT01179334|Urological Agents|urological agents|mesh-ancestor
138723951|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
138723961|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
138723962|NCT01683747|Coagulants|coagulants|mesh-ancestor
138723963|NCT01178671|Mirtazapine|mirtazapine|mesh-list
138723964|NCT01178671|Sertraline|sertraline|mesh-list
138723965|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
138723966|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138723967|NCT01178671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138723968|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138723969|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138723970|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723971|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138723972|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
138723973|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138723974|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138723975|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
138723976|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
138723977|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138723978|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138723979|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138723980|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138723981|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138723982|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138723983|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
138723984|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138723985|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138723986|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138723987|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
138723988|NCT04532060|Nystatin|nystatin|mesh-list
138723989|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138723990|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
138723991|NCT04532060|Ionophores|ionophores|mesh-ancestor
138723992|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138723993|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138723994|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138723995|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
138723996|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138723997|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138723998|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138723999|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724000|NCT01649739|Urological Agents|urological agents|mesh-ancestor
138724001|NCT04532333|Heparin|heparin|mesh-list
138724002|NCT04532333|Bivalirudin|bivalirudin|mesh-list
138724003|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
138724004|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138724005|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138724006|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724007|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
138724008|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138724009|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
138724010|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724011|NCT01649895|Cycloserine|cycloserine|mesh-list
138724012|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138724013|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724014|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138653847|NCT06041646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138724030|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138724031|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724032|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
138724033|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724034|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138724035|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138724036|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138724037|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
138724038|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138724039|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724040|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724041|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724042|NCT01643070|Capecitabine|capecitabine|mesh-list
138724043|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
138724044|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138724045|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
138724046|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724047|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724048|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
138724049|NCT01684059|Astringents|astringents|mesh-ancestor
138724050|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724051|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
138724052|NCT04531748|Toremifene|toremifene|mesh-list
138724053|NCT04531748|Melatonin|melatonin|mesh-list
138724054|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
138724055|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724056|NCT04531748|Protective Agents|protective agents|mesh-ancestor
138724057|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724058|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138724059|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138724060|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724061|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138724062|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138724063|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
138724064|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724065|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138724066|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138724067|NCT01177813|Empagliflozin|empagliflozin|mesh-list
138724068|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138724069|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724070|NCT01177813|Incretins|incretins|mesh-ancestor
138724071|NCT01177813|Hormones|hormones|mesh-ancestor
138724072|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724073|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138724074|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
138724091|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724092|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
138724093|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724094|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
138724095|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724096|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
138724097|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138724098|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138724099|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724100|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
138724101|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138724102|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138724103|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724104|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138724105|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724106|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
138724107|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724108|NCT04531475|Lansoprazole|lansoprazole|mesh-list
138724109|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
138724110|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138724111|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138724112|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138724113|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724114|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724115|NCT01684449|Sirolimus|sirolimus|mesh-list
138724116|NCT01684449|Gemcitabine|gemcitabine|mesh-list
138724117|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138724118|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
138724119|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724120|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724121|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138724122|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724123|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138724124|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
138724125|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138724126|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
138724127|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724128|NCT01684683|Theophylline|theophylline|mesh-list
138724129|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138724130|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
138724131|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653868|NCT05972772|Doxycycline|doxycycline|mesh-list
138724137|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577222|NCT00462631|Paclitaxel|paclitaxel|mesh-list
138724138|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
138724139|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138724140|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138724141|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
138724142|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138724143|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138724144|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
138724145|NCT01684800|Coagulants|coagulants|mesh-ancestor
138724146|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138724147|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
138724148|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724150|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138724151|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
138724152|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724153|NCT04531163|Expectorants|expectorants|mesh-ancestor
138724154|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
138724155|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138724156|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
138724157|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724158|NCT04531163|Protective Agents|protective agents|mesh-ancestor
138724159|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724160|NCT04531163|Antidotes|antidotes|mesh-ancestor
138724161|NCT01684995|Nicotine|nicotine|mesh-list
138724162|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138724163|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
138724164|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724165|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724166|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138724167|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138724168|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
138724169|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138724170|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724171|NCT01685502|Acarbose|acarbose|mesh-list
138724172|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138724173|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724174|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724175|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138724176|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724177|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
138724178|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138724179|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724181|NCT01200355|Posaconazole|posaconazole|mesh-list
138724182|NCT01200355|Micafungin|micafungin|mesh-list
138724183|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
138724184|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724185|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138724186|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138724187|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138724188|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138724189|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138724190|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724191|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724192|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138724193|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
138724194|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138546673|NCT00063596|Vitamin A|vitamin a|mesh-list
138724195|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724196|NCT04527666|Anticoagulants|anticoagulants|mesh-list
138724197|NCT04530500|Androgens|androgens|mesh-list
138724198|NCT04530500|Hormones|hormones|mesh-ancestor
138724199|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724200|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724217|NCT04530578|Enoxaparin|enoxaparin|mesh-list
138724218|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138724219|NCT04530578|Tinzaparin|tinzaparin|mesh-list
138724220|NCT04530578|Dalteparin|dalteparin|mesh-list
138724221|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
138724222|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138724223|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138724224|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724225|NCT01685853|Bisacodyl|bisacodyl|mesh-list
138724226|NCT01685853|Cathartics|cathartics|mesh-ancestor
138724227|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138724228|NCT01685853|Laxatives|laxatives|mesh-ancestor
138724229|NCT04530422|Azithromycin|azithromycin|mesh-list
138724230|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
138724231|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
138724232|NCT04530422|Oseltamivir|oseltamivir|mesh-list
138724233|NCT04530422|Ledipasvir|ledipasvir|mesh-list
138724234|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138724235|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724236|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
138724237|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138724238|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138724239|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066132|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
138724240|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724241|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138724242|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
138724243|NCT02887573|Mosapride|mosapride|mesh-list
138724244|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724245|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138724246|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138724247|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
138724248|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577260|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
138724249|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724250|NCT01685892|Venetoclax|venetoclax|mesh-list
138724251|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
138724252|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724253|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138724254|NCT02887534|Tizanidine|tizanidine|mesh-list
138724255|NCT02887534|Analgesics|analgesics|mesh-ancestor
138724256|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
138724257|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724258|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724259|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
138724260|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138724261|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138724262|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
138724263|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
138653891|NCT05935748|Palbociclib|palbociclib|mesh-list
138724276|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138724277|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138724278|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
138724279|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138724280|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724281|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138724282|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138724283|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
138724284|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
138724285|NCT01685970|Cathartics|cathartics|mesh-ancestor
138724286|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138724287|NCT04530617|Camostat|camostat|mesh-list
138724288|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
138724289|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724290|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724291|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138724292|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138724293|NCT01686009|Ketamine|ketamine|mesh-list
138724294|NCT01686009|Analgesics|analgesics|mesh-ancestor
138724295|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
138724296|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724297|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724298|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138724299|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138724300|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
138724301|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
138724302|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138724303|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138724304|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138724305|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138724306|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724308|NCT04536662|Prednisone|prednisone|mesh-list
138724309|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
138724310|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138724311|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
138724312|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
138724313|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724314|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724315|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138724316|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
138724317|NCT04536662|Hormones|hormones|mesh-ancestor
138724318|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724319|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138724320|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724321|NCT01686321|Rituximab|rituximab|mesh-list
138724322|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138724323|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138724324|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724325|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
138653906|NCT05879146|Nirogacestat|nirogacestat|mesh-list
138724335|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724337|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724338|NCT01686555|Venetoclax|venetoclax|mesh-list
138724339|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724340|NCT01686789|Interferons|interferons|mesh-list
138724341|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
138724342|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
138724343|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138724344|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724345|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
138724346|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724347|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
138724348|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724349|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
138724350|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138724351|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
138724352|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724353|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724354|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138724355|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
138724356|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138724357|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
139066197|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724358|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724359|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138724360|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138577314|NCT00463762|Cefoperazone|cefoperazone|mesh-list
138724361|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
138724362|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
138724363|NCT02217683|Protective Agents|protective agents|mesh-ancestor
138724364|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138724365|NCT02217722|Amoxicillin|amoxicillin|mesh-list
138724366|NCT02217722|Metronidazole|metronidazole|mesh-list
138724367|NCT02217722|Doxycycline|doxycycline|mesh-list
138724368|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724369|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138724370|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138724371|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
138724372|NCT02217839|Octreotide|octreotide|mesh-list
138724373|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138724374|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138724375|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724376|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
138724377|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138724378|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
138724379|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
138724380|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724382|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138724383|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724384|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138724385|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138724386|NCT02217956|Growth Substances|growth substances|mesh-ancestor
138724387|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724388|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
138724389|NCT01687140|Cycloserine|cycloserine|mesh-list
138724390|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138724391|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724403|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724405|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724406|NCT04536428|Hemostatics|hemostatics|mesh-list
138724407|NCT04536428|Coagulants|coagulants|mesh-ancestor
138724408|NCT01687374|Hormones|hormones|mesh-list
138724409|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
138724410|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724411|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724412|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138724413|NCT04530188|Propofol|propofol|mesh-list
138724414|NCT04530188|Sevoflurane|sevoflurane|mesh-list
138724415|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138724416|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138724417|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724418|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138724420|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
138724421|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138724422|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138724423|NCT01687491|Enoxaparin|enoxaparin|mesh-list
138724424|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
138724425|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138724426|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138724427|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724428|NCT04530227|Paclitaxel|paclitaxel|mesh-list
138724429|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138724430|NCT04530227|Pemetrexed|pemetrexed|mesh-list
138724431|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138724432|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724433|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
138724434|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
138724435|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
138724436|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724437|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724438|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138724439|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138724440|NCT01199263|Paclitaxel|paclitaxel|mesh-list
138724441|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138724442|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138724443|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724444|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
138724445|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
138724446|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
138724447|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724448|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
138724449|NCT02218034|Tazarotene|tazarotene|mesh-list
138724450|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
138724451|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
138724452|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
138724453|NCT02218034|Vitamins|vitamins|mesh-ancestor
138724454|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
138724455|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724465|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
138724466|NCT01688349|Hormones|hormones|mesh-ancestor
138724467|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724468|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724469|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
138724470|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138724471|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138724472|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724473|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
138724474|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
138724475|NCT04535804|Aspirin|aspirin|mesh-list
138724476|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138724477|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138724478|NCT04535804|Analgesics|analgesics|mesh-ancestor
138724479|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
138724480|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724481|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724482|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138724483|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138724484|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138724485|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138724486|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724487|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138724488|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138724489|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724490|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
138724491|NCT04529525|Ivermectin|ivermectin|mesh-list
138724492|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138724493|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724495|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138724496|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724497|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138724498|NCT05126121|Amoxicillin|amoxicillin|mesh-list
138724499|NCT05126121|Clarithromycin|clarithromycin|mesh-list
138724500|NCT05126121|Levofloxacin|levofloxacin|mesh-list
138724501|NCT05126121|Ofloxacin|ofloxacin|mesh-list
138724502|NCT05126121|Tetracycline|tetracycline|mesh-list
138724503|NCT05126121|Tinidazole|tinidazole|mesh-list
138724504|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138724505|NCT05126121|Furazolidone|furazolidone|mesh-list
138724506|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724507|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
138724508|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138724509|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724510|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724511|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138724512|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138724513|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138724514|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138724515|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138724516|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724517|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138724518|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138724519|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138724520|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138724521|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138724522|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138724523|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
138724535|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138724537|NCT01198795|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138724538|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138724539|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138724540|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724541|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138724542|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
138724543|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724544|NCT02278913|Insulin|insulin|mesh-list
138724545|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
138724546|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138724547|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138724548|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724549|NCT02216513|Deferoxamine|deferoxamine|mesh-list
138724550|NCT02216513|Siderophores|siderophores|mesh-ancestor
138724551|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138724552|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
138724553|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
138724554|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724555|NCT02218775|Aticaprant|aticaprant|mesh-list
138724556|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138724557|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724558|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
138724559|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724560|NCT02216552|Resveratrol|resveratrol|mesh-list
138724561|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
138724562|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724563|NCT02216552|Protective Agents|protective agents|mesh-ancestor
138724564|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724565|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724566|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138724567|NCT01198756|Vaccines|vaccines|mesh-list
138724568|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
138724569|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724570|NCT02216487|Irinotecan|irinotecan|mesh-list
138724571|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138724572|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138724573|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724574|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724575|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724576|NCT02218814|Bupivacaine|bupivacaine|mesh-list
138724577|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
138724578|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
138724579|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138724580|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724581|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
138724582|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724583|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138724584|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138724585|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138724607|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
138724608|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138724609|NCT02219165|Antibodies|antibodies|mesh-list
138724610|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
138724611|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724612|NCT04534478|Prednisone|prednisone|mesh-list
138724613|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138724614|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
138724615|NCT04534478|Hormones|hormones|mesh-ancestor
138724616|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724617|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724618|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138724619|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724620|NCT02216669|Imidazole|imidazole|mesh-list
138724621|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724622|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724623|NCT03772158|Cetirizine|cetirizine|mesh-list
138724624|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138724625|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138724626|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138724627|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
138724628|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
138724629|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138724630|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724631|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724632|NCT01196416|Cisplatin|cisplatin|mesh-list
138724633|NCT01196416|Temozolomide|temozolomide|mesh-list
138724634|NCT01196416|Vinblastine|vinblastine|mesh-list
138724635|NCT01196416|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
138724636|NCT01196416|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
138724637|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724638|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138724639|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
138653960|NCT05723510|Anticoagulants|anticoagulants|mesh-ancestor
138724659|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138724660|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
138724661|NCT04534322|Hormones|hormones|mesh-ancestor
138577543|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
138724662|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724663|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138724664|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724665|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138724666|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
138724667|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724668|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138724669|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138724670|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
138724671|NCT02219672|Ritonavir|ritonavir|mesh-list
138724672|NCT02219672|Lopinavir|lopinavir|mesh-list
138724673|NCT02219672|Tenofovir|tenofovir|mesh-list
138724674|NCT02219672|Lamivudine|lamivudine|mesh-list
138724675|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
138724676|NCT02219672|Triptolide|triptolide|mesh-list
138724677|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138724678|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138724679|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
138724680|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724681|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681001|NCT02955641|Hormones|hormones|mesh-ancestor
138724682|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138724683|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138724684|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
138724685|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724686|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138724687|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138724688|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138724689|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138724690|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138724691|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138724692|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138724693|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724694|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138724695|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
138724696|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138724704|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724705|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138724706|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138724707|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724708|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724709|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138724710|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138724711|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724712|NCT04534452|Phenylephrine|phenylephrine|mesh-list
138724713|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
138724714|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138724715|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
138724716|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
138724717|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724718|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724719|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
138724720|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138724721|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
138724722|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
138724723|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138724724|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138724725|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138724726|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
138724727|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138724728|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724729|NCT04534452|Protective Agents|protective agents|mesh-ancestor
138724730|NCT02219789|Fulvestrant|fulvestrant|mesh-list
138724731|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138724732|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724733|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138724734|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138724735|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
138724736|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724737|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724738|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138724739|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138724740|NCT04533867|Ondansetron|ondansetron|mesh-list
138724741|NCT04533867|Palonosetron|palonosetron|mesh-list
138724742|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
138724743|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
138724744|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724745|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724746|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138724747|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
138724748|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
138577607|NCT00474019|Esomeprazole|esomeprazole|mesh-list
138724749|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138724750|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138724751|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
138724752|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138724753|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724755|NCT02219867|Analgesics|analgesics|mesh-ancestor
138724756|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
138724757|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724758|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724759|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138724760|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138724761|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
138724762|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
138724763|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138724764|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138330709|NCT05764798|GABA Agents|gaba agents|mesh-ancestor
138724775|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724776|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724777|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138724778|NCT04533243|Fentanyl|fentanyl|mesh-list
138724779|NCT04533243|Morphine|morphine|mesh-list
138724780|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138724781|NCT04533243|Narcotics|narcotics|mesh-ancestor
138546690|NCT00231517|Morphine|morphine|mesh-list
138724782|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138724783|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724784|NCT04533243|Analgesics|analgesics|mesh-ancestor
138724785|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
138724786|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724787|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138724788|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138724789|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
138724790|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
138724791|NCT04533321|Afatinib|afatinib|mesh-list
138724792|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724793|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138724794|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724795|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724796|NCT01195831|Calcipotriene|calcipotriene|mesh-list
138724797|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
138724798|NCT01195675|Empagliflozin|empagliflozin|mesh-list
138724799|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
138724800|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138724801|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724802|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138724803|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138724804|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724805|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724806|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724807|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724808|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138724809|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138724810|NCT04532931|Acetaminophen|acetaminophen|mesh-list
138724811|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
138724812|NCT04532931|Artesunate|artesunate|mesh-list
138724813|NCT04532931|Favipiravir|favipiravir|mesh-list
138724814|NCT04532931|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
138724815|NCT04532931|Amodiaquine|amodiaquine|mesh-list
138724816|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
138724817|NCT04532931|Pyronaridine|pyronaridine|mesh-list
138724818|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138724819|NCT04532931|Analgesics|analgesics|mesh-ancestor
138724820|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
138724821|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724822|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724823|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
138724824|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
138724825|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724826|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
138724827|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138724828|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138724829|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724830|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
138724839|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724841|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138724842|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138724843|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724844|NCT01195090|Incretins|incretins|mesh-ancestor
138724845|NCT01195090|Hormones|hormones|mesh-ancestor
138724846|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724847|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138724848|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
138577675|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
138724849|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724850|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724851|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
139066627|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138724852|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138724853|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
138724854|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138724855|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724856|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138724857|NCT02213627|Menotropins|menotropins|mesh-list
138724858|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138724859|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
138724860|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138724861|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724862|NCT02216799|Insulin|insulin|mesh-list
138724863|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138724864|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
138724865|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138724866|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724867|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
138724868|NCT02216877|Antacids|antacids|mesh-ancestor
138724869|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724870|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138724871|NCT02214563|Vitamin D|vitamin d|mesh-list
138724872|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
138724873|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
138724874|NCT02214563|Vitamins|vitamins|mesh-list
138724875|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
138724876|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724877|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138724878|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138724879|NCT01194973|Eculizumab|eculizumab|mesh-list
138724880|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138724881|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138724882|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
138724883|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724884|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
138724885|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
138724886|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138724887|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138724888|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138724889|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138724890|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
138724891|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724892|NCT02216747|Prednisone|prednisone|mesh-list
138724893|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138724894|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
138724895|NCT02216747|Hormones|hormones|mesh-ancestor
138724896|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724897|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724916|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138724917|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724918|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724919|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
138724920|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138724921|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724922|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138724923|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
138724924|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138724925|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
138724926|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138724927|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138724928|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724929|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
138724930|NCT02279186|Coagulants|coagulants|mesh-ancestor
138724931|NCT01177540|Decitabine|decitabine|mesh-list
138724932|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138724933|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
138724934|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724935|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724936|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724937|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138724938|NCT01177384|Glimepiride|glimepiride|mesh-list
138724939|NCT01177384|Acarbose|acarbose|mesh-list
138724940|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138724941|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724942|NCT01177384|Incretins|incretins|mesh-ancestor
138724943|NCT01177384|Hormones|hormones|mesh-ancestor
138724944|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138724945|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138724946|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
138724947|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138724948|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138724949|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138724950|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138724951|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
138724952|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138724953|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
138724961|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138724963|NCT01194154|Hematinics|hematinics|mesh-ancestor
138724964|NCT01640210|Insulin|insulin|mesh-list
138724965|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138724966|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724967|NCT01640405|Bevacizumab|bevacizumab|mesh-list
138724968|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138724969|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724970|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138724971|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138724972|NCT01640405|Growth Substances|growth substances|mesh-ancestor
138724973|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724974|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
138724975|NCT01640444|Bevacizumab|bevacizumab|mesh-list
138724976|NCT01640444|Cetuximab|cetuximab|mesh-list
138724977|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138724978|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138724979|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138724980|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138681300|NCT00506051|Pemetrexed|pemetrexed|mesh-list
138724981|NCT01640444|Growth Substances|growth substances|mesh-ancestor
138724982|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724983|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
138724984|NCT01642433|Prazosin|prazosin|mesh-list
138724985|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138724986|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138724987|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138724988|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138724989|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
138724990|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138724991|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577776|NCT00475189|Estrogens|estrogens|mesh-ancestor
138724992|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724993|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
138724994|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138724995|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
138724996|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138724997|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138724998|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138724999|NCT01640639|Thalidomide|thalidomide|mesh-list
138725000|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138725001|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
138725002|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725003|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
138725004|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138725005|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725006|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138725007|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138725008|NCT01640639|Growth Substances|growth substances|mesh-ancestor
138725009|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
138725010|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725011|NCT01642667|Saruplase|saruplase|mesh-list
138725012|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138725013|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138725014|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725015|NCT01642745|Mannitol|mannitol|mesh-list
138725016|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
138725017|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138725018|NCT01642745|Diuretics|diuretics|mesh-ancestor
138725041|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138725042|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138725043|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
138725044|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725045|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138725046|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138725047|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725048|NCT01642940|Ticagrelor|ticagrelor|mesh-list
138725049|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138725050|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138725051|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138725052|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138725053|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138725054|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
138725055|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725056|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066685|NCT01293136|Analgesics|analgesics|mesh-ancestor
138725057|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725059|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
138725060|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138725061|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138725062|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725063|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725064|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725065|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138725066|NCT01641224|Pinaverium|pinaverium|mesh-list
138725067|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138725068|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138725069|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725082|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
138725083|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138725084|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138725085|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725086|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138725087|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138725088|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138725089|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725090|NCT01641419|Dexamethasone|dexamethasone|mesh-list
138725091|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
138725092|NCT01641419|BB 1101|bb 1101|mesh-list
138725093|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725094|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
138725095|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
138725096|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725097|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725098|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138725099|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
138725100|NCT01641419|Hormones|hormones|mesh-ancestor
138725101|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138725102|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138725103|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725104|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
138725105|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725106|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725107|NCT01643252|Riboflavin|riboflavin|mesh-list
138725108|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138725109|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138725110|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
138725111|NCT01643252|Vitamins|vitamins|mesh-ancestor
138725112|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
138725113|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725114|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138725115|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
138725116|NCT01641458|Capecitabine|capecitabine|mesh-list
138725117|NCT01641458|Fluorouracil|fluorouracil|mesh-list
138725118|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138725119|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
138725120|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725121|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725122|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138725123|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
138725124|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725126|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
138725127|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725128|NCT01641575|Gemcitabine|gemcitabine|mesh-list
138725129|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725130|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138725131|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
138725132|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654069|NCT05563220|Everolimus|everolimus|mesh-list
138725148|NCT02755844|Olaparib|olaparib|mesh-list
138725149|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138725150|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
138725151|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725152|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138725153|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138725154|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
138725155|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725156|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725157|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138725158|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138725159|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138725160|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725161|NCT06032195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138725162|NCT06032039|Triamcinolone|triamcinolone|mesh-list
138725163|NCT06032039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725164|NCT06032039|Glucocorticoids|glucocorticoids|mesh-ancestor
138725165|NCT06032039|Hormones|hormones|mesh-ancestor
138725166|NCT06032039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138725167|NCT06032039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725168|NCT06031961|Melatonin|melatonin|mesh-list
138725169|NCT06031961|Antioxidants|antioxidants|mesh-ancestor
138725170|NCT06031961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725171|NCT06031961|Protective Agents|protective agents|mesh-ancestor
138725172|NCT06031961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725173|NCT06031961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138725174|NCT06031883|Fentanyl|fentanyl|mesh-list
138725175|NCT06031883|Ketamine|ketamine|mesh-list
138725176|NCT06031883|Analgesics|analgesics|mesh-ancestor
138725177|NCT06031883|Sensory System Agents|sensory system agents|mesh-ancestor
138725178|NCT06031883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725179|NCT06031883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725180|NCT06031883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138725181|NCT06031883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138725182|NCT06031883|Anesthetics, General|anesthetics, general|mesh-ancestor
138725183|NCT06031883|Anesthetics|anesthetics|mesh-ancestor
138725184|NCT06031883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138725185|NCT06031883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138725186|NCT06031883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138725187|NCT06031883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725188|NCT06031883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725189|NCT06031883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138725190|NCT06031883|Narcotics|narcotics|mesh-ancestor
138725191|NCT06031883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138725192|NCT06031688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138725211|NCT06048913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138725212|NCT06048913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725213|NCT06048887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138725215|NCT06048705|Fludarabine|fludarabine|mesh-list
138725216|NCT06048705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138725217|NCT06048705|Immunologic Factors|immunologic factors|mesh-ancestor
138725218|NCT06048705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725219|NCT06048705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138725220|NCT06048705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138725221|NCT06048705|Alkylating Agents|alkylating agents|mesh-ancestor
138725222|NCT06048705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725223|NCT06048705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725224|NCT06048705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138725225|NCT06048692|Ampicillin|ampicillin|mesh-list
138725226|NCT06048692|Cefepime|cefepime|mesh-list
138725227|NCT06048692|Sulbactam|sulbactam|mesh-list
138725228|NCT06048692|Sultamicillin|sultamicillin|mesh-list
138725229|NCT06048692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138725230|NCT06048692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725231|NCT06048692|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138725232|NCT06048692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725233|NCT06048692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725234|NCT06048484|Folfirinox|folfirinox|mesh-list
138725235|NCT06048484|Quemliclustat|quemliclustat|mesh-list
138725236|NCT06048484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725237|NCT06048484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138725238|NCT06048484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725239|NCT06048484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138725240|NCT06048367|Iron|iron|mesh-list
138725241|NCT06048367|Trace Elements|trace elements|mesh-ancestor
138725242|NCT06048367|Micronutrients|micronutrients|mesh-ancestor
138725243|NCT06048367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725244|NCT06047860|Interleukin-2|interleukin-2|mesh-list
138725245|NCT06047860|Endostatins|endostatins|mesh-list
138725246|NCT06047860|Molgramostim|molgramostim|mesh-list
138725247|NCT06047860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138725248|NCT06047860|Sargramostim|sargramostim|mesh-list
138725249|NCT06047860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725250|NCT06047860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138725251|NCT06047860|Analgesics|analgesics|mesh-ancestor
138725252|NCT06047860|Sensory System Agents|sensory system agents|mesh-ancestor
138725297|NCT06046963|Antimitotic Agents|antimitotic agents|mesh-ancestor
138725298|NCT06046963|Mitosis Modulators|mitosis modulators|mesh-ancestor
139066756|NCT01193452|Vitamins|vitamins|mesh-ancestor
138725299|NCT06046963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725301|NCT06046859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138725302|NCT06046859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138725303|NCT06046859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138725304|NCT06046859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725305|NCT06046859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725306|NCT06046859|Serotonin Agents|serotonin agents|mesh-ancestor
138725307|NCT06046859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725308|NCT06046859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138725309|NCT06046859|Antidepressive Agents|antidepressive agents|mesh-ancestor
138725310|NCT06046859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138725311|NCT06046859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138725312|NCT06046859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138725313|NCT06046859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725314|NCT06046638|Propofol|propofol|mesh-list
138725315|NCT06046638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138725316|NCT06046638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138725317|NCT06046638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725318|NCT06046638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138725319|NCT06046638|Anesthetics, General|anesthetics, general|mesh-ancestor
138725320|NCT06046638|Anesthetics|anesthetics|mesh-ancestor
138725321|NCT06046612|Empagliflozin|empagliflozin|mesh-list
138725322|NCT06046612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138725323|NCT06046612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725324|NCT06046612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138725325|NCT06046612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725326|NCT06046560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138725327|NCT06046560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725328|NCT06046560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138725329|NCT06046560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725330|NCT06046313|Decitabine|decitabine|mesh-list
138725331|NCT06046313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138725332|NCT06046313|Antimetabolites|antimetabolites|mesh-ancestor
138725333|NCT06046313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725357|NCT06046105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138725358|NCT06046105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138725360|NCT06046105|Adrenergic Agents|adrenergic agents|mesh-ancestor
138725361|NCT06046105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725362|NCT06046105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725363|NCT06046105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138725364|NCT06046105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725365|NCT06046105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138725366|NCT06046105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138725367|NCT06046105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725368|NCT06045975|Durvalumab|durvalumab|mesh-list
138725370|NCT06045975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138725371|NCT06045975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725372|NCT06045936|Lidocaine|lidocaine|mesh-list
138725373|NCT06045936|Anesthetics, Local|anesthetics, local|mesh-ancestor
138725374|NCT06045936|Anesthetics|anesthetics|mesh-ancestor
138725375|NCT06045936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138725376|NCT06045936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725377|NCT06045936|Sensory System Agents|sensory system agents|mesh-ancestor
138725378|NCT06045936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725379|NCT06045936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138725380|NCT06045936|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138725381|NCT06045936|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138725382|NCT06045936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138725383|NCT06045936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725384|NCT06045858|Anticoagulants|anticoagulants|mesh-list
138725385|NCT06045832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138725409|NCT06045364|Analgesics|analgesics|mesh-ancestor
138725410|NCT06045364|Sensory System Agents|sensory system agents|mesh-ancestor
138725411|NCT06045364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725412|NCT06045364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725413|NCT06045364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138725414|NCT06045364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138725415|NCT06045364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138725416|NCT06045364|Parasympatholytics|parasympatholytics|mesh-ancestor
138725417|NCT06045364|Autonomic Agents|autonomic agents|mesh-ancestor
138725418|NCT06045364|Vasodilator Agents|vasodilator agents|mesh-ancestor
138725419|NCT06045364|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138725420|NCT06045364|Antioxidants|antioxidants|mesh-ancestor
138725421|NCT06045364|Protective Agents|protective agents|mesh-ancestor
138725422|NCT06045286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138725423|NCT06045286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725424|NCT06045286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138725425|NCT06045286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725426|NCT06045260|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
138725427|NCT06045260|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138725428|NCT06045260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725429|NCT06045195|Pembrolizumab|pembrolizumab|mesh-list
138725430|NCT06045195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138725431|NCT06045195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725432|NCT06045195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138725433|NCT06045195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066821|NCT01199458|Alfentanil|alfentanil|mesh-list
138725435|NCT06045156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138725436|NCT06045156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138725437|NCT06045156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654193|NCT05285813|Dexamethasone|dexamethasone|mesh-list
138725454|NCT06045013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138725456|NCT06045013|Protective Agents|protective agents|mesh-ancestor
138725457|NCT06045013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138725458|NCT06045013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725459|NCT06044974|Mitogens|mitogens|mesh-list
138725460|NCT06044974|Mitosis Modulators|mitosis modulators|mesh-ancestor
138725461|NCT06044974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725462|NCT06044883|Botulinum Toxins|botulinum toxins|mesh-list
138725463|NCT06044883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138725464|NCT06044883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138725465|NCT06044883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725466|NCT06044883|Cholinergic Agents|cholinergic agents|mesh-ancestor
138725467|NCT06044883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725468|NCT06044883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725469|NCT06044844|Tofacitinib|tofacitinib|mesh-list
138725470|NCT06044844|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138725471|NCT06044844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138725472|NCT06044844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725473|NCT06044844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725474|NCT06044675|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138725475|NCT06044675|Hallucinogens|hallucinogens|mesh-ancestor
138725476|NCT06044675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725477|NCT06044675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138725478|NCT06044675|Serotonin Agents|serotonin agents|mesh-ancestor
138725479|NCT06044675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725480|NCT06044675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725481|NCT06044675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138725482|NCT06044675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138725483|NCT06044675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138725484|NCT06044675|Adrenergic Agents|adrenergic agents|mesh-ancestor
138725485|NCT06044480|Dexamethasone|dexamethasone|mesh-list
138725486|NCT06044480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725487|NCT06044480|Antiemetics|antiemetics|mesh-ancestor
138725488|NCT06044480|Autonomic Agents|autonomic agents|mesh-ancestor
138725489|NCT06044480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066843|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
138725490|NCT06044480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725491|NCT06044480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138725492|NCT06044480|Glucocorticoids|glucocorticoids|mesh-ancestor
138725494|NCT06044480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138725495|NCT06044480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138725515|NCT06043908|Cyclosporins|cyclosporins|mesh-list
138725516|NCT06043908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725517|NCT06043908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725518|NCT06043908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138725519|NCT06043908|Immunologic Factors|immunologic factors|mesh-ancestor
138725520|NCT06043908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725521|NCT06043908|Antifungal Agents|antifungal agents|mesh-ancestor
138725522|NCT06043908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725523|NCT06043908|Dermatologic Agents|dermatologic agents|mesh-ancestor
138725524|NCT06043908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138725525|NCT06043908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138725526|NCT06043908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138725527|NCT06043544|Hyaluronic Acid|hyaluronic acid|mesh-list
138725528|NCT06043544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138725529|NCT06043544|Immunologic Factors|immunologic factors|mesh-ancestor
138725530|NCT06043544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725531|NCT06043544|Viscosupplements|viscosupplements|mesh-ancestor
138725532|NCT06043544|Protective Agents|protective agents|mesh-ancestor
138725533|NCT06043427|Paclitaxel|paclitaxel|mesh-list
138725534|NCT06043427|Ramucirumab|ramucirumab|mesh-list
138725535|NCT06043427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138725536|NCT06043427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725537|NCT06043427|Tubulin Modulators|tubulin modulators|mesh-ancestor
138725538|NCT06043427|Antimitotic Agents|antimitotic agents|mesh-ancestor
138725539|NCT06043427|Mitosis Modulators|mitosis modulators|mesh-ancestor
138725540|NCT06043427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725541|NCT06043349|Minoxidil|minoxidil|mesh-list
138725542|NCT06043349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138725543|NCT06043349|Vasodilator Agents|vasodilator agents|mesh-ancestor
138725544|NCT06043336|Dexamethasone|dexamethasone|mesh-list
138725545|NCT06043336|Palonosetron|palonosetron|mesh-list
138725546|NCT06043336|Granisetron|granisetron|mesh-list
138725547|NCT06043336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725548|NCT06043336|Antiemetics|antiemetics|mesh-ancestor
138725549|NCT06043336|Autonomic Agents|autonomic agents|mesh-ancestor
138725550|NCT06043336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725551|NCT06043336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725552|NCT06043336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138725553|NCT06043336|Glucocorticoids|glucocorticoids|mesh-ancestor
138725554|NCT06043336|Hormones|hormones|mesh-ancestor
138725568|NCT06043310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725570|NCT06043310|Cholinergic Agents|cholinergic agents|mesh-ancestor
138725571|NCT06043310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725572|NCT06043310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725573|NCT06043024|Salicylic Acid|salicylic acid|mesh-list
138725574|NCT06043024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725575|NCT06043024|Antifungal Agents|antifungal agents|mesh-ancestor
138725576|NCT06043024|Keratolytic Agents|keratolytic agents|mesh-ancestor
138725577|NCT06043024|Dermatologic Agents|dermatologic agents|mesh-ancestor
138725578|NCT06042985|Calcium, Dietary|calcium, dietary|mesh-list
138725579|NCT06042985|Calcium Carbonate|calcium carbonate|mesh-list
138725580|NCT06042985|Citric Acid|citric acid|mesh-list
138725581|NCT06042985|Sodium Citrate|sodium citrate|mesh-list
138725582|NCT06042985|Calcium|calcium|mesh-list
138725583|NCT06042985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138725584|NCT06042985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725585|NCT06042985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138725586|NCT06042985|Anticoagulants|anticoagulants|mesh-ancestor
138725587|NCT06042985|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138725588|NCT06042985|Chelating Agents|chelating agents|mesh-ancestor
138725589|NCT06042985|Sequestering Agents|sequestering agents|mesh-ancestor
138725590|NCT06042985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725591|NCT06042985|Antacids|antacids|mesh-ancestor
138725592|NCT06042985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138725593|NCT06042816|Analgesics, Opioid|analgesics, opioid|mesh-list
138725594|NCT06042816|Anesthetics|anesthetics|mesh-list
138725595|NCT06042816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138578145|NCT00477880|Cetuximab|cetuximab|mesh-list
138725596|NCT06042816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725597|NCT06042816|Narcotics|narcotics|mesh-ancestor
138725598|NCT06042816|Analgesics|analgesics|mesh-ancestor
138725599|NCT06042816|Sensory System Agents|sensory system agents|mesh-ancestor
138725600|NCT06042816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725601|NCT06038903|Caffeine|caffeine|mesh-list
138725602|NCT06038903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138725603|NCT06038903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725604|NCT06038903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138725605|NCT06038903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725606|NCT06038903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725607|NCT06038903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138725608|NCT06038903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138725609|NCT06038903|Purinergic Agents|purinergic agents|mesh-ancestor
138725610|NCT06038903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725612|NCT06038682|Argatroban|argatroban|mesh-list
138725613|NCT06038682|Anticoagulants|anticoagulants|mesh-ancestor
138725614|NCT06038682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138725615|NCT06038682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138725638|NCT06037993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138725640|NCT06034873|Bupivacaine|bupivacaine|mesh-list
138725641|NCT06034873|Propofol|propofol|mesh-list
138725642|NCT06034873|Anesthetics, Local|anesthetics, local|mesh-ancestor
138725643|NCT06034873|Anesthetics|anesthetics|mesh-ancestor
138725644|NCT06034873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138725645|NCT06034873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725646|NCT06034873|Sensory System Agents|sensory system agents|mesh-ancestor
138725647|NCT06034873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725648|NCT06034873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138681968|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725649|NCT06034873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138725650|NCT06034873|Anesthetics, General|anesthetics, general|mesh-ancestor
138725651|NCT06034873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138725652|NCT06034873|Narcotics|narcotics|mesh-ancestor
138725653|NCT06034873|Analgesics|analgesics|mesh-ancestor
138725654|NCT06034873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138725655|NCT06034379|Atropine|atropine|mesh-list
138725656|NCT06034379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138725657|NCT06034379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138725658|NCT06034379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138725659|NCT06034379|Autonomic Agents|autonomic agents|mesh-ancestor
138725660|NCT06034379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725661|NCT06034379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725662|NCT06034379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138725663|NCT06034379|Respiratory System Agents|respiratory system agents|mesh-ancestor
138725664|NCT06034379|Mydriatics|mydriatics|mesh-ancestor
138725665|NCT06034379|Parasympatholytics|parasympatholytics|mesh-ancestor
138725666|NCT06034379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138725678|NCT06034158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725679|NCT06034158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725680|NCT06034158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725681|NCT06034158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138725682|NCT06034158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138725683|NCT06034158|Vasodilator Agents|vasodilator agents|mesh-ancestor
138725684|NCT06034158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725685|NCT06034158|Dopamine Agents|dopamine agents|mesh-ancestor
138725686|NCT06034158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138725687|NCT06034158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138725688|NCT06018688|Aspirin|aspirin|mesh-list
138725689|NCT06018688|Osimertinib|osimertinib|mesh-list
138725690|NCT06018688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138725691|NCT06018688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138725692|NCT06018688|Analgesics|analgesics|mesh-ancestor
138725693|NCT06018688|Sensory System Agents|sensory system agents|mesh-ancestor
138725694|NCT06018688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725695|NCT06018688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725696|NCT06018688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725697|NCT06018688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138725698|NCT06018688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138725699|NCT06018688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138725700|NCT06018688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725701|NCT06018688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138725702|NCT06018688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138725703|NCT06018688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725704|NCT06018688|Antipyretics|antipyretics|mesh-ancestor
138725705|NCT06018688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725706|NCT06018688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138725707|NCT06010810|Tranexamic Acid|tranexamic acid|mesh-list
138725708|NCT06010810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138725709|NCT06010810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138725710|NCT06010810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725711|NCT06010810|Hemostatics|hemostatics|mesh-ancestor
138725712|NCT06010810|Coagulants|coagulants|mesh-ancestor
138725713|NCT06009653|Tirzepatide|tirzepatide|mesh-list
138725714|NCT06009653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138725715|NCT06009653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725716|NCT06009653|Incretins|incretins|mesh-ancestor
138725717|NCT06009653|Hormones|hormones|mesh-ancestor
138725718|NCT06009653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578268|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
138725719|NCT06009107|Cyclophosphamide|cyclophosphamide|mesh-list
138725720|NCT06009107|Fludarabine|fludarabine|mesh-list
138725721|NCT06009107|Fludarabine phosphate|fludarabine phosphate|mesh-list
138725722|NCT06009107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138725723|NCT06009107|Immunologic Factors|immunologic factors|mesh-ancestor
138725724|NCT06009107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725725|NCT06009107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138682042|NCT02949258|Etoposide|etoposide|mesh-list
138725726|NCT06009107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138725727|NCT06009107|Alkylating Agents|alkylating agents|mesh-ancestor
138725728|NCT06009107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725729|NCT06009107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654289|NCT05166577|Valganciclovir|valganciclovir|mesh-list
138725746|NCT05986331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725747|NCT05976464|Magnesium Sulfate|magnesium sulfate|mesh-list
138725748|NCT05976464|Analgesics|analgesics|mesh-ancestor
138725749|NCT05976464|Sensory System Agents|sensory system agents|mesh-ancestor
138725750|NCT05976464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725751|NCT05976464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725752|NCT05976464|Anesthetics|anesthetics|mesh-ancestor
138725753|NCT05976464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138725754|NCT05976464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138725755|NCT05976464|Anticonvulsants|anticonvulsants|mesh-ancestor
138725756|NCT05976464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138725757|NCT05976464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138725758|NCT05976464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725759|NCT05976464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138725760|NCT05976464|Tocolytic Agents|tocolytic agents|mesh-ancestor
138725761|NCT05976464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138725762|NCT05975684|Baclofen|baclofen|mesh-list
138725763|NCT05975684|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138725764|NCT05975684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725765|NCT05975684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138725766|NCT05975684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725767|NCT05975684|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138725769|NCT05975684|GABA Agents|gaba agents|mesh-ancestor
138725770|NCT05975684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725771|NCT05975684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725772|NCT05966376|Hemostatics|hemostatics|mesh-list
138725773|NCT05966376|Coagulants|coagulants|mesh-ancestor
138725774|NCT05964452|Methimazole|methimazole|mesh-list
138725775|NCT05964452|Antithyroid Agents|antithyroid agents|mesh-ancestor
138725776|NCT05964452|Hormone Antagonists|hormone antagonists|mesh-ancestor
138725777|NCT05964452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138725778|NCT05964452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725779|NCT05944510|Dextromethorphan|dextromethorphan|mesh-list
138725780|NCT05944510|Antitussive Agents|antitussive agents|mesh-ancestor
138725781|NCT05944510|Respiratory System Agents|respiratory system agents|mesh-ancestor
138725782|NCT05944510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138725783|NCT05944510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138725784|NCT05944510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725785|NCT05944510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654296|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725802|NCT05918822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725803|NCT05918822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725804|NCT05918822|Antiviral Agents|antiviral agents|mesh-ancestor
138725805|NCT05918822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725806|NCT05895838|Dexamethasone|dexamethasone|mesh-list
138725808|NCT05895838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725809|NCT05895838|Antiemetics|antiemetics|mesh-ancestor
138725810|NCT05895838|Autonomic Agents|autonomic agents|mesh-ancestor
138725811|NCT05895838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725812|NCT05895838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725813|NCT05895838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138725814|NCT05895838|Glucocorticoids|glucocorticoids|mesh-ancestor
138725815|NCT05895838|Hormones|hormones|mesh-ancestor
138725816|NCT05895838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138725817|NCT05895838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138725818|NCT05895838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725819|NCT05895838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138725820|NCT05895838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138725821|NCT05895838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138725822|NCT05895838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138725823|NCT05895838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138725824|NCT05895838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138725825|NCT05895838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138725826|NCT05895838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725827|NCT05895838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725828|NCT05895838|Serotonin Agents|serotonin agents|mesh-ancestor
138725829|NCT05888896|Antihypertensive Agents|antihypertensive agents|mesh-list
138725830|NCT05888896|Methyldopa|methyldopa|mesh-list
138725831|NCT05888896|Sympatholytics|sympatholytics|mesh-ancestor
138725832|NCT05888896|Autonomic Agents|autonomic agents|mesh-ancestor
138725833|NCT05888896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725834|NCT05888896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725835|NCT05888896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138725836|NCT05888896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138725837|NCT05888896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138725838|NCT05888896|Adrenergic Agents|adrenergic agents|mesh-ancestor
138725839|NCT05888896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725840|NCT05888896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725841|NCT05886582|Rotigotine|rotigotine|mesh-list
138725842|NCT05886582|Dopamine Agonists|dopamine agonists|mesh-ancestor
138725843|NCT05886582|Dopamine Agents|dopamine agents|mesh-ancestor
138725844|NCT05886582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725856|NCT05885932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725857|NCT05885932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725858|NCT05885932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138725859|NCT05885932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138725860|NCT05885932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138725861|NCT05885932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725862|NCT05885932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138725863|NCT05885932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138725864|NCT05885932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725865|NCT05885932|Antipyretics|antipyretics|mesh-ancestor
138725866|NCT05885932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138725867|NCT05885932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138725868|NCT05885932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138725869|NCT05885932|Purinergic Agents|purinergic agents|mesh-ancestor
138725870|NCT05885932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725871|NCT05885932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138725872|NCT05885932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725873|NCT05885932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138725874|NCT05885932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725875|NCT05885932|Antifungal Agents|antifungal agents|mesh-ancestor
138725876|NCT05885932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138725877|NCT05885932|Immunologic Factors|immunologic factors|mesh-ancestor
138725878|NCT05884671|Sulpiride|sulpiride|mesh-list
139067031|NCT04638790|Hormones|hormones|mesh-ancestor
138725879|NCT05884671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138725880|NCT05884671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138725881|NCT05884671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138725882|NCT05884671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725883|NCT05884671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138725884|NCT05884671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138725885|NCT05884671|Dopamine Agents|dopamine agents|mesh-ancestor
138725886|NCT05884671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138725887|NCT05884671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725888|NCT05884671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138725889|NCT05884671|Antidepressive Agents|antidepressive agents|mesh-ancestor
138725890|NCT05846568|Immunoglobulins|immunoglobulins|mesh-list
138725891|NCT05846568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138725892|NCT05846568|Antibodies|antibodies|mesh-list
138725893|NCT05846568|Immunologic Factors|immunologic factors|mesh-ancestor
138725894|NCT05846568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725895|NCT05845450|Trastuzumab|trastuzumab|mesh-list
138725896|NCT05845450|Durvalumab|durvalumab|mesh-list
138725897|NCT05845450|Panitumumab|panitumumab|mesh-list
138725898|NCT05845450|Sotorasib|sotorasib|mesh-list
138725899|NCT05845450|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138725900|NCT05845450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138725901|NCT05845450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725902|NCT05845450|Immunoconjugates|immunoconjugates|mesh-ancestor
138725903|NCT05845450|Immunologic Factors|immunologic factors|mesh-ancestor
138725904|NCT05845450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725905|NCT05845450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138725906|NCT05845450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725907|NCT05842213|Golimumab|golimumab|mesh-list
138725908|NCT05842213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138725909|NCT05842213|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138725910|NCT05842213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725919|NCT05802225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138725921|NCT05801835|Cytarabine|cytarabine|mesh-list
138725922|NCT05801835|Daunorubicin|daunorubicin|mesh-list
138725923|NCT05801835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138725924|NCT05801835|Antimetabolites|antimetabolites|mesh-ancestor
138725925|NCT05801835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725926|NCT05801835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725928|NCT05801835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725929|NCT05801835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138725930|NCT05801835|Immunologic Factors|immunologic factors|mesh-ancestor
138725931|NCT05801835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725932|NCT05801835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138725933|NCT05801835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138725934|NCT05801835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138725935|NCT05801835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725936|NCT05790681|Insulin|insulin|mesh-list
138725937|NCT05790681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138725938|NCT05790681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725939|NCT05780216|Harmine|harmine|mesh-list
138725940|NCT05780216|Hallucinogens|hallucinogens|mesh-ancestor
138725941|NCT05780216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725942|NCT05780216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138578392|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
138725943|NCT05780216|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138725944|NCT05780216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138725945|NCT05780216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725946|NCT05766631|Methadone|methadone|mesh-list
138725947|NCT05766631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138725948|NCT05766631|Narcotics|narcotics|mesh-ancestor
139067042|NCT01200706|Amoxicillin|amoxicillin|mesh-list
138725949|NCT05766631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138725950|NCT05766631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725951|NCT05766631|Analgesics|analgesics|mesh-ancestor
138725952|NCT05766631|Sensory System Agents|sensory system agents|mesh-ancestor
138725953|NCT05766631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725954|NCT05766631|Antitussive Agents|antitussive agents|mesh-ancestor
138725955|NCT05766631|Respiratory System Agents|respiratory system agents|mesh-ancestor
138725956|NCT05753306|Cisplatin|cisplatin|mesh-list
138725957|NCT05753306|Docetaxel|docetaxel|mesh-list
138725958|NCT05753306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725959|NCT05753306|Tubulin Modulators|tubulin modulators|mesh-ancestor
138725960|NCT05753306|Antimitotic Agents|antimitotic agents|mesh-ancestor
138725961|NCT05753306|Mitosis Modulators|mitosis modulators|mesh-ancestor
138725962|NCT05753306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138725963|NCT05752734|Dexamethasone|dexamethasone|mesh-list
138725964|NCT05752734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138725965|NCT05752734|Antiemetics|antiemetics|mesh-ancestor
138725966|NCT05752734|Autonomic Agents|autonomic agents|mesh-ancestor
138725967|NCT05752734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138725968|NCT05752734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138725969|NCT05752734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138725970|NCT05752734|Glucocorticoids|glucocorticoids|mesh-ancestor
138725971|NCT05752734|Hormones|hormones|mesh-ancestor
138725972|NCT05752734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138725973|NCT05752734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138725974|NCT05752734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138725975|NCT05746520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138725976|NCT05746520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138725977|NCT05746520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138725978|NCT05746520|Antitubercular Agents|antitubercular agents|mesh-ancestor
138725979|NCT05741905|Levofloxacin|levofloxacin|mesh-list
138726003|NCT05717049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726004|NCT05717049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726005|NCT05717049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138726006|NCT05717049|Respiratory System Agents|respiratory system agents|mesh-ancestor
138726007|NCT05717049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138726008|NCT05717049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726009|NCT05717049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726010|NCT05717049|Vasodilator Agents|vasodilator agents|mesh-ancestor
138726011|NCT05717049|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138726012|NCT05717049|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138726013|NCT05717049|Purinergic Agents|purinergic agents|mesh-ancestor
138726014|NCT05717049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138726015|NCT05698147|Rituximab|rituximab|mesh-list
138726016|NCT05698147|Methotrexate|methotrexate|mesh-list
138726017|NCT05698147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726018|NCT05698147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726019|NCT05698147|Immunologic Factors|immunologic factors|mesh-ancestor
138726020|NCT05698147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726021|NCT05698147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138726022|NCT05698147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138726023|NCT05698147|Abortifacient Agents|abortifacient agents|mesh-ancestor
138726024|NCT05698147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138726025|NCT05698147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138682339|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
138726026|NCT05698147|Antimetabolites|antimetabolites|mesh-ancestor
138726027|NCT05698147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726028|NCT05698147|Dermatologic Agents|dermatologic agents|mesh-ancestor
138726029|NCT05698147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726030|NCT05698147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138654351|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
138726055|NCT05663515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726056|NCT05663515|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138726057|NCT05663515|Incretins|incretins|mesh-ancestor
138726058|NCT05663515|Hormones|hormones|mesh-ancestor
138726059|NCT05663515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726060|NCT05654623|Fulvestrant|fulvestrant|mesh-list
138726061|NCT05654623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138726062|NCT05654623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726063|NCT05654623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138726064|NCT05654623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138726065|NCT05654623|Hormone Antagonists|hormone antagonists|mesh-ancestor
138726066|NCT05654623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578461|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
138726067|NCT05654623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726069|NCT05654363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138726070|NCT05654363|Narcotics|narcotics|mesh-ancestor
138726071|NCT05654363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138726072|NCT05654363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726073|NCT05654363|Analgesics|analgesics|mesh-ancestor
138726074|NCT05654363|Sensory System Agents|sensory system agents|mesh-ancestor
138726075|NCT05654363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726076|NCT05653401|Diclofenac|diclofenac|mesh-list
138726077|NCT05653401|Lidocaine|lidocaine|mesh-list
138726078|NCT05653401|Magnesium Sulfate|magnesium sulfate|mesh-list
138726079|NCT05653401|Anesthetics, Local|anesthetics, local|mesh-ancestor
138726080|NCT05653401|Anesthetics|anesthetics|mesh-ancestor
138726081|NCT05653401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138726082|NCT05653401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726083|NCT05653401|Sensory System Agents|sensory system agents|mesh-ancestor
138726084|NCT05653401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726085|NCT05653401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138726096|NCT05653401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726097|NCT05653401|Anticonvulsants|anticonvulsants|mesh-ancestor
138726098|NCT05653401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138726099|NCT05653401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138682421|NCT00523458|Efavirenz|efavirenz|mesh-list
138726100|NCT05653401|Tocolytic Agents|tocolytic agents|mesh-ancestor
138726101|NCT05653401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138726103|NCT05624996|Etoposide|etoposide|mesh-list
138726104|NCT05624996|Podophyllotoxin|podophyllotoxin|mesh-list
138726105|NCT05624996|Cisplatin|cisplatin|mesh-list
138726106|NCT05624996|Carboplatin|carboplatin|mesh-list
138726107|NCT05624996|Pemetrexed|pemetrexed|mesh-list
138726108|NCT05624996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138726109|NCT05624996|Etoposide phosphate|etoposide phosphate|mesh-list
138726110|NCT05624996|Durvalumab|durvalumab|mesh-list
138726111|NCT05624996|Immunoglobulins|immunoglobulins|mesh-list
138726112|NCT05624996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138726113|NCT05624996|Immunoglobulin G|immunoglobulin g|mesh-list
138726114|NCT05624996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138578495|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
138726115|NCT05624996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726116|NCT05624996|Tubulin Modulators|tubulin modulators|mesh-ancestor
138726117|NCT05624996|Antimitotic Agents|antimitotic agents|mesh-ancestor
138726118|NCT05624996|Mitosis Modulators|mitosis modulators|mesh-ancestor
138726119|NCT05624996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726120|NCT05624996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138726121|NCT05624996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138726122|NCT05624996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726123|NCT05624996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138726124|NCT05624996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138726125|NCT05624996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726126|NCT05624996|Immunologic Factors|immunologic factors|mesh-ancestor
138726127|NCT05624996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726128|NCT05624996|Keratolytic Agents|keratolytic agents|mesh-ancestor
138726129|NCT05624996|Dermatologic Agents|dermatologic agents|mesh-ancestor
138726130|NCT05619653|Prednisolone|prednisolone|mesh-list
138726131|NCT05619653|Losartan|losartan|mesh-list
138726132|NCT05619653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138726133|NCT05619653|Glucocorticoids|glucocorticoids|mesh-ancestor
138726134|NCT05619653|Hormones|hormones|mesh-ancestor
138726135|NCT05619653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726136|NCT05619653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726137|NCT05619653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138726138|NCT05619653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726139|NCT05619653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138726140|NCT05619653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138726141|NCT05619653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138726142|NCT05619653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138726143|NCT05619653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726144|NCT05610657|Mitapivat|mitapivat|mesh-list
138726145|NCT05610657|Enzyme Activators|enzyme activators|mesh-ancestor
138726146|NCT05610657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726147|NCT05600114|Cannabidiol|cannabidiol|mesh-list
138726148|NCT05600114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138726149|NCT05600114|Anticonvulsants|anticonvulsants|mesh-ancestor
138726161|NCT05569811|Letrozole|letrozole|mesh-list
138726162|NCT05569811|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
138726163|NCT05569811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726164|NCT05569811|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138726165|NCT05569811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138726166|NCT05569811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726167|NCT05569811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726168|NCT05569811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138726169|NCT05569811|Hormone Antagonists|hormone antagonists|mesh-ancestor
138726170|NCT05569811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726171|NCT05569811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726172|NCT05569811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726173|NCT05525546|Vaccines|vaccines|mesh-list
138726174|NCT05525546|Immunologic Factors|immunologic factors|mesh-ancestor
138682483|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
138726175|NCT05525546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726176|NCT05525247|Gemcitabine|gemcitabine|mesh-list
138726177|NCT05525247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138726178|NCT05525247|Antimetabolites|antimetabolites|mesh-ancestor
138726179|NCT05525247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726180|NCT05525247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726181|NCT05520814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138726182|NCT05520814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726183|NCT05520814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726196|NCT05513209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138726197|NCT05513209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726198|NCT05511610|Sevoflurane|sevoflurane|mesh-list
138726199|NCT05511610|Desflurane|desflurane|mesh-list
138726200|NCT05511610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138726201|NCT05511610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138726202|NCT05511610|Anesthetics, General|anesthetics, general|mesh-ancestor
138726203|NCT05511610|Anesthetics|anesthetics|mesh-ancestor
138726204|NCT05511610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138726205|NCT05511610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726206|NCT05509569|Icatibant|icatibant|mesh-list
138726207|NCT05509569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138726208|NCT05509569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138726209|NCT05509569|Analgesics|analgesics|mesh-ancestor
138726210|NCT05509569|Sensory System Agents|sensory system agents|mesh-ancestor
138726211|NCT05509569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726223|NCT05506566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726224|NCT05505825|Chiauranib|chiauranib|mesh-list
138726225|NCT05505825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726226|NCT05505825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138726227|NCT05505825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726228|NCT05505825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726229|NCT05500170|Niacinamide|niacinamide|mesh-list
138726231|NCT05500170|Nicotinic Acids|nicotinic acids|mesh-list
138726232|NCT05500170|Vitamins|vitamins|mesh-ancestor
138726233|NCT05500170|Micronutrients|micronutrients|mesh-ancestor
138726234|NCT05500170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726235|NCT05500170|Vitamin B Complex|vitamin b complex|mesh-ancestor
138726236|NCT05500170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138726237|NCT05500170|Antimetabolites|antimetabolites|mesh-ancestor
138726238|NCT05500170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726239|NCT05500170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138726240|NCT05500170|Vasodilator Agents|vasodilator agents|mesh-ancestor
138726241|NCT05499390|Pembrolizumab|pembrolizumab|mesh-list
138726242|NCT05499390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726244|NCT05499390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138726245|NCT05499390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726246|NCT05454891|Insulin|insulin|mesh-list
138726247|NCT05454891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138726248|NCT05454891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138726249|NCT05454891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726250|NCT05440383|Leuprolide|leuprolide|mesh-list
138726251|NCT05440383|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138726252|NCT05440383|Fertility Agents|fertility agents|mesh-ancestor
138726253|NCT05440383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138726254|NCT05440383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726255|NCT05440383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138726256|NCT05440383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726257|NCT05434689|Dexamethasone|dexamethasone|mesh-list
138726258|NCT05434689|Daratumumab|daratumumab|mesh-list
138726259|NCT05434689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138726260|NCT05434689|Antiemetics|antiemetics|mesh-ancestor
138726261|NCT05434689|Autonomic Agents|autonomic agents|mesh-ancestor
138726262|NCT05434689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726263|NCT05434689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726264|NCT05434689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138726265|NCT05434689|Glucocorticoids|glucocorticoids|mesh-ancestor
138726266|NCT05434689|Hormones|hormones|mesh-ancestor
138726267|NCT05434689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726268|NCT05434689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138726269|NCT05434689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726270|NCT05431920|Vitamin D|vitamin d|mesh-list
138726271|NCT05431920|Ergocalciferols|ergocalciferols|mesh-list
138726272|NCT05431920|Cholecalciferol|cholecalciferol|mesh-list
138726274|NCT05431920|Calcifediol|calcifediol|mesh-list
138726275|NCT05431920|Vitamins|vitamins|mesh-list
138726276|NCT05431920|Micronutrients|micronutrients|mesh-ancestor
138726305|NCT05411991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138726306|NCT05411991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138726308|NCT05410860|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138726309|NCT05410860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138726310|NCT05410860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726311|NCT05410860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138726312|NCT05410860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726313|NCT05408845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138726314|NCT05408845|Trastuzumab|trastuzumab|mesh-list
138726315|NCT05408845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138726316|NCT05408845|Docetaxel|docetaxel|mesh-list
138726317|NCT05408845|Maytansine|maytansine|mesh-list
138726318|NCT05408845|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
138726319|NCT05408845|Antibodies|antibodies|mesh-list
138726320|NCT05408845|Immunoglobulins|immunoglobulins|mesh-list
138726321|NCT05408845|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138726322|NCT05408845|Immunoconjugates|immunoconjugates|mesh-list
138726332|NCT05407662|Mineralocorticoids|mineralocorticoids|mesh-list
138726333|NCT05407662|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138726334|NCT05407662|Hormones|hormones|mesh-ancestor
138726335|NCT05407662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726336|NCT05407662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726337|NCT05407662|Hormone Antagonists|hormone antagonists|mesh-ancestor
138726338|NCT05407662|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138726339|NCT05407662|Diuretics|diuretics|mesh-ancestor
138726340|NCT05407662|Natriuretic Agents|natriuretic agents|mesh-ancestor
138726341|NCT05403385|Carboplatin|carboplatin|mesh-list
138726342|NCT05403385|Pemetrexed|pemetrexed|mesh-list
138726343|NCT05403385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726344|NCT05403385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726345|NCT05403385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726346|NCT05403385|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138256267|NCT01352117|Etoposide|etoposide|mesh-list
138726347|NCT05403385|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138726349|NCT05400863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138726350|NCT05400863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726351|NCT05396833|Avelumab|avelumab|mesh-list
138726352|NCT05396833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726353|NCT05396833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726354|NCT05395052|Cyclophosphamide|cyclophosphamide|mesh-list
138726355|NCT05395052|Pembrolizumab|pembrolizumab|mesh-list
138726356|NCT05395052|Nivolumab|nivolumab|mesh-list
138726357|NCT05395052|Trastuzumab|trastuzumab|mesh-list
138726358|NCT05395052|Fludarabine|fludarabine|mesh-list
138726359|NCT05395052|Cetuximab|cetuximab|mesh-list
138726360|NCT05395052|Atezolizumab|atezolizumab|mesh-list
138726361|NCT05395052|Interleukin-2|interleukin-2|mesh-list
138726362|NCT05395052|Avelumab|avelumab|mesh-list
138726363|NCT05395052|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138726364|NCT05395052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138726365|NCT05395052|Immunologic Factors|immunologic factors|mesh-ancestor
138726366|NCT05395052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726367|NCT05395052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138726368|NCT05395052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138726369|NCT05395052|Alkylating Agents|alkylating agents|mesh-ancestor
138726370|NCT05395052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726371|NCT05395052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726372|NCT05395052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138726373|NCT05395052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726374|NCT05395052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138726375|NCT05395052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138726376|NCT05395052|Analgesics|analgesics|mesh-ancestor
138726377|NCT05395052|Sensory System Agents|sensory system agents|mesh-ancestor
138726378|NCT05395052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726379|NCT05389527|Pembrolizumab|pembrolizumab|mesh-list
138726380|NCT05389527|Lenvatinib|lenvatinib|mesh-list
138726381|NCT05389527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726382|NCT05389527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726383|NCT05389527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138726384|NCT05389527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726385|NCT05389527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138726386|NCT05389527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726387|NCT05389423|Prednisone|prednisone|mesh-list
139067245|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
138726389|NCT05389423|Rituximab|rituximab|mesh-list
138726390|NCT05389423|Doxorubicin|doxorubicin|mesh-list
138726413|NCT05389423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138726414|NCT05389423|Tubulin Modulators|tubulin modulators|mesh-ancestor
138726415|NCT05389423|Antimitotic Agents|antimitotic agents|mesh-ancestor
138726416|NCT05389423|Mitosis Modulators|mitosis modulators|mesh-ancestor
138726417|NCT05389423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138726418|NCT05389423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138726419|NCT05389423|Growth Substances|growth substances|mesh-ancestor
138726420|NCT05389423|Growth Inhibitors|growth inhibitors|mesh-ancestor
138726421|NCT05370235|Afamelanotide|afamelanotide|mesh-list
138726422|NCT05370235|Dermatologic Agents|dermatologic agents|mesh-ancestor
138726423|NCT05361720|Nivolumab|nivolumab|mesh-list
138726424|NCT05361720|Ipilimumab|ipilimumab|mesh-list
138726425|NCT05361720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726426|NCT05361720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726427|NCT05361720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138726428|NCT05361720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726429|NCT05359653|Clemastine|clemastine|mesh-list
138726430|NCT05359653|Antipruritics|antipruritics|mesh-ancestor
138726431|NCT05359653|Dermatologic Agents|dermatologic agents|mesh-ancestor
138726432|NCT05359653|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138726433|NCT05359653|Histamine Antagonists|histamine antagonists|mesh-ancestor
138726434|NCT05359653|Histamine Agents|histamine agents|mesh-ancestor
138726435|NCT05359653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138726436|NCT05359653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726437|NCT05359653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726438|NCT05359653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138726439|NCT05358704|Leucovorin|leucovorin|mesh-list
138726440|NCT05358704|Capecitabine|capecitabine|mesh-list
138726441|NCT05358704|Fluorouracil|fluorouracil|mesh-list
138726442|NCT05358704|Oxaliplatin|oxaliplatin|mesh-list
138726443|NCT05358704|Irinotecan|irinotecan|mesh-list
138654467|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
138726474|NCT05347238|Sympathomimetics|sympathomimetics|mesh-ancestor
138726475|NCT05347238|Autonomic Agents|autonomic agents|mesh-ancestor
138726476|NCT05347238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726477|NCT05347238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138682784|NCT00507221|Albendazole|albendazole|mesh-list
138726478|NCT05347238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138726479|NCT05347238|Dopamine Agents|dopamine agents|mesh-ancestor
138726480|NCT05347238|Protective Agents|protective agents|mesh-ancestor
138726481|NCT05316168|Dexamethasone|dexamethasone|mesh-list
138726482|NCT05316168|Bupivacaine|bupivacaine|mesh-list
138726483|NCT05316168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138726484|NCT05316168|Antiemetics|antiemetics|mesh-ancestor
138726485|NCT05316168|Autonomic Agents|autonomic agents|mesh-ancestor
138726486|NCT05316168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726487|NCT05316168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726488|NCT05316168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138654490|NCT04402073|Lomustine|lomustine|mesh-list
138726502|NCT05293509|Dexamethasone|dexamethasone|mesh-list
138726503|NCT05293509|Cyclophosphamide|cyclophosphamide|mesh-list
138726504|NCT05293509|Busulfan|busulfan|mesh-list
138726505|NCT05293509|Rituximab|rituximab|mesh-list
138726506|NCT05293509|Fludarabine|fludarabine|mesh-list
138726507|NCT05293509|Bortezomib|bortezomib|mesh-list
138726508|NCT05293509|Tacrolimus|tacrolimus|mesh-list
138726509|NCT05293509|Cyclosporins|cyclosporins|mesh-list
138726510|NCT05293509|Thymoglobulin|thymoglobulin|mesh-list
138726511|NCT05293509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138726512|NCT05293509|Immunologic Factors|immunologic factors|mesh-ancestor
138726513|NCT05293509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726514|NCT05293509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138726515|NCT05293509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138726516|NCT05293509|Alkylating Agents|alkylating agents|mesh-ancestor
138726517|NCT05293509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726518|NCT05293509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726519|NCT05293509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138726520|NCT05293509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138726521|NCT05293509|Antiemetics|antiemetics|mesh-ancestor
138726522|NCT05293509|Autonomic Agents|autonomic agents|mesh-ancestor
138726523|NCT05293509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726524|NCT05293509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138726525|NCT05293509|Glucocorticoids|glucocorticoids|mesh-ancestor
138726526|NCT05293509|Hormones|hormones|mesh-ancestor
138726527|NCT05293509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726528|NCT05293509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138726529|NCT05293509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726530|NCT05293509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138726531|NCT05293509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726532|NCT05293509|Antifungal Agents|antifungal agents|mesh-ancestor
138726533|NCT05293509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138726534|NCT05293509|Dermatologic Agents|dermatologic agents|mesh-ancestor
138726535|NCT05293509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138726536|NCT05293509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138726537|NCT05293509|Antitubercular Agents|antitubercular agents|mesh-ancestor
138726538|NCT05293509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138726539|NCT05284643|Bevacizumab|bevacizumab|mesh-list
138726540|NCT05284643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726541|NCT05284643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726542|NCT05284643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138726543|NCT05284643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138726544|NCT05284643|Growth Substances|growth substances|mesh-ancestor
138726545|NCT05284643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726546|NCT05284643|Growth Inhibitors|growth inhibitors|mesh-ancestor
138726548|NCT05263206|Fexofenadine|fexofenadine|mesh-list
138726549|NCT05263206|Antipruritics|antipruritics|mesh-ancestor
138726550|NCT05263206|Dermatologic Agents|dermatologic agents|mesh-ancestor
138726551|NCT05263206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138726552|NCT05263206|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138726570|NCT05208879|Protective Agents|protective agents|mesh-ancestor
138726571|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726573|NCT05201313|Mepivacaine|mepivacaine|mesh-list
138726574|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
138726575|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
138726576|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138726577|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726578|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
138726579|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726580|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138726581|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138726582|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138726583|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138726584|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726585|NCT05200988|Nivolumab|nivolumab|mesh-list
138726586|NCT05200988|Ipilimumab|ipilimumab|mesh-list
138726587|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726588|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726589|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138726590|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726591|NCT05199753|Antibodies|antibodies|mesh-list
138726592|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
138726593|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726594|NCT05198934|Trifluridine|trifluridine|mesh-list
138726595|NCT05198934|Panitumumab|panitumumab|mesh-list
138726596|NCT05198934|Sotorasib|sotorasib|mesh-list
138726597|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726598|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726599|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
138726600|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726601|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
138726602|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138726603|NCT05198934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138726605|NCT05195918|Nintedanib|nintedanib|mesh-list
138726606|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138726607|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726608|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138726609|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726610|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726627|NCT05183412|Methamphetamine|methamphetamine|mesh-list
138726628|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138726629|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682935|NCT00526305|Dexamethasone|dexamethasone|mesh-list
138726630|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
138726631|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
138726632|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726633|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
138726634|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138726635|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726636|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
138726637|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138726638|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138726639|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138726640|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138726641|NCT05147376|Curcumin|curcumin|mesh-list
138726642|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138546772|NCT00097227|Paclitaxel|paclitaxel|mesh-list
138726644|NCT05147376|Analgesics|analgesics|mesh-ancestor
138726645|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
138726646|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726647|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726648|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138726649|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138726650|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726651|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726652|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726653|NCT05118854|Cisplatin|cisplatin|mesh-list
138726654|NCT05118854|Carboplatin|carboplatin|mesh-list
138726655|NCT05118854|Pemetrexed|pemetrexed|mesh-list
138726656|NCT05118854|Sotorasib|sotorasib|mesh-list
138726657|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726658|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067360|NCT03722524|Amlodipine|amlodipine|mesh-list
138726659|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726660|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138726661|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138726662|NCT05118854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138726663|NCT05118854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138726664|NCT05116007|Carboplatin|carboplatin|mesh-list
138726665|NCT05116007|Etoposide|etoposide|mesh-list
138726666|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726667|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138726668|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138726669|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138726676|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726677|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726679|NCT05090358|Fulvestrant|fulvestrant|mesh-list
138726680|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138726681|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726682|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138726683|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138726684|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
138726685|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726686|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726687|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138726688|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726689|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138726690|NCT05083312|Fluticasone|fluticasone|mesh-list
138726691|NCT05083312|Xhance|xhance|mesh-list
138726692|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138726693|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138726694|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
138726695|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726696|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726697|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138726698|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
138726699|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
138726700|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138726701|NCT05080946|Aspirin|aspirin|mesh-list
138726702|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138726703|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138726704|NCT05080946|Analgesics|analgesics|mesh-ancestor
138726705|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
138726706|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726707|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726708|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138726709|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138726710|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138726711|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139067387|NCT01203592|Albuterol|albuterol|mesh-list
138726712|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726713|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138726714|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138726715|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726716|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
138726717|NCT05079698|177Lu-PSMA-617|177lu-psma-617|mesh-list
138726718|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138726719|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726720|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
138726721|NCT05078138|Hematinics|hematinics|mesh-ancestor
138726722|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
138726723|NCT05069935|Fludarabine|fludarabine|mesh-list
138726724|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138726725|NCT05069935|Antibodies|antibodies|mesh-list
138726726|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
138726727|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138726728|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138726729|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
138726730|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726731|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138726732|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138726733|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
138726734|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726735|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726736|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138726737|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
138726747|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138726748|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726749|NCT05053152|Relugolix|relugolix|mesh-list
138726750|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
138726751|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
138726752|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578873|NCT00483730|Actovegin|actovegin|mesh-list
138726753|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726754|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
138726755|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138726756|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726757|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138726758|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726759|NCT05050162|Cisplatin|cisplatin|mesh-list
138726760|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
138726761|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726762|NCT05050084|Leuprolide|leuprolide|mesh-list
138726763|NCT05050084|Goserelin|goserelin|mesh-list
138726764|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138726765|NCT05050084|Flutamide|flutamide|mesh-list
138726766|NCT05050084|Bicalutamide|bicalutamide|mesh-list
138726767|NCT05050084|Tryptophan|tryptophan|mesh-list
138726768|NCT05050084|Buserelin|buserelin|mesh-list
138726769|NCT05050084|Hormones|hormones|mesh-list
138726770|NCT05050084|Relugolix|relugolix|mesh-list
138726771|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726772|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726774|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
138726775|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138726776|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138726777|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726778|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
138726779|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
138726780|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
138726781|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138726782|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
138726783|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138726784|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138726785|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
138726786|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138726787|NCT05043870|Infliximab|infliximab|mesh-list
138726788|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138726789|NCT05043870|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138726790|NCT05043870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138726792|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138726793|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138726794|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
138726795|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726796|NCT05029596|Heparin|heparin|mesh-list
138726797|NCT05029596|Calcium heparin|calcium heparin|mesh-list
138726798|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
138726799|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138726800|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138726801|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726802|NCT05027386|Irinotecan|irinotecan|mesh-list
138726803|NCT05027386|Temozolomide|temozolomide|mesh-list
138726829|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138726830|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726831|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726832|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726834|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138726835|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726836|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138726837|NCT04979611|Incretins|incretins|mesh-ancestor
138726838|NCT04979611|Hormones|hormones|mesh-ancestor
138726839|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726840|NCT04971577|Simvastatin|simvastatin|mesh-list
138726841|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139067444|NCT03818932|Celecoxib|celecoxib|mesh-list
138726842|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138726843|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
138726844|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726845|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138726846|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138726847|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726848|NCT04967248|Fulvestrant|fulvestrant|mesh-list
138726849|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138726850|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726851|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138726865|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138726866|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138726867|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
138726868|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726869|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726870|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138726871|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
138726872|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
138726874|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726875|NCT04947631|Tadalafil|tadalafil|mesh-list
138726876|NCT04947631|Dutasteride|dutasteride|mesh-list
138726877|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
138726878|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138726879|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138726880|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726881|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726882|NCT04947631|Urological Agents|urological agents|mesh-ancestor
138726883|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138726884|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138578951|NCT00120653|Metoclopramide|metoclopramide|mesh-list
138726885|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
138726886|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138726887|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726888|NCT04914910|Insulin|insulin|mesh-list
138726889|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138726890|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726891|NCT04913610|Ivermectin|ivermectin|mesh-list
138726892|NCT04913610|Albendazole|albendazole|mesh-list
138726894|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138726895|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
138726896|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
138726897|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138726898|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138726899|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
138726900|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
138726901|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
138726902|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726903|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726904|NCT04903197|Lenalidomide|lenalidomide|mesh-list
138726905|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
138726906|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726907|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138726908|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138726909|NCT04903197|Growth Substances|growth substances|mesh-ancestor
138726910|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
138726911|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726912|NCT04893161|Belimumab|belimumab|mesh-list
138726913|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138726925|NCT04891757|Immunologic Factors|immunologic factors|mesh-ancestor
138726926|NCT04891757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683236|NCT00508859|Sertraline|sertraline|mesh-list
138726927|NCT04891757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138726928|NCT04890470|Vasopressins|vasopressins|mesh-list
138726929|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
138726930|NCT04890470|Oxytocin|oxytocin|mesh-list
138726931|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
138726932|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138726933|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726935|NCT04890470|Coagulants|coagulants|mesh-ancestor
138726936|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138726937|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138726938|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
138726939|NCT04865159|Tipifarnib|tipifarnib|mesh-list
138726940|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726941|NCT04864210|Bupivacaine|bupivacaine|mesh-list
138726942|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
138726943|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
138726944|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138726945|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726946|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
138726947|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138726948|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138726950|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726951|NCT04829760|Psyllium|psyllium|mesh-list
138726952|NCT04829760|Cathartics|cathartics|mesh-ancestor
138726953|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138726954|NCT04828031|Vitamin D|vitamin d|mesh-list
138726955|NCT04828031|Vitamins|vitamins|mesh-ancestor
138726956|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
138726957|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726958|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138726959|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
138726960|NCT04825496|Fludarabine|fludarabine|mesh-list
138726961|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138726962|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
138726963|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726964|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138726965|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138726966|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
138726967|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138726968|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138726969|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138726970|NCT04809220|Dulaglutide|dulaglutide|mesh-list
138726971|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138726972|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726973|NCT04800471|Insulin|insulin|mesh-list
138726974|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138726975|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138726976|NCT04798755|Adalimumab|adalimumab|mesh-list
138726977|NCT04798755|Methotrexate|methotrexate|mesh-list
138726978|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138726979|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
138726980|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138654623|NCT03706365|Prednisone|prednisone|mesh-list
138727002|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727003|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727004|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138683318|NCT00509015|Artesunate|artesunate|mesh-list
138727005|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
138727006|NCT04775550|Hormones|hormones|mesh-ancestor
138727007|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727008|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138727009|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727010|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
138727011|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138727012|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138727013|NCT04775550|Growth Substances|growth substances|mesh-ancestor
138727014|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
138727015|NCT04775082|Liraglutide|liraglutide|mesh-list
138727016|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138727017|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727018|NCT04775082|Incretins|incretins|mesh-ancestor
138727019|NCT04775082|Hormones|hormones|mesh-ancestor
138727020|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727021|NCT04774991|Azithromycin|azithromycin|mesh-list
138727022|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138727023|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727024|NCT04764162|Choline|choline|mesh-list
138727025|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
138727026|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138727027|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
138727028|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727029|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138727030|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138727031|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
138727032|NCT04760613|Cannabidiol|cannabidiol|mesh-list
138727033|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
138727034|NCT04744883|Naloxone|naloxone|mesh-list
138727035|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138654637|NCT03684564|Warfarin|warfarin|mesh-list
138727049|NCT04732494|Tislelizumab|tislelizumab|mesh-list
138727050|NCT04732494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727051|NCT04732494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727052|NCT04721132|Bevacizumab|bevacizumab|mesh-list
138727053|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138727054|NCT04721132|Atezolizumab|atezolizumab|mesh-list
138727055|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
138727056|NCT04721132|Antibodies|antibodies|mesh-list
138727057|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
138727058|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138727059|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
138727060|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727061|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138727062|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138727063|NCT04721132|Growth Substances|growth substances|mesh-ancestor
138727064|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727065|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
138727066|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
138727067|NCT04721132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138727068|NCT04721132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727069|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
138727070|NCT04701476|Tirapazamine|tirapazamine|mesh-list
138727071|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727072|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727073|NCT04701476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138727074|NCT04701476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067568|NCT03813784|Apatinib|apatinib|mesh-list
138727075|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138727078|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138727079|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727080|NCT04614909|Temozolomide|temozolomide|mesh-list
138727081|NCT04614909|Olaparib|olaparib|mesh-list
138683387|NCT00528177|Analgesics|analgesics|mesh-ancestor
138727082|NCT04614909|Pamiparib|pamiparib|mesh-list
138727083|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138727084|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
138727085|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727086|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727087|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138727088|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727089|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
138727090|NCT04614636|Fludarabine|fludarabine|mesh-list
138727091|NCT04614636|Daratumumab|daratumumab|mesh-list
138727092|NCT04614636|Elotuzumab|elotuzumab|mesh-list
138727093|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727094|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
138727095|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654657|NCT03579446|Oxymorphone|oxymorphone|mesh-list
138727107|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138727108|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579123|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
138727109|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727110|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
138727111|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727112|NCT04588246|Memantine|memantine|mesh-list
138727113|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138727114|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138727115|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
138727116|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727117|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727118|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727119|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138727120|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138727121|NCT04564755|Abrocitinib|abrocitinib|mesh-list
138727122|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138727123|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546908|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727124|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727125|NCT04553666|Vitamins|vitamins|mesh-list
138727126|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
138727127|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138727128|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
139067597|NCT01206946|Betamethasone|betamethasone|mesh-list
138727129|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727130|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
138727131|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727132|NCT04553666|Protective Agents|protective agents|mesh-ancestor
138727133|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138727134|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138727135|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727136|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138727137|NCT04551885|Aldesleukin|aldesleukin|mesh-list
138727138|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
138727139|NCT04551885|Fludarabine|fludarabine|mesh-list
138727140|NCT04551885|Avelumab|avelumab|mesh-list
138727141|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727142|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
138546973|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
138727143|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727144|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138727145|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138727146|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
138727147|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727148|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727149|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138727151|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138727152|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
138579176|NCT00121277|Capecitabine|capecitabine|mesh-list
138727153|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727154|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727155|NCT04545242|Dexamethasone|dexamethasone|mesh-list
138727156|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138727158|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
138654667|NCT03579446|Analgesics|analgesics|mesh-ancestor
138727175|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
138727176|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
138727177|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727178|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138727179|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
138727180|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138727181|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138727182|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138727183|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727184|NCT04515186|Miltefosine|miltefosine|mesh-list
138727185|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138727186|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
138727187|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727188|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727189|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138727190|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138727192|NCT04513717|Goserelin|goserelin|mesh-list
138727193|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138727194|NCT04513717|Flutamide|flutamide|mesh-list
138727195|NCT04513717|Bicalutamide|bicalutamide|mesh-list
138727196|NCT04513717|Tryptophan|tryptophan|mesh-list
138727197|NCT04513717|Buserelin|buserelin|mesh-list
138727198|NCT04513717|Hormones|hormones|mesh-list
138727199|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727200|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727201|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138727202|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
138727203|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138727204|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138727205|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727206|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
138727207|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
138727208|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
138727209|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138727210|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
138579201|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
138727211|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138727212|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138727213|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
138727214|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138727215|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
138727216|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
138727217|NCT04505254|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138727218|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727237|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
138727238|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727239|NCT04464265|Propofol|propofol|mesh-list
138727240|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138727241|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138727242|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727243|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138727244|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
138727245|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
138727246|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
138727247|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138727248|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138727249|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727250|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
138727251|NCT04448184|Coagulants|coagulants|mesh-ancestor
138727252|NCT04437888|Ketamine|ketamine|mesh-list
138727253|NCT04437888|Analgesics|analgesics|mesh-ancestor
138727254|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
138727255|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727256|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727257|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138727258|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138727259|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
138727260|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
138727261|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138727262|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138547440|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
138727263|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138727264|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727265|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727266|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
138727267|NCT04432506|Fludarabine|fludarabine|mesh-list
138727268|NCT04432506|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138727269|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138727270|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727271|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
138727272|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727273|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138727284|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727286|NCT04406389|Calcium heparin|calcium heparin|mesh-list
138727287|NCT04406389|Enoxaparin|enoxaparin|mesh-list
138727288|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
138727289|NCT04406389|Argatroban|argatroban|mesh-list
138727290|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
138727291|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138727292|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138727293|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727294|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
138727295|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138727296|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
138727297|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727298|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138727299|NCT04356729|Bevacizumab|bevacizumab|mesh-list
138727300|NCT04356729|Atezolizumab|atezolizumab|mesh-list
138727301|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727302|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727304|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138727305|NCT04356729|Growth Substances|growth substances|mesh-ancestor
138727306|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547618|NCT00236821|Levofloxacin|levofloxacin|mesh-list
138727307|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
138727308|NCT04356729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138727309|NCT04356729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727310|NCT04329650|Dexamethasone|dexamethasone|mesh-list
138727311|NCT04329650|Siltuximab|siltuximab|mesh-list
138727312|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138727313|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
138727314|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
138727315|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727316|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727317|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138727318|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
138727319|NCT04329650|Hormones|hormones|mesh-ancestor
138727320|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727321|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138727322|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727323|NCT04327310|Meplazumab|meplazumab|mesh-list
138727324|NCT04327310|Antiviral Agents|antiviral agents|mesh-ancestor
138727325|NCT04327310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727326|NCT04282187|Azacitidine|azacitidine|mesh-list
138727327|NCT04282187|Decitabine|decitabine|mesh-list
138727328|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138727329|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138727330|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
138727331|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727332|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727333|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727334|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138547744|NCT00237484|Interferons|interferons|mesh-list
138727335|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138727336|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
138727360|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
138727361|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727362|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727363|NCT04246151|Vancomycin|vancomycin|mesh-list
138727364|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138727365|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727366|NCT04235140|Ivacaftor|ivacaftor|mesh-list
138727367|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138727368|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138727369|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727370|NCT04220684|Cytarabine|cytarabine|mesh-list
138727371|NCT04220684|Fludarabine|fludarabine|mesh-list
138727372|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727373|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138727374|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
138727375|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727376|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727378|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727379|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
138727380|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727381|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
138727382|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138683685|NCT02950935|Hormones|hormones|mesh-ancestor
138727383|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138727384|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727385|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138727386|NCT04204798|Analgesics|analgesics|mesh-ancestor
138727410|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727411|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138727412|NCT04171843|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138727413|NCT04171843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727414|NCT04165993|Docetaxel|docetaxel|mesh-list
138727415|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727416|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
138727417|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
138727418|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
138727419|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727420|NCT04141501|Psilocybin|psilocybin|mesh-list
138727421|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
138727422|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727423|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138727424|NCT04134260|Hormones|hormones|mesh-list
138727425|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727426|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727427|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138727428|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138727429|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
138727430|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727431|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727432|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727434|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727435|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268459|NCT02403895|Paclitaxel|paclitaxel|mesh-list
138727443|NCT04080284|Niraparib|niraparib|mesh-list
138727444|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138727445|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727446|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727447|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727448|NCT04067115|Alovudine|alovudine|mesh-list
138727449|NCT04067115|Irinotecan|irinotecan|mesh-list
138727450|NCT04067115|Trabectedin|trabectedin|mesh-list
138727451|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138727452|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138727453|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727454|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683764|NCT02944227|Ranibizumab|ranibizumab|mesh-list
138727455|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727456|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138727457|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
138727458|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
138727459|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727461|NCT04054375|Prednisolone|prednisolone|mesh-list
138727462|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138727463|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
138727464|NCT04054375|Hormones|hormones|mesh-ancestor
138727465|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727466|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727467|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138727468|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727469|NCT04037254|Niraparib|niraparib|mesh-list
138727470|NCT04037254|Hormones|hormones|mesh-list
138727471|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138727472|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138727473|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727474|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727475|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138727476|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727477|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727478|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727479|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138727480|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138727481|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727482|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
138727483|NCT04017442|Morphine|morphine|mesh-list
138727484|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138727485|NCT04017442|Narcotics|narcotics|mesh-ancestor
138727486|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138727487|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727488|NCT04017442|Analgesics|analgesics|mesh-ancestor
138727489|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
138727490|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727491|NCT04015622|Docetaxel|docetaxel|mesh-list
138727492|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727493|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
138727494|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
138727495|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
138727496|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727497|NCT04010578|Vitamin D|vitamin d|mesh-list
138727498|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
138727499|NCT04010578|Vitamins|vitamins|mesh-ancestor
138727500|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
138727501|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727502|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138654777|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138727531|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727533|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138727534|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138727535|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
138727536|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727537|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
138727538|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
138727539|NCT03873818|Ipilimumab|ipilimumab|mesh-list
138727540|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727541|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727542|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138727543|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727544|NCT03848676|Immunomodulating Agents|immunomodulating agents|mesh-list
138727545|NCT03848676|Immunologic Factors|immunologic factors|mesh-ancestor
138727546|NCT03848676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727547|NCT03843294|Nivolumab|nivolumab|mesh-list
138727548|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727570|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727572|NCT03765541|Dexamethasone|dexamethasone|mesh-list
138727573|NCT03765541|Azacitidine|azacitidine|mesh-list
138727574|NCT03765541|Amsacrine|amsacrine|mesh-list
138727575|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138727576|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
138727577|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
138727578|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727579|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727580|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138727581|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
138727582|NCT03765541|Hormones|hormones|mesh-ancestor
138727583|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727584|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138727585|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727586|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138727587|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
138727588|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727589|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
138727590|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727591|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727592|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
138727593|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727594|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138727595|NCT03712956|Doxorubicin|doxorubicin|mesh-list
138727596|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138727597|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727598|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138727599|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138727600|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727601|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727602|NCT03712098|Liraglutide|liraglutide|mesh-list
138727603|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138727604|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727605|NCT03712098|Incretins|incretins|mesh-ancestor
138727624|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
138727625|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727626|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138579321|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727627|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138727628|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
138727629|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727630|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727631|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138727632|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138727633|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
138727634|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
138727635|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727636|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138727637|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
138727639|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727640|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138727641|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
138727642|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727643|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138727644|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138727645|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138727646|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138727647|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
138727648|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138727649|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138727650|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
138727651|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
138727652|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138727653|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138727654|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
138727655|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727656|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138727657|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
138727658|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
138727659|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
138727660|NCT03704688|Trametinib|trametinib|mesh-list
138727661|NCT03704688|Ponatinib|ponatinib|mesh-list
138727662|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727663|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138727664|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727665|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727666|NCT03686332|Atezolizumab|atezolizumab|mesh-list
138727667|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138727684|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727685|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727686|NCT03646175|Choline|choline|mesh-list
138727687|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
138727688|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138727689|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
138727690|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727691|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138727692|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138727693|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
138727694|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
138727695|NCT03630991|Edetic Acid|edetic acid|mesh-list
138727696|NCT03630991|Calcium|calcium|mesh-list
138727697|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
138727698|NCT03630991|Succimer|succimer|mesh-list
138727699|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548033|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138727700|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138727701|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138727702|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
138727703|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138727704|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
138727705|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
138727706|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727708|NCT03630991|Protective Agents|protective agents|mesh-ancestor
138727709|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138727710|NCT03616886|Paclitaxel|paclitaxel|mesh-list
138727711|NCT03616886|Carboplatin|carboplatin|mesh-list
138727712|NCT03616886|Durvalumab|durvalumab|mesh-list
138727713|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138727714|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727715|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
138727716|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
138727717|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
138727718|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727719|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727720|NCT03609840|Thiotepa|thiotepa|mesh-list
138727721|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
138727722|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
138727723|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
138727724|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727725|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138727726|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727727|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
138727745|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138727746|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
138727747|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
138727748|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138727749|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138727750|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138727751|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727752|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727753|NCT03562507|Nivolumab|nivolumab|mesh-list
139067921|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
138727754|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727755|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727756|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138727757|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727758|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
138727759|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138727760|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138727761|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727762|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
138727763|NCT03552705|Coagulants|coagulants|mesh-ancestor
138727764|NCT03534713|Paclitaxel|paclitaxel|mesh-list
138727765|NCT03534713|Carboplatin|carboplatin|mesh-list
138727766|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138727767|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727768|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
138727769|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
138727770|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
138727771|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727772|NCT03518203|Eculizumab|eculizumab|mesh-list
138727773|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138727774|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727775|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
138727776|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727777|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
138727778|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138727779|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138727780|NCT03493932|Nivolumab|nivolumab|mesh-list
138727781|NCT03493932|Relatlimab|relatlimab|mesh-list
138727782|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727783|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727784|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138727785|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727803|NCT03465774|Doxycycline|doxycycline|mesh-list
138727804|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138727805|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727806|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
138727807|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138727808|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138727809|NCT03427814|Pamiparib|pamiparib|mesh-list
138727810|NCT03427814|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138727811|NCT03427814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727812|NCT03427814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727813|NCT03427814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727814|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
138727815|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138727816|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138727817|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727818|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
138727819|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727820|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727821|NCT03379909|Metformin|metformin|mesh-list
138727822|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138727823|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727824|NCT03368664|Interferons|interferons|mesh-list
138727825|NCT03368664|Acyclovir|acyclovir|mesh-list
138727826|NCT03368664|Interferon-beta|interferon-beta|mesh-list
138727827|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
138727828|NCT03368664|Prednisolone|prednisolone|mesh-list
138727829|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
138727830|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
138727831|NCT03368664|Ranitidine|ranitidine|mesh-list
138727832|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
138727833|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
138727834|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727835|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
138727836|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727837|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138727838|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
138727839|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
138727840|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727841|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727842|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138727843|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
138727844|NCT03368664|Hormones|hormones|mesh-ancestor
138727845|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727855|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138727856|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
138727857|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
138727858|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727859|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727860|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138727861|NCT03343054|Talazoparib|talazoparib|mesh-list
138727862|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138727863|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067971|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727864|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727866|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
138727867|NCT03339596|Hematinics|hematinics|mesh-ancestor
138727868|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
138727869|NCT03322358|Promethazine|promethazine|mesh-list
138727870|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138727871|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138727872|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138727873|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727874|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
138727875|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
138727876|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
138727877|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727878|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
138727879|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
138727880|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138727881|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138727882|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
138727883|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
138727884|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727885|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727886|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138727888|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
138727889|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
138727890|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
138727891|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
138727892|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
138727893|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727894|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727895|NCT03309878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138727896|NCT03309878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727897|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
138727898|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727899|NCT03298295|Insulin|insulin|mesh-list
138727900|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138727901|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727902|NCT03291158|Minocycline|minocycline|mesh-list
138727903|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138727904|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138727905|NCT03259867|Nivolumab|nivolumab|mesh-list
138727906|NCT03259867|Tirapazamine|tirapazamine|mesh-list
138727907|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138727908|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727909|NCT03259867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138727910|NCT03259867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727911|NCT03226691|Plerixafor|plerixafor|mesh-list
138727912|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138727926|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138727927|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727928|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138727929|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
138727930|NCT03202628|Hormones|hormones|mesh-ancestor
138727931|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138727932|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138727933|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727934|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727935|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
138727936|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727937|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
138727938|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138727939|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138727940|NCT03202628|Growth Substances|growth substances|mesh-ancestor
138727941|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
138727942|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
138727943|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
138727944|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138727945|NCT03176472|Ricolinostat|ricolinostat|mesh-list
138727946|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727947|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138727948|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727949|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727950|NCT03164057|Cytarabine|cytarabine|mesh-list
138727951|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
138727952|NCT03164057|Methotrexate|methotrexate|mesh-list
138727953|NCT03164057|Azacitidine|azacitidine|mesh-list
138727954|NCT03164057|Decitabine|decitabine|mesh-list
138727955|NCT03164057|Fludarabine|fludarabine|mesh-list
138727956|NCT03164057|Etoposide|etoposide|mesh-list
138260715|NCT02712047|Xhance|xhance|mesh-list
138727957|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
138727958|NCT03164057|Sorafenib|sorafenib|mesh-list
138727959|NCT03164057|Daunorubicin|daunorubicin|mesh-list
138727960|NCT03164057|Asparaginase|asparaginase|mesh-list
138727961|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
138727962|NCT03164057|Idarubicin|idarubicin|mesh-list
138727963|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
138727964|NCT03164057|Razoxane|razoxane|mesh-list
138727965|NCT03164057|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
138727966|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138727967|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
138727968|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138727969|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138727970|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138727971|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
138727972|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138727973|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138727974|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
138727975|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138727976|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138727977|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138727978|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
138727979|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138654901|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728005|NCT03136146|Ofatumumab|ofatumumab|mesh-list
138728006|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
138728007|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138728008|NCT03136146|Antibodies|antibodies|mesh-list
138728009|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
138728010|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138728011|NCT03136146|Lenograstim|lenograstim|mesh-list
138728012|NCT03136146|BB 1101|bb 1101|mesh-list
138728013|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138728014|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
138728015|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728016|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138728017|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138728018|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
138728019|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728020|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728021|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138728022|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138728023|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
138728024|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
138728025|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728026|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138728027|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
138728028|NCT03136146|Hormones|hormones|mesh-ancestor
138728029|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138728030|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138728031|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
138728032|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728033|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138728053|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138728054|NCT03127631|Simvastatin|simvastatin|mesh-list
138728055|NCT03127631|Pravastatin|pravastatin|mesh-list
138728056|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138728057|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138728058|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138728059|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
138728060|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728061|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138728062|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138728063|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728064|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
138728065|NCT03067571|Daratumumab|daratumumab|mesh-list
138728066|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728067|NCT06081101|Methylprednisolone|methylprednisolone|mesh-list
138728068|NCT06081101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138728069|NCT06081101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138728070|NCT06081101|Prednisolone|prednisolone|mesh-list
138728071|NCT06081101|Prednisolone acetate|prednisolone acetate|mesh-list
138728072|NCT06081101|Ketorolac|ketorolac|mesh-list
138728073|NCT06081101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138728074|NCT06081101|Prednisolone phosphate|prednisolone phosphate|mesh-list
138728075|NCT06081101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138728076|NCT06081101|Antiemetics|antiemetics|mesh-ancestor
138728077|NCT06081101|Autonomic Agents|autonomic agents|mesh-ancestor
138728078|NCT06081101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728079|NCT06081101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728080|NCT06081101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138728081|NCT06081101|Glucocorticoids|glucocorticoids|mesh-ancestor
138728082|NCT06081101|Hormones|hormones|mesh-ancestor
138728083|NCT06081101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138728084|NCT06081101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138728085|NCT06081101|Protective Agents|protective agents|mesh-ancestor
138728086|NCT06081101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138728087|NCT06081101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728088|NCT06081101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138728089|NCT06081101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138728090|NCT06081101|Analgesics|analgesics|mesh-ancestor
138728091|NCT06081101|Sensory System Agents|sensory system agents|mesh-ancestor
138728092|NCT06081101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138728104|NCT06080880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138728105|NCT06080880|Glucocorticoids|glucocorticoids|mesh-ancestor
138728106|NCT06080880|Hormones|hormones|mesh-ancestor
139068114|NCT01080612|Pregabalin|pregabalin|mesh-list
138728107|NCT06080880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138728108|NCT06080880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138728109|NCT06080880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728110|NCT06080880|Antipruritics|antipruritics|mesh-ancestor
138728111|NCT06080880|Dermatologic Agents|dermatologic agents|mesh-ancestor
138728112|NCT06080880|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138728113|NCT06080880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138728114|NCT06080880|Serotonin Agents|serotonin agents|mesh-ancestor
138728115|NCT06080880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138728116|NCT06080880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728117|NCT06080880|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138728119|NCT06080854|Gemcitabine|gemcitabine|mesh-list
138728120|NCT06080854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138728121|NCT06080854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728122|NCT06080854|Tubulin Modulators|tubulin modulators|mesh-ancestor
138728123|NCT06080854|Antimitotic Agents|antimitotic agents|mesh-ancestor
138728124|NCT06080854|Mitosis Modulators|mitosis modulators|mesh-ancestor
138728125|NCT06080854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728126|NCT06080854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138728127|NCT06080854|Antimetabolites|antimetabolites|mesh-ancestor
138728128|NCT06080841|Curcumin|curcumin|mesh-list
138728129|NCT06080841|Piperine|piperine|mesh-list
138728130|NCT06080841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138728131|NCT06080841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138728132|NCT06080841|Analgesics|analgesics|mesh-ancestor
138728133|NCT06080841|Sensory System Agents|sensory system agents|mesh-ancestor
138728134|NCT06080841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728135|NCT06080841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728136|NCT06080841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138728137|NCT06080841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138728138|NCT06080841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728139|NCT06080841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728140|NCT06080841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728141|NCT06080841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138684443|NCT00515801|Glyburide|glyburide|mesh-list
138728142|NCT06080802|Metformin|metformin|mesh-list
138728143|NCT06080802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138728144|NCT06080802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728145|NCT06080724|Dexamethasone|dexamethasone|mesh-list
138728146|NCT06080724|Bleomycin|bleomycin|mesh-list
138728147|NCT06080724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138728148|NCT06080724|Antiemetics|antiemetics|mesh-ancestor
138728149|NCT06080724|Autonomic Agents|autonomic agents|mesh-ancestor
138728150|NCT06080724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728151|NCT06080724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728152|NCT06080724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138728153|NCT06080724|Glucocorticoids|glucocorticoids|mesh-ancestor
138728154|NCT06080724|Hormones|hormones|mesh-ancestor
138728155|NCT06080724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138728156|NCT06080724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138654961|NCT01524926|Crizotinib|crizotinib|mesh-list
138728218|NCT06079918|Trace Elements|trace elements|mesh-list
138728219|NCT06079918|Micronutrients|micronutrients|mesh-list
138579444|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138728220|NCT06079918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728221|NCT06079788|Hormones|hormones|mesh-list
138728222|NCT06079788|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138728223|NCT06079788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138728224|NCT06079788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728225|NCT06079606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138728226|NCT06079606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138728227|NCT06079346|Folfirinox|folfirinox|mesh-list
138728228|NCT06079346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728229|NCT06079333|Trametinib|trametinib|mesh-list
138728230|NCT06079333|Dabrafenib|dabrafenib|mesh-list
138728231|NCT06079333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728232|NCT06079333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138728233|NCT06079333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728234|NCT06079333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728235|NCT06079047|Dexamethasone|dexamethasone|mesh-list
138728236|NCT06079047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138728237|NCT06079047|Antiemetics|antiemetics|mesh-ancestor
138728238|NCT06079047|Autonomic Agents|autonomic agents|mesh-ancestor
138728239|NCT06079047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728240|NCT06079047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728241|NCT06079047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138728242|NCT06079047|Glucocorticoids|glucocorticoids|mesh-ancestor
138728243|NCT06079047|Hormones|hormones|mesh-ancestor
138655003|NCT00679029|Bevacizumab|bevacizumab|mesh-list
138728261|NCT06078839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138258151|NCT02469701|Nivolumab|nivolumab|mesh-list
138728262|NCT06078839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138728263|NCT06078839|Analgesics|analgesics|mesh-ancestor
138728264|NCT06078839|Sensory System Agents|sensory system agents|mesh-ancestor
138728265|NCT06078839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728266|NCT06078839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728267|NCT06078839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138728268|NCT06078839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138728269|NCT06078839|Anticoagulants|anticoagulants|mesh-ancestor
138728270|NCT06078839|Protease Inhibitors|protease inhibitors|mesh-ancestor
138728271|NCT06078839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728272|NCT06078839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728273|NCT06078839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138728274|NCT06078839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138728275|NCT06078839|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138728276|NCT06078839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138728277|NCT06078839|Immunologic Factors|immunologic factors|mesh-ancestor
138728278|NCT06078787|Olaparib|olaparib|mesh-list
138728279|NCT06078787|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138728280|NCT06078787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728281|NCT06078787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728282|NCT06078787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728283|NCT06078696|Sirolimus|sirolimus|mesh-list
138728284|NCT06078696|Cyclophosphamide|cyclophosphamide|mesh-list
138728285|NCT06078696|Rituximab|rituximab|mesh-list
138728286|NCT06078696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138728287|NCT06078696|Immunologic Factors|immunologic factors|mesh-ancestor
138728288|NCT06078696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728289|NCT06078696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138728290|NCT06078696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138728291|NCT06078696|Alkylating Agents|alkylating agents|mesh-ancestor
139068154|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138728292|NCT06078696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728293|NCT06078696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728294|NCT06078696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138728295|NCT06078696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728296|NCT06078696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138728297|NCT06078696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138728298|NCT06078696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138655030|NCT00519116|Sirolimus|sirolimus|mesh-list
138728320|NCT06078592|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138728321|NCT06078592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138728322|NCT06078592|Maleic acid|maleic acid|mesh-list
138728323|NCT06078592|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
138728324|NCT06078592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138728325|NCT06078592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728326|NCT06078592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728327|NCT06078592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138728328|NCT06078592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138728329|NCT06078592|Adrenergic Agents|adrenergic agents|mesh-ancestor
138728330|NCT06078592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138728331|NCT06078592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728333|NCT06078592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138728334|NCT06078592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138728335|NCT06078592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138728336|NCT06078592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138728337|NCT06076980|Acetaminophen|acetaminophen|mesh-list
138728338|NCT06076980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138728339|NCT06076980|Analgesics|analgesics|mesh-ancestor
138728340|NCT06076980|Sensory System Agents|sensory system agents|mesh-ancestor
138728341|NCT06076980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728342|NCT06076980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728343|NCT06076980|Antipyretics|antipyretics|mesh-ancestor
138728344|NCT06073704|Anti-Infective Agents|anti-infective agents|mesh-list
138728345|NCT06073704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138728346|NCT06070961|Immunoglobulin G|immunoglobulin g|mesh-list
138728347|NCT06070961|Immunologic Factors|immunologic factors|mesh-ancestor
138728348|NCT06070961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728349|NCT06070350|Tranexamic Acid|tranexamic acid|mesh-list
138728350|NCT06070350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138728351|NCT06070350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138728352|NCT06070350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728353|NCT06070350|Hemostatics|hemostatics|mesh-ancestor
138728354|NCT06070350|Coagulants|coagulants|mesh-ancestor
138728355|NCT06064448|Sildenafil Citrate|sildenafil citrate|mesh-list
138728356|NCT06064448|Vasodilator Agents|vasodilator agents|mesh-ancestor
138728371|NCT05988697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728372|NCT05988697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138728373|NCT05988697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728374|NCT05988697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728375|NCT05975450|Abatacept|abatacept|mesh-list
138728376|NCT05975450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138728377|NCT05975450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728378|NCT05975450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728379|NCT05975450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728380|NCT05975450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138728381|NCT05975450|Immunologic Factors|immunologic factors|mesh-ancestor
138728382|NCT05975450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728383|NCT05975450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138728384|NCT05943821|Allopurinol|allopurinol|mesh-list
138728385|NCT05943821|Antimetabolites|antimetabolites|mesh-ancestor
138728386|NCT05943821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728387|NCT05943821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728388|NCT05943821|Gout Suppressants|gout suppressants|mesh-ancestor
138728389|NCT05943821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138728390|NCT05943821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138728391|NCT05943821|Antioxidants|antioxidants|mesh-ancestor
138728392|NCT05943821|Protective Agents|protective agents|mesh-ancestor
138728393|NCT05943821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728394|NCT05888311|Charcoal|charcoal|mesh-list
138728395|NCT05888311|Antidotes|antidotes|mesh-ancestor
138728396|NCT05888311|Protective Agents|protective agents|mesh-ancestor
138728397|NCT05888311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728398|NCT05878951|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138728399|NCT05878951|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138728400|NCT05878951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138728401|NCT05878951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728402|NCT05878951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728403|NCT05878951|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138728404|NCT05878951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138728405|NCT05878951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728406|NCT05878951|Cholinergic Agents|cholinergic agents|mesh-ancestor
138728407|NCT05878951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138728408|NCT05877027|Diclofenac|diclofenac|mesh-list
138728409|NCT05877027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138728410|NCT05877027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138728411|NCT05877027|Analgesics|analgesics|mesh-ancestor
138728412|NCT05877027|Sensory System Agents|sensory system agents|mesh-ancestor
138728413|NCT05877027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728414|NCT05877027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655070|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
138728428|NCT05827874|Immunologic Factors|immunologic factors|mesh-ancestor
138728429|NCT05827874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728431|NCT05824728|Anticonvulsants|anticonvulsants|mesh-ancestor
138728432|NCT05824728|Nootropic Agents|nootropic agents|mesh-ancestor
138728433|NCT05818085|Allopurinol|allopurinol|mesh-list
138728434|NCT05818085|Antimetabolites|antimetabolites|mesh-ancestor
138728435|NCT05818085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728436|NCT05818085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728437|NCT05818085|Gout Suppressants|gout suppressants|mesh-ancestor
138728438|NCT05818085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138728439|NCT05818085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138728440|NCT05818085|Antioxidants|antioxidants|mesh-ancestor
138728441|NCT05818085|Protective Agents|protective agents|mesh-ancestor
138728442|NCT05818085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728443|NCT05816343|Orlistat|orlistat|mesh-list
138728444|NCT05816343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728445|NCT05816343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728446|NCT05816343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138728447|NCT05816343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138728448|NCT05813314|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
138728449|NCT05813314|Natriuretic Agents|natriuretic agents|mesh-ancestor
138728450|NCT05813314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728451|NCT05789173|Efavirenz|efavirenz|mesh-list
138728452|NCT05789173|Clonidine|clonidine|mesh-list
138728453|NCT05789173|Methadone|methadone|mesh-list
138728454|NCT05789173|Tizanidine|tizanidine|mesh-list
138728455|NCT05789173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138728456|NCT05789173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138728457|NCT05789173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728458|NCT05789173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728459|NCT05789173|Antiviral Agents|antiviral agents|mesh-ancestor
138728460|NCT05789173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138728461|NCT05789173|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138728462|NCT05789173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138728463|NCT05789173|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138728464|NCT05789173|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138728465|NCT05789173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138728466|NCT05789173|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138728467|NCT05789173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138728468|NCT05789173|Narcotics|narcotics|mesh-ancestor
138728469|NCT05789173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138728470|NCT05789173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728471|NCT05789173|Analgesics|analgesics|mesh-ancestor
138728472|NCT05789173|Sensory System Agents|sensory system agents|mesh-ancestor
138728473|NCT05789173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728474|NCT05789173|Antitussive Agents|antitussive agents|mesh-ancestor
138728475|NCT05789173|Respiratory System Agents|respiratory system agents|mesh-ancestor
138728495|NCT05721755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728496|NCT05721755|Tubulin Modulators|tubulin modulators|mesh-ancestor
138728497|NCT05721755|Antimitotic Agents|antimitotic agents|mesh-ancestor
138728498|NCT05721755|Mitosis Modulators|mitosis modulators|mesh-ancestor
139068247|NCT00144170|Ritonavir|ritonavir|mesh-list
138728499|NCT05721755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728500|NCT05721755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728501|NCT05721755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138728502|NCT05721755|Antimetabolites|antimetabolites|mesh-ancestor
138728503|NCT05721755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138728504|NCT05721755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138728505|NCT05721755|Immunologic Factors|immunologic factors|mesh-ancestor
138728506|NCT05721755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728507|NCT05717166|Hormones|hormones|mesh-list
138728508|NCT05717166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138728509|NCT05717166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728510|NCT05687266|Paclitaxel|paclitaxel|mesh-list
138728511|NCT05687266|Carboplatin|carboplatin|mesh-list
138728512|NCT05687266|Pembrolizumab|pembrolizumab|mesh-list
138728513|NCT05687266|Pemetrexed|pemetrexed|mesh-list
138728514|NCT05687266|Durvalumab|durvalumab|mesh-list
138728515|NCT05687266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138728516|NCT05687266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728517|NCT05687266|Tubulin Modulators|tubulin modulators|mesh-ancestor
138684820|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138728518|NCT05687266|Antimitotic Agents|antimitotic agents|mesh-ancestor
138728519|NCT05687266|Mitosis Modulators|mitosis modulators|mesh-ancestor
138728520|NCT05687266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728521|NCT05687266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728522|NCT05687266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138728523|NCT05687266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728524|NCT05687266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138728525|NCT05687266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138728526|NCT05684055|Antihypertensive Agents|antihypertensive agents|mesh-list
138728527|NCT05656443|Ritonavir|ritonavir|mesh-list
138728528|NCT05656443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138728529|NCT05656443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138728530|NCT05656443|Protease Inhibitors|protease inhibitors|mesh-ancestor
138728531|NCT05656443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728532|NCT05656443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728533|NCT05656443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138655101|NCT00349362|Testosterone|testosterone|mesh-list
138728545|NCT05630755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138728546|NCT05630755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138728547|NCT05621174|Dextroamphetamine|dextroamphetamine|mesh-list
138728548|NCT05621174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138728549|NCT05621174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728550|NCT05621174|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138728551|NCT05621174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138728552|NCT05621174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138728553|NCT05621174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728554|NCT05621174|Dopamine Agents|dopamine agents|mesh-ancestor
138728555|NCT05621174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138728557|NCT05553145|Autoantibodies|autoantibodies|mesh-list
138728558|NCT05553145|Immunologic Factors|immunologic factors|mesh-ancestor
138728559|NCT05553145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728560|NCT05544565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138728561|NCT05544565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138728562|NCT05509257|Naltrexone|naltrexone|mesh-list
138728563|NCT05509257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138728564|NCT05509257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138728565|NCT05509257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728566|NCT05509257|Sensory System Agents|sensory system agents|mesh-ancestor
138728567|NCT05509257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728568|NCT05507541|Pembrolizumab|pembrolizumab|mesh-list
138728569|NCT05507541|Immunoglobulin G|immunoglobulin g|mesh-list
138728570|NCT05507541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728571|NCT05507541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728572|NCT05507541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138728573|NCT05507541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728574|NCT05507541|Immunologic Factors|immunologic factors|mesh-ancestor
138728575|NCT05507541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728576|NCT05501054|Nivolumab|nivolumab|mesh-list
138728577|NCT05501054|Ipilimumab|ipilimumab|mesh-list
138728578|NCT05501054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728579|NCT05501054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728580|NCT05501054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138728581|NCT05501054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728582|NCT05463965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138728583|NCT05463965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138728584|NCT05463965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138728585|NCT05463965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728586|NCT05463965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728587|NCT05463965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138728588|NCT05463965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138684896|NCT02940444|Heparin|heparin|mesh-list
138728589|NCT05463965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728590|NCT05463965|Cholinergic Agents|cholinergic agents|mesh-ancestor
138728591|NCT05463965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138728592|NCT05395091|Denosumab|denosumab|mesh-list
138728593|NCT05395091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138728594|NCT05395091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728595|NCT05387759|Moxifloxacin|moxifloxacin|mesh-list
138728616|NCT05314933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728617|NCT05314933|Antiviral Agents|antiviral agents|mesh-ancestor
138728618|NCT05314933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138728619|NCT05309187|Pembrolizumab|pembrolizumab|mesh-list
138728620|NCT05309187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728621|NCT05309187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728622|NCT05309187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138728623|NCT05309187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728624|NCT05223010|Sevoflurane|sevoflurane|mesh-list
138728625|NCT05223010|Melatonin|melatonin|mesh-list
138728626|NCT05223010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138728627|NCT05223010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138728628|NCT05223010|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138728629|NCT05223010|Anesthetics, General|anesthetics, general|mesh-ancestor
138728630|NCT05223010|Anesthetics|anesthetics|mesh-ancestor
138728631|NCT05223010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138728632|NCT05223010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728633|NCT05223010|Antioxidants|antioxidants|mesh-ancestor
138728634|NCT05223010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728635|NCT05223010|Protective Agents|protective agents|mesh-ancestor
138728636|NCT05181592|Luspatercept|luspatercept|mesh-list
138728637|NCT05181592|Hematinics|hematinics|mesh-ancestor
138728639|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138728640|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728641|NCT05169554|Amoxicillin|amoxicillin|mesh-list
138728642|NCT05169554|Clarithromycin|clarithromycin|mesh-list
138728643|NCT05169554|Rifampin|rifampin|mesh-list
138728644|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
138728645|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
138728646|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138728647|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138728648|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138728649|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138728650|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728651|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728652|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138728663|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138728664|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138728665|NCT05154994|Durvalumab|durvalumab|mesh-list
138728666|NCT05154994|Belinostat|belinostat|mesh-list
138728667|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
138579561|NCT00489658|Nifurtimox|nifurtimox|mesh-list
138728668|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138728669|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
138728670|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728671|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728672|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
138728673|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728674|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138728675|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728676|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728677|NCT05128162|Psilocybin|psilocybin|mesh-list
138728678|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
138728679|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728680|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138728682|NCT05117554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138728683|NCT05117554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138728684|NCT05117554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138728685|NCT05117554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728686|NCT05117554|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138728687|NCT05117554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138728688|NCT05117554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138728689|NCT05117554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138728690|NCT05117554|Anesthetics, General|anesthetics, general|mesh-ancestor
138728691|NCT05117554|Anesthetics|anesthetics|mesh-ancestor
138728692|NCT05117554|GABA Modulators|gaba modulators|mesh-ancestor
138728693|NCT05117554|GABA Agents|gaba agents|mesh-ancestor
138728694|NCT05117554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138728695|NCT05117554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728696|NCT05112952|Lazertinib|lazertinib|mesh-list
138728697|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138728698|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728699|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728700|NCT05101356|Pembrolizumab|pembrolizumab|mesh-list
138728701|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
138728702|NCT05101356|Vaccines|vaccines|mesh-list
138728703|NCT05101356|Sargramostim|sargramostim|mesh-list
138728704|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
138728705|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728706|NCT05101356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728707|NCT05101356|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138728708|NCT05101356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728710|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138728711|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728712|NCT05088876|Acetaminophen|acetaminophen|mesh-list
138728713|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138728714|NCT05088876|Analgesics|analgesics|mesh-ancestor
138728715|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
138685052|NCT00520949|Bismuth|bismuth|mesh-list
138728736|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138728737|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728738|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
138728739|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728740|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138728741|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138728742|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138728743|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138728744|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728746|NCT04902443|Pomalidomide|pomalidomide|mesh-list
138728747|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728748|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728749|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138728750|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728751|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
138728752|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728753|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138728754|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138728755|NCT04902443|Growth Substances|growth substances|mesh-ancestor
138728756|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
138728757|NCT04879368|Trifluridine|trifluridine|mesh-list
138728758|NCT04879368|Paclitaxel|paclitaxel|mesh-list
138728759|NCT04879368|Docetaxel|docetaxel|mesh-list
138728760|NCT04879368|Nivolumab|nivolumab|mesh-list
138728761|NCT04879368|Irinotecan|irinotecan|mesh-list
138728762|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138728763|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728764|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
138728765|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
138728766|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
138728767|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728768|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728769|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138728770|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138728784|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138728785|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138728786|NCT04852224|Leuprolide|leuprolide|mesh-list
138728787|NCT04852224|Goserelin|goserelin|mesh-list
138728788|NCT04852224|Androgens|androgens|mesh-list
138728789|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138728790|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
138728791|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138728792|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728793|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138728794|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728795|NCT04852224|Hormones|hormones|mesh-ancestor
138728796|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138728797|NCT04833114|Carboplatin|carboplatin|mesh-list
138728798|NCT04833114|Etoposide|etoposide|mesh-list
138728799|NCT04833114|Rituximab|rituximab|mesh-list
138728800|NCT04833114|Ifosfamide|ifosfamide|mesh-list
138728801|NCT04833114|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138728802|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728803|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138728804|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138728805|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138728806|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728807|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728808|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728809|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
138728810|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548125|NCT00239395|Meloxicam|meloxicam|mesh-list
138728811|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138728812|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138728814|NCT04833114|Immunoconjugates|immunoconjugates|mesh-ancestor
138728815|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
138728816|NCT04812535|Vilobelimab|vilobelimab|mesh-list
138728817|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728818|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728819|NCT04812535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138728820|NCT04812535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728821|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138728822|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138728823|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
138579596|NCT00489775|Analgesics|analgesics|mesh-ancestor
138728824|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728825|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
138728826|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138728827|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728828|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138728829|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728830|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
138728831|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728832|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728833|NCT04725331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138728860|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
138728861|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138728862|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
138728863|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728864|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068344|NCT01304602|Irinotecan|irinotecan|mesh-list
138728865|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138728866|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
138728867|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728868|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728869|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138728870|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728871|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138728872|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138728873|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138728874|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728875|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138728876|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
138728877|NCT04660799|Hormones|hormones|mesh-ancestor
138728878|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138728879|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138728880|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138728881|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
138728882|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
138728883|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
138728906|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
138728907|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728908|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138728909|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
138728910|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138728911|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138728912|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728913|NCT04640779|Salicylates|salicylates|mesh-list
138728914|NCT04640779|Choline|choline|mesh-list
138728915|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
138728916|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138728917|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
138728918|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728919|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138728920|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138728921|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
138728922|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138728923|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138579610|NCT00489892|Modafinil|modafinil|mesh-list
138728924|NCT04640779|Analgesics|analgesics|mesh-ancestor
138728925|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
138728926|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728927|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728928|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138728929|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138728930|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138728931|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728932|NCT04598321|Talazoparib|talazoparib|mesh-list
138728933|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138728934|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728935|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728936|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728937|NCT04564898|Trifluridine|trifluridine|mesh-list
138728938|NCT04564898|Bevacizumab|bevacizumab|mesh-list
138728939|NCT04564898|Capecitabine|capecitabine|mesh-list
138728940|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728941|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728951|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138728952|NCT04523701|SMOFlipid|smoflipid|mesh-list
138728953|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138548128|NCT00239395|Analgesics|analgesics|mesh-ancestor
138728954|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138728956|NCT04477850|Luspatercept|luspatercept|mesh-list
138728957|NCT04477850|Hematinics|hematinics|mesh-ancestor
138728958|NCT04471233|Pregabalin|pregabalin|mesh-list
138728959|NCT04471233|Analgesics|analgesics|mesh-ancestor
138728960|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
138728961|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138728962|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728964|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138728965|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138728966|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728967|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138728968|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138728969|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138728970|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138728971|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138728972|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138728973|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
138728974|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
138728975|NCT04391049|Paclitaxel|paclitaxel|mesh-list
138728976|NCT04391049|Carboplatin|carboplatin|mesh-list
138728977|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138728978|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138728979|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728980|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
138728981|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
138728982|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
138728983|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728984|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
138728985|NCT04370509|Axitinib|axitinib|mesh-list
138728986|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138728987|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138728988|NCT04370509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138728989|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138728990|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138728991|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138728993|NCT04355572|Vitamins|vitamins|mesh-ancestor
138728994|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
138728995|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138728996|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138728997|NCT04312659|Infliximab|infliximab|mesh-list
138728998|NCT04312659|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138728999|NCT04312659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138729000|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
138729001|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138729002|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138729003|NCT04245397|Decitabine|decitabine|mesh-list
138729004|NCT04245397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138729005|NCT04245397|Antimetabolites|antimetabolites|mesh-ancestor
138729006|NCT04245397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729007|NCT04245397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729008|NCT04245397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729021|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729022|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138729023|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
138729024|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
138729025|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729026|NCT04151342|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138729027|NCT04151342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138729029|NCT04151342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729031|NCT04116112|Hydralazine|hydralazine|mesh-list
138729032|NCT04116112|Nicardipine|nicardipine|mesh-list
138729033|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138729034|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138729035|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
138729036|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138729037|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729038|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729039|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138729040|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
138729041|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
138729042|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729043|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138729044|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138729045|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
138729046|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138729047|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138729048|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138729049|NCT04077684|Interleukin-2|interleukin-2|mesh-list
138729050|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729051|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138729052|NCT04077684|Analgesics|analgesics|mesh-ancestor
138729053|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
138729054|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729055|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729056|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
138729057|NCT04027972|Neostigmine|neostigmine|mesh-list
138729058|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138729059|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729060|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729061|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
138729062|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138729063|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729064|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138729065|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
138729066|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729067|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138729068|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138729069|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138729071|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
138729072|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729073|NCT04013854|Nivolumab|nivolumab|mesh-list
138729074|NCT04013854|Ipilimumab|ipilimumab|mesh-list
138729090|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729092|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
138729093|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138729094|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
138729096|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138729097|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729098|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138729099|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729100|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138729101|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729102|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729103|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
138729104|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138729105|NCT03821246|Atezolizumab|atezolizumab|mesh-list
138729106|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138729107|NCT03821246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138685418|NCT00523757|Spironolactone|spironolactone|mesh-list
138729108|NCT03821246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729109|NCT03821246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729110|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729111|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
138729112|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729113|NCT03806985|Psilocybin|psilocybin|mesh-list
138729114|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
138729115|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729116|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138729117|NCT03739411|Temozolomide|temozolomide|mesh-list
138729118|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138729119|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
138729120|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729121|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729122|NCT03721653|Leucovorin|leucovorin|mesh-list
138729123|NCT03721653|Bevacizumab|bevacizumab|mesh-list
138729124|NCT03721653|Atezolizumab|atezolizumab|mesh-list
138729125|NCT03721653|Fluorouracil|fluorouracil|mesh-list
138729126|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
138729127|NCT03721653|Irinotecan|irinotecan|mesh-list
138729128|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
138729129|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729130|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729131|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138729132|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138729133|NCT03721653|Growth Substances|growth substances|mesh-ancestor
138729134|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729145|NCT03721653|Protective Agents|protective agents|mesh-ancestor
138729146|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
138729147|NCT03721653|Vitamins|vitamins|mesh-ancestor
138729148|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
138729149|NCT03721653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138729150|NCT03709992|Tamsulosin|tamsulosin|mesh-list
138729151|NCT03709992|Trospium chloride|trospium chloride|mesh-list
138729152|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138729153|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138729154|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138729155|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
138729156|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138729157|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729158|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729159|NCT03709992|Urological Agents|urological agents|mesh-ancestor
138729160|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
138729162|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729163|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138729164|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138729165|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
138729166|NCT03606499|Ustekinumab|ustekinumab|mesh-list
138729167|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
138729168|NCT03570632|Metformin|metformin|mesh-list
138729169|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138729170|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729171|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-list
138729172|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
138729173|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138729174|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
138729175|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138729176|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729177|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729178|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
138729179|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
138729180|NCT03511664|177Lu-PSMA-617|177lu-psma-617|mesh-list
138729181|NCT03511664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138729182|NCT03511664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729183|NCT03490760|Durvalumab|durvalumab|mesh-list
138729184|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729185|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729186|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138729187|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
138729188|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729189|NCT03341689|Psilocybin|psilocybin|mesh-list
138729190|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
138729191|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729192|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138729193|NCT03307746|Rituximab|rituximab|mesh-list
138729194|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729195|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729196|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
138729197|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729198|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138729199|NCT03287908|Dexamethasone|dexamethasone|mesh-list
138729200|NCT03287908|Pomalidomide|pomalidomide|mesh-list
138729201|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138729210|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138729211|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729212|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
138729213|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138729214|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138729215|NCT03287908|Growth Substances|growth substances|mesh-ancestor
138729216|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
138729218|NCT03266991|Rifapentine|rifapentine|mesh-list
138729219|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
138729220|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138729221|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138729222|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138729223|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138729224|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
138729225|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729226|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138729227|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138729228|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
138729229|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138729230|NCT03104855|Calcifediol|calcifediol|mesh-list
138729231|NCT03104855|Vitamins|vitamins|mesh-ancestor
138729232|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
138729233|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729234|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138729235|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
138729236|NCT03089905|Remifentanil|remifentanil|mesh-list
138729237|NCT03089905|Sevoflurane|sevoflurane|mesh-list
138729238|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138729239|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138729240|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729241|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138729243|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
138729244|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729245|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138729246|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138729247|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138729248|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
138729249|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138729250|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729251|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138729252|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138579719|NCT00122291|Capecitabine|capecitabine|mesh-list
138729253|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
138729254|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
138729255|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138729256|NCT03089905|Narcotics|narcotics|mesh-ancestor
138729257|NCT02981329|Metformin|metformin|mesh-list
138729258|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138729259|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729260|NCT02921256|Leucovorin|leucovorin|mesh-list
138729261|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
138729262|NCT02921256|Capecitabine|capecitabine|mesh-list
138729263|NCT02921256|Fluorouracil|fluorouracil|mesh-list
138729264|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
138729265|NCT02921256|Veliparib|veliparib|mesh-list
138729266|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729267|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729268|NCT02921256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138729269|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655284|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
138729284|NCT02757885|Fludarabine|fludarabine|mesh-list
138729285|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
138729286|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
138729287|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138729288|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
138729289|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138729290|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
138729291|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729292|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138729293|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138729294|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
138729295|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729296|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729297|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138729298|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138729299|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
138729300|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
138729301|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729302|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138729303|NCT02703623|Prednisone|prednisone|mesh-list
138729304|NCT02703623|Cortisone|cortisone|mesh-list
138729305|NCT02703623|Carboplatin|carboplatin|mesh-list
138729306|NCT02703623|Ipilimumab|ipilimumab|mesh-list
138729307|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
138729308|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729309|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138729310|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
138729311|NCT02703623|Hormones|hormones|mesh-ancestor
138729312|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138729313|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729314|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138729315|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729316|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138729317|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729318|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138729319|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729320|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
138729321|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138729322|NCT02654119|Paclitaxel|paclitaxel|mesh-list
138729323|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
138729324|NCT02654119|Trastuzumab|trastuzumab|mesh-list
138729325|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138729326|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138729327|NCT02654119|Antibodies|antibodies|mesh-list
138729328|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
138729329|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138729330|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138729331|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729332|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
138655294|NCT00317330|Rifampin|rifampin|mesh-list
138729359|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
138729360|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
138729361|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729362|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729363|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138729364|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
138729365|NCT02400242|Hormones|hormones|mesh-ancestor
138729366|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138729367|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138729368|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729369|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
138729370|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138729371|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138729372|NCT02400242|Growth Substances|growth substances|mesh-ancestor
138729373|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
138729374|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729375|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729376|NCT02397720|Nivolumab|nivolumab|mesh-list
138729377|NCT02397720|Ipilimumab|ipilimumab|mesh-list
138729378|NCT02397720|Azacitidine|azacitidine|mesh-list
138729379|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729398|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
138729399|NCT02158091|Rituximab|rituximab|mesh-list
138729400|NCT02158091|Fludarabine|fludarabine|mesh-list
138729401|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138729402|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
138729403|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729404|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138729405|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138729406|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
138729407|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729408|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729409|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138729410|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729411|NCT02057133|Tamoxifen|tamoxifen|mesh-list
138729412|NCT02057133|Trastuzumab|trastuzumab|mesh-list
138729413|NCT02057133|Pertuzumab|pertuzumab|mesh-list
138729414|NCT02057133|Everolimus|everolimus|mesh-list
138685718|NCT00526175|Vincristine|vincristine|mesh-list
138729415|NCT02057133|Letrozole|letrozole|mesh-list
138729416|NCT02057133|Fulvestrant|fulvestrant|mesh-list
138729417|NCT02057133|Anastrozole|anastrozole|mesh-list
138729418|NCT02057133|Exemestane|exemestane|mesh-list
138729419|NCT02057133|Loperamide|loperamide|mesh-list
138729420|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729421|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729422|NCT02057133|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138729423|NCT02057133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138729424|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729425|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729426|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138729427|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
138729428|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729429|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138729430|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138729431|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138729432|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
138729433|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138729434|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138729435|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138729436|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138729437|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138729438|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138729439|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
138729440|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138729441|NCT02054429|Insulin|insulin|mesh-list
138729442|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138729443|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138729444|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729445|NCT01460654|Alendronate|alendronate|mesh-list
138729468|NCT03021460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138729469|NCT03021460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729470|NCT03020199|Betamethasone|betamethasone|mesh-list
138729471|NCT03020199|Calcipotriene|calcipotriene|mesh-list
138729472|NCT03020199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138729473|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138729474|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
138729475|NCT03020199|Hormones|hormones|mesh-ancestor
138729476|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138729477|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068576|NCT05623540|Diphosphonates|diphosphonates|mesh-list
138729478|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138729479|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
138729480|NCT03020199|Immunologic Factors|immunologic factors|mesh-ancestor
138548194|NCT00239551|Lansoprazole|lansoprazole|mesh-list
138729481|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
138729482|NCT02926859|Cannabidiol|cannabidiol|mesh-list
138729483|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
138729484|NCT02876107|Paclitaxel|paclitaxel|mesh-list
138729485|NCT02876107|Carboplatin|carboplatin|mesh-list
138729486|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138729487|NCT02876107|Panitumumab|panitumumab|mesh-list
138729488|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138729489|NCT02876107|Antibodies|antibodies|mesh-list
138729490|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
138729491|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138729492|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138729493|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729494|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
138729495|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
138729496|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
138729497|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729506|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729508|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729509|NCT02831933|Valacyclovir|valacyclovir|mesh-list
138729510|NCT02831933|Nivolumab|nivolumab|mesh-list
138729511|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729512|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729513|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138729514|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729515|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
138729516|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138729517|NCT02763566|Letrozole|letrozole|mesh-list
138729518|NCT02763566|Fulvestrant|fulvestrant|mesh-list
138729519|NCT02763566|Anastrozole|anastrozole|mesh-list
138729520|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729521|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138729522|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138729523|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729524|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729525|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138729526|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
138729527|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138729528|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729529|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138729530|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138729531|NCT02760407|Adalimumab|adalimumab|mesh-list
138729532|NCT02760407|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138729533|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138729534|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138729535|NCT02747004|Tamoxifen|tamoxifen|mesh-list
138729536|NCT02747004|Loperamide|loperamide|mesh-list
138729537|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
138729538|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139068590|NCT01306318|Analgesics|analgesics|mesh-ancestor
138729539|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
138729540|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138729541|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729542|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138729543|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729544|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138729545|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138729546|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138729547|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138729549|NCT02741570|Carboplatin|carboplatin|mesh-list
138729550|NCT02741570|Fluorouracil|fluorouracil|mesh-list
138729551|NCT02741570|Nivolumab|nivolumab|mesh-list
138729552|NCT02741570|Cetuximab|cetuximab|mesh-list
138729553|NCT02741570|Ipilimumab|ipilimumab|mesh-list
138729554|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729555|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
138729556|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729557|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138729558|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138729559|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
138729560|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729561|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729562|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138729563|NCT02730416|Paclitaxel|paclitaxel|mesh-list
138729564|NCT02730416|Carboplatin|carboplatin|mesh-list
138729565|NCT02730416|Nintedanib|nintedanib|mesh-list
138729566|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138729581|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138729582|NCT02703610|Analgesics|analgesics|mesh-ancestor
138729583|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
138729584|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729585|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729586|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
138729587|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138729588|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138729589|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138729590|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138729591|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729592|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729593|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138729594|NCT02703610|Narcotics|narcotics|mesh-ancestor
138729595|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138729596|NCT02675231|Trastuzumab|trastuzumab|mesh-list
138729597|NCT02675231|Fulvestrant|fulvestrant|mesh-list
138729598|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729599|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729600|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138729601|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138729602|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138729603|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
138729604|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138729605|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729606|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
138729607|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
138729608|NCT02661035|Fludarabine|fludarabine|mesh-list
138729609|NCT02661035|Allopurinol|allopurinol|mesh-list
138729610|NCT02661035|Tacrolimus|tacrolimus|mesh-list
138729611|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138729612|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138729613|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
138729614|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729615|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138729616|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138729617|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
138729618|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729619|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729620|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138729621|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
138729622|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138729623|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729624|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138729625|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138729626|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
138729627|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138729655|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138729656|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
138729657|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138729658|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
138729659|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
138729660|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
138729661|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138729662|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138729663|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
138729664|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729665|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729666|NCT02603887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138729667|NCT02603887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729668|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138729669|NCT02581787|Antibodies|antibodies|mesh-list
138729670|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
138729671|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138729672|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
138729673|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
138729674|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729675|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729676|NCT02554279|Menotropins|menotropins|mesh-list
138729690|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
138729691|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
138729692|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
138729693|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729694|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138729696|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729697|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138729698|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138729699|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729701|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138729702|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
138729703|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729704|NCT02515773|Metformin|metformin|mesh-list
138729705|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138729706|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729707|NCT02484248|Ketotifen|ketotifen|mesh-list
138729708|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
138729709|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
138729710|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138729711|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
138729712|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
138729713|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138729714|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729715|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686022|NCT02945163|Tenofovir|tenofovir|mesh-list
138729716|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138729717|NCT02478788|Amphetamine|amphetamine|mesh-list
138729718|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138729719|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729720|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
138729721|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
138729722|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729723|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
138729724|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138729725|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729726|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
138729727|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138729728|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138729729|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138729730|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138729731|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138729732|NCT02456194|Calcium|calcium|mesh-list
138729733|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138729734|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729735|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138729736|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
138729737|NCT02439450|Nivolumab|nivolumab|mesh-list
138729738|NCT02439450|Pemetrexed|pemetrexed|mesh-list
138729739|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729740|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138655416|NCT00350181|Sirolimus|sirolimus|mesh-list
138729752|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138729753|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729754|NCT02403778|Ipilimumab|ipilimumab|mesh-list
138729755|NCT02403778|Tretinoin|tretinoin|mesh-list
138729756|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729757|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729758|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138729759|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729760|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
138729761|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
138729762|NCT02386826|Bevacizumab|bevacizumab|mesh-list
138579873|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138729763|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138729764|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729765|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138729766|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138729767|NCT02386826|Growth Substances|growth substances|mesh-ancestor
138729768|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729769|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
138729770|NCT02312258|Ixazomib|ixazomib|mesh-list
138729771|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729772|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
138729773|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729774|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729775|NCT02276274|Alogliptin|alogliptin|mesh-list
138729776|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138729777|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729778|NCT02276274|Incretins|incretins|mesh-ancestor
138729779|NCT02276274|Hormones|hormones|mesh-ancestor
138729780|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138729781|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138729782|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
138729783|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729784|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729785|NCT02199184|Prednisone|prednisone|mesh-list
138729787|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
138729788|NCT02199184|Rituximab|rituximab|mesh-list
138729789|NCT02199184|Doxorubicin|doxorubicin|mesh-list
138729790|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138729791|NCT02199184|Etoposide|etoposide|mesh-list
138729792|NCT02199184|Vincristine|vincristine|mesh-list
138729793|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
138729794|NCT02199184|Ofatumumab|ofatumumab|mesh-list
138729796|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138729797|NCT02199184|Antibodies|antibodies|mesh-list
138729798|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
138729799|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138729800|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138729801|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
138729802|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729803|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138655433|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729824|NCT02165007|Sirolimus|sirolimus|mesh-list
138729825|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138729826|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138729827|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138729828|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729829|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
139068729|NCT03790228|Pemetrexed|pemetrexed|mesh-list
138729830|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138729831|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
138729832|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729833|NCT02164734|Remifentanil|remifentanil|mesh-list
138729834|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138729835|NCT02164734|Narcotics|narcotics|mesh-ancestor
138729836|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138729837|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729838|NCT02164734|Analgesics|analgesics|mesh-ancestor
138729839|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
138729840|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729841|NCT02135133|Ofatumumab|ofatumumab|mesh-list
138729842|NCT02135133|Idelalisib|idelalisib|mesh-list
138729843|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729844|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729845|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729846|NCT02110069|Sirolimus|sirolimus|mesh-list
138729847|NCT02110069|Vincristine|vincristine|mesh-list
138729848|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138729849|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729850|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
138729851|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
138729852|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
138729853|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729854|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138729855|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138729856|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138729857|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
138729858|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138729859|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
138729884|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729886|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138729887|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
138729888|NCT02046460|Coagulants|coagulants|mesh-ancestor
138729889|NCT02004522|Ofatumumab|ofatumumab|mesh-list
138729890|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729891|NCT01959139|Leucovorin|leucovorin|mesh-list
138729892|NCT01959139|Fluorouracil|fluorouracil|mesh-list
138729893|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
138729894|NCT01959139|Irinotecan|irinotecan|mesh-list
138729895|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
138729896|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729897|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
138729898|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729899|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138729900|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729901|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138729902|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
138729903|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138729904|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138729905|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729906|NCT01959139|Antidotes|antidotes|mesh-ancestor
138729907|NCT01959139|Protective Agents|protective agents|mesh-ancestor
138729908|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
138729909|NCT01959139|Vitamins|vitamins|mesh-ancestor
138729910|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
138729911|NCT01932697|Docetaxel|docetaxel|mesh-list
138729912|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729913|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
138729914|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
138729916|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579938|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138729933|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729934|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138729935|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138729936|NCT01724346|Chlorambucil|chlorambucil|mesh-list
138729937|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138729938|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
138729939|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729941|NCT01659658|Thalidomide|thalidomide|mesh-list
138729942|NCT01659658|Dexamethasone|dexamethasone|mesh-list
138729943|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
138729944|NCT01659658|Melphalan|melphalan|mesh-list
138686242|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
138729945|NCT01659658|Lenalidomide|lenalidomide|mesh-list
138729946|NCT01659658|Ixazomib|ixazomib|mesh-list
138729947|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138729948|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
138729949|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138729950|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138729951|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138729952|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
138729953|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138729954|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138729955|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138729956|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138729957|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
138729958|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
138729959|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138729960|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138729961|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
138729962|NCT01659658|Hormones|hormones|mesh-ancestor
138729963|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138729964|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138729965|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138729966|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138729967|NCT01659658|Growth Substances|growth substances|mesh-ancestor
138729968|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
138729969|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
138729970|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138729971|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138729972|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
138729973|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138729974|NCT01523977|Prednisone|prednisone|mesh-list
138729975|NCT01523977|Doxorubicin|doxorubicin|mesh-list
138729976|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
138729977|NCT01523977|Vincristine|vincristine|mesh-list
138729978|NCT01523977|Everolimus|everolimus|mesh-list
138729979|NCT01523977|Asparaginase|asparaginase|mesh-list
138730008|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730009|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138730010|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138730011|NCT01517243|Growth Substances|growth substances|mesh-ancestor
138730012|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730013|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
138730014|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138730015|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730016|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730017|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730018|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
138730019|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138730020|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730021|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138730022|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
138730024|NCT01357161|Carboplatin|carboplatin|mesh-list
138730025|NCT01357161|Adavosertib|adavosertib|mesh-list
138730026|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138730027|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730028|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
138730029|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
138730063|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138730065|NCT01190930|Vincristine|vincristine|mesh-list
138730066|NCT01190930|Asparaginase|asparaginase|mesh-list
138730067|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
138730068|NCT01190930|Pegaspargase|pegaspargase|mesh-list
138730069|NCT01190930|Thioguanine|thioguanine|mesh-list
138730070|NCT01190930|BB 1101|bb 1101|mesh-list
138730071|NCT01190930|Calcium|calcium|mesh-list
138730072|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
138730074|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730075|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
138730076|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730077|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138730078|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138730079|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
138730108|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730109|NCT01190930|Antidotes|antidotes|mesh-ancestor
138730110|NCT01190930|Protective Agents|protective agents|mesh-ancestor
138730111|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
138730112|NCT01190930|Vitamins|vitamins|mesh-ancestor
138730113|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
138730114|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138730115|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
138730116|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
138730117|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
138730118|NCT01190930|Hematinics|hematinics|mesh-ancestor
138730119|NCT01169259|Vitamin D|vitamin d|mesh-list
138730120|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
138730121|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
138730122|NCT01169259|Vitamins|vitamins|mesh-list
138730123|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
138730124|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730125|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138655561|NCT00345735|Fentanyl|fentanyl|mesh-list
138730132|NCT01007578|Paclitaxel|paclitaxel|mesh-list
138730133|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138730134|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730135|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
138730136|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
138730137|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
138730138|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730139|NCT00707473|Cisplatin|cisplatin|mesh-list
138730141|NCT00707473|Docetaxel|docetaxel|mesh-list
138730142|NCT00707473|Fluorouracil|fluorouracil|mesh-list
138730143|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730144|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
138730145|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
138730146|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
138730147|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730148|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
138730149|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138730150|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730151|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
138730152|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730153|NCT00648648|Carboplatin|carboplatin|mesh-list
138730154|NCT00648648|Gemcitabine|gemcitabine|mesh-list
138730155|NCT00648648|Adavosertib|adavosertib|mesh-list
138730156|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730157|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138730158|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
138730159|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730160|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730161|NCT00608725|Propranolol|propranolol|mesh-list
138580088|NCT00493987|Hormones|hormones|mesh-ancestor
138730162|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138730163|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138730164|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
138730165|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730166|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730167|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730168|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138730169|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138730170|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
138730172|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
138730173|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138730174|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138730175|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138730176|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730177|NCT00536172|Escitalopram|escitalopram|mesh-list
138730178|NCT00536172|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138730179|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138730180|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138730181|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730182|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730184|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730185|NCT00003838|Cyclosporine|cyclosporine|mesh-list
138730186|NCT00003838|Methotrexate|methotrexate|mesh-list
138730187|NCT00003838|Cyclosporins|cyclosporins|mesh-list
138730188|NCT00003838|Lenograstim|lenograstim|mesh-list
138730189|NCT00003838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138730190|NCT00003838|Abortifacient Agents|abortifacient agents|mesh-ancestor
138730191|NCT00003838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138730192|NCT00003838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730193|NCT00003838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138730194|NCT00003838|Antimetabolites|antimetabolites|mesh-ancestor
138730195|NCT00003838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730221|NCT06031376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730222|NCT06031363|Indomethacin|indomethacin|mesh-list
138730223|NCT06031363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138730224|NCT06031363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138730226|NCT06031363|Sensory System Agents|sensory system agents|mesh-ancestor
138730227|NCT06031363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730228|NCT06031363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730229|NCT06031363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138730230|NCT06031363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138730231|NCT06031363|Gout Suppressants|gout suppressants|mesh-ancestor
138730232|NCT06031363|Tocolytic Agents|tocolytic agents|mesh-ancestor
138730233|NCT06031363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138730234|NCT06031363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138730235|NCT06031363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730236|NCT06031363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730237|NCT06031285|Bevacizumab|bevacizumab|mesh-list
138730238|NCT06031285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138730239|NCT06031285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730240|NCT06031285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138730241|NCT06031285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138730242|NCT06031285|Growth Substances|growth substances|mesh-ancestor
138730243|NCT06031285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730260|NCT06031233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730261|NCT06031168|Metformin|metformin|mesh-list
138730262|NCT06031168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138730263|NCT06031168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730264|NCT06031129|Butorphanol|butorphanol|mesh-list
138580170|NCT00127010|Vaccines|vaccines|mesh-list
138730265|NCT06031129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138730266|NCT06031129|Narcotics|narcotics|mesh-ancestor
138730267|NCT06031129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138730268|NCT06031129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730269|NCT06031129|Analgesics|analgesics|mesh-ancestor
138730270|NCT06031129|Sensory System Agents|sensory system agents|mesh-ancestor
138730271|NCT06031129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730272|NCT06031129|Antitussive Agents|antitussive agents|mesh-ancestor
138730273|NCT06031129|Respiratory System Agents|respiratory system agents|mesh-ancestor
138730274|NCT06031129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138730276|NCT06031090|Granisetron|granisetron|mesh-list
138730277|NCT06031090|Analgesics|analgesics|mesh-ancestor
138730278|NCT06031090|Sensory System Agents|sensory system agents|mesh-ancestor
138730279|NCT06031090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730280|NCT06031090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730281|NCT06031090|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138730282|NCT06031090|Sympatholytics|sympatholytics|mesh-ancestor
138730283|NCT06031090|Autonomic Agents|autonomic agents|mesh-ancestor
138730284|NCT06031090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138730285|NCT06031090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138730286|NCT06031090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138730287|NCT06031090|Adrenergic Agents|adrenergic agents|mesh-ancestor
138730288|NCT06031090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730289|NCT06031090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730290|NCT06031090|Antiemetics|antiemetics|mesh-ancestor
138730291|NCT06031090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138730292|NCT06031090|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138730293|NCT06031090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138730294|NCT06031090|Serotonin Agents|serotonin agents|mesh-ancestor
138730295|NCT06031012|Thalidomide|thalidomide|mesh-list
138730296|NCT06031012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730297|NCT06031012|Immunologic Factors|immunologic factors|mesh-ancestor
138730298|NCT06031012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730299|NCT06031012|Leprostatic Agents|leprostatic agents|mesh-ancestor
138730300|NCT06031012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138730301|NCT06031012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730302|NCT06031012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138730303|NCT06031012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138730304|NCT06031012|Growth Substances|growth substances|mesh-ancestor
138655623|NCT00318773|Sertraline|sertraline|mesh-list
138580212|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
138730323|NCT06030557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138730324|NCT06030557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138730325|NCT06030557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730326|NCT06030557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730327|NCT06030557|Antiviral Agents|antiviral agents|mesh-ancestor
138730328|NCT06030557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730329|NCT06030557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138730330|NCT06030557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138686625|NCT00531323|Etravirine|etravirine|mesh-list
138730331|NCT06030492|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138730332|NCT06030492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138730333|NCT06030492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548334|NCT00240448|Valsartan|valsartan|mesh-list
138730334|NCT06030479|Epinephrine|epinephrine|mesh-list
138730335|NCT06030479|Racepinephrine|racepinephrine|mesh-list
138730336|NCT06030479|Epinephryl borate|epinephryl borate|mesh-list
138730337|NCT06030479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138730338|NCT06030479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138730339|NCT06030479|Adrenergic Agents|adrenergic agents|mesh-ancestor
138730340|NCT06030479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730341|NCT06030479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730342|NCT06030479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730343|NCT06030479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138730344|NCT06030479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138730345|NCT06030479|Autonomic Agents|autonomic agents|mesh-ancestor
138730346|NCT06030479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730347|NCT06030479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138580283|NCT00495781|Iron|iron|mesh-list
138730348|NCT06030479|Respiratory System Agents|respiratory system agents|mesh-ancestor
138730349|NCT06030479|Mydriatics|mydriatics|mesh-ancestor
138730350|NCT06030479|Sympathomimetics|sympathomimetics|mesh-ancestor
138730351|NCT06030479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138730352|NCT06029179|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
138730353|NCT06029179|Chelating Agents|chelating agents|mesh-ancestor
138730354|NCT06029179|Sequestering Agents|sequestering agents|mesh-ancestor
138730355|NCT06029179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730356|NCT06027528|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138730357|NCT06027528|Hemostatics|hemostatics|mesh-ancestor
138730358|NCT06027528|Coagulants|coagulants|mesh-ancestor
138730359|NCT06027099|Tizanidine|tizanidine|mesh-list
138730373|NCT06027099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730374|NCT06027099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730375|NCT06026358|Tirbanibulin|tirbanibulin|mesh-list
138730376|NCT06026358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730377|NCT06026358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730378|NCT06021275|Insulin|insulin|mesh-list
138730379|NCT06021275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138730380|NCT06021275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138730381|NCT06021275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730382|NCT06014073|Cyclophosphamide|cyclophosphamide|mesh-list
138730383|NCT06014073|Fludarabine|fludarabine|mesh-list
138730384|NCT06014073|Fludarabine phosphate|fludarabine phosphate|mesh-list
138730385|NCT06014073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730386|NCT06014073|Immunologic Factors|immunologic factors|mesh-ancestor
138580295|NCT00405405|Growth Substances|growth substances|mesh-ancestor
138730387|NCT06014073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068877|NCT01038167|Tacrolimus|tacrolimus|mesh-list
138730388|NCT06014073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138730389|NCT06014073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138730390|NCT06014073|Alkylating Agents|alkylating agents|mesh-ancestor
138730391|NCT06014073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730392|NCT06014073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730393|NCT06014073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138730394|NCT06014073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138730395|NCT06014073|Antimetabolites|antimetabolites|mesh-ancestor
138730396|NCT06013319|Esmolol|esmolol|mesh-list
138548342|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
138730397|NCT06013319|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138730398|NCT06013319|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138730399|NCT06013319|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138730400|NCT06013319|Adrenergic Agents|adrenergic agents|mesh-ancestor
138730401|NCT06013319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730402|NCT06013319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730403|NCT06013319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730404|NCT05975060|Vaccines|vaccines|mesh-list
138730405|NCT05975060|Immunologic Factors|immunologic factors|mesh-ancestor
138730406|NCT05975060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730407|NCT05931965|Vitamin B 12|vitamin b 12|mesh-list
138730408|NCT05931965|Hydroxocobalamin|hydroxocobalamin|mesh-list
138730410|NCT05931965|Micronutrients|micronutrients|mesh-ancestor
138730411|NCT05931965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730412|NCT05931965|Vitamin B Complex|vitamin b complex|mesh-ancestor
138730413|NCT05931965|Hematinics|hematinics|mesh-ancestor
138730414|NCT05903339|MEDI9197|medi9197|mesh-list
138730415|NCT05903339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138730416|NCT05903339|Immunologic Factors|immunologic factors|mesh-ancestor
138730417|NCT05903339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730418|NCT05898672|Ritonavir|ritonavir|mesh-list
138730419|NCT05898672|Nirmatrelvir|nirmatrelvir|mesh-list
138730420|NCT05898672|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
138730421|NCT05898672|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138655649|NCT00319007|Sulindac|sulindac|mesh-list
138730432|NCT05898672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138730434|NCT05898672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138730435|NCT05898672|Antimetabolites|antimetabolites|mesh-ancestor
138730436|NCT05898672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138730437|NCT05898672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138730438|NCT05897554|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138730439|NCT05897554|Plasminogen|plasminogen|mesh-list
138730440|NCT05897554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138730441|NCT05897554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138730442|NCT05897554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730443|NCT05856994|Tacrolimus|tacrolimus|mesh-list
138730444|NCT05856994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730445|NCT05856994|Immunologic Factors|immunologic factors|mesh-ancestor
138730446|NCT05856994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730447|NCT05856994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138730448|NCT05856994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730449|NCT05856994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730450|NCT05846399|Amoxicillin|amoxicillin|mesh-list
138730451|NCT05846399|Ciprofloxacin|ciprofloxacin|mesh-list
138730452|NCT05846399|Clindamycin|clindamycin|mesh-list
138730453|NCT05846399|Clindamycin palmitate|clindamycin palmitate|mesh-list
138730454|NCT05846399|Clindamycin phosphate|clindamycin phosphate|mesh-list
138730455|NCT05846399|Clavulanic Acid|clavulanic acid|mesh-list
139068892|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
138730456|NCT05846399|Clavulanic Acids|clavulanic acids|mesh-list
138730457|NCT05846399|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138730458|NCT05846399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138730459|NCT05846399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730460|NCT05846399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138730461|NCT05846399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138730462|NCT05846399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730463|NCT05846399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730464|NCT05846399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730465|NCT05846399|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138730466|NCT05846399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138730467|NCT05846399|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138730468|NCT05846399|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138730470|NCT05842759|Propofol|propofol|mesh-list
138730471|NCT05842759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138730472|NCT05842759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138730473|NCT05842759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730474|NCT05842759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138730475|NCT05842759|Anesthetics, General|anesthetics, general|mesh-ancestor
138730476|NCT05842759|Anesthetics|anesthetics|mesh-ancestor
138730477|NCT05842759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138730478|NCT05842759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138730479|NCT05842759|Adrenergic Agents|adrenergic agents|mesh-ancestor
138730480|NCT05842759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730481|NCT05842759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730482|NCT05842759|Sympathomimetics|sympathomimetics|mesh-ancestor
138730483|NCT05842759|Autonomic Agents|autonomic agents|mesh-ancestor
138730484|NCT05842759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655662|NCT00350961|Gemcitabine|gemcitabine|mesh-list
138730496|NCT05779007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138730497|NCT05779007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138730498|NCT05779007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138730500|NCT05731323|Cycloserine|cycloserine|mesh-list
138730501|NCT05731323|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138730502|NCT05731323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730503|NCT05731323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138730504|NCT05731323|Antitubercular Agents|antitubercular agents|mesh-ancestor
138730505|NCT05731323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138730506|NCT05731323|Antimetabolites|antimetabolites|mesh-ancestor
138730507|NCT05731323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730508|NCT05646563|Eculizumab|eculizumab|mesh-list
138730509|NCT05646563|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138730510|NCT05646563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730511|NCT05646563|Immunologic Factors|immunologic factors|mesh-ancestor
138730512|NCT05646563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730513|NCT05629260|Cyclophosphamide|cyclophosphamide|mesh-list
138730514|NCT05629260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730515|NCT05629260|Immunologic Factors|immunologic factors|mesh-ancestor
138730516|NCT05629260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730517|NCT05629260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138730518|NCT05629260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138730519|NCT05629260|Alkylating Agents|alkylating agents|mesh-ancestor
138730520|NCT05629260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730521|NCT05629260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730522|NCT05629260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138730524|NCT05615012|Metformin|metformin|mesh-list
138730525|NCT05615012|Methotrexate|methotrexate|mesh-list
138730526|NCT05615012|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138730527|NCT05615012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138730528|NCT05615012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580414|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
138730529|NCT05615012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138730530|NCT05615012|Abortifacient Agents|abortifacient agents|mesh-ancestor
138730531|NCT05615012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138730532|NCT05615012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138730533|NCT05615012|Antimetabolites|antimetabolites|mesh-ancestor
138730534|NCT05615012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730535|NCT05615012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730536|NCT05615012|Dermatologic Agents|dermatologic agents|mesh-ancestor
138730537|NCT05615012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730538|NCT05615012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138730539|NCT05615012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730540|NCT05615012|Immunologic Factors|immunologic factors|mesh-ancestor
138730541|NCT05615012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138730542|NCT05615012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138730543|NCT05615012|Antidotes|antidotes|mesh-ancestor
138730544|NCT05615012|Protective Agents|protective agents|mesh-ancestor
138730545|NCT05615012|Vitamin B Complex|vitamin b complex|mesh-ancestor
138730546|NCT05615012|Vitamins|vitamins|mesh-ancestor
138730547|NCT05615012|Micronutrients|micronutrients|mesh-ancestor
138655676|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
138730556|NCT05511623|Tislelizumab|tislelizumab|mesh-list
138730557|NCT05511623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138730558|NCT05511623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730559|NCT05465317|Empagliflozin|empagliflozin|mesh-list
138730560|NCT05465317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138730562|NCT05465317|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138730563|NCT05465317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730564|NCT05465317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138730565|NCT05465317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730566|NCT05465317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138730567|NCT05465317|Hormones|hormones|mesh-ancestor
138730568|NCT05465317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138730569|NCT05465317|Incretins|incretins|mesh-ancestor
138730570|NCT05405270|Imiquimod|imiquimod|mesh-list
138730571|NCT05405270|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138580451|NCT00497497|Cetuximab|cetuximab|mesh-list
138730572|NCT05405270|Immunologic Factors|immunologic factors|mesh-ancestor
138730573|NCT05405270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730574|NCT05405270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730575|NCT05405270|Interferon Inducers|interferon inducers|mesh-ancestor
138730576|NCT05338190|Rituximab|rituximab|mesh-list
138730577|NCT05338190|Belimumab|belimumab|mesh-list
138730578|NCT05338190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138730579|NCT05338190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730580|NCT05338190|Immunologic Factors|immunologic factors|mesh-ancestor
138730581|NCT05338190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730582|NCT05338190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138730583|NCT05338190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730584|NCT05287503|Ambroxol|ambroxol|mesh-list
138730585|NCT05287503|Expectorants|expectorants|mesh-ancestor
138730586|NCT05287503|Respiratory System Agents|respiratory system agents|mesh-ancestor
138730587|NCT05263908|Ritonavir|ritonavir|mesh-list
138730588|NCT05263908|Nirmatrelvir|nirmatrelvir|mesh-list
138730589|NCT05263908|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
138730590|NCT05263908|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138730591|NCT05263908|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138548381|NCT00066092|Lenograstim|lenograstim|mesh-list
138730592|NCT05263908|Protease Inhibitors|protease inhibitors|mesh-ancestor
138730593|NCT05263908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730594|NCT05263908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730595|NCT05263908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138730596|NCT05263908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138730597|NCT05263908|Antiviral Agents|antiviral agents|mesh-ancestor
138730598|NCT05263908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730599|NCT05263908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138730600|NCT05263908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138730601|NCT05227001|Camphor|camphor|mesh-list
138730602|NCT05227001|Menthol|menthol|mesh-list
138730603|NCT05227001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138730604|NCT05227001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730605|NCT05227001|Antipruritics|antipruritics|mesh-ancestor
138730606|NCT05227001|Dermatologic Agents|dermatologic agents|mesh-ancestor
138730607|NCT05212571|Ketamine|ketamine|mesh-list
138730608|NCT05212571|Esketamine|esketamine|mesh-list
138730609|NCT05212571|Analgesics|analgesics|mesh-ancestor
138730610|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
138730611|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730612|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730613|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138730614|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138730632|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730633|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730634|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138730635|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
138730636|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138730637|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730638|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138730639|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
138730640|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138730641|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138730642|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138730644|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138730645|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
138730646|NCT05198050|Urological Agents|urological agents|mesh-ancestor
138730647|NCT05189223|Buprenorphine|buprenorphine|mesh-list
138730648|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138730649|NCT05189223|Narcotics|narcotics|mesh-ancestor
138730650|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138730651|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730652|NCT05189223|Analgesics|analgesics|mesh-ancestor
138730653|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
138730654|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730655|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138730656|NCT05176418|Nicotine|nicotine|mesh-list
138730657|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138730658|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
138730659|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730660|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730661|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138730662|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138730663|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
138730664|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730665|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730666|NCT05130060|Trifluridine|trifluridine|mesh-list
138730667|NCT05130060|Vaccines|vaccines|mesh-list
138730668|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
138730669|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730670|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
138730671|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730672|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
138730673|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730674|NCT05114486|Pilocarpine|pilocarpine|mesh-list
138730684|NCT05058976|Vitamin D|vitamin d|mesh-list
138730685|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
138730686|NCT05058976|Calcium|calcium|mesh-list
138730687|NCT05058976|Vitamins|vitamins|mesh-ancestor
138730688|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
138730689|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730690|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138730691|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138730692|NCT05041647|Dronabinol|dronabinol|mesh-list
138730693|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
138730694|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730695|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138730696|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138730697|NCT05041647|Analgesics|analgesics|mesh-ancestor
138730698|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
138730699|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730700|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138730701|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138730702|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730703|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730704|NCT05041647|Hormones|hormones|mesh-ancestor
138730705|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138730706|NCT05014815|Tislelizumab|tislelizumab|mesh-list
138730707|NCT05014815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138730708|NCT05014815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730709|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138730710|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138730711|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730712|NCT04966299|Erythritol|erythritol|mesh-list
138730713|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
138730714|NCT04943848|Iodine|iodine|mesh-list
138730715|NCT04943848|Vaccines|vaccines|mesh-list
138730716|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
138730717|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730718|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138730719|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730720|NCT04943848|Trace Elements|trace elements|mesh-ancestor
138730721|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
138730722|NCT04942860|Methotrexate|methotrexate|mesh-list
138730723|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138730724|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
138730725|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138730726|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730727|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138730728|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
138730729|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730730|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730731|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
138730732|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730733|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138730734|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730735|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
138730736|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138730737|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138730738|NCT04781673|Lidocaine|lidocaine|mesh-list
138730740|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
138730741|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
138730742|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138730762|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730764|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
138730765|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730766|NCT04620213|Phentolamine|phentolamine|mesh-list
138730767|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138730768|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138730769|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138580606|NCT01245166|Acarbose|acarbose|mesh-list
138730770|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138730771|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
138730772|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138730773|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730774|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730775|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138730776|NCT04608955|Bedaquiline|bedaquiline|mesh-list
138730777|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
138730778|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138730779|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730780|NCT04607421|Leucovorin|leucovorin|mesh-list
138730781|NCT04607421|Bevacizumab|bevacizumab|mesh-list
138730782|NCT04607421|Cetuximab|cetuximab|mesh-list
138730783|NCT04607421|Capecitabine|capecitabine|mesh-list
138730784|NCT04607421|Fluorouracil|fluorouracil|mesh-list
138730785|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
138730786|NCT04607421|Irinotecan|irinotecan|mesh-list
138730787|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138730788|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730789|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138730790|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138730791|NCT04607421|Growth Substances|growth substances|mesh-ancestor
138730792|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730793|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
138730794|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138730795|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
138730796|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730806|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
138730807|NCT04546633|Lumefantrine|lumefantrine|mesh-list
138730808|NCT04546633|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138730809|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
138730810|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138260653|NCT02703779|Bortezomib|bortezomib|mesh-list
138730811|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138730812|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730814|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
138730815|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138730816|NCT04476173|Narcotics|narcotics|mesh-ancestor
138730817|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138730818|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730819|NCT04476173|Analgesics|analgesics|mesh-ancestor
138730820|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
138730821|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580645|NCT00498901|Leuprolide|leuprolide|mesh-list
138730822|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138730823|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
138730824|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
138730825|NCT04467723|Pirfenidone|pirfenidone|mesh-list
138730826|NCT04467723|Atezolizumab|atezolizumab|mesh-list
138730827|NCT04467723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138730828|NCT04467723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730829|NCT04467723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138730830|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730831|NCT04467723|Analgesics|analgesics|mesh-ancestor
138730832|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
138730833|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730834|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730835|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138730836|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138730837|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138730838|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138730839|NCT04464070|Aspirin|aspirin|mesh-list
138730840|NCT04464070|Niacin|niacin|mesh-list
138730841|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138730842|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138730843|NCT04464070|Analgesics|analgesics|mesh-ancestor
138730844|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
138730845|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138730846|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730847|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138730848|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138730849|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138730850|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138730851|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730852|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138730853|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138730854|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730855|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
138730856|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138730857|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
138730858|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138730859|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
138730860|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
138730861|NCT04464070|Vitamins|vitamins|mesh-ancestor
138730862|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
138687151|NCT06025916|Tranexamic Acid|tranexamic acid|mesh-list
138730863|NCT04459234|Ketamine|ketamine|mesh-list
138730864|NCT04459234|Analgesics|analgesics|mesh-ancestor
138730865|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
138730879|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730881|NCT04311502|Pyridoxal|pyridoxal|mesh-list
138730882|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
138730883|NCT04311502|Rifampin|rifampin|mesh-list
138730884|NCT04311502|Rifapentine|rifapentine|mesh-list
138730885|NCT04311502|Clofazimine|clofazimine|mesh-list
138730886|NCT04311502|Isoniazid|isoniazid|mesh-list
138730887|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
138730888|NCT04311502|Ethambutol|ethambutol|mesh-list
138730889|NCT04311502|Vitamins|vitamins|mesh-ancestor
138730890|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
138730891|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730892|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
138730893|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138730894|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
138730895|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138730896|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138730897|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
138730898|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138730899|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730900|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730901|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138730902|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138730903|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138730904|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138730905|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138730906|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138580714|NCT00499018|Lenograstim|lenograstim|mesh-list
138730907|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138730908|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138730909|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
138730910|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138730911|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138730912|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
138730913|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138730914|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138730915|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730916|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
138730917|NCT04311073|Coagulants|coagulants|mesh-ancestor
138730918|NCT04283669|Crizotinib|crizotinib|mesh-list
138730919|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730920|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138730921|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730922|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730923|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
138730924|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138730925|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138730926|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730938|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
138730939|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730940|NCT04238546|Sirolimus|sirolimus|mesh-list
138730941|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138730942|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069041|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
138730943|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138730944|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730945|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
138730946|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730947|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
138548401|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
138730948|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730949|NCT04212416|Leflunomide|leflunomide|mesh-list
138580760|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
138730950|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730951|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730952|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730953|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
138730954|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730955|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
138730956|NCT04187105|Fludarabine|fludarabine|mesh-list
138730957|NCT04187105|Tacrolimus|tacrolimus|mesh-list
138730958|NCT04187105|Complement Factor H|complement factor h|mesh-list
138730959|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138730960|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
138730961|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138730962|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138730963|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138730964|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
138730965|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730966|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730967|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138730968|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138730969|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730970|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138730971|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
138730972|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730973|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138730974|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138730975|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730976|NCT04099888|Gemcitabine|gemcitabine|mesh-list
138730977|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138730978|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138730979|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
138730980|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138730981|NCT04081389|Interferons|interferons|mesh-list
138730982|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
138730983|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
138730984|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138730985|NCT04081389|Celecoxib|celecoxib|mesh-list
138730986|NCT04081389|Paclitaxel|paclitaxel|mesh-list
138730987|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
138730988|NCT04081389|Doxorubicin|doxorubicin|mesh-list
138730989|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138730990|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138731021|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138731024|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138731025|NCT04079218|Estrogens|estrogens|mesh-ancestor
138731026|NCT04079218|Hormones|hormones|mesh-ancestor
138731027|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138731028|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731029|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138731030|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
138731031|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138731032|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138731033|NCT04075396|Lazertinib|lazertinib|mesh-list
138731034|NCT04075396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138731061|NCT03970720|Metoclopramide|metoclopramide|mesh-list
138731062|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
138731063|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
138731064|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731065|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731066|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138731067|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138731068|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138731069|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
138731070|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731071|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731072|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138731073|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138731074|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548419|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731075|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138731076|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
138731077|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731079|NCT03912818|Gemcitabine|gemcitabine|mesh-list
138731080|NCT03912818|Doxorubicin|doxorubicin|mesh-list
138731081|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138731082|NCT03912818|Methotrexate|methotrexate|mesh-list
138731095|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
138731096|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138731097|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731098|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
138731099|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138731100|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138731101|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
138731102|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731103|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138731104|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138731105|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138731106|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
138731107|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
138731108|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
138731133|NCT03779854|Methotrexate|methotrexate|mesh-list
138731134|NCT03779854|Fludarabine|fludarabine|mesh-list
138731135|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
138731136|NCT03779854|Tacrolimus|tacrolimus|mesh-list
138731137|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138731138|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
138731139|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731140|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731141|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138731142|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
138731143|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731144|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731145|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138655827|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731155|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138731156|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
138731157|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731158|NCT03729362|Miglustat|miglustat|mesh-list
138731159|NCT03729362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731160|NCT03729362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731161|NCT03729362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138731162|NCT03729362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138731163|NCT03729362|Antiviral Agents|antiviral agents|mesh-ancestor
138731164|NCT03729362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731165|NCT03729362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138731166|NCT03729362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138731167|NCT03729362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731169|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138731170|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138731171|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731172|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731173|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731174|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
138731175|NCT03630211|Thiotepa|thiotepa|mesh-list
138731176|NCT03630211|Rituximab|rituximab|mesh-list
138731177|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
138731178|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
138731179|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138731180|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
138731181|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138731182|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
138731183|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138731184|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138731185|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
138731186|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731187|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731188|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138731189|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
138731190|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731191|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731192|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138731193|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138731194|NCT03587961|Ivacaftor|ivacaftor|mesh-list
138731195|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138731196|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138580911|NCT00500422|Gemcitabine|gemcitabine|mesh-list
138731197|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731198|NCT03534453|Olaparib|olaparib|mesh-list
138731199|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138731200|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731201|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731202|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731203|NCT03426293|Heparin|heparin|mesh-list
138731204|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
138731205|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138731206|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138731207|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731208|NCT03387423|Tofacitinib|tofacitinib|mesh-list
138731209|NCT03387423|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138731210|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138731211|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731226|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731227|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
138731228|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138580957|NCT01246180|Diclofenac|diclofenac|mesh-list
138731229|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138731230|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
138731231|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138731232|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138731233|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731234|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138731235|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
138731236|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138731237|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
138731238|NCT03190265|Nivolumab|nivolumab|mesh-list
138731239|NCT03190265|Ipilimumab|ipilimumab|mesh-list
138731240|NCT03190265|Pancrelipase|pancrelipase|mesh-list
138731241|NCT03190265|Vaccines|vaccines|mesh-list
138731242|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
138731256|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138731257|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731258|NCT03150329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138731259|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731260|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138731261|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731262|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
138731263|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138731264|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731265|NCT02882282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138731266|NCT02882282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731267|NCT02615691|Factor VIII|factor viii|mesh-list
138731268|NCT02615691|BAX 855|bax 855|mesh-list
138731269|NCT02615691|Coagulants|coagulants|mesh-ancestor
138731270|NCT02530463|Nivolumab|nivolumab|mesh-list
138731271|NCT02530463|Ipilimumab|ipilimumab|mesh-list
138731272|NCT02530463|Azacitidine|azacitidine|mesh-list
138731287|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138731288|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731289|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138731290|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731291|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069153|NCT03777280|Cobalt|cobalt|mesh-list
138731306|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138731307|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138731308|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138731309|NCT01977417|Analgesics|analgesics|mesh-ancestor
138731310|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
138731311|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731312|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687596|NCT05942313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138731314|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731315|NCT01969578|Paclitaxel|paclitaxel|mesh-list
138731316|NCT01969578|Carboplatin|carboplatin|mesh-list
138731317|NCT01969578|Doxorubicin|doxorubicin|mesh-list
138731318|NCT01969578|Bicalutamide|bicalutamide|mesh-list
138731319|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138731320|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138731321|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731322|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
138731323|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
138731324|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
138731325|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731326|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138731327|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138731328|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138731329|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731330|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
138731331|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
138731380|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138731381|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731382|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138731383|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731384|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138731385|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138731386|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
138731387|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138731388|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138731389|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
138731390|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138731391|NCT01698840|Vitamin D|vitamin d|mesh-list
138731392|NCT01698840|Vitamins|vitamins|mesh-ancestor
138731393|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
138731394|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731395|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138731396|NCT01499888|Sirolimus|sirolimus|mesh-list
138731397|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
138731398|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138731399|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731400|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138731401|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731402|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
138731403|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138731404|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
138731405|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731406|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138731407|NCT00745316|Adenosine|adenosine|mesh-list
138731408|NCT00745316|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-list
138731409|NCT00745316|Analgesics|analgesics|mesh-ancestor
138731410|NCT00745316|Sensory System Agents|sensory system agents|mesh-ancestor
138731411|NCT00745316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731412|NCT00745316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731413|NCT00745316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138731414|NCT00745316|Vasodilator Agents|vasodilator agents|mesh-ancestor
138731415|NCT00745316|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138731416|NCT00745316|Purinergic Agonists|purinergic agonists|mesh-ancestor
138731417|NCT00745316|Purinergic Agents|purinergic agents|mesh-ancestor
138731418|NCT00745316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731419|NCT00745316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731420|NCT00745316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138731421|NCT00745316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138731422|NCT00709865|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|mesh-list
138731423|NCT00709865|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-ancestor
138731424|NCT00709865|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138731436|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138731437|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
138731438|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731439|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731440|NCT00107198|Prednisone|prednisone|mesh-list
138731441|NCT00107198|Cortisone|cortisone|mesh-list
138731442|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
138731443|NCT00107198|Doxorubicin|doxorubicin|mesh-list
138731444|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138731445|NCT00107198|Vincristine|vincristine|mesh-list
138731446|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138731447|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
138731448|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731449|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731450|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138731451|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
138731452|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731453|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731454|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138731455|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138731456|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138731457|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138731458|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731459|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138731460|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
138731461|NCT00107198|Hormones|hormones|mesh-ancestor
138687749|NCT05876949|Denosumab|denosumab|mesh-list
138731462|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138731463|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138731464|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138731465|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
138731466|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
138731467|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
138731468|NCT01601106|Prednisolone|prednisolone|mesh-list
138731469|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138731470|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
138731471|NCT01601106|Hormones|hormones|mesh-ancestor
138731472|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138731473|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731474|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138731475|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731476|NCT02750540|Tenofovir|tenofovir|mesh-list
138731477|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
138731478|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731479|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138731480|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138731481|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731482|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731483|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138731484|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138731485|NCT01601184|Temozolomide|temozolomide|mesh-list
138731486|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138731487|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
138731502|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731503|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138731505|NCT04528628|Serotonin|serotonin|mesh-list
138731506|NCT04528628|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138731507|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
138731508|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138731509|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138731510|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
138731511|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731512|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731513|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731514|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
138731515|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
138731516|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731517|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138731518|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138731519|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138731520|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
138731521|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138731522|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
138731523|NCT01641341|Pancrelipase|pancrelipase|mesh-list
138731524|NCT01641341|Pancreatin|pancreatin|mesh-list
138731525|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138731526|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731527|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138731528|NCT01680107|Cycloserine|cycloserine|mesh-list
138731529|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138731530|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731531|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138731532|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
138731533|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138731534|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
138731535|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731536|NCT01680146|Caseins|caseins|mesh-list
138731537|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
138731538|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
138731539|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731540|NCT01680185|Insulin|insulin|mesh-list
138731541|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138731542|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
138731543|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
138731544|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
138731545|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
138731546|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
138731547|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138731548|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731549|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138731563|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138731564|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731565|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731566|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
138731567|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731568|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138731569|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138731570|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
138731571|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
138731572|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731573|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138731574|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138731575|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
138731576|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138731577|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
138731578|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138731579|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138731580|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138731581|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138731582|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138731584|NCT01644071|Citalopram|citalopram|mesh-list
138731585|NCT01644071|Escitalopram|escitalopram|mesh-list
138731586|NCT01644071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138731587|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138731588|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138731589|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731590|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731591|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
138731592|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731593|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138731594|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138731595|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
138731596|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
138731597|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731598|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138731599|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138731600|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
138731601|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138731602|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
138731603|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138731604|NCT01680536|Maraviroc|maraviroc|mesh-list
138731605|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138731606|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138731607|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731608|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138731609|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138731610|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
138731618|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138731619|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138731620|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
138731621|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731622|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731623|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138731624|NCT01193920|Vaccines|vaccines|mesh-list
138731625|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
138731626|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731627|NCT01644773|Dasatinib|dasatinib|mesh-list
138731628|NCT01644773|Crizotinib|crizotinib|mesh-list
138731629|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731630|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138731631|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731632|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731633|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
138731634|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
138731635|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138731636|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138731637|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731638|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731639|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581243|NCT00147654|Tamsulosin|tamsulosin|mesh-list
138731640|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731641|NCT01681550|Incretins|incretins|mesh-list
138731642|NCT01681550|Hormones|hormones|mesh-ancestor
138731643|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138731644|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731645|NCT01645085|Mannitol|mannitol|mesh-list
138731646|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138731647|NCT01645085|Diuretics|diuretics|mesh-ancestor
138731648|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
138731649|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731650|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
138731651|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731652|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
138731653|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731654|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731655|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138731656|NCT01602861|Spironolactone|spironolactone|mesh-list
138731657|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138731658|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
138731659|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138731660|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731661|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138731662|NCT01602861|Diuretics|diuretics|mesh-ancestor
138731663|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
138731664|NCT01681667|Ibuprofen|ibuprofen|mesh-list
138731665|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138731666|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138731667|NCT01681667|Analgesics|analgesics|mesh-ancestor
138731668|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
138731669|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731670|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731671|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138687968|NCT05411718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731672|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731673|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138731674|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731675|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731676|NCT01600365|Ganciclovir|ganciclovir|mesh-list
138731677|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138731678|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
138731712|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
138731713|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731714|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138731715|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
138731716|NCT01603134|Protective Agents|protective agents|mesh-ancestor
138731717|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731718|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138731719|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
138731720|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138731736|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138731737|NCT01603212|Analgesics|analgesics|mesh-ancestor
138731738|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
138731739|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731740|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138731741|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138731742|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138731743|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731744|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731745|NCT01645748|Cisplatin|cisplatin|mesh-list
138731746|NCT01645748|Docetaxel|docetaxel|mesh-list
138731747|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731748|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
138731749|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
138731750|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
138731751|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731752|NCT02484924|Clopidogrel|clopidogrel|mesh-list
138731753|NCT02484924|Ticagrelor|ticagrelor|mesh-list
138731754|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138731755|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138731756|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138731757|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138731758|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
138731759|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548475|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138731760|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731761|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731763|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138731764|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138731765|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138731766|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731767|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138731768|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731769|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
138731770|NCT01607034|Pramipexole|pramipexole|mesh-list
138731771|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
138731772|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731773|NCT01607034|Protective Agents|protective agents|mesh-ancestor
138731774|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731775|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138731776|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138731777|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
138731778|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
138731779|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731780|NCT01603251|Ivermectin|ivermectin|mesh-list
138731781|NCT01603251|Lumefantrine|lumefantrine|mesh-list
138731782|NCT01603251|Artemether|artemether|mesh-list
138731807|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138731808|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138731809|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
138731810|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138731811|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069269|NCT01309126|Cetuximab|cetuximab|mesh-list
138731812|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
138731813|NCT01646567|Betamethasone|betamethasone|mesh-list
138731814|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
138731815|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138731816|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
138731817|NCT01646567|Calcipotriene|calcipotriene|mesh-list
138731818|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138731819|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138731820|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
138731821|NCT01646567|Hormones|hormones|mesh-ancestor
138731822|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138731823|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731824|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138731825|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
138731826|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
138731827|NCT01681979|Fluticasone|fluticasone|mesh-list
138731828|NCT01681979|Xhance|xhance|mesh-list
138731829|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138731830|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138731831|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138731832|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
138731833|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731834|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731835|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138731850|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138731851|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138731852|NCT01607580|Prednisolone|prednisolone|mesh-list
138731853|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
138731854|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138731855|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
138731856|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
138731857|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138731858|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
138731859|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
138731860|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731861|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731862|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138731863|NCT01607580|Hormones|hormones|mesh-ancestor
138731864|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138731865|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138731866|NCT01607580|Protective Agents|protective agents|mesh-ancestor
138731867|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138731868|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731869|NCT01647152|Ustekinumab|ustekinumab|mesh-list
138731870|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
138731871|NCT01604187|Fentanyl|fentanyl|mesh-list
138731872|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138731873|NCT01604187|Narcotics|narcotics|mesh-ancestor
138731874|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138731875|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731876|NCT01604187|Analgesics|analgesics|mesh-ancestor
138731877|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
138731878|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731879|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138731880|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138731881|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
138731882|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
138731883|NCT01604382|Remifentanil|remifentanil|mesh-list
138731884|NCT01604382|Bupivacaine|bupivacaine|mesh-list
138731885|NCT01604382|Anesthetics|anesthetics|mesh-list
138731886|NCT01604382|Propofol|propofol|mesh-list
138731887|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
138731888|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138731889|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731890|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
138731891|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731892|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138731893|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138731894|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
138731895|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138731896|NCT01604382|Narcotics|narcotics|mesh-ancestor
138731897|NCT01604382|Analgesics|analgesics|mesh-ancestor
138731904|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731905|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138731906|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138731907|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138731908|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
138731909|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
138731910|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731911|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731912|NCT01607970|Oxytocin|oxytocin|mesh-list
138731913|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
138731914|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138731915|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731916|NCT01608009|Paclitaxel|paclitaxel|mesh-list
138731917|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138731918|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731919|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
138731920|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
138731921|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
138731922|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731923|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
138731924|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138731925|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731926|NCT01604031|Lenalidomide|lenalidomide|mesh-list
138731927|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
138731928|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731929|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138731930|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138731931|NCT01604031|Growth Substances|growth substances|mesh-ancestor
138731932|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
138731933|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731934|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
138731935|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138731936|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138731937|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138731938|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731940|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
138731941|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
138731942|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138731943|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731944|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
138731945|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138731946|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138731947|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138731948|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138731949|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138731950|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731951|NCT01647659|Trametinib|trametinib|mesh-list
138731952|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731953|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138731954|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731955|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731956|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
138731957|NCT01604811|Tamsulosin|tamsulosin|mesh-list
138731958|NCT01604811|Urological Agents|urological agents|mesh-ancestor
138731959|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138731960|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138731961|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138731962|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
138731963|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138731964|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731965|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138731966|NCT01683032|Methylphenidate|methylphenidate|mesh-list
138731983|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688263|NCT05065190|Nintedanib|nintedanib|mesh-list
138731985|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138731986|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138731988|NCT01683149|Sorafenib|sorafenib|mesh-list
138731989|NCT01683149|Topotecan|topotecan|mesh-list
138731990|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
138731991|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138731992|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138731993|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138731994|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138731995|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138731996|NCT01608555|Tobramycin|tobramycin|mesh-list
138731997|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138731998|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138731999|NCT01647893|Bivalirudin|bivalirudin|mesh-list
138732000|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
138732001|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138732002|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
138732003|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069331|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
138732004|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732005|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
138732007|NCT01648010|Mitomycin|mitomycin|mesh-list
138732008|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138732009|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732010|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
138732011|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732012|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138732013|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732014|NCT01608711|Gemcitabine|gemcitabine|mesh-list
138732015|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138732016|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
138732017|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732018|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732019|NCT01605357|Mannitol|mannitol|mesh-list
138732020|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138732021|NCT01605357|Diuretics|diuretics|mesh-ancestor
138732022|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
138732023|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656071|NCT00322127|Plerixafor|plerixafor|mesh-list
138732036|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732037|NCT04528277|Isoniazid|isoniazid|mesh-list
138732038|NCT04528277|Rifapentine|rifapentine|mesh-list
138732039|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
138732040|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138732041|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732042|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138732043|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138732044|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
138732045|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732046|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138732047|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138732048|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
138732049|NCT01683656|Niacin|niacin|mesh-list
138732050|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138732051|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
138732052|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732053|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138732054|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
138732055|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
138732056|NCT01683656|Vitamins|vitamins|mesh-ancestor
138732057|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
138732058|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732059|NCT01605864|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138732060|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138732061|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732062|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
138732063|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138732064|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138732065|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138732066|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138732068|NCT01608984|Isoflurane|isoflurane|mesh-list
138732069|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138732070|NCT01608984|Narcotics|narcotics|mesh-ancestor
138732071|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732072|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732073|NCT01608984|Analgesics|analgesics|mesh-ancestor
138732074|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
138732075|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732076|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138732077|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138732078|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
138732079|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
138732080|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138732081|NCT01648517|Carboplatin|carboplatin|mesh-list
138732082|NCT01648517|Gemcitabine|gemcitabine|mesh-list
138732083|NCT01648517|Docetaxel|docetaxel|mesh-list
138732084|NCT01648517|Vinorelbine|vinorelbine|mesh-list
138732085|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732086|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138732087|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
138732088|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732089|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
138732090|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
138732091|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
138732092|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138732108|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732109|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732111|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
138732112|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732113|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138732114|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138732115|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
138732116|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
138732117|NCT01648634|Nebivolol|nebivolol|mesh-list
138732118|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138732119|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
138732120|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138732121|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138732122|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138732123|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
138732124|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732125|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732126|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732127|NCT01606059|Acetaminophen|acetaminophen|mesh-list
138732128|NCT01606059|Tramadol|tramadol|mesh-list
138732129|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138732130|NCT01606059|Analgesics|analgesics|mesh-ancestor
138732131|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
138732132|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732133|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732134|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
138732135|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138732136|NCT01606059|Narcotics|narcotics|mesh-ancestor
138732137|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732138|NCT01648712|Heparin|heparin|mesh-list
138732139|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
138688405|NCT04753879|Paclitaxel|paclitaxel|mesh-list
138732140|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138732141|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138732142|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732143|NCT01688544|Benzimidazole|benzimidazole|mesh-list
138732144|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
138732145|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138732146|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732148|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138732149|NCT01688583|Narcotics|narcotics|mesh-ancestor
138732150|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732151|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732152|NCT01688583|Analgesics|analgesics|mesh-ancestor
138732153|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
138732154|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732168|NCT01688700|Paclitaxel|paclitaxel|mesh-list
138732169|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
138732170|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138732171|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732172|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
138732173|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
138732174|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
138732175|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732176|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138732177|NCT01684085|Lorazepam|lorazepam|mesh-list
138732178|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
138732179|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
138732180|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
138732181|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732182|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732183|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138732184|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138732185|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732186|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138732187|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138732188|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138732189|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
138732190|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
138732191|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732192|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732193|NCT01684241|Vaccines|vaccines|mesh-list
138732194|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
138732195|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732196|NCT01688934|Naproxen|naproxen|mesh-list
138732197|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138732198|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138732199|NCT01688934|Analgesics|analgesics|mesh-ancestor
138732200|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
138732201|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732202|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732203|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138732204|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138732205|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
138732206|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138732207|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732208|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732209|NCT01684319|Caseins|caseins|mesh-list
138732210|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
138732211|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
138732212|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732213|NCT02279576|Paclitaxel|paclitaxel|mesh-list
138732214|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138732215|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138732216|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732217|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
138732251|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138732252|NCT01689090|Analgesics|analgesics|mesh-ancestor
138732253|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
138732254|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732255|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732256|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138732257|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138732258|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732259|NCT01689129|Insulin|insulin|mesh-list
138732260|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138732279|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138732280|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138732281|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732282|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
138732283|NCT01609413|Antacids|antacids|mesh-ancestor
138548571|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
138732284|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732285|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138732286|NCT02279966|Vortioxetine|vortioxetine|mesh-list
138732287|NCT02279966|Paroxetine|paroxetine|mesh-list
138688555|NCT04528329|BB 1101|bb 1101|mesh-list
138732288|NCT02279966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138732289|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138732290|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138732291|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732292|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732293|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
138732294|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732295|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138732296|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
138732297|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138732298|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138732299|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138732300|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732301|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138732302|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138732303|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732304|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138732305|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138732306|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138732307|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138732308|NCT01684787|Ribavirin|ribavirin|mesh-list
138732309|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138732310|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
138732311|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
138732312|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732313|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
138732314|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732328|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732329|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732330|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138732331|NCT01649336|Paclitaxel|paclitaxel|mesh-list
138732332|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
138732333|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138732334|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732335|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
138732336|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
138732337|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732339|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
138732340|NCT01609491|Norepinephrine|norepinephrine|mesh-list
138732341|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138732342|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
138732343|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
138732344|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732345|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732346|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
138732347|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138732348|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
138732349|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
138732350|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138732351|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138732352|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138732353|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
138732354|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732355|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581503|NCT03712826|Ustekinumab|ustekinumab|mesh-list
138732356|NCT01609491|Protective Agents|protective agents|mesh-ancestor
138732357|NCT01684865|Rituximab|rituximab|mesh-list
138732358|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138732359|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732360|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
138732361|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732362|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138732363|NCT01580163|Methadone|methadone|mesh-list
138732364|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138732365|NCT01580163|Narcotics|narcotics|mesh-ancestor
138732366|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732367|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732368|NCT01580163|Analgesics|analgesics|mesh-ancestor
138732369|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
138732370|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732371|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
138732372|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
138732373|NCT01609647|Clopidogrel|clopidogrel|mesh-list
138732374|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138732375|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138732376|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138732377|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138732408|NCT01609959|Valsartan|valsartan|mesh-list
138732409|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138732410|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138732411|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138732412|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138732413|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732414|NCT01609998|Vaccines|vaccines|mesh-list
138732415|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
138732416|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732417|NCT01649921|Interferons|interferons|mesh-list
138732418|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
138732419|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732420|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
138732421|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732422|NCT01606566|Bleomycin|bleomycin|mesh-list
138732423|NCT01606566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138732431|NCT01649999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732432|NCT01649999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732433|NCT01649999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138732434|NCT01649999|Immunologic Factors|immunologic factors|mesh-ancestor
138732435|NCT01649999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688701|NCT04256824|Triclosan|triclosan|mesh-list
138732437|NCT01604889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138732438|NCT01604889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732439|NCT01604889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138732440|NCT01604889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732441|NCT01685762|Metformin|metformin|mesh-list
138732442|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138732443|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732444|NCT01602822|Ritonavir|ritonavir|mesh-list
138732445|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138732446|NCT01602822|Tenofovir|tenofovir|mesh-list
138732447|NCT01602822|Emtricitabine|emtricitabine|mesh-list
138732448|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138732449|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138732450|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138732451|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
138732452|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732453|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732454|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138732455|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138732456|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
138732457|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732458|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138732459|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138732460|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138732461|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138732462|NCT02273154|Buspirone|buspirone|mesh-list
138732463|NCT02273154|Paroxetine|paroxetine|mesh-list
138732464|NCT02273154|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138732465|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138732466|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138732467|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732468|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732469|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
138732470|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732471|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138732472|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
138732473|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138732474|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138732475|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138732476|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732477|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138732478|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138732479|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732480|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138732481|NCT01602393|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
138732482|NCT01602393|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138732483|NCT01602393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656216|NCT00322907|Analgesics|analgesics|mesh-ancestor
138732504|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732505|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732506|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138732508|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138732509|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138732510|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138732511|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138732512|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
138732513|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732514|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732515|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138732516|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
138732517|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
138732518|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138732519|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138732520|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138732521|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138732522|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
138732523|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732524|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732525|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
138732526|NCT02270424|Hormones|hormones|mesh-ancestor
138732527|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138732528|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
138732529|NCT01686347|Ropivacaine|ropivacaine|mesh-list
138732530|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
138732531|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
138732532|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732533|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732534|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
138732535|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732549|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732550|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732551|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732552|NCT01688570|Analgesics|analgesics|mesh-ancestor
138732553|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
138732554|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732555|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
138732556|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138732557|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
138732558|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
138732559|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
138732560|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138732561|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138732562|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
138732563|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
138732564|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138732565|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
138732566|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138732567|NCT01686464|Valacyclovir|valacyclovir|mesh-list
138732568|NCT01686464|Prednisone|prednisone|mesh-list
138732569|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138732570|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
138732571|NCT01686464|Hormones|hormones|mesh-ancestor
138732572|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138732573|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732574|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138732575|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732576|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
138732577|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732578|NCT02270970|Belimumab|belimumab|mesh-list
138732579|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138732580|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
138732581|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732582|NCT01688648|Lidocaine|lidocaine|mesh-list
138732583|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
138732584|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
138732585|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
138732586|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732587|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732588|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
138732589|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732590|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138732591|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138732592|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138732593|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138732594|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732595|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138732619|NCT02271126|Coagulants|coagulants|mesh-ancestor
138732620|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
138732621|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138732622|NCT02271165|Antibodies|antibodies|mesh-list
138732623|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
138732624|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732625|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
138732626|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138732627|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732628|NCT02271282|Toremifene|toremifene|mesh-list
138732629|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138732630|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732631|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138732632|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138732633|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
138732634|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138732635|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732636|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138732637|NCT01688960|Aflibercept|aflibercept|mesh-list
138732638|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138732639|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138732640|NCT01688960|Growth Substances|growth substances|mesh-ancestor
138732641|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732642|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
138732643|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732644|NCT02271360|Cabergoline|cabergoline|mesh-list
138732645|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
138732646|NCT02271360|Calcium|calcium|mesh-list
138732647|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138732648|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732663|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732664|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138732665|NCT02271399|Aspirin|aspirin|mesh-list
138732666|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
138732667|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138732668|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138732669|NCT02271399|Analgesics|analgesics|mesh-ancestor
138732670|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
138732671|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732672|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732673|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138732674|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138732675|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138732676|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138732677|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732678|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138732679|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138732680|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732681|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
138732682|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138732683|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
138732684|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138732685|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
138732686|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
138732687|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
138732688|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138732689|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138732690|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732691|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138548601|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
138732692|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138732693|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732694|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732695|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732696|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138732697|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
138732698|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138732699|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732700|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138732701|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138732702|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138732703|NCT02271555|Remifentanil|remifentanil|mesh-list
138732704|NCT02271555|Sevoflurane|sevoflurane|mesh-list
138732705|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138732706|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138732731|NCT01687439|Vinorelbine|vinorelbine|mesh-list
138732732|NCT01687439|Endostar protein|endostar protein|mesh-list
138732733|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069508|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
138732734|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138732735|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
138732736|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
138732737|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
138732738|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732739|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138732740|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138732741|NCT01687439|Growth Substances|growth substances|mesh-ancestor
138732742|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732743|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
138732744|NCT01588704|Bevacizumab|bevacizumab|mesh-list
138732745|NCT01588704|Pemetrexed|pemetrexed|mesh-list
138732746|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138732747|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732748|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138732749|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138732750|NCT01588704|Growth Substances|growth substances|mesh-ancestor
138732751|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732752|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
138732753|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732754|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732755|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138732756|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138732758|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138732783|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138732784|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
138732785|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138581649|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
138732786|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732787|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138732788|NCT02272101|Vitamin D|vitamin d|mesh-list
138732789|NCT02272101|Vitamins|vitamins|mesh-ancestor
138732790|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
138732791|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732792|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138732793|NCT02278133|Cetuximab|cetuximab|mesh-list
138732794|NCT02278133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138732795|NCT02278133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732796|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
138732797|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138732798|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732799|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732800|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138732801|NCT01687868|Analgesics|analgesics|mesh-ancestor
138732802|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
138732803|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732804|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138732805|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138732806|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138732807|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
138732808|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732809|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732811|NCT01688024|Mitomycin|mitomycin|mesh-list
138732826|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138732827|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732828|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
138732829|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732830|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
138732832|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
138732833|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732834|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732835|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732836|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138732837|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138732838|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138581693|NCT02736422|Xenon|xenon|mesh-list
138732839|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
138732840|NCT02272647|Estradiol|estradiol|mesh-list
138732841|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138732842|NCT02272647|Progesterone|progesterone|mesh-list
138732843|NCT02272647|Estrogens|estrogens|mesh-ancestor
138732844|NCT02272647|Hormones|hormones|mesh-ancestor
138732845|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138732846|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732847|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138732848|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
138732849|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138732850|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138732851|NCT02272647|Progestins|progestins|mesh-ancestor
138732852|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138732853|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138732854|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138732855|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138732856|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138732857|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732858|NCT02272764|Itraconazole|itraconazole|mesh-list
138732859|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
138732860|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
138732861|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138732862|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138732863|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138732864|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732865|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732866|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138732867|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
138732868|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138732869|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732894|NCT05654064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138732895|NCT05654064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732896|NCT05654064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732897|NCT05654064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138732899|NCT05654064|Sensory System Agents|sensory system agents|mesh-ancestor
138732900|NCT05654064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732901|NCT05654064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138732902|NCT05654064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138732903|NCT05654064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138732904|NCT05654064|Adrenergic Agents|adrenergic agents|mesh-ancestor
138732905|NCT05654064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138732906|NCT05654064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732907|NCT05654064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138732908|NCT05654064|Narcotics|narcotics|mesh-ancestor
138732909|NCT05654064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138732910|NCT05654064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138732911|NCT05654064|Anesthetics, General|anesthetics, general|mesh-ancestor
138732912|NCT05654064|Anesthetics|anesthetics|mesh-ancestor
138732913|NCT01687985|Laxatives|laxatives|mesh-list
138732914|NCT01687985|Cathartics|cathartics|mesh-list
138732915|NCT01687985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138732916|NCT01686620|Insulin Lispro|insulin lispro|mesh-list
138732917|NCT01686620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138732918|NCT01686620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732919|NCT01685255|Tamoxifen|tamoxifen|mesh-list
138732920|NCT01685255|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138732921|NCT01685255|Hormone Antagonists|hormone antagonists|mesh-ancestor
138732922|NCT01685255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138656351|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
138732934|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732935|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732937|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
138732938|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732939|NCT01380093|Naltrexone|naltrexone|mesh-list
138732940|NCT01380093|Morphine|morphine|mesh-list
138732941|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138732942|NCT01380093|Narcotics|narcotics|mesh-ancestor
138732943|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138732944|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732945|NCT01380093|Analgesics|analgesics|mesh-ancestor
138732946|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
138732947|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732948|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138732949|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138732950|NCT01379937|Vaccines|vaccines|mesh-list
138732951|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
138732952|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732953|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138732954|NCT03558854|Aspirin|aspirin|mesh-list
138732955|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138732956|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138732957|NCT03558854|Analgesics|analgesics|mesh-ancestor
138732958|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
138732959|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138732960|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732961|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138732962|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138732963|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138732964|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138732965|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732966|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138732967|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138732968|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732969|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
138732970|NCT01335477|Nintedanib|nintedanib|mesh-list
138732971|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138732972|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138732973|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138732974|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138732975|NCT03389438|Immunomodulating Agents|immunomodulating agents|mesh-list
138732976|NCT03389438|Immunologic Factors|immunologic factors|mesh-ancestor
138732977|NCT03389438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138732978|NCT01371747|Losartan|losartan|mesh-list
138732979|NCT01371747|Spironolactone|spironolactone|mesh-list
138732980|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138732981|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138732982|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138732983|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138732984|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656379|NCT01059773|Methotrexate|methotrexate|mesh-list
138732995|NCT01335399|Elotuzumab|elotuzumab|mesh-list
138732996|NCT01335399|BB 1101|bb 1101|mesh-list
138732997|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138732998|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
138732999|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
138733000|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733001|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733002|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138733003|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
138733004|NCT01335399|Hormones|hormones|mesh-ancestor
138581732|NCT00139269|Docetaxel|docetaxel|mesh-list
138733005|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138733006|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138733007|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733008|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
138733009|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733010|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733011|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
138733012|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138733013|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138733014|NCT01335399|Growth Substances|growth substances|mesh-ancestor
138733015|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
138733016|NCT04825262|Tacrolimus|tacrolimus|mesh-list
138733017|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138733018|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
138733019|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733020|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138733021|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733022|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733023|NCT01335009|Antibodies|antibodies|mesh-list
138733024|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138733025|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
138733026|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733028|NCT01332630|Dexamethasone|dexamethasone|mesh-list
138733029|NCT01332630|Ranitidine|ranitidine|mesh-list
138733030|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138733031|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138733032|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
138733033|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
138733034|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733035|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733036|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138733037|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
138733038|NCT01332630|Hormones|hormones|mesh-ancestor
138733039|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138733040|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138733041|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733042|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138733043|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138733044|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138733045|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
138733046|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
138733047|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
138733048|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138733049|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
138733050|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
138733072|NCT02995694|Hormones|hormones|mesh-ancestor
138733073|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138733074|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733075|NCT01365468|Everolimus|everolimus|mesh-list
138733076|NCT01365468|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138733077|NCT01365468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138733078|NCT01365468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733079|NCT01365468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733080|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138733081|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
138733082|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733083|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733084|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
138733085|NCT04827836|Povidone|povidone|mesh-list
138733086|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138733087|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138733088|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
138733089|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
138733090|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138733091|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733092|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
138733093|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138733094|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138733095|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138733096|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138733097|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733098|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
138733099|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733100|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733101|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138733102|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733103|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
138733104|NCT01332318|Promethazine|promethazine|mesh-list
138733105|NCT01332318|Gabapentin|gabapentin|mesh-list
138733107|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
139069621|NCT01035671|Protective Agents|protective agents|mesh-ancestor
138733108|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733122|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
138733123|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
138733124|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
138733125|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
138733126|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138733127|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138733128|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
138733129|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
138733130|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138733131|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
138733132|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
138733133|NCT01331109|Milnacipran|milnacipran|mesh-list
138733134|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
138733135|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138733136|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138733137|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138733138|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733139|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733140|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733141|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138733143|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
138733144|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733145|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
138733146|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138733147|NCT01351350|Paclitaxel|paclitaxel|mesh-list
138733148|NCT01351350|Trastuzumab|trastuzumab|mesh-list
138733149|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138733150|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733151|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
138733152|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
138733153|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
138733154|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733155|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138733156|NCT02271503|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138733157|NCT02271503|Carbidopa|carbidopa|mesh-list
138733158|NCT02271503|Levodopa|levodopa|mesh-list
138733159|NCT02271503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138733160|NCT02271503|Immunologic Factors|immunologic factors|mesh-ancestor
138733161|NCT02271503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733162|NCT02271503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138733163|NCT02271503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138733164|NCT02271503|Dopamine Agonists|dopamine agonists|mesh-ancestor
138733165|NCT02271503|Dopamine Agents|dopamine agents|mesh-ancestor
138733166|NCT02271503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733167|NCT02271503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733168|NCT02271503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138733169|NCT02271503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733170|NCT01350804|Abatacept|abatacept|mesh-list
138733188|NCT01348542|Trazodone|trazodone|mesh-list
138733189|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138733190|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138733191|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138733192|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733193|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138733194|NCT01348542|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138733195|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138733196|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138733197|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733198|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733199|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
138733201|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
138733202|NCT01346592|Vaccines|vaccines|mesh-list
138733203|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
138733204|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733205|NCT01193335|Vaccines|vaccines|mesh-list
138733206|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138733207|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
138733208|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733209|NCT02893995|Treprostinil|treprostinil|mesh-list
138733210|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138733211|NCT01342887|Cyclosporine|cyclosporine|mesh-list
138733212|NCT01342887|Etoposide|etoposide|mesh-list
138733213|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
138733214|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
138733215|NCT01342887|Pravastatin|pravastatin|mesh-list
138733216|NCT01342887|Cyclosporins|cyclosporins|mesh-list
138733217|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138733218|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733219|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138733220|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138733221|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581790|NCT00402974|Vitamin K|vitamin k|mesh-list
138733222|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733223|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138733224|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
138733225|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733226|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
138733250|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733251|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138733252|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733253|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138733255|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138733256|NCT01340625|Norethindrone|norethindrone|mesh-list
138733257|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
138733258|NCT01340625|Estradiol|estradiol|mesh-list
138733259|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138733260|NCT01340625|Estrogens|estrogens|mesh-ancestor
138733261|NCT01340625|Hormones|hormones|mesh-ancestor
138733262|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138733263|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733264|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138733265|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
138733266|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138733267|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138733268|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138733269|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138733270|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138733271|NCT04823468|Cisplatin|cisplatin|mesh-list
138733272|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733273|NCT01340196|Tenofovir|tenofovir|mesh-list
138733274|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
138733275|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733276|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138733277|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138733278|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656448|NCT00324467|Doxorubicin|doxorubicin|mesh-list
138656453|NCT00324467|Mesna|mesna|mesh-list
138733297|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138733298|NCT04328493|Analgesics|analgesics|mesh-ancestor
138733299|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
138733300|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733301|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733302|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138733303|NCT04328493|Filaricides|filaricides|mesh-ancestor
138733304|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
138733305|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
138733306|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
138733307|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
138733308|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733309|NCT01327599|Timolol|timolol|mesh-list
138733310|NCT01327599|Travoprost|travoprost|mesh-list
138733311|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138733312|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138733313|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138733314|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138733315|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
138733316|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069696|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138733317|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733318|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733319|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138733320|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138733322|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138733323|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
138733324|NCT01193257|Hormones|hormones|mesh-ancestor
138733325|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138733326|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733327|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138733328|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733329|NCT02893371|Lamotrigine|lamotrigine|mesh-list
138733330|NCT02893371|Carbamazepine|carbamazepine|mesh-list
138733331|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
138733332|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138733333|NCT02893371|Valproic Acid|valproic acid|mesh-list
138733334|NCT02893371|Haloperidol|haloperidol|mesh-list
138733335|NCT02893371|Olanzapine|olanzapine|mesh-list
138733336|NCT02893371|Risperidone|risperidone|mesh-list
138733337|NCT02893371|Aripiprazole|aripiprazole|mesh-list
138733338|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138733351|NCT02893371|Sertraline|sertraline|mesh-list
138733352|NCT02893371|Fluoxetine|fluoxetine|mesh-list
138733353|NCT02893371|Paroxetine|paroxetine|mesh-list
138733354|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138733355|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138733356|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138733357|NCT02893371|Escitalopram|escitalopram|mesh-list
138733358|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138733359|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
138733360|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733361|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733362|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733363|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138733364|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138733365|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138733366|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138733367|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138733368|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
138733369|NCT02893371|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138733370|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138733371|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138733372|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138733373|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
138733374|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733375|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138733376|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
138733377|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
138733378|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138733379|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138733380|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138733381|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138733382|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733383|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
138733384|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138733385|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138733386|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138733387|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138733388|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138733389|NCT02893371|Analgesics|analgesics|mesh-ancestor
138733390|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
138733391|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
138733392|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
138733393|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138733394|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138733395|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138733396|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
138733397|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138733398|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
138733399|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
138733400|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138733401|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138733402|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138733403|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138733404|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
138733405|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138733415|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138733417|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
138733418|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
138733419|NCT05138978|Protective Agents|protective agents|mesh-ancestor
138733420|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733421|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138733422|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733423|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138733424|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138733426|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138733427|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138733428|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733429|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138733430|NCT01193218|Empagliflozin|empagliflozin|mesh-list
138733431|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138733432|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733433|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138733434|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733435|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138733436|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138733437|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733438|NCT04328805|Ibuprofen|ibuprofen|mesh-list
139069752|NCT03763396|Ketoconazole|ketoconazole|mesh-list
138733439|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138733440|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138733441|NCT04328805|Analgesics|analgesics|mesh-ancestor
138581846|NCT00130676|Mifepristone|mifepristone|mesh-list
138733442|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
138733443|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733444|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733445|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138733446|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138733447|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138733448|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733449|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733450|NCT04329000|Esomeprazole|esomeprazole|mesh-list
138733451|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138733452|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138733453|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138733454|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733455|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733456|NCT01192399|Eculizumab|eculizumab|mesh-list
138733457|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138733458|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138733459|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
138733460|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733461|NCT01176916|Exemestane|exemestane|mesh-list
138733462|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733463|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138733464|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138733465|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733466|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733467|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138733479|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138733480|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138733481|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733482|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733484|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138733485|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138733487|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138733488|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138733489|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138733490|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138733491|NCT01600625|Minocycline|minocycline|mesh-list
138733492|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138733493|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733494|NCT01600742|Vorinostat|vorinostat|mesh-list
138733495|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733496|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138733497|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733498|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733499|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
138733500|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138733501|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139069769|NCT01320436|Curcumin|curcumin|mesh-list
138733503|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733504|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138733505|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138733506|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733507|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733508|NCT02893488|Lamivudine|lamivudine|mesh-list
138733509|NCT02893488|Dolutegravir|dolutegravir|mesh-list
138733510|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138733511|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138733512|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733513|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733514|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
138733515|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733516|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138733517|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138733518|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138733519|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138733520|NCT04328883|Aspirin|aspirin|mesh-list
138733521|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138733522|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138733523|NCT04328883|Analgesics|analgesics|mesh-ancestor
138733524|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
138733525|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733526|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733527|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138733528|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138733529|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138733530|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138733531|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733532|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138733545|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
138733546|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
138733547|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138733548|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138733549|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138733550|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
138733551|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733552|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581888|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138733553|NCT01600235|Protective Agents|protective agents|mesh-ancestor
138733554|NCT02893254|Adalimumab|adalimumab|mesh-list
138733555|NCT02893254|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138733556|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138733557|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138733558|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
138733560|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138733561|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733562|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138733563|NCT04455776|Propofol|propofol|mesh-list
138733564|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138733565|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138733566|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733567|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138733568|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
138733570|NCT04135092|Aldesleukin|aldesleukin|mesh-list
138733571|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
138733572|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
138733573|NCT04135092|Fludarabine|fludarabine|mesh-list
138733574|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138733575|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
138733576|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733577|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138733578|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138733579|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
138733580|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733581|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733582|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138733583|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138733584|NCT04135092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138733585|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138733586|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138733587|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
138733588|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733589|NCT00592215|Misoprostol|misoprostol|mesh-list
138733590|NCT00592215|Mifepristone|mifepristone|mesh-list
138733591|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138733592|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
138733593|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138733594|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733595|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138733596|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138733597|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
138656521|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
138733612|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138733614|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138733615|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138733616|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138733617|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
138733618|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
138733619|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733620|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733621|NCT04477382|Tretinoin|tretinoin|mesh-list
138733622|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733623|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
138733624|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
138733625|NCT01600274|Dienogest|dienogest|mesh-list
138733626|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138733627|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138733628|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138733629|NCT01600274|Estradiol|estradiol|mesh-list
138733630|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138733631|NCT01600274|Nandrolone|nandrolone|mesh-list
138733632|NCT01600274|Estrogens|estrogens|mesh-ancestor
138733633|NCT01600274|Hormones|hormones|mesh-ancestor
138581980|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138733634|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138733635|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733636|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138733637|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
138733638|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138733639|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138733640|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138733641|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138733642|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138733643|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
138733644|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138733645|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733646|NCT01600274|Androgens|androgens|mesh-ancestor
138733647|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
138733648|NCT01176565|Nicardipine|nicardipine|mesh-list
138733649|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138733650|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138733651|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138733652|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733653|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138733654|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733655|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
138733656|NCT04374123|Antibodies|antibodies|mesh-list
138733667|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138733668|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138733669|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138733670|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138733671|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
138733672|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
138733673|NCT00591708|Citric Acid|citric acid|mesh-list
138733674|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
138733675|NCT00591708|Calcium|calcium|mesh-list
138733676|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
138733677|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138733678|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733679|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138733680|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
138733681|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138733682|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
138733683|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
138733684|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733685|NCT01176058|Fluconazole|fluconazole|mesh-list
138733686|NCT01176058|Anidulafungin|anidulafungin|mesh-list
138733687|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
138733688|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733689|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139069847|NCT01561456|Docetaxel|docetaxel|mesh-list
138733690|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138733691|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733692|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548723|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
138733693|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138733694|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
138733695|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138733696|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733697|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138733698|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138733700|NCT04328766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138733701|NCT02273765|Tenofovir|tenofovir|mesh-list
138733702|NCT02273765|Lamivudine|lamivudine|mesh-list
138733703|NCT02273765|Efavirenz|efavirenz|mesh-list
138733704|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
138733705|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
138689994|NCT05034536|Infliximab|infliximab|mesh-list
138733706|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733707|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138733708|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138733709|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733710|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733711|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138733712|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138733713|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138733714|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138733715|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138733716|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138733717|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138733718|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138733719|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138733732|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138733733|NCT01601093|Sulbactam|sulbactam|mesh-list
138733734|NCT01601093|Cefoperazone|cefoperazone|mesh-list
138733735|NCT01601093|Sulperazone|sulperazone|mesh-list
138733736|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138733737|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733738|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138733739|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733740|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733741|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138733742|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
138733743|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138733744|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
138733745|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733746|NCT01175824|Insulin|insulin|mesh-list
138733747|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138733748|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
138733749|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
138733750|NCT01175824|Protamines|protamines|mesh-list
138733751|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138733752|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733753|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
138733754|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733755|NCT01175824|Coagulants|coagulants|mesh-ancestor
138733756|NCT01175707|Vancomycin|vancomycin|mesh-list
138733757|NCT01175707|Daptomycin|daptomycin|mesh-list
138733758|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138733759|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733760|NCT01112059|Doxycycline|doxycycline|mesh-list
138733761|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138733762|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138733763|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
138733764|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138733765|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138733766|NCT01175668|Clonidine|clonidine|mesh-list
138733767|NCT01175668|Phenobarbital|phenobarbital|mesh-list
138733768|NCT01175668|Analgesics|analgesics|mesh-ancestor
138733769|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
138733770|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733771|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733772|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138733773|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
138733774|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
138733775|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138733776|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138733777|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138733778|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
138733779|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733780|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690061|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
139069900|NCT03767920|BB 1101|bb 1101|mesh-list
138733782|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138733783|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138733797|NCT01601327|Androgens|androgens|mesh-ancestor
138733798|NCT01601327|Hormones|hormones|mesh-ancestor
138733799|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138733800|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733801|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138733802|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733803|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
138733804|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138733805|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
138733806|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
138733807|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138733808|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138733809|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733810|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138733811|NCT01607762|Olanzapine|olanzapine|mesh-list
138733812|NCT01607762|Risperidone|risperidone|mesh-list
138733813|NCT01607762|Aripiprazole|aripiprazole|mesh-list
138733814|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138733815|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138733816|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138733817|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
138733818|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733819|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733820|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733821|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138733822|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138733823|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138733824|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138733825|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138733826|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
138733827|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
138733828|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
138733829|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733830|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138733831|NCT01607762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138733832|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138733833|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138733834|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
138733835|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
138733836|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138733837|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138733838|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138733839|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138733840|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
138820565|NCT01003886|Doxazosin|doxazosin|mesh-list
138733841|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138733842|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
138733843|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733844|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
138733845|NCT04327947|Protective Agents|protective agents|mesh-ancestor
138733859|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138733860|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138733861|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138733862|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138733864|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138733865|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733866|NCT01601561|Insulin|insulin|mesh-list
138733867|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138733868|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138733869|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733870|NCT01601795|Sevoflurane|sevoflurane|mesh-list
138733871|NCT01601795|Isoflurane|isoflurane|mesh-list
138733872|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138733873|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138733874|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
138733875|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
138733876|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138733877|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733878|NCT01601912|Dexetimide|dexetimide|mesh-list
138733879|NCT01601912|Citalopram|citalopram|mesh-list
138733880|NCT01601912|Escitalopram|escitalopram|mesh-list
138733881|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138733882|NCT01601912|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138733883|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138733884|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138733885|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733886|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733887|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
138733888|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733889|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138733890|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
138733891|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139070058|NCT03760354|Hormones|hormones|mesh-ancestor
138733892|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138733893|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138733894|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
138733895|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
138733896|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733897|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138733898|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138733899|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
138733900|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138733901|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
138733902|NCT01111825|Sirolimus|sirolimus|mesh-list
138733903|NCT01111825|Temsirolimus|temsirolimus|mesh-list
138733904|NCT01111825|MTOR Inhibitors|mtor inhibitors|mesh-list
138733905|NCT01111825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138733906|NCT01111825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138733907|NCT01111825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733908|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138733932|NCT01111552|Aripiprazole|aripiprazole|mesh-list
138733933|NCT01111552|Escitalopram|escitalopram|mesh-list
138733934|NCT01111552|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138733935|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138733936|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138733937|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733938|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138733939|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
138733940|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733941|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
138733942|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138733943|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138733944|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138733945|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138733946|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
138733947|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
138733948|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138733949|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138733950|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138733951|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138733952|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138733953|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138733954|NCT01602185|Memantine|memantine|mesh-list
138733955|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
138733956|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
138733957|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138733958|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138733959|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
138733960|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656593|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138733973|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138548746|NCT00243100|Vorinostat|vorinostat|mesh-list
138733974|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138733975|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
138733976|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138733977|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138733978|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138733979|NCT01602302|Analgesics|analgesics|mesh-ancestor
138733980|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
138733981|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138733982|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733983|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138733984|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
138733985|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138733986|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138733987|NCT01602302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138733988|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138733989|NCT02893722|Oxytocin|oxytocin|mesh-list
138733990|NCT02893722|Atosiban|atosiban|mesh-list
138733991|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
138733992|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138733993|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138733994|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
138733995|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138733996|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
138733997|NCT01608269|Lamivudine|lamivudine|mesh-list
138733998|NCT01608269|Abacavir|abacavir|mesh-list
138733999|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138734000|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138734001|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734002|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734003|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
138734004|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734005|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138690297|NCT02937779|Tenofovir|tenofovir|mesh-list
138734006|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138734008|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
138734009|NCT01608347|Hematinics|hematinics|mesh-ancestor
138734010|NCT01608347|Vitamins|vitamins|mesh-ancestor
138734011|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
138734012|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734013|NCT04405284|Disinfectants|disinfectants|mesh-list
138734014|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734015|NCT01608464|Cisplatin|cisplatin|mesh-list
138734016|NCT01608464|Docetaxel|docetaxel|mesh-list
138734017|NCT01608464|Fluorouracil|fluorouracil|mesh-list
138734018|NCT01608464|Irinotecan|irinotecan|mesh-list
138734019|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734020|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
138734021|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
138734022|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
138734023|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734024|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
138656616|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138734030|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138734031|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734032|NCT01608698|Drospirenone|drospirenone|mesh-list
138734033|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138734034|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
138734035|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138734036|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138734037|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138734038|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
138734039|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138734040|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734041|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138734042|NCT01608698|Estrogens|estrogens|mesh-ancestor
138734043|NCT01608698|Hormones|hormones|mesh-ancestor
138734044|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138734045|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138734046|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
138734047|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138734048|NCT01608698|Diuretics|diuretics|mesh-ancestor
138734049|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
138734050|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
138734051|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138734052|NCT04310254|Edetic Acid|edetic acid|mesh-list
138734053|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138734054|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
138734055|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
138734056|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138734057|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
138734058|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
138734059|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734060|NCT04310254|Antidotes|antidotes|mesh-ancestor
138734061|NCT04310254|Protective Agents|protective agents|mesh-ancestor
138734062|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734063|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138734064|NCT01603511|Charcoal|charcoal|mesh-list
138734065|NCT01603511|Antidotes|antidotes|mesh-ancestor
138734066|NCT01603511|Protective Agents|protective agents|mesh-ancestor
138734067|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070133|NCT02531724|Simendan|simendan|mesh-list
138734068|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138734069|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138734070|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734071|NCT01174186|Adalimumab|adalimumab|mesh-list
138734072|NCT01174186|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138734073|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138734074|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138734075|NCT01609049|Ribavirin|ribavirin|mesh-list
138734076|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138734077|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
138734078|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734079|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
138734080|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734081|NCT01609088|Erythritol|erythritol|mesh-list
138734082|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
138734083|NCT01609127|Capecitabine|capecitabine|mesh-list
138734084|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138734085|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
138734086|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734087|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734088|NCT01609166|Allopurinol|allopurinol|mesh-list
138734089|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
138734090|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734091|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734092|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
138734093|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138734094|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138734095|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
138734109|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
138734110|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
138734111|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734112|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734113|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138734114|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
138734115|NCT00592566|Hormones|hormones|mesh-ancestor
139070168|NCT01081158|Ritonavir|ritonavir|mesh-list
138734116|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138734117|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138734118|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734119|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
138734120|NCT00592566|Coagulants|coagulants|mesh-ancestor
138734121|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138734122|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
138734123|NCT01111123|Halobetasol|halobetasol|mesh-list
138734124|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138734125|NCT01604330|Baclofen|baclofen|mesh-list
138734126|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138734127|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734128|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138734129|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734130|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138734131|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
138734132|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
138734133|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734134|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734135|NCT00622830|Darapladib|darapladib|mesh-list
138734136|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138734137|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734138|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734139|NCT01173679|Rituximab|rituximab|mesh-list
138734140|NCT01173679|Fludarabine|fludarabine|mesh-list
138734141|NCT01173679|Dasatinib|dasatinib|mesh-list
138734142|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138734143|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734144|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
138734145|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734146|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138734147|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734148|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138734149|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734150|NCT02881528|Metformin|metformin|mesh-list
138734151|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138734152|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734153|NCT01609439|Vitamin D|vitamin d|mesh-list
138734154|NCT01609439|Vitamins|vitamins|mesh-ancestor
138734155|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
138734156|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734157|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138734158|NCT01110382|Amoxicillin|amoxicillin|mesh-list
138734159|NCT01110382|Meropenem|meropenem|mesh-list
138734163|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138734164|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138734165|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734166|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138734167|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734168|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734169|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
138734171|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
138734172|NCT00592917|Calcium|calcium|mesh-list
138734173|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138734174|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734175|NCT00592917|Vitamins|vitamins|mesh-ancestor
138734177|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138734178|NCT00592917|Antacids|antacids|mesh-ancestor
138734179|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734180|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138734181|NCT01609517|Bupivacaine|bupivacaine|mesh-list
138734182|NCT01609517|Anesthetics|anesthetics|mesh-list
138734183|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
138734184|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138734185|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734186|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
138734187|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734188|NCT00593151|Interferons|interferons|mesh-list
138734189|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
138734190|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
138734191|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138734192|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734193|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
138734194|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734195|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
138734196|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734197|NCT01173601|Serotonin|serotonin|mesh-list
138734198|NCT01173601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138734199|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138734200|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
138734201|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734202|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734203|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734204|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138734205|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138734206|NCT01609673|Everolimus|everolimus|mesh-list
138734207|NCT01609673|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138734208|NCT01609673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138734209|NCT01609673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734210|NCT01609673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734211|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138734212|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
138734213|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734214|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734215|NCT01173055|Milnacipran|milnacipran|mesh-list
138734216|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
138734217|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138734218|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138734219|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138734220|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734221|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734222|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734223|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138734224|NCT01173055|Analgesics|analgesics|mesh-ancestor
138734225|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
138734226|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734227|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
138734228|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138734229|NCT00593502|Oseltamivir|oseltamivir|mesh-list
138734230|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
138734231|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734232|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734241|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138734242|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734243|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138734244|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138734245|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138734246|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
138734247|NCT00593580|Vitamin D|vitamin d|mesh-list
138734248|NCT00593580|Alendronate|alendronate|mesh-list
138734249|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138734250|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734251|NCT00593580|Vitamins|vitamins|mesh-ancestor
138734252|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
138734253|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138734254|NCT04327011|Flucytosine|flucytosine|mesh-list
138734255|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
138734256|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734257|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
138734258|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734260|NCT00593619|Dextrans|dextrans|mesh-list
138734261|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138734262|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
138734263|NCT00593619|Trace Elements|trace elements|mesh-ancestor
138734264|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
138734265|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734266|NCT00593619|Hematinics|hematinics|mesh-ancestor
138734267|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
138734268|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
138734269|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
138734270|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
138734271|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138734272|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734273|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734274|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138734275|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138734276|NCT00593658|Protective Agents|protective agents|mesh-ancestor
138734277|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734278|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
138734279|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138734280|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
138734281|NCT00593697|Docetaxel|docetaxel|mesh-list
138734282|NCT00593697|Trastuzumab|trastuzumab|mesh-list
138734283|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734284|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
138734285|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
138734286|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
138734287|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734289|NCT01601522|Ranitidine|ranitidine|mesh-list
138734290|NCT01601522|Desloratadine|desloratadine|mesh-list
138734291|NCT01601522|Histamine Antagonists|histamine antagonists|mesh-list
138734292|NCT01601522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138734293|NCT01601522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138734294|NCT01601522|Cholinergic Agents|cholinergic agents|mesh-ancestor
138734295|NCT01601522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734296|NCT01601522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734297|NCT01601522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656646|NCT00325325|Everolimus|everolimus|mesh-list
138734313|NCT01607294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138734314|NCT01607294|Antimetabolites|antimetabolites|mesh-ancestor
138734315|NCT01607294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734316|NCT01607294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138734317|NCT01607294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734318|NCT01607294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138734319|NCT01607294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734321|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138734322|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138734323|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734324|NCT00594126|Imetelstat|imetelstat|mesh-list
138734325|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
138734326|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734327|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734328|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138734329|NCT01605344|Leucovorin|leucovorin|mesh-list
138734330|NCT01605344|Fluorouracil|fluorouracil|mesh-list
138734331|NCT01605344|Irinotecan|irinotecan|mesh-list
138734332|NCT01605344|Atorvastatin|atorvastatin|mesh-list
138734333|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
138734334|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734335|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138734336|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734337|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138734338|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
138734339|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734340|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138734342|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734343|NCT01605344|Antidotes|antidotes|mesh-ancestor
138734344|NCT01605344|Protective Agents|protective agents|mesh-ancestor
138734345|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
138734346|NCT01605344|Vitamins|vitamins|mesh-ancestor
138734347|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
138734348|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138734349|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138734350|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138582362|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138734351|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138734352|NCT00593463|Cycloserine|cycloserine|mesh-list
138734353|NCT00593463|Verapamil|verapamil|mesh-list
138734354|NCT00593463|Diltiazem|diltiazem|mesh-list
138734355|NCT00593463|Isradipine|isradipine|mesh-list
138734356|NCT00593463|Nifedipine|nifedipine|mesh-list
138734357|NCT00593463|Gabapentin|gabapentin|mesh-list
138734379|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138734380|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138734381|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734382|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138734383|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
138734384|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138734385|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
138690675|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138734386|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138734387|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138734388|NCT00592410|Insulin|insulin|mesh-list
138734389|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138734390|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138734391|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734392|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138734393|NCT04328064|Calcium|calcium|mesh-list
138734394|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138734395|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734396|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138734397|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138734398|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
138734399|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734400|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139070467|NCT03966560|Dorzolamide|dorzolamide|mesh-list
138734401|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138734402|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734403|NCT01605734|Sorafenib|sorafenib|mesh-list
138734404|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
138734405|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734406|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138734407|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734408|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734409|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138734418|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734420|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138734421|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734422|NCT00594555|Cytarabine|cytarabine|mesh-list
138734423|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
138734424|NCT00594555|Cladribine|cladribine|mesh-list
138734425|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138734426|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
138734427|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734428|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734429|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
138734430|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318127|NCT01466790|Ribavirin|ribavirin|mesh-list
138734431|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138734432|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
138734433|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734434|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138734435|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734436|NCT01605929|Mepivacaine|mepivacaine|mesh-list
138734437|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
138734438|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
138734439|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138734440|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734441|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
138734442|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734443|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
138734444|NCT02270606|Leucovorin|leucovorin|mesh-list
138734445|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
138734446|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
138734447|NCT02270606|Fluorouracil|fluorouracil|mesh-list
138734448|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
138734449|NCT02270606|Calcium|calcium|mesh-list
138734450|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
138734451|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138734452|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734453|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138734454|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
138734455|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734456|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138734457|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734458|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138734459|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
138734460|NCT02270606|Antidotes|antidotes|mesh-ancestor
138734461|NCT02270606|Protective Agents|protective agents|mesh-ancestor
138734462|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
138734463|NCT02270606|Vitamins|vitamins|mesh-ancestor
138734464|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
138734465|NCT00594633|Donepezil|donepezil|mesh-list
138734466|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138734467|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734468|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734469|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
138734470|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734471|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734472|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
138734473|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138734474|NCT01605968|Laxatives|laxatives|mesh-ancestor
138734475|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138734476|NCT01606046|Anesthetics|anesthetics|mesh-list
138734477|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
138734478|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138734484|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138734485|NCT02892942|Cetrorelix|cetrorelix|mesh-list
138734486|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138734488|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138734489|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734490|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
138734491|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138734492|NCT00594867|Aspirin|aspirin|mesh-list
138734493|NCT00594867|Acetaminophen|acetaminophen|mesh-list
138734494|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138734495|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138734496|NCT00594867|Analgesics|analgesics|mesh-ancestor
138734497|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
138734498|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734499|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734500|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138734501|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138734502|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138734503|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138734504|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734505|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138734506|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138734507|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734508|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
138734509|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
138734510|NCT01606241|Vaccines|vaccines|mesh-list
138734511|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
138734512|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734513|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138734514|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138734515|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138734516|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
138734517|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734518|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734519|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138734521|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138734522|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
138734523|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138734524|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
138734525|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734526|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734527|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
138734528|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
138734529|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138734530|NCT00595140|Octreotide|octreotide|mesh-list
138734531|NCT00595140|Dopamine|dopamine|mesh-list
138734532|NCT00595140|Cabergoline|cabergoline|mesh-list
138734533|NCT00595140|Somatostatin|somatostatin|mesh-list
138734534|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
138734535|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138734536|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138690828|NCT02933684|Cycloserine|cycloserine|mesh-list
138734537|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734538|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138734539|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
138734540|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
138734541|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734542|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734543|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
138734544|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734545|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734546|NCT00595140|Protective Agents|protective agents|mesh-ancestor
138734548|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138734549|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138734557|NCT01606358|Carboplatin|carboplatin|mesh-list
138734558|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734559|NCT02271113|Enoxaparin|enoxaparin|mesh-list
138734560|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
138734561|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
138734562|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138734563|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138734564|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734565|NCT02271191|Nicardipine|nicardipine|mesh-list
138734566|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138734567|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138734568|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138734569|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734570|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138734571|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734572|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
138734573|NCT00595374|Insulin|insulin|mesh-list
138734574|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138734575|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
138734576|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
138734577|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
138734578|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
138734579|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
138734580|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138734581|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734582|NCT00595569|Insulin|insulin|mesh-list
138734583|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138734584|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734585|NCT02271347|Brincidofovir|brincidofovir|mesh-list
138734587|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734588|NCT01172938|Thalidomide|thalidomide|mesh-list
138734589|NCT01172938|Apremilast|apremilast|mesh-list
138734590|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138734591|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138734593|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
138734594|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734595|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734596|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138734597|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138734598|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138734599|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138734600|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734601|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734602|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138734603|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
138734604|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
138734605|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138734606|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734607|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138734608|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138734609|NCT01172938|Growth Substances|growth substances|mesh-ancestor
138734610|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
138734611|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734612|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
138690906|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
138734613|NCT02271464|Bevacizumab|bevacizumab|mesh-list
138734614|NCT02271464|Capecitabine|capecitabine|mesh-list
138734615|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138734616|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
138734617|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734618|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138734619|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138734620|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
138734627|NCT02271464|Growth Substances|growth substances|mesh-ancestor
138734628|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
138734629|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138734630|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
138734631|NCT04326894|Methotrexate|methotrexate|mesh-list
138734632|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138734633|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
138734634|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138734635|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734636|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138734637|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
138734638|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734639|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734640|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
138734641|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734642|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138734643|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138734644|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
138734645|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138734646|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138734647|NCT02271542|Propofol|propofol|mesh-list
138734648|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138734649|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138734650|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734651|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138734652|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
138734653|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
138734654|NCT01109992|Regadenoson|regadenoson|mesh-list
138734655|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138734656|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138734657|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
138734658|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
138548814|NCT00244075|Hormones|hormones|mesh-list
138734659|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734660|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734661|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734662|NCT02892357|Omeprazole|omeprazole|mesh-list
138734663|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138734664|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138734665|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138734666|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734667|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734668|NCT01109524|Cetuximab|cetuximab|mesh-list
138734669|NCT01109524|Vinorelbine|vinorelbine|mesh-list
138734670|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734671|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138734672|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138734673|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
138734674|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
138734675|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
138734676|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734677|NCT01109173|Nepafenac|nepafenac|mesh-list
138734678|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138734679|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138734680|NCT01109173|Analgesics|analgesics|mesh-ancestor
138734681|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
138734682|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734683|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734684|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138734685|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138690979|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
138734694|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138734695|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138734696|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
138734697|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734698|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734699|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138734700|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
138734701|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
138734702|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138734703|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
138734704|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734705|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734706|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138734707|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138734708|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138734709|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
138734710|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
138734711|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138734712|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
138734713|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734714|NCT01172275|Expectorants|expectorants|mesh-ancestor
138734715|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
138734716|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138734717|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
138734718|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734719|NCT01172275|Protective Agents|protective agents|mesh-ancestor
138734720|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734721|NCT01172275|Antidotes|antidotes|mesh-ancestor
138734722|NCT05034952|Acetaminophen|acetaminophen|mesh-list
138734723|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138734724|NCT05034952|Analgesics|analgesics|mesh-ancestor
138734725|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
138734726|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734727|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734728|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
138734729|NCT00596037|Hormones|hormones|mesh-list
138548820|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
138734730|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138734732|NCT02273102|Tretinoin|tretinoin|mesh-list
138734733|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
138734734|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734735|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
138734736|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
138734737|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
138734738|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138734739|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138734740|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734741|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734742|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138734743|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138734744|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138734745|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734747|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
138734748|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138734749|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
138734750|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734751|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734752|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734753|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138734754|NCT02272478|Immunotoxins|immunotoxins|mesh-ancestor
138734772|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138734773|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138734774|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138734776|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
138734777|NCT02272829|Narcotics|narcotics|mesh-ancestor
138734778|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138734779|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734780|NCT02272829|Analgesics|analgesics|mesh-ancestor
138734781|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
138734782|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734783|NCT00596115|Pramipexole|pramipexole|mesh-list
138734784|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
138734785|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734786|NCT00596115|Protective Agents|protective agents|mesh-ancestor
138734787|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734788|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138734789|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138734790|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
138734791|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
138734792|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734793|NCT02272868|Rifaximin|rifaximin|mesh-list
138734794|NCT02272868|Omeprazole|omeprazole|mesh-list
138734795|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138734796|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138734797|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138734798|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138734799|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734800|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734801|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138734802|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734804|NCT02273453|Oxazepam|oxazepam|mesh-list
138734805|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138734806|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138734807|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734808|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138734809|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138734810|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138734811|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
138734812|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
138734819|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138734820|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734821|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734823|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138734824|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138734825|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138734826|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138734827|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138734828|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
138734829|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138734830|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138734831|NCT02273258|Insulin|insulin|mesh-list
138734832|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138734833|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
138734834|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138734835|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691140|NCT02923583|Abatacept|abatacept|mesh-list
138734836|NCT05015686|Vaccines|vaccines|mesh-list
138734837|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
138734838|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734839|NCT04327245|Tagatose|tagatose|mesh-list
138734840|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138734841|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
138734842|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
138734843|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734844|NCT01588769|Immunomodulating Agents|immunomodulating agents|mesh-list
138734845|NCT01588769|Immunologic Factors|immunologic factors|mesh-ancestor
138734846|NCT01588769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734847|NCT04327401|Dexamethasone|dexamethasone|mesh-list
138734848|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138734849|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
138734850|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
138734851|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734852|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734853|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138734854|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
138734855|NCT04327401|Hormones|hormones|mesh-ancestor
138734856|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138734857|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138734858|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734859|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
138734860|NCT01340027|Mirabegron|mirabegron|mesh-list
138734861|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138734862|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138734863|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
138734864|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138734865|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734866|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734867|NCT01340027|Urological Agents|urological agents|mesh-ancestor
138734868|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138734869|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138734870|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138734871|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
138734872|NCT01107925|Clopidogrel|clopidogrel|mesh-list
138734873|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138734874|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138734875|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138734876|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138734877|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138734878|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
138734886|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
138734887|NCT01588847|Sufentanil|sufentanil|mesh-list
138734888|NCT01588847|Bupivacaine|bupivacaine|mesh-list
138734889|NCT01588847|Anesthetics|anesthetics|mesh-list
138734891|NCT01588847|Sevoflurane|sevoflurane|mesh-list
138734892|NCT01588847|Rocuronium|rocuronium|mesh-list
138734893|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
138734894|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138734895|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734896|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
138734897|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138734898|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138582609|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
138734899|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138734900|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
138734901|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138734902|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138734903|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138734904|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138734905|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138734906|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138734907|NCT01588847|Narcotics|narcotics|mesh-ancestor
138734908|NCT01588847|Analgesics|analgesics|mesh-ancestor
138734909|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138734910|NCT00107900|Edoxaban|edoxaban|mesh-list
138734911|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138734913|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138734914|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
138734915|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734916|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734917|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
138734918|NCT00107315|Bevacizumab|bevacizumab|mesh-list
138734919|NCT00107315|Capecitabine|capecitabine|mesh-list
138734920|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138734921|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734922|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138734923|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138734924|NCT00107315|Growth Substances|growth substances|mesh-ancestor
138734925|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734926|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
138734927|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138734928|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
139070985|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138734929|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734931|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138734932|NCT01335971|Protective Agents|protective agents|mesh-ancestor
138734933|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734934|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734935|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
138734936|NCT00107276|Capecitabine|capecitabine|mesh-list
138734937|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138734938|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
138734939|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734940|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138734941|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138734942|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
138734943|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734944|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734945|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138734946|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138734948|NCT01335698|Ritonavir|ritonavir|mesh-list
138734968|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734969|NCT01335464|Nintedanib|nintedanib|mesh-list
138734970|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734971|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138734972|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138734973|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734974|NCT00106184|Rituximab|rituximab|mesh-list
138734975|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138734976|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734977|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
138734978|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138734979|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138734980|NCT00598923|Topiramate|topiramate|mesh-list
138734981|NCT00598923|Phenytoin|phenytoin|mesh-list
138734982|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
138734983|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138734984|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691276|NCT03924440|Nonoxynol|nonoxynol|mesh-list
138734985|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138734986|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138734987|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138734988|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734989|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138734990|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138734991|NCT02892318|Atezolizumab|atezolizumab|mesh-list
138734992|NCT02892318|Guadecitabine|guadecitabine|mesh-list
138734993|NCT02892318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138734994|NCT02892318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138734995|NCT02892318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138734996|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138734997|NCT01334918|Regadenoson|regadenoson|mesh-list
138734998|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138734999|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138735000|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138735013|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
138735014|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
138735015|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138735016|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735017|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735018|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138735019|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138735020|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138735021|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138735022|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138735023|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138735024|NCT01332968|Prednisone|prednisone|mesh-list
138735025|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
138735026|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138735027|NCT01332968|Rituximab|rituximab|mesh-list
138735028|NCT01332968|Doxorubicin|doxorubicin|mesh-list
138735029|NCT01332968|Vincristine|vincristine|mesh-list
138735030|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
138735031|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138735032|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
138735033|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735034|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138735035|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138735036|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
138735037|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735038|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735039|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138735040|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138735041|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138735042|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138735043|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138735044|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735045|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138735046|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
138735047|NCT01332968|Hormones|hormones|mesh-ancestor
138735048|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735049|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138735050|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138735051|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
138735052|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
138735053|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
138735054|NCT00599079|Azithromycin|azithromycin|mesh-list
138735055|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138735056|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691358|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
138735057|NCT00599235|Hydralazine|hydralazine|mesh-list
138735058|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
138735059|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
138735060|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138735061|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138735062|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735076|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138735077|NCT01332227|Tenofovir|tenofovir|mesh-list
138735078|NCT01332227|Emtricitabine|emtricitabine|mesh-list
138735079|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
138735080|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138735081|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138548836|NCT02967029|Esmolol|esmolol|mesh-list
138735082|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
138735083|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735084|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735085|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138735086|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138735087|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
138735088|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735089|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138735090|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138735091|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138735092|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138735093|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138735094|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138735095|NCT01332149|Pregabalin|pregabalin|mesh-list
138735096|NCT01332149|Analgesics|analgesics|mesh-ancestor
138735097|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
138735098|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735099|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735100|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
138735101|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138735102|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735103|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735104|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138735105|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139071081|NCT04537078|Estrogens|estrogens|mesh-ancestor
138735106|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138735107|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138735108|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138735109|NCT01326702|Rituximab|rituximab|mesh-list
138735110|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138735111|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138735112|NCT01326702|Veliparib|veliparib|mesh-list
138735113|NCT01326702|Antibodies|antibodies|mesh-list
138735114|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
138735115|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138735116|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
138735117|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735118|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735119|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138735120|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138735121|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
138735122|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735123|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138735124|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735136|NCT05649878|Prednisolone|prednisolone|mesh-list
138735137|NCT05649878|Prednisolone acetate|prednisolone acetate|mesh-list
138735138|NCT05649878|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138735139|NCT05649878|Prednisolone phosphate|prednisolone phosphate|mesh-list
138735140|NCT05649878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138735141|NCT05649878|Antiemetics|antiemetics|mesh-ancestor
138735142|NCT05649878|Autonomic Agents|autonomic agents|mesh-ancestor
138735143|NCT05649878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735144|NCT05649878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735145|NCT05649878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138735146|NCT05649878|Glucocorticoids|glucocorticoids|mesh-ancestor
138735147|NCT05649878|Hormones|hormones|mesh-ancestor
138735148|NCT05649878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735150|NCT05649878|Protective Agents|protective agents|mesh-ancestor
138735151|NCT05649878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138735152|NCT05649878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735153|NCT01327703|Pancreatin|pancreatin|mesh-list
138735154|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138735155|NCT01380080|Efavirenz|efavirenz|mesh-list
138735156|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138735157|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138735158|NCT01380080|Rifampin|rifampin|mesh-list
138735159|NCT01380080|Isoniazid|isoniazid|mesh-list
138735160|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
138735161|NCT01380080|Ethambutol|ethambutol|mesh-list
138735162|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
138735163|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138735164|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138735165|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735166|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735167|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
138735168|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735169|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138735170|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138735171|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138735172|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138735173|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138735174|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138735175|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138735176|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138735177|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138735178|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
138735179|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138735180|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
138735181|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138735182|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138735183|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138735184|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138735195|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138735196|NCT01371851|Doxazosin|doxazosin|mesh-list
138735197|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138735198|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138735199|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138735200|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138735201|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
138735202|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735203|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735204|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735205|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138735206|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138735207|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138735208|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735209|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735210|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735211|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735212|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
138735213|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138735214|NCT04328870|Oxytocin|oxytocin|mesh-list
138735215|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735216|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
138735217|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138735218|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138735219|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138265085|NCT05637086|Phenytoin|phenytoin|mesh-list
138735221|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138735222|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735223|NCT00591617|Analgesics|analgesics|mesh-ancestor
138735224|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
138735225|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735226|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138735227|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
138735228|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138735229|NCT01357889|Incretins|incretins|mesh-ancestor
138735230|NCT01357889|Hormones|hormones|mesh-ancestor
138735231|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735232|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735233|NCT01357655|Dasatinib|dasatinib|mesh-list
138735234|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735235|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138735236|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735237|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735238|NCT01357616|Timolol|timolol|mesh-list
138735239|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138735240|NCT01357616|Brinzolamide|brinzolamide|mesh-list
138735241|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138735242|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138735243|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138735244|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
138735245|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735246|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735247|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735248|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138735262|NCT01348763|Darunavir|darunavir|mesh-list
138735263|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138735264|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138735265|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735266|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735267|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
138735268|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735269|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138735270|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138735271|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138735272|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138735273|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138735274|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138735275|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138735276|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
138735278|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735279|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138735280|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735281|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735282|NCT01342913|Fluticasone|fluticasone|mesh-list
138735283|NCT01342913|Xhance|xhance|mesh-list
138735284|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138735285|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138735286|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138735287|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
138735288|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735289|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735290|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138735291|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
138735292|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
138735293|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138735294|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138735295|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138735296|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138735297|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
138735298|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735299|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735300|NCT01342796|Vaccines|vaccines|mesh-list
138735301|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
138735302|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735303|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
138735304|NCT01342640|Hematinics|hematinics|mesh-ancestor
138735305|NCT01342484|Linagliptin|linagliptin|mesh-list
138735306|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138735307|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735308|NCT01342484|Incretins|incretins|mesh-ancestor
138735309|NCT01342484|Hormones|hormones|mesh-ancestor
138656823|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138735324|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138735326|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138735327|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138735328|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
138735329|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735330|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735331|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138735332|NCT01342094|Timolol|timolol|mesh-list
138735333|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138735334|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138735335|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138735336|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138735337|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
138735338|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735339|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735340|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735341|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138735342|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138735343|NCT01340768|Metformin|metformin|mesh-list
138735344|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138735345|NCT01340768|Glimepiride|glimepiride|mesh-list
138735346|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138735347|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691654|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
138735349|NCT01340768|Hormones|hormones|mesh-ancestor
138735350|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735351|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138735352|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
138735353|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735354|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735355|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138735356|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138735357|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
138735358|NCT01340300|Metformin|metformin|mesh-list
138735359|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138735360|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735361|NCT01107535|Palivizumab|palivizumab|mesh-list
138735362|NCT01107535|Antibodies|antibodies|mesh-list
138735363|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138735364|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
138735365|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071244|NCT04701658|Bamlanivimab|bamlanivimab|mesh-list
138735380|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735382|NCT00598338|Laxatives|laxatives|mesh-ancestor
138735383|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138735384|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138735385|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138735386|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
138735387|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735388|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735389|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735390|NCT00598572|Deferoxamine|deferoxamine|mesh-list
138735391|NCT00598572|Siderophores|siderophores|mesh-ancestor
138735392|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138735393|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
138735394|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
138735395|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735396|NCT00599820|Bevacizumab|bevacizumab|mesh-list
138735397|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138735398|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735399|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138735400|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138735401|NCT00599820|Growth Substances|growth substances|mesh-ancestor
138735402|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735403|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
138735405|NCT00599898|Atosiban|atosiban|mesh-list
138735406|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138735407|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138582799|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138735408|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735409|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138735410|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735411|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
138735412|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
138735413|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138735414|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
138735415|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735416|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
138735418|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138735419|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
138735420|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691727|NCT02919293|Vaccines|vaccines|mesh-list
138735421|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138735422|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735423|NCT00600210|Bevacizumab|bevacizumab|mesh-list
138735424|NCT00600210|Carboplatin|carboplatin|mesh-list
138735438|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
138735439|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735440|NCT00600600|Tigecycline|tigecycline|mesh-list
138735441|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138735442|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735443|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138735444|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735445|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735446|NCT00623064|Gemcitabine|gemcitabine|mesh-list
138735447|NCT00623064|Lapatinib|lapatinib|mesh-list
138735448|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735449|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138735450|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
138735451|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735452|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138735453|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735454|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
138735455|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138735456|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
138735457|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
138735458|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138735459|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735460|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138735461|NCT00623220|Analgesics|analgesics|mesh-ancestor
138735462|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
138735463|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735464|NCT00600912|SMOFlipid|smoflipid|mesh-list
138735465|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138735466|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138735467|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138735468|NCT00600990|Vestipitant|vestipitant|mesh-list
138735469|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138735470|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582822|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735471|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735472|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735473|NCT00601302|Amlodipine|amlodipine|mesh-list
138735474|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138735475|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138735476|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735477|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735478|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138735479|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735480|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
138735481|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
138735482|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
138735483|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138735484|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735485|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735486|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
138735500|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
138735501|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735502|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138735503|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138735504|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735506|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138735507|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138735508|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138735509|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138735510|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735511|NCT00602082|Capecitabine|capecitabine|mesh-list
138735512|NCT00602082|Streptozocin|streptozocin|mesh-list
138735513|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735514|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138735515|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
138735516|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735517|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138735518|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
138735519|NCT01171963|Vaccines|vaccines|mesh-list
138735520|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
138735521|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735522|NCT01171183|Carvedilol|carvedilol|mesh-list
138735523|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139071360|NCT03749356|Tacrolimus|tacrolimus|mesh-list
138735524|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138735525|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
138735526|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735527|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735528|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735529|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138735530|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
138735531|NCT01171183|Protective Agents|protective agents|mesh-ancestor
138735532|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138735533|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735534|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138735535|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
138548866|NCT00244309|Tamsulosin|tamsulosin|mesh-list
138735536|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138735537|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138735538|NCT01169779|Metformin|metformin|mesh-list
138735539|NCT01169779|Lixisenatide|lixisenatide|mesh-list
138735540|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138735541|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735542|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
138735543|NCT01169701|Everolimus|everolimus|mesh-list
138735544|NCT01169701|Tacrolimus|tacrolimus|mesh-list
138735545|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138735546|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
138735547|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735548|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138735549|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656878|NCT00419549|Analgesics|analgesics|mesh-ancestor
138735569|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735570|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138735571|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139071378|NCT00096278|Leucovorin|leucovorin|mesh-list
138735572|NCT01115491|Growth Substances|growth substances|mesh-ancestor
138735573|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735574|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
138735575|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138735576|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
138735577|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735578|NCT01113931|Doxycycline|doxycycline|mesh-list
138735579|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138735580|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735581|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
138735582|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138735583|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138735585|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
138735586|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138735587|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735588|NCT02880787|Rocuronium|rocuronium|mesh-list
138735589|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138735590|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138735591|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138735592|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735593|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735594|NCT01106677|Metformin|metformin|mesh-list
138735595|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138735596|NCT01106677|Canagliflozin|canagliflozin|mesh-list
138735597|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138735598|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735599|NCT01106677|Incretins|incretins|mesh-ancestor
138735600|NCT01106677|Hormones|hormones|mesh-ancestor
138735601|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735602|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138735603|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
138735609|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138735610|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138735611|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735613|NCT04308343|Letrozole|letrozole|mesh-list
138735614|NCT04308343|Cetrorelix|cetrorelix|mesh-list
138735615|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138735616|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
138735617|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138735618|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735619|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138735620|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
138735621|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735622|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735623|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
138735624|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735625|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138735626|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138735627|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
138735628|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138735629|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138735630|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138735631|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138735632|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138735633|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
138735634|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735635|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138735636|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
138735637|NCT01099579|Ritonavir|ritonavir|mesh-list
138735638|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138735639|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138691957|NCT05466149|Aflutinib|aflutinib|mesh-list
138735640|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138735641|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
138735642|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071465|NCT04336228|Citalopram|citalopram|mesh-list
138735643|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735644|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138735645|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138735646|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
138735647|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735648|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138735649|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138735650|NCT01103713|Azithromycin|azithromycin|mesh-list
138735651|NCT01103713|Chloroquine|chloroquine|mesh-list
138735652|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138735653|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735654|NCT01103713|Amebicides|amebicides|mesh-ancestor
138735655|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138582897|NCT02964455|Docetaxel|docetaxel|mesh-list
138735656|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138735657|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
138735658|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138735659|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138735660|NCT01103245|Spironolactone|spironolactone|mesh-list
138735661|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138735662|NCT01103245|Diuretics|diuretics|mesh-ancestor
138735663|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
138735664|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735665|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138735666|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735667|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735668|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138735669|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
138735686|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735688|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138735689|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138735690|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138735691|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138735692|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
138735693|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
138735694|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
138735695|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
138735696|NCT02880007|Cisplatin|cisplatin|mesh-list
138735697|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735698|NCT02880085|Lidocaine|lidocaine|mesh-list
138735699|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
138735700|NCT02880085|Anesthetics|anesthetics|mesh-list
138735701|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138735702|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735703|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
139071508|NCT04167670|Amoxicillin|amoxicillin|mesh-list
138735704|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735705|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138735706|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138735707|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138735708|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735709|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735710|NCT01098097|Ribavirin|ribavirin|mesh-list
138735711|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
138735712|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735713|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
138735714|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735715|NCT04407572|Vitamin D|vitamin d|mesh-list
138735716|NCT04407572|Vitamins|vitamins|mesh-list
138735717|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
138735718|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
138735719|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
138735720|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735721|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138735722|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
138735723|NCT04407572|Hematinics|hematinics|mesh-ancestor
138735724|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
138735725|NCT04328636|Analgesics|analgesics|mesh-ancestor
138656919|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
138735741|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138582919|NCT00134888|Buprenorphine|buprenorphine|mesh-list
138735742|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735743|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735744|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138735745|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735746|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
138735747|NCT02893280|Aspirin|aspirin|mesh-list
138735748|NCT02893280|Enoxaparin|enoxaparin|mesh-list
138735749|NCT02893280|Streptokinase|streptokinase|mesh-list
138735750|NCT02893280|Clopidogrel|clopidogrel|mesh-list
138735751|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138735752|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138735753|NCT02893280|Analgesics|analgesics|mesh-ancestor
138735754|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
138735755|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735756|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735757|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138735758|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138735759|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138735760|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138735761|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735762|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138735763|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138735764|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735765|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
138735766|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138735767|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138735768|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138735769|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
138735770|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735772|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138735773|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138735774|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
138735775|NCT04328480|Colchicine|colchicine|mesh-list
138735776|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
138735777|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138735778|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
138735779|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
138735780|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
138735781|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656933|NCT04708353|Pregabalin|pregabalin|mesh-list
138735794|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735795|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735796|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
138735797|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735798|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138582940|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735799|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
138735800|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138735801|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138735802|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138735803|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735804|NCT04327232|Spironolactone|spironolactone|mesh-list
138735805|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138735806|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
138735807|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735808|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735809|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138735810|NCT04327232|Diuretics|diuretics|mesh-ancestor
138735811|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
138735812|NCT00593138|Methylphenidate|methylphenidate|mesh-list
138735813|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
138735814|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138735815|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735816|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138735817|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138735818|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735819|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735820|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
138735821|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735822|NCT00593294|Drospirenone|drospirenone|mesh-list
138735823|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138735824|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735825|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138735826|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
138735827|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735828|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138735829|NCT00593294|Diuretics|diuretics|mesh-ancestor
138735830|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
138735831|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138735832|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138735833|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138735834|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
138735835|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138735836|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138735837|NCT00593294|Estrogens|estrogens|mesh-ancestor
138735838|NCT00593294|Hormones|hormones|mesh-ancestor
138735839|NCT00593996|Vitamin D|vitamin d|mesh-list
138735840|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
138735841|NCT00593996|Vitamins|vitamins|mesh-ancestor
138735849|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138735850|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138735851|NCT00595322|Growth Substances|growth substances|mesh-ancestor
138582969|NCT00135122|Prednisolone|prednisolone|mesh-list
138735852|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735853|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
138735854|NCT00596336|Imiquimod|imiquimod|mesh-list
138735855|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138735856|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
138735857|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735858|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735859|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
138735860|NCT00596414|Midazolam|midazolam|mesh-list
138735861|NCT00596414|Meperidine|meperidine|mesh-list
138735862|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138735863|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138692177|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
138735864|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138735865|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735866|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138735867|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138735868|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138735869|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138735870|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
138735871|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
138735872|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
138735873|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
138735874|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735875|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735876|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138735877|NCT00596414|Narcotics|narcotics|mesh-ancestor
138735878|NCT00596414|Analgesics|analgesics|mesh-ancestor
138735879|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
138582995|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138735880|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735881|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138735882|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735883|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138735884|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735885|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735886|NCT00596804|Veltuzumab|veltuzumab|mesh-list
138735887|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735888|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
138735889|NCT00622934|Hematinics|hematinics|mesh-ancestor
138735890|NCT00597662|Icodextrin|icodextrin|mesh-list
138735891|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
138735892|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138735893|NCT00598052|Escitalopram|escitalopram|mesh-list
138735894|NCT00598052|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138735895|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138735896|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735897|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735898|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138735899|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
138735900|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735901|NCT04326296|Lenalidomide|lenalidomide|mesh-list
138735902|NCT04326296|Antibodies|antibodies|mesh-list
138735903|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138735904|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
138735905|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735906|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138735907|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138735908|NCT04326296|Growth Substances|growth substances|mesh-ancestor
138735909|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
138735916|NCT00598676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138735917|NCT00598676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735918|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138735919|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
138735920|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735921|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735922|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138735923|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735924|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138735925|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
138735926|NCT00599222|Ranibizumab|ranibizumab|mesh-list
138735927|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138735928|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138735929|NCT00599222|Growth Substances|growth substances|mesh-ancestor
138735930|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735931|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
138735932|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735933|NCT00599534|Montelukast|montelukast|mesh-list
138735934|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138735935|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
138735936|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138735937|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
138735938|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735939|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735940|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138735941|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138735942|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735944|NCT00600158|Hydromorphone|hydromorphone|mesh-list
138735945|NCT00600158|Bupivacaine|bupivacaine|mesh-list
138735946|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
138735947|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
138735948|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138735949|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735950|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
138735951|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735952|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138735953|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138735954|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138735955|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138735956|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138735957|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138735959|NCT00600158|Analgesics|analgesics|mesh-ancestor
138735960|NCT04325984|Dexamethasone|dexamethasone|mesh-list
138735961|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138735962|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
138735963|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
138735964|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138735965|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735966|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138735967|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
138735968|NCT04325984|Hormones|hormones|mesh-ancestor
138735969|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138735970|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138735971|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735972|NCT00600548|Miltefosine|miltefosine|mesh-list
138735973|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138735974|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
138735975|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138735976|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138735977|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138735978|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138735979|NCT00600626|Insulin|insulin|mesh-list
138735980|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138735981|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
138735996|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138735997|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
138735998|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138735999|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736000|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
138736001|NCT00601328|Calcitriol|calcitriol|mesh-list
138736002|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138736003|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736004|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139071701|NCT01078142|Sirolimus|sirolimus|mesh-list
138736005|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138736006|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736007|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138736008|NCT00601328|Vitamins|vitamins|mesh-ancestor
138736009|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
138736010|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138736011|NCT00601562|Zidovudine|zidovudine|mesh-list
138736012|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
138736013|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736014|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138736015|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138736016|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736017|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
138736018|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736019|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138736020|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138736021|NCT00601874|Pilocarpine|pilocarpine|mesh-list
138736022|NCT00601874|Miotics|miotics|mesh-ancestor
138736023|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
138736024|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736025|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736026|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138736027|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138736028|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
138736029|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736030|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736031|NCT01326026|Insulin|insulin|mesh-list
138736032|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138736033|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
138736034|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138736035|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736036|NCT01097629|Suvorexant|suvorexant|mesh-list
138736037|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138736038|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138736039|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138736040|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736041|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138736042|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138656975|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
138736054|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138736055|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138736056|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138736057|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736058|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736059|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736060|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138736061|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138736062|NCT01324388|Dulaglutide|dulaglutide|mesh-list
138736063|NCT01324388|Metoprolol|metoprolol|mesh-list
138736064|NCT01324388|Lisinopril|lisinopril|mesh-list
138736065|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138736066|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138736067|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
138736068|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
138736069|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736070|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736071|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139071742|NCT00096044|Rituximab|rituximab|mesh-list
138736072|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138736073|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138736074|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
138736075|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736076|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736077|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138736078|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
138736079|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736080|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138736081|NCT01324388|Protective Agents|protective agents|mesh-ancestor
138736082|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138736083|NCT02878681|Ranibizumab|ranibizumab|mesh-list
138736084|NCT02878681|Aflibercept|aflibercept|mesh-list
138736085|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138736086|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138736087|NCT02878681|Growth Substances|growth substances|mesh-ancestor
138736088|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692405|NCT05471453|Tocotrienols|tocotrienols|mesh-list
138736089|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
138736090|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736091|NCT01324310|Ketoconazole|ketoconazole|mesh-list
138736093|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
138736094|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736095|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138583136|NCT00152841|Vitamins|vitamins|mesh-ancestor
138736096|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138736097|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736098|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736099|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138736100|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
138736101|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138736102|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736103|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138736112|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138736113|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
138736114|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736115|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
138736116|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736117|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138736118|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138736119|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736120|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736121|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138736122|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138736123|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
138736124|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736126|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138736127|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
138736128|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736129|NCT01324232|Quinidine|quinidine|mesh-list
138736130|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
138736131|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
138736132|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
138736133|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138736134|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138736135|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736136|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736137|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736138|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138736139|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138736140|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
138736141|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138736142|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
138736143|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138736144|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138736145|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736146|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736147|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138736148|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138736149|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
138736150|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138736151|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138736152|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138736153|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138736154|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138736155|NCT02878291|Vaccines|vaccines|mesh-list
138736156|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
138736157|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736158|NCT05350891|Immunomodulating Agents|immunomodulating agents|mesh-list
138736159|NCT05350891|Immunologic Factors|immunologic factors|mesh-ancestor
138736160|NCT05350891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736161|NCT01323920|Methotrexate|methotrexate|mesh-list
138692481|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
138736163|NCT01323920|Tacrolimus|tacrolimus|mesh-list
138736164|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138736165|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
138736166|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138736167|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736168|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138736169|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
138736170|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736187|NCT02891967|Z 350|z 350|mesh-list
138736188|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138736189|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138736190|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736191|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736192|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
138736193|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138736194|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736195|NCT00598377|Cosyntropin|cosyntropin|mesh-list
138736196|NCT00598377|Hormones|hormones|mesh-ancestor
138736197|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138736198|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736199|NCT00598533|Sirolimus|sirolimus|mesh-list
138736200|NCT00598533|Probucol|probucol|mesh-list
138736201|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138736202|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736203|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138736204|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736205|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
139071840|NCT04049578|Balovaptan|balovaptan|mesh-list
138736207|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
138736208|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736209|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736210|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138736211|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138736212|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
138736213|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138736214|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
138736215|NCT00598533|Protective Agents|protective agents|mesh-ancestor
138736216|NCT00599937|Tretinoin|tretinoin|mesh-list
138736217|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736218|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
138736219|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
138736220|NCT00600093|Amantadine|amantadine|mesh-list
138736221|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138736222|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138736223|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
138736224|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736225|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
138583173|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138736226|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736227|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736228|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736229|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138736238|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
138736239|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736240|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138736242|NCT00600405|Oxycodone|oxycodone|mesh-list
138736243|NCT00600405|Tamsulosin|tamsulosin|mesh-list
138736244|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138736245|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138736246|NCT00600405|Analgesics|analgesics|mesh-ancestor
138736247|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
138736248|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736249|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736250|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138736251|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138736252|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138736253|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736254|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736255|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138736256|NCT00600405|Narcotics|narcotics|mesh-ancestor
138736257|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138736258|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138736259|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138736260|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138736261|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
138736262|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736263|NCT00600405|Urological Agents|urological agents|mesh-ancestor
138736264|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138736265|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138736266|NCT00600639|Prednisolone|prednisolone|mesh-list
138736267|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138736268|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
138736269|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138736270|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
138736271|NCT00600639|Albuterol|albuterol|mesh-list
138736272|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138736273|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
138736274|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736275|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
138736276|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138736277|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
138736278|NCT00600639|Hormones|hormones|mesh-ancestor
138736279|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138736280|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736281|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138736282|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736283|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
138736284|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
138736285|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736286|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138736287|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138736288|NCT00600639|Protective Agents|protective agents|mesh-ancestor
138736289|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138736290|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138736291|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
138736292|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
138736293|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138736294|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138736295|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138548955|NCT00244738|Castor Oil|castor oil|mesh-list
138736296|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138736321|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
138736322|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
138736323|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138736324|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
138736325|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
138736326|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138736327|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
138736328|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
138736329|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138736330|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736331|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736332|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
138736333|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138736334|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138736335|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736336|NCT00601887|Meloxicam|meloxicam|mesh-list
138548961|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
138736337|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138736338|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138736339|NCT00601887|Analgesics|analgesics|mesh-ancestor
138736340|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
138736341|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736342|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736343|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138736344|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138736345|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138736346|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138736360|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138736361|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736362|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736363|NCT01325337|Bimatoprost|bimatoprost|mesh-list
138736365|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138736366|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138736367|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
138736368|NCT01324947|Pomalidomide|pomalidomide|mesh-list
138736369|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
138736370|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736371|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138659919|NCT03277209|Plerixafor|plerixafor|mesh-list
138736372|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138736373|NCT01324947|Growth Substances|growth substances|mesh-ancestor
138736374|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
138736375|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736376|NCT01101841|Paroxetine|paroxetine|mesh-list
138736377|NCT01101841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138736378|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138736379|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138736380|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736382|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
138736383|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736384|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138736385|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
138736386|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138736387|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138548993|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138736388|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138736389|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736390|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
138736391|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138736392|NCT02877511|Protective Agents|protective agents|mesh-ancestor
138736393|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736394|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
138736395|NCT01324323|Rifampin|rifampin|mesh-list
138736396|NCT01324323|Romidepsin|romidepsin|mesh-list
138736397|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138736398|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
138736399|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139071969|NCT03743896|Capsaicin|capsaicin|mesh-list
138736400|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736401|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
138736402|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138736403|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736404|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657052|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138736419|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
138736420|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736421|NCT01323582|Azithromycin|azithromycin|mesh-list
138736422|NCT01323582|Erythromycin|erythromycin|mesh-list
138736423|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
138736424|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138736425|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
138736426|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138736427|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736428|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138736429|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138736430|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736431|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736432|NCT05367765|Imatinib Mesylate|imatinib mesylate|mesh-list
138736433|NCT05367765|Flumatinib|flumatinib|mesh-list
138736434|NCT05367765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736435|NCT05367765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138736436|NCT05367765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736437|NCT05367765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736438|NCT01323621|Fluticasone|fluticasone|mesh-list
138736439|NCT01323621|Xhance|xhance|mesh-list
138736440|NCT01323621|Albuterol|albuterol|mesh-list
138736441|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138736442|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138736443|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138736444|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
138736445|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736446|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736447|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138736448|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
138736449|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
138736450|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138736451|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138736452|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138736453|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138736454|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
138736455|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736456|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736457|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
138736458|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138736459|NCT05645289|Alendronate|alendronate|mesh-list
138736460|NCT05645289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138736461|NCT05645289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736462|NCT01320033|Doxycycline|doxycycline|mesh-list
138736463|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138736481|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736482|NCT01317615|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138736483|NCT01317615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138736484|NCT01317615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736485|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138736486|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
138736487|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736488|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
138736489|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138736490|NCT01078675|Calcium|calcium|mesh-list
138736491|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138736492|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736493|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138736495|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138736496|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
138736497|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736498|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138736499|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138736500|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736501|NCT01100437|Naltrexone|naltrexone|mesh-list
138736502|NCT01100437|Morphine|morphine|mesh-list
138736503|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138736504|NCT01100437|Narcotics|narcotics|mesh-ancestor
138736505|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138736506|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736507|NCT01100437|Analgesics|analgesics|mesh-ancestor
138736508|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
138736509|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736510|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138736511|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138736512|NCT01322490|Molgramostim|molgramostim|mesh-list
138736513|NCT01322490|Sargramostim|sargramostim|mesh-list
138736514|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
138736515|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549035|NCT00245245|Factor VIII|factor viii|mesh-list
138736516|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736517|NCT01314261|Interferons|interferons|mesh-list
138736518|NCT01314261|Ribavirin|ribavirin|mesh-list
138736519|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736520|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
138736521|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736522|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
138736523|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736524|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138736532|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736533|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
138736534|NCT01321008|Prednisone|prednisone|mesh-list
138736535|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
138736536|NCT01321008|Doxorubicin|doxorubicin|mesh-list
138736537|NCT01321008|Vincristine|vincristine|mesh-list
138736538|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138736539|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
138736540|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736541|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138736542|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138736543|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
138736544|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736545|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736546|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138736547|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138736548|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138736549|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138736550|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736551|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138736552|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
138736553|NCT01321008|Hormones|hormones|mesh-ancestor
138736554|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138736555|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138736556|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138736557|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
138736558|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
138736559|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
138736560|NCT01323530|Capecitabine|capecitabine|mesh-list
138736561|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138736562|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
138736563|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736564|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736565|NCT01313637|Bromides|bromides|mesh-list
138736566|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
138736567|NCT01320722|Vitamin D|vitamin d|mesh-list
138736568|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
138736569|NCT01320722|Cholecalciferol|cholecalciferol|mesh-list
138736570|NCT01320722|Vitamins|vitamins|mesh-list
138736571|NCT01320722|Allopurinol|allopurinol|mesh-list
138736572|NCT01320722|Probenecid|probenecid|mesh-list
138736573|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
138736574|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736575|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138736576|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138736577|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
138736578|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736579|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736581|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138736582|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138736584|NCT01320722|Protective Agents|protective agents|mesh-ancestor
138736585|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
138736586|NCT01313559|Everolimus|everolimus|mesh-list
138736587|NCT01313559|Pasireotide|pasireotide|mesh-list
138736588|NCT01313559|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138736589|NCT01313559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138736590|NCT01313559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736591|NCT01313559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736592|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138736593|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
138657097|NCT05458076|Ritonavir|ritonavir|mesh-list
138736604|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138736605|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736606|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138736607|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736608|NCT01312467|Metformin|metformin|mesh-list
138736609|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139072099|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736610|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736611|NCT01310127|Nepafenac|nepafenac|mesh-list
138736612|NCT01310127|Bromfenac|bromfenac|mesh-list
138736613|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138736614|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138736615|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138736616|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138736617|NCT01310127|Analgesics|analgesics|mesh-ancestor
138736618|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
138736619|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736620|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736621|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138736622|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138736623|NCT01318902|Dexamethasone|dexamethasone|mesh-list
138736624|NCT01318902|Ixazomib|ixazomib|mesh-list
138736625|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138736626|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
138736627|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
138736628|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549055|NCT00245401|Sirolimus|sirolimus|mesh-list
138736629|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736630|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138736631|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
138736632|NCT01318902|Hormones|hormones|mesh-ancestor
138736633|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138736634|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138736635|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736636|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
138736637|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736638|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736639|NCT01313858|Golimumab|golimumab|mesh-list
138736640|NCT01313858|Methotrexate|methotrexate|mesh-list
138736641|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138736642|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
138736643|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138736644|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736645|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138736646|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
138736647|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736648|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736649|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
138736650|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736651|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138736652|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138736653|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
138736654|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138736655|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138736656|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138736657|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138736669|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
138736670|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736672|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
138736673|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138736674|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
138736675|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138736676|NCT01170208|Insulin|insulin|mesh-list
138736677|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138736678|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736679|NCT02891018|Paclitaxel|paclitaxel|mesh-list
138736680|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138736681|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138736682|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736683|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
138736684|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
138736685|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
138736686|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693010|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
138736687|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138736688|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138736689|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736690|NCT01169038|Azithromycin|azithromycin|mesh-list
138736691|NCT01169038|Rifampin|rifampin|mesh-list
138736692|NCT01169038|Ethambutol|ethambutol|mesh-list
138736693|NCT01169038|Levofloxacin|levofloxacin|mesh-list
138736694|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138736695|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549078|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
138736696|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138736697|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
138736698|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
138736699|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138736700|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736701|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736702|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138736703|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138736704|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138736705|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138736706|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138736707|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138736708|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138736709|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138736710|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138736711|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736712|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138736713|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138736714|NCT00624754|Budesonide|budesonide|mesh-list
138736715|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
138736716|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138736717|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138736718|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
138736719|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138657113|NCT00426192|Mannitol|mannitol|mesh-list
138736737|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
138736738|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138736739|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138736740|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138736741|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138736742|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736743|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
138736744|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736745|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736746|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138736747|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736748|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
138736750|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138736751|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736752|NCT01114672|Vitamins|vitamins|mesh-ancestor
138736753|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
138736754|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138736755|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138736756|NCT01114516|Clindamycin|clindamycin|mesh-list
138736757|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
138736758|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
138736759|NCT01114516|Cefazolin|cefazolin|mesh-list
138736760|NCT01114516|Indomethacin|indomethacin|mesh-list
138736761|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736762|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138736763|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736764|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736765|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138736766|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138736767|NCT01114516|Analgesics|analgesics|mesh-ancestor
138736768|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
138736769|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736770|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736772|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138736773|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
138736774|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
138736787|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736788|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138736789|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736790|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736791|NCT01075321|Lenalidomide|lenalidomide|mesh-list
138736792|NCT01075321|Everolimus|everolimus|mesh-list
138736793|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
138736794|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736795|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138736796|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138736797|NCT01075321|Growth Substances|growth substances|mesh-ancestor
138583342|NCT00153192|Hormones|hormones|mesh-ancestor
138736798|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
138736799|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736800|NCT01075321|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138736801|NCT01075321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138736802|NCT01075321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736803|NCT01075321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736804|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138736805|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138736806|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138736807|NCT01114204|Hematinics|hematinics|mesh-ancestor
138736808|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138736809|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138736810|NCT01075243|Acetaminophen|acetaminophen|mesh-list
138736811|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138736812|NCT01075243|Analgesics|analgesics|mesh-ancestor
138736813|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
138736814|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736815|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736816|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
138736817|NCT01078441|Dexamethasone|dexamethasone|mesh-list
138736818|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
138736819|NCT01078441|Doxorubicin|doxorubicin|mesh-list
138736820|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138736821|NCT01078441|Bortezomib|bortezomib|mesh-list
138736822|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138736823|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
138736824|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736825|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138225407|NCT01578707|Ofatumumab|ofatumumab|mesh-list
138736826|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138736827|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
138736828|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736829|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736830|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138736831|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138736832|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
138736833|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
138693155|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736834|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138736835|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139072245|NCT00408629|Adalimumab|adalimumab|mesh-list
138736838|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138736849|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736850|NCT00626665|Urological Agents|urological agents|mesh-ancestor
138736851|NCT01090063|Ustekinumab|ustekinumab|mesh-list
138736852|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
138736853|NCT01306214|Empagliflozin|empagliflozin|mesh-list
138736854|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138736855|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736856|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138736857|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736858|NCT00623402|Interferons|interferons|mesh-list
138583358|NCT00136565|Prednisone|prednisone|mesh-list
138736860|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736861|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
138736862|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736863|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138736864|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736865|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736866|NCT01077739|Leucovorin|leucovorin|mesh-list
138736867|NCT01077739|Bevacizumab|bevacizumab|mesh-list
138736868|NCT01077739|Capecitabine|capecitabine|mesh-list
138736869|NCT01077739|Fluorouracil|fluorouracil|mesh-list
138736870|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
138736871|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138736872|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736873|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138736874|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138736875|NCT01077739|Growth Substances|growth substances|mesh-ancestor
138736876|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736877|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
138736878|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138736879|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
138736880|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736881|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138736882|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
138736883|NCT01077739|Antidotes|antidotes|mesh-ancestor
138736884|NCT01077739|Protective Agents|protective agents|mesh-ancestor
138736885|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
138736887|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
138736888|NCT01306058|Sorafenib|sorafenib|mesh-list
138736889|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736890|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138736891|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072267|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138736892|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736893|NCT00626509|Sunitinib|sunitinib|mesh-list
138736894|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736895|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138736896|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138736897|NCT00626509|Growth Substances|growth substances|mesh-ancestor
138736898|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736899|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
138736900|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138736901|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736902|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736903|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138736904|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138736913|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736914|NCT01305200|Calcium|calcium|mesh-list
138736915|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138736916|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736917|NCT01304498|Vaccines|vaccines|mesh-list
138736918|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
138736919|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736920|NCT01074931|Ritonavir|ritonavir|mesh-list
138736921|NCT01074931|Lopinavir|lopinavir|mesh-list
138736922|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138736923|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138736924|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
138736925|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736926|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736927|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138736928|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138736929|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
138736930|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138736931|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138736932|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138736933|NCT04774159|Colchicine|colchicine|mesh-list
138736934|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
138736935|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138736936|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
138736937|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
138736938|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
139072298|NCT03822182|Bupivacaine|bupivacaine|mesh-list
138736939|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736940|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736941|NCT01303172|Gemcitabine|gemcitabine|mesh-list
138736942|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138736943|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
138736944|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736945|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138736946|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138736947|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138736948|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138736949|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
138736950|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138736951|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736952|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736953|NCT01302938|Urological Agents|urological agents|mesh-ancestor
138736954|NCT01076647|Insulin|insulin|mesh-list
138736955|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138736956|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
138736957|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138736958|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736959|NCT04306081|Evolocumab|evolocumab|mesh-list
138736960|NCT04306081|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138736961|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138736962|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138736963|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
138736964|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736965|NCT04306081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138736966|NCT04306081|Protease Inhibitors|protease inhibitors|mesh-ancestor
138736967|NCT04306081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736968|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138736969|NCT01074307|Bisoprolol|bisoprolol|mesh-list
138736970|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138736985|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
138736986|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
138736987|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
138736988|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736989|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138736990|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
138736991|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138736992|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138736993|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138736994|NCT01309737|Tofacitinib|tofacitinib|mesh-list
138736995|NCT01309737|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138736996|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138736997|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138736998|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138736999|NCT01074229|Ropivacaine|ropivacaine|mesh-list
138737000|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
138737001|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
138737002|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138737003|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737004|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
138737005|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737006|NCT01106014|Selexipag|selexipag|mesh-list
138737007|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138737008|NCT01105936|Acetaminophen|acetaminophen|mesh-list
138737009|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138737010|NCT01105936|Analgesics|analgesics|mesh-ancestor
138737011|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
138737012|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737013|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737016|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138737017|NCT01309659|Trace Elements|trace elements|mesh-ancestor
138737018|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
138737019|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737020|NCT01309659|Hematinics|hematinics|mesh-ancestor
138737021|NCT04989166|Curcumin|curcumin|mesh-list
138737022|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138737023|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138737024|NCT04989166|Analgesics|analgesics|mesh-ancestor
138737025|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
138737026|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737027|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737028|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737029|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138737030|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737031|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737032|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737033|NCT05320705|Dexmedetomidine|dexmedetomidine|mesh-list
138657174|NCT00427596|Solabegron|solabegron|mesh-list
138737045|NCT05320705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737046|NCT05320705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737047|NCT01104766|Aripiprazole|aripiprazole|mesh-list
138737048|NCT01104766|Cariprazine|cariprazine|mesh-list
138737049|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
138737050|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138737051|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138737052|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139072369|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
138737053|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138737054|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737055|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
138737056|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
138737057|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737058|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737059|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138737061|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
138737062|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138737063|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138737064|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138737065|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138737066|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138737067|NCT02880280|Menotropins|menotropins|mesh-list
138737068|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138737069|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737070|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138737071|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
138737072|NCT01104376|Efavirenz|efavirenz|mesh-list
138737073|NCT01104376|Voriconazole|voriconazole|mesh-list
138737074|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138737075|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138737076|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737077|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737078|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
138737079|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737080|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138737081|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139072393|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138737082|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138737083|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138737084|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138737085|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138737086|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
138737087|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138737088|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138737089|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
138737090|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138737091|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737092|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138737093|NCT02875873|Methamphetamine|methamphetamine|mesh-list
138737094|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
138737101|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737102|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737103|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
138737104|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138737105|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138737106|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138737107|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138737108|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138737109|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138737110|NCT01072357|Bevacizumab|bevacizumab|mesh-list
138737111|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138737112|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138737113|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737114|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138737115|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138737116|NCT01072357|Growth Substances|growth substances|mesh-ancestor
138737117|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737118|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
138737119|NCT01072357|Laxatives|laxatives|mesh-ancestor
138737120|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138737121|NCT01072201|Triclosan|triclosan|mesh-list
138737122|NCT01072201|Fluorides|fluorides|mesh-list
138737123|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
138737124|NCT01072201|Protective Agents|protective agents|mesh-ancestor
138737125|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737126|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138737127|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737128|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138737129|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138737130|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
138737131|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737132|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138737134|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138737135|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138737136|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138737137|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737138|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737139|NCT04972396|Metformin|metformin|mesh-list
138737140|NCT04972396|Digoxin|digoxin|mesh-list
138737141|NCT04972396|Warfarin|warfarin|mesh-list
138737142|NCT04972396|Atorvastatin|atorvastatin|mesh-list
138737143|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
138737144|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138737145|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138737146|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737147|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138737148|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138737149|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
139072438|NCT03961464|Cycloserine|cycloserine|mesh-list
138737150|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737151|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138737152|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138737153|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737154|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
138737155|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138737156|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
138737157|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138737158|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138737159|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138737160|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138737161|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138737162|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138737163|NCT04972396|Protective Agents|protective agents|mesh-ancestor
138737164|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138737174|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138737176|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
138737177|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138737178|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138737179|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138737180|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737181|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737182|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138737183|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138737184|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138737185|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138737186|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737187|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737188|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
138737189|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737190|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138737191|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138737192|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138737193|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138737194|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
138737195|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
138737196|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138737197|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737198|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
138737199|NCT01087489|Lidocaine|lidocaine|mesh-list
138737200|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
138737201|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
138737202|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138737203|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737204|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
138737205|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737206|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138737207|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138583505|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
138737208|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139072450|NCT01087632|Hematinics|hematinics|mesh-ancestor
138737209|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138737210|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737211|NCT04306627|Amlodipine|amlodipine|mesh-list
138737212|NCT04306627|Perindopril|perindopril|mesh-list
138737213|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
138737214|NCT04306627|Atorvastatin|atorvastatin|mesh-list
138737215|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138737216|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138737217|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
138737218|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737219|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138737220|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138737221|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737222|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138737223|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138737224|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138737225|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138737226|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737227|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
138737237|NCT04306471|Protease Inhibitors|protease inhibitors|mesh-ancestor
138737238|NCT04306471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737239|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138737240|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138737241|NCT04296253|Mitogens|mitogens|mesh-list
138737242|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
138737243|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737244|NCT01082965|Donepezil|donepezil|mesh-list
138737245|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138737246|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737247|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737248|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
138737249|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737250|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737251|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
138737252|NCT01102426|Dexamethasone|dexamethasone|mesh-list
138737253|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737254|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
138737255|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
138737256|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737257|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737258|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138737259|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
138737260|NCT01102426|Hormones|hormones|mesh-ancestor
138737261|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138737262|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138737263|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737264|NCT04308850|Vitamin D|vitamin d|mesh-list
138737265|NCT04308850|Vitamins|vitamins|mesh-ancestor
138737266|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
138737267|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737268|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138737269|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138737270|NCT01101334|Efatutazone|efatutazone|mesh-list
138737271|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737272|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138737273|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737274|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737275|NCT01327547|Maraviroc|maraviroc|mesh-list
138693603|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737276|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138737277|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138737278|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737279|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138737280|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138737281|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
138737282|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737283|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138737284|NCT01308567|Prednisone|prednisone|mesh-list
138737285|NCT01308567|Docetaxel|docetaxel|mesh-list
138737286|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737287|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
138737288|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
138737289|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
138737290|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737291|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737292|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
138737293|NCT01308567|Hormones|hormones|mesh-ancestor
138737306|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737308|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
138737309|NCT04325061|BB 1101|bb 1101|mesh-list
138737310|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737311|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
138737312|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
138737313|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737314|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072519|NCT00394433|Cisplatin|cisplatin|mesh-list
138737315|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138737317|NCT04325061|Hormones|hormones|mesh-ancestor
138737318|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138737319|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138737320|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737321|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
138737322|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737323|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737324|NCT01307319|Beclomethasone|beclomethasone|mesh-list
138737325|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737326|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
138737327|NCT01307319|Hormones|hormones|mesh-ancestor
138737328|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138737329|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737330|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138737331|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
138737332|NCT04365725|Remdesivir|remdesivir|mesh-list
138737333|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
138583559|NCT00137774|Bevacizumab|bevacizumab|mesh-list
138549182|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138737334|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737335|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
138737336|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737337|NCT01080391|Dexamethasone|dexamethasone|mesh-list
138737338|NCT01080391|Lenalidomide|lenalidomide|mesh-list
138737339|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737340|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
138737341|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
138737342|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737343|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737344|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138737345|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
138737346|NCT01080391|Hormones|hormones|mesh-ancestor
138737347|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138737348|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138737349|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737350|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
138737351|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138693680|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
138737352|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138737353|NCT01080391|Growth Substances|growth substances|mesh-ancestor
138737354|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
138737369|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138737370|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138737372|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
138737373|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737374|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737375|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737376|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138737377|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138737378|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138737379|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737380|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138737381|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138737382|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737383|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
138737384|NCT02875717|Aspirin|aspirin|mesh-list
138737385|NCT02875717|Heparin|heparin|mesh-list
138737386|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138737387|NCT02875717|Tinzaparin|tinzaparin|mesh-list
138737388|NCT02875717|Dalteparin|dalteparin|mesh-list
138737389|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
138737390|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138737391|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138737392|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737393|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138737394|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138737395|NCT02875717|Analgesics|analgesics|mesh-ancestor
138737396|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
138737397|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737398|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737399|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737400|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138737401|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138737402|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138737403|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737404|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
138737406|NCT04334837|Trace Elements|trace elements|mesh-ancestor
138583581|NCT00137813|Bevacizumab|bevacizumab|mesh-list
138737407|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
138737408|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737409|NCT00593099|Bupropion|bupropion|mesh-list
138737410|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138737411|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
138737412|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138737413|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138737414|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138737431|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
138737432|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138737433|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737435|NCT00593801|Hematinics|hematinics|mesh-ancestor
138737436|NCT00593879|Mecamylamine|mecamylamine|mesh-list
138737437|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138737438|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138737439|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
138737440|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737441|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737442|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138737443|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138737444|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
138737445|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737446|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737447|NCT00594191|Simvastatin|simvastatin|mesh-list
138737448|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138737449|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138737450|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
138737451|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737452|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138737453|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138737454|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737455|NCT00594269|Risperidone|risperidone|mesh-list
138737456|NCT00594269|Citalopram|citalopram|mesh-list
138737457|NCT00594269|Sertraline|sertraline|mesh-list
138737458|NCT00594269|Paroxetine|paroxetine|mesh-list
138737459|NCT00594269|Escitalopram|escitalopram|mesh-list
138737460|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138737461|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
138737462|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737463|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737464|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737465|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138737466|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138737467|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138737468|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138737469|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138737470|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
138737471|NCT00594269|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138657256|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
138737505|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138737506|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138737507|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737508|NCT00595985|Sorafenib|sorafenib|mesh-list
138737509|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737535|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737536|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
138737538|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
138737539|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
138737540|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138737541|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737542|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
138737543|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737544|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138737545|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138737546|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138737547|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138737548|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737549|NCT00596531|Acamprosate|acamprosate|mesh-list
138737550|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138737551|NCT00596609|Morphine|morphine|mesh-list
138737552|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138737553|NCT00596609|Narcotics|narcotics|mesh-ancestor
138737554|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138737555|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737556|NCT00596609|Analgesics|analgesics|mesh-ancestor
138737557|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
138737566|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
138737567|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
138737568|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138737569|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737570|NCT01064401|Interferons|interferons|mesh-list
138737571|NCT01064401|Interferon-beta|interferon-beta|mesh-list
138737572|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
138737573|NCT01064401|Daclizumab|daclizumab|mesh-list
138693909|NCT03910998|Rocuronium|rocuronium|mesh-list
139072645|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
138737574|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737575|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
138737576|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737577|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
138737578|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737579|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138737580|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138737581|NCT00597389|Propranolol|propranolol|mesh-list
138737582|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138737583|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138737584|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
138737585|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737586|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737587|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737588|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138737589|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138737590|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
138737591|NCT01306617|Ritonavir|ritonavir|mesh-list
138737592|NCT01306617|Ribavirin|ribavirin|mesh-list
138737593|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138737594|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138737595|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
138737596|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737597|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737598|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138737599|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138737600|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
138737601|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737602|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138737603|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138737604|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
138737605|NCT00597623|Adalimumab|adalimumab|mesh-list
138737606|NCT00597623|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138737607|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737608|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138737609|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
138737610|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737611|NCT00627133|Levetiracetam|levetiracetam|mesh-list
138737612|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
138737613|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
138737614|NCT00598013|Pioglitazone|pioglitazone|mesh-list
139072676|NCT01044329|Triamcinolone|triamcinolone|mesh-list
138737615|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138737616|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737617|NCT04303429|Capecitabine|capecitabine|mesh-list
138737618|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138737619|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
138737620|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737621|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737622|NCT00598091|Gemcitabine|gemcitabine|mesh-list
138737623|NCT00598091|Dasatinib|dasatinib|mesh-list
138737624|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138737625|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
138737626|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737627|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737637|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138737638|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138737639|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737640|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549249|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138737641|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737642|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138737643|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
138737644|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737645|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
138737646|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138737647|NCT00598169|Dexamethasone|dexamethasone|mesh-list
138737649|NCT00598169|Carboplatin|carboplatin|mesh-list
138737651|NCT00598169|Bortezomib|bortezomib|mesh-list
138737652|NCT00598169|Ifosfamide|ifosfamide|mesh-list
139072709|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138737653|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737655|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
138737656|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737657|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737658|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138737659|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
138737660|NCT00598169|Hormones|hormones|mesh-ancestor
138737661|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138737662|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138737663|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737664|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138737665|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
138737666|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138737667|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138737668|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138737669|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138737670|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737671|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737672|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138737673|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
138737674|NCT00598247|Paclitaxel|paclitaxel|mesh-list
138737675|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138737676|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138737677|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737678|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
138737679|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
138737680|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
138737681|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737682|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
138737683|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
138737684|NCT00598403|Cefditoren|cefditoren|mesh-list
138737685|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138737686|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072757|NCT01044485|Docetaxel|docetaxel|mesh-list
138737687|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138737688|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138737690|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737691|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737692|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138737693|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138737694|NCT00598637|Everolimus|everolimus|mesh-list
138737714|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
138737715|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138737716|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
138737717|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737718|NCT00598793|Insulin|insulin|mesh-list
138737719|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138737720|NCT00598793|Metformin|metformin|mesh-list
138737721|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
138737722|NCT00598793|Pioglitazone|pioglitazone|mesh-list
138737723|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
138737724|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
138737725|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138737726|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737727|NCT01326845|Deferasirox|deferasirox|mesh-list
138737728|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138737729|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
138737730|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
138737731|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737733|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138737734|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
138737735|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138737736|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737737|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138737738|NCT01062763|Diuretics|diuretics|mesh-ancestor
138737739|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
138737740|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
138737741|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138737742|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
138737743|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737744|NCT00599573|Ondansetron|ondansetron|mesh-list
138737745|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
138737746|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
138737747|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737748|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737749|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138737750|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
138737751|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
138737764|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
138737765|NCT00599807|Vitamins|vitamins|mesh-ancestor
138737766|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
138737767|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737768|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138737769|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138737770|NCT00599885|Valsartan|valsartan|mesh-list
138737771|NCT00599885|Telmisartan|telmisartan|mesh-list
138737772|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138737773|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138737774|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138737775|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737776|NCT01303965|Sirolimus|sirolimus|mesh-list
138737777|NCT01303965|Lenalidomide|lenalidomide|mesh-list
138737778|NCT01303965|Tacrolimus|tacrolimus|mesh-list
138737779|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138737780|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
138737781|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737782|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138737783|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737784|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737785|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138737786|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138737787|NCT01303965|Growth Substances|growth substances|mesh-ancestor
138737788|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
138737789|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737790|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138737791|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737792|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138737793|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
138737794|NCT00600041|Pantoprazole|pantoprazole|mesh-list
138737795|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138737796|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138737797|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138737798|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737799|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737800|NCT01045993|Analgesics|analgesics|mesh-list
138737801|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
138737802|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737803|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737804|NCT00600509|Levetiracetam|levetiracetam|mesh-list
138737805|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
138737806|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
138737807|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
138737808|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
138737809|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138737810|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138737811|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737812|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737813|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737814|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138737815|NCT00600587|Carboplatin|carboplatin|mesh-list
138737816|NCT00600587|Gemcitabine|gemcitabine|mesh-list
138737817|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138737849|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737850|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138737851|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138737852|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072889|NCT01086332|Nelfinavir|nelfinavir|mesh-list
138737853|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737854|NCT00601211|Pilocarpine|pilocarpine|mesh-list
138737856|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
138737857|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737858|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737859|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138737860|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138737861|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
138737862|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138657370|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138737878|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138737879|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138737880|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
138737881|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737883|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737884|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737885|NCT04325633|Naproxen|naproxen|mesh-list
138737886|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138737887|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138737888|NCT04325633|Analgesics|analgesics|mesh-ancestor
138737889|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
138737890|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737891|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737892|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737893|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138737894|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
138737895|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138737896|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737897|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737898|NCT01061359|Epirubicin|epirubicin|mesh-list
138737899|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138737900|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737901|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138737902|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138737903|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737904|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737905|NCT05643417|Bevacizumab|bevacizumab|mesh-list
138737906|NCT05643417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138737907|NCT05643417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737908|NCT05643417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138737909|NCT05643417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138737910|NCT05643417|Growth Substances|growth substances|mesh-ancestor
138737911|NCT05643417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737912|NCT05643417|Growth Inhibitors|growth inhibitors|mesh-ancestor
138737913|NCT04303741|Apatinib|apatinib|mesh-list
138737914|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737915|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138737916|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138737917|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737918|NCT00626977|Clonidine|clonidine|mesh-list
138737919|NCT00626977|Ropivacaine|ropivacaine|mesh-list
138737933|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
138737934|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737935|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737937|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138737938|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737939|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138737940|NCT04303819|Incretins|incretins|mesh-ancestor
138737941|NCT04303819|Hormones|hormones|mesh-ancestor
138737942|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138737943|NCT01301079|Ketamine|ketamine|mesh-list
138737944|NCT01301079|Analgesics|analgesics|mesh-ancestor
138737945|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
138737946|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737947|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737948|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138737949|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138737950|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
138737951|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
138737952|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138694277|NCT01266148|Cyclosporine|cyclosporine|mesh-list
138737953|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138737954|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138737955|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138737956|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737957|NCT05271721|Dexamethasone|dexamethasone|mesh-list
138737958|NCT05271721|Dexamethasone acetate|dexamethasone acetate|mesh-list
138737959|NCT05271721|BB 1101|bb 1101|mesh-list
138737960|NCT05271721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138737961|NCT05271721|Antiemetics|antiemetics|mesh-ancestor
138737962|NCT05271721|Autonomic Agents|autonomic agents|mesh-ancestor
138737963|NCT05271721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737964|NCT05271721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737965|NCT05271721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138737966|NCT05271721|Glucocorticoids|glucocorticoids|mesh-ancestor
138737967|NCT05271721|Hormones|hormones|mesh-ancestor
138737968|NCT05271721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138737969|NCT05271721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138737970|NCT05271721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138737971|NCT05271721|Protease Inhibitors|protease inhibitors|mesh-ancestor
138737972|NCT05271721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072948|NCT00118040|Genistein|genistein|mesh-list
138737973|NCT05271721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138737974|NCT01301001|Gabapentin|gabapentin|mesh-list
138737975|NCT01301001|Analgesics|analgesics|mesh-ancestor
138737976|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
138737977|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138737978|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737979|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
138737980|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138737988|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
138737989|NCT01300923|Acamprosate|acamprosate|mesh-list
138737990|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138737991|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
138737992|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
138737993|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138737994|NCT02890173|Eplerenone|eplerenone|mesh-list
138737995|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138737996|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
138737997|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138737998|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138737999|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138738000|NCT02890173|Diuretics|diuretics|mesh-ancestor
138738001|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
138738002|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138738003|NCT01300455|Suvorexant|suvorexant|mesh-list
138738004|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138738005|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138738006|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138738007|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738008|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138738009|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738010|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738011|NCT01101178|Oxycodone|oxycodone|mesh-list
138738012|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138738013|NCT01101178|Narcotics|narcotics|mesh-ancestor
138738014|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138738015|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738016|NCT01101178|Analgesics|analgesics|mesh-ancestor
138738017|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
138583751|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738018|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738019|NCT05637645|Bupivacaine|bupivacaine|mesh-list
138738020|NCT05637645|Anesthetics, Local|anesthetics, local|mesh-ancestor
138738021|NCT05637645|Anesthetics|anesthetics|mesh-ancestor
138738022|NCT05637645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138738023|NCT05637645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738024|NCT05637645|Sensory System Agents|sensory system agents|mesh-ancestor
138738025|NCT05637645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072975|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138738026|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138738027|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138738028|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738029|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138738030|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138738031|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138738032|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738034|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738035|NCT02879110|Sulforaphane|sulforaphane|mesh-list
138738036|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138738037|NCT02879110|Protective Agents|protective agents|mesh-ancestor
138738038|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738039|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738040|NCT04207515|Anesthetics|anesthetics|mesh-list
138738041|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138738042|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738043|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
138738044|NCT01100944|Doxorubicin|doxorubicin|mesh-list
138549278|NCT00246415|Memantine|memantine|mesh-list
138738054|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138738055|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138738056|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138738057|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138738058|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738059|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138738061|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138738062|NCT01100320|Narcotics|narcotics|mesh-ancestor
138738063|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138738064|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738065|NCT01100320|Analgesics|analgesics|mesh-ancestor
138738066|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
138738067|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738068|NCT04309708|Nimodipine|nimodipine|mesh-list
138738069|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138738070|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138738071|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138738072|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738073|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138738074|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738075|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
138738076|NCT01100086|Oxycodone|oxycodone|mesh-list
138738077|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138738078|NCT01100086|Narcotics|narcotics|mesh-ancestor
138738079|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138738080|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738081|NCT01100086|Analgesics|analgesics|mesh-ancestor
138738082|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
138738083|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738084|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138738085|NCT00626080|Insulin|insulin|mesh-list
138738086|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138738087|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
138738088|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
138738089|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
138738090|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
138738091|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138738092|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738093|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
138738094|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138738095|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
138738096|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138738097|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
138738098|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738099|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738100|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
138738101|NCT01035229|Everolimus|everolimus|mesh-list
138738102|NCT01035229|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138738103|NCT01035229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138738104|NCT01035229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738105|NCT01035229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549287|NCT00246532|Morphine|morphine|mesh-list
138738106|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138738107|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
138738108|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738109|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738110|NCT01059799|Insulin|insulin|mesh-list
138738117|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
138738118|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138738119|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138738120|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138738121|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138738123|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
138738124|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738125|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
138738126|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138738127|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138738128|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738129|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138738130|NCT04307290|Analgesics|analgesics|mesh-ancestor
138738131|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
138738132|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738133|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138738134|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138738135|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138738136|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
138738137|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738138|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738139|NCT01325207|Trastuzumab|trastuzumab|mesh-list
138738140|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138738141|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738142|NCT01324349|Hemostatics|hemostatics|mesh-list
138738143|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138738144|NCT01324349|Coagulants|coagulants|mesh-ancestor
138738145|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138738146|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
138738147|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738148|NCT01095094|Ritonavir|ritonavir|mesh-list
138738149|NCT01095094|Lopinavir|lopinavir|mesh-list
138738150|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138738151|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138738152|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
138738153|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738154|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738155|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138738156|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138738157|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
138738158|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738159|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138738160|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138738162|NCT00623285|Analgesics|analgesics|mesh-ancestor
138738163|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
138738164|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738165|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738166|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
138738167|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138738168|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138738169|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738170|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138738171|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138738172|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138738173|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549308|NCT04728516|Pantoprazole|pantoprazole|mesh-list
138738174|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138738175|NCT01097044|Afamelanotide|afamelanotide|mesh-list
138694496|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
138738176|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
138738177|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
138738178|NCT01322009|Probenecid|probenecid|mesh-list
138738187|NCT01322009|Protective Agents|protective agents|mesh-ancestor
138660390|NCT00345059|Docetaxel|docetaxel|mesh-list
138738188|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738189|NCT01322009|Antidotes|antidotes|mesh-ancestor
138738190|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
138738191|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
138738192|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138738193|NCT01320683|Leucovorin|leucovorin|mesh-list
138738194|NCT01320683|Bevacizumab|bevacizumab|mesh-list
138738195|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138738196|NCT01320683|Fluorouracil|fluorouracil|mesh-list
138738197|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
138738198|NCT01320683|Irinotecan|irinotecan|mesh-list
138738199|NCT01320683|Antibodies|antibodies|mesh-list
138738200|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
138738201|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138738202|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
138738203|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738204|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138738205|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138738206|NCT01320683|Growth Substances|growth substances|mesh-ancestor
138738207|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738208|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
138738209|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
138738210|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
138738211|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738212|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138738213|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138738214|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138738215|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138738216|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738217|NCT01320683|Antidotes|antidotes|mesh-ancestor
138738218|NCT01320683|Protective Agents|protective agents|mesh-ancestor
138738219|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
138738220|NCT01320683|Vitamins|vitamins|mesh-ancestor
138738221|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
138738222|NCT01320293|Adalimumab|adalimumab|mesh-list
138738223|NCT01320293|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138738224|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138738225|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138738226|NCT01318811|Heparin|heparin|mesh-list
138738227|NCT01318811|Calcium heparin|calcium heparin|mesh-list
138738228|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
138738229|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138738230|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138738231|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738232|NCT05644769|Lisinopril|lisinopril|mesh-list
138738233|NCT05644769|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138738234|NCT05644769|Protease Inhibitors|protease inhibitors|mesh-ancestor
138738235|NCT05644769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738236|NCT05644769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738237|NCT05644769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138738238|NCT05644769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138738239|NCT05644769|Protective Agents|protective agents|mesh-ancestor
138738240|NCT05644769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738241|NCT05644691|Emollients|emollients|mesh-list
138738242|NCT05644691|Dermatologic Agents|dermatologic agents|mesh-ancestor
138738243|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138583839|NCT00161070|Aspirin|aspirin|mesh-list
138738244|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
138738245|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738246|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
138738247|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138738248|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138738249|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
138738259|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138738261|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738262|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138738263|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738264|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738265|NCT02878018|Hormones|hormones|mesh-list
138738266|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
138738267|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138738268|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138738269|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138738270|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738271|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738272|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738273|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
138738274|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
138738275|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738276|NCT01313663|Pemetrexed|pemetrexed|mesh-list
138738277|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738278|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738279|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738280|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138738281|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138738282|NCT01092832|Voriconazole|voriconazole|mesh-list
138738283|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
138738284|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738285|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138738286|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138738287|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738288|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738289|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138738290|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
138738291|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138738292|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738293|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138738295|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
138738296|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138738297|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738298|NCT04308070|Hemostatics|hemostatics|mesh-list
138738299|NCT04308070|Coagulants|coagulants|mesh-ancestor
138738300|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
138738301|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
138738302|NCT01313273|Lanreotide|lanreotide|mesh-list
138738303|NCT01313273|Androgens|androgens|mesh-list
138738304|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138738305|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138738306|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
138738307|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
138738308|NCT01313273|Hormones|hormones|mesh-ancestor
138738309|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138738310|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738311|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
138738312|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738313|NCT01313273|Protective Agents|protective agents|mesh-ancestor
138738314|NCT01313273|Vitamins|vitamins|mesh-ancestor
138583859|NCT00138983|Alendronate|alendronate|mesh-list
138738324|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138738325|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138738326|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138694652|NCT00546936|Ranibizumab|ranibizumab|mesh-list
138738327|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738329|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
138738330|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738331|NCT01313117|Protective Agents|protective agents|mesh-ancestor
138738332|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738333|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
138738335|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
138738336|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138738337|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
138738338|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138738339|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138738340|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138738341|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738342|NCT01312961|Fluticasone|fluticasone|mesh-list
138738343|NCT01312961|Xhance|xhance|mesh-list
138738344|NCT01312961|Albuterol|albuterol|mesh-list
138738345|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138738346|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138738347|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138738348|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138738349|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138738350|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
138738351|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738352|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738353|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138738354|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
138738355|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
138738356|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138738357|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138738358|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138738359|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138738360|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
138738361|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738362|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738363|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
138738364|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138738365|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
138738366|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
138738367|NCT01312961|Hormones|hormones|mesh-ancestor
138738368|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138738369|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
138738370|NCT00626158|Gemcitabine|gemcitabine|mesh-list
138738371|NCT00626158|Capecitabine|capecitabine|mesh-list
138738372|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138738373|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
138738374|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738375|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738376|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138738377|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138738378|NCT01310777|Brinzolamide|brinzolamide|mesh-list
138738379|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138738380|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138738381|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138738400|NCT01309841|Naloxegol|naloxegol|mesh-list
138738401|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138738402|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738403|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
138738404|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738405|NCT01308749|Oxytocin|oxytocin|mesh-list
138738406|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
138738407|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138738408|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738409|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138738411|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738412|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138738413|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
138738414|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
138738415|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
138738416|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738417|NCT05644301|Minocycline|minocycline|mesh-list
138738418|NCT05644301|Celecoxib|celecoxib|mesh-list
138738419|NCT05644301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138738420|NCT05644301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138738421|NCT05644301|Analgesics|analgesics|mesh-ancestor
138738422|NCT05644301|Sensory System Agents|sensory system agents|mesh-ancestor
138738423|NCT05644301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738424|NCT05644301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738425|NCT05644301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138738426|NCT05644301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138738427|NCT05644301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138738428|NCT05644301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138738429|NCT05644301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738430|NCT05644301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738431|NCT05644301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138738432|NCT05644301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738433|NCT02890745|Empagliflozin|empagliflozin|mesh-list
138738434|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138738435|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738436|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138738449|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738450|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138738451|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138738452|NCT01057693|Pregabalin|pregabalin|mesh-list
138738453|NCT01057693|Analgesics|analgesics|mesh-ancestor
138738454|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
138738455|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738456|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738457|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
138738458|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138738459|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138738460|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738461|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138738462|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138738463|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138738464|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138738465|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138738466|NCT04325009|Atorvastatin|atorvastatin|mesh-list
138738467|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138738468|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138738469|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
138738470|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549391|NCT00247741|Lidocaine|lidocaine|mesh-list
138738471|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138738472|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138738473|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738474|NCT01034137|Methotrexate|methotrexate|mesh-list
138738475|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138738476|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
138738477|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138738478|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738479|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138738480|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
138738481|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738482|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738483|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
138738484|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738485|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138738486|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138738487|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
138738488|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138738489|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138738490|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
138738491|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138738492|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
138738493|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738494|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138657503|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
138738505|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138738506|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
138738507|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738508|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738509|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
138738510|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738511|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138738512|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
138738513|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738515|NCT01033825|Dexamethasone|dexamethasone|mesh-list
138738516|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
138738517|NCT01033825|BB 1101|bb 1101|mesh-list
138738518|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138738519|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
138738520|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
138738521|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738522|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583923|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
138738523|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138738524|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
138738525|NCT01033825|Hormones|hormones|mesh-ancestor
138738526|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139073517|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
138738527|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138738528|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738529|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
138738530|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738531|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738532|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138738533|NCT01033747|Deferasirox|deferasirox|mesh-list
138738534|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138738535|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
138738536|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
138738537|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738538|NCT02875015|Lidocaine|lidocaine|mesh-list
138738539|NCT02875015|Bupivacaine|bupivacaine|mesh-list
138738540|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
138738541|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
138738542|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138738543|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738544|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
138738545|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738546|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138738547|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138738549|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138738550|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738551|NCT01091428|Paclitaxel|paclitaxel|mesh-list
138738552|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138738553|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738554|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
138738556|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
138738557|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738568|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138738569|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138738570|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
138738571|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
138738572|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738573|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738574|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138738575|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738576|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
138738577|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138738578|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138738579|NCT01049503|Fluorides|fluorides|mesh-list
138738580|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
138738581|NCT01049503|Protective Agents|protective agents|mesh-ancestor
138738582|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738583|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
138738584|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138738585|NCT04301557|Capecitabine|capecitabine|mesh-list
138738586|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
138738587|NCT04301557|Antibodies|antibodies|mesh-list
138738588|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
138738589|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738590|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138738591|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
138738592|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738593|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738594|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138738595|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738596|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
138738597|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138738598|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
138738599|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738600|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
138738601|NCT01029535|Protective Agents|protective agents|mesh-ancestor
138738602|NCT01028053|Flutemetamol|flutemetamol|mesh-list
138738603|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138738604|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738605|NCT01023217|Lamivudine|lamivudine|mesh-list
138738606|NCT01023217|Adefovir|adefovir|mesh-list
138738608|NCT01023217|Entecavir|entecavir|mesh-list
138738609|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138738610|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138738611|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738612|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738613|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
138738614|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738615|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138738616|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138738617|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138738618|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138738619|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138738620|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138738621|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738654|NCT05661045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738655|NCT01294683|Niacin|niacin|mesh-list
138738656|NCT01294683|Niacinamide|niacinamide|mesh-list
138738657|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
138738658|NCT01294683|Simvastatin|simvastatin|mesh-list
138738659|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138738660|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138738661|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
138738662|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738663|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138738664|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138738665|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738666|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
138738667|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
138738687|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138738688|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
138738690|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138738691|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138738692|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138695019|NCT01262872|Vaccines|vaccines|mesh-list
138738693|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
138738694|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138738696|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738697|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138738698|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138738699|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138738700|NCT01293123|Tenofovir|tenofovir|mesh-list
138738701|NCT01293123|Emtricitabine|emtricitabine|mesh-list
138738702|NCT01293123|Efavirenz|efavirenz|mesh-list
138738703|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
138738704|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
138738705|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738706|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138738707|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138738708|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738709|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738710|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138738711|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138738712|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138738713|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138738714|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138738715|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138738716|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138738717|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138738718|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138738719|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138738720|NCT01292187|Calcitonin|calcitonin|mesh-list
138738721|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
138738722|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138738723|NCT01292187|Katacalcin|katacalcin|mesh-list
138738724|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138738728|NCT01026493|Temozolomide|temozolomide|mesh-list
138738730|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138738731|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
138738732|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738733|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738734|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138738735|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738736|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138738737|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138738738|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738739|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139073700|NCT01079481|Everolimus|everolimus|mesh-list
138738740|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138738741|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138738742|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738743|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
138738744|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738745|NCT01291017|Palbociclib|palbociclib|mesh-list
138738746|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738747|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138738748|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738749|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738750|NCT01290315|Dextrans|dextrans|mesh-list
138738751|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138738752|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
138738753|NCT01290315|Hematinics|hematinics|mesh-ancestor
138738754|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
138738755|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
138738756|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
138738757|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
138738758|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138738759|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138738760|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
138738761|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738762|NCT01021813|Suvorexant|suvorexant|mesh-list
138738763|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138738764|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138738765|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695092|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738766|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738767|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138738768|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738769|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738770|NCT01025635|Azelaic acid|azelaic acid|mesh-list
138738771|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738772|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
138738773|NCT01021423|Lenalidomide|lenalidomide|mesh-list
138738774|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
138738775|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738776|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138738777|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138738778|NCT01021423|Growth Substances|growth substances|mesh-ancestor
138738779|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
138738780|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738781|NCT01020877|Metronidazole|metronidazole|mesh-list
138738782|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738783|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138738784|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138738785|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138738786|NCT01020799|Escitalopram|escitalopram|mesh-list
138738787|NCT01020799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138738788|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138549436|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738789|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138738790|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738791|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738792|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
138738808|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138738810|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738811|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738812|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138738813|NCT02872597|Protective Agents|protective agents|mesh-ancestor
138738814|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138738815|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138738816|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
138738817|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
138738818|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138738819|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138738820|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139073754|NCT01324583|Hormones|hormones|mesh-ancestor
138738821|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138738822|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
138738823|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138738824|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138738825|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
138738826|NCT02873065|Amoxicillin|amoxicillin|mesh-list
138738827|NCT02873065|Clarithromycin|clarithromycin|mesh-list
138738828|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
138738829|NCT02873065|Bismuth|bismuth|mesh-list
138738830|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738831|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138738832|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738833|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138738834|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738835|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138738836|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138738837|NCT02873065|Antacids|antacids|mesh-ancestor
138738838|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138738839|NCT02873065|Diuretics|diuretics|mesh-ancestor
138738840|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
138738841|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738842|NCT02873065|Expectorants|expectorants|mesh-ancestor
138738843|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
138738844|NCT00628225|Bupropion|bupropion|mesh-list
138738845|NCT00628225|Nicotine|nicotine|mesh-list
138738846|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138738847|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
138738848|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138738849|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738850|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138738851|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138738852|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
138738853|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584041|NCT00406341|Difluprednate|difluprednate|mesh-list
138738854|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657579|NCT00429234|Dasatinib|dasatinib|mesh-list
138738892|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738893|NCT01020019|Hormones|hormones|mesh-ancestor
138738913|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695243|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
138738914|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138738915|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
138738916|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738917|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
138738918|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738919|NCT02877238|Sevoflurane|sevoflurane|mesh-list
138738920|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
138738921|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138738922|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738923|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139073839|NCT03735082|Paclitaxel|paclitaxel|mesh-list
138738924|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138738925|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
138738926|NCT01288911|Bicalutamide|bicalutamide|mesh-list
138738927|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
138738928|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
138738929|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138738930|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738931|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738932|NCT01288443|Atorvastatin|atorvastatin|mesh-list
138738934|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138738935|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138738936|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138738937|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
138738938|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738939|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138738940|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138738941|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138738942|NCT01288443|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138738943|NCT01288443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138738944|NCT01288443|Protease Inhibitors|protease inhibitors|mesh-ancestor
138738945|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
138738946|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738947|NCT01288209|Ribavirin|ribavirin|mesh-list
138738963|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
138738964|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738965|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138738966|NCT01287117|Omalizumab|omalizumab|mesh-list
138738967|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139073900|NCT03734614|Aspirin|aspirin|mesh-list
138738968|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138738969|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
138738970|NCT01287039|Reslizumab|reslizumab|mesh-list
138738971|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138738972|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
138738973|NCT05572203|Caseins|caseins|mesh-list
138738974|NCT05572203|Chelating Agents|chelating agents|mesh-ancestor
138738975|NCT05572203|Sequestering Agents|sequestering agents|mesh-ancestor
138738976|NCT05572203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738977|NCT01285401|Interferons|interferons|mesh-list
138738978|NCT01285401|Interferon-beta|interferon-beta|mesh-list
138738979|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
138738980|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138738981|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
138738982|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138738983|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
138738984|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738985|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138738986|NCT01285323|Reslizumab|reslizumab|mesh-list
138738987|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138738988|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
138695326|NCT02897765|Nivolumab|nivolumab|mesh-list
138738989|NCT01284621|Empagliflozin|empagliflozin|mesh-list
138738990|NCT01284621|Ramipril|ramipril|mesh-list
138738991|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138738992|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
138738993|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549522|NCT00068081|Capsaicin|capsaicin|mesh-list
138738994|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138738995|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138738996|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138738997|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138738998|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138738999|NCT01283139|Sifalimumab|sifalimumab|mesh-list
138739000|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138739001|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
139073939|NCT00098306|Maraviroc|maraviroc|mesh-list
138739002|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739003|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
138739004|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138739006|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
138739007|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138739008|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
138739009|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739010|NCT01281813|Ritonavir|ritonavir|mesh-list
138739022|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138739024|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739025|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739026|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739027|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
138739028|NCT01090102|Mesalamine|mesalamine|mesh-list
138739029|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138739030|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138739031|NCT01090102|Analgesics|analgesics|mesh-ancestor
138739032|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
138739033|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739034|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739035|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739036|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739037|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
138739038|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138739039|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739040|NCT01281189|Pramipexole|pramipexole|mesh-list
138739041|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
138739042|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739043|NCT01281189|Protective Agents|protective agents|mesh-ancestor
138739044|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739045|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138739046|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138739047|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
138739048|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
138739049|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739050|NCT04306666|Anesthetics|anesthetics|mesh-list
138739051|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739052|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739053|NCT01280955|Plerixafor|plerixafor|mesh-list
138739054|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138739055|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138739056|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
138739057|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739058|NCT01280721|Tolvaptan|tolvaptan|mesh-list
138739059|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138739060|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739061|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
138739062|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739063|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
138739064|NCT01087762|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138739065|NCT01087762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739066|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138739067|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
138739068|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739069|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739070|NCT04306354|Oxytocin|oxytocin|mesh-list
138739071|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
138739072|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138739073|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739074|NCT04306276|Dienogest|dienogest|mesh-list
138739087|NCT01078168|Acitretin|acitretin|mesh-list
138739088|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
139074024|NCT03731494|Nickel|nickel|mesh-list
138739089|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
138739090|NCT01086358|Naproxen|naproxen|mesh-list
138739091|NCT01086358|Sumatriptan|sumatriptan|mesh-list
138739092|NCT01086358|Naratriptan|naratriptan|mesh-list
138739093|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
138739094|NCT01086358|Rizatriptan|rizatriptan|mesh-list
138739095|NCT01086358|Eletriptan|eletriptan|mesh-list
138739096|NCT01086358|Almotriptan|almotriptan|mesh-list
138739097|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138739098|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138739099|NCT01086358|Analgesics|analgesics|mesh-ancestor
138739100|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
138739101|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739102|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739103|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739104|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739105|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
138739106|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138739107|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739108|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739109|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138739110|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138739111|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138739112|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
138739113|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739114|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138739115|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
138739116|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739117|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
138739118|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138739119|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
138739120|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739121|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739122|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138739123|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
138739124|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
138739125|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138739126|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
138739127|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739128|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739129|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138739130|NCT01081834|Canagliflozin|canagliflozin|mesh-list
138739131|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138739132|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739133|NCT01081834|Incretins|incretins|mesh-ancestor
138739134|NCT01081834|Hormones|hormones|mesh-ancestor
138739135|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138739136|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138739158|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
138739159|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139074119|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
138739160|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138739161|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739162|NCT01079806|Entecavir|entecavir|mesh-list
138739163|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
138739164|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739165|NCT02876770|Melatonin|melatonin|mesh-list
138739166|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
138739167|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739168|NCT02876770|Protective Agents|protective agents|mesh-ancestor
138739169|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739170|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739171|NCT01077622|Ofatumumab|ofatumumab|mesh-list
138739172|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739173|NCT01313676|Fluticasone|fluticasone|mesh-list
138739174|NCT01313676|Xhance|xhance|mesh-list
138739175|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739176|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138739177|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
138739178|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739179|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739180|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138739181|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
138739182|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
138739183|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138739184|NCT00623376|Dronabinol|dronabinol|mesh-list
138739185|NCT00623376|Nabilone|nabilone|mesh-list
138739186|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
138739187|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
138739188|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739189|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739190|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138739191|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138657692|NCT00328796|Lidocaine|lidocaine|mesh-list
138739220|NCT01075984|Posaconazole|posaconazole|mesh-list
138739221|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
138739222|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739223|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138739224|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138739225|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138739226|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138739227|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138739228|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739229|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739230|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138739231|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
138739232|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138739233|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739234|NCT01024231|Nivolumab|nivolumab|mesh-list
138739235|NCT01024231|Ipilimumab|ipilimumab|mesh-list
138739236|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138739237|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739238|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138739274|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
138739275|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
138739276|NCT01016977|Vitamins|vitamins|mesh-ancestor
138739277|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
138739278|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739279|NCT02871661|Amitriptyline|amitriptyline|mesh-list
138739310|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739311|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739312|NCT00627991|Valsartan|valsartan|mesh-list
138739313|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138739314|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138739315|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138739316|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739317|NCT01006291|Insulin|insulin|mesh-list
138739318|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138739320|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
138739321|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138739322|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739323|NCT02871349|Propranolol|propranolol|mesh-list
138657767|NCT00429624|Analgesics|analgesics|mesh-ancestor
138739387|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739388|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739389|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739390|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739391|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138739392|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739393|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739394|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
138739395|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
138739396|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138739397|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138739398|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138739399|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
138739462|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739463|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739465|NCT01309386|Tapentadol|tapentadol|mesh-list
138739466|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138739467|NCT01309386|Narcotics|narcotics|mesh-ancestor
138739495|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739496|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138739497|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138739498|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
138739499|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739501|NCT04295551|Lopinavir|lopinavir|mesh-list
138739502|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138739503|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138739504|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
138739505|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739506|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739507|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138739508|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138739509|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
138739510|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739511|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138739512|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138739513|NCT01266291|Vigabatrin|vigabatrin|mesh-list
138739514|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
138739515|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739546|NCT01264965|Acetaminophen|acetaminophen|mesh-list
138739547|NCT01264965|Oxycodone|oxycodone|mesh-list
138739548|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138739549|NCT01264965|Analgesics|analgesics|mesh-ancestor
138739550|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
138739551|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739552|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739553|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
138739554|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138739555|NCT01264965|Narcotics|narcotics|mesh-ancestor
138739556|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739557|NCT01264887|Tapentadol|tapentadol|mesh-list
138739558|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138739559|NCT01264887|Narcotics|narcotics|mesh-ancestor
138739560|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739561|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739595|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
138739596|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739597|NCT01263093|Clopidogrel|clopidogrel|mesh-list
138739598|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138739599|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138739600|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138739601|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138739637|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138739638|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138739639|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739640|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
138739641|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
138739642|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
138739643|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138739673|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739675|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739676|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739677|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
138739678|NCT01306032|Veliparib|veliparib|mesh-list
138739679|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138739680|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
138739681|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739682|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138739683|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138739684|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
138739685|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074357|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
138739686|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739687|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138739688|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138739689|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739720|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138739721|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739722|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138739723|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138739724|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739725|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138739726|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138739727|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
138739728|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138739730|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138739731|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739732|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138739796|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138739798|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
138739799|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138739800|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138739801|NCT04479267|Prednisolone|prednisolone|mesh-list
138334924|NCT00799578|Cysteamine|cysteamine|mesh-list
138739835|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
138739836|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
138739837|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739838|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138739839|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138739840|NCT04479267|Protective Agents|protective agents|mesh-ancestor
138739841|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138739842|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138739844|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138739845|NCT04021017|Estrogens|estrogens|mesh-ancestor
138739846|NCT04021017|Hormones|hormones|mesh-ancestor
138739873|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
138739874|NCT04320225|Dexamethasone|dexamethasone|mesh-list
138739875|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138739876|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
138739877|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
138739878|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739879|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739880|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138739881|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
138739882|NCT04320225|Hormones|hormones|mesh-ancestor
138739883|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138739884|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138739885|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138739886|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
138739887|NCT03219177|Narcotics|narcotics|mesh-ancestor
138739888|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138739889|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138739890|NCT03219177|Analgesics|analgesics|mesh-ancestor
138739891|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
138739892|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138739893|NCT02866071|Ketamine|ketamine|mesh-list
138739894|NCT02866071|Analgesics|analgesics|mesh-ancestor
138696230|NCT02465606|Hormones|hormones|mesh-ancestor
138739895|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
138739998|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138739999|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
138740000|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740002|NCT05640804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740003|NCT05640804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138740004|NCT05640804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740005|NCT05640804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740006|NCT00623688|Imidacloprid|imidacloprid|mesh-list
138740007|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
138740008|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740127|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138740128|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138740130|NCT01295814|Adalimumab|adalimumab|mesh-list
138740131|NCT01295814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138740132|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138740133|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138740134|NCT01254045|Oxytocin|oxytocin|mesh-list
138740135|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
138740136|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138740137|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740138|NCT01075282|Metformin|metformin|mesh-list
138740139|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
138740140|NCT01075282|Glimepiride|glimepiride|mesh-list
138740141|NCT01075282|Dulaglutide|dulaglutide|mesh-list
138740142|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138740143|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740144|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138740145|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138740146|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
138740147|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
138740148|NCT04324086|Calcium|calcium|mesh-list
138740149|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138740150|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740151|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138740152|NCT01295034|Vitamin D|vitamin d|mesh-list
138740153|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
138740181|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138740182|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740183|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138740184|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138740185|NCT02876224|Growth Substances|growth substances|mesh-ancestor
138740186|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740187|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
138584263|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740188|NCT02876224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138740189|NCT02876224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740190|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
138740191|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138549759|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138740193|NCT01253265|Ixekizumab|ixekizumab|mesh-list
138740194|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
138740195|NCT01293006|Suvorexant|suvorexant|mesh-list
138740196|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138740197|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138740198|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138740199|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740200|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138740352|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740353|NCT02876146|Albendazole|albendazole|mesh-list
138740354|NCT02876146|Benzimidazole|benzimidazole|mesh-list
138740355|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
138740356|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138740357|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740358|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
138740359|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138740361|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
138740362|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
138740363|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
138740364|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740365|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740366|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138740367|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
138740368|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740371|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138740372|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740373|NCT02874820|Idazoxan|idazoxan|mesh-list
138658804|NCT00334412|Caspofungin|caspofungin|mesh-list
138740526|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138740527|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740528|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138740529|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740530|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740531|NCT01037218|Udenafil|udenafil|mesh-list
138740532|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138740533|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138740534|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740535|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740536|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138740537|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740538|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138740539|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740540|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740541|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
138740542|NCT01269918|Remifentanil|remifentanil|mesh-list
138740670|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138740671|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
138740672|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740673|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740674|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740675|NCT01243671|Adalimumab|adalimumab|mesh-list
138740676|NCT01243671|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138740677|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138740678|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138740679|NCT01240785|Metformin|metformin|mesh-list
138740680|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138659150|NCT00437814|Ketamine|ketamine|mesh-list
138740767|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138740768|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
138740769|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138740770|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740771|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740772|NCT01028014|Urological Agents|urological agents|mesh-ancestor
138740773|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138740774|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138740775|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
138740776|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138740777|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
138740778|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138740779|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138740780|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
138740781|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
138659272|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
138740812|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
138740813|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740814|NCT01032070|Etoposide|etoposide|mesh-list
138740815|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138740816|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138740817|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740818|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138740819|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138740820|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740821|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740822|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138740823|NCT01237899|Eplerenone|eplerenone|mesh-list
139074605|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
138740855|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138740856|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138740857|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740859|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740860|NCT01237587|Analgesics|analgesics|mesh-ancestor
138740861|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
138740862|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138740863|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
138740864|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138740865|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
138740866|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
138740904|NCT01030900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138740920|NCT01026454|Acyclovir|acyclovir|mesh-list
138740921|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
138740922|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138740923|NCT01026220|Prednisone|prednisone|mesh-list
138740924|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
138740925|NCT01026220|Ifosfamide|ifosfamide|mesh-list
138740926|NCT01026220|Doxorubicin|doxorubicin|mesh-list
138740927|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138740928|NCT01026220|Etoposide|etoposide|mesh-list
138740929|NCT01026220|Vincristine|vincristine|mesh-list
138740930|NCT01026220|Vinorelbine|vinorelbine|mesh-list
138740931|NCT01026220|Bleomycin|bleomycin|mesh-list
138740932|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
138740933|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138740934|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
138740935|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138740936|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138740937|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138740938|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
138740939|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740940|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740941|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138740942|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138740944|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138740945|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138740946|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138740948|NCT01026220|Hormones|hormones|mesh-ancestor
138740949|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138740950|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138740951|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138740952|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
138740953|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
138740954|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
138740955|NCT01026142|Capecitabine|capecitabine|mesh-list
138740956|NCT01026142|Trastuzumab|trastuzumab|mesh-list
138740957|NCT01026142|Pertuzumab|pertuzumab|mesh-list
138740958|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138740959|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
138740960|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138740961|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138740962|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138740963|NCT06055465|Pembrolizumab|pembrolizumab|mesh-list
138740964|NCT06055465|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138740965|NCT06055465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138740966|NCT06055465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659401|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
138741000|NCT06055257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138741002|NCT06055244|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138741003|NCT06055244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138741004|NCT06055244|Antiviral Agents|antiviral agents|mesh-ancestor
138741005|NCT06055244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138741006|NCT06055244|Dopamine Agents|dopamine agents|mesh-ancestor
138741007|NCT06055244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741008|NCT06055244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074685|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741036|NCT06055101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138741037|NCT06055101|Analgesics|analgesics|mesh-ancestor
138741038|NCT06055101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138741039|NCT06055101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138741040|NCT06055101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138741041|NCT06055101|Adrenergic Agents|adrenergic agents|mesh-ancestor
138741042|NCT06055101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741043|NCT06055101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741044|NCT06055101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138741045|NCT06055101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741046|NCT06055101|Cholinergic Agents|cholinergic agents|mesh-ancestor
138741047|NCT06055101|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138741048|NCT06055101|Autonomic Agents|autonomic agents|mesh-ancestor
138741049|NCT06054919|Vitamin D|vitamin d|mesh-list
138741050|NCT06054919|Cholecalciferol|cholecalciferol|mesh-list
138741051|NCT06054919|Vitamins|vitamins|mesh-ancestor
138741052|NCT06054919|Micronutrients|micronutrients|mesh-ancestor
138741053|NCT06054919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741054|NCT06054919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138741055|NCT06054919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138741056|NCT06054789|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138741057|NCT06054789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138659448|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
138741089|NCT06054321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138741090|NCT06054321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138741091|NCT06054321|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138741092|NCT06054321|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138741093|NCT06054321|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138741094|NCT06054321|Histamine Antagonists|histamine antagonists|mesh-ancestor
138741096|NCT06054321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138741097|NCT06054321|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139074733|NCT01087983|Metformin|metformin|mesh-list
138741098|NCT06054321|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138741099|NCT06054321|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138741100|NCT06054321|Adrenergic Agents|adrenergic agents|mesh-ancestor
138741101|NCT06054321|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138741130|NCT06050824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138741131|NCT06050824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138741132|NCT06050824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138741133|NCT06050824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138741134|NCT06024096|Atorvastatin|atorvastatin|mesh-list
138741135|NCT06024096|Vaccines|vaccines|mesh-list
138741136|NCT06024096|Immunologic Factors|immunologic factors|mesh-ancestor
138741137|NCT06024096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741138|NCT06024096|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138741139|NCT06024096|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138741140|NCT06024096|Antimetabolites|antimetabolites|mesh-ancestor
138741141|NCT06024096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741142|NCT06024096|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138741143|NCT06024096|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138741144|NCT06024096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741145|NCT05983354|Ibuprofen|ibuprofen|mesh-list
138741146|NCT05983354|Ketorolac|ketorolac|mesh-list
138741147|NCT05983354|Metoclopramide|metoclopramide|mesh-list
138741148|NCT05983354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138741180|NCT05955924|Vitamins|vitamins|mesh-ancestor
138741181|NCT05955924|Micronutrients|micronutrients|mesh-ancestor
138741182|NCT05955924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741183|NCT05955924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138741184|NCT05955924|Antimetabolites|antimetabolites|mesh-ancestor
138741185|NCT05955924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741186|NCT05955924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138584421|NCT04511416|Metformin|metformin|mesh-list
138741187|NCT05955924|Vasodilator Agents|vasodilator agents|mesh-ancestor
138741188|NCT05954962|Progesterone|progesterone|mesh-list
138741189|NCT05954962|Ganirelix|ganirelix|mesh-list
138741190|NCT05954962|Progestins|progestins|mesh-ancestor
138741191|NCT05954962|Hormones|hormones|mesh-ancestor
138741192|NCT05954962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138741193|NCT05954962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741194|NCT05954962|Hormone Antagonists|hormone antagonists|mesh-ancestor
138741195|NCT05943691|Dexamethasone|dexamethasone|mesh-list
138741196|NCT05943691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138741197|NCT05943691|Antiemetics|antiemetics|mesh-ancestor
138741351|NCT05852769|Midazolam|midazolam|mesh-list
138741352|NCT05852769|Caffeine|caffeine|mesh-list
138741353|NCT05852769|Omeprazole|omeprazole|mesh-list
138741354|NCT05852769|Pravastatin|pravastatin|mesh-list
138741355|NCT05852769|Montelukast|montelukast|mesh-list
138741356|NCT05852769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138741357|NCT05852769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138741358|NCT05852769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741359|NCT05852769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741360|NCT05852769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138741361|NCT05852769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138741362|NCT05852769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138741363|NCT05852769|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138741364|NCT05852769|Anesthetics, General|anesthetics, general|mesh-ancestor
138741365|NCT05852769|Anesthetics|anesthetics|mesh-ancestor
138741366|NCT05852769|GABA Modulators|gaba modulators|mesh-ancestor
138741367|NCT05852769|GABA Agents|gaba agents|mesh-ancestor
138741368|NCT05852769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741369|NCT05852769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260808|NCT03614663|Cannabidiol|cannabidiol|mesh-list
138659661|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138741398|NCT05852769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138741399|NCT05852769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138741400|NCT05852769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138741401|NCT05852769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138741402|NCT05809700|Hyaluronic Acid|hyaluronic acid|mesh-list
138741403|NCT05809700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138741404|NCT05809700|Immunologic Factors|immunologic factors|mesh-ancestor
138741405|NCT05809700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741406|NCT05809700|Viscosupplements|viscosupplements|mesh-ancestor
138741407|NCT05809700|Protective Agents|protective agents|mesh-ancestor
138741408|NCT05793060|Dexamethasone|dexamethasone|mesh-list
138741409|NCT05793060|Dexamethasone acetate|dexamethasone acetate|mesh-list
138741410|NCT05793060|Dexmedetomidine|dexmedetomidine|mesh-list
138741411|NCT05793060|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138741413|NCT05793060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138741414|NCT05793060|Antiemetics|antiemetics|mesh-ancestor
138741415|NCT05793060|Autonomic Agents|autonomic agents|mesh-ancestor
138741443|NCT05734443|Luteolytic Agents|luteolytic agents|mesh-ancestor
138741444|NCT05734443|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138741445|NCT05734443|Contraceptive Agents|contraceptive agents|mesh-ancestor
138741446|NCT05734443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138741447|NCT05734443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741448|NCT05734443|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138741449|NCT05734443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138741450|NCT05734443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741452|NCT05707455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138741453|NCT05707455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138741454|NCT05707455|Analgesics|analgesics|mesh-ancestor
138741455|NCT05707455|Sensory System Agents|sensory system agents|mesh-ancestor
138741456|NCT05707455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741457|NCT05707455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741458|NCT05707455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138741459|NCT05707455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138741460|NCT05615051|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138584486|NCT00155259|Docetaxel|docetaxel|mesh-list
138741489|NCT05579119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138741490|NCT05579119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138741491|NCT05579119|Protease Inhibitors|protease inhibitors|mesh-ancestor
138741492|NCT05579119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741493|NCT05579119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741495|NCT05575180|Methazolamide|methazolamide|mesh-list
138741496|NCT05575180|Anticonvulsants|anticonvulsants|mesh-ancestor
138741497|NCT05575180|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138741498|NCT05575180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741499|NCT05575180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741500|NCT05575180|Diuretics|diuretics|mesh-ancestor
138741501|NCT05575180|Natriuretic Agents|natriuretic agents|mesh-ancestor
138741502|NCT05575180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741503|NCT05530954|Calcium|calcium|mesh-list
138741504|NCT05530954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138741505|NCT05530954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741506|NCT05518929|Propofol|propofol|mesh-list
138741539|NCT05422001|Anesthetics|anesthetics|mesh-ancestor
138741540|NCT05422001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741541|NCT05422001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138741542|NCT05422001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138741543|NCT05422001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138741544|NCT05422001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741545|NCT05363631|Selenium|selenium|mesh-list
138741547|NCT05363631|Axitinib|axitinib|mesh-list
138659774|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138741580|NCT05295589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138741581|NCT05294965|Fenoterol|fenoterol|mesh-list
138741582|NCT05294965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138741583|NCT05294965|Autonomic Agents|autonomic agents|mesh-ancestor
138741584|NCT05294965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741585|NCT05294965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741586|NCT05294965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138741587|NCT05294965|Respiratory System Agents|respiratory system agents|mesh-ancestor
138741588|NCT05294965|Sympathomimetics|sympathomimetics|mesh-ancestor
138741589|NCT05294965|Tocolytic Agents|tocolytic agents|mesh-ancestor
138741590|NCT05294965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138741591|NCT05294965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138741615|NCT05247320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741616|NCT05247320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139074897|NCT03591406|Hematinics|hematinics|mesh-ancestor
138741618|NCT05247320|Autonomic Agents|autonomic agents|mesh-ancestor
138741619|NCT05247320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741620|NCT05238714|Venglustat|venglustat|mesh-list
138741621|NCT05238714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741622|NCT05238714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741623|NCT05228496|Tislelizumab|tislelizumab|mesh-list
138741624|NCT05228496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138741625|NCT05228496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741626|NCT05214599|Budesonide|budesonide|mesh-list
138741627|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138741628|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138741629|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
138741630|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741631|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741632|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138741633|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
138741634|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
138741635|NCT05214599|Hormones|hormones|mesh-ancestor
138741636|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138741637|NCT05183204|Metformin|metformin|mesh-list
138741638|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138741639|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741640|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
138741641|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138741642|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741677|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
138741678|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741679|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
138741680|NCT05130814|Protective Agents|protective agents|mesh-ancestor
138741681|NCT05124457|Insulin|insulin|mesh-list
138741682|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138741683|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
138741722|NCT04989283|Atezolizumab|atezolizumab|mesh-list
138741723|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138741724|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138741725|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741756|NCT04973254|Cabotegravir|cabotegravir|mesh-list
138741757|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138741758|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138741759|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741760|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741761|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
138741762|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138741763|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138741764|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138741765|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138741766|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138741767|NCT04964505|Azacitidine|azacitidine|mesh-list
138741768|NCT04964505|Venetoclax|venetoclax|mesh-list
138741769|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138741770|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
138741771|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741790|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
138741791|NCT04615403|Travoprost|travoprost|mesh-list
138741792|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138741793|NCT04577014|Gemcitabine|gemcitabine|mesh-list
138741794|NCT04577014|Docetaxel|docetaxel|mesh-list
138741795|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138741796|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
138741797|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741798|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741799|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
138741800|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
138741801|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
138741802|NCT04567784|Cannabidiol|cannabidiol|mesh-list
138741803|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
138741804|NCT04531046|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138741805|NCT04531046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138741806|NCT04531046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741807|NCT04494503|Rituximab|rituximab|mesh-list
138741808|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138741809|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741810|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
138741811|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741812|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138741813|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
138741814|NCT04477304|Narcotics|narcotics|mesh-ancestor
138741815|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741816|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741817|NCT04477304|Analgesics|analgesics|mesh-ancestor
138741818|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
138741819|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741820|NCT04448873|Sirolimus|sirolimus|mesh-list
138741821|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138741822|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138741823|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138741824|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741825|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
138741826|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138741827|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
138741828|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741829|NCT04368429|Vaccines|vaccines|mesh-list
138741830|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
138659965|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138741852|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138741853|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741854|NCT04300049|Incretins|incretins|mesh-ancestor
138741856|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138741857|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
138741858|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138741859|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
138741860|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741861|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741862|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
138741863|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138741864|NCT04216017|Lidocaine|lidocaine|mesh-list
138741865|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
138741866|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
138741867|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741868|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741869|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
138741870|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741871|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139075075|NCT05781633|Bevacizumab|bevacizumab|mesh-list
138741872|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138741873|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138741874|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138741875|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741876|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138741877|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
138741878|NCT04216017|Hormones|hormones|mesh-ancestor
138741879|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138741880|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138741881|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
138741882|NCT04206813|Vaccines|vaccines|mesh-list
138741883|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
138659994|NCT00446979|UC-781|uc-781|mesh-list
138741915|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741917|NCT04059224|Dabrafenib|dabrafenib|mesh-list
138741918|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741919|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138741920|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138741921|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138741922|NCT04002518|Cimetidine|cimetidine|mesh-list
138741923|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138698237|NCT02136147|Guanfacine|guanfacine|mesh-list
138741924|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138741925|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138660003|NCT00447018|Diuretics|diuretics|mesh-ancestor
138741950|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138741951|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741953|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
138741954|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741955|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138741956|NCT03890367|Vaccines|vaccines|mesh-list
138741957|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
138741958|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741959|NCT03877549|Dexamethasone|dexamethasone|mesh-list
138741960|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138741961|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
138741962|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
138741963|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138741964|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741965|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138741966|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
138741967|NCT03877549|Hormones|hormones|mesh-ancestor
138741968|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138741969|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138741970|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138741971|NCT03868124|Travoprost|travoprost|mesh-list
138741972|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138741973|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138741974|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138741975|NCT03720717|Baclofen|baclofen|mesh-list
138741976|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138741977|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138741978|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138660037|NCT00343265|Hormones|hormones|mesh-ancestor
138742010|NCT03678129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138742011|NCT03678129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138742012|NCT03678129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742013|NCT03678129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138742014|NCT03678129|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138742015|NCT03678129|GABA Agonists|gaba agonists|mesh-ancestor
138742016|NCT03678129|GABA Agents|gaba agents|mesh-ancestor
138742017|NCT03678129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742018|NCT03678129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742019|NCT03661684|Prednisone|prednisone|mesh-list
138742020|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138742021|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
138742022|NCT03661684|Hormones|hormones|mesh-ancestor
138742023|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138742024|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742025|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138742026|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742027|NCT03561376|Petrolatum|petrolatum|mesh-list
138742060|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138742061|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
138742062|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138742063|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742064|NCT03425279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742065|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742066|NCT03376672|Dexamethasone|dexamethasone|mesh-list
138742067|NCT03376672|Lenalidomide|lenalidomide|mesh-list
138742068|NCT03376672|Ixazomib|ixazomib|mesh-list
138742069|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138742070|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
138742071|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
138742106|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138742108|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742109|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138742110|NCT03285321|Nivolumab|nivolumab|mesh-list
138742111|NCT03285321|Ipilimumab|ipilimumab|mesh-list
138742112|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742113|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742183|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
138742185|NCT03126630|Anetumab ravtansine|anetumab ravtansine|mesh-list
138742186|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742187|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742188|NCT03126630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138742189|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742228|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742252|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138742253|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138742255|NCT02744898|Carboplatin|carboplatin|mesh-list
138742256|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138742257|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138742258|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742259|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
138742260|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
138742261|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
138742262|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742263|NCT02652195|Oxytocin|oxytocin|mesh-list
138742264|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
138742265|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138742266|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742267|NCT02398773|Estradiol|estradiol|mesh-list
138742268|NCT02398773|Estrogens|estrogens|mesh-ancestor
138742269|NCT02398773|Hormones|hormones|mesh-ancestor
139075260|NCT05518799|Anesthetics|anesthetics|mesh-ancestor
138742270|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138742271|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742272|NCT02350764|Nivolumab|nivolumab|mesh-list
138742273|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742274|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742275|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138742276|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742277|NCT02095132|Irinotecan|irinotecan|mesh-list
138742278|NCT02095132|Camptothecin|camptothecin|mesh-list
138742302|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138742304|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
138742305|NCT01867333|Metronidazole|metronidazole|mesh-list
138742306|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138742307|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138742308|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138742309|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138742310|NCT01833715|Morphine|morphine|mesh-list
138742311|NCT01833715|Methadone|methadone|mesh-list
138742312|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138742313|NCT01833715|Narcotics|narcotics|mesh-ancestor
138742314|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138742315|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742316|NCT01833715|Analgesics|analgesics|mesh-ancestor
138742317|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
138742318|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742319|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
138742320|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
138742322|NCT01650701|Lenalidomide|lenalidomide|mesh-list
138742323|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138742324|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138742325|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742326|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
138742327|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742328|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138742329|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138742330|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138742331|NCT01650701|Growth Substances|growth substances|mesh-ancestor
138742364|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
138742365|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138742366|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742367|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138742368|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138742369|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138742370|NCT00602797|Paclitaxel|paclitaxel|mesh-list
138742371|NCT00602797|Vinorelbine|vinorelbine|mesh-list
138742372|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138742373|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138742374|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138660341|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
138742500|NCT02890238|Clomiphene|clomiphene|mesh-list
138742530|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742531|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138742532|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138742533|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
138742534|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742535|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742536|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138742537|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
138584709|NCT02275663|Azacitidine|azacitidine|mesh-list
138742538|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138742539|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138742540|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138742541|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138742543|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138742544|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138742545|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742546|NCT01299584|Remifentanil|remifentanil|mesh-list
138742547|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138742581|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138742582|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742584|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138742585|NCT04322760|Analgesics|analgesics|mesh-ancestor
138742586|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138742587|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138742609|NCT01299272|Serotonin|serotonin|mesh-list
138742610|NCT01299272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138742611|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138742612|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
138742613|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742614|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742615|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742616|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138742617|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138742618|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
138742619|NCT01299116|Etonogestrel|etonogestrel|mesh-list
138742620|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
138742621|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138742622|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742623|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138742624|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138742625|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138742626|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138742627|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
138742628|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138742629|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742630|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742631|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138742632|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138742633|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138742634|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
138660598|NCT04698213|Avelumab|avelumab|mesh-list
138742670|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138742671|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138742672|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
138742674|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138742708|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
138742709|NCT01259856|Aspirin|aspirin|mesh-list
138742710|NCT01259856|Interferons|interferons|mesh-list
138742711|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
138742712|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
138742713|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138742714|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
138742715|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742716|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
138742717|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481037|NCT00005988|Hormones|hormones|mesh-ancestor
138742718|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138742750|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
138742751|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
138742752|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138742753|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742754|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742755|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
138742756|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138742757|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138742758|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742759|NCT05525910|Ritonavir|ritonavir|mesh-list
138742842|NCT00691158|Pramlintide|pramlintide|mesh-list
138742843|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
138742844|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138742845|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742846|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
138742847|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138742848|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
138742849|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742850|NCT01235793|Temozolomide|temozolomide|mesh-list
138742851|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138742852|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
138742853|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742854|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742855|NCT05601648|Psilocybin|psilocybin|mesh-list
138742856|NCT05601648|Hallucinogens|hallucinogens|mesh-ancestor
138742857|NCT05601648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742858|NCT05601648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138742859|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138742860|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
138742861|NCT01235715|Coagulants|coagulants|mesh-ancestor
138742862|NCT01235403|Lacosamide|lacosamide|mesh-list
139075440|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
138742863|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
138742864|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138742865|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138742866|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138742867|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742868|NCT01024036|Siltuximab|siltuximab|mesh-list
138660788|NCT00347867|Urological Agents|urological agents|mesh-ancestor
138742956|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138742957|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138742958|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138742959|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
138742960|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742961|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138742962|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138742963|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138742964|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138742965|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
138742966|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138742967|NCT02875288|Bupivacaine|bupivacaine|mesh-list
138742968|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
138742969|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
138742970|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584741|NCT00141713|Etanercept|etanercept|mesh-list
138742971|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138742972|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
138742973|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138742974|NCT01054222|Fesoterodine|fesoterodine|mesh-list
138742975|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138742976|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138742977|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
138742978|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743044|NCT01020526|Analgesics|analgesics|mesh-ancestor
138743045|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
138743046|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743047|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743049|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138743050|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138743051|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743052|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138743053|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138743054|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138743055|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138743056|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138743086|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
138743087|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743088|NCT01228071|Testosterone|testosterone|mesh-list
138743089|NCT01228071|Androgens|androgens|mesh-ancestor
138743090|NCT01228071|Hormones|hormones|mesh-ancestor
138743091|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138743092|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743093|NCT04319289|Vitamin D|vitamin d|mesh-list
138743094|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
138743095|NCT04319289|Cholecalciferol|cholecalciferol|mesh-list
138743096|NCT04319289|Vitamins|vitamins|mesh-list
138743097|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
138743098|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743099|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138743100|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138743101|NCT01008475|Irinotecan|irinotecan|mesh-list
138743102|NCT01008475|Cetuximab|cetuximab|mesh-list
138743103|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138743104|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138743105|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660991|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
138743139|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743140|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743141|NCT01296932|BI 836826|bi 836826|mesh-list
138743142|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138743143|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743201|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138743202|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
138743203|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138743204|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743205|NCT02871505|Penicillins|penicillins|mesh-list
138743206|NCT02871505|Penicillin G|penicillin g|mesh-list
138743207|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138743208|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
138743209|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138743210|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138743211|NCT01294670|Etoposide|etoposide|mesh-list
138743212|NCT01294670|Vorinostat|vorinostat|mesh-list
138743213|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138550464|NCT00255502|Metoprolol|metoprolol|mesh-list
138743214|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743215|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138743216|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138743217|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743218|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743219|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138743220|NCT01006603|Glimepiride|glimepiride|mesh-list
138743256|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743257|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743258|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743259|NCT01294592|Urological Agents|urological agents|mesh-ancestor
138743296|NCT01224639|Vaccines|vaccines|mesh-list
138743297|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
138743298|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743299|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
138743601|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743602|NCT01018264|Urological Agents|urological agents|mesh-ancestor
138743603|NCT01018186|Fluticasone|fluticasone|mesh-list
138743605|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138743606|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138743607|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
138743608|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138661530|NCT00466128|Indomethacin|indomethacin|mesh-list
138743631|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743632|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743633|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743635|NCT00989833|Terbutaline|terbutaline|mesh-list
138743636|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
138743637|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138743638|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138743639|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
138743640|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138743641|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743642|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138743643|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
138743644|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
138743646|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138743647|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138743648|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138743649|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138743650|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
138743651|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138743652|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743653|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
138584797|NCT00162591|Remifentanil|remifentanil|mesh-list
138743654|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
138743655|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138743656|NCT04292119|Crizotinib|crizotinib|mesh-list
138743657|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743658|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138743659|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743660|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743661|NCT01218477|Dasatinib|dasatinib|mesh-list
138743662|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743693|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138743694|NCT01013740|Capecitabine|capecitabine|mesh-list
138743695|NCT01013740|Vinorelbine|vinorelbine|mesh-list
138743696|NCT01013740|Lapatinib|lapatinib|mesh-list
138743697|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138743698|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
138743699|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138743700|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138743701|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138743702|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
138743703|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
138743704|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
138743705|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138743706|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138743707|NCT01217073|Metformin|metformin|mesh-list
138743708|NCT01217073|Pioglitazone|pioglitazone|mesh-list
138744003|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139075572|NCT03477396|Estrogens|estrogens|mesh-list
138744004|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138744005|NCT00628810|Growth Substances|growth substances|mesh-ancestor
138744006|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744007|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
138744008|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138744045|NCT04290013|Coagulants|coagulants|mesh-ancestor
138744046|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138744047|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138744048|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138744101|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138744134|NCT05406765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138744135|NCT05406765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744136|NCT05406765|Sensory System Agents|sensory system agents|mesh-ancestor
138744137|NCT05406765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744138|NCT01011556|Teriparatide|teriparatide|mesh-list
138744140|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
138744141|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138744142|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744143|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138339044|NCT01292304|Tolvaptan|tolvaptan|mesh-list
138744430|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138744431|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744432|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138744433|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
138744434|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138744437|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138744438|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
138744439|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744440|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744441|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138744442|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744443|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
138744444|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138744445|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138744446|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138339564|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
138744480|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
138744481|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138744482|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138744483|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744484|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138744485|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138744512|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744513|NCT00972595|Ondansetron|ondansetron|mesh-list
138744514|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
138744515|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
138744516|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744517|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744518|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138744519|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
138744520|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
138744521|NCT00972595|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138744522|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138744523|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
138744524|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138744525|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744526|NCT01196091|Antimalarials|antimalarials|mesh-list
138744527|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138744528|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138744529|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138744530|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138744531|NCT01196091|Analgesics|analgesics|mesh-ancestor
138744532|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
138744533|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744569|NCT01193517|Decitabine|decitabine|mesh-list
138744570|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
138744571|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138744572|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
139075652|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
138744573|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744574|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744575|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744576|NCT02863705|Timolol|timolol|mesh-list
138662887|NCT06186596|Glucocorticoids|glucocorticoids|mesh-ancestor
138744734|NCT05658549|Antiviral Agents|antiviral agents|mesh-ancestor
138744735|NCT05658549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744736|NCT05658549|Expectorants|expectorants|mesh-ancestor
138744737|NCT05658549|Respiratory System Agents|respiratory system agents|mesh-ancestor
138744738|NCT05658549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138744739|NCT05658549|Antioxidants|antioxidants|mesh-ancestor
138744740|NCT05658549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744741|NCT05658549|Protective Agents|protective agents|mesh-ancestor
138744742|NCT05658549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138744743|NCT05658549|Antidotes|antidotes|mesh-ancestor
138744744|NCT02887365|Tegafur|tegafur|mesh-list
138744745|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138744746|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
138744747|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138744748|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138744749|NCT05658159|Vitamin D|vitamin d|mesh-list
138744750|NCT05658159|Ergocalciferols|ergocalciferols|mesh-list
138744751|NCT05658159|Cholecalciferol|cholecalciferol|mesh-list
138744752|NCT05658159|Vitamins|vitamins|mesh-list
138744753|NCT05658159|Micronutrients|micronutrients|mesh-ancestor
138744754|NCT05658159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663089|NCT06118411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744787|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138744788|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138744789|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138744790|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138744791|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138744873|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
138744874|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138744875|NCT05927922|Ibuprofen|ibuprofen|mesh-list
138744876|NCT05927922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138744877|NCT05927922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138744878|NCT05927922|Analgesics|analgesics|mesh-ancestor
138744879|NCT05927922|Sensory System Agents|sensory system agents|mesh-ancestor
138744880|NCT05927922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138744980|NCT05926869|Clindamycin palmitate|clindamycin palmitate|mesh-list
138744981|NCT05926869|Clindamycin phosphate|clindamycin phosphate|mesh-list
138744982|NCT05926869|Dapsone|dapsone|mesh-list
138744983|NCT05926869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138744984|NCT05926869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745078|NCT05382208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745079|NCT05382208|Antimalarials|antimalarials|mesh-ancestor
138745080|NCT05382208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138745081|NCT05382208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138745082|NCT05354453|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
138745114|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138745115|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
138745116|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745117|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745118|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745120|NCT04917406|Lidocaine|lidocaine|mesh-list
138745121|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138745122|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
138745123|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
138745124|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745125|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745126|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138745153|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745154|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745155|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
138745156|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745157|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745158|NCT04691375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138745159|NCT04691375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745160|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
138745161|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138745162|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138745163|NCT04466917|Paclitaxel|paclitaxel|mesh-list
138745164|NCT04466917|Bevacizumab|bevacizumab|mesh-list
138745165|NCT04466917|Carboplatin|carboplatin|mesh-list
138745166|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138745167|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745168|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
138745169|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
138745170|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
138745171|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745172|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745203|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138745204|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745205|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138745206|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
138745207|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138745208|NCT04283656|Diuretics|diuretics|mesh-ancestor
138745209|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
138745210|NCT04238624|Trametinib|trametinib|mesh-list
138745211|NCT04238624|Dabrafenib|dabrafenib|mesh-list
138745213|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138745214|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745215|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745217|NCT04106414|Linrodostat|linrodostat|mesh-list
138745218|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745219|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745220|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138745281|NCT03576690|Antiviral Agents|antiviral agents|mesh-ancestor
138745282|NCT03576690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745283|NCT03573947|Paclitaxel|paclitaxel|mesh-list
138745284|NCT03573947|Nivolumab|nivolumab|mesh-list
138745285|NCT03573947|Ipilimumab|ipilimumab|mesh-list
139075712|NCT02621944|Melatonin|melatonin|mesh-list
138745286|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138745287|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745288|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
138745289|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
138745290|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
138745291|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745292|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745293|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138745295|NCT03567642|Osimertinib|osimertinib|mesh-list
138745296|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138745297|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745298|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138745356|NCT03069352|Cytarabine|cytarabine|mesh-list
138745357|NCT03069352|Venetoclax|venetoclax|mesh-list
138745358|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138745359|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
138745360|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745361|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745362|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
138745363|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138745364|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138745365|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
138745366|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745367|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
138745368|NCT03037437|Sorafenib|sorafenib|mesh-list
138745369|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745370|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138745371|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745372|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745373|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
138745398|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138745399|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138745400|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138745401|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745402|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745403|NCT03036488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138745404|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138745406|NCT02993523|Venetoclax|venetoclax|mesh-list
138745407|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138745409|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745410|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745411|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745412|NCT02989584|Gemcitabine|gemcitabine|mesh-list
138745413|NCT02989584|Atezolizumab|atezolizumab|mesh-list
138745414|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745415|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138745416|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
138745417|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745418|NCT02989584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138745419|NCT02989584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745420|NCT02884219|Ibuprofen|ibuprofen|mesh-list
138745421|NCT02884219|Indomethacin|indomethacin|mesh-list
138745422|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
138745423|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138745424|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138745425|NCT02884219|Analgesics|analgesics|mesh-ancestor
138745426|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
138745427|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138745531|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138745532|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138745533|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745534|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
138745535|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138745536|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138745537|NCT02185820|Growth Substances|growth substances|mesh-ancestor
138745538|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
138745540|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745541|NCT02085408|Cytarabine|cytarabine|mesh-list
138745542|NCT02085408|Decitabine|decitabine|mesh-list
138745543|NCT02085408|Clofarabine|clofarabine|mesh-list
138745544|NCT02085408|Azacitidine|azacitidine|mesh-list
138745545|NCT02085408|Daunorubicin|daunorubicin|mesh-list
138745546|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138745547|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
138745548|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745549|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663951|NCT05518149|Aticaprant|aticaprant|mesh-list
138745586|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
138745587|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138745588|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138745589|NCT01908777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138745684|NCT00673309|Propranolol|propranolol|mesh-list
138745685|NCT00673309|Hormones|hormones|mesh-list
138745686|NCT00673309|Oxandrolone|oxandrolone|mesh-list
138745687|NCT00673309|Nandrolone|nandrolone|mesh-list
138745688|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138550691|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
138745689|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745690|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138664092|NCT05417165|Immunologic Factors|immunologic factors|mesh-ancestor
138745783|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745784|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745785|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138745786|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138745787|NCT01301729|Paclitaxel|paclitaxel|mesh-list
138745788|NCT01301729|Docetaxel|docetaxel|mesh-list
138745789|NCT01301729|Trastuzumab|trastuzumab|mesh-list
138745790|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138745791|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745792|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
138745793|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
138745794|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
138745795|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138745796|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138745797|NCT05643677|Irinotecan|irinotecan|mesh-list
138745798|NCT05643677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138745799|NCT05643677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138664218|NCT05192200|Interferon-beta|interferon-beta|mesh-list
138745836|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
138745837|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745838|NCT02890511|Paclitaxel|paclitaxel|mesh-list
138745839|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138745840|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138745871|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138745872|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138745873|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745874|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138745875|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138745876|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
138745877|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138745878|NCT01300247|Fludarabine|fludarabine|mesh-list
138745879|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
138745880|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138745881|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
138745882|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138745883|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138746262|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746263|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138702594|NCT02930057|Hormones|hormones|mesh-ancestor
138746264|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746265|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664865|NCT04623541|Prednisone|prednisone|mesh-list
138746444|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139075860|NCT05532358|Serotonin Agents|serotonin agents|mesh-ancestor
138746445|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138746446|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138746447|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138746449|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138746450|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138746451|NCT01172535|Ritonavir|ritonavir|mesh-list
138746452|NCT01172535|Lopinavir|lopinavir|mesh-list
138746453|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138746454|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138746455|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
138746456|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138746457|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746458|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138746459|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138746845|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138746846|NCT01288937|Analgesics|analgesics|mesh-ancestor
138746847|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
138746848|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138746849|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
138746850|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138746851|NCT01288469|Atorvastatin|atorvastatin|mesh-list
138746852|NCT01288469|Alirocumab|alirocumab|mesh-list
138746853|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138746854|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138746855|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138746856|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
138746857|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138746858|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138746859|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138746860|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747390|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138747392|NCT01235442|Clobetasol|clobetasol|mesh-list
138747393|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138747394|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138747395|NCT01235442|Analgesics|analgesics|mesh-ancestor
138747396|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
138747397|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075898|NCT05491512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138747552|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747554|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747555|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747584|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138747585|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747586|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747587|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138747588|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
138747589|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138747590|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747591|NCT01154673|Ritonavir|ritonavir|mesh-list
138747592|NCT01154673|Lopinavir|lopinavir|mesh-list
138747593|NCT01154673|Tenofovir|tenofovir|mesh-list
138747594|NCT01154673|Emtricitabine|emtricitabine|mesh-list
138747595|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
138747596|NCT01154673|Maraviroc|maraviroc|mesh-list
138747597|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138747598|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138747599|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
138747600|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747601|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747602|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138747603|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138747604|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
138747633|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138747635|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138550833|NCT00104793|Irinotecan|irinotecan|mesh-list
138747636|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138747637|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138747638|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
138747639|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747640|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747641|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747643|NCT01228734|Folic Acid|folic acid|mesh-list
138747644|NCT01228734|Fluorouracil|fluorouracil|mesh-list
138747645|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
138747646|NCT01228734|Cetuximab|cetuximab|mesh-list
138747647|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
138747648|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
138667168|NCT00430547|Carbimazole|carbimazole|mesh-list
138747857|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138747858|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138747859|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
138747860|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138747861|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138747862|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
138747863|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138747864|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
138747865|NCT04269109|Narcotics|narcotics|mesh-ancestor
138747866|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138747867|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138747868|NCT04269109|Analgesics|analgesics|mesh-ancestor
138747869|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
138747870|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138747937|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138747938|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
138747939|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
138667540|NCT02957435|Diuretics|diuretics|mesh-ancestor
138748026|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138748027|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138748028|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
138748029|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748030|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748031|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748033|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138748034|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138748095|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138748096|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748097|NCT01143051|Epinephrine|epinephrine|mesh-list
138748098|NCT01143051|Racepinephrine|racepinephrine|mesh-list
138748099|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
138748100|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138748101|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138748102|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
138748103|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748104|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748105|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138667760|NCT00591526|Cytarabine|cytarabine|mesh-list
138748136|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748137|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748138|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748139|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138748140|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138748141|NCT01283516|Ceritinib|ceritinib|mesh-list
138748142|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748143|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138748144|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748145|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748146|NCT01283282|Clopidogrel|clopidogrel|mesh-list
138748147|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138748148|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138748149|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138748150|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138667791|NCT00463827|Atorvastatin|atorvastatin|mesh-list
138748367|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138748368|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138748369|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
138748370|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138748371|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748372|NCT00603343|Urological Agents|urological agents|mesh-ancestor
138748373|NCT01277510|Cinacalcet|cinacalcet|mesh-list
138748374|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138748375|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138748376|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138748377|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
138748378|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138748379|NCT00937495|Bortezomib|bortezomib|mesh-list
138748380|NCT00937495|Vorinostat|vorinostat|mesh-list
138748381|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138748382|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138748383|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138748384|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138748385|NCT04265833|Calcium|calcium|mesh-list
138748386|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138748387|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138749022|NCT05207436|Oxytocin|oxytocin|mesh-list
138749023|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
138749332|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138749333|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138749334|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138749335|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
138749336|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138749337|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138749338|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
138749339|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138749340|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
138749341|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138749342|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138749343|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138749917|NCT05410821|Sequestering Agents|sequestering agents|mesh-ancestor
138749918|NCT05410821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671009|NCT00496002|Adefovir|adefovir|mesh-list
138751152|NCT01130103|Paroxetine|paroxetine|mesh-list
138751153|NCT01130103|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138751154|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138751155|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138751156|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751157|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751158|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
138751159|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751160|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138751161|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
138751162|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138751163|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138751164|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138751165|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751166|NCT04254523|Morphine|morphine|mesh-list
138751167|NCT04254523|Bupivacaine|bupivacaine|mesh-list
138751168|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
138751169|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
138751170|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138673732|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
138751192|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138751194|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138751195|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751196|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138751197|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138751198|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751199|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751201|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138751202|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138751203|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138751204|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751205|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
138751206|NCT04254679|Analgesics|analgesics|mesh-list
138751207|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
138751208|NCT04254679|Narcotics|narcotics|mesh-ancestor
138751209|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138751210|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751211|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
138751212|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751213|NCT01129011|Naproxen|naproxen|mesh-list
138751214|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138751215|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138751216|NCT01129011|Analgesics|analgesics|mesh-ancestor
138751217|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
138751218|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751219|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751220|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138751221|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138751222|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
138751223|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138673759|NCT01325350|Bimatoprost|bimatoprost|mesh-list
138751241|NCT04962841|Ramipril|ramipril|mesh-list
138751242|NCT04962841|Nebivolol|nebivolol|mesh-list
138751243|NCT04962841|Rivastigmine|rivastigmine|mesh-list
138751244|NCT04962841|Sertraline|sertraline|mesh-list
138751245|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138751246|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751247|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138751248|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138751249|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138551105|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138751250|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751251|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138751252|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
138751253|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
138751254|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138751255|NCT04962841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138751256|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138751257|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751258|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
138751259|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138751260|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
138751261|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751262|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138751263|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138751264|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138425486|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
138751266|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138751267|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
138751268|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138751269|NCT04962841|Protective Agents|protective agents|mesh-ancestor
138751270|NCT00919867|Guanfacine|guanfacine|mesh-list
138751271|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138751272|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138751273|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751274|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138751275|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138751276|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138751277|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751278|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
138751279|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751280|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138751296|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
138751297|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751298|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138751299|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138751300|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
138751301|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751302|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751303|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138751304|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138751305|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138751306|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138751307|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
138751308|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751309|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138751310|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138751311|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138751312|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
138751313|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751314|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138751315|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138751316|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751317|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138751318|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138751319|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751320|NCT01128621|Incretins|incretins|mesh-ancestor
138751321|NCT01128621|Hormones|hormones|mesh-ancestor
138751322|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138751323|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138751325|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751326|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751327|NCT00918463|Dasatinib|dasatinib|mesh-list
138751328|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751329|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138751330|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751331|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751332|NCT05330065|Bevacizumab|bevacizumab|mesh-list
139076218|NCT05933213|Hallucinogens|hallucinogens|mesh-ancestor
138751333|NCT05330065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138751335|NCT05330065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138751336|NCT05330065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138751337|NCT05330065|Growth Substances|growth substances|mesh-ancestor
138751338|NCT05330065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751339|NCT05330065|Growth Inhibitors|growth inhibitors|mesh-ancestor
138751340|NCT01128543|Vinorelbine|vinorelbine|mesh-list
138751341|NCT01128543|Lapatinib|lapatinib|mesh-list
138751342|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138751353|NCT01214850|Vaccines|vaccines|mesh-list
138751354|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
138751355|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751356|NCT01128153|Saxagliptin|saxagliptin|mesh-list
138751357|NCT01128153|Incretins|incretins|mesh-ancestor
138751358|NCT01128153|Hormones|hormones|mesh-ancestor
138751359|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138751360|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751361|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138751362|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
138751363|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751364|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751365|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138751366|NCT00925015|Irinotecan|irinotecan|mesh-list
138751367|NCT00925015|Cetuximab|cetuximab|mesh-list
138751368|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138751369|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138751370|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138751371|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751372|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751373|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751374|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138751375|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
138751376|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751377|NCT01127763|Carboplatin|carboplatin|mesh-list
138751378|NCT01127763|Everolimus|everolimus|mesh-list
138751379|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751380|NCT01127763|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138751381|NCT01127763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138751382|NCT01127763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751383|NCT01127763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751384|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138751385|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
138751386|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751387|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138751388|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138751389|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751390|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138751391|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138751392|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138751393|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751394|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
138751395|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751396|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
138751397|NCT00924781|Hematinics|hematinics|mesh-ancestor
138751398|NCT01127451|Denileukin diftitox|denileukin diftitox|mesh-list
138751399|NCT01127451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751400|NCT01214616|Vinorelbine|vinorelbine|mesh-list
138751402|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138751403|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751404|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
138751405|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
138751406|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
138673813|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138751414|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138751415|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076303|NCT05932277|Fexofenadine|fexofenadine|mesh-list
138751416|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751418|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138751419|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
138751420|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751421|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751422|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138751423|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138751424|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
138751425|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751426|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751427|NCT01212588|Mifepristone|mifepristone|mesh-list
138751428|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138751429|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
138751430|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138751431|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751432|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138751433|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138751434|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138751435|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
138751436|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138751437|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138751438|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
138751439|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138751440|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
138751441|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138751442|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138751443|NCT00918385|Dasatinib|dasatinib|mesh-list
138751444|NCT00918385|Nilutamide|nilutamide|mesh-list
138751445|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751446|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138751447|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751448|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751449|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
138751450|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
138751451|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138751452|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751453|NCT00637819|Leflunomide|leflunomide|mesh-list
138751454|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751455|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751456|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138751457|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
138751458|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751459|NCT00631501|Doxycycline|doxycycline|mesh-list
138751460|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138751461|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751463|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138751464|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138751465|NCT04746547|Dolutegravir|dolutegravir|mesh-list
138751466|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138751467|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138751468|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751469|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751470|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138751471|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138751472|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
138751498|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138751499|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751500|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
138751501|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
138751502|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
138751503|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751505|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138751506|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751507|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138751508|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751509|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751510|NCT04318158|Fentanyl|fentanyl|mesh-list
138751511|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
138751512|NCT04318158|Bupivacaine|bupivacaine|mesh-list
138751513|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
138751514|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
138751515|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138751516|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751517|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
139076368|NCT05931757|Blinatumomab|blinatumomab|mesh-list
138751518|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751519|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138751520|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138751521|NCT04318158|Analgesics|analgesics|mesh-ancestor
138751522|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138751523|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138751524|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138751525|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
138751526|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751536|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138751537|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751538|NCT01207596|Analgesics|analgesics|mesh-ancestor
138751539|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
138751540|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751541|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
138751542|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138751543|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138751544|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138751545|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138751546|NCT04203043|Pycnogenols|pycnogenols|mesh-list
138751547|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138751548|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
138751549|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751550|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
138751551|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751552|NCT04203043|Protective Agents|protective agents|mesh-ancestor
138751553|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138751555|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
138751556|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751557|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751558|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138751559|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138751560|NCT00631813|Prucalopride|prucalopride|mesh-list
138751561|NCT00631813|Laxatives|laxatives|mesh-ancestor
138751562|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138751563|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138751564|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138751565|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
138751566|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751567|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751568|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751570|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138751571|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
138751572|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751573|NCT04911517|Capecitabine|capecitabine|mesh-list
138751574|NCT04911517|Antibodies|antibodies|mesh-list
138751575|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138751576|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
138751577|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585154|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138751578|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138751579|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
138751580|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751581|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751582|NCT00637897|Paclitaxel|paclitaxel|mesh-list
138751583|NCT00637897|Docetaxel|docetaxel|mesh-list
138751584|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138751585|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138751586|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751587|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
138751588|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
138751589|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
138751590|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751591|NCT03992443|Reteplase|reteplase|mesh-list
138751592|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138751593|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138673852|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
138751637|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138751638|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076452|NCT05930912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751639|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751640|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
138751641|NCT00909181|Oxybutynin|oxybutynin|mesh-list
138751642|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
138751643|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
138751644|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751645|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751646|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138751647|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138751648|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
138751649|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751650|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751651|NCT00909181|Urological Agents|urological agents|mesh-ancestor
138751652|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138751653|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751654|NCT01286987|Talazoparib|talazoparib|mesh-list
138751655|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138751656|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751657|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751658|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751659|NCT01286753|Vemurafenib|vemurafenib|mesh-list
138751660|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751661|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138751662|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751663|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751664|NCT01284959|Risperidone|risperidone|mesh-list
139076500|NCT05930236|Hormones|hormones|mesh-ancestor
138751666|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138751667|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
138751668|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751669|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751670|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751671|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138751672|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138751673|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138751674|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138751675|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138751676|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
138751677|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138751678|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138751679|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
138751680|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138751681|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138751682|NCT01283009|Prednisolone|prednisolone|mesh-list
138751683|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
138751684|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138751685|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
138751686|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138751687|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
138751688|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
138751689|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751690|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751691|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138751692|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
138751694|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138751695|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138751696|NCT01283009|Protective Agents|protective agents|mesh-ancestor
138751697|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138751698|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751700|NCT01282463|Ramucirumab|ramucirumab|mesh-list
138673900|NCT00471965|Leucovorin|leucovorin|mesh-list
138751722|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138751723|NCT01281839|Simeprevir|simeprevir|mesh-list
138751724|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
138751725|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751726|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
138751727|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751728|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
138751729|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751730|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
138585198|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
138751731|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138751732|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138751733|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751734|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
138751735|NCT01280981|Coagulants|coagulants|mesh-ancestor
138751736|NCT01280591|Naproxen|naproxen|mesh-list
138751737|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138751738|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138751739|NCT01280591|Analgesics|analgesics|mesh-ancestor
138751740|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
138751741|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751742|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751743|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138751744|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138751745|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
138751746|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138751747|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751748|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751749|NCT04323761|Remdesivir|remdesivir|mesh-list
138751750|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
138751751|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751752|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
138751753|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751754|NCT05566223|Aldesleukin|aldesleukin|mesh-list
138751755|NCT05566223|Cyclophosphamide|cyclophosphamide|mesh-list
138673918|NCT00471965|Vitamins|vitamins|mesh-ancestor
138751777|NCT05566223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751779|NCT01271933|Analgesics|analgesics|mesh-ancestor
138751780|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
138751781|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751782|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751783|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
138751784|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138751785|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138751786|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751787|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138751788|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138751789|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138751790|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138751791|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138751792|NCT01269125|Leuprolide|leuprolide|mesh-list
138751793|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138751794|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
138751795|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138751796|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751797|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138751798|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751799|NCT01268891|Rasagiline|rasagiline|mesh-list
138751800|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138751801|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751802|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751803|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138751804|NCT01268891|Protective Agents|protective agents|mesh-ancestor
138751805|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751806|NCT04323527|Chloroquine|chloroquine|mesh-list
138751807|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138751808|NCT04323527|Amebicides|amebicides|mesh-ancestor
138751809|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138751826|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751828|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138751829|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751830|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
138751831|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751832|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138751833|NCT01266161|Ibuprofen|ibuprofen|mesh-list
138751834|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138751835|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138751836|NCT01266161|Analgesics|analgesics|mesh-ancestor
138751837|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
138751838|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751839|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751840|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138751841|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138751842|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138751843|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751844|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751845|NCT01265849|Indomethacin|indomethacin|mesh-list
138751846|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
138751847|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138751848|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
138751849|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751850|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138751851|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138751852|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
138751853|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751854|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751855|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138751856|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138751857|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138751858|NCT01265849|Analgesics|analgesics|mesh-ancestor
138751859|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
138751860|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751861|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138751862|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
138751863|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
138751864|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138426097|NCT01696448|Vitamins|vitamins|mesh-ancestor
138660921|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
138751865|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138751866|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751867|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
138751868|NCT01265615|Vitamin D|vitamin d|mesh-list
138751869|NCT01265615|Calcitriol|calcitriol|mesh-list
138751879|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138751880|NCT01264679|Hematinics|hematinics|mesh-ancestor
138751881|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138751882|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138751883|NCT01263509|Inositol|inositol|mesh-list
138751884|NCT01263509|Alogliptin|alogliptin|mesh-list
138751885|NCT01263509|Voglibose|voglibose|mesh-list
138751886|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138751887|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751888|NCT01263509|Incretins|incretins|mesh-ancestor
138751889|NCT01263509|Hormones|hormones|mesh-ancestor
138751890|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138751891|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138751892|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
138751893|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751894|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751895|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138751896|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
138751897|NCT01263509|Vitamins|vitamins|mesh-ancestor
138751898|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
138751899|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
138751900|NCT01263197|Propranolol|propranolol|mesh-list
138751901|NCT01263197|Albuterol|albuterol|mesh-list
138751902|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138751903|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138751904|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
138751905|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751906|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751907|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751908|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138751909|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138751910|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
138751911|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138751912|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
138751913|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138751914|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138751915|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
138751916|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
138751917|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138751918|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138751919|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138751920|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138751921|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138751922|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751923|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
138751924|NCT01263119|Warfarin|warfarin|mesh-list
138751925|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
138751926|NCT01262651|Nabiximols|nabiximols|mesh-list
138751927|NCT01262651|Analgesics|analgesics|mesh-ancestor
138751928|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
138751929|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585286|NCT00163488|Ciclesonide|ciclesonide|mesh-list
138751930|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751931|NCT01261793|Epratuzumab|epratuzumab|mesh-list
138751932|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138751933|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751934|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
138751935|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
138751945|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138751946|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751947|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751949|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
138751950|NCT01260467|Memantine|memantine|mesh-list
138751951|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138751952|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138751953|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
138751954|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751955|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751956|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751957|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138751958|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138751959|NCT01260311|Fesoterodine|fesoterodine|mesh-list
138751960|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138751961|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138751962|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
138751963|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751964|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751965|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751966|NCT01260311|Urological Agents|urological agents|mesh-ancestor
138751968|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
138751969|NCT01259375|Amrubicin|amrubicin|mesh-list
138751970|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138751971|NCT00624143|Voriconazole|voriconazole|mesh-list
138751972|NCT00624143|Amphotericin B|amphotericin b|mesh-list
138751973|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138751974|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
138751975|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138751976|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138751977|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138751978|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138751979|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751980|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138751981|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
138751982|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138751983|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751984|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138751986|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138751987|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138751988|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138751989|NCT04005287|Pirenzepine|pirenzepine|mesh-list
138751990|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138751991|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138751992|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138751993|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138751994|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
138751995|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138751996|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138751997|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138751998|NCT04320173|Lidocaine|lidocaine|mesh-list
138751999|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
138752000|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
138752001|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138752002|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752003|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
138673972|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138752015|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752016|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138752017|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752018|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752019|NCT01613495|Octreotide|octreotide|mesh-list
138752020|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138752021|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138752022|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752023|NCT00694733|Anastrozole|anastrozole|mesh-list
138752024|NCT00694733|Leuprolide|leuprolide|mesh-list
138752025|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
138752026|NCT00694733|Estradiol|estradiol|mesh-list
138752027|NCT00694733|Estrogens|estrogens|mesh-list
138752028|NCT00694733|Testosterone|testosterone|mesh-list
138752029|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
138752030|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
139076743|NCT05615948|Ketamine|ketamine|mesh-list
138752031|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138752032|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138752033|NCT00694733|Hormones|hormones|mesh-ancestor
138752034|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138752035|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752036|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138752037|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138752038|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752039|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138752040|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752041|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752042|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138752043|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
138752044|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138752045|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
138752046|NCT00694733|Androgens|androgens|mesh-ancestor
138752047|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
138752048|NCT01259297|Amlodipine|amlodipine|mesh-list
138752049|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138752050|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138752051|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138752052|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752053|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752054|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138752055|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752056|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
138752057|NCT01259297|Diuretics|diuretics|mesh-ancestor
138752058|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
138752059|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138752060|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
138752061|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138752062|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
139076781|NCT05573360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139076782|NCT05571319|Metformin|metformin|mesh-list
138752063|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752064|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752065|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138752066|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
138752077|NCT01126359|Lidocaine|lidocaine|mesh-list
138752078|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
138752079|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
138752080|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138752081|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752082|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
138752083|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752084|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138752085|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138752086|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138752087|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752088|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426319|NCT01697657|Insulin|insulin|mesh-list
138752089|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
138752090|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138752091|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138752092|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138752093|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752094|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752095|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
138752096|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752097|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752098|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138752099|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752100|NCT01125813|Factor VIII|factor viii|mesh-list
138752101|NCT01125813|Coagulants|coagulants|mesh-ancestor
138752102|NCT04311645|Charcoal|charcoal|mesh-list
139076824|NCT05416658|Antipsychotic Agents|antipsychotic agents|mesh-list
139076825|NCT05416658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138752103|NCT04311645|Antidotes|antidotes|mesh-ancestor
138752104|NCT04311645|Protective Agents|protective agents|mesh-ancestor
138752105|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752106|NCT01257581|Tamoxifen|tamoxifen|mesh-list
138752107|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138752108|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
138752109|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138752110|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752111|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138752112|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752113|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138752114|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138752115|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138752116|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
138752117|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138752118|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752119|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138752120|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
138752121|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138752122|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
138752123|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138752124|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752125|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138752126|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138752127|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752128|NCT00995488|Paclitaxel|paclitaxel|mesh-list
138752129|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138752144|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752146|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138752147|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138752148|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138752149|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
138752150|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
138752151|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752152|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752153|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752154|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138752155|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138752157|NCT02869672|Vaccines|vaccines|mesh-list
138752158|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
138752159|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752160|NCT01125189|Interferons|interferons|mesh-list
138752161|NCT01125189|Ribavirin|ribavirin|mesh-list
138752162|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
138752163|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
138752164|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138752165|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752166|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
138752167|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752168|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
138752169|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752170|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
138585371|NCT00143702|Abacavir|abacavir|mesh-list
138752171|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752172|NCT01256567|Docetaxel|docetaxel|mesh-list
138752173|NCT01256567|Ramucirumab|ramucirumab|mesh-list
138752174|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752175|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
138752176|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
138752177|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
139076913|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752178|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752179|NCT00996736|Voriconazole|voriconazole|mesh-list
138752180|NCT00996736|Natamycin|natamycin|mesh-list
138752181|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
138752182|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752183|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138752184|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138752185|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752186|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752187|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138752188|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
138752189|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138752212|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138752213|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138752214|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138752215|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138752216|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752217|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752218|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138752219|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076954|NCT05155579|Vaccines|vaccines|mesh-list
138752220|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
138752221|NCT01256411|Diuretics|diuretics|mesh-ancestor
138752222|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
138752223|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138752224|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138752225|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
138752226|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138752227|NCT00996580|Estradiol|estradiol|mesh-list
138752228|NCT00996580|Estrogens|estrogens|mesh-ancestor
138752229|NCT00996580|Hormones|hormones|mesh-ancestor
138752230|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138752231|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752232|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138752233|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
138752234|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138752235|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138752236|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138752237|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138752238|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138585417|NCT00143780|Vaccines|vaccines|mesh-list
138752240|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138752241|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138752256|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
138752257|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138752258|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752259|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138752260|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
138752261|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
138752262|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752263|NCT00999544|Oxycodone|oxycodone|mesh-list
138752264|NCT00999544|Aprepitant|aprepitant|mesh-list
138752265|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
138752266|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138752267|NCT00999544|Narcotics|narcotics|mesh-ancestor
138752268|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138752269|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752270|NCT00999544|Analgesics|analgesics|mesh-ancestor
138752271|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
138752272|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752273|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
138752274|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
138752275|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138752276|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138752277|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752278|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752279|NCT02869984|Ramosetron|ramosetron|mesh-list
138752280|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
138752281|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
138551178|NCT00259870|Olanzapine|olanzapine|mesh-list
139077006|NCT05096468|Ketamine|ketamine|mesh-list
138752282|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752283|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752284|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138752285|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138752286|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
138752287|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752288|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752289|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138752290|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
138752291|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138752292|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138752293|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752294|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752296|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
138752297|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138752298|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
138752299|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
138752300|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
138752312|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752313|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752314|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752316|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138752317|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138752318|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138752319|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138752320|NCT04540835|Calcium|calcium|mesh-list
138752321|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138752322|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752323|NCT01255163|Exenatide|exenatide|mesh-list
138752324|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138752325|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752326|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138752327|NCT01255163|Incretins|incretins|mesh-ancestor
138752328|NCT01255163|Hormones|hormones|mesh-ancestor
138752329|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138752330|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
138752331|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
138752332|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752333|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138752334|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
138752335|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138752337|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
138752338|NCT01254305|Milnacipran|milnacipran|mesh-list
138752339|NCT01254305|Sertraline|sertraline|mesh-list
138752340|NCT01254305|Fluoxetine|fluoxetine|mesh-list
138752341|NCT01254305|Paroxetine|paroxetine|mesh-list
138752342|NCT01254305|Citalopram|citalopram|mesh-list
138752343|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
138752344|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
138752345|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138752346|NCT01254305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138752347|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138752348|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752349|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752350|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752351|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
138752352|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752353|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138752354|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138752355|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138752356|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752357|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752358|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138752359|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138752360|NCT01254305|Analgesics|analgesics|mesh-ancestor
138752361|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
138752362|NCT01122927|Aripiprazole|aripiprazole|mesh-list
138752387|NCT04311255|Anesthetics|anesthetics|mesh-list
138752388|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138752389|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752390|NCT01122381|Ethosuximide|ethosuximide|mesh-list
138752391|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
138752392|NCT00996034|Nicotine|nicotine|mesh-list
138752393|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752394|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138752395|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
138752396|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752397|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138752398|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138752399|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
138752400|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752401|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752402|NCT01121991|Hormones|hormones|mesh-list
138752403|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138752404|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752405|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
138752406|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
138752407|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138752408|NCT04292236|Protective Agents|protective agents|mesh-ancestor
138752409|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752410|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752412|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138752413|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138752414|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138752415|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752422|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
138752423|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138752424|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
138752425|NCT02868814|Pregabalin|pregabalin|mesh-list
138752426|NCT02868814|Analgesics|analgesics|mesh-ancestor
138752427|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
138752428|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752429|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752430|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
138752431|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138752432|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752433|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752434|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138752435|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138752436|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138752437|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138752438|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138752439|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
138752440|NCT04292314|Deferoxamine|deferoxamine|mesh-list
138752441|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752442|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
138752443|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752444|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752445|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138752446|NCT04292314|Siderophores|siderophores|mesh-ancestor
138752447|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138752448|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
138752449|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
138752450|NCT01121757|Lenalidomide|lenalidomide|mesh-list
138752451|NCT01121757|Azacitidine|azacitidine|mesh-list
138752452|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
138752453|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752454|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138426707|NCT01700322|Ticagrelor|ticagrelor|mesh-list
138752455|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138752456|NCT01121757|Growth Substances|growth substances|mesh-ancestor
138752457|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
138752458|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752459|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138752460|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
138752461|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752462|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752463|NCT04319471|Capecitabine|capecitabine|mesh-list
138752464|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138752465|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
138752466|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752467|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752468|NCT02882217|Histamine|histamine|mesh-list
138752469|NCT02882217|Glutarimide|glutarimide|mesh-list
138752470|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
138752471|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
138752472|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752473|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752474|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752475|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138752476|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752477|NCT01253135|Petrolatum|petrolatum|mesh-list
138752478|NCT01253135|Emollients|emollients|mesh-ancestor
138752479|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
138752480|NCT00993616|Carboplatin|carboplatin|mesh-list
138752481|NCT00993616|Belinostat|belinostat|mesh-list
138752482|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752490|NCT01120275|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138752491|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752492|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752493|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
138752494|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138752495|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752496|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138752497|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
138752498|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138752499|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752500|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752501|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752502|NCT01119963|Castor Oil|castor oil|mesh-list
138752503|NCT01119963|Progesterone|progesterone|mesh-list
138752504|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138752505|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138752506|NCT01119963|Progestins|progestins|mesh-ancestor
138752507|NCT01119963|Hormones|hormones|mesh-ancestor
138752508|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138752509|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752510|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138752511|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
138752512|NCT01119963|Cathartics|cathartics|mesh-ancestor
138752513|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138752514|NCT01252667|Cyclosporine|cyclosporine|mesh-list
138752515|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
138752516|NCT01252667|Clofarabine|clofarabine|mesh-list
138752517|NCT01252667|Cyclosporins|cyclosporins|mesh-list
138752518|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752519|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752520|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138752521|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
138752522|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752523|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
138752524|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752525|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
138752526|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138752527|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138752528|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138752529|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752530|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138752531|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
138752532|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138752533|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138752536|NCT02868580|Abacavir|abacavir|mesh-list
138752537|NCT02868580|Dolutegravir|dolutegravir|mesh-list
138752538|NCT02868580|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
138752539|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138752540|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138752541|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752542|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752543|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
138752544|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752545|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138752547|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138752548|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138752558|NCT01118949|Lacosamide|lacosamide|mesh-list
138752559|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
138752560|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138752561|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138752562|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752563|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752564|NCT01252355|Interferons|interferons|mesh-list
138752565|NCT01252355|Interferon-beta|interferon-beta|mesh-list
138752566|NCT01252355|Teriflunomide|teriflunomide|mesh-list
138752567|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752568|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
138752569|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752570|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
138752571|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752572|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139077223|NCT04723394|Antiviral Agents|antiviral agents|mesh-ancestor
138752573|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138752574|NCT01252355|Analgesics|analgesics|mesh-ancestor
138752575|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
138752576|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752577|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138752578|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138752579|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138752580|NCT01118325|Clopidogrel|clopidogrel|mesh-list
138752581|NCT01118325|Ticagrelor|ticagrelor|mesh-list
138752582|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138752583|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138752584|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138752585|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138752586|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
138752587|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752588|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752589|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752590|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138752591|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138752592|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138752593|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752594|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752595|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752596|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752597|NCT01117857|Analgesics|analgesics|mesh-ancestor
138752598|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
138752599|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752600|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
138752601|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138752602|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
138752603|NCT00991276|Pregabalin|pregabalin|mesh-list
138752604|NCT00991276|Pramipexole|pramipexole|mesh-list
138752605|NCT00991276|Analgesics|analgesics|mesh-ancestor
138752606|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
138752607|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077249|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
138752608|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752609|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
138752610|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138752611|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138752612|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674103|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
138752624|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752625|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138752626|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138752627|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752628|NCT00990652|Temozolomide|temozolomide|mesh-list
138752629|NCT00990652|Bortezomib|bortezomib|mesh-list
138752630|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138752631|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
138752632|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752633|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752634|NCT02867878|Adenosine|adenosine|mesh-list
138752635|NCT02867878|Analgesics|analgesics|mesh-ancestor
138752636|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
138752637|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752638|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752639|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138752640|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
138752641|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138752642|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
139077296|NCT04409002|Niraparib|niraparib|mesh-list
138752643|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
138752644|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752645|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752647|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752648|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138752649|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752650|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752651|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138752652|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138752653|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138752654|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
138752655|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752656|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138752657|NCT00990106|Prazosin|prazosin|mesh-list
138752658|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138752659|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138752660|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138752661|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138752662|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
138752663|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752664|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752665|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752666|NCT02867566|Rituximab|rituximab|mesh-list
138752667|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138752668|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752669|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
138752670|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752671|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138752672|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138752673|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138752674|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
138752675|NCT02867800|Acetaminophen|acetaminophen|mesh-list
138674114|NCT04325581|Hormones|hormones|mesh-ancestor
138752682|NCT02867800|Methotrexate|methotrexate|mesh-list
138752683|NCT02867800|Fludarabine|fludarabine|mesh-list
138752684|NCT02867800|Melphalan|melphalan|mesh-list
138752685|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
138752686|NCT02867800|Abatacept|abatacept|mesh-list
138752687|NCT02867800|Thiotepa|thiotepa|mesh-list
138752688|NCT02867800|Meperidine|meperidine|mesh-list
138752689|NCT02867800|Tacrolimus|tacrolimus|mesh-list
138752690|NCT02867800|Cyclosporins|cyclosporins|mesh-list
138752691|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
138752692|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138752693|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
138752694|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138752695|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752696|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138752698|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752699|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752700|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
138752701|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752702|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138752703|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138752704|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
138752705|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138752706|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138752707|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138752708|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
138752709|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752710|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138752711|NCT02867800|Analgesics|analgesics|mesh-ancestor
138752712|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
138752713|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138752714|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
138752715|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138752716|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138752717|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
138752718|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138752719|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138752720|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
138752721|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
138752722|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138752723|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
138752724|NCT02867800|Hormones|hormones|mesh-ancestor
138752725|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138752726|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138752727|NCT02867800|Protective Agents|protective agents|mesh-ancestor
138752728|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138752729|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
138752730|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138752731|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138752732|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138752733|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138752734|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138752735|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138752736|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
138752737|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
138752738|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138752739|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
138752740|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
138752741|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752742|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138752743|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
138752744|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138752745|NCT02867800|Narcotics|narcotics|mesh-ancestor
138752746|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138752747|NCT00629200|Interferons|interferons|mesh-list
138752748|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
138752749|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
138752750|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138752751|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752752|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
138752780|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138752781|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138752782|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752783|NCT00982228|Insulin|insulin|mesh-list
138752784|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138752785|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
138752786|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
138752787|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138752788|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752789|NCT02867956|Etoposide|etoposide|mesh-list
138752790|NCT02867956|Apatinib|apatinib|mesh-list
138752791|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138752792|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752793|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138752795|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752796|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752797|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138752798|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
138752799|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138752800|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752801|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
138752802|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752803|NCT04291066|Expectorants|expectorants|mesh-ancestor
138752814|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138752815|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752816|NCT00629278|Tamoxifen|tamoxifen|mesh-list
138752817|NCT00629278|Docetaxel|docetaxel|mesh-list
138752818|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
138752819|NCT00629278|Doxorubicin|doxorubicin|mesh-list
138752820|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138752821|NCT00629278|Fluorouracil|fluorouracil|mesh-list
138752822|NCT00629278|Trastuzumab|trastuzumab|mesh-list
138752823|NCT00629278|Epirubicin|epirubicin|mesh-list
138752824|NCT00629278|Hormones|hormones|mesh-list
138752825|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138752826|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752827|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
138752828|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
138752829|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
138752830|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752831|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138752832|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
138752833|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752834|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138752835|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138752836|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
138752837|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138752838|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138551237|NCT00260416|Abciximab|abciximab|mesh-list
138752839|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138752840|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138752841|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752842|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
138752843|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138752844|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138752845|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138752846|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138752847|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
138752848|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138752849|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138752850|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138752851|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138752852|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138752854|NCT04207112|Linezolid|linezolid|mesh-list
138752855|NCT04207112|Bedaquiline|bedaquiline|mesh-list
138752856|NCT04207112|Clofazimine|clofazimine|mesh-list
138752857|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138752858|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752859|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138752860|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138752861|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752862|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752863|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752864|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138752865|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
138752866|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138752867|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
138752868|NCT01259492|Methylphenidate|methylphenidate|mesh-list
138752869|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138674152|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
138752881|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138752882|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752883|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752884|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138585633|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
138752885|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138752886|NCT05512910|Minocycline|minocycline|mesh-list
138752887|NCT05512910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138752888|NCT05512910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752890|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752891|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138752892|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752893|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752894|NCT05101928|Prednisone|prednisone|mesh-list
138752895|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138752896|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
138752897|NCT05101928|Hormones|hormones|mesh-ancestor
138752898|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138752899|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752900|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138752901|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752902|NCT04654052|Clopidogrel|clopidogrel|mesh-list
138752903|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138752904|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138752905|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138427148|NCT01702857|Vaccines|vaccines|mesh-list
138551241|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
138752907|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
138752908|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138585675|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138752909|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752910|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752911|NCT05625308|Folic Acid|folic acid|mesh-list
138752912|NCT05625308|Vitamin B 12|vitamin b 12|mesh-list
138752913|NCT05625308|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138752914|NCT05625308|Hyaluronic Acid|hyaluronic acid|mesh-list
138752915|NCT05625308|Vitamins|vitamins|mesh-ancestor
138752916|NCT05625308|Micronutrients|micronutrients|mesh-ancestor
138752917|NCT05625308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752918|NCT05625308|Hematinics|hematinics|mesh-ancestor
138752919|NCT05625308|Vitamin B Complex|vitamin b complex|mesh-ancestor
138752920|NCT05625308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138752921|NCT05625308|Immunologic Factors|immunologic factors|mesh-ancestor
138752922|NCT05625308|Viscosupplements|viscosupplements|mesh-ancestor
138752923|NCT05625308|Protective Agents|protective agents|mesh-ancestor
138752924|NCT05625308|Antioxidants|antioxidants|mesh-ancestor
138752925|NCT05625308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752926|NCT05625308|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138752927|NCT05625308|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138752928|NCT05625308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752929|NCT05625308|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138752930|NCT04291664|Prednisone|prednisone|mesh-list
138752931|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
138752932|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138752945|NCT04187469|Rifampin|rifampin|mesh-list
138752946|NCT04187469|Isoniazid|isoniazid|mesh-list
138752947|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
138752948|NCT04187469|Ethambutol|ethambutol|mesh-list
138752949|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138752950|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138752951|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138752952|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138752953|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752954|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752955|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752956|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138752957|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
138752958|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
139077649|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138752959|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138752960|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138752961|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138752962|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138585725|NCT05143762|Acetaminophen|acetaminophen|mesh-list
138752963|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138752964|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138752965|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138752966|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138752967|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138752968|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
138752969|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138752970|NCT01116687|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
138752971|NCT01116687|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138752972|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138752973|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138752974|NCT02867020|Prednisone|prednisone|mesh-list
138752975|NCT02867020|Goserelin|goserelin|mesh-list
138752976|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138752977|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
138752978|NCT02867020|Hormones|hormones|mesh-ancestor
138427224|NCT01703390|Cetuximab|cetuximab|mesh-list
138752979|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138752980|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752981|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138752982|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138752984|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138752985|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138752986|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138752987|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138752988|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138752989|NCT04319978|Dexamethasone|dexamethasone|mesh-list
138752990|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
138752991|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138752999|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138753001|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753002|NCT01114737|Verapamil|verapamil|mesh-list
138753003|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138753004|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138753005|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138753006|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753007|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138753008|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753009|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
138753010|NCT00624182|Gemcitabine|gemcitabine|mesh-list
138753011|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138753012|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
138753013|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753014|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753015|NCT00625677|Vaccines|vaccines|mesh-list
138753016|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
138753017|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753018|NCT00979576|Pemetrexed|pemetrexed|mesh-list
138753019|NCT00979576|Nintedanib|nintedanib|mesh-list
138585762|NCT00148395|Ifosfamide|ifosfamide|mesh-list
138753020|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753021|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753022|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753023|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138753024|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138753025|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138753026|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
138753027|NCT02867332|Interleukin-2|interleukin-2|mesh-list
138753028|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138753029|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
138753030|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753031|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138753032|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138753033|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
138753034|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753035|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753036|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138753037|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138753038|NCT02867332|Analgesics|analgesics|mesh-ancestor
138753039|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
138753040|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753041|NCT02702180|Molgramostim|molgramostim|mesh-list
138753042|NCT02702180|Sargramostim|sargramostim|mesh-list
138753043|NCT02702180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753044|NCT02702180|Immunologic Factors|immunologic factors|mesh-ancestor
138753045|NCT02702180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753046|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
138753048|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138753049|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138753050|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
138753051|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138753052|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138753053|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753054|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753055|NCT04116502|Interferons|interferons|mesh-list
138753056|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
138753057|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
138753058|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
138753059|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753067|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138753068|NCT04290442|Ropivacaine|ropivacaine|mesh-list
138753069|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
138753070|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
138753071|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138753072|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753073|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
138753074|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753075|NCT02866786|Metformin|metformin|mesh-list
138753076|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
138753077|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138753078|NCT02866786|Estradiol|estradiol|mesh-list
138753079|NCT02866786|Cyproterone|cyproterone|mesh-list
138753080|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138753081|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753082|NCT02866786|Estrogens|estrogens|mesh-ancestor
138753083|NCT02866786|Hormones|hormones|mesh-ancestor
138753084|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138753085|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138753086|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
138753087|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138753088|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138753089|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138753090|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138753091|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
138753092|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
138753093|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753094|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138753095|NCT00979654|Sifalimumab|sifalimumab|mesh-list
138753096|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
138753097|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753098|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138753099|NCT00978562|Hematinics|hematinics|mesh-ancestor
138753100|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138753101|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138753102|NCT04289974|Fulvestrant|fulvestrant|mesh-list
138753103|NCT04289974|Palbociclib|palbociclib|mesh-list
138753104|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138753105|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753106|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138753108|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
138753109|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138753110|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753111|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138753112|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753113|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753114|NCT02865616|Vancomycin|vancomycin|mesh-list
138753115|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138753116|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138753117|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
138753118|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
138753119|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753120|NCT02865460|Vitamins|vitamins|mesh-ancestor
138753121|NCT01206816|Afatinib|afatinib|mesh-list
138753122|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753123|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138753124|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753125|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753126|NCT01259102|Buprenorphine|buprenorphine|mesh-list
138753127|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138753128|NCT01259102|Narcotics|narcotics|mesh-ancestor
138427376|NCT01704508|Artemether|artemether|mesh-list
138753148|NCT04319900|Amebicides|amebicides|mesh-ancestor
138753149|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138753150|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138753151|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138753152|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
138753153|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138753154|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
138753156|NCT01257698|Dorzolamide|dorzolamide|mesh-list
138753157|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138753158|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138753159|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138753160|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
138753161|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753162|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753163|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753164|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138753165|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138753166|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138753167|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138753168|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753169|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
138753170|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
138753171|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
138753172|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138753173|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138753174|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753175|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753176|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753178|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139077933|NCT02728050|Cytarabine|cytarabine|mesh-list
138753180|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753181|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753182|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138753183|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
138753184|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
138674205|NCT00477737|Propofol|propofol|mesh-list
138753196|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138753197|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
138753198|NCT01204710|Hormones|hormones|mesh-ancestor
138753199|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138753200|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753201|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138753202|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753203|NCT01204710|Analgesics|analgesics|mesh-ancestor
138753205|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753206|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138753207|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139077961|NCT02581943|Paclitaxel|paclitaxel|mesh-list
138753208|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753209|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753210|NCT01256450|Buprenorphine|buprenorphine|mesh-list
138753211|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138753212|NCT01256450|Narcotics|narcotics|mesh-ancestor
138753213|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138753214|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753215|NCT01256450|Analgesics|analgesics|mesh-ancestor
138753216|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
138753217|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753218|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138753220|NCT01204398|Telmisartan|telmisartan|mesh-list
138753221|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138753222|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138753223|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138753224|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138753225|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753226|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138753227|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753228|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
138753229|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138753230|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138753231|NCT01111851|Dexamethasone|dexamethasone|mesh-list
138753232|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
138753233|NCT01111851|Ondansetron|ondansetron|mesh-list
138753235|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
138753236|NCT01111851|BB 1101|bb 1101|mesh-list
138753237|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138753238|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
138753239|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
138753240|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753241|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753242|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138753243|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
138753244|NCT01111851|Hormones|hormones|mesh-ancestor
138753245|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138753246|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138753247|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753248|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
138753249|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753250|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753276|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
138753277|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585854|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138753278|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138753279|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138753280|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138753281|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
138753282|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753283|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753284|NCT01255670|Metronidazole|metronidazole|mesh-list
138753285|NCT01255670|Penicillins|penicillins|mesh-list
138753286|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138753287|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138753288|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138753289|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138753291|NCT01203930|Idelalisib|idelalisib|mesh-list
138753292|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138753293|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753294|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
138753295|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753296|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138753297|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753298|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753299|NCT01254890|Azacitidine|azacitidine|mesh-list
138753300|NCT01254890|Sorafenib|sorafenib|mesh-list
138674240|NCT00477854|Chromium|chromium|mesh-list
139078061|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753313|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753314|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753315|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138753316|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138753317|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138753318|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
138753319|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753320|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753321|NCT01203852|Diuretics|diuretics|mesh-ancestor
138753322|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
138753323|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138753324|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138753326|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138753327|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
138753328|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138753329|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
138753330|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753331|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753332|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
138753333|NCT01105377|Azacitidine|azacitidine|mesh-list
138753334|NCT01105377|Entinostat|entinostat|mesh-list
138753335|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138753336|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138753337|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
138753338|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753339|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753340|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753341|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138753342|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138753343|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138753344|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138753345|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138753346|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
138753347|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753348|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753349|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753350|NCT01111539|Aripiprazole|aripiprazole|mesh-list
138753351|NCT01111539|Escitalopram|escitalopram|mesh-list
138753352|NCT01111539|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138753353|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138753354|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138753355|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753356|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753357|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
138753358|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753359|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
138753360|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138753361|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138753362|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138753369|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138551300|NCT00071942|Vaccines|vaccines|mesh-list
138753370|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138753371|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138753372|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
138753373|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138753374|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753375|NCT02880345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138753376|NCT02880345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753377|NCT02879955|Acarbose|acarbose|mesh-list
138753378|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138753379|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753380|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753381|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138753382|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753383|NCT02880033|Deferiprone|deferiprone|mesh-list
138753384|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138753385|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
138753386|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
138753387|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753388|NCT00625911|Ketamine|ketamine|mesh-list
138753389|NCT00625911|Morphine|morphine|mesh-list
138753390|NCT00625911|Analgesics|analgesics|mesh-ancestor
138753391|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
138753392|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753393|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753394|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138753395|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138753396|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
138753397|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
138753398|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138753399|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138753400|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138753401|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753402|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753403|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138753404|NCT00625911|Narcotics|narcotics|mesh-ancestor
138753405|NCT01111149|Bupropion|bupropion|mesh-list
138753406|NCT01111149|Varenicline|varenicline|mesh-list
138753407|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138753408|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
138753409|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138753410|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138753411|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138753412|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138753413|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753414|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
138753415|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753416|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753417|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138753418|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138753419|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753420|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138753421|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138753422|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
138753423|NCT01254656|Efavirenz|efavirenz|mesh-list
138753424|NCT01254656|Etravirine|etravirine|mesh-list
138753425|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138753426|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138753427|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674269|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138753439|NCT01254344|Ertapenem|ertapenem|mesh-list
138753440|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138753441|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138753442|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138753443|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138753444|NCT05051007|Lidocaine|lidocaine|mesh-list
138753445|NCT05051007|Fentanyl|fentanyl|mesh-list
138753446|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
138753447|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
138753448|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138753449|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753450|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
138753451|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753452|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138753453|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138753454|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138753455|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138753456|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753457|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138753458|NCT05051007|Narcotics|narcotics|mesh-ancestor
138753459|NCT05051007|Analgesics|analgesics|mesh-ancestor
138753460|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138753461|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138753462|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
138753463|NCT01102803|Cycloserine|cycloserine|mesh-list
138753464|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138753465|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138753466|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138753467|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
138753468|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138753469|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
138753470|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753471|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138753472|NCT01109979|Drospirenone|drospirenone|mesh-list
138753473|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139078223|NCT00098787|Antidotes|antidotes|mesh-ancestor
138753474|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138753475|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
138753476|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138753478|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138753479|NCT01109979|Estrogens|estrogens|mesh-ancestor
138753480|NCT01109979|Hormones|hormones|mesh-ancestor
138753481|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138753482|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753483|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138753484|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
138753485|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138753486|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138753487|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138753488|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138753489|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138753506|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753507|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753508|NCT01108809|Telmisartan|telmisartan|mesh-list
138753509|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138753510|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138753511|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138753512|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753513|NCT01253408|Dronabinol|dronabinol|mesh-list
138753514|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
138753515|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753516|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138753517|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138753518|NCT01253408|Analgesics|analgesics|mesh-ancestor
138753519|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
138753520|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753521|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138753522|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138753523|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753524|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753525|NCT01253408|Hormones|hormones|mesh-ancestor
138753526|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138753527|NCT02879643|Vincristine|vincristine|mesh-list
138753528|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138753529|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753530|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
138753531|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
138753532|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
138753533|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753534|NCT02879721|Candesartan|candesartan|mesh-list
138753535|NCT02879721|Candesartan cilexetil|candesartan cilexetil|mesh-list
138753536|NCT02879721|Enalapril|enalapril|mesh-list
138753537|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138753538|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138753539|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138753540|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753541|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138753542|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
138753543|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753544|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
138753545|NCT01253174|Drospirenone|drospirenone|mesh-list
138753546|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138753547|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
138674285|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138753556|NCT01108731|Milnacipran|milnacipran|mesh-list
138753557|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
138753558|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138753559|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138753560|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138753561|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753562|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753563|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753564|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138753565|NCT01108731|Analgesics|analgesics|mesh-ancestor
138753566|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
138753567|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753568|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
138753569|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138753570|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
138753571|NCT04308525|Narcotics|narcotics|mesh-ancestor
138753572|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138753573|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753574|NCT04308525|Analgesics|analgesics|mesh-ancestor
138753575|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
138753576|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753577|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138753579|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138753580|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
138753581|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753582|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753583|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
138753584|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
138753585|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138753586|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138753587|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138753588|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753589|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753590|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138753591|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138753592|NCT01252238|Amlodipine|amlodipine|mesh-list
138753593|NCT01252238|Valsartan|valsartan|mesh-list
138753594|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138753595|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138753596|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138753597|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753598|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138753599|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753600|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
138753601|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138753602|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138753603|NCT01101321|Oxycodone|oxycodone|mesh-list
138753604|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138753605|NCT01101321|Narcotics|narcotics|mesh-ancestor
138753606|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139078320|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
138753607|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753608|NCT01101321|Analgesics|analgesics|mesh-ancestor
138753609|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
138753610|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753611|NCT04309929|Analgesics|analgesics|mesh-list
138674301|NCT01247493|Cytarabine|cytarabine|mesh-list
138753625|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138753626|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753627|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
138753628|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753629|NCT02879097|Paclitaxel|paclitaxel|mesh-list
138753630|NCT02879097|Carboplatin|carboplatin|mesh-list
138753631|NCT02879097|Bevacizumab|bevacizumab|mesh-list
138753632|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138753633|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753634|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
138753635|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
138753636|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
138753637|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753638|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138753639|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138753640|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138753641|NCT02879097|Growth Substances|growth substances|mesh-ancestor
138753642|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753643|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
138753644|NCT02878863|Peoniflorin|peoniflorin|mesh-list
138753646|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
138753647|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753648|NCT02878863|Protective Agents|protective agents|mesh-ancestor
138753649|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753650|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138753651|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138753652|NCT02878863|Analgesics|analgesics|mesh-ancestor
138753653|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
138753654|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753655|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138753657|NCT02881125|Paclitaxel|paclitaxel|mesh-list
138753658|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138753659|NCT02881125|Nortriptyline|nortriptyline|mesh-list
138753660|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138753661|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753662|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
138753663|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
138753664|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
138753665|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753666|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138753667|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
138753668|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138753669|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138753670|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138753671|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138753672|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
138753673|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753674|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753686|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138753687|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138753688|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138753689|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138753690|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138753691|NCT01097421|Pramipexole|pramipexole|mesh-list
138753692|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
139078405|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138753693|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753694|NCT01097421|Protective Agents|protective agents|mesh-ancestor
138753695|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753696|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138753697|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138753698|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
138753699|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
138753700|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753701|NCT01251614|Adalimumab|adalimumab|mesh-list
138753702|NCT01251614|Methotrexate|methotrexate|mesh-list
138753703|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138753704|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
138753705|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138753706|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753707|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138753708|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
138753709|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753710|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753711|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
138753712|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753713|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138753714|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138753715|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
138753716|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138753717|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138753718|NCT01251614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138753719|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138753721|NCT01106625|Canagliflozin|canagliflozin|mesh-list
138753722|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138753723|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753724|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138753725|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753726|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
138753727|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138753728|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138753729|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138753730|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138753731|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753732|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
138753733|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753734|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753735|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138753736|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753738|NCT01251146|Bisoprolol|bisoprolol|mesh-list
138753744|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753745|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138753746|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139078510|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138753747|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138753748|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
138753749|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753750|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753751|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
138753752|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138753753|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138753754|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753755|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138753756|NCT02878707|Analgesics|analgesics|mesh-ancestor
138753757|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
138753758|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753759|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138753760|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138753761|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138753762|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
138753763|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753764|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753766|NCT01096017|Terbutaline|terbutaline|mesh-list
138753767|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138753768|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
138753769|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753770|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753771|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138753772|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
138753773|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
138753774|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138753775|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138753776|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138753777|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138753778|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
138753779|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753780|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753781|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
138753782|NCT00626223|Folic Acid|folic acid|mesh-list
138753783|NCT00626223|Hematinics|hematinics|mesh-ancestor
138753784|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
138753785|NCT00626223|Vitamins|vitamins|mesh-ancestor
138753786|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
138753787|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753788|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
138753789|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
138753790|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753791|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138753792|NCT04828005|Naloxone|naloxone|mesh-list
138753793|NCT04828005|Nalmefene|nalmefene|mesh-list
138428048|NCT01708837|Propofol|propofol|mesh-list
138753794|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138753795|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753796|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
138753797|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753798|NCT02878161|Prednisone|prednisone|mesh-list
138753799|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
138753800|NCT02878161|Adalimumab|adalimumab|mesh-list
138753801|NCT02878161|Infliximab|infliximab|mesh-list
138753802|NCT02878161|Etanercept|etanercept|mesh-list
138753803|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138753804|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138753805|NCT02878161|Methotrexate|methotrexate|mesh-list
138753807|NCT02878161|Leflunomide|leflunomide|mesh-list
138753808|NCT02878161|Hormones|hormones|mesh-ancestor
138753809|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138753821|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138753822|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138753823|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
138753824|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138753825|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138753826|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
138753827|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
138753828|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753829|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138753830|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138753831|NCT02878161|Protective Agents|protective agents|mesh-ancestor
138753832|NCT02878161|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138753833|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138753834|NCT02878161|Analgesics|analgesics|mesh-ancestor
138753835|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
138753836|NCT01093755|Omeprazole|omeprazole|mesh-list
138753837|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
138753838|NCT01093755|Lansoprazole|lansoprazole|mesh-list
138753839|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138753840|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138753841|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138753842|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753843|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753844|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138753845|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138753846|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138753847|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753848|NCT01092663|Incretins|incretins|mesh-ancestor
138753849|NCT01092663|Hormones|hormones|mesh-ancestor
138753850|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138753851|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138753852|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
138753853|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753854|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753855|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138753856|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138753857|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
138753858|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138753859|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
138753860|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138753861|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
138753862|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753863|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753864|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138753865|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
138753866|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138753867|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138753868|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138753869|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
138753870|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753871|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753884|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138753886|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138753887|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138753888|NCT01091259|Growth Substances|growth substances|mesh-ancestor
138753889|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753890|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
139078690|NCT02537509|Vitamins|vitamins|mesh-ancestor
138753892|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138753893|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753894|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753895|NCT01078389|Febuxostat|febuxostat|mesh-list
138753896|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
138753897|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138753898|NCT01090323|Deferasirox|deferasirox|mesh-list
138753899|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138753900|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
138753901|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
138753902|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753903|NCT02876991|Listerine|listerine|mesh-list
138753904|NCT02876991|Fluorides|fluorides|mesh-list
138753905|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
138753906|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
138753907|NCT02876991|Protective Agents|protective agents|mesh-ancestor
138753908|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753909|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138753910|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138753911|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138753912|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138753913|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753914|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138753915|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
138753916|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753917|NCT00637611|Fexofenadine|fexofenadine|mesh-list
138753918|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138753919|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138753920|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138753921|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
138753922|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
138753923|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138753924|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078733|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
138753925|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753927|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138753928|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138753929|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138753930|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753931|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753932|NCT01200810|Bicalutamide|bicalutamide|mesh-list
138770259|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674354|NCT01247688|Fludarabine|fludarabine|mesh-list
138753940|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753941|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753943|NCT01200342|Carboplatin|carboplatin|mesh-list
138753945|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138753946|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753947|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
138753948|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
138753949|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
138753950|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753951|NCT01198548|Vitamin D|vitamin d|mesh-list
138753952|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
138753953|NCT01198548|Leucovorin|leucovorin|mesh-list
138753954|NCT01198548|Bevacizumab|bevacizumab|mesh-list
138753955|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138753956|NCT01198548|Fluorouracil|fluorouracil|mesh-list
138753957|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
138753958|NCT01198548|Antibodies|antibodies|mesh-list
138753959|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
138753960|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138753961|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
138753962|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138753963|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138586180|NCT03271918|Cabergoline|cabergoline|mesh-list
138753964|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138753965|NCT01198548|Growth Substances|growth substances|mesh-ancestor
138753966|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753967|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
138753968|NCT01198548|Vitamins|vitamins|mesh-ancestor
138753969|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
138753970|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
138753971|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138753972|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138753973|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
138753974|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753975|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138753976|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138753977|NCT01198548|Antidotes|antidotes|mesh-ancestor
138753978|NCT01198548|Protective Agents|protective agents|mesh-ancestor
138753979|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
138753980|NCT00977938|Aspirin|aspirin|mesh-list
138753981|NCT00977938|Clopidogrel|clopidogrel|mesh-list
138753982|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138753983|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138753984|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138753985|NCT00977938|Analgesics|analgesics|mesh-ancestor
138753986|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
138753987|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138753988|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138753989|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138753990|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138753991|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138753992|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138753993|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138753994|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138753995|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138753996|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138753997|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
138753998|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138754005|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138754006|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754007|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754008|NCT04290208|Acetaminophen|acetaminophen|mesh-list
138754009|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138754010|NCT04290208|Analgesics|analgesics|mesh-ancestor
138754011|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
138754012|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754013|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754014|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
138754015|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138754016|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754017|NCT01090011|Cetuximab|cetuximab|mesh-list
138754018|NCT01090011|Afatinib|afatinib|mesh-list
138754019|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138754020|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754021|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138754022|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754023|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754024|NCT02877615|S44819|s44819|mesh-list
138754025|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
138754026|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
138754027|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
138754028|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754029|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754030|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754031|NCT02437279|Nivolumab|nivolumab|mesh-list
138754032|NCT02437279|Ipilimumab|ipilimumab|mesh-list
138586212|NCT00467662|Acyclovir|acyclovir|mesh-list
138754033|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138754034|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754035|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138754036|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754037|NCT01251653|Gemcitabine|gemcitabine|mesh-list
138754038|NCT01251653|Docetaxel|docetaxel|mesh-list
138754039|NCT01251653|Afatinib|afatinib|mesh-list
138754040|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138754041|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
138754042|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754043|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754044|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
138754045|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
138754046|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
138754047|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138754048|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754049|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
138754050|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138754051|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754052|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138754053|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
138754054|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139078838|NCT03721744|Paclitaxel|paclitaxel|mesh-list
138754055|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754056|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754057|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754058|NCT01077375|Milnacipran|milnacipran|mesh-list
138754059|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
138754060|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138754061|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138754062|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138754063|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754064|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754065|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754066|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138754077|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
138754078|NCT04306653|Hormones|hormones|mesh-ancestor
138754079|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754080|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754081|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138754082|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
138754083|NCT04306731|Trimethoprim|trimethoprim|mesh-list
138754084|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138754085|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754086|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
138754087|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138754088|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138754089|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138754090|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754091|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428348|NCT01710696|Estradiol|estradiol|mesh-list
138754092|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138754093|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138754094|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138754096|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138754097|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
138754098|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754099|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754100|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138754101|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
138754102|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
138754103|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138754104|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138754105|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138754106|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138754107|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
138754108|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754109|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754111|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
138754112|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138754113|NCT01250873|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138754114|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138754115|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138754116|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754117|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754118|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
138754119|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754120|NCT02888327|Oseltamivir|oseltamivir|mesh-list
138754121|NCT02888327|Digoxin|digoxin|mesh-list
138754122|NCT02888327|Midazolam|midazolam|mesh-list
138754123|NCT02888327|Pitavastatin|pitavastatin|mesh-list
138754124|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138754125|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138754126|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586241|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
138754127|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754129|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138754130|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138754131|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138754132|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
138754133|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
138754134|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
138754146|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138754147|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
138754148|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138754149|NCT01248065|Vitamin D|vitamin d|mesh-list
138754150|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
138754151|NCT01248065|Ciclesonide|ciclesonide|mesh-list
138754152|NCT01248065|Vitamins|vitamins|mesh-ancestor
138754153|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
138754154|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754155|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138754156|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138754157|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
138754158|NCT01248065|Hormones|hormones|mesh-ancestor
138754159|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754160|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138754161|NCT01250756|Vaccines|vaccines|mesh-list
138754162|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138754163|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
138754164|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754165|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
138754166|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138754167|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754168|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138754169|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754170|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754171|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
138754172|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138754173|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138754174|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754175|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138754176|NCT02865304|Endostar protein|endostar protein|mesh-list
138754177|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138754178|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138754179|NCT02865304|Growth Substances|growth substances|mesh-ancestor
138754180|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754181|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
138754182|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754183|NCT04075474|Listerine|listerine|mesh-list
138754184|NCT04075474|Fluorides|fluorides|mesh-list
138754185|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
139078952|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
138586290|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
138754187|NCT04075474|Protective Agents|protective agents|mesh-ancestor
138754188|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754189|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138754190|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754191|NCT02866396|Pregabalin|pregabalin|mesh-list
138754192|NCT02866396|Analgesics|analgesics|mesh-ancestor
138754193|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
138754194|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754195|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754196|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
138754197|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138754198|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770260|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
138754212|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138754213|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754214|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754215|NCT00626613|Risperidone|risperidone|mesh-list
138754216|NCT00626613|Galantamine|galantamine|mesh-list
138754217|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138754218|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
138754219|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754220|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754221|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754222|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138754223|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138754224|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138754225|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139079000|NCT00072176|Sirolimus|sirolimus|mesh-list
138754226|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138754227|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
138754228|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138754229|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754230|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
138754231|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138754232|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
138754233|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754234|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
138754236|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138754237|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754238|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138754239|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138754240|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138754241|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754243|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138754244|NCT01079949|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138754245|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138754246|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
138754247|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138754248|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754249|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
138754250|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754251|NCT01079949|Hormones|hormones|mesh-ancestor
138754252|NCT00909727|Ivacaftor|ivacaftor|mesh-list
138754253|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138754254|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138754255|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754256|NCT00977080|Cinacalcet|cinacalcet|mesh-list
138754257|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138754258|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754259|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138754260|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
138674397|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
138754275|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
138754276|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138754277|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754279|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138754280|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
138754281|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754282|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138754283|NCT03741517|Edotreotide|edotreotide|mesh-list
138754284|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138754285|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754286|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138754287|NCT00908011|Ezetimibe|ezetimibe|mesh-list
138754288|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138754289|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138754290|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
138754291|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754292|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138754293|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138754294|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754295|NCT00976456|Bevacizumab|bevacizumab|mesh-list
138754296|NCT00976456|Carboplatin|carboplatin|mesh-list
138754297|NCT00976456|Pemetrexed|pemetrexed|mesh-list
138754298|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138754299|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754300|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138754301|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138754302|NCT00976456|Growth Substances|growth substances|mesh-ancestor
138754303|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754304|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
138754305|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754306|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754307|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138754308|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138754309|NCT01243151|Bococizumab|bococizumab|mesh-list
138754310|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139079085|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
138754311|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138754312|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
138754313|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754314|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138754315|NCT00629512|Esomeprazole|esomeprazole|mesh-list
138754316|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138754317|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138754318|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138754319|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754320|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754321|NCT01711021|Amphetamine|amphetamine|mesh-list
138754322|NCT01711021|Dextroamphetamine|dextroamphetamine|mesh-list
138754334|NCT01711021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138586337|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
138754335|NCT01711021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138754338|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138754339|NCT02864602|BB 1101|bb 1101|mesh-list
138754340|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138754341|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
138754342|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
138754343|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754344|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754345|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138754346|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
138754347|NCT02864602|Hormones|hormones|mesh-ancestor
138754348|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754349|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138754350|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754351|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
138754352|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754353|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754354|NCT00993148|Ritonavir|ritonavir|mesh-list
138754355|NCT00993148|Darunavir|darunavir|mesh-list
138754356|NCT00993148|Maraviroc|maraviroc|mesh-list
138754357|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138754358|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138754359|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
138754360|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754361|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754362|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138754363|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138754364|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
138754365|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754366|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138754367|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138754369|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138754370|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138754371|NCT00907153|Vitamin D|vitamin d|mesh-list
138754372|NCT00907153|Vitamins|vitamins|mesh-ancestor
138754373|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
138754374|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754375|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138754376|NCT00904033|Calcitriol|calcitriol|mesh-list
138754377|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138754378|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754379|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138754380|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138754381|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754382|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138754383|NCT00904033|Vitamins|vitamins|mesh-ancestor
138754396|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754397|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754398|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138754399|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138754400|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138754401|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138754402|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
138754403|NCT01241591|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138754404|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138754405|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754406|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754407|NCT04319705|Azithromycin|azithromycin|mesh-list
138754408|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138754409|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754410|NCT00906373|Sorafenib|sorafenib|mesh-list
138754411|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138754412|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754413|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138754414|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754415|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754416|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
138754417|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754418|NCT02850445|Olanzapine|olanzapine|mesh-list
138754419|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
138754420|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
138754421|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754422|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754423|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138754424|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138754425|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138754426|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138754427|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138754428|NCT02850445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138754429|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139079156|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
138754430|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138754431|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754432|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754433|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
138754435|NCT04220203|Trastuzumab|trastuzumab|mesh-list
138754436|NCT04220203|Tucatinib|tucatinib|mesh-list
138754437|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138754438|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
138754439|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754440|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754441|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138754442|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138754443|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754444|NCT02850211|Ibuprofen|ibuprofen|mesh-list
138754445|NCT02850211|Celecoxib|celecoxib|mesh-list
138754446|NCT02850211|Tramadol|tramadol|mesh-list
138754455|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138754456|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754457|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754458|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138754459|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138754461|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138754462|NCT02850289|Interferons|interferons|mesh-list
138754463|NCT02850289|Ribavirin|ribavirin|mesh-list
138754464|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754465|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
138754466|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754467|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
138754468|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754469|NCT05331781|Morphine|morphine|mesh-list
138754470|NCT05331781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138754471|NCT05331781|Narcotics|narcotics|mesh-ancestor
139079176|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
138754472|NCT05331781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138754473|NCT05331781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754474|NCT05331781|Analgesics|analgesics|mesh-ancestor
138754475|NCT05331781|Sensory System Agents|sensory system agents|mesh-ancestor
138754476|NCT05331781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754477|NCT04202887|Fentanyl|fentanyl|mesh-list
138754478|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138754479|NCT04202887|Narcotics|narcotics|mesh-ancestor
138754480|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138754481|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754482|NCT04202887|Analgesics|analgesics|mesh-ancestor
138754483|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
138754484|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754485|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138754486|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138754487|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
138754488|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
138754489|NCT05324215|Fentanyl|fentanyl|mesh-list
138754490|NCT05324215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138754491|NCT05324215|Narcotics|narcotics|mesh-ancestor
138754492|NCT05324215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586418|NCT06182800|Growth Substances|growth substances|mesh-ancestor
138754493|NCT05324215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754494|NCT05324215|Analgesics|analgesics|mesh-ancestor
138754495|NCT05324215|Sensory System Agents|sensory system agents|mesh-ancestor
138754496|NCT05324215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754497|NCT05324215|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138754498|NCT05324215|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138754499|NCT05324215|Anesthetics, General|anesthetics, general|mesh-ancestor
138754500|NCT05324215|Anesthetics|anesthetics|mesh-ancestor
138754501|NCT00905437|Pregabalin|pregabalin|mesh-list
138754502|NCT00905437|Analgesics|analgesics|mesh-ancestor
138754503|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
138754504|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754505|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754506|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
138754507|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138754508|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138754509|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754510|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138754511|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138754512|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138754513|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138754540|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138754541|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138754543|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
138754544|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754545|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754546|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138754547|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138551393|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
138754548|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138754549|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754550|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754551|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
138754552|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754554|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138754555|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138754556|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
138754557|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754558|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138754559|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138754560|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754561|NCT01237223|Amlodipine|amlodipine|mesh-list
138754562|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138754563|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138674455|NCT00473174|Ramipril|ramipril|mesh-list
138754592|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754593|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138754594|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
138754595|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754596|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754597|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
138754598|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754599|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138754600|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138754601|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
138754602|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138754603|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138754604|NCT01868269|Dexamethasone|dexamethasone|mesh-list
138586455|NCT06182618|Metformin|metformin|mesh-list
138754605|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
138754606|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
138754619|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
138754620|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
138754621|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754622|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138754623|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
138754624|NCT01868269|Hormones|hormones|mesh-ancestor
138754625|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754626|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138754627|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
138754628|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754629|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138754630|NCT01235351|Clopidogrel|clopidogrel|mesh-list
138754631|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138754632|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138754633|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138754634|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138754635|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
138754636|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754637|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754638|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754639|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
138754640|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138754641|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138754642|NCT01234649|Metformin|metformin|mesh-list
138754643|NCT01234649|Liraglutide|liraglutide|mesh-list
138754644|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138754645|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754646|NCT01234649|Incretins|incretins|mesh-ancestor
138754647|NCT01234649|Hormones|hormones|mesh-ancestor
138754648|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754649|NCT02876679|Cyclosporine|cyclosporine|mesh-list
138754650|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
138754651|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
138754652|NCT02876679|Cyclosporins|cyclosporins|mesh-list
138754653|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138754654|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138754655|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
138754656|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754657|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138754658|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138754659|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
138754660|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754661|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754662|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138754663|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754664|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
138754665|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754666|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
138754667|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138754668|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138754677|NCT01072149|Xhance|xhance|mesh-list
138754678|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138754679|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138754680|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
138754681|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754682|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754683|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138754684|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
138754686|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138754687|NCT04413253|Dexamethasone|dexamethasone|mesh-list
138754688|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138428950|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138754689|NCT04413253|Lifitegrast|lifitegrast|mesh-list
138754690|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138754691|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138754692|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
138754693|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
138754694|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754695|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754696|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138754697|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
138754698|NCT04413253|Hormones|hormones|mesh-ancestor
138754699|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754700|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138754701|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754702|NCT01679119|Prednisolone|prednisolone|mesh-list
138754703|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
138754704|NCT01679119|Rituximab|rituximab|mesh-list
138754705|NCT01679119|Gemcitabine|gemcitabine|mesh-list
138754706|NCT01679119|Vincristine|vincristine|mesh-list
138754707|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138754708|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138754709|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
138754710|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754711|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138754712|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138754713|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
138754714|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754715|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754716|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138754717|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138754718|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138754719|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
138754720|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138754721|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
138754722|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
138754723|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
138754724|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138754725|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
138754726|NCT01679119|Hormones|hormones|mesh-ancestor
138754727|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139079425|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754728|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138754729|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138754730|NCT01679119|Immunotoxins|immunotoxins|mesh-ancestor
138754731|NCT01679119|Immunoconjugates|immunoconjugates|mesh-ancestor
138754732|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
138754733|NCT04778787|Digoxin|digoxin|mesh-list
138754734|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138754735|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
138754755|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754756|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138754757|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138754758|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138754759|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
138754760|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754761|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754762|NCT02875587|Cabergoline|cabergoline|mesh-list
138429030|NCT01714128|Estradiol|estradiol|mesh-list
138754763|NCT02875587|Calcium|calcium|mesh-list
138754764|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138754765|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754766|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138754767|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138754768|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
138754769|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
138754770|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754771|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754772|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138754773|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138754775|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138754776|NCT01070979|Estrogens|estrogens|mesh-list
138754777|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138754778|NCT01070979|Hormones|hormones|mesh-ancestor
138754779|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754780|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754781|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138754782|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
138754783|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138754784|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138754785|NCT01234337|Capecitabine|capecitabine|mesh-list
138754786|NCT01234337|Sorafenib|sorafenib|mesh-list
138754787|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138754788|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
138674528|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138754803|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754805|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138754806|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138754807|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754808|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754809|NCT01070043|Amlodipine|amlodipine|mesh-list
138754810|NCT01070043|Valsartan|valsartan|mesh-list
138754811|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138754812|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138754813|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138754814|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754815|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138754816|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754817|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
138754818|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138754819|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138754820|NCT01074255|Aprepitant|aprepitant|mesh-list
138754821|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
138754822|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
138754823|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754824|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754825|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138754826|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138754827|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138754828|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754829|NCT01073943|Bisacodyl|bisacodyl|mesh-list
138754830|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
138754831|NCT01073943|Cathartics|cathartics|mesh-ancestor
138754832|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138754833|NCT01073943|Laxatives|laxatives|mesh-ancestor
138754834|NCT01073865|Goserelin|goserelin|mesh-list
138754835|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138754836|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754837|NCT04862065|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
138754838|NCT04862065|Immunologic Factors|immunologic factors|mesh-ancestor
138754839|NCT04862065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754840|NCT01064635|Letrozole|letrozole|mesh-list
138754841|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754842|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138754843|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138754844|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754845|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754846|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138754847|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
138770261|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754854|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754855|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754856|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138754857|NCT04697485|Diuretics|diuretics|mesh-ancestor
138754858|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
138754859|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138754860|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138754861|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138754862|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754863|NCT01073631|Voriconazole|voriconazole|mesh-list
138754864|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
138754865|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754866|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138754867|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138754868|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754869|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754870|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138754871|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
138754872|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754873|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754874|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138754875|NCT00626769|Genistein|genistein|mesh-list
138754876|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138754877|NCT00626769|Protective Agents|protective agents|mesh-ancestor
138754878|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754879|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754880|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138754881|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754882|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754883|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
138754884|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138754885|NCT00626769|Estrogens|estrogens|mesh-ancestor
138754886|NCT00626769|Hormones|hormones|mesh-ancestor
138754887|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754888|NCT02875743|Posaconazole|posaconazole|mesh-list
138754889|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
138754890|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138754891|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138754892|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138754893|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138754894|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138754895|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138754896|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079610|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138754897|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754898|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138754899|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
138754900|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754901|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754902|NCT01073163|Rituximab|rituximab|mesh-list
138754903|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138754904|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138754905|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754906|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
138754907|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754908|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138754909|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138754910|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
138754911|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754921|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
138754922|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138754923|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138754924|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754925|NCT04304313|Urological Agents|urological agents|mesh-ancestor
138754926|NCT01072929|Modafinil|modafinil|mesh-list
138754927|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138754928|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754929|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138754930|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138754931|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138754932|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754933|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
138754934|NCT04305015|Narcotics|narcotics|mesh-ancestor
138754935|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138754936|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754937|NCT04305015|Analgesics|analgesics|mesh-ancestor
138754938|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
138754939|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138754940|NCT01231607|Finasteride|finasteride|mesh-list
138754941|NCT01231607|Dutasteride|dutasteride|mesh-list
138754942|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138754943|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138754944|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551432|NCT00072137|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
138754945|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754946|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
138754947|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138754948|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079663|NCT00050960|Paclitaxel|paclitaxel|mesh-list
138754949|NCT01231607|Urological Agents|urological agents|mesh-ancestor
138754950|NCT01231373|Polidocanol|polidocanol|mesh-list
138754951|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138754952|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138754953|NCT00975130|Golimumab|golimumab|mesh-list
138754954|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138754955|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138754956|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138754957|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138754958|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
138754959|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754960|NCT01230827|Golimumab|golimumab|mesh-list
138754961|NCT01230827|Methotrexate|methotrexate|mesh-list
138754962|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138754963|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
138754964|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138754965|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754966|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138754967|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
138754968|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754969|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754970|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
138754971|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754972|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138754973|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138754974|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
138754975|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138754982|NCT00903175|Everolimus|everolimus|mesh-list
138754983|NCT00903175|Sunitinib|sunitinib|mesh-list
138754984|NCT00903175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138754985|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138754986|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138754987|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138754988|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138754989|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
138754990|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138754991|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138754992|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138754993|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138754994|NCT00903175|Growth Substances|growth substances|mesh-ancestor
138754995|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
138754996|NCT01229735|Topiramate|topiramate|mesh-list
138754997|NCT01229735|Levetiracetam|levetiracetam|mesh-list
138754998|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
138754999|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138755000|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755001|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
138755002|NCT03866200|Resveratrol|resveratrol|mesh-list
138755003|NCT03866200|Antioxidants|antioxidants|mesh-ancestor
138755004|NCT03866200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755005|NCT03866200|Protective Agents|protective agents|mesh-ancestor
138755006|NCT03866200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755007|NCT03866200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755008|NCT03866200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138755009|NCT02848183|Cytarabine|cytarabine|mesh-list
138755010|NCT02848183|Etoposide|etoposide|mesh-list
138755011|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
138755012|NCT02848183|Idarubicin|idarubicin|mesh-list
138755013|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138755014|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755015|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138755016|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138755017|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755018|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755019|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138755020|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
138755021|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
138755022|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138755023|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138755024|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
138755025|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755026|NCT02848183|Analgesics|analgesics|mesh-ancestor
138755027|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
138755028|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755029|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138755030|NCT00974974|Levodopa|levodopa|mesh-list
138755031|NCT00974974|Carbidopa|carbidopa|mesh-list
138755032|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138755033|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138755034|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138755035|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
138755036|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755037|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755038|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755039|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138755040|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755041|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138755042|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
138755043|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
138755044|NCT02848417|Curcumin|curcumin|mesh-list
138755045|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138755062|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138755063|NCT02848339|Aspirin|aspirin|mesh-list
138755064|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138755065|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138755066|NCT02848339|Analgesics|analgesics|mesh-ancestor
138755067|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
138755068|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755069|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755070|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755071|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755072|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138755073|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138755074|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755075|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138755076|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138755077|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755078|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
138755079|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138755080|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138755081|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138755082|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
138755083|NCT04216303|Chrysarobin|chrysarobin|mesh-list
138755084|NCT04216303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138755085|NCT04216303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138755086|NCT04216303|Analgesics|analgesics|mesh-ancestor
138755087|NCT04216303|Sensory System Agents|sensory system agents|mesh-ancestor
138755088|NCT04216303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755089|NCT04216303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755090|NCT04216303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755091|NCT04216303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755092|NCT02847013|Bupivacaine|bupivacaine|mesh-list
138755093|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
138755094|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
138755095|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138755096|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755097|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
138755098|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755099|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
138755100|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138755101|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755102|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138674584|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
138755115|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755117|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
138755118|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755119|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
138755120|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138755121|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138755122|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755123|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
138755124|NCT04201951|Coagulants|coagulants|mesh-ancestor
138755125|NCT04753723|Gentamicins|gentamicins|mesh-list
138755126|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138755127|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138755128|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138755129|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755130|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755131|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
138755132|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138755133|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138755134|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
138755135|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755136|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755137|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755138|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
138755139|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
138755140|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755141|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
138755142|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138755143|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
138755144|NCT02844517|Pancrelipase|pancrelipase|mesh-list
138755145|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138755146|NCT03901729|Furosemide|furosemide|mesh-list
138755147|NCT03901729|Diuretics|diuretics|mesh-ancestor
139079849|NCT03449446|Firsocostat|firsocostat|mesh-list
138755148|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
138755149|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755150|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138755151|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138755152|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755153|NCT02846857|Insulin|insulin|mesh-list
138755154|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138755155|NCT02846857|Glucagon|glucagon|mesh-list
138755156|NCT02846857|Hormones|hormones|mesh-list
138755157|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138755158|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755159|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138755160|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138755161|NCT04672525|Rifampin|rifampin|mesh-list
138755162|NCT04672525|Rifabutin|rifabutin|mesh-list
138755163|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138755164|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
138755174|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138755175|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138755176|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138755177|NCT00992446|Cytarabine|cytarabine|mesh-list
138755178|NCT00992446|Rituximab|rituximab|mesh-list
138755179|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138755180|NCT00992446|Etoposide|etoposide|mesh-list
138755181|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
138755182|NCT00992446|Bortezomib|bortezomib|mesh-list
138755183|NCT00992446|Melphalan|melphalan|mesh-list
138755184|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
138755185|NCT00992446|Vorinostat|vorinostat|mesh-list
138755186|NCT00992446|Carmustine|carmustine|mesh-list
138755187|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
138755188|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138755189|NCT00992446|Antibodies|antibodies|mesh-list
138755190|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
138755191|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138755192|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
138755193|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755194|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755195|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755196|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138755197|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138755198|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138755199|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755200|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755201|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138755202|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
138755203|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
138755204|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138755205|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138755206|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138429467|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755207|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
138755208|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138755209|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138755210|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
138755211|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
138755212|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
138755213|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
138755214|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
138755215|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138755216|NCT04452565|Dexamethasone|dexamethasone|mesh-list
138755217|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
138755218|NCT04452565|BB 1101|bb 1101|mesh-list
138755219|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755220|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
138755221|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
138755222|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755223|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755224|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138755225|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
138755226|NCT04452565|Hormones|hormones|mesh-ancestor
138586813|NCT06172400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755227|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138755228|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138755229|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755230|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
138755247|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138755248|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138755249|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138755250|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138755251|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755252|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755253|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755254|NCT02846701|Analgesics|analgesics|mesh-ancestor
138755255|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
138755256|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755257|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
138755258|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138755259|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
138755267|NCT04292704|Clotrimazole|clotrimazole|mesh-list
138755268|NCT04292704|Miconazole|miconazole|mesh-list
138755269|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138755270|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138755271|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
138755272|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138755273|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138755274|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755275|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755276|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138755277|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
138755278|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138755279|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755280|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138227798|NCT02022644|Irinotecan|irinotecan|mesh-list
138755281|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138755282|NCT05242783|Terlipressin|terlipressin|mesh-list
138755283|NCT05242783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138755284|NCT05242783|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138755285|NCT03987685|Topotecan|topotecan|mesh-list
138755286|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138755287|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139079992|NCT01085721|Ephedrine|ephedrine|mesh-list
138755295|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755296|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138755297|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138755298|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138755299|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
138755300|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755301|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755302|NCT04136743|Dexamethasone|dexamethasone|mesh-list
138755303|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755304|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
138755305|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
138755306|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755307|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755308|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138755309|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
138755310|NCT04136743|Hormones|hormones|mesh-ancestor
138755311|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138755312|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138755313|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755314|NCT03931057|Midazolam|midazolam|mesh-list
138755315|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138755316|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138755317|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138755318|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755319|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138755320|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138755321|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138755322|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138755323|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
138755324|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
138755325|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
138755326|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
138755327|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755328|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755329|NCT02846155|Simethicone|simethicone|mesh-list
138755330|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
138755331|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755332|NCT02846155|Emollients|emollients|mesh-ancestor
138755333|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
138755334|NCT02845843|Interferons|interferons|mesh-list
138755335|NCT02845843|Ritonavir|ritonavir|mesh-list
138755336|NCT02845843|Lopinavir|lopinavir|mesh-list
138755337|NCT02845843|Interferon-beta|interferon-beta|mesh-list
138755338|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
138755339|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755340|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
138755341|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138755342|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138755343|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138755345|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755346|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755347|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138755348|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138755349|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138755350|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138755351|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
138755352|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755353|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138755355|NCT02845999|Fludarabine|fludarabine|mesh-list
138755356|NCT02845999|Cetuximab|cetuximab|mesh-list
138755357|NCT02845999|Interleukin-2|interleukin-2|mesh-list
138674635|NCT01248858|Trametinib|trametinib|mesh-list
138755376|NCT05337085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755377|NCT05337085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138755379|NCT05337085|Sensory System Agents|sensory system agents|mesh-ancestor
138755380|NCT05337085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755381|NCT05337085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138755382|NCT05337085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138755383|NCT05337085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138755384|NCT05337085|Adrenergic Agents|adrenergic agents|mesh-ancestor
138755385|NCT05337085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755386|NCT05337085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755387|NCT05337085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138755388|NCT05337085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138755389|NCT05337085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138755390|NCT05337085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138755391|NCT05337085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138755392|NCT05337085|Anesthetics, General|anesthetics, general|mesh-ancestor
138755393|NCT05337085|Anesthetics|anesthetics|mesh-ancestor
138755394|NCT05337085|GABA Modulators|gaba modulators|mesh-ancestor
138755395|NCT05337085|GABA Agents|gaba agents|mesh-ancestor
138755396|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
138755397|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138755398|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755399|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755400|NCT01723579|Estradiol|estradiol|mesh-list
138755401|NCT01723579|Estrogens|estrogens|mesh-ancestor
138755402|NCT01723579|Hormones|hormones|mesh-ancestor
138755403|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138755404|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755405|NCT00901927|Rituximab|rituximab|mesh-list
138755406|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138755407|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
138755408|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138755409|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755410|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
138755411|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755412|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755413|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138755414|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
138674640|NCT01313728|Dapsone|dapsone|mesh-list
138755425|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
138755426|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755427|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
138755428|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138755429|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138755430|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138755431|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138755432|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
138755433|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138755434|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755435|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138755436|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138755437|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138755438|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138755439|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138755440|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138755441|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138755442|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138755443|NCT00968968|Trastuzumab|trastuzumab|mesh-list
138755444|NCT00968968|Lapatinib|lapatinib|mesh-list
138755445|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138755446|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755447|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138755448|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755449|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755451|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138755452|NCT00973102|Hormones|hormones|mesh-ancestor
138755453|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138755454|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755455|NCT03691090|Paclitaxel|paclitaxel|mesh-list
138755456|NCT03691090|Cisplatin|cisplatin|mesh-list
138755457|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138755458|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755459|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
138755460|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
138755461|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
138755462|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755463|NCT00783211|Fexofenadine|fexofenadine|mesh-list
138755464|NCT00783211|Desloratadine|desloratadine|mesh-list
138755465|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138755466|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
138755467|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755468|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755469|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755470|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138755471|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138755472|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
138755473|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
139080119|NCT00377819|Denosumab|denosumab|mesh-list
138755474|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138755475|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
138755476|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755477|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
138755478|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138755492|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138586927|NCT06072781|Paclitaxel|paclitaxel|mesh-list
138755493|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
138755495|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138755496|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138755497|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
138755498|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755499|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138755500|NCT02839213|Scopolamine|scopolamine|mesh-list
138755501|NCT02839213|Bromides|bromides|mesh-list
138755502|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138755503|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
138755504|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138755505|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
138755506|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
138755507|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755508|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755509|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138755510|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
138755511|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138755512|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
138755513|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755514|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755515|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138755516|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
138755517|NCT05334043|Curcumin|curcumin|mesh-list
138755518|NCT05334043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138755519|NCT05334043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138755520|NCT05334043|Analgesics|analgesics|mesh-ancestor
138755521|NCT05334043|Sensory System Agents|sensory system agents|mesh-ancestor
138755522|NCT05334043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755523|NCT05334043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755524|NCT05334043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755525|NCT05334043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755526|NCT05334043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755527|NCT05334043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755528|NCT05334043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755529|NCT02838823|Antibodies|antibodies|mesh-list
138755530|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138755531|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
138755532|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755533|NCT00156091|Olanzapine|olanzapine|mesh-list
138755534|NCT00156091|Asenapine|asenapine|mesh-list
138755535|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
138755536|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
138755537|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755538|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755539|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138755540|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138755541|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138755542|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138755543|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138755554|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138755555|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138755556|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755557|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138755558|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755559|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
138755560|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138755561|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138755562|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138755563|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
138755564|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755565|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
138755566|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755567|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
138755568|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138755569|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138755570|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138755572|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139080202|NCT01049633|Aspirin|aspirin|mesh-list
138755573|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138755575|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
138755576|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755577|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755578|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755579|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755580|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138755581|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138755582|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755583|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755584|NCT00092755|Ibuprofen|ibuprofen|mesh-list
138755585|NCT00092755|Etoricoxib|etoricoxib|mesh-list
138755586|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138755587|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138755588|NCT00092755|Analgesics|analgesics|mesh-ancestor
138755589|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
138755590|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755591|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755592|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755593|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755594|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138755595|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755596|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755597|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138755598|NCT00899431|Rituximab|rituximab|mesh-list
138755599|NCT00899431|Fludarabine|fludarabine|mesh-list
138755600|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
138755601|NCT00899431|Lenalidomide|lenalidomide|mesh-list
138755602|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138755603|NCT00899431|Allopurinol|allopurinol|mesh-list
138755604|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
138755605|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138755606|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138755607|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755608|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
138755615|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138755616|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138755617|NCT00899431|Growth Substances|growth substances|mesh-ancestor
138755618|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
138755619|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138755620|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
138755621|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755622|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
138755623|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138755625|NCT00899431|Protective Agents|protective agents|mesh-ancestor
138755626|NCT00898807|Citalopram|citalopram|mesh-list
138755627|NCT00898807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138755628|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138755629|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138755630|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755631|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755632|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
138755633|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755634|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138755635|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
138755636|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138755637|NCT01229267|Vaccines|vaccines|mesh-list
138755638|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
138755639|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755640|NCT00897715|Rilonacept|rilonacept|mesh-list
138755641|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755642|NCT01229111|Leucovorin|leucovorin|mesh-list
138755643|NCT01229111|Fluorouracil|fluorouracil|mesh-list
138755644|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
138755645|NCT01229111|Cediranib|cediranib|mesh-list
138755646|NCT01229111|Calcium|calcium|mesh-list
138755647|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
138755648|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138755649|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755650|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
138755651|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755652|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138755653|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755654|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138755655|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
138755656|NCT01229111|Antidotes|antidotes|mesh-ancestor
138755658|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
138755659|NCT01229111|Vitamins|vitamins|mesh-ancestor
138755660|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
138755661|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755662|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138755663|NCT02843815|Immunomodulating Agents|immunomodulating agents|mesh-list
138755664|NCT02843815|Immunologic Factors|immunologic factors|mesh-ancestor
138755665|NCT02843815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755666|NCT01228175|Riboflavin|riboflavin|mesh-list
138755667|NCT01228175|Varenicline|varenicline|mesh-list
139080334|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
138755668|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138755669|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138755670|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
138755671|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755672|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755673|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755674|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
138755675|NCT01228175|Vitamins|vitamins|mesh-ancestor
138755676|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
138755677|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138755678|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
138755679|NCT01228019|Niacin|niacin|mesh-list
138755696|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138755697|NCT01227707|Growth Substances|growth substances|mesh-ancestor
138755698|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755699|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
138755700|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138755701|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
138755702|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755703|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138755704|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
138755705|NCT01227707|Antidotes|antidotes|mesh-ancestor
138755706|NCT01227707|Protective Agents|protective agents|mesh-ancestor
138755707|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
138755708|NCT01227707|Vitamins|vitamins|mesh-ancestor
138755709|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
138755710|NCT00633373|Cyclosporine|cyclosporine|mesh-list
138755711|NCT00633373|Cyclosporins|cyclosporins|mesh-list
138755712|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587033|NCT05976347|Analgesics|analgesics|mesh-ancestor
138755713|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139080372|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
138755714|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138755715|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
138755716|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755717|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
138755718|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138755719|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
138755720|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755721|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138755722|NCT05334745|Hyaluronic Acid|hyaluronic acid|mesh-list
138755723|NCT05334745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138755724|NCT05334745|Immunologic Factors|immunologic factors|mesh-ancestor
138755725|NCT05334745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755726|NCT05334745|Viscosupplements|viscosupplements|mesh-ancestor
138755727|NCT05334745|Protective Agents|protective agents|mesh-ancestor
138755728|NCT02838589|Exenatide|exenatide|mesh-list
138755729|NCT02838589|Glucagon|glucagon|mesh-list
138755730|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138755731|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138755732|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755733|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138755734|NCT02838589|Incretins|incretins|mesh-ancestor
138755735|NCT02838589|Hormones|hormones|mesh-ancestor
138755736|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138755737|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138755739|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138755740|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138755742|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
138755743|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755752|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
138755753|NCT00895843|Ibuprofen|ibuprofen|mesh-list
138755754|NCT00895843|Epinephrine|epinephrine|mesh-list
138755755|NCT00895843|Bupivacaine|bupivacaine|mesh-list
138755756|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
138755757|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
138755758|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138755759|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755760|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
138755761|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755762|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138755763|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138755764|NCT00895843|Analgesics|analgesics|mesh-ancestor
138755765|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755767|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138755768|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755769|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755770|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138755771|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138755772|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
138755773|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139080462|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
138755774|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138755775|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138755776|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
138755777|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138755778|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
138755779|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
138755780|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
138755781|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138755782|NCT05333809|Pembrolizumab|pembrolizumab|mesh-list
138755783|NCT05333809|Disitamab vedotin|disitamab vedotin|mesh-list
138755784|NCT05333809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138755785|NCT05333809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755786|NCT05333809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138755787|NCT05333809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755788|NCT05333809|Immunoconjugates|immunoconjugates|mesh-ancestor
138755789|NCT05333809|Immunologic Factors|immunologic factors|mesh-ancestor
138755790|NCT05333809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755791|NCT05333731|Oxytocin|oxytocin|mesh-list
138755792|NCT05333731|Oxytocics|oxytocics|mesh-ancestor
138755793|NCT05333731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138755794|NCT05333731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755795|NCT02843581|Immunomodulating Agents|immunomodulating agents|mesh-list
138755796|NCT02843581|Immunologic Factors|immunologic factors|mesh-ancestor
138755797|NCT02843581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755798|NCT00895453|Iron|iron|mesh-list
138755799|NCT00895453|Itraconazole|itraconazole|mesh-list
138755800|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
138755801|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139080511|NCT03948620|Penicillins|penicillins|mesh-list
138755802|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138755803|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138755804|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755805|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755806|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138755807|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
138755808|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138755809|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755810|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138755827|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138755828|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138755829|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138587098|NCT05911906|Antiviral Agents|antiviral agents|mesh-ancestor
138755830|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
138755831|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755832|NCT00893113|Alfuzosin|alfuzosin|mesh-list
138755833|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138755834|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138755835|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138755836|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
138755837|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755838|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755839|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755840|NCT00893113|Urological Agents|urological agents|mesh-ancestor
138755841|NCT02840929|Esomeprazole|esomeprazole|mesh-list
138755842|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138755843|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138755844|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138755845|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755846|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755847|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
138755848|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138755849|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755850|NCT02837965|Doxycycline|doxycycline|mesh-list
138755851|NCT02837965|Prednisone|prednisone|mesh-list
138755852|NCT02837965|Methotrexate|methotrexate|mesh-list
138755853|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138755854|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
138755855|NCT02837965|Hormones|hormones|mesh-ancestor
138755856|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138755857|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755858|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138755859|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755860|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138755861|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
138755862|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138755863|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138755864|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
138755865|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755866|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
138755867|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587124|NCT05896228|Analgesics|analgesics|mesh-ancestor
138755868|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138755869|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138755870|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
138755893|NCT05322733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755894|NCT05322733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138755895|NCT05322733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138755896|NCT05322733|Alkylating Agents|alkylating agents|mesh-ancestor
138755897|NCT05322733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755898|NCT05322733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755899|NCT05322733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138755900|NCT05322733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138755903|NCT00968812|Canagliflozin|canagliflozin|mesh-list
138755904|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138755905|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755906|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138755907|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138755908|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
138755909|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138755910|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755911|NCT02834845|Sevoflurane|sevoflurane|mesh-list
138755912|NCT02834845|Desflurane|desflurane|mesh-list
138755913|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138755914|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138755915|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
138755916|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
138755917|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138755918|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755919|NCT00992056|Metoprolol|metoprolol|mesh-list
138755920|NCT00992056|Nebivolol|nebivolol|mesh-list
138755921|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138755922|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138755923|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
138755924|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
138755925|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139080652|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
138755926|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755936|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138755937|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138755938|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138755939|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755940|NCT00967798|Incretins|incretins|mesh-ancestor
138755941|NCT00967798|Hormones|hormones|mesh-ancestor
138755942|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138755943|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138755944|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
138755945|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587172|NCT05851898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755946|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755947|NCT04248205|Ketamine|ketamine|mesh-list
138755948|NCT04248205|Analgesics|analgesics|mesh-ancestor
138755949|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
138755950|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138755951|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755952|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138755953|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138755954|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
138755955|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
138755956|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138755957|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138430226|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138755958|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138755959|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755960|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755962|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138755963|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138755964|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138755965|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138755966|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138755967|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755968|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138755969|NCT02833987|Warfarin|warfarin|mesh-list
138755970|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
138755971|NCT02833987|Dabigatran|dabigatran|mesh-list
138755972|NCT02833987|Apixaban|apixaban|mesh-list
138755973|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
138755974|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138755975|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
138755976|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138755977|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
138755978|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551531|NCT00262405|Analgesics|analgesics|mesh-ancestor
138755979|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755980|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
138755981|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138755982|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138755983|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138755984|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
138755985|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138755986|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138755987|NCT00965458|Alefacept|alefacept|mesh-list
138755988|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
138755989|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
138756008|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138756009|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
138756010|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138756011|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756013|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756014|NCT05333419|Latanoprost|latanoprost|mesh-list
138756015|NCT05333419|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138756016|NCT05333419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138756017|NCT02836795|Antibodies|antibodies|mesh-list
138756018|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138756019|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
138756020|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756021|NCT02836483|Linezolid|linezolid|mesh-list
138756022|NCT02836483|Delpazolid|delpazolid|mesh-list
138756023|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
138756024|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138756025|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138756026|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138756027|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756028|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756029|NCT02836171|Itraconazole|itraconazole|mesh-list
138756030|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
138756031|NCT02836171|Apatinib|apatinib|mesh-list
138756032|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430312|NCT01730495|Etanercept|etanercept|mesh-list
138756033|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138756034|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756035|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756036|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
138756037|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138756038|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138756039|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138756040|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138756041|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
138756042|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138756043|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756044|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138756045|NCT00971932|Carboplatin|carboplatin|mesh-list
138756051|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138756052|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138756053|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
138756054|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756055|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138756056|NCT04400929|Molgramostim|molgramostim|mesh-list
138756057|NCT04400929|Sargramostim|sargramostim|mesh-list
138756058|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
138756059|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756060|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756061|NCT05170672|Abatacept|abatacept|mesh-list
138756062|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138756063|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756064|NCT05170672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138756065|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756066|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138756067|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
138756068|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756069|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138756070|NCT00970684|Bevacizumab|bevacizumab|mesh-list
138756071|NCT00970684|Gemcitabine|gemcitabine|mesh-list
138756072|NCT00970684|Docetaxel|docetaxel|mesh-list
138756073|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138756074|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756075|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138756076|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138756077|NCT00970684|Growth Substances|growth substances|mesh-ancestor
138756078|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756079|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
138756080|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138756081|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
138756082|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756083|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
138756084|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
138756085|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
138756086|NCT00967330|Bevacizumab|bevacizumab|mesh-list
138756087|NCT00967330|Irinotecan|irinotecan|mesh-list
138756088|NCT00967330|Temozolomide|temozolomide|mesh-list
138756089|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138756090|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756091|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138756092|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138756093|NCT00967330|Growth Substances|growth substances|mesh-ancestor
138756094|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756095|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
138756096|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138756097|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138756098|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756099|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756100|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138756101|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
138756103|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138756104|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138756105|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430422|NCT01731132|Copper|copper|mesh-list
138756107|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138756108|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138756109|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138756110|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
138756111|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756112|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756113|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756139|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
138756140|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
138756141|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756142|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756143|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
138756144|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756145|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139080860|NCT05841121|Antiemetics|antiemetics|mesh-ancestor
138756146|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138756147|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138756148|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138756149|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756150|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138756151|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138756152|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
138756153|NCT04285528|Analgesics|analgesics|mesh-ancestor
138756154|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138756155|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138756156|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138756157|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756158|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138756159|NCT04285528|Narcotics|narcotics|mesh-ancestor
138756160|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138756161|NCT00629824|Interferons|interferons|mesh-list
138756162|NCT00629824|Ribavirin|ribavirin|mesh-list
138756163|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
138756164|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138756165|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756166|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
138674791|NCT01313182|Mupirocin|mupirocin|mesh-list
138756175|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138756176|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
138756177|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756178|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138756179|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
138756180|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
138756182|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
138756183|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756184|NCT00964678|Carvedilol|carvedilol|mesh-list
138756185|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138756186|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138756187|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
138756188|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756189|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756190|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139080906|NCT05768932|Paclitaxel|paclitaxel|mesh-list
138756191|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138756192|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
138756193|NCT00964678|Protective Agents|protective agents|mesh-ancestor
138756194|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138756195|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138756196|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138756197|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
138756198|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138756199|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138756200|NCT00964366|Clindamycin|clindamycin|mesh-list
138756201|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
138756202|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
138756203|NCT00964366|Dapsone|dapsone|mesh-list
138756204|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138756205|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138756206|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138756207|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138756208|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756209|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756210|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
138756211|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
138756212|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138756213|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138756214|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138756215|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
138756216|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139080958|NCT05417113|Bupivacaine|bupivacaine|mesh-list
138756218|NCT02860936|Lenvatinib|lenvatinib|mesh-list
138756219|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756220|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138756221|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756222|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756223|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
138756224|NCT00630214|Vitamin D|vitamin d|mesh-list
138756225|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
138756226|NCT00630214|Cholecalciferol|cholecalciferol|mesh-list
138756227|NCT00630214|Vitamins|vitamins|mesh-list
138756228|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
138756229|NCT00630214|Calcium|calcium|mesh-list
138756230|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
138756231|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756232|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138756233|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138756234|NCT00630214|Antacids|antacids|mesh-ancestor
138756235|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756236|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138756242|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
138756243|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756245|NCT00960076|Saxagliptin|saxagliptin|mesh-list
138756246|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138756247|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756248|NCT00960076|Incretins|incretins|mesh-ancestor
138756249|NCT00960076|Hormones|hormones|mesh-ancestor
138756250|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138756251|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138756252|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
138756253|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756254|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756255|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138756256|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138756257|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138756258|NCT04284202|Dasatinib|dasatinib|mesh-list
138756259|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756260|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138756261|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756262|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756263|NCT01227629|Warfarin|warfarin|mesh-list
138756264|NCT01227629|Dabigatran|dabigatran|mesh-list
138756265|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
138756266|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
138756267|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138756268|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
138756269|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756270|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756271|NCT00963820|Ixazomib|ixazomib|mesh-list
138756272|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756273|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756274|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
138756275|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756276|NCT03241186|Nivolumab|nivolumab|mesh-list
138756277|NCT03241186|Ipilimumab|ipilimumab|mesh-list
139081044|NCT05096663|Antibodies|antibodies|mesh-list
138756278|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138756279|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756280|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138756281|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756282|NCT01227395|Azithromycin|azithromycin|mesh-list
138756283|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138756284|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138756286|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138756287|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
138756288|NCT01225991|Milnacipran|milnacipran|mesh-list
138756289|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
138756290|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138756291|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138756292|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138756293|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756294|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756295|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756296|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138756297|NCT01225991|Analgesics|analgesics|mesh-ancestor
138587342|NCT05553938|Empagliflozin|empagliflozin|mesh-list
138756298|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
138756299|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756300|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
138756301|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138756302|NCT04283110|Midazolam|midazolam|mesh-list
138756303|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138756304|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138756305|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756315|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756316|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756318|NCT02860780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138756319|NCT02860780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756320|NCT02860780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756321|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138756323|NCT01225835|Menotropins|menotropins|mesh-list
138756324|NCT01225835|Progesterone|progesterone|mesh-list
138756325|NCT01225835|Progestins|progestins|mesh-ancestor
138756326|NCT01225835|Hormones|hormones|mesh-ancestor
138756327|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138756328|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756329|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138756330|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138756331|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
138756332|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
138756333|NCT04282096|Caseins|caseins|mesh-list
138756334|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
138756335|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
138756336|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756337|NCT02899000|Doxycycline|doxycycline|mesh-list
138756338|NCT02899000|Adapalene|adapalene|mesh-list
138756339|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138756340|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138756341|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138756342|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
138756343|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138756344|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138756345|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
138756346|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138756347|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138756348|NCT02899000|Analgesics|analgesics|mesh-ancestor
138756349|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
138756350|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756351|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756352|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138756353|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138587372|NCT05514912|Paclitaxel|paclitaxel|mesh-list
138756354|NCT04281862|Prednisolone|prednisolone|mesh-list
138756355|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138756356|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
138756357|NCT04281862|Hormones|hormones|mesh-ancestor
138756358|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138756359|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756360|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138756361|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756362|NCT03122002|Clopidogrel|clopidogrel|mesh-list
138756363|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756364|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756365|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138756366|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138756367|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138756368|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138756369|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
138756370|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756371|NCT02861482|Oxytocin|oxytocin|mesh-list
138756372|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
138756373|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
138756374|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138756386|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139081184|NCT03903133|Vitamin E|vitamin e|mesh-list
138756388|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138756389|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138756390|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138756391|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
138756392|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756393|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756394|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138756395|NCT02861716|Narcotics|narcotics|mesh-ancestor
138756396|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138756397|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138756398|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
138756399|NCT00960934|Vitamin D|vitamin d|mesh-list
138756400|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
138756401|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
138756402|NCT00960934|Calcium|calcium|mesh-list
138756403|NCT00960934|Vitamins|vitamins|mesh-ancestor
138756404|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
138587397|NCT05512819|Vaccines|vaccines|mesh-list
138756405|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756406|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138756407|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138756408|NCT00960934|Antacids|antacids|mesh-ancestor
138756409|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756410|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138756411|NCT00892177|Bevacizumab|bevacizumab|mesh-list
138756412|NCT00892177|Dasatinib|dasatinib|mesh-list
138756413|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138756414|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756415|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138756416|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138756417|NCT00892177|Growth Substances|growth substances|mesh-ancestor
138756418|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756419|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
138756420|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138756421|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756422|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756423|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138756424|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138756425|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138756426|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138756427|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756428|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
138756429|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756430|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756431|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
138756432|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138756433|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756434|NCT02821000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138756435|NCT02821000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756436|NCT02860624|Esomeprazole|esomeprazole|mesh-list
138756447|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756448|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138756449|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138756450|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
138756452|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138756453|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138756454|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
138756455|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756456|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138756457|NCT00958438|Rilonacept|rilonacept|mesh-list
138756458|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138756459|NCT02835469|Menotropins|menotropins|mesh-list
138756460|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138756461|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
138756462|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138756463|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756464|NCT02832973|Ramipril|ramipril|mesh-list
138756465|NCT02832973|Bisoprolol|bisoprolol|mesh-list
138756466|NCT02832973|Amiloride|amiloride|mesh-list
138756467|NCT02832973|Furosemide|furosemide|mesh-list
138756468|NCT02832973|Spironolactone|spironolactone|mesh-list
138756469|NCT02832973|Diuretics|diuretics|mesh-list
138756470|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138756471|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
138756472|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756473|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138756474|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138756475|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756476|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138756477|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
138756478|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138756479|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138756480|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
138756481|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756482|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138756483|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
138756484|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
138756485|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756486|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138756487|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138756488|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138756489|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
138756490|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756491|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138756492|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138756493|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138756494|NCT02831491|Docetaxel|docetaxel|mesh-list
138756495|NCT02831491|Ramucirumab|ramucirumab|mesh-list
138756496|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756497|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
138756498|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
138756499|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
138756500|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756501|NCT02860234|Capecitabine|capecitabine|mesh-list
138756502|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
138756537|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
138756538|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756539|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756540|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138756541|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
138756542|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138756543|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756544|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
138756545|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
138756546|NCT02830789|Calcium|calcium|mesh-list
138756547|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138756570|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138756571|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138756573|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756574|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138756575|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138756576|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756577|NCT01243424|Glimepiride|glimepiride|mesh-list
138756578|NCT01243424|Linagliptin|linagliptin|mesh-list
138756579|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138756580|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138756581|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756582|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138756583|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
138756584|NCT01243424|Incretins|incretins|mesh-ancestor
138756585|NCT01243424|Hormones|hormones|mesh-ancestor
138756586|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138756587|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138756588|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
138756589|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756590|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756591|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
138756592|NCT02831023|Piperaquine|piperaquine|mesh-list
138756593|NCT02831023|Primaquine|primaquine|mesh-list
138756594|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
138551590|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756595|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138756596|NCT02831023|Amodiaquine|amodiaquine|mesh-list
138756597|NCT02831023|Artenimol|artenimol|mesh-list
138756598|NCT02831023|Methylene Blue|methylene blue|mesh-list
138756599|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
138756600|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138756601|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138756602|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138756632|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
138756633|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
138756634|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
138430908|NCT01734473|Caseins|caseins|mesh-list
138756636|NCT02827747|Antioxidants|antioxidants|mesh-list
138756637|NCT02827747|Vitamins|vitamins|mesh-ancestor
138756638|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
138756639|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139081489|NCT00397631|Pioglitazone|pioglitazone|mesh-list
138587486|NCT05339529|Glycine|glycine|mesh-list
138756640|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756641|NCT02827747|Protective Agents|protective agents|mesh-ancestor
138756642|NCT04281628|Ketamine|ketamine|mesh-list
138756643|NCT04281628|Analgesics|analgesics|mesh-ancestor
138756644|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
138756645|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756646|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770262|NCT02654587|Docetaxel|docetaxel|mesh-list
138756664|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138756665|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
138756666|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
138756667|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138756668|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138756669|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
138756670|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756671|NCT00953680|Losartan|losartan|mesh-list
138756672|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138756673|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138756674|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138756675|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138756676|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138756677|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756678|NCT00953680|Diuretics|diuretics|mesh-ancestor
138756679|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
138756680|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756681|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138756682|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138756683|NCT00890929|Lenalidomide|lenalidomide|mesh-list
138756685|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
138756686|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756687|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138756688|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138756689|NCT00890929|Growth Substances|growth substances|mesh-ancestor
138756690|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
138756691|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756692|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138756693|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
138756694|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756695|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756696|NCT04246567|Fentanyl|fentanyl|mesh-list
138756697|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138756698|NCT04246567|Narcotics|narcotics|mesh-ancestor
138756699|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756700|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756701|NCT04246567|Analgesics|analgesics|mesh-ancestor
138756702|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
138756728|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756730|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138756731|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138756732|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
138756733|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
138756734|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756735|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756736|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138756737|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
138756738|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756739|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138756740|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
138587572|NCT05302388|Hormones|hormones|mesh-ancestor
138756741|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
138756742|NCT02826343|Hormones|hormones|mesh-ancestor
138756743|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138756744|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
138756745|NCT04246255|Lidocaine|lidocaine|mesh-list
138756746|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
138756747|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
138756748|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756749|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756750|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
138756751|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756752|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138756753|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138674953|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
138756765|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756766|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
138756767|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
138756768|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138756769|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
138756770|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756771|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
138756772|NCT02826031|Protective Agents|protective agents|mesh-ancestor
138756773|NCT02829697|Ropivacaine|ropivacaine|mesh-list
138756774|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
138756775|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
138756776|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756777|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756778|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
138756779|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756780|NCT02829151|Aspirin|aspirin|mesh-list
138756781|NCT02829151|Cilostazol|cilostazol|mesh-list
138756782|NCT02829151|Clopidogrel|clopidogrel|mesh-list
138756783|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138756784|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138756785|NCT02829151|Analgesics|analgesics|mesh-ancestor
138756786|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
138756787|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756788|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756789|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138756790|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138756791|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138756792|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138756793|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587603|NCT05266846|Growth Inhibitors|growth inhibitors|mesh-ancestor
138587604|NCT05266846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138587605|NCT05266846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587630|NCT05259696|Cemiplimab|cemiplimab|mesh-list
138587631|NCT05259696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587632|NCT05259696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587633|NCT05254002|Empagliflozin|empagliflozin|mesh-list
138478659|NCT02026505|Bortezomib|bortezomib|mesh-list
138756794|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138756795|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138756796|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756797|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
138756798|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138756799|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138756800|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138756801|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
138756802|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756803|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138756804|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
138551603|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138756805|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138756806|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
138756807|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
138756808|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138756809|NCT02829151|Protective Agents|protective agents|mesh-ancestor
139081643|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
138756810|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138756811|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138756812|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
138756813|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
138756814|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138756815|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138756816|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756825|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138756826|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138756827|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
138756828|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
138756829|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756830|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756831|NCT04241731|Cetuximab|cetuximab|mesh-list
138756832|NCT04241731|Raltitrexed|raltitrexed|mesh-list
138756833|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138756834|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756835|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138756836|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
138756837|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756838|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138756839|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756840|NCT04241887|Anesthetics|anesthetics|mesh-list
138756841|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756842|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756843|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138756844|NCT02825797|Antibodies|antibodies|mesh-list
138756845|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
138756846|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138756847|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
138756848|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756849|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138756850|NCT02824315|Simeprevir|simeprevir|mesh-list
138756851|NCT02824315|Odalasvir|odalasvir|mesh-list
138756852|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
138756853|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138756854|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
138756855|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756856|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756857|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
138756858|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138756859|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
138756860|NCT02823925|Pamidronate|pamidronate|mesh-list
138756861|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138756862|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756863|NCT04201249|Piroxicam|piroxicam|mesh-list
138756864|NCT04201249|Lidocaine|lidocaine|mesh-list
138756865|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
138756866|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
138756867|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756868|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756869|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
138756870|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756871|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138756872|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138756873|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138756874|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138756875|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756876|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138756877|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138756878|NCT04201249|Analgesics|analgesics|mesh-ancestor
138756879|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138756880|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138756881|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138756882|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756883|NCT00633685|Fluoxetine|fluoxetine|mesh-list
138756884|NCT00633685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138756907|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
138756908|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756909|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138756910|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138756911|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138756912|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138756913|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756914|NCT04195009|Anesthetics|anesthetics|mesh-list
138756915|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756916|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756917|NCT05660083|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138756918|NCT05660083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756919|NCT05660083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756920|NCT02822131|Sevelamer|sevelamer|mesh-list
138756921|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
138756922|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
138756923|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756924|NCT02821897|Anesthetics|anesthetics|mesh-list
138756925|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756926|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756927|NCT02820493|Vedolizumab|vedolizumab|mesh-list
138756928|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138756929|NCT02820259|Tacrolimus|tacrolimus|mesh-list
138756930|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138756931|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
138756932|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756933|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138756934|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675000|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
138756946|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
138756947|NCT02819869|Metformin|metformin|mesh-list
138756948|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138756949|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756950|NCT02820883|Vaccines|vaccines|mesh-list
138756951|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
138756952|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756953|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
138756954|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138756955|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138756956|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756957|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138756958|NCT02819089|Analgesics|analgesics|mesh-ancestor
138756959|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
138756960|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756961|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138756962|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138756963|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138756964|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
138756965|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138756966|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756967|NCT04238923|Vancomycin|vancomycin|mesh-list
138756968|NCT04238923|Gentamicins|gentamicins|mesh-list
138756969|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138756970|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138756971|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138756972|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138756973|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756974|NCT02815657|Valsartan|valsartan|mesh-list
138756975|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138756976|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138756977|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138756978|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138756979|NCT04597333|Dinoprostone|dinoprostone|mesh-list
138756980|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
138756981|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138756982|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756983|NCT00957580|Niacinamide|niacinamide|mesh-list
138756984|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
138756985|NCT00957580|Vitamins|vitamins|mesh-ancestor
138756986|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
138756987|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756988|NCT00957424|Nicotine|nicotine|mesh-list
138756989|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138756990|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
138756991|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138756992|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138756993|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138756994|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138756995|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
138756997|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757016|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138757018|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
138757019|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757020|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138757021|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138757022|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138757023|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
138757024|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757025|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757028|NCT01061151|Tenofovir|tenofovir|mesh-list
138757029|NCT01061151|Lamivudine|lamivudine|mesh-list
138757030|NCT01061151|Emtricitabine|emtricitabine|mesh-list
138757031|NCT01061151|Zidovudine|zidovudine|mesh-list
138757032|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138757033|NCT01061151|Nevirapine|nevirapine|mesh-list
138757034|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138757035|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138757036|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138757037|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
138757038|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757039|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139081932|NCT01051583|Bevacizumab|bevacizumab|mesh-list
138757040|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138757041|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138757042|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
138757043|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138757044|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138757045|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138757046|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138757047|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138757048|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
138757049|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138757050|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138757051|NCT04472143|Granisetron|granisetron|mesh-list
138757070|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
138757071|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757072|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757073|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757074|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138757075|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138757076|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757077|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138757078|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138757079|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138757080|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
138757081|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138757082|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138757083|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
138757084|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138757085|NCT02817217|Valsartan|valsartan|mesh-list
138757086|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138757087|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138757088|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138757089|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757090|NCT00948922|Fludarabine|fludarabine|mesh-list
138757091|NCT00948922|Bortezomib|bortezomib|mesh-list
138757092|NCT00948922|Melphalan|melphalan|mesh-list
138757093|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757094|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757095|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138757096|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
138757097|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757098|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138757099|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
138757100|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138757101|NCT00634309|Candesartan|candesartan|mesh-list
138757102|NCT00634309|Candesartan cilexetil|candesartan cilexetil|mesh-list
138757103|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138757104|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138675048|NCT00482378|Pamidronate|pamidronate|mesh-list
138757117|NCT02816905|Fluorometholone|fluorometholone|mesh-list
138757118|NCT02816905|Dexamethasone|dexamethasone|mesh-list
138757119|NCT02816905|Rimexolone|rimexolone|mesh-list
138757120|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138757121|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
138757122|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
138757123|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757124|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757125|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138757126|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
138757127|NCT02816905|Hormones|hormones|mesh-ancestor
138551646|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138757128|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138757129|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138757130|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757131|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138757133|NCT05654077|Fludarabine|fludarabine|mesh-list
138757134|NCT05654077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138757135|NCT05654077|Immunologic Factors|immunologic factors|mesh-ancestor
138757136|NCT05654077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757137|NCT05654077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138757138|NCT05654077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138757139|NCT05654077|Alkylating Agents|alkylating agents|mesh-ancestor
138757140|NCT05654077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757141|NCT05654077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757142|NCT05654077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138757143|NCT04303767|Calcium|calcium|mesh-list
138757144|NCT04303767|Caseins|caseins|mesh-list
138757145|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138757146|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757147|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
138757148|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
138757149|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757150|NCT02874963|Ethanol|ethanol|mesh-list
138757151|NCT02874963|Listerine|listerine|mesh-list
138757152|NCT02874963|Thymol|thymol|mesh-list
138757153|NCT02874963|Eucalyptol|eucalyptol|mesh-list
138757154|NCT02874963|Salicylates|salicylates|mesh-list
138757155|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
138757156|NCT02874963|Menthol|menthol|mesh-list
138757157|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138757158|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138757159|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757160|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757161|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
138757162|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
138757163|NCT02874963|Protective Agents|protective agents|mesh-ancestor
138757164|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138757165|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138757166|NCT02874963|Analgesics|analgesics|mesh-ancestor
138757167|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
138757168|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757169|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138757170|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138757181|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
138757182|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
138757183|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757184|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757185|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757186|NCT01238822|Methylphenidate|methylphenidate|mesh-list
139082050|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
138757187|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138757188|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757189|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138757190|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138757191|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138757192|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757193|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
138757194|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757195|NCT02818387|Midazolam|midazolam|mesh-list
138757196|NCT02818387|Remifentanil|remifentanil|mesh-list
138757197|NCT02818387|Propofol|propofol|mesh-list
138757198|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138757199|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757200|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757201|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138757202|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
138757203|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
138757204|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138757205|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138757206|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138757207|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138757208|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
138757209|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
138757210|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757211|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757212|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138757213|NCT02818387|Narcotics|narcotics|mesh-ancestor
138757214|NCT02818387|Analgesics|analgesics|mesh-ancestor
138757215|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
138757216|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757217|NCT05296629|Doxycycline|doxycycline|mesh-list
138757218|NCT05296629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138757219|NCT05296629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138757220|NCT05296629|Antimalarials|antimalarials|mesh-ancestor
138757221|NCT05296629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138757222|NCT05296629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138757224|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
138757225|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
138757226|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757227|NCT00627003|Cabergoline|cabergoline|mesh-list
138757228|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138757229|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138757230|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
138757231|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
138431501|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
138757232|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757233|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757234|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675082|NCT00482495|Bevacizumab|bevacizumab|mesh-list
138757256|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757257|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138757258|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138757259|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757260|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757261|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138757262|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
138757263|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139082138|NCT02952586|Avelumab|avelumab|mesh-list
138757265|NCT04237987|Cyclosporine|cyclosporine|mesh-list
138757266|NCT04237987|Aldesleukin|aldesleukin|mesh-list
138757267|NCT04237987|Interleukin-2|interleukin-2|mesh-list
138757268|NCT04237987|Cyclosporins|cyclosporins|mesh-list
138757269|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757270|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757271|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138757272|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
138757273|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757274|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
138757275|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138757276|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
138757277|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138757278|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138757279|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757280|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138757281|NCT04237987|Analgesics|analgesics|mesh-ancestor
138757282|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
138757283|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757284|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138757285|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138757286|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
138757287|NCT01045707|Insulin|insulin|mesh-list
138757288|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138757289|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
138675090|NCT00480935|Sunitinib|sunitinib|mesh-list
138757303|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757304|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757305|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138757306|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138757308|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138757309|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757311|NCT02874729|Chelating Agents|chelating agents|mesh-ancestor
138757312|NCT02874729|Sequestering Agents|sequestering agents|mesh-ancestor
138757313|NCT02874729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757314|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
138757315|NCT04275661|Ketamine|ketamine|mesh-list
138757316|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
138757317|NCT04275661|Analgesics|analgesics|mesh-ancestor
138757318|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
138757319|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757320|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757321|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138757322|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138757323|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
138757324|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
138757325|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757326|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138757327|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138757328|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757329|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757330|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138757331|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
138757332|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138757333|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138757334|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138757335|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
138757336|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138757337|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
138757338|NCT00948766|Rivastigmine|rivastigmine|mesh-list
138757339|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138757340|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588013|NCT04486352|Immunoconjugates|immunoconjugates|mesh-ancestor
138757341|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757342|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
138757343|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757344|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757345|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138757346|NCT00948766|Protective Agents|protective agents|mesh-ancestor
138757347|NCT01053663|Oseltamivir|oseltamivir|mesh-list
138757348|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
138757349|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138757350|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675116|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
138757371|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757372|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757373|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138757374|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
138757375|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
138757376|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138757377|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
138757378|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757379|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757381|NCT00948688|Vorinostat|vorinostat|mesh-list
138757382|NCT00948688|Fluorouracil|fluorouracil|mesh-list
138757383|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757384|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138757385|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757386|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757387|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
139082270|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
138757388|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138757389|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138757390|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
138757391|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757392|NCT01233050|Ethanol|ethanol|mesh-list
138757393|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
138757394|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138757395|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138757396|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138757397|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757398|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757399|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
138757400|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
138757401|NCT01049217|Pregabalin|pregabalin|mesh-list
138757402|NCT01049217|Analgesics|analgesics|mesh-ancestor
138757403|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
138770263|NCT02654587|Pemetrexed|pemetrexed|mesh-list
138757423|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138551722|NCT00264355|Cyclosporine|cyclosporine|mesh-list
138757424|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757425|NCT00957268|Incretins|incretins|mesh-ancestor
138757426|NCT00957268|Hormones|hormones|mesh-ancestor
138757427|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138757428|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138757429|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
138757430|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757431|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757432|NCT02888444|Varenicline|varenicline|mesh-list
138757433|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138757434|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138757435|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
138757436|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757437|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757438|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757439|NCT01230788|Rituximab|rituximab|mesh-list
138757440|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138757441|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757442|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
138757443|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757444|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139082323|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
138757445|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138757446|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757447|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138757448|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757449|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757451|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138757452|NCT00627081|Narcotics|narcotics|mesh-ancestor
138757453|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757454|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757455|NCT00627081|Analgesics|analgesics|mesh-ancestor
138757463|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
138757464|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138757465|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138757467|NCT02888054|Protective Agents|protective agents|mesh-ancestor
138757468|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757469|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
138757470|NCT01040793|Olodaterol|olodaterol|mesh-list
138757471|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138757472|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
138757473|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757474|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757475|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138757476|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
138757477|NCT02811055|Aprepitant|aprepitant|mesh-list
138757478|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
138757479|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
138757480|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757481|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757482|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138757483|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138757484|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757485|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757486|NCT04192903|Cisplatin|cisplatin|mesh-list
138757487|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757488|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
138757489|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138757490|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757491|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757492|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138757493|NCT02810899|Analgesics|analgesics|mesh-ancestor
138551734|NCT00264472|Eniluracil|eniluracil|mesh-list
138757494|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
138757495|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757496|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138757497|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138757498|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138757499|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
138757500|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757501|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757502|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
138757503|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138757504|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757505|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138757506|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138757507|NCT02810275|Leucovorin|leucovorin|mesh-list
138757508|NCT02810275|Folic Acid|folic acid|mesh-list
138757509|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
138757510|NCT02810275|Antidotes|antidotes|mesh-ancestor
138757511|NCT02810275|Protective Agents|protective agents|mesh-ancestor
138757512|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757513|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
138757514|NCT02810275|Vitamins|vitamins|mesh-ancestor
138757515|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
138757516|NCT02810275|Hematinics|hematinics|mesh-ancestor
138757517|NCT00948064|Azacitidine|azacitidine|mesh-list
138757518|NCT00948064|Vorinostat|vorinostat|mesh-list
138757519|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138757520|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
138757521|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757522|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757523|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757524|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138757533|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138757534|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757536|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
138757537|NCT02858206|Nedaplatin|nedaplatin|mesh-list
138757538|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138757539|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757540|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
138757541|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
138757542|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
138757543|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757544|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138757545|NCT02815189|Acetaminophen|acetaminophen|mesh-list
138757546|NCT02815189|Ibuprofen|ibuprofen|mesh-list
138757547|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138757548|NCT02815189|Analgesics|analgesics|mesh-ancestor
138757549|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
138757550|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757551|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757552|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
138757553|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138757554|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138757555|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138757556|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138757557|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757558|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757559|NCT02809963|Eplerenone|eplerenone|mesh-list
138757560|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138757561|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
138551737|NCT00101829|Rituximab|rituximab|mesh-list
138757562|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139082508|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
138757563|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757564|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138757566|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
138757567|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138757568|NCT02815111|Acetaminophen|acetaminophen|mesh-list
138757569|NCT02815111|Lidocaine|lidocaine|mesh-list
138757570|NCT02815111|Ketamine|ketamine|mesh-list
138757571|NCT02815111|Gabapentin|gabapentin|mesh-list
138757572|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
138757573|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
138757574|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757575|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757576|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
138757577|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757578|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138757579|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138757580|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138757581|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138757582|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757583|NCT02815111|Analgesics|analgesics|mesh-ancestor
138757584|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138757585|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138757586|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
138757587|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138757588|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138757589|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757590|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138757602|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138757604|NCT04303377|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138757605|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138431877|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138757606|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138757607|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
138757608|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757609|NCT04303377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138757610|NCT04303377|Protease Inhibitors|protease inhibitors|mesh-ancestor
138757611|NCT04303377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757612|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138757613|NCT00953524|Vaccines|vaccines|mesh-list
138757614|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
138757615|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757616|NCT02809573|Prednisone|prednisone|mesh-list
138757617|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
138757618|NCT02809573|Vincristine|vincristine|mesh-list
138757619|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138757620|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
138757621|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757622|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138757623|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138757624|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
138757625|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757626|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757627|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138757628|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138757629|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
138757630|NCT02809573|Hormones|hormones|mesh-ancestor
138757631|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138757632|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138757633|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138757634|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
138757635|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
138757636|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
138757637|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
138757638|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138757639|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
138757640|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757641|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757642|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138757643|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
138757644|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138757645|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
138757646|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757647|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757648|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138757649|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
138757650|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
138757651|NCT04388683|Protective Agents|protective agents|mesh-ancestor
138757652|NCT01040403|Bromides|bromides|mesh-list
138757653|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
138757654|NCT01040403|Olodaterol|olodaterol|mesh-list
138757655|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138757656|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
138757664|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757665|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757666|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
138757667|NCT00957034|Testosterone|testosterone|mesh-list
138757668|NCT00957034|Androgens|androgens|mesh-ancestor
138757669|NCT00957034|Hormones|hormones|mesh-ancestor
139082651|NCT01112540|Morphine|morphine|mesh-list
138757670|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138757671|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757673|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
138757674|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138757675|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757676|NCT02812693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138757677|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757678|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138757679|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757680|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
138757681|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138757682|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
138757683|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757684|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
138757685|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138757686|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757687|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138757688|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757689|NCT02689999|Rabeprazole|rabeprazole|mesh-list
138757690|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138757691|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139082687|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
138757692|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138757693|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588252|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138588253|NCT03989037|Carboplatin|carboplatin|mesh-list
138588254|NCT03989037|Docetaxel|docetaxel|mesh-list
138588255|NCT03989037|Trastuzumab|trastuzumab|mesh-list
138588256|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757694|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757695|NCT02809105|Linaclotide|linaclotide|mesh-list
138757696|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138757697|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
138757698|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757699|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138757700|NCT00953056|Vaccines|vaccines|mesh-list
138757701|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
138757702|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757703|NCT02811289|Mirabegron|mirabegron|mesh-list
138757704|NCT02811289|Glycerol|glycerol|mesh-list
138757705|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138757706|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138757707|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138757708|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
138757709|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757710|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757711|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757712|NCT02811289|Urological Agents|urological agents|mesh-ancestor
138757713|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138757714|NCT02811289|Protective Agents|protective agents|mesh-ancestor
138757715|NCT02808949|Dapivirine|dapivirine|mesh-list
138757716|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138757717|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138757718|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
138757719|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138757721|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138757722|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138757728|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757730|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
138757731|NCT04303065|Hormones|hormones|mesh-ancestor
138757732|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138757733|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138757734|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757735|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138757736|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138757737|NCT00952822|Factor VIII|factor viii|mesh-list
138757738|NCT00952822|Coagulants|coagulants|mesh-ancestor
138757739|NCT02854072|Gemcitabine|gemcitabine|mesh-list
138757740|NCT02854072|Capecitabine|capecitabine|mesh-list
138757741|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138757742|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
138757743|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757744|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757745|NCT02537314|Benzocaine|benzocaine|mesh-list
138757746|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
138757747|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
138757748|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757749|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757750|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
138757751|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757752|NCT00631150|Levetiracetam|levetiracetam|mesh-list
138551760|NCT00265018|Doxorubicin|doxorubicin|mesh-list
138757754|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
138757755|NCT04278040|Melphalan|melphalan|mesh-list
138757756|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138757757|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
139082784|NCT01114490|Anacetrapib|anacetrapib|mesh-list
138757758|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757759|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757760|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138757761|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138757762|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
138757763|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757764|NCT02856724|Dinoprostone|dinoprostone|mesh-list
138757765|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
138757766|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138757767|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757768|NCT02808325|Polygeline|polygeline|mesh-list
138757769|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
138757770|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
138757771|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138757772|NCT00955474|Citalopram|citalopram|mesh-list
138757773|NCT00955474|Sertraline|sertraline|mesh-list
138757774|NCT00955474|Escitalopram|escitalopram|mesh-list
138757775|NCT00955474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138757776|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138757777|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138757778|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757779|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757780|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
138757781|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757782|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138757783|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
138757784|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138757785|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138757786|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138757787|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757788|NCT02808247|Ifosfamide|ifosfamide|mesh-list
138757789|NCT02808247|Nintedanib|nintedanib|mesh-list
138757790|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138757791|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
138757792|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757793|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757806|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757807|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757808|NCT05598853|Nivolumab|nivolumab|mesh-list
138757809|NCT05598853|Ipilimumab|ipilimumab|mesh-list
138757810|NCT05598853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138662174|NCT00427232|BQ 788|bq 788|mesh-list
138757811|NCT05598853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757812|NCT05598853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138757813|NCT05598853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757814|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138757815|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757816|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138757818|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757819|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138757821|NCT02814409|Tenecteplase|tenecteplase|mesh-list
138757822|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138757823|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138757824|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757825|NCT01227902|Ezogabine|ezogabine|mesh-list
138757826|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
138757827|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138757828|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757829|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138757830|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138432102|NCT01742689|Analgesics|analgesics|mesh-ancestor
138757831|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138757832|NCT00946192|Desogestrel|desogestrel|mesh-list
138757833|NCT00946192|Estradiol|estradiol|mesh-list
138757834|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138757835|NCT00946192|Progesterone|progesterone|mesh-list
138757836|NCT00946192|Estrogens|estrogens|mesh-ancestor
138757837|NCT00946192|Hormones|hormones|mesh-ancestor
138757838|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138757839|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757840|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138757841|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
138757842|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138757843|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138757844|NCT00946192|Progestins|progestins|mesh-ancestor
138757845|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138757846|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138757847|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138757848|NCT01037127|Trametinib|trametinib|mesh-list
138757849|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139082928|NCT03940430|Lactoferrin|lactoferrin|mesh-list
138757851|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757852|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757853|NCT02806999|Insulin|insulin|mesh-list
138757854|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138757855|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138757856|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757857|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
138757858|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
138757873|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757874|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757875|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138757876|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
138757877|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
138757878|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
138757879|NCT02800447|Procarbazine|procarbazine|mesh-list
138757880|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757881|NCT01038921|Melatonin|melatonin|mesh-list
138757882|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
138757883|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757884|NCT01038921|Protective Agents|protective agents|mesh-ancestor
138757885|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757886|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757887|NCT02856568|Cisplatin|cisplatin|mesh-list
138757888|NCT02856568|Gemcitabine|gemcitabine|mesh-list
138757889|NCT02856568|Ricolinostat|ricolinostat|mesh-list
138757890|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138757891|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139082969|NCT03939884|Analgesics|analgesics|mesh-ancestor
138757892|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
138757893|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757894|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138757895|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757896|NCT04081831|Aspirin|aspirin|mesh-list
138757897|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138757898|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138757899|NCT04081831|Analgesics|analgesics|mesh-ancestor
138757900|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
138757901|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757902|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757903|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138757904|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138757905|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138757906|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138757907|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757908|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138757909|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138757910|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138757911|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
138757912|NCT01081912|Hydrocodone|hydrocodone|mesh-list
138757913|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138757914|NCT01081912|Narcotics|narcotics|mesh-ancestor
138757915|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757916|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757917|NCT01081912|Analgesics|analgesics|mesh-ancestor
138757918|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
138757919|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757920|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
138757929|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757931|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
138588517|NCT03188432|Carboplatin|carboplatin|mesh-list
138757932|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083017|NCT01311778|Analgesics|analgesics|mesh-ancestor
138757933|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138757934|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
138757935|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
138757936|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
138757937|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138757938|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138757939|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138757940|NCT02857582|Metronidazole|metronidazole|mesh-list
138757941|NCT02857582|Vancomycin|vancomycin|mesh-list
138757942|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138757943|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138757944|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138757945|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138757946|NCT04301895|Remifentanil|remifentanil|mesh-list
138757947|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138757948|NCT04301895|Narcotics|narcotics|mesh-ancestor
138757949|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757950|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757951|NCT04301895|Analgesics|analgesics|mesh-ancestor
138757952|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
138757953|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757954|NCT02853526|Propranolol|propranolol|mesh-list
138757955|NCT02853526|Warfarin|warfarin|mesh-list
138757956|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
138757957|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138757958|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138757959|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
138757960|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757961|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757962|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757963|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138757964|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138757965|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
138757966|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
138757967|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138757968|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757969|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138757970|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138757971|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138757972|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138757973|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
138757974|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138757975|NCT04269460|Bupivacaine|bupivacaine|mesh-list
138757976|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
138757977|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
138757978|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757979|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757980|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
138757981|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138757982|NCT04236115|Felypressin|felypressin|mesh-list
138757983|NCT04236115|Carticaine|carticaine|mesh-list
138757984|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
138757985|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
138757986|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138757987|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138757988|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
138758000|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758001|NCT02690155|Vitamin K|vitamin k|mesh-list
138758002|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
138758003|NCT02690155|Vitamins|vitamins|mesh-ancestor
138758004|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
138758005|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758006|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138758007|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
138758008|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138758009|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
138758010|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758011|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758012|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
138758013|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138758014|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138758015|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
138758016|NCT02690155|Coagulants|coagulants|mesh-ancestor
138758017|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
138758018|NCT02806375|Busulfan|busulfan|mesh-list
138758019|NCT02806375|Fludarabine|fludarabine|mesh-list
138758020|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
138758021|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138758022|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
138758023|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758024|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138758025|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138758026|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
138758027|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758028|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758029|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138758030|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138758031|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
138758032|NCT04273984|Misoprostol|misoprostol|mesh-list
138758033|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138758034|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
138758035|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138758036|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758037|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138758038|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138758040|NCT00943852|Losartan|losartan|mesh-list
138758041|NCT00943852|Isosorbide|isosorbide|mesh-list
138758042|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138758043|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138758044|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138758045|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138758046|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138758047|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138758048|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758049|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138758050|NCT00943852|Diuretics|diuretics|mesh-ancestor
138758051|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
138758052|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758053|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
138758062|NCT02853136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138758063|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138758064|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138758065|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758066|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138758068|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138758069|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
138758070|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138758071|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138758072|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139083190|NCT01210430|Vitamins|vitamins|mesh-list
138588607|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758073|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138758074|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138758075|NCT02806141|Colistin|colistin|mesh-list
138758076|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138758077|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758078|NCT00952276|Vaccines|vaccines|mesh-list
138758079|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
138758080|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758081|NCT02805829|Trastuzumab|trastuzumab|mesh-list
138758082|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138758083|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758084|NCT02856178|Caspofungin|caspofungin|mesh-list
138758085|NCT02856178|Olorofim|olorofim|mesh-list
138758086|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
138758087|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758088|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758089|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758090|NCT02800135|Furosemide|furosemide|mesh-list
138758091|NCT02800135|Diuretics|diuretics|mesh-ancestor
138758092|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
138758093|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758094|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138758095|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138758096|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758097|NCT02802163|Dexamethasone|dexamethasone|mesh-list
138758098|NCT02802163|Lenalidomide|lenalidomide|mesh-list
138758099|NCT02802163|Panobinostat|panobinostat|mesh-list
138758100|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138758101|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
138758102|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
138588649|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
138588653|NCT02784210|Prednisone|prednisone|mesh-list
138758103|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758104|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758105|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138758106|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
138758107|NCT02802163|Hormones|hormones|mesh-ancestor
138758108|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758109|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138758110|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758111|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
138758112|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138758113|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138758114|NCT02802163|Growth Substances|growth substances|mesh-ancestor
138758116|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138758117|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758118|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758119|NCT02805049|Caspofungin|caspofungin|mesh-list
138758139|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
138758140|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138758141|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758142|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
138758144|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138758145|NCT02799589|Narcotics|narcotics|mesh-ancestor
138758146|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138758147|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758148|NCT02801383|Interferons|interferons|mesh-list
138758149|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758150|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
138758151|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758152|NCT02799355|Interferons|interferons|mesh-list
138758154|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
138758155|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758156|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
138758157|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758158|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
138758159|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758160|NCT02801305|Diltiazem|diltiazem|mesh-list
138758161|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
138758162|NCT02801305|Petrolatum|petrolatum|mesh-list
138758163|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
138758164|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138758165|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138758166|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138758167|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758168|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138758169|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758170|NCT02801305|Emollients|emollients|mesh-ancestor
138758171|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
138758172|NCT00637975|Pregabalin|pregabalin|mesh-list
138758173|NCT00637975|Oxycodone|oxycodone|mesh-list
138758174|NCT00637975|Analgesics|analgesics|mesh-ancestor
138758175|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
138758176|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758177|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758178|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
138758185|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758186|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138758187|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138758188|NCT00637975|Narcotics|narcotics|mesh-ancestor
138758189|NCT02801227|Oxytocin|oxytocin|mesh-list
138758190|NCT02801227|Dinoprostone|dinoprostone|mesh-list
138758191|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
138758192|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138758193|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758194|NCT02795299|Folic Acid|folic acid|mesh-list
138758195|NCT02795299|Methotrexate|methotrexate|mesh-list
138758196|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138758197|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
138758198|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138758199|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758200|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138758201|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
139083266|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758202|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758203|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758204|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
138758205|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758206|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138758207|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138758208|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
138758209|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138758210|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138758211|NCT02795299|Hematinics|hematinics|mesh-ancestor
138758212|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
138758213|NCT02795299|Vitamins|vitamins|mesh-ancestor
138758214|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
138758215|NCT02799277|Testosterone|testosterone|mesh-list
138758216|NCT02799277|Androgens|androgens|mesh-ancestor
138758217|NCT02799277|Hormones|hormones|mesh-ancestor
138758218|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758219|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758220|NCT01198002|Methotrexate|methotrexate|mesh-list
138758221|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138758222|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
138758223|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138758224|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758225|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138758226|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
138758227|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758228|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758229|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
138758230|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758231|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138758232|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138758233|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
138758234|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138758235|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138758236|NCT02795065|Enoxaparin|enoxaparin|mesh-list
138758237|NCT02795065|Bemiparin|bemiparin|mesh-list
138758239|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138758240|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138758241|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758242|NCT04233697|Romidepsin|romidepsin|mesh-list
138758243|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138758244|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758245|NCT04233697|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138758246|NCT04233697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758247|NCT04233697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758248|NCT03826303|Ethanol|ethanol|mesh-list
138758256|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758257|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758259|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758260|NCT04233463|Budesonide|budesonide|mesh-list
138758261|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138758262|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138758263|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
138758264|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758265|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758266|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138758267|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
138758268|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
138758269|NCT04233463|Hormones|hormones|mesh-ancestor
138758270|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758271|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
138758272|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138758273|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
138758274|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758275|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
138758276|NCT02793739|Protective Agents|protective agents|mesh-ancestor
138758277|NCT02793505|Metformin|metformin|mesh-list
138758278|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138758279|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758280|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138758281|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138758282|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758283|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
138758284|NCT04234321|Mitogens|mitogens|mesh-list
138758285|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
138758286|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758288|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
138758289|NCT02797717|Dacarbazine|dacarbazine|mesh-list
138758290|NCT02797717|Doxorubicin|doxorubicin|mesh-list
138758291|NCT02797717|Etoposide|etoposide|mesh-list
138758292|NCT02797717|Vincristine|vincristine|mesh-list
138758293|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138758294|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
138758295|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758296|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138758297|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138758298|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
138758299|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758300|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758301|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138758302|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138758303|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138758304|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138758305|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758306|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138758307|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
138758308|NCT02797717|Hormones|hormones|mesh-ancestor
138758309|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758310|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138758311|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138758312|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
138758313|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
138758314|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
138758315|NCT04235569|Enoxaparin|enoxaparin|mesh-list
138758316|NCT04235569|Warfarin|warfarin|mesh-list
138758317|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
138758318|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
138758335|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
138758336|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758337|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758338|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138758339|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138758340|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138758341|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138758342|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138758343|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758344|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138758345|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
138758347|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758348|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138758349|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138758350|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
138758351|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
138758352|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
138758353|NCT02792803|Latanoprost|latanoprost|mesh-list
138758354|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138758355|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138758356|NCT02797249|Aspirin|aspirin|mesh-list
138758357|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
138758358|NCT02797249|Salicylates|salicylates|mesh-list
138265154|NCT04652414|Prednisone|prednisone|mesh-list
138758359|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138758360|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138758361|NCT02797249|Analgesics|analgesics|mesh-ancestor
138758363|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758364|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758365|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138758366|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138758367|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138758368|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138758369|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758370|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138758371|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138758372|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758373|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
138758374|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758375|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
138758376|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
138758377|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
138758378|NCT02792335|Warfarin|warfarin|mesh-list
138758379|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
138758390|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138758391|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758393|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138758394|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758395|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758397|NCT04200235|Analgesics|analgesics|mesh-ancestor
138758398|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
138758399|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758400|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138758401|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138758402|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138758403|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
138758404|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138758405|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758406|NCT02791243|Finasteride|finasteride|mesh-list
138758407|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138758408|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138758409|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758410|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758411|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
138758412|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758413|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758414|NCT02791243|Urological Agents|urological agents|mesh-ancestor
138758415|NCT02797015|Ozanimod|ozanimod|mesh-list
138758416|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138758417|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758418|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138758419|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
138758420|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758421|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
138758422|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
138758423|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
138758424|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758425|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758426|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
138758427|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758428|NCT01196988|Vaccines|vaccines|mesh-list
138758429|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
138758430|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758431|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
138758432|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138758433|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758434|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758435|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138758436|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138758437|NCT02796469|Protective Agents|protective agents|mesh-ancestor
138758438|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758439|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
138758440|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138758441|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
138758442|NCT02796157|Everolimus|everolimus|mesh-list
138758443|NCT02796157|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138758454|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138758455|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758456|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138758457|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
138758458|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
138758459|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
138758460|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758462|NCT01196052|Immunoconjugates|immunoconjugates|mesh-ancestor
138758463|NCT01196052|Immunologic Factors|immunologic factors|mesh-ancestor
138758464|NCT01196052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758465|NCT02689921|Trastuzumab|trastuzumab|mesh-list
138758466|NCT02689921|Pertuzumab|pertuzumab|mesh-list
138758467|NCT02689921|Letrozole|letrozole|mesh-list
138758468|NCT02689921|Anastrozole|anastrozole|mesh-list
138758469|NCT02689921|Leuprolide|leuprolide|mesh-list
138758470|NCT02689921|Exemestane|exemestane|mesh-list
138758471|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138758472|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758473|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138758474|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138758475|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758476|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758477|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138758478|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
138758479|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758480|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758481|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138758482|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138758483|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
138758484|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138758485|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
138588969|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
138758486|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
138758487|NCT03116425|Vitamins|vitamins|mesh-ancestor
138758488|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
138758489|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758490|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
138758491|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138758492|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758493|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138758494|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758495|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
138758496|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138758497|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138758498|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138758499|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138758500|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758501|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
138758502|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138758503|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758504|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138758505|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758518|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
138758519|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758520|NCT02787967|Beclomethasone|beclomethasone|mesh-list
138758521|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
138758522|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138758523|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
138758524|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139083374|NCT00337727|Dexamethasone|dexamethasone|mesh-list
138589002|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589003|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138589004|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589028|NCT00089245|Iodine|iodine|mesh-list
138758525|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758526|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138758527|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
138758528|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138758529|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138758530|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138758531|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
138758532|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138758533|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758534|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138758537|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758538|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138758539|NCT02788123|Pantoprazole|pantoprazole|mesh-list
138758540|NCT02788123|Bismuth|bismuth|mesh-list
138758541|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138758542|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138758543|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138758544|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758545|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758546|NCT02788123|Antacids|antacids|mesh-ancestor
138758547|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758548|NCT01194804|Eculizumab|eculizumab|mesh-list
138758549|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138758550|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138758551|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
138758552|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758553|NCT02785549|Acetaminophen|acetaminophen|mesh-list
138758554|NCT02785549|Amoxicillin|amoxicillin|mesh-list
138758555|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
138758556|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
138758557|NCT02785549|Ibuprofen|ibuprofen|mesh-list
138758558|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138758559|NCT02785549|Analgesics|analgesics|mesh-ancestor
138758560|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
138758561|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758562|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758563|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
138758564|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138758565|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138758566|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138758567|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138758568|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758569|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758570|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138758571|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758583|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
138551915|NCT00266539|Fentanyl|fentanyl|mesh-list
138758584|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758585|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758586|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138758588|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758589|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138758590|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
138758592|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138758593|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138758594|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138758595|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138758596|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
139083401|NCT03987893|Lactulose|lactulose|mesh-list
138758597|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138758598|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758599|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758600|NCT02787031|Anesthetics|anesthetics|mesh-list
138758601|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758602|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758603|NCT02784223|Choline|choline|mesh-list
138758604|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
138758605|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138758606|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
138758607|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758608|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138758609|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138758610|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
138758611|NCT05262751|Nintedanib|nintedanib|mesh-list
138758612|NCT05262751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758613|NCT05262751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138589074|NCT00004112|Prednisone|prednisone|mesh-list
138758614|NCT05262751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758615|NCT05262751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758616|NCT04231123|Anesthetics|anesthetics|mesh-list
138758617|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
138758618|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758619|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758620|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
138758621|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758622|NCT04231279|Secretin|secretin|mesh-list
138758623|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138758624|NCT04231279|Hormones|hormones|mesh-ancestor
138758625|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758626|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758627|NCT02782273|Ketorolac|ketorolac|mesh-list
138758628|NCT02782273|Morphine|morphine|mesh-list
138758629|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138758630|NCT02782273|Narcotics|narcotics|mesh-ancestor
138758631|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758632|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758633|NCT02782273|Analgesics|analgesics|mesh-ancestor
138758634|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
138758635|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758636|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138758654|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758655|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083407|NCT01208480|Bevacizumab|bevacizumab|mesh-list
138758656|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138758657|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758658|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138758659|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
138432937|NCT01747564|Mirabegron|mirabegron|mesh-list
138758660|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138758661|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138758662|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758663|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758664|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
138758665|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138758666|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
138758667|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138758668|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
138758669|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758670|NCT02783989|Protective Agents|protective agents|mesh-ancestor
138758671|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758672|NCT02782429|Ketamine|ketamine|mesh-list
138758673|NCT02782429|Analgesics|analgesics|mesh-ancestor
138758674|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
138758675|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758676|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758677|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138758678|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138758679|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
138758680|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
138758681|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758682|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138758683|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138758684|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138758685|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758686|NCT04229719|Melatonin|melatonin|mesh-list
138758687|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
138758688|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758689|NCT04229719|Protective Agents|protective agents|mesh-ancestor
138758690|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758691|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758692|NCT01855867|Tenofovir|tenofovir|mesh-list
138758693|NCT01855867|Emtricitabine|emtricitabine|mesh-list
138758716|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758717|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138758718|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
138758719|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138758720|NCT05341999|Ibuprofen|ibuprofen|mesh-list
138758721|NCT05341999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138758722|NCT05341999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138758723|NCT05341999|Analgesics|analgesics|mesh-ancestor
138758724|NCT05341999|Sensory System Agents|sensory system agents|mesh-ancestor
138758725|NCT05341999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758726|NCT05341999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758727|NCT05341999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138758728|NCT05341999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138758729|NCT05341999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138758730|NCT05341999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758731|NCT05341999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758732|NCT02781805|Alendronate|alendronate|mesh-list
138433011|NCT01747720|Vitamin D|vitamin d|mesh-list
138758733|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138758734|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758736|NCT02781493|Laxatives|laxatives|mesh-ancestor
138758737|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138758738|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138758739|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138758740|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
138758741|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138758742|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758743|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758744|NCT02783053|Metformin|metformin|mesh-list
138758745|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138675357|NCT01308580|Prednisone|prednisone|mesh-list
138758769|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138758770|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138758772|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138758773|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758774|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138758775|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138758776|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
138552023|NCT00267826|Rituximab|rituximab|mesh-list
138758777|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138758778|NCT05297617|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138758779|NCT05297617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138758780|NCT05297617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758781|NCT05297617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758782|NCT05297617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138758783|NCT05297617|Hormone Antagonists|hormone antagonists|mesh-ancestor
138758784|NCT05297617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758785|NCT05297617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758786|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
138758787|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138758789|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
138758790|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758791|NCT00638131|Bosentan|bosentan|mesh-list
138758792|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138758793|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138758794|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758795|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
138758796|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138758797|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138758798|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758806|NCT05340985|Dehydrocholesterols|dehydrocholesterols|mesh-list
138758807|NCT05340985|7-dehydrocholesterol|7-dehydrocholesterol|mesh-list
138758808|NCT05340985|Micronutrients|micronutrients|mesh-ancestor
138758809|NCT05340985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758810|NCT05340985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138758811|NCT05340985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138758813|NCT02784457|Cetrorelix|cetrorelix|mesh-list
138758814|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138758815|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
138758816|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138758817|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758818|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
138758819|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758820|NCT02780323|Celecoxib|celecoxib|mesh-list
138758821|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138758822|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138758823|NCT02780323|Analgesics|analgesics|mesh-ancestor
138758824|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
138758825|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758826|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758827|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138758828|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138758829|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138758830|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138758831|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758832|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758833|NCT05331859|Insulin|insulin|mesh-list
138758834|NCT05331859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138758835|NCT05331859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758836|NCT04229407|Vitamins|vitamins|mesh-list
138758837|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
138758838|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
138758839|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758840|NCT04231435|Metformin|metformin|mesh-list
138758841|NCT04231435|Digoxin|digoxin|mesh-list
138758842|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138758843|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138758844|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758845|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138758846|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138758847|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
138589219|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758848|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758849|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138758850|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138758851|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758852|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138758853|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138758854|NCT04231435|Protective Agents|protective agents|mesh-ancestor
138758855|NCT05340439|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138758856|NCT05340439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138758857|NCT05340439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758858|NCT05340439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758859|NCT05340439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138758860|NCT05340439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138758861|NCT05340439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758862|NCT05340439|Cholinergic Agents|cholinergic agents|mesh-ancestor
138758863|NCT05340439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138758864|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
138758865|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138758866|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138758867|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138758868|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758869|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758881|NCT05322031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758882|NCT05322031|Dopamine Agonists|dopamine agonists|mesh-ancestor
138758883|NCT05322031|Dopamine Agents|dopamine agents|mesh-ancestor
138758884|NCT05322031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138758885|NCT05322031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758886|NCT05322031|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138758887|NCT05322031|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138758888|NCT05322031|Serotonin Agents|serotonin agents|mesh-ancestor
138758889|NCT05322031|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138758890|NCT05322031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138758891|NCT05322031|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138758892|NCT05322031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138758893|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138758894|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138758895|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758896|NCT02780011|Immunotoxins|immunotoxins|mesh-ancestor
138276822|NCT00005607|Leucovorin|leucovorin|mesh-list
138758897|NCT02780011|Immunoconjugates|immunoconjugates|mesh-ancestor
138758898|NCT02780011|Immunologic Factors|immunologic factors|mesh-ancestor
138758899|NCT02780011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758900|NCT02780479|Dexamethasone|dexamethasone|mesh-list
138758901|NCT02780479|Prednisone|prednisone|mesh-list
138758902|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138758903|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
138758904|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
138758905|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138758906|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758907|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138758908|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
138758909|NCT02780479|Hormones|hormones|mesh-ancestor
138758910|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758911|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138758912|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138758913|NCT05252923|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
138758914|NCT05252923|Anticoagulants|anticoagulants|mesh-ancestor
138758915|NCT05252923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138758916|NCT05252923|Antimetabolites|antimetabolites|mesh-ancestor
138758917|NCT05252923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758918|NCT05252923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138758919|NCT05252923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138758920|NCT05252923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138758921|NCT05252923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139083483|NCT01213238|Bevacizumab|bevacizumab|mesh-list
138758922|NCT05252923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758923|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
138758924|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138758925|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138758926|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138758927|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138758928|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758929|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
138758930|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675397|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758961|NCT05338489|Antifungal Agents|antifungal agents|mesh-ancestor
138758962|NCT05338489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138758963|NCT05338489|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138758964|NCT05338489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138589298|NCT03271255|Apatinib|apatinib|mesh-list
138758965|NCT05338489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138758966|NCT05338489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138758967|NCT05338489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138758968|NCT05338489|Hormone Antagonists|hormone antagonists|mesh-ancestor
138758969|NCT05338489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138758970|NCT05338489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138758971|NCT05338489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138758972|NCT05338489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138758973|NCT05338489|Antitubercular Agents|antitubercular agents|mesh-ancestor
138758974|NCT05338489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138758975|NCT05338489|Leprostatic Agents|leprostatic agents|mesh-ancestor
138758976|NCT05338489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138758977|NCT05338489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138758978|NCT05338489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138759004|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138759005|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138759006|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
138759007|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138759008|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759009|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138759010|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
138759011|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
138759012|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138759013|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138759014|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138759015|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138759016|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
138759017|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
138759019|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138759020|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
138759021|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
138759022|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
138759023|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
138759024|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138759025|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759026|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
138759027|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
138759028|NCT04883437|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138759029|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138759030|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433320|NCT01749228|Etodolac|etodolac|mesh-list
138759047|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138759048|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138759049|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138759050|NCT02777671|Gliclazide|gliclazide|mesh-list
138759051|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138759052|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
138759053|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138759054|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138759055|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138759056|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759057|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138759058|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759059|NCT02778919|Leuprolide|leuprolide|mesh-list
138759060|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138759061|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
138759062|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138759063|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759064|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138759065|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759066|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138759067|NCT02779153|Hormones|hormones|mesh-ancestor
138759068|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138759069|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759070|NCT04226443|Midazolam|midazolam|mesh-list
138759071|NCT04226443|Remifentanil|remifentanil|mesh-list
138759072|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138759073|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138759074|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759075|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759076|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138759077|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138759078|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138759079|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138759080|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
138759081|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
138759082|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
138759083|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
138759084|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552090|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138759085|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759086|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138759087|NCT04226443|Narcotics|narcotics|mesh-ancestor
138759106|NCT05157997|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
138759108|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
138759109|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759110|NCT05157997|Antiviral Agents|antiviral agents|mesh-ancestor
138759111|NCT05157997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759112|NCT02773147|Pyridoxine|pyridoxine|mesh-list
138759113|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
138759114|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
138759115|NCT02773147|Hematinics|hematinics|mesh-ancestor
138759116|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
138759117|NCT02773147|Vitamins|vitamins|mesh-ancestor
138759118|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
138759119|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759120|NCT02773927|Metformin|metformin|mesh-list
138759121|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138759122|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759123|NCT02773459|Capecitabine|capecitabine|mesh-list
138759124|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138759125|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
138759126|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759127|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759128|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
138759129|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138759130|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138759131|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759132|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138759133|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138759134|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759135|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759136|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759137|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138759138|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
138759139|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138759140|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759141|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138759142|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138759143|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138759144|NCT04771741|Acetaminophen|acetaminophen|mesh-list
138759145|NCT04771741|Ketorolac|ketorolac|mesh-list
138759146|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138759147|NCT04771741|Meloxicam|meloxicam|mesh-list
138759148|NCT04771741|Pregabalin|pregabalin|mesh-list
138759177|NCT02772601|Caffeine|caffeine|mesh-list
138759178|NCT02772601|Omeprazole|omeprazole|mesh-list
138759179|NCT02772601|Warfarin|warfarin|mesh-list
138759180|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138433463|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
138759181|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138759182|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759183|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759184|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138759185|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138759186|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138759187|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138759188|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
138759189|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
138759190|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
138759191|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
138759192|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138759193|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759194|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
138759195|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138675494|NCT01307020|Tramadol|tramadol|mesh-list
138759210|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138759211|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138759212|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
138759213|NCT02772211|Cycloserine|cycloserine|mesh-list
138759214|NCT02772211|Ketamine|ketamine|mesh-list
138759215|NCT02772211|Analgesics|analgesics|mesh-ancestor
138759216|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
138759217|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759218|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759219|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138759220|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138759221|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
138759222|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
138759223|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759224|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138759225|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138759226|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138759227|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759228|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138759229|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759230|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138759231|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
138759232|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138759233|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
138759234|NCT04225195|Amphotericin B|amphotericin b|mesh-list
138759235|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138759236|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
138759237|NCT04225195|Amebicides|amebicides|mesh-ancestor
138759238|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138759239|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138759240|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759241|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138759242|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
138759243|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138759244|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
138759245|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759246|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759247|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138759248|NCT04225195|Protective Agents|protective agents|mesh-ancestor
138759249|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759250|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759251|NCT02771509|Mitogens|mitogens|mesh-list
138759252|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
138759253|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759254|NCT02696941|Metformin|metformin|mesh-list
138759255|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138759256|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138759273|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138759274|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138759275|NCT02767219|Growth Substances|growth substances|mesh-ancestor
138759276|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759277|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
138759278|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138759279|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
138759280|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
138759281|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759282|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138759284|NCT02767219|Hormones|hormones|mesh-ancestor
138759285|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138759286|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138759287|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
138759288|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759289|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138759290|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138759291|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
138759292|NCT02771587|Ethanol|ethanol|mesh-list
138759293|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138759294|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589514|NCT00337246|Rituximab|rituximab|mesh-list
138759295|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759296|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759297|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
138759298|NCT02771743|Ifosfamide|ifosfamide|mesh-list
138759299|NCT02771743|Carboplatin|carboplatin|mesh-list
138759300|NCT02771743|Doxorubicin|doxorubicin|mesh-list
138759301|NCT02771743|Etoposide|etoposide|mesh-list
138759302|NCT02771743|Interleukin-2|interleukin-2|mesh-list
138759303|NCT02771743|Isotretinoin|isotretinoin|mesh-list
138759304|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138759305|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
138759306|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759307|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138759308|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138759309|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
138759310|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759311|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759312|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138759313|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138759314|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138675535|NCT02890771|Turmeric extract|turmeric extract|mesh-list
138759329|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759330|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138759332|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
138759333|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138759335|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759336|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759337|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138759338|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
138759339|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138759341|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759342|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138759343|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138759344|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
138759345|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
138759346|NCT04224103|Protective Agents|protective agents|mesh-ancestor
138759348|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138759349|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138759350|NCT02766439|Analgesics|analgesics|mesh-ancestor
138759351|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
138759352|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759353|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759354|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138759355|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138759356|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138759357|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138759358|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
138759359|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
138759360|NCT02765971|Cathartics|cathartics|mesh-ancestor
138759361|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138759362|NCT02765815|Ketorolac|ketorolac|mesh-list
138759363|NCT02765815|Epinephrine|epinephrine|mesh-list
138759364|NCT02765815|Racepinephrine|racepinephrine|mesh-list
138759365|NCT02765815|Morphine|morphine|mesh-list
138759366|NCT02765815|Bupivacaine|bupivacaine|mesh-list
138759367|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
138759368|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
138759369|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
138759370|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759371|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759372|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
138759373|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759374|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138759375|NCT02765815|Narcotics|narcotics|mesh-ancestor
138759376|NCT02765815|Analgesics|analgesics|mesh-ancestor
138759377|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138759378|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138759379|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
138759380|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138759412|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138759414|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759415|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138759416|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138759417|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759418|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759419|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759420|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138759421|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
138759422|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138675566|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
138759439|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
138759440|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138759441|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138759442|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
138759444|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759445|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759446|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759447|NCT02769325|Ketorolac|ketorolac|mesh-list
138759448|NCT02769325|Atropine|atropine|mesh-list
138759449|NCT02769325|Morphine|morphine|mesh-list
138759450|NCT02769325|Propofol|propofol|mesh-list
138759451|NCT02769325|Sevoflurane|sevoflurane|mesh-list
138759452|NCT02769325|Rocuronium|rocuronium|mesh-list
138759453|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138759454|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759455|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759456|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138759457|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
138759458|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
138759459|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138759460|NCT02769325|Narcotics|narcotics|mesh-ancestor
138759461|NCT02769325|Analgesics|analgesics|mesh-ancestor
138759462|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
138759463|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759464|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138759465|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138759466|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138759467|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138759468|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138759469|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138759470|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138759471|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759472|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759473|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138759474|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138759475|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138759476|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138759477|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138759478|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138759479|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
138759480|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138675598|NCT00488540|Analgesics|analgesics|mesh-ancestor
138759494|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759495|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138759496|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138759497|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759498|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138759499|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138759500|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138759501|NCT04224649|Lidocaine|lidocaine|mesh-list
138759502|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
138759503|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
138759504|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
138759505|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759506|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759507|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
138589638|NCT00158496|Ribavirin|ribavirin|mesh-list
138759508|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759509|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138759510|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138759511|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138759512|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138759513|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759514|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138759515|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
138759516|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
138759517|NCT04224649|Protective Agents|protective agents|mesh-ancestor
138759518|NCT02769169|Ranibizumab|ranibizumab|mesh-list
138759519|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138759520|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138759521|NCT02769169|Growth Substances|growth substances|mesh-ancestor
138759522|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759523|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
138759524|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759525|NCT02769013|Praziquantel|praziquantel|mesh-list
138759526|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
138759527|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138759528|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759529|NCT02768545|Ezetimibe|ezetimibe|mesh-list
138759530|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138759531|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138759532|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
138759533|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759534|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138759535|NCT02764723|Bupivacaine|bupivacaine|mesh-list
138759536|NCT02764723|Ropivacaine|ropivacaine|mesh-list
138759537|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
138759538|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
138759539|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759540|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759541|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
138759542|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759543|NCT04664959|Denosumab|denosumab|mesh-list
138675615|NCT01241097|Simvastatin|simvastatin|mesh-list
138589649|NCT00337792|Midazolam|midazolam|mesh-list
138759552|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
138759553|NCT00951496|Antibodies|antibodies|mesh-list
138759554|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
138759555|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138759556|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
138759557|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138433844|NCT05996133|Anesthetics|anesthetics|mesh-ancestor
138759558|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759559|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
138759560|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
138759561|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
138759562|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759563|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138759564|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138759565|NCT00951496|Growth Substances|growth substances|mesh-ancestor
138759566|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759567|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
138759568|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
138759569|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138759570|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138759571|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138759572|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138759573|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138759574|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
138759575|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138759576|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759577|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759578|NCT02768077|Melatonin|melatonin|mesh-list
138759579|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
138759580|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759581|NCT02768077|Protective Agents|protective agents|mesh-ancestor
139083677|NCT01119638|Risperidone|risperidone|mesh-list
138759582|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759583|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759585|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138759586|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
138759587|NCT01193244|Hormones|hormones|mesh-ancestor
138759588|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138759589|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759590|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138759591|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759592|NCT04224337|Doxorubicin|doxorubicin|mesh-list
138759593|NCT04224337|Durvalumab|durvalumab|mesh-list
138759594|NCT04224337|Ifosfamide|ifosfamide|mesh-list
138759595|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138759596|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759597|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138759598|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138759599|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759600|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759601|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138759602|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138759603|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
138759604|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138759605|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759606|NCT02762617|Tenofovir|tenofovir|mesh-list
138759607|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
138759608|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759609|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138759610|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138759661|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138759662|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138759663|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
138759664|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759665|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759666|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138759667|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138759668|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
138759669|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759670|NCT02758015|Betaine|betaine|mesh-list
138759671|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138759672|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
138759673|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138759674|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
138759675|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759676|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138759677|NCT02757703|Terlipressin|terlipressin|mesh-list
138759678|NCT02757703|Pantoprazole|pantoprazole|mesh-list
138759679|NCT02757703|Somatostatin|somatostatin|mesh-list
138759680|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139083694|NCT03338998|Siponimod|siponimod|mesh-list
138759681|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138759682|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138759683|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759684|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759685|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138759686|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138759688|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138759689|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759690|NCT02763007|Pioglitazone|pioglitazone|mesh-list
138759691|NCT02763007|Alogliptin|alogliptin|mesh-list
138759692|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138759693|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759694|NCT02763007|Incretins|incretins|mesh-ancestor
138759695|NCT02763007|Hormones|hormones|mesh-ancestor
138759696|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138589779|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
138759697|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138759698|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
138759699|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759700|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759701|NCT00635323|Capecitabine|capecitabine|mesh-list
138759702|NCT00635323|Irinotecan|irinotecan|mesh-list
138759703|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138759704|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
138759705|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433991|NCT05715814|Empagliflozin|empagliflozin|mesh-list
138759706|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759707|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138759708|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138759710|NCT01191840|Vancomycin|vancomycin|mesh-list
138759711|NCT01191840|Cefazolin|cefazolin|mesh-list
138759712|NCT01191840|Daptomycin|daptomycin|mesh-list
138759713|NCT01191840|Cloxacillin|cloxacillin|mesh-list
138759714|NCT01191840|Oxacillin|oxacillin|mesh-list
138759715|NCT01191840|Nafcillin|nafcillin|mesh-list
138759724|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138759725|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138759726|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138759727|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759728|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759729|NCT02757469|Drospirenone|drospirenone|mesh-list
138759730|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138759731|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138759732|NCT02757469|Estradiol|estradiol|mesh-list
138759733|NCT02757469|Estrogens|estrogens|mesh-ancestor
138759734|NCT02757469|Hormones|hormones|mesh-ancestor
138759735|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138759736|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759737|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138759738|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
138759739|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138759740|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138759741|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138759742|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138759743|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138759744|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
138759745|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138759746|NCT02757469|Diuretics|diuretics|mesh-ancestor
138759747|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
138759748|NCT02757391|Aldesleukin|aldesleukin|mesh-list
138759749|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
138759750|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
138759751|NCT02757391|Interleukin-2|interleukin-2|mesh-list
138759752|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
138759753|NCT02757391|Immunomodulating Agents|immunomodulating agents|mesh-list
138759754|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138759755|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759756|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138759757|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138759758|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
138759759|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759760|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759761|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138759762|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138759763|NCT02757391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138759764|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138759765|NCT02757391|Analgesics|analgesics|mesh-ancestor
138759766|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
138759767|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759768|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138759769|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138759770|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
138759771|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759772|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
138759773|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138759774|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759775|NCT04564417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138759776|NCT04564417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589923|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759779|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759780|NCT02757079|Protective Agents|protective agents|mesh-ancestor
138759781|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759782|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759821|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138759822|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759823|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
138759824|NCT00942994|Amlodipine|amlodipine|mesh-list
138759825|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138759826|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138759827|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138759828|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138759829|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759830|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138759831|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759832|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
138759833|NCT00942994|Diuretics|diuretics|mesh-ancestor
138759834|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
138759835|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138759836|NCT04268602|Anesthetics|anesthetics|mesh-list
138759837|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
138759838|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759839|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434142|NCT05483010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138434143|NCT05483010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434144|NCT05464719|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
138434145|NCT05464719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434146|NCT05464719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434165|NCT05427383|Paclitaxel|paclitaxel|mesh-list
138434166|NCT05427383|Docetaxel|docetaxel|mesh-list
138434167|NCT05427383|Irinotecan|irinotecan|mesh-list
138434168|NCT05427383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138434169|NCT05427383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434170|NCT05427383|Tubulin Modulators|tubulin modulators|mesh-ancestor
138434171|NCT05427383|Antimitotic Agents|antimitotic agents|mesh-ancestor
138434172|NCT05427383|Mitosis Modulators|mitosis modulators|mesh-ancestor
138434173|NCT05427383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434174|NCT05427383|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138590037|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138434175|NCT05427383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138434176|NCT05427383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434177|NCT05426252|Sirolimus|sirolimus|mesh-list
138759840|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
138759841|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138759842|NCT04314336|Coal Tar|coal tar|mesh-list
138759843|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
138759844|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
138759845|NCT00624702|Maleic acid|maleic acid|mesh-list
138759846|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759847|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759848|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
138759849|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138759850|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
138759851|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138759852|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759854|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
138759855|NCT02752477|Anesthetics|anesthetics|mesh-list
138759856|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
138759857|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759858|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759859|NCT04204096|Vaccines|vaccines|mesh-list
138759860|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
138759884|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
138759885|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759886|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759887|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138759888|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138759889|NCT02855632|Hormones|hormones|mesh-list
138759890|NCT02855632|Progesterone|progesterone|mesh-list
138759891|NCT02855632|Lenograstim|lenograstim|mesh-list
138759892|NCT02855632|Estrogens|estrogens|mesh-list
138759893|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138759894|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759895|NCT02855632|Progestins|progestins|mesh-ancestor
138759896|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138759897|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
138759898|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
138759899|NCT04220281|Propofol|propofol|mesh-list
138759900|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138590091|NCT00150423|Pregabalin|pregabalin|mesh-list
138759901|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759902|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759903|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138759904|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
138759905|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
138759906|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
138759907|NCT02751619|Lidocaine|lidocaine|mesh-list
138759908|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
138759909|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
138759910|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759911|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759938|NCT02761291|Valganciclovir|valganciclovir|mesh-list
138759939|NCT02761291|Gemcitabine|gemcitabine|mesh-list
138759940|NCT02761291|Valproic Acid|valproic acid|mesh-list
138759941|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138759942|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
138759943|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759944|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759945|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
138759946|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759947|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
138759948|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552471|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
138759949|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759950|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
138759951|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138759952|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759953|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138759954|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
138759955|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138759957|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138759958|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759973|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138759974|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138759975|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138759977|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
138759978|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
138759979|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
138759980|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138759981|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759982|NCT02751307|Metformin|metformin|mesh-list
138759983|NCT02751307|Clozapine|clozapine|mesh-list
138759984|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138759985|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138759986|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138759987|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
138434293|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
138759988|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138759989|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138759990|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138759991|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138759992|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138759993|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138759994|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
138759995|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
138759996|NCT00638209|Insulin|insulin|mesh-list
138759997|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138759998|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138759999|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139083850|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
138760000|NCT05429671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138760001|NCT05429671|Gentamicins|gentamicins|mesh-list
138760002|NCT05429671|Tobramycin|tobramycin|mesh-list
138760003|NCT05429671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138760004|NCT05429671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138760005|NCT05429671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760006|NCT05429671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760007|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
138760008|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138760009|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760010|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
138760011|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760012|NCT02754817|Liraglutide|liraglutide|mesh-list
138760013|NCT02754817|Xultophy|xultophy|mesh-list
138760014|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138760015|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760016|NCT02754817|Incretins|incretins|mesh-ancestor
138760017|NCT02754817|Hormones|hormones|mesh-ancestor
138760018|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760019|NCT04230031|Daratumumab|daratumumab|mesh-list
138760020|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760021|NCT01186458|Rituximab|rituximab|mesh-list
138760022|NCT01186458|Fludarabine|fludarabine|mesh-list
138760051|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760053|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
138760054|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760055|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138760056|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138760057|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
138760058|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138760059|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138760060|NCT01185288|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138760061|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138760063|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138760064|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138760065|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
138760066|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760067|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760068|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138760069|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
138675808|NCT00484328|Ribavirin|ribavirin|mesh-list
138760089|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
138760090|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760091|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760092|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
138760093|NCT02855788|Leucovorin|leucovorin|mesh-list
138760094|NCT02855788|Paclitaxel|paclitaxel|mesh-list
138760095|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
138760096|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138760097|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760098|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
138760099|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
138760100|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
138760101|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760102|NCT02855788|Antidotes|antidotes|mesh-ancestor
138760103|NCT02855788|Protective Agents|protective agents|mesh-ancestor
138760104|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760105|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
138760106|NCT02855788|Vitamins|vitamins|mesh-ancestor
138760107|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
138760108|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138760109|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138760110|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138760111|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138760112|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760113|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138760114|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760115|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
138760116|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138760117|NCT01190436|Bisoprolol|bisoprolol|mesh-list
138760118|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138760119|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
138760120|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
138760121|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760122|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760123|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138760124|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138760125|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138760126|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
138760127|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675835|NCT00484692|Bupropion|bupropion|mesh-list
138434454|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
138760130|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
138760131|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138760132|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
138760133|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760134|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138760135|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138760136|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
138760138|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138760139|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138760140|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
138760141|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760142|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760143|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138760144|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138760145|NCT00602524|Pilocarpine|pilocarpine|mesh-list
138760146|NCT00602524|Miotics|miotics|mesh-ancestor
138760147|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
138760148|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760149|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760150|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138760151|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138760152|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
138760153|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138760154|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760155|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138760156|NCT01189890|Glimepiride|glimepiride|mesh-list
138760157|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138760158|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760159|NCT01189890|Incretins|incretins|mesh-ancestor
138760160|NCT01189890|Hormones|hormones|mesh-ancestor
138760161|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760162|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138760163|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
138760164|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760165|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760166|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138760167|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138760169|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
138760170|NCT01189812|Citalopram|citalopram|mesh-list
138760171|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
138760172|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138760173|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760174|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760175|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
138760176|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138760205|NCT00938860|Cyclosporins|cyclosporins|mesh-list
138760206|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138760207|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
138760208|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760209|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138760210|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760211|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760212|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
139084050|NCT01222052|Docetaxel|docetaxel|mesh-list
138760213|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138760214|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
138760215|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138760217|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138760218|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
138760219|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
138675870|NCT00484601|Doxorubicin|doxorubicin|mesh-list
138760251|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138760252|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760254|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
138760255|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760256|NCT05381428|Indomethacin|indomethacin|mesh-list
138760257|NCT05381428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138760258|NCT05381428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138760259|NCT05381428|Analgesics|analgesics|mesh-ancestor
138760260|NCT05381428|Sensory System Agents|sensory system agents|mesh-ancestor
138760261|NCT05381428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760262|NCT05381428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760263|NCT05381428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138760264|NCT05381428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138760265|NCT05381428|Gout Suppressants|gout suppressants|mesh-ancestor
138760266|NCT05381428|Tocolytic Agents|tocolytic agents|mesh-ancestor
138760267|NCT05381428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138760269|NCT05381428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760270|NCT05381428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760271|NCT01022853|Nintedanib|nintedanib|mesh-list
138760272|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760273|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138760274|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760275|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760276|NCT00937768|Leuprolide|leuprolide|mesh-list
138760277|NCT00937768|Goserelin|goserelin|mesh-list
138760278|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138760279|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
138760280|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138760281|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760282|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138760283|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760284|NCT00631228|Everolimus|everolimus|mesh-list
138760285|NCT00631228|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138760286|NCT00631228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138760287|NCT00631228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760288|NCT00631228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760289|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138760290|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
138760291|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760292|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760293|NCT05381038|Paclitaxel|paclitaxel|mesh-list
138760294|NCT05381038|Docetaxel|docetaxel|mesh-list
138760295|NCT05381038|Irinotecan|irinotecan|mesh-list
138760296|NCT05381038|Azacitidine|azacitidine|mesh-list
138760297|NCT05381038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138760298|NCT05381038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760299|NCT05381038|Tubulin Modulators|tubulin modulators|mesh-ancestor
138760300|NCT05381038|Antimitotic Agents|antimitotic agents|mesh-ancestor
138760301|NCT05381038|Mitosis Modulators|mitosis modulators|mesh-ancestor
138760302|NCT05381038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760303|NCT05381038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138760304|NCT05381038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138760305|NCT05381038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760306|NCT05381038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138760307|NCT05381038|Antimetabolites|antimetabolites|mesh-ancestor
138760308|NCT05380960|Fibrin fragment D|fibrin fragment d|mesh-list
138760309|NCT05380960|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138760310|NCT05380960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138760311|NCT05380960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760312|NCT05380960|Hemostatics|hemostatics|mesh-ancestor
138760314|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
138760315|NCT00604630|Hematinics|hematinics|mesh-ancestor
138760316|NCT01189266|Vorinostat|vorinostat|mesh-list
138760317|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760318|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138760319|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760320|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760321|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138760322|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138760323|NCT01188798|Methotrexate|methotrexate|mesh-list
138760324|NCT01188798|Pentostatin|pentostatin|mesh-list
138675930|NCT02275806|Irinotecan|irinotecan|mesh-list
138434665|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760344|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760346|NCT01183104|Hormones|hormones|mesh-ancestor
138760347|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760348|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138760349|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
138760350|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760351|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760352|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138760353|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138760354|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
138760355|NCT02885688|Insulin|insulin|mesh-list
138760356|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138760357|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760358|NCT00950248|Idebenone|idebenone|mesh-list
138760359|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
138760360|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139084186|NCT05133310|Simvastatin|simvastatin|mesh-list
138760361|NCT00950248|Protective Agents|protective agents|mesh-ancestor
138760362|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760363|NCT04269928|Epinephrine|epinephrine|mesh-list
138760364|NCT04269928|Racepinephrine|racepinephrine|mesh-list
138760365|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
138760366|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138760367|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138760368|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
138760369|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138760370|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760371|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760372|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138760373|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138760374|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
138760375|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760376|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138760377|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
138760379|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
138760380|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138760396|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138760398|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138760399|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138760400|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138760401|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760402|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760403|NCT00949702|Vemurafenib|vemurafenib|mesh-list
138760404|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760405|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138552660|NCT04730375|Analgesics|analgesics|mesh-ancestor
138760406|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760407|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760409|NCT01034631|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138434741|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434742|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138434743|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138434744|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434745|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
138434746|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138434747|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138434748|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
138434749|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138434751|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
138760410|NCT01034631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138760411|NCT01034631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760412|NCT01034631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760413|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138760414|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
138760415|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760416|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760418|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
138760419|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138760420|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138760421|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138760422|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138760423|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760424|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
138760425|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
138760426|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552692|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138760427|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760428|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138760429|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138760430|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
138675955|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138760444|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138760445|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138760446|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760447|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
138760448|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760449|NCT01034163|Panobinostat|panobinostat|mesh-list
138760450|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760451|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138760452|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760453|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760454|NCT01162122|Vaccines|vaccines|mesh-list
138760455|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
138760456|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760457|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138760458|NCT01033071|Olmesartan|olmesartan|mesh-list
138760459|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138760460|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
138760461|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138760462|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138760463|NCT01033071|Diuretics|diuretics|mesh-ancestor
138760464|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
138760465|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760466|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138760467|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138760468|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760469|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138760470|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138760471|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138760472|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
138760473|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760474|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138760475|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760476|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138760477|NCT02873559|Testosterone|testosterone|mesh-list
138760478|NCT02873559|Androgens|androgens|mesh-ancestor
138760479|NCT02873559|Hormones|hormones|mesh-ancestor
138760480|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760481|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760482|NCT01029795|Glyburide|glyburide|mesh-list
138760483|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139084381|NCT01224470|Analgesics|analgesics|mesh-ancestor
138760484|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760485|NCT02885454|Simeprevir|simeprevir|mesh-list
138760486|NCT02885454|Odalasvir|odalasvir|mesh-list
138760487|NCT02885454|Drospirenone|drospirenone|mesh-list
138760488|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138760489|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138760490|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138760491|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138760499|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760500|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138760501|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
138590565|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760502|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138760503|NCT02885454|Diuretics|diuretics|mesh-ancestor
138760504|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
138760505|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
138760506|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138760507|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
138760508|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760509|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760510|NCT01032837|Oseltamivir|oseltamivir|mesh-list
138760511|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
138760512|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138760513|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760514|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760515|NCT01180296|Progesterone|progesterone|mesh-list
138760516|NCT01180296|Progestins|progestins|mesh-ancestor
138760517|NCT01180296|Hormones|hormones|mesh-ancestor
138760518|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760519|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760520|NCT01160640|Metronidazole|metronidazole|mesh-list
138760521|NCT01160640|Doxycycline|doxycycline|mesh-list
138760522|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
138760523|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138760524|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138760525|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138760526|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138760527|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
138760528|NCT01160484|Lenalidomide|lenalidomide|mesh-list
138760529|NCT01160484|Bortezomib|bortezomib|mesh-list
138760530|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
138760531|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760532|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138760533|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138760534|NCT01160484|Growth Substances|growth substances|mesh-ancestor
138760535|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
138760536|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760537|NCT01032291|Lenalidomide|lenalidomide|mesh-list
138760538|NCT01032291|Cetuximab|cetuximab|mesh-list
138760539|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
138760540|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760541|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138760542|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138760543|NCT01032291|Growth Substances|growth substances|mesh-ancestor
138760544|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
138760545|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760546|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138760547|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
138760548|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138760549|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760550|NCT02873871|Hemostatics|hemostatics|mesh-list
138760551|NCT02873871|Coagulants|coagulants|mesh-ancestor
138434895|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
138434896|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
138434897|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
138434898|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434899|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138434900|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
138760552|NCT04301739|Paclitaxel|paclitaxel|mesh-list
138760553|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
138760554|NCT04301739|Carboplatin|carboplatin|mesh-list
138760555|NCT04301739|Doxorubicin|doxorubicin|mesh-list
138760556|NCT04301739|Epirubicin|epirubicin|mesh-list
138760562|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760564|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
138760565|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760566|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138760567|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138760568|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
138760569|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138760570|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138760571|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138760572|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138760573|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760574|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
138760575|NCT04301583|Procyanidin|procyanidin|mesh-list
138760576|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
138760577|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760578|NCT04301583|Protective Agents|protective agents|mesh-ancestor
138760579|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760580|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138760581|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138760582|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138760583|NCT01021683|Itraconazole|itraconazole|mesh-list
138760584|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
138760585|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138760586|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138760587|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138760588|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760589|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760590|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138760591|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
138760592|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760593|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760594|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138760595|NCT04625725|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
138760596|NCT04625725|Antiviral Agents|antiviral agents|mesh-ancestor
138760597|NCT04625725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138760598|NCT01021215|Celecoxib|celecoxib|mesh-list
138760599|NCT01021215|Zileuton|zileuton|mesh-list
138760600|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138760601|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138760602|NCT01021215|Analgesics|analgesics|mesh-ancestor
138760603|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
138760604|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760605|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760606|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138760607|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138760608|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138760609|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138760610|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760611|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760612|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138760613|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138760614|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
138760615|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760617|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138760618|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760619|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
138760620|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138760621|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
138675987|NCT00489437|Heparin|heparin|mesh-list
138760653|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760655|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
138760656|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760657|NCT02760823|Protective Agents|protective agents|mesh-ancestor
138760658|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760659|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
138760660|NCT02760823|Vitamins|vitamins|mesh-ancestor
138760661|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
138760662|NCT01020747|Bevacizumab|bevacizumab|mesh-list
138760663|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138760664|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760665|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138760666|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138760681|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760682|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760683|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138760684|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138760685|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138760686|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
138760687|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138760688|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760689|NCT01031979|Urological Agents|urological agents|mesh-ancestor
138760690|NCT02753803|Pioglitazone|pioglitazone|mesh-list
138760691|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138760692|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760694|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
138760695|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138760696|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
138760697|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760698|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760699|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
138760700|NCT00635401|Varenicline|varenicline|mesh-list
138760701|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138760702|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138760703|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
138760704|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138760705|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760706|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760707|NCT02753725|Fentanyl|fentanyl|mesh-list
138760708|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138760709|NCT02753725|Narcotics|narcotics|mesh-ancestor
138760710|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138760711|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760712|NCT02753725|Analgesics|analgesics|mesh-ancestor
138760713|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
138760714|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590841|NCT05861466|Ranibizumab|ranibizumab|mesh-list
138760715|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138760716|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138760717|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
138760718|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
138760719|NCT01020123|Glipizide|glipizide|mesh-list
138760720|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138760721|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760722|NCT04300959|Cisplatin|cisplatin|mesh-list
138760723|NCT04300959|Gemcitabine|gemcitabine|mesh-list
138760724|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760725|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138760726|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
138760727|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760728|NCT02760355|Ribavirin|ribavirin|mesh-list
138760729|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
138760747|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138760748|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138760749|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138760750|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138760751|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760752|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138760753|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760754|NCT01179672|Analgesics|analgesics|mesh-ancestor
138760755|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
138760756|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760757|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
138760758|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138760759|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
138760760|NCT04301349|Misoprostol|misoprostol|mesh-list
138760761|NCT04301349|Dinoprostone|dinoprostone|mesh-list
138760762|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138760763|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
138760764|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138760765|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760766|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138760767|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138760769|NCT02753647|Prednisone|prednisone|mesh-list
138760770|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
138760771|NCT02753647|Rituximab|rituximab|mesh-list
138760772|NCT02753647|Doxorubicin|doxorubicin|mesh-list
138760773|NCT02753647|Vincristine|vincristine|mesh-list
138760774|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138760775|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
138760776|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760777|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138435125|NCT02939872|Analgesics|analgesics|mesh-ancestor
138760778|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138760779|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
138760780|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760781|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760782|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138760783|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138760784|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138760785|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138760786|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138676045|NCT00485108|Analgesics|analgesics|mesh-ancestor
139084545|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
138760794|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
138760795|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
138760796|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
138760797|NCT02872389|Sevoflurane|sevoflurane|mesh-list
138760798|NCT02872389|Desflurane|desflurane|mesh-list
138760799|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138760800|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138760801|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
138760802|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
138760803|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138760804|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760805|NCT01179516|Vortioxetine|vortioxetine|mesh-list
138760806|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
138760807|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138760808|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138760809|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138760810|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138760811|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760812|NCT01179516|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138760813|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138760814|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138760815|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760816|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138760817|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
138760818|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138760819|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138760820|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138760821|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138760822|NCT00635791|Sorafenib|sorafenib|mesh-list
138760823|NCT00635791|Vorinostat|vorinostat|mesh-list
138760824|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760825|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138760826|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760827|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760828|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138760829|NCT02760121|Acetazolamide|acetazolamide|mesh-list
138760830|NCT02760121|Methazolamide|methazolamide|mesh-list
138760831|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
138760832|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138760833|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760834|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760835|NCT02760121|Diuretics|diuretics|mesh-ancestor
138760836|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
138760837|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760838|NCT05215873|Misoprostol|misoprostol|mesh-list
138760839|NCT05215873|Oxytocin|oxytocin|mesh-list
138760840|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
138760841|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138760842|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760843|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138760844|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
138760845|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138760846|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138760847|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138760848|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138760849|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760851|NCT02750917|Lornoxicam|lornoxicam|mesh-list
138760852|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138760853|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138760867|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760868|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760869|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760870|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138760871|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
138760872|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760873|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138760874|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138760875|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
138760876|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138760877|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760878|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760880|NCT04299633|Sevelamer|sevelamer|mesh-list
138760881|NCT04299633|Calcium acetate|calcium acetate|mesh-list
138760882|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138760883|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760884|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
138760885|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
138760886|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760887|NCT02695459|Everolimus|everolimus|mesh-list
138760888|NCT02695459|Cisplatin|cisplatin|mesh-list
138760889|NCT02695459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138760890|NCT02695459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138760891|NCT02695459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760892|NCT02695459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760893|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138760894|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
138760895|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760896|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591088|NCT05709990|Cholinergic Agents|cholinergic agents|mesh-ancestor
138760898|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138760899|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138760900|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
138760901|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760902|NCT05112991|Lenvatinib|lenvatinib|mesh-list
138760903|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760904|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138760905|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760906|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760907|NCT01030341|Insulin|insulin|mesh-list
138760908|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138760909|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138760910|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760911|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
138760912|NCT02750293|Vitamin D|vitamin d|mesh-list
138760913|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138760914|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760926|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760927|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138760928|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138760930|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
138760931|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
138591147|NCT05491278|Propofol|propofol|mesh-list
138760932|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138760933|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760934|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
139084577|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138760935|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760937|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138760938|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
138760939|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
138760940|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138760941|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760942|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138760943|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
138760945|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760946|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138760947|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760948|NCT02750059|Tenofovir|tenofovir|mesh-list
138760949|NCT02750059|Lamivudine|lamivudine|mesh-list
138760950|NCT02750059|Efavirenz|efavirenz|mesh-list
138760951|NCT02750059|Telmisartan|telmisartan|mesh-list
138760952|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
138760953|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138760954|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138591181|NCT05346562|Cannabidiol|cannabidiol|mesh-list
138760955|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138760956|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138760957|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760958|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138760959|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138760960|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138760961|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138760962|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138760963|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138760964|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138760965|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138760966|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138760967|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138760968|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138760969|NCT02749825|Goserelin|goserelin|mesh-list
138760970|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138760971|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138760972|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138760973|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138760974|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138760975|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
138760976|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138760977|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
138760978|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138760986|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
138760987|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138760988|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138760990|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
138760991|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138760992|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138760993|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138760994|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
138760995|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138760996|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138760997|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138760998|NCT02749747|Sulpiride|sulpiride|mesh-list
138760999|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138761000|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138761001|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761002|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761003|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138761004|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138761005|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
138761006|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761007|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761008|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138761009|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
138761010|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
138761011|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138761012|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138761013|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138761014|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138761015|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761016|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
138761017|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761018|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761019|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138761020|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761021|NCT04359979|Tamsulosin|tamsulosin|mesh-list
138761022|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138761023|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138761024|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138761025|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
138761026|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761027|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761029|NCT04359979|Urological Agents|urological agents|mesh-ancestor
138761030|NCT04180813|Linagliptin|linagliptin|mesh-list
138761031|NCT04180813|Acarbose|acarbose|mesh-list
138761032|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138761033|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761034|NCT04180813|Incretins|incretins|mesh-ancestor
138761035|NCT04180813|Hormones|hormones|mesh-ancestor
138761036|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138761037|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138761038|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
138761039|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761040|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761041|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138761042|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
138676089|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138761050|NCT02749123|Lidocaine|lidocaine|mesh-list
138761051|NCT02749123|Menthol|menthol|mesh-list
138761052|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
138761053|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
138761054|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761055|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761056|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
138761057|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761058|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138591310|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138761059|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138761060|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138761061|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138761062|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761063|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
138761064|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
138761065|NCT00635557|Carboplatin|carboplatin|mesh-list
138761066|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761067|NCT02748265|Epoprostenol|epoprostenol|mesh-list
138761068|NCT02748265|Phenylephrine|phenylephrine|mesh-list
138761069|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
138435440|NCT01750359|Curcumin|curcumin|mesh-list
138435441|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138435442|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138761070|NCT02748265|Tezosentan|tezosentan|mesh-list
138761071|NCT02748265|Propofol|propofol|mesh-list
138761072|NCT02748265|Sevoflurane|sevoflurane|mesh-list
138761073|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138761074|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761075|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761076|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138761077|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
138761078|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
138761079|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138761080|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138761081|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138761082|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
138761083|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
138761084|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761085|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
138761086|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138761087|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
138761088|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
138761089|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138761090|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138761091|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138761092|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
138761093|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761094|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761095|NCT02748265|Protective Agents|protective agents|mesh-ancestor
138761096|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138761097|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
138761098|NCT01015833|Doxorubicin|doxorubicin|mesh-list
138761099|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138761100|NCT01015833|Sorafenib|sorafenib|mesh-list
138761101|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138761102|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761103|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138761104|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138761105|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770264|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761127|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138761128|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138761130|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138761131|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138761132|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138761133|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138761134|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761135|NCT02746783|Vaccines|vaccines|mesh-list
138761136|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
138761137|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761138|NCT02747953|Afatinib|afatinib|mesh-list
138761139|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761140|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138761141|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761142|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761143|NCT02735239|Leucovorin|leucovorin|mesh-list
138761144|NCT02735239|Paclitaxel|paclitaxel|mesh-list
138761145|NCT02735239|Docetaxel|docetaxel|mesh-list
138761146|NCT02735239|Carboplatin|carboplatin|mesh-list
138761147|NCT02735239|Capecitabine|capecitabine|mesh-list
138761148|NCT02735239|Fluorouracil|fluorouracil|mesh-list
138761149|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
138761150|NCT02735239|Durvalumab|durvalumab|mesh-list
138761151|NCT02735239|Tremelimumab|tremelimumab|mesh-list
138761152|NCT02735239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138761153|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761154|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
138761155|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
138761156|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
138761157|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552814|NCT00272584|Risperidone|risperidone|mesh-list
138770265|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
138761185|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761187|NCT02644291|Mebendazole|mebendazole|mesh-list
138761188|NCT02644291|Piperazine|piperazine|mesh-list
138761189|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
138761190|NCT02644291|DMP 777|dmp 777|mesh-list
138761191|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
138761192|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
138761193|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138761194|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761195|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
138761196|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
138761197|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
138761198|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761199|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761200|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761201|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138761202|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138761203|NCT01015677|Estradiol|estradiol|mesh-list
138761204|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138761205|NCT01015677|Estrogens|estrogens|mesh-ancestor
138761206|NCT01015677|Hormones|hormones|mesh-ancestor
138761207|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138761208|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761233|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761234|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138761235|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138761236|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138761237|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138761238|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
138761239|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
138761240|NCT04216459|Vitamin D|vitamin d|mesh-list
138761241|NCT04216459|Thiamine|thiamine|mesh-list
138761242|NCT04216459|Vitamins|vitamins|mesh-ancestor
138761243|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
138761244|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761245|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138761246|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138761247|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
138761248|NCT04216771|Cytarabine|cytarabine|mesh-list
138761249|NCT04216771|Idarubicin|idarubicin|mesh-list
138761250|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138761251|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
138761252|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761253|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761254|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
138761255|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761256|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138761257|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
138761258|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761259|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139084697|NCT03928262|Benralizumab|benralizumab|mesh-list
138761260|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138761261|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138761262|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761263|NCT00636259|Bicalutamide|bicalutamide|mesh-list
138761282|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761283|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138761284|NCT02736019|Narcotics|narcotics|mesh-ancestor
138761285|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761286|NCT04284397|Aspirin|aspirin|mesh-list
138761287|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138761288|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138761289|NCT04284397|Analgesics|analgesics|mesh-ancestor
138761290|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
138761291|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761292|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761293|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138761294|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138761295|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138761296|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138761297|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761298|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138761299|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138761300|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761301|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
138761302|NCT05595889|Irinotecan|irinotecan|mesh-list
138761303|NCT05595889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138761304|NCT05595889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138761305|NCT05595889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761306|NCT05595889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761307|NCT05595889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761308|NCT02735395|Amoxicillin|amoxicillin|mesh-list
138761309|NCT02735395|Metronidazole|metronidazole|mesh-list
138761310|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138761311|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761312|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138761313|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138761314|NCT02741947|Levodopa|levodopa|mesh-list
138761315|NCT02741947|Benserazide|benserazide|mesh-list
138761316|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
138761317|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138761318|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138761319|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
138761320|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761344|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138761345|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
138761346|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
138761347|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761348|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138761349|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
138761350|NCT02735317|Hormones|hormones|mesh-ancestor
138761351|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591545|NCT03739645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138761352|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138761353|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761354|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
138761355|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138761356|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761357|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138761358|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139084722|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
138761359|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761360|NCT02735317|Hematinics|hematinics|mesh-ancestor
138761361|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
138761362|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
138761363|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761364|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
138761365|NCT02739529|genexol-PM|genexol-pm|mesh-list
138761366|NCT02739529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761367|NCT02739529|Tubulin Modulators|tubulin modulators|mesh-ancestor
138761368|NCT02739529|Antimitotic Agents|antimitotic agents|mesh-ancestor
138761369|NCT02739529|Mitosis Modulators|mitosis modulators|mesh-ancestor
138761370|NCT02739529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761371|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138761372|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761373|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138761374|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761392|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138761393|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761394|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138761395|NCT02745925|Ibuprofen|ibuprofen|mesh-list
138761396|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138761397|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138761398|NCT02745925|Analgesics|analgesics|mesh-ancestor
138761399|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
138761400|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761401|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761402|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138761403|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138761404|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138761405|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761406|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761407|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138761408|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
138761409|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761410|NCT02738905|Rifaximin|rifaximin|mesh-list
138761411|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138761412|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761413|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138761414|NCT02745691|Gefitinib|gefitinib|mesh-list
138761415|NCT02745691|Crizotinib|crizotinib|mesh-list
138761416|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761417|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138761418|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761419|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761420|NCT02745769|Ramucirumab|ramucirumab|mesh-list
138761421|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761422|NCT02737813|Bupivacaine|bupivacaine|mesh-list
138761423|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
138761424|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
138761425|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139084739|NCT01129388|Clopidogrel|clopidogrel|mesh-list
138761426|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761427|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
138761428|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761430|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138761431|NCT00636415|Narcotics|narcotics|mesh-ancestor
138761440|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761441|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761443|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
138761444|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761445|NCT02737423|Vitamin D|vitamin d|mesh-list
138761447|NCT02737423|Vitamins|vitamins|mesh-ancestor
138761448|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
138761449|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761450|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138761451|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138761452|NCT02733679|Metformin|metformin|mesh-list
138761453|NCT02733679|Pioglitazone|pioglitazone|mesh-list
138761454|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138761455|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761456|NCT02744131|Metformin|metformin|mesh-list
138761457|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
138761458|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
138761459|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
138761460|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138761461|NCT02744131|Estradiol|estradiol|mesh-list
138761462|NCT02744131|Cyproterone|cyproterone|mesh-list
138761463|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138761464|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761465|NCT02744131|Estrogens|estrogens|mesh-ancestor
138761466|NCT02744131|Hormones|hormones|mesh-ancestor
138761467|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138761468|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138761469|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138761470|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
138761471|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
138761472|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761473|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138761474|NCT02743975|Bevacizumab|bevacizumab|mesh-list
138761475|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138761476|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761477|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138761478|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138761479|NCT02743975|Growth Substances|growth substances|mesh-ancestor
138761480|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761481|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
138761482|NCT02743663|Albuterol|albuterol|mesh-list
138761483|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
138761484|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
138761485|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761486|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761487|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138761488|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
138761489|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
138761490|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138761491|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138761492|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138761493|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138761494|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
138761495|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139084766|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138761496|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761497|NCT02733445|Dasatinib|dasatinib|mesh-list
138761498|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761499|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138761500|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761530|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
138761531|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761532|NCT04205929|Curcumin|curcumin|mesh-list
138761533|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138761534|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138761535|NCT04205929|Analgesics|analgesics|mesh-ancestor
138761536|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
138761537|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591708|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138761538|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761539|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138761540|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138761541|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761542|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761543|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761544|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138761545|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138761546|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
138761547|NCT00636493|Hormones|hormones|mesh-ancestor
138770266|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
138761567|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138761568|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761569|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138761570|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
138761571|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
138761572|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
138761573|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138761574|NCT02742805|Vitamin D|vitamin d|mesh-list
138761575|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
138761576|NCT02742805|Cholecalciferol|cholecalciferol|mesh-list
138761577|NCT02742805|Vitamins|vitamins|mesh-list
138761578|NCT02742805|Omalizumab|omalizumab|mesh-list
138761579|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
138761580|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761581|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138761582|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138761583|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138761584|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139084785|NCT01228370|Silodosin|silodosin|mesh-list
138761585|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
138761587|NCT02690389|Antidotes|antidotes|mesh-ancestor
138761588|NCT02690389|Protective Agents|protective agents|mesh-ancestor
138761589|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761590|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
138761591|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
138761592|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761593|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761594|NCT02732197|Thiopental|thiopental|mesh-list
138761595|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
138761596|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138761597|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761598|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761599|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138435953|NCT01754844|AZD7624|azd7624|mesh-list
138761600|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
138761601|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
138761602|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
138676264|NCT00489983|Gemcitabine|gemcitabine|mesh-list
138761610|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591812|NCT00517270|Rabeprazole|rabeprazole|mesh-list
138761611|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138761612|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138761613|NCT02729935|Analgesics|analgesics|mesh-ancestor
138761614|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
138761615|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761616|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761617|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138761618|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138761619|NCT02729467|Itraconazole|itraconazole|mesh-list
138761620|NCT02729467|Rifampin|rifampin|mesh-list
138761621|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
138761622|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761623|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138761624|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138761625|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761626|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761627|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138761628|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
138761629|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138761630|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761631|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138761632|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138761633|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
138761634|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138761635|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
138761636|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138761637|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138761638|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138761639|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138761640|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138761641|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138761642|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138761643|NCT02727205|Rotigotine|rotigotine|mesh-list
138761644|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
138761645|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
138761646|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761647|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552850|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
138761648|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761649|NCT02721433|Denosumab|denosumab|mesh-list
138761650|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
138761651|NCT02721433|Pamidronate|pamidronate|mesh-list
138761652|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138761653|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761654|NCT02721043|Lenalidomide|lenalidomide|mesh-list
138761655|NCT02721043|Vaccines|vaccines|mesh-list
138761656|NCT02721043|Poly ICLC|poly iclc|mesh-list
138761657|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
138761658|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761659|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138761660|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138761661|NCT02721043|Growth Substances|growth substances|mesh-ancestor
138761662|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
138761663|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761664|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
138761665|NCT02728843|Deferiprone|deferiprone|mesh-list
138761666|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138761667|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
138761668|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
138761669|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761683|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
138761684|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761685|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761686|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
138761687|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761688|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138761689|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138761690|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138761691|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138761692|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761693|NCT02720575|Vitamin D|vitamin d|mesh-list
138761694|NCT02720575|Vitamins|vitamins|mesh-ancestor
138761695|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
138761696|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761697|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138761698|NCT02720341|Armin|armin|mesh-list
138761699|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138761700|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761701|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761702|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
138761703|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761704|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761705|NCT02728453|Empagliflozin|empagliflozin|mesh-list
138761706|NCT02728453|Glimepiride|glimepiride|mesh-list
138761707|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138761708|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761709|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138761710|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761711|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139084824|NCT01127282|Vitamins|vitamins|mesh-list
138761712|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138761713|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
138761714|NCT02728687|Mannitol|mannitol|mesh-list
138761715|NCT02728687|Menthol|menthol|mesh-list
138761716|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138761717|NCT02728687|Diuretics|diuretics|mesh-ancestor
138761718|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
138761719|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761720|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
138761721|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
138761722|NCT02726269|Ofloxacin|ofloxacin|mesh-list
138761723|NCT02726269|Levofloxacin|levofloxacin|mesh-list
138761724|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138761725|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761726|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138761727|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138761728|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138761729|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761730|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761731|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761748|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138761749|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138436109|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
138761750|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761751|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
138761752|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761753|NCT02719405|Caseins|caseins|mesh-list
138761754|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
138761755|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
138761756|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761757|NCT02725255|Albendazole|albendazole|mesh-list
138761758|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
138761759|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138761760|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761761|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
138761762|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138761763|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138761764|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
138761765|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
138761766|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
138761767|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761768|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761769|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
138761770|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138761771|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761772|NCT02719015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138591971|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
138761773|NCT02719015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761774|NCT02725489|Durvalumab|durvalumab|mesh-list
138761775|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138761776|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761777|NCT02718547|Timolol|timolol|mesh-list
138761778|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138761779|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138761780|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
138761781|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138761782|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761783|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138761784|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138761785|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
138761786|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552859|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
138761787|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761799|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761800|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761801|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761803|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138761804|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138761805|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761807|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138761808|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138761809|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761810|NCT02265367|Milnacipran|milnacipran|mesh-list
138761811|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
138761812|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138761813|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138761814|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138761815|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761816|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761817|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761818|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
138761819|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138761820|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138761821|NCT02265367|Analgesics|analgesics|mesh-ancestor
138761822|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
138761823|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761824|NCT02718469|Vaccines|vaccines|mesh-list
138761825|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
138761826|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761827|NCT02716285|Peppermint oil|peppermint oil|mesh-list
138761828|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
138761829|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
138761830|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761831|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761832|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138761833|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
138761834|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
138761835|NCT01224821|Antibodies|antibodies|mesh-list
138761836|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
138761837|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761838|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761839|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
138761840|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
138761841|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
138761842|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138761843|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761844|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
138761845|NCT02684851|Coagulants|coagulants|mesh-ancestor
138761846|NCT01224431|Lidocaine|lidocaine|mesh-list
138761847|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
138761848|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
138761849|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138592040|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
138761850|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761851|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
138761875|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761877|NCT02718079|Expectorants|expectorants|mesh-ancestor
138761878|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
138761879|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138761880|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
138761881|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761882|NCT02718079|Protective Agents|protective agents|mesh-ancestor
138761883|NCT02718079|Antidotes|antidotes|mesh-ancestor
138761884|NCT02717923|Capecitabine|capecitabine|mesh-list
138761885|NCT02717923|Cetuximab|cetuximab|mesh-list
138761886|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138761887|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
138761888|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761889|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761890|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138761891|NCT02724163|Cytarabine|cytarabine|mesh-list
138761892|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
138761893|NCT02724163|Busulfan|busulfan|mesh-list
138761894|NCT02724163|Fludarabine|fludarabine|mesh-list
138761895|NCT02724163|Daunorubicin|daunorubicin|mesh-list
138761896|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
138761897|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
138761898|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138761899|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
138761900|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761901|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138761902|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138761903|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
138761904|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761905|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761916|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
138761917|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761918|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138761919|NCT02724163|Immunotoxins|immunotoxins|mesh-ancestor
138761920|NCT02724163|Immunoconjugates|immunoconjugates|mesh-ancestor
138761922|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
138761923|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138761924|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761925|NCT02715193|Volagidemab|volagidemab|mesh-list
138761926|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138761927|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761928|NCT01223027|Sorafenib|sorafenib|mesh-list
138761929|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761930|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138761931|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138761932|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761933|NCT02714959|Aldesleukin|aldesleukin|mesh-list
138761934|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138761935|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138761936|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138318194|NCT01413360|Vitamins|vitamins|mesh-list
138761937|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
138761938|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761939|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
138761940|NCT02714725|Propofol|propofol|mesh-list
138761941|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138761942|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761943|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761944|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138761945|NCT02714725|Analgesics|analgesics|mesh-ancestor
138761946|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
138761947|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761948|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138761949|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138761950|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138761951|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
138761952|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138761953|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138761954|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138761955|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
138761956|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
138761957|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138761958|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138761959|NCT02714179|Acetaminophen|acetaminophen|mesh-list
138761960|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138761961|NCT02714179|Analgesics|analgesics|mesh-ancestor
138761962|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
138761963|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761964|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761965|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
138761966|NCT01015131|Alovudine|alovudine|mesh-list
138761967|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
138761968|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138761969|NCT02723383|Baclofen|baclofen|mesh-list
138761970|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138761971|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138761972|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138761980|NCT05269537|Fentanyl|fentanyl|mesh-list
138761981|NCT05269537|Bupivacaine|bupivacaine|mesh-list
138761982|NCT05269537|Oxytocin|oxytocin|mesh-list
138761983|NCT05269537|Anesthetics, Local|anesthetics, local|mesh-ancestor
138761984|NCT05269537|Anesthetics|anesthetics|mesh-ancestor
138761985|NCT05269537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138761986|NCT05269537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592116|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
138761987|NCT05269537|Sensory System Agents|sensory system agents|mesh-ancestor
138761988|NCT05269537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138761989|NCT05269537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138761990|NCT05269537|Narcotics|narcotics|mesh-ancestor
138761991|NCT05269537|Analgesics|analgesics|mesh-ancestor
138761992|NCT05269537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138761993|NCT05269537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138761994|NCT05269537|Anesthetics, General|anesthetics, general|mesh-ancestor
138761995|NCT05269537|Oxytocics|oxytocics|mesh-ancestor
138761996|NCT05269537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138761997|NCT05269537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138761998|NCT05269537|Sympathomimetics|sympathomimetics|mesh-ancestor
138761999|NCT05269537|Autonomic Agents|autonomic agents|mesh-ancestor
138762000|NCT05269537|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138762001|NCT05269537|Adrenergic Agents|adrenergic agents|mesh-ancestor
138762002|NCT05269537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762003|NCT05269537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762004|NCT01222715|Sirolimus|sirolimus|mesh-list
138762005|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
138762006|NCT01222715|Bevacizumab|bevacizumab|mesh-list
138762007|NCT01222715|Temsirolimus|temsirolimus|mesh-list
138762008|NCT01222715|Vinorelbine|vinorelbine|mesh-list
138762009|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138762010|NCT01222715|MTOR Inhibitors|mtor inhibitors|mesh-list
138762011|NCT01222715|Antibodies|antibodies|mesh-list
138762012|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
138762013|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138762014|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
138762015|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
138762016|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592148|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
138762017|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
138762018|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762019|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138762020|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138762021|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
138762022|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762023|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762024|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138762025|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138762026|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138762027|NCT01222715|Growth Substances|growth substances|mesh-ancestor
138762028|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
138762029|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138762030|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762031|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139084972|NCT01228994|Baclofen|baclofen|mesh-list
138762032|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
138762033|NCT01222715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138762034|NCT01222715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762035|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138762036|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
138762037|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
138762038|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
138762039|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
138762040|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
138762041|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762042|NCT02722759|Chrysarobin|chrysarobin|mesh-list
138762043|NCT02722759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138762051|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
138762052|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138592208|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
138762053|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
138762054|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138762055|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
138762056|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762057|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762058|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
138762060|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
138762061|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
138762062|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762063|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138762064|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
138762065|NCT02722369|Carboplatin|carboplatin|mesh-list
138762066|NCT02722369|Gemcitabine|gemcitabine|mesh-list
138762067|NCT02722369|Etoposide|etoposide|mesh-list
138762068|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762069|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138762070|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
138762071|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762072|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138762073|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138762074|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138762075|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762076|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
138762077|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138762078|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138762079|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762080|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138762081|NCT01222247|Betamethasone|betamethasone|mesh-list
138762082|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138762083|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
138762084|NCT01222247|Hormones|hormones|mesh-ancestor
138762085|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138762086|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762087|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138592302|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
138762088|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
138762089|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
138762090|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138762091|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138762092|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762093|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
138762094|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138762095|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
138762096|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762097|NCT03982537|Expectorants|expectorants|mesh-ancestor
138762098|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
138762099|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138762100|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
138762101|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762102|NCT03982537|Protective Agents|protective agents|mesh-ancestor
138762103|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762104|NCT03982537|Antidotes|antidotes|mesh-ancestor
138762105|NCT05260593|Vitamins|vitamins|mesh-list
138762106|NCT05260593|Hydroxocobalamin|hydroxocobalamin|mesh-list
138762107|NCT05260593|Vitamin B 12|vitamin b 12|mesh-list
138762108|NCT05260593|Vitamin B Complex|vitamin b complex|mesh-list
138762109|NCT05260593|Micronutrients|micronutrients|mesh-ancestor
138762110|NCT05260593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762111|NCT05260593|Hematinics|hematinics|mesh-ancestor
138762112|NCT02713477|Insulin|insulin|mesh-list
138762113|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138762114|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
138762123|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762124|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762125|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762126|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138762127|NCT01014585|Analgesics|analgesics|mesh-ancestor
138762128|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
138762129|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762130|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
138762131|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138762132|NCT00611143|Atorvastatin|atorvastatin|mesh-list
138762133|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138762134|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138762135|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
138762136|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762137|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138762138|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138762139|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762140|NCT02712619|Metformin|metformin|mesh-list
138762141|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138762142|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762143|NCT01220609|Epothilones|epothilones|mesh-list
138762144|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
138762145|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
138762146|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
138762147|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762148|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762149|NCT02713087|Phenylephrine|phenylephrine|mesh-list
138762150|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
138762151|NCT02713087|Ephedrine|ephedrine|mesh-list
138762152|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138762153|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
138762154|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
138762155|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762156|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762157|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
138762158|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138762159|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
138762160|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
138762161|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138762162|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138762163|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138762164|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
138762165|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762166|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762167|NCT02713087|Protective Agents|protective agents|mesh-ancestor
138592523|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138762168|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138762169|NCT02722603|Gabapentin|gabapentin|mesh-list
138762170|NCT02722603|Tramadol|tramadol|mesh-list
138762171|NCT02722603|Analgesics|analgesics|mesh-ancestor
138762172|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
138762173|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762174|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762175|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
138762176|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138762177|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138762178|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138762179|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138762180|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138762181|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138762195|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
138762197|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
138762198|NCT01220297|Carmustine|carmustine|mesh-list
138762199|NCT01220297|Etoposide|etoposide|mesh-list
138762200|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
138762201|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138762202|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
138762203|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552893|NCT00107835|Lidocaine|lidocaine|mesh-list
138762204|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138762205|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138436553|NCT01757899|Prednisolone|prednisolone|mesh-list
138762206|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
138762207|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762208|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762209|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138762210|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138762211|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138762212|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138762213|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762214|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138762215|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138762216|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
138762217|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138762218|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762219|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
138762220|NCT02712775|Minocycline|minocycline|mesh-list
138762221|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138762222|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762223|NCT04318847|Ondansetron|ondansetron|mesh-list
138762224|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
138762225|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
138762226|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762227|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762228|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138762229|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
138762230|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
138762231|NCT04318847|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138762232|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138762233|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
138762234|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762235|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762237|NCT02721511|Diuretics|diuretics|mesh-ancestor
138762238|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
138762239|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762240|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138762241|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138762242|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762256|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138762257|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138762258|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138762259|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762260|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
138762262|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
138762263|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762264|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138762265|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
138762266|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762267|NCT00612625|Glucagon|glucagon|mesh-list
138762268|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138762269|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138762270|NCT00612625|Hormones|hormones|mesh-ancestor
138762271|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138762272|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762273|NCT00612625|Incretins|incretins|mesh-ancestor
138762274|NCT02711917|Propofol|propofol|mesh-list
138762275|NCT02711917|Etomidate|etomidate|mesh-list
138762276|NCT02711917|Rocuronium|rocuronium|mesh-list
138762277|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138762278|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138762279|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762280|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138762281|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
138762282|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
138762283|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138762284|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138762285|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138762286|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762287|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
138762288|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138762289|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138762290|NCT02711449|Prednisolone|prednisolone|mesh-list
138762291|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
138762292|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138762293|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
138762294|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138762295|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
138762296|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
138762297|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762298|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762299|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138762300|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
138762301|NCT02711449|Hormones|hormones|mesh-ancestor
138762302|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138762303|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138762304|NCT02711449|Protective Agents|protective agents|mesh-ancestor
138762305|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138762337|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762338|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762339|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
138762340|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762341|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
138762342|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138762343|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138762344|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138762345|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138762346|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
138762347|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138762348|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138762349|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
138762350|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138762351|NCT00940342|Rituximab|rituximab|mesh-list
138762352|NCT00940342|Molgramostim|molgramostim|mesh-list
138762369|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
138762370|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762371|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762372|NCT00604942|Domperidone|domperidone|mesh-list
138762373|NCT00604942|Esomeprazole|esomeprazole|mesh-list
138762374|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138762375|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138762376|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138762377|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762378|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762379|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
138762380|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
138762381|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762382|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762383|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138762384|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
138762385|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762386|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
138762387|NCT02711683|Donepezil|donepezil|mesh-list
138762388|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138762389|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552933|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138762390|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762391|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
138762392|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085056|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762393|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762395|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138762396|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138762397|NCT02711683|Protective Agents|protective agents|mesh-ancestor
138762398|NCT05079061|Misoprostol|misoprostol|mesh-list
138762399|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138762400|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
138592977|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762401|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138762402|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762403|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138762404|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138762405|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
138762406|NCT00605020|Insulin|insulin|mesh-list
138762407|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138762408|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
138762409|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
138762410|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138762411|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
138762412|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
138676441|NCT00485979|Docetaxel|docetaxel|mesh-list
138762424|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138762425|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138762426|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762427|NCT00605098|Ritonavir|ritonavir|mesh-list
138762428|NCT00605098|Lopinavir|lopinavir|mesh-list
138762429|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138762430|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138593031|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
138762431|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
138762432|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762433|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762434|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138762435|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138762436|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
138762437|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762438|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138762439|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138762440|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138762441|NCT02711215|Mirtazapine|mirtazapine|mesh-list
138762442|NCT02711215|Citalopram|citalopram|mesh-list
138762443|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138762444|NCT02711215|Escitalopram|escitalopram|mesh-list
138762445|NCT02711215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138762446|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138762447|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138762448|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762449|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762450|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
138762451|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762452|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762453|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138762454|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
138762455|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138762456|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138762458|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
138762459|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
138762460|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138762461|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
138762462|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
138762463|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138762464|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138762465|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593095|NCT02946970|Analgesics|analgesics|mesh-ancestor
138762466|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138762467|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138762468|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138762469|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
138762470|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138762471|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138762472|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138762473|NCT00603772|Tretinoin|tretinoin|mesh-list
138762474|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762475|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
138762495|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762496|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762497|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138762498|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138762499|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
138762500|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762501|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762502|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138762504|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138762505|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
138762506|NCT02706535|Itraconazole|itraconazole|mesh-list
138762507|NCT02706535|Rifampin|rifampin|mesh-list
138762508|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
138762509|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762510|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138762511|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138762513|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762514|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138762515|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
138762516|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138762517|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762518|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138762519|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138762520|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
138762521|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138762522|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
138762523|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138762524|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138762525|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138762526|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138762527|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138762528|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138762529|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138762530|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
138762531|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138762551|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
138762552|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762553|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138762554|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762555|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762556|NCT01025817|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138762557|NCT01025817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138762558|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762559|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138762560|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138762561|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
138762562|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138762563|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762564|NCT00636883|Gemcitabine|gemcitabine|mesh-list
138762565|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
138762566|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138762567|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
138762568|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762569|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762571|NCT00605410|Ipratropium|ipratropium|mesh-list
138762572|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
138762573|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138762574|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
138762575|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762576|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762577|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138762578|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
138762579|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138762580|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
138762581|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138436935|NCT01760018|Desflurane|desflurane|mesh-list
138593215|NCT00516607|Temozolomide|temozolomide|mesh-list
138762582|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762584|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138762585|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
138762586|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138676474|NCT04511715|Bevacizumab|bevacizumab|mesh-list
138762617|NCT05264077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138762618|NCT05264077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138762619|NCT05264077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138762620|NCT05264077|Anesthetics, General|anesthetics, general|mesh-ancestor
138762621|NCT05264077|Anesthetics|anesthetics|mesh-ancestor
138762622|NCT05264077|GABA Modulators|gaba modulators|mesh-ancestor
138762623|NCT05264077|GABA Agents|gaba agents|mesh-ancestor
138762624|NCT00612859|Levetiracetam|levetiracetam|mesh-list
138762625|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
138762626|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
138762627|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
138762628|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
138762629|NCT01010217|Melphalan|melphalan|mesh-list
138762630|NCT01010217|Thiotepa|thiotepa|mesh-list
138762631|NCT01010217|Rituximab|rituximab|mesh-list
138762632|NCT01010217|Fludarabine|fludarabine|mesh-list
138762633|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
138762634|NCT01010217|Tacrolimus|tacrolimus|mesh-list
138762635|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138762650|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138762651|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138762652|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
138762653|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138762654|NCT00604006|Spironolactone|spironolactone|mesh-list
138762655|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138762656|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
138762657|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138762658|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762659|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138762661|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
138762663|NCT00604084|Permethrin|permethrin|mesh-list
138762664|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138762665|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762666|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552957|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
138762667|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762668|NCT05379478|Antibodies|antibodies|mesh-list
138762669|NCT05379478|Immunologic Factors|immunologic factors|mesh-ancestor
138762670|NCT05379478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762671|NCT04267042|Budesonide|budesonide|mesh-list
138762672|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138762673|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138762674|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
138762675|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762676|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762677|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138762678|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
138762679|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
138762680|NCT04267042|Hormones|hormones|mesh-ancestor
138762681|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138762682|NCT01217957|Dexamethasone|dexamethasone|mesh-list
138762683|NCT01217957|Lenalidomide|lenalidomide|mesh-list
138762684|NCT01217957|Ixazomib|ixazomib|mesh-list
138762685|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138762686|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
138762687|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
138762688|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762689|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762690|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138762691|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
138762692|NCT01217957|Hormones|hormones|mesh-ancestor
138762693|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138762694|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138762714|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
138762715|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762716|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762717|NCT00935818|Bupropion|bupropion|mesh-list
138762718|NCT00935818|Varenicline|varenicline|mesh-list
138762719|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138762720|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
138762721|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138762722|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138762723|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138762724|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138762725|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762726|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
138762727|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762728|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762729|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138762730|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138762731|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762732|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138762733|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138762734|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
138762735|NCT02709265|Amikacin|amikacin|mesh-list
138762737|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138762738|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762739|NCT00611845|Aprotinin|aprotinin|mesh-list
138762740|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
138762741|NCT00611845|Coagulants|coagulants|mesh-ancestor
138762742|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138762743|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138762744|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
138762745|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762746|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762747|NCT01216163|Acetaminophen|acetaminophen|mesh-list
138762748|NCT01216163|Ibuprofen|ibuprofen|mesh-list
138762749|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138762750|NCT01216163|Analgesics|analgesics|mesh-ancestor
138762751|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
138770267|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
138762752|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762753|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762754|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
138762755|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138762756|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138762757|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138762758|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138762759|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593410|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
138762760|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762761|NCT05260255|Vitamin D|vitamin d|mesh-list
138762762|NCT05260255|Ergocalciferols|ergocalciferols|mesh-list
138762763|NCT05260255|Vitamins|vitamins|mesh-ancestor
138762764|NCT05260255|Micronutrients|micronutrients|mesh-ancestor
138762765|NCT05260255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762766|NCT05260255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138762767|NCT05260255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138762768|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
138762769|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138762770|NCT00612469|Listerine|listerine|mesh-list
138762771|NCT00612469|Vancomycin|vancomycin|mesh-list
138762772|NCT00612469|Fluorides|fluorides|mesh-list
138762773|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
138762774|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
138762775|NCT00612469|Protective Agents|protective agents|mesh-ancestor
138762776|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762777|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138762778|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762779|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
138762780|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
138762781|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138762782|NCT00933244|Vitamin D|vitamin d|mesh-list
138762783|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
138762784|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
138762785|NCT00933244|Vitamins|vitamins|mesh-list
138762786|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
138762787|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762788|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138593465|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138762789|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138762790|NCT02709187|Candesartan|candesartan|mesh-list
138762791|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
138762792|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138762793|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138762794|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138762795|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
138762796|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762797|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138762798|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138762799|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762800|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138762801|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138762802|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138762803|NCT00930046|Ropivacaine|ropivacaine|mesh-list
138762804|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
138762805|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
138762806|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138762807|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762808|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
138552968|NCT00273559|Prednisone|prednisone|mesh-list
138762809|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762810|NCT05244031|Analgesics, Opioid|analgesics, opioid|mesh-list
138762811|NCT05244031|Narcotics|narcotics|mesh-ancestor
138762812|NCT05244031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138762813|NCT05244031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762814|NCT05244031|Analgesics|analgesics|mesh-ancestor
138676556|NCT00486564|Nifurtimox|nifurtimox|mesh-list
138762815|NCT05244031|Sensory System Agents|sensory system agents|mesh-ancestor
138762816|NCT05244031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762818|NCT04712071|Analgesics|analgesics|mesh-ancestor
138762819|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
138762820|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762821|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762822|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138762823|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138762824|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
138762825|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
138762826|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138762827|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138762828|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138762829|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762830|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762831|NCT00609388|Tacrolimus|tacrolimus|mesh-list
138762832|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138762833|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
138762834|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762835|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138762836|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762837|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762838|NCT02709031|Cicletanine|cicletanine|mesh-list
138762839|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139085271|NCT01134848|Morphine|morphine|mesh-list
138762840|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138762841|NCT02709031|Diuretics|diuretics|mesh-ancestor
138762842|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
138762843|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762845|NCT05225545|Trace Elements|trace elements|mesh-ancestor
138762846|NCT05225545|Micronutrients|micronutrients|mesh-ancestor
138762847|NCT05225545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762848|NCT00612547|Artesunate|artesunate|mesh-list
138762849|NCT00612547|Amodiaquine|amodiaquine|mesh-list
138762850|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
138762851|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138762852|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138762853|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762854|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762855|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
138762856|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
138762857|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138762858|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
138762859|NCT00606268|Micafungin|micafungin|mesh-list
138762860|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
138762861|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762862|NCT05342857|Aflibercept|aflibercept|mesh-list
138762863|NCT05342857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138762864|NCT05342857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138762865|NCT05342857|Growth Substances|growth substances|mesh-ancestor
138762866|NCT05342857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762867|NCT05342857|Growth Inhibitors|growth inhibitors|mesh-ancestor
138762868|NCT05342857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762869|NCT04264624|Erythritol|erythritol|mesh-list
138762870|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
138762871|NCT04188691|Vaccines|vaccines|mesh-list
138762872|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
138762873|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762874|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
138762875|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
138762876|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138762877|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762878|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138762879|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138762880|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762881|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762882|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762883|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
138762884|NCT00613093|Temozolomide|temozolomide|mesh-list
138437252|NCT01761201|Ofloxacin|ofloxacin|mesh-list
138762885|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138762886|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138762887|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
138762888|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762889|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762890|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762891|NCT00607750|Mecamylamine|mecamylamine|mesh-list
138762892|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138762893|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138762894|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
138762895|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762896|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762897|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138762898|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138762899|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
138762900|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138762901|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762902|NCT00609544|Rilonacept|rilonacept|mesh-list
138762903|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138762904|NCT04908475|Apremilast|apremilast|mesh-list
138762905|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138762906|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138762907|NCT04908475|Analgesics|analgesics|mesh-ancestor
138762908|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
138762909|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138762910|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762911|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138762912|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138762913|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138762914|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138762915|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762916|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762917|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
138762918|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138762919|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762920|NCT04611139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138762921|NCT04611139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762922|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138762923|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138762924|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
138762925|NCT05198791|Eplerenone|eplerenone|mesh-list
138762926|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138762927|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
138762928|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138762929|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762930|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138762931|NCT05198791|Diuretics|diuretics|mesh-ancestor
138762932|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
138762933|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138762934|NCT01010061|Rituximab|rituximab|mesh-list
138762935|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
138762936|NCT01010061|Chlorambucil|chlorambucil|mesh-list
138762937|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138762938|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762939|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
138762940|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762941|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138762942|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138762943|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
138762944|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762946|NCT00607984|Thiotepa|thiotepa|mesh-list
138762947|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138762948|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
138762949|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762950|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762951|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138762952|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138762953|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
138762954|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762955|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138762956|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138762957|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138437310|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
138762958|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138762959|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
138762960|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762961|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138762962|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138762963|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
138762964|NCT00609856|Pioglitazone|pioglitazone|mesh-list
138762965|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138762966|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762967|NCT04527757|Anesthetics|anesthetics|mesh-list
138762968|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138762969|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138762970|NCT00613249|Dapivirine|dapivirine|mesh-list
138762971|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138762972|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138762973|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
138762974|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138762975|NCT00613561|Fludarabine|fludarabine|mesh-list
138762976|NCT00613561|Busulfan|busulfan|mesh-list
138762977|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138762978|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762979|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762980|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138762981|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
138762982|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593822|NCT02944201|Carvedilol|carvedilol|mesh-list
138762983|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
138762984|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138762985|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138762986|NCT01009983|Paclitaxel|paclitaxel|mesh-list
138762987|NCT01009983|Carboplatin|carboplatin|mesh-list
138762988|NCT01009983|Panitumumab|panitumumab|mesh-list
138762989|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138762990|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138762991|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
138762992|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
138762993|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
139085240|NCT01134536|Narcotics|narcotics|mesh-ancestor
138762994|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138762995|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138762996|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
138762997|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138762999|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138763000|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138763001|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
138763002|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763003|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138763004|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
138763005|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
138763006|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
138763007|NCT04297215|Coagulants|coagulants|mesh-ancestor
138763008|NCT02873091|Sufentanil|sufentanil|mesh-list
138763009|NCT02873091|Ropivacaine|ropivacaine|mesh-list
138763010|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
138763011|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
138763012|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138763013|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763014|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
138763015|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763016|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138763017|NCT02873091|Narcotics|narcotics|mesh-ancestor
138763018|NCT02873091|Analgesics|analgesics|mesh-ancestor
138763019|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138763020|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138763021|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
138763022|NCT04298775|Morphine|morphine|mesh-list
138763023|NCT04298775|Anesthetics|anesthetics|mesh-list
138763024|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138763025|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763026|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138763027|NCT04298775|Narcotics|narcotics|mesh-ancestor
138763028|NCT04298775|Analgesics|analgesics|mesh-ancestor
138763029|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
138763030|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763031|NCT01215227|Rasagiline|rasagiline|mesh-list
138763032|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138763033|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763034|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763035|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138763036|NCT01215227|Protective Agents|protective agents|mesh-ancestor
138763037|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763038|NCT01009515|Paclitaxel|paclitaxel|mesh-list
138763039|NCT01009515|Carboplatin|carboplatin|mesh-list
138763040|NCT01009515|Temozolomide|temozolomide|mesh-list
138593903|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
138763041|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138763042|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763043|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
138763044|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
138763045|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
138763046|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763047|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138763048|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
138763049|NCT04550481|Lisinopril|lisinopril|mesh-list
138763050|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138763051|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
138763052|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763053|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763054|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138763055|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138763056|NCT04550481|Protective Agents|protective agents|mesh-ancestor
138763057|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763058|NCT01214915|Anagrelide|anagrelide|mesh-list
138763059|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138763060|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138763061|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763062|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138763063|NCT01009203|Sirolimus|sirolimus|mesh-list
138763064|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138763065|NCT01009203|Temsirolimus|temsirolimus|mesh-list
138763066|NCT01009203|MTOR Inhibitors|mtor inhibitors|mesh-list
138763067|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763068|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138763069|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763070|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763071|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138763072|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
138763073|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763074|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138593942|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
138763075|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763076|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138763077|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
138763078|NCT01009047|Aripiprazole|aripiprazole|mesh-list
138763079|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138763080|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
138763081|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138763082|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138763083|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138763084|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138763085|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763086|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
138763087|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
138763088|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763089|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763090|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138763091|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139085369|NCT01135550|Hormones|hormones|mesh-ancestor
138763093|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138763094|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138763095|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138763096|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138763097|NCT04205097|Neostigmine|neostigmine|mesh-list
138763098|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138763099|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763100|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763101|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
138763102|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763103|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763104|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138763105|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
138763106|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763108|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138763109|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
138763110|NCT01025193|Belimumab|belimumab|mesh-list
138763111|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138763112|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
138763113|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763114|NCT01008423|Budesonide|budesonide|mesh-list
138763115|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138763116|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138763117|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
138763118|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763119|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763120|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138763121|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
138763122|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
138763123|NCT01008423|Hormones|hormones|mesh-ancestor
138763124|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763125|NCT04735861|Bevacizumab|bevacizumab|mesh-list
138763126|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138763127|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763128|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138763129|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138763130|NCT04735861|Growth Substances|growth substances|mesh-ancestor
138763131|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763132|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
138763133|NCT03685747|Vancomycin|vancomycin|mesh-list
138763134|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138763135|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763136|NCT03586687|Triamcinolone|triamcinolone|mesh-list
138763137|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138763138|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
138763139|NCT03586687|Hormones|hormones|mesh-ancestor
138763140|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763141|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763142|NCT01212185|Oxytocin|oxytocin|mesh-list
138763143|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
138763144|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138763145|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763146|NCT00613717|Vitamin D|vitamin d|mesh-list
138763147|NCT00613717|Vitamins|vitamins|mesh-list
138763148|NCT00613717|Folic Acid|folic acid|mesh-list
138763149|NCT00613717|Vitamin A|vitamin a|mesh-list
138763150|NCT00613717|Iron|iron|mesh-list
138763151|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
138763152|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
138763153|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
138763154|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763155|NCT00613717|Trace Elements|trace elements|mesh-ancestor
138763156|NCT00613717|Hematinics|hematinics|mesh-ancestor
138763157|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
138763158|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763159|NCT00613717|Protective Agents|protective agents|mesh-ancestor
138763160|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138763161|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763162|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138763163|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
138763164|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138763165|NCT03369301|Antibodies|antibodies|mesh-list
138763166|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
138763167|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763168|NCT05345119|Sirolimus|sirolimus|mesh-list
138763169|NCT05345119|Methylprednisolone|methylprednisolone|mesh-list
138763170|NCT05345119|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138763171|NCT05345119|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138763172|NCT05345119|Prednisolone|prednisolone|mesh-list
138763173|NCT05345119|Prednisolone acetate|prednisolone acetate|mesh-list
138763174|NCT05345119|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138763175|NCT05345119|Prednisolone phosphate|prednisolone phosphate|mesh-list
138763176|NCT05345119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138763177|NCT05345119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763178|NCT05345119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138763179|NCT05345119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763180|NCT05345119|Antifungal Agents|antifungal agents|mesh-ancestor
138763181|NCT05345119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138763182|NCT05345119|Immunologic Factors|immunologic factors|mesh-ancestor
138763183|NCT05345119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763184|NCT05345119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138763185|NCT05345119|Antiemetics|antiemetics|mesh-ancestor
138763186|NCT05345119|Autonomic Agents|autonomic agents|mesh-ancestor
138763187|NCT05345119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437539|NCT01762670|Metronidazole|metronidazole|mesh-list
138763188|NCT05345119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138763189|NCT05345119|Glucocorticoids|glucocorticoids|mesh-ancestor
138763190|NCT05345119|Hormones|hormones|mesh-ancestor
138763191|NCT05345119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763192|NCT05345119|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138763193|NCT05345119|Protective Agents|protective agents|mesh-ancestor
138763194|NCT05345119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138763195|NCT03529123|Insulin|insulin|mesh-list
138763196|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138763197|NCT03529123|Metformin|metformin|mesh-list
138763198|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
138763199|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
138763200|NCT03529123|Lixisenatide|lixisenatide|mesh-list
138763201|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138763202|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763203|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
138763204|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138763205|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138763206|NCT04074187|Prednisolone|prednisolone|mesh-list
138763207|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
138763208|NCT04074187|Rituximab|rituximab|mesh-list
138763209|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138763210|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
138763211|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138763212|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138763213|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763214|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
138763215|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763216|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138763217|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138763218|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
138763219|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
138763220|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763221|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138763222|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
138763224|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763225|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138763226|NCT04074187|Protective Agents|protective agents|mesh-ancestor
138763227|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138763228|NCT03128905|Prednisone|prednisone|mesh-list
138763229|NCT03128905|Colchicine|colchicine|mesh-list
138763230|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138763231|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
138763232|NCT03128905|Hormones|hormones|mesh-ancestor
138763233|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763234|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763235|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138763236|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763237|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
138763238|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138763239|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
138763240|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
138763241|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
138763242|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763243|NCT02430181|Interferons|interferons|mesh-list
138763244|NCT02430181|Ritonavir|ritonavir|mesh-list
138763245|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
138763246|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138763247|NCT02430181|Lonafarnib|lonafarnib|mesh-list
138763248|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763249|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
138763250|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763251|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138763252|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138763253|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
138763254|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763255|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763256|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138763257|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138763258|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138763259|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138763260|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
138763261|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437673|NCT01763463|Xhance|xhance|mesh-list
138763262|NCT00614653|Bevacizumab|bevacizumab|mesh-list
138763263|NCT00614653|Capecitabine|capecitabine|mesh-list
138763264|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138763265|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138763266|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594211|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
138763267|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138763268|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138763269|NCT00614653|Growth Substances|growth substances|mesh-ancestor
138763270|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763271|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
138763272|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138763273|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
138763274|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763275|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138763276|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763277|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138763278|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138763279|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763280|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138763281|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763282|NCT03463135|Immunomodulating Agents|immunomodulating agents|mesh-list
138763283|NCT03463135|Immunologic Factors|immunologic factors|mesh-ancestor
138763284|NCT03463135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763285|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
138763286|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138763287|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
138763288|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763289|NCT03596125|Expectorants|expectorants|mesh-ancestor
138763290|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
138763291|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138763292|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
138594246|NCT00174759|Clopidogrel|clopidogrel|mesh-list
138763293|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763294|NCT03596125|Protective Agents|protective agents|mesh-ancestor
138763295|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763296|NCT03596125|Antidotes|antidotes|mesh-ancestor
138763297|NCT02118727|Memantine|memantine|mesh-list
138763298|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138763299|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138763300|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
138763301|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763302|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763303|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763304|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138763305|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138763306|NCT05343637|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138763307|NCT05343637|Vasodilator Agents|vasodilator agents|mesh-ancestor
138676663|NCT01242098|Fluticasone|fluticasone|mesh-list
138763308|NCT05343637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138763309|NCT05343637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138763310|NCT05343637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763311|NCT05343637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763312|NCT05343637|Urological Agents|urological agents|mesh-ancestor
138763313|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138763314|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138763315|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763316|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138763317|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763318|NCT00614809|Gefitinib|gefitinib|mesh-list
138763319|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763320|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138763321|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763322|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763323|NCT02964013|Carboplatin|carboplatin|mesh-list
138763324|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
138763325|NCT02964013|Etoposide|etoposide|mesh-list
138763326|NCT02964013|Pemetrexed|pemetrexed|mesh-list
138763327|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763328|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138763329|NCT02964013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138763330|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763331|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138763332|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138763333|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138763334|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763335|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138763336|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138763338|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763339|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138763340|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763341|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763342|NCT00615823|Atorvastatin|atorvastatin|mesh-list
138763343|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138763344|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138763345|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
138763346|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763347|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138763348|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138763349|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763350|NCT02699281|Palmidrol|palmidrol|mesh-list
138763351|NCT02699281|Analgesics|analgesics|mesh-ancestor
138763352|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
138594324|NCT02940379|Midazolam|midazolam|mesh-list
138763353|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138676683|NCT01242098|Hormones|hormones|mesh-ancestor
138763354|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763355|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138763356|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138763357|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138763358|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138763359|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
138763360|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763361|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138763362|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138763363|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763364|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763366|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763367|NCT02704507|Triamcinolone|triamcinolone|mesh-list
138763368|NCT02704507|Tretinoin|tretinoin|mesh-list
138763369|NCT02704507|Emollients|emollients|mesh-list
138763370|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138763371|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
138763372|NCT02704507|Hormones|hormones|mesh-ancestor
138763373|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763374|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763375|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763376|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
138763377|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
138763378|NCT01210001|Empagliflozin|empagliflozin|mesh-list
138763379|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138763380|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763381|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138763382|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763383|NCT00624455|Gabapentin|gabapentin|mesh-list
138763384|NCT00624455|Analgesics|analgesics|mesh-ancestor
138763385|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
138676696|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763386|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763387|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763388|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
138763389|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138763390|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138763391|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138763392|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138763393|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138763394|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138763395|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763396|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763397|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
138763398|NCT01127659|Testosterone|testosterone|mesh-list
138763399|NCT01127659|Androgens|androgens|mesh-ancestor
138763400|NCT01127659|Hormones|hormones|mesh-ancestor
138763401|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763402|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763403|NCT02698969|Atropine|atropine|mesh-list
138763404|NCT02698969|Fentanyl|fentanyl|mesh-list
138763405|NCT02698969|Propofol|propofol|mesh-list
138763406|NCT02698969|Sevoflurane|sevoflurane|mesh-list
138763407|NCT02698969|Rocuronium|rocuronium|mesh-list
138763408|NCT02698969|Neostigmine|neostigmine|mesh-list
138763409|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138763410|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138594411|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
138763411|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763413|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
138763414|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
138763415|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138763416|NCT02698969|Narcotics|narcotics|mesh-ancestor
138763417|NCT02698969|Analgesics|analgesics|mesh-ancestor
138763418|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
138763419|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763420|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138763421|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138763422|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138763423|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138763424|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138763425|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138763426|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138763427|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138763428|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
138763429|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138763430|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
138763431|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
138763432|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
138763433|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138763434|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138763435|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
138763436|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763437|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763438|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138763439|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594464|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
138763440|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138763441|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
138763442|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138763443|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
138763444|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763445|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763446|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138763447|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
138763448|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138763449|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
138763450|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763451|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763452|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138763453|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
138763454|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
138763455|NCT00848731|Protective Agents|protective agents|mesh-ancestor
138763456|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
138763457|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138763458|NCT01209143|Norethindrone|norethindrone|mesh-list
138763459|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
138763460|NCT01209143|Estradiol|estradiol|mesh-list
138763461|NCT01209143|Estrogens|estrogens|mesh-ancestor
138763462|NCT01209143|Hormones|hormones|mesh-ancestor
138763463|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763464|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763465|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138763466|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
138763467|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138763468|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138763469|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138763470|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138763471|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138763472|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138763473|NCT00454285|Amoxicillin|amoxicillin|mesh-list
138763474|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138763475|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763476|NCT00614965|Irinotecan|irinotecan|mesh-list
138763477|NCT00614965|Pemetrexed|pemetrexed|mesh-list
138763478|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763479|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138763480|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138763481|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763482|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763483|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138437834|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138763484|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139085505|NCT00369629|Gemcitabine|gemcitabine|mesh-list
138763486|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138763488|NCT00405613|Analgesics|analgesics|mesh-ancestor
138763489|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
138763490|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763491|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763492|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138763493|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138763494|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138763495|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138763496|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763497|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138763498|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138763499|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763500|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
138763501|NCT02703961|Cisplatin|cisplatin|mesh-list
138763502|NCT02703961|Docetaxel|docetaxel|mesh-list
138763503|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763504|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
138763505|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
138763506|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
138763507|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763509|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763511|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138763512|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763513|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763514|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138763515|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
138763516|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594550|NCT00175227|Furosemide|furosemide|mesh-list
138763517|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763518|NCT02703571|Trametinib|trametinib|mesh-list
138763519|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763520|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138763521|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763522|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763523|NCT02703415|Tramadol|tramadol|mesh-list
138763524|NCT02703415|Bupivacaine|bupivacaine|mesh-list
138763525|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
138763526|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
138763527|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138763528|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763529|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
138763530|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763531|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138763533|NCT02703415|Analgesics|analgesics|mesh-ancestor
138763534|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
138763535|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139085528|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
138763536|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763538|NCT04215835|Misoprostol|misoprostol|mesh-list
138763539|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763540|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138763541|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138763542|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763543|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763544|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138763545|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
138763546|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763547|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763548|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138763549|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
138763550|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138763551|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138763552|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138763553|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
138763554|NCT01208207|Naproxen|naproxen|mesh-list
138763555|NCT01208207|Etoricoxib|etoricoxib|mesh-list
138676971|NCT00506298|Analgesics|analgesics|mesh-ancestor
138763556|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138763557|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138763558|NCT01208207|Analgesics|analgesics|mesh-ancestor
138763559|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
138763560|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763561|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763562|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138763563|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138763564|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
138763565|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138763566|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763567|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763568|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138763569|NCT05420285|Dapagliflozin|dapagliflozin|mesh-list
138763570|NCT05420285|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138594630|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
138763571|NCT05420285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763572|NCT05420285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138763573|NCT05420285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763574|NCT01012713|Calcitriol|calcitriol|mesh-list
138763575|NCT01012713|Clobetasol|clobetasol|mesh-list
138763576|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138763577|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
138763578|NCT01012713|Hormones|hormones|mesh-ancestor
138763579|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763580|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677025|NCT00492128|Diuretics|diuretics|mesh-ancestor
138763581|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138763582|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138763583|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138763584|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763585|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138763586|NCT01012713|Vitamins|vitamins|mesh-ancestor
138763587|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
138763588|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138763589|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
138763590|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138763591|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
138763592|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763593|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
138763594|NCT02698813|Protective Agents|protective agents|mesh-ancestor
138763595|NCT02702323|Apatinib|apatinib|mesh-list
138763596|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763597|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138763598|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763599|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763600|NCT01007253|Fluticasone|fluticasone|mesh-list
138763601|NCT01007253|Xhance|xhance|mesh-list
138763602|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138763603|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138763604|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138763605|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138763606|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138763607|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
138763608|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763609|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763610|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138763611|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
138763612|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
138763613|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138763614|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138763615|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138763616|NCT01007253|Analgesics|analgesics|mesh-ancestor
138763617|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
138763618|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138763619|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138763620|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138763621|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
138763622|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
138763623|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763624|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763625|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
138763626|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138763627|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763628|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138763629|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
138763630|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138763631|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763632|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763633|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763635|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
138763636|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
138763637|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763638|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763639|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138763640|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
138763641|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
138763642|NCT01006707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138763643|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138763644|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
138763645|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763646|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763647|NCT01006629|Palivizumab|palivizumab|mesh-list
138763648|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
138763649|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553025|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763651|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138763652|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763653|NCT02701933|Ketamine|ketamine|mesh-list
138763654|NCT02701933|Analgesics|analgesics|mesh-ancestor
138763655|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
138763656|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763657|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763658|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138763659|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138763660|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
138763661|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
138763662|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138763663|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138763664|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138763665|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085612|NCT01134224|Insulin|insulin|mesh-list
138763666|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763667|NCT04295967|Formaldehyde|formaldehyde|mesh-list
138763668|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
138763669|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763670|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
138763671|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
138763672|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763673|NCT02871765|Warfarin|warfarin|mesh-list
138763674|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
138763675|NCT02549209|Paclitaxel|paclitaxel|mesh-list
138763676|NCT02549209|Carboplatin|carboplatin|mesh-list
138763677|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
138763678|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138763679|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763680|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
138763681|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
138763682|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
138763683|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763684|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138763685|NCT02549209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138763686|NCT02698267|Itraconazole|itraconazole|mesh-list
138763687|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
138763688|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763689|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138763690|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138763691|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763692|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763693|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138763694|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
138763695|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763696|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763697|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138763698|NCT01011465|Oxytocin|oxytocin|mesh-list
138763699|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
138763700|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138763701|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763702|NCT02494141|Curcumin|curcumin|mesh-list
138763703|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138763704|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138763705|NCT02494141|Analgesics|analgesics|mesh-ancestor
138763706|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
138763707|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763708|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763709|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138763710|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138763711|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763712|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763713|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763714|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138763715|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138763716|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138763717|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763718|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
138763719|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138763720|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
138763721|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
138763722|NCT04214821|Levofloxacin|levofloxacin|mesh-list
138763723|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138763724|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138763725|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138763726|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763727|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138763728|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138763729|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763730|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763731|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763732|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138763733|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138763734|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138763735|NCT00616213|Lenograstim|lenograstim|mesh-list
138763736|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138763737|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
138763738|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763739|NCT00615667|Tacrolimus|tacrolimus|mesh-list
138763740|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138763741|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
138763742|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763743|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138763744|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763745|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763746|NCT02697955|Epinephrine|epinephrine|mesh-list
138763747|NCT02697955|Bupivacaine|bupivacaine|mesh-list
138763748|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
138763749|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
138763750|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138763751|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763752|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
138763753|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763754|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138763755|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138763756|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
138763757|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594838|NCT00147875|Doxorubicin|doxorubicin|mesh-list
138763758|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763759|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138763760|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138763761|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
138763762|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138763763|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
138763764|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
138763765|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
138763766|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138763767|NCT04294329|Bupivacaine|bupivacaine|mesh-list
138763768|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
138763769|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
138763770|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138763771|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763772|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
138763773|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763775|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
138763776|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
138763777|NCT02701309|Trace Elements|trace elements|mesh-ancestor
138763778|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
138763779|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763780|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138763781|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
138763782|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763783|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763784|NCT03250507|Bupivacaine|bupivacaine|mesh-list
138763785|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
138763786|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
138763787|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138763788|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763789|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
138553041|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
138763790|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677407|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763791|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138763792|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138763794|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
138763795|NCT00997893|Estradiol|estradiol|mesh-list
138763796|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138763797|NCT00997893|Estrogens|estrogens|mesh-list
138763798|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
138763799|NCT00997893|Hormones|hormones|mesh-ancestor
138763800|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763801|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763802|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138763803|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
138763804|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138763805|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138763806|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138763807|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138594862|NCT00147914|Amoxicillin|amoxicillin|mesh-list
138763808|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138763809|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138763810|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138763811|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763812|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138763813|NCT02697877|Regadenoson|regadenoson|mesh-list
138763814|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138763815|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138763816|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
138763817|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
138763818|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763819|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763820|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763821|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
138763822|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
138763823|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763824|NCT04214665|Protective Agents|protective agents|mesh-ancestor
138763825|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763826|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
138763827|NCT04214665|Vitamins|vitamins|mesh-ancestor
138763828|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
138763829|NCT02870673|Triamcinolone|triamcinolone|mesh-list
138763830|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138763831|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138763832|NCT02870673|Lidocaine|lidocaine|mesh-list
138763833|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138763834|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138763835|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
138763836|NCT02870673|Hormones|hormones|mesh-ancestor
138763837|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138763838|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763839|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138763840|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
138763841|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763842|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763843|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
138763844|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
138763845|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138763846|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
138763847|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763848|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138763849|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138763850|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138763851|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138763852|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138763853|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138763854|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138763855|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553043|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138763856|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763857|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
138763858|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138763859|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138763860|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138763861|NCT05324839|Botulinum Toxins|botulinum toxins|mesh-list
138763862|NCT05324839|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138763863|NCT05324839|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138763864|NCT05324839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138763865|NCT05324839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138664319|NCT05104723|Tofacitinib|tofacitinib|mesh-list
138763866|NCT05324839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763867|NCT05324839|Cholinergic Agents|cholinergic agents|mesh-ancestor
138763868|NCT05324839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763869|NCT05324839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763870|NCT05324839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138763871|NCT05324839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763872|NCT02700685|Methylphenidate|methylphenidate|mesh-list
138763873|NCT02700685|Pycnogenols|pycnogenols|mesh-list
138763874|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138763875|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763876|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138763877|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138763878|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138763879|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763880|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
138763881|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763882|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138763883|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
138763884|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
138763885|NCT02700685|Protective Agents|protective agents|mesh-ancestor
138763886|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138763887|NCT02700763|Dabrafenib|dabrafenib|mesh-list
138763888|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763889|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139085704|NCT00318461|Metformin|metformin|mesh-list
138763890|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763891|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763892|NCT03151681|Propranolol|propranolol|mesh-list
138763893|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138763894|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138763895|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
138763896|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138763897|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763898|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763899|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138763900|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138763901|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
138763902|NCT04215445|Empagliflozin|empagliflozin|mesh-list
138763903|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138763904|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763905|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138763906|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763907|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138763908|NCT00951457|Alemtuzumab|alemtuzumab|mesh-list
138763909|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138763910|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
138763911|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763912|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763913|NCT00951457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138763914|NCT02691871|Docetaxel|docetaxel|mesh-list
138763915|NCT02691871|Apatinib|apatinib|mesh-list
138763916|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763917|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
138763918|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
138763919|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
138677642|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
138763920|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763921|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138763922|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763923|NCT02700217|Remifentanil|remifentanil|mesh-list
138763924|NCT02700217|Heroin|heroin|mesh-list
138763926|NCT02700217|Propofol|propofol|mesh-list
138763927|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
138763928|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
138763929|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138763930|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763931|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
138763932|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763933|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138763934|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138763935|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
138763936|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138763938|NCT02700217|Analgesics|analgesics|mesh-ancestor
138763939|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
138763940|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
138763941|NCT02699827|Analgesics|analgesics|mesh-ancestor
138763942|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
138763943|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138763944|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763945|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
138763946|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138763947|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138763948|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
138763949|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138763950|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138763951|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763952|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138763953|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
138763954|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138763955|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
138763956|NCT02705989|Branebrutinib|branebrutinib|mesh-list
138763957|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138763958|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763959|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763960|NCT02706067|Orlistat|orlistat|mesh-list
138763961|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763962|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763963|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138763964|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138763965|NCT05323201|Cyclophosphamide|cyclophosphamide|mesh-list
138763966|NCT05323201|Fludarabine|fludarabine|mesh-list
138763967|NCT05323201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138763968|NCT05323201|Immunologic Factors|immunologic factors|mesh-ancestor
138763969|NCT05323201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763970|NCT05323201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138763971|NCT05323201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138763972|NCT05323201|Alkylating Agents|alkylating agents|mesh-ancestor
138677755|NCT05146674|Tadalafil|tadalafil|mesh-list
138763973|NCT05323201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763974|NCT05323201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763975|NCT05323201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138763977|NCT01208051|Cediranib|cediranib|mesh-list
138763978|NCT01208051|Maleic acid|maleic acid|mesh-list
138763979|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
138763980|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138763981|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138763982|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138763983|NCT01208051|Growth Substances|growth substances|mesh-ancestor
138763984|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
138763985|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138763986|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138763987|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085744|NCT05032508|Lidocaine|lidocaine|mesh-list
138763988|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138763989|NCT05322889|Telmisartan|telmisartan|mesh-list
138763990|NCT05322889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138677791|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
138763991|NCT05322889|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138763992|NCT05322889|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138763993|NCT05322889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138763995|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138763996|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
138763997|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138763998|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138763999|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138764000|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138764001|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764002|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
138764003|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764004|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764005|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138764006|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138764007|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764009|NCT05410223|Clarithromycin|clarithromycin|mesh-list
138764010|NCT05410223|Doxycycline|doxycycline|mesh-list
138764011|NCT05410223|Furazolidone|furazolidone|mesh-list
138764012|NCT05410223|Bismuth|bismuth|mesh-list
138764013|NCT05410223|Antibodies|antibodies|mesh-list
138764014|NCT05410223|Immunoglobulins|immunoglobulins|mesh-list
138764015|NCT05410223|Immunologic Factors|immunologic factors|mesh-ancestor
138764016|NCT05410223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764017|NCT05410223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138764018|NCT05410223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138764019|NCT05410223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138764020|NCT05410223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764021|NCT05410223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764022|NCT05410223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138764023|NCT05410223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138764024|NCT05410223|Antimalarials|antimalarials|mesh-ancestor
138764025|NCT05410223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138764026|NCT05410223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138764027|NCT05410223|Antacids|antacids|mesh-ancestor
138764028|NCT05410223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138764029|NCT05410223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138764030|NCT05410223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138764031|NCT05410223|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138764032|NCT05410223|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138764033|NCT01206101|Liraglutide|liraglutide|mesh-list
138764034|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138764035|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764036|NCT01206101|Incretins|incretins|mesh-ancestor
138764037|NCT01206101|Hormones|hormones|mesh-ancestor
138764038|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764039|NCT00997503|Aspirin|aspirin|mesh-list
138764040|NCT00997503|Paclitaxel|paclitaxel|mesh-list
138764041|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138764042|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138764043|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764044|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
138764045|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
138764046|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
138764047|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764048|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138764049|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138764050|NCT00997503|Analgesics|analgesics|mesh-ancestor
138764051|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
138764052|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764053|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764054|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764055|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138764056|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138764057|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138764058|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138764059|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138764060|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764061|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
138764062|NCT02705053|Insulin|insulin|mesh-list
138595038|NCT02929459|Riboflavin|riboflavin|mesh-list
138764063|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138764064|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764065|NCT01204775|Metformin|metformin|mesh-list
138764066|NCT01204775|Saxagliptin|saxagliptin|mesh-list
138764067|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138764068|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764069|NCT01204775|Incretins|incretins|mesh-ancestor
138764070|NCT01204775|Hormones|hormones|mesh-ancestor
138764071|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764072|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138764073|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
138764074|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764075|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764076|NCT02844907|Dexamethasone|dexamethasone|mesh-list
138764077|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764078|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
138764079|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
138764080|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764081|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764082|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138764083|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
138764084|NCT02844907|Hormones|hormones|mesh-ancestor
138764085|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764086|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138764087|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764088|NCT00628719|Amphotericin B|amphotericin b|mesh-list
138764089|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138764090|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
138764092|NCT00628719|Amebicides|amebicides|mesh-ancestor
138764093|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138764094|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138764095|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138764096|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138764097|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
138764098|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138764099|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138764100|NCT00616993|Difluprednate|difluprednate|mesh-list
138764101|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
138764102|NCT00616993|Hormones|hormones|mesh-ancestor
138764103|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764104|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764105|NCT02870361|Insulin|insulin|mesh-list
138764106|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138764107|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764108|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
138764109|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
138764110|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138764111|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138764112|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138764113|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764114|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138764115|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138764116|NCT00997035|Voriconazole|voriconazole|mesh-list
138764117|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
138764118|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138764119|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138764120|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138764121|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678034|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764122|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764123|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138764124|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
138764125|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764126|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764127|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138764128|NCT01204697|Docetaxel|docetaxel|mesh-list
138764129|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138764130|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764131|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
138764132|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
138764133|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
138764134|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764135|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138764136|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764137|NCT01203917|Gefitinib|gefitinib|mesh-list
138764138|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138678094|NCT05145270|Sulforaphane|sulforaphane|mesh-list
138764139|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138764141|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764143|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138764144|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764145|NCT04318223|Palbociclib|palbociclib|mesh-list
138764146|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764147|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138764148|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764149|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764150|NCT01202903|Omalizumab|omalizumab|mesh-list
138764151|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138438507|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
138764152|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138764153|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
138764154|NCT00618631|Carfentanil|carfentanil|mesh-list
138764155|NCT00618631|Nicotine|nicotine|mesh-list
138764156|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138764157|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
138764158|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764159|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764160|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138764161|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138764162|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
138764163|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764164|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764165|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138764166|NCT00618631|Narcotics|narcotics|mesh-ancestor
138764167|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138764168|NCT00618631|Analgesics|analgesics|mesh-ancestor
138764169|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
138764170|NCT04213573|Fluorides|fluorides|mesh-list
138764171|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
138764172|NCT04213573|Protective Agents|protective agents|mesh-ancestor
138764173|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764174|NCT00620269|Irinotecan|irinotecan|mesh-list
138764175|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138764176|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764177|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139085851|NCT05308342|Hormones|hormones|mesh-list
138764178|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138764179|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764180|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764181|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138764182|NCT04212403|Levofloxacin|levofloxacin|mesh-list
138764183|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138764184|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138764185|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138764186|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138764187|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138764188|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764189|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764190|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764191|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138764192|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138764193|NCT00637117|Interferons|interferons|mesh-list
138764194|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
138553071|NCT00274339|Lansoprazole|lansoprazole|mesh-list
138764195|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764196|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
138764197|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138764198|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
138764199|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764200|NCT02052193|Vemurafenib|vemurafenib|mesh-list
138764201|NCT02052193|Dabrafenib|dabrafenib|mesh-list
138764202|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764203|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138764204|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764205|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764206|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
138764207|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138764208|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138764209|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
138764210|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764211|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764212|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764213|NCT00619021|Gemcitabine|gemcitabine|mesh-list
138764214|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138764215|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
138764216|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764217|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764218|NCT00620347|Sunitinib|sunitinib|mesh-list
138764219|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764220|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138764221|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138764222|NCT00620347|Growth Substances|growth substances|mesh-ancestor
138764223|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764224|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
138764225|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138764226|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764227|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764228|NCT04213105|Denosumab|denosumab|mesh-list
138764229|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138764230|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764232|NCT01887301|Analgesics|analgesics|mesh-ancestor
138764233|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
138764234|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764235|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764236|NCT00996801|Vitamin D|vitamin d|mesh-list
138764237|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
138764238|NCT00996801|Alendronate|alendronate|mesh-list
138764239|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
138764240|NCT00996801|Calcium|calcium|mesh-list
138764241|NCT00996801|Vitamins|vitamins|mesh-ancestor
138764242|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
138764243|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764244|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138764245|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138764246|NCT00996801|Antacids|antacids|mesh-ancestor
138764247|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764248|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138764249|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138764250|NCT00619333|Hormones|hormones|mesh-ancestor
138764251|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764252|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764253|NCT04924621|Midazolam|midazolam|mesh-list
138764254|NCT04924621|Sufentanil|sufentanil|mesh-list
138764255|NCT04924621|Propofol|propofol|mesh-list
138764256|NCT04924621|Tetracaine|tetracaine|mesh-list
138764257|NCT04924621|Rocuronium|rocuronium|mesh-list
138764258|NCT04924621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138764259|NCT04924621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138764260|NCT04924621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764261|NCT04924621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138764262|NCT04924621|Anesthetics, General|anesthetics, general|mesh-ancestor
138764263|NCT04924621|Anesthetics|anesthetics|mesh-ancestor
138764264|NCT04924621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138764265|NCT04924621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138764266|NCT04924621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138764267|NCT04924621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138764268|NCT04924621|GABA Modulators|gaba modulators|mesh-ancestor
138764269|NCT04924621|GABA Agents|gaba agents|mesh-ancestor
138764270|NCT04924621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764271|NCT04924621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764272|NCT04924621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138764273|NCT04924621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138764274|NCT04924621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138764275|NCT04924621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764277|NCT04924621|Narcotics|narcotics|mesh-ancestor
138764278|NCT04924621|Analgesics|analgesics|mesh-ancestor
138764279|NCT04924621|Sensory System Agents|sensory system agents|mesh-ancestor
138764280|NCT04924621|Anesthetics, Local|anesthetics, local|mesh-ancestor
138764281|NCT00618163|Meloxicam|meloxicam|mesh-list
138764282|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138764283|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138764284|NCT00618163|Analgesics|analgesics|mesh-ancestor
138764285|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
138764286|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764287|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085889|NCT04828538|Hematinics|hematinics|mesh-ancestor
138764288|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764289|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138764290|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138764291|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138764292|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764293|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764294|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
138764295|NCT00618241|Lamotrigine|lamotrigine|mesh-list
138764296|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138764297|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138764298|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
138764299|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138764300|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138764301|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138764302|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764303|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764304|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
138764305|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138764306|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138764307|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138764308|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764309|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138764310|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138764311|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138764312|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138764313|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138764314|NCT00618397|Ketamine|ketamine|mesh-list
138764315|NCT00618397|Analgesics|analgesics|mesh-ancestor
138764316|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
138764317|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764318|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764319|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138764320|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138764321|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
138764322|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
138764323|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138764324|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138764325|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138764326|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764327|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764328|NCT04211545|Rabeprazole|rabeprazole|mesh-list
138764329|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138764330|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138764331|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138764332|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764333|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764334|NCT00620581|Paroxetine|paroxetine|mesh-list
138764335|NCT00620581|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138678417|NCT06030622|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138764336|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138764337|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138764338|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764339|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764340|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
139085918|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
138764341|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764342|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138764343|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
138764344|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138764345|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138764346|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138764347|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764348|NCT01000311|Vaccines|vaccines|mesh-list
138764349|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138764350|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
138764351|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764352|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138764353|NCT04209439|Bupivacaine|bupivacaine|mesh-list
138764354|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
138764355|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
138764356|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138764357|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764358|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
138764359|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764360|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138764361|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138764362|NCT04209439|Analgesics|analgesics|mesh-ancestor
138764363|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764364|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138764365|NCT05228041|Benralizumab|benralizumab|mesh-list
138764366|NCT05228041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138764367|NCT05228041|Respiratory System Agents|respiratory system agents|mesh-ancestor
138764368|NCT01003899|Afatinib|afatinib|mesh-list
138764369|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764370|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138764371|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764372|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764373|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
138764374|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764375|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764376|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138764378|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138764379|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764380|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138764381|NCT04160377|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138764382|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138764383|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138764384|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764385|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
138764386|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139085928|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
138764387|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
138764388|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138764389|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138764390|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138764392|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764393|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138764394|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764395|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764396|NCT00999921|Tamoxifen|tamoxifen|mesh-list
138764397|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
138764398|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138764399|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
138595364|NCT00170781|Analgesics|analgesics|mesh-ancestor
138764400|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764401|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764402|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138764403|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764404|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138764405|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138764406|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138764407|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138764408|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138764409|NCT00999921|Analgesics|analgesics|mesh-ancestor
138764410|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
138764411|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764412|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764413|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138764414|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138764415|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
138764416|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764417|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138764418|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
138764419|NCT02869347|Complement C1s|complement c1s|mesh-list
138764420|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138764421|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138764422|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
138764423|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764424|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138764425|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138764426|NCT00621673|Factor VIII|factor viii|mesh-list
138764427|NCT00621673|Coagulants|coagulants|mesh-ancestor
138764428|NCT01002573|Acetaminophen|acetaminophen|mesh-list
138764429|NCT01002573|Ibuprofen|ibuprofen|mesh-list
138764430|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138764431|NCT01002573|Analgesics|analgesics|mesh-ancestor
138764432|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
138764433|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764434|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764435|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
138764436|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138764437|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764438|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138764439|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138764440|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764441|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764442|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
138764443|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138764444|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138764445|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138764447|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
138438806|NCT01769820|Hormones|hormones|mesh-ancestor
138764448|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764449|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138764450|NCT00996333|Gemcitabine|gemcitabine|mesh-list
138764451|NCT00996333|Capecitabine|capecitabine|mesh-list
138764452|NCT00996333|Docetaxel|docetaxel|mesh-list
138764453|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138764454|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
138764455|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678808|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
138764456|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764457|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
138764458|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
138764459|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
138764460|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
138764461|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
138764462|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
138764463|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138764464|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764465|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
138764466|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764467|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
138764468|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
138764469|NCT01349101|Busulfan|busulfan|mesh-list
138764470|NCT01349101|Fludarabine|fludarabine|mesh-list
138764471|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
138764472|NCT01349101|Tacrolimus|tacrolimus|mesh-list
138764473|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138764474|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
138764475|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764476|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138764477|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138764478|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
138678862|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764479|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764480|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764481|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138764482|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138764483|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
138764484|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138764485|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138595441|NCT02916238|Fluoxetine|fluoxetine|mesh-list
138764486|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764487|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138764488|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138764489|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
138764490|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138764492|NCT00620971|Cisplatin|cisplatin|mesh-list
138764493|NCT00620971|Gemcitabine|gemcitabine|mesh-list
138764494|NCT00620971|Docetaxel|docetaxel|mesh-list
138764495|NCT00620971|Vinorelbine|vinorelbine|mesh-list
138764496|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138764497|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764498|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138764499|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138764501|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764503|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138764504|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
138764505|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764506|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
138764507|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
138764508|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
138764509|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138764510|NCT04223661|Dexamethasone|dexamethasone|mesh-list
138764511|NCT04223661|Lenalidomide|lenalidomide|mesh-list
138764512|NCT04223661|Daratumumab|daratumumab|mesh-list
138764513|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764514|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
138764515|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
138764516|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764517|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764518|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138764519|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
138764520|NCT04223661|Hormones|hormones|mesh-ancestor
138764521|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138438880|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
138764522|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138764523|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764524|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
138764525|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138764526|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138764527|NCT04223661|Growth Substances|growth substances|mesh-ancestor
138764528|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
138764529|NCT00622141|Saquinavir|saquinavir|mesh-list
138764530|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138764531|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138764532|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
138764533|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764534|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764535|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138764536|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138764537|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
138764538|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138764539|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138764540|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138764541|NCT04210765|Clomiphene|clomiphene|mesh-list
138764542|NCT04210765|Enclomiphene|enclomiphene|mesh-list
138764543|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
138764544|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138764545|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
138764546|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764547|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764548|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138764549|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
138764550|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138764551|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138764552|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138764553|NCT00621283|Secretin|secretin|mesh-list
138764554|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138764555|NCT00621283|Hormones|hormones|mesh-ancestor
138764556|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764571|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138764572|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138764573|NCT00621361|Etoposide|etoposide|mesh-list
138764574|NCT00621361|Cediranib|cediranib|mesh-list
138764575|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764576|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138764577|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138764578|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138764579|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764580|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764581|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138764582|NCT04208581|Fluticasone|fluticasone|mesh-list
138764584|NCT04208581|Budesonide|budesonide|mesh-list
138764585|NCT04208581|Bromides|bromides|mesh-list
138764586|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
138764587|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
138764588|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138764589|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138764590|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764591|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138764593|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764594|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764595|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138764596|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
138764597|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
138438956|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
138764598|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138764601|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764602|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138764603|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138764604|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138764605|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
138764606|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764607|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764608|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
138764609|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138764610|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
138764611|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
138764612|NCT05368675|Buprenorphine|buprenorphine|mesh-list
138764613|NCT05368675|Methadone|methadone|mesh-list
138764614|NCT05368675|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138764615|NCT05368675|Naloxone|naloxone|mesh-list
138764616|NCT05368675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138764617|NCT05368675|Narcotics|narcotics|mesh-ancestor
138764618|NCT05368675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138764619|NCT05368675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764620|NCT05368675|Analgesics|analgesics|mesh-ancestor
138764621|NCT05368675|Sensory System Agents|sensory system agents|mesh-ancestor
138764622|NCT05368675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764623|NCT05368675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138764624|NCT05368675|Antitussive Agents|antitussive agents|mesh-ancestor
138764625|NCT05368675|Respiratory System Agents|respiratory system agents|mesh-ancestor
138764626|NCT05368051|Capecitabine|capecitabine|mesh-list
138764627|NCT05368051|Antibodies|antibodies|mesh-list
138764628|NCT05368051|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138764629|NCT05368051|Immunologic Factors|immunologic factors|mesh-ancestor
138764630|NCT05368051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764631|NCT05368051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138764632|NCT05368051|Antimetabolites|antimetabolites|mesh-ancestor
138764633|NCT05368051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764634|NCT05368051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764635|NCT02641873|Leucovorin|leucovorin|mesh-list
138764636|NCT02641873|Bevacizumab|bevacizumab|mesh-list
138764637|NCT02641873|Irinotecan|irinotecan|mesh-list
138764638|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
138764639|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138764640|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764641|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138764642|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138764643|NCT02641873|Growth Substances|growth substances|mesh-ancestor
138764644|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764645|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
138764646|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138764647|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138764648|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764649|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764650|NCT02641873|Antidotes|antidotes|mesh-ancestor
138764651|NCT02641873|Protective Agents|protective agents|mesh-ancestor
138764652|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
138764653|NCT02641873|Vitamins|vitamins|mesh-ancestor
138764654|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
138764655|NCT00998985|Grazoprevir|grazoprevir|mesh-list
138764656|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
138764657|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138764658|NCT05240391|Midodrine|midodrine|mesh-list
138764659|NCT05240391|Sympathomimetics|sympathomimetics|mesh-ancestor
138764660|NCT05240391|Autonomic Agents|autonomic agents|mesh-ancestor
138764661|NCT05240391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764662|NCT05240391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764663|NCT05240391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138764664|NCT05240391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138764665|NCT05240391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138764666|NCT05240391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138764667|NCT05240391|Adrenergic Agents|adrenergic agents|mesh-ancestor
138764668|NCT05240391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086030|NCT01312714|Vitamin D|vitamin d|mesh-list
138764669|NCT05240391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764670|NCT00628953|Esomeprazole|esomeprazole|mesh-list
138764671|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138764672|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138764673|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138764674|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764675|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764676|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138764677|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138764678|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138764679|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138764680|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764681|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595557|NCT05785429|Tubulin Modulators|tubulin modulators|mesh-ancestor
138764682|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764684|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
138764685|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764686|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
138764687|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138764688|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
138764689|NCT02869815|Methylene Blue|methylene blue|mesh-list
138764690|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764691|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764692|NCT04293081|Maleic acid|maleic acid|mesh-list
138764693|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764694|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764696|NCT02868801|Analgesics|analgesics|mesh-ancestor
138764697|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
138764698|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764699|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764700|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
138764701|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138764702|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138764703|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764704|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138764705|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138764706|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138764707|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138764708|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138764709|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
138764710|NCT01002339|Cyclosporine|cyclosporine|mesh-list
138764711|NCT01002339|Prednisone|prednisone|mesh-list
138764712|NCT01002339|Tacrolimus|tacrolimus|mesh-list
138764713|NCT01002339|Basiliximab|basiliximab|mesh-list
138764714|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138764715|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
138764716|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764717|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138764718|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764719|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764720|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138764721|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764722|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138764723|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
138764724|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138764725|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138764726|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764727|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
138764728|NCT01002339|Hormones|hormones|mesh-ancestor
138764729|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764730|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138764731|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
138764732|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
138764733|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138764734|NCT01002105|Baclofen|baclofen|mesh-list
138764735|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138764736|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764737|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138764738|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764739|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138764740|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
138764741|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
138764742|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764743|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764744|NCT02605993|Ravulizumab|ravulizumab|mesh-list
138764745|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138764746|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138764747|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
138764748|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764749|NCT00995085|Pyridoxine|pyridoxine|mesh-list
138764750|NCT00995085|Metadoxine|metadoxine|mesh-list
138764751|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138764752|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
138764753|NCT00995085|Vitamins|vitamins|mesh-ancestor
138764754|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
138764755|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764756|NCT00603733|Mesalamine|mesalamine|mesh-list
138764757|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138764758|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138764759|NCT00603733|Analgesics|analgesics|mesh-ancestor
138764760|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
138764761|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764762|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764763|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764764|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138764765|NCT02471911|Dexamethasone|dexamethasone|mesh-list
138764766|NCT02471911|Rituximab|rituximab|mesh-list
138764767|NCT02471911|Carboplatin|carboplatin|mesh-list
138764768|NCT02471911|Etoposide|etoposide|mesh-list
138764769|NCT02471911|Ifosfamide|ifosfamide|mesh-list
138764770|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764771|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
138764772|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
138764773|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764774|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764775|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138764776|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
138764777|NCT02471911|Hormones|hormones|mesh-ancestor
138764778|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764779|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138764780|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764781|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138764782|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
138764783|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138764784|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138764785|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138764786|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138764787|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764788|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764789|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138764790|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
138764792|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138764793|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138764794|NCT00622375|Analgesics|analgesics|mesh-ancestor
138764795|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
138764796|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764797|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764798|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764799|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138764800|NCT02691325|Charcoal|charcoal|mesh-list
138764801|NCT02691325|Nemiralisib|nemiralisib|mesh-list
138764802|NCT02691325|Antidotes|antidotes|mesh-ancestor
138764803|NCT02691325|Protective Agents|protective agents|mesh-ancestor
138764804|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764805|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138764806|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764807|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764808|NCT02697331|Progesterone|progesterone|mesh-list
138764809|NCT02697331|Progestins|progestins|mesh-ancestor
138764810|NCT02697331|Hormones|hormones|mesh-ancestor
138764811|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764812|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764813|NCT04278625|Acetaminophen|acetaminophen|mesh-list
138764814|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138764815|NCT04278625|Analgesics|analgesics|mesh-ancestor
138764816|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
138764817|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764818|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764819|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
138764820|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138764822|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138764823|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
138764824|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764825|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764827|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138764828|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
138764829|NCT02691403|Bupivacaine|bupivacaine|mesh-list
138764830|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
138764831|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
138764832|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
138764833|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138764834|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764835|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
138764836|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764837|NCT00995007|Carboplatin|carboplatin|mesh-list
138764838|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764839|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
138764840|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138764841|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138764842|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764843|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
139086153|NCT01048307|Betaine|betaine|mesh-list
138764844|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764845|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764847|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138764848|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
138764849|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764850|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764851|NCT00994461|Celecoxib|celecoxib|mesh-list
138764852|NCT00994461|Loxoprofen|loxoprofen|mesh-list
138764853|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138764854|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138764855|NCT00994461|Analgesics|analgesics|mesh-ancestor
138764856|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
138764857|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764858|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764859|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138764860|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138764861|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138764862|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138764863|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764864|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764865|NCT00993915|Atorvastatin|atorvastatin|mesh-list
138764866|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138764867|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138764868|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
138764869|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764870|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138553148|NCT00274690|Casopitant|casopitant|mesh-list
138764871|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138764872|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764873|NCT01202591|Fulvestrant|fulvestrant|mesh-list
138764874|NCT01202591|Exemestane|exemestane|mesh-list
138764875|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138764876|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764877|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138764878|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138764879|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
138764880|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138764881|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764882|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138764883|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138595671|NCT05778266|Laxatives|laxatives|mesh-ancestor
138764884|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764885|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764886|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
138764887|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
138764889|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
138764890|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138764891|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
138764892|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764893|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764894|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138764895|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
138764896|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
138764897|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138764898|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
138764899|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
138764900|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764901|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764902|NCT01202279|Expectorants|expectorants|mesh-ancestor
138764903|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138764904|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138764905|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
138764906|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138764907|NCT03877315|Cimetidine|cimetidine|mesh-list
138764908|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138764909|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138764910|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138764911|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
138764912|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
138764913|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764914|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764915|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764916|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138764917|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138764918|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764919|NCT02687347|Morphine|morphine|mesh-list
138764920|NCT02687347|Methadone|methadone|mesh-list
138764921|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138764922|NCT02687347|Narcotics|narcotics|mesh-ancestor
139086225|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
138764923|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138764924|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764926|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
138764927|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138764928|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
138764929|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
138764930|NCT02687425|Pioglitazone|pioglitazone|mesh-list
138764931|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
138764932|NCT02687425|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138764933|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138764934|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764935|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764936|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138764937|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764938|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764939|NCT02687269|Ranolazine|ranolazine|mesh-list
138764940|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138764941|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138764942|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764943|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
138764944|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
138764945|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
138764946|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138764947|NCT04185805|Fexuprazan|fexuprazan|mesh-list
138764948|NCT04185805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138764949|NCT01201811|Azacitidine|azacitidine|mesh-list
138764950|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138764951|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
138764952|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764953|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138764954|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764955|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
138764956|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138764957|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
138764958|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
138764959|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
138764960|NCT05392127|Vitamin K|vitamin k|mesh-list
138764961|NCT05392127|Vitamin K 1|vitamin k 1|mesh-list
138764962|NCT05392127|Repaglinide|repaglinide|mesh-list
138764963|NCT05392127|Midazolam|midazolam|mesh-list
138764964|NCT05392127|Omeprazole|omeprazole|mesh-list
138764965|NCT05392127|Warfarin|warfarin|mesh-list
138764966|NCT05392127|Vitamins|vitamins|mesh-ancestor
138764967|NCT05392127|Micronutrients|micronutrients|mesh-ancestor
138764968|NCT05392127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138764969|NCT05392127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138764970|NCT05392127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138764971|NCT05392127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086249|NCT04971746|Pirfenidone|pirfenidone|mesh-list
138764972|NCT05392127|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138764973|NCT05392127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138764974|NCT05392127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138764975|NCT05392127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138764977|NCT05392127|Anesthetics|anesthetics|mesh-ancestor
138764978|NCT05392127|GABA Modulators|gaba modulators|mesh-ancestor
138764979|NCT05392127|GABA Agents|gaba agents|mesh-ancestor
138764980|NCT05392127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138764981|NCT05392127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764982|NCT05392127|Anticoagulants|anticoagulants|mesh-ancestor
138764983|NCT05392127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138764984|NCT05392127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138764985|NCT05392127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138764986|NCT05392127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764987|NCT05392127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138764988|NCT05392127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138764989|NCT05392127|Hemostatics|hemostatics|mesh-ancestor
138764990|NCT05392127|Coagulants|coagulants|mesh-ancestor
138764991|NCT05392127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138764992|NCT05378399|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138764993|NCT05378399|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138764994|NCT05378399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138764995|NCT05378399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138764996|NCT05378399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138764997|NCT05378399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138764998|NCT05378399|Antiviral Agents|antiviral agents|mesh-ancestor
138764999|NCT05378399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138765000|NCT05378399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138765001|NCT05378399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138765002|NCT02685163|Antioxidants|antioxidants|mesh-list
138765003|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765004|NCT02685163|Protective Agents|protective agents|mesh-ancestor
138765005|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765006|NCT00640003|Baclofen|baclofen|mesh-list
138765007|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138765008|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765009|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138765010|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765011|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138765012|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
138765013|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
138765014|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765015|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765016|NCT01201343|Interferons|interferons|mesh-list
138765017|NCT01201343|Interferon-beta|interferon-beta|mesh-list
138765018|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
138679614|NCT00732212|Hemostatics|hemostatics|mesh-list
138765020|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
138765021|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138765022|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
138765023|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765024|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138765025|NCT04185649|Capecitabine|capecitabine|mesh-list
138765026|NCT04185649|Lapatinib|lapatinib|mesh-list
138765027|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138765028|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
138765029|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765030|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765031|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138765032|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765033|NCT01201265|Bevacizumab|bevacizumab|mesh-list
138765034|NCT01201265|Carboplatin|carboplatin|mesh-list
138765035|NCT01201265|Gemcitabine|gemcitabine|mesh-list
138765036|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138765037|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765038|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138765039|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138765040|NCT01201265|Growth Substances|growth substances|mesh-ancestor
138765041|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765042|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
138765043|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138765044|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
138765045|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765046|NCT04246801|Clobetasol|clobetasol|mesh-list
138765047|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138765048|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
138765049|NCT04246801|Hormones|hormones|mesh-ancestor
138439403|NCT01773681|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138765050|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138765051|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765052|NCT00638677|Sorbitol|sorbitol|mesh-list
138765053|NCT00638677|Cathartics|cathartics|mesh-ancestor
138765054|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138765055|NCT01200485|Allopurinol|allopurinol|mesh-list
138765056|NCT01200485|Rasburicase|rasburicase|mesh-list
138765057|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
138765058|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765059|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765060|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
138765061|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765062|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138765063|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
138765064|NCT01200485|Protective Agents|protective agents|mesh-ancestor
138765065|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765066|NCT02688907|Adavosertib|adavosertib|mesh-list
138765067|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765068|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765069|NCT02686645|Metronidazole|metronidazole|mesh-list
138765070|NCT02686645|Vancomycin|vancomycin|mesh-list
138765071|NCT02686645|Loperamide|loperamide|mesh-list
138765072|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
138765073|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138765074|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138765075|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138765076|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138765077|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138765078|NCT04318067|Melatonin|melatonin|mesh-list
138765079|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
138765080|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765081|NCT04318067|Protective Agents|protective agents|mesh-ancestor
138765082|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765083|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138765084|NCT01200407|Amlodipine|amlodipine|mesh-list
138765085|NCT01200407|Olmesartan|olmesartan|mesh-list
138765086|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138765087|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138765088|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138765089|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138765090|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765091|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138765092|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679777|NCT00507585|Antidotes|antidotes|mesh-ancestor
138765093|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
138765094|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138765095|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138765097|NCT02685085|Dinoprostone|dinoprostone|mesh-list
138765098|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138765099|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
138765100|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138765101|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765102|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138765103|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138765104|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
138765105|NCT02688595|Anesthetics|anesthetics|mesh-list
138765106|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138765107|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765108|NCT01200329|Gemcitabine|gemcitabine|mesh-list
138765109|NCT01200329|Melphalan|melphalan|mesh-list
138765110|NCT01200329|Busulfan|busulfan|mesh-list
138765111|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138765112|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
138765113|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765114|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765115|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138765116|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
138765117|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138765118|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765119|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
138765120|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765121|NCT01199939|Ritonavir|ritonavir|mesh-list
138765122|NCT01199939|Darunavir|darunavir|mesh-list
138765123|NCT01199939|Etravirine|etravirine|mesh-list
138765124|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139086318|NCT01237028|Vitamins|vitamins|mesh-ancestor
138765125|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138765126|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
138765127|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765128|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765129|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138765130|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138765131|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
138765132|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138765133|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138765134|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138765135|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138765136|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138765137|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
138765138|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138765139|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138765140|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
138765141|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138765142|NCT02688361|Expectorants|expectorants|mesh-ancestor
138765143|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
138765144|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138765145|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
138765146|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765147|NCT02688361|Protective Agents|protective agents|mesh-ancestor
138765148|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765149|NCT02688361|Antidotes|antidotes|mesh-ancestor
138765150|NCT01199861|Vaccines|vaccines|mesh-list
138765151|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138765152|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
138765153|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765154|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138765155|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765156|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765157|NCT03196219|Anti-Infective Agents|anti-infective agents|mesh-list
138765158|NCT03196219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138765159|NCT00640081|Leucovorin|leucovorin|mesh-list
138765160|NCT00640081|Capecitabine|capecitabine|mesh-list
138765161|NCT00640081|Fluorouracil|fluorouracil|mesh-list
138765162|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
138765163|NCT00640081|Cetuximab|cetuximab|mesh-list
138765164|NCT00640081|Calcium|calcium|mesh-list
138765165|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
138765166|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138765167|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765168|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138765169|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
138765170|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765171|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765172|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765173|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
138765174|NCT00640081|Antidotes|antidotes|mesh-ancestor
138765175|NCT00640081|Protective Agents|protective agents|mesh-ancestor
138765176|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
138765177|NCT00640081|Vitamins|vitamins|mesh-ancestor
138765178|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
138765179|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138765180|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
138765181|NCT01199705|Antibodies|antibodies|mesh-list
138765182|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
138765183|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138765184|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139086401|NCT01237262|Analgesics|analgesics|mesh-ancestor
138765185|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
138765186|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553210|NCT00277342|Insulin|insulin|mesh-list
138765188|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138765189|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138765190|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765191|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
138765192|NCT02688127|Coagulants|coagulants|mesh-ancestor
138765193|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138765194|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765195|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138765196|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765197|NCT00638833|Memantine|memantine|mesh-list
138765198|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138765199|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138765200|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
138765201|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765202|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765204|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138765205|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138765206|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
138679885|NCT01247909|Penicillins|penicillins|mesh-list
138679891|NCT01245998|Dalteparin|dalteparin|mesh-list
138765207|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138765208|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138765209|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138765210|NCT01198145|Analgesics|analgesics|mesh-ancestor
138765211|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
138765212|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765213|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765214|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138765215|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765216|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138765217|NCT01179048|Liraglutide|liraglutide|mesh-list
138765218|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138765219|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765220|NCT01179048|Incretins|incretins|mesh-ancestor
138765221|NCT01179048|Hormones|hormones|mesh-ancestor
138765222|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138765223|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138765224|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138765225|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138765226|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138765227|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765228|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765229|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765230|NCT00603265|Analgesics|analgesics|mesh-ancestor
138765231|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
138765232|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765233|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
138765234|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138765235|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
138765237|NCT02686177|Liraglutide|liraglutide|mesh-list
138765238|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138765239|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765240|NCT02686177|Incretins|incretins|mesh-ancestor
138765241|NCT02686177|Hormones|hormones|mesh-ancestor
138765242|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138765243|NCT02686021|Dipyrone|dipyrone|mesh-list
138765244|NCT02686021|Ibuprofen|ibuprofen|mesh-list
138765245|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138765246|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138765247|NCT02686021|Analgesics|analgesics|mesh-ancestor
138765248|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
138765249|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765250|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765251|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138765252|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765253|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138765254|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765255|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765256|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
138765258|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
138765259|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
138765260|NCT01158534|Celecoxib|celecoxib|mesh-list
138765261|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765262|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
138680048|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
138765264|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
138765265|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765266|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138765267|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138765268|NCT01158534|Analgesics|analgesics|mesh-ancestor
138765269|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
138765270|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765271|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138765272|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138569788|NCT00430144|Belotecan|belotecan|mesh-list
138765273|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138765274|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138765275|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439650|NCT01776515|Tramadol|tramadol|mesh-list
138765276|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765277|NCT02687971|Miltefosine|miltefosine|mesh-list
138765278|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
138765279|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138680130|NCT02955524|Lidocaine|lidocaine|mesh-list
138765280|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765281|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138765282|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138765283|NCT02683213|Fluoxetine|fluoxetine|mesh-list
138765284|NCT02683213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138765285|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138765286|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138765287|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765288|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765289|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
138765290|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765291|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138765292|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
138765293|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138765294|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138765295|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138765296|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765297|NCT04185103|Valsartan|valsartan|mesh-list
138765298|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138765299|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139085241|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138765300|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138765301|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138765302|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765303|NCT04033939|Propofol|propofol|mesh-list
138765304|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138765305|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138765306|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765307|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138765308|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
138765309|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
138765310|NCT00639691|Omalizumab|omalizumab|mesh-list
138765311|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138765312|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138765313|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
138765315|NCT02684071|Methotrexate|methotrexate|mesh-list
138765316|NCT02684071|Topotecan|topotecan|mesh-list
138765317|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765318|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
138765319|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765320|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765321|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138765322|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
138765323|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765324|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765325|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138765326|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138765327|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
138765328|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138765329|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138765330|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
138765331|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
138765332|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765333|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138765334|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138765335|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138765336|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138765337|NCT00640861|Vaccines|vaccines|mesh-list
138765338|NCT00640861|Sargramostim|sargramostim|mesh-list
138765339|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
138765340|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
138765341|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765342|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138765343|NCT01158222|Sunitinib|sunitinib|mesh-list
138765344|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765345|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138765346|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138765347|NCT01158222|Growth Substances|growth substances|mesh-ancestor
138765348|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765349|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
138765350|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138765351|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765352|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765354|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
138765355|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138765356|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680269|NCT00510588|Metformin|metformin|mesh-list
138765357|NCT02940769|Methamphetamine|methamphetamine|mesh-list
138765358|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138765359|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765360|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
138765361|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
138765362|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765363|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
138765364|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765365|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765366|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
138765367|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138765368|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138765369|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138765370|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138765371|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
138765372|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138765373|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
138765374|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138765375|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680308|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
138765376|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765377|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
138765378|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
138765379|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138765380|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
138765381|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765382|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
138765383|NCT02683291|Sirolimus|sirolimus|mesh-list
138765384|NCT02683291|Prednisone|prednisone|mesh-list
138765386|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
138765387|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138765388|NCT02683291|Basiliximab|basiliximab|mesh-list
138765389|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138765390|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
138765391|NCT02683291|Hormones|hormones|mesh-ancestor
138765392|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138680368|NCT00502190|Silicon|silicon|mesh-list
138765393|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765394|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138765395|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765396|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765397|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
138765398|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138765399|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765400|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765401|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138765402|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138765403|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
138765404|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138765405|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138765406|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
138765407|NCT02685397|Leuprolide|leuprolide|mesh-list
138765408|NCT02685397|Goserelin|goserelin|mesh-list
138765409|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138765410|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138765411|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
138765412|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138765413|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765414|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138765415|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765416|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
138765417|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138765418|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
138765419|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138765420|NCT02683837|Remifentanil|remifentanil|mesh-list
138765421|NCT02683837|Sevoflurane|sevoflurane|mesh-list
138765422|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138765423|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138765424|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
138439787|NCT01777919|Copper|copper|mesh-list
138765425|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
138765426|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138765427|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765428|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138765429|NCT02683837|Narcotics|narcotics|mesh-ancestor
138765430|NCT02683837|Analgesics|analgesics|mesh-ancestor
138765431|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
138765432|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765434|NCT02680951|Fludarabine|fludarabine|mesh-list
138765435|NCT02680951|Dasatinib|dasatinib|mesh-list
138765436|NCT02680951|Idarubicin|idarubicin|mesh-list
138765437|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765438|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138765439|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
138765440|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765441|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765442|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
138765443|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765444|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
138765445|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138765446|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138765447|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765448|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138765449|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138765450|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138765451|NCT02680717|Clobetasol|clobetasol|mesh-list
138765452|NCT02680717|Calcipotriene|calcipotriene|mesh-list
138765453|NCT02680717|Tacrolimus|tacrolimus|mesh-list
138765454|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765455|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
138680485|NCT00510939|Tipifarnib|tipifarnib|mesh-list
138765456|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765457|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138765458|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765459|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765460|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138765461|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
138765463|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138765464|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
138765466|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765467|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138765468|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765469|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765470|NCT00640237|Calcifediol|calcifediol|mesh-list
138765471|NCT00640237|Vitamins|vitamins|mesh-ancestor
138765472|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
138765473|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765474|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138765475|NCT02683759|Curcumin|curcumin|mesh-list
138765476|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138584043|NCT00406341|Hormones|hormones|mesh-ancestor
138765477|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138596049|NCT04298983|Androgens|androgens|mesh-list
138765479|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
138765480|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765481|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765482|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138765483|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765484|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765485|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765486|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765487|NCT04292691|Ropivacaine|ropivacaine|mesh-list
138765488|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
138765489|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
138765490|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138765491|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765492|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
138765493|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765494|NCT00990249|Busulfan|busulfan|mesh-list
138765495|NCT00990249|Clofarabine|clofarabine|mesh-list
138765496|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
138765497|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138765498|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
138765499|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765500|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765501|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
138765502|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765503|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138765504|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765505|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138765506|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138765508|NCT02846545|Golimumab|golimumab|mesh-list
138765509|NCT02846545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138765510|NCT02846545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138765511|NCT02846545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765512|NCT02846545|Immunologic Factors|immunologic factors|mesh-ancestor
138765513|NCT02846545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765514|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
138765515|NCT04291755|Nivolumab|nivolumab|mesh-list
138765516|NCT04291755|Ipilimumab|ipilimumab|mesh-list
138596064|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138765517|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138765518|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765519|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138765520|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765521|NCT04292769|Decitabine|decitabine|mesh-list
138765522|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138765523|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
138680558|NCT00510393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765524|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765525|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765526|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765527|NCT00640939|Diclofenac|diclofenac|mesh-list
138765528|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138765529|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138765530|NCT00640939|Analgesics|analgesics|mesh-ancestor
138765531|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
138765532|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587858|NCT04818216|Niacin|niacin|mesh-list
138765533|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765534|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138765535|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765536|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138765537|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765538|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765540|NCT05663749|Topiramate|topiramate|mesh-list
138765541|NCT05663749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138765542|NCT05663749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765543|NCT05663749|Anticonvulsants|anticonvulsants|mesh-ancestor
138765544|NCT02867553|Rituximab|rituximab|mesh-list
138765545|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138765546|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765547|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
138765548|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765549|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765550|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
138765551|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138765552|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765553|NCT00642577|Leucovorin|leucovorin|mesh-list
138765554|NCT00642577|Bevacizumab|bevacizumab|mesh-list
138765555|NCT00642577|Fluorouracil|fluorouracil|mesh-list
138765556|NCT00642577|Irinotecan|irinotecan|mesh-list
138765557|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138765558|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765559|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138765560|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138765561|NCT00642577|Growth Substances|growth substances|mesh-ancestor
138765562|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765563|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
138765564|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
138765565|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765566|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138765567|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765568|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
138765569|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138765570|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138765571|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765572|NCT00642577|Antidotes|antidotes|mesh-ancestor
138765573|NCT00642577|Protective Agents|protective agents|mesh-ancestor
138765574|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
138765576|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
138765577|NCT02682121|Metformin|metformin|mesh-list
138765578|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138765579|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765581|NCT02683603|Colistin|colistin|mesh-list
138765582|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138765583|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138765584|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
138765585|NCT00641095|Rituximab|rituximab|mesh-list
138765586|NCT00641095|Fludarabine|fludarabine|mesh-list
138765587|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765588|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
138765589|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765590|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765591|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138765592|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
138765593|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765594|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765595|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138765596|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138765597|NCT01196975|Vaccines|vaccines|mesh-list
138765598|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
138765599|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765600|NCT00992589|Rabeprazole|rabeprazole|mesh-list
138765601|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138765602|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138765603|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138765604|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765605|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765606|NCT01196741|Paclitaxel|paclitaxel|mesh-list
138765607|NCT01196741|Saracatinib|saracatinib|mesh-list
138765608|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138765609|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765610|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
138765611|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
138765612|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
138765613|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765614|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765615|NCT00629187|Temozolomide|temozolomide|mesh-list
138765616|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138765617|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
138765618|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765619|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765620|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
138765621|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138765622|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765623|NCT00983385|Tapentadol|tapentadol|mesh-list
138765624|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138765625|NCT00983385|Narcotics|narcotics|mesh-ancestor
138765626|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138765627|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765628|NCT00983385|Analgesics|analgesics|mesh-ancestor
138765629|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
138765630|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765631|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138765632|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138765633|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138765634|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765635|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
138765636|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765637|NCT00992511|Vaccines|vaccines|mesh-list
138765638|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
138765639|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765640|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138765641|NCT02869035|Escitalopram|escitalopram|mesh-list
138765642|NCT02869035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138765643|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138765644|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138765645|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765646|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765647|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
138765648|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765649|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765650|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
138765651|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138765652|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138765653|NCT02869035|Analgesics|analgesics|mesh-ancestor
138765654|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
138765655|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
138765656|NCT04290819|Caffeine|caffeine|mesh-list
138765657|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138765658|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765659|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138765661|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765662|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138765663|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138765664|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
138765665|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765666|NCT01196429|Sirolimus|sirolimus|mesh-list
138765667|NCT01196429|Paclitaxel|paclitaxel|mesh-list
138765668|NCT01196429|Docetaxel|docetaxel|mesh-list
138765669|NCT01196429|Carboplatin|carboplatin|mesh-list
138765670|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138765671|NCT01196429|Temsirolimus|temsirolimus|mesh-list
138765672|NCT01196429|MTOR Inhibitors|mtor inhibitors|mesh-list
138765673|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138765674|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765675|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
138765676|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
138765677|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
138765678|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765679|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138765680|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138765681|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138765682|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
138765683|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765684|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
138765685|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765686|NCT01196429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138765687|NCT01196429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765688|NCT01157364|Bimatoprost|bimatoprost|mesh-list
138765689|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138765690|NCT01195415|Gemcitabine|gemcitabine|mesh-list
138765691|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138765692|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
138765693|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765694|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765695|NCT01195103|Midazolam|midazolam|mesh-list
138765696|NCT01195103|Fentanyl|fentanyl|mesh-list
138765697|NCT01195103|Fospropofol|fospropofol|mesh-list
138765698|NCT01195103|Propofol|propofol|mesh-list
138765699|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138765700|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138765701|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138765702|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765703|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138765704|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138765705|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138765706|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138765707|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
138765708|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
138765710|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
138765711|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765712|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765713|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138765714|NCT01195103|Narcotics|narcotics|mesh-ancestor
138765715|NCT01195103|Analgesics|analgesics|mesh-ancestor
138765716|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
138765717|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765718|NCT01194869|Paclitaxel|paclitaxel|mesh-list
138765719|NCT01194869|Cisplatin|cisplatin|mesh-list
138765720|NCT01194869|Sorafenib|sorafenib|mesh-list
138765721|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138765722|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765723|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
138765724|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
138765725|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
138765726|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765727|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138765728|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440085|NCT01779908|Vitamin D|vitamin d|mesh-list
138765729|NCT01177800|Infliximab|infliximab|mesh-list
138765730|NCT01177800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138765731|NCT01177800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138765732|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
138787904|NCT04293822|Minoxidil|minoxidil|mesh-list
138765733|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138765734|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765735|NCT01177722|Vaccines|vaccines|mesh-list
138765736|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
138765737|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765738|NCT02884986|Etoricoxib|etoricoxib|mesh-list
138765739|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138765740|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138765741|NCT02884986|Analgesics|analgesics|mesh-ancestor
138765742|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
138765743|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765744|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765745|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138765746|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765747|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138765748|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138765749|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765750|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765751|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
138765752|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138765753|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
138765754|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
138765755|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138765756|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765757|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138765758|NCT04124562|Analgesics|analgesics|mesh-ancestor
138765759|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
138765760|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765761|NCT01177410|Mesalamine|mesalamine|mesh-list
138765762|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138765763|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138765764|NCT01177410|Analgesics|analgesics|mesh-ancestor
138765765|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
138765766|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765767|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765768|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138765769|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765770|NCT02884596|Serotonin|serotonin|mesh-list
138765771|NCT02884596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138765772|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138765773|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
138765774|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765775|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765776|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765777|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138765778|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138357599|NCT00003612|Paclitaxel|paclitaxel|mesh-list
138765779|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
138765780|NCT04205916|Dexamethasone|dexamethasone|mesh-list
138765781|NCT04205916|Ketorolac|ketorolac|mesh-list
138765782|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138765783|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
138765784|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
138765785|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765786|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765787|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138765788|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
138765789|NCT04205916|Hormones|hormones|mesh-ancestor
138765790|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138765791|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138765792|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765793|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138765794|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138765795|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138765796|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138765797|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765798|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765799|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138765800|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138765801|NCT04205916|Analgesics|analgesics|mesh-ancestor
138765802|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
138765803|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765804|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138765805|NCT01176240|Mannitol|mannitol|mesh-list
138765806|NCT01176240|Droxidopa|droxidopa|mesh-list
138765807|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138765808|NCT01176240|Diuretics|diuretics|mesh-ancestor
138595391|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765809|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
138765810|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765811|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138765812|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138765814|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138765815|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
138765816|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765817|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
138765818|NCT02867397|Epirubicin|epirubicin|mesh-list
138680807|NCT00504491|Rituximab|rituximab|mesh-list
138765819|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765820|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138765821|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138765822|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138765824|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765825|NCT01175382|Tamsulosin|tamsulosin|mesh-list
138765826|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138765827|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138765828|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138765829|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138765830|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
138765831|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765832|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765833|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765834|NCT01175382|Urological Agents|urological agents|mesh-ancestor
138765835|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138765836|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138765837|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
138765838|NCT01194245|Insulin|insulin|mesh-list
138765839|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138765840|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
138765841|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
138765842|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
138765843|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
138765844|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138765845|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765846|NCT00979407|Vaccines|vaccines|mesh-list
138765847|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
138765848|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765849|NCT00975975|Basiliximab|basiliximab|mesh-list
138765850|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765851|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
138765852|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765853|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138765854|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138765855|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138765856|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138765857|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765858|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138765859|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138765860|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138765861|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
138765862|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765863|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765864|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138765865|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138765866|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
138765867|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
138765868|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765869|NCT04289883|Calcium|calcium|mesh-list
138596306|NCT02425904|Clofarabine|clofarabine|mesh-list
138765870|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138765871|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765872|NCT02865369|Asunaprevir|asunaprevir|mesh-list
138765873|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
138765874|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765875|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765876|NCT01192295|Oxycodone|oxycodone|mesh-list
138765877|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138765878|NCT01192295|Narcotics|narcotics|mesh-ancestor
138765879|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138765880|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765882|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
138765883|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765884|NCT04289103|Inolimomab|inolimomab|mesh-list
138765885|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765886|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
138765887|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765888|NCT01154166|Ropinirole|ropinirole|mesh-list
138765889|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138765890|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138765891|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
138765892|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
138765893|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765894|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765895|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765896|NCT04290195|Aflibercept|aflibercept|mesh-list
138765897|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138765898|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138765899|NCT04290195|Growth Substances|growth substances|mesh-ancestor
138765900|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765901|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
138765902|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765903|NCT05656703|Anesthetics|anesthetics|mesh-list
138680930|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138765904|NCT05656703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138765905|NCT05656703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765906|NCT05656079|Cyclophosphamide|cyclophosphamide|mesh-list
138765907|NCT05656079|Docetaxel|docetaxel|mesh-list
138765908|NCT05656079|Doxorubicin|doxorubicin|mesh-list
138765909|NCT05656079|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138765910|NCT05656079|Trastuzumab|trastuzumab|mesh-list
138765911|NCT05656079|Epirubicin|epirubicin|mesh-list
138765912|NCT05656079|Pertuzumab|pertuzumab|mesh-list
138765913|NCT05656079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765914|NCT05656079|Immunologic Factors|immunologic factors|mesh-ancestor
138596353|NCT01964989|Vaccines|vaccines|mesh-list
138765915|NCT05656079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765916|NCT05656079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765917|NCT05656079|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138765918|NCT05656079|Alkylating Agents|alkylating agents|mesh-ancestor
138765919|NCT05656079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765920|NCT05656079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765921|NCT05656079|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138765922|NCT05656079|Tubulin Modulators|tubulin modulators|mesh-ancestor
138765923|NCT05656079|Antimitotic Agents|antimitotic agents|mesh-ancestor
138765924|NCT05656079|Mitosis Modulators|mitosis modulators|mesh-ancestor
138765925|NCT05656079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138765926|NCT05656079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138765927|NCT05656079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138765928|NCT05656079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765929|NCT05656079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138765931|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138765932|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765933|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765934|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
138765935|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138765936|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765937|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138765938|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
138765939|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138765940|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
138765941|NCT00932698|Ixazomib|ixazomib|mesh-list
138765942|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765943|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
138765944|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765945|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765946|NCT00978627|Insulin|insulin|mesh-list
138765947|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138765948|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
138765949|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
138765950|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138765951|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
138765952|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138553273|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
138765953|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765954|NCT01181609|Bevacizumab|bevacizumab|mesh-list
138765955|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138765956|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765957|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138596382|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
138765958|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138765959|NCT01181609|Growth Substances|growth substances|mesh-ancestor
138765960|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765961|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
138765962|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
138765963|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138765964|NCT04261426|Antibodies|antibodies|mesh-list
138765965|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
138765966|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138599844|NCT04686643|Niacin|niacin|mesh-list
138765967|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
138765968|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765969|NCT04264078|Fludarabine|fludarabine|mesh-list
138765970|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
138765971|NCT04264078|Melphalan|melphalan|mesh-list
138765972|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765973|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765974|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138765975|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
138765976|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765977|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138765978|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138765979|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
138765980|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138765981|NCT00608218|Ciclesonide|ciclesonide|mesh-list
138765982|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
138765983|NCT00608218|Hormones|hormones|mesh-ancestor
138765984|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138765985|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765986|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138765987|NCT02884050|Topiramate|topiramate|mesh-list
138765988|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
138765989|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138765990|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138765991|NCT00609934|Sorafenib|sorafenib|mesh-list
138681023|NCT01242176|Empagliflozin|empagliflozin|mesh-list
138765992|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138765993|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138765994|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138765995|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138765996|NCT01147926|Prucalopride|prucalopride|mesh-list
138765997|NCT01147926|Laxatives|laxatives|mesh-ancestor
138765998|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138765999|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138766000|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138766001|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
138766002|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766003|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766004|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766005|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
138766006|NCT05115136|Promethazine|promethazine|mesh-list
138766007|NCT05115136|Doxepin|doxepin|mesh-list
138766008|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138766009|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138766010|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138766011|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766012|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
138766013|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
138766014|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
138766015|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766016|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
138766017|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
138766018|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138596445|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
138766019|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138766020|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
138296140|NCT00002816|Cobalt|cobalt|mesh-list
138766021|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
138766022|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766023|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681044|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
138766024|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138766025|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
138766026|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
138766027|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138766028|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
138766029|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138766030|NCT00608374|Fludarabine|fludarabine|mesh-list
138766031|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
138766032|NCT00608374|Chlorambucil|chlorambucil|mesh-list
138766033|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766034|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138766035|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
138766036|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766037|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138766038|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
138766039|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766040|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138766041|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
138766042|NCT00625014|Haloperidol|haloperidol|mesh-list
138766043|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
138766044|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
138766045|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
138766046|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766047|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766048|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138766049|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138766050|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138766051|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138766052|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138766053|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138766054|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
138766055|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766056|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766057|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138766058|NCT01147848|Fluticasone|fluticasone|mesh-list
138766059|NCT01147848|Xhance|xhance|mesh-list
138766060|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138766061|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766062|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138766063|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
138766064|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681083|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
138766065|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766066|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138766067|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
138766068|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
138766069|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138766070|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138766071|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138766072|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138766073|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
138766074|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766075|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766076|NCT04261270|Ritonavir|ritonavir|mesh-list
138766077|NCT04261270|Oseltamivir|oseltamivir|mesh-list
138766078|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138766079|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138766080|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
138766081|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766082|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766083|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138766084|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138766085|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
138766086|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138766087|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138766088|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138766089|NCT01152996|Vortioxetine|vortioxetine|mesh-list
138766090|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
138766091|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138766092|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138766093|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138766094|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138766095|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766096|NCT01152996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138766097|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138766098|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138766099|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766100|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766101|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
138766102|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138766103|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138766104|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138766105|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138766106|NCT00624936|Azacitidine|azacitidine|mesh-list
138440464|NCT01782937|Brodalumab|brodalumab|mesh-list
138766107|NCT00624936|Bortezomib|bortezomib|mesh-list
138766108|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138766109|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
138766110|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766111|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766112|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766113|NCT00979953|Oxycodone|oxycodone|mesh-list
138766114|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138766115|NCT00979953|Narcotics|narcotics|mesh-ancestor
138681118|NCT01240811|Trace Elements|trace elements|mesh-ancestor
138766116|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138766118|NCT00979953|Analgesics|analgesics|mesh-ancestor
138766119|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
138766120|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766121|NCT01181531|Vitamin D|vitamin d|mesh-list
138766122|NCT01181531|Cinacalcet|cinacalcet|mesh-list
138766123|NCT01181531|Vitamins|vitamins|mesh-ancestor
138766124|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
138766125|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766126|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138766127|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138766128|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138766129|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
138766130|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138766131|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
138766132|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138766133|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
138766134|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766135|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766136|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138766137|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
138766138|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
138766139|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138766140|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
138766141|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766142|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766143|NCT00610246|Sorafenib|sorafenib|mesh-list
138766144|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766145|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138766146|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766147|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766148|NCT01181141|Enoxaparin|enoxaparin|mesh-list
138766149|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
138766150|NCT01181141|Edoxaban|edoxaban|mesh-list
138766151|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
138766152|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138766153|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138766154|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766155|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138766156|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
138766157|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138766158|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
138766159|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766160|NCT00606814|Docetaxel|docetaxel|mesh-list
138766161|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766162|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
138766163|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
138766164|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
138553284|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138766165|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766167|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138766168|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766169|NCT01173120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138766170|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766171|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138766172|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
138766173|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766174|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138766175|NCT00977379|Capecitabine|capecitabine|mesh-list
138788101|NCT00640432|Diclofenac|diclofenac|mesh-list
138766176|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138766177|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
138766178|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766179|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766180|NCT04263844|Midazolam|midazolam|mesh-list
138440539|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
138766181|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
138766182|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138766183|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138766184|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766185|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138766186|NCT04263844|Analgesics|analgesics|mesh-ancestor
138766187|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
138766188|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766189|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138766190|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138766191|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138766192|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
138766193|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596707|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138766194|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766195|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138766196|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138766197|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138766198|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138766199|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138766200|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
138766201|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
138766202|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
138766203|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
138766204|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
138766205|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138766206|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138766207|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138766208|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
138766209|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
138766210|NCT02884128|Leucovorin|leucovorin|mesh-list
138766211|NCT02884128|Fluorouracil|fluorouracil|mesh-list
138766212|NCT02884128|Irinotecan|irinotecan|mesh-list
138766213|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
138596750|NCT02843230|Growth Substances|growth substances|mesh-ancestor
138766214|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766215|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138766216|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766217|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138766218|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
138766219|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766220|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138766221|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138766222|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766223|NCT02884128|Antidotes|antidotes|mesh-ancestor
138766224|NCT02884128|Protective Agents|protective agents|mesh-ancestor
138766225|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
138766226|NCT02884128|Vitamins|vitamins|mesh-ancestor
138766227|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
138766228|NCT00629343|Azacitidine|azacitidine|mesh-list
138766229|NCT00629343|Temozolomide|temozolomide|mesh-list
138766230|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138766231|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
138766232|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766233|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766234|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766235|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138766236|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
138766237|NCT01180049|Sirolimus|sirolimus|mesh-list
138766238|NCT01180049|Temsirolimus|temsirolimus|mesh-list
138766239|NCT01180049|MTOR Inhibitors|mtor inhibitors|mesh-list
138766240|NCT01180049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138766241|NCT01180049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766242|NCT01180049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766243|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138766244|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
138766245|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766246|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766247|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138766248|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138766249|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138766250|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
138766251|NCT01147458|Naproxen|naproxen|mesh-list
138766252|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138766253|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138766254|NCT01147458|Analgesics|analgesics|mesh-ancestor
138766255|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
138766256|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766257|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766258|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766259|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138766260|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
138766261|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138766262|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766263|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766264|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
138766265|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138766266|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138766267|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
138766268|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766269|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766270|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138766271|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
138766272|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
138766273|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138766274|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
138766275|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766276|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766277|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138766278|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138766279|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138766280|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
138766281|NCT04315194|Clarithromycin|clarithromycin|mesh-list
138766282|NCT04315194|Oseltamivir|oseltamivir|mesh-list
138766284|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138766285|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138766286|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138766287|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766288|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766289|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138766290|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138766291|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138766292|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138766293|NCT04315194|Analgesics|analgesics|mesh-ancestor
138766294|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
138766295|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766296|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766297|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766298|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138766299|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
138766300|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138766301|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
138766302|NCT01149486|Losartan|losartan|mesh-list
138766303|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138681296|NCT04519385|Hormones|hormones|mesh-ancestor
138766304|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138766305|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138553291|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
138766306|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138766307|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138766308|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766309|NCT01149486|Diuretics|diuretics|mesh-ancestor
138766310|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
138766311|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766312|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138766313|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138766314|NCT00601705|Fluorouracil|fluorouracil|mesh-list
138766315|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
138766316|NCT00601705|Epirubicin|epirubicin|mesh-list
138766317|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766318|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
138766319|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766320|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138766321|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138766322|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
138766323|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766324|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138766325|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138766326|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138766327|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766328|NCT00641173|Paroxetine|paroxetine|mesh-list
138766329|NCT00641173|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138766330|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138766331|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138766332|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766333|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766334|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
138766335|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766336|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138766337|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
138766338|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138766339|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138766340|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138766342|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
138766343|NCT00929110|Bromides|bromides|mesh-list
138766344|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
138766345|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138766347|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766348|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766349|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138766350|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
138766351|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
138766352|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138766353|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
138766354|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766355|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766356|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
138766357|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138766358|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138766359|NCT00922519|Listerine|listerine|mesh-list
138766360|NCT00922519|Fluorides|fluorides|mesh-list
138766361|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
138766362|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
138766363|NCT00922519|Protective Agents|protective agents|mesh-ancestor
138766364|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766365|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138766366|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138766367|NCT00640549|Atorvastatin|atorvastatin|mesh-list
138766368|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138766369|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138766370|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
138766371|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766372|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138766373|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138596969|NCT00532285|Paclitaxel|paclitaxel|mesh-list
138766374|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766376|NCT02683369|Trace Elements|trace elements|mesh-ancestor
138766377|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
138766378|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766379|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
138766380|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
138766381|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
138766382|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766383|NCT01147068|Coagulants|coagulants|mesh-ancestor
138766384|NCT00640627|Celecoxib|celecoxib|mesh-list
138766385|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138766386|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138766387|NCT00640627|Analgesics|analgesics|mesh-ancestor
138766388|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
138766389|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766390|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766391|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766392|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138766393|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138766394|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138766395|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766396|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766397|NCT02681887|Melatonin|melatonin|mesh-list
138766398|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
138681406|NCT02275299|Methotrexate|methotrexate|mesh-list
138766399|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766400|NCT02681887|Protective Agents|protective agents|mesh-ancestor
138766401|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766402|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138766403|NCT01134042|Fluticasone|fluticasone|mesh-list
138766404|NCT01134042|Xhance|xhance|mesh-list
138766405|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766406|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138766407|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
138766408|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766409|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766410|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138766411|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
138766412|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
138766413|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138766414|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
138766415|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138766416|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
138766417|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766418|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766419|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138766420|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
138766421|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
138766422|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138766423|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
138766424|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766425|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766426|NCT01146288|Furosemide|furosemide|mesh-list
138766427|NCT01146288|Acetazolamide|acetazolamide|mesh-list
138766428|NCT01146288|Diuretics|diuretics|mesh-ancestor
138766429|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
138766430|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766431|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138597060|NCT05467384|Vasodilator Agents|vasodilator agents|mesh-ancestor
138766432|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138766433|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766434|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
138766435|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138766436|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766437|NCT01146054|Gemcitabine|gemcitabine|mesh-list
138766438|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138766439|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138766440|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
138766441|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766442|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766443|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138766444|NCT00640705|Diclofenac|diclofenac|mesh-list
138766445|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138766446|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138766447|NCT00640705|Analgesics|analgesics|mesh-ancestor
138766448|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
138766449|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766450|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766451|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766452|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138766453|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138766454|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766455|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766456|NCT01145898|Timolol|timolol|mesh-list
138766457|NCT01145898|Dorzolamide|dorzolamide|mesh-list
138766458|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138766459|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138766460|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
138766461|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597097|NCT04723875|Paclitaxel|paclitaxel|mesh-list
138766462|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766463|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766464|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138766465|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138766466|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138766467|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766468|NCT02681653|Atorvastatin|atorvastatin|mesh-list
138766469|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138766470|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138766472|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766473|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138681483|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138766474|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138766475|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766476|NCT04315116|Loperamide|loperamide|mesh-list
138766477|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
138766478|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138766479|NCT02883114|Itraconazole|itraconazole|mesh-list
138766480|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
138766481|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138766482|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138766483|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138766484|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766485|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766486|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138766487|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
138766488|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138766489|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766490|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138766491|NCT04183387|Simvastatin|simvastatin|mesh-list
138766492|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138766493|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138766494|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
138766495|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766496|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138766497|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138766498|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766499|NCT00625092|Leucovorin|leucovorin|mesh-list
138766500|NCT00625092|Fluorouracil|fluorouracil|mesh-list
138766501|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
138766502|NCT00625092|Calcium|calcium|mesh-list
138766503|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
138766504|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138766505|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766506|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
138766507|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766508|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138766509|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766510|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138766511|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
138766512|NCT00625092|Antidotes|antidotes|mesh-ancestor
138766513|NCT00625092|Protective Agents|protective agents|mesh-ancestor
138766514|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
138766515|NCT00625092|Vitamins|vitamins|mesh-ancestor
138766516|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
138766517|NCT00931918|Prednisone|prednisone|mesh-list
138766518|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
138766519|NCT00931918|Rituximab|rituximab|mesh-list
138766520|NCT00931918|Doxorubicin|doxorubicin|mesh-list
138766521|NCT00931918|Vincristine|vincristine|mesh-list
138766522|NCT00931918|Bortezomib|bortezomib|mesh-list
138766523|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138766524|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
138766525|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766526|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138766527|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138766528|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
138766529|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766530|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766531|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138766532|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138766533|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138766534|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138766535|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138766536|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766537|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766538|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
138766539|NCT00931918|Hormones|hormones|mesh-ancestor
138766540|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138766541|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138766542|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138766543|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
138766544|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
138766545|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
138766546|NCT04183075|Vitamins|vitamins|mesh-list
138766547|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
138766548|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
138766549|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766550|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
138766551|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766552|NCT04183075|Protective Agents|protective agents|mesh-ancestor
138766553|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
138766554|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766555|NCT02678221|Aspirin|aspirin|mesh-list
138440918|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138766556|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
138597229|NCT00151541|Dapsone|dapsone|mesh-list
138766557|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138766558|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138681573|NCT02950038|Nivolumab|nivolumab|mesh-list
138766559|NCT02678221|Analgesics|analgesics|mesh-ancestor
138766560|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
138766561|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766562|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766563|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766564|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138766565|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138766566|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138766567|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766568|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138766569|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138766570|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766571|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
138766572|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
138766573|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138766574|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138766575|NCT02678221|Urological Agents|urological agents|mesh-ancestor
138766577|NCT00641329|Analgesics|analgesics|mesh-ancestor
138766578|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
138766579|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766580|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766581|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138766583|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
138766584|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138766585|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138766586|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138766587|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
138766588|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766589|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766590|NCT01179191|Naltrexone|naltrexone|mesh-list
138766591|NCT01179191|Morphine|morphine|mesh-list
138766592|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138766593|NCT01179191|Narcotics|narcotics|mesh-ancestor
138766594|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138766595|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766596|NCT01179191|Analgesics|analgesics|mesh-ancestor
138766597|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
138766598|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766599|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138766600|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138766601|NCT00642421|Octreotide|octreotide|mesh-list
138766602|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138766603|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138766604|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766605|NCT00642187|Budesonide|budesonide|mesh-list
138766606|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766607|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138766608|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
138766609|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766610|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766611|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138766612|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
138766613|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
138766614|NCT00642187|Hormones|hormones|mesh-ancestor
138766615|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138766616|NCT05663125|Temozolomide|temozolomide|mesh-list
138766617|NCT05663125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138766618|NCT05663125|Alkylating Agents|alkylating agents|mesh-ancestor
138766619|NCT05663125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766620|NCT05663125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766621|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
138766622|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
138766623|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138766624|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138766625|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766626|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766627|NCT01132482|Urological Agents|urological agents|mesh-ancestor
138766628|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138766630|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138766631|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138766633|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766634|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138766635|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766636|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766637|NCT00641407|Insulin|insulin|mesh-list
138766638|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138766639|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
138766640|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138766641|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766642|NCT02677597|Paclitaxel|paclitaxel|mesh-list
138766643|NCT02677597|Cisplatin|cisplatin|mesh-list
138766644|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138766645|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766646|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
138766647|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
138766648|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
138766649|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766650|NCT01132326|Droxidopa|droxidopa|mesh-list
138766652|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138766653|NCT02681263|Temocillin|temocillin|mesh-list
138766654|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138766655|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138766656|NCT02677519|Methylphenidate|methylphenidate|mesh-list
138766657|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138766658|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766659|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138766660|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138766661|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138887533|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766662|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766664|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766665|NCT01145508|Metronidazole|metronidazole|mesh-list
138766666|NCT01145508|Prednisone|prednisone|mesh-list
138766667|NCT01145508|Cortisone|cortisone|mesh-list
138766668|NCT01145508|Docetaxel|docetaxel|mesh-list
138766669|NCT01145508|Vaccines|vaccines|mesh-list
138766670|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
138766671|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766672|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766673|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
138766674|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
138766675|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
138766676|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766677|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766678|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
138766679|NCT01145508|Hormones|hormones|mesh-ancestor
138766680|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138766681|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138766682|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138766683|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138766684|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138766685|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138766686|NCT00931528|Tadalafil|tadalafil|mesh-list
138766687|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
138766688|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138766689|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138766690|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085242|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766691|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766693|NCT04312152|Vitamins|vitamins|mesh-list
138766694|NCT04312152|Vitamin E|vitamin e|mesh-list
138766695|NCT04312152|Tocopherols|tocopherols|mesh-list
138766696|NCT04312152|Folic Acid|folic acid|mesh-list
138766697|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
138766698|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
138766699|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766700|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
138766701|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766702|NCT04312152|Protective Agents|protective agents|mesh-ancestor
138766703|NCT04312152|Hematinics|hematinics|mesh-ancestor
138766704|NCT00975195|Fluticasone|fluticasone|mesh-list
138766705|NCT00975195|Xhance|xhance|mesh-list
138766706|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
138766707|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138766708|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766709|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138766710|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
138766711|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597442|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138766712|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766713|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138766714|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
138766715|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
138766716|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138766717|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
138766718|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138766719|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
138766720|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766721|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766722|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138766723|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138766724|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138766725|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
138766726|NCT00642499|Dronabinol|dronabinol|mesh-list
138766727|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
138766728|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766729|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138766730|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138766731|NCT00642499|Analgesics|analgesics|mesh-ancestor
138766732|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
138766733|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766734|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138766735|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138766736|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766737|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766738|NCT00642499|Hormones|hormones|mesh-ancestor
138766739|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138766740|NCT00644215|Mitomycins|mitomycins|mesh-list
138766741|NCT00644215|Mitomycin|mitomycin|mesh-list
138766742|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138766743|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766744|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
138766745|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766746|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138766747|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766748|NCT01145352|Etanercept|etanercept|mesh-list
138766749|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138766750|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138766751|NCT01145352|Analgesics|analgesics|mesh-ancestor
138766752|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
138766753|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681796|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766754|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766755|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766756|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138766757|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138766758|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138766759|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
138766760|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138766761|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138766762|NCT02673463|Spironolactone|spironolactone|mesh-list
138766763|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138766764|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
138766765|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138766766|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766767|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138766768|NCT02673463|Diuretics|diuretics|mesh-ancestor
138766769|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
138766770|NCT01169532|Vorinostat|vorinostat|mesh-list
138766771|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766772|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138766773|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766774|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766775|NCT02537353|Epinephrine|epinephrine|mesh-list
138597529|NCT00152360|Orlistat|orlistat|mesh-list
138766776|NCT02537353|Racepinephrine|racepinephrine|mesh-list
138766777|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
138766778|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138766779|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138766780|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
138766781|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766782|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766783|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766784|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138766785|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138766786|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
138766787|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766788|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138766789|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
138766790|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
138766791|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
138766792|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138766793|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
138766794|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138766795|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
138766796|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
138766797|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138766798|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766799|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138766800|NCT00643357|Analgesics|analgesics|mesh-ancestor
138766801|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
138766802|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766803|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138766804|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138766805|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138766806|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138766807|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766808|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
138766809|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138766810|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597557|NCT00152438|Progesterone|progesterone|mesh-list
138766811|NCT04178785|Remifentanil|remifentanil|mesh-list
138766812|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138766813|NCT04178785|Narcotics|narcotics|mesh-ancestor
138766814|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138766815|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766816|NCT04178785|Analgesics|analgesics|mesh-ancestor
138766817|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
138766818|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766820|NCT00928486|Lenalidomide|lenalidomide|mesh-list
138766821|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138766822|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
138766823|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
138766824|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138766825|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766826|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138766827|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
138766829|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138766830|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138766831|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766832|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
138766833|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138766834|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138766835|NCT00928486|Growth Substances|growth substances|mesh-ancestor
138766836|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
138597595|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138597596|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
138597597|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138597598|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597599|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138597600|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138597601|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
138597602|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138597603|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138597604|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138597605|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138597606|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597642|NCT00152633|Losartan|losartan|mesh-list
138597643|NCT00152633|Metoprolol|metoprolol|mesh-list
138597644|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138487249|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138487251|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138766837|NCT05655221|Mitogens|mitogens|mesh-list
138766838|NCT05655221|Mitosis Modulators|mitosis modulators|mesh-ancestor
138766839|NCT05655221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766840|NCT00610792|Doxorubicin|doxorubicin|mesh-list
138766841|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138766842|NCT00610792|Bortezomib|bortezomib|mesh-list
138766843|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138766844|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766845|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138766846|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138766847|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766848|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766849|NCT00610870|Atorvastatin|atorvastatin|mesh-list
138766850|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138766851|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138766852|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
138766853|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766854|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138681934|NCT00518895|Dacarbazine|dacarbazine|mesh-list
138766855|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138766856|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766857|NCT01168596|Rasagiline|rasagiline|mesh-list
138766858|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138766859|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085243|NCT01134536|Analgesics|analgesics|mesh-ancestor
138766860|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766861|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138766862|NCT01168596|Protective Agents|protective agents|mesh-ancestor
138766863|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766864|NCT02675647|Heparin|heparin|mesh-list
138766866|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
138766867|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138766868|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138766869|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766870|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
138766871|NCT02675647|Coagulants|coagulants|mesh-ancestor
138766872|NCT05370898|Calcium Carbonate|calcium carbonate|mesh-list
138766873|NCT05370898|Antacids|antacids|mesh-ancestor
138766874|NCT05370898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766875|NCT05370898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138766876|NCT00610948|Leucovorin|leucovorin|mesh-list
138766877|NCT00610948|Fluorouracil|fluorouracil|mesh-list
138766879|NCT00610948|Everolimus|everolimus|mesh-list
138766880|NCT00610948|Panitumumab|panitumumab|mesh-list
138766881|NCT00610948|Calcium|calcium|mesh-list
138766882|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
138766883|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138766884|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766885|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
138766886|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766887|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138766888|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766889|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138766890|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
138766891|NCT00610948|Antidotes|antidotes|mesh-ancestor
138766892|NCT00610948|Protective Agents|protective agents|mesh-ancestor
138766893|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
138766894|NCT00610948|Vitamins|vitamins|mesh-ancestor
138766895|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
138766896|NCT00610948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138766897|NCT00610948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138766898|NCT00610948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766899|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138766900|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138766901|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
138766902|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138766903|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
138766904|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766905|NCT00928408|Cinacalcet|cinacalcet|mesh-list
138766906|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138766907|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766908|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138766909|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
138766910|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138766911|NCT00928252|Fluorides|fluorides|mesh-list
138766912|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
138766913|NCT00928252|Protective Agents|protective agents|mesh-ancestor
138766914|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766915|NCT02673229|Bacitracin|bacitracin|mesh-list
138766916|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138766917|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138766918|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138766919|NCT00644293|Azithromycin|azithromycin|mesh-list
138766920|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138766921|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682043|NCT02949258|Epirubicin|epirubicin|mesh-list
138766922|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
138766923|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138766924|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138766925|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138766926|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138766927|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766928|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766929|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766930|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138441314|NCT01788982|Nintedanib|nintedanib|mesh-list
138766931|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138766932|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
138766933|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138766934|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
138766935|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766936|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
138766937|NCT01176773|Protective Agents|protective agents|mesh-ancestor
138766938|NCT02887625|Insulin|insulin|mesh-list
138766939|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
138766940|NCT02887625|Pioglitazone|pioglitazone|mesh-list
138766941|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
138766942|NCT02887625|Exenatide|exenatide|mesh-list
138766943|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138766944|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766945|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138766946|NCT02887625|Incretins|incretins|mesh-ancestor
138766947|NCT02887625|Hormones|hormones|mesh-ancestor
138766948|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138766949|NCT02886377|Antibodies|antibodies|mesh-list
138766950|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
138766951|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766952|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138766953|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138766954|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766955|NCT02675335|Incretins|incretins|mesh-ancestor
138766956|NCT02675335|Hormones|hormones|mesh-ancestor
138766957|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138597768|NCT02935933|Analgesics|analgesics|mesh-ancestor
138766958|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138766959|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
138766960|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766961|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766962|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
138766963|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138766964|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138766965|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
138766966|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766967|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138766968|NCT00928018|Cyclosporine|cyclosporine|mesh-list
138766969|NCT00928018|Sirolimus|sirolimus|mesh-list
138766970|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
138766971|NCT00928018|Methotrexate|methotrexate|mesh-list
138766972|NCT00928018|Tacrolimus|tacrolimus|mesh-list
138766973|NCT00928018|Cyclosporins|cyclosporins|mesh-list
138766974|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138766975|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
138766976|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138766977|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138766978|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138766979|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
138766980|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766981|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138766982|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
138766983|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138766984|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138766985|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138766986|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
138766987|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138766988|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138766989|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138766990|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
138766991|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138766992|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138766993|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138766994|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
138766995|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138766996|NCT02672839|Betadex|betadex|mesh-list
138766997|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
138766998|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138766999|NCT00609154|Glucagon|glucagon|mesh-list
138767000|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138767001|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138767002|NCT00609154|Hormones|hormones|mesh-ancestor
138767003|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138767004|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767005|NCT00609154|Incretins|incretins|mesh-ancestor
138767006|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
138767007|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767008|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767009|NCT00927862|Warfarin|warfarin|mesh-list
138767010|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
138767011|NCT02672527|Dexamethasone|dexamethasone|mesh-list
138767012|NCT02672527|Trabectedin|trabectedin|mesh-list
138767013|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138767014|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
138767015|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
138767016|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138767017|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767018|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138767019|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
138767020|NCT02672527|Hormones|hormones|mesh-ancestor
138767021|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138767022|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138767023|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767024|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138767025|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
138597868|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767026|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767027|NCT00976989|Docetaxel|docetaxel|mesh-list
138767028|NCT00976989|Trastuzumab|trastuzumab|mesh-list
138767029|NCT00976989|Pertuzumab|pertuzumab|mesh-list
138767030|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767031|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
138767032|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
138767034|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767035|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767036|NCT05449171|Vitamin D|vitamin d|mesh-list
138767037|NCT05449171|Vitamins|vitamins|mesh-list
138767038|NCT05449171|Thioctic Acid|thioctic acid|mesh-list
138767039|NCT05449171|Vitamin B 6|vitamin b 6|mesh-list
138767040|NCT05449171|Pyridoxal|pyridoxal|mesh-list
138767041|NCT05449171|Pyridoxine|pyridoxine|mesh-list
138767042|NCT05449171|Hyaluronic Acid|hyaluronic acid|mesh-list
138767043|NCT05449171|Micronutrients|micronutrients|mesh-ancestor
138767044|NCT05449171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767045|NCT05449171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138767046|NCT05449171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138767047|NCT05449171|Immunologic Factors|immunologic factors|mesh-ancestor
138767048|NCT05449171|Viscosupplements|viscosupplements|mesh-ancestor
138767049|NCT05449171|Protective Agents|protective agents|mesh-ancestor
138767050|NCT05449171|Vitamin B Complex|vitamin b complex|mesh-ancestor
138767051|NCT05449171|Antioxidants|antioxidants|mesh-ancestor
138358957|NCT00005070|Irofulven|irofulven|mesh-list
138682117|NCT00519480|Metformin|metformin|mesh-list
138597904|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138767052|NCT05449171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767053|NCT02675023|Adalimumab|adalimumab|mesh-list
138767054|NCT02675023|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138767055|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138767056|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138767057|NCT00644371|Rituximab|rituximab|mesh-list
138767058|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767059|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767060|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
138767061|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767062|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138767063|NCT02864199|Ribavirin|ribavirin|mesh-list
138767064|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138767065|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
138767066|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767067|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
138767068|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138767069|NCT05911126|Celecoxib|celecoxib|mesh-list
138767070|NCT05911126|Scopolamine|scopolamine|mesh-list
138767071|NCT05911126|Bromides|bromides|mesh-list
138767072|NCT05911126|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138767073|NCT05911126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138767074|NCT05911126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138767075|NCT05911126|Analgesics|analgesics|mesh-ancestor
138767076|NCT05911126|Sensory System Agents|sensory system agents|mesh-ancestor
138767077|NCT05911126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138767078|NCT05911126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767079|NCT05911126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138767080|NCT05911126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138767081|NCT05911126|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138767082|NCT05911126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138767083|NCT05911126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767084|NCT05911126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597955|NCT00153140|Laxatives|laxatives|mesh-ancestor
138767085|NCT05911126|Anticonvulsants|anticonvulsants|mesh-ancestor
138767086|NCT05911126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138767087|NCT05911126|Antiemetics|antiemetics|mesh-ancestor
138767088|NCT05911126|Autonomic Agents|autonomic agents|mesh-ancestor
138767089|NCT05911126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138767090|NCT05911126|Mydriatics|mydriatics|mesh-ancestor
138767091|NCT05911126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138767092|NCT05911126|Cholinergic Agents|cholinergic agents|mesh-ancestor
138767093|NCT05911126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138767094|NCT05911126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138767095|NCT05911126|Parasympatholytics|parasympatholytics|mesh-ancestor
138767096|NCT05908513|Acetylcysteine|acetylcysteine|mesh-list
138767097|NCT05908513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138767098|NCT05908513|Antiviral Agents|antiviral agents|mesh-ancestor
138767099|NCT05908513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138767100|NCT05908513|Expectorants|expectorants|mesh-ancestor
138767101|NCT05908513|Respiratory System Agents|respiratory system agents|mesh-ancestor
138767102|NCT05908513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138767103|NCT05908513|Antioxidants|antioxidants|mesh-ancestor
138767104|NCT05908513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767105|NCT05908513|Protective Agents|protective agents|mesh-ancestor
138767106|NCT05908513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767107|NCT05908513|Antidotes|antidotes|mesh-ancestor
138767108|NCT05908305|Epinephrine|epinephrine|mesh-list
138767109|NCT05908305|Racepinephrine|racepinephrine|mesh-list
138767110|NCT05908305|Anesthetics|anesthetics|mesh-list
138767111|NCT05908305|Carticaine|carticaine|mesh-list
138767112|NCT05908305|Mepivacaine|mepivacaine|mesh-list
138767113|NCT05908305|Epinephryl borate|epinephryl borate|mesh-list
138767114|NCT05908305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138767115|NCT05908305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767116|NCT05908305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138767117|NCT05908305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138767118|NCT05908305|Adrenergic Agents|adrenergic agents|mesh-ancestor
138767119|NCT05908305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138767120|NCT05908305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767121|NCT05908305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138767122|NCT05908305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138767123|NCT05908305|Autonomic Agents|autonomic agents|mesh-ancestor
138767124|NCT05908305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138767125|NCT05908305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138767127|NCT05908305|Mydriatics|mydriatics|mesh-ancestor
138767128|NCT05908305|Sympathomimetics|sympathomimetics|mesh-ancestor
138767129|NCT05908305|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138767130|NCT05908305|Anesthetics, Local|anesthetics, local|mesh-ancestor
138767131|NCT05908305|Sensory System Agents|sensory system agents|mesh-ancestor
138767132|NCT02672995|Bevacizumab|bevacizumab|mesh-list
138767133|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767134|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767135|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138767136|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138767137|NCT02672995|Growth Substances|growth substances|mesh-ancestor
138767138|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767139|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
138767140|NCT05907902|Aspirin|aspirin|mesh-list
138767141|NCT05907902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138767142|NCT05907902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138767143|NCT05907902|Analgesics|analgesics|mesh-ancestor
138767144|NCT05907902|Sensory System Agents|sensory system agents|mesh-ancestor
138767145|NCT05907902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138767146|NCT05907902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767147|NCT05907902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138767148|NCT05907902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138767149|NCT05907902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138767150|NCT05907902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138767151|NCT05907902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767152|NCT05907902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138767153|NCT05907902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138767154|NCT05907902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767155|NCT05907902|Antipyretics|antipyretics|mesh-ancestor
138767156|NCT05907733|Mitogens|mitogens|mesh-list
138598028|NCT02933788|Aspirin|aspirin|mesh-list
138767157|NCT05907733|Mitosis Modulators|mitosis modulators|mesh-ancestor
138767158|NCT05907733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767159|NCT05907499|Decitabine|decitabine|mesh-list
138767160|NCT05907499|Epoetin Alfa|epoetin alfa|mesh-list
138767161|NCT05907499|Lenograstim|lenograstim|mesh-list
138767162|NCT05907499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138767163|NCT05907499|Antimetabolites|antimetabolites|mesh-ancestor
139085244|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
138767164|NCT05907499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441526|NCT01793038|Clomiphene|clomiphene|mesh-list
138767166|NCT05907499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767167|NCT05907499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138767168|NCT05907499|Immunologic Factors|immunologic factors|mesh-ancestor
138767169|NCT05907499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767170|NCT05907499|Hematinics|hematinics|mesh-ancestor
138767171|NCT05907486|Cytarabine|cytarabine|mesh-list
138767172|NCT05907486|Acetylcysteine|acetylcysteine|mesh-list
138767173|NCT05907486|Cyclophosphamide|cyclophosphamide|mesh-list
138767174|NCT05907486|Busulfan|busulfan|mesh-list
138767175|NCT05907486|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138767176|NCT05907486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138767177|NCT05907486|Immunologic Factors|immunologic factors|mesh-ancestor
138767178|NCT05907486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767179|NCT05907486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138767180|NCT05907486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138767181|NCT05907486|Alkylating Agents|alkylating agents|mesh-ancestor
138767182|NCT05907486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767183|NCT05907486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767184|NCT05907486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138767185|NCT05907486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138767186|NCT05907486|Antimetabolites|antimetabolites|mesh-ancestor
138767187|NCT05907486|Antiviral Agents|antiviral agents|mesh-ancestor
138767188|NCT05907486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138767189|NCT05907486|Expectorants|expectorants|mesh-ancestor
138767190|NCT05907486|Respiratory System Agents|respiratory system agents|mesh-ancestor
138767191|NCT05907486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138767192|NCT05907486|Antioxidants|antioxidants|mesh-ancestor
138767193|NCT05907486|Protective Agents|protective agents|mesh-ancestor
138767194|NCT05907486|Antidotes|antidotes|mesh-ancestor
138767195|NCT05906992|Ocrelizumab|ocrelizumab|mesh-list
138767196|NCT05906992|Immunologic Factors|immunologic factors|mesh-ancestor
138767197|NCT05906992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767199|NCT05906576|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138767200|NCT05906576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138767201|NCT05906576|Dermatologic Agents|dermatologic agents|mesh-ancestor
138767202|NCT05906576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138767203|NCT05906576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138767204|NCT05906563|Metformin|metformin|mesh-list
138767205|NCT05906563|Melatonin|melatonin|mesh-list
138767206|NCT05906563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138767207|NCT05906563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767208|NCT05906563|Antioxidants|antioxidants|mesh-ancestor
138767209|NCT05906563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767210|NCT05906563|Protective Agents|protective agents|mesh-ancestor
138767211|NCT05906563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138767212|NCT05906524|Bevacizumab|bevacizumab|mesh-list
138767213|NCT05906524|Tislelizumab|tislelizumab|mesh-list
138767214|NCT05906524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767215|NCT05906524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767216|NCT05906524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138767217|NCT05906524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138767218|NCT05906524|Growth Substances|growth substances|mesh-ancestor
138767219|NCT05906524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767220|NCT05906524|Growth Inhibitors|growth inhibitors|mesh-ancestor
138767221|NCT05906498|Vitamin E|vitamin e|mesh-list
138767222|NCT05906498|Acetylcysteine|acetylcysteine|mesh-list
138767223|NCT05906498|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138767224|NCT05906498|Vitamins|vitamins|mesh-ancestor
138767225|NCT05906498|Micronutrients|micronutrients|mesh-ancestor
138767226|NCT05906498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767227|NCT05906498|Antioxidants|antioxidants|mesh-ancestor
138767228|NCT05906498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767229|NCT05906498|Protective Agents|protective agents|mesh-ancestor
138767230|NCT05906498|Antiviral Agents|antiviral agents|mesh-ancestor
138767231|NCT05906498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138767232|NCT05906498|Expectorants|expectorants|mesh-ancestor
138767233|NCT05906498|Respiratory System Agents|respiratory system agents|mesh-ancestor
138553350|NCT00278278|Hormones|hormones|mesh-ancestor
138767234|NCT05906498|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138767235|NCT05906498|Antidotes|antidotes|mesh-ancestor
138767236|NCT05901961|Zinc|zinc|mesh-list
138767237|NCT05901961|Zinc Oxide|zinc oxide|mesh-list
138767238|NCT05901961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138767239|NCT05901961|Trace Elements|trace elements|mesh-ancestor
138767240|NCT05901961|Micronutrients|micronutrients|mesh-ancestor
138767241|NCT05901961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767242|NCT05901961|Dermatologic Agents|dermatologic agents|mesh-ancestor
138767243|NCT05901961|Sunscreening Agents|sunscreening agents|mesh-ancestor
138767244|NCT05901961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138767246|NCT05892510|Tenecteplase|tenecteplase|mesh-list
138767247|NCT05892510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138767248|NCT05892510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138767249|NCT05892510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767251|NCT05879835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138767252|NCT05879835|Anticoagulants|anticoagulants|mesh-ancestor
138767253|NCT05879835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138767254|NCT05879835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138767255|NCT05879835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767256|NCT05760807|Oxytocin|oxytocin|mesh-list
138767257|NCT05760807|Oxytocics|oxytocics|mesh-ancestor
138767258|NCT05760807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138767259|NCT05760807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767260|NCT05746442|Nicotine|nicotine|mesh-list
138767261|NCT05746442|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138767262|NCT05746442|Autonomic Agents|autonomic agents|mesh-ancestor
138767263|NCT05746442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138767264|NCT05746442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767265|NCT05746442|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138767266|NCT05746442|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138767267|NCT05746442|Cholinergic Agents|cholinergic agents|mesh-ancestor
138767268|NCT05746442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138767269|NCT05746442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767270|NCT05736874|Fluticasone|fluticasone|mesh-list
138767271|NCT05736874|Xhance|xhance|mesh-list
138767272|NCT05736874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138767273|NCT05736874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138767274|NCT05736874|Autonomic Agents|autonomic agents|mesh-ancestor
138767275|NCT05736874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138767276|NCT05736874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767277|NCT05736874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138767278|NCT05736874|Respiratory System Agents|respiratory system agents|mesh-ancestor
138767279|NCT05736874|Dermatologic Agents|dermatologic agents|mesh-ancestor
138767280|NCT05736874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138767281|NCT05699655|Oxaliplatin|oxaliplatin|mesh-list
138767282|NCT05699655|Apatinib|apatinib|mesh-list
138767283|NCT05699655|Tislelizumab|tislelizumab|mesh-list
138767284|NCT05699655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767285|NCT05699655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138767286|NCT05699655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767287|NCT05699655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767288|NCT05699655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767289|NCT05687500|Glyburide|glyburide|mesh-list
138767290|NCT05687500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138767291|NCT05687500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767292|NCT05675163|Vitamin K|vitamin k|mesh-list
138767293|NCT05675163|Vitamin K 2|vitamin k 2|mesh-list
138767294|NCT05675163|Vitamins|vitamins|mesh-ancestor
138767295|NCT05675163|Micronutrients|micronutrients|mesh-ancestor
138767296|NCT05675163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767297|NCT05675163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138767298|NCT05675163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138767299|NCT05675163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767300|NCT05675163|Hemostatics|hemostatics|mesh-ancestor
138767301|NCT05675163|Coagulants|coagulants|mesh-ancestor
138767302|NCT05596786|Rituximab|rituximab|mesh-list
138598192|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767303|NCT05596786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767304|NCT05596786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767305|NCT05596786|Immunologic Factors|immunologic factors|mesh-ancestor
138767306|NCT05596786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767307|NCT05596786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138767308|NCT05582707|Pioglitazone|pioglitazone|mesh-list
138887944|NCT04018690|Triamcinolone|triamcinolone|mesh-list
138767309|NCT05582707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138767310|NCT05582707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767311|NCT05564611|Omalizumab|omalizumab|mesh-list
138767312|NCT05564611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138767313|NCT05564611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138767314|NCT05564611|Respiratory System Agents|respiratory system agents|mesh-ancestor
138767315|NCT05559164|Atorvastatin|atorvastatin|mesh-list
138767316|NCT05559164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138767317|NCT05559164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138767318|NCT05559164|Antimetabolites|antimetabolites|mesh-ancestor
138598227|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138767319|NCT05559164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767320|NCT05559164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138767321|NCT05559164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138767322|NCT05559164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767323|NCT05553405|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138767324|NCT05553405|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138767325|NCT05553405|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138767326|NCT05553405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138767327|NCT05487261|Valsartan|valsartan|mesh-list
138767328|NCT05487261|Enalapril|enalapril|mesh-list
138767329|NCT05487261|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138767330|NCT05487261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138767331|NCT05487261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138767332|NCT05487261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138767333|NCT05487261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767334|NCT05487261|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138767335|NCT05487261|Protease Inhibitors|protease inhibitors|mesh-ancestor
138767336|NCT05487261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767337|NCT05479240|Capecitabine|capecitabine|mesh-list
138767338|NCT05479240|Oxaliplatin|oxaliplatin|mesh-list
138767339|NCT05479240|Tislelizumab|tislelizumab|mesh-list
138767340|NCT05479240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138767341|NCT05479240|Antimetabolites|antimetabolites|mesh-ancestor
138767342|NCT05479240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767343|NCT05479240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767344|NCT05479240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767345|NCT05442684|Vaccines|vaccines|mesh-list
138767346|NCT05442684|Immunologic Factors|immunologic factors|mesh-ancestor
138767347|NCT05442684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767348|NCT05380388|Vaccines|vaccines|mesh-list
138767349|NCT05380388|Immunologic Factors|immunologic factors|mesh-ancestor
138767350|NCT05380388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767351|NCT05332444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138767352|NCT05332444|Amoxicillin|amoxicillin|mesh-list
138767353|NCT05332444|Metronidazole|metronidazole|mesh-list
138767354|NCT05332444|Clarithromycin|clarithromycin|mesh-list
138767355|NCT05332444|Levofloxacin|levofloxacin|mesh-list
138767356|NCT05332444|Tetracycline|tetracycline|mesh-list
138767357|NCT05332444|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138767358|NCT05332444|Rabeprazole|rabeprazole|mesh-list
138767359|NCT05332444|Bismuth|bismuth|mesh-list
138767360|NCT05332444|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138767361|NCT05332444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138767362|NCT05332444|Antitubercular Agents|antitubercular agents|mesh-ancestor
138767363|NCT05332444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138767364|NCT05332444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138767365|NCT05332444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138767366|NCT05332444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767367|NCT05332444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767368|NCT05332444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138767369|NCT05332444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138767370|NCT05332444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138767371|NCT05332444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138767372|NCT05332444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138767373|NCT05332444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767374|NCT05332444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138767375|NCT05332444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138888013|NCT02615340|Melatonin|melatonin|mesh-list
138767376|NCT05332444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138767377|NCT05332444|Antacids|antacids|mesh-ancestor
138767379|NCT05290740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138767380|NCT05290740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138767381|NCT05290740|Adrenergic Agents|adrenergic agents|mesh-ancestor
138767382|NCT05290740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138767383|NCT05290740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767384|NCT05290740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767385|NCT05290740|Sympathomimetics|sympathomimetics|mesh-ancestor
138767386|NCT05290740|Autonomic Agents|autonomic agents|mesh-ancestor
138767387|NCT05290740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138767388|NCT05290740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138767389|NCT05234554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138767390|NCT05234554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138767391|NCT05212311|Chitosan|chitosan|mesh-list
138767392|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138767393|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138767394|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
138767395|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767396|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138767397|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
138767398|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
138767399|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
138767400|NCT05212311|Coagulants|coagulants|mesh-ancestor
138767401|NCT05159752|Afamelanotide|afamelanotide|mesh-list
138767402|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
138767403|NCT05093322|Gemcitabine|gemcitabine|mesh-list
138767404|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138767405|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
138767406|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767407|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767408|NCT05074355|Azacitidine|azacitidine|mesh-list
138767409|NCT05074355|Venetoclax|venetoclax|mesh-list
138767410|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138767411|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
138767412|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767413|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767414|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767415|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138767416|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138767417|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138767418|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767419|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138767420|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138682485|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138767421|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767422|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
138767423|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138767424|NCT05001152|Ozanimod|ozanimod|mesh-list
138767425|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138767426|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767427|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138767428|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
138767429|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767430|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
138767431|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
138767432|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
138767433|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
138767434|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767435|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767436|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
138767437|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138767438|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767439|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
138767440|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767441|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767442|NCT04840394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138767443|NCT04840394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767444|NCT04839549|Fluorometholone|fluorometholone|mesh-list
138767445|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138767446|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767448|NCT04839549|Hormones|hormones|mesh-ancestor
138767449|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138767450|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138767451|NCT04794569|Tinzaparin|tinzaparin|mesh-list
138767452|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138767453|NCT04794569|Dalteparin|dalteparin|mesh-list
138767454|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
138767455|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138767456|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
138767457|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138767458|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
138767459|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767460|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767461|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
138767462|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138767463|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138767464|NCT04787042|Pembrolizumab|pembrolizumab|mesh-list
138767465|NCT04787042|Obinutuzumab|obinutuzumab|mesh-list
138767466|NCT04787042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767467|NCT04787042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767468|NCT04787042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138767469|NCT04787042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441819|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
138767472|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767473|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767474|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138767475|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767476|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138767477|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767478|NCT04563338|Bevacizumab|bevacizumab|mesh-list
138767479|NCT04563338|Atezolizumab|atezolizumab|mesh-list
138767480|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767481|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767482|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138767483|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138767484|NCT04563338|Growth Substances|growth substances|mesh-ancestor
138767485|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767486|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
138767487|NCT04563338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138767488|NCT04563338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767489|NCT04524910|Aflibercept|aflibercept|mesh-list
138767490|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138767491|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138767492|NCT04524910|Growth Substances|growth substances|mesh-ancestor
138767493|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767494|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
138767495|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767496|NCT04410653|Afatinib|afatinib|mesh-list
138767497|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767498|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138767499|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767500|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767501|NCT04377087|Olaparib|olaparib|mesh-list
138767502|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138767503|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767504|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767505|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767506|NCT04341779|Tenofovir|tenofovir|mesh-list
138767507|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
138767508|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138767509|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138767510|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138767511|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767512|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767513|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138767514|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138767516|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
138767517|NCT04205838|Fludarabine|fludarabine|mesh-list
138767518|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
138767520|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138767521|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138767522|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
138767523|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767524|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138767525|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138767526|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
138767527|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767528|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767529|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138767530|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138767531|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
138767532|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
138767533|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138767534|NCT04205838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767535|NCT04196530|Atezolizumab|atezolizumab|mesh-list
138767536|NCT04196530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138767537|NCT04196530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767538|NCT04196530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767539|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767540|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
138767541|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138767542|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767543|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138767544|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767545|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
138767546|NCT04163016|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138767547|NCT04163016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138767548|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138767549|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
138767550|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888145|NCT00738556|Sirolimus|sirolimus|mesh-list
138767551|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138767552|NCT04147013|Celecoxib|celecoxib|mesh-list
138767553|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138767554|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138767555|NCT04147013|Analgesics|analgesics|mesh-ancestor
138767556|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
138767557|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138767558|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767559|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138767560|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138767561|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138767562|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138767563|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598583|NCT02920567|Octreotide|octreotide|mesh-list
138767564|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767565|NCT04084717|Crizotinib|crizotinib|mesh-list
138767566|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682569|NCT00523887|Fentanyl|fentanyl|mesh-list
138767567|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138767568|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767569|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767570|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
138767571|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767572|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767573|NCT03991819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138767574|NCT03991819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767575|NCT03919552|Cisplatin|cisplatin|mesh-list
138767576|NCT03919552|Carboplatin|carboplatin|mesh-list
138767577|NCT03919552|Docetaxel|docetaxel|mesh-list
138767578|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767579|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
138767580|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
138767581|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
138767582|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767583|NCT03853707|Paclitaxel|paclitaxel|mesh-list
138767584|NCT03853707|Carboplatin|carboplatin|mesh-list
138767585|NCT03853707|Capecitabine|capecitabine|mesh-list
138767586|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138767587|NCT03853707|Atezolizumab|atezolizumab|mesh-list
138767588|NCT03853707|Ipatasertib|ipatasertib|mesh-list
138767589|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138767590|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138767591|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767592|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
138767593|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
138767594|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
138767595|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767596|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138767597|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
138767598|NCT03853707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138767599|NCT03853707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767600|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
138767601|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767602|NCT03853707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138767603|NCT03853707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767604|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
138767605|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138767606|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
138767607|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138767609|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767610|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138767611|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682587|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767612|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767613|NCT03641456|Dexamethasone|dexamethasone|mesh-list
138441967|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138767614|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
138767615|NCT03641456|Lenalidomide|lenalidomide|mesh-list
138767617|NCT03641456|BB 1101|bb 1101|mesh-list
138767618|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138767619|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
138767620|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
138767621|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138767622|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767623|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138767624|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
138767625|NCT03641456|Hormones|hormones|mesh-ancestor
138767626|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138767627|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138767628|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767629|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
138767630|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767631|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767632|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
138767633|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138767634|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138767635|NCT03641456|Growth Substances|growth substances|mesh-ancestor
138767636|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
138767637|NCT03493152|Everolimus|everolimus|mesh-list
138767638|NCT03493152|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138767639|NCT03493152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138767640|NCT03493152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682616|NCT05142098|Analgesics|analgesics|mesh-ancestor
138767641|NCT03493152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767642|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138767643|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
138767644|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767645|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767646|NCT03492671|Paclitaxel|paclitaxel|mesh-list
138767647|NCT03492671|Gemcitabine|gemcitabine|mesh-list
138767648|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138767649|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767650|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
138767651|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
138767652|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
138767653|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767654|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138767655|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
138767656|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
138767657|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767658|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767659|NCT03486301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138767660|NCT03486301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767661|NCT03391479|Avelumab|avelumab|mesh-list
138767662|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767663|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767664|NCT03355300|Cannabidiol|cannabidiol|mesh-list
138767665|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
138767666|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
138767667|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767668|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
138767669|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138767670|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767671|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
138767672|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767673|NCT03087903|Protective Agents|protective agents|mesh-ancestor
138767674|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767675|NCT03074045|Drospirenone|drospirenone|mesh-list
138767676|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
138767677|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138767678|NCT03074045|Estradiol|estradiol|mesh-list
138767679|NCT03074045|Estrogens|estrogens|mesh-ancestor
138767680|NCT03074045|Hormones|hormones|mesh-ancestor
139085245|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138767681|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138682664|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138767683|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138767685|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138767686|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138767687|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138767688|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138767689|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138442043|NCT01802593|Methotrexate|methotrexate|mesh-list
138767690|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138767691|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
138767692|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138767693|NCT03074045|Diuretics|diuretics|mesh-ancestor
138767694|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
138767695|NCT02948543|Mitomycins|mitomycins|mesh-list
138767696|NCT02948543|Mitomycin|mitomycin|mesh-list
138767697|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138767698|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767699|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
138767700|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767701|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138767702|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767703|NCT02901184|Spironolactone|spironolactone|mesh-list
138767704|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138767705|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
138767706|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138767707|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767708|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138888333|NCT00656786|Vitamin K|vitamin k|mesh-list
138767709|NCT02901184|Diuretics|diuretics|mesh-ancestor
138767710|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
138767711|NCT02901041|Zonisamide|zonisamide|mesh-list
138767712|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
138767713|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138767714|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138767715|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767716|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138767717|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767718|NCT02840227|Anesthetics|anesthetics|mesh-list
138767719|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138767720|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767721|NCT02705508|Gemcitabine|gemcitabine|mesh-list
138767722|NCT02705508|Etoposide|etoposide|mesh-list
138767724|NCT02705508|Pegaspargase|pegaspargase|mesh-list
138767725|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138767726|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
138598785|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138767727|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767728|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767729|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138767730|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138767731|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138767732|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767733|NCT02636322|Prednisone|prednisone|mesh-list
138767734|NCT02636322|Cortisone|cortisone|mesh-list
138767735|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
138767736|NCT02636322|Rituximab|rituximab|mesh-list
138767737|NCT02636322|Doxorubicin|doxorubicin|mesh-list
138767738|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138767739|NCT02636322|Etoposide|etoposide|mesh-list
138767740|NCT02636322|Vincristine|vincristine|mesh-list
138767741|NCT02636322|Lenalidomide|lenalidomide|mesh-list
138767742|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
138767743|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
138767744|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138767745|NCT02636322|Antibodies|antibodies|mesh-list
138767746|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
138767747|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138767748|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138767749|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
138767750|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767751|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138767752|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138767753|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
138767754|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767755|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767756|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138767757|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138767758|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138767759|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138767760|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767761|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138767762|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
138767763|NCT02636322|Hormones|hormones|mesh-ancestor
139085246|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138767764|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138598824|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138767765|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138767766|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138767768|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
138767769|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
138767770|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138767771|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138767772|NCT02636322|Growth Substances|growth substances|mesh-ancestor
138767773|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
138767774|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
138767775|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
138767778|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767779|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
138767780|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
138767781|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
138767782|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767783|NCT02523040|Lenalidomide|lenalidomide|mesh-list
138767784|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
138767785|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767786|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138767787|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138767788|NCT02523040|Growth Substances|growth substances|mesh-ancestor
138767789|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
138767790|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767791|NCT02396043|Cytarabine|cytarabine|mesh-list
138767792|NCT02396043|Dexamethasone|dexamethasone|mesh-list
138767793|NCT02396043|Prednisone|prednisone|mesh-list
138767794|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
138767795|NCT02396043|Methotrexate|methotrexate|mesh-list
138767796|NCT02396043|Vincristine|vincristine|mesh-list
138767797|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
138767798|NCT02396043|Pegaspargase|pegaspargase|mesh-list
138767799|NCT02396043|Asparaginase|asparaginase|mesh-list
138767800|NCT02396043|Pirarubicin|pirarubicin|mesh-list
138767801|NCT02396043|Doxorubicin|doxorubicin|mesh-list
138767802|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138767803|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
138767804|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767805|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138767806|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138767807|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
138767808|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767809|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767810|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138767811|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138767812|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
138767813|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
138767814|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138767815|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138767816|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
138767817|NCT02396043|Hormones|hormones|mesh-ancestor
138767818|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138767819|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138767820|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767821|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138767822|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
138767823|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138767824|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138767825|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
138767826|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
138767827|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138767828|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138767829|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
138767830|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138767831|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138767832|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
138767833|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
138767834|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
138767835|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138767836|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138767837|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138767838|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138767839|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
138767840|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442188|NCT01803321|Rilonacept|rilonacept|mesh-list
138767841|NCT01525966|Paclitaxel|paclitaxel|mesh-list
138767842|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138767843|NCT01525966|Carboplatin|carboplatin|mesh-list
138767844|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138767845|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767847|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
138767848|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
138767849|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767850|NCT01273610|Trastuzumab|trastuzumab|mesh-list
138767851|NCT01273610|Lapatinib|lapatinib|mesh-list
138767852|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767853|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767854|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138767855|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767856|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767857|NCT00999804|Trastuzumab|trastuzumab|mesh-list
138767858|NCT00999804|Letrozole|letrozole|mesh-list
138767859|NCT00999804|Lapatinib|lapatinib|mesh-list
138767860|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138767861|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767862|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138767863|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138767864|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767865|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767866|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138767867|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
138767868|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138767869|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767870|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138767871|NCT00544830|Leuprolide|leuprolide|mesh-list
138767873|NCT00544830|Bicalutamide|bicalutamide|mesh-list
138767874|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138767875|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
138767876|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138767877|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767878|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138767879|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767880|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
138767881|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
138767882|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138767883|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
138767884|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138767885|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138767886|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138767887|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
138767888|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
138767889|NCT00077129|Paclitaxel|paclitaxel|mesh-list
138767890|NCT00077129|Carboplatin|carboplatin|mesh-list
138767891|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138767892|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767893|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
138767894|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
138767895|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
138888473|NCT00711880|Nabiximols|nabiximols|mesh-list
138767896|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767897|NCT00052884|Melphalan|melphalan|mesh-list
138767898|NCT00052884|Amifostine|amifostine|mesh-list
138767899|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
138767900|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767901|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138767902|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
138767903|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767904|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767905|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138767906|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138767907|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138767908|NCT00052884|Protective Agents|protective agents|mesh-ancestor
138767909|NCT00040807|Docetaxel|docetaxel|mesh-list
138767910|NCT00040807|Irinotecan|irinotecan|mesh-list
138767911|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767912|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
138767913|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
138767914|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
138767915|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767916|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138767917|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138767918|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767919|NCT00028678|Dalteparin|dalteparin|mesh-list
138767920|NCT00028678|Tinzaparin|tinzaparin|mesh-list
138767921|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138767922|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
138767923|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138767924|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138767925|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767926|NCT00004223|Gemcitabine|gemcitabine|mesh-list
138767927|NCT00004223|Docetaxel|docetaxel|mesh-list
138767928|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138767929|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
138767930|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767931|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767932|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
138767933|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
138767934|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
138767935|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
138767936|NCT00003764|Fludarabine|fludarabine|mesh-list
138767937|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
138767938|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138767939|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
138767940|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767941|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138767942|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138767943|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
138767944|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767945|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767946|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138767947|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138767948|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
138767950|NCT00003601|Fenretinide|fenretinide|mesh-list
138767951|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767952|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
138767953|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
138767954|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138767955|NCT00003601|Protective Agents|protective agents|mesh-ancestor
138767956|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767957|NCT00003266|Methylphenidate|methylphenidate|mesh-list
138767958|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138767959|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138767960|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138767961|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138767962|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138767963|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767964|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
138767965|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138767966|NCT00003236|ISIS 5132|isis 5132|mesh-list
138767967|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767968|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138767969|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767970|NCT00003057|Octreotide|octreotide|mesh-list
138767971|NCT00003057|Loperamide|loperamide|mesh-list
138767972|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
138767973|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138767974|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138767976|NCT00002922|Paclitaxel|paclitaxel|mesh-list
138767977|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138767978|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138767979|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
138767980|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
138767981|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
138767982|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138767983|NCT00002514|Leucovorin|leucovorin|mesh-list
138767984|NCT00002514|Cytarabine|cytarabine|mesh-list
138767985|NCT00002514|Dexamethasone|dexamethasone|mesh-list
138767986|NCT00002514|Prednisone|prednisone|mesh-list
138767987|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
138767988|NCT00002514|Methotrexate|methotrexate|mesh-list
138767989|NCT00002514|Etoposide|etoposide|mesh-list
138767990|NCT00002514|Vincristine|vincristine|mesh-list
138767991|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
138767992|NCT00002514|Daunorubicin|daunorubicin|mesh-list
138767993|NCT00002514|Asparaginase|asparaginase|mesh-list
138767994|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
138767995|NCT00002514|Thioguanine|thioguanine|mesh-list
138767996|NCT00002514|Sargramostim|sargramostim|mesh-list
138767997|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
138767998|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138767999|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
138768000|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768001|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138768002|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138768003|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
138768004|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768005|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768006|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138768007|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138768008|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
138768009|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
138768010|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768011|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138768012|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
138768013|NCT00002514|Hormones|hormones|mesh-ancestor
138888511|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888512|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888513|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059175|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138768014|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138768015|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138768016|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138768017|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
138768018|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138768019|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138768020|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
138768021|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
138768022|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768023|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138768024|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138768025|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138768026|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138768027|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138768028|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
138768029|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768030|NCT00002514|Antidotes|antidotes|mesh-ancestor
138768031|NCT00002514|Protective Agents|protective agents|mesh-ancestor
138768032|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
138768033|NCT00002514|Vitamins|vitamins|mesh-ancestor
138768034|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
138768035|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
138768036|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
138768037|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
138768038|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138768039|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138768040|NCT00607282|Udenafil|udenafil|mesh-list
138768041|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138768042|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138768043|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768044|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768045|NCT00927472|Permethrin|permethrin|mesh-list
138768046|NCT00927472|Malathion|malathion|mesh-list
138599137|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
138599138|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138599139|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599161|NCT01715974|Molgramostim|molgramostim|mesh-list
138599162|NCT01715974|Sargramostim|sargramostim|mesh-list
138599163|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
138599164|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599165|NCT01715974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599166|NCT05471479|Charcoal|charcoal|mesh-list
138599167|NCT05471479|Antidotes|antidotes|mesh-ancestor
138599168|NCT05471479|Protective Agents|protective agents|mesh-ancestor
138485708|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
138599169|NCT05471479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599170|NCT00188877|Fluorouracil|fluorouracil|mesh-list
138599171|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
138599172|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599173|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138488484|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599174|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488485|NCT00001038|Valacyclovir|valacyclovir|mesh-list
138599175|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138768047|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768048|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768049|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138768050|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
138768051|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768052|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768053|NCT00642655|Rituximab|rituximab|mesh-list
138768054|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138768055|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768056|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
138768057|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768058|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138888541|NCT00613145|Capecitabine|capecitabine|mesh-list
138888543|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138888544|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
138888545|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888546|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888547|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138888548|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888549|NCT04570085|Caffeine|caffeine|mesh-list
138888550|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138768060|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138768061|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138768063|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768064|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768065|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138768066|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768067|NCT00927394|Valsartan|valsartan|mesh-list
138768068|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138768069|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138768070|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139059176|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138768071|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768072|NCT00643825|Temozolomide|temozolomide|mesh-list
138768073|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138768074|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
138768075|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768076|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768078|NCT04178863|Latanoprost|latanoprost|mesh-list
138768079|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138683066|NCT00525681|Tacrolimus|tacrolimus|mesh-list
138768080|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138768081|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
138768082|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768083|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768084|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768085|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138768086|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138768087|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138768088|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138768089|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
138768090|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138768091|NCT04264858|Antibodies|antibodies|mesh-list
138768092|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
138768093|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
138768094|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768095|NCT00976911|Paclitaxel|paclitaxel|mesh-list
138768096|NCT00976911|Bevacizumab|bevacizumab|mesh-list
138768097|NCT00976911|Doxorubicin|doxorubicin|mesh-list
138768098|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138768099|NCT00976911|Topotecan|topotecan|mesh-list
138768100|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138768102|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
138768103|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
138768104|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
138768105|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768106|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138768107|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138768108|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138768109|NCT00976911|Growth Substances|growth substances|mesh-ancestor
138768110|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768111|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
138768112|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138768113|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138768114|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138768115|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768116|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138768118|NCT05336968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138768119|NCT05336968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138768120|NCT05336968|Ketorolac|ketorolac|mesh-list
138768121|NCT05336968|Ropivacaine|ropivacaine|mesh-list
138768122|NCT05336968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138768123|NCT05336968|Anesthetics, Local|anesthetics, local|mesh-ancestor
138768124|NCT05336968|Anesthetics|anesthetics|mesh-ancestor
138768125|NCT05336968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768126|NCT05336968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768127|NCT05336968|Sensory System Agents|sensory system agents|mesh-ancestor
138768128|NCT05336968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768129|NCT05336968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138768130|NCT05336968|Glucocorticoids|glucocorticoids|mesh-ancestor
138768131|NCT05336968|Hormones|hormones|mesh-ancestor
138599330|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138768132|NCT05336968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138768133|NCT05336968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138768134|NCT05336968|Immunologic Factors|immunologic factors|mesh-ancestor
138768135|NCT05336968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768136|NCT05336968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768137|NCT05336968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138768138|NCT05336968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138768139|NCT05336968|Analgesics|analgesics|mesh-ancestor
138768140|NCT05336968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138768141|NCT05336968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138768142|NCT02674555|Naquotinib|naquotinib|mesh-list
138768143|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768144|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138768145|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768146|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768147|NCT00934648|Rituximab|rituximab|mesh-list
138768148|NCT00934648|Methotrexate|methotrexate|mesh-list
138768149|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138768150|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768151|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
138768152|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768153|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138298258|NCT00003728|Leucovorin|leucovorin|mesh-list
138768154|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138768155|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
138768156|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138768157|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138768158|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
138683274|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
138768159|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768160|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
138768161|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768162|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138768163|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138768164|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138768165|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138768166|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
138768167|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138768168|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
138768169|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768170|NCT00644449|Azithromycin|azithromycin|mesh-list
138768171|NCT00644449|Levofloxacin|levofloxacin|mesh-list
138768172|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138768173|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768174|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138768175|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138768176|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138768177|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768178|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768179|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768180|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138768181|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138768182|NCT04287777|Mupirocin|mupirocin|mesh-list
138768183|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138768184|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768185|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138768186|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768187|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768188|NCT04180657|Protein C|protein c|mesh-list
138768189|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
138768190|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138768191|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138768192|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768193|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138768194|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
138768195|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768196|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
138768197|NCT02674243|Povidone|povidone|mesh-list
138768198|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138275794|NCT00004095|Irinotecan|irinotecan|mesh-list
138768199|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
138768200|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
138768201|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138768202|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768203|NCT04256200|Dienogest|dienogest|mesh-list
138768204|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
138768205|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
138768206|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138768207|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138768208|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768209|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138768210|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138768211|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138768212|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138768213|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
138768214|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138768215|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138768216|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768219|NCT00976677|Carboplatin|carboplatin|mesh-list
138768220|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138768221|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138768223|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
138768224|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138768225|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138768226|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768227|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
138768228|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
138768229|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
138768230|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768231|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138768232|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138768233|NCT00976677|Growth Substances|growth substances|mesh-ancestor
138768234|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768235|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
138768236|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
138768237|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138768238|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768239|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
138768240|NCT00642967|Hematinics|hematinics|mesh-ancestor
138768241|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
138768242|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138768243|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768244|NCT04287543|Melatonin|melatonin|mesh-list
138768245|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
138768246|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768247|NCT04287543|Protective Agents|protective agents|mesh-ancestor
138768248|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768249|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768250|NCT04287387|Pioglitazone|pioglitazone|mesh-list
138768251|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
138768252|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138768253|NCT04287387|Metformin|metformin|mesh-list
138768254|NCT04287387|Glimepiride|glimepiride|mesh-list
138768255|NCT04287387|Acarbose|acarbose|mesh-list
138768256|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138768257|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768258|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138768259|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768260|NCT04287387|Incretins|incretins|mesh-ancestor
138768261|NCT04287387|Hormones|hormones|mesh-ancestor
138768262|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138768263|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138768264|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
138888640|NCT04131582|Hormones|hormones|mesh-ancestor
138768265|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768266|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138768267|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138768268|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
138768269|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138768270|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
138768271|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
138768272|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138768273|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138768274|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768275|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768276|NCT00644605|Urological Agents|urological agents|mesh-ancestor
138768278|NCT02865681|Clomiphene|clomiphene|mesh-list
138768279|NCT02865681|Enclomiphene|enclomiphene|mesh-list
138768280|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
138768281|NCT02865681|Menotropins|menotropins|mesh-list
138768282|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599491|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
138768283|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768284|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138768285|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138768286|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768287|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138768288|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
138768289|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138768290|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553423|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
138768291|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138768292|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
138768293|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138768294|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138768295|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138768297|NCT00644137|Analgesics|analgesics|mesh-ancestor
138768298|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
138768299|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683575|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
138768300|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768301|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
138768302|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138768303|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138768304|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768305|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138768306|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138768307|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138768308|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768309|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138768310|NCT00910195|Acetaminophen|acetaminophen|mesh-list
138768311|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138768312|NCT00910195|Analgesics|analgesics|mesh-ancestor
138768313|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
138768314|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768315|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768316|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
138768317|NCT04176367|Nicergoline|nicergoline|mesh-list
138768318|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138768319|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138768320|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
138768321|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768322|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768323|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768324|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
138599534|NCT00157079|Antibodies|antibodies|mesh-list
138768325|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
138768327|NCT04259476|Analgesics|analgesics|mesh-ancestor
138683619|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138768329|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768330|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768331|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138768332|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138768333|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
138768334|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
138768335|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768336|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138768337|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138768338|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768339|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768340|NCT00970281|Olanzapine|olanzapine|mesh-list
138768341|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
138768342|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
138768343|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768344|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768345|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138768346|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138683664|NCT00511628|Risperidone|risperidone|mesh-list
138768347|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138768348|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768349|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138768350|NCT00970281|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138768351|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138599557|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
138768352|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138768353|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768354|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768356|NCT00607438|Paclitaxel|paclitaxel|mesh-list
138768357|NCT00607438|Sorafenib|sorafenib|mesh-list
138768358|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138768359|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138768360|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768362|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
138768363|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
138768364|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768365|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138768366|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768367|NCT00976209|Phenylephrine|phenylephrine|mesh-list
138768368|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
138768369|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138768371|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
138768372|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768373|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768374|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
138768375|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138768376|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
138768377|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
138768378|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138768379|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138768380|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138768381|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
138768382|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768383|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768384|NCT00976209|Protective Agents|protective agents|mesh-ancestor
138768385|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
138768386|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138768387|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
138768388|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138768389|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
138768390|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768391|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768392|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
138768393|NCT00925990|Ribavirin|ribavirin|mesh-list
138768394|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
138768395|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768396|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
138768397|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768398|NCT02670655|Lidocaine|lidocaine|mesh-list
138768399|NCT02670655|Prilocaine|prilocaine|mesh-list
138768400|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138768401|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
138768402|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
138768403|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768404|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768405|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
138768406|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768407|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138768408|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138768409|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138768410|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138768411|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768412|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138768413|NCT01131078|Bevacizumab|bevacizumab|mesh-list
138768414|NCT01131078|Capecitabine|capecitabine|mesh-list
138768415|NCT01131078|Irinotecan|irinotecan|mesh-list
138768416|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138768417|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599644|NCT00406796|Growth Substances|growth substances|mesh-ancestor
138768418|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138768419|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138768420|NCT01131078|Growth Substances|growth substances|mesh-ancestor
138768421|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768422|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
138768423|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138768424|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
138768425|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768426|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138768427|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138768428|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768429|NCT03709017|Ponatinib|ponatinib|mesh-list
138768430|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768431|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138768433|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768435|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138768436|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138768437|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
138768438|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768439|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768440|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768441|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
138768442|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
138768443|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768444|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138768445|NCT04177303|Metformin|metformin|mesh-list
138768446|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138768447|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768448|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
138768449|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
138768450|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138768451|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
138768452|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768453|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138683878|NCT00511979|Insulin|insulin|mesh-list
138768454|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138768455|NCT02862873|Ondansetron|ondansetron|mesh-list
138768456|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768457|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
138768458|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
138768459|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768460|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138768461|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
138768462|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
138768463|NCT02862873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138768464|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138768465|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
138768466|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768467|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768468|NCT03814005|Paclitaxel|paclitaxel|mesh-list
138768469|NCT03814005|Docetaxel|docetaxel|mesh-list
138768470|NCT03814005|Carboplatin|carboplatin|mesh-list
138768471|NCT03814005|Azacitidine|azacitidine|mesh-list
138768472|NCT03814005|Pevonedistat|pevonedistat|mesh-list
138768473|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138768474|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768475|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
138768476|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
138768477|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138768478|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768479|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138768480|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
138768481|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768482|NCT04016233|Tenofovir|tenofovir|mesh-list
138768483|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
138768484|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768485|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138768486|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138768487|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768488|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768489|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138768490|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138768491|NCT04033471|Midazolam|midazolam|mesh-list
138768492|NCT04033471|Morphine|morphine|mesh-list
138768493|NCT04033471|Bupivacaine|bupivacaine|mesh-list
138768494|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
138768495|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
138599733|NCT00406874|Folic Acid|folic acid|mesh-list
138768496|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768497|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768498|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
138768499|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768500|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138768501|NCT04033471|Narcotics|narcotics|mesh-ancestor
138768502|NCT04033471|Analgesics|analgesics|mesh-ancestor
138768503|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138768504|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138768505|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138768506|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138768507|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138683970|NCT00512408|Hormones|hormones|mesh-ancestor
138768508|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138768509|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
138768510|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
138768511|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
138768512|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768513|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768514|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
138768515|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138768516|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768517|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138442873|NCT01811251|Analgesics|analgesics|mesh-ancestor
138768518|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138768519|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768520|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768521|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768522|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138768523|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138768525|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
138768526|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768527|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
138768528|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
138768529|NCT02668159|Vitamin D|vitamin d|mesh-list
138768530|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
138768531|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
138768532|NCT02668159|Vitamins|vitamins|mesh-list
138768533|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
138768534|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768535|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138768536|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138768537|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
138768539|NCT02670109|Carmustine|carmustine|mesh-list
138768540|NCT02670109|Carboplatin|carboplatin|mesh-list
138768541|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138888732|NCT00853047|Octreotide|octreotide|mesh-list
138768542|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
138768543|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768544|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138768545|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138768546|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
138768547|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768548|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768549|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138768550|NCT00922636|Methylphenidate|methylphenidate|mesh-list
138684071|NCT00530868|Bevacizumab|bevacizumab|mesh-list
138768551|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138768552|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768553|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138768554|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138768555|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138599806|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138768556|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768557|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
138768558|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768559|NCT02667925|Cisplatin|cisplatin|mesh-list
138768560|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768561|NCT02669719|Carboplatin|carboplatin|mesh-list
138768562|NCT02669719|Pemetrexed|pemetrexed|mesh-list
138768563|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768564|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768565|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768566|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138768567|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138768568|NCT00644761|Adefovir|adefovir|mesh-list
138768569|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138768570|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
138768571|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768572|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138768573|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138768574|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768575|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768576|NCT00645073|Levofloxacin|levofloxacin|mesh-list
138768577|NCT00645073|Cefdinir|cefdinir|mesh-list
138768578|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138768579|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768580|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138768581|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138768582|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138768583|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768584|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768585|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768586|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138768587|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138768588|NCT04259008|Manganese|manganese|mesh-list
138768589|NCT04259008|Trace Elements|trace elements|mesh-ancestor
138768590|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
138768591|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768592|NCT04258930|Calcium|calcium|mesh-list
138768593|NCT04258930|Calcium acetate|calcium acetate|mesh-list
138768594|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
138888766|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
138768595|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138768596|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768598|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
138768599|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768600|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138768601|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
138768602|NCT01175135|Risperidone|risperidone|mesh-list
138768603|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138768604|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
138768605|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768606|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768607|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684313|NCT04695197|Artesunate|artesunate|mesh-list
138768608|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138768609|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138768610|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768611|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138768612|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138768613|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
138768614|NCT02669641|Choline|choline|mesh-list
138768615|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
138768616|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138768617|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
138768618|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768619|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138768620|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138768621|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
138768622|NCT00922480|Losartan|losartan|mesh-list
138768623|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138768624|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138768625|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138768626|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138768627|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768628|NCT04963036|Anesthetics|anesthetics|mesh-list
138768629|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768630|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768631|NCT00973479|Golimumab|golimumab|mesh-list
138768632|NCT00973479|Methotrexate|methotrexate|mesh-list
138768633|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138768634|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
138768635|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138768636|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768637|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138768638|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
138768639|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768640|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888787|NCT04071119|Oxytocin|oxytocin|mesh-list
138768642|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768643|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138768644|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138768645|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
138768646|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138768647|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138768648|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138768649|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138768651|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768652|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684432|NCT00515684|Bevacizumab|bevacizumab|mesh-list
138768653|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
138768654|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138768655|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138768656|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768657|NCT02862483|Tadalafil|tadalafil|mesh-list
138768658|NCT02862483|Tamsulosin|tamsulosin|mesh-list
138768659|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
138768660|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138768661|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138768662|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768663|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768664|NCT02862483|Urological Agents|urological agents|mesh-ancestor
138768665|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138768666|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138768667|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138768668|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
138768669|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768670|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768671|NCT02667535|Isosorbide|isosorbide|mesh-list
138768672|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138768673|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138768674|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138768675|NCT02667535|Diuretics|diuretics|mesh-ancestor
138768676|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
138768677|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768678|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
138768679|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138768680|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768681|NCT04286841|Immunomodulating Agents|immunomodulating agents|mesh-list
138768682|NCT04286841|Immunologic Factors|immunologic factors|mesh-ancestor
138768683|NCT04286841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768684|NCT00645151|Atorvastatin|atorvastatin|mesh-list
138768685|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138768686|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138768687|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
138768688|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768689|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138768690|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138768692|NCT00645229|Ziprasidone|ziprasidone|mesh-list
138768693|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138768694|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
138768695|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768696|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768697|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768698|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138768699|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138768700|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768701|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138768702|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138768703|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
138768704|NCT01172873|Cycloserine|cycloserine|mesh-list
138768705|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138768706|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768707|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138768708|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
138600003|NCT00158210|Protective Agents|protective agents|mesh-ancestor
138768709|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138768710|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
138768711|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768713|NCT02886299|Fenofibrate|fenofibrate|mesh-list
138768714|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138768715|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138768716|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
138768717|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768718|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138768719|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138768720|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768721|NCT00925600|Denosumab|denosumab|mesh-list
138768722|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138768723|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768724|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138768725|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138768726|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138768727|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768728|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768729|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138768730|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138768731|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138768732|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
138768733|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768734|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768735|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138768736|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138768737|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
138768738|NCT02668861|Vitamin D|vitamin d|mesh-list
138768739|NCT02668861|Budesonide|budesonide|mesh-list
138768740|NCT02668861|Vitamins|vitamins|mesh-ancestor
138768741|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
138443104|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
138768742|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768743|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138600111|NCT00538486|Amlodipine|amlodipine|mesh-list
138768744|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138768745|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138768746|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
138768747|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768748|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138768749|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
138768750|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
138768751|NCT02668861|Hormones|hormones|mesh-ancestor
138768752|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138768753|NCT00968253|Cytarabine|cytarabine|mesh-list
138768754|NCT00968253|Dexamethasone|dexamethasone|mesh-list
138768755|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
138768756|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138768757|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138768758|NCT00968253|Prednisolone|prednisolone|mesh-list
138768759|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
138768760|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
138768761|NCT00968253|Doxorubicin|doxorubicin|mesh-list
138768762|NCT00968253|Methotrexate|methotrexate|mesh-list
138768763|NCT00968253|Vincristine|vincristine|mesh-list
138768764|NCT00968253|Everolimus|everolimus|mesh-list
138768765|NCT00968253|Lenograstim|lenograstim|mesh-list
138768766|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138768767|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
138768768|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138768769|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
138768770|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768771|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138768772|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138768773|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
138768774|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888865|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
138768775|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768776|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138768777|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138768778|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
138768779|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
138768780|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768781|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138768782|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
138768783|NCT00968253|Hormones|hormones|mesh-ancestor
138768784|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138768785|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138768786|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138768787|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138768788|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138768789|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768790|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138768791|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
138768792|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138768793|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138768794|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
138768795|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
138768796|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138768797|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138768798|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
138768799|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768800|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138768801|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
138768802|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
138768803|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
138768804|NCT00968253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138768805|NCT00968253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138768806|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138768807|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138768808|NCT00968253|Protective Agents|protective agents|mesh-ancestor
138768809|NCT00646009|Fluticasone|fluticasone|mesh-list
138768810|NCT00646009|Budesonide|budesonide|mesh-list
138768811|NCT00646009|Albuterol|albuterol|mesh-list
138768812|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
138768813|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138768814|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138768815|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138768816|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138768817|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
138768818|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768819|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768820|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138768821|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
138768822|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
138768823|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138768824|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
138768825|NCT00646009|Hormones|hormones|mesh-ancestor
138768826|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138888896|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138768827|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138768828|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138768829|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138768830|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
138768831|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768832|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768833|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
138768834|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138768835|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
138768837|NCT00646087|Analgesics|analgesics|mesh-ancestor
138768838|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
138768839|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768840|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768841|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138768842|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138768843|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
138768844|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
138768845|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768846|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138768847|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138768848|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768849|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768850|NCT04255576|Vitamin D|vitamin d|mesh-list
138768851|NCT04255576|Calcium|calcium|mesh-list
138768852|NCT04255576|Vitamins|vitamins|mesh-ancestor
138768853|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
138768854|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768855|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138768856|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138768857|NCT04255498|Etanercept|etanercept|mesh-list
138768858|NCT04255498|Mifepristone|mifepristone|mesh-list
138768859|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138768860|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138768861|NCT04255498|Analgesics|analgesics|mesh-ancestor
138768862|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
138768863|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768864|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768865|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138768866|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138768867|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138768868|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138768869|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
138600310|NCT00537550|Asparaginase|asparaginase|mesh-list
138768870|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138768871|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
138768872|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138768873|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138768874|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138768875|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138768876|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
138768877|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138768878|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138768879|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
138768880|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138768881|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
138768882|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138768883|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138768884|NCT02666209|Dexamethasone|dexamethasone|mesh-list
138768885|NCT02666209|Lenalidomide|lenalidomide|mesh-list
138768886|NCT02666209|Bortezomib|bortezomib|mesh-list
138768887|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138768888|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
138768889|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
138768890|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768891|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768892|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138768893|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
138768895|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138768896|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138768897|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768898|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
138768899|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138768900|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138768901|NCT02666209|Growth Substances|growth substances|mesh-ancestor
138768902|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
138768903|NCT00964743|Cytarabine|cytarabine|mesh-list
138768904|NCT00964743|Sorafenib|sorafenib|mesh-list
138768905|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138768906|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
138768907|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768908|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768909|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
138768910|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768911|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138768912|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
138768913|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768914|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138768915|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768916|NCT02862327|Dexamethasone|dexamethasone|mesh-list
138768918|NCT02862327|Ropivacaine|ropivacaine|mesh-list
138768921|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
138768922|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
138768923|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768924|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768925|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138768926|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
138768927|NCT02862327|Hormones|hormones|mesh-ancestor
138768928|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138768929|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138768930|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768931|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
138768932|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768933|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768934|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
138768936|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768937|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
138768938|NCT04945720|Durvalumab|durvalumab|mesh-list
138768939|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138768940|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138768941|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768942|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
138768943|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768944|NCT02666365|Cefazolin|cefazolin|mesh-list
138768945|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138768946|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768947|NCT02666443|Dexamethasone|dexamethasone|mesh-list
138768948|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
138768949|NCT02666443|BB 1101|bb 1101|mesh-list
138768950|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138768951|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
138768952|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
138768953|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138768954|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768955|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138768957|NCT02666443|Hormones|hormones|mesh-ancestor
138768958|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138768959|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138768960|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768961|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
138768962|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768963|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768964|NCT01130532|Tadalafil|tadalafil|mesh-list
138768965|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
138768966|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138443324|NCT01814085|Escitalopram|escitalopram|mesh-list
138768967|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138768968|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768969|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768971|NCT04258306|Resveratrol|resveratrol|mesh-list
138768972|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
138685160|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
138768973|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768974|NCT04258306|Protective Agents|protective agents|mesh-ancestor
138768975|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768977|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138768979|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
138768980|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768981|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768983|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138768984|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138768986|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138768987|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138768988|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138768989|NCT00972777|Besifloxacin|besifloxacin|mesh-list
138768990|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138768991|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138768992|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138768993|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138768994|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138768995|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138768996|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768997|NCT04254874|Interferons|interferons|mesh-list
138768998|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138768999|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
138769000|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769001|NCT02667223|Bococizumab|bococizumab|mesh-list
138769002|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138769003|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138769004|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
138769005|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769006|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138769007|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
138769008|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138600429|NCT00540202|Lumefantrine|lumefantrine|mesh-list
138769009|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
138769010|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769011|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
138769012|NCT00918736|Protective Agents|protective agents|mesh-ancestor
138769013|NCT02666053|Fostemsavir|fostemsavir|mesh-list
138769014|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138769015|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138769016|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
138769017|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769018|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138769019|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138769020|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769021|NCT04257838|Meropenem|meropenem|mesh-list
138769022|NCT04257838|Tazobactam|tazobactam|mesh-list
138769023|NCT04257838|Piperacillin|piperacillin|mesh-list
138769024|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138769025|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138769026|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769027|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138769028|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769029|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769030|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
138769031|NCT01172639|Prednisone|prednisone|mesh-list
138769032|NCT01172639|Methotrexate|methotrexate|mesh-list
138769033|NCT01172639|Leflunomide|leflunomide|mesh-list
138769034|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138769035|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
138769036|NCT01172639|Hormones|hormones|mesh-ancestor
138769037|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138769038|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769039|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138769040|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769041|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138769042|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
138769043|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138769044|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138769045|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
138769046|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769047|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
138600450|NCT00159224|Ritonavir|ritonavir|mesh-list
138769048|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769049|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138769050|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138769051|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
138229831|NCT02481219|Erythromycin|erythromycin|mesh-list
138769053|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138769054|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769055|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138769056|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138769057|NCT01172639|Analgesics|analgesics|mesh-ancestor
138769058|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
138769059|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769060|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138769061|NCT01225562|Ticagrelor|ticagrelor|mesh-list
138769062|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138769063|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138769064|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138769066|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
138769067|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769068|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769069|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769070|NCT00925288|Vaccines|vaccines|mesh-list
138769071|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
138769072|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769073|NCT01143714|Petrolatum|petrolatum|mesh-list
138769074|NCT01143714|Emollients|emollients|mesh-ancestor
138769075|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
138769076|NCT04920682|Iodine|iodine|mesh-list
138769077|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138769078|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769079|NCT04920682|Trace Elements|trace elements|mesh-ancestor
138769080|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
138769081|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769082|NCT04174339|Apatinib|apatinib|mesh-list
138769083|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769084|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138769085|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600479|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
138769086|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769087|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138769088|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
138769089|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769090|NCT00925132|Temozolomide|temozolomide|mesh-list
138769091|NCT00925132|Decitabine|decitabine|mesh-list
138769092|NCT00925132|Panobinostat|panobinostat|mesh-list
138769093|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138769094|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
138769095|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769096|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769097|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138769098|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
138769099|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769100|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138769101|NCT02862015|Gemcitabine|gemcitabine|mesh-list
138769102|NCT02862015|Folfirinox|folfirinox|mesh-list
138769103|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138769104|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
138685517|NCT02276846|Paclitaxel|paclitaxel|mesh-list
138769105|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769106|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769108|NCT01143402|Dacarbazine|dacarbazine|mesh-list
138769109|NCT01143402|Imidazole|imidazole|mesh-list
138769110|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138769111|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
138769112|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769113|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769114|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769115|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
138769116|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138769117|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
138769118|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
138769119|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138769120|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769122|NCT00646945|Analgesics|analgesics|mesh-ancestor
138553492|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
138600513|NCT00540787|Amiodarone|amiodarone|mesh-list
138769123|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
138685539|NCT02935764|Fluorouracil|fluorouracil|mesh-list
138769124|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769125|NCT00629889|Pregabalin|pregabalin|mesh-list
138769126|NCT00629889|Levetiracetam|levetiracetam|mesh-list
138769127|NCT00629889|Analgesics|analgesics|mesh-ancestor
138769128|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
138769129|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769130|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769131|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
138769132|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138769133|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138769134|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769135|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138769136|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138769137|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138769138|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138769139|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138769140|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
138769141|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
138769142|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138769143|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138685605|NCT00525005|Docetaxel|docetaxel|mesh-list
138769145|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138769146|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769147|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
138769148|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769149|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769150|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138769151|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769152|NCT00630045|Capecitabine|capecitabine|mesh-list
138769153|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
138769154|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138769155|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
138769156|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769157|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769158|NCT02861859|Olanzapine|olanzapine|mesh-list
138769159|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
138600561|NCT00540943|Irinotecan|irinotecan|mesh-list
138769160|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
138769161|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769162|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769163|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138769164|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138769165|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138769166|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138769167|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138769168|NCT02861859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138769169|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138769170|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138769171|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769172|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769173|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
138769174|NCT00647023|Metformin|metformin|mesh-list
138769175|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138769176|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769177|NCT00924898|Tenofovir|tenofovir|mesh-list
138769178|NCT00924898|Emtricitabine|emtricitabine|mesh-list
138769179|NCT00924898|Efavirenz|efavirenz|mesh-list
138769180|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
138769181|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769182|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138769183|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138769184|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769185|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769186|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138769187|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138769188|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138769189|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138769190|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138769191|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138443549|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
138769192|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138769193|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138769194|NCT01167192|Carboplatin|carboplatin|mesh-list
138769195|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769197|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
138769198|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138769199|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138769200|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138769201|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
138769202|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769203|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769204|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138666375|NCT02502786|Antibodies|antibodies|mesh-list
138600584|NCT00541138|Carboplatin|carboplatin|mesh-list
138769205|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
138769206|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
138769207|NCT00646321|Hormones|hormones|mesh-ancestor
138769208|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138769209|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138769210|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138769211|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138769212|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
138769213|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769214|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769215|NCT00647101|Latanoprost|latanoprost|mesh-list
138769216|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138769217|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138769218|NCT01166958|Teriparatide|teriparatide|mesh-list
138769219|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138769220|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138769221|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769222|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138769223|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138769224|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
138769225|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138769226|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138769227|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138769228|NCT01170221|Linezolid|linezolid|mesh-list
138769229|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
138769230|NCT01170221|Tedizolid|tedizolid|mesh-list
138769231|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138769232|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769233|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138769234|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769235|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769236|NCT04254640|Cytarabine|cytarabine|mesh-list
138769237|NCT04254640|Cladribine|cladribine|mesh-list
138769238|NCT04254640|Aclarubicin|aclarubicin|mesh-list
138769239|NCT04254640|Lenograstim|lenograstim|mesh-list
138769240|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138769241|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
138769242|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769243|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769244|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
138769245|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769246|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138769247|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
138600609|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
138600616|NCT00541216|Ephedrine|ephedrine|mesh-list
138769248|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769249|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138769250|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138769251|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138769252|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138769253|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769254|NCT01166646|Clobetasol|clobetasol|mesh-list
138769255|NCT01166646|Halobetasol|halobetasol|mesh-list
138769256|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138769257|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138769258|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
138769259|NCT01166646|Hormones|hormones|mesh-ancestor
138769260|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138769261|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769262|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138769263|NCT01129284|Hormones|hormones|mesh-ancestor
138769264|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138769265|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769266|NCT00647257|Losartan|losartan|mesh-list
138769267|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138769268|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138769269|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138769270|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138769271|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769272|NCT01166178|Vitamin D|vitamin d|mesh-list
138769273|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
138769275|NCT01166178|Vitamins|vitamins|mesh-ancestor
138769276|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
138769277|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769278|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138769279|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138769280|NCT00924820|Bevacizumab|bevacizumab|mesh-list
138889114|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
138769281|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138769282|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769283|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138769284|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138769285|NCT00924820|Growth Substances|growth substances|mesh-ancestor
138769286|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769287|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
138769288|NCT01225172|Letrozole|letrozole|mesh-list
138769289|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769290|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138769291|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138769292|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600688|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138600704|NCT00159614|Rolofylline|rolofylline|mesh-list
138769293|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769294|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138769295|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
138769296|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138769297|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769298|NCT02665039|Carboplatin|carboplatin|mesh-list
138769299|NCT02665039|Gemcitabine|gemcitabine|mesh-list
138769300|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769301|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138769302|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
138685870|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138889140|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138769303|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769305|NCT00647491|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138769306|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138769307|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138769308|NCT04252456|Leucovorin|leucovorin|mesh-list
138769309|NCT04252456|Folic Acid|folic acid|mesh-list
138769310|NCT04252456|Fluorouracil|fluorouracil|mesh-list
138769311|NCT04252456|Aflibercept|aflibercept|mesh-list
138769312|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
138769313|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
138769314|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769315|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138769316|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769317|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138769318|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
138769319|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769320|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138769321|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138769322|NCT04252456|Growth Substances|growth substances|mesh-ancestor
138769323|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
138769324|NCT04252456|Antidotes|antidotes|mesh-ancestor
138769325|NCT04252456|Protective Agents|protective agents|mesh-ancestor
138769326|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
138769327|NCT04252456|Vitamins|vitamins|mesh-ancestor
138769328|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
138769329|NCT04252456|Hematinics|hematinics|mesh-ancestor
138769330|NCT02665351|Peramivir|peramivir|mesh-list
138769331|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
138769332|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769333|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769334|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769335|NCT01222520|Amlodipine|amlodipine|mesh-list
138769336|NCT01222520|Telmisartan|telmisartan|mesh-list
138769337|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138769338|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138769339|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138769340|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138769341|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769342|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138769343|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769345|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138769346|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138769347|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
138769348|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
138600784|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769349|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769350|NCT01221350|Protective Agents|protective agents|mesh-ancestor
138769351|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769352|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
138769353|NCT01221350|Vitamins|vitamins|mesh-ancestor
138769354|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
138769355|NCT00647647|Terbinafine|terbinafine|mesh-list
138769356|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
138769357|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769358|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769359|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769360|NCT01221272|Ranolazine|ranolazine|mesh-list
138769361|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138769362|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138769363|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769364|NCT01220414|Naltrexone|naltrexone|mesh-list
138769365|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138769366|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138686020|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
138769367|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769368|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
138769369|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769370|NCT01128894|Liraglutide|liraglutide|mesh-list
138769371|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
138769372|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138769373|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769374|NCT01128894|Incretins|incretins|mesh-ancestor
138769375|NCT01128894|Hormones|hormones|mesh-ancestor
138769376|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138769377|NCT01220180|Pregabalin|pregabalin|mesh-list
138769378|NCT01220180|Analgesics|analgesics|mesh-ancestor
138769379|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
138769380|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769381|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769382|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
138769383|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138600833|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138769384|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138686076|NCT00526877|Risperidone|risperidone|mesh-list
138769385|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769386|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138769387|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138769388|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138769389|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138769390|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138769391|NCT01220024|Bupivacaine|bupivacaine|mesh-list
138769392|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
138769393|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
138769394|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138889227|NCT02638376|Vitamins|vitamins|mesh-ancestor
138769395|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769396|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
138769397|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769398|NCT00625248|Anticoagulants|anticoagulants|mesh-list
138769399|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138769400|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138769401|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138769402|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138769403|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138769404|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769405|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138769406|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138769407|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138769408|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138769409|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
138769410|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769411|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769412|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138769413|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138769414|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
138769415|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138769416|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138769417|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
138769418|NCT05125146|Trazodone|trazodone|mesh-list
138769419|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138769420|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138769421|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138769422|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769423|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138769424|NCT05125146|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138769425|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138769426|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138769427|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769428|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769429|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
138769430|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138769431|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
138769432|NCT01165554|Flutemetamol|flutemetamol|mesh-list
138769433|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138769434|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769435|NCT01218308|Vaccines|vaccines|mesh-list
138769436|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
138769437|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769438|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
138769439|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138769440|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138769441|NCT02887976|Prednisolone|prednisolone|mesh-list
138769442|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
138769443|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
138769444|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138769445|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
138769447|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
138769448|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
138769449|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889250|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
138769450|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769451|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138769452|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
138769453|NCT02887976|Hormones|hormones|mesh-ancestor
138769454|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138769455|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138769456|NCT02887976|Protective Agents|protective agents|mesh-ancestor
138769457|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138769458|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769459|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138769460|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769461|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769462|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
138769463|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138769464|NCT01165320|Caspofungin|caspofungin|mesh-list
138769465|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
138769466|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769467|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769468|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769469|NCT01217606|Timolol|timolol|mesh-list
138769470|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138769471|NCT01217606|Bimatoprost|bimatoprost|mesh-list
138769472|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138769473|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138769474|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138769475|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138769476|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
138769477|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769478|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769479|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769480|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138769481|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138769482|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138769483|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138769484|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138769485|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138769486|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
138769487|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138769488|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138769489|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138769490|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138769491|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769493|NCT01217060|Docetaxel|docetaxel|mesh-list
138769494|NCT01217060|Fluorouracil|fluorouracil|mesh-list
138769495|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138769496|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
138769497|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
138769498|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769499|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769500|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138769501|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
138769502|NCT01217060|Hormones|hormones|mesh-ancestor
138769503|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138769504|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138769505|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769506|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
138769507|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
138769508|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
138769509|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769510|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
138769511|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138769512|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138769513|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
138769514|NCT01170065|Nintedanib|nintedanib|mesh-list
138769515|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769516|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138769517|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769518|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769519|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138769520|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769521|NCT00966693|Thalidomide|thalidomide|mesh-list
138769522|NCT00966693|Dexamethasone|dexamethasone|mesh-list
138769523|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
138769524|NCT00966693|Lenalidomide|lenalidomide|mesh-list
138769525|NCT00966693|Ichthammol|ichthammol|mesh-list
138769526|NCT00966693|BB 1101|bb 1101|mesh-list
138769527|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138769528|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
138769529|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
138769530|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769531|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769532|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138769533|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
138769535|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138769536|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138553527|NCT00279760|Abatacept|abatacept|mesh-list
138769537|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769538|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
138769539|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138769540|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138769541|NCT00966693|Growth Substances|growth substances|mesh-ancestor
138769542|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
138769543|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
138769544|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769545|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769546|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138769547|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
138769548|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138769549|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769550|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
138769551|NCT01215968|Dulaglutide|dulaglutide|mesh-list
138769552|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138769553|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769554|NCT02663713|Clopidogrel|clopidogrel|mesh-list
138769555|NCT02663713|Ticagrelor|ticagrelor|mesh-list
138769556|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138769557|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138769558|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138686385|NCT00528983|Cc-486|cc-486|mesh-list
138769560|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
138769561|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769562|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769563|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769564|NCT02664649|Apixaban|apixaban|mesh-list
138769565|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
138769566|NCT02664649|Anticoagulants|anticoagulants|mesh-list
138769567|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
138769568|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138769569|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
138769570|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769571|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769572|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
138769573|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138769574|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138769575|NCT02664493|Prednisolone|prednisolone|mesh-list
138769576|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
138769577|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138769578|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
138769579|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138601088|NCT00544219|Hormones|hormones|mesh-ancestor
138769580|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
138769581|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
138769582|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769583|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769584|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138769585|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
138769586|NCT02664493|Hormones|hormones|mesh-ancestor
138769587|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138769588|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138769589|NCT02664493|Protective Agents|protective agents|mesh-ancestor
138769590|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138769591|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769592|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
138769593|NCT00963807|Alovudine|alovudine|mesh-list
138769594|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
138769595|NCT00963807|Cisplatin|cisplatin|mesh-list
138769596|NCT00963807|Docetaxel|docetaxel|mesh-list
138769597|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138769598|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769599|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
138769600|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
138769601|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
138553536|NCT00109200|Omalizumab|omalizumab|mesh-list
138769602|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769603|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138769604|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
138769605|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
138769606|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769607|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138769608|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138769609|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769610|NCT01142466|Interferons|interferons|mesh-list
138769611|NCT01142466|Interferon-beta|interferon-beta|mesh-list
138769612|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
138769613|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769614|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
138769615|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769616|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
138769617|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769618|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138769619|NCT00648505|Metformin|metformin|mesh-list
138769620|NCT00648505|Glipizide|glipizide|mesh-list
138769621|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138769622|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769623|NCT01215734|Vaccines|vaccines|mesh-list
138769624|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
138769625|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769626|NCT04172311|Levetiracetam|levetiracetam|mesh-list
138769627|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
138769628|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
138769629|NCT02863185|Atorvastatin|atorvastatin|mesh-list
138769630|NCT02863185|Pitavastatin|pitavastatin|mesh-list
138769631|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138769632|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138769633|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
138769634|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769635|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138601158|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138769636|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138769637|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769638|NCT00647881|Paroxetine|paroxetine|mesh-list
138769639|NCT00647881|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138769640|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138769641|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138769642|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769643|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769644|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
138769645|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769646|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138769647|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
138769648|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138769649|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138769650|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138769651|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769652|NCT04174261|Clopidogrel|clopidogrel|mesh-list
138769653|NCT04174261|Ticagrelor|ticagrelor|mesh-list
138769654|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138769655|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138769656|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138769657|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138769658|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
138769659|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769660|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769661|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889404|NCT00826449|Dasatinib|dasatinib|mesh-list
138769662|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
138769663|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138769664|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769665|NCT00910741|Gemcitabine|gemcitabine|mesh-list
138769666|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138769667|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
138601203|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
138769668|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769669|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769670|NCT00647959|Doxycycline|doxycycline|mesh-list
138769671|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138769672|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769673|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
138769674|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138769675|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138769677|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
138769678|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
138769679|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769680|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769682|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
138769683|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
138769684|NCT00648583|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138769685|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138769686|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
138769687|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769688|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769689|NCT03809481|Danaparoid|danaparoid|mesh-list
138769690|NCT03809481|Argatroban|argatroban|mesh-list
138769691|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
138769692|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138769693|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
138769694|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769695|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769696|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
138769697|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138769698|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138769699|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138769700|NCT00649129|Oxybutynin|oxybutynin|mesh-list
138769701|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
138769702|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
138769703|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769704|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769705|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138769706|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138769707|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
138769708|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769709|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769710|NCT00649129|Urological Agents|urological agents|mesh-ancestor
138769711|NCT01127646|Methylphenidate|methylphenidate|mesh-list
138769712|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138769713|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138444073|NCT01819220|Amlodipine|amlodipine|mesh-list
138769714|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769715|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138769716|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138769717|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138769718|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769719|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
138769720|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769721|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138769722|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
138769723|NCT02660047|Liraglutide|liraglutide|mesh-list
138769724|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138769725|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769726|NCT02660047|Incretins|incretins|mesh-ancestor
138769727|NCT02660047|Hormones|hormones|mesh-ancestor
138769728|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138769729|NCT00648661|Dexetimide|dexetimide|mesh-list
138769730|NCT00648661|Citalopram|citalopram|mesh-list
138769731|NCT00648661|Escitalopram|escitalopram|mesh-list
138769732|NCT00648661|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138769733|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138769734|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138601305|NCT00545935|Artesunate|artesunate|mesh-list
138686563|NCT02925351|Clofarabine|clofarabine|mesh-list
138769735|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769736|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769737|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
138769738|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769739|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138769740|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138553545|NCT00416767|Leucovorin|leucovorin|mesh-list
138769741|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
138769742|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
138769743|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769744|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138769745|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138769746|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
139085247|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138769747|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138769748|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
138769749|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138769750|NCT05367414|Tea Tree Oil|tea tree oil|mesh-list
138769751|NCT05367414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138769752|NCT05367414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769753|NCT04171687|Clopidogrel|clopidogrel|mesh-list
138686601|NCT02922348|Estradiol|estradiol|mesh-list
138769754|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138769755|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138769756|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138769757|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138769758|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
138769759|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769760|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769761|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769762|NCT00648817|Tenofovir|tenofovir|mesh-list
138769763|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
138769764|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769765|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138769766|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138769767|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769768|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769769|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138769770|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138769771|NCT02663323|Sirolimus|sirolimus|mesh-list
138769772|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138769773|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769774|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138769775|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769776|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
138769777|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138769778|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
138769779|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085248|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138769780|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138769781|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
138769782|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769784|NCT04285281|Analgesics|analgesics|mesh-ancestor
138769785|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
138769786|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769787|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769788|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
138769789|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138769790|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138769791|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138769792|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138769793|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138769794|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138769795|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769796|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769797|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
138769798|NCT02659657|Interleukin-2|interleukin-2|mesh-list
138769799|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769800|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138769801|NCT02659657|Analgesics|analgesics|mesh-ancestor
138769802|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
138769803|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769804|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769805|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138769806|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
138769807|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769809|NCT00648193|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138769810|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138769811|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138769812|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769813|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769814|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
138769815|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769816|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138769817|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
138769818|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138769819|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138769820|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138769821|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769824|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769825|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138769826|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
138769827|NCT02664103|Capecitabine|capecitabine|mesh-list
138769828|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138769829|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
138769830|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601405|NCT00546442|Metformin|metformin|mesh-list
138769831|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138769832|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138769833|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
138769834|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769835|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769836|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138769837|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138769838|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
138769839|NCT02662855|Favipiravir|favipiravir|mesh-list
138769840|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
138769841|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769843|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138769844|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138769845|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
138769846|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
138769847|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769848|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769849|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138769850|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138769851|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138769852|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
138769853|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769854|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769855|NCT00648349|Rabeprazole|rabeprazole|mesh-list
138769856|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138769857|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138769858|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138769859|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769860|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769861|NCT00649207|Veliparib|veliparib|mesh-list
138769862|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138769864|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769865|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769866|NCT00920686|Sumatriptan|sumatriptan|mesh-list
138769867|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138769868|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138769869|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138769870|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
138769871|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769872|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769873|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769874|NCT00648427|Paroxetine|paroxetine|mesh-list
138769875|NCT00648427|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138769876|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138769877|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138686867|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
138769878|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769879|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769880|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
138769881|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769882|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138769883|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
138769885|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138769886|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138769887|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769888|NCT04170751|Vasopressins|vasopressins|mesh-list
138769889|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
138769890|NCT04170751|Norepinephrine|norepinephrine|mesh-list
138769891|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138769892|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138769893|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
138769894|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601493|NCT00547417|Urological Agents|urological agents|mesh-ancestor
138769895|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769896|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769897|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
138769898|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
138769899|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769900|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138769901|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
138769902|NCT04170751|Coagulants|coagulants|mesh-ancestor
138769903|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138769904|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
138769905|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
138769906|NCT02659033|Cephalosporins|cephalosporins|mesh-list
138769907|NCT02659033|Cefotaxime|cefotaxime|mesh-list
138769908|NCT02659033|Cefoxitin|cefoxitin|mesh-list
138769909|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138769910|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138769911|NCT04170595|Trastuzumab|trastuzumab|mesh-list
138769912|NCT04170595|Capecitabine|capecitabine|mesh-list
138769913|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138769914|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769915|NCT04170595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138769916|NCT04170595|Antimetabolites|antimetabolites|mesh-ancestor
138769917|NCT04170595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769918|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
138769919|NCT00648973|Promethazine|promethazine|mesh-list
138769920|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
138769921|NCT00648973|Ephedrine|ephedrine|mesh-list
138769922|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138769923|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138769924|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138769925|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769926|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
138769927|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
138769928|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
138769929|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769930|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
138769931|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
138769932|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138769933|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138769934|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
138769935|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
138444298|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
138769936|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769937|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769938|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138769939|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
138769941|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138769942|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138769943|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
138769944|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
138769945|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138553564|NCT00416767|Vitamins|vitamins|mesh-ancestor
138769946|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138769947|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
138769948|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
138769949|NCT02662309|Atezolizumab|atezolizumab|mesh-list
138769950|NCT02662309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138769951|NCT02662309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769952|NCT02662309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138769953|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769954|NCT04032691|Clonidine|clonidine|mesh-list
138769955|NCT04032691|Analgesics|analgesics|mesh-ancestor
138769956|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
138769957|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769958|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769959|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138686994|NCT02916420|Hormones|hormones|mesh-ancestor
138769961|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
138769962|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138769963|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138769964|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138769965|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
138769966|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138769967|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769968|NCT02658799|Diclofenac|diclofenac|mesh-list
138769969|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138769970|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138769971|NCT02658799|Analgesics|analgesics|mesh-ancestor
138769972|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
138769973|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138769974|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769975|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138769976|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138769977|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138769978|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769979|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769980|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138769981|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138769982|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769983|NCT02655757|Incretins|incretins|mesh-ancestor
138769984|NCT02655757|Hormones|hormones|mesh-ancestor
138769985|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138769986|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138769987|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
138769988|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138769989|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138769990|NCT01214720|Bevacizumab|bevacizumab|mesh-list
138769991|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138769992|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138769993|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138769994|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138769995|NCT01214720|Growth Substances|growth substances|mesh-ancestor
138601646|NCT00548509|Vitamin K|vitamin k|mesh-list
138769996|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138769997|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
138769998|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
138769999|NCT02655913|Vitamins|vitamins|mesh-ancestor
138770000|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
138770001|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770002|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
138770003|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770004|NCT02655913|Protective Agents|protective agents|mesh-ancestor
138770005|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
138770006|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138770007|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770008|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138770009|NCT04169269|Enoxaparin|enoxaparin|mesh-list
138770010|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
138770011|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138770012|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
138770013|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138553565|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
138770014|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
138770015|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770016|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770017|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
138770018|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138770019|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138770021|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138770022|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138770023|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
138770024|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770025|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138770026|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138770027|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770028|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770029|NCT00649051|Metolazone|metolazone|mesh-list
138770030|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138770031|NCT00649051|Diuretics|diuretics|mesh-ancestor
138770032|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
138770033|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770034|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138770035|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770036|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770037|NCT00649987|Albuterol|albuterol|mesh-list
138601663|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770038|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138770039|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
138770040|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770041|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770042|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138770043|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
138770044|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
138770045|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138770046|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138770047|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138770048|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138770049|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
138770050|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770051|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770052|NCT01142232|Lenalidomide|lenalidomide|mesh-list
138770053|NCT01142232|Melphalan|melphalan|mesh-list
138770054|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
138770055|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770056|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138770057|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138770058|NCT01142232|Growth Substances|growth substances|mesh-ancestor
138770059|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
138770060|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770061|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138770062|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
138770063|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687189|NCT06025812|Vaccines|vaccines|mesh-list
138770064|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138770065|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138770066|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
138770067|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138770068|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
138601696|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770069|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770070|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
138770071|NCT02536807|Protective Agents|protective agents|mesh-ancestor
138770072|NCT02536495|Docetaxel|docetaxel|mesh-list
138770073|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770074|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
138770075|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
138770076|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
138770077|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770078|NCT02536417|Melatonin|melatonin|mesh-list
138770079|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
138770080|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770081|NCT02536417|Protective Agents|protective agents|mesh-ancestor
138770082|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770083|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138444440|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
138770084|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138770085|NCT01140906|Vortioxetine|vortioxetine|mesh-list
138770086|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138770087|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138770088|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770089|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770090|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770091|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770092|NCT01140906|Analgesics|analgesics|mesh-ancestor
138770093|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
138770094|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770095|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
138770096|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138770097|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
138770098|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138770099|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138687294|NCT06025071|Colchicine|colchicine|mesh-list
138770100|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138770101|NCT01140906|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138770103|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138770104|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138770105|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138770106|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138770108|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138770109|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138770110|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138770111|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
138770112|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
138770113|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770114|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770115|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770116|NCT04170439|Chromium|chromium|mesh-list
138770117|NCT04170439|Metformin|metformin|mesh-list
138770118|NCT04170439|Citric Acid|citric acid|mesh-list
138770119|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
138770120|NCT04170439|Clomiphene|clomiphene|mesh-list
138770121|NCT04170439|Enclomiphene|enclomiphene|mesh-list
138770122|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
138770123|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138770124|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770125|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
138770126|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138770127|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
138770128|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
138770129|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770130|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138770131|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
138770132|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138770133|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138770134|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
138770135|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138770136|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138770137|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138770138|NCT04170439|Trace Elements|trace elements|mesh-ancestor
138770139|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
138770140|NCT00649363|Ondansetron|ondansetron|mesh-list
138770141|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
138770142|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
138601831|NCT00161486|Acyline|acyline|mesh-list
138770143|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770144|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770145|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138770146|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
138770147|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
138770148|NCT00649363|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138770149|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138770151|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770152|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770153|NCT02654743|Sulforaphane|sulforaphane|mesh-list
138770154|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138770155|NCT02654743|Protective Agents|protective agents|mesh-ancestor
138553573|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138770156|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770157|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770158|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
138770159|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138770160|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138770161|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770162|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138770163|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138770164|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770165|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770166|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770167|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138770168|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
138770169|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138770170|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770171|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138770172|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138770173|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138770174|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138770176|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138770177|NCT00649441|Diuretics|diuretics|mesh-ancestor
138770178|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
138770179|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770180|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138770181|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770182|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770183|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138770184|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
138770185|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770186|NCT02654665|Liraglutide|liraglutide|mesh-list
138770187|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138770188|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770189|NCT02654665|Incretins|incretins|mesh-ancestor
138770190|NCT02654665|Hormones|hormones|mesh-ancestor
138770191|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138770192|NCT02658721|Diclofenac|diclofenac|mesh-list
138770193|NCT02658721|Lidocaine|lidocaine|mesh-list
138770194|NCT02658721|Atropine|atropine|mesh-list
138770195|NCT02658721|Ephedrine|ephedrine|mesh-list
138770196|NCT02658721|Midazolam|midazolam|mesh-list
138770197|NCT02658721|Fentanyl|fentanyl|mesh-list
138770198|NCT02658721|Tramadol|tramadol|mesh-list
138770199|NCT02658721|Ondansetron|ondansetron|mesh-list
138687499|NCT06013618|Irinotecan|irinotecan|mesh-list
138889754|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139039578|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139039580|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139039581|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139039582|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
139039583|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039584|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039586|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
139039587|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
139039588|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039589|NCT00395304|Fluticasone|fluticasone|mesh-list
139039590|NCT00395304|Xhance|xhance|mesh-list
139039591|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139039592|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139039593|NCT00395304|Montelukast|montelukast|mesh-list
139039594|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139039595|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139039596|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
139039597|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039598|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039599|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139039600|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
139039601|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
139039602|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139039603|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139039604|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139039605|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139039606|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
139039607|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039608|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039609|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139039610|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
139039611|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139039612|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139039613|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139039615|NCT00395304|Hormones|hormones|mesh-ancestor
139039616|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
139039617|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
139039618|NCT00395226|Astringents|astringents|mesh-ancestor
139039619|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039620|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
139039621|NCT00394914|Pleconaril|pleconaril|mesh-list
139039622|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
139039623|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039624|NCT00366444|Diclofenac|diclofenac|mesh-list
139039625|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139039626|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139039627|NCT00366444|Analgesics|analgesics|mesh-ancestor
138889778|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
139039628|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
138770200|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
139039630|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039631|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139039632|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139039633|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139039634|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039635|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039636|NCT00365976|Eszopiclone|eszopiclone|mesh-list
139039637|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139039638|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139039639|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039640|NCT00378534|Cyclosporine|cyclosporine|mesh-list
139039641|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
139039642|NCT00378534|Fludarabine|fludarabine|mesh-list
139039643|NCT00378534|Cyclosporins|cyclosporins|mesh-list
139039644|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139039645|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
139039646|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039647|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139039648|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139039649|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
139039650|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039651|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039652|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139039654|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
139039655|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039656|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
139039657|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139039658|NCT00377676|Bromocriptine|bromocriptine|mesh-list
139039659|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139039660|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139039661|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
139039662|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139039663|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039664|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
139039665|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
139039666|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039667|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039668|NCT00377520|Pemetrexed|pemetrexed|mesh-list
139039669|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039670|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039671|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039672|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139039673|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139039674|NCT00377364|Acetaminophen|acetaminophen|mesh-list
139039675|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139039676|NCT00377364|Analgesics|analgesics|mesh-ancestor
139039677|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
139039678|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889804|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889805|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039679|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039680|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
139039681|NCT00365508|Nicotine|nicotine|mesh-list
139039682|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139039683|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
139039684|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039685|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039686|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139039687|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139039688|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
139039689|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039690|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039691|NCT00365352|Gabapentin|gabapentin|mesh-list
139039692|NCT00365352|Analgesics|analgesics|mesh-ancestor
139039693|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
139039694|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039695|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039696|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
139039697|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139039698|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139039699|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139039700|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139039701|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139039702|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139039703|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039704|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602195|NCT00162227|Efavirenz|efavirenz|mesh-list
139039705|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
139039706|NCT00410384|Belimumab|belimumab|mesh-list
139039707|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139039708|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
139039709|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039710|NCT00370032|Alosetron|alosetron|mesh-list
139039711|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139039712|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139039713|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
139039714|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039715|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889828|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
139039716|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039717|NCT00410072|Tenofovir|tenofovir|mesh-list
139039718|NCT00410072|Entecavir|entecavir|mesh-list
139039719|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
139039720|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039721|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139039722|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139039723|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039724|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039725|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139039726|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139039727|NCT00409838|Methotrexate|methotrexate|mesh-list
139039728|NCT00409838|Abatacept|abatacept|mesh-list
139039729|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139039730|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
139039731|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138770201|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
139039733|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139039734|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
139039735|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039736|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039737|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
139039738|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039739|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139039740|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139039741|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
139039742|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139039743|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139039744|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139039745|NCT00409838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139039746|NCT01041872|Lidocaine|lidocaine|mesh-list
139039747|NCT01041872|Propofol|propofol|mesh-list
139039748|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
139039749|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
139039750|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138602265|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
139039751|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039752|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
139039753|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039754|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139039755|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139039756|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139039757|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139039758|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039759|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139039760|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139039761|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
139039762|NCT00399542|Lubiprostone|lubiprostone|mesh-list
139039763|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139039764|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139039765|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039766|NCT01039766|Oxytocin|oxytocin|mesh-list
139039767|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
139039768|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139039769|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039770|NCT00409682|Adalimumab|adalimumab|mesh-list
139039771|NCT00409682|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138602322|NCT00162461|Phenytoin|phenytoin|mesh-list
139039772|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139039773|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139039774|NCT01039844|Paclitaxel|paclitaxel|mesh-list
139039775|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139039776|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039777|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
139039778|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
139039779|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
139039780|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039781|NCT01042028|Capecitabine|capecitabine|mesh-list
139039782|NCT01042028|Irinotecan|irinotecan|mesh-list
139039783|NCT01042028|Cetuximab|cetuximab|mesh-list
139039784|NCT01042028|Everolimus|everolimus|mesh-list
139039785|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
139039786|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139039787|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
139039788|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039789|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039790|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139039791|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139039792|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039793|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138602373|NCT00162812|Epirubicin|epirubicin|mesh-list
139039794|NCT01042028|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139039795|NCT01042028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139039796|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139039797|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
139039798|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039799|NCT03993626|Nivolumab|nivolumab|mesh-list
139039800|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139039801|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039802|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139039803|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039804|NCT00398216|Edoxaban|edoxaban|mesh-list
139039805|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
139039806|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
139039807|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139039808|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
139039809|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039810|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039811|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
139039812|NCT00398138|Sargramostim|sargramostim|mesh-list
139039813|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
139039814|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
139039815|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602421|NCT03757585|Inositol|inositol|mesh-list
139039816|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139039817|NCT00397982|Sirolimus|sirolimus|mesh-list
139039818|NCT00397982|Bevacizumab|bevacizumab|mesh-list
139039819|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139039820|NCT00397982|Temsirolimus|temsirolimus|mesh-list
139039821|NCT00397982|MTOR Inhibitors|mtor inhibitors|mesh-list
139039822|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
139039823|NCT00397982|Antibodies|antibodies|mesh-list
139039824|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
139039825|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139039826|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
139039827|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039828|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139039829|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139039830|NCT00397982|Growth Substances|growth substances|mesh-ancestor
139039831|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039832|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
139039833|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
139039834|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139039835|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039836|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139039837|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
139039838|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139039839|NCT00397982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139039840|NCT00397982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039841|NCT00397982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039842|NCT03715166|Bumetanide|bumetanide|mesh-list
139039843|NCT03715166|Diuretics|diuretics|mesh-ancestor
139039844|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
139039845|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039846|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139039847|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139039848|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039849|NCT01042574|Clevidipine|clevidipine|mesh-list
139039850|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139039851|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770202|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139039852|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039853|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139039854|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039855|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
139039856|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139039857|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139039858|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
139039859|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039860|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139039861|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139039862|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039863|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039864|NCT01040078|Vaccines|vaccines|mesh-list
139039865|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
139039866|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039867|NCT01035320|Simvastatin|simvastatin|mesh-list
139039868|NCT01035320|Ezetimibe|ezetimibe|mesh-list
139039869|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139039870|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139039871|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
139039872|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039873|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139039874|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139039875|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039876|NCT01042730|Pitavastatin|pitavastatin|mesh-list
139039877|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139039878|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139039879|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139039880|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
139039881|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039882|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039883|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139039884|NCT00396812|Rituximab|rituximab|mesh-list
138889909|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
139039885|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139039886|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039887|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
139039888|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039889|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139039890|NCT01566578|Mitogens|mitogens|mesh-list
139039891|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
139039892|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039893|NCT01040234|Bupivacaine|bupivacaine|mesh-list
139039894|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
139039895|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
139039896|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138688202|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139039897|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039898|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
139039899|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039900|NCT00396656|Atenolol|atenolol|mesh-list
139039901|NCT00396656|Valsartan|valsartan|mesh-list
139039902|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139039903|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139039904|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139039905|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139039906|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039907|NCT00396656|Diuretics|diuretics|mesh-ancestor
139039908|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
139039909|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039910|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138688257|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139039911|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138790534|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
139039912|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139039913|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
139039914|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
139039915|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039916|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139039917|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139039918|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139039919|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
139039920|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039922|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039923|NCT01040312|Cisplatin|cisplatin|mesh-list
139039924|NCT01040312|Carboplatin|carboplatin|mesh-list
139039925|NCT01040312|Nedaplatin|nedaplatin|mesh-list
139039926|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139039927|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139039928|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138688319|NCT04956692|Carboplatin|carboplatin|mesh-list
139039929|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139039930|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139039931|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039932|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139039933|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139039934|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039935|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
138602597|NCT00163319|Hormones|hormones|mesh-ancestor
139039936|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039937|NCT01043510|Insulin|insulin|mesh-list
139039938|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139039939|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
139039940|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139039941|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039942|NCT01043666|Mirabegron|mirabegron|mesh-list
139039943|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139039944|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139039945|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139039946|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139039947|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
139039948|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039949|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039950|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039951|NCT01043666|Urological Agents|urological agents|mesh-ancestor
139039952|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139039953|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139039954|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
139039955|NCT00394472|Lesogaberan|lesogaberan|mesh-list
139039956|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139039957|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139039958|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
139039959|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
139039960|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139039961|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602641|NCT00163397|Hormones|hormones|mesh-ancestor
139039962|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039963|NCT00395486|Atorvastatin|atorvastatin|mesh-list
139039964|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139039965|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139039966|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139039967|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
139039968|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039969|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139039970|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139039971|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039972|NCT01043744|Lumefantrine|lumefantrine|mesh-list
139039973|NCT01043744|Artemether|artemether|mesh-list
139039974|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139039975|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
139039976|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139039977|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139039978|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039979|NCT00395018|Entecavir|entecavir|mesh-list
139039980|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
139039981|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039982|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
139039983|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139039984|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139039985|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139039986|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
139039987|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
139039988|NCT00375518|Atorvastatin|atorvastatin|mesh-list
139039989|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139039990|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139039991|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
139039992|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139039993|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138770203|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602688|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139039994|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139039995|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139039996|NCT01045772|Rilonacept|rilonacept|mesh-list
139039997|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139039998|NCT01045928|Rituximab|rituximab|mesh-list
139039999|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139040000|NCT01045928|Lenalidomide|lenalidomide|mesh-list
139040001|NCT01045928|Antibodies|antibodies|mesh-list
139040002|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
139040003|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139040004|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
139040005|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040006|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040007|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139040008|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139040009|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139040010|NCT01045928|Growth Substances|growth substances|mesh-ancestor
139040011|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
139040012|NCT00256750|Cyclosporine|cyclosporine|mesh-list
139040013|NCT00256750|Abatacept|abatacept|mesh-list
139040014|NCT00256750|Cyclosporins|cyclosporins|mesh-list
138602727|NCT05808387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602728|NCT05808387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602729|NCT05808387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138602730|NCT05808231|Quinine|quinine|mesh-list
139040015|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040016|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040017|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139040018|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
139040019|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040020|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
139040021|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139040022|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
139040023|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139040024|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139040025|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139040026|NCT00256750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139040027|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040028|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
139040029|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
139040030|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
139040031|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
139040032|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
139040033|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139040034|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040036|NCT00203476|Ezetimibe|ezetimibe|mesh-list
139040037|NCT00203476|Colestipol|colestipol|mesh-list
139040038|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139040039|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139040040|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
139040041|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040042|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139040043|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
139040044|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
139040045|NCT00203476|Vitamins|vitamins|mesh-ancestor
139040046|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
139040047|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040048|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
139040049|NCT00203242|Valproic Acid|valproic acid|mesh-list
139040050|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
139040051|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040052|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040053|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
139040054|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040055|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040056|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
139040057|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139040058|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138688647|NCT04381832|Docetaxel|docetaxel|mesh-list
139040059|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139040060|NCT00200356|Ozagrel|ozagrel|mesh-list
139040061|NCT00200356|Edaravone|edaravone|mesh-list
139040062|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139040063|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
138602841|NCT05807035|Immunologic Factors|immunologic factors|mesh-ancestor
138602843|NCT05781698|Mesalamine|mesalamine|mesh-list
139040064|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040065|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139040066|NCT00200356|Protective Agents|protective agents|mesh-ancestor
139040067|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040068|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040069|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139040070|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139040071|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
139040073|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040074|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139040075|NCT00227266|Valproic Acid|valproic acid|mesh-list
139040076|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
139040077|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040078|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040079|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
139040080|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040081|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040082|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
139040083|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139040084|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139040085|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139040086|NCT00256282|Docetaxel|docetaxel|mesh-list
139040087|NCT00256282|Vinorelbine|vinorelbine|mesh-list
139040088|NCT00256282|Sargramostim|sargramostim|mesh-list
139040089|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040090|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
139040091|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
139040092|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
139040093|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040094|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139040095|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
139040096|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040097|NCT00256204|Rasagiline|rasagiline|mesh-list
139040098|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139040099|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602890|NCT05693844|Immunologic Factors|immunologic factors|mesh-ancestor
139040100|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040101|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139040102|NCT00256204|Protective Agents|protective agents|mesh-ancestor
139040103|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040105|NCT03972358|Mifepristone|mifepristone|mesh-list
139040106|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139040107|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
139040108|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139040109|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040110|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139040111|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139040112|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
138424678|NCT03573115|Adapalene|adapalene|mesh-list
139040113|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139040114|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139040116|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139040117|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
139040118|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139040119|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139040120|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
139040121|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139040122|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
138651205|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139040123|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139040124|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139040125|NCT01073332|Antioxidants|antioxidants|mesh-list
139040126|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040127|NCT01073332|Protective Agents|protective agents|mesh-ancestor
139040128|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040129|NCT03972046|Trametinib|trametinib|mesh-list
139040130|NCT03972046|Dabrafenib|dabrafenib|mesh-list
139040131|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139040132|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040133|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139040134|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040135|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040136|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139040137|NCT01071772|Insulin|insulin|mesh-list
139040138|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139040139|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040140|NCT01074346|Interferons|interferons|mesh-list
139040141|NCT01074346|Interferon-beta|interferon-beta|mesh-list
139040142|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
139040143|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040144|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
139040145|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139040146|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
139040147|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040148|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139040149|NCT00278889|Leucovorin|leucovorin|mesh-list
139040150|NCT00278889|Bevacizumab|bevacizumab|mesh-list
139040151|NCT00278889|Fluorouracil|fluorouracil|mesh-list
139040152|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
139040153|NCT00278889|Cediranib|cediranib|mesh-list
139040154|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139040155|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040156|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139040157|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139040158|NCT00278889|Growth Substances|growth substances|mesh-ancestor
139040159|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040160|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
139040161|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
139040162|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040163|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139040164|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139040165|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
139040166|NCT00278889|Antidotes|antidotes|mesh-ancestor
139040167|NCT00278889|Protective Agents|protective agents|mesh-ancestor
139040168|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
139040169|NCT00278889|Vitamins|vitamins|mesh-ancestor
139040170|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
139040171|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139040172|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040174|NCT01070745|Indomethacin|indomethacin|mesh-list
139040175|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139040176|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139040177|NCT01070745|Analgesics|analgesics|mesh-ancestor
139040178|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
139040179|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040180|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040181|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139040182|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139040183|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139040184|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040185|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040186|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
139040187|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
139040188|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139040189|NCT01071057|Morphine|morphine|mesh-list
139040190|NCT01071057|Naloxone|naloxone|mesh-list
139040191|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139040192|NCT01071057|Narcotics|narcotics|mesh-ancestor
139040193|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139040194|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040195|NCT01071057|Analgesics|analgesics|mesh-ancestor
139040196|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
139040197|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040198|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139040199|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
139040200|NCT00278109|Doxorubicin|doxorubicin|mesh-list
139040201|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139040202|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
139040203|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603066|NCT04685980|Morphine|morphine|mesh-list
139040204|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139040205|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139040206|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
139040207|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040208|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040209|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139040210|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139040211|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139040212|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139040213|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040214|NCT00296517|Bupropion|bupropion|mesh-list
138790830|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
139040215|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139040216|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
139040217|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139040218|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139040219|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139040220|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139040221|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040222|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
139040223|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040224|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040225|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139040226|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139040227|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040228|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139040229|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139040230|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139040231|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040232|NCT00266409|Alprazolam|alprazolam|mesh-list
139040233|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139040234|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139040235|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040236|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139040237|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139040238|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139040239|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
139040240|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
139040241|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040242|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040243|NCT00265785|Pemetrexed|pemetrexed|mesh-list
139040244|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040245|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040246|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040247|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139040248|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139040249|NCT02532153|Ketamine|ketamine|mesh-list
139040250|NCT02532153|Analgesics|analgesics|mesh-ancestor
139040251|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
139040252|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040253|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040254|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139040255|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138689061|NCT03710122|Vancomycin|vancomycin|mesh-list
139040256|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
139040258|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139040259|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139040260|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139040261|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040262|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040263|NCT00265395|Interferons|interferons|mesh-list
139040264|NCT00265395|Ribavirin|ribavirin|mesh-list
139040265|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
139040266|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
139040267|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139040268|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040269|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
139040270|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139040271|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
138890122|NCT00657254|Sorafenib|sorafenib|mesh-list
139040272|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040273|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
139040274|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040275|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139040276|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
139040277|NCT00195442|Factor VIII|factor viii|mesh-list
139040278|NCT00195442|Coagulants|coagulants|mesh-ancestor
139040279|NCT01070823|Natalizumab|natalizumab|mesh-list
139040280|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
138689096|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
139040281|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040282|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139040283|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
139040284|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139040285|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139040286|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139040287|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139040288|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040289|NCT00275301|Olanzapine|olanzapine|mesh-list
139040290|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
138790915|NCT00986154|Heparin|heparin|mesh-list
139040291|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
139040292|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040293|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040294|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139040295|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139040296|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139040297|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139040298|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139040299|NCT00275301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139040300|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139040301|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139040302|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040303|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040304|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
139040305|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139040306|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139040307|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040308|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
139040309|NCT00251745|Lansoprazole|lansoprazole|mesh-list
139040310|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139040311|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139040312|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139040313|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040314|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040315|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
139040316|NCT00255190|Lansoprazole|lansoprazole|mesh-list
139040317|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139040318|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139040319|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139040320|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040321|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603401|NCT01527149|Vincristine|vincristine|mesh-list
139040322|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139040323|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139040324|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139040325|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040326|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
139040327|NCT01049646|Giapreza|giapreza|mesh-list
139040328|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
139040329|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139040330|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139040331|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
139040332|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040333|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040334|NCT02286414|Vitamins|vitamins|mesh-list
139040335|NCT02286414|Vitamin K|vitamin k|mesh-list
139040336|NCT02286414|Warfarin|warfarin|mesh-list
139040337|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
139040338|NCT02286414|Dabigatran|dabigatran|mesh-list
139040339|NCT02286414|Apixaban|apixaban|mesh-list
139040340|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
139040341|NCT02286414|Fluindione|fluindione|mesh-list
139040342|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
139040343|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040344|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
139040345|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139040346|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
139040347|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139040348|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
139040349|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040350|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040351|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139040352|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139040353|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
139040354|NCT02286414|Coagulants|coagulants|mesh-ancestor
139040355|NCT00255034|Ribavirin|ribavirin|mesh-list
139040357|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
139040358|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
139040359|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040360|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
139040361|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139040362|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
139040363|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040364|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
139040365|NCT00254566|Azithromycin|azithromycin|mesh-list
138890155|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139040366|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138790988|NCT00654160|Leucovorin|leucovorin|mesh-list
139040367|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139040368|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139040369|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139040370|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139040371|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040372|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040373|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040374|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139040375|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
138689223|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139040376|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139040377|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040378|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139040379|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139040380|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139040381|NCT01048086|Tretinoin|tretinoin|mesh-list
139040382|NCT01048086|Isotretinoin|isotretinoin|mesh-list
139040383|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040384|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
139040385|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
139040386|NCT03830892|Nicotine|nicotine|mesh-list
139040387|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139040388|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
139040389|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040390|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040391|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139040392|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139040393|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
139040394|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040395|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040396|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
139040397|NCT01049880|Gemcitabine|gemcitabine|mesh-list
139040398|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139040399|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
139040400|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040401|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040402|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
139040403|NCT01049880|Protective Agents|protective agents|mesh-ancestor
139040404|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040405|NCT01049880|Vitamins|vitamins|mesh-ancestor
139040406|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
139040407|NCT00253630|Vorinostat|vorinostat|mesh-list
139040408|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040409|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139040410|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040411|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040412|NCT00358644|Decitabine|decitabine|mesh-list
139040413|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139040414|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
139040415|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040416|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040417|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040418|NCT01048320|Gemcitabine|gemcitabine|mesh-list
139040419|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
139040420|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
139040421|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139040422|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
139040423|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040424|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040425|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139040426|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040427|NCT03990480|Amlodipine|amlodipine|mesh-list
139040428|NCT03990480|Valsartan|valsartan|mesh-list
139040429|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139040430|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139040431|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139040432|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040433|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139040434|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040435|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
139040436|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139040437|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139040438|NCT00369486|Triamcinolone|triamcinolone|mesh-list
139040439|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139040440|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139040441|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139040442|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139040444|NCT00369486|Hormones|hormones|mesh-ancestor
139040445|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139040446|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040447|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139040448|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
139040449|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040450|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040451|NCT00363480|Fluticasone|fluticasone|mesh-list
139040452|NCT00363480|Albuterol|albuterol|mesh-list
139040453|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139040454|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139040455|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139040456|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
139040457|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040458|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040459|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139040460|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
139040461|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
139040462|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139040463|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139040464|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139040465|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139040466|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
139040467|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040468|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040469|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
139040470|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139040471|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139040472|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139040473|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
139040474|NCT01048398|Acetaminophen|acetaminophen|mesh-list
139040475|NCT01048398|Remifentanil|remifentanil|mesh-list
139040476|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139040477|NCT01048398|Analgesics|analgesics|mesh-ancestor
139040478|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
139040479|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040480|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040481|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
139040482|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139040483|NCT01048398|Narcotics|narcotics|mesh-ancestor
139040484|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139040485|NCT01073644|Sunitinib|sunitinib|mesh-list
139040486|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040487|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139040488|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139040489|NCT01073644|Growth Substances|growth substances|mesh-ancestor
139040490|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040491|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
139040492|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139040493|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040494|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040495|NCT03992586|Methamphetamine|methamphetamine|mesh-list
139040496|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139040497|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040498|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
139040499|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
139040500|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040501|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
139040502|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040503|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040504|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
139040505|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139040506|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139040507|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139040508|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139040509|NCT00221104|Pravastatin|pravastatin|mesh-list
139040510|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139040511|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139040512|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
139040513|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040514|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138791132|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139040515|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139040516|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040517|NCT00189202|Sirolimus|sirolimus|mesh-list
139040518|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139040519|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139040520|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139040521|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040522|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
139040523|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139040524|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
139040525|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040526|NCT01071928|Docetaxel|docetaxel|mesh-list
139040527|NCT01071928|Vadimezan|vadimezan|mesh-list
139040528|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040529|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
139040530|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
139040531|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
139040532|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040533|NCT00187486|Temozolomide|temozolomide|mesh-list
139040534|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139040535|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139040536|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
139040537|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040538|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040539|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139040540|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040541|NCT00220636|Aripiprazole|aripiprazole|mesh-list
139040542|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
139040543|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139040544|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139040545|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139040546|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139040547|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040548|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
139040549|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
139040550|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040551|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040552|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139040553|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139040554|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
139040555|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139040556|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139040557|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139040558|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139040559|NCT00362232|Enoxaparin|enoxaparin|mesh-list
139040560|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
139040561|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
139040562|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139040563|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
139040564|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139040565|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
139040566|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040567|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040568|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
139040569|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139040570|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139040571|NCT01048554|Bevacizumab|bevacizumab|mesh-list
139040572|NCT01048554|Temozolomide|temozolomide|mesh-list
139040573|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139040574|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040575|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139040576|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139040577|NCT01048554|Growth Substances|growth substances|mesh-ancestor
139040578|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040579|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
139040580|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139040581|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
138689469|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
139040582|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040583|NCT00219544|Pregabalin|pregabalin|mesh-list
139040584|NCT00219544|Analgesics|analgesics|mesh-ancestor
139040585|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
139040586|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040587|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040588|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
139040589|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139040590|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139040591|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318336|NCT01405560|Ribavirin|ribavirin|mesh-list
139040592|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139040593|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139040594|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139040595|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139040596|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139040597|NCT00357552|Ritonavir|ritonavir|mesh-list
139040598|NCT00357552|Lopinavir|lopinavir|mesh-list
139040599|NCT00357552|Tenofovir|tenofovir|mesh-list
139040600|NCT00357552|Emtricitabine|emtricitabine|mesh-list
139040601|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139040602|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139040603|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139040604|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
139040605|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040606|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040607|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138604071|NCT00177021|Imiquimod|imiquimod|mesh-list
139040608|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139040609|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
139040610|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689519|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040611|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139040612|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139040613|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139040614|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139040616|NCT00187096|Fludarabine|fludarabine|mesh-list
139040617|NCT00187096|Etoposide|etoposide|mesh-list
139040618|NCT00187096|Interleukin-2|interleukin-2|mesh-list
139040619|NCT00187096|Clofarabine|clofarabine|mesh-list
139040620|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139040621|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
138604120|NCT03413800|Dexamethasone|dexamethasone|mesh-list
139040622|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040623|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139040624|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139040625|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
139040626|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040627|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040628|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139040629|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139040630|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
139040631|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139040632|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139040633|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139040634|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604186|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
139040635|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139040636|NCT00187096|Analgesics|analgesics|mesh-ancestor
139040637|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
139040638|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040639|NCT00357396|Melphalan|melphalan|mesh-list
139040640|NCT00357396|Busulfan|busulfan|mesh-list
139040641|NCT00357396|Thiotepa|thiotepa|mesh-list
139040642|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139040643|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
139040644|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040645|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040646|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139040647|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139040648|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
139040649|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040650|NCT00186628|Acetaminophen|acetaminophen|mesh-list
139040651|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
139040652|NCT00186628|Promethazine|promethazine|mesh-list
138890280|NCT04215731|Leucovorin|leucovorin|mesh-list
139040653|NCT00186628|Cyclosporine|cyclosporine|mesh-list
139040654|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
139040655|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
139040656|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139040657|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139040658|NCT00186628|Prednisolone|prednisolone|mesh-list
138604241|NCT05296213|Calcium|calcium|mesh-list
139040659|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
139040660|NCT00186628|Rituximab|rituximab|mesh-list
139040661|NCT00186628|Granisetron|granisetron|mesh-list
139040662|NCT00186628|Lenograstim|lenograstim|mesh-list
139040663|NCT00186628|Cyclosporins|cyclosporins|mesh-list
139040664|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
139040665|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139040666|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139040667|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
139040668|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139040669|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040670|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
139040671|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040672|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139040673|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139040674|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040675|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040676|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139040677|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
139040678|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139040679|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
139040680|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139040681|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139040682|NCT00186628|Analgesics|analgesics|mesh-ancestor
138604347|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
139040683|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
139040684|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040685|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
139040686|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139040687|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
139040688|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
139040689|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139040690|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
139040691|NCT00186628|Hormones|hormones|mesh-ancestor
139040692|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139040693|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139040694|NCT00186628|Protective Agents|protective agents|mesh-ancestor
139040695|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139040696|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139040697|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139040698|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139040699|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
139040700|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
138604413|NCT00195078|Gefitinib|gefitinib|mesh-list
139040701|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139040702|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
139040703|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
139040704|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040705|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139040706|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
139040707|NCT00186628|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139040708|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139040709|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
139040710|NCT00368550|Sertraline|sertraline|mesh-list
139040711|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
139040712|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138890307|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139040713|NCT00368550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139040714|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139040715|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138604466|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139040716|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040717|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040718|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
139040719|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040720|NCT01050036|Busulfan|busulfan|mesh-list
139040721|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
139040722|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040723|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139040724|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
139040725|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040726|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139040728|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139040729|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139040730|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139040731|NCT00357006|Estradiol|estradiol|mesh-list
139040732|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139040733|NCT00357006|Estrogens|estrogens|mesh-ancestor
139040734|NCT00357006|Hormones|hormones|mesh-ancestor
139040735|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139040736|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040737|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139040738|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
139040739|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139040740|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139040741|NCT01050114|Oxybutynin|oxybutynin|mesh-list
139040742|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139040743|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139040744|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040745|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040746|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139040747|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139040748|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040749|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
139040750|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040751|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
139040752|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
139040753|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139040754|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139040755|NCT01050114|Urological Agents|urological agents|mesh-ancestor
139040757|NCT01048632|Androgens|androgens|mesh-ancestor
139040758|NCT01048632|Hormones|hormones|mesh-ancestor
139040759|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139040760|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040761|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
139040762|NCT00165646|Rabeprazole|rabeprazole|mesh-list
139040763|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139040764|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139040765|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139040766|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040767|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040768|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
139040769|NCT01050270|Ondansetron|ondansetron|mesh-list
139040770|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139040771|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
139040772|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
139040773|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040774|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604649|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040775|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139040776|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
139040777|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
139040778|NCT01050270|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139040779|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139040780|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
139040781|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040782|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040783|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
139040784|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139040785|NCT01050270|Expectorants|expectorants|mesh-ancestor
139040786|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
139040787|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139040788|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
139040789|NCT01050270|Protective Agents|protective agents|mesh-ancestor
139040790|NCT01050270|Antidotes|antidotes|mesh-ancestor
139040791|NCT00367770|Bosentan|bosentan|mesh-list
139040792|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139040793|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139040794|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040795|NCT00185614|Cyclosporine|cyclosporine|mesh-list
139040796|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
139040797|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
139040798|NCT00185614|Melphalan|melphalan|mesh-list
139040799|NCT00185614|Cyclosporins|cyclosporins|mesh-list
139040800|NCT00185614|Lenograstim|lenograstim|mesh-list
139040801|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139040802|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
139040803|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040804|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139040805|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139040806|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
139040807|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040808|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040809|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139040810|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139040811|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040812|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
139040813|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139040814|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
139040815|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139040816|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139040817|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139040818|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
139040819|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139040820|NCT01075438|Vaccines|vaccines|mesh-list
139040821|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139040822|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
139040823|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040824|NCT00361842|Irinotecan|irinotecan|mesh-list
139040825|NCT00361842|Floxuridine|floxuridine|mesh-list
139040826|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139040827|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139040828|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040829|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040830|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040831|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139040832|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
139040833|NCT01324752|Losartan|losartan|mesh-list
139040834|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139040835|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139040836|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139040837|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139040838|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040839|NCT01050348|Atorvastatin|atorvastatin|mesh-list
139040840|NCT01050348|Calcium|calcium|mesh-list
139040841|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138689966|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139040842|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040843|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139040844|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139040845|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
139040846|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040847|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139040848|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139040849|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040850|NCT01053390|Leucovorin|leucovorin|mesh-list
139040851|NCT01053390|Fluorouracil|fluorouracil|mesh-list
139040852|NCT01053390|Epirubicin|epirubicin|mesh-list
139040853|NCT01053390|Somatostatin|somatostatin|mesh-list
139040854|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040855|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
139040856|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040857|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139040858|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139040859|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
139040860|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040861|NCT01053390|Antidotes|antidotes|mesh-ancestor
139040862|NCT01053390|Protective Agents|protective agents|mesh-ancestor
139040863|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
139040864|NCT01053390|Vitamins|vitamins|mesh-ancestor
139040865|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
139040866|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139040867|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139040868|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139040869|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040870|NCT01053390|Hormones|hormones|mesh-ancestor
139040871|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139040872|NCT00356148|Ampicillin|ampicillin|mesh-list
139040873|NCT00356148|Sulbactam|sulbactam|mesh-list
139040874|NCT00356148|Sultamicillin|sultamicillin|mesh-list
138604842|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
139040875|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139040876|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139040877|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139040878|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040879|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040880|NCT00361218|Citalopram|citalopram|mesh-list
139040881|NCT00361218|Escitalopram|escitalopram|mesh-list
138690017|NCT02938988|Methylene Blue|methylene blue|mesh-list
139040882|NCT00361218|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139040884|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139040885|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139040886|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040887|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040888|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
139040889|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040890|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139040891|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
139040892|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139040893|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139040895|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139040896|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139040897|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139040898|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139040899|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139040900|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040901|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040902|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040903|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139040904|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
139040905|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138604949|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139040906|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040907|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139040908|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139040909|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139040910|NCT02534610|Etoricoxib|etoricoxib|mesh-list
139040911|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139040912|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139040913|NCT02534610|Analgesics|analgesics|mesh-ancestor
139040914|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
139040915|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040916|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040917|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139040918|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139040919|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139040920|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139040921|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040922|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040923|NCT01050426|Leucovorin|leucovorin|mesh-list
139040924|NCT01050426|Cetuximab|cetuximab|mesh-list
139040925|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
139040926|NCT01050426|Antidotes|antidotes|mesh-ancestor
139040927|NCT01050426|Protective Agents|protective agents|mesh-ancestor
139040928|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605020|NCT05994742|Antimetabolites|antimetabolites|mesh-ancestor
139040929|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
139040930|NCT01050426|Vitamins|vitamins|mesh-ancestor
138890433|NCT02705651|Hormones|hormones|mesh-ancestor
139040931|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
139040932|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139040933|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040935|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139040936|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139040937|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
139040938|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040939|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139040940|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139040941|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040942|NCT00252694|Candesartan|candesartan|mesh-list
139040943|NCT00252694|Candesartan cilexetil|candesartan cilexetil|mesh-list
139040944|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139040945|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139040946|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138605065|NCT05880459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139040947|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040948|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
139040949|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139040950|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
139040951|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139040952|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040953|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139040954|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139040955|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139040956|NCT01077466|Natalizumab|natalizumab|mesh-list
139040957|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
139040958|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040959|NCT00160654|Levetiracetam|levetiracetam|mesh-list
139040960|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
139040961|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
139040962|NCT01582672|Sunitinib|sunitinib|mesh-list
139040963|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139040964|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139040965|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139040966|NCT01582672|Growth Substances|growth substances|mesh-ancestor
139040967|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040968|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
138180141|NCT04952194|Levodopa|levodopa|mesh-list
139040969|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139040970|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139040971|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040972|NCT00366678|Vaccines|vaccines|mesh-list
139040973|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139040974|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
139040975|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040976|NCT01049178|Silymarin|silymarin|mesh-list
139040977|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
139040978|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040979|NCT01049178|Protective Agents|protective agents|mesh-ancestor
139040980|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040981|NCT02534454|Nicotine|nicotine|mesh-list
139040982|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139040983|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
139040984|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040985|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040986|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139040987|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139040988|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
139040989|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139040990|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139040991|NCT00355368|Rocuronium|rocuronium|mesh-list
139040992|NCT00355368|Succinylcholine|succinylcholine|mesh-list
139040993|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139040994|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139040995|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139040996|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139040997|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139040998|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
139040999|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
138487433|NCT00000609|Amiodarone|amiodarone|mesh-list
139041000|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139041001|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041002|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139041003|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041004|NCT00360282|Rizatriptan|rizatriptan|mesh-list
139041005|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139041006|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
139041007|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041008|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041009|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041010|NCT00373958|Vaccines|vaccines|mesh-list
139041011|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139041012|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
139041013|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041014|NCT00373880|Cocaine|cocaine|mesh-list
139041015|NCT00373880|Aripiprazole|aripiprazole|mesh-list
139041016|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
139041017|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139041018|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139041019|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139041020|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139041021|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041022|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
139041023|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
139041024|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041025|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041026|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139041027|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139041028|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
139041029|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139041030|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139041031|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139041032|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139041033|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
139041034|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
139041035|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
139041036|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041037|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139041038|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138887243|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139041039|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139041040|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139041042|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139041043|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
139041044|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
139041045|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139041046|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
139041047|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
139041048|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138605282|NCT04801589|Midazolam|midazolam|mesh-list
139041049|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041050|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139041051|NCT00265317|Sunitinib|sunitinib|mesh-list
139041052|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041053|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139041054|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041055|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041056|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139041057|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139041058|NCT00265317|Growth Substances|growth substances|mesh-ancestor
139041059|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041060|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
139041062|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041063|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139041064|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041065|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041066|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139041067|NCT00251589|Vorinostat|vorinostat|mesh-list
139041068|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041069|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139041070|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041071|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041072|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139041073|NCT00265239|Edaravone|edaravone|mesh-list
139041074|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139041075|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
139041076|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041077|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139041078|NCT00265239|Protective Agents|protective agents|mesh-ancestor
138690140|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139041079|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041080|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
139041081|NCT00159874|Citric Acid|citric acid|mesh-list
139041082|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
139041083|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
139041084|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139041085|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
139041086|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
139041087|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041088|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
139041089|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139041090|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139041091|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041092|NCT00159874|Urological Agents|urological agents|mesh-ancestor
139041093|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
139041094|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
139041095|NCT00184054|Vitamins|vitamins|mesh-ancestor
139041096|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
139041097|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041098|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
139041099|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041100|NCT00184054|Protective Agents|protective agents|mesh-ancestor
139041101|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041102|NCT02533908|Fentanyl|fentanyl|mesh-list
139041103|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139041104|NCT02533908|Narcotics|narcotics|mesh-ancestor
139041105|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139041106|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041107|NCT02533908|Analgesics|analgesics|mesh-ancestor
138542702|NCT00187993|Hormones|hormones|mesh-list
139041108|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
139041109|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041110|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139041111|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139041112|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
139041113|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
139041114|NCT00183430|Prazosin|prazosin|mesh-list
139041115|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139041116|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139041117|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139041118|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139041119|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
139041120|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041121|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041122|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041123|NCT00183274|Norepinephrine|norepinephrine|mesh-list
139041124|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139041125|NCT00183274|Serotonin|serotonin|mesh-list
139041126|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
139041127|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139041128|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139041129|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
139041130|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041131|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041132|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041133|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
139041134|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
139041135|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041136|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139041137|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139041138|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138281752|NCT00370760|Colchicine|colchicine|mesh-list
139041139|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139041140|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
139041141|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139041142|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139041143|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
139041145|NCT00183196|Gabapentin|gabapentin|mesh-list
139041146|NCT00183196|Analgesics|analgesics|mesh-ancestor
139041147|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
139041148|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041149|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041150|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
139041151|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139041152|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139041153|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139041154|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139041155|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139041156|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139041157|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041158|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041159|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
139041160|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139041161|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139041162|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
139041163|NCT00349752|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139041164|NCT00349752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139041165|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139041166|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
139041167|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041168|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139041169|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
139041170|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139041171|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041172|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139041173|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041175|NCT00348816|Docetaxel|docetaxel|mesh-list
139041176|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041177|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
139041178|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
139041179|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
139041180|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041181|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139041182|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
139041183|NCT00348816|Hormones|hormones|mesh-ancestor
139041184|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139041185|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041186|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139041187|NCT03989310|Manganese|manganese|mesh-list
139041188|NCT03989310|Paclitaxel|paclitaxel|mesh-list
139041189|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139041190|NCT03989310|Gemcitabine|gemcitabine|mesh-list
139041191|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139041193|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
139041194|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139041195|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041196|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
139041197|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
139041198|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
139041199|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041200|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
139041201|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041202|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139041203|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
139041204|NCT03989310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139041205|NCT03989310|Trace Elements|trace elements|mesh-ancestor
139041206|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
139041207|NCT03966898|Letrozole|letrozole|mesh-list
138690162|NCT02910141|Insulin|insulin|mesh-list
139041208|NCT03966898|Anastrozole|anastrozole|mesh-list
139041209|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041210|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139041211|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139041212|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041213|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041214|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139041215|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
139041216|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139041217|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041218|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139041219|NCT03989700|Thiamine|thiamine|mesh-list
139041220|NCT03989700|Vitamins|vitamins|mesh-ancestor
139041221|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
139041222|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041223|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
139041224|NCT01051284|Gemcitabine|gemcitabine|mesh-list
139041225|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139041226|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
139041227|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041228|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041229|NCT01051362|Carboplatin|carboplatin|mesh-list
139041230|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041231|NCT01055808|Insulin|insulin|mesh-list
139041232|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139041233|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041234|NCT00265083|Golimumab|golimumab|mesh-list
139041235|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139041236|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139041237|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139041238|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139041239|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
139041240|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041241|NCT00264849|Omalizumab|omalizumab|mesh-list
139041242|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139041243|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139041244|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
139041245|NCT01073709|Acetaminophen|acetaminophen|mesh-list
139041246|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139041247|NCT01073709|Analgesics|analgesics|mesh-ancestor
139041248|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
139041249|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041250|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041251|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
139041252|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139041253|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139041254|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139041255|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139041256|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041257|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041258|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041259|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139041260|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
139041262|NCT01071291|Niacin|niacin|mesh-list
138887244|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
139041263|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
139041264|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139041265|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
139041266|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041267|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139041268|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
139041269|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
139041270|NCT01071291|Vitamins|vitamins|mesh-ancestor
139041271|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
139041272|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041273|NCT00129766|Palivizumab|palivizumab|mesh-list
138690173|NCT04817033|Analgesics|analgesics|mesh-ancestor
139041274|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
139041275|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139041276|NCT00150592|Guanfacine|guanfacine|mesh-list
139041277|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139041278|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139041279|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139041280|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139041281|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
139041282|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041283|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041284|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041285|NCT00149890|Cyclosporine|cyclosporine|mesh-list
139041286|NCT00149890|Cyclosporins|cyclosporins|mesh-list
139041287|NCT00149890|Basiliximab|basiliximab|mesh-list
139041288|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041289|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041290|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139041291|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
139041292|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041293|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
139041294|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139041295|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
139041296|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139041297|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139041298|NCT00174382|Donepezil|donepezil|mesh-list
139041299|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139041300|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041301|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041302|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
138890655|NCT00856830|Carboplatin|carboplatin|mesh-list
139041303|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041304|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041305|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
139041306|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139041307|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139041308|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041309|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139041310|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
139041311|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041312|NCT00171730|Pasireotide|pasireotide|mesh-list
139041313|NCT00171730|Hormones|hormones|mesh-ancestor
139041314|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139041315|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041316|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
139041317|NCT00348348|Besifloxacin|besifloxacin|mesh-list
139041318|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139041319|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139041320|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139041321|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139041322|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041323|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041324|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041325|NCT00354744|Dactinomycin|dactinomycin|mesh-list
139041326|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
139041327|NCT00354744|Ifosfamide|ifosfamide|mesh-list
138690188|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
139041328|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
139041329|NCT00354744|Doxorubicin|doxorubicin|mesh-list
139041330|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139041331|NCT00354744|Irinotecan|irinotecan|mesh-list
139041332|NCT00354744|Etoposide|etoposide|mesh-list
139041333|NCT00354744|Vincristine|vincristine|mesh-list
139041334|NCT00354744|Camptothecin|camptothecin|mesh-list
139041335|NCT00354744|Lenograstim|lenograstim|mesh-list
139041336|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139041337|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
139041338|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041339|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139041340|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139041341|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
139041342|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041343|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041344|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139041345|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139041346|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139041347|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139041348|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041349|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139041350|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139041351|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139041352|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
139041353|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
139041354|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
139041355|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139041356|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139041357|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139041358|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139041359|NCT01055964|Tacrolimus|tacrolimus|mesh-list
139041360|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139041361|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
139041362|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041363|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139041364|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041365|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041366|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139041367|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139041368|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
139041369|NCT01056042|Gestodene|gestodene|mesh-list
139041370|NCT01056042|Estradiol|estradiol|mesh-list
139041371|NCT01056042|Estrogens|estrogens|mesh-ancestor
139041372|NCT01056042|Hormones|hormones|mesh-ancestor
139041373|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139041374|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041375|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139041376|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
138605930|NCT00169013|Gabapentin|gabapentin|mesh-list
139041377|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139041378|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138890721|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139041379|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139041380|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139041381|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139041382|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139041383|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138690208|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
139041384|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041385|NCT01056042|Progestins|progestins|mesh-ancestor
139041386|NCT00373256|Paclitaxel|paclitaxel|mesh-list
139041387|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139041388|NCT00373256|Bevacizumab|bevacizumab|mesh-list
139041389|NCT00373256|Sunitinib|sunitinib|mesh-list
139041390|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139041391|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041392|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
139041393|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
139041394|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
139041395|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041396|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139041397|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139041398|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139041399|NCT00373256|Growth Substances|growth substances|mesh-ancestor
139041400|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041401|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
139041402|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139041403|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041404|NCT01324544|Buprenorphine|buprenorphine|mesh-list
139041405|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139041406|NCT01324544|Narcotics|narcotics|mesh-ancestor
139041407|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139041408|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041409|NCT01324544|Analgesics|analgesics|mesh-ancestor
139041410|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
138690220|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
139041411|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041412|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139041413|NCT00394082|Paclitaxel|paclitaxel|mesh-list
139041414|NCT00394082|Bevacizumab|bevacizumab|mesh-list
139041415|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139041416|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139041417|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041418|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
139041419|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
139041420|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
139041421|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041422|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139041423|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139041424|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139041425|NCT00394082|Growth Substances|growth substances|mesh-ancestor
139041426|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041427|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
139041428|NCT00393848|Ketoconazole|ketoconazole|mesh-list
139041429|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
138890760|NCT02630264|Paclitaxel|paclitaxel|mesh-list
139041431|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139041432|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139041433|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041434|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041435|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139041436|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
139041437|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139041438|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041439|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139041440|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
139041441|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139041442|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
139041443|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041444|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041445|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139041446|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
139041447|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139041448|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139041449|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139041450|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
139041451|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041452|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041453|NCT01046006|Dexamethasone|dexamethasone|mesh-list
139041454|NCT01046006|Rituximab|rituximab|mesh-list
139041455|NCT01046006|Bortezomib|bortezomib|mesh-list
139041456|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139041457|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
139041458|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
139041459|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041460|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041461|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139041462|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
139041463|NCT01046006|Hormones|hormones|mesh-ancestor
139041464|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139041465|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139041466|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041467|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139041468|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
139041469|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139041470|NCT01046162|Alprazolam|alprazolam|mesh-list
139041471|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139041472|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139041473|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041474|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139041475|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139041476|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139041477|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
139041478|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
139041479|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041480|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041481|NCT00417482|Risperidone|risperidone|mesh-list
139041482|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139041483|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
139041484|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041485|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041486|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041487|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139041488|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139041489|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139041490|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139041491|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139041492|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
139041493|NCT00417248|Etoposide|etoposide|mesh-list
139041494|NCT00417248|Sorafenib|sorafenib|mesh-list
139041495|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041496|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139041497|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139041498|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139041499|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041500|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041501|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139041502|NCT01046240|Palonosetron|palonosetron|mesh-list
139041503|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
138606234|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041504|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
139041505|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041506|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041507|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139041508|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139041509|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139041510|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
139041511|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041512|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041513|NCT00392288|Ciclesonide|ciclesonide|mesh-list
139041514|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
139041515|NCT00392288|Hormones|hormones|mesh-ancestor
139041516|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139041517|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041518|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139041519|NCT00417170|Amlodipine|amlodipine|mesh-list
139041520|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139041521|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139041522|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139041523|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041524|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139041525|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041526|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
139041528|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
139041529|NCT00392990|Ifosfamide|ifosfamide|mesh-list
139041530|NCT00392990|Rituximab|rituximab|mesh-list
139041531|NCT00392990|Doxorubicin|doxorubicin|mesh-list
139041532|NCT00392990|Methotrexate|methotrexate|mesh-list
139041533|NCT00392990|Etoposide|etoposide|mesh-list
139041534|NCT00392990|Vincristine|vincristine|mesh-list
139041535|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
139041536|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139041537|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
139041538|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139041539|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
139041540|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041541|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139041542|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139041543|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
139041544|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041545|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041546|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139041547|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139041548|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139041549|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139041550|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139041551|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041552|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139041553|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
139041554|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139041555|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139041556|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
139041557|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
139041558|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139041559|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139041560|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139041561|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
138792177|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139041562|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139041563|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
139041564|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
139041565|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
139041566|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
139041568|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138890824|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041569|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139041570|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139041571|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139041572|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
139041573|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041574|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041575|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041576|NCT01037348|Ranibizumab|ranibizumab|mesh-list
139041577|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139041578|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139041579|NCT01037348|Growth Substances|growth substances|mesh-ancestor
139041580|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041581|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
139041582|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041583|NCT03490292|Paclitaxel|paclitaxel|mesh-list
139041584|NCT03490292|Carboplatin|carboplatin|mesh-list
139041585|NCT03490292|Avelumab|avelumab|mesh-list
138690307|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139041586|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139041587|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041588|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
139041589|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
139041590|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
139041591|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041592|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139041593|NCT01046630|Ketamine|ketamine|mesh-list
139041594|NCT01046630|Analgesics|analgesics|mesh-ancestor
139041595|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
139041596|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041597|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041598|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139041599|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139041600|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
139041601|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
139041602|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139041603|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139041604|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139041605|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041606|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041607|NCT01046708|Progesterone|progesterone|mesh-list
139041608|NCT01046708|Progestins|progestins|mesh-ancestor
139041609|NCT01046708|Hormones|hormones|mesh-ancestor
139041610|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139041611|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041613|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139041614|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139041615|NCT01046786|Prednisolone|prednisolone|mesh-list
139041616|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
139041617|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139041618|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
139041619|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139041620|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
139041621|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
139041622|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041623|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041624|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139041625|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
139041626|NCT01046786|Hormones|hormones|mesh-ancestor
139041627|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139041628|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139041629|NCT01046786|Protective Agents|protective agents|mesh-ancestor
139041630|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139041631|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041632|NCT00391976|Tobramycin|tobramycin|mesh-list
138606418|NCT00409851|Amlodipine|amlodipine|mesh-list
139041633|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139041634|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139041635|NCT00762554|Fentanyl|fentanyl|mesh-list
138792270|NCT00820027|Ibuprofen|ibuprofen|mesh-list
139041636|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139041637|NCT00762554|Narcotics|narcotics|mesh-ancestor
139041638|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139041639|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041640|NCT00762554|Analgesics|analgesics|mesh-ancestor
139041641|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
139041642|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041643|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139041644|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139041645|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
138690325|NCT02890186|Propofol|propofol|mesh-list
139041647|NCT00391898|Levodopa|levodopa|mesh-list
139041648|NCT00391898|Carbidopa|carbidopa|mesh-list
139041649|NCT00391898|Entacapone|entacapone|mesh-list
139041650|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139041651|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139041652|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
139041653|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041654|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041655|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041656|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139041657|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041658|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139041659|NCT01046864|Leucovorin|leucovorin|mesh-list
139041660|NCT01046864|Fluorouracil|fluorouracil|mesh-list
139041661|NCT01046864|Irinotecan|irinotecan|mesh-list
139041662|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
139041663|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041664|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139041665|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041666|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139041667|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
139041668|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041670|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139041671|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041672|NCT01046864|Antidotes|antidotes|mesh-ancestor
139041673|NCT01046864|Protective Agents|protective agents|mesh-ancestor
139041674|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
139041675|NCT01046864|Vitamins|vitamins|mesh-ancestor
139041676|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
139041677|NCT01046942|Aspirin|aspirin|mesh-list
139041678|NCT01046942|Clopidogrel|clopidogrel|mesh-list
139041679|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139041680|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139041681|NCT01046942|Analgesics|analgesics|mesh-ancestor
139041682|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
139041683|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041684|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041685|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139041686|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139041687|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139041688|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139041689|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041690|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139041691|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139041692|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041693|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
139041694|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139041695|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139041696|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139041697|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
139041698|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041699|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139041700|NCT01049438|Doxycycline|doxycycline|mesh-list
139041701|NCT01049438|Minocycline|minocycline|mesh-list
139041702|NCT01049438|Mupirocin|mupirocin|mesh-list
139041703|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139041704|NCT01049438|Trimethoprim|trimethoprim|mesh-list
139041705|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
139041706|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
139041707|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139041708|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
139041709|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139041710|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139041711|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139041712|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139041713|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041714|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041715|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139041716|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139041717|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139041718|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139041719|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139041720|NCT01047098|Iron|iron|mesh-list
139041721|NCT01047098|Trace Elements|trace elements|mesh-ancestor
139041722|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
139041723|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041724|NCT00391586|Paclitaxel|paclitaxel|mesh-list
139041725|NCT00391586|Etoposide|etoposide|mesh-list
139041726|NCT00391586|Vinorelbine|vinorelbine|mesh-list
139041727|NCT00391586|Docetaxel|docetaxel|mesh-list
139041728|NCT00391586|Gemcitabine|gemcitabine|mesh-list
139041729|NCT00391586|Irinotecan|irinotecan|mesh-list
139041730|NCT00391586|Pemetrexed|pemetrexed|mesh-list
139041731|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139041732|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139041733|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041734|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
139041735|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
139041736|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
139041737|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041738|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139041739|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
139041740|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139041741|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138606543|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
139041742|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041743|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139041744|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139041745|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139041746|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139041747|NCT00391430|Sertraline|sertraline|mesh-list
139041748|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
139041749|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139041750|NCT00391430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139041751|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139041752|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139041753|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041754|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041755|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
139041756|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041757|NCT00391274|Docetaxel|docetaxel|mesh-list
139041758|NCT00391274|Pemetrexed|pemetrexed|mesh-list
138606587|NCT00170768|Oxybutynin|oxybutynin|mesh-list
139041759|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041760|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
139041761|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
139041762|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
139041763|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041764|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041765|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139041766|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139041767|NCT00391118|Paclitaxel|paclitaxel|mesh-list
139041768|NCT00391118|Carboplatin|carboplatin|mesh-list
139041769|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139041770|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041771|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
139041772|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
139041773|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
139041774|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041775|NCT00390884|Vaccines|vaccines|mesh-list
139041776|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
139041777|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041778|NCT01047488|Pregabalin|pregabalin|mesh-list
139041779|NCT01047488|Imipramine|imipramine|mesh-list
139041780|NCT01047488|Analgesics|analgesics|mesh-ancestor
139041781|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
139041782|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041783|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041784|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
139041785|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139041786|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138169908|NCT03844256|Mitomycins|mitomycins|mesh-list
139041787|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041788|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139041789|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139041790|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139041791|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139041792|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139041793|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139041794|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
139041795|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139041796|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139041797|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
139041798|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041799|NCT01047566|Digoxin|digoxin|mesh-list
139041800|NCT01047566|Dronedarone|dronedarone|mesh-list
139041801|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
139041802|NCT01047566|Calcium|calcium|mesh-list
139041803|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139041804|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139041805|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041806|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139041807|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138606699|NCT05349448|Analgesics|analgesics|mesh-ancestor
139041808|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041809|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041810|NCT01047566|Protective Agents|protective agents|mesh-ancestor
139041811|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139041812|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
139041813|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041814|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139041815|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
139041816|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139041817|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041818|NCT00264537|Golimumab|golimumab|mesh-list
139041819|NCT00264537|Methotrexate|methotrexate|mesh-list
139041820|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138606744|NCT00171431|Tegaserod|tegaserod|mesh-list
139041821|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139041822|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
139041823|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139041824|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041825|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139041826|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
139041827|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041828|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041829|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
139041830|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041831|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139041832|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139041833|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
139041834|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139041835|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139041836|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139041837|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139041838|NCT00371150|Entecavir|entecavir|mesh-list
139041839|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
139041840|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139041841|NCT00264303|Levocetirizine|levocetirizine|mesh-list
139041842|NCT00264303|Desloratadine|desloratadine|mesh-list
139041843|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139041844|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139041845|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
139041846|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
139041847|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770204|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
139041848|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041849|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041850|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139041851|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
139041852|NCT01071369|Betamethasone|betamethasone|mesh-list
139041853|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
139041854|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139041855|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
139041856|NCT01071369|Lidocaine|lidocaine|mesh-list
139041857|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139041858|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
139041859|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
139041860|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139041861|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041862|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
139041863|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041864|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139041865|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139041866|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139041867|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139041868|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041869|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139041870|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
139041871|NCT01071369|Hormones|hormones|mesh-ancestor
139041872|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139041873|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139041874|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
139041875|NCT00370682|Vaccines|vaccines|mesh-list
139041876|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
139041877|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041878|NCT00264147|Diclofenac|diclofenac|mesh-list
139041879|NCT00264147|Etoricoxib|etoricoxib|mesh-list
139041880|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139041881|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139041882|NCT00264147|Analgesics|analgesics|mesh-ancestor
139041883|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
139041884|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041885|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041886|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139041887|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139041888|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139041889|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041890|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041891|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139041892|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
138690426|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139041893|NCT01044446|Icodextrin|icodextrin|mesh-list
139041894|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139041895|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
139041896|NCT03971019|Atorvastatin|atorvastatin|mesh-list
139041897|NCT03971019|Simvastatin|simvastatin|mesh-list
139041898|NCT03971019|Calcium|calcium|mesh-list
139041899|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139041900|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041901|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139041902|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139041903|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139041904|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
139041905|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041906|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139041907|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139041908|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041909|NCT03974685|Niacinamide|niacinamide|mesh-list
139041911|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
139041912|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
139041913|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
139041914|NCT03974685|Vitamins|vitamins|mesh-ancestor
139041915|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
139041916|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041917|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139041918|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
139041919|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041920|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139041921|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
139041922|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041923|NCT00263211|Aspirin|aspirin|mesh-list
139041924|NCT00263211|Clopidogrel|clopidogrel|mesh-list
139041925|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139041926|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139041927|NCT00263211|Analgesics|analgesics|mesh-ancestor
139041928|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
139041929|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139041930|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041931|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139041932|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139041933|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139041934|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139041935|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041936|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139041938|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041939|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
138606923|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
139041940|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139041941|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139041943|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
139041944|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041945|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
139041946|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139041947|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
139041948|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139041949|NCT00248625|Expectorants|expectorants|mesh-ancestor
139041950|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
139041951|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139041952|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
139041953|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041954|NCT00248625|Protective Agents|protective agents|mesh-ancestor
139041955|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041956|NCT00248625|Antidotes|antidotes|mesh-ancestor
139041957|NCT00262821|Tirapazamine|tirapazamine|mesh-list
139041958|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139041959|NCT01326117|Tadalafil|tadalafil|mesh-list
139041960|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
139041961|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139041962|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139041963|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041964|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041965|NCT01326117|Urological Agents|urological agents|mesh-ancestor
139041966|NCT03970239|Ketanserin|ketanserin|mesh-list
139041967|NCT03970239|Fluorides|fluorides|mesh-list
139041968|NCT03970239|Altanserin|altanserin|mesh-list
139041969|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
139041970|NCT03970239|Protective Agents|protective agents|mesh-ancestor
139041971|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041972|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139041973|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
139041974|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139041975|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041976|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138891099|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139041977|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139041978|NCT00170950|Amlodipine|amlodipine|mesh-list
139041979|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139041980|NCT00170950|Benazepril|benazepril|mesh-list
139041981|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139041982|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139041983|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139041984|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139041985|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139041986|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041987|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
139041988|NCT00170950|Diuretics|diuretics|mesh-ancestor
139041989|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
139041990|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139041991|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139041992|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
139041993|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139041995|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
139041996|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139041997|NCT00208767|Valsartan|valsartan|mesh-list
139041998|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139041999|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139042000|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139042001|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042002|NCT02531529|Fentanyl|fentanyl|mesh-list
139042003|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139042004|NCT02531529|Narcotics|narcotics|mesh-ancestor
139042005|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139042006|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042007|NCT02531529|Analgesics|analgesics|mesh-ancestor
139042008|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
139042009|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042010|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139042011|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139042012|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
139042013|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
139042014|NCT01071525|Niacin|niacin|mesh-list
139042015|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139042016|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
139042017|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042018|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139042019|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
139042020|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
139042021|NCT01071525|Vitamins|vitamins|mesh-ancestor
139042022|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
139042023|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042024|NCT01072695|Ribavirin|ribavirin|mesh-list
139042025|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139042026|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
139042027|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042028|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
139042029|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042030|NCT00390806|Topotecan|topotecan|mesh-list
139042031|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139042032|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139042033|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042034|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042035|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042036|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
139042037|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042038|NCT01047722|Aspirin|aspirin|mesh-list
139042039|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139042040|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139042041|NCT01047722|Analgesics|analgesics|mesh-ancestor
139042042|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
139042043|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607062|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139042044|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042045|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139042046|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139042047|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139042048|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139042049|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042050|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139042051|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139042052|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042053|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
139042054|NCT00390416|Leucovorin|leucovorin|mesh-list
139042055|NCT00390416|Bevacizumab|bevacizumab|mesh-list
139042056|NCT00390416|Docetaxel|docetaxel|mesh-list
139042057|NCT00390416|Fluorouracil|fluorouracil|mesh-list
139042058|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139042059|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042060|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138690489|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
139042061|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139042062|NCT00390416|Growth Substances|growth substances|mesh-ancestor
139042063|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042064|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
139042065|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
139042066|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
139042067|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
139042068|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042069|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
139042070|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139042071|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139042072|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
139042073|NCT00390416|Antidotes|antidotes|mesh-ancestor
139042074|NCT00390416|Protective Agents|protective agents|mesh-ancestor
139042075|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
139042077|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
139042078|NCT00261495|Oxycodone|oxycodone|mesh-list
139042079|NCT00261495|Hydromorphone|hydromorphone|mesh-list
139042080|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139042081|NCT00261495|Narcotics|narcotics|mesh-ancestor
139042082|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139042083|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042084|NCT00261495|Analgesics|analgesics|mesh-ancestor
139042085|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
138607098|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
139042086|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042087|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
139042088|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139042089|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
139042090|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042091|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042092|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139042093|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
139042095|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138690494|NCT01289353|Carboplatin|carboplatin|mesh-list
139042096|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
139042097|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139042098|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042099|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
139042100|NCT00365456|Hormones|hormones|mesh-list
139042101|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
139042102|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139042103|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042104|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139042105|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139042106|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042107|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139042108|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139042109|NCT01047956|Methadone|methadone|mesh-list
139042110|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139042111|NCT01047956|Narcotics|narcotics|mesh-ancestor
139042112|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139042113|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042114|NCT01047956|Analgesics|analgesics|mesh-ancestor
139042115|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
139042116|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042117|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
139042118|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
139042119|NCT00206427|Lapatinib|lapatinib|mesh-list
139042120|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042121|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139042122|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042123|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042124|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
139042125|NCT00389324|Antibodies|antibodies|mesh-list
139042126|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
139042127|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139042128|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139042129|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
139042130|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
139042131|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042132|NCT00365300|Pantoprazole|pantoprazole|mesh-list
139042133|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139042134|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139042135|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139042136|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042137|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042138|NCT01048034|Azacitidine|azacitidine|mesh-list
139042139|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
139042140|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139042141|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
139042142|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042143|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042144|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042145|NCT01048034|Hematinics|hematinics|mesh-ancestor
139042146|NCT00370292|Pemetrexed|pemetrexed|mesh-list
139042147|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042148|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042149|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042150|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139042151|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139042153|NCT01049672|Heroin|heroin|mesh-list
139042154|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139042155|NCT01049672|Narcotics|narcotics|mesh-ancestor
139042156|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139042157|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042158|NCT01049672|Analgesics|analgesics|mesh-ancestor
139042159|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
139042160|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042161|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139042162|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
139042163|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
139042164|NCT01048190|Vaccines|vaccines|mesh-list
139042165|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
139042166|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042167|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
139042168|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139042169|NCT01048268|Incretins|incretins|mesh-ancestor
139042170|NCT01048268|Hormones|hormones|mesh-ancestor
139042171|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139042172|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042173|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139042174|NCT03993236|Ezetimibe|ezetimibe|mesh-list
139042175|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139042176|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139042177|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
139042178|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042179|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139042180|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139042181|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042182|NCT00388154|Cisplatin|cisplatin|mesh-list
139042183|NCT00388154|Gemcitabine|gemcitabine|mesh-list
139042184|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042185|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139042186|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
139042187|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042188|NCT02535104|Ranpirnase|ranpirnase|mesh-list
139042189|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042190|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139042191|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042192|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042193|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
139042194|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139042195|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139042196|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042197|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139042198|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042199|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139042200|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
139042201|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139042202|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042203|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139042204|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
139042205|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139042206|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042207|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042208|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042209|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
139042210|NCT00529373|Vitamin D|vitamin d|mesh-list
139042211|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
139042212|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
139042213|NCT00529373|Calcium|calcium|mesh-list
139042214|NCT00529373|Vitamins|vitamins|mesh-ancestor
139042215|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
139042216|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770205|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042217|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139042218|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139042219|NCT00529373|Antacids|antacids|mesh-ancestor
138607251|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
139042220|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042221|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139042222|NCT00369122|Bevacizumab|bevacizumab|mesh-list
139042223|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139042224|NCT00369122|Cisplatin|cisplatin|mesh-list
139042225|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
139042226|NCT00369122|Antibodies|antibodies|mesh-list
139042227|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
139042228|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139042229|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
139042230|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042231|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139042232|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139042233|NCT00369122|Growth Substances|growth substances|mesh-ancestor
139042234|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042235|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
139042236|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
139042237|NCT05173493|Amoxicillin|amoxicillin|mesh-list
139042238|NCT05173493|Levofloxacin|levofloxacin|mesh-list
139042239|NCT05173493|Tetracycline|tetracycline|mesh-list
139042240|NCT05173493|Furazolidone|furazolidone|mesh-list
139042241|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139042242|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042243|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139042244|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138891365|NCT00705016|Cetuximab|cetuximab|mesh-list
139042245|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139042246|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042247|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042248|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042249|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139042250|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139042251|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139042252|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139042253|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139042254|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139042255|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139042256|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139042258|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139042259|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139042260|NCT03872843|Analgesics|analgesics|mesh-ancestor
139042261|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
139042262|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042263|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042264|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139042265|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139042266|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139042267|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042268|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042269|NCT03966040|Vaccines|vaccines|mesh-list
139042270|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
139042271|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042272|NCT03999125|Dexamethasone|dexamethasone|mesh-list
139042273|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
139042274|NCT03999125|Ranibizumab|ranibizumab|mesh-list
139042275|NCT03999125|Aflibercept|aflibercept|mesh-list
139042276|NCT03999125|BB 1101|bb 1101|mesh-list
139042277|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139042278|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
139042279|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
139042280|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042281|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042282|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139042283|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
139042284|NCT03999125|Hormones|hormones|mesh-ancestor
139042285|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139042286|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138690563|NCT02935790|Nivolumab|nivolumab|mesh-list
139042287|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042288|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
139042289|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042290|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042291|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139042292|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139042293|NCT03999125|Growth Substances|growth substances|mesh-ancestor
139042294|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
139042295|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
139042296|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139042297|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
139042298|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042299|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139042300|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042301|NCT00166114|Desipramine|desipramine|mesh-list
139042302|NCT00166114|Escitalopram|escitalopram|mesh-list
139042303|NCT00166114|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139042304|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139042305|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139042306|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042307|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139042308|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
139042309|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042310|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
139042311|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139042312|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139042313|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042314|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139042315|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
139042316|NCT05032781|Minocycline|minocycline|mesh-list
139042317|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139042318|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042319|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
139042320|NCT00129376|Docetaxel|docetaxel|mesh-list
139042321|NCT00129376|Doxorubicin|doxorubicin|mesh-list
139042322|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138891423|NCT01009801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139042323|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
139042324|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042325|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139042326|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139042327|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
139042328|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042329|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042330|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139042331|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
139042332|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
139042333|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
139042334|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139042335|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139042336|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139042337|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042338|NCT04878107|Docetaxel|docetaxel|mesh-list
139042339|NCT04878107|Apatinib|apatinib|mesh-list
138690568|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042340|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042341|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
139042342|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
139042343|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
139042344|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042345|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139042346|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042347|NCT03998969|Pantoprazole|pantoprazole|mesh-list
139042348|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139042349|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139042350|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139042351|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042352|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042353|NCT00129220|Haloperidol|haloperidol|mesh-list
139042354|NCT00129220|Olanzapine|olanzapine|mesh-list
139042355|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
139042356|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
139042357|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
139042358|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042359|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042360|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139042361|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139042362|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139042363|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139042364|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139042365|NCT00129220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139042366|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139042367|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139042368|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042369|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139042370|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
139042371|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139042372|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
139042373|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139042374|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
139042375|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042376|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
139042377|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139042378|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139042379|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042380|NCT03686813|Urological Agents|urological agents|mesh-ancestor
139042381|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139042382|NCT00128830|Etravirine|etravirine|mesh-list
139042383|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
139042384|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139042385|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
139042386|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139042387|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042388|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042389|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
139042390|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042391|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139042392|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139042393|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139042394|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139042395|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139042396|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139042397|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
139042398|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
139042399|NCT01074892|Progestins|progestins|mesh-list
139042400|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139042401|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
139042402|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139042403|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042404|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138607514|NCT00410631|Melphalan|melphalan|mesh-list
139042405|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139042406|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139042408|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139042409|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139042410|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042411|NCT01074892|Hormones|hormones|mesh-ancestor
139042412|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139042413|NCT00128206|Rifampin|rifampin|mesh-list
139042414|NCT00128206|Isoniazid|isoniazid|mesh-list
139042415|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139042416|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
139042417|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139042418|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042419|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
138891493|NCT00510289|Sorafenib|sorafenib|mesh-list
139042420|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139042421|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042422|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042423|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139042424|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139042425|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139042426|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139042427|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139042428|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139042429|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139042430|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139042431|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
139042432|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139042433|NCT01075828|Cetuximab|cetuximab|mesh-list
139042434|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139042435|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042436|NCT01074970|Cisplatin|cisplatin|mesh-list
139042437|NCT01074970|Rucaparib|rucaparib|mesh-list
139042438|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042439|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139042440|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042441|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042442|NCT03968146|Acetaminophen|acetaminophen|mesh-list
139042443|NCT03968146|Ketorolac|ketorolac|mesh-list
139042444|NCT03968146|Fentanyl|fentanyl|mesh-list
139042445|NCT03968146|Meperidine|meperidine|mesh-list
139042446|NCT03968146|Morphine|morphine|mesh-list
139042447|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139042448|NCT03968146|Narcotics|narcotics|mesh-ancestor
139042449|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139042450|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042451|NCT03968146|Analgesics|analgesics|mesh-ancestor
139042452|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
139042453|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042454|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139042455|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139042456|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
139042457|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
139042458|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139042459|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
139042460|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139042461|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139042462|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138607600|NCT00410748|Analgesics|analgesics|mesh-ancestor
139042463|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139042464|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042465|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042468|NCT03966118|Ramucirumab|ramucirumab|mesh-list
139042469|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139042470|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042471|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
139042472|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
139042473|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
139042474|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042475|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139042476|NCT03968224|Metformin|metformin|mesh-list
139042477|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
139042478|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139042479|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042480|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139042481|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042482|NCT01075126|Valproic Acid|valproic acid|mesh-list
139042483|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139042484|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042485|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042486|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
139042487|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139042488|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139042489|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042490|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
139042491|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
139042492|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139042493|NCT03823378|Upadacitinib|upadacitinib|mesh-list
139042494|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139042495|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139042496|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042497|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042498|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139042499|NCT00141778|Ramipril|ramipril|mesh-list
139042500|NCT00141778|Spironolactone|spironolactone|mesh-list
139042501|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139042502|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139042503|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139042504|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
139042505|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
139042506|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139042507|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042508|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139042509|NCT00141778|Diuretics|diuretics|mesh-ancestor
139042510|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
139042511|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
139042512|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042513|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139042514|NCT00141778|Hormones|hormones|mesh-ancestor
139042515|NCT01079884|Esomeprazole|esomeprazole|mesh-list
139042516|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139042517|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139042518|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139042519|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042520|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042521|NCT01075906|Colchicine|colchicine|mesh-list
139042522|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
139042523|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139042524|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
139042525|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
139042526|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
139042527|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042528|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042529|NCT01076062|Misoprostol|misoprostol|mesh-list
139042530|NCT01076062|Oxytocin|oxytocin|mesh-list
139042531|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
139042532|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139042533|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042534|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139042535|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
139042536|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139042537|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139042538|NCT00115336|Ibuprofen|ibuprofen|mesh-list
139042539|NCT00115336|Ketorolac|ketorolac|mesh-list
139042540|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138793155|NCT05834478|Dopamine Agents|dopamine agents|mesh-ancestor
139042541|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139042542|NCT00115336|Analgesics|analgesics|mesh-ancestor
139042543|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
139042544|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042545|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042546|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139042547|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139042548|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139042549|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042550|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042551|NCT01076140|Lisinopril|lisinopril|mesh-list
139042552|NCT01076140|Nebivolol|nebivolol|mesh-list
139042553|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139042554|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
139042555|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042556|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042557|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139042558|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139042559|NCT01076140|Protective Agents|protective agents|mesh-ancestor
139042560|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042561|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
139042562|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139042563|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139042564|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139042565|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
139042566|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139042567|NCT00205803|Vaccines|vaccines|mesh-list
139042568|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139042569|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
139042570|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042571|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139042572|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139042573|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042575|NCT00127192|Hormones|hormones|mesh-ancestor
139042576|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139042577|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139042578|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
139042579|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042580|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042581|NCT00127036|Bevacizumab|bevacizumab|mesh-list
139042582|NCT00127036|Capecitabine|capecitabine|mesh-list
139042583|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
139042584|NCT00127036|Irinotecan|irinotecan|mesh-list
139042585|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139042586|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042587|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139042588|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139042589|NCT00127036|Growth Substances|growth substances|mesh-ancestor
139042590|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042591|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
139042592|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139042593|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
139042594|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042595|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139042596|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139042597|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042598|NCT00259857|Alendronate|alendronate|mesh-list
139042599|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139042600|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042601|NCT01071681|Telmisartan|telmisartan|mesh-list
139042602|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139042603|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139042604|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139042605|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042606|NCT00203307|Olanzapine|olanzapine|mesh-list
139042607|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
139042608|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
139042609|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042610|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042611|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139042612|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139042613|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139042614|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139042616|NCT00203307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139042617|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139042618|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138891581|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042619|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042620|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139042621|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
139042622|NCT00126568|Sorafenib|sorafenib|mesh-list
139042623|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042624|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139042625|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042626|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042627|NCT00202839|Ribavirin|ribavirin|mesh-list
139042628|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139042629|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
139042630|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
139042631|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042632|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
139042633|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042634|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
139042635|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042636|NCT00126490|Aldesleukin|aldesleukin|mesh-list
139042637|NCT00126490|Bevacizumab|bevacizumab|mesh-list
139042638|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139042639|NCT00126490|Interleukin-2|interleukin-2|mesh-list
139042640|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
139042641|NCT00126490|Antibodies|antibodies|mesh-list
139042642|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
139042643|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139042644|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
139042645|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042646|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139042647|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139042648|NCT00126490|Growth Substances|growth substances|mesh-ancestor
139042649|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042650|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
139042651|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
139042652|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139042653|NCT00126490|Analgesics|analgesics|mesh-ancestor
139042654|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
139042655|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042656|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139042657|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139042658|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
139042659|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042660|NCT00200967|Beclomethasone|beclomethasone|mesh-list
139042661|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139042662|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139042663|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
139042664|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042665|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042666|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139042667|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
139042668|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139042669|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139042670|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139042671|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
139042672|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139042673|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042674|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139042676|NCT00200967|Hormones|hormones|mesh-ancestor
139042677|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139042678|NCT02533440|Anesthetics|anesthetics|mesh-list
139042679|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
139042680|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139042681|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042682|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
139042683|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042684|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139042685|NCT00354432|Caseins|caseins|mesh-list
139042686|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139042687|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139042688|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138607902|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
139042689|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042690|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139042691|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042692|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139042693|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
139042694|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139042695|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
139042696|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
139042697|NCT00140140|Paclitaxel|paclitaxel|mesh-list
139042698|NCT00140140|Vinorelbine|vinorelbine|mesh-list
139042699|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139042700|NCT00140140|Trastuzumab|trastuzumab|mesh-list
139042701|NCT00140140|Lenograstim|lenograstim|mesh-list
139042702|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139042703|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042704|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
139042705|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
139042706|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
139042707|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042708|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139042709|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139042710|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
139042711|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042712|NCT00346398|Immunomodulating Agents|immunomodulating agents|mesh-list
139042713|NCT00346398|Immunologic Factors|immunologic factors|mesh-ancestor
139042714|NCT00346398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042715|NCT00346164|Doxorubicin|doxorubicin|mesh-list
139042716|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139042717|NCT00346164|Ifosfamide|ifosfamide|mesh-list
139042718|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139042719|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042720|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139042721|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139042722|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042723|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042724|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139042725|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
139042726|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
139042727|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139042728|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042729|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139042730|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139042731|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042732|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042733|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042734|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139042735|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139042737|NCT00114244|Sorafenib|sorafenib|mesh-list
139042738|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139042739|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
139042740|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042741|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042742|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139042743|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042744|NCT01054872|Vaccines|vaccines|mesh-list
139042745|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
139042746|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042747|NCT00337662|Olanzapine|olanzapine|mesh-list
139042748|NCT00337662|Risperidone|risperidone|mesh-list
139042749|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139042750|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
139042751|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139042752|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042753|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042754|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139042755|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139042756|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139042757|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139042758|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139042759|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
139042760|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
139042761|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
139042762|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042763|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139042764|NCT00337662|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139042765|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138608053|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
139042766|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139042767|NCT00138424|Cidofovir|cidofovir|mesh-list
139042768|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
139042769|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042770|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042771|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042772|NCT00368966|Vaccines|vaccines|mesh-list
139042773|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139042774|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
139042775|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042776|NCT00114166|Topotecan|topotecan|mesh-list
139042777|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139042778|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139042779|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042780|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042781|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042782|NCT00337428|Vaccines|vaccines|mesh-list
139042783|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
139042784|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042785|NCT00235989|Interferons|interferons|mesh-list
139042786|NCT00235989|Interferon-beta|interferon-beta|mesh-list
139042787|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
139042788|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042789|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
139042790|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042791|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
139042792|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042793|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139042794|NCT00113386|Docetaxel|docetaxel|mesh-list
139042795|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042796|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
139042797|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
138891708|NCT04502095|Ofloxacin|ofloxacin|mesh-list
139042799|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042800|NCT00353262|Capecitabine|capecitabine|mesh-list
139042801|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
139042802|NCT00353262|Bevacizumab|bevacizumab|mesh-list
139042803|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139042804|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
139042805|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042806|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042807|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139042808|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139042809|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139042810|NCT00353262|Growth Substances|growth substances|mesh-ancestor
138608154|NCT00174707|Docetaxel|docetaxel|mesh-list
139042811|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042812|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
139042813|NCT00125164|Mecasermin|mecasermin|mesh-list
139042814|NCT00125164|Growth Substances|growth substances|mesh-ancestor
139042815|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042816|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
139042817|NCT03985410|Durlobactam|durlobactam|mesh-list
139042818|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139042819|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042820|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139042821|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139042822|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042823|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042824|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042825|NCT03985410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139042826|NCT00136318|Ribavirin|ribavirin|mesh-list
139042827|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139042828|NCT00136318|Escitalopram|escitalopram|mesh-list
139042829|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
139042830|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042831|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
139042832|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042833|NCT00136318|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139042834|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139042835|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139042836|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139042837|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
138793452|NCT05233605|Dexmedetomidine|dexmedetomidine|mesh-list
139042838|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891732|NCT00674102|Vadimezan|vadimezan|mesh-list
139042840|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139042841|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042842|NCT00136084|Cytarabine|cytarabine|mesh-list
139042843|NCT00136084|Dexamethasone|dexamethasone|mesh-list
139042844|NCT00136084|Prednisone|prednisone|mesh-list
139042845|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
139042846|NCT00136084|Methotrexate|methotrexate|mesh-list
139042847|NCT00136084|Etoposide|etoposide|mesh-list
139042848|NCT00136084|Vincristine|vincristine|mesh-list
139042849|NCT00136084|Daunorubicin|daunorubicin|mesh-list
139042850|NCT00136084|Asparaginase|asparaginase|mesh-list
139042852|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
139042853|NCT00136084|Cladribine|cladribine|mesh-list
139042854|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
139042855|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139042856|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
139042857|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042858|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139042859|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139042860|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
139042861|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042862|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042863|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139042864|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139042865|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
139042866|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
139042867|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139042868|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138608330|NCT04675528|Paclitaxel|paclitaxel|mesh-list
139042869|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
139042870|NCT00136084|Hormones|hormones|mesh-ancestor
139042871|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139042872|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139042873|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139042874|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
139042875|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139042876|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139042877|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
139042878|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
139042879|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042880|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139042881|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139042882|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139042883|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139042884|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139042885|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
139042886|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042887|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
138891762|NCT00503425|Rituximab|rituximab|mesh-list
139042888|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
139042889|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
139042890|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139042891|NCT00136084|Analgesics|analgesics|mesh-ancestor
139042892|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
139042893|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139042894|NCT00136084|Immunotoxins|immunotoxins|mesh-ancestor
139042895|NCT00136084|Immunoconjugates|immunoconjugates|mesh-ancestor
139042896|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
139042897|NCT00364832|Hematinics|hematinics|mesh-ancestor
139042898|NCT00235755|Ezogabine|ezogabine|mesh-list
139042899|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
139042900|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139042901|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042902|NCT01581879|Ziprasidone|ziprasidone|mesh-list
139042903|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139042904|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
139042905|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608445|NCT04230187|Leucovorin|leucovorin|mesh-list
139042906|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042907|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042908|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139042909|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139042910|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139042911|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139042912|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139042913|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
139042914|NCT00337194|Gemcitabine|gemcitabine|mesh-list
139042915|NCT00337194|Doxorubicin|doxorubicin|mesh-list
139042916|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139042918|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139042919|NCT00337194|Antibodies|antibodies|mesh-list
139042920|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139042921|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
139042922|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690682|NCT02935010|Bismuth|bismuth|mesh-list
139042923|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139042924|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
139042925|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042926|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042927|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139042928|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139042929|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139042930|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042931|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139042932|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
139042933|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
139042934|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
139042935|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139042936|NCT00337194|Immunotoxins|immunotoxins|mesh-ancestor
139042937|NCT00337194|Immunoconjugates|immunoconjugates|mesh-ancestor
139042938|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
139042939|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139042940|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042941|NCT01074333|Cetuximab|cetuximab|mesh-list
139042942|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139042943|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042944|NCT00385736|Adalimumab|adalimumab|mesh-list
139042945|NCT00385736|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139042946|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139042947|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139042948|NCT01057212|Bevacizumab|bevacizumab|mesh-list
139042949|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139042950|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042951|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139042952|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139042953|NCT01057212|Growth Substances|growth substances|mesh-ancestor
139042954|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139042955|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
139042956|NCT03988452|Ritonavir|ritonavir|mesh-list
139042957|NCT03988452|Darunavir|darunavir|mesh-list
139042958|NCT03988452|Tenofovir|tenofovir|mesh-list
139042959|NCT03988452|Lamivudine|lamivudine|mesh-list
139042960|NCT03988452|Zidovudine|zidovudine|mesh-list
139042961|NCT03988452|Dolutegravir|dolutegravir|mesh-list
139042962|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139042963|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138608621|NCT03758287|Gefitinib|gefitinib|mesh-list
139042964|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
139042965|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139042966|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042967|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139042968|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139042969|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
139042970|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139042971|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139042972|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139042973|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139042974|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139042975|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
139042976|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139042977|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139042978|NCT01048580|Capecitabine|capecitabine|mesh-list
139042979|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139042980|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
139042981|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042982|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042983|NCT00195819|Adalimumab|adalimumab|mesh-list
139042984|NCT00195819|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139042985|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139042986|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139042987|NCT00527735|Paclitaxel|paclitaxel|mesh-list
139042988|NCT00527735|Carboplatin|carboplatin|mesh-list
139042989|NCT00527735|Ipilimumab|ipilimumab|mesh-list
139042990|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139042991|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139042992|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
139042993|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
139042994|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
139042995|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139042996|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139042997|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139042998|NCT00336492|Infliximab|infliximab|mesh-list
139042999|NCT00336492|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139043000|NCT00336492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139043001|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
139043002|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139043003|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139043004|NCT00194025|Valproic Acid|valproic acid|mesh-list
139043005|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
139043006|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043007|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043008|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
139043009|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139043010|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043011|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
139043012|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139043013|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139043014|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139043015|NCT00521339|Apremilast|apremilast|mesh-list
139043016|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139043017|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139043018|NCT00521339|Analgesics|analgesics|mesh-ancestor
139043019|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
139043020|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043021|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043022|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139043023|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139043024|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139043025|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139043026|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043027|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043028|NCT00363896|Bromides|bromides|mesh-list
139043029|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
139043030|NCT00527423|Aflibercept|aflibercept|mesh-list
139043031|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139043032|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139043033|NCT00527423|Growth Substances|growth substances|mesh-ancestor
139043034|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043035|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
139043036|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043037|NCT00527111|Fluorouracil|fluorouracil|mesh-list
139043038|NCT00527111|Cetuximab|cetuximab|mesh-list
139043039|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
139043040|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043041|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138608852|NCT02372578|Pregabalin|pregabalin|mesh-list
139043042|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043043|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139043044|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
139043045|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043046|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138891847|NCT04154852|Vitamins|vitamins|mesh-ancestor
139043048|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139043049|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
139043050|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043051|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043052|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043053|NCT04090697|Oxandrolone|oxandrolone|mesh-list
138690700|NCT02935010|Antacids|antacids|mesh-ancestor
139043054|NCT04090697|Androgens|androgens|mesh-ancestor
139043055|NCT04090697|Hormones|hormones|mesh-ancestor
139043056|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139043057|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043058|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
139043059|NCT00367640|Immunomodulating Agents|immunomodulating agents|mesh-list
139043060|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
139043061|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043062|NCT01325220|Baclofen|baclofen|mesh-list
139043063|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139043064|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043065|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138608957|NCT02296645|Disinfectants|disinfectants|mesh-ancestor
139043066|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043067|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139043068|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
139043069|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
139043070|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139043071|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043072|NCT00367484|Interferons|interferons|mesh-list
139043073|NCT00367484|Interferon-beta|interferon-beta|mesh-list
139043074|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
139043075|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043076|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
139043077|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043078|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
139043079|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043080|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139043082|NCT00526799|Topotecan|topotecan|mesh-list
139043083|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043084|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139043085|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043086|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043087|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139043088|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139043089|NCT01059084|Valacyclovir|valacyclovir|mesh-list
139043090|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
138609017|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139043091|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043092|NCT03992144|Amoxicillin|amoxicillin|mesh-list
139043093|NCT03992144|Metronidazole|metronidazole|mesh-list
139043094|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139043095|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043096|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139043097|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139043098|NCT02534870|Ritonavir|ritonavir|mesh-list
139043099|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139043100|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139043101|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
139043102|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043103|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043104|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139043105|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139043106|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
139043107|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043108|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139043109|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139043110|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
139043111|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
139043112|NCT03992066|Hematinics|hematinics|mesh-ancestor
139043113|NCT03986268|Vitamin D|vitamin d|mesh-list
139043114|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
139043115|NCT03986268|Vitamins|vitamins|mesh-ancestor
139043116|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
139043117|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043118|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139043119|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139043120|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
138609081|NCT00200187|Anesthetics|anesthetics|mesh-list
139043121|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139043122|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
139043123|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043124|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139043125|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139043126|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
139043127|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043128|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043129|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139043130|NCT01259648|Remifentanil|remifentanil|mesh-list
139043131|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139043132|NCT01259648|Narcotics|narcotics|mesh-ancestor
139043133|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139043134|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043136|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
139043137|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043138|NCT01049048|Vitamin D|vitamin d|mesh-list
139043139|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
139043140|NCT01049048|Vitamins|vitamins|mesh-ancestor
139043141|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
139043142|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793753|NCT04592913|Durvalumab|durvalumab|mesh-list
139043143|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139043144|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139043145|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139043146|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
139043147|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043148|NCT01044992|Levodopa|levodopa|mesh-list
139043149|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139043150|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139043151|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
139043152|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139043153|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043154|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043155|NCT00520403|Interferons|interferons|mesh-list
139043156|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
139043157|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
139043158|NCT00520403|Bevacizumab|bevacizumab|mesh-list
139043159|NCT00520403|Vinblastine|vinblastine|mesh-list
139043160|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139043161|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043162|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139043163|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139043164|NCT00520403|Growth Substances|growth substances|mesh-ancestor
138690734|NCT02934464|Vitamins|vitamins|mesh-ancestor
139043165|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043166|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
139043167|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
139043168|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043169|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
139043170|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139043171|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
139043172|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
139043173|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
139043174|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043175|NCT00520013|Paclitaxel|paclitaxel|mesh-list
139043176|NCT00520013|Bevacizumab|bevacizumab|mesh-list
139043177|NCT00520013|Carboplatin|carboplatin|mesh-list
139043178|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139043179|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139043180|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043181|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
139043182|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
139043183|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
139043184|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043185|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139043186|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139043187|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139043188|NCT00520013|Growth Substances|growth substances|mesh-ancestor
139043189|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043190|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
139043191|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139043192|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043193|NCT00526097|Bisacodyl|bisacodyl|mesh-list
139043194|NCT00526097|Cathartics|cathartics|mesh-ancestor
139043195|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139043196|NCT00526097|Laxatives|laxatives|mesh-ancestor
139043197|NCT00525785|Leucovorin|leucovorin|mesh-list
139043198|NCT00525785|Folic Acid|folic acid|mesh-list
139043199|NCT00525785|Fluorouracil|fluorouracil|mesh-list
139043200|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
139043201|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
139043202|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
139043203|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043204|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139043205|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043206|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139043207|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
139043208|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043209|NCT00525785|Antidotes|antidotes|mesh-ancestor
139043210|NCT00525785|Protective Agents|protective agents|mesh-ancestor
139043211|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
139043212|NCT00525785|Vitamins|vitamins|mesh-ancestor
139043213|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
139043214|NCT00525785|Hematinics|hematinics|mesh-ancestor
139043215|NCT00525161|Sorafenib|sorafenib|mesh-list
139043216|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043217|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139043218|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043219|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793826|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139043220|NCT00135694|Prednisone|prednisone|mesh-list
139043221|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139043222|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139043223|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
139043225|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139043226|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043227|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139043228|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043229|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043230|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043231|NCT00524459|Docetaxel|docetaxel|mesh-list
139043232|NCT00524459|Doxorubicin|doxorubicin|mesh-list
139043233|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139043234|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043235|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
139043236|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
139043237|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
139043238|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043239|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139043240|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139043241|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139043242|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043243|NCT00519623|Insulin|insulin|mesh-list
139043244|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139043245|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043246|NCT01076530|Temozolomide|temozolomide|mesh-list
139043247|NCT01076530|Vorinostat|vorinostat|mesh-list
139043248|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139043249|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
139043250|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043251|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043252|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139043253|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043254|NCT00519077|Gefitinib|gefitinib|mesh-list
139043255|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043256|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139043257|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043258|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043259|NCT00124618|Cetuximab|cetuximab|mesh-list
139043260|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139043261|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043262|NCT00124072|Folic Acid|folic acid|mesh-list
139043263|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
139043264|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
139043265|NCT00124072|Simvastatin|simvastatin|mesh-list
139043266|NCT00124072|Vitamins|vitamins|mesh-ancestor
139043267|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
139043268|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043269|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139043270|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139043271|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
139043272|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043273|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139043274|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139043275|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043276|NCT00124072|Hematinics|hematinics|mesh-ancestor
139043277|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
139043278|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
139043279|NCT01080352|Vitamins|vitamins|mesh-ancestor
139043280|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
138891976|NCT06157320|Sympathomimetics|sympathomimetics|mesh-ancestor
139043281|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043282|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
139043283|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043284|NCT01080352|Protective Agents|protective agents|mesh-ancestor
139043286|NCT00524303|Trastuzumab|trastuzumab|mesh-list
139043287|NCT00524303|Lapatinib|lapatinib|mesh-list
139043288|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139043289|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043290|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
139043291|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
139043292|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
139043293|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043294|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139043295|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139043296|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043297|NCT04461041|Empagliflozin|empagliflozin|mesh-list
139043298|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138609405|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
139043299|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043300|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139043301|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043302|NCT00335556|Dactinomycin|dactinomycin|mesh-list
139043303|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
139043304|NCT00335556|Carboplatin|carboplatin|mesh-list
139043305|NCT00335556|Doxorubicin|doxorubicin|mesh-list
139043306|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139043307|NCT00335556|Irinotecan|irinotecan|mesh-list
139043308|NCT00335556|Etoposide|etoposide|mesh-list
139043309|NCT00335556|Vincristine|vincristine|mesh-list
139043310|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139043311|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
139043312|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043313|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139043314|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139043315|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
139043316|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043317|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043318|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139043319|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139043320|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139043321|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139043322|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043323|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139043324|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139043325|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
139043326|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
139043327|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
139043328|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139043329|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043330|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139043331|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139043332|NCT00518687|Vaccines|vaccines|mesh-list
139043333|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
139043334|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043335|NCT00134056|Prednisone|prednisone|mesh-list
139043336|NCT00134056|Docetaxel|docetaxel|mesh-list
139043337|NCT00134056|Atrasentan|atrasentan|mesh-list
139043338|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043339|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
139043340|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
139043341|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
139043342|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043343|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139043344|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
139043345|NCT00134056|Hormones|hormones|mesh-ancestor
139043346|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138544108|NCT00048204|Paroxetine|paroxetine|mesh-list
139043347|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043348|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139043349|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139043350|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139043351|NCT00518531|Denosumab|denosumab|mesh-list
139043352|NCT00518531|Alendronate|alendronate|mesh-list
139043353|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139043354|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043355|NCT01326442|Vitamin D|vitamin d|mesh-list
139043356|NCT01326442|Vitamins|vitamins|mesh-ancestor
139043357|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
139043358|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043359|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139043360|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
139043361|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139043362|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
139043363|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043364|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043365|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139043366|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
139043367|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
139043368|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139043369|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
139043370|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139043371|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043372|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
139043373|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043374|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
139043375|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043376|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043377|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139043378|NCT00345540|Carboplatin|carboplatin|mesh-list
139043379|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043381|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139043382|NCT00335322|Tenofovir|tenofovir|mesh-list
139043383|NCT00335322|Emtricitabine|emtricitabine|mesh-list
139043384|NCT00335322|Zidovudine|zidovudine|mesh-list
139043385|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139043386|NCT00335322|Abacavir|abacavir|mesh-list
139043387|NCT00335322|Efavirenz|efavirenz|mesh-list
139043388|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138892090|NCT06155916|Pregabalin|pregabalin|mesh-list
139043389|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139043390|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
139043391|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043392|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043393|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139043394|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139043395|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
139043396|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043397|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138609613|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
139043398|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139043399|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139043400|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139043401|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
139043402|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139043403|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139043404|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139043405|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139043406|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139043407|NCT01059396|Propranolol|propranolol|mesh-list
139043408|NCT01059396|Carvedilol|carvedilol|mesh-list
139043409|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139043410|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139043411|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
139043412|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139043413|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043414|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043415|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139043416|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139043417|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
139043418|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
139043419|NCT01059396|Protective Agents|protective agents|mesh-ancestor
139043420|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139043421|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138892125|NCT06134375|Pembrolizumab|pembrolizumab|mesh-list
139043422|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139043423|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139043424|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138609651|NCT00560209|Landiolol|landiolol|mesh-list
139043426|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043427|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139043428|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043429|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043430|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
139043431|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139043432|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043433|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
139043434|NCT03755765|Amoxicillin|amoxicillin|mesh-list
139043435|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
139043436|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
139043437|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139043438|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139043439|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043440|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139043441|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043442|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043443|NCT01061112|Tolbutamide|tolbutamide|mesh-list
139043444|NCT01061112|Fluconazole|fluconazole|mesh-list
139043445|NCT01061112|Ketoprofen|ketoprofen|mesh-list
139043446|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
139043447|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
139043448|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043449|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139043450|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139043451|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043452|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043453|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139043454|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
139043455|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139043456|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043457|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139043458|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139043459|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139043460|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139043461|NCT01061112|Analgesics|analgesics|mesh-ancestor
139043462|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
139043463|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043464|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139043465|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139043466|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139043467|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139043468|NCT01061190|Propranolol|propranolol|mesh-list
139043469|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139043470|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139043471|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
139043472|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139043473|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043474|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043475|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139043476|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139043477|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
139043478|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139043479|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043481|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
139043482|NCT00517829|Cetuximab|cetuximab|mesh-list
139043483|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043484|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
139043485|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
139043486|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
139043487|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043488|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139043489|NCT00343512|Docetaxel|docetaxel|mesh-list
139043490|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043491|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
139043492|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
139043493|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
139043494|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043495|NCT00334542|Simvastatin|simvastatin|mesh-list
139043496|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139043497|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139043498|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
139043499|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043500|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139043501|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139043502|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043503|NCT00112294|Paclitaxel|paclitaxel|mesh-list
139043504|NCT00112294|Docetaxel|docetaxel|mesh-list
139043506|NCT00112294|Cetuximab|cetuximab|mesh-list
139043507|NCT00112294|Taxane|taxane|mesh-list
139043508|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139043509|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043510|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
139043511|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
139043512|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
139043513|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043514|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139043515|NCT00235443|Lacosamide|lacosamide|mesh-list
139043516|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
139043517|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139043518|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139043519|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139043520|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794128|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043521|NCT00234039|Gemcitabine|gemcitabine|mesh-list
139043522|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139043523|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
139043524|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043525|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043526|NCT02531451|Aspirin|aspirin|mesh-list
139043527|NCT02531451|Ibuprofen|ibuprofen|mesh-list
139043528|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139043529|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139043530|NCT02531451|Analgesics|analgesics|mesh-ancestor
139043531|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
139043532|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043533|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043534|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139043535|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139043536|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139043537|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043538|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043539|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139043540|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139043541|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139043542|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
139043543|NCT01073007|Simvastatin|simvastatin|mesh-list
139043544|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139043545|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139043546|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
138892234|NCT06019728|Anesthetics|anesthetics|mesh-ancestor
139043547|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043548|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139043549|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139043550|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043552|NCT03741621|Cathartics|cathartics|mesh-ancestor
139043553|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139043554|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
139043555|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
139043556|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139043557|NCT00323622|Amodiaquine|amodiaquine|mesh-list
139043558|NCT00323622|Vaccines|vaccines|mesh-list
139043559|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
139043560|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043561|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
139043562|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139043563|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139043564|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043565|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139043566|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043567|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043568|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139043569|NCT01326039|Bupivacaine|bupivacaine|mesh-list
139043570|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
139043571|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
139043572|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139043573|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043574|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
139043575|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043576|NCT01057758|Simvastatin|simvastatin|mesh-list
139043577|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139043578|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139043579|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
139043580|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043581|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139043582|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139043583|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043584|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
139043585|NCT00186537|Fenofibrate|fenofibrate|mesh-list
139043586|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139043587|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043588|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139043589|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
139043590|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043591|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139043592|NCT03968835|Bacitracin|bacitracin|mesh-list
139043593|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139043594|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043595|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138794208|NCT03590652|Dexamethasone|dexamethasone|mesh-list
139043596|NCT00322842|Plerixafor|plerixafor|mesh-list
139043597|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139043598|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139043599|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
139043600|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043601|NCT00255723|Carboplatin|carboplatin|mesh-list
139043602|NCT00255723|Etoposide|etoposide|mesh-list
139043603|NCT00255723|Ifosfamide|ifosfamide|mesh-list
139043604|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043605|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139043606|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139043607|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139043608|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043609|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043610|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139043611|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
139043612|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
139043613|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139043614|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139043615|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043616|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
139043617|NCT01060176|Coagulants|coagulants|mesh-ancestor
139043618|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
139043619|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139043620|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043621|NCT03982992|Blinatumomab|blinatumomab|mesh-list
139043622|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043623|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139043624|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
139043625|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139043626|NCT00517361|Bevacizumab|bevacizumab|mesh-list
139043627|NCT00517361|Carboplatin|carboplatin|mesh-list
138609962|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139043628|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139043629|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043630|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139043631|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139043632|NCT00517361|Growth Substances|growth substances|mesh-ancestor
139043633|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043634|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
139043635|NCT00516893|Natalizumab|natalizumab|mesh-list
139043636|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
139043637|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043638|NCT00522431|Testosterone|testosterone|mesh-list
139043639|NCT00522431|Androgens|androgens|mesh-ancestor
139043640|NCT00522431|Hormones|hormones|mesh-ancestor
139043641|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139043642|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043643|NCT00185211|Interferons|interferons|mesh-list
139043644|NCT00185211|Interferon-beta|interferon-beta|mesh-list
139043645|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
139043646|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043647|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
139043648|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043649|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
139043650|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043651|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139043652|NCT00516737|Rizatriptan|rizatriptan|mesh-list
139043653|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139043654|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
139043655|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139043656|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610014|NCT00561106|Hormones|hormones|mesh-ancestor
138610018|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043657|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043658|NCT03540485|Melatonin|melatonin|mesh-list
139043659|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
139043660|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043661|NCT03540485|Protective Agents|protective agents|mesh-ancestor
139043662|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043663|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139043664|NCT00132730|MK 0873|mk 0873|mesh-list
139043665|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139043666|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139043667|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043668|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043669|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
139043670|NCT02531841|Dexamethasone|dexamethasone|mesh-list
139043671|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
139043672|NCT02531841|Etoposide|etoposide|mesh-list
139043673|NCT02531841|Thiotepa|thiotepa|mesh-list
139043674|NCT02531841|Ifosfamide|ifosfamide|mesh-list
139043675|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
139043676|NCT02531841|Carmustine|carmustine|mesh-list
139043677|NCT02531841|Busulfan|busulfan|mesh-list
139043678|NCT02531841|BB 1101|bb 1101|mesh-list
139043680|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
139043681|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
139043682|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043683|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043684|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139043685|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
139043686|NCT02531841|Hormones|hormones|mesh-ancestor
139043687|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139043688|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139043689|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043690|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
139043691|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043692|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043693|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139043694|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139043695|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139043696|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139043697|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
139043698|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139043699|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139043700|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
139043701|NCT01074411|Carboplatin|carboplatin|mesh-list
139043702|NCT01074411|Bortezomib|bortezomib|mesh-list
139043703|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043704|NCT03973047|Ondansetron|ondansetron|mesh-list
139043705|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
139043706|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
139043707|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043708|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043709|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139043710|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
139043711|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
138610114|NCT00180089|Hormones|hormones|mesh-ancestor
139043712|NCT03973047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139043713|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139043714|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
139043715|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139043716|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043717|NCT00522275|Lacosamide|lacosamide|mesh-list
139043718|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
139043719|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139043720|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139043721|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139043722|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043723|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
139043724|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139043725|NCT01074567|Protective Agents|protective agents|mesh-ancestor
139043726|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043727|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139043728|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
139043729|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043730|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
139043731|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
139043732|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
139043733|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043734|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
139043735|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043736|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043737|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139043738|NCT06169475|Dexmedetomidine|dexmedetomidine|mesh-list
139043739|NCT06169475|Esmolol|esmolol|mesh-list
139043740|NCT06169475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139043741|NCT06169475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139043742|NCT06169475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043743|NCT06169475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139043744|NCT06169475|Analgesics|analgesics|mesh-ancestor
139043745|NCT06169475|Sensory System Agents|sensory system agents|mesh-ancestor
139043746|NCT06169475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043747|NCT06169475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139043748|NCT06169475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139043749|NCT06169475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139043750|NCT06169475|Adrenergic Agents|adrenergic agents|mesh-ancestor
139043751|NCT06169475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139043752|NCT06169475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043753|NCT06169475|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139043754|NCT06169475|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139043755|NCT06169475|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139043756|NCT06169215|Dexamethasone|dexamethasone|mesh-list
139043757|NCT06169215|Dexamethasone acetate|dexamethasone acetate|mesh-list
139043758|NCT06169215|Lenalidomide|lenalidomide|mesh-list
139043759|NCT06169215|Bortezomib|bortezomib|mesh-list
139043760|NCT06169215|Daratumumab|daratumumab|mesh-list
139043761|NCT06169215|Ichthammol|ichthammol|mesh-list
139043762|NCT06169215|BB 1101|bb 1101|mesh-list
139043763|NCT06169215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139043764|NCT06169215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139043765|NCT06169215|Antiemetics|antiemetics|mesh-ancestor
139043766|NCT06169215|Autonomic Agents|autonomic agents|mesh-ancestor
139043767|NCT06169215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043768|NCT06169215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043769|NCT06169215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139043770|NCT06169215|Glucocorticoids|glucocorticoids|mesh-ancestor
139043771|NCT06169215|Hormones|hormones|mesh-ancestor
139043772|NCT06169215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139043773|NCT06169215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139043774|NCT06169215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043775|NCT06169215|Protease Inhibitors|protease inhibitors|mesh-ancestor
139043776|NCT06169215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043777|NCT06169215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043778|NCT06169215|Immunologic Factors|immunologic factors|mesh-ancestor
139043779|NCT06169215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139043780|NCT06169215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139043781|NCT06169215|Growth Substances|growth substances|mesh-ancestor
139043782|NCT06169215|Growth Inhibitors|growth inhibitors|mesh-ancestor
138892380|NCT05878093|Budesonide|budesonide|mesh-list
139043783|NCT06169215|Dermatologic Agents|dermatologic agents|mesh-ancestor
139043784|NCT06169202|Capecitabine|capecitabine|mesh-list
139043785|NCT06169202|Irinotecan|irinotecan|mesh-list
139043786|NCT06169202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139043787|NCT06169202|Antimetabolites|antimetabolites|mesh-ancestor
139043788|NCT06169202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043789|NCT06169202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043790|NCT06169202|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139043791|NCT06169202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139043792|NCT06169202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043793|NCT06168994|Eplerenone|eplerenone|mesh-list
139043794|NCT06168994|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139043795|NCT06168994|Hormone Antagonists|hormone antagonists|mesh-ancestor
139043796|NCT06168994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139043797|NCT06168994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043798|NCT06168994|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139043799|NCT06168994|Diuretics|diuretics|mesh-ancestor
139043800|NCT06168994|Natriuretic Agents|natriuretic agents|mesh-ancestor
138690862|NCT02933099|Aprepitant|aprepitant|mesh-list
139043801|NCT06168994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139043802|NCT06168890|Choline|choline|mesh-list
139043803|NCT06168890|Lipotropic Agents|lipotropic agents|mesh-ancestor
139043804|NCT06168890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139043805|NCT06168890|Antimetabolites|antimetabolites|mesh-ancestor
139043806|NCT06168890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043807|NCT06168890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139043808|NCT06168890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139043809|NCT06168890|Nootropic Agents|nootropic agents|mesh-ancestor
139043810|NCT06168877|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139043811|NCT06168877|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139043812|NCT06168877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043813|NCT06168851|Antibodies|antibodies|mesh-list
138610317|NCT00187005|Hormones|hormones|mesh-ancestor
139043814|NCT06168851|Immunologic Factors|immunologic factors|mesh-ancestor
139043815|NCT06168851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043816|NCT06168838|Anticoagulants|anticoagulants|mesh-list
139043817|NCT06168773|Magnesium Sulfate|magnesium sulfate|mesh-list
139043818|NCT06168773|Haloperidol|haloperidol|mesh-list
139043819|NCT06168773|Haloperidol decanoate|haloperidol decanoate|mesh-list
139043820|NCT06168773|Analgesics|analgesics|mesh-ancestor
139043821|NCT06168773|Sensory System Agents|sensory system agents|mesh-ancestor
139043822|NCT06168773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043823|NCT06168773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794429|NCT03049306|Propranolol|propranolol|mesh-list
139043824|NCT06168773|Anesthetics|anesthetics|mesh-ancestor
139043825|NCT06168773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139043826|NCT06168773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139043827|NCT06168773|Anticonvulsants|anticonvulsants|mesh-ancestor
139043828|NCT06168773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139043829|NCT06168773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139043830|NCT06168773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043831|NCT06168773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139043832|NCT06168773|Tocolytic Agents|tocolytic agents|mesh-ancestor
139043833|NCT06168773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139043834|NCT06168773|Antiemetics|antiemetics|mesh-ancestor
139043835|NCT06168773|Autonomic Agents|autonomic agents|mesh-ancestor
139043836|NCT06168773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139043837|NCT06168773|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139043838|NCT06168773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139043839|NCT06168773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139043840|NCT06168773|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139043841|NCT06168773|Dopamine Agents|dopamine agents|mesh-ancestor
139043842|NCT06168773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139043843|NCT06168773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139043844|NCT06168734|Meropenem|meropenem|mesh-list
139043845|NCT06168734|Cefepime|cefepime|mesh-list
139043846|NCT06168734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139043847|NCT06168734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043848|NCT06168708|Gentamicins|gentamicins|mesh-list
139043849|NCT06168708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139043850|NCT06168708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043851|NCT06168708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139043852|NCT06168708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043853|NCT06168708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043854|NCT06168487|Telmisartan|telmisartan|mesh-list
139043855|NCT06168487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139043856|NCT06168487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139043857|NCT06168487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139043858|NCT06168487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043859|NCT06168461|Aspirin|aspirin|mesh-list
139043860|NCT06168461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139043861|NCT06168461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139043862|NCT06168461|Analgesics|analgesics|mesh-ancestor
139043863|NCT06168461|Sensory System Agents|sensory system agents|mesh-ancestor
139043864|NCT06168461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043865|NCT06168461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043866|NCT06168461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139043867|NCT06168461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139043868|NCT06168461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139043869|NCT06168461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139043870|NCT06168461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043871|NCT06168461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139043872|NCT06168461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139043873|NCT06168461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043874|NCT06168461|Antipyretics|antipyretics|mesh-ancestor
139043875|NCT06168279|Salicylic Acid|salicylic acid|mesh-list
139043876|NCT06168279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043877|NCT06168279|Antifungal Agents|antifungal agents|mesh-ancestor
139043878|NCT06168279|Keratolytic Agents|keratolytic agents|mesh-ancestor
139043879|NCT06168279|Dermatologic Agents|dermatologic agents|mesh-ancestor
139043880|NCT06168084|Amoxicillin|amoxicillin|mesh-list
139043881|NCT06168084|Tetracycline|tetracycline|mesh-list
139043882|NCT06168084|Furazolidone|furazolidone|mesh-list
139043883|NCT06168084|Esomeprazole|esomeprazole|mesh-list
139043884|NCT06168084|Bismuth|bismuth|mesh-list
139043885|NCT06168084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139043886|NCT06168084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139043887|NCT06168084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139043888|NCT06168084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139043889|NCT06168084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139043890|NCT06168084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043891|NCT06168084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043892|NCT06168084|Antacids|antacids|mesh-ancestor
139043893|NCT06168084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139043894|NCT06168084|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139043895|NCT06168084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139043896|NCT06168084|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139043897|NCT06168084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139043898|NCT06168084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139043899|NCT06168084|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138794505|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
139043900|NCT06167837|Metoclopramide|metoclopramide|mesh-list
139043901|NCT06167837|Antiemetics|antiemetics|mesh-ancestor
139043902|NCT06167837|Autonomic Agents|autonomic agents|mesh-ancestor
139043903|NCT06167837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043904|NCT06167837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043905|NCT06167837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139043906|NCT06167837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139043907|NCT06167837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139043908|NCT06167837|Dopamine Agents|dopamine agents|mesh-ancestor
139043909|NCT06167837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139043910|NCT06167837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043911|NCT06156215|Vaccines|vaccines|mesh-list
139043912|NCT06156215|Immunologic Factors|immunologic factors|mesh-ancestor
139043913|NCT06156215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043914|NCT06154083|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139043915|NCT06154083|Hormones|hormones|mesh-ancestor
139043916|NCT06154083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139043917|NCT06154083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043918|NCT06152497|Fexofenadine|fexofenadine|mesh-list
139043919|NCT06152497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139043920|NCT06152497|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139043921|NCT06152497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139043922|NCT06152497|Histamine Antagonists|histamine antagonists|mesh-ancestor
139043923|NCT06152497|Histamine Agents|histamine agents|mesh-ancestor
139043924|NCT06152497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139043925|NCT06152497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043926|NCT06152497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043927|NCT06142396|Dexamethasone|dexamethasone|mesh-list
139043928|NCT06142396|Cyclophosphamide|cyclophosphamide|mesh-list
139043930|NCT06142396|Daratumumab|daratumumab|mesh-list
139043931|NCT06142396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139043932|NCT06142396|Immunologic Factors|immunologic factors|mesh-ancestor
139043933|NCT06142396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043934|NCT06142396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138690874|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139043935|NCT06142396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139043936|NCT06142396|Alkylating Agents|alkylating agents|mesh-ancestor
139043937|NCT06142396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043938|NCT06142396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043939|NCT06142396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139043940|NCT06142396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139043941|NCT06142396|Antiemetics|antiemetics|mesh-ancestor
139043942|NCT06142396|Autonomic Agents|autonomic agents|mesh-ancestor
139043943|NCT06142396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043944|NCT06142396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139043945|NCT06142396|Glucocorticoids|glucocorticoids|mesh-ancestor
139043946|NCT06142396|Hormones|hormones|mesh-ancestor
139043947|NCT06142396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139043948|NCT06142396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139043949|NCT06112379|Paclitaxel|paclitaxel|mesh-list
139043950|NCT06112379|Cyclophosphamide|cyclophosphamide|mesh-list
139043951|NCT06112379|Carboplatin|carboplatin|mesh-list
139043952|NCT06112379|Doxorubicin|doxorubicin|mesh-list
139043953|NCT06112379|Pembrolizumab|pembrolizumab|mesh-list
139043954|NCT06112379|Capecitabine|capecitabine|mesh-list
139043955|NCT06112379|Durvalumab|durvalumab|mesh-list
139043956|NCT06112379|Epirubicin|epirubicin|mesh-list
139043957|NCT06112379|Olaparib|olaparib|mesh-list
139043958|NCT06112379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139043959|NCT06112379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139043960|NCT06112379|Tubulin Modulators|tubulin modulators|mesh-ancestor
139043961|NCT06112379|Antimitotic Agents|antimitotic agents|mesh-ancestor
139043962|NCT06112379|Mitosis Modulators|mitosis modulators|mesh-ancestor
139043963|NCT06112379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043964|NCT06112379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139043965|NCT06112379|Immunologic Factors|immunologic factors|mesh-ancestor
139043966|NCT06112379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043967|NCT06112379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139043968|NCT06112379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138892479|NCT05575167|Alendronate|alendronate|mesh-list
139043970|NCT06112379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139043971|NCT06112379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139043972|NCT06112379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139043973|NCT06112379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139043974|NCT06112379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139043975|NCT06112379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139043976|NCT06112379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139043977|NCT06112379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139043978|NCT06112379|Antimetabolites|antimetabolites|mesh-ancestor
139043979|NCT06112379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139043980|NCT06111339|Ketamine|ketamine|mesh-list
139043981|NCT06111339|Analgesics|analgesics|mesh-ancestor
139043982|NCT06111339|Sensory System Agents|sensory system agents|mesh-ancestor
139043983|NCT06111339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139043984|NCT06111339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139043985|NCT06111339|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139043986|NCT06111339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139043987|NCT06111339|Anesthetics, General|anesthetics, general|mesh-ancestor
139043988|NCT06111339|Anesthetics|anesthetics|mesh-ancestor
139043989|NCT06111339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139043990|NCT06111339|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139043991|NCT06111339|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139043992|NCT06111339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139043993|NCT06111339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139043995|NCT06108544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139043996|NCT06108544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139043997|NCT06108544|Analgesics|analgesics|mesh-ancestor
139043998|NCT06108544|Sensory System Agents|sensory system agents|mesh-ancestor
139043999|NCT06108544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610660|NCT00209079|Docetaxel|docetaxel|mesh-list
139044000|NCT06108544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044001|NCT06108544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139044002|NCT06108544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044003|NCT06108544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139044004|NCT06108544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139044005|NCT06108544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044006|NCT06108544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044007|NCT06105632|Everolimus|everolimus|mesh-list
139044008|NCT06105632|Fulvestrant|fulvestrant|mesh-list
139044009|NCT06105632|Exemestane|exemestane|mesh-list
139044010|NCT06105632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139044011|NCT06105632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139044012|NCT06105632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044013|NCT06105632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044014|NCT06105632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139044015|NCT06105632|Immunologic Factors|immunologic factors|mesh-ancestor
139044016|NCT06105632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044017|NCT06105632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044018|NCT06105632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139044019|NCT06105632|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139044020|NCT06105632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139044021|NCT06105632|Hormone Antagonists|hormone antagonists|mesh-ancestor
139044022|NCT06105632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044023|NCT06105632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139044024|NCT06105632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139044025|NCT06099171|Caryophyllene|caryophyllene|mesh-list
139044026|NCT06099171|Cannabidiol|cannabidiol|mesh-list
139044027|NCT06099171|Anticonvulsants|anticonvulsants|mesh-ancestor
139044028|NCT06099171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139044029|NCT06099171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139044030|NCT06099171|Analgesics|analgesics|mesh-ancestor
139044031|NCT06099171|Sensory System Agents|sensory system agents|mesh-ancestor
139044032|NCT06099171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044033|NCT06099171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044034|NCT06099171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139044035|NCT06099171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044036|NCT06088043|Apremilast|apremilast|mesh-list
138892559|NCT05304767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139044037|NCT06088043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139044038|NCT06088043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139044039|NCT06088043|Analgesics|analgesics|mesh-ancestor
139044040|NCT06088043|Sensory System Agents|sensory system agents|mesh-ancestor
139044041|NCT06088043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044042|NCT06088043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044043|NCT06088043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139044044|NCT06088043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044045|NCT06088043|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139044046|NCT06088043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139044047|NCT06088043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044048|NCT06088043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044049|NCT06084663|Apremilast|apremilast|mesh-list
139044050|NCT06084663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139044051|NCT06084663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139044052|NCT06084663|Analgesics|analgesics|mesh-ancestor
139044053|NCT06084663|Sensory System Agents|sensory system agents|mesh-ancestor
139044054|NCT06084663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044055|NCT06084663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044056|NCT06084663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139044057|NCT06084663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044058|NCT06084663|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139044059|NCT06084663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139044060|NCT06084663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044061|NCT06084663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044062|NCT06083844|Cyclophosphamide|cyclophosphamide|mesh-list
139044063|NCT06083844|Bevacizumab|bevacizumab|mesh-list
139044064|NCT06083844|Pembrolizumab|pembrolizumab|mesh-list
139044065|NCT06083844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139044066|NCT06083844|Immunologic Factors|immunologic factors|mesh-ancestor
138892601|NCT05292664|Antimetabolites|antimetabolites|mesh-ancestor
139044067|NCT06083844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044068|NCT06083844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044069|NCT06083844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139044070|NCT06083844|Alkylating Agents|alkylating agents|mesh-ancestor
139044071|NCT06083844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044072|NCT06083844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044073|NCT06083844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139044074|NCT06083844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044075|NCT06083844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139044076|NCT06083844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139044077|NCT06083844|Growth Substances|growth substances|mesh-ancestor
139044078|NCT06083844|Growth Inhibitors|growth inhibitors|mesh-ancestor
139044079|NCT06083844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139044081|NCT06071442|Carbamazepine|carbamazepine|mesh-list
139044082|NCT06071442|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139044083|NCT06071442|Levonorgestrel|levonorgestrel|mesh-list
139044084|NCT06071442|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139044085|NCT06071442|Estradiol|estradiol|mesh-list
139044086|NCT06071442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139044087|NCT06071442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044088|NCT06071442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139044089|NCT06071442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139044090|NCT06071442|Antimetabolites|antimetabolites|mesh-ancestor
139044091|NCT06071442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044092|NCT06071442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139044093|NCT06071442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139044094|NCT06071442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044095|NCT06071442|Estrogens|estrogens|mesh-ancestor
139044096|NCT06071442|Hormones|hormones|mesh-ancestor
139044097|NCT06071442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044098|NCT06071442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139044099|NCT06071442|Contraceptive Agents|contraceptive agents|mesh-ancestor
139044100|NCT06071442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139044101|NCT06071442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139044102|NCT06071442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139044103|NCT06071442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139044104|NCT06071442|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139044105|NCT06071442|Anticonvulsants|anticonvulsants|mesh-ancestor
139044106|NCT06071442|Antimanic Agents|antimanic agents|mesh-ancestor
139044107|NCT06071442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139044108|NCT06071442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139044109|NCT06071442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139044110|NCT06071442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139044111|NCT06071442|Analgesics|analgesics|mesh-ancestor
139044112|NCT06071442|Sensory System Agents|sensory system agents|mesh-ancestor
138610830|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139044113|NCT06071442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044114|NCT06071442|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139044115|NCT06071442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139044116|NCT06071442|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139044117|NCT06071442|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139044118|NCT06045650|Oxytocin|oxytocin|mesh-list
139044119|NCT06045650|Oxytocics|oxytocics|mesh-ancestor
139044120|NCT06045650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139044121|NCT06045650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044122|NCT06043297|Apixaban|apixaban|mesh-list
139044123|NCT06043297|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139044124|NCT06043297|Antithrombins|antithrombins|mesh-ancestor
139044125|NCT06043297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139044126|NCT06043297|Protease Inhibitors|protease inhibitors|mesh-ancestor
139044127|NCT06043297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044128|NCT06043297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044129|NCT06043297|Anticoagulants|anticoagulants|mesh-ancestor
139044130|NCT05992311|Montelukast|montelukast|mesh-list
139044131|NCT05992311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139044132|NCT05992311|Respiratory System Agents|respiratory system agents|mesh-ancestor
139044133|NCT05992311|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139044134|NCT05992311|Hormone Antagonists|hormone antagonists|mesh-ancestor
139044135|NCT05992311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044136|NCT05992311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044137|NCT05992311|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139044138|NCT05992311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139044139|NCT05992311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044140|NCT05984381|Dapsone|dapsone|mesh-list
139044141|NCT05984381|Prednisolone|prednisolone|mesh-list
139044142|NCT05984381|Methotrexate|methotrexate|mesh-list
139044143|NCT05984381|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139044144|NCT05984381|Abortifacient Agents|abortifacient agents|mesh-ancestor
139044145|NCT05984381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139044146|NCT05984381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044147|NCT05984381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139044148|NCT05984381|Antimetabolites|antimetabolites|mesh-ancestor
139044149|NCT05984381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044150|NCT05984381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044151|NCT05984381|Dermatologic Agents|dermatologic agents|mesh-ancestor
139044152|NCT05984381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044153|NCT05984381|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139044154|NCT05984381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139044155|NCT05984381|Immunologic Factors|immunologic factors|mesh-ancestor
139044156|NCT05984381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044157|NCT05984381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139044158|NCT05984381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139044159|NCT05984381|Glucocorticoids|glucocorticoids|mesh-ancestor
139044160|NCT05984381|Hormones|hormones|mesh-ancestor
139044161|NCT05984381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044162|NCT05984381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139044163|NCT05984381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139044164|NCT05984381|Antimalarials|antimalarials|mesh-ancestor
139044165|NCT05984381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139044166|NCT05984381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139044167|NCT05984381|Leprostatic Agents|leprostatic agents|mesh-ancestor
139044168|NCT05984381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139044169|NCT05957211|Cyclosporine|cyclosporine|mesh-list
139044170|NCT05957211|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139044171|NCT05957211|Cyclosporins|cyclosporins|mesh-list
139044172|NCT05957211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044173|NCT05957211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044174|NCT05957211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139044175|NCT05957211|Immunologic Factors|immunologic factors|mesh-ancestor
139044176|NCT05957211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044177|NCT05957211|Antifungal Agents|antifungal agents|mesh-ancestor
139044178|NCT05957211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139044179|NCT05957211|Dermatologic Agents|dermatologic agents|mesh-ancestor
139044180|NCT05957211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044181|NCT05957211|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139044182|NCT05957211|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139044183|NCT05948462|Cisplatin|cisplatin|mesh-list
139044184|NCT05948462|Carboplatin|carboplatin|mesh-list
139044185|NCT05948462|Pemetrexed|pemetrexed|mesh-list
139044186|NCT05948462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044187|NCT05948462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044188|NCT05948462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044189|NCT05948462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138690917|NCT02932007|Chloroquine|chloroquine|mesh-list
139044190|NCT05948462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139044192|NCT05886244|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139044193|NCT05886244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139044194|NCT05886244|Immunologic Factors|immunologic factors|mesh-ancestor
139044195|NCT05886244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044196|NCT05872204|Letrozole|letrozole|mesh-list
139044197|NCT05872204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044198|NCT05872204|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139044199|NCT05872204|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139044200|NCT05872204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044201|NCT05872204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044202|NCT05872204|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139044203|NCT05872204|Hormone Antagonists|hormone antagonists|mesh-ancestor
139044204|NCT05872204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044205|NCT05872204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044206|NCT05854667|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139044207|NCT05854667|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139044208|NCT05854667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044209|NCT05854667|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139044210|NCT05854667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139044211|NCT05854667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139044212|NCT05854667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044213|NCT05854667|Dopamine Agents|dopamine agents|mesh-ancestor
139044214|NCT05854667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139044215|NCT05852691|Paclitaxel|paclitaxel|mesh-list
139044216|NCT05852691|Pembrolizumab|pembrolizumab|mesh-list
139044217|NCT05852691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139044218|NCT05852691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044219|NCT05852691|Tubulin Modulators|tubulin modulators|mesh-ancestor
139044220|NCT05852691|Antimitotic Agents|antimitotic agents|mesh-ancestor
139044221|NCT05852691|Mitosis Modulators|mitosis modulators|mesh-ancestor
139044222|NCT05852691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044223|NCT05852691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044224|NCT05852691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139044225|NCT05829356|Vaccines|vaccines|mesh-list
139044226|NCT05829356|Immunologic Factors|immunologic factors|mesh-ancestor
139044227|NCT05829356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044228|NCT05820685|Dronabinol|dronabinol|mesh-list
139044229|NCT05820685|Hallucinogens|hallucinogens|mesh-ancestor
139044230|NCT05820685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044232|NCT05820685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139044233|NCT05820685|Analgesics|analgesics|mesh-ancestor
139044234|NCT05820685|Sensory System Agents|sensory system agents|mesh-ancestor
139044235|NCT05820685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044236|NCT05820685|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139044237|NCT05820685|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139044238|NCT05820685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139044239|NCT05820685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044240|NCT05820685|Hormones|hormones|mesh-ancestor
139044241|NCT05820685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044242|NCT05813912|Insulin|insulin|mesh-list
139044243|NCT05813912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139044244|NCT05813912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044245|NCT05789082|Carboplatin|carboplatin|mesh-list
139044246|NCT05789082|Pembrolizumab|pembrolizumab|mesh-list
139044247|NCT05789082|Pemetrexed|pemetrexed|mesh-list
139044248|NCT05789082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044249|NCT05789082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044250|NCT05789082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139044251|NCT05789082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044252|NCT05789082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044253|NCT05789082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139044254|NCT05789082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139044255|NCT05780879|Venetoclax|venetoclax|mesh-list
139044256|NCT05780879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044258|NCT05776862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139044259|NCT05776862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139044260|NCT05776862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044261|NCT05776862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139044262|NCT05776862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044263|NCT05776862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044264|NCT05776862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139044265|NCT05776862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139044266|NCT05776862|Analgesics|analgesics|mesh-ancestor
139044267|NCT05776862|Sensory System Agents|sensory system agents|mesh-ancestor
139044268|NCT05776862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044269|NCT05776862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044270|NCT05776862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139044271|NCT05776862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044273|NCT05776108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139044274|NCT05776108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139044275|NCT05776108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044276|NCT05776108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044277|NCT05776108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139044278|NCT05776108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139044279|NCT05776108|Antiviral Agents|antiviral agents|mesh-ancestor
139044280|NCT05776108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139044281|NCT05768334|Lubiprostone|lubiprostone|mesh-list
139044282|NCT05768334|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139044283|NCT05768334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139044284|NCT05768334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044285|NCT05732701|Oxymetazoline|oxymetazoline|mesh-list
139044286|NCT05732701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139044287|NCT05732701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139044288|NCT05732701|Adrenergic Agents|adrenergic agents|mesh-ancestor
139044289|NCT05732701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139044290|NCT05732701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044291|NCT05732701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044292|NCT05732701|Sympathomimetics|sympathomimetics|mesh-ancestor
139044293|NCT05732701|Autonomic Agents|autonomic agents|mesh-ancestor
139044294|NCT05732701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044295|NCT05732701|Nasal Decongestants|nasal decongestants|mesh-ancestor
139044296|NCT05732701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139044297|NCT05732701|Respiratory System Agents|respiratory system agents|mesh-ancestor
139044298|NCT05704985|Paclitaxel|paclitaxel|mesh-list
139044299|NCT05704985|Carboplatin|carboplatin|mesh-list
139044300|NCT05704985|Pembrolizumab|pembrolizumab|mesh-list
139044301|NCT05704985|Capecitabine|capecitabine|mesh-list
139044302|NCT05704985|Fluorouracil|fluorouracil|mesh-list
139044303|NCT05704985|Oxaliplatin|oxaliplatin|mesh-list
139044304|NCT05704985|Nivolumab|nivolumab|mesh-list
139044305|NCT05704985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139044306|NCT05704985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139044307|NCT05704985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044308|NCT05704985|Tubulin Modulators|tubulin modulators|mesh-ancestor
139044309|NCT05704985|Antimitotic Agents|antimitotic agents|mesh-ancestor
139044310|NCT05704985|Mitosis Modulators|mitosis modulators|mesh-ancestor
139044311|NCT05704985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044312|NCT05704985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044313|NCT05704985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139044314|NCT05704985|Antimetabolites|antimetabolites|mesh-ancestor
139044315|NCT05704985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139044316|NCT05704985|Immunologic Factors|immunologic factors|mesh-ancestor
139044317|NCT05704985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044318|NCT05664789|Acetylcysteine|acetylcysteine|mesh-list
139044319|NCT05664789|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139044320|NCT05664789|Antiviral Agents|antiviral agents|mesh-ancestor
139044321|NCT05664789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138611152|NCT00182312|Caffeine|caffeine|mesh-list
139044322|NCT05664789|Expectorants|expectorants|mesh-ancestor
139044323|NCT05664789|Respiratory System Agents|respiratory system agents|mesh-ancestor
139044324|NCT05664789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139044325|NCT05664789|Antioxidants|antioxidants|mesh-ancestor
139044326|NCT05664789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044327|NCT05664789|Protective Agents|protective agents|mesh-ancestor
139044328|NCT05664789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044330|NCT05659576|Sucralfate|sucralfate|mesh-list
139044331|NCT05659576|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139044332|NCT05659576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139044333|NCT05611307|Hormones|hormones|mesh-list
139044334|NCT05611307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044335|NCT05611307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044336|NCT05579626|Ezetimibe|ezetimibe|mesh-list
139044337|NCT05579626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139044338|NCT05579626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139044339|NCT05579626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139044340|NCT05579626|Antimetabolites|antimetabolites|mesh-ancestor
139044341|NCT05579626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044342|NCT05579626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139044343|NCT05579626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044344|NCT05564546|Nitric Oxide|nitric oxide|mesh-list
139044345|NCT05564546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139044346|NCT05564546|Autonomic Agents|autonomic agents|mesh-ancestor
139044347|NCT05564546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044348|NCT05564546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044349|NCT05564546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139044350|NCT05564546|Respiratory System Agents|respiratory system agents|mesh-ancestor
139044351|NCT05564546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139044352|NCT05564546|Antioxidants|antioxidants|mesh-ancestor
139044353|NCT05564546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044354|NCT05564546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139044355|NCT05564546|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139044356|NCT05564546|Vasodilator Agents|vasodilator agents|mesh-ancestor
139044357|NCT05564546|Gasotransmitters|gasotransmitters|mesh-ancestor
139044358|NCT05564546|Protective Agents|protective agents|mesh-ancestor
139044359|NCT05554133|Proflavine|proflavine|mesh-list
139044360|NCT05554133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139044361|NCT05554133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139044362|NCT05494398|Acetylcysteine|acetylcysteine|mesh-list
139044363|NCT05494398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139044364|NCT05494398|Antiviral Agents|antiviral agents|mesh-ancestor
139044365|NCT05494398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139044366|NCT05494398|Expectorants|expectorants|mesh-ancestor
139044367|NCT05494398|Respiratory System Agents|respiratory system agents|mesh-ancestor
139044368|NCT05494398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139044369|NCT05494398|Antioxidants|antioxidants|mesh-ancestor
139044370|NCT05494398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044371|NCT05494398|Protective Agents|protective agents|mesh-ancestor
139044372|NCT05494398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044373|NCT05494398|Antidotes|antidotes|mesh-ancestor
139044374|NCT05424016|Propranolol|propranolol|mesh-list
139044375|NCT05424016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139044376|NCT05424016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139044377|NCT05424016|Adrenergic Agents|adrenergic agents|mesh-ancestor
139044378|NCT05424016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139044379|NCT05424016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044380|NCT05424016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044381|NCT05424016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139044382|NCT05424016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139044383|NCT05424016|Vasodilator Agents|vasodilator agents|mesh-ancestor
139044384|NCT05395117|Digoxin|digoxin|mesh-list
139044385|NCT05395117|Midazolam|midazolam|mesh-list
139044386|NCT05395117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139044387|NCT05395117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139044388|NCT05395117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139044389|NCT05395117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139044390|NCT05395117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044391|NCT05395117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139044392|NCT05395117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139044393|NCT05395117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139044394|NCT05395117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139044395|NCT05395117|Anesthetics, General|anesthetics, general|mesh-ancestor
139044396|NCT05395117|Anesthetics|anesthetics|mesh-ancestor
139044397|NCT05395117|GABA Modulators|gaba modulators|mesh-ancestor
139044398|NCT05395117|GABA Agents|gaba agents|mesh-ancestor
139044399|NCT05395117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139044400|NCT05395117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044401|NCT05395117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139044402|NCT05395117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139044403|NCT05395117|Antimetabolites|antimetabolites|mesh-ancestor
139044404|NCT05395117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139044405|NCT05395117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139044406|NCT05395117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044407|NCT05395117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139044408|NCT05395117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139044409|NCT05395117|Protective Agents|protective agents|mesh-ancestor
139044410|NCT05371600|Midazolam|midazolam|mesh-list
139044411|NCT05371600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139044412|NCT05371600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139044413|NCT05371600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139044414|NCT05371600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044415|NCT05371600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139044416|NCT05371600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139044417|NCT05371600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139044418|NCT05371600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139044419|NCT05371600|Anesthetics, General|anesthetics, general|mesh-ancestor
139044420|NCT05371600|Anesthetics|anesthetics|mesh-ancestor
138795036|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139044421|NCT05371600|GABA Modulators|gaba modulators|mesh-ancestor
139044422|NCT05371600|GABA Agents|gaba agents|mesh-ancestor
139044423|NCT05371600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139044424|NCT05371600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044425|NCT05358691|Durvalumab|durvalumab|mesh-list
139044426|NCT05358691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044427|NCT05358691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044428|NCT05357989|Phenserine|phenserine|mesh-list
139044429|NCT05357989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139044430|NCT05357989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044431|NCT05357989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044432|NCT05357989|Cholinergic Agents|cholinergic agents|mesh-ancestor
139044433|NCT05357989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139044434|NCT05357989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044435|NCT05318105|Diuretics|diuretics|mesh-list
139044436|NCT05318105|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
139044437|NCT05318105|Natriuretic Agents|natriuretic agents|mesh-ancestor
139044438|NCT05318105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044439|NCT05318105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138611334|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
139044440|NCT05318105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044441|NCT05297864|Niraparib|niraparib|mesh-list
139044442|NCT05297864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139044443|NCT05297864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044444|NCT05297864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044445|NCT05297864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044446|NCT05288153|Metformin|metformin|mesh-list
139044447|NCT05288153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139044448|NCT05288153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044454|NCT05261269|Niraparib|niraparib|mesh-list
139044455|NCT05261269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139044456|NCT05261269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044457|NCT05261269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044458|NCT05261269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044459|NCT05260320|Anesthetics|anesthetics|mesh-list
139044460|NCT05260320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139044461|NCT05260320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044462|NCT05239091|Lidocaine|lidocaine|mesh-list
139044463|NCT05239091|Anesthetics, Local|anesthetics, local|mesh-list
139044464|NCT05239091|Anesthetics|anesthetics|mesh-list
139044465|NCT05239091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139044466|NCT05239091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044467|NCT05239091|Sensory System Agents|sensory system agents|mesh-ancestor
139044468|NCT05239091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044469|NCT05239091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139044470|NCT05239091|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139044471|NCT05239091|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138611365|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
139044472|NCT05239091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139044473|NCT05239091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044475|NCT05229653|Analgesics|analgesics|mesh-ancestor
139044476|NCT05229653|Sensory System Agents|sensory system agents|mesh-ancestor
139044477|NCT05229653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044478|NCT05229653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044479|NCT05229653|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139044480|NCT05229653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139044481|NCT05229653|Anesthetics, General|anesthetics, general|mesh-ancestor
139044482|NCT05229653|Anesthetics|anesthetics|mesh-ancestor
139044483|NCT05229653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139044484|NCT05229653|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139044485|NCT05229653|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139044486|NCT05229653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139044487|NCT05229653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044488|NCT05226598|Paclitaxel|paclitaxel|mesh-list
139044489|NCT05226598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139044490|NCT05226598|Carboplatin|carboplatin|mesh-list
139044491|NCT05226598|Pembrolizumab|pembrolizumab|mesh-list
139044492|NCT05226598|Pemetrexed|pemetrexed|mesh-list
139044493|NCT05226598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139044494|NCT05226598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044496|NCT05226598|Antimitotic Agents|antimitotic agents|mesh-ancestor
139044497|NCT05226598|Mitosis Modulators|mitosis modulators|mesh-ancestor
139044498|NCT05226598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044499|NCT05226598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892921|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044500|NCT05226598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139044501|NCT05226598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044502|NCT05226598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139044503|NCT05226598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139044504|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139044505|NCT05169684|Docetaxel|docetaxel|mesh-list
139044506|NCT05169684|Nivolumab|nivolumab|mesh-list
139044507|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044508|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
139044509|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
139044510|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
139044511|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044512|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044513|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139044514|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139044515|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044516|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044517|NCT05149768|Immunotoxins|immunotoxins|mesh-ancestor
139044518|NCT05149768|Immunoconjugates|immunoconjugates|mesh-ancestor
138611408|NCT00182702|Epothilone B|epothilone b|mesh-list
139044519|NCT05149768|Immunologic Factors|immunologic factors|mesh-ancestor
139044520|NCT05149768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044521|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
139044522|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044523|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044524|NCT05117476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139044525|NCT05117476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044526|NCT05112549|Nivolumab|nivolumab|mesh-list
139044527|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044528|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044529|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139044530|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044531|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
139044532|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139044533|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139044534|NCT05097976|Prednisolone|prednisolone|mesh-list
139044535|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
139044536|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139044537|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
139044538|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139044539|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
139044540|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
139044541|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044542|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044543|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139044544|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
139044545|NCT05097976|Hormones|hormones|mesh-ancestor
139044546|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044547|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139044548|NCT05097976|Protective Agents|protective agents|mesh-ancestor
139044549|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139044550|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044551|NCT05082662|Diclofenac|diclofenac|mesh-list
139044552|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139044553|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139044554|NCT05082662|Analgesics|analgesics|mesh-ancestor
139044555|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
139044556|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044557|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044558|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139044559|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044560|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139044561|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044562|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044563|NCT05018091|Dexamethasone|dexamethasone|mesh-list
139044564|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
139044565|NCT05018091|BB 1101|bb 1101|mesh-list
139044566|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139044567|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
139044568|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
139044569|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044570|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044571|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139044572|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
139044573|NCT05018091|Hormones|hormones|mesh-ancestor
139044574|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044575|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139044576|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044577|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
139044578|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044579|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044580|NCT05015621|Leucovorin|leucovorin|mesh-list
139044581|NCT05015621|Fluorouracil|fluorouracil|mesh-list
139044582|NCT05015621|Irinotecan|irinotecan|mesh-list
139044583|NCT05015621|Calcium|calcium|mesh-list
139044584|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
139044585|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139044586|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044587|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
139044588|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044589|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139044590|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044591|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139044592|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
139044593|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139044594|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139044595|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044596|NCT05015621|Antidotes|antidotes|mesh-ancestor
139044597|NCT05015621|Protective Agents|protective agents|mesh-ancestor
139044598|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
139044599|NCT05015621|Vitamins|vitamins|mesh-ancestor
138611474|NCT00182741|Prednisone|prednisone|mesh-list
139044600|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
139044601|NCT04977830|Xenon|xenon|mesh-list
139044602|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139044603|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
139044604|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
139044605|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139044606|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044607|NCT04974528|Insulin|insulin|mesh-list
139044608|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139044609|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
139044610|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
139044611|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
139044612|NCT04974528|Insulin Detemir|insulin detemir|mesh-list
139044613|NCT04974528|Insulin glulisine|insulin glulisine|mesh-list
139044614|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
139044615|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139044616|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044617|NCT04966507|Listerine|listerine|mesh-list
139044618|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139044619|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139044620|NCT04933617|Prednisone|prednisone|mesh-list
139044621|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
139044622|NCT04933617|Rituximab|rituximab|mesh-list
139044623|NCT04933617|Doxorubicin|doxorubicin|mesh-list
139044624|NCT04933617|Etoposide|etoposide|mesh-list
139044625|NCT04933617|Vincristine|vincristine|mesh-list
139044626|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139044627|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
138611505|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044628|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044629|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044630|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139044631|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
139044632|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044633|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044634|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139044635|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044636|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139044637|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139044638|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139044639|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044640|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139044641|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
139044642|NCT04933617|Hormones|hormones|mesh-ancestor
139044643|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044644|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139044645|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795264|NCT01081262|Carboplatin|carboplatin|mesh-list
139044646|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
139044647|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
139044648|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
139044649|NCT04904614|Letermovir|letermovir|mesh-list
139044650|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139044651|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044652|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044653|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044654|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
139044655|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139044656|NCT04899921|Nivolumab|nivolumab|mesh-list
139044657|NCT04899921|Ipilimumab|ipilimumab|mesh-list
139044658|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044659|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044660|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139044661|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044662|NCT04745832|Prednisone|prednisone|mesh-list
139044663|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
139044664|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139044665|NCT04745832|Rituximab|rituximab|mesh-list
139044666|NCT04745832|Vincristine|vincristine|mesh-list
139044667|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139044668|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
139044669|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044670|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044671|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139044672|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
139044673|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044674|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044675|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139044676|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044677|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139044678|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
139044679|NCT04745832|Hormones|hormones|mesh-ancestor
139044680|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044681|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139044682|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139044683|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
139044684|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
139044685|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
139044686|NCT04726592|Ketoprofen|ketoprofen|mesh-list
139044687|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
139044688|NCT04726592|Metoclopramide|metoclopramide|mesh-list
139044689|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
139044690|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
138611599|NCT04574791|Tizanidine|tizanidine|mesh-list
139044691|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044692|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044693|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139044694|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139044695|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139044696|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
139044697|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139044698|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044699|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139044700|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139044701|NCT04726592|Analgesics|analgesics|mesh-ancestor
139044702|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
139044703|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139044704|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044705|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139044706|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044707|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
139044708|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139044709|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139044710|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139044711|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139044712|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
139044713|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
139044714|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139044715|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139044716|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044717|NCT04686799|Doxycycline|doxycycline|mesh-list
139044718|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139044719|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139044720|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
139044721|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139044722|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139044723|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
139044724|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138611654|NCT00477295|Carbamazepine|carbamazepine|mesh-list
139044725|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044726|NCT04675294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893082|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
139044727|NCT04675294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044728|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
139044729|NCT04626024|Dasatinib|dasatinib|mesh-list
139044730|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044731|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139044732|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044733|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044734|NCT04561375|Fentanyl|fentanyl|mesh-list
139044735|NCT04561375|Sufentanil|sufentanil|mesh-list
139044736|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139044737|NCT04561375|Narcotics|narcotics|mesh-ancestor
139044738|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139044739|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044740|NCT04561375|Analgesics|analgesics|mesh-ancestor
139044741|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
139044742|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044743|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139044744|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139044745|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
139044746|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
139044747|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139044748|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139044749|NCT04535362|Nicotine|nicotine|mesh-list
139044750|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139044751|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
139044752|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044753|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044754|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139044755|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139044756|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
139044757|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139044758|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044759|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
139044760|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044761|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044762|NCT04534205|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139044763|NCT04534205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044764|NCT04526795|Cytarabine|cytarabine|mesh-list
139044765|NCT04526795|Fludarabine|fludarabine|mesh-list
139044766|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044767|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139044768|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
139044769|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044770|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139044771|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
139044772|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044773|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
139044774|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139044775|NCT04518293|Amlodipine|amlodipine|mesh-list
139044776|NCT04518293|Telmisartan|telmisartan|mesh-list
139044777|NCT04518293|Indapamide|indapamide|mesh-list
139044778|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139044779|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139044780|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139044781|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044782|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139044783|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044784|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
139044785|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139044786|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139044787|NCT04518293|Diuretics|diuretics|mesh-ancestor
139044788|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
139044789|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139044790|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
139044791|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
139044792|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044793|NCT04475276|Protective Agents|protective agents|mesh-ancestor
139044794|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044795|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
139044796|NCT04475276|Vitamins|vitamins|mesh-ancestor
139044797|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
139044798|NCT04472429|Paclitaxel|paclitaxel|mesh-list
139044799|NCT04472429|Carboplatin|carboplatin|mesh-list
139044800|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139044801|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044802|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
139044803|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
139044804|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
139044805|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044806|NCT04456387|Factor VIII|factor viii|mesh-list
139044807|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
139044808|NCT04456387|Coagulants|coagulants|mesh-ancestor
139044809|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
139044810|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044811|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
139044812|NCT04439799|Testosterone|testosterone|mesh-list
139044813|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
139044814|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
139044815|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139044816|NCT04439799|Androgens|androgens|mesh-ancestor
139044817|NCT04439799|Hormones|hormones|mesh-ancestor
139044818|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044819|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044820|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139044821|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044822|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
139044823|NCT04435782|Selexipag|selexipag|mesh-list
139044824|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139044825|NCT04415944|Carboplatin|carboplatin|mesh-list
139044826|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044827|NCT04405596|Ambroxol|ambroxol|mesh-list
139044828|NCT04405596|Expectorants|expectorants|mesh-ancestor
139044829|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
139044830|NCT04396821|Paclitaxel|paclitaxel|mesh-list
139044831|NCT04396821|Gemcitabine|gemcitabine|mesh-list
139044833|NCT04396821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139044834|NCT04396821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139044835|NCT04396821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044836|NCT04396821|Tubulin Modulators|tubulin modulators|mesh-ancestor
139044837|NCT04396821|Antimitotic Agents|antimitotic agents|mesh-ancestor
139044838|NCT04396821|Mitosis Modulators|mitosis modulators|mesh-ancestor
139044839|NCT04396821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044840|NCT04396821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139044841|NCT04396821|Antimetabolites|antimetabolites|mesh-ancestor
139044842|NCT04396821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044843|NCT04396821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139044844|NCT04382898|Cemiplimab|cemiplimab|mesh-list
139044845|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138611744|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
139044846|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044847|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
139044848|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139044849|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
139044850|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139044851|NCT04278898|Expectorants|expectorants|mesh-ancestor
139044852|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
139044853|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139044854|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
139044855|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044856|NCT04278898|Protective Agents|protective agents|mesh-ancestor
139044857|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044858|NCT04278898|Antidotes|antidotes|mesh-ancestor
139044859|NCT04246047|Dexamethasone|dexamethasone|mesh-list
139044860|NCT04246047|Bortezomib|bortezomib|mesh-list
139044861|NCT04246047|Daratumumab|daratumumab|mesh-list
139044862|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139044863|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
139044864|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
139044865|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139044866|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044867|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139044869|NCT04246047|Hormones|hormones|mesh-ancestor
139044870|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044871|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139044872|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044873|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139044874|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
139044875|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139044876|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
139044877|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139044878|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044879|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139044880|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139044881|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044883|NCT04240002|Fludarabine|fludarabine|mesh-list
139044884|NCT04240002|Lenograstim|lenograstim|mesh-list
139044885|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044886|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139044887|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
139044888|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044889|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139044890|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
139044891|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044892|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
139044893|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139044894|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139044895|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139044896|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139044897|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
139044898|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044899|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044900|NCT04194216|Clindamycin|clindamycin|mesh-list
139044901|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
139044902|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
139044903|NCT04194216|Cephalexin|cephalexin|mesh-list
139044905|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139044906|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139044907|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044908|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044909|NCT04150939|Immunomodulating Agents|immunomodulating agents|mesh-list
139044910|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
139044911|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044912|NCT04080804|Nivolumab|nivolumab|mesh-list
139044913|NCT04080804|Ipilimumab|ipilimumab|mesh-list
139044914|NCT04080804|Relatlimab|relatlimab|mesh-list
139044915|NCT04080804|Antibodies|antibodies|mesh-list
139044916|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
139044917|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
139044918|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044919|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044920|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044921|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139044922|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044923|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
139044924|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139044925|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044926|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139044927|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044928|NCT04070768|Venetoclax|venetoclax|mesh-list
139044929|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
139044930|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044931|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044932|NCT04070768|Immunotoxins|immunotoxins|mesh-ancestor
138611812|NCT00183911|Vitamins|vitamins|mesh-ancestor
139044933|NCT04070768|Immunoconjugates|immunoconjugates|mesh-ancestor
139044934|NCT04070768|Immunologic Factors|immunologic factors|mesh-ancestor
139044935|NCT04070768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044936|NCT04058743|Cobalt|cobalt|mesh-list
139044937|NCT04058743|Chromium|chromium|mesh-list
139044938|NCT04058743|Nickel|nickel|mesh-list
139044939|NCT04058743|Trace Elements|trace elements|mesh-ancestor
139044940|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
139044941|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044942|NCT03971409|Doxorubicin|doxorubicin|mesh-list
139044943|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139044944|NCT03971409|Avelumab|avelumab|mesh-list
139044945|NCT03971409|Camptothecin|camptothecin|mesh-list
139044946|NCT03971409|Antibodies|antibodies|mesh-list
139044947|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139044948|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
139044949|NCT03971409|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139044950|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
139044951|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
138795579|NCT00644228|Hormones|hormones|mesh-ancestor
139044952|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044953|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139044954|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044955|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139044956|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139044957|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044958|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044959|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044960|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139044961|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139044963|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044964|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139044965|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139044966|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044967|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044968|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139044969|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
139044970|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139044971|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044972|NCT03933215|Cladribine|cladribine|mesh-list
139044973|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044974|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139044975|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
139044976|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044977|NCT03928210|Digoxin|digoxin|mesh-list
139044978|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139044979|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139044980|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611849|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139044981|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044982|NCT03928210|Protective Agents|protective agents|mesh-ancestor
139044983|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044984|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139044985|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139044986|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
139044987|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139044988|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139044989|NCT03897881|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139044990|NCT03897881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044991|NCT03857321|Insulin|insulin|mesh-list
139044992|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139044993|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
139044994|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139044995|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139044996|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
139044997|NCT03831711|Bombesin|bombesin|mesh-list
139044998|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139044999|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045000|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045001|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139045003|NCT03789110|Ipilimumab|ipilimumab|mesh-list
139045004|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045005|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045006|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139045007|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045008|NCT03721341|Hormones|hormones|mesh-list
139045009|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045010|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045011|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
139045012|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139045013|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139045014|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045015|NCT03682289|Durvalumab|durvalumab|mesh-list
139045016|NCT03682289|Olaparib|olaparib|mesh-list
139045017|NCT03682289|Adenosine|adenosine|mesh-list
139045018|NCT03682289|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139045019|NCT03682289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045020|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045021|NCT03682289|Immunologic Factors|immunologic factors|mesh-ancestor
139045022|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795655|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
139045023|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139045024|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045025|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045026|NCT03682289|Analgesics|analgesics|mesh-ancestor
139045027|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
139045028|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045029|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139045030|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
139045031|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139045032|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
139045033|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
139045034|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045035|NCT03675256|Vaccines|vaccines|mesh-list
139045036|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
139045037|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045038|NCT03645863|Iron|iron|mesh-list
139045039|NCT03645863|Trace Elements|trace elements|mesh-ancestor
139045040|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
139045041|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045042|NCT03643367|Propofol|propofol|mesh-list
139045043|NCT03643367|Sevoflurane|sevoflurane|mesh-list
139045044|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139045045|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139045046|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045047|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139045048|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
139045049|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
139045050|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139045051|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139045052|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139045053|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139045054|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045055|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045056|NCT03587844|Immunotoxins|immunotoxins|mesh-ancestor
139045057|NCT03587844|Immunoconjugates|immunoconjugates|mesh-ancestor
139045058|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
139045059|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045060|NCT03584152|Acetaminophen|acetaminophen|mesh-list
139045061|NCT03584152|Ibuprofen|ibuprofen|mesh-list
139045062|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139045063|NCT03584152|Analgesics|analgesics|mesh-ancestor
139045064|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
139045065|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045066|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045067|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
139045068|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139045069|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139045070|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045071|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139045072|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045073|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045075|NCT03545464|Levocetirizine|levocetirizine|mesh-list
139045076|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139045077|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
139045078|NCT03545464|Hormones|hormones|mesh-ancestor
139045079|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045080|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045081|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139045082|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045083|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139045084|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139045085|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
139045087|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045088|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045089|NCT03456076|Carboplatin|carboplatin|mesh-list
139045090|NCT03456076|Gemcitabine|gemcitabine|mesh-list
139045091|NCT03456076|Pemetrexed|pemetrexed|mesh-list
139045092|NCT03456076|Vinorelbine|vinorelbine|mesh-list
139045093|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045094|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139045095|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
139045096|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045097|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045098|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139045099|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139045100|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139045101|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
139045102|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
139045103|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
139045104|NCT03351348|Bupivacaine|bupivacaine|mesh-list
139045105|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
139045106|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
139045107|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139045108|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045109|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
139045110|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045111|NCT03326791|Aspirin|aspirin|mesh-list
139045112|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139045113|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139045114|NCT03326791|Analgesics|analgesics|mesh-ancestor
139045115|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
139045116|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045117|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045118|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139045119|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045120|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139045121|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138691094|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
139045122|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045123|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139045124|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139045125|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045126|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
139045127|NCT03280563|Tamoxifen|tamoxifen|mesh-list
139045128|NCT03280563|Bevacizumab|bevacizumab|mesh-list
139045129|NCT03280563|Atezolizumab|atezolizumab|mesh-list
139045130|NCT03280563|Fulvestrant|fulvestrant|mesh-list
139045131|NCT03280563|Exemestane|exemestane|mesh-list
139045132|NCT03280563|Entinostat|entinostat|mesh-list
139045133|NCT03280563|Ipatasertib|ipatasertib|mesh-list
139045134|NCT03280563|Antibodies|antibodies|mesh-list
139045135|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045136|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045137|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139045138|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139045139|NCT03280563|Growth Substances|growth substances|mesh-ancestor
139045140|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045141|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
139045142|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
139045143|NCT03280563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139045144|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045145|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139045146|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
139045147|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045148|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139045149|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139045150|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139045151|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139045152|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139045153|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139045154|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139045155|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045156|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139045157|NCT03280563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139045158|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
139045159|NCT03220776|Gabapentin|gabapentin|mesh-list
139045160|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139045161|NCT03220776|Analgesics|analgesics|mesh-ancestor
139045162|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
139045163|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045164|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045165|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
139045166|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139045167|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139045168|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139045169|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139045170|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138795809|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139045171|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139045172|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045173|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045174|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
139045175|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
139045176|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139045177|NCT03220776|Expectorants|expectorants|mesh-ancestor
139045178|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
139045179|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139045180|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
139045181|NCT03220776|Protective Agents|protective agents|mesh-ancestor
139045182|NCT03220776|Antidotes|antidotes|mesh-ancestor
139045183|NCT03171025|Nivolumab|nivolumab|mesh-list
139045184|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045185|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045186|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139045187|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045188|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139045189|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139045190|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045191|NCT03122197|Temozolomide|temozolomide|mesh-list
139045192|NCT03122197|Letrozole|letrozole|mesh-list
139045193|NCT03122197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139045194|NCT03122197|Alkylating Agents|alkylating agents|mesh-ancestor
139045195|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045196|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045197|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139045198|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139045199|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045200|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139045201|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
139045202|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045203|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045204|NCT03029702|Metformin|metformin|mesh-list
139045205|NCT03029702|Glyburide|glyburide|mesh-list
139045206|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139045207|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045208|NCT03014648|Atezolizumab|atezolizumab|mesh-list
139045209|NCT03014648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139045210|NCT03014648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045211|NCT03014648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045212|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045213|NCT03009045|Tedizolid|tedizolid|mesh-list
139045214|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
139045215|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
139045216|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139045217|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139045218|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139045219|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045220|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045221|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
139045222|NCT03006926|Lenvatinib|lenvatinib|mesh-list
139045223|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045224|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045225|NCT03006926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893488|NCT03820193|Hydrocodone|hydrocodone|mesh-list
139045226|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045227|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139045228|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045230|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139045231|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
139045232|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045233|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045234|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
139045235|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045236|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045237|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139045238|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
139045239|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045240|NCT02861417|Vidarabine|vidarabine|mesh-list
139045241|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
139045242|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
139045243|NCT02861417|Busulfan|busulfan|mesh-list
139045244|NCT02861417|Thiotepa|thiotepa|mesh-list
139045246|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
139045247|NCT02861417|Tacrolimus|tacrolimus|mesh-list
138795888|NCT01120028|Sirolimus|sirolimus|mesh-list
139045248|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139045249|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
139045250|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045251|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045252|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139045253|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
139045254|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045255|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045256|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139045257|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139045258|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
139045259|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
139045260|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139045261|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139045262|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045263|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139045264|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139045265|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
139045266|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139045267|NCT02807636|Carboplatin|carboplatin|mesh-list
139045268|NCT02807636|Gemcitabine|gemcitabine|mesh-list
139045269|NCT02807636|Atezolizumab|atezolizumab|mesh-list
139045270|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045271|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139045272|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
139045273|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045274|NCT02807636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139045275|NCT02807636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045276|NCT02760498|Cemiplimab|cemiplimab|mesh-list
139045277|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045278|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045279|NCT02684058|Carboplatin|carboplatin|mesh-list
139045280|NCT02684058|Vincristine|vincristine|mesh-list
139045281|NCT02684058|Trametinib|trametinib|mesh-list
139045282|NCT02684058|Dabrafenib|dabrafenib|mesh-list
139045283|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045284|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139045285|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
139045286|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
139045287|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
139045288|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045289|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139045290|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045291|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
139045292|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045293|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045294|NCT02644369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139045295|NCT02644369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045296|NCT02561273|Prednisone|prednisone|mesh-list
139045297|NCT02561273|Cortisone|cortisone|mesh-list
139045298|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
139045299|NCT02561273|Doxorubicin|doxorubicin|mesh-list
139045300|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139045301|NCT02561273|Etoposide|etoposide|mesh-list
139045302|NCT02561273|Vincristine|vincristine|mesh-list
139045303|NCT02561273|Lenalidomide|lenalidomide|mesh-list
139045304|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
139045305|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
139045306|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139045307|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
139045308|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045309|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045310|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139045311|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
139045312|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045313|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045314|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139045315|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139045316|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139045317|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139045318|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045319|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139045320|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
138612254|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
139045322|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045323|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139045324|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139045325|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
139045326|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
139045327|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
139045328|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139045329|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139045330|NCT02561273|Growth Substances|growth substances|mesh-ancestor
139045331|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
139045332|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
139045333|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
139045334|NCT02506959|Gemcitabine|gemcitabine|mesh-list
139045335|NCT02506959|Melphalan|melphalan|mesh-list
139045336|NCT02506959|Busulfan|busulfan|mesh-list
139045337|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
139045338|NCT02506959|Panobinostat|panobinostat|mesh-list
139045339|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139045340|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139045341|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
139045342|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045343|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045344|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139045345|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
139045346|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139045347|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139045348|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
139045349|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045350|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139045351|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045352|NCT02502006|Celecoxib|celecoxib|mesh-list
139045353|NCT02502006|Naproxen|naproxen|mesh-list
139045354|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139045355|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139045356|NCT02502006|Analgesics|analgesics|mesh-ancestor
139045357|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
139045358|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045359|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045360|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139045361|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045362|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139045363|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139045364|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045365|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045366|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
139045367|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
139045368|NCT02457598|Idelalisib|idelalisib|mesh-list
139045369|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045370|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045371|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045372|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045373|NCT02327455|Dobutamine|dobutamine|mesh-list
139045374|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139045375|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
139045376|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
139045377|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045378|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045379|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139045380|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139045381|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139045382|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
139045383|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045384|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045385|NCT02327455|Protective Agents|protective agents|mesh-ancestor
139045386|NCT02323698|Caffeine|caffeine|mesh-list
139045387|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139045388|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045389|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139045390|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045391|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045392|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139045393|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139045394|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
139045395|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045396|NCT02308072|Olaparib|olaparib|mesh-list
139045397|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045398|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139045399|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045400|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045401|NCT02304809|Vemurafenib|vemurafenib|mesh-list
139045402|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045403|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139045404|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045405|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045406|NCT02246270|Heparin|heparin|mesh-list
139045407|NCT02246270|Calcium heparin|calcium heparin|mesh-list
139045408|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
139045409|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139045410|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139045411|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045412|NCT02101008|Disulfiram|disulfiram|mesh-list
139045413|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139045414|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139045415|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045416|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045417|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
139045418|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045419|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139045420|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045421|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045422|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
139045423|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045424|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045425|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139045426|NCT02006576|Ibuprofen|ibuprofen|mesh-list
139045427|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139045428|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139045429|NCT02006576|Analgesics|analgesics|mesh-ancestor
139045430|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
139045431|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045432|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045433|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139045434|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045435|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139045436|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045437|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045438|NCT01913730|Dexamethasone|dexamethasone|mesh-list
139045439|NCT01913730|Bortezomib|bortezomib|mesh-list
139045440|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139045441|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
139045442|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
139045443|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045444|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045445|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139045446|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
139045447|NCT01913730|Hormones|hormones|mesh-ancestor
139045448|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045449|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139045450|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045451|NCT01651403|Tenofovir|tenofovir|mesh-list
139045452|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
139045453|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139045454|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139045455|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139045456|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045457|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045458|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139045459|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139045460|NCT01515748|Docetaxel|docetaxel|mesh-list
139045461|NCT01515748|Fluorouracil|fluorouracil|mesh-list
139045462|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
139045463|NCT01515748|Tegafur|tegafur|mesh-list
139045464|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045465|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
139045466|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
139045467|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
139045468|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045470|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138612475|NCT00211419|Growth Substances|growth substances|mesh-ancestor
139045471|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139045472|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
139045473|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045475|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045476|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045477|NCT01352520|Immunotoxins|immunotoxins|mesh-ancestor
139045478|NCT01352520|Immunoconjugates|immunoconjugates|mesh-ancestor
139045479|NCT01352520|Immunologic Factors|immunologic factors|mesh-ancestor
139045480|NCT01352520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045481|NCT01309672|Prednisone|prednisone|mesh-list
139045482|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
139045483|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139045484|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
139045485|NCT01309672|Hormones|hormones|mesh-ancestor
139045486|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045487|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045488|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139045489|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045490|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139045491|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045492|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045493|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
139045494|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139045495|NCT01088750|Prednisolone|prednisolone|mesh-list
139045496|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
139045497|NCT01088750|Vinblastine|vinblastine|mesh-list
139045498|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139045499|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
139045500|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045501|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045502|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139045503|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
138893654|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139045504|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045505|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045506|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139045507|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139045508|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
139045510|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138612582|NCT00211848|Ribavirin|ribavirin|mesh-list
139045511|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139045512|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139045513|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
139045514|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
139045515|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
139045516|NCT00393471|Etanercept|etanercept|mesh-list
139045517|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139045518|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139045519|NCT00393471|Analgesics|analgesics|mesh-ancestor
139045520|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
139045521|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045522|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045523|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139045524|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045525|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139045526|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139045527|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
139045528|NCT00340704|Tamsulosin|tamsulosin|mesh-list
138612629|NCT00187928|Topiramate|topiramate|mesh-list
139045529|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139045530|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139045531|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139045532|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
139045533|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045534|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045535|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045536|NCT00340704|Urological Agents|urological agents|mesh-ancestor
139045537|NCT00132496|Rabeprazole|rabeprazole|mesh-list
139045538|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139045539|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139045540|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139045541|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045542|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045543|NCT01080586|Cyclosporine|cyclosporine|mesh-list
139045544|NCT01080586|Cyclosporins|cyclosporins|mesh-list
139045545|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796181|NCT05769842|Propofol|propofol|mesh-list
139045546|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045547|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139045548|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
139045549|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045550|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
139045551|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139045552|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
139045553|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045554|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139045556|NCT00231777|Aprepitant|aprepitant|mesh-list
139045557|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
139045558|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
139045559|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045560|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045561|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139045562|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
139045563|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
139045564|NCT00231777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139045565|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139045566|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
139045567|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045568|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045569|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139045570|NCT01076842|Insulin|insulin|mesh-list
139045571|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139045572|NCT01076842|Exenatide|exenatide|mesh-list
138612767|NCT02963051|Copper|copper|mesh-list
139045573|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
139045574|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139045575|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045576|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139045577|NCT01076842|Incretins|incretins|mesh-ancestor
139045578|NCT01076842|Hormones|hormones|mesh-ancestor
139045579|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045580|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
139045581|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139045582|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
139045583|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045584|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045585|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139045586|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
139045587|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045588|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045589|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139045591|NCT00231465|Gefitinib|gefitinib|mesh-list
139045592|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045593|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
139045594|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
139045595|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
139045596|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045597|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139045598|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045599|NCT00254397|Leuprolide|leuprolide|mesh-list
139045600|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139045601|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
139045602|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139045603|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045604|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139045605|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045606|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
139045607|NCT00254163|Rituximab|rituximab|mesh-list
139045608|NCT00254163|Fludarabine|fludarabine|mesh-list
139045610|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139045611|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
139045612|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045613|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045614|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139045615|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
139045616|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045617|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045618|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139045619|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139045620|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139045621|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045623|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139045624|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045625|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139045626|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
139045627|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045629|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045630|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139045631|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
139045632|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139045633|NCT00122278|Dexamethasone|dexamethasone|mesh-list
139045634|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139045635|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
139045636|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
139045637|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045638|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045639|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139045640|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
139045641|NCT00122278|Hormones|hormones|mesh-ancestor
139045642|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045643|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139045644|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045645|NCT00182091|Hormones|hormones|mesh-list
139045646|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045647|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045649|NCT01072071|Diuretics|diuretics|mesh-ancestor
139045650|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
139045651|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045652|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139045653|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139045654|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045655|NCT00181155|Allopurinol|allopurinol|mesh-list
139045656|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
139045657|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045658|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045659|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
139045660|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045661|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139045662|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
139045663|NCT00181155|Protective Agents|protective agents|mesh-ancestor
139045664|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045665|NCT00322452|Paclitaxel|paclitaxel|mesh-list
139045666|NCT00322452|Carboplatin|carboplatin|mesh-list
139045667|NCT00322452|Gefitinib|gefitinib|mesh-list
139045668|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139045669|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045670|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
139045671|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
139045672|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
139045673|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045674|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139045675|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045676|NCT00110812|Aldesleukin|aldesleukin|mesh-list
139045677|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045678|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139045679|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139045680|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
138893857|NCT02859064|Lanreotide|lanreotide|mesh-list
139045681|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139045682|NCT00516269|Methylphenidate|methylphenidate|mesh-list
139045683|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139045684|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045685|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139045686|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139045687|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139045688|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045690|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045691|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139045692|NCT00228813|Lenograstim|lenograstim|mesh-list
139045693|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139045694|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
138796328|NCT05276596|Norepinephrine|norepinephrine|mesh-list
139045695|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045696|NCT00322374|Epirubicin|epirubicin|mesh-list
139045697|NCT00322374|Epothilones|epothilones|mesh-list
139045698|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139045699|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045700|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139045701|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139045702|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045703|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045704|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
139045705|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
139045706|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
139045707|NCT00174447|Ziprasidone|ziprasidone|mesh-list
139045708|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139045709|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
139045710|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045711|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045712|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045713|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139045714|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139045715|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139045716|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139045717|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139045718|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
139045719|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
139045720|NCT00321984|Lansoprazole|lansoprazole|mesh-list
139045721|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139045722|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139045723|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139045724|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045725|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045726|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
139045728|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045729|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045730|NCT01060566|Ivacaftor|ivacaftor|mesh-list
139045731|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139045732|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139045733|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045734|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
139045735|NCT02533284|Analgesics|analgesics|mesh-ancestor
139045736|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
139045737|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045738|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045739|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
139045740|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139045741|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139045742|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
139045743|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139045744|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139045745|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045746|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139045747|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
138613100|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
139045748|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139045749|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
139045750|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139045751|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
139045752|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045753|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139045754|NCT00110266|Deferasirox|deferasirox|mesh-list
139045755|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139045756|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
139045757|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
139045758|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045759|NCT00366548|Vaccines|vaccines|mesh-list
139045760|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139045761|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
139045762|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045763|NCT01074645|Tenofovir|tenofovir|mesh-list
139045764|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
139045765|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139045766|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139045767|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138796417|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
139045768|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045769|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045770|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139045771|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139045773|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045774|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139045775|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045776|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045778|NCT01045304|Gemcitabine|gemcitabine|mesh-list
139045779|NCT01045304|Iniparib|iniparib|mesh-list
139045780|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045781|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139045782|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
139045783|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045784|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139045785|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045786|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139045787|NCT01080742|Bisoprolol|bisoprolol|mesh-list
139045788|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139045789|NCT01080742|Diuretics|diuretics|mesh-ancestor
139045790|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
139045791|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045792|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139045793|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139045794|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045795|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
139045796|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
139045797|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045798|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139045799|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139045800|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139045801|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
139045802|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045803|NCT00131248|Metoclopramide|metoclopramide|mesh-list
139045804|NCT00131248|Ranitidine|ranitidine|mesh-list
139045805|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
139045806|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
139045807|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
139045808|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045809|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045810|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139045811|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139045812|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139045813|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
139045814|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045815|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045816|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139045817|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139045818|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
139045819|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
139045821|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
139045822|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045823|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
139045824|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
139045825|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139045826|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139045827|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139045828|NCT01049204|Maraviroc|maraviroc|mesh-list
139045829|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138613310|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139045830|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139045831|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045832|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139045833|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139045834|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
139045835|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139045836|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139045837|NCT00096382|Aldesleukin|aldesleukin|mesh-list
139045838|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
139045839|NCT00096382|Fludarabine|fludarabine|mesh-list
139045840|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
139045841|NCT00096382|Interleukin-2|interleukin-2|mesh-list
139045842|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139045843|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
139045844|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045845|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139045846|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139045847|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
139045848|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045849|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045850|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139045851|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139045852|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
139045853|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139045854|NCT00096382|Analgesics|analgesics|mesh-ancestor
139045855|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
139045856|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045857|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139045858|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139045859|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
139045860|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139045861|NCT00384332|Olanzapine|olanzapine|mesh-list
139045862|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
139045863|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
139045864|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045865|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045866|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139045867|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139045868|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139045869|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139045870|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139045871|NCT00384332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139045872|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139045873|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139045874|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691256|NCT01285609|Paclitaxel|paclitaxel|mesh-list
139045876|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
139045877|NCT00096226|Paclitaxel|paclitaxel|mesh-list
139045878|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139045879|NCT00096226|Carboplatin|carboplatin|mesh-list
139045880|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139045881|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045882|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
139045883|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
139045884|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
139045885|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045887|NCT01078714|Diuretics|diuretics|mesh-ancestor
139045888|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
139045889|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045890|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139045891|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139045892|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045893|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
139045894|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139045895|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
139045896|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045897|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045898|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139045899|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
139045900|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139045901|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
139045902|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045903|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045904|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139045905|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
139045906|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
139045907|NCT03964324|Protective Agents|protective agents|mesh-ancestor
139045908|NCT01082848|Aripiprazole|aripiprazole|mesh-list
139045909|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
139045910|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139045911|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139045912|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139045913|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139045914|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045915|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
139045916|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
139045917|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613444|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
139045918|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045919|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139045920|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139045921|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
139045922|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139045923|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139045924|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139045925|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139045926|NCT01082926|Aldesleukin|aldesleukin|mesh-list
139045927|NCT01082926|Interleukin-2|interleukin-2|mesh-list
139045928|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045929|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139045930|NCT01082926|Analgesics|analgesics|mesh-ancestor
139045931|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
139045932|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045946|NCT01078870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139045947|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139045948|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139045949|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045950|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045951|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
139045952|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045953|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139045954|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
139045955|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139045956|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139045957|NCT01078870|Analgesics|analgesics|mesh-ancestor
139045958|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
139045959|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
139045960|NCT00105196|Aripiprazole|aripiprazole|mesh-list
139045961|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
139045962|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139045963|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139045964|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139045965|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139045966|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045967|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
139045968|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
139045969|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139045970|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045971|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139045972|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139045973|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
139045974|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139045975|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139045976|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139045977|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139045979|NCT00104572|Anastrozole|anastrozole|mesh-list
139045980|NCT00104572|Calcium|calcium|mesh-list
139045981|NCT00104572|Testosterone|testosterone|mesh-list
139045982|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139045983|NCT00104572|Vitamins|vitamins|mesh-ancestor
139045984|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
139045985|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139045986|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139045987|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139045988|NCT00104572|Androgens|androgens|mesh-ancestor
138691278|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
139045990|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139045991|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139045992|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139045993|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139045995|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139045996|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139045997|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
139045998|NCT00514943|Cetuximab|cetuximab|mesh-list
139045999|NCT00514943|Afatinib|afatinib|mesh-list
139046000|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139046001|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046002|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139046003|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046004|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046005|NCT00103402|Alfuzosin|alfuzosin|mesh-list
139046006|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139046007|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139046008|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139046009|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
139046010|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046011|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046012|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046013|NCT00103402|Urological Agents|urological agents|mesh-ancestor
139046014|NCT00095836|Gefitinib|gefitinib|mesh-list
139046015|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046016|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139046017|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046018|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046019|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
139046020|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139046021|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
139046022|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046023|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046024|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139046025|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
139046026|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
139046027|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139046028|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
139046029|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046030|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046031|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
139046032|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139046033|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139046034|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139046035|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139046036|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139046037|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046039|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046040|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046041|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139046042|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046043|NCT03235505|Nicotine|nicotine|mesh-list
139046044|NCT03235505|Varenicline|varenicline|mesh-list
139046045|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139046046|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
139046047|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046048|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046049|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139046050|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139046051|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
139046052|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046053|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046054|NCT00251979|Esomeprazole|esomeprazole|mesh-list
139046055|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139046056|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139046057|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139046058|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046059|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046060|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
139046061|NCT00511901|Hematinics|hematinics|mesh-ancestor
139046062|NCT04580147|Aflibercept|aflibercept|mesh-list
139046063|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139046064|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139046065|NCT04580147|Growth Substances|growth substances|mesh-ancestor
139046066|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046067|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
139046068|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046069|NCT00228423|Clopidogrel|clopidogrel|mesh-list
139046070|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139046071|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138613617|NCT06111573|Diclofenac|diclofenac|mesh-list
139046072|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139046073|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139046074|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
139046075|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046076|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046078|NCT00513695|Paclitaxel|paclitaxel|mesh-list
139046079|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
139046080|NCT00513695|Doxorubicin|doxorubicin|mesh-list
139046081|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139046082|NCT00513695|Sunitinib|sunitinib|mesh-list
139046083|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139046084|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046085|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
139046086|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
139046087|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
139046088|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046089|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139046090|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
139046091|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046092|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139046093|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139046094|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
139046095|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139046096|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139046097|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139046098|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139046099|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046100|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139046101|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139046102|NCT00513695|Growth Substances|growth substances|mesh-ancestor
139046103|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
139046104|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139046105|NCT00162981|Clobazam|clobazam|mesh-list
139046106|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
139046107|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139046108|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139046109|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139046110|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046111|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139046112|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139046113|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
139046114|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
139046115|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046116|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046117|NCT00099268|Levodopa|levodopa|mesh-list
139046118|NCT00099268|Carbidopa|carbidopa|mesh-list
139046119|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139046120|NCT00099268|Entacapone|entacapone|mesh-list
139046121|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139046122|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138613648|NCT05981365|Metformin|metformin|mesh-list
139046123|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
139046124|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046125|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046126|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046127|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139046128|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046129|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139046130|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
139046131|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
139046132|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139046133|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
139046134|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139046135|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139046137|NCT00511355|Estrogens|estrogens|mesh-ancestor
139046138|NCT00511355|Hormones|hormones|mesh-ancestor
139046139|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139046140|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046141|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139046142|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
139046143|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139046144|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139046145|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139046146|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139046147|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139046148|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139046149|NCT01083784|Valproic Acid|valproic acid|mesh-list
139046150|NCT01083784|Clonazepam|clonazepam|mesh-list
139046151|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
139046152|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046153|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046154|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
139046155|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046156|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046157|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
139046158|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139046159|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139046160|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139046161|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
139046162|NCT00095212|Testosterone|testosterone|mesh-list
139046163|NCT00095212|Androgens|androgens|mesh-ancestor
139046164|NCT00095212|Hormones|hormones|mesh-ancestor
139046165|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139046166|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046167|NCT00120874|Memantine|memantine|mesh-list
139046168|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139046169|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139046170|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
139046171|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046172|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046173|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046174|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139046175|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139046176|NCT00120250|Eszopiclone|eszopiclone|mesh-list
139046177|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139046178|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139046179|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046180|NCT01081600|Trastuzumab|trastuzumab|mesh-list
139046181|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139046182|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046183|NCT01079338|Caffeine|caffeine|mesh-list
139046184|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139046185|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046186|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139046187|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046188|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046189|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139046190|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139046191|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
139046192|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046193|NCT00384176|Leucovorin|leucovorin|mesh-list
139046194|NCT00384176|Bevacizumab|bevacizumab|mesh-list
139046195|NCT00384176|Fluorouracil|fluorouracil|mesh-list
139046196|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
139046197|NCT00384176|Cediranib|cediranib|mesh-list
139046198|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139046199|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046200|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139046201|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139046202|NCT00384176|Growth Substances|growth substances|mesh-ancestor
139046203|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046204|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
139046205|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
139046206|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046207|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139046208|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139046209|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
139046210|NCT00384176|Antidotes|antidotes|mesh-ancestor
139046211|NCT00384176|Protective Agents|protective agents|mesh-ancestor
139046212|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
139046213|NCT00384176|Vitamins|vitamins|mesh-ancestor
139046214|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
139046215|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139046217|NCT00513305|Cytarabine|cytarabine|mesh-list
139046218|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
139046219|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139046220|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
139046221|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046222|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046223|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
139046224|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139046225|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139046226|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
139046227|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046228|NCT00513071|Saracatinib|saracatinib|mesh-list
139046229|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046230|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046231|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046232|NCT00510887|Dexamethasone|dexamethasone|mesh-list
139046233|NCT00510887|Rituximab|rituximab|mesh-list
139046234|NCT00510887|Fludarabine|fludarabine|mesh-list
139046235|NCT00510887|Bortezomib|bortezomib|mesh-list
139046236|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
139046237|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139046238|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
139046239|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
139046240|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046241|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046242|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139046243|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
139046244|NCT00510887|Hormones|hormones|mesh-ancestor
139046245|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139046246|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139046247|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046248|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139046249|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
139046250|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139046251|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046252|NCT00510887|Analgesics|analgesics|mesh-ancestor
139046253|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
139046254|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139046255|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139046256|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046257|NCT01012349|Aspirin|aspirin|mesh-list
139046258|NCT01012349|Citric Acid|citric acid|mesh-list
139046259|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
139046260|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139046261|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139046262|NCT01012349|Analgesics|analgesics|mesh-ancestor
139046263|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
139046264|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046265|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046266|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139046267|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139046268|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139046269|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139046270|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046271|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139046272|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139046273|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046274|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
139046275|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
139046276|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139046277|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
139046278|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
139046279|NCT00358826|Atreleuton|atreleuton|mesh-list
139046280|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139046281|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046282|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046283|NCT01009541|Pregabalin|pregabalin|mesh-list
139046284|NCT01009541|Analgesics|analgesics|mesh-ancestor
139046285|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
139046286|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046287|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046288|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
139046289|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139046290|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139046291|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046292|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139046293|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139046294|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139046295|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139046296|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139046297|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
139046298|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046299|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139046300|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046301|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046302|NCT01009697|Codeine|codeine|mesh-list
139046303|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139046304|NCT01009697|Narcotics|narcotics|mesh-ancestor
139046305|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139046306|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046307|NCT01009697|Analgesics|analgesics|mesh-ancestor
139046308|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
139046309|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046310|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
139046311|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
139046312|NCT01009853|Codeine|codeine|mesh-list
139046313|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139046314|NCT01009853|Narcotics|narcotics|mesh-ancestor
139046315|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139046316|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046317|NCT01009853|Analgesics|analgesics|mesh-ancestor
139046318|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
139046319|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046320|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
139046321|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
139046322|NCT00506285|Methylphenidate|methylphenidate|mesh-list
139046323|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139046324|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046325|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139046326|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139046327|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139046328|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046329|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
139046330|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046331|NCT00506129|Fludarabine|fludarabine|mesh-list
139046332|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
139046333|NCT00506129|Melphalan|melphalan|mesh-list
139046334|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
139046335|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139046336|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046337|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139046338|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
139046339|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046340|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139046341|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
139046342|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046343|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139046344|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
139046345|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139046346|NCT00358670|Infliximab|infliximab|mesh-list
139046347|NCT00358670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138678796|NCT04942626|Capecitabine|capecitabine|mesh-list
139046348|NCT00358670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139046349|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
139046350|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139046351|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139046352|NCT01010087|Oseltamivir|oseltamivir|mesh-list
139046353|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
139046354|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139046355|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046356|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046357|NCT00505661|Letrozole|letrozole|mesh-list
139046358|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046359|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139046360|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139046361|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894311|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139046362|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797004|NCT01117454|Flecainide|flecainide|mesh-list
139046363|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139046364|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
139046365|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139046366|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046368|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
139046369|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
139046370|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046371|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046372|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139046373|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139046374|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046375|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046376|NCT05358977|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139046377|NCT05358977|Hemostatics|hemostatics|mesh-ancestor
139046378|NCT05358977|Coagulants|coagulants|mesh-ancestor
139046379|NCT01010243|Pioglitazone|pioglitazone|mesh-list
139046380|NCT01010243|Dexamethasone|dexamethasone|mesh-list
139046381|NCT01010243|Lenalidomide|lenalidomide|mesh-list
139046382|NCT01010243|Treosulfan|treosulfan|mesh-list
139046383|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139046384|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
139046385|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
139046386|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046387|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046388|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139046389|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
139046390|NCT01010243|Hormones|hormones|mesh-ancestor
139046391|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138613823|NCT05823948|Insulin|insulin|mesh-list
139046392|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139046393|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046394|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
139046395|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139046396|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139046397|NCT01010243|Growth Substances|growth substances|mesh-ancestor
139046398|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
139046399|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139046400|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139046401|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
139046402|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046403|NCT00383708|Lanreotide|lanreotide|mesh-list
139046404|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046405|NCT00504881|Brivaracetam|brivaracetam|mesh-list
139046406|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
139046408|NCT00504725|Analgesics|analgesics|mesh-ancestor
139046409|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
139046410|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046411|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046412|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139046413|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139046414|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
139046415|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
139046416|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139046417|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139046418|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139046419|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046420|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046421|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
139046422|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
139046423|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139046424|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
139046425|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046426|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046427|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139046428|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
139046429|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139046430|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139046431|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139046432|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
139046433|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046434|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046435|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139046436|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
139046437|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139046438|NCT00362180|Mipomersen|mipomersen|mesh-list
138797086|NCT01142726|Abatacept|abatacept|mesh-list
139046439|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139046440|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139046441|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
139046442|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046443|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139046444|NCT00383162|Naproxen|naproxen|mesh-list
139046445|NCT00383162|Sumatriptan|sumatriptan|mesh-list
139046446|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139046447|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139046448|NCT00383162|Analgesics|analgesics|mesh-ancestor
138691342|NCT02921282|Protective Agents|protective agents|mesh-ancestor
139046449|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
139046450|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046451|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046452|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139046453|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139046454|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
139046455|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139046456|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046457|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046458|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139046459|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139046460|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139046461|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
139046462|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046464|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139046465|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139046466|NCT01052792|Analgesics|analgesics|mesh-ancestor
139046467|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
139046468|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046469|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046470|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139046471|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139046472|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
139046473|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139046474|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046475|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046476|NCT01052870|Finasteride|finasteride|mesh-list
139046477|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139046478|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139046479|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046480|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046481|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
139046482|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139046483|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046484|NCT01052870|Urological Agents|urological agents|mesh-ancestor
139046485|NCT00358436|Bromides|bromides|mesh-list
139046486|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
139046487|NCT01053026|Olmesartan|olmesartan|mesh-list
139046488|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139046489|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139046490|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138770206|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139046491|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046493|NCT01045538|Vorinostat|vorinostat|mesh-list
139046494|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046495|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139046496|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
138894397|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046497|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046498|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139046499|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046501|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139046502|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139046503|NCT00361634|Analgesics|analgesics|mesh-ancestor
139046504|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
139046505|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046506|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046507|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139046508|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139046509|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139046510|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139046511|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
139046512|NCT00357968|Clopidogrel|clopidogrel|mesh-list
139046513|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139046514|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139046515|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139046516|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139046517|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139046519|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613917|NCT05500443|Vitamin K|vitamin k|mesh-list
139046520|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046521|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046522|NCT00357656|Factor VIII|factor viii|mesh-list
139046523|NCT00357656|Coagulants|coagulants|mesh-ancestor
139046524|NCT00357500|Thalidomide|thalidomide|mesh-list
139046525|NCT00357500|Celecoxib|celecoxib|mesh-list
139046526|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
139046527|NCT00357500|Etoposide|etoposide|mesh-list
139046528|NCT00357500|Fenofibrate|fenofibrate|mesh-list
139046529|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139046530|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
139046531|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046532|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139046533|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139046534|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
139046535|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894423|NCT00684632|Fentanyl|fentanyl|mesh-list
139046536|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046537|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139046538|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139046539|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139046540|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139046542|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139046543|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139046544|NCT00357500|Analgesics|analgesics|mesh-ancestor
139046545|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
139046546|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046547|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139046548|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139046549|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139046550|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
139046551|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139046552|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139046553|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139046554|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139046555|NCT00357500|Growth Substances|growth substances|mesh-ancestor
139046556|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
139046557|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139046558|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
138613944|NCT05405439|Hormones|hormones|mesh-ancestor
139046559|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139046560|NCT00357110|Fulvestrant|fulvestrant|mesh-list
139046561|NCT00357110|Anastrozole|anastrozole|mesh-list
139046562|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139046563|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046564|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139046565|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139046566|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
139046567|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139046568|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046569|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139046570|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139046571|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046572|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046573|NCT00098722|Maraviroc|maraviroc|mesh-list
139046574|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139046575|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139046576|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046577|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139046578|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139046579|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
139046580|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139046581|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139046582|NCT02531152|Latanoprost|latanoprost|mesh-list
139046583|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139046584|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139046585|NCT01084408|Paclitaxel|paclitaxel|mesh-list
139046586|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139046587|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139046588|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046589|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
139046590|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
139046591|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
139046592|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046593|NCT00098254|Sorafenib|sorafenib|mesh-list
139046594|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046595|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139046596|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046597|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046598|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139046599|NCT00095056|Glipizide|glipizide|mesh-list
139046600|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139046601|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046602|NCT00095056|Incretins|incretins|mesh-ancestor
139046604|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139046605|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139046606|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
138613993|NCT05296512|Lenvatinib|lenvatinib|mesh-list
139046607|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046608|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046609|NCT00098020|Isotretinoin|isotretinoin|mesh-list
139046610|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
139046611|NCT00381680|Leucovorin|leucovorin|mesh-list
139046612|NCT00381680|Cytarabine|cytarabine|mesh-list
139046613|NCT00381680|Dexamethasone|dexamethasone|mesh-list
139046614|NCT00381680|Prednisone|prednisone|mesh-list
139046615|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
139046616|NCT00381680|Doxorubicin|doxorubicin|mesh-list
139046617|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139046618|NCT00381680|Methotrexate|methotrexate|mesh-list
139046619|NCT00381680|Etoposide|etoposide|mesh-list
139046620|NCT00381680|Vincristine|vincristine|mesh-list
139046621|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
139046622|NCT00381680|Asparaginase|asparaginase|mesh-list
139046623|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
139046624|NCT00381680|Pegaspargase|pegaspargase|mesh-list
139046625|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
139046626|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139046627|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
139046628|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046629|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139046630|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139046631|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
139046632|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046633|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046634|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139046635|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139046636|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
139046637|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
139046638|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046639|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139046640|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
139046641|NCT00381680|Hormones|hormones|mesh-ancestor
139046642|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139046643|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139046644|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139046645|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139046646|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139046647|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046648|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139046649|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
139046650|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139046651|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139046652|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
139046653|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
139046654|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139046655|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139046656|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139046657|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
139046658|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139046659|NCT00381680|Antidotes|antidotes|mesh-ancestor
139046660|NCT00381680|Protective Agents|protective agents|mesh-ancestor
139046661|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
139046662|NCT00381680|Vitamins|vitamins|mesh-ancestor
139046663|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
139046664|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
139046665|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
139046666|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
139046667|NCT03292250|Durvalumab|durvalumab|mesh-list
139046668|NCT03292250|Tremelimumab|tremelimumab|mesh-list
139046669|NCT03292250|Nintedanib|nintedanib|mesh-list
139046670|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139046671|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046672|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139046673|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894524|NCT02566252|Albuterol|albuterol|mesh-list
138691421|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046674|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046676|NCT01053338|Promethazine|promethazine|mesh-list
139046678|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046679|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139046680|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139046681|NCT01053338|Analgesics|analgesics|mesh-ancestor
139046682|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
139046683|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046684|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046685|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139046686|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139046687|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139046688|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046689|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139046690|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139046691|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139046692|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
139046693|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
139046694|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
139046695|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
139046696|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139046697|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139046698|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
139046699|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
139046700|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046701|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139046702|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
139046703|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
139046704|NCT01050374|Albendazole|albendazole|mesh-list
139046705|NCT01050374|Praziquantel|praziquantel|mesh-list
139046706|NCT01050374|Mebendazole|mebendazole|mesh-list
139046707|NCT01050374|Piperazine|piperazine|mesh-list
139046708|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
139046709|NCT01050374|DMP 777|dmp 777|mesh-list
139046710|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
139046711|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139046712|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139046713|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
139046714|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139046715|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139046716|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
139046717|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
139046718|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
139046719|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046720|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046721|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
139046722|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046723|NCT00360698|Insulin|insulin|mesh-list
139046724|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139046725|NCT00360698|Metformin|metformin|mesh-list
139046726|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
139046727|NCT00360698|Glimepiride|glimepiride|mesh-list
139046728|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
139046729|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139046730|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046731|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139046732|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138691430|NCT01283464|Tretinoin|tretinoin|mesh-list
139046733|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
139046734|NCT03990194|Leuprolide|leuprolide|mesh-list
139046735|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139046736|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
139046737|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139046738|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046739|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139046740|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046741|NCT00380978|Narcotics|narcotics|mesh-list
139046742|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139046743|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046744|NCT00380978|Analgesics|analgesics|mesh-ancestor
139046745|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
139046746|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046747|NCT00162123|Ipilimumab|ipilimumab|mesh-list
139046748|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139046749|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046750|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139046751|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046752|NCT00227721|Gemcitabine|gemcitabine|mesh-list
139046753|NCT00227721|Docetaxel|docetaxel|mesh-list
139046754|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139046755|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
139046756|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046757|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046758|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
139046759|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
139046760|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
139046761|NCT01074723|Carotenoids|carotenoids|mesh-list
139046763|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046764|NCT01074723|Protective Agents|protective agents|mesh-ancestor
139046765|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046766|NCT01074801|Insulin|insulin|mesh-list
139046767|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139046768|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139046769|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046770|NCT01074879|Caseins|caseins|mesh-list
139046771|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
139046772|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
139046773|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046774|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
139046775|NCT00226941|Promethazine|promethazine|mesh-list
139046776|NCT00226941|Capecitabine|capecitabine|mesh-list
139046777|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
139046778|NCT00226941|Cetuximab|cetuximab|mesh-list
138614113|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
139046779|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139046780|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
139046781|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046782|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046783|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138894617|NCT00822237|Vaccines|vaccines|mesh-list
139046784|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139046785|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139046786|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139046787|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046788|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
139046789|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
139046790|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
139046791|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046792|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
139046793|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
139046794|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139046795|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139046796|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
139046797|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
139046798|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185966|NCT05555251|Trastuzumab|trastuzumab|mesh-list
139046799|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139046800|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
139046801|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
139046802|NCT01075503|Ropivacaine|ropivacaine|mesh-list
139046803|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
139046804|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
139046805|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139046806|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046807|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
139046808|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046809|NCT01075581|Epinephrine|epinephrine|mesh-list
139046810|NCT01075581|Racepinephrine|racepinephrine|mesh-list
139046811|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
139046812|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139046813|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139046814|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
139046815|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046816|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046817|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046818|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139046819|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139046820|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
139046821|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046822|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139046823|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
139046824|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
139046825|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
139046826|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139046827|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
139046828|NCT00356408|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139046829|NCT00356408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139046830|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139046831|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
139046832|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046833|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139046834|NCT00509795|Ranibizumab|ranibizumab|mesh-list
139046835|NCT00509795|Aflibercept|aflibercept|mesh-list
139046836|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139046837|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139046838|NCT00509795|Growth Substances|growth substances|mesh-ancestor
139046839|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046840|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
139046841|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046842|NCT00504257|Bevacizumab|bevacizumab|mesh-list
139046843|NCT00504257|Docetaxel|docetaxel|mesh-list
139046844|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139046845|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046846|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139046847|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139046848|NCT00504257|Growth Substances|growth substances|mesh-ancestor
139046849|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046850|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
139046851|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
139046852|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
139046853|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
139046854|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046855|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
139046856|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046857|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139046858|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046859|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046860|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
138614184|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139046861|NCT00160641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139046862|NCT00160641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139046863|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139046864|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
139046865|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046866|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139046867|NCT00493025|Paclitaxel|paclitaxel|mesh-list
139046868|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139046869|NCT00493025|Cisplatin|cisplatin|mesh-list
139046870|NCT00493025|Gefitinib|gefitinib|mesh-list
139046871|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139046872|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046873|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
139046874|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
139046875|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
139046876|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046877|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139046878|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046879|NCT01075113|Sorafenib|sorafenib|mesh-list
139046880|NCT01075113|Vorinostat|vorinostat|mesh-list
139046881|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046882|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139046883|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894692|NCT02325011|Analgesics|analgesics|mesh-ancestor
139046884|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046885|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139046887|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139046888|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046889|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046890|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
139046891|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046892|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046893|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139046894|NCT01073319|Protective Agents|protective agents|mesh-ancestor
139046895|NCT00160563|Levocetirizine|levocetirizine|mesh-list
138797523|NCT00960804|Tanezumab|tanezumab|mesh-list
139046896|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139046897|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139046898|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
138614206|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046899|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
139046900|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046901|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046902|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046903|NCT01050452|Ivermectin|ivermectin|mesh-list
139046904|NCT01050452|Albendazole|albendazole|mesh-list
139046905|NCT01050452|Mebendazole|mebendazole|mesh-list
139046906|NCT01050452|Piperazine|piperazine|mesh-list
139046907|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
139046908|NCT01050452|DMP 777|dmp 777|mesh-list
139046909|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139046910|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139046911|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
139046912|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
139046913|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139046914|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139046915|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
139046916|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
139046917|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
139046918|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046919|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046920|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
139046921|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046922|NCT00380588|Gemcitabine|gemcitabine|mesh-list
139046923|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046924|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139046925|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
139046926|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046927|NCT00379808|Montelukast|montelukast|mesh-list
139046928|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139046929|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
139046930|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139046931|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
139046932|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139046933|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894727|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
138691465|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139046934|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139046935|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139046936|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046937|NCT03990038|Ropivacaine|ropivacaine|mesh-list
139046938|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
139046939|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
139046940|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139046941|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046942|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
139046943|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046944|NCT00355784|Hormones|hormones|mesh-list
139046945|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139046946|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046947|NCT02534636|Interferons|interferons|mesh-list
139046948|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
139046949|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
139046950|NCT02534636|Deucravacitinib|deucravacitinib|mesh-list
139046951|NCT02534636|Famotidine|famotidine|mesh-list
139046952|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046953|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
139046954|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139046955|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
139046956|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046957|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139046958|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139046959|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139046960|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
139046961|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
139046962|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139046963|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046964|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
139046965|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139046966|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046967|NCT01053650|Acetaminophen|acetaminophen|mesh-list
139046968|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139046969|NCT01053650|Analgesics|analgesics|mesh-ancestor
138797594|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139046970|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
139046971|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139046972|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046973|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
139046974|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
139046975|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139046976|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046977|NCT01050608|Ethanol|ethanol|mesh-list
139046978|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139046979|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139046980|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139046981|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046982|NCT01053806|Lenalidomide|lenalidomide|mesh-list
139046983|NCT01053806|Azacitidine|azacitidine|mesh-list
139046984|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
139046985|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139046986|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139046987|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138614353|NCT03713294|Elotuzumab|elotuzumab|mesh-list
139046988|NCT01053806|Growth Substances|growth substances|mesh-ancestor
139046989|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
139046990|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046991|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139046992|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
139046993|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139046994|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139046995|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
139046996|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139046997|NCT01053884|Anidulafungin|anidulafungin|mesh-list
139046998|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
139046999|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139047000|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139047001|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
139047002|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047003|NCT01010789|Modafinil|modafinil|mesh-list
139047004|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139047005|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614374|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
139047006|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139047007|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139047008|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139047009|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047010|NCT01015235|Ketorolac|ketorolac|mesh-list
139047011|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139047012|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139047013|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139047014|NCT01015235|Analgesics|analgesics|mesh-ancestor
139047015|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
139047016|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047017|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047018|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139047019|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139047020|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139047021|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047022|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047023|NCT00508157|Olanzapine|olanzapine|mesh-list
139047024|NCT00508157|Risperidone|risperidone|mesh-list
139047025|NCT00508157|Aripiprazole|aripiprazole|mesh-list
139047026|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139047027|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
139047028|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139047029|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
139047030|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139047031|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047032|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047033|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139047034|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139047035|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139047036|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139047037|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
139047038|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
139047039|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
139047040|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047041|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139047042|NCT00508157|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138614432|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139047043|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139047044|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139047045|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
139047046|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
139047047|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139047048|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139047049|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139047050|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139047052|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139047053|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
139047054|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139047055|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047056|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139047057|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047058|NCT01015391|Azathioprine|azathioprine|mesh-list
139047059|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
139047060|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047061|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139047062|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047063|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047064|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
139047065|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047066|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139047067|NCT01010945|Paclitaxel|paclitaxel|mesh-list
139047068|NCT01010945|Gemcitabine|gemcitabine|mesh-list
139047069|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139047070|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139047071|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047072|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
139047073|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
139047074|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
139047075|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047076|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139047077|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
139047078|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139047079|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047081|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139047082|NCT00507689|Antibodies|antibodies|mesh-list
139047083|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
139047084|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047085|NCT00491387|Metoprolol|metoprolol|mesh-list
138614475|NCT03222492|Immunotoxins|immunotoxins|mesh-ancestor
139047086|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139047087|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139047088|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
139047089|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
139047090|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047091|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047092|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139047093|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139047094|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139047095|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
139047096|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139047097|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047098|NCT01011257|Clopidogrel|clopidogrel|mesh-list
139047099|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139047100|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139047101|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139047102|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139047103|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
139047104|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139047105|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047106|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047107|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
139047108|NCT01015547|Infliximab|infliximab|mesh-list
139047109|NCT01015547|Methotrexate|methotrexate|mesh-list
139047110|NCT01015547|Naltrexone|naltrexone|mesh-list
139047111|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139047112|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
139047113|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139047114|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047115|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139047116|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
139047117|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797741|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
139047118|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047119|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
139047120|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047121|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139047122|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047123|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
139047124|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139047125|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139047126|NCT01015547|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139047127|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138614509|NCT02994069|Cisplatin|cisplatin|mesh-list
139047128|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139047129|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139047130|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139047131|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139047133|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
139047134|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047135|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139047136|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139047137|NCT00491075|Gemcitabine|gemcitabine|mesh-list
139047138|NCT00491075|Pemetrexed|pemetrexed|mesh-list
139047139|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139047140|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
139047141|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047142|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047143|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047144|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139047145|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139047146|NCT00507455|Tamsulosin|tamsulosin|mesh-list
139047147|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
139047148|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139047149|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139047150|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139047151|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
139047152|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139047153|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047154|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047155|NCT00507455|Urological Agents|urological agents|mesh-ancestor
139047156|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139047157|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139047158|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
139047159|NCT04275713|Metformin|metformin|mesh-list
139047160|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139047161|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047162|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
139047163|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047164|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139047165|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047166|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047167|NCT00490919|Buprenorphine|buprenorphine|mesh-list
139047168|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139047169|NCT00490919|Narcotics|narcotics|mesh-ancestor
139047170|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139047171|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047172|NCT00490919|Analgesics|analgesics|mesh-ancestor
139047173|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
139047174|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047175|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139047176|NCT01015937|Losartan|losartan|mesh-list
139047177|NCT01015937|Enalapril|enalapril|mesh-list
139047178|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
139047179|NCT01015937|Giapreza|giapreza|mesh-list
139047180|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139047181|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
139047182|NCT01015937|Turmeric extract|turmeric extract|mesh-list
139047183|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139047184|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139047185|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139047186|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139047187|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047188|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
139047189|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047190|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
139047191|NCT01015937|Protective Agents|protective agents|mesh-ancestor
139047192|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047193|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139047194|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139047195|NCT01012193|Cilostazol|cilostazol|mesh-list
139047196|NCT01012193|Clopidogrel|clopidogrel|mesh-list
138614569|NCT02420717|Dexamethasone|dexamethasone|mesh-list
139047197|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139047198|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139047199|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139047200|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139047201|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
139047202|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139047203|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047204|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047205|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139047206|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
139047207|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047208|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139047209|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
139047210|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139047211|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139047212|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
139047213|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139047214|NCT01012193|Protective Agents|protective agents|mesh-ancestor
139047215|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139047216|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139047217|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047218|NCT00503399|Teriparatide|teriparatide|mesh-list
139047219|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
139047220|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139047221|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047222|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139047223|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139047224|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139047225|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047226|NCT00506519|Antithrombins|antithrombins|mesh-list
139047227|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
139047228|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139047229|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
139047230|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047231|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047232|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
139047233|NCT00503009|Fluticasone|fluticasone|mesh-list
139047235|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139047236|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139047237|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139047238|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
138691595|NCT02932020|Protective Agents|protective agents|mesh-ancestor
139047239|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047240|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047241|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139047242|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
139047243|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
139047244|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139047245|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139047246|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139047247|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139047248|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
139047249|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894921|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047250|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047251|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
139047252|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139047253|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047254|NCT00160251|Ribavirin|ribavirin|mesh-list
139047255|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139047256|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
139047257|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047258|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
139047259|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139047260|NCT01075425|Bortezomib|bortezomib|mesh-list
139047261|NCT01075425|Belinostat|belinostat|mesh-list
139047262|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047263|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139047264|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047265|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047266|NCT00378014|Everolimus|everolimus|mesh-list
139047267|NCT00378014|Basiliximab|basiliximab|mesh-list
139047268|NCT00378014|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139047269|NCT00378014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139047270|NCT00378014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047271|NCT00378014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047272|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047273|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
139047274|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047275|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047277|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
139047278|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138894946|NCT02622126|Atropine|atropine|mesh-list
139047279|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
139047280|NCT00485303|Hormones|hormones|mesh-ancestor
139047281|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047282|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047283|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139047284|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047285|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139047286|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047287|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047288|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
139047289|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139047290|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
139047291|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139047292|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047293|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139047294|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047295|NCT01016249|Epinephrine|epinephrine|mesh-list
139047296|NCT01016249|Racepinephrine|racepinephrine|mesh-list
139047297|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
139047298|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139047299|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139047300|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
139047301|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139047302|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047303|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047304|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139047305|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139047306|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
139047307|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047308|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139047309|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
139047310|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
139047311|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
139047312|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139047313|NCT00377858|Insulin|insulin|mesh-list
139047314|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139047315|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
139047316|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
139047317|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139047318|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047319|NCT00502775|Fluticasone|fluticasone|mesh-list
139047320|NCT00502775|Xhance|xhance|mesh-list
139047321|NCT00502775|Fexofenadine|fexofenadine|mesh-list
139047322|NCT00502775|Terfenadine|terfenadine|mesh-list
139047323|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139047324|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139047325|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
139047326|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047327|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047328|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139047329|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
139047330|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
139047331|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139047332|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139047333|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139047334|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
139047335|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
139047336|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139047337|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047338|NCT01013675|Vaccines|vaccines|mesh-list
139047339|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
138797968|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
139047340|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047341|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139047342|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139047343|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047344|NCT01054118|Incretins|incretins|mesh-ancestor
139047345|NCT01054118|Hormones|hormones|mesh-ancestor
139047346|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047347|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139047348|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
139047349|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047350|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047351|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139047352|NCT01050842|Bicalutamide|bicalutamide|mesh-list
139047353|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
139047354|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
139047355|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047356|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047357|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047358|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139047359|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139047360|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139047361|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139047362|NCT00485069|Levodopa|levodopa|mesh-list
139047363|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139047364|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139047365|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
139047366|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139047367|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047368|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047369|NCT03989336|Manganese|manganese|mesh-list
139047370|NCT03989336|Paclitaxel|paclitaxel|mesh-list
139047371|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139047372|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139047373|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139047374|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047375|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
139047376|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
139047377|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
139047378|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047379|NCT03989336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139047380|NCT03989336|Trace Elements|trace elements|mesh-ancestor
139047381|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
139047382|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047383|NCT00355082|Lamotrigine|lamotrigine|mesh-list
139047384|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
139047385|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139047386|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139047387|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047388|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139047389|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047390|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139047391|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139047392|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139047393|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139047394|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139047395|NCT00502307|Tivozanib|tivozanib|mesh-list
139047396|NCT00502307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139047397|NCT00502307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047398|NCT00502307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047399|NCT00484679|Triamcinolone|triamcinolone|mesh-list
139047400|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139047401|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139047402|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139047403|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139047404|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
139047405|NCT00484679|Hormones|hormones|mesh-ancestor
139047406|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047407|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047408|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047409|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
139047410|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047411|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047412|NCT00377312|Hormones|hormones|mesh-list
139047413|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
138798037|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139047414|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047416|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139047417|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
139047418|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
139047419|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139047420|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139047421|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047422|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139047423|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047424|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139047425|NCT00376688|Sirolimus|sirolimus|mesh-list
139047426|NCT00376688|Temsirolimus|temsirolimus|mesh-list
139047427|NCT00376688|MTOR Inhibitors|mtor inhibitors|mesh-list
139047428|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138614858|NCT00214110|Tamoxifen|tamoxifen|mesh-list
139047429|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139047430|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139047431|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895043|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
139047432|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
139047433|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047434|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
139047435|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047436|NCT00376688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139047437|NCT00376688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047438|NCT00376688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047440|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
139047441|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139047442|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139047443|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139047444|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047445|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047446|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139047447|NCT00376220|Protective Agents|protective agents|mesh-ancestor
139047448|NCT00375752|Letrozole|letrozole|mesh-list
139047449|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047450|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139047451|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139047452|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047453|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047454|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139047455|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
139047456|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047457|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047458|NCT00484289|Abatacept|abatacept|mesh-list
139047459|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139047460|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047461|NCT00484289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139047462|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047463|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047464|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
139047465|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047466|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139047467|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139047468|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047469|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139047470|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047471|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047472|NCT01013909|Terbinafine|terbinafine|mesh-list
139047473|NCT01013909|Bifonazole|bifonazole|mesh-list
139047474|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
138895060|NCT04138472|Lidocaine|lidocaine|mesh-list
139047475|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139047476|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047477|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047479|NCT01013987|Darunavir|darunavir|mesh-list
139047480|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
139047481|NCT01013987|Maraviroc|maraviroc|mesh-list
139047482|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139047483|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139047484|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
139047485|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691646|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
139047486|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047487|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139047488|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139047489|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
139047490|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139047491|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138614942|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
139047492|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139047493|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139047494|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139047495|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139047496|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139047497|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139047498|NCT01019291|Formaldehyde|formaldehyde|mesh-list
139047499|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
139047500|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139047501|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
139047502|NCT01019447|Triclosan|triclosan|mesh-list
139047503|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139047504|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139047505|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139047506|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139047507|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
139047508|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047509|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139047510|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
139047511|NCT00490529|Rituximab|rituximab|mesh-list
139047512|NCT00490529|Vaccines|vaccines|mesh-list
139047513|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
139047514|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047515|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047516|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139047517|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139047518|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
139047519|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047520|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047521|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139047522|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139047523|NCT00333840|Interferons|interferons|mesh-list
139047524|NCT00333840|Cytarabine|cytarabine|mesh-list
139047525|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
139047526|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
139047527|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
139047528|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047529|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
139047530|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139047531|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139047533|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047534|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047535|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
139047536|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047537|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139047538|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047539|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
139047540|NCT01019603|Tazarotene|tazarotene|mesh-list
139047541|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
139047542|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
139047543|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
139047544|NCT01019603|Vitamins|vitamins|mesh-ancestor
139047545|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
139047546|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047547|NCT00321906|Sirolimus|sirolimus|mesh-list
139047548|NCT00321906|Azathioprine|azathioprine|mesh-list
139047549|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139047550|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139047551|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139047552|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047553|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
139047554|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047555|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
139047556|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047557|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047558|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
139047559|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139047560|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138798188|NCT00811135|Bevacizumab|bevacizumab|mesh-list
139047561|NCT00339144|Dasatinib|dasatinib|mesh-list
139047562|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047563|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139047564|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047565|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047566|NCT00321828|Leucovorin|leucovorin|mesh-list
139047567|NCT00321828|Bevacizumab|bevacizumab|mesh-list
139047568|NCT00321828|Fluorouracil|fluorouracil|mesh-list
139047569|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
139047570|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
139047571|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139047572|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047573|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139047574|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139047575|NCT00321828|Growth Substances|growth substances|mesh-ancestor
139047576|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047577|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
139047578|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
139047579|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047580|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139047581|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047582|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
139047583|NCT00321828|Antidotes|antidotes|mesh-ancestor
139047584|NCT00321828|Protective Agents|protective agents|mesh-ancestor
139047585|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
139047586|NCT00321828|Vitamins|vitamins|mesh-ancestor
138691781|NCT04727775|Remdesivir|remdesivir|mesh-list
139047588|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139047589|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139047590|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047591|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047592|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
139047593|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047594|NCT01061658|Vaccines|vaccines|mesh-list
139047595|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
139047596|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047597|NCT01058382|Progesterone|progesterone|mesh-list
139047598|NCT01058382|Progestins|progestins|mesh-ancestor
139047599|NCT01058382|Hormones|hormones|mesh-ancestor
139047600|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047601|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047602|NCT01061814|Mipomersen|mipomersen|mesh-list
139047603|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139047604|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139047605|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
139047606|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047607|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139047608|NCT00331422|Paclitaxel|paclitaxel|mesh-list
139047609|NCT00331422|Carboplatin|carboplatin|mesh-list
139047610|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139047611|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047612|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
139047613|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
139047614|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
139047615|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047616|NCT00331344|Prednisone|prednisone|mesh-list
139047617|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
139047618|NCT00331344|Epothilone B|epothilone b|mesh-list
139047619|NCT00331344|Epothilones|epothilones|mesh-list
139047620|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139047621|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
139047622|NCT00331344|Hormones|hormones|mesh-ancestor
139047623|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047624|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047625|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139047626|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047627|NCT00331344|Analgesics|analgesics|mesh-ancestor
139047628|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
139047629|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047630|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139047631|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139047632|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047633|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047635|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
139047636|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
139047637|NCT00321672|Capsaicin|capsaicin|mesh-list
139047638|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
139047639|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
139047640|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
139047641|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047642|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047643|NCT00330174|Acamprosate|acamprosate|mesh-list
139047644|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139047645|NCT00320424|PENTA|penta|mesh-list
139047646|NCT00320424|Fondaparinux|fondaparinux|mesh-list
139047647|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139047648|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
139047649|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139047650|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
139047651|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047652|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047653|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
139047654|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139047655|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139047656|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
139047657|NCT00338286|Hematinics|hematinics|mesh-ancestor
139047658|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
139047659|NCT00329550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139047660|NCT00329550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139047661|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047662|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
139047663|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047664|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139047665|NCT00375674|Sunitinib|sunitinib|mesh-list
139047666|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615062|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
139047667|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139047668|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139047669|NCT00375674|Growth Substances|growth substances|mesh-ancestor
139047670|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047671|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
139047672|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139047673|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047674|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047675|NCT03991910|Ramipril|ramipril|mesh-list
139047676|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139047677|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
139047678|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047679|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047680|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139047681|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
139047682|NCT00320190|Dasatinib|dasatinib|mesh-list
139047683|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047684|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139047685|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047686|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047687|NCT02534402|Prednisone|prednisone|mesh-list
139047688|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139047689|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
139047690|NCT02534402|Hormones|hormones|mesh-ancestor
139047691|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047692|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047693|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139047694|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047695|NCT00319956|Azithromycin|azithromycin|mesh-list
138615111|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
139047696|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139047697|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139047698|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139047699|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139047700|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047701|NCT01062048|Incretins|incretins|mesh-ancestor
139047703|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047704|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139047705|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
139047706|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047707|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047708|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
139047709|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139047710|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139047711|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139047712|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047713|NCT03987698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139047714|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047715|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
139047717|NCT01054508|Niacinamide|niacinamide|mesh-list
139047718|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
139047719|NCT01054508|Vitamins|vitamins|mesh-ancestor
139047720|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
139047721|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047722|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139047723|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
139047724|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047725|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139047726|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
139047727|NCT00348686|Felodipine|felodipine|mesh-list
139047728|NCT00348686|Candesartan|candesartan|mesh-list
139047729|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
139047730|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139047731|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139047732|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139047733|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047734|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139047735|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139047736|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139047737|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139047738|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047739|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
139047740|NCT00360230|Vaccines|vaccines|mesh-list
139047741|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
139047742|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047743|NCT03989024|Clomiphene|clomiphene|mesh-list
139047744|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139047745|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139047746|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
139047747|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047748|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047749|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139047750|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
139047751|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139047752|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139047753|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139047754|NCT03989024|Hormones|hormones|mesh-ancestor
139047755|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
139047756|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139047757|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047758|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
139047759|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139047760|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047761|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139047762|NCT03742232|Laxatives|laxatives|mesh-ancestor
139047763|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139047764|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
139047765|NCT00352664|Donepezil|donepezil|mesh-list
139047766|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139047767|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047768|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047769|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
139047770|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139047771|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047772|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
139047773|NCT03991442|Amlodipine|amlodipine|mesh-list
139047774|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139047775|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139047776|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139047777|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047778|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139047779|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047780|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
139047781|NCT03742310|Vitamin D|vitamin d|mesh-list
139047782|NCT03742310|Calcitriol|calcitriol|mesh-list
139047783|NCT03742310|Vitamins|vitamins|mesh-ancestor
139047784|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
139047785|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047786|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139047787|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139047788|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139047789|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139047790|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047791|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139047792|NCT00490139|Trastuzumab|trastuzumab|mesh-list
139047793|NCT00490139|Lapatinib|lapatinib|mesh-list
139047794|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139047795|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047796|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139047797|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047798|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047799|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
139047800|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139047801|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047802|NCT01051388|Rabeprazole|rabeprazole|mesh-list
139047803|NCT01051388|Gefarnate|gefarnate|mesh-list
139047804|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139047805|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139047806|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139047807|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047808|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047809|NCT00490061|Lapatinib|lapatinib|mesh-list
138615223|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139047810|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047811|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139047812|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047813|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047814|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
139047815|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
139047816|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139047817|NCT00483119|Antibodies|antibodies|mesh-list
139047818|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
139047819|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139047820|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047821|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
139047822|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047823|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139047824|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139047825|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
139047826|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047827|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895239|NCT02621970|Cisplatin|cisplatin|mesh-list
139047828|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139047829|NCT01016639|Capecitabine|capecitabine|mesh-list
139047830|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
139047831|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139047832|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
138615260|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615261|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
138615263|NCT00474487|Vaccines|vaccines|mesh-list
139047833|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047834|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047835|NCT00501293|Methylphenidate|methylphenidate|mesh-list
139047836|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139047837|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047838|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139047839|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139047840|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139047841|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047842|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
139047843|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139047844|NCT01014221|Prednisolone|prednisolone|mesh-list
139047845|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139047846|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
139047847|NCT01014221|Hormones|hormones|mesh-ancestor
139047848|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047849|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047850|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139047851|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047852|NCT00482729|Metformin|metformin|mesh-list
139047853|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139047854|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139047855|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047856|NCT00482729|Incretins|incretins|mesh-ancestor
139047857|NCT00482729|Hormones|hormones|mesh-ancestor
139047858|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047859|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139047860|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
138798486|NCT00677248|Ezetimibe|ezetimibe|mesh-list
139047861|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047862|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047864|NCT00359762|Glimepiride|glimepiride|mesh-list
139047865|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139047866|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047867|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139047868|NCT00359762|Incretins|incretins|mesh-ancestor
139047869|NCT00359762|Hormones|hormones|mesh-ancestor
139047870|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138615367|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047871|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139047872|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047873|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
139047874|NCT03988010|Amantadine|amantadine|mesh-list
139047875|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139047876|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139047877|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
139047878|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895269|NCT00621101|Temsirolimus|temsirolimus|mesh-list
139047879|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
139047880|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139047881|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047882|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047883|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139047884|NCT03988010|Analgesics|analgesics|mesh-ancestor
139047885|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
139047886|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047887|NCT01055522|Interleukin-2|interleukin-2|mesh-list
139047888|NCT01055522|Dacarbazine|dacarbazine|mesh-list
139047889|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047890|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138615418|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139047891|NCT01055522|Analgesics|analgesics|mesh-ancestor
139047892|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
139047893|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047894|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047895|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139047896|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
139047897|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047898|NCT03987152|Sirolimus|sirolimus|mesh-list
139047899|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139047900|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139047901|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139047902|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047903|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
139047904|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047905|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
139047906|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047907|NCT00347438|Capecitabine|capecitabine|mesh-list
139047908|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139047909|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
139047910|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047911|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047912|NCT00329238|Warfarin|warfarin|mesh-list
139047913|NCT00329238|Dabigatran|dabigatran|mesh-list
139047914|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
139047915|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
139047916|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139047917|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
139047918|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047919|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047920|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139047921|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139047922|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139047923|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
139047924|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047925|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139047926|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139047927|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047928|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139047929|NCT00328926|Hormones|hormones|mesh-list
139047930|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139047931|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139047932|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047933|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139047934|NCT00347360|Carvedilol|carvedilol|mesh-list
139047935|NCT00347360|Lisinopril|lisinopril|mesh-list
139047937|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139047938|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
139047939|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139047940|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047941|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047942|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139047943|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
139047944|NCT00347360|Protective Agents|protective agents|mesh-ancestor
139047945|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138615524|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
138615525|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138615526|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
138615527|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615528|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139047946|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139047947|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139047948|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
139047949|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139047950|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139047951|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139047952|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
139047953|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139047954|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139047955|NCT00319020|Bosentan|bosentan|mesh-list
139047956|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139047957|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139047958|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047959|NCT01056224|Remifentanil|remifentanil|mesh-list
139047960|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139047961|NCT01056224|Narcotics|narcotics|mesh-ancestor
139047962|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139047963|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047964|NCT01056224|Analgesics|analgesics|mesh-ancestor
139047965|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
139047966|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139047967|NCT03982680|Gemcitabine|gemcitabine|mesh-list
139047968|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139047969|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
139047970|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047971|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047972|NCT00352118|Docetaxel|docetaxel|mesh-list
139047973|NCT00352118|Fluorouracil|fluorouracil|mesh-list
139047974|NCT00352118|Lenograstim|lenograstim|mesh-list
139047975|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047976|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
139047977|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
139047978|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
139047979|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047980|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
139047981|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139047982|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139047984|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139047985|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139047986|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
139047987|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139047988|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139047989|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139047990|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139047991|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139047992|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
139047993|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139047994|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139047995|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139047996|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
139047998|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139047999|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138615623|NCT00193115|Docetaxel|docetaxel|mesh-list
139048000|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048001|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048002|NCT00350792|Carboplatin|carboplatin|mesh-list
139048003|NCT00350792|Pemetrexed|pemetrexed|mesh-list
139048004|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048005|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048006|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048007|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138798645|NCT00876928|Vitamin D|vitamin d|mesh-list
139048008|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139048009|NCT00317772|Topotecan|topotecan|mesh-list
139048010|NCT00317772|Gefitinib|gefitinib|mesh-list
139048011|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139048012|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139048013|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048014|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048015|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048016|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139048017|NCT01325298|Riboflavin|riboflavin|mesh-list
139048018|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
139048019|NCT01325298|Vitamins|vitamins|mesh-ancestor
139048020|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
139048021|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048022|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139048023|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
139048024|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
139048025|NCT00350636|Oxybutynin|oxybutynin|mesh-list
139048026|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
139048027|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
139048028|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048029|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048030|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139048031|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139048032|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
139048033|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048034|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048035|NCT00350636|Urological Agents|urological agents|mesh-ancestor
139048036|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139048037|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139048038|NCT01051544|Factor VIII|factor viii|mesh-list
139048039|NCT01051544|Coagulants|coagulants|mesh-ancestor
139048040|NCT01058720|Vitamin D|vitamin d|mesh-list
139048041|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
139048042|NCT01058720|Vitamins|vitamins|mesh-ancestor
139048043|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
139048044|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048045|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138615717|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
139048046|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139048047|NCT00346268|Parecoxib|parecoxib|mesh-list
139048048|NCT00346268|Morphine|morphine|mesh-list
139048049|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139048050|NCT00346268|Narcotics|narcotics|mesh-ancestor
139048051|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048052|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048053|NCT00346268|Analgesics|analgesics|mesh-ancestor
139048054|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
139048055|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048056|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139048057|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139048058|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048059|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048060|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139048061|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139048062|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048063|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139048064|NCT00327444|Aflibercept|aflibercept|mesh-list
139048065|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139048066|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139048067|NCT00327444|Growth Substances|growth substances|mesh-ancestor
139048068|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615765|NCT00193544|Thalidomide|thalidomide|mesh-list
138615766|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
139048069|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
139048070|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048071|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
139048072|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139048073|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048074|NCT03982134|Panobinostat|panobinostat|mesh-list
139048075|NCT03982134|Spartalizumab|spartalizumab|mesh-list
139048076|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048077|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139048078|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048079|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048080|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139048081|NCT03982134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139048082|NCT00337610|Metformin|metformin|mesh-list
139048083|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139048084|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139048085|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048086|NCT00337610|Incretins|incretins|mesh-ancestor
139048087|NCT00337610|Hormones|hormones|mesh-ancestor
139048088|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139048089|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139048090|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
138615818|NCT00216021|Capecitabine|capecitabine|mesh-list
139048091|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048092|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048093|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139048094|NCT01062204|Laxatives|laxatives|mesh-ancestor
139048095|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139048096|NCT01062282|Iloprost|iloprost|mesh-list
139048097|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139048098|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
139048099|NCT03985280|Anesthetics|anesthetics|mesh-list
139048100|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
139048101|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048102|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048103|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
139048104|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048105|NCT01058876|Nicotine|nicotine|mesh-list
139048106|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139048107|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
139048108|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048109|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048110|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138615882|NCT00216294|Hormones|hormones|mesh-ancestor
139048111|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139048112|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
139048113|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048114|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048115|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
139048116|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
139048117|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139048118|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139048119|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691848|NCT02918591|Empagliflozin|empagliflozin|mesh-list
139048120|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048121|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139048122|NCT01051934|Paclitaxel|paclitaxel|mesh-list
139048123|NCT01051934|Bevacizumab|bevacizumab|mesh-list
139048124|NCT01051934|Carboplatin|carboplatin|mesh-list
139048125|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139048126|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048127|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
139048128|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
139048129|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
139048130|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048131|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139048132|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139048133|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139048134|NCT01051934|Growth Substances|growth substances|mesh-ancestor
139048135|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048136|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
139048137|NCT01325168|Oxytocin|oxytocin|mesh-list
139048138|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
139048139|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139048140|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048141|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
139048142|NCT00316914|Calcium|calcium|mesh-list
139048143|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139048144|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048145|NCT00316914|Analgesics|analgesics|mesh-ancestor
139048146|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
139048147|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048148|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
139048149|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048150|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139048151|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
139048152|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139048153|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139048154|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048155|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
139048156|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139048157|NCT00316602|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139048159|NCT00316602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139048160|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
139048161|NCT00335972|Remifentanil|remifentanil|mesh-list
139048162|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139048163|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048164|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048165|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139048166|NCT00335972|Analgesics|analgesics|mesh-ancestor
139048167|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
139048168|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048169|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139048170|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139048171|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139048172|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
139048173|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048174|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048175|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139048176|NCT00335972|Narcotics|narcotics|mesh-ancestor
139048177|NCT03983460|Betamethasone|betamethasone|mesh-list
139048178|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
139048179|NCT03983460|Clobetasol|clobetasol|mesh-list
139048180|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048181|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
139048182|NCT03983460|Hormones|hormones|mesh-ancestor
138615973|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139048183|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139048184|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048185|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139048186|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
139048188|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
139048189|NCT01056614|Fludarabine|fludarabine|mesh-list
139048190|NCT01056614|Busulfan|busulfan|mesh-list
139048191|NCT01056614|Tacrolimus|tacrolimus|mesh-list
139048192|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
139048193|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139048194|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
139048195|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139048196|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
139048197|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139048198|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048199|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139048200|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
139048201|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048202|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048203|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
139048204|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048205|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139048206|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139048207|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
139048208|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139048209|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139048210|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139048211|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
139048212|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139048213|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139048214|NCT00346034|Pregabalin|pregabalin|mesh-list
139048215|NCT00346034|Analgesics|analgesics|mesh-ancestor
139048216|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
139048217|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048218|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048219|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
139048220|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139048221|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139048222|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048223|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139048225|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139048226|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048227|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139048228|NCT00345878|Vaccines|vaccines|mesh-list
139048229|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
139048230|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048231|NCT01059110|Salicylates|salicylates|mesh-list
139048232|NCT01059110|Imiquimod|imiquimod|mesh-list
139048233|NCT01059110|Fluorouracil|fluorouracil|mesh-list
139048234|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139048235|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
139048236|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048237|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048238|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
139048239|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
139048240|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048241|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139048242|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139048243|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139048244|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139048245|NCT01059110|Analgesics|analgesics|mesh-ancestor
139048246|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
139048247|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048248|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048249|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139048250|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139048251|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048252|NCT03991364|Methamphetamine|methamphetamine|mesh-list
139048253|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139048254|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048255|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
139048256|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
139048257|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048258|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
139048259|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048260|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048261|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
139048262|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139048263|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139048264|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139048265|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139048266|NCT00335738|Carboplatin|carboplatin|mesh-list
139048268|NCT00335738|Vincristine|vincristine|mesh-list
139048269|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
139048270|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048271|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139048272|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139048273|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139048274|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048275|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048276|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
139048277|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
139048278|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
139048279|NCT02533076|Capsaicin|capsaicin|mesh-list
139048280|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
139048281|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
139048282|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
139048283|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048284|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048285|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139048286|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139048287|NCT01056926|Nicotine|nicotine|mesh-list
139048288|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139048289|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
139048290|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048291|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048292|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139048293|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139048294|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
139048295|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048296|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048297|NCT01059422|Lamivudine|lamivudine|mesh-list
139048298|NCT01059422|Abacavir|abacavir|mesh-list
139048299|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
139048300|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139048301|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139048302|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048303|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048304|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
139048305|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139048306|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139048307|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139048308|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139048309|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139048310|NCT01052246|Clindamycin|clindamycin|mesh-list
139048311|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
139048312|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
139048313|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139048314|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139048315|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139048316|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139048317|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048318|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048319|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
139048320|NCT00334958|Rufinamide|rufinamide|mesh-list
139048321|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
139048322|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139048323|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139048324|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139048325|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048326|NCT00326898|Sorafenib|sorafenib|mesh-list
139048327|NCT00326898|Sunitinib|sunitinib|mesh-list
139048328|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048329|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139048330|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048331|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048332|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138616255|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048333|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139048334|NCT00326898|Growth Substances|growth substances|mesh-ancestor
139048335|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048336|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
139048337|NCT01062360|Aspirin|aspirin|mesh-list
139048338|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
139048339|NCT01062360|Ephedrine|ephedrine|mesh-list
139048340|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139048341|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139048342|NCT01062360|Analgesics|analgesics|mesh-ancestor
139048343|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
139048344|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048345|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048346|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048347|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139048348|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139048349|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139048350|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048351|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139048352|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139048353|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048354|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
139048355|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139048356|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
139048357|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139048358|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
139048359|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
139048360|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139048361|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139048362|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
139048363|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
139048364|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048365|NCT01063842|Acetaminophen|acetaminophen|mesh-list
139048366|NCT01063842|Tramadol|tramadol|mesh-list
139048367|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139048368|NCT01063842|Analgesics|analgesics|mesh-ancestor
139048369|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
139048370|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048371|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048372|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
138616349|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048373|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139048374|NCT01063842|Narcotics|narcotics|mesh-ancestor
139048375|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048376|NCT01063920|Naproxen|naproxen|mesh-list
139048377|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139048378|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139048379|NCT01063920|Analgesics|analgesics|mesh-ancestor
139048380|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
139048381|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048382|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048383|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048384|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138895452|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
139048386|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139048387|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048388|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048389|NCT01062516|Esomeprazole|esomeprazole|mesh-list
139048390|NCT01062516|Famotidine|famotidine|mesh-list
139048391|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139048392|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139048393|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139048394|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048395|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048396|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139048397|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
139048398|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
139048399|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048400|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048401|NCT00334802|Paclitaxel|paclitaxel|mesh-list
139048402|NCT00334802|Gemcitabine|gemcitabine|mesh-list
139048403|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139048404|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048405|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
139048406|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
139048407|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
139048408|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048409|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139048410|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
139048411|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
139048412|NCT03985358|Narcotics|narcotics|mesh-ancestor
139048413|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048414|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048415|NCT03985358|Analgesics|analgesics|mesh-ancestor
139048416|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
139048417|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048418|NCT01052324|Remifentanil|remifentanil|mesh-list
139048419|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139048420|NCT01052324|Narcotics|narcotics|mesh-ancestor
139048421|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048422|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048423|NCT01052324|Analgesics|analgesics|mesh-ancestor
139048424|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
139048425|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048426|NCT01059890|Metronidazole|metronidazole|mesh-list
139048427|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
139048428|NCT01059890|Cefotaxime|cefotaxime|mesh-list
139048429|NCT01059890|Cefoxitin|cefoxitin|mesh-list
139048430|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139048431|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139048432|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139048433|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139048434|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139048435|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139048436|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048437|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048438|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048439|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139048440|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139048441|NCT01057160|Rizatriptan|rizatriptan|mesh-list
139048442|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139048443|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
139048444|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048445|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048446|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048447|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
139048448|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139048449|NCT00307086|Bortezomib|bortezomib|mesh-list
139048450|NCT00307086|Melphalan|melphalan|mesh-list
139048451|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048452|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139048453|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
139048454|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048455|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139048456|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139048457|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
138616577|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139048458|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799085|NCT05660473|Cytarabine|cytarabine|mesh-list
139048459|NCT02533544|Tenofovir|tenofovir|mesh-list
139048460|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
139048461|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139048462|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139048463|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139048464|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048465|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048466|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139048467|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139048468|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
139048469|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
139048470|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139048471|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139048472|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139048473|NCT00325416|Melphalan|melphalan|mesh-list
139048474|NCT00325416|Topotecan|topotecan|mesh-list
139048475|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139048476|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
139048477|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048478|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048479|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139048480|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139048481|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
139048482|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048483|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139048484|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139048485|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048486|NCT00314808|Dronabinol|dronabinol|mesh-list
139048487|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
139048488|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048489|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139048490|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139048491|NCT00314808|Analgesics|analgesics|mesh-ancestor
139048492|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
139048493|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048494|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139048495|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139048496|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048497|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048499|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139048500|NCT01060514|Vinorelbine|vinorelbine|mesh-list
139048501|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139048502|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048503|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
139048504|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
139048505|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
139048506|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048507|NCT01061216|Insulin|insulin|mesh-list
139048508|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139048509|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139048510|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048511|NCT00314574|Omalizumab|omalizumab|mesh-list
139048512|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139048513|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139048514|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
139048516|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139048517|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139048518|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
139048519|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048520|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048521|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048522|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139048523|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
139048524|NCT01064154|Protective Agents|protective agents|mesh-ancestor
139048525|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139048526|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139048527|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139048528|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
139048529|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139048530|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139048531|NCT00314340|Acetaminophen|acetaminophen|mesh-list
139048532|NCT00314340|Morphine|morphine|mesh-list
139048533|NCT00314340|Hydrocodone|hydrocodone|mesh-list
139048535|NCT00314340|Amphetamine|amphetamine|mesh-list
139048536|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139048537|NCT00314340|Narcotics|narcotics|mesh-ancestor
139048538|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048539|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048540|NCT00314340|Analgesics|analgesics|mesh-ancestor
139048541|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
139048542|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048543|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139048544|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
139048545|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
139048546|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
139048547|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139048548|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
139048549|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
139048550|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
139048551|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048552|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048553|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
139048554|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139048555|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139048556|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139048557|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139048558|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
139048559|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139048560|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139048561|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139048562|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
139048563|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
139048564|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139048565|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139048566|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139048567|NCT00306852|Mitomycins|mitomycins|mesh-list
139048568|NCT00306852|Mitomycin|mitomycin|mesh-list
139048569|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139048570|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048571|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
139048572|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048573|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139048574|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048575|NCT00314262|Celecoxib|celecoxib|mesh-list
139048576|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139048577|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048578|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139048579|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048580|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616824|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
139048581|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139048582|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139048584|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
139048585|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048586|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048587|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048588|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139048589|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139048590|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139048591|NCT00333866|Pregabalin|pregabalin|mesh-list
139048592|NCT00333866|Analgesics|analgesics|mesh-ancestor
139048593|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
139048594|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048595|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048596|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
139048597|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139048598|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139048599|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048600|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139048602|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139048603|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048604|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139048605|NCT00324740|Vorinostat|vorinostat|mesh-list
139048606|NCT00324740|Isotretinoin|isotretinoin|mesh-list
139048607|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048608|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139048609|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048610|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048611|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
139048612|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
139048613|NCT00333788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139048614|NCT00333788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048615|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139048616|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
139048617|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048618|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139048619|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
139048620|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139048621|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139048622|NCT00332696|Prednisolone|prednisolone|mesh-list
139048623|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
139048624|NCT00332696|Octreotide|octreotide|mesh-list
139048625|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139048626|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
139048627|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048628|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
139048629|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
139048630|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048631|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048632|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139048633|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
139048634|NCT00332696|Hormones|hormones|mesh-ancestor
139048635|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139048636|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139048637|NCT00332696|Protective Agents|protective agents|mesh-ancestor
139048638|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139048639|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048640|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
139048641|NCT00313716|Hematinics|hematinics|mesh-ancestor
139048642|NCT00313170|Fulvestrant|fulvestrant|mesh-list
139048643|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139048644|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048645|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139048647|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
138770207|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139048648|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139048649|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048650|NCT00332462|Cyclosporine|cyclosporine|mesh-list
139048651|NCT00332462|Cyclosporins|cyclosporins|mesh-list
139048652|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048653|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048654|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139048655|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
139048656|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048657|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
139048658|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139048659|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
139048660|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139048661|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139048662|NCT00324038|Acetaminophen|acetaminophen|mesh-list
139048663|NCT00324038|Buprenorphine|buprenorphine|mesh-list
139048664|NCT00324038|Codeine|codeine|mesh-list
139048665|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139048666|NCT00324038|Analgesics|analgesics|mesh-ancestor
139048667|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
139048668|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048669|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048670|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
139048671|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139048672|NCT00324038|Narcotics|narcotics|mesh-ancestor
139048673|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048674|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139048675|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
139048676|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
139048677|NCT03984110|Dexamethasone|dexamethasone|mesh-list
139048678|NCT03984110|Aflibercept|aflibercept|mesh-list
139048679|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048680|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
139048681|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
139048682|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048683|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617122|NCT00203060|Rasagiline|rasagiline|mesh-list
139048684|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139048685|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
139048686|NCT03984110|Hormones|hormones|mesh-ancestor
139048687|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139048688|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139048689|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048690|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139048691|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139048693|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
139048694|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
139048695|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048696|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
139048697|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139048698|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139048699|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048700|NCT00159861|Urological Agents|urological agents|mesh-ancestor
139048701|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
139048702|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139048703|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048704|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139048705|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048706|NCT00331760|Cisplatin|cisplatin|mesh-list
139048707|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048708|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139048709|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139048710|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139048711|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
139048712|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048713|NCT00313014|Oxycodone|oxycodone|mesh-list
139048714|NCT00313014|Buprenorphine|buprenorphine|mesh-list
139048715|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139048716|NCT00313014|Narcotics|narcotics|mesh-ancestor
139048717|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048718|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048719|NCT00313014|Analgesics|analgesics|mesh-ancestor
139048720|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
139048721|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048722|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139048723|NCT01075659|Nicotine|nicotine|mesh-list
139048724|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139048725|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
139048726|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048727|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048728|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139048729|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139048730|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
139048731|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048732|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048733|NCT01077453|Letrozole|letrozole|mesh-list
139048734|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048735|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139048736|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139048737|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048738|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048739|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139048740|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
139048741|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139048742|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048743|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
139048744|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139048745|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
139048746|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048747|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139048748|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139048749|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
139048750|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048751|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048752|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139048753|NCT00312858|Vaccines|vaccines|mesh-list
139048754|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139048755|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
139048756|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048757|NCT00156819|Fluticasone|fluticasone|mesh-list
139048759|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139048760|NCT00156819|Montelukast|montelukast|mesh-list
139048761|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048762|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139048763|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
139048764|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048765|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048766|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139048767|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
139048768|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
139048769|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139048770|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139048771|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139048772|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139048773|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
139048774|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048775|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048776|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139048777|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
139048778|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139048779|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139048780|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139048782|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139048783|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139048784|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139048785|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
139048786|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048787|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048788|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048789|NCT00224133|Urological Agents|urological agents|mesh-ancestor
139048790|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
139048791|NCT00224055|Hematinics|hematinics|mesh-ancestor
139048792|NCT00150345|Voriconazole|voriconazole|mesh-list
139048793|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
139048794|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139048795|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139048796|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139048797|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048798|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048799|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139048800|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
139048801|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139048802|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048803|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139048804|NCT01077609|Fluticasone|fluticasone|mesh-list
139048805|NCT01077609|Xhance|xhance|mesh-list
139048806|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048807|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139048808|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
139048809|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048810|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048811|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139048812|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
139048813|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
139048814|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139048815|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
139048816|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
139048817|NCT00223977|Hematinics|hematinics|mesh-ancestor
139048818|NCT00148941|Vaccines|vaccines|mesh-list
139048819|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
139048820|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048821|NCT01073553|Cephalexin|cephalexin|mesh-list
139048822|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139048823|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139048824|NCT00148317|Dexamethasone|dexamethasone|mesh-list
139048825|NCT00148317|Doxorubicin|doxorubicin|mesh-list
139048826|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139048827|NCT00148317|Bortezomib|bortezomib|mesh-list
139048828|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048829|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
139048830|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
139048831|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799455|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048832|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048833|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139048834|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
139048835|NCT00148317|Hormones|hormones|mesh-ancestor
139048836|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139048837|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139048838|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048839|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139048840|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139048841|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139048842|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048843|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048844|NCT00323882|Ipilimumab|ipilimumab|mesh-list
139048845|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139048846|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048847|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139048848|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048849|NCT00331682|Docetaxel|docetaxel|mesh-list
139048850|NCT00331682|Alvocidib|alvocidib|mesh-list
139048851|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048852|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
139048853|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
139048854|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
139048855|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048856|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
139048857|NCT00331682|Growth Substances|growth substances|mesh-ancestor
139048858|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048859|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139048860|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048861|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139048862|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139048863|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139048864|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048865|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048866|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
139048867|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139048868|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139048869|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139048870|NCT00331136|Artesunate|artesunate|mesh-list
139048871|NCT00331136|Pyronaridine|pyronaridine|mesh-list
139048872|NCT00331136|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139048873|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
139048874|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139048875|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139048876|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139048877|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048878|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
139048879|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
139048880|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139048881|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
139048882|NCT00330668|Mecasermin|mecasermin|mesh-list
139048883|NCT00330668|Growth Substances|growth substances|mesh-ancestor
139048884|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048885|NCT00306384|Alogliptin|alogliptin|mesh-list
139048886|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139048887|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048888|NCT00306384|Incretins|incretins|mesh-ancestor
139048889|NCT00306384|Hormones|hormones|mesh-ancestor
139048890|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139048891|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139048892|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
139048893|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048894|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048895|NCT01062906|Lidocaine|lidocaine|mesh-list
139048896|NCT01062906|Fentanyl|fentanyl|mesh-list
139048897|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
139048898|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
139048899|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048900|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048901|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
139048902|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048903|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139048904|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139048905|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138799533|NCT00680212|Vitamins|vitamins|mesh-ancestor
139048906|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139048907|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048908|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139048909|NCT01062906|Narcotics|narcotics|mesh-ancestor
139048910|NCT01062906|Analgesics|analgesics|mesh-ancestor
139048911|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139048912|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139048913|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
139048914|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139048915|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139048916|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048917|NCT00305604|Incretins|incretins|mesh-ancestor
139048918|NCT00305604|Hormones|hormones|mesh-ancestor
139048919|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139048920|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139048921|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
139048922|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048923|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048924|NCT01064232|Risperidone|risperidone|mesh-list
139048925|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139048926|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
139048927|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048928|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048929|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048930|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139048931|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139048932|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139048933|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139048934|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139048935|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
139048936|NCT00501059|Aspirin|aspirin|mesh-list
139048937|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139048938|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139048939|NCT00501059|Analgesics|analgesics|mesh-ancestor
139048940|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
139048941|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139048942|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048943|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048944|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139048945|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139048946|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139048947|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048948|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139048949|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139048950|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048951|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
139048952|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139048953|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
139048954|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048955|NCT00322868|Pioglitazone|pioglitazone|mesh-list
139048956|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138895692|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
139048958|NCT01016717|Omeprazole|omeprazole|mesh-list
139048959|NCT01016717|Pantoprazole|pantoprazole|mesh-list
139048960|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139048961|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139048962|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139048963|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048964|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048965|NCT01016795|Lenograstim|lenograstim|mesh-list
139048966|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139048967|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
139048968|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048969|NCT00343382|Pilocarpine|pilocarpine|mesh-list
139048970|NCT00343382|Miotics|miotics|mesh-ancestor
139048971|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
139048972|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691961|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139048973|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048974|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139048975|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139048976|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
139048977|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139048978|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048980|NCT00481871|Folic Acid|folic acid|mesh-list
139048982|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
139048983|NCT00481871|Gemcitabine|gemcitabine|mesh-list
139048984|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
139048985|NCT00481871|Aminopterin|aminopterin|mesh-list
139048986|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
139048987|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139048988|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139048989|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
139048990|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139048991|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139048992|NCT00481871|Hematinics|hematinics|mesh-ancestor
139048993|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139048994|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139048995|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
139048996|NCT00329420|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139048997|NCT00329420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139048998|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139048999|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
139049000|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049001|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139049002|NCT00329108|Olanzapine|olanzapine|mesh-list
139049003|NCT00329108|Ziprasidone|ziprasidone|mesh-list
139049004|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
139049005|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
139049006|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049007|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049008|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139049009|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139049010|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139049011|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139049012|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139049013|NCT00329108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139049014|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139049015|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139049016|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049017|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049018|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
139049019|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139049020|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139049021|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
139049022|NCT00329030|Rituximab|rituximab|mesh-list
139049023|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
139049024|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139049025|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049026|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
139049027|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049028|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139049029|NCT00328562|Gefitinib|gefitinib|mesh-list
139049030|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049031|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139049032|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049033|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049034|NCT00328172|Metformin|metformin|mesh-list
139049035|NCT00328172|Linagliptin|linagliptin|mesh-list
139049036|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139049037|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049038|NCT00328172|Incretins|incretins|mesh-ancestor
139049039|NCT00328172|Hormones|hormones|mesh-ancestor
139049040|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049041|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139049042|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
139049043|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049044|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049045|NCT01061372|Pregabalin|pregabalin|mesh-list
139049046|NCT01061372|Analgesics|analgesics|mesh-ancestor
139049047|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
139049048|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049049|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049050|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
139049051|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139049052|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139049053|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799678|NCT01110200|Hormones|hormones|mesh-ancestor
139049054|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139049055|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139049056|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139049057|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139049058|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139049059|NCT00328094|Insulin|insulin|mesh-list
139049060|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139049061|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139049062|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049063|NCT00295932|Prednisone|prednisone|mesh-list
139049064|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
139049065|NCT00295932|Rituximab|rituximab|mesh-list
139049066|NCT00295932|Bortezomib|bortezomib|mesh-list
139049067|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139049068|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
139049070|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139049071|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139049072|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
139049073|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049074|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049075|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139049076|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139049077|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139049078|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
139049079|NCT00295932|Hormones|hormones|mesh-ancestor
138617915|NCT00230763|Latanoprost|latanoprost|mesh-list
138617926|NCT00204386|Topiramate|topiramate|mesh-list
139049080|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049081|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139049082|NCT01063140|Vaccines|vaccines|mesh-list
139049083|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
139049084|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049085|NCT00305448|Fulvestrant|fulvestrant|mesh-list
139049086|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138691981|NCT00532415|Hormones|hormones|mesh-ancestor
139049087|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049088|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139049089|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139049090|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
139049091|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049092|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049093|NCT01063218|Emollients|emollients|mesh-list
139049094|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
139049095|NCT00305058|Morphine|morphine|mesh-list
139049096|NCT00305058|Hydromorphone|hydromorphone|mesh-list
139049097|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139049098|NCT00305058|Narcotics|narcotics|mesh-ancestor
139049099|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139049100|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049101|NCT00305058|Analgesics|analgesics|mesh-ancestor
139049102|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
139049103|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049104|NCT01061450|Simvastatin|simvastatin|mesh-list
139049105|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139049106|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139049107|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
139049108|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049109|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139049110|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139049111|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049112|NCT03986294|Leucovorin|leucovorin|mesh-list
139049113|NCT03986294|Antidotes|antidotes|mesh-ancestor
139049114|NCT03986294|Protective Agents|protective agents|mesh-ancestor
139049115|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049116|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
139049117|NCT03986294|Vitamins|vitamins|mesh-ancestor
139049118|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
139049119|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
139049120|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139049121|NCT00322556|Antibodies|antibodies|mesh-list
139049122|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
139049123|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049124|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
139049125|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
139049126|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
139049127|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
139049128|NCT00321932|Calcium|calcium|mesh-list
139049129|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139049130|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049131|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138618021|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
139049132|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049133|NCT00321932|Vitamins|vitamins|mesh-ancestor
139049134|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
139049135|NCT00321932|Antacids|antacids|mesh-ancestor
139049136|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139049137|NCT00326612|Midazolam|midazolam|mesh-list
139049138|NCT00326612|Diazepam|diazepam|mesh-list
139049139|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139049140|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139049141|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139049142|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049143|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139049144|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139049145|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139049146|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139049147|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
139049148|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
139049149|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
139049150|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
139049151|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770208|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139049152|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049153|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
139049154|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
139049155|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
139049156|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049157|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139049158|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139049159|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139049160|NCT01060826|Somatostatin|somatostatin|mesh-list
139049161|NCT01060826|Hormones|hormones|mesh-ancestor
139049162|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049163|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049164|NCT00321854|Pramipexole|pramipexole|mesh-list
139049165|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
138895772|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139049166|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049167|NCT00321854|Protective Agents|protective agents|mesh-ancestor
139049168|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049169|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139049170|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139049171|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
139049172|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
139049173|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049174|NCT03982862|Triamcinolone|triamcinolone|mesh-list
139049176|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
139049177|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139049178|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139049179|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
139049180|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
139049181|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139049182|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049183|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
139049184|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895824|NCT00681902|Lidocaine|lidocaine|mesh-list
139049186|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139049187|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139049188|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139049189|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049190|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139049191|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
139049192|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049193|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139049194|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
139049195|NCT03982862|Hormones|hormones|mesh-ancestor
138618170|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049196|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049197|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139049198|NCT01060904|Doxorubicin|doxorubicin|mesh-list
139049199|NCT01060904|Bleomycin|bleomycin|mesh-list
139049200|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139049201|NCT01060904|Dacarbazine|dacarbazine|mesh-list
139049202|NCT01060904|Vinblastine|vinblastine|mesh-list
139049203|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139049204|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139049205|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049206|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139049207|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139049208|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049209|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049210|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139049211|NCT01060904|Immunotoxins|immunotoxins|mesh-ancestor
139049212|NCT01060904|Immunoconjugates|immunoconjugates|mesh-ancestor
139049213|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
139049214|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049215|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139049216|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
139049217|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139049218|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
139049220|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
139049221|NCT01058174|Fluconazole|fluconazole|mesh-list
139049222|NCT01058174|Amphotericin B|amphotericin b|mesh-list
139049223|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
139049224|NCT01058174|Caspofungin|caspofungin|mesh-list
139049225|NCT01058174|Micafungin|micafungin|mesh-list
139049226|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
139049227|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139049228|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139049229|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139049230|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049231|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049232|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139049233|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
139049234|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049235|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049236|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139049237|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139049238|NCT01058174|Amebicides|amebicides|mesh-ancestor
139049239|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139049240|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139049241|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139049242|NCT01058252|Indomethacin|indomethacin|mesh-list
139049243|NCT01058252|Letrozole|letrozole|mesh-list
139049244|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049245|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139049246|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139049247|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049248|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049249|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139049250|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
139049251|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049252|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049253|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139049254|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139049255|NCT01058252|Analgesics|analgesics|mesh-ancestor
139049256|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
139049257|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049258|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139049259|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139049260|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
139049261|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
139049262|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139049263|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139049264|NCT01058408|Cisplatin|cisplatin|mesh-list
139049265|NCT01058408|Everolimus|everolimus|mesh-list
139049266|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049267|NCT01058408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139049268|NCT01058408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139049269|NCT01058408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049270|NCT01058408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049271|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139049272|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
139049273|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049274|NCT01061060|Epoprostenol|epoprostenol|mesh-list
139049275|NCT01061060|Beraprost|beraprost|mesh-list
139049276|NCT01061060|Tezosentan|tezosentan|mesh-list
139049277|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139049278|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
139049279|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139049280|NCT00310388|Ezogabine|ezogabine|mesh-list
139049281|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
139049282|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139049283|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049285|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138618469|NCT00205283|Nelfinavir|nelfinavir|mesh-list
139049286|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049287|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139049289|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049291|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139049292|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049293|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049294|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
139049295|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049296|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049297|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
139049298|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
139049299|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139049300|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
139049301|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049302|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
139049303|NCT03981458|Protective Agents|protective agents|mesh-ancestor
139049304|NCT00309842|Cyclosporine|cyclosporine|mesh-list
139049305|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
139049306|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
139049307|NCT00309842|Fludarabine|fludarabine|mesh-list
139049308|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
139049309|NCT00309842|Cyclosporins|cyclosporins|mesh-list
139049310|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139049311|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
138618523|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049312|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049313|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139049314|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139049315|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
139049316|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049317|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049318|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139049319|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139049321|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049322|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
139049323|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139049324|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
139049325|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139049326|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139049327|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138295012|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049328|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
139049329|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139049330|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
139049331|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139049332|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139049333|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139049334|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139049335|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049336|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
139049337|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049338|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049339|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139049340|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049341|NCT00499889|Vidarabine|vidarabine|mesh-list
139049342|NCT00499889|Methotrexate|methotrexate|mesh-list
139049343|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
139049344|NCT00499889|Fludarabine|fludarabine|mesh-list
139049345|NCT00499889|Busulfan|busulfan|mesh-list
139049346|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
139049347|NCT00499889|Tacrolimus|tacrolimus|mesh-list
139049348|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
138618636|NCT00229593|ST 1435|st 1435|mesh-list
139049349|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139049350|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139049351|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
139049352|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139049353|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049354|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139049355|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
139049356|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049357|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049358|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
139049359|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895959|NCT00499681|Lapatinib|lapatinib|mesh-list
139049360|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139049361|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139049362|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
139049363|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139049364|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139049365|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
139049366|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139049367|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139049368|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
139049369|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139049370|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139049371|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139049372|NCT00309608|Glimepiride|glimepiride|mesh-list
139049373|NCT00309608|Linagliptin|linagliptin|mesh-list
139049374|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139049375|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139049376|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049377|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139049378|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
139049379|NCT00309608|Incretins|incretins|mesh-ancestor
138618681|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139049381|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049382|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139049383|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
139049384|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049385|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049386|NCT00308750|Carboplatin|carboplatin|mesh-list
139049387|NCT00308750|Docetaxel|docetaxel|mesh-list
139049388|NCT00308750|Pemetrexed|pemetrexed|mesh-list
139049389|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049390|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
139049391|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
139049392|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
139049393|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049394|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049395|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139049396|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139049397|NCT00489359|Carboplatin|carboplatin|mesh-list
139049398|NCT00489359|Pemetrexed|pemetrexed|mesh-list
139049399|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049400|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049401|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049402|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139049403|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139049404|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
139049406|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049407|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139049408|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049409|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049410|NCT04101461|Iron|iron|mesh-list
139049411|NCT04101461|Hepcidins|hepcidins|mesh-list
139049412|NCT04101461|Trace Elements|trace elements|mesh-ancestor
139049413|NCT04101461|Micronutrients|micronutrients|mesh-ancestor
139049414|NCT04101461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049415|NCT04101461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139049416|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
139049417|NCT01017107|Protein C|protein c|mesh-list
139049418|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
139049419|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139049420|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138770209|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139049421|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049422|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139049423|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
139049424|NCT03997019|Narcotics|narcotics|mesh-ancestor
138618773|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
139049425|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139049426|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049427|NCT03997019|Analgesics|analgesics|mesh-ancestor
139049428|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
139049429|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049430|NCT00480857|Docetaxel|docetaxel|mesh-list
139049431|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049432|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
139049433|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
139049434|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
139049435|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049436|NCT00499031|Cetuximab|cetuximab|mesh-list
139049437|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139049438|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049439|NCT00498797|Prednisolone|prednisolone|mesh-list
139049440|NCT00498797|Docetaxel|docetaxel|mesh-list
139049441|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049442|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
139049443|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
139049444|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
139049445|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049446|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139049447|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
139049448|NCT00498797|Hormones|hormones|mesh-ancestor
139049449|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618823|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
138618833|NCT00206999|Imipramine|imipramine|mesh-list
139049450|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049451|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139049452|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
139049453|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139049454|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139049455|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
139049456|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
139049457|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139049458|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049459|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139049460|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139049461|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139049462|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139049463|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049464|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
139049465|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049466|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049467|NCT00295620|Anastrozole|anastrozole|mesh-list
139049468|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139049469|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049470|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139049471|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139049472|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049473|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049474|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139049475|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
139049476|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049477|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049478|NCT03980496|Omeprazole|omeprazole|mesh-list
139049479|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139049480|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139049481|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139049482|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049483|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049484|NCT01063530|Fluorides|fluorides|mesh-list
139049485|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
138618944|NCT00207662|Infliximab|infliximab|mesh-list
139049486|NCT01063530|Protective Agents|protective agents|mesh-ancestor
139049487|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049488|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
139049489|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139049490|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139049491|NCT01069302|Clopidogrel|clopidogrel|mesh-list
139049492|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139049493|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139049494|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139049495|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139049496|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
139049497|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049498|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049499|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049500|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
139049501|NCT00321620|Denosumab|denosumab|mesh-list
139049502|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139049503|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049504|NCT00304278|Cisplatin|cisplatin|mesh-list
139049505|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139049506|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049507|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139049508|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049509|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049511|NCT03981068|Cisplatin|cisplatin|mesh-list
139049512|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049513|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
139049514|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139049515|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139049516|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139049517|NCT01064102|Cetirizine|cetirizine|mesh-list
139049518|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139049519|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139049520|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139049521|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
139049522|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
139049523|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049524|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049525|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049526|NCT02532114|Niclosamide|niclosamide|mesh-list
139049527|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
139049528|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139049529|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
139049530|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138619104|NCT00208130|Topiramate|topiramate|mesh-list
139049531|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139049532|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
139049533|NCT00307736|Bevacizumab|bevacizumab|mesh-list
139049534|NCT00307736|Fluorouracil|fluorouracil|mesh-list
139049535|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139049536|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139049537|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049538|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139049539|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139049540|NCT00307736|Growth Substances|growth substances|mesh-ancestor
139049541|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049542|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
139049543|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
138692065|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
139049544|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049545|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139049546|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139049547|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
139049548|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139049549|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049550|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139049551|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139049552|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139049553|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139049554|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049555|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
138896074|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139049556|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049557|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049558|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
139049559|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139049560|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
139049561|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049562|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
139049563|NCT03979586|Protective Agents|protective agents|mesh-ancestor
139049565|NCT00294762|Carboplatin|carboplatin|mesh-list
139049566|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139049567|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139049568|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049569|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
139049570|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
139049571|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
139049572|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049573|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139049574|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049575|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
139049576|NCT00294684|Prednisolone|prednisolone|mesh-list
139049577|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139049578|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
139049579|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
139049580|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049581|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049582|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139049583|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
139049584|NCT00294684|Hormones|hormones|mesh-ancestor
139049585|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049586|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139049587|NCT00294684|Protective Agents|protective agents|mesh-ancestor
139049588|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139049589|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049590|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139049591|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
139049592|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049593|NCT01061996|Basiliximab|basiliximab|mesh-list
139049594|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139049595|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
139049596|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049597|NCT01064180|Carvedilol|carvedilol|mesh-list
139049598|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139049599|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139049600|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
139049601|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049602|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049603|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049604|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139049606|NCT01064180|Protective Agents|protective agents|mesh-ancestor
139049607|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139049608|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139049609|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139049610|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
139049611|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139049612|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139049613|NCT01069536|Metoclopramide|metoclopramide|mesh-list
139049614|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
139049615|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
139049616|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049617|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049618|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138619385|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139049619|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139049620|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139049621|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
139049622|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049623|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049624|NCT00320216|Ustekinumab|ustekinumab|mesh-list
139049625|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
139049626|NCT00290706|Gemcitabine|gemcitabine|mesh-list
139049627|NCT00290706|Bortezomib|bortezomib|mesh-list
139049628|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139049629|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
139049630|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049631|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049632|NCT03978156|Dronabinol|dronabinol|mesh-list
139049633|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
139049634|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049635|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139049636|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139049637|NCT03978156|Analgesics|analgesics|mesh-ancestor
139049638|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
139049639|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049640|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139049641|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139049642|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049643|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049644|NCT03978156|Hormones|hormones|mesh-ancestor
139049645|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049646|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139049647|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139049648|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139049649|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139049650|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049651|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
139049652|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049653|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049654|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139049655|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049657|NCT01066494|Amonafide|amonafide|mesh-list
139049658|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139049659|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
139049660|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049661|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049662|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
139049663|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139049664|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139049665|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
139049666|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049667|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049668|NCT01069770|Sunitinib|sunitinib|mesh-list
139049669|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049670|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139049671|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139049672|NCT01069770|Growth Substances|growth substances|mesh-ancestor
139049673|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049674|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
139049675|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139049676|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692089|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139049677|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049679|NCT00303108|Doxorubicin|doxorubicin|mesh-list
139049680|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139049681|NCT00303108|Trastuzumab|trastuzumab|mesh-list
139049682|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049683|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139049684|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139049685|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139049686|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049687|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049688|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139049689|NCT00302952|Lovastatin|lovastatin|mesh-list
139049690|NCT00302952|L 647318|l 647318|mesh-list
139049691|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
139049692|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139049693|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139049694|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
139049695|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049696|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139049697|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139049698|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049700|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139049701|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
139049702|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049703|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049704|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139049705|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139049706|NCT01066572|Protective Agents|protective agents|mesh-ancestor
139049707|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049708|NCT01066650|Everolimus|everolimus|mesh-list
139049709|NCT01066650|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139049710|NCT01066650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139049711|NCT01066650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049712|NCT01066650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049713|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139049714|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
139049715|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049716|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049717|NCT01066728|Theophylline|theophylline|mesh-list
139049718|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139049719|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
139049720|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049721|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049722|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139049723|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
139049724|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139049725|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049726|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049727|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
139049728|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139049729|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139049730|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
139049731|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049732|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
139049733|NCT01325610|Vitamin D|vitamin d|mesh-list
139049734|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139049735|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049736|NCT01325610|Vitamins|vitamins|mesh-ancestor
139049737|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
139049738|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139049739|NCT00301080|Cycloserine|cycloserine|mesh-list
139049740|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139049741|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139049742|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139049743|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
139049744|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139049745|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
139049746|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049747|NCT01066806|Calcium|calcium|mesh-list
139049748|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139049749|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049750|NCT03977610|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139049751|NCT03977610|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139049752|NCT03977610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049753|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139049754|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049755|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139049756|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049757|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049758|NCT02532270|Phenylephrine|phenylephrine|mesh-list
139049759|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
139049760|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139049761|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
139049762|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
139049763|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049764|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049765|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
139049766|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139049767|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
139049768|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
139049769|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139049770|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139049771|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139049772|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
138619895|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049773|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049774|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049775|NCT02532270|Protective Agents|protective agents|mesh-ancestor
139049776|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
139049777|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139049778|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
139049779|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
139049780|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139049781|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049782|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139049783|NCT01581450|Analgesics|analgesics|mesh-ancestor
139049784|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
139049785|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049786|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139049787|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139049788|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049789|NCT00289848|Incretins|incretins|mesh-ancestor
139049790|NCT00289848|Hormones|hormones|mesh-ancestor
139049791|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049792|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139049793|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
139049794|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049795|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049796|NCT00289536|Factor VIII|factor viii|mesh-list
139049797|NCT00289536|Coagulants|coagulants|mesh-ancestor
139049798|NCT01066962|Ritonavir|ritonavir|mesh-list
139049799|NCT01066962|Darunavir|darunavir|mesh-list
139049800|NCT01066962|Tenofovir|tenofovir|mesh-list
139049801|NCT01066962|Emtricitabine|emtricitabine|mesh-list
139049802|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
139049803|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139049804|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139049805|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
139049806|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049807|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049808|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139049809|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139049810|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
139049811|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139049812|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139049813|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139049814|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139049815|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139049816|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139049817|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139049819|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139049820|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
139049821|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139049822|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049823|NCT01067274|Cytarabine|cytarabine|mesh-list
139049824|NCT01067274|Azacitidine|azacitidine|mesh-list
139049825|NCT01067274|Tretinoin|tretinoin|mesh-list
139049826|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139049827|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
139049828|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049829|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049830|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
139049831|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139049832|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139049833|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
139049834|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049835|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049836|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
139049837|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
139049838|NCT01065246|Catumaxomab|catumaxomab|mesh-list
139049839|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139049840|NCT01325844|Anesthetics|anesthetics|mesh-list
139049841|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139049842|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049843|NCT01067430|Diclofenac|diclofenac|mesh-list
139049844|NCT01067430|Etoricoxib|etoricoxib|mesh-list
139049845|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139049846|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139049847|NCT01067430|Analgesics|analgesics|mesh-ancestor
139049848|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
139049849|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049850|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049851|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139049852|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139049853|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139049854|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049855|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049856|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139049857|NCT00305864|Temozolomide|temozolomide|mesh-list
139049858|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
139049859|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139049860|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
139049861|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049862|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463534|NCT01946035|Doxazosin|doxazosin|mesh-list
139049863|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139049864|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
139049866|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139049867|NCT03982784|Narcotics|narcotics|mesh-ancestor
139049868|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139049869|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620178|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049870|NCT03982784|Analgesics|analgesics|mesh-ancestor
139049871|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
139049872|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049873|NCT03978884|Losartan|losartan|mesh-list
139049874|NCT03978884|Amlodipine|amlodipine|mesh-list
139049875|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139049876|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139049877|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139049878|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139049879|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049880|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139049881|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049882|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
139049883|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139049884|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139049885|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139049886|NCT03978884|Diuretics|diuretics|mesh-ancestor
139049887|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
139049888|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139049889|NCT00319982|Diltiazem|diltiazem|mesh-list
139049890|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139049891|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138620242|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049892|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139049893|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049894|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139049895|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049896|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
139049897|NCT00319592|Vaccines|vaccines|mesh-list
139049898|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
139049899|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049900|NCT03980990|Metformin|metformin|mesh-list
139049901|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139049902|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049903|NCT03980756|Esomeprazole|esomeprazole|mesh-list
139049904|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139049905|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139049906|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139049907|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049908|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049909|NCT03978494|Tacrolimus|tacrolimus|mesh-list
139049910|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139049912|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049913|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139049914|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049915|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049916|NCT01064570|Tretinoin|tretinoin|mesh-list
139049917|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049918|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
139049919|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
139049920|NCT01581164|Vaccines|vaccines|mesh-list
139049921|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
139049922|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049923|NCT00319046|Miglustat|miglustat|mesh-list
139049924|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049925|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049926|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139049927|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139049928|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
139049929|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139049930|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139049931|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138620293|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
139049932|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049933|NCT00303602|Olanzapine|olanzapine|mesh-list
139049934|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
139049935|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
139049936|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049937|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049938|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139049939|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139049940|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139049941|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139049942|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139049943|NCT00303602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139049944|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139049945|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139049946|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049947|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139049948|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
139049949|NCT03979976|Ramipril|ramipril|mesh-list
139049950|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139049951|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139049952|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
139049953|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049954|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139049955|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
139049956|NCT00299130|Rituximab|rituximab|mesh-list
139049957|NCT00299130|Methotrexate|methotrexate|mesh-list
139049958|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139049959|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049960|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
139049961|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049962|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139049963|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139049964|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
139049965|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139049966|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139049967|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
139049968|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049969|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
139049970|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139049971|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139049972|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139049973|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139049974|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139049975|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
139049976|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
139049977|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139049978|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139049979|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
139049980|NCT00299130|Hormones|hormones|mesh-ancestor
139049981|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049982|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139049983|NCT00299130|Protective Agents|protective agents|mesh-ancestor
139049984|NCT00288054|Docetaxel|docetaxel|mesh-list
139049985|NCT00288054|Cetuximab|cetuximab|mesh-list
139049986|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139049987|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
139049988|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
139049989|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
139049990|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139049991|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139049992|NCT00287586|Testosterone|testosterone|mesh-list
139049993|NCT00287586|Androgens|androgens|mesh-ancestor
139049994|NCT00287586|Hormones|hormones|mesh-ancestor
139049995|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139049996|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139049997|NCT01070160|Metformin|metformin|mesh-list
139049998|NCT01070160|Progesterone|progesterone|mesh-list
139049999|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139050000|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050001|NCT01070160|Progestins|progestins|mesh-ancestor
139050002|NCT01070160|Hormones|hormones|mesh-ancestor
139050003|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050004|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
139050005|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139050006|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050007|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
139050008|NCT03977220|Paclitaxel|paclitaxel|mesh-list
139050009|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139050010|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050011|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
139050012|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
139050013|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
139050014|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050015|NCT00293202|Etanercept|etanercept|mesh-list
139050016|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139050017|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139050018|NCT00293202|Analgesics|analgesics|mesh-ancestor
139050019|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
139050020|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050021|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050022|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050023|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139050024|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139050025|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050026|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
139050027|NCT00286494|Pioglitazone|pioglitazone|mesh-list
139050028|NCT00286494|Alogliptin|alogliptin|mesh-list
139050029|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139050030|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050031|NCT00286494|Incretins|incretins|mesh-ancestor
139050032|NCT00286494|Hormones|hormones|mesh-ancestor
139050033|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050034|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139050035|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
139050036|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050037|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050038|NCT00298740|Insulin|insulin|mesh-list
139050039|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139050040|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050041|NCT01067898|Vitamin D|vitamin d|mesh-list
139050042|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
139050043|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
139050044|NCT01067898|Vitamins|vitamins|mesh-list
139050045|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
139050046|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
139050047|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050048|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139050049|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139050051|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050052|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139050053|NCT03979248|Deucravacitinib|deucravacitinib|mesh-list
138620460|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139050054|NCT03979248|Rabeprazole|rabeprazole|mesh-list
139050055|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139050056|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139050057|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139050058|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050059|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050060|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
139050061|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139050062|NCT00285012|Varenicline|varenicline|mesh-list
139050063|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139050064|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139050065|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
139050066|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139050067|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050068|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050069|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
139050070|NCT00284934|Prednisone|prednisone|mesh-list
139050071|NCT00284934|Tacrolimus|tacrolimus|mesh-list
139050072|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050073|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
139050074|NCT00284934|Hormones|hormones|mesh-ancestor
139050075|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050076|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050077|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139050078|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050079|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050080|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
139050081|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139050082|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050083|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050084|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139050085|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139050086|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
139050087|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139050088|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050089|NCT00284856|Fluticasone|fluticasone|mesh-list
139050090|NCT00284856|Montelukast|montelukast|mesh-list
139050091|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050092|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139050093|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
139050094|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050095|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050096|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139050097|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
139050098|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
139050099|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139050100|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139050101|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
138800727|NCT00685672|Epinephrine|epinephrine|mesh-list
139050102|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050103|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139050104|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139050105|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050106|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
139050108|NCT00298272|Etanercept|etanercept|mesh-list
139050109|NCT00298272|Rituximab|rituximab|mesh-list
139050110|NCT00298272|Methotrexate|methotrexate|mesh-list
139050111|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139050112|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050113|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
139050114|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050115|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139050116|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139050117|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
138692166|NCT00532857|Paclitaxel|paclitaxel|mesh-list
139050118|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139050119|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139050120|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
139050121|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050122|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
139050123|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050124|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139050125|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050126|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139050127|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050128|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
139050129|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
139050130|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050131|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139050132|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
139050133|NCT00298272|Hormones|hormones|mesh-ancestor
139050134|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050135|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139050136|NCT00298272|Protective Agents|protective agents|mesh-ancestor
139050137|NCT00298272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139050138|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139050139|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139050140|NCT00298272|Analgesics|analgesics|mesh-ancestor
139050141|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
139050142|NCT01068054|Cyclosporine|cyclosporine|mesh-list
139050143|NCT01068054|Tacrolimus|tacrolimus|mesh-list
139050144|NCT01068054|Cyclosporins|cyclosporins|mesh-list
139050145|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050146|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
139050147|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050148|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139050149|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050150|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050151|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
139050152|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050153|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
139050154|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139050155|NCT00298038|Rifaximin|rifaximin|mesh-list
139050156|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139050157|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050158|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139050159|NCT00283686|Telmisartan|telmisartan|mesh-list
139050160|NCT00283686|Lisinopril|lisinopril|mesh-list
139050161|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139050162|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139050163|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139050164|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139050165|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050166|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
139050167|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050168|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139050169|NCT00283686|Protective Agents|protective agents|mesh-ancestor
139050170|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050171|NCT00297882|Artesunate|artesunate|mesh-list
139050172|NCT00297882|Lumefantrine|lumefantrine|mesh-list
139050173|NCT00297882|Artemether|artemether|mesh-list
139050174|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139050175|NCT00297882|Amodiaquine|amodiaquine|mesh-list
139050176|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
139050177|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139050178|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139050179|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050180|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050181|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
139050182|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
139050183|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139050184|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
139050185|NCT01065870|Gemcitabine|gemcitabine|mesh-list
139050186|NCT01065870|Capecitabine|capecitabine|mesh-list
139050187|NCT01065870|Docetaxel|docetaxel|mesh-list
139050188|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139050189|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
139050190|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050191|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050192|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
139050193|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
139050194|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
139050195|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
139050196|NCT00297648|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139050197|NCT00297648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050198|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050199|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
139050200|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050201|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139050202|NCT01068132|Cetuximab|cetuximab|mesh-list
139050203|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139050204|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050205|NCT00297492|Nicotine|nicotine|mesh-list
139050206|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139050207|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
139050208|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050209|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050210|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139050211|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139050212|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
139050213|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139050214|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050215|NCT00496769|Aspirin|aspirin|mesh-list
139050216|NCT00496769|Apixaban|apixaban|mesh-list
139050217|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139050218|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139050219|NCT00496769|Analgesics|analgesics|mesh-ancestor
139050220|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
139050221|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050222|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050223|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050224|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139050225|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139050226|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139050227|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050228|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139050229|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139050230|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050232|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139050233|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
139050234|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139050235|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
139050236|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
139050237|NCT01014845|Vaccines|vaccines|mesh-list
139050238|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
139050239|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050240|NCT00488345|Tigecycline|tigecycline|mesh-list
139050241|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139050242|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050243|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139050244|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050245|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050247|NCT00283062|Leuprolide|leuprolide|mesh-list
139050248|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050249|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
139050250|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
139050251|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
139050252|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050253|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139050254|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
138800874|NCT00684112|Gabapentin|gabapentin|mesh-list
139050255|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139050256|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050257|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139050258|NCT00282984|Varenicline|varenicline|mesh-list
139050259|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139050260|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139050261|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
139050262|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139050263|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050264|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050265|NCT00296400|Atorvastatin|atorvastatin|mesh-list
139050266|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139050267|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138620973|NCT00212810|Topiramate|topiramate|mesh-list
139050268|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139050269|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
139050270|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050271|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139050272|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139050273|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050274|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
139050275|NCT00296244|Prednisone|prednisone|mesh-list
139050276|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
139050277|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139050279|NCT00296244|Basiliximab|basiliximab|mesh-list
139050280|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050281|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
139050282|NCT00296244|Hormones|hormones|mesh-ancestor
139050283|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050284|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050285|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139050286|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050287|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050288|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
139050289|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139050290|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050291|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050292|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
139050293|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
139050294|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050295|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139050296|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139050297|NCT00296244|Protective Agents|protective agents|mesh-ancestor
139050298|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139050300|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
139050301|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139050302|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050303|NCT01068444|Pioglitazone|pioglitazone|mesh-list
139050304|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139050305|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050306|NCT00282048|Axitinib|axitinib|mesh-list
139050307|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050308|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139050309|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621248|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
139050310|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050311|NCT00474539|Vaccines|vaccines|mesh-list
139050312|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139050313|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
139050314|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050315|NCT01017809|Aprepitant|aprepitant|mesh-list
139050316|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
139050317|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
139050318|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050319|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050320|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139050321|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139050322|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621304|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
139050323|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050324|NCT01020539|Fludarabine|fludarabine|mesh-list
139050325|NCT01020539|Busulfan|busulfan|mesh-list
139050326|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
139050327|NCT01020539|Isotretinoin|isotretinoin|mesh-list
139050328|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
139050329|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139050330|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050331|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050332|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050333|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
139050334|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050335|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
139050336|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139050337|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139050338|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
139050339|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139050340|NCT01020539|Immunotoxins|immunotoxins|mesh-ancestor
139050341|NCT01020539|Immunoconjugates|immunoconjugates|mesh-ancestor
139050342|NCT00281580|Amlodipine|amlodipine|mesh-list
139050343|NCT00281580|Telmisartan|telmisartan|mesh-list
139050344|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139050345|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139050346|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139050347|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050348|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139050349|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050350|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
139050351|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138692217|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
139050352|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139050354|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139050355|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050356|NCT01070862|Thalidomide|thalidomide|mesh-list
139050357|NCT01070862|Dexamethasone|dexamethasone|mesh-list
139050358|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
139050359|NCT01070862|Doxorubicin|doxorubicin|mesh-list
139050360|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139050361|NCT01070862|Melphalan|melphalan|mesh-list
139050362|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
139050363|NCT01070862|Vincristine|vincristine|mesh-list
139050364|NCT01070862|BB 1101|bb 1101|mesh-list
139050365|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050366|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
139050367|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
139050368|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050369|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050370|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139050371|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
139050372|NCT01070862|Hormones|hormones|mesh-ancestor
139050373|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050374|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139050375|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050376|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
139050377|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050378|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050379|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139050380|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139050381|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139050382|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139050383|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
139050384|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139050385|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050386|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
139050387|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
139050388|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139050389|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050390|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139050391|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139050392|NCT01070862|Growth Substances|growth substances|mesh-ancestor
139050393|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
139050394|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139050395|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139050396|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
139050397|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
139050398|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
139050399|NCT00495677|PF 232798|pf 232798|mesh-list
139050400|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139050401|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050402|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139050403|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139050404|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
139050405|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050406|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
139050407|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
139050408|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139050409|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050410|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
139050411|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139050412|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050413|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050414|NCT00292188|Pregabalin|pregabalin|mesh-list
139050415|NCT00292188|Analgesics|analgesics|mesh-ancestor
139050416|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
139050417|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050418|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050419|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
139050420|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139050421|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139050422|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050423|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139050424|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139050425|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139050426|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139050427|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139050428|NCT00271596|Citalopram|citalopram|mesh-list
138621438|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139050429|NCT00271596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139050430|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138896548|NCT01014637|Miconazole|miconazole|mesh-list
139050431|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139050432|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050433|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139050434|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
139050435|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050436|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139050437|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
139050438|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139050439|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
139050440|NCT01068756|Rifampin|rifampin|mesh-list
139050441|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139050442|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050443|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139050444|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050445|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139050446|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
139050447|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139050448|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050449|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
139050450|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139050451|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050452|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139050453|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138621480|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
139050454|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138692264|NCT04686890|Tramadol|tramadol|mesh-list
139050455|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139050456|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139050457|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139050458|NCT00291642|Cetirizine|cetirizine|mesh-list
139050459|NCT00291642|Levocetirizine|levocetirizine|mesh-list
139050460|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139050461|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139050462|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139050463|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
139050464|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
139050465|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139050466|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050467|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050468|NCT01070472|Misoprostol|misoprostol|mesh-list
139050469|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139050470|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
139050471|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139050472|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050473|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139050474|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139050475|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
139050476|NCT00280566|Ziprasidone|ziprasidone|mesh-list
139050477|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139050478|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
139050479|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896590|NCT01017133|Fluorides|fluorides|mesh-list
139050480|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050481|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050482|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139050483|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139050484|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139050485|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139050486|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139050487|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
139050488|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
139050489|NCT00270894|Docetaxel|docetaxel|mesh-list
139050490|NCT00270894|Trastuzumab|trastuzumab|mesh-list
139050491|NCT00270894|Epirubicin|epirubicin|mesh-list
139050492|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050493|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
139050494|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050495|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139050496|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139050497|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
139050498|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050499|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050500|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139050501|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
139050502|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
139050503|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
139050504|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139050505|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139050506|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139050507|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139050508|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050509|NCT01070628|Levodopa|levodopa|mesh-list
139050510|NCT01070628|Carbidopa|carbidopa|mesh-list
139050511|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139050512|NCT01070628|Entacapone|entacapone|mesh-list
139050513|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139050514|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139050515|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
139050516|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139050517|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050518|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050519|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139050520|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050521|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139050522|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
139050523|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
139050524|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139050525|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
139050526|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050527|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050528|NCT00317642|Cytarabine|cytarabine|mesh-list
139050529|NCT00317642|Clofarabine|clofarabine|mesh-list
139050530|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139050531|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
139050532|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050533|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050534|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
139050535|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050536|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138896599|NCT00869258|Gemcitabine|gemcitabine|mesh-list
139050537|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
139050538|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050539|NCT01064726|Fluticasone|fluticasone|mesh-list
139050540|NCT01064726|Xhance|xhance|mesh-list
139050541|NCT01064726|Ibuprofen|ibuprofen|mesh-list
139050542|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139050543|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139050544|NCT01064726|Analgesics|analgesics|mesh-ancestor
139050545|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
139050546|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050547|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050548|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050549|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139050550|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139050551|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050552|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050553|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139050554|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
139050555|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139050556|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
139050557|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
139050558|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139050560|NCT00295022|Levocetirizine|levocetirizine|mesh-list
139050561|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139050562|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
139050563|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139050564|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
139050565|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050566|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050567|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139050568|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139050569|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050570|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139050571|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139050572|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
139050573|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
139050574|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139050575|NCT01062152|Lenalidomide|lenalidomide|mesh-list
139050576|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
139050577|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050578|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139050579|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139050580|NCT01062152|Growth Substances|growth substances|mesh-ancestor
139050581|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
138621716|NCT00216008|Docetaxel|docetaxel|mesh-list
139050582|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050583|NCT00303446|Dutasteride|dutasteride|mesh-list
139050584|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139050585|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139050586|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050587|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050588|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
138692289|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
139050589|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050590|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050591|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
139050592|NCT01065038|Anagrelide|anagrelide|mesh-list
139050593|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050594|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
139050595|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050596|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050597|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139050598|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139050599|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139050600|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139050601|NCT00291486|Capecitabine|capecitabine|mesh-list
139050602|NCT00291486|Antibodies|antibodies|mesh-list
139050603|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139050604|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
139050605|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621768|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
139050606|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139050607|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
139050608|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050609|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050610|NCT00301964|Bevacizumab|bevacizumab|mesh-list
139050611|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139050612|NCT00301964|Antibodies|antibodies|mesh-list
139050613|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
139050614|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139050615|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050616|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139050617|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139050618|NCT00301964|Growth Substances|growth substances|mesh-ancestor
139050619|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050620|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
139050621|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
139050622|NCT01070706|Paclitaxel|paclitaxel|mesh-list
139050623|NCT01070706|Gemcitabine|gemcitabine|mesh-list
139050624|NCT01070706|Sunitinib|sunitinib|mesh-list
139050625|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139050626|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050627|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
138801252|NCT00935220|Linagliptin|linagliptin|mesh-list
138896653|NCT04134650|Metformin|metformin|mesh-list
139050628|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
139050629|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
139050630|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050631|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139050632|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
139050633|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139050634|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139050635|NCT01070706|Growth Substances|growth substances|mesh-ancestor
139050636|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050637|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
139050638|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139050639|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050640|NCT00268242|Gemcitabine|gemcitabine|mesh-list
139050641|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
139050642|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139050643|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
139050644|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050645|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050646|NCT00268242|Analgesics|analgesics|mesh-ancestor
139050647|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
139050648|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050649|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050650|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139050651|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139050652|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050654|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139050655|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139050656|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
138692299|NCT04942730|Busulfan|busulfan|mesh-list
139050657|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139050658|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050659|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050660|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139050661|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139050663|NCT00294398|Xhance|xhance|mesh-list
139050664|NCT00294398|Budesonide|budesonide|mesh-list
138621925|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
139050665|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050666|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139050667|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
139050668|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050669|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896670|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
139050670|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139050671|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
139050672|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
139050673|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139050674|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
139050675|NCT00294398|Hormones|hormones|mesh-ancestor
139050676|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050677|NCT00279708|Atorvastatin|atorvastatin|mesh-list
139050678|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139050679|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139050680|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
139050681|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050682|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139050683|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139050684|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050685|NCT00299702|Aripiprazole|aripiprazole|mesh-list
139050686|NCT00299702|Risperidone|risperidone|mesh-list
139050687|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
139050688|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139050689|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139050690|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139050691|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139050692|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050693|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
139050694|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
139050695|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139050696|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050697|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139050698|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139050699|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
139050700|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139050701|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139050702|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139050703|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139050704|NCT00291330|Warfarin|warfarin|mesh-list
139050705|NCT00291330|Dabigatran|dabigatran|mesh-list
139050706|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
139050707|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
139050708|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139050709|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
139050710|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050711|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050712|NCT03975036|Antibodies|antibodies|mesh-list
139050713|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
139050714|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050715|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
139050716|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139050717|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050718|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139050719|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
139050720|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139050721|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050722|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622038|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050723|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050724|NCT01582230|Vildagliptin|vildagliptin|mesh-list
139050725|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139050726|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050727|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139050728|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
139050729|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050730|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050731|NCT00278148|Paclitaxel|paclitaxel|mesh-list
139050732|NCT00278148|Carboplatin|carboplatin|mesh-list
139050733|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139050734|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139050735|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050736|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
139050737|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
139050738|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
139050739|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050740|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138622139|NCT00217295|Topiramate|topiramate|mesh-list
139050741|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050742|NCT00299546|Golimumab|golimumab|mesh-list
139050743|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139050744|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139050745|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050746|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050747|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
139050748|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050749|NCT03975270|Paclitaxel|paclitaxel|mesh-list
139050750|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139050751|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050752|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
139050753|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
139050754|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
139050755|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050756|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139050757|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
139050758|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139050759|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139050760|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050761|NCT03977792|Docosanol|docosanol|mesh-list
139050762|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
139050763|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050764|NCT01066598|Rituximab|rituximab|mesh-list
139050765|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139050766|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050767|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
139050768|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050769|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139050770|NCT01066676|Ibuprofen|ibuprofen|mesh-list
139050771|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139050772|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139050773|NCT01066676|Analgesics|analgesics|mesh-ancestor
139050774|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
139050775|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050776|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050777|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050778|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139050779|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139050780|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050781|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050782|NCT01065194|Simendan|simendan|mesh-list
139050783|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139050784|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
139050785|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139050786|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139050787|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050788|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050789|NCT01065194|Protective Agents|protective agents|mesh-ancestor
139050790|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050791|NCT01065272|Dexamethasone|dexamethasone|mesh-list
139050792|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050793|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
139050794|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
139050795|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050796|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050797|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139050798|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
139050799|NCT01065272|Hormones|hormones|mesh-ancestor
139050800|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050801|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139050802|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050803|NCT00299156|Clofarabine|clofarabine|mesh-list
139050804|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139050805|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
139050806|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050807|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050808|NCT00277212|Lamotrigine|lamotrigine|mesh-list
139050809|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
139050810|NCT00277212|Aripiprazole|aripiprazole|mesh-list
139050811|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
139050812|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139050813|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139050814|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139050815|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138896763|NCT00498355|Growth Substances|growth substances|mesh-ancestor
139050816|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050818|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
139050819|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139050820|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050821|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139050822|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139050823|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
139050824|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139050825|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138622316|NCT04644484|Vaccines|vaccines|mesh-list
139050826|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139050827|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139050828|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139050829|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139050830|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139050831|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139050832|NCT01066754|Fexofenadine|fexofenadine|mesh-list
139050833|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139050834|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139050835|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139050836|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
139050837|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
139050838|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139050839|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050840|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050842|NCT00276744|Gemcitabine|gemcitabine|mesh-list
139050843|NCT00276744|Capecitabine|capecitabine|mesh-list
139050844|NCT00276744|Docetaxel|docetaxel|mesh-list
139050845|NCT00276744|Irinotecan|irinotecan|mesh-list
139050846|NCT00276744|Cetuximab|cetuximab|mesh-list
139050847|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139050848|NCT00276744|Mitomycins|mitomycins|mesh-list
139050849|NCT00276744|Mitomycin|mitomycin|mesh-list
139050850|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139050851|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
139050852|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050853|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050854|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
139050855|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
139050856|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
139050857|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139050858|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139050859|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050860|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139050861|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139050862|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139050863|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050864|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139050865|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
139050866|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050867|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
139050868|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050869|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
139050870|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139050871|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
139050872|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
139050873|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139050874|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896780|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
139050875|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050876|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
139050877|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139050878|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139050879|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050880|NCT02532192|Cytarabine|cytarabine|mesh-list
139050881|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
139050882|NCT02532192|Fluconazole|fluconazole|mesh-list
139050883|NCT02532192|Dexamethasone|dexamethasone|mesh-list
139050884|NCT02532192|Rituximab|rituximab|mesh-list
139050885|NCT02532192|Cisplatin|cisplatin|mesh-list
139050886|NCT02532192|Belinostat|belinostat|mesh-list
139050887|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050888|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
139050889|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
139050890|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692361|NCT01269385|Antibodies|antibodies|mesh-list
139050891|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050892|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139050893|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
139050894|NCT02532192|Hormones|hormones|mesh-ancestor
139050895|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050896|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139050897|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050898|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139050899|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
139050900|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139050901|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139050902|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
139050903|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050904|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
139050905|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050906|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050907|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139050908|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139050909|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139050910|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050911|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139050912|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139050913|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
139050914|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139050915|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139050916|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
139050917|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139050918|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139050919|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139050920|NCT00293462|Sargramostim|sargramostim|mesh-list
139050921|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
139050922|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050923|NCT00316082|Metformin|metformin|mesh-list
139050924|NCT00316082|Saxagliptin|saxagliptin|mesh-list
139050925|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139050926|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801565|NCT00693862|Levodopa|levodopa|mesh-list
139050927|NCT00316082|Incretins|incretins|mesh-ancestor
139050928|NCT00316082|Hormones|hormones|mesh-ancestor
139050929|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050930|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139050931|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
139050932|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050933|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050934|NCT00316004|Dextrans|dextrans|mesh-list
139050935|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
139050936|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
139050937|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
139050938|NCT01066832|Paclitaxel|paclitaxel|mesh-list
139050939|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139050940|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050941|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
139050942|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
139050943|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
138622567|NCT00246207|Methylphenidate|methylphenidate|mesh-list
139050944|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050945|NCT00298766|Bortezomib|bortezomib|mesh-list
139050946|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050947|NCT03979664|Dexamethasone|dexamethasone|mesh-list
139050948|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139050949|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
139050950|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
139050951|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050952|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050953|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139050954|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
139050955|NCT03979664|Hormones|hormones|mesh-ancestor
138692373|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
139050956|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139050957|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139050958|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050959|NCT01325558|Gemcitabine|gemcitabine|mesh-list
139050960|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139050961|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
139050962|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050963|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050964|NCT00315458|Buprenorphine|buprenorphine|mesh-list
139050965|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139050966|NCT00315458|Narcotics|narcotics|mesh-ancestor
139050967|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139050968|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050969|NCT00315458|Analgesics|analgesics|mesh-ancestor
139050970|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
139050971|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139050972|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139050973|NCT01065662|Sirolimus|sirolimus|mesh-list
139050974|NCT01065662|Temsirolimus|temsirolimus|mesh-list
139050975|NCT01065662|MTOR Inhibitors|mtor inhibitors|mesh-list
139050976|NCT01065662|Cediranib|cediranib|mesh-list
139050977|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139050978|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050979|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050980|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139050981|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
139050982|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139050983|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139050984|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139050985|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138622656|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050986|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139050987|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
139050988|NCT01581242|Adefovir|adefovir|mesh-list
139050989|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139050990|NCT01581242|Clevudine|clevudine|mesh-list
139050991|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
139050992|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139050993|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139050994|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139050995|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139050996|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139050997|NCT03982238|Metformin|metformin|mesh-list
139050998|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
139050999|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139051000|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051001|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139051002|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801628|NCT00674596|Ramipril|ramipril|mesh-list
139051003|NCT00293384|Dexamethasone|dexamethasone|mesh-list
139051004|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
139051005|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
139051006|NCT00293384|Aprepitant|aprepitant|mesh-list
139051007|NCT00293384|Granisetron|granisetron|mesh-list
139051008|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139051009|NCT00293384|BB 1101|bb 1101|mesh-list
139051010|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139051011|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
139051012|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051013|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139051014|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139051015|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
139051016|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051017|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051018|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139051019|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139051020|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
139051021|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
139051022|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051023|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139051024|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
139051026|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139051027|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139051028|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
139051029|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051030|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139051031|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139051032|NCT00293384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139051033|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139051034|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
139051035|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
139051036|NCT00297830|Alendronate|alendronate|mesh-list
139051037|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139051038|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051039|NCT00296816|Bevacizumab|bevacizumab|mesh-list
139051041|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
139051042|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139051043|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051044|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139051045|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139051046|NCT00296816|Growth Substances|growth substances|mesh-ancestor
139051047|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051048|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
139051049|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
139051050|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
139051051|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
139051052|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051053|NCT01066988|Emollients|emollients|mesh-list
139051054|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139051056|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
139051057|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139051058|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139051059|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051060|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
139051061|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139051062|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
139051063|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139051064|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139051065|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051066|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139051067|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051068|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139051069|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139051070|NCT01084486|Metformin|metformin|mesh-list
139051071|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139051072|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051073|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139051074|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139051075|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139051076|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138801704|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
139051077|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051078|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139051079|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139051080|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139051081|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139051082|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
139051083|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139051084|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051085|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139051086|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139051087|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
139051088|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139051089|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139051090|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
139051091|NCT01084720|V0034CR|v0034cr|mesh-list
139051092|NCT01084720|Emollients|emollients|mesh-ancestor
139051093|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
139051094|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
139051095|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139051096|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139051097|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051098|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
139051099|NCT03963466|Coagulants|coagulants|mesh-ancestor
139051100|NCT01084876|Paclitaxel|paclitaxel|mesh-list
139051101|NCT01084876|Trastuzumab|trastuzumab|mesh-list
139051102|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139051103|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051104|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
139051105|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
139051106|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
139051107|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896917|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
139051108|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139051109|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139051110|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139051111|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139051112|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139051113|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051114|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051115|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
139051116|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051117|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139051118|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139051119|NCT00251004|Cyclosporine|cyclosporine|mesh-list
139051120|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
139051121|NCT00251004|Everolimus|everolimus|mesh-list
139051122|NCT00251004|Cyclosporins|cyclosporins|mesh-list
139051123|NCT00251004|Basiliximab|basiliximab|mesh-list
139051124|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051125|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051126|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139051127|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
139051128|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051129|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
139051130|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051131|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
139051132|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139051133|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139051134|NCT00251004|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139051135|NCT00251004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139051136|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051137|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139051138|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139051139|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
139051140|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139051141|NCT00275262|Leuprolide|leuprolide|mesh-list
139051142|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139051143|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
139051144|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139051145|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051146|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139051147|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051149|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051150|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623028|NCT00220064|Antidotes|antidotes|mesh-ancestor
139051151|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051152|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139051153|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
139051154|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051155|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139051156|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051157|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051158|NCT04357457|Almitrine|almitrine|mesh-list
139051159|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
139051160|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
139051161|NCT00493649|Docetaxel|docetaxel|mesh-list
139051162|NCT00493649|Trastuzumab|trastuzumab|mesh-list
139051163|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139051164|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
139051165|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051166|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139051167|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139051168|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
139051169|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051170|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051171|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139051172|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
139051173|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
139051174|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
138623070|NCT04623385|Hormones|hormones|mesh-ancestor
139051175|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139051177|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139051178|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
139051179|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051180|NCT01021163|Expectorants|expectorants|mesh-ancestor
139051181|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
139051182|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139051183|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
139051184|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051185|NCT01021163|Protective Agents|protective agents|mesh-ancestor
139051186|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051187|NCT01021163|Antidotes|antidotes|mesh-ancestor
139051188|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
139051189|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139051190|NCT01022333|Protective Agents|protective agents|mesh-ancestor
139051191|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051192|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051193|NCT00117598|Sirolimus|sirolimus|mesh-list
139051194|NCT00117598|Temsirolimus|temsirolimus|mesh-list
139051195|NCT00117598|MTOR Inhibitors|mtor inhibitors|mesh-list
139051196|NCT00117598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139051197|NCT00117598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051198|NCT00117598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051199|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139051200|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
139051201|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051202|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051203|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139051204|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051205|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139051206|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
139051207|NCT01082458|Lidocaine|lidocaine|mesh-list
139051208|NCT01082458|Remifentanil|remifentanil|mesh-list
139051209|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
139051210|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
139051211|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138623119|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
139051212|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051213|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
139051214|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051216|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139051217|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139051218|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139051219|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051220|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139051221|NCT01082458|Narcotics|narcotics|mesh-ancestor
139051222|NCT01082458|Analgesics|analgesics|mesh-ancestor
139051223|NCT00469859|Cytarabine|cytarabine|mesh-list
139051224|NCT00469859|Idarubicin|idarubicin|mesh-list
139051225|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139051226|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
139051227|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051228|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051229|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
139051230|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051231|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139051232|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
139051233|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051234|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139051235|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139051236|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139051237|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051238|NCT01021475|Domperidone|domperidone|mesh-list
139051239|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
139051240|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
139051241|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051242|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051243|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139051244|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139051245|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
139051246|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623211|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139051247|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051248|NCT01085032|Nicotine|nicotine|mesh-list
139051249|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139051250|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
139051251|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051252|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051253|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139051254|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139051255|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
139051256|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139051257|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051258|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
139051259|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
139051260|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139051261|NCT01021787|Protective Agents|protective agents|mesh-ancestor
139051262|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051263|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
139051264|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139051265|NCT00093808|Capecitabine|capecitabine|mesh-list
139051266|NCT00093808|Trastuzumab|trastuzumab|mesh-list
139051267|NCT00093808|Vinorelbine|vinorelbine|mesh-list
139051268|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138692429|NCT00535808|Nitroprusside|nitroprusside|mesh-list
139051269|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
139051270|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051271|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051272|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139051273|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139051274|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
139051275|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
139051276|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
139051277|NCT00469079|Nicotine|nicotine|mesh-list
139051278|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139051279|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
139051280|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051281|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051282|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139051283|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139051284|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
139051285|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139051286|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051287|NCT01326754|Artesunate|artesunate|mesh-list
139051288|NCT01326754|Lumefantrine|lumefantrine|mesh-list
139051289|NCT01326754|Artemether|artemether|mesh-list
139051290|NCT01326754|Piperaquine|piperaquine|mesh-list
139051291|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139051292|NCT01326754|Amodiaquine|amodiaquine|mesh-list
139051293|NCT01326754|Artenimol|artenimol|mesh-list
139051294|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
139051295|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
139051296|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139051297|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139051298|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051299|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051300|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
139051301|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
139051302|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139051303|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
139051304|NCT00093496|Gemcitabine|gemcitabine|mesh-list
139051305|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139051306|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
139051307|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051308|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051309|NCT00265122|Ustekinumab|ustekinumab|mesh-list
139051310|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
139051311|NCT00096538|Valganciclovir|valganciclovir|mesh-list
139051312|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
139051313|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051314|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
139051315|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139051316|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051317|NCT03971214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139051318|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051319|NCT01073748|Acetaminophen|acetaminophen|mesh-list
139051320|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139051321|NCT01073748|Analgesics|analgesics|mesh-ancestor
139051322|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
138623377|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
139051323|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051324|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623475|NCT00221390|Ropinirole|ropinirole|mesh-list
139051325|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
139051326|NCT00468845|Pregabalin|pregabalin|mesh-list
139051327|NCT00468845|Analgesics|analgesics|mesh-ancestor
139051328|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
139051329|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051330|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051331|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
139051332|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139051333|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139051334|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051335|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139051337|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139051338|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139051339|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139051340|NCT00468299|Misoprostol|misoprostol|mesh-list
139051341|NCT00468299|Mifepristone|mifepristone|mesh-list
139051342|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139051343|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
139051344|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139051345|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051346|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139051347|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139051348|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
139051349|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139051350|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139051351|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139051352|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139051353|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
139051354|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139051355|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139051356|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
139051357|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139051358|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
139051359|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139051360|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139051361|NCT01021865|Glucagon|glucagon|mesh-list
139051362|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139051363|NCT01021865|Regadenoson|regadenoson|mesh-list
139051364|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139051365|NCT01021865|Hormones|hormones|mesh-ancestor
139051366|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139051367|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051368|NCT01021865|Incretins|incretins|mesh-ancestor
139051369|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
139051370|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139051371|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
139051372|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
138897026|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
139051373|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139051374|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051375|NCT00468143|Adderall|adderall|mesh-list
139051376|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138692459|NCT05471063|Amebicides|amebicides|mesh-ancestor
139051377|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051378|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
139051379|NCT00467831|Erythromycin|erythromycin|mesh-list
139051380|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
139051381|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139051382|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
139051384|NCT00467831|Losartan|losartan|mesh-list
139051385|NCT00467831|Pravastatin|pravastatin|mesh-list
139051386|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139051387|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139051388|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139051389|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139051390|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139051391|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051392|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
139051393|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051394|NCT00467831|Expectorants|expectorants|mesh-ancestor
139051395|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
139051396|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139051397|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
139051398|NCT00467831|Protective Agents|protective agents|mesh-ancestor
139051399|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051400|NCT00467831|Antidotes|antidotes|mesh-ancestor
139051401|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139051402|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139051403|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
139051404|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139051405|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139051406|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051407|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139051408|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139051409|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139051410|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139051411|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139051412|NCT00467831|Analgesics|analgesics|mesh-ancestor
139051413|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
139051414|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051415|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139051416|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139051417|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139051418|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139051419|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
139051420|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139051421|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
139051422|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
138623724|NCT06177041|Antimetabolites|antimetabolites|mesh-ancestor
139051423|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139051424|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139051425|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139051426|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051427|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139051428|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139051429|NCT01021943|Spironolactone|spironolactone|mesh-list
139051430|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139051431|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
139051432|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139051433|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051434|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139051435|NCT01021943|Diuretics|diuretics|mesh-ancestor
139051436|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
139051437|NCT01022021|Rituximab|rituximab|mesh-list
138692493|NCT01267825|Bupivacaine|bupivacaine|mesh-list
139051438|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138623774|NCT06176729|Rituximab|rituximab|mesh-list
138623775|NCT06176729|Lenalidomide|lenalidomide|mesh-list
139051439|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139051440|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051441|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
139051442|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051443|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139051444|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139051445|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
139051446|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051447|NCT00467597|Levodopa|levodopa|mesh-list
139051448|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139051449|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139051450|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
139051451|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139051452|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051453|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051454|NCT00115804|Fluoxetine|fluoxetine|mesh-list
139051455|NCT00115804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139051456|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139051457|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139051458|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051459|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139051460|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
139051461|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623831|NCT06166394|Anesthetics|anesthetics|mesh-list
139051462|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139051463|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
139051464|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139051465|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139051466|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139051467|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051468|NCT00467363|Aspirin|aspirin|mesh-list
139051469|NCT00467363|Folic Acid|folic acid|mesh-list
139051470|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139051471|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139051472|NCT00467363|Analgesics|analgesics|mesh-ancestor
139051473|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
139051474|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051475|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051476|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139051477|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139051478|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139051479|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139051480|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051481|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139051482|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139051483|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051484|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
139051485|NCT00467363|Hematinics|hematinics|mesh-ancestor
139051486|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
139051487|NCT00467363|Vitamins|vitamins|mesh-ancestor
139051488|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
139051489|NCT01071174|Dapivirine|dapivirine|mesh-list
139051490|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139051491|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139051492|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
139051493|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623878|NCT06140186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623879|NCT06140186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623880|NCT06140186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138623881|NCT06140186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138623882|NCT06140186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138623883|NCT06140186|Glucocorticoids|glucocorticoids|mesh-ancestor
138623884|NCT06140186|Hormones|hormones|mesh-ancestor
138623885|NCT06140186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138623886|NCT06140186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139051494|NCT00466505|Celecoxib|celecoxib|mesh-list
139051495|NCT00466505|Cetuximab|cetuximab|mesh-list
139051496|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139051497|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051498|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139051499|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139051500|NCT00466505|Analgesics|analgesics|mesh-ancestor
139051501|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
139051502|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051503|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051504|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139051505|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139051506|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139051507|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139051508|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051509|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051510|NCT02531568|Warfarin|warfarin|mesh-list
139051511|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
139051512|NCT00467051|Paclitaxel|paclitaxel|mesh-list
139051513|NCT00467051|Carboplatin|carboplatin|mesh-list
139051514|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139051515|NCT00467051|Ifosfamide|ifosfamide|mesh-list
139051516|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
139051517|NCT00467051|Lenograstim|lenograstim|mesh-list
139051518|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139051519|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051520|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
139051521|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
139051522|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
139051523|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051524|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139051525|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
139051526|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802161|NCT00927186|Teriparatide|teriparatide|mesh-list
139051527|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139051528|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
139051529|NCT00264498|Carboplatin|carboplatin|mesh-list
139051530|NCT00264498|Gemcitabine|gemcitabine|mesh-list
139051531|NCT00264498|Gefitinib|gefitinib|mesh-list
139051532|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051533|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139051534|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
139051535|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051536|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139051537|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051538|NCT00466193|Zolpidem|zolpidem|mesh-list
139051539|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139051540|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139051541|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139051542|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051543|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139051544|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
139051545|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
139051546|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139051547|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051548|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
139051549|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139051550|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051551|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139051552|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051553|NCT01072734|Vaccines|vaccines|mesh-list
139051554|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
139051555|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051556|NCT03970668|Insulin|insulin|mesh-list
139051557|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139051558|NCT03970668|Linagliptin|linagliptin|mesh-list
139051559|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139051560|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051561|NCT03970668|Incretins|incretins|mesh-ancestor
139051562|NCT03970668|Hormones|hormones|mesh-ancestor
139051563|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139051564|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139051565|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
139051566|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051567|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051568|NCT00454181|Interferons|interferons|mesh-list
139051569|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
139051570|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051571|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
139051572|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051573|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
139051574|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051575|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139051576|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139051577|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051578|NCT01073826|Incretins|incretins|mesh-ancestor
139051579|NCT01073826|Hormones|hormones|mesh-ancestor
138624174|NCT05685602|Paclitaxel|paclitaxel|mesh-list
139051580|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139051581|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139051582|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
139051583|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051584|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051585|NCT01072812|Phenserine|phenserine|mesh-list
139051586|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139051587|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051588|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051589|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
139051590|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139051591|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051592|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
139051593|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139051594|NCT00237042|Estradiol|estradiol|mesh-list
139051595|NCT00237042|Estrogens|estrogens|mesh-ancestor
139051596|NCT00237042|Hormones|hormones|mesh-ancestor
139051597|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139051598|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051599|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138624230|NCT05602636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624231|NCT05602636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138624232|NCT05602636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138624233|NCT05602636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139051600|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
139051601|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139051602|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139051603|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139051604|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139051605|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139051606|NCT00465647|Hydromorphone|hydromorphone|mesh-list
139051607|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139051608|NCT00465647|Narcotics|narcotics|mesh-ancestor
139051609|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139051610|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051611|NCT00465647|Analgesics|analgesics|mesh-ancestor
139051612|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
139051613|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051614|NCT00090766|Valganciclovir|valganciclovir|mesh-list
139051615|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
139051616|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051617|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
139051618|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139051619|NCT03961828|Ledipasvir|ledipasvir|mesh-list
139051620|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
139051621|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138624296|NCT05402111|Aripiprazole|aripiprazole|mesh-list
138624297|NCT05402111|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138624298|NCT05402111|Antipsychotic Agents|antipsychotic agents|mesh-list
138624299|NCT05402111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139051622|NCT00465179|Sunitinib|sunitinib|mesh-list
139051623|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051624|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139051625|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139051626|NCT00465179|Growth Substances|growth substances|mesh-ancestor
139051627|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051628|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
139051629|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139051630|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051631|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051632|NCT00084136|Tenofovir|tenofovir|mesh-list
139051633|NCT00084136|Lamivudine|lamivudine|mesh-list
139051634|NCT00084136|Emtricitabine|emtricitabine|mesh-list
138624357|NCT05317546|Cannabidiol|cannabidiol|mesh-list
138624358|NCT05317546|Anticonvulsants|anticonvulsants|mesh-ancestor
138624359|NCT05313243|Pembrolizumab|pembrolizumab|mesh-list
138624360|NCT05313243|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138624361|NCT05313243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624362|NCT05313243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624363|NCT05313243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624364|NCT05313243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624365|NCT05313243|Immunotoxins|immunotoxins|mesh-ancestor
138624366|NCT05313243|Immunoconjugates|immunoconjugates|mesh-ancestor
138624367|NCT05313243|Immunologic Factors|immunologic factors|mesh-ancestor
138624368|NCT05313243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624386|NCT05221645|Rituximab|rituximab|mesh-list
138624387|NCT05221645|Pembrolizumab|pembrolizumab|mesh-list
138624388|NCT05221645|Carboplatin|carboplatin|mesh-list
138624389|NCT05221645|Etoposide|etoposide|mesh-list
138624390|NCT05221645|Ifosfamide|ifosfamide|mesh-list
138624391|NCT05221645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139051635|NCT00084136|Zidovudine|zidovudine|mesh-list
139051636|NCT00084136|Efavirenz|efavirenz|mesh-list
139051637|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139051638|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139051639|NCT00084136|Didanosine|didanosine|mesh-list
139051640|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139051641|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
139051642|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051643|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139051644|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139051645|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624423|NCT05136846|Papaverine|papaverine|mesh-list
139051646|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051647|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139051648|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139051649|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
139051650|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139051651|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139051652|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139051653|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139051654|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139051655|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139051656|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139051657|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139051658|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
139051659|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
139051660|NCT03812380|Cathartics|cathartics|mesh-ancestor
139051661|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139051662|NCT01085422|Temozolomide|temozolomide|mesh-list
139051663|NCT01085422|Veliparib|veliparib|mesh-list
139051664|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139051665|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
139051666|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051667|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051668|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139051669|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051670|NCT01085656|Combretastatin|combretastatin|mesh-list
139051671|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139051672|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051673|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
139051674|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
139051675|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
139051676|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051677|NCT01087138|Calcium|calcium|mesh-list
138802300|NCT01078922|Ofatumumab|ofatumumab|mesh-list
139051678|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139051679|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051680|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139051681|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
139051682|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051683|NCT00464087|Heparin|heparin|mesh-list
139051684|NCT00464087|Calcium heparin|calcium heparin|mesh-list
139051686|NCT00464087|Bivalirudin|bivalirudin|mesh-list
139051687|NCT00464087|Fondaparinux|fondaparinux|mesh-list
139051688|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
138624627|NCT04681105|Ibuprofen|ibuprofen|mesh-list
139051689|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139051690|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139051691|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051692|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
139051693|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139051694|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
139051695|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051696|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139051697|NCT00452699|Fluticasone|fluticasone|mesh-list
139051698|NCT00452699|Xhance|xhance|mesh-list
139051699|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139051700|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139051701|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139051702|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
139051703|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051704|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051705|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139051706|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
139051707|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
139051708|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139051709|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139051710|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139051711|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139051712|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
139051713|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139051714|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051715|NCT00069784|Insulin|insulin|mesh-list
139051717|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
139051718|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139051719|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051720|NCT00090610|Carboplatin|carboplatin|mesh-list
139051721|NCT00090610|Docetaxel|docetaxel|mesh-list
139051722|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051723|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
139051724|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
139051725|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
139051726|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051727|NCT01326988|Anesthetics|anesthetics|mesh-list
139051728|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139051729|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051730|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
139051731|NCT03962296|Calcium|calcium|mesh-list
139051732|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139051733|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051734|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
139051735|NCT03962296|Coagulants|coagulants|mesh-ancestor
139051736|NCT01086046|Heparin|heparin|mesh-list
139051737|NCT01086046|Enoxaparin|enoxaparin|mesh-list
139051738|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139051739|NCT01086046|Tinzaparin|tinzaparin|mesh-list
139051740|NCT01086046|Dalteparin|dalteparin|mesh-list
139051741|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
139051742|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139051743|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139051744|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051745|NCT01090648|Etravirine|etravirine|mesh-list
139051746|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139051747|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139051748|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051749|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051750|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
139051751|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051752|NCT03741244|Temozolomide|temozolomide|mesh-list
139051753|NCT03741244|Apatinib|apatinib|mesh-list
139051754|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139051755|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
139051756|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051757|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692557|NCT04885686|Thymol|thymol|mesh-list
139051758|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139051759|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051760|NCT00463385|Thalidomide|thalidomide|mesh-list
139051761|NCT00463385|Prednisone|prednisone|mesh-list
139051762|NCT00463385|Pomalidomide|pomalidomide|mesh-list
139051763|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139051764|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
139051765|NCT00463385|Hormones|hormones|mesh-ancestor
139051766|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139051767|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051768|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139051769|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051770|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
139051771|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139051772|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139051773|NCT00463385|Growth Substances|growth substances|mesh-ancestor
139051774|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
139051775|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139051776|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
139051777|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139051778|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051779|NCT03839693|Botulinum Toxins|botulinum toxins|mesh-list
139051780|NCT03839693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139051781|NCT03839693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139051782|NCT03839693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139051783|NCT03839693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139051784|NCT03839693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051785|NCT03839693|Cholinergic Agents|cholinergic agents|mesh-ancestor
139051786|NCT03839693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139051787|NCT03839693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051788|NCT03839693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139051789|NCT03839693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051790|NCT00068692|Leucovorin|leucovorin|mesh-list
139051791|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
139051792|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
139051793|NCT00068692|Fluorouracil|fluorouracil|mesh-list
139051794|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
139051795|NCT00068692|Irinotecan|irinotecan|mesh-list
139051796|NCT00068692|Camptothecin|camptothecin|mesh-list
139051797|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
139051798|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051799|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
139051800|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625015|NCT03609580|Tamsulosin|tamsulosin|mesh-list
139051801|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139051802|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051803|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139051804|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
139051805|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139051806|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139051807|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051808|NCT00068692|Antidotes|antidotes|mesh-ancestor
139051809|NCT00068692|Protective Agents|protective agents|mesh-ancestor
139051810|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
139051811|NCT00068692|Vitamins|vitamins|mesh-ancestor
139051812|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
139051813|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139051814|NCT00463151|Rebamipide|rebamipide|mesh-list
139051815|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139051816|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139051817|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
139051818|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051819|NCT00463151|Protective Agents|protective agents|mesh-ancestor
139051820|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051821|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051822|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
139051823|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051824|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139051825|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051826|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802449|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051827|NCT00067990|Losartan|losartan|mesh-list
139051828|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139051829|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139051830|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139051831|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139051832|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051833|NCT00263328|Tacrolimus|tacrolimus|mesh-list
139051834|NCT00263328|Tofacitinib|tofacitinib|mesh-list
139051835|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139051836|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
139051837|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051838|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139051839|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051840|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051841|NCT00263328|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139051842|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139051843|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
139051844|NCT03741660|Cathartics|cathartics|mesh-ancestor
139051845|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139051846|NCT00262860|Gemcitabine|gemcitabine|mesh-list
139051847|NCT00262860|Bortezomib|bortezomib|mesh-list
139051848|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139051849|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
139051850|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051851|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051852|NCT00236184|Rabeprazole|rabeprazole|mesh-list
139051853|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139051854|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139051855|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139051856|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051857|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051858|NCT00296504|Ritonavir|ritonavir|mesh-list
139051859|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
139051860|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139051861|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139051862|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
139051863|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051864|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051865|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139051866|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139051867|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
139051868|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051869|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139051870|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139051871|NCT00313820|Pregabalin|pregabalin|mesh-list
139051872|NCT00313820|Analgesics|analgesics|mesh-ancestor
139051873|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
139051874|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051875|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051876|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
139051877|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139051878|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139051879|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051880|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139051881|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139051882|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139051883|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139051884|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139051885|NCT00235872|Adalimumab|adalimumab|mesh-list
139051886|NCT00235872|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139051887|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139051888|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139051889|NCT00461981|Vaccines|vaccines|mesh-list
139051890|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
139051891|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051892|NCT00296036|Pyridoxine|pyridoxine|mesh-list
139051893|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
139051894|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
139051895|NCT00296036|Vitamins|vitamins|mesh-ancestor
139051896|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
139051897|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051898|NCT01072890|Sirolimus|sirolimus|mesh-list
139051899|NCT01072890|Temsirolimus|temsirolimus|mesh-list
139051900|NCT01072890|MTOR Inhibitors|mtor inhibitors|mesh-list
139051901|NCT01072890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139051902|NCT01072890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051903|NCT01072890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051904|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139051905|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
139051906|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051907|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051908|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139051909|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051910|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139051912|NCT00089674|Denosumab|denosumab|mesh-list
139051913|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139051914|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051915|NCT01090882|Bupivacaine|bupivacaine|mesh-list
139051916|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
139051917|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
139051918|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139051919|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051920|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
138625376|NCT02452918|Oritavancin|oritavancin|mesh-list
139051921|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051922|NCT01090960|Ipatasertib|ipatasertib|mesh-list
139051923|NCT01090960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051924|NCT01090960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139051925|NCT01090960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051926|NCT01090960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051927|NCT01067066|Temozolomide|temozolomide|mesh-list
139051928|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139051929|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
139051930|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051931|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051932|NCT00313586|Azacitidine|azacitidine|mesh-list
139051933|NCT00313586|Entinostat|entinostat|mesh-list
139051934|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139051935|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139051936|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
139051937|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051938|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051939|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051940|NCT01069328|Paclitaxel|paclitaxel|mesh-list
139051941|NCT01069328|Bevacizumab|bevacizumab|mesh-list
139051942|NCT01069328|Carboplatin|carboplatin|mesh-list
139051943|NCT01069328|Sorafenib|sorafenib|mesh-list
139051944|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138897338|NCT02563054|Capecitabine|capecitabine|mesh-list
139051945|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051946|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
139051947|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
139051948|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
139051949|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051950|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139051951|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138625565|NCT01012817|Topotecan|topotecan|mesh-list
139051952|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139051953|NCT01069328|Growth Substances|growth substances|mesh-ancestor
139051954|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051955|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
139051956|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139051957|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051958|NCT01067222|Modafinil|modafinil|mesh-list
139051959|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139051960|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051961|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139051962|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139051963|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139051964|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051965|NCT00312572|Buprenorphine|buprenorphine|mesh-list
139051966|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139051967|NCT00312572|Narcotics|narcotics|mesh-ancestor
139051968|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139051969|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051970|NCT00312572|Analgesics|analgesics|mesh-ancestor
139051971|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
139051972|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139051973|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139051974|NCT00290732|Doxorubicin|doxorubicin|mesh-list
139051975|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139051976|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139051977|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139051978|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139051979|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139051980|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139051981|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051982|NCT00312494|Ziprasidone|ziprasidone|mesh-list
139051983|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139051984|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
139051985|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139051986|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139051987|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139051988|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139051989|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139051990|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139051991|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139051992|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139051993|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
139051994|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
139051995|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139051996|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139051997|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139051998|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139051999|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139052000|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052001|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052002|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052003|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139052004|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
139052005|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139052006|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052007|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139052008|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139052009|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139052011|NCT00290498|Dexamethasone|dexamethasone|mesh-list
139052012|NCT00290498|Prednisone|prednisone|mesh-list
139052013|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
139052014|NCT00290498|Rituximab|rituximab|mesh-list
139052015|NCT00290498|Doxorubicin|doxorubicin|mesh-list
139052016|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139052017|NCT00290498|Methotrexate|methotrexate|mesh-list
139052018|NCT00290498|Vincristine|vincristine|mesh-list
139052019|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139052020|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
139052021|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052022|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139052023|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139052024|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
139052025|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052026|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052027|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139052028|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139052029|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
139052030|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
139052031|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052032|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139052033|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
139052034|NCT00290498|Hormones|hormones|mesh-ancestor
139052035|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139052036|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139052037|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052038|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139052039|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139052040|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138625765|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
139052041|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052042|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139052043|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
139052044|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139052045|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139052046|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
139052047|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
139052048|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139052049|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139052050|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
139052051|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052052|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139052053|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
138802672|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052055|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
139052056|NCT01069796|Paclitaxel|paclitaxel|mesh-list
139052057|NCT01069796|Bevacizumab|bevacizumab|mesh-list
139052058|NCT01069796|Capecitabine|capecitabine|mesh-list
139052059|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139052060|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052061|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
139052062|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
139052063|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
138625828|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052064|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052065|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052066|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139052067|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139052068|NCT01069796|Growth Substances|growth substances|mesh-ancestor
139052069|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052070|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
139052071|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139052072|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
139052073|NCT01067534|Albuterol|albuterol|mesh-list
139052074|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139052075|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
139052076|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052077|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052078|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139052079|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
139052080|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
139052081|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139052082|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139052083|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139052084|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139052085|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
139052086|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139052087|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052088|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
139052089|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
139052090|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
139052091|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
139052092|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139052093|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
139052094|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052095|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139052096|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139052097|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139052098|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139052099|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139052100|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052102|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139052103|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052104|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
139052105|NCT01069874|Vitamin D|vitamin d|mesh-list
139052106|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
139052107|NCT01069874|Vitamins|vitamins|mesh-ancestor
139052108|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
139052109|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052110|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138625936|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139052111|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139052112|NCT01022645|Copper|copper|mesh-list
139052113|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
139052114|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139052115|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
139052116|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139052117|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052118|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139052119|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139052120|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139052121|NCT01022645|Trace Elements|trace elements|mesh-ancestor
139052122|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
139052123|NCT01025765|Metformin|metformin|mesh-list
139052124|NCT01025765|Pioglitazone|pioglitazone|mesh-list
139052125|NCT01025765|Acarbose|acarbose|mesh-list
139052126|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139052127|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052128|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139052129|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052130|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052131|NCT03824912|Ketoconazole|ketoconazole|mesh-list
139052132|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
139052133|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052134|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139052135|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139052136|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052137|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052138|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139052139|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
139052140|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139052141|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052142|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139052143|NCT01062776|Furosemide|furosemide|mesh-list
139052144|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139052145|NCT01062776|Diuretics|diuretics|mesh-ancestor
139052146|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
139052147|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692618|NCT02690064|Vitamins|vitamins|mesh-list
139052148|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139052149|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139052150|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052151|NCT01070030|Amlodipine|amlodipine|mesh-list
139052152|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139052153|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139052154|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139052155|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139052156|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052157|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139052158|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052159|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
139052160|NCT01070030|Diuretics|diuretics|mesh-ancestor
139052161|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
139052162|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139052163|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139052164|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
139052165|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139052166|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139052167|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052168|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052169|NCT00461123|Urological Agents|urological agents|mesh-ancestor
139052170|NCT00290342|Edetic Acid|edetic acid|mesh-list
139052171|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
139052172|NCT00290342|Antidotes|antidotes|mesh-ancestor
139052173|NCT00290342|Protective Agents|protective agents|mesh-ancestor
139052174|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052175|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
139052176|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
139052177|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052178|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139052179|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
139052180|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139052181|NCT00460811|Linaclotide|linaclotide|mesh-list
139052182|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139052183|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
139052184|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052185|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139052186|NCT01070108|Ketamine|ketamine|mesh-list
139052187|NCT01070108|Analgesics|analgesics|mesh-ancestor
139052188|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
139052189|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052190|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052191|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139052192|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139052193|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
139052194|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
139052195|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139052196|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139052197|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139052198|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139052199|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052200|NCT01067690|Indinavir|indinavir|mesh-list
139052201|NCT01067690|Bleomycin|bleomycin|mesh-list
139052202|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139052203|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139052204|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
139052205|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052206|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052207|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139052208|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139052209|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
139052210|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052211|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139052212|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052213|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
139052214|NCT03982004|Imiquimod|imiquimod|mesh-list
139052215|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052216|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052217|NCT03982004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139052218|NCT03982004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052219|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139052220|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
139052221|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052222|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
139052223|NCT01025921|Colistin|colistin|mesh-list
139052224|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138626132|NCT00199121|Zidovudine|zidovudine|mesh-list
139052225|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052226|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139052227|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052228|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052229|NCT01026233|Immunotoxins|immunotoxins|mesh-ancestor
139052230|NCT01026233|Immunoconjugates|immunoconjugates|mesh-ancestor
139052231|NCT01026233|Immunologic Factors|immunologic factors|mesh-ancestor
139052232|NCT01026233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052233|NCT01062932|Cycloserine|cycloserine|mesh-list
139052234|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139052235|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052236|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139052237|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
139052238|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139052239|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
139052240|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052241|NCT01026311|Ubiquinone|ubiquinone|mesh-list
139052242|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
139052243|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
139052244|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052245|NCT01026311|Vitamins|vitamins|mesh-ancestor
139052246|NCT01063010|Bevacizumab|bevacizumab|mesh-list
139052247|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052248|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052249|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139052250|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139052251|NCT01063010|Growth Substances|growth substances|mesh-ancestor
139052252|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052253|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
139052254|NCT00460577|Bromides|bromides|mesh-list
139052255|NCT00460577|Fenoterol|fenoterol|mesh-list
139052256|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
139052257|NCT00460577|Ipratropium|ipratropium|mesh-list
139052258|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139052259|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
138626160|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
139052260|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052261|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052262|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139052263|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
139052264|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139052265|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139052266|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139052267|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
139052268|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139052269|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052270|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
139052271|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139052272|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
139052273|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
139052274|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
139052275|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139052276|NCT01581320|Vitamin D|vitamin d|mesh-list
139052277|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
139052278|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
139052280|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
139052281|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052282|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139052283|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139052284|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139052285|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052286|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052287|NCT00288704|Rilonacept|rilonacept|mesh-list
139052288|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139052289|NCT00288626|Cytarabine|cytarabine|mesh-list
139052290|NCT00288626|Prednisone|prednisone|mesh-list
139052291|NCT00288626|Etoposide|etoposide|mesh-list
139052292|NCT00288626|Melphalan|melphalan|mesh-list
139052293|NCT00288626|Carmustine|carmustine|mesh-list
139052294|NCT00288626|Lenograstim|lenograstim|mesh-list
139052295|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139052296|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
139052297|NCT00288626|Hormones|hormones|mesh-ancestor
139052298|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139052299|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052300|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139052301|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052302|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139052303|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139052304|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139052305|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052306|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052307|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139052308|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
139052309|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
139052310|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052311|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139052312|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
139052313|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139052314|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
139052315|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139052316|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139052317|NCT00087490|Vancomycin|vancomycin|mesh-list
139052318|NCT00087490|Linezolid|linezolid|mesh-list
139052319|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139052320|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052321|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139052322|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626317|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139052323|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052324|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
139052325|NCT00087178|Doxorubicin|doxorubicin|mesh-list
139052326|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139052327|NCT00087178|Fluorouracil|fluorouracil|mesh-list
139052328|NCT00087178|Epirubicin|epirubicin|mesh-list
139052329|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139052331|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052332|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139052333|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139052334|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
139052335|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052336|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052337|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139052338|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139052339|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139052340|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139052341|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052342|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
139052343|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139052344|NCT00288080|Dexamethasone|dexamethasone|mesh-list
139052345|NCT00288080|Prednisone|prednisone|mesh-list
139052346|NCT00288080|Docetaxel|docetaxel|mesh-list
139052347|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
139052348|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139052349|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
139052350|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
139052351|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052352|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802973|NCT00699478|Vitamins|vitamins|mesh-ancestor
139052353|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139052354|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
139052355|NCT00288080|Hormones|hormones|mesh-ancestor
139052356|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139052357|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139052358|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052359|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
139052360|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
139052361|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
139052362|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052363|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
139052364|NCT01068392|Prednisolone|prednisolone|mesh-list
139052365|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
139052366|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052367|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139052368|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
139052369|NCT01068392|Hormones|hormones|mesh-ancestor
139052370|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138626412|NCT00565240|Progestins|progestins|mesh-ancestor
139052371|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052372|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139052373|NCT01086826|Cisplatin|cisplatin|mesh-list
139052374|NCT01086826|Docetaxel|docetaxel|mesh-list
139052375|NCT01086826|Fluorouracil|fluorouracil|mesh-list
139052376|NCT01086826|Cetuximab|cetuximab|mesh-list
139052377|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052378|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
139052379|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
139052380|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
138897594|NCT00866918|Antioxidants|antioxidants|mesh-ancestor
139052381|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052382|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
139052383|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139052384|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139052385|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
139052386|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052387|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052388|NCT00287690|Genistein|genistein|mesh-list
139052389|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139052390|NCT00287690|Protective Agents|protective agents|mesh-ancestor
139052391|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626464|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
139052392|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052393|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139052394|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052395|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052396|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
139052397|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139052398|NCT00287690|Estrogens|estrogens|mesh-ancestor
139052399|NCT00287690|Hormones|hormones|mesh-ancestor
139052400|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139052401|NCT01070186|Sunitinib|sunitinib|mesh-list
139052402|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052403|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139052404|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139052405|NCT01070186|Growth Substances|growth substances|mesh-ancestor
139052406|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052407|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
139052408|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139052409|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052410|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052411|NCT00066742|Etoposide|etoposide|mesh-list
139052412|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
139052413|NCT00066742|Tirapazamine|tirapazamine|mesh-list
139052414|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052415|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139052416|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139052417|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139052418|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052419|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052420|NCT01026467|Carboplatin|carboplatin|mesh-list
139052421|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052422|NCT01094158|Cholic Acids|cholic acids|mesh-list
139052423|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139052424|NCT00460109|Rituximab|rituximab|mesh-list
139052425|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
139052426|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052427|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803050|NCT01074554|Rifampin|rifampin|mesh-list
139052428|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
138897614|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139052429|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052430|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139052432|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139052433|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052434|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
139052435|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139052436|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139052437|NCT01091818|Midazolam|midazolam|mesh-list
139052438|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
139052439|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139052440|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139052441|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052442|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139052443|NCT01091818|Analgesics|analgesics|mesh-ancestor
139052444|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
139052445|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052446|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139052447|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139052448|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139052449|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
139052450|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139052451|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052452|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139052453|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139052454|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139052455|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139052456|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139052457|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
139052458|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
139052459|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
139052460|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
139052461|NCT01091896|Bevacizumab|bevacizumab|mesh-list
139052462|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052463|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052464|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139052465|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139052466|NCT01091896|Growth Substances|growth substances|mesh-ancestor
139052467|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052468|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
139052469|NCT00065260|Cyclosporine|cyclosporine|mesh-list
139052470|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
139052471|NCT00065260|Cyclosporins|cyclosporins|mesh-list
139052472|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
139052473|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139052474|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052475|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052476|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139052477|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
139052478|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052479|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
139052480|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052481|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
139052482|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139052483|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139052484|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052485|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052486|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
139052487|NCT01327066|Droxidopa|droxidopa|mesh-list
139052488|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139052489|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052490|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139052491|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139052492|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052493|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052494|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052495|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139052496|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139052497|NCT01094626|Secretin|secretin|mesh-list
139052498|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139052499|NCT01094626|Hormones|hormones|mesh-ancestor
139052500|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139052501|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052502|NCT03956134|Tapentadol|tapentadol|mesh-list
139052503|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139052504|NCT03956134|Narcotics|narcotics|mesh-ancestor
139052505|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139052506|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052507|NCT03956134|Analgesics|analgesics|mesh-ancestor
139052508|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
139052509|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052510|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139052511|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139052512|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139052513|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052514|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
139052515|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139052516|NCT00460031|Ketoconazole|ketoconazole|mesh-list
139052517|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
139052518|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139052519|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139052520|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139052521|NCT00460031|Lenalidomide|lenalidomide|mesh-list
139052522|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
139052523|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052524|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139052525|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139052526|NCT00460031|Growth Substances|growth substances|mesh-ancestor
139052527|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
139052528|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052529|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139052531|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052532|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139052533|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139052534|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052535|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052536|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139052537|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
139052538|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139052539|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139052540|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
139052541|NCT00451217|Neostigmine|neostigmine|mesh-list
139052542|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139052543|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052544|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052545|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
139052546|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139052547|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052548|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139052549|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
139052550|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052551|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139052552|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139052553|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139052554|NCT00459953|Nicotine|nicotine|mesh-list
139052555|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139052556|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
139052557|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052558|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052559|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139052560|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139052561|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
139052562|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139052563|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052564|NCT00459875|Sunitinib|sunitinib|mesh-list
139052565|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052566|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139052567|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139052568|NCT00459875|Growth Substances|growth substances|mesh-ancestor
139052569|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052570|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
139052571|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139052572|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052573|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052574|NCT00311402|Aspirin|aspirin|mesh-list
139052575|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
139052576|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139052577|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139052578|NCT00311402|Analgesics|analgesics|mesh-ancestor
138803193|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
139052579|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
139052580|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052581|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052582|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139052583|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139052584|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139052585|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139052586|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052587|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139052588|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139052589|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052590|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
139052591|NCT00450749|Lycopene|lycopene|mesh-list
139052592|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
139052593|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052594|NCT00450749|Protective Agents|protective agents|mesh-ancestor
139052595|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052596|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139052597|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139052598|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139052599|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052600|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139052601|NCT00292370|Paroxetine|paroxetine|mesh-list
139052602|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
139052603|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139052604|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139052605|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139052606|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692745|NCT05558449|Anesthetics|anesthetics|mesh-ancestor
139052607|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052608|NCT00292370|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138897722|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139052609|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139052610|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139052611|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052612|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139052613|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
139052614|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139052615|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139052616|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139052617|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052618|NCT00065182|Docetaxel|docetaxel|mesh-list
139052619|NCT00065182|Topotecan|topotecan|mesh-list
139052620|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052621|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
139052622|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
139052623|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
139052624|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052625|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139052626|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139052627|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052628|NCT01026701|Bortezomib|bortezomib|mesh-list
139052629|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052630|NCT01092130|Vitamin D|vitamin d|mesh-list
139052631|NCT01092130|Vitamins|vitamins|mesh-ancestor
139052632|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
139052633|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052634|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139052635|NCT00064792|Simvastatin|simvastatin|mesh-list
139052636|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139052637|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139052638|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
139052639|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052640|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139052641|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139052642|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052643|NCT01095016|Fenoterol|fenoterol|mesh-list
139052644|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139052645|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
139052646|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052647|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627065|NCT04591444|Fluorides|fluorides|mesh-list
139052648|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139052649|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
139052650|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
139052651|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
139052652|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139052653|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138692764|NCT00595543|Diclofenac|diclofenac|mesh-list
139052654|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139052655|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139052656|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
139052658|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052659|NCT01095172|Prednisolone|prednisolone|mesh-list
139052660|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139052661|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
139052662|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139052663|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
139052664|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
139052666|NCT01095172|Tacrolimus|tacrolimus|mesh-list
139052667|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139052668|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
138627074|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139052669|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052670|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052671|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
139052672|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052673|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139052674|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139052675|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139052676|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052677|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052678|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139052679|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
139052680|NCT01095172|Hormones|hormones|mesh-ancestor
139052681|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139052682|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139052683|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
139052684|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
139052685|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052686|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139052687|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139052688|NCT01095172|Protective Agents|protective agents|mesh-ancestor
139052689|NCT00286442|Metformin|metformin|mesh-list
139052690|NCT00286442|Alogliptin|alogliptin|mesh-list
139052691|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139052692|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052693|NCT00286442|Incretins|incretins|mesh-ancestor
139052694|NCT00286442|Hormones|hormones|mesh-ancestor
139052695|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139052696|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139052697|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
139052698|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052699|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052700|NCT00063934|Docetaxel|docetaxel|mesh-list
139052701|NCT00063934|Doxorubicin|doxorubicin|mesh-list
139052702|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139052703|NCT00063934|Oblimersen|oblimersen|mesh-list
138627175|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
138627176|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627177|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
138627178|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138627179|NCT04589299|Antibodies|antibodies|mesh-list
139052704|NCT00063934|Lenograstim|lenograstim|mesh-list
139052705|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052706|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
139052707|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
139052708|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
138897780|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052709|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052710|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139052711|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139052712|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139052713|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052714|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139052715|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
139052716|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052718|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052719|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052720|NCT01092520|Gabapentin|gabapentin|mesh-list
139052721|NCT01092520|Analgesics|analgesics|mesh-ancestor
139052722|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
139052723|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052724|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052725|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
139052726|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139052727|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139052728|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139052729|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139052730|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139052731|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139052732|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139052733|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052734|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
139052735|NCT00458705|Thalidomide|thalidomide|mesh-list
139052736|NCT00458705|Dexamethasone|dexamethasone|mesh-list
139052737|NCT00458705|Doxorubicin|doxorubicin|mesh-list
139052738|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139052739|NCT00458705|Bortezomib|bortezomib|mesh-list
139052740|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139052741|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
139052743|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052744|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052745|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139052746|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
139052747|NCT00458705|Hormones|hormones|mesh-ancestor
139052748|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139052749|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139052750|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052751|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139052752|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139052753|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139052754|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052755|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052756|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139052757|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
139052758|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
139052759|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139052760|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052761|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139052762|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139052763|NCT00458705|Growth Substances|growth substances|mesh-ancestor
139052764|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
139052765|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
139052766|NCT00062374|Alovudine|alovudine|mesh-list
139052767|NCT00062374|Cisplatin|cisplatin|mesh-list
139052768|NCT00062374|Irinotecan|irinotecan|mesh-list
139052769|NCT00062374|Camptothecin|camptothecin|mesh-list
139052770|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139052771|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052772|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139052773|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139052774|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052775|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052776|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139052777|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139052778|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
139052779|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
139052780|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052781|NCT00285818|Mifepristone|mifepristone|mesh-list
139052782|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139052783|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
139052784|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139052785|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052786|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139052787|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139052788|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139052789|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
139052790|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139052791|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139052792|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
139052793|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139052794|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
139052795|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139052796|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139052798|NCT01023347|genexol-PM|genexol-pm|mesh-list
139052799|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139052800|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139052801|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052802|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
139052803|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
139052804|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
139052805|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052807|NCT06202755|Ticagrelor|ticagrelor|mesh-list
139052808|NCT06202755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139052809|NCT06202755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139052810|NCT06202755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139052811|NCT06202755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139052812|NCT06202755|Purinergic Agents|purinergic agents|mesh-ancestor
139052813|NCT06202755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139052814|NCT06202755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052815|NCT06202755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052816|NCT06202755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139052817|NCT06202755|Autonomic Agents|autonomic agents|mesh-ancestor
139052818|NCT06202755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052819|NCT06202755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139052820|NCT06202755|Respiratory System Agents|respiratory system agents|mesh-ancestor
139052821|NCT06202755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139052822|NCT06202755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139052823|NCT06202755|Vasodilator Agents|vasodilator agents|mesh-ancestor
139052824|NCT06202755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139052825|NCT06202755|Protective Agents|protective agents|mesh-ancestor
139052826|NCT06202755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139052827|NCT06202755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139052828|NCT06202755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052829|NCT06202703|Vaccines|vaccines|mesh-list
139052830|NCT06202703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139052831|NCT06202703|Immunologic Factors|immunologic factors|mesh-ancestor
139052832|NCT06202703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052833|NCT06202664|Analgesics, Opioid|analgesics, opioid|mesh-list
139052834|NCT06202664|Analgesics|analgesics|mesh-list
139052835|NCT06202664|Narcotics|narcotics|mesh-ancestor
139052836|NCT06202664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139052837|NCT06202664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052838|NCT06202664|Sensory System Agents|sensory system agents|mesh-ancestor
139052839|NCT06202664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052840|NCT06202560|Tofacitinib|tofacitinib|mesh-list
139052841|NCT06202560|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139052842|NCT06202560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139052843|NCT06202560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052844|NCT06202560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052845|NCT06202495|Fluorides|fluorides|mesh-list
139052846|NCT06202495|Cariostatic Agents|cariostatic agents|mesh-ancestor
139052847|NCT06202495|Protective Agents|protective agents|mesh-ancestor
139052848|NCT06202495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052849|NCT06202261|Docetaxel|docetaxel|mesh-list
139052850|NCT06202261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052851|NCT06202261|Tubulin Modulators|tubulin modulators|mesh-ancestor
139052852|NCT06202261|Antimitotic Agents|antimitotic agents|mesh-ancestor
139052853|NCT06202261|Mitosis Modulators|mitosis modulators|mesh-ancestor
139052854|NCT06202261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052855|NCT06202079|Insulin|insulin|mesh-list
139052856|NCT06202079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139052857|NCT06202079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052858|NCT06202066|Temozolomide|temozolomide|mesh-list
139052859|NCT06202066|Sargramostim|sargramostim|mesh-list
139052860|NCT06202066|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139052861|NCT06202066|Freund's Adjuvant|freund's adjuvant|mesh-list
139052862|NCT06202066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138692867|NCT05468450|Polidocanol|polidocanol|mesh-list
139052863|NCT06202066|Alkylating Agents|alkylating agents|mesh-ancestor
139052864|NCT06202066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052865|NCT06202066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052866|NCT06202066|Immunologic Factors|immunologic factors|mesh-ancestor
139052867|NCT06202066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052868|NCT06202066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139052869|NCT06202001|Trifluridine|trifluridine|mesh-list
139052870|NCT06202001|Bevacizumab|bevacizumab|mesh-list
139052872|NCT06202001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139052873|NCT06202001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052874|NCT06202001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139052875|NCT06202001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139052876|NCT06202001|Growth Substances|growth substances|mesh-ancestor
139052877|NCT06202001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052878|NCT06202001|Growth Inhibitors|growth inhibitors|mesh-ancestor
138803494|NCT02614612|Prednisone|prednisone|mesh-list
139052879|NCT06202001|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139052880|NCT06202001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139052881|NCT06202001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052882|NCT06202001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052883|NCT06202001|Antimetabolites|antimetabolites|mesh-ancestor
139052884|NCT06202001|Antiviral Agents|antiviral agents|mesh-ancestor
139052885|NCT06202001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052886|NCT06201949|Carticaine|carticaine|mesh-list
139052887|NCT06201949|Anesthetics, Local|anesthetics, local|mesh-ancestor
139052888|NCT06201949|Anesthetics|anesthetics|mesh-ancestor
139052889|NCT06201949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139052890|NCT06201949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052891|NCT06201949|Sensory System Agents|sensory system agents|mesh-ancestor
139052892|NCT06201949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052916|NCT06201676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052917|NCT06201624|Isotretinoin|isotretinoin|mesh-list
139052918|NCT06201624|Dermatologic Agents|dermatologic agents|mesh-ancestor
139052919|NCT06201611|Thioctic Acid|thioctic acid|mesh-list
139052920|NCT06201611|Nebivolol|nebivolol|mesh-list
139052921|NCT06201611|Epalrestat|epalrestat|mesh-list
139052922|NCT06201611|Antioxidants|antioxidants|mesh-ancestor
139052923|NCT06201611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052924|NCT06201611|Protective Agents|protective agents|mesh-ancestor
139052925|NCT06201611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052927|NCT06201611|Vitamins|vitamins|mesh-ancestor
139052928|NCT06201611|Micronutrients|micronutrients|mesh-ancestor
139052929|NCT06201611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139052930|NCT06201611|Vasodilator Agents|vasodilator agents|mesh-ancestor
139052931|NCT06201611|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139052932|NCT06201611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139052933|NCT06201611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139052934|NCT06201611|Adrenergic Agents|adrenergic agents|mesh-ancestor
139052935|NCT06201611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139052936|NCT06201611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052937|NCT06201559|Albendazole|albendazole|mesh-list
139052938|NCT06201559|Anthelmintics|anthelmintics|mesh-ancestor
139052939|NCT06201559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139052940|NCT06201559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052941|NCT06201559|Anticestodal Agents|anticestodal agents|mesh-ancestor
139052942|NCT06201559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139052943|NCT06201559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139052944|NCT06201559|Tubulin Modulators|tubulin modulators|mesh-ancestor
139052945|NCT06201559|Antimitotic Agents|antimitotic agents|mesh-ancestor
139052946|NCT06201559|Mitosis Modulators|mitosis modulators|mesh-ancestor
139052947|NCT06201559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052948|NCT06201559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052949|NCT06201234|Niraparib|niraparib|mesh-list
139052950|NCT06201234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139052951|NCT06201234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052952|NCT06201234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052953|NCT06201234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803569|NCT03172377|Adalimumab|adalimumab|mesh-list
139052954|NCT06201195|Iodine|iodine|mesh-list
139052955|NCT06201195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139052956|NCT06201195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139052957|NCT06201195|Trace Elements|trace elements|mesh-ancestor
139052958|NCT06201195|Micronutrients|micronutrients|mesh-ancestor
139052959|NCT06201195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052960|NCT06201065|Leucovorin|leucovorin|mesh-list
139052961|NCT06201065|Fluorouracil|fluorouracil|mesh-list
139052962|NCT06201065|Oxaliplatin|oxaliplatin|mesh-list
139052963|NCT06201065|Lenvatinib|lenvatinib|mesh-list
139052964|NCT06201065|Antimetabolites|antimetabolites|mesh-ancestor
139052965|NCT06201065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052966|NCT06201065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139052967|NCT06201065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139052968|NCT06201065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139052969|NCT06201065|Immunologic Factors|immunologic factors|mesh-ancestor
139052970|NCT06201065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052971|NCT06201065|Antidotes|antidotes|mesh-ancestor
139052972|NCT06201065|Protective Agents|protective agents|mesh-ancestor
139052973|NCT06201065|Vitamin B Complex|vitamin b complex|mesh-ancestor
139052974|NCT06201065|Vitamins|vitamins|mesh-ancestor
139052975|NCT06201065|Micronutrients|micronutrients|mesh-ancestor
139052976|NCT06201065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139052977|NCT06201065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139052978|NCT06201039|Lidocaine|lidocaine|mesh-list
139052979|NCT06201039|Anesthetics, Local|anesthetics, local|mesh-ancestor
139052980|NCT06201039|Anesthetics|anesthetics|mesh-ancestor
139052981|NCT06201039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139052982|NCT06201039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052983|NCT06201039|Sensory System Agents|sensory system agents|mesh-ancestor
139052984|NCT06201039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139052985|NCT06201039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139052986|NCT06201039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138627632|NCT00223691|Diuretics|diuretics|mesh-ancestor
139052987|NCT06201039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139052988|NCT06201039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139052989|NCT06201039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139052990|NCT06201013|Vitamin D|vitamin d|mesh-list
139052991|NCT06201013|Ergocalciferols|ergocalciferols|mesh-list
139052992|NCT06201013|Cholecalciferol|cholecalciferol|mesh-list
139052993|NCT06201013|Vitamins|vitamins|mesh-list
139052994|NCT06201013|Solifenacin Succinate|solifenacin succinate|mesh-list
139052995|NCT06201013|Micronutrients|micronutrients|mesh-ancestor
139052996|NCT06201013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139052997|NCT06201013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139052998|NCT06201013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139052999|NCT06201013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139053000|NCT06201013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139053001|NCT06201013|Cholinergic Agents|cholinergic agents|mesh-ancestor
139053002|NCT06201013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139053003|NCT06201013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053004|NCT06201013|Urological Agents|urological agents|mesh-ancestor
139053005|NCT06200883|Choline|choline|mesh-list
139053006|NCT06200883|Lipotropic Agents|lipotropic agents|mesh-ancestor
139053007|NCT06200883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139053008|NCT06200883|Antimetabolites|antimetabolites|mesh-ancestor
139053009|NCT06200883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053010|NCT06200883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139053011|NCT06200883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139053012|NCT06200883|Nootropic Agents|nootropic agents|mesh-ancestor
139053013|NCT06200779|Amoxicillin|amoxicillin|mesh-list
139053014|NCT06200779|Clarithromycin|clarithromycin|mesh-list
139053015|NCT06200779|Levofloxacin|levofloxacin|mesh-list
139053016|NCT06200779|Ofloxacin|ofloxacin|mesh-list
139053017|NCT06200779|Metronidazole|metronidazole|mesh-list
139053018|NCT06200779|Tetracycline|tetracycline|mesh-list
139053019|NCT06200779|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
139053020|NCT06200779|Bismuth|bismuth|mesh-list
139053021|NCT06200779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139053022|NCT06200779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053023|NCT06200779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139053024|NCT06200779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053025|NCT06200779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053026|NCT06200779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139053027|NCT06200779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139053028|NCT06200779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139053029|NCT06200779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139053030|NCT06200779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139053031|NCT06200779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053032|NCT06200779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139053033|NCT06200779|Antacids|antacids|mesh-ancestor
139053034|NCT06200779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139053035|NCT06200779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139053036|NCT06200779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139053037|NCT06200779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139053038|NCT06200766|Mometasone Furoate|mometasone furoate|mesh-list
139053039|NCT06200766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139053040|NCT06200766|Dermatologic Agents|dermatologic agents|mesh-ancestor
139053041|NCT06200766|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139053042|NCT06200662|Analgesics|analgesics|mesh-list
139053043|NCT06200662|Sensory System Agents|sensory system agents|mesh-ancestor
139053044|NCT06200662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053045|NCT06200662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053046|NCT06200584|Vitamin D|vitamin d|mesh-list
139053047|NCT06200584|Ergocalciferols|ergocalciferols|mesh-list
139053048|NCT06200584|Cholecalciferol|cholecalciferol|mesh-list
139053049|NCT06200584|Vitamins|vitamins|mesh-list
139053050|NCT06200584|Vitamin E|vitamin e|mesh-list
139053051|NCT06200584|Tocopherols|tocopherols|mesh-list
139053052|NCT06200584|Tocotrienols|tocotrienols|mesh-list
139053053|NCT06200584|alpha-Tocopherol|alpha-tocopherol|mesh-list
139053054|NCT06200584|Olanzapine|olanzapine|mesh-list
139053055|NCT06200584|Risperidone|risperidone|mesh-list
139053056|NCT06200584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139053057|NCT06200584|Antipsychotic Agents|antipsychotic agents|mesh-list
139053058|NCT06200584|Micronutrients|micronutrients|mesh-ancestor
139053059|NCT06200584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053060|NCT06200584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139053061|NCT06200584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139053062|NCT06200584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139053063|NCT06200584|Serotonin Agents|serotonin agents|mesh-ancestor
139053064|NCT06200584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139053065|NCT06200584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053066|NCT06200584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139053067|NCT06200584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139053068|NCT06200584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139053069|NCT06200584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139053070|NCT06200584|Dopamine Agents|dopamine agents|mesh-ancestor
139053071|NCT06200584|Antiemetics|antiemetics|mesh-ancestor
139053072|NCT06200584|Autonomic Agents|autonomic agents|mesh-ancestor
139053073|NCT06200584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053074|NCT06200584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139053075|NCT06200584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139053087|NCT06200298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053088|NCT06200298|Sensory System Agents|sensory system agents|mesh-ancestor
139053089|NCT06200298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053090|NCT06198322|Vitamin D|vitamin d|mesh-list
139053091|NCT06198322|Cholecalciferol|cholecalciferol|mesh-list
139053092|NCT06198322|Vitamins|vitamins|mesh-ancestor
139053093|NCT06198322|Micronutrients|micronutrients|mesh-ancestor
139053094|NCT06198322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053095|NCT06198322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139053096|NCT06198322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138803716|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053108|NCT06195540|Heparin|heparin|mesh-list
139053109|NCT06195540|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139053110|NCT06195540|Dalteparin|dalteparin|mesh-list
139053111|NCT06195540|Rivaroxaban|rivaroxaban|mesh-list
139053112|NCT06195540|Anticoagulants|anticoagulants|mesh-ancestor
139053113|NCT06195540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139053114|NCT06195540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139053115|NCT06195540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898045|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
139053127|NCT06184659|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138627872|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139053129|NCT06184659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053130|NCT06171659|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139053131|NCT06171659|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139053132|NCT06171659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053133|NCT06162559|Trastuzumab|trastuzumab|mesh-list
139053134|NCT06162559|Pertuzumab|pertuzumab|mesh-list
139053135|NCT06162559|Tucatinib|tucatinib|mesh-list
139053136|NCT06162559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053137|NCT06162559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053138|NCT06162559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139053139|NCT06162559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053140|NCT06162559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053141|NCT06144255|Insulin|insulin|mesh-list
139053142|NCT06144255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139053143|NCT06144255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053154|NCT06128369|Dexamethasone|dexamethasone|mesh-list
139053155|NCT06128369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139053156|NCT06128369|Antiemetics|antiemetics|mesh-ancestor
139053157|NCT06128369|Autonomic Agents|autonomic agents|mesh-ancestor
139053158|NCT06128369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053159|NCT06128369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053160|NCT06128369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139053161|NCT06128369|Glucocorticoids|glucocorticoids|mesh-ancestor
139053162|NCT06128369|Hormones|hormones|mesh-ancestor
139053163|NCT06128369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139053164|NCT06128369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139053165|NCT06128369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053166|NCT06117774|AMG 757|amg 757|mesh-list
139053167|NCT06117774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053168|NCT06113211|Narcotics|narcotics|mesh-list
139053169|NCT06113211|Analgesics|analgesics|mesh-list
139053170|NCT06113211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139053171|NCT06113211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053172|NCT06113211|Sensory System Agents|sensory system agents|mesh-ancestor
139053173|NCT06113211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053174|NCT06109779|Gemcitabine|gemcitabine|mesh-list
139053175|NCT06109779|Capecitabine|capecitabine|mesh-list
139053176|NCT06109779|Tegafur|tegafur|mesh-list
138628007|NCT00570856|Vitamins|vitamins|mesh-ancestor
139053177|NCT06109779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053178|NCT06109779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139053179|NCT06109779|Antimetabolites|antimetabolites|mesh-ancestor
139053180|NCT06109779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053181|NCT06103760|Esketamine|esketamine|mesh-list
138803790|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053182|NCT06103760|Antidepressive Agents|antidepressive agents|mesh-ancestor
139053183|NCT06103760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139053184|NCT06092931|Repaglinide|repaglinide|mesh-list
139053185|NCT06092931|Digoxin|digoxin|mesh-list
139053186|NCT06092931|Midazolam|midazolam|mesh-list
139053187|NCT06092931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139053188|NCT06092931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139053189|NCT06092931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139053190|NCT06092931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139053191|NCT06092931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053192|NCT06092931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139053193|NCT06092931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139053194|NCT06092931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139053195|NCT06092931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139053196|NCT06092931|Anesthetics, General|anesthetics, general|mesh-ancestor
139053197|NCT06092931|Anesthetics|anesthetics|mesh-ancestor
139053198|NCT06092931|GABA Modulators|gaba modulators|mesh-ancestor
139053199|NCT06092931|GABA Agents|gaba agents|mesh-ancestor
139053200|NCT06092931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139053201|NCT06092931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053202|NCT06092931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139053203|NCT06092931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139053204|NCT06092931|Antimetabolites|antimetabolites|mesh-ancestor
139053205|NCT06092931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139053206|NCT06092931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139053207|NCT06092931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053208|NCT06092931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139053209|NCT06092931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139053210|NCT06092931|Protective Agents|protective agents|mesh-ancestor
139053211|NCT06092931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139053213|NCT06081153|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139053214|NCT06081153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139053215|NCT06081153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139053216|NCT06081153|Antimetabolites|antimetabolites|mesh-ancestor
139053217|NCT06081153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053218|NCT06081153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139053219|NCT06081153|Protease Inhibitors|protease inhibitors|mesh-ancestor
139053220|NCT06081153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053221|NCT06081153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139053222|NCT06078501|Misoprostol|misoprostol|mesh-list
139053223|NCT06078501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139053224|NCT06078501|Abortifacient Agents|abortifacient agents|mesh-ancestor
139053225|NCT06078501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139053226|NCT06078501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053227|NCT06078501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139053228|NCT06078501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139053229|NCT06078501|Oxytocics|oxytocics|mesh-ancestor
139053230|NCT06067828|Budesonide|budesonide|mesh-list
139053231|NCT06067828|Glycopyrrolate|glycopyrrolate|mesh-list
139053232|NCT06067828|Formoterol Fumarate|formoterol fumarate|mesh-list
139053233|NCT06067828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139053234|NCT06067828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139053235|NCT06067828|Autonomic Agents|autonomic agents|mesh-ancestor
139053236|NCT06067828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053237|NCT06067828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053238|NCT06067828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139053239|NCT06067828|Respiratory System Agents|respiratory system agents|mesh-ancestor
139053240|NCT06067828|Glucocorticoids|glucocorticoids|mesh-ancestor
139053241|NCT06067828|Hormones|hormones|mesh-ancestor
139053242|NCT06067828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139053243|NCT06067828|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139053244|NCT06067828|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139053245|NCT06067828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139053246|NCT06067828|Adrenergic Agents|adrenergic agents|mesh-ancestor
139053247|NCT06067828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692925|NCT05312866|Narcotics|narcotics|mesh-ancestor
139053248|NCT06067828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053249|NCT06067828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139053250|NCT06067828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139053251|NCT06067828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139053252|NCT06067828|Cholinergic Agents|cholinergic agents|mesh-ancestor
139053254|NCT06060665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139053255|NCT06060665|Antimetabolites|antimetabolites|mesh-ancestor
138898133|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
139053256|NCT06060665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053257|NCT06060665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139053258|NCT06048263|Ketamine|ketamine|mesh-list
139053259|NCT06048263|Analgesics|analgesics|mesh-ancestor
139053260|NCT06048263|Sensory System Agents|sensory system agents|mesh-ancestor
139053261|NCT06048263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053262|NCT06048263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053263|NCT06048263|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139053264|NCT06048263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139053265|NCT06048263|Anesthetics, General|anesthetics, general|mesh-ancestor
139053267|NCT06048263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139053268|NCT06048263|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139053269|NCT06048263|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139053270|NCT06048263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139053271|NCT06048263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053272|NCT06045754|Adalimumab|adalimumab|mesh-list
139053273|NCT06045754|Ustekinumab|ustekinumab|mesh-list
139053274|NCT06045754|Vedolizumab|vedolizumab|mesh-list
139053275|NCT06045754|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139053276|NCT06045754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138628156|NCT00572065|Cytarabine|cytarabine|mesh-list
139053277|NCT06045754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139053278|NCT06045754|Dermatologic Agents|dermatologic agents|mesh-ancestor
139053279|NCT06045754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139053280|NCT06034470|Cytarabine|cytarabine|mesh-list
139053281|NCT06034470|Fludarabine|fludarabine|mesh-list
139053282|NCT06034470|Idarubicin|idarubicin|mesh-list
139053283|NCT06034470|Lenograstim|lenograstim|mesh-list
139053284|NCT06034470|Immunoconjugates|immunoconjugates|mesh-list
139053285|NCT06034470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053286|NCT06034470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139053287|NCT06034470|Antimetabolites|antimetabolites|mesh-ancestor
139053288|NCT06034470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053289|NCT06034470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139053290|NCT06034470|Immunologic Factors|immunologic factors|mesh-ancestor
139053291|NCT06034470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053292|NCT06034470|Antiviral Agents|antiviral agents|mesh-ancestor
139053293|NCT06034470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053294|NCT06034470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139053295|NCT06034470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139053296|NCT06034470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139053297|NCT06034470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139053298|NCT06034470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053299|NCT06028932|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139053300|NCT06028932|Immunoconjugates|immunoconjugates|mesh-ancestor
139053301|NCT06028932|Immunologic Factors|immunologic factors|mesh-ancestor
139053302|NCT06028932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053303|NCT06027606|Budesonide|budesonide|mesh-list
139053304|NCT06027606|Albuterol|albuterol|mesh-list
139053305|NCT06027606|Formoterol Fumarate|formoterol fumarate|mesh-list
139053306|NCT06027606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139053307|NCT06027606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139053308|NCT06027606|Autonomic Agents|autonomic agents|mesh-ancestor
139053309|NCT06027606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053310|NCT06027606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053311|NCT06027606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139053312|NCT06027606|Respiratory System Agents|respiratory system agents|mesh-ancestor
139053313|NCT06027606|Glucocorticoids|glucocorticoids|mesh-ancestor
139053314|NCT06027606|Hormones|hormones|mesh-ancestor
139053315|NCT06027606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139053316|NCT06027606|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139053317|NCT06027606|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139053318|NCT06027606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139053319|NCT06027606|Adrenergic Agents|adrenergic agents|mesh-ancestor
139053320|NCT06027606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139053321|NCT06027606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053322|NCT06027606|Tocolytic Agents|tocolytic agents|mesh-ancestor
139053323|NCT06027606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139053324|NCT06006013|Atezolizumab|atezolizumab|mesh-list
139053325|NCT06006013|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139053326|NCT06006013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139053327|NCT06006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053328|NCT06006013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053329|NCT06006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053330|NCT06006013|Immunologic Factors|immunologic factors|mesh-ancestor
139053331|NCT06006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053332|NCT06005610|Estradiol|estradiol|mesh-list
139053333|NCT06005610|Estrogens|estrogens|mesh-ancestor
139053334|NCT06005610|Hormones|hormones|mesh-ancestor
139053335|NCT06005610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139053336|NCT06005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053337|NCT05999734|Bupivacaine|bupivacaine|mesh-list
139053338|NCT05999734|Anesthetics, Local|anesthetics, local|mesh-ancestor
139053339|NCT05999734|Anesthetics|anesthetics|mesh-ancestor
139053340|NCT05999734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139053341|NCT05999734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053342|NCT05999734|Sensory System Agents|sensory system agents|mesh-ancestor
139053343|NCT05999734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053344|NCT05997433|Amoxicillin|amoxicillin|mesh-list
139053345|NCT05997433|Tetracycline|tetracycline|mesh-list
139053347|NCT05997433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139053348|NCT05997433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053349|NCT05997433|Antacids|antacids|mesh-ancestor
139053350|NCT05997433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053351|NCT05997433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138898199|NCT00486811|Oxycodone|oxycodone|mesh-list
139053353|NCT05997433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053354|NCT05988632|Insulin|insulin|mesh-list
138628340|NCT00225290|Thalidomide|thalidomide|mesh-list
139053355|NCT05988632|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139053356|NCT05988632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139053357|NCT05988632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053358|NCT05973422|Insulin|insulin|mesh-list
139053359|NCT05973422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139053360|NCT05973422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053361|NCT05960578|Golimumab|golimumab|mesh-list
139053362|NCT05960578|Immunoglobulins|immunoglobulins|mesh-list
139053363|NCT05960578|Immunoglobulin G|immunoglobulin g|mesh-list
139053364|NCT05960578|Immunologic Factors|immunologic factors|mesh-ancestor
139053365|NCT05960578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053366|NCT05960578|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139053367|NCT05960578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139053368|NCT05960578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139053369|NCT05941767|Lidocaine|lidocaine|mesh-list
139053370|NCT05941767|Dexmedetomidine|dexmedetomidine|mesh-list
139053376|NCT05941767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053377|NCT05941767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139053378|NCT05941767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139053379|NCT05941767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139053380|NCT05941767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139053381|NCT05941767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053382|NCT05941767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139053383|NCT05941767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139053385|NCT05941767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139053386|NCT05941767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139053387|NCT05941767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139053388|NCT05941767|Adrenergic Agents|adrenergic agents|mesh-ancestor
139053389|NCT05941767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139053396|NCT05890118|Ustekinumab|ustekinumab|mesh-list
139053397|NCT05890118|Dermatologic Agents|dermatologic agents|mesh-ancestor
139053398|NCT05888493|Prednisone|prednisone|mesh-list
139053399|NCT05888493|Prednisolone|prednisolone|mesh-list
139053400|NCT05888493|Cyclophosphamide|cyclophosphamide|mesh-list
139053401|NCT05888493|Rituximab|rituximab|mesh-list
139053402|NCT05888493|Doxorubicin|doxorubicin|mesh-list
138628396|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138628397|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138628398|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138628399|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138320979|NCT06124157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628422|NCT00574015|Acetaminophen|acetaminophen|mesh-list
138628423|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138628424|NCT00574015|Hydrocodone|hydrocodone|mesh-list
138628425|NCT00574015|Bupivacaine|bupivacaine|mesh-list
138628426|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
138628427|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
138628428|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628429|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628430|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
138628431|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138628432|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138628434|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
138628435|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138628436|NCT00574015|Narcotics|narcotics|mesh-ancestor
139053403|NCT05888493|Vincristine|vincristine|mesh-list
139053404|NCT05888493|Lenalidomide|lenalidomide|mesh-list
139053405|NCT05888493|Tisagenlecleucel|tisagenlecleucel|mesh-list
139053406|NCT05888493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139053407|NCT05888493|Immunologic Factors|immunologic factors|mesh-ancestor
139053408|NCT05888493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053409|NCT05888493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139053410|NCT05888493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139053411|NCT05888493|Alkylating Agents|alkylating agents|mesh-ancestor
139053412|NCT05888493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053413|NCT05888493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053414|NCT05888493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139053415|NCT05888493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053416|NCT05888493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138628437|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
139053417|NCT05888493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139053418|NCT05888493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139053419|NCT05888493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053420|NCT05888493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139053421|NCT05888493|Glucocorticoids|glucocorticoids|mesh-ancestor
139053423|NCT05888493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139053424|NCT05888493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139053425|NCT05888493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139053426|NCT05888493|Tubulin Modulators|tubulin modulators|mesh-ancestor
139053427|NCT05888493|Antimitotic Agents|antimitotic agents|mesh-ancestor
139053428|NCT05888493|Mitosis Modulators|mitosis modulators|mesh-ancestor
139053429|NCT05888493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139053430|NCT05888493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139053431|NCT05888493|Growth Substances|growth substances|mesh-ancestor
139053432|NCT05888493|Growth Inhibitors|growth inhibitors|mesh-ancestor
139053433|NCT05885646|Sulthiame|sulthiame|mesh-list
139053434|NCT05885646|Anticonvulsants|anticonvulsants|mesh-ancestor
139053435|NCT05882214|Niacinamide|niacinamide|mesh-list
139053437|NCT05882214|Nicotinic Acids|nicotinic acids|mesh-list
139053438|NCT05882214|Vitamin B Complex|vitamin b complex|mesh-ancestor
139053439|NCT05882214|Vitamins|vitamins|mesh-ancestor
139053440|NCT05882214|Micronutrients|micronutrients|mesh-ancestor
139053441|NCT05882214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053442|NCT05882214|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139053443|NCT05882214|Antimetabolites|antimetabolites|mesh-ancestor
139053444|NCT05882214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898249|NCT02681705|Temozolomide|temozolomide|mesh-list
139053446|NCT05882214|Vasodilator Agents|vasodilator agents|mesh-ancestor
139053447|NCT05848128|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139053448|NCT05848128|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139053449|NCT05838521|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139053450|NCT05838521|Immunoconjugates|immunoconjugates|mesh-ancestor
139053451|NCT05838521|Immunologic Factors|immunologic factors|mesh-ancestor
139053452|NCT05838521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053453|NCT05836571|Nivolumab|nivolumab|mesh-list
139053454|NCT05836571|Ipilimumab|ipilimumab|mesh-list
139053455|NCT05836571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053456|NCT05836571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053457|NCT05836571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139053458|NCT05836571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053459|NCT05829226|Azacitidine|azacitidine|mesh-list
139053460|NCT05829226|Decitabine|decitabine|mesh-list
139053461|NCT05829226|Venetoclax|venetoclax|mesh-list
139053462|NCT05829226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139053463|NCT05829226|Antimetabolites|antimetabolites|mesh-ancestor
139053464|NCT05829226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053465|NCT05829226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053466|NCT05829226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053467|NCT05821374|Deucravacitinib|deucravacitinib|mesh-list
139053468|NCT05821374|Dermatologic Agents|dermatologic agents|mesh-ancestor
139053469|NCT05821374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139053470|NCT05821374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628551|NCT00575068|Galiximab|galiximab|mesh-list
138628552|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139053471|NCT05821374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053472|NCT05807126|Olaparib|olaparib|mesh-list
139053473|NCT05807126|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139053474|NCT05807126|Magrolimab|magrolimab|mesh-list
139053475|NCT05807126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053476|NCT05807126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053477|NCT05807126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053478|NCT05807126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053479|NCT05806021|Triamcinolone|triamcinolone|mesh-list
139053480|NCT05806021|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139053481|NCT05806021|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139053482|NCT05806021|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139053483|NCT05806021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139053484|NCT05806021|Glucocorticoids|glucocorticoids|mesh-ancestor
139053485|NCT05806021|Hormones|hormones|mesh-ancestor
139053486|NCT05806021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139053487|NCT05806021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053488|NCT05806021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139053489|NCT05806021|Immunologic Factors|immunologic factors|mesh-ancestor
139053490|NCT05806021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053491|NCT05806021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053492|NCT05795062|Warfarin|warfarin|mesh-list
139053493|NCT05795062|Apixaban|apixaban|mesh-list
139053494|NCT05795062|Anticoagulants|anticoagulants|mesh-ancestor
139053495|NCT05795062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139053496|NCT05795062|Antithrombins|antithrombins|mesh-ancestor
139053497|NCT05795062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139053498|NCT05795062|Protease Inhibitors|protease inhibitors|mesh-ancestor
139053499|NCT05795062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053500|NCT05795062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053501|NCT05765487|Sildenafil Citrate|sildenafil citrate|mesh-list
139053502|NCT05765487|Vasodilator Agents|vasodilator agents|mesh-ancestor
139053503|NCT05765487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139053504|NCT05765487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139053505|NCT05765487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053506|NCT05765487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053507|NCT05765487|Urological Agents|urological agents|mesh-ancestor
139053508|NCT05762328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139053509|NCT05762328|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139053510|NCT05762328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053511|NCT05762328|Antitubercular Agents|antitubercular agents|mesh-ancestor
139053512|NCT05752526|Diclofenac|diclofenac|mesh-list
139053513|NCT05752526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139053514|NCT05752526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139053515|NCT05752526|Analgesics|analgesics|mesh-ancestor
139053516|NCT05752526|Sensory System Agents|sensory system agents|mesh-ancestor
139053517|NCT05752526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053518|NCT05752526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053519|NCT05752526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139053520|NCT05752526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139053521|NCT05752526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139053522|NCT05752526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053523|NCT05752526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053524|NCT05740566|Topotecan|topotecan|mesh-list
139053525|NCT05740566|Amrubicin|amrubicin|mesh-list
139053526|NCT05740566|AMG 757|amg 757|mesh-list
139053527|NCT05740566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139053528|NCT05740566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139053529|NCT05740566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053530|NCT05740566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053531|NCT05740566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053532|NCT05709028|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139053533|NCT05709028|Fosfomycin|fosfomycin|mesh-list
139053534|NCT05709028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053535|NCT05691829|Pembrolizumab|pembrolizumab|mesh-list
139053536|NCT05691829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138628640|NCT03451435|Protective Agents|protective agents|mesh-ancestor
139053537|NCT05691829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053538|NCT05691829|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139053539|NCT05691829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053540|NCT05691010|Paclitaxel|paclitaxel|mesh-list
139053541|NCT05691010|Carboplatin|carboplatin|mesh-list
139053542|NCT05691010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139053543|NCT05691010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053544|NCT05691010|Tubulin Modulators|tubulin modulators|mesh-ancestor
139053545|NCT05691010|Antimitotic Agents|antimitotic agents|mesh-ancestor
139053546|NCT05691010|Mitosis Modulators|mitosis modulators|mesh-ancestor
138692981|NCT05470764|Amlodipine|amlodipine|mesh-list
138692983|NCT05470764|Indapamide|indapamide|mesh-list
139053547|NCT05691010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053548|NCT05672095|Selenium|selenium|mesh-list
139053549|NCT05672095|Niraparib|niraparib|mesh-list
139053550|NCT05672095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139053551|NCT05672095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053552|NCT05672095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053553|NCT05672095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053554|NCT05672095|Antioxidants|antioxidants|mesh-ancestor
139053555|NCT05672095|Protective Agents|protective agents|mesh-ancestor
139053556|NCT05672095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053557|NCT05672095|Trace Elements|trace elements|mesh-ancestor
139053558|NCT05672095|Micronutrients|micronutrients|mesh-ancestor
139053559|NCT05669664|Leuprolide|leuprolide|mesh-list
139053560|NCT05669664|Androgen Antagonists|androgen antagonists|mesh-list
138181707|NCT04380025|Protective Agents|protective agents|mesh-ancestor
139053561|NCT05669664|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138628678|NCT00235287|Enalapril|enalapril|mesh-list
139053562|NCT05669664|Fertility Agents|fertility agents|mesh-ancestor
139053563|NCT05669664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139053564|NCT05669664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053565|NCT05669664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139053566|NCT05669664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053567|NCT05669664|Hormone Antagonists|hormone antagonists|mesh-ancestor
139053568|NCT05669664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139053569|NCT05669001|Mycophenolic Acid|mycophenolic acid|mesh-list
139053571|NCT05669001|Tacrolimus|tacrolimus|mesh-list
139053572|NCT05669001|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139053573|NCT05669001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139053574|NCT05669001|Immunologic Factors|immunologic factors|mesh-ancestor
139053575|NCT05669001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053576|NCT05669001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139053577|NCT05669001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053578|NCT05669001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053579|NCT05669001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139053580|NCT05669001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053581|NCT05669001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053582|NCT05669001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139053583|NCT05669001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139053584|NCT05669001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139053585|NCT05669001|Antitubercular Agents|antitubercular agents|mesh-ancestor
138628725|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139053586|NCT05669001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139053587|NCT05669001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053588|NCT05656534|Suvorexant|suvorexant|mesh-list
139053589|NCT05656534|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139053590|NCT05656534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139053591|NCT05656534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139053592|NCT05656534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053593|NCT05656534|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139053594|NCT05656534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139053595|NCT05656534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053596|NCT05650164|Avelumab|avelumab|mesh-list
139053597|NCT05650164|Axitinib|axitinib|mesh-list
139053598|NCT05650164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053599|NCT05650164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053600|NCT05650164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139053601|NCT05650164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053602|NCT05650164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053603|NCT05642845|Atorvastatin|atorvastatin|mesh-list
139053604|NCT05642845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139053605|NCT05642845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139053606|NCT05642845|Antimetabolites|antimetabolites|mesh-ancestor
139053607|NCT05642845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053608|NCT05642845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139053609|NCT05642845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139053610|NCT05642845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053611|NCT05608369|Vorinostat|vorinostat|mesh-list
139053612|NCT05608369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053613|NCT05608369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139053614|NCT05608369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693005|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139053615|NCT05608369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053617|NCT05603754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139053618|NCT05589792|Acetazolamide|acetazolamide|mesh-list
139053619|NCT05589792|Anticonvulsants|anticonvulsants|mesh-ancestor
139053620|NCT05589792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139053621|NCT05589792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053622|NCT05589792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053623|NCT05589792|Diuretics|diuretics|mesh-ancestor
139053624|NCT05589792|Natriuretic Agents|natriuretic agents|mesh-ancestor
139053625|NCT05589792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053626|NCT05577676|Triamcinolone|triamcinolone|mesh-list
139053627|NCT05577676|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139053628|NCT05577676|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139053629|NCT05577676|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139053630|NCT05577676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139053631|NCT05577676|Glucocorticoids|glucocorticoids|mesh-ancestor
139053632|NCT05577676|Hormones|hormones|mesh-ancestor
139053633|NCT05577676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139053634|NCT05577676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053635|NCT05577676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139053636|NCT05577676|Immunologic Factors|immunologic factors|mesh-ancestor
139053637|NCT05577676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053638|NCT05577676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053639|NCT05538208|Mycophenolic Acid|mycophenolic acid|mesh-list
139053640|NCT05538208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139053641|NCT05538208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053642|NCT05538208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139053643|NCT05538208|Antitubercular Agents|antitubercular agents|mesh-ancestor
139053644|NCT05538208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139053645|NCT05538208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053646|NCT05538208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053647|NCT05538208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053648|NCT05537766|Cyclophosphamide|cyclophosphamide|mesh-list
139053649|NCT05537766|Fludarabine|fludarabine|mesh-list
139053650|NCT05537766|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
139053651|NCT05537766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139053652|NCT05537766|Immunologic Factors|immunologic factors|mesh-ancestor
139053653|NCT05537766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053654|NCT05537766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139053655|NCT05537766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139053656|NCT05537766|Alkylating Agents|alkylating agents|mesh-ancestor
138628812|NCT03450109|Goserelin|goserelin|mesh-list
139053657|NCT05537766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053658|NCT05537766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053659|NCT05537766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139053660|NCT05537766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053661|NCT05508867|Gemcitabine|gemcitabine|mesh-list
139053662|NCT05508867|Pembrolizumab|pembrolizumab|mesh-list
139053663|NCT05508867|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139053664|NCT05508867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139053665|NCT05508867|Antimetabolites|antimetabolites|mesh-ancestor
139053666|NCT05508867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053667|NCT05508867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053668|NCT05508867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053669|NCT05508867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139053670|NCT05508867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139053680|NCT05468489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053681|NCT05468489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053682|NCT05468489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139053683|NCT05468489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053685|NCT05445128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139053686|NCT05445128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139053687|NCT05445128|Antiviral Agents|antiviral agents|mesh-ancestor
139053688|NCT05445128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053689|NCT05411484|Doxycycline|doxycycline|mesh-list
139053690|NCT05411484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139053691|NCT05411484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053692|NCT05411484|Antimalarials|antimalarials|mesh-ancestor
139053693|NCT05411484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139053694|NCT05411484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139053703|NCT05378113|Lidocaine|lidocaine|mesh-list
139053704|NCT05378113|Ondansetron|ondansetron|mesh-list
139053705|NCT05378113|Anesthetics, Local|anesthetics, local|mesh-ancestor
139053706|NCT05378113|Anesthetics|anesthetics|mesh-ancestor
139053707|NCT05378113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139053708|NCT05378113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053709|NCT05378113|Sensory System Agents|sensory system agents|mesh-ancestor
139053710|NCT05378113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053711|NCT05378113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139053712|NCT05378113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139053713|NCT05378113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139053714|NCT05378113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138628852|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
139053715|NCT05378113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053716|NCT05378113|Antiemetics|antiemetics|mesh-ancestor
139053717|NCT05378113|Autonomic Agents|autonomic agents|mesh-ancestor
139053718|NCT05378113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139053719|NCT05378113|Antipruritics|antipruritics|mesh-ancestor
139053720|NCT05378113|Dermatologic Agents|dermatologic agents|mesh-ancestor
139053721|NCT05378113|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139053722|NCT05378113|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139053723|NCT05378113|Serotonin Agents|serotonin agents|mesh-ancestor
139053724|NCT05378113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139053725|NCT05353439|Pembrolizumab|pembrolizumab|mesh-list
139053726|NCT05353439|Topotecan|topotecan|mesh-list
139053727|NCT05353439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053728|NCT05353439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053729|NCT05353439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139053730|NCT05353439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053731|NCT05353439|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139053732|NCT05353439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139053733|NCT05353439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053734|NCT05353335|Antihypertensive Agents|antihypertensive agents|mesh-list
139053736|NCT05352815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139053737|NCT05352815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053738|NCT05350202|Empagliflozin|empagliflozin|mesh-list
139053739|NCT05350202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139053740|NCT05350202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053741|NCT05350202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139053742|NCT05350202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053743|NCT05346393|Terlipressin|terlipressin|mesh-list
139053744|NCT05346393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139053745|NCT05346393|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139053746|NCT05338970|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
138628888|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
139053747|NCT05338970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053748|NCT05338970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053749|NCT05333458|Atezolizumab|atezolizumab|mesh-list
139053750|NCT05333458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139053751|NCT05333458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139053752|NCT05333458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898418|NCT02677571|Morphine|morphine|mesh-list
139053753|NCT05333458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053754|NCT05333458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053755|NCT05333458|Immunologic Factors|immunologic factors|mesh-ancestor
139053756|NCT05333458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053758|NCT05330429|Bevacizumab|bevacizumab|mesh-list
139053759|NCT05330429|Magrolimab|magrolimab|mesh-list
139053760|NCT05330429|Fluorouracil|fluorouracil|mesh-list
139053761|NCT05330429|Irinotecan|irinotecan|mesh-list
139053762|NCT05330429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053763|NCT05330429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053764|NCT05330429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139053765|NCT05330429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139053766|NCT05330429|Growth Substances|growth substances|mesh-ancestor
139053767|NCT05330429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053768|NCT05330429|Growth Inhibitors|growth inhibitors|mesh-ancestor
139053769|NCT05330429|Antimetabolites|antimetabolites|mesh-ancestor
139053770|NCT05330429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053771|NCT05330429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139053772|NCT05330429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139053773|NCT05330429|Immunologic Factors|immunologic factors|mesh-ancestor
139053774|NCT05330429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139053775|NCT05330429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139053776|NCT05330429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053777|NCT05330429|Antidotes|antidotes|mesh-ancestor
139053778|NCT05330429|Protective Agents|protective agents|mesh-ancestor
139053779|NCT05330429|Vitamin B Complex|vitamin b complex|mesh-ancestor
139053780|NCT05330429|Vitamins|vitamins|mesh-ancestor
139053781|NCT05330429|Micronutrients|micronutrients|mesh-ancestor
139053782|NCT05321810|Warfarin|warfarin|mesh-list
139053783|NCT05321810|Apixaban|apixaban|mesh-list
139053784|NCT05321810|Anticoagulants|anticoagulants|mesh-ancestor
139053785|NCT05321810|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139053786|NCT05321810|Antithrombins|antithrombins|mesh-ancestor
139053787|NCT05321810|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139053789|NCT05321810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053790|NCT05321810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053791|NCT05317364|Estradiol|estradiol|mesh-list
139053792|NCT05317364|Estrogens|estrogens|mesh-ancestor
139053793|NCT05317364|Hormones|hormones|mesh-ancestor
139053800|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139053801|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
139053802|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139053803|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053804|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
139053805|NCT05178472|Immunomodulating Agents|immunomodulating agents|mesh-list
139053806|NCT05178472|Immunologic Factors|immunologic factors|mesh-ancestor
138898447|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
139053809|NCT05172258|Ipatasertib|ipatasertib|mesh-list
139053810|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053811|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053812|NCT05172258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139053813|NCT05172258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628969|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139053814|NCT05172258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139053815|NCT05172258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053816|NCT05171387|Androgens|androgens|mesh-list
139053817|NCT05171387|Hormones|hormones|mesh-ancestor
139053818|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139053819|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053826|NCT05111574|Nivolumab|nivolumab|mesh-list
139053827|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053828|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053829|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139053830|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053831|NCT05097326|Misoprostol|misoprostol|mesh-list
139053832|NCT05097326|Mifepristone|mifepristone|mesh-list
139053833|NCT05097326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139053834|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
139053835|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139053836|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053837|NCT05097326|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139053838|NCT05097326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139053839|NCT05097326|Oxytocics|oxytocics|mesh-ancestor
139053840|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139053841|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139053842|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139053843|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139053844|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
139053845|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139053846|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139053847|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
139053848|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139053849|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
139053850|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139053851|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139053852|NCT05096884|Metoprolol|metoprolol|mesh-list
138693063|NCT00598234|Celecoxib|celecoxib|mesh-list
139053853|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139053854|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139053855|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
138629017|NCT00227357|Buprenorphine|buprenorphine|mesh-list
139053856|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
139053857|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053858|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053859|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139053860|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139053861|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139053862|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
139053863|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139053864|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053866|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053867|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
139053868|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
139053869|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
139053870|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053871|NCT05069831|Abrocitinib|abrocitinib|mesh-list
139053872|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139053873|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053874|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053875|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
139053876|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053877|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
139053878|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139053879|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139053880|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053881|NCT05061368|Urological Agents|urological agents|mesh-ancestor
139053882|NCT05050253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139053883|NCT05024552|Cytarabine|cytarabine|mesh-list
139053884|NCT05024552|Daunorubicin|daunorubicin|mesh-list
139053885|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139053886|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
139053887|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053888|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053889|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
139053890|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053891|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139053892|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
139053893|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053894|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139053895|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139053896|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139053897|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053898|NCT05019716|Cisplatin|cisplatin|mesh-list
139053899|NCT05019716|Etoposide|etoposide|mesh-list
139053900|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
139053901|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
139053902|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053903|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139053904|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139053905|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139053906|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053907|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053908|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
139053909|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
139053910|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
139053911|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
139053912|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
139053913|NCT05007821|Linezolid|linezolid|mesh-list
139053914|NCT05007821|Bedaquiline|bedaquiline|mesh-list
139053915|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
139053916|NCT05007821|Clofazimine|clofazimine|mesh-list
139053917|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139053918|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139053919|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139053920|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053921|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053922|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
139053923|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138629090|NCT00227708|Docetaxel|docetaxel|mesh-list
139053924|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
139053925|NCT04996160|Dexamethasone|dexamethasone|mesh-list
139053926|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
139053927|NCT04996160|Doxorubicin|doxorubicin|mesh-list
139053928|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139053929|NCT04996160|Bortezomib|bortezomib|mesh-list
139053930|NCT04996160|Palbociclib|palbociclib|mesh-list
139053931|NCT04996160|BB 1101|bb 1101|mesh-list
139053932|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139053933|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
139053934|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
139053935|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139053936|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053937|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139053938|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
139053939|NCT04996160|Hormones|hormones|mesh-ancestor
139053940|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139053941|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139053942|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053943|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
139053944|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053945|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053946|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139053947|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138629146|NCT00227942|Zolpidem|zolpidem|mesh-list
139053948|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139053949|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139053950|NCT04995484|Belzutifan|belzutifan|mesh-list
139053951|NCT04995484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053952|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
139053953|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
138898524|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053954|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139053955|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139053956|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053957|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053958|NCT04985929|Urological Agents|urological agents|mesh-ancestor
139053959|NCT04958785|Paclitaxel|paclitaxel|mesh-list
139053960|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139053961|NCT04958785|Magrolimab|magrolimab|mesh-list
139053962|NCT04958785|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139053963|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139053964|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053965|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
139053966|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
139053967|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
139053968|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053969|NCT04958785|Immunoconjugates|immunoconjugates|mesh-ancestor
139053970|NCT04958785|Immunologic Factors|immunologic factors|mesh-ancestor
138629185|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
139053971|NCT04958785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053972|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053973|NCT04925960|Epalrestat|epalrestat|mesh-list
139053974|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053975|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053976|NCT04922723|Daratumumab|daratumumab|mesh-list
139053977|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053978|NCT04907851|Denosumab|denosumab|mesh-list
139053979|NCT04907851|Pembrolizumab|pembrolizumab|mesh-list
139053980|NCT04907851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139053981|NCT04907851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053982|NCT04907851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139053983|NCT04907851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053984|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139053985|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139053986|NCT04905407|Azacitidine|azacitidine|mesh-list
139053987|NCT04905407|Venetoclax|venetoclax|mesh-list
139053988|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139053989|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
139053990|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053991|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053992|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053993|NCT04840199|Letermovir|letermovir|mesh-list
139053994|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139053995|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139053996|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139053997|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139053998|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
139053999|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054000|NCT04829383|Bevacizumab|bevacizumab|mesh-list
139054001|NCT04829383|Atezolizumab|atezolizumab|mesh-list
139054002|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054003|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054004|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139054005|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139054006|NCT04829383|Growth Substances|growth substances|mesh-ancestor
139054007|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054008|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
139054009|NCT04829383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139054010|NCT04829383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054011|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
139054012|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139054013|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
139054014|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139054015|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054016|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139054017|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139054018|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054019|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054020|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054021|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139054022|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
139054023|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139054024|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054025|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138629282|NCT00193609|Capecitabine|capecitabine|mesh-list
139054026|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139054027|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139054028|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139054029|NCT04804644|Memantine|memantine|mesh-list
139054030|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139054031|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139054032|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
139054033|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054034|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054035|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054036|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139054037|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139054038|NCT04762875|Plerixafor|plerixafor|mesh-list
139054039|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139054040|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139054041|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
139054042|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054043|NCT04761627|Ustekinumab|ustekinumab|mesh-list
139054044|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
139054045|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
139054046|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054047|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054048|NCT04754321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138693093|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
139054049|NCT04754321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054050|NCT04739800|Paclitaxel|paclitaxel|mesh-list
139054051|NCT04739800|Doxorubicin|doxorubicin|mesh-list
139054052|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139054053|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139054054|NCT04739800|Durvalumab|durvalumab|mesh-list
139054055|NCT04739800|Topotecan|topotecan|mesh-list
139054056|NCT04739800|Olaparib|olaparib|mesh-list
139054057|NCT04739800|Cediranib|cediranib|mesh-list
139054058|NCT04739800|Maleic acid|maleic acid|mesh-list
139054059|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
139054060|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139054061|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
139054062|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139054063|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054064|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
139054065|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
139054066|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
139054067|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054068|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139054069|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139054070|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139054071|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054072|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054073|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
139054074|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054075|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139054076|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139054077|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054078|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
139054079|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
139054080|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139054081|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054082|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
139054083|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
139054084|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804694|NCT00791557|Infliximab|infliximab|mesh-list
139054085|NCT04709380|Sorafenib|sorafenib|mesh-list
139054086|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054087|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054088|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054089|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054090|NCT04700527|Butyric Acid|butyric acid|mesh-list
139054091|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
139054092|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
139054093|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054094|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054095|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054096|NCT04644068|Paclitaxel|paclitaxel|mesh-list
139054097|NCT04644068|Carboplatin|carboplatin|mesh-list
139054098|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139054099|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054100|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
139054101|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
139054102|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
139054103|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054104|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
139054105|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139054106|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
139054107|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054108|NCT04632069|Expectorants|expectorants|mesh-ancestor
139054109|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
139054110|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139054112|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054114|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054115|NCT04632069|Antidotes|antidotes|mesh-ancestor
139054116|NCT04627064|Belzutifan|belzutifan|mesh-list
139054117|NCT04627064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054118|NCT04625946|Metformin|metformin|mesh-list
139054124|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054125|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
139054126|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
139054127|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
139054128|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054129|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139054130|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
139054131|NCT04612751|Carboplatin|carboplatin|mesh-list
139054132|NCT04612751|Durvalumab|durvalumab|mesh-list
139054133|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054134|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054140|NCT04579224|Paclitaxel|paclitaxel|mesh-list
139054141|NCT04579224|Docetaxel|docetaxel|mesh-list
139054142|NCT04579224|Halichondrin B|halichondrin b|mesh-list
139054143|NCT04579224|Gemcitabine|gemcitabine|mesh-list
139054144|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139054145|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139054146|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054147|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
139054148|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
139054149|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
139054150|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054151|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139054152|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
139054153|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
138898766|NCT05584319|Empagliflozin|empagliflozin|mesh-list
139054154|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054155|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054156|NCT04555837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139054157|NCT04555837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054158|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
139054159|NCT04541017|Magrolimab|magrolimab|mesh-list
139054160|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
139054161|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
139054162|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
139054163|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054164|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054165|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054168|NCT04493203|Nivolumab|nivolumab|mesh-list
139054169|NCT04493203|Axitinib|axitinib|mesh-list
139054170|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054171|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054172|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139054173|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054174|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054175|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054176|NCT04452344|Analgesics|analgesics|mesh-list
139054177|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054178|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
139054179|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139054180|NCT04375631|Cytarabine|cytarabine|mesh-list
139054181|NCT04375631|Cyclosporine|cyclosporine|mesh-list
139054182|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
139054183|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
139054184|NCT04375631|Fludarabine|fludarabine|mesh-list
139054185|NCT04375631|Fludarabine phosphate|fludarabine phosphate|mesh-list
139054186|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
139054187|NCT04375631|Idarubicin|idarubicin|mesh-list
139054188|NCT04375631|Cladribine|cladribine|mesh-list
139054189|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
139054190|NCT04375631|Cyclosporins|cyclosporins|mesh-list
139054191|NCT04375631|Lenograstim|lenograstim|mesh-list
139054192|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139054193|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
139054194|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054195|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139054196|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139054197|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
139054198|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054199|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054200|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139054201|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139054202|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
139054203|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
139054204|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054205|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139054206|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054207|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
139054208|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
139054209|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139054210|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139054211|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139054212|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
139054213|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139054214|NCT04375631|Analgesics|analgesics|mesh-ancestor
139054215|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
139054216|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139054217|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139054218|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139054219|NCT04340193|Nivolumab|nivolumab|mesh-list
139054220|NCT04340193|Ipilimumab|ipilimumab|mesh-list
139054221|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054222|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054223|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139054224|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054225|NCT04336982|Azacitidine|azacitidine|mesh-list
139054226|NCT04336982|Venetoclax|venetoclax|mesh-list
139054227|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139054228|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
139054229|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054230|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054231|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054232|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
139054233|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
139054234|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139054235|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139054236|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054237|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139054238|NCT04324463|Aspirin|aspirin|mesh-list
139054239|NCT04324463|Interferons|interferons|mesh-list
139054240|NCT04324463|Interferon-beta|interferon-beta|mesh-list
139054241|NCT04324463|Colchicine|colchicine|mesh-list
139054242|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
139054243|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054244|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
139054245|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054246|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139054247|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139054248|NCT04324463|Analgesics|analgesics|mesh-ancestor
139054249|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
139054250|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139054251|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054252|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139054253|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139054254|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139054255|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139054256|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054257|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139054258|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139054259|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054260|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
139054261|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139054263|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139054264|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
139054265|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
139054266|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
139054267|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
139054268|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
139054269|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
139054270|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
139054271|NCT04291079|Antibodies|antibodies|mesh-list
139054272|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
139054273|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054274|NCT04251416|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139054275|NCT04251416|Immunoconjugates|immunoconjugates|mesh-ancestor
139054276|NCT04251416|Immunologic Factors|immunologic factors|mesh-ancestor
139054277|NCT04251416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054278|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
139054279|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139054280|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
139054281|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629575|NCT00236418|Topiramate|topiramate|mesh-list
139054282|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054283|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139054284|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
139054285|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139054286|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
139054287|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054288|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054289|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139054290|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
139054291|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
139054292|NCT04231760|Protective Agents|protective agents|mesh-ancestor
139054293|NCT04225117|Pembrolizumab|pembrolizumab|mesh-list
139054294|NCT04225117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054295|NCT04225117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054296|NCT04225117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139054297|NCT04225117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054314|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
139054315|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054316|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054317|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139054318|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
139054319|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
139054320|NCT04181359|Protective Agents|protective agents|mesh-ancestor
139054321|NCT04168710|Bupivacaine|bupivacaine|mesh-list
139054322|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
139054323|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
139054324|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139054325|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054326|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
139054327|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139054328|NCT04149210|Fluorometholone|fluorometholone|mesh-list
139054329|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
139054330|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139054331|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138898975|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
139054332|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139054333|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
139054334|NCT04149210|Hormones|hormones|mesh-ancestor
139054335|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139054336|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054337|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139054338|NCT04085887|Panitumumab|panitumumab|mesh-list
139054339|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054340|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054341|NCT04071236|Avelumab|avelumab|mesh-list
139054342|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
139054343|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139054344|NCT04071236|Peposertib|peposertib|mesh-list
139054345|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054346|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054347|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
139054348|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054349|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054350|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054351|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054352|NCT04065009|Ropivacaine|ropivacaine|mesh-list
139054353|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
139054354|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
139054355|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139054356|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054357|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
139054358|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139054359|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
139054360|NCT04042701|Trastuzumab|trastuzumab|mesh-list
139054361|NCT04042701|Camptothecin|camptothecin|mesh-list
139054362|NCT04042701|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139054363|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
139054364|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054368|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
139054369|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054370|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139054371|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139054372|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139054373|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054377|NCT04029480|Metformin|metformin|mesh-list
139054378|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
139054379|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139054380|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054381|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139054382|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054383|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139054384|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139054385|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054386|NCT04002947|Rituximab|rituximab|mesh-list
139054387|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
139054388|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054389|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054391|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054392|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139054393|NCT04002297|Rituximab|rituximab|mesh-list
139054394|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139054395|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
139054396|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054397|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054398|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
139054399|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054400|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138629709|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629710|NCT00199472|Diuretics|diuretics|mesh-list
139054401|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139054402|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
139054403|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054404|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054405|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054428|NCT03967054|Ivermectin|ivermectin|mesh-list
139054429|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139054430|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054431|NCT03962894|Prednisolone|prednisolone|mesh-list
139054432|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139054433|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
139054434|NCT03962894|Hormones|hormones|mesh-ancestor
139054435|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139054436|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899059|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054437|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139054438|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054439|NCT03962855|Ifetroban|ifetroban|mesh-list
139054440|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139054441|NCT03943173|Olaparib|olaparib|mesh-list
139054442|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139054443|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054444|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054445|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054446|NCT03933904|Sirolimus|sirolimus|mesh-list
139054447|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139054448|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054449|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139054450|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054451|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
139054452|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139054453|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
139054454|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054455|NCT03932864|Plerixafor|plerixafor|mesh-list
139054456|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139054457|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139054458|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
139054459|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054460|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139054461|NCT03809078|Bombesin|bombesin|mesh-list
138805054|NCT00826540|Antibodies|antibodies|mesh-list
139054462|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139054463|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054464|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054465|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054466|NCT03776071|Temozolomide|temozolomide|mesh-list
139054467|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139054468|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
139054469|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054470|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054471|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
138629797|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
139054472|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139054473|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
139054474|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139054475|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054476|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139054477|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
139054478|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139054479|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
139054480|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054481|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054482|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139054483|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
139054484|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
139054485|NCT03679312|Protective Agents|protective agents|mesh-ancestor
139054486|NCT03604978|Nivolumab|nivolumab|mesh-list
139054487|NCT03604978|Ipilimumab|ipilimumab|mesh-list
139054488|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054489|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054490|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139054491|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054492|NCT03501979|Capecitabine|capecitabine|mesh-list
139054493|NCT03501979|Trastuzumab|trastuzumab|mesh-list
139054494|NCT03501979|Tucatinib|tucatinib|mesh-list
139054495|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139054496|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
139054497|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054498|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054499|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054500|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054501|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054502|NCT03474107|Paclitaxel|paclitaxel|mesh-list
139054503|NCT03474107|Docetaxel|docetaxel|mesh-list
139054504|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139054505|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054506|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
139054507|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
139054508|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
139054509|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054510|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
139054511|NCT03456843|Docetaxel|docetaxel|mesh-list
139054512|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
139054513|NCT03456843|Hormones|hormones|mesh-list
139054514|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139054515|NCT03456843|Androgens|androgens|mesh-list
139054516|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
139054517|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054518|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
139054519|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
139054520|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
139054521|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054522|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139054523|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054524|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
139054525|NCT03456843|Protective Agents|protective agents|mesh-ancestor
139054526|NCT03456843|Vitamins|vitamins|mesh-ancestor
139054527|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
139054528|NCT03456843|Estrogens|estrogens|mesh-ancestor
139054529|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139054530|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
139054531|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
139054533|NCT03400332|Ipilimumab|ipilimumab|mesh-list
139054534|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054535|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054536|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139054537|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054538|NCT03395184|PF-06700841|pf-06700841|mesh-list
139054539|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054541|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054542|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
139054543|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054544|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054545|NCT03190941|Aldesleukin|aldesleukin|mesh-list
139054546|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
139054547|NCT03190941|Fludarabine|fludarabine|mesh-list
138629953|NCT02484664|Celecoxib|celecoxib|mesh-list
139054548|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139054549|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
139054550|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054551|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139054552|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139054553|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
139054554|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054555|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054556|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139054557|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139054558|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139054559|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
139054560|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054561|NCT03147287|Fulvestrant|fulvestrant|mesh-list
139054562|NCT03147287|Palbociclib|palbociclib|mesh-list
139054563|NCT03147287|Avelumab|avelumab|mesh-list
139054564|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139054565|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054566|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139054567|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139054568|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
139054569|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139054570|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054571|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054572|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629998|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139054573|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054574|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054575|NCT03068442|Flutemetamol|flutemetamol|mesh-list
139054576|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139054577|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054578|NCT03049462|Mirabegron|mirabegron|mesh-list
139054579|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054580|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054581|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139054582|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139054583|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139054584|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
139054585|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054586|NCT03049462|Urological Agents|urological agents|mesh-ancestor
139054587|NCT02990546|Midodrine|midodrine|mesh-list
139054588|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
139054589|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
139054590|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139054591|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054592|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139054593|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139054594|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139054595|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139054596|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
139054597|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054598|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054599|NCT02965963|Dopamine|dopamine|mesh-list
139054600|NCT02965963|Metoclopramide|metoclopramide|mesh-list
139054601|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
139054602|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
139054603|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139054604|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054605|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139054606|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139054607|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139054608|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
139054609|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054610|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054611|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139054612|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
139054613|NCT02965963|Protective Agents|protective agents|mesh-ancestor
139054614|NCT02865135|Cyclophosphamide|cyclophosphamide|mesh-list
139054615|NCT02865135|Vaccines|vaccines|mesh-list
139054616|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
139054617|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054618|NCT02865135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139054619|NCT02865135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139054620|NCT02865135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139054621|NCT02865135|Alkylating Agents|alkylating agents|mesh-ancestor
139054622|NCT02865135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054623|NCT02865135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054624|NCT02865135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139054625|NCT02858310|Aldesleukin|aldesleukin|mesh-list
139054626|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
139054627|NCT02858310|Fludarabine|fludarabine|mesh-list
139054628|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139054629|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
139054630|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054631|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139054632|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138630102|NCT00265278|Modafinil|modafinil|mesh-list
139054633|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
139054634|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054635|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054636|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139054637|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139054638|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139054639|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
139054640|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054641|NCT02769962|Olaparib|olaparib|mesh-list
139054642|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139054643|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054644|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054645|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054646|NCT02709720|Cisplatin|cisplatin|mesh-list
139054647|NCT02709720|Vinorelbine|vinorelbine|mesh-list
139054648|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054649|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139054650|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
139054651|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
139054652|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
139054653|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054654|NCT02652260|Tenofovir|tenofovir|mesh-list
139054655|NCT02652260|Lamivudine|lamivudine|mesh-list
139054656|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139054657|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
139054658|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054659|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139054660|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139054661|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054662|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054663|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139054664|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139054665|NCT02593526|Bumetanide|bumetanide|mesh-list
139054667|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139054668|NCT02593526|Diuretics|diuretics|mesh-ancestor
139054669|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
139054670|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054671|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139054672|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139054673|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054674|NCT02571725|Olaparib|olaparib|mesh-list
139054675|NCT02571725|Tremelimumab|tremelimumab|mesh-list
139054676|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139054677|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054678|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054679|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054680|NCT02501941|Ketamine|ketamine|mesh-list
139054681|NCT02501941|Analgesics|analgesics|mesh-ancestor
139054682|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
139054683|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139054684|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054685|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139054686|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138805277|NCT00912912|Sunitinib|sunitinib|mesh-list
139054687|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
139054688|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
139054689|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139054690|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139054691|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139054692|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054693|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054695|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139054696|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139054697|NCT02470299|Analgesics|analgesics|mesh-ancestor
139054698|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
139054699|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139054700|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054701|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139054702|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139054703|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139054704|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054705|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054713|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
139054714|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054715|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054716|NCT02332668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139054717|NCT02332668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054718|NCT02179086|Temozolomide|temozolomide|mesh-list
139054719|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139054720|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
139054721|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054722|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054723|NCT02016924|Cobicistat|cobicistat|mesh-list
139054724|NCT02016924|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
139054725|NCT02016924|Emtricitabine|emtricitabine|mesh-list
139054726|NCT02016924|Tenofovir|tenofovir|mesh-list
139054727|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054728|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054729|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139054730|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139054731|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
139054732|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054733|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139054734|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139054735|NCT02016924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139054736|NCT02016924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139054737|NCT01996865|Rituximab|rituximab|mesh-list
139054738|NCT01996865|Lenalidomide|lenalidomide|mesh-list
139054739|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054740|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054741|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
139054742|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054743|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139054744|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139054745|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139054746|NCT01996865|Growth Substances|growth substances|mesh-ancestor
139054747|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
139054748|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
139054749|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139054750|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054751|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054752|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139054753|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139054754|NCT01774487|Protective Agents|protective agents|mesh-ancestor
139054755|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054756|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
139054757|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139054758|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
139054759|NCT01763645|Paclitaxel|paclitaxel|mesh-list
138805353|NCT00631722|Haloperidol|haloperidol|mesh-list
139054760|NCT01763645|Bevacizumab|bevacizumab|mesh-list
139054761|NCT01763645|Carboplatin|carboplatin|mesh-list
139054762|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139054763|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054764|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
139054765|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
139054766|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
139054767|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054768|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054769|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139054770|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139054771|NCT01763645|Growth Substances|growth substances|mesh-ancestor
139054772|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054773|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
139054774|NCT01517100|Dronabinol|dronabinol|mesh-list
139054775|NCT01517100|Nabilone|nabilone|mesh-list
139054776|NCT01517100|Antiemetics|antiemetics|mesh-ancestor
139054777|NCT01517100|Autonomic Agents|autonomic agents|mesh-ancestor
139054778|NCT01517100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139054779|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054780|NCT01517100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139054781|NCT01517100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139054782|NCT01517100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139054783|NCT01517100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139054784|NCT01517100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139054792|NCT01517100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054794|NCT01517100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139054795|NCT00754260|Caffeine|caffeine|mesh-list
139054796|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139054797|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054798|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139054799|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054800|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054801|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139054802|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139054803|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
139054804|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054806|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139054807|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139054808|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139054809|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054810|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054818|NCT00001379|Interferons|interferons|mesh-list
139054819|NCT00001379|Rituximab|rituximab|mesh-list
139054820|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054821|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
139054822|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054823|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054824|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
139054825|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054826|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139054827|NCT01023425|Donepezil|donepezil|mesh-list
139054828|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139054829|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054830|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054831|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
139054832|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054833|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054834|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
139054835|NCT00285584|Bupropion|bupropion|mesh-list
139054836|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139054837|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
139054838|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139054839|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139054840|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139054841|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139054842|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054843|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
139054844|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054845|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054846|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139054847|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139054848|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054849|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139054850|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054851|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054852|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054853|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139054854|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
139054855|NCT00291668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139054856|NCT00291668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139054857|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139054858|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
139054859|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054860|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139054861|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139054862|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139054863|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139054864|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054865|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054866|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
139054867|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054868|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139054869|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139054871|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054872|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054873|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630414|NCT00266097|Gemcitabine|gemcitabine|mesh-list
139054874|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054875|NCT01095484|Rotigotine|rotigotine|mesh-list
139054876|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
139054877|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
139054878|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139054879|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054880|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054881|NCT01063478|Everolimus|everolimus|mesh-list
139054882|NCT01063478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139054883|NCT01063478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054884|NCT01063478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054885|NCT01063478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054886|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139054887|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
139054888|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054889|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054890|NCT01327144|Acyclovir|acyclovir|mesh-list
139054891|NCT01327144|Famciclovir|famciclovir|mesh-list
139054892|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
139054893|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054894|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139054895|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054896|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054897|NCT01323101|Doxycycline|doxycycline|mesh-list
139054898|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139054899|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054900|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
139054901|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139054902|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139054903|NCT00310856|Vaccines|vaccines|mesh-list
139054904|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
139054905|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805500|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054907|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
138630435|NCT00202241|Hormones|hormones|mesh-ancestor
139054908|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054909|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139054910|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139054911|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054912|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054913|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139054914|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139054915|NCT02532062|Vitamin D|vitamin d|mesh-list
139054916|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
139054917|NCT02532062|Vitamins|vitamins|mesh-ancestor
139054918|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
139054919|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054920|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139054921|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139054922|NCT00283712|Infliximab|infliximab|mesh-list
139054923|NCT00283712|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139054924|NCT00283712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139054925|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
139054926|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139054927|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139054928|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139054929|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
139054930|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139054931|NCT00449033|Gemcitabine|gemcitabine|mesh-list
139054932|NCT00449033|Sorafenib|sorafenib|mesh-list
139054933|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054934|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139054935|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
139054936|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054937|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054938|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054939|NCT01024205|Sunitinib|sunitinib|mesh-list
139054940|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054941|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139054942|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139054943|NCT01024205|Growth Substances|growth substances|mesh-ancestor
139054944|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054945|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
139054946|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054947|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054948|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054949|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
139054950|NCT00448019|Bevacizumab|bevacizumab|mesh-list
139054951|NCT00448019|Rituximab|rituximab|mesh-list
139054952|NCT00448019|Fludarabine|fludarabine|mesh-list
139054953|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
139054954|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139054955|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
139054957|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139054958|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139054959|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
139054960|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054961|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054962|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139054963|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139054964|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139054965|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139054966|NCT00448019|Growth Substances|growth substances|mesh-ancestor
139054967|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
139054968|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139054969|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
139054971|NCT00457691|Fluorouracil|fluorouracil|mesh-list
139054972|NCT00457691|Irinotecan|irinotecan|mesh-list
139054973|NCT00457691|Sunitinib|sunitinib|mesh-list
139054974|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
139054975|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
139054976|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139054977|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139054978|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630512|NCT00259155|Rifaximin|rifaximin|mesh-list
139054979|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139054980|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
139054981|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139054982|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139054983|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139054984|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054985|NCT00457691|Antidotes|antidotes|mesh-ancestor
139054986|NCT00457691|Protective Agents|protective agents|mesh-ancestor
139054987|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
139054988|NCT00457691|Vitamins|vitamins|mesh-ancestor
139054989|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
139054990|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139054991|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139054992|NCT00457691|Growth Substances|growth substances|mesh-ancestor
139054993|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
139054994|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054995|NCT00447005|Axitinib|axitinib|mesh-list
139054996|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139054997|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139054998|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139054999|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055000|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
138899472|NCT02655965|Clonidine|clonidine|mesh-list
139055001|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
139055002|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139055003|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055004|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055005|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
139055006|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139055007|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055008|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055009|NCT00446849|Mesalamine|mesalamine|mesh-list
139055010|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139055011|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139055012|NCT00446849|Analgesics|analgesics|mesh-ancestor
139055013|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
139055014|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055015|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055016|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139055017|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139055018|NCT01565837|Ipilimumab|ipilimumab|mesh-list
139055019|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055020|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055021|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139055022|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055023|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
139055024|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139055025|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055026|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139055027|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
139055028|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139055029|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139055030|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055031|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055032|NCT00456599|Gemcitabine|gemcitabine|mesh-list
139055033|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
139055034|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139055035|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
139055036|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055037|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055038|NCT00456521|Naltrexone|naltrexone|mesh-list
139055039|NCT00456521|Bupropion|bupropion|mesh-list
139055040|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139055041|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139055042|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055043|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
139055044|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055045|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139055046|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
139055047|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139055048|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139055049|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139055050|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139055051|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055052|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
139055053|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055054|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139055055|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139055056|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055057|NCT00456365|Pravastatin|pravastatin|mesh-list
139055058|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139055059|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139055060|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
139055061|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055062|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139055063|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139055064|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055065|NCT03843047|Nicotine|nicotine|mesh-list
139055066|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139055067|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
139055068|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055069|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055070|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139055071|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139055072|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
139055073|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055074|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055075|NCT00455741|Estradiol|estradiol|mesh-list
139055076|NCT00455741|Progesterone|progesterone|mesh-list
139055077|NCT00455741|Estrogens|estrogens|mesh-ancestor
139055078|NCT00455741|Hormones|hormones|mesh-ancestor
139085249|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055079|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139055080|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055081|NCT00455741|Progestins|progestins|mesh-ancestor
139055082|NCT00445679|Paroxetine|paroxetine|mesh-list
139055083|NCT00445679|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139055084|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139055085|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139055086|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055087|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055089|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055090|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139055091|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
139055092|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139055093|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139055094|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139055095|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055096|NCT00445601|Gemcitabine|gemcitabine|mesh-list
139055097|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139055098|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
139055099|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055100|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055101|NCT00444587|Trastuzumab|trastuzumab|mesh-list
139055102|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055103|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055104|NCT00235716|Vitamins|vitamins|mesh-list
139055105|NCT00235716|Vitamin E|vitamin e|mesh-list
139055106|NCT00235716|Tocopherols|tocopherols|mesh-list
139055107|NCT00235716|Tocotrienols|tocotrienols|mesh-list
139055108|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
139055109|NCT00235716|Memantine|memantine|mesh-list
139055110|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
139055111|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055112|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
139055113|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055114|NCT00235716|Protective Agents|protective agents|mesh-ancestor
139055115|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139055116|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139055117|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
139055118|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055119|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139055120|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139055121|NCT00274742|Blinatumomab|blinatumomab|mesh-list
139055122|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139055123|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055124|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
139055125|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055126|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
139055127|NCT03970044|Exenatide|exenatide|mesh-list
139055128|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138805726|NCT00845182|Incretins|incretins|mesh-ancestor
139055129|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055130|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139055131|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899568|NCT00649259|Oxybutynin|oxybutynin|mesh-list
139055132|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139055133|NCT03970044|Incretins|incretins|mesh-ancestor
139055134|NCT03970044|Hormones|hormones|mesh-ancestor
139055135|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139055136|NCT00444275|Esomeprazole|esomeprazole|mesh-list
139055137|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139055138|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139055139|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139055140|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055141|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055142|NCT00454805|Fulvestrant|fulvestrant|mesh-list
139055143|NCT00454805|Cediranib|cediranib|mesh-list
139055144|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139055145|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055146|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139055147|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139055148|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
139055149|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139055150|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055151|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139055152|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055153|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055154|NCT00283244|Gemcitabine|gemcitabine|mesh-list
139055155|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139055156|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139055157|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
139055158|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055159|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055160|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139055161|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055162|NCT00282464|Ziprasidone|ziprasidone|mesh-list
139055163|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139055164|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
139055165|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055166|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055167|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055168|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139055169|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139055170|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055171|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139055172|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139055173|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
139055174|NCT03841331|Serlopitant|serlopitant|mesh-list
139055176|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055177|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055178|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055179|NCT00262080|Ecallantide|ecallantide|mesh-list
139055180|NCT00262080|Analgesics|analgesics|mesh-ancestor
139055181|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
139055182|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055183|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055184|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139055185|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139055186|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139055187|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139055188|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
139055189|NCT01073904|Norgestrel|norgestrel|mesh-list
139055190|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139055191|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
139055192|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139055193|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055194|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139055195|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139055196|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139055197|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139055198|NCT00282308|Rituximab|rituximab|mesh-list
139055199|NCT00282308|Methotrexate|methotrexate|mesh-list
139055200|NCT00282308|Vaccines|vaccines|mesh-list
139055201|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139055202|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138805801|NCT00822172|Cilostazol|cilostazol|mesh-list
139055203|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
139055204|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055205|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055206|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055207|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139055208|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139055209|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
139055210|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139055211|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139055212|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
139055213|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055214|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
138693341|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139055215|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055216|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139055217|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139055218|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139055219|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139055220|NCT00281840|Bevacizumab|bevacizumab|mesh-list
139055221|NCT00281840|Docetaxel|docetaxel|mesh-list
139055222|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055223|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055224|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139055225|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139055226|NCT00281840|Growth Substances|growth substances|mesh-ancestor
139055227|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055228|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
139055229|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
139055230|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
139055231|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
139055232|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055233|NCT00272792|Verapamil|verapamil|mesh-list
139055234|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139055235|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139055236|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139055237|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055238|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139055239|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055240|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
139055241|NCT01069094|Leuprolide|leuprolide|mesh-list
139055242|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139055243|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
139055244|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139055245|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055246|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139055247|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055248|NCT00048568|Methotrexate|methotrexate|mesh-list
139055249|NCT00048568|Abatacept|abatacept|mesh-list
139055250|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139055251|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
139055252|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139055253|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055254|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139055255|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
139055256|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055257|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055258|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
138630822|NCT02211976|Laxatives|laxatives|mesh-ancestor
139055259|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055260|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139055261|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139055262|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
139055263|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139055264|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139055265|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139085250|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
139055266|NCT00048568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055267|NCT00262002|Vaccines|vaccines|mesh-list
139055268|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
139055269|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055270|NCT01584076|Donepezil|donepezil|mesh-list
139055271|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139055272|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055273|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055274|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
139055275|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055276|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055277|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
139055278|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
139055280|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055281|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055282|NCT03954964|Analgesics|analgesics|mesh-ancestor
139055283|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
139055284|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055286|NCT00281528|Bevacizumab|bevacizumab|mesh-list
139055287|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139055288|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139055289|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055290|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
139055291|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
139055292|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
139055293|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055294|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055295|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139055296|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139055297|NCT00281528|Growth Substances|growth substances|mesh-ancestor
139055298|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055299|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
139055300|NCT01095640|Adapalene|adapalene|mesh-list
139055301|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139055302|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139055303|NCT01095640|Analgesics|analgesics|mesh-ancestor
139055304|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
139055305|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055306|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055307|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139055308|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139055309|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
139055310|NCT00280748|Pemetrexed|pemetrexed|mesh-list
139055311|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055312|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630940|NCT04557475|Aspirin|aspirin|mesh-list
139055313|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055314|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139055315|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139055316|NCT03975374|Tobramycin|tobramycin|mesh-list
139055317|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
139055318|NCT03975374|Dexamethasone|dexamethasone|mesh-list
139055319|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139055320|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139055321|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
139055322|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
139055323|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138307545|NCT00002423|Amprenavir|amprenavir|mesh-list
139055324|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055325|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139055326|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
139055327|NCT03975374|Hormones|hormones|mesh-ancestor
139055328|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139055329|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139055330|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055331|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139055332|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139055333|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139055334|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
139055335|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055336|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055337|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139055338|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
139055339|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
139055340|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139055341|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
139055342|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055343|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
139055344|NCT03741686|Cathartics|cathartics|mesh-ancestor
139055345|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139055346|NCT00279812|Selenium|selenium|mesh-list
139055347|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
139055348|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055349|NCT00279812|Protective Agents|protective agents|mesh-ancestor
139055350|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055351|NCT00279812|Trace Elements|trace elements|mesh-ancestor
139055352|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
139055353|NCT01070732|Acetaminophen|acetaminophen|mesh-list
139055354|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139055355|NCT01070732|Analgesics|analgesics|mesh-ancestor
139055356|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
139055357|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631028|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055358|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055359|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
139055360|NCT00207714|Infliximab|infliximab|mesh-list
139055361|NCT00207714|Golimumab|golimumab|mesh-list
139055362|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139055363|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139055364|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
139055365|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139055366|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139055367|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139055368|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
139055369|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055370|NCT00207090|Rifampin|rifampin|mesh-list
139055371|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139055372|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
138631069|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
139055373|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139055374|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139055375|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
139055376|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139055377|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055378|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055379|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139055380|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139055381|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139055382|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139055383|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139055384|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139055385|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
139055386|NCT00059332|Analgesics|analgesics|mesh-ancestor
139055387|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
139055388|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055389|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055390|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
139055391|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055392|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139055393|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
139055394|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139055395|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139055396|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055397|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139055398|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
139055399|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139055400|NCT00233454|Midostaurin|midostaurin|mesh-list
139055401|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631148|NCT04564456|Hormones|hormones|mesh-ancestor
139055402|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139055403|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055404|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055405|NCT00047320|Carboplatin|carboplatin|mesh-list
139055406|NCT00047320|Etoposide|etoposide|mesh-list
139055407|NCT00047320|Ifosfamide|ifosfamide|mesh-list
139055408|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
139055409|NCT00047320|Thiotepa|thiotepa|mesh-list
139055410|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055411|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139055412|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139055413|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139055414|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055415|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055416|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139055417|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
139055418|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139055419|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139055420|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
139055421|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055423|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
139055424|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139055425|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
139055426|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139055427|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139055428|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055429|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055430|NCT03973086|Protective Agents|protective agents|mesh-ancestor
139055431|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055432|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
139055433|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139055434|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055435|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139055436|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
139055437|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139055438|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139055439|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631175|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139055440|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055442|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139055443|NCT00278954|Antibodies|antibodies|mesh-list
139055444|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
139055445|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139055446|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
139055447|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055448|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
139055449|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139055450|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139055451|NCT00278564|Prednisolone|prednisolone|mesh-list
139055452|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
139055453|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
139055454|NCT00278564|Rituximab|rituximab|mesh-list
139055455|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139055456|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
139055457|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139055458|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
139055459|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055460|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139055461|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139055462|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
139055463|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055464|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055465|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139055466|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055467|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139055468|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
139055469|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
139055470|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055471|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139055472|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
139055473|NCT00278564|Hormones|hormones|mesh-ancestor
139055474|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139055475|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139055476|NCT00278564|Protective Agents|protective agents|mesh-ancestor
139055477|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138770210|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693384|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
139055478|NCT01071564|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139055479|NCT01071564|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139055480|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055481|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055482|NCT00268346|Gefitinib|gefitinib|mesh-list
139055483|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055484|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139055485|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055486|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055487|NCT00250718|Levofloxacin|levofloxacin|mesh-list
139055488|NCT00250718|Ofloxacin|ofloxacin|mesh-list
139055489|NCT00250718|Dexamethasone|dexamethasone|mesh-list
139055490|NCT00250718|Rituximab|rituximab|mesh-list
139055491|NCT00250718|Etoposide|etoposide|mesh-list
139055492|NCT00250718|Vincristine|vincristine|mesh-list
139055493|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139055494|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
139055495|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
139055496|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055497|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055498|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138806117|NCT02818803|Propolis|propolis|mesh-list
139055499|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
139055500|NCT00250718|Hormones|hormones|mesh-ancestor
139055501|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139055502|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139055503|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055504|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055505|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
139055506|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139055507|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139055508|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139055509|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139055510|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055511|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055512|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
139055513|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
139055514|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
139055515|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139055516|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139055517|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139055518|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139055519|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139055520|NCT00276614|Bortezomib|bortezomib|mesh-list
139055521|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055522|NCT00276458|Atorvastatin|atorvastatin|mesh-list
139055523|NCT00276458|Ezetimibe|ezetimibe|mesh-list
139055524|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139055525|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139055526|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
139055527|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055528|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139055529|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139055530|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055531|NCT00276380|Aspirin|aspirin|mesh-list
139055532|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139055533|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139055534|NCT00276380|Analgesics|analgesics|mesh-ancestor
139055535|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
138899745|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139055536|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055537|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055538|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139055539|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139055540|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139055541|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139055542|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055543|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139055544|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139055545|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055547|NCT02531984|Azithromycin|azithromycin|mesh-list
139055548|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139055549|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139055550|NCT00267956|Ustekinumab|ustekinumab|mesh-list
139055551|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
139055552|NCT00267488|Topotecan|topotecan|mesh-list
139055553|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139055554|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139055555|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055556|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055557|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055558|NCT01073696|Granisetron|granisetron|mesh-list
139055559|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
139055560|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
139055561|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055562|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055563|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139055564|NCT01073696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139055565|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139055566|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
139055567|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055568|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055569|NCT00058552|Pertuzumab|pertuzumab|mesh-list
139055570|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055571|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055572|NCT01093768|Vasopressins|vasopressins|mesh-list
139055573|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
139055574|NCT01093768|Oxytocin|oxytocin|mesh-list
139055575|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
139055576|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139055577|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055578|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
139055579|NCT01093768|Coagulants|coagulants|mesh-ancestor
139055580|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139055581|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139055582|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
139055583|NCT00044512|Sorafenib|sorafenib|mesh-list
139055584|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055585|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139055586|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055587|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055588|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
139055589|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
139055590|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
139055591|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055592|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055593|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
139055594|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055595|NCT01096420|Topiramate|topiramate|mesh-list
139055596|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
139055597|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139055598|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055599|NCT06186154|Leucovorin|leucovorin|mesh-list
139055600|NCT06186154|Folic Acid|folic acid|mesh-list
139055601|NCT06186154|Vitamin B 12|vitamin b 12|mesh-list
139055602|NCT06186154|Hydroxocobalamin|hydroxocobalamin|mesh-list
139055603|NCT06186154|Levoleucovorin|levoleucovorin|mesh-list
139055604|NCT06186154|Antidotes|antidotes|mesh-ancestor
139055605|NCT06186154|Protective Agents|protective agents|mesh-ancestor
139055606|NCT06186154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055607|NCT06186154|Vitamin B Complex|vitamin b complex|mesh-ancestor
139055608|NCT06186154|Vitamins|vitamins|mesh-ancestor
139055609|NCT06186154|Micronutrients|micronutrients|mesh-ancestor
139055610|NCT06186154|Hematinics|hematinics|mesh-ancestor
139055611|NCT06186141|Morphine|morphine|mesh-list
139055612|NCT06186141|Oxycodone|oxycodone|mesh-list
139055613|NCT06186141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139055614|NCT06186141|Narcotics|narcotics|mesh-ancestor
139055615|NCT06186141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055616|NCT06186141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055617|NCT06186141|Analgesics|analgesics|mesh-ancestor
139055618|NCT06186141|Sensory System Agents|sensory system agents|mesh-ancestor
139055619|NCT06186141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899800|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
139055632|NCT06186037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139055633|NCT06186037|Antimetabolites|antimetabolites|mesh-ancestor
139055634|NCT06186037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055635|NCT06186037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139055636|NCT06186037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139055637|NCT06186037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055638|NCT06185621|Aspirin|aspirin|mesh-list
139055639|NCT06185621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139055640|NCT06185621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139055641|NCT06185621|Analgesics|analgesics|mesh-ancestor
139055642|NCT06185621|Sensory System Agents|sensory system agents|mesh-ancestor
139055643|NCT06185621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055644|NCT06185621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055645|NCT06185621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139055646|NCT06185621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139055647|NCT06185621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139055648|NCT06185621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139055649|NCT06185621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055650|NCT06185621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139055651|NCT06185621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139055652|NCT06185621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055653|NCT06185621|Antipyretics|antipyretics|mesh-ancestor
139055654|NCT06185608|Ropivacaine|ropivacaine|mesh-list
139055655|NCT06185608|Anesthetics, Local|anesthetics, local|mesh-ancestor
139055656|NCT06185608|Anesthetics|anesthetics|mesh-ancestor
139055657|NCT06185608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055658|NCT06185608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055659|NCT06185608|Sensory System Agents|sensory system agents|mesh-ancestor
139055660|NCT06185608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055661|NCT06185595|Glycerol|glycerol|mesh-list
139055662|NCT06185595|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139055663|NCT06185595|Protective Agents|protective agents|mesh-ancestor
139055664|NCT06185595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055665|NCT06185400|Osimertinib|osimertinib|mesh-list
139055666|NCT06185400|Aflutinib|aflutinib|mesh-list
139055667|NCT06185400|Disitamab vedotin|disitamab vedotin|mesh-list
139055669|NCT06185400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139055670|NCT06185400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770211|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139055671|NCT06185400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055673|NCT06185400|Immunologic Factors|immunologic factors|mesh-ancestor
139055674|NCT06185400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055675|NCT06185361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139055676|NCT06185361|Fluoxetine|fluoxetine|mesh-list
139055677|NCT06185361|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139055678|NCT06185361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139055679|NCT06185361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139055680|NCT06185361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055681|NCT06185361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055682|NCT06185361|Serotonin Agents|serotonin agents|mesh-ancestor
139055683|NCT06185361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055684|NCT06185361|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139055685|NCT06185361|Antidepressive Agents|antidepressive agents|mesh-ancestor
139055686|NCT06185361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139055687|NCT06185361|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139055688|NCT06185361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139055689|NCT06185361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055690|NCT06185361|Hemostatics|hemostatics|mesh-ancestor
139055691|NCT06185361|Coagulants|coagulants|mesh-ancestor
139055692|NCT06185361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139055693|NCT06185361|Natriuretic Agents|natriuretic agents|mesh-ancestor
139055694|NCT06185218|Botulinum Toxins|botulinum toxins|mesh-list
139055695|NCT06185218|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139055696|NCT06185218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139055697|NCT06185218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055698|NCT06185218|Cholinergic Agents|cholinergic agents|mesh-ancestor
139055699|NCT06185218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631526|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
139055700|NCT06185218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055701|NCT06185127|Midazolam|midazolam|mesh-list
139055702|NCT06185127|Fentanyl|fentanyl|mesh-list
139055703|NCT06185127|Dexmedetomidine|dexmedetomidine|mesh-list
139055704|NCT06185127|Ketamine|ketamine|mesh-list
139055705|NCT06185127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139055706|NCT06185127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055707|NCT06185127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055708|NCT06185127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139055709|NCT06185127|Analgesics|analgesics|mesh-ancestor
139055710|NCT06185127|Sensory System Agents|sensory system agents|mesh-ancestor
139055711|NCT06185127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055712|NCT06185127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139055713|NCT06185127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139055714|NCT06185127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139055715|NCT06185127|Adrenergic Agents|adrenergic agents|mesh-ancestor
139055716|NCT06185127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055717|NCT06185127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055718|NCT06185127|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139055719|NCT06185127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139055720|NCT06185127|Anesthetics, General|anesthetics, general|mesh-ancestor
139055721|NCT06185127|Anesthetics|anesthetics|mesh-ancestor
139055722|NCT06185127|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139055723|NCT06185127|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139055724|NCT06185127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139055725|NCT06185127|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139055726|NCT06185127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139055727|NCT06185127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139055728|NCT06185127|GABA Modulators|gaba modulators|mesh-ancestor
139055729|NCT06185127|GABA Agents|gaba agents|mesh-ancestor
139055730|NCT06185127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139055731|NCT06185127|Narcotics|narcotics|mesh-ancestor
139055732|NCT06184958|Lidocaine|lidocaine|mesh-list
139055733|NCT06184958|Ketamine|ketamine|mesh-list
139055734|NCT06184958|Anesthetics, Local|anesthetics, local|mesh-ancestor
139055736|NCT06184958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055737|NCT06184958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055738|NCT06184958|Sensory System Agents|sensory system agents|mesh-ancestor
139055739|NCT06184958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055740|NCT06184958|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139055741|NCT06184958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139055742|NCT06184958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139055743|NCT06184958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139055744|NCT06184958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055745|NCT06184958|Analgesics|analgesics|mesh-ancestor
138899915|NCT00847808|Lansoprazole|lansoprazole|mesh-list
139055747|NCT06184958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139055748|NCT06184958|Anesthetics, General|anesthetics, general|mesh-ancestor
139055749|NCT06184958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139055750|NCT06184958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139055751|NCT06184958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055752|NCT06181838|Tretinoin|tretinoin|mesh-list
139055753|NCT06181838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055754|NCT06181838|Keratolytic Agents|keratolytic agents|mesh-ancestor
139055755|NCT06181838|Dermatologic Agents|dermatologic agents|mesh-ancestor
139055756|NCT06180889|Enoxaparin|enoxaparin|mesh-list
139055757|NCT06180889|Anticoagulants|anticoagulants|mesh-ancestor
139055758|NCT06180889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139055759|NCT06180889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139055760|NCT06180889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055761|NCT06179303|Tamoxifen|tamoxifen|mesh-list
139055762|NCT06179303|Deoxyglucose|deoxyglucose|mesh-list
139055763|NCT06179303|Letrozole|letrozole|mesh-list
139055764|NCT06179303|Fulvestrant|fulvestrant|mesh-list
139055765|NCT06179303|Anastrozole|anastrozole|mesh-list
139055766|NCT06179303|Exemestane|exemestane|mesh-list
139055767|NCT06179303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139055768|NCT06179303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139055769|NCT06179303|Hormones|hormones|mesh-list
139055770|NCT06179303|Estradiol|estradiol|mesh-list
139055771|NCT06179303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139055772|NCT06179303|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
139055773|NCT06179303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139055774|NCT06179303|Fluorides|fluorides|mesh-list
139055775|NCT06179303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139055776|NCT06179303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055777|NCT06179303|Estrogens|estrogens|mesh-ancestor
139055778|NCT06179303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139055779|NCT06179303|Contraceptive Agents|contraceptive agents|mesh-ancestor
139055780|NCT06179303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139055781|NCT06179303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139055782|NCT06179303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055783|NCT06179303|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139055784|NCT06179303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139055785|NCT06179303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055786|NCT06179303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055787|NCT06179303|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139055788|NCT06179303|Hormone Antagonists|hormone antagonists|mesh-ancestor
139055789|NCT06179303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139055790|NCT06179303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139055791|NCT06179303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139055792|NCT06179303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139055793|NCT06179303|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139055794|NCT06179303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139055795|NCT06179303|Cariostatic Agents|cariostatic agents|mesh-ancestor
139055796|NCT06179303|Protective Agents|protective agents|mesh-ancestor
139055797|NCT06179303|Antimetabolites|antimetabolites|mesh-ancestor
139055798|NCT06179303|Antiviral Agents|antiviral agents|mesh-ancestor
139055799|NCT06179303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139055800|NCT06165991|Bupivacaine|bupivacaine|mesh-list
139055801|NCT06165991|Anesthetics, Local|anesthetics, local|mesh-ancestor
139055802|NCT06165991|Anesthetics|anesthetics|mesh-ancestor
139055803|NCT06165991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055804|NCT06165991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055805|NCT06165991|Sensory System Agents|sensory system agents|mesh-ancestor
139055806|NCT06165991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055807|NCT06162949|Amoxicillin|amoxicillin|mesh-list
139055808|NCT06162949|Clarithromycin|clarithromycin|mesh-list
139055809|NCT06162949|Esomeprazole|esomeprazole|mesh-list
139055810|NCT06162949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139055811|NCT06162949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139055812|NCT06162949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139055813|NCT06162949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139055814|NCT06162949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139055815|NCT06162949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055816|NCT06162949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055817|NCT06162949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139055818|NCT06162949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139055819|NCT06162949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139055820|NCT06162819|Flunarizine|flunarizine|mesh-list
139055821|NCT06162819|Amitriptyline|amitriptyline|mesh-list
139055822|NCT06162819|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139055823|NCT06162819|Antidepressive Agents|antidepressive agents|mesh-ancestor
139055824|NCT06162819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139055825|NCT06162819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139055826|NCT06162819|Analgesics|analgesics|mesh-ancestor
139055827|NCT06162819|Sensory System Agents|sensory system agents|mesh-ancestor
139055828|NCT06162819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055829|NCT06162819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055830|NCT06162819|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139055831|NCT06162819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139055832|NCT06162819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139055833|NCT06162819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055834|NCT06162819|Adrenergic Agents|adrenergic agents|mesh-ancestor
139055835|NCT06162819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055836|NCT06162819|Anticonvulsants|anticonvulsants|mesh-ancestor
139055837|NCT06162819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139055838|NCT06162819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139055839|NCT06162819|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139055840|NCT06162819|Histamine Antagonists|histamine antagonists|mesh-ancestor
139055841|NCT06162819|Histamine Agents|histamine agents|mesh-ancestor
139055842|NCT06162819|Vasodilator Agents|vasodilator agents|mesh-ancestor
139055843|NCT06158451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139055844|NCT06158451|Propolis|propolis|mesh-list
139055845|NCT06158451|Zinc Oxide|zinc oxide|mesh-list
139055846|NCT06158451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139055847|NCT06158451|Dermatologic Agents|dermatologic agents|mesh-ancestor
139055848|NCT06158451|Sunscreening Agents|sunscreening agents|mesh-ancestor
139055849|NCT06158451|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139055850|NCT06158451|Protective Agents|protective agents|mesh-ancestor
139055851|NCT06158451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693444|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139055853|NCT06149104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139055854|NCT06149104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139055855|NCT06149104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139055856|NCT06149104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139055857|NCT06149104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055858|NCT06124235|Chlorhexidine|chlorhexidine|mesh-list
139055859|NCT06124235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139055860|NCT06124235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139055861|NCT06124235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139055862|NCT06124235|Disinfectants|disinfectants|mesh-ancestor
139055863|NCT06124235|Dermatologic Agents|dermatologic agents|mesh-ancestor
139055864|NCT06120725|Clopidogrel|clopidogrel|mesh-list
139055865|NCT06120725|Ticagrelor|ticagrelor|mesh-list
139055866|NCT06120725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139055867|NCT06120725|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139055868|NCT06120725|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139055869|NCT06120725|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139055870|NCT06120725|Purinergic Agents|purinergic agents|mesh-ancestor
139055871|NCT06120725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055872|NCT06120725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055873|NCT06120725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055874|NCT06094387|Thrombin|thrombin|mesh-list
139055875|NCT06094387|Hemostatics|hemostatics|mesh-ancestor
139055876|NCT06094387|Coagulants|coagulants|mesh-ancestor
139055877|NCT06086275|Buprenorphine|buprenorphine|mesh-list
139055878|NCT06086275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139055879|NCT06086275|Narcotics|narcotics|mesh-ancestor
139055880|NCT06086275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055881|NCT06086275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055883|NCT06086275|Sensory System Agents|sensory system agents|mesh-ancestor
139055884|NCT06086275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631694|NCT04561921|Mepivacaine|mepivacaine|mesh-list
139055885|NCT06086275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139055886|NCT06074471|Bupivacaine|bupivacaine|mesh-list
139055887|NCT06074471|Anesthetics, Local|anesthetics, local|mesh-ancestor
139055888|NCT06074471|Anesthetics|anesthetics|mesh-ancestor
139055889|NCT06074471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055890|NCT06074471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055891|NCT06074471|Sensory System Agents|sensory system agents|mesh-ancestor
139055892|NCT06074471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055893|NCT06047457|Botulinum Toxins|botulinum toxins|mesh-list
139055894|NCT06047457|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139055895|NCT06047457|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139055896|NCT06047457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139055897|NCT06047457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139055898|NCT06047457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055899|NCT06047457|Cholinergic Agents|cholinergic agents|mesh-ancestor
139055900|NCT06047457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055901|NCT06047457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055902|NCT06047457|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138899993|NCT00600353|Hormones|hormones|mesh-ancestor
139055904|NCT06047444|Botulinum Toxins|botulinum toxins|mesh-list
139055905|NCT06047444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139055906|NCT06047444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139055907|NCT06047444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139055908|NCT06047444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139055909|NCT06047444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055910|NCT06047444|Cholinergic Agents|cholinergic agents|mesh-ancestor
139055911|NCT06047444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055912|NCT06047444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055913|NCT06047444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139055914|NCT06047444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055915|NCT06041802|Pembrolizumab|pembrolizumab|mesh-list
139055916|NCT06041802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055917|NCT06041802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055918|NCT06041802|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139055919|NCT06041802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055920|NCT06035692|Ropivacaine|ropivacaine|mesh-list
139055921|NCT06035692|Anesthetics, Local|anesthetics, local|mesh-ancestor
139055922|NCT06035692|Anesthetics|anesthetics|mesh-ancestor
139055923|NCT06035692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055924|NCT06035692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055925|NCT06035692|Sensory System Agents|sensory system agents|mesh-ancestor
139055926|NCT06035692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055927|NCT06030804|Dexmedetomidine|dexmedetomidine|mesh-list
139055928|NCT06030804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139055929|NCT06030804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055930|NCT06030804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055931|NCT06030804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139055932|NCT06030804|Analgesics|analgesics|mesh-ancestor
139055933|NCT06030804|Sensory System Agents|sensory system agents|mesh-ancestor
139055934|NCT06030804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055935|NCT06030804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139055936|NCT06030804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139055937|NCT06030804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139055938|NCT06030804|Adrenergic Agents|adrenergic agents|mesh-ancestor
139055939|NCT06030804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055940|NCT06030804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055941|NCT06005818|Pembrolizumab|pembrolizumab|mesh-list
139055942|NCT06005818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055943|NCT06005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055944|NCT06005818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139055945|NCT06005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055946|NCT06001372|Ketamine|ketamine|mesh-list
139055947|NCT06001372|Analgesics|analgesics|mesh-ancestor
139055948|NCT06001372|Sensory System Agents|sensory system agents|mesh-ancestor
139055949|NCT06001372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055950|NCT06001372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806548|NCT01057862|Naltrexone|naltrexone|mesh-list
139055951|NCT06001372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139055952|NCT06001372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139055953|NCT06001372|Anesthetics, General|anesthetics, general|mesh-ancestor
139055954|NCT06001372|Anesthetics|anesthetics|mesh-ancestor
138900011|NCT00691210|Niacin|niacin|mesh-list
139055955|NCT06001372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139055956|NCT06001372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139055957|NCT06001372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139055958|NCT06001372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139055959|NCT06001372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055960|NCT05996627|Belumosudil|belumosudil|mesh-list
139055961|NCT05996627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139055962|NCT05996627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055963|NCT05996627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055964|NCT05972473|Aflibercept|aflibercept|mesh-list
139055965|NCT05972473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139055966|NCT05972473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139055967|NCT05972473|Growth Substances|growth substances|mesh-ancestor
139055968|NCT05972473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055969|NCT05972473|Growth Inhibitors|growth inhibitors|mesh-ancestor
139055970|NCT05972473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055971|NCT05971251|Acalabrutinib|acalabrutinib|mesh-list
139055972|NCT05971251|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
139055973|NCT05971251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055974|NCT05971251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055975|NCT05861986|Risdiplam|risdiplam|mesh-list
139055976|NCT05861986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139055977|NCT05861986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139055978|NCT05861986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139055979|NCT05759754|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139055980|NCT05759754|Protease Inhibitors|protease inhibitors|mesh-ancestor
139055981|NCT05759754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139055982|NCT05759754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055983|NCT05743270|Paclitaxel|paclitaxel|mesh-list
139055984|NCT05743270|Carboplatin|carboplatin|mesh-list
139055985|NCT05743270|Nivolumab|nivolumab|mesh-list
139055986|NCT05743270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139055987|NCT05743270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139055988|NCT05743270|Tubulin Modulators|tubulin modulators|mesh-ancestor
139055989|NCT05743270|Antimitotic Agents|antimitotic agents|mesh-ancestor
139055990|NCT05743270|Mitosis Modulators|mitosis modulators|mesh-ancestor
139055991|NCT05743270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139055992|NCT05743270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139055993|NCT05743270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139055994|NCT05611879|Paclitaxel|paclitaxel|mesh-list
139055995|NCT05611879|Carboplatin|carboplatin|mesh-list
139055996|NCT05611879|Pemetrexed|pemetrexed|mesh-list
139055997|NCT05611879|Tislelizumab|tislelizumab|mesh-list
139055998|NCT05611879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139055999|NCT05611879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056000|NCT05611879|Tubulin Modulators|tubulin modulators|mesh-ancestor
139056001|NCT05611879|Antimitotic Agents|antimitotic agents|mesh-ancestor
138900037|NCT00650429|Ziprasidone|ziprasidone|mesh-list
139056002|NCT05611879|Mitosis Modulators|mitosis modulators|mesh-ancestor
139056003|NCT05611879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056004|NCT05611879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631879|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
139056005|NCT05611879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139056006|NCT05611879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139056007|NCT05611879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056008|NCT05604170|Ganaxolone|ganaxolone|mesh-list
139056009|NCT05604170|Neurosteroids|neurosteroids|mesh-ancestor
139056010|NCT05604170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056011|NCT05604170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056012|NCT05604170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056013|NCT05604170|GABA Modulators|gaba modulators|mesh-ancestor
139056014|NCT05604170|GABA Agents|gaba agents|mesh-ancestor
139056015|NCT05571670|Sirolimus|sirolimus|mesh-list
139056016|NCT05571670|MTOR Inhibitors|mtor inhibitors|mesh-list
139056017|NCT05571670|Temsirolimus|temsirolimus|mesh-list
139056018|NCT05571670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056019|NCT05571670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139056020|NCT05571670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056021|NCT05571670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056022|NCT05571670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139056023|NCT05571670|Immunologic Factors|immunologic factors|mesh-ancestor
139056024|NCT05571670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806621|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
139056025|NCT05571670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139056026|NCT05571670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139056027|NCT05571670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139056028|NCT05571670|Antifungal Agents|antifungal agents|mesh-ancestor
139056029|NCT05517330|Tislelizumab|tislelizumab|mesh-list
139056030|NCT05517330|Afatinib|afatinib|mesh-list
139056031|NCT05517330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056032|NCT05517330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056033|NCT05517330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139056034|NCT05517330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056035|NCT05517330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056036|NCT05516589|Paclitaxel|paclitaxel|mesh-list
139056037|NCT05516589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139056038|NCT05516589|Tislelizumab|tislelizumab|mesh-list
139056039|NCT05516589|Afatinib|afatinib|mesh-list
139056040|NCT05516589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138693487|NCT01824537|Vaccines|vaccines|mesh-list
139056041|NCT05516589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056042|NCT05516589|Tubulin Modulators|tubulin modulators|mesh-ancestor
139056043|NCT05516589|Antimitotic Agents|antimitotic agents|mesh-ancestor
139056044|NCT05516589|Mitosis Modulators|mitosis modulators|mesh-ancestor
139056045|NCT05516589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056046|NCT05516589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056047|NCT05516589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138631945|NCT00235274|Secretin|secretin|mesh-list
139056048|NCT05516589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056049|NCT05492591|Valacyclovir|valacyclovir|mesh-list
139056050|NCT05492591|Antiviral Agents|antiviral agents|mesh-ancestor
139056051|NCT05492591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139056052|NCT05446129|Pembrolizumab|pembrolizumab|mesh-list
139056053|NCT05446129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056054|NCT05446129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056055|NCT05446129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139056056|NCT05446129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056057|NCT05381363|Interferons|interferons|mesh-list
139056058|NCT05381363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056059|NCT05381363|Antiviral Agents|antiviral agents|mesh-ancestor
139056060|NCT05381363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139056061|NCT05365178|Fulvestrant|fulvestrant|mesh-list
139056062|NCT05365178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139056063|NCT05365178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056064|NCT05365178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139056065|NCT05365178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139056066|NCT05365178|Hormone Antagonists|hormone antagonists|mesh-ancestor
139056067|NCT05365178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056068|NCT05365178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056069|NCT05351801|Dronabinol|dronabinol|mesh-list
139056070|NCT05351801|Nabiximols|nabiximols|mesh-list
139056071|NCT05351801|Hallucinogens|hallucinogens|mesh-ancestor
139056072|NCT05351801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056073|NCT05351801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139056074|NCT05351801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139056075|NCT05351801|Analgesics|analgesics|mesh-ancestor
139056076|NCT05351801|Sensory System Agents|sensory system agents|mesh-ancestor
139056077|NCT05351801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139056078|NCT05351801|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139056079|NCT05351801|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139056080|NCT05351801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056081|NCT05351801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056082|NCT05351801|Hormones|hormones|mesh-ancestor
139056083|NCT05351801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056084|NCT05294640|Lidocaine|lidocaine|mesh-list
139056085|NCT05294640|Epinephrine|epinephrine|mesh-list
139056086|NCT05294640|Anesthetics, Local|anesthetics, local|mesh-list
139056087|NCT05294640|Anesthetics|anesthetics|mesh-list
139056088|NCT05294640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056089|NCT05294640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056090|NCT05294640|Sensory System Agents|sensory system agents|mesh-ancestor
139056091|NCT05294640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139056092|NCT05294640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139056093|NCT05294640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139056094|NCT05294640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138631950|NCT00268398|Leucovorin|leucovorin|mesh-list
139056095|NCT05294640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139056096|NCT05294640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056097|NCT05294640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138806704|NCT00830128|Pregabalin|pregabalin|mesh-list
139056098|NCT05294640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139056099|NCT05294640|Adrenergic Agents|adrenergic agents|mesh-ancestor
139056100|NCT05294640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056101|NCT05294640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139056102|NCT05294640|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139056104|NCT05294640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139056105|NCT05294640|Respiratory System Agents|respiratory system agents|mesh-ancestor
139056106|NCT05294640|Mydriatics|mydriatics|mesh-ancestor
139056107|NCT05294640|Sympathomimetics|sympathomimetics|mesh-ancestor
139056108|NCT05294640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139056109|NCT05239741|Leucovorin|leucovorin|mesh-list
139056110|NCT05239741|Bevacizumab|bevacizumab|mesh-list
139056111|NCT05239741|Pembrolizumab|pembrolizumab|mesh-list
139056112|NCT05239741|Cetuximab|cetuximab|mesh-list
139056113|NCT05239741|Fluorouracil|fluorouracil|mesh-list
139056114|NCT05239741|Oxaliplatin|oxaliplatin|mesh-list
139056115|NCT05239741|Irinotecan|irinotecan|mesh-list
139056116|NCT05239741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056117|NCT05239741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056118|NCT05239741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139056119|NCT05239741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139056120|NCT05239741|Growth Substances|growth substances|mesh-ancestor
139056121|NCT05239741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056122|NCT05239741|Growth Inhibitors|growth inhibitors|mesh-ancestor
139056123|NCT05239741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139056124|NCT05239741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056125|NCT05239741|Antimetabolites|antimetabolites|mesh-ancestor
139056126|NCT05239741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139056127|NCT05239741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139056128|NCT05239741|Immunologic Factors|immunologic factors|mesh-ancestor
139056129|NCT05239741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139056130|NCT05239741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139056131|NCT05239741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056132|NCT05239741|Antidotes|antidotes|mesh-ancestor
139056133|NCT05239741|Protective Agents|protective agents|mesh-ancestor
139056134|NCT05239741|Vitamin B Complex|vitamin b complex|mesh-ancestor
139056135|NCT05239741|Vitamins|vitamins|mesh-ancestor
139056136|NCT05239741|Micronutrients|micronutrients|mesh-ancestor
139056137|NCT05158777|Vaccines|vaccines|mesh-list
139056138|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
139056139|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056140|NCT05125185|Insulin|insulin|mesh-list
139056141|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139056142|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056143|NCT05062889|Leucovorin|leucovorin|mesh-list
139056144|NCT05062889|Trifluridine|trifluridine|mesh-list
139056145|NCT05062889|Capecitabine|capecitabine|mesh-list
139056146|NCT05062889|Fluorouracil|fluorouracil|mesh-list
139056147|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
139056148|NCT05062889|Trastuzumab|trastuzumab|mesh-list
139056149|NCT05062889|Irinotecan|irinotecan|mesh-list
139056150|NCT05062889|Tucatinib|tucatinib|mesh-list
139056151|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
138631977|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139056152|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139056153|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
139056154|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056155|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056156|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139056157|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
139056158|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056159|NCT05062889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056160|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139056161|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139056162|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056163|NCT05062889|Antidotes|antidotes|mesh-ancestor
139056164|NCT05062889|Protective Agents|protective agents|mesh-ancestor
139056165|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
139056166|NCT05062889|Vitamins|vitamins|mesh-ancestor
139056167|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
139056168|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
139056169|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139056170|NCT05062889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139056171|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139056172|NCT05037045|Incretins|incretins|mesh-ancestor
139056173|NCT05037045|Hormones|hormones|mesh-ancestor
139056174|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056175|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056176|NCT04997993|Leflunomide|leflunomide|mesh-list
139056177|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056178|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056179|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139056180|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
139056181|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056182|NCT04975269|Acetazolamide|acetazolamide|mesh-list
139056183|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
139056184|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139056185|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056186|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056187|NCT04975269|Diuretics|diuretics|mesh-ancestor
139056188|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
139056189|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056190|NCT04931511|Betamethasone|betamethasone|mesh-list
139056191|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
139056192|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139056193|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
139056194|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139056195|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139056196|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
139056198|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056199|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056200|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139056201|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
139056202|NCT04738318|Dexamethasone|dexamethasone|mesh-list
139056203|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
139056204|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
139056205|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139056206|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
139056207|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
139056208|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139056209|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056210|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139056211|NCT04738318|Hormones|hormones|mesh-ancestor
139056212|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056213|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139056214|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056215|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139056216|NCT04738318|Protective Agents|protective agents|mesh-ancestor
139056217|NCT04721353|Prazosin|prazosin|mesh-list
139056218|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139056219|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139056220|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139056221|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139056222|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
139056223|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056224|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056225|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056226|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
139056227|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139056228|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
139056229|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056230|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139056231|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139056232|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
139056233|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056234|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056236|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
139056237|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139056238|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
139056239|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056240|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139056241|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139056242|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
139056243|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056244|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056245|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139056246|NCT04704154|Nivolumab|nivolumab|mesh-list
139056247|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056248|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056249|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139056250|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056251|NCT04684420|Metformin|metformin|mesh-list
139056252|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139056253|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056254|NCT04557449|Letrozole|letrozole|mesh-list
139056255|NCT04557449|Fulvestrant|fulvestrant|mesh-list
139056256|NCT04557449|Midazolam|midazolam|mesh-list
139056257|NCT04557449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139056258|NCT04557449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139056259|NCT04557449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056260|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056261|NCT04557449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139056262|NCT04557449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139056263|NCT04557449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139056264|NCT04557449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139056265|NCT04557449|Anesthetics, General|anesthetics, general|mesh-ancestor
139056266|NCT04557449|Anesthetics|anesthetics|mesh-ancestor
139056267|NCT04557449|GABA Modulators|gaba modulators|mesh-ancestor
139056268|NCT04557449|GABA Agents|gaba agents|mesh-ancestor
139056269|NCT04557449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056270|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056271|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056272|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139056273|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139056274|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056275|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139056276|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
139056277|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056278|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139056279|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139056280|NCT04551131|Dexamethasone|dexamethasone|mesh-list
139056281|NCT04551131|Etoposide|etoposide|mesh-list
139056282|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
139056283|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139056284|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
139056285|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
139056286|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139056287|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056288|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139056289|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
139056290|NCT04551131|Hormones|hormones|mesh-ancestor
139056291|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056292|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139056293|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056294|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139056295|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139056296|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139056297|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252830|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
138632046|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139056298|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056300|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139056301|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
139056302|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139056303|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056304|NCT04438382|Prednisone|prednisone|mesh-list
139056305|NCT04438382|Infliximab|infliximab|mesh-list
139056306|NCT04438382|Cortisone|cortisone|mesh-list
139056307|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
139056308|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139056309|NCT04438382|Antibodies|antibodies|mesh-list
139056310|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
139056311|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139056312|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
139056313|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139056314|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
139056315|NCT04438382|Hormones|hormones|mesh-ancestor
139056316|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056317|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056318|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139056319|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056320|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
139056321|NCT04438382|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139056322|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
139056323|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139056324|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806923|NCT00770341|Vancomycin|vancomycin|mesh-list
139056325|NCT04352101|Bupropion|bupropion|mesh-list
139056326|NCT04352101|Escitalopram|escitalopram|mesh-list
139056327|NCT04352101|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139056328|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139056329|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139056330|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056331|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056332|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
139056333|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056334|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139056335|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
139056336|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139056337|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139056338|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
139056339|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139056340|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139056341|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056342|NCT04317872|Dexamethasone|dexamethasone|mesh-list
139056343|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
139056345|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139056346|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
139056347|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
139056348|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139056349|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056350|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139056351|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
139056352|NCT04317872|Hormones|hormones|mesh-ancestor
139056353|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056354|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139056355|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056356|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
139056357|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056358|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056359|NCT04304820|Cyclosporine|cyclosporine|mesh-list
139056360|NCT04304820|Cyclosporins|cyclosporins|mesh-list
139056361|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139056362|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056363|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252844|NCT00002487|Methotrexate|methotrexate|mesh-list
139056364|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139056365|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
139056366|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056367|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
139056368|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139056369|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
139056370|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139056371|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139056373|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139056374|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
139056375|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139056376|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056377|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139056378|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139056379|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056380|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056381|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056382|NCT04244552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139056383|NCT04221555|Docetaxel|docetaxel|mesh-list
139056384|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
139056385|NCT04221555|Durvalumab|durvalumab|mesh-list
139056386|NCT04221555|Tremelimumab|tremelimumab|mesh-list
139056387|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139056388|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056389|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
139056390|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
139056391|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
139056392|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056393|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056394|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
139056395|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056396|NCT04208178|Trastuzumab|trastuzumab|mesh-list
139056397|NCT04208178|Pertuzumab|pertuzumab|mesh-list
139056398|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056399|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138308772|NCT04330547|Analgesics|analgesics|mesh-list
139056400|NCT04187053|Methylene Blue|methylene blue|mesh-list
139056401|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806996|NCT02798367|Melatonin|melatonin|mesh-list
139056402|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900374|NCT02643563|Epinephrine|epinephrine|mesh-list
139056404|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056405|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056406|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139056407|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056408|NCT04135898|Bevacizumab|bevacizumab|mesh-list
139056409|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056410|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056411|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139056412|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139056413|NCT04135898|Growth Substances|growth substances|mesh-ancestor
139056414|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056415|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
139056416|NCT03879694|Octreotide|octreotide|mesh-list
139056417|NCT03879694|Sargramostim|sargramostim|mesh-list
139056418|NCT03879694|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139056419|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
139056420|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
139056421|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056422|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056423|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139056424|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139056425|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139056426|NCT03833479|Dostarlimab|dostarlimab|mesh-list
139056427|NCT03833479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056428|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
139056429|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139056430|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056431|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139056432|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056433|NCT03749460|Nivolumab|nivolumab|mesh-list
139056434|NCT03749460|Ipilimumab|ipilimumab|mesh-list
139056435|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056436|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632199|NCT00261261|Midazolam|midazolam|mesh-list
139056437|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139056438|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056439|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
139056440|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056441|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056442|NCT03598608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139056443|NCT03598608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056444|NCT03430843|Paclitaxel|paclitaxel|mesh-list
139056445|NCT03430843|Docetaxel|docetaxel|mesh-list
139056446|NCT03430843|Irinotecan|irinotecan|mesh-list
139056447|NCT03430843|Tislelizumab|tislelizumab|mesh-list
139056448|NCT03430843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139056449|NCT03430843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056450|NCT03430843|Tubulin Modulators|tubulin modulators|mesh-ancestor
139056451|NCT03430843|Antimitotic Agents|antimitotic agents|mesh-ancestor
139056452|NCT03430843|Mitosis Modulators|mitosis modulators|mesh-ancestor
139056453|NCT03430843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056454|NCT03430843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139056455|NCT03430843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139056456|NCT03430843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056457|NCT03430843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056458|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
139056459|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
139056460|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056461|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056462|NCT03382600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139056463|NCT03382600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056464|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
139056465|NCT03211416|Sorafenib|sorafenib|mesh-list
139056466|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056467|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056468|NCT03211416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139056469|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056470|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139056471|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056472|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
139056473|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
138807073|NCT00762073|Budesonide|budesonide|mesh-list
139056474|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139056475|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
139056476|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056477|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139056478|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139056479|NCT02787369|Idelalisib|idelalisib|mesh-list
139056480|NCT02787369|Ricolinostat|ricolinostat|mesh-list
139056481|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056482|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056483|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056484|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139056485|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
139056486|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139056487|NCT02759861|Ledipasvir|ledipasvir|mesh-list
139056488|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
139056489|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139056491|NCT02550028|Phenobarbital|phenobarbital|mesh-list
139056492|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
139056493|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
139056494|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139056495|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056496|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056497|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139056498|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139056499|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056500|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056501|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
139056502|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
139056503|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139056504|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139056505|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139056507|NCT02520063|Letrozole|letrozole|mesh-list
139056508|NCT02520063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139056509|NCT02520063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139056510|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056511|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056512|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139056513|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
139056514|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056515|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056516|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139056517|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139056518|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139056519|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
139056520|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056521|NCT02472314|Bupivacaine|bupivacaine|mesh-list
139056522|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
139056523|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
139056524|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056525|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056526|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
139056527|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139056528|NCT02158507|Lapatinib|lapatinib|mesh-list
139056529|NCT02158507|Veliparib|veliparib|mesh-list
139056530|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056531|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139056532|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056533|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056534|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139056535|NCT01561391|Factor VIII|factor viii|mesh-list
139056536|NCT01561391|Coagulants|coagulants|mesh-ancestor
139056537|NCT01524705|Insulin|insulin|mesh-list
139056538|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139056539|NCT01524705|Metformin|metformin|mesh-list
139056540|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
139056541|NCT01524705|Exenatide|exenatide|mesh-list
139056542|NCT01524705|Glucagon|glucagon|mesh-list
139056543|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139056544|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056545|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139056546|NCT01524705|Incretins|incretins|mesh-ancestor
139056547|NCT01524705|Hormones|hormones|mesh-ancestor
139056548|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056549|NCT01524705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139056550|NCT01072539|Tigecycline|tigecycline|mesh-list
139056551|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139056552|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139056553|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139056554|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056555|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056556|NCT00715611|Carboplatin|carboplatin|mesh-list
139056557|NCT00715611|Pemetrexed|pemetrexed|mesh-list
139056558|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056559|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632304|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
139056560|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056561|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139056562|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139056563|NCT00667043|Midazolam|midazolam|mesh-list
139056564|NCT00667043|Fentanyl|fentanyl|mesh-list
139056565|NCT00667043|Remifentanil|remifentanil|mesh-list
139056566|NCT00667043|Propofol|propofol|mesh-list
139056567|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139056568|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056569|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056570|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139056571|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
139056572|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
139056573|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139056574|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139056575|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139056576|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139056577|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
139056578|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
139056579|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056580|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056581|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139056582|NCT00667043|Narcotics|narcotics|mesh-ancestor
139056583|NCT00667043|Analgesics|analgesics|mesh-ancestor
139056584|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
139056585|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139056586|NCT03953716|Desogestrel|desogestrel|mesh-list
138900500|NCT02646137|Hormones|hormones|mesh-ancestor
139056587|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139056588|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139056589|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139056590|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
139056591|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139056592|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056593|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139056594|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139056595|NCT03953716|Progestins|progestins|mesh-ancestor
139056596|NCT03953716|Hormones|hormones|mesh-ancestor
139056597|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056598|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
139056599|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139056600|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
139056601|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139056602|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056603|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139056604|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139056605|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139056606|NCT00147537|Paclitaxel|paclitaxel|mesh-list
139056607|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139056608|NCT00147537|Carboplatin|carboplatin|mesh-list
139056609|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139056610|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139056611|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139056612|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056613|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
139056614|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
139056615|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
139056616|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056617|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139056618|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056619|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
139056620|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056621|NCT00222729|Bevacizumab|bevacizumab|mesh-list
139056622|NCT00222729|Pemetrexed|pemetrexed|mesh-list
139056623|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056624|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807221|NCT05804630|Anesthetics, Local|anesthetics, local|mesh-ancestor
139056625|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139056626|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139056628|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056629|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
139056630|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056631|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056632|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139056633|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139056634|NCT00147225|Carboplatin|carboplatin|mesh-list
139056635|NCT00147225|Doxorubicin|doxorubicin|mesh-list
139056636|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139056637|NCT00147225|Ifosfamide|ifosfamide|mesh-list
139056638|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056639|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139056640|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139056641|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139056642|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056643|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056644|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139056645|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
139056646|NCT00222105|Thalidomide|thalidomide|mesh-list
139056647|NCT00222105|Dexamethasone|dexamethasone|mesh-list
139056648|NCT00222105|Doxorubicin|doxorubicin|mesh-list
139056649|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139056650|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139056651|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
139056652|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
139056653|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139056654|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056655|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139056656|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
139056657|NCT00222105|Hormones|hormones|mesh-ancestor
139056658|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056659|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139056660|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056661|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139056662|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139056663|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139056664|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056665|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056666|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139056667|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
139056668|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
139056669|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139056670|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139056671|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139056672|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139056673|NCT00222105|Growth Substances|growth substances|mesh-ancestor
139056674|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
139056675|NCT00247676|Sunitinib|sunitinib|mesh-list
139056676|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056677|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139056678|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139056679|NCT00247676|Growth Substances|growth substances|mesh-ancestor
139056680|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056681|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
139056682|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139056683|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056684|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056685|NCT00267020|Gemcitabine|gemcitabine|mesh-list
139056686|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139056687|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
139056688|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056689|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056690|NCT03975062|Dabigatran|dabigatran|mesh-list
139056691|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
139056692|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139056693|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
139056694|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056695|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056696|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
139056697|NCT03970772|Glucagon|glucagon|mesh-list
139056698|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139056699|NCT03970772|Hormones|hormones|mesh-ancestor
139056700|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056701|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056702|NCT00242216|Ritonavir|ritonavir|mesh-list
139056703|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139056704|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
139056705|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139056706|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139056707|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
139056708|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056709|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056710|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139056711|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139056712|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
139056713|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632430|NCT04548271|Apatinib|apatinib|mesh-list
139056714|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139056715|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139056716|NCT00240110|Valproic Acid|valproic acid|mesh-list
139056717|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
139056718|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
139056719|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139056720|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056721|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056722|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
138900595|NCT02645903|Morphine|morphine|mesh-list
139056723|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139056724|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056725|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056726|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
139056727|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
139056728|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056729|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
139056730|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
139056731|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056732|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139056733|NCT02532140|Cefepime|cefepime|mesh-list
139056734|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139056735|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139056736|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
139056737|NCT00266864|Testosterone|testosterone|mesh-list
139056738|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
139056739|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
139056740|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139056741|NCT00266864|Androgens|androgens|mesh-ancestor
139056742|NCT00266864|Hormones|hormones|mesh-ancestor
139056743|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056744|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056745|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139056746|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056747|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
139056748|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
139056749|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
139056750|NCT00266708|Diphosphonates|diphosphonates|mesh-list
139056751|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139056752|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139056753|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056754|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139056755|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056756|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139056757|NCT00266630|Carbamazepine|carbamazepine|mesh-list
139056758|NCT00266630|Valproic Acid|valproic acid|mesh-list
139056759|NCT00266630|Olanzapine|olanzapine|mesh-list
139056760|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
139056761|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
139056762|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139056763|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056764|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139056765|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139056766|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139056767|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056768|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139056769|NCT00266630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139056770|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139056771|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139085251|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056772|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056773|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056774|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
139056775|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807369|NCT05802888|Bismuth|bismuth|mesh-list
139056777|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
139056778|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
139056779|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139056780|NCT00266630|Analgesics|analgesics|mesh-ancestor
139056781|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
139056782|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139056783|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139056784|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139056785|NCT02531672|Choline|choline|mesh-list
139056786|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
139056787|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139056788|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
139056789|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056790|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139056791|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139056792|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
139056793|NCT00129129|Vaccines|vaccines|mesh-list
139056794|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
139056795|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056796|NCT00221403|Valproic Acid|valproic acid|mesh-list
139056797|NCT00221403|Risperidone|risperidone|mesh-list
139056798|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139056799|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139056800|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
139056801|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056802|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056803|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056804|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139056805|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139056806|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056807|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139056808|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139056809|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
139056810|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
139056811|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056812|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
139056813|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
139056814|NCT00145977|Vitamin D|vitamin d|mesh-list
139056815|NCT00145977|Alendronate|alendronate|mesh-list
139056816|NCT00145977|Calcium|calcium|mesh-list
139056817|NCT00145977|Vitamins|vitamins|mesh-ancestor
139056818|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
139056819|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056820|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139056821|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139056822|NCT00238238|Rituximab|rituximab|mesh-list
139056823|NCT00238238|Lenalidomide|lenalidomide|mesh-list
139056824|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056825|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056826|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
139056827|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056828|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139056829|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139056830|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139056831|NCT00238238|Growth Substances|growth substances|mesh-ancestor
139056832|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
139056833|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
139056834|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
139056835|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139056836|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139056837|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139056838|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056839|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056840|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139056841|NCT01071122|Valsartan|valsartan|mesh-list
139056842|NCT01071122|Nifedipine|nifedipine|mesh-list
139056843|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139056844|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139056845|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139056846|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056847|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139056848|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139056849|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139056850|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056851|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
139056852|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
139056853|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139056854|NCT01072604|Aspirin|aspirin|mesh-list
139056855|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139056856|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139056857|NCT01072604|Analgesics|analgesics|mesh-ancestor
139056858|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
139056859|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139056860|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056861|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139056862|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139056863|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139056864|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139056865|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056866|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139056867|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139056868|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056869|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
139056870|NCT00128661|Vaccines|vaccines|mesh-list
139056871|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
139056872|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056874|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139056875|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138900692|NCT00654173|Atorvastatin|atorvastatin|mesh-list
139056876|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056877|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056878|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139056880|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
139056881|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139056882|NCT03965949|Hormones|hormones|mesh-list
139056883|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056884|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056885|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
139056886|NCT00220779|Antibodies|antibodies|mesh-list
139056887|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
139056888|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139056889|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139056890|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
139056891|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
139056892|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056893|NCT00207740|Golimumab|golimumab|mesh-list
139056894|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139056895|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139056896|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139056897|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
139056898|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056899|NCT00265382|Ziprasidone|ziprasidone|mesh-list
139056900|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139056901|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
139056902|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056903|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056904|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056905|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139056906|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139056907|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056908|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139056909|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139056910|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
139056911|NCT03974984|Anesthetics|anesthetics|mesh-list
139056912|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056913|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056914|NCT00206726|Fludarabine|fludarabine|mesh-list
139056915|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
139056916|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056917|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056918|NCT00237458|Lacosamide|lacosamide|mesh-list
139056919|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
139056920|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139056921|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139056922|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139056923|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056924|NCT01581788|Valproic Acid|valproic acid|mesh-list
138252946|NCT00002517|Daunorubicin|daunorubicin|mesh-list
139056925|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
139056926|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139056927|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056928|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
139056929|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056930|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056932|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139056933|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056934|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139056935|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
139056936|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139056937|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056938|NCT00043186|Denosumab|denosumab|mesh-list
139056939|NCT00043186|Alendronate|alendronate|mesh-list
139056940|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139056941|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056942|NCT00041470|Paclitaxel|paclitaxel|mesh-list
139056943|NCT00041470|Vinorelbine|vinorelbine|mesh-list
139056944|NCT00041470|Trastuzumab|trastuzumab|mesh-list
139056945|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139056946|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056947|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
139056948|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
139056949|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
139056950|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056951|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139056952|NCT03953950|Losartan|losartan|mesh-list
139056953|NCT03953950|Spironolactone|spironolactone|mesh-list
139056954|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139056955|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139056956|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139056957|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139056958|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056959|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138900742|NCT00691054|Paclitaxel|paclitaxel|mesh-list
139056960|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
139056961|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056962|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056963|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139056964|NCT03953950|Diuretics|diuretics|mesh-ancestor
139056965|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
139056966|NCT00206102|Risperidone|risperidone|mesh-list
139056967|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139056968|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139056969|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
139056970|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139056971|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139056972|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056973|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139056974|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139056975|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056976|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139056977|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139056978|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
139056979|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
139056980|NCT03954262|Propofol|propofol|mesh-list
139056981|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139056982|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139056983|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056984|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139056985|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
139056986|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
139056987|NCT00041080|Tamoxifen|tamoxifen|mesh-list
139056988|NCT00041080|Thalidomide|thalidomide|mesh-list
139056989|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139056990|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
139056991|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139056992|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139056993|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139056994|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139056995|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139056996|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139056997|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139056998|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139056999|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
139057000|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
139057001|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139057002|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057003|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139057004|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139057005|NCT00041080|Growth Substances|growth substances|mesh-ancestor
139057006|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
139057007|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
139057008|NCT00205712|Ketamine|ketamine|mesh-list
139057009|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139057010|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139057011|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057012|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139057013|NCT00205712|Analgesics|analgesics|mesh-ancestor
139057014|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
139057015|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139057016|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139057017|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139057018|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139057019|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
139057020|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139057021|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057022|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139057023|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139057024|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
139057025|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
139057026|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139057027|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139057028|NCT03969758|Metronidazole|metronidazole|mesh-list
139057029|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
139057030|NCT03969758|Cefixime|cefixime|mesh-list
139057031|NCT03969758|Liver Extracts|liver extracts|mesh-list
139057032|NCT03969758|Hematinics|hematinics|mesh-ancestor
139057033|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057034|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139057035|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139057036|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139057037|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139057038|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139057039|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057040|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057041|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057042|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139057043|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139057044|NCT00203294|Triamcinolone|triamcinolone|mesh-list
139057045|NCT00203294|Lidocaine|lidocaine|mesh-list
139057046|NCT00203294|Bupivacaine|bupivacaine|mesh-list
139057047|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
139057048|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
139057049|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139057050|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057051|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
139057052|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139057053|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138470702|NCT01990144|Rituximab|rituximab|mesh-list
139057054|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139057055|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139057056|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138632904|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057057|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057058|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139057059|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
139057060|NCT00203294|Hormones|hormones|mesh-ancestor
139057061|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139057062|NCT01074086|Everolimus|everolimus|mesh-list
139057063|NCT01074086|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139057064|NCT01074086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139057065|NCT01074086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057066|NCT01074086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057067|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139057068|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
139057069|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057070|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057071|NCT00264290|Valganciclovir|valganciclovir|mesh-list
139057072|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
139057073|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057074|NCT00234494|Bevacizumab|bevacizumab|mesh-list
139057075|NCT00234494|Gemcitabine|gemcitabine|mesh-list
139057076|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139057078|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139057079|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139057080|NCT00234494|Growth Substances|growth substances|mesh-ancestor
139057081|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057082|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
139057083|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139057084|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
139057085|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057086|NCT00234104|Tolvaptan|tolvaptan|mesh-list
139057087|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139057088|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057089|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
139057090|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057091|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
139057092|NCT01582568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139057093|NCT01582568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139057094|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139057095|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
139057096|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057097|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139057098|NCT00195338|Etanercept|etanercept|mesh-list
139057099|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139057100|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139057101|NCT00195338|Analgesics|analgesics|mesh-ancestor
139057102|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
139057103|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139057104|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057105|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139057106|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139057107|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139057108|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139057109|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
139057110|NCT01096654|Epinephrine|epinephrine|mesh-list
139057111|NCT01096654|Racepinephrine|racepinephrine|mesh-list
139057112|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
139057113|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139057114|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139057115|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
139057116|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139057117|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057118|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057119|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139057120|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139085252|NCT01134692|Norfloxacin|norfloxacin|mesh-list
139057122|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139057123|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139057124|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
139057125|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
139057126|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
139057127|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139057128|NCT00035932|Ritonavir|ritonavir|mesh-list
139057129|NCT00035932|Lopinavir|lopinavir|mesh-list
139057130|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139057131|NCT00035932|Saquinavir|saquinavir|mesh-list
139057132|NCT00035932|Tenofovir|tenofovir|mesh-list
139057133|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139057134|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139057135|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
139057136|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057137|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057138|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139057139|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139057140|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
139057141|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057142|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139057143|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139057144|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139057145|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139057146|NCT03953326|Nitroprusside|nitroprusside|mesh-list
139057147|NCT03953326|Acetylcholine|acetylcholine|mesh-list
139057148|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139057149|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
139057150|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138807749|NCT04045028|Rituximab|rituximab|mesh-list
139057151|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057152|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139057153|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
138900822|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
139057154|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139057155|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057158|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139057159|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057160|NCT01097278|Vitamins|vitamins|mesh-ancestor
139057161|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
139057162|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139057163|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
139057164|NCT00022516|Methotrexate|methotrexate|mesh-list
139057165|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139057166|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
139057167|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057168|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139057169|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139057170|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
139057171|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057172|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057173|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139057174|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139057175|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
138253003|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057176|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139057177|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139057178|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
139057179|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
139057180|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057181|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139057182|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139057183|NCT01097512|Gemcitabine|gemcitabine|mesh-list
139057184|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139057185|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
139057186|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057187|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057188|NCT00033514|Trastuzumab|trastuzumab|mesh-list
139057189|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139057190|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139057191|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057192|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139057193|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057194|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057196|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139057197|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057198|NCT02529982|Curcumin|curcumin|mesh-list
139057199|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139057200|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139057201|NCT02529982|Analgesics|analgesics|mesh-ancestor
139057202|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
139057203|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139057204|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633129|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
139057205|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139057206|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139057207|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057208|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057209|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057210|NCT00454649|Paclitaxel|paclitaxel|mesh-list
139057211|NCT00454649|Docetaxel|docetaxel|mesh-list
139057212|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139057213|NCT00454649|Cisplatin|cisplatin|mesh-list
139057214|NCT00454649|Carboplatin|carboplatin|mesh-list
139057215|NCT00454649|Gemcitabine|gemcitabine|mesh-list
139057216|NCT00454649|Capecitabine|capecitabine|mesh-list
139057217|NCT00454649|Pemetrexed|pemetrexed|mesh-list
139057218|NCT00454649|Axitinib|axitinib|mesh-list
139057219|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139057220|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057221|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
139057222|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
139057223|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
139057224|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057225|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139057226|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
139057227|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057228|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139057229|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139057230|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139057231|NCT00454571|Leuprolide|leuprolide|mesh-list
139057232|NCT00454571|Goserelin|goserelin|mesh-list
139057233|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139057234|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
139057235|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139057236|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057237|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138253020|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139057238|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057240|NCT01323257|Darunavir|darunavir|mesh-list
139057241|NCT01323257|Erythromycin|erythromycin|mesh-list
139057242|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
139057243|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139057244|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
139057245|NCT01323257|Simeprevir|simeprevir|mesh-list
139057246|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139057247|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139057248|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
139057249|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057250|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057251|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139057252|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139057253|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
139057254|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057255|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139057256|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139057257|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139057258|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139057259|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139057260|NCT03837743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139057261|NCT01323335|Rasburicase|rasburicase|mesh-list
139057262|NCT01323335|Uric Acid|uric acid|mesh-list
139057263|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
139057264|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139057265|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
139057266|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057267|NCT01323335|Protective Agents|protective agents|mesh-ancestor
139057268|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057269|NCT03836729|Tenofovir|tenofovir|mesh-list
139057270|NCT03836729|Emtricitabine|emtricitabine|mesh-list
139057271|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
139057272|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057273|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139057274|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139057275|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057276|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057277|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139057278|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139057279|NCT01027481|Ranibizumab|ranibizumab|mesh-list
139057280|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139057281|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139057282|NCT01027481|Growth Substances|growth substances|mesh-ancestor
139057283|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057284|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
139057285|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057286|NCT00443729|Ritonavir|ritonavir|mesh-list
139057287|NCT00443729|Lopinavir|lopinavir|mesh-list
139057288|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
139057289|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139057290|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139057291|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
139057292|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057293|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057294|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139057295|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139057296|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
139057297|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057299|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139057300|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138633282|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139057301|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139057302|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139057303|NCT00443651|Rituximab|rituximab|mesh-list
139057304|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139057305|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057306|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
139057307|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057308|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139057309|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
139057310|NCT00443261|Azacitidine|azacitidine|mesh-list
139057311|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057312|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139057313|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
139057314|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057315|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057316|NCT00439517|Cetuximab|cetuximab|mesh-list
139057317|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139057318|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057319|NCT01028261|CKD732|ckd732|mesh-list
139057320|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139057321|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139057322|NCT01028261|Growth Substances|growth substances|mesh-ancestor
139057323|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057324|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
138633384|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
139057325|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057326|NCT01028339|Mannitol|mannitol|mesh-list
139057327|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139057328|NCT01028339|Diuretics|diuretics|mesh-ancestor
139057329|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
139057330|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057331|NCT01031459|Interferons|interferons|mesh-list
139057332|NCT01031459|Interferon-beta|interferon-beta|mesh-list
139057333|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
139057334|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057335|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
139057336|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057337|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
139057338|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057339|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139057340|NCT00438815|Complement C1s|complement c1s|mesh-list
139057341|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139057342|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
139057343|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
139057344|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057345|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139057346|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139057347|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
139057348|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139057349|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
139057350|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139057351|NCT01028495|Gemcitabine|gemcitabine|mesh-list
139057352|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139057353|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
138633507|NCT00238628|Bexarotene|bexarotene|mesh-list
139057354|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057355|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057412|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
139057413|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139057414|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
139057415|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253073|NCT04826237|Dexamethasone|dexamethasone|mesh-list
139057416|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057417|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139085253|NCT01134692|Propranolol|propranolol|mesh-list
139057418|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139057419|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057420|NCT01323491|Nicotine|nicotine|mesh-list
139057421|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139057422|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
139057423|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633571|NCT04534465|Mannitol|mannitol|mesh-list
139057424|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057425|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139057426|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139057427|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
139057428|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139057429|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057430|NCT00441545|Sevelamer|sevelamer|mesh-list
139057431|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
139057432|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
139057433|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057434|NCT00436553|Ranibizumab|ranibizumab|mesh-list
139057435|NCT00436553|Verteporfin|verteporfin|mesh-list
139057436|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139057437|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139057438|NCT00436553|Growth Substances|growth substances|mesh-ancestor
139057439|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057440|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
139057441|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057442|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139057443|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
139057444|NCT01028729|Gemcitabine|gemcitabine|mesh-list
139057445|NCT01028729|Endostar protein|endostar protein|mesh-list
139057446|NCT01028729|Endostatins|endostatins|mesh-list
139057447|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057448|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139057449|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
138633624|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139057450|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057451|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139057452|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139057453|NCT01028729|Growth Substances|growth substances|mesh-ancestor
139057454|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057455|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
139057456|NCT03357419|Clindamycin|clindamycin|mesh-list
139057457|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
139057458|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
139057459|NCT03357419|Cephalexin|cephalexin|mesh-list
139057460|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139057461|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057462|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139057463|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057464|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057465|NCT01031927|Glycine|glycine|mesh-list
139057466|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
139057467|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139057468|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633670|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
139057469|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057470|NCT01032083|Citalopram|citalopram|mesh-list
139057471|NCT01032083|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139057472|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139057473|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139085254|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139057474|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057475|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139057476|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
139057477|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057478|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139057479|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
138253083|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
139057480|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139057481|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139057482|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
139057483|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057484|NCT00006604|Ritonavir|ritonavir|mesh-list
139057485|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139057486|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139057487|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
138633747|NCT05896930|Rifampin|rifampin|mesh-list
139057488|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057489|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057490|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139057491|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139057492|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
139057493|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057494|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139057495|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139057496|NCT01097902|Ibuprofen|ibuprofen|mesh-list
139057497|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139057498|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139057499|NCT01097902|Analgesics|analgesics|mesh-ancestor
139057500|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
139057501|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139057502|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057503|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139057504|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139057505|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139057506|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057507|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057508|NCT00436007|Vaccines|vaccines|mesh-list
139057509|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
139057510|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057511|NCT00435461|Fluticasone|fluticasone|mesh-list
139057512|NCT00435461|Xhance|xhance|mesh-list
139057513|NCT00435461|Fexofenadine|fexofenadine|mesh-list
139057514|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139057515|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139057516|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
139057517|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139057518|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057519|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139057520|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
139057521|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
139057522|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139057523|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139057524|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139057525|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
139057526|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
139057527|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139057528|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057530|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139057531|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139057532|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138633844|NCT05815758|Ketotifen|ketotifen|mesh-list
139057533|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057534|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139057535|NCT01097980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139057536|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139057537|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139057538|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057539|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139057540|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
139057541|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139057542|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
139057543|NCT01029275|Octreotide|octreotide|mesh-list
139057544|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139057545|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139057547|NCT04829903|Liraglutide|liraglutide|mesh-list
139057548|NCT04829903|Dulaglutide|dulaglutide|mesh-list
139057549|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139057550|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057551|NCT04829903|Incretins|incretins|mesh-ancestor
139057552|NCT04829903|Hormones|hormones|mesh-ancestor
139057553|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139057554|NCT00440999|Artesunate|artesunate|mesh-list
139057555|NCT00440999|Chloroquine|chloroquine|mesh-list
139057556|NCT00440999|Pyronaridine|pyronaridine|mesh-list
139057557|NCT00440999|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139057558|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
139057559|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139057560|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139057561|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057562|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057563|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
139057564|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
139057565|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139057566|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
139057567|NCT00440999|Amebicides|amebicides|mesh-ancestor
139057568|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139057569|NCT00434213|Methylphenidate|methylphenidate|mesh-list
139057570|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139057571|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057572|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139057573|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139057574|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139057575|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057576|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
139057577|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139057578|NCT01029743|Aspirin|aspirin|mesh-list
139057579|NCT01029743|PENTA|penta|mesh-list
139057580|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
139057581|NCT01029743|Fondaparinux|fondaparinux|mesh-list
139057582|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139057583|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139057584|NCT01029743|Analgesics|analgesics|mesh-ancestor
139057585|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
138901137|NCT00655109|Analgesics|analgesics|mesh-ancestor
139057586|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139057587|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057589|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139057590|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139057591|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139057592|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057594|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139057595|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057596|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
139057597|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139057598|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
139057599|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139057600|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
139057601|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
139057602|NCT01029821|Heparin|heparin|mesh-list
139057603|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139057604|NCT01029821|Tinzaparin|tinzaparin|mesh-list
139057605|NCT01029821|Dalteparin|dalteparin|mesh-list
139057606|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
139057607|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139057608|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139057609|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057610|NCT00006184|Cyclosporine|cyclosporine|mesh-list
139057611|NCT00006184|Prednisone|prednisone|mesh-list
139057612|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
139057613|NCT00006184|Doxorubicin|doxorubicin|mesh-list
139057614|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139057615|NCT00006184|Methotrexate|methotrexate|mesh-list
139057616|NCT00006184|Fludarabine|fludarabine|mesh-list
139057617|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
139057618|NCT00006184|Etoposide|etoposide|mesh-list
139057619|NCT00006184|Vincristine|vincristine|mesh-list
139057620|NCT00006184|Bortezomib|bortezomib|mesh-list
139057621|NCT00006184|Molgramostim|molgramostim|mesh-list
139057622|NCT00006184|Cyclosporins|cyclosporins|mesh-list
139057623|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
139057624|NCT00006184|Lenograstim|lenograstim|mesh-list
139057625|NCT00006184|Sargramostim|sargramostim|mesh-list
139057626|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
139057627|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139057628|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
139057629|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057630|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138633923|NCT05359939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139057631|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139057632|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
139057633|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057634|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057635|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139057636|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138901160|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
139057637|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139057638|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139057639|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057640|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139057641|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
139057642|NCT00006184|Hormones|hormones|mesh-ancestor
139057643|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139057644|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139057645|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139057646|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
139057647|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139057648|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139057649|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
139057650|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
139057651|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139057652|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139057653|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139057654|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
139057655|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
139057656|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
139057657|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
139057658|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057659|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139057660|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139057661|NCT00433199|Testosterone|testosterone|mesh-list
139057662|NCT00433199|Androgens|androgens|mesh-ancestor
139057663|NCT00433199|Hormones|hormones|mesh-ancestor
139057664|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139057665|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057666|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139057667|NCT01098448|Amoxicillin|amoxicillin|mesh-list
139057668|NCT01098448|Metronidazole|metronidazole|mesh-list
139057669|NCT01098448|Tetracycline|tetracycline|mesh-list
139057670|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057671|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139057672|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139057673|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139057674|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057675|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057676|NCT01098526|Efavirenz|efavirenz|mesh-list
139057677|NCT01098526|Dolutegravir|dolutegravir|mesh-list
139057678|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139057679|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139057680|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057681|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057682|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
139057683|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057684|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139057685|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138279647|NCT05730907|Simendan|simendan|mesh-list
139057686|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139057687|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139057688|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139057689|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139057690|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139057691|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139057692|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139057693|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139057694|NCT00005908|Tamoxifen|tamoxifen|mesh-list
139057695|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
139057696|NCT00005908|Docetaxel|docetaxel|mesh-list
139057697|NCT00005908|Doxorubicin|doxorubicin|mesh-list
139057698|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139057699|NCT00005908|Capecitabine|capecitabine|mesh-list
139057700|NCT00005908|Anastrozole|anastrozole|mesh-list
139057701|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139057702|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
139057703|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057704|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139057705|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139057706|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
139057707|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057708|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057709|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139057710|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
138633970|NCT04933383|Hormones|hormones|mesh-ancestor
139057711|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
139057712|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
139057713|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139057714|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139057715|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139057716|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057717|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139057718|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
139057719|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139057720|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
139057721|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139057722|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139057723|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139057724|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139057725|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139057726|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139057727|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139057728|NCT00431951|Tecovirimat|tecovirimat|mesh-list
139057729|NCT00431951|Antiviral Agents|antiviral agents|mesh-ancestor
139057730|NCT00431951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057731|NCT00004978|Aldesleukin|aldesleukin|mesh-list
139057732|NCT00004978|Interleukin-2|interleukin-2|mesh-list
139057733|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057734|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139057735|NCT00004978|Analgesics|analgesics|mesh-ancestor
139057736|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
139057737|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139057738|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057740|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139057741|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
139057742|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057743|NCT01030601|Dexamethasone|dexamethasone|mesh-list
139057744|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
139057745|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139057746|NCT01030601|BB 1101|bb 1101|mesh-list
139057747|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138634015|NCT04381143|Analgesics|analgesics|mesh-ancestor
139057748|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
139057749|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
139057750|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139057751|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057752|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138808376|NCT02789397|Rituximab|rituximab|mesh-list
139057753|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
139057754|NCT01030601|Hormones|hormones|mesh-ancestor
138770212|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139057755|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139057756|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139057757|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057758|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
139057759|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057760|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057761|NCT00430937|Vancomycin|vancomycin|mesh-list
139057762|NCT00430937|Daptomycin|daptomycin|mesh-list
139057763|NCT00430937|Teicoplanin|teicoplanin|mesh-list
139057764|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139057765|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057766|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
139057767|NCT01101412|Ethanol|ethanol|mesh-list
139057768|NCT01101412|Trimethoprim|trimethoprim|mesh-list
139057769|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
139057770|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139057771|NCT01101412|Edetic Acid|edetic acid|mesh-list
139057772|NCT01101412|Calcium|calcium|mesh-list
139057773|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
139057774|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139057775|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901236|NCT00752518|Bortezomib|bortezomib|mesh-list
139057776|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139057777|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139057778|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057779|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138634052|NCT04177433|Hormones|hormones|mesh-ancestor
139057780|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139057781|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
139057782|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139057783|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139057784|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139057785|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057786|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057787|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139057788|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139057789|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139057790|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139057791|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
139057792|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139057793|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
139057794|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
139057795|NCT01101412|Antidotes|antidotes|mesh-ancestor
139057796|NCT01101412|Protective Agents|protective agents|mesh-ancestor
139057797|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139057798|NCT00004888|Docetaxel|docetaxel|mesh-list
139057799|NCT00004888|Doxorubicin|doxorubicin|mesh-list
139057800|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139057801|NCT00004888|Trastuzumab|trastuzumab|mesh-list
139057802|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057803|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
139057804|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
139057805|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
139057806|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057807|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139057808|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139057809|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139057810|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057811|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139057812|NCT01098760|Sorafenib|sorafenib|mesh-list
139057813|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057814|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139057815|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057816|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057817|NCT00430781|Lapatinib|lapatinib|mesh-list
139057818|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057819|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139057820|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057821|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057823|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139057824|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
139057825|NCT01033097|Hormones|hormones|mesh-ancestor
139057826|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138901269|NCT00576628|Hematinics|hematinics|mesh-ancestor
138687513|NCT06012734|LB100|lb100|mesh-list
139057827|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057828|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139057829|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
139057831|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
139057833|NCT00429299|Trastuzumab|trastuzumab|mesh-list
139057834|NCT00429299|Lapatinib|lapatinib|mesh-list
139057835|NCT00429299|Epirubicin|epirubicin|mesh-list
139057836|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139057837|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057838|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
139057839|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
139057840|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
139057841|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057842|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139057843|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
139057844|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057845|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139057846|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139057847|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
139057848|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139057849|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
139057850|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139057851|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139057852|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139057853|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057854|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139057855|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139057856|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139057857|NCT01033877|Vaccines|vaccines|mesh-list
139057858|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
139057859|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057860|NCT00428597|Sunitinib|sunitinib|mesh-list
139057861|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057862|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139057863|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139057864|NCT00428597|Growth Substances|growth substances|mesh-ancestor
139057865|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057866|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
139057867|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139057868|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057869|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057870|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139057871|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139057872|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139057873|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
139057874|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057875|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139057876|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139057877|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057878|NCT00428441|Warfarin|warfarin|mesh-list
139057879|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
139057880|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
139057881|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139057882|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
139057883|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139057884|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057885|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139057886|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
139057887|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
139057888|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139057889|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
139057890|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139057891|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057892|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
139057893|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139057894|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
139057895|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057896|NCT03967665|Expectorants|expectorants|mesh-ancestor
139057897|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
139057898|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139057899|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
139057900|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057901|NCT03967665|Protective Agents|protective agents|mesh-ancestor
139057902|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057903|NCT03967665|Antidotes|antidotes|mesh-ancestor
139057904|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
139057905|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139057906|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139057907|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057908|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139057909|NCT00127803|Vaccines|vaccines|mesh-list
139057910|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
139057911|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057912|NCT01077999|Paclitaxel|paclitaxel|mesh-list
139057913|NCT01077999|Carboplatin|carboplatin|mesh-list
139057914|NCT01077999|Panitumumab|panitumumab|mesh-list
139057915|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139057916|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057917|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
139057918|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
139057919|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
139057920|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057921|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139057922|NCT01033409|Vaccines|vaccines|mesh-list
139057923|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
139057924|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057925|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
139057926|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139057927|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
139057928|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057929|NCT01037465|Expectorants|expectorants|mesh-ancestor
139057930|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
139057931|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139057932|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
139057933|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057934|NCT01037465|Protective Agents|protective agents|mesh-ancestor
139057935|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057936|NCT01037465|Antidotes|antidotes|mesh-ancestor
139057937|NCT01582425|Isavuconazole|isavuconazole|mesh-list
139057938|NCT01582425|Methadone|methadone|mesh-list
139057939|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139057940|NCT01582425|Narcotics|narcotics|mesh-ancestor
139057941|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139057942|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057943|NCT01582425|Analgesics|analgesics|mesh-ancestor
139057944|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
139057945|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139057946|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
139057947|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
139057948|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
139057949|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139057950|NCT00143403|Leucovorin|leucovorin|mesh-list
139057951|NCT00143403|Folic Acid|folic acid|mesh-list
139057952|NCT00143403|Irinotecan|irinotecan|mesh-list
139057953|NCT00143403|Fluorouracil|fluorouracil|mesh-list
139057954|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
139057955|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139057956|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139057957|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057958|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253215|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
139057959|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057960|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
139057961|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139057962|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139057963|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
139057964|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057965|NCT00143403|Antidotes|antidotes|mesh-ancestor
139057966|NCT00143403|Protective Agents|protective agents|mesh-ancestor
139057967|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
139057968|NCT00143403|Vitamins|vitamins|mesh-ancestor
139057969|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
139057970|NCT00143403|Hematinics|hematinics|mesh-ancestor
139057971|NCT00220701|Dexetimide|dexetimide|mesh-list
139057972|NCT00220701|Citalopram|citalopram|mesh-list
139057973|NCT00220701|Escitalopram|escitalopram|mesh-list
139057974|NCT00220701|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139057975|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139057976|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139057977|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057978|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139057979|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
139057980|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139057981|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139057982|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139057983|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
139057985|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139057986|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139057987|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139057988|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
139057989|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139057990|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
139057991|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139057993|NCT00127101|Bexarotene|bexarotene|mesh-list
139057994|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139057995|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139057996|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139057997|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139057998|NCT00126555|Gefitinib|gefitinib|mesh-list
139057999|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058000|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139058001|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058002|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058003|NCT00004228|Leucovorin|leucovorin|mesh-list
139058004|NCT00004228|Cytarabine|cytarabine|mesh-list
139058005|NCT00004228|Dexamethasone|dexamethasone|mesh-list
139058006|NCT00004228|Prednisone|prednisone|mesh-list
139058007|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
139058008|NCT00004228|Doxorubicin|doxorubicin|mesh-list
139058009|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139058010|NCT00004228|Methotrexate|methotrexate|mesh-list
139058011|NCT00004228|Vincristine|vincristine|mesh-list
139058012|NCT00004228|Daunorubicin|daunorubicin|mesh-list
139058013|NCT00004228|Asparaginase|asparaginase|mesh-list
139058014|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
139058015|NCT00004228|Thioguanine|thioguanine|mesh-list
139058016|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
139058017|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058018|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
139058019|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058020|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139058021|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139058022|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
139058023|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058024|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058025|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139058026|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139058027|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
139058028|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
139058029|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139058030|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139058031|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
139058032|NCT00004228|Hormones|hormones|mesh-ancestor
139058033|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138901364|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
139058034|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139058035|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139058036|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139058037|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139058038|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058039|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139058040|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
139058041|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138634186|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058042|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139058043|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
139058044|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
139058045|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138770213|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139058046|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139058047|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
139058048|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058049|NCT00004228|Antidotes|antidotes|mesh-ancestor
139058050|NCT00004228|Protective Agents|protective agents|mesh-ancestor
139058051|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
139058052|NCT00004228|Vitamins|vitamins|mesh-ancestor
139058053|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
139058054|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139058055|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
139058056|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
139058057|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
139058058|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139058059|NCT01101568|Simvastatin|simvastatin|mesh-list
139058060|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139058061|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139058062|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
139058063|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058064|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139058065|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139058066|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058068|NCT01087840|Emtricitabine|emtricitabine|mesh-list
139058069|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
139058070|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
139058071|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058072|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139058073|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139058074|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634213|NCT02935634|Nivolumab|nivolumab|mesh-list
139058075|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058076|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139058077|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139058078|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139058079|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139058080|NCT01098994|Vitamin E|vitamin e|mesh-list
139058081|NCT01098994|Tocopherols|tocopherols|mesh-list
139058082|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
139058083|NCT01098994|Vitamins|vitamins|mesh-ancestor
139058084|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
139058085|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058086|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
139058087|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058088|NCT01098994|Protective Agents|protective agents|mesh-ancestor
139058089|NCT01099072|Methylphenidate|methylphenidate|mesh-list
138770214|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139058090|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139058091|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058092|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139058093|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139058094|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139058095|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058096|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
139058097|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139058098|NCT00031486|Valacyclovir|valacyclovir|mesh-list
139058099|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
139058100|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058101|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
139058102|NCT01099150|Procyanidin|procyanidin|mesh-list
139058103|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
139058104|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058105|NCT01099150|Protective Agents|protective agents|mesh-ancestor
139058106|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058107|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139058108|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139058109|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058110|NCT02530060|Tenofovir|tenofovir|mesh-list
139058111|NCT02530060|Emtricitabine|emtricitabine|mesh-list
139058112|NCT02530060|Rilpivirine|rilpivirine|mesh-list
139058114|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058115|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139058116|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139058117|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634268|NCT02684578|Metformin|metformin|mesh-list
139058118|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058119|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139058120|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139058121|NCT01101646|Rabeprazole|rabeprazole|mesh-list
139058122|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139058123|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139058124|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139058125|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058126|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058127|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
139058128|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139058129|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058130|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139058131|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
139058132|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139058133|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058134|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058135|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058136|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139058137|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058138|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058139|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058140|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139058141|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
139058142|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139058143|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139058144|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058145|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
139058146|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139058147|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058149|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139058150|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139058151|NCT01099462|Analgesics|analgesics|mesh-ancestor
139058152|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
139058153|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139058154|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058155|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139058156|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139058157|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139058158|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058159|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058161|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
139058162|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
139058163|NCT00003298|Paclitaxel|paclitaxel|mesh-list
139058164|NCT00003298|Cisplatin|cisplatin|mesh-list
139058165|NCT00003298|Fluorouracil|fluorouracil|mesh-list
139058166|NCT00003298|Calcium|calcium|mesh-list
139058167|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
139058168|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139058169|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058170|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
139058171|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
139058172|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
139058173|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058174|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139058175|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058176|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
139058177|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139058178|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058179|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
139058180|NCT00003298|Antidotes|antidotes|mesh-ancestor
139058181|NCT00003298|Protective Agents|protective agents|mesh-ancestor
139058182|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
139058183|NCT00003298|Vitamins|vitamins|mesh-ancestor
139058184|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
139058185|NCT03960970|Azithromycin|azithromycin|mesh-list
139058186|NCT03960970|Cefoxitin|cefoxitin|mesh-list
139058187|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139058188|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058189|NCT00002842|Leucovorin|leucovorin|mesh-list
139058190|NCT00002842|Fluorouracil|fluorouracil|mesh-list
139058191|NCT00002842|Floxuridine|floxuridine|mesh-list
139058192|NCT00002842|Calcium|calcium|mesh-list
139058193|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
139058194|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139058195|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058196|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
139058197|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058198|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139058199|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058200|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058201|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
139058202|NCT00002842|Antidotes|antidotes|mesh-ancestor
139058203|NCT00002842|Protective Agents|protective agents|mesh-ancestor
139058204|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
139058205|NCT00002842|Vitamins|vitamins|mesh-ancestor
139058206|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
139058207|NCT00143247|Insulin|insulin|mesh-list
139058208|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139058209|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058210|NCT00125853|Atenolol|atenolol|mesh-list
139058211|NCT00125853|Nebivolol|nebivolol|mesh-list
139058212|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139058213|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139058214|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
139058216|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139058217|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058218|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139058219|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139058220|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139058221|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
139058222|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139058223|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058224|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
139058225|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139058226|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139058227|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139058228|NCT00219141|Losartan|losartan|mesh-list
139058229|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139058230|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139058231|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139058232|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139058233|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058234|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
139058235|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
139058236|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058237|NCT00233948|Nelfinavir|nelfinavir|mesh-list
139058238|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139058239|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139058240|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
139058241|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058242|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058243|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139058244|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139058245|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
139058246|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058247|NCT00233480|Atorvastatin|atorvastatin|mesh-list
139058248|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139058249|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139058250|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
139058251|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058252|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138634362|NCT04532554|Hormones|hormones|mesh-list
139085255|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139058253|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139058255|NCT03801928|Infliximab|infliximab|mesh-list
139058256|NCT03801928|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139058257|NCT03801928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139058258|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
139058259|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139058260|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139058261|NCT02530918|Ranibizumab|ranibizumab|mesh-list
139058262|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139058263|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139058264|NCT02530918|Growth Substances|growth substances|mesh-ancestor
138770215|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139058265|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058266|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
139058267|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058268|NCT03950518|Levamisole|levamisole|mesh-list
139058269|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139058270|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
139058271|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058272|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
139058273|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
139058274|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139058275|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058276|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139058277|NCT01100164|Eszopiclone|eszopiclone|mesh-list
139058278|NCT01100164|Zopiclone|zopiclone|mesh-list
139058279|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139058280|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139058281|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058282|NCT01102114|Vaccines|vaccines|mesh-list
139058283|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
139058284|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058285|NCT01327222|Bevacizumab|bevacizumab|mesh-list
139058286|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139058287|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058288|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139058289|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139058290|NCT01327222|Growth Substances|growth substances|mesh-ancestor
139058291|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058292|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
139058293|NCT03950362|Avelumab|avelumab|mesh-list
139058294|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139058295|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058296|NCT00263588|Lapatinib|lapatinib|mesh-list
139058297|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058298|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139058299|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058300|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058301|NCT00213135|Cladribine|cladribine|mesh-list
139058302|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058303|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058304|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
139058305|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058306|NCT00077974|Sunitinib|sunitinib|mesh-list
139058307|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058308|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139058309|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139058310|NCT00077974|Growth Substances|growth substances|mesh-ancestor
139058311|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058312|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
139058313|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139058314|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058315|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058316|NCT00141921|Etanercept|etanercept|mesh-list
139058317|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139058318|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139058319|NCT00141921|Analgesics|analgesics|mesh-ancestor
139058320|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
139058321|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139058322|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058323|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139058324|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139058325|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139058326|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058327|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
139058328|NCT01088620|Pemetrexed|pemetrexed|mesh-list
139058329|NCT01088620|Panitumumab|panitumumab|mesh-list
139058330|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058331|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058332|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058333|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139058334|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139058335|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139058336|NCT00026494|Temozolomide|temozolomide|mesh-list
139058337|NCT00026494|Vinorelbine|vinorelbine|mesh-list
139058338|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139058339|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
139058340|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058341|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058342|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139058343|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
139058344|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
139058345|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
139058346|NCT03950050|Ambroxol|ambroxol|mesh-list
139058347|NCT03950050|Expectorants|expectorants|mesh-ancestor
139058348|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
139058349|NCT00023764|Bortezomib|bortezomib|mesh-list
138901568|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
139058350|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058351|NCT03961126|Clobetasol|clobetasol|mesh-list
139058352|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139058353|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
139058354|NCT03961126|Hormones|hormones|mesh-ancestor
139058355|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139058356|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058357|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
139058358|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
139058359|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058360|NCT00189488|Methotrexate|methotrexate|mesh-list
139058361|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139058362|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
139058363|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139058364|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058365|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139058366|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
139058367|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058368|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058369|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
139058370|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058371|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139058372|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058373|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
139058374|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139058375|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139058376|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139058377|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
139058378|NCT00023452|Isoniazid|isoniazid|mesh-list
139058379|NCT00023452|Rifapentine|rifapentine|mesh-list
139058380|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
139058381|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139058382|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058383|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139058384|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139058385|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
139058386|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058387|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139058388|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139058389|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
139058390|NCT01088932|SRX246|srx246|mesh-list
139058391|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139058392|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058393|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
139058394|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058395|NCT03961048|Ropivacaine|ropivacaine|mesh-list
139058396|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139058397|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
139058398|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
139085256|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
139058399|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139058400|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058401|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
139058402|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139058403|NCT00022672|Trastuzumab|trastuzumab|mesh-list
139058404|NCT00022672|Anastrozole|anastrozole|mesh-list
139058405|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138634420|NCT04531267|Calcium|calcium|mesh-list
139058406|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058407|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139058408|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139058409|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139058410|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058411|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058412|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139058413|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
139058414|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139058415|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058417|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139058418|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139058419|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139058420|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139058421|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058422|NCT00076570|Sirolimus|sirolimus|mesh-list
139058423|NCT00076570|Tacrolimus|tacrolimus|mesh-list
139058424|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058425|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
139058426|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058427|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139058428|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058429|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058430|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139058431|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058432|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139058433|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058434|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
139058435|NCT00124449|Abatacept|abatacept|mesh-list
139058436|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139058437|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058438|NCT00124449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139058439|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058440|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058441|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
139058442|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058443|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139058444|NCT00076336|Lamivudine|lamivudine|mesh-list
139058445|NCT00076336|Telbivudine|telbivudine|mesh-list
139058446|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139058447|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139058448|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058449|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058450|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
139058451|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058452|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139058453|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139058454|NCT00185588|Gemcitabine|gemcitabine|mesh-list
139058455|NCT00185588|Vatalanib|vatalanib|mesh-list
139058456|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139058457|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
139058458|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058459|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058460|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139058461|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058462|NCT00231842|Ifosfamide|ifosfamide|mesh-list
139058463|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058464|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139058465|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
139058466|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058467|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
139058468|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139058469|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058470|NCT00076102|Pirfenidone|pirfenidone|mesh-list
139058471|NCT00076102|Analgesics|analgesics|mesh-ancestor
139058472|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
139058473|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139058474|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058475|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139058476|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139058477|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139058478|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139058479|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058480|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
139058481|NCT03968588|Tacrolimus|tacrolimus|mesh-list
139058482|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058483|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
139058484|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058485|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139058486|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058487|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058488|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139058489|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058490|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139058491|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
139058492|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139058493|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058495|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139058496|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
139058497|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139058498|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058499|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139058500|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
139058501|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
139058502|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
139058503|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139058504|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139058505|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139058506|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139058507|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
139058508|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139058509|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058511|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139058512|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058514|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
139058515|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139058516|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058517|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
139058518|NCT00184028|Docetaxel|docetaxel|mesh-list
139058519|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058520|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
139058521|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
139058522|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
139058523|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058524|NCT00183872|Docetaxel|docetaxel|mesh-list
139058525|NCT00183872|Irinotecan|irinotecan|mesh-list
139058526|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058527|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
139058528|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
139058529|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
139058530|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901683|NCT05862064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058531|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139058532|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139058533|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058535|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139058536|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139058537|NCT03815175|Analgesics|analgesics|mesh-ancestor
139058538|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
139058539|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139058540|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058541|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139058542|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139058543|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139058544|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139058545|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058546|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139058547|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139058548|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058549|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
139058550|NCT01080027|Interferons|interferons|mesh-list
139058551|NCT01080027|Interferon-beta|interferon-beta|mesh-list
139058552|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
139058553|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058554|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
139058555|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058556|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
139058557|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058558|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139058559|NCT00262028|Vaccines|vaccines|mesh-list
139058560|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
139058561|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058562|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
139058563|NCT00183248|Sirolimus|sirolimus|mesh-list
139058564|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
139058565|NCT00183248|Tacrolimus|tacrolimus|mesh-list
139058566|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058567|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
139058568|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058569|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139058570|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058571|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058572|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139058573|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058574|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139058575|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
139058576|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139058577|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058578|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
139058579|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139058580|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
139058581|NCT00230282|Fludarabine|fludarabine|mesh-list
139058582|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
139058583|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058584|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
139058585|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058586|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139058587|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139058588|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
139058589|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058590|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058591|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139058592|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139058593|NCT00261950|Cinacalcet|cinacalcet|mesh-list
139058594|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139058595|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058596|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139058597|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
139058598|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139058599|NCT00229658|Pramlintide|pramlintide|mesh-list
139058600|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139058601|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058602|NCT00182078|Sertraline|sertraline|mesh-list
139058603|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
139058604|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139058605|NCT00182078|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139058606|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139058607|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139058608|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058609|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139058610|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
139058611|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058612|NCT00181844|Lamotrigine|lamotrigine|mesh-list
139058613|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
139058614|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139058615|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139058616|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058617|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138253464|NCT05806307|Oxytocin|oxytocin|mesh-list
139058618|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058619|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139058620|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138634570|NCT02218021|Narcotics|narcotics|mesh-ancestor
139058621|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139058622|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139058623|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139058624|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139058625|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139058626|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139058627|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139058628|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058629|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
139058630|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139058631|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058633|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
139058634|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139058635|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139058636|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139058637|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139058638|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058639|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139058640|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139058641|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139058642|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139058643|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
139058644|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139058645|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058646|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139058647|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139058648|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
139058649|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139058650|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139058651|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
139058652|NCT00076024|Docetaxel|docetaxel|mesh-list
139058653|NCT00076024|Axitinib|axitinib|mesh-list
139058654|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058655|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
139058656|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
139058657|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
139058658|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058659|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139058660|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058661|NCT01103050|Cetirizine|cetirizine|mesh-list
139058662|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139058663|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139058664|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139058665|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
139058666|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
139058667|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139058668|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058669|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058670|NCT00075478|Cyclosporine|cyclosporine|mesh-list
139058671|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
139058672|NCT00075478|Fludarabine|fludarabine|mesh-list
139058673|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
139058674|NCT00075478|Cyclosporins|cyclosporins|mesh-list
139058675|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058676|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139058677|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
139058678|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058679|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058680|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
139058681|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058682|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058683|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
139058684|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058685|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
139058686|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139058687|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139058688|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139058689|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139058690|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
139058691|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139058692|NCT00175916|Brivaracetam|brivaracetam|mesh-list
139058693|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
139058694|NCT01089088|Gemcitabine|gemcitabine|mesh-list
139058695|NCT01089088|Sunitinib|sunitinib|mesh-list
139058696|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058697|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139058698|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
139058699|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058700|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139058701|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139058702|NCT01089088|Growth Substances|growth substances|mesh-ancestor
139058703|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058704|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
139058705|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139058706|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058707|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
139058708|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058709|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139058710|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058711|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058712|NCT01103206|Cinacalcet|cinacalcet|mesh-list
139058713|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139058714|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058715|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139058716|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
139058717|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139058718|NCT00228566|Modafinil|modafinil|mesh-list
139058719|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139058720|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058721|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139058722|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138634622|NCT00263718|Hormones|hormones|mesh-ancestor
139058723|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139058724|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058725|NCT01089166|Metformin|metformin|mesh-list
139058726|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139058727|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058728|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
139058729|NCT00203502|Bevacizumab|bevacizumab|mesh-list
139058730|NCT00203502|Docetaxel|docetaxel|mesh-list
139058731|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058732|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
139058733|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058734|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139058735|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139058736|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
139058737|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058738|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058739|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139058740|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139058741|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139058742|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139058743|NCT00203502|Growth Substances|growth substances|mesh-ancestor
139058744|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
139058745|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
139058746|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
139058747|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
139058748|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
139058749|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139058750|NCT01103518|Estradiol|estradiol|mesh-list
139058751|NCT01103518|Cyproterone|cyproterone|mesh-list
139058752|NCT01103518|Estrogens|estrogens|mesh-ancestor
139058753|NCT01103518|Hormones|hormones|mesh-ancestor
139058754|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139058755|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058756|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139058757|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
139058758|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139058759|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139058760|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139058761|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139058762|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
139058763|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
139058764|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058765|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139058766|NCT01327534|Clopidogrel|clopidogrel|mesh-list
139058767|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138901917|NCT04942340|Caffeine|caffeine|mesh-list
139058768|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139058769|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139058770|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139058771|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139058772|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
139058773|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139058774|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058775|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058776|NCT00232596|Ezogabine|ezogabine|mesh-list
139058777|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
139058778|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138634648|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139058779|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058781|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
139058782|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
139058783|NCT00073918|Etoposide|etoposide|mesh-list
139058784|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
139058785|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
139058786|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139058787|NCT00073918|Antibodies|antibodies|mesh-list
139058788|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
139058789|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139058790|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058791|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
139058792|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058793|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138253507|NCT05805930|Hormones|hormones|mesh-ancestor
139058794|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139058795|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
139058796|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058797|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058798|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139058799|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139058800|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139058801|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139058802|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058803|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139058804|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058805|NCT00073918|Trace Elements|trace elements|mesh-ancestor
139058806|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
139058807|NCT00231894|Pioglitazone|pioglitazone|mesh-list
139058808|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139058809|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058810|NCT00203424|Bevacizumab|bevacizumab|mesh-list
139058811|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139058812|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139058813|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058814|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139058815|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139058816|NCT00203424|Growth Substances|growth substances|mesh-ancestor
139058817|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058818|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
139058819|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139058820|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058821|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058822|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
139058823|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139058824|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
139058825|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
139058826|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139058827|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058828|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058829|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139058830|NCT00203268|Analgesics|analgesics|mesh-ancestor
139058831|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
139058832|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139058833|NCT00168818|Enoxaparin|enoxaparin|mesh-list
139058834|NCT00168818|Dabigatran|dabigatran|mesh-list
139058835|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
138634668|NCT01642108|Incretins|incretins|mesh-ancestor
139058836|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139058837|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139058838|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058839|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
139058840|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139058841|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
139058842|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058843|NCT00260832|Cytarabine|cytarabine|mesh-list
139058844|NCT00260832|Decitabine|decitabine|mesh-list
139058845|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139058846|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
139058847|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058848|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058849|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
138901958|NCT04812548|Azacitidine|azacitidine|mesh-list
139058850|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058851|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058852|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
139058853|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058854|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058855|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
139058856|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139058857|NCT00168038|Antibodies|antibodies|mesh-list
139058858|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
139058859|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058860|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
139058861|NCT00166712|Sirolimus|sirolimus|mesh-list
139058862|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
139058863|NCT00166712|Tacrolimus|tacrolimus|mesh-list
139058864|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058865|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
139058866|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058867|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139058868|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058869|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058870|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139058871|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058872|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139058873|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
139058874|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139058875|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058876|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
139058877|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139058878|NCT00073528|Letrozole|letrozole|mesh-list
139058879|NCT00073528|Lapatinib|lapatinib|mesh-list
139058880|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058881|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139058882|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139058883|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058884|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058885|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139058886|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
139058887|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139058888|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058889|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139058890|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
139058891|NCT03801148|Lansoprazole|lansoprazole|mesh-list
139058892|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139058893|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139058894|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139058895|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085257|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139058896|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058897|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
139058898|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139058899|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058900|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
139058901|NCT01103830|Lumefantrine|lumefantrine|mesh-list
139058902|NCT01103830|Artemether|artemether|mesh-list
139058903|NCT01103830|Piperaquine|piperaquine|mesh-list
139058904|NCT01103830|Artenimol|artenimol|mesh-list
139058905|NCT01103830|Artemisinins|artemisinins|mesh-list
139058906|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139058907|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139058908|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139058909|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058910|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139058911|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139058912|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058913|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058914|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058915|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139058916|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
139058917|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139058918|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058919|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139058920|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139058921|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139058923|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139058924|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139058925|NCT00072280|Dactinomycin|dactinomycin|mesh-list
139058926|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
139058927|NCT00072280|Ifosfamide|ifosfamide|mesh-list
139058928|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
139058929|NCT00072280|Etoposide|etoposide|mesh-list
139058930|NCT00072280|Vincristine|vincristine|mesh-list
139058931|NCT00072280|Lenograstim|lenograstim|mesh-list
139058933|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058934|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
139058935|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058936|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139058937|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139058938|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
139058939|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058940|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058941|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139058942|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139058943|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139058944|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139058945|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139058946|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139058947|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
139058948|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
139058949|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
139058950|NCT00072280|Protective Agents|protective agents|mesh-ancestor
139058951|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139058952|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139058953|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139058954|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139058955|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139058956|NCT01106716|Lidocaine|lidocaine|mesh-list
139058957|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
139058958|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
139058959|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139058960|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058961|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
139058962|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139058963|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139058964|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139058965|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139058966|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138902063|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
139058967|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058968|NCT00071812|Belimumab|belimumab|mesh-list
139058969|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139058970|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
139058971|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058972|NCT01104298|Doxorubicin|doxorubicin|mesh-list
139058973|NCT01104298|Trabectedin|trabectedin|mesh-list
139058974|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139058975|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058976|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139058977|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139058978|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770216|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139058979|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058980|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139058981|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
139058983|NCT01106872|Gemcitabine|gemcitabine|mesh-list
139058984|NCT01106872|Docetaxel|docetaxel|mesh-list
139058985|NCT01106872|Valproic Acid|valproic acid|mesh-list
139058986|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139058987|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139058988|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139058989|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139058990|NCT01106872|Growth Substances|growth substances|mesh-ancestor
139058991|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139058992|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
139058993|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139058994|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
139058995|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139058996|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
139058997|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
139058998|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
139058999|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
139059000|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059001|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
139059002|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059003|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
139059004|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139059005|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059006|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139059007|NCT03960268|Brodalumab|brodalumab|mesh-list
139059008|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
139059009|NCT05485480|Analgesics, Opioid|analgesics, opioid|mesh-list
139059010|NCT05485480|Narcotics|narcotics|mesh-ancestor
139059011|NCT05485480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059012|NCT05485480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059013|NCT05485480|Analgesics|analgesics|mesh-ancestor
139059014|NCT05485480|Sensory System Agents|sensory system agents|mesh-ancestor
139059015|NCT05485480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059016|NCT05470270|Hydroxyurea|hydroxyurea|mesh-list
139059017|NCT05470270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059018|NCT05470270|Antisickling Agents|antisickling agents|mesh-ancestor
139059019|NCT05470270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059020|NCT05470270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059021|NCT05470270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139059022|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
139059023|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139059024|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
139059025|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139059026|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059027|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139059028|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
139059029|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
139059031|NCT00259610|Methotrexate|methotrexate|mesh-list
139059032|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139059033|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
139059034|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139059035|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059036|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138809636|NCT00752557|Vitamin D|vitamin d|mesh-list
139059037|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
139059038|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059039|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059040|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
139059041|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059042|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139059043|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139059044|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
139059045|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139059046|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139059047|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
139059048|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139059049|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139059050|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139059051|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139059052|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139059053|NCT00259610|Analgesics|analgesics|mesh-ancestor
139059054|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
139059055|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059056|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139059057|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139059058|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
139059059|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
139059060|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139059061|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139059062|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139059063|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139059064|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059065|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
139059066|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059067|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059068|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139059069|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059070|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139059071|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
139059072|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139059073|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139059074|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059075|NCT00165698|Vitamins|vitamins|mesh-ancestor
139059076|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
139059077|NCT01075022|Vitamin D|vitamin d|mesh-list
139059078|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
139059079|NCT01075022|Vitamins|vitamins|mesh-ancestor
139059080|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
139059081|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059082|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139059083|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139059084|NCT00225758|Lapatinib|lapatinib|mesh-list
139059085|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059086|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139059087|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059088|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059089|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139059090|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
139059091|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139059092|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059093|NCT01104532|Incretins|incretins|mesh-ancestor
139059094|NCT01104532|Hormones|hormones|mesh-ancestor
139059095|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139059096|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139059097|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
139059098|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059099|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059100|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139059101|NCT01107574|Gabapentin|gabapentin|mesh-list
139059102|NCT01107574|Analgesics|analgesics|mesh-ancestor
139059103|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
139059104|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059105|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059106|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
139059107|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139059108|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139059109|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059110|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138809706|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
139059111|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139059112|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139059113|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059114|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059115|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
139059116|NCT03971500|Ticagrelor|ticagrelor|mesh-list
139059117|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059118|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059119|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139059120|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139059121|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139059122|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139059123|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
138902151|NCT03950674|Hormones|hormones|mesh-ancestor
139059124|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059125|NCT00259298|Teriparatide|teriparatide|mesh-list
139059126|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139059127|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059128|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139059129|NCT01108744|Mannitol|mannitol|mesh-list
139059130|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139059131|NCT01108744|Diuretics|diuretics|mesh-ancestor
139059132|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
138634800|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
139019592|NCT04278404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139019593|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139019594|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139019595|NCT04278404|Diuretics|diuretics|mesh-ancestor
139019596|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
139019597|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139019598|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
139019599|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
139019600|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
139019601|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
139019602|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139019603|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
139019604|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139019605|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139019606|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139019607|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139019608|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
139019609|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
139019610|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139019611|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
139019612|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139019613|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139019614|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139019616|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
139019617|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
139019618|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139019619|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139019620|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139019621|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139019622|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139019623|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139019624|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139019625|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
138539257|NCT00044889|Clofarabine|clofarabine|mesh-list
139019626|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139019627|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139019628|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139019629|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139019630|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
139019631|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
139019632|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139019633|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139019634|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139019635|NCT04278404|Protective Agents|protective agents|mesh-ancestor
139019636|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139019637|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139019638|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139019639|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139019640|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139019641|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139019643|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139019644|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139019645|NCT04166071|Naltrexone|naltrexone|mesh-list
139019646|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139019647|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138634831|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019648|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019649|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
139019650|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019651|NCT06083129|Thymoglobulin|thymoglobulin|mesh-list
138539308|NCT00163501|Hormones|hormones|mesh-ancestor
139019652|NCT06083129|Immunologic Factors|immunologic factors|mesh-ancestor
139019653|NCT06083129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019654|NCT06083129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139019655|NCT06083116|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139019656|NCT06083116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139019657|NCT06083116|Diuretics|diuretics|mesh-ancestor
139019658|NCT06083116|Natriuretic Agents|natriuretic agents|mesh-ancestor
139019659|NCT06083116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019660|NCT06083116|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139019661|NCT06083116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139019662|NCT06083116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138975979|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
139019663|NCT06083103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139019664|NCT06083103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139019665|NCT06083103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019666|NCT06082973|Insulin|insulin|mesh-list
139019667|NCT06082973|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139019668|NCT06082973|Glucagon|glucagon|mesh-list
139019669|NCT06082973|Hormones|hormones|mesh-list
139019670|NCT06082973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139019671|NCT06082973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019672|NCT06082973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139019673|NCT06082973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139019674|NCT06082934|Dexamethasone|dexamethasone|mesh-list
139019675|NCT06082934|Venetoclax|venetoclax|mesh-list
139019676|NCT06082934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139019677|NCT06082934|Antiemetics|antiemetics|mesh-ancestor
139019678|NCT06082934|Autonomic Agents|autonomic agents|mesh-ancestor
139019679|NCT06082934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019680|NCT06082934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019681|NCT06082934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139019682|NCT06082934|Glucocorticoids|glucocorticoids|mesh-ancestor
139019684|NCT06082934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139019685|NCT06082934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139019686|NCT06082934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019687|NCT06082635|Crizotinib|crizotinib|mesh-list
139019688|NCT06082635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019689|NCT06082635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139019690|NCT06082635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019691|NCT06082635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019692|NCT06082622|Laxatives|laxatives|mesh-list
139019693|NCT06082622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139019694|NCT06082531|Hyaluronic Acid|hyaluronic acid|mesh-list
139019695|NCT06082531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139019696|NCT06082531|Immunologic Factors|immunologic factors|mesh-ancestor
139019697|NCT06082531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019698|NCT06082531|Viscosupplements|viscosupplements|mesh-ancestor
139019699|NCT06082531|Protective Agents|protective agents|mesh-ancestor
139019700|NCT06082388|Atropine|atropine|mesh-list
139019701|NCT06082388|Isoproterenol|isoproterenol|mesh-list
139019702|NCT06082388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139019703|NCT06082388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139019704|NCT06082388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139019705|NCT06082388|Autonomic Agents|autonomic agents|mesh-ancestor
139019706|NCT06082388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138539406|NCT00044928|Tazobactam|tazobactam|mesh-list
139019707|NCT06082388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019708|NCT06082388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139019709|NCT06082388|Respiratory System Agents|respiratory system agents|mesh-ancestor
139019710|NCT06082388|Mydriatics|mydriatics|mesh-ancestor
139019711|NCT06082388|Parasympatholytics|parasympatholytics|mesh-ancestor
139019712|NCT06082388|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139019713|NCT06082388|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139019714|NCT06082388|Cholinergic Agents|cholinergic agents|mesh-ancestor
139019715|NCT06082388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138976009|NCT04849455|Morphine|morphine|mesh-list
139019717|NCT06082388|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139019718|NCT06082388|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139019719|NCT06082388|Adrenergic Agents|adrenergic agents|mesh-ancestor
139019720|NCT06082388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139019721|NCT06082388|Sympathomimetics|sympathomimetics|mesh-ancestor
139019722|NCT06082388|Protective Agents|protective agents|mesh-ancestor
138770391|NCT01169675|Pemetrexed|pemetrexed|mesh-list
139019723|NCT06082375|Vitamin D|vitamin d|mesh-list
139019724|NCT06082375|Cholecalciferol|cholecalciferol|mesh-list
139019725|NCT06082375|Vitamins|vitamins|mesh-ancestor
139019726|NCT06082375|Micronutrients|micronutrients|mesh-ancestor
139019727|NCT06082375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019728|NCT06082375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139019729|NCT06082375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139019732|NCT06082245|Lidocaine|lidocaine|mesh-list
139019733|NCT06082245|Anesthetics, Local|anesthetics, local|mesh-ancestor
139019734|NCT06082245|Anesthetics|anesthetics|mesh-ancestor
139019735|NCT06082245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139019736|NCT06082245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539468|NCT00164749|Curcumin|curcumin|mesh-list
139019737|NCT06082245|Sensory System Agents|sensory system agents|mesh-ancestor
139019738|NCT06082245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019739|NCT06082245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139019740|NCT06082245|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139019741|NCT06082245|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139019742|NCT06082245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139019743|NCT06082245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019744|NCT06082076|Meperidine|meperidine|mesh-list
139019745|NCT06082076|Dexmedetomidine|dexmedetomidine|mesh-list
139019746|NCT06082076|Ketamine|ketamine|mesh-list
139019747|NCT06082076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139019748|NCT06082076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139019749|NCT06082076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019750|NCT06082076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139019751|NCT06082076|Analgesics|analgesics|mesh-ancestor
139019752|NCT06082076|Sensory System Agents|sensory system agents|mesh-ancestor
139019753|NCT06082076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019754|NCT06082076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139019755|NCT06082076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139019756|NCT06082076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139019757|NCT06082076|Adrenergic Agents|adrenergic agents|mesh-ancestor
139019758|NCT06082076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019759|NCT06082076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019760|NCT06082076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139019761|NCT06082076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139019762|NCT06082076|Anesthetics, General|anesthetics, general|mesh-ancestor
139019763|NCT06082076|Anesthetics|anesthetics|mesh-ancestor
139019764|NCT06082076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139019765|NCT06082076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139019766|NCT06082076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139019767|NCT06082076|Narcotics|narcotics|mesh-ancestor
139019768|NCT06082076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139019769|NCT06082063|Aspirin|aspirin|mesh-list
139019770|NCT06082063|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
139019771|NCT06082063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139019772|NCT06082063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139019773|NCT06082063|Analgesics|analgesics|mesh-ancestor
139019774|NCT06082063|Sensory System Agents|sensory system agents|mesh-ancestor
139019775|NCT06082063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019776|NCT06082063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019777|NCT06082063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139019778|NCT06082063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139019779|NCT06082063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139019780|NCT06082063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139019781|NCT06082063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019782|NCT06082063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139019783|NCT06082063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139019784|NCT06082063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019785|NCT06082063|Antipyretics|antipyretics|mesh-ancestor
139019786|NCT06082063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139019787|NCT06082063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139019788|NCT06081959|Gemcitabine|gemcitabine|mesh-list
139019789|NCT06081959|Capecitabine|capecitabine|mesh-list
139019790|NCT06081959|Vinorelbine|vinorelbine|mesh-list
139019791|NCT06081959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139019792|NCT06081959|Antimetabolites|antimetabolites|mesh-ancestor
139019793|NCT06081959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019794|NCT06081959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019795|NCT06081959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139019796|NCT06081959|Tubulin Modulators|tubulin modulators|mesh-ancestor
139019797|NCT06081959|Antimitotic Agents|antimitotic agents|mesh-ancestor
139019798|NCT06081959|Mitosis Modulators|mitosis modulators|mesh-ancestor
139019799|NCT06081933|Dexmedetomidine|dexmedetomidine|mesh-list
139019800|NCT06081933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139019801|NCT06081933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139019802|NCT06081933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019803|NCT06081933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139019804|NCT06081933|Analgesics|analgesics|mesh-ancestor
139019805|NCT06081933|Sensory System Agents|sensory system agents|mesh-ancestor
139019806|NCT06081933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019807|NCT06081933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139019808|NCT06081933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139019809|NCT06081933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139019810|NCT06081933|Adrenergic Agents|adrenergic agents|mesh-ancestor
139019811|NCT06081933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019812|NCT06081933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019814|NCT06081868|Fluorides, Topical|fluorides, topical|mesh-list
139019815|NCT06081868|Cariostatic Agents|cariostatic agents|mesh-ancestor
139019816|NCT06081868|Protective Agents|protective agents|mesh-ancestor
139019817|NCT06081868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019818|NCT06081842|Contraceptive Agents|contraceptive agents|mesh-list
139019819|NCT06081842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139019820|NCT06081842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019821|NCT06081803|Evolocumab|evolocumab|mesh-list
139019822|NCT06081803|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139019823|NCT06081803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139019824|NCT06081803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139019825|NCT06081803|Antimetabolites|antimetabolites|mesh-ancestor
139019826|NCT06081803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019827|NCT06081803|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139019828|NCT06081803|Protease Inhibitors|protease inhibitors|mesh-ancestor
139019829|NCT06081803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019830|NCT06081803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139019831|NCT06081738|Neostigmine|neostigmine|mesh-list
139019832|NCT06081738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139019833|NCT06081738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019834|NCT06081738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019835|NCT06081738|Cholinergic Agents|cholinergic agents|mesh-ancestor
139019836|NCT06081738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019837|NCT06081738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019838|NCT06081738|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139019839|NCT06081738|Autonomic Agents|autonomic agents|mesh-ancestor
139019840|NCT06081738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019841|NCT06081673|Paclitaxel|paclitaxel|mesh-list
139019842|NCT06081673|Cisplatin|cisplatin|mesh-list
139019843|NCT06081673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139019844|NCT06081673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019845|NCT06081673|Tubulin Modulators|tubulin modulators|mesh-ancestor
139019846|NCT06081673|Antimitotic Agents|antimitotic agents|mesh-ancestor
139019847|NCT06081673|Mitosis Modulators|mitosis modulators|mesh-ancestor
139019848|NCT06081673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019849|NCT06081595|Apatinib|apatinib|mesh-list
139019850|NCT06081595|Fluzoparib|fluzoparib|mesh-list
139019851|NCT06081595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019852|NCT06081595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139019853|NCT06081595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539641|NCT00053885|Vatalanib|vatalanib|mesh-list
139019854|NCT06081595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019855|NCT06081595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139019856|NCT06081582|Cisplatin|cisplatin|mesh-list
139019857|NCT06081582|Cetuximab|cetuximab|mesh-list
139019858|NCT06081582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019859|NCT06081582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139019860|NCT06081387|Vitamin D|vitamin d|mesh-list
139019861|NCT06081387|Vitamins|vitamins|mesh-ancestor
139019862|NCT06081387|Micronutrients|micronutrients|mesh-ancestor
139019863|NCT06081387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019864|NCT06081387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139019865|NCT06081166|Calcium, Dietary|calcium, dietary|mesh-list
139019866|NCT06081166|Atorvastatin|atorvastatin|mesh-list
139019867|NCT06081166|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139019868|NCT06081166|Calcium|calcium|mesh-list
139019869|NCT06081166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139019870|NCT06081166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019871|NCT06081166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139019872|NCT06081166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139019873|NCT06081166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139019874|NCT06081166|Antimetabolites|antimetabolites|mesh-ancestor
139019875|NCT06081166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019876|NCT06081166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139019877|NCT06081166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139019878|NCT06081166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019879|NCT06078384|Paclitaxel|paclitaxel|mesh-list
139019880|NCT06078384|Pembrolizumab|pembrolizumab|mesh-list
139019881|NCT06078384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139019882|NCT06078384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019883|NCT06078384|Tubulin Modulators|tubulin modulators|mesh-ancestor
139019884|NCT06078384|Antimitotic Agents|antimitotic agents|mesh-ancestor
139019885|NCT06078384|Mitosis Modulators|mitosis modulators|mesh-ancestor
138539742|NCT00045318|Exatecan|exatecan|mesh-list
139019886|NCT06078384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019887|NCT06078384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139019888|NCT06078384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139019889|NCT06078215|Cerebrolysin|cerebrolysin|mesh-list
139019890|NCT06078215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139019891|NCT06078215|Protective Agents|protective agents|mesh-ancestor
139019892|NCT06078215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019893|NCT06078215|Nootropic Agents|nootropic agents|mesh-ancestor
139019894|NCT06076551|Adenosine|adenosine|mesh-list
139019895|NCT06076551|Analgesics|analgesics|mesh-ancestor
139019896|NCT06076551|Sensory System Agents|sensory system agents|mesh-ancestor
139019897|NCT06076551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019898|NCT06076551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019899|NCT06076551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139019900|NCT06076551|Vasodilator Agents|vasodilator agents|mesh-ancestor
139019901|NCT06076551|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139019902|NCT06076551|Purinergic Agonists|purinergic agonists|mesh-ancestor
139019903|NCT06076551|Purinergic Agents|purinergic agents|mesh-ancestor
139019904|NCT06076551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634927|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
139019905|NCT06076551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019906|NCT06076304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139019907|NCT06076304|Amoxicillin|amoxicillin|mesh-list
139019908|NCT06076304|Clavulanic Acid|clavulanic acid|mesh-list
139019909|NCT06076304|Clavulanic Acids|clavulanic acids|mesh-list
139019910|NCT06076304|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139019911|NCT06076304|Budesonide|budesonide|mesh-list
139019912|NCT06076304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139019913|NCT06076304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139019914|NCT06076304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139019915|NCT06076304|Autonomic Agents|autonomic agents|mesh-ancestor
139019916|NCT06076304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019917|NCT06076304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019918|NCT06076304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139019919|NCT06076304|Respiratory System Agents|respiratory system agents|mesh-ancestor
139019920|NCT06076304|Glucocorticoids|glucocorticoids|mesh-ancestor
139019921|NCT06076304|Hormones|hormones|mesh-ancestor
139019922|NCT06076304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139019923|NCT06076304|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139019924|NCT06076304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019925|NCT06076304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019926|NCT06067269|Edetic Acid|edetic acid|mesh-list
138976108|NCT00845156|Vitamins|vitamins|mesh-ancestor
139019927|NCT06067269|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139019928|NCT06067269|Chelating Agents|chelating agents|mesh-ancestor
139019929|NCT06067269|Sequestering Agents|sequestering agents|mesh-ancestor
139019930|NCT06067269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019931|NCT06067269|Anticoagulants|anticoagulants|mesh-ancestor
139019932|NCT06067269|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139019933|NCT06067269|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139019934|NCT06063941|Iodine|iodine|mesh-list
139019935|NCT06063941|Cadexomer iodine|cadexomer iodine|mesh-list
139019936|NCT06063941|Lugol's solution|lugol's solution|mesh-list
139019937|NCT06063941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139019938|NCT06063941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139019939|NCT06063941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139019940|NCT06063941|Trace Elements|trace elements|mesh-ancestor
139019941|NCT06063941|Micronutrients|micronutrients|mesh-ancestor
139019942|NCT06063941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019943|NCT06063941|Hemostatics|hemostatics|mesh-ancestor
139019944|NCT06063941|Coagulants|coagulants|mesh-ancestor
139019945|NCT06054464|Rabeprazole|rabeprazole|mesh-list
139019946|NCT06054464|Famotidine|famotidine|mesh-list
139019947|NCT06054464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139019948|NCT06054464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138770609|NCT02652637|Neomycin|neomycin|mesh-list
139019949|NCT06054464|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139019950|NCT06054464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019951|NCT06054464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019952|NCT06054464|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139019953|NCT06054464|Histamine Antagonists|histamine antagonists|mesh-ancestor
139019954|NCT06054464|Histamine Agents|histamine agents|mesh-ancestor
139019955|NCT06054464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019956|NCT06054464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019957|NCT06045104|Micronutrients|micronutrients|mesh-list
139019958|NCT06045104|Trace Elements|trace elements|mesh-list
139019959|NCT06045104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019960|NCT06042725|Dexamethasone|dexamethasone|mesh-list
139019961|NCT06042725|Dexamethasone acetate|dexamethasone acetate|mesh-list
139019962|NCT06042725|Lenalidomide|lenalidomide|mesh-list
139019963|NCT06042725|Venetoclax|venetoclax|mesh-list
139019964|NCT06042725|Daratumumab|daratumumab|mesh-list
139019965|NCT06042725|Ichthammol|ichthammol|mesh-list
139019966|NCT06042725|BB 1101|bb 1101|mesh-list
139019967|NCT06042725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139019968|NCT06042725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139019969|NCT06042725|Antiemetics|antiemetics|mesh-ancestor
139019970|NCT06042725|Autonomic Agents|autonomic agents|mesh-ancestor
139019971|NCT06042725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019972|NCT06042725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019973|NCT06042725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139019974|NCT06042725|Glucocorticoids|glucocorticoids|mesh-ancestor
139019975|NCT06042725|Hormones|hormones|mesh-ancestor
139019976|NCT06042725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138540036|NCT00167986|Vancomycin|vancomycin|mesh-list
139019977|NCT06042725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139019978|NCT06042725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139019979|NCT06042725|Protease Inhibitors|protease inhibitors|mesh-ancestor
139019980|NCT06042725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139019981|NCT06042725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019982|NCT06042725|Immunologic Factors|immunologic factors|mesh-ancestor
139019983|NCT06042725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139019984|NCT06042725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139019985|NCT06042725|Growth Substances|growth substances|mesh-ancestor
139019986|NCT06042725|Growth Inhibitors|growth inhibitors|mesh-ancestor
139019987|NCT06042725|Dermatologic Agents|dermatologic agents|mesh-ancestor
139019988|NCT06034288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139019989|NCT06034288|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139019990|NCT06034288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139019991|NCT06034288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139019992|NCT06034288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139019993|NCT06034288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139019994|NCT06034288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139019995|NCT06034288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139019996|NCT06034288|Cholinergic Agents|cholinergic agents|mesh-ancestor
139019997|NCT06034288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139019999|NCT06012175|Antioxidants|antioxidants|mesh-ancestor
139020000|NCT06012175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020001|NCT06012175|Protective Agents|protective agents|mesh-ancestor
139020002|NCT06012175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020003|NCT06012175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139020004|NCT06003348|Potassium Citrate|potassium citrate|mesh-list
139020005|NCT06003348|Diuretics|diuretics|mesh-ancestor
139020006|NCT06003348|Natriuretic Agents|natriuretic agents|mesh-ancestor
139020007|NCT06003348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020008|NCT06003348|Expectorants|expectorants|mesh-ancestor
139020009|NCT06003348|Respiratory System Agents|respiratory system agents|mesh-ancestor
139020010|NCT05994638|Niacinamide|niacinamide|mesh-list
139020011|NCT05994638|Hyaluronic Acid|hyaluronic acid|mesh-list
139020012|NCT05994638|Vitamins|vitamins|mesh-ancestor
139020013|NCT05994638|Micronutrients|micronutrients|mesh-ancestor
139020014|NCT05994638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020015|NCT05994638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139020016|NCT05994638|Immunologic Factors|immunologic factors|mesh-ancestor
139020017|NCT05994638|Viscosupplements|viscosupplements|mesh-ancestor
138634979|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
139020018|NCT05994638|Protective Agents|protective agents|mesh-ancestor
139020019|NCT05994638|Vitamin B Complex|vitamin b complex|mesh-ancestor
139020020|NCT05947162|Nicotine|nicotine|mesh-list
139020021|NCT05947162|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139020022|NCT05947162|Autonomic Agents|autonomic agents|mesh-ancestor
139020023|NCT05947162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020024|NCT05947162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020025|NCT05947162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139020026|NCT05947162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139020027|NCT05947162|Cholinergic Agents|cholinergic agents|mesh-ancestor
138540134|NCT00168649|Vitamin A|vitamin a|mesh-list
139020028|NCT05947162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020029|NCT05947162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020030|NCT05945680|Tranexamic Acid|tranexamic acid|mesh-list
139020031|NCT05945680|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139020032|NCT05945680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139020033|NCT05945680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020034|NCT05945680|Hemostatics|hemostatics|mesh-ancestor
139020035|NCT05945680|Coagulants|coagulants|mesh-ancestor
139020036|NCT05943795|Docetaxel|docetaxel|mesh-list
139020037|NCT05943795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020038|NCT05943795|Tubulin Modulators|tubulin modulators|mesh-ancestor
139020039|NCT05943795|Antimitotic Agents|antimitotic agents|mesh-ancestor
139020040|NCT05943795|Mitosis Modulators|mitosis modulators|mesh-ancestor
139020041|NCT05943795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020042|NCT05939414|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
139020043|NCT05939414|Chelating Agents|chelating agents|mesh-ancestor
139020044|NCT05939414|Sequestering Agents|sequestering agents|mesh-ancestor
139020045|NCT05939414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020047|NCT05938959|Anesthetics, Local|anesthetics, local|mesh-ancestor
139020048|NCT05938959|Anesthetics|anesthetics|mesh-ancestor
139020049|NCT05938959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139020050|NCT05938959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020051|NCT05938959|Sensory System Agents|sensory system agents|mesh-ancestor
139020052|NCT05938959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020053|NCT05880849|Choline|choline|mesh-list
139020054|NCT05880849|Lipotropic Agents|lipotropic agents|mesh-ancestor
139020055|NCT05880849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139020056|NCT05880849|Antimetabolites|antimetabolites|mesh-ancestor
139020057|NCT05880849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020058|NCT05880849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139020059|NCT05880849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139020060|NCT05880849|Nootropic Agents|nootropic agents|mesh-ancestor
139020061|NCT05878015|Acetaminophen|acetaminophen|mesh-list
139020062|NCT05878015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139020063|NCT05878015|Analgesics|analgesics|mesh-ancestor
139020064|NCT05878015|Sensory System Agents|sensory system agents|mesh-ancestor
139020065|NCT05878015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020066|NCT05878015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020067|NCT05878015|Antipyretics|antipyretics|mesh-ancestor
139020068|NCT05844657|Ferrous fumarate|ferrous fumarate|mesh-list
139020069|NCT05844657|Trace Elements|trace elements|mesh-ancestor
139020070|NCT05844657|Micronutrients|micronutrients|mesh-ancestor
139020071|NCT05844657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020072|NCT05816226|Hydrocortisone|hydrocortisone|mesh-list
139020073|NCT05816226|Diclofenac|diclofenac|mesh-list
139020074|NCT05816226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139020075|NCT05816226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138635008|NCT01648036|Heparin|heparin|mesh-list
139020076|NCT05816226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139020077|NCT05816226|Analgesics|analgesics|mesh-ancestor
139020078|NCT05816226|Sensory System Agents|sensory system agents|mesh-ancestor
139020079|NCT05816226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020080|NCT05816226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020081|NCT05816226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139020082|NCT05816226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139020083|NCT05816226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138976148|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139020084|NCT05816226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020085|NCT05771779|Vaccines|vaccines|mesh-list
139020086|NCT05771779|Immunologic Factors|immunologic factors|mesh-ancestor
139020087|NCT05771779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020088|NCT05763667|Bupivacaine|bupivacaine|mesh-list
139020089|NCT05763667|Anesthetics, Local|anesthetics, local|mesh-ancestor
139020090|NCT05763667|Anesthetics|anesthetics|mesh-ancestor
139020091|NCT05763667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139020092|NCT05763667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020093|NCT05763667|Sensory System Agents|sensory system agents|mesh-ancestor
139020094|NCT05763667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020095|NCT05753670|Tamsulosin|tamsulosin|mesh-list
139020096|NCT05753670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139020097|NCT05753670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139020098|NCT05753670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139020099|NCT05753670|Adrenergic Agents|adrenergic agents|mesh-ancestor
139020100|NCT05753670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020101|NCT05753670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020102|NCT05753670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020104|NCT05742698|Dronabinol|dronabinol|mesh-list
139020105|NCT05742698|Nabilone|nabilone|mesh-list
139020106|NCT05742698|Antiemetics|antiemetics|mesh-ancestor
139020107|NCT05742698|Autonomic Agents|autonomic agents|mesh-ancestor
139020108|NCT05742698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020109|NCT05742698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020110|NCT05742698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139020111|NCT05742698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139020112|NCT05742698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139020113|NCT05742698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139020114|NCT05742698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139020115|NCT05742698|Hallucinogens|hallucinogens|mesh-ancestor
139020116|NCT05742698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139020117|NCT05742698|Analgesics|analgesics|mesh-ancestor
138976188|NCT04042220|Hormones|hormones|mesh-ancestor
139020118|NCT05742698|Sensory System Agents|sensory system agents|mesh-ancestor
139020119|NCT05742698|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139020120|NCT05742698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139020121|NCT05742698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020122|NCT05742698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020123|NCT05742698|Hormones|hormones|mesh-ancestor
139020124|NCT05742698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139020125|NCT05731960|Dexamethasone|dexamethasone|mesh-list
139020126|NCT05731960|Metoclopramide|metoclopramide|mesh-list
139020127|NCT05731960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139020128|NCT05731960|Antiemetics|antiemetics|mesh-ancestor
139020129|NCT05731960|Autonomic Agents|autonomic agents|mesh-ancestor
139020130|NCT05731960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020131|NCT05731960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020132|NCT05731960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139020133|NCT05731960|Glucocorticoids|glucocorticoids|mesh-ancestor
139020134|NCT05731960|Hormones|hormones|mesh-ancestor
139020135|NCT05731960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139020136|NCT05731960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139020137|NCT05731960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020138|NCT05731960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139020139|NCT05731960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139020140|NCT05731960|Dopamine Agents|dopamine agents|mesh-ancestor
139020141|NCT05731960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020142|NCT05731960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020143|NCT05688436|Interferons|interferons|mesh-list
139020144|NCT05688436|Interferon-beta|interferon-beta|mesh-list
139020145|NCT05688436|Alemtuzumab|alemtuzumab|mesh-list
139020146|NCT05688436|Ofatumumab|ofatumumab|mesh-list
139020147|NCT05688436|Glatiramer Acetate|glatiramer acetate|mesh-list
139020148|NCT05688436|Ocrelizumab|ocrelizumab|mesh-list
139020149|NCT05688436|Natalizumab|natalizumab|mesh-list
139020150|NCT05688436|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139020151|NCT05688436|(T,G)-A-L|(t,g)-a-l|mesh-list
139020152|NCT05688436|Ozanimod|ozanimod|mesh-list
139020153|NCT05688436|Ponesimod|ponesimod|mesh-list
139020154|NCT05688436|Siponimod|siponimod|mesh-list
139020155|NCT05688436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020156|NCT05688436|Antiviral Agents|antiviral agents|mesh-ancestor
139020157|NCT05688436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139020158|NCT05688436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139020159|NCT05688436|Immunologic Factors|immunologic factors|mesh-ancestor
139020161|NCT05688436|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139020162|NCT05688436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020163|NCT05688436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139020164|NCT05688436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139020165|NCT05688436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139020166|NCT05658575|Dapansutrile|dapansutrile|mesh-list
139020167|NCT05658575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139020168|NCT05637515|Adalimumab|adalimumab|mesh-list
139020169|NCT05637515|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139020170|NCT05637515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139020171|NCT05637515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139020172|NCT05635162|Rituximab|rituximab|mesh-list
139020173|NCT05635162|Zanubrutinib|zanubrutinib|mesh-list
139020174|NCT05635162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139020175|NCT05635162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020176|NCT05635162|Immunologic Factors|immunologic factors|mesh-ancestor
139020177|NCT05635162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020178|NCT05635162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139020179|NCT05635162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139020180|NCT05635162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020181|NCT05635162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020183|NCT05614544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139020184|NCT05614544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139020185|NCT05614544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020186|NCT05614544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139020187|NCT05614544|Anesthetics, General|anesthetics, general|mesh-ancestor
139020188|NCT05614544|Anesthetics|anesthetics|mesh-ancestor
139020189|NCT05533372|Methotrexate|methotrexate|mesh-list
139020190|NCT05533372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139020191|NCT05533372|Abortifacient Agents|abortifacient agents|mesh-ancestor
139020192|NCT05533372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139020193|NCT05533372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020194|NCT05533372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139020195|NCT05533372|Antimetabolites|antimetabolites|mesh-ancestor
139020196|NCT05533372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020197|NCT05533372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020198|NCT05533372|Dermatologic Agents|dermatologic agents|mesh-ancestor
139020199|NCT05533372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020200|NCT05533372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139020201|NCT05533372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139020202|NCT05533372|Immunologic Factors|immunologic factors|mesh-ancestor
139020203|NCT05533372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139020204|NCT05533372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139020205|NCT05525078|Nicotine|nicotine|mesh-list
139020206|NCT05525078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139020207|NCT05525078|Autonomic Agents|autonomic agents|mesh-ancestor
139020208|NCT05525078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020209|NCT05525078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020210|NCT05525078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139020211|NCT05525078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139020212|NCT05525078|Cholinergic Agents|cholinergic agents|mesh-ancestor
139020213|NCT05525078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020214|NCT05525078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020215|NCT05493657|Aspirin|aspirin|mesh-list
139020216|NCT05493657|Clopidogrel|clopidogrel|mesh-list
139020217|NCT05493657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139020218|NCT05493657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139020219|NCT05493657|Analgesics|analgesics|mesh-ancestor
139020220|NCT05493657|Sensory System Agents|sensory system agents|mesh-ancestor
139020221|NCT05493657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020222|NCT05493657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020223|NCT05493657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139020224|NCT05493657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139020225|NCT05493657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138635061|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020226|NCT05493657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139020227|NCT05493657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020228|NCT05493657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139020229|NCT05493657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139020230|NCT05493657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020231|NCT05493657|Antipyretics|antipyretics|mesh-ancestor
139020232|NCT05493657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139020233|NCT05493657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139020234|NCT05493657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139020235|NCT05493657|Purinergic Agents|purinergic agents|mesh-ancestor
139020236|NCT05493657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020237|NCT05476094|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
139020238|NCT05476094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139020240|NCT05476094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020241|NCT05476094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139020242|NCT05439902|Tamsulosin|tamsulosin|mesh-list
139020243|NCT05439902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139020244|NCT05439902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139020245|NCT05439902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139020246|NCT05439902|Adrenergic Agents|adrenergic agents|mesh-ancestor
139020247|NCT05439902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020248|NCT05439902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020249|NCT05439902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020250|NCT05439902|Urological Agents|urological agents|mesh-ancestor
138770918|NCT00651235|Losartan|losartan|mesh-list
139020251|NCT05424757|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139020252|NCT05424757|Laxatives|laxatives|mesh-ancestor
139020253|NCT05424757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139020254|NCT05419427|Denosumab|denosumab|mesh-list
139020255|NCT05419427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139020256|NCT05419427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020257|NCT05414305|Lidocaine|lidocaine|mesh-list
139020258|NCT05414305|Heparin|heparin|mesh-list
139020259|NCT05414305|Anesthetics, Local|anesthetics, local|mesh-ancestor
138540727|NCT00055835|Paclitaxel|paclitaxel|mesh-list
139020261|NCT05414305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139020262|NCT05414305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020263|NCT05414305|Sensory System Agents|sensory system agents|mesh-ancestor
139020264|NCT05414305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020265|NCT05414305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139020266|NCT05414305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139020267|NCT05414305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139020268|NCT05414305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139020269|NCT05414305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020270|NCT05414305|Anticoagulants|anticoagulants|mesh-ancestor
139020271|NCT05414305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139020272|NCT05414305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139020273|NCT05356897|Trifluridine|trifluridine|mesh-list
139020274|NCT05356897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139020275|NCT05356897|Trastuzumab|trastuzumab|mesh-list
139020276|NCT05356897|Tucatinib|tucatinib|mesh-list
139020277|NCT05356897|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
139020278|NCT05356897|Antibodies|antibodies|mesh-list
139020279|NCT05356897|Immunoglobulins|immunoglobulins|mesh-list
139020280|NCT05356897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139020281|NCT05356897|Immunologic Factors|immunologic factors|mesh-ancestor
139020282|NCT05356897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020283|NCT05356897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020284|NCT05356897|Antimetabolites|antimetabolites|mesh-ancestor
139020285|NCT05356897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540856|NCT00174304|Amlodipine|amlodipine|mesh-list
139020286|NCT05356897|Antiviral Agents|antiviral agents|mesh-ancestor
139020287|NCT05356897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139020288|NCT05356897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138635195|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139020289|NCT05356897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020290|NCT05320887|Nicotine|nicotine|mesh-list
139020291|NCT05320887|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139020292|NCT05320887|Autonomic Agents|autonomic agents|mesh-ancestor
139020293|NCT05320887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020294|NCT05320887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020295|NCT05320887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139020296|NCT05320887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139020297|NCT05320887|Cholinergic Agents|cholinergic agents|mesh-ancestor
139020298|NCT05320887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020299|NCT05320887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020300|NCT05287464|Pembrolizumab|pembrolizumab|mesh-list
139020301|NCT05287464|Nivolumab|nivolumab|mesh-list
139020302|NCT05287464|Ipilimumab|ipilimumab|mesh-list
139020303|NCT05287464|Atezolizumab|atezolizumab|mesh-list
139020304|NCT05287464|Avelumab|avelumab|mesh-list
139020305|NCT05287464|Lenvatinib|lenvatinib|mesh-list
139020306|NCT05287464|Axitinib|axitinib|mesh-list
139020307|NCT05287464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139020308|NCT05287464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020309|NCT05287464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139020310|NCT05287464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540905|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020311|NCT05287464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139020312|NCT05287464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020313|NCT05275907|Amlodipine|amlodipine|mesh-list
139020314|NCT05275907|Chlorthalidone|chlorthalidone|mesh-list
139020315|NCT05275907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139020316|NCT05275907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138635249|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020317|NCT05275907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139020318|NCT05275907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020319|NCT05275907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139020320|NCT05275907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020321|NCT05275907|Vasodilator Agents|vasodilator agents|mesh-ancestor
139020322|NCT05275907|Diuretics|diuretics|mesh-ancestor
139020323|NCT05275907|Natriuretic Agents|natriuretic agents|mesh-ancestor
139020324|NCT05275907|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139020325|NCT05274048|Trastuzumab|trastuzumab|mesh-list
138770982|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
139020326|NCT05274048|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139020327|NCT05274048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139020329|NCT05274048|Immunoconjugates|immunoconjugates|mesh-ancestor
139020330|NCT05274048|Immunologic Factors|immunologic factors|mesh-ancestor
139020331|NCT05274048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020332|NCT05250843|Lenvatinib|lenvatinib|mesh-list
139020333|NCT05250843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020334|NCT05250843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139020335|NCT05250843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020336|NCT05250843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020337|NCT05223829|Brexanolone|brexanolone|mesh-list
139020338|NCT05223829|Neurosteroids|neurosteroids|mesh-ancestor
139020339|NCT05223829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020340|NCT05223829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020341|NCT05223829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020342|NCT05223829|GABA Modulators|gaba modulators|mesh-ancestor
139020343|NCT05223829|GABA Agents|gaba agents|mesh-ancestor
139020344|NCT05197842|Prednisone|prednisone|mesh-list
139020345|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
139020346|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
139020347|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139020348|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
139020349|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020350|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139020351|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139020352|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
139020353|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020354|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020355|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139020356|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139020357|NCT05197842|Hormones|hormones|mesh-ancestor
139020358|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139020359|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139020360|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
139020361|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139020362|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020363|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139020364|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020365|NCT05107219|Linaclotide|linaclotide|mesh-list
139020366|NCT05107219|Plecanatide|plecanatide|mesh-list
139020367|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
139020368|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
139020369|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020370|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139020371|NCT05091372|Lenalidomide|lenalidomide|mesh-list
139020372|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
139020373|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020374|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139020375|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139020376|NCT05091372|Growth Substances|growth substances|mesh-ancestor
139020377|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
139020378|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020379|NCT05081219|Insulin|insulin|mesh-list
139020380|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139020381|NCT05081219|Empagliflozin|empagliflozin|mesh-list
139020383|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020384|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139020385|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020386|NCT05071313|Vaccines|vaccines|mesh-list
139020387|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
139020388|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020389|NCT05048797|Carboplatin|carboplatin|mesh-list
139020390|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
139020391|NCT05048797|Trastuzumab|trastuzumab|mesh-list
139020392|NCT05048797|Pemetrexed|pemetrexed|mesh-list
139020393|NCT05048797|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
139020394|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020395|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139020396|NCT05048797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139020397|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020398|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020399|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138771057|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
139020400|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139020401|NCT05048797|Immunoconjugates|immunoconjugates|mesh-ancestor
139020402|NCT05048797|Immunologic Factors|immunologic factors|mesh-ancestor
138976299|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
139020403|NCT05048797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020404|NCT04890236|Tisagenlecleucel|tisagenlecleucel|mesh-list
139020405|NCT04890236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139020406|NCT04890236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020408|NCT04885998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020409|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
139020410|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139020411|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020412|NCT04747054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139020413|NCT04747054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020414|NCT04682834|Probenecid|probenecid|mesh-list
139020415|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
139020416|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
139020417|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139020418|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
139020419|NCT04643574|Fludarabine|fludarabine|mesh-list
139020420|NCT04643574|Interleukin-2|interleukin-2|mesh-list
139020421|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139020422|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
139020423|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020424|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139020425|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139020426|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
139020427|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020428|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020429|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139020430|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139020431|NCT04643574|Analgesics|analgesics|mesh-ancestor
139020432|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
139020433|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020434|NCT04626791|Cytarabine|cytarabine|mesh-list
139020435|NCT04626791|Prednisone|prednisone|mesh-list
139020436|NCT04626791|Cortisone|cortisone|mesh-list
139020437|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
139020438|NCT04626791|Rituximab|rituximab|mesh-list
139020439|NCT04626791|Doxorubicin|doxorubicin|mesh-list
139020440|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139020441|NCT04626791|Bortezomib|bortezomib|mesh-list
139020442|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
139020443|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139020444|NCT04626791|Antibodies|antibodies|mesh-list
139020445|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
139020446|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139020447|NCT04626791|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139020448|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139020449|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
139020450|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020451|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139020452|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139020453|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
139020454|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020455|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020456|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139020457|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139020458|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138976318|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
139020459|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139020460|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020461|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139020462|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
139020463|NCT04626791|Hormones|hormones|mesh-ancestor
139020464|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139020465|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139020466|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139020467|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
139020468|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
139020469|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139020470|NCT04626791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139020471|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
139020472|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139020473|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
139020474|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139020475|NCT04585295|Betaine|betaine|mesh-list
139020476|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139020477|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
139020478|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139020479|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
139020480|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020481|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139020482|NCT04572815|Interleukin-12|interleukin-12|mesh-list
139020483|NCT04572815|Ustekinumab|ustekinumab|mesh-list
139020484|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
139020485|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
139020486|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
139020487|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020488|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
139020489|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139020490|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139020491|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139020492|NCT04572815|Growth Substances|growth substances|mesh-ancestor
139020493|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
139020494|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020495|NCT04544475|Estrogens|estrogens|mesh-list
139020496|NCT04544475|Estradiol|estradiol|mesh-list
139020497|NCT04544475|Hormones|hormones|mesh-ancestor
139020498|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139020499|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020500|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
139020501|NCT04507438|Donepezil|donepezil|mesh-list
139020502|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139020503|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020504|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020505|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
139020506|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020507|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020508|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
139020509|NCT04459273|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139020510|NCT04459273|FAPI-46|fapi-46|mesh-list
139020511|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139020512|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020513|NCT04457232|FAPI-46|fapi-46|mesh-list
139020514|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138976333|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
139020515|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020516|NCT04440358|Carboplatin|carboplatin|mesh-list
139020517|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020518|NCT04417088|Carboplatin|carboplatin|mesh-list
139020519|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020520|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
139020521|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139020522|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
139020523|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139020524|NCT04381897|Expectorants|expectorants|mesh-ancestor
139020525|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
139020526|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139020527|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
139020528|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020529|NCT04381897|Protective Agents|protective agents|mesh-ancestor
139020530|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020531|NCT04381897|Antidotes|antidotes|mesh-ancestor
139020532|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
139020533|NCT04379596|Capecitabine|capecitabine|mesh-list
139020534|NCT04379596|Fluorouracil|fluorouracil|mesh-list
139020535|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
139020536|NCT04379596|Trastuzumab|trastuzumab|mesh-list
139020539|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020540|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139020541|NCT04379596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139020542|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020543|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139020544|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
139020545|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139020546|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
139020547|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020548|NCT04379596|Immunoconjugates|immunoconjugates|mesh-ancestor
139020549|NCT04330690|Artesunate|artesunate|mesh-list
139020550|NCT04330690|Dexamethasone|dexamethasone|mesh-list
139020551|NCT04330690|Infliximab|infliximab|mesh-list
139020552|NCT04330690|Imatinib Mesylate|imatinib mesylate|mesh-list
139020553|NCT04330690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139020554|NCT04330690|Antiemetics|antiemetics|mesh-ancestor
139020555|NCT04330690|Autonomic Agents|autonomic agents|mesh-ancestor
139020556|NCT04330690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020557|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020558|NCT04330690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139020559|NCT04330690|Glucocorticoids|glucocorticoids|mesh-ancestor
139020561|NCT04330690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139020562|NCT04330690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139020563|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020564|NCT04330690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139020565|NCT04330690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020566|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020567|NCT04330690|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139020568|NCT04330690|Dermatologic Agents|dermatologic agents|mesh-ancestor
139020569|NCT04330690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139020570|NCT04330690|Antimalarials|antimalarials|mesh-ancestor
139020571|NCT04330690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139020572|NCT04330690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139020573|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139020574|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
139020575|NCT04330690|Schistosomicides|schistosomicides|mesh-ancestor
139020576|NCT04330690|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139020577|NCT04330690|Anthelmintics|anthelmintics|mesh-ancestor
139020578|NCT04268199|Bortezomib|bortezomib|mesh-list
139020579|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020580|NCT04198116|Guanfacine|guanfacine|mesh-list
139020581|NCT04198116|Varenicline|varenicline|mesh-list
139020582|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139020583|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139020584|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
139020585|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020586|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020587|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020588|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139020589|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139020590|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139020591|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139020592|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
139020593|NCT04172844|Azacitidine|azacitidine|mesh-list
139020594|NCT04172844|Venetoclax|venetoclax|mesh-list
139020595|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139020596|NCT04172844|Pevonedistat|pevonedistat|mesh-list
139020597|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139020598|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
139020599|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020600|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020601|NCT04147494|Edetic Acid|edetic acid|mesh-list
139020602|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139020603|NCT04147494|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139020604|NCT04147494|FAPI-46|fapi-46|mesh-list
139020606|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
139020607|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020608|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
139020609|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139020610|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139020611|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139020612|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139020613|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139020614|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020615|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020616|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139020617|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139020618|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020619|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
139020620|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020622|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139020623|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139020624|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020625|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020626|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020627|NCT04045613|Atezolizumab|atezolizumab|mesh-list
139020628|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139020629|NCT04045613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139020630|NCT04045613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541786|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
139020631|NCT04045613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139020632|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020633|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
139020634|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020636|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139020637|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020638|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020639|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020640|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
139020641|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139020642|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
139020643|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020644|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020645|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139020646|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
139020647|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
139020648|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139020649|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
139020650|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020651|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020652|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139020653|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139020654|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020655|NCT03947255|Immunotoxins|immunotoxins|mesh-ancestor
139020656|NCT03947255|Immunoconjugates|immunoconjugates|mesh-ancestor
139020657|NCT03947255|Immunologic Factors|immunologic factors|mesh-ancestor
139020658|NCT03947255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020659|NCT03929757|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138635521|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
139020660|NCT03929757|Antiviral Agents|antiviral agents|mesh-ancestor
139020661|NCT03929757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139020662|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
139020663|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139020664|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
139020665|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139020666|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
138541859|NCT00182104|Warfarin|warfarin|mesh-list
139020667|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020668|NCT03786081|Bevacizumab|bevacizumab|mesh-list
139020669|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
139020670|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
139020671|NCT03786081|Carboplatin|carboplatin|mesh-list
139020672|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139020673|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020674|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138976469|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139020675|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139020676|NCT03786081|Growth Substances|growth substances|mesh-ancestor
139020677|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020678|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
139020679|NCT03786081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139020680|NCT03786081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020681|NCT03748823|Ravulizumab|ravulizumab|mesh-list
139020682|NCT03748823|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139020683|NCT03748823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139020684|NCT03748823|Immunologic Factors|immunologic factors|mesh-ancestor
139020685|NCT03748823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020686|NCT03588754|Propranolol|propranolol|mesh-list
139020687|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139020688|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139020689|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
139020690|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020691|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020692|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020693|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139020694|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139020695|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
139020696|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
139020697|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
139020698|NCT03565913|Calcium|calcium|mesh-list
139020699|NCT03565913|Calcium acetate|calcium acetate|mesh-list
139020700|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139020701|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020702|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139020703|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
139020704|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
139020705|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020708|NCT03535883|Anticoagulants|anticoagulants|mesh-list
139020709|NCT03535883|Coagulants|coagulants|mesh-list
139020710|NCT03523156|Azithromycin|azithromycin|mesh-list
138635557|NCT04529512|Dexamethasone|dexamethasone|mesh-list
138635558|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635559|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
138635560|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
138635561|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635562|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635563|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138635564|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
139020711|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139020712|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139020713|NCT03503058|Chloroquine|chloroquine|mesh-list
138541921|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
139020714|NCT03503058|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139020715|NCT03503058|Amebicides|amebicides|mesh-ancestor
139020716|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139020717|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139020718|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139020719|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
139020720|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139020721|NCT03503058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139020722|NCT03503058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139020723|NCT03503058|Analgesics|analgesics|mesh-ancestor
139020724|NCT03503058|Sensory System Agents|sensory system agents|mesh-ancestor
139020725|NCT03503058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020726|NCT03503058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020727|NCT03503058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139020728|NCT03503058|Filaricides|filaricides|mesh-ancestor
139020729|NCT03503058|Antinematodal Agents|antinematodal agents|mesh-ancestor
139020730|NCT03503058|Anthelmintics|anthelmintics|mesh-ancestor
139020731|NCT03428633|Morphine|morphine|mesh-list
139020732|NCT03428633|Ropivacaine|ropivacaine|mesh-list
139020733|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139020734|NCT03428633|Narcotics|narcotics|mesh-ancestor
139020735|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139020736|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020737|NCT03428633|Analgesics|analgesics|mesh-ancestor
139020738|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
139020739|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020740|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
139020741|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
139020742|NCT03330405|Avelumab|avelumab|mesh-list
139020743|NCT03330405|Talazoparib|talazoparib|mesh-list
139020744|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139020745|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139020746|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020747|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
139020748|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020749|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139020750|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020751|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020752|NCT03207958|Belimumab|belimumab|mesh-list
138635583|NCT02219737|Etoposide|etoposide|mesh-list
139020753|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139020754|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
139020755|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020757|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139020758|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020759|NCT03153280|Capecitabine|capecitabine|mesh-list
139020760|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
139020761|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139020762|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
139020763|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020764|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020765|NCT03150797|Melatonin|melatonin|mesh-list
139020766|NCT03150797|Antioxidants|antioxidants|mesh-ancestor
139020767|NCT03150797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020768|NCT03150797|Protective Agents|protective agents|mesh-ancestor
139020769|NCT03150797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020770|NCT03150797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139020771|NCT03096418|Paclitaxel|paclitaxel|mesh-list
139020772|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139020773|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020774|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
139020775|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
139020776|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
139020777|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020778|NCT03074513|Bevacizumab|bevacizumab|mesh-list
139020779|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138771431|NCT01166945|Amoxicillin|amoxicillin|mesh-list
139020780|NCT03074513|Atezolizumab|atezolizumab|mesh-list
139020781|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
139020783|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
139020784|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139020785|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
139020786|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020787|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139020788|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139020789|NCT03074513|Growth Substances|growth substances|mesh-ancestor
139020790|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020791|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
139020792|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
139020793|NCT03074513|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139020794|NCT03074513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020795|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139020797|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139020798|NCT02758717|Antibodies|antibodies|mesh-list
139020799|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
139020800|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139020801|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
139020802|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
139020803|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020804|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020805|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139020806|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020808|NCT02756897|Venetoclax|venetoclax|mesh-list
139020809|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020810|NCT02683239|Fasinumab|fasinumab|mesh-list
138635622|NCT02210806|Tocolytic Agents|tocolytic agents|mesh-ancestor
139020811|NCT02683239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139020812|NCT02683239|Analgesics|analgesics|mesh-ancestor
139020813|NCT02683239|Sensory System Agents|sensory system agents|mesh-ancestor
139020814|NCT02683239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020815|NCT02683239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020816|NCT02551237|Capecitabine|capecitabine|mesh-list
138542272|NCT00185107|Simvastatin|simvastatin|mesh-list
139020817|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139020818|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
139020819|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020820|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020821|NCT02097134|Melphalan|melphalan|mesh-list
139020822|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
139020823|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139020824|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139020825|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
139020826|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020827|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020828|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139020829|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139020830|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
139020831|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020832|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
139020833|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139020834|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
139020835|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139020836|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020837|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139020838|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139020839|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139020840|NCT01954992|Fluorouracil|fluorouracil|mesh-list
139020841|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
139020842|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020843|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139020844|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020845|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139020846|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
139020847|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020848|NCT01927744|Docetaxel|docetaxel|mesh-list
139020849|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139020850|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020851|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
139020852|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
139020853|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
139020854|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020855|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139020856|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020857|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
139020858|NCT01891981|Immunotoxins|immunotoxins|mesh-ancestor
139020859|NCT01891981|Immunoconjugates|immunoconjugates|mesh-ancestor
138635644|NCT02219659|Midazolam|midazolam|mesh-list
139020860|NCT01891981|Immunologic Factors|immunologic factors|mesh-ancestor
139020861|NCT01891981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020862|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020863|NCT01696734|Domperidone|domperidone|mesh-list
139020864|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
139020865|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
139020866|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020867|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020868|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139020869|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139020870|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
139020871|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020872|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020873|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139020874|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020875|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139020876|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020877|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020878|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139020879|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020881|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020882|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020883|NCT00575549|Dobutamine|dobutamine|mesh-list
139020884|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139020885|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
139020886|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
139020887|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020888|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020889|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139020890|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139020891|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139020892|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
139020893|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020894|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020895|NCT00575549|Protective Agents|protective agents|mesh-ancestor
139020897|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139020898|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
139020899|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020900|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020901|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139020902|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139020903|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
139020904|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020905|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020906|NCT00488072|Mirtazapine|mirtazapine|mesh-list
139020907|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
139020908|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139020909|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139020910|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
139020911|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
139020912|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139020913|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020914|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020915|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139020916|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139020917|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139020918|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139020919|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139020920|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139020921|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
139020922|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139020923|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139020925|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139020926|NCT00398034|Testosterone|testosterone|mesh-list
139020927|NCT00398034|Androgens|androgens|mesh-ancestor
139020928|NCT00398034|Hormones|hormones|mesh-ancestor
139020929|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139020930|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020931|NCT00329043|Sunitinib|sunitinib|mesh-list
139020932|NCT00329043|Leuprolide|leuprolide|mesh-list
139020933|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020934|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139020935|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139020936|NCT00329043|Growth Substances|growth substances|mesh-ancestor
139020937|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020938|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
139020939|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139020940|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020941|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020942|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139020943|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
139020944|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139020945|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139020946|NCT00254384|Cisplatin|cisplatin|mesh-list
139020947|NCT00254384|Docetaxel|docetaxel|mesh-list
139020948|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139020949|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020951|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
139020952|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
139020953|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020954|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139020955|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020956|NCT00253318|Dexamethasone|dexamethasone|mesh-list
139020957|NCT00253318|Docetaxel|docetaxel|mesh-list
139020958|NCT00253318|Everolimus|everolimus|mesh-list
139020959|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139020960|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
139020961|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
139020962|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139020963|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020964|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139020965|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
139020966|NCT00253318|Hormones|hormones|mesh-ancestor
139020967|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139020968|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139020969|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020970|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
139020971|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
139020972|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
139020973|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020974|NCT00253318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139020975|NCT00253318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139020976|NCT00253318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020977|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139020978|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
139020979|NCT00081874|Everolimus|everolimus|mesh-list
139020980|NCT00081874|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139020981|NCT00081874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139020982|NCT00081874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139020983|NCT00081874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020984|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138976831|NCT00864188|Provitamins|provitamins|mesh-ancestor
139020985|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
139020986|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139020987|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020988|NCT04119674|Temozolomide|temozolomide|mesh-list
139020989|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139020990|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
139020991|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139020992|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139020993|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
139020994|NCT04042155|Apixaban|apixaban|mesh-list
139020995|NCT04042155|Edoxaban|edoxaban|mesh-list
139020996|NCT04042155|Dabigatran|dabigatran|mesh-list
139020997|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139020998|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
139020999|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139021000|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
139021001|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771656|NCT01124604|Tapentadol|tapentadol|mesh-list
139021002|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021003|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
139021004|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
139021005|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021006|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021007|NCT04032847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139021008|NCT04032847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021009|NCT04031430|Antihypertensive Agents|antihypertensive agents|mesh-list
139021010|NCT03990571|Avelumab|avelumab|mesh-list
139021011|NCT03990571|Axitinib|axitinib|mesh-list
139021012|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139021013|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021014|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021015|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139021016|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542759|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139021017|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021018|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
138976881|NCT00864812|Hormones|hormones|mesh-ancestor
139021019|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021021|NCT03944434|Goserelin|goserelin|mesh-list
139021022|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139021023|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139021024|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139021025|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
139021026|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139021027|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021028|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139021029|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635757|NCT02962037|Melatonin|melatonin|mesh-list
139021030|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
139021031|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139021032|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
139021033|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139021034|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139021035|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021036|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021037|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139021038|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
139021039|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021040|NCT03905265|Moxidectin|moxidectin|mesh-list
139021041|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
139021042|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139021043|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139021044|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
139021045|NCT03901469|Talazoparib|talazoparib|mesh-list
139021046|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139021047|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021048|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021049|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021050|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
139021051|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021052|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021053|NCT03848845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139021054|NCT03848845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021055|NCT03807765|Nivolumab|nivolumab|mesh-list
139021056|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021057|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021058|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138542867|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139021059|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021060|NCT03781440|Lidocaine|lidocaine|mesh-list
139021061|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
139021062|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
139021063|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139021064|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021065|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
139021066|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021067|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139021068|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139021069|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139021070|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139021071|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021072|NCT03714815|Macitentan|macitentan|mesh-list
139021073|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
139021074|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139021075|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021076|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
139021077|NCT03712943|Nivolumab|nivolumab|mesh-list
139021078|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021079|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021080|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139021081|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021082|NCT03686488|Ramucirumab|ramucirumab|mesh-list
139021083|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021084|NCT03640312|Candesartan|candesartan|mesh-list
139021085|NCT03640312|Candesartan cilexetil|candesartan cilexetil|mesh-list
139021086|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139021087|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139021088|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139021089|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021090|NCT03625388|Dasatinib|dasatinib|mesh-list
139021091|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021092|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139021093|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021094|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021095|NCT03598309|Curcumin|curcumin|mesh-list
139021096|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138543032|NCT00190099|Dexamethasone|dexamethasone|mesh-list
139021097|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139021098|NCT03598309|Analgesics|analgesics|mesh-ancestor
139021099|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
139021100|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021101|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021102|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021103|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139021104|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021105|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021106|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021107|NCT03576417|Nivolumab|nivolumab|mesh-list
139021108|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138976984|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021109|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021110|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138635828|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
139021111|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021112|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
139021113|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
139021114|NCT03570827|Androgens|androgens|mesh-list
139021115|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139021116|NCT03570827|Hormones|hormones|mesh-ancestor
139021117|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021118|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021119|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
139021120|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021121|NCT03570827|Protective Agents|protective agents|mesh-ancestor
139021122|NCT03570827|Vitamins|vitamins|mesh-ancestor
139021123|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
139021124|NCT03570827|Estrogens|estrogens|mesh-ancestor
139021125|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139021126|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021127|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
139021128|NCT03543189|Nivolumab|nivolumab|mesh-list
139021129|NCT03543189|Androgens|androgens|mesh-list
139021130|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021131|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021132|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139021133|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021134|NCT03543189|Hormones|hormones|mesh-ancestor
139021135|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021136|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021137|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
139021138|NCT03404310|Astringents|astringents|mesh-ancestor
139021139|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021140|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
139021141|NCT03387553|Immunomodulating Agents|immunomodulating agents|mesh-list
139021142|NCT03387553|Immunologic Factors|immunologic factors|mesh-ancestor
139021143|NCT03387553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021145|NCT03367533|Analgesics|analgesics|mesh-ancestor
139021146|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
139021147|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021148|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021149|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139021150|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139021151|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
139021152|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
139021153|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139021154|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139021155|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139021156|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139021157|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021158|NCT03340896|Docetaxel|docetaxel|mesh-list
139021159|NCT03340896|Fluorouracil|fluorouracil|mesh-list
139021160|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021161|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
139021162|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
139021163|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
139021164|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021165|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
139021166|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139021167|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139021168|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
139021169|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021170|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
139021171|NCT03299088|Trametinib|trametinib|mesh-list
139021172|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021173|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021174|NCT03299088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139021175|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021176|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139021177|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021178|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
139021179|NCT03290079|Lenvatinib|lenvatinib|mesh-list
139021180|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138543369|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139021181|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021182|NCT03290079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139021183|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021184|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139021185|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021186|NCT03272464|Trametinib|trametinib|mesh-list
139021187|NCT03272464|Dabrafenib|dabrafenib|mesh-list
139021188|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021189|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139021190|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021191|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021192|NCT03263481|Secretin|secretin|mesh-list
138635889|NCT00273429|Timolol|timolol|mesh-list
139021193|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139021194|NCT03263481|Hormones|hormones|mesh-ancestor
139021195|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021196|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021197|NCT03177291|Pirfenidone|pirfenidone|mesh-list
139021198|NCT03177291|Paclitaxel|paclitaxel|mesh-list
139021199|NCT03177291|Carboplatin|carboplatin|mesh-list
139021200|NCT03177291|Pemetrexed|pemetrexed|mesh-list
139021201|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139021202|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021203|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
139021204|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
139021205|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
139021206|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021207|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021208|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139021209|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139021210|NCT03177291|Analgesics|analgesics|mesh-ancestor
139021211|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
139021212|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021213|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021214|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139021215|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138543428|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
139021216|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021217|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139021218|NCT03079011|Letrozole|letrozole|mesh-list
139021219|NCT03079011|Fulvestrant|fulvestrant|mesh-list
139021220|NCT03079011|Palbociclib|palbociclib|mesh-list
139021221|NCT03079011|Anastrozole|anastrozole|mesh-list
139021222|NCT03079011|Exemestane|exemestane|mesh-list
139021223|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139021224|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021225|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139021226|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021227|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021228|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139021229|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
139021230|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021231|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021232|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139021233|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139021234|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139021235|NCT03071406|Nivolumab|nivolumab|mesh-list
139021236|NCT03071406|Ipilimumab|ipilimumab|mesh-list
139021237|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021238|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021239|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139021240|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021241|NCT02866383|Nivolumab|nivolumab|mesh-list
139021242|NCT02866383|Ipilimumab|ipilimumab|mesh-list
139021243|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021244|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021245|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139021246|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021247|NCT02841215|Ivermectin|ivermectin|mesh-list
139021248|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139021249|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139021250|NCT02807571|Anesthetics|anesthetics|mesh-list
139021251|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139021252|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021253|NCT02793466|Durvalumab|durvalumab|mesh-list
139021254|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139021255|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021256|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021257|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
139021258|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021259|NCT02767557|Paclitaxel|paclitaxel|mesh-list
139021260|NCT02767557|Gemcitabine|gemcitabine|mesh-list
139021261|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139021262|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021263|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
139021264|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
139021265|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
139021266|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021267|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139021269|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
139021270|NCT02638090|Vorinostat|vorinostat|mesh-list
139021271|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021272|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021273|NCT02638090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139021274|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021275|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139021276|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021277|NCT02461368|Triamcinolone|triamcinolone|mesh-list
139021278|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139021279|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139021280|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139021281|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021283|NCT02461368|Hormones|hormones|mesh-ancestor
139021284|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021285|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021286|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139021287|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
139021288|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021289|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021290|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
139021291|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
139021292|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
139021293|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021294|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021295|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139021296|NCT02303678|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
139021297|NCT02303678|Immunoconjugates|immunoconjugates|mesh-ancestor
139021298|NCT02303678|Immunologic Factors|immunologic factors|mesh-ancestor
139021299|NCT02303678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021300|NCT02285140|Vancomycin|vancomycin|mesh-list
139021301|NCT02285140|Cefazolin|cefazolin|mesh-list
139021302|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139021303|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139021304|NCT02254278|Cisplatin|cisplatin|mesh-list
139021305|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021306|NCT02174549|Tirapazamine|tirapazamine|mesh-list
139021307|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021308|NCT02059499|Fluorouracil|fluorouracil|mesh-list
139021309|NCT02059499|Imiquimod|imiquimod|mesh-list
139021310|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
139021311|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021312|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139021313|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021314|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139021315|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
139021316|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021317|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139021318|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
139021319|NCT01607879|Androgens|androgens|mesh-list
139021320|NCT01607879|Hormones|hormones|mesh-ancestor
139021321|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021322|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021323|NCT01336933|Prednisone|prednisone|mesh-list
139021324|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
139021325|NCT01336933|Etoposide|etoposide|mesh-list
139021326|NCT01336933|Vincristine|vincristine|mesh-list
139021327|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
139021328|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139021329|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
139021330|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021331|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139021332|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139021333|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
139021334|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021335|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021336|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139021337|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021338|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
139021339|NCT01336933|Hormones|hormones|mesh-ancestor
139021340|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021341|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139021342|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139021343|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138543806|NCT00195364|Etanercept|etanercept|mesh-list
139021344|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139021345|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021347|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
139021348|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
139021349|NCT01107522|Temozolomide|temozolomide|mesh-list
139021350|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139021351|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
139021352|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021353|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021354|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
139021355|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139021356|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021357|NCT00352027|Prednisone|prednisone|mesh-list
139021358|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
139021359|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
139021360|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
139021361|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139021362|NCT00352027|Doxorubicin|doxorubicin|mesh-list
139021363|NCT00352027|Etoposide|etoposide|mesh-list
139021364|NCT00352027|Vincristine|vincristine|mesh-list
139021365|NCT00352027|Bleomycin|bleomycin|mesh-list
139021366|NCT00352027|Vinblastine|vinblastine|mesh-list
139021368|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
139021369|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021370|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139021371|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139021372|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
138543895|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
139021373|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021374|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021375|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139021376|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138772024|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
139021377|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139021378|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139021379|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021380|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021381|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
139021382|NCT00352027|Hormones|hormones|mesh-ancestor
139021383|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021384|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139021385|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139021386|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
139021387|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
139021388|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
139021389|NCT00262470|Indomethacin|indomethacin|mesh-list
139021390|NCT00262470|Octreotide|octreotide|mesh-list
139021391|NCT00262470|Propranolol|propranolol|mesh-list
139021392|NCT00262470|Clonidine|clonidine|mesh-list
139021393|NCT00262470|Mecamylamine|mecamylamine|mesh-list
139021394|NCT00262470|Acetazolamide|acetazolamide|mesh-list
139021395|NCT00262470|Isosorbide|isosorbide|mesh-list
139021396|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139021397|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139021398|NCT00262470|Midodrine|midodrine|mesh-list
139021399|NCT00262470|Memantine|memantine|mesh-list
139021400|NCT00262470|Entacapone|entacapone|mesh-list
139021401|NCT00262470|Melatonin|melatonin|mesh-list
139021402|NCT00262470|Modafinil|modafinil|mesh-list
139021403|NCT00262470|Sertraline|sertraline|mesh-list
139021404|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139021405|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
139021406|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021407|NCT00262470|Protective Agents|protective agents|mesh-ancestor
139021408|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021409|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139021410|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139021411|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138977310|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
139021414|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139021415|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139021416|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
139021417|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
139021418|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139021419|NCT00262470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139021420|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139021421|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139021422|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
139021423|NCT00262470|Analgesics|analgesics|mesh-ancestor
139021424|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
139021425|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021426|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
139021427|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
139021428|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139021429|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139021431|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139021432|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139021433|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
139021434|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139021435|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139021436|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139021437|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138544245|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
139021438|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021439|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139021440|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139021441|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139021442|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139021443|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139021444|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139021445|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139021446|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021447|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139021448|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
139021449|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
139021450|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138636017|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
139021451|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138544325|NCT00084708|Gefitinib|gefitinib|mesh-list
139021452|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021453|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
139021454|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139021455|NCT00262470|Diuretics|diuretics|mesh-ancestor
139021456|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
139021457|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
139021458|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139021459|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139021460|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139021461|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139021462|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
139021463|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
139021464|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
139021465|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139021466|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
139021467|NCT00440271|Ritonavir|ritonavir|mesh-list
139021468|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
139021469|NCT00440271|Maraviroc|maraviroc|mesh-list
139021470|NCT00440271|Tipranavir|tipranavir|mesh-list
139021471|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
139021472|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139021473|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139021474|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139021475|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
139021476|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021477|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021478|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139021479|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139021480|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
139021481|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139021482|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139021483|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139021484|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139021485|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139021486|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139021487|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139021488|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139021489|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139021492|NCT00346216|Naproxen|naproxen|mesh-list
139021493|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139021494|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139021495|NCT00346216|Analgesics|analgesics|mesh-ancestor
139021496|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
139021497|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021498|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021499|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021500|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139021501|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139021502|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021503|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021504|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138636041|NCT00244127|Vincristine|vincristine|mesh-list
139021505|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
139021506|NCT01051648|Triamcinolone|triamcinolone|mesh-list
139021507|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139021508|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139021509|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139021510|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021511|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
139021513|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021514|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021515|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139021516|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
139021517|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021518|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021519|NCT00429273|Guanfacine|guanfacine|mesh-list
139021520|NCT00429273|Methylphenidate|methylphenidate|mesh-list
139021521|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
139021522|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139021523|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021524|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139021525|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138977511|NCT00994383|Morphine|morphine|mesh-list
139021526|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139021527|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021528|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
139021529|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139021530|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139021531|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139021532|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139021533|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139021534|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
139021536|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139021537|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139021538|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139021539|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021540|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021541|NCT01324960|Aldesleukin|aldesleukin|mesh-list
139021542|NCT01324960|Azacitidine|azacitidine|mesh-list
139021543|NCT01324960|Histamine|histamine|mesh-list
139021544|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139021545|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
139021546|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021547|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021548|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021549|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021550|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139021551|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139021552|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
139021553|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139021554|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
138977536|NCT00532935|Metformin|metformin|mesh-list
139021555|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
139021556|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139021557|NCT00417885|Sunitinib|sunitinib|mesh-list
139021558|NCT00417885|Exemestane|exemestane|mesh-list
139021559|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021560|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139021561|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139021562|NCT00417885|Growth Substances|growth substances|mesh-ancestor
139021563|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021564|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
139021565|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139021566|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021567|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021568|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139021569|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139021570|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139021571|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
139021572|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021573|NCT01036893|Prucalopride|prucalopride|mesh-list
139021574|NCT01036893|Laxatives|laxatives|mesh-ancestor
139021575|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139021576|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
139021577|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139021578|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
139021579|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139021580|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021581|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021582|NCT00525044|Ambroxol|ambroxol|mesh-list
139021583|NCT00525044|Expectorants|expectorants|mesh-ancestor
139021584|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
139021585|NCT00355342|Fluticasone|fluticasone|mesh-list
139021586|NCT00355342|Xhance|xhance|mesh-list
139021587|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139021588|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021589|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139021590|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
139021591|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021592|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021593|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139021594|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
139021595|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
139021596|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139021597|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139021598|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139021599|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139021600|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
139021601|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139021602|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021603|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139021604|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
139021605|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139021606|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
139021607|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
139021608|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139021609|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139021610|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139021611|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021612|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021613|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139021614|NCT03989830|Endostatins|endostatins|mesh-list
139021615|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139021616|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139021617|NCT03989830|Growth Substances|growth substances|mesh-ancestor
139021618|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021619|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
139021620|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021621|NCT02533648|Allopurinol|allopurinol|mesh-list
139021622|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
139021623|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021624|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021625|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
139021626|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139021627|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139021628|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
139021629|NCT02533648|Protective Agents|protective agents|mesh-ancestor
139021630|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021632|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139021633|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139021634|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139021635|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139021636|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
139021637|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021638|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139021639|NCT01056874|Maraviroc|maraviroc|mesh-list
139021640|NCT01056874|Digoxin|digoxin|mesh-list
139021641|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139021642|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139021643|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021644|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021645|NCT01056874|Protective Agents|protective agents|mesh-ancestor
139021646|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021647|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139021648|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139021649|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139021650|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139021651|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
139021652|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139021653|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139021654|NCT00355030|Leuprolide|leuprolide|mesh-list
139021655|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139021656|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
139021657|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139021658|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021659|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139021660|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021661|NCT01057030|BMS 708163|bms 708163|mesh-list
139021662|NCT01057030|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139021663|NCT01057030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021664|NCT01057030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021665|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
139021666|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
139021667|NCT01057186|Sevelamer|sevelamer|mesh-list
139021668|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
139021669|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
139021670|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544790|NCT00201682|Analgesics|analgesics|mesh-ancestor
139021671|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139021672|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021673|NCT01057186|Vitamins|vitamins|mesh-ancestor
139021674|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
139021675|NCT01057264|Paclitaxel|paclitaxel|mesh-list
139021676|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139021677|NCT01057264|Bevacizumab|bevacizumab|mesh-list
139021678|NCT01057264|Gemcitabine|gemcitabine|mesh-list
139021679|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139021680|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021681|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
139021682|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
139021683|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
139021684|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021685|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021686|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139021687|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139021688|NCT01057264|Growth Substances|growth substances|mesh-ancestor
139021689|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021690|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
139021691|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139021692|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
139021694|NCT03991312|Rifampin|rifampin|mesh-list
139021695|NCT03991312|Mitapivat|mitapivat|mesh-list
139021696|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
139021697|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139021698|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139021699|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139021700|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021701|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021702|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139021703|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
138544818|NCT00061451|Gemcitabine|gemcitabine|mesh-list
138544819|NCT00061451|Pemetrexed|pemetrexed|mesh-list
139021704|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021705|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021706|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139021707|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139021708|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
139021709|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139021710|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
139021711|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139021712|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139021713|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139021714|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139021715|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139021716|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139021717|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139021718|NCT03991312|Enzyme Activators|enzyme activators|mesh-ancestor
139021719|NCT01057342|Paclitaxel|paclitaxel|mesh-list
139021720|NCT01057342|Carboplatin|carboplatin|mesh-list
139021721|NCT01057342|Vadimezan|vadimezan|mesh-list
139021722|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139021723|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021724|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
139021725|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
139021726|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
139021727|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021729|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139021730|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139021731|NCT01057498|Analgesics|analgesics|mesh-ancestor
139021732|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
139021733|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021734|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021735|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021737|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139021738|NCT03742258|Prednisone|prednisone|mesh-list
139021739|NCT03742258|Cortisone|cortisone|mesh-list
139021740|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
139021741|NCT03742258|Rituximab|rituximab|mesh-list
139021742|NCT03742258|Doxorubicin|doxorubicin|mesh-list
139021743|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139021744|NCT03742258|Vincristine|vincristine|mesh-list
139021745|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139021746|NCT03742258|Antibodies|antibodies|mesh-list
139021747|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
139021748|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139021749|NCT03742258|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139021750|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139021751|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
139021752|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021753|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139021754|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139021755|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
138544909|NCT00048828|Clozapine|clozapine|mesh-list
139021756|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021757|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021758|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139021759|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139021760|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139021761|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139021762|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021763|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021764|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
139059133|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021766|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021767|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139021768|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139021769|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
139021770|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
139021771|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
139021772|NCT03742258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139021773|NCT00354172|Cyclosporine|cyclosporine|mesh-list
139021774|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
139021775|NCT00354172|Aldesleukin|aldesleukin|mesh-list
139021776|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
139021777|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139021778|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139021779|NCT00354172|Prednisolone|prednisolone|mesh-list
139021780|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
139021781|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
139021782|NCT00354172|Fludarabine|fludarabine|mesh-list
139021783|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
139021784|NCT00354172|Interleukin-2|interleukin-2|mesh-list
139021785|NCT00354172|Cyclosporins|cyclosporins|mesh-list
139021786|NCT00354172|Lenograstim|lenograstim|mesh-list
139021787|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139021788|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
139021789|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139021790|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
139021791|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021793|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139021794|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
139021795|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021796|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021797|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139021798|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139021799|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
139021800|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139021801|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021802|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
139021803|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139021804|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
139021805|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139021806|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139021807|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139021808|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
139021809|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139021810|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021811|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
139021812|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
139021813|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021814|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139021815|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
139021816|NCT00354172|Hormones|hormones|mesh-ancestor
139021817|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021818|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139021819|NCT00354172|Protective Agents|protective agents|mesh-ancestor
139021820|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139021821|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139021822|NCT00354172|Analgesics|analgesics|mesh-ancestor
139021823|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
139021824|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139021825|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139021826|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
139021827|NCT00353704|Pregabalin|pregabalin|mesh-list
139021828|NCT00353704|Morphine|morphine|mesh-list
138772480|NCT02848768|Sunitinib|sunitinib|mesh-list
139021829|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139021830|NCT00353704|Narcotics|narcotics|mesh-ancestor
139021831|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139021832|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021833|NCT00353704|Analgesics|analgesics|mesh-ancestor
139021834|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
139021835|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021836|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
139021837|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139021838|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139021839|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021840|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139021841|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139021842|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139021843|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139021844|NCT03742180|Ketorolac|ketorolac|mesh-list
139021845|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
139021846|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139021847|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139021848|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021849|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139021850|NCT03742180|Analgesics|analgesics|mesh-ancestor
139021851|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
139021852|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021853|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139021854|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139021855|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139021856|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
139021857|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139021858|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021859|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138545048|NCT00222820|Escitalopram|escitalopram|mesh-list
139021860|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021861|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139021862|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139021863|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021865|NCT00512252|Plerixafor|plerixafor|mesh-list
139021866|NCT00512252|Etoposide|etoposide|mesh-list
139021867|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
139021868|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139021869|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021870|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139021871|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139021872|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021873|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021874|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139021875|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
139021876|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
139021877|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139021878|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139021879|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
139021880|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021881|NCT00512252|Analgesics|analgesics|mesh-ancestor
139021882|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
139021883|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021884|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139021885|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139021886|NCT00516386|Mecasermin|mecasermin|mesh-list
139021887|NCT00516386|Growth Substances|growth substances|mesh-ancestor
139021888|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021889|NCT00512096|Paclitaxel|paclitaxel|mesh-list
139021890|NCT00512096|Cisplatin|cisplatin|mesh-list
139021891|NCT00512096|Ifosfamide|ifosfamide|mesh-list
139021892|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138545080|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021893|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021894|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
139021895|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
139021896|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
139021897|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021898|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139021899|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
139021900|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
139021901|NCT04462796|Cathartics|cathartics|mesh-ancestor
139021902|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139021903|NCT00524030|Pregabalin|pregabalin|mesh-list
139021904|NCT00524030|Analgesics|analgesics|mesh-ancestor
139021905|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
139021906|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021907|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021909|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139021910|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139021911|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021912|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139021913|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139021914|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139021915|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139021916|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139021917|NCT00523718|Riluzole|riluzole|mesh-list
139021918|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
139021919|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139021920|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139021921|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139021922|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021923|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021924|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139021925|NCT00523718|Protective Agents|protective agents|mesh-ancestor
139021926|NCT00523640|Bevacizumab|bevacizumab|mesh-list
139021927|NCT00523640|Gemcitabine|gemcitabine|mesh-list
139021928|NCT00523640|Capecitabine|capecitabine|mesh-list
139021929|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139021930|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021931|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139021932|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139021933|NCT00523640|Growth Substances|growth substances|mesh-ancestor
139021934|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021935|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
139021936|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139021937|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
139021938|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021939|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139021940|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
139021941|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021943|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139021944|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021945|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139021946|NCT00516074|Incretins|incretins|mesh-ancestor
139021947|NCT00516074|Hormones|hormones|mesh-ancestor
139021948|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021949|NCT01057654|Pravastatin|pravastatin|mesh-list
139021950|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139021951|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139021952|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
139021953|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021954|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139021955|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139021956|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021957|NCT00515294|Caffeine|caffeine|mesh-list
139021958|NCT00515294|Methamphetamine|methamphetamine|mesh-list
139021959|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139021960|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021961|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139021962|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139021963|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139021964|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139021965|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139021966|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
139021967|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139021968|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
139021969|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
139021970|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021971|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
139021972|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
138545147|NCT00085449|Melphalan|melphalan|mesh-list
139021973|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139021974|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139021975|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139021976|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139021977|NCT00345046|Prednisolone|prednisolone|mesh-list
139021978|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139021979|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
139021980|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139021982|NCT00345046|Prednisone|prednisone|mesh-list
139021983|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139021984|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
139021985|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139021986|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
139021987|NCT00345046|Hormones|hormones|mesh-ancestor
139021988|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139021989|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139021990|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139021991|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139021992|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
139021993|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
139021994|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139021995|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139021996|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139021997|NCT00345046|Protective Agents|protective agents|mesh-ancestor
139021998|NCT00515216|Leucovorin|leucovorin|mesh-list
139021999|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
139022000|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
139022001|NCT00515216|Fluorouracil|fluorouracil|mesh-list
139022002|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
139022003|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
139022004|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
139022005|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022006|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139022007|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022008|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139022009|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
139022010|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022011|NCT00515216|Antidotes|antidotes|mesh-ancestor
139022012|NCT00515216|Protective Agents|protective agents|mesh-ancestor
139022013|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
139022014|NCT00515216|Vitamins|vitamins|mesh-ancestor
139022015|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
139022016|NCT00440193|Enoxaparin|enoxaparin|mesh-list
139022017|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
139022018|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139022019|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
139022020|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139022021|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
139022022|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022023|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022024|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
139022025|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139022026|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139022027|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
139022028|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139022029|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022031|NCT01033305|Cyclosporins|cyclosporins|mesh-list
139022032|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022033|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022034|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139022035|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
139022036|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022037|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
139022038|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139022039|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
139022040|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139022041|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139022043|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
139022044|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022045|NCT00440115|Bupropion|bupropion|mesh-list
139022046|NCT00440115|Nicotine|nicotine|mesh-list
139022047|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139022048|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
138545220|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139022049|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022050|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022051|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139022052|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139022053|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
139022054|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022055|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022056|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139022057|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
139022058|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139022059|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139022060|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139022061|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139022063|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139022064|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139022065|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022066|NCT01033461|Calcium|calcium|mesh-list
139022067|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139022068|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022069|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
139022070|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
139022071|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138978299|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
139022072|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139022073|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
139022074|NCT00416715|Vitamin D|vitamin d|mesh-list
139022075|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
139022076|NCT00416715|Letrozole|letrozole|mesh-list
139022077|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
139022078|NCT00416715|Citric Acid|citric acid|mesh-list
139022079|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
139022080|NCT00416715|Calcium|calcium|mesh-list
139022081|NCT00416715|Vitamins|vitamins|mesh-ancestor
139022082|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
139022083|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022084|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139022085|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139022086|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
139022087|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139022088|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
139022089|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
139022090|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022091|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022092|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139022093|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139022094|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022095|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139022096|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
139022097|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139022099|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139022100|NCT01037517|Plerixafor|plerixafor|mesh-list
139022101|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139022102|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139022103|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
139022104|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139022105|NCT00406029|Levodopa|levodopa|mesh-list
139022106|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139022107|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139022108|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
139022109|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022110|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022111|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022112|NCT00514514|Cyclosporine|cyclosporine|mesh-list
139022113|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
139022114|NCT00514514|Everolimus|everolimus|mesh-list
139022115|NCT00514514|Cyclosporins|cyclosporins|mesh-list
139022116|NCT00514514|Basiliximab|basiliximab|mesh-list
139022117|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022118|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138978333|NCT00996723|Dasatinib|dasatinib|mesh-list
139022119|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139022120|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
139022121|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022122|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
139022123|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139022124|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
139022125|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139022126|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139022127|NCT00514514|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139022128|NCT00514514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139022129|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022130|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139022131|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139022132|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
139022133|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139022134|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139022135|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
139022136|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022137|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
139022138|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139022139|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
139022140|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139022141|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
139022142|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022143|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022144|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
139022146|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139022147|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
139022148|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022149|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
139022150|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139022151|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
139022152|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022153|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022154|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139022155|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
139022156|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
139022157|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139022158|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
139022159|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022160|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022161|NCT01010646|Ribavirin|ribavirin|mesh-list
139022162|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
139022163|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
139022164|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
139022165|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
139022166|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022167|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
139022168|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139022169|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
139022170|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022171|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022172|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
139022173|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139022174|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022175|NCT00515112|Testosterone|testosterone|mesh-list
139022176|NCT00515112|Androgens|androgens|mesh-ancestor
139022177|NCT00515112|Hormones|hormones|mesh-ancestor
139022178|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139022179|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022180|NCT03742557|Ketamine|ketamine|mesh-list
139022181|NCT03742557|Analgesics|analgesics|mesh-ancestor
139022182|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
139022183|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022184|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022185|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139022186|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139022187|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
139022189|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139022190|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139022191|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139022192|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022193|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022194|NCT01324089|Resveratrol|resveratrol|mesh-list
139022195|NCT01324089|Piperine|piperine|mesh-list
139022196|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
139022197|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022198|NCT01324089|Protective Agents|protective agents|mesh-ancestor
139022199|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022200|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022201|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139022202|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139022203|NCT00404547|Ciclesonide|ciclesonide|mesh-list
139022204|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
139022205|NCT00404547|Hormones|hormones|mesh-ancestor
139022206|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139022207|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022208|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139022209|NCT00515034|Imipenem|imipenem|mesh-list
139022210|NCT00515034|Doripenem|doripenem|mesh-list
139022211|NCT00515034|Cilastatin|cilastatin|mesh-list
139022212|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139022213|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139022214|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
139022215|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022216|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022218|NCT00404235|Carboplatin|carboplatin|mesh-list
139022219|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139022220|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139022221|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022222|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
139022223|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
139022224|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
139022225|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022226|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139022227|NCT00509262|Glipizide|glipizide|mesh-list
139022228|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139022229|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022231|NCT00509262|Hormones|hormones|mesh-ancestor
139022232|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139022233|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139022234|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
139022235|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022236|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022237|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
139022238|NCT00509106|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
139022239|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139022240|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139022241|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139022242|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139022243|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139022244|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139022245|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545446|NCT00224809|Aspirin|aspirin|mesh-list
139022246|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
139022247|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022248|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022249|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
139022250|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139022251|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
139022252|NCT00344968|Hormones|hormones|mesh-ancestor
138978493|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022253|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139022254|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022255|NCT00509028|Budesonide|budesonide|mesh-list
139022256|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139022257|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139022258|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
139022259|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022260|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022261|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139022262|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
139022263|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
139022264|NCT00509028|Hormones|hormones|mesh-ancestor
139022265|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139022266|NCT00352846|Vitamin D|vitamin d|mesh-list
139022267|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
139022268|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
139022269|NCT00352846|Calcium|calcium|mesh-list
139022270|NCT00352846|Vitamins|vitamins|mesh-ancestor
139022271|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
139022272|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022273|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139022274|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139022275|NCT00352846|Antacids|antacids|mesh-ancestor
139022276|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636389|NCT00245609|Pregabalin|pregabalin|mesh-list
139022277|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139022278|NCT00508872|Leucovorin|leucovorin|mesh-list
139022279|NCT00508872|Bevacizumab|bevacizumab|mesh-list
139022280|NCT00508872|Fluorouracil|fluorouracil|mesh-list
139022281|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
139022282|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139022283|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022284|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139022285|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139022286|NCT00508872|Growth Substances|growth substances|mesh-ancestor
139022287|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221821|NCT01365611|Xhance|xhance|mesh-list
139022288|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
139022289|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
139022290|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022291|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139022292|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139022293|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
139022294|NCT00508872|Antidotes|antidotes|mesh-ancestor
139022295|NCT00508872|Protective Agents|protective agents|mesh-ancestor
139022296|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
139022297|NCT00508872|Vitamins|vitamins|mesh-ancestor
139022298|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
139022299|NCT00508482|Lactulose|lactulose|mesh-list
139022300|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139022301|NCT00344032|Vaccines|vaccines|mesh-list
139022302|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
139022303|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022304|NCT00607373|Mipomersen|mipomersen|mesh-list
139022305|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139022306|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139022307|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
139022308|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022309|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139022310|NCT00508404|Panitumumab|panitumumab|mesh-list
139022311|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139022312|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022313|NCT00352690|Paclitaxel|paclitaxel|mesh-list
139022314|NCT00352690|Carboplatin|carboplatin|mesh-list
139022315|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
139022316|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139022317|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022318|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
139022319|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
139022320|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
139022321|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022322|NCT00895505|Warfarin|warfarin|mesh-list
139022323|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
139022324|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
139022325|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
139022326|NCT03249012|Calcitriol|calcitriol|mesh-list
139022327|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
139022328|NCT03249012|Calcium|calcium|mesh-list
139022329|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139022330|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545534|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022331|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139022332|NCT03249012|Antacids|antacids|mesh-ancestor
139022333|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022334|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139022335|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139022336|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139022337|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139022338|NCT03249012|Vitamins|vitamins|mesh-ancestor
139022339|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
139022340|NCT00893477|Rituximab|rituximab|mesh-list
139022341|NCT00893477|Sargramostim|sargramostim|mesh-list
139022342|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139022343|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022344|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
139022345|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022346|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139022347|NCT00609245|Valproic Acid|valproic acid|mesh-list
139022348|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
139022349|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022350|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022351|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
139022352|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022353|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022354|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
139022355|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139022356|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139022357|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139022358|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
139022359|NCT01010802|Hematinics|hematinics|mesh-ancestor
139022360|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
139022361|NCT04036253|Hematinics|hematinics|mesh-ancestor
139022362|NCT00893555|Voriconazole|voriconazole|mesh-list
139022363|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
139022364|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139022365|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139022366|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139022367|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022368|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022369|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139022370|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
139022371|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139022372|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022373|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139022375|NCT02541071|Yohimbine|yohimbine|mesh-list
139022376|NCT02541071|Analgesics|analgesics|mesh-ancestor
139022377|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
139022378|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022379|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022380|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139022381|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
139022382|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
139022383|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138729500|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
139022384|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139022385|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139022386|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
139022387|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022388|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022389|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
139022390|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139022391|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139022392|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139022393|NCT02541071|Urological Agents|urological agents|mesh-ancestor
139022394|NCT01058824|Lincomycin|lincomycin|mesh-list
139022395|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139022396|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139022397|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139022398|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022399|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022400|NCT00895739|Cyclosporine|cyclosporine|mesh-list
139022401|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
139022402|NCT00895739|Cyclosporins|cyclosporins|mesh-list
139022403|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022404|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022405|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139022406|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
139022407|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022408|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
139022409|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139022410|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
139022411|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138545605|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
139022412|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139022413|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139022414|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022415|NCT01058902|Aspirin|aspirin|mesh-list
139022416|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139022417|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139022418|NCT01058902|Analgesics|analgesics|mesh-ancestor
139022419|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
139022420|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022421|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022422|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139022423|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139022424|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139022425|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138636464|NCT00284193|Thrombin|thrombin|mesh-list
139022426|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022427|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139022428|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139022429|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022431|NCT00609167|Dexamethasone|dexamethasone|mesh-list
139022432|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
139022433|NCT00609167|Bortezomib|bortezomib|mesh-list
139022434|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139022435|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
139022436|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022437|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139022438|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139022439|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
139022440|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022441|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022442|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139022443|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139022444|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
139022445|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
139022446|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022447|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139022448|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
138978730|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139022450|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138545664|NCT00225589|Calcium|calcium|mesh-list
139022451|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139022452|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
139022453|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
139022454|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
139022455|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139022456|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
139022457|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
139022458|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022459|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022460|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022461|NCT00606281|Aripiprazole|aripiprazole|mesh-list
139022462|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
139022463|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138636491|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
139022464|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139022465|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139022466|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139022467|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022468|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
139022469|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
139022470|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022471|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022472|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139022473|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139022474|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
139022475|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139022476|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139022477|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139022478|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139022480|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139022481|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022482|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
139022483|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
139022484|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
139022485|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022486|NCT00891605|Paclitaxel|paclitaxel|mesh-list
139022487|NCT00891605|Navitoclax|navitoclax|mesh-list
139022488|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139022489|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022490|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
139022491|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
139022492|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
138636530|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
139022493|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022494|NCT00893711|Vitamin D|vitamin d|mesh-list
139022495|NCT00893711|Vitamins|vitamins|mesh-ancestor
139022496|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
139022497|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022498|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139022499|NCT00514020|Leucovorin|leucovorin|mesh-list
139022500|NCT00514020|Fluorouracil|fluorouracil|mesh-list
139022501|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
139022502|NCT00514020|Calcium|calcium|mesh-list
139022503|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
139022504|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139022505|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022506|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
139022507|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022508|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139022509|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022510|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139022511|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
139022512|NCT00514020|Antidotes|antidotes|mesh-ancestor
139022513|NCT00514020|Protective Agents|protective agents|mesh-ancestor
139022514|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
139022515|NCT00514020|Vitamins|vitamins|mesh-ancestor
139022516|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
139022517|NCT03560531|Palbociclib|palbociclib|mesh-list
139022518|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022519|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139022520|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022521|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022522|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
139022523|NCT00896285|Analgesics|analgesics|mesh-list
139022524|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
139022525|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
139022526|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022527|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022528|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139022529|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139022530|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139022531|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139022532|NCT00896285|Narcotics|narcotics|mesh-ancestor
139022533|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139022534|NCT00891761|Dexamethasone|dexamethasone|mesh-list
139022535|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
139022536|NCT00891761|Ondansetron|ondansetron|mesh-list
139022537|NCT00891761|Casopitant|casopitant|mesh-list
139022538|NCT00891761|BB 1101|bb 1101|mesh-list
139022539|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139022540|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
139022541|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
139022542|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022543|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022544|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139022545|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
139022546|NCT00891761|Hormones|hormones|mesh-ancestor
139022547|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139022548|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139022549|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022550|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
139022551|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022552|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022553|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
139022554|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
139022555|NCT00891761|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139022556|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139022557|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
139022558|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022559|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139022560|NCT01012830|Huperzine A|huperzine a|mesh-list
139022561|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139022562|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022563|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022564|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
139022565|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022566|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022567|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139022568|NCT01012830|Protective Agents|protective agents|mesh-ancestor
139022569|NCT00513474|Cyclosporine|cyclosporine|mesh-list
139022570|NCT00513474|Sirolimus|sirolimus|mesh-list
139022571|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
139022572|NCT00513474|Busulfan|busulfan|mesh-list
139022573|NCT00513474|Methotrexate|methotrexate|mesh-list
139022574|NCT00513474|Fludarabine|fludarabine|mesh-list
139022575|NCT00513474|Etoposide|etoposide|mesh-list
139022576|NCT00513474|Allopurinol|allopurinol|mesh-list
139022577|NCT00513474|Rasburicase|rasburicase|mesh-list
139022578|NCT00513474|Tacrolimus|tacrolimus|mesh-list
139022579|NCT00513474|Cyclosporins|cyclosporins|mesh-list
139022580|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139022581|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
139022582|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022583|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138978903|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022584|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139022585|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
139022586|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022587|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022588|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138773226|NCT00794794|Cetirizine|cetirizine|mesh-list
139022589|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139022590|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
139022591|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139022592|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139022594|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
139022595|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022596|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138545800|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
139022597|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139022598|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139022599|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139022600|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139022601|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139022602|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
139022603|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139022604|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139022605|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139022606|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
139022607|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139022608|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
139022609|NCT00513474|Protective Agents|protective agents|mesh-ancestor
139022610|NCT01010958|Valproic Acid|valproic acid|mesh-list
139022611|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
139022612|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022613|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022614|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
139022615|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022616|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022617|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
139022618|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139022619|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139022620|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139022622|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
139022623|NCT00896519|Rituximab|rituximab|mesh-list
139022624|NCT00896519|Doxorubicin|doxorubicin|mesh-list
139022625|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139022626|NCT00896519|Vincristine|vincristine|mesh-list
139022627|NCT00896519|Sargramostim|sargramostim|mesh-list
138545827|NCT00226408|Interferons|interferons|mesh-list
139022629|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
139022630|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022631|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139022632|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139022633|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
139022634|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022635|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022636|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139022637|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139022638|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139022639|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139022640|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139022641|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022642|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139022643|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
139022644|NCT00896519|Hormones|hormones|mesh-ancestor
139022645|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138978991|NCT03742713|Docetaxel|docetaxel|mesh-list
139022646|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139022647|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139022648|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
139022649|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
139022650|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
139022651|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139022652|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139022653|NCT00505752|Hormones|hormones|mesh-ancestor
139022654|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139022655|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022656|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139022657|NCT01011036|Clonazepam|clonazepam|mesh-list
139022658|NCT01011036|Clobazam|clobazam|mesh-list
139022659|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139022660|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139022661|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139022662|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
139022663|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022664|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773300|NCT00690898|Lanreotide|lanreotide|mesh-list
138545874|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
139022665|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022666|NCT01011036|Urological Agents|urological agents|mesh-ancestor
139022667|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
139022668|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
139022669|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
139022670|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139022671|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139022672|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139022673|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139022674|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139022675|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
139022676|NCT03601637|Ivacaftor|ivacaftor|mesh-list
139022677|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
139022678|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139022679|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022680|NCT00894023|Abciximab|abciximab|mesh-list
139022681|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
139022682|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139022683|NCT00892073|Metformin|metformin|mesh-list
139022684|NCT00892073|Diazoxide|diazoxide|mesh-list
139022685|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139022686|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022687|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139022688|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
139022689|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
139022690|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
139022691|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139022692|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022693|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022694|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022696|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139022697|NCT02541227|Protective Agents|protective agents|mesh-ancestor
139022698|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022699|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
139022700|NCT00896987|Lamotrigine|lamotrigine|mesh-list
139022701|NCT00896987|Carbamazepine|carbamazepine|mesh-list
139022702|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
139022703|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139022704|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139022705|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022706|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139022707|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022708|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139022709|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139022710|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139022711|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138545910|NCT00399243|Sumatriptan|sumatriptan|mesh-list
139022712|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139022713|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
139022714|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139022715|NCT00896987|Analgesics|analgesics|mesh-ancestor
139022716|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
139022717|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022718|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139022719|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139022720|NCT00897065|Antibodies|antibodies|mesh-list
139022721|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
139022722|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022723|NCT00343252|Teriparatide|teriparatide|mesh-list
139022724|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
139022725|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
139022726|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139022727|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022728|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139022729|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139022730|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139022731|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022732|NCT00892229|Misoprostol|misoprostol|mesh-list
139022733|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139022734|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
139022735|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139022736|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022737|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139022738|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139022739|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
139022740|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139022741|NCT00897221|Deferiprone|deferiprone|mesh-list
139022742|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139022743|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
139022744|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
139022745|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022746|NCT00892307|Adenosine|adenosine|mesh-list
139022747|NCT00892307|Analgesics|analgesics|mesh-ancestor
139022748|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
139022749|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022750|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022751|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139022752|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
139022753|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139022754|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
139022755|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
139022756|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022757|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022759|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
139022760|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022761|NCT00897377|Temozolomide|temozolomide|mesh-list
139022762|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139022763|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
139022764|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022765|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022766|NCT00894569|Paclitaxel|paclitaxel|mesh-list
139022767|NCT00894569|Carboplatin|carboplatin|mesh-list
139022768|NCT00894569|Cetuximab|cetuximab|mesh-list
139022769|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139022770|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022771|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
139022772|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
139022773|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
139022774|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022775|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139022776|NCT00337168|Cytarabine|cytarabine|mesh-list
139022777|NCT00337168|Clofarabine|clofarabine|mesh-list
139022778|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139022779|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
139022780|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022781|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022782|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
139022783|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139022784|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139022785|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
139022786|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022787|NCT00892385|Temozolomide|temozolomide|mesh-list
139022788|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139022789|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
139022790|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022791|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022792|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139022793|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
139022794|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139022795|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139022796|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139022797|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139022798|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022799|NCT01011114|Cinacalcet|cinacalcet|mesh-list
139022800|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139022801|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022802|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139022803|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
138545959|NCT00095901|Capecitabine|capecitabine|mesh-list
139022804|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139022805|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
139022806|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
139022807|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139022808|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139022809|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
139022810|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022811|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
139022812|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
139022813|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139022814|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022815|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022816|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
139022817|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139022818|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139022819|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022820|NCT03063762|Bevacizumab|bevacizumab|mesh-list
139022821|NCT03063762|Atezolizumab|atezolizumab|mesh-list
139022822|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139022823|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022824|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139022825|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139022826|NCT03063762|Growth Substances|growth substances|mesh-ancestor
139022827|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022828|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
139022829|NCT03063762|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139059134|NCT01581866|Ziprasidone|ziprasidone|mesh-list
139022830|NCT03063762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022831|NCT05278637|Aspirin|aspirin|mesh-list
139022832|NCT05278637|Ticagrelor|ticagrelor|mesh-list
139022833|NCT05278637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139022834|NCT05278637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139022835|NCT05278637|Analgesics|analgesics|mesh-ancestor
139022836|NCT05278637|Sensory System Agents|sensory system agents|mesh-ancestor
139022837|NCT05278637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022838|NCT05278637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022839|NCT05278637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139022840|NCT05278637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139022841|NCT05278637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139022842|NCT05278637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139022843|NCT05278637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022844|NCT05278637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139022845|NCT05278637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139022846|NCT05278637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022847|NCT05278637|Antipyretics|antipyretics|mesh-ancestor
139022848|NCT05278637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139022849|NCT05278637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139022850|NCT05278637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139022851|NCT05278637|Purinergic Agents|purinergic agents|mesh-ancestor
139022852|NCT05278637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022853|NCT04017377|Paclitaxel|paclitaxel|mesh-list
139022854|NCT04017377|Cisplatin|cisplatin|mesh-list
139022855|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139022856|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022857|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
139022858|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
139022859|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
139022860|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022861|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
139022863|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022864|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139022865|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139022866|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139022867|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022869|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
139022870|NCT02539745|Vitamins|vitamins|mesh-ancestor
139022871|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
138636688|NCT00247130|Omeprazole|omeprazole|mesh-list
139022872|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022873|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139022874|NCT00894959|Heparin|heparin|mesh-list
139022875|NCT00894959|Calcium heparin|calcium heparin|mesh-list
139022876|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
139022877|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139022878|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139022879|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022880|NCT00895115|Vitamin E|vitamin e|mesh-list
139022881|NCT00895115|Vitamins|vitamins|mesh-ancestor
139022882|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
139022883|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022885|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022886|NCT00895115|Protective Agents|protective agents|mesh-ancestor
139022887|NCT00901745|Norepinephrine|norepinephrine|mesh-list
139022888|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
139022889|NCT00901745|Giapreza|giapreza|mesh-list
139022890|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
139022891|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139022892|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139022893|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
139022894|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022895|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022896|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022897|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
139022898|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
139022899|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022900|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139022901|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139022903|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022904|NCT02540837|Bupivacaine|bupivacaine|mesh-list
139022905|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
139022906|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
139022907|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139022908|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022909|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
138546074|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139022910|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022912|NCT00901823|Choline|choline|mesh-list
139022913|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
138979608|NCT01020292|Nelfinavir|nelfinavir|mesh-list
139022914|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139022915|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
139022916|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022917|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139022918|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139022919|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
139022920|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138636719|NCT00247247|Entacapone|entacapone|mesh-list
139022921|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
139022922|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139022923|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
139022924|NCT00902057|Coagulants|coagulants|mesh-ancestor
139022925|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139022926|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
139022927|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022928|NCT00902135|Interferons|interferons|mesh-list
139022929|NCT00902135|Interferon-beta|interferon-beta|mesh-list
139022930|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
139022931|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022932|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
139022933|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139022934|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
139022935|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022936|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139022937|NCT02540369|Aflibercept|aflibercept|mesh-list
139022938|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139022939|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139022940|NCT02540369|Growth Substances|growth substances|mesh-ancestor
139022941|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022942|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
139022943|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022944|NCT00605267|Tamoxifen|tamoxifen|mesh-list
139022945|NCT00605267|Goserelin|goserelin|mesh-list
139022946|NCT00605267|Anastrozole|anastrozole|mesh-list
139022947|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139022948|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
139022949|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139022950|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022951|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139022952|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022953|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139022954|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139022955|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139022956|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139022957|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139022958|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139022959|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022960|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139022961|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
139022962|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022963|NCT00902603|Iloprost|iloprost|mesh-list
139022964|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139022965|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
139022966|NCT00902681|Fesoterodine|fesoterodine|mesh-list
139022967|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139022968|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139022969|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
139022970|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139022971|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022972|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022973|NCT00902681|Urological Agents|urological agents|mesh-ancestor
139022974|NCT00906113|Melphalan|melphalan|mesh-list
139022975|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139022976|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
139022977|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139022978|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139022979|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139022980|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139022981|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
139022982|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022983|NCT00902837|Oxycodone|oxycodone|mesh-list
139022984|NCT00902837|Naloxone|naloxone|mesh-list
139022985|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139022986|NCT00902837|Narcotics|narcotics|mesh-ancestor
139022987|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139022988|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139022989|NCT00902837|Analgesics|analgesics|mesh-ancestor
139022990|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
139022991|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139022992|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139022993|NCT00605813|Sertraline|sertraline|mesh-list
139022994|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
139022995|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139022996|NCT00605813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139022997|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139022998|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138979695|NCT00870038|Paclitaxel|paclitaxel|mesh-list
138546134|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139022999|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023000|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023001|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
139023002|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023003|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
139023004|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
139023005|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139023006|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139023007|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023008|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023009|NCT00906269|Urological Agents|urological agents|mesh-ancestor
139023010|NCT00902915|Dexamethasone|dexamethasone|mesh-list
139023011|NCT00902915|Lenalidomide|lenalidomide|mesh-list
139023012|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139023013|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
139023014|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
139023015|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023016|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023017|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139023018|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
139023020|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139023021|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139023022|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023023|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
139023024|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139023025|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139023026|NCT00902915|Growth Substances|growth substances|mesh-ancestor
139023027|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
139023028|NCT04034771|Propofol|propofol|mesh-list
139023029|NCT04034771|Melatonin|melatonin|mesh-list
139023030|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139023031|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023032|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023033|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139023034|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
139023035|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
139023036|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
139023037|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023038|NCT04034771|Protective Agents|protective agents|mesh-ancestor
139023039|NCT00899483|Insulin|insulin|mesh-list
139023040|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139023041|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023042|NCT02539199|Misoprostol|misoprostol|mesh-list
139023043|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138636820|NCT00247715|Antacids|antacids|mesh-ancestor
139023044|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
139023045|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139023046|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023047|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139023048|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139023049|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
139023050|NCT00903227|Fluticasone|fluticasone|mesh-list
139023051|NCT00903227|Xhance|xhance|mesh-list
139023052|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139023053|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139023054|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
139023055|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023056|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023057|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139023058|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
139023059|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
139023060|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139023061|NCT00605657|Valproic Acid|valproic acid|mesh-list
139023062|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
139023063|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023064|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023065|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
139023066|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023067|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023068|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
139023069|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139023070|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023071|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139023072|NCT00899951|Fentanyl|fentanyl|mesh-list
139023073|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139023074|NCT00899951|Narcotics|narcotics|mesh-ancestor
139023075|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023076|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023077|NCT00899951|Analgesics|analgesics|mesh-ancestor
139023078|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
139023079|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023080|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139023081|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139023082|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
139023083|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
139023084|NCT02539979|Acetaminophen|acetaminophen|mesh-list
139023085|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139023086|NCT02539979|Analgesics|analgesics|mesh-ancestor
138636851|NCT00247910|Diuretics|diuretics|mesh-ancestor
139023087|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
139023088|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023089|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023090|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
139023091|NCT05277701|Lazertinib|lazertinib|mesh-list
139023092|NCT05277701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139023093|NCT05277701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023094|NCT05277701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023095|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
139023096|NCT00605345|Hematinics|hematinics|mesh-ancestor
139023097|NCT00903851|Lidocaine|lidocaine|mesh-list
139023098|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
139023099|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
139023100|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023101|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023103|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023104|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139023105|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139023106|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139023107|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139023108|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023109|NCT00900887|Ketorolac|ketorolac|mesh-list
139023110|NCT00900887|Nepafenac|nepafenac|mesh-list
139023111|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139023112|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139023113|NCT00900887|Analgesics|analgesics|mesh-ancestor
139023114|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
139023115|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023116|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023117|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139023118|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139023119|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139023120|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023121|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023123|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139023125|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023126|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023127|NCT00904085|Analgesics|analgesics|mesh-ancestor
139023128|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
139023129|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023130|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139023131|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
139023132|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
139023133|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139023134|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139023135|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023137|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023138|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139023139|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139023140|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636879|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023141|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023142|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139023143|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
139023144|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139023145|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023146|NCT00904397|Celecoxib|celecoxib|mesh-list
139023147|NCT00904397|Lidocaine|lidocaine|mesh-list
139023148|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
139023149|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
139023150|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023151|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023152|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
139023153|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023154|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139023155|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139023156|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139023157|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139023158|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023159|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139023160|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139023161|NCT00904397|Analgesics|analgesics|mesh-ancestor
139023162|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139023163|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139023164|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139023165|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139023166|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023167|NCT00904475|Lidocaine|lidocaine|mesh-list
139023168|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
139023169|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
139023170|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023171|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023172|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
139023173|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023174|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139023175|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139023176|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139023177|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139023178|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023179|NCT00908921|Glimepiride|glimepiride|mesh-list
139023180|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139023181|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139023182|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023183|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139023184|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
139023185|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
139023186|NCT00904631|Salicylates|salicylates|mesh-list
139023187|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139023188|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
139023190|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
139023191|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139023192|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139023193|NCT00904631|Analgesics|analgesics|mesh-ancestor
139023194|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
139023195|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023196|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023197|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139023198|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139023199|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139023200|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023201|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023202|NCT00909077|Dexamethasone|dexamethasone|mesh-list
139023203|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
139023205|NCT00909077|BB 1101|bb 1101|mesh-list
139023206|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139023207|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
139023208|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
139023209|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023210|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023211|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139023212|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
139023213|NCT00909077|Hormones|hormones|mesh-ancestor
139023214|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139023215|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139023216|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023217|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
139023218|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138980156|NCT00888602|Psyllium|psyllium|mesh-list
139023219|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023220|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139023221|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
139023222|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139023223|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
139023224|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139023225|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139023226|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023227|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
139023228|NCT00904709|Coagulants|coagulants|mesh-ancestor
139023229|NCT00340834|Interferons|interferons|mesh-list
139023230|NCT00340834|Interferon-beta|interferon-beta|mesh-list
139023231|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
139023232|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139023233|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023234|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
139023235|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139023236|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
139023237|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023238|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139023239|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
139023240|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023241|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139023242|NCT01057966|Vitamins|vitamins|mesh-list
139023243|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
139023244|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023246|NCT00603941|Efatutazone|efatutazone|mesh-list
139023247|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139023248|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023249|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
139023250|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
139023251|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
139023252|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023254|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139023255|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139023256|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139023257|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139023258|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023259|NCT01055470|Diclofenac|diclofenac|mesh-list
139023260|NCT01055470|Lornoxicam|lornoxicam|mesh-list
139023261|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139023262|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138773891|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
139023263|NCT01055470|Analgesics|analgesics|mesh-ancestor
139023264|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
139023265|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023266|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023267|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139023268|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139023269|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139023270|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023271|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023273|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139023274|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023275|NCT03986008|Incretins|incretins|mesh-ancestor
139023276|NCT03986008|Hormones|hormones|mesh-ancestor
139023277|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139023278|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
139023279|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
139023280|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139023281|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139023282|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023283|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023284|NCT00909233|Urological Agents|urological agents|mesh-ancestor
139023285|NCT00909311|Ritonavir|ritonavir|mesh-list
138546370|NCT00229567|Lidocaine|lidocaine|mesh-list
139023286|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139023287|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139023288|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
139023289|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023290|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023291|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139023292|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139023293|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
139023294|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139023295|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139023296|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139023297|NCT00907751|Rituximab|rituximab|mesh-list
139023298|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139023299|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023300|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
139023301|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023302|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139023303|NCT00905333|Felodipine|felodipine|mesh-list
139023304|NCT00905333|Candesartan|candesartan|mesh-list
139023305|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
138637017|NCT00248963|Estradiol|estradiol|mesh-list
139023306|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139023307|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139023308|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139023309|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023310|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139023311|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139023312|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139023313|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139023314|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023315|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
139023316|NCT00907829|Lidocaine|lidocaine|mesh-list
139023317|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
139023318|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
139023319|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023320|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023321|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
139023322|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023323|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139023324|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139023325|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139023326|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139023327|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023328|NCT00336544|Clarithromycin|clarithromycin|mesh-list
139023329|NCT00336544|Cethromycin|cethromycin|mesh-list
139023330|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139023331|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139023332|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139023333|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023334|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023335|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139023336|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139023337|NCT01059058|Fluorides|fluorides|mesh-list
139023338|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
138980326|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139023339|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
139023340|NCT01059058|Protective Agents|protective agents|mesh-ancestor
139023341|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023342|NCT00605033|Buprenorphine|buprenorphine|mesh-list
139023343|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139023344|NCT00605033|Naloxone|naloxone|mesh-list
139023345|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139023346|NCT00605033|Narcotics|narcotics|mesh-ancestor
139023347|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023348|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023349|NCT00605033|Analgesics|analgesics|mesh-ancestor
139023350|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
139023351|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023352|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139023353|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139023354|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139023355|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023356|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023357|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139023358|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
139023359|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139023360|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023361|NCT00905723|Estradiol|estradiol|mesh-list
139023362|NCT00905723|Estrogens|estrogens|mesh-ancestor
139023363|NCT00905723|Hormones|hormones|mesh-ancestor
139023364|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139023365|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023367|NCT00907985|Vofopitant|vofopitant|mesh-list
139023368|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
139023369|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139023370|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139023371|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023372|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139023373|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023374|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139023375|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139023376|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023377|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139023378|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139023379|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
139023380|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
139023381|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023382|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139023383|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139023384|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023385|NCT01325194|Cytarabine|cytarabine|mesh-list
139023386|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139023387|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
139023388|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023389|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023390|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
139023391|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139023392|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139023393|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
139023394|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023396|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139023397|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023398|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139023399|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139023400|NCT00908219|Growth Substances|growth substances|mesh-ancestor
139023401|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023402|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
139023403|NCT00908297|Ubiquinone|ubiquinone|mesh-list
139023404|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
139023405|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
139023406|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023407|NCT00908297|Vitamins|vitamins|mesh-ancestor
139023408|NCT00927407|Malathion|malathion|mesh-list
139023409|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139023410|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023411|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774040|NCT00667771|Naltrexone|naltrexone|mesh-list
139023412|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
139023413|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023414|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023416|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
139023417|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139023418|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139023419|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139023420|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
139023421|NCT00927797|Rituximab|rituximab|mesh-list
139023422|NCT00927797|Pentostatin|pentostatin|mesh-list
139023423|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139023424|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
139023425|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023426|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139023427|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139023428|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
138546518|NCT00230464|Vildagliptin|vildagliptin|mesh-list
139023429|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023430|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023431|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139023432|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139023433|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139023434|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023435|NCT00338962|Naltrexone|naltrexone|mesh-list
139023436|NCT00338962|Paroxetine|paroxetine|mesh-list
139023437|NCT00338962|Desipramine|desipramine|mesh-list
139023438|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139023439|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139023440|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023441|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
139023442|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023443|NCT00338962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139023444|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139023445|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139023446|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023447|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023448|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
139023449|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139023450|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
139023451|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139023452|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139023453|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139023454|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023455|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139023456|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139023457|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
139023458|NCT00931775|Pindolol|pindolol|mesh-list
139023459|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139023460|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139023461|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
139023462|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023463|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023464|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023465|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139023466|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139023468|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
139023469|NCT00927875|Carboplatin|carboplatin|mesh-list
139023470|NCT00927875|Etoposide|etoposide|mesh-list
139023471|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023472|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139023473|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139023474|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139023475|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023476|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023477|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
139023478|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139023479|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
139023480|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023481|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023482|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139023483|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
139023484|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139023485|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
139023486|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023487|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023488|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139023489|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
139023490|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
139023491|NCT00568061|Protective Agents|protective agents|mesh-ancestor
139023492|NCT03547427|Acetaminophen|acetaminophen|mesh-list
139023494|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139023495|NCT03547427|Pramlintide|pramlintide|mesh-list
139023496|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139023497|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023498|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139023499|NCT03547427|Analgesics|analgesics|mesh-ancestor
139023500|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
139023501|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023502|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
139023503|NCT00338884|Sunitinib|sunitinib|mesh-list
139023504|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023505|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139023506|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139023507|NCT00338884|Growth Substances|growth substances|mesh-ancestor
139023508|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023509|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
139023510|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139023511|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023512|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023513|NCT03038100|Paclitaxel|paclitaxel|mesh-list
139023514|NCT03038100|Bevacizumab|bevacizumab|mesh-list
139023515|NCT03038100|Carboplatin|carboplatin|mesh-list
139023516|NCT03038100|Atezolizumab|atezolizumab|mesh-list
139023517|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139023518|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139023519|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023520|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
139023521|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
139023522|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
139023523|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023524|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139023525|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139023526|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139023527|NCT03038100|Growth Substances|growth substances|mesh-ancestor
138546635|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139023528|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023529|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
139023530|NCT03038100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139023531|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
138637289|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139023533|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
139023534|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023535|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139023536|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139023537|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023538|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023539|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139023540|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
139023541|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139023542|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023543|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139023544|NCT01059136|Spironolactone|spironolactone|mesh-list
139023545|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139023546|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
139023547|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139023548|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023549|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139023550|NCT01059136|Diuretics|diuretics|mesh-ancestor
139023551|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
139023553|NCT00336856|Cetuximab|cetuximab|mesh-list
139023554|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139023555|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139023556|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023557|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774190|NCT02630095|Calcium|calcium|mesh-list
139023558|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023559|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139023560|NCT00566501|Donepezil|donepezil|mesh-list
139023561|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139023562|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023563|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023564|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
139023565|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023566|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023567|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
139023568|NCT00504894|Thiopental|thiopental|mesh-list
139023569|NCT00504894|Propofol|propofol|mesh-list
138980550|NCT03178487|Upadacitinib|upadacitinib|mesh-list
139023570|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139023571|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023572|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023573|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139023574|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
139023575|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
139023576|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
139023577|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
139023578|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
139023579|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023580|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023581|NCT00924755|Caffeine|caffeine|mesh-list
139023582|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139023583|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023584|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139023585|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023586|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023587|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139023588|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139023589|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
139023590|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023591|NCT01011348|Ubiquinone|ubiquinone|mesh-list
139023592|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
139023593|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
139023594|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023595|NCT01011348|Vitamins|vitamins|mesh-ancestor
139023596|NCT00928655|Acetazolamide|acetazolamide|mesh-list
139023597|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
139023598|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139023599|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023600|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023601|NCT00928655|Diuretics|diuretics|mesh-ancestor
139023602|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
139023603|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023604|NCT01011426|Bisacodyl|bisacodyl|mesh-list
139023605|NCT01011426|Cathartics|cathartics|mesh-ancestor
139023606|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139023607|NCT01011426|Laxatives|laxatives|mesh-ancestor
139023608|NCT00932555|Factor VIII|factor viii|mesh-list
139023609|NCT00932555|Coagulants|coagulants|mesh-ancestor
139023610|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
139023611|NCT00513240|Hematinics|hematinics|mesh-ancestor
139023612|NCT00928811|Basiliximab|basiliximab|mesh-list
139023613|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139023614|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
139023615|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023616|NCT00932867|Telmisartan|telmisartan|mesh-list
139023617|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139023618|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139023619|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139023620|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023622|NCT00928967|Interferon-beta|interferon-beta|mesh-list
139023623|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
139023624|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023625|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
139023626|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139023627|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
139023628|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023629|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139023631|NCT00933023|Betamethasone|betamethasone|mesh-list
139023632|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139023633|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
139023634|NCT00933023|Hormones|hormones|mesh-ancestor
138774263|NCT00659503|Ciclesonide|ciclesonide|mesh-list
139023635|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139023636|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023637|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139023638|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
139023639|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
139023640|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
139023641|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
139023642|NCT00933179|Gestodene|gestodene|mesh-list
139023643|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139023644|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
139023645|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139023646|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023647|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139023648|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139023649|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139023650|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139023651|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139023652|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
139023653|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139023654|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139023655|NCT00933179|Progestins|progestins|mesh-ancestor
139023656|NCT00933179|Hormones|hormones|mesh-ancestor
139023657|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139023658|NCT00504348|Tacrolimus|tacrolimus|mesh-list
139023659|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139023661|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023662|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139023663|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023664|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023665|NCT00925457|Domperidone|domperidone|mesh-list
139023666|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139023667|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023668|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023669|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
139023670|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
139023671|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023672|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023673|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139023674|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139023675|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
139023676|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023678|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
139023679|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139023680|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
139023681|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139023682|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023683|NCT00335764|Sirolimus|sirolimus|mesh-list
139023684|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139023685|NCT00335764|Sorafenib|sorafenib|mesh-list
139023686|NCT00335764|Temsirolimus|temsirolimus|mesh-list
139023687|NCT00335764|Tipifarnib|tipifarnib|mesh-list
139023688|NCT00335764|MTOR Inhibitors|mtor inhibitors|mesh-list
139023689|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023690|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139023691|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023692|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023693|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139023694|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
139023695|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023696|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139023697|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139023698|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139023699|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
139023700|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
139023701|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139023702|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023703|NCT03981484|Thrombin|thrombin|mesh-list
139023704|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
139023705|NCT03981484|Coagulants|coagulants|mesh-ancestor
139023706|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139023707|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023708|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139023709|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023710|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774343|NCT02887313|Leucovorin|leucovorin|mesh-list
139023711|NCT01063660|Treosulfan|treosulfan|mesh-list
139023712|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139023714|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023715|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023716|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
139023717|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
139023718|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139023719|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023720|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023721|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
139023722|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139023723|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023724|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023725|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
139023726|NCT00492726|Ertapenem|ertapenem|mesh-list
139023727|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139023728|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139023729|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139023730|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139023731|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139023732|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023733|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023734|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023735|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139023736|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
138637467|NCT00251030|Nelfinavir|nelfinavir|mesh-list
139023737|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138980824|NCT00528879|Metformin|metformin|mesh-list
139023738|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023739|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139023740|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139023741|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139023742|NCT00309946|Cediranib|cediranib|mesh-list
139023743|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023744|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023745|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023746|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139023747|NCT00929591|Tamoxifen|tamoxifen|mesh-list
139023748|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
139023749|NCT00929591|Doxorubicin|doxorubicin|mesh-list
139023750|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139023751|NCT00929591|Fluorouracil|fluorouracil|mesh-list
139023752|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139023753|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
139023754|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023755|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139023756|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139023757|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
139023758|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023759|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023760|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139023761|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139023762|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139023763|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139023764|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023765|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
139023766|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139023767|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139023768|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
139023769|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139023770|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139023771|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139023772|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139023773|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139023774|NCT03997500|Norepinephrine|norepinephrine|mesh-list
139023775|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139023776|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139023777|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
139023778|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023779|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023780|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023782|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
138774412|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
139023783|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023785|NCT01011660|Amlodipine|amlodipine|mesh-list
139023786|NCT01011660|Telmisartan|telmisartan|mesh-list
139023787|NCT01011660|Amiloride|amiloride|mesh-list
139023788|NCT01011660|Simvastatin|simvastatin|mesh-list
139023789|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139023790|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139023791|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139023792|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023793|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139023794|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023795|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
139023796|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139023797|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139023798|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
139023799|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139023800|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139023801|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023802|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139023803|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139023804|NCT01011660|Diuretics|diuretics|mesh-ancestor
139023805|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
139023806|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139023807|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139023808|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139023809|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139023810|NCT01015248|Rituximab|rituximab|mesh-list
139023811|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139023812|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139023813|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023815|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023816|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139023817|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139023818|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
139023819|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023820|NCT00506922|Methotrexate|methotrexate|mesh-list
139023821|NCT00506922|Pentostatin|pentostatin|mesh-list
139023823|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139023824|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
139023825|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139023826|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023827|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139023828|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
139023829|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023830|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023831|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
139023832|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023833|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139023834|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139023835|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
139023836|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138637528|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
139023837|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139023838|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139023839|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139023840|NCT00934193|Gabapentin|gabapentin|mesh-list
139023841|NCT00934193|Analgesics|analgesics|mesh-ancestor
139023842|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
139023843|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023844|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023845|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
139023846|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139023847|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139023848|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023849|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139023850|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139023851|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139023852|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023853|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023854|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
139023855|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
139023856|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139023857|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139023858|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139023859|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139023860|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139023861|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023862|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023863|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023864|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139023865|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
139023866|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139023867|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023868|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139023869|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139023870|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139023871|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
139023872|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
139023873|NCT00926315|Calcitriol|calcitriol|mesh-list
139023874|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139023875|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023876|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139023877|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139023878|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023879|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139023880|NCT00926315|Vitamins|vitamins|mesh-ancestor
139023881|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
139023882|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139023883|NCT01013454|Varenicline|varenicline|mesh-list
139023884|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139023885|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139023886|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
138981089|NCT00896558|Midazolam|midazolam|mesh-list
139023887|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139023888|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023889|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023890|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139023891|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
139023892|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139023894|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139023895|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138637601|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139023896|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023897|NCT00934739|Thalidomide|thalidomide|mesh-list
139023898|NCT00934739|Dexamethasone|dexamethasone|mesh-list
139023899|NCT00934739|Celecoxib|celecoxib|mesh-list
139023900|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
139023901|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139023902|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
139023903|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023904|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139023905|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139023906|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
139023907|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023908|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139023909|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139023910|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139023911|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
139023912|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
139023913|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023914|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139023915|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
139023916|NCT00934739|Hormones|hormones|mesh-ancestor
139023917|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139023918|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139023919|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
139023920|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139023921|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139023922|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139023923|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139023924|NCT00934739|Growth Substances|growth substances|mesh-ancestor
138981111|NCT00129259|Iron|iron|mesh-list
139023925|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
139023926|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139023927|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139023928|NCT00934739|Analgesics|analgesics|mesh-ancestor
139023929|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
139023930|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139023931|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139023932|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023933|NCT01015482|Midazolam|midazolam|mesh-list
139023934|NCT01015482|Remifentanil|remifentanil|mesh-list
139023935|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139023936|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139023937|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139023938|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023939|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139023940|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139023941|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139023942|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139023943|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
139023944|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
139023945|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
139023946|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
139023947|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637646|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
139023948|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023949|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139023950|NCT01015482|Narcotics|narcotics|mesh-ancestor
139023951|NCT01015482|Analgesics|analgesics|mesh-ancestor
139023952|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
139023953|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023954|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
139023955|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139023956|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139023957|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
139023959|NCT00934817|Glimepiride|glimepiride|mesh-list
139023960|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139023961|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023962|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139023963|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139023964|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
139023965|NCT01013532|Aspirin|aspirin|mesh-list
139023966|NCT01013532|Cilostazol|cilostazol|mesh-list
139023967|NCT01013532|Probucol|probucol|mesh-list
139023968|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139023969|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139023970|NCT01013532|Analgesics|analgesics|mesh-ancestor
139023971|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
139023972|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139023973|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139023974|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139023975|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139023976|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139023977|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139023978|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139023979|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139023980|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139023981|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139023982|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
139023983|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139023984|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
139023985|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139023986|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
139023987|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
139023988|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139023989|NCT01013532|Protective Agents|protective agents|mesh-ancestor
139023990|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139023991|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139023992|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139023993|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138637667|NCT04823065|Scopolamine|scopolamine|mesh-list
139023994|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
139023995|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139023996|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
139023997|NCT00926705|Fentanyl|fentanyl|mesh-list
139023998|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
139023999|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139024000|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139024001|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024002|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139024003|NCT00926705|Analgesics|analgesics|mesh-ancestor
138774636|NCT02832778|Tenofovir|tenofovir|mesh-list
139024004|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
139024005|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024006|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139024007|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139024008|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139024009|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
139024010|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024011|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024012|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139024013|NCT00926705|Narcotics|narcotics|mesh-ancestor
139024014|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139024015|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139024016|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
139024017|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
139024018|NCT01012284|Bedaquiline|bedaquiline|mesh-list
139024019|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
139024020|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139024021|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024022|NCT00934973|Mebeverine|mebeverine|mesh-list
139024023|NCT00934973|Alverine|alverine|mesh-list
139024024|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
139024025|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
139024026|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
139024027|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024028|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024029|NCT00485472|Lacosamide|lacosamide|mesh-list
139024030|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
139024031|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139024032|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139024033|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139024034|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024035|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
139024036|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139024037|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024038|NCT01018836|Riluzole|riluzole|mesh-list
139024039|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
139024040|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138981281|NCT06089356|Topiramate|topiramate|mesh-list
139024041|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139024042|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024043|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024044|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024045|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139024046|NCT01018836|Protective Agents|protective agents|mesh-ancestor
139024048|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139024049|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139024050|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024051|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
139024052|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
139024053|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
139024054|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024055|NCT00491400|Atorvastatin|atorvastatin|mesh-list
139024056|NCT00491400|Fenofibrate|fenofibrate|mesh-list
139024057|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139024058|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139024059|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
139024060|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024061|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139024062|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139024063|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024064|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
139024065|NCT00491322|Vitamin D|vitamin d|mesh-list
139024066|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139024067|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024068|NCT00491322|Vitamins|vitamins|mesh-ancestor
139024069|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
139024070|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139024071|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139024072|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
139024073|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024074|NCT00930839|Aspirin|aspirin|mesh-list
139024075|NCT00930839|Niacin|niacin|mesh-list
139024076|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
139024077|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138981328|NCT06088433|Aspirin|aspirin|mesh-list
139024078|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139024079|NCT00930839|Analgesics|analgesics|mesh-ancestor
139024080|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
139024081|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024082|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024083|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139024084|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139024085|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139024086|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138547187|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139024087|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024088|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139024089|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139024090|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024091|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
139024092|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139024093|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
139024094|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139024095|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
139024096|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
139024097|NCT00930839|Vitamins|vitamins|mesh-ancestor
139024098|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
139024099|NCT01015794|Ephedrine|ephedrine|mesh-list
139024100|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
139024101|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139024102|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024103|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
139024104|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
139024105|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024106|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139024107|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
139024108|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024109|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024110|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139024111|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139024112|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
139024113|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
139024114|NCT00935363|Glyburide|glyburide|mesh-list
139024115|NCT00935363|Rifampin|rifampin|mesh-list
139024116|NCT00935363|Fluconazole|fluconazole|mesh-list
139024117|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139024118|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
139024119|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139024120|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024121|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
139024122|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139024123|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024124|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024125|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139024126|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139024127|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139024128|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139024129|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139024130|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139024131|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
139024132|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139024133|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139024134|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139024135|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
139024136|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139024137|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024138|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139024139|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139024140|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139024142|NCT00930995|Candesartan cilexetil|candesartan cilexetil|mesh-list
139024143|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139024144|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139024145|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139024146|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024147|NCT00931073|Ketoconazole|ketoconazole|mesh-list
139024148|NCT00931073|Omeprazole|omeprazole|mesh-list
139024149|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139024150|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139024151|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139024152|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024153|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024154|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
139024155|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024156|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139024157|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139024158|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139024159|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
139024160|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139024161|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024162|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139024164|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
139024165|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139024166|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024167|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139024168|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139024169|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024170|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024171|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139024173|NCT00936689|Hormones|hormones|mesh-ancestor
139024174|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139024175|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024176|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139024177|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
139024178|NCT01018914|Tacrolimus|tacrolimus|mesh-list
139024179|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138981511|NCT06053021|Cilostazol|cilostazol|mesh-list
139024180|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
139024181|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024182|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139024183|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024184|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024185|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139024186|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024187|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139024188|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
139024189|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139024190|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024191|NCT01019070|Asunaprevir|asunaprevir|mesh-list
139024192|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
139024193|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024194|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024195|NCT00936767|Artesunate|artesunate|mesh-list
139024196|NCT00936767|Mefloquine|mefloquine|mesh-list
139024197|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
139024198|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139024199|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139024200|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024201|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024202|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
139024203|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
139024204|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139024205|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
139024206|NCT00931229|Entecavir|entecavir|mesh-list
139024207|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
139024208|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024209|NCT00936923|Furosemide|furosemide|mesh-list
139024210|NCT00936923|Diuretics|diuretics|mesh-list
139024211|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
139024212|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024213|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139024214|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138981579|NCT05966688|Ethambutol|ethambutol|mesh-list
139024215|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024216|NCT01019382|Gemcitabine|gemcitabine|mesh-list
139024217|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139024218|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
139024219|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024220|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024221|NCT00935675|Escitalopram|escitalopram|mesh-list
139024222|NCT00935675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139024223|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139024224|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139024225|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024226|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024227|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
138774869|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
139024228|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024229|NCT01016184|Vitamin D|vitamin d|mesh-list
139024230|NCT01016184|Vitamins|vitamins|mesh-ancestor
139024231|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
139024232|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024233|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139024234|NCT02567825|Amoxicillin|amoxicillin|mesh-list
139024235|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
139024236|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
139024237|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
139024238|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139024239|NCT02567825|Ofloxacin|ofloxacin|mesh-list
139024240|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139024241|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024242|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139024243|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024244|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024245|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139024246|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139024247|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139024249|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139024250|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139024251|NCT00490776|Panobinostat|panobinostat|mesh-list
139024252|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024253|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139024254|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024255|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024256|NCT00566735|Galantamine|galantamine|mesh-list
139024257|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139024258|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024259|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024260|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
139024261|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024262|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024263|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139024264|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
139024265|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024266|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
139024267|NCT00936143|Infliximab|infliximab|mesh-list
139024268|NCT00936143|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139024269|NCT00936143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139024270|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
139024271|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139024272|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139024273|NCT00937079|Exenatide|exenatide|mesh-list
139024274|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139024275|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024276|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139024277|NCT00937079|Incretins|incretins|mesh-ancestor
139024278|NCT00937079|Hormones|hormones|mesh-ancestor
139024279|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139024280|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
139024281|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138981650|NCT05816070|Ofloxacin|ofloxacin|mesh-list
139024282|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024283|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
139024284|NCT00937625|Fludarabine|fludarabine|mesh-list
139024285|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
139024286|NCT00937625|Interleukin-2|interleukin-2|mesh-list
139024287|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139024288|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
139024289|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024290|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139024291|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138547412|NCT00064649|Alfuzosin|alfuzosin|mesh-list
139024292|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
139024293|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024294|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024295|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139024296|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139024298|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139024299|NCT00937625|Analgesics|analgesics|mesh-ancestor
139024300|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
139024301|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024302|NCT04014101|Apatinib|apatinib|mesh-list
139024303|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024304|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139024305|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024306|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637948|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024308|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139024309|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
139024310|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139024311|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139024312|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024313|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
139024314|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024315|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024316|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139024317|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024318|NCT00564629|Acetaminophen|acetaminophen|mesh-list
139024319|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139024320|NCT00564629|Analgesics|analgesics|mesh-ancestor
139024321|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
139024322|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024323|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024324|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
139024325|NCT00564395|Insulin|insulin|mesh-list
139024326|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139024327|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
139024328|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139024329|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024330|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
139024331|NCT04013243|Analgesics|analgesics|mesh-ancestor
139024332|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
139024333|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024334|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024335|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
139024336|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139024337|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139024338|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
139024339|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139024340|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138981737|NCT05660525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024341|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024342|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139024344|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139024345|NCT00938171|Anesthetics|anesthetics|mesh-list
139024346|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139024347|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024348|NCT00939497|Risperidone|risperidone|mesh-list
139024349|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139024350|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
139024351|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024352|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024353|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024354|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139024355|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139024356|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139024357|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139024358|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139024359|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
139024360|NCT00502242|Ramipril|ramipril|mesh-list
139024361|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139024362|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
139024363|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024364|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024365|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139024366|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139024367|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139024368|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139024369|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
139024370|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024371|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139024372|NCT03045653|Tamoxifen|tamoxifen|mesh-list
139024373|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139024374|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
139024375|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139024376|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138981778|NCT05586971|Antioxidants|antioxidants|mesh-ancestor
139024377|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139024378|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024379|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139024380|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139024381|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139024383|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139024384|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024385|NCT03972137|Nicotine|nicotine|mesh-list
139024386|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139024387|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
139024388|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024389|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024390|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139024391|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139024392|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
139024393|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024394|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024395|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
138489285|NCT01929811|Docetaxel|docetaxel|mesh-list
139024396|NCT00490698|Atorvastatin|atorvastatin|mesh-list
139024397|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139024398|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139024399|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
139024400|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024401|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139024402|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139024403|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024404|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139024405|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024406|NCT04492254|Enoxaparin|enoxaparin|mesh-list
139024407|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
139024409|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139024410|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024411|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
139024412|NCT03855228|Loratadine|loratadine|mesh-list
139024413|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139024414|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
139024415|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139024416|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
139024417|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138547609|NCT00097968|Everolimus|everolimus|mesh-list
139024418|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139024419|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
139024420|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
139024421|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024422|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024423|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024424|NCT04013477|Donepezil|donepezil|mesh-list
139024425|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139024426|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024427|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024428|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
139024429|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024430|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024431|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
139024432|NCT00940667|Losartan|losartan|mesh-list
139024433|NCT00940667|Amlodipine|amlodipine|mesh-list
139024434|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139024435|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139024436|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138489339|NCT00005948|Busulfan|busulfan|mesh-list
138981861|NCT05508594|Anesthetics|anesthetics|mesh-ancestor
139024437|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024438|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139024439|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024440|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
139024441|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139024442|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138547639|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024443|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139024444|NCT01019772|Vaccines|vaccines|mesh-list
139024445|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
139024446|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024447|NCT00513500|Amoxicillin|amoxicillin|mesh-list
139024448|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139024449|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139024450|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024451|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
139024452|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139024453|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139024454|NCT00511004|Albendazole|albendazole|mesh-list
139024455|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
139024456|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
139024457|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139024458|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024459|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
139024460|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139024461|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139024462|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
139024463|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
139024464|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
139024465|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024466|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024468|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
139024469|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139024470|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024471|NCT02550197|Vaccines|vaccines|mesh-list
139024472|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
139024473|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024474|NCT00939965|Isotretinoin|isotretinoin|mesh-list
139024475|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
139024476|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
139024477|NCT02877134|Ustekinumab|ustekinumab|mesh-list
139024478|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
139024479|NCT00563381|Bromides|bromides|mesh-list
139024480|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
139024481|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139024482|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139024483|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
138489370|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024484|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024485|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024486|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139024487|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
139024488|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
139024489|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139024490|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
139024491|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024492|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547688|NCT00237250|Vildagliptin|vildagliptin|mesh-list
139024493|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139024495|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139024496|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
139024497|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
139024498|NCT00512798|Temozolomide|temozolomide|mesh-list
139024499|NCT00512798|Bortezomib|bortezomib|mesh-list
139024500|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139024501|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
139024502|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024503|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024504|NCT00940121|Mirabegron|mirabegron|mesh-list
139024505|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139024506|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139024507|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139024508|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
139024509|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024510|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024511|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024512|NCT00940121|Urological Agents|urological agents|mesh-ancestor
139024513|NCT04012619|Cisplatin|cisplatin|mesh-list
139024514|NCT04012619|Carboplatin|carboplatin|mesh-list
139024515|NCT04012619|Pemetrexed|pemetrexed|mesh-list
139024516|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024517|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024518|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024519|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139024520|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139024521|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
139024522|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
139024523|NCT00941057|Dienogest|dienogest|mesh-list
139024524|NCT00941057|Calcium|calcium|mesh-list
139024525|NCT00941057|Nandrolone|nandrolone|mesh-list
139024526|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139024527|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024528|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139024530|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
139024531|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139024532|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139024533|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139024534|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139024535|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139024536|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
139024537|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139024538|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139024539|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024540|NCT00941057|Androgens|androgens|mesh-ancestor
139024541|NCT00941057|Hormones|hormones|mesh-ancestor
139024542|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
139024543|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
139024544|NCT00941057|Vitamins|vitamins|mesh-ancestor
139024545|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
139024546|NCT00561821|Mirtazapine|mirtazapine|mesh-list
139024547|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
139024548|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139024549|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139024550|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
139024551|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
139024552|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024553|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024554|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547762|NCT00237523|Iodine|iodine|mesh-list
139024555|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139024556|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139024557|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139024558|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139024559|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139024560|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139024561|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
139024562|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139024563|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139024564|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
139024565|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139024566|NCT03684044|Baloxavir|baloxavir|mesh-list
139024567|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
139024568|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024569|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024570|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024571|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
139024572|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139024573|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139024574|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024576|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139024577|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
139024578|NCT00335452|Clopidogrel|clopidogrel|mesh-list
139024579|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139024580|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139024581|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138982090|NCT04940299|Nivolumab|nivolumab|mesh-list
139024582|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139024583|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
139024584|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024585|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024586|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024587|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
139024588|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139024589|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024590|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139024591|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
139024592|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139024593|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024594|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024595|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024597|NCT00522392|Lenalidomide|lenalidomide|mesh-list
139024598|NCT00522392|Bortezomib|bortezomib|mesh-list
139024599|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139024600|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
138982130|NCT04849416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138982131|NCT04849416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138982132|NCT04849416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982133|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138982134|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138982147|NCT04763577|Bradykinin|bradykinin|mesh-list
139024601|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
139024602|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024603|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024604|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139024607|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139024608|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139024609|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024610|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
139024611|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139024612|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139024613|NCT00522392|Growth Substances|growth substances|mesh-ancestor
139024614|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
139024616|NCT01061320|Vitamin E|vitamin e|mesh-list
139024617|NCT01061320|Tocotrienols|tocotrienols|mesh-list
139024618|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
139024619|NCT01061320|Vitamins|vitamins|mesh-ancestor
139024620|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
139024621|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024622|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
138982186|NCT04489433|Trametinib|trametinib|mesh-list
138982187|NCT04489433|Dabrafenib|dabrafenib|mesh-list
139024623|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024624|NCT01061320|Protective Agents|protective agents|mesh-ancestor
139024625|NCT01012544|Clopidogrel|clopidogrel|mesh-list
139024626|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139024627|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138489517|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
139024628|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139024629|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139024630|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
139024631|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024632|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024633|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024634|NCT01012700|Poly ICLC|poly iclc|mesh-list
139024635|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
139024636|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
139024637|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024638|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
139024639|NCT01565720|Isavuconazole|isavuconazole|mesh-list
139024640|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139024641|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024642|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139024643|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139024644|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024645|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024646|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024647|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
139024648|NCT00309244|Insulin|insulin|mesh-list
139024649|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139024650|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
139024651|NCT00309244|Protamines|protamines|mesh-list
139024652|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139024653|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024654|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
139024655|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024656|NCT00309244|Coagulants|coagulants|mesh-ancestor
139024657|NCT00483756|Cyclosporine|cyclosporine|mesh-list
139024658|NCT00483756|Cyclosporins|cyclosporins|mesh-list
139024659|NCT00483756|Tofacitinib|tofacitinib|mesh-list
139024660|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024661|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024662|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139024663|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
139024664|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024665|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
139024666|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138982303|NCT03792841|Analgesics|analgesics|mesh-ancestor
139024667|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
139024668|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139024669|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139024670|NCT00483756|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139024671|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139024672|NCT00309166|Vaccines|vaccines|mesh-list
139024673|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
139024674|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024675|NCT01063816|Carboplatin|carboplatin|mesh-list
139024676|NCT01063816|Gemcitabine|gemcitabine|mesh-list
138775313|NCT00676117|Analgesics|analgesics|mesh-ancestor
139024677|NCT01063816|Veliparib|veliparib|mesh-list
139024678|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024679|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139024680|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
139024681|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024682|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139024683|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024684|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
139024685|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
139024686|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138547948|NCT00098280|Eculizumab|eculizumab|mesh-list
139024687|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
139024688|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024689|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024690|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139024691|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
139024692|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
139024693|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139024694|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
139024695|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024696|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138982348|NCT03697720|Naproxen|naproxen|mesh-list
139024697|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139024698|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139024700|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024701|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
139024702|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
139024703|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
139024704|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024705|NCT00490542|Ziprasidone|ziprasidone|mesh-list
139024706|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139024707|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
139024708|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024709|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024710|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024711|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139024712|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139024713|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139024714|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139024715|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139024716|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
139024717|NCT01059604|Naproxen|naproxen|mesh-list
139024718|NCT01059604|Sumatriptan|sumatriptan|mesh-list
139024719|NCT01059604|Naratriptan|naratriptan|mesh-list
139024720|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139024721|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139024722|NCT01059604|Analgesics|analgesics|mesh-ancestor
139024723|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
139024724|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024725|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024726|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139024727|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139024728|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
139024729|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139024730|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024731|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024732|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138982391|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
139024733|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139024734|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139024736|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024737|NCT02532634|Dexamethasone|dexamethasone|mesh-list
139024738|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
139024739|NCT02532634|Aprepitant|aprepitant|mesh-list
139024740|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
139024741|NCT02532634|Palonosetron|palonosetron|mesh-list
139024742|NCT02532634|Ramosetron|ramosetron|mesh-list
139024743|NCT02532634|BB 1101|bb 1101|mesh-list
139024745|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
139024746|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
139024747|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024748|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024749|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139024750|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
139024751|NCT02532634|Hormones|hormones|mesh-ancestor
139024752|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139024753|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139024754|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024756|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024757|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024758|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139024759|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024760|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139024761|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139024762|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
139024763|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
139024764|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
139024765|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139024766|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024767|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024768|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
139024769|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139024770|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139024771|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024772|NCT01014156|Epoprostenol|epoprostenol|mesh-list
139024773|NCT01014156|Tezosentan|tezosentan|mesh-list
139024774|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139024775|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139024776|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
139024778|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139024779|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024780|NCT01014234|Cyclosporine|cyclosporine|mesh-list
139024781|NCT01014234|Sirolimus|sirolimus|mesh-list
139024782|NCT01014234|Cyclosporins|cyclosporins|mesh-list
138548066|NCT02961829|Maraviroc|maraviroc|mesh-list
139024784|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024785|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139024786|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
139024787|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024788|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
139024789|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024790|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
139024791|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139024792|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139024793|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139024794|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139024795|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024796|NCT00501228|Lenograstim|lenograstim|mesh-list
139024797|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139024798|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
139024799|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024800|NCT00308620|Chloroquine|chloroquine|mesh-list
139024801|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139024802|NCT00308620|Amebicides|amebicides|mesh-ancestor
139024803|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139024804|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139024805|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024806|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
139024807|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139024808|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139024809|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139024810|NCT00308620|Analgesics|analgesics|mesh-ancestor
139024811|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
139024812|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024813|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024814|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139024816|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
139024817|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
139024818|NCT00492752|Sorafenib|sorafenib|mesh-list
139024819|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024820|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139024821|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024822|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024823|NCT00308308|Insulin|insulin|mesh-list
139024824|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139024825|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024826|NCT00505934|Levetiracetam|levetiracetam|mesh-list
138775459|NCT00676819|Insulin|insulin|mesh-list
139024827|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
139024828|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
139024829|NCT02532790|Prednisone|prednisone|mesh-list
139024831|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
139024832|NCT02532790|Hormones|hormones|mesh-ancestor
139024833|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139024834|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024835|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139024836|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024838|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139024839|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139024840|NCT00505778|Analgesics|analgesics|mesh-ancestor
139024841|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
139024842|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024843|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024844|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139024845|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139024846|NCT00308074|Aripiprazole|aripiprazole|mesh-list
139024847|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
139024848|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139024849|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139024850|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139024851|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139024852|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024853|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
139024854|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
139024855|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024856|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024857|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139024858|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139024859|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
139024860|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139024861|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139024862|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139024863|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139024865|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
139024866|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139024867|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139024868|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139024869|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138982556|NCT02918864|Oxytocin|oxytocin|mesh-list
139024870|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139024871|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
139024872|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
139024873|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024874|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024875|NCT00500760|Panitumumab|panitumumab|mesh-list
139024876|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024877|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139024878|NCT01016730|Bortezomib|bortezomib|mesh-list
139024879|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024880|NCT01012934|Alendronate|alendronate|mesh-list
139024881|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139024882|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024883|NCT04334330|Trastuzumab|trastuzumab|mesh-list
139024884|NCT04334330|Fulvestrant|fulvestrant|mesh-list
139024885|NCT04334330|Palbociclib|palbociclib|mesh-list
139024886|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138489850|NCT00006002|Hormones|hormones|mesh-ancestor
139024887|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024888|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139024889|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138982595|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
139024890|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139024891|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
139024892|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139024893|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024894|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139024895|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024896|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024897|NCT01015196|Daunorubicin|daunorubicin|mesh-list
139024898|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139024899|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024900|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139024901|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139024902|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024903|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024905|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139024907|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139024908|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024909|NCT01009892|Analgesics|analgesics|mesh-ancestor
139024910|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
139024911|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024912|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
139024913|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
139024914|NCT00307684|Methylphenidate|methylphenidate|mesh-list
139024915|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139024916|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024917|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139024918|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139024919|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139024920|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024921|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
139024922|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139024923|NCT00489918|Teriparatide|teriparatide|mesh-list
139024924|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139024925|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024926|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139024928|NCT01061788|Panitumumab|panitumumab|mesh-list
139024929|NCT01061788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139024930|NCT01061788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139024931|NCT01061788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024932|NCT01061788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024933|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139024934|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
139024935|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024936|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024937|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139024938|NCT00307294|Thalidomide|thalidomide|mesh-list
139024939|NCT00307294|Doxorubicin|doxorubicin|mesh-list
139024940|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139024941|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024942|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139024943|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139024944|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024945|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024946|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139024947|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
139024948|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024949|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
139024950|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139024951|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139024952|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139024953|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139024954|NCT00307294|Growth Substances|growth substances|mesh-ancestor
139024955|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
139024956|NCT03981094|Pirfenidone|pirfenidone|mesh-list
139024958|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
139024959|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024960|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024961|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139024962|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139024963|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139024964|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139024965|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024966|NCT03963401|PF-06700841|pf-06700841|mesh-list
139024967|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139024968|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139024969|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139024970|NCT04410965|Teriflunomide|teriflunomide|mesh-list
139024971|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139024972|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139024973|NCT04410965|Analgesics|analgesics|mesh-ancestor
139024974|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
139024975|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139024976|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024977|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139024978|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139024979|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139024980|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
139024982|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139024983|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139024984|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024985|NCT00944723|Vitamins|vitamins|mesh-list
139024986|NCT00944723|Zinc|zinc|mesh-list
139024987|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
139024988|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
139024989|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
139024990|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139024991|NCT00944723|Trace Elements|trace elements|mesh-ancestor
139024992|NCT00944723|Astringents|astringents|mesh-ancestor
139024993|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
139024994|NCT00944801|Doxorubicin|doxorubicin|mesh-list
139024995|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139024996|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139024997|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139024998|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139024999|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139025000|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025001|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025002|NCT01060228|Valproic Acid|valproic acid|mesh-list
139025003|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139025004|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139025005|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139025006|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139025007|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025008|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139025009|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139025010|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139025011|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
139025012|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025013|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025014|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139025015|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139025016|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
139025017|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
139025018|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025019|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
139025020|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
139025021|NCT00306670|Prednisone|prednisone|mesh-list
139025022|NCT00306670|Rituximab|rituximab|mesh-list
139025023|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139025024|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025025|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
139025026|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025027|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139025028|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025029|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
139025030|NCT00306670|Hormones|hormones|mesh-ancestor
139025031|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139025032|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139025033|NCT00306592|Natalizumab|natalizumab|mesh-list
139025034|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
139025035|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025036|NCT00321646|Bevacizumab|bevacizumab|mesh-list
139025037|NCT00321646|Docetaxel|docetaxel|mesh-list
139025038|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139025040|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139025041|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139025042|NCT00321646|Growth Substances|growth substances|mesh-ancestor
139025043|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025044|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
139025045|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
139025046|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
139025047|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
139025048|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025049|NCT00403767|Warfarin|warfarin|mesh-list
139025050|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
139025051|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
139025052|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138489925|NCT00016198|Leucovorin|leucovorin|mesh-list
139025053|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
139025054|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139025055|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
139025056|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025057|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025058|NCT00492284|Dexamethasone|dexamethasone|mesh-list
139025059|NCT00492284|Ranibizumab|ranibizumab|mesh-list
139025060|NCT00492284|Verteporfin|verteporfin|mesh-list
139025061|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025062|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
139025063|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
139025064|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025065|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025066|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139025067|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
139025068|NCT00492284|Hormones|hormones|mesh-ancestor
139025069|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139025070|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139025071|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025072|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139025073|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139025074|NCT00492284|Growth Substances|growth substances|mesh-ancestor
139025075|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
139025076|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139025077|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
139025078|NCT01013012|Dexamethasone|dexamethasone|mesh-list
139025079|NCT01013012|Ramosetron|ramosetron|mesh-list
139025080|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025081|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
139025083|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025084|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025085|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139025086|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
139025087|NCT01013012|Hormones|hormones|mesh-ancestor
139025088|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139025089|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139025090|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025091|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139025092|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
139025093|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025094|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025095|NCT01009970|Prednisone|prednisone|mesh-list
139025096|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
139025097|NCT01009970|Rituximab|rituximab|mesh-list
139025098|NCT01009970|Doxorubicin|doxorubicin|mesh-list
139025099|NCT01009970|Vincristine|vincristine|mesh-list
139025100|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025101|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
139025102|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025103|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139025104|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139025105|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
139025106|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025107|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025108|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139025109|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139025110|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139025111|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139025112|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139025113|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675179|NCT01240148|Lidocaine|lidocaine|mesh-list
138982911|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
139025114|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025115|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
139025116|NCT01009970|Hormones|hormones|mesh-ancestor
139025117|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139025118|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139025119|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139025120|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
139025121|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
139025122|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
139025123|NCT01015352|Azacitidine|azacitidine|mesh-list
139025124|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
139025125|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139025126|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
139025127|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775759|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025128|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025129|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025131|NCT03563157|Leucovorin|leucovorin|mesh-list
139025132|NCT03563157|Paclitaxel|paclitaxel|mesh-list
139025133|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
139025134|NCT03563157|Capecitabine|capecitabine|mesh-list
139025135|NCT03563157|Fluorouracil|fluorouracil|mesh-list
139025136|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
139025137|NCT03563157|Cetuximab|cetuximab|mesh-list
139025138|NCT03563157|Avelumab|avelumab|mesh-list
139025139|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139025140|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025141|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
139025142|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
139025143|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
139025144|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025145|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025146|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
139025147|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025148|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139025149|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139025150|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
139025151|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139025152|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139025154|NCT03563157|Antidotes|antidotes|mesh-ancestor
139025155|NCT03563157|Protective Agents|protective agents|mesh-ancestor
139025156|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
139025157|NCT03563157|Vitamins|vitamins|mesh-ancestor
139025158|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
139025159|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139025160|NCT01010048|Nifedipine|nifedipine|mesh-list
139025161|NCT01010048|Bromides|bromides|mesh-list
139025162|NCT01010048|Propantheline|propantheline|mesh-list
139025163|NCT01010048|Tamsulosin|tamsulosin|mesh-list
139025164|NCT01010048|Progesterone|progesterone|mesh-list
139025165|NCT01010048|Progestins|progestins|mesh-ancestor
139025166|NCT01010048|Hormones|hormones|mesh-ancestor
139025167|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139025168|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025169|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
139025170|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139025171|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139025172|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139025173|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
139025174|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025175|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025176|NCT01010048|Urological Agents|urological agents|mesh-ancestor
139025177|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139025178|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139025179|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139025180|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
139025181|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
139025182|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139025183|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139025184|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139025185|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138982994|NCT00520767|BB 1101|bb 1101|mesh-list
139025186|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139025187|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
139025189|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025190|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139025191|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139025192|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
139025193|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139025194|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139025195|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139025196|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139025197|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025198|NCT01013402|Insulin|insulin|mesh-list
139025199|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139025200|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139025201|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025202|NCT01013480|Baclofen|baclofen|mesh-list
139025203|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139025204|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025205|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139025206|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025207|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139025208|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
139025209|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
139025210|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260440|NCT05044871|Paclitaxel|paclitaxel|mesh-list
139025211|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025213|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139025214|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025215|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139025216|NCT00500370|Incretins|incretins|mesh-ancestor
139025217|NCT00500370|Hormones|hormones|mesh-ancestor
138489990|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139025218|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139025219|NCT00320788|Aflibercept|aflibercept|mesh-list
139025220|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139025221|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139025222|NCT00320788|Growth Substances|growth substances|mesh-ancestor
139025223|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025224|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
138983031|NCT01017796|Expectorants|expectorants|mesh-ancestor
139025225|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025226|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
139025227|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
139025228|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
139025229|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139025230|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
139025231|NCT03996486|Paraproteins|paraproteins|mesh-list
139025232|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
139025233|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025234|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
139025235|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139025236|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139025237|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025238|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139025239|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
139025240|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025241|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139025242|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
139025243|NCT01014468|Bevacizumab|bevacizumab|mesh-list
139025244|NCT01014468|Ranibizumab|ranibizumab|mesh-list
139025245|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139025246|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025247|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139025248|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139025249|NCT01014468|Growth Substances|growth substances|mesh-ancestor
139025250|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025251|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
139025252|NCT00503984|Prednisone|prednisone|mesh-list
139025253|NCT00503984|Docetaxel|docetaxel|mesh-list
139025254|NCT00503984|Azacitidine|azacitidine|mesh-list
139025255|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025256|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
139025257|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
139025258|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
139025259|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025260|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025261|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
139025263|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139025264|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025265|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139025266|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139025267|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
139025268|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025269|NCT03996564|Acetaminophen|acetaminophen|mesh-list
139025270|NCT03996564|Diclofenac|diclofenac|mesh-list
139025271|NCT03996564|Ketorolac|ketorolac|mesh-list
139025272|NCT03996564|Diazepam|diazepam|mesh-list
139025273|NCT03996564|Hydrocodone|hydrocodone|mesh-list
139025274|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139025275|NCT03996564|Analgesics|analgesics|mesh-ancestor
139025276|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
139025277|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025278|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025280|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139025281|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025282|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139025283|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139025284|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025285|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025286|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139025287|NCT03996564|Narcotics|narcotics|mesh-ancestor
139025288|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139025289|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
139025290|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
139025291|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139025292|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
139025293|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
139025294|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
139025295|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139025296|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139025297|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139025298|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139025299|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139025300|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139025301|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139025302|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139025303|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
139025304|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
139025305|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
139025306|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
139025307|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025308|NCT00565409|Etanercept|etanercept|mesh-list
139025309|NCT00565409|Methotrexate|methotrexate|mesh-list
139025310|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139025311|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
139025312|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139025313|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025314|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139025315|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
139025316|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025318|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
139025319|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025320|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139025321|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025322|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
139025323|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139025324|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139025325|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139025326|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139025327|NCT00565409|Analgesics|analgesics|mesh-ancestor
139025328|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
139025329|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025330|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025331|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139025332|NCT00394251|Paclitaxel|paclitaxel|mesh-list
139025333|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
139025334|NCT00394251|Bevacizumab|bevacizumab|mesh-list
139025335|NCT00394251|Doxorubicin|doxorubicin|mesh-list
139025336|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139025337|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139025338|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139025339|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983149|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
139025340|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
139025341|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
139025342|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
139025343|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025344|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025345|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
139025346|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025347|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139025348|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139025349|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
139025350|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139025351|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139025352|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139025353|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139025354|NCT00394251|Growth Substances|growth substances|mesh-ancestor
139025355|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
139025356|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139025357|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138775987|NCT04964622|Ibuprofen|ibuprofen|mesh-list
139025358|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139025359|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025360|NCT02532400|Goserelin|goserelin|mesh-list
139025361|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139025362|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025363|NCT00394095|Topiramate|topiramate|mesh-list
139025364|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
139025365|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139025366|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025367|NCT00503906|Paclitaxel|paclitaxel|mesh-list
139025368|NCT00503906|Bevacizumab|bevacizumab|mesh-list
139025369|NCT00503906|Gemcitabine|gemcitabine|mesh-list
139025370|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139025371|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138548471|NCT00241189|Sirolimus|sirolimus|mesh-list
139025372|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025373|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
139025374|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
139025375|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
139025376|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025377|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139025378|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139025379|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138490053|NCT00016744|Genistein|genistein|mesh-list
139025380|NCT00503906|Growth Substances|growth substances|mesh-ancestor
139025381|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025382|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
139025383|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139025384|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
139025385|NCT00305110|Hydromorphone|hydromorphone|mesh-list
139025386|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139025387|NCT00305110|Narcotics|narcotics|mesh-ancestor
139025388|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139025389|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025390|NCT00305110|Analgesics|analgesics|mesh-ancestor
139025391|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
139025392|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025394|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
139025395|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
139025396|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025397|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
139025398|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139025399|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139025400|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139025401|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
139025402|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025403|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025404|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025405|NCT01060618|Maraviroc|maraviroc|mesh-list
139025406|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139025407|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139025408|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025409|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139025410|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139025411|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
139025412|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139025413|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139025414|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
139025415|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025416|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
139025417|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139025418|NCT00500292|Leucovorin|leucovorin|mesh-list
139025419|NCT00500292|Folic Acid|folic acid|mesh-list
139025420|NCT00500292|Fluorouracil|fluorouracil|mesh-list
139025421|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
139025422|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
139025423|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
139025424|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025425|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139025426|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025427|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025428|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
139025429|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025430|NCT00500292|Antidotes|antidotes|mesh-ancestor
139025431|NCT00500292|Protective Agents|protective agents|mesh-ancestor
139025432|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
139025433|NCT00500292|Vitamins|vitamins|mesh-ancestor
139025434|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
139025435|NCT00500292|Hematinics|hematinics|mesh-ancestor
139025437|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139025438|NCT01013558|Narcotics|narcotics|mesh-ancestor
139025439|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139025440|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025441|NCT01013558|Analgesics|analgesics|mesh-ancestor
139025442|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
139025443|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025444|NCT00499746|Tramadol|tramadol|mesh-list
139025445|NCT00499746|Hydromorphone|hydromorphone|mesh-list
139025446|NCT00499746|Methylphenidate|methylphenidate|mesh-list
139025447|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139025448|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025449|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139025450|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139025451|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139025452|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025453|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
139025454|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025455|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139025456|NCT00499746|Narcotics|narcotics|mesh-ancestor
139025457|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139025458|NCT00499746|Analgesics|analgesics|mesh-ancestor
139025459|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
139025460|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025461|NCT01010516|Niacin|niacin|mesh-list
139025462|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139025463|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139025464|NCT01010516|Fenofibrate|fenofibrate|mesh-list
139025465|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139025466|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139025467|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
139025468|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025469|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139025470|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025471|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
139025472|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
139025473|NCT01010516|Vitamins|vitamins|mesh-ancestor
139025474|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
139025475|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025476|NCT01020162|Gabapentin|gabapentin|mesh-list
139025477|NCT01020162|Amitriptyline|amitriptyline|mesh-list
139025478|NCT01020162|Analgesics|analgesics|mesh-ancestor
139025479|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
139025480|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025481|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025482|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
139025483|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139025484|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139025485|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139025486|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139025487|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139025488|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139025489|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025490|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025491|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
139025492|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139025493|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
139025494|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139025495|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139025496|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139025497|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139025498|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
139025499|NCT01016886|Bisoprolol|bisoprolol|mesh-list
139025500|NCT01016886|Perindopril|perindopril|mesh-list
139025501|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139025502|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
139025503|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
139025504|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025505|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025506|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139025507|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139025508|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139025509|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
139025510|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025511|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025512|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139025513|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
139025514|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025515|NCT00499590|Ranibizumab|ranibizumab|mesh-list
139025516|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139025517|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139025518|NCT00499590|Growth Substances|growth substances|mesh-ancestor
138983407|NCT05799755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025519|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025520|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
139025521|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025523|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
139025524|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
139025525|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025526|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025527|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139025528|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139025529|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139025530|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139025531|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139025532|NCT00510146|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139025533|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139025534|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139025535|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025536|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025537|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
139025538|NCT00480636|Dalteparin|dalteparin|mesh-list
139025539|NCT00480636|Tinzaparin|tinzaparin|mesh-list
139025540|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139025541|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
139025542|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139025543|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139025544|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025545|NCT01017198|Antacids|antacids|mesh-list
139025546|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025547|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139025548|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
139025549|NCT00499122|Docetaxel|docetaxel|mesh-list
139025550|NCT00499122|Doxorubicin|doxorubicin|mesh-list
138490110|NCT00016978|Antidotes|antidotes|mesh-ancestor
139025551|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025552|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
139025553|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025554|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139025555|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139025556|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
139025557|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025558|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025559|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139025560|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
139025561|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
139025562|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
139025563|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139025564|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139025565|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139025566|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025567|NCT00393939|Docetaxel|docetaxel|mesh-list
139025568|NCT00393939|Sunitinib|sunitinib|mesh-list
139025569|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025570|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
139025571|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
139025572|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
139025573|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025574|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139025575|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139025576|NCT00393939|Growth Substances|growth substances|mesh-ancestor
139025577|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025578|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
139025579|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139025580|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025581|NCT00488982|Docetaxel|docetaxel|mesh-list
139025582|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025583|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
139025584|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
139025585|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
139025586|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025588|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139025589|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
139025590|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025591|NCT01017354|Calcifediol|calcifediol|mesh-list
139025593|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
138490126|NCT00017095|Epirubicin|epirubicin|mesh-list
139025594|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025595|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139025596|NCT00393861|Bevacizumab|bevacizumab|mesh-list
139025597|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
139025598|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139025599|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025600|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139025601|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139025602|NCT00393861|Growth Substances|growth substances|mesh-ancestor
139025603|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025604|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
139025605|NCT01040559|Idarubicin|idarubicin|mesh-list
139025606|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139025607|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025608|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139025609|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139025610|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025611|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025612|NCT01020396|Metronidazole|metronidazole|mesh-list
139025613|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139025614|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139025615|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139025616|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139025617|NCT00488592|Molgramostim|molgramostim|mesh-list
139025618|NCT00488592|Sargramostim|sargramostim|mesh-list
139025619|NCT00488592|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139025620|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
139025621|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025622|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025623|NCT00488592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139025625|NCT00488514|Sumatriptan|sumatriptan|mesh-list
139025626|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139025627|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139025628|NCT00488514|Analgesics|analgesics|mesh-ancestor
139025629|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
139025630|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025631|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025632|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025633|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139025634|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
138983597|NCT05264896|Vitamin B Complex|vitamin b complex|mesh-ancestor
138983598|NCT05264896|Vitamins|vitamins|mesh-ancestor
138983599|NCT05264896|Micronutrients|micronutrients|mesh-ancestor
138983626|NCT05248919|Sofosbuvir|sofosbuvir|mesh-list
138983627|NCT05248919|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138983628|NCT05248919|Velpatasvir|velpatasvir|mesh-list
138983629|NCT05248919|Antiviral Agents|antiviral agents|mesh-ancestor
138983630|NCT05248919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138983631|NCT05228574|Amiloride|amiloride|mesh-list
138983632|NCT05228574|Diuretics|diuretics|mesh-ancestor
138983633|NCT05228574|Natriuretic Agents|natriuretic agents|mesh-ancestor
138983634|NCT05228574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138983635|NCT05228574|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138983636|NCT05228574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138983637|NCT05228574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138983638|NCT05228574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138983639|NCT05228574|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138983640|NCT05228574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138983641|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
138983642|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138983643|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138983644|NCT05176509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138608658|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139025635|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139025636|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025637|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025638|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139025639|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138490193|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139025640|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139025641|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
139025642|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025643|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
139025644|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139025645|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025646|NCT00320398|PENTA|penta|mesh-list
139025647|NCT00320398|Fondaparinux|fondaparinux|mesh-list
139025648|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139025649|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
139025650|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139025651|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
139025652|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263148|NCT02922959|Naloxone|naloxone|mesh-list
139025653|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025654|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
139025655|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139025656|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139025657|NCT00498186|Rotigotine|rotigotine|mesh-list
139025658|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
139025659|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
138776286|NCT00678769|Sirolimus|sirolimus|mesh-list
139025660|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025661|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025662|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025663|NCT03984526|Atropine|atropine|mesh-list
139025664|NCT03984526|Ephedrine|ephedrine|mesh-list
139025665|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139025666|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139025667|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139025668|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
139025669|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025670|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025671|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139025672|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
139025673|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
139025674|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
139025675|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139025676|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139025677|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
139025678|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025679|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025680|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139025681|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
139025682|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139025683|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
139025684|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
139025685|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
139025686|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139025687|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139025688|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
139025689|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025690|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025691|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025692|NCT01017744|Anesthetics|anesthetics|mesh-list
139025693|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139025694|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025695|NCT00477594|Mipomersen|mipomersen|mesh-list
139025696|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139025697|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139025698|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
139025699|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025700|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139025702|NCT00304954|Infliximab|infliximab|mesh-list
139025703|NCT00304954|Daclizumab|daclizumab|mesh-list
139025704|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139025705|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139025706|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139025707|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025708|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
139025709|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025710|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
139025711|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025712|NCT00304954|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139025713|NCT00304954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025714|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
139025715|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139025716|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139025717|NCT00475176|Ribavirin|ribavirin|mesh-list
139025718|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139025719|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
139025720|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025721|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
139025722|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139025723|NCT00393705|Insulin|insulin|mesh-list
139025724|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139025725|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
139025726|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139025727|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025728|NCT00303628|Leucovorin|leucovorin|mesh-list
139025729|NCT00303628|Bevacizumab|bevacizumab|mesh-list
139025730|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139025731|NCT00303628|Fluorouracil|fluorouracil|mesh-list
139025732|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
139025733|NCT00303628|Antibodies|antibodies|mesh-list
139025734|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
139025735|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138776355|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139025736|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
139025737|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025738|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139025739|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139025740|NCT00303628|Growth Substances|growth substances|mesh-ancestor
139025741|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025742|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
139025743|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
139025744|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
139025745|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025746|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139025747|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025748|NCT00303628|Antidotes|antidotes|mesh-ancestor
138983729|NCT04989348|Hormones|hormones|mesh-list
139025749|NCT00303628|Protective Agents|protective agents|mesh-ancestor
139025750|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
139025751|NCT00303628|Vitamins|vitamins|mesh-ancestor
139025752|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
139025753|NCT00414453|Lidocaine|lidocaine|mesh-list
139025754|NCT00414453|Oxycodone|oxycodone|mesh-list
139025755|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
139025756|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
139025757|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139025758|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025759|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
139025760|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025761|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139025762|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139025763|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139025764|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139025765|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025766|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139025767|NCT00414453|Narcotics|narcotics|mesh-ancestor
139025768|NCT00414453|Analgesics|analgesics|mesh-ancestor
139025769|NCT01037595|Turmeric extract|turmeric extract|mesh-list
139025770|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
139025771|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025772|NCT01037595|Protective Agents|protective agents|mesh-ancestor
139025773|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025774|NCT00332488|Insulin|insulin|mesh-list
139025775|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139025776|NCT00332488|Metformin|metformin|mesh-list
139025777|NCT00332488|Secretagogues|secretagogues|mesh-list
139025778|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139025779|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025780|NCT00332332|Etanercept|etanercept|mesh-list
139025781|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139025782|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139025783|NCT00332332|Analgesics|analgesics|mesh-ancestor
139025784|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
138983755|NCT04899778|Micronutrients|micronutrients|mesh-ancestor
139025786|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025787|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025788|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139025789|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139025790|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025791|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
139025792|NCT00392925|Pramlintide|pramlintide|mesh-list
139025793|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
139025794|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139025795|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025796|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
139025797|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139025798|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
139025799|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025800|NCT00474786|Sirolimus|sirolimus|mesh-list
139025801|NCT00474786|Sorafenib|sorafenib|mesh-list
139025802|NCT00474786|Temsirolimus|temsirolimus|mesh-list
139025803|NCT00474786|MTOR Inhibitors|mtor inhibitors|mesh-list
139025804|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025805|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139025806|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025807|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025808|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025809|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
139025810|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025811|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139025812|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139025813|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139025814|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
139025815|NCT00392769|Cetuximab|cetuximab|mesh-list
139025816|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139025817|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025818|NCT01041183|Ramosetron|ramosetron|mesh-list
139025819|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
139025820|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
139025821|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025822|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025823|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139025824|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139025825|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
139025826|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025827|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025828|NCT00319696|Bosentan|bosentan|mesh-list
139025829|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139025830|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139025831|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025832|NCT00474630|Naltrexone|naltrexone|mesh-list
139025833|NCT00474630|Bupropion|bupropion|mesh-list
139025834|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139025835|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139025836|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025837|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
139025838|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025839|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139025840|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
139025841|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139025842|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139025843|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139025844|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139025845|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025846|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
139025847|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025848|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139025849|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139025850|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025851|NCT01064752|Minocycline|minocycline|mesh-list
139025852|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139025853|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139025854|NCT00392379|Nicotine|nicotine|mesh-list
139025855|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139025856|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
139025857|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025858|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025859|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139025860|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139025861|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
139025862|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139025863|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025864|NCT01038063|Lumefantrine|lumefantrine|mesh-list
139025865|NCT01038063|Artemether|artemether|mesh-list
138548855|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139025866|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139025867|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
139025868|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139025869|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139025870|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139025871|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
139025872|NCT01043991|Hematinics|hematinics|mesh-ancestor
139025873|NCT01020630|Sunitinib|sunitinib|mesh-list
139025874|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025875|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139025876|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139025877|NCT01020630|Growth Substances|growth substances|mesh-ancestor
139025878|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025879|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
139025880|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138983888|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
139025881|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025882|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025883|NCT00403455|Paroxetine|paroxetine|mesh-list
139025884|NCT00403455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139025885|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139025886|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138776510|NCT04371952|Doxycycline|doxycycline|mesh-list
139025887|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025889|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
138548898|NCT00244426|Aspirin|aspirin|mesh-list
139025890|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025891|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139025892|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
139025893|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139025894|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139025895|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139025896|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025897|NCT00318370|Farletuzumab|farletuzumab|mesh-list
139025898|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025899|NCT00510068|Everolimus|everolimus|mesh-list
139025900|NCT00510068|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139025901|NCT00510068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139025902|NCT00510068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059135|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139025903|NCT00510068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025904|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025905|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
139025906|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025907|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025908|NCT00509600|Etanercept|etanercept|mesh-list
139025909|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139025910|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139025911|NCT00509600|Analgesics|analgesics|mesh-ancestor
139025912|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
139025913|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025914|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025915|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025916|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139025917|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139025918|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025919|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
138983919|NCT04488926|Hormones|hormones|mesh-ancestor
139025920|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
139025921|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139025922|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139025924|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
139025925|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139025926|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
139025927|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025928|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
139025929|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
139025930|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025931|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025932|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139025933|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
139025934|NCT01014104|Hormones|hormones|mesh-ancestor
139025935|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139025936|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139025937|NCT01014104|Protective Agents|protective agents|mesh-ancestor
139025938|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139025939|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025940|NCT00402987|Celecoxib|celecoxib|mesh-list
138548965|NCT00067301|Citalopram|citalopram|mesh-list
139025941|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139025942|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139025944|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
139025945|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139025946|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025947|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139025948|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139025949|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139025950|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139025951|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025952|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025953|NCT01015664|Sirolimus|sirolimus|mesh-list
139025954|NCT01015664|Cetuximab|cetuximab|mesh-list
139025955|NCT01015664|Temsirolimus|temsirolimus|mesh-list
139025956|NCT01015664|MTOR Inhibitors|mtor inhibitors|mesh-list
139025957|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025958|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139025959|NCT01015664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139025960|NCT01015664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025961|NCT01015664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025962|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025963|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
139025964|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025965|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139025966|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139025967|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139025968|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
139025970|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
139025971|NCT00501644|Carboplatin|carboplatin|mesh-list
139025972|NCT00501644|Molgramostim|molgramostim|mesh-list
139025973|NCT00501644|Sargramostim|sargramostim|mesh-list
139025974|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025975|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
139025976|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139025977|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
139025978|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025979|NCT01014260|Doxycycline|doxycycline|mesh-list
139025980|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139025981|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139025982|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
139025983|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139025984|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139025985|NCT01010672|Sirolimus|sirolimus|mesh-list
139025986|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139025987|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139025989|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139025990|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
139025991|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139025992|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
139025993|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139025994|NCT01014338|Fosinopril|fosinopril|mesh-list
139025995|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139025996|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
139025997|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139025998|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139025999|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139026000|NCT01014416|Tolvaptan|tolvaptan|mesh-list
139026001|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139026002|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026003|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
138490394|NCT00017719|Lamivudine|lamivudine|mesh-list
139026004|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026005|NCT00497796|Ganciclovir|ganciclovir|mesh-list
139026006|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139026007|NCT00497796|Maribavir|maribavir|mesh-list
139026008|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
139026009|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026010|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139026011|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026012|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026013|NCT01017822|Gemcitabine|gemcitabine|mesh-list
139026014|NCT01017822|Capecitabine|capecitabine|mesh-list
139026015|NCT01017822|Conatumumab|conatumumab|mesh-list
139026016|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139026017|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
139026018|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026019|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026020|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139026022|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139026023|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139026024|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026025|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139026026|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139026027|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
139026028|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026029|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139026030|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
139026031|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
139026032|NCT01020708|Mesalamine|mesalamine|mesh-list
139026033|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139026034|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
139026035|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776655|NCT04237480|Vitamins|vitamins|mesh-list
139026037|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
139026038|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139026039|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
139026040|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026042|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026043|NCT01020708|Antidotes|antidotes|mesh-ancestor
139026044|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139026045|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139026046|NCT01020708|Analgesics|analgesics|mesh-ancestor
139026047|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
139026048|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026049|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139026050|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139026051|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
139026052|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139026053|NCT01020864|Carboplatin|carboplatin|mesh-list
139026054|NCT01020864|Cetuximab|cetuximab|mesh-list
139026055|NCT01020864|Vinorelbine|vinorelbine|mesh-list
139059136|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
139026056|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026057|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139026058|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139026059|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
139026060|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
139026061|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
139026062|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026063|NCT04428372|Mannitol|mannitol|mesh-list
139026064|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139026065|NCT04428372|Diuretics|diuretics|mesh-ancestor
139026066|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
139026067|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026068|NCT01014858|Donepezil|donepezil|mesh-list
139026069|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139026070|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549112|NCT00102843|Vitamins|vitamins|mesh-ancestor
139026071|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026072|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
139026073|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026074|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026075|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
139026076|NCT00471276|Sunitinib|sunitinib|mesh-list
139026077|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026078|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139026079|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139026080|NCT00471276|Growth Substances|growth substances|mesh-ancestor
139026081|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026083|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139026084|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026085|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026086|NCT00470262|Pioglitazone|pioglitazone|mesh-list
139026087|NCT00470262|Fenofibrate|fenofibrate|mesh-list
139026088|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139026089|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026090|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139026091|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
139026092|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026093|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139026094|NCT04034862|Lamivudine|lamivudine|mesh-list
139026095|NCT04034862|Dolutegravir|dolutegravir|mesh-list
139026096|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139026097|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139026098|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026099|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026100|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
139026101|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026102|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139026103|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139026104|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139026105|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139026106|NCT00496470|Budesonide|budesonide|mesh-list
139026107|NCT00496470|Bromides|bromides|mesh-list
139026108|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
139026109|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
139026110|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139026111|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139026112|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138549151|NCT00246064|Infliximab|infliximab|mesh-list
139026114|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026115|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026116|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139026117|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
139026118|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
139026120|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139026121|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139026122|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139026123|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139026124|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
139026125|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026126|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026127|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
139026128|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139026129|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
139026130|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
139026131|NCT01021176|Diltiazem|diltiazem|mesh-list
139026132|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139026133|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139026134|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139026135|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026136|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139026137|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026138|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
139026139|NCT01018368|Rifampin|rifampin|mesh-list
139026140|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139026141|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
138689949|NCT00990275|Ethanol|ethanol|mesh-list
139026142|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139026143|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026144|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
139026145|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139026146|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026147|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026148|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139026149|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139026150|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139026151|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138984139|NCT03743766|Nivolumab|nivolumab|mesh-list
139026152|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139026153|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139026154|NCT00487578|Naratriptan|naratriptan|mesh-list
139026155|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139026156|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139026157|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139026158|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
139026159|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026160|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026161|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026162|NCT00495612|Omalizumab|omalizumab|mesh-list
139026163|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139026164|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139026165|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
139026166|NCT01021488|Enoxaparin|enoxaparin|mesh-list
139026167|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139026168|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139026169|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139026170|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
139026171|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026172|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139026173|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139026174|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026175|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
139026176|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139026177|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139026178|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139026179|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
139026180|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
139026181|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026182|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139026183|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139026184|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026186|NCT00509366|Cisplatin|cisplatin|mesh-list
139026187|NCT00509366|Gemcitabine|gemcitabine|mesh-list
139026188|NCT00509366|Docetaxel|docetaxel|mesh-list
139026189|NCT00509366|Pemetrexed|pemetrexed|mesh-list
139026190|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026191|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139026192|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
139026193|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026194|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
139026195|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
139026196|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
139026197|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026198|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139026199|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139026200|NCT01016054|Carboplatin|carboplatin|mesh-list
139026201|NCT01016054|Gemcitabine|gemcitabine|mesh-list
139026202|NCT01016054|Doxorubicin|doxorubicin|mesh-list
139026203|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139026204|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026205|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139026206|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
139026207|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026208|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139026209|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139026210|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139026211|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026212|NCT00500318|Bromides|bromides|mesh-list
139026213|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
139026214|NCT00499694|Bevacizumab|bevacizumab|mesh-list
139026215|NCT00499694|Satraplatin|satraplatin|mesh-list
139026216|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139026217|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026218|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139026219|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139026220|NCT00499694|Growth Substances|growth substances|mesh-ancestor
139026221|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026222|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
139026223|NCT00486954|Paclitaxel|paclitaxel|mesh-list
139026224|NCT00486954|Lapatinib|lapatinib|mesh-list
139026225|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139026226|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026227|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
139026228|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
139026229|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
139026230|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026231|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139026232|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026233|NCT00494676|Methamphetamine|methamphetamine|mesh-list
139026234|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139026235|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026236|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
139026237|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
139026238|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026239|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
139026240|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026241|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026242|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
139026243|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139026244|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139026245|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139026246|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139026247|NCT00486720|Vorinostat|vorinostat|mesh-list
139026248|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026249|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139026250|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026251|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026252|NCT00486330|Ritonavir|ritonavir|mesh-list
139026253|NCT00486330|Tipranavir|tipranavir|mesh-list
139026254|NCT00486330|Buprenorphine|buprenorphine|mesh-list
139026255|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139026256|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139026257|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
139026258|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026259|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026260|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139026261|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139026262|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
139026263|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026264|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139026265|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139026266|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139026267|NCT00486330|Narcotics|narcotics|mesh-ancestor
139026268|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139026269|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026270|NCT00486330|Analgesics|analgesics|mesh-ancestor
139026271|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
139026272|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026273|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139026274|NCT01021566|Methadone|methadone|mesh-list
139026275|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139026276|NCT01021566|Narcotics|narcotics|mesh-ancestor
139026277|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139026278|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026279|NCT01021566|Analgesics|analgesics|mesh-ancestor
139026280|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
139026281|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026282|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
139026283|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
139026284|NCT00494442|Olaparib|olaparib|mesh-list
138490549|NCT00386750|Lumefantrine|lumefantrine|mesh-list
139026285|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
139026286|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026287|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026288|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026289|NCT00493974|Zileuton|zileuton|mesh-list
139026290|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139026291|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139026292|NCT00493974|Analgesics|analgesics|mesh-ancestor
139026293|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
139026294|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026295|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026296|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139026297|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139026298|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139026299|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026300|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026301|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139026302|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
139026303|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139026304|NCT01018446|Busulfan|busulfan|mesh-list
139026305|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
139026306|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026307|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139026308|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
139026309|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026310|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139026311|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026312|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139026313|NCT01018602|Vildagliptin|vildagliptin|mesh-list
139026314|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139026315|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549301|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139026316|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139026317|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
139026318|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026319|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026320|NCT01018758|Palonosetron|palonosetron|mesh-list
139026321|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
139026322|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
139026323|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026324|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026325|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139026326|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139026327|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139026328|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
139026329|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026330|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026331|NCT00469092|Insulin|insulin|mesh-list
139026332|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139026333|NCT00469092|Metformin|metformin|mesh-list
139026334|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
139026336|NCT00469092|Glimepiride|glimepiride|mesh-list
139026337|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
139026338|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139026339|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026340|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139026341|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139026342|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
139026343|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
139026344|NCT00499616|Carboplatin|carboplatin|mesh-list
139026345|NCT00499616|Doxorubicin|doxorubicin|mesh-list
139026346|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139026347|NCT00499616|Etoposide|etoposide|mesh-list
138984232|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138984233|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984234|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984235|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138984236|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138984237|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
138984238|NCT03161379|Nivolumab|nivolumab|mesh-list
138984239|NCT03161379|Pancrelipase|pancrelipase|mesh-list
138984240|NCT03161379|Vaccines|vaccines|mesh-list
138984241|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
138984242|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138984243|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138984244|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138984245|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139026348|NCT00499616|Topotecan|topotecan|mesh-list
139026349|NCT00499616|Isotretinoin|isotretinoin|mesh-list
139026350|NCT00499616|Lenograstim|lenograstim|mesh-list
139026351|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139026352|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
139026353|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026354|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139026355|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139026356|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
139026357|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026358|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026359|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139026360|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139026361|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139026362|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139026363|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026364|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139026365|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139026366|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139026367|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
139026368|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
139026369|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139026370|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
139026371|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139026372|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
139026373|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887232|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
138984282|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
138984283|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138984284|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138984286|NCT02873338|Idarubicin|idarubicin|mesh-list
138984287|NCT02873338|Heparin|heparin|mesh-list
138984288|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138984289|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
139026374|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026375|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
139026376|NCT00469014|Fludarabine|fludarabine|mesh-list
138549404|NCT00099684|Ezetimibe|ezetimibe|mesh-list
139026377|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
139026378|NCT00469014|Busulfan|busulfan|mesh-list
139026379|NCT00469014|Clofarabine|clofarabine|mesh-list
139026380|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
139026381|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139026382|NCT00469014|Lenograstim|lenograstim|mesh-list
139026383|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026384|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139026385|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
139026386|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026387|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139026388|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
139026389|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026390|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139026391|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
139026392|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139026393|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139026394|NCT00493038|Amoxicillin|amoxicillin|mesh-list
139026395|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
139026396|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
139026397|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
139026398|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139026399|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139026400|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139026401|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026402|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139026403|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139026404|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026405|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026406|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026407|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139026408|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
139026409|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139026410|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026411|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139026412|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139026413|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139026414|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139026415|NCT00392223|Azithromycin|azithromycin|mesh-list
139026416|NCT00392223|Minocycline|minocycline|mesh-list
139026417|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139026418|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026419|NCT00402285|Lycopene|lycopene|mesh-list
139026420|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139026421|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
139026422|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026423|NCT00402285|Protective Agents|protective agents|mesh-ancestor
139026424|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026425|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139026426|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139026427|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026428|NCT00413283|Carboplatin|carboplatin|mesh-list
139026429|NCT00413283|Gemcitabine|gemcitabine|mesh-list
139026430|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026431|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139026432|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
139026433|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026434|NCT00402051|Carboplatin|carboplatin|mesh-list
139026435|NCT00402051|Pemetrexed|pemetrexed|mesh-list
139026436|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026437|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026438|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026439|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139026440|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139026441|NCT00401973|Metformin|metformin|mesh-list
139026442|NCT00401973|Amantadine|amantadine|mesh-list
139026443|NCT00401973|Zonisamide|zonisamide|mesh-list
139026444|NCT00401973|Olanzapine|olanzapine|mesh-list
139026445|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139026446|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026447|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
138549488|NCT00103272|Bortezomib|bortezomib|mesh-list
139026448|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
139026449|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026450|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139026451|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139026452|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139026453|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139026454|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139026455|NCT00401973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139026456|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139026457|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139026458|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026459|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026460|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
139026461|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139026462|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139026463|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
139026464|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026465|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
139026466|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139026467|NCT00401973|Analgesics|analgesics|mesh-ancestor
139026468|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
139026469|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
139026470|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139026471|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139026472|NCT01038453|Vitamin D|vitamin d|mesh-list
139026473|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
139026474|NCT01038453|Vitamins|vitamins|mesh-ancestor
139026475|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
139026476|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026477|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138984346|NCT02517684|Azathioprine|azathioprine|mesh-list
139026478|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139026479|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
139026480|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139026481|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139026482|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026483|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
138777107|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
139026484|NCT00401193|Coagulants|coagulants|mesh-ancestor
139026485|NCT00400569|Sunitinib|sunitinib|mesh-list
139026486|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026487|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138549528|NCT00249223|Risperidone|risperidone|mesh-list
138490691|NCT05419921|Anesthetics|anesthetics|mesh-ancestor
139026488|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139026489|NCT00400569|Growth Substances|growth substances|mesh-ancestor
139026490|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026491|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
139026492|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139026493|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026494|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026496|NCT00413049|Valsartan|valsartan|mesh-list
139026497|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139026498|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139026499|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139026500|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026501|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139026502|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026503|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
139026504|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139026505|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139026506|NCT03732495|Denosumab|denosumab|mesh-list
139026507|NCT03732495|Lenvatinib|lenvatinib|mesh-list
139026509|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139026510|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026511|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026512|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139026513|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026514|NCT01041729|Atorvastatin|atorvastatin|mesh-list
139026515|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139026516|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139026517|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
139026518|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026519|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139026520|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139026521|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026522|NCT01324245|Fenoldopam|fenoldopam|mesh-list
139026523|NCT01324245|Enalaprilat|enalaprilat|mesh-list
139026524|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139026525|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
139026526|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
139026527|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
139026528|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026529|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026530|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026531|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139026532|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
139026533|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026534|NCT00454194|Pemetrexed|pemetrexed|mesh-list
139026535|NCT00454194|Sorafenib|sorafenib|mesh-list
139026536|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026537|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026538|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026539|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139026540|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139026541|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139026542|NCT00468546|Methotrexate|methotrexate|mesh-list
139026543|NCT00468546|Rituximab|rituximab|mesh-list
139026544|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139026545|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
139026546|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139026547|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026548|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139026549|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
139026550|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026551|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026552|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
139026553|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026554|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139026555|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139026556|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
139026557|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139026558|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139026559|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139026561|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
139026562|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026563|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
139026564|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139026565|NCT01064986|Epinephrine|epinephrine|mesh-list
139026566|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139026567|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138984460|NCT01472562|Rituximab|rituximab|mesh-list
139026568|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
139026569|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026570|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026571|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026572|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139026573|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139026574|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
139026575|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026576|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139026577|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
139026578|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
139026579|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
138490766|NCT00001752|Estrogens|estrogens|mesh-list
139026580|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139026581|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139026582|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
139026583|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139026584|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
139026585|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139026586|NCT03980002|Thalidomide|thalidomide|mesh-list
139026587|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139026588|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
139026589|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026590|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
139026591|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139026592|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026593|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139026594|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139026595|NCT03980002|Growth Substances|growth substances|mesh-ancestor
139026596|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
139026597|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026598|NCT00331864|Ranibizumab|ranibizumab|mesh-list
139026599|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139026600|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139026601|NCT00331864|Growth Substances|growth substances|mesh-ancestor
139026602|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026603|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
139026604|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026606|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139026607|NCT00331630|Lapatinib|lapatinib|mesh-list
139026608|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139026609|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026610|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
139026611|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
139026612|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
139026613|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026614|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139026615|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026616|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
139026617|NCT00331552|Doxorubicin|doxorubicin|mesh-list
139026618|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139026619|NCT00331552|Trastuzumab|trastuzumab|mesh-list
139026620|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139026621|NCT00331552|Antibodies|antibodies|mesh-list
139026622|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
139026623|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139026624|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139026625|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
139026626|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026627|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139026628|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139026629|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
138490770|NCT00001758|Efavirenz|efavirenz|mesh-list
139026630|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026631|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549672|NCT00103545|Abagovomab|abagovomab|mesh-list
139026632|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139026633|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139026634|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139026635|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139026636|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026637|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139026638|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026639|NCT00331006|Rituximab|rituximab|mesh-list
139026640|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139026641|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026642|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
139026643|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026644|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139026645|NCT00302458|Methylphenidate|methylphenidate|mesh-list
139026646|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139026647|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026648|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139026649|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139026650|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139026651|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026652|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
139026653|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026654|NCT00391053|Vaccines|vaccines|mesh-list
139026655|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
139026656|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026657|NCT00317044|Esomeprazole|esomeprazole|mesh-list
139026658|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139026659|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139026660|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139026661|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026662|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026664|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
139026665|NCT00301834|Methotrexate|methotrexate|mesh-list
139026666|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
139026667|NCT00301834|Fludarabine|fludarabine|mesh-list
139026668|NCT00301834|Busulfan|busulfan|mesh-list
139026669|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
139026670|NCT00301834|Cyclosporins|cyclosporins|mesh-list
139026671|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139026672|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
139026673|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139026674|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549708|NCT00099957|Vildagliptin|vildagliptin|mesh-list
139026675|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139026676|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
139026677|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026678|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026679|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
139026680|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026681|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139026682|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139026683|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
139026684|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139026685|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139026686|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
139026687|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026688|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139026689|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139026690|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
139026691|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
139026692|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026693|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139026694|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
139026695|NCT00301834|Hormones|hormones|mesh-ancestor
139026696|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139026697|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139026698|NCT00301834|Protective Agents|protective agents|mesh-ancestor
139026699|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
139026700|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139026701|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139026702|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139026703|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
139026704|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139026705|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026706|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026707|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139026708|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139026709|NCT00466440|Prednisone|prednisone|mesh-list
139026710|NCT00466440|Docetaxel|docetaxel|mesh-list
139026711|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026712|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
139026713|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
139026714|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
139026715|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026716|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139026717|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
138549739|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139026719|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139026720|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026721|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139026723|NCT00465972|Temazepam|temazepam|mesh-list
139026724|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138984614|NCT00132301|Prednisone|prednisone|mesh-list
139026725|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138490822|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
139026726|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139026727|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026728|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139026729|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
139026730|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139026731|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
139026732|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
139026733|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026734|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026735|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139026736|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139026737|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
139026738|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
139026740|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139026741|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139026742|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139026743|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
139026744|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026745|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026746|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026747|NCT03926754|Urological Agents|urological agents|mesh-ancestor
139026748|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139026749|NCT00465894|Estradiol|estradiol|mesh-list
139026750|NCT00465894|Estrogens|estrogens|mesh-ancestor
139026751|NCT00465894|Hormones|hormones|mesh-ancestor
139026752|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139026753|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026754|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139026755|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139026756|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
139026757|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026758|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026759|NCT00465894|Urological Agents|urological agents|mesh-ancestor
139026760|NCT00330460|Denosumab|denosumab|mesh-list
139026762|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139026763|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026764|NCT01062490|Treosulfan|treosulfan|mesh-list
139026765|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139026766|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
139026767|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026768|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026769|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
138984649|NCT00184093|Gemcitabine|gemcitabine|mesh-list
139026771|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139026772|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139026773|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139026774|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139026775|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026776|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
139026777|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026778|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026779|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139026780|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026781|NCT00400179|Cisplatin|cisplatin|mesh-list
139026782|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026783|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
139026784|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139026785|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139026786|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026787|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026788|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
139026789|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139026790|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139026791|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026792|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139026793|NCT00464490|Analgesics|analgesics|mesh-ancestor
139026794|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
139026795|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026796|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139026797|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139026798|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139026799|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
139026800|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026801|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026802|NCT00412893|Voriconazole|voriconazole|mesh-list
139026803|NCT00412893|Isavuconazole|isavuconazole|mesh-list
139026804|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
139026805|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026806|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139026807|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139026809|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026810|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139026811|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
139026812|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139026813|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026814|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139026815|NCT00412737|Oseltamivir|oseltamivir|mesh-list
139026816|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
139026817|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026818|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026819|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026821|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139026822|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
139026823|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026824|NCT01041963|Losartan|losartan|mesh-list
139026825|NCT01041963|Enalapril|enalapril|mesh-list
139026826|NCT01041963|Enalaprilat|enalaprilat|mesh-list
139026827|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139026828|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139026829|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139026830|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139026831|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490867|NCT00392470|Irinotecan|irinotecan|mesh-list
139026832|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139026833|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
139026834|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026835|NCT01044225|Cetuximab|cetuximab|mesh-list
139026836|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139026837|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026838|NCT00508274|Capecitabine|capecitabine|mesh-list
139026839|NCT00508274|Lapatinib|lapatinib|mesh-list
139026840|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139026841|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
139026842|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026843|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026844|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139026845|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026846|NCT01042041|Doxorubicin|doxorubicin|mesh-list
139026847|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139026848|NCT01042041|Sorafenib|sorafenib|mesh-list
139026849|NCT01042041|Mitomycins|mitomycins|mesh-list
139026850|NCT01042041|Mitomycin|mitomycin|mesh-list
138984726|NCT00493246|Acetaminophen|acetaminophen|mesh-list
139026851|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026852|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139026853|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139026854|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139026855|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026856|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026857|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139026858|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
139026859|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139026860|NCT00499460|Oxycodone|oxycodone|mesh-list
139026861|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139026862|NCT00499460|Narcotics|narcotics|mesh-ancestor
139026863|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139026864|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026865|NCT00499460|Analgesics|analgesics|mesh-ancestor
139026866|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
139026867|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026868|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
139026869|NCT00412113|Amlodipine|amlodipine|mesh-list
139026870|NCT00412113|Atorvastatin|atorvastatin|mesh-list
139026871|NCT00412113|Calcium|calcium|mesh-list
139026872|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139026873|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026874|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139026875|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139026876|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139026877|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
139026878|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026879|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139026880|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139026881|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026882|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139026883|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139026884|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139026885|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
139026886|NCT01014650|Glycine|glycine|mesh-list
139026887|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
139026888|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139026889|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026890|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026891|NCT00411645|Maribavir|maribavir|mesh-list
139026892|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
139026893|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026894|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139026895|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
139026896|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026897|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
139026898|NCT01039155|Azacitidine|azacitidine|mesh-list
139026899|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026900|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139026901|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
139026902|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026903|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026904|NCT01039233|Bicalutamide|bicalutamide|mesh-list
139026905|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
139026906|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
139026907|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139026908|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026909|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026910|NCT00490646|Docetaxel|docetaxel|mesh-list
139026911|NCT00490646|Trastuzumab|trastuzumab|mesh-list
139026912|NCT00490646|Epothilones|epothilones|mesh-list
139026913|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026914|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
139026915|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
139026916|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
138490916|NCT00386984|Octreotide|octreotide|mesh-list
139026917|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026918|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139026919|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
139026920|NCT03992937|Progesterone|progesterone|mesh-list
139026921|NCT03992937|Progestins|progestins|mesh-ancestor
139026922|NCT03992937|Hormones|hormones|mesh-ancestor
139026923|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139026924|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026925|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139026926|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
139026927|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139026928|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139026929|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139026930|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139026931|NCT01039545|Norfloxacin|norfloxacin|mesh-list
139026932|NCT01039545|Diclofenac|diclofenac|mesh-list
138777551|NCT02620813|Tretinoin|tretinoin|mesh-list
139026933|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139026934|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139026935|NCT01039545|Analgesics|analgesics|mesh-ancestor
139026936|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
139026937|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139026938|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026939|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139026940|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139026941|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139026943|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026944|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139026945|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026946|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139026947|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139026948|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026949|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139026950|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139026951|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
139026952|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139026953|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026954|NCT00561353|Ribavirin|ribavirin|mesh-list
139026955|NCT00561353|Simeprevir|simeprevir|mesh-list
139026956|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
139026957|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026958|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
139026959|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026960|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
139026961|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026962|NCT00944957|Efavirenz|efavirenz|mesh-list
139026963|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
139026964|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139026965|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139026966|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026967|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026968|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
139026969|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026970|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139026971|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139026972|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139026973|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139026974|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139026975|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139026976|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139026977|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139026978|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139026979|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139026980|NCT00945347|Miglustat|miglustat|mesh-list
138549920|NCT02966522|Growth Substances|growth substances|mesh-ancestor
139026981|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139026982|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026984|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139026985|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
139026986|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139026987|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139026988|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139026989|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139026990|NCT00941135|Docetaxel|docetaxel|mesh-list
139026991|NCT00941135|Cetuximab|cetuximab|mesh-list
139026992|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139026993|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
139026994|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
139026995|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
139026996|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139026997|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139026998|NCT00556439|Abatacept|abatacept|mesh-list
139026999|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139027000|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027001|NCT00556439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139027002|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027003|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139027004|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
139027005|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027006|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027007|NCT04012307|Candesartan|candesartan|mesh-list
139027008|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
139027009|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139027010|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139027011|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139027012|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027013|NCT00387465|Azacitidine|azacitidine|mesh-list
139027014|NCT00387465|Entinostat|entinostat|mesh-list
139027015|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139027016|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139027017|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
139027018|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027019|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027020|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027021|NCT01042665|Latanoprost|latanoprost|mesh-list
139027022|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139027023|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139027024|NCT00949949|Gemcitabine|gemcitabine|mesh-list
139027025|NCT00949949|Everolimus|everolimus|mesh-list
139027026|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027027|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139027028|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
139027029|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027030|NCT00949949|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139027031|NCT00949949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139027032|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027033|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139027034|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
139027036|NCT00941369|Insulin|insulin|mesh-list
139027037|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
139027038|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
139027039|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
139027040|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
139027041|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139027042|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027043|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
139027044|NCT00950027|Povidone|povidone|mesh-list
139027045|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
139027046|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
139027047|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139027048|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027049|NCT00941525|Latanoprost|latanoprost|mesh-list
139027050|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139027051|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139027052|NCT00456261|Bevacizumab|bevacizumab|mesh-list
139027053|NCT00456261|Carboplatin|carboplatin|mesh-list
139027054|NCT00456261|Gemcitabine|gemcitabine|mesh-list
139027055|NCT00456261|Pemetrexed|pemetrexed|mesh-list
139027056|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139027057|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027058|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139027059|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139027060|NCT00456261|Growth Substances|growth substances|mesh-ancestor
139027061|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027062|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
139027063|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139027064|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
139027065|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027066|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027067|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139027068|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139027069|NCT00386607|Valsartan|valsartan|mesh-list
139027070|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139027071|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139027072|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139027073|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139027074|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027075|NCT00386607|Diuretics|diuretics|mesh-ancestor
139027076|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
139027077|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027078|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139027079|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139027080|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
139027081|NCT00410163|Fludarabine|fludarabine|mesh-list
139027082|NCT00410163|Ofatumumab|ofatumumab|mesh-list
139027083|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139027084|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139027085|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
139027086|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027087|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027088|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139027089|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
139027090|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027091|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027092|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139027093|NCT03617523|Vaccines|vaccines|mesh-list
139027094|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
139027095|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027096|NCT00409617|Adalimumab|adalimumab|mesh-list
139027097|NCT00409617|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139027098|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139027099|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027100|NCT00300274|Cyclosporine|cyclosporine|mesh-list
139027101|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
139027103|NCT00300274|Cyclosporins|cyclosporins|mesh-list
139027104|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027105|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027106|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139027107|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
139027108|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027109|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
139027110|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027111|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
139027112|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027113|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139027114|NCT00300274|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139027115|NCT00300274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139027116|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027117|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139027118|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139027119|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
139027120|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139027121|NCT01043211|Lidocaine|lidocaine|mesh-list
139027122|NCT01043211|Epinephrine|epinephrine|mesh-list
139027123|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
139027124|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
139027125|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139027126|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027127|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
139027128|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027129|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139027130|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139027131|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139027132|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139027133|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027134|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139027135|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139027136|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
139027137|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027138|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139027139|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139027140|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
139027141|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139027142|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
139027143|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
139027144|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
139027145|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139027146|NCT01043445|Glycerol|glycerol|mesh-list
139027147|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139027148|NCT01043445|Protective Agents|protective agents|mesh-ancestor
139027149|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027150|NCT00396591|Aflibercept|aflibercept|mesh-list
139027151|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139027152|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139027153|NCT00396591|Growth Substances|growth substances|mesh-ancestor
139027154|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777779|NCT02801188|Analgesics|analgesics|mesh-ancestor
139027155|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
139027156|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027157|NCT00316264|Palivizumab|palivizumab|mesh-list
139027159|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027161|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
139027162|NCT00385827|Siltuximab|siltuximab|mesh-list
139027163|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139027164|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
139027165|NCT00385827|Hormones|hormones|mesh-ancestor
139027166|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139027167|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027168|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139027169|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027170|NCT00385827|Analgesics|analgesics|mesh-ancestor
139027171|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
139027172|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027173|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139027174|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139027175|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027176|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027177|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
139027178|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139027179|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
139027180|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027181|NCT00507728|Bupropion|bupropion|mesh-list
139027182|NCT00507728|Varenicline|varenicline|mesh-list
139027183|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139027184|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
139027185|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138550020|NCT00251797|Growth Substances|growth substances|mesh-ancestor
139027186|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139027187|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139027188|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139027189|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027190|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
139027191|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027192|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027193|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139027194|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139027195|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027196|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139027197|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139027198|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
139027199|NCT00498368|Rituximab|rituximab|mesh-list
139027200|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
139027201|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139027202|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027203|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
138984958|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139027204|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027205|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027206|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139027207|NCT04460066|Paclitaxel|paclitaxel|mesh-list
139027208|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139027209|NCT04460066|Antibodies|antibodies|mesh-list
139027210|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139027211|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027212|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
139027213|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
139027214|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
139027215|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027216|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
139027217|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027218|NCT00385671|Pregabalin|pregabalin|mesh-list
139027219|NCT00385671|Gabapentin|gabapentin|mesh-list
139027220|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139027221|NCT00385671|Analgesics|analgesics|mesh-ancestor
139027222|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
139027223|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027224|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027225|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
139027226|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139027227|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139027228|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027229|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139027230|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139027231|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138777850|NCT00872989|Docetaxel|docetaxel|mesh-list
139027232|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139027233|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139027234|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139027235|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139027236|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027237|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
139027238|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139027239|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139027240|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
139027241|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
139027242|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
139027243|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139027244|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
139027245|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139027246|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139027247|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139027248|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139027249|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027250|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
139027251|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027252|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027253|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139027254|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027256|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139027257|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139027258|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139027259|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139027260|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027261|NCT00490490|Iodine|iodine|mesh-list
139027262|NCT00490490|Lugol's solution|lugol's solution|mesh-list
139027263|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139027264|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139027265|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027266|NCT00490490|Trace Elements|trace elements|mesh-ancestor
139027267|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
139027268|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027269|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
139027270|NCT00490490|Coagulants|coagulants|mesh-ancestor
139027271|NCT05049980|Mifepristone|mifepristone|mesh-list
139027272|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139027273|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
139027274|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139027275|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027276|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139027277|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139027278|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139027279|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
139027280|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139027281|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139027282|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
139027283|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139027284|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
139027285|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139027286|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139027288|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
139027289|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139027290|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139027291|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139027292|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
139027293|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027294|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027295|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139027296|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
139027297|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
139027298|NCT00385593|Hormones|hormones|mesh-ancestor
139027299|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139027300|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139027301|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139027302|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139027303|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
139027304|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027305|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027307|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139027308|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139027309|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
139027310|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027311|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027312|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027313|NCT01015040|Urological Agents|urological agents|mesh-ancestor
139027315|NCT00495170|Carboplatin|carboplatin|mesh-list
139027316|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139027317|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027318|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
139027319|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
139027320|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
139027321|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027322|NCT01011374|Ranibizumab|ranibizumab|mesh-list
139027323|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139027324|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139027325|NCT01011374|Growth Substances|growth substances|mesh-ancestor
139027326|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027327|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
139027328|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027329|NCT00385203|Cediranib|cediranib|mesh-list
139027330|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027331|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139027332|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027333|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027334|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
139027335|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139027336|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
139027337|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027338|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027339|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139027340|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
139027341|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139027342|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139027343|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139027344|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
139027345|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027346|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027347|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139027348|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
139027349|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139027350|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139027351|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139027352|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139027353|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027354|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139027355|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139027356|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139027357|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139027358|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027359|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027360|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027361|NCT00408993|Analgesics|analgesics|mesh-ancestor
139027362|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
139027363|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027364|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
139027365|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139027366|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
139027367|NCT00395967|Plerixafor|plerixafor|mesh-list
139027368|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139027369|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139027370|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
139027371|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027372|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139027373|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139027374|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027375|NCT00395343|Incretins|incretins|mesh-ancestor
139027376|NCT00395343|Hormones|hormones|mesh-ancestor
138778000|NCT02689882|Vitamins|vitamins|mesh-ancestor
139027377|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139027378|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139027379|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
139027380|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027381|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027382|NCT00560573|Gemcitabine|gemcitabine|mesh-list
139027383|NCT00560573|Pemetrexed|pemetrexed|mesh-list
139027384|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027385|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139027386|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
139027387|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027388|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027389|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139027390|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139027391|NCT00950105|Semapimod|semapimod|mesh-list
139027392|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139027393|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139027394|NCT00950105|Analgesics|analgesics|mesh-ancestor
138550187|NCT00100464|Paroxetine|paroxetine|mesh-list
139027395|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
139027396|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027397|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027398|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139027399|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027400|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139027401|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
139027403|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027404|NCT05280197|Bupivacaine|bupivacaine|mesh-list
139027405|NCT05280197|Anesthetics, Local|anesthetics, local|mesh-ancestor
139027406|NCT05280197|Anesthetics|anesthetics|mesh-ancestor
139027407|NCT05280197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139027408|NCT05280197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027409|NCT05280197|Sensory System Agents|sensory system agents|mesh-ancestor
139027410|NCT05280197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027411|NCT00946595|Ritonavir|ritonavir|mesh-list
139027412|NCT00946595|Lopinavir|lopinavir|mesh-list
139027413|NCT00946595|Tenofovir|tenofovir|mesh-list
139027414|NCT00946595|Efavirenz|efavirenz|mesh-list
139027415|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139027416|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139027417|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
139027418|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027419|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027420|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139027421|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139027422|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
139027423|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027424|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139027425|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139027426|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139027427|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139027428|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139027429|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139027430|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138985090|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
139027431|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139027432|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139027434|NCT00494780|Prednisolone|prednisolone|mesh-list
139027435|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
139027436|NCT00494780|Doxorubicin|doxorubicin|mesh-list
139027437|NCT00494780|Vincristine|vincristine|mesh-list
139027438|NCT00494780|Ofatumumab|ofatumumab|mesh-list
139027439|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139027440|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
139027441|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027442|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027443|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139027444|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
139027445|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027446|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027447|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139027448|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139027449|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139027450|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138778079|NCT02789566|Primaquine|primaquine|mesh-list
139027451|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027452|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139027453|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
139027455|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139027456|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139027457|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139027458|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
139027459|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
139027460|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
139027461|NCT01011452|Montelukast|montelukast|mesh-list
139027462|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139027463|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
139027464|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139027465|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
139027466|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139027467|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027468|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139027469|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139027470|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027471|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
139027472|NCT00490022|Androgens|androgens|mesh-ancestor
139027473|NCT00490022|Hormones|hormones|mesh-ancestor
139027474|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139027475|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027476|NCT01011530|Pevonedistat|pevonedistat|mesh-list
139027477|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027478|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027479|NCT00493454|Rituximab|rituximab|mesh-list
139027480|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139027481|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139027482|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027483|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
139027484|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027485|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027486|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
139027487|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139027488|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027489|NCT00950339|Omeprazole|omeprazole|mesh-list
139027490|NCT00950339|Pantoprazole|pantoprazole|mesh-list
139027491|NCT00950339|Famotidine|famotidine|mesh-list
139027492|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139027493|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139027494|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139027495|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550225|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027496|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027497|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139027498|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
139027499|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
139027500|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027501|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027502|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
139027503|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139027504|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027505|NCT00946673|Vorinostat|vorinostat|mesh-list
139027506|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027507|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139027508|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027509|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027510|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
139027511|NCT00394953|Hematinics|hematinics|mesh-ancestor
139027512|NCT00946751|Levetiracetam|levetiracetam|mesh-list
139027513|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
139027514|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
139027515|NCT00485732|Vaccines|vaccines|mesh-list
139027516|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
139027517|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027518|NCT00946829|Telmisartan|telmisartan|mesh-list
139027519|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139027520|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139027521|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139027522|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027523|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139027524|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
139027525|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027526|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
139027527|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
139027528|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139027529|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027530|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027531|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
139027532|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139027533|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139027534|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027535|NCT00560417|Insulin|insulin|mesh-list
139027536|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139027537|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
139027538|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
139027539|NCT00560417|Protamines|protamines|mesh-list
139027540|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139027541|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027542|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
139027543|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027544|NCT00560417|Coagulants|coagulants|mesh-ancestor
139027545|NCT01040091|Tenofovir|tenofovir|mesh-list
139027546|NCT01040091|Emtricitabine|emtricitabine|mesh-list
139027547|NCT01040091|Efavirenz|efavirenz|mesh-list
139027548|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139027549|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
139027550|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027551|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139027552|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139027553|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027554|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027555|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139027556|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139027557|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139027558|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139027559|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139027560|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139027561|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139027562|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139027563|NCT00946907|Aspirin|aspirin|mesh-list
139027564|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139027565|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139027566|NCT00946907|Analgesics|analgesics|mesh-ancestor
139027567|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
139027568|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027569|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027570|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139027571|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027572|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139027573|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139027574|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027575|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139027576|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139027577|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027578|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
139027579|NCT00942539|Midazolam|midazolam|mesh-list
139027580|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139027581|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139027582|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139027583|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027584|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139027585|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139027586|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139027587|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139027588|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
139027589|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
139027590|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
139027591|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
139027592|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027593|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027594|NCT00947063|Promethazine|promethazine|mesh-list
139027595|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
139027596|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
139027597|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
139027598|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139027599|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
139027600|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
139027601|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027602|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027603|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027604|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139027605|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139027606|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139027607|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139027608|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
139027609|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
139027610|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
139027611|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027612|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
139027613|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
139027614|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139027616|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139027617|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139027618|NCT00942617|Analgesics|analgesics|mesh-ancestor
139027619|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
139027620|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027621|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027622|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139027623|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027624|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139027625|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139027626|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027627|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139027628|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139027629|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027631|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
139027632|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139027633|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027634|NCT03968159|Pimavanserin|pimavanserin|mesh-list
139027635|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139027636|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139027637|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139027638|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139027639|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139027640|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027641|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139027642|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139027643|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139027644|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
139027645|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027646|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027647|NCT00947141|Valganciclovir|valganciclovir|mesh-list
139027648|NCT00947141|Ganciclovir|ganciclovir|mesh-list
139027649|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
139027650|NCT00947141|Foscarnet|foscarnet|mesh-list
139027651|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
139027652|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
139027653|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027654|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139027655|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027656|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027657|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139027658|NCT03966365|Timolol|timolol|mesh-list
139027659|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139027660|NCT03966365|Dorzolamide|dorzolamide|mesh-list
139027661|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139027662|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139027663|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
139027664|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027665|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027666|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027667|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139027668|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139027669|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138550342|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
139027670|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139027671|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139027672|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139027673|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027675|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139027676|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027677|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139027678|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027679|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027680|NCT03965351|Probenecid|probenecid|mesh-list
139027681|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
139027682|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
139027683|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027684|NCT00947375|Lamotrigine|lamotrigine|mesh-list
139027685|NCT00947375|Haloperidol|haloperidol|mesh-list
139027686|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
139027687|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
139027688|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
139027689|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027690|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027691|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139027692|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139027693|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139027694|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139027695|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139027696|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139027697|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
139027698|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027699|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027700|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139027701|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
139027702|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139027703|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139027704|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139027705|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139027706|NCT00947453|Montelukast|montelukast|mesh-list
139027707|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139027708|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
139027709|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139027710|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
139027711|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139027712|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027713|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139027714|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139027715|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027716|NCT00942773|Voriconazole|voriconazole|mesh-list
139027717|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
139027718|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027719|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139027720|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139027721|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027722|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027723|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139027724|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
139027725|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139027726|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027727|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139027728|NCT00374907|Metformin|metformin|mesh-list
139027729|NCT00374907|Saxagliptin|saxagliptin|mesh-list
139027730|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139027731|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027732|NCT00374907|Incretins|incretins|mesh-ancestor
139027733|NCT00374907|Hormones|hormones|mesh-ancestor
139027734|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139027735|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139027736|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
139027737|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027738|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027739|NCT01045083|Methylphenidate|methylphenidate|mesh-list
139027740|NCT01045083|Escitalopram|escitalopram|mesh-list
138985324|NCT00709553|Midazolam|midazolam|mesh-list
139027741|NCT01045083|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139027742|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139027743|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139027744|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027746|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
139027747|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027748|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139027749|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139027750|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
139027752|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
139027753|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027754|NCT00947843|Aspirin|aspirin|mesh-list
139027755|NCT00947843|Clopidogrel|clopidogrel|mesh-list
139027756|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139027757|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139027758|NCT00947843|Analgesics|analgesics|mesh-ancestor
139027759|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
139027760|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027761|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027762|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139027763|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027764|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139027765|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139027766|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027767|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139027768|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139027769|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027770|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
139027771|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139027772|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139027773|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139027774|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
139027775|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027776|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
139027777|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
139027778|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139027779|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027780|NCT00407745|Pregabalin|pregabalin|mesh-list
139027781|NCT00407745|Analgesics|analgesics|mesh-ancestor
139027782|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
139027783|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027784|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027785|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
138491335|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
139027786|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139027787|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139027788|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027789|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139027790|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139027791|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138550440|NCT00255385|Micronutrients|micronutrients|mesh-list
139027792|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139027793|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139027795|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139027796|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139027797|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139027798|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027799|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027801|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139027802|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139027803|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027804|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
139027805|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027806|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027807|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139027808|NCT00299494|Immunotoxins|immunotoxins|mesh-ancestor
139027809|NCT00299494|Immunoconjugates|immunoconjugates|mesh-ancestor
139027810|NCT00943553|Decitabine|decitabine|mesh-list
139027811|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139027812|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
139027813|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027814|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027815|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027816|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
139027817|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139027818|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
139027819|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027820|NCT00453180|Expectorants|expectorants|mesh-ancestor
139027821|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
139027822|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139027823|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
139027824|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027825|NCT00453180|Protective Agents|protective agents|mesh-ancestor
139027826|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027827|NCT00453180|Antidotes|antidotes|mesh-ancestor
139027828|NCT00943709|Insulin|insulin|mesh-list
139027829|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139027830|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
139027831|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139027832|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027833|NCT00464178|Bortezomib|bortezomib|mesh-list
139027834|NCT00464178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027835|NCT00316186|Carboplatin|carboplatin|mesh-list
139027836|NCT00316186|Topotecan|topotecan|mesh-list
139027837|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027838|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139027839|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138985377|NCT00946608|Loratadine|loratadine|mesh-list
139027840|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027841|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027842|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
139027843|NCT01065220|Testolactone|testolactone|mesh-list
139027844|NCT01065220|Lynestrenol|lynestrenol|mesh-list
139027845|NCT01065220|Estradiol|estradiol|mesh-list
139027846|NCT01065220|Cyproterone|cyproterone|mesh-list
139027847|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
139027848|NCT01065220|Estrogens|estrogens|mesh-ancestor
139027849|NCT01065220|Hormones|hormones|mesh-ancestor
139027850|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139027851|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027852|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139027853|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
139027854|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139027855|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139027856|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
139027857|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
139027858|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027859|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139027860|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139027861|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027862|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027863|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139027864|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139027865|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139027866|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139027867|NCT00943943|Plerixafor|plerixafor|mesh-list
139027868|NCT00943943|Sorafenib|sorafenib|mesh-list
139027869|NCT00943943|Lenograstim|lenograstim|mesh-list
139027870|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138985394|NCT00463606|Calcium|calcium|mesh-list
139027871|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139027872|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027873|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027874|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139027875|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
139027876|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027877|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139027878|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139027879|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
138491369|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
139027880|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027881|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139027882|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139027883|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139027884|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
139027885|NCT00453102|Rituximab|rituximab|mesh-list
139027886|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139027887|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027888|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
139027889|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027890|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027891|NCT00299182|Cytarabine|cytarabine|mesh-list
139027892|NCT00299182|Dexamethasone|dexamethasone|mesh-list
139027893|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
139027894|NCT00299182|Rituximab|rituximab|mesh-list
139027895|NCT00299182|Doxorubicin|doxorubicin|mesh-list
138778532|NCT01106352|Docetaxel|docetaxel|mesh-list
139027896|NCT00299182|Methotrexate|methotrexate|mesh-list
139027897|NCT00299182|Vincristine|vincristine|mesh-list
139027898|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139027899|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
139027900|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027901|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139027902|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139027903|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
139027904|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027905|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027906|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139027907|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139027908|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
139027909|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
139027910|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027911|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139027912|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
139027913|NCT00299182|Hormones|hormones|mesh-ancestor
139027914|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139027915|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139027916|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139027917|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139027918|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139027919|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139027920|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027921|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139027922|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
139027923|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139027924|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139027925|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
139027926|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
139027927|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138550546|NCT00070187|Interferons|interferons|mesh-list
139027928|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139027929|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
139027931|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139027932|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
139027933|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
139027934|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
139027935|NCT00467142|Leucovorin|leucovorin|mesh-list
139027936|NCT00467142|Bevacizumab|bevacizumab|mesh-list
139027937|NCT00467142|Fluorouracil|fluorouracil|mesh-list
139027938|NCT00467142|Irinotecan|irinotecan|mesh-list
139027939|NCT00467142|Calcium|calcium|mesh-list
139027940|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
139027941|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139027942|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139027943|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139027944|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139027945|NCT00467142|Growth Substances|growth substances|mesh-ancestor
139027946|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027947|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
139027948|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139027949|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
139027950|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027951|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139027952|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139027953|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
139027954|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139027955|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139027956|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139027957|NCT00467142|Antidotes|antidotes|mesh-ancestor
139027958|NCT00467142|Protective Agents|protective agents|mesh-ancestor
139027959|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
139027960|NCT00467142|Vitamins|vitamins|mesh-ancestor
139027961|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
139027962|NCT01065376|Cabergoline|cabergoline|mesh-list
139027963|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139027964|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139027965|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
139027966|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
139027967|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027968|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027969|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027970|NCT00944177|Metformin|metformin|mesh-list
139027971|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138274608|NCT00362245|Amikacin|amikacin|mesh-list
139027972|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027973|NCT00553475|Pregabalin|pregabalin|mesh-list
139027974|NCT00553475|Analgesics|analgesics|mesh-ancestor
139027975|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
139027976|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139027977|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027979|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139027980|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139027981|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027982|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139027983|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139027984|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139027985|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139027986|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139027987|NCT00329602|Ropinirole|ropinirole|mesh-list
139027988|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139027989|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139027990|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
139027991|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
139027992|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139027993|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139027994|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139027995|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
139027996|NCT01060696|Scopolamine|scopolamine|mesh-list
139027997|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139027998|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139027999|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
139028000|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
139028001|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028002|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028003|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139028004|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
139028005|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139028006|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
139028007|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028008|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028009|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139028010|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
139028011|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139028012|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139028013|NCT01060696|Analgesics|analgesics|mesh-ancestor
139028014|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
139028015|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028016|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139028017|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139028018|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028019|NCT01065610|Oxytocin|oxytocin|mesh-list
139028020|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
139028021|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139028022|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028023|NCT00463866|Budesonide|budesonide|mesh-list
139028024|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
139028025|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028026|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139028027|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
139028028|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028029|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028030|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139028031|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
139028032|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
139028033|NCT00463866|Hormones|hormones|mesh-ancestor
139028034|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139028035|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139028036|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139028037|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139028038|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
139028039|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028040|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028041|NCT00313846|Buprenorphine|buprenorphine|mesh-list
139028042|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139028043|NCT00313846|Narcotics|narcotics|mesh-ancestor
139028044|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139028045|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028046|NCT00313846|Analgesics|analgesics|mesh-ancestor
139028047|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
139028048|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028049|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139028050|NCT00949247|Bevacizumab|bevacizumab|mesh-list
139028051|NCT00949247|Trastuzumab|trastuzumab|mesh-list
139028052|NCT00949247|Carboplatin|carboplatin|mesh-list
139028053|NCT00949247|Docetaxel|docetaxel|mesh-list
139028054|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139028055|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028056|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139028057|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139028058|NCT00949247|Growth Substances|growth substances|mesh-ancestor
139028059|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028060|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
139028061|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
139028062|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
139028063|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
139028064|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028066|NCT00551135|Analgesics|analgesics|mesh-ancestor
139028067|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
139028068|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028069|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028070|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
139028071|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139028072|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139028073|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028074|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139028075|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139028076|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139028077|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139028078|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139028079|NCT00944333|Clopidogrel|clopidogrel|mesh-list
139028080|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139028081|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139028082|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139028083|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139028084|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
139028085|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028086|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028087|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028088|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
139028089|NCT00299104|Rituximab|rituximab|mesh-list
139028090|NCT00299104|Methotrexate|methotrexate|mesh-list
139028091|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139028092|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028093|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
139028094|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028095|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139028096|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139028097|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
139028098|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139028099|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139028100|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
139028101|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028102|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
139028103|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028104|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139028105|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139028106|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139028107|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028108|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
139028109|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
139028110|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138550642|NCT00256321|Analgesics|analgesics|mesh-ancestor
139028111|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139028112|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
139028113|NCT00299104|Hormones|hormones|mesh-ancestor
139028114|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139028115|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139028116|NCT00299104|Protective Agents|protective agents|mesh-ancestor
139028117|NCT03979456|Rituximab|rituximab|mesh-list
139028118|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138985555|NCT00168805|Enoxaparin|enoxaparin|mesh-list
139028119|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028120|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
139028121|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028122|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139028124|NCT00313612|Topotecan|topotecan|mesh-list
139028125|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028126|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139028127|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139028128|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028129|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028130|NCT00507416|Thalidomide|thalidomide|mesh-list
139028131|NCT00507416|Dexamethasone|dexamethasone|mesh-list
139028132|NCT00507416|Prednisone|prednisone|mesh-list
139028133|NCT00507416|Bortezomib|bortezomib|mesh-list
139028134|NCT00507416|Melphalan|melphalan|mesh-list
139028135|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028136|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
139028137|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
139028138|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028139|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028140|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139028141|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
139028142|NCT00507416|Hormones|hormones|mesh-ancestor
139028143|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139028144|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139028145|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028146|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139028147|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
138491486|NCT00387413|Niacinamide|niacinamide|mesh-list
139028148|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028149|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139028150|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139028151|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
139028152|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
139028153|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139028154|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139028155|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139028156|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139028157|NCT00507416|Growth Substances|growth substances|mesh-ancestor
139028158|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
139028159|NCT00489476|Loxapine|loxapine|mesh-list
139028160|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139028161|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139028162|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139028163|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028164|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139028165|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139028166|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
139028167|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028168|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028169|NCT04216043|Caseins|caseins|mesh-list
139028170|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
139028171|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
139028172|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028173|NCT00957125|Bevacizumab|bevacizumab|mesh-list
139028174|NCT00957125|Docetaxel|docetaxel|mesh-list
139028175|NCT00957125|Epirubicin|epirubicin|mesh-list
139028176|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139028177|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028178|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139028179|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139028180|NCT00957125|Growth Substances|growth substances|mesh-ancestor
139028181|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028182|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
139028183|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
139028184|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
139028185|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
139028186|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028187|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139028188|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139028189|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139028190|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028191|NCT00957203|Istradefylline|istradefylline|mesh-list
139028192|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
139028193|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139028194|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139028195|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
139028196|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028197|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028198|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028199|NCT00952913|Lansoprazole|lansoprazole|mesh-list
139028200|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
139028201|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139028202|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139028203|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139028204|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028205|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028206|NCT00952991|Vildagliptin|vildagliptin|mesh-list
139028207|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139028208|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028209|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139028210|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
139028211|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028212|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028213|NCT00953303|Dexamethasone|dexamethasone|mesh-list
138985590|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
139028214|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
139028215|NCT00953303|Prednisone|prednisone|mesh-list
139028216|NCT00953303|Torsemide|torsemide|mesh-list
139028217|NCT00953303|Dobutamine|dobutamine|mesh-list
139028218|NCT00953303|Dopamine|dopamine|mesh-list
139028219|NCT00953303|Furosemide|furosemide|mesh-list
139028220|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
139028221|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
139028222|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139028223|NCT00953303|BB 1101|bb 1101|mesh-list
139028224|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028225|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
139028226|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
139028227|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028228|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028229|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139028230|NCT00953303|Hormones|hormones|mesh-ancestor
139028231|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139028232|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139028233|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028234|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
139028235|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028236|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028237|NCT00953303|Diuretics|diuretics|mesh-ancestor
139028238|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
139028239|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139028240|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139028241|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
139028242|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139028243|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
139028244|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139028245|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139028246|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139028247|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
139028248|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028249|NCT00953303|Protective Agents|protective agents|mesh-ancestor
139028250|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
139028251|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139028252|NCT05300555|Warfarin|warfarin|mesh-list
139028253|NCT05300555|Rivaroxaban|rivaroxaban|mesh-list
139028254|NCT05300555|Anticoagulants|anticoagulants|mesh-ancestor
139028255|NCT05300555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139028256|NCT05300555|Antithrombins|antithrombins|mesh-ancestor
139028257|NCT05300555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139028258|NCT05300555|Protease Inhibitors|protease inhibitors|mesh-ancestor
139028259|NCT05300555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028260|NCT05300555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028261|NCT04010669|Somatostatin|somatostatin|mesh-list
139028262|NCT04010669|Hormones|hormones|mesh-ancestor
139028263|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139028264|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028265|NCT00452790|Vaccines|vaccines|mesh-list
139028266|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139028267|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
139028268|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028269|NCT00953381|Omeprazole|omeprazole|mesh-list
139028270|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139028271|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139028272|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139028273|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028274|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028275|NCT05300477|Acetazolamide|acetazolamide|mesh-list
139028276|NCT05300477|Epoetin Alfa|epoetin alfa|mesh-list
139028277|NCT05300477|Hematinics|hematinics|mesh-ancestor
139028278|NCT05300477|Anticonvulsants|anticonvulsants|mesh-ancestor
139028279|NCT05300477|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139028280|NCT05300477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028281|NCT05300477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028282|NCT05300477|Diuretics|diuretics|mesh-ancestor
139028283|NCT05300477|Natriuretic Agents|natriuretic agents|mesh-ancestor
139028284|NCT05300477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028286|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139028287|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028288|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139028289|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139028290|NCT00953459|Growth Substances|growth substances|mesh-ancestor
139028291|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028292|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
139028293|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139028294|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028295|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028296|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139028297|NCT00953537|Capecitabine|capecitabine|mesh-list
139028298|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139028299|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
139028300|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028301|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028302|NCT00463788|Cisplatin|cisplatin|mesh-list
139028303|NCT00463788|Cetuximab|cetuximab|mesh-list
139028304|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028305|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139028306|NCT00548249|Iron|iron|mesh-list
139028307|NCT00548249|Trace Elements|trace elements|mesh-ancestor
139028308|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
139028309|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028310|NCT01025466|Memantine|memantine|mesh-list
139028311|NCT01025466|Rivastigmine|rivastigmine|mesh-list
139028312|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139028313|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139028314|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
138276880|NCT00005637|Temozolomide|temozolomide|mesh-list
139028315|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028316|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028317|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028318|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139028319|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139028320|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139028321|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028322|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
139028323|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139028324|NCT01025466|Protective Agents|protective agents|mesh-ancestor
139028325|NCT01025544|Vaccines|vaccines|mesh-list
139028326|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
139028327|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028328|NCT03839940|Dexamethasone|dexamethasone|mesh-list
139028329|NCT03839940|Everolimus|everolimus|mesh-list
139028330|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028331|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
139028332|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
139028333|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028334|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028335|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139028336|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
139028337|NCT03839940|Hormones|hormones|mesh-ancestor
139028338|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139028339|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139028340|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028341|NCT03839940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139028342|NCT03839940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139028343|NCT03839940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028344|NCT03839940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028345|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139028346|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
139028347|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
139028348|NCT01027494|Dexamethasone|dexamethasone|mesh-list
139028349|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028350|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
139028351|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
139028352|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028353|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028354|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138550788|NCT00257140|Levofloxacin|levofloxacin|mesh-list
139028355|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
139028356|NCT01027494|Hormones|hormones|mesh-ancestor
139028357|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139028358|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139028359|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028360|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139028361|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139028362|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139028363|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139028364|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028365|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028366|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139028367|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139028368|NCT00462462|Ethanol|ethanol|mesh-list
139028369|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139028370|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139028371|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139028372|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028373|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
139028374|NCT00462384|Hematinics|hematinics|mesh-ancestor
139028375|NCT00452400|Olodaterol|olodaterol|mesh-list
139028376|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139028377|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
139028378|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028379|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138985723|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
139028380|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139028381|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
139028382|NCT01566474|Melatonin|melatonin|mesh-list
139028383|NCT01566474|Omeprazole|omeprazole|mesh-list
139028384|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
139028385|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028386|NCT01566474|Protective Agents|protective agents|mesh-ancestor
139028387|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028388|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139028389|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139028390|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139028391|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139028392|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028393|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
139028394|NCT01025778|Thiotepa|thiotepa|mesh-list
139028395|NCT01025778|Etoposide|etoposide|mesh-list
139028396|NCT01025778|Clofarabine|clofarabine|mesh-list
139028397|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139028398|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
139028399|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028400|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139028401|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139028402|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
139028403|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028404|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028405|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139028406|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139028407|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139028408|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139028409|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028410|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139028411|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
139028412|NCT00443430|Prednisone|prednisone|mesh-list
139028413|NCT00443430|Prednisolone|prednisolone|mesh-list
139028414|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139028415|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
139028416|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139028417|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
139028418|NCT00443430|Etanercept|etanercept|mesh-list
139028419|NCT00443430|Methotrexate|methotrexate|mesh-list
139028420|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139028421|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
139028422|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028423|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
139028424|NCT00443430|Hormones|hormones|mesh-ancestor
138779059|NCT04187807|Melatonin|melatonin|mesh-list
138491583|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
139028425|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139028426|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028427|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139028428|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028429|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139028430|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
139028431|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139028432|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138985755|NCT02573519|Acetylcholine|acetylcholine|mesh-list
139028433|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
139028434|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028435|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
139028436|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028437|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139028438|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139028439|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
139028440|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139028441|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139028442|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
139028443|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
139028444|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028445|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139028446|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139028447|NCT00443430|Protective Agents|protective agents|mesh-ancestor
139028448|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139028449|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139028450|NCT00443430|Analgesics|analgesics|mesh-ancestor
139028451|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
139028452|NCT01022658|Insulin|insulin|mesh-list
139028453|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
139028454|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
139028455|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139028456|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028457|NCT01022736|Gabapentin|gabapentin|mesh-list
139028458|NCT01022736|Analgesics|analgesics|mesh-ancestor
139028459|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
139028460|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028461|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028462|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
139028463|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139028464|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139028465|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139028466|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139028467|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139028468|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139028469|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028470|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028471|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
139028472|NCT01025934|Bevacizumab|bevacizumab|mesh-list
139028473|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138985786|NCT00718601|Imetelstat|imetelstat|mesh-list
139028474|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028475|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139028476|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139028477|NCT01025934|Growth Substances|growth substances|mesh-ancestor
139028478|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028479|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
139028480|NCT01026090|Dronedarone|dronedarone|mesh-list
139028481|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139028482|NCT00460746|Ritonavir|ritonavir|mesh-list
139028483|NCT00460746|Darunavir|darunavir|mesh-list
139028484|NCT00460746|Etravirine|etravirine|mesh-list
139028485|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139028486|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139028487|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
139028488|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028489|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028490|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139028491|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139028492|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
139028493|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139028494|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139028495|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139028496|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139028497|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139028498|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
139028499|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
139028500|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139028501|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139028502|NCT01025700|Nabilone|nabilone|mesh-list
139028503|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
139028504|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
139028505|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028506|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028507|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139028508|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139028509|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139028510|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139028511|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139028512|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139028513|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028514|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139028515|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028516|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028518|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028519|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139028520|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028521|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028522|NCT00442962|Tenofovir|tenofovir|mesh-list
139028523|NCT00442962|Emtricitabine|emtricitabine|mesh-list
139028524|NCT00442962|Efavirenz|efavirenz|mesh-list
139028525|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139028526|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
139028527|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139028528|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139028529|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138985818|NCT00957216|Ubiquinone|ubiquinone|mesh-list
139028530|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028531|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028532|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139028533|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139028534|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139028535|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139028536|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139028537|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139028538|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139028539|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139028540|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139028541|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
139028542|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139028543|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028544|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028545|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139028546|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139028547|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139028548|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028549|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139028550|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
139028551|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
139028552|NCT01026636|Cephalosporins|cephalosporins|mesh-list
139028553|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139028554|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139028555|NCT00313300|Apixaban|apixaban|mesh-list
139028556|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139028557|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
139028558|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139028559|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
139028560|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028561|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028562|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
139028563|NCT00459186|Prednisone|prednisone|mesh-list
139028564|NCT00459186|Docetaxel|docetaxel|mesh-list
139028565|NCT00459186|Everolimus|everolimus|mesh-list
139028566|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028567|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
138550945|NCT00258193|Linaclotide|linaclotide|mesh-list
139028568|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
139028569|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
139028570|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028571|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028572|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
139028573|NCT00459186|Hormones|hormones|mesh-ancestor
139028574|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138779261|NCT01198574|Iron|iron|mesh-list
139028575|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028576|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139028577|NCT00459186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139028578|NCT00459186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139028579|NCT00459186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028580|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139028581|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
139028583|NCT01026714|Fluconazole|fluconazole|mesh-list
139028584|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
139028585|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139028586|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
139028587|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139028588|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139028589|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
139028590|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139028591|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028592|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028593|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139028594|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139028595|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139028596|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139028597|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139028598|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139028599|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
139028600|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139028601|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138985855|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
139028602|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139028603|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
139028604|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139028605|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028606|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139028607|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139028608|NCT01026714|Analgesics|analgesics|mesh-ancestor
139028609|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
139028610|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028611|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139028612|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139028613|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028614|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139028615|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139028616|NCT03996252|Calcitriol|calcitriol|mesh-list
139028617|NCT03996252|Fluorouracil|fluorouracil|mesh-list
139028618|NCT03996252|Calcipotriene|calcipotriene|mesh-list
139028619|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
139028620|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028621|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139028622|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028623|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139028624|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
139028625|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028626|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
139028627|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139028628|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139028629|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139028630|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139028631|NCT03996252|Vitamins|vitamins|mesh-ancestor
139028632|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
139028633|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139028634|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
139028635|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139028636|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028637|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028638|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139028639|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139028640|NCT00459108|Dasatinib|dasatinib|mesh-list
139028641|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028642|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139028643|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028644|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028645|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
139028646|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139028647|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028648|NCT00450450|Lenograstim|lenograstim|mesh-list
139028649|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139028651|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028652|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
139028653|NCT03440892|Methotrexate|methotrexate|mesh-list
139028654|NCT03440892|Abatacept|abatacept|mesh-list
139028655|NCT03440892|Tofacitinib|tofacitinib|mesh-list
139028656|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139028657|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
139028658|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139028659|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028660|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139028661|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
139028662|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028663|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028664|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
139028665|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028666|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139028667|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139028668|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
139028669|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139028670|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139028671|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139028672|NCT03440892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138985946|NCT00506415|Rivastigmine|rivastigmine|mesh-list
139028673|NCT03440892|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139028674|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139028675|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139028676|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139028677|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139028678|NCT03440892|Analgesics|analgesics|mesh-ancestor
139028679|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
139028680|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028681|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028682|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139028683|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139028684|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
139028685|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139028686|NCT01023360|Esomeprazole|esomeprazole|mesh-list
139028687|NCT01023360|Rabeprazole|rabeprazole|mesh-list
138491732|NCT01464697|Hormones|hormones|mesh-ancestor
139028688|NCT01023360|Pantoprazole|pantoprazole|mesh-list
139028689|NCT01023360|Clopidogrel|clopidogrel|mesh-list
139028690|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139028691|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139028692|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139028693|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138551034|NCT00258739|Carboplatin|carboplatin|mesh-list
139028694|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139028695|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
139028696|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028697|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028698|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028699|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139028700|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139028701|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028702|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
139028703|NCT00442416|Hematinics|hematinics|mesh-ancestor
139028704|NCT00441792|Midazolam|midazolam|mesh-list
139028705|NCT00441792|Etomidate|etomidate|mesh-list
139028706|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139028707|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139028708|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138985987|NCT00952302|Iron|iron|mesh-list
139028709|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028710|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139028711|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139028712|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139028713|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139028714|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
139028715|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
139028716|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
139028717|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
139028718|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028719|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028720|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
139028721|NCT00312208|Docetaxel|docetaxel|mesh-list
139028722|NCT00312208|Doxorubicin|doxorubicin|mesh-list
139028723|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139028724|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139028725|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
139028726|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028727|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139028728|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139028729|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
139028730|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028731|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028732|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139028733|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
139028734|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
139028735|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
138986030|NCT02541734|Exenatide|exenatide|mesh-list
139028736|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138491775|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
139028737|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139028738|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139028739|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028740|NCT00297778|Pramipexole|pramipexole|mesh-list
139028741|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
139028742|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028743|NCT00297778|Protective Agents|protective agents|mesh-ancestor
139028744|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028745|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139028746|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139028747|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
139028748|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
139028749|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028750|NCT03848832|Cannabidiol|cannabidiol|mesh-list
139028751|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
139028752|NCT00327340|Docetaxel|docetaxel|mesh-list
139028753|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
139028754|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028755|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
139028756|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
139028757|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
139028758|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028759|NCT00327340|Analgesics|analgesics|mesh-ancestor
139028760|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
139028761|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028762|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028763|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139028764|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139028765|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028766|NCT00958139|Permethrin|permethrin|mesh-list
139028767|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028768|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028769|NCT00450216|Ibuprofen|ibuprofen|mesh-list
139028770|NCT00450216|Famotidine|famotidine|mesh-list
139028771|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139028772|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139028773|NCT00450216|Analgesics|analgesics|mesh-ancestor
139028774|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
139028775|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028776|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028777|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028778|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139028779|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139028780|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281045|NCT05448001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138986067|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139028781|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028782|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139028783|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139028784|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139028785|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
139028787|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028788|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
139028789|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
138491798|NCT00847678|Flucytosine|flucytosine|mesh-list
139028790|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139028791|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028792|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139028793|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
139028794|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139028795|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139028796|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028797|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028798|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139028799|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
139028800|NCT00958451|Vitamin D|vitamin d|mesh-list
139028801|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139028802|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028803|NCT00958451|Vitamins|vitamins|mesh-ancestor
139028804|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
139028805|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139028806|NCT05352191|Beclomethasone|beclomethasone|mesh-list
139028807|NCT05352191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028808|NCT05352191|Glucocorticoids|glucocorticoids|mesh-ancestor
139028809|NCT05352191|Hormones|hormones|mesh-ancestor
139028810|NCT05352191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139028811|NCT05352191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028812|NCT05352191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139028813|NCT05352191|Respiratory System Agents|respiratory system agents|mesh-ancestor
139028814|NCT00954005|Rituximab|rituximab|mesh-list
139028815|NCT00954005|Gemcitabine|gemcitabine|mesh-list
139028816|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
139028817|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139028818|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028819|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
139028820|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028821|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139028822|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139028823|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
139028824|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028825|NCT01023750|Fenofibrate|fenofibrate|mesh-list
139028826|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139028827|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
138551126|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028828|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028829|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139028830|NCT05300009|Methotrexate|methotrexate|mesh-list
139028831|NCT05300009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139028832|NCT05300009|Abortifacient Agents|abortifacient agents|mesh-ancestor
139028833|NCT05300009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138491822|NCT00847366|Tamoxifen|tamoxifen|mesh-list
139028834|NCT05300009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028835|NCT05300009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139028836|NCT05300009|Antimetabolites|antimetabolites|mesh-ancestor
139028837|NCT05300009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028838|NCT05300009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028839|NCT05300009|Dermatologic Agents|dermatologic agents|mesh-ancestor
139028840|NCT05300009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028841|NCT05300009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139028842|NCT05300009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139028843|NCT05300009|Immunologic Factors|immunologic factors|mesh-ancestor
139028844|NCT05300009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139028845|NCT05300009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139028846|NCT05352113|Antidepressive Agents|antidepressive agents|mesh-list
139028847|NCT05352113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
139028848|NCT05352113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139028849|NCT05352113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139028850|NCT05352113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139028851|NCT05352113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028852|NCT05352113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028853|NCT05352113|Serotonin Agents|serotonin agents|mesh-ancestor
139028854|NCT05352113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028855|NCT00547703|Nortriptyline|nortriptyline|mesh-list
139028856|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139028857|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
139028858|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139028859|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139028860|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139028861|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139028862|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028863|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
138551151|NCT00071240|Hormones|hormones|mesh-list
139028864|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028865|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028866|NCT00297232|Natalizumab|natalizumab|mesh-list
139028867|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
139028868|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028869|NCT01062802|Atorvastatin|atorvastatin|mesh-list
139028870|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139028871|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138779499|NCT02778178|Clonidine|clonidine|mesh-list
139028872|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
139028873|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028874|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139028875|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139028876|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028877|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
139028879|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139028880|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028881|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139028882|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
139028883|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
139028884|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139028885|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139028886|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028887|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
139028888|NCT00954395|Coagulants|coagulants|mesh-ancestor
139028889|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
139028890|NCT03741101|Trametinib|trametinib|mesh-list
139028891|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028892|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139028893|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028894|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028895|NCT00449670|Vaccines|vaccines|mesh-list
139028896|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
139028897|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028898|NCT04010903|Insulin|insulin|mesh-list
139028899|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139028900|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028901|NCT00296374|Atorvastatin|atorvastatin|mesh-list
139028902|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139028903|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139028904|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139028905|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
139028906|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028907|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139028908|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139028909|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028910|NCT01060774|Lidocaine|lidocaine|mesh-list
139028911|NCT01060774|Bupivacaine|bupivacaine|mesh-list
139028912|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
139028913|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
138282263|NCT05348239|Copper|copper|mesh-list
139028914|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139028915|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028916|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
139028917|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028918|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139028919|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139028920|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139028921|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139028922|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028924|NCT00954785|Etoricoxib|etoricoxib|mesh-list
139028925|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139028926|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139028927|NCT00954785|Analgesics|analgesics|mesh-ancestor
139028928|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
139028929|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028930|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028931|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028932|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139028933|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139028934|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028935|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028936|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139028937|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
139028938|NCT00548717|Sirolimus|sirolimus|mesh-list
139028939|NCT00548717|Bortezomib|bortezomib|mesh-list
139028940|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139028941|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028942|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139028943|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
139028944|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138779572|NCT00626262|Esomeprazole|esomeprazole|mesh-list
139028945|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139028946|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028947|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028948|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
139028949|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139028950|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
139028951|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028952|NCT00441168|Dexamethasone|dexamethasone|mesh-list
139028953|NCT00441168|Vincristine|vincristine|mesh-list
139028954|NCT00441168|Doxorubicin|doxorubicin|mesh-list
139028955|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139028956|NCT00441168|Bortezomib|bortezomib|mesh-list
139028957|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139028958|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
139028959|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
139028960|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139028961|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028963|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
139028964|NCT00441168|Hormones|hormones|mesh-ancestor
139028965|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139028966|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139028967|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139028968|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139028969|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
139028970|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
139028971|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
139028972|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028973|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139028974|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139028975|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139028976|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139028977|NCT01062958|Vitamins|vitamins|mesh-list
139028978|NCT01062958|Folic Acid|folic acid|mesh-list
139028979|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
139028980|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
139028981|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
139028982|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028983|NCT01062958|Hematinics|hematinics|mesh-ancestor
139028984|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
139028985|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
139028986|NCT01028976|Vitamins|vitamins|mesh-ancestor
139028987|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
139028988|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139028989|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
139028990|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028992|NCT01024140|Escitalopram|escitalopram|mesh-list
139028993|NCT01024140|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139028994|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139028995|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139028996|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139028997|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139028998|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
139028999|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029000|NCT00457626|Valsartan|valsartan|mesh-list
139029001|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139029002|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139029003|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139029004|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029006|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139029007|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029008|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139029009|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029010|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029011|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139029012|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139029013|NCT02748707|Analgesics|analgesics|mesh-ancestor
139029014|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
139029015|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029016|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029017|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139029018|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029019|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139029020|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139029021|NCT05014061|Adenosine|adenosine|mesh-list
139029022|NCT05014061|Analgesics|analgesics|mesh-ancestor
139029023|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
139029024|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029025|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029026|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139029027|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
138690569|NCT02912637|Xenon|xenon|mesh-list
139029028|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
139029029|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
139029030|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
139029031|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029032|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029033|NCT00373113|Capecitabine|capecitabine|mesh-list
139029034|NCT00373113|Sunitinib|sunitinib|mesh-list
139029035|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139029036|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
139029037|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029038|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029039|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139029040|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139029041|NCT00373113|Growth Substances|growth substances|mesh-ancestor
139029042|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029043|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
139029044|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139029045|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029046|NCT01045941|Gemcitabine|gemcitabine|mesh-list
139029047|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139029048|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
139029049|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029050|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029051|NCT00407511|Pregabalin|pregabalin|mesh-list
139029052|NCT00407511|Analgesics|analgesics|mesh-ancestor
139029053|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
139029054|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029055|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029056|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
139029057|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139029058|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139029059|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029060|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139029061|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139029062|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139029063|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139029064|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139029065|NCT00384189|Ciclesonide|ciclesonide|mesh-list
139029066|NCT00384189|Albuterol|albuterol|mesh-list
139029067|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139029068|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
139029069|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138283381|NCT03035929|Hormones|hormones|mesh-ancestor
139029070|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029071|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139029072|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
139029073|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
139029074|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139029075|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139029076|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139029077|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139029078|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
139029079|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029080|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029081|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
139029082|NCT00384189|Hormones|hormones|mesh-ancestor
139059137|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029083|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139029084|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139029085|NCT00326716|Ritonavir|ritonavir|mesh-list
139029086|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139029087|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139029088|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139029089|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139029090|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
139029091|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029092|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029093|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139029094|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139029095|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
139029096|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029097|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139029098|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139029099|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138986339|NCT00115765|Bevacizumab|bevacizumab|mesh-list
139029100|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139029101|NCT01063192|Leucovorin|leucovorin|mesh-list
139029102|NCT01063192|Gemcitabine|gemcitabine|mesh-list
139029103|NCT01063192|Fluorouracil|fluorouracil|mesh-list
139029104|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
139029105|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139029106|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
139029107|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029108|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029109|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139029110|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
139029111|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029112|NCT01063192|Antidotes|antidotes|mesh-ancestor
139029113|NCT01063192|Protective Agents|protective agents|mesh-ancestor
139029114|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
139029115|NCT01063192|Vitamins|vitamins|mesh-ancestor
139029116|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
139029117|NCT01063426|Enoxaparin|enoxaparin|mesh-list
139029118|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
139029119|NCT01063426|Atorvastatin|atorvastatin|mesh-list
139029120|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139029121|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139029122|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
139029123|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029124|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139029125|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139029126|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029127|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
139029128|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139029129|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139029130|NCT00548405|Interferons|interferons|mesh-list
139029131|NCT00548405|Interferon-beta|interferon-beta|mesh-list
139029132|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
139029133|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
139029134|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029135|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
139029136|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029137|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139029138|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
139029139|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029140|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139029141|NCT00959075|Thiamine|thiamine|mesh-list
139029142|NCT00959075|Vitamins|vitamins|mesh-ancestor
139029143|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
139029144|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029145|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
139029146|NCT00295750|Leuprolide|leuprolide|mesh-list
139029147|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139029148|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
139029149|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139029150|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029151|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139029152|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029153|NCT00959231|Cyclosporine|cyclosporine|mesh-list
139029154|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
139029155|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
139029156|NCT00959231|Fludarabine|fludarabine|mesh-list
139029157|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
139029158|NCT00959231|Cyclosporins|cyclosporins|mesh-list
139029159|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139029160|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
139029161|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029162|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029163|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139029164|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
139029165|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029166|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029167|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139029168|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139029169|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
139029170|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029171|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
139029172|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029173|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
139029174|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139029175|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139029176|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139029177|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
139029178|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139029179|NCT03948581|Vedolizumab|vedolizumab|mesh-list
139029180|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139029181|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139029182|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139029183|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139029184|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139029185|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029186|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
139029187|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029188|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029189|NCT04720547|Zolpidem|zolpidem|mesh-list
139029190|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139029191|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139029192|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139029193|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029195|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
139029196|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
139029197|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029198|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029199|NCT00959387|Paclitaxel|paclitaxel|mesh-list
139029200|NCT00959387|Cisplatin|cisplatin|mesh-list
139029201|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139029202|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029203|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
139029204|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
139029205|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
139029206|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029207|NCT04718285|Favipiravir|favipiravir|mesh-list
139029208|NCT04718285|Montelukast|montelukast|mesh-list
139029209|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139029210|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
139029211|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139029212|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
139029213|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139029214|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029215|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139029216|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139029217|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029218|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
139029219|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029220|NCT00959621|Aspirin|aspirin|mesh-list
139029221|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139029222|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139029223|NCT00959621|Analgesics|analgesics|mesh-ancestor
139029224|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
139029225|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029226|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029227|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139029228|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138986445|NCT00893906|Vaccines|vaccines|mesh-list
139029229|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139029230|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139029231|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029232|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139029233|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139029235|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
139029236|NCT00959777|Lenograstim|lenograstim|mesh-list
139029237|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139029238|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
139029239|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029240|NCT00959933|Ribavirin|ribavirin|mesh-list
139029241|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
139029242|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029243|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
139029244|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779883|NCT00944697|Oxycodone|oxycodone|mesh-list
139029245|NCT00960245|Nadolol|nadolol|mesh-list
139029246|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139029247|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139029248|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
139029249|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138492072|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139029250|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551499|NCT02966288|Ibuprofen|ibuprofen|mesh-list
139029251|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029252|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139029253|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139029255|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
139029256|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029257|NCT00406653|Abatacept|abatacept|mesh-list
139029258|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139029259|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029260|NCT00406653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139029261|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029262|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139029263|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
139029264|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029265|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029266|NCT00547157|Cisplatin|cisplatin|mesh-list
139029267|NCT00547157|Panitumumab|panitumumab|mesh-list
139029268|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029269|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139029270|NCT00960479|Ribavirin|ribavirin|mesh-list
139029271|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
139029272|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029273|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
139029274|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029275|NCT00960557|Combretastatin|combretastatin|mesh-list
139029276|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139029277|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029278|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
139029279|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
139029280|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
139029281|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029282|NCT00960635|Vitamin D|vitamin d|mesh-list
139029283|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
139029284|NCT00960635|Calcitriol|calcitriol|mesh-list
139029285|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
139029286|NCT00960635|Vitamins|vitamins|mesh-ancestor
139029287|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
139029288|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029289|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139029290|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139029291|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139029292|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139029293|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029294|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139029295|NCT00960713|Rituximab|rituximab|mesh-list
139029296|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139029297|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029298|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
139029299|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029300|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029301|NCT04009889|Silicon|silicon|mesh-list
139029302|NCT04009889|Trace Elements|trace elements|mesh-ancestor
139029303|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
139029304|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029305|NCT00962507|Everolimus|everolimus|mesh-list
139029306|NCT00962507|Panobinostat|panobinostat|mesh-list
139029307|NCT00962507|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139029308|NCT00962507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139029309|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029310|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029311|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139029312|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
139029313|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029314|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029315|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139029316|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139029317|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139029318|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139029319|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139029320|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139029321|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029322|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029323|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029325|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
139029326|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029327|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
139029328|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139029329|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
139029330|NCT00962663|Ibuprofen|ibuprofen|mesh-list
139029331|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139029332|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139029333|NCT00962663|Analgesics|analgesics|mesh-ancestor
139029334|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
139029335|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029336|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029337|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139029338|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029339|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139029340|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029341|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029342|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139029343|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
139029344|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029345|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
139029346|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
139029347|NCT00075387|Carboplatin|carboplatin|mesh-list
139029348|NCT00075387|Etoposide|etoposide|mesh-list
139029349|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
139029350|NCT00075387|Antidotes|antidotes|mesh-list
139029351|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139029352|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
139029353|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029354|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029355|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139029356|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
139029357|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029358|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029359|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139029360|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139029361|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139029362|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139029363|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029364|NCT00075387|Protective Agents|protective agents|mesh-ancestor
139029365|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
139029366|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
139029367|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139029368|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029369|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
139029370|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
139029371|NCT00963131|Antioxidants|antioxidants|mesh-list
139029372|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029373|NCT00963131|Protective Agents|protective agents|mesh-ancestor
139029374|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029375|NCT00963209|Tamoxifen|tamoxifen|mesh-list
139029376|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139029377|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
139029378|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139029379|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029380|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139029381|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029382|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139029383|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139029384|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139029385|NCT00963443|Aspirin|aspirin|mesh-list
139029386|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
139029387|NCT00963443|Ephedrine|ephedrine|mesh-list
139029388|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139029389|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139029390|NCT00963443|Analgesics|analgesics|mesh-ancestor
139029391|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
139029392|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029393|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029394|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139029395|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029396|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139029397|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138986498|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029398|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029399|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139029401|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029402|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
139029403|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139029404|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
139029405|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139029406|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
139029407|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
139029408|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139029409|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139029410|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
139029411|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
139029412|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029413|NCT00963833|Interferons|interferons|mesh-list
139029414|NCT00963833|Interferon-beta|interferon-beta|mesh-list
139029415|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
139029416|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029417|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
139029418|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029419|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
139029420|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029421|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139029422|NCT00967655|Capecitabine|capecitabine|mesh-list
139029423|NCT00967655|Irinotecan|irinotecan|mesh-list
139029424|NCT00967655|Panitumumab|panitumumab|mesh-list
139029425|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139029426|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
139029427|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029428|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029429|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139029430|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139029431|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029432|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139029433|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
139029434|NCT00546377|Rituximab|rituximab|mesh-list
139029435|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
139029436|NCT00546377|Pentostatin|pentostatin|mesh-list
139029437|NCT00546377|Sargramostim|sargramostim|mesh-list
139029438|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139029439|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
139029440|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029441|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029442|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139029443|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
139029444|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029445|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029446|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139029447|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139029448|NCT00546377|Analgesics|analgesics|mesh-ancestor
139029449|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
139029450|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029451|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139029452|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139029453|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029454|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139029455|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
139029456|NCT00967967|Desloratadine|desloratadine|mesh-list
139029457|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139029458|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
139029459|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138986598|NCT04920149|Analgesics|analgesics|mesh-ancestor
139029460|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139029461|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
139029462|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029463|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029464|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029465|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139029466|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139029467|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
139029468|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
139029469|NCT00964457|Cetuximab|cetuximab|mesh-list
139029470|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139029472|NCT00964535|Budesonide|budesonide|mesh-list
139029473|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
139029474|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139029475|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139029476|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139029477|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
139029478|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029479|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029480|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139029481|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
139029482|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
139029483|NCT00964535|Hormones|hormones|mesh-ancestor
139029484|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139029485|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139029486|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139029487|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139029488|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
139029489|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029490|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029491|NCT00964691|Chloroquine|chloroquine|mesh-list
139029492|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
139029493|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
139029494|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139029495|NCT00964691|Amebicides|amebicides|mesh-ancestor
139029496|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139029497|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139029498|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029499|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
139029500|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029501|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139029502|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029503|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029504|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139029505|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139029506|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
139029507|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029508|NCT00968435|Bevacizumab|bevacizumab|mesh-list
139029509|NCT00968435|Cetuximab|cetuximab|mesh-list
139029510|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139029511|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029512|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139029513|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139029514|NCT00968435|Growth Substances|growth substances|mesh-ancestor
139029515|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029516|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
139029517|NCT05253287|Hormones|hormones|mesh-list
139029518|NCT05253287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139029519|NCT05253287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029520|NCT00968591|Everolimus|everolimus|mesh-list
139029521|NCT00968591|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139029522|NCT00968591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139029523|NCT00968591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029524|NCT00968591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029525|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139029526|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
139029527|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029528|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029529|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
139029530|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139029531|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139029532|NCT00968903|Prednisolone|prednisolone|mesh-list
139029533|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
139029534|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139029535|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
139029536|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139029537|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
139029538|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
139029539|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551899|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
139029540|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029541|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139029542|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
139029543|NCT00968903|Hormones|hormones|mesh-ancestor
139029544|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139029545|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139029546|NCT00968903|Protective Agents|protective agents|mesh-ancestor
139029547|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139029548|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029549|NCT00969137|Nicotine|nicotine|mesh-list
139029550|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139029551|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
139029552|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029553|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029554|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139029555|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139029556|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
139029557|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029558|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029559|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139029560|NCT00965315|Fenofibrate|fenofibrate|mesh-list
139029561|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139029562|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139029563|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
139029564|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029565|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139029566|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139029567|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029568|NCT00969293|Ecallantide|ecallantide|mesh-list
139029569|NCT00969293|Analgesics|analgesics|mesh-ancestor
139029570|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
139029571|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029572|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029573|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139029574|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139029575|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139029576|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029577|NCT00969449|Naproxen|naproxen|mesh-list
139029578|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139029579|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139029580|NCT00969449|Analgesics|analgesics|mesh-ancestor
139029581|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
139029582|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029583|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029584|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139029585|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029586|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
139029587|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139029588|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029589|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029590|NCT00965393|Bradykinin|bradykinin|mesh-list
139029591|NCT00965393|Kininogens|kininogens|mesh-list
139029592|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
139029593|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
139029594|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
139029595|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
139029596|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029597|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029598|NCT00965549|Insulin|insulin|mesh-list
139029599|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139029600|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
139029601|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
139029602|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
139029603|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139029604|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029605|NCT00966251|Pidilizumab|pidilizumab|mesh-list
139029606|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139029607|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029608|NCT00966329|Maraviroc|maraviroc|mesh-list
139029609|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138492243|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139029610|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139029611|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029612|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139029613|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139029614|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
139029615|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029616|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139029617|NCT00970697|Becaplermin|becaplermin|mesh-list
139029618|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
139029619|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
139029620|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139029621|NCT00970697|Growth Substances|growth substances|mesh-ancestor
139029622|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029624|NCT00967031|Lapatinib|lapatinib|mesh-list
139029625|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139029626|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
139029627|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029628|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029629|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139029630|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029631|NCT00967109|Chrysarobin|chrysarobin|mesh-list
139029632|NCT00967109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139029633|NCT00967109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139029635|NCT00967109|Sensory System Agents|sensory system agents|mesh-ancestor
139029636|NCT00967109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138986644|NCT02539940|Paclitaxel|paclitaxel|mesh-list
139029637|NCT00967109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029638|NCT00967109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139029639|NCT00967109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029640|NCT00545753|Permethrin|permethrin|mesh-list
139029641|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029642|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029643|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
139029644|NCT00970931|Amiloride|amiloride|mesh-list
139029645|NCT00970931|Diuretics|diuretics|mesh-list
139029646|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
139029647|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029648|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139029649|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139029650|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139029651|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029652|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139029653|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139029654|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139029655|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139029656|NCT00406419|Methotrexate|methotrexate|mesh-list
139029657|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
139029658|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139029659|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
139029660|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139029661|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029662|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139029663|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
139029664|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029665|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029666|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
139029667|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552004|NCT00106548|Methotrexate|methotrexate|mesh-list
139029668|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139029669|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139029670|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
139029671|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029672|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139029673|NCT00967421|Ethanol|ethanol|mesh-list
139029674|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139029675|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029676|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139029677|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029678|NCT00971165|Losartan|losartan|mesh-list
139029679|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
139029680|NCT00971165|Amiloride|amiloride|mesh-list
139029681|NCT00971165|Diuretics|diuretics|mesh-list
139029682|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139029683|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139029684|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139029685|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139029686|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029687|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
139029688|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029689|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139029690|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139029691|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139029692|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139029693|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139029694|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139029695|NCT00971399|Ondansetron|ondansetron|mesh-list
139029696|NCT00971399|Ramosetron|ramosetron|mesh-list
139029697|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
139029698|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
139029699|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029700|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029701|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139029702|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
139029703|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
139029704|NCT00971399|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139029705|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139029706|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
139029707|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029708|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029709|NCT00973505|Anastrozole|anastrozole|mesh-list
139029710|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139029711|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029712|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139029713|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029714|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029715|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139029716|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
139029717|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139029718|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029719|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139029720|NCT00973583|Vitamin D|vitamin d|mesh-list
139029721|NCT00973583|Vitamins|vitamins|mesh-ancestor
139029722|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
139029723|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029724|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139029725|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
139029726|NCT00972101|Rituximab|rituximab|mesh-list
139029727|NCT00972101|Fludarabine|fludarabine|mesh-list
139029728|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
139029729|NCT00972101|Etoposide|etoposide|mesh-list
139029730|NCT00972101|Melphalan|melphalan|mesh-list
139029731|NCT00972101|Thiotepa|thiotepa|mesh-list
139029732|NCT00972101|Tacrolimus|tacrolimus|mesh-list
139029733|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139029734|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139029735|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029736|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
139029737|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029738|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029739|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139029740|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
139029741|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029742|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139029743|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029744|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139029745|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139029746|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139029747|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029748|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139029749|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139029750|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139029751|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
139029752|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139029753|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139029754|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
139029755|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139029756|NCT00325468|Denosumab|denosumab|mesh-list
138986499|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029757|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139029758|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029759|NCT00972257|Timolol|timolol|mesh-list
139029760|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139029761|NCT00972257|Dorzolamide|dorzolamide|mesh-list
139029762|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139029763|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139029764|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
139029765|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029766|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029767|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029768|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139029769|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139029770|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139029771|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139029772|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139029773|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139029774|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029775|NCT00311584|Irinotecan|irinotecan|mesh-list
139029776|NCT00311584|Temozolomide|temozolomide|mesh-list
139029777|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139029778|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139029779|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029780|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029781|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029782|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139029783|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
139029784|NCT00383331|Gemcitabine|gemcitabine|mesh-list
139029785|NCT00383331|Pemetrexed|pemetrexed|mesh-list
139029786|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139029787|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
139029788|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029789|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029790|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029791|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139029792|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139029793|NCT03934541|Vaccines|vaccines|mesh-list
139029794|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
139029795|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029796|NCT00325234|Carboplatin|carboplatin|mesh-list
139029797|NCT00325234|Gemcitabine|gemcitabine|mesh-list
139029798|NCT00325234|Pemetrexed|pemetrexed|mesh-list
139029799|NCT00325234|Vinorelbine|vinorelbine|mesh-list
139029800|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029801|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139029802|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
139029803|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029804|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029805|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139029806|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138737504|NCT00595049|Bosentan|bosentan|mesh-list
139029807|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139029808|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
139029809|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
139029810|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
139029811|NCT01063504|Teriparatide|teriparatide|mesh-list
139029812|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139029813|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029814|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139029816|NCT00366249|Tigecycline|tigecycline|mesh-list
138492339|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
139029817|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139029818|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029819|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139029820|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029821|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029822|NCT03927911|Bupivacaine|bupivacaine|mesh-list
139029823|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
139029824|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
139029825|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139029826|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029827|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
139029828|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029829|NCT00383019|Latanoprost|latanoprost|mesh-list
139029830|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139029831|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139029832|NCT00310804|Vaccines|vaccines|mesh-list
139029833|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
139029834|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029836|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029837|NCT03978364|Azacitidine|azacitidine|mesh-list
139029838|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139029839|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
139029840|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029841|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029842|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780477|NCT01132313|Ribavirin|ribavirin|mesh-list
139029843|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
139029844|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
138492357|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
139029845|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139029846|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
139029847|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029848|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029849|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139029850|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
139029851|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138986711|NCT02539628|Ropivacaine|ropivacaine|mesh-list
139029852|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029853|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139029854|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139029855|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029856|NCT03978286|Vortioxetine|vortioxetine|mesh-list
139029857|NCT03978286|Sertraline|sertraline|mesh-list
139029858|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
139029859|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139029860|NCT03978286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139029861|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139029862|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139029863|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029864|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029865|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
139029866|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029867|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139029868|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139029869|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139029870|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139029871|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139029872|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139029873|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139029874|NCT03933449|Paclitaxel|paclitaxel|mesh-list
139029875|NCT03933449|Docetaxel|docetaxel|mesh-list
139029876|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
138492416|NCT04230499|Sirolimus|sirolimus|mesh-list
139029878|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139029879|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029880|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
139029881|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
139029882|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
139029883|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029884|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139029885|NCT03933449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139029886|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139029887|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139029888|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029889|NCT00974441|Valproic Acid|valproic acid|mesh-list
139029890|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
139029891|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029892|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029893|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
139029894|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029895|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029896|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
139029897|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139029898|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139029899|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139029900|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
139029901|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139029902|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139029903|NCT01049451|Prednisolone|prednisolone|mesh-list
139029904|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
139029905|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139029906|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
139029907|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139029908|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
139029909|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
139029910|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029911|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138986742|NCT00722579|Cobalt|cobalt|mesh-list
139029912|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139029913|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
139029914|NCT01049451|Hormones|hormones|mesh-ancestor
139029915|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139029916|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139029917|NCT01049451|Protective Agents|protective agents|mesh-ancestor
139029919|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029920|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
139029921|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
139029922|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029923|NCT00974753|Ketorolac|ketorolac|mesh-list
139029924|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139029925|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139029926|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139029927|NCT00974753|Analgesics|analgesics|mesh-ancestor
139029928|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
139029929|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029930|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029931|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139029932|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139029933|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139029934|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029935|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029936|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
139029937|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139029938|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139029939|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
139029940|NCT02908269|Vaccines|vaccines|mesh-list
139029941|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
139029942|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029943|NCT00974987|Temozolomide|temozolomide|mesh-list
139029944|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139029945|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
139029946|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029947|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029948|NCT00975065|Metformin|metformin|mesh-list
139029949|NCT00975065|Vildagliptin|vildagliptin|mesh-list
139029950|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139029951|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029952|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139029954|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029955|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029956|NCT00972881|Capecitabine|capecitabine|mesh-list
139029957|NCT00972881|Irinotecan|irinotecan|mesh-list
139029958|NCT00972881|Cetuximab|cetuximab|mesh-list
139029959|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139029960|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
139029961|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029962|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029963|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139029964|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139029965|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029966|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139029967|NCT00290758|Genistein|genistein|mesh-list
139029968|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139029970|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029971|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029972|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139029973|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139029974|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492481|NCT00006044|Hormones|hormones|mesh-ancestor
139029975|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
139029976|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139029977|NCT00290758|Estrogens|estrogens|mesh-ancestor
139029978|NCT00290758|Hormones|hormones|mesh-ancestor
139029979|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139029980|NCT00975299|Bombesin|bombesin|mesh-list
139029981|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139029982|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029983|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029984|NCT01060930|Epinephrine|epinephrine|mesh-list
139029985|NCT01060930|Norepinephrine|norepinephrine|mesh-list
139029986|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
139029987|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139029988|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139029989|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
139029990|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780621|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139029991|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139029992|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139029993|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139029994|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139029995|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
139029996|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139029997|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139029998|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
139029999|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
139030000|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
139030001|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139030002|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030004|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139030005|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
139030006|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139030007|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030008|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139030009|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030010|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139030011|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139030012|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139030013|NCT00973115|Simvastatin|simvastatin|mesh-list
139030014|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139030015|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139030016|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
139030017|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030018|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139030019|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139030020|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030021|NCT00973193|Panitumumab|panitumumab|mesh-list
139030022|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139030023|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030024|NCT00975533|Insulin|insulin|mesh-list
139030025|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139030026|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030027|NCT00372567|Sunitinib|sunitinib|mesh-list
139030028|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
139030029|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030030|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139030031|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139030032|NCT00372567|Growth Substances|growth substances|mesh-ancestor
139030033|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492551|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
139030034|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
139030035|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139030036|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030037|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030038|NCT00973271|Atorvastatin|atorvastatin|mesh-list
139030039|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
139030040|NCT00973271|Fenofibrate|fenofibrate|mesh-list
139030041|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139030042|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139030043|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
139030044|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030045|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139030046|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139030047|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030049|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139030050|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030051|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
139030052|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
139030053|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
139030054|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030055|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139030056|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030057|NCT00365547|Bevacizumab|bevacizumab|mesh-list
139030058|NCT00365547|Topotecan|topotecan|mesh-list
139030059|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139030060|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030061|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139030062|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139030063|NCT00365547|Growth Substances|growth substances|mesh-ancestor
138780704|NCT04130815|Furosemide|furosemide|mesh-list
139030064|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030065|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
139030066|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139030067|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139030068|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030069|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030070|NCT00979589|Aspirin|aspirin|mesh-list
139030071|NCT00979589|Clopidogrel|clopidogrel|mesh-list
139030072|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139030073|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139030074|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139030075|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139030076|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
139030077|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030078|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030079|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030080|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139030081|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139030082|NCT00979589|Analgesics|analgesics|mesh-ancestor
138986855|NCT02571491|Ketamine|ketamine|mesh-list
139030083|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
139030084|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030085|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139030086|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139030087|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139030088|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139030089|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139030090|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030091|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
139030092|NCT00294658|Prednisone|prednisone|mesh-list
139030093|NCT00294658|Prednisolone|prednisolone|mesh-list
139030094|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139030095|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
139030096|NCT00294658|Hormones|hormones|mesh-ancestor
139030097|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139030098|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030099|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139030100|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030101|NCT00979667|Oseltamivir|oseltamivir|mesh-list
139030102|NCT00979667|Zanamivir|zanamivir|mesh-list
139030103|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
139030104|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030105|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030106|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030107|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
139030108|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
139030109|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030110|NCT03978052|Protective Agents|protective agents|mesh-ancestor
139030111|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030112|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139030113|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139030114|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030115|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139030116|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
139030117|NCT03923933|Bumetanide|bumetanide|mesh-list
139030118|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139030119|NCT03923933|Diuretics|diuretics|mesh-ancestor
139030120|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
139030121|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492618|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
139030122|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139030123|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139030124|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030125|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139030126|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
139030127|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030128|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139030129|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030130|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030131|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
139030132|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139030133|NCT00980213|Sunitinib|sunitinib|mesh-list
139030135|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139030136|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139030137|NCT00980213|Growth Substances|growth substances|mesh-ancestor
139030138|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030139|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
139030140|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139030141|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030142|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030143|NCT00976469|Vaccines|vaccines|mesh-list
139030144|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
139030145|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030146|NCT00980603|Docetaxel|docetaxel|mesh-list
139030147|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030148|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
139030149|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
139030150|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
139030151|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030152|NCT00274456|Paclitaxel|paclitaxel|mesh-list
139030153|NCT00274456|Docetaxel|docetaxel|mesh-list
139030154|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139030155|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139030156|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030157|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
139030158|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
139030159|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
139030160|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030161|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
139030162|NCT00977093|Antidotes|antidotes|mesh-ancestor
139030163|NCT00977093|Protective Agents|protective agents|mesh-ancestor
139030164|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030165|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
139030166|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
139030167|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030168|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139030169|NCT00977249|Varenicline|varenicline|mesh-list
139030170|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139030171|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139030172|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
138986909|NCT00450658|Ibuprofen|ibuprofen|mesh-list
139030173|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030174|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552381|NCT00269386|Clarithromycin|clarithromycin|mesh-list
139030175|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030177|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139030178|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139030179|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139030180|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030181|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139030182|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139030183|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139030184|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139030185|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
139030186|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
139030187|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
139030188|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
139030189|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030190|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030191|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
139030192|NCT00364923|Aminopterin|aminopterin|mesh-list
139030193|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139030194|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030195|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030196|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030197|NCT00273052|Metoprolol|metoprolol|mesh-list
139030198|NCT00273052|Carvedilol|carvedilol|mesh-list
139030199|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139030200|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139030201|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
139030202|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
139030203|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030204|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030205|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139030206|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139030207|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139030208|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
139030209|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030210|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030211|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
139030212|NCT00273052|Protective Agents|protective agents|mesh-ancestor
139030213|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139030214|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139030215|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138552426|NCT00074204|Docetaxel|docetaxel|mesh-list
139030216|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
139030217|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139030218|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139030220|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139030221|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030222|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139030223|NCT01046721|Incretins|incretins|mesh-ancestor
139030224|NCT01046721|Hormones|hormones|mesh-ancestor
139030225|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139030226|NCT01046799|Entecavir|entecavir|mesh-list
139030227|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
139030228|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030229|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
139030230|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
139030231|NCT00290290|Povidone|povidone|mesh-list
138986944|NCT00724295|Ribavirin|ribavirin|mesh-list
139030232|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139030233|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030234|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
138552457|NCT00269737|Analgesics|analgesics|mesh-ancestor
139030235|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
139030236|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
139030237|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139030238|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
139030239|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030240|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
139030241|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139030242|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139030243|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030244|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
139030245|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
139030247|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139030248|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030249|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
139030250|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
139030251|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139030252|NCT01046955|Daclizumab|daclizumab|mesh-list
139030253|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
139030254|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030255|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139030256|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139030257|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030258|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139030259|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030260|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139030261|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030262|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030263|NCT00271024|Naltrexone|naltrexone|mesh-list
139030264|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139030265|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139030266|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030267|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
139030268|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030269|NCT00381693|Azacitidine|azacitidine|mesh-list
139030270|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139030271|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
139030272|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030273|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030274|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030275|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
139030276|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139030277|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030278|NCT00977405|Gentamicins|gentamicins|mesh-list
139030279|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139030280|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030281|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139030282|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030283|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030284|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139030285|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139030286|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
139030287|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
139030288|NCT00977873|Vitamin D|vitamin d|mesh-list
139030289|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139030290|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030291|NCT00977873|Vitamins|vitamins|mesh-ancestor
139030292|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
139030293|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139030294|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139030295|NCT00457392|Sunitinib|sunitinib|mesh-list
139030296|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030297|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139030298|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030299|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030300|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139030301|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139030302|NCT00457392|Growth Substances|growth substances|mesh-ancestor
139030303|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030304|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
139030305|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
139030306|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139030307|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030308|NCT00381615|Vaccines|vaccines|mesh-list
139030309|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
139030310|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030311|NCT00978107|Flucytosine|flucytosine|mesh-list
139030312|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
139030313|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030314|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
139030315|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030316|NCT01029132|Galantamine|galantamine|mesh-list
139030317|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139030318|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030319|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030320|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
139030321|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030322|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030323|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139030324|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
139030325|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030326|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
139030327|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
139030328|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
139030329|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030330|NCT01049763|Oseltamivir|oseltamivir|mesh-list
139030331|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
139030332|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030333|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030334|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030336|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139030337|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139030338|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030339|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139030340|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139030341|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
139030342|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030343|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139030344|NCT01049841|Sirolimus|sirolimus|mesh-list
139030345|NCT01049841|Temsirolimus|temsirolimus|mesh-list
139030346|NCT01049841|MTOR Inhibitors|mtor inhibitors|mesh-list
139030347|NCT01049841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139030348|NCT01049841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030349|NCT01049841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030350|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139030351|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
139030352|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030353|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030354|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139030355|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030356|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139030357|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
139030358|NCT00978263|Metformin|metformin|mesh-list
139030359|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139030360|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030361|NCT00981851|Albuterol|albuterol|mesh-list
139030362|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
139030363|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139030364|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
139030365|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030366|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030367|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139030368|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
139030369|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
139030370|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139030371|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
139030372|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030373|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030374|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
139030375|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139030376|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139030377|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139030378|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139030379|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
139030380|NCT00981929|Losartan|losartan|mesh-list
139030381|NCT00981929|Tramadol|tramadol|mesh-list
139030382|NCT00981929|Caffeine|caffeine|mesh-list
139030383|NCT00981929|Omeprazole|omeprazole|mesh-list
139030384|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139030385|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139030386|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139030387|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139030388|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030389|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139030390|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030391|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139030392|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030393|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139030394|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139030395|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
139030396|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030397|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139030398|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139030399|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139030401|NCT00981929|Narcotics|narcotics|mesh-ancestor
139030402|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139030403|NCT00981929|Analgesics|analgesics|mesh-ancestor
139030404|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
139030405|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030406|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
139030407|NCT00364845|Hematinics|hematinics|mesh-ancestor
139030408|NCT00978653|Allopurinol|allopurinol|mesh-list
139030409|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
139030410|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030411|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030412|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
139030413|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139030414|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139030415|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
139030416|NCT00978653|Protective Agents|protective agents|mesh-ancestor
139030417|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030418|NCT00293722|Etanercept|etanercept|mesh-list
139030419|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139030420|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139030421|NCT00293722|Analgesics|analgesics|mesh-ancestor
139030422|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
139030423|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030424|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030425|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139030426|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139030427|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139030428|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139030429|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
139030430|NCT00381303|Ritonavir|ritonavir|mesh-list
139030431|NCT00381303|Darunavir|darunavir|mesh-list
139030432|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139030433|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139030434|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
139030435|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030436|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030437|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139030438|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290346|NCT00000440|Naltrexone|naltrexone|mesh-list
139030439|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
139030440|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030441|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139030442|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139030443|NCT00364689|Rifaximin|rifaximin|mesh-list
139030444|NCT00364689|Lactulose|lactulose|mesh-list
139030445|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139030446|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030447|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139030448|NCT00545129|Tanezumab|tanezumab|mesh-list
139030449|NCT00545129|Analgesics|analgesics|mesh-ancestor
139030450|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
139030451|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030452|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030453|NCT00956111|Vaccines|vaccines|mesh-list
139030454|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
139030455|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030456|NCT00982631|Sirolimus|sirolimus|mesh-list
139030457|NCT00982631|Temsirolimus|temsirolimus|mesh-list
139030458|NCT00982631|MTOR Inhibitors|mtor inhibitors|mesh-list
139030459|NCT00982631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139030460|NCT00982631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030461|NCT00982631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030462|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139030463|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
139030464|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030465|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030466|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139030467|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030468|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139030469|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
139030470|NCT00364611|Bevacizumab|bevacizumab|mesh-list
139030471|NCT00364611|Trastuzumab|trastuzumab|mesh-list
139030472|NCT00364611|Docetaxel|docetaxel|mesh-list
139030473|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139030474|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030475|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139030476|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139030477|NCT00364611|Growth Substances|growth substances|mesh-ancestor
139030478|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030479|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
139030480|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
139030481|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
139030482|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
139030483|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030484|NCT00956189|Aripiprazole|aripiprazole|mesh-list
139030485|NCT00956189|Amisulpride|amisulpride|mesh-list
139030486|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
139030487|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139030488|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139030489|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139030490|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139030491|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030492|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
139030493|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
139030494|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030495|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030496|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139030497|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139030498|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
139030499|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139030500|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139030501|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139030502|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139030503|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139030505|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030506|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139030507|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139030508|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030509|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030510|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139030511|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
138552718|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
139030512|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139030513|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030514|NCT04007003|Insulin|insulin|mesh-list
139030515|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139030516|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781171|NCT02759224|Lafutidine|lafutidine|mesh-list
139030517|NCT00364533|Oxycodone|oxycodone|mesh-list
139030519|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139030520|NCT00364533|Narcotics|narcotics|mesh-ancestor
139030521|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139030522|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030523|NCT00364533|Analgesics|analgesics|mesh-ancestor
139030524|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
139030525|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030526|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139030527|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139030528|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139030529|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030530|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
139030531|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030533|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139030534|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139030535|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
139030536|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030537|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139030538|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139030539|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030540|NCT00984737|Insulin|insulin|mesh-list
139030541|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139030542|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030543|NCT01047579|Rivastigmine|rivastigmine|mesh-list
139030544|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139030545|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030546|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030547|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
139030548|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030549|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030550|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139030551|NCT01047579|Protective Agents|protective agents|mesh-ancestor
139030552|NCT04006847|Dasatinib|dasatinib|mesh-list
139030553|NCT04006847|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139030554|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030555|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139030556|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290749|NCT00002156|Ganciclovir|ganciclovir|mesh-list
139030557|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030559|NCT00984893|Diphosphonates|diphosphonates|mesh-list
139030560|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139030561|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030562|NCT00983021|Insulin|insulin|mesh-list
139030563|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139030564|NCT00983021|Liraglutide|liraglutide|mesh-list
139030565|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
139030566|NCT00983021|Xultophy|xultophy|mesh-list
139030567|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139030568|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030569|NCT00983021|Incretins|incretins|mesh-ancestor
139030570|NCT00983021|Hormones|hormones|mesh-ancestor
138987188|NCT02540720|Dexamethasone|dexamethasone|mesh-list
139030571|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139030572|NCT00984971|Tenofovir|tenofovir|mesh-list
139030573|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
139030574|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030575|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139030576|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139030577|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030578|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030579|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139030580|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139030581|NCT00544817|Temozolomide|temozolomide|mesh-list
139030582|NCT00544817|Sorafenib|sorafenib|mesh-list
139030583|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139030584|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
139030585|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030586|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030587|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139030588|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030589|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
139030590|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138781226|NCT02758990|Niacin|niacin|mesh-list
139030591|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030592|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139030593|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
139030594|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030596|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
139030597|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139030598|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
139030599|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
139030600|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
139030601|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030602|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030603|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
139030604|NCT00983255|Tedizolid|tedizolid|mesh-list
139030605|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
139030606|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139030607|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030608|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139030609|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030610|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030612|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030613|NCT00988481|Topiramate|topiramate|mesh-list
139030614|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
139030615|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139030616|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030617|NCT00289900|Atorvastatin|atorvastatin|mesh-list
139030618|NCT00289900|Simvastatin|simvastatin|mesh-list
139030619|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139030620|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139030621|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
139030622|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030623|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139030624|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139030625|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030626|NCT00543725|Efavirenz|efavirenz|mesh-list
139030627|NCT00543725|Rilpivirine|rilpivirine|mesh-list
139030628|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139030629|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139030630|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030631|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030632|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
139030633|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030634|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139030635|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139030636|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139030637|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139030638|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139030639|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139030640|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139030641|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139030642|NCT00985361|Vitamin D|vitamin d|mesh-list
139030643|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
139030644|NCT00985361|Vitamins|vitamins|mesh-list
139030645|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
139030646|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030647|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139030648|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139030649|NCT00269152|Carboplatin|carboplatin|mesh-list
139030650|NCT00269152|Pemetrexed|pemetrexed|mesh-list
139030651|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030652|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030653|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030654|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139030655|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139030656|NCT00988715|Cyclosporine|cyclosporine|mesh-list
138492914|NCT00085696|Rituximab|rituximab|mesh-list
139030657|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
139030658|NCT00988715|Fludarabine|fludarabine|mesh-list
139030659|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
139030660|NCT00988715|Cyclosporins|cyclosporins|mesh-list
139030661|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030662|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139030663|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
139030664|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030665|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139030667|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030668|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030669|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
139030670|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030671|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
139030672|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139030673|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139030674|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139030675|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139030676|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
139030677|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139030678|NCT03975166|Fluticasone|fluticasone|mesh-list
139030680|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139030681|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139030682|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139030683|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139030684|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
139030685|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030686|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030687|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139030688|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
139030689|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
139030690|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139030691|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139030692|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139030693|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139030694|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
139030695|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030696|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030698|NCT03975166|Hormones|hormones|mesh-ancestor
139030699|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139030700|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
139030701|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139030703|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139030704|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139030705|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
139030706|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030707|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139030708|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139030709|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030710|NCT00379899|Vitamin D|vitamin d|mesh-list
139030711|NCT00379899|Cinacalcet|cinacalcet|mesh-list
139030712|NCT00379899|Vitamins|vitamins|mesh-ancestor
139030713|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
139030714|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030715|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139030716|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139030717|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
139030718|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
139030719|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139030720|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
139030721|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139030722|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139030723|NCT02535039|Prednisolone|prednisolone|mesh-list
139030724|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
139030725|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139030726|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
139030727|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139030728|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
139030729|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
139030730|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030731|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030732|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139030733|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
139030734|NCT02535039|Hormones|hormones|mesh-ancestor
139030735|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139030736|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139030737|NCT02535039|Protective Agents|protective agents|mesh-ancestor
139030738|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138492995|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887235|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030739|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030740|NCT00363129|Vitamin E|vitamin e|mesh-list
139030741|NCT00363129|Vitamins|vitamins|mesh-ancestor
139030742|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
139030743|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030744|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
139030745|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030746|NCT00363129|Protective Agents|protective agents|mesh-ancestor
139030747|NCT00268996|Darapladib|darapladib|mesh-list
139030748|NCT00268996|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
139030749|NCT00268996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030750|NCT00268996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030751|NCT00379587|Rituximab|rituximab|mesh-list
139030752|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139030753|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030754|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
139030755|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030756|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139030757|NCT00363051|Everolimus|everolimus|mesh-list
139030758|NCT00363051|Octreotide|octreotide|mesh-list
139030759|NCT00363051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139030760|NCT00363051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139030761|NCT00363051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030762|NCT00363051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030763|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139030764|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
139030765|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030766|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030767|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139030768|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139030769|NCT00379353|Thalidomide|thalidomide|mesh-list
139030770|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139030771|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
139030772|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030773|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
139030774|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139030775|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030776|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139030777|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139030778|NCT00379353|Growth Substances|growth substances|mesh-ancestor
139030779|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
139030780|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030781|NCT01047657|Orlistat|orlistat|mesh-list
139030782|NCT01047657|Sibutramine|sibutramine|mesh-list
139030783|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030784|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030785|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139030786|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139030787|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
139030788|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139030789|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
139030790|NCT00378573|Bevacizumab|bevacizumab|mesh-list
139030791|NCT00378573|Gemcitabine|gemcitabine|mesh-list
139030792|NCT00378573|Docetaxel|docetaxel|mesh-list
139030793|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139030794|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030795|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139030796|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138987345|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
139030797|NCT00378573|Growth Substances|growth substances|mesh-ancestor
139030798|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030799|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
139030800|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139030801|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
139030802|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030803|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
139030804|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
139030805|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
139030806|NCT01047891|Sorafenib|sorafenib|mesh-list
139030807|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030808|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139030809|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030810|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030811|NCT02534571|Epinephrine|epinephrine|mesh-list
139030812|NCT02534571|Hemostatics|hemostatics|mesh-list
138781441|NCT05429086|Propofol|propofol|mesh-list
139030813|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139030814|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139030815|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
139030816|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030817|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030818|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030819|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139030820|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139030821|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
139030822|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030823|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139030824|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
139030825|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
139030826|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
139030827|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139030828|NCT02534571|Coagulants|coagulants|mesh-ancestor
139030829|NCT00457002|Enoxaparin|enoxaparin|mesh-list
139030830|NCT00457002|Apixaban|apixaban|mesh-list
139030831|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
139030832|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139030833|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139030834|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030835|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139030836|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
139030837|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139030838|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
139030839|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030840|NCT00362115|Olmesartan|olmesartan|mesh-list
139030841|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139030842|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139030843|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139030844|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139030845|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030846|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
139030847|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139030848|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139030849|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
138987366|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
139030850|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030851|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139030852|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139030853|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030854|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030855|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
139030856|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139030857|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139030858|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
139030859|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139030860|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139030861|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138493085|NCT00006107|Docetaxel|docetaxel|mesh-list
139030862|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030863|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030864|NCT03975010|Naltrexone|naltrexone|mesh-list
139030865|NCT03975010|Buprenorphine|buprenorphine|mesh-list
139030866|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139030867|NCT03975010|Narcotics|narcotics|mesh-ancestor
139030868|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139030869|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030870|NCT03975010|Analgesics|analgesics|mesh-ancestor
139030871|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
139030872|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030873|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139030874|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139030875|NCT01016990|Valproic Acid|valproic acid|mesh-list
139030876|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
139030877|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030878|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030879|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
139030880|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030881|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030882|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
139030883|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139030884|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139030885|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139030886|NCT01048047|Amlodipine|amlodipine|mesh-list
139030887|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139030888|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139030889|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139030890|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030891|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139030892|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030893|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
139030894|NCT01324635|Panobinostat|panobinostat|mesh-list
139030895|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
139030896|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030897|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030898|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030899|NCT00456846|Paclitaxel|paclitaxel|mesh-list
139030900|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139030901|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139030902|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030903|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
139030904|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
139030905|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
139030906|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030907|NCT03324282|Avelumab|avelumab|mesh-list
139030908|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139030909|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030910|NCT00484094|Sirolimus|sirolimus|mesh-list
139030911|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139030912|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138613854|NCT05694936|Cetuximab|cetuximab|mesh-list
139030913|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139030914|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030915|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
139030916|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139030917|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
139030918|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030919|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139030920|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030921|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
139030922|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139030923|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030924|NCT01029522|Atorvastatin|atorvastatin|mesh-list
139030925|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138553085|NCT00274417|Dutasteride|dutasteride|mesh-list
139030927|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
139030928|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030929|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139030930|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139030931|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030932|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
139030933|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139030934|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139030935|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139030936|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139030937|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030938|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
139030939|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139030940|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030941|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139030942|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139030943|NCT01565772|Etoposide|etoposide|mesh-list
139030944|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030945|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139030946|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139030947|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139030948|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553093|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
139030949|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030951|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139030952|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030953|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139030954|NCT00456300|Incretins|incretins|mesh-ancestor
139030955|NCT00456300|Hormones|hormones|mesh-ancestor
139030956|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139030957|NCT00267748|Sunitinib|sunitinib|mesh-list
139030958|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030959|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139030960|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139030961|NCT00267748|Growth Substances|growth substances|mesh-ancestor
139030962|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030963|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
139030964|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139030965|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139030966|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030967|NCT00267202|Omalizumab|omalizumab|mesh-list
139030968|NCT00267202|Immunomodulating Agents|immunomodulating agents|mesh-list
139030969|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
139030970|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139030971|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139030972|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139030973|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
139030974|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
139030975|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139030976|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139030977|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030978|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
139030979|NCT01067638|Coagulants|coagulants|mesh-ancestor
139030980|NCT00267046|Doxorubicin|doxorubicin|mesh-list
139030981|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139030982|NCT00267046|Vincristine|vincristine|mesh-list
139030983|NCT00267046|Ifosfamide|ifosfamide|mesh-list
139030984|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030985|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138553142|NCT00075374|Docetaxel|docetaxel|mesh-list
139030986|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139030987|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139030989|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139030990|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139030991|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
139030992|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
139030993|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
139030994|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139030995|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
139030996|NCT01029678|Vinorelbine|vinorelbine|mesh-list
139030997|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139030998|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139030999|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
139031000|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
139031001|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
139031002|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031003|NCT00286468|Alogliptin|alogliptin|mesh-list
139031004|NCT00286468|Glyburide|glyburide|mesh-list
139031005|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139031006|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031007|NCT00286468|Incretins|incretins|mesh-ancestor
139031008|NCT00286468|Hormones|hormones|mesh-ancestor
139031009|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139031010|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139031011|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
139031012|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031013|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031014|NCT00507026|Diclofenac|diclofenac|mesh-list
139031015|NCT00507026|Ketorolac|ketorolac|mesh-list
139031016|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139031017|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139031018|NCT00507026|Analgesics|analgesics|mesh-ancestor
139031019|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
139031020|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031021|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031022|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139031023|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138229524|NCT00363285|Hormones|hormones|mesh-list
139031024|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139031025|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031026|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031027|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
139031028|NCT01019174|Lenalidomide|lenalidomide|mesh-list
139031029|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031030|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
139031031|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031032|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031033|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139031034|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
139031035|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031036|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031037|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139031038|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138781679|NCT00607503|Terbutaline|terbutaline|mesh-list
139031039|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139031040|NCT01019174|Growth Substances|growth substances|mesh-ancestor
139031041|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
139031042|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
139031043|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139031044|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031046|NCT01011920|Rituximab|rituximab|mesh-list
139031047|NCT01011920|Methotrexate|methotrexate|mesh-list
139031048|NCT01011920|Thiotepa|thiotepa|mesh-list
139031049|NCT01011920|Carmustine|carmustine|mesh-list
139031050|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139031051|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031052|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
139031053|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031054|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031055|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139031056|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
139031057|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139031058|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139031059|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
139031060|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553213|NCT00277498|Timolol|timolol|mesh-list
139031061|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
139031062|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031063|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139031064|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031065|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139031066|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
139031067|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031068|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139031069|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
139031070|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139031071|NCT03976102|Rituximab|rituximab|mesh-list
139031072|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139031073|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031074|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
139031075|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031076|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031077|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
139031078|NCT00506948|Sirolimus|sirolimus|mesh-list
139031079|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
139031080|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139031081|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139031082|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031083|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139031084|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
139031085|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139031086|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031087|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138987429|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139031088|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031090|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031091|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
139031092|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031093|NCT00286234|Niacin|niacin|mesh-list
139031094|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
139031095|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139031096|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
139031097|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031098|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139031099|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
138553250|NCT00075452|Gemcitabine|gemcitabine|mesh-list
139031100|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
139031101|NCT00286234|Vitamins|vitamins|mesh-ancestor
139031102|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
139031103|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031104|NCT01019408|Chloroquine|chloroquine|mesh-list
139031105|NCT01019408|Amebicides|amebicides|mesh-ancestor
139031106|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139031107|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139031108|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031109|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
139031110|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031111|NCT01067950|Pancrelipase|pancrelipase|mesh-list
139031112|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139031113|NCT00445848|Bevacizumab|bevacizumab|mesh-list
139031114|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139031115|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138781744|NCT02499562|Entecavir|entecavir|mesh-list
139031116|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031117|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139031118|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139031119|NCT00445848|Growth Substances|growth substances|mesh-ancestor
139031120|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031121|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
139031122|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139031123|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031124|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031125|NCT00286156|Sirolimus|sirolimus|mesh-list
139031126|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139031127|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031128|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139031129|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031130|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
139031131|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031132|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
139031133|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031134|NCT00455520|Tapentadol|tapentadol|mesh-list
139031135|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139031136|NCT00455520|Narcotics|narcotics|mesh-ancestor
139031137|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139031138|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031139|NCT00455520|Analgesics|analgesics|mesh-ancestor
139031140|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
139031141|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031142|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139031143|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139031144|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139031145|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031146|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
139031147|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139031148|NCT00284050|Ranibizumab|ranibizumab|mesh-list
139031149|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139031150|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139031151|NCT00284050|Growth Substances|growth substances|mesh-ancestor
139031152|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031153|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
139031154|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031155|NCT00293020|Fentanyl|fentanyl|mesh-list
139031156|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139031157|NCT00293020|Narcotics|narcotics|mesh-ancestor
139031158|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139031159|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031160|NCT00293020|Analgesics|analgesics|mesh-ancestor
139031161|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
139031162|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031163|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139031164|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139031165|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
139031166|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
139031167|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
139031168|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
139031169|NCT00377637|Azathioprine|azathioprine|mesh-list
139031170|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031171|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
139031172|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031173|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138553317|NCT00278122|Paclitaxel|paclitaxel|mesh-list
139031174|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139031176|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031177|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031178|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139031179|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139031180|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139031181|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
139031182|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139031183|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031184|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031185|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
139031186|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139031187|NCT00377403|Acetaminophen|acetaminophen|mesh-list
139031188|NCT00377403|Amoxicillin|amoxicillin|mesh-list
139031189|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
139031190|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
139031191|NCT00377403|Ephedrine|ephedrine|mesh-list
139031193|NCT00377403|Guaifenesin|guaifenesin|mesh-list
139031194|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
139031195|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139031196|NCT00377403|Analgesics|analgesics|mesh-ancestor
139031197|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
139031198|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031199|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031200|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
139031201|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139031202|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031203|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
139031204|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
139031205|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139031206|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139031207|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139031208|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031209|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139031210|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
139031211|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139031212|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
139031213|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139031214|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139031215|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
139031216|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
139031217|NCT00377403|Expectorants|expectorants|mesh-ancestor
139031218|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139031219|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139031220|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
139031221|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139031222|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139031223|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031224|NCT00292942|Artesunate|artesunate|mesh-list
139031225|NCT00292942|Mannitol|mannitol|mesh-list
139031226|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
139031227|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139031228|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139031229|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031230|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031231|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
139031232|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
139031233|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139031234|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
139031235|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139031236|NCT00292942|Diuretics|diuretics|mesh-ancestor
139031237|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
139031238|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031239|NCT00483938|Interferons|interferons|mesh-list
139031240|NCT00483938|Ribavirin|ribavirin|mesh-list
139031241|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
139031242|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
139031243|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139031244|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031245|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
139031246|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031247|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
139031248|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031249|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
139031250|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031251|NCT00370071|Interferons|interferons|mesh-list
139031252|NCT00370071|Interferon-beta|interferon-beta|mesh-list
139031253|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
139031254|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031255|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
139031256|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031257|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
139031258|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031259|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139031260|NCT00369915|Scopolamine|scopolamine|mesh-list
139031261|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139031262|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139031263|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
139031264|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
139031265|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031266|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031267|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139031268|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
138781895|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
139031269|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139031270|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
139031271|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139031272|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031273|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139031274|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
139031275|NCT03991845|Levocetirizine|levocetirizine|mesh-list
139031276|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139031277|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139031278|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
139031279|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
139031280|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139031281|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031282|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031284|NCT01017380|Etoricoxib|etoricoxib|mesh-list
139031285|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139031286|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139031287|NCT01017380|Analgesics|analgesics|mesh-ancestor
139031288|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
139031289|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031290|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031291|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139031292|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031293|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139031294|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139031295|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690968|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031296|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031297|NCT00369681|Rituximab|rituximab|mesh-list
139031298|NCT00369681|Doxorubicin|doxorubicin|mesh-list
139031299|NCT00369681|Dacarbazine|dacarbazine|mesh-list
139031300|NCT00369681|Bleomycin|bleomycin|mesh-list
139031301|NCT00369681|Vinblastine|vinblastine|mesh-list
139031302|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139031303|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031304|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
139031305|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031306|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031307|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139031308|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139031309|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139031310|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031311|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031312|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139031313|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
139031314|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139031315|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
139031316|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
139031317|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
139031318|NCT00266812|Temozolomide|temozolomide|mesh-list
139031319|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139031320|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
139031321|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031322|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031323|NCT00488774|Golimumab|golimumab|mesh-list
139031324|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139031325|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139031326|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139031327|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031328|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
139031329|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031330|NCT00361569|Estrogens|estrogens|mesh-list
139031331|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139031332|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
139031333|NCT00361569|Hormones|hormones|mesh-ancestor
139031334|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139031335|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031336|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
139031337|NCT01011998|Valproic Acid|valproic acid|mesh-list
139031338|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031339|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139031340|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031341|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031342|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
139031343|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
139031344|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138493359|NCT00088894|Growth Substances|growth substances|mesh-ancestor
139031345|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031346|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
139031347|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139031348|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139031349|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139031350|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
139031351|NCT01017458|Testosterone|testosterone|mesh-list
139031352|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
139031353|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
139031354|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139031355|NCT01017458|Androgens|androgens|mesh-ancestor
139031357|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139031358|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031359|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139031360|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031361|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
139031362|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
139031363|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139031364|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
139031365|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031366|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
139031367|NCT02534415|Protective Agents|protective agents|mesh-ancestor
139031368|NCT00488618|Cariprazine|cariprazine|mesh-list
139031369|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139031370|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139031371|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139031372|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031373|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139031374|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
139031375|NCT01019642|Vitamin D|vitamin d|mesh-list
139031376|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139031377|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031378|NCT01019642|Vitamins|vitamins|mesh-ancestor
139031379|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
139031380|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139031381|NCT00266656|Hormones|hormones|mesh-list
139031382|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139031383|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031384|NCT00483548|Ziprasidone|ziprasidone|mesh-list
139031385|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139031386|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
139031387|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138987593|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138493385|NCT00088933|Metronidazole|metronidazole|mesh-list
139031388|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031389|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031390|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139031391|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139031392|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139031393|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139031394|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139031395|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
139031397|NCT00445770|Methotrexate|methotrexate|mesh-list
139031398|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139031399|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
139031400|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139031401|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031402|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139031403|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
139031404|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031405|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031406|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
139031407|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031408|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139031409|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031410|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
139031411|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031412|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139031413|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138553666|NCT00280696|Levetiracetam|levetiracetam|mesh-list
139031414|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139031416|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
139031417|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031418|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139031419|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139031420|NCT00266032|Drospirenone|drospirenone|mesh-list
139031421|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139031422|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
139031423|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139031424|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031425|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139031426|NCT00266032|Diuretics|diuretics|mesh-ancestor
139031427|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
139031428|NCT01019798|Docetaxel|docetaxel|mesh-list
139031429|NCT01019798|Sunitinib|sunitinib|mesh-list
139031430|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031431|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
139031432|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
139031433|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
139031434|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031435|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139031436|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139031437|NCT01019798|Growth Substances|growth substances|mesh-ancestor
139031438|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031439|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
139031440|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139031441|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031442|NCT00483002|Varenicline|varenicline|mesh-list
139031443|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139031444|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139031445|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
139031446|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139031447|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031448|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031449|NCT00482612|Mirtazapine|mirtazapine|mesh-list
139031450|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
139031451|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139031452|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139031453|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
139031454|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
139031455|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139031456|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031457|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031458|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139031459|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139031460|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139031461|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139031462|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139031463|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139031464|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
139031465|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139031466|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139031467|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
139031468|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139031469|NCT00282568|Tacrolimus|tacrolimus|mesh-list
139031470|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031471|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
139031472|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031473|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139031474|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031475|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031476|NCT02532322|Acetaminophen|acetaminophen|mesh-list
139031477|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139031478|NCT02532322|Analgesics|analgesics|mesh-ancestor
139031479|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
139031480|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031481|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031482|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
139031483|NCT00445692|Clarithromycin|clarithromycin|mesh-list
138440681|NCT01784549|Gefitinib|gefitinib|mesh-list
139031484|NCT00445692|Dexamethasone|dexamethasone|mesh-list
139031485|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
139031486|NCT00445692|Lenalidomide|lenalidomide|mesh-list
139031487|NCT00445692|Ichthammol|ichthammol|mesh-list
139031488|NCT00445692|BB 1101|bb 1101|mesh-list
139031489|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139031490|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
139031491|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
139031492|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031493|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031494|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139031496|NCT00445692|Hormones|hormones|mesh-ancestor
139031497|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139031498|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139031499|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031500|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
139031501|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139031502|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139031503|NCT00445692|Growth Substances|growth substances|mesh-ancestor
139031504|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
139031505|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139031506|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031507|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139031508|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031509|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031510|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139031511|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139031512|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
139031513|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
139031514|NCT00282412|Cyclosporine|cyclosporine|mesh-list
139031515|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
139031516|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
139031517|NCT00282412|Fludarabine|fludarabine|mesh-list
139031518|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
139031519|NCT00282412|Cyclosporins|cyclosporins|mesh-list
139031520|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031521|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
139031522|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031523|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031524|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139031525|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
139031526|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031527|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031528|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139031529|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031530|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
139031531|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031532|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
139031533|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139031534|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139031535|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138493471|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139031536|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
139031537|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138304020|NCT02034552|Hormones|hormones|mesh-ancestor
139031538|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139031539|NCT00282256|Tacrolimus|tacrolimus|mesh-list
139031540|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031541|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
139031542|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031543|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139031544|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031545|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031546|NCT00265330|Ziprasidone|ziprasidone|mesh-list
139031547|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139031548|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
139031549|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139031550|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031551|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031552|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139031553|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139031554|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139031555|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139031556|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139031557|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
139031558|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
139031560|NCT00543569|Tacrolimus|tacrolimus|mesh-list
139031561|NCT00543569|Basiliximab|basiliximab|mesh-list
139031562|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031563|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
139031564|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031565|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139031566|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031567|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031568|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139031569|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031570|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139031571|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
139031572|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139031573|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031574|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
139031575|NCT00984347|Oxytocin|oxytocin|mesh-list
139031576|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
139031577|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139031578|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031579|NCT00984425|Sorafenib|sorafenib|mesh-list
139031580|NCT00984425|Lapatinib|lapatinib|mesh-list
139031581|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493513|NCT00423982|Vancomycin|vancomycin|mesh-list
139031582|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139031583|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031584|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031585|NCT05596955|Naltrexone|naltrexone|mesh-list
139031586|NCT05596955|Buprenorphine|buprenorphine|mesh-list
139031587|NCT05596955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139031588|NCT05596955|Narcotics|narcotics|mesh-ancestor
139031589|NCT05596955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139031590|NCT05596955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031591|NCT05596955|Analgesics|analgesics|mesh-ancestor
139031592|NCT05596955|Sensory System Agents|sensory system agents|mesh-ancestor
139031593|NCT05596955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031594|NCT05596955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139031595|NCT05596955|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139031596|NCT00445458|Paclitaxel|paclitaxel|mesh-list
139031597|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139031598|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031599|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
139031600|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
139031601|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
139031602|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031603|NCT03914417|Imiquimod|imiquimod|mesh-list
139031604|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139031605|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
139031606|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031607|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031608|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
139031609|NCT05586113|Bismuth|bismuth|mesh-list
139031610|NCT05586113|Antacids|antacids|mesh-ancestor
139031611|NCT05586113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031612|NCT05586113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139031613|NCT00541385|Artesunate|artesunate|mesh-list
139031614|NCT00541385|Lumefantrine|lumefantrine|mesh-list
139031615|NCT00541385|Pyronaridine|pyronaridine|mesh-list
139031616|NCT00541385|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
139031617|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
139031618|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139031619|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139031620|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031621|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031622|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
139031623|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
139031624|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139031625|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
139031626|NCT00988949|Spiradoline|spiradoline|mesh-list
139031627|NCT00988949|Analgesics|analgesics|mesh-ancestor
139031628|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
139031629|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031630|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031631|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139031632|NCT00988949|Diuretics|diuretics|mesh-ancestor
139031633|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
139031634|NCT00989027|Oxytocin|oxytocin|mesh-list
139031635|NCT00989027|Carboprost|carboprost|mesh-list
139031636|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
139031637|NCT00989027|Ergonovine|ergonovine|mesh-list
139031638|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
138493536|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
139031639|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139031640|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031641|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139031642|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
139031643|NCT00265096|Golimumab|golimumab|mesh-list
139031644|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139031645|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139031646|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139031647|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031648|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
139031649|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031651|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139031652|NCT00986609|Vaccines|vaccines|mesh-list
139031653|NCT00986609|Poly ICLC|poly iclc|mesh-list
139031654|NCT00986609|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
139031655|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
139031656|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031657|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
139031658|NCT00986609|Laxatives|laxatives|mesh-ancestor
139031659|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139031660|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
139031661|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031662|NCT00986609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139031663|NCT00281320|Asenapine|asenapine|mesh-list
139031664|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139031665|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139031666|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139031667|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031668|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139031669|NCT00541307|Heparin|heparin|mesh-list
139031670|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
139031671|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139031672|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139031673|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031674|NCT05499689|Bupivacaine|bupivacaine|mesh-list
139031675|NCT05499689|Anesthetics, Local|anesthetics, local|mesh-ancestor
139031676|NCT05499689|Anesthetics|anesthetics|mesh-ancestor
139031677|NCT05499689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139031678|NCT05499689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554306|NCT00284947|Prednisone|prednisone|mesh-list
139031679|NCT05499689|Sensory System Agents|sensory system agents|mesh-ancestor
139031680|NCT05499689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031681|NCT01012232|Ropivacaine|ropivacaine|mesh-list
139031682|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
139031683|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
139031684|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139031685|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031686|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
139031687|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031688|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139031689|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139031690|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031691|NCT00541229|Incretins|incretins|mesh-ancestor
139031692|NCT00541229|Hormones|hormones|mesh-ancestor
139031693|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139031694|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139031696|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031697|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031698|NCT04006691|Mitomycins|mitomycins|mesh-list
139031699|NCT04006691|Mitomycin|mitomycin|mesh-list
139031700|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139031701|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031702|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
139031703|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031704|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139031705|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031706|NCT00986765|Aspirin|aspirin|mesh-list
139031707|NCT00986765|Enoxaparin|enoxaparin|mesh-list
139031708|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139031709|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139031710|NCT00986765|Analgesics|analgesics|mesh-ancestor
139031711|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
139031712|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031713|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031714|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139031715|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031716|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139031717|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138554481|NCT00077519|Tipifarnib|tipifarnib|mesh-list
139031718|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031719|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138887236|NCT00867360|Mifepristone|mifepristone|mesh-list
139031720|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138493565|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
139031721|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031722|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
139031723|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
139031724|NCT00986843|Irinotecan|irinotecan|mesh-list
139031725|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139031726|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139031727|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031728|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031729|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031730|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
139031731|NCT01019876|Fludarabine|fludarabine|mesh-list
139031732|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031733|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
139031734|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031735|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031736|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139031737|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
139031738|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031739|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031740|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139031741|NCT01017770|Artesunate|artesunate|mesh-list
139031742|NCT01017770|Lumefantrine|lumefantrine|mesh-list
139031743|NCT01017770|Artemether|artemether|mesh-list
139031744|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
139031745|NCT01017770|Amodiaquine|amodiaquine|mesh-list
139031746|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
139031747|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139031748|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139031749|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031750|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031751|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
139031752|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
139031753|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139031754|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
139031755|NCT01017926|Triazolam|triazolam|mesh-list
139031756|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139031757|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139031758|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139031759|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139031760|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031761|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139031762|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
139031763|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
139031764|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139031765|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031766|NCT00481832|Cyclosporine|cyclosporine|mesh-list
139031767|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
139031768|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
139031769|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138554656|NCT00077792|Enoxaparin|enoxaparin|mesh-list
139031770|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139031772|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
139031773|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
139031774|NCT00481832|Carmustine|carmustine|mesh-list
139031775|NCT00481832|Rituximab|rituximab|mesh-list
139031776|NCT00481832|Etoposide|etoposide|mesh-list
139031777|NCT00481832|Cyclosporins|cyclosporins|mesh-list
139031778|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139031779|NCT00481832|Lenograstim|lenograstim|mesh-list
139031780|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139031781|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
139031782|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031783|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
138554717|NCT00077948|Metoprolol|metoprolol|mesh-list
139031784|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031786|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139031787|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
139031788|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031789|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031790|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139031791|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139031792|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139031793|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139031794|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139031795|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031796|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139031797|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
139031798|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031799|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
139031800|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139031801|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139031802|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139031803|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
139031804|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139031805|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139031806|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
139031807|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
139031808|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031809|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139031810|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
139031811|NCT00481832|Hormones|hormones|mesh-ancestor
138554846|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139031812|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139031813|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139031814|NCT00481832|Protective Agents|protective agents|mesh-ancestor
139031815|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139031816|NCT00481676|Omalizumab|omalizumab|mesh-list
139031817|NCT00481676|Loratadine|loratadine|mesh-list
139031818|NCT00481676|Clemastine|clemastine|mesh-list
139031819|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139031820|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139031821|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138554904|NCT00078182|Tenofovir|tenofovir|mesh-list
139031822|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
139031823|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
139031824|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031825|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
139031826|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
139031827|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139031828|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139031829|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
139031830|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
139031831|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139031832|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031833|NCT00987233|Triamcinolone|triamcinolone|mesh-list
139031834|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139031835|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139031836|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139031837|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139031838|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
139031839|NCT00987233|Hormones|hormones|mesh-ancestor
139031840|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139031841|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031842|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031843|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
139031844|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031845|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031846|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
139031847|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139031848|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139031849|NCT04377503|Prednisolone|prednisolone|mesh-list
139031850|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
139031851|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139031852|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
139031853|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139031854|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
139031855|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
139031856|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139031857|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031858|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139031859|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
139031860|NCT04377503|Hormones|hormones|mesh-ancestor
139031861|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139031862|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139031863|NCT04377503|Protective Agents|protective agents|mesh-ancestor
139031864|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139031865|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031866|NCT00542789|Esomeprazole|esomeprazole|mesh-list
139031867|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139031868|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139031869|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139031870|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031871|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031872|NCT00464672|Vaccines|vaccines|mesh-list
139031873|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
139031874|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031875|NCT03996434|Cetrorelix|cetrorelix|mesh-list
138782504|NCT02731378|Iron|iron|mesh-list
139031876|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139031877|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
139031878|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139031879|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031880|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
139031881|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139031883|NCT00987779|Analgesics|analgesics|mesh-ancestor
139031884|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
139031885|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555216|NCT00291382|Fluticasone|fluticasone|mesh-list
139031886|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031887|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
139031888|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139031889|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139031890|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139031891|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139031892|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139031893|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139031894|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139031895|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031896|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
139031897|NCT01018160|Rabeprazole|rabeprazole|mesh-list
139031898|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139031899|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139031900|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139031901|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031902|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031903|NCT00473876|Metformin|metformin|mesh-list
139031904|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139031905|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031906|NCT00463580|Infliximab|infliximab|mesh-list
139031907|NCT00463580|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139031908|NCT00463580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138555284|NCT00078611|Natalizumab|natalizumab|mesh-list
139031909|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
139031910|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139031911|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031913|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
139031914|NCT01020734|Busulfan|busulfan|mesh-list
138493697|NCT00091078|Oblimersen|oblimersen|mesh-list
139031915|NCT01020734|Methotrexate|methotrexate|mesh-list
139031916|NCT01020734|Fludarabine|fludarabine|mesh-list
139031917|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
139031918|NCT01020734|Cyclosporins|cyclosporins|mesh-list
139031919|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138555335|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
139031920|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031921|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
139031922|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031923|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031924|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139031925|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
139031926|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031927|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031928|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139031929|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139031930|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
139031931|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139031932|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138555412|NCT00102765|Xhance|xhance|mesh-list
139031933|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
139031934|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
139031935|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031936|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139031937|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139031938|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
139031939|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031940|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139031941|NCT00540449|Efavirenz|efavirenz|mesh-list
139031942|NCT00540449|Rilpivirine|rilpivirine|mesh-list
139031943|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139031944|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139031945|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031946|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031947|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
139031948|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139031949|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139031950|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139031951|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139031952|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139031953|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139031954|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139031955|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139031956|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139031957|NCT03911843|Vitamin D|vitamin d|mesh-list
139031958|NCT03911843|Vitamins|vitamins|mesh-ancestor
139031959|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
139031960|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031961|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139031962|NCT00361335|Golimumab|golimumab|mesh-list
139031963|NCT00361335|Methotrexate|methotrexate|mesh-list
139031964|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139031965|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
139031966|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139031967|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031968|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139031969|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
139031970|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031971|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031972|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
139031973|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031975|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031976|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
139031977|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138988020|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
139031978|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139031979|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139031980|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139031981|NCT00264550|Golimumab|golimumab|mesh-list
139031982|NCT00264550|Methotrexate|methotrexate|mesh-list
139031983|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139031984|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139031985|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
139031986|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139031987|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139031988|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139031989|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
139031990|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139031991|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139031992|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
139031993|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139031994|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139031995|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139031997|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139031998|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139031999|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139032000|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032001|NCT04004507|Phentolamine|phentolamine|mesh-list
139032002|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139032003|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139032004|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139032005|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139032006|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
139032007|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032008|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032009|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032010|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139032011|NCT01070290|Capecitabine|capecitabine|mesh-list
139032012|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
139032013|NCT01070290|Irinotecan|irinotecan|mesh-list
139032014|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139032015|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
139032016|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032017|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032018|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139032019|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139032020|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032022|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
139032023|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139032024|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
139032025|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032026|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032027|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139032028|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
139032030|NCT01050387|Vitamins|vitamins|mesh-ancestor
139032031|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
139032032|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032033|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139032034|NCT01070524|Budesonide|budesonide|mesh-list
139032035|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139032036|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032037|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139032038|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
139032039|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032040|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032041|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139032042|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
139032043|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
139032044|NCT01070524|Hormones|hormones|mesh-ancestor
139032045|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139032046|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
139032047|NCT01071304|Midazolam|midazolam|mesh-list
139032048|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139032049|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139032050|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139032051|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032052|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139032053|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139032054|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139032055|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139032056|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
139032057|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
138555752|NCT00079469|Bupropion|bupropion|mesh-list
139032058|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
139032059|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
139032060|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032061|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032062|NCT01069042|Enalapril|enalapril|mesh-list
139032063|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139032064|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
139032065|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032066|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032067|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139032068|NCT00368979|Dutasteride|dutasteride|mesh-list
139032069|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139032070|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139032071|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032072|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032073|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
139032074|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139032075|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032076|NCT00264238|Memantine|memantine|mesh-list
139032077|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139032078|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139032079|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
139032080|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032081|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032082|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032083|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139032084|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139032085|NCT00540293|Atorvastatin|atorvastatin|mesh-list
139032086|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139032087|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139032088|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
139032089|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032090|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139032091|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139032092|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032093|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
139032094|NCT01050621|Vitamins|vitamins|mesh-ancestor
139032095|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
139032096|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032097|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
138555854|NCT00299377|Abciximab|abciximab|mesh-list
139032098|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782717|NCT00913315|Urological Agents|urological agents|mesh-ancestor
139032099|NCT01050621|Protective Agents|protective agents|mesh-ancestor
139032100|NCT00359073|Montelukast|montelukast|mesh-list
139032101|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139032102|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
139032103|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139032104|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
139032105|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139032106|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032107|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139032108|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139032109|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032110|NCT00368745|Pregabalin|pregabalin|mesh-list
139032111|NCT00368745|Analgesics|analgesics|mesh-ancestor
139032112|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
139032113|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032114|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032115|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
139032116|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139032117|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139032118|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032119|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139032121|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139032122|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139032123|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139032125|NCT04573673|Cathartics|cathartics|mesh-ancestor
139032126|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032127|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139032128|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032129|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032130|NCT01050699|Midazolam|midazolam|mesh-list
139032131|NCT01050699|Fentanyl|fentanyl|mesh-list
139032132|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
139032133|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139032134|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139032135|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032136|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139032137|NCT01050699|Analgesics|analgesics|mesh-ancestor
139032138|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
139032139|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032140|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139032141|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139032142|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139032143|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
139032144|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032145|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555958|NCT00418171|Olanzapine|olanzapine|mesh-list
139032146|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139032147|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139032148|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139032149|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139032150|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139032151|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
139032153|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
139032154|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
139032155|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139032156|NCT01050699|Narcotics|narcotics|mesh-ancestor
139032157|NCT02408315|Misoprostol|misoprostol|mesh-list
139032158|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139032159|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
139032160|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139032161|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032162|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139032163|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032164|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
139032165|NCT05711693|Bepridil|bepridil|mesh-list
139032166|NCT05711693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139032167|NCT05711693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139032168|NCT05711693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139032169|NCT05711693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139032170|NCT05711693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032171|NCT05711693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138782792|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032172|NCT05711693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032173|NCT05711693|Vasodilator Agents|vasodilator agents|mesh-ancestor
139032175|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139032176|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139032177|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
139032178|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032179|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032180|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032181|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139032182|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139032183|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
139032184|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
139032185|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139032186|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139032187|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
139032188|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032189|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139032190|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139032191|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032192|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032193|NCT00358917|Ritonavir|ritonavir|mesh-list
139032194|NCT00358917|Lopinavir|lopinavir|mesh-list
139032195|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139032196|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139032197|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139032198|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
139032199|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032200|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032201|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139032202|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139032203|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
139032204|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032205|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139032206|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139032207|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139032208|NCT01048515|Caffeine|caffeine|mesh-list
139032209|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139032210|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032211|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139032212|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032213|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032214|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138988248|NCT00507429|Paclitaxel|paclitaxel|mesh-list
139032215|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139032216|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
139032217|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032218|NCT01050777|Paromomycin|paromomycin|mesh-list
139032219|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
139032220|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139032221|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032222|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139032223|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139032224|NCT00264004|Cediranib|cediranib|mesh-list
139032225|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032226|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139032227|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032228|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032229|NCT01069198|Vitamin A|vitamin a|mesh-list
139032230|NCT01069198|Albendazole|albendazole|mesh-list
139032231|NCT01069198|Vitamins|vitamins|mesh-ancestor
139032232|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
139032233|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032234|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032235|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032236|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
139032237|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139032238|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032239|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
139032240|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139032241|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139032242|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
139032243|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
139032244|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
139032245|NCT00368355|Cytarabine|cytarabine|mesh-list
139032246|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
139032247|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
139032248|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139032249|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
139032250|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032251|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139032252|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139032253|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
139032254|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032255|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032256|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139032257|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139032258|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
139032259|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
138988272|NCT01011621|Hormones|hormones|mesh-ancestor
139032260|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032261|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139032262|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
139032263|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139032264|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139032265|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032266|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139032267|NCT01070680|Analgesics|analgesics|mesh-ancestor
139032268|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
139032269|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032270|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139032271|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139032272|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139032273|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
139032274|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032275|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032276|NCT00445146|Elvitegravir|elvitegravir|mesh-list
139032277|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139032278|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139032279|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
139032280|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032281|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139032282|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032283|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032284|NCT01581736|Insulin|insulin|mesh-list
139032285|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139032286|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139032287|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032288|NCT01030302|Bortezomib|bortezomib|mesh-list
139032289|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032290|NCT00368277|Amlodipine|amlodipine|mesh-list
139032291|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139032292|NCT00368277|Ramipril|ramipril|mesh-list
139032293|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139032294|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139032295|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139032296|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032297|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139032298|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032299|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
139032300|NCT00368277|Diuretics|diuretics|mesh-ancestor
139032301|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
139032302|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139032303|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139032304|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
139032305|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032306|NCT00280150|Paclitaxel|paclitaxel|mesh-list
139032307|NCT00280150|Bevacizumab|bevacizumab|mesh-list
139032308|NCT00280150|Carboplatin|carboplatin|mesh-list
139032309|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139032310|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139032311|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032312|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
139032313|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
139032314|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
139032315|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032316|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139032317|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139032318|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139032319|NCT00280150|Growth Substances|growth substances|mesh-ancestor
139032320|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032321|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
139032322|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139032323|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032325|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139032326|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139032327|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139032328|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032329|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
139032330|NCT00279916|Hormones|hormones|mesh-ancestor
139032331|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139032332|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032333|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139032334|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
139032335|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032336|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032337|NCT02534337|Leucovorin|leucovorin|mesh-list
139032338|NCT02534337|Gemcitabine|gemcitabine|mesh-list
139032339|NCT02534337|Fluorouracil|fluorouracil|mesh-list
139032340|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
139032341|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139032342|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
139032343|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032344|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032345|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139032346|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
139032347|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032348|NCT02534337|Antidotes|antidotes|mesh-ancestor
139032349|NCT02534337|Protective Agents|protective agents|mesh-ancestor
139032350|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
139032351|NCT02534337|Vitamins|vitamins|mesh-ancestor
139032352|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
139032353|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139032354|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
139032355|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032356|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
139032357|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
139032358|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032359|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
139032360|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032361|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032362|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
139032363|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032364|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
139032365|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139032367|NCT00251758|Lansoprazole|lansoprazole|mesh-list
139032368|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139032369|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032370|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139032371|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032372|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032373|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
139032374|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032375|NCT00262834|Vorinostat|vorinostat|mesh-list
139032376|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032377|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139032378|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032379|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032380|NCT04417361|Erenumab|erenumab|mesh-list
139032381|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139032382|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032383|NCT04417361|Analgesics|analgesics|mesh-ancestor
139032384|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
139032385|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032386|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032387|NCT00541775|Metformin|metformin|mesh-list
139032388|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139032389|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
139032390|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139032391|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032392|NCT00541775|Incretins|incretins|mesh-ancestor
139032393|NCT00541775|Hormones|hormones|mesh-ancestor
139032394|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139032395|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139032396|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
139032397|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032398|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032399|NCT04004117|Fentanyl|fentanyl|mesh-list
139032400|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139032401|NCT04004117|Narcotics|narcotics|mesh-ancestor
139032402|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139032403|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032404|NCT04004117|Analgesics|analgesics|mesh-ancestor
139032405|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
139032406|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032407|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139032408|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139032409|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
139032410|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
139032411|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
139032412|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138988356|NCT00740363|Hormones|hormones|mesh-ancestor
139032413|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
139032414|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032415|NCT00539513|Expectorants|expectorants|mesh-ancestor
139032416|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
139032417|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139032418|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
139032419|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032420|NCT00539513|Protective Agents|protective agents|mesh-ancestor
139032421|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032422|NCT00539513|Antidotes|antidotes|mesh-ancestor
139032423|NCT00454584|Etanercept|etanercept|mesh-list
139032424|NCT00454584|Ustekinumab|ustekinumab|mesh-list
139032425|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139032426|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139032427|NCT00454584|Analgesics|analgesics|mesh-ancestor
139032428|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
139032429|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032430|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032431|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032433|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032434|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139032435|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
139032436|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
139032437|NCT04204343|Bupivacaine|bupivacaine|mesh-list
139032438|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
139032439|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
139032440|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139032441|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032442|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
139032443|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032444|NCT02845271|Acetaminophen|acetaminophen|mesh-list
139032445|NCT02845271|Tramadol|tramadol|mesh-list
139032446|NCT02845271|Codeine|codeine|mesh-list
139032447|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139032448|NCT02845271|Analgesics|analgesics|mesh-ancestor
138493980|NCT00093262|Clevidipine|clevidipine|mesh-list
139032449|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
139032450|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032451|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032452|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
139032453|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139032454|NCT02845271|Narcotics|narcotics|mesh-ancestor
139032455|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139032456|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
139032457|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
139032458|NCT00445068|Panobinostat|panobinostat|mesh-list
139032459|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032460|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139032461|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032462|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032463|NCT02404337|Betaine|betaine|mesh-list
139032464|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032465|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
139032466|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139032467|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
139032468|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032469|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139032470|NCT05360147|Metformin|metformin|mesh-list
139032471|NCT05360147|Liraglutide|liraglutide|mesh-list
139032472|NCT05360147|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139032473|NCT05360147|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
139032474|NCT05360147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032475|NCT05360147|Incretins|incretins|mesh-ancestor
139032476|NCT05360147|Hormones|hormones|mesh-ancestor
139032477|NCT05360147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139032478|NCT00444912|Plerixafor|plerixafor|mesh-list
139032479|NCT00444912|Rituximab|rituximab|mesh-list
139032480|NCT00444912|Lenograstim|lenograstim|mesh-list
139032481|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139032482|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032483|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
139032484|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032485|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139032486|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139032487|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139032488|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139032489|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
139032490|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032491|NCT00538733|Clarithromycin|clarithromycin|mesh-list
139032492|NCT00538733|Thalidomide|thalidomide|mesh-list
139032493|NCT00538733|Dexamethasone|dexamethasone|mesh-list
139032494|NCT00538733|Lenalidomide|lenalidomide|mesh-list
139032495|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032496|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
139032497|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
139032498|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032499|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032500|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032501|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
139032502|NCT00538733|Hormones|hormones|mesh-ancestor
139032503|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139032504|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139032505|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032506|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
139032507|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139032508|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139032509|NCT00538733|Growth Substances|growth substances|mesh-ancestor
139032510|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
139032511|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139032512|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032513|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139032514|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032515|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032516|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139032517|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139032518|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139032519|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
139032520|NCT00444678|Capecitabine|capecitabine|mesh-list
139032521|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
139032522|NCT00444678|Cetuximab|cetuximab|mesh-list
139032523|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139032524|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
139032525|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032526|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032527|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139032528|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
139032529|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
139032530|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032532|NCT00539981|Coagulants|coagulants|mesh-ancestor
139032533|NCT00990197|Nicotine|nicotine|mesh-list
139032534|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139032535|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
139032536|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032537|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032538|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139032539|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139032540|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
139032541|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032542|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032543|NCT01051011|Metformin|metformin|mesh-list
139032544|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
139032545|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139032546|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138494044|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
139032547|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032548|NCT01051011|Incretins|incretins|mesh-ancestor
139032549|NCT01051011|Hormones|hormones|mesh-ancestor
139032550|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139032551|NCT01048827|Busulfan|busulfan|mesh-list
139032552|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
139032553|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032554|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139032555|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
139032556|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032557|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139032558|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032559|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139032560|NCT01302327|Exenatide|exenatide|mesh-list
139032561|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139032562|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032563|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139032564|NCT01302327|Incretins|incretins|mesh-ancestor
139032565|NCT01302327|Hormones|hormones|mesh-ancestor
139032566|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139032567|NCT01048983|Minocycline|minocycline|mesh-list
139032568|NCT01048983|Curcumin|curcumin|mesh-list
139032569|NCT01048983|Modafinil|modafinil|mesh-list
139032570|NCT01048983|Bupropion|bupropion|mesh-list
139032571|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138556280|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139032572|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
139032573|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139032574|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139032575|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139032576|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139032577|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032578|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
139032579|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032580|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032581|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139032582|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139032583|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032584|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139032585|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139032586|NCT01048983|Analgesics|analgesics|mesh-ancestor
139032587|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
139032588|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032589|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032590|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139032591|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032592|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139032593|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556311|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139032594|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139032595|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139032596|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139032597|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139032598|NCT01340417|Melatonin|melatonin|mesh-list
139032599|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
139032600|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032601|NCT01340417|Protective Agents|protective agents|mesh-ancestor
139032602|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032603|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139032604|NCT01049061|Farletuzumab|farletuzumab|mesh-list
139032605|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032606|NCT00367341|Escitalopram|escitalopram|mesh-list
139032607|NCT00367341|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139032608|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139032609|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139032610|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032611|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032612|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
139032613|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032614|NCT01052961|Oseltamivir|oseltamivir|mesh-list
139032615|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
139032616|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032617|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032618|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032619|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
139032620|NCT00440466|Hematinics|hematinics|mesh-ancestor
139032621|NCT01051167|Cetuximab|cetuximab|mesh-list
139032622|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139032623|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032624|NCT00616967|Paclitaxel|paclitaxel|mesh-list
139032625|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139032626|NCT00616967|Carboplatin|carboplatin|mesh-list
139032627|NCT00616967|Vorinostat|vorinostat|mesh-list
139032628|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139032629|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032630|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
139032631|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
139032632|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
139032633|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032634|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139032635|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032636|NCT00989651|Paclitaxel|paclitaxel|mesh-list
139032637|NCT00989651|Bevacizumab|bevacizumab|mesh-list
139032638|NCT00989651|Cisplatin|cisplatin|mesh-list
139032639|NCT00989651|Carboplatin|carboplatin|mesh-list
139032640|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139032641|NCT00989651|Veliparib|veliparib|mesh-list
139032642|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139032643|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
139032644|NCT00989651|Antibodies|antibodies|mesh-list
139032645|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
139032646|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139032647|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
139032648|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139032649|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032650|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
139032651|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
139032652|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
138494090|NCT00094003|Poly I-C|poly i-c|mesh-list
139032653|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032654|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139032655|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139032656|NCT00989651|Growth Substances|growth substances|mesh-ancestor
139032657|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032658|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
139032659|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
139032660|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139032661|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032662|NCT05590559|Morphine|morphine|mesh-list
139032663|NCT05590559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139032664|NCT05590559|Narcotics|narcotics|mesh-ancestor
139032665|NCT05590559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139032666|NCT05590559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032667|NCT05590559|Analgesics|analgesics|mesh-ancestor
139032668|NCT05590559|Sensory System Agents|sensory system agents|mesh-ancestor
139032669|NCT05590559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032670|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
139032671|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139032672|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139032674|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
139032675|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139032676|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
139032677|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032678|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
139032679|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
139032680|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032681|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032682|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032683|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
139032684|NCT00989729|Hormones|hormones|mesh-ancestor
139032685|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139032686|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139032687|NCT00989729|Protective Agents|protective agents|mesh-ancestor
139032688|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139032689|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032690|NCT00989807|Aztreonam|aztreonam|mesh-list
139032691|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139032692|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032693|NCT00990587|Ciclopirox|ciclopirox|mesh-list
138494122|NCT00094315|Cocaine|cocaine|mesh-list
139032694|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
139032695|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032696|NCT00537329|Anidulafungin|anidulafungin|mesh-list
139032697|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
139032698|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032699|NCT03905135|Avelumab|avelumab|mesh-list
139032700|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139032701|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032702|NCT00991055|Pioglitazone|pioglitazone|mesh-list
139032703|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139032704|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556439|NCT00120081|Antacids|antacids|mesh-ancestor
139032706|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032707|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032708|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139032709|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
139032710|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
139032711|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139032712|NCT00991211|Doxorubicin|doxorubicin|mesh-list
139032713|NCT00991211|Vincristine|vincristine|mesh-list
139032714|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139032715|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
139032716|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032717|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139032718|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139032719|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
139032720|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032721|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032722|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139032723|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139032724|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139032725|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139032726|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032727|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139032728|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
139032729|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
139032730|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
139032731|NCT00357903|Etanercept|etanercept|mesh-list
139032732|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139032733|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139032734|NCT00357903|Analgesics|analgesics|mesh-ancestor
139032735|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
139032736|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032737|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032738|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032739|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139032740|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032741|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139032742|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
139032743|NCT01053039|Morphine|morphine|mesh-list
139032744|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139032745|NCT01053039|Narcotics|narcotics|mesh-ancestor
139032746|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139032747|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032748|NCT01053039|Analgesics|analgesics|mesh-ancestor
139032749|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
139032750|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032751|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139032752|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139032753|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139032754|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
139032755|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032756|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139032757|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139032758|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032759|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
139032760|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
139032761|NCT00348933|Betaine|betaine|mesh-list
139032762|NCT00348933|Vitamins|vitamins|mesh-ancestor
139032763|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
139032764|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032765|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
139032766|NCT00348933|Hematinics|hematinics|mesh-ancestor
139032767|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032768|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
139032769|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139032770|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
139032771|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032772|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139032773|NCT01051479|Choline|choline|mesh-list
139032774|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
139032775|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139032776|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
139032777|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032778|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032779|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139032780|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
139032781|NCT01055691|Metformin|metformin|mesh-list
139032782|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
139032783|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139032784|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032785|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139032786|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032787|NCT03896477|Vaccines|vaccines|mesh-list
139032788|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139032789|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
139032790|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032791|NCT00444600|Triamcinolone|triamcinolone|mesh-list
139032792|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139032793|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139032794|NCT00444600|Ranibizumab|ranibizumab|mesh-list
139032795|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139032796|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138494183|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
139032797|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139032798|NCT00444600|Growth Substances|growth substances|mesh-ancestor
139032799|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032800|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
139032801|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032802|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032803|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
139032804|NCT00444600|Hormones|hormones|mesh-ancestor
139032805|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139032806|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139032807|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
139032808|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032809|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032810|NCT00443898|Terbinafine|terbinafine|mesh-list
139032811|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
139032812|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032813|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032814|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032815|NCT00537017|Levodopa|levodopa|mesh-list
138988560|NCT00905528|Telmisartan|telmisartan|mesh-list
139032816|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139032817|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139032818|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
139032819|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032820|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032821|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032822|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
139032823|NCT00348309|Donepezil|donepezil|mesh-list
139032824|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139032825|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032826|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032827|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
139032828|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032829|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032830|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
139032831|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139032832|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
139032833|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139032834|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032835|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139032836|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032837|NCT05493683|Tislelizumab|tislelizumab|mesh-list
139032838|NCT05493683|Disitamab vedotin|disitamab vedotin|mesh-list
139032839|NCT05493683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139032840|NCT05493683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032841|NCT05493683|Immunoconjugates|immunoconjugates|mesh-ancestor
139032842|NCT05493683|Immunologic Factors|immunologic factors|mesh-ancestor
139032843|NCT05493683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032844|NCT05440487|Chelating Agents|chelating agents|mesh-list
139032845|NCT05440487|Sequestering Agents|sequestering agents|mesh-ancestor
138494198|NCT00094666|Gaboxadol|gaboxadol|mesh-list
139032846|NCT05440487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032847|NCT00440310|Talaporfin|talaporfin|mesh-list
139032848|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032849|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139032850|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
139032851|NCT01055847|Aztreonam|aztreonam|mesh-list
139032852|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139032853|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032854|NCT02533791|Vaccines|vaccines|mesh-list
139032855|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
139032856|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032857|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139032859|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032860|NCT00440232|Frovatriptan|frovatriptan|mesh-list
139032861|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139032862|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
139032863|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032864|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032865|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032867|NCT01564199|Xhance|xhance|mesh-list
139032868|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139032869|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032870|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139032871|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
139032872|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032873|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032874|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139032875|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
139032876|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
139032877|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139032878|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139032879|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139032880|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139032881|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
139032882|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032883|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032884|NCT02533323|Gemcitabine|gemcitabine|mesh-list
139032885|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
139032886|NCT02533323|Pegaspargase|pegaspargase|mesh-list
139032887|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139032888|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
139032889|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032890|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032891|NCT05357885|Antibodies|antibodies|mesh-list
138494230|NCT00094978|Alvocidib|alvocidib|mesh-list
139032892|NCT05357885|Immunologic Factors|immunologic factors|mesh-ancestor
139032893|NCT05357885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032894|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139032895|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
139032896|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139032897|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032898|NCT00356889|Bevacizumab|bevacizumab|mesh-list
139032899|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139032900|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139032901|NCT00356889|Antibodies|antibodies|mesh-list
139032902|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
139032903|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139032904|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032905|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139032906|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139032907|NCT00356889|Growth Substances|growth substances|mesh-ancestor
139032908|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032909|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
139032910|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
139032911|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139032912|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032913|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138988610|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
139032915|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032916|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032917|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032918|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
139032919|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
139032920|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032921|NCT04715022|Protective Agents|protective agents|mesh-ancestor
139032922|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032923|NCT04715022|Vitamins|vitamins|mesh-ancestor
139032924|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
139032925|NCT00356811|Paclitaxel|paclitaxel|mesh-list
139032926|NCT00356811|Lapatinib|lapatinib|mesh-list
139032927|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139032928|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032929|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
139032930|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
139032931|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
139032932|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032933|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139032934|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032935|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
139032936|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032937|NCT01030614|Dexamethasone|dexamethasone|mesh-list
139032938|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032939|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
139032940|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
139032941|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032942|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032943|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139032944|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
139032946|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139032947|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139032948|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032949|NCT01030692|Rivastigmine|rivastigmine|mesh-list
139032950|NCT01030692|Huperzine A|huperzine a|mesh-list
139032951|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139032952|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494253|NCT00006257|Paclitaxel|paclitaxel|mesh-list
139032953|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032954|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
139032955|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139032956|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032957|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139032958|NCT01030692|Protective Agents|protective agents|mesh-ancestor
139032959|NCT03138252|Oxytocin|oxytocin|mesh-list
139032960|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
139032961|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139032962|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032963|NCT04994561|Niacinamide|niacinamide|mesh-list
139032964|NCT04994561|Metformin|metformin|mesh-list
139032965|NCT04994561|Dasatinib|dasatinib|mesh-list
139032966|NCT04994561|Resveratrol|resveratrol|mesh-list
139032967|NCT04994561|Quercetin|quercetin|mesh-list
139032968|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138556657|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
139032969|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032970|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032971|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139032972|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138988634|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
139032973|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139032975|NCT04994561|Protective Agents|protective agents|mesh-ancestor
139032976|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139032977|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
139032978|NCT04994561|Vitamins|vitamins|mesh-ancestor
139032979|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
139032980|NCT01030770|Ranibizumab|ranibizumab|mesh-list
139032981|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139032982|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139032983|NCT01030770|Growth Substances|growth substances|mesh-ancestor
139032984|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032985|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
139032986|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139032987|NCT04941443|Ibuprofen|ibuprofen|mesh-list
139032988|NCT04941443|Methadone|methadone|mesh-list
139032989|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139032990|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139032991|NCT04941443|Analgesics|analgesics|mesh-ancestor
139032992|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
139032993|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139032994|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139032995|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139032996|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139032997|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139032998|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139032999|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033000|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139033001|NCT04941443|Narcotics|narcotics|mesh-ancestor
139033002|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033003|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
139033004|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
139033005|NCT03994692|Ether|ether|mesh-list
139033006|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139033007|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
139033008|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
139033009|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033010|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033011|NCT01030926|Insulin|insulin|mesh-list
139033012|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139033013|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
139033014|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139033015|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033016|NCT00536939|Paclitaxel|paclitaxel|mesh-list
139033017|NCT00536939|Bevacizumab|bevacizumab|mesh-list
139033018|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139033019|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033020|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
139033021|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
139033022|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
139033023|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033024|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139033025|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139033026|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139033027|NCT00536939|Growth Substances|growth substances|mesh-ancestor
139033028|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033029|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
139033031|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033032|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139033033|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033034|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033035|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
139033036|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139033037|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139033038|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139033039|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139033040|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033041|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
139033042|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033043|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616010|NCT00223548|Mesna|mesna|mesh-list
139033044|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139033045|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033047|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139033048|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
139033049|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139033050|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033051|NCT03990129|Dipyrone|dipyrone|mesh-list
139033052|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139033053|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139033054|NCT03990129|Analgesics|analgesics|mesh-ancestor
139033055|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
139033056|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033057|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033058|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139033059|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139033060|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
139033061|NCT01051947|Metoprolol|metoprolol|mesh-list
139033062|NCT01051947|Nebivolol|nebivolol|mesh-list
139033063|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139033064|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139033065|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
139033066|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
139033067|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033068|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033069|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139033070|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139033071|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139033072|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
139033073|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033074|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033075|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
139033076|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139033077|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139033078|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139033079|NCT01052025|Curcumin|curcumin|mesh-list
139033080|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139033081|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139033082|NCT01052025|Analgesics|analgesics|mesh-ancestor
139033083|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
139033084|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033085|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033087|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139033088|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033089|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033090|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033091|NCT00443820|Terbinafine|terbinafine|mesh-list
139033092|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
139033093|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033094|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033095|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033096|NCT00438672|Dexamethasone|dexamethasone|mesh-list
139033097|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139033098|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
139033099|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
139033100|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033101|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033102|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139033103|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
139033104|NCT00438672|Hormones|hormones|mesh-ancestor
139033105|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139033106|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139033107|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033109|NCT00438360|Cyclosporins|cyclosporins|mesh-list
139033110|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033111|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033112|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139033113|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
138988793|NCT06136897|Pertuzumab|pertuzumab|mesh-list
139033114|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033115|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
139033116|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033117|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
139033118|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139033119|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139033120|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139033121|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139033122|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139033123|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139033124|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033125|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033126|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033127|NCT00536471|Analgesics|analgesics|mesh-ancestor
139033128|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
139033129|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033130|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
139033131|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139033132|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
139033133|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139033134|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
138556848|NCT00303004|Bosentan|bosentan|mesh-list
139033135|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139033136|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139033137|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139033138|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
139033139|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139033140|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033141|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139033142|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139033143|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139033144|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139033145|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033147|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139033148|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139033149|NCT04002635|Estradiol|estradiol|mesh-list
139033150|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139033151|NCT04002635|Progesterone|progesterone|mesh-list
139033152|NCT04002635|Estrogens|estrogens|mesh-ancestor
139033153|NCT04002635|Hormones|hormones|mesh-ancestor
139033154|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139033155|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783766|NCT04189198|Carticaine|carticaine|mesh-list
139033156|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139033158|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139033159|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139033160|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033161|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139033162|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139033163|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033164|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033165|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139033166|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
139033167|NCT04002635|Progestins|progestins|mesh-ancestor
139033168|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
139033169|NCT01052181|Vitamin D|vitamin d|mesh-list
139033170|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139033171|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033172|NCT01052181|Vitamins|vitamins|mesh-ancestor
139033173|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
139033174|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139033175|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
139033176|NCT01056237|Azathioprine|azathioprine|mesh-list
139033177|NCT01056237|Tacrolimus|tacrolimus|mesh-list
139033178|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139033179|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
139033180|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033181|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139033182|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033183|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033184|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139033185|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033186|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139033187|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
139033188|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139033189|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033190|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
139033191|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139033192|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139033194|NCT02533557|Epinephrine|epinephrine|mesh-list
139033195|NCT02533557|Racepinephrine|racepinephrine|mesh-list
139033196|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
139033197|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
139033198|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
139033199|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033200|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033201|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
139033202|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033203|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139033204|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139033205|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139033206|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139033207|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033208|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139033209|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139033210|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
139033211|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033212|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139033213|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139033214|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
139033215|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139033216|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
139033217|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
139033218|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
139033219|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139033220|NCT00356265|Phenylephrine|phenylephrine|mesh-list
139033221|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
139033222|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139033223|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
139033224|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
139033225|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033226|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033227|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
138783835|NCT02691195|Ropivacaine|ropivacaine|mesh-list
139033228|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139033229|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
139033230|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
139033231|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139033232|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139033233|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139033234|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
139033235|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033236|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033237|NCT00356265|Protective Agents|protective agents|mesh-ancestor
139033239|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139033240|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033241|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139033242|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033243|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139033244|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
139033245|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139033246|NCT01052259|Protective Agents|protective agents|mesh-ancestor
139033247|NCT01056549|Exenatide|exenatide|mesh-list
139033248|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139033249|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033250|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139033251|NCT01056549|Incretins|incretins|mesh-ancestor
139033252|NCT01056549|Hormones|hormones|mesh-ancestor
139033253|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139033254|NCT01052337|Anesthetics|anesthetics|mesh-list
139033255|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033256|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033257|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139033258|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138557023|NCT00304018|Etoposide|etoposide|mesh-list
139033260|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033261|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033262|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139033263|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139033264|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139033265|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
139033266|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033267|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033268|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139033269|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139033270|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
139033271|NCT01056627|Valproic Acid|valproic acid|mesh-list
139033272|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
139033273|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033274|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033275|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
139033276|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033277|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033278|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
138494375|NCT00095758|Aripiprazole|aripiprazole|mesh-list
139033279|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138557059|NCT00304213|Testosterone|testosterone|mesh-list
139033280|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033281|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139033283|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139033284|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033285|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139033286|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033287|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139033288|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
139033289|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
139033290|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033291|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033292|NCT01564355|Triamcinolone|triamcinolone|mesh-list
139033293|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139033294|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
139033295|NCT01564355|Hormones|hormones|mesh-ancestor
139033296|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139033297|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033298|NCT01056705|Vaccines|vaccines|mesh-list
139033299|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
139033300|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033301|NCT00437268|Irinotecan|irinotecan|mesh-list
139033302|NCT00437268|Cetuximab|cetuximab|mesh-list
139033303|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139033304|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138783905|NCT01119131|Vitamin D|vitamin d|mesh-list
139033306|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033307|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033308|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139033309|NCT04002089|Bupivacaine|bupivacaine|mesh-list
139033310|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
139033311|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
139033312|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033313|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033314|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
139033315|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033316|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
139033317|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033318|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
139033319|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139033320|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139033321|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139033322|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139033323|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033324|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
139033325|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033326|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033327|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138557164|NCT00120510|Lamivudine|lamivudine|mesh-list
139033328|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033330|NCT05355467|Antiviral Agents|antiviral agents|mesh-ancestor
139033331|NCT05355467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033332|NCT05355467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139033333|NCT05355467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139033334|NCT05355467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033335|NCT05355467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033336|NCT05355467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139033337|NCT05355467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139033338|NCT04139525|Heparin|heparin|mesh-list
139033339|NCT04139525|Calcium heparin|calcium heparin|mesh-list
139033340|NCT04139525|Citric Acid|citric acid|mesh-list
139033341|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
139033342|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
139033343|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139033344|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
139033345|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
139033346|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033347|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139033348|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139033349|NCT00437034|Aflibercept|aflibercept|mesh-list
139033351|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139033352|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139033353|NCT00437034|Growth Substances|growth substances|mesh-ancestor
139033354|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033355|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
139033356|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033357|NCT00337467|Ritonavir|ritonavir|mesh-list
139033358|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139033359|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139033360|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139033361|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
138557219|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
139033362|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033363|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033364|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139033365|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139033366|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
139033367|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033368|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139033369|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139033370|NCT00428220|Sunitinib|sunitinib|mesh-list
139033371|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033372|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139033373|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139033374|NCT00428220|Growth Substances|growth substances|mesh-ancestor
139033375|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033376|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
139033377|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139033378|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033379|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033380|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139033381|NCT01057329|Olanzapine|olanzapine|mesh-list
139033382|NCT01057329|Aripiprazole|aripiprazole|mesh-list
139033383|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139033384|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
139033385|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
139033386|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033387|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033388|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139033389|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139033390|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139033391|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033392|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139033393|NCT01057329|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139033394|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139033395|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139033396|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033397|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033398|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
138557252|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139033399|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
139033400|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
139033401|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
139033402|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139033403|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139033404|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139033405|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139033406|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139033407|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139033408|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139033409|NCT01057329|Analgesics|analgesics|mesh-ancestor
139033410|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
139033411|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139033412|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
139033413|NCT01057407|Sevelamer|sevelamer|mesh-list
139033414|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
139033415|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
139033416|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033417|NCT02873975|Prexasertib|prexasertib|mesh-list
139033418|NCT02873975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139033419|NCT02873975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033420|NCT02873975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033422|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139033423|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139033424|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033425|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
139033426|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
139033427|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
139033428|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033429|NCT00345579|PENTA|penta|mesh-list
139033430|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
139033431|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139033432|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139033433|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033434|NCT04002323|Lamivudine|lamivudine|mesh-list
139033435|NCT04002323|Dolutegravir|dolutegravir|mesh-list
139033436|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139033437|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139033438|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033439|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033440|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
139033441|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033442|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139033443|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139033444|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139033445|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139033446|NCT04001855|Acetic Acid|acetic acid|mesh-list
139033447|NCT04001855|Retinol acetate|retinol acetate|mesh-list
139033448|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139033449|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033450|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139033451|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
139033452|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033453|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139033454|NCT04001855|Protective Agents|protective agents|mesh-ancestor
139033455|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033457|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139033458|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033459|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139033460|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139033461|NCT00335829|Growth Substances|growth substances|mesh-ancestor
139033462|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033463|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
139033464|NCT02533011|Heparin|heparin|mesh-list
139033465|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
139033466|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139033467|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139033468|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033469|NCT05262257|Metformin|metformin|mesh-list
139033470|NCT05262257|Dapagliflozin|dapagliflozin|mesh-list
138557350|NCT00082784|Bortezomib|bortezomib|mesh-list
139033471|NCT05262257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139033472|NCT05262257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033473|NCT05262257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139033474|NCT05262257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033475|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
139033476|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139033477|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
139033478|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139033479|NCT03989817|Protective Agents|protective agents|mesh-ancestor
139033480|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033481|NCT01059123|Amoxicillin|amoxicillin|mesh-list
139033482|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139033483|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033484|NCT03986385|Capecitabine|capecitabine|mesh-list
139033485|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
139033486|NCT03986385|Apatinib|apatinib|mesh-list
139033487|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139033488|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
139033489|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033490|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033491|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139033492|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033493|NCT00344019|Atorvastatin|atorvastatin|mesh-list
139033494|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139033495|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139033496|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
139033497|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033498|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139033499|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139033501|NCT00535847|Interferons|interferons|mesh-list
139033502|NCT00535847|Ribavirin|ribavirin|mesh-list
139033503|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
139033504|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
139033505|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139033506|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033507|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
139033508|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033509|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
139033510|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033511|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
139033512|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033513|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
139033514|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139033515|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139033516|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033517|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
139033518|NCT03606785|Coagulants|coagulants|mesh-ancestor
139033519|NCT05356169|Venetoclax|venetoclax|mesh-list
139033520|NCT05356169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033521|NCT01057875|Caffeine|caffeine|mesh-list
139033522|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139033523|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033524|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139033525|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033526|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033527|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139033528|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139033529|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
139033530|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033531|NCT04001387|Anesthetics|anesthetics|mesh-list
139033532|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033533|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033534|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
139033535|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
139033536|NCT00334737|Hematinics|hematinics|mesh-ancestor
139033537|NCT03986073|Linagliptin|linagliptin|mesh-list
139033538|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139033539|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033540|NCT03986073|Incretins|incretins|mesh-ancestor
139033541|NCT03986073|Hormones|hormones|mesh-ancestor
138494536|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139033542|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139033543|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139033544|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
139033545|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033546|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033547|NCT01060137|Fentanyl|fentanyl|mesh-list
139033548|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139033549|NCT01060137|Narcotics|narcotics|mesh-ancestor
139033550|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033551|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033552|NCT01060137|Analgesics|analgesics|mesh-ancestor
139033553|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
139033554|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033555|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139033556|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139033557|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
139033558|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
139033559|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
139033560|NCT01058109|Calcium|calcium|mesh-list
139033561|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139033562|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033563|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139033564|NCT00992069|Efavirenz|efavirenz|mesh-list
139033565|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139033566|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139033567|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033568|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033569|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
139033570|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033571|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139033572|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139033573|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139033574|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139033575|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139033576|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139033577|NCT01060293|Dopamine|dopamine|mesh-list
139033578|NCT01060293|Furosemide|furosemide|mesh-list
139033579|NCT01060293|Diuretics|diuretics|mesh-ancestor
139033580|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
139033581|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033582|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139033583|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139033584|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033585|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139033586|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
139033587|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
139033588|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033589|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
139033590|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033591|NCT01060293|Protective Agents|protective agents|mesh-ancestor
139033592|NCT05343767|Metformin|metformin|mesh-list
139033593|NCT05343767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139033594|NCT05343767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033595|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139033596|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033597|NCT00416598|Cytarabine|cytarabine|mesh-list
139033598|NCT00416598|Etoposide|etoposide|mesh-list
139033599|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
139033600|NCT00416598|Daunorubicin|daunorubicin|mesh-list
139033601|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
139033602|NCT00416598|Busulfan|busulfan|mesh-list
139033603|NCT00416598|Decitabine|decitabine|mesh-list
138494631|NCT00390312|Morphine|morphine|mesh-list
139033604|NCT00416598|Lenograstim|lenograstim|mesh-list
139033605|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139033606|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033607|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139033608|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139033610|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033611|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139033612|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
139033613|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
139033614|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033615|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139033616|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
139033617|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033618|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139033619|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
139033620|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139033621|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139033622|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139033623|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
139033624|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
139033625|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
139033626|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
139033627|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
139033628|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139033629|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
139033630|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139033631|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139033632|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139033633|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033634|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033635|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
139033636|NCT04001465|Miotics|miotics|mesh-ancestor
139033637|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
139033638|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033639|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033640|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139033641|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139033642|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
139033643|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139033644|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139033645|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
139033646|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033647|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033648|NCT00992381|Naproxen|naproxen|mesh-list
139033649|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139033650|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139033651|NCT00992381|Analgesics|analgesics|mesh-ancestor
138494674|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
139033652|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
139033653|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033654|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033655|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139033656|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139033657|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
139033658|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139033659|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033660|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033662|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139033663|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
139033664|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
139033665|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139033666|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139033667|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033668|NCT00992693|Ribavirin|ribavirin|mesh-list
139033669|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
139033670|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033671|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
139033672|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033673|NCT00992771|Varenicline|varenicline|mesh-list
139033674|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139033675|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139033676|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
139033677|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033678|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033679|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033680|NCT00992849|Bevacizumab|bevacizumab|mesh-list
139033681|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139033682|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033683|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139033684|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139033685|NCT00992849|Growth Substances|growth substances|mesh-ancestor
139033686|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033687|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
139033688|NCT04001231|Exenatide|exenatide|mesh-list
139033689|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139033690|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033691|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139033692|NCT04001231|Incretins|incretins|mesh-ancestor
139033693|NCT04001231|Hormones|hormones|mesh-ancestor
138494700|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139033694|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139033695|NCT03892889|Aripiprazole|aripiprazole|mesh-list
139033696|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
139033697|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139033698|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139033699|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139033700|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033701|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033702|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
139033703|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
139033704|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033705|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033706|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138989109|NCT06069180|Busulfan|busulfan|mesh-list
139033707|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139033708|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
138557615|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
139033709|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139033710|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139033711|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139033712|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139033713|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
139033714|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139033715|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
139033716|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033717|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
139033718|NCT00993707|Protective Agents|protective agents|mesh-ancestor
139033720|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139033721|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139033722|NCT00473330|Growth Substances|growth substances|mesh-ancestor
139033723|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033724|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
139033725|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033726|NCT00416520|Sevelamer|sevelamer|mesh-list
139033727|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
139033728|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
139033729|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033730|NCT00533429|Bevacizumab|bevacizumab|mesh-list
139033731|NCT00533429|Carboplatin|carboplatin|mesh-list
139033732|NCT00533429|Pemetrexed|pemetrexed|mesh-list
139033733|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139033734|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033735|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139033736|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139033737|NCT00533429|Growth Substances|growth substances|mesh-ancestor
138494732|NCT00006347|Antibodies|antibodies|mesh-list
139033738|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033739|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
139033740|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033741|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033742|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139033743|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139033744|NCT01034124|Vitamin K|vitamin k|mesh-list
139033745|NCT01034124|Midazolam|midazolam|mesh-list
139033746|NCT01034124|Warfarin|warfarin|mesh-list
139033747|NCT01034124|Vitamins|vitamins|mesh-ancestor
139033748|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
139033749|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033750|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139033751|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139033752|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033753|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139033754|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139033755|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139033756|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139033757|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
139033758|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
139033759|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
139033760|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
139033761|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033762|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033763|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
139033764|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139033765|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139033766|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
139033767|NCT01034124|Coagulants|coagulants|mesh-ancestor
139033768|NCT00339183|Panitumumab|panitumumab|mesh-list
139033769|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139033770|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033771|NCT01060605|Sirolimus|sirolimus|mesh-list
139033772|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139033773|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033774|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139033775|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033776|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
139033777|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139033778|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
139033779|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033780|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
139033781|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033782|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
139033783|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033784|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033785|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139033786|NCT00993863|Ibuprofen|ibuprofen|mesh-list
139033787|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139033788|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139033789|NCT00993863|Analgesics|analgesics|mesh-ancestor
139033790|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
139033791|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033792|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033793|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139033795|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139033796|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033797|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033798|NCT00995423|Paclitaxel|paclitaxel|mesh-list
139033799|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139033800|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033801|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
139033802|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
139033803|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
139033804|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033805|NCT00995657|Fluticasone|fluticasone|mesh-list
139033806|NCT00995657|Xhance|xhance|mesh-list
139033807|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139033808|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139033809|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
139033810|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033811|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033812|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139033813|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
139033814|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
139033815|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139033816|NCT00994097|Gemcitabine|gemcitabine|mesh-list
139033817|NCT00994097|Pemetrexed|pemetrexed|mesh-list
139033818|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033819|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139033820|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
139033821|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033822|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033823|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139033824|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139033825|NCT04000919|Carbidopa|carbidopa|mesh-list
139033826|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139033827|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139033828|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
139033829|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033830|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033831|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033832|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139033833|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033834|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139033835|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139033836|NCT00994253|Diuretics|diuretics|mesh-ancestor
139033837|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
139033838|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033839|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139033840|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139033841|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033842|NCT00338949|Olanzapine|olanzapine|mesh-list
139033843|NCT00338949|Risperidone|risperidone|mesh-list
139033845|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139033846|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
139033847|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033848|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033849|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557782|NCT00309517|Leucovorin|leucovorin|mesh-list
139033850|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139033851|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139033852|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033853|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139033854|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139033855|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
139033856|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
139033857|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
139033858|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033859|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139033860|NCT00338949|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139033861|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139033862|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139033863|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139033864|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139033865|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033866|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
139033867|NCT00332709|Letrozole|letrozole|mesh-list
139033868|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033869|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139033870|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139033871|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139033872|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033873|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139033874|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
139033875|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139033876|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033877|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139033879|NCT03988725|Vitamins|vitamins|mesh-ancestor
139033880|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
139033881|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033882|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
139033883|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033884|NCT03988725|Protective Agents|protective agents|mesh-ancestor
139033885|NCT00332241|Aripiprazole|aripiprazole|mesh-list
139033886|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
139033887|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139033888|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139033889|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139033890|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033891|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138989219|NCT06007911|Analgesics|analgesics|mesh-ancestor
139033892|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
139033893|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
139033894|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033895|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033896|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138494809|NCT00400582|Candesartan|candesartan|mesh-list
139033897|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139033898|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
139033899|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139033900|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139033901|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139033902|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139033903|NCT01058577|Somatostatin|somatostatin|mesh-list
139033904|NCT01058577|Hormones|hormones|mesh-ancestor
139033905|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139033906|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033907|NCT03983889|Midazolam|midazolam|mesh-list
139033908|NCT03983889|Fentanyl|fentanyl|mesh-list
139033909|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
139033910|NCT03983889|Remifentanil|remifentanil|mesh-list
139033911|NCT03983889|Propofol|propofol|mesh-list
139033912|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139033913|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139033914|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033915|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139033916|NCT03983889|Analgesics|analgesics|mesh-ancestor
139033917|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
139033918|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139033919|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139033920|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139033921|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139033922|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
139033923|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139033924|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033925|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139033926|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
139033927|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
139033928|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139033929|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139033930|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139033931|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139033932|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
139033933|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
139033934|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139033935|NCT03983889|Narcotics|narcotics|mesh-ancestor
139033936|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
139033937|NCT00337935|Hematinics|hematinics|mesh-ancestor
139033938|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
139033939|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
139033940|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139033941|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
138494826|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033942|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033943|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139033944|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139033945|NCT00352755|Leucovorin|leucovorin|mesh-list
139033946|NCT00352755|Fluorouracil|fluorouracil|mesh-list
139033947|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
139033948|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
139033949|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033950|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139033951|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033952|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139033953|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
139033954|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033955|NCT00352755|Antidotes|antidotes|mesh-ancestor
139033956|NCT00352755|Protective Agents|protective agents|mesh-ancestor
139033957|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
139033958|NCT00352755|Vitamins|vitamins|mesh-ancestor
139033959|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
139033960|NCT00533897|Abatacept|abatacept|mesh-list
139033961|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139033962|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033963|NCT00533897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139033964|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139033965|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139033966|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
139033967|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033968|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139033969|NCT00426660|Maraviroc|maraviroc|mesh-list
139033970|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139033971|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139033972|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033973|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139033974|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139033975|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
139033976|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139033977|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139033978|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
138784575|NCT01055496|Hormones|hormones|mesh-ancestor
139033979|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
139033980|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033981|NCT00330681|Edaravone|edaravone|mesh-list
139033982|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139033983|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
138558021|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
139033984|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139033986|NCT00330681|Protective Agents|protective agents|mesh-ancestor
139033987|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033988|NCT00329901|Vaccines|vaccines|mesh-list
139033989|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
139033990|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033991|NCT00436956|Prednisone|prednisone|mesh-list
139033992|NCT00436956|Cediranib|cediranib|mesh-list
139033993|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139033994|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
139033995|NCT00436956|Hormones|hormones|mesh-ancestor
139033996|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139033997|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139033998|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139033999|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034000|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034001|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034002|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034003|NCT00436644|Topotecan|topotecan|mesh-list
139034004|NCT00436644|Lapatinib|lapatinib|mesh-list
139034005|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139034006|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139034007|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034008|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034009|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034010|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034011|NCT00324987|Bevacizumab|bevacizumab|mesh-list
139034012|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139034013|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
139034014|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
139034015|NCT00324987|Antibodies|antibodies|mesh-list
139034016|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
139034017|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139034018|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
139034019|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034020|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139034021|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139034022|NCT00324987|Growth Substances|growth substances|mesh-ancestor
139034023|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034024|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
139034025|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
139034026|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034027|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034028|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034029|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
139034030|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139034031|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034032|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
139034033|NCT01055145|Levofloxacin|levofloxacin|mesh-list
139034034|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139034035|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034036|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139034037|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139034038|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034039|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034040|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034041|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139034042|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139034043|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139034044|NCT00436566|Paclitaxel|paclitaxel|mesh-list
139034045|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
139034046|NCT00436566|Doxorubicin|doxorubicin|mesh-list
139034047|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139034048|NCT00436566|Trastuzumab|trastuzumab|mesh-list
139034049|NCT00436566|Lapatinib|lapatinib|mesh-list
139034050|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139034051|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034052|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
139034053|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
139034054|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
139034055|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034056|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139034057|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
139034058|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034059|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139034060|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139034061|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
139034062|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139034063|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139034064|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139034065|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139034066|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034067|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139034068|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034069|NCT01060683|Chrysarobin|chrysarobin|mesh-list
139034070|NCT01060683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139034071|NCT01060683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139034072|NCT01060683|Analgesics|analgesics|mesh-ancestor
139034073|NCT01060683|Sensory System Agents|sensory system agents|mesh-ancestor
139034074|NCT01060683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034075|NCT01060683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034076|NCT01060683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139034077|NCT01060683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139034078|NCT01055301|Thalidomide|thalidomide|mesh-list
139034079|NCT01055301|Dexamethasone|dexamethasone|mesh-list
139034080|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
139034082|NCT01055301|Doxorubicin|doxorubicin|mesh-list
139034083|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139034085|NCT01055301|Lenalidomide|lenalidomide|mesh-list
139034086|NCT01055301|Bortezomib|bortezomib|mesh-list
139034087|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139034088|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
139034089|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034090|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139034091|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139034092|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
139034093|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034094|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034095|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139034096|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139034097|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
139034098|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
139034099|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034100|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139034101|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
139034102|NCT01055301|Hormones|hormones|mesh-ancestor
139034103|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139034104|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139034105|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139034106|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139034107|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139034108|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034109|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139034110|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139034111|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139034112|NCT01055301|Growth Substances|growth substances|mesh-ancestor
139034113|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
139034114|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
139034115|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139034116|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034117|NCT01055379|Rasagiline|rasagiline|mesh-list
139034118|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139034119|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034120|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034121|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139034122|NCT01055379|Protective Agents|protective agents|mesh-ancestor
139034123|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034124|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139034125|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139034126|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139034127|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
139034128|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034129|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139034130|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139034131|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784726|NCT00609999|Dasatinib|dasatinib|mesh-list
139034133|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
139034134|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034135|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139034136|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139034137|NCT00352365|Growth Substances|growth substances|mesh-ancestor
139034138|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
139034139|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034140|NCT01055535|Plasminogen|plasminogen|mesh-list
139034141|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139034142|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139034143|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034144|NCT03987867|Paclitaxel|paclitaxel|mesh-list
139034145|NCT03987867|Carboplatin|carboplatin|mesh-list
139034146|NCT03987867|Pemetrexed|pemetrexed|mesh-list
139034147|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139034148|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139034149|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034150|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
139034151|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
139034152|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
139034153|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034154|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034155|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139034156|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139034157|NCT03987867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139034158|NCT00532493|Prazosin|prazosin|mesh-list
139034159|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139034160|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139034161|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139034162|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139034163|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
139034164|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139034165|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034166|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034167|NCT00996515|Azacitidine|azacitidine|mesh-list
139034168|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139034169|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139034170|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
139034171|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034172|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034173|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034174|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034175|NCT00994799|Ranibizumab|ranibizumab|mesh-list
139034176|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139034177|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139034178|NCT00994799|Growth Substances|growth substances|mesh-ancestor
139034179|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034180|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
139034181|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034182|NCT00533507|Vaccines|vaccines|mesh-list
139034183|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139034184|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
139034185|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034186|NCT00352053|Tenofovir|tenofovir|mesh-list
139034187|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
139034188|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034189|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139034190|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139034191|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034192|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034193|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139034194|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139034195|NCT00995033|Varenicline|varenicline|mesh-list
139034196|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139034197|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139034198|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
139034199|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139034200|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034201|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034202|NCT00997061|Topotecan|topotecan|mesh-list
139034203|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139034204|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138784788|NCT01028352|Analgesics|analgesics|mesh-ancestor
139034205|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034206|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034207|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034208|NCT00351819|Testosterone|testosterone|mesh-list
139034209|NCT00351819|Androgens|androgens|mesh-ancestor
139034210|NCT00351819|Hormones|hormones|mesh-ancestor
139034211|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139034212|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034213|NCT00998933|Testosterone|testosterone|mesh-list
139034214|NCT00998933|Androgens|androgens|mesh-ancestor
139034215|NCT00998933|Hormones|hormones|mesh-ancestor
139034216|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139034217|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034218|NCT00323115|Temozolomide|temozolomide|mesh-list
139034219|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139034220|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
139034221|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034222|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034224|NCT00322881|Carboplatin|carboplatin|mesh-list
139034225|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139034226|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034227|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
139034228|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
139034229|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
139034230|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034231|NCT00415194|Pemetrexed|pemetrexed|mesh-list
139034232|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034233|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034234|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034235|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139034236|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139034238|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139034239|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139034240|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034241|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139034242|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139034243|NCT00436332|Growth Substances|growth substances|mesh-ancestor
139034244|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034245|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
139034246|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034247|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034248|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034249|NCT00532259|Pidilizumab|pidilizumab|mesh-list
139034250|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139034251|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034252|NCT00322491|Plerixafor|plerixafor|mesh-list
139034253|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139034254|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139034255|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
139034256|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034257|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
139034258|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139034259|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034260|NCT00997607|Vaccines|vaccines|mesh-list
139034261|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
139034262|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034263|NCT00997685|Capecitabine|capecitabine|mesh-list
139034264|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
139034265|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139034266|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
139034267|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034268|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034269|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139034270|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
139034271|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034272|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
139034273|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139034274|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139034275|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034276|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139034277|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138784870|NCT04309643|Estradiol|estradiol|mesh-list
139034278|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034279|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034280|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034281|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139034282|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
139034283|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139034284|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034285|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139034286|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139034287|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139034288|NCT00998075|Esomeprazole|esomeprazole|mesh-list
139034289|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034290|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034291|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139034292|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139034293|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139034294|NCT00531947|Selegiline|selegiline|mesh-list
139034295|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
139034296|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139034297|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139034298|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139034299|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139034300|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034301|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034302|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139034303|NCT00531947|Protective Agents|protective agents|mesh-ancestor
139034304|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034305|NCT01003847|Fenofibrate|fenofibrate|mesh-list
139034306|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139034307|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
139034308|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034309|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139034310|NCT00530855|Lacosamide|lacosamide|mesh-list
139034311|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
139034312|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139034313|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139034314|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139034315|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034316|NCT01004237|Valsartan|valsartan|mesh-list
139034317|NCT01004237|Pravastatin|pravastatin|mesh-list
139034318|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139034319|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139034320|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139034321|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034322|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139034323|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139034324|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
139034325|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139034326|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139034327|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034328|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139034329|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139034330|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139034331|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
139034332|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558420|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034333|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034334|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034335|NCT01004315|Urological Agents|urological agents|mesh-ancestor
139034336|NCT05239637|Heparin|heparin|mesh-list
139034337|NCT05239637|Calcium heparin|calcium heparin|mesh-list
139034338|NCT05239637|Anticoagulants|anticoagulants|mesh-ancestor
139034339|NCT05239637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139034340|NCT05239637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139034341|NCT05239637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034342|NCT01005095|Vitamin D|vitamin d|mesh-list
139034343|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
139034344|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
139034345|NCT01005095|Vitamins|vitamins|mesh-list
139034346|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
139034347|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034348|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139034349|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139034350|NCT01005641|Lapatinib|lapatinib|mesh-list
138784931|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
139034352|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034353|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034354|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034355|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034356|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139034357|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139034358|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139034359|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
139034360|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139034361|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034363|NCT01005797|Panobinostat|panobinostat|mesh-list
139034364|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034365|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034366|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034367|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034368|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139034369|NCT01006031|Interferons|interferons|mesh-list
139034370|NCT01006031|Ribavirin|ribavirin|mesh-list
139034371|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
139034372|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
139034373|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139034374|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034375|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
139034376|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034377|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
139034378|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034379|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
139034380|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034381|NCT01006187|Lidocaine|lidocaine|mesh-list
139034382|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
139034383|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
139034384|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139034385|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034386|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
139034387|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034388|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139034389|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139034390|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139034391|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139034392|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034393|NCT00530777|Valacyclovir|valacyclovir|mesh-list
139034394|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
139034395|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034396|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
139034397|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139034398|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034399|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034400|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139034401|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139034402|NCT01006499|Protective Agents|protective agents|mesh-ancestor
139034403|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034404|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
139034405|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139034406|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
139034407|NCT03882047|Fluticasone|fluticasone|mesh-list
139034409|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
139034410|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139034411|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139034412|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
139034413|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034414|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495102|NCT00006386|Carmustine|carmustine|mesh-list
139034415|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139034416|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
139034417|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
138989447|NCT05839561|Letrozole|letrozole|mesh-list
139034419|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139034420|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139034421|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139034422|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
139034423|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034424|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139034425|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139034427|NCT00530621|Pemetrexed|pemetrexed|mesh-list
139034428|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034429|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034430|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034431|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139034432|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139034433|NCT00531479|Voriconazole|voriconazole|mesh-list
139034434|NCT00531479|Anidulafungin|anidulafungin|mesh-list
139034435|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
139034436|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034437|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138316689|NCT05414500|Immunoconjugates|immunoconjugates|mesh-ancestor
139034439|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034440|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034441|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139034442|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
139034443|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139034444|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034445|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139034446|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
139034447|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139034448|NCT00999479|Norethindrone|norethindrone|mesh-list
139034449|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
139034450|NCT00999479|Estradiol|estradiol|mesh-list
139034451|NCT00999479|Estrogens|estrogens|mesh-ancestor
139034452|NCT00999479|Hormones|hormones|mesh-ancestor
139034453|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139034454|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034455|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139034456|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
139034457|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139034458|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139034459|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139034460|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139034461|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139034462|NCT00999479|Trace Elements|trace elements|mesh-ancestor
139034463|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
139034464|NCT00999557|Bimatoprost|bimatoprost|mesh-list
139034465|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139034466|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139034467|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139034468|NCT01008137|Vaccines|vaccines|mesh-list
139034469|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
139034470|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034471|NCT00999791|Diclofenac|diclofenac|mesh-list
139034472|NCT00999791|Bevacizumab|bevacizumab|mesh-list
139034473|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139034474|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034475|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139034476|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139034477|NCT00999791|Growth Substances|growth substances|mesh-ancestor
139034478|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034479|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
139034480|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139034481|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139034482|NCT00999791|Analgesics|analgesics|mesh-ancestor
139034483|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
139034484|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034485|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139034486|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139034487|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139034488|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034489|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034490|NCT00999869|Triamcinolone|triamcinolone|mesh-list
139034491|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139034492|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139034493|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
139034494|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139034495|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139034496|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139034497|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139034498|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139034499|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034500|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
139034501|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139034502|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034503|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139034504|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
139034505|NCT00999869|Hormones|hormones|mesh-ancestor
139034506|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139034507|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139034508|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
139034509|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034511|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034513|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139034514|NCT01008527|Poly ICLC|poly iclc|mesh-list
139034515|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
139034516|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
139034517|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034518|NCT01000415|Cisplatin|cisplatin|mesh-list
139034519|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034520|NCT01008761|Azithromycin|azithromycin|mesh-list
139034521|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139034522|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034523|NCT01008917|Sirolimus|sirolimus|mesh-list
139034524|NCT01008917|Sorafenib|sorafenib|mesh-list
139034525|NCT01008917|Temsirolimus|temsirolimus|mesh-list
139034526|NCT01008917|MTOR Inhibitors|mtor inhibitors|mesh-list
139034527|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034528|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034529|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034530|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034531|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139034532|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
139034533|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034534|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139034535|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034536|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139034537|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
139034538|NCT01009073|Irinotecan|irinotecan|mesh-list
139034539|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139034540|NCT01009073|Navitoclax|navitoclax|mesh-list
139034541|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139034542|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139034543|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034544|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034545|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034546|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034547|NCT00530075|Gusperimus|gusperimus|mesh-list
139034548|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139034549|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034550|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139034551|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034552|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139034553|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
139034554|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139034555|NCT00530075|Protective Agents|protective agents|mesh-ancestor
139034556|NCT01001585|Sevoflurane|sevoflurane|mesh-list
139034557|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139034558|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139034559|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
139034560|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
139034561|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139034562|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034563|NCT01001897|Misoprostol|misoprostol|mesh-list
139034564|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139034565|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
139034566|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139034567|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034568|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139034569|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139034570|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
139034571|NCT05734001|Hemostatics|hemostatics|mesh-list
139034572|NCT05734001|Coagulants|coagulants|mesh-ancestor
139034573|NCT01002911|Cefazolin|cefazolin|mesh-list
139034574|NCT01002911|Cephalexin|cephalexin|mesh-list
139034575|NCT01002911|Bacitracin|bacitracin|mesh-list
139034576|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139034577|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034578|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139034579|NCT00531011|Paclitaxel|paclitaxel|mesh-list
139034580|NCT00531011|Everolimus|everolimus|mesh-list
139034581|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139034582|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034583|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
139034584|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
139034585|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
139034586|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034587|NCT00531011|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139034588|NCT00531011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034589|NCT00531011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034590|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139034591|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
139034592|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034593|NCT04000295|Paclitaxel|paclitaxel|mesh-list
139034594|NCT04000295|Etoposide|etoposide|mesh-list
139034595|NCT04000295|Apatinib|apatinib|mesh-list
139034596|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139034597|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034598|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
139034599|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
139034600|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
139034601|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034602|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139034603|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139034604|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034605|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034606|NCT01003613|Tranilast|tranilast|mesh-list
139034607|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139034608|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139034609|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139034610|NCT01003613|Analgesics|analgesics|mesh-ancestor
139034611|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
139034612|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034613|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034614|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139034615|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139034616|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139034617|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139034618|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034619|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139034620|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139034621|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
139034622|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
139034624|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139034625|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139034626|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
139034627|NCT01003613|Coagulants|coagulants|mesh-ancestor
139034628|NCT00471146|Gemcitabine|gemcitabine|mesh-list
139034629|NCT00471146|Axitinib|axitinib|mesh-list
139034630|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139034631|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
139034632|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034633|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034634|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034635|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034637|NCT01021358|Navitoclax|navitoclax|mesh-list
139034638|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
139034639|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034640|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139034641|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139034642|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034643|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495331|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
139034644|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139034645|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
139034646|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139034647|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034648|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139034649|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785234|NCT02705950|Baclofen|baclofen|mesh-list
139034650|NCT00469898|Carboplatin|carboplatin|mesh-list
139034651|NCT00469898|Irinotecan|irinotecan|mesh-list
139034652|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034653|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139034654|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139034655|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034656|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034658|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139034659|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034660|NCT00529763|Dasatinib|dasatinib|mesh-list
139034661|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034662|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034663|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034664|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034665|NCT00486902|Ketamine|ketamine|mesh-list
139034666|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
139034667|NCT00486902|Analgesics|analgesics|mesh-ancestor
139034668|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
139034669|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034670|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034671|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139034672|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139034673|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
139034674|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
139034675|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139034676|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139034677|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139034678|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139034679|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034680|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
139034681|NCT03687827|Insulin|insulin|mesh-list
139034682|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139034683|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
139034684|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139034685|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034686|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139034687|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139034688|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
139034689|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034690|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034691|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139034692|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
139034693|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139034694|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139034695|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139034696|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
139034697|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139034698|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034699|NCT05685953|Vaccines|vaccines|mesh-list
139034700|NCT05685953|Immunologic Factors|immunologic factors|mesh-ancestor
139034701|NCT05685953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034702|NCT00486434|Calcitonin|calcitonin|mesh-list
139034703|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
138559541|NCT05999942|Amikacin|amikacin|mesh-list
139034704|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
139034705|NCT00486434|Katacalcin|katacalcin|mesh-list
139034706|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139034707|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034708|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139034709|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
139034710|NCT00529451|Ramipril|ramipril|mesh-list
139034711|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139034712|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
139034713|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034714|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034715|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139034716|NCT05641259|Azacitidine|azacitidine|mesh-list
139034717|NCT05641259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139034718|NCT05641259|Antimetabolites|antimetabolites|mesh-ancestor
139034719|NCT05641259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034720|NCT05641259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034721|NCT05641259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034723|NCT05405387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138785306|NCT02705638|Rituximab|rituximab|mesh-list
139034724|NCT05405387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139034725|NCT05405387|Autonomic Agents|autonomic agents|mesh-ancestor
139034726|NCT05405387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034727|NCT05405387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034728|NCT05405387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139034729|NCT05405387|Respiratory System Agents|respiratory system agents|mesh-ancestor
139034730|NCT05405387|Glucocorticoids|glucocorticoids|mesh-ancestor
139034731|NCT05405387|Hormones|hormones|mesh-ancestor
139034732|NCT05405387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139034733|NCT03999437|Terbinafine|terbinafine|mesh-list
139034734|NCT03999437|Butenafine|butenafine|mesh-list
138495454|NCT00006449|Naltrexone|naltrexone|mesh-list
139034735|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
139034736|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034737|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034738|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034740|NCT05637281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139034741|NCT05637281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139034742|NCT05637281|Analgesics|analgesics|mesh-ancestor
139034743|NCT05637281|Sensory System Agents|sensory system agents|mesh-ancestor
139034744|NCT05637281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034745|NCT05637281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034746|NCT05637281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139034747|NCT05637281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139034748|NCT05637281|Gout Suppressants|gout suppressants|mesh-ancestor
139034749|NCT05637281|Tocolytic Agents|tocolytic agents|mesh-ancestor
139034750|NCT05637281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139034751|NCT05637281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139034753|NCT05637281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034754|NCT00321711|Azacitidine|azacitidine|mesh-list
139034755|NCT00321711|Decitabine|decitabine|mesh-list
139034756|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139034757|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
139034758|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034759|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034760|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034761|NCT00486044|Simvastatin|simvastatin|mesh-list
139034762|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139034763|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139034764|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
139034765|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034766|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139034767|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139034768|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034769|NCT00351273|Azithromycin|azithromycin|mesh-list
139034770|NCT00351273|Doxycycline|doxycycline|mesh-list
139034771|NCT00351273|Rifampin|rifampin|mesh-list
139034772|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139034773|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559739|NCT05997485|Ritonavir|ritonavir|mesh-list
139034774|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
139034775|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139034776|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139034777|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139034778|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
139034779|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
139034780|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139034781|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034782|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034783|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139034784|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139034785|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139034786|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139034787|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139034788|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139034789|NCT00327717|Zonisamide|zonisamide|mesh-list
139034790|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
139034791|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139034792|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139034793|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989680|NCT05647512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139034794|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139034795|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785391|NCT02699710|Vitamins|vitamins|mesh-ancestor
139034797|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139034798|NCT01022528|Dexamethasone|dexamethasone|mesh-list
139034799|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
139034800|NCT01022528|BB 1101|bb 1101|mesh-list
139034801|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139034802|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
139034803|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
139034804|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034805|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495531|NCT00104260|Verapamil|verapamil|mesh-list
139034806|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139034807|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
139034808|NCT01022528|Hormones|hormones|mesh-ancestor
139034809|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139034810|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138559862|NCT05995392|Spironolactone|spironolactone|mesh-list
139034811|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034812|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
139034813|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034814|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034815|NCT01025102|Sufentanil|sufentanil|mesh-list
139034816|NCT01025102|Ropivacaine|ropivacaine|mesh-list
139034817|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139034818|NCT01025102|Narcotics|narcotics|mesh-ancestor
139034819|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139034820|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034821|NCT01025102|Analgesics|analgesics|mesh-ancestor
139034822|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
139034823|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034824|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139034825|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139034826|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
139034827|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
139034828|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
139034829|NCT00424476|Belimumab|belimumab|mesh-list
139034830|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139034831|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
139034832|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034833|NCT01037634|Oseltamivir|oseltamivir|mesh-list
139034834|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
139034835|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034836|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034837|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034838|NCT01037712|Valacyclovir|valacyclovir|mesh-list
138236343|NCT00369603|Donepezil|donepezil|mesh-list
139034839|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
139034840|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034841|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139034842|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034843|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034844|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034845|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034846|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
139034847|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139034848|NCT00461786|Pemetrexed|pemetrexed|mesh-list
139034849|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034850|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034851|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034852|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139034853|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139034854|NCT01021592|Bortezomib|bortezomib|mesh-list
139034855|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034856|NCT00435162|Valsartan|valsartan|mesh-list
139034857|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138560049|NCT05828966|Analgesics|analgesics|mesh-ancestor
138495634|NCT00104845|Vaccines|vaccines|mesh-list
139034858|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139034859|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139034860|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034862|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139034863|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139034864|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139034865|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139034866|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
139034867|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139034868|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034869|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034870|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139034871|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139034872|NCT00350727|Lapatinib|lapatinib|mesh-list
139034873|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034874|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034875|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034876|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034877|NCT01032486|Rasagiline|rasagiline|mesh-list
139034878|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139034879|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495666|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034880|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034881|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139034882|NCT01032486|Protective Agents|protective agents|mesh-ancestor
139034883|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034884|NCT01061697|Pregabalin|pregabalin|mesh-list
139034885|NCT01061697|Analgesics|analgesics|mesh-ancestor
139034886|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
139034887|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034888|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034889|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
139034890|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139034891|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139034892|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034893|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139034894|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139034895|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139034896|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139034897|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139034898|NCT00434304|Ropinirole|ropinirole|mesh-list
139034899|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139034900|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139034901|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
139034902|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
139034903|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495721|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
139034904|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034905|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034906|NCT00424008|Fluticasone|fluticasone|mesh-list
139034908|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
139034909|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
139034910|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139034911|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139034912|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139034913|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139034914|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
139034915|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139034916|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034917|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139034918|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
139034919|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
139034920|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139034921|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139034922|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139034923|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139034924|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
139034925|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139034926|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034927|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
139034928|NCT00424008|Hormones|hormones|mesh-ancestor
139034929|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139034930|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
139034931|NCT00423930|Bevacizumab|bevacizumab|mesh-list
138495776|NCT00106288|Micafungin|micafungin|mesh-list
139034932|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139034933|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034934|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139034935|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139034936|NCT00423930|Growth Substances|growth substances|mesh-ancestor
139034937|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034938|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
139034939|NCT00423852|Paclitaxel|paclitaxel|mesh-list
139034940|NCT00423852|Carboplatin|carboplatin|mesh-list
139034941|NCT00423852|Ifosfamide|ifosfamide|mesh-list
139034942|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139034943|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034944|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
139034945|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
139034946|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
138785550|NCT01099709|Oxycodone|oxycodone|mesh-list
139034947|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034948|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139034949|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
139034950|NCT00461708|Gemcitabine|gemcitabine|mesh-list
139034951|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139034952|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139034953|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
139034954|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034955|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034956|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139034957|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034958|NCT00327171|Aflibercept|aflibercept|mesh-list
139034959|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139034960|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139034961|NCT00327171|Growth Substances|growth substances|mesh-ancestor
139034962|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034963|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
139034964|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034965|NCT01038024|Antioxidants|antioxidants|mesh-list
139034966|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034967|NCT01038024|Protective Agents|protective agents|mesh-ancestor
139034968|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034969|NCT00461630|Niacin|niacin|mesh-list
139034970|NCT00461630|Simvastatin|simvastatin|mesh-list
139034971|NCT00461630|Ezetimibe|ezetimibe|mesh-list
139034972|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
139034973|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139034974|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139034975|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
139034976|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139034977|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138560443|NCT05406700|Niraparib|niraparib|mesh-list
138495877|NCT00106834|Infliximab|infliximab|mesh-list
139034978|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139034979|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139034980|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
139034981|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
139034982|NCT00461630|Vitamins|vitamins|mesh-ancestor
139034983|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
139034984|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034985|NCT01061853|Sirolimus|sirolimus|mesh-list
139034986|NCT01061853|Betamethasone|betamethasone|mesh-list
139034987|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139034988|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139034989|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139034990|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139034991|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
139034992|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139034993|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
139034994|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139034995|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139034996|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
139034997|NCT01061853|Hormones|hormones|mesh-ancestor
139034998|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139034999|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139035000|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
139035001|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
139035002|NCT01325415|Naloxegol|naloxegol|mesh-list
139035003|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139035004|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035005|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139035006|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139035007|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035008|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138989745|NCT05593055|Eplerenone|eplerenone|mesh-list
139035009|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035010|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035011|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139035012|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
139035013|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035014|NCT01022840|Ketamine|ketamine|mesh-list
139035015|NCT01022840|Esketamine|esketamine|mesh-list
139035016|NCT01022840|Analgesics|analgesics|mesh-ancestor
139035017|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
139035018|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035019|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035020|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139035021|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139035022|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
139035023|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
139035024|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139035025|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139035026|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139035027|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138560726|NCT05011383|Androgens|androgens|mesh-list
139035028|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035029|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
139035031|NCT01025570|Gemcitabine|gemcitabine|mesh-list
139035032|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139035033|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
139035034|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035035|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035036|NCT03983876|Adalimumab|adalimumab|mesh-list
139035037|NCT03983876|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139035038|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139035039|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139035040|NCT00327015|Metformin|metformin|mesh-list
139035041|NCT00327015|Pioglitazone|pioglitazone|mesh-list
139035042|NCT00327015|Saxagliptin|saxagliptin|mesh-list
139035043|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139035044|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035045|NCT00327015|Incretins|incretins|mesh-ancestor
139035046|NCT00327015|Hormones|hormones|mesh-ancestor
138560755|NCT04938765|Analgesics|analgesics|mesh-ancestor
139035047|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035048|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139035049|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
139035050|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035051|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035052|NCT00434148|Pasireotide|pasireotide|mesh-list
139035053|NCT00434148|Hormones|hormones|mesh-ancestor
139035054|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035055|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035056|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
138496019|NCT00107848|Modafinil|modafinil|mesh-list
139035057|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139035058|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139035059|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139035060|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139035061|NCT00468728|Vancomycin|vancomycin|mesh-list
139035062|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139035063|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035064|NCT00433914|Vaccines|vaccines|mesh-list
139035065|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
139035066|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035067|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
139035068|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035069|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
139035070|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139035071|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139035072|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237155|NCT02743377|Rolipram|rolipram|mesh-list
139035073|NCT00468650|Urological Agents|urological agents|mesh-ancestor
139035074|NCT00423150|Temozolomide|temozolomide|mesh-list
139035075|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139035076|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
139035077|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035078|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035079|NCT00433836|Valsartan|valsartan|mesh-list
139035080|NCT00433836|Enalapril|enalapril|mesh-list
139035081|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139035082|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139035083|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139035084|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035085|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139035086|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
139035087|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035088|NCT01022918|Bevacizumab|bevacizumab|mesh-list
139035089|NCT01022918|Temozolomide|temozolomide|mesh-list
139035090|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139035091|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035092|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139035093|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139035094|NCT01022918|Growth Substances|growth substances|mesh-ancestor
139035095|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035096|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
139035097|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139035098|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
139035099|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035100|NCT00433446|Siltuximab|siltuximab|mesh-list
139035101|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035102|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139035103|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139035104|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139035105|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035106|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
139035108|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139035109|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
139035110|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035111|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139035112|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139035113|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139035114|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139035115|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139035116|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139035117|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035118|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035119|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035120|NCT00433290|Analgesics|analgesics|mesh-ancestor
139035121|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
139035122|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560976|NCT04647084|Lidocaine|lidocaine|mesh-list
139035123|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
139035124|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139035125|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
139035126|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
139035127|NCT00467870|Testosterone|testosterone|mesh-list
139035128|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
139035129|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
139035130|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139035131|NCT00467870|Androgens|androgens|mesh-ancestor
139035132|NCT00467870|Hormones|hormones|mesh-ancestor
139035133|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035134|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561032|NCT04605393|Hormones|hormones|mesh-ancestor
139035135|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139035136|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035137|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
139035139|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139035140|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139035141|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035142|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
139035143|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035144|NCT00422292|Vaccines|vaccines|mesh-list
139035145|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
139035146|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035147|NCT00452348|Fluticasone|fluticasone|mesh-list
139035148|NCT00452348|Xhance|xhance|mesh-list
139035149|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139035150|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139035151|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139035152|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139035153|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
139035154|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035155|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035156|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139035157|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
139035158|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
139035159|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139035160|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139035161|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139035162|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139035163|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
139035164|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035165|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035166|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
139035167|NCT00452348|Hormones|hormones|mesh-ancestor
139035168|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035169|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
139035170|NCT01323062|Bavituximab|bavituximab|mesh-list
139035171|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139035172|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035173|NCT00320541|Paclitaxel|paclitaxel|mesh-list
139035174|NCT00320541|Bevacizumab|bevacizumab|mesh-list
139035175|NCT00320541|Gemcitabine|gemcitabine|mesh-list
139035176|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139035177|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561103|NCT04434664|Metoprolol|metoprolol|mesh-list
139035178|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
139035179|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
139035180|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
139035181|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035182|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139035183|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139035184|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139035185|NCT00320541|Growth Substances|growth substances|mesh-ancestor
138496128|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035186|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035187|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
139035188|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139035189|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
139035190|NCT00320385|Trastuzumab|trastuzumab|mesh-list
139035192|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139035193|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035194|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139035195|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035196|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035197|NCT00309777|Simvastatin|simvastatin|mesh-list
139035198|NCT00309777|Pitavastatin|pitavastatin|mesh-list
139035199|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139035200|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139035201|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
139035202|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035203|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139035204|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139035205|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035206|NCT00325143|Edetic Acid|edetic acid|mesh-list
139035207|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
139035208|NCT00325143|Antidotes|antidotes|mesh-ancestor
139035209|NCT00325143|Protective Agents|protective agents|mesh-ancestor
138561183|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
139035210|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035212|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
139035213|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035214|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139035215|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
138496164|NCT00109096|Pemetrexed|pemetrexed|mesh-list
139035216|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139035217|NCT00319839|Paclitaxel|paclitaxel|mesh-list
139035218|NCT00319839|Cetuximab|cetuximab|mesh-list
139035219|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139035220|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139035221|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035222|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
139035223|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
139035224|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
139035225|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035226|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139035228|NCT01062087|Bupivacaine|bupivacaine|mesh-list
139035229|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
139035230|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
139035231|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139035232|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035233|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
139035234|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035235|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139035236|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139035237|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139035238|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139035239|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035241|NCT00319449|Ezetimibe|ezetimibe|mesh-list
139035242|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139035243|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138785830|NCT02873364|Vitamins|vitamins|mesh-list
139035244|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
139035245|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035246|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139035247|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139035248|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035249|NCT00308685|Albuterol|albuterol|mesh-list
139035250|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139035251|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
139035252|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035253|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035254|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139035255|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
139035257|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139035258|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139035259|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139035260|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138496196|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
139035261|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
139035262|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035263|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035264|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
139035265|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035266|NCT03981081|Prednisone|prednisone|mesh-list
139035267|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139035268|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
139035269|NCT03981081|Hormones|hormones|mesh-ancestor
139035270|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035271|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035272|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139035273|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035274|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
139035275|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139035276|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
139035277|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139035278|NCT00316719|Lamivudine|lamivudine|mesh-list
139035279|NCT00316719|Adefovir|adefovir|mesh-list
139035280|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139035281|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139035282|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139035283|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035284|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035285|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
139035286|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035287|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139035288|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139035289|NCT01065987|Tizanidine|tizanidine|mesh-list
139035290|NCT01065987|Analgesics|analgesics|mesh-ancestor
139035291|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
139035292|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035293|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035294|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
139035295|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139035296|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139035297|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
139035298|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
139035299|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139035300|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139035301|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139035302|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
139035303|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035304|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035305|NCT01064115|Cetirizine|cetirizine|mesh-list
139035306|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138561395|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035307|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139035308|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139035309|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
139035310|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
139035311|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035312|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035313|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035316|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139035317|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035318|NCT00422058|Incretins|incretins|mesh-ancestor
139035319|NCT00422058|Hormones|hormones|mesh-ancestor
139035320|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035321|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035322|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035323|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139035324|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139035326|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
139035327|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
138561447|NCT03874884|Olaparib|olaparib|mesh-list
139035328|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139035329|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035330|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
139035331|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035333|NCT00413244|Androgens|androgens|mesh-ancestor
139035334|NCT00413244|Hormones|hormones|mesh-ancestor
139035335|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035336|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035338|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035339|NCT01038570|Oxytocin|oxytocin|mesh-list
139035340|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
139035341|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139035342|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035343|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
139035344|NCT00420342|Drospirenone|drospirenone|mesh-list
139035345|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139035346|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139035347|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
139035348|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138561563|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
139035349|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139035350|NCT00420342|Estradiol|estradiol|mesh-list
139035351|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139035352|NCT00420342|Estrogens|estrogens|mesh-ancestor
139035353|NCT00420342|Hormones|hormones|mesh-ancestor
139035354|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035355|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035356|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139035357|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
139035358|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139035359|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139035360|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139035361|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139035362|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139035363|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
139035364|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138989917|NCT05512520|Capecitabine|capecitabine|mesh-list
139035365|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035366|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139035367|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
139035368|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139035369|NCT00420342|Diuretics|diuretics|mesh-ancestor
139035370|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
139035371|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139035372|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139035373|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035374|NCT01038648|Incretins|incretins|mesh-ancestor
139035375|NCT01038648|Hormones|hormones|mesh-ancestor
139035376|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035377|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138496302|NCT00110188|Sirolimus|sirolimus|mesh-list
139035378|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
139035379|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035380|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035381|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139035382|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139035383|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035384|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035385|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139035386|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139035387|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035388|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
139035389|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035390|NCT00451958|Leuprolide|leuprolide|mesh-list
139035391|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139035392|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
139035393|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139035394|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035395|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139035396|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035397|NCT01025882|Gemcitabine|gemcitabine|mesh-list
139035398|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139035399|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
139035400|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035401|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035402|NCT01026116|Paclitaxel|paclitaxel|mesh-list
139035403|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
139035404|NCT01026116|Epirubicin|epirubicin|mesh-list
139035405|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139035406|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035407|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
139035408|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
139035409|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
139035410|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035411|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139035412|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
139035413|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035414|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139035415|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139035416|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
139035417|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139035418|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139035419|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139035420|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139035421|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035422|NCT00432276|Metformin|metformin|mesh-list
139035423|NCT00432276|Pioglitazone|pioglitazone|mesh-list
139035424|NCT00432276|Alogliptin|alogliptin|mesh-list
139035425|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139035426|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035427|NCT00432276|Incretins|incretins|mesh-ancestor
139035428|NCT00432276|Hormones|hormones|mesh-ancestor
139035429|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035430|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139035431|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
139035432|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035433|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035434|NCT01027520|Monensin|monensin|mesh-list
139035435|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
139035436|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035437|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139035438|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139035439|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
139035440|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
139035441|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
139035442|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035443|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035444|NCT01027520|Ionophores|ionophores|mesh-ancestor
139035445|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139035446|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
139035447|NCT01023230|Entecavir|entecavir|mesh-list
139035448|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
139035449|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035450|NCT01027832|Tazobactam|tazobactam|mesh-list
139035451|NCT01027832|Piperacillin|piperacillin|mesh-list
139035452|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
139035453|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139035454|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139035455|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139035456|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138989966|NCT05476770|Vincristine|vincristine|mesh-list
139035457|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035458|NCT00413010|Pregabalin|pregabalin|mesh-list
138496385|NCT00110851|Metformin|metformin|mesh-list
139035459|NCT00413010|Analgesics|analgesics|mesh-ancestor
139035460|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
139035461|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035462|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035463|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
139035464|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139035465|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139035466|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035467|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139035468|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139035469|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139035470|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139035471|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139035472|NCT00459290|Mifepristone|mifepristone|mesh-list
139035473|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
139035474|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
139035475|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139035476|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035477|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139035478|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139035479|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139035480|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
139035481|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
139035482|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
139035483|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
139035484|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035485|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
139035486|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139035487|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
139035488|NCT00443534|Sunitinib|sunitinib|mesh-list
139035489|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139035490|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139035491|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139035492|NCT00443534|Growth Substances|growth substances|mesh-ancestor
139035493|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035494|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
139035495|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138317627|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
139035496|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139035497|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035498|NCT00419952|Budesonide|budesonide|mesh-list
139035499|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
139035500|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139035502|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139035503|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
139035504|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139035505|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035506|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139035507|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
139035508|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
139035509|NCT00419952|Hormones|hormones|mesh-ancestor
139035510|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035511|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138238454|NCT05894239|Taxane|taxane|mesh-list
139035512|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139035513|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139035514|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
139035515|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035516|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035517|NCT00443456|Amlodipine|amlodipine|mesh-list
139035518|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139035519|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139035520|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139035521|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035522|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139035523|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035524|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
139035525|NCT00419562|Insulin|insulin|mesh-list
139035526|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139035527|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035528|NCT03557294|Varenicline|varenicline|mesh-list
139035529|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139035530|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139035531|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
139035532|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035533|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035534|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035536|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
139035537|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035538|NCT01026428|Levodopa|levodopa|mesh-list
139035539|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139035540|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139035542|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035543|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035544|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035545|NCT00308139|Exenatide|exenatide|mesh-list
139035546|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139035547|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035548|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139035549|NCT00308139|Incretins|incretins|mesh-ancestor
139035550|NCT00308139|Hormones|hormones|mesh-ancestor
139035551|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139035552|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139035553|NCT00459056|Carvedilol|carvedilol|mesh-list
139035554|NCT00459056|Lisinopril|lisinopril|mesh-list
139035555|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139035556|NCT00459056|Diuretics|diuretics|mesh-ancestor
139035557|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
139035558|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139035559|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139035560|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139035561|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139035562|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139035563|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139035564|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
139035565|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139035566|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
139035567|NCT00459056|Protective Agents|protective agents|mesh-ancestor
139035568|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138496552|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138496553|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138496554|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496555|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496558|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138496559|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496560|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
138496561|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
138496562|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
138496563|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496564|NCT00112021|Pramlintide|pramlintide|mesh-list
138496565|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
138496566|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138496567|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496568|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
138496569|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138496570|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
138496571|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496572|NCT00007358|Dexamethasone|dexamethasone|mesh-list
138496573|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138496574|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
138496575|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
138496576|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496577|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496578|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138496579|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
138496580|NCT00007358|Hormones|hormones|mesh-ancestor
138496581|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138496582|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138496583|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496584|NCT00112138|Gabapentin|gabapentin|mesh-list
138496585|NCT00112138|Analgesics|analgesics|mesh-ancestor
138496586|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
138496587|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496588|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496589|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
138496590|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138496591|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138496592|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138525263|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
138525264|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
138496593|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138496594|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138496595|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138496596|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138496597|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496598|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
138496599|NCT03330639|Capsaicin|capsaicin|mesh-list
138496600|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
138496601|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
138496602|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
138496603|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496604|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496605|NCT00007436|Tenofovir|tenofovir|mesh-list
138496606|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
138496607|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496608|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138496609|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138496610|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496611|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496612|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138496613|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138496614|NCT00112216|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138496615|NCT00112216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138496616|NCT00112216|Immunologic Factors|immunologic factors|mesh-ancestor
138496617|NCT00112216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496618|NCT00112372|Sirolimus|sirolimus|mesh-list
138496619|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138496620|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496621|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138496622|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496623|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
138496624|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496625|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
138496626|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496627|NCT00112528|Bevacizumab|bevacizumab|mesh-list
138496628|NCT00112528|Gemcitabine|gemcitabine|mesh-list
138496629|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
138496630|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138496631|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496632|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138496633|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138496634|NCT00112528|Growth Substances|growth substances|mesh-ancestor
138496635|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496636|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
138496637|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138496638|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
138496639|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703944|NCT06225466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138703945|NCT06225466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138703946|NCT06225466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703947|NCT06225440|Palmidrol|palmidrol|mesh-list
138703948|NCT06225440|Analgesics|analgesics|mesh-ancestor
138703949|NCT06225440|Sensory System Agents|sensory system agents|mesh-ancestor
138703950|NCT06225440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703951|NCT06225440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703960|NCT06225440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138703961|NCT06225440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703962|NCT06225440|Hormones|hormones|mesh-ancestor
138703963|NCT06225440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138703964|NCT06225349|Magnesium citrate|magnesium citrate|mesh-list
138703965|NCT06225349|Magnesium Oxide|magnesium oxide|mesh-list
138703966|NCT06225349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703967|NCT06225349|Cathartics|cathartics|mesh-ancestor
138703980|NCT06224855|Immunoconjugates|immunoconjugates|mesh-list
138703981|NCT06224855|Immunologic Factors|immunologic factors|mesh-ancestor
138703982|NCT06224855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703984|NCT06224725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138703985|NCT06224725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138703986|NCT06224725|Analgesics|analgesics|mesh-ancestor
138703987|NCT06224725|Sensory System Agents|sensory system agents|mesh-ancestor
138703988|NCT06224725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703989|NCT06224725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703990|NCT06224725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138703991|NCT06224725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138703992|NCT06223854|Folic Acid|folic acid|mesh-list
138703993|NCT06223854|Vitamin B Complex|vitamin b complex|mesh-list
138703994|NCT06223854|Iodine|iodine|mesh-list
138703995|NCT06223854|Hematinics|hematinics|mesh-ancestor
138703996|NCT06223854|Vitamins|vitamins|mesh-ancestor
138703997|NCT06223854|Micronutrients|micronutrients|mesh-ancestor
138703998|NCT06223854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703999|NCT06223854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138704000|NCT06223854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138704001|NCT06223854|Trace Elements|trace elements|mesh-ancestor
138173126|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
138704009|NCT06220422|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
138496640|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
138496642|NCT00007592|Diuretics|diuretics|mesh-ancestor
138496643|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
138496644|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496645|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138496646|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138496647|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496648|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138496649|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138496651|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496652|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
138496653|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
138496655|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
138496656|NCT00112567|Thiotepa|thiotepa|mesh-list
138496657|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496658|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138496659|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
138496660|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496661|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496662|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
138496663|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496664|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138496665|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
138496666|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138496667|NCT00112645|Cyclosporine|cyclosporine|mesh-list
138496668|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
138496669|NCT00112645|Methotrexate|methotrexate|mesh-list
138496671|NCT00112645|Busulfan|busulfan|mesh-list
138496672|NCT00112645|Cyclosporins|cyclosporins|mesh-list
138496673|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138496674|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138496675|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
138496676|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138496677|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496678|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138496679|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
138496680|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496681|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496682|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
138496683|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496684|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138496685|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496686|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
138496687|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138496688|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138496689|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
138496690|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496691|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138496692|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138496693|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
138496694|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
138496695|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496696|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138496697|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
138496698|NCT00112645|Hormones|hormones|mesh-ancestor
138496699|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138496701|NCT00112645|Protective Agents|protective agents|mesh-ancestor
138496702|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138496703|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
138496704|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138496705|NCT00112684|Alvocidib|alvocidib|mesh-list
138496706|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496707|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
138496708|NCT00112684|Growth Substances|growth substances|mesh-ancestor
138496709|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496710|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138496711|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496712|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496713|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
138496714|NCT00112879|Thalidomide|thalidomide|mesh-list
138496715|NCT00112879|Dexamethasone|dexamethasone|mesh-list
138496716|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
138496717|NCT00112879|Mitogens|mitogens|mesh-list
138496718|NCT00112879|Immunomodulating Agents|immunomodulating agents|mesh-list
138496719|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138496720|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
138496721|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
138496722|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496723|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496724|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138496725|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
138496726|NCT00112879|Hormones|hormones|mesh-ancestor
138496727|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138496728|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138496729|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496730|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
138496731|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496732|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496733|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
138496734|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
138496735|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138496737|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138496738|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138496739|NCT00112879|Growth Substances|growth substances|mesh-ancestor
138496740|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
138496741|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
138496742|NCT00112879|Protective Agents|protective agents|mesh-ancestor
138496743|NCT00112879|Vitamins|vitamins|mesh-ancestor
138496744|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
138496745|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
138496746|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
138496747|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496748|NCT00112996|Protective Agents|protective agents|mesh-ancestor
138496749|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496750|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
138496751|NCT00112996|Vitamins|vitamins|mesh-ancestor
138496752|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
138496753|NCT00113074|Nicotine|nicotine|mesh-list
138496754|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138496755|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
138496756|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496757|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496758|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138496759|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138496760|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
138496761|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138496762|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496763|NCT00113113|Rubitecan|rubitecan|mesh-list
138496764|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496765|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138496766|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138496767|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496768|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496769|NCT00007787|Cyclosporine|cyclosporine|mesh-list
138496770|NCT00007787|Tacrolimus|tacrolimus|mesh-list
138496771|NCT00007787|Cyclosporins|cyclosporins|mesh-list
138496772|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
138496773|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496774|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
138496775|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496776|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138496777|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496778|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496779|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
138496780|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496781|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
138496782|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138496783|NCT00390897|Interferons|interferons|mesh-list
138692283|NCT00534651|Acetaminophen|acetaminophen|mesh-list
138496784|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496785|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
138685833|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138496786|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496787|NCT00113347|Docetaxel|docetaxel|mesh-list
138496788|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138496789|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496790|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
138496791|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
138496792|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
138704010|NCT06220422|Antithrombins|antithrombins|mesh-ancestor
138327016|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138496793|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496794|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138496795|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496797|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
138496798|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496799|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138496800|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496801|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496802|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
138496803|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496804|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138496805|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138496806|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
138496807|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
138496808|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496809|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496810|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138496811|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138496812|NCT00113542|Growth Substances|growth substances|mesh-ancestor
138496813|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496814|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
138496815|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496816|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138496817|NCT00007826|Vaccines|vaccines|mesh-list
138496818|NCT00007826|Antibodies|antibodies|mesh-list
138496819|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138496820|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
138496821|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
138496822|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
138496823|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496824|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138496825|NCT00007826|Antacids|antacids|mesh-ancestor
138496826|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496827|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138496828|NCT00007865|Rituximab|rituximab|mesh-list
138496829|NCT00007865|Carboplatin|carboplatin|mesh-list
138496830|NCT00007865|Etoposide|etoposide|mesh-list
138496831|NCT00007865|Ifosfamide|ifosfamide|mesh-list
138496832|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138496833|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685858|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
138496835|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496836|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138496837|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138496838|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138496839|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138496840|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496841|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496842|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138496843|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
138496844|NCT00113698|Enalapril|enalapril|mesh-list
138496845|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138496846|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
138496847|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496848|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496849|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138496850|NCT00113737|Fluoxetine|fluoxetine|mesh-list
138496851|NCT00113737|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138496852|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138496853|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138496854|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173344|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173345|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
138173346|NCT04278950|Povidone|povidone|mesh-list
138173347|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
138173348|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
138173349|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138173350|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173351|NCT00755755|Iron|iron|mesh-list
138173352|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
138173353|NCT00755755|Trace Elements|trace elements|mesh-ancestor
138173354|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
138525631|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138173355|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496855|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138496856|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
138496857|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496858|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138496859|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
138496860|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138496861|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138496862|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138496863|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496864|NCT03272295|Fenugreek seed meal|fenugreek seed meal|mesh-list
138496865|NCT03272295|Menthol|menthol|mesh-list
138496866|NCT03272295|Sorbitol|sorbitol|mesh-list
138496867|NCT03272295|Glycerol|glycerol|mesh-list
138496868|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
138685903|NCT00525707|Tezosentan|tezosentan|mesh-list
138496870|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138496871|NCT03272295|Protective Agents|protective agents|mesh-ancestor
138496872|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496873|NCT03272295|Cathartics|cathartics|mesh-ancestor
138496874|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138496875|NCT03272295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138496876|NCT00007904|Tamoxifen|tamoxifen|mesh-list
138496877|NCT00007904|Paclitaxel|paclitaxel|mesh-list
138496878|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
138496879|NCT00007904|Doxorubicin|doxorubicin|mesh-list
138496881|NCT00007904|Lenograstim|lenograstim|mesh-list
138496882|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138496883|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496884|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
138496885|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
138496886|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
138496887|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496888|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496889|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
138496890|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496891|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138496892|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138496893|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
138496894|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138496895|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138496896|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138496897|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138496898|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496899|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138496900|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138496901|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
138496902|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138496903|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138496904|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138496905|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138496906|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138496908|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
138496909|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138496910|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496911|NCT00113854|Mannitol|mannitol|mesh-list
138496912|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138496913|NCT00113854|Diuretics|diuretics|mesh-ancestor
138496914|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
138496915|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496916|NCT00007943|Gemcitabine|gemcitabine|mesh-list
138496917|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138496918|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
138496919|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496920|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496921|NCT00113971|Epratuzumab|epratuzumab|mesh-list
138496922|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138496923|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496924|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138496925|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138496926|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
138496927|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496928|NCT00114010|Antacids|antacids|mesh-ancestor
138496929|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496930|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138327082|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
138496932|NCT00007982|Thiotepa|thiotepa|mesh-list
138496933|NCT00007982|Carmustine|carmustine|mesh-list
138496934|NCT00007982|Etoposide|etoposide|mesh-list
138496935|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496936|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
138496937|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496938|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138496939|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138496940|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
138496941|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496942|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496943|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138496944|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138496945|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138496946|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138496947|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496948|NCT00114205|Docetaxel|docetaxel|mesh-list
138496949|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496950|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
138496951|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
138496952|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
138496953|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496955|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496956|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138496957|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496958|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496960|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138685959|NCT00526409|Cytarabine|cytarabine|mesh-list
138496961|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
138496962|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496963|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
138496964|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496965|NCT00114400|Vitamins|vitamins|mesh-list
138496966|NCT00114400|Folic Acid|folic acid|mesh-list
138496967|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
138496968|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
138496969|NCT00114400|Pyridoxal|pyridoxal|mesh-list
138496970|NCT00114400|Pyridoxine|pyridoxine|mesh-list
138496971|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
138496972|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
138496973|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496974|NCT00114400|Hematinics|hematinics|mesh-ancestor
138496975|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
138496976|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
138496977|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138496978|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496979|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496980|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
138496981|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138496982|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138496983|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496984|NCT00114478|Epinephrine|epinephrine|mesh-list
138496985|NCT00114478|Albuterol|albuterol|mesh-list
138496986|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138496987|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138496988|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
138496989|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138496990|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496991|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496992|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138496993|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138496994|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
138496995|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496996|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138496997|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
138496999|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
138497000|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138497001|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
138497002|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138497003|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138497004|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
138497005|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138497006|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497007|NCT00008021|Cyclosporine|cyclosporine|mesh-list
138497008|NCT00008021|Paclitaxel|paclitaxel|mesh-list
138497009|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138497010|NCT00008021|Antibodies|antibodies|mesh-list
138497011|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
138497012|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138497013|NCT00008021|Cyclosporins|cyclosporins|mesh-list
138497014|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138497015|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497016|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
138497017|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
138497018|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
138497019|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497020|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
138497021|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497022|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497023|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138497024|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
138525857|NCT00395252|Cetuximab|cetuximab|mesh-list
138497025|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497026|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
138497027|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138497028|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138497029|NCT03079440|Capecitabine|capecitabine|mesh-list
138497030|NCT03079440|Temozolomide|temozolomide|mesh-list
138497032|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
138497033|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497034|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497035|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138497036|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
138497037|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138497038|NCT00008060|Leucovorin|leucovorin|mesh-list
138497039|NCT00008060|Fluorouracil|fluorouracil|mesh-list
138497040|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
138497041|NCT00008060|Irinotecan|irinotecan|mesh-list
138497042|NCT00008060|Calcium|calcium|mesh-list
138497043|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
138497044|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138497045|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497046|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
138497047|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497048|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138497049|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497050|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138497051|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
138497052|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138497053|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138497054|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497055|NCT00008060|Antidotes|antidotes|mesh-ancestor
138497056|NCT00008060|Protective Agents|protective agents|mesh-ancestor
138497057|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
138497058|NCT00008060|Vitamins|vitamins|mesh-ancestor
138497060|NCT00114868|Vitamins|vitamins|mesh-list
138497061|NCT00114868|Vitamin A|vitamin a|mesh-list
138497062|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
138497063|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
138497064|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497065|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
138497066|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497067|NCT00114868|Protective Agents|protective agents|mesh-ancestor
138497068|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138497069|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497070|NCT03034200|TIC10 compound|tic10 compound|mesh-list
138497071|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497072|NCT00114946|Bevacizumab|bevacizumab|mesh-list
138497073|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138497074|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497075|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138497076|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138497077|NCT00114946|Growth Substances|growth substances|mesh-ancestor
138497078|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497079|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
138497080|NCT00115024|Estradiol|estradiol|mesh-list
138497081|NCT00115024|Estrogens|estrogens|mesh-ancestor
138497082|NCT00115024|Hormones|hormones|mesh-ancestor
138497083|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138497084|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497086|NCT00008177|Cyclosporine|cyclosporine|mesh-list
138497087|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
138497088|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138497089|NCT00008177|Fludarabine|fludarabine|mesh-list
138497090|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
138497091|NCT00008177|Antibodies|antibodies|mesh-list
138497092|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
138497093|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138497094|NCT00008177|Cyclosporins|cyclosporins|mesh-list
138497095|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
138497096|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497097|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497098|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138497099|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
138497100|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497101|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138497102|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497103|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
138497104|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497105|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
138497106|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138497107|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138497108|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138686029|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497109|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138497110|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
138497111|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138497112|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138497113|NCT00008177|Trace Elements|trace elements|mesh-ancestor
138497114|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
138497116|NCT03007407|Tremelimumab|tremelimumab|mesh-list
138497117|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138497118|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497119|NCT00115102|Fentanyl|fentanyl|mesh-list
138497121|NCT00115102|Esketamine|esketamine|mesh-list
138497122|NCT00115102|Analgesics|analgesics|mesh-ancestor
138497123|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
138497124|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497125|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497126|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138497127|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138497128|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
138497129|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
138497130|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138497131|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138497132|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138497133|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138497134|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497135|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138497136|NCT00115102|Narcotics|narcotics|mesh-ancestor
138497137|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138497138|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
138497139|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138497140|NCT00115219|Etanercept|etanercept|mesh-list
138497141|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138497142|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138497143|NCT00115219|Analgesics|analgesics|mesh-ancestor
138497144|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
138497145|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497146|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497147|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138497148|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138497149|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138497150|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525967|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
138497151|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
138497152|NCT00115375|Clopidogrel|clopidogrel|mesh-list
138497153|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138497154|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138497155|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138497156|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138497157|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
138497158|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138497159|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497160|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497161|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
138497162|NCT00115414|Docetaxel|docetaxel|mesh-list
138497163|NCT00115414|Doxorubicin|doxorubicin|mesh-list
138497164|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138497165|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
138497166|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497167|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138497168|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138497169|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
138497170|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497171|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497172|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138497173|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
138497174|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
138497175|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
138497176|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138497177|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138497178|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138497180|NCT00115492|Fluticasone|fluticasone|mesh-list
138497181|NCT00115492|Xhance|xhance|mesh-list
138497182|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138497183|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138497184|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138497185|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138497186|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
138497187|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497188|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497189|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138497190|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
138497191|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
138497192|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138497193|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138327199|NCT00227994|Donepezil|donepezil|mesh-list
138497194|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138497195|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138497196|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
138497197|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138497198|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497199|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
138497200|NCT00115492|Hormones|hormones|mesh-ancestor
138497201|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138497202|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
138497203|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138497204|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138497205|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
138497206|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497207|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138497208|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497209|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138497210|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497211|NCT00115531|Vaccines|vaccines|mesh-list
138497212|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
138497213|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497214|NCT00115570|Insulin|insulin|mesh-list
138497215|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138497216|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
138497217|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
138526038|NCT00053118|Etoposide|etoposide|mesh-list
138497218|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
138497219|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
138497220|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
138686096|NCT00527033|Mirabegron|mirabegron|mesh-list
138497221|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
138497222|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138497223|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497225|NCT00115609|Emtricitabine|emtricitabine|mesh-list
138497226|NCT00115609|Efavirenz|efavirenz|mesh-list
138497227|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
138497228|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497229|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138497230|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138497231|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497232|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497233|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138692427|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
138497234|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138497235|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138497236|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138497237|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138327230|NCT00288366|Aripiprazole|aripiprazole|mesh-list
138497238|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138497239|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138497240|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138497242|NCT00115648|Nevirapine|nevirapine|mesh-list
138497243|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
138497244|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497245|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138497246|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138497247|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497248|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
138497249|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497250|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138497251|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138497252|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138497253|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138497254|NCT00008294|Leucovorin|leucovorin|mesh-list
138497255|NCT00008294|Dexamethasone|dexamethasone|mesh-list
138497256|NCT00008294|Fluorouracil|fluorouracil|mesh-list
138497257|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
138497258|NCT00008294|Floxuridine|floxuridine|mesh-list
138497259|NCT00008294|Calcium|calcium|mesh-list
138497260|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
138497261|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138497262|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
138497263|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
138497264|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497265|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497266|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138497267|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
138497268|NCT00008294|Hormones|hormones|mesh-ancestor
138497269|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138497270|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138497271|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497272|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138686105|NCT02945072|Sevoflurane|sevoflurane|mesh-list
138497273|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
138497274|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497275|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138497276|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138497277|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
138497279|NCT00008294|Protective Agents|protective agents|mesh-ancestor
138497280|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
138497281|NCT00008294|Vitamins|vitamins|mesh-ancestor
138497282|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
138497283|NCT00115687|Nicotine|nicotine|mesh-list
138497284|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138497285|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
138497286|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497287|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497288|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138497289|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138497290|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
138497291|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138497292|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497293|NCT00115726|Furosemide|furosemide|mesh-list
138497294|NCT00115726|Diuretics|diuretics|mesh-ancestor
138497295|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
138497296|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497297|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138497298|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138497299|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497300|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
138497301|NCT00401869|Hematinics|hematinics|mesh-ancestor
138526104|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138526115|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
138497302|NCT00008333|Vinorelbine|vinorelbine|mesh-list
138497303|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138497304|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497305|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
138497306|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
138497307|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
138497308|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497309|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
138497310|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497311|NCT00115921|Antimalarials|antimalarials|mesh-list
138497312|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138497313|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138497314|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497315|NCT00008411|Docetaxel|docetaxel|mesh-list
138497316|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497317|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
138497318|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
138497319|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
138497320|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497321|NCT00008450|Cyclosporine|cyclosporine|mesh-list
138497322|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
138497323|NCT00008450|Cyclosporins|cyclosporins|mesh-list
138497324|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497325|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497327|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
138497328|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497329|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
138497330|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497331|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
138497332|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138497333|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138497334|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138497336|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138497337|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
138497338|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138497339|NCT00008489|Didanosine|didanosine|mesh-list
138497340|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
138497341|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497342|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138497343|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138497344|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497345|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
138497346|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497347|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138497348|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138497349|NCT00116350|Misoprostol|misoprostol|mesh-list
138497350|NCT00116350|Oxytocin|oxytocin|mesh-list
138497351|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
138497352|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138497353|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497354|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138497355|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
138497356|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138497357|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138497358|NCT00116389|Gemcitabine|gemcitabine|mesh-list
138497359|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138497360|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
138497361|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497362|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497363|NCT00116467|Vaccines|vaccines|mesh-list
138497364|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
138497365|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497366|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
138497367|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138497368|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138497369|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497370|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138497372|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
138497373|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497374|NCT00116506|Bevacizumab|bevacizumab|mesh-list
138497375|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138497376|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138497377|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497378|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138497379|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138497380|NCT00116506|Growth Substances|growth substances|mesh-ancestor
138497381|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497382|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
138497383|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138497384|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497385|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497386|NCT00116545|Troglitazone|troglitazone|mesh-list
138497387|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138173892|NCT03793439|Prednisone|prednisone|mesh-list
138497388|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497389|NCT00116623|Indomethacin|indomethacin|mesh-list
138497390|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
138497391|NCT00116623|Analgesics|analgesics|mesh-ancestor
138497392|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
138497393|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497394|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497395|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
138526171|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
138497396|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138497397|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138497398|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
138497399|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138497400|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138497401|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497402|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138497403|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
138497404|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138497405|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138497406|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138497407|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138497409|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
138497410|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138497411|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497412|NCT02909322|Hydromorphone|hydromorphone|mesh-list
138497413|NCT02909322|Bupivacaine|bupivacaine|mesh-list
138497414|NCT02909322|Ropivacaine|ropivacaine|mesh-list
138497415|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
138497416|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
138497417|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138497418|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497419|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
138497420|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497421|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138497422|NCT02909322|Narcotics|narcotics|mesh-ancestor
138497423|NCT02909322|Analgesics|analgesics|mesh-ancestor
138497424|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
138497425|NCT00116701|Hematinics|hematinics|mesh-ancestor
138497426|NCT00116896|Cisplatin|cisplatin|mesh-list
138497427|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497428|NCT02752815|Prednisone|prednisone|mesh-list
138497429|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
138497430|NCT02752815|Rituximab|rituximab|mesh-list
138497431|NCT02752815|Vincristine|vincristine|mesh-list
138497432|NCT02752815|Epirubicin|epirubicin|mesh-list
138497433|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138497434|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
138497435|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497436|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138497437|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138497438|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
138497439|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526196|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
138497440|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497441|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138526197|NCT00025649|Melphalan|melphalan|mesh-list
138497442|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138497443|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138497444|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
138497445|NCT02752815|Hormones|hormones|mesh-ancestor
138497446|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138497447|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138497448|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138497449|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
138497450|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
138497451|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
138497452|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138497453|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138497454|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138497455|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497456|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
138497457|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497458|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138497459|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497460|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497461|NCT00388388|Losartan|losartan|mesh-list
138497462|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138497464|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138497465|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138497466|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138497467|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497468|NCT00388388|Diuretics|diuretics|mesh-ancestor
138497469|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
138497470|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497471|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138497472|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138497474|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138526230|NCT00025727|Lopinavir|lopinavir|mesh-list
138497475|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138497476|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497477|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497478|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497479|NCT00117052|Cinacalcet|cinacalcet|mesh-list
138497480|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138497481|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497482|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138497483|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
138497484|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138497485|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138497486|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138497487|NCT02972450|Vedolizumab|vedolizumab|mesh-list
138497488|NCT02972450|Vaccines|vaccines|mesh-list
138497489|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
138497490|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497491|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138497492|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
138497493|NCT00117130|Hematinics|hematinics|mesh-ancestor
138497494|NCT00117208|Mannitol|mannitol|mesh-list
138497495|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138497496|NCT00117208|Diuretics|diuretics|mesh-ancestor
138497497|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
138497498|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497499|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
138497500|NCT00117247|Hematinics|hematinics|mesh-ancestor
138497501|NCT00388427|Cetuximab|cetuximab|mesh-list
138497502|NCT00388427|Dasatinib|dasatinib|mesh-list
138497503|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138497504|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497505|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138526271|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138526272|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138526273|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138526274|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138526275|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526276|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
138497506|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497507|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497508|NCT00117364|Sacchachitin|sacchachitin|mesh-list
138497509|NCT00117364|Antioxidants|antioxidants|mesh-ancestor
138497510|NCT00117364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497511|NCT00117364|Protective Agents|protective agents|mesh-ancestor
138497512|NCT00117364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497513|NCT00117403|Vitamins|vitamins|mesh-list
138497514|NCT00117403|Vitamin E|vitamin e|mesh-list
138497515|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
138497516|NCT00117403|Coenzyme Q10|coenzyme q10|mesh-list
138497517|NCT00117403|Ubiquinone|ubiquinone|mesh-list
138497518|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
138497519|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327347|NCT00296322|Mitomycin|mitomycin|mesh-list
138497520|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
138497521|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497522|NCT00117403|Protective Agents|protective agents|mesh-ancestor
138497523|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
138497524|NCT00117442|Paclitaxel|paclitaxel|mesh-list
138497525|NCT00117442|Carboplatin|carboplatin|mesh-list
138497526|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138497527|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497528|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
138497529|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
138497530|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
138497531|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497532|NCT00117520|Caffeine|caffeine|mesh-list
138497533|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138497534|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497535|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138497536|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497537|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497538|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138497539|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138497540|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
138174013|NCT01933815|Growth Substances|growth substances|mesh-ancestor
138497541|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138497542|NCT04727515|Fentanyl|fentanyl|mesh-list
138497543|NCT04727515|Isoflurane|isoflurane|mesh-list
138497544|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138497545|NCT04727515|Narcotics|narcotics|mesh-ancestor
138497546|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138497547|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497548|NCT04727515|Analgesics|analgesics|mesh-ancestor
138526312|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526316|NCT00026078|Docetaxel|docetaxel|mesh-list
138497549|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
138497550|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497551|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138497552|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138497553|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
138497554|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
138497555|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138497556|NCT00117754|Terbinafine|terbinafine|mesh-list
138497557|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
138497558|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497559|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497560|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497561|NCT00117832|Azelastine|azelastine|mesh-list
138497562|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138497563|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
138497564|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497565|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497566|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138497567|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
138497568|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138497569|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497570|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497571|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138497572|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138497573|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138497574|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
138497576|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138497577|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
138497578|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
138497579|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138497580|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
138497581|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138526345|NCT00054210|Paclitaxel|paclitaxel|mesh-list
138497582|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138497583|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497584|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138497585|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497586|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497587|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138497588|NCT00118066|Calcitriol|calcitriol|mesh-list
138497589|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138692535|NCT00533169|Tretinoin|tretinoin|mesh-list
138497590|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497591|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138497592|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138497593|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497594|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138497595|NCT00118066|Vitamins|vitamins|mesh-ancestor
138497596|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
138497597|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138497598|NCT00118105|Bevacizumab|bevacizumab|mesh-list
138497599|NCT00118105|Capecitabine|capecitabine|mesh-list
138497600|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
138686287|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
138497601|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138497602|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497603|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138497604|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138497605|NCT00118105|Growth Substances|growth substances|mesh-ancestor
138497606|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497607|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
138497608|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138497609|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
138497610|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497611|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138497613|NCT00118183|Docetaxel|docetaxel|mesh-list
138497614|NCT00118183|Bortezomib|bortezomib|mesh-list
138497615|NCT00118183|Antibodies|antibodies|mesh-list
138497616|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
138497617|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138497618|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
138497619|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497620|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497621|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
138497622|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
138497623|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
138497624|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497625|NCT00390975|Tegaserod|tegaserod|mesh-list
138497626|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138497627|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
138497628|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138497629|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497630|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497631|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138497632|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
138497635|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138497636|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
138497637|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
138497638|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138497639|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497640|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497641|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
138497642|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138497643|NCT00118261|Leucovorin|leucovorin|mesh-list
138497644|NCT00118261|Bevacizumab|bevacizumab|mesh-list
138497645|NCT00118261|Fluorouracil|fluorouracil|mesh-list
138497646|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
138497647|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138497649|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
138497650|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138497651|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497652|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138497653|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138497654|NCT00118261|Growth Substances|growth substances|mesh-ancestor
138497655|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497656|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
138497657|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138497658|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
138497659|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497660|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138497661|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138497662|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
138497663|NCT00118261|Antidotes|antidotes|mesh-ancestor
138497664|NCT00118261|Protective Agents|protective agents|mesh-ancestor
138497665|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
138497666|NCT00118261|Vitamins|vitamins|mesh-ancestor
138497667|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
138497668|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138497669|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497670|NCT00118300|Capecitabine|capecitabine|mesh-list
138497671|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138497672|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
138497673|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497674|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497675|NCT00118690|Fluticasone|fluticasone|mesh-list
138497676|NCT00118690|Xhance|xhance|mesh-list
138497677|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138497678|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138497679|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138497680|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
138497681|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138526423|NCT00026351|Pentostatin|pentostatin|mesh-list
138497682|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497683|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138497684|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
138497685|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
138497686|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138497687|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138497688|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138497689|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138497690|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
138497691|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138497692|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497694|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
138497695|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497696|NCT00118768|Interferons|interferons|mesh-list
138497697|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
138497698|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497700|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497701|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
138497702|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497703|NCT00118807|Artesunate|artesunate|mesh-list
138497704|NCT00118807|Chloroquine|chloroquine|mesh-list
138497705|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
138497706|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
138497707|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138497708|NCT00118807|Amodiaquine|amodiaquine|mesh-list
138497709|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
138497710|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138497711|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138497712|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497713|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497714|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
138497715|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
138497716|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138497717|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
138497718|NCT00118807|Amebicides|amebicides|mesh-ancestor
138497719|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138497720|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138497721|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497722|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497723|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138497724|NCT00118963|Metformin|metformin|mesh-list
138497725|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
138497726|NCT00118963|Repaglinide|repaglinide|mesh-list
138497727|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138497728|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497729|NCT00119002|Dexamethasone|dexamethasone|mesh-list
138497730|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138497731|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
138497732|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
138497733|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497734|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497735|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138497736|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
138497737|NCT00119002|Hormones|hormones|mesh-ancestor
138526442|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
138497738|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138497739|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138497740|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497741|NCT00119119|Tocopherols|tocopherols|mesh-list
138497742|NCT00119119|Vitamin E|vitamin e|mesh-list
138497743|NCT00119119|Tocotrienols|tocotrienols|mesh-list
138497744|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
138497745|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
138497746|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497747|NCT00119119|Protective Agents|protective agents|mesh-ancestor
138497748|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497749|NCT00119119|Vitamins|vitamins|mesh-ancestor
138497750|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
138497751|NCT00119236|Irinotecan|irinotecan|mesh-list
138497752|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138497753|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138497754|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497755|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497756|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497757|NCT00119314|Gemcitabine|gemcitabine|mesh-list
138497758|NCT00119314|Capecitabine|capecitabine|mesh-list
138497759|NCT00119314|Docetaxel|docetaxel|mesh-list
138497760|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138497761|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
138497762|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497763|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497764|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
138497765|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
138174235|NCT02299089|Octreotide|octreotide|mesh-list
138497766|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
138497767|NCT00119431|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138497768|NCT00119431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138497769|NCT00119431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138497770|NCT00119431|Immunologic Factors|immunologic factors|mesh-ancestor
138497771|NCT00119431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497772|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
138692580|NCT00536237|Niacin|niacin|mesh-list
138497774|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
138497775|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
138497776|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497777|NCT00119626|Protective Agents|protective agents|mesh-ancestor
138497778|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497779|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
138497780|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138497781|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138497782|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138497783|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138497784|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497785|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
138497786|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138497787|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497788|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138497789|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497790|NCT00120055|Atorvastatin|atorvastatin|mesh-list
138497791|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138497792|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138497793|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
138497794|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497795|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138497796|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138497797|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497798|NCT00120133|Atorvastatin|atorvastatin|mesh-list
138497799|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138497800|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138497801|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
138497802|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497803|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138497804|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138497805|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497807|NCT00120172|Capecitabine|capecitabine|mesh-list
138497808|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
138497809|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138497810|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497811|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138497812|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138497813|NCT00120172|Growth Substances|growth substances|mesh-ancestor
138497814|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497815|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
138497816|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138497817|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
138327412|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138497818|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497819|NCT00402181|Dexamethasone|dexamethasone|mesh-list
138497820|NCT00402181|Siltuximab|siltuximab|mesh-list
138497821|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138497822|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
138497823|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
138497824|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497825|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497826|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138497827|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
138497828|NCT00402181|Hormones|hormones|mesh-ancestor
138497829|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138497830|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138497831|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497832|NCT04727437|Heparin|heparin|mesh-list
138497833|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138497834|NCT04727437|Tinzaparin|tinzaparin|mesh-list
138497835|NCT04727437|Dalteparin|dalteparin|mesh-list
138497836|NCT04727437|Warfarin|warfarin|mesh-list
138497837|NCT04727437|Anticoagulants|anticoagulants|mesh-list
138526488|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138497838|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138497839|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138497840|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497841|NCT00120367|Tenofovir|tenofovir|mesh-list
138497842|NCT00120367|Emtricitabine|emtricitabine|mesh-list
138497843|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
138497844|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
138497845|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497846|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138497847|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138497848|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497849|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497850|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138497851|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138497852|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138497853|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138497854|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
138497855|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
138497856|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497857|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138497858|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138497859|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
138497860|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
138497862|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
138497863|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497864|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
138497865|NCT00120484|Hematinics|hematinics|mesh-ancestor
138497866|NCT00391014|Amphotericin B|amphotericin b|mesh-list
138497867|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138497868|NCT00391014|Amebicides|amebicides|mesh-ancestor
138497869|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138497870|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138497871|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497872|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138497873|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
138497874|NCT00120601|Naltrexone|naltrexone|mesh-list
138497875|NCT00120601|Acamprosate|acamprosate|mesh-list
138497876|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138497877|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138497878|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526514|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497879|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
138497880|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497881|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138497882|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138497883|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138497884|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
138497885|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138497886|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497887|NCT00120640|Progestins|progestins|mesh-ancestor
138497888|NCT00120640|Hormones|hormones|mesh-ancestor
138497890|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
138497891|NCT00120679|Hematinics|hematinics|mesh-ancestor
138497892|NCT00120718|Fasudil|fasudil|mesh-list
138497893|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138497894|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138497895|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497896|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138497897|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497898|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
138497899|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138497900|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497901|NCT00120757|Alendronate|alendronate|mesh-list
138497902|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138497903|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497904|NCT00120796|Lamivudine|lamivudine|mesh-list
138497905|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138497906|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138497907|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497908|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497909|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
138497910|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497911|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138497912|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138497913|NCT00120835|Interferons|interferons|mesh-list
138497914|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497915|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
138497916|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497917|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
138497918|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138497919|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138497920|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
138497921|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138174407|NCT00699491|Sirolimus|sirolimus|mesh-list
138497922|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497923|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
138497924|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
138497925|NCT00121030|Hematinics|hematinics|mesh-ancestor
138497926|NCT00121069|Escitalopram|escitalopram|mesh-list
138497927|NCT00121069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138497928|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138497929|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138497930|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497931|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138497933|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497934|NCT00121147|Travoprost|travoprost|mesh-list
138497935|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138497936|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138497937|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138497938|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138497939|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138497940|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
138497941|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138497942|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497943|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497944|NCT00121264|Sorafenib|sorafenib|mesh-list
138497945|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497946|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138497947|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497948|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497949|NCT00121303|Cytarabine|cytarabine|mesh-list
138497950|NCT00121303|Daunorubicin|daunorubicin|mesh-list
138497951|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
138497952|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138497953|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
138497954|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497955|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497956|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
138497957|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497958|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138497959|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
138497960|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497961|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138497962|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138497963|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138497964|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497965|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138497966|NCT00121303|Immunotoxins|immunotoxins|mesh-ancestor
138497967|NCT00121303|Immunoconjugates|immunoconjugates|mesh-ancestor
138497968|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
138497969|NCT00121381|Tacrolimus|tacrolimus|mesh-list
138497970|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138497971|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138497972|NCT00121381|Analgesics|analgesics|mesh-ancestor
138497973|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
138497974|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138497975|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497976|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138497977|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138497978|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
138497979|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138497980|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
138497981|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138497982|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138497983|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138497984|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
138497985|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497986|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138497987|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
138497988|NCT00121459|Psyllium|psyllium|mesh-list
138497989|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
138497990|NCT00121459|Cathartics|cathartics|mesh-ancestor
138497991|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138497992|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
138497993|NCT00121498|Lidocaine|lidocaine|mesh-list
138497994|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
138497995|NCT00121498|Anesthetics|anesthetics|mesh-list
138497996|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138497997|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497998|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
138497999|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498000|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138498001|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138498002|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138498003|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138498004|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498006|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138498007|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138498008|NCT00121615|Analgesics|analgesics|mesh-ancestor
138498009|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
138498010|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498011|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498012|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138498013|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138498014|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138498015|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498016|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
138498017|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138498018|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498019|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138498020|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498021|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498023|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
138498024|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
138498025|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138498026|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498027|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
138498028|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498029|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
138498030|NCT04705948|Ketamine|ketamine|mesh-list
138498031|NCT04705948|Analgesics|analgesics|mesh-ancestor
138498032|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
138498033|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498034|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498035|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138498036|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138498037|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
138498038|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
138498039|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138498040|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138498041|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138498042|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498043|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498044|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138498045|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
138498046|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138498047|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138498048|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138498049|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
138498050|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138498051|NCT00121888|Paroxetine|paroxetine|mesh-list
138498052|NCT00121888|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138498053|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138498054|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138498055|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327468|NCT00242502|Growth Substances|growth substances|mesh-ancestor
138498056|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498057|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
138498058|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498059|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138526712|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138498060|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
138498061|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138498062|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138498063|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138498064|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498065|NCT00121966|Insulin|insulin|mesh-list
138498066|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138498067|NCT00121966|Metformin|metformin|mesh-list
138498068|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
138498069|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
138498070|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
138498071|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
138498072|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
138498073|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138498074|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498075|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
138498076|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138498077|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138498078|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138498079|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138498080|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
138498081|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498082|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498083|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498084|NCT02013492|Propranolol|propranolol|mesh-list
138498085|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138318719|NCT01395888|Xhance|xhance|mesh-list
138498087|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
138498088|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498089|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498090|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498091|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138498092|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138498093|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
138498094|NCT00122356|Alendronate|alendronate|mesh-list
138498095|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138498096|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498097|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
138498098|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138498099|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
138498100|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498101|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498102|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138498103|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
138498104|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
138498105|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138498106|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
138498107|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498108|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498109|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
138498110|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498111|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138498112|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498113|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498115|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
138498116|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498117|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138498118|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138498119|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498120|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498121|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138498122|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138498123|NCT01720407|Imiquimod|imiquimod|mesh-list
138498124|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138498125|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
138498126|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498127|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498128|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
138498129|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138498130|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
138498131|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498132|NCT00122590|Ritonavir|ritonavir|mesh-list
138498133|NCT00122590|Lopinavir|lopinavir|mesh-list
138498134|NCT00122590|Nelfinavir|nelfinavir|mesh-list
138498135|NCT00122590|Indinavir|indinavir|mesh-list
138498136|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138498137|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138498138|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
138498139|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498140|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498141|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138498142|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138498143|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
138526771|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138498144|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498145|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138498146|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138498148|NCT00122629|Ribavirin|ribavirin|mesh-list
138498149|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
138498150|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
138498151|NCT00122629|Amantadine|amantadine|mesh-list
138498152|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138498153|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498155|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498156|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
138498157|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498158|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
138498159|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498160|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138498161|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138498162|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
138498163|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498164|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138498165|NCT00122629|Analgesics|analgesics|mesh-ancestor
138498166|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
138498167|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498168|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138498169|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
138498170|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
138498171|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138498172|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498173|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498174|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
138498175|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498176|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138498177|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138498178|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138498179|NCT05637164|Norepinephrine|norepinephrine|mesh-list
138498180|NCT05637164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138498181|NCT05637164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138498182|NCT05637164|Adrenergic Agents|adrenergic agents|mesh-ancestor
138498183|NCT05637164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498184|NCT05637164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498185|NCT05637164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498186|NCT05637164|Sympathomimetics|sympathomimetics|mesh-ancestor
138498187|NCT05637164|Autonomic Agents|autonomic agents|mesh-ancestor
138498188|NCT05637164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498189|NCT05637164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138498190|NCT00129337|Bavituximab|bavituximab|mesh-list
138498191|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138498192|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498193|NCT00129298|Tiagabine|tiagabine|mesh-list
138498194|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
138498195|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
138498196|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138498197|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138498198|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498199|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
138498200|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498201|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498202|NCT00129181|Levodopa|levodopa|mesh-list
138498203|NCT00129181|Carbidopa|carbidopa|mesh-list
138498204|NCT00129181|Cabergoline|cabergoline|mesh-list
138498205|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138498206|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138327556|NCT00134004|Tacrolimus|tacrolimus|mesh-list
138498207|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138498208|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
138498209|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498210|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498211|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498212|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138498213|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498214|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
138498215|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138498216|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
138498217|NCT00129142|Toremifene|toremifene|mesh-list
138498218|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138498219|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498220|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138498221|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138498222|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
138174679|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138498223|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138498224|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498225|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138498227|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138498228|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498229|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138498230|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
138498231|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138498232|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498233|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498234|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498236|NCT00819780|Panitumumab|panitumumab|mesh-list
138498237|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138498238|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498239|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138498240|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138498241|NCT00819780|Growth Substances|growth substances|mesh-ancestor
138498242|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498243|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
138498244|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138498245|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
138498246|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498247|NCT00128791|Nitroprusside|nitroprusside|mesh-list
138498248|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138498249|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
138498250|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138498251|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498252|NCT00128752|Beta Carotene|beta carotene|mesh-list
138498253|NCT00128752|Carotenoids|carotenoids|mesh-list
138498254|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
138498255|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498256|NCT00128752|Protective Agents|protective agents|mesh-ancestor
138498257|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498258|NCT00128752|Provitamins|provitamins|mesh-ancestor
138498259|NCT00128752|Vitamins|vitamins|mesh-ancestor
138498261|NCT00063414|Alicaforsen|alicaforsen|mesh-list
138498262|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138498263|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498264|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
138498265|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498266|NCT05638451|Bevacizumab|bevacizumab|mesh-list
138498267|NCT05638451|Temozolomide|temozolomide|mesh-list
138498268|NCT05638451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138498269|NCT05638451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498270|NCT05638451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138498271|NCT05638451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138498272|NCT05638451|Growth Substances|growth substances|mesh-ancestor
138498273|NCT05638451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498274|NCT05638451|Growth Inhibitors|growth inhibitors|mesh-ancestor
138498275|NCT05638451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138498276|NCT05638451|Alkylating Agents|alkylating agents|mesh-ancestor
138498277|NCT05638451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498278|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138498279|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
138498280|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
138498281|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498282|NCT05638763|Ketoconazole|ketoconazole|mesh-list
138498284|NCT05638763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498285|NCT05638763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138498286|NCT05638763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498287|NCT05638763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498288|NCT05638763|Antifungal Agents|antifungal agents|mesh-ancestor
138498289|NCT05638763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498290|NCT05638763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138498291|NCT05638763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138498292|NCT05638763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138498293|NCT05638763|Hormone Antagonists|hormone antagonists|mesh-ancestor
138711076|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527010|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138498294|NCT05638763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138498295|NCT05638763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498296|NCT05638763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138498297|NCT00128635|Antibodies|antibodies|mesh-list
138498298|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138498300|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498301|NCT00009048|Levodopa|levodopa|mesh-list
138498302|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138498303|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138498304|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
138498305|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498306|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498307|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498309|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498310|NCT00128557|Vitamin A|vitamin a|mesh-list
138498311|NCT00128557|Vitamins|vitamins|mesh-ancestor
138498312|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
138498313|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498314|NCT00128518|Perindopril|perindopril|mesh-list
138498315|NCT00128518|Indapamide|indapamide|mesh-list
138327597|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
138498316|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138498317|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
138498318|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498319|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498320|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138498321|NCT00128518|Diuretics|diuretics|mesh-ancestor
138498322|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
138498323|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527047|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498324|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138498325|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138498326|NCT00009204|Perphenazine|perphenazine|mesh-list
138498328|NCT00009204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138498329|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138498330|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138498331|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498332|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498333|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
138498334|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498335|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138498336|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
138498337|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138498338|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138498339|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138498340|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138498341|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138498342|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
138498343|NCT00394459|Anesthetics|anesthetics|mesh-list
138498344|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138498345|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498346|NCT00394498|Lenograstim|lenograstim|mesh-list
138498347|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138498348|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
138498349|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498351|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138498352|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138498353|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
138498354|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138527091|NCT00423696|Capecitabine|capecitabine|mesh-list
138498355|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498356|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498357|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138498358|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
138498359|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
138498360|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498361|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138498362|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138498363|NCT00009555|Testosterone|testosterone|mesh-list
138498364|NCT00009555|Androgens|androgens|mesh-ancestor
138498365|NCT00009555|Hormones|hormones|mesh-ancestor
138498366|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138498367|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498368|NCT00128479|Mifepristone|mifepristone|mesh-list
138498369|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138498370|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
138498371|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138498372|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498373|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138498374|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138498375|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138498376|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
138498377|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138527137|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
138498378|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138498379|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
138498380|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138498381|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
138498382|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138498383|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138498384|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
138498385|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138498386|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
138498387|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498388|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498389|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138498390|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
138498391|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
138498392|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138498393|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
138498394|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498395|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498396|NCT00128401|Cycloserine|cycloserine|mesh-list
138498397|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138498398|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498399|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138498400|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
138498401|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138498402|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
138498403|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498405|NCT00128323|Gentian Violet|gentian violet|mesh-list
138498406|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138498407|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138498408|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498409|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
138498410|NCT00128323|Ionophores|ionophores|mesh-ancestor
138498411|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138498412|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498413|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138498416|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138498417|NCT00009672|Narcotics|narcotics|mesh-ancestor
138527189|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138527201|NCT00029861|Hormones|hormones|mesh-ancestor
138498418|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138498419|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498420|NCT00009672|Analgesics|analgesics|mesh-ancestor
138498421|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
138498422|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498423|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138498424|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
138498425|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138498426|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138498427|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138498428|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138498429|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498430|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
138686806|NCT03403569|Triptolide|triptolide|mesh-list
138498431|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498432|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138498434|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138498435|NCT00018733|Paroxetine|paroxetine|mesh-list
138498436|NCT00018733|Desipramine|desipramine|mesh-list
138498437|NCT00018733|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138498438|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138498439|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138498440|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498441|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498442|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
138498443|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498444|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138498445|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
138498446|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138498447|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138498448|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138498449|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498450|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138498451|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138498452|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
138498454|NCT00018850|Ondansetron|ondansetron|mesh-list
138498455|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
138527225|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
138527227|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498456|NCT00018850|Nicotine|nicotine|mesh-list
138498457|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138498458|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
138498459|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498460|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498461|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138498462|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138498463|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
138498464|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138498465|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498466|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
138498467|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138498468|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
138498469|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
138686837|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138498470|NCT00018850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138498471|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138498472|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
138498473|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138498474|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138498475|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138498476|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138498477|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138498478|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
138527261|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
138498479|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138498480|NCT00009750|Cyclosporine|cyclosporine|mesh-list
138498481|NCT00009750|Paclitaxel|paclitaxel|mesh-list
138498482|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138498483|NCT00009750|Antibodies|antibodies|mesh-list
138498484|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
138498485|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138498486|NCT00009750|Cyclosporins|cyclosporins|mesh-list
138498487|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138498488|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498489|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
138498490|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
138498491|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
138498492|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498493|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
138498494|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498495|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498496|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498497|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
138498498|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498499|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
138498500|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138498501|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138498502|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
138498503|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138498504|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
138498505|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498507|NCT00019084|Vaccines|vaccines|mesh-list
138498508|NCT00019084|Sargramostim|sargramostim|mesh-list
138498509|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
138498510|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498511|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498512|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138498513|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138498514|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
138498515|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498516|NCT00019123|Thalidomide|thalidomide|mesh-list
138498517|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498518|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
138498519|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498520|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
138498521|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138498522|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498523|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138498524|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138498525|NCT00019123|Growth Substances|growth substances|mesh-ancestor
138498526|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
138498527|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498529|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
138498530|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498531|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498532|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327679|NCT05266716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498533|NCT00019357|Aldesleukin|aldesleukin|mesh-list
138498534|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498535|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138498536|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138498537|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
138498538|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527348|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527349|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
138527350|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138527351|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
138527352|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527353|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
138527354|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527355|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
138527356|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138498539|NCT00019396|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138498540|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
138498541|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138498542|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
138498543|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498544|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138498545|NCT00019396|Protective Agents|protective agents|mesh-ancestor
138498546|NCT00009828|Leucovorin|leucovorin|mesh-list
138498547|NCT00009828|Paclitaxel|paclitaxel|mesh-list
138498548|NCT00009828|Tegafur|tegafur|mesh-list
138498549|NCT00009828|Calcium|calcium|mesh-list
138498550|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
138498551|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138498552|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498553|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
138498554|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
138498555|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
138686904|NCT02941913|Palonosetron|palonosetron|mesh-list
138498556|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498557|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138498558|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498559|NCT00009828|Antidotes|antidotes|mesh-ancestor
138498560|NCT00009828|Protective Agents|protective agents|mesh-ancestor
138498561|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
138498562|NCT00009828|Vitamins|vitamins|mesh-ancestor
138498563|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
138498564|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498565|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
138498566|NCT00019435|Immunotoxins|immunotoxins|mesh-list
138498567|NCT00019435|Immunoconjugates|immunoconjugates|mesh-ancestor
138498568|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
138498569|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498570|NCT00019474|Interferons|interferons|mesh-list
138498571|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
138498572|NCT00019474|Fluorouracil|fluorouracil|mesh-list
138498573|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
138498574|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
138498575|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527393|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138498576|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498577|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498578|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498579|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
138498580|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498582|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498583|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
138498584|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498585|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138498587|NCT00019513|Gemcitabine|gemcitabine|mesh-list
138498588|NCT00019513|Fluorouracil|fluorouracil|mesh-list
138498589|NCT00019513|Calcium|calcium|mesh-list
138498590|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
138498591|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498592|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
138498593|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498594|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138175066|NCT00240097|Carboplatin|carboplatin|mesh-list
138498595|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138498596|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498597|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498598|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
138498599|NCT00019513|Antidotes|antidotes|mesh-ancestor
138498600|NCT00019513|Protective Agents|protective agents|mesh-ancestor
138498601|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
138498602|NCT00019513|Vitamins|vitamins|mesh-ancestor
138527438|NCT00030797|Irinotecan|irinotecan|mesh-list
138498603|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
138498604|NCT00019552|Irofulven|irofulven|mesh-list
138498605|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138498606|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
138498607|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498608|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498609|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
138498610|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498611|NCT00019591|Aldesleukin|aldesleukin|mesh-list
138498612|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498613|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138498614|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138498615|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
138498616|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498617|NCT00019630|Doxorubicin|doxorubicin|mesh-list
138498618|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138498619|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138498620|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498621|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138498622|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138498623|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498624|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498625|NCT00019669|Aldesleukin|aldesleukin|mesh-list
138498626|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498627|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138498628|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138498629|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
138498630|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498631|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
138498632|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498633|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138498634|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498635|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498637|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138498638|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
138498639|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498640|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498641|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138498642|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498643|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
138498644|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498645|NCT00019825|Decitabine|decitabine|mesh-list
138498646|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498647|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
138498648|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498649|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498650|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498651|NCT00019864|Leucovorin|leucovorin|mesh-list
138498652|NCT00019864|Doxorubicin|doxorubicin|mesh-list
138498653|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138498654|NCT00019864|Methotrexate|methotrexate|mesh-list
138498655|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
138498656|NCT00019864|Razoxane|razoxane|mesh-list
138498657|NCT00019864|Calcium|calcium|mesh-list
138498658|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
138498659|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498660|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138498661|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138498662|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138498663|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498664|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527522|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138498665|NCT00019864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138498666|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498667|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138498668|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
138498669|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138498670|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498671|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
138498672|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
138498673|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138175147|NCT00602225|Cytarabine|cytarabine|mesh-list
138498674|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498675|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
138498676|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138498677|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138498678|NCT00019864|Antidotes|antidotes|mesh-ancestor
138498679|NCT00019864|Protective Agents|protective agents|mesh-ancestor
138498680|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
138498681|NCT00019864|Vitamins|vitamins|mesh-ancestor
138498682|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
138498683|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138498684|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
138498685|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
138498686|NCT00020176|Cyclosporine|cyclosporine|mesh-list
138498687|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
138498688|NCT00020176|Fludarabine|fludarabine|mesh-list
138498689|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
138498690|NCT00020176|Cyclosporins|cyclosporins|mesh-list
138498691|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498692|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
138498693|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498694|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138498695|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138498696|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
138498697|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498698|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498699|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138498700|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498701|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
138498702|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498703|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
138498704|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498705|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
138498706|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138498707|NCT00020254|Aldesleukin|aldesleukin|mesh-list
138498708|NCT00020254|Nilutamide|nilutamide|mesh-list
138498709|NCT00020254|Vaccines|vaccines|mesh-list
138498710|NCT00020254|Sargramostim|sargramostim|mesh-list
138498711|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
138498712|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498713|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498714|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138498715|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138498716|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
138498717|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498718|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
138498719|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
138498720|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138498721|NCT00009984|Thalidomide|thalidomide|mesh-list
138527594|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498722|NCT00009984|Fludarabine|fludarabine|mesh-list
138498723|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
138498724|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498725|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498726|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
138498727|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498728|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498729|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
138498730|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498731|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
138498732|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138498733|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498734|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138498735|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138498736|NCT00009984|Growth Substances|growth substances|mesh-ancestor
138498737|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
138175202|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138175203|NCT00746395|Lubiprostone|lubiprostone|mesh-list
138175204|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138175205|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138175206|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175221|NCT01276067|Donepezil|donepezil|mesh-list
138175222|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138175223|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175224|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138175225|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
138175226|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175227|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175229|NCT04183868|Empagliflozin|empagliflozin|mesh-list
138498738|NCT00020332|Docetaxel|docetaxel|mesh-list
138498741|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
138498742|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
138498743|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
138498744|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498745|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
138498746|NCT00020332|Growth Substances|growth substances|mesh-ancestor
138687034|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
138498747|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498748|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138498749|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498751|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138498752|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
138498753|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498754|NCT00020410|Antibodies|antibodies|mesh-list
138498755|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138498756|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
138498757|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527669|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
138527670|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527671|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
138527673|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
138498758|NCT00020449|Paclitaxel|paclitaxel|mesh-list
138498759|NCT00020449|Doxorubicin|doxorubicin|mesh-list
138498760|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138498761|NCT00020449|Interleukin-12|interleukin-12|mesh-list
138498762|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138498763|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498764|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
138498765|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
138498766|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
138498767|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498768|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138498769|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138498770|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138498771|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498772|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138498773|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
138498774|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498775|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138498776|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138498777|NCT00020449|Growth Substances|growth substances|mesh-ancestor
138498778|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
138498779|NCT00010023|Capecitabine|capecitabine|mesh-list
138498780|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498781|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498782|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
138527718|NCT00031733|Interleukin-12|interleukin-12|mesh-list
138498783|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498785|NCT00020488|Fluorouracil|fluorouracil|mesh-list
138498786|NCT00020488|Irinotecan|irinotecan|mesh-list
138498787|NCT00020488|Calcium|calcium|mesh-list
138498788|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
138498789|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138498790|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498791|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
138498792|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498793|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138687046|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
138498794|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498795|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498796|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
138498797|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138498798|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138498799|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498800|NCT00020488|Antidotes|antidotes|mesh-ancestor
138498801|NCT00020488|Protective Agents|protective agents|mesh-ancestor
138498802|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
138498803|NCT00020488|Vitamins|vitamins|mesh-ancestor
138498804|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
138498805|NCT00020527|Caspofungin|caspofungin|mesh-list
138498806|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
138498807|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498808|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498809|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498810|NCT00020566|Dactinomycin|dactinomycin|mesh-list
138498811|NCT00020566|Doxorubicin|doxorubicin|mesh-list
138498812|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138498813|NCT00020566|Etoposide|etoposide|mesh-list
138498814|NCT00020566|Vincristine|vincristine|mesh-list
138498815|NCT00020566|Melphalan|melphalan|mesh-list
138498816|NCT00020566|Busulfan|busulfan|mesh-list
138498817|NCT00020566|Ifosfamide|ifosfamide|mesh-list
138498818|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138498819|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498820|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138498821|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138498822|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498823|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498824|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138498826|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
138498827|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
138498828|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138498829|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
138498830|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138498831|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498832|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
138498833|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498834|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138498835|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498836|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138498837|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138498838|NCT00010062|Fluorouracil|fluorouracil|mesh-list
138498839|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
138498840|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498841|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498842|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498843|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498844|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
138498845|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498846|NCT00020605|Naloxone|naloxone|mesh-list
138498847|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138498848|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498849|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
138498850|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498851|NCT00020644|Gemcitabine|gemcitabine|mesh-list
138498852|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498853|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
138498854|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498855|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498857|NCT00020761|Irinotecan|irinotecan|mesh-list
138498858|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138498859|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498860|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
138498861|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
138498862|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
138498863|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498864|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138498865|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138498866|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498868|NCT00020800|Fludarabine|fludarabine|mesh-list
138498869|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
138498870|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138498871|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498872|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
138498873|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498874|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138498875|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498876|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
138498877|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498878|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498879|NCT00020839|Temozolomide|temozolomide|mesh-list
138498880|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138498881|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
138498882|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498883|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498884|NCT00010140|Tamoxifen|tamoxifen|mesh-list
138498885|NCT00010140|Docetaxel|docetaxel|mesh-list
138498886|NCT00010140|Epirubicin|epirubicin|mesh-list
138498887|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498888|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
138498889|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
138498890|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
138692870|NCT00535860|Teriparatide|teriparatide|mesh-list
138498891|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498892|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138498893|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138498894|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138498895|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498896|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138527898|NCT00060255|Melphalan|melphalan|mesh-list
138498897|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
138318725|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498898|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138498900|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138498901|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138498902|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138498903|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138498905|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138498906|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138498907|NCT00020878|Analgesics|analgesics|mesh-ancestor
138498908|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
138498909|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138498910|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498911|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138498912|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138498913|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138498914|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138498915|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498916|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498917|NCT00020917|Leucovorin|leucovorin|mesh-list
138498918|NCT00020917|Fluorouracil|fluorouracil|mesh-list
138498919|NCT00020917|Irinotecan|irinotecan|mesh-list
138498920|NCT00020917|Cetuximab|cetuximab|mesh-list
138498921|NCT00020917|Calcium|calcium|mesh-list
138498922|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
138498923|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138498924|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498925|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
138498926|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498927|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498928|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498929|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498931|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138498932|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138498933|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498934|NCT00020917|Antidotes|antidotes|mesh-ancestor
138498935|NCT00020917|Protective Agents|protective agents|mesh-ancestor
138498936|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
138498937|NCT00020917|Vitamins|vitamins|mesh-ancestor
138498938|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
138498939|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138498940|NCT00021034|Taurolidine|taurolidine|mesh-list
138498941|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138498942|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138498943|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498944|NCT00010179|Lurtotecan|lurtotecan|mesh-list
138498945|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498946|NCT00021073|Leucovorin|leucovorin|mesh-list
138498947|NCT00021073|Fluorouracil|fluorouracil|mesh-list
138498948|NCT00021073|Irinotecan|irinotecan|mesh-list
138498949|NCT00021073|Alvocidib|alvocidib|mesh-list
138498950|NCT00021073|Calcium|calcium|mesh-list
138498951|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
138498952|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138498953|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498954|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
138498955|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498956|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498957|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498958|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498959|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
138498960|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138498961|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138498962|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498963|NCT00021073|Antidotes|antidotes|mesh-ancestor
138498964|NCT00021073|Protective Agents|protective agents|mesh-ancestor
138498965|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
138498967|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
138498968|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
138498969|NCT00021073|Growth Substances|growth substances|mesh-ancestor
138498970|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138498971|NCT00021112|Etoposide|etoposide|mesh-list
138498972|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498973|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138498975|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138498976|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498977|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498978|NCT00000122|Fluorouracil|fluorouracil|mesh-list
138498979|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
138498980|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498981|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138498982|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498983|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138498984|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
138498985|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498986|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
138498987|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138498988|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498989|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
138498990|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498991|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
138498992|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498993|NCT00021307|Carboplatin|carboplatin|mesh-list
138498994|NCT00021307|Temozolomide|temozolomide|mesh-list
138327904|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
138498996|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138498997|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
138498998|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498999|NCT00021346|Carboplatin|carboplatin|mesh-list
138499000|NCT00021346|Gemcitabine|gemcitabine|mesh-list
138499001|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499002|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138499003|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
138499004|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499005|NCT00021385|Squalamine|squalamine|mesh-list
138499006|NCT00021385|Carboplatin|carboplatin|mesh-list
138499007|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499008|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138499009|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499010|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138499011|NCT00021385|Protective Agents|protective agents|mesh-ancestor
138499012|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687161|NCT06025825|Lidocaine|lidocaine|mesh-list
138499013|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138499014|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138499015|NCT00021385|Growth Substances|growth substances|mesh-ancestor
138499016|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
138499018|NCT00021463|Zidovudine|zidovudine|mesh-list
138499019|NCT00021463|Efavirenz|efavirenz|mesh-list
138499020|NCT00021463|Nevirapine|nevirapine|mesh-list
138499021|NCT00021463|Abacavir|abacavir|mesh-list
138499022|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
138499023|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138499024|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138499025|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499026|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499027|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
138499028|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499029|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138499030|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138499031|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
138528127|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138528128|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138499032|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138499033|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138499034|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138499035|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138499036|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138499037|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138499038|NCT00021502|Chrysarobin|chrysarobin|mesh-list
138499039|NCT00021502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138499040|NCT00021502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138499041|NCT00021502|Analgesics|analgesics|mesh-ancestor
138499042|NCT00021502|Sensory System Agents|sensory system agents|mesh-ancestor
138499043|NCT00021502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499044|NCT00021502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499045|NCT00021502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138499046|NCT00021502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138499047|NCT00000134|Ganciclovir|ganciclovir|mesh-list
138499049|NCT00000134|Foscarnet|foscarnet|mesh-list
138499050|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
138499051|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499052|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138499054|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499055|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138499056|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
138499057|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499058|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
138499059|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499060|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138499061|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138499062|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
138499063|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499064|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499065|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138499066|NCT00010452|Picibanil|picibanil|mesh-list
138528151|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
138499067|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499068|NCT00394693|Interferons|interferons|mesh-list
138499069|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
138499070|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499071|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
138499072|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499073|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
138499074|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499075|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
138499076|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
138499077|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
138692918|NCT05312866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138499078|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499080|NCT00021814|Finasteride|finasteride|mesh-list
138499081|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138499082|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138499083|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499084|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499085|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
138499086|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138499087|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528192|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528194|NCT00061113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138528195|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138528218|NCT00033566|S 3304|s 3304|mesh-list
138499088|NCT00021814|Urological Agents|urological agents|mesh-ancestor
138499089|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138499090|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138499091|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138499092|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138499093|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
138499094|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138499095|NCT00019318|Romidepsin|romidepsin|mesh-list
138499096|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138499097|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528234|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138528235|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138528236|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138528237|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528238|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499098|NCT00019318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138499099|NCT00019318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499100|NCT00019318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499101|NCT00022009|Gemcitabine|gemcitabine|mesh-list
138499102|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138499103|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
138499104|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499105|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499106|NCT00388661|Melatonin|melatonin|mesh-list
138499107|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
138499108|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499109|NCT00388661|Protective Agents|protective agents|mesh-ancestor
138499110|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499111|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138499112|NCT00022048|Bevacizumab|bevacizumab|mesh-list
138327932|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
138499113|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138499114|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499115|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138499116|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138499117|NCT00022048|Growth Substances|growth substances|mesh-ancestor
138499118|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499119|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
138499120|NCT00022087|Vitamin D|vitamin d|mesh-list
138499121|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
138499122|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
138499123|NCT00022087|Calcium|calcium|mesh-list
138499124|NCT00022087|Vitamins|vitamins|mesh-ancestor
138499125|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
138499126|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499127|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138499128|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138499129|NCT00388700|Leucovorin|leucovorin|mesh-list
138499130|NCT00388700|Bevacizumab|bevacizumab|mesh-list
138499131|NCT00388700|Fluorouracil|fluorouracil|mesh-list
138499132|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138499133|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499134|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138499135|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138499136|NCT00388700|Growth Substances|growth substances|mesh-ancestor
138499137|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499138|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
138499139|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
138499140|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499141|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138499142|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499143|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
138499144|NCT00388700|Antidotes|antidotes|mesh-ancestor
138499145|NCT00388700|Protective Agents|protective agents|mesh-ancestor
138499146|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
138499147|NCT00388700|Vitamins|vitamins|mesh-ancestor
138499148|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
138499149|NCT00022126|Cytarabine|cytarabine|mesh-list
138499150|NCT00022126|Cyclosporine|cyclosporine|mesh-list
138499151|NCT00022126|Dexamethasone|dexamethasone|mesh-list
138499152|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
138499153|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
138687250|NCT06025214|Xhance|xhance|mesh-list
138499155|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138499156|NCT00022126|Methotrexate|methotrexate|mesh-list
138499157|NCT00022126|Vincristine|vincristine|mesh-list
138499158|NCT00022126|Daunorubicin|daunorubicin|mesh-list
138499159|NCT00022126|Asparaginase|asparaginase|mesh-list
138499160|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
138499161|NCT00022126|Pegaspargase|pegaspargase|mesh-list
138499162|NCT00022126|Thioguanine|thioguanine|mesh-list
138499163|NCT00022126|Cyclosporins|cyclosporins|mesh-list
138499164|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499165|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
138499166|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499167|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138499168|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138499169|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
138499170|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499171|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499172|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138499173|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138528399|NCT00396500|Vitamins|vitamins|mesh-ancestor
138528400|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
138528401|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528402|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528403|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528404|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
138499174|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
138499175|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
138499176|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499177|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138528405|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138499178|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
138499179|NCT00022126|Hormones|hormones|mesh-ancestor
138499180|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138327944|NCT00353652|Spironolactone|spironolactone|mesh-list
138499181|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138499182|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138499183|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138499184|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138499185|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499186|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138499187|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
138499188|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138499189|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138499190|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
138499191|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
138499192|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138499193|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138687269|NCT06025214|Hormones|hormones|mesh-ancestor
138499194|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
138499195|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499196|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138499197|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
138499198|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
138499199|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
138499200|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
138499201|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138499202|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138499203|NCT00022126|Protective Agents|protective agents|mesh-ancestor
138499204|NCT00022165|Selenium|selenium|mesh-list
138499205|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
138499206|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499207|NCT00022165|Protective Agents|protective agents|mesh-ancestor
138499208|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499209|NCT00022165|Trace Elements|trace elements|mesh-ancestor
138499210|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
138499211|NCT00022204|Vitamin E|vitamin e|mesh-list
138499212|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
138499213|NCT00022204|Vitamins|vitamins|mesh-ancestor
138499214|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
138499215|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499216|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
138499217|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499218|NCT00022204|Protective Agents|protective agents|mesh-ancestor
138499219|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138499220|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499221|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138499222|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138499223|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
138499224|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138499225|NCT00388739|Prednisolone|prednisolone|mesh-list
138499226|NCT00388739|Budesonide|budesonide|mesh-list
138499227|NCT00388739|Albuterol|albuterol|mesh-list
138499228|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138499229|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
138499230|NCT00388739|Hormones|hormones|mesh-ancestor
138499231|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138499232|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499233|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138327956|NCT02982798|Metformin|metformin|mesh-list
138499234|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499235|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
138499236|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499237|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138499238|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138499239|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
138499240|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
138499241|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138499242|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138499243|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138499244|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138499245|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
138499246|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138499247|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499248|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
138499249|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138499250|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499251|NCT00022321|Immunotoxins|immunotoxins|mesh-ancestor
138499252|NCT00022321|Immunoconjugates|immunoconjugates|mesh-ancestor
138499253|NCT00022321|Immunologic Factors|immunologic factors|mesh-ancestor
138499254|NCT00022321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499255|NCT00022360|Taurolidine|taurolidine|mesh-list
138499256|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499257|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138499258|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499259|NCT00022399|Celecoxib|celecoxib|mesh-list
138499260|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138499261|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138499262|NCT00022399|Analgesics|analgesics|mesh-ancestor
138499263|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
138499264|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499265|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499266|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138499267|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138499268|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138499269|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138175734|NCT01278745|Rituximab|rituximab|mesh-list
138528711|NCT00035321|Fluoxetine|fluoxetine|mesh-list
138528712|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
138528713|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
138528714|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528715|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528716|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138528717|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138528718|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138528719|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138528720|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138528721|NCT00035321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138528722|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138528723|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138528724|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528725|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528726|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
138528727|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138528728|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
138528729|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138528730|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138528731|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499270|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499271|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499272|NCT00000143|Ganciclovir|ganciclovir|mesh-list
138499273|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138499274|NCT00000143|Cidofovir|cidofovir|mesh-list
138499275|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
138499276|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499277|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138499278|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499279|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499280|NCT00022438|Aldesleukin|aldesleukin|mesh-list
138499281|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
138499282|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499283|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138499284|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138499285|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
138499286|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499287|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138499288|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
138499289|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687326|NCT06024746|Empagliflozin|empagliflozin|mesh-list
138499290|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
138499291|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138499292|NCT00010686|Estrogens|estrogens|mesh-ancestor
138499293|NCT00010686|Hormones|hormones|mesh-ancestor
138327978|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138499294|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138499295|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499296|NCT00022555|Vincristine|vincristine|mesh-list
138499297|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
138499298|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138499299|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499300|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
138499301|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
138499302|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
138499303|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499304|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138499305|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
138499306|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528793|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138499308|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
138499309|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138499310|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138499311|NCT00000146|Prednisolone|prednisolone|mesh-list
138499312|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
138499313|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138499314|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
138499315|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138499316|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
138499317|NCT00000146|Hormones|hormones|mesh-ancestor
138499318|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138499319|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528839|NCT00036179|Micafungin|micafungin|mesh-list
138528840|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
138499320|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138499321|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499322|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
138499323|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
138499324|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499325|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138499326|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138499327|NCT00000146|Protective Agents|protective agents|mesh-ancestor
138499328|NCT00010725|Vitamins|vitamins|mesh-list
138499329|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
138499330|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499331|NCT00022594|Lurtotecan|lurtotecan|mesh-list
138499332|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528904|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
138499333|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138499334|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138528905|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528906|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528907|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138499335|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
138499336|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138499337|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499338|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499339|NCT00022711|Temozolomide|temozolomide|mesh-list
138499340|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138499341|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
138499342|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499343|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499344|NCT00010842|Vitamin E|vitamin e|mesh-list
138499345|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
138499346|NCT00010842|Selenium|selenium|mesh-list
138499347|NCT00010842|Vitamins|vitamins|mesh-ancestor
138499348|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
138499349|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528962|NCT02967432|Petrolatum|petrolatum|mesh-list
138499351|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499352|NCT00010842|Protective Agents|protective agents|mesh-ancestor
138499353|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
138499354|NCT00010842|Trace Elements|trace elements|mesh-ancestor
138499355|NCT00000152|Aspirin|aspirin|mesh-list
138499356|NCT00000152|Beta Carotene|beta carotene|mesh-list
138499357|NCT00000152|Carotenoids|carotenoids|mesh-list
138499358|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138499359|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138499360|NCT00000152|Analgesics|analgesics|mesh-ancestor
138499361|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
138499362|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499363|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499364|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138529028|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
138499365|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138499366|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138499367|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138499368|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499369|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138499370|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138499371|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499372|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
138499373|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
138499374|NCT00000152|Protective Agents|protective agents|mesh-ancestor
138499375|NCT00000152|Provitamins|provitamins|mesh-ancestor
138499376|NCT00000152|Vitamins|vitamins|mesh-ancestor
138499377|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
138499378|NCT00010881|Antioxidants|antioxidants|mesh-list
138499379|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499380|NCT00010881|Protective Agents|protective agents|mesh-ancestor
138499381|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499382|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
138499383|NCT00022906|Antibodies|antibodies|mesh-list
138499384|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
138499385|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499386|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499387|NCT00022945|Prednisone|prednisone|mesh-list
138499388|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
138499389|NCT00022945|Doxorubicin|doxorubicin|mesh-list
138499390|NCT00022945|Vincristine|vincristine|mesh-list
138499391|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
138499392|NCT00022945|Antibodies|antibodies|mesh-list
138499393|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499394|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
138499395|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499396|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138499397|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138499398|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
138499399|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499400|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499401|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138499402|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138529145|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
138499403|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138499404|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138499405|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499406|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138499407|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
138499409|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138499410|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138499411|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138499412|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
138499413|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
138499414|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
138499416|NCT00023218|Lopinavir|lopinavir|mesh-list
138499417|NCT00023218|Efavirenz|efavirenz|mesh-list
138499418|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138499419|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138499420|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
138499421|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499422|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499423|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138499424|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138499425|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
138499426|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499427|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138499428|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138499429|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138499430|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138499431|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138499432|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138499433|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138499434|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138499435|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138499436|NCT00394966|Rolapitant|rolapitant|mesh-list
138499437|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138499438|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138499439|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499440|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499441|NCT00000170|Atropine|atropine|mesh-list
138499442|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138499443|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138499444|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138499445|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
138499446|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499447|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499448|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138499449|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
138499450|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
138499451|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
138499452|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138499453|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138499454|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
138499455|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138499456|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499457|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
138499458|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138499459|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
138499460|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529288|NCT00396578|Vancomycin|vancomycin|mesh-list
138499461|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499462|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138499463|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
138499464|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138499465|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
138499466|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499467|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138499468|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138499469|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
138499470|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
138499471|NCT00023296|Protective Agents|protective agents|mesh-ancestor
138499473|NCT00023335|Rifapentine|rifapentine|mesh-list
138499474|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
138499475|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138499476|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499477|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138499478|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138499479|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
138711077|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138499480|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499481|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138499482|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138499483|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
138499484|NCT00000173|Vitamin E|vitamin e|mesh-list
138499485|NCT00000173|Donepezil|donepezil|mesh-list
138499486|NCT00000173|Vitamins|vitamins|mesh-ancestor
138499487|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
138499488|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499489|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138499490|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499491|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499492|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
138499493|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138499494|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
138499495|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
138499496|NCT00000173|Protective Agents|protective agents|mesh-ancestor
138499497|NCT00023374|Rifampin|rifampin|mesh-list
138499498|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
138499499|NCT00023374|Ethambutol|ethambutol|mesh-list
138499500|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138499501|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
138499502|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138499503|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499504|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
138499505|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138529466|NCT00070200|Melphalan|melphalan|mesh-list
138499506|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499507|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499508|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138499509|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138499510|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138499511|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138499512|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138499513|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138499514|NCT00023413|Efavirenz|efavirenz|mesh-list
138499515|NCT00023413|Rifabutin|rifabutin|mesh-list
138499516|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138499517|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138499518|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499519|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499520|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
138499521|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499522|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138499523|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138499524|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138499525|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138499526|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138499527|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138499528|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138499529|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138499530|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
138499531|NCT00023530|Thalidomide|thalidomide|mesh-list
138499532|NCT00023530|Fluconazole|fluconazole|mesh-list
138499533|NCT00023530|Voriconazole|voriconazole|mesh-list
138499534|NCT00023530|Dexamethasone|dexamethasone|mesh-list
138499535|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138499536|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
138499537|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
138499538|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499539|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499540|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138499541|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
138499542|NCT00023530|Hormones|hormones|mesh-ancestor
138499543|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138499544|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138499545|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499546|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499547|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
138499548|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
138499549|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138499550|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499551|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138499552|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138499553|NCT00023530|Growth Substances|growth substances|mesh-ancestor
138499554|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
138499555|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
138499556|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138499557|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138499558|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499559|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499560|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138499561|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
138499562|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138499563|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138499564|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138499565|NCT00000176|Progesterone|progesterone|mesh-list
138499566|NCT00000176|Estrogens|estrogens|mesh-list
138499567|NCT00000176|Progestins|progestins|mesh-ancestor
138499568|NCT00000176|Hormones|hormones|mesh-ancestor
138693013|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
138499569|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138499570|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499571|NCT00000179|Haloperidol|haloperidol|mesh-list
138499573|NCT00000179|Trazodone|trazodone|mesh-list
138499574|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
138499576|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499577|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499578|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138499579|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138499580|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138499581|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138499582|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138499583|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138499584|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
138499585|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138499586|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499587|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138499588|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138499589|NCT00000179|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138499590|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138499591|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138529769|NCT00396929|Paclitaxel|paclitaxel|mesh-list
138499592|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
138499593|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138499594|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
138499596|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138499597|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138687466|NCT06019741|Aspirin|aspirin|mesh-list
138499599|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499600|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
138499601|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499602|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138499603|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499604|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499605|NCT00391404|Alendronate|alendronate|mesh-list
138499606|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138499607|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499608|NCT00000191|Carbamazepine|carbamazepine|mesh-list
138499609|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
138499610|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
138499611|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138499612|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138499613|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499614|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138499615|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138499616|NCT00000191|Analgesics|analgesics|mesh-ancestor
138499617|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
138499618|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499619|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138499620|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138499621|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499622|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138499623|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138499624|NCT00023842|Mitomycins|mitomycins|mesh-list
138499625|NCT00023842|Mitomycin|mitomycin|mesh-list
138499626|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
138499627|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138499628|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499629|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
138499630|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499631|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138499632|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499633|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138499634|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
138499635|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499637|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138499638|NCT00000221|Narcotics|narcotics|mesh-ancestor
138499639|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711078|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
138499640|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499641|NCT00000221|Analgesics|analgesics|mesh-ancestor
138499642|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
138499643|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499644|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138499645|NCT00023881|Bortezomib|bortezomib|mesh-list
138499648|NCT00023920|Bevacizumab|bevacizumab|mesh-list
138499649|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138499650|NCT00023920|Idarubicin|idarubicin|mesh-list
138499651|NCT00023920|Antibodies|antibodies|mesh-list
138499652|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
138499653|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138499654|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499655|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138499656|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138499657|NCT00023920|Growth Substances|growth substances|mesh-ancestor
138499658|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499659|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
138499660|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
138499661|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138499662|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
138499663|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499664|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
138499665|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499666|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499667|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138499668|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138499669|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138499670|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499671|NCT00023959|Bevacizumab|bevacizumab|mesh-list
138693047|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499672|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138499673|NCT00023959|Fluorouracil|fluorouracil|mesh-list
138499674|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
138499675|NCT00023959|Antibodies|antibodies|mesh-list
138499676|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
138499677|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138499678|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499679|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138499680|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138499681|NCT00023959|Growth Substances|growth substances|mesh-ancestor
138499682|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499683|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
138499684|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
138499685|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
138499686|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499687|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138499688|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499689|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
138499690|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499691|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138499692|NCT00023998|Leucovorin|leucovorin|mesh-list
138499693|NCT00023998|Doxorubicin|doxorubicin|mesh-list
138499694|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138499695|NCT00023998|Methotrexate|methotrexate|mesh-list
138499696|NCT00023998|Trastuzumab|trastuzumab|mesh-list
138499697|NCT00023998|Etoposide|etoposide|mesh-list
138499698|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
138499699|NCT00023998|Ifosfamide|ifosfamide|mesh-list
138499700|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
138499701|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499702|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138499703|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138499704|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138499705|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545736|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138499706|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499707|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499708|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138499709|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
138499710|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138499711|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138499712|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
138499713|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
138499714|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138499715|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499716|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
138499717|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138499718|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138499719|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138499721|NCT00023998|Antidotes|antidotes|mesh-ancestor
138499722|NCT00023998|Protective Agents|protective agents|mesh-ancestor
138499723|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
138499724|NCT00023998|Vitamins|vitamins|mesh-ancestor
138499725|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
138499726|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138499728|NCT00024115|Antibodies|antibodies|mesh-list
138499729|NCT00024115|Immunotoxins|immunotoxins|mesh-list
138499730|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
138499731|NCT00024115|Immunomodulating Agents|immunomodulating agents|mesh-list
138499732|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499733|NCT00024115|Immunoconjugates|immunoconjugates|mesh-ancestor
138499734|NCT00024154|Trastuzumab|trastuzumab|mesh-list
138499735|NCT00024154|Gefitinib|gefitinib|mesh-list
138499736|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138499737|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499738|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138499739|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499740|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499741|NCT00011076|Pirfenidone|pirfenidone|mesh-list
138499742|NCT00011076|Analgesics|analgesics|mesh-ancestor
138499743|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
138499744|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499745|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499746|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138499747|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138499748|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138499749|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138499750|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499752|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
138499753|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
138499754|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138499755|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499756|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499757|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
138499758|NCT00024193|Melphalan|melphalan|mesh-list
138499759|NCT00024193|Busulfan|busulfan|mesh-list
138499760|NCT00024193|Doxorubicin|doxorubicin|mesh-list
138499761|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138499762|NCT00024193|Etoposide|etoposide|mesh-list
138499763|NCT00024193|Vincristine|vincristine|mesh-list
138499764|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499765|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
138499766|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499767|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138499768|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138499769|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
138499770|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499771|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499772|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138499773|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138499774|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138499775|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138499776|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499777|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138499778|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
138499779|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
138499780|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
138499782|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138499783|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
138499784|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499785|NCT00024271|Interferons|interferons|mesh-list
138499786|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
138499787|NCT00024271|Gemcitabine|gemcitabine|mesh-list
138499788|NCT00024271|Doxorubicin|doxorubicin|mesh-list
138499789|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138499790|NCT00024271|Mitomycins|mitomycins|mesh-list
138499791|NCT00024271|Mitomycin|mitomycin|mesh-list
138499792|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499793|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138499794|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
138499795|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499796|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138499797|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138499798|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138499799|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499801|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499802|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
138499803|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138499804|NCT00024310|Folic Acid|folic acid|mesh-list
138499805|NCT00024310|Paclitaxel|paclitaxel|mesh-list
138499806|NCT00024310|Lometrexol|lometrexol|mesh-list
138499807|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138499808|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499809|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
138499810|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
138499811|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
138499812|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499813|NCT00024310|Hematinics|hematinics|mesh-ancestor
138499814|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
138499815|NCT00024310|Vitamins|vitamins|mesh-ancestor
138499816|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
138499817|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499818|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138499819|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
138499820|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138499821|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499822|NCT00024349|Fluorouracil|fluorouracil|mesh-list
138499823|NCT00024349|Mitomycins|mitomycins|mesh-list
138499824|NCT00024349|Mitomycin|mitomycin|mesh-list
138499825|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
138499826|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499827|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138693137|NCT00536211|Metformin|metformin|mesh-list
138499828|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499829|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499830|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
138499831|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499832|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138499833|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
138499834|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138499835|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499836|NCT00000251|Isoflurane|isoflurane|mesh-list
138499837|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138499838|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
138499839|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
138499840|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138499841|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499842|NCT00024388|Paclitaxel|paclitaxel|mesh-list
138499843|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138499844|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499845|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
138499846|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
138499847|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
138499848|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499849|NCT00024427|Gemcitabine|gemcitabine|mesh-list
138499850|NCT00024427|Fluorouracil|fluorouracil|mesh-list
138499851|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138499852|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
138499853|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499854|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499855|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499856|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
138499857|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499858|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
138499859|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138499860|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
138499861|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
138499862|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138499863|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499864|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138499865|NCT00000257|Analgesics|analgesics|mesh-ancestor
138499866|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
138499868|NCT00024466|Vaccines|vaccines|mesh-list
138499869|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
138499870|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499871|NCT04733131|Abatacept|abatacept|mesh-list
138499872|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138499873|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499874|NCT04733131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138499876|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499877|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
138499878|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499880|NCT00024544|Antibodies|antibodies|mesh-list
138499881|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138499882|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
138499883|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499885|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138499886|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138499887|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
138499888|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499889|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499890|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138499891|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
138499892|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
138499893|NCT00395239|Hormones|hormones|mesh-ancestor
138499894|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138499895|NCT00025012|Isotretinoin|isotretinoin|mesh-list
138499896|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
138499897|NCT00025051|Celecoxib|celecoxib|mesh-list
138499898|NCT00025051|Mitogens|mitogens|mesh-list
138499899|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138499900|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138499901|NCT00025051|Analgesics|analgesics|mesh-ancestor
138499902|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
138499903|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138499904|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499905|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138499906|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138499907|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138499908|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138499909|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499910|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499911|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
138499912|NCT00025090|Fluorouracil|fluorouracil|mesh-list
138499913|NCT00025090|Mitomycins|mitomycins|mesh-list
138499914|NCT00025090|Mitomycin|mitomycin|mesh-list
138499915|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499916|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
138499917|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499918|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138499919|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530614|NCT00039611|Leucovorin|leucovorin|mesh-list
138499920|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
138499921|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499922|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138499923|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
138499924|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138499925|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499926|NCT00000368|Paroxetine|paroxetine|mesh-list
138499927|NCT00000368|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138499928|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138499929|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138499930|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499931|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138499932|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
138499933|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499934|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138499935|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
138499936|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138499937|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138693179|NCT04685642|Aspirin|aspirin|mesh-list
138499938|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138499939|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499941|NCT00025168|Irinotecan|irinotecan|mesh-list
138499942|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138499943|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
138499944|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499945|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499946|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138499947|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138499948|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499949|NCT00025207|Gefitinib|gefitinib|mesh-list
138499950|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499951|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138499952|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499953|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499955|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499956|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138499957|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499958|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499959|NCT00025285|Thalidomide|thalidomide|mesh-list
138499960|NCT00025285|Carboplatin|carboplatin|mesh-list
138499961|NCT00025285|Irinotecan|irinotecan|mesh-list
138499962|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499963|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138499964|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138499965|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499966|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499967|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499968|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
138499969|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499970|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
138499971|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138499972|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138499973|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138499974|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138499975|NCT00025285|Growth Substances|growth substances|mesh-ancestor
138499976|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
138499977|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
138499978|NCT00025324|Thiotepa|thiotepa|mesh-list
138530874|NCT00072852|Irinotecan|irinotecan|mesh-list
138499979|NCT00025324|Carboplatin|carboplatin|mesh-list
138499980|NCT00025324|Etoposide|etoposide|mesh-list
138499981|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138499982|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
138499983|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499984|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138499985|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138499986|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
138499987|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138499988|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499989|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138499990|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138499991|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138499992|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138499993|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138499994|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
138499995|NCT00025363|Ifosfamide|ifosfamide|mesh-list
138499996|NCT00025363|Doxorubicin|doxorubicin|mesh-list
138499997|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138499998|NCT00025363|Irinotecan|irinotecan|mesh-list
138499999|NCT00025363|Etoposide|etoposide|mesh-list
138500000|NCT00025363|Vincristine|vincristine|mesh-list
138500001|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
138500002|NCT00025363|Tirapazamine|tirapazamine|mesh-list
138500003|NCT00025363|Sargramostim|sargramostim|mesh-list
138500004|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500005|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
138500006|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500007|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500008|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500009|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
138500010|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500011|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500012|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138500013|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138500014|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138500015|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138500016|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500017|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138500018|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138500019|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
138500020|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
138500021|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
138500022|NCT00025402|Interferons|interferons|mesh-list
138500023|NCT00025402|Cytarabine|cytarabine|mesh-list
138500024|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
138500025|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
138500026|NCT00025402|Busulfan|busulfan|mesh-list
138500027|NCT00025402|Etoposide|etoposide|mesh-list
138500028|NCT00025402|Idarubicin|idarubicin|mesh-list
138176475|NCT00782821|Rituximab|rituximab|mesh-list
138500030|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500031|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
138500032|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500033|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500034|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500035|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
138500036|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500037|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500038|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138500039|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138500040|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138500041|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138500042|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500043|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
138500044|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500045|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138500046|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
138500047|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138500048|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
138500049|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138500050|NCT00025441|Dactinomycin|dactinomycin|mesh-list
138500051|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
138500052|NCT00025441|Ifosfamide|ifosfamide|mesh-list
138500053|NCT00025441|Carboplatin|carboplatin|mesh-list
138500054|NCT00025441|Doxorubicin|doxorubicin|mesh-list
138500055|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138500056|NCT00025441|Etoposide|etoposide|mesh-list
138500057|NCT00025441|Vincristine|vincristine|mesh-list
138500058|NCT00025441|Epirubicin|epirubicin|mesh-list
138500059|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500060|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
138500061|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500062|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138229954|NCT02411292|Enoxaparin|enoxaparin|mesh-list
138500063|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500064|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
138500065|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500066|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500067|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138500068|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138500069|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138500070|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138500071|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500072|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138500073|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
138500074|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
138500076|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138500077|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500078|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138500079|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138500081|NCT00000395|Leucovorin|leucovorin|mesh-list
138500082|NCT00000395|Methotrexate|methotrexate|mesh-list
138500083|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
138500084|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138500085|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
138500086|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138500087|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500088|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138500089|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
138500090|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500091|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500092|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
138531334|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
138500093|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500094|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138500095|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500096|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
138500097|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500098|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138500099|NCT00000395|Hematinics|hematinics|mesh-ancestor
138500100|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
138500101|NCT00000395|Vitamins|vitamins|mesh-ancestor
138500102|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
138500103|NCT00000395|Antidotes|antidotes|mesh-ancestor
138500104|NCT00000395|Protective Agents|protective agents|mesh-ancestor
138176554|NCT00784225|Trace Elements|trace elements|mesh-ancestor
138500105|NCT00025480|Paclitaxel|paclitaxel|mesh-list
138500106|NCT00025480|Carboplatin|carboplatin|mesh-list
138500107|NCT00025480|Tipifarnib|tipifarnib|mesh-list
138500108|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138500109|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500110|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
138500111|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
138500112|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
138500113|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500114|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
138500115|NCT00025519|Thalidomide|thalidomide|mesh-list
138500116|NCT00025519|Fludarabine|fludarabine|mesh-list
138500117|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
138500119|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500120|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138500121|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
138500122|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500123|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500124|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
138500125|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500126|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138500127|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500128|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138500129|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138500130|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
138500131|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138500132|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500133|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
138500134|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138500135|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138500136|NCT00025519|Growth Substances|growth substances|mesh-ancestor
138500137|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
138500138|NCT00025558|Carboplatin|carboplatin|mesh-list
138500139|NCT00025558|Temozolomide|temozolomide|mesh-list
138500140|NCT00025558|Thiotepa|thiotepa|mesh-list
138531443|NCT00209872|Analgesics|analgesics|mesh-ancestor
138500141|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500142|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
138500143|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500144|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500145|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
138500146|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500147|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138500148|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500149|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
138500150|NCT00025597|Carboplatin|carboplatin|mesh-list
138500151|NCT00025597|Doxorubicin|doxorubicin|mesh-list
138500152|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138500153|NCT00025597|Etoposide|etoposide|mesh-list
138500154|NCT00025597|Vincristine|vincristine|mesh-list
138500155|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500156|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
138500157|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500158|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500159|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500160|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
138500161|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500162|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500163|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138500164|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138500165|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138500166|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138500167|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500168|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138500169|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
138500170|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
138500171|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
138500173|NCT00025636|Dexamethasone|dexamethasone|mesh-list
138500174|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
138500175|NCT00025636|Melphalan|melphalan|mesh-list
138500176|NCT00025636|Carmustine|carmustine|mesh-list
138531546|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500177|NCT00025636|Methotrexate|methotrexate|mesh-list
138500178|NCT00025636|Etoposide|etoposide|mesh-list
138500179|NCT00025636|Vincristine|vincristine|mesh-list
138500180|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500181|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
138176628|NCT01272635|Hormones|hormones|mesh-ancestor
138500182|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500183|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500184|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500185|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
138500186|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500187|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500188|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138500189|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138500190|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
138500191|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
138500192|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138500193|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138500194|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
138500196|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138500197|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138500198|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138500199|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
138500200|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138500201|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138500202|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
138500203|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
138500204|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500205|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138500206|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138500207|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138500208|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138500209|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138500210|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
138500211|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500212|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
138500213|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
138500214|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
138500215|NCT00025675|Gefitinib|gefitinib|mesh-list
138500216|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500217|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138500218|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500219|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500220|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
138500221|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138500222|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500223|NCT00025792|Pramipexole|pramipexole|mesh-list
138500224|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
138500225|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531711|NCT00211315|Anecortave|anecortave|mesh-list
138500226|NCT00025792|Protective Agents|protective agents|mesh-ancestor
138500227|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500228|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138500229|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138500230|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
138500231|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
138500232|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138500233|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138500234|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138500235|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138500236|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
138500237|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138500238|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500239|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138500240|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138500241|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138500242|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500244|NCT00000419|Hormones|hormones|mesh-ancestor
138500245|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138500246|NCT00026104|Paclitaxel|paclitaxel|mesh-list
138500247|NCT00026104|Gemcitabine|gemcitabine|mesh-list
138500248|NCT00026104|Tipifarnib|tipifarnib|mesh-list
138500249|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138500250|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500251|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
138500252|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
138687869|NCT05661279|Anesthetics|anesthetics|mesh-list
138500253|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
138500254|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500255|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138500256|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
138500257|NCT00026143|Interferons|interferons|mesh-list
138500258|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
138500259|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
138500260|NCT00026143|Interleukin-12|interleukin-12|mesh-list
138500261|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500262|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
138500263|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500264|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
138500265|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500266|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138500267|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138500268|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138500269|NCT00026143|Growth Substances|growth substances|mesh-ancestor
138500270|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
138500271|NCT00026182|Rituximab|rituximab|mesh-list
138500272|NCT00026182|Interleukin-12|interleukin-12|mesh-list
138500273|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138500274|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500275|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
138500276|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500277|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500278|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138500279|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138500280|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138500281|NCT00026182|Growth Substances|growth substances|mesh-ancestor
138500282|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
138500283|NCT00026260|Semaxinib|semaxinib|mesh-list
138500284|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138500285|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138531878|NCT00213109|Miglitol|miglitol|mesh-list
138500286|NCT00026260|Growth Substances|growth substances|mesh-ancestor
138500287|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500288|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
138500289|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500290|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138500291|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500292|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500293|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
138500294|NCT00026299|Gefitinib|gefitinib|mesh-list
138500295|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500296|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138500297|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687891|NCT05641363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138500298|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500299|NCT00026338|Gemcitabine|gemcitabine|mesh-list
138500300|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138500301|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138500302|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
138500303|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500304|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500305|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138500306|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500307|NCT00026377|Leuprolide|leuprolide|mesh-list
138500308|NCT00026377|Goserelin|goserelin|mesh-list
138500309|NCT00026377|Flutamide|flutamide|mesh-list
138500310|NCT00026377|Bicalutamide|bicalutamide|mesh-list
138500311|NCT00026377|Semaxinib|semaxinib|mesh-list
138500312|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138500313|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
138500314|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138500315|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500316|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138500317|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500318|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
138500319|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
138500320|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138500321|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138500322|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138500323|NCT00026377|Growth Substances|growth substances|mesh-ancestor
138500324|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
138500325|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138500326|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500327|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500328|NCT00026416|Interferons|interferons|mesh-list
138500329|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
138500330|NCT00026416|Thalidomide|thalidomide|mesh-list
138500331|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500332|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
138500333|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500334|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
138500335|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500336|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500337|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
138500338|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138500339|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138500340|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138500341|NCT00026416|Growth Substances|growth substances|mesh-ancestor
138500342|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
138500343|NCT00026533|Thalidomide|thalidomide|mesh-list
138500344|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500345|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
138500346|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500347|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
138531974|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
138500348|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138500349|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500350|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138500351|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138500352|NCT00026533|Growth Substances|growth substances|mesh-ancestor
138500353|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
138500354|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500355|NCT00026962|Estradiol|estradiol|mesh-list
138500356|NCT00026962|Progesterone|progesterone|mesh-list
138500357|NCT00026962|Estrogens|estrogens|mesh-ancestor
138500358|NCT00026962|Hormones|hormones|mesh-ancestor
138500359|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138500360|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500361|NCT00026962|Progestins|progestins|mesh-ancestor
138500362|NCT00027040|Selegiline|selegiline|mesh-list
138500363|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
138500364|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138500365|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138500366|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138500367|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138500368|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532008|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
138532016|NCT00214630|Calcium|calcium|mesh-list
138500369|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500370|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138500371|NCT00027040|Protective Agents|protective agents|mesh-ancestor
138500372|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500373|NCT00027079|Naltrexone|naltrexone|mesh-list
138500374|NCT00027079|Ondansetron|ondansetron|mesh-list
138500375|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138500376|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138500377|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500378|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
138500379|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138500380|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
138500381|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
138500382|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138500383|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
138500384|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
138500385|NCT00027079|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138500386|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138500388|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264949|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500389|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500390|NCT00011778|Bortezomib|bortezomib|mesh-list
138500391|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500392|NCT00000425|Acetaminophen|acetaminophen|mesh-list
138500393|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138500394|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138500395|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138500396|NCT00000425|Analgesics|analgesics|mesh-ancestor
138500397|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
138500398|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138500399|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500400|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
138500401|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500402|NCT00000428|Amitriptyline|amitriptyline|mesh-list
138500403|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138500404|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
138500405|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138500406|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138500407|NCT00000428|Analgesics|analgesics|mesh-ancestor
138532109|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
138500408|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
138500409|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687996|NCT05385432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500410|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176856|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
138500411|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138500412|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138500413|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138500414|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500415|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
138500416|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138500418|NCT00027391|Oxandrolone|oxandrolone|mesh-list
138500419|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138500420|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
138500421|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138500422|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500423|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138500424|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
138500425|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
138500426|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138500427|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138500428|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138500429|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138500430|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
138500431|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138500432|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500433|NCT00027391|Androgens|androgens|mesh-ancestor
138500434|NCT00027391|Hormones|hormones|mesh-ancestor
138500435|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138500436|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
138500438|NCT00000461|Pravastatin|pravastatin|mesh-list
138500439|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
138500440|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
138500441|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138500442|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
138500443|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500444|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138500445|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
138500446|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
138500447|NCT00000461|Vitamins|vitamins|mesh-ancestor
138500448|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
138500449|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500450|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138500451|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138500452|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188455|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
138500453|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138532211|NCT00216073|Capecitabine|capecitabine|mesh-list
138500454|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138500455|NCT00027508|Trabectedin|trabectedin|mesh-list
138500456|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500457|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
138318732|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
138500458|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500460|NCT00027547|Cytarabine|cytarabine|mesh-list
138500461|NCT00027547|Cyclosporine|cyclosporine|mesh-list
138500462|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
138500463|NCT00027547|Methotrexate|methotrexate|mesh-list
138500464|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
138500465|NCT00027547|Fludarabine|fludarabine|mesh-list
138500466|NCT00027547|Cyclosporins|cyclosporins|mesh-list
138500467|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138500468|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
138500469|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138500470|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500471|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138500472|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
138500473|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500474|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500475|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
138500476|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500477|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138500478|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500479|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
138500480|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500481|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138500482|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
138500483|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500484|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
138176943|NCT01276379|Vitamins|vitamins|mesh-ancestor
138500485|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138500486|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138500487|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138500488|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
138500489|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138500490|NCT00011895|Lamivudine|lamivudine|mesh-list
138500491|NCT00011895|Zidovudine|zidovudine|mesh-list
138500492|NCT00011895|Efavirenz|efavirenz|mesh-list
138500493|NCT00011895|Abacavir|abacavir|mesh-list
138500494|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138500495|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138500496|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500497|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500498|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
138500499|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500500|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138500501|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138500502|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
138500503|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138500504|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138500505|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138500506|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138500507|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138500508|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138500509|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
138500510|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500511|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138328352|NCT00321594|Belinostat|belinostat|mesh-list
138500512|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500513|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500514|NCT00000464|Quinidine|quinidine|mesh-list
138500515|NCT00000464|Amiodarone|amiodarone|mesh-list
138500516|NCT00000464|Sotalol|sotalol|mesh-list
138500517|NCT00000464|Propafenone|propafenone|mesh-list
138500518|NCT00000464|Mexiletine|mexiletine|mesh-list
138500519|NCT00000464|Procainamide|procainamide|mesh-list
138500520|NCT00000464|Imipramine|imipramine|mesh-list
138500521|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138500522|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
138500523|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138500524|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138500525|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500526|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138500527|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138500528|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138500529|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500530|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138500531|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138532372|NCT00216931|Iloprost|iloprost|mesh-list
138500532|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138500533|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138500534|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138500535|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
138500536|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138500537|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500538|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
138500539|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
138500540|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138500541|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138500542|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
138500543|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138500544|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138500545|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138500546|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138500547|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
138500548|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138500549|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138500550|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500551|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138500552|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138500553|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
138500554|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138500555|NCT00027625|Temozolomide|temozolomide|mesh-list
138500556|NCT00027625|Gefitinib|gefitinib|mesh-list
138500557|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500558|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
138704011|NCT06220422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138500559|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500560|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500561|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138500562|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500563|NCT00027664|Interferons|interferons|mesh-list
138500564|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
138500565|NCT00027664|Thalidomide|thalidomide|mesh-list
138500566|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500567|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
138328366|NCT00390234|Growth Substances|growth substances|mesh-ancestor
138500568|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500569|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
138500570|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500571|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500572|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
138500573|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138500574|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138500575|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138500576|NCT00027664|Growth Substances|growth substances|mesh-ancestor
138500577|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
138500578|NCT00027703|Bevacizumab|bevacizumab|mesh-list
138500579|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138500580|NCT00027703|Gemcitabine|gemcitabine|mesh-list
138500581|NCT00027703|Antibodies|antibodies|mesh-list
138500582|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
138500583|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138500584|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500585|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138500586|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138500587|NCT00027703|Growth Substances|growth substances|mesh-ancestor
138500588|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500589|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
138500590|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
138500591|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138500592|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
138500593|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500594|NCT00011934|Interferons|interferons|mesh-list
138500595|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
138500596|NCT00011934|Sargramostim|sargramostim|mesh-list
138500597|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500598|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
138500599|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500600|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
138500601|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500602|NCT00027742|Interferons|interferons|mesh-list
138500603|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
138500604|NCT00027742|Temozolomide|temozolomide|mesh-list
138500605|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500606|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
138500607|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500608|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500609|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
138532508|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
138500610|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500611|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
138500612|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500613|NCT00027820|Cyclosporine|cyclosporine|mesh-list
138500614|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
138500615|NCT00027820|Fludarabine|fludarabine|mesh-list
138500616|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
138500617|NCT00027820|Cyclosporins|cyclosporins|mesh-list
138500618|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500619|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138500620|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
138693338|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
138500621|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500622|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500624|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500625|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328385|NCT00392496|Sunitinib|sunitinib|mesh-list
138500627|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500628|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
138500629|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500630|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138500631|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138500632|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138500633|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
138500634|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138500635|NCT00011973|Fenretinide|fenretinide|mesh-list
138500636|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500637|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138500638|NCT00011973|Protective Agents|protective agents|mesh-ancestor
138500639|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500640|NCT00027898|Carboplatin|carboplatin|mesh-list
138500641|NCT00027898|Etoposide|etoposide|mesh-list
138500642|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
138500643|NCT00027898|Bortezomib|bortezomib|mesh-list
138500644|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500645|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138500646|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138500647|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138532610|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
138532613|NCT00412321|Siltuximab|siltuximab|mesh-list
138500648|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500649|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500650|NCT00027937|Aldesleukin|aldesleukin|mesh-list
138500651|NCT00027937|Paclitaxel|paclitaxel|mesh-list
138500652|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
138500653|NCT00027937|Melphalan|melphalan|mesh-list
138500654|NCT00027937|Busulfan|busulfan|mesh-list
138500655|NCT00027937|Thiotepa|thiotepa|mesh-list
138500656|NCT00027937|Sargramostim|sargramostim|mesh-list
138500657|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138500658|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500659|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
138500660|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
138500661|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
138500662|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500663|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500664|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
138500665|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500666|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500667|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500668|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
138500669|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138500671|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138500672|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
138500673|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500674|NCT00012051|Cytarabine|cytarabine|mesh-list
138500675|NCT00012051|Dexamethasone|dexamethasone|mesh-list
138500676|NCT00012051|Rituximab|rituximab|mesh-list
138500677|NCT00012051|Methotrexate|methotrexate|mesh-list
138500678|NCT00012051|Etoposide|etoposide|mesh-list
138500679|NCT00012051|Melphalan|melphalan|mesh-list
138500680|NCT00012051|Ifosfamide|ifosfamide|mesh-list
138500681|NCT00012051|Carmustine|carmustine|mesh-list
138500682|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138500683|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
138500684|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
138500685|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138500686|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693346|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
138500687|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138500688|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
138500690|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138500691|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138500692|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500693|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138706249|NCT01652092|Mesna|mesna|mesh-list
138500694|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
138500695|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500696|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138500697|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
138500698|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138500699|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138500700|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
138500701|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688242|NCT05080322|Xhance|xhance|mesh-list
138500702|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
138500703|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500704|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138500705|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500706|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138532742|NCT00219973|Bemiparin|bemiparin|mesh-list
138500707|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138500708|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138177161|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500709|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138500710|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
138500711|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500712|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500713|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
138500714|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138500715|NCT00027976|Celecoxib|celecoxib|mesh-list
138500716|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138500717|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138500718|NCT00027976|Analgesics|analgesics|mesh-ancestor
138500719|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
138500720|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138500721|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500722|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138500723|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500724|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138500725|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138500726|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500727|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500728|NCT00000479|Aspirin|aspirin|mesh-list
138500729|NCT00000479|Vitamin E|vitamin e|mesh-list
138500730|NCT00000479|Vitamins|vitamins|mesh-ancestor
138500731|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
138500732|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500733|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138500734|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138500735|NCT00000479|Analgesics|analgesics|mesh-ancestor
138500736|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
138500737|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138500738|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138500739|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500740|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138500741|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138500742|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500743|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138500744|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138500745|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500746|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
138500747|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
138500748|NCT00000479|Protective Agents|protective agents|mesh-ancestor
138500749|NCT00028132|Tenofovir|tenofovir|mesh-list
138688261|NCT05066308|Cannabidiol|cannabidiol|mesh-list
138500750|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
138500751|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693358|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
138500752|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138500753|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138500754|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500755|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500756|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138500757|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138500759|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500760|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
138500761|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500762|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138500763|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500764|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500766|NCT00012090|Bicalutamide|bicalutamide|mesh-list
138500767|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138500768|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500769|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
138500770|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
138500771|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138500772|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500773|NCT00395395|Calcitonin|calcitonin|mesh-list
138500774|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
138500775|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138500776|NCT00395395|Katacalcin|katacalcin|mesh-list
138500777|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138500778|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500779|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138500780|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
138500782|NCT00395434|Combretastatin|combretastatin|mesh-list
138500783|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
138500784|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138500785|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500786|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138500787|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138177258|NCT00796705|Adalimumab|adalimumab|mesh-list
138500788|NCT00395434|Growth Substances|growth substances|mesh-ancestor
138500789|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500790|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
138500791|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138500792|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
138500793|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
138500794|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
138500795|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500796|NCT00395551|Ranibizumab|ranibizumab|mesh-list
138500797|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138500798|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138500799|NCT00395551|Growth Substances|growth substances|mesh-ancestor
138500800|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500801|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
138500802|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500804|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138500805|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500806|NCT00028288|Daclizumab|daclizumab|mesh-list
138532941|NCT00402259|Esomeprazole|esomeprazole|mesh-list
138500807|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500808|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
138500809|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500810|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
138500811|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138500812|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500813|NCT00000482|Niacin|niacin|mesh-list
138500814|NCT00000482|Clofibrate|clofibrate|mesh-list
138500815|NCT00000482|Estrogens|estrogens|mesh-list
138500816|NCT00000482|Hormones|hormones|mesh-ancestor
138500817|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138500818|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500819|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138500820|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
138500821|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500822|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138500823|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
138500824|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
138500825|NCT00000482|Vitamins|vitamins|mesh-ancestor
138500826|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
138500827|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138500828|NCT00028327|Lamivudine|lamivudine|mesh-list
138500829|NCT00028327|Zidovudine|zidovudine|mesh-list
138500830|NCT00028327|Efavirenz|efavirenz|mesh-list
138500831|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138500832|NCT00028327|Nelfinavir|nelfinavir|mesh-list
138500833|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138500834|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138500835|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500836|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500837|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
138500838|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500839|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138500840|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138500841|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
138500842|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138500843|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138500844|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138500845|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138500846|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138688314|NCT04982614|Vaccines|vaccines|mesh-list
138500847|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138500848|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138500849|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138500850|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
138500851|NCT00028366|Ritonavir|ritonavir|mesh-list
138500852|NCT00028366|Lopinavir|lopinavir|mesh-list
138500853|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
138500854|NCT00028366|Tenofovir|tenofovir|mesh-list
138500855|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138328448|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
138500856|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138500858|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500859|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500860|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138500861|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138500862|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
138500863|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500864|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138500865|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138500866|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138500867|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138500868|NCT00028405|Talaporfin|talaporfin|mesh-list
138500869|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500870|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138500871|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
138500872|NCT00012207|Aldesleukin|aldesleukin|mesh-list
138500873|NCT00012207|Prednisone|prednisone|mesh-list
138500874|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
138500875|NCT00012207|Vincristine|vincristine|mesh-list
138500876|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500877|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
138500878|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500879|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500880|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500881|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
138500882|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500883|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500884|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138500885|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138500886|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
138500887|NCT00012207|Hormones|hormones|mesh-ancestor
138500888|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138500889|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138500890|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138500891|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
138533146|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500892|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
138500893|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
138500894|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138500895|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138500896|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
138500897|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500898|NCT00028483|Docetaxel|docetaxel|mesh-list
138500899|NCT00028483|Doxorubicin|doxorubicin|mesh-list
138500900|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
138328475|NCT00374244|Pimozide|pimozide|mesh-list
138500901|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500902|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
138500903|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
138533196|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
138500904|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
138500905|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500906|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138500907|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138500908|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138500909|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500910|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
138500911|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500912|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
138500914|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
138500915|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500917|NCT00028561|Epothilone B|epothilone b|mesh-list
138500918|NCT00028561|Epothilones|epothilones|mesh-list
138500919|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500920|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
138500921|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
138500922|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
138500923|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500924|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
138500926|NCT00028600|Methotrexate|methotrexate|mesh-list
138500927|NCT00028600|Fludarabine|fludarabine|mesh-list
138500928|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
138500929|NCT00028600|Tacrolimus|tacrolimus|mesh-list
138500930|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500931|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
138230030|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500932|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500933|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500934|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500935|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
138500936|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177390|NCT00763061|Timolol|timolol|mesh-list
138500937|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500938|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138500939|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138500940|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
138500941|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138500942|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138500943|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
138500944|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
138500945|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500946|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138500947|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138500948|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138500949|NCT00388778|Doxycycline|doxycycline|mesh-list
138500950|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138500951|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138500952|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
138500953|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138500954|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138500955|NCT00012246|Sargramostim|sargramostim|mesh-list
138500956|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
138500957|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
138500958|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500959|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138500960|NCT00028717|Prednisone|prednisone|mesh-list
138500961|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
138500962|NCT00028717|Rituximab|rituximab|mesh-list
138500963|NCT00028717|Doxorubicin|doxorubicin|mesh-list
138500964|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138500965|NCT00028717|Vincristine|vincristine|mesh-list
138500966|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138500967|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
138500968|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138500969|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138500970|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138500971|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
138500972|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500973|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500974|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138500975|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138500976|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138500977|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138500978|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138500979|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138500980|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138500982|NCT00028717|Hormones|hormones|mesh-ancestor
138500983|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138500984|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138500985|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138500986|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
138500987|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
138500988|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
138500990|NCT00028756|Doxorubicin|doxorubicin|mesh-list
138500991|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138500992|NCT00028756|Methotrexate|methotrexate|mesh-list
138500993|NCT00028756|Vinblastine|vinblastine|mesh-list
138500994|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500995|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138500996|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
138500997|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138500998|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138500999|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138501000|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138501001|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501002|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138501003|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
138533405|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533406|NCT00124930|Olanzapine|olanzapine|mesh-list
138501004|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138501005|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501006|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
138501007|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138501008|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138501009|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
138501010|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138501011|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138501012|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138501013|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
138501014|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
138501015|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
138501016|NCT00012324|Doxorubicin|doxorubicin|mesh-list
138501017|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138501018|NCT00012324|Nolatrexed|nolatrexed|mesh-list
138501019|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138501020|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501021|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138501022|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138501023|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501024|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533457|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138501025|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138501026|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
138501027|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138501028|NCT00028795|Temozolomide|temozolomide|mesh-list
138501029|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138501030|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
138501031|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328511|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138501032|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501034|NCT00012363|Irinotecan|irinotecan|mesh-list
138501035|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138501036|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
138501037|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501038|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501039|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138501040|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138501041|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501042|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
138501043|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501044|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138501045|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501046|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501047|NCT00028834|Bevacizumab|bevacizumab|mesh-list
138501048|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138501049|NCT00028834|Gemcitabine|gemcitabine|mesh-list
138501050|NCT00028834|Antibodies|antibodies|mesh-list
138501051|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
138501052|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138501053|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501054|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138501055|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138501056|NCT00028834|Growth Substances|growth substances|mesh-ancestor
138501057|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501058|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
138501059|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
138501060|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138501061|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
138501062|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501063|NCT00028873|Paclitaxel|paclitaxel|mesh-list
138501064|NCT00028873|Docetaxel|docetaxel|mesh-list
138501065|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138501066|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501067|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
138501068|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
138501069|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
138501070|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501071|NCT00028912|Carboplatin|carboplatin|mesh-list
138501072|NCT00028912|Bortezomib|bortezomib|mesh-list
138501073|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501074|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138501075|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
138501076|NCT00028951|Coagulants|coagulants|mesh-ancestor
138501077|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
138501078|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138501079|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138501080|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
138501081|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501082|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138501083|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
138501084|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138501085|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501086|NCT00000491|Aspirin|aspirin|mesh-list
138501087|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138501088|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138501089|NCT00000491|Analgesics|analgesics|mesh-ancestor
138501090|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
138501091|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501092|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501093|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138501094|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138501095|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138501096|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138533609|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138501097|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501098|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138501099|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138501100|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501102|NCT00029380|Cyclosporine|cyclosporine|mesh-list
138501103|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
138501104|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
138501105|NCT00029380|Busulfan|busulfan|mesh-list
138501106|NCT00029380|Cyclosporins|cyclosporins|mesh-list
138501107|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138501108|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
138501109|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501111|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138501112|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
138501113|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501114|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501115|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138501116|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501117|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
138501118|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138501119|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
138501120|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138501121|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138501122|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138501123|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
138501124|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138501125|NCT00029458|Clozapine|clozapine|mesh-list
138501126|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138501127|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
138501128|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501129|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501130|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501131|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138501132|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138501133|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138501134|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138501135|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
138501137|NCT00029497|Amitriptyline|amitriptyline|mesh-list
138501138|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138501139|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
138501140|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138501141|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138501142|NCT00029497|Analgesics|analgesics|mesh-ancestor
138501143|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
138501144|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501145|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501146|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138501147|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138501148|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138501149|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501150|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
138501151|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501152|NCT00000494|Indomethacin|indomethacin|mesh-list
138501153|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138501154|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138501155|NCT00000494|Analgesics|analgesics|mesh-ancestor
138501156|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
138501157|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501158|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501160|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138501161|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
138501162|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
138501163|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138501164|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138501165|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704012|NCT06220422|Protease Inhibitors|protease inhibitors|mesh-ancestor
138501166|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501167|NCT00012519|Ritonavir|ritonavir|mesh-list
138501168|NCT00012519|Indinavir|indinavir|mesh-list
138501169|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138501170|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138501171|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
138501172|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501173|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501174|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138501175|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138501176|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
138501177|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138501178|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138501179|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138501180|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138501181|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138501182|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138501183|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138501184|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501185|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
138501186|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501187|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501188|NCT00029770|Acetaminophen|acetaminophen|mesh-list
138501189|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138533830|NCT00127114|Amantadine|amantadine|mesh-list
138501190|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138501191|NCT00029770|Codeine|codeine|mesh-list
138501192|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138501193|NCT00029770|Analgesics|analgesics|mesh-ancestor
138501194|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
138501195|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501196|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501197|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
138501198|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138501199|NCT00029770|Narcotics|narcotics|mesh-ancestor
138501200|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138501201|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
138693509|NCT01258660|Folic Acid|folic acid|mesh-list
138647552|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
138647553|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
138647554|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138647555|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
138647556|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647557|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647558|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
138647559|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138647560|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138647561|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138647562|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138647563|NCT03961919|Fludarabine|fludarabine|mesh-list
138647565|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533874|NCT00043823|Bevacizumab|bevacizumab|mesh-list
138647566|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647567|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138647568|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
138647570|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647571|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138647572|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647573|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647574|NCT03942328|Bevacizumab|bevacizumab|mesh-list
138647575|NCT03942328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138647576|NCT03942328|Atezolizumab|atezolizumab|mesh-list
138647579|NCT03942328|Immunoglobulins|immunoglobulins|mesh-list
138647580|NCT03942328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138647581|NCT03942328|Immunoglobulin G|immunoglobulin g|mesh-list
138647582|NCT03942328|Endothelial Growth Factors|endothelial growth factors|mesh-list
138647583|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
138252831|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
138647584|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647585|NCT03942328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647586|NCT03942328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138647587|NCT03942328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138647588|NCT03942328|Growth Substances|growth substances|mesh-ancestor
138647589|NCT03942328|Growth Inhibitors|growth inhibitors|mesh-ancestor
138647590|NCT03942328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647591|NCT03942328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647593|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138647594|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
138647595|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138647596|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688585|NCT04495608|Fluconazole|fluconazole|mesh-list
138647599|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
138647600|NCT03927144|Erenumab|erenumab|mesh-list
138647601|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138647602|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647603|NCT03927144|Analgesics|analgesics|mesh-ancestor
138647604|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
138647605|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138647606|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647607|NCT03917381|Docetaxel|docetaxel|mesh-list
138647608|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
138647609|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647610|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
138647611|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
138647612|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
138647613|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647614|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647615|NCT03917381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647616|NCT03904251|Cytarabine|cytarabine|mesh-list
138647617|NCT03904251|Daunorubicin|daunorubicin|mesh-list
138647618|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
138647619|NCT03904251|Calicheamicins|calicheamicins|mesh-list
138647620|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138647621|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
138647622|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647623|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647624|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
138647625|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138647626|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138647627|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
138647628|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647629|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138647630|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138647631|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138647632|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647633|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647634|NCT03904251|Immunotoxins|immunotoxins|mesh-ancestor
138647635|NCT03904251|Immunoconjugates|immunoconjugates|mesh-ancestor
138647636|NCT03901339|Gemcitabine|gemcitabine|mesh-list
138647637|NCT03901339|Capecitabine|capecitabine|mesh-list
138647638|NCT03901339|Vinorelbine|vinorelbine|mesh-list
138647639|NCT03901339|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138647640|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138647641|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
138647642|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647643|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647644|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138647645|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
138647646|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
138647647|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
138647648|NCT03901339|Immunoconjugates|immunoconjugates|mesh-ancestor
138647649|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
138647650|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647651|NCT03885713|Adalimumab|adalimumab|mesh-list
138647652|NCT03885713|Infliximab|infliximab|mesh-list
138647653|NCT03885713|Golimumab|golimumab|mesh-list
138647654|NCT03885713|Ustekinumab|ustekinumab|mesh-list
138647655|NCT03885713|Vedolizumab|vedolizumab|mesh-list
138647656|NCT03885713|Tofacitinib|tofacitinib|mesh-list
138647657|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138647658|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138647659|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138647660|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
138647661|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138647662|NCT03885713|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138647663|NCT03885713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138647664|NCT03885713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328606|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138647665|NCT03885713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647666|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138647667|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
138647668|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453587|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
138324389|NCT04129788|Bisacodyl|bisacodyl|mesh-list
138647701|NCT03869892|Trifluridine|trifluridine|mesh-list
138647702|NCT03869892|Bevacizumab|bevacizumab|mesh-list
138647703|NCT03869892|Capecitabine|capecitabine|mesh-list
138647704|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647705|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252930|NCT00002265|Zalcitabine|zalcitabine|mesh-list
138647706|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138647707|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138647708|NCT03869892|Growth Substances|growth substances|mesh-ancestor
138647709|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647710|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
138647711|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138647712|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
138647713|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647714|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
138647715|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138647717|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
138647718|NCT03831932|Osimertinib|osimertinib|mesh-list
138647719|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647720|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138647721|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647722|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647724|NCT03784677|Calcium|calcium|mesh-list
138647725|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138647726|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534134|NCT00044525|Taxane|taxane|mesh-list
138647727|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647728|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138647729|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138647730|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647732|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138647733|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138647734|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647735|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
138647736|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138647737|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138647738|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138647739|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138647740|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
138647741|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647742|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647743|NCT03684811|Gemcitabine|gemcitabine|mesh-list
138647744|NCT03684811|Nivolumab|nivolumab|mesh-list
138647745|NCT03684811|Azacitidine|azacitidine|mesh-list
138647746|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647747|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138647748|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
138647749|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647750|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647751|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647752|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647753|NCT03672773|Temozolomide|temozolomide|mesh-list
138647754|NCT03672773|Talazoparib|talazoparib|mesh-list
138647755|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138647756|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
138647757|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647758|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647759|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138647760|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647761|NCT03661723|Bevacizumab|bevacizumab|mesh-list
138647762|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
138647763|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647764|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647765|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138647766|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138647767|NCT03661723|Growth Substances|growth substances|mesh-ancestor
138647768|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647769|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
138647770|NCT03661723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647771|NCT03661723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647772|NCT03629340|Metformin|metformin|mesh-list
138647773|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138647774|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647775|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
138647776|NCT03598595|Gemcitabine|gemcitabine|mesh-list
138647778|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138324459|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
138647779|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
138647780|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647781|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647782|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
138647783|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
138647784|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
138328628|NCT00382824|Ubiquinone|ubiquinone|mesh-list
138647785|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
138647786|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138647787|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138647788|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138647789|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647790|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138647791|NCT03568994|Cytarabine|cytarabine|mesh-list
138647792|NCT03568994|Atovaquone|atovaquone|mesh-list
138647793|NCT03568994|Etoposide|etoposide|mesh-list
138647794|NCT03568994|Daunorubicin|daunorubicin|mesh-list
138647795|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
138647796|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138253006|NCT00002523|Antidotes|antidotes|mesh-ancestor
138647797|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647798|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138647799|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138647800|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647801|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647802|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138647803|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
138647804|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
138647805|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138647806|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138647807|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
138647808|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647809|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138647810|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647811|NCT03568994|Immunotoxins|immunotoxins|mesh-ancestor
138647812|NCT03568994|Immunoconjugates|immunoconjugates|mesh-ancestor
138647813|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
138647814|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138647815|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138647816|NCT03509012|Paclitaxel|paclitaxel|mesh-list
138647817|NCT03509012|Etoposide|etoposide|mesh-list
138647818|NCT03509012|Cisplatin|cisplatin|mesh-list
138647819|NCT03509012|Carboplatin|carboplatin|mesh-list
138647820|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
138647821|NCT03509012|Pemetrexed|pemetrexed|mesh-list
138647822|NCT03509012|Durvalumab|durvalumab|mesh-list
138647823|NCT03509012|Tremelimumab|tremelimumab|mesh-list
138647824|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138647825|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647826|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
138647827|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
138328658|NCT00383448|Melphalan|melphalan|mesh-list
138647828|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
138647829|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647830|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138647831|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138647832|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647833|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138647834|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138647835|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647837|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
138647838|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
138647839|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138253035|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138647840|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647841|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
138647842|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138647843|NCT03484299|Gemcitabine|gemcitabine|mesh-list
138647844|NCT03484299|Folfirinox|folfirinox|mesh-list
138647845|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138647846|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
138647847|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647848|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647851|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138647852|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138647853|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138647854|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647855|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647856|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138647857|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138647859|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
138647860|NCT03441048|Cladribine|cladribine|mesh-list
138647861|NCT03441048|Lintuzumab|lintuzumab|mesh-list
138647862|NCT03441048|Lenograstim|lenograstim|mesh-list
138647863|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138647864|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
138647865|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647866|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647867|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
138647868|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138647869|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138647870|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
138534421|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647871|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647872|NCT03441048|Analgesics|analgesics|mesh-ancestor
138647873|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
138647874|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138647875|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138647876|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138647877|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647878|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647879|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138647880|NCT03414983|Leucovorin|leucovorin|mesh-list
138647881|NCT03414983|Bevacizumab|bevacizumab|mesh-list
138647882|NCT03414983|Nivolumab|nivolumab|mesh-list
138647883|NCT03414983|Fluorouracil|fluorouracil|mesh-list
138647884|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
138647885|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647886|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647887|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138647888|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138647889|NCT03414983|Growth Substances|growth substances|mesh-ancestor
138647890|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647891|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
138647892|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
138688768|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647893|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647894|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138647896|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
138647897|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647898|NCT03414983|Antidotes|antidotes|mesh-ancestor
138647899|NCT03414983|Protective Agents|protective agents|mesh-ancestor
138647900|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
138647902|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
138647903|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
138647904|NCT03396575|Fludarabine|fludarabine|mesh-list
138647905|NCT03396575|Vaccines|vaccines|mesh-list
138647906|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
138647907|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647908|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138647909|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138647910|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138647911|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
138647912|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647913|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647914|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138647915|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
138647916|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647917|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647918|NCT03395847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647919|NCT03395847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647920|NCT03340675|Ifetroban|ifetroban|mesh-list
138647921|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138647922|NCT03340506|Trametinib|trametinib|mesh-list
138647923|NCT03340506|Dabrafenib|dabrafenib|mesh-list
138647924|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647925|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138647926|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647927|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647928|NCT03288974|Pomalidomide|pomalidomide|mesh-list
138647929|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
138647930|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647931|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138324609|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138647932|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138647933|NCT03288974|Growth Substances|growth substances|mesh-ancestor
138647934|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
138647935|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647936|NCT03272477|Tamoxifen|tamoxifen|mesh-list
138647937|NCT03272477|Paclitaxel|paclitaxel|mesh-list
138647938|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138647939|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
138647940|NCT03272477|Trastuzumab|trastuzumab|mesh-list
138647941|NCT03272477|Letrozole|letrozole|mesh-list
138647942|NCT03272477|Epirubicin|epirubicin|mesh-list
138647945|NCT03272477|Exemestane|exemestane|mesh-list
138647946|NCT03272477|Goserelin|goserelin|mesh-list
138647947|NCT03272477|Leuprolide|leuprolide|mesh-list
138647948|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138647949|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647950|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
138647951|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
138647952|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
138647953|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647954|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138647955|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
138647956|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647957|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138647958|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138647959|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
138647960|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138647961|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647962|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138647963|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138647964|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647965|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138647966|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
138711079|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647967|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138647969|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138647970|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138647971|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138647972|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138647973|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138647974|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138647975|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138647976|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
138647977|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138647978|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
138647979|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
138647980|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647981|NCT03176953|Topiramate|topiramate|mesh-list
138647982|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
138647983|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138647984|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647985|NCT03110978|Nivolumab|nivolumab|mesh-list
138647986|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647987|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647989|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647990|NCT03091075|Oxandrolone|oxandrolone|mesh-list
138647991|NCT03091075|Androgens|androgens|mesh-ancestor
138647992|NCT03091075|Hormones|hormones|mesh-ancestor
138647993|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138647994|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647995|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
138647996|NCT03080974|Nivolumab|nivolumab|mesh-list
138647997|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647998|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647999|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138648000|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648001|NCT03059563|Varenicline|varenicline|mesh-list
138648002|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138648003|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138648004|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
138648005|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138648006|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648007|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648008|NCT03040973|Gefitinib|gefitinib|mesh-list
138648009|NCT03040973|Osimertinib|osimertinib|mesh-list
138648010|NCT03040973|Nazartinib|nazartinib|mesh-list
138648011|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648012|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138648013|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648014|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648015|NCT03031730|Dexamethasone|dexamethasone|mesh-list
138648016|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
138648017|NCT03031730|Lenalidomide|lenalidomide|mesh-list
138648018|NCT03031730|Ichthammol|ichthammol|mesh-list
138648019|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138648021|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138648022|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
138648023|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
138648024|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648025|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648026|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138648027|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
138648028|NCT03031730|Hormones|hormones|mesh-ancestor
138648029|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253152|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
138648030|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138648031|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648032|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
138648033|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648034|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648035|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
138648036|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138648037|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138648038|NCT03031730|Growth Substances|growth substances|mesh-ancestor
138648039|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
138648040|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
138648042|NCT03004287|Dexamethasone|dexamethasone|mesh-list
138648043|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
138648044|NCT03004287|Melphalan|melphalan|mesh-list
138648045|NCT03004287|Doxorubicin|doxorubicin|mesh-list
138648046|NCT03004287|Etoposide|etoposide|mesh-list
138648047|NCT03004287|Lenalidomide|lenalidomide|mesh-list
138648048|NCT03004287|Bortezomib|bortezomib|mesh-list
138648049|NCT03004287|Daratumumab|daratumumab|mesh-list
138648050|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138648051|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
138648052|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648053|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138648054|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138648055|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
138648056|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648057|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648058|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138648059|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138648060|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
138648061|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
138648062|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648063|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138648064|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
138648066|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138648067|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138648068|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138253177|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
138534817|NCT00130585|Folic Acid|folic acid|mesh-list
138648069|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138648070|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138648071|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648072|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138648073|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138648074|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138648075|NCT03004287|Growth Substances|growth substances|mesh-ancestor
138648076|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
138648077|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
138648078|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138648079|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138648081|NCT02986659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138648082|NCT02986659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648083|NCT02837978|Methotrexate|methotrexate|mesh-list
138648084|NCT02837978|Tacrolimus|tacrolimus|mesh-list
138648085|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138648086|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
138648087|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138648088|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648089|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138648090|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
138648091|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648092|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648093|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
138648094|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648095|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138648096|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138648097|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
138648098|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138648099|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138648100|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138648101|NCT02743806|Vedolizumab|vedolizumab|mesh-list
138648102|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138648103|NCT02668653|Cytarabine|cytarabine|mesh-list
138648104|NCT02668653|Daunorubicin|daunorubicin|mesh-list
138648105|NCT02668653|Idarubicin|idarubicin|mesh-list
138648106|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138648107|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
138648108|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648109|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648110|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
138648111|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138648112|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138648113|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
138648114|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648115|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138648116|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138648117|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138648118|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648119|NCT02652052|Dasatinib|dasatinib|mesh-list
138648120|NCT02652052|Quercetin|quercetin|mesh-list
138328747|NCT00385788|Gemcitabine|gemcitabine|mesh-list
138648121|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648122|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138648123|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648124|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648126|NCT02652052|Protective Agents|protective agents|mesh-ancestor
138648127|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648128|NCT02615119|Isoproterenol|isoproterenol|mesh-list
138648129|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138648130|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138648131|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
138688907|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
138648132|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138648133|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648134|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648135|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138648136|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
138648137|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648138|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138648139|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
138648140|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138648141|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
138648142|NCT02615119|Protective Agents|protective agents|mesh-ancestor
138648144|NCT02558010|Methadone|methadone|mesh-list
138648145|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138648146|NCT02558010|Narcotics|narcotics|mesh-ancestor
138648147|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138648148|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648149|NCT02558010|Analgesics|analgesics|mesh-ancestor
138648150|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
138648151|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138166858|NCT00553969|Lisinopril|lisinopril|mesh-list
138648152|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
138648153|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
138648154|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
138648155|NCT02530502|Temozolomide|temozolomide|mesh-list
138648156|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138648157|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648158|NCT02530502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138648159|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648160|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138648161|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
138648163|NCT02484404|Olaparib|olaparib|mesh-list
138648164|NCT02484404|Cediranib|cediranib|mesh-list
138648165|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138648166|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648167|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138648168|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648169|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648170|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138648171|NCT02437318|Fulvestrant|fulvestrant|mesh-list
138648172|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138648173|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648174|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138688939|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
138648175|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138648176|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
138648177|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138648178|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648180|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138648181|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138648182|NCT02305238|Growth Substances|growth substances|mesh-ancestor
138648183|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648184|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
138648185|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648186|NCT02176148|Fluocinonide|fluocinonide|mesh-list
138648187|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138648188|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
138253440|NCT05806671|Fulvestrant|fulvestrant|mesh-list
138648190|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138648191|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648192|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138648194|NCT02143050|Trametinib|trametinib|mesh-list
138648195|NCT02143050|Dabrafenib|dabrafenib|mesh-list
138648196|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138648197|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648198|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648199|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138648200|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648201|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648202|NCT02075840|Crizotinib|crizotinib|mesh-list
138648203|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648204|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138648205|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648206|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648207|NCT01957956|Temozolomide|temozolomide|mesh-list
138648208|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138648209|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
138648210|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648211|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648212|NCT01863550|Dexamethasone|dexamethasone|mesh-list
138688981|NCT03759093|Bortezomib|bortezomib|mesh-list
138648214|NCT01863550|Lenalidomide|lenalidomide|mesh-list
138648215|NCT01863550|Bortezomib|bortezomib|mesh-list
138648216|NCT01863550|Ichthammol|ichthammol|mesh-list
138648217|NCT01863550|BB 1101|bb 1101|mesh-list
138648218|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138648219|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
138648220|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
138648221|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648222|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648223|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138648224|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
138648225|NCT01863550|Hormones|hormones|mesh-ancestor
138535182|NCT00132925|Triamcinolone|triamcinolone|mesh-list
138648226|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138648227|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138648228|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648229|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
138648230|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138648231|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138648232|NCT01863550|Growth Substances|growth substances|mesh-ancestor
138648233|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
138648234|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
138648235|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648236|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648237|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
138648239|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
138648240|NCT01572506|Vitamins|vitamins|mesh-ancestor
138648241|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
138648242|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648243|NCT00288743|Insulin|insulin|mesh-list
138648244|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138648245|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648246|NCT00321633|Carboplatin|carboplatin|mesh-list
138648247|NCT00321633|Docetaxel|docetaxel|mesh-list
138648248|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648249|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
138648250|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
138648251|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
138648252|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648253|NCT00288782|Mirtazapine|mirtazapine|mesh-list
138648254|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
138648255|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138648256|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138648257|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
138648258|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
138648259|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138648260|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648261|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648262|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138648263|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138648264|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138648265|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138648266|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138648267|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138689010|NCT03756961|Lidocaine|lidocaine|mesh-list
138648268|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
138648269|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138648270|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138648271|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
138648272|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138648274|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138648275|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
138648276|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138648277|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648278|NCT01059825|Incretins|incretins|mesh-ancestor
138648279|NCT01059825|Hormones|hormones|mesh-ancestor
138648280|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138648281|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138648282|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
138648283|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648284|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648285|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138648286|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
138535349|NCT00047021|Cytarabine|cytarabine|mesh-list
138648287|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138648288|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138648289|NCT00321750|Analgesics|analgesics|mesh-ancestor
138648290|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
138648291|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648292|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648293|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138648294|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138648295|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
138648296|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138648297|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
138648298|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138648299|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648300|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648301|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138648302|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138689030|NCT03756961|Analgesics|analgesics|mesh-ancestor
138648303|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
138648304|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648305|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648306|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
138648307|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138648308|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648310|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138648311|NCT00323154|Narcotics|narcotics|mesh-ancestor
138648312|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138648313|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648315|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
138648316|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648318|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
138648319|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
138648320|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138648321|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
138648322|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138648323|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138648324|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138648325|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648326|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
138648327|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
138648328|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138648329|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
138648330|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138648331|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648332|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648333|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138648334|NCT00323505|Interferons|interferons|mesh-list
138648335|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
138648336|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
138648337|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648338|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
138648339|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138648340|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
138648341|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648342|NCT00289406|Amlodipine|amlodipine|mesh-list
138648343|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138648344|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138648345|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138648346|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648347|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138648348|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648349|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
138648350|NCT00323544|Tenofovir|tenofovir|mesh-list
138648351|NCT00323544|Lamivudine|lamivudine|mesh-list
138648352|NCT00323544|Emtricitabine|emtricitabine|mesh-list
138648353|NCT00323544|Zidovudine|zidovudine|mesh-list
138648354|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138648355|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
138648356|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138648357|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138648358|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138648359|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648360|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535636|NCT00047294|Thalidomide|thalidomide|mesh-list
138648361|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138648362|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138648363|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
138648365|NCT00289445|Folic Acid|folic acid|mesh-list
138648366|NCT00289445|Mitomycins|mitomycins|mesh-list
138648367|NCT00289445|Mitomycin|mitomycin|mesh-list
138648368|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
138648369|NCT00289445|Antidotes|antidotes|mesh-ancestor
138648370|NCT00289445|Protective Agents|protective agents|mesh-ancestor
138648371|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648372|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
138648373|NCT00289445|Vitamins|vitamins|mesh-ancestor
138648374|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
138648375|NCT00289445|Hematinics|hematinics|mesh-ancestor
138648376|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138648377|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648378|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
138648379|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648380|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138648381|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648382|NCT00323583|Leucovorin|leucovorin|mesh-list
138648383|NCT00323583|Paclitaxel|paclitaxel|mesh-list
138648384|NCT00323583|Fluorouracil|fluorouracil|mesh-list
138648385|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
138648386|NCT00323583|Calcium|calcium|mesh-list
138648387|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138648388|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648389|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
138648390|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
138648391|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
138648392|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648393|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138648394|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648395|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
138535752|NCT00042861|Vitamins|vitamins|mesh-ancestor
138648396|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138648397|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138648398|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
138648399|NCT00323583|Antidotes|antidotes|mesh-ancestor
138648400|NCT00323583|Protective Agents|protective agents|mesh-ancestor
138648401|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
138648402|NCT00323583|Vitamins|vitamins|mesh-ancestor
138648403|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
138648404|NCT00289601|Eptifibatide|eptifibatide|mesh-list
138648405|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138648406|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
138648407|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138648408|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
138648409|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648410|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
138648411|NCT00323778|Protective Agents|protective agents|mesh-ancestor
138648412|NCT00323817|Z 338|z 338|mesh-list
138648413|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138648414|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453588|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648415|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648416|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
138648417|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138648418|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648419|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138648420|NCT00289835|Paclitaxel|paclitaxel|mesh-list
138648421|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138648422|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138648423|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648424|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
138648425|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
138648426|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
138648427|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648428|NCT00303225|Tecovirimat|tecovirimat|mesh-list
138648429|NCT00303225|Antiviral Agents|antiviral agents|mesh-ancestor
138648430|NCT00303225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138648431|NCT00323934|Mocetinostat|mocetinostat|mesh-list
138648432|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138648433|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648434|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648435|NCT00290030|Alfuzosin|alfuzosin|mesh-list
138648436|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138648437|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138648438|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138648439|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
138689124|NCT03586999|Alkylating Agents|alkylating agents|mesh-ancestor
138648441|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648442|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648443|NCT00290030|Urological Agents|urological agents|mesh-ancestor
138648444|NCT00303264|Esomeprazole|esomeprazole|mesh-list
138648445|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138648446|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138648447|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138648448|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648449|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648450|NCT00290069|Sirolimus|sirolimus|mesh-list
138648451|NCT00290069|Tacrolimus|tacrolimus|mesh-list
138648452|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138648453|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
138648454|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648455|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138648456|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648457|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648458|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138648459|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711081|NCT04621110|Fentanyl|fentanyl|mesh-list
138648460|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138648461|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648462|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
138648464|NCT04718259|Bupivacaine|bupivacaine|mesh-list
138648465|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
138648466|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
138648467|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138648468|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648469|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
138648470|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648471|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138648472|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138648473|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138648474|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138648475|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138648476|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138648477|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
138648478|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
138648479|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
138648480|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138648481|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648483|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138648484|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138648485|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648486|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138648487|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
138648488|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
138648490|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138648491|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
138648492|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
138648493|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648494|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648495|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138648496|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138648497|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138648498|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
138648499|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138648500|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648501|NCT00324012|Docetaxel|docetaxel|mesh-list
138648502|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648503|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
138648504|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
138648505|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
138648506|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648507|NCT00290264|Budesonide|budesonide|mesh-list
138648508|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
138648509|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138648510|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138648511|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
138648512|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648513|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648514|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138648515|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
138648516|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
138648517|NCT00290264|Hormones|hormones|mesh-ancestor
138648518|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138648519|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138648520|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138648521|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138648522|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
138648523|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138648524|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648525|NCT00324051|Olanzapine|olanzapine|mesh-list
138648526|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
138648527|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
138536081|NCT00042978|Etoposide|etoposide|mesh-list
138648528|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648529|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648530|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138648531|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138648532|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138648533|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138648534|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138648535|NCT00324051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138648536|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138648537|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138648538|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648539|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138648540|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
138648541|NCT00303381|Interferons|interferons|mesh-list
138648542|NCT00303381|Interferon-beta|interferon-beta|mesh-list
138648543|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
138648544|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648545|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
138648546|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138648547|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
138648548|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648549|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138648550|NCT00290420|Chloroquine|chloroquine|mesh-list
138648551|NCT00290420|Amebicides|amebicides|mesh-ancestor
138648552|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138648553|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138648554|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138648555|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
138648556|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138648557|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138648558|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138648559|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138648560|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648562|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138648563|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648564|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648566|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138689253|NCT03304080|Pertuzumab|pertuzumab|mesh-list
138648568|NCT00290849|Bivalirudin|bivalirudin|mesh-list
138648569|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
138648570|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138648571|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
138648572|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648573|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648574|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
138648575|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
138648576|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138648577|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648578|NCT00303576|Dapivirine|dapivirine|mesh-list
138648579|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138648580|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138648581|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
138648582|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138648583|NCT00291005|Docetaxel|docetaxel|mesh-list
138648585|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
138648586|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
138648587|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138648588|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648589|NCT00303615|Anastrozole|anastrozole|mesh-list
138648590|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
138648591|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138648592|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648593|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138648594|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138648595|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648596|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648597|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138648598|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
138648599|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138536240|NCT00048152|Daclizumab|daclizumab|mesh-list
138648600|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648601|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
138648602|NCT00303615|Hormones|hormones|mesh-ancestor
138648603|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
138648604|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138648605|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138648606|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138648607|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138648608|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138648609|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648610|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648611|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648612|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138648613|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
138648614|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138325288|NCT02716974|Docetaxel|docetaxel|mesh-list
138648615|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648616|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138648617|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138689259|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648618|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138648620|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138648621|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138648622|NCT00291122|Analgesics|analgesics|mesh-ancestor
138648623|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
138648624|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648625|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648626|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138648627|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138648628|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138648629|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138648630|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648631|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648633|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138648634|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648635|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138648636|NCT00324363|Incretins|incretins|mesh-ancestor
138648637|NCT00324363|Hormones|hormones|mesh-ancestor
138328920|NCT00477204|Simvastatin|simvastatin|mesh-list
138648638|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138648639|NCT00303732|Everolimus|everolimus|mesh-list
138648640|NCT00303732|Vatalanib|vatalanib|mesh-list
138648641|NCT00303732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138648642|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138648643|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648644|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648645|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138648646|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
138648647|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648648|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648650|NCT00303771|Fluorouracil|fluorouracil|mesh-list
138648651|NCT00303771|Irinotecan|irinotecan|mesh-list
138648652|NCT00303771|Calcium|calcium|mesh-list
138648653|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
138648654|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138648655|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648656|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
138648657|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648658|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138648659|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648660|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138648661|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
138648662|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138648663|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138648664|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648667|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
138648668|NCT00303771|Vitamins|vitamins|mesh-ancestor
138648669|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
138648670|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
138648671|NCT00303810|Thiotepa|thiotepa|mesh-list
138648672|NCT00303810|Lomustine|lomustine|mesh-list
138648673|NCT00303810|Carboplatin|carboplatin|mesh-list
138648674|NCT00303810|Methotrexate|methotrexate|mesh-list
138648675|NCT00303810|Etoposide|etoposide|mesh-list
138648676|NCT00303810|Vincristine|vincristine|mesh-list
138648677|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
138648678|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138648679|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
138648680|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648681|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138648682|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138648683|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
138648684|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648685|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648686|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138648687|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138648688|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
138325372|NCT02666742|Aspirin|aspirin|mesh-list
138648689|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138648690|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138648691|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
138648692|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
138648693|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648694|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138648695|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138648696|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138648697|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138648698|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138648699|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
138648700|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
138648701|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
138648703|NCT00324480|Alvocidib|alvocidib|mesh-list
138648704|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648705|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138648706|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648707|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648708|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
138648709|NCT00324480|Growth Substances|growth substances|mesh-ancestor
138648710|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648711|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138648712|NCT00303888|Docetaxel|docetaxel|mesh-list
138648713|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648714|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
138689307|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689308|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138689313|NCT03235739|Naloxegol|naloxegol|mesh-list
138648716|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
138536508|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
138648717|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648718|NCT00291707|Pemetrexed|pemetrexed|mesh-list
138648719|NCT00291707|Cetuximab|cetuximab|mesh-list
138648720|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648721|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648722|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253969|NCT02975492|Vitamin D|vitamin d|mesh-list
138648723|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138648724|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138648725|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138648726|NCT00324519|Misoprostol|misoprostol|mesh-list
138648727|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138648728|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
138648729|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138648730|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648731|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138648732|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138648733|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
138648734|NCT00291746|Esomeprazole|esomeprazole|mesh-list
138648735|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138648736|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138648737|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138648738|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536548|NCT00148720|Capecitabine|capecitabine|mesh-list
138648739|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648740|NCT00303927|Capecitabine|capecitabine|mesh-list
138648741|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138648742|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
138648743|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648744|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648745|NCT00419484|Pioglitazone|pioglitazone|mesh-list
138648746|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138648747|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648748|NCT00291785|Leucovorin|leucovorin|mesh-list
138648749|NCT00291785|Folic Acid|folic acid|mesh-list
138648750|NCT00291785|Fluorouracil|fluorouracil|mesh-list
138648751|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
138648752|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
138648753|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648754|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138648755|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648756|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138648757|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
138648758|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648760|NCT00291785|Protective Agents|protective agents|mesh-ancestor
138689345|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138689346|NCT03109795|Clonidine|clonidine|mesh-list
138689347|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138689348|NCT03109795|Diuretics|diuretics|mesh-ancestor
138689349|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
138689350|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689351|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138689352|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138689353|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689354|NCT03109795|Analgesics|analgesics|mesh-ancestor
138648762|NCT00291785|Vitamins|vitamins|mesh-ancestor
138648763|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
138648764|NCT00291785|Hematinics|hematinics|mesh-ancestor
138648765|NCT00324558|Bemiparin|bemiparin|mesh-list
138648766|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
138648767|NCT00291863|Simvastatin|simvastatin|mesh-list
138648768|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138648769|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138648770|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
138648771|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648772|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138648773|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138648774|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648775|NCT00304200|Temozolomide|temozolomide|mesh-list
138648776|NCT00304200|Sunitinib|sunitinib|mesh-list
138648777|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138648778|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
138648779|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648780|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648781|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138648782|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138648783|NCT00304200|Growth Substances|growth substances|mesh-ancestor
138648784|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648785|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
138648786|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138648787|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648788|NCT00291980|Vaccines|vaccines|mesh-list
138648789|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
138648790|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648791|NCT00324597|Gemcitabine|gemcitabine|mesh-list
138648792|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
138648793|NCT00324597|Imetelstat|imetelstat|mesh-list
138648794|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138648795|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
138648796|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648797|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648798|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138648799|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648800|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
138648801|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138648802|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138648803|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648804|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138648805|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648806|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138648808|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138648809|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138648810|NCT00304317|Analgesics|analgesics|mesh-ancestor
138648811|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
138648812|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648813|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648814|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138648815|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138648816|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138648817|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138648818|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648819|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648820|NCT00324792|Insulin|insulin|mesh-list
138648821|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138648822|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648823|NCT00292214|Acetaminophen|acetaminophen|mesh-list
138648824|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138648825|NCT00292214|Analgesics|analgesics|mesh-ancestor
138648826|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
138648827|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648828|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648829|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
138648830|NCT00324831|Prednisone|prednisone|mesh-list
138648831|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
138648832|NCT00324831|Rituximab|rituximab|mesh-list
138648834|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138648835|NCT00324831|Vincristine|vincristine|mesh-list
138648836|NCT00324831|Vaccines|vaccines|mesh-list
138648837|NCT00324831|Antibodies|antibodies|mesh-list
138648838|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
138648839|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138648840|NCT00324831|Sargramostim|sargramostim|mesh-list
138648841|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138648842|NCT00324831|Immunomodulating Agents|immunomodulating agents|mesh-list
138648843|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
138711082|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
138648844|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648845|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138648846|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138648847|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138648848|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
138648849|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648850|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648851|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138648852|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138648853|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138648854|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138648855|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138648856|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648857|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138648858|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
138648859|NCT00324831|Hormones|hormones|mesh-ancestor
138648860|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138648861|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138648862|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138648863|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
138648864|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
138648865|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
138648866|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
138689399|NCT02939742|Betamethasone|betamethasone|mesh-list
138648867|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138648868|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
138648869|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648870|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648871|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
138328985|NCT00425802|Cyclosporine|cyclosporine|mesh-list
138648872|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138648873|NCT00304434|Oseltamivir|oseltamivir|mesh-list
138648875|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
138648876|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138648877|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648878|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648879|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
138648880|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
138648881|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138648882|NCT00292409|Aripiprazole|aripiprazole|mesh-list
138648883|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
138648884|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138648885|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138648886|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138648887|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138648888|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648890|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
138648891|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138648892|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648893|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138648894|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138648895|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
138648896|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138648897|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138648898|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138648899|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138648900|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138648901|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
138648902|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138648903|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138648904|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138648905|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138648906|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648907|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
138648908|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138648909|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
138648910|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648911|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648912|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138648913|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
138648914|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
138648915|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138648916|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
138648917|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138648918|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648920|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138648921|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
138648922|NCT00324948|Urological Agents|urological agents|mesh-ancestor
138648923|NCT00304551|Ribavirin|ribavirin|mesh-list
138648924|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138648925|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
138648926|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
138648927|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648928|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
138648929|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138648930|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
138648931|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648933|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138648934|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
138648935|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138648936|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648937|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138648938|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138648939|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
138648940|NCT00325104|Calcium|calcium|mesh-list
138648941|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
138648942|NCT00325104|Hormones|hormones|mesh-list
138648943|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138648944|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648945|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138648946|NCT00292526|Enalapril|enalapril|mesh-list
138648947|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138648948|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
138648949|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689445|NCT02845882|Daunorubicin|daunorubicin|mesh-list
138648950|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648951|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138648952|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
138648953|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
138648954|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138648955|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
138648956|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254253|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
138648957|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648958|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138648959|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
138648960|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138648961|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138648962|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138648963|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
138648964|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138648965|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648966|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138648967|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
138648968|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138648969|NCT00292721|Celecoxib|celecoxib|mesh-list
138648970|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138648971|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138648972|NCT00292721|Analgesics|analgesics|mesh-ancestor
138648973|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
138648974|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138648975|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648976|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138648977|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138648978|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138648979|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138648980|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648981|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648982|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
138648983|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138648984|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138648985|NCT00325182|Levetiracetam|levetiracetam|mesh-list
138648986|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
138648987|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
138648989|NCT00292799|Orlistat|orlistat|mesh-list
138648990|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138648991|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689488|NCT02829918|Nivolumab|nivolumab|mesh-list
138648992|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648993|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648995|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138648996|NCT00304629|Galantamine|galantamine|mesh-list
138648997|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138648998|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138648999|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649000|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
138649001|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649002|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649003|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138649004|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
138649005|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649006|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
138649007|NCT00292838|Fluticasone|fluticasone|mesh-list
138649008|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138649009|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138649010|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
138649011|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649012|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649013|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138649014|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
138649015|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
138649016|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138649017|NCT00304668|Dapivirine|dapivirine|mesh-list
138649018|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138649019|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138649020|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
138649021|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649022|NCT00292955|Cetuximab|cetuximab|mesh-list
138649023|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138649024|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649025|NCT00293072|Rituximab|rituximab|mesh-list
138649026|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138649027|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649028|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
138649029|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649030|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138649031|NCT00293111|Etodolac|etodolac|mesh-list
138649032|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138649033|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138649034|NCT00293111|Analgesics|analgesics|mesh-ancestor
138649035|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
138649036|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649037|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649038|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138649039|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138649040|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138649041|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138649042|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711083|NCT04621110|Ketamine|ketamine|mesh-list
138649043|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649044|NCT00304785|Latanoprost|latanoprost|mesh-list
138649045|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138329039|NCT00428298|Valacyclovir|valacyclovir|mesh-list
138649046|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138649048|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138649049|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
138649050|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138649051|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649052|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138649055|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138649056|NCT00293228|Isoniazid|isoniazid|mesh-list
138649057|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
138649058|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138649059|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649060|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138649061|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138649062|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
138649063|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649064|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138649065|NCT00293345|Gemcitabine|gemcitabine|mesh-list
138649066|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138649067|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
138649068|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649069|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649070|NCT00293501|Tinzaparin|tinzaparin|mesh-list
138649071|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138649072|NCT00293501|Dalteparin|dalteparin|mesh-list
138649073|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
138649074|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138649075|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138649076|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649077|NCT00325455|Anacetrapib|anacetrapib|mesh-list
138649078|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138649079|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138649080|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
138649081|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649082|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138649083|NCT00293657|Lornoxicam|lornoxicam|mesh-list
138649084|NCT00293657|Piroxicam|piroxicam|mesh-list
138649085|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138649086|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138649087|NCT00293657|Analgesics|analgesics|mesh-ancestor
138649088|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
138649089|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649090|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649091|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138649092|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138649093|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138649094|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649095|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649097|NCT00293696|Bicalutamide|bicalutamide|mesh-list
138649098|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138649099|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649100|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
138649101|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
138649102|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138649103|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649104|NCT00293735|Labetalol|labetalol|mesh-list
138649105|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138649106|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138649107|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
138649108|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649109|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649110|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649111|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138649112|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
138649113|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
138649114|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649115|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138649116|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138649117|NCT00304980|Lumefantrine|lumefantrine|mesh-list
138649118|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
138649120|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
138649121|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138649122|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138649123|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
138649124|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138649125|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138649126|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537429|NCT00152620|Prednisolone|prednisolone|mesh-list
138649127|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138649128|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649129|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649130|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138649131|NCT00293891|Tacrolimus|tacrolimus|mesh-list
138649132|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138649133|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
138649134|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649135|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138649136|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254459|NCT02976623|Metronidazole|metronidazole|mesh-list
138649137|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649139|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138649140|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
138649141|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325816|NCT01896336|Zolpidem|zolpidem|mesh-list
138649142|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138649143|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649144|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649145|NCT00305019|Clevudine|clevudine|mesh-list
138649146|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
138649147|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649148|NCT00293969|Morphine|morphine|mesh-list
138649149|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138649150|NCT00293969|Narcotics|narcotics|mesh-ancestor
138649151|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138649152|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649153|NCT00293969|Analgesics|analgesics|mesh-ancestor
138649154|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
138649155|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649156|NCT00294008|Risperidone|risperidone|mesh-list
138649157|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138649158|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
138329085|NCT00533910|Rifaximin|rifaximin|mesh-list
138649159|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649160|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649161|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649162|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138649163|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138649164|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138649165|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138649166|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138649167|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
138649168|NCT00294086|Valsartan|valsartan|mesh-list
138649169|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138649170|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138649171|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138649172|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649173|NCT00325689|Risperidone|risperidone|mesh-list
138649174|NCT00325689|Aripiprazole|aripiprazole|mesh-list
138649175|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138649176|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138649177|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
138649178|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649179|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649180|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649181|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138649182|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138649183|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138649184|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138649185|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138649186|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
138649187|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
138649188|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
138649189|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138649190|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138649191|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138649192|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138649193|NCT00294164|Hormones|hormones|mesh-list
138649194|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138649195|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649196|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138649197|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138649198|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138649199|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138537637|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138649200|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649201|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
138649202|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649203|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649204|NCT00417833|Bevacizumab|bevacizumab|mesh-list
138649205|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138649206|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649207|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138649208|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138649209|NCT00417833|Growth Substances|growth substances|mesh-ancestor
138254532|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
138649210|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649211|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
138649213|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
138649214|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138325897|NCT01212822|Leucovorin|leucovorin|mesh-list
138649215|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138649216|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138649217|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138649218|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
138649219|NCT00294203|Hematinics|hematinics|mesh-ancestor
138649221|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138649222|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649223|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138537699|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138649224|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138649225|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138689616|NCT02425566|Trimethaphan|trimethaphan|mesh-list
138649226|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649227|NCT00305331|Domperidone|domperidone|mesh-list
138649228|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
138649229|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
138649230|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649231|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649232|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138649233|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138649234|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
138649235|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649236|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649237|NCT00325767|Albuterol|albuterol|mesh-list
138649238|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138649239|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
138649240|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649241|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649242|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138649243|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
138649244|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
138649245|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138649246|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138649247|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138649248|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138649249|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
138649250|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649251|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649252|NCT00294359|Bevacizumab|bevacizumab|mesh-list
138649253|NCT00294359|Capecitabine|capecitabine|mesh-list
138649255|NCT00294359|Mitomycin|mitomycin|mesh-list
138649256|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138649257|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649258|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138649259|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138649261|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649262|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
138649263|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138649264|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
138649265|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649266|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138649267|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
138649268|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138649269|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649270|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
138649271|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138649272|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649274|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
138649275|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138649276|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138649277|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138649278|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138649279|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649280|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
138649281|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
138649282|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649283|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329096|NCT00535002|Yohimbine|yohimbine|mesh-list
138649284|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138537872|NCT04705987|Colchicine|colchicine|mesh-list
138649285|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138649286|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
138649287|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138649288|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138649289|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138649290|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138649291|NCT00325806|Ramipril|ramipril|mesh-list
138649292|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138649293|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
138649294|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649295|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649296|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138649297|NCT00305409|Sulfalene|sulfalene|mesh-list
138649298|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649299|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138649300|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
138649301|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138649302|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138649304|NCT00294593|Folic Acid|folic acid|mesh-list
138649305|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
138649306|NCT00294593|Antidotes|antidotes|mesh-ancestor
138649307|NCT00294593|Protective Agents|protective agents|mesh-ancestor
138649308|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649309|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
138649310|NCT00294593|Vitamins|vitamins|mesh-ancestor
138649311|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
138649312|NCT00294593|Hematinics|hematinics|mesh-ancestor
138649313|NCT00325845|Hylan|hylan|mesh-list
138649314|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
138649315|NCT00325845|Protective Agents|protective agents|mesh-ancestor
138649316|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649317|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
138649318|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138649319|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649321|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138649322|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649323|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649324|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649325|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138649326|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138649327|NCT00325962|Verapamil|verapamil|mesh-list
138649328|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138649329|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138649330|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138649331|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649332|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138649333|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649334|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
138649335|NCT00305487|Ciclesonide|ciclesonide|mesh-list
138649336|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
138649337|NCT00305487|Hormones|hormones|mesh-ancestor
138649338|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138649339|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649340|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138649341|NCT00294944|Idazoxan|idazoxan|mesh-list
138649342|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138537960|NCT00083460|Hormones|hormones|mesh-ancestor
138649343|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138649344|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138649345|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
138649346|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649347|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649348|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649349|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138649350|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
138649351|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649352|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138649353|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138649354|NCT00295100|Tamoxifen|tamoxifen|mesh-list
138649356|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
138649357|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138649358|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649359|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138649360|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649361|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138649362|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138649363|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138649365|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138649366|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138649367|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138649368|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649369|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138649370|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138649371|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
138649372|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649373|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649374|NCT00295178|Vancomycin|vancomycin|mesh-list
138649375|NCT00295178|Daptomycin|daptomycin|mesh-list
138649376|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138649377|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649378|NCT00305838|Tamoxifen|tamoxifen|mesh-list
138649380|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
138649381|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138649382|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649383|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138649384|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649385|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138649386|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138649387|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138649388|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138649389|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138649390|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138649391|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
138649392|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649393|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138649394|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138649395|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649396|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138649397|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
138649398|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138649399|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138538042|NCT00155233|Analgesics|analgesics|mesh-ancestor
138649400|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138649401|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138329128|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
138649402|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649403|NCT00326352|Remifentanil|remifentanil|mesh-list
138649404|NCT00326352|Propofol|propofol|mesh-list
138689746|NCT01431326|Cefepime|cefepime|mesh-list
138649405|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138649406|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138649407|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649408|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138649409|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
138649411|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138649412|NCT00326352|Narcotics|narcotics|mesh-ancestor
138649413|NCT00326352|Analgesics|analgesics|mesh-ancestor
138649414|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
138649415|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649416|NCT00419601|Fentanyl|fentanyl|mesh-list
138649417|NCT00419601|Remifentanil|remifentanil|mesh-list
138649418|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138649419|NCT00419601|Narcotics|narcotics|mesh-ancestor
138649420|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138649421|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649422|NCT00419601|Analgesics|analgesics|mesh-ancestor
138649423|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
138649424|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649425|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138649426|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138649427|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
138649428|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
138649429|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138649430|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
138649431|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138649432|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
138649433|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
138649434|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649435|NCT00295607|Antibodies|antibodies|mesh-list
138649436|NCT00295607|Tacrolimus|tacrolimus|mesh-list
138649437|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
138649438|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649439|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138649440|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138649441|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649442|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649443|NCT00326391|Methylphenidate|methylphenidate|mesh-list
138649444|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138649445|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649446|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138649447|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138649448|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138689776|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138649449|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649450|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
138649451|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649452|NCT00295685|Antacids|antacids|mesh-list
138649453|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649454|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138649455|NCT00306150|Aprotinin|aprotinin|mesh-list
138649456|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
138649457|NCT00306150|Coagulants|coagulants|mesh-ancestor
138649458|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138649459|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138649460|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
138649461|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649462|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649463|NCT00417911|Bortezomib|bortezomib|mesh-list
138649464|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649465|NCT00326469|Lanreotide|lanreotide|mesh-list
138649466|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649467|NCT00417950|Acarbose|acarbose|mesh-list
138649468|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138649469|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649470|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649471|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138649472|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649473|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
138649474|NCT00306267|Hematinics|hematinics|mesh-ancestor
138649475|NCT00326508|Daclizumab|daclizumab|mesh-list
138649476|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138649477|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
138649478|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649479|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
138649480|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
138649481|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
138649482|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138649483|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649484|NCT00295841|Cytarabine|cytarabine|mesh-list
138649485|NCT00295841|Clofarabine|clofarabine|mesh-list
138649486|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138649487|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
138649488|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649489|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649490|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
138649491|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649492|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138649493|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
138649494|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649495|NCT00326664|Cediranib|cediranib|mesh-list
138649496|NCT00326664|Maleic acid|maleic acid|mesh-list
138649497|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649498|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649499|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649500|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138649501|NCT00295919|Ketoconazole|ketoconazole|mesh-list
138649502|NCT00295919|Fenretinide|fenretinide|mesh-list
138649503|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
138649504|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649505|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138649506|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138649507|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649508|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649509|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138649510|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
138649511|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138649512|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649513|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138649514|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649515|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138649516|NCT00295919|Protective Agents|protective agents|mesh-ancestor
138649517|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
138649518|NCT00295958|Immunotoxins|immunotoxins|mesh-list
138649519|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138649520|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
138649521|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649522|NCT00295958|Immunoconjugates|immunoconjugates|mesh-ancestor
138649523|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
138649524|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
138649525|NCT00295997|Busulfan|busulfan|mesh-list
138649526|NCT00295997|Methotrexate|methotrexate|mesh-list
138649527|NCT00295997|Fludarabine|fludarabine|mesh-list
138649528|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
138649529|NCT00295997|Tacrolimus|tacrolimus|mesh-list
138649530|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138649531|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138649532|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
138649533|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649534|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138649535|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138649536|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
138649537|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649538|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649539|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138649540|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138649541|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
138649542|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138649544|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
138649545|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
138649546|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649547|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138649548|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138649549|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138649550|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138649551|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138649552|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
138649553|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138649554|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649555|NCT00418067|Sirolimus|sirolimus|mesh-list
138649556|NCT00418067|Paclitaxel|paclitaxel|mesh-list
138649557|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138188324|NCT03018535|Protective Agents|protective agents|mesh-ancestor
138649558|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649559|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
138649560|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
138649561|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
138649562|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649563|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138649564|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649565|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138649566|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
138649567|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138649568|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
138649569|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649570|NCT00296309|Tacrolimus|tacrolimus|mesh-list
138649571|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138649572|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
138649573|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649574|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138649575|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649576|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649577|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
138649578|NCT00296348|Tacrolimus|tacrolimus|mesh-list
138649579|NCT00296348|Daclizumab|daclizumab|mesh-list
138649580|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138649581|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
138649582|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649583|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138254896|NCT04593459|Metformin|metformin|mesh-list
138649585|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649586|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138649587|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649588|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138649589|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
138649590|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138649591|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649592|NCT00296387|Atorvastatin|atorvastatin|mesh-list
138649593|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138649594|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138649595|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138649596|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
138649597|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649598|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138649599|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138649600|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649601|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
138649602|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
138649603|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138649604|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649605|NCT00296465|Citric Acid|citric acid|mesh-list
138649606|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
138649607|NCT00296465|Clomiphene|clomiphene|mesh-list
138649608|NCT00296465|Enclomiphene|enclomiphene|mesh-list
138649609|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
138649610|NCT00296465|Hormones|hormones|mesh-list
138649611|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138649612|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
138649613|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138649614|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
138649615|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
138649616|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649617|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138649618|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649619|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138649620|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
138649621|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138649622|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
138649623|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138649624|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138649625|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138649626|NCT00326859|Remifentanil|remifentanil|mesh-list
138649627|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138649628|NCT00326859|Narcotics|narcotics|mesh-ancestor
138649629|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138649630|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649631|NCT00326859|Analgesics|analgesics|mesh-ancestor
138649632|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
138649633|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649634|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138649635|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138649636|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138649637|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138649638|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649639|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649640|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649641|NCT00296699|Analgesics|analgesics|mesh-ancestor
138649642|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
138649643|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649644|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
138649645|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138649646|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
138649648|NCT00296777|Imipramine|imipramine|mesh-list
138649650|NCT00296777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138649651|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138649652|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138649653|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649654|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649655|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
138649656|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649657|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138649658|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
138649659|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138649660|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138649661|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
138326356|NCT00074802|Paroxetine|paroxetine|mesh-list
138649662|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138649663|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138649664|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649665|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138649666|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138649667|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
138649669|NCT00296894|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138649670|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138649671|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138649672|NCT00296933|Bupropion|bupropion|mesh-list
138649673|NCT00296933|Escitalopram|escitalopram|mesh-list
138649674|NCT00296933|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138649675|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138649676|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138329230|NCT00492336|Rasagiline|rasagiline|mesh-list
138538407|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138649677|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649678|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649679|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
138649680|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649681|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138649682|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
138649683|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138649684|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138649685|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
138649686|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138255023|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
138649687|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138649688|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649690|NCT00296972|Ribavirin|ribavirin|mesh-list
138649691|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649692|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
138649693|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649694|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
138649695|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649696|NCT00297011|Valacyclovir|valacyclovir|mesh-list
138649697|NCT00297011|Clobetasol|clobetasol|mesh-list
138649698|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
138649699|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649700|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138649701|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
138649702|NCT00297011|Hormones|hormones|mesh-ancestor
138649703|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138649704|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649705|NCT00327093|Bevacizumab|bevacizumab|mesh-list
138649706|NCT00327093|Cetuximab|cetuximab|mesh-list
138649707|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138538450|NCT00158548|Amebicides|amebicides|mesh-ancestor
138649708|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649709|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138649710|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138649711|NCT00327093|Growth Substances|growth substances|mesh-ancestor
138649712|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649713|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
138649714|NCT00297050|Peramivir|peramivir|mesh-list
138649715|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
138649716|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649717|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649718|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649719|NCT00297128|Capecitabine|capecitabine|mesh-list
138649720|NCT00297128|Cetuximab|cetuximab|mesh-list
138649721|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138649722|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
138649723|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649724|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649725|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138649726|NCT00327132|Amoxicillin|amoxicillin|mesh-list
138649727|NCT00327132|Clarithromycin|clarithromycin|mesh-list
138649728|NCT00327132|Omeprazole|omeprazole|mesh-list
138649729|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138649730|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649731|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138649732|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138649733|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138649734|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255137|NCT00000315|Cocaine|cocaine|mesh-list
138453589|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138649735|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326415|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649736|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138649737|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138329240|NCT00538824|Thalidomide|thalidomide|mesh-list
138770268|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770269|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770270|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138770271|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138770272|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
138770274|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770275|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
138770276|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138770277|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138770278|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770279|NCT01122264|Urological Agents|urological agents|mesh-ancestor
138770280|NCT00920218|Vaccines|vaccines|mesh-list
138770281|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
138770282|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770283|NCT00649519|Amlodipine|amlodipine|mesh-list
138770284|NCT00649519|Benazepril|benazepril|mesh-list
138770285|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138770286|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138770287|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770288|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770289|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138770290|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770291|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
138770292|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138770293|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
138770294|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770295|NCT00629811|Mitogens|mitogens|mesh-list
138770296|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
138770297|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770298|NCT02652091|Interferons|interferons|mesh-list
138770300|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
138770301|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770302|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
138770303|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770304|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
138770305|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770306|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138770307|NCT00625560|Lamivudine|lamivudine|mesh-list
138770308|NCT00625560|Entecavir|entecavir|mesh-list
138770309|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138770310|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138770311|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770312|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770313|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
138770314|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770315|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138770316|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138770317|NCT00650455|Naproxen|naproxen|mesh-list
138770318|NCT00650455|Valdecoxib|valdecoxib|mesh-list
138689961|NCT02915796|Lenograstim|lenograstim|mesh-list
138770319|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138770320|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138770321|NCT00650455|Analgesics|analgesics|mesh-ancestor
138770322|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
138770323|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770324|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770325|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138770326|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138770327|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
138770328|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138770329|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770330|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770331|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138770333|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
138770334|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
138770335|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138770336|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770337|NCT02658409|Vaccines|vaccines|mesh-list
138770338|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
138770339|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770340|NCT01121562|Sunitinib|sunitinib|mesh-list
138770341|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770342|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138770343|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138770344|NCT01121562|Growth Substances|growth substances|mesh-ancestor
138770345|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770346|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
138770347|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138770348|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770349|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770350|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138770351|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138770352|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
138770353|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770354|NCT02658253|Antacids|antacids|mesh-ancestor
138770355|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770356|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138770357|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
138770358|NCT02651623|Sertraline|sertraline|mesh-list
138770359|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138770360|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770361|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138770362|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138770363|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553585|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
138770364|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770366|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689990|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
138770367|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
138282933|NCT03001843|Ketamine|ketamine|mesh-list
138770368|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138770369|NCT02651623|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138770370|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138770371|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770372|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770373|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
138770374|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138770375|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138770376|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138770377|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770378|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770379|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138538675|NCT00407017|Analgesics|analgesics|mesh-ancestor
138770380|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770381|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
138770382|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138770383|NCT00650221|Pravastatin|pravastatin|mesh-list
138770384|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138770385|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138770386|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
138770387|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770388|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138770389|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138770390|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770392|NCT01169675|Afatinib|afatinib|mesh-list
138770393|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770394|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770395|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770396|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138770397|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138770398|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138770399|NCT00650533|Glimepiride|glimepiride|mesh-list
138770400|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138770401|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138770402|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770403|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138770404|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
138770405|NCT02881866|Furosemide|furosemide|mesh-list
138770406|NCT02881866|Diuretics|diuretics|mesh-ancestor
138770407|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
138770408|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770409|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138770410|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770411|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770412|NCT00924664|Tanezumab|tanezumab|mesh-list
138770413|NCT00924664|Analgesics|analgesics|mesh-ancestor
138538714|NCT00160264|Vitamin D|vitamin d|mesh-list
138770414|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
138770415|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770416|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770417|NCT02653651|Lidocaine|lidocaine|mesh-list
138770418|NCT02653651|Ketamine|ketamine|mesh-list
138770419|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
138770420|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
138770421|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138770422|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770423|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
138770424|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770425|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138770426|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138770427|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138770428|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770429|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770430|NCT02653651|Analgesics|analgesics|mesh-ancestor
138770431|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138770432|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138770433|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
138770434|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138770435|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138770436|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770437|NCT02651311|Ibuprofen|ibuprofen|mesh-list
138770438|NCT02651311|Fentanyl|fentanyl|mesh-list
138770439|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138770440|NCT02651311|Narcotics|narcotics|mesh-ancestor
138770441|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138770442|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770443|NCT02651311|Analgesics|analgesics|mesh-ancestor
138770444|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
138770445|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770446|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138770447|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138770448|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
138770449|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
138770450|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138770451|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138770452|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138770453|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138770454|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138770455|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770456|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444818|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
138770457|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
138770458|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138770459|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138770460|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770461|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
138770462|NCT02653261|Coagulants|coagulants|mesh-ancestor
138770463|NCT02653339|Loratadine|loratadine|mesh-list
138770464|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
138770465|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
138770466|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138770467|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138770468|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138770469|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
138770470|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
138770471|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770472|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770473|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770474|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138770475|NCT00649597|Benazepril|benazepril|mesh-list
138770476|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138770477|NCT00649597|Diuretics|diuretics|mesh-ancestor
138770478|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
138770479|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770480|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138770481|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770482|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770483|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138770484|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
138770485|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770486|NCT02653027|Ivacaftor|ivacaftor|mesh-list
138770487|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138770488|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770489|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770490|NCT02652793|Lamivudine|lamivudine|mesh-list
138770491|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138770492|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138770493|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138770494|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553598|NCT00280267|Hormones|hormones|mesh-ancestor
138770495|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770496|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
138770497|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770498|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138770499|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138770500|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138770501|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138770502|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
138770503|NCT00650611|Ziprasidone|ziprasidone|mesh-list
138770504|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138770505|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
138770506|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770507|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770508|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770509|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138770510|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138770511|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138770512|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138770513|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138770514|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
138770515|NCT00600067|Topiramate|topiramate|mesh-list
138770516|NCT00600067|Phentermine|phentermine|mesh-list
138770517|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
138770518|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138770519|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770520|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138770521|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
138770522|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138770523|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
138770524|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
138770525|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770526|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
138770527|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770528|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770529|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
138770530|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138770531|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138770532|NCT02650609|Prednisolone|prednisolone|mesh-list
138770533|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
138770534|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138770535|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
138770536|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138770537|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
138770538|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
138770539|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770540|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770541|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138770542|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
138770544|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138770545|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138770546|NCT02650609|Protective Agents|protective agents|mesh-ancestor
138770547|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138770548|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770549|NCT02652871|Cytarabine|cytarabine|mesh-list
138770550|NCT02652871|Idarubicin|idarubicin|mesh-list
138770551|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138770552|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
138770553|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770554|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770556|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770557|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138770558|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
138770559|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770560|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138770561|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138770562|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138770563|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770564|NCT00650299|Alprazolam|alprazolam|mesh-list
138770565|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138770566|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138770567|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770569|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138770570|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138770571|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
138770572|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
138770573|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770574|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770575|NCT04168099|Cefotaxime|cefotaxime|mesh-list
138770576|NCT04168099|Cefoxitin|cefoxitin|mesh-list
138770577|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
138770578|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138770579|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770580|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138770581|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138770582|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770583|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770584|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770585|NCT04283877|Methylphenidate|methylphenidate|mesh-list
138770586|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138770587|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770588|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138770589|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138770590|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770591|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770592|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
138770593|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770594|NCT04283487|Levan|levan|mesh-list
138770595|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770596|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
138770597|NCT04283331|Propoxycaine|propoxycaine|mesh-list
138770598|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
138770599|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
138770600|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138770601|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770602|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
138770603|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770604|NCT02657473|Tobramycin|tobramycin|mesh-list
138770605|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138770606|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138770607|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770608|NCT02652637|Metronidazole|metronidazole|mesh-list
138770610|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770611|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138770612|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138770613|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138770614|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138770615|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770616|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770617|NCT00649675|Meloxicam|meloxicam|mesh-list
138770618|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138770619|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138770620|NCT00649675|Analgesics|analgesics|mesh-ancestor
138770621|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
138770622|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770623|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770624|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690117|NCT02918331|Hormones|hormones|mesh-ancestor
138770625|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138770626|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138770627|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138770628|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553624|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138770629|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770630|NCT02860923|Exenatide|exenatide|mesh-list
138770631|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138770632|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770633|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138770634|NCT02860923|Incretins|incretins|mesh-ancestor
138770635|NCT02860923|Hormones|hormones|mesh-ancestor
138770636|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138770637|NCT01121406|Paclitaxel|paclitaxel|mesh-list
138770638|NCT01121406|Gemcitabine|gemcitabine|mesh-list
138770639|NCT01121406|Doxorubicin|doxorubicin|mesh-list
138770640|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138770641|NCT01121406|Topotecan|topotecan|mesh-list
138770642|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138770643|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770644|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
138770645|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
138770646|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
138770647|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770648|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138770649|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
138283022|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138770650|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138770651|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138770652|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138770653|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770654|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138770655|NCT02652325|Iodine|iodine|mesh-list
138770656|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
138770657|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
138770658|NCT02652325|Povidone|povidone|mesh-list
138770659|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138770660|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770661|NCT02652325|Trace Elements|trace elements|mesh-ancestor
138770662|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
138770663|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770664|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
138770665|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
138770666|NCT00960687|Fenofibrate|fenofibrate|mesh-list
138770667|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
138770668|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138770669|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
138770670|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770671|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138770672|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138770673|NCT00920140|Trametinib|trametinib|mesh-list
138770674|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770675|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138770676|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770677|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770678|NCT01120626|Donepezil|donepezil|mesh-list
138770679|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138770680|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770681|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770682|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
138770683|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770684|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770685|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
138770686|NCT00650377|Finasteride|finasteride|mesh-list
138770687|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138770688|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138770689|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770690|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770691|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
138770692|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138770693|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770694|NCT00650377|Urological Agents|urological agents|mesh-ancestor
138770695|NCT02649751|Roscovitine|roscovitine|mesh-list
138770696|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770697|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
138770698|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770699|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138770700|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770701|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770702|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138770703|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138770704|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138770705|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
138770706|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770707|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138770708|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138770709|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770710|NCT00924508|Triamcinolone|triamcinolone|mesh-list
138770711|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138770712|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138770713|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138770714|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138770715|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
138770716|NCT00924508|Hormones|hormones|mesh-ancestor
138770717|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138770718|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770719|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138770720|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
138770721|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770722|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770723|NCT00650923|Temozolomide|temozolomide|mesh-list
138770724|NCT00650923|Aflibercept|aflibercept|mesh-list
138770725|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
138770726|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138770727|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
138539207|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
138770728|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770729|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770730|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138770731|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138770732|NCT00650923|Growth Substances|growth substances|mesh-ancestor
138770733|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770734|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
138770735|NCT00637858|Lycopene|lycopene|mesh-list
138770736|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138770737|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
138770738|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770739|NCT00637858|Protective Agents|protective agents|mesh-ancestor
138770740|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770741|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138770742|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138770743|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770744|NCT02657161|Vaccines|vaccines|mesh-list
138770745|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
138770746|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770748|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
138770749|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
138770750|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
138770751|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
138770752|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
138770753|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
138770754|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770755|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138770756|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
138770757|NCT04251832|Antidotes|antidotes|mesh-ancestor
138445116|NCT01826526|Taurolidine|taurolidine|mesh-list
138770758|NCT04251832|Protective Agents|protective agents|mesh-ancestor
138770759|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770760|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
138770761|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770762|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
138770763|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138770764|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770765|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
138770766|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
138770767|NCT02656771|Metronidazole|metronidazole|mesh-list
138770768|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770769|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138770770|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138770771|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138770772|NCT00917644|Atorvastatin|atorvastatin|mesh-list
138770773|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138770774|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138770775|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
138770776|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770777|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138770778|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138770779|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770780|NCT00625170|Haloperidol|haloperidol|mesh-list
138770781|NCT00625170|Olanzapine|olanzapine|mesh-list
138770782|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
138770783|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
138770784|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
138770785|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770786|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770787|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138770788|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138770789|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138770790|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138770791|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138770792|NCT00625170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138283104|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
138770793|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138770794|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770795|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770796|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770797|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
138770798|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138770799|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
138770800|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138770801|NCT00599755|Carboplatin|carboplatin|mesh-list
138770802|NCT00599755|Gemcitabine|gemcitabine|mesh-list
138770803|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770804|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138770805|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
138770806|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770807|NCT04251364|Acetazolamide|acetazolamide|mesh-list
138770808|NCT04251364|Atorvastatin|atorvastatin|mesh-list
138770809|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138770810|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138770811|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
138770812|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770813|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138770814|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138770815|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770816|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
138770817|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138770818|NCT04251364|Diuretics|diuretics|mesh-ancestor
138770819|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
138770820|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770821|NCT02648425|Leucovorin|leucovorin|mesh-list
138770822|NCT02648425|Cisplatin|cisplatin|mesh-list
138770823|NCT02648425|Capecitabine|capecitabine|mesh-list
138770824|NCT02648425|Fluorouracil|fluorouracil|mesh-list
138553637|NCT00280540|Valsartan|valsartan|mesh-list
138770825|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770826|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138770828|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770829|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138770830|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
138770831|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770832|NCT02648425|Antidotes|antidotes|mesh-ancestor
138770833|NCT02648425|Protective Agents|protective agents|mesh-ancestor
138770834|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
138770835|NCT02648425|Vitamins|vitamins|mesh-ancestor
138770836|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
138770837|NCT02648503|Atropine|atropine|mesh-list
138770838|NCT02648503|Rocuronium|rocuronium|mesh-list
138770839|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138770840|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138770841|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138770842|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
138770843|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770844|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770845|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138770846|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
138770847|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
138770848|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
138770849|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138770850|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138770851|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
138770852|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283129|NCT03018925|Golimumab|golimumab|mesh-list
138770853|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770854|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138539444|NCT00164710|Artemether|artemether|mesh-list
138770855|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138770856|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138770857|NCT05253508|Lidocaine|lidocaine|mesh-list
138770858|NCT05253508|Anesthetics, Local|anesthetics, local|mesh-ancestor
138770859|NCT05253508|Anesthetics|anesthetics|mesh-ancestor
138770860|NCT05253508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138770861|NCT05253508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770862|NCT05253508|Sensory System Agents|sensory system agents|mesh-ancestor
138770863|NCT05253508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770864|NCT05253508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138770865|NCT05253508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138770866|NCT05253508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138770867|NCT05253508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770868|NCT05253508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770869|NCT04524130|Lidocaine|lidocaine|mesh-list
138770870|NCT04524130|Ketamine|ketamine|mesh-list
138770871|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
138770872|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
138770873|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138770874|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770875|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
138770876|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770877|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138770878|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138770879|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138770880|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770881|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770882|NCT04524130|Analgesics|analgesics|mesh-ancestor
138770883|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138770884|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138770885|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
138770886|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138770887|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138770888|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770889|NCT00649831|Amoxicillin|amoxicillin|mesh-list
138770890|NCT00649831|Azithromycin|azithromycin|mesh-list
138770891|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138770892|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770894|NCT02648659|Metronidazole|metronidazole|mesh-list
138770895|NCT02648659|Clarithromycin|clarithromycin|mesh-list
138770896|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138770897|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770898|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138770899|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138770900|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138770901|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770902|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770903|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138770904|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138770905|NCT01125930|Tretinoin|tretinoin|mesh-list
138770906|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770907|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
138770908|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
138770909|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
138770910|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283138|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
138770911|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138770912|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770913|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770914|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
138770915|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138770916|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770917|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138770919|NCT00651235|Propranolol|propranolol|mesh-list
138770920|NCT00651235|Atenolol|atenolol|mesh-list
138770921|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138770922|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138770923|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138770924|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138770925|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770926|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138770927|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138770928|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
138770929|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138539535|NCT00165139|Lenograstim|lenograstim|mesh-list
138770930|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770931|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
138770932|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
138770933|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
138770934|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770935|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138770936|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138770937|NCT04015219|Lifitegrast|lifitegrast|mesh-list
138770938|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138770939|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
138770940|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138770941|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770942|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138770943|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770944|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
138770946|NCT01168973|Ramucirumab|ramucirumab|mesh-list
138770947|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138770948|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770949|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
138770950|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
138770951|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
138770952|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770953|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
138770954|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770955|NCT00631618|Sunitinib|sunitinib|mesh-list
138539572|NCT00165178|Prednisone|prednisone|mesh-list
138770956|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138770957|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138770958|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138770959|NCT00631618|Growth Substances|growth substances|mesh-ancestor
138770960|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553658|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
138770961|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
138770962|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138770963|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770964|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770965|NCT04431778|Ethosuximide|ethosuximide|mesh-list
138770966|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
138770967|NCT04669132|Olanzapine|olanzapine|mesh-list
138770968|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
138770969|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
138770970|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770971|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770972|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138770973|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138770974|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138770975|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138770976|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138770977|NCT04669132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138770978|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138770979|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770980|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445341|NCT01828294|Antibodies|antibodies|mesh-list
138770981|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770983|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
138770984|NCT01168349|Hematinics|hematinics|mesh-ancestor
138770985|NCT00915772|Metformin|metformin|mesh-list
138770986|NCT00915772|Linagliptin|linagliptin|mesh-list
138770988|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138770989|NCT00915772|Incretins|incretins|mesh-ancestor
138770990|NCT00915772|Hormones|hormones|mesh-ancestor
138770991|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138770992|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138770993|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
138770994|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770995|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770996|NCT00632086|Aspirin|aspirin|mesh-list
138770997|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138770998|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138770999|NCT00632086|Analgesics|analgesics|mesh-ancestor
138771000|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
138771001|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771002|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539664|NCT00165451|Etoposide|etoposide|mesh-list
138771003|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771004|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138771005|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138771006|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138771007|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771008|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138771009|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138771010|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771011|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
138771012|NCT00912964|Mirabegron|mirabegron|mesh-list
138771013|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138771014|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138771015|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138771016|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
138771017|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771018|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771019|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771020|NCT00912964|Urological Agents|urological agents|mesh-ancestor
138771021|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
138771022|NCT02641639|Combretastatin|combretastatin|mesh-list
138771023|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138771024|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771025|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
138771026|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
138771027|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
138771028|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771030|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138771031|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771032|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138771033|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771034|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539729|NCT00165763|Donepezil|donepezil|mesh-list
138771035|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138771036|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138771037|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
138771038|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690215|NCT01292239|Ribavirin|ribavirin|mesh-list
138771040|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138771041|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
138771042|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771044|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771045|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138771046|NCT00910897|Thalidomide|thalidomide|mesh-list
138771047|NCT00910897|Dexamethasone|dexamethasone|mesh-list
138771048|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
138771049|NCT00910897|Bortezomib|bortezomib|mesh-list
138771050|NCT00910897|BB 1101|bb 1101|mesh-list
138771051|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771052|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
138771053|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
138771054|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771055|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771056|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138771058|NCT00910897|Hormones|hormones|mesh-ancestor
138771059|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771060|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138771061|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771062|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
138771063|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771064|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771065|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138771066|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
138771067|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
138771068|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138771069|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771070|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138539777|NCT00045396|Tipifarnib|tipifarnib|mesh-list
138771071|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138771072|NCT00910897|Growth Substances|growth substances|mesh-ancestor
138771073|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
138771074|NCT00651547|Budesonide|budesonide|mesh-list
138283191|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
138771075|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
138771076|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771077|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138771078|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
138771079|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771080|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771081|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138771082|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
138771083|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
138771084|NCT00651547|Hormones|hormones|mesh-ancestor
138771085|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771086|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138771087|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138771088|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138771089|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
138771090|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690234|NCT05600179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138539808|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
138771091|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771092|NCT00912808|Donepezil|donepezil|mesh-list
138771093|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138771094|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771095|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771096|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
138771097|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553672|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
138771098|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771099|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
138771100|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
138771101|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138771102|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138771103|NCT02647255|Prednisolone|prednisolone|mesh-list
138771104|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
138771105|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138771106|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
138771107|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771108|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
138771109|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
138771110|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771111|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771112|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138771113|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
138771114|NCT02647255|Hormones|hormones|mesh-ancestor
138771115|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771116|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138771117|NCT02647255|Protective Agents|protective agents|mesh-ancestor
138771118|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138771119|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771120|NCT04329442|Tenofovir|tenofovir|mesh-list
138771121|NCT04329442|Emtricitabine|emtricitabine|mesh-list
138771122|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
138771123|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771124|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138771125|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138771126|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771127|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771128|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138445493|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771129|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138771130|NCT04414228|Anesthetics|anesthetics|mesh-list
138771131|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138283218|NCT03022526|Fentanyl|fentanyl|mesh-list
138771132|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771134|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138771135|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
138771136|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771137|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
138771138|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138771139|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
138771140|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771141|NCT00652639|Clonazepam|clonazepam|mesh-list
138771142|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
138771143|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
138771144|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
138771145|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771146|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771147|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771148|NCT02644915|Edaravone|edaravone|mesh-list
138771149|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138771150|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
138690259|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
138771151|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771152|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138771153|NCT02644915|Protective Agents|protective agents|mesh-ancestor
138771154|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771155|NCT00651703|Imiquimod|imiquimod|mesh-list
138771156|NCT00651703|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138771157|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138771158|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
138771159|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771160|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771161|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
138771162|NCT02964585|Canagliflozin|canagliflozin|mesh-list
138771163|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138771164|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771165|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138771166|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771167|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138771168|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
138771169|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283233|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771170|NCT00651781|Bortezomib|bortezomib|mesh-list
138771171|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771172|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
138771173|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138771174|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138771175|NCT00957801|Prednisolone|prednisolone|mesh-list
138771176|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
138771177|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
138771178|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138771179|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
138771180|NCT00957801|Testosterone|testosterone|mesh-list
138771181|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
138771182|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
138771183|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138771184|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771185|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
138771186|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
138771187|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771188|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771189|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138771190|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
138771191|NCT00957801|Hormones|hormones|mesh-ancestor
138771192|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771193|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138771194|NCT00957801|Protective Agents|protective agents|mesh-ancestor
138771195|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138771196|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771197|NCT00957801|Androgens|androgens|mesh-ancestor
138771198|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
138771199|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
138771200|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138771201|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138771202|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771203|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
138771204|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
138771205|NCT02646709|Ketamine|ketamine|mesh-list
138771206|NCT02646709|Rocuronium|rocuronium|mesh-list
138771207|NCT02646709|Analgesics|analgesics|mesh-ancestor
138771208|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
138771209|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771210|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771211|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138283275|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
138771212|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138771213|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
138771214|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
138771215|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138771216|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138771217|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138771218|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771219|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771220|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138771221|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138771222|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138771223|NCT00651859|Bimatoprost|bimatoprost|mesh-list
138771224|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138771225|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138771226|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138771227|NCT02955823|Dexamethasone|dexamethasone|mesh-list
138771228|NCT02955823|Rituximab|rituximab|mesh-list
138771229|NCT02955823|Lenalidomide|lenalidomide|mesh-list
138771230|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771231|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
138771232|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
138771233|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771234|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771235|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138771236|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
138771237|NCT02955823|Hormones|hormones|mesh-ancestor
138771238|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771239|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138771240|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771241|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138771242|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
138771243|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138283304|NCT03032965|Adenosine|adenosine|mesh-list
138771244|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138771245|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138771246|NCT02955823|Growth Substances|growth substances|mesh-ancestor
138771247|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
138771248|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138771250|NCT02646397|Benidipine|benidipine|mesh-list
138771251|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138771252|NCT02646397|Diuretics|diuretics|mesh-ancestor
138771253|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
138771254|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771255|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138771256|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138771257|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771258|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138771259|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
138771260|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771261|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138771262|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138771263|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
138771264|NCT00652795|Doxycycline|doxycycline|mesh-list
138771265|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138771266|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771267|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
138771268|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138771269|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138771270|NCT00911170|Bevacizumab|bevacizumab|mesh-list
138771271|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138771272|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771273|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138771274|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138771275|NCT00911170|Growth Substances|growth substances|mesh-ancestor
138771276|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771277|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
138771278|NCT00910975|Interferons|interferons|mesh-list
138771279|NCT00910975|Ribavirin|ribavirin|mesh-list
138771280|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
138771282|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138771283|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771284|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
138771285|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771286|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
138771287|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771288|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
138771289|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771290|NCT01167881|Glimepiride|glimepiride|mesh-list
138771291|NCT01167881|Empagliflozin|empagliflozin|mesh-list
138540075|NCT00407407|Carboplatin|carboplatin|mesh-list
138771292|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138771293|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138771294|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771295|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138771296|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
138771297|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138771298|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771299|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
138771300|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138771301|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771303|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771304|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771305|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771306|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138771307|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138771308|NCT04829344|Carticaine|carticaine|mesh-list
138771309|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
138771311|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138771312|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771313|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
138771314|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771315|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
138771317|NCT00960063|Ifosfamide|ifosfamide|mesh-list
138771318|NCT00960063|Doxorubicin|doxorubicin|mesh-list
138771319|NCT00960063|Irinotecan|irinotecan|mesh-list
138771320|NCT00960063|Etoposide|etoposide|mesh-list
138771321|NCT00960063|Vincristine|vincristine|mesh-list
138771322|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138771323|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
138771324|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771325|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138771326|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138771327|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
138771328|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771329|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771330|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138771331|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138771332|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138771333|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138771334|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771335|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138771336|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138771337|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
138771338|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
138771339|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
138771340|NCT02646319|Sirolimus|sirolimus|mesh-list
138771341|NCT02646319|Temsirolimus|temsirolimus|mesh-list
138771342|NCT02646319|MTOR Inhibitors|mtor inhibitors|mesh-list
138771343|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138540170|NCT04731909|Cisplatin|cisplatin|mesh-list
138771344|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771345|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138771346|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771347|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
138771348|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138771349|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
138771350|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771351|NCT02646319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138771352|NCT02646319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771353|NCT02646319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771354|NCT00653965|Atorvastatin|atorvastatin|mesh-list
138771355|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138771356|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138445729|NCT01837290|Midazolam|midazolam|mesh-list
138771357|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138771358|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
138771359|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771360|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138771361|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138771362|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771363|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
138771364|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138771365|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138771366|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138771367|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138771368|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138771369|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771370|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
138283429|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138283431|NCT02954198|Prednisone|prednisone|mesh-list
138771371|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771372|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771373|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138771374|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771375|NCT00912340|Trastuzumab|trastuzumab|mesh-list
138771376|NCT00912340|Everolimus|everolimus|mesh-list
138771377|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138771378|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771379|NCT00912340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138771380|NCT00912340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138771381|NCT00912340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771382|NCT00912340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771383|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138771384|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
138771385|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771386|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
138771387|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138771388|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138771389|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138771390|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138771391|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771392|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
138771393|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771394|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771395|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138771396|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771397|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138771398|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138771399|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771400|NCT01119846|Incretins|incretins|mesh-ancestor
138771401|NCT01119846|Hormones|hormones|mesh-ancestor
138771402|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771403|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138771404|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
138771405|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771406|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771407|NCT03775525|Capecitabine|capecitabine|mesh-list
138771408|NCT03775525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138771409|NCT03775525|Antimetabolites|antimetabolites|mesh-ancestor
138771410|NCT03775525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771411|NCT03775525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771412|NCT00654043|Torsemide|torsemide|mesh-list
138771413|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138771414|NCT00654043|Diuretics|diuretics|mesh-ancestor
138771415|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
138771416|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771417|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138540306|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138771418|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138771419|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771420|NCT04167007|Gemcitabine|gemcitabine|mesh-list
138771421|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138771422|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
138771423|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771424|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771425|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138771426|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138771427|NCT00654121|Insulin|insulin|mesh-list
138771428|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138771429|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138771430|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771432|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
138771433|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
138649738|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138771434|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138771435|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138771436|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771437|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138771438|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771439|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771440|NCT02639533|Pregabalin|pregabalin|mesh-list
138771441|NCT02639533|Analgesics|analgesics|mesh-ancestor
138771442|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
138771443|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771444|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771445|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
138771446|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138553696|NCT00280930|Letrozole|letrozole|mesh-list
138771447|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138771448|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771449|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138771450|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138771451|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138771452|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138771453|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138771454|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
138771455|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138771456|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138771457|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771458|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
138771459|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
138771460|NCT00910000|Carboplatin|carboplatin|mesh-list
138771461|NCT00910000|Gemcitabine|gemcitabine|mesh-list
138771463|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771464|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138771465|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
138771466|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771467|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138771468|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771469|NCT02885909|Insulin|insulin|mesh-list
138771470|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138771471|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771472|NCT05657171|Cyproterone Acetate|cyproterone acetate|mesh-list
138771473|NCT05657171|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138771474|NCT05657171|Estradiol|estradiol|mesh-list
138771475|NCT05657171|Cyproterone|cyproterone|mesh-list
138771476|NCT05657171|Estrogens|estrogens|mesh-ancestor
138771477|NCT05657171|Hormones|hormones|mesh-ancestor
138771478|NCT05657171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771479|NCT05657171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771480|NCT05657171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138771481|NCT05657171|Contraceptive Agents|contraceptive agents|mesh-ancestor
138771482|NCT05657171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138771483|NCT05657171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138771484|NCT05657171|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138771485|NCT05657171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138771486|NCT05657171|Androgen Antagonists|androgen antagonists|mesh-ancestor
138283456|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771487|NCT05657171|Hormone Antagonists|hormone antagonists|mesh-ancestor
138771488|NCT05657171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771489|NCT05657171|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138771490|NCT00652873|Cabergoline|cabergoline|mesh-list
138771491|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138771492|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138771493|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
138771494|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
138771495|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771496|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771497|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771498|NCT00652171|Lamotrigine|lamotrigine|mesh-list
138771499|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
138771500|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138445863|NCT01840696|Regadenoson|regadenoson|mesh-list
138771501|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138771502|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771503|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138690400|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771504|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771505|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138771506|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138771507|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138771508|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138771509|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138771510|NCT01119768|Esomeprazole|esomeprazole|mesh-list
138771511|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138771512|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138771513|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138771514|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771515|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771516|NCT01165307|Naproxen|naproxen|mesh-list
138771517|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
138771518|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
138771519|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
138771520|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138771521|NCT01165307|Estradiol|estradiol|mesh-list
138771522|NCT01165307|Estrogens|estrogens|mesh-ancestor
138771523|NCT01165307|Hormones|hormones|mesh-ancestor
138771524|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771525|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771526|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138771527|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138771528|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138771529|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138771530|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138771531|NCT01165307|Analgesics|analgesics|mesh-ancestor
138771532|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
138771533|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771534|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771535|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138771536|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
138771537|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138771539|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771540|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138771541|NCT02639143|Clopidogrel|clopidogrel|mesh-list
138771542|NCT02639143|Ticagrelor|ticagrelor|mesh-list
138771543|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138540485|NCT00055484|Zonisamide|zonisamide|mesh-list
138771544|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138771545|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138771546|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138771547|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
138771548|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771549|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771550|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771551|NCT02644057|Dobutamine|dobutamine|mesh-list
138771552|NCT02644057|Milrinone|milrinone|mesh-list
138771553|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138771554|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
138771555|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
138771556|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771557|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771558|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138771559|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138771560|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138771561|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
138771562|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771563|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771564|NCT02644057|Protective Agents|protective agents|mesh-ancestor
138771565|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138771566|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
138771567|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138771568|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138771569|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771570|NCT00654277|Ondansetron|ondansetron|mesh-list
138771571|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
138771572|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
138771573|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771574|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771575|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138445934|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771576|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
138771577|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
138771578|NCT00654277|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138771579|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138771580|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
138771581|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771582|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771583|NCT01124838|Prednisone|prednisone|mesh-list
138771584|NCT01124838|Adalimumab|adalimumab|mesh-list
138771585|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771586|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
138771594|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138771595|NCT00630435|Estrogens|estrogens|mesh-ancestor
138771596|NCT00630435|Hormones|hormones|mesh-ancestor
138771597|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771598|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771599|NCT02858193|Carbocysteine|carbocysteine|mesh-list
138771600|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138771601|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771602|NCT02858193|Expectorants|expectorants|mesh-ancestor
138771603|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
138771604|NCT02581215|Ramucirumab|ramucirumab|mesh-list
138771605|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771606|NCT04282941|Ibuprofen|ibuprofen|mesh-list
138771607|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138771608|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138771609|NCT04282941|Analgesics|analgesics|mesh-ancestor
138771610|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
138771611|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771612|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771613|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771614|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138771615|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138771616|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771617|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771618|NCT00910858|Lenalidomide|lenalidomide|mesh-list
138771619|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
138771620|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
138771621|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771622|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138771623|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138771624|NCT00910858|Growth Substances|growth substances|mesh-ancestor
138771625|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
138771626|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771627|NCT00910858|Hematinics|hematinics|mesh-ancestor
138771628|NCT02859285|Estradiol|estradiol|mesh-list
138771629|NCT02859285|Estrogens|estrogens|mesh-ancestor
138771630|NCT02859285|Hormones|hormones|mesh-ancestor
138771631|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771632|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771633|NCT04260412|Psyllium|psyllium|mesh-list
138771634|NCT04260412|Cathartics|cathartics|mesh-ancestor
138771635|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138771642|NCT04476550|Lenograstim|lenograstim|mesh-list
138771643|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138771644|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
138690484|NCT02936492|Hormones|hormones|mesh-ancestor
138771645|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771646|NCT00598975|Irinotecan|irinotecan|mesh-list
138771647|NCT00598975|Cetuximab|cetuximab|mesh-list
138771648|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
138771649|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138771650|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138446027|NCT01841658|Folic Acid|folic acid|mesh-list
138771652|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771654|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138771655|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138771657|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138771658|NCT01124604|Narcotics|narcotics|mesh-ancestor
138771659|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138771660|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771661|NCT01124604|Analgesics|analgesics|mesh-ancestor
138771662|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
138771663|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771664|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138771665|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138771666|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138771667|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771668|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
138771669|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771670|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138771671|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
138771672|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138771673|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
138771674|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138771675|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771676|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138771677|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138771678|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771679|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
138771680|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
138771681|NCT01124448|Growth Substances|growth substances|mesh-ancestor
138771682|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771683|NCT02638909|Ceritinib|ceritinib|mesh-list
138771684|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771685|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138771686|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771687|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771688|NCT02643823|Methotrexate|methotrexate|mesh-list
138771689|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
138771690|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138771691|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
138771692|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138771693|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771694|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138771695|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
138771696|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771697|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771698|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
138771699|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771700|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138771701|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138771702|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
138771703|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138771704|NCT02638831|Ketorolac|ketorolac|mesh-list
138771705|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138771706|NCT02638831|Ketoprofen|ketoprofen|mesh-list
138771707|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138771708|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138771709|NCT02638831|Analgesics|analgesics|mesh-ancestor
138771710|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
138771711|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771712|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771713|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771714|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138771715|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138771716|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771717|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771718|NCT01136772|Haloperidol|haloperidol|mesh-list
138771719|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138771720|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
138771721|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138771722|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138771723|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138771724|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771725|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138771726|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138771727|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138771728|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
138771729|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771730|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771731|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138771732|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138771733|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
138771734|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
138540820|NCT00056030|Antidotes|antidotes|mesh-ancestor
138771735|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
138771736|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771737|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138771738|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138771740|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138771741|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138771742|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771743|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138771744|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138771745|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771746|NCT01136382|Budesonide|budesonide|mesh-list
138771747|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771748|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138771749|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
138771750|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771751|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771752|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138771753|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
138771754|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
138771755|NCT01136382|Hormones|hormones|mesh-ancestor
138690534|NCT01289119|Incretins|incretins|mesh-ancestor
138771756|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771758|NCT02731729|Ipilimumab|ipilimumab|mesh-list
138771759|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138771760|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771761|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138429355|NCT01715701|Iodine|iodine|mesh-list
138771762|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771763|NCT02645461|Palmidrol|palmidrol|mesh-list
138771764|NCT02645461|Riluzole|riluzole|mesh-list
138771765|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
138771766|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138771767|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138771768|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771769|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771770|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771771|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138771772|NCT02645461|Protective Agents|protective agents|mesh-ancestor
138771773|NCT02645461|Analgesics|analgesics|mesh-ancestor
138771774|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
138771775|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771776|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138771777|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138771778|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138771779|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138771780|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
138771781|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771782|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138771783|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138771784|NCT02645461|Hormones|hormones|mesh-ancestor
138771785|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771786|NCT00654589|Deferasirox|deferasirox|mesh-list
138771787|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138771788|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
138771789|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
138771790|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771791|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138771792|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138771793|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138771794|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
138771795|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771796|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138771797|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138540913|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
138771798|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771799|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138771800|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138771801|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138771802|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138771803|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138283585|NCT05827497|Abortifacient Agents|abortifacient agents|mesh-ancestor
138771804|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138771805|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138771806|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
138771807|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771808|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771809|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771810|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
138771811|NCT01119066|Melphalan|melphalan|mesh-list
138771812|NCT01119066|Busulfan|busulfan|mesh-list
138771813|NCT01119066|Thiotepa|thiotepa|mesh-list
138771814|NCT01119066|Fludarabine|fludarabine|mesh-list
138771815|NCT01119066|Clofarabine|clofarabine|mesh-list
138771816|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138771817|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
138771818|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771819|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138771820|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138771821|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
138771822|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771823|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771824|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138771825|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138771826|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
138771827|NCT00910624|Ribavirin|ribavirin|mesh-list
138771828|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138540958|NCT00174694|Telithromycin|telithromycin|mesh-list
138771829|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
138771830|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771831|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
138771832|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771833|NCT00654667|Resveratrol|resveratrol|mesh-list
138771834|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
138771835|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771836|NCT00654667|Protective Agents|protective agents|mesh-ancestor
138771837|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771838|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771839|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138771840|NCT01123980|Insulin|insulin|mesh-list
138771841|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138771842|NCT01123980|Metformin|metformin|mesh-list
138771843|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
138771844|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
138771845|NCT01123980|Glimepiride|glimepiride|mesh-list
138771846|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
138771847|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138771848|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138771849|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771850|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138771851|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138771852|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
138771853|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138771854|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138771855|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138771856|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138771857|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
138771858|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690598|NCT02912676|Methotrexate|methotrexate|mesh-list
138771859|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138771860|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138771861|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771862|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138771863|NCT04164823|Analgesics|analgesics|mesh-list
138771864|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
138771865|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771866|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771867|NCT02857959|Penicillins|penicillins|mesh-list
138771868|NCT02857959|Penicillin G|penicillin g|mesh-list
138771869|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138771870|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
138771871|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138771872|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771873|NCT02643433|Vaccines|vaccines|mesh-list
138771874|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
138771875|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771876|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
138771877|NCT00632476|Vitamins|vitamins|mesh-ancestor
138771878|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
138771879|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771880|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
138771881|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771882|NCT00632476|Protective Agents|protective agents|mesh-ancestor
138771883|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
138771884|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138771885|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771886|NCT04164745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138541034|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771887|NCT04164745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771888|NCT01198522|Gemcitabine|gemcitabine|mesh-list
138771889|NCT01198522|Antibodies|antibodies|mesh-list
138771890|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138771891|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
138771892|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771893|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138771894|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
138771895|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771896|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771897|NCT02638285|Clomiphene|clomiphene|mesh-list
138771898|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138771899|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
138771900|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771901|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771902|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138771903|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
138771904|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138771905|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138771906|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138771907|NCT01134250|Paclitaxel|paclitaxel|mesh-list
138771908|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138771909|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771910|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
138771911|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
138771912|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
138771913|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771914|NCT01118520|Amlodipine|amlodipine|mesh-list
138771915|NCT01118520|Perindopril|perindopril|mesh-list
138771916|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138771917|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138771918|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138771919|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771920|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138771921|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771922|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
138771923|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138771924|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
138771925|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771926|NCT01135992|Insulin|insulin|mesh-list
138771927|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138771928|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
138771929|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138771930|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771931|NCT03734770|Progesterone|progesterone|mesh-list
138771932|NCT03734770|Progestins|progestins|mesh-ancestor
138771933|NCT03734770|Hormones|hormones|mesh-ancestor
138553731|NCT00281125|Pemetrexed|pemetrexed|mesh-list
138771934|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138168819|NCT00624013|Sertraline|sertraline|mesh-list
138771935|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771936|NCT00959049|Vaccines|vaccines|mesh-list
138771937|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
138771938|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771939|NCT00956943|Nicotine|nicotine|mesh-list
138771940|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138771941|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
138771942|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771943|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771944|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138771945|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138771946|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
138446309|NCT01843452|Panitumumab|panitumumab|mesh-list
138771947|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771948|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771949|NCT01135914|Ranibizumab|ranibizumab|mesh-list
138771950|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138771951|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138771952|NCT01135914|Growth Substances|growth substances|mesh-ancestor
138771953|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771954|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
138771955|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771956|NCT00907738|Vorinostat|vorinostat|mesh-list
138771957|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771958|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138771959|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771960|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771962|NCT01123356|Ofatumumab|ofatumumab|mesh-list
138771963|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
138771964|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771965|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138771966|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138771967|NCT01123356|Growth Substances|growth substances|mesh-ancestor
138771968|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
138771969|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771970|NCT00630357|Levetiracetam|levetiracetam|mesh-list
138771971|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
138771972|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
138771973|NCT02858817|Atovaquone|atovaquone|mesh-list
138771974|NCT02858817|Proguanil|proguanil|mesh-list
138771975|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138771976|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138771977|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
138771978|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138771979|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138771980|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138771981|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771982|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
138771983|NCT02883192|Ondansetron|ondansetron|mesh-list
138771984|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
138771985|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
138771986|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771987|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771988|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138771989|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
138771990|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
138771991|NCT02883192|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138771992|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138771993|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
138771994|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138771995|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138771996|NCT00632554|Prednisolone|prednisolone|mesh-list
138771997|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138771998|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
138771999|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138772000|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
138772001|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138772002|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
138772003|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138772004|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
138772005|NCT00632554|Hormones|hormones|mesh-ancestor
138553734|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772006|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772007|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772008|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138772009|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772010|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
138772011|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
138772012|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772013|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138772014|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138772015|NCT00632554|Protective Agents|protective agents|mesh-ancestor
138772016|NCT03082209|Bevacizumab|bevacizumab|mesh-list
138772017|NCT03082209|Venetoclax|venetoclax|mesh-list
138772018|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138772019|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772020|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138772021|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138772022|NCT03082209|Growth Substances|growth substances|mesh-ancestor
138446391|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
138772023|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772025|NCT02224144|Vitamin D|vitamin d|mesh-list
138772026|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
138772027|NCT02224144|Calcitriol|calcitriol|mesh-list
138772028|NCT02224144|Vitamins|vitamins|mesh-ancestor
138772029|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
138772030|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772031|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138772032|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138772033|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138772034|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138772035|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772036|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138772037|NCT05419180|Stiripentol|stiripentol|mesh-list
138772038|NCT05419180|Anticonvulsants|anticonvulsants|mesh-ancestor
138772039|NCT04280289|Cannabidiol|cannabidiol|mesh-list
138772040|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
138772041|NCT03302728|Lenalidomide|lenalidomide|mesh-list
138772042|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138772043|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
138772044|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772045|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138772046|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138772047|NCT03302728|Growth Substances|growth substances|mesh-ancestor
138772048|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
138772049|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772050|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138772051|NCT03302728|Immunotoxins|immunotoxins|mesh-ancestor
138772052|NCT03302728|Immunoconjugates|immunoconjugates|mesh-ancestor
138772053|NCT03832972|Estrogens|estrogens|mesh-list
138772054|NCT03832972|Hormones|hormones|mesh-ancestor
138772055|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772056|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772057|NCT02860299|Heparin|heparin|mesh-list
138772058|NCT02860299|Calcium heparin|calcium heparin|mesh-list
138772059|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
138772060|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772061|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138772062|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138772063|NCT02858505|Iron|iron|mesh-list
138772064|NCT02858505|Trace Elements|trace elements|mesh-ancestor
138772065|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
138772066|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772067|NCT02860221|Epinephrine|epinephrine|mesh-list
138772068|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
138772069|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138541371|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138772070|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138649739|NCT00297206|Valacyclovir|valacyclovir|mesh-list
138772071|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772072|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
138772073|NCT02860221|Coagulants|coagulants|mesh-ancestor
138772074|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138772075|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138772076|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
138553739|NCT00109746|Chromium|chromium|mesh-list
138772077|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138772078|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772079|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138772080|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138772081|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
138772082|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772083|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138772084|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
138772085|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
138772086|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
138772087|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138772088|NCT02857569|Nivolumab|nivolumab|mesh-list
138772089|NCT02857569|Ipilimumab|ipilimumab|mesh-list
138772090|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138772091|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772092|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138772093|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772095|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
138541427|NCT00056966|Fludarabine|fludarabine|mesh-list
138772096|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138772097|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138446463|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
138772098|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772099|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772100|NCT04164355|Urological Agents|urological agents|mesh-ancestor
138772101|NCT01605253|Eszopiclone|eszopiclone|mesh-list
138772102|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138772103|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138772104|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772105|NCT00655135|Vedolizumab|vedolizumab|mesh-list
138772106|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138772107|NCT00955305|Paclitaxel|paclitaxel|mesh-list
138772108|NCT00955305|Bevacizumab|bevacizumab|mesh-list
138772109|NCT00955305|Carboplatin|carboplatin|mesh-list
138772110|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138772111|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772112|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
138772113|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
138772114|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
138772115|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772116|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138772117|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138772118|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138772119|NCT00955305|Growth Substances|growth substances|mesh-ancestor
138772120|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772121|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
138772122|NCT00656695|Cyclosporine|cyclosporine|mesh-list
138772123|NCT00656695|Cyclosporins|cyclosporins|mesh-list
138772124|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
138772125|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772126|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
138772127|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772128|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772129|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138772130|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
138772131|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772132|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138772133|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138772134|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
138772135|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138772136|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
138772137|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772138|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
138772139|NCT04204083|Protective Agents|protective agents|mesh-ancestor
138772140|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
138772141|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
138772142|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138772143|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138772144|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772145|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772146|NCT00598585|Urological Agents|urological agents|mesh-ancestor
138541513|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
138772148|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772149|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138772150|NCT02635243|Hormones|hormones|mesh-ancestor
138772151|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772152|NCT00953667|Niacin|niacin|mesh-list
138772153|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138772154|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
138772155|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772156|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138772157|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
138772158|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
138772159|NCT00953667|Vitamins|vitamins|mesh-ancestor
138772160|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
138772161|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772162|NCT02857491|Ranibizumab|ranibizumab|mesh-list
138772163|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138772164|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138772165|NCT02857491|Growth Substances|growth substances|mesh-ancestor
138772166|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772167|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
138772168|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772169|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
138772170|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
138772171|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138772172|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
138772173|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772174|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138772175|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138772176|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
138772177|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772178|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772179|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138772180|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138772181|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138772182|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
138772183|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138772184|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772185|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772186|NCT02856867|Leucovorin|leucovorin|mesh-list
138772187|NCT02856867|Fluorouracil|fluorouracil|mesh-list
138772188|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
138772189|NCT02856867|Nintedanib|nintedanib|mesh-list
138772190|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
138772191|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772192|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138772193|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772194|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138772196|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772197|NCT02856867|Antidotes|antidotes|mesh-ancestor
138772198|NCT02856867|Protective Agents|protective agents|mesh-ancestor
138772199|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
138772200|NCT02856867|Vitamins|vitamins|mesh-ancestor
138772201|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
138772202|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138772203|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772204|NCT00630513|Ampicillin|ampicillin|mesh-list
138772205|NCT00630513|Ertapenem|ertapenem|mesh-list
138772206|NCT00630513|Sulbactam|sulbactam|mesh-list
138772207|NCT00630513|Sultamicillin|sultamicillin|mesh-list
138772208|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138772209|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772210|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138283760|NCT05577845|Ramosetron|ramosetron|mesh-list
138772211|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772212|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772213|NCT05287360|Apatinib|apatinib|mesh-list
138772214|NCT05287360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772215|NCT05287360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138772216|NCT05287360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772217|NCT05287360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772218|NCT00954447|Linagliptin|linagliptin|mesh-list
138772219|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138772220|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772221|NCT00954447|Incretins|incretins|mesh-ancestor
138772222|NCT00954447|Hormones|hormones|mesh-ancestor
138772223|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772224|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138772225|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
138772226|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772227|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772228|NCT00903760|Decitabine|decitabine|mesh-list
138772229|NCT00903760|Clofarabine|clofarabine|mesh-list
138772230|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138772231|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
138772232|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772234|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772235|NCT05177614|Micronutrients|micronutrients|mesh-list
138772236|NCT05177614|Trace Elements|trace elements|mesh-list
138772237|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772238|NCT04202536|Tenofovir|tenofovir|mesh-list
138541657|NCT00180037|Ubiquinone|ubiquinone|mesh-list
138772239|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
138772240|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772241|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138772242|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138772243|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772244|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772245|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138772246|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138772247|NCT02794402|Exenatide|exenatide|mesh-list
138772248|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138772249|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772250|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138772251|NCT02794402|Incretins|incretins|mesh-ancestor
138772252|NCT02794402|Hormones|hormones|mesh-ancestor
138772253|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772254|NCT00883051|Lasmiditan|lasmiditan|mesh-list
138772255|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138772256|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
138772257|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138772258|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772259|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772260|NCT03395587|Temozolomide|temozolomide|mesh-list
138772261|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138772262|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
138772263|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772264|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772265|NCT00903682|Efavirenz|efavirenz|mesh-list
138772266|NCT00903682|Etravirine|etravirine|mesh-list
138649740|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
138772267|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138772268|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138772269|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772270|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772271|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
138772272|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772273|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138772274|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138772275|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138772276|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138772277|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138772278|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138772279|NCT00655603|Pancrelipase|pancrelipase|mesh-list
138772280|NCT00655603|Hormones|hormones|mesh-list
138772281|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772282|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772283|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138772284|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138772285|NCT00655681|Pamidronate|pamidronate|mesh-list
138772286|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138772287|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772288|NCT04221568|Fentanyl|fentanyl|mesh-list
138772289|NCT04221568|Bupivacaine|bupivacaine|mesh-list
138772290|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
138772291|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
138772292|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
138772293|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138772294|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772295|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
138772296|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772297|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138772298|NCT04221568|Narcotics|narcotics|mesh-ancestor
138772299|NCT04221568|Analgesics|analgesics|mesh-ancestor
138772300|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138772301|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138541757|NCT00057356|Conivaptan|conivaptan|mesh-list
138772302|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
138772303|NCT01135524|Buprenorphine|buprenorphine|mesh-list
138772304|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138772305|NCT01135524|Narcotics|narcotics|mesh-ancestor
138772306|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138772307|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772308|NCT01135524|Analgesics|analgesics|mesh-ancestor
138772309|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
138772310|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772311|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138772312|NCT00948675|Paclitaxel|paclitaxel|mesh-list
138772313|NCT00948675|Bevacizumab|bevacizumab|mesh-list
138772314|NCT00948675|Carboplatin|carboplatin|mesh-list
138772315|NCT00948675|Pemetrexed|pemetrexed|mesh-list
138772316|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138772317|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772318|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
138772319|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
138772320|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
138772321|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772322|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138772323|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138772324|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138772325|NCT00948675|Growth Substances|growth substances|mesh-ancestor
138446699|NCT01845558|Wobenzym|wobenzym|mesh-list
138772326|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772327|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
138772328|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772329|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138772330|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138772331|NCT02642497|Ketamine|ketamine|mesh-list
138772332|NCT02642497|Analgesics|analgesics|mesh-ancestor
138772333|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
138772334|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772335|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772336|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138772337|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138772338|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
138772339|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
138772340|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138772341|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138772342|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138772343|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138772344|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772345|NCT04273581|Thalidomide|thalidomide|mesh-list
138772346|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138772347|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
138772348|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772349|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
138772350|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138772351|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772352|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138772353|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138772354|NCT04273581|Growth Substances|growth substances|mesh-ancestor
138772355|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
138772356|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772357|NCT01110408|Amoxicillin|amoxicillin|mesh-list
138772358|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
138772359|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
138772360|NCT01110408|Cefepime|cefepime|mesh-list
138772361|NCT01110408|Doripenem|doripenem|mesh-list
138772362|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138772363|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138772364|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772365|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138772366|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541906|NCT00182455|Topiramate|topiramate|mesh-list
138772367|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772368|NCT00953043|Lubiprostone|lubiprostone|mesh-list
138772369|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138772370|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138772371|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772372|NCT02850484|Budesonide|budesonide|mesh-list
138772373|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
138772374|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138283835|NCT05362877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772375|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138283836|NCT05362877|Antifungal Agents|antifungal agents|mesh-ancestor
138772377|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772378|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772379|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138772380|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
138772381|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
138772382|NCT02850484|Hormones|hormones|mesh-ancestor
138772383|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772384|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138772385|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138772386|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138772387|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
138772388|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138772389|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772390|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
138772391|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138772392|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
138772393|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138772394|NCT00948441|Ethanol|ethanol|mesh-list
138772395|NCT00948441|Heparin|heparin|mesh-list
138772396|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
138772397|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138772398|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138772399|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772400|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138772401|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772402|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138772403|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772404|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
138772405|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138772406|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138772407|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772408|NCT00630903|Methoxsalen|methoxsalen|mesh-list
138772409|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138772410|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
138772411|NCT02883426|Vaccines|vaccines|mesh-list
138772412|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
138283859|NCT05326087|Cetrorelix|cetrorelix|mesh-list
138772413|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772414|NCT02849314|Immunomodulating Agents|immunomodulating agents|mesh-list
138772415|NCT02849314|Immunologic Factors|immunologic factors|mesh-ancestor
138772416|NCT02849314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772417|NCT02849236|Ropivacaine|ropivacaine|mesh-list
138772418|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
138772419|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
138772420|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138772421|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541980|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
138772422|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
138772423|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772424|NCT02856789|Hemostatics|hemostatics|mesh-list
138772425|NCT02856789|Coagulants|coagulants|mesh-ancestor
138772427|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
138772428|NCT01117350|Liraglutide|liraglutide|mesh-list
138772429|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138772430|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772431|NCT01117350|Incretins|incretins|mesh-ancestor
138772432|NCT01117350|Hormones|hormones|mesh-ancestor
138772433|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772434|NCT00952731|Tamoxifen|tamoxifen|mesh-list
138772435|NCT00952731|Afimoxifene|afimoxifene|mesh-list
138772436|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138772437|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
138772438|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772439|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772440|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138772441|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772442|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138772443|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138772444|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138772445|NCT04202224|Acetaminophen|acetaminophen|mesh-list
138772446|NCT04202224|Ibuprofen|ibuprofen|mesh-list
138772447|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138772448|NCT04202224|Analgesics|analgesics|mesh-ancestor
138772449|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
138772450|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772451|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772452|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
138772453|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138772454|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138772455|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138772456|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138772457|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772458|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772459|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138772460|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
138772461|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772463|NCT02848612|Calcium heparin|calcium heparin|mesh-list
138772464|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
138772465|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138772466|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138772467|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772468|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138772469|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138772470|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138772472|NCT04235062|Calcium|calcium|mesh-list
138772473|NCT04235062|Diuretics|diuretics|mesh-list
138772474|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138772475|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138772476|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772477|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
138772478|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138711084|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138542087|NCT00183898|Capecitabine|capecitabine|mesh-list
138772479|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772481|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772482|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138772483|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138772484|NCT02848768|Growth Substances|growth substances|mesh-ancestor
138772485|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772486|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
138772487|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138772488|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772489|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772490|NCT02848300|Bimatoprost|bimatoprost|mesh-list
138772491|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138772492|NCT00953745|Aripiprazole|aripiprazole|mesh-list
138772493|NCT00953745|Escitalopram|escitalopram|mesh-list
138772494|NCT00953745|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138772495|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138772496|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138772497|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772498|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138772499|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
138772500|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772501|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
138772502|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138772503|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138772504|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138772505|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138772507|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
138772508|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138772509|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138772510|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138772511|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138772512|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138772513|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138772514|NCT04202380|Azithromycin|azithromycin|mesh-list
138772515|NCT04202380|Ampicillin|ampicillin|mesh-list
138772516|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138772517|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772518|NCT02847442|Levodopa|levodopa|mesh-list
138772519|NCT02847442|Opicapone|opicapone|mesh-list
138283934|NCT05001724|Docetaxel|docetaxel|mesh-list
138772521|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
138772522|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138772523|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138772524|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
138772525|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138772526|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772527|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772528|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138772529|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772530|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138772531|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
138772532|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138772533|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
138772534|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138772535|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772536|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138542184|NCT00184795|Estradiol|estradiol|mesh-list
138772537|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138772538|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772539|NCT01478698|Plasminogen|plasminogen|mesh-list
138772540|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138772541|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138772542|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138772543|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772544|NCT01199380|Nicotine|nicotine|mesh-list
138772545|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138772546|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
138772547|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772548|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772549|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138772550|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138772551|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
138772552|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138772553|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772554|NCT02847286|Dapivirine|dapivirine|mesh-list
138772555|NCT02847286|Clotrimazole|clotrimazole|mesh-list
138772556|NCT02847286|Miconazole|miconazole|mesh-list
138772557|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138772558|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138772559|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
138772560|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772561|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138772562|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
138772563|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138772564|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138772565|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772566|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772567|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138772568|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
138772569|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772570|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542236|NCT00184912|Caffeine|caffeine|mesh-list
138772571|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138772572|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138772574|NCT00902668|L 647318|l 647318|mesh-list
138772575|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
138772576|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138772577|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138772578|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
138772579|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772580|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138772581|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138772582|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772583|NCT00433420|Paclitaxel|paclitaxel|mesh-list
138772584|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
138772585|NCT00433420|Fluorouracil|fluorouracil|mesh-list
138772587|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138772588|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772589|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
138772590|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
138772591|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
138772592|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772593|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138772594|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
138772595|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772596|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138772597|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138772598|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
138772599|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138772600|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
138772601|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138772602|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138772603|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138772604|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138772605|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772606|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
138772607|NCT04202068|Sulbactam|sulbactam|mesh-list
138772608|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138772609|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772610|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138772611|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772612|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772613|NCT02850250|Cefuroxime|cefuroxime|mesh-list
138542329|NCT03784014|Olaparib|olaparib|mesh-list
138772614|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
138772615|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138772616|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772617|NCT05012644|Palbociclib|palbociclib|mesh-list
138772618|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138772619|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772620|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138772621|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446993|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138772622|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772623|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138772624|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138772625|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
138772626|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772627|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772628|NCT02846506|Metformin|metformin|mesh-list
138772629|NCT02846506|Canagliflozin|canagliflozin|mesh-list
138772630|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138553780|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772631|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772632|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138772633|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772634|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
138772635|NCT02846428|Docetaxel|docetaxel|mesh-list
138772636|NCT02846428|Capecitabine|capecitabine|mesh-list
138772637|NCT02846428|Fluorouracil|fluorouracil|mesh-list
138772638|NCT02846428|Epirubicin|epirubicin|mesh-list
138772639|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138772640|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
138772641|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772642|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138772643|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138772645|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542370|NCT00185419|Hormones|hormones|mesh-ancestor
138772646|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772647|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138772648|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
138772649|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
138772650|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
138772651|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138772652|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
138772653|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138772654|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138772655|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138772656|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772657|NCT02844712|beta-Lactams|beta-lactams|mesh-list
138772658|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138772659|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772660|NCT00947349|Interferons|interferons|mesh-list
138772661|NCT00947349|Ribavirin|ribavirin|mesh-list
138772662|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772663|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
138772664|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772665|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
138772666|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772667|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138772668|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138772669|NCT03425812|Analgesics|analgesics|mesh-ancestor
138772670|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
138772671|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772672|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772673|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138772674|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138772675|NCT02845804|Everolimus|everolimus|mesh-list
138772676|NCT02845804|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138772677|NCT02845804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138772678|NCT02845804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772679|NCT02845804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772680|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138772681|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
138772682|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772683|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772684|NCT02844634|Tenofovir|tenofovir|mesh-list
138772685|NCT02844634|Emtricitabine|emtricitabine|mesh-list
138772686|NCT02844634|Doxycycline|doxycycline|mesh-list
138772687|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
138772688|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772689|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138772690|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138772691|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772692|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772693|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138772694|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138772695|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138447068|NCT01848652|Doxorubicin|doxorubicin|mesh-list
138772696|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
138772697|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138772698|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138283959|NCT04987892|Tamsulosin|tamsulosin|mesh-list
138772699|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138772701|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553786|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138772702|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772703|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772704|NCT00952419|Vaccines|vaccines|mesh-list
138772705|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
138772706|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772707|NCT02844322|Rituximab|rituximab|mesh-list
138772708|NCT02844322|Bortezomib|bortezomib|mesh-list
138772709|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138772710|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772711|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
138772712|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772713|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138772714|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138772715|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138772716|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772717|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138772718|NCT00630981|Escitalopram|escitalopram|mesh-list
138772719|NCT00630981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138772720|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138772721|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138772722|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772723|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138772724|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
138772725|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772726|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
138772727|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138772728|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138772729|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138772730|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138772731|NCT00952341|Dexamethasone|dexamethasone|mesh-list
138772732|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
138772733|NCT00952341|Aprepitant|aprepitant|mesh-list
138772734|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
138772735|NCT00952341|Granisetron|granisetron|mesh-list
138772736|NCT00952341|BB 1101|bb 1101|mesh-list
138772737|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138772738|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
138772739|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
138772740|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772741|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772742|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138772743|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
138691105|NCT05590936|Ondansetron|ondansetron|mesh-list
138772744|NCT00952341|Hormones|hormones|mesh-ancestor
138772745|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772746|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138772747|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772748|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
138283981|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
138772750|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772751|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138772752|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138772753|NCT00952341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138772754|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138772755|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
138772756|NCT02845024|Doxycycline|doxycycline|mesh-list
138772757|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138772758|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772759|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
138772760|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138772761|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138772762|NCT02853903|Immunomodulating Agents|immunomodulating agents|mesh-list
138772763|NCT02853903|Immunologic Factors|immunologic factors|mesh-ancestor
138772764|NCT02853903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772765|NCT05242120|Anesthetics|anesthetics|mesh-list
138772766|NCT05242120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138772767|NCT05242120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772768|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
138772769|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
138772770|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
138772771|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138772772|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772773|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
138772774|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772775|NCT02844790|Insulin|insulin|mesh-list
138772776|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
138772777|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138772778|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772779|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
138772780|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772781|NCT04410328|Aspirin|aspirin|mesh-list
138772782|NCT04410328|Dipyridamole|dipyridamole|mesh-list
138772783|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138772784|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138772785|NCT04410328|Analgesics|analgesics|mesh-ancestor
138772786|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
138772787|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772788|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772789|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138772790|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138772791|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138542535|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
138772792|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138772793|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772794|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138772795|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138772796|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772797|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
138772798|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138772799|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
138772800|NCT02852577|Clonazepam|clonazepam|mesh-list
138772801|NCT02852577|Paroxetine|paroxetine|mesh-list
138772802|NCT02852577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138772803|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138772804|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138772805|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772806|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138772807|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
138772808|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772809|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138772810|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
138772811|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138772812|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138772813|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138772814|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772815|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
138772817|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
138772818|NCT04201990|Apatinib|apatinib|mesh-list
138772819|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772820|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138772821|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691184|NCT00532194|Cediranib|cediranib|mesh-list
138772822|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772823|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
138772824|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
138772825|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138772826|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138772827|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772828|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772829|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772830|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138772831|NCT00901186|Ranibizumab|ranibizumab|mesh-list
138772832|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138772833|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138772834|NCT00901186|Growth Substances|growth substances|mesh-ancestor
138772835|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772836|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
138772837|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772838|NCT05040880|Telmisartan|telmisartan|mesh-list
138772839|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138772840|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138772841|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138772842|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772843|NCT04073290|Rifaximin|rifaximin|mesh-list
138772844|NCT04073290|Lactulose|lactulose|mesh-list
138772845|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138447216|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138772846|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542618|NCT00187525|Memantine|memantine|mesh-list
138772847|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138772848|NCT03936790|Fentanyl|fentanyl|mesh-list
138772849|NCT03936790|Ropivacaine|ropivacaine|mesh-list
138772850|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
138772851|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
138772852|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138772853|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772854|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
138772855|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772856|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138772857|NCT03936790|Narcotics|narcotics|mesh-ancestor
138772858|NCT03936790|Analgesics|analgesics|mesh-ancestor
138772859|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138772860|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138772861|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
138772862|NCT04782700|Prednisone|prednisone|mesh-list
138772863|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138772864|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
138772866|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772867|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772868|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138772869|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772870|NCT03711448|Prednisone|prednisone|mesh-list
138772871|NCT03711448|Ustekinumab|ustekinumab|mesh-list
138772872|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138772873|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
138772874|NCT03711448|Hormones|hormones|mesh-ancestor
138772875|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772876|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772877|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138772878|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772879|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
138772880|NCT00885703|Fluconazole|fluconazole|mesh-list
138772882|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138772883|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
138772884|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
138772885|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
138772886|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772887|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138772888|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138772889|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772890|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772891|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138772892|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
138772893|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772894|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772895|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138772896|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138772897|NCT00885703|Amebicides|amebicides|mesh-ancestor
138772898|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138772899|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138772900|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138772901|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138772902|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138772904|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
138772905|NCT02642419|Clopidogrel|clopidogrel|mesh-list
138772906|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138772907|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138772908|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138772909|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138772910|NCT02642419|Analgesics|analgesics|mesh-ancestor
138772911|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
138772912|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138303109|NCT02124564|Lacosamide|lacosamide|mesh-list
138772913|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772914|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138772915|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138772916|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138772917|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138772918|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772919|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138772920|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772921|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
138772922|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138772923|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138772924|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138772925|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
138772926|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138772927|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138772928|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
138772929|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138772930|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
138772931|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
138772932|NCT00901576|Methylphenidate|methylphenidate|mesh-list
138772933|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138772934|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772935|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138772936|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138772937|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138772938|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772939|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
138772940|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138772941|NCT00655837|Rituximab|rituximab|mesh-list
138542758|NCT00188383|Amantadine|amantadine|mesh-list
138772942|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
138772944|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138772945|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772946|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
138772947|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772948|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138772949|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138772950|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
138772951|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772952|NCT00655915|Betamethasone|betamethasone|mesh-list
138772953|NCT00655915|Lidocaine|lidocaine|mesh-list
138772954|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
138772955|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
138772956|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138772957|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772958|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
138772959|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772960|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138772961|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138772962|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138772963|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138772964|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772965|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138772966|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
138772967|NCT00655915|Hormones|hormones|mesh-ancestor
138772968|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138772969|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138772970|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
138772971|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
138772972|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138772973|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138772974|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138772975|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138772976|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138772977|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138772978|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138772979|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772980|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138772981|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138772982|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138772983|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138772984|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284036|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
138772985|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138772986|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
138772987|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138772989|NCT00656773|Morphine|morphine|mesh-list
138772990|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138772991|NCT00656773|Narcotics|narcotics|mesh-ancestor
138772992|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138772993|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447369|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
138772994|NCT00656773|Analgesics|analgesics|mesh-ancestor
138772995|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
138772996|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772997|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138772998|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138772999|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
138773000|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
138773001|NCT00882583|Cisplatin|cisplatin|mesh-list
138773002|NCT00882583|Cetuximab|cetuximab|mesh-list
138773003|NCT00882583|Dasatinib|dasatinib|mesh-list
138773004|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773005|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138773006|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138773007|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773008|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773009|NCT04481308|Fentanyl|fentanyl|mesh-list
138773010|NCT04481308|Propofol|propofol|mesh-list
138773011|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138773012|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773013|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773014|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138773015|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
138773016|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
138773017|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138773018|NCT04481308|Narcotics|narcotics|mesh-ancestor
138773019|NCT04481308|Analgesics|analgesics|mesh-ancestor
138773020|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
138773021|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773022|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138773023|NCT02634541|Adalimumab|adalimumab|mesh-list
138773024|NCT02634541|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138773025|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773026|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138773027|NCT04475848|Midazolam|midazolam|mesh-list
138773028|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138773029|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138773030|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773031|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773032|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138773033|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138773034|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138773035|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138773036|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
138773037|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
138773038|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
138773039|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
138773040|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773041|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773042|NCT00599521|Adapalene|adapalene|mesh-list
138773043|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138773044|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138773045|NCT00599521|Analgesics|analgesics|mesh-ancestor
138773046|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
138773047|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773048|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773049|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138284063|NCT04531943|Estrogens|estrogens|mesh-list
138773050|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138773051|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
138773052|NCT04201678|Anesthetics|anesthetics|mesh-list
138773053|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773054|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773055|NCT00653341|Insulin|insulin|mesh-list
138773056|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138773057|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
138773058|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
138542943|NCT00189553|Paclitaxel|paclitaxel|mesh-list
138773059|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
138773060|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
138773061|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138773062|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773063|NCT02642263|Carbetocin|carbetocin|mesh-list
138773064|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
138773065|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138773066|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773067|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
138773068|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773069|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
138773070|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138773071|NCT02636803|Albendazole|albendazole|mesh-list
138773072|NCT02636803|Oxfendazole|oxfendazole|mesh-list
138773073|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
138773074|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138773075|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773076|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
138773077|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138773078|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138773079|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
138773080|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
138773081|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
138773082|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773083|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542979|NCT00189787|Tacrolimus|tacrolimus|mesh-list
138773084|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
138773085|NCT02634463|Olanzapine|olanzapine|mesh-list
138773086|NCT02634463|Risperidone|risperidone|mesh-list
138773087|NCT02634463|Aripiprazole|aripiprazole|mesh-list
138773088|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138773089|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138773090|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
138773091|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773092|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773093|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773094|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138773095|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138773096|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773097|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138773098|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138773099|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
138773100|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
138773101|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
138773102|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773103|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138773104|NCT02634463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138773105|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138773106|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138773107|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
138773108|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
138773109|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138773110|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138773111|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138773112|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138773114|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138773115|NCT00882115|Protective Agents|protective agents|mesh-ancestor
138773116|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773117|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773118|NCT00653419|Buspirone|buspirone|mesh-list
138773119|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138773120|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138773121|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773122|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773124|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138773126|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773127|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773128|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138773129|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138773130|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138773131|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773132|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
138773133|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138773134|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
138773135|NCT00656929|Vitamin D|vitamin d|mesh-list
138773136|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
138773137|NCT00656929|Vitamins|vitamins|mesh-ancestor
138773138|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
138773139|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773140|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138773141|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138773142|NCT00884221|Menotropins|menotropins|mesh-list
138773143|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138773144|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
138773145|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138773146|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773147|NCT02153632|Amantadine|amantadine|mesh-list
138773148|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138773149|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138773150|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
138773151|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773152|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
138773153|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773154|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773155|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773156|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138773157|NCT02153632|Analgesics|analgesics|mesh-ancestor
138691446|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138773158|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
138773159|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773160|NCT03524326|Cetuximab|cetuximab|mesh-list
138773161|NCT03524326|Lenvatinib|lenvatinib|mesh-list
138773162|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138773163|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773164|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138773165|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773166|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773167|NCT01236430|Atorvastatin|atorvastatin|mesh-list
138773168|NCT01236430|Ezetimibe|ezetimibe|mesh-list
138773169|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138773170|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138773171|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
138773172|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773173|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138773174|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138773175|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773176|NCT00726856|Ezetimibe|ezetimibe|mesh-list
138773177|NCT00726856|Fenofibrate|fenofibrate|mesh-list
138773178|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138773179|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138773180|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
138773181|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773182|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138773183|NCT00651274|Ezetimibe|ezetimibe|mesh-list
138773184|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138773185|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138773186|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
138773187|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773188|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138773189|NCT00212836|Olanzapine|olanzapine|mesh-list
138773190|NCT00212836|Asenapine|asenapine|mesh-list
138773191|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
138773192|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
138773193|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773194|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773196|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138773197|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138773198|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773199|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138691474|NCT02932644|Vitamin D|vitamin d|mesh-list
138773200|NCT00212836|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138773201|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138773202|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138773203|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773204|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773205|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
138773206|NCT00805324|Desloratadine|desloratadine|mesh-list
138773207|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138773208|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
138773209|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711085|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773210|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773211|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773212|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138773213|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138773214|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
138773215|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
138773216|NCT00157924|Atorvastatin|atorvastatin|mesh-list
138773217|NCT00157924|Simvastatin|simvastatin|mesh-list
138773218|NCT00157924|Ezetimibe|ezetimibe|mesh-list
138773219|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138773220|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138773221|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
138773222|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447604|NCT01852409|Bevacizumab|bevacizumab|mesh-list
138773223|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138773224|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138773225|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773227|NCT00794794|Desloratadine|desloratadine|mesh-list
138773228|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138773229|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138773230|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138773231|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
138773232|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
138773233|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773234|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773235|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773236|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138773237|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
138773238|NCT03612466|Plerixafor|plerixafor|mesh-list
138543271|NCT00191347|Pemetrexed|pemetrexed|mesh-list
138773239|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
138773240|NCT03612466|Calcium|calcium|mesh-list
138773241|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138773242|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773243|NCT03612466|Antacids|antacids|mesh-ancestor
138691507|NCT02920502|Vitamin D|vitamin d|mesh-list
138773244|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773245|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138773246|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138773247|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138773248|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
138773249|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773250|NCT00142558|Indomethacin|indomethacin|mesh-list
138773251|NCT00142558|Etoricoxib|etoricoxib|mesh-list
138773252|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773253|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773254|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773255|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138773256|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138773257|NCT00142558|Analgesics|analgesics|mesh-ancestor
138773258|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
138773259|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773260|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138773261|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
138773262|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
138773263|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138773264|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138773265|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773266|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138773267|NCT02842294|Bevacizumab|bevacizumab|mesh-list
138773268|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138773269|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773270|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138773271|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138773272|NCT02842294|Growth Substances|growth substances|mesh-ancestor
138691539|NCT01281202|Vigabatrin|vigabatrin|mesh-list
138773273|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773274|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
138773275|NCT02841982|Morphine|morphine|mesh-list
138773276|NCT02841982|Ropivacaine|ropivacaine|mesh-list
138773277|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138773278|NCT02841982|Narcotics|narcotics|mesh-ancestor
138773279|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773280|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773281|NCT02841982|Analgesics|analgesics|mesh-ancestor
138773282|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
138773283|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773284|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
138773285|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
138773287|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138773288|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773289|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773290|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138773291|NCT02843698|Analgesics|analgesics|mesh-ancestor
138773292|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
138773293|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773294|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138773295|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138773296|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138447665|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773297|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
138773298|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773299|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773301|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773302|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
138773303|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
138773304|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138773305|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138553830|NCT00109941|Mitogens|mitogens|mesh-list
138773306|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773307|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138773308|NCT00895414|Doxorubicin|doxorubicin|mesh-list
138773309|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138773310|NCT00895414|Enalapril|enalapril|mesh-list
138773311|NCT00895414|Enalaprilat|enalaprilat|mesh-list
138773312|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138773313|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773314|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138773315|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138773316|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773317|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773318|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138773319|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
138773320|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138773321|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138773322|NCT01822288|Tibolone|tibolone|mesh-list
138773323|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
138773324|NCT01822288|Estradiol|estradiol|mesh-list
138773325|NCT01822288|Estrogens|estrogens|mesh-ancestor
138773326|NCT01822288|Hormones|hormones|mesh-ancestor
138773327|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138773328|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773329|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138773330|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
138773331|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138773332|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138773333|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138773334|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138773335|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138773336|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138773337|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138773338|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773339|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
138773340|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
138284141|NCT04125927|Cysteamine|cysteamine|mesh-list
138773341|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138773342|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138773343|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
138773344|NCT01328626|Venetoclax|venetoclax|mesh-list
138773345|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773346|NCT02840812|Nemonoxacin|nemonoxacin|mesh-list
138773347|NCT02840812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138773348|NCT02840812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773349|NCT01212770|Thalidomide|thalidomide|mesh-list
138773350|NCT01212770|Apremilast|apremilast|mesh-list
138773351|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138773352|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138773353|NCT01212770|Analgesics|analgesics|mesh-ancestor
138773354|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
138773355|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773356|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773357|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773358|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138773359|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138773360|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138773361|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553864|NCT00281710|Hormones|hormones|mesh-ancestor
138773362|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773363|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138773364|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
138773365|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
138773366|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138773367|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773368|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138773369|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138773370|NCT01212770|Growth Substances|growth substances|mesh-ancestor
138447742|NCT01853709|Bisacodyl|bisacodyl|mesh-list
138773371|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
138773372|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773373|NCT05334316|Dexamethasone|dexamethasone|mesh-list
138773374|NCT05334316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773375|NCT05334316|Antiemetics|antiemetics|mesh-ancestor
138773376|NCT05334316|Autonomic Agents|autonomic agents|mesh-ancestor
138773377|NCT05334316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773378|NCT05334316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773379|NCT05334316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138773380|NCT05334316|Glucocorticoids|glucocorticoids|mesh-ancestor
138773381|NCT05334316|Hormones|hormones|mesh-ancestor
138284158|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
138773382|NCT05334316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138773383|NCT05334316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138773384|NCT05334316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773385|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
138773386|NCT00598273|Hematinics|hematinics|mesh-ancestor
138773387|NCT02636491|Insulin|insulin|mesh-list
138691659|NCT02920190|Incretins|incretins|mesh-ancestor
138773388|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138773389|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138773390|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773392|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138773393|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
138773394|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773395|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
138773396|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138773397|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138773398|NCT04318652|Prednisolone|prednisolone|mesh-list
138773399|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
138773400|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138773401|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138773402|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
138773403|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773404|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
138773405|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
138773406|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773407|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773408|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138773409|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
138773410|NCT04318652|Hormones|hormones|mesh-ancestor
138773411|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138773412|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138773413|NCT04318652|Protective Agents|protective agents|mesh-ancestor
138773414|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138773415|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773416|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138773417|NCT02633995|Anesthetics|anesthetics|mesh-list
138773418|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773419|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773420|NCT02633683|Gabapentin|gabapentin|mesh-list
138773421|NCT02633683|Analgesics|analgesics|mesh-ancestor
138773422|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
138773423|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691698|NCT05465733|Pemetrexed|pemetrexed|mesh-list
138773424|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543498|NCT00193024|Docetaxel|docetaxel|mesh-list
138773425|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
138553879|NCT00076544|Analgesics|analgesics|mesh-ancestor
138773426|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138773427|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138773428|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773429|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138773430|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138773431|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138773432|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773433|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773434|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
138773435|NCT01211522|Haloperidol|haloperidol|mesh-list
138773436|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
138773437|NCT01211522|Ziprasidone|ziprasidone|mesh-list
138773438|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
138773439|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
138773440|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773441|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773442|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138773443|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138773444|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138169484|NCT01672814|Riboflavin|riboflavin|mesh-list
138773445|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138447815|NCT01854203|Cisplatin|cisplatin|mesh-list
138773446|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138773447|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138773448|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
138773449|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773450|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773451|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138773452|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138773453|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
138773454|NCT05404724|Itraconazole|itraconazole|mesh-list
138773455|NCT05404724|Antifungal Agents|antifungal agents|mesh-ancestor
138773456|NCT05404724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773457|NCT05404724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138773458|NCT05404724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138773459|NCT05404724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773460|NCT05404724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773461|NCT05404724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138773462|NCT05404724|Hormone Antagonists|hormone antagonists|mesh-ancestor
138773463|NCT05404724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138773464|NCT05404724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773465|NCT05404724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138773466|NCT02633761|Misoprostol|misoprostol|mesh-list
138773467|NCT02633761|Mifepristone|mifepristone|mesh-list
138773468|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138773469|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
138773470|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138773471|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773472|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138773473|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138773474|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
138773475|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138773476|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138773477|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138773478|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138773479|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
138773480|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138773481|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138773483|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138773484|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
138773485|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138773486|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138773488|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138773489|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138773490|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
138773491|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773492|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773493|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773494|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138773495|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773496|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
138773497|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138773498|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773499|NCT00657397|Methadone|methadone|mesh-list
138773500|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138773501|NCT00657397|Narcotics|narcotics|mesh-ancestor
138773502|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773503|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773504|NCT00657397|Analgesics|analgesics|mesh-ancestor
138773505|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
138773506|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773507|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
138773508|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
138773509|NCT04160611|Midazolam|midazolam|mesh-list
138773510|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138773511|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138773512|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773513|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773514|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138773515|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138773516|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138773517|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138773518|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
138447897|NCT01854606|Everolimus|everolimus|mesh-list
138773519|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
138773520|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
138773521|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
138773522|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691749|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
138773523|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773525|NCT04161001|Olmesartan|olmesartan|mesh-list
138773526|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138773527|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
138773528|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138773529|NCT04161001|Ezetimibe|ezetimibe|mesh-list
138773530|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138773531|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138773532|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138773533|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773534|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138773535|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773536|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
138773537|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138773538|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138773539|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
138773540|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138773541|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138773542|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553907|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
138773543|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138773544|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138773545|NCT00881569|Efatutazone|efatutazone|mesh-list
138773546|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773548|NCT00657163|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138773549|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138773550|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138773551|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773552|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773553|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
138773554|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773555|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138773556|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
138773557|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138773558|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138543728|NCT00194740|Docetaxel|docetaxel|mesh-list
138691779|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138773559|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138773560|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773561|NCT02636101|Betamethasone|betamethasone|mesh-list
138773562|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
138773563|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138773564|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
138773565|NCT02636101|Calcipotriene|calcipotriene|mesh-list
138773566|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138773567|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773568|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
138773569|NCT02636101|Hormones|hormones|mesh-ancestor
138773570|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138773571|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773572|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138773573|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
138773574|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
138773575|NCT00657475|Heparin|heparin|mesh-list
138773576|NCT00657475|Calcium heparin|calcium heparin|mesh-list
138773577|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
138773578|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138773579|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138773580|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773581|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
138773582|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
138773583|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138773584|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138773585|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773586|NCT04159597|Upadacitinib|upadacitinib|mesh-list
138773587|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138773588|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138773589|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284263|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
138773590|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447984|NCT01855256|Oxybutynin|oxybutynin|mesh-list
138773591|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138773592|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138773593|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
138773594|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138773595|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138773596|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773597|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773598|NCT00661219|Urological Agents|urological agents|mesh-ancestor
138773599|NCT00665743|Naproxen|naproxen|mesh-list
138773600|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138773601|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138773602|NCT00665743|Analgesics|analgesics|mesh-ancestor
138773603|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
138773604|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773605|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773606|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773607|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138773608|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
138773609|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138773610|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553917|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773611|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773612|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138773613|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
138773614|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138773615|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138773616|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773617|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773618|NCT00661297|Urological Agents|urological agents|mesh-ancestor
138773619|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
138773621|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138773622|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773623|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138543818|NCT00195481|Sirolimus|sirolimus|mesh-list
138773624|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773625|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773626|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138773627|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138773628|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
138773629|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773630|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
138691854|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
138773631|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773633|NCT00894790|Diclofenac|diclofenac|mesh-list
138773634|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138773635|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138773636|NCT00894790|Analgesics|analgesics|mesh-ancestor
138773637|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
138773638|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773639|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773640|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773641|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138773642|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138773643|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138773644|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773645|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773646|NCT00665977|Triamcinolone|triamcinolone|mesh-list
138773647|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138773648|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138773649|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138773650|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773651|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
138773652|NCT00665977|Hormones|hormones|mesh-ancestor
138773653|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138773654|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773655|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138773656|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
138773657|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773658|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773659|NCT00666055|Ritonavir|ritonavir|mesh-list
138773660|NCT00666055|Lopinavir|lopinavir|mesh-list
138773661|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138773662|NCT00666055|Tenofovir|tenofovir|mesh-list
138773663|NCT00666055|Lamivudine|lamivudine|mesh-list
138773664|NCT00666055|Emtricitabine|emtricitabine|mesh-list
138448057|NCT01855581|Ketamine|ketamine|mesh-list
138773665|NCT00666055|Zidovudine|zidovudine|mesh-list
138773666|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
138773667|NCT00666055|Maraviroc|maraviroc|mesh-list
138773668|NCT00666055|Efavirenz|efavirenz|mesh-list
138773669|NCT00666055|Etravirine|etravirine|mesh-list
138773670|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138773671|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138773672|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
138773673|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773674|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773675|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138773676|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138773677|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
138773678|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773679|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138773680|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138691885|NCT04687332|Tryptophan|tryptophan|mesh-list
138691889|NCT05467709|Midazolam|midazolam|mesh-list
138773681|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138773682|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138773683|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
138773684|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138773685|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138773686|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138773687|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138773688|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138773689|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138773690|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138773691|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138773692|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138773693|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138773694|NCT00661375|Sorafenib|sorafenib|mesh-list
138773695|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773696|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138284309|NCT02194829|Paclitaxel|paclitaxel|mesh-list
138773697|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773698|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773699|NCT00911287|Oxymorphone|oxymorphone|mesh-list
138773700|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138773701|NCT00911287|Narcotics|narcotics|mesh-ancestor
138773702|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773703|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773704|NCT00911287|Analgesics|analgesics|mesh-ancestor
138773705|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
138773706|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773707|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138773708|NCT02631031|Valsartan|valsartan|mesh-list
138773709|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138773710|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138773711|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138773712|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773713|NCT02839408|Azithromycin|azithromycin|mesh-list
138773714|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138773715|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773716|NCT02837614|Acetaminophen|acetaminophen|mesh-list
138773717|NCT02837614|Amoxicillin|amoxicillin|mesh-list
138773718|NCT02837614|Dexamethasone|dexamethasone|mesh-list
138773719|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
138773720|NCT02837614|BB 1101|bb 1101|mesh-list
138773721|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773722|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
138773723|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
138773724|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773725|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773726|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138773727|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
138773728|NCT02837614|Hormones|hormones|mesh-ancestor
138773729|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138773730|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138773731|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773732|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
138773733|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773734|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773735|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138773736|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773737|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138773738|NCT02837614|Analgesics|analgesics|mesh-ancestor
138773739|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
138773740|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
138773741|NCT02839486|Vancomycin|vancomycin|mesh-list
138773742|NCT02839486|Cefoxitin|cefoxitin|mesh-list
138773743|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138773744|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773745|NCT00879229|Ambrisentan|ambrisentan|mesh-list
138773746|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138220289|NCT04743661|Antipyretics|antipyretics|mesh-list
138773747|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
138773748|NCT04249570|Povidone|povidone|mesh-list
138773749|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
138773750|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
138773751|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138773752|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773754|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138773755|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
138773756|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138773757|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138773758|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138773759|NCT02837770|Analgesics|analgesics|mesh-ancestor
138773760|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
138773761|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773762|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773763|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773764|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138773765|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138773766|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773767|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773768|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
138773769|NCT00878995|Testosterone|testosterone|mesh-list
138773770|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
138773771|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
138773772|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138773773|NCT00878995|Androgens|androgens|mesh-ancestor
138773774|NCT00878995|Hormones|hormones|mesh-ancestor
138773775|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138773776|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773777|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138773778|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773779|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
138773780|NCT02837146|Methotrexate|methotrexate|mesh-list
138773781|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138773782|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
138773783|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138773784|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773785|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138773786|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
138773787|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773788|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773789|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
138773790|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773791|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138773792|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138773793|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
138773794|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138773795|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138773796|NCT00657865|Ramipril|ramipril|mesh-list
138773797|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138773798|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
138773799|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773800|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773801|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138773802|NCT00661765|Varenicline|varenicline|mesh-list
138773803|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138773804|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138773805|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
138773806|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220319|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
138773807|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773808|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773809|NCT00657943|Insulin|insulin|mesh-list
138773810|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138773812|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
138773813|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
138773814|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138773815|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
138773816|NCT00657943|Protamines|protamines|mesh-list
138773817|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138773818|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773819|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
138773820|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773821|NCT00657943|Coagulants|coagulants|mesh-ancestor
138773822|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
138773823|NCT04249804|Analgesics|analgesics|mesh-ancestor
138773824|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
138773825|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773826|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773827|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
138773828|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773829|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138773831|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138773832|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138773833|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773834|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138773835|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
138773836|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138773837|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
138773838|NCT02631109|Doxorubicin|doxorubicin|mesh-list
138773839|NCT02631109|Etoposide|etoposide|mesh-list
138773840|NCT02631109|Pegaspargase|pegaspargase|mesh-list
138773841|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138773842|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773843|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138773844|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138773845|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773846|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773847|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138773848|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773849|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
138773850|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
138773851|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773852|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773853|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138773854|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
138773855|NCT02631109|Hormones|hormones|mesh-ancestor
138773856|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138773857|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138773858|NCT02631109|Protective Agents|protective agents|mesh-ancestor
138773859|NCT02630485|Inositol|inositol|mesh-list
138773860|NCT02630485|Letrozole|letrozole|mesh-list
138773861|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773862|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138773863|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138773864|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544124|NCT00197080|Ropinirole|ropinirole|mesh-list
138773865|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773866|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138773867|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
138773868|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138773869|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691998|NCT01275625|Maraviroc|maraviroc|mesh-list
138773870|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
138773871|NCT02630485|Vitamins|vitamins|mesh-ancestor
138773872|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
138773873|NCT00894556|Sumatriptan|sumatriptan|mesh-list
138773874|NCT00894556|Rizatriptan|rizatriptan|mesh-list
138553951|NCT00281944|Leucovorin|leucovorin|mesh-list
138773875|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138773876|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138773877|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138773878|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
138773879|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773880|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773881|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773882|NCT01210352|Oxymorphone|oxymorphone|mesh-list
138773883|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138773884|NCT01210352|Narcotics|narcotics|mesh-ancestor
138773885|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773886|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773887|NCT01210352|Analgesics|analgesics|mesh-ancestor
138773888|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
138773889|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773890|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138448272|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
138773892|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138773893|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773894|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138773895|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138773896|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773897|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773898|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773899|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
138773900|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138692020|NCT04686825|DA-8010|da-8010|mesh-list
138773901|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773902|NCT00658099|Insulin|insulin|mesh-list
138773903|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138773904|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
138773905|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
138773906|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
138773907|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
138773908|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138773909|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773910|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138773911|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
138773912|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138773913|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138773914|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138773915|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773916|NCT00658177|Urological Agents|urological agents|mesh-ancestor
138773917|NCT00658255|Budesonide|budesonide|mesh-list
138773918|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
138773919|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138773920|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138773921|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
138544212|NCT00197743|Vitamin A|vitamin a|mesh-list
138773922|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773923|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773924|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138773925|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
138773926|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
138773927|NCT00658255|Hormones|hormones|mesh-ancestor
138773928|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138773929|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138773930|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138773931|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138773932|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
138773933|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773934|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773936|NCT02836288|Analgesics|analgesics|mesh-ancestor
138773937|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
138773938|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773939|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773940|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138773941|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138773942|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
138773943|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
138773944|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773945|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138773946|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138773947|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773948|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773950|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
138773951|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138773952|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138773953|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138773954|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138773955|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773957|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138773958|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138773959|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138773960|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
138773961|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773962|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448347|NCT01857154|Antacids|antacids|mesh-ancestor
138773963|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773964|NCT01208324|Estrogens|estrogens|mesh-list
138773965|NCT01208324|Hormones|hormones|mesh-ancestor
138773966|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138773967|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773968|NCT02838940|Cefazolin|cefazolin|mesh-list
138773969|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138773970|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773971|NCT02835742|Sargramostim|sargramostim|mesh-list
138773972|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
138773973|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773974|NCT05326360|Ramosetron|ramosetron|mesh-list
138773975|NCT05326360|Antiemetics|antiemetics|mesh-ancestor
138773976|NCT05326360|Autonomic Agents|autonomic agents|mesh-ancestor
138773977|NCT05326360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138773978|NCT05326360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773979|NCT05326360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138773980|NCT05326360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138773981|NCT05326360|Serotonin Agents|serotonin agents|mesh-ancestor
138773982|NCT05326360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138773983|NCT05326360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773984|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
138773985|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138773986|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138773987|NCT01207388|Blinatumomab|blinatumomab|mesh-list
138773988|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138773989|NCT02835664|Niacinamide|niacinamide|mesh-list
138773991|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
138773992|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
138773993|NCT02835664|Vitamins|vitamins|mesh-ancestor
138773994|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
138773995|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553964|NCT00281944|Antidotes|antidotes|mesh-ancestor
138773996|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138773997|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
138773998|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138773999|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138774000|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
138774001|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
138774002|NCT02838472|Vitamins|vitamins|mesh-ancestor
138774003|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
138774004|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774005|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
138774006|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774007|NCT02838472|Protective Agents|protective agents|mesh-ancestor
138774008|NCT00666991|Paclitaxel|paclitaxel|mesh-list
138774009|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138774010|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774011|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
138774012|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
138774013|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
138774014|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774015|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138774016|NCT00667147|Paclitaxel|paclitaxel|mesh-list
138774017|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774018|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138774019|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
138774020|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
138774021|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
138774022|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774023|NCT02835586|Paclitaxel|paclitaxel|mesh-list
138774024|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138774025|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284414|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774026|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
138774027|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
138774028|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
138544332|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
138774029|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774031|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
138774032|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774033|NCT02838238|Capecitabine|capecitabine|mesh-list
138774034|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138774035|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
138774036|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774037|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774038|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138774039|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774041|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138774042|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138774043|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774044|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
138774045|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774046|NCT01206764|Everolimus|everolimus|mesh-list
138774047|NCT01206764|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138774048|NCT01206764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138774049|NCT01206764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774050|NCT01206764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774051|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138774052|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
138774053|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774054|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774055|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
138774056|NCT00667927|Busulfan|busulfan|mesh-list
138774057|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138774058|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
138774059|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774060|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138774061|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138774062|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
138774063|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774064|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774065|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138774066|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138774067|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
138774068|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138774069|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138774070|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774071|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774072|NCT00668005|Urological Agents|urological agents|mesh-ancestor
138774073|NCT00668239|Triamcinolone|triamcinolone|mesh-list
138774074|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138774076|NCT00668239|Hormones|hormones|mesh-ancestor
138774077|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138774078|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774079|NCT02631499|Epirubicin|epirubicin|mesh-list
138774080|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
138774081|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138774082|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774083|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138774084|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138774085|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774086|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774087|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
138774088|NCT00662233|Ifosfamide|ifosfamide|mesh-list
138774089|NCT00662233|Doxorubicin|doxorubicin|mesh-list
138774090|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138774091|NCT00662233|Etoposide|etoposide|mesh-list
138774092|NCT00662233|Vincristine|vincristine|mesh-list
138774093|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138774094|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
138774095|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774096|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138774097|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138774098|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
138774099|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774100|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774101|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138774102|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138774103|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138774104|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138774105|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774106|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138774107|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
138774108|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
138774109|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
138774110|NCT00658957|Gentamicins|gentamicins|mesh-list
138774111|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138774112|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774113|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138774114|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774115|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774116|NCT00662467|Aspirin|aspirin|mesh-list
138774117|NCT00662467|Warfarin|warfarin|mesh-list
138774118|NCT00662467|Clopidogrel|clopidogrel|mesh-list
138774119|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138774120|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138774121|NCT00662467|Analgesics|analgesics|mesh-ancestor
138774122|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
138774123|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774124|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774125|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138692205|NCT00534378|Midazolam|midazolam|mesh-list
138774126|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138774127|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138774128|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138774129|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774130|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138774131|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138774132|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774134|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138774135|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138774136|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138774137|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
138774138|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138304358|NCT01964898|Nicotine|nicotine|mesh-list
138774141|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
138774142|NCT00668941|Alendronate|alendronate|mesh-list
138774143|NCT00668941|Teriparatide|teriparatide|mesh-list
138774144|NCT00668941|Calcium|calcium|mesh-list
138774145|NCT00668941|Vitamins|vitamins|mesh-ancestor
138774146|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
138774147|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774148|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138774149|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138774150|NCT00894322|Exenatide|exenatide|mesh-list
138774151|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138774152|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774153|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138774154|NCT00894322|Incretins|incretins|mesh-ancestor
138774155|NCT00894322|Hormones|hormones|mesh-ancestor
138774156|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138774157|NCT00633412|Esomeprazole|esomeprazole|mesh-list
138774158|NCT00633412|Ranitidine|ranitidine|mesh-list
138774159|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138774160|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138774161|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138774162|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138774163|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774164|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774165|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138774166|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
138774167|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
138774168|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774169|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774170|NCT00659113|Tegafur|tegafur|mesh-list
138774171|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774172|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138774173|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
138774174|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774175|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
138774176|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138774177|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
138774178|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774179|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774180|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138774181|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
138774182|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138774183|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138774184|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138774185|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
138774186|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774187|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774188|NCT02630095|Nadroparin|nadroparin|mesh-list
138774189|NCT02630095|Warfarin|warfarin|mesh-list
138448569|NCT01858090|Promethazine|promethazine|mesh-list
138774191|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138774192|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774193|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
138774194|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138774195|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138774196|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774197|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138774198|NCT00669487|Lamivudine|lamivudine|mesh-list
138774199|NCT00669487|Stavudine|stavudine|mesh-list
138774200|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138774201|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138774202|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774203|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774204|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
138774205|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774206|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138774207|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138774208|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
138774209|NCT00669565|Bavituximab|bavituximab|mesh-list
138774210|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138774211|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774213|NCT00669643|Dapsone|dapsone|mesh-list
138774214|NCT00669643|Clofazimine|clofazimine|mesh-list
138774215|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138774216|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
138774217|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138774218|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774219|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
138774220|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138774221|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774222|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774223|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138774224|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138774225|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138774226|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138774227|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138774228|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138774229|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
138774230|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138774231|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138774232|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138544638|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
138774233|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138774234|NCT00669721|Heparin|heparin|mesh-list
138774235|NCT00669721|Calcium heparin|calcium heparin|mesh-list
138774236|NCT00669721|Nadroparin|nadroparin|mesh-list
138774237|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
138774238|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138774239|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138774240|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774241|NCT00894166|Bupropion|bupropion|mesh-list
138774242|NCT00894166|Nicotine|nicotine|mesh-list
138774243|NCT00894166|Varenicline|varenicline|mesh-list
138774244|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138774245|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
138774246|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774247|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774248|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138774249|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138774250|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
138774251|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774252|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774253|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138774254|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
138774255|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138774256|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138774257|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138774258|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138774259|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
138774260|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138544681|NCT00048555|Galiximab|galiximab|mesh-list
138774261|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138774262|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448650|NCT01858311|Tocotrienols|tocotrienols|mesh-list
138774264|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
138774265|NCT00659503|Hormones|hormones|mesh-ancestor
138774266|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138774267|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774268|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138774269|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
138774270|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138774271|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138774272|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774273|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
138774274|NCT00670345|Coagulants|coagulants|mesh-ancestor
138774275|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
138774276|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138774277|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774278|NCT00670423|Sirolimus|sirolimus|mesh-list
138774279|NCT00670423|Bortezomib|bortezomib|mesh-list
138774280|NCT00670423|Tacrolimus|tacrolimus|mesh-list
138774281|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138774282|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
138774283|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774284|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138774285|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284477|NCT03043274|Cangrelor|cangrelor|mesh-list
138774286|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774287|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774288|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138774289|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774290|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138774291|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
138774292|NCT00659659|Benralizumab|benralizumab|mesh-list
138774293|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138774294|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
138774295|NCT00670501|Vitamin D|vitamin d|mesh-list
138774296|NCT00670501|Teriparatide|teriparatide|mesh-list
138774297|NCT00670501|Calcium|calcium|mesh-list
138774298|NCT00670501|Vitamins|vitamins|mesh-ancestor
138774299|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
138774300|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774301|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138774302|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138774303|NCT00663247|Mesalamine|mesalamine|mesh-list
138774304|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138774305|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138774306|NCT00663247|Analgesics|analgesics|mesh-ancestor
138774307|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
138774308|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774309|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774310|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138774311|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138774312|NCT01163747|Methotrexate|methotrexate|mesh-list
138774313|NCT01163747|Vaccines|vaccines|mesh-list
138774314|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138774315|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
138774316|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774317|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138774318|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
138774319|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138774320|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138774321|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
138774322|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774323|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774324|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
138774325|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774326|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138774327|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138774328|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138774329|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138774330|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138774331|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
138774332|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774333|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138774334|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138774335|NCT05657015|Simvastatin|simvastatin|mesh-list
138774336|NCT05657015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138774337|NCT05657015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138774338|NCT05657015|Antimetabolites|antimetabolites|mesh-ancestor
138774339|NCT05657015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774340|NCT05657015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138774341|NCT05657015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138774342|NCT05657015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774345|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
138774346|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
138774347|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774348|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138774349|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774350|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138774351|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
138774352|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774353|NCT02887313|Antidotes|antidotes|mesh-ancestor
138774354|NCT02887313|Protective Agents|protective agents|mesh-ancestor
138774355|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
138774356|NCT02887313|Vitamins|vitamins|mesh-ancestor
138774357|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
138774358|NCT01206140|Sirolimus|sirolimus|mesh-list
138774359|NCT01206140|Temsirolimus|temsirolimus|mesh-list
138774360|NCT01206140|MTOR Inhibitors|mtor inhibitors|mesh-list
138774361|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138774362|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774363|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138774364|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774365|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
138774366|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138774367|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
138774368|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774369|NCT01206140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138774370|NCT01206140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774371|NCT01206140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774372|NCT01162421|Adalimumab|adalimumab|mesh-list
138774373|NCT01162421|Methotrexate|methotrexate|mesh-list
138774374|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138774375|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
138774376|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138774377|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774378|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138774379|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
138774380|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774381|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774382|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
138774383|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774384|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138774385|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138774386|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
138774387|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138774388|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138774389|NCT01162421|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138774390|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138774392|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138774393|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138774394|NCT02885441|Analgesics|analgesics|mesh-ancestor
138774395|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
138774396|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774397|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774398|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138774399|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138774400|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138774401|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774402|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774403|NCT02885597|Methotrexate|methotrexate|mesh-list
138774404|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138774405|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
138774406|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138774407|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774408|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138774409|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
138774410|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774411|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448797|NCT01859234|Bevacizumab|bevacizumab|mesh-list
138774413|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774414|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138774415|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138774416|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
138774417|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138774418|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138774419|NCT01188551|Midazolam|midazolam|mesh-list
138774420|NCT01188551|Fentanyl|fentanyl|mesh-list
138774421|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
138774422|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138774423|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138774424|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544980|NCT00222079|Esomeprazole|esomeprazole|mesh-list
138774425|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138774426|NCT01188551|Analgesics|analgesics|mesh-ancestor
138774427|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
138774428|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774429|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138774430|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138774431|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138774432|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
138774433|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774434|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774435|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138774436|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138774437|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138774438|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138774439|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138774440|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
138774441|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
138774442|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
138774443|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
138774444|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138774445|NCT01188551|Narcotics|narcotics|mesh-ancestor
138774446|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
138774447|NCT01161407|Calcium|calcium|mesh-list
138774448|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138774449|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774450|NCT01161407|Antacids|antacids|mesh-ancestor
138774451|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774452|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138774453|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138774454|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774455|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138774457|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774458|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138774459|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138774460|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138774461|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138774462|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138774463|NCT01159769|Analgesics|analgesics|mesh-ancestor
138774464|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
138774465|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774466|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774467|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138774468|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138774469|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138774470|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138774471|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138774472|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
138774473|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
138774474|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774475|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774476|NCT01185821|Siponimod|siponimod|mesh-list
138774477|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138230345|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
138774478|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774479|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138774480|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
138774481|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774482|NCT00893464|Ixazomib|ixazomib|mesh-list
138774483|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774484|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
138774485|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774486|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774487|NCT00891904|Cetuximab|cetuximab|mesh-list
138774488|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138774490|NCT02834260|Dexamethasone|dexamethasone|mesh-list
138774491|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138774492|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
138774493|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
138774494|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774495|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774496|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138774497|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
138774498|NCT02834260|Hormones|hormones|mesh-ancestor
138774499|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138774500|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138774501|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774502|NCT01157351|Olanzapine|olanzapine|mesh-list
138774503|NCT01157351|Risperidone|risperidone|mesh-list
138774504|NCT01157351|Aripiprazole|aripiprazole|mesh-list
138774505|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138774506|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138774508|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138774509|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
138545114|NCT00061802|Risperidone|risperidone|mesh-list
138774510|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774511|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774512|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774513|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138774514|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138774515|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138774516|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138774517|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138774518|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
138774519|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
138774520|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
138774521|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774522|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138774523|NCT01157351|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138774524|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138774525|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138774526|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
138774527|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
138545152|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
138774528|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138774529|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138774530|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138774531|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138774532|NCT02831686|Dexamethasone|dexamethasone|mesh-list
138774533|NCT02831686|Ixazomib|ixazomib|mesh-list
138774534|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138774535|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
138774536|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
138774537|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774538|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774539|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138774540|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
138774541|NCT02831686|Hormones|hormones|mesh-ancestor
138774542|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138774543|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138774544|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774545|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
138774546|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554029|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138774547|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774548|NCT00633490|Apatinib|apatinib|mesh-list
138774549|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774550|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138774551|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774552|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774553|NCT02831374|Anesthetics|anesthetics|mesh-list
138774554|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138774555|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774556|NCT02831218|Aspirin|aspirin|mesh-list
138774557|NCT02831218|Clopidogrel|clopidogrel|mesh-list
138545211|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138774558|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138774559|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138774560|NCT02831218|Analgesics|analgesics|mesh-ancestor
138774561|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
138774562|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774563|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774564|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138774565|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138774566|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138774567|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138774568|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774569|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138774570|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138774571|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774572|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
138774573|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138774574|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138774575|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138774576|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
138774577|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774578|NCT02833480|Fluticasone|fluticasone|mesh-list
138774579|NCT02833480|Budesonide|budesonide|mesh-list
138774580|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
138774581|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138774582|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138774583|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
138774584|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774585|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774586|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138774587|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
138774588|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
138774589|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138545250|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
138774590|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
138774591|NCT02833480|Hormones|hormones|mesh-ancestor
138774592|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138774593|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138774594|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138774595|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138774596|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
138774597|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692536|NCT00533169|Isotretinoin|isotretinoin|mesh-list
138774598|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774599|NCT04201054|Fluconazole|fluconazole|mesh-list
138774600|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
138774601|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774602|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138774603|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138774604|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774605|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774606|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138774607|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
138774608|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138774609|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774610|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138774611|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138774612|NCT01157117|Omalizumab|omalizumab|mesh-list
138774613|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138774614|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138554035|NCT00110253|Lidocaine|lidocaine|mesh-list
138774615|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138774616|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
138774617|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
138774618|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774620|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774621|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774622|NCT02830906|Ondansetron|ondansetron|mesh-list
138774623|NCT02830906|Ramosetron|ramosetron|mesh-list
138774624|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
138774625|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
138774626|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774627|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774628|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138774629|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
138774630|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
138774631|NCT02830906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138774632|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138774633|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
138449019|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
138774634|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774635|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774637|NCT02832778|Lamivudine|lamivudine|mesh-list
138774638|NCT02832778|Emtricitabine|emtricitabine|mesh-list
138774640|NCT02832778|Efavirenz|efavirenz|mesh-list
138774641|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138774642|NCT02832778|Isoniazid|isoniazid|mesh-list
138774643|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
138774644|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774645|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138774646|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138774647|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774648|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774649|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138774650|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138774651|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
138774652|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138774653|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138774654|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138774655|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138774656|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138774657|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138774658|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
138774659|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138774660|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138774661|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138774662|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138774663|NCT01185509|Trastuzumab|trastuzumab|mesh-list
138774664|NCT01185509|Vinorelbine|vinorelbine|mesh-list
138774665|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138774666|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774667|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138774668|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
138774669|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
138774670|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
138774671|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774672|NCT04247230|Tetracaine|tetracaine|mesh-list
138774673|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
138774674|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
138774675|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138774676|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774677|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
138774678|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774679|NCT02832700|Caseins|caseins|mesh-list
138774680|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
138774681|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
138774682|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774683|NCT02831842|Bevacizumab|bevacizumab|mesh-list
138774684|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138692610|NCT00536276|Vitamin D|vitamin d|mesh-list
138774685|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774686|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138774687|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138774688|NCT02831842|Growth Substances|growth substances|mesh-ancestor
138774689|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774690|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
138774691|NCT02830048|Glyburide|glyburide|mesh-list
138774692|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138774693|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774694|NCT02830126|Anesthetics|anesthetics|mesh-list
138774695|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138774696|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774697|NCT02828566|Ketamine|ketamine|mesh-list
138774698|NCT02828566|Analgesics|analgesics|mesh-ancestor
138774699|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
138774700|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774701|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774702|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138774703|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138774704|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
138774705|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
138774706|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138774707|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138774708|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138774709|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774710|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774711|NCT04245046|Amlodipine|amlodipine|mesh-list
138774712|NCT04245046|Candesartan|candesartan|mesh-list
138774713|NCT04245046|Candesartan cilexetil|candesartan cilexetil|mesh-list
138774714|NCT04245046|Atorvastatin|atorvastatin|mesh-list
138774715|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138774716|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138774717|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
138774718|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774719|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138774720|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138774721|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774722|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138774723|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138774724|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138774725|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138774726|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774727|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
138774728|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138774729|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138774730|NCT02828176|Anesthetics|anesthetics|mesh-list
138692634|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
138774731|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138774732|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774733|NCT00633568|Cisplatin|cisplatin|mesh-list
138774734|NCT00633568|Docetaxel|docetaxel|mesh-list
138774735|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774736|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
138774737|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
138774738|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
138774739|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774740|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
138774741|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138774742|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138774743|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774744|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
138774745|NCT02829346|Coagulants|coagulants|mesh-ancestor
138774746|NCT05210764|Ketamine|ketamine|mesh-list
138774748|NCT05210764|Propofol|propofol|mesh-list
138774750|NCT05210764|Esketamine|esketamine|mesh-list
138774751|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138774752|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774753|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138774754|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138545596|NCT00062426|Vitamins|vitamins|mesh-ancestor
138774755|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
138774756|NCT05210764|Analgesics|analgesics|mesh-ancestor
138774757|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
138774758|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774759|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138774760|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138774761|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138774762|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774763|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774764|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138774765|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138774766|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
138774767|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138774768|NCT00889720|Varenicline|varenicline|mesh-list
138774769|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138774770|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138774771|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
138774772|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774773|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774774|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774776|NCT04243954|Hydromorphone|hydromorphone|mesh-list
138774777|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138774778|NCT04243954|Narcotics|narcotics|mesh-ancestor
138774779|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138774780|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774781|NCT04243954|Analgesics|analgesics|mesh-ancestor
138774782|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
138774783|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774784|NCT02827942|Amoxicillin|amoxicillin|mesh-list
138774785|NCT02827942|Metronidazole|metronidazole|mesh-list
138774786|NCT02827942|Clarithromycin|clarithromycin|mesh-list
138774787|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138774788|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774789|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138774790|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138774791|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138774792|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774793|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774794|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138774795|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138774796|NCT00889252|Ketotifen|ketotifen|mesh-list
138774797|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
138774798|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
138774799|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138774800|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
138774801|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
138774802|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774803|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774804|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774805|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138774806|NCT00670813|Modafinil|modafinil|mesh-list
138545682|NCT00225667|Irbesartan|irbesartan|mesh-list
138774807|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138774808|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774809|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138774810|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138774811|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138774812|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774813|NCT01110330|Ketoconazole|ketoconazole|mesh-list
138774814|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
138774815|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774816|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138774817|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138774818|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774819|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774820|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138774821|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
138774822|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138774823|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774824|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138774825|NCT00663481|Leucovorin|leucovorin|mesh-list
138774826|NCT00663481|Antidotes|antidotes|mesh-ancestor
138774827|NCT00663481|Protective Agents|protective agents|mesh-ancestor
138774828|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774829|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
138774830|NCT00663481|Vitamins|vitamins|mesh-ancestor
138774831|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
138774832|NCT04308954|Flumazenil|flumazenil|mesh-list
138774833|NCT04308954|Antidotes|antidotes|mesh-ancestor
138774834|NCT04308954|Protective Agents|protective agents|mesh-ancestor
138774835|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774836|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
138774837|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
138774838|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774839|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774840|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
138774841|NCT00596947|Prednisone|prednisone|mesh-list
138774842|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
138774843|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138774844|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138774845|NCT00596947|Prednisolone|prednisolone|mesh-list
138774846|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
138774847|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138774848|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
138774849|NCT00596947|Tacrolimus|tacrolimus|mesh-list
138774850|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
138774851|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138774852|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138774853|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
138774854|NCT00596947|Hormones|hormones|mesh-ancestor
138774855|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138774856|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774857|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138774858|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774859|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138774860|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
138774861|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138774862|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774863|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638003|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138774864|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138774865|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138774866|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
138774867|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138774868|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774870|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
138774871|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774872|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138774873|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138774874|NCT00596947|Protective Agents|protective agents|mesh-ancestor
138774875|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
138774877|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138774878|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774879|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
138774880|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138774881|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774882|NCT00663559|Sunitinib|sunitinib|mesh-list
138774883|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774884|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138774885|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138774886|NCT00663559|Growth Substances|growth substances|mesh-ancestor
138774887|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774888|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
138774889|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138774890|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774891|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692755|NCT04326985|Protective Agents|protective agents|mesh-ancestor
138774893|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774894|NCT00888940|Ecallantide|ecallantide|mesh-list
138774895|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
138774896|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138774897|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138774898|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774899|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
138774900|NCT00888940|Coagulants|coagulants|mesh-ancestor
138774901|NCT00888940|Analgesics|analgesics|mesh-ancestor
138774902|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
138774903|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774904|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774905|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138774906|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138774907|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138774908|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138774909|NCT02826070|Adefovir|adefovir|mesh-list
138774910|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138774911|NCT02826070|Telbivudine|telbivudine|mesh-list
138774912|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
138774913|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774914|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138774915|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138774916|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774917|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774918|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
138774919|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
138774920|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774921|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774923|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
138774924|NCT00671203|Erythromycin|erythromycin|mesh-list
138774925|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
138774926|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138774927|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
138774928|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138774929|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774930|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138774931|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138774932|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774933|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774934|NCT04157803|Acetic Acid|acetic acid|mesh-list
138774935|NCT04157803|Retinol acetate|retinol acetate|mesh-list
138774936|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138774937|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138774938|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138774939|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
138774940|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774941|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138774942|NCT04157803|Protective Agents|protective agents|mesh-ancestor
138774943|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774945|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
138774946|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138774947|NCT00660283|Temozolomide|temozolomide|mesh-list
138774948|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138774949|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
138774950|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774951|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138774952|NCT00663949|Captopril|captopril|mesh-list
138774953|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
138774954|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138774955|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774956|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774957|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138774958|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138774959|NCT00663949|Protective Agents|protective agents|mesh-ancestor
138774960|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774961|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
138774962|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138774963|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
138774964|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138774965|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
138774966|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138774967|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138774968|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138774969|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774970|NCT00888238|Incretins|incretins|mesh-ancestor
138774971|NCT00888238|Hormones|hormones|mesh-ancestor
138774972|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138774973|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138774974|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
138774975|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138774976|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774977|NCT05660356|Hormones|hormones|mesh-list
138774978|NCT05660356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138774979|NCT05660356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774980|NCT02825914|Caseins|caseins|mesh-list
138774981|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
138774982|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
138692825|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
138774983|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774984|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
138774985|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138284668|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
138774986|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138774987|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138774988|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
138774989|NCT00671281|Coagulants|coagulants|mesh-ancestor
138774990|NCT04155229|Acetaminophen|acetaminophen|mesh-list
138774991|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138774992|NCT04155229|Oxycodone|oxycodone|mesh-list
138774993|NCT04155229|Hydrocodone|hydrocodone|mesh-list
138774994|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138774995|NCT04155229|Analgesics|analgesics|mesh-ancestor
138774996|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
138774997|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138774998|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774999|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
138775000|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138775001|NCT04155229|Narcotics|narcotics|mesh-ancestor
138775002|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775003|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
138775004|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
138775005|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138775006|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138775007|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138775008|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
138775009|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138775010|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775011|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
138775012|NCT04153201|Antimalarials|antimalarials|mesh-list
138775013|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138775014|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138775015|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775016|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775017|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775018|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138775019|NCT05660278|Caseins|caseins|mesh-list
138775020|NCT05660278|Chelating Agents|chelating agents|mesh-ancestor
138775021|NCT05660278|Sequestering Agents|sequestering agents|mesh-ancestor
138775022|NCT05660278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775023|NCT04153123|Epinephrine|epinephrine|mesh-list
138775024|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138775025|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138775026|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
138775027|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692850|NCT00596128|Insulin|insulin|mesh-list
138775028|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775029|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775030|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138775031|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138775032|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
138775033|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775034|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138775035|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
138775036|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
138775037|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
138775038|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138775039|NCT00671593|Phenol|phenol|mesh-list
138775040|NCT00671593|Glycerol|glycerol|mesh-list
138775041|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138775042|NCT00671593|Protective Agents|protective agents|mesh-ancestor
138775043|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775044|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138775045|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775046|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
138775047|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138775048|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138775049|NCT01104870|Treprostinil|treprostinil|mesh-list
138284680|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
138775050|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138775051|NCT02632279|Tryptophan|tryptophan|mesh-list
138775052|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138775053|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
138775054|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138775055|NCT00664417|Vaccines|vaccines|mesh-list
138775056|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
138775057|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775058|NCT04031755|Minocycline|minocycline|mesh-list
138775059|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138775060|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775061|NCT01104792|Cariprazine|cariprazine|mesh-list
138775062|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138546185|NCT00228319|Vitamins|vitamins|mesh-list
138775063|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138775064|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775065|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775066|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138775067|NCT01205126|Oxycodone|oxycodone|mesh-list
138775068|NCT01205126|Hydromorphone|hydromorphone|mesh-list
138775069|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138775070|NCT01205126|Narcotics|narcotics|mesh-ancestor
138775071|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775072|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775073|NCT01205126|Analgesics|analgesics|mesh-ancestor
138775075|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775076|NCT02629627|Metformin|metformin|mesh-list
138775077|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138775078|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775079|NCT00946647|Azacitidine|azacitidine|mesh-list
138775080|NCT00946647|Panobinostat|panobinostat|mesh-list
138775081|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138775082|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
138775083|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775084|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775085|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775086|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138775087|NCT05117736|Valsartan|valsartan|mesh-list
138775088|NCT05117736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138775089|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138775090|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138775091|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138775092|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775093|NCT04157491|Antibodies|antibodies|mesh-list
138775094|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
138775095|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775096|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138775097|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138284688|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138775098|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138775099|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138775100|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775101|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775102|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775104|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
138775105|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775106|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
138775107|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138775109|NCT00664963|Sirolimus|sirolimus|mesh-list
138775110|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138775111|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775112|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138775113|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775114|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
138775115|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138775116|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
138775117|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775118|NCT00672295|Paclitaxel|paclitaxel|mesh-list
138775119|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138775120|NCT00672295|Carboplatin|carboplatin|mesh-list
138775121|NCT00672295|Dasatinib|dasatinib|mesh-list
138775122|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138775123|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775124|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
138775125|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
138775126|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
138775127|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775128|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138775129|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775130|NCT00665041|Quinagolide|quinagolide|mesh-list
138775131|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
138775132|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
138775133|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775134|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775135|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775136|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
138775137|NCT04152655|Idebenone|idebenone|mesh-list
138775138|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
138775139|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775140|NCT04152655|Vitamins|vitamins|mesh-ancestor
138775141|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
138775142|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775143|NCT04152655|Protective Agents|protective agents|mesh-ancestor
138775144|NCT00665119|Remifentanil|remifentanil|mesh-list
138775145|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138775146|NCT00665119|Narcotics|narcotics|mesh-ancestor
138775147|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775148|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775149|NCT00665119|Analgesics|analgesics|mesh-ancestor
138775150|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
138775151|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775152|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138775153|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138692942|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138775154|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138775155|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138775156|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449545|NCT01864083|Fluorides|fluorides|mesh-list
138775158|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775159|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
138775161|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
138775162|NCT00672763|Vitamin D|vitamin d|mesh-list
138775163|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
138775164|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
138775165|NCT00672763|Vitamins|vitamins|mesh-list
138775166|NCT00672763|Calcium|calcium|mesh-list
138775167|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
138775168|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775169|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138775170|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138775171|NCT04154449|Insulin|insulin|mesh-list
138775172|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138775173|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775174|NCT00661063|Clonidine|clonidine|mesh-list
138775175|NCT00661063|Ketamine|ketamine|mesh-list
138775176|NCT00661063|Analgesics|analgesics|mesh-ancestor
138775177|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
138775178|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775179|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554067|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
138775180|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138775181|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138775182|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
138775183|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
138775184|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775185|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138775186|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138775187|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775188|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775189|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138775190|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
138775191|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
138775192|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138775193|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138775194|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138775195|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
138775196|NCT00672919|Pioglitazone|pioglitazone|mesh-list
138775197|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138775198|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775199|NCT01109316|Insulin|insulin|mesh-list
138775200|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138775201|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
138775202|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
138775203|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138775204|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284733|NCT03108482|Narcotics|narcotics|mesh-ancestor
138775205|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138775206|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138775207|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
138775208|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138775209|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
138775210|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138775211|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775212|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138775213|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138775214|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775215|NCT00675961|Naltrexone|naltrexone|mesh-list
138775216|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138775217|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138775218|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775219|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
138775220|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775221|NCT00887068|Azacitidine|azacitidine|mesh-list
138775222|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138775223|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
138775224|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775225|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775226|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775227|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138775228|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
138775229|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775230|NCT00886834|Misoprostol|misoprostol|mesh-list
138775231|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138775232|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
138775233|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138775234|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775235|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138775236|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138775237|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
138775238|NCT00880009|Letrozole|letrozole|mesh-list
138775239|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775240|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138775241|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138222719|NCT01510457|Analgesics|analgesics|mesh-ancestor
138775242|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775243|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775244|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138775245|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
138775246|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138775247|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775248|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138775249|NCT00676039|Citalopram|citalopram|mesh-list
138775250|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138775251|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138775252|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138775253|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775254|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775255|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775256|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138775257|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
138775258|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138775259|NCT00676039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138775260|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
138775261|NCT01104636|Varenicline|varenicline|mesh-list
138775262|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138775263|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138775264|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
138775265|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775266|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775267|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775268|NCT04931602|Vitamin D|vitamin d|mesh-list
138775269|NCT04931602|Vitamins|vitamins|mesh-ancestor
138775270|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
138775271|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775272|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138775273|NCT04157257|Tenofovir|tenofovir|mesh-list
138775274|NCT04157257|Entecavir|entecavir|mesh-list
138775275|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
138775276|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775277|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138775278|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138775279|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775280|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775281|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138775282|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138775283|NCT04152889|Docetaxel|docetaxel|mesh-list
138775284|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775285|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
138775286|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
138775287|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
138775288|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775289|NCT00602511|Thalidomide|thalidomide|mesh-list
138775290|NCT00602511|Bortezomib|bortezomib|mesh-list
138775291|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775292|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138775293|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
138775294|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775295|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
138775296|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138775297|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775298|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138775299|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138775300|NCT00602511|Growth Substances|growth substances|mesh-ancestor
138775301|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
138775302|NCT02826616|Trimetazidine|trimetazidine|mesh-list
138775303|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
138775304|NCT00676117|Loxoprofen|loxoprofen|mesh-list
138775305|NCT00676117|Esomeprazole|esomeprazole|mesh-list
138775306|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138775307|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138775308|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138775309|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775310|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775311|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138775312|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138775314|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
138775315|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775316|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775317|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138775318|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138775319|NCT01104558|Bisoprolol|bisoprolol|mesh-list
138775320|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138775321|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
138554077|NCT00282607|Udenafil|udenafil|mesh-list
138775322|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
138775323|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775324|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775325|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138775326|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138775327|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138775328|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
138775329|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775330|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775331|NCT00602589|Levofloxacin|levofloxacin|mesh-list
138775333|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138775334|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775335|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138775336|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138775337|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138775338|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775339|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775340|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775341|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138775342|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138775343|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
138775344|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
138775345|NCT02856087|Remifentanil|remifentanil|mesh-list
138775346|NCT02856087|Naloxone|naloxone|mesh-list
138775347|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138775348|NCT02856087|Narcotics|narcotics|mesh-ancestor
138775349|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775350|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775351|NCT02856087|Analgesics|analgesics|mesh-ancestor
138775352|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
138775353|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775354|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138775355|NCT00676429|Ziprasidone|ziprasidone|mesh-list
138775356|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138775357|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
138775358|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284811|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775359|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775360|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775361|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138775362|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138693094|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
138775363|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775364|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138775365|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138775366|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
138775367|NCT02629315|Formaldehyde|formaldehyde|mesh-list
138775368|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
138775369|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775370|NCT01204658|Vaccines|vaccines|mesh-list
138775371|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138775372|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
138775373|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775374|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138775375|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
138775376|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138775377|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138775378|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138775379|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775380|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775381|NCT01104246|Testosterone|testosterone|mesh-list
138775382|NCT01104246|Androgens|androgens|mesh-ancestor
138775383|NCT01104246|Hormones|hormones|mesh-ancestor
138775384|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138775385|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775386|NCT00676741|Insulin|insulin|mesh-list
138775387|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138775388|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
138775389|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
138775390|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138775391|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
138775392|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
138775393|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138775394|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138775395|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775396|NCT01103778|Bortezomib|bortezomib|mesh-list
138775397|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775398|NCT00673621|Albuterol|albuterol|mesh-list
138775399|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
138775400|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775401|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138775402|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
138775403|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775404|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138775405|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
138467876|NCT01969032|Paclitaxel|paclitaxel|mesh-list
138775406|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
138775407|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138775408|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138775409|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138775410|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138775411|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
138775412|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775413|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775414|NCT00673621|Miotics|miotics|mesh-ancestor
138775415|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138775416|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138775417|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138775418|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138775419|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
138775420|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
138775421|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138546650|NCT00230815|Hormones|hormones|mesh-ancestor
138775422|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
138775423|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138284824|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
138775424|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
138775425|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775426|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775427|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
138775428|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138775429|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138775430|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138775431|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138775432|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775433|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775434|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775435|NCT00945945|Analgesics|analgesics|mesh-ancestor
138775436|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
138775437|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775438|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
138775439|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138775440|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
138775442|NCT01112982|Febuxostat|febuxostat|mesh-list
138775443|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
138775444|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138775445|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
138775446|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
138546682|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
138775447|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
138775448|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775449|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775451|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138775452|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138775453|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
138775454|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775455|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775456|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
138775457|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138775458|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
138775460|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138775461|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
138775462|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138775463|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775464|NCT00625794|Nicotine|nicotine|mesh-list
138775465|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138775466|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
138775467|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775468|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775469|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138775470|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138775471|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
138775472|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775473|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775474|NCT01203098|Enoxaparin|enoxaparin|mesh-list
138775475|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
138775476|NCT01203098|Edoxaban|edoxaban|mesh-list
138775477|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
138775478|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138775479|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138775480|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775481|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138775482|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
138775483|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138775484|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
138775486|NCT05032794|Bisacodyl|bisacodyl|mesh-list
138775487|NCT05032794|Cathartics|cathartics|mesh-ancestor
138775488|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138775489|NCT05032794|Laxatives|laxatives|mesh-ancestor
138775490|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138775491|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775492|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138775493|NCT01108458|Pertuzumab|pertuzumab|mesh-list
138775494|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775495|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138775496|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775497|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775498|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138775499|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138775500|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775501|NCT00680485|Ketoconazole|ketoconazole|mesh-list
138775502|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
138775503|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775504|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138775505|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138775506|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775507|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775508|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138775509|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
138711086|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775510|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138775511|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775512|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138775513|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
138775514|NCT00680563|Hematinics|hematinics|mesh-ancestor
138775515|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
138775516|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775517|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
138775518|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138775519|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775520|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
138775521|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138775522|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775523|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775524|NCT00680641|Simvastatin|simvastatin|mesh-list
138775525|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138775526|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138775527|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
138775528|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775529|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138775530|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138775531|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775532|NCT01201850|Bevacizumab|bevacizumab|mesh-list
138449925|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
138775533|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138775534|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775535|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138775536|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138775537|NCT01201850|Growth Substances|growth substances|mesh-ancestor
138775538|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775539|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
138775540|NCT05660122|Fexuprazan|fexuprazan|mesh-list
138775541|NCT05660122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138775542|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
138775543|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138775544|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138775545|NCT02825056|Morphine|morphine|mesh-list
138775546|NCT02825056|Bupivacaine|bupivacaine|mesh-list
138775547|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
138775548|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
138775549|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775550|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775551|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
138775552|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775553|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138775554|NCT02825056|Narcotics|narcotics|mesh-ancestor
138775555|NCT02825056|Analgesics|analgesics|mesh-ancestor
138775556|NCT02826772|Androgens|androgens|mesh-list
138775557|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
138775558|NCT02826772|Hormones|hormones|mesh-ancestor
138775559|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138775560|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775561|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
138775562|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
138775563|NCT00674011|Bevacizumab|bevacizumab|mesh-list
138775564|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138775565|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775566|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138775567|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138775568|NCT00674011|Growth Substances|growth substances|mesh-ancestor
138775569|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775570|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
138775571|NCT00674089|Vitamin A|vitamin a|mesh-list
138775572|NCT00674089|Vitamins|vitamins|mesh-ancestor
138775573|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
138775574|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775575|NCT01200992|Mitomycins|mitomycins|mesh-list
138775576|NCT01200992|Mitomycin|mitomycin|mesh-list
138775577|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138775578|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775579|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
138775580|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775581|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138775582|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775583|NCT02824666|Fallypride|fallypride|mesh-list
138775584|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138775585|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138775586|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
138775587|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775588|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775589|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775590|NCT00674167|Docetaxel|docetaxel|mesh-list
138775591|NCT00674167|Capecitabine|capecitabine|mesh-list
138775592|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775593|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
138775594|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
138775595|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
138775596|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775597|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138775598|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
138775599|NCT00912145|Alprazolam|alprazolam|mesh-list
138775600|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138775601|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775602|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775603|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138775604|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138775605|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138775606|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
138775607|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
138775608|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546906|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
138775609|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775610|NCT02824510|Insulin|insulin|mesh-list
138775611|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138775612|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
138775613|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138775614|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775615|NCT00674245|Pantoprazole|pantoprazole|mesh-list
138775616|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138775617|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138775618|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138775619|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775620|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775621|NCT00878215|Liver Extracts|liver extracts|mesh-list
138775622|NCT00878215|Hematinics|hematinics|mesh-ancestor
138775623|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
138775624|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775625|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
138775626|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138775627|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138775628|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775629|NCT02628847|Urological Agents|urological agents|mesh-ancestor
138775630|NCT00677443|Capecitabine|capecitabine|mesh-list
138775631|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
138775632|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138775633|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
138775634|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775635|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775636|NCT00674557|Exemestane|exemestane|mesh-list
138775637|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138775638|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775639|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138775640|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138775641|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775642|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775643|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138775644|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
138649741|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138546946|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138775645|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138775646|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775648|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
138775649|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138775650|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138775651|NCT00674557|Growth Substances|growth substances|mesh-ancestor
138775652|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
138775653|NCT00677521|Acarbose|acarbose|mesh-list
138775654|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138775655|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775656|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775657|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138775658|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775659|NCT00674713|Ondansetron|ondansetron|mesh-list
138775660|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138775661|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
138775662|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
138775663|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775664|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775665|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138775666|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
138775667|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
138775668|NCT00674713|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138775669|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138775670|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
138775671|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775672|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775674|NCT04241380|Anticoagulants|anticoagulants|mesh-list
138775675|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138775676|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138693327|NCT00537524|Vaccines|vaccines|mesh-list
138775677|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138775678|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775679|NCT02824354|Nalmefene|nalmefene|mesh-list
138775680|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138775681|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775682|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
138775683|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775684|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
138450074|NCT01868750|Vitamins|vitamins|mesh-ancestor
138775685|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138775686|NCT02823496|Protective Agents|protective agents|mesh-ancestor
138775687|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775688|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
138775689|NCT00677755|Misoprostol|misoprostol|mesh-list
138775690|NCT00677755|Mifepristone|mifepristone|mesh-list
138775691|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138775692|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
138775693|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138775694|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775695|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138775696|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138775697|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
138775698|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138775699|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138775700|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138775701|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138775702|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
138775703|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138775704|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138775705|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
138775706|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138775707|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
138775708|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138775709|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138775710|NCT00674947|huB3F6-SPDB-DM4 immunoconjugate|hub3f6-spdb-dm4 immunoconjugate|mesh-list
138775711|NCT00674947|Immunoconjugates|immunoconjugates|mesh-ancestor
138775712|NCT00674947|Immunologic Factors|immunologic factors|mesh-ancestor
138775713|NCT00674947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775714|NCT02824042|Itraconazole|itraconazole|mesh-list
138775715|NCT02824042|Maytansine|maytansine|mesh-list
138775716|NCT02824042|Anetumab ravtansine|anetumab ravtansine|mesh-list
138775718|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775719|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138775720|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138775721|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775722|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775723|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138775724|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
138775725|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138775726|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775727|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138775728|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138775729|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775730|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
138775731|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
138775732|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
138775733|NCT02824042|Immunoconjugates|immunoconjugates|mesh-ancestor
138775734|NCT02824042|Immunologic Factors|immunologic factors|mesh-ancestor
138775735|NCT00675181|Melatonin|melatonin|mesh-list
138775736|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
138775737|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775738|NCT00675181|Protective Agents|protective agents|mesh-ancestor
138775739|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547057|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138775740|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775741|NCT04241458|Midazolam|midazolam|mesh-list
138775742|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138775743|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138775744|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775745|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775746|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138775747|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138775748|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138775749|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138775750|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
138775751|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
138775752|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
138775753|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
138775754|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775755|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775756|NCT02823808|Glimepiride|glimepiride|mesh-list
138775757|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138775758|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138775760|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138775761|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
138775762|NCT04151719|Bromides|bromides|mesh-list
138775763|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
138775764|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
138775765|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138775766|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775767|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
138775768|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775769|NCT02822482|Cetuximab|cetuximab|mesh-list
138775770|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138775771|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775772|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
138775773|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
138775774|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138775775|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138775776|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775779|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138775780|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138775781|NCT04240834|Analgesics|analgesics|mesh-ancestor
138775782|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
138775783|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775784|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775785|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138775786|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138775787|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138775788|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138775789|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775790|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138775791|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138775792|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775793|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
138775794|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138775795|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138775796|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138775797|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
138775798|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775799|NCT01200758|Prednisone|prednisone|mesh-list
138775800|NCT01200758|Prednisolone|prednisolone|mesh-list
138775801|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
138775802|NCT01200758|Rituximab|rituximab|mesh-list
138775803|NCT01200758|Doxorubicin|doxorubicin|mesh-list
138775804|NCT01200758|Vincristine|vincristine|mesh-list
138775805|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138775806|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
138775807|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775808|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138775809|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138775810|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
138775811|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547133|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
138775812|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775813|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138775814|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138775815|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138775816|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138775817|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138775818|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775819|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138775820|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
138775821|NCT01200758|Hormones|hormones|mesh-ancestor
138775822|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138775823|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138775824|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138775825|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
138775826|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
138775827|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
138775828|NCT02823106|Verapamil|verapamil|mesh-list
138775829|NCT02823106|Choline|choline|mesh-list
138775830|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138547180|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
138775831|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
138775832|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138775833|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
138775834|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775835|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138775836|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138775837|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
138775838|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138775839|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138775840|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138775841|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138775842|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775843|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
138775844|NCT02821858|Odalasvir|odalasvir|mesh-list
138775845|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
138775846|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138775847|NCT00876343|Aripiprazole|aripiprazole|mesh-list
138554147|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
138775848|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
138775849|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138775850|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138775851|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138775852|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775853|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775854|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
138775855|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
138775856|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775857|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775858|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138693416|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
138775859|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138775860|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
138775861|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138775862|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138775863|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138775864|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138775865|NCT02627989|Diflucortolone|diflucortolone|mesh-list
138775866|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
138775867|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138775868|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
138775869|NCT02627989|Hormones|hormones|mesh-ancestor
138775870|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138775871|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775872|NCT00675649|Golimumab|golimumab|mesh-list
138775873|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138775874|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138775875|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138775876|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
138775877|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775878|NCT01107912|Clopidogrel|clopidogrel|mesh-list
138775879|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138775880|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138775881|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138775882|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138775883|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138775884|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
138775885|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775886|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775887|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775888|NCT00678145|Epinephrine|epinephrine|mesh-list
138775889|NCT00678145|Morphine|morphine|mesh-list
138775890|NCT00678145|Naloxone|naloxone|mesh-list
138775891|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775892|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138775893|NCT00678145|Narcotics|narcotics|mesh-ancestor
138775894|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775895|NCT00678145|Analgesics|analgesics|mesh-ancestor
138775896|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
138775897|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775898|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138775899|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138775900|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
138775901|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138775902|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775903|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138775904|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138775905|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
138775906|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138775907|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
138775909|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
138775910|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138775911|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138775912|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
138775913|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
138284989|NCT00375050|Riluzole|riluzole|mesh-list
138775915|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775916|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775917|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
138775918|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775920|NCT02690506|Analgesics|analgesics|mesh-ancestor
138775921|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
138775922|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775923|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775924|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
138775925|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138775926|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138775927|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775928|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138775929|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138775930|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138775931|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138775932|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138775933|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
138775934|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138775935|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775937|NCT04239586|Glipizide|glipizide|mesh-list
138775938|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138775939|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775940|NCT02628613|Paclitaxel|paclitaxel|mesh-list
138775941|NCT02628613|Vinorelbine|vinorelbine|mesh-list
138775942|NCT02628613|Epirubicin|epirubicin|mesh-list
138775943|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138775944|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775945|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
138775946|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
138775947|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
138775948|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775949|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138775950|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138775951|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138775952|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775953|NCT01100034|Etanercept|etanercept|mesh-list
138775954|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138775955|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138775956|NCT01100034|Analgesics|analgesics|mesh-ancestor
138775957|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
138775958|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775959|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775960|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138775961|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138775962|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138775963|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138775964|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
138775965|NCT04148833|Paclitaxel|paclitaxel|mesh-list
138775966|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138775967|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138775968|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
138775969|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
138775970|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
138775971|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775972|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138775973|NCT02821468|Acetaminophen|acetaminophen|mesh-list
138775974|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
138775975|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138775976|NCT02821468|Analgesics|analgesics|mesh-ancestor
138775977|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
138775978|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775979|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775980|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
138775981|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138775982|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775983|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775984|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138775985|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138775986|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138775988|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138775989|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138775990|NCT04964622|Analgesics|analgesics|mesh-ancestor
138775991|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
138775992|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138775993|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775994|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138775995|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138775996|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138775997|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775998|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775999|NCT04769050|Docetaxel|docetaxel|mesh-list
138776000|NCT04769050|Capecitabine|capecitabine|mesh-list
138776001|NCT04769050|Trastuzumab|trastuzumab|mesh-list
138776002|NCT04769050|Pertuzumab|pertuzumab|mesh-list
138776003|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776004|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
138776005|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
138776006|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
138776007|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776008|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138776009|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
138776010|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138776011|NCT02821390|Nepafenac|nepafenac|mesh-list
138776012|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138776013|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
138776014|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138776015|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138776016|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138776017|NCT02821390|Analgesics|analgesics|mesh-ancestor
138776018|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
138776019|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776020|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776021|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138776022|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138776024|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138776025|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138285041|NCT03090620|Lorazepam|lorazepam|mesh-list
138776026|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
138776027|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776028|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776029|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776030|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
138776031|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138776032|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
138776033|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776034|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776035|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138776036|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
138776037|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138776038|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
138776039|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776040|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776041|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138776042|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
138776043|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
138776044|NCT02821156|Protective Agents|protective agents|mesh-ancestor
138776045|NCT02820922|Anesthetics|anesthetics|mesh-list
138776046|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776047|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776048|NCT00633958|Alovudine|alovudine|mesh-list
138776049|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
138776050|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776051|NCT02820688|Bupivacaine|bupivacaine|mesh-list
138776052|NCT02820688|Prilocaine|prilocaine|mesh-list
138776053|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
138776054|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
138776055|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776056|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776057|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
138776058|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776059|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138776060|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138776061|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138776062|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138776063|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138776064|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138776065|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138776066|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138252890|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
138776067|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
138776068|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776069|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776070|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776071|NCT02818816|Laxatives|laxatives|mesh-ancestor
138776072|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138776073|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
138776074|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
138776075|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138776076|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776077|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776078|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138776079|NCT02820610|Analgesics|analgesics|mesh-ancestor
138776080|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
138776081|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776082|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138776083|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138776084|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138776085|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
138776086|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776087|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776088|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
138776089|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138776090|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
138776091|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138776092|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138776093|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138776094|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
138776095|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138776097|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
138776098|NCT04745728|Rituximab|rituximab|mesh-list
138776099|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138776100|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
138776101|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776102|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138776103|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138776104|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
138776105|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776106|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776107|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138776108|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138776109|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138776110|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
138776111|NCT04745728|Hormones|hormones|mesh-ancestor
138776112|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138776113|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138776114|NCT02818660|Cosyntropin|cosyntropin|mesh-list
138776115|NCT02818660|Hormones|hormones|mesh-ancestor
138776116|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138776117|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776118|NCT05659186|Tislelizumab|tislelizumab|mesh-list
138776119|NCT05659186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138776120|NCT05659186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776122|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776123|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
138776124|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
138776125|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
138776126|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776127|NCT04238806|Desflurane|desflurane|mesh-list
138776128|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138776129|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
138776130|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
138776131|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776132|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776133|NCT00876187|Naproxen|naproxen|mesh-list
138776134|NCT00876187|Tanezumab|tanezumab|mesh-list
138776135|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138776136|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138776137|NCT00876187|Analgesics|analgesics|mesh-ancestor
138776138|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
138776139|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776140|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776141|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138776142|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138776143|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
138776144|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138776145|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776146|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776147|NCT04238884|Voriconazole|voriconazole|mesh-list
138776148|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
138776149|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776150|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138776151|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138776152|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776153|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776154|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138776155|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
138776156|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138776157|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776158|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138776159|NCT01102374|Vitamin D|vitamin d|mesh-list
138776160|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
138776161|NCT01102374|Cholecalciferol|cholecalciferol|mesh-list
138776162|NCT01102374|Vitamins|vitamins|mesh-list
138776163|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
138776164|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776165|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138776166|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138776167|NCT05658640|Cytarabine|cytarabine|mesh-list
138776168|NCT05658640|Dexamethasone|dexamethasone|mesh-list
138776169|NCT05658640|Cyclophosphamide|cyclophosphamide|mesh-list
138776170|NCT05658640|Trametinib|trametinib|mesh-list
138776171|NCT05658640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138776172|NCT05658640|Immunologic Factors|immunologic factors|mesh-ancestor
138776173|NCT05658640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776174|NCT05658640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138776175|NCT05658640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138776176|NCT05658640|Alkylating Agents|alkylating agents|mesh-ancestor
138776177|NCT05658640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776178|NCT05658640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776179|NCT05658640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138776180|NCT05658640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138776181|NCT05658640|Antiemetics|antiemetics|mesh-ancestor
138776182|NCT05658640|Autonomic Agents|autonomic agents|mesh-ancestor
138776183|NCT05658640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776184|NCT05658640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138776185|NCT05658640|Glucocorticoids|glucocorticoids|mesh-ancestor
138776186|NCT05658640|Hormones|hormones|mesh-ancestor
138776187|NCT05658640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138776188|NCT05658640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138776189|NCT05658640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138776190|NCT05658640|Antimetabolites|antimetabolites|mesh-ancestor
138776191|NCT05658640|Antiviral Agents|antiviral agents|mesh-ancestor
138776192|NCT05658640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776193|NCT05658640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138776194|NCT05658640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776195|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
138776196|NCT02818270|Albuterol|albuterol|mesh-list
138776197|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138776198|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
138776199|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776200|NCT02818270|Expectorants|expectorants|mesh-ancestor
138776201|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
138776202|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138776203|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
138776204|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776205|NCT02818270|Protective Agents|protective agents|mesh-ancestor
138649742|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
138776206|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450596|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138776207|NCT02818270|Antidotes|antidotes|mesh-ancestor
138776208|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138776209|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
138776210|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776211|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138776212|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
138776213|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138776214|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138776215|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138776216|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138776217|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
138776218|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776219|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
138776220|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138776221|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776222|NCT02879760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138776223|NCT02879760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776224|NCT02818348|Darunavir|darunavir|mesh-list
138776225|NCT02818348|Cobicistat|cobicistat|mesh-list
138776226|NCT02818348|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
138776227|NCT02818348|Etravirine|etravirine|mesh-list
138776228|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138776229|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138776230|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
138776231|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776232|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776233|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138776234|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138776235|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
138776236|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776237|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138776238|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138776239|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138776240|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138776242|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138776243|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776244|NCT00684463|Palonosetron|palonosetron|mesh-list
138253009|NCT00002523|Vitamins|vitamins|mesh-ancestor
138776245|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
138776246|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
138776247|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776248|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776249|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138547717|NCT00065273|Olanzapine|olanzapine|mesh-list
138776250|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138776251|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138776252|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
138776253|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776254|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776255|NCT00678457|Ondansetron|ondansetron|mesh-list
138776256|NCT00678457|Olanzapine|olanzapine|mesh-list
138776257|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
138776258|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
138776259|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776260|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776261|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138776262|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
138776263|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
138776264|NCT00678457|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138776265|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138776266|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
138776267|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776268|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776269|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138776270|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138776271|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776272|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138776273|NCT00678457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138776274|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138776275|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138776276|NCT00678613|Norfloxacin|norfloxacin|mesh-list
138776277|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138776278|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776279|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138776280|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138776281|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776282|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776283|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776284|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138776285|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138776288|NCT00678769|MTOR Inhibitors|mtor inhibitors|mesh-list
138776289|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138776290|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138776291|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776292|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138776293|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776294|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
138776295|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138776296|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
138776297|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776298|NCT00678769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138776299|NCT00678769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776300|NCT00678769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776301|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138776302|NCT04146883|Cephalexin|cephalexin|mesh-list
138776303|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776304|NCT02817256|Vitamins|vitamins|mesh-list
138776305|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
138776306|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776307|NCT02817100|Itraconazole|itraconazole|mesh-list
138776308|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
138776309|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776310|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138776311|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138776312|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776313|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776314|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138776315|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
138776316|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138776317|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776318|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138776319|NCT00684853|Bevacizumab|bevacizumab|mesh-list
138776320|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138776321|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776322|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138776323|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138776324|NCT00684853|Growth Substances|growth substances|mesh-ancestor
138776325|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776326|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
138776327|NCT02816476|Daratumumab|daratumumab|mesh-list
138554189|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
138776328|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776329|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
138253077|NCT04826237|Prednisolone|prednisolone|mesh-list
138776330|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138776331|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776332|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776333|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138776334|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138776335|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138776336|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
138776337|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776338|NCT00685009|Hormones|hormones|mesh-list
138776339|NCT00685009|Progesterone|progesterone|mesh-list
138776340|NCT00685009|Estrogens|estrogens|mesh-list
138776341|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138776342|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776343|NCT00685009|Progestins|progestins|mesh-ancestor
138776344|NCT00679237|Metformin|metformin|mesh-list
138776345|NCT00679237|Glimepiride|glimepiride|mesh-list
138776346|NCT00679237|Ezetimibe|ezetimibe|mesh-list
138776347|NCT00679237|Diuretics|diuretics|mesh-list
138776348|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138776349|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776350|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138776351|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138776352|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
138776353|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776354|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138450744|NCT01872039|Nicardipine|nicardipine|mesh-list
138776356|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138776357|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
138776358|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
138776359|NCT00681733|Pioglitazone|pioglitazone|mesh-list
138776360|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
138776361|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138776362|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776363|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138776364|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776365|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776366|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138547835|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
138776367|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138776368|NCT00681733|Protective Agents|protective agents|mesh-ancestor
138776369|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
138776370|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138776371|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
138776372|NCT00679315|Alfuzosin|alfuzosin|mesh-list
138776373|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138776374|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138776375|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138776376|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
138776377|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776378|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776379|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776380|NCT00679315|Urological Agents|urological agents|mesh-ancestor
138776381|NCT05652400|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138776383|NCT05652400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776384|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138776385|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
138776386|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776387|NCT00633802|Risperidone|risperidone|mesh-list
138776388|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138776389|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
138776390|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776391|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776392|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776393|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138776394|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138776395|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776396|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138776397|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138776398|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
138776399|NCT04460248|Rituximab|rituximab|mesh-list
138776400|NCT04460248|Lenalidomide|lenalidomide|mesh-list
138776402|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138776403|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776404|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
138776405|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776406|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138776407|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138776408|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138776409|NCT04460248|Growth Substances|growth substances|mesh-ancestor
138776410|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
138776411|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138776412|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776413|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776414|NCT05658874|Methenamine|methenamine|mesh-list
138776415|NCT05658874|Methenamine hippurate|methenamine hippurate|mesh-list
138776416|NCT05658874|Methenamine mandelate|methenamine mandelate|mesh-list
138776417|NCT05658874|Gabapentin|gabapentin|mesh-list
138776418|NCT05658874|Amitriptyline|amitriptyline|mesh-list
138776419|NCT05658874|Mirabegron|mirabegron|mesh-list
138776420|NCT05658874|Oxybutynin|oxybutynin|mesh-list
138776421|NCT05658874|Estrogens|estrogens|mesh-list
138776422|NCT05658874|Analgesics|analgesics|mesh-ancestor
138776423|NCT05658874|Sensory System Agents|sensory system agents|mesh-ancestor
138776424|NCT05658874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776425|NCT05658874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253128|NCT00002547|Cytarabine|cytarabine|mesh-list
138776426|NCT05658874|Anticonvulsants|anticonvulsants|mesh-ancestor
138776427|NCT05658874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138776428|NCT05658874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138776429|NCT05658874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776430|NCT05658874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138776431|NCT05658874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138776432|NCT05658874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138776433|NCT05658874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776434|NCT05658874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776435|NCT05658874|Antimanic Agents|antimanic agents|mesh-ancestor
138776436|NCT05658874|Hormones|hormones|mesh-ancestor
138776437|NCT05658874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138776438|NCT05658874|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138776439|NCT05658874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138776440|NCT05658874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138776441|NCT05658874|Adrenergic Agents|adrenergic agents|mesh-ancestor
138776442|NCT05658874|Urological Agents|urological agents|mesh-ancestor
138776443|NCT05658874|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138776444|NCT05658874|Antidepressive Agents|antidepressive agents|mesh-ancestor
138776445|NCT05658874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138776446|NCT05658874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138776447|NCT05658874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138776448|NCT05658874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138776449|NCT05658874|Parasympatholytics|parasympatholytics|mesh-ancestor
138776450|NCT05658874|Autonomic Agents|autonomic agents|mesh-ancestor
138776451|NCT05658874|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138776452|NCT05658874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138776453|NCT05658874|Cholinergic Agents|cholinergic agents|mesh-ancestor
138776454|NCT05658874|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138776455|NCT05658874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776456|NCT05658874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138776457|NCT04425538|Infliximab|infliximab|mesh-list
138776458|NCT04425538|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138776459|NCT04425538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138776460|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
138776461|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138776462|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138776463|NCT02627521|Ticagrelor|ticagrelor|mesh-list
138776464|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138776465|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138776466|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138776467|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138776468|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
138776469|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776470|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776471|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776472|NCT00681967|Gefitinib|gefitinib|mesh-list
138776473|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776474|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138776475|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253147|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
138776476|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776477|NCT04239118|Hemostatics|hemostatics|mesh-list
138776478|NCT04239118|Coagulants|coagulants|mesh-ancestor
138776479|NCT04139941|Antibodies|antibodies|mesh-list
138776480|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
138776481|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
138776482|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776483|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
138776484|NCT00875017|Sevelamer|sevelamer|mesh-list
138776485|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
138776486|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
138711087|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138776487|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776488|NCT00679705|Atosiban|atosiban|mesh-list
138776489|NCT00679705|Ritodrine|ritodrine|mesh-list
138776490|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
138776491|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138776492|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776493|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
138776494|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138776495|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
138776496|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
138776497|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776498|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138776499|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138776500|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138776501|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
138776502|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776503|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776504|NCT00685633|Bicalutamide|bicalutamide|mesh-list
138776505|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
138776506|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
138776507|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138776508|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776509|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776511|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138776512|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776513|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
138776514|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138776515|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138776516|NCT04329832|Azithromycin|azithromycin|mesh-list
138776517|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
138776518|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138776519|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776520|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
138776521|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138776522|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138776523|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776524|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776525|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138776527|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138776528|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
138776529|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776530|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138776531|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547962|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138776532|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776533|NCT00680095|Tavaborole|tavaborole|mesh-list
138776534|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
138776535|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776536|NCT02814058|Zolpidem|zolpidem|mesh-list
138776537|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138776538|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138776539|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776540|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776541|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138776542|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
138776543|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
138776544|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776545|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776546|NCT00680173|Interferons|interferons|mesh-list
138776547|NCT00680173|Ribavirin|ribavirin|mesh-list
138776548|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
138776549|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
138776550|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138776551|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776552|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
138776553|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776554|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
138776555|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776556|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
138776557|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776558|NCT00682279|Topotecan|topotecan|mesh-list
138776559|NCT00682279|Lapatinib|lapatinib|mesh-list
138253198|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138776560|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138776561|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138776563|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776564|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776565|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138547996|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
138776566|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
138776568|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138776569|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776570|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138776571|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776572|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138776573|NCT02811484|Incretins|incretins|mesh-ancestor
138776574|NCT02811484|Hormones|hormones|mesh-ancestor
138776575|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138776576|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
138776577|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138776578|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776579|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138450974|NCT05855629|Inositol|inositol|mesh-list
138776580|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138776581|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776582|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776583|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776584|NCT00922597|Factor VIII|factor viii|mesh-list
138776585|NCT00922597|Coagulants|coagulants|mesh-ancestor
138776586|NCT00874939|Donepezil|donepezil|mesh-list
138776587|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138776588|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776589|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776590|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
138776591|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776592|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776593|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
138776594|NCT00634348|Aripiprazole|aripiprazole|mesh-list
138776595|NCT00634348|Ziprasidone|ziprasidone|mesh-list
138776596|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
138776597|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138776598|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138776599|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138776600|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776601|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776602|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
138776603|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
138776604|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776605|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776606|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138776607|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138776608|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
138776609|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138776610|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138776611|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138776612|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138776614|NCT00680329|Travoprost|travoprost|mesh-list
138776615|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138776616|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138776617|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138776618|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138776619|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
138776620|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776621|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776622|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776623|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138776624|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138776625|NCT02811016|Budesonide|budesonide|mesh-list
138776626|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138776627|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138776628|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
138776629|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776630|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776631|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138776632|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
138776633|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
138776634|NCT02811016|Hormones|hormones|mesh-ancestor
138776635|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138776636|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
138776637|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138776638|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138776639|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776640|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138776641|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138776642|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776643|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776644|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776645|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138776646|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
138776647|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138776648|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776649|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138776650|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138776651|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138776653|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
138776654|NCT04237480|Cholecalciferol|cholecalciferol|mesh-list
138776656|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
138776657|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776658|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138776659|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138776660|NCT02810782|Morphine|morphine|mesh-list
138776661|NCT02810782|Phenobarbital|phenobarbital|mesh-list
138776662|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
138776663|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138776664|NCT02810782|Narcotics|narcotics|mesh-ancestor
138776665|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776666|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776667|NCT02810782|Analgesics|analgesics|mesh-ancestor
138776668|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
138776669|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776670|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
138776671|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138776672|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138776673|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138776674|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776675|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776676|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
138776677|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
138776678|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138776679|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138776680|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138776681|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
138776682|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
138776683|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138776684|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138776685|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138776686|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138776687|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138776688|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
138776689|NCT02810548|Mitogens|mitogens|mesh-list
138776690|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
138776691|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776692|NCT01155869|Naltrexone|naltrexone|mesh-list
138776693|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138776694|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138776695|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776696|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
138776697|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776698|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
138776699|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138776700|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776701|NCT02625415|Vitamins|vitamins|mesh-list
138776702|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
138776703|NCT02625415|Pyridoxal|pyridoxal|mesh-list
138776704|NCT02625415|Pyridoxine|pyridoxine|mesh-list
138776705|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
138776706|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
138776707|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776708|NCT02809768|Itraconazole|itraconazole|mesh-list
138776709|NCT02809768|Fluconazole|fluconazole|mesh-list
138776710|NCT02809768|Rifampin|rifampin|mesh-list
138285255|NCT03109015|Sunitinib|sunitinib|mesh-list
138776711|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
138776712|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776713|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138776714|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138776715|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776716|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776717|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138776718|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
138776719|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138776720|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776721|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138776722|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138776723|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
138548200|NCT00239629|Teriparatide|teriparatide|mesh-list
138776724|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138776725|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
138776726|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138776727|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138451134|NCT05852730|Anesthetics|anesthetics|mesh-ancestor
138776728|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138776729|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138776730|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138776731|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138776732|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138776733|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138776734|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138776735|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
138776736|NCT04237090|Promethazine|promethazine|mesh-list
138776737|NCT04237090|Cetirizine|cetirizine|mesh-list
138776738|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138776739|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138776740|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776741|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776742|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
138776743|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
138776744|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
138776745|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776747|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
138776748|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138776749|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138776750|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
138776751|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
138776752|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776753|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776754|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138776755|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
138776756|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
138776757|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138776758|NCT00690781|Caseins|caseins|mesh-list
138776759|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
138776760|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
138776761|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776762|NCT00682825|Anesthetics|anesthetics|mesh-list
138776763|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
138776764|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776765|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776766|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
138776767|NCT00912379|Chrysarobin|chrysarobin|mesh-list
138776768|NCT00912379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138776769|NCT00912379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138776770|NCT00912379|Analgesics|analgesics|mesh-ancestor
138776771|NCT00912379|Sensory System Agents|sensory system agents|mesh-ancestor
138776772|NCT00912379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776773|NCT00912379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776774|NCT00912379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138776775|NCT00912379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138776777|NCT02809378|Thiopental|thiopental|mesh-list
138776778|NCT02809378|Palonosetron|palonosetron|mesh-list
138776779|NCT02809378|Propofol|propofol|mesh-list
138776780|NCT02809378|Sevoflurane|sevoflurane|mesh-list
138776781|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138776782|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776783|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776784|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138776785|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
138776786|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
138776787|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138776788|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138776789|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138776790|NCT02809378|Narcotics|narcotics|mesh-ancestor
138776791|NCT02809378|Analgesics|analgesics|mesh-ancestor
138776792|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
138776793|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776794|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
138776795|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
138776796|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138776797|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138776798|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138776799|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
138776800|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776801|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776802|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
138776803|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
138776804|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
138776805|NCT00683059|Paclitaxel|paclitaxel|mesh-list
138776806|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138776807|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776808|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
138776809|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
138776810|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
138548336|NCT00240448|Telmisartan|telmisartan|mesh-list
138776811|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776813|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138776814|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
138776815|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138776816|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776817|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138776818|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
138776819|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776820|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776821|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
138776822|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776823|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138776824|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138776825|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
138776826|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138776827|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138776828|NCT00683137|Valdecoxib|valdecoxib|mesh-list
138776829|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138776830|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138776831|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776832|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776833|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138776834|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138776835|NCT00683137|Analgesics|analgesics|mesh-ancestor
138776836|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
138776837|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138776838|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776839|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138776840|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138776841|NCT02809456|Nicorandil|nicorandil|mesh-list
138776842|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138776843|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138776844|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
138776845|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
138776846|NCT02809456|Vitamins|vitamins|mesh-ancestor
138776847|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
138776848|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776849|NCT05576740|Contraceptive Agents|contraceptive agents|mesh-list
138776850|NCT05576740|Hormones|hormones|mesh-list
138776851|NCT05576740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138776852|NCT05576740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776853|NCT05576740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138776854|NCT04139629|Antibodies|antibodies|mesh-list
138776855|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
138776856|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776857|NCT02813044|Anesthetics|anesthetics|mesh-list
138776858|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776859|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776860|NCT04236778|Vancomycin|vancomycin|mesh-list
138776861|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138776862|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138776863|NCT02812888|Propranolol|propranolol|mesh-list
138776864|NCT02812888|Methimazole|methimazole|mesh-list
138776865|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
138776866|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138776867|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138776868|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
138776869|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776870|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776871|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776872|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138776873|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138776874|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
138776875|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
138776877|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138451270|NCT05528718|GABA Agents|gaba agents|mesh-ancestor
138776878|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
138776879|NCT00687661|Diphosphonates|diphosphonates|mesh-list
138776880|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138776881|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776882|NCT00687817|Paclitaxel|paclitaxel|mesh-list
138776883|NCT00687817|Carboplatin|carboplatin|mesh-list
138776884|NCT00687817|Bavituximab|bavituximab|mesh-list
138776885|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138776886|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307088|NCT00002039|Foscarnet|foscarnet|mesh-list
138776887|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
138776888|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
138776889|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
138776890|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776891|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138776892|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
138776893|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138776894|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776895|NCT02625805|Methylphenidate|methylphenidate|mesh-list
138776896|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138776897|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548472|NCT00241189|Methotrexate|methotrexate|mesh-list
138776898|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138776899|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138776900|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138776901|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776902|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
138776903|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776904|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
138776905|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138776906|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776907|NCT02880462|Sulforaphane|sulforaphane|mesh-list
138776908|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138776909|NCT02880462|Protective Agents|protective agents|mesh-ancestor
138776910|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776911|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776912|NCT00688363|Chrysarobin|chrysarobin|mesh-list
138776913|NCT00688363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138776914|NCT00688363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138776915|NCT00688363|Analgesics|analgesics|mesh-ancestor
138776916|NCT00688363|Sensory System Agents|sensory system agents|mesh-ancestor
138776917|NCT00688363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711088|NCT04621110|Analgesics|analgesics|mesh-ancestor
138776918|NCT00688363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776919|NCT00688363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138776920|NCT00688363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138776921|NCT02812654|Doxorubicin|doxorubicin|mesh-list
138776922|NCT02812654|Ifosfamide|ifosfamide|mesh-list
138776923|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138776924|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776925|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138776926|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138776927|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776928|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776929|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138776930|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
138776931|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
138776932|NCT02809066|Calcium|calcium|mesh-list
138776933|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138776934|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776935|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138776936|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
138776937|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776938|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138776939|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776940|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776941|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
138776942|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138776943|NCT02808676|Vitamin D|vitamin d|mesh-list
138776944|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
138776945|NCT02808676|Vitamins|vitamins|mesh-ancestor
138776946|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
138776947|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776948|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138776949|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138776950|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138776951|NCT00690937|Sevelamer|sevelamer|mesh-list
138776952|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
138451348|NCT05265806|Oxytocin|oxytocin|mesh-list
138776953|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
138776954|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776955|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138776956|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138776957|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
138776958|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138776959|NCT00689143|Sargramostim|sargramostim|mesh-list
138776960|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
138776961|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776962|NCT00912457|Donepezil|donepezil|mesh-list
138776963|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138776964|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776965|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776966|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
138776967|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776968|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776969|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
138776970|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
138253524|NCT05805553|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138776971|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138776972|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776973|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138776974|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776975|NCT02625103|Clozapine|clozapine|mesh-list
138776976|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138776977|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
138776978|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138776979|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776980|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776981|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138285365|NCT03503942|Metformin|metformin|mesh-list
138776983|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776984|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138776985|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
138776986|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
138776987|NCT01155479|Rasagiline|rasagiline|mesh-list
138776988|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138776989|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138776990|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138776991|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138776992|NCT01155479|Protective Agents|protective agents|mesh-ancestor
138776993|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776994|NCT02807272|Tipifarnib|tipifarnib|mesh-list
138776995|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138776996|NCT02807194|Anesthetics|anesthetics|mesh-list
138776997|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138776998|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138776999|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138777000|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
138777001|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138777002|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138777003|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138777004|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777005|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777006|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
138777007|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138777008|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
138777009|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777010|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
138777011|NCT02625727|Protective Agents|protective agents|mesh-ancestor
138777012|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138777013|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
138777014|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777015|NCT01155167|Lidocaine|lidocaine|mesh-list
138777016|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
138777017|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
138777018|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
138777019|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777020|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777021|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
138777022|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777023|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138777024|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138777025|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138451426|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
138777026|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138777027|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777028|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
138777029|NCT05238155|Antimetabolites|antimetabolites|mesh-list
138777030|NCT05238155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777031|NCT01106586|Ritonavir|ritonavir|mesh-list
138777032|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138777033|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138777034|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138777035|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
138777036|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777037|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777038|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138777039|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138777040|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
138777041|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777042|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138777043|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138777044|NCT00683995|Fentanyl|fentanyl|mesh-list
138777045|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138777046|NCT00683995|Narcotics|narcotics|mesh-ancestor
138777047|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777048|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777049|NCT00683995|Analgesics|analgesics|mesh-ancestor
138777050|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
138253582|NCT05751044|Alkylating Agents|alkylating agents|mesh-ancestor
138777051|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548697|NCT00242437|Coagulants|coagulants|mesh-ancestor
138777052|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138777053|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138777054|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
138777055|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
138777056|NCT02806882|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138777057|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138777058|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777060|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138777061|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777062|NCT02806804|Vaccines|vaccines|mesh-list
138777063|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
138777064|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777065|NCT02879292|Anesthetics|anesthetics|mesh-list
138777066|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777067|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777068|NCT02806648|Palbociclib|palbociclib|mesh-list
138777069|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777070|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138777071|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777072|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777073|NCT00689845|Cytarabine|cytarabine|mesh-list
138777074|NCT00689845|Prednisone|prednisone|mesh-list
138777075|NCT00689845|Prednisolone|prednisolone|mesh-list
138777076|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
138777077|NCT00689845|Ifosfamide|ifosfamide|mesh-list
138777078|NCT00689845|Rituximab|rituximab|mesh-list
138777079|NCT00689845|Doxorubicin|doxorubicin|mesh-list
138777080|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138777081|NCT00689845|Methotrexate|methotrexate|mesh-list
138777082|NCT00689845|Etoposide|etoposide|mesh-list
138777083|NCT00689845|Vincristine|vincristine|mesh-list
138777084|NCT00689845|Bleomycin|bleomycin|mesh-list
138777085|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
138777086|NCT00689845|Vindesine|vindesine|mesh-list
138777087|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138777088|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
138777089|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777090|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138777091|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138777092|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
138777093|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777094|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777095|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138548729|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777096|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138777097|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138777098|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138777099|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138777100|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777101|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138777103|NCT00689845|Hormones|hormones|mesh-ancestor
138777104|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138777105|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138777106|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138777108|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138777109|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138777110|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
138777111|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
138777112|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138777113|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138777114|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138777115|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
138777116|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777117|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
138777118|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
138777119|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
138777120|NCT00624767|Insulin|insulin|mesh-list
138777121|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138777122|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
138777123|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138777124|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777125|NCT02806492|Phenylephrine|phenylephrine|mesh-list
138777126|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
138777127|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138777128|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
138777129|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
138777130|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777131|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777132|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
138777133|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138777134|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
138777135|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
138777136|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138548761|NCT00099216|Protective Agents|protective agents|mesh-ancestor
138777137|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138777138|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138777139|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
138777140|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777141|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777142|NCT02806492|Protective Agents|protective agents|mesh-ancestor
138777143|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138777144|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
138777145|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138777146|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
138777147|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777148|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777149|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138777150|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
138777151|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138777152|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138777153|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138777154|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
138777155|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777156|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777157|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138777158|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138777159|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138777160|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138777161|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138777162|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777163|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
138777164|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777165|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777166|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138777167|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138777168|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
138777169|NCT02804776|Gefitinib|gefitinib|mesh-list
138777170|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777171|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138777172|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777173|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777174|NCT01154153|Loratadine|loratadine|mesh-list
138777175|NCT01154153|Triamcinolone|triamcinolone|mesh-list
138777176|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138777177|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138777178|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138777179|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138777180|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
138777181|NCT01154153|Hormones|hormones|mesh-ancestor
138777182|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138777183|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777184|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138777185|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
138777186|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253669|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
138777187|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777188|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
138777189|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
138777190|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138777191|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138777192|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138777193|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
138777194|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
138777195|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777196|NCT00684229|Anesthetics|anesthetics|mesh-list
138777197|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777198|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777199|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
138777200|NCT00874237|Loxapine|loxapine|mesh-list
138777201|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138777202|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777203|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138777204|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138777205|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548839|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777206|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777207|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777208|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777209|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138777210|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138777211|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777212|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138777213|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138777214|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
138777215|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777216|NCT02805946|Posaconazole|posaconazole|mesh-list
138777217|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
138777218|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777219|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138777220|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138777221|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138777222|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138777223|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138777225|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777226|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138253708|NCT04860011|Metolazone|metolazone|mesh-list
138777227|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
138777228|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138777229|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777231|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
138777232|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777233|NCT02805868|Siltuximab|siltuximab|mesh-list
138777234|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138777235|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777236|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
138777237|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777238|NCT00684385|Gefitinib|gefitinib|mesh-list
138777239|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777240|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138777241|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777242|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777243|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
138777244|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138777245|NCT02690038|Antibodies|antibodies|mesh-list
138777246|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
138777247|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138777248|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
138777249|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777250|NCT00691795|Clonidine|clonidine|mesh-list
138777251|NCT00691795|Fentanyl|fentanyl|mesh-list
138777252|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138777253|NCT00691795|Narcotics|narcotics|mesh-ancestor
138777254|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777255|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777256|NCT00691795|Analgesics|analgesics|mesh-ancestor
138777257|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
138777258|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777259|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138777260|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138777261|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
138777262|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
138777263|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138777264|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
138777265|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
138777266|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138777267|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138777268|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138548926|NCT00099450|INS 50589|ins 50589|mesh-list
138777269|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
138777270|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777271|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777272|NCT02805556|Fostemsavir|fostemsavir|mesh-list
138777273|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138777274|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138777275|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
138777276|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777277|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138777278|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138285443|NCT04736810|Gemcitabine|gemcitabine|mesh-list
138777279|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777280|NCT00694291|Sorafenib|sorafenib|mesh-list
138777281|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777282|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138777283|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777284|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777285|NCT01153763|Dabrafenib|dabrafenib|mesh-list
138777286|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777287|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138777288|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777289|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777290|NCT00691873|Omalizumab|omalizumab|mesh-list
138777291|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138777292|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138777293|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
138777294|NCT05538052|Lidocaine|lidocaine|mesh-list
138777295|NCT05538052|Tramadol|tramadol|mesh-list
138328285|NCT00318708|Xhance|xhance|mesh-list
138777296|NCT05538052|Anesthetics, Local|anesthetics, local|mesh-ancestor
138777297|NCT05538052|Anesthetics|anesthetics|mesh-ancestor
138777298|NCT05538052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777299|NCT05538052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777300|NCT05538052|Sensory System Agents|sensory system agents|mesh-ancestor
138777301|NCT05538052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777302|NCT05538052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138777303|NCT05538052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138777304|NCT05538052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138777305|NCT05538052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138777306|NCT05538052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777307|NCT05538052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138777309|NCT05538052|Analgesics|analgesics|mesh-ancestor
138253780|NCT04365257|Prazosin|prazosin|mesh-list
138777310|NCT05298475|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
138777311|NCT05298475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138777312|NCT05298475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138777313|NCT05298475|Antimetabolites|antimetabolites|mesh-ancestor
138777314|NCT05298475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777315|NCT05298475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138777316|NCT05298475|Protease Inhibitors|protease inhibitors|mesh-ancestor
138777317|NCT05298475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777318|NCT05298475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138777320|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
138777321|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138777322|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138777323|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
138777324|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777325|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777326|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138777327|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
138777328|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
138777329|NCT00691951|Hormones|hormones|mesh-ancestor
138777330|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138777331|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138777332|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138777333|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138777334|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
138777335|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777336|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777337|NCT04316351|Pemetrexed|pemetrexed|mesh-list
138777338|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777339|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777340|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777341|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138777342|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138777343|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
138777344|NCT02625337|Trametinib|trametinib|mesh-list
138777345|NCT02625337|Dabrafenib|dabrafenib|mesh-list
138777346|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138777347|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777348|NCT02625337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138777349|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777350|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138777351|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777352|NCT04236310|Trastuzumab|trastuzumab|mesh-list
138777353|NCT04236310|Anastrozole|anastrozole|mesh-list
138777354|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138777355|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777356|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138777357|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138777358|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138777359|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777360|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777361|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138777362|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
138777363|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138777364|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777365|NCT02621515|Nivolumab|nivolumab|mesh-list
138777366|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138777367|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554275|NCT00110604|Folic Acid|folic acid|mesh-list
138777368|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138777369|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777370|NCT02803918|Metformin|metformin|mesh-list
138777371|NCT02803918|Lixisenatide|lixisenatide|mesh-list
138777372|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138777373|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777374|NCT02805010|Abatacept|abatacept|mesh-list
138777375|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138777376|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777377|NCT02805010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138777378|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777379|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138777380|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
138777381|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777382|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138777383|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
138777384|NCT02800408|Provitamins|provitamins|mesh-ancestor
138777385|NCT02800408|Vitamins|vitamins|mesh-ancestor
138777386|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
138777387|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777388|NCT00692263|Tramadol|tramadol|mesh-list
138777389|NCT00692263|Escitalopram|escitalopram|mesh-list
138777390|NCT00692263|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138777391|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138777392|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138777393|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777394|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777395|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
138777396|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777397|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777398|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138777399|NCT00692263|Narcotics|narcotics|mesh-ancestor
138451794|NCT03317158|Tubulin Modulators|tubulin modulators|mesh-ancestor
138777400|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777402|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
138777404|NCT00694759|Pioglitazone|pioglitazone|mesh-list
138777405|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138777406|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777407|NCT00694837|Nelfinavir|nelfinavir|mesh-list
138777408|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138777409|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138777410|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
138777411|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777412|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777413|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138777414|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138777415|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
138777416|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777417|NCT02800252|Aspirin|aspirin|mesh-list
138777418|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138777419|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138777420|NCT02800252|Analgesics|analgesics|mesh-ancestor
138777421|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
138777422|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777423|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777424|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138777425|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138777426|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138777427|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138777428|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266818|NCT04729725|Cemiplimab|cemiplimab|mesh-list
138777429|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138777430|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138777431|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777432|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
138777433|NCT02621359|Doxycycline|doxycycline|mesh-list
138777434|NCT02621359|Levofloxacin|levofloxacin|mesh-list
138777435|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
138777436|NCT02621359|Omeprazole|omeprazole|mesh-list
138777437|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138777438|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138777439|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138777440|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777441|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777442|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138777443|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777444|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
138777445|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138777446|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138777447|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138777448|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138777449|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138777450|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253861|NCT03927222|Molgramostim|molgramostim|mesh-list
138777451|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138777452|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138777454|NCT01152437|Afatinib|afatinib|mesh-list
138777455|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138777456|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777457|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138777458|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777459|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777460|NCT02800174|Clopidogrel|clopidogrel|mesh-list
138777461|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138777462|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777463|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777464|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138777465|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138777466|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138777467|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
138777468|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777469|NCT02800330|Esomeprazole|esomeprazole|mesh-list
138777470|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138777471|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138777472|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138777473|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777474|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777475|NCT02799862|Paclitaxel|paclitaxel|mesh-list
138777476|NCT02799862|Carboplatin|carboplatin|mesh-list
138777477|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138777478|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777479|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
138777480|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
138777481|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
138777482|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777483|NCT01151579|Albuterol|albuterol|mesh-list
138777484|NCT01151579|Ipratropium|ipratropium|mesh-list
138554283|NCT00284791|Lamotrigine|lamotrigine|mesh-list
138777485|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138777486|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
138777487|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777488|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777489|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138777490|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
138777491|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
138777492|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138777493|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138777494|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138777495|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138285588|NCT03154333|Diacerein|diacerein|mesh-list
138777496|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
138777497|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777498|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777499|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138777500|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
138777502|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138777503|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
138777504|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777505|NCT01097616|Suvorexant|suvorexant|mesh-list
138777506|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138231159|NCT05570292|Folic Acid|folic acid|mesh-list
138777507|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138777508|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777509|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777510|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138777511|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777512|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777513|NCT00695071|Itraconazole|itraconazole|mesh-list
138777514|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
138777515|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777516|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138777517|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138777518|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777519|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777520|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138777521|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
138777522|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138777523|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777524|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138777525|NCT04939428|Molnupiravir|molnupiravir|mesh-list
138777526|NCT04939428|Antiviral Agents|antiviral agents|mesh-ancestor
138777527|NCT04939428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777528|NCT02803216|Amoxicillin|amoxicillin|mesh-list
138777529|NCT02803216|Clarithromycin|clarithromycin|mesh-list
138777530|NCT02803216|Omeprazole|omeprazole|mesh-list
138777531|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138777532|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777533|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138777534|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138777535|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138777536|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777537|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777538|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138777539|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138777540|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138777541|NCT02799316|Antibodies|antibodies|mesh-list
138777542|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
138777543|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777544|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
138777545|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138777546|NCT02799238|Temozolomide|temozolomide|mesh-list
138777547|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138777548|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
138777549|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777550|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777552|NCT02620813|Isotretinoin|isotretinoin|mesh-list
138777553|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
138777554|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777555|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
138777556|NCT00692731|Caffeine|caffeine|mesh-list
138777557|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138777558|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777559|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138777560|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777561|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777562|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138777563|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138777564|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
138777565|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777566|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
138777567|NCT02624401|Ketamine|ketamine|mesh-list
138777568|NCT02624401|Propofol|propofol|mesh-list
138777569|NCT02624401|Sevoflurane|sevoflurane|mesh-list
138777570|NCT02624401|Esketamine|esketamine|mesh-list
138777571|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138777572|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777573|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777574|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138777575|NCT02624401|Analgesics|analgesics|mesh-ancestor
138777576|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
138777577|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777578|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138777579|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138777580|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138777581|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
138777582|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777583|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777584|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138777585|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
138777586|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
138777587|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138777588|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138777589|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138777590|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138777591|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138777592|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
138777593|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138777594|NCT02802748|Letrozole|letrozole|mesh-list
138777595|NCT02802748|Vinorelbine|vinorelbine|mesh-list
138777596|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777598|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138777599|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285637|NCT03865615|Oxytocin|oxytocin|mesh-list
138777600|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777601|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138777602|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
138777603|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138777604|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777605|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138777606|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
138777607|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
138777608|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
138777609|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
138777610|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138777611|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138777612|NCT02798068|Prednisolone|prednisolone|mesh-list
138777613|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
138777614|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138777615|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
138777616|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138777617|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
138777618|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
138777619|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777620|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777621|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138777623|NCT02798068|Hormones|hormones|mesh-ancestor
138777624|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138549389|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777625|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138777626|NCT02798068|Protective Agents|protective agents|mesh-ancestor
138777627|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138777628|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777629|NCT00593827|Epothilones|epothilones|mesh-list
138777630|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
138777631|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
138777632|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
138777633|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777634|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777635|NCT04135885|Folic Acid|folic acid|mesh-list
138777636|NCT04135885|Hematinics|hematinics|mesh-ancestor
138777637|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
138777638|NCT04135885|Vitamins|vitamins|mesh-ancestor
138777639|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
138777640|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777641|NCT00693043|Lidocaine|lidocaine|mesh-list
138777642|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
138777644|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777645|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777646|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
138777647|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777648|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138777649|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138777650|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138777651|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138777652|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777653|NCT00695929|Simendan|simendan|mesh-list
138777654|NCT00695929|Milrinone|milrinone|mesh-list
138285657|NCT03606889|Bupivacaine|bupivacaine|mesh-list
138777655|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138777656|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
138777657|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138777658|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138777659|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777660|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777661|NCT00695929|Protective Agents|protective agents|mesh-ancestor
138777662|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777663|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138777664|NCT04235296|Mitogens|mitogens|mesh-list
138777665|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
138777666|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777667|NCT02620501|Lidocaine|lidocaine|mesh-list
138777668|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
138777669|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
138777670|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777671|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777672|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
138777673|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777674|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138777675|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138777676|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138777677|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138777678|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777679|NCT00693121|Amantadine|amantadine|mesh-list
138777680|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138777681|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138777682|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
138777683|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777684|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
138777685|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777686|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777687|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777688|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138554325|NCT00110682|Imiquimod|imiquimod|mesh-list
138777689|NCT00693121|Analgesics|analgesics|mesh-ancestor
138777690|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
138777691|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777693|NCT02620423|Gemcitabine|gemcitabine|mesh-list
138777694|NCT02620423|Fluorouracil|fluorouracil|mesh-list
138777695|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
138777696|NCT02620423|Irinotecan|irinotecan|mesh-list
138777697|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138777698|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
138777699|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777700|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777701|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138777702|NCT02620423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138777703|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138777704|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
138777705|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777706|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138777707|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138777708|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777709|NCT02620423|Antidotes|antidotes|mesh-ancestor
138777710|NCT02620423|Protective Agents|protective agents|mesh-ancestor
138777711|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
138777712|NCT02620423|Vitamins|vitamins|mesh-ancestor
138777713|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
138777714|NCT00696007|Gemcitabine|gemcitabine|mesh-list
138549519|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
138777715|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777716|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138777717|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
138777718|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777719|NCT02624089|Ropivacaine|ropivacaine|mesh-list
138777720|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
138777721|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
138777722|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777723|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777724|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
138777725|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777726|NCT02796196|Coal Tar|coal tar|mesh-list
138777727|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
138777728|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
138777729|NCT00693199|Amlodipine|amlodipine|mesh-list
138777730|NCT00693199|Prazosin|prazosin|mesh-list
138777731|NCT00693199|Terazosin|terazosin|mesh-list
138777732|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138777733|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138777734|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138777735|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777736|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138777737|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777738|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
138777739|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138777740|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138777741|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138777742|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
138777743|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777744|NCT00693199|Urological Agents|urological agents|mesh-ancestor
138777745|NCT02795884|Cisplatin|cisplatin|mesh-list
138777746|NCT02795884|Pemetrexed|pemetrexed|mesh-list
138777747|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138777748|NCT02795884|Vinorelbine|vinorelbine|mesh-list
138777749|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777750|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777751|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777752|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138777753|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138777754|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138777755|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138777756|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
138777757|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
138777758|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
138777759|NCT02795572|Vitamin D|vitamin d|mesh-list
138777760|NCT02795572|Vitamins|vitamins|mesh-list
138777761|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
138777762|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
138777763|NCT02795572|Pyridoxal|pyridoxal|mesh-list
138777764|NCT02795572|Pyridoxine|pyridoxine|mesh-list
138777765|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
138777766|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
138777767|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777768|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138777769|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
138777770|NCT02801188|Bupivacaine|bupivacaine|mesh-list
138777771|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
138777772|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
138777773|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777774|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777775|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
138777776|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777777|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138777778|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138777780|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138777781|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138777782|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138777783|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
138777784|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777785|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777786|NCT02801032|Tadalafil|tadalafil|mesh-list
138777787|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
138777788|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138777789|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138777790|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777791|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777792|NCT02801032|Urological Agents|urological agents|mesh-ancestor
138777793|NCT05442190|Hypericin|hypericin|mesh-list
138777794|NCT05442190|Antidepressive Agents|antidepressive agents|mesh-ancestor
138777795|NCT05442190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138777796|NCT05442190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777797|NCT05442190|Antiviral Agents|antiviral agents|mesh-ancestor
138777798|NCT05442190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777799|NCT05442190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777800|NCT05442190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777801|NCT05442190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138777802|NCT05442190|Immunologic Factors|immunologic factors|mesh-ancestor
138777803|NCT05442190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777804|NCT02689960|Prednisone|prednisone|mesh-list
138777805|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138777806|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
138777807|NCT02689960|Hormones|hormones|mesh-ancestor
138777808|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138777809|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777810|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138777811|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777812|NCT01150097|Everolimus|everolimus|mesh-list
138777813|NCT01150097|Tacrolimus|tacrolimus|mesh-list
138777814|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138777815|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
138777816|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777818|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777819|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777820|NCT01150097|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138777821|NCT01150097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138777822|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777823|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138777824|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138777825|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
138777826|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777828|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138777829|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138777830|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
138777831|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777832|NCT02794792|Metformin|metformin|mesh-list
138777833|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
138777834|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138777835|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777836|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138777837|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777838|NCT01149473|Losartan|losartan|mesh-list
138777839|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138777840|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138777841|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138777842|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138777843|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138777844|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777846|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
138777847|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777848|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138452247|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777849|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138777851|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777852|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
138777853|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
138777854|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
138777855|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777856|NCT02794714|Rocuronium|rocuronium|mesh-list
138777857|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138777858|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138777859|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138777860|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777861|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777862|NCT01148771|Ertapenem|ertapenem|mesh-list
138777863|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138777864|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777865|NCT01148693|Gentamicins|gentamicins|mesh-list
138777866|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138777867|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777868|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138777869|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777870|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777871|NCT00693355|Butyric Acid|butyric acid|mesh-list
138777872|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
138777873|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
138777874|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777875|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777876|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777877|NCT00693433|Sirolimus|sirolimus|mesh-list
138777878|NCT00693433|Dexamethasone|dexamethasone|mesh-list
138777879|NCT00693433|Temsirolimus|temsirolimus|mesh-list
138777880|NCT00693433|MTOR Inhibitors|mtor inhibitors|mesh-list
138777881|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138777882|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
138777883|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
138777884|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777885|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777886|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138777887|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
138777888|NCT00693433|Hormones|hormones|mesh-ancestor
138554348|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138711089|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
138777889|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138777890|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138777891|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777892|NCT00693433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138777893|NCT00693433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777894|NCT00693433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777895|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138777896|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
138777897|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138777898|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777899|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138777900|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
138777901|NCT05414422|Ketamine|ketamine|mesh-list
138777902|NCT05414422|Analgesics|analgesics|mesh-ancestor
138777903|NCT05414422|Sensory System Agents|sensory system agents|mesh-ancestor
138777904|NCT05414422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777905|NCT05414422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777906|NCT05414422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138777907|NCT05414422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138777908|NCT05414422|Anesthetics, General|anesthetics, general|mesh-ancestor
138777909|NCT05414422|Anesthetics|anesthetics|mesh-ancestor
138777910|NCT05414422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777911|NCT05414422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138777912|NCT05414422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138777913|NCT05414422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138777914|NCT05414422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777915|NCT00872599|Fenofibrate|fenofibrate|mesh-list
138777916|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138777917|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
138777918|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777919|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138777920|NCT02623621|Bevacizumab|bevacizumab|mesh-list
138777921|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138777922|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777923|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138777924|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138777925|NCT02623621|Growth Substances|growth substances|mesh-ancestor
138777926|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777927|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
138777928|NCT00693589|Folic Acid|folic acid|mesh-list
138777929|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
138777930|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
138777931|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138777932|NCT00693589|Vitamins|vitamins|mesh-ancestor
138777933|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
138777934|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777935|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138777936|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138777937|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
138777938|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777939|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138777940|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138777941|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777942|NCT00693589|Hematinics|hematinics|mesh-ancestor
138777943|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
138777944|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
138777945|NCT01148537|Buprenorphine|buprenorphine|mesh-list
138777946|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138777947|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138777948|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777949|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138777950|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138777951|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777952|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777953|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777954|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138777955|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
138777956|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138777957|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777958|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138777960|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138777961|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138777962|NCT01148537|Narcotics|narcotics|mesh-ancestor
138777963|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138777964|NCT01148537|Analgesics|analgesics|mesh-ancestor
138777965|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
138777966|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777967|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138777968|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
138777969|NCT02793544|Sirolimus|sirolimus|mesh-list
138777970|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
138777971|NCT02793544|Busulfan|busulfan|mesh-list
138777972|NCT02793544|Fludarabine|fludarabine|mesh-list
138777973|NCT02793544|Mesna|mesna|mesh-list
138777974|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138777975|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
138777976|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777977|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138777978|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138777979|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
138777980|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138777981|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138777982|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138777983|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138777984|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138777985|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
138285773|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138777986|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138777987|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138777988|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138777989|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
138777990|NCT02793544|Protective Agents|protective agents|mesh-ancestor
138777992|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
138777993|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138777994|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138777995|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452393|NCT01876290|Dexamethasone|dexamethasone|mesh-list
138777996|NCT02689882|Niacinamide|niacinamide|mesh-list
138777997|NCT02689882|Niacin|niacin|mesh-list
138777998|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
138777999|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
138778001|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
138778002|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778003|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138778004|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
138711090|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778005|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778006|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138778007|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
138778008|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138778009|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138778010|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138778011|NCT04234594|Panitumumab|panitumumab|mesh-list
138778012|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138778013|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778014|NCT02789488|Fenugreek seed meal|fenugreek seed meal|mesh-list
138778015|NCT02789488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138778016|NCT02789488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778017|NCT01148459|Vaccines|vaccines|mesh-list
138778018|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
138778019|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778020|NCT03913234|Trastuzumab|trastuzumab|mesh-list
138778021|NCT03913234|Letrozole|letrozole|mesh-list
138778022|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138778023|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778025|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138778026|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778027|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778028|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138778029|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
138778030|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254182|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
138778031|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778033|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138778034|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
138778035|NCT02789332|Carboplatin|carboplatin|mesh-list
138778037|NCT02789332|Olaparib|olaparib|mesh-list
138778038|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138436075|NCT01755468|Insulin|insulin|mesh-list
138778039|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778040|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
138778041|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
138778042|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
138778043|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778044|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138778045|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
138778046|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778047|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138778048|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138778049|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
138778050|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138778051|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138778052|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138778053|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138778054|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778055|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138778056|NCT02792140|Naltrexone|naltrexone|mesh-list
138778057|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138778058|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138778059|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778060|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
138778061|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778062|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
138778063|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138778064|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778065|NCT02791594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138778066|NCT02791594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778067|NCT04234516|Morphine|morphine|mesh-list
138778068|NCT04234516|Buprenorphine|buprenorphine|mesh-list
138711091|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138778069|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138778070|NCT04234516|Naloxone|naloxone|mesh-list
138778071|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138778072|NCT04234516|Narcotics|narcotics|mesh-ancestor
138778073|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778074|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778075|NCT04234516|Analgesics|analgesics|mesh-ancestor
138778076|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
138778077|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778078|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138778080|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
138778081|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138778082|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138778083|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778084|NCT00697021|Aspirin|aspirin|mesh-list
138778085|NCT00697021|Clopidogrel|clopidogrel|mesh-list
138778086|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138778087|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138778088|NCT00697021|Analgesics|analgesics|mesh-ancestor
138778089|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
138778090|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778091|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778092|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138778093|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138778094|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138778095|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138778096|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778097|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138778098|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138778099|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778100|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
138778101|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138778102|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138778103|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138778104|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
138778105|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138778106|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
138778107|NCT02620345|Progestins|progestins|mesh-ancestor
138778108|NCT02620345|Hormones|hormones|mesh-ancestor
138778109|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138778110|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778111|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
138778112|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
138778113|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138778114|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138778115|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778116|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
138778117|NCT02790580|Doxorubicin|doxorubicin|mesh-list
138778118|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138778119|NCT02790580|Sunitinib|sunitinib|mesh-list
138778121|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
138778122|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778123|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138778124|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138778125|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
138778126|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778127|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778128|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138778129|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138778130|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138778131|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138778132|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778133|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138778134|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138778135|NCT02790580|Growth Substances|growth substances|mesh-ancestor
138778136|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
138778137|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138778138|NCT02788864|Piperaquine|piperaquine|mesh-list
138778139|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
138778140|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138778141|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138778142|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778143|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
138778144|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138778145|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
138550002|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138778146|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138778147|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778148|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
138778149|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
138778150|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
138778151|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138778152|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778153|NCT00693979|Paclitaxel|paclitaxel|mesh-list
138778154|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138778155|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778156|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
138778157|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
138778158|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
138778159|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778160|NCT04232800|Riboflavin|riboflavin|mesh-list
138778161|NCT04232800|Vitamins|vitamins|mesh-ancestor
138778162|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
138778163|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778164|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
138778165|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138778166|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
138778167|NCT01148225|Adalimumab|adalimumab|mesh-list
138778168|NCT01148225|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138778169|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138778170|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138778171|NCT02788240|Meropenem|meropenem|mesh-list
138778172|NCT02788240|Terlipressin|terlipressin|mesh-list
138778173|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138778174|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778175|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138778176|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138778177|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
138778178|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
138254261|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
138778179|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138778180|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550043|NCT00100308|Heparin|heparin|mesh-list
138778181|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138778183|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138778184|NCT02884115|Penicillin G|penicillin g|mesh-list
138778185|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
138778186|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138778187|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778188|NCT01190813|Levodopa|levodopa|mesh-list
138778189|NCT01190813|Carbidopa|carbidopa|mesh-list
138778190|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138778191|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138778192|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
138778193|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138778194|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778195|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778196|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138778197|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778198|NCT03641326|Sunitinib|sunitinib|mesh-list
138778199|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778200|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138778201|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138778202|NCT03641326|Growth Substances|growth substances|mesh-ancestor
138778203|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778204|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
138778205|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138778206|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778207|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778208|NCT00870727|Aripiprazole|aripiprazole|mesh-list
138778209|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
138778210|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138778211|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138778212|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138778213|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778214|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778215|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
138778216|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
138778217|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138778218|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778219|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138778220|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138778221|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
138778222|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138778223|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138778224|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138778225|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138778226|NCT02787928|Hydromorphone|hydromorphone|mesh-list
138778227|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138778228|NCT02787928|Narcotics|narcotics|mesh-ancestor
138778229|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778230|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778231|NCT02787928|Analgesics|analgesics|mesh-ancestor
138778232|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
138778233|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778234|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
138778235|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138778236|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138778237|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778238|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
138778239|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138778240|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778241|NCT02788552|Vitamins|vitamins|mesh-list
138778242|NCT02788552|Thiamine|thiamine|mesh-list
138778243|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
138778244|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778246|NCT01147055|Rifampin|rifampin|mesh-list
138778247|NCT01147055|Crizotinib|crizotinib|mesh-list
138778248|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138778249|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
138778250|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138778251|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778252|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
138550118|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
138550119|NCT00252811|Gefitinib|gefitinib|mesh-list
138778253|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138778254|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778255|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778256|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138778257|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138778258|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138778259|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138778260|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138778261|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138778262|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778263|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138778264|NCT02623231|Escitalopram|escitalopram|mesh-list
138778265|NCT02623231|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138778266|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138778267|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138778268|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778269|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138778270|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
138778271|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778272|NCT02623153|Docetaxel|docetaxel|mesh-list
138778273|NCT02623153|Capecitabine|capecitabine|mesh-list
138778274|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
138778275|NCT02623153|Tegafur|tegafur|mesh-list
138778276|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778277|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
138778278|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
138778279|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
138778280|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254311|NCT00002691|Cytarabine|cytarabine|mesh-list
138778281|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138778282|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
138778283|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
138778284|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138778285|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778286|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138778287|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138778288|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778289|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778290|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778291|NCT02884037|Rifaximin|rifaximin|mesh-list
138778292|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138778293|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138285927|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138778294|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138778295|NCT04233502|Melatonin|melatonin|mesh-list
138778296|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
138778297|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778298|NCT04233502|Protective Agents|protective agents|mesh-ancestor
138778299|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778300|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778301|NCT00696475|Diazoxide|diazoxide|mesh-list
138778302|NCT00696475|Choline|choline|mesh-list
138778303|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
138778304|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138778305|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
138778306|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778307|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138778308|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138778309|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
138778310|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138778311|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
138778312|NCT03628066|Letrozole|letrozole|mesh-list
138778313|NCT03628066|Palbociclib|palbociclib|mesh-list
138778314|NCT03628066|Goserelin|goserelin|mesh-list
138778315|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778316|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138778317|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138778318|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308535|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778319|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778320|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138778321|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
138778322|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138778323|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778324|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138778325|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138778326|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
138778327|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
138778328|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138778329|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138778330|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778331|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778332|NCT00625079|Urological Agents|urological agents|mesh-ancestor
138778333|NCT02786992|Misoprostol|misoprostol|mesh-list
138778335|NCT02786992|Carbetocin|carbetocin|mesh-list
138778336|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
138778337|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138778338|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778339|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138778340|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
138778341|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138778342|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138778343|NCT04232644|Amphetamine|amphetamine|mesh-list
138778344|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
138778345|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138778346|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778347|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
138778348|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
138778349|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778350|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
138285947|NCT03296072|Listerine|listerine|mesh-list
138778351|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138778352|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778353|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
138778354|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138778355|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138778356|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138778357|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138778358|NCT03557788|Rifaximin|rifaximin|mesh-list
138778359|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138778360|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778361|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138778362|NCT04133155|Paclitaxel|paclitaxel|mesh-list
138778363|NCT04133155|Gemcitabine|gemcitabine|mesh-list
138778364|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138778365|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778366|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
138778367|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
138778368|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
138778369|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778370|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138778371|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
138778372|NCT01190267|Asenapine|asenapine|mesh-list
138778373|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138778374|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138778375|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778376|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778377|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138778378|NCT00869089|Apremilast|apremilast|mesh-list
138778379|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138778380|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138778381|NCT00869089|Analgesics|analgesics|mesh-ancestor
138778382|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
138778383|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778384|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778385|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138778386|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138778388|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138778389|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778390|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778391|NCT02616367|Bupivacaine|bupivacaine|mesh-list
138778392|NCT02616367|Ropivacaine|ropivacaine|mesh-list
138778393|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
138778394|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
138778395|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778396|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778397|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
138778398|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778399|NCT04200040|Dacarbazine|dacarbazine|mesh-list
138778400|NCT04200040|Molgramostim|molgramostim|mesh-list
138778401|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138778402|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
138778403|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778404|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778405|NCT04232722|Sorafenib|sorafenib|mesh-list
138778406|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778407|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138778408|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254406|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138778409|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778410|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138778411|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138778412|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138778413|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
138778414|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138778415|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778416|NCT02787226|Bupivacaine|bupivacaine|mesh-list
138778417|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
138778418|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
138778419|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778420|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778421|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
138778422|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778423|NCT00697567|Vaccines|vaccines|mesh-list
138778424|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
138778425|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778426|NCT02616289|Emollients|emollients|mesh-list
138778427|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
138778428|NCT03421756|Sirolimus|sirolimus|mesh-list
138778429|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
138778430|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138778431|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778432|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138778433|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778434|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
138778435|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138778436|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
138778437|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778438|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138778439|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
138778440|NCT00870103|Dexamethasone|dexamethasone|mesh-list
138778441|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138778442|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138778443|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
138778444|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
138778445|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778446|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778447|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138778448|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
138778449|NCT00870103|Hormones|hormones|mesh-ancestor
138778450|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138778451|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138452844|NCT01880112|Cefazolin|cefazolin|mesh-list
138778452|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778453|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138778454|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778455|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138778456|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138778457|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778458|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778459|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138778460|NCT03365752|Anesthetics|anesthetics|mesh-list
138778461|NCT03365752|Mepivacaine|mepivacaine|mesh-list
138778462|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
138778463|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
138778464|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778465|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778466|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
138778467|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
138778468|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778470|NCT02785666|Grazoprevir|grazoprevir|mesh-list
138778471|NCT02785666|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138778472|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
138778473|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778474|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
138778475|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778476|NCT01145417|Pregabalin|pregabalin|mesh-list
138778477|NCT01145417|Analgesics|analgesics|mesh-ancestor
138778478|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
138778479|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778480|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778481|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
138778482|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138778483|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138778484|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778485|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138778486|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138778487|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138778488|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778489|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138778490|NCT04232332|Mitogens|mitogens|mesh-list
138778491|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
138778492|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778493|NCT02785276|Ropivacaine|ropivacaine|mesh-list
138778494|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
138778495|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
138778496|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778497|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778498|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
138254485|NCT01625923|Olanzapine|olanzapine|mesh-list
138778499|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778500|NCT04316039|Temozolomide|temozolomide|mesh-list
138778501|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138778502|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
138778503|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778504|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778505|NCT00696631|Dronedarone|dronedarone|mesh-list
138778506|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138778507|NCT02615977|Ethanol|ethanol|mesh-list
138778508|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138778509|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778510|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778511|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778512|NCT01189487|Ampicillin|ampicillin|mesh-list
138778513|NCT01189487|Sulbactam|sulbactam|mesh-list
138778514|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138778515|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778516|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138778517|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778518|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778519|NCT02621905|Itraconazole|itraconazole|mesh-list
138778520|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
138778521|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
138778522|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778523|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138778524|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138778525|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452926|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
138778526|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778527|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138778528|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
138778529|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138778530|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778531|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138778533|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138778534|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778536|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
138778537|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
138778538|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778539|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
138778541|NCT01144403|Fludarabine|fludarabine|mesh-list
138778542|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
138778543|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138778544|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
138778545|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778546|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138778547|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138778548|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
138778549|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778550|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778551|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138778552|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138778553|NCT01144403|Analgesics|analgesics|mesh-ancestor
138778554|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
138778555|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778556|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138778557|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138778558|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778559|NCT03071926|Doxorubicin|doxorubicin|mesh-list
138778560|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138778561|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138778562|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778563|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138778564|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138778565|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778566|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778567|NCT02883647|Tenofovir|tenofovir|mesh-list
138778568|NCT02883647|Entecavir|entecavir|mesh-list
138778569|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
138778570|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778571|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138550467|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
138778572|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138778573|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778574|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778575|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138778576|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138778577|NCT02621827|Calcifediol|calcifediol|mesh-list
138778578|NCT02621827|Vitamins|vitamins|mesh-ancestor
138778579|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
138778580|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778581|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138778582|NCT01143389|Riboflavin|riboflavin|mesh-list
138778583|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
138778584|NCT01143389|Vitamins|vitamins|mesh-ancestor
138778585|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
138778586|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778587|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138778588|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
138778590|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
138778591|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138778592|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
138778593|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778594|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778595|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138778596|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
138778597|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
138778598|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138778599|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
138452994|NCT01881074|Protective Agents|protective agents|mesh-ancestor
138778600|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138778601|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778602|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
138778603|NCT04231864|Durvalumab|durvalumab|mesh-list
138778604|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
138778605|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138778606|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
138778607|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138778608|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778609|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
138778610|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778611|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138778612|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138778613|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138778614|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778615|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778616|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138778617|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138778618|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138778620|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
138778621|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138778622|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778623|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138778624|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138778625|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
138778626|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138778627|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138778628|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
138778629|NCT02786446|Naproxen|naproxen|mesh-list
138778630|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138778631|NCT02786446|Lidocaine|lidocaine|mesh-list
138778632|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
138778633|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
138778634|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778635|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778636|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
138778637|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778638|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138778639|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138778640|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138778641|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138778642|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778643|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138778644|NCT02786446|Analgesics|analgesics|mesh-ancestor
138778645|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138778646|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138778647|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
138778648|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138778649|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778650|NCT02619019|Dexamethasone|dexamethasone|mesh-list
138778651|NCT02619019|Meperidine|meperidine|mesh-list
138778652|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138778653|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
138778654|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
138554401|NCT00077363|Capecitabine|capecitabine|mesh-list
138778655|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778656|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778657|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138778658|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
138778659|NCT02619019|Hormones|hormones|mesh-ancestor
138778660|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138778661|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138778662|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778663|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138778664|NCT02619019|Narcotics|narcotics|mesh-ancestor
138778665|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778666|NCT02619019|Analgesics|analgesics|mesh-ancestor
138778667|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
138778668|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138778669|NCT02947516|Liver Extracts|liver extracts|mesh-list
138778670|NCT02947516|Hematinics|hematinics|mesh-ancestor
138778671|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138778672|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
138778673|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138778674|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138778675|NCT00864721|Sunitinib|sunitinib|mesh-list
138778676|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778677|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138778678|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138778679|NCT00864721|Growth Substances|growth substances|mesh-ancestor
138778680|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778681|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
138778682|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138778683|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778684|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778685|NCT05308420|Morphine|morphine|mesh-list
138778686|NCT05308420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778687|NCT05308420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778688|NCT05308420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138778689|NCT05308420|Narcotics|narcotics|mesh-ancestor
138778690|NCT05308420|Analgesics|analgesics|mesh-ancestor
138778691|NCT05308420|Sensory System Agents|sensory system agents|mesh-ancestor
138778692|NCT05308420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778693|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
138778694|NCT02897050|Docetaxel|docetaxel|mesh-list
138778695|NCT02897050|Capecitabine|capecitabine|mesh-list
138778696|NCT02897050|Fluorouracil|fluorouracil|mesh-list
138778697|NCT02897050|Epirubicin|epirubicin|mesh-list
138778698|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138778699|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
138778700|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778701|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138778702|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138778703|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
138254652|NCT00361907|Insulin|insulin|mesh-list
138778704|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778705|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778706|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138778707|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
138778708|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
138778709|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
138778710|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138778711|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
138778712|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138778713|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138778714|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138778715|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778716|NCT01095666|Metformin|metformin|mesh-list
138778717|NCT01095666|Pioglitazone|pioglitazone|mesh-list
138778718|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
138778719|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138778720|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778721|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138778722|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778723|NCT01100658|Methylphenidate|methylphenidate|mesh-list
138778724|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138554407|NCT00285415|Carboplatin|carboplatin|mesh-list
138778725|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778726|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138778727|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138778728|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138778729|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778730|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
138778731|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138778732|NCT05276908|Bupivacaine|bupivacaine|mesh-list
138778733|NCT05276908|Anesthetics|anesthetics|mesh-list
138778734|NCT05276908|Anesthetics, Local|anesthetics, local|mesh-ancestor
138778735|NCT05276908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778736|NCT05276908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778737|NCT05276908|Sensory System Agents|sensory system agents|mesh-ancestor
138778738|NCT05276908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778739|NCT02785978|Levodopa|levodopa|mesh-list
138778740|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138778741|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138778742|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
138778743|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138778744|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778745|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778746|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
138778747|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138778748|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778749|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778750|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138778751|NCT02786212|Analgesics|analgesics|mesh-ancestor
138778752|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
138778753|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254670|NCT05669313|Anticoagulants|anticoagulants|mesh-ancestor
138778754|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138778755|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138778756|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138778757|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
138778758|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138778759|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778760|NCT05273710|Folic Acid|folic acid|mesh-list
138778761|NCT05273710|Hematinics|hematinics|mesh-ancestor
138778762|NCT05273710|Vitamin B Complex|vitamin b complex|mesh-ancestor
138778763|NCT05273710|Vitamins|vitamins|mesh-ancestor
138778764|NCT05273710|Micronutrients|micronutrients|mesh-ancestor
138778765|NCT05273710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778766|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
138778767|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
138778768|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138778769|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778770|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138778771|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138778772|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778773|NCT01100502|Immunotoxins|immunotoxins|mesh-ancestor
138778774|NCT01100502|Immunoconjugates|immunoconjugates|mesh-ancestor
138778775|NCT01100502|Immunologic Factors|immunologic factors|mesh-ancestor
138778776|NCT01100502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778777|NCT02784340|Dexamethasone|dexamethasone|mesh-list
138778778|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
138778779|NCT02784340|Bupivacaine|bupivacaine|mesh-list
138778780|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138778781|NCT02784340|BB 1101|bb 1101|mesh-list
138778782|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138778783|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
138778784|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
138778785|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778786|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778788|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
138778789|NCT02784340|Hormones|hormones|mesh-ancestor
138778790|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138778791|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138778792|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778793|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
138778794|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554416|NCT00285727|Ropinirole|ropinirole|mesh-list
138778795|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778796|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
138778797|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
138778798|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778799|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
138778800|NCT02878512|Anesthetics|anesthetics|mesh-list
138778801|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778802|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778803|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
138778804|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138778805|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
138550759|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
138778806|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138778807|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
138778808|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778809|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778810|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
138778811|NCT01094808|Pregabalin|pregabalin|mesh-list
138778812|NCT01094808|Analgesics|analgesics|mesh-ancestor
138778813|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
138778814|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778815|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778816|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
138778817|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138778818|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138778819|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778820|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138778821|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138778822|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138778823|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453226|NCT01883869|Ticagrelor|ticagrelor|mesh-list
138778824|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138778825|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138778826|NCT00864253|Dacarbazine|dacarbazine|mesh-list
138778827|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778828|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138778829|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
138778830|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778831|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138778832|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138778833|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
138778834|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778835|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778836|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138778837|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
138778838|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
138778839|NCT02782312|Hormones|hormones|mesh-ancestor
138778840|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138778841|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
138778842|NCT04229758|Anticoagulants|anticoagulants|mesh-list
138778843|NCT00698425|Citric Acid|citric acid|mesh-list
138778844|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
138778845|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
138778846|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138778847|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
138778848|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
138778849|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778850|NCT05342272|Lactoferrin|lactoferrin|mesh-list
138778851|NCT05342272|Muramidase|muramidase|mesh-list
138778852|NCT05342272|Betaine|betaine|mesh-list
138778854|NCT05342272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138778855|NCT05342272|Lipotropic Agents|lipotropic agents|mesh-ancestor
138778856|NCT05342272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138778857|NCT05342272|Antimetabolites|antimetabolites|mesh-ancestor
138778858|NCT05342272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778859|NCT05342272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138778860|NCT04230460|Ethanol|ethanol|mesh-list
138778861|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138778862|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778863|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778864|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778865|NCT02783638|Pregabalin|pregabalin|mesh-list
138778866|NCT02783638|Analgesics|analgesics|mesh-ancestor
138778867|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
138778868|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778869|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778870|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
138778871|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138778872|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138778873|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778874|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138778875|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138778876|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138778877|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778878|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138778879|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138778880|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138778881|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
138778882|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138778883|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138778884|NCT04230070|Estradiol|estradiol|mesh-list
138778885|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138778886|NCT04230070|Estrogens|estrogens|mesh-ancestor
138778887|NCT04230070|Hormones|hormones|mesh-ancestor
138778888|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138778889|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778890|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138778891|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
138778892|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138778893|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138778894|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138778895|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138778896|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138778897|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138778898|NCT02782078|Rifampin|rifampin|mesh-list
138778899|NCT02782078|Clindamycin|clindamycin|mesh-list
138778900|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
138778901|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
138778902|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138778903|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
138778904|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138778905|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138778906|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
138778907|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138778908|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778909|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778910|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138778911|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138778912|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138778913|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138778914|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138778915|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138778916|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138778917|NCT01293682|Calcitriol|calcitriol|mesh-list
138550932|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
138778918|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138778919|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778920|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138778921|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138778922|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778923|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138778924|NCT01293682|Vitamins|vitamins|mesh-ancestor
138778925|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
138778926|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138778927|NCT00864097|Diclofenac|diclofenac|mesh-list
138778928|NCT00864097|Tanezumab|tanezumab|mesh-list
138554423|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778929|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138778931|NCT00864097|Analgesics|analgesics|mesh-ancestor
138778932|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
138778933|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778934|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778935|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138778936|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138778937|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138778938|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778939|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778940|NCT02782624|Empagliflozin|empagliflozin|mesh-list
138778941|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138778942|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778943|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138778944|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778945|NCT02781766|Thrombin|thrombin|mesh-list
138778946|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
138778947|NCT02781766|Coagulants|coagulants|mesh-ancestor
138778948|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
138778949|NCT00887536|Bevacizumab|bevacizumab|mesh-list
138778950|NCT00887536|Docetaxel|docetaxel|mesh-list
138778951|NCT00887536|Doxorubicin|doxorubicin|mesh-list
138778952|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138778953|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
138778954|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778955|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138778956|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138778957|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
138778958|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778959|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138778960|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138778961|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138778962|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138778963|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138286080|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
138778965|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
138778966|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
138778967|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
138778968|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
138778969|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138778970|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138778971|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138778972|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778973|NCT02614339|Metformin|metformin|mesh-list
138778974|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138778975|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778976|NCT02618395|Hydrocodone|hydrocodone|mesh-list
138778977|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138778978|NCT02618395|Narcotics|narcotics|mesh-ancestor
138778979|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138778980|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778981|NCT02618395|Analgesics|analgesics|mesh-ancestor
138778982|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
138778983|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138778984|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
138778985|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
138778986|NCT01183013|Pioglitazone|pioglitazone|mesh-list
138778987|NCT01183013|Linagliptin|linagliptin|mesh-list
138778988|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138254801|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138778989|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138778990|NCT01183013|Incretins|incretins|mesh-ancestor
138778991|NCT01183013|Hormones|hormones|mesh-ancestor
138778992|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138778993|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138778994|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
138778995|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138778996|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138778997|NCT04229212|Cimetidine|cimetidine|mesh-list
138778998|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138778999|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138779000|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138779001|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
138779002|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
138779003|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138779004|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779005|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779006|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138779007|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138779008|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779010|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138779011|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779012|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138779013|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138779014|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138779015|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138779016|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779017|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138779018|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779019|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138779020|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
138779021|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138779022|NCT05298163|Calcitriol|calcitriol|mesh-list
138779023|NCT05298163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138779024|NCT05298163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779025|NCT05298163|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138551056|NCT00259051|Omeprazole|omeprazole|mesh-list
138779026|NCT05298163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138779027|NCT05298163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779028|NCT05298163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138779029|NCT05298163|Vitamins|vitamins|mesh-ancestor
138779030|NCT05298163|Micronutrients|micronutrients|mesh-ancestor
138779031|NCT05298163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138779032|NCT01141283|Buprenorphine|buprenorphine|mesh-list
138779033|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138779034|NCT01141283|Narcotics|narcotics|mesh-ancestor
138779035|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138779036|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779037|NCT01141283|Analgesics|analgesics|mesh-ancestor
138779038|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
138779039|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779040|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138779041|NCT05340946|Anesthetics|anesthetics|mesh-list
138779042|NCT05340946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138779043|NCT05340946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779044|NCT00863707|Regadenoson|regadenoson|mesh-list
138779045|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138779046|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138779047|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
138779048|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
138779049|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138779050|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779051|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779052|NCT05340634|Contraceptive Agents|contraceptive agents|mesh-list
138779053|NCT05340634|Contraceptives, Oral|contraceptives, oral|mesh-list
138779054|NCT05340634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138779055|NCT05340634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779056|NCT05340634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138779057|NCT05367479|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138779058|NCT05367479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779060|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
138779061|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779062|NCT04187807|Protective Agents|protective agents|mesh-ancestor
138779063|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779064|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138779065|NCT01094184|Paclitaxel|paclitaxel|mesh-list
138779066|NCT01094184|Docetaxel|docetaxel|mesh-list
138779067|NCT01094184|Bevacizumab|bevacizumab|mesh-list
138779068|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138779069|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309313|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
138779070|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
138779071|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
138779072|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
138779073|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779074|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138779075|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138779076|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138779077|NCT01094184|Growth Substances|growth substances|mesh-ancestor
138779078|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779079|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
138779080|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138254859|NCT01644331|Tolvaptan|tolvaptan|mesh-list
138779081|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551137|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779082|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779083|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138779084|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138779085|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779086|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138779087|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138779088|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779089|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138779090|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138779091|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138779092|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
138779093|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138779094|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138779095|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138779096|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
138779097|NCT04132063|Levetiracetam|levetiracetam|mesh-list
138779098|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
138779099|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
138779100|NCT02618317|Minocycline|minocycline|mesh-list
138779101|NCT02618317|Heparin|heparin|mesh-list
138779102|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
138551174|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
138779103|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779104|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138779105|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138779106|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138779107|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779108|NCT01140503|Apremilast|apremilast|mesh-list
138779109|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138779110|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138779111|NCT01140503|Analgesics|analgesics|mesh-ancestor
138779112|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
138779113|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779114|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779115|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779116|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779117|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138779118|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138779119|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453527|NCT01885585|Apixaban|apixaban|mesh-list
138779120|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779121|NCT02689726|Imiquimod|imiquimod|mesh-list
138779122|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138779123|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
138779124|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779125|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779126|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
138779127|NCT00863317|Montelukast|montelukast|mesh-list
138779128|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138779129|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
138779130|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138779131|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
138779132|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138779133|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779134|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138779135|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138779136|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779137|NCT01200368|Vaccines|vaccines|mesh-list
138779138|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138779139|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
138779140|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779141|NCT04125121|Propofol|propofol|mesh-list
138779142|NCT04125121|Sevoflurane|sevoflurane|mesh-list
138779143|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138779144|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138779145|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551227|NCT00260260|Narcotics|narcotics|mesh-ancestor
138779146|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138779147|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
138779148|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
138779149|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138779150|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138779151|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138779152|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138779153|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
138779154|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779155|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779156|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138779157|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
138779158|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138779159|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138779160|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138779161|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
138779162|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138779163|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779164|NCT01078974|Dexamethasone|dexamethasone|mesh-list
138779165|NCT01078974|Rituximab|rituximab|mesh-list
138779166|NCT01078974|Pomalidomide|pomalidomide|mesh-list
138779167|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779168|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
138779169|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
138779170|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779171|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779172|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138779173|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
138779174|NCT01078974|Hormones|hormones|mesh-ancestor
138779175|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138779176|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138779177|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779178|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138779179|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
138779180|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779181|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138779182|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138779183|NCT01078974|Growth Substances|growth substances|mesh-ancestor
138779184|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
138779185|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
138779186|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
138779187|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779188|NCT02878200|Piperaquine|piperaquine|mesh-list
138779189|NCT02878200|Artenimol|artenimol|mesh-list
138779190|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
138779191|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138779192|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138779193|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779194|NCT04302012|Mydriatics|mydriatics|mesh-list
138779195|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
138779196|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779197|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779198|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138779199|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138779200|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138551296|NCT00261391|Marimastat|marimastat|mesh-list
138779201|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138779202|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779203|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779204|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
138779205|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779206|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138779209|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138779210|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138779211|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
138779212|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779213|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138779214|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138779215|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779216|NCT04205682|Cannabidiol|cannabidiol|mesh-list
138779217|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
138779218|NCT01134263|Vaccines|vaccines|mesh-list
138779219|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
138779220|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779221|NCT01199822|Olaratumab|olaratumab|mesh-list
138779222|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779223|NCT01096056|Vaccines|vaccines|mesh-list
138779224|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
138779225|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779226|NCT00866359|Apremilast|apremilast|mesh-list
138779227|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138779228|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138779229|NCT00866359|Analgesics|analgesics|mesh-ancestor
138779230|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
138286177|NCT03437564|Vortioxetine|vortioxetine|mesh-list
138779231|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779232|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779233|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779234|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779235|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138779236|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138779237|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779238|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779239|NCT01199198|Tolvaptan|tolvaptan|mesh-list
138779240|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138779241|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779242|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
138779243|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779244|NCT01095978|Clarithromycin|clarithromycin|mesh-list
138779245|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138779246|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779247|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138779248|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779249|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779250|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138779251|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138779252|NCT01134107|Insulin|insulin|mesh-list
138779253|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138779254|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
138779255|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
138779256|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138779257|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779258|NCT01198574|Vitamins|vitamins|mesh-list
138779259|NCT01198574|Folic Acid|folic acid|mesh-list
138779260|NCT01198574|Vitamin A|vitamin a|mesh-list
138779262|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
138779263|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
138779264|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779265|NCT01198574|Trace Elements|trace elements|mesh-ancestor
138779266|NCT01198574|Hematinics|hematinics|mesh-ancestor
138779267|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
138779268|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
138779269|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779270|NCT01198574|Protective Agents|protective agents|mesh-ancestor
138779271|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138779272|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779273|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138779274|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779275|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138779276|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779277|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779278|NCT01092780|Modafinil|modafinil|mesh-list
138779279|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138779280|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779281|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138779282|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138779283|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138779284|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779285|NCT05338606|Bimatoprost|bimatoprost|mesh-list
138551464|NCT00262210|Prednisolone|prednisolone|mesh-list
138779286|NCT05338606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138779287|NCT01092546|Flutemetamol|flutemetamol|mesh-list
138779288|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138779289|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779290|NCT02779348|Warfarin|warfarin|mesh-list
138779291|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
138779292|NCT02779582|Progesterone|progesterone|mesh-list
138779293|NCT02779582|Progestins|progestins|mesh-ancestor
138779294|NCT02779582|Hormones|hormones|mesh-ancestor
138779295|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138779296|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779297|NCT00634894|Letrozole|letrozole|mesh-list
138779298|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779299|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138779300|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138779301|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779302|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779303|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138779304|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
138711092|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138551498|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
138779305|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138779306|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779307|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
138779308|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138779309|NCT02779270|Protective Agents|protective agents|mesh-ancestor
138779310|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779311|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
138779312|NCT01078662|Olaparib|olaparib|mesh-list
138779313|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138779314|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779315|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779316|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779317|NCT04227886|Capecitabine|capecitabine|mesh-list
138779318|NCT04227886|Irinotecan|irinotecan|mesh-list
138779319|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138779320|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
138779321|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779322|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779323|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138779324|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138779325|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779326|NCT02200978|Cytarabine|cytarabine|mesh-list
138779327|NCT02200978|Methotrexate|methotrexate|mesh-list
138779328|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
138779329|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
138779330|NCT02200978|Tretinoin|tretinoin|mesh-list
138779331|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
138779332|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138779333|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
138779334|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138779335|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779336|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138779337|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
138779338|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779339|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779340|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
138779341|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453749|NCT01887197|Diuretics|diuretics|mesh-ancestor
138779342|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138779343|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138779344|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
138779345|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779346|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138779347|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
138779348|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779350|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
138779351|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779352|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138779353|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138779354|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
138779355|NCT02779192|Ebselen|ebselen|mesh-list
138779356|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138779357|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138779358|NCT02779192|Analgesics|analgesics|mesh-ancestor
138779359|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
138779360|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779361|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779362|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779363|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779364|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138286244|NCT04332536|Narcotics|narcotics|mesh-ancestor
138779365|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138779366|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
138779367|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779368|NCT02779192|Protective Agents|protective agents|mesh-ancestor
138779369|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138779370|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779371|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138779372|NCT05020210|Sivelestat|sivelestat|mesh-list
138779373|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138779374|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
138779375|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779376|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779377|NCT04227808|Lenvatinib|lenvatinib|mesh-list
138779378|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779379|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138779380|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779381|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779382|NCT01091454|Cisplatin|cisplatin|mesh-list
138551661|NCT00072527|Carboplatin|carboplatin|mesh-list
138779383|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779384|NCT01140347|Ramucirumab|ramucirumab|mesh-list
138779385|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779386|NCT04227652|Ibuprofen|ibuprofen|mesh-list
138779387|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138779388|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138779389|NCT04227652|Analgesics|analgesics|mesh-ancestor
138779390|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
138779391|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779392|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779393|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779394|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779395|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138779396|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779397|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779398|NCT02883569|Ibuprofen|ibuprofen|mesh-list
138779399|NCT02883569|Aceclofenac|aceclofenac|mesh-list
138779400|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
138779401|NCT02883569|Tramadol|tramadol|mesh-list
138779402|NCT02883569|Codeine|codeine|mesh-list
138779403|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138779404|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138779405|NCT02883569|Analgesics|analgesics|mesh-ancestor
138779406|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
138779407|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779408|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779409|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779410|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779411|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138779412|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779413|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779414|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138779415|NCT02883569|Narcotics|narcotics|mesh-ancestor
138779416|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138779417|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
138779418|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
138779419|NCT02883023|Bleomycin|bleomycin|mesh-list
138779420|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138779421|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779422|NCT02778958|Acetaminophen|acetaminophen|mesh-list
138779423|NCT02778958|Ibuprofen|ibuprofen|mesh-list
138779424|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138779425|NCT02778958|Analgesics|analgesics|mesh-ancestor
138779426|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
138711093|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138779427|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779428|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779429|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
138779430|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138779431|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779432|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779433|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138779434|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779435|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779436|NCT01197560|Rituximab|rituximab|mesh-list
138779437|NCT01197560|Gemcitabine|gemcitabine|mesh-list
138779438|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
138779439|NCT01197560|Etoposide|etoposide|mesh-list
138779440|NCT01197560|Lenalidomide|lenalidomide|mesh-list
138779441|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138779442|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779443|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
138779444|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779445|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779446|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138779447|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
138779448|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779449|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138779450|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138779451|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138779452|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779453|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138779454|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138779455|NCT01197560|Growth Substances|growth substances|mesh-ancestor
138779456|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
138779457|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138779458|NCT01196078|Vinorelbine|vinorelbine|mesh-list
138779459|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779460|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138779461|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779462|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779463|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138779464|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
138779465|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
138779467|NCT05314660|Fluorides|fluorides|mesh-list
138779468|NCT05314660|Cariostatic Agents|cariostatic agents|mesh-ancestor
138779469|NCT05314660|Protective Agents|protective agents|mesh-ancestor
138779470|NCT05314660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779471|NCT04920292|Oxfendazole|oxfendazole|mesh-list
138779472|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
138779473|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138779474|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779475|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
138779476|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
138779477|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
138779478|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
138779479|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138779480|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138779481|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
138779482|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
138779483|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138779484|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779485|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779486|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138779487|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
138779488|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138779489|NCT01194830|Linagliptin|linagliptin|mesh-list
138779490|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138779491|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779493|NCT01194830|Hormones|hormones|mesh-ancestor
138779494|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138779495|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138779496|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
138779497|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779498|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779500|NCT02778178|Ropivacaine|ropivacaine|mesh-list
138779501|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
138779502|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
138779503|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138779504|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779505|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
138779506|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779507|NCT02778178|Analgesics|analgesics|mesh-ancestor
138779508|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138779509|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
138779510|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
138779511|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138779512|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138779513|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138779514|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
138779515|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138649743|NCT04478019|Povidone|povidone|mesh-list
138779516|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779517|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
138779518|NCT01194440|Letrozole|letrozole|mesh-list
138779519|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779520|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138779521|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138779522|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779523|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779524|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138779525|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
138779526|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138779527|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779528|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138779529|NCT04823052|Sulindac|sulindac|mesh-list
138779530|NCT04823052|Gaboxadol|gaboxadol|mesh-list
138779531|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138779532|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138779533|NCT04823052|Analgesics|analgesics|mesh-ancestor
138779534|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
138779535|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779536|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779537|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779538|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779539|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779540|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138779541|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779542|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779543|NCT04823052|Anticonvulsants|anticonvulsants|mesh-ancestor
138779544|NCT04823052|GABA Agonists|gaba agonists|mesh-ancestor
138779545|NCT04823052|GABA Agents|gaba agents|mesh-ancestor
138779546|NCT04823052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138779547|NCT00951015|Efavirenz|efavirenz|mesh-list
138779548|NCT00951015|Dolutegravir|dolutegravir|mesh-list
138779549|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138779550|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138779551|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779552|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779553|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
138779554|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779555|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138779556|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138779557|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138779558|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138779559|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138779560|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138779561|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138779562|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138779563|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138255115|NCT01598545|Analgesics|analgesics|mesh-ancestor
138779564|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138779566|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
138779567|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
138453974|NCT01888120|Analgesics|analgesics|mesh-ancestor
138779568|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138779569|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779570|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
138779571|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779573|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138779574|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138779575|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138779576|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779577|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779578|NCT02876796|Firsocostat|firsocostat|mesh-list
138779579|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779580|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779581|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
138779582|NCT01193660|Hematinics|hematinics|mesh-ancestor
138779583|NCT02777788|Paclitaxel|paclitaxel|mesh-list
138779584|NCT02777788|Vinorelbine|vinorelbine|mesh-list
138779585|NCT02777788|Docetaxel|docetaxel|mesh-list
138779586|NCT02777788|Carboplatin|carboplatin|mesh-list
138779587|NCT02777788|Gemcitabine|gemcitabine|mesh-list
138779588|NCT02777788|Pemetrexed|pemetrexed|mesh-list
138779589|NCT02777788|Cisplatin|cisplatin|mesh-list
138779590|NCT02777788|Nedaplatin|nedaplatin|mesh-list
138779591|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138779592|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779593|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
138779594|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
138779595|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
138779596|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779597|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138779598|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
138779599|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779600|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138779601|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138779602|NCT01076166|Clarithromycin|clarithromycin|mesh-list
138779603|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138779604|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779605|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138779606|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779607|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779608|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138779609|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138779611|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138779612|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779613|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138779614|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
138779615|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779616|NCT00602901|Naproxen|naproxen|mesh-list
138779617|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138779618|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138779619|NCT00602901|Analgesics|analgesics|mesh-ancestor
138779620|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
138779621|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779622|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779623|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779624|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779625|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
138779626|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138554471|NCT00110877|Darunavir|darunavir|mesh-list
138779627|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779628|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779629|NCT01076088|Metformin|metformin|mesh-list
138779630|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138779631|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138779632|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779633|NCT01076088|Incretins|incretins|mesh-ancestor
138779634|NCT01076088|Hormones|hormones|mesh-ancestor
138779635|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138779636|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138779637|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
138779638|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779639|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779640|NCT02777320|Acetaminophen|acetaminophen|mesh-list
138454047|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138779641|NCT02777320|Ibuprofen|ibuprofen|mesh-list
138779642|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138779643|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138779644|NCT02777320|Analgesics|analgesics|mesh-ancestor
138779645|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
138779646|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779647|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779648|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779649|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779650|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138779651|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255171|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
138779657|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
138779658|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779659|NCT00945321|Aprepitant|aprepitant|mesh-list
138779660|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
138779661|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
138779662|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
138779663|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779664|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779665|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138779666|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138779667|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138779668|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779669|NCT02776228|Brotizolam|brotizolam|mesh-list
138779670|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138551984|NCT00267514|Sevelamer|sevelamer|mesh-list
138779671|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138779672|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779678|NCT01192178|Fluticasone|fluticasone|mesh-list
138779680|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138779681|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138779682|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779683|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138779684|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
138779685|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779686|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779687|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138779688|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
138779689|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
138779690|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138779691|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138779692|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138779693|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138779694|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
138779695|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138779696|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779697|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
138779699|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138779700|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
138779702|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138779703|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779704|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138779705|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779706|NCT00869401|Temozolomide|temozolomide|mesh-list
138779707|NCT00869401|Dasatinib|dasatinib|mesh-list
138779708|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138779709|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
138779710|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779711|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711094|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
138779712|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138779713|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779714|NCT01076010|Sorafenib|sorafenib|mesh-list
138779715|NCT01076010|Tivozanib|tivozanib|mesh-list
138779716|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779717|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138779718|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779719|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779720|NCT04225780|Ganciclovir|ganciclovir|mesh-list
138779721|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138779722|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
138779723|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779724|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138779725|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779726|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779727|NCT04045171|Tacrolimus|tacrolimus|mesh-list
138779728|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138779730|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779731|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138779732|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779733|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779735|NCT01075152|Zidovudine|zidovudine|mesh-list
138779736|NCT01075152|Efavirenz|efavirenz|mesh-list
138779737|NCT01075152|Stavudine|stavudine|mesh-list
138779738|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138779739|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138779740|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779741|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779742|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
138779743|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779744|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138779745|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138779746|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
138779747|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138779748|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138779749|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138779750|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138779751|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138779752|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138779753|NCT04134637|Bupivacaine|bupivacaine|mesh-list
138779754|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
138779755|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
138779756|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138779757|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779758|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
138779759|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779760|NCT02617849|Paclitaxel|paclitaxel|mesh-list
138779761|NCT02617849|Carboplatin|carboplatin|mesh-list
138779762|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
138779763|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138779764|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779765|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
138779766|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
138779767|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
138779768|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779769|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138779770|NCT02617849|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138779771|NCT00950859|Dolutegravir|dolutegravir|mesh-list
138779772|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138779773|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138779775|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779776|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138779777|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138779778|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
138779779|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779780|NCT02775292|Aldesleukin|aldesleukin|mesh-list
138779781|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
138779782|NCT02775292|Nivolumab|nivolumab|mesh-list
138779783|NCT02775292|Fludarabine|fludarabine|mesh-list
138779784|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
138779785|NCT02775292|Interleukin-2|interleukin-2|mesh-list
138779786|NCT02775292|Vaccines|vaccines|mesh-list
138779787|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
138779788|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779789|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138779790|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779791|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138779792|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
138779793|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779794|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779795|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138779796|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138779797|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138779798|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138779799|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
138779800|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138779801|NCT02775292|Analgesics|analgesics|mesh-ancestor
138779802|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
138779803|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779804|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138779805|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138779806|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
138779807|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779808|NCT00862849|Insulin|insulin|mesh-list
138779809|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138779810|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
138779811|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138779812|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779813|NCT01090050|Naproxen|naproxen|mesh-list
138779814|NCT01090050|Sumatriptan|sumatriptan|mesh-list
138779815|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138779816|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138779817|NCT01090050|Analgesics|analgesics|mesh-ancestor
138779818|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
138779819|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255301|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
138779820|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779821|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779822|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779823|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
138779824|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138779825|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649744|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
138779826|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779828|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138779829|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138779830|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
138779831|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138779832|NCT02775370|Apatinib|apatinib|mesh-list
138779833|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779834|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138779835|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779836|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779837|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
138779838|NCT04225468|Narcotics|narcotics|mesh-ancestor
138779839|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138779840|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779841|NCT04225468|Analgesics|analgesics|mesh-ancestor
138779842|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
138779843|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779844|NCT02855307|Insulin|insulin|mesh-list
138779845|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138779846|NCT02855307|Hormones|hormones|mesh-list
138779847|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138779848|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779849|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138779850|NCT01077960|Hormones|hormones|mesh-list
138779851|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138779852|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779853|NCT04269369|Fluorouracil|fluorouracil|mesh-list
138779854|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
138779855|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779856|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138779857|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779858|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138779859|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
138779860|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779861|NCT02776540|Aspirin|aspirin|mesh-list
138779862|NCT02776540|Clopidogrel|clopidogrel|mesh-list
138779863|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138779864|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138779865|NCT02776540|Analgesics|analgesics|mesh-ancestor
138779866|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
138779867|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779868|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779869|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779870|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779871|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138779872|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138779873|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779874|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138779875|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138779876|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779877|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
138779878|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138779879|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138779880|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138779881|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
138779882|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138779884|NCT00944697|Naloxone|naloxone|mesh-list
138779885|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138779886|NCT00944697|Narcotics|narcotics|mesh-ancestor
138779887|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286588|NCT03393494|Adapalene|adapalene|mesh-list
138779888|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779889|NCT00944697|Analgesics|analgesics|mesh-ancestor
138779890|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
138779891|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779892|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138779893|NCT02878122|Carboplatin|carboplatin|mesh-list
138779894|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779895|NCT04807348|Metformin|metformin|mesh-list
138779896|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138779897|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779898|NCT04224922|Paclitaxel|paclitaxel|mesh-list
138779899|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
138779900|NCT04224922|Epirubicin|epirubicin|mesh-list
138779901|NCT04224922|Carboplatin|carboplatin|mesh-list
138779902|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138779903|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779904|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
138779905|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
138779906|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
138779907|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779908|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138779909|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
138779910|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779911|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779912|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138552340|NCT00268957|Sevelamer|sevelamer|mesh-list
138779913|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
138779914|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138779915|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138779916|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138779917|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138779918|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779919|NCT02877888|Fluorides|fluorides|mesh-list
138779920|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
138779921|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
138779922|NCT02877888|Protective Agents|protective agents|mesh-ancestor
138779923|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779924|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138779925|NCT02772640|Ezetimibe|ezetimibe|mesh-list
138779926|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138779927|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138779928|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
138779929|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779930|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138779931|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138779932|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779933|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138779934|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
138779935|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779936|NCT00866281|Midostaurin|midostaurin|mesh-list
138779937|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779938|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138779939|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779940|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779941|NCT04121611|Aspirin|aspirin|mesh-list
138779942|NCT04121611|Heparin|heparin|mesh-list
138779943|NCT04121611|Calcium heparin|calcium heparin|mesh-list
138779944|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
138779945|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138779946|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138779947|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255401|NCT04713189|Fentanyl|fentanyl|mesh-list
138779948|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138779949|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138779950|NCT04121611|Analgesics|analgesics|mesh-ancestor
138779951|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
138779952|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779953|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779954|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138779955|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138779956|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138779957|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138779958|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779959|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
138779960|NCT02771860|Denosumab|denosumab|mesh-list
138779961|NCT02771860|Calcium|calcium|mesh-list
138779962|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138779963|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779964|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138779965|NCT02771782|Vaccines|vaccines|mesh-list
138779966|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
138779967|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
138779968|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779969|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138779970|NCT02771392|Tetracaine|tetracaine|mesh-list
138779971|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138779972|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
138779973|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
138779974|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138779975|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779976|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
138779977|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779978|NCT02771704|Iodine|iodine|mesh-list
138779979|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
138779980|NCT02771704|Fluorides|fluorides|mesh-list
138779981|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
138779982|NCT02771704|Protective Agents|protective agents|mesh-ancestor
138779983|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779984|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138779985|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138779986|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
138779987|NCT02771704|Trace Elements|trace elements|mesh-ancestor
138779988|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
138779989|NCT02771314|Osimertinib|osimertinib|mesh-list
138779990|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138779991|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138779992|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779993|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138779994|NCT02771158|Midodrine|midodrine|mesh-list
138779995|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
138779996|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
138779997|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779998|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138779999|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138780000|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138780001|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138780002|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138780003|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
138780004|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780005|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780006|NCT02770690|Lidocaine|lidocaine|mesh-list
138780007|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
138780008|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
138780009|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
138780010|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138780011|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780012|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
138780013|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780014|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138780015|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138780016|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138780017|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138780018|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780019|NCT02770378|Ritonavir|ritonavir|mesh-list
138780020|NCT02770378|Itraconazole|itraconazole|mesh-list
138780021|NCT02770378|Minocycline|minocycline|mesh-list
138780022|NCT02770378|Celecoxib|celecoxib|mesh-list
138780023|NCT02770378|Temozolomide|temozolomide|mesh-list
138780024|NCT02770378|Auranofin|auranofin|mesh-list
138780025|NCT02770378|Captopril|captopril|mesh-list
138780026|NCT02770378|Disulfiram|disulfiram|mesh-list
138780027|NCT02770378|Aprepitant|aprepitant|mesh-list
138780028|NCT02770378|Sertraline|sertraline|mesh-list
138780029|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138780030|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138780031|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
138780032|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780033|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780034|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138780035|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138780036|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
138780037|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780038|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138780039|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138780040|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138780041|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
138780042|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780043|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138780044|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138780045|NCT02770378|Analgesics|analgesics|mesh-ancestor
138780046|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
138780047|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780048|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780050|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780051|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138780052|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138780053|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
138780054|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138780055|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138780056|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
138780057|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138780058|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
138780059|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138711095|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780060|NCT02770378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138780061|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138780062|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138780063|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780064|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
138780065|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138780066|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
138780067|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
138780068|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138780069|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138780070|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138780071|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138780072|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138780073|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138780074|NCT02770222|Rifampin|rifampin|mesh-list
138780075|NCT02770222|Selexipag|selexipag|mesh-list
138780076|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
138780077|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138780078|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
138780079|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138780080|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780081|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
138780082|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138780083|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255481|NCT00000447|Naltrexone|naltrexone|mesh-list
138780084|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780085|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138780086|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138780087|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138780088|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138780089|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138780090|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138780091|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138780092|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
138780093|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138780094|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138649745|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
138780095|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138780096|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138780098|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138780099|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780100|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138780101|NCT00943917|Incretins|incretins|mesh-ancestor
138780102|NCT00943917|Hormones|hormones|mesh-ancestor
138780103|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138780104|NCT02876250|Cyclosporine|cyclosporine|mesh-list
138780105|NCT02876250|Cyclosporins|cyclosporins|mesh-list
138780106|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780107|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780108|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138780109|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
138780110|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780111|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
138780112|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138554509|NCT00286273|Heparin|heparin|mesh-list
138780114|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780115|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138780116|NCT02769910|Capsaicin|capsaicin|mesh-list
138780117|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
138780118|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
138780119|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
138780120|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780121|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780122|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138780123|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138780124|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138255511|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
138780125|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138780126|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
138780127|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780128|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138780129|NCT02876484|Cathartics|cathartics|mesh-ancestor
138780130|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138780131|NCT02876094|Celecoxib|celecoxib|mesh-list
138780132|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138780133|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138780134|NCT02876094|Analgesics|analgesics|mesh-ancestor
138780135|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
138780136|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780137|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780138|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138780139|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780140|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138780141|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138780142|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780143|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780144|NCT00603135|Levetiracetam|levetiracetam|mesh-list
138780145|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
138780146|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
138780147|NCT02769286|Osimertinib|osimertinib|mesh-list
138780148|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780149|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138780150|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780151|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780152|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
138780153|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138780154|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
138780155|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780156|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
138780157|NCT02855073|Protective Agents|protective agents|mesh-ancestor
138780158|NCT02769130|Losartan|losartan|mesh-list
138780159|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138780160|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138780161|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138780162|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138780163|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780164|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
138780165|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138780166|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138780167|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138454569|NCT01900106|Darunavir|darunavir|mesh-list
138780168|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138780169|NCT02851095|Metformin|metformin|mesh-list
138780170|NCT02851095|Canagliflozin|canagliflozin|mesh-list
138780171|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138780172|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255540|NCT01675297|Vitamins|vitamins|mesh-ancestor
138780173|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138780174|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780175|NCT01074450|Pramipexole|pramipexole|mesh-list
138780176|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
138780177|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780178|NCT01074450|Protective Agents|protective agents|mesh-ancestor
138780179|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780180|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138554511|NCT00286273|Tinzaparin|tinzaparin|mesh-list
138780181|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138780182|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
138780183|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
138780184|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780185|NCT02768116|Sirolimus|sirolimus|mesh-list
138780186|NCT02768116|Temsirolimus|temsirolimus|mesh-list
138780187|NCT02768116|MTOR Inhibitors|mtor inhibitors|mesh-list
138780188|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138780189|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780190|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138780191|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286714|NCT03523988|Analgesics|analgesics|mesh-ancestor
138780192|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
138780193|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138780194|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
138780195|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780196|NCT02768116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138780197|NCT02768116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780198|NCT02768116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780199|NCT00635284|Sirolimus|sirolimus|mesh-list
138780200|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138780201|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780202|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138780203|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780204|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
138780205|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138780206|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
138780207|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780208|NCT04131595|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138780209|NCT04131595|Antiviral Agents|antiviral agents|mesh-ancestor
138780210|NCT04131595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780211|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
138780212|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
138780213|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138780214|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138780215|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
138780216|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780217|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780218|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780219|NCT00699049|Urological Agents|urological agents|mesh-ancestor
138780220|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138780221|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
138780222|NCT04131283|Epinephrine|epinephrine|mesh-list
138780223|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138780224|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138780225|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
138780226|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780227|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780228|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780229|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138780230|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138780231|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
138780232|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780233|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138780234|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
138780235|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
138780236|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
138780237|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138780238|NCT00943761|Interferons|interferons|mesh-list
138780239|NCT00943761|Ribavirin|ribavirin|mesh-list
138780240|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780241|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
138780242|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780243|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
138286748|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138780244|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780245|NCT02617771|Vitamin D|vitamin d|mesh-list
138780246|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
138780247|NCT02617771|Vitamins|vitamins|mesh-ancestor
138780248|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
138780249|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780250|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138780251|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138780252|NCT02696590|Vitamin D|vitamin d|mesh-list
138780253|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
138780254|NCT02696590|Vitamins|vitamins|mesh-ancestor
138780255|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
138780256|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552675|NCT00271063|Annamycin|annamycin|mesh-list
138780257|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138255597|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138780258|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138780259|NCT02617459|Betaxolol|betaxolol|mesh-list
138780260|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138780261|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138780262|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138780263|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
138780264|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
138780265|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780266|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780267|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138780268|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138780269|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138780270|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
138780271|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780272|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780273|NCT02854995|Triamcinolone|triamcinolone|mesh-list
138780274|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138780275|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
138780276|NCT02854995|Hormones|hormones|mesh-ancestor
138780277|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138780278|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780279|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
138780280|NCT02696512|Minocycline|minocycline|mesh-list
138780281|NCT02696512|Lamotrigine|lamotrigine|mesh-list
138780282|NCT02696512|Flumazenil|flumazenil|mesh-list
138780283|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138780284|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780285|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
138780286|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138780287|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138780288|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780289|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138780290|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780291|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138780292|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138780293|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138780294|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138780295|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138780296|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
138780297|NCT02696512|Protective Agents|protective agents|mesh-ancestor
138780298|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
138780299|NCT02696512|Vitamins|vitamins|mesh-ancestor
138780300|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
138780301|NCT02696512|Antidotes|antidotes|mesh-ancestor
138780302|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
138780303|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
138780304|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780305|NCT00949533|Oseltamivir|oseltamivir|mesh-list
138780306|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
138780307|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780308|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780309|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780310|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
138780311|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138780312|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138780313|NCT02854761|Vitamin D|vitamin d|mesh-list
138780314|NCT02854761|Vitamins|vitamins|mesh-ancestor
138780315|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
138780316|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780317|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138780318|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138780319|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138780320|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780321|NCT00866047|Immunotoxins|immunotoxins|mesh-ancestor
138780322|NCT00866047|Immunoconjugates|immunoconjugates|mesh-ancestor
138780323|NCT00866047|Immunologic Factors|immunologic factors|mesh-ancestor
138780324|NCT00866047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780325|NCT01706692|Cyclosporine|cyclosporine|mesh-list
138780326|NCT01706692|Adalimumab|adalimumab|mesh-list
138780327|NCT01706692|Infliximab|infliximab|mesh-list
138780328|NCT01706692|Etanercept|etanercept|mesh-list
138780329|NCT01706692|Methotrexate|methotrexate|mesh-list
138780330|NCT01706692|Ustekinumab|ustekinumab|mesh-list
138780331|NCT01706692|Cyclosporins|cyclosporins|mesh-list
138780332|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138780333|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
138780334|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138780335|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780336|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138780337|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
138780338|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780339|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780340|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
138780341|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780342|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138780343|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138780344|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
138780345|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780346|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138780347|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
138780348|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780349|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138780350|NCT01706692|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138780351|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138780352|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138780353|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138780354|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138780355|NCT01706692|Analgesics|analgesics|mesh-ancestor
138255658|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
138780356|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
138780357|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780358|NCT00869323|Rituximab|rituximab|mesh-list
138780359|NCT00869323|Bortezomib|bortezomib|mesh-list
138780360|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138780361|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780362|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
138780363|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780364|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780365|NCT02767102|Melatonin|melatonin|mesh-list
138780366|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
138780367|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780368|NCT02767102|Protective Agents|protective agents|mesh-ancestor
138780369|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780370|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138780371|NCT02774902|Clarithromycin|clarithromycin|mesh-list
138780372|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138780373|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780374|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138780375|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780376|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780377|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138780378|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138780379|NCT02767024|Nitroprusside|nitroprusside|mesh-list
138780380|NCT02767024|Dobutamine|dobutamine|mesh-list
138780381|NCT02767024|Furosemide|furosemide|mesh-list
138780382|NCT02767024|Diuretics|diuretics|mesh-ancestor
138780383|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
138780384|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286825|NCT03633344|Silicon|silicon|mesh-list
138780385|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138780386|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138780387|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780388|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138780389|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
138780390|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
138780391|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780392|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138454797|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780393|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138780394|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138780395|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
138780396|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780397|NCT02767024|Protective Agents|protective agents|mesh-ancestor
138780398|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138780399|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
138780400|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138780401|NCT02774200|Apatinib|apatinib|mesh-list
138780402|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780403|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138780404|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780405|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780406|NCT02766634|Lenograstim|lenograstim|mesh-list
138780407|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138780408|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
138780409|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780410|NCT02774044|Beractant|beractant|mesh-list
138780411|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
138780412|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138780413|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
138780414|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
138780415|NCT02766556|Ropivacaine|ropivacaine|mesh-list
138780416|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138780417|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138780418|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780419|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138780420|NCT02766556|Analgesics|analgesics|mesh-ancestor
138780421|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
138780422|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780423|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138780424|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138780425|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138780426|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
138780427|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780428|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780429|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
138780430|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
138780431|NCT01191944|Pramipexole|pramipexole|mesh-list
138780432|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
138780433|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780434|NCT01191944|Protective Agents|protective agents|mesh-ancestor
138780435|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780436|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138780437|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138286854|NCT04456634|Lumefantrine|lumefantrine|mesh-list
138780438|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
138780439|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
138780440|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780441|NCT00940875|Gemcitabine|gemcitabine|mesh-list
138780442|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138780443|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138780444|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
138780445|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780446|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780447|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138780448|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780449|NCT02766322|Ethanol|ethanol|mesh-list
138780450|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138780451|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780452|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138780453|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780454|NCT05655728|Metformin|metformin|mesh-list
138780455|NCT05655728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138780456|NCT05655728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780457|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138780459|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
138780460|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780461|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
138780462|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138780463|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
138780464|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554531|NCT00286351|Goserelin|goserelin|mesh-list
138780465|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780466|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138780467|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
138780468|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780469|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780470|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138780471|NCT05655338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138780472|NCT05655338|Amoxicillin|amoxicillin|mesh-list
138780473|NCT05655338|Metronidazole|metronidazole|mesh-list
138780474|NCT05655338|Anti-Infective Agents|anti-infective agents|mesh-list
138780475|NCT05655338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138780476|NCT05655338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138780478|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
138780479|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780480|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
138780481|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780482|NCT00422565|Sirolimus|sirolimus|mesh-list
138780483|NCT00422565|Paclitaxel|paclitaxel|mesh-list
138780484|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138780485|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780486|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
138780487|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
138286878|NCT04713956|Busulfan|busulfan|mesh-list
138780488|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
138780489|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780490|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138780491|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780492|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138780493|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
138780494|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138780495|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
138780496|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780497|NCT04316936|Dexamethasone|dexamethasone|mesh-list
138780498|NCT04316936|Prednisolone|prednisolone|mesh-list
138780499|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138780500|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
138780502|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
138780503|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138780504|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
138780505|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138780506|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
138780507|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
138780508|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780509|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780510|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138780511|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
138780513|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138780514|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138780515|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780516|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138780517|NCT04316936|Protective Agents|protective agents|mesh-ancestor
138780519|NCT00861757|Tamsulosin|tamsulosin|mesh-list
138780520|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
138780521|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138780522|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138780523|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780524|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780525|NCT00861757|Urological Agents|urological agents|mesh-ancestor
138780526|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138780527|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138780528|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138780529|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
138780530|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286902|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138286903|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
138780531|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780532|NCT02762812|Infliximab|infliximab|mesh-list
138780533|NCT02762812|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138780534|NCT02762812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138780535|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
138780536|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138780537|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780538|NCT02762890|Iodine|iodine|mesh-list
138780539|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138780540|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780541|NCT02762890|Trace Elements|trace elements|mesh-ancestor
138780542|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
138780543|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780544|NCT02613715|Ethanol|ethanol|mesh-list
138780545|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138780546|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780547|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138780548|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780549|NCT02762656|Lidocaine|lidocaine|mesh-list
138780550|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
138780551|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
138780552|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138780553|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780554|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
138780555|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780556|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138780557|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138780558|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138780559|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138780560|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780561|NCT00637325|Trastuzumab|trastuzumab|mesh-list
138780562|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138780563|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780564|NCT02762344|Heparin|heparin|mesh-list
138780565|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
138780566|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138780567|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138780568|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780569|NCT04663282|Insulin|insulin|mesh-list
138780570|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138780571|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780572|NCT01130597|Spironolactone|spironolactone|mesh-list
138780573|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138780574|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
138780575|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138780576|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554567|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138780577|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138780578|NCT01130597|Diuretics|diuretics|mesh-ancestor
138780579|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
138780580|NCT00939003|Adalimumab|adalimumab|mesh-list
138780581|NCT00939003|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138780582|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138780583|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780584|NCT01188668|Aripiprazole|aripiprazole|mesh-list
138780585|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138780586|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
138780587|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138780588|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138780589|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138780590|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138780591|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780592|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
138780593|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
138780594|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780595|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780596|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138780597|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138780598|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
138780599|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138780600|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138780601|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138780602|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138780603|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138780604|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138780605|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138780607|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
138780608|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780609|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
138286956|NCT04342130|Morphine|morphine|mesh-list
138780610|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
138780611|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
138780612|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780613|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780614|NCT00865189|Leucovorin|leucovorin|mesh-list
138780615|NCT00865189|Folic Acid|folic acid|mesh-list
138780616|NCT00865189|Bevacizumab|bevacizumab|mesh-list
138780617|NCT00865189|Fluorouracil|fluorouracil|mesh-list
138780618|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
138780619|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
138780620|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138780622|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138780623|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138780624|NCT00865189|Growth Substances|growth substances|mesh-ancestor
138780625|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780626|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
138780627|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
138780628|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780629|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138780630|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138780631|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
138780632|NCT00865189|Antidotes|antidotes|mesh-ancestor
138780633|NCT00865189|Protective Agents|protective agents|mesh-ancestor
138780634|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
138780635|NCT00865189|Vitamins|vitamins|mesh-ancestor
138780636|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
138780637|NCT00865189|Hematinics|hematinics|mesh-ancestor
138780638|NCT00698269|Insulin|insulin|mesh-list
138780639|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138780640|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
138780641|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
138780642|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138780644|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
138780645|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138780646|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138780647|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780648|NCT01182194|Drospirenone|drospirenone|mesh-list
138780650|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138780651|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138780652|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138780653|NCT01182194|Estradiol|estradiol|mesh-list
138780654|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138780655|NCT01182194|Estrogens|estrogens|mesh-ancestor
138780656|NCT01182194|Hormones|hormones|mesh-ancestor
138780657|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138780658|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780659|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138780660|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
138780661|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138780662|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138780663|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138780664|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138780665|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138780666|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
138780667|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138780668|NCT01182194|Diuretics|diuretics|mesh-ancestor
138780669|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
138780670|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138780671|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138780672|NCT01181726|Norethindrone|norethindrone|mesh-list
138780673|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
138780674|NCT01181726|Estradiol|estradiol|mesh-list
138780675|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138780676|NCT01181726|Estrogens|estrogens|mesh-ancestor
138780677|NCT01181726|Hormones|hormones|mesh-ancestor
138780678|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138780679|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780680|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138780681|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
138780682|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138780683|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138780684|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138780685|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138780686|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138780687|NCT01137071|Antibodies|antibodies|mesh-list
138780688|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138780689|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
138780690|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780691|NCT00603759|Celecoxib|celecoxib|mesh-list
138780692|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138780693|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138780694|NCT00603759|Analgesics|analgesics|mesh-ancestor
138780695|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
138780696|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780697|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780698|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138780699|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780700|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138780701|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138780702|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780703|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780705|NCT04130815|Diuretics|diuretics|mesh-ancestor
138780706|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
138780707|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780708|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138780709|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138780710|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780711|NCT04256265|Risdiplam|risdiplam|mesh-list
138780712|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138780713|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780714|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780716|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138780717|NCT04312061|Narcotics|narcotics|mesh-ancestor
138780718|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138780719|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780720|NCT04312061|Analgesics|analgesics|mesh-ancestor
138780721|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
138780722|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780723|NCT00860743|Antioxidants|antioxidants|mesh-list
138780724|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780725|NCT00860743|Protective Agents|protective agents|mesh-ancestor
138780726|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780727|NCT01186796|Fulvestrant|fulvestrant|mesh-list
138780728|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138780729|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780730|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138780731|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138780732|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
138780733|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138780734|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780735|NCT05383131|Pirfenidone|pirfenidone|mesh-list
138780736|NCT05383131|Nintedanib|nintedanib|mesh-list
138780737|NCT05383131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780738|NCT05383131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138780739|NCT05383131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780740|NCT05383131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780741|NCT05383131|Analgesics|analgesics|mesh-ancestor
138780742|NCT05383131|Sensory System Agents|sensory system agents|mesh-ancestor
138780743|NCT05383131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780744|NCT05383131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780745|NCT05383131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138780746|NCT05383131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138780747|NCT05383131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138780748|NCT05383131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780749|NCT02761486|Aspirin|aspirin|mesh-list
138553223|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138780750|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138780751|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138780752|NCT02761486|Analgesics|analgesics|mesh-ancestor
138780753|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
138780754|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780755|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780756|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138780757|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780758|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138780759|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138780760|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780761|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138780762|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138780763|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780764|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
138780765|NCT02882789|Delpazolid|delpazolid|mesh-list
138780766|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
138780767|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138780768|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138780769|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138780770|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780771|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780772|NCT00940017|Voriconazole|voriconazole|mesh-list
138780773|NCT00940017|Anidulafungin|anidulafungin|mesh-list
138780774|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
138780775|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553251|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
138780776|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138780777|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138780778|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780779|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780780|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138780781|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
138780782|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138780783|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780784|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138780785|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
138780786|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138780787|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138780788|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138780789|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138780790|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780791|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
138780792|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553297|NCT00108576|Valproic Acid|valproic acid|mesh-list
138296673|NCT00002599|Cobalt|cobalt|mesh-list
138780793|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780794|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138780795|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780796|NCT01186328|Cytarabine|cytarabine|mesh-list
138780797|NCT01186328|Prednisone|prednisone|mesh-list
138780799|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138780800|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138780801|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138780802|NCT01186328|Cortisone|cortisone|mesh-list
138780803|NCT01186328|Doxorubicin|doxorubicin|mesh-list
138780804|NCT01186328|Methotrexate|methotrexate|mesh-list
138780805|NCT01186328|Vincristine|vincristine|mesh-list
138780806|NCT01186328|Asparaginase|asparaginase|mesh-list
138780807|NCT01186328|Pegaspargase|pegaspargase|mesh-list
138780808|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138780809|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780810|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138780811|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138780812|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780813|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780814|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138780815|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
138780816|NCT01186328|Hormones|hormones|mesh-ancestor
138780817|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138780818|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780819|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138780820|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138780821|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
138780822|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138780823|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138780824|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
138780825|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
138780826|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138780827|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138780828|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
138780829|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780830|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138780831|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
138780832|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255985|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
138287214|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138780833|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138780834|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
138780835|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
138780836|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
138780837|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
138780838|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
138780839|NCT00848497|Testosterone|testosterone|mesh-list
138780840|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
138780841|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
138230942|NCT01205828|Temozolomide|temozolomide|mesh-list
138455253|NCT01904214|Siponimod|siponimod|mesh-list
138780843|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780844|NCT00848497|Androgens|androgens|mesh-ancestor
138780845|NCT00848497|Hormones|hormones|mesh-ancestor
138780846|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138780847|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780848|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138780849|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780850|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
138780851|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
138780852|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138780853|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138780854|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780855|NCT00848497|Urological Agents|urological agents|mesh-ancestor
138780856|NCT02763592|Lidocaine|lidocaine|mesh-list
138780857|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
138780858|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
138780859|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138780860|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780861|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
138780862|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780863|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138780864|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138780865|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138780866|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138780867|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780868|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
138780869|NCT01185782|Hormones|hormones|mesh-list
138780870|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138780871|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138780872|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287235|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780873|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138780874|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
138780875|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138780876|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
138780877|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138780878|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138256024|NCT01704781|Lenalidomide|lenalidomide|mesh-list
138780879|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138780880|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138780881|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138780882|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
138780883|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138780884|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780885|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780886|NCT02882555|Capsaicin|capsaicin|mesh-list
138780887|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
138780888|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
138780889|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
138780890|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780891|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780892|NCT00699361|Pantoprazole|pantoprazole|mesh-list
138780893|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138780894|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138780895|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138780896|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780897|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780898|NCT01185704|Cetrorelix|cetrorelix|mesh-list
138780899|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138780900|NCT01185704|Hormones|hormones|mesh-list
138780901|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138780902|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138780903|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780904|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138780905|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
138780906|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138780907|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
138780908|NCT01128959|Carbamazepine|carbamazepine|mesh-list
138780909|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
138780910|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
138780911|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138780912|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138780913|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780914|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138780915|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138780916|NCT01128959|Analgesics|analgesics|mesh-ancestor
138780917|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
138780918|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780919|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138780920|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138780921|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780922|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138780923|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138780924|NCT04119739|Ibuprofen|ibuprofen|mesh-list
138780925|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138780926|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138780927|NCT04119739|Analgesics|analgesics|mesh-ancestor
138780928|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
138780929|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780930|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780931|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138780932|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138780933|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138780934|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780935|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780936|NCT00859573|Modafinil|modafinil|mesh-list
138780937|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138780938|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780939|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138780940|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138780941|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138780942|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780943|NCT02758444|Micronutrients|micronutrients|mesh-list
138780944|NCT02758444|Trace Elements|trace elements|mesh-list
138780945|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780946|NCT01185548|Tolbutamide|tolbutamide|mesh-list
138780947|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138780948|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780949|NCT01128569|Fluticasone|fluticasone|mesh-list
138780950|NCT01128569|Xhance|xhance|mesh-list
138780951|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138780952|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138780953|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
138299661|NCT04568876|Hormones|hormones|mesh-ancestor
138780954|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780955|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780956|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138780957|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
138780958|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
138780959|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138780960|NCT04582942|Lactulose|lactulose|mesh-list
138780961|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138780962|NCT02883179|Lidocaine|lidocaine|mesh-list
138780963|NCT02883179|Prilocaine|prilocaine|mesh-list
138780964|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138780965|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
138780966|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
138780967|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138780968|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780969|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
138780970|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780971|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138780972|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138780973|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138780974|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138780975|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780976|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138780978|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138780979|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780980|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138780981|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138300308|NCT00003463|Irinotecan|irinotecan|mesh-list
138780982|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138780983|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780984|NCT00637403|Megestrol|megestrol|mesh-list
138780985|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
138780986|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138780987|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138780988|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138780989|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
138780990|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138780991|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138780992|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138780993|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138780994|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138780995|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138780996|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
138780997|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138780998|NCT01185080|Adenosine|adenosine|mesh-list
138780999|NCT01185080|Analgesics|analgesics|mesh-ancestor
138781000|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
138781001|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781002|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553613|NCT00109356|AQ4N|aq4n|mesh-list
138781003|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138781004|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
138781005|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138781006|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
138781007|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
138781008|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781009|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781010|NCT01181102|Enoxaparin|enoxaparin|mesh-list
138781011|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
138781012|NCT01181102|Edoxaban|edoxaban|mesh-list
138781013|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
138781014|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138781015|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138781016|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781017|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138781018|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
138781019|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138781020|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
138781021|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781022|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
138781023|NCT00858637|Simvastatin|simvastatin|mesh-list
138781024|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138781025|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138781026|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
138781027|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781028|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138781029|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138781030|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781031|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138781032|NCT02760316|Prednisolone|prednisolone|mesh-list
138781033|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138781034|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
138781035|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138781036|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
138781037|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138781038|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
138781039|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138781040|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
138781041|NCT02760316|Hormones|hormones|mesh-ancestor
138256149|NCT00421811|Melphalan|melphalan|mesh-list
138781042|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138781043|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781044|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138781045|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781046|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
138781047|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
138781049|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138781050|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138781051|NCT02760316|Protective Agents|protective agents|mesh-ancestor
138781052|NCT00858403|Dasatinib|dasatinib|mesh-list
138781053|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781054|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138781055|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781056|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781057|NCT02760472|SMOFlipid|smoflipid|mesh-list
138781058|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138781059|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138781060|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138781061|NCT00858247|Vitamin D|vitamin d|mesh-list
138781062|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
138781063|NCT00858247|Vitamins|vitamins|mesh-ancestor
138781064|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
138781065|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781066|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138781067|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138781068|NCT04222348|Metformin|metformin|mesh-list
138781069|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
138781070|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138781071|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781072|NCT04222114|Catumaxomab|catumaxomab|mesh-list
138781073|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138781074|NCT00838435|Verapamil|verapamil|mesh-list
138781075|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138781076|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138781077|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138781078|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781079|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138781080|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781081|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
138781082|NCT02757508|Vitamins|vitamins|mesh-list
138781083|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
138781084|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781085|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
138781086|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138781087|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138256190|NCT04342247|Androgens|androgens|mesh-ancestor
138781088|NCT02757196|Prednisolone|prednisolone|mesh-list
138781089|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
138781090|NCT02757196|Rituximab|rituximab|mesh-list
138781091|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138781092|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
138781093|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138781094|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781095|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
138781096|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781097|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138781098|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138781099|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
138781100|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
138302544|NCT00386269|Codeine|codeine|mesh-list
138781101|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781102|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138781103|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
138781104|NCT02757196|Hormones|hormones|mesh-ancestor
138781105|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138781106|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138781107|NCT02757196|Protective Agents|protective agents|mesh-ancestor
138781108|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138781109|NCT04403698|Alendronate|alendronate|mesh-list
138781110|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138781111|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781112|NCT02759926|Quinine|quinine|mesh-list
138781113|NCT02759926|Denatonium|denatonium|mesh-list
138781114|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
138781115|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138781116|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138781117|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138781118|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138781119|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781120|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138781121|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781122|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138781124|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
138781125|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
138781126|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781127|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
138781128|NCT04221256|Escitalopram|escitalopram|mesh-list
138256213|NCT05738564|Oxymetazoline|oxymetazoline|mesh-list
138302887|NCT00004825|Insulin|insulin|mesh-list
138781129|NCT04221256|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138781130|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138781131|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138781132|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781133|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781134|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
138781135|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781136|NCT00838201|Denosumab|denosumab|mesh-list
138781137|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138781138|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781139|NCT00837967|Terbutaline|terbutaline|mesh-list
138781140|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138781141|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138781142|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
138781143|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138781144|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
138781145|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781146|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781147|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
138781148|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
138781149|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138781150|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138781151|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138781152|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138781153|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
138781154|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781155|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781156|NCT02759614|Bevacizumab|bevacizumab|mesh-list
138781157|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138781158|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138781159|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781160|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138781161|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138781162|NCT02759614|Growth Substances|growth substances|mesh-ancestor
138781163|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781164|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
138781165|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138781166|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781167|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781168|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
138781169|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781170|NCT02759224|Irsogladine|irsogladine|mesh-list
138781172|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781173|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138781174|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138781175|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138781176|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
138781177|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
138781178|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781179|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781180|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781181|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138781182|NCT02759224|Protective Agents|protective agents|mesh-ancestor
138781183|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138781185|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138781186|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
138781187|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554628|NCT00417430|Fulvestrant|fulvestrant|mesh-list
138553883|NCT00281788|Carboplatin|carboplatin|mesh-list
138781188|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781189|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138781190|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138781191|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
138781192|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781193|NCT04586920|Itraconazole|itraconazole|mesh-list
138781194|NCT04586920|Midazolam|midazolam|mesh-list
138781195|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138781196|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138781197|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138781198|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781199|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138781200|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138781201|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138781202|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138781203|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
138781204|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
138781205|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
138781206|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
138781207|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781208|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781209|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
138781210|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138781211|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138256286|NCT03379207|Dimercaprol|dimercaprol|mesh-list
138781212|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138781213|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781214|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138781215|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
138781216|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138781217|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138781218|NCT02758990|Vitamin D|vitamin d|mesh-list
138781219|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
138781220|NCT02758990|Vitamins|vitamins|mesh-list
138781221|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
138781222|NCT02758990|Vitamin E|vitamin e|mesh-list
138781223|NCT02758990|Tocopherols|tocopherols|mesh-list
138781224|NCT02758990|Vitamin A|vitamin a|mesh-list
138781225|NCT02758990|Niacinamide|niacinamide|mesh-list
138781227|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
138781228|NCT02758990|Pyridoxine|pyridoxine|mesh-list
138781229|NCT02758990|Pyridoxal|pyridoxal|mesh-list
138781230|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
138781231|NCT02758990|Caffeine|caffeine|mesh-list
138781232|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
138781233|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781234|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138781235|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138781236|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
138781237|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781238|NCT02758990|Protective Agents|protective agents|mesh-ancestor
138781239|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138781240|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138781241|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781242|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138781243|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138781244|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
138781245|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256318|NCT01707043|Calcitriol|calcitriol|mesh-list
138781246|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
138781247|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138553973|NCT00281983|Rituximab|rituximab|mesh-list
138781248|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
138781249|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138781250|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
138781251|NCT02756104|Vitamin D|vitamin d|mesh-list
138781252|NCT02756104|Vitamins|vitamins|mesh-ancestor
138781253|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
138781254|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781255|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138781256|NCT02756026|Micronutrients|micronutrients|mesh-list
138781257|NCT02756026|Trace Elements|trace elements|mesh-list
138781258|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781259|NCT02755714|Bromides|bromides|mesh-list
138781260|NCT02755714|Ipratropium|ipratropium|mesh-list
138781261|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
138781262|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138781263|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
138781264|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781265|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781266|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138781267|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
138781268|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138781269|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
138781270|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781271|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781272|NCT02758522|Insulin|insulin|mesh-list
138781273|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138781274|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138781275|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781276|NCT00942357|Paclitaxel|paclitaxel|mesh-list
138781277|NCT00942357|Cisplatin|cisplatin|mesh-list
138781278|NCT00942357|Carboplatin|carboplatin|mesh-list
138554017|NCT00282139|Aripiprazole|aripiprazole|mesh-list
138781279|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138781280|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138781281|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781282|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
138256356|NCT03634917|Calcium|calcium|mesh-list
138781283|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
138781284|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
138781285|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781286|NCT02752828|Insulin|insulin|mesh-list
138781287|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138781288|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
138781289|NCT02752828|Lixisenatide|lixisenatide|mesh-list
138781290|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138455706|NCT01907529|Docetaxel|docetaxel|mesh-list
138781291|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781292|NCT02753062|Rituximab|rituximab|mesh-list
138781293|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138781294|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138781295|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781296|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
138781297|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781298|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138781299|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138781300|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
138781301|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781302|NCT02752204|Rituximab|rituximab|mesh-list
138781303|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138781304|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781305|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
138781306|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781307|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138781308|NCT04220398|Hormones|hormones|mesh-list
138781309|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138781310|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781311|NCT04220632|Prednisone|prednisone|mesh-list
138781312|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
138781313|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138781314|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138781315|NCT04220632|Prednisolone|prednisolone|mesh-list
138781316|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
138781317|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138781318|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
138781319|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138781320|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
138781321|NCT04220632|Hormones|hormones|mesh-ancestor
138781322|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138781323|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781324|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138781325|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781326|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
138781327|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
138781328|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781329|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138781330|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138781331|NCT04220632|Protective Agents|protective agents|mesh-ancestor
138781332|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138781333|NCT00939627|Cetuximab|cetuximab|mesh-list
138781334|NCT00939627|Sorafenib|sorafenib|mesh-list
138781335|NCT00939627|Antibodies|antibodies|mesh-list
138781336|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
138781337|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138781338|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
138781339|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781340|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554109|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138781341|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138781342|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781343|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781344|NCT05382741|Durvalumab|durvalumab|mesh-list
138781345|NCT05382741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138781346|NCT05382741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781347|NCT04220476|Letrozole|letrozole|mesh-list
138781348|NCT04220476|Palbociclib|palbociclib|mesh-list
138781349|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781350|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138781351|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138554153|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
138781352|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781353|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781354|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138781355|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
138781356|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138781357|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781358|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138781359|NCT02695810|Metformin|metformin|mesh-list
138781360|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
138781361|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138781362|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781363|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138781364|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781365|NCT02753764|Prednisone|prednisone|mesh-list
138781366|NCT02753764|AZD7624|azd7624|mesh-list
138781367|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138781368|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
138781369|NCT02753764|Hormones|hormones|mesh-ancestor
138781370|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138781371|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781372|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138781373|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781374|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138781375|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781376|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781377|NCT02695654|Clonidine|clonidine|mesh-list
138781378|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
138781379|NCT02695654|Analgesics|analgesics|mesh-ancestor
138781380|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
138781381|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138554213|NCT00110448|Aspirin|aspirin|mesh-list
138781382|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781383|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138781384|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
138781385|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
138781386|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138781387|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138781388|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138781389|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
138781390|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781391|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781392|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
138781393|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
138781394|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138781395|NCT02696122|Anesthetics|anesthetics|mesh-list
138781396|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138781397|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781398|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138781399|NCT01135511|Tofacitinib|tofacitinib|mesh-list
138781400|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
138781401|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138781402|NCT01135511|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138781403|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138781404|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781405|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781406|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138781407|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
138781408|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781409|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
138781410|NCT01135511|Protective Agents|protective agents|mesh-ancestor
138781411|NCT02753140|Docetaxel|docetaxel|mesh-list
138781412|NCT02753140|Cetuximab|cetuximab|mesh-list
138781413|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781414|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
138781415|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
138781416|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
138781417|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781418|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138781419|NCT02753218|Midazolam|midazolam|mesh-list
138781420|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138781421|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138287660|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781422|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138781423|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781424|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138781425|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138781426|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138781427|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138781428|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
138781429|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
138781430|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
138781431|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
138781432|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781433|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781434|NCT05429554|Vildagliptin|vildagliptin|mesh-list
138781435|NCT05429554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138781436|NCT05429554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781437|NCT05429554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138781438|NCT05429554|Protease Inhibitors|protease inhibitors|mesh-ancestor
138781439|NCT05429554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781440|NCT05429554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455853|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138307718|NCT00002489|Etoposide|etoposide|mesh-list
138781442|NCT05429086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138781443|NCT05429086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138781444|NCT05429086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781445|NCT05429086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138781446|NCT05429086|Anesthetics, General|anesthetics, general|mesh-ancestor
138781447|NCT05429086|Anesthetics|anesthetics|mesh-ancestor
138781448|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
138781449|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138781450|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138781451|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781452|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
138781453|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138781454|NCT01184846|Antibodies|antibodies|mesh-list
138781455|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
138781456|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781457|NCT01191086|Topiramate|topiramate|mesh-list
138781458|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
138781459|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138781460|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781461|NCT05318560|Lidocaine|lidocaine|mesh-list
138781462|NCT05318560|Anesthetics, Local|anesthetics, local|mesh-ancestor
138781463|NCT05318560|Anesthetics|anesthetics|mesh-ancestor
138781464|NCT05318560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138781465|NCT05318560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781466|NCT05318560|Sensory System Agents|sensory system agents|mesh-ancestor
138307974|NCT00002255|Zidovudine|zidovudine|mesh-list
138781467|NCT05318560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311753|NCT04723134|Folic Acid|folic acid|mesh-list
138781468|NCT05318560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138781469|NCT05318560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138781470|NCT05318560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138781471|NCT05318560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138781472|NCT05318560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781473|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
138781474|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138781475|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138781476|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138781477|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138781478|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781479|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
138781480|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781481|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781482|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138256541|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
138781483|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781484|NCT01086384|Fluticasone|fluticasone|mesh-list
138781485|NCT01086384|Xhance|xhance|mesh-list
138781486|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138781487|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138554388|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
138781488|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
138781489|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781490|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781491|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138781492|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
138781493|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
138781494|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138781495|NCT00635986|Fentanyl|fentanyl|mesh-list
138781496|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138781497|NCT00635986|Narcotics|narcotics|mesh-ancestor
138781498|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138781499|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781500|NCT00635986|Analgesics|analgesics|mesh-ancestor
138781501|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
138781502|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781503|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138781504|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138781505|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
138781506|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
138781507|NCT04799626|Levofloxacin|levofloxacin|mesh-list
138781508|NCT04799626|Meropenem|meropenem|mesh-list
138781509|NCT04799626|Tazobactam|tazobactam|mesh-list
138781510|NCT04799626|Piperacillin|piperacillin|mesh-list
138781511|NCT04799626|Tigecycline|tigecycline|mesh-list
138781512|NCT04799626|Biapenem|biapenem|mesh-list
138781513|NCT04799626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138781514|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138781515|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138455938|NCT01909037|Curcumin|curcumin|mesh-list
138781516|NCT04799626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138781517|NCT04799626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138781518|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781519|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781520|NCT04799626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781521|NCT04799626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138781522|NCT04799626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138781523|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138781524|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138554439|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781525|NCT00636064|Parecoxib|parecoxib|mesh-list
138781526|NCT00636064|Valdecoxib|valdecoxib|mesh-list
138781527|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138781528|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138781529|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781530|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781531|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138781532|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138781533|NCT00636064|Analgesics|analgesics|mesh-ancestor
138781534|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
138781535|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781536|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781537|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138554655|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
138781538|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138781539|NCT02751034|Lidocaine|lidocaine|mesh-list
138781540|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
138781541|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
138781542|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138781543|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781544|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
138781545|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781546|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138781547|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138781548|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138781549|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138781550|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781551|NCT04217668|Isosorbide|isosorbide|mesh-list
138781552|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138781553|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138781554|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138781555|NCT04217668|Diuretics|diuretics|mesh-ancestor
138781556|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
138781557|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781558|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
138781559|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138781560|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781561|NCT01127165|Zonisamide|zonisamide|mesh-list
138781562|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
138781563|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138781564|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138781565|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781566|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138781567|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781568|NCT04278508|Progesterone|progesterone|mesh-list
138781569|NCT04278508|Progestins|progestins|mesh-ancestor
138781570|NCT04278508|Hormones|hormones|mesh-ancestor
138781571|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138781572|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781573|NCT05382351|Tenofovir|tenofovir|mesh-list
138781574|NCT05382351|Entecavir|entecavir|mesh-list
138781575|NCT05382351|Antiviral Agents|antiviral agents|mesh-ancestor
138781576|NCT05382351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138781577|NCT05382351|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138781578|NCT05382351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138781579|NCT05382351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781580|NCT05382351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781581|NCT05382351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138781582|NCT05382351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138781583|NCT04218760|Isosorbide|isosorbide|mesh-list
138781584|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138781585|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138781586|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138781587|NCT04218760|Diuretics|diuretics|mesh-ancestor
138781588|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
138781589|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781590|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
138781591|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138781592|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781593|NCT02750254|Plerixafor|plerixafor|mesh-list
138781594|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
138781595|NCT02750254|Melphalan|melphalan|mesh-list
138781596|NCT02750254|Busulfan|busulfan|mesh-list
138781597|NCT02750254|Fludarabine|fludarabine|mesh-list
138781598|NCT02750254|Fludarabine phosphate|fludarabine phosphate|mesh-list
138781599|NCT02750254|Azacitidine|azacitidine|mesh-list
138781600|NCT02750254|Lenograstim|lenograstim|mesh-list
138781601|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138781602|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
138781603|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781604|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138781605|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138781606|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
138781607|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781608|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781609|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138781610|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138781611|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
138781612|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781613|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138781614|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138781615|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138781616|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
138781617|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138781618|NCT00941655|Leucovorin|leucovorin|mesh-list
138781619|NCT00941655|Fluorouracil|fluorouracil|mesh-list
138781620|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
138781621|NCT00941655|Irinotecan|irinotecan|mesh-list
138781622|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
138781623|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781624|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138781625|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781626|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138781627|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
138781628|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781629|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138781630|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138781631|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781632|NCT00941655|Antidotes|antidotes|mesh-ancestor
138781633|NCT00941655|Protective Agents|protective agents|mesh-ancestor
138781634|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
138781635|NCT00941655|Vitamins|vitamins|mesh-ancestor
138781636|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
138781637|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
138781638|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
138781639|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781640|NCT00605787|Protective Agents|protective agents|mesh-ancestor
138781641|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781642|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138781643|NCT00936117|Posaconazole|posaconazole|mesh-list
138781644|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
138781645|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138781646|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138781648|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138781649|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138781650|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138781651|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781652|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781653|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138781654|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
138781655|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138781656|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781657|NCT04267653|Lactoferrin|lactoferrin|mesh-list
138781658|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138781659|NCT04088500|Nivolumab|nivolumab|mesh-list
138781660|NCT04088500|Ipilimumab|ipilimumab|mesh-list
138781661|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138781662|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781663|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138781664|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781665|NCT01082874|Clonidine|clonidine|mesh-list
138781666|NCT01082874|Analgesics|analgesics|mesh-ancestor
138781667|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
138781668|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138554662|NCT00111267|Vitamins|vitamins|mesh-list
138781669|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781670|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781671|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138781672|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
138781673|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
138781674|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138781675|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138781676|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138781677|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
138781678|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781680|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138781681|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
138781682|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781683|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781684|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138781685|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
138781686|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
138781687|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
138781688|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138781689|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138781690|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138781691|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138287787|NCT02892500|Betamethasone|betamethasone|mesh-list
138781692|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
138554636|NCT00077753|Enoxaparin|enoxaparin|mesh-list
138781693|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781694|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781696|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138781697|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138781698|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138781699|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781700|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781701|NCT01079988|Cyclosporine|cyclosporine|mesh-list
138781702|NCT01079988|Methotrexate|methotrexate|mesh-list
138781703|NCT01079988|Cyclosporins|cyclosporins|mesh-list
138781704|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138781705|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
138781706|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138781707|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781708|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138781709|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
138781710|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781711|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781712|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
138781713|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781714|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138781715|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138781716|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
138781717|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138781718|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138781719|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
138781720|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138781721|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138781722|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
138781723|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138781724|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
138781725|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138781726|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
138781727|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781728|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781729|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
138781730|NCT01074216|Vitamin D|vitamin d|mesh-list
138781731|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
138781732|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
138781733|NCT01074216|Vitamins|vitamins|mesh-list
138781734|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
138781735|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781736|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138781737|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138781739|NCT00636142|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138456156|NCT01910415|Ivacaftor|ivacaftor|mesh-list
138554680|NCT00111306|Epratuzumab|epratuzumab|mesh-list
138781740|NCT00636142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138781741|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
138781742|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138781743|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138781745|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
138781746|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138781747|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
138781748|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138781749|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138781750|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781751|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138781752|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781753|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
138781754|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781755|NCT02875002|Belinostat|belinostat|mesh-list
138781756|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781757|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138781758|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781759|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781760|NCT02749396|Interferons|interferons|mesh-list
138781761|NCT02749396|Interferon-beta|interferon-beta|mesh-list
138781762|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
138781763|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
138781764|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781765|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
138554738|NCT00111345|Idarubicin|idarubicin|mesh-list
138781766|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138781767|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
138781768|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781769|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138781771|NCT02749162|Dexamethasone|dexamethasone|mesh-list
138781772|NCT02749162|Lidocaine|lidocaine|mesh-list
138781773|NCT02749162|Morphine|morphine|mesh-list
138781774|NCT02749162|Ropivacaine|ropivacaine|mesh-list
138781775|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138781776|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138781777|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
138781778|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
138781779|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781780|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781781|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138781782|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
138781783|NCT02749162|Hormones|hormones|mesh-ancestor
138781784|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138781785|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138781786|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781787|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
138781788|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
138781789|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138781790|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
138781791|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138781792|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138781793|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138781794|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138554773|NCT00077987|Sunitinib|sunitinib|mesh-list
138781795|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781796|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138781797|NCT02749162|Narcotics|narcotics|mesh-ancestor
138781798|NCT02749162|Analgesics|analgesics|mesh-ancestor
138781799|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138781800|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
138781801|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138781802|NCT02041234|Liraglutide|liraglutide|mesh-list
138781803|NCT02041234|Empagliflozin|empagliflozin|mesh-list
138781804|NCT02041234|Linagliptin|linagliptin|mesh-list
138781805|NCT02041234|Canagliflozin|canagliflozin|mesh-list
138781806|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138781807|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138781808|NCT02041234|Orlistat|orlistat|mesh-list
138781809|NCT02041234|Incretins|incretins|mesh-list
138781810|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138781811|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781813|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138781814|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
138781815|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456231|NCT01910766|Vitamins|vitamins|mesh-ancestor
138781816|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781817|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138781818|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138781819|NCT02695732|Carvedilol|carvedilol|mesh-list
138781820|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138781821|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138781822|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
138781823|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781824|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781825|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781826|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138781827|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
138781828|NCT02695732|Protective Agents|protective agents|mesh-ancestor
138781829|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138781830|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138781831|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138781832|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
138781833|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138781834|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138781835|NCT02751268|Ropivacaine|ropivacaine|mesh-list
138781836|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
138781837|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
138781838|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138781839|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781840|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
138781841|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781842|NCT02748772|Thalidomide|thalidomide|mesh-list
138781843|NCT02748772|Endostar protein|endostar protein|mesh-list
138781844|NCT02748772|Endostatins|endostatins|mesh-list
138781845|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138781846|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
138781847|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781848|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
138781849|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138781850|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138781851|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138781852|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138554858|NCT00288028|Bortezomib|bortezomib|mesh-list
138781853|NCT02748772|Growth Substances|growth substances|mesh-ancestor
138781854|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
138781855|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781857|NCT04216888|Analgesics|analgesics|mesh-ancestor
138781858|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
138781859|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781860|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781861|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138781862|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138781863|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
138781864|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
138781865|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138781866|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138781867|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138781868|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138781869|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781871|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138781872|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138781873|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781874|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
138781875|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781876|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138781877|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
138781878|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138781879|NCT02748304|Aspirin|aspirin|mesh-list
138781880|NCT02748304|Sorafenib|sorafenib|mesh-list
138781881|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138781882|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138781883|NCT02748304|Analgesics|analgesics|mesh-ancestor
138781884|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
138781885|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781886|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781887|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138781888|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138781889|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138781890|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138781891|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781892|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138781893|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138781894|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781896|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781897|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138781898|NCT02746276|Metronidazole|metronidazole|mesh-list
138287870|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138781899|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
138781900|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138781901|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138781902|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138781903|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138781904|NCT02745886|Metformin|metformin|mesh-list
138781905|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138781906|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781907|NCT02742142|Fluorides|fluorides|mesh-list
138781908|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
138781909|NCT02742142|Protective Agents|protective agents|mesh-ancestor
138781910|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781911|NCT00636298|Bevacizumab|bevacizumab|mesh-list
138781912|NCT00636298|Cetuximab|cetuximab|mesh-list
138781913|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138781914|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781915|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138781916|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138781917|NCT00636298|Growth Substances|growth substances|mesh-ancestor
138781918|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781919|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
138781920|NCT02744716|Aspirin|aspirin|mesh-list
138781921|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138781922|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138781923|NCT02744716|Analgesics|analgesics|mesh-ancestor
138781924|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
138781925|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138781926|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781927|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138781928|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138781929|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138781930|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138781931|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781932|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138781933|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138781934|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781935|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
138781936|NCT02744872|Felodipine|felodipine|mesh-list
138781937|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138781938|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138781939|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138781940|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138781941|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781942|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138781943|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781944|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
138781946|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138781947|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138781948|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138781949|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138781950|NCT02740894|Gefitinib|gefitinib|mesh-list
138781951|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781952|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138781953|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781954|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781955|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
138781956|NCT00857389|Busulfan|busulfan|mesh-list
138781957|NCT00857389|Thiotepa|thiotepa|mesh-list
138781958|NCT00857389|Methotrexate|methotrexate|mesh-list
138781959|NCT00857389|Clofarabine|clofarabine|mesh-list
138781960|NCT00857389|Tacrolimus|tacrolimus|mesh-list
138781961|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
138781962|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138781963|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138781964|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
138781965|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781966|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138781967|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138781968|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
138781969|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781970|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781971|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138781972|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138781973|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
138781974|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138781975|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138781976|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
138781977|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
138781978|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138781979|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138781980|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138781981|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138781982|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
138781983|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138781984|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138781985|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138781986|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138781987|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781988|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138781989|NCT01071798|Rituximab|rituximab|mesh-list
138781990|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138781991|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138781992|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
138781993|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781994|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138781995|NCT00857311|Vaccines|vaccines|mesh-list
138781996|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
138781997|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781998|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
138781999|NCT02874768|Propofol|propofol|mesh-list
138782000|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138782001|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782002|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782003|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138782004|NCT02874768|Analgesics|analgesics|mesh-ancestor
138782005|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
138782006|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782007|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138782008|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138782009|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138555036|NCT00112086|Paclitaxel|paclitaxel|mesh-list
138782010|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
138782011|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782012|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782013|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138782014|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
138782015|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
138782016|NCT00857233|Memantine|memantine|mesh-list
138782017|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138782018|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138782019|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
138782020|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782021|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782022|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782023|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138287921|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
138782024|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138782025|NCT02740426|Pirarubicin|pirarubicin|mesh-list
138782026|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782027|NCT02743234|Vancomycin|vancomycin|mesh-list
138782028|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
138782029|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138782030|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782031|NCT02740270|Spartalizumab|spartalizumab|mesh-list
138782032|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138782033|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782034|NCT02740270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138782035|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782036|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138782037|NCT00856843|Laxatives|laxatives|mesh-ancestor
138782038|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138782039|NCT02743390|Infliximab|infliximab|mesh-list
138782040|NCT02743390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138782041|NCT02743390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138782042|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
138782043|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138782044|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138782045|NCT00856609|Exenatide|exenatide|mesh-list
138782046|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138782047|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782048|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138782049|NCT00856609|Incretins|incretins|mesh-ancestor
138782050|NCT00856609|Hormones|hormones|mesh-ancestor
138782051|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138782052|NCT02739958|Propofol|propofol|mesh-list
138782053|NCT02739958|Isoflurane|isoflurane|mesh-list
138782054|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138782055|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782056|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782057|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138782058|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
138782059|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
138782060|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138782061|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
138782062|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138782063|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
138782064|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782065|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
138782066|NCT02739880|Protective Agents|protective agents|mesh-ancestor
138782067|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
138782068|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138782069|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138782070|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138782071|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138782072|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782073|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
138257050|NCT04635241|Heparin|heparin|mesh-list
138782074|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782075|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782076|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138782077|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782079|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
138782080|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138287924|NCT03565328|Niacin|niacin|mesh-list
138782082|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554706|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
138555093|NCT00290641|Fludarabine|fludarabine|mesh-list
138782083|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782084|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782085|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138782086|NCT01070784|Budesonide|budesonide|mesh-list
138782087|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
138782088|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138782089|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138782090|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138782091|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
138782092|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782093|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782094|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138782095|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
138782096|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
138782097|NCT01070784|Hormones|hormones|mesh-ancestor
138782098|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138782099|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138782100|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138782101|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138782102|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
138782103|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782104|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782105|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
138782106|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138782107|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782108|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138782109|NCT00837577|Voglibose|voglibose|mesh-list
138782110|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138782111|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782112|NCT00837577|Incretins|incretins|mesh-ancestor
138782113|NCT00837577|Hormones|hormones|mesh-ancestor
138782114|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138782115|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138782116|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
138555128|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138555140|NCT00290719|Irinotecan|irinotecan|mesh-list
138782117|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782118|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782119|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138782120|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138782121|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
138782122|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782123|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138782124|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
138782125|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138782126|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
138782127|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138782128|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782129|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138782130|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138782131|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782133|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138782134|NCT04030741|Metronidazole|metronidazole|mesh-list
138782135|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782136|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138782137|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138782138|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138782139|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138782140|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138782141|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
138782142|NCT00856297|Vaccines|vaccines|mesh-list
138782143|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
138782144|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782145|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
138782146|NCT02736604|Anesthetics|anesthetics|mesh-list
138782147|NCT02736604|Sevoflurane|sevoflurane|mesh-list
138782148|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782149|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782150|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138782151|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138782152|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
138782153|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138782154|NCT02736604|Analgesics|analgesics|mesh-ancestor
138782155|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
138782156|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782157|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
138782158|NCT02613013|Pilocarpine|pilocarpine|mesh-list
138782159|NCT02613013|Miotics|miotics|mesh-ancestor
138782160|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
138782161|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782162|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782163|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138782164|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138782165|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
138782166|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782167|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782168|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
138782169|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
138782170|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782171|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
138782172|NCT02611921|Ketamine|ketamine|mesh-list
138782173|NCT02611921|Analgesics|analgesics|mesh-ancestor
138782174|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
138782175|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782176|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782177|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138782178|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138782179|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
138782180|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
138782181|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782182|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138782183|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138782184|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782185|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782186|NCT02736448|Capecitabine|capecitabine|mesh-list
138782187|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138782188|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
138555210|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
138782189|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782190|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782191|NCT00703651|Vaccines|vaccines|mesh-list
138782192|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
138782193|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782194|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
138782195|NCT01046136|Guaifenesin|guaifenesin|mesh-list
138782196|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
138782197|NCT01046136|Expectorants|expectorants|mesh-ancestor
138782198|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
138782199|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138782200|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138554737|NCT00111345|Daunorubicin|daunorubicin|mesh-list
138782201|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
138782202|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782203|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782204|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782205|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
138782206|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138782207|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
138287978|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138782208|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
138782209|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782210|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
138782211|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138782212|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138782213|NCT02736682|Metronidazole|metronidazole|mesh-list
138782214|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138782215|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782216|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
138782217|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138782218|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138782219|NCT02874690|Methylphenidate|methylphenidate|mesh-list
138782220|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138782221|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782222|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138782223|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138782224|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138782225|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782226|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
138782227|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782228|NCT02738632|Amlodipine|amlodipine|mesh-list
138782229|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138782230|NCT02738632|Telmisartan|telmisartan|mesh-list
138782231|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138782232|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138782233|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138782234|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138782235|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782236|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138782237|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782238|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
138782239|NCT02738632|Diuretics|diuretics|mesh-ancestor
138782240|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
138782241|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138782242|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138782243|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138782244|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138782245|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138782246|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782247|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138782248|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138782249|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138782250|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782251|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
138782252|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782253|NCT00703807|Everolimus|everolimus|mesh-list
138782254|NCT00703807|Topotecan|topotecan|mesh-list
138782255|NCT00703807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138782256|NCT00703807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138782257|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782258|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782259|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138782260|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
138782261|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782262|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782263|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138782264|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138782265|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138456680|NCT01913808|Glycine|glycine|mesh-list
138782266|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782267|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782268|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782269|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138782270|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
138782271|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138782272|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138782273|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782274|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
138782275|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782276|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782277|NCT03633058|Ketamine|ketamine|mesh-list
138782278|NCT03633058|Analgesics|analgesics|mesh-ancestor
138782279|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
138782280|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782281|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782282|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138782283|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138782284|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
138782285|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
138782286|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782287|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138782288|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138782289|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782290|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782291|NCT01070316|Everolimus|everolimus|mesh-list
138782292|NCT01070316|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138782293|NCT01070316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138782294|NCT01070316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782295|NCT01070316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782296|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138782297|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
138782298|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782299|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782300|NCT02737774|Carboplatin|carboplatin|mesh-list
138782301|NCT02737774|Pemetrexed|pemetrexed|mesh-list
138782302|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782303|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782304|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782305|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138782306|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138782307|NCT02735590|Isoniazid|isoniazid|mesh-list
138782308|NCT02735590|Rifapentine|rifapentine|mesh-list
138782309|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
138782310|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138782311|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782312|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138782313|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138782314|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
138782315|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782317|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138782318|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
138782319|NCT05626348|Hydroxychloroquine|hydroxychloroquine|mesh-list
138782320|NCT05626348|Adalimumab|adalimumab|mesh-list
138782321|NCT05626348|Methotrexate|methotrexate|mesh-list
138782322|NCT05626348|Leflunomide|leflunomide|mesh-list
138782323|NCT05626348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138782324|NCT05626348|Abortifacient Agents|abortifacient agents|mesh-ancestor
138782325|NCT05626348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138782326|NCT05626348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782327|NCT05626348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138782328|NCT05626348|Antimetabolites|antimetabolites|mesh-ancestor
138782329|NCT05626348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782330|NCT05626348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782331|NCT05626348|Dermatologic Agents|dermatologic agents|mesh-ancestor
138782332|NCT05626348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782333|NCT05626348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138782334|NCT05626348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138782335|NCT05626348|Immunologic Factors|immunologic factors|mesh-ancestor
138782336|NCT05626348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138782337|NCT05626348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138782338|NCT05626348|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138782339|NCT05626348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138782340|NCT05626348|Antimalarials|antimalarials|mesh-ancestor
138782341|NCT05626348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138782342|NCT05626348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138782343|NCT05626348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782344|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
138782345|NCT02737696|Narcotics|narcotics|mesh-ancestor
138782346|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782347|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782348|NCT02737696|Analgesics|analgesics|mesh-ancestor
138782349|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
138782350|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782351|NCT02737228|Gemcitabine|gemcitabine|mesh-list
138782352|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138782353|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138782354|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
138782355|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782356|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782357|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138782358|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782360|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138782361|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782362|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
138782363|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782364|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138782365|NCT02737150|Anesthetics|anesthetics|mesh-list
138782366|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782367|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782368|NCT02735356|Itraconazole|itraconazole|mesh-list
138782369|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
138782370|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782371|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138782372|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138782373|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782374|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782375|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138782376|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
138782377|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138782378|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782379|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138782380|NCT00625469|Bosentan|bosentan|mesh-list
138782381|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138782382|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138782383|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782384|NCT05577910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138782385|NCT05577910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138782386|NCT00637481|Atorvastatin|atorvastatin|mesh-list
138782387|NCT00637481|Calcium|calcium|mesh-list
138782388|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138782389|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782390|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138782391|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138782392|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
138782393|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782394|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138782395|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138782396|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782397|NCT00637559|Esomeprazole|esomeprazole|mesh-list
138782398|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138555534|NCT00394303|Insulin|insulin|mesh-list
138782399|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138782400|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138782401|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782402|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782403|NCT00836875|Voriconazole|voriconazole|mesh-list
138782404|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
138782405|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782406|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138554753|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
138782407|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138782408|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782409|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782410|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138782411|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
138782412|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138782413|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782414|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138782416|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138782417|NCT01125917|Buprenorphine|buprenorphine|mesh-list
138782418|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138782419|NCT01125917|Narcotics|narcotics|mesh-ancestor
138782420|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782421|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782422|NCT01125917|Analgesics|analgesics|mesh-ancestor
138782423|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
138782424|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782425|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138782426|NCT02732236|Rituximab|rituximab|mesh-list
138782427|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138782428|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782429|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
138782430|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782431|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138782432|NCT01121549|Exemestane|exemestane|mesh-list
138782433|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782434|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138782435|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138782436|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782437|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782439|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
138782440|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138782441|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782442|NCT00847405|Sumatriptan|sumatriptan|mesh-list
138782443|NCT00847405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138782444|NCT00847405|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138782445|NCT00847405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138782446|NCT00847405|Serotonin Agents|serotonin agents|mesh-ancestor
138782447|NCT00847405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782448|NCT00847405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782449|NCT00847405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782450|NCT02731846|Fluticasone|fluticasone|mesh-list
138782452|NCT02731846|Albuterol|albuterol|mesh-list
138782453|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138782454|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138782455|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
138782456|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782457|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782458|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138782459|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
138782460|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
138782461|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138782462|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
138782463|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138782464|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138782465|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138782466|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138782467|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
138782468|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782469|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782470|NCT04248712|Loratadine|loratadine|mesh-list
138782471|NCT04248712|Famotidine|famotidine|mesh-list
138782472|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138782473|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138782474|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138782475|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
138782476|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
138782477|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782478|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782479|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782480|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
138782481|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
138782482|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138782483|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138456904|NCT01915134|Growth Substances|growth substances|mesh-ancestor
138782484|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138782485|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
138782486|NCT02734732|Trimethoprim|trimethoprim|mesh-list
138782487|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
138782488|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138782489|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782490|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138782491|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138782492|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782493|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782494|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782495|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138782496|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138782497|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138782498|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
138782499|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138782500|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138782501|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138782502|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138782503|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138782505|NCT02731378|Dextrans|dextrans|mesh-list
138782506|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
138782507|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
138782508|NCT02731378|Trace Elements|trace elements|mesh-ancestor
138782509|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
138782510|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782511|NCT02731378|Hematinics|hematinics|mesh-ancestor
138782512|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
138782513|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
138782514|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
138782515|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138782516|NCT02731534|Hematinics|hematinics|mesh-ancestor
138782517|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
138782518|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
138782519|NCT02734420|Coagulants|coagulants|mesh-ancestor
138782520|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
138555630|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
138782521|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782522|NCT00704275|Cyclosporine|cyclosporine|mesh-list
138782523|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138782524|NCT00704275|Cyclosporins|cyclosporins|mesh-list
138782525|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782526|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782527|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138782528|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
138782529|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782530|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
138782531|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782532|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
138782533|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138782534|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138782535|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138782536|NCT00847015|Gemcitabine|gemcitabine|mesh-list
138782538|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782539|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138782540|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
138782541|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782542|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138782543|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138782544|NCT00847015|Growth Substances|growth substances|mesh-ancestor
138782545|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782546|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
138782547|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138782548|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782549|NCT00627354|Prednisone|prednisone|mesh-list
138782550|NCT00627354|Etoposide|etoposide|mesh-list
138782551|NCT00627354|Vinorelbine|vinorelbine|mesh-list
138782552|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
138782553|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138782554|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
138782555|NCT00627354|Hormones|hormones|mesh-ancestor
138782556|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138782557|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782558|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138782559|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782560|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138782561|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138782562|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138782563|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782564|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782565|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
138782566|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
138782567|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
138782568|NCT00627354|Analgesics|analgesics|mesh-ancestor
138782569|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
138782570|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782571|NCT00704431|Darapladib|darapladib|mesh-list
138782572|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138782573|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782574|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782575|NCT02734186|Praziquantel|praziquantel|mesh-list
138782576|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
138782577|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138782578|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782579|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138782580|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
138782581|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138288140|NCT00376129|Alefacept|alefacept|mesh-list
138288144|NCT01035944|Chitosan|chitosan|mesh-list
138782582|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138782583|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138782584|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782585|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782586|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
138782587|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138782588|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138782589|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782590|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
138782591|NCT02733952|Coagulants|coagulants|mesh-ancestor
138782592|NCT02733640|Pantoprazole|pantoprazole|mesh-list
138782593|NCT02733640|Ranitidine|ranitidine|mesh-list
138782594|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138782595|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138782596|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138782597|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138782598|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782599|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782600|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138782601|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
138782602|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
138555697|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
138782603|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782604|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782605|NCT02730676|Menthol|menthol|mesh-list
138782606|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
138782607|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
138782608|NCT00855595|Metronidazole|metronidazole|mesh-list
138782609|NCT00855595|Doxycycline|doxycycline|mesh-list
138782610|NCT00855595|Azelaic acid|azelaic acid|mesh-list
138782611|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782612|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138782613|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138782614|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138782615|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
138257618|NCT05635903|Anesthetics|anesthetics|mesh-ancestor
138782616|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782617|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
138782618|NCT05433532|Azacitidine|azacitidine|mesh-list
138782619|NCT05433532|Venetoclax|venetoclax|mesh-list
138782620|NCT05433532|Flumatinib|flumatinib|mesh-list
138782621|NCT05433532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138782622|NCT05433532|Antimetabolites|antimetabolites|mesh-ancestor
138782623|NCT05433532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782624|NCT05433532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782625|NCT05433532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782626|NCT05433532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138782627|NCT00855439|Exenatide|exenatide|mesh-list
138782628|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138782629|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782630|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138782631|NCT00855439|Incretins|incretins|mesh-ancestor
138782632|NCT00855439|Hormones|hormones|mesh-ancestor
138782633|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138782634|NCT01064856|Adalimumab|adalimumab|mesh-list
138782635|NCT01064856|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138457056|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
138782636|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138782637|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138782638|NCT02730442|Fluconazole|fluconazole|mesh-list
138782639|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
138782640|NCT02730442|Clotrimazole|clotrimazole|mesh-list
138782641|NCT02730442|Miconazole|miconazole|mesh-list
138782642|NCT02730442|Olorofim|olorofim|mesh-list
138782643|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782644|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138232062|NCT01291784|Antibodies|antibodies|mesh-list
138782645|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138782646|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782647|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782648|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138782649|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
138782650|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138782651|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782652|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138782653|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138782654|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138782655|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138782656|NCT02733874|Betamethasone|betamethasone|mesh-list
138782657|NCT02733874|Clobetasol|clobetasol|mesh-list
138782658|NCT02733874|Calcipotriene|calcipotriene|mesh-list
138782659|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138782660|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
138782661|NCT02733874|Hormones|hormones|mesh-ancestor
138782662|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138782663|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782664|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138782666|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
138782667|NCT02730364|Acetaminophen|acetaminophen|mesh-list
138782668|NCT02730364|Pheniramine|pheniramine|mesh-list
138782669|NCT02730364|Phenylephrine|phenylephrine|mesh-list
138782670|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
138782671|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782672|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138782673|NCT02730364|Analgesics|analgesics|mesh-ancestor
138782674|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
138782675|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782676|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
138782677|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782678|NCT02730364|Protective Agents|protective agents|mesh-ancestor
138782679|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138782680|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
138782681|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
138782682|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
138782683|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138782684|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
138782685|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
138782686|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138782687|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138782688|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138782689|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
138782690|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782691|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
138782692|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
138782693|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138288203|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138288205|NCT04327843|Haloperidol|haloperidol|mesh-list
138782694|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
138782695|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
138782696|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138782697|NCT01042392|Ramipril|ramipril|mesh-list
138782698|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138782699|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
138782700|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782701|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782702|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138782703|NCT00704665|Methocarbamol|methocarbamol|mesh-list
138555808|NCT00299026|Paclitaxel|paclitaxel|mesh-list
138782704|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138782705|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782706|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138782707|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782708|NCT00913315|Tamsulosin|tamsulosin|mesh-list
138782709|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138782710|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138782711|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138782712|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138782713|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
138782714|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782715|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782716|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782718|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138782719|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138782720|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
138782722|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782723|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782724|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782725|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138782726|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138782727|NCT02729662|Tolvaptan|tolvaptan|mesh-list
138782728|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138782729|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782730|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
138782731|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782732|NCT02733250|Paclitaxel|paclitaxel|mesh-list
138782733|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
138782734|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138782735|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782736|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
138782737|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
138782738|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
138782739|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782740|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138782741|NCT02733250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138782742|NCT03188068|Sirolimus|sirolimus|mesh-list
138782743|NCT03188068|Prednisolone|prednisolone|mesh-list
138782744|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138782745|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782746|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138782747|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782748|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
138782749|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138782750|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
138782751|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782752|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138782753|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
138782754|NCT03188068|Hormones|hormones|mesh-ancestor
138782755|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138782756|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138782757|NCT01064310|Sunitinib|sunitinib|mesh-list
138782758|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782759|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138782760|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138782761|NCT01064310|Growth Substances|growth substances|mesh-ancestor
138782762|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782763|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
138782764|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138782765|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782766|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782767|NCT02726854|Apatinib|apatinib|mesh-list
138782768|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782769|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138782770|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782771|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782772|NCT04724928|Immunomodulating Agents|immunomodulating agents|mesh-list
138782773|NCT04724928|Immunologic Factors|immunologic factors|mesh-ancestor
138782774|NCT04724928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782775|NCT02728492|Paclitaxel|paclitaxel|mesh-list
138782776|NCT02728492|Carboplatin|carboplatin|mesh-list
138782777|NCT02728492|Gemcitabine|gemcitabine|mesh-list
138782778|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138782779|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782780|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
138782781|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
138782782|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
138649746|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138782783|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441312|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
138782784|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138782786|NCT02726308|Dexamethasone|dexamethasone|mesh-list
138782787|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138782788|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
138782789|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
138782790|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782791|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782793|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
138782794|NCT02726308|Hormones|hormones|mesh-ancestor
138782795|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138782796|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138782797|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782798|NCT01037244|Udenafil|udenafil|mesh-list
138782799|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138782800|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138782801|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782802|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782803|NCT00627432|Gemcitabine|gemcitabine|mesh-list
138782804|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
138782805|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138782806|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
138782807|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782808|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782809|NCT02727712|Anesthetics|anesthetics|mesh-list
138782810|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782811|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782812|NCT01042236|Fesoterodine|fesoterodine|mesh-list
138782813|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138782814|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138782815|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
138782816|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288280|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
138782817|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782818|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782819|NCT01042236|Urological Agents|urological agents|mesh-ancestor
138782821|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782822|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782823|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782824|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138782825|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138782826|NCT00592501|Fluorouracil|fluorouracil|mesh-list
138782827|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782828|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
138782829|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782830|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138782831|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138782832|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
138782833|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782834|NCT01040832|Cetuximab|cetuximab|mesh-list
138782835|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138782836|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782837|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
138782838|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138782839|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138782840|NCT04304196|TEMPO|tempo|mesh-list
138782841|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
138782842|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782843|NCT04304196|Protective Agents|protective agents|mesh-ancestor
138782844|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782845|NCT02720770|Hormones|hormones|mesh-list
138782846|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138782847|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782848|NCT02720926|Capecitabine|capecitabine|mesh-list
138782849|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
138782850|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138782851|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
138782852|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782853|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782854|NCT00854581|Interferons|interferons|mesh-list
138782855|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
138782856|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
138782857|NCT00854581|Zidovudine|zidovudine|mesh-list
138782858|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138782859|NCT00854581|Valproic Acid|valproic acid|mesh-list
138782860|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782861|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
138782862|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782863|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
138782864|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782865|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
138782866|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173020|NCT00618917|Carboplatin|carboplatin|mesh-list
138782867|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138782868|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138782869|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782870|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138782871|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138782872|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
138782873|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
138782874|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782875|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
138782876|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138782877|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782878|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138782879|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138782880|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782881|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782882|NCT00833911|Tramadol|tramadol|mesh-list
138782883|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138782884|NCT00833911|Narcotics|narcotics|mesh-ancestor
138782885|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554804|NCT00287677|Hormones|hormones|mesh-list
138782886|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782887|NCT00833911|Analgesics|analgesics|mesh-ancestor
138257800|NCT01767103|Deferiprone|deferiprone|mesh-list
138782888|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
138782889|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782891|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
138782892|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138782893|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782894|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138782895|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782896|NCT01125293|Rituximab|rituximab|mesh-list
138782897|NCT01125293|Everolimus|everolimus|mesh-list
138782898|NCT01125293|Bortezomib|bortezomib|mesh-list
138782899|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138782900|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782901|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
138782902|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782903|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138782904|NCT01125293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138782905|NCT01125293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138782906|NCT01125293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782907|NCT01125293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782908|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138782909|NCT02719834|Acetaminophen|acetaminophen|mesh-list
138782910|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138782911|NCT02719834|Analgesics|analgesics|mesh-ancestor
138782912|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
138782913|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782914|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782915|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
138782916|NCT02719210|Mannitol|mannitol|mesh-list
138782917|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138782918|NCT02719210|Diuretics|diuretics|mesh-ancestor
138782919|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
138782920|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782921|NCT02719132|Metformin|metformin|mesh-list
138782922|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
138782923|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138782924|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782925|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138782926|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782927|NCT02718976|Lidocaine|lidocaine|mesh-list
138782928|NCT02718976|Epinephrine|epinephrine|mesh-list
138782929|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138782930|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
138782931|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
138782932|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782933|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782934|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
138782935|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138782936|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138782937|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138457353|NCT01917721|Doxycycline|doxycycline|mesh-list
138782938|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138782939|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138782940|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782941|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138782942|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138782943|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
138782944|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138782945|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138782946|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138782947|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
138782948|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138782949|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
138556036|NCT00119769|Hormones|hormones|mesh-list
138782950|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
138782951|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
138782952|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138782953|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
138782954|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
138782955|NCT02718742|Paclitaxel|paclitaxel|mesh-list
138288387|NCT05286554|Progestins|progestins|mesh-ancestor
138782956|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138782957|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138782958|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782959|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
138782960|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
138782961|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
138782962|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782964|NCT02717884|Tretinoin|tretinoin|mesh-list
138782965|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
138782966|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138782967|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
138782968|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782969|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782970|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
138782971|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138782972|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138782973|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
138782974|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782975|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
138782976|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
138782977|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
138782978|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138782979|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138782980|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782981|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138782982|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138782983|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138782984|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138782985|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138782986|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782987|NCT01121393|Gemcitabine|gemcitabine|mesh-list
138782988|NCT01121393|Afatinib|afatinib|mesh-list
138782989|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138782990|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138782991|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
138782992|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138782993|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138782994|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138782995|NCT02882477|Metformin|metformin|mesh-list
138782996|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138782997|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
138782998|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138782999|NCT02882477|Deferiprone|deferiprone|mesh-list
138783000|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138783001|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783002|NCT02882477|Incretins|incretins|mesh-ancestor
138783003|NCT02882477|Hormones|hormones|mesh-ancestor
138783004|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783005|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138783006|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
138783007|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138649747|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783008|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783009|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
138783010|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783012|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
138783013|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138783014|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
138783015|NCT02882477|Protective Agents|protective agents|mesh-ancestor
138783016|NCT02882477|Antidotes|antidotes|mesh-ancestor
138783017|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138783018|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
138783019|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
138783020|NCT04163224|Imidacloprid|imidacloprid|mesh-list
138783021|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
138783022|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783023|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783024|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783025|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
138783026|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138783027|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783028|NCT04964284|Hormones|hormones|mesh-list
138257883|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138783029|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783030|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783031|NCT02716090|Adapalene|adapalene|mesh-list
138783032|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138783033|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
138783034|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138783035|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138783036|NCT02716090|Analgesics|analgesics|mesh-ancestor
138783037|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
138783038|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783039|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783040|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138783041|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138783042|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138783043|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138783044|NCT01227616|Hematinics|hematinics|mesh-ancestor
138783045|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138783046|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138783047|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138783048|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
138783049|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783050|NCT02714998|Methotrexate|methotrexate|mesh-list
138783051|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138783052|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
138783053|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138783054|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783055|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138783056|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
138783057|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783058|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783059|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
138783060|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783061|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138783062|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138783063|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
138783064|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138783065|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138783066|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
138783067|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
138783068|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783069|NCT00765310|Protective Agents|protective agents|mesh-ancestor
138783070|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556127|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
138783071|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
138783072|NCT00765310|Vitamins|vitamins|mesh-ancestor
138783073|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
138783074|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
138783075|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138783076|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138783077|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783078|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138783079|NCT02715154|Analgesics|analgesics|mesh-ancestor
138783080|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
138783081|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783082|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138783083|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138783084|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138783085|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
138783086|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783087|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783088|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138783089|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
138783090|NCT02715232|Lynestrenol|lynestrenol|mesh-list
138783091|NCT02715232|Estradiol|estradiol|mesh-list
138783092|NCT02715232|Testosterone|testosterone|mesh-list
138783094|NCT02715232|Estrogens|estrogens|mesh-ancestor
138783095|NCT02715232|Hormones|hormones|mesh-ancestor
138783096|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783097|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783098|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138783099|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
138783100|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138783101|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138783102|NCT02715232|Androgens|androgens|mesh-ancestor
138783103|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138783104|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783105|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
138783106|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
138783107|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
138783108|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138783109|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138783110|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138783111|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138556168|NCT00301171|Fluticasone|fluticasone|mesh-list
138783112|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138783113|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
138783114|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783116|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138783117|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138783118|NCT02714842|Analgesics|analgesics|mesh-ancestor
138783119|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
138783120|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783121|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783122|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138783123|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138783124|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138783125|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783126|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783127|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138783128|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783129|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138783130|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783131|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783132|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
138783133|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138783134|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783135|NCT04000906|Paclitaxel|paclitaxel|mesh-list
138783136|NCT04000906|Cisplatin|cisplatin|mesh-list
138649748|NCT00297284|Modafinil|modafinil|mesh-list
138783137|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138783138|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783139|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
138783140|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
138783141|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
138783142|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783143|NCT00636766|Metformin|metformin|mesh-list
138783144|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
138783145|NCT00636766|Rimonabant|rimonabant|mesh-list
138783146|NCT00636766|Atorvastatin|atorvastatin|mesh-list
138783147|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138556199|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
138783148|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783149|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138783150|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138783151|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
138783152|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783153|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138783154|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138783155|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783156|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138783157|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138783158|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138783159|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783160|NCT00636766|Hormones|hormones|mesh-ancestor
138783161|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783162|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138783163|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138783164|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138783165|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138783166|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783167|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138783168|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138783169|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138783170|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
138783171|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783172|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783173|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138783174|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138783175|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
138783176|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138783177|NCT00611416|Caffeine|caffeine|mesh-list
138783178|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138783179|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783180|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138783181|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783182|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783183|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138783184|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138783185|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
138783186|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783187|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
138783188|NCT00611416|Protective Agents|protective agents|mesh-ancestor
138783189|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138783190|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138783191|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783192|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138783193|NCT02712658|Terbutaline|terbutaline|mesh-list
138783194|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138783195|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
138783196|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783197|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783198|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138783199|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
138783200|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
138783201|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
138783202|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138783203|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138783204|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138783205|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138783206|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
138783207|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783208|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783209|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
138783210|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138783211|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783212|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138783213|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
138783214|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138783215|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783216|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783217|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783218|NCT02712502|Amoxicillin|amoxicillin|mesh-list
138783219|NCT02712502|Levofloxacin|levofloxacin|mesh-list
138783220|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
138783221|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
138783222|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138783223|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138783224|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783225|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138783226|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138783227|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138783228|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783229|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783230|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554830|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
138783231|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138783232|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138783233|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138783234|NCT02712346|Ambrisentan|ambrisentan|mesh-list
138783235|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138783236|NCT02711410|Clopidogrel|clopidogrel|mesh-list
138783237|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138783238|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138783239|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138783240|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138783241|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
138783242|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783243|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783244|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783245|NCT02711176|Amoxicillin|amoxicillin|mesh-list
138783246|NCT02711176|Clarithromycin|clarithromycin|mesh-list
138783247|NCT02711176|Tinidazole|tinidazole|mesh-list
138783248|NCT02711176|Esomeprazole|esomeprazole|mesh-list
138783249|NCT02711176|Lansoprazole|lansoprazole|mesh-list
138783250|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138783251|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783252|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138783253|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138783254|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138783255|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783256|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783257|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138783258|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138783259|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138783260|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
138258109|NCT02694809|Estrogens|estrogens|mesh-list
138783262|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138783263|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138783264|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138783265|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
138783266|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783267|NCT00611650|Protective Agents|protective agents|mesh-ancestor
138783268|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783269|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138783270|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138783271|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783272|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138783273|NCT02710552|Amlodipine|amlodipine|mesh-list
138783274|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
138783275|NCT02710552|Perindopril|perindopril|mesh-list
138783276|NCT02710552|Indapamide|indapamide|mesh-list
138783277|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138783278|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138783279|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783280|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138783281|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783282|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
138783283|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138783284|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
138783285|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783286|NCT02710552|Diuretics|diuretics|mesh-ancestor
138783287|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
138783288|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138783289|NCT02710396|Paclitaxel|paclitaxel|mesh-list
138783290|NCT02710396|Carboplatin|carboplatin|mesh-list
138783291|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
138783292|NCT02710396|Pemetrexed|pemetrexed|mesh-list
138783293|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138783294|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783295|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
138783296|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
138783297|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
138783298|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783299|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138783300|NCT02710396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138783301|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554838|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
138783302|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138783303|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138783304|NCT02710162|Capsaicin|capsaicin|mesh-list
138783305|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
138783306|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
138783307|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
138783308|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783309|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457726|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
138783310|NCT00611728|Irinotecan|irinotecan|mesh-list
138783311|NCT00611728|Sunitinib|sunitinib|mesh-list
138783312|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138783313|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138783314|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783315|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783316|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783317|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138783318|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138783319|NCT00611728|Growth Substances|growth substances|mesh-ancestor
138783320|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783321|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
138783322|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138783323|NCT02709304|Lidocaine|lidocaine|mesh-list
138556325|NCT00086775|Rituximab|rituximab|mesh-list
138783324|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
138783325|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
138783326|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138783327|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783328|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
138783329|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783330|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138783331|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138783332|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138783333|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138783334|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783336|NCT04189666|Rivastigmine|rivastigmine|mesh-list
138783337|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
138783338|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783339|NCT04189666|Protective Agents|protective agents|mesh-ancestor
138783340|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783341|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138783342|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138783343|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783344|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
138783345|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783346|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138783347|NCT00937521|Antipyretics|antipyretics|mesh-list
138783348|NCT00937521|Vaccines|vaccines|mesh-list
138783349|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
138783350|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783351|NCT02709382|Tazobactam|tazobactam|mesh-list
138783352|NCT02709382|Cefepime|cefepime|mesh-list
138783353|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138783354|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783355|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138783356|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783357|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783358|NCT02708992|Azithromycin|azithromycin|mesh-list
138783359|NCT02708992|Cefixime|cefixime|mesh-list
138554840|NCT00287950|Etoposide|etoposide|mesh-list
138783360|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138783361|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783363|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
138783364|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138783365|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783366|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
138783367|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
138783368|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
138783369|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783370|NCT00606099|Adefovir|adefovir|mesh-list
138783371|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138783372|NCT00606099|Telbivudine|telbivudine|mesh-list
138783373|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
138783374|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783375|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138783376|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138783377|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783378|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783379|NCT00935883|Eculizumab|eculizumab|mesh-list
138783380|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138783381|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138783382|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
138783383|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783384|NCT02708446|Misoprostol|misoprostol|mesh-list
138783385|NCT02708446|Mifepristone|mifepristone|mesh-list
138783386|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138783387|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
138783388|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138783389|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783390|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138783391|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138783392|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
138783393|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138783394|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138783395|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138783396|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138783397|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
138783398|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138783399|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138783400|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
138783401|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783402|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
138783403|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138783404|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138783406|NCT05378919|Leucovorin|leucovorin|mesh-list
138783407|NCT05378919|Fluorouracil|fluorouracil|mesh-list
138783408|NCT05378919|Oxaliplatin|oxaliplatin|mesh-list
138783409|NCT05378919|Levoleucovorin|levoleucovorin|mesh-list
138783410|NCT05378919|Antimetabolites|antimetabolites|mesh-ancestor
138783411|NCT05378919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783412|NCT05378919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138783413|NCT05378919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783414|NCT05378919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138783415|NCT05378919|Immunologic Factors|immunologic factors|mesh-ancestor
138783416|NCT05378919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783417|NCT05378919|Hematinics|hematinics|mesh-ancestor
138783418|NCT05378919|Vitamin B Complex|vitamin b complex|mesh-ancestor
138783419|NCT05378919|Vitamins|vitamins|mesh-ancestor
138783420|NCT05378919|Micronutrients|micronutrients|mesh-ancestor
138783421|NCT05378919|Antidotes|antidotes|mesh-ancestor
138783422|NCT05378919|Protective Agents|protective agents|mesh-ancestor
138783423|NCT00607581|Dexamethasone|dexamethasone|mesh-list
138783424|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
138783425|NCT00607581|Lenalidomide|lenalidomide|mesh-list
138783426|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138783427|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
138783428|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783429|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138783430|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138783431|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
138783432|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783433|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783434|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138783435|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138783436|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
138783437|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
138783438|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783439|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138783440|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
138783441|NCT00607581|Hormones|hormones|mesh-ancestor
138783442|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783443|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138783444|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138783445|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138783446|NCT00607581|Growth Substances|growth substances|mesh-ancestor
138783447|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
138783448|NCT02707900|Vorinostat|vorinostat|mesh-list
138783449|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783450|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138783451|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783452|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783453|NCT05380479|Megestrol|megestrol|mesh-list
138783454|NCT05380479|Megestrol Acetate|megestrol acetate|mesh-list
138783455|NCT05380479|Mirtazapine|mirtazapine|mesh-list
138783456|NCT05380479|Antidepressive Agents|antidepressive agents|mesh-ancestor
138783457|NCT05380479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138783458|NCT05380479|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138783459|NCT05380479|Histamine Antagonists|histamine antagonists|mesh-ancestor
138783460|NCT05380479|Histamine Agents|histamine agents|mesh-ancestor
138783461|NCT05380479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783462|NCT05380479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783463|NCT05380479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783464|NCT05380479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138783465|NCT05380479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138783466|NCT05380479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138783467|NCT05380479|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138783468|NCT05380479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138783469|NCT05380479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138783470|NCT05380479|Adrenergic Agents|adrenergic agents|mesh-ancestor
138783471|NCT05380479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138783472|NCT05380479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138783473|NCT05380479|Serotonin Agents|serotonin agents|mesh-ancestor
138783474|NCT05380479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138783475|NCT05380479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138783476|NCT05380479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138783477|NCT05380479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138783478|NCT05380479|Contraceptive Agents|contraceptive agents|mesh-ancestor
138783479|NCT05380479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138783480|NCT05380479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138783481|NCT05380479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138783482|NCT05380479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138783483|NCT05380479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288677|NCT00624650|Furosemide|furosemide|mesh-list
138783484|NCT05380479|Appetite Stimulants|appetite stimulants|mesh-ancestor
138783485|NCT05380479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138783486|NCT00936975|Listerine|listerine|mesh-list
138783487|NCT00936975|Fluorides|fluorides|mesh-list
138783488|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
138783490|NCT00936975|Protective Agents|protective agents|mesh-ancestor
138783491|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783492|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138783493|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783494|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138783495|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
138783496|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138783497|NCT02693470|Ustekinumab|ustekinumab|mesh-list
138783498|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
138783499|NCT00936897|Denosumab|denosumab|mesh-list
138783500|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
138783501|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138783502|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783503|NCT05265676|Enoxaparin|enoxaparin|mesh-list
138783504|NCT05265676|Enoxaparin sodium|enoxaparin sodium|mesh-list
138783505|NCT05265676|Anticoagulants|anticoagulants|mesh-ancestor
138783506|NCT05265676|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138783507|NCT05265676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138783508|NCT05265676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783509|NCT00606333|Sirolimus|sirolimus|mesh-list
138783510|NCT00606333|Paclitaxel|paclitaxel|mesh-list
138783511|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138783512|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138783513|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783514|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
138783515|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
138783516|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
138783517|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783518|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138783519|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783520|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138783521|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
138783522|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138783523|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
138783524|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783525|NCT05265442|Methadone|methadone|mesh-list
138783526|NCT05265442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138783527|NCT05265442|Narcotics|narcotics|mesh-ancestor
138783528|NCT05265442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138783529|NCT05265442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783530|NCT05265442|Analgesics|analgesics|mesh-ancestor
138783531|NCT05265442|Sensory System Agents|sensory system agents|mesh-ancestor
138783532|NCT05265442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783533|NCT05265442|Antitussive Agents|antitussive agents|mesh-ancestor
138783534|NCT05265442|Respiratory System Agents|respiratory system agents|mesh-ancestor
138783535|NCT00606411|Topiramate|topiramate|mesh-list
138457963|NCT01930552|Leucovorin|leucovorin|mesh-list
138783536|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
138783537|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138783538|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783539|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
138783540|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138783541|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783542|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
138783543|NCT01120691|Albuterol|albuterol|mesh-list
138783544|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
138783545|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138783546|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
138783547|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783548|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783549|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138783550|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
138783551|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
138783552|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138783553|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
138783554|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783555|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783556|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
138783557|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138554880|NCT00288262|Melatonin|melatonin|mesh-list
138783558|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138783559|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138783560|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138783561|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
138783562|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138783563|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138783565|NCT00612274|Methotrexate|methotrexate|mesh-list
138783566|NCT00612274|Tacrolimus|tacrolimus|mesh-list
138783567|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138258306|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
138783568|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
138783569|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138783570|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783571|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138783572|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
138288715|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
138783573|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783574|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783575|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
138783576|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783577|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138783578|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138783579|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
138783580|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138783581|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138783582|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138783583|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138783584|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783585|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138783586|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
138783587|NCT05263882|Gemcitabine|gemcitabine|mesh-list
138783588|NCT05263882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138783589|NCT05263882|Antimetabolites|antimetabolites|mesh-ancestor
138783590|NCT05263882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783591|NCT05263882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783592|NCT02724904|Methotrexate|methotrexate|mesh-list
138783593|NCT02724904|Fludarabine|fludarabine|mesh-list
138783595|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138783596|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
138783597|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138783598|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783599|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138783600|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
138783601|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783602|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783603|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
138783604|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783605|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138783606|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138783607|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
138783608|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138288761|NCT00378716|Protective Agents|protective agents|mesh-ancestor
138783609|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138783610|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138783611|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
138783612|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138783614|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138783615|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138783616|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138783617|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138783618|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
138783619|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783620|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783621|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783622|NCT05380245|Clarithromycin|clarithromycin|mesh-list
138783623|NCT05380245|Voriconazole|voriconazole|mesh-list
138783624|NCT05380245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138783625|NCT05380245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783626|NCT05380245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138783627|NCT05380245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783628|NCT05380245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783629|NCT05380245|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138783630|NCT05380245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138783631|NCT05380245|Antifungal Agents|antifungal agents|mesh-ancestor
138783632|NCT05380245|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138783633|NCT05380245|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138783634|NCT05380245|Hormone Antagonists|hormone antagonists|mesh-ancestor
138783635|NCT05380245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783636|NCT05380245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783637|NCT00935259|Simvastatin|simvastatin|mesh-list
138783638|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138783639|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138783640|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
138783641|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783642|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138783643|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138783644|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783645|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138783646|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138783647|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138783648|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
138783649|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783650|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783651|NCT02937766|Progestins|progestins|mesh-ancestor
138783652|NCT02937766|Hormones|hormones|mesh-ancestor
138783653|NCT00607971|Renzapride|renzapride|mesh-list
138783654|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138783655|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
138783656|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783657|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783658|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783659|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
138783660|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138783661|NCT02724358|Estrogens|estrogens|mesh-ancestor
138783662|NCT02724358|Hormones|hormones|mesh-ancestor
138783663|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783664|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783665|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138783666|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783667|NCT02724202|Curcumin|curcumin|mesh-list
138783668|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138783669|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138783670|NCT02724202|Analgesics|analgesics|mesh-ancestor
138783671|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
138783672|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783673|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783674|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138783675|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138783676|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783677|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783678|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783680|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138783681|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783682|NCT00625547|Levodopa|levodopa|mesh-list
138783683|NCT00625547|Cabergoline|cabergoline|mesh-list
138458108|NCT01931215|Clonidine|clonidine|mesh-list
138783684|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138783685|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138783686|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
138783687|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556676|NCT00087165|Docetaxel|docetaxel|mesh-list
138783688|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783689|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783690|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
138783691|NCT05241340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138783692|NCT05241340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783693|NCT05241340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138783694|NCT05241340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783696|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138783697|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783698|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138783699|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138783700|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783701|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783702|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783703|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138783704|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138783705|NCT01124045|Prednisolone|prednisolone|mesh-list
138783706|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138783707|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
138783708|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138783709|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
138783710|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138783711|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
138783712|NCT01124045|Difluprednate|difluprednate|mesh-list
138783713|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138783714|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
138783715|NCT01124045|Hormones|hormones|mesh-ancestor
138783716|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783717|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783718|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138783719|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783720|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
138783721|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
138783722|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783723|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138783724|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138783725|NCT01124045|Protective Agents|protective agents|mesh-ancestor
138783726|NCT01123889|Lidocaine|lidocaine|mesh-list
138783727|NCT01123889|Ropivacaine|ropivacaine|mesh-list
138783728|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
138783729|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
138783730|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138783731|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783732|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
138783733|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783734|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138783735|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138783736|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138783737|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138783738|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783739|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138783740|NCT00606957|Vitamin D|vitamin d|mesh-list
138783741|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
138783742|NCT00606957|Vitamins|vitamins|mesh-ancestor
138783743|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
138783744|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783745|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138783746|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138783747|NCT00934947|Propranolol|propranolol|mesh-list
138783748|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138783749|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138783750|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
138783751|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783752|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783753|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783754|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138783755|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138783756|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
138783757|NCT02723578|Pemetrexed|pemetrexed|mesh-list
138783758|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138783759|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783760|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556777|NCT00087282|Irinotecan|irinotecan|mesh-list
138783761|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783762|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138783763|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138783764|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138783765|NCT04189198|Bupivacaine|bupivacaine|mesh-list
138783767|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
138783768|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
138783769|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138783770|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783771|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
138783772|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783773|NCT00608361|Dasatinib|dasatinib|mesh-list
138783774|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258420|NCT02417831|Tamsulosin|tamsulosin|mesh-list
138783775|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138783776|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783777|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783778|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
138783779|NCT00934791|Sirolimus|sirolimus|mesh-list
138783780|NCT00934791|Prednisone|prednisone|mesh-list
138783781|NCT00934791|Tacrolimus|tacrolimus|mesh-list
138783782|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138783783|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
138783784|NCT00934791|Hormones|hormones|mesh-ancestor
138783785|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783786|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783787|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138783788|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783789|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138783790|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
138783791|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138783792|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783793|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783794|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138783795|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138783796|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
138783797|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138783798|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783799|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
138783800|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138783801|NCT00607035|Olmesartan|olmesartan|mesh-list
138783802|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138783803|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138783804|NCT00607035|Diuretics|diuretics|mesh-ancestor
138783805|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
138783806|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783807|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138783808|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138783809|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783810|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138783811|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138783813|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
138783814|NCT02723266|Protective Agents|protective agents|mesh-ancestor
138783815|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783816|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
138783817|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138783818|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783819|NCT02722954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138783820|NCT02722954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783821|NCT00625859|Bupropion|bupropion|mesh-list
138783822|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138783823|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
138783824|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138783825|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138783826|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138783827|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138783828|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783829|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
138783830|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288855|NCT01692158|Heparin|heparin|mesh-list
138783831|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783832|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138783833|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138783834|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783836|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
138783837|NCT02691195|Anesthetics|anesthetics|mesh-list
138783838|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138783839|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783840|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
138783841|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783843|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138783844|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783845|NCT01111019|Hormones|hormones|mesh-list
138783846|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783847|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783848|NCT02883400|Spironolactone|spironolactone|mesh-list
138783849|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138783850|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
138783851|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783852|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783853|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138783854|NCT02883400|Diuretics|diuretics|mesh-ancestor
138783855|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
138783856|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138783857|NCT01119287|Dexamethasone|dexamethasone|mesh-list
138783858|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138783859|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138783860|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
138783861|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
138783862|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783863|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783864|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138783865|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
138783866|NCT01119287|Hormones|hormones|mesh-ancestor
138783867|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783868|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138783869|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783870|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138783871|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138783872|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138783873|NCT01119287|Analgesics|analgesics|mesh-ancestor
138783874|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
138783875|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138783876|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138783877|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138783878|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138783879|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
138783880|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
138783881|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138783882|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783883|NCT01110707|Hormones|hormones|mesh-list
138783884|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138783885|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138783886|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783887|NCT04931368|Rituximab|rituximab|mesh-list
138783888|NCT04931368|Methotrexate|methotrexate|mesh-list
138554909|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783889|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138783890|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783891|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
138783892|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288871|NCT03928327|Rifampin|rifampin|mesh-list
138783893|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138783894|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138783895|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
138783896|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138783897|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138783898|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
138783899|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783900|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
138783901|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783902|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138783903|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138783904|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138783906|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
138783907|NCT01119131|Calcium|calcium|mesh-list
138783908|NCT01119131|Vitamins|vitamins|mesh-ancestor
138783909|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
138783910|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783911|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138783912|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138783913|NCT00636922|Everolimus|everolimus|mesh-list
138783914|NCT00636922|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138783915|NCT00636922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138783916|NCT00636922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783917|NCT00636922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783918|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138783919|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
138783920|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783921|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783922|NCT02722096|Lidocaine|lidocaine|mesh-list
138783923|NCT02722096|Ropivacaine|ropivacaine|mesh-list
138783924|NCT02722096|Anesthetics|anesthetics|mesh-list
138783925|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
138783926|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138783927|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258544|NCT05324995|Sympathomimetics|sympathomimetics|mesh-ancestor
138783928|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
138556968|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138783929|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138783930|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138783931|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138783932|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138783933|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138783934|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783935|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138783937|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138783938|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138783939|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
138783940|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783941|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138783942|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138783943|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783944|NCT01118975|Lapatinib|lapatinib|mesh-list
138783945|NCT01118975|Vorinostat|vorinostat|mesh-list
138783946|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783947|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138783948|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783949|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783950|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138783951|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
138783952|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138783953|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783954|NCT04829422|Lazertinib|lazertinib|mesh-list
138783955|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138783956|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288881|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783957|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783958|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138783959|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138783960|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138783961|NCT00612898|Lamivudine|lamivudine|mesh-list
138783962|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138783963|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138783964|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783965|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783966|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
138783967|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783968|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138783969|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138783970|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
138783971|NCT01118663|Edetic Acid|edetic acid|mesh-list
138783972|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138783973|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
138783974|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
138783975|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138783976|NCT01118663|Expectorants|expectorants|mesh-ancestor
138783977|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
138783978|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138783979|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
138783980|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783981|NCT01118663|Protective Agents|protective agents|mesh-ancestor
138783982|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783983|NCT01118663|Antidotes|antidotes|mesh-ancestor
138783984|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
138783985|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138783986|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
138783987|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
138783988|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138783989|NCT01118351|Sunitinib|sunitinib|mesh-list
138783990|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138783991|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138783992|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138783993|NCT01118351|Growth Substances|growth substances|mesh-ancestor
138783994|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138783995|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
138783996|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138557053|NCT00304135|Gemcitabine|gemcitabine|mesh-list
138783997|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138783998|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138783999|NCT02693392|Metformin|metformin|mesh-list
138784000|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138784001|NCT02693392|Fenugreek seed meal|fenugreek seed meal|mesh-list
138784002|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784003|NCT04175626|Sirolimus|sirolimus|mesh-list
138784004|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138784005|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784006|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138784007|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784008|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
138784009|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138784010|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
138784011|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784012|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
138784013|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
138784014|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784015|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138784016|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784017|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784018|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
138784019|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138784020|NCT00613132|Everolimus|everolimus|mesh-list
138784021|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
138784023|NCT00613132|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138784024|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138784025|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784026|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784027|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138784028|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
138784029|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784030|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784031|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
138784032|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138784033|NCT04558216|Rifampin|rifampin|mesh-list
138784034|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138784035|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
138784036|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138784037|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784038|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
138784039|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138784040|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784041|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784042|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138784043|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138784044|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138784045|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138784046|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138784047|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138784048|NCT04120870|Ketamine|ketamine|mesh-list
138784049|NCT04120870|Etomidate|etomidate|mesh-list
138784050|NCT04120870|Analgesics|analgesics|mesh-ancestor
138784051|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
138784052|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557146|NCT00082199|Aripiprazole|aripiprazole|mesh-list
138784053|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784054|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138784055|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138784056|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
138784057|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
138784058|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784059|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138784060|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138784061|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784062|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784063|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138784064|NCT03747562|Gabapentin|gabapentin|mesh-list
138784065|NCT03747562|Analgesics|analgesics|mesh-ancestor
138784066|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
138784067|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784068|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784069|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
138784070|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138784071|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138784072|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784073|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138784074|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138784075|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138784076|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784077|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784078|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
138784079|NCT01109849|Methylphenidate|methylphenidate|mesh-list
138784080|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
138784081|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784082|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138784083|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138784084|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138784085|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784086|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
138784087|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784088|NCT01061736|Folic Acid|folic acid|mesh-list
138784089|NCT01061736|Methotrexate|methotrexate|mesh-list
138784090|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138784091|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
138784092|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138784093|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784094|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138784095|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
138784096|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784097|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784098|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
138784099|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784100|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138784101|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138784102|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
138784103|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784104|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138784105|NCT01061736|Hematinics|hematinics|mesh-ancestor
138784106|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
138784107|NCT01061736|Vitamins|vitamins|mesh-ancestor
138784108|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
138554993|NCT00289510|Vaccines|vaccines|mesh-list
138784109|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
138784110|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138258683|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138784111|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784112|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784113|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138784114|NCT02874378|Analgesics|analgesics|mesh-ancestor
138784115|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
138784116|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784117|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138784118|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138784119|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138784120|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
138784121|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557222|NCT00082316|Capsaicin|capsaicin|mesh-list
138784122|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784123|NCT01117181|Methylphenidate|methylphenidate|mesh-list
138784124|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138784125|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784126|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138784127|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138784128|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138784129|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784130|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
138784131|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784132|NCT02881619|Etodolac|etodolac|mesh-list
138784133|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138784134|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138784135|NCT02881619|Analgesics|analgesics|mesh-ancestor
138784136|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
138784137|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784138|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784139|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138784140|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784141|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138784142|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138784143|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784144|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784145|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138784146|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138784147|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138784148|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
138784149|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784150|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138784151|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138784152|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784154|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138784155|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
138784156|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138784157|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784158|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138784159|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
138784160|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784161|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784162|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
138784163|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784164|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138784165|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138784166|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
138784167|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784168|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138784169|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
138784170|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138784171|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784172|NCT04303884|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138784173|NCT04303884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784174|NCT01040130|Olodaterol|olodaterol|mesh-list
138784175|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138784176|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
138784177|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784178|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784179|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138784180|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
138784181|NCT00932451|Crizotinib|crizotinib|mesh-list
138784182|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784183|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138784184|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784185|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784186|NCT05297682|Propofol|propofol|mesh-list
138784187|NCT05297682|Anesthetics|anesthetics|mesh-ancestor
138784188|NCT05297682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784189|NCT05297682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784190|NCT05297682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138784191|NCT05297682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138784192|NCT05297682|Anesthetics, General|anesthetics, general|mesh-ancestor
138784193|NCT01108055|Paclitaxel|paclitaxel|mesh-list
138784194|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138784195|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784196|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
138784197|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
138784198|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
138784199|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784200|NCT00609375|Cefepime|cefepime|mesh-list
138784201|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138784202|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784203|NCT01107899|Clopidogrel|clopidogrel|mesh-list
138784204|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138784205|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138784206|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138784207|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138784208|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138784209|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
138784210|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784211|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784212|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784213|NCT01107743|Amlodipine|amlodipine|mesh-list
138784214|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
138784215|NCT01107743|Atorvastatin|atorvastatin|mesh-list
138784216|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138784217|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138784218|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
138784219|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784220|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138557339|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138784221|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138784222|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784223|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138784224|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138784225|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138784226|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138784227|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784228|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
138784229|NCT01059864|Atorvastatin|atorvastatin|mesh-list
138784230|NCT01059864|Tofacitinib|tofacitinib|mesh-list
138784231|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138784232|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138784233|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
138784234|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784235|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138784236|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138784237|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784238|NCT01059864|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138784239|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138784240|NCT01035138|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
138784241|NCT01035138|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138784242|NCT01035138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784243|NCT01035138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784244|NCT03739840|Padsevonil|padsevonil|mesh-list
138784245|NCT03739840|Anticonvulsants|anticonvulsants|mesh-ancestor
138784246|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
138784247|NCT00613600|Cathartics|cathartics|mesh-ancestor
138784248|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138784249|NCT04302402|Rifaximin|rifaximin|mesh-list
138784250|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138784251|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138288951|NCT00521924|Chloroquine|chloroquine|mesh-list
138784252|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138784253|NCT03931408|Gentamicins|gentamicins|mesh-list
138784254|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138784255|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784256|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138557379|NCT00087945|Abacavir|abacavir|mesh-list
138784257|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784258|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784259|NCT03398824|Metformin|metformin|mesh-list
138784260|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138784261|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784262|NCT01033734|Oseltamivir|oseltamivir|mesh-list
138784263|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
138784264|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784265|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784266|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784267|NCT03792256|Cytarabine|cytarabine|mesh-list
138784268|NCT03792256|Prednisone|prednisone|mesh-list
138784269|NCT03792256|Prednisolone|prednisolone|mesh-list
138458707|NCT01935141|Growth Substances|growth substances|mesh-ancestor
138784270|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
138784271|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138784272|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138784273|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138784274|NCT03792256|Doxorubicin|doxorubicin|mesh-list
138784275|NCT03792256|Methotrexate|methotrexate|mesh-list
138784276|NCT03792256|Vincristine|vincristine|mesh-list
138784277|NCT03792256|Palbociclib|palbociclib|mesh-list
138784278|NCT03792256|Pegaspargase|pegaspargase|mesh-list
138784279|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138784280|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784281|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138784282|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138784283|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784284|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784285|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138784286|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
138784287|NCT03792256|Hormones|hormones|mesh-ancestor
138784288|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138784289|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784290|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138784291|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138784292|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
138784293|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138784294|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138784295|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
138784296|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
138784297|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138784298|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138784299|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
138784300|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784301|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138784302|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
138784303|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784304|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138784305|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
138784306|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
138784307|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
138784308|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138784309|NCT00613288|Testosterone|testosterone|mesh-list
138784310|NCT00613288|Androgens|androgens|mesh-ancestor
138784311|NCT00613288|Hormones|hormones|mesh-ancestor
138784312|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138784313|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784314|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
138784315|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138784316|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
138784317|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784318|NCT03711838|Expectorants|expectorants|mesh-ancestor
138784319|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
138784320|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138784321|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
138784322|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784323|NCT03711838|Protective Agents|protective agents|mesh-ancestor
138784324|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784325|NCT03711838|Antidotes|antidotes|mesh-ancestor
138784326|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
138784327|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
138784328|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138784329|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138784330|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784331|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784332|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784333|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784334|NCT01115855|Eplerenone|eplerenone|mesh-list
138784335|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138784336|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
138784337|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138784338|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784339|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138784340|NCT01115855|Diuretics|diuretics|mesh-ancestor
138784341|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
138784342|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138784343|NCT03615508|Phenylephrine|phenylephrine|mesh-list
138784344|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
138784345|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138784346|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
138784347|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
138784348|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784349|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784350|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
138784351|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138784352|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
138784353|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
138784354|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138784355|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138784356|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138784357|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
138784358|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784359|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784360|NCT03615508|Protective Agents|protective agents|mesh-ancestor
138784361|NCT02880995|Amisulpride|amisulpride|mesh-list
138784362|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138784363|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138784364|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784365|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258794|NCT02547623|Hormones|hormones|mesh-ancestor
138784366|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138784367|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138784368|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
138784369|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784370|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784371|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138784372|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
138784373|NCT03522064|Carboplatin|carboplatin|mesh-list
138784374|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
138784375|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138784376|NCT03522064|Testosterone|testosterone|mesh-list
138784377|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
138784378|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
138784379|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138555016|NCT00289861|Risperidone|risperidone|mesh-list
138784380|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784382|NCT03522064|Hormones|hormones|mesh-ancestor
138784383|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138784384|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784385|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138784386|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
138784387|NCT04310579|Midazolam|midazolam|mesh-list
138784388|NCT04310579|Oxycodone|oxycodone|mesh-list
138784389|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138784390|NCT04310579|Paroxetine|paroxetine|mesh-list
138784391|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138784392|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138784393|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784394|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784395|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138784396|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138784397|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138784398|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138784399|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
138784400|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
138784401|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
138784402|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
138784403|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784404|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784405|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138784406|NCT04310579|Narcotics|narcotics|mesh-ancestor
138784407|NCT04310579|Analgesics|analgesics|mesh-ancestor
138784408|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
138258807|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
138784410|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
138784411|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138784412|NCT04310579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138784413|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138784414|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138784415|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
138784416|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138784417|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138784418|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138784419|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784420|NCT05244538|Remifentanil|remifentanil|mesh-list
138784421|NCT05244538|Propofol|propofol|mesh-list
138784422|NCT05244538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138784423|NCT05244538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784424|NCT05244538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784425|NCT05244538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138784426|NCT05244538|Anesthetics, General|anesthetics, general|mesh-ancestor
138784427|NCT05244538|Anesthetics|anesthetics|mesh-ancestor
138784428|NCT05244538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138784429|NCT05244538|Narcotics|narcotics|mesh-ancestor
138784430|NCT05244538|Analgesics|analgesics|mesh-ancestor
138784431|NCT05244538|Sensory System Agents|sensory system agents|mesh-ancestor
138784432|NCT05244538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784433|NCT03638128|Denosumab|denosumab|mesh-list
138557644|NCT00308503|SR 46349B|sr 46349b|mesh-list
138784434|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138784435|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784436|NCT05345236|Aflibercept|aflibercept|mesh-list
138784437|NCT05345236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138784438|NCT05345236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138784439|NCT05345236|Growth Substances|growth substances|mesh-ancestor
138784440|NCT05345236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784441|NCT05345236|Growth Inhibitors|growth inhibitors|mesh-ancestor
138784442|NCT05345236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784443|NCT02692534|Cocaine|cocaine|mesh-list
138784444|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
138784445|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
138784446|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784447|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784448|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
138784449|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784450|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138784451|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138784452|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138784453|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138784454|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784455|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
138784456|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784457|NCT00614536|Rabeprazole|rabeprazole|mesh-list
138784458|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138784459|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138784460|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138557698|NCT00309049|Epothilones|epothilones|mesh-list
138784461|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289014|NCT04713644|Propofol|propofol|mesh-list
138784462|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784463|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
138784464|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
138784465|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138784466|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138784467|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784468|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784469|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784470|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784471|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138784473|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138784474|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
138784475|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784476|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784477|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138784478|NCT04142086|Vaccines|vaccines|mesh-list
138784479|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
138784480|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784481|NCT03664882|Fexofenadine|fexofenadine|mesh-list
138784482|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138557752|NCT04727502|Analgesics|analgesics|mesh-ancestor
138784483|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138784484|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138784485|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
138784486|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
138784487|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784488|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784489|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784490|NCT03903016|Insulin|insulin|mesh-list
138784491|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138784492|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
138784493|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138784494|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784495|NCT03514732|Melatonin|melatonin|mesh-list
138784496|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
138784497|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784498|NCT03514732|Protective Agents|protective agents|mesh-ancestor
138784499|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784500|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784501|NCT03800836|Paclitaxel|paclitaxel|mesh-list
138784502|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138784503|NCT03800836|Atezolizumab|atezolizumab|mesh-list
138784504|NCT03800836|Ipatasertib|ipatasertib|mesh-list
138784505|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138784506|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784507|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
138784508|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
138784509|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
138784510|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784511|NCT03800836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138784512|NCT03800836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138784513|NCT03800836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138784514|NCT03800836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784515|NCT00932373|Trastuzumab|trastuzumab|mesh-list
138784516|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138557792|NCT00121017|Ritonavir|ritonavir|mesh-list
138784517|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138784518|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784519|NCT00932373|Immunotoxins|immunotoxins|mesh-ancestor
138289053|NCT00000764|Isotretinoin|isotretinoin|mesh-list
138784520|NCT00932373|Immunoconjugates|immunoconjugates|mesh-ancestor
138784521|NCT00932373|Immunologic Factors|immunologic factors|mesh-ancestor
138784522|NCT00932373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784523|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
138784524|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
138784525|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
138784526|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784527|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
138784528|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138784529|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
138784530|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784531|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
138784532|NCT04265001|Protective Agents|protective agents|mesh-ancestor
138784533|NCT00608595|Celecoxib|celecoxib|mesh-list
138784534|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138784535|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138784536|NCT00608595|Analgesics|analgesics|mesh-ancestor
138784537|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
138784538|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784539|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784540|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138784541|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784542|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138784543|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138784544|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784545|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784546|NCT03761134|Metformin|metformin|mesh-list
138258900|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784547|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138784548|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138784549|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784550|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138784551|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784552|NCT01055496|Dexamethasone|dexamethasone|mesh-list
138784553|NCT01055496|Prednisone|prednisone|mesh-list
138784554|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
138784555|NCT01055496|Rituximab|rituximab|mesh-list
138784556|NCT01055496|Gemcitabine|gemcitabine|mesh-list
138784557|NCT01055496|Vincristine|vincristine|mesh-list
138784558|NCT01055496|Cisplatin|cisplatin|mesh-list
138784559|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138784560|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138784561|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
138784562|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784563|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784564|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138784565|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
138784566|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784567|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784568|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138784569|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138784570|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
138784571|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
138784572|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784573|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138784574|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
138784576|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138784577|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138784578|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138784579|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138784580|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
138784581|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138784582|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
138784583|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
138784585|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138784586|NCT01055496|Immunotoxins|immunotoxins|mesh-ancestor
138784587|NCT01055496|Immunoconjugates|immunoconjugates|mesh-ancestor
138784589|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138784590|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
138784591|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
138784592|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138784593|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138784594|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784595|NCT00609531|Citalopram|citalopram|mesh-list
138784596|NCT00609531|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138557870|NCT00309790|Urological Agents|urological agents|mesh-ancestor
138784597|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138784598|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138784599|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784600|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784601|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
138784602|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784603|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138784604|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
138784605|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138784606|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
138784607|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138784608|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784609|NCT01052844|Gabapentin|gabapentin|mesh-list
138784610|NCT01052844|Analgesics|analgesics|mesh-ancestor
138784611|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
138784612|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784613|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784614|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
138784615|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138784616|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138784617|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784618|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138784619|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138784620|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138784621|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784622|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784623|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
138557904|NCT00088686|Capsaicin|capsaicin|mesh-list
138784624|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
138784625|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138784626|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784627|NCT02584426|Cefazolin|cefazolin|mesh-list
138784628|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138784629|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784630|NCT00934089|Latanoprost|latanoprost|mesh-list
138784631|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138784632|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138784633|NCT01032174|Azithromycin|azithromycin|mesh-list
138784634|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138784635|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784636|NCT02704780|Misoprostol|misoprostol|mesh-list
138784637|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138258963|NCT02505269|Immunotoxins|immunotoxins|mesh-ancestor
138784638|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
138784639|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138784640|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784641|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138784642|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138784643|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
138784644|NCT02704546|Methylphenidate|methylphenidate|mesh-list
138459081|NCT06070701|Morphine|morphine|mesh-list
138784645|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138784646|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784647|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138784648|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138784649|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138784650|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784651|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
138784652|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784653|NCT01032018|Bupropion|bupropion|mesh-list
138784654|NCT01032018|Citalopram|citalopram|mesh-list
138784655|NCT01032018|Sertraline|sertraline|mesh-list
138784656|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138784657|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
138784658|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138784659|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138784660|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138784661|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138557948|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
138784662|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784663|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
138784664|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784665|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784666|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138784667|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138784668|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784669|NCT01032018|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138784670|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
138784671|NCT00927069|Adalimumab|adalimumab|mesh-list
138784672|NCT00927069|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138784673|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138784674|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784675|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
138784676|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784677|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138784678|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784679|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784680|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
138784681|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784682|NCT00608673|Betamethasone|betamethasone|mesh-list
138784683|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
138784684|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138784685|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
138784686|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
138784687|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138784688|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138784689|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
138784691|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138784692|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784693|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138289106|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138784694|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
138784695|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138784696|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138784697|NCT00608673|Analgesics|analgesics|mesh-ancestor
138784698|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
138784699|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784700|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784701|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
138784702|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138784703|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
138784704|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138784705|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784706|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784707|NCT04263519|Tacrolimus|tacrolimus|mesh-list
138784708|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138784709|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
138784710|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784711|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138784712|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784713|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784714|NCT00637767|Melphalan|melphalan|mesh-list
138784715|NCT00637767|Antibodies|antibodies|mesh-list
138259020|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
138784716|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138784717|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
138784718|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784719|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138784720|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
138784721|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784722|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784723|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138784724|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138784725|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138784727|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784728|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138784729|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784730|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784731|NCT00627250|Amantadine|amantadine|mesh-list
138784732|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138784733|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138784734|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
138784735|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784736|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
138784737|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784738|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784739|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784740|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138784741|NCT00627250|Analgesics|analgesics|mesh-ancestor
138784742|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
138784743|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784744|NCT04300374|Anesthetics|anesthetics|mesh-list
138784745|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784746|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784747|NCT02703376|Prednisone|prednisone|mesh-list
138784748|NCT02703376|Prednisolone|prednisolone|mesh-list
138784749|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138784750|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
138784751|NCT02703376|Hormones|hormones|mesh-ancestor
138784752|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138784753|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784754|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138784755|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784756|NCT00610077|Letrozole|letrozole|mesh-list
138784757|NCT00610077|Clomiphene|clomiphene|mesh-list
138784758|NCT00610077|Enclomiphene|enclomiphene|mesh-list
138784759|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
138453621|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784760|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784761|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784762|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138784763|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138784770|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
138784771|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138784772|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138784773|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138784775|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
138784776|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
138784777|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784778|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784779|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
138784780|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784781|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138459235|NCT06041282|Anesthetics|anesthetics|mesh-list
138459236|NCT06041282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138459237|NCT06041282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459238|NCT06037135|Dexmedetomidine|dexmedetomidine|mesh-list
138459239|NCT06037135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138555052|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138784782|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138784783|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138784784|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138784785|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784786|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784787|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784789|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
138784790|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784791|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
138784792|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138784793|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
138784794|NCT03172780|Diclofenac|diclofenac|mesh-list
138784795|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138784796|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138784798|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
138784799|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784800|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784801|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138453627|NCT01886209|Protective Agents|protective agents|mesh-ancestor
138784802|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784803|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138784804|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784805|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784806|NCT05011617|Anesthetics|anesthetics|mesh-list
138784807|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784808|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784809|NCT00926367|Clindamycin|clindamycin|mesh-list
138784810|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
138784811|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
138784812|NCT00926367|Adapalene|adapalene|mesh-list
138784813|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138784814|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138784815|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784816|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138784817|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784818|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784819|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
138784820|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138784821|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138784822|NCT00926367|Analgesics|analgesics|mesh-ancestor
138784823|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
138784824|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784825|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784826|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138784827|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784828|NCT04261023|Abatacept|abatacept|mesh-list
138784829|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138784830|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784831|NCT04261023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138784832|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784833|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138784834|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
138784835|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784836|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784837|NCT01114529|Cyclosporine|cyclosporine|mesh-list
138784838|NCT01114529|Everolimus|everolimus|mesh-list
138784839|NCT01114529|Tacrolimus|tacrolimus|mesh-list
138784840|NCT01114529|Cyclosporins|cyclosporins|mesh-list
138784841|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138784842|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
138784843|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784844|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138784845|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784846|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784847|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
138784848|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138784849|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
138784850|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138784851|NCT01114529|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138784852|NCT01114529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138784853|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784855|NCT00926289|Telmisartan|telmisartan|mesh-list
138453648|NCT01886443|Infliximab|infliximab|mesh-list
138784856|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138784857|NCT00926289|Diuretics|diuretics|mesh-ancestor
138784858|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
138784859|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784860|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138784861|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138784862|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784863|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138784864|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138784865|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
138784866|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138784867|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
138784868|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
138784869|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138784871|NCT04309643|Estrogens|estrogens|mesh-ancestor
138784872|NCT04309643|Hormones|hormones|mesh-ancestor
138558183|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138784873|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138784874|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784875|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138784876|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138784877|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138784878|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138784879|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138784880|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138784881|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138784882|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138784883|NCT04259073|Pregabalin|pregabalin|mesh-list
138784884|NCT04259073|Analgesics|analgesics|mesh-ancestor
138784885|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
138784886|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784887|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784888|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
138784889|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138259137|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784890|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138784891|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784892|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138784893|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138784894|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138784895|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784896|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138784897|NCT00609063|Atorvastatin|atorvastatin|mesh-list
138784898|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138784899|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138784900|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
138784901|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784902|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138784903|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138784904|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138784905|NCT02703064|Fenugreek seed meal|fenugreek seed meal|mesh-list
138784906|NCT02703064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138784907|NCT02703064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784908|NCT01114373|Melatonin|melatonin|mesh-list
138784909|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
138784910|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784911|NCT01114373|Protective Agents|protective agents|mesh-ancestor
138784912|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784913|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784914|NCT00925899|Melatonin|melatonin|mesh-list
138784915|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
138784916|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784917|NCT00925899|Protective Agents|protective agents|mesh-ancestor
138784918|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784919|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784921|NCT02601586|Levodopa|levodopa|mesh-list
138784922|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138784923|NCT02601586|Narcotics|narcotics|mesh-ancestor
138784924|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138784925|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784926|NCT02601586|Analgesics|analgesics|mesh-ancestor
138784927|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
138784928|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784929|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138784930|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138784932|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784933|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784934|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138784935|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
138784936|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784937|NCT00610389|Immunomodulating Agents|immunomodulating agents|mesh-list
138784938|NCT00610389|Immunologic Factors|immunologic factors|mesh-ancestor
138784939|NCT00610389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784940|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138784941|NCT01114217|Hematinics|hematinics|mesh-ancestor
138784942|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138784943|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138784944|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
138784945|NCT01030536|Immunotoxins|immunotoxins|mesh-ancestor
138784946|NCT01030536|Immunoconjugates|immunoconjugates|mesh-ancestor
138784947|NCT01030536|Immunologic Factors|immunologic factors|mesh-ancestor
138784948|NCT01030536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784949|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138784950|NCT01030458|Amlodipine|amlodipine|mesh-list
138784951|NCT01030458|Valsartan|valsartan|mesh-list
138784952|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138784953|NCT01030458|Bisoprolol|bisoprolol|mesh-list
138784954|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138784955|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138784956|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138784957|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784958|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138784959|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784960|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
138784961|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138784962|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138784963|NCT01030458|Diuretics|diuretics|mesh-ancestor
138784964|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
138784965|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138784966|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
138784967|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
138784968|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138784969|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138784970|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138784971|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138784972|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
138784973|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784974|NCT02702674|Propranolol|propranolol|mesh-list
138784975|NCT02702674|Oxytocin|oxytocin|mesh-list
138784976|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
138259193|NCT01834261|Oxytocin|oxytocin|mesh-list
138784977|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138784978|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784979|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138784980|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138784981|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
138784982|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138784983|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784984|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138784985|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138784986|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
138784987|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138784988|NCT01114139|Hematinics|hematinics|mesh-ancestor
138555070|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
138784989|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138784990|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138784992|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
138784993|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138784994|NCT01027884|Protective Agents|protective agents|mesh-ancestor
138784995|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784996|NCT02699008|Clopidogrel|clopidogrel|mesh-list
138784997|NCT02699008|Ticagrelor|ticagrelor|mesh-list
138784998|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138784999|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138785000|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138785001|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138785002|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
138459456|NCT05628038|Antidotes|antidotes|mesh-ancestor
138785003|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785004|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785005|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785006|NCT00627666|Leucovorin|leucovorin|mesh-list
138785007|NCT00627666|Methotrexate|methotrexate|mesh-list
138785008|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
138785009|NCT00627666|Fludarabine|fludarabine|mesh-list
138785010|NCT00627666|Busulfan|busulfan|mesh-list
138785011|NCT00627666|Calcium|calcium|mesh-list
138785012|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138785013|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
138785014|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138785015|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785016|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138785017|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
138785018|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138785019|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138785020|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
138785021|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785022|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259231|NCT03528941|Lamivudine|lamivudine|mesh-list
138785023|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
138785024|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785025|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138785026|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138785027|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
138785028|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138785029|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138785030|NCT00627666|Antidotes|antidotes|mesh-ancestor
138785031|NCT00627666|Protective Agents|protective agents|mesh-ancestor
138785032|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
138785033|NCT00627666|Vitamins|vitamins|mesh-ancestor
138785034|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
138785035|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
138785036|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138785037|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138785038|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138785039|NCT01022580|Calfactant|calfactant|mesh-list
138785040|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
138785041|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
138785042|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138785043|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138785044|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785045|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138453700|NCT01886638|Abacavir|abacavir|mesh-list
138785046|NCT02698930|Analgesics|analgesics|mesh-ancestor
138785047|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
138785048|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785049|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138785050|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138785051|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138558377|NCT00293371|Prednisone|prednisone|mesh-list
138785052|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
138785053|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785054|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785056|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138785057|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
138785058|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138785059|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138785060|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138785061|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138785062|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785063|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
138785064|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785065|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785066|NCT02702206|Triamcinolone|triamcinolone|mesh-list
138785067|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
138785068|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138785069|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
138785070|NCT02702206|Hormones|hormones|mesh-ancestor
138785071|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785072|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785073|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
138785074|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138785075|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
138785076|NCT02702206|Protective Agents|protective agents|mesh-ancestor
138785077|NCT04216186|Ubiquinone|ubiquinone|mesh-list
138785078|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
138785079|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138785080|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138785081|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138785082|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138785083|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785084|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
138785085|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785086|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785087|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
138785089|NCT01989598|Trametinib|trametinib|mesh-list
138785090|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785091|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138785092|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785093|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785094|NCT04214938|Lidocaine|lidocaine|mesh-list
138785095|NCT04214938|Xylometazoline|xylometazoline|mesh-list
138785096|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
138785097|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
138785098|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138785099|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785100|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
138785101|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785102|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138785103|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138785104|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138785105|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138785106|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785107|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
138785108|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138785109|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
138785110|NCT00615160|Dacarbazine|dacarbazine|mesh-list
138785111|NCT00615160|Vatalanib|vatalanib|mesh-list
138785112|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138785113|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
138785114|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785115|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785116|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138785117|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785118|NCT01112267|Acetaminophen|acetaminophen|mesh-list
138785119|NCT01112267|Tramadol|tramadol|mesh-list
138785120|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138785121|NCT01112267|Analgesics|analgesics|mesh-ancestor
138785122|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
138785123|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785124|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785125|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
138785126|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138785127|NCT01112267|Narcotics|narcotics|mesh-ancestor
138785128|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138785129|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
138785130|NCT00925587|Hematinics|hematinics|mesh-ancestor
138785131|NCT02698306|Dexamethasone|dexamethasone|mesh-list
138785132|NCT02698306|Diclofenac|diclofenac|mesh-list
138785133|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138785134|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
138785135|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
138785136|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785137|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785138|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138785139|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
138785140|NCT02698306|Hormones|hormones|mesh-ancestor
138785141|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785142|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138785143|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785144|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138785145|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138785146|NCT02698306|Analgesics|analgesics|mesh-ancestor
138558563|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
138785147|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
138785148|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138785149|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138785150|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785151|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785152|NCT02698228|Morphine|morphine|mesh-list
138785153|NCT02698228|Bupivacaine|bupivacaine|mesh-list
138785154|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
138785155|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
138785156|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138785157|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785158|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
138785159|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785160|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138785161|NCT02698228|Narcotics|narcotics|mesh-ancestor
138785162|NCT02698228|Analgesics|analgesics|mesh-ancestor
138785163|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
138785164|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138785165|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138785166|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785167|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
138785168|NCT02702128|Coagulants|coagulants|mesh-ancestor
138785169|NCT00610545|Atorvastatin|atorvastatin|mesh-list
138785170|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138785171|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138785172|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
138785173|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785174|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138785175|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138785176|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785177|NCT00193414|Gemcitabine|gemcitabine|mesh-list
138785179|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138785180|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
138785181|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785182|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785183|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785184|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138785185|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138785186|NCT04260711|Interferons|interferons|mesh-list
138785187|NCT04260711|Teriflunomide|teriflunomide|mesh-list
138785188|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
138785189|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138785190|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
138785191|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785192|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
138785193|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138785194|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138785195|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
138785196|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785197|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138785198|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138785199|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138785200|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138785201|NCT04260711|Analgesics|analgesics|mesh-ancestor
138785202|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
138785203|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785204|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138785205|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
138785206|NCT00610623|Azithromycin|azithromycin|mesh-list
138785207|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138785208|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138785209|NCT02697838|Paclitaxel|paclitaxel|mesh-list
138785210|NCT02697838|Apatinib|apatinib|mesh-list
138785211|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138785212|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785213|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
138785214|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
138785215|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
138785216|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785217|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138785218|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785219|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
138785220|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
138785221|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785222|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
138785223|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785224|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785225|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138785226|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138785227|NCT04956705|Vitamin D|vitamin d|mesh-list
138785228|NCT04956705|Calcium|calcium|mesh-list
138785229|NCT04956705|Vitamins|vitamins|mesh-ancestor
138785230|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
138785231|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785232|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138785233|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138785235|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138785236|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785237|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138785238|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785239|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138785240|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
138785242|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785243|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785244|NCT04951323|Vaccines|vaccines|mesh-list
138785245|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
138785246|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785247|NCT02705872|Sufentanil|sufentanil|mesh-list
138785248|NCT02705872|Dsuvia|dsuvia|mesh-list
138785249|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
138785250|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138785251|NCT02705872|Narcotics|narcotics|mesh-ancestor
138785252|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138785253|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785254|NCT02705872|Analgesics|analgesics|mesh-ancestor
138785255|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
138785256|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785257|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138785258|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138785259|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
138785260|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
138785261|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
138785262|NCT02701348|Letrozole|letrozole|mesh-list
138785263|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138785264|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785265|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138785266|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785267|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785268|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138785269|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
138785270|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785271|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785272|NCT05324800|Turmeric extract|turmeric extract|mesh-list
138785273|NCT05324800|Antioxidants|antioxidants|mesh-ancestor
138558827|NCT00089856|Prednisone|prednisone|mesh-list
138785274|NCT05324800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785275|NCT05324800|Protective Agents|protective agents|mesh-ancestor
138785276|NCT05324800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785277|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
138785278|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138785279|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785280|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138785281|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785282|NCT00930579|Metformin|metformin|mesh-list
138785283|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138785284|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785285|NCT02700568|Axitinib|axitinib|mesh-list
138785286|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785287|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138785288|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785289|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785290|NCT00925353|Lidocaine|lidocaine|mesh-list
138785291|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
138785292|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
138785293|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138785294|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785295|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
138785296|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785297|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138555135|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785298|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138785299|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138785300|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138785301|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138459756|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138785303|NCT02705482|Tremelimumab|tremelimumab|mesh-list
138785304|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138785305|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785307|NCT02705638|Lenalidomide|lenalidomide|mesh-list
138785308|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138785309|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785310|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
138785311|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785312|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138785313|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138785314|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138785315|NCT02705638|Growth Substances|growth substances|mesh-ancestor
138785316|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
138785317|NCT02691910|Chloroquine|chloroquine|mesh-list
138785318|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138785319|NCT02691910|Primaquine|primaquine|mesh-list
138785320|NCT02691910|Amebicides|amebicides|mesh-ancestor
138785321|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138785322|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138785323|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138785324|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
138558943|NCT00296959|Topiramate|topiramate|mesh-list
138785325|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138785326|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138785327|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138785328|NCT02691910|Analgesics|analgesics|mesh-ancestor
138785329|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
138785330|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785331|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785332|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138785333|NCT02691910|Filaricides|filaricides|mesh-ancestor
138785334|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
138785335|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
138785336|NCT02705014|Hormones|hormones|mesh-list
138785337|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785338|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785339|NCT02704624|Vitamin D|vitamin d|mesh-list
138785340|NCT02704624|Vitamins|vitamins|mesh-ancestor
138785341|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
138785342|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558971|NCT00297466|Nicotine|nicotine|mesh-list
138785343|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138785344|NCT02700022|Prednisone|prednisone|mesh-list
138785345|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
138785346|NCT02700022|Doxorubicin|doxorubicin|mesh-list
138785347|NCT02700022|Etoposide|etoposide|mesh-list
138785348|NCT02700022|Vincristine|vincristine|mesh-list
138785349|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138785350|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
138785351|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785352|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138785353|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138785354|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
138649749|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138785355|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785356|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785357|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138785358|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138785359|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138785360|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138785361|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785362|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138785363|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
138785365|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785366|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138785367|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138559045|NCT00090246|Aprepitant|aprepitant|mesh-list
138785368|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
138315669|NCT01524198|Budesonide|budesonide|mesh-list
138785369|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
138785370|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
138785371|NCT02699710|Folic Acid|folic acid|mesh-list
138785372|NCT02699710|Methotrexate|methotrexate|mesh-list
138785373|NCT02699710|Rabeprazole|rabeprazole|mesh-list
138785374|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138785375|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
138785376|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138785377|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459845|NCT04759664|LUT014|lut014|mesh-list
138785378|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138785379|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
138785380|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785381|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785382|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
138785383|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785384|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138785385|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138785386|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
138785387|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138785388|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138785390|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
138785392|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
138785393|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138785394|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138785395|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138785396|NCT03140488|Oxytocin|oxytocin|mesh-list
138785397|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
138785398|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138785399|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785400|NCT00616408|Octreotide|octreotide|mesh-list
138785401|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138785402|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138785403|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785404|NCT02691754|Acetaminophen|acetaminophen|mesh-list
138785405|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138785406|NCT02691754|Analgesics|analgesics|mesh-ancestor
138785407|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
138785408|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785409|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785410|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
138785411|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
138785412|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138785413|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138785414|NCT05321602|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138785415|NCT05321602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138785416|NCT05321602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138785417|NCT05321602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138785418|NCT05321602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785419|NCT05321602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138785420|NCT05321602|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138785421|NCT05321602|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138785422|NCT05321602|Serotonin Agents|serotonin agents|mesh-ancestor
138785423|NCT05321602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785424|NCT05321602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785425|NCT05321602|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138785426|NCT05321602|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138785427|NCT05321602|Dopamine Agents|dopamine agents|mesh-ancestor
138785428|NCT01106651|Canagliflozin|canagliflozin|mesh-list
138785429|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138785430|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138785431|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785432|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785433|NCT00637078|Amlodipine|amlodipine|mesh-list
138785434|NCT00637078|Spironolactone|spironolactone|mesh-list
138785435|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138785436|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138785437|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138785438|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555148|NCT00290836|Thrombin|thrombin|mesh-list
138785439|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138785440|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785441|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
138785442|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138785443|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
138785444|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785445|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138785446|NCT00637078|Diuretics|diuretics|mesh-ancestor
138785447|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
138785448|NCT00625781|Insulin|insulin|mesh-list
138785449|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138785450|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
138785451|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138785452|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785453|NCT01027650|Dexamethasone|dexamethasone|mesh-list
138785454|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138785455|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
138785456|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
138785457|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785458|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785459|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138785460|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
138785461|NCT01027650|Hormones|hormones|mesh-ancestor
138785462|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785463|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138785464|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785465|NCT00616876|Lactulose|lactulose|mesh-list
138785466|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138785467|NCT01106027|Eculizumab|eculizumab|mesh-list
138785468|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138785469|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138785470|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
138785471|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785472|NCT01027416|Tamoxifen|tamoxifen|mesh-list
138785473|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138785474|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
138785475|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785476|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785477|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138785478|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785479|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138785480|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138785481|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138785482|NCT02873520|Immunomodulating Agents|immunomodulating agents|mesh-list
138785483|NCT02873520|Immunologic Factors|immunologic factors|mesh-ancestor
138785484|NCT02873520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785485|NCT05026203|Midazolam|midazolam|mesh-list
138785486|NCT05026203|Ketamine|ketamine|mesh-list
138785487|NCT05026203|Analgesics|analgesics|mesh-ancestor
138785488|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
138785489|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559214|NCT00323011|Fluorouracil|fluorouracil|mesh-list
138785490|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785491|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138785492|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138785493|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
138785494|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
138785495|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138785496|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138785497|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138785498|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785499|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785500|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138785501|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138785502|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138785503|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138785504|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138785505|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
138785506|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
138785507|NCT01015638|Clindamycin|clindamycin|mesh-list
138785508|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
138785509|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
138785510|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138785511|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138785512|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138235593|NCT02651259|Vitamins|vitamins|mesh-list
138785513|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138785514|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785515|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785516|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
138785517|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138785518|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138785519|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785520|NCT00627744|Incretins|incretins|mesh-ancestor
138785521|NCT00627744|Hormones|hormones|mesh-ancestor
138785522|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785523|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138785524|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
138785525|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785526|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785527|NCT01105091|Epoprostenol|epoprostenol|mesh-list
138785528|NCT01105091|Tezosentan|tezosentan|mesh-list
138785529|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138785530|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138785531|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
138785532|NCT00628056|Perhexiline|perhexiline|mesh-list
138785533|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138785534|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138785535|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785536|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138785537|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785538|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
138785539|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
138785540|NCT00924729|Besifloxacin|besifloxacin|mesh-list
138785541|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138785542|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138785543|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138785544|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138785545|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138785546|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138785547|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785548|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785549|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785551|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138785552|NCT01099709|Narcotics|narcotics|mesh-ancestor
138785553|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138785554|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785555|NCT01099709|Analgesics|analgesics|mesh-ancestor
138785556|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
138785557|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785558|NCT04907019|Rifampin|rifampin|mesh-list
138785559|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138785560|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
138785561|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138785562|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138785563|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
138785564|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138785565|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785566|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785567|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138785568|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138785569|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138785570|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138785571|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138785572|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138785573|NCT01022424|Tolvaptan|tolvaptan|mesh-list
138785574|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138785575|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785576|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
138785577|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785578|NCT05329857|Metformin|metformin|mesh-list
138785580|NCT05329857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138453829|NCT01887561|Dasatinib|dasatinib|mesh-list
138785581|NCT05329857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785582|NCT05329857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138785583|NCT05329857|Protease Inhibitors|protease inhibitors|mesh-ancestor
138785584|NCT05329857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785585|NCT05329857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785586|NCT01026948|Dinoprostone|dinoprostone|mesh-list
138785587|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
138785588|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138785589|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785590|NCT01104779|Cariprazine|cariprazine|mesh-list
138785591|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138785592|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138785593|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138785594|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785595|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138785597|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138785598|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138785599|NCT04308161|Vitamin D|vitamin d|mesh-list
138785600|NCT04308161|Miconazole|miconazole|mesh-list
138785601|NCT04308161|Vitamins|vitamins|mesh-ancestor
138785602|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
138785603|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785604|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138785605|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
138785606|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138785607|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138785608|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138785609|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785610|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785611|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138785612|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
138785613|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785614|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138785615|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138785616|NCT04939467|Pirfenidone|pirfenidone|mesh-list
138785617|NCT04939467|Nintedanib|nintedanib|mesh-list
138785618|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785619|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138785620|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785621|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785622|NCT04939467|Analgesics|analgesics|mesh-ancestor
138785623|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
138785624|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785625|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785626|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138785627|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138785628|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138785629|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138785630|NCT01015560|Antibodies|antibodies|mesh-list
138785631|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138559443|NCT06001619|Tamsulosin|tamsulosin|mesh-list
138785632|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
138785633|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785634|NCT04253223|Volagidemab|volagidemab|mesh-list
138785635|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138785636|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785637|NCT00918879|Saxagliptin|saxagliptin|mesh-list
138785638|NCT00918879|Incretins|incretins|mesh-ancestor
138785639|NCT00918879|Hormones|hormones|mesh-ancestor
138785640|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785641|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785642|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138785643|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
138785644|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785645|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785646|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138785647|NCT01026792|Sirolimus|sirolimus|mesh-list
138785648|NCT01026792|Temsirolimus|temsirolimus|mesh-list
138785649|NCT01026792|MTOR Inhibitors|mtor inhibitors|mesh-list
138785650|NCT01026792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138785651|NCT01026792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785652|NCT01026792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785653|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138785654|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
138785655|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785656|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785657|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138785658|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138785659|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138785660|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
138785661|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
138785662|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138785663|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559486|NCT06001125|Immunologic Factors|immunologic factors|mesh-ancestor
138785664|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785665|NCT04300686|Adalimumab|adalimumab|mesh-list
138785666|NCT04300686|Antibodies|antibodies|mesh-list
138785667|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
138785668|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
138785669|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785670|NCT04300686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138785671|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138785672|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138785673|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138785674|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
138785675|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138785676|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785677|NCT01098539|Incretins|incretins|mesh-ancestor
138785678|NCT01098539|Hormones|hormones|mesh-ancestor
138785679|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785680|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138785681|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
138785682|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785683|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785684|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
138785685|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138785686|NCT01098461|Incretins|incretins|mesh-ancestor
138785687|NCT01098461|Hormones|hormones|mesh-ancestor
138785688|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785689|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785690|NCT01098305|Varenicline|varenicline|mesh-list
138785691|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138785692|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138785693|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
138785694|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785695|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785696|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785697|NCT00833833|Aspirin|aspirin|mesh-list
138785698|NCT00833833|Dexamethasone|dexamethasone|mesh-list
138785699|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
138785700|NCT00833833|Pomalidomide|pomalidomide|mesh-list
138785701|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138785702|NCT00833833|BB 1101|bb 1101|mesh-list
138785703|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138785704|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
138785705|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
138785706|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785707|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785708|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138785709|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
138785710|NCT00833833|Hormones|hormones|mesh-ancestor
138785711|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785712|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138785714|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
138785715|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785716|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785717|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138785718|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138785719|NCT00833833|Analgesics|analgesics|mesh-ancestor
138785720|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
138785721|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138785722|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138785723|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138785724|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138785725|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138785726|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
138785727|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
138785728|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138785729|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138785730|NCT00833833|Growth Substances|growth substances|mesh-ancestor
138785731|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
138785732|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
138559628|NCT05998551|Analgesics|analgesics|mesh-ancestor
138785733|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138785734|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
138785735|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138785736|NCT02612545|Piperaquine|piperaquine|mesh-list
138785737|NCT02612545|Artenimol|artenimol|mesh-list
138785738|NCT02612545|Mefloquine|mefloquine|mesh-list
138785739|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
138785740|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138785741|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138785742|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138785743|NCT00704743|Calpastatin|calpastatin|mesh-list
138785744|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138785745|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
138785746|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785747|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785748|NCT01097057|Plerixafor|plerixafor|mesh-list
138785749|NCT01097057|Rituximab|rituximab|mesh-list
138785750|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138785751|NCT01097057|Carboplatin|carboplatin|mesh-list
138785752|NCT01097057|Etoposide|etoposide|mesh-list
138460204|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
138785753|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
138785754|NCT01097057|Ifosfamide|ifosfamide|mesh-list
138785755|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
138785756|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
138785757|NCT01097057|Antibodies|antibodies|mesh-list
138785758|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
138785759|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138785760|NCT01097057|Lenograstim|lenograstim|mesh-list
138785761|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
138785762|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785763|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785764|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138785765|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138785766|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138785767|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138785768|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785769|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785770|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138785771|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138785772|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
138785773|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138785774|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138785775|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
138785776|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138785777|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
138785778|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
138785779|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
138785780|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
138785781|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
138785783|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138785784|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
138785785|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785786|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785787|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138785788|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138785789|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
138785790|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785791|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785792|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
138785793|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138785794|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138785795|NCT01096667|Diuretics|diuretics|mesh-ancestor
138785797|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785798|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138785799|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138785800|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785801|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138785802|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138785803|NCT01014624|Clopidogrel|clopidogrel|mesh-list
138785804|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138785805|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138785806|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138785807|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138785808|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138785809|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
138785810|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785811|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785812|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785813|NCT01021878|Icodextrin|icodextrin|mesh-list
138785814|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
138785815|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138785816|NCT02872428|Valproic Acid|valproic acid|mesh-list
138785817|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
138785818|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785819|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785820|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
138785821|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559851|NCT05996393|Antifungal Agents|antifungal agents|mesh-ancestor
138785822|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785823|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
138785824|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138785825|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138785826|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138785827|NCT02873364|Vitamin D|vitamin d|mesh-list
138785828|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
138785829|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
138785831|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
138785832|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785833|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138785834|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138785835|NCT00628290|Cannabidiol|cannabidiol|mesh-list
138559911|NCT05990985|Hormones|hormones|mesh-ancestor
138785836|NCT00628290|Amisulpride|amisulpride|mesh-list
138785837|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
138785838|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138785839|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138259612|NCT02605187|Acetaminophen|acetaminophen|mesh-list
138785840|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138785841|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785842|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138785843|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138785844|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
138785845|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785846|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785847|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138785848|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
138785849|NCT04559412|Etanercept|etanercept|mesh-list
138785850|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138785851|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138785852|NCT04559412|Analgesics|analgesics|mesh-ancestor
138785853|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
138785854|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785855|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785856|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138785857|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138785858|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138785859|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138785860|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
138785861|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138785862|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785863|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138555174|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785864|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785865|NCT02872584|Prednisone|prednisone|mesh-list
138785866|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138555217|NCT00291382|Xhance|xhance|mesh-list
138785867|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
138785868|NCT02872584|Hormones|hormones|mesh-ancestor
138785869|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138785870|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785871|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138785872|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785873|NCT00704821|Docetaxel|docetaxel|mesh-list
138785874|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785875|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
138785876|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
138785877|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
138785878|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785879|NCT00704899|Amitriptyline|amitriptyline|mesh-list
138785880|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138785881|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
138785882|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138785883|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138316979|NCT04504669|Durvalumab|durvalumab|mesh-list
138785884|NCT00704899|Analgesics|analgesics|mesh-ancestor
138259644|NCT02989207|Mitomycins|mitomycins|mesh-list
138785885|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
138785886|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785887|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785888|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138785889|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138785890|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138785891|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785892|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
138785893|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785894|NCT01104701|Exenatide|exenatide|mesh-list
138785895|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138785896|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785897|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138785898|NCT01104701|Incretins|incretins|mesh-ancestor
138785899|NCT01104701|Hormones|hormones|mesh-ancestor
138785900|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460354|NCT03735628|Nivolumab|nivolumab|mesh-list
138785901|NCT00833755|Ketamine|ketamine|mesh-list
138785902|NCT00833755|Analgesics|analgesics|mesh-ancestor
138785903|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
138785904|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785905|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785907|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138785908|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
138785909|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
138785910|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138785911|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138785912|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138785913|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785914|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785915|NCT01021332|Tamsulosin|tamsulosin|mesh-list
138785916|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
138785917|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138785918|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138785919|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138785920|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
138785921|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785922|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785923|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785924|NCT01021332|Urological Agents|urological agents|mesh-ancestor
138785925|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138785926|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138785927|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
138785928|NCT00923091|Amlodipine|amlodipine|mesh-list
138785930|NCT00923091|Olmesartan|olmesartan|mesh-list
138785931|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138785932|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
138785933|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138785934|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138785935|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138785936|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785937|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138785938|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785939|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
138785940|NCT00923091|Diuretics|diuretics|mesh-ancestor
138785941|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
138785942|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138555624|NCT00129727|Bevacizumab|bevacizumab|mesh-list
138785943|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138785945|NCT00853957|Amlodipine|amlodipine|mesh-list
138785946|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138785947|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138785948|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138785949|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785950|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138785951|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785952|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
138785953|NCT01021020|Colchicine|colchicine|mesh-list
138785954|NCT01021020|Probenecid|probenecid|mesh-list
138785955|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
138785956|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138785957|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
138785958|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
138785959|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
138785960|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785961|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785962|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
138785963|NCT00833053|Infliximab|infliximab|mesh-list
138785964|NCT00833053|Methotrexate|methotrexate|mesh-list
138453893|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138785965|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138785966|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
138785967|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138785968|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785969|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138785971|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138785972|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785973|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
138460427|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
138785974|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785975|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138785976|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138785977|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
138785978|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138555907|NCT00299884|Atorvastatin|atorvastatin|mesh-list
138785979|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138785980|NCT00833053|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138785982|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138785983|NCT01020786|Carboplatin|carboplatin|mesh-list
138785984|NCT01020786|Pemetrexed|pemetrexed|mesh-list
138785985|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785986|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785987|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259698|NCT00552175|Analgesics|analgesics|mesh-ancestor
138785988|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138785989|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138785991|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138785992|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785994|NCT01020474|Analgesics|analgesics|mesh-ancestor
138785995|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
138785996|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785997|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785998|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
138785999|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138786000|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138786001|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786002|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138786003|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138786004|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138786005|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138786006|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138786007|NCT02872818|Metformin|metformin|mesh-list
138786008|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138786009|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138786010|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138786011|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
138786012|NCT02872818|Estradiol|estradiol|mesh-list
138786013|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138786014|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138560337|NCT05569746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786015|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786016|NCT02872818|Estrogens|estrogens|mesh-ancestor
138786017|NCT02872818|Hormones|hormones|mesh-ancestor
138556152|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
138786018|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138786019|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138786020|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
138786021|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138786022|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138786023|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138786024|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138786025|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138786026|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138786027|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138786028|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786029|NCT00922779|Ribavirin|ribavirin|mesh-list
138786030|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138786031|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
138786032|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786033|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
138786034|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786035|NCT04570410|Gemcitabine|gemcitabine|mesh-list
138786036|NCT04570410|Tislelizumab|tislelizumab|mesh-list
138786037|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786038|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138786039|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
138786040|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786041|NCT04570410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138786042|NCT04203771|Ibuprofen|ibuprofen|mesh-list
138786043|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138786044|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138786045|NCT04203771|Analgesics|analgesics|mesh-ancestor
138560382|NCT05512039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138786046|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
138259712|NCT01644474|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138786047|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786048|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786049|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138786050|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138786051|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138786052|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786053|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786055|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
138786056|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
138786057|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
138786058|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786059|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786060|NCT01025232|Ranibizumab|ranibizumab|mesh-list
138786061|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138786062|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138786063|NCT01025232|Growth Substances|growth substances|mesh-ancestor
138786064|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786065|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
138786066|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786067|NCT04300452|Carbetocin|carbetocin|mesh-list
138786068|NCT04300452|Ergonovine|ergonovine|mesh-list
138786069|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
138786070|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138786071|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786072|NCT01025154|Cytarabine|cytarabine|mesh-list
138786073|NCT01025154|Clofarabine|clofarabine|mesh-list
138786074|NCT01025154|Idarubicin|idarubicin|mesh-list
138786075|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138786076|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
138649750|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786077|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786078|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786079|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
138786080|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786081|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138786082|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
138786083|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786084|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138786085|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138786086|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138786087|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786089|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138786090|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786091|NCT04252365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138786092|NCT04252365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786093|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
138786094|NCT04252443|Analgesics|analgesics|mesh-list
138786096|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138786097|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786098|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
138786099|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786100|NCT00832819|Paclitaxel|paclitaxel|mesh-list
138786101|NCT00832819|Carboplatin|carboplatin|mesh-list
138786102|NCT00832819|Lenvatinib|lenvatinib|mesh-list
138786103|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138786104|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786105|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
138786106|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
138786107|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
138786108|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786109|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138786110|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786111|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
138786112|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
138786113|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786114|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786115|NCT00853723|Teriparatide|teriparatide|mesh-list
138786116|NCT00853723|Hormones|hormones|mesh-list
138786117|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
138786118|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
138556424|NCT00080795|Ifosfamide|ifosfamide|mesh-list
138786119|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138453944|NCT01888042|Everolimus|everolimus|mesh-list
138786120|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786121|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138786122|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138786123|NCT00918255|Adalimumab|adalimumab|mesh-list
138786124|NCT00918255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138786125|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138786126|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138786127|NCT01096589|Monensin|monensin|mesh-list
138786128|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
138786129|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786130|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138786131|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138786132|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
138786133|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
138786134|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
138786135|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786136|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786137|NCT01096589|Ionophores|ionophores|mesh-ancestor
138786138|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138786139|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
138786140|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138786141|NCT04252521|Ketoprofen|ketoprofen|mesh-list
138786142|NCT04252521|Metoclopramide|metoclopramide|mesh-list
138786143|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
138786144|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
138786145|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786146|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786147|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138786148|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138786149|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138786150|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
138786151|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556679|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
138786152|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786153|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138556751|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
138786154|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138786155|NCT04252521|Analgesics|analgesics|mesh-ancestor
138786156|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
138786157|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138786158|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138786159|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138786160|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786161|NCT00845065|Ribavirin|ribavirin|mesh-list
138786162|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138786163|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
138786164|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786165|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
138786166|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786167|NCT04772001|Carboplatin|carboplatin|mesh-list
138786168|NCT04772001|Cisplatin|cisplatin|mesh-list
138786169|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786170|NCT00702091|Ramipril|ramipril|mesh-list
138786171|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138786172|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
138556823|NCT00302692|Esmolol|esmolol|mesh-list
138786173|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786174|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556887|NCT00081614|Bevacizumab|bevacizumab|mesh-list
138786175|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138786176|NCT00832585|Alefacept|alefacept|mesh-list
138786177|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
138786178|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
138786179|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786180|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138786181|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138786182|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138786183|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138786184|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556952|NCT00081848|Metronidazole|metronidazole|mesh-list
138786185|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
138786186|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138786187|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786189|NCT05252325|Hyaluronic Acid|hyaluronic acid|mesh-list
138786190|NCT05252325|Anesthetics, Local|anesthetics, local|mesh-ancestor
138786191|NCT05252325|Anesthetics|anesthetics|mesh-ancestor
138786192|NCT05252325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138786193|NCT05252325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786194|NCT05252325|Sensory System Agents|sensory system agents|mesh-ancestor
138786195|NCT05252325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786196|NCT05252325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138786197|NCT05252325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138460653|NCT01993810|Paclitaxel|paclitaxel|mesh-list
138786198|NCT05252325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138786199|NCT05252325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138560540|NCT05331664|Glucocorticoids|glucocorticoids|mesh-ancestor
138786200|NCT05252325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786201|NCT05252325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138786202|NCT05252325|Immunologic Factors|immunologic factors|mesh-ancestor
138786203|NCT05252325|Viscosupplements|viscosupplements|mesh-ancestor
138786204|NCT05252325|Protective Agents|protective agents|mesh-ancestor
138786205|NCT01024920|Sunitinib|sunitinib|mesh-list
138786206|NCT01024920|Nintedanib|nintedanib|mesh-list
138786207|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786208|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138786209|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138786210|NCT01024920|Growth Substances|growth substances|mesh-ancestor
138786211|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786212|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
138786213|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138786214|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786215|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786216|NCT00832117|Cisplatin|cisplatin|mesh-list
138786217|NCT00832117|Epothilones|epothilones|mesh-list
138454005|NCT01888302|Sirolimus|sirolimus|mesh-list
138786218|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786219|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
138786220|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
138786221|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
138786222|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786224|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138786225|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786226|NCT00831493|Vorinostat|vorinostat|mesh-list
138786227|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786228|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138786229|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786230|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786231|NCT00705445|Zinc|zinc|mesh-list
138786232|NCT00705445|Trace Elements|trace elements|mesh-list
138786233|NCT00705445|Micronutrients|micronutrients|mesh-list
138786234|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786235|NCT02879981|Trimethoprim|trimethoprim|mesh-list
138786236|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
138786237|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
138786238|NCT02879981|Guaifenesin|guaifenesin|mesh-list
138786239|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
138786240|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138786241|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786242|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
138786243|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138786244|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138786245|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138786246|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786247|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786248|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138786249|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138786250|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138786252|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
138786253|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138786254|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138786255|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
138786256|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138786257|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786258|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
138786259|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138786260|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
138786261|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
138557703|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786262|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786263|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
138786264|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138786265|NCT04307693|Ritonavir|ritonavir|mesh-list
138786266|NCT04307693|Lopinavir|lopinavir|mesh-list
138786267|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
138786268|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138786269|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138786270|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
138786271|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786272|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786273|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138460736|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
138786274|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138786275|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
138786276|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786277|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138786278|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138786279|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
138786280|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138786281|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138786282|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138786283|NCT02878421|Nicotine|nicotine|mesh-list
138786284|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138786285|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
138557907|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
138786286|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786287|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786288|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138786289|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138786290|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
138557963|NCT00310336|Betaine|betaine|mesh-list
138786291|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138786292|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786293|NCT01019694|Albuterol|albuterol|mesh-list
138786294|NCT01019694|Ipratropium|ipratropium|mesh-list
138786295|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138786296|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
138786297|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786298|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786299|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138786300|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
138786302|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138786303|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138786304|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138786305|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138786306|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
138558177|NCT00311896|Bemiparin|bemiparin|mesh-list
138558242|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
138786307|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138786308|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558320|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
138786309|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138786310|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
138786311|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138786312|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138558392|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786313|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138558469|NCT00293917|Tacrolimus|tacrolimus|mesh-list
138786314|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138786315|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786316|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138560634|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560635|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560636|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560645|NCT05137067|Cisplatin|cisplatin|mesh-list
138560646|NCT05137067|Docetaxel|docetaxel|mesh-list
138560647|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
138560648|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
138560649|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
138560650|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
138786317|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786318|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
138786319|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138786320|NCT01095653|Metformin|metformin|mesh-list
138786321|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
138786322|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138786323|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558680|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
138786324|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138786325|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786326|NCT00920907|Ipilimumab|ipilimumab|mesh-list
138558748|NCT00295945|Analgesics|analgesics|mesh-ancestor
138786327|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138786328|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786329|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138786330|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786331|NCT00700297|Colchicine|colchicine|mesh-list
138786332|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
138786333|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138786334|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
138454036|NCT01888536|Pregabalin|pregabalin|mesh-list
138786335|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
138786336|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
138786337|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786338|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786339|NCT04307147|Capecitabine|capecitabine|mesh-list
138786340|NCT04307147|Vinorelbine|vinorelbine|mesh-list
138786341|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138786343|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786344|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786345|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138460807|NCT01234025|Prednisone|prednisone|mesh-list
138786346|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
138786347|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
138786348|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
138786349|NCT00844831|Lubiprostone|lubiprostone|mesh-list
138786350|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138786351|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138558880|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138786352|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786354|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138786355|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138558941|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138786356|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559018|NCT00090207|Aprepitant|aprepitant|mesh-list
138786357|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
138786358|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786359|NCT05010876|Icatibant|icatibant|mesh-list
138786360|NCT05010876|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138786361|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138559090|NCT00298012|Methotrexate|methotrexate|mesh-list
138786362|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138786363|NCT05010876|Analgesics|analgesics|mesh-ancestor
138786364|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
138786365|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786366|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786368|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138786369|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138786370|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138786371|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559228|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138786372|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138786373|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138786374|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
138786375|NCT04307069|Oxytocin|oxytocin|mesh-list
138786376|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
138786377|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138786378|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786379|NCT02878265|Vitamins|vitamins|mesh-list
138786380|NCT02878265|Vitamin A|vitamin a|mesh-list
138786382|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
138786383|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
138259870|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
138786384|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786385|NCT02878265|Trace Elements|trace elements|mesh-ancestor
138786386|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
138786387|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786388|NCT02878265|Protective Agents|protective agents|mesh-ancestor
138786389|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138786390|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786391|NCT00831181|Leucovorin|leucovorin|mesh-list
138786392|NCT00831181|Fluorouracil|fluorouracil|mesh-list
138786393|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
138786394|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
138786395|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786396|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138786397|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786398|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138786399|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
138786400|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786401|NCT00831181|Antidotes|antidotes|mesh-ancestor
138786402|NCT00831181|Protective Agents|protective agents|mesh-ancestor
138786403|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
138786404|NCT00831181|Vitamins|vitamins|mesh-ancestor
138786405|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
138786406|NCT01023672|Modafinil|modafinil|mesh-list
138786407|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138786408|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786409|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138786410|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138786411|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138786412|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786413|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138786414|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138786415|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
138786416|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786417|NCT00705835|Antacids|antacids|mesh-ancestor
138786418|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786419|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138786420|NCT00702637|Modafinil|modafinil|mesh-list
138786421|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138786422|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786423|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138786424|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138786425|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138786426|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786427|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138786428|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138786429|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138786430|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138454074|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
138786431|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786432|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
138786433|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138786434|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786435|NCT05525611|Cabergoline|cabergoline|mesh-list
138786436|NCT05525611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138786437|NCT05525611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138786438|NCT05525611|Dopamine Agonists|dopamine agonists|mesh-ancestor
138786439|NCT05525611|Dopamine Agents|dopamine agents|mesh-ancestor
138560786|NCT04921189|Vitamins|vitamins|mesh-ancestor
138786440|NCT05525611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138786441|NCT05525611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786442|NCT05525611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786443|NCT00917553|Doxycycline|doxycycline|mesh-list
138786444|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138786445|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786446|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
138786447|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138786448|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138786449|NCT04255251|Fluorides|fluorides|mesh-list
138786450|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
138786451|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
138786452|NCT04255251|Protective Agents|protective agents|mesh-ancestor
138786453|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786454|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138786455|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138786456|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138786457|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138786458|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786459|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138786460|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786461|NCT01018680|Analgesics|analgesics|mesh-ancestor
138786462|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
138786463|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786464|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
138786465|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138786466|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
138786467|NCT04255017|Ritonavir|ritonavir|mesh-list
138786468|NCT04255017|Lopinavir|lopinavir|mesh-list
138786469|NCT04255017|Oseltamivir|oseltamivir|mesh-list
138786470|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138786471|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138786472|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
138786473|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786474|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786476|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138786477|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
138786478|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786479|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138786480|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138786481|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138786482|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
138786483|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
138786484|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786485|NCT01017120|Tazarotene|tazarotene|mesh-list
138786486|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
138786487|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
138786488|NCT02872038|Cefazolin|cefazolin|mesh-list
138786489|NCT02872038|Ceftazidime|ceftazidime|mesh-list
138786490|NCT02872038|Cefepime|cefepime|mesh-list
138786491|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138786492|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786493|NCT00627900|Sirolimus|sirolimus|mesh-list
138786494|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138786495|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786496|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138454098|NCT01888744|Progesterone|progesterone|mesh-list
138786497|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786498|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
138786499|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138786500|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
138786501|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786503|NCT02996110|Ipilimumab|ipilimumab|mesh-list
138786504|NCT02996110|Relatlimab|relatlimab|mesh-list
138786505|NCT02996110|Linrodostat|linrodostat|mesh-list
138786506|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138786507|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560967|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560968|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138560969|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138560970|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
138560971|NCT04651088|Diuretics|diuretics|mesh-ancestor
138560972|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
138560973|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560974|NCT04651088|Expectorants|expectorants|mesh-ancestor
138560975|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
138560977|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
138560978|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
138560979|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138786508|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138786509|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786510|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786511|NCT01103063|Azithromycin|azithromycin|mesh-list
138786512|NCT01103063|Chloroquine|chloroquine|mesh-list
138786513|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
138786514|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
138786515|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138786516|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138786517|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786518|NCT01103063|Amebicides|amebicides|mesh-ancestor
138786519|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138786520|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138786521|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
138786522|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138786523|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138786524|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786525|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786526|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138786528|NCT02987998|Etoposide|etoposide|mesh-list
138786529|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786530|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138786531|NCT02987998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138786532|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174670|NCT00250445|Diclofenac|diclofenac|mesh-list
138786533|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138786534|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138559590|NCT05999383|Autonomic Agents|autonomic agents|mesh-ancestor
138786535|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138786536|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786537|NCT04213378|Paclitaxel|paclitaxel|mesh-list
138786538|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138786539|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138786540|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786541|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
138786542|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
138786543|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
138786544|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786545|NCT04213924|Ibuprofen|ibuprofen|mesh-list
138786546|NCT04213924|Lidocaine|lidocaine|mesh-list
138786548|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
138786549|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
138561159|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
138786550|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138786551|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786552|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
138786553|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786554|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138786555|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138786556|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138786557|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138786558|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786559|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138786560|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138786562|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138786563|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138454108|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
138786564|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138786565|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786567|NCT00616720|Aldesleukin|aldesleukin|mesh-list
138786568|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
138786569|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786570|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
138786571|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786572|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138786573|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138786574|NCT01091675|Etoricoxib|etoricoxib|mesh-list
138786575|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138786576|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138786577|NCT01091675|Analgesics|analgesics|mesh-ancestor
138786578|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
138786579|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786580|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786581|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138786582|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561222|NCT04233164|Prednisolone|prednisolone|mesh-list
138786583|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138786584|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138786585|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786586|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786587|NCT02739412|Aldesleukin|aldesleukin|mesh-list
138786588|NCT02739412|Interleukin-2|interleukin-2|mesh-list
138786589|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786590|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138786591|NCT02739412|Analgesics|analgesics|mesh-ancestor
138786592|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
138786593|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786594|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786595|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138786596|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138786597|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
138786598|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786599|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
138786600|NCT04213612|Doxorubicin|doxorubicin|mesh-list
138786601|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138786602|NCT04213612|Vincristine|vincristine|mesh-list
138559969|NCT05966194|Cisplatin|cisplatin|mesh-list
138786603|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138786604|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
138786605|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786606|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138786607|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138786608|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
138786609|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786610|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786611|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138786612|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138786613|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138786614|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138561268|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561277|NCT04198649|Azithromycin|azithromycin|mesh-list
138561278|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138561279|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138561280|NCT04177706|Ketamine|ketamine|mesh-list
138561281|NCT04177706|Analgesics|analgesics|mesh-ancestor
138561282|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
138561283|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561284|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561285|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138561286|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138561287|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
138561288|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
138561289|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138561290|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138561291|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138561292|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138561293|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444421|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
138174843|NCT00592475|Conivaptan|conivaptan|mesh-list
138786615|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786616|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138786617|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
138786618|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
138786619|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
138786620|NCT01091519|Fesoterodine|fesoterodine|mesh-list
138786621|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138786622|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138786623|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
138786624|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138786625|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786626|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786627|NCT01091519|Urological Agents|urological agents|mesh-ancestor
138786628|NCT02878031|Amoxicillin|amoxicillin|mesh-list
138786629|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138786630|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786631|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
138786632|NCT02879669|Carboplatin|carboplatin|mesh-list
138786633|NCT02879669|Pemetrexed|pemetrexed|mesh-list
138786634|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138786635|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
138561324|NCT04126473|Ivacaftor|ivacaftor|mesh-list
138561325|NCT04126473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138561326|NCT04126473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138561327|NCT04126473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561328|NCT04119336|Dexamethasone|dexamethasone|mesh-list
138786636|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786637|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138786638|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138786639|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
138259997|NCT02279641|Allopurinol|allopurinol|mesh-list
138786640|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786641|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786642|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138786643|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786644|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138786645|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138461108|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
138786647|NCT00918333|Panobinostat|panobinostat|mesh-list
138786648|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138786649|NCT00918333|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138786650|NCT00918333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138786651|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786652|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786653|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138786654|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
138786655|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786656|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786657|NCT01090973|Panobinostat|panobinostat|mesh-list
138786658|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138786659|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786660|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786661|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786662|NCT02607904|Cannabidiol|cannabidiol|mesh-list
138786663|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
138786664|NCT05295394|Lamivudine|lamivudine|mesh-list
138786665|NCT05295394|Dolutegravir|dolutegravir|mesh-list
138786666|NCT05295394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138786667|NCT05295394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138786668|NCT05295394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786669|NCT05295394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786670|NCT05295394|Antiviral Agents|antiviral agents|mesh-ancestor
138786671|NCT05295394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786672|NCT05295394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138786673|NCT05295394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138786674|NCT05295394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138786675|NCT05295394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138786676|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
138786677|NCT02871648|Eplerenone|eplerenone|mesh-list
138561434|NCT03908593|Pantoprazole|pantoprazole|mesh-list
138786678|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138786679|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
138454145|NCT01888835|Mirtazapine|mirtazapine|mesh-list
138786680|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138786681|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786682|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138786683|NCT02871648|Diuretics|diuretics|mesh-ancestor
138786684|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
138786685|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138786686|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138786687|NCT00637845|Esomeprazole|esomeprazole|mesh-list
138786688|NCT00637845|Lansoprazole|lansoprazole|mesh-list
138786689|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
138786690|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138786691|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138786692|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138786693|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786694|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786695|NCT02497300|Amiloride|amiloride|mesh-list
138786696|NCT02497300|Spironolactone|spironolactone|mesh-list
138560176|NCT05721027|Analgesics|analgesics|mesh-ancestor
138786697|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138786698|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
138561486|NCT03774394|Clopidogrel|clopidogrel|mesh-list
138786699|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138786700|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786701|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138786703|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
138786704|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138786705|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138786706|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138786707|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786708|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138786709|NCT04254471|Carboplatin|carboplatin|mesh-list
138786710|NCT04254471|Etoposide|etoposide|mesh-list
138786711|NCT04254471|Rabeprazole|rabeprazole|mesh-list
138786712|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786713|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138786714|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138786715|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138786716|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786717|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786718|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138786719|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138461184|NCT01938144|Acetaminophen|acetaminophen|mesh-list
138786720|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138786721|NCT00631527|Sunitinib|sunitinib|mesh-list
138786722|NCT00631527|Leuprolide|leuprolide|mesh-list
138786723|NCT00631527|Goserelin|goserelin|mesh-list
138786724|NCT00631527|Bicalutamide|bicalutamide|mesh-list
138786725|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786726|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138786727|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138454150|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
138786728|NCT00631527|Growth Substances|growth substances|mesh-ancestor
138786729|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786730|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
138786731|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138786732|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786733|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786734|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138786735|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
138786736|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138786737|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138786738|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
138786739|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
138786740|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138786741|NCT00620620|Zaleplon|zaleplon|mesh-list
138786742|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
138786743|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138786744|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138786745|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786746|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
138786747|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
138786749|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786750|NCT00916383|Donepezil|donepezil|mesh-list
138786751|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138786752|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786753|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561569|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138561570|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138561571|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138561572|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561587|NCT03692403|Quinagolide|quinagolide|mesh-list
138561588|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
138561589|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
138561590|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138561591|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561592|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561593|NCT03683433|Azacitidine|azacitidine|mesh-list
138561594|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138561599|NCT03649230|Palonosetron|palonosetron|mesh-list
138786754|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
138786755|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138786756|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786757|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
138786758|NCT00617500|Hormones|hormones|mesh-list
138560406|NCT05475665|Amlodipine|amlodipine|mesh-list
138786759|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138786760|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786762|NCT04209478|Tramadol|tramadol|mesh-list
138786763|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138786764|NCT04209478|Narcotics|narcotics|mesh-ancestor
138786765|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138786766|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786768|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
138786769|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786770|NCT05252715|Vaccines|vaccines|mesh-list
138786771|NCT05252715|Immunologic Factors|immunologic factors|mesh-ancestor
138786772|NCT05252715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786773|NCT04209166|Norepinephrine|norepinephrine|mesh-list
138561687|NCT03430297|Dacarbazine|dacarbazine|mesh-list
138786774|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138786775|NCT04209166|Serotonin|serotonin|mesh-list
138786776|NCT04209166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138786777|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
138786778|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
138786779|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138786780|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138786781|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138786782|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138786783|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560541|NCT05331664|Hormones|hormones|mesh-ancestor
138786784|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138786785|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138786786|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
138786787|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138786788|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786789|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
138786790|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
138786791|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138454176|NCT01888978|Docetaxel|docetaxel|mesh-list
138786792|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138786793|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138786794|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138786795|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
138786796|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138786797|NCT04766008|Metformin|metformin|mesh-list
138786798|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138786799|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786800|NCT00916149|Lamotrigine|lamotrigine|mesh-list
138786801|NCT00916149|Levetiracetam|levetiracetam|mesh-list
138786802|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
138786812|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138786813|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138786824|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138786826|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138786827|NCT00175162|Protective Agents|protective agents|mesh-ancestor
138786828|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786829|NCT04213222|Bevacizumab|bevacizumab|mesh-list
138786830|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138786831|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786832|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138786833|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138786834|NCT04213222|Growth Substances|growth substances|mesh-ancestor
138786835|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786836|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
138786837|NCT00621166|Ritonavir|ritonavir|mesh-list
138786838|NCT00621166|Lopinavir|lopinavir|mesh-list
138786839|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138786840|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138786841|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
138786842|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786843|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786844|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138786845|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138786846|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
138786847|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786848|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138786849|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138786850|NCT04555798|Meropenem|meropenem|mesh-list
138786851|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138786852|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138786854|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786855|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
138786856|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
138786857|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
138786858|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786859|NCT00621400|Dexamethasone|dexamethasone|mesh-list
138786860|NCT00621400|Lenalidomide|lenalidomide|mesh-list
138786861|NCT00621400|Melphalan|melphalan|mesh-list
138786862|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138786863|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
138786864|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
138786865|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786866|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786867|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138786868|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
138786869|NCT00621400|Hormones|hormones|mesh-ancestor
138786870|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138461338|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138786871|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138786872|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786873|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
138786874|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138786875|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138786876|NCT00621400|Growth Substances|growth substances|mesh-ancestor
138786877|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
138786878|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138786879|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
138786880|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786881|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138786882|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138786883|NCT04208854|Vinorelbine|vinorelbine|mesh-list
138786884|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138786885|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786886|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
138786887|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
138786888|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
138786889|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786890|NCT01090427|Ustekinumab|ustekinumab|mesh-list
138786891|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
138786892|NCT04208776|Propranolol|propranolol|mesh-list
138786893|NCT04208776|Midodrine|midodrine|mesh-list
138786894|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138786895|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138786896|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
138786897|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138786898|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786899|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786900|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138786901|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138786902|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
138786903|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
138786905|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786906|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138786907|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138786908|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138786909|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138786910|NCT02879435|Bupivacaine|bupivacaine|mesh-list
138786911|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
138786912|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
138786913|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138786914|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786915|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
138786916|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786917|NCT02879513|Paclitaxel|paclitaxel|mesh-list
138786918|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
138786919|NCT02879513|Epirubicin|epirubicin|mesh-list
138786920|NCT02879513|Fluorouracil|fluorouracil|mesh-list
138786921|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138786922|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138786923|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
138786924|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
138786925|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
138562090|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138786926|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786927|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138786928|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
138260092|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
138786929|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786930|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138786931|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138786932|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
138786933|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138786934|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138786935|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138786936|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138786937|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786938|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
138786939|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138786940|NCT00621478|Diazepam|diazepam|mesh-list
138786941|NCT00621478|Lorazepam|lorazepam|mesh-list
138786942|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
138786943|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
138786944|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
138461449|NCT01939639|Oxytocin|oxytocin|mesh-list
138786945|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786946|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786947|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138786948|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138786949|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138786950|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138786951|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138786952|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138786953|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
138786954|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
138786955|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138786956|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786957|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138786958|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138786959|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138786960|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138786961|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
138786962|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
138786964|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138786965|NCT00621556|Hormones|hormones|mesh-ancestor
138786966|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138786967|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786968|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
138786969|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
138786970|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138786971|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138786972|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138561244|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138786973|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786974|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138786975|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138786976|NCT04308551|Aspirin|aspirin|mesh-list
138786977|NCT04308551|Indobufen|indobufen|mesh-list
138786978|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138786979|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138786980|NCT04308551|Analgesics|analgesics|mesh-ancestor
138786981|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
138786982|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138786983|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138786984|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138786986|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138786987|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138786988|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138786989|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138786990|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138786991|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786992|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
138786993|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
138786994|NCT04306913|Esmolol|esmolol|mesh-list
138786995|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138786996|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138786997|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138786998|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
138786999|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138787000|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787001|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787002|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138787003|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
138787005|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138787006|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138787007|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787008|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138787009|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787010|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
138787011|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
138787012|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138787013|NCT01016262|Mesalamine|mesalamine|mesh-list
138787014|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138787015|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138787016|NCT01016262|Analgesics|analgesics|mesh-ancestor
138787017|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
138787018|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787019|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787020|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138787021|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138787022|NCT00625937|Docetaxel|docetaxel|mesh-list
138787023|NCT00625937|Tegafur|tegafur|mesh-list
138787024|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787025|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
138787026|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
138787027|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
138787028|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787029|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138787030|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
138787031|NCT01001910|Carboplatin|carboplatin|mesh-list
138787032|NCT01001910|Pemetrexed|pemetrexed|mesh-list
138787033|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787034|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787035|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787036|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138787037|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138787038|NCT04308317|Tetrandrine|tetrandrine|mesh-list
138787039|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
138787040|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138787041|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138787042|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138787043|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138787044|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787045|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
138787046|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138787047|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138787048|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787049|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138787050|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787051|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138787052|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
138787053|NCT01009554|Listerine|listerine|mesh-list
138787054|NCT01009554|Fluorides|fluorides|mesh-list
138787055|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
138787056|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
138787057|NCT01009554|Protective Agents|protective agents|mesh-ancestor
138562411|NCT00314704|Dopamine|dopamine|mesh-list
138787058|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787059|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138787060|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138787061|NCT04211896|Nivolumab|nivolumab|mesh-list
138787062|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138787063|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787064|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138787065|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787066|NCT04188184|Epinephrine|epinephrine|mesh-list
138787067|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
138787068|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138787069|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138787070|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787071|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
138787072|NCT04188184|Coagulants|coagulants|mesh-ancestor
138787073|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138787074|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138787075|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
138562469|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
138787076|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138787077|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787078|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138787079|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138787080|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
138787081|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787082|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138787083|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
138787084|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
138787085|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
138787086|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138787087|NCT01006590|Metformin|metformin|mesh-list
138787088|NCT01006590|Saxagliptin|saxagliptin|mesh-list
138787089|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138787090|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787091|NCT01006590|Incretins|incretins|mesh-ancestor
138787092|NCT01006590|Hormones|hormones|mesh-ancestor
138787093|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138461567|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138787094|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138787095|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
138787096|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787097|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787098|NCT04212832|Bupivacaine|bupivacaine|mesh-list
138787099|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
138787100|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
138787101|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138787102|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787103|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
138787104|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787105|NCT00621790|Fenoldopam|fenoldopam|mesh-list
138787106|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138787107|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
138562587|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
138787108|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
138787109|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
138787110|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138787111|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787112|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787113|NCT00618124|Capecitabine|capecitabine|mesh-list
138787114|NCT00618124|Sunitinib|sunitinib|mesh-list
138787115|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138787116|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
138787117|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787118|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787119|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138787120|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138787121|NCT00618124|Growth Substances|growth substances|mesh-ancestor
138787122|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787123|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
138787124|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138787126|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
138787127|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138787128|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787129|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138787130|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787131|NCT01882660|Decitabine|decitabine|mesh-list
138787132|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138787133|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
138787134|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787135|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787137|NCT01001832|Abatacept|abatacept|mesh-list
138787138|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138787139|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787140|NCT01001832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138787141|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787142|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138787143|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
138787144|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787145|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138787146|NCT01001598|Danazol|danazol|mesh-list
138787147|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138787148|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
138787149|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138787150|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787151|NCT01006356|Hydromorphone|hydromorphone|mesh-list
138787152|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138787153|NCT01006356|Narcotics|narcotics|mesh-ancestor
138787154|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138787155|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787156|NCT01006356|Analgesics|analgesics|mesh-ancestor
138787157|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
138787158|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787159|NCT01089725|Tanezumab|tanezumab|mesh-list
138787160|NCT01089725|Analgesics|analgesics|mesh-ancestor
138787161|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
138787162|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787163|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787164|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
138561732|NCT03322995|Fluorouracil|fluorouracil|mesh-list
138787165|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138787166|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787167|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138787168|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
138787169|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138562676|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787170|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138787171|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787172|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787173|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
138561788|NCT03260504|Analgesics|analgesics|mesh-ancestor
138787174|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
138787175|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787176|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138787177|NCT00618202|Balsalazide|balsalazide|mesh-list
138787178|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138787179|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138787180|NCT00618202|Analgesics|analgesics|mesh-ancestor
138787181|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
138787182|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787183|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260201|NCT01938079|Ketamine|ketamine|mesh-list
138787184|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138787185|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561847|NCT03118492|Melphalan|melphalan|mesh-list
138787186|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138787188|NCT00626015|Daclizumab|daclizumab|mesh-list
138787189|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138787190|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
138787191|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787192|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787193|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138787194|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
138562741|NCT00315016|Eplerenone|eplerenone|mesh-list
138787195|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787196|NCT00618280|Nicotine|nicotine|mesh-list
138787197|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138787198|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
138787199|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787200|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787201|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138787202|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138787203|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
138787204|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138787205|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787206|NCT01101191|Oxycodone|oxycodone|mesh-list
138787207|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138787208|NCT01101191|Narcotics|narcotics|mesh-ancestor
138787209|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138787210|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787211|NCT01101191|Analgesics|analgesics|mesh-ancestor
138787212|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
138787213|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787214|NCT00622258|Everolimus|everolimus|mesh-list
138787215|NCT00622258|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138787216|NCT00622258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138787217|NCT00622258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787218|NCT00622258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787219|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138787220|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
138562777|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
138787221|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260219|NCT02641691|Fluorouracil|fluorouracil|mesh-list
138787222|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787223|NCT01812616|Nabiximols|nabiximols|mesh-list
138787224|NCT01812616|Analgesics|analgesics|mesh-ancestor
138787225|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
138787226|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787227|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787228|NCT00618358|Thrombin|thrombin|mesh-list
138787229|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
138787230|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
138787231|NCT00618358|Coagulants|coagulants|mesh-ancestor
138787232|NCT01178762|Azithromycin|azithromycin|mesh-list
138787233|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138787234|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138787235|NCT03563560|Cytarabine|cytarabine|mesh-list
138787236|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
138787237|NCT03563560|Alvocidib|alvocidib|mesh-list
138787238|NCT03563560|Daunorubicin|daunorubicin|mesh-list
138787239|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138787240|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
138787241|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787242|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787243|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
138787244|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138787245|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138787246|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
138787247|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787248|NCT03563560|Analgesics|analgesics|mesh-ancestor
138787249|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
138787250|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787251|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138787252|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138787253|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787254|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
138787255|NCT03563560|Growth Substances|growth substances|mesh-ancestor
138787256|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138787257|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138787259|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138787260|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138787261|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138787262|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138787263|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
138787264|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138787265|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562872|NCT00091806|Panitumumab|panitumumab|mesh-list
138787266|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787267|NCT01190228|Vaccines|vaccines|mesh-list
138787268|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
138787269|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787270|NCT01009086|Ustekinumab|ustekinumab|mesh-list
138787271|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
138787272|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
138787273|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138787274|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138787275|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787276|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
138787277|NCT01190150|Coagulants|coagulants|mesh-ancestor
138787278|NCT04315688|Insulin|insulin|mesh-list
138787279|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138787280|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787281|NCT05210062|Succinylcholine|succinylcholine|mesh-list
138454284|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787282|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138787283|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138787285|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787286|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787287|NCT01001520|Tolcapone|tolcapone|mesh-list
138787288|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138787289|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138787290|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138787291|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787292|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787293|NCT00619840|Methylphenidate|methylphenidate|mesh-list
138787294|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138787295|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787296|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138787297|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138787298|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138787299|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787300|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
138787301|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138787302|NCT01189604|Propofol|propofol|mesh-list
138787303|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138787304|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138787305|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787306|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138787307|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
138787308|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
138787309|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
138787310|NCT02697058|Leucovorin|leucovorin|mesh-list
138787311|NCT02697058|Fluorouracil|fluorouracil|mesh-list
138787314|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138787315|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787316|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138787317|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
138787318|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787319|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138787320|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787321|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138787322|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
138787323|NCT02697058|Antidotes|antidotes|mesh-ancestor
138787324|NCT02697058|Protective Agents|protective agents|mesh-ancestor
138787325|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
138787326|NCT02697058|Vitamins|vitamins|mesh-ancestor
138787327|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
138787328|NCT00622414|Aflibercept|aflibercept|mesh-list
138787329|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
138787330|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138787331|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138787332|NCT00622414|Growth Substances|growth substances|mesh-ancestor
138787333|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787334|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
138562016|NCT02157974|Exenatide|exenatide|mesh-list
138787335|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787336|NCT01008696|Rabeprazole|rabeprazole|mesh-list
138787337|NCT01008696|Lansoprazole|lansoprazole|mesh-list
138787338|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
138787339|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138787340|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138562067|NCT02037126|Psilocybin|psilocybin|mesh-list
138787341|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138787342|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787343|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787344|NCT01955980|Budesonide|budesonide|mesh-list
138787345|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138787346|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138787347|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
138787348|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787349|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787350|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138787351|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
138787352|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
138787353|NCT01955980|Hormones|hormones|mesh-ancestor
138562353|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
138787354|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138787356|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138787357|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138787358|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138787359|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138787360|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138787361|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
138787362|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787363|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787364|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138787365|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
138787367|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
138787368|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138562492|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787369|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138787370|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
138787371|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562564|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
138787372|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787373|NCT04296162|Capecitabine|capecitabine|mesh-list
138787374|NCT04296162|Trastuzumab|trastuzumab|mesh-list
138787375|NCT04296162|Vinorelbine|vinorelbine|mesh-list
138787376|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138787377|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
138787378|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787379|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787380|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138787381|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138787382|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
138787383|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
138787384|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
138787386|NCT00619996|Sorafenib|sorafenib|mesh-list
138787387|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787388|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
138787389|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
138787390|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
138787391|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787392|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138787393|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787394|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138787396|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138787397|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787398|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562915|NCT00327730|Eperisone|eperisone|mesh-list
138563141|NCT03352427|Dasatinib|dasatinib|mesh-list
138787399|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
138787400|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138787402|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138787403|NCT00622570|Pentobarbital|pentobarbital|mesh-list
138787405|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
138787407|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138787408|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563140|NCT03352427|Everolimus|everolimus|mesh-list
138787409|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138787410|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
138787411|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
138787412|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
138787413|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
138787414|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454304|NCT01889771|Nicotine|nicotine|mesh-list
138787415|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787416|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138787418|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
138787420|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
138787421|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787422|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138787423|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
138787424|NCT01176968|Eplerenone|eplerenone|mesh-list
138563343|NCT01821833|Paclitaxel|paclitaxel|mesh-list
138787425|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138787427|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138787428|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787429|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138787430|NCT01176968|Diuretics|diuretics|mesh-ancestor
138787431|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
138787432|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138787433|NCT02697370|Factor VIII|factor viii|mesh-list
138787434|NCT02697370|Coagulants|coagulants|mesh-ancestor
138787435|NCT02691442|Epinephrine|epinephrine|mesh-list
138787436|NCT02691442|Ropivacaine|ropivacaine|mesh-list
138787437|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
138787438|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
138787439|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
138787440|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138563702|NCT00124098|Hematinics|hematinics|mesh-ancestor
138787441|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787442|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
138787443|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787444|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138787445|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138787446|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
138787447|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563229|NCT00316927|Analgesics|analgesics|mesh-ancestor
138563847|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138787448|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787449|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138787450|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138787451|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
138787452|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138787453|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
138787454|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
138787455|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
138787456|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138787457|NCT00622648|Enoxaparin|enoxaparin|mesh-list
138787458|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
138787459|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138787460|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138787461|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787462|NCT02687854|Vitamin K|vitamin k|mesh-list
138787463|NCT02687854|Apixaban|apixaban|mesh-list
138787464|NCT02687854|Vitamins|vitamins|mesh-ancestor
138787465|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
138563981|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
138787466|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787467|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138787468|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
138787469|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138787470|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
138787471|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787472|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787473|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
138787474|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138787475|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138787476|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
138787477|NCT02687854|Coagulants|coagulants|mesh-ancestor
138787478|NCT01005966|Listerine|listerine|mesh-list
138787479|NCT01005966|Fluorides|fluorides|mesh-list
138787480|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
138787481|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
138787482|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
138787483|NCT01005966|Protective Agents|protective agents|mesh-ancestor
138563276|NCT00317434|Lapatinib|lapatinib|mesh-list
138787484|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787485|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138787486|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138787487|NCT00628680|Heparin|heparin|mesh-list
138787488|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
138787489|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138787490|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138787491|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787492|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
138787493|NCT00603304|Urological Agents|urological agents|mesh-ancestor
138787494|NCT01176032|Losartan|losartan|mesh-list
138787495|NCT01176032|Amlodipine|amlodipine|mesh-list
138564178|NCT00319072|Hormones|hormones|mesh-list
138787496|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138787497|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138787498|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138787499|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138787500|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787501|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138787502|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787503|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
138787504|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138787505|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138787506|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138787507|NCT01176032|Diuretics|diuretics|mesh-ancestor
138787508|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
138564382|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787509|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138787511|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138787512|NCT01008618|Narcotics|narcotics|mesh-ancestor
138787513|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138787514|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787515|NCT01008618|Analgesics|analgesics|mesh-ancestor
138787516|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
138787517|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787518|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138787519|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138787520|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
138787521|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
138787522|NCT01001208|Etanercept|etanercept|mesh-list
138787523|NCT01001208|Methotrexate|methotrexate|mesh-list
138787524|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138787525|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
138564453|NCT00320320|Irinotecan|irinotecan|mesh-list
138787526|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138787527|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787528|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138787529|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
138787530|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787531|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564659|NCT05458180|Prednisone|prednisone|mesh-list
138787532|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
138787533|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787534|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138787535|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138787536|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
138787537|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138787538|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138787539|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138564795|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
138787540|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138787541|NCT01001208|Analgesics|analgesics|mesh-ancestor
138787542|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
138787543|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462013|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138787544|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138787545|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138564943|NCT00124722|Bromides|bromides|mesh-list
138787546|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138787547|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
138787548|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565016|NCT00332176|Ribavirin|ribavirin|mesh-list
138787549|NCT01004406|Atorvastatin|atorvastatin|mesh-list
138787550|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138787551|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138787552|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138787553|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
138787554|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787555|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138787557|NCT01093612|Copper|copper|mesh-list
138787558|NCT01093612|Trastuzumab|trastuzumab|mesh-list
138787559|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138787560|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787561|NCT01093612|Trace Elements|trace elements|mesh-ancestor
138787562|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
138787563|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787564|NCT01182350|Bevacizumab|bevacizumab|mesh-list
138787565|NCT01182350|Temozolomide|temozolomide|mesh-list
138565439|NCT00126633|Bevacizumab|bevacizumab|mesh-list
138787567|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138787568|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565514|NCT05831761|Lidocaine|lidocaine|mesh-list
138787569|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138787570|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138787571|NCT01182350|Growth Substances|growth substances|mesh-ancestor
138787572|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565580|NCT05830864|Anesthetics|anesthetics|mesh-ancestor
138787573|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
138787574|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138787575|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
138787576|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787577|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138787578|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787580|NCT00603538|Carboplatin|carboplatin|mesh-list
138787581|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138787582|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787583|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
138787584|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
138787585|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
138787586|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787587|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138787588|NCT02537860|Fentanyl|fentanyl|mesh-list
138787589|NCT02537860|Bupivacaine|bupivacaine|mesh-list
138787590|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
138787592|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138787593|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787594|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
138787595|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787596|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138787597|NCT02537860|Narcotics|narcotics|mesh-ancestor
138787598|NCT02537860|Analgesics|analgesics|mesh-ancestor
138787599|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138787600|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138787601|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
138787602|NCT01162304|Oxycodone|oxycodone|mesh-list
138787603|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138787604|NCT01162304|Narcotics|narcotics|mesh-ancestor
138787605|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138787606|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787607|NCT01162304|Analgesics|analgesics|mesh-ancestor
138787608|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
138787609|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787610|NCT04515394|Cetuximab|cetuximab|mesh-list
138787611|NCT04515394|Tepotinib|tepotinib|mesh-list
138242631|NCT02247362|Vaccines|vaccines|mesh-list
138787612|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138454329|NCT01889979|Tramadol|tramadol|mesh-list
138787613|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787614|NCT04206176|Ticagrelor|ticagrelor|mesh-list
138787615|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138787616|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138566444|NCT05794997|Antioxidants|antioxidants|mesh-ancestor
138787617|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138566513|NCT05635357|Letrozole|letrozole|mesh-list
138787618|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138787619|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
138787620|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138787621|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787622|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787623|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138787625|NCT00638326|Clopidogrel|clopidogrel|mesh-list
138787626|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138787627|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138787628|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138787630|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
138787631|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566878|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501202|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
138501203|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138501204|NCT00012558|Inositol|inositol|mesh-list
138501205|NCT00012558|Lamotrigine|lamotrigine|mesh-list
138501206|NCT00012558|Valproic Acid|valproic acid|mesh-list
138501207|NCT00012558|Risperidone|risperidone|mesh-list
138318735|NCT01381692|Sirolimus|sirolimus|mesh-list
138501208|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
138501209|NCT00012558|Bupropion|bupropion|mesh-list
138501210|NCT00012558|Paroxetine|paroxetine|mesh-list
138501211|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138501212|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
138501213|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501214|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501215|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501216|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138501217|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138501218|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138501219|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138501220|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138501221|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
138501222|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138501223|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
138501224|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138501225|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138501227|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138501228|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138501229|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501230|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
138501231|NCT00012558|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138501232|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
138501233|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138501234|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138501235|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138501236|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
138501237|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
138501238|NCT00012558|Vitamins|vitamins|mesh-ancestor
138501239|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
138501240|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138501241|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138501242|NCT00395707|Ranibizumab|ranibizumab|mesh-list
138501243|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138501244|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138501245|NCT00395707|Growth Substances|growth substances|mesh-ancestor
138501246|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501247|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
138501248|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501249|NCT00000500|Aspirin|aspirin|mesh-list
138501250|NCT00000500|Carotenoids|carotenoids|mesh-list
138501251|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138501252|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138501253|NCT00000500|Analgesics|analgesics|mesh-ancestor
138501254|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
138501255|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501256|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501257|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138501258|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138501259|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138693520|NCT01258660|Diuretics|diuretics|mesh-ancestor
138501260|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138501261|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563520|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138501262|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138501263|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138501264|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501265|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
138501266|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
138501267|NCT00000500|Protective Agents|protective agents|mesh-ancestor
138501268|NCT00395902|Cinacalcet|cinacalcet|mesh-list
138501269|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138501270|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260490|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
138501272|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
138501273|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138501274|NCT00029848|Rimonabant|rimonabant|mesh-list
138501275|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138501276|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138501277|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138501278|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501279|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501280|NCT00029848|Hormones|hormones|mesh-ancestor
138501281|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138501282|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501283|NCT00000503|Streptokinase|streptokinase|mesh-list
138501284|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
138501285|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
138501286|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138501287|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138501288|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501289|NCT00030004|Midazolam|midazolam|mesh-list
138501290|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138501291|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138501292|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138501293|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501294|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138501295|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138501296|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138501297|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138501298|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
138501299|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
138501300|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
138501301|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
138501302|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501303|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501304|NCT00030082|Melphalan|melphalan|mesh-list
138501305|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138501306|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
138260517|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138501307|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501308|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454352|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
138501309|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138501310|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138501311|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
138501312|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177758|NCT02000973|Bupivacaine|bupivacaine|mesh-list
138501314|NCT00000518|Sotalol|sotalol|mesh-list
138501315|NCT00000518|Mexiletine|mexiletine|mesh-list
138501316|NCT00000518|Procainamide|procainamide|mesh-list
138501317|NCT00000518|Imipramine|imipramine|mesh-list
138501318|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138501319|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138501320|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
138501321|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501322|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501323|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501324|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138501325|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
138501326|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
138501327|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501328|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138501329|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
138501330|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138501331|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138501332|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138501333|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138501334|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138501335|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
138501336|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138501337|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138501338|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138501339|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501340|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138501341|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138501342|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
138501343|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138501344|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138501345|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138501346|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138501347|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
138501348|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
138501349|NCT00030238|Calcium|calcium|mesh-list
138501350|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138501351|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501352|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
138501353|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138501354|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501355|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138501356|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501357|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501358|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
138501359|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501360|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138501361|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501362|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501363|NCT00395941|Pioglitazone|pioglitazone|mesh-list
138501364|NCT00395941|Acitretin|acitretin|mesh-list
138454357|NCT01891292|Expectorants|expectorants|mesh-ancestor
138501365|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138501366|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501367|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
138501368|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
138501369|NCT00030433|Gemcitabine|gemcitabine|mesh-list
138501370|NCT00030433|Irinotecan|irinotecan|mesh-list
138501371|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138501372|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
138260553|NCT02679911|Ciclopirox|ciclopirox|mesh-list
138501373|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501374|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501375|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138501376|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138501377|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501378|NCT00030472|Doxorubicin|doxorubicin|mesh-list
138501379|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138501380|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138501381|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501382|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138501383|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138501384|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501385|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501386|NCT00000527|Aspirin|aspirin|mesh-list
138501387|NCT00000527|Dipyridamole|dipyridamole|mesh-list
138501388|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138177833|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
138501389|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138501390|NCT00000527|Analgesics|analgesics|mesh-ancestor
138501391|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
138501392|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501393|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501394|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138501395|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138501396|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138501397|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138501398|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501399|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138501400|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138501401|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501402|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
138501403|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138501404|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
138501405|NCT00030511|Fluorouracil|fluorouracil|mesh-list
138501406|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
138501407|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501408|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138501409|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501410|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138501411|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
138501412|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501413|NCT00030550|Thalidomide|thalidomide|mesh-list
138501414|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138501415|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
138501416|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501417|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
138501418|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138501419|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138501420|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138501421|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138501422|NCT00030550|Growth Substances|growth substances|mesh-ancestor
138501423|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
138501424|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501425|NCT00030589|Bexarotene|bexarotene|mesh-list
138501426|NCT00030589|Methoxsalen|methoxsalen|mesh-list
138501427|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501428|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138501429|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
138501430|NCT00000530|Nifedipine|nifedipine|mesh-list
138454374|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
138501431|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138501432|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138563695|NCT00093249|Clevidipine|clevidipine|mesh-list
138501433|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501434|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138501435|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501436|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
138501437|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
138501438|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138501439|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
138501440|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501441|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138501442|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501443|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501444|NCT00030745|Gemcitabine|gemcitabine|mesh-list
138501445|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501446|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138501447|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
138693555|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138501448|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501449|NCT00030784|Doxorubicin|doxorubicin|mesh-list
138501450|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138501452|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138501453|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501454|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138501455|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138501456|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501457|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501458|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138501459|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
138501461|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177908|NCT02008617|Bupivacaine|bupivacaine|mesh-list
138501462|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138501463|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138501464|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501465|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501466|NCT00000539|Vitamins|vitamins|mesh-list
138501467|NCT00000539|Vitamin E|vitamin e|mesh-list
138501468|NCT00000539|Beta Carotene|beta carotene|mesh-list
138501469|NCT00000539|Warfarin|warfarin|mesh-list
138501470|NCT00000539|Pravastatin|pravastatin|mesh-list
138501471|NCT00000539|Carotenoids|carotenoids|mesh-list
138501472|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
138501473|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501474|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
138501475|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
138563745|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138501476|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501477|NCT00000539|Protective Agents|protective agents|mesh-ancestor
138501478|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138501479|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
138501480|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138501481|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138501482|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138501483|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501484|NCT00000539|Provitamins|provitamins|mesh-ancestor
138501485|NCT00030979|Donepezil|donepezil|mesh-list
138501486|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138501487|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501488|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501489|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
138501490|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501491|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501492|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
138501493|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
138501494|NCT00031018|Donepezil|donepezil|mesh-list
138501495|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138501496|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501497|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501498|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
138501499|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501500|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501501|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
138501502|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
138563799|NCT00324454|Levetiracetam|levetiracetam|mesh-list
138501503|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138501504|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501505|NCT00031057|Riboflavin|riboflavin|mesh-list
138501506|NCT00031057|Thiamine|thiamine|mesh-list
138501507|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
138501509|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
138501510|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501511|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138501512|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
138501513|NCT00000554|Dobutamine|dobutamine|mesh-list
138501514|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138501515|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
138501516|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
138501517|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501518|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501519|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138501520|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138501521|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138501522|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
138501523|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501524|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501525|NCT00000554|Protective Agents|protective agents|mesh-ancestor
138501526|NCT00012909|Hormones|hormones|mesh-list
138501527|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138501528|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501529|NCT00031096|Azelaic acid|azelaic acid|mesh-list
138501530|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501531|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
138501532|NCT00031135|Choline|choline|mesh-list
138563821|NCT00324610|Capecitabine|capecitabine|mesh-list
138501533|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
138501534|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138501535|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
138501536|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177982|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
138501537|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138501538|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138501539|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
138501540|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
138501542|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
138501543|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138501544|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138501545|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
138501546|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501547|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
138501548|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138501549|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260585|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138501550|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501551|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501552|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138501553|NCT00396058|Methylphenidate|methylphenidate|mesh-list
138501554|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138501555|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501556|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138501557|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138501558|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138501559|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501560|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
138501561|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501562|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138501563|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
138501564|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138501565|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138501566|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138501567|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138501568|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501569|NCT00000563|Dexamethasone|dexamethasone|mesh-list
138501570|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138501571|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
138501572|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
138501573|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501574|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501575|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138501576|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
138501578|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138501579|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138501580|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501581|NCT00031564|Aldesleukin|aldesleukin|mesh-list
138501582|NCT00031564|Interleukin-2|interleukin-2|mesh-list
138501583|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501584|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501585|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138501586|NCT00031564|Analgesics|analgesics|mesh-ancestor
138501587|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
138501588|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501589|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138501590|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138501591|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
138501592|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138501593|NCT00031642|Rituximab|rituximab|mesh-list
138501594|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138501595|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501596|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
138501597|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501598|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138501599|NCT00031681|Irinotecan|irinotecan|mesh-list
138501600|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138501601|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138501602|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138501603|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501604|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501605|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501606|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138501607|NCT00031720|Tamoxifen|tamoxifen|mesh-list
138501608|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138501609|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
138501610|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138501611|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501612|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138501613|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501614|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138501615|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138501616|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138501617|NCT00000569|Triamcinolone|triamcinolone|mesh-list
138501618|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138501619|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
138501620|NCT00000569|Hormones|hormones|mesh-ancestor
138501621|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138501622|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501623|NCT00031759|Imiquimod|imiquimod|mesh-list
138501624|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138501625|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
138501626|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501627|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501629|NCT01791816|Phenylephrine|phenylephrine|mesh-list
138501630|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
138501631|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138501632|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138501633|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
138501634|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
138501635|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501636|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501637|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
138501638|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138501640|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
138501641|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138501642|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138501643|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138501644|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
138501645|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501646|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501647|NCT01791816|Protective Agents|protective agents|mesh-ancestor
138501648|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501649|NCT00031798|Methylphenidate|methylphenidate|mesh-list
138501650|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138501651|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501652|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138501653|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138318738|NCT01381692|Rituximab|rituximab|mesh-list
138501654|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138501655|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501656|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
138501657|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501658|NCT00031837|Gemcitabine|gemcitabine|mesh-list
138501659|NCT00031837|Dalteparin|dalteparin|mesh-list
138501660|NCT00031837|Tinzaparin|tinzaparin|mesh-list
138501661|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138501662|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138501663|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
138501664|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501665|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501666|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
138501667|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138501668|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138501669|NCT00031876|Paclitaxel|paclitaxel|mesh-list
138501670|NCT00031876|Capecitabine|capecitabine|mesh-list
138501671|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138501672|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501673|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
138501674|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
138501675|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
138501676|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501677|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138501678|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
138501679|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
138501680|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501681|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138501682|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501683|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501684|NCT00031954|Paclitaxel|paclitaxel|mesh-list
138501685|NCT00031954|Carboplatin|carboplatin|mesh-list
138501686|NCT00031954|Gemcitabine|gemcitabine|mesh-list
138501687|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138501688|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454486|NCT01897051|Rifaximin|rifaximin|mesh-list
138501690|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
138501691|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
138501692|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501693|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138501694|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
138501695|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138501696|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501697|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138501698|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501699|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501700|NCT00000575|Nedocromil|nedocromil|mesh-list
138501701|NCT00000575|Budesonide|budesonide|mesh-list
138501702|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138260666|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
138501703|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138501704|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
138501705|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501706|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501707|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138501708|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
138501709|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
138501711|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138501712|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
138501713|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
138501714|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138501715|NCT00032032|Paclitaxel|paclitaxel|mesh-list
138564025|NCT02959879|Folfirinox|folfirinox|mesh-list
138501716|NCT00032032|Carboplatin|carboplatin|mesh-list
138501717|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138501718|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501719|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
138501720|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
138501721|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
138501722|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501723|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138501724|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501725|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138501726|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501727|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501728|NCT00032149|Prednisolone|prednisolone|mesh-list
138501729|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
138501730|NCT00032149|Etoposide|etoposide|mesh-list
138501731|NCT00032149|Vincristine|vincristine|mesh-list
138501732|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
138501733|NCT00032149|Bleomycin|bleomycin|mesh-list
138501734|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138501735|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
138501736|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501737|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138501738|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138501739|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
138501740|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501741|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501742|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138501743|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138501744|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138501745|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138501746|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501747|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
138501748|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
138501749|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
138501750|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138501751|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
138501752|NCT00032149|Hormones|hormones|mesh-ancestor
138501753|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138501754|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138501755|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501756|NCT00032149|Analgesics|analgesics|mesh-ancestor
138501757|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
138501758|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138501759|NCT00032188|Aldesleukin|aldesleukin|mesh-list
138501760|NCT00032188|Interleukin-2|interleukin-2|mesh-list
138501761|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
138501762|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501763|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138501764|NCT00032188|Analgesics|analgesics|mesh-ancestor
138501765|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
138501766|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501767|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501768|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138693614|NCT04106999|Analgesics|analgesics|mesh-ancestor
138564099|NCT00325858|Analgesics|analgesics|mesh-ancestor
138501769|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138501770|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
138501771|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138501772|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138501773|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
138501774|NCT00032305|Visilizumab|visilizumab|mesh-list
138501775|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
138501776|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501777|NCT00000596|Dapsone|dapsone|mesh-list
138501778|NCT00000596|Prednisone|prednisone|mesh-list
138501779|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
138501780|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138501781|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
138501782|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501783|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138501784|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138501785|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
138501786|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501787|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501788|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138501789|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138501790|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
138501791|NCT00000596|Hormones|hormones|mesh-ancestor
138501792|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138501793|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138501794|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138501795|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
138501796|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138501797|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138501798|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138501799|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501800|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
138501801|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138501802|NCT00000599|Niacin|niacin|mesh-list
138501803|NCT00000599|Colestipol|colestipol|mesh-list
138501804|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138501805|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
138501806|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501807|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138501808|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
138501809|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
138501810|NCT00000599|Vitamins|vitamins|mesh-ancestor
138501811|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
138501812|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501813|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
138501814|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
138501815|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501816|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
138501817|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501818|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501819|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138501820|NCT00032734|Satavaptan|satavaptan|mesh-list
138454510|NCT01898065|Misonidazole|misonidazole|mesh-list
138501821|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138501822|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501823|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
138501824|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501825|NCT00032773|Pentostatin|pentostatin|mesh-list
138501826|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501827|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138501828|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501829|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501830|NCT00032812|Raclopride|raclopride|mesh-list
138501831|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138501832|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138501833|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138501834|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501835|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138501836|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138501837|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
138501838|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501839|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501840|NCT00032890|Celecoxib|celecoxib|mesh-list
138501841|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138501842|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138501843|NCT00032890|Analgesics|analgesics|mesh-ancestor
138501844|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
138501845|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501846|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501847|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138501848|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138501849|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138501850|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138501851|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501852|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501853|NCT00032929|Selegiline|selegiline|mesh-list
138501854|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
138501855|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138501856|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138501857|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138501858|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138501859|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501860|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501861|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138501862|NCT00032929|Protective Agents|protective agents|mesh-ancestor
138501863|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501865|NCT00000611|Calcium|calcium|mesh-list
138501866|NCT00000611|Hormones|hormones|mesh-list
138501867|NCT00000611|Estrogens|estrogens|mesh-list
138501868|NCT00000611|Progestins|progestins|mesh-list
138501869|NCT00000611|Vitamins|vitamins|mesh-ancestor
138501870|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
138501871|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501872|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138501873|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138501874|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138501875|NCT00032968|Buprenorphine|buprenorphine|mesh-list
138501876|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138501877|NCT00032968|Naloxone|naloxone|mesh-list
138501878|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138501879|NCT00032968|Narcotics|narcotics|mesh-ancestor
138501880|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138501881|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501882|NCT00032968|Analgesics|analgesics|mesh-ancestor
138501883|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
138501884|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501885|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138501887|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138501888|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501889|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138564229|NCT00326092|Timolol|timolol|mesh-list
138501890|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138501891|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138501892|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501893|NCT00033085|Ondansetron|ondansetron|mesh-list
138501894|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
138501895|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
138501896|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501897|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501898|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138501899|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
138501900|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
138501901|NCT00033085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138501902|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138501903|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
138501904|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501905|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501906|NCT00033163|Tenofovir|tenofovir|mesh-list
138501907|NCT00033163|Adefovir|adefovir|mesh-list
138501908|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138501909|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
138501910|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138564255|NCT00326248|Casopitant|casopitant|mesh-list
138501911|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138501912|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138501913|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501914|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501915|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138501916|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138501917|NCT00033241|Gemcitabine|gemcitabine|mesh-list
138501918|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138501919|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138501920|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
138501921|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501922|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501923|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138501924|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501925|NCT00000620|Insulin|insulin|mesh-list
138501926|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138501927|NCT00000620|Metformin|metformin|mesh-list
138501928|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
138501929|NCT00000620|Pioglitazone|pioglitazone|mesh-list
138501930|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
138501931|NCT00000620|Glimepiride|glimepiride|mesh-list
138501932|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
138501933|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
138501934|NCT00000620|Acarbose|acarbose|mesh-list
138501935|NCT00000620|Repaglinide|repaglinide|mesh-list
138501936|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138501937|NCT00000620|Metoprolol|metoprolol|mesh-list
138501938|NCT00000620|Felodipine|felodipine|mesh-list
138501939|NCT00000620|Amlodipine|amlodipine|mesh-list
138501940|NCT00000620|Valsartan|valsartan|mesh-list
138501941|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138501942|NCT00000620|Carvedilol|carvedilol|mesh-list
138501943|NCT00000620|Candesartan|candesartan|mesh-list
138501944|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
138501945|NCT00000620|Lisinopril|lisinopril|mesh-list
138501946|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
138501947|NCT00000620|Diltiazem|diltiazem|mesh-list
138501948|NCT00000620|Benazepril|benazepril|mesh-list
138501949|NCT00000620|Hydralazine|hydralazine|mesh-list
138501950|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
138501951|NCT00000620|Reserpine|reserpine|mesh-list
138501952|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
138501953|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
138501954|NCT00000620|Triamterene|triamterene|mesh-list
138501955|NCT00000620|Furosemide|furosemide|mesh-list
138501956|NCT00000620|Simvastatin|simvastatin|mesh-list
138501957|NCT00000620|Fenofibrate|fenofibrate|mesh-list
138501958|NCT00000620|Terazosin|terazosin|mesh-list
138501959|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501960|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138564311|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138501961|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138501962|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138501963|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138501964|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
138501965|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138501966|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138501967|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
138501968|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138501969|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138501970|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693643|NCT01255423|Diclofenac|diclofenac|mesh-list
138501971|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138501972|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138501974|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
138501975|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138501976|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138501977|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138501978|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138501979|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
138501980|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
138501981|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
138501982|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138501983|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138501984|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138501985|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138501986|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
138501987|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138501989|NCT00000620|Protective Agents|protective agents|mesh-ancestor
138501990|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138501991|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138501992|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138501993|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
138501994|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138501995|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138501996|NCT00000620|Urological Agents|urological agents|mesh-ancestor
138501997|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138501998|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138501999|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138564343|NCT00326404|Progestins|progestins|mesh-ancestor
138502000|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138502001|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138502002|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138502003|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138502004|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138502005|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138502006|NCT00033280|Temozolomide|temozolomide|mesh-list
138502007|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138502008|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
138502009|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502010|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502011|NCT00033319|Aspirin|aspirin|mesh-list
138502012|NCT00033319|Folic Acid|folic acid|mesh-list
138502013|NCT00033319|Hematinics|hematinics|mesh-ancestor
138502014|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
138502015|NCT00033319|Vitamins|vitamins|mesh-ancestor
138502016|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
138502017|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502018|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138502019|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138502020|NCT00033319|Analgesics|analgesics|mesh-ancestor
138502021|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
138502022|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502023|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138502024|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260790|NCT02265744|Antibodies|antibodies|mesh-list
138502025|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138502026|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138502027|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502028|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138502029|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138502030|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502031|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
138502032|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138502033|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138502034|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
138502035|NCT00033358|Norgestrel|norgestrel|mesh-list
138502036|NCT00033358|Estradiol|estradiol|mesh-list
138502037|NCT00033358|Estrogens|estrogens|mesh-ancestor
138502038|NCT00033358|Hormones|hormones|mesh-ancestor
138502039|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138502040|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502041|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138502042|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
138502043|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138502044|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138502045|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138502046|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138502047|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138502048|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138502049|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138502050|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502051|NCT02971696|Sorafenib|sorafenib|mesh-list
138502052|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502053|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138502054|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502055|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502056|NCT00033436|Niacinamide|niacinamide|mesh-list
138502057|NCT00033436|Niacin|niacin|mesh-list
138502058|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
138502059|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
138502060|NCT00033436|Vitamins|vitamins|mesh-ancestor
138502061|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
138502062|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502063|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138502064|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
138502065|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502066|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138502067|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
138502068|NCT00000635|Trifluridine|trifluridine|mesh-list
138502069|NCT00000635|Polymyxins|polymyxins|mesh-list
138502070|NCT00000635|Bacitracin|bacitracin|mesh-list
138502071|NCT00000635|Polymyxin B|polymyxin b|mesh-list
138502072|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
138502073|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502074|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
138502075|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502077|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138502078|NCT00033553|Paclitaxel|paclitaxel|mesh-list
138502079|NCT00033553|Carboplatin|carboplatin|mesh-list
138502080|NCT00033553|Gemcitabine|gemcitabine|mesh-list
138502081|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138502082|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502083|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
138502084|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
138502085|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
138502086|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502087|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138502088|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
138502089|NCT00033592|Bupropion|bupropion|mesh-list
138502090|NCT00033592|Nicotine|nicotine|mesh-list
138502091|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138502092|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
138502093|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564397|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
138502094|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502095|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138502096|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138502097|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
138502098|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693659|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138260839|NCT05544786|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138502099|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502100|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138502101|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
138502102|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138502103|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138502104|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138502105|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138502107|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138502108|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138502109|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502110|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
138502111|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
138502112|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138502113|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
138502114|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138502115|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138502116|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502117|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138502118|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502119|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502120|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138502121|NCT00033709|Thalidomide|thalidomide|mesh-list
138502122|NCT00033709|Temozolomide|temozolomide|mesh-list
138502123|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138502124|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
138502125|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502126|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502127|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138502128|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
138502129|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502130|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
138502131|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138502132|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502133|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138502134|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138502135|NCT00033709|Growth Substances|growth substances|mesh-ancestor
138502136|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
138502137|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138502138|NCT00033748|Antibodies|antibodies|mesh-list
138502139|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
138502140|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138502141|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
138502142|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502143|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502144|NCT00000641|Azithromycin|azithromycin|mesh-list
138502145|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
138502146|NCT00000641|Rifampin|rifampin|mesh-list
138178583|NCT05718609|Antacids|antacids|mesh-ancestor
138502147|NCT00000641|Amikacin|amikacin|mesh-list
138502148|NCT00000641|Ethambutol|ethambutol|mesh-list
138502149|NCT00000641|Clofazimine|clofazimine|mesh-list
138502150|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138502151|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502153|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138502154|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502155|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502156|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502157|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138502158|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138502159|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138693671|NCT01254604|Timolol|timolol|mesh-list
138502160|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
138502161|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
138502162|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502163|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138502164|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138502165|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138502166|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138502167|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138502168|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138502169|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138502170|NCT00000644|Clarithromycin|clarithromycin|mesh-list
138502171|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138502172|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502173|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138502174|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502175|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502176|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138318743|NCT01381692|Antibodies|antibodies|mesh-list
138502177|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138502179|NCT02971423|Sulbactam|sulbactam|mesh-list
138502180|NCT02971423|Durlobactam|durlobactam|mesh-list
138502181|NCT02971423|Cilastatin|cilastatin|mesh-list
138502182|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138502183|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502184|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
138502185|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502186|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502187|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138502188|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138502189|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138502190|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
138502191|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502192|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502193|NCT00389090|Temozolomide|temozolomide|mesh-list
138502194|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138502195|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138502196|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
138502197|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502198|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502199|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502200|NCT00033982|Posaconazole|posaconazole|mesh-list
138502201|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
138502202|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502203|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138502204|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138260914|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502205|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138502206|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138502207|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138502208|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502209|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502210|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138502211|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
138502212|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138502213|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502214|NCT00034060|Etanercept|etanercept|mesh-list
138502215|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138564486|NCT00327145|Valsartan|valsartan|mesh-list
138502216|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138502217|NCT00034060|Analgesics|analgesics|mesh-ancestor
138502218|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
138704013|NCT06220422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502219|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502220|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502221|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138502222|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138502223|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138502224|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138502225|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
138502226|NCT00034138|Oregovomab|oregovomab|mesh-list
138502227|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138502228|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502229|NCT00034177|Paclitaxel|paclitaxel|mesh-list
138454613|NCT01900327|Gemcitabine|gemcitabine|mesh-list
138502230|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138502231|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138502232|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502233|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
138502234|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
138502235|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
138502236|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502238|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138502239|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138502240|NCT00389129|Analgesics|analgesics|mesh-ancestor
138502241|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
138502242|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502243|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502244|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138502245|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138502246|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138502247|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138502248|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502249|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138502250|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138502252|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
138502253|NCT00013962|Vitamin D|vitamin d|mesh-list
138502254|NCT00013962|Vitamins|vitamins|mesh-ancestor
138502255|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
138502256|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564522|NCT00419302|Insulin|insulin|mesh-list
138502257|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138502258|NCT00000665|Ganciclovir|ganciclovir|mesh-list
138502259|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138502260|NCT00000665|Foscarnet|foscarnet|mesh-list
138502261|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138502262|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
138502263|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502264|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502265|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502266|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502267|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138502268|NCT00034372|Oregovomab|oregovomab|mesh-list
138502269|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138564560|NCT00094029|Sunitinib|sunitinib|mesh-list
138502270|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502271|NCT00014001|Olanzapine|olanzapine|mesh-list
138502272|NCT00014001|Risperidone|risperidone|mesh-list
138502273|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138502274|NCT00014001|Ziprasidone|ziprasidone|mesh-list
138502275|NCT00014001|Clozapine|clozapine|mesh-list
138502276|NCT00014001|Perphenazine|perphenazine|mesh-list
138502277|NCT00014001|Fluphenazine|fluphenazine|mesh-list
138502278|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
138502279|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
138502280|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138502281|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
138502282|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138502283|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502284|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502285|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138502286|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138502287|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138502288|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138502289|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138502290|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
138502291|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
138502292|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
138502293|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502294|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138502295|NCT00014001|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138454632|NCT01900496|Rituximab|rituximab|mesh-list
138502296|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138502297|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138502298|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
138502299|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
138502300|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
138502301|NCT00000671|Zidovudine|zidovudine|mesh-list
138502302|NCT00000671|Didanosine|didanosine|mesh-list
138502303|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
138502304|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502305|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138502306|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502307|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502308|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
138502309|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502310|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138502311|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138502312|NCT02971540|Dipyrone|dipyrone|mesh-list
138502313|NCT02971540|Tramadol|tramadol|mesh-list
138502314|NCT02971540|Bupivacaine|bupivacaine|mesh-list
138502315|NCT02971540|Ropivacaine|ropivacaine|mesh-list
138502316|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
138502317|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
138502318|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138502319|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502320|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
138502321|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502322|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138502324|NCT02971540|Analgesics|analgesics|mesh-ancestor
138502325|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138564665|NCT05458180|Immunologic Factors|immunologic factors|mesh-ancestor
138502326|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138502327|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138502328|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138502329|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
138502330|NCT00034489|Gemcitabine|gemcitabine|mesh-list
138502331|NCT00034489|Pemetrexed|pemetrexed|mesh-list
138502332|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138502333|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
138502334|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502335|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502336|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502337|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138502338|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502339|NCT00396487|Capecitabine|capecitabine|mesh-list
138502340|NCT00396487|Fluorouracil|fluorouracil|mesh-list
138502341|NCT00396487|Irinotecan|irinotecan|mesh-list
138502342|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138502343|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
138502344|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502345|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502346|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138502347|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
138502348|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502349|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138502350|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138502351|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502352|NCT00000674|Leucovorin|leucovorin|mesh-list
138502353|NCT00000674|Clindamycin|clindamycin|mesh-list
138502354|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
138502355|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
138502356|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
138502357|NCT00000674|Calcium|calcium|mesh-list
138502358|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
138260971|NCT04739111|Antibodies|antibodies|mesh-list
138502360|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502361|NCT00000674|Antidotes|antidotes|mesh-ancestor
138502362|NCT00000674|Protective Agents|protective agents|mesh-ancestor
138502363|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
138502365|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
138502366|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138502367|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502368|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138502369|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502370|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502371|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
138502372|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138502373|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138502374|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138502375|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
138502376|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138502377|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
138502378|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502379|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502380|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138502381|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
138502382|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138502383|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
138502384|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502385|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138502386|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138502387|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
138502388|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
138502389|NCT00014040|Protective Agents|protective agents|mesh-ancestor
138502391|NCT00034528|Fludarabine|fludarabine|mesh-list
138502392|NCT00034528|Busulfan|busulfan|mesh-list
138502393|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138502394|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
138502395|NCT00034528|Hormones|hormones|mesh-ancestor
138502396|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138502397|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502398|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138502399|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502400|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502402|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
138502403|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
138502404|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138502405|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138502406|NCT00000677|Sch 39304|sch 39304|mesh-list
138502407|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
138502408|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502409|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
138502410|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138502411|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
138261002|NCT00369551|Bevacizumab|bevacizumab|mesh-list
138502413|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
138502414|NCT04711642|Protective Agents|protective agents|mesh-ancestor
138502415|NCT00034606|Gemcitabine|gemcitabine|mesh-list
138502416|NCT00034606|Pemetrexed|pemetrexed|mesh-list
138502417|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138502418|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
138502419|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502420|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502421|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502422|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138502423|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502424|NCT00034645|Posaconazole|posaconazole|mesh-list
138502425|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
138502426|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502427|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138502428|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138502429|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138502430|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138502431|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138502432|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502433|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502434|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138502435|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
138502436|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138502437|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502438|NCT00034762|Risperidone|risperidone|mesh-list
138502439|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138502440|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
138502441|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138502442|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502443|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502444|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138502445|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138502446|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693754|NCT04683458|Paclitaxel|paclitaxel|mesh-list
138502447|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138502448|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138502451|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
138502452|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502454|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502455|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502456|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
138502457|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502458|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138502459|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138502460|NCT00034801|Olanzapine|olanzapine|mesh-list
138502461|NCT00034801|Ziprasidone|ziprasidone|mesh-list
138502462|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
138502463|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
138502464|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502465|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502466|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138502468|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138502469|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138502470|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138502471|NCT00034801|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138502472|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138502473|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138502474|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502475|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138502476|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
138502477|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138502478|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138502479|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
138502480|NCT00014196|Docetaxel|docetaxel|mesh-list
138502481|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502482|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
138502483|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
138502484|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
138564826|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502485|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502486|NCT00034840|Valsartan|valsartan|mesh-list
138502487|NCT00034840|Telmisartan|telmisartan|mesh-list
138502488|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138502489|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138502490|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138502491|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502492|NCT00000689|Leucovorin|leucovorin|mesh-list
138502493|NCT00000689|Cytarabine|cytarabine|mesh-list
138502494|NCT00000689|Dexamethasone|dexamethasone|mesh-list
138502495|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
138502496|NCT00000689|Doxorubicin|doxorubicin|mesh-list
138502497|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138502498|NCT00000689|Methotrexate|methotrexate|mesh-list
138502499|NCT00000689|Vincristine|vincristine|mesh-list
138502500|NCT00000689|Bleomycin|bleomycin|mesh-list
138502501|NCT00000689|Sargramostim|sargramostim|mesh-list
138502502|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
138502503|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138502504|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
138502505|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502506|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138261043|NCT05446415|Incretins|incretins|mesh-list
138502507|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138502509|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502510|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502511|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138502512|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138502513|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
138502514|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
138564860|NCT00086801|Gemcitabine|gemcitabine|mesh-list
138502515|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502516|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138502517|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
138502518|NCT00000689|Hormones|hormones|mesh-ancestor
138502519|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138502520|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138502521|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138502522|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138502523|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138502524|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502525|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138502527|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138502528|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138502529|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
138502530|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
138502531|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138502532|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502533|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
138502534|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502536|NCT00000689|Protective Agents|protective agents|mesh-ancestor
138502537|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
138502538|NCT00000689|Vitamins|vitamins|mesh-ancestor
138502539|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
138502540|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138502541|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
138502542|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
138502543|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
138502544|NCT00034879|Gefitinib|gefitinib|mesh-list
138502545|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502546|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138502547|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502548|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502549|NCT00000707|Pentamidine|pentamidine|mesh-list
138502550|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
138502551|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502552|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138502553|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138502554|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138502555|NCT00014235|Cyclosporine|cyclosporine|mesh-list
138502556|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
138502557|NCT00014235|Fludarabine|fludarabine|mesh-list
138502558|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
138502559|NCT00014235|Cyclosporins|cyclosporins|mesh-list
138502560|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502561|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138502562|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
138502563|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502564|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138502565|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
138502566|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502567|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502568|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
138502569|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502570|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
138502571|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138502572|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138502573|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138502574|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138502575|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
138502576|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138502577|NCT00000710|Didanosine|didanosine|mesh-list
138502578|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
138502579|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502580|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138502581|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502582|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502583|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
138502584|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502585|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138502586|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138502588|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
138502589|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502590|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138502591|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502592|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502593|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
138502594|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502595|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138502596|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138502597|NCT00014274|Carboplatin|carboplatin|mesh-list
138502598|NCT00014274|Gemcitabine|gemcitabine|mesh-list
138502599|NCT00014274|Methotrexate|methotrexate|mesh-list
138502600|NCT00014274|Vinblastine|vinblastine|mesh-list
138502601|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502602|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138502603|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
138502604|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502605|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138502606|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
138502607|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138502608|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502609|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
138502610|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502611|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138454688|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138502612|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138502613|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
138502614|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138502615|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502616|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138502617|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
138502618|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
138502619|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
138502620|NCT00035035|Gemcitabine|gemcitabine|mesh-list
138502621|NCT00035035|Pemetrexed|pemetrexed|mesh-list
138502622|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138502623|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
138502624|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502625|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502626|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502627|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138502628|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502629|NCT00000719|Zidovudine|zidovudine|mesh-list
138502630|NCT00000719|Zalcitabine|zalcitabine|mesh-list
138502631|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
138502632|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502633|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138502634|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502635|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502636|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
138502637|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502638|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138502639|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138502640|NCT00014313|Etoposide|etoposide|mesh-list
138502641|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502642|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138502643|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138502644|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138502645|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502646|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502647|NCT00035074|Methotrexate|methotrexate|mesh-list
138502648|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138502649|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
138502650|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138502651|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502652|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138502653|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
138502654|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502655|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502656|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
138502657|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502658|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138502659|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138502660|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
138502661|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138502662|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502663|NCT00035113|Epothilones|epothilones|mesh-list
138502664|NCT00035113|Epothilone B|epothilone b|mesh-list
138502665|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
138502666|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
138454715|NCT01900717|Vitamins|vitamins|mesh-ancestor
138502667|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
138261123|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138502668|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502669|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502671|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
138502672|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502673|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138502674|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138502675|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138502676|NCT00035152|Paclitaxel|paclitaxel|mesh-list
138502678|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138502679|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502680|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
138502681|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
138502682|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
138502683|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502685|NCT00014352|Docetaxel|docetaxel|mesh-list
138502686|NCT00014352|Doxorubicin|doxorubicin|mesh-list
138502687|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138502688|NCT00014352|Estramustine|estramustine|mesh-list
138502689|NCT00014352|Warfarin|warfarin|mesh-list
138502690|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502691|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
138502692|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
138502693|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
138502694|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502695|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138502696|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138502697|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138502698|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502699|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
138502700|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
138502701|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502702|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138502703|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138502704|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138502705|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
138502706|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138502707|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502708|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138502709|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138502710|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
138502711|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138502712|NCT00035191|Galantamine|galantamine|mesh-list
138502713|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138502714|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502715|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502716|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
138502717|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138502718|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502719|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138502720|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
138502721|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502722|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
138502723|NCT00035230|Topiramate|topiramate|mesh-list
138502724|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
138502725|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138502726|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502727|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138502728|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502729|NCT00014391|Ribavirin|ribavirin|mesh-list
138502730|NCT00014391|Palivizumab|palivizumab|mesh-list
138502731|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
138502732|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502733|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
138502734|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502735|NCT00035308|Abetimus|abetimus|mesh-list
138502736|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138502737|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
138502738|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502739|NCT00035347|Azithromycin|azithromycin|mesh-list
138502740|NCT00035347|Levofloxacin|levofloxacin|mesh-list
138502741|NCT00035347|Ofloxacin|ofloxacin|mesh-list
138502742|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
138502743|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138502744|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502745|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138502746|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138502747|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138502748|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502749|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502750|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502751|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138502752|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138502754|NCT00014430|Vinorelbine|vinorelbine|mesh-list
138502755|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138502756|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502758|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
138502759|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
138502760|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
138502761|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502762|NCT00035425|Vancomycin|vancomycin|mesh-list
138502763|NCT00035425|Linezolid|linezolid|mesh-list
138502764|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138502765|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502766|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138502767|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502768|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502769|NCT00000752|Cefuroxime|cefuroxime|mesh-list
138502770|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
138502771|NCT00000752|Beclomethasone|beclomethasone|mesh-list
138502772|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
138502773|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
138502774|NCT00000752|Ephedrine|ephedrine|mesh-list
138502775|NCT00000752|Guaifenesin|guaifenesin|mesh-list
138565127|NCT00094848|Mapatumumab|mapatumumab|mesh-list
138502776|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
138502777|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138502778|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
138502779|NCT00000752|Hormones|hormones|mesh-ancestor
138502780|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138502781|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502782|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138502783|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
138502784|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138502785|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
138502786|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502787|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
138502788|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138502789|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138502790|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
138502791|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
138502792|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138502793|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502794|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138502795|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502796|NCT00000752|Expectorants|expectorants|mesh-ancestor
138502797|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138502798|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138502799|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
138502800|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138502801|NCT00035464|Azimilide|azimilide|mesh-list
138502802|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138502803|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138502804|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138502805|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502806|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138502807|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502808|NCT00014469|Methotrexate|methotrexate|mesh-list
138502810|NCT00014469|Busulfan|busulfan|mesh-list
138502811|NCT00014469|Tacrolimus|tacrolimus|mesh-list
138502812|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138502813|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
138502814|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138502815|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502816|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138502817|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
138502818|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502819|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502820|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
138502821|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502822|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138502823|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138502824|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
138502825|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138179264|NCT05664971|Immunologic Factors|immunologic factors|mesh-ancestor
138502826|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502827|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138502828|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138502829|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
138502831|NCT00000755|Zidovudine|zidovudine|mesh-list
138502832|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
138502833|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502834|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138502835|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138502836|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502837|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
138502838|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502839|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138502840|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138502841|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138502842|NCT00035581|Poly I-C|poly i-c|mesh-list
138502843|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
138502844|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565207|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
138502845|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
138502846|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
138502847|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502848|NCT00000758|Fluorouracil|fluorouracil|mesh-list
138502849|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
138502850|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502851|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138502852|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502853|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138502854|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
138502855|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502856|NCT00035620|Lenograstim|lenograstim|mesh-list
138502857|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138502858|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
138502859|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502860|NCT00014547|BBR 3464|bbr 3464|mesh-list
138502861|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502862|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
138502863|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138502864|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
138502865|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502866|NCT02971306|Expectorants|expectorants|mesh-ancestor
138502867|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
138502868|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138502869|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
138261224|NCT02466581|Analgesics|analgesics|mesh-ancestor
138502870|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502871|NCT02971306|Protective Agents|protective agents|mesh-ancestor
138502872|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502873|NCT02971306|Antidotes|antidotes|mesh-ancestor
138502874|NCT00000761|Interferons|interferons|mesh-list
138502875|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
138502876|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502877|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
138502878|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502879|NCT00014586|Goserelin|goserelin|mesh-list
138502880|NCT00014586|Bicalutamide|bicalutamide|mesh-list
138502881|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138502882|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502883|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
138502884|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
138502885|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138502886|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502887|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
138502888|NCT04732390|Bupivacaine|bupivacaine|mesh-list
138502889|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
138502890|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
138502891|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138502892|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502893|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
138502894|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502895|NCT04732390|Analgesics|analgesics|mesh-ancestor
138502896|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138502897|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
138502898|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138502899|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138502900|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502901|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138502902|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
138502903|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138502904|NCT00035854|Linezolid|linezolid|mesh-list
138502905|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138502907|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138502908|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502909|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502910|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138502911|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138502912|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
138502913|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502914|NCT00000779|Antacids|antacids|mesh-ancestor
138454755|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
138565276|NCT00087581|Cyclosporine|cyclosporine|mesh-list
138502915|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502916|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138502917|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138502918|NCT00035893|Poly I-C|poly i-c|mesh-list
138502919|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
138502920|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502921|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
138502922|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
138502923|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502924|NCT00035971|Alendronate|alendronate|mesh-list
138502925|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138502926|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138502927|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502928|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138502929|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
138502930|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138502931|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138502932|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138502933|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
138502934|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502935|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138502936|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502937|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502939|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
138502940|NCT02971345|Epirubicin|epirubicin|mesh-list
138502941|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
138502942|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138502943|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138502944|NCT02971345|Trace Elements|trace elements|mesh-ancestor
138502945|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
138502946|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565331|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
138502947|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138502948|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138502949|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138502950|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138502951|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138502952|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502953|NCT00036088|Olanzapine|olanzapine|mesh-list
138502954|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
138502955|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
138502956|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502957|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502958|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138502959|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138502960|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138502961|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138502962|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138502963|NCT00036088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138502964|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138502965|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138502966|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502967|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138502968|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
138502969|NCT00036127|Aripiprazole|aripiprazole|mesh-list
138502970|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
138502971|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138502972|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138502973|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138502974|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138502975|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502976|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
138502977|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
138502978|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138502979|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138502980|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138502981|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138502982|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
138502983|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138693907|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138502985|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138502986|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138502987|NCT00000788|Fluconazole|fluconazole|mesh-list
138502988|NCT00000788|Methadone|methadone|mesh-list
138502989|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138502990|NCT00000788|Narcotics|narcotics|mesh-ancestor
138502991|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138502992|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138502993|NCT00000788|Analgesics|analgesics|mesh-ancestor
138502994|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
138502995|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138502996|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
138502997|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
138502998|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
138502999|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503000|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138503001|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138503002|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503003|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503004|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138503005|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
138503006|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138503007|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138503008|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138503009|NCT00036166|Micafungin|micafungin|mesh-list
138503010|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
138503011|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503012|NCT00000794|Leucovorin|leucovorin|mesh-list
138503013|NCT00000794|Clarithromycin|clarithromycin|mesh-list
138503014|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
138503015|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
138503016|NCT00000794|Atovaquone|atovaquone|mesh-list
138503017|NCT00000794|Calcium|calcium|mesh-list
138503018|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
138503019|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138503020|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503021|NCT00000794|Antidotes|antidotes|mesh-ancestor
138503022|NCT00000794|Protective Agents|protective agents|mesh-ancestor
138503023|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
138503024|NCT00000794|Vitamins|vitamins|mesh-ancestor
138503025|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
138503026|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138503027|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503028|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138503029|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261295|NCT00370253|Norepinephrine|norepinephrine|mesh-list
138503030|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503031|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138503032|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138503034|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138503035|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138503036|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138503037|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
138503038|NCT00036244|Secretin|secretin|mesh-list
138503039|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138503040|NCT00036244|Hormones|hormones|mesh-ancestor
138503041|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138503042|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503043|NCT00036283|Celecoxib|celecoxib|mesh-list
138503044|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138503045|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138503046|NCT00036283|Analgesics|analgesics|mesh-ancestor
138503047|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
138503048|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138503049|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503050|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138503051|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138503052|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138503053|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138503055|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503056|NCT00391638|Interferons|interferons|mesh-list
138503057|NCT00391638|Tenofovir|tenofovir|mesh-list
138503058|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138503059|NCT00391638|Emtricitabine|emtricitabine|mesh-list
138503060|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138503061|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503062|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
138503063|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503064|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503065|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503066|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503067|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503068|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503069|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503070|NCT00036361|Aripiprazole|aripiprazole|mesh-list
138503071|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
138503072|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138503073|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138503074|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138503075|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138503076|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503077|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
138503078|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
138503080|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503081|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138503082|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138503083|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
138503084|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138503085|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138503086|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138503087|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138503088|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
138503089|NCT00036400|Hematinics|hematinics|mesh-ancestor
138503090|NCT00036439|Infliximab|infliximab|mesh-list
138503091|NCT00036439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138503092|NCT00036439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138503093|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
138503094|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138503095|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138503096|NCT00000821|Aldesleukin|aldesleukin|mesh-list
138503097|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503098|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503099|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503100|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
138503101|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503102|NCT00036556|Atrasentan|atrasentan|mesh-list
138503103|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503104|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138503105|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138503106|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503107|NCT00000827|Immune Sera|immune sera|mesh-list
138503108|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
138503109|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503111|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
138503112|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503113|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503114|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503115|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503116|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503117|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503118|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503119|NCT00000851|Didanosine|didanosine|mesh-list
138503120|NCT00000851|Stavudine|stavudine|mesh-list
138503121|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
138503122|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503123|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503124|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503125|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503126|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
138503127|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503128|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503129|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503130|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
138503131|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503132|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138503133|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503134|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503135|NCT00036790|Doxorubicin|doxorubicin|mesh-list
138503137|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
138503138|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138503139|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503140|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138503141|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138503142|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503143|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503144|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138503145|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
138503146|NCT00000857|Interleukin-12|interleukin-12|mesh-list
138503147|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138503148|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
138503149|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503150|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138503151|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138503152|NCT00000857|Growth Substances|growth substances|mesh-ancestor
138503153|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
138503154|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503155|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
138503156|NCT00036868|Fluorouracil|fluorouracil|mesh-list
138503157|NCT00036868|Methotrexate|methotrexate|mesh-list
138503158|NCT00036868|Trastuzumab|trastuzumab|mesh-list
138503159|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503160|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
138503161|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503162|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138503163|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138503164|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
138503165|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503166|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503167|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138503168|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
138503169|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138503170|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138503171|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
138503172|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138503173|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
138503174|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503175|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138503176|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503177|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138503178|NCT00036946|Aflibercept|aflibercept|mesh-list
138503179|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138503180|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138503181|NCT00036946|Growth Substances|growth substances|mesh-ancestor
138503182|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503183|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
138503184|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503185|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
138503186|NCT00036985|Doxorubicin|doxorubicin|mesh-list
138503187|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138503188|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503189|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
138503190|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503191|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138503192|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138503193|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
138503194|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503195|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261364|NCT00371111|Hormones|hormones|mesh-ancestor
138503196|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138503197|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138503198|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138503199|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138503200|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503203|NCT00037063|Riboflavin|riboflavin|mesh-list
138503204|NCT00037063|Thiamine|thiamine|mesh-list
138503207|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503208|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
138503209|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503210|NCT00037063|Protective Agents|protective agents|mesh-ancestor
138503211|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
138503212|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138503213|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
138503214|NCT00000869|Nevirapine|nevirapine|mesh-list
138503215|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503216|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503217|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503218|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503219|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
138503220|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503221|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503222|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503223|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138503224|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138503225|NCT00037102|Interferons|interferons|mesh-list
138503226|NCT00037102|Interferon-beta|interferon-beta|mesh-list
138503227|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
138503228|NCT00037102|Methotrexate|methotrexate|mesh-list
138503229|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138503230|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
138503231|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138503232|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503233|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138503234|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
138503235|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503236|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503238|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503239|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138503240|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503241|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
138503242|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138503243|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503244|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
138503245|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503246|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138503247|NCT00037141|Ethanol|ethanol|mesh-list
138503248|NCT00037141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138503249|NCT00037141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503250|NCT00037141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138503251|NCT00037141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503252|NCT00037180|Leucovorin|leucovorin|mesh-list
138503253|NCT00037180|Celecoxib|celecoxib|mesh-list
138503254|NCT00037180|Fluorouracil|fluorouracil|mesh-list
138503255|NCT00037180|Irinotecan|irinotecan|mesh-list
138503256|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
138503257|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503258|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138503259|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503260|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503261|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
138503262|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503263|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138503264|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138503265|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503266|NCT00037180|Antidotes|antidotes|mesh-ancestor
138503267|NCT00037180|Protective Agents|protective agents|mesh-ancestor
138503268|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
138503269|NCT00037180|Vitamins|vitamins|mesh-ancestor
138503270|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
138503271|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138503272|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138503273|NCT00037180|Analgesics|analgesics|mesh-ancestor
138503274|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
138503275|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138503276|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138503277|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138503278|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138503279|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138503281|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
138503282|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503283|NCT00000893|Efavirenz|efavirenz|mesh-list
138503284|NCT00000893|Nelfinavir|nelfinavir|mesh-list
138503285|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503286|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503287|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503288|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503289|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
138503290|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503291|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138503292|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138503293|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138503294|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138503295|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138693982|NCT04157153|Sirolimus|sirolimus|mesh-list
138503296|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138454841|NCT01901549|Metoprolol|metoprolol|mesh-list
138503297|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138503298|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138503299|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
138503300|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503301|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503302|NCT00396526|Amoxicillin|amoxicillin|mesh-list
138503303|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138503304|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138503305|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503306|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138503307|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
138503308|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138503309|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138503310|NCT00037531|Sirolimus|sirolimus|mesh-list
138503311|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138503312|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503313|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138503314|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261395|NCT05451719|Capecitabine|capecitabine|mesh-list
138503315|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
138503316|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503317|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
138503318|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503320|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138503321|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138503322|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138503323|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503324|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503325|NCT00000899|Lamivudine|lamivudine|mesh-list
138503326|NCT00000899|Stavudine|stavudine|mesh-list
138503327|NCT00000899|Nelfinavir|nelfinavir|mesh-list
138503328|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
138503329|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503330|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
138503331|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503332|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138503333|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138503334|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
138503335|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503336|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503337|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138503338|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503339|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503340|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503341|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
138503342|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503343|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503344|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503345|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138503346|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138503347|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
138503348|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
138503349|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
138503350|NCT00037609|Capecitabine|capecitabine|mesh-list
138503351|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138179788|NCT05105074|Morphine|morphine|mesh-list
138503352|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
138503353|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503355|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138503356|NCT00037609|Protective Agents|protective agents|mesh-ancestor
138503357|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503358|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138503359|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503360|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138503361|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138503362|NCT00037609|Analgesics|analgesics|mesh-ancestor
138454856|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
138261412|NCT01898689|Ropivacaine|ropivacaine|mesh-list
138503363|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
138503364|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138503365|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138503366|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138503367|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138503368|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138503370|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138445967|NCT01841320|Methadone|methadone|mesh-list
138503371|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138503372|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503373|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503374|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503375|NCT00037882|Interferons|interferons|mesh-list
138503376|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
138503377|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
138503378|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138503379|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503380|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
138503381|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503382|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
138503383|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503384|NCT00037999|Testosterone|testosterone|mesh-list
138503385|NCT00037999|Androgens|androgens|mesh-ancestor
138503386|NCT00037999|Hormones|hormones|mesh-ancestor
138503387|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138503388|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503389|NCT00038077|Metoprolol|metoprolol|mesh-list
138503390|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138503391|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138503392|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
138503393|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
138503394|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138503395|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503396|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138503397|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138503398|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138503399|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
138503400|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138503401|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503402|NCT00038116|Dopamine|dopamine|mesh-list
138503403|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138503404|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
138503405|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
138503406|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138503407|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503408|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
138503409|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138261432|NCT05062577|GABA Agents|gaba agents|mesh-ancestor
138503410|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503411|NCT00038116|Protective Agents|protective agents|mesh-ancestor
138503412|NCT00038194|Docetaxel|docetaxel|mesh-list
138503413|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
138503414|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503415|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
138503416|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
138503417|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
138503418|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503419|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138503420|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503421|NCT00038233|Thalidomide|thalidomide|mesh-list
138503422|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503423|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
138503424|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503425|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
138503426|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138454868|NCT01901666|Hormones|hormones|mesh-list
138179858|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503427|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503428|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138503429|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138503430|NCT00038233|Growth Substances|growth substances|mesh-ancestor
138503431|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
138503432|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503433|NCT00000926|Nonoxynol|nonoxynol|mesh-list
138503434|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138503435|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138503436|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503437|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138503438|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
138503439|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138503440|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138503441|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
138503442|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138503443|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503444|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138503445|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
138503446|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138503447|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261466|NCT00370019|Estradiol|estradiol|mesh-list
138503448|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503449|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503450|NCT00000941|Ritonavir|ritonavir|mesh-list
138503451|NCT00000941|Nelfinavir|nelfinavir|mesh-list
138503452|NCT00000941|Saquinavir|saquinavir|mesh-list
138503453|NCT00000941|Atorvastatin|atorvastatin|mesh-list
138503454|NCT00000941|Simvastatin|simvastatin|mesh-list
138503455|NCT00000941|Pravastatin|pravastatin|mesh-list
138503456|NCT00000941|Calcium|calcium|mesh-list
138503457|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138503458|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503459|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138503460|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138503461|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
138503462|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503463|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138503464|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138503465|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503466|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138317945|NCT03026244|Caseins|caseins|mesh-list
138503467|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138503468|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
138503469|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503470|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503471|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
138503472|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503473|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138503474|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138503475|NCT00014937|Ritonavir|ritonavir|mesh-list
138503476|NCT00014937|Lopinavir|lopinavir|mesh-list
138503477|NCT00014937|Lamivudine|lamivudine|mesh-list
138503478|NCT00014937|Zidovudine|zidovudine|mesh-list
138503479|NCT00014937|Didanosine|didanosine|mesh-list
138503480|NCT00014937|Stavudine|stavudine|mesh-list
138503481|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138503482|NCT00014937|Efavirenz|efavirenz|mesh-list
138503483|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138503484|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138503485|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
138503486|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503487|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503488|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503489|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503490|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
138503491|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503492|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138503493|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138503494|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503495|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503496|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
138503497|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138503498|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138503499|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138503500|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138503501|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138503502|NCT00000959|Pyridoxine|pyridoxine|mesh-list
138503503|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
138503504|NCT00000959|Isoniazid|isoniazid|mesh-list
138503505|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
138503506|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138503507|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565820|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
138503508|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138503509|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138503510|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
138503511|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503512|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138503513|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
138503514|NCT00000959|Vitamins|vitamins|mesh-ancestor
138503515|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
138503516|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503517|NCT00000962|Nevirapine|nevirapine|mesh-list
138503518|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503519|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503520|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503521|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503522|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
138503523|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503524|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503525|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503526|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138503527|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138503528|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
138503529|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503530|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
138503531|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565856|NCT04394975|Sunitinib|sunitinib|mesh-list
138503532|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138503533|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138503534|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
138503535|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503536|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503537|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138503538|NCT00396721|Sirolimus|sirolimus|mesh-list
138503539|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138503540|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138503541|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138503542|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503543|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138503544|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503545|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
138503546|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503547|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
138503548|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503549|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503550|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503551|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138503552|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138503553|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
138503554|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138503555|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
138503556|NCT00000965|Zidovudine|zidovudine|mesh-list
138503557|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
138503558|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503559|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503560|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503561|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503562|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
138503563|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503564|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503565|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503566|NCT00015054|Methylphenidate|methylphenidate|mesh-list
138503567|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138565905|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
138503568|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503569|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138503570|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138503571|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138503572|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503573|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
138503574|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138503575|NCT00015132|Sertraline|sertraline|mesh-list
138503576|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
138503578|NCT00015132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138503579|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138503580|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138503581|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503582|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138503583|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
138503584|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503585|NCT00000971|Zidovudine|zidovudine|mesh-list
138503586|NCT00000971|Didanosine|didanosine|mesh-list
138503587|NCT00000971|Clarithromycin|clarithromycin|mesh-list
138503588|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
138503589|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503590|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503591|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503592|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503593|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
138503594|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503595|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503596|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503597|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138503598|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138503599|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138503600|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138503601|NCT00015171|Buprenorphine|buprenorphine|mesh-list
138503602|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138503603|NCT00015171|Naloxone|naloxone|mesh-list
138503604|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138503605|NCT00015171|Narcotics|narcotics|mesh-ancestor
138503606|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138503607|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503608|NCT00015171|Analgesics|analgesics|mesh-ancestor
138503609|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
138503610|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138503611|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138503612|NCT00015210|Nefazodone|nefazodone|mesh-list
138503613|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138503614|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138503615|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138649751|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138503616|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503617|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138503618|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503619|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138503620|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
138503621|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138503622|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138503623|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138503624|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
138503626|NCT00000986|Aldesleukin|aldesleukin|mesh-list
138503627|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
138503628|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503629|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503630|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503631|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503632|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
138503633|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503634|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503635|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503636|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503637|NCT00015249|Amantadine|amantadine|mesh-list
138503638|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138503639|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138503640|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
138503641|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503642|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
138503643|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138503644|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503645|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503646|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138503647|NCT00015249|Analgesics|analgesics|mesh-ancestor
138503648|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
138180083|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503650|NCT05195242|Dexamethasone|dexamethasone|mesh-list
138503651|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138503654|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138503655|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503656|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138503657|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
138503658|NCT05195242|Hormones|hormones|mesh-ancestor
138503659|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138503660|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138503661|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503662|NCT00015288|Buprenorphine|buprenorphine|mesh-list
138503663|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138503664|NCT00015288|Naloxone|naloxone|mesh-list
138503665|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138503666|NCT00015288|Narcotics|narcotics|mesh-ancestor
138503667|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261551|NCT04679831|Praziquantel|praziquantel|mesh-list
138503668|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503669|NCT00015288|Analgesics|analgesics|mesh-ancestor
138503670|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
138503671|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138503672|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138503673|NCT05083975|Anesthetics|anesthetics|mesh-list
138503674|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
138503675|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138503676|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503677|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
138503678|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138503679|NCT00000998|Leucovorin|leucovorin|mesh-list
138503680|NCT00000998|Trimetrexate|trimetrexate|mesh-list
138503681|NCT00000998|Calcium|calcium|mesh-list
138503682|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
138503683|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138454908|NCT01902160|Sirolimus|sirolimus|mesh-list
138503684|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503685|NCT00000998|Antidotes|antidotes|mesh-ancestor
138503686|NCT00000998|Protective Agents|protective agents|mesh-ancestor
138503687|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
138503688|NCT00000998|Vitamins|vitamins|mesh-ancestor
138503689|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
138503690|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
138503691|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503692|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138503693|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
138503694|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503695|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503696|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138503697|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503698|NCT00001001|Zidovudine|zidovudine|mesh-list
138503699|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
138503700|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503701|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503702|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503703|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503704|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
138503705|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503706|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503707|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503708|NCT05076877|Metformin|metformin|mesh-list
138503709|NCT05076877|Midazolam|midazolam|mesh-list
138503710|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138503712|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138503713|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503714|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138503715|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138503716|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138503717|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138503718|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138503719|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138503720|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138503721|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
138503722|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
138503723|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
138503724|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
138503725|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138503726|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503727|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138503728|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138503729|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
138503730|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138503731|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138503732|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503733|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138503734|NCT00001004|Interferons|interferons|mesh-list
138503735|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
138503736|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503737|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
138503738|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503739|NCT00396604|Maleic acid|maleic acid|mesh-list
138503740|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503741|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503742|NCT04896541|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
138503743|NCT04896541|Antiviral Agents|antiviral agents|mesh-ancestor
138503744|NCT04896541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503745|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
138503747|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138503748|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138503749|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503750|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
138503751|NCT00396760|Coagulants|coagulants|mesh-ancestor
138503752|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138503753|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138503754|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
138503755|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503756|NCT00001007|Zidovudine|zidovudine|mesh-list
138503757|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
138503758|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503759|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138261610|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
138503760|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503761|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503763|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503764|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503765|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503766|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
138503768|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138503769|NCT00396799|Hormones|hormones|mesh-ancestor
138503770|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138503771|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503772|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138503773|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138503774|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
138503775|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138503776|NCT01786434|Fentanyl|fentanyl|mesh-list
138503777|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138503778|NCT01786434|Narcotics|narcotics|mesh-ancestor
138503779|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138503780|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503781|NCT01786434|Analgesics|analgesics|mesh-ancestor
138503782|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
138503783|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138503784|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138503785|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138503786|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
138503787|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
138503788|NCT00001010|Zidovudine|zidovudine|mesh-list
138503789|NCT00001010|Acyclovir|acyclovir|mesh-list
138503790|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
138503791|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503792|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503793|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503794|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503795|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
138503796|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503797|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503798|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503799|NCT00001013|Leucovorin|leucovorin|mesh-list
138503800|NCT00001013|Trimethoprim|trimethoprim|mesh-list
138503801|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138503802|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
138503803|NCT00001013|Pentamidine|pentamidine|mesh-list
138503804|NCT00001013|Trimetrexate|trimetrexate|mesh-list
138503805|NCT00001013|Calcium|calcium|mesh-list
138503806|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
138503807|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138503808|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503809|NCT00001013|Antidotes|antidotes|mesh-ancestor
138503810|NCT00001013|Protective Agents|protective agents|mesh-ancestor
138503811|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
138503812|NCT00001013|Vitamins|vitamins|mesh-ancestor
138503813|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
138503814|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138503815|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503817|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138503818|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138503819|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138503821|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503822|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138503823|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138503824|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138503825|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
138503826|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138503827|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138503828|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138503829|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
138503830|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503831|NCT04680442|Trastuzumab|trastuzumab|mesh-list
138503832|NCT04680442|Pertuzumab|pertuzumab|mesh-list
138503833|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138503834|NCT04680442|Maytansine|maytansine|mesh-list
138503835|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138503836|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503837|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138503838|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
138503839|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
138503840|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
138503841|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503842|NCT04680442|Immunotoxins|immunotoxins|mesh-ancestor
138503843|NCT04680442|Immunoconjugates|immunoconjugates|mesh-ancestor
138503844|NCT04680442|Immunologic Factors|immunologic factors|mesh-ancestor
138503845|NCT04680442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503846|NCT00015834|Cytarabine|cytarabine|mesh-list
138503847|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
138503848|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138503849|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
138503850|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503851|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503852|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
138503853|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503854|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503855|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
138503856|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503857|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138503858|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503859|NCT00001040|Zidovudine|zidovudine|mesh-list
138503860|NCT00001040|Zalcitabine|zalcitabine|mesh-list
138503861|NCT00001040|Saquinavir|saquinavir|mesh-list
138503862|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
138503863|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503864|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503865|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503866|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503867|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
138503868|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503869|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503870|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503871|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138503872|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138503873|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
138503874|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138503875|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138503876|NCT00015873|Cytarabine|cytarabine|mesh-list
138180308|NCT02633488|Metformin|metformin|mesh-list
138503877|NCT00015873|Prednisolone|prednisolone|mesh-list
138503878|NCT00015873|Methotrexate|methotrexate|mesh-list
138503879|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
138503880|NCT00015873|Vincristine|vincristine|mesh-list
138503881|NCT00015873|Asparaginase|asparaginase|mesh-list
138503882|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138503883|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
138503884|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138503885|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503886|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138503887|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
138503888|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503889|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503890|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
138503891|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503892|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138503893|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503894|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
138503895|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138503896|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503897|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
138503898|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503899|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138503900|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
138503901|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
138503902|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
138503903|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138503904|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
138503906|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138503907|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138503908|NCT00015912|Interferons|interferons|mesh-list
138503909|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
138503910|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
138503911|NCT00015912|Thalidomide|thalidomide|mesh-list
138503912|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503913|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
138503914|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503915|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
138503916|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503917|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503918|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
138503919|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138503920|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138503921|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138503922|NCT00015912|Growth Substances|growth substances|mesh-ancestor
138503923|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
138503924|NCT03668431|Trametinib|trametinib|mesh-list
138503925|NCT03668431|Dabrafenib|dabrafenib|mesh-list
138503926|NCT03668431|Spartalizumab|spartalizumab|mesh-list
138503927|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503928|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138503929|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503930|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503931|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138503932|NCT03668431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138503933|NCT00001073|Isotretinoin|isotretinoin|mesh-list
138503934|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
138503935|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
138503936|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
138503937|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138503938|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138503939|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138503940|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503941|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
138503942|NCT00015951|Cytarabine|cytarabine|mesh-list
138503943|NCT00015951|Bevacizumab|bevacizumab|mesh-list
138503944|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
138503945|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138503946|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503947|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138503948|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138503949|NCT00015951|Growth Substances|growth substances|mesh-ancestor
138503950|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503951|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
138503952|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138566157|NCT02187224|Progesterone|progesterone|mesh-list
138503953|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
138261714|NCT03251651|Propofol|propofol|mesh-list
138503954|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503956|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503957|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503958|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
138503960|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
138503961|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138503962|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138503963|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138503966|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138503967|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
138503968|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503969|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138503970|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503971|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
138503972|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503973|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
138503974|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138503975|NCT00001076|Protective Agents|protective agents|mesh-ancestor
138503976|NCT00015990|Thalidomide|thalidomide|mesh-list
138503977|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138503978|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
138503979|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503980|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
138503981|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138503982|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503983|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138503984|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138503985|NCT00015990|Growth Substances|growth substances|mesh-ancestor
138503986|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
138503987|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503988|NCT00001085|Lamivudine|lamivudine|mesh-list
138503989|NCT00001085|Zidovudine|zidovudine|mesh-list
138503990|NCT00001085|Amprenavir|amprenavir|mesh-list
138503991|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138503992|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138503993|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503994|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138503995|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
138503996|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503997|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138503998|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138503999|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
138504000|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138504001|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
138504002|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138504004|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138504005|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
138504006|NCT02970916|Aflibercept|aflibercept|mesh-list
138504007|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138504008|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138504009|NCT02970916|Growth Substances|growth substances|mesh-ancestor
138504010|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504011|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
138504012|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504013|NCT00016068|Valganciclovir|valganciclovir|mesh-list
138504014|NCT00016068|Ganciclovir|ganciclovir|mesh-list
138504015|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138504016|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
138504017|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504018|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138504019|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504020|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504021|NCT00016107|Bevacizumab|bevacizumab|mesh-list
138504022|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138504023|NCT00016107|Docetaxel|docetaxel|mesh-list
138566203|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566204|NCT01946477|Dexamethasone|dexamethasone|mesh-list
138566205|NCT01946477|Daratumumab|daratumumab|mesh-list
138566206|NCT01946477|Pomalidomide|pomalidomide|mesh-list
138566207|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138566208|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
138566209|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
138566210|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566211|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566212|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138566213|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
138566214|NCT01946477|Hormones|hormones|mesh-ancestor
138566215|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138504024|NCT00016107|Estramustine|estramustine|mesh-list
138504025|NCT00016107|Antibodies|antibodies|mesh-list
138504026|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
138504027|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138504028|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504029|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138504030|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138504031|NCT00016107|Growth Substances|growth substances|mesh-ancestor
138504032|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504033|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
138504034|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
138504036|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
138504037|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
138504038|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504039|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138504040|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
138504041|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138504042|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
138504043|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138504044|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138504045|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504046|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138504047|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138504048|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
138504050|NCT00016185|Docetaxel|docetaxel|mesh-list
138504051|NCT00016185|Alvocidib|alvocidib|mesh-list
138504052|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504053|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
138504054|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
138504055|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
138504056|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504057|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
138504058|NCT00016185|Growth Substances|growth substances|mesh-ancestor
138504059|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504060|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138504061|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504062|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138504063|NCT00001151|Calcitriol|calcitriol|mesh-list
138504064|NCT00001151|Vitamins|vitamins|mesh-ancestor
138504065|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
138504066|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504067|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138504068|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138566254|NCT05952921|Chlorhexidine|chlorhexidine|mesh-list
138504069|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138504070|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138504071|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504072|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138504073|NCT00016224|Thalidomide|thalidomide|mesh-list
138504074|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504075|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
138504076|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504077|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
138504078|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138504079|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504080|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138504081|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138504082|NCT00016224|Growth Substances|growth substances|mesh-ancestor
138504083|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
138504084|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504085|NCT00016263|Dacarbazine|dacarbazine|mesh-list
138504086|NCT00016263|Oblimersen|oblimersen|mesh-list
138504087|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138504088|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
138504089|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504090|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504091|NCT00016302|Leucovorin|leucovorin|mesh-list
138504092|NCT00016302|Cytarabine|cytarabine|mesh-list
138504093|NCT00016302|Dexamethasone|dexamethasone|mesh-list
138504094|NCT00016302|Prednisone|prednisone|mesh-list
138504095|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
138504096|NCT00016302|Doxorubicin|doxorubicin|mesh-list
138504097|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138504098|NCT00016302|Methotrexate|methotrexate|mesh-list
138504099|NCT00016302|Vincristine|vincristine|mesh-list
138504100|NCT00016302|Daunorubicin|daunorubicin|mesh-list
138504101|NCT00016302|Asparaginase|asparaginase|mesh-list
138504102|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
138504103|NCT00016302|Pegaspargase|pegaspargase|mesh-list
138504104|NCT00016302|Thioguanine|thioguanine|mesh-list
138504105|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
138504106|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504107|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
138504108|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504109|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504110|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138504111|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
138504112|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504113|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504114|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138504115|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138504116|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
138504117|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
138504118|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138504119|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138504120|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
138694212|NCT00538005|Sorafenib|sorafenib|mesh-list
138504122|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138504123|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138504124|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138504125|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138504126|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138504127|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566288|NCT05952050|Analgesics|analgesics|mesh-ancestor
138504128|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138504129|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
138504130|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138504131|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138504132|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
138504133|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
138504134|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138504135|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138504136|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
138504137|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504138|NCT00016302|Antidotes|antidotes|mesh-ancestor
138504139|NCT00016302|Protective Agents|protective agents|mesh-ancestor
138504140|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
138504142|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
138504143|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138504144|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
138504145|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
138504146|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
138504147|NCT00389285|Sorafenib|sorafenib|mesh-list
138504148|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504149|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138504150|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504151|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504152|NCT00016341|Tamoxifen|tamoxifen|mesh-list
138504153|NCT00016341|Paclitaxel|paclitaxel|mesh-list
138504154|NCT00016341|Doxorubicin|doxorubicin|mesh-list
138504155|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138504156|NCT00016341|Megestrol|megestrol|mesh-list
138504157|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
138504158|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138504159|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504160|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
138504161|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
138504162|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
138504163|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504164|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138504165|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138504166|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138504167|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504168|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504169|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138504170|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
138504171|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138504172|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138504173|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138504174|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138504175|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138504176|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138504177|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138504178|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138504179|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
138504180|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138504181|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138504182|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138504183|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
138504184|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138504186|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138504187|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504188|NCT00016380|Dexamethasone|dexamethasone|mesh-list
138504189|NCT00016380|Ondansetron|ondansetron|mesh-list
138504190|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138504191|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
138504192|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
138504193|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138504194|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504195|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138504196|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
138504198|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138504199|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138504200|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504202|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
138504203|NCT00016380|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138504204|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138504205|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
138504206|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138504207|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504209|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504210|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504211|NCT00001202|Testolactone|testolactone|mesh-list
138504212|NCT00001202|Spironolactone|spironolactone|mesh-list
138504213|NCT00001202|Deslorelin|deslorelin|mesh-list
138504214|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138504215|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
138504216|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138504217|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504218|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138504219|NCT00001202|Diuretics|diuretics|mesh-ancestor
138504220|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
138504221|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138566327|NCT05951413|Estrogens|estrogens|mesh-ancestor
138504222|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504223|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504224|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504225|NCT00016419|Cyclosporine|cyclosporine|mesh-list
138504226|NCT00016419|Cyclosporins|cyclosporins|mesh-list
138504227|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138504228|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504229|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504230|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504231|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
138504232|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504233|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
138504234|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504235|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
138504236|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138261895|NCT05417659|Niacin|niacin|mesh-list
138504237|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138504238|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
138504239|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138455033|NCT01902550|Metoprolol|metoprolol|mesh-list
138504240|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504241|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
138504242|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504243|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504244|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138504245|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
138504246|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504247|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504248|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138504249|NCT01156545|Afatinib|afatinib|mesh-list
138504250|NCT01156545|Simvastatin|simvastatin|mesh-list
138504251|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138504252|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138504253|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
138504254|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504255|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138504256|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138180679|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
138504257|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504258|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504259|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138504260|NCT00001262|Copper|copper|mesh-list
138504261|NCT00001262|Trace Elements|trace elements|mesh-ancestor
138504262|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
138504263|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504264|NCT00001280|Itraconazole|itraconazole|mesh-list
138504265|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
138504266|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504267|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138504268|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138504269|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504270|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504271|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138504272|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
138504273|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138504274|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504275|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138504277|NCT00016887|Cytarabine|cytarabine|mesh-list
138504278|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
138504279|NCT00016887|Dexamethasone|dexamethasone|mesh-list
138504280|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
138504281|NCT00016887|Melphalan|melphalan|mesh-list
138504282|NCT00016887|Carmustine|carmustine|mesh-list
138504283|NCT00016887|Etoposide|etoposide|mesh-list
138504284|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504285|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
138504286|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504287|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138455046|NCT01902641|Rocuronium|rocuronium|mesh-list
138504288|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138504289|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
138504290|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504291|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504292|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138504293|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138504294|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
138504295|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
138504296|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138504297|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138504298|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
138504299|NCT00016887|Hormones|hormones|mesh-ancestor
138504300|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138504301|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138504302|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138694245|NCT01266460|Vaccines|vaccines|mesh-list
138504303|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138504304|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138504305|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504306|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
138504307|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504308|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138504309|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
138504310|NCT00038389|Rofecoxib|rofecoxib|mesh-list
138504311|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138504312|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138504313|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504314|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504315|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138504316|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138504317|NCT00038389|Analgesics|analgesics|mesh-ancestor
138504318|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
138504319|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138504320|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504321|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138504322|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504323|NCT00038506|Tenofovir|tenofovir|mesh-list
138504324|NCT00038506|Lamivudine|lamivudine|mesh-list
138504325|NCT00038506|Zidovudine|zidovudine|mesh-list
138504326|NCT00038506|Abacavir|abacavir|mesh-list
138504327|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138504328|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
138504329|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261966|NCT04337879|Irinotecan|irinotecan|mesh-list
138504331|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138504332|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504333|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504334|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138504335|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138504336|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
138504337|NCT00016926|Capecitabine|capecitabine|mesh-list
138504338|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138504339|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
138504340|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504341|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504342|NCT00038545|Paclitaxel|paclitaxel|mesh-list
138504343|NCT00038545|Topotecan|topotecan|mesh-list
138504344|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138504345|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504346|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
138504347|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
138455061|NCT01902810|Propranolol|propranolol|mesh-list
138504348|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
138504349|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504350|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138504351|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138504352|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504353|NCT00038584|Lonafarnib|lonafarnib|mesh-list
138504354|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504355|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504356|NCT00038623|Rituximab|rituximab|mesh-list
138504357|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138504358|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504359|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
138504360|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504361|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504362|NCT00038662|Atrasentan|atrasentan|mesh-list
138504363|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504364|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138566410|NCT05901974|Venetoclax|venetoclax|mesh-list
138504365|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138694265|NCT01266265|Urological Agents|urological agents|mesh-ancestor
138504366|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504367|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
138504368|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138504369|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504370|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138504371|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138504372|NCT00038701|Growth Substances|growth substances|mesh-ancestor
138504373|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504374|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
138504375|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138504376|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138504377|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138504378|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138504379|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504380|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138504381|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504382|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138504383|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
138504384|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138504385|NCT00038935|Factor VIII|factor viii|mesh-list
138504386|NCT00038935|Coagulants|coagulants|mesh-ancestor
138504387|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
138504388|NCT00017004|Hematinics|hematinics|mesh-ancestor
138504389|NCT00038974|Ribavirin|ribavirin|mesh-list
138566465|NCT05726110|Cytarabine|cytarabine|mesh-list
138504390|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138504391|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
138504392|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504393|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
138504394|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504395|NCT00039013|Exenatide|exenatide|mesh-list
138504396|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138504397|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504398|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138504399|NCT00039013|Incretins|incretins|mesh-ancestor
138504400|NCT00039013|Hormones|hormones|mesh-ancestor
138504401|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138504402|NCT00039052|Interleukin-4|interleukin-4|mesh-list
138504403|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138504404|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
138318755|NCT01381692|Hormones|hormones|mesh-ancestor
138504405|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504406|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504407|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504408|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
138504409|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504410|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138504411|NCT00039091|Ipilimumab|ipilimumab|mesh-list
138504412|NCT00039091|Antibodies|antibodies|mesh-list
138504413|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
138262035|NCT02295553|Ketamine|ketamine|mesh-list
138504414|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138504415|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
138504416|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504417|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504418|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138504419|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504420|NCT00039169|IDN 5109|idn 5109|mesh-list
138504421|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504422|NCT00001304|Vitamin D|vitamin d|mesh-list
138504423|NCT00001304|Calcitriol|calcitriol|mesh-list
138504424|NCT00001304|Calcium|calcium|mesh-list
138504425|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
138504426|NCT00001304|Hormones|hormones|mesh-list
138504427|NCT00001304|Vitamins|vitamins|mesh-ancestor
138504428|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
138504429|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504430|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138504431|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138504432|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138504433|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138504434|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138504435|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504436|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138504437|NCT00039208|Leucovorin|leucovorin|mesh-list
138504438|NCT00039208|Fluorouracil|fluorouracil|mesh-list
138504439|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
138504440|NCT00039208|Irinotecan|irinotecan|mesh-list
138504441|NCT00039208|Calcium|calcium|mesh-list
138504442|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
138504443|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138504444|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504445|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
138649752|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138504446|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504447|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138504448|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504449|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504450|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
138504451|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138504452|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138504453|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504454|NCT00039208|Antidotes|antidotes|mesh-ancestor
138504455|NCT00039208|Protective Agents|protective agents|mesh-ancestor
138504456|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
138504457|NCT00039208|Vitamins|vitamins|mesh-ancestor
138504458|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
138504459|NCT00017121|Sargramostim|sargramostim|mesh-list
138504460|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
138504461|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504462|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138504463|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138504464|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504465|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
138504466|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504467|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138504468|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504469|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504470|NCT00039403|Gemcitabine|gemcitabine|mesh-list
138504471|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138504472|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138504473|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
138504474|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504475|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504476|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138504477|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504478|NCT00039442|Capecitabine|capecitabine|mesh-list
138504479|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138504480|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
138504481|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504482|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504483|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
138504484|NCT00039481|Doxorubicin|doxorubicin|mesh-list
138504485|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138504486|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
138504487|NCT00039481|Razoxane|razoxane|mesh-list
138504488|NCT00039481|Oblimersen|oblimersen|mesh-list
138504489|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504490|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
138504491|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504492|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504493|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138504494|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
138504495|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504496|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504497|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138566509|NCT05635370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138504498|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138504499|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138504500|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138504501|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504502|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138504503|NCT00039481|Protective Agents|protective agents|mesh-ancestor
138504504|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
138504505|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
138504507|NCT00001322|Estradiol|estradiol|mesh-list
138504508|NCT00001322|Progesterone|progesterone|mesh-list
138504509|NCT00001322|Estrogens|estrogens|mesh-ancestor
138504510|NCT00001322|Hormones|hormones|mesh-ancestor
138504511|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138504512|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504513|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138504514|NCT00001322|Progestins|progestins|mesh-ancestor
138504515|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138504516|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
138504517|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138504518|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504519|NCT00039520|Sulindac|sulindac|mesh-list
138504520|NCT00039520|Docetaxel|docetaxel|mesh-list
138504521|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504522|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
138504523|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
138504524|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
138504525|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504526|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138504527|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138504528|NCT00039520|Analgesics|analgesics|mesh-ancestor
138504529|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
138504530|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138504531|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504532|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138504533|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504534|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138504535|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504536|NCT00001328|Ganciclovir|ganciclovir|mesh-list
138504537|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138504538|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
138504539|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504540|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138504541|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504542|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504543|NCT00017160|Doxorubicin|doxorubicin|mesh-list
138504544|NCT00017160|Ifosfamide|ifosfamide|mesh-list
138504545|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
138504546|NCT00017160|Immunomodulating Agents|immunomodulating agents|mesh-list
138504547|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138504548|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504549|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138504550|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138504551|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504552|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504553|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504554|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138504555|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
138504557|NCT00039832|Abciximab|abciximab|mesh-list
138504558|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
138504559|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138180984|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
138504560|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138504561|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138504562|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504563|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
138504564|NCT00039988|Albuterol|albuterol|mesh-list
138504565|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
138504566|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138504567|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
138504568|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138504570|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138504571|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
138504572|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
138504573|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138504574|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138504575|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138504576|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138504577|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
138504578|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138694342|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
138504579|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504580|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138504581|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
138504582|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504583|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504584|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138504585|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
138504586|NCT00040027|Thymalfasin|thymalfasin|mesh-list
138504587|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
138504588|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504589|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
138504590|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504591|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138504592|NCT00001343|Oxandrolone|oxandrolone|mesh-list
138504593|NCT00001343|Androgens|androgens|mesh-ancestor
138504595|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138504596|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504597|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
138504598|NCT00040066|Cocaine|cocaine|mesh-list
138504599|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
138504600|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
138504601|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138504602|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504603|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
138504604|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138504605|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138504606|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138504607|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138504608|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138504609|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504610|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
138504611|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138504612|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
138504613|NCT00040105|Tipifarnib|tipifarnib|mesh-list
138504614|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504615|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138504616|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504617|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504618|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
138504619|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138504620|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138504621|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504622|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504623|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
138504624|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504625|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138504626|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138504627|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138504628|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504629|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138504630|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504631|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504632|NCT00040261|Memantine|memantine|mesh-list
138504633|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138504634|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138504636|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138694364|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138504637|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504638|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504639|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138504640|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138504641|NCT00040300|Racivir|racivir|mesh-list
138504642|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
138504643|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504644|NCT00040378|Vitamins|vitamins|mesh-list
138504645|NCT00040378|Vitamin E|vitamin e|mesh-list
138504646|NCT00040378|Tocopherols|tocopherols|mesh-list
138504647|NCT00040378|Tocotrienols|tocotrienols|mesh-list
138504648|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
138504649|NCT00040378|Selenium|selenium|mesh-list
138504650|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
138504651|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504652|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
138504653|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504654|NCT00040378|Protective Agents|protective agents|mesh-ancestor
138504655|NCT00040378|Trace Elements|trace elements|mesh-ancestor
138504656|NCT00017199|Bortezomib|bortezomib|mesh-list
138504657|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504658|NCT00040417|Fludarabine|fludarabine|mesh-list
138504660|NCT00040417|Lenograstim|lenograstim|mesh-list
138504661|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504662|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
138504663|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504664|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138504665|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138504666|NCT00040495|Pantoprazole|pantoprazole|mesh-list
138504667|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138504668|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138504669|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138504670|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504671|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504672|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
138504673|NCT00040651|Fludarabine|fludarabine|mesh-list
138504674|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
138504675|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504676|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
138504677|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504678|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504679|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138504680|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
138504681|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504682|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504683|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138504684|NCT00040690|Leucovorin|leucovorin|mesh-list
138504685|NCT00040690|Cytarabine|cytarabine|mesh-list
138504686|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
138504687|NCT00040690|Ifosfamide|ifosfamide|mesh-list
138504688|NCT00040690|Doxorubicin|doxorubicin|mesh-list
138504689|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138504690|NCT00040690|Methotrexate|methotrexate|mesh-list
138504691|NCT00040690|Etoposide|etoposide|mesh-list
138504692|NCT00040690|Vincristine|vincristine|mesh-list
138504693|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
138504694|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504695|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
138504696|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504697|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504698|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138504699|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
138504700|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504701|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504702|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138504703|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138504704|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138504705|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138504706|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504707|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138504708|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
138504709|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138504710|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138504711|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
138262108|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
138504712|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
138504713|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138504714|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138504715|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138504716|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
138504717|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504719|NCT00040690|Protective Agents|protective agents|mesh-ancestor
138504720|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
138504722|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
138504723|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
138504724|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
138504725|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
138504726|NCT00040768|Bortezomib|bortezomib|mesh-list
138504727|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504728|NCT00017238|KRN 5500|krn 5500|mesh-list
138504729|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504730|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138504731|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566649|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504732|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504733|NCT00040885|Infliximab|infliximab|mesh-list
138504734|NCT00040885|Docetaxel|docetaxel|mesh-list
138504735|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504736|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
138504737|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
138504738|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
138504739|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504740|NCT00040885|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138504741|NCT00040885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138504742|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
138504743|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138504744|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504745|NCT00001421|Methimazole|methimazole|mesh-list
138504746|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
138504747|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
138504748|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138504749|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504750|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
138504751|NCT00017277|Hematinics|hematinics|mesh-ancestor
138504752|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
138504753|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504754|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138504755|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504756|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504757|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
138504758|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504759|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138504760|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504761|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504762|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
138504763|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504764|NCT00041236|Exatecan|exatecan|mesh-list
138504765|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138504766|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138504767|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262125|NCT05272787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138504768|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504769|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504770|NCT00017316|Thalidomide|thalidomide|mesh-list
138504771|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504772|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
138504773|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504774|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
138504775|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138504776|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504777|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138504778|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138504779|NCT00017316|Growth Substances|growth substances|mesh-ancestor
138504780|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
138566669|NCT05059600|Brexanolone|brexanolone|mesh-list
138504781|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504783|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
138504784|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138504785|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138504786|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138504787|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
138504788|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138504789|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504790|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138504791|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138504792|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138504793|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504794|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
138504795|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138504796|NCT00017355|Lenograstim|lenograstim|mesh-list
138504797|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138504798|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
138504799|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504800|NCT00397072|Sagopilone|sagopilone|mesh-list
138504801|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504802|NCT00017394|Bevacizumab|bevacizumab|mesh-list
138504803|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138504804|NCT00017394|Vinorelbine|vinorelbine|mesh-list
138504805|NCT00017394|Antibodies|antibodies|mesh-list
138504806|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
138504807|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138504808|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504809|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138504810|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138504811|NCT00017394|Growth Substances|growth substances|mesh-ancestor
138504812|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504813|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
138504814|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
138504815|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138504816|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
138504817|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
138504818|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
138504819|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504820|NCT00041431|Hormones|hormones|mesh-list
138504821|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138504822|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504823|NCT00001436|Tamoxifen|tamoxifen|mesh-list
138504824|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138504825|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
138504826|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138262153|NCT04365049|Paclitaxel|paclitaxel|mesh-list
138504827|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504828|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138504829|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504830|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138566693|NCT05049902|Antacids|antacids|mesh-ancestor
138504831|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138504832|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138504833|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
138504834|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138455183|NCT01903785|Albuterol|albuterol|mesh-list
138504835|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
138504836|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138504837|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504838|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138504839|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
138504840|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138504841|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
138504842|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504843|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138504844|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138504845|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
138504846|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
138504847|NCT00041548|Protective Agents|protective agents|mesh-ancestor
138504848|NCT00041587|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
138504849|NCT00041587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504850|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
138504851|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504852|NCT00041665|Mitogens|mitogens|mesh-list
138504853|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
138504854|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504855|NCT00041704|Anidulafungin|anidulafungin|mesh-list
138504856|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
138504857|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504858|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138504860|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
138504861|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138504862|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
138504863|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504864|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504865|NCT00041782|Dalteparin|dalteparin|mesh-list
138504866|NCT00041782|Tinzaparin|tinzaparin|mesh-list
138694449|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
138504867|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138504868|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
138504869|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138504870|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138504871|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504872|NCT00017511|Cevimeline|cevimeline|mesh-list
138504873|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138504874|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
138504875|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138504876|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504877|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138504878|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138504879|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
138504880|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138504881|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504882|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
138504883|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138504884|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
138504885|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138504886|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504887|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138504888|NCT00041977|Doxycycline|doxycycline|mesh-list
138504889|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138504890|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504891|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
138504892|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138504893|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138504894|NCT00042016|Decitabine|decitabine|mesh-list
138504895|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138504896|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
138694481|NCT00539331|Paclitaxel|paclitaxel|mesh-list
138504897|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504898|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504899|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504900|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138504901|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
138504902|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504903|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504905|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138455190|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
138504906|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138504907|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504908|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504909|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
138504910|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504911|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138504912|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138504913|NCT00042172|Donepezil|donepezil|mesh-list
138504914|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138504915|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504916|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504917|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
138504918|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138504919|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504920|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
138504921|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
138504922|NCT00017589|Oblimersen|oblimersen|mesh-list
138504923|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138504924|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504925|NCT00017589|Immunotoxins|immunotoxins|mesh-ancestor
138504926|NCT00017589|Immunoconjugates|immunoconjugates|mesh-ancestor
138504927|NCT00017589|Immunologic Factors|immunologic factors|mesh-ancestor
138504928|NCT00017589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504929|NCT00001475|Thalidomide|thalidomide|mesh-list
138504930|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504931|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
138504932|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504934|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138504935|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504936|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138504937|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138504938|NCT00001475|Growth Substances|growth substances|mesh-ancestor
138504940|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504941|NCT00042328|Valacyclovir|valacyclovir|mesh-list
138504942|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
138504943|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138504944|NCT00042367|Mafosfamide|mafosfamide|mesh-list
138504945|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
138504946|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138504947|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
138504948|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504949|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504950|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504951|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504952|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138504953|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
138504954|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504955|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138504956|NCT02970643|Olanzapine|olanzapine|mesh-list
138504957|NCT02970643|Palonosetron|palonosetron|mesh-list
138504958|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
138504959|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
138504960|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138504961|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504962|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138504963|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138504964|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138504965|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138504966|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138504967|NCT02970643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138504968|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138504969|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138504970|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566795|NCT04485039|Tecovirimat|tecovirimat|mesh-list
138504971|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138504972|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
138504973|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138504974|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138504975|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
138504976|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138504977|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138504978|NCT00017628|Prednisolone|prednisolone|mesh-list
138504979|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
138504980|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
138504981|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138504982|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
138504983|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138504984|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
138504985|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138504986|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138504987|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138504988|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
138504989|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138504990|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138504991|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138504992|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138504993|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
138504994|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
138504995|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138504996|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138504997|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
138504998|NCT00017628|Hormones|hormones|mesh-ancestor
138504999|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138505000|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138505001|NCT00017628|Protective Agents|protective agents|mesh-ancestor
138262263|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
138505003|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138505004|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138505005|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138505006|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138505007|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505008|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138505009|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505011|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
138505012|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138505013|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
138505014|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138505015|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
138505016|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138505017|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138505018|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
138505019|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505021|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138505022|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505023|NCT00042679|Carboplatin|carboplatin|mesh-list
138505024|NCT00042679|Gemcitabine|gemcitabine|mesh-list
138505025|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566806|NCT04413890|Dinoprostone|dinoprostone|mesh-list
138505026|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138505027|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
138505028|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505029|NCT00042718|Amoxicillin|amoxicillin|mesh-list
138505030|NCT00042718|Azithromycin|azithromycin|mesh-list
138505031|NCT00042718|Levofloxacin|levofloxacin|mesh-list
138505032|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
138505033|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
138505034|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138505035|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138505036|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505037|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138505038|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138505039|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138505040|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505041|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505042|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505043|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138505044|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138505045|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138505046|NCT00042796|Decitabine|decitabine|mesh-list
138505047|NCT00042796|Azacitidine|azacitidine|mesh-list
138505048|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138505049|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
138505050|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505051|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505052|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505053|NCT00042835|Paclitaxel|paclitaxel|mesh-list
138505054|NCT00042835|Etoposide|etoposide|mesh-list
138505055|NCT00042835|Docetaxel|docetaxel|mesh-list
138505056|NCT00042835|Carboplatin|carboplatin|mesh-list
138505057|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
138505058|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138505059|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138505060|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505061|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
138505062|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
138505063|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
138505064|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505065|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138505066|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138505067|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505068|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138505069|NCT00017784|Valganciclovir|valganciclovir|mesh-list
138505070|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
138505071|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505072|NCT00042874|Leucovorin|leucovorin|mesh-list
138505073|NCT00042874|Fluorouracil|fluorouracil|mesh-list
138505074|NCT00042874|Irinotecan|irinotecan|mesh-list
138505075|NCT00042874|Alvocidib|alvocidib|mesh-list
138505076|NCT00042874|Calcium|calcium|mesh-list
138505077|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
138505078|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138505079|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505080|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
138505081|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505082|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138505083|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566832|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
138505084|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138505085|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
138505086|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138505087|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138181510|NCT03219853|Selenium|selenium|mesh-list
138505088|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505089|NCT00042874|Antidotes|antidotes|mesh-ancestor
138505090|NCT00042874|Protective Agents|protective agents|mesh-ancestor
138505091|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
138262312|NCT00373451|Bivalirudin|bivalirudin|mesh-list
138505093|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
138505094|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
138505095|NCT00042874|Growth Substances|growth substances|mesh-ancestor
138505096|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138505097|NCT00042913|Epratuzumab|epratuzumab|mesh-list
138505098|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138505099|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505100|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
138505101|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505102|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138505103|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505104|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505105|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
138505106|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
138505107|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
138505109|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
138505110|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
138505111|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138505112|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505113|NCT00043069|Vitamins|vitamins|mesh-ancestor
138505114|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
138505115|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138505116|NCT00043069|Hormones|hormones|mesh-ancestor
138505117|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138505118|NCT00043069|Antacids|antacids|mesh-ancestor
138505119|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505120|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138505121|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138505122|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138505123|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
138505124|NCT00043147|Prednisone|prednisone|mesh-list
138505125|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
138505126|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138505127|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138505128|NCT00043147|Prednisolone|prednisolone|mesh-list
138505129|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
138505130|NCT00043147|Beclomethasone|beclomethasone|mesh-list
138505131|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138262359|NCT02778113|Glucagon|glucagon|mesh-list
138505132|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
138505133|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138505134|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
138505135|NCT00043147|Hormones|hormones|mesh-ancestor
138505136|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138505137|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505138|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138505139|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505140|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
138505141|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
138505142|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138505143|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138505144|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138505145|NCT00043147|Protective Agents|protective agents|mesh-ancestor
138505146|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138505147|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
138505148|NCT00017862|Reslizumab|reslizumab|mesh-list
138505149|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138505150|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
138505151|NCT00043264|Azithromycin|azithromycin|mesh-list
138505152|NCT00043264|Rifampin|rifampin|mesh-list
138505153|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138566890|NCT04153032|Diltiazem|diltiazem|mesh-list
138505154|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505155|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138505156|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
138505157|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
138505158|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138505159|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505160|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505161|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138505162|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138505163|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138505164|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138505165|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138505166|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138505167|NCT00043303|Interferons|interferons|mesh-list
138505168|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
138505169|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505170|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
138505171|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505172|NCT00017940|Mitogens|mitogens|mesh-list
138505173|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
138505174|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505175|NCT02970604|Aspirin|aspirin|mesh-list
138505176|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138505177|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138505178|NCT02970604|Analgesics|analgesics|mesh-ancestor
138505179|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
138505180|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138505181|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505182|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138505183|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138505184|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138505185|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138505186|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178465|NCT02352831|Capecitabine|capecitabine|mesh-list
138566932|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
138505187|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138505188|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138505189|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505190|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
138505191|NCT00043342|Interferons|interferons|mesh-list
138505192|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
138505193|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505194|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
138505195|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505196|NCT00043381|Decitabine|decitabine|mesh-list
138505197|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138505198|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
138505199|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505200|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505201|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505202|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
138505203|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138505204|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
138505205|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505206|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
138505207|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505208|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138505209|NCT00043537|Fluoxetine|fluoxetine|mesh-list
138505210|NCT00043537|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138505211|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138505212|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138505213|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505214|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138505215|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
138505216|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505217|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138505218|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
138505219|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138505220|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138505221|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138505222|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505223|NCT00043576|Calcitriol|calcitriol|mesh-list
138505224|NCT00043576|Docetaxel|docetaxel|mesh-list
138505225|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505226|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
138505227|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
138505228|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
138505229|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505230|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138455309|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
138505232|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138505233|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138505234|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138505235|NCT00043576|Vitamins|vitamins|mesh-ancestor
138505236|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
138505237|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138505239|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138505240|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
138505241|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138505242|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505243|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138505244|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138505245|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138505246|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
138505247|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138505248|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138505249|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
138505250|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138505251|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
138505252|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138505253|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138505254|NCT00043771|Tolvaptan|tolvaptan|mesh-list
138505255|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138505256|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505257|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
138505258|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505259|NCT00043810|Fludarabine|fludarabine|mesh-list
138505260|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
138505261|NCT00043810|Busulfan|busulfan|mesh-list
138505262|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
138505263|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505264|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138505265|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
138505266|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505267|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138505268|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
138505269|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505270|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
138693569|NCT04687878|Insulin|insulin|mesh-list
138505271|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138505272|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138505273|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138505274|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138505275|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505276|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138505277|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
138505278|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138505279|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138505280|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138505281|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138505282|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505283|NCT00001586|Rituximab|rituximab|mesh-list
138505284|NCT00001586|Fludarabine|fludarabine|mesh-list
138505285|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
138505286|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138505287|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505288|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
138414273|NCT01652534|Analgesics|analgesics|mesh-ancestor
138505289|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505290|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138505291|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138262440|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
138505292|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
138505293|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505294|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138505295|NCT00043888|Ritonavir|ritonavir|mesh-list
138505296|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
138505297|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138505298|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138505299|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138505300|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
138505301|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505302|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505303|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138505304|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138505305|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
138505306|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505307|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138505308|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138505309|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138505310|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138505313|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505314|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138505315|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138505316|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505317|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
138505318|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505319|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138505320|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138505321|NCT00043927|Cisplatin|cisplatin|mesh-list
138505322|NCT00043927|Etoposide|etoposide|mesh-list
138505323|NCT00043927|Topotecan|topotecan|mesh-list
138505324|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505325|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138505326|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138505327|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138505328|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505329|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505330|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138505331|NCT00043966|Ritonavir|ritonavir|mesh-list
138505332|NCT00043966|Lopinavir|lopinavir|mesh-list
138505333|NCT00043966|Tenofovir|tenofovir|mesh-list
138505334|NCT00043966|Emtricitabine|emtricitabine|mesh-list
138505336|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138505337|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
138505338|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505339|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505340|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138505341|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138505342|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
138505343|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505344|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138505345|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138505346|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138505347|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138505348|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138505349|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138505350|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
138505351|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505352|NCT04731727|Riboflavin|riboflavin|mesh-list
138505353|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
138505354|NCT04731727|Vitamins|vitamins|mesh-ancestor
138505355|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
138505356|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505357|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138505358|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
138505359|NCT00044278|Lamotrigine|lamotrigine|mesh-list
138505360|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
138505361|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138505362|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138505363|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505364|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138505365|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505366|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138505367|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138505368|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138505369|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138505370|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138505371|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
138505372|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505373|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505374|NCT00044434|Bupropion|bupropion|mesh-list
138505375|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138505376|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
138693626|NCT05003089|Hormones|hormones|mesh-ancestor
138693627|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138505377|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138505378|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138505379|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138505380|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138262490|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
138505381|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505382|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
138505383|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138505384|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505385|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138505386|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138505387|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505388|NCT00044473|Levofloxacin|levofloxacin|mesh-list
138505389|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138505390|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505391|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138505392|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138505393|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138505394|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505395|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505396|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505397|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138505398|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138505400|NCT00044551|IDN 5109|idn 5109|mesh-list
138505401|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505402|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138505403|NCT00018135|Calcium|calcium|mesh-list
138505404|NCT00018135|Sevelamer|sevelamer|mesh-list
138505405|NCT00018135|Calcium acetate|calcium acetate|mesh-list
138505406|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138505407|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505408|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
138505409|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
138455354|NCT01904786|Melatonin|melatonin|mesh-list
138505410|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505411|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138505412|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
138505413|NCT00018135|Antacids|antacids|mesh-ancestor
138505414|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138505415|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138505416|NCT00397384|Cetuximab|cetuximab|mesh-list
138505417|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138505418|NCT00397384|Antibodies|antibodies|mesh-list
138505419|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
138505420|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138505421|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
138505422|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505423|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505424|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138505425|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505426|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505427|NCT00397423|Lenograstim|lenograstim|mesh-list
138505428|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138505429|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
138505430|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505431|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
138505433|NCT00397501|Methotrexate|methotrexate|mesh-list
138505434|NCT00397501|Trastuzumab|trastuzumab|mesh-list
138505435|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505436|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138505437|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
138505438|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138505439|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505440|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138505441|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
138505442|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505443|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
138505444|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505445|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138505446|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138505447|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
138505448|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138505449|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138505450|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138505451|NCT00397501|Antidotes|antidotes|mesh-ancestor
138505452|NCT00397501|Protective Agents|protective agents|mesh-ancestor
138505453|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
138505454|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
138505455|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138505456|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505457|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
138505458|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
138505459|NCT00018174|Fluoxetine|fluoxetine|mesh-list
138505460|NCT00018174|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138505461|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138505462|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138505463|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505464|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138505465|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
138505466|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505467|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138505468|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
138505469|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138694662|NCT01263496|Alogliptin|alogliptin|mesh-list
138505470|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138505471|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138505472|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693681|NCT04390698|Anesthetics|anesthetics|mesh-list
138505473|NCT00044629|Zolpidem|zolpidem|mesh-list
138291323|NCT00378547|Analgesics|analgesics|mesh-ancestor
138505475|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138505476|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138505477|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505478|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138505479|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
138505480|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
138505481|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138505482|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505483|NCT00044668|Exenatide|exenatide|mesh-list
138505484|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138505485|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505486|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138505487|NCT00044668|Incretins|incretins|mesh-ancestor
138505488|NCT00044668|Hormones|hormones|mesh-ancestor
138505489|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138505490|NCT00044707|Pramlintide|pramlintide|mesh-list
138505491|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138505492|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505493|NCT00044746|Tazobactam|tazobactam|mesh-list
138505494|NCT00044746|Piperacillin|piperacillin|mesh-list
138505495|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138505496|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138505497|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505498|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138505499|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505500|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505501|NCT00044785|Leucovorin|leucovorin|mesh-list
138505502|NCT00044785|Fluorouracil|fluorouracil|mesh-list
138505503|NCT00044785|Irinotecan|irinotecan|mesh-list
138505504|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
138505505|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505506|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138505507|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505508|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138505509|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
138505510|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505511|NCT00044785|Antidotes|antidotes|mesh-ancestor
138505512|NCT00044785|Protective Agents|protective agents|mesh-ancestor
138505513|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
138505514|NCT00044785|Vitamins|vitamins|mesh-ancestor
138505515|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
138505516|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138505517|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138505518|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505519|NCT00044824|Fexofenadine|fexofenadine|mesh-list
138505520|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138505521|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138505522|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138505523|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
138693695|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138505524|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
138505525|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138505526|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505527|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505529|NCT00018213|Nicotine|nicotine|mesh-list
138505530|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138505531|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
138505532|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138505533|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505534|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138505535|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138505536|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
138505537|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262559|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
138505538|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505539|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138505540|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138505541|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
138455372|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
138505543|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138505544|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505545|NCT00044902|Epratuzumab|epratuzumab|mesh-list
138505546|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138505547|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505549|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138505550|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
138505551|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505552|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505553|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138505554|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138505555|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
138505556|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505557|NCT00001649|Valacyclovir|valacyclovir|mesh-list
138505558|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
138505559|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505560|NCT00018291|Gabapentin|gabapentin|mesh-list
138505561|NCT00018291|Risperidone|risperidone|mesh-list
138505562|NCT00018291|Analgesics|analgesics|mesh-ancestor
138505563|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
138505564|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138505565|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505566|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
138505567|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138505568|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138505569|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138505570|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138505571|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138505572|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138505573|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138505574|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505575|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
138694709|NCT00547092|Tadalafil|tadalafil|mesh-list
138505576|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138505577|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
138505578|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138505579|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138702108|NCT00448838|Gemcitabine|gemcitabine|mesh-list
138505580|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
138505581|NCT00045175|Topotecan|topotecan|mesh-list
138262586|NCT02003911|Azithromycin|azithromycin|mesh-list
138505583|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138505584|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138505585|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505586|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505587|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505588|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138505589|NCT00045292|Valacyclovir|valacyclovir|mesh-list
138505590|NCT00045292|Acyclovir|acyclovir|mesh-list
138505591|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
138505592|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505593|NCT00045370|Interferons|interferons|mesh-list
138505594|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
138505595|NCT00045370|Sirolimus|sirolimus|mesh-list
138505596|NCT00045370|Temsirolimus|temsirolimus|mesh-list
138505597|NCT00045370|MTOR Inhibitors|mtor inhibitors|mesh-list
138505598|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505599|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
138505600|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505601|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
138505602|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505603|NCT00045370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138505604|NCT00045370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505605|NCT00045370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455379|NCT01905059|Lamivudine|lamivudine|mesh-list
138505606|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138505607|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138505608|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138505609|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
138505611|NCT02970682|Fulvestrant|fulvestrant|mesh-list
138505612|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138505613|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138505614|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
138505615|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138505616|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505617|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138505618|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505619|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138505620|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138505621|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138505622|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138505623|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138505624|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505625|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505626|NCT00045448|Docetaxel|docetaxel|mesh-list
138505627|NCT00045448|Alvocidib|alvocidib|mesh-list
138505628|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505629|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
138505630|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
138505631|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
138461203|NCT01938235|Exenatide|exenatide|mesh-list
138505632|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505633|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
138505634|NCT00045448|Growth Substances|growth substances|mesh-ancestor
138505635|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505636|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138505637|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505638|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138505639|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505640|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138505641|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505642|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505643|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
138505644|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505645|NCT00045604|Irinotecan|irinotecan|mesh-list
138505646|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
138505647|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505648|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138505649|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138505650|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505651|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505652|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138505653|NCT00045682|Paclitaxel|paclitaxel|mesh-list
138505654|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138505655|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138505656|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138505657|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505658|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
138505659|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
138505660|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
138505661|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505662|NCT00045721|Carmustine|carmustine|mesh-list
138505663|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138505664|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138505665|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
138505666|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505667|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505668|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505669|NCT04731766|Listerine|listerine|mesh-list
138693759|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
138505670|NCT04731766|Fluorides|fluorides|mesh-list
138505671|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
138505672|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
138505673|NCT04731766|Protective Agents|protective agents|mesh-ancestor
138505674|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505675|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138505676|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505677|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138505678|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505680|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
138505681|NCT00018447|Protective Agents|protective agents|mesh-ancestor
138505682|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505684|NCT00001688|Nevirapine|nevirapine|mesh-list
138505685|NCT00001688|Stavudine|stavudine|mesh-list
138505686|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138505687|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138505688|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
138505689|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505690|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505691|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138505692|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138505693|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
138505694|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505695|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138505696|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138505697|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138505698|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138505699|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138505700|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138505701|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
138505702|NCT00389402|Ritonavir|ritonavir|mesh-list
138505703|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138505704|NCT00389402|Saquinavir|saquinavir|mesh-list
138505705|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138505706|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138505707|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
138505708|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505709|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505710|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138505711|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138505712|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
138505713|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505714|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138505715|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138693794|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
138505716|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
138505717|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138505718|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
138505719|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505720|NCT00045799|Omeprazole|omeprazole|mesh-list
138505721|NCT00045799|Cimetidine|cimetidine|mesh-list
138505722|NCT00045799|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
138505723|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138505724|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138505725|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138505726|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505727|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505728|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138505729|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
138505730|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
138505731|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138505732|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505733|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138505734|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138505735|NCT04394130|Ropivacaine|ropivacaine|mesh-list
138505736|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
138505737|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
138505738|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138505739|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505740|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
138505741|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138505743|NCT00045877|Rituximab|rituximab|mesh-list
138505744|NCT00045877|Interleukin-2|interleukin-2|mesh-list
138505745|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138505746|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505747|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
138505748|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505749|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138505750|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138505751|NCT00045877|Analgesics|analgesics|mesh-ancestor
138505752|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
138505753|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138505754|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138505755|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138505756|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
138505757|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505758|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138505759|NCT00045916|Nortriptyline|nortriptyline|mesh-list
138505760|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
138182190|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
138505762|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505763|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505764|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138505765|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138505766|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138505767|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138505768|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138505769|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138505770|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138505771|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
138505772|NCT04380207|QPX7728|qpx7728|mesh-list
138505773|NCT04380207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138505774|NCT04380207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505775|NCT04380207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505776|NCT04380207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138505777|NCT04380207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505778|NCT00045955|Fexofenadine|fexofenadine|mesh-list
138505779|NCT00045955|Montelukast|montelukast|mesh-list
138505780|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138505781|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
138505782|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138505783|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
138505784|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138505785|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694790|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505786|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138505787|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138505788|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262692|NCT04492358|Colchicine|colchicine|mesh-list
138505789|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138505790|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138505791|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138505792|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
138505793|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
138505794|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138505795|NCT00046033|Ritonavir|ritonavir|mesh-list
138505796|NCT00046033|Lopinavir|lopinavir|mesh-list
138505797|NCT00046033|Saquinavir|saquinavir|mesh-list
138505798|NCT00046033|Amprenavir|amprenavir|mesh-list
138505799|NCT00046033|Tenofovir|tenofovir|mesh-list
138505800|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138505801|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138505802|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
138505803|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505804|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505805|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138505806|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138505807|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
138505808|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505809|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138505810|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138505811|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138505812|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138505813|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138505814|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
138505815|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138505816|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138505817|NCT04369560|Hematinics|hematinics|mesh-ancestor
138505818|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138505819|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138505821|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138505822|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138505823|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505824|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505825|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505826|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
138505827|NCT00001724|Analgesics|analgesics|mesh-ancestor
138505828|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
138505829|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138505830|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505831|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138505832|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138505834|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138505835|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138505836|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505837|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505838|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
138505840|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505841|NCT00046267|Niacin|niacin|mesh-list
138505842|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138505843|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
138505844|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505845|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138505846|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
138505847|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
138505848|NCT00046267|Vitamins|vitamins|mesh-ancestor
138505849|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
138318894|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
138505850|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505851|NCT00046306|Antioxidants|antioxidants|mesh-list
138505852|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505853|NCT00046306|Protective Agents|protective agents|mesh-ancestor
138505854|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505855|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138505856|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138505857|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138505858|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
138505859|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505860|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505861|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138505862|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138505863|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
138505864|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505865|NCT00397657|Niacin|niacin|mesh-list
138693866|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505866|NCT00397657|Ezetimibe|ezetimibe|mesh-list
138505867|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138505868|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138505869|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
138455413|NCT01905150|Mitomycins|mitomycins|mesh-list
138505870|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505871|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138505872|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
138505873|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
138505875|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
138505876|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505877|NCT00001763|Interleukin-12|interleukin-12|mesh-list
138505878|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138505879|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
138505880|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505881|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138505882|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138505883|NCT00001763|Growth Substances|growth substances|mesh-ancestor
138505884|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
138505885|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505886|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
138505887|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138505888|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
138505889|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138505890|NCT00397735|Expectorants|expectorants|mesh-ancestor
138505891|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
138505892|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138505893|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
138505894|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505895|NCT00397735|Protective Agents|protective agents|mesh-ancestor
138505896|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505897|NCT00397735|Antidotes|antidotes|mesh-ancestor
138505898|NCT00046384|Aripiprazole|aripiprazole|mesh-list
138505899|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
138505900|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138505901|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138505902|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138505903|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138505904|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505905|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
138505906|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
138505907|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138505908|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505909|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138505910|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138505911|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
138505912|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138505913|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138693898|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
138505914|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138505915|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138505916|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138505917|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505918|NCT04258410|Quercetin|quercetin|mesh-list
138505919|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
138505920|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505921|NCT04258410|Protective Agents|protective agents|mesh-ancestor
138505922|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505923|NCT00046462|Metformin|metformin|mesh-list
138505924|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
138505925|NCT00046462|Glyburide|glyburide|mesh-list
138505926|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
138505927|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138505928|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505929|NCT00001766|Ritonavir|ritonavir|mesh-list
138505930|NCT00001766|Nelfinavir|nelfinavir|mesh-list
138505931|NCT00001766|Amprenavir|amprenavir|mesh-list
138505932|NCT00001766|Abacavir|abacavir|mesh-list
138505933|NCT00001766|Efavirenz|efavirenz|mesh-list
138319331|NCT03023358|Prednisone|prednisone|mesh-list
138505934|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138505935|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138505936|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
138505937|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505938|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505939|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138505940|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138505941|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
138505942|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319471|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138505943|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138505944|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138505945|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138505946|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138505947|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138505948|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138505949|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138505950|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138505951|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138319688|NCT05586204|Vaccines|vaccines|mesh-list
138505952|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138505953|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
138505954|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138505955|NCT00046501|Insulin|insulin|mesh-list
138505956|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
138505957|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138505958|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
138505959|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
138505960|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138505961|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505962|NCT00046735|Lenalidomide|lenalidomide|mesh-list
138505963|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
138505964|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505965|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138505966|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138505967|NCT00046735|Growth Substances|growth substances|mesh-ancestor
138505968|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
138505969|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505971|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138505972|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138505973|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138262797|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
138505974|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138505975|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505976|NCT00046813|Nicotine|nicotine|mesh-list
138505977|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138505978|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
138505979|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138505980|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505982|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138505983|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
138505984|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138505985|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505986|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
138505987|NCT00046852|Melphalan|melphalan|mesh-list
138505988|NCT00046852|Carmustine|carmustine|mesh-list
138505989|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138505990|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138505991|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
138505992|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505993|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138505994|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138505995|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
138505996|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505997|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138505998|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138506000|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506001|NCT00001805|Rituximab|rituximab|mesh-list
138693945|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138693946|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
138506002|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138506003|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506004|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
138506005|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506006|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138506007|NCT00047047|Gemcitabine|gemcitabine|mesh-list
138506008|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506009|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506010|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
138506011|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506012|NCT04733781|Lidocaine|lidocaine|mesh-list
138506014|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
138506015|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
138506016|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138506017|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506018|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
138506019|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506020|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138506021|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138506022|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138506023|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138506024|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506026|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138506027|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
138506028|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138506029|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138506030|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138693983|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138506032|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138506033|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
138506034|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
138506035|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
138506036|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138506037|NCT00047164|Ipilimumab|ipilimumab|mesh-list
138506038|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138506039|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506040|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138506041|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506043|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506044|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
138506045|NCT00047203|Growth Substances|growth substances|mesh-ancestor
138506046|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506047|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138506048|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506049|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506050|NCT04163874|Pramlintide|pramlintide|mesh-list
138506051|NCT04163874|Pancrelipase|pancrelipase|mesh-list
138506052|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138506053|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138506054|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506055|NCT00047242|Irinotecan|irinotecan|mesh-list
138506056|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138506057|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138506058|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138506059|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506060|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320927|NCT06124300|Hormones|hormones|mesh-list
138506061|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506062|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138506063|NCT00047281|Thalidomide|thalidomide|mesh-list
138506064|NCT00047281|Celecoxib|celecoxib|mesh-list
138506065|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
138506066|NCT00047281|Etoposide|etoposide|mesh-list
138321004|NCT06124157|Antiemetics|antiemetics|mesh-ancestor
138506067|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138694028|NCT05264142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138506069|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506070|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138506071|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138506072|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
138506073|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321145|NCT06086340|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138506074|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506075|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138506076|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138506077|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138506078|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138506079|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506080|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138506081|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138506082|NCT00047281|Analgesics|analgesics|mesh-ancestor
138506083|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
138506084|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506085|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138506086|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138506087|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138506088|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
138506089|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138321449|NCT05202860|Vaccines|vaccines|mesh-list
138506090|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506091|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138694880|NCT00534846|Toremifene|toremifene|mesh-list
138506092|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138506093|NCT00047281|Growth Substances|growth substances|mesh-ancestor
138506094|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
138321491|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138506095|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
138506096|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138506097|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506098|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138506099|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138506100|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138506101|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506102|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
138506103|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138506104|NCT00047554|Travoprost|travoprost|mesh-list
138321642|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
138506105|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138506106|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138506107|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138506108|NCT00047632|Interferons|interferons|mesh-list
138506109|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
138506110|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506111|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
138506112|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506114|NCT00047671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138506115|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138321782|NCT04068597|Venetoclax|venetoclax|mesh-list
138506116|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138506117|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506118|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138506119|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
138506120|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506121|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138506122|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
138506123|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138506124|NCT00047710|Bevacizumab|bevacizumab|mesh-list
138506125|NCT00047710|Capecitabine|capecitabine|mesh-list
138506126|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138506127|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506129|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138506130|NCT00047710|Growth Substances|growth substances|mesh-ancestor
138506131|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506132|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
138506133|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506135|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506136|NCT00047749|Ziconotide|ziconotide|mesh-list
138506137|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138506138|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138506139|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506140|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138506141|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506142|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138506143|NCT00047749|Protective Agents|protective agents|mesh-ancestor
138506144|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138506145|NCT00047749|Analgesics|analgesics|mesh-ancestor
138506146|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
138506147|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506148|NCT00047827|Amphotericin B|amphotericin b|mesh-list
138506149|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138506150|NCT00047827|Micafungin|micafungin|mesh-list
138506151|NCT00047827|Amebicides|amebicides|mesh-ancestor
138506152|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138506153|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138506154|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506155|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138506156|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
138506157|NCT00048139|Capecitabine|capecitabine|mesh-list
138506158|NCT00048139|Irinotecan|irinotecan|mesh-list
138506159|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138694082|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
138506160|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
138506161|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506162|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506163|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138506164|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138506165|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506166|NCT00048334|Romidepsin|romidepsin|mesh-list
138506167|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138506168|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506169|NCT00048334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138506170|NCT00048334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506171|NCT00048334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506173|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138322403|NCT03462966|Rifaximin|rifaximin|mesh-list
138506174|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138262910|NCT00374621|Isosorbide|isosorbide|mesh-list
138322466|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506176|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
138506177|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506178|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506179|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138506180|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138506181|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138506182|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506183|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
138506185|NCT05641337|Metformin|metformin|mesh-list
138506186|NCT05641337|Insulin Aspart|insulin aspart|mesh-list
138506187|NCT05641337|Linagliptin|linagliptin|mesh-list
138694911|NCT02907749|Diuretics|diuretics|mesh-ancestor
138506188|NCT05641337|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138506189|NCT05641337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138506190|NCT05641337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506192|NCT05641337|Hormones|hormones|mesh-ancestor
138506193|NCT05641337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694119|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138694121|NCT01267201|Prednisolone|prednisolone|mesh-list
138506194|NCT05641337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138506195|NCT05641337|Protease Inhibitors|protease inhibitors|mesh-ancestor
138506197|NCT05641337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322766|NCT01679106|Fentanyl|fentanyl|mesh-list
138506198|NCT00048412|Fludarabine|fludarabine|mesh-list
138506199|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
138506200|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506201|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138506202|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
138506203|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506204|NCT00048607|Aprepitant|aprepitant|mesh-list
138506205|NCT00048607|Paroxetine|paroxetine|mesh-list
138506206|NCT00048607|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138506207|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138506208|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138506209|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506210|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138506211|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
138506212|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506213|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138506214|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
138506215|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138506216|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138506217|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138506218|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506219|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
138506220|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
138506221|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506222|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138455496|NCT01905904|Sevoflurane|sevoflurane|mesh-list
138506223|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138506225|NCT00048646|Progestins|progestins|mesh-ancestor
138506226|NCT00048646|Hormones|hormones|mesh-ancestor
138506227|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138506228|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506229|NCT00048763|Cilostazol|cilostazol|mesh-list
138506230|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138506231|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
138506232|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506233|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506234|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138506235|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
138323159|NCT03261570|Digoxin|digoxin|mesh-list
138506236|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138506237|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138694160|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506238|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506239|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138506240|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
138506241|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138506242|NCT00048763|Protective Agents|protective agents|mesh-ancestor
138506243|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138506244|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138506245|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506246|NCT05576298|Insulin|insulin|mesh-list
138506247|NCT05576298|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138506248|NCT05576298|Insulin, Long-Acting|insulin, long-acting|mesh-list
138506249|NCT05576298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138506250|NCT05576298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506251|NCT00048802|Valproic Acid|valproic acid|mesh-list
138506252|NCT00048802|Olanzapine|olanzapine|mesh-list
138506253|NCT00048802|Risperidone|risperidone|mesh-list
138506254|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138506255|NCT00048802|Ziprasidone|ziprasidone|mesh-list
138506256|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138506257|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
138506258|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138506259|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506260|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506261|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138506262|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138506263|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138506264|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138506265|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138506266|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
138506267|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
138506268|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
138506269|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506270|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138323574|NCT05241132|Tubulin Modulators|tubulin modulators|mesh-ancestor
138506271|NCT00048802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138506272|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138506273|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138506274|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
138506275|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506276|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
138506277|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
138506279|NCT00048841|Alendronate|alendronate|mesh-list
138506280|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138694192|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
138506281|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506282|NCT00048880|Antibodies|antibodies|mesh-list
138506283|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138506284|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
138506285|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506286|NCT00049075|Fludarabine|fludarabine|mesh-list
138506287|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
138506288|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506289|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506290|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
138506291|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506292|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138323781|NCT01923090|Dutasteride|dutasteride|mesh-list
138506294|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506296|NCT00049114|Doxorubicin|doxorubicin|mesh-list
138506297|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138506298|NCT00049114|Tipifarnib|tipifarnib|mesh-list
138506299|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506300|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
138506301|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506302|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138506303|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138506304|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
138506305|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506306|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506307|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138506308|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138506309|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138506310|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138506311|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506312|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
138506313|NCT00049192|Oblimersen|oblimersen|mesh-list
138506314|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506315|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138506316|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506317|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506319|NCT05576181|Fludarabine|fludarabine|mesh-list
138506321|NCT05576181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506322|NCT05576181|Immunologic Factors|immunologic factors|mesh-ancestor
138506323|NCT05576181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506324|NCT05576181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138506325|NCT05576181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138506326|NCT05576181|Alkylating Agents|alkylating agents|mesh-ancestor
138506327|NCT05576181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506328|NCT05576181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506329|NCT05576181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138506330|NCT05576181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138506331|NCT05576181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138506332|NCT05576181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138506333|NCT05576181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506334|NCT00049387|Temozolomide|temozolomide|mesh-list
138506335|NCT00049387|Tipifarnib|tipifarnib|mesh-list
138694223|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
138694224|NCT03610412|Antacids|antacids|mesh-ancestor
138506336|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138506337|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
138262966|NCT01962428|Ticagrelor|ticagrelor|mesh-list
138506338|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506339|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506340|NCT05640791|Paclitaxel|paclitaxel|mesh-list
138506341|NCT05640791|Gemcitabine|gemcitabine|mesh-list
138506342|NCT05640791|Durvalumab|durvalumab|mesh-list
138506343|NCT05640791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138506344|NCT05640791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506345|NCT05640791|Tubulin Modulators|tubulin modulators|mesh-ancestor
138506346|NCT05640791|Antimitotic Agents|antimitotic agents|mesh-ancestor
138506347|NCT05640791|Mitosis Modulators|mitosis modulators|mesh-ancestor
138506348|NCT05640791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506349|NCT05640791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506350|NCT05640791|Antimetabolites|antimetabolites|mesh-ancestor
138506351|NCT05640791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138506352|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
138506353|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138506354|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
138506355|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506356|NCT00391911|Expectorants|expectorants|mesh-ancestor
138506357|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
138506358|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138506359|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
138506360|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506361|NCT00391911|Protective Agents|protective agents|mesh-ancestor
138506362|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506363|NCT00391911|Antidotes|antidotes|mesh-ancestor
138506365|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
138506366|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138506367|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138506368|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506369|NCT00049582|Decitabine|decitabine|mesh-list
138506370|NCT00049582|Azacitidine|azacitidine|mesh-list
138506371|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506372|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
138506373|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506374|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506375|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506376|NCT00049660|Capecitabine|capecitabine|mesh-list
138506377|NCT00049660|Vinorelbine|vinorelbine|mesh-list
138506378|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506379|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
138506380|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506381|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694252|NCT01266265|Treprostinil|treprostinil|mesh-list
138506382|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138506383|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
138506384|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
138506385|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
138506386|NCT05640713|Cyclophosphamide|cyclophosphamide|mesh-list
138506387|NCT05640713|Fludarabine|fludarabine|mesh-list
138506388|NCT05640713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506389|NCT05640713|Immunologic Factors|immunologic factors|mesh-ancestor
138506390|NCT05640713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506391|NCT05640713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262987|NCT01969435|Carmustine|carmustine|mesh-list
138506392|NCT05640713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138506393|NCT05640713|Alkylating Agents|alkylating agents|mesh-ancestor
138506394|NCT05640713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506395|NCT05640713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506396|NCT05640713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138506397|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
138506398|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138506399|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506400|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138506401|NCT00049777|Heparin|heparin|mesh-list
138506402|NCT00049777|Calcium heparin|calcium heparin|mesh-list
138506403|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138506404|NCT00049777|Tinzaparin|tinzaparin|mesh-list
138506405|NCT00049777|Dalteparin|dalteparin|mesh-list
138506406|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
138506407|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138506408|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138506409|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506410|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506411|NCT00392028|Ertapenem|ertapenem|mesh-list
138506412|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138506413|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506414|NCT00392067|Calcipotriene|calcipotriene|mesh-list
138506415|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
138506416|NCT00389558|Amikacin|amikacin|mesh-list
138506417|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138506418|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506419|NCT00049972|Paroxetine|paroxetine|mesh-list
138506420|NCT00049972|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138506421|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138506422|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138506423|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506424|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138506426|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506427|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138506428|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
138506429|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138325225|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506430|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138506431|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138506432|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506434|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
138263021|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
138506435|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
138506436|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138506437|NCT00389636|Growth Substances|growth substances|mesh-ancestor
138506438|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506440|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
138506441|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
138506442|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506443|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506444|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138325373|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
138506445|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138506446|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138506447|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138506448|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138506449|NCT00050206|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138506450|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138506451|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138506452|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506453|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138506454|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
138506456|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138506457|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506458|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
138506459|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506460|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138506461|NCT00050362|Rofecoxib|rofecoxib|mesh-list
138506462|NCT00050362|Bupivacaine|bupivacaine|mesh-list
138506463|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
138506464|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
138694317|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506465|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138506466|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506467|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
138506468|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506469|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138506470|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138506471|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506472|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506473|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138506474|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138325494|NCT02983422|Furosemide|furosemide|mesh-list
138506476|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138506477|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138506479|NCT00050401|Tobramycin|tobramycin|mesh-list
138506480|NCT00050401|Meropenem|meropenem|mesh-list
138506481|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138506482|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506483|NCT05640362|Benzydamine|benzydamine|mesh-list
138506484|NCT05640362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138506485|NCT00050440|Dexamethasone|dexamethasone|mesh-list
138455550|NCT01906528|Mivacurium|mivacurium|mesh-list
138506486|NCT00050440|Trabectedin|trabectedin|mesh-list
138506487|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138506488|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
138506489|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
138506490|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506491|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506492|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138506493|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
138506494|NCT00050440|Hormones|hormones|mesh-ancestor
138506495|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138506496|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138506497|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506498|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138694990|NCT04682132|Antibodies|antibodies|mesh-list
138506499|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
138506500|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506501|NCT00050479|Celecoxib|celecoxib|mesh-list
138325616|NCT04390152|Ritonavir|ritonavir|mesh-list
138506502|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138506503|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138506504|NCT00050479|Analgesics|analgesics|mesh-ancestor
138506505|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
138506506|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506507|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506508|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138182938|NCT00371410|Hormones|hormones|mesh-ancestor
138506509|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138506510|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138506511|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138506512|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506513|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506514|NCT00050596|Docetaxel|docetaxel|mesh-list
138506515|NCT00050596|Ipilimumab|ipilimumab|mesh-list
138506516|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506517|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
138506518|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
138506519|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
138506520|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506521|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138506522|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138506523|NCT00050635|Octreotide|octreotide|mesh-list
138506524|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138506525|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138506526|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506527|NCT00050674|Lenograstim|lenograstim|mesh-list
138506528|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138506529|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
138506530|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506531|NCT00050713|Sirolimus|sirolimus|mesh-list
138506532|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138506533|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506534|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138506535|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506536|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
138506537|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506538|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
138506539|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506540|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
138506541|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
138506542|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
138506543|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138506544|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506545|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
138506546|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506548|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138506549|NCT00050830|Protective Agents|protective agents|mesh-ancestor
138506550|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
138506551|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
138506552|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138506553|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138694371|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
138506554|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138506555|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506556|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138506557|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138506558|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
138506559|NCT00051142|Travoprost|travoprost|mesh-list
138506560|NCT00051142|Latanoprost|latanoprost|mesh-list
138506561|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138506562|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138506563|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138506564|NCT00051181|Travoprost|travoprost|mesh-list
138506565|NCT00051181|Latanoprost|latanoprost|mesh-list
138506566|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138506567|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138506568|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138506569|NCT00051259|Bupropion|bupropion|mesh-list
138506570|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138506571|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
138506572|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138506573|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138506574|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138506575|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138506576|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506577|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
138506578|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138506579|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506580|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138506581|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138506582|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506583|NCT05639777|Dexmedetomidine|dexmedetomidine|mesh-list
138506584|NCT05639777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138506585|NCT05639777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138506586|NCT05639777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506587|NCT05639777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138506588|NCT05639777|Analgesics|analgesics|mesh-ancestor
138506589|NCT05639777|Sensory System Agents|sensory system agents|mesh-ancestor
138506590|NCT05639777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506591|NCT05639777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138506592|NCT05639777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138506593|NCT05639777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138506594|NCT05639777|Adrenergic Agents|adrenergic agents|mesh-ancestor
138506595|NCT05639777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138506596|NCT05639777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506597|NCT00051298|Olanzapine|olanzapine|mesh-list
138506598|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
138506599|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
138506600|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506601|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506602|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138506603|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138506604|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138506605|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138506606|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138506607|NCT00051298|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138506608|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138506609|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138506610|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506611|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138506612|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
138506614|NCT00398008|Buprenorphine|buprenorphine|mesh-list
138506615|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138506616|NCT00398008|Narcotics|narcotics|mesh-ancestor
138506617|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138506618|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506619|NCT00398008|Analgesics|analgesics|mesh-ancestor
138506620|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
138506621|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506622|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138506623|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138506624|NCT00051493|Carboplatin|carboplatin|mesh-list
138506625|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506626|NCT00051532|Seocalcitol|seocalcitol|mesh-list
138506627|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506628|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506629|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
138506630|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506631|NCT00051571|Docetaxel|docetaxel|mesh-list
138506632|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506633|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
138506634|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
138506635|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
138506636|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506637|NCT05573958|Aspirin|aspirin|mesh-list
138506638|NCT05573958|Rivaroxaban|rivaroxaban|mesh-list
138506639|NCT05573958|Clopidogrel|clopidogrel|mesh-list
138506640|NCT05573958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138506641|NCT05573958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138506642|NCT05573958|Analgesics|analgesics|mesh-ancestor
138506643|NCT05573958|Sensory System Agents|sensory system agents|mesh-ancestor
138506644|NCT05573958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506645|NCT05573958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506646|NCT05573958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138506647|NCT05573958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138694431|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506648|NCT05573958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138506649|NCT05573958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138506650|NCT05573958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506651|NCT05573958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138506652|NCT05573958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138506653|NCT05573958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506654|NCT05573958|Antipyretics|antipyretics|mesh-ancestor
138506655|NCT05573958|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138506656|NCT05573958|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138326207|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
138506657|NCT05573958|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138506659|NCT05573958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138506660|NCT05573958|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138506661|NCT05573958|Antithrombins|antithrombins|mesh-ancestor
138506662|NCT05573958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138506663|NCT05573958|Protease Inhibitors|protease inhibitors|mesh-ancestor
138506664|NCT05573958|Anticoagulants|anticoagulants|mesh-ancestor
138506665|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
138506666|NCT00051688|Tezacitabine|tezacitabine|mesh-list
138506667|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506668|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506669|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506670|NCT00051844|Capravirine|capravirine|mesh-list
138506671|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138506672|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138506673|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506674|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506675|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
138506676|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506677|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138506678|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138506679|NCT00052000|Antibodies|antibodies|mesh-list
138506680|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138506681|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
138506682|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506683|NCT00052039|Interferons|interferons|mesh-list
138506684|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
138506685|NCT00052039|Azathioprine|azathioprine|mesh-list
138506687|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
138506688|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506689|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
138506690|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326312|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138506691|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506693|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
138506694|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506695|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138506696|NCT00052117|Capravirine|capravirine|mesh-list
138506697|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138263127|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506698|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138506699|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506700|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506701|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
138506702|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506703|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138506704|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138506705|NCT00052273|Capecitabine|capecitabine|mesh-list
138506706|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506707|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
138506708|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506709|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506710|NCT00052312|Paclitaxel|paclitaxel|mesh-list
138506711|NCT00052312|Doxorubicin|doxorubicin|mesh-list
138506712|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138506713|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138506714|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506715|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
138506716|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
138506717|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
138455617|NCT01906944|Hormones|hormones|mesh-ancestor
138506718|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506719|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138506720|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138506721|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138506722|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506723|NCT00052351|Metronidazole|metronidazole|mesh-list
138506724|NCT00052351|Paclitaxel|paclitaxel|mesh-list
138506725|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
138506726|NCT00052351|Doxorubicin|doxorubicin|mesh-list
138506727|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138506728|NCT00052351|Vaccines|vaccines|mesh-list
138506729|NCT00052351|Sargramostim|sargramostim|mesh-list
138506730|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
138506731|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506732|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138506733|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506734|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
138506735|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
138506736|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
138506737|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506738|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506739|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138506740|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138506741|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
138506742|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138506743|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138506744|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138694486|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
138506746|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506747|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506748|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138506749|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138506750|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138506751|NCT00052390|Bevacizumab|bevacizumab|mesh-list
138506752|NCT00052390|Doxorubicin|doxorubicin|mesh-list
138506753|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138506754|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138506755|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506756|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138506757|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138506758|NCT00052390|Growth Substances|growth substances|mesh-ancestor
138506759|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506760|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
138506761|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138506762|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138506763|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138506764|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326698|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
138506765|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506767|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138506768|NCT00052468|Carboplatin|carboplatin|mesh-list
138506769|NCT00052468|Gemcitabine|gemcitabine|mesh-list
138506770|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138506771|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506772|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
138506773|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
138506774|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
138506775|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506776|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506777|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
138506778|NCT00052507|Bortezomib|bortezomib|mesh-list
138506779|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506780|NCT00052585|Leucovorin|leucovorin|mesh-list
138506781|NCT00052585|Fluorouracil|fluorouracil|mesh-list
138506782|NCT00052585|Irinotecan|irinotecan|mesh-list
138506783|NCT00052585|Gefitinib|gefitinib|mesh-list
138506784|NCT00052585|Calcium|calcium|mesh-list
138506785|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
138506786|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138506787|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506788|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
138506789|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506790|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506791|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506792|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506793|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
138506794|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138506795|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138506796|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506797|NCT00052585|Antidotes|antidotes|mesh-ancestor
138506798|NCT00052585|Protective Agents|protective agents|mesh-ancestor
138506799|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
138506800|NCT00052585|Vitamins|vitamins|mesh-ancestor
138506801|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
138506802|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138506803|NCT00052780|Temozolomide|temozolomide|mesh-list
138506804|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138506805|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138506806|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
138506807|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506808|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506809|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506810|NCT00052936|Prednisone|prednisone|mesh-list
138506811|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
138506812|NCT00052936|Rituximab|rituximab|mesh-list
138506814|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138506815|NCT00052936|Vincristine|vincristine|mesh-list
138506816|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506817|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
138506818|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506819|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138506820|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138506821|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
138506822|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506823|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506824|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138506825|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138506826|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138506827|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138506828|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138506829|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506830|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138506831|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
138506832|NCT00052936|Hormones|hormones|mesh-ancestor
138506833|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138506834|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138506835|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138506836|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
138506837|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
138506838|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
138506839|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
138506840|NCT00053092|Rituximab|rituximab|mesh-list
138506841|NCT00053092|Fludarabine|fludarabine|mesh-list
138506842|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
138506843|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506844|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
138506845|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506846|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138506847|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138506848|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
138506849|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506850|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506851|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138506852|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138506853|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506854|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
138506855|NCT00053131|Cytarabine|cytarabine|mesh-list
138506856|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
138506857|NCT00053131|Sargramostim|sargramostim|mesh-list
138506858|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506859|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
138506860|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506861|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506862|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
138263212|NCT02837237|Hormones|hormones|mesh-ancestor
138506863|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506864|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506865|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
138506866|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506867|NCT00053131|Analgesics|analgesics|mesh-ancestor
138506868|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
138506869|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506870|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138506871|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138506872|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506873|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
138506874|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
138506875|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695055|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
138506876|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138506877|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506878|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506879|NCT00053287|Thalidomide|thalidomide|mesh-list
138506880|NCT00053287|Carboplatin|carboplatin|mesh-list
138506881|NCT00053287|Fludarabine|fludarabine|mesh-list
138506882|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
138506883|NCT00053287|Topotecan|topotecan|mesh-list
138506884|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506885|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506886|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
138506887|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506888|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506889|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
138506890|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506891|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138506892|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138506893|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506894|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
138506895|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138506896|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506897|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138263216|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
138506898|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138506899|NCT00053287|Growth Substances|growth substances|mesh-ancestor
138506900|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
138506901|NCT00053326|Fenretinide|fenretinide|mesh-list
138506902|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506903|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138506904|NCT00053326|Protective Agents|protective agents|mesh-ancestor
138506905|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506906|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138694557|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694558|NCT01310192|Choline|choline|mesh-list
138506907|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138506908|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
138455651|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
138506909|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506910|NCT00053599|Simvastatin|simvastatin|mesh-list
138506911|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138506912|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138506913|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
138506914|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506916|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138506917|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506918|NCT00053638|Tenofovir|tenofovir|mesh-list
138506919|NCT00053638|Lamivudine|lamivudine|mesh-list
138506920|NCT00053638|Efavirenz|efavirenz|mesh-list
138506921|NCT00053638|Abacavir|abacavir|mesh-list
138506922|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
138506923|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138506924|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138506925|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138506926|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327592|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
138506927|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506928|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138506929|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138506930|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138506931|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138506932|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138506933|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138506934|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138506935|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138506936|NCT00053716|Alprostadil|alprostadil|mesh-list
138506937|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138506938|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
138506939|NCT00053716|Urological Agents|urological agents|mesh-ancestor
138327737|NCT00324870|Vorinostat|vorinostat|mesh-list
138506940|NCT02970175|Terlipressin|terlipressin|mesh-list
138506941|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138506942|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138506943|NCT00053833|Irinotecan|irinotecan|mesh-list
138506944|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138506945|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138506946|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506947|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506948|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506950|NCT00053872|Lomustine|lomustine|mesh-list
138506951|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506952|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138506953|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
138506954|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
138506955|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
138506956|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506957|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138506958|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
138506959|NCT00053911|Tamoxifen|tamoxifen|mesh-list
138506960|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
138506961|NCT00053911|Docetaxel|docetaxel|mesh-list
138506962|NCT00053911|Fluorouracil|fluorouracil|mesh-list
138506963|NCT00053911|Epirubicin|epirubicin|mesh-list
138506965|NCT00053911|Goserelin|goserelin|mesh-list
138506966|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138506967|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
138506968|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506969|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138506970|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138506971|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
138506972|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506973|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506974|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138506975|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
138506976|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
138506977|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
138506978|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
138506979|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138506980|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138506981|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138506982|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138506983|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506984|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138506985|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
138506986|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138506987|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138506988|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138506989|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138506990|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138506991|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138506992|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138506994|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506995|NCT00054067|Cisplatin|cisplatin|mesh-list
138506996|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506997|NCT00054184|Paclitaxel|paclitaxel|mesh-list
138506998|NCT00054184|Docetaxel|docetaxel|mesh-list
138506999|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138507000|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138507001|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694627|NCT02581007|Melphalan|melphalan|mesh-list
138327849|NCT00345384|Analgesics|analgesics|mesh-ancestor
138507002|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
138507003|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
138507004|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
138507005|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507006|NCT00054340|Cyclosporine|cyclosporine|mesh-list
138507007|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
138507009|NCT00054340|Methotrexate|methotrexate|mesh-list
138507010|NCT00054340|Cyclosporins|cyclosporins|mesh-list
138507011|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138507012|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138507013|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
138327950|NCT00353652|Diuretics|diuretics|mesh-ancestor
138507014|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507015|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138507016|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138507017|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
138507018|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507019|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507020|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138507021|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138507022|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
138507023|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138507024|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507025|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
138507026|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
138507027|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507028|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138507029|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138507030|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
138507031|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507032|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138507033|NCT00054418|Vitamin D|vitamin d|mesh-list
138507034|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
138507035|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
138507036|NCT00054418|Calcium|calcium|mesh-list
138507037|NCT00054418|Vitamins|vitamins|mesh-ancestor
138507038|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
138507039|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507040|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138507041|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138507043|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507044|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138507045|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138507046|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138507047|NCT00054457|Docetaxel|docetaxel|mesh-list
138507048|NCT00054457|Capecitabine|capecitabine|mesh-list
138507049|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507050|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
138507051|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
138507052|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
138507053|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507054|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507055|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
138507056|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138507057|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507058|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138507059|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507060|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507061|NCT00054535|Aldesleukin|aldesleukin|mesh-list
138507062|NCT00054535|Vaccines|vaccines|mesh-list
138507063|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
138507064|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507065|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507066|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138507067|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138507068|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
138507069|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507070|NCT00054574|Panitumumab|panitumumab|mesh-list
138507071|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138507072|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507073|NCT00054613|Methoxsalen|methoxsalen|mesh-list
138507074|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138507075|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
138507076|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
138507077|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138507078|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507079|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507080|NCT00054886|Sunitinib|sunitinib|mesh-list
138507081|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507082|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138507083|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138507084|NCT00054886|Growth Substances|growth substances|mesh-ancestor
138507085|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507086|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
138507087|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138507088|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507089|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507090|NCT02970097|Midazolam|midazolam|mesh-list
138507091|NCT02970097|Fentanyl|fentanyl|mesh-list
138507092|NCT02970097|Ropivacaine|ropivacaine|mesh-list
138507093|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138507094|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138507095|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138328177|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507096|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455695|NCT01907373|Probenecid|probenecid|mesh-list
138507097|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138507098|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138507099|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138507100|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138507101|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
138507103|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
138507104|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
138507105|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138507106|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507107|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138507108|NCT02970097|Narcotics|narcotics|mesh-ancestor
138507109|NCT02970097|Analgesics|analgesics|mesh-ancestor
138507110|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
138507111|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138507112|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
138507113|NCT00398281|Dutasteride|dutasteride|mesh-list
138507114|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138183545|NCT01040689|Olodaterol|olodaterol|mesh-list
138507115|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138507116|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507117|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507118|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
138507119|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138507120|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507122|NCT00055042|Vitamins|vitamins|mesh-ancestor
138507123|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
138507124|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507125|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
138507126|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507127|NCT00055042|Protective Agents|protective agents|mesh-ancestor
138507129|NCT00055120|Lopinavir|lopinavir|mesh-list
138507130|NCT00055120|Tenofovir|tenofovir|mesh-list
138507131|NCT00055120|Emtricitabine|emtricitabine|mesh-list
138507132|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138507133|NCT00055120|Stavudine|stavudine|mesh-list
138507134|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138507135|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138507136|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
138694708|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
138507137|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507138|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507139|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138507140|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138507141|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
138507142|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507143|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138507144|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138507145|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138507146|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138507147|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
138507148|NCT00055159|Plasminogen|plasminogen|mesh-list
138507149|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138507150|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138507151|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138507152|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507153|NCT00055198|Daptomycin|daptomycin|mesh-list
138507154|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138507155|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507156|NCT05525325|Anesthetics|anesthetics|mesh-list
138507157|NCT05525325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138507158|NCT05525325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507160|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138507161|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
138507162|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138507163|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138507164|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138507165|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138507166|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507167|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
138507168|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138507169|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507170|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138507171|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138507172|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507173|NCT00055432|Gemcitabine|gemcitabine|mesh-list
138507174|NCT00055432|Pemetrexed|pemetrexed|mesh-list
138507175|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507176|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
138507177|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507178|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507179|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507180|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138507181|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138507183|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
138507184|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
138507185|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
138507186|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138507187|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138507188|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138507189|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507190|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507191|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
138507192|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
138507193|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
138507194|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138507195|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138507196|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138507197|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138507198|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138507199|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138507200|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138507201|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
138507202|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
138507203|NCT00055666|Beclomethasone|beclomethasone|mesh-list
138507204|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138507205|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
138507206|NCT00055666|Hormones|hormones|mesh-ancestor
138507207|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138507208|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507209|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138507210|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
138507211|NCT00055822|Leucovorin|leucovorin|mesh-list
138507212|NCT00055822|Fluorouracil|fluorouracil|mesh-list
138507213|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
138507214|NCT00055822|Oblimersen|oblimersen|mesh-list
138507215|NCT00055822|Calcium|calcium|mesh-list
138507216|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
138507217|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138329254|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
138507218|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507219|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
138507220|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507221|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507222|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507223|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138507224|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
138507226|NCT00055822|Protective Agents|protective agents|mesh-ancestor
138507227|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
138507228|NCT00055822|Vitamins|vitamins|mesh-ancestor
138507229|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
138507230|NCT00055861|Bevacizumab|bevacizumab|mesh-list
138507231|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138507232|NCT00055861|Docetaxel|docetaxel|mesh-list
138507233|NCT00055861|Antibodies|antibodies|mesh-list
138507234|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
138507235|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138507236|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507237|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138507238|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138507239|NCT00055861|Growth Substances|growth substances|mesh-ancestor
138329467|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
138507240|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507241|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
138507242|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
138507244|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
138507245|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
138507246|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507248|NCT00392106|Flecainide|flecainide|mesh-list
138507249|NCT00392106|Propafenone|propafenone|mesh-list
138507250|NCT00392106|Dofetilide|dofetilide|mesh-list
138507251|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138507252|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
138329675|NCT00555048|Methotrexate|methotrexate|mesh-list
138507254|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138507255|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507256|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138507257|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138507258|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138507259|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507260|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138507261|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138507262|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138507263|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138507264|NCT00055939|Exatecan|exatecan|mesh-list
138507265|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138507266|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138507267|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507268|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507269|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507270|NCT00055978|Celecoxib|celecoxib|mesh-list
138507271|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138507272|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138507273|NCT00055978|Analgesics|analgesics|mesh-ancestor
138507274|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
138507275|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138694787|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
138507276|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507277|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138507278|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138507279|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138507280|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138507281|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507282|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507283|NCT00056056|Bexarotene|bexarotene|mesh-list
138507284|NCT00056056|Methoxsalen|methoxsalen|mesh-list
138507285|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138293151|NCT00947791|Midazolam|midazolam|mesh-list
138507286|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138507287|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
138507288|NCT00056095|Cyclosporine|cyclosporine|mesh-list
138507289|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
138507290|NCT00056095|Fludarabine|fludarabine|mesh-list
138507291|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
138507292|NCT00056095|Cyclosporins|cyclosporins|mesh-list
138507293|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138507294|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
138507295|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507296|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138507297|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138507298|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
138507299|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507300|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507301|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138507302|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507303|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
138507304|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507305|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
138507306|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507307|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
138507308|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138507310|NCT00056329|Tocopherols|tocopherols|mesh-list
138507311|NCT00056329|Vitamins|vitamins|mesh-ancestor
138507312|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
138507313|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507314|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
138507315|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507316|NCT00056329|Protective Agents|protective agents|mesh-ancestor
138507317|NCT00056368|Fluconazole|fluconazole|mesh-list
138507318|NCT00056368|Anidulafungin|anidulafungin|mesh-list
138507319|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
138507320|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507321|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138507322|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138507323|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330211|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
138507324|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507325|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138507326|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
138694811|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
138507327|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138507328|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507329|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138507330|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138507331|NCT00056446|Vatalanib|vatalanib|mesh-list
138507332|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138507333|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507334|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507335|NCT00398437|Trastuzumab|trastuzumab|mesh-list
138507336|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138507337|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183784|NCT03400111|Acetaminophen|acetaminophen|mesh-list
138507338|NCT05433675|Macitentan|macitentan|mesh-list
138507339|NCT05433675|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138507340|NCT05433675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138507341|NCT05433675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507342|NCT05433675|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138507343|NCT00423709|Fludarabine|fludarabine|mesh-list
138507344|NCT00423709|Melphalan|melphalan|mesh-list
138507345|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507346|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507347|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138507348|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
138507349|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507350|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138507351|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
138507352|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138507353|NCT00056797|Interleukin-2|interleukin-2|mesh-list
138507354|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507355|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138507356|NCT00056797|Analgesics|analgesics|mesh-ancestor
138507357|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
138507358|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138507359|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507360|NCT00056836|Ranibizumab|ranibizumab|mesh-list
138507361|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138507362|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138507363|NCT00056836|Growth Substances|growth substances|mesh-ancestor
138507364|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507365|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
138507366|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507368|NCT05495321|Interleukin-2|interleukin-2|mesh-list
138507369|NCT05495321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507370|NCT05495321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138507371|NCT05495321|Analgesics|analgesics|mesh-ancestor
138507372|NCT05495321|Sensory System Agents|sensory system agents|mesh-ancestor
138507373|NCT05495321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138507374|NCT05495321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507375|NCT05495321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138507376|NCT05495321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138507377|NCT05495321|Antiviral Agents|antiviral agents|mesh-ancestor
138507378|NCT05495321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507379|NCT00056875|Mitogens|mitogens|mesh-list
138507380|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
138507381|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507382|NCT05410197|Gemcitabine|gemcitabine|mesh-list
138507383|NCT05410197|Lenvatinib|lenvatinib|mesh-list
138507384|NCT05410197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507385|NCT05410197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507386|NCT05410197|Antimetabolites|antimetabolites|mesh-ancestor
138507387|NCT05410197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507388|NCT05410197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138507389|NCT05410197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507390|NCT03262454|Atezolizumab|atezolizumab|mesh-list
138507391|NCT03262454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138507392|NCT03262454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507393|NCT03262454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138507394|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507396|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138507397|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507398|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138507399|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138507400|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507401|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138507402|NCT00057031|Vitamins|vitamins|mesh-ancestor
138507403|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
138507404|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138507405|NCT00057265|Lamivudine|lamivudine|mesh-list
138507406|NCT00057265|Telbivudine|telbivudine|mesh-list
138507407|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138507408|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138507409|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507410|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507411|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
138507412|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507413|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138507414|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138507415|NCT00057343|Rituximab|rituximab|mesh-list
138507416|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138507417|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507418|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
138507419|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507420|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138694868|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138694869|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694870|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
138507421|NCT00057382|Doxorubicin|doxorubicin|mesh-list
138507422|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138507423|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507424|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138507425|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138507426|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507427|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507428|NCT00057421|Prednisolone|prednisolone|mesh-list
138507429|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138507430|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
138507432|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138507433|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507434|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138507435|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507436|NCT00057616|Lenalidomide|lenalidomide|mesh-list
138507437|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
138507438|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507439|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138507440|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138507441|NCT00057616|Growth Substances|growth substances|mesh-ancestor
138507442|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
138507443|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507444|NCT02969746|Charcoal|charcoal|mesh-list
138507445|NCT02969746|Antidotes|antidotes|mesh-ancestor
138507446|NCT02969746|Protective Agents|protective agents|mesh-ancestor
138507447|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507448|NCT00057850|Cisplatin|cisplatin|mesh-list
138507449|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507450|NCT00057889|Ipilimumab|ipilimumab|mesh-list
138507451|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138507452|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507453|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138507454|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507455|NCT00057928|Paclitaxel|paclitaxel|mesh-list
138507456|NCT00057928|Gemcitabine|gemcitabine|mesh-list
138507457|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138507458|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507459|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
138507460|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
138507461|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
138695231|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138507462|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507463|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507464|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
138507466|NCT05309304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138507467|NCT05309304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507468|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
138507469|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138507470|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507471|NCT00058006|Celecoxib|celecoxib|mesh-list
138263547|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507472|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138507473|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138507474|NCT00058006|Analgesics|analgesics|mesh-ancestor
138507475|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
138507476|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138507477|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507478|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138507479|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138507480|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138507481|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138507482|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507483|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507484|NCT00058045|Aldesleukin|aldesleukin|mesh-list
138507485|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507486|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138507487|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138507488|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
138507489|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507490|NCT00058084|Prednisone|prednisone|mesh-list
138507491|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
138507492|NCT00058084|Epothilone B|epothilone b|mesh-list
138507493|NCT00058084|Epothilones|epothilones|mesh-list
138507494|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138507495|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
138507496|NCT00058084|Hormones|hormones|mesh-ancestor
138507497|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138507498|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507499|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138507500|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507501|NCT00058084|Analgesics|analgesics|mesh-ancestor
138507502|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
138507503|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138507504|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138507505|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138507506|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507507|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507508|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
138507509|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
138507510|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
138507511|NCT02969629|Apomorphine|apomorphine|mesh-list
138507512|NCT02969629|Emetics|emetics|mesh-ancestor
138507513|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507514|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
138507515|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138507516|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138507517|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
138507518|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
138507519|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138507520|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507521|NCT00058201|Leucovorin|leucovorin|mesh-list
138507522|NCT00058201|Gemcitabine|gemcitabine|mesh-list
138507523|NCT00058201|Fluorouracil|fluorouracil|mesh-list
138507524|NCT00058201|Calcium|calcium|mesh-list
138507525|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
138372090|NCT01416116|Narcotics|narcotics|mesh-ancestor
138507526|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507527|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
138694907|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
138694909|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507528|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507529|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507530|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138507531|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507532|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138507533|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
138507534|NCT00058201|Antidotes|antidotes|mesh-ancestor
138507535|NCT00058201|Protective Agents|protective agents|mesh-ancestor
138507536|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
138507537|NCT00058201|Vitamins|vitamins|mesh-ancestor
138507538|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
138507539|NCT00058279|Aldesleukin|aldesleukin|mesh-list
138507540|NCT00058279|Ipilimumab|ipilimumab|mesh-list
138507541|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138507542|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330285|NCT00610740|Gemcitabine|gemcitabine|mesh-list
138507543|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138507544|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507545|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138507546|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138507547|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
138507548|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507549|NCT00058318|Gemcitabine|gemcitabine|mesh-list
138507550|NCT00058318|Capecitabine|capecitabine|mesh-list
138507551|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507552|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
138507553|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507554|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507555|NCT00058357|Lidocaine|lidocaine|mesh-list
138507556|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
138507557|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
138507558|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138507559|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507560|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
138507561|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183990|NCT00014911|Sirolimus|sirolimus|mesh-list
138507562|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138507563|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138507564|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138263605|NCT01981772|Lidocaine|lidocaine|mesh-list
138507565|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138507566|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507567|NCT00058435|Abagovomab|abagovomab|mesh-list
138507568|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138507569|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507570|NCT00058474|Capecitabine|capecitabine|mesh-list
138507571|NCT00058474|Fluorouracil|fluorouracil|mesh-list
138507572|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
138507573|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507574|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
138507575|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507576|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507577|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138507579|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507580|NCT00392262|Amlodipine|amlodipine|mesh-list
138507581|NCT00392262|Valsartan|valsartan|mesh-list
138507582|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138507583|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138507584|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138507585|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507586|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138507587|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507588|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
138507589|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138507590|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138507591|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
138507592|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507593|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138507594|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507595|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507596|NCT00058903|Sertraline|sertraline|mesh-list
138507597|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
138507598|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138507599|NCT00058903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138507600|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138507601|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138507602|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507603|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138507604|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
138507605|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507606|NCT02969473|Cisplatin|cisplatin|mesh-list
138507607|NCT02969473|Docetaxel|docetaxel|mesh-list
138507608|NCT02969473|Fluorouracil|fluorouracil|mesh-list
138507609|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507610|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
138507611|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
138507612|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
138507613|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507614|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
138507615|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507616|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138507617|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
138507618|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507619|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
138507620|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507621|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507622|NCT01349907|Asenapine|asenapine|mesh-list
138507623|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138507624|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138507625|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138507626|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507627|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138507628|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138507629|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138507630|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507631|NCT00059722|Gefitinib|gefitinib|mesh-list
138507632|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507633|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138694945|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
138694952|NCT02907710|Endostar protein|endostar protein|mesh-list
138507634|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507635|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507636|NCT02969239|Phenylephrine|phenylephrine|mesh-list
138507637|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
138507638|NCT02969239|Norepinephrine|norepinephrine|mesh-list
138507639|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138507640|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138507641|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
138507642|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
138507643|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138507644|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507645|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
138507646|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
138507647|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
138507648|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138507649|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138507650|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138507651|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
138507652|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138507653|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507654|NCT02969239|Protective Agents|protective agents|mesh-ancestor
138507656|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507657|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138507658|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138507659|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507660|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507661|NCT00059800|Boron|boron|mesh-list
138507662|NCT00059800|Trace Elements|trace elements|mesh-ancestor
138507663|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
138507664|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507665|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
138507666|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138507667|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138507668|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507669|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
138507670|NCT03216083|Coagulants|coagulants|mesh-ancestor
138507671|NCT00059878|Interferons|interferons|mesh-list
138507672|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
138507673|NCT00059878|Voriconazole|voriconazole|mesh-list
138507674|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507675|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
138507676|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507677|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
138507678|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138507679|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138507680|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507681|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507682|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138507683|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
138507684|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138507685|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507686|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138507687|NCT00059917|Camptothecin|camptothecin|mesh-list
138507688|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138507689|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507690|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138507691|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138507692|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138455840|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507693|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507694|NCT00060112|Gemcitabine|gemcitabine|mesh-list
138507695|NCT00060112|Oblimersen|oblimersen|mesh-list
138507696|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507697|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
138507698|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507699|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507700|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138507701|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507702|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138507703|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507704|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507705|NCT02968927|Vitamin D|vitamin d|mesh-list
138507706|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
138507707|NCT02968927|Rifabutin|rifabutin|mesh-list
138507708|NCT02968927|Everolimus|everolimus|mesh-list
138507709|NCT02968927|Auranofin|auranofin|mesh-list
138507710|NCT02968927|CC-11050|cc-11050|mesh-list
138507711|NCT02968927|Vitamins|vitamins|mesh-ancestor
138507712|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
138507713|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507714|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138507715|NCT02968927|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138507716|NCT02968927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138507717|NCT02968927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507718|NCT02968927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507719|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138507720|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
138507721|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507722|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138507723|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138507724|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507725|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138694991|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
138507726|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
138507727|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138507728|NCT02968927|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138507729|NCT02968927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138507730|NCT00398515|Sirolimus|sirolimus|mesh-list
138507731|NCT00398515|Lenalidomide|lenalidomide|mesh-list
138507732|NCT00398515|Temsirolimus|temsirolimus|mesh-list
138507733|NCT00398515|MTOR Inhibitors|mtor inhibitors|mesh-list
138507734|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
138507735|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507736|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138507737|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138507738|NCT00398515|Growth Substances|growth substances|mesh-ancestor
138507739|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
138507740|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507741|NCT00398515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138507742|NCT00398515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507743|NCT00398515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507744|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138507745|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138507746|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507747|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138507748|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
138507749|NCT05105685|Hormones|hormones|mesh-list
138507750|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138507751|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507752|NCT05325164|Morphine|morphine|mesh-list
138507753|NCT05325164|Methadone|methadone|mesh-list
138507754|NCT05325164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138507755|NCT05325164|Narcotics|narcotics|mesh-ancestor
138507756|NCT05325164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138507757|NCT05325164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507758|NCT05325164|Analgesics|analgesics|mesh-ancestor
138507759|NCT05325164|Sensory System Agents|sensory system agents|mesh-ancestor
138507760|NCT05325164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263734|NCT01983020|Lidocaine|lidocaine|mesh-list
138507761|NCT05325164|Antitussive Agents|antitussive agents|mesh-ancestor
138507762|NCT05325164|Respiratory System Agents|respiratory system agents|mesh-ancestor
138507764|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
138507765|NCT00060385|Doxorubicin|doxorubicin|mesh-list
138507766|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138507767|NCT00060385|Etoposide|etoposide|mesh-list
138507768|NCT00060385|Vincristine|vincristine|mesh-list
138507769|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138695016|NCT02907437|Minocycline|minocycline|mesh-list
138695017|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138507770|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
138507771|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507772|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138507773|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138507774|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
138507775|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507776|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507777|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138507778|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138507779|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138507780|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138507781|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507782|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138507783|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
138507784|NCT00060385|Hormones|hormones|mesh-ancestor
138507785|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138507786|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138507787|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138507788|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
138507789|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
138507790|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
138507791|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
138507792|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
138507793|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138507794|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507795|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138507796|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138507797|NCT02968693|Vancomycin|vancomycin|mesh-list
138507798|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138507799|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138507800|NCT02968693|Calcium|calcium|mesh-list
138507801|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138507802|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507803|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507804|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
138507805|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
138507806|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138507807|NCT02968693|Protective Agents|protective agents|mesh-ancestor
138507808|NCT00060502|Infliximab|infliximab|mesh-list
138507809|NCT00060502|Gemcitabine|gemcitabine|mesh-list
138507810|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507811|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
138507812|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507813|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507814|NCT00060502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138507815|NCT00060502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138507816|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
138507817|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138507818|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138507820|NCT05312372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138507821|NCT05312372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507822|NCT05312372|Tubulin Modulators|tubulin modulators|mesh-ancestor
138507823|NCT05312372|Antimitotic Agents|antimitotic agents|mesh-ancestor
138507824|NCT05312372|Mitosis Modulators|mitosis modulators|mesh-ancestor
138507825|NCT05312372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507826|NCT05038410|Wobenzym|wobenzym|mesh-list
138507827|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138507828|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
138507829|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507830|NCT02968498|Methamphetamine|methamphetamine|mesh-list
138507831|NCT02968498|Lactulose|lactulose|mesh-list
138507832|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138507833|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138507834|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507835|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
138507836|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
138507837|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138507838|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
138507839|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138507840|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507841|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
138507842|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138507843|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138507844|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138507845|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138507846|NCT00060931|Metoprolol|metoprolol|mesh-list
138507847|NCT00060931|Carvedilol|carvedilol|mesh-list
138507848|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138507849|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138507850|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
138507851|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
138507852|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138507853|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507854|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138507855|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138507856|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138507857|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
138507858|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138507859|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507860|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
138507861|NCT00060931|Protective Agents|protective agents|mesh-ancestor
138507862|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138507863|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138507864|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138507865|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
138507866|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138507867|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138507868|NCT00061087|Methylphenidate|methylphenidate|mesh-list
138507869|NCT00061087|Bupropion|bupropion|mesh-list
138507870|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138507871|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507872|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138507873|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138507874|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138507875|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507876|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
138455878|NCT01908322|Sorafenib|sorafenib|mesh-list
138507877|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138507878|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138507879|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
138507880|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138507881|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138507882|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138507883|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507884|NCT00061243|Vaccines|vaccines|mesh-list
138507885|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
138507886|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507887|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138507888|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
138507889|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138507890|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138507891|NCT00061321|Nevirapine|nevirapine|mesh-list
138695121|NCT04043494|Asparaginase|asparaginase|mesh-list
138695122|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
138507892|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138507893|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138507894|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507895|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507896|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
138507897|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507898|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138263796|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138507899|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138507900|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138507901|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138507902|NCT00061360|Cyclosporine|cyclosporine|mesh-list
138507903|NCT00061360|Sirolimus|sirolimus|mesh-list
138507904|NCT00061360|Cyclosporins|cyclosporins|mesh-list
138507905|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695311|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138507906|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507907|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138507908|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
138507909|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507910|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
138507911|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507912|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
138507913|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138507914|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138507915|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138507916|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138507917|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507918|NCT06197776|Cisplatin|cisplatin|mesh-list
138507919|NCT06197776|Immunomodulating Agents|immunomodulating agents|mesh-list
138507920|NCT06197776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507921|NCT06197776|Immunologic Factors|immunologic factors|mesh-ancestor
138507922|NCT06197776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507923|NCT06197763|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138507924|NCT06197763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138507925|NCT06197763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138507926|NCT06197763|Antimetabolites|antimetabolites|mesh-ancestor
138507927|NCT06197763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507928|NCT06197763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138507929|NCT06197698|Technetium Tc 99m TRODAT-1|technetium tc 99m trodat-1|mesh-list
138507930|NCT06197698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138507931|NCT06197698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507932|NCT06197581|Capecitabine|capecitabine|mesh-list
138507933|NCT06197581|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138507934|NCT06197581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507935|NCT06197581|Antimetabolites|antimetabolites|mesh-ancestor
138695152|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
138507936|NCT06197581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507937|NCT06197581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507938|NCT06197581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507939|NCT06197555|Calcium Carbonate|calcium carbonate|mesh-list
138507940|NCT06197555|Calcium|calcium|mesh-list
138507941|NCT06197555|Fluorides|fluorides|mesh-list
138507942|NCT06197555|Tin Fluorides|tin fluorides|mesh-list
138507943|NCT06197555|Fluorophosphate|fluorophosphate|mesh-list
138507944|NCT06197555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138507945|NCT06197555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507946|NCT06197555|Cariostatic Agents|cariostatic agents|mesh-ancestor
138507947|NCT06197555|Protective Agents|protective agents|mesh-ancestor
138507948|NCT06197555|Antacids|antacids|mesh-ancestor
138507949|NCT06197555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507950|NCT06197555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138507951|NCT06197529|Capsaicin|capsaicin|mesh-list
138507956|NCT06197529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507957|NCT06197438|Leucovorin|leucovorin|mesh-list
138507958|NCT06197438|Paclitaxel|paclitaxel|mesh-list
138507959|NCT06197438|Fluorouracil|fluorouracil|mesh-list
138507960|NCT06197438|Oxaliplatin|oxaliplatin|mesh-list
138507961|NCT06197438|Irinotecan|irinotecan|mesh-list
138507962|NCT06197438|Tislelizumab|tislelizumab|mesh-list
138507963|NCT06197438|Levoleucovorin|levoleucovorin|mesh-list
138507964|NCT06197438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138507965|NCT06197438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507966|NCT06197438|Tubulin Modulators|tubulin modulators|mesh-ancestor
138507967|NCT06197438|Antimitotic Agents|antimitotic agents|mesh-ancestor
138507968|NCT06197438|Mitosis Modulators|mitosis modulators|mesh-ancestor
138507969|NCT06197438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507970|NCT06197438|Antimetabolites|antimetabolites|mesh-ancestor
138507971|NCT06197438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138507972|NCT06197438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138507973|NCT06197438|Immunologic Factors|immunologic factors|mesh-ancestor
138507974|NCT06197438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138507975|NCT06197438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138507976|NCT06197438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138507977|NCT06197438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138507978|NCT06197438|Antidotes|antidotes|mesh-ancestor
138507979|NCT06197438|Protective Agents|protective agents|mesh-ancestor
138507980|NCT06197438|Vitamin B Complex|vitamin b complex|mesh-ancestor
138507981|NCT06197438|Vitamins|vitamins|mesh-ancestor
138507982|NCT06197438|Micronutrients|micronutrients|mesh-ancestor
138507983|NCT06197438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138507984|NCT06197425|Trifluridine|trifluridine|mesh-list
138507985|NCT06197425|Antimetabolites|antimetabolites|mesh-ancestor
138507986|NCT06197425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507987|NCT06197425|Antiviral Agents|antiviral agents|mesh-ancestor
138507988|NCT06197425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507993|NCT06197022|Sirolimus|sirolimus|mesh-list
138507994|NCT06197022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138507995|NCT06197022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138507996|NCT06197022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138507997|NCT06197022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138507998|NCT06197022|Antifungal Agents|antifungal agents|mesh-ancestor
138507999|NCT06197022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138508001|NCT06197022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508002|NCT06196918|Rivaroxaban|rivaroxaban|mesh-list
138508003|NCT06196918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138508004|NCT06196918|Antithrombins|antithrombins|mesh-ancestor
138508005|NCT06196918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138508006|NCT06196918|Protease Inhibitors|protease inhibitors|mesh-ancestor
138508007|NCT06196918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508008|NCT06196918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508009|NCT06196918|Anticoagulants|anticoagulants|mesh-ancestor
138508010|NCT06196853|Aminophylline|aminophylline|mesh-list
138508011|NCT06196853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138184437|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138508012|NCT06196853|Autonomic Agents|autonomic agents|mesh-ancestor
138508013|NCT06196853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138508014|NCT06196853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508015|NCT06196853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138508016|NCT06196853|Respiratory System Agents|respiratory system agents|mesh-ancestor
138508017|NCT06196853|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138508018|NCT06196853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138508019|NCT06196853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138508020|NCT06196853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508021|NCT06196853|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138508022|NCT06196853|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138508023|NCT06196853|Purinergic Agents|purinergic agents|mesh-ancestor
138508024|NCT06196853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508025|NCT06196853|Protective Agents|protective agents|mesh-ancestor
138508026|NCT06196840|Aflibercept|aflibercept|mesh-list
138508027|NCT06196840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138508028|NCT06196840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138508029|NCT06196840|Growth Substances|growth substances|mesh-ancestor
138508030|NCT06196840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508031|NCT06196840|Growth Inhibitors|growth inhibitors|mesh-ancestor
138508032|NCT06196840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508033|NCT06196788|Paclitaxel|paclitaxel|mesh-list
138508034|NCT06196788|Gemcitabine|gemcitabine|mesh-list
138508035|NCT06196788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138508036|NCT06196788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508037|NCT06196788|Tubulin Modulators|tubulin modulators|mesh-ancestor
138508038|NCT06196788|Antimitotic Agents|antimitotic agents|mesh-ancestor
138508039|NCT06196788|Mitosis Modulators|mitosis modulators|mesh-ancestor
138508040|NCT06196788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508041|NCT06196788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138695207|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138695209|NCT00549120|Propranolol|propranolol|mesh-list
138508042|NCT06196788|Antimetabolites|antimetabolites|mesh-ancestor
138508043|NCT06196697|Capecitabine|capecitabine|mesh-list
138508044|NCT06196697|Tegafur|tegafur|mesh-list
138508045|NCT06196697|Oxaliplatin|oxaliplatin|mesh-list
138508046|NCT06196697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138508047|NCT06196697|Antimetabolites|antimetabolites|mesh-ancestor
138508048|NCT06196697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508049|NCT06196697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508050|NCT06196671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138508051|NCT06196671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508052|NCT06196671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138508053|NCT06196671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138508054|NCT06196606|Botulinum Toxins|botulinum toxins|mesh-list
138508055|NCT06196606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138508057|NCT06196606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138508058|NCT06196606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138508059|NCT06196606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508060|NCT06196606|Cholinergic Agents|cholinergic agents|mesh-ancestor
138508061|NCT06196606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508062|NCT06196606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709256|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709257|NCT03774901|Avelumab|avelumab|mesh-list
138709258|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138709259|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709260|NCT03762018|Bevacizumab|bevacizumab|mesh-list
138709261|NCT03762018|Atezolizumab|atezolizumab|mesh-list
138709262|NCT03762018|Carboplatin|carboplatin|mesh-list
138709263|NCT03762018|Pemetrexed|pemetrexed|mesh-list
138709264|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138709265|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709266|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138709267|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138709268|NCT03762018|Growth Substances|growth substances|mesh-ancestor
138709269|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709270|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
138709271|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709272|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709273|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138709274|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138709275|NCT03762018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138709276|NCT03456882|RNS60|rns60|mesh-list
138709277|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138709278|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138709279|NCT03456882|Analgesics|analgesics|mesh-ancestor
138709280|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
138709281|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695235|NCT04680884|Miconazole|miconazole|mesh-list
138695253|NCT00535509|Cisplatin|cisplatin|mesh-list
138709282|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709283|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138709284|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138709285|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138709286|NCT03433807|Idebenone|idebenone|mesh-list
138709287|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
138709288|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709289|NCT03433807|Protective Agents|protective agents|mesh-ancestor
138709290|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709292|NCT03416179|Azacitidine|azacitidine|mesh-list
138709293|NCT03416179|Daunorubicin|daunorubicin|mesh-list
138709294|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138709295|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
138709296|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709297|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709298|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
138709299|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138709300|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138709301|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
138709302|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709303|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709304|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138709305|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138709306|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138709307|NCT03313544|Nivolumab|nivolumab|mesh-list
138709308|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138709309|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709310|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138709311|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709312|NCT03251859|Ticagrelor|ticagrelor|mesh-list
138709313|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138709314|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138709315|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138709316|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138709317|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
138709318|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709319|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709320|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709322|NCT02918409|Colistin|colistin|mesh-list
138709323|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138709324|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138709325|NCT02859792|Riluzole|riluzole|mesh-list
138709326|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
138709327|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138709328|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138709329|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709330|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695259|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
138709331|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709332|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138709333|NCT02859792|Protective Agents|protective agents|mesh-ancestor
138709334|NCT02774005|Idebenone|idebenone|mesh-list
138709335|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
138709336|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709337|NCT02774005|Protective Agents|protective agents|mesh-ancestor
138709338|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709339|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
138709340|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138709341|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138709342|NCT02695771|Gemcitabine|gemcitabine|mesh-list
138709343|NCT02695771|Mitomycins|mitomycins|mesh-list
138709344|NCT02695771|Mitomycin|mitomycin|mesh-list
138709345|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138709346|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
138709347|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709348|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709349|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138709350|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
138709351|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138709353|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
138709354|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
138709355|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709356|NCT01941641|Capecitabine|capecitabine|mesh-list
138709357|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138709358|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
138709359|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709360|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709361|NCT01792934|Bevacizumab|bevacizumab|mesh-list
138709362|NCT01792934|Irinotecan|irinotecan|mesh-list
138709363|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138709364|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709365|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138709366|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138709367|NCT01792934|Growth Substances|growth substances|mesh-ancestor
138709368|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709369|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
138709370|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138709371|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138709372|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709373|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709374|NCT01669915|Vitamin D|vitamin d|mesh-list
138709375|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
138709376|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
138695284|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
138709377|NCT01669915|Vitamins|vitamins|mesh-list
138709378|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
138709379|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709380|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138709381|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138709382|NCT01653223|Simvastatin|simvastatin|mesh-list
138709453|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138709454|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138709455|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138709456|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
138709457|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709458|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709459|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138709460|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
138709461|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
138709462|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138709463|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138709464|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138709465|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138709466|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
138709467|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709468|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709469|NCT00521222|Tocolytic Agents|tocolytic agents|mesh-ancestor
138709470|NCT00521222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138709471|NCT00521222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138709472|NCT00521222|Cholinergic Agents|cholinergic agents|mesh-ancestor
138709473|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
138709474|NCT00521222|Hormones|hormones|mesh-ancestor
138709475|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138709476|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
138709477|NCT00545012|Levetiracetam|levetiracetam|mesh-list
138709478|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
138709479|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
138709480|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
138709481|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138709482|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709483|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
138709484|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138709485|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709486|NCT00545246|Docetaxel|docetaxel|mesh-list
138709487|NCT00545246|Aflibercept|aflibercept|mesh-list
138709488|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709489|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
138709490|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
138695310|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709491|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
138709492|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709493|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138508063|NCT06196606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138709494|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138709495|NCT00545246|Growth Substances|growth substances|mesh-ancestor
138709496|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709497|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
138709500|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709501|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138709502|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709503|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709504|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138709505|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138709506|NCT03456401|Growth Substances|growth substances|mesh-ancestor
138709507|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709508|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
138709510|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138709511|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709512|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
138709513|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
138709514|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709515|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138709516|NCT00545558|Tenofovir|tenofovir|mesh-list
138709517|NCT00545558|Emtricitabine|emtricitabine|mesh-list
138709518|NCT00545558|Efavirenz|efavirenz|mesh-list
138709519|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138709520|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
138709521|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138709522|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138709523|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138709524|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709525|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709526|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138709527|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138709528|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138709529|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138709530|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138709531|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138709532|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138709533|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138709534|NCT04684667|Propranolol|propranolol|mesh-list
138709535|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138709536|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138709537|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
138709538|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709539|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709540|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709541|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138709542|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138709543|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
138709544|NCT00545675|Valproic Acid|valproic acid|mesh-list
138709545|NCT00545675|Aripiprazole|aripiprazole|mesh-list
138709546|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
138709547|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138709548|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138709549|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138709550|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138709551|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709552|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
138709553|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
138709554|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709555|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709556|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138709557|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138709558|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
138709559|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138709560|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138545398|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
138709561|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138709562|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138709564|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709565|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
138709566|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
138709567|NCT00545831|Taurolidine|taurolidine|mesh-list
138709568|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138709569|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138709570|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709571|NCT00545870|Bevacizumab|bevacizumab|mesh-list
138709572|NCT00545870|Ranibizumab|ranibizumab|mesh-list
138709573|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138709574|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695376|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138665884|NCT03517969|Carboplatin|carboplatin|mesh-list
138709575|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138709576|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138709578|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709579|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
138709580|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
138709581|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138709582|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709584|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138709585|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
138709586|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709587|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709588|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138709589|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138709590|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
138709591|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709592|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709593|NCT00546065|Esomeprazole|esomeprazole|mesh-list
138709594|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138709595|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138709596|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138709597|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709598|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709599|NCT00546143|Omalizumab|omalizumab|mesh-list
138709600|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138709601|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138709602|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138709603|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
138709604|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
138709605|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709606|NCT00560079|Allopurinol|allopurinol|mesh-list
138709607|NCT00560079|Dipyridamole|dipyridamole|mesh-list
138709608|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
138709609|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709610|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709611|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
138709612|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138709613|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138695400|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138695401|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138695402|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695403|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138695404|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138695405|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695406|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695407|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
138695408|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138695409|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695410|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
138709614|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
138709615|NCT00560079|Protective Agents|protective agents|mesh-ancestor
138709616|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709617|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138709618|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138709619|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
138709620|NCT00560118|Fotemustine|fotemustine|mesh-list
138709621|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709622|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138709623|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138709624|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138709625|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709626|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709627|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709628|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709629|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138709630|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
138709631|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138709633|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138709634|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138709635|NCT00546533|Analgesics|analgesics|mesh-ancestor
138709636|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
138709637|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709638|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709639|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138709640|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138709641|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138709643|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
138709644|NCT00558480|Vitamins|vitamins|mesh-list
138709645|NCT00558480|Vitamin A|vitamin a|mesh-list
138709646|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
138709647|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
138709648|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665963|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709649|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
138709650|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709651|NCT00558480|Protective Agents|protective agents|mesh-ancestor
138709652|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138709653|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709654|NCT00546650|Sumatriptan|sumatriptan|mesh-list
138709655|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138709656|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138709657|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138709658|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
138709659|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138695427|NCT03556696|Propofol|propofol|mesh-list
138695428|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138709660|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709661|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264122|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
138709662|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138709663|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138709664|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138709665|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709666|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709667|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709668|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709669|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138709670|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
138709671|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138709673|NCT00547001|Estrogens|estrogens|mesh-ancestor
138709674|NCT00547001|Hormones|hormones|mesh-ancestor
138709675|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138709676|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709677|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
138709678|NCT00547352|Tadalafil|tadalafil|mesh-list
138709679|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
138709680|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138709681|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138709682|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709683|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709684|NCT00547352|Urological Agents|urological agents|mesh-ancestor
138709685|NCT00547508|Tadalafil|tadalafil|mesh-list
138709686|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
138709687|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138709688|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138709689|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695457|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138695483|NCT00551850|MP 412|mp 412|mesh-list
138709690|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709691|NCT00547508|Urological Agents|urological agents|mesh-ancestor
138709692|NCT00560274|Ribavirin|ribavirin|mesh-list
138709693|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138709694|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
138709695|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709696|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
138709697|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138709698|NCT00547547|Selenium|selenium|mesh-list
138709699|NCT00547547|Capecitabine|capecitabine|mesh-list
138709700|NCT00547547|Irinotecan|irinotecan|mesh-list
138709701|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138709702|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
138709703|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709704|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709705|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138709706|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138709707|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709708|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
138709709|NCT00547547|Protective Agents|protective agents|mesh-ancestor
138709710|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709711|NCT00547547|Trace Elements|trace elements|mesh-ancestor
138709712|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
138709713|NCT00547625|Tadalafil|tadalafil|mesh-list
138709714|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
138709715|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138709716|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138709717|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709718|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709719|NCT00547625|Urological Agents|urological agents|mesh-ancestor
138709721|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138666065|NCT03258593|Durvalumab|durvalumab|mesh-list
138709722|NCT00547664|Narcotics|narcotics|mesh-ancestor
138709723|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138709724|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695498|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138709725|NCT00547664|Analgesics|analgesics|mesh-ancestor
138709726|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
138709727|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709728|NCT00560430|Telmisartan|telmisartan|mesh-list
138709729|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138709730|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138709731|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138709732|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709733|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
138709734|NCT00560547|Hematinics|hematinics|mesh-ancestor
138709735|NCT04636125|Doxycycline|doxycycline|mesh-list
138709736|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138709737|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138709738|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
138709739|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138709740|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138709741|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138709742|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138709743|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
138709744|NCT00548288|Pamidronate|pamidronate|mesh-list
138709745|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138709746|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709747|NCT04644354|Nifedipine|nifedipine|mesh-list
138709748|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138709749|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709750|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709751|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138709752|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709753|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
138709754|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
138709755|NCT04644354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138709756|NCT00548483|Dexamethasone|dexamethasone|mesh-list
138709757|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138709758|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
138709759|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
138709760|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709762|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138709763|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
138709765|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138709766|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138709767|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709768|NCT04635852|Fentanyl|fentanyl|mesh-list
138709769|NCT04635852|Morphine|morphine|mesh-list
138709770|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138709771|NCT04635852|Narcotics|narcotics|mesh-ancestor
138709772|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695543|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
138709773|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709774|NCT04635852|Analgesics|analgesics|mesh-ancestor
138709775|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
138709776|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709777|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138709778|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138709779|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
138709780|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
138709781|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
138709782|NCT00548561|Razoxane|razoxane|mesh-list
138709783|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709784|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138709785|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138709786|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138709787|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709788|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709789|NCT00548561|Protective Agents|protective agents|mesh-ancestor
138709790|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709791|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
138709792|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
138709793|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
138709794|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
138709795|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
138709796|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138709797|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709798|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
138709799|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709800|NCT00548678|Aspirin|aspirin|mesh-list
138709801|NCT00548678|Diclofenac|diclofenac|mesh-list
138709802|NCT00548678|Ketorolac|ketorolac|mesh-list
138709803|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138709804|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138709805|NCT00548678|Analgesics|analgesics|mesh-ancestor
138709806|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
138709807|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709808|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709809|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138709810|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138709811|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138709812|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138709813|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709814|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138709815|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138709816|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709817|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
138709818|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
138709819|NCT00548834|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138709820|NCT00548834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138709821|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138695564|NCT00550485|Escitalopram|escitalopram|mesh-list
138709822|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
138709823|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709824|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138709825|NCT04684199|Melatonin|melatonin|mesh-list
138709826|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
138709827|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709828|NCT04684199|Protective Agents|protective agents|mesh-ancestor
138709829|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709830|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138709832|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138709833|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138709834|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
138709835|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709836|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709837|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138709838|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
138709839|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
138709840|NCT00560586|Hormones|hormones|mesh-ancestor
138709841|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138709842|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
138709843|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138709844|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709845|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709846|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138709847|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709848|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138709849|NCT00549107|Simendan|simendan|mesh-list
138709850|NCT00549107|Milrinone|milrinone|mesh-list
138709851|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138709852|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
138709853|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138709854|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138709855|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709856|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709857|NCT00549107|Protective Agents|protective agents|mesh-ancestor
138709858|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709859|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138709860|NCT00549146|Fluticasone|fluticasone|mesh-list
138709861|NCT00549146|Xhance|xhance|mesh-list
138695595|NCT02895113|Aspirin|aspirin|mesh-list
138709862|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138709863|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138709864|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138709865|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138709866|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
138709867|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709868|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709869|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138709870|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
138709871|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
138709873|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138709874|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138709875|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138709876|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
138709877|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709878|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709879|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
138709880|NCT00549146|Hormones|hormones|mesh-ancestor
138709881|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138709882|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
138709883|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
138709884|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138709885|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709886|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709887|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
138709888|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709889|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709890|NCT00549419|Dobutamine|dobutamine|mesh-list
138709891|NCT00549419|Norepinephrine|norepinephrine|mesh-list
138709892|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138709893|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138709894|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
138647168|NCT04981860|Povidone|povidone|mesh-list
138709895|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709896|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709897|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709898|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
138709899|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
138709900|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709901|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138709902|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138709903|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138709904|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138709905|NCT00549419|Protective Agents|protective agents|mesh-ancestor
138709907|NCT04643691|Spironolactone|spironolactone|mesh-list
138709908|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138709909|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138709910|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138264262|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709911|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138709912|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709913|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138709914|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
138709915|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138709916|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709917|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138709919|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
138709920|NCT03455972|Immunomodulating Agents|immunomodulating agents|mesh-list
138709921|NCT03455972|Immunologic Factors|immunologic factors|mesh-ancestor
138709922|NCT03455972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709923|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
138709924|NCT00549536|Calcium|calcium|mesh-list
138709925|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138709926|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709927|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138709928|NCT00549614|Acipimox|acipimox|mesh-list
138709929|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138709930|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
138709931|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695667|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138695668|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
138709932|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138709933|NCT00559026|Dacarbazine|dacarbazine|mesh-list
138709934|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138545454|NCT00224809|Analgesics|analgesics|mesh-ancestor
138709935|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
138709936|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709937|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709939|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138709940|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138709941|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709942|NCT00549926|Atorvastatin|atorvastatin|mesh-list
138709943|NCT00549926|Pravastatin|pravastatin|mesh-list
138709944|NCT00549926|Pitavastatin|pitavastatin|mesh-list
138709946|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138709947|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
138709948|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709949|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138709950|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138709951|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709952|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
138709953|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138709954|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709955|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709956|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138709957|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709958|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138709959|NCT00550004|Gemcitabine|gemcitabine|mesh-list
138647173|NCT04979910|Ixekizumab|ixekizumab|mesh-list
138709960|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138709961|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
138709962|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709963|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709964|NCT04634721|Bupivacaine|bupivacaine|mesh-list
138709965|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
138709966|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
138709967|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138709968|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709969|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
138709970|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709971|NCT00550160|Artesunate|artesunate|mesh-list
138709972|NCT00550160|Amodiaquine|amodiaquine|mesh-list
138709973|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
138709974|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138709975|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138709976|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138709977|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709978|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
138709979|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
138709980|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138709981|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
138709982|NCT00550199|Gemcitabine|gemcitabine|mesh-list
138709983|NCT00550199|Panobinostat|panobinostat|mesh-list
138709984|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138709985|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
138709986|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709987|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709988|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138709989|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709990|NCT04643301|Liraglutide|liraglutide|mesh-list
138709991|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138709992|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709993|NCT04643301|Incretins|incretins|mesh-ancestor
138709994|NCT04643301|Hormones|hormones|mesh-ancestor
138709995|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138709996|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
138709997|NCT00550433|Estrogens|estrogens|mesh-list
138709998|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138710000|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138710001|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710002|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138710003|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138710004|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
138710005|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138710006|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138710007|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710008|NCT04634058|Antibodies|antibodies|mesh-list
138710009|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
138710010|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
138695741|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
138710011|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710012|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138710013|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138710014|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710015|NCT00560820|Deferasirox|deferasirox|mesh-list
138710016|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138710017|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
138710018|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
138710019|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710020|NCT00550784|Paclitaxel|paclitaxel|mesh-list
138710021|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
138710022|NCT00550784|Melphalan|melphalan|mesh-list
138710023|NCT00550784|Topotecan|topotecan|mesh-list
138710024|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138710025|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710026|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
138710027|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
138710028|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
138710029|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710030|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138710031|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
138710032|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710033|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138710034|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138710035|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
138710036|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138710037|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138710038|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138710039|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710040|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
138710041|NCT00550901|Razoxane|razoxane|mesh-list
138710042|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710043|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138710044|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138710045|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138710046|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710047|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710048|NCT00550901|Protective Agents|protective agents|mesh-ancestor
138710049|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710050|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
138710051|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
138710052|NCT04633746|Endostatins|endostatins|mesh-list
138710053|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710054|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138545483|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
138710055|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138710056|NCT04633746|Growth Substances|growth substances|mesh-ancestor
138710057|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264335|NCT02371850|Nicotine|nicotine|mesh-list
138710058|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
138710059|NCT00551018|Tenofovir|tenofovir|mesh-list
138710060|NCT00551018|Emtricitabine|emtricitabine|mesh-list
138710061|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
138710062|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710063|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138710064|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138710065|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710066|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710067|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138710068|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138710069|NCT00551096|Gemcitabine|gemcitabine|mesh-list
138710070|NCT00551096|Capecitabine|capecitabine|mesh-list
138710071|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138710072|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
138710073|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710074|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710075|NCT00551252|Gemcitabine|gemcitabine|mesh-list
138710076|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
138710077|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138710078|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
138710079|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710080|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710081|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138710082|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710083|NCT01125761|Clemastine|clemastine|mesh-list
138710084|NCT01125761|Dexamethasone|dexamethasone|mesh-list
138710085|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
138710086|NCT01125761|BB 1101|bb 1101|mesh-list
138710087|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138710088|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
138710089|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
138710090|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710091|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710092|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138710093|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
138710094|NCT01125761|Hormones|hormones|mesh-ancestor
138710095|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138710096|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138710097|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710098|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
138710099|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710100|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710102|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
138710103|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138710104|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
138710105|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
138710106|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710107|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138710108|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
138710109|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
138710110|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710111|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710112|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710113|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
138710114|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
138710115|NCT05408312|Vaccines|vaccines|mesh-list
138710116|NCT05408312|Immunologic Factors|immunologic factors|mesh-ancestor
138710117|NCT05408312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710118|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138710119|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
138710120|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710121|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
138710122|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710123|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
138545503|NCT00413179|Metformin|metformin|mesh-list
138710124|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710126|NCT00553124|Selenium|selenium|mesh-list
138710127|NCT00553124|Vitamins|vitamins|mesh-ancestor
138710128|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
138710129|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710130|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
138710131|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710132|NCT00553124|Protective Agents|protective agents|mesh-ancestor
138710133|NCT00553124|Trace Elements|trace elements|mesh-ancestor
138710134|NCT04640181|Enoxaparin|enoxaparin|mesh-list
138710135|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
138710136|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138710137|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
138710138|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138710139|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
138710140|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710141|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710142|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
138710143|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138710144|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138710145|NCT00559455|Leucovorin|leucovorin|mesh-list
138710146|NCT00559455|Fluorouracil|fluorouracil|mesh-list
138710147|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
138710148|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
138710149|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710150|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138710151|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710152|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138710153|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
138710154|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710155|NCT00559455|Antidotes|antidotes|mesh-ancestor
138710156|NCT00559455|Protective Agents|protective agents|mesh-ancestor
138710157|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
138710158|NCT00559455|Vitamins|vitamins|mesh-ancestor
138710159|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
138710160|NCT00559494|Minocycline|minocycline|mesh-list
138710161|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138710162|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710163|NCT05186675|Epinephrine|epinephrine|mesh-list
138710164|NCT05186675|Racepinephrine|racepinephrine|mesh-list
138710165|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
138710166|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138710167|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138710168|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
138710169|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710170|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710171|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710172|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138710173|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138710174|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
138695833|NCT01099449|Calcium|calcium|mesh-list
138710175|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710176|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138710177|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
138710178|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
138710179|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
138710180|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138710181|NCT04639362|Venetoclax|venetoclax|mesh-list
138710182|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
138710183|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710184|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138710185|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
138710186|NCT04639284|Antibodies|antibodies|mesh-list
138710187|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
138710188|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710189|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138710190|NCT04639284|Growth Substances|growth substances|mesh-ancestor
138710191|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
138710192|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710194|NCT00559689|Beclomethasone|beclomethasone|mesh-list
138710195|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138710196|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138710197|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
138710198|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710199|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710200|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138710201|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
138710202|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
138710203|NCT00559689|Hormones|hormones|mesh-ancestor
138695841|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138710204|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138710205|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138710206|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710207|NCT04629027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138710208|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710209|NCT00561288|Acetaminophen|acetaminophen|mesh-list
138710210|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138710211|NCT00561288|Analgesics|analgesics|mesh-ancestor
138710212|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
138710213|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710214|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710215|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
138710216|NCT00561327|Losartan|losartan|mesh-list
138710217|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138710218|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138710219|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138710220|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138647209|NCT04827992|Narcotics|narcotics|mesh-ancestor
138710221|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710223|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138710224|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
138710225|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710226|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710227|NCT03454620|Irinotecan|irinotecan|mesh-list
138710228|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138710229|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138710230|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710231|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710232|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710233|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
138710234|NCT04628559|Ketamine|ketamine|mesh-list
138710235|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138710236|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138710237|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710238|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138710239|NCT04628559|Analgesics|analgesics|mesh-ancestor
138710240|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
138710241|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710242|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138710243|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138710244|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138710245|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
138710246|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710247|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710248|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138710249|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138695903|NCT01211665|Hormones|hormones|mesh-ancestor
138710250|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
138710251|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
138710252|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138710253|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138710254|NCT04683341|Tenofovir|tenofovir|mesh-list
138710255|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
138710256|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710257|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138710258|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138710259|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710260|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710261|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138710262|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138710263|NCT04628676|Epinephrine|epinephrine|mesh-list
138710264|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
138710265|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
138710266|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138710267|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138710268|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710269|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
138710270|NCT04628676|Coagulants|coagulants|mesh-ancestor
138710271|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138710272|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138710273|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
138710274|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710275|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710276|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138710277|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138710278|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
138710279|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710280|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138710281|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
138710282|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
138710283|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
138710284|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138710285|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
138710286|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138710287|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138710288|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710289|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138710290|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138710291|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138710292|NCT04628325|Furosemide|furosemide|mesh-list
138710293|NCT04628325|Diuretics|diuretics|mesh-ancestor
138710294|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
138710295|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710296|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138710297|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138710298|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710299|NCT04657497|Camostat|camostat|mesh-list
138710300|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
138710301|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710302|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710303|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138710304|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138710305|NCT01214434|Emollients|emollients|mesh-list
138710306|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
138710307|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
138710308|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138710309|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710310|NCT01214239|Linagliptin|linagliptin|mesh-list
138710311|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138710312|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710313|NCT01214239|Incretins|incretins|mesh-ancestor
138710314|NCT01214239|Hormones|hormones|mesh-ancestor
138710315|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138710316|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138710317|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
138710318|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710319|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710320|NCT01214044|Dexetimide|dexetimide|mesh-list
138666637|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
138710321|NCT01214044|Citalopram|citalopram|mesh-list
138710322|NCT01214044|Escitalopram|escitalopram|mesh-list
138710323|NCT01214044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138710324|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138710325|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138710326|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710327|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710328|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
138710329|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710330|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138710331|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138710332|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
138710333|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
138710334|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710335|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138710336|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138710337|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
138710338|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138710339|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
138710340|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138710341|NCT01213966|Artefenomel|artefenomel|mesh-list
138710342|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
138710343|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138710344|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138710345|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710346|NCT01213264|Anesthetics|anesthetics|mesh-list
138710347|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695948|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138710348|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710349|NCT04657107|Ketamine|ketamine|mesh-list
138710350|NCT04657107|Esketamine|esketamine|mesh-list
138710351|NCT04657107|Analgesics|analgesics|mesh-ancestor
138710352|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
138710353|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710354|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710355|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138710356|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138710357|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
138710358|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
138710359|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138710360|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138710361|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138710362|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710363|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710364|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
138710365|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138710366|NCT00561717|Cetirizine|cetirizine|mesh-list
138710367|NCT00561717|Loratadine|loratadine|mesh-list
138710368|NCT00561717|Azelastine|azelastine|mesh-list
138710369|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138710370|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138710371|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138710372|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
138710373|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
138710374|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710375|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710376|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710377|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
138710378|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
138710379|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138710380|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
138710381|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710382|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138710383|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
138710384|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138710385|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710387|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
138710388|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710389|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
138710390|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138710391|NCT04683146|Propranolol|propranolol|mesh-list
138666711|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138710392|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138695963|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138710393|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710394|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
138710395|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
138710396|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138710397|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138710398|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
138710399|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710400|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710401|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710402|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138710403|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138710404|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
138710406|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138710407|NCT04800302|Narcotics|narcotics|mesh-ancestor
138710408|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138710409|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710410|NCT04800302|Analgesics|analgesics|mesh-ancestor
138710411|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
138710412|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710413|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
138710414|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138710415|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
138710416|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710417|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
138710418|NCT04711304|Protective Agents|protective agents|mesh-ancestor
138710419|NCT04710719|Triamcinolone|triamcinolone|mesh-list
138710420|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138710421|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138710422|NCT04710719|Fluorouracil|fluorouracil|mesh-list
138710423|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138710424|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
138710425|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710426|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138710427|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710428|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138710429|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
138710430|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710431|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138710432|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
138710433|NCT04710719|Hormones|hormones|mesh-ancestor
138710434|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138710435|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710436|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
138710437|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
138710438|NCT04627779|Analgesics|analgesics|mesh-ancestor
138710439|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
138710440|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710441|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179903|NCT00828841|Paclitaxel|paclitaxel|mesh-list
138710442|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138710443|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138710444|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138710445|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138710446|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138710447|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710448|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710449|NCT04537598|Morphine|morphine|mesh-list
138710450|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138710451|NCT04537598|Narcotics|narcotics|mesh-ancestor
138710452|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138710453|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710454|NCT04537598|Analgesics|analgesics|mesh-ancestor
138710455|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
138710456|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710457|NCT04627467|Chloroquine|chloroquine|mesh-list
138710458|NCT04627467|Amebicides|amebicides|mesh-ancestor
138710459|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138710460|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138710461|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710462|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
138710463|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138710464|NCT04627623|Antibodies|antibodies|mesh-list
138710465|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
138710466|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
138710467|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710468|NCT04656249|Lenvatinib|lenvatinib|mesh-list
138710469|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710470|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138710471|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710472|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710473|NCT04682795|Insulin|insulin|mesh-list
138710474|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138710475|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710476|NCT04655664|Vitamin D|vitamin d|mesh-list
138710477|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
138710478|NCT04655664|Cholecalciferol|cholecalciferol|mesh-list
138710479|NCT04655664|Vitamins|vitamins|mesh-list
138710480|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
138710481|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710482|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138710483|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138710484|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138710485|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138264596|NCT03170219|Furosemide|furosemide|mesh-list
138710486|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
138710487|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710488|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710489|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138710490|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
138710491|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
138696011|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138710493|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138710494|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
138710495|NCT04655040|Caffeine|caffeine|mesh-list
138710496|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138710497|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710498|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138710499|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710500|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710501|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138710502|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138710503|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
138710504|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710505|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
138710506|NCT04626765|Fludarabine|fludarabine|mesh-list
138710507|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138710508|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
138710509|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710510|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138710511|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138710512|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
138710513|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710514|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710515|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138710516|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
138710517|NCT04626726|Fludarabine|fludarabine|mesh-list
138710518|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138710519|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
138710520|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710521|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138710522|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138710523|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
138264611|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
138710524|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710525|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710526|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138710527|NCT04654962|Anesthetics|anesthetics|mesh-list
138710528|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138710529|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710530|NCT04626414|Ferric maltol|ferric maltol|mesh-list
138710531|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
138710532|NCT04626414|Hematinics|hematinics|mesh-ancestor
138710533|NCT04654416|Colchicine|colchicine|mesh-list
138710534|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
138710535|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138710536|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
138710537|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
138696034|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
138710538|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
138710539|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710540|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710541|NCT02906150|Cisplatin|cisplatin|mesh-list
138710542|NCT02906150|Carboplatin|carboplatin|mesh-list
138710543|NCT02906150|Pemetrexed|pemetrexed|mesh-list
138710544|NCT02906150|Thymalfasin|thymalfasin|mesh-list
138710545|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710546|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710547|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710548|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138710549|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138710550|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138710551|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
138710552|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710553|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
138710554|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138710555|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710556|NCT02905994|Cytarabine|cytarabine|mesh-list
138710557|NCT02905994|Idarubicin|idarubicin|mesh-list
138710558|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138710559|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
138710560|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710561|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710562|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
138710563|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710564|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138710565|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
138710566|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710567|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138710568|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138710569|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138710570|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710571|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138710572|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
138710573|NCT02905682|Coagulants|coagulants|mesh-ancestor
138710574|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138710575|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
138710576|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710577|NCT04626258|Fluconazole|fluconazole|mesh-list
138710578|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
138710579|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710580|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138710581|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138710582|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710583|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710584|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138710585|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
138710586|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138710587|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710588|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138710589|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138710590|NCT04626063|Acetaminophen|acetaminophen|mesh-list
138710591|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138710592|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138710593|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138710594|NCT04626063|Analgesics|analgesics|mesh-ancestor
138710595|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
138710596|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710597|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710598|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
138710599|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138710600|NCT04625985|Metformin|metformin|mesh-list
138710601|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138710602|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710603|NCT02905760|Furosemide|furosemide|mesh-list
138710604|NCT02905760|Diuretics|diuretics|mesh-list
138710605|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
138710606|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710607|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138710608|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138710609|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710610|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
138710611|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138710612|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710613|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
138710614|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138710615|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138710616|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710617|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
138666936|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138710618|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
138710619|NCT04654026|Aspirin|aspirin|mesh-list
138710620|NCT04654026|Clopidogrel|clopidogrel|mesh-list
138710621|NCT04654026|Ticagrelor|ticagrelor|mesh-list
138710622|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138710623|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138710624|NCT04654026|Analgesics|analgesics|mesh-ancestor
138710625|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
138710626|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710627|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710628|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138710629|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138710631|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138710632|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710633|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138710634|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138710635|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710636|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
138710637|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138710638|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138710639|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138710640|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
138710641|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710642|NCT04625595|Methyldopa|methyldopa|mesh-list
138710643|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138710644|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
138696092|NCT03570983|Carmustine|carmustine|mesh-list
138710645|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
138710646|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710647|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710648|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138710649|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138710650|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138710651|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
138710652|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710653|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710654|NCT02905058|Ketoprofen|ketoprofen|mesh-list
138710655|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138710656|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138710657|NCT02905058|Analgesics|analgesics|mesh-ancestor
138710658|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
138710659|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710660|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710661|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138710662|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138710663|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138710664|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710665|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710667|NCT04653792|Analgesics|analgesics|mesh-ancestor
138710668|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
138710669|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710670|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710671|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
138710672|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138710673|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138710674|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710675|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138710676|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138710677|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138710678|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138710679|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138710680|NCT00557700|Bromides|bromides|mesh-list
138710681|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
138710682|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138710683|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
138710684|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710685|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710686|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138710687|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
138710689|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138710690|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
138710691|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667011|NCT00429533|Dapsone|dapsone|mesh-list
138710692|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710693|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
138710694|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
138710695|NCT00557739|Nortriptyline|nortriptyline|mesh-list
138710696|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138710697|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
138179997|NCT05236907|Midazolam|midazolam|mesh-list
138710698|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138710699|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138710700|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
138710701|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138710702|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138710703|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138710704|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138710705|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710706|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
138710707|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710708|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710709|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
138710710|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138710711|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
138710712|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138710713|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710714|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138710715|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138710716|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138710718|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
138710719|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138710720|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138710721|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710722|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710723|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710724|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138710725|NCT04652739|Prednisolone|prednisolone|mesh-list
138710727|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138710728|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
138710729|NCT04652739|Hormones|hormones|mesh-ancestor
138710730|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138710731|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710732|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138710733|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710734|NCT04652739|Protective Agents|protective agents|mesh-ancestor
138710735|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
138710736|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710737|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138710738|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138710739|NCT02903498|Tegafur|tegafur|mesh-list
138710740|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138710741|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
138710742|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710743|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710744|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
138696130|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
138710745|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138710746|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138710747|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710748|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138710749|NCT04652427|Analgesics|analgesics|mesh-ancestor
138710750|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
138710751|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710752|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138710753|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138710754|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138710755|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
138710756|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710757|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710758|NCT04623879|Ivacaftor|ivacaftor|mesh-list
138710759|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138710760|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138710761|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710762|NCT00562068|Prednisolone|prednisolone|mesh-list
138710763|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
138667086|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138710765|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138710766|NCT00562068|Vincristine|vincristine|mesh-list
138710767|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
138710768|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138710769|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
138710770|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710771|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138264751|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
138710772|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138710773|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
138710774|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710775|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710776|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138710777|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138710778|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138710779|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138710780|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710781|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138710782|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
138710783|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
138710784|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
138710785|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138710786|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
138647318|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138710788|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138710789|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138710790|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138710791|NCT00562185|Carboplatin|carboplatin|mesh-list
138710792|NCT00562185|Doxorubicin|doxorubicin|mesh-list
138710793|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138710794|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710795|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138710796|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138710797|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138710798|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710799|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710800|NCT00562224|Abexinostat|abexinostat|mesh-list
138710801|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138710802|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710803|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710804|NCT02903069|Temozolomide|temozolomide|mesh-list
138710805|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138710806|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
138710807|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710808|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710809|NCT04623840|Tadalafil|tadalafil|mesh-list
138710810|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
138710811|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138710812|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138710813|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710814|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710815|NCT04623840|Urological Agents|urological agents|mesh-ancestor
138710816|NCT02902640|Trimethoprim|trimethoprim|mesh-list
138710817|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
138710818|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
138710819|NCT02902640|Guaifenesin|guaifenesin|mesh-list
138545690|NCT00225706|Analgesics|analgesics|mesh-ancestor
138264771|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138710820|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
138710821|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138710822|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710823|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
138710824|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138710825|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138710826|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138710827|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710828|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710829|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138710830|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138710831|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138710832|NCT02902640|Expectorants|expectorants|mesh-ancestor
138710833|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
138696190|NCT05093205|Hormones|hormones|mesh-ancestor
138667160|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138710834|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138710835|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138710836|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
138710837|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710838|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710839|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
138710840|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138710841|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
138710842|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
138710843|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710844|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
138710845|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138710846|NCT04624893|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138710847|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
138710848|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138710849|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
138647327|NCT04569747|Trastuzumab|trastuzumab|mesh-list
138710850|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710852|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
138710853|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710854|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138710855|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138710856|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710857|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710858|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138710859|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138710861|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138710862|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138710863|NCT02902289|Analgesics|analgesics|mesh-ancestor
138710864|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
138710865|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710866|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710867|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138710868|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138696213|NCT02469155|Serotonin Agents|serotonin agents|mesh-ancestor
138710869|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138710870|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710871|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710872|NCT02902133|Acetazolamide|acetazolamide|mesh-list
138710873|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
138710874|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138710875|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710876|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710877|NCT02902133|Diuretics|diuretics|mesh-ancestor
138710878|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
138710879|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710880|NCT04623021|Nafamostat|nafamostat|mesh-list
138710881|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138710882|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138710883|NCT04623021|Analgesics|analgesics|mesh-ancestor
138710884|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
138710885|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710886|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710887|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138710888|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138710889|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
138710890|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
138710891|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710892|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710893|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138710894|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138710895|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138710896|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138710897|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
138710898|NCT02901977|Ramipril|ramipril|mesh-list
138710899|NCT02901977|Doxazosin|doxazosin|mesh-list
138710900|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138710901|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
138710902|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710903|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710904|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138710905|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138710906|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138710907|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138710908|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
138710909|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138710910|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696250|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138710912|NCT00553553|Remifentanil|remifentanil|mesh-list
138710913|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138710914|NCT00553553|Narcotics|narcotics|mesh-ancestor
138710915|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138710916|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710917|NCT00553553|Analgesics|analgesics|mesh-ancestor
138710918|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
138710919|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710920|NCT04622982|Vitamin D|vitamin d|mesh-list
138710921|NCT04622982|Vitamins|vitamins|mesh-ancestor
138710922|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
138710923|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710924|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138710925|NCT04622202|Pregabalin|pregabalin|mesh-list
138710926|NCT04622202|Analgesics|analgesics|mesh-ancestor
138710927|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
138710928|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710929|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710930|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
138710931|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138710932|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138710933|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710934|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138710935|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138710936|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138710937|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138710938|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138710939|NCT04622358|Rabeprazole|rabeprazole|mesh-list
138710940|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138710941|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138710942|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138710943|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710944|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710945|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138710946|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
138264872|NCT02069041|Leucovorin|leucovorin|mesh-list
138710947|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138710948|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138710949|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138710950|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138710951|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710952|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
138710953|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138710954|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138710955|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710956|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
138710957|NCT04622397|Coagulants|coagulants|mesh-ancestor
138710958|NCT02901353|Sirolimus|sirolimus|mesh-list
138710959|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138710960|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710961|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138710962|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710963|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
138710964|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138710965|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
138710966|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710968|NCT04621461|Astringents|astringents|mesh-ancestor
138710969|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710970|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
138710971|NCT02901236|Antifibrotic Agents|antifibrotic agents|mesh-list
138710972|NCT02901236|Bevacizumab|bevacizumab|mesh-list
138710973|NCT02901236|Mitomycins|mitomycins|mesh-list
138710974|NCT02901236|Mitomycin|mitomycin|mesh-list
138710975|NCT02901236|Antimetabolites|antimetabolites|mesh-list
138710976|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138710977|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710978|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138710979|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138710980|NCT02901236|Growth Substances|growth substances|mesh-ancestor
138710981|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710982|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
138710983|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138710984|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
138667313|NCT00431561|Temozolomide|temozolomide|mesh-list
138710985|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138710986|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138710987|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138710988|NCT02901236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138710990|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
138710991|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
138710992|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138710993|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138710994|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138710995|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138710996|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138710997|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138710998|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
138710999|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711000|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711001|NCT01212757|Thalidomide|thalidomide|mesh-list
138711003|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138711004|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138711005|NCT01212757|Analgesics|analgesics|mesh-ancestor
138711006|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
138711007|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711008|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711009|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138711010|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138711011|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138711012|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138711013|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711014|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696311|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711015|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138711016|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
138711017|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
138711018|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138711019|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711020|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138711021|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138711022|NCT01212757|Growth Substances|growth substances|mesh-ancestor
138711023|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
138711024|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711025|NCT00562419|Irinotecan|irinotecan|mesh-list
138711026|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138711027|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138711028|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711029|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711030|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711031|NCT00562458|Anastrozole|anastrozole|mesh-list
138711032|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138711033|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711034|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138711035|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138711036|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711037|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711038|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138711039|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
138711040|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138711041|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711042|NCT02900729|Losartan|losartan|mesh-list
138711043|NCT02900729|Amlodipine|amlodipine|mesh-list
138711044|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138711045|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138696328|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711046|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138711047|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138711048|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696329|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
139059177|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059178|NCT01108042|Docetaxel|docetaxel|mesh-list
139059179|NCT01108042|Fluorouracil|fluorouracil|mesh-list
139059180|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059181|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
139059182|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
139059183|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
139059184|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059185|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
139059186|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139059187|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139059188|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
139059189|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059190|NCT01105234|Vitamin D|vitamin d|mesh-list
139059191|NCT01105234|Calcipotriene|calcipotriene|mesh-list
139059192|NCT01105234|Vitamins|vitamins|mesh-ancestor
139059193|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
139059194|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059195|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139059196|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
139059197|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
139059198|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139059199|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
139059200|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139059201|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
139059202|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
139059203|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139059204|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139059205|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059206|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059207|NCT01108900|Urological Agents|urological agents|mesh-ancestor
139059208|NCT01105390|Pemetrexed|pemetrexed|mesh-list
139059209|NCT01105390|Rilotumumab|rilotumumab|mesh-list
139059210|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139059211|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059212|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059213|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059214|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139059215|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139059216|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139059217|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
139059218|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059219|NCT03947242|Trastuzumab|trastuzumab|mesh-list
139059220|NCT03947242|Vinorelbine|vinorelbine|mesh-list
139059221|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139059222|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059223|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139059224|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
139059225|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
139059226|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
139059227|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059228|NCT03944980|Docetaxel|docetaxel|mesh-list
138696368|NCT02339129|Analgesics|analgesics|mesh-ancestor
139059229|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059230|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
139059231|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
139059232|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
139059233|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059234|NCT03576664|Carvedilol|carvedilol|mesh-list
139059235|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139059236|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139059237|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
139059238|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059239|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059240|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059241|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139059242|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
139059243|NCT03576664|Protective Agents|protective agents|mesh-ancestor
139059244|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139059245|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139059246|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139059247|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
139059248|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139059249|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139059250|NCT01109134|Tirofiban|tirofiban|mesh-list
139059251|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139059252|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139059253|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059254|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139059255|NCT01108588|Aspirin|aspirin|mesh-list
139059256|NCT01108588|Clopidogrel|clopidogrel|mesh-list
139059257|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139059258|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139059259|NCT01108588|Analgesics|analgesics|mesh-ancestor
139059260|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
139059261|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770217|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
139059262|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059263|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139059264|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139059265|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139059267|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059268|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139059269|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139059270|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059271|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
139059272|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139059273|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139059274|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139059275|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
139059276|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059277|NCT01208740|Metformin|metformin|mesh-list
139059278|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139059279|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059280|NCT01208818|Dexamethasone|dexamethasone|mesh-list
139059281|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
139059282|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
139059283|NCT01208818|Bortezomib|bortezomib|mesh-list
139059284|NCT01208818|BB 1101|bb 1101|mesh-list
139059285|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139059286|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
139059287|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059288|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139059289|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139059290|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
139059291|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059292|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059293|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139059294|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139059295|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
139059296|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
139059297|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059298|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139059299|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
139059300|NCT01208818|Hormones|hormones|mesh-ancestor
139059301|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139059302|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139059303|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
139059304|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059305|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
139059306|NCT01111630|Hematinics|hematinics|mesh-ancestor
139059307|NCT03942796|Pregabalin|pregabalin|mesh-list
139059308|NCT03942796|Analgesics|analgesics|mesh-ancestor
139059309|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
139059310|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059311|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059312|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
139059313|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139059314|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139059315|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059316|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139059317|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139059318|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139059319|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059320|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139059321|NCT01114282|Bortezomib|bortezomib|mesh-list
139059322|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059323|NCT01109212|Bindarit|bindarit|mesh-list
139059324|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139059325|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139059326|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059327|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059328|NCT01111864|Micronutrients|micronutrients|mesh-list
139059329|NCT01111864|Trace Elements|trace elements|mesh-list
139059330|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059331|NCT01111942|Cisplatin|cisplatin|mesh-list
139059332|NCT01111942|Carboplatin|carboplatin|mesh-list
139059333|NCT01111942|Docetaxel|docetaxel|mesh-list
139059334|NCT01111942|Fluorouracil|fluorouracil|mesh-list
139059335|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059336|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
139059337|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
139059338|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
139059339|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059340|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
139059341|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139059342|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139059343|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
139059344|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059345|NCT01211860|Diazoxide|diazoxide|mesh-list
139059346|NCT01211860|Choline|choline|mesh-list
139059347|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
139059348|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139059349|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
139059350|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059351|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139059352|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139059353|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
139059354|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139059355|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
139059356|NCT01211938|Cetuximab|cetuximab|mesh-list
139059357|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138696453|NCT02224235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139059358|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059359|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
139059360|NCT02947438|Hematinics|hematinics|mesh-ancestor
139059361|NCT01209130|Rituximab|rituximab|mesh-list
139059363|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139059364|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059365|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
139059366|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059367|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139059368|NCT01209130|Immunoconjugates|immunoconjugates|mesh-ancestor
139059369|NCT01209208|Budesonide|budesonide|mesh-list
139059370|NCT01209208|Mesalamine|mesalamine|mesh-list
139059371|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139059372|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139059373|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
139059374|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059375|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059376|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139059377|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
139059378|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
139059379|NCT01209208|Hormones|hormones|mesh-ancestor
139059380|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139059381|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139059382|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139059383|NCT01209208|Analgesics|analgesics|mesh-ancestor
139059384|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
139059385|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139059386|NCT01114750|Dextrans|dextrans|mesh-list
139059387|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
139059388|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
139059389|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
139059390|NCT01328470|Cilostazol|cilostazol|mesh-list
139059391|NCT01328470|Clopidogrel|clopidogrel|mesh-list
139059392|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139059393|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139059394|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139059395|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139059396|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
139059397|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059398|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059399|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059400|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139059401|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
139059402|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059403|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139059404|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
139059405|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139059406|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139059407|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
139059408|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139059409|NCT01328470|Protective Agents|protective agents|mesh-ancestor
139059410|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139059411|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139059412|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059413|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139059415|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139059416|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
138902385|NCT00707772|Ribavirin|ribavirin|mesh-list
139059417|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059419|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
139059420|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139059421|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139059422|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139059423|NCT01115062|Lidocaine|lidocaine|mesh-list
139059424|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
139059425|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
139059426|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059427|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059428|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
139059429|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059430|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139059431|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139059432|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139059433|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139059434|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059435|NCT01115140|Folic Acid|folic acid|mesh-list
139059436|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
139059437|NCT01115140|Metformin|metformin|mesh-list
139059438|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139059439|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059440|NCT01115140|Hematinics|hematinics|mesh-ancestor
139059441|NCT01115140|Vitamins|vitamins|mesh-ancestor
139059442|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
139059443|NCT01112644|Oxycodone|oxycodone|mesh-list
139059444|NCT01112644|Naloxone|naloxone|mesh-list
139059445|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139059446|NCT01112644|Narcotics|narcotics|mesh-ancestor
139059447|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059448|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059449|NCT01112644|Analgesics|analgesics|mesh-ancestor
139059450|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
139059451|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059452|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139059453|NCT01112722|Histamine|histamine|mesh-list
139059454|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
139059455|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
139059456|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059457|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059458|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059459|NCT01015222|Paclitaxel|paclitaxel|mesh-list
139059460|NCT01015222|Bevacizumab|bevacizumab|mesh-list
139059461|NCT01015222|Dasatinib|dasatinib|mesh-list
139059462|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139059463|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059464|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
139059465|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
139059466|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
139059467|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059468|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139059469|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139059470|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139059471|NCT01015222|Growth Substances|growth substances|mesh-ancestor
139059472|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059473|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
139059474|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139059475|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059476|NCT01212250|Carvedilol|carvedilol|mesh-list
139059477|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139059478|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139059479|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
139059480|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059481|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059482|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059483|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139059484|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
139059485|NCT01212250|Protective Agents|protective agents|mesh-ancestor
139059486|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139059487|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139059488|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139059489|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
139059490|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139059491|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139059492|NCT01209988|Tamsulosin|tamsulosin|mesh-list
139059493|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139059494|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139059495|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139059496|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
139059497|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059498|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059499|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059500|NCT01209988|Urological Agents|urological agents|mesh-ancestor
139059501|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
139059502|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139059503|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
139059504|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059505|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
139059506|NCT03943186|Protective Agents|protective agents|mesh-ancestor
139059507|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
139059509|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
139059510|NCT01210066|Narcotics|narcotics|mesh-ancestor
139059511|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059512|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059513|NCT01210066|Analgesics|analgesics|mesh-ancestor
139059514|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
139059515|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059516|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139059517|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139059518|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
139059519|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
139059520|NCT01112878|Clonidine|clonidine|mesh-list
139059521|NCT01112878|Gabapentin|gabapentin|mesh-list
139059522|NCT01112878|Analgesics|analgesics|mesh-ancestor
139059523|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
139059524|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059525|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696594|NCT01230892|Nebivolol|nebivolol|mesh-list
139059526|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
139059527|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139059528|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139059529|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059530|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139059531|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139059532|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139059533|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059534|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059535|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
139059536|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139059537|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
139059538|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
139059539|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139059540|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139059541|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139059542|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
139059544|NCT01212406|Vitamins|vitamins|mesh-ancestor
139059545|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
139059546|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059547|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139059548|NCT01109758|Fenofibrate|fenofibrate|mesh-list
139059549|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139059550|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
139059551|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059552|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139059553|NCT01328236|Dexamethasone|dexamethasone|mesh-list
139059554|NCT01328236|Doxorubicin|doxorubicin|mesh-list
139059555|NCT01328236|Bortezomib|bortezomib|mesh-list
139059556|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139059557|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
139059558|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
139059559|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059560|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059561|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139059562|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
139059563|NCT01328236|Hormones|hormones|mesh-ancestor
139059564|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139059565|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139059566|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059567|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139059568|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139059569|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139059570|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059571|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059573|NCT01328392|Lansoprazole|lansoprazole|mesh-list
139059574|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139059575|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139059576|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139059577|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059578|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059579|NCT01115842|Vitamin D|vitamin d|mesh-list
139059580|NCT01115842|Vitamins|vitamins|mesh-ancestor
139059581|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
139059582|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059583|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139059584|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
139059585|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
139059586|NCT01116154|Lenalidomide|lenalidomide|mesh-list
139059587|NCT01116154|Vorinostat|vorinostat|mesh-list
139059588|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
139059589|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059590|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139059591|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139059592|NCT01116154|Growth Substances|growth substances|mesh-ancestor
139059593|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
139059594|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059595|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139059596|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059597|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059598|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
139059599|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139059600|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
139059601|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139059602|NCT01210456|Expectorants|expectorants|mesh-ancestor
139059603|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
139059604|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139059605|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
138770218|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
139059606|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059607|NCT01210456|Protective Agents|protective agents|mesh-ancestor
139059608|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059611|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
139059612|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138696656|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139059613|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059614|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059615|NCT01210846|Tivozanib|tivozanib|mesh-list
139059616|NCT01210846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139059617|NCT01210846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059618|NCT01210846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059619|NCT01116388|Caseins|caseins|mesh-list
139059620|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
139059621|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
139059622|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059623|NCT03941626|Immunomodulating Agents|immunomodulating agents|mesh-list
139059624|NCT03941626|Immunologic Factors|immunologic factors|mesh-ancestor
139059625|NCT03941626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059626|NCT01211002|Endostatins|endostatins|mesh-list
139059627|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059628|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139059629|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139059630|NCT01211002|Growth Substances|growth substances|mesh-ancestor
139059631|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059632|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
139059633|NCT01211080|Propranolol|propranolol|mesh-list
138902599|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
139059634|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139059635|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139059636|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
139059637|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059638|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059639|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059640|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139059641|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138810227|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
139059642|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
139059644|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139059645|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059646|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059647|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139059648|NCT01116700|Analgesics|analgesics|mesh-ancestor
139059649|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
139059650|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059651|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139059652|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139059653|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139059654|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
139059655|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059656|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059657|NCT01113424|Nicotine|nicotine|mesh-list
139059658|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139059659|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
139059660|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059661|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059662|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139059663|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139059664|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
139059665|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059666|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059667|NCT01211158|Ketamine|ketamine|mesh-list
139059668|NCT01211158|Propofol|propofol|mesh-list
139059669|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139059670|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059671|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059672|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139059673|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
139059674|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
139059675|NCT01211158|Analgesics|analgesics|mesh-ancestor
139059676|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
139059677|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059678|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138902637|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
139059679|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139059680|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139059681|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059682|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059683|NCT01110226|Cisplatin|cisplatin|mesh-list
139059684|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
139059685|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059686|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059687|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059688|NCT03789292|Adalimumab|adalimumab|mesh-list
139059689|NCT03789292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139059690|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139059691|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139059692|NCT01211314|Enalapril|enalapril|mesh-list
139059693|NCT01211314|Lercanidipine|lercanidipine|mesh-list
139059694|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139059695|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
139059696|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059697|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059698|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139059699|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139059700|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139059701|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139059702|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059703|NCT01110304|Analgesics|analgesics|mesh-list
139059704|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
139059705|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059706|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059707|NCT02529514|Baclofen|baclofen|mesh-list
139059708|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139059709|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059710|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139059711|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770219|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
139059712|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139059713|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
138810312|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
139059715|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059716|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059717|NCT01211470|Daptomycin|daptomycin|mesh-list
139059718|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139059719|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139059720|NCT01114048|Thalidomide|thalidomide|mesh-list
139059721|NCT01114048|Dexamethasone|dexamethasone|mesh-list
139059722|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
139059723|NCT01114048|Bortezomib|bortezomib|mesh-list
139059724|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139059725|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
139059726|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059727|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139059728|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139059729|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
139059730|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059731|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059732|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139059733|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139059734|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
139059735|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
139059736|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059737|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139059738|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
139059739|NCT01114048|Hormones|hormones|mesh-ancestor
139059740|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139059741|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139059742|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
139059743|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139059744|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139059745|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139059746|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139059747|NCT01114048|Growth Substances|growth substances|mesh-ancestor
139059748|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
139059749|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
139059750|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059751|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139059752|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139059753|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139059754|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059755|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059756|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139059757|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139059758|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139059759|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
139059760|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059761|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059762|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139059763|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139059764|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
139059765|NCT02529670|Lidocaine|lidocaine|mesh-list
139059766|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
139059767|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
139059768|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059769|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059770|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
139059771|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059772|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139059773|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139059774|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139059775|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139059776|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059777|NCT01117636|Aspirin|aspirin|mesh-list
139059778|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139059780|NCT01117636|Analgesics|analgesics|mesh-ancestor
139059781|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
139059782|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059783|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059784|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139059785|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139059786|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139059787|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138696775|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138696780|NCT04665362|Apatinib|apatinib|mesh-list
139059788|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059789|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139059790|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139059791|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059792|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
139059793|NCT03938740|Insulin|insulin|mesh-list
139059794|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139059795|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
139059796|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
139059797|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139059798|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059799|NCT01110616|Lorazepam|lorazepam|mesh-list
139059800|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
139059801|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
139059802|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
139059803|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902738|NCT02630303|Coal Tar|coal tar|mesh-list
139059804|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059805|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139059806|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139059807|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059808|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139059809|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139059810|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139059811|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
139059812|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
139059813|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059814|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059815|NCT03938662|Choline|choline|mesh-list
139059816|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
139059817|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139059818|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
139059819|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059820|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138696809|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139059821|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139059822|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
139059823|NCT01213498|Atorvastatin|atorvastatin|mesh-list
139059824|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139059825|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139059826|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
139059827|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059828|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139059829|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139059830|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059831|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139059832|NCT01111084|Hormones|hormones|mesh-ancestor
139059833|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139059834|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059835|NCT01118260|Anesthetics|anesthetics|mesh-list
139059836|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059837|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059838|NCT01121770|PENTA|penta|mesh-list
139059839|NCT01121770|Fondaparinux|fondaparinux|mesh-list
139059840|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139059841|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
139059842|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139059843|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
139059844|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059845|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059846|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
139059847|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139059848|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139059850|NCT01121848|Fluorouracil|fluorouracil|mesh-list
139059851|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
139059852|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
139059853|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059854|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138696851|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696853|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
139059855|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902763|NCT00668759|Amiodarone|amiodarone|mesh-list
139059856|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139059857|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
139059858|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059859|NCT01121848|Antidotes|antidotes|mesh-ancestor
139059860|NCT01121848|Protective Agents|protective agents|mesh-ancestor
139059861|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
139059862|NCT01121848|Vitamins|vitamins|mesh-ancestor
139059863|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
139059864|NCT01122004|Pregabalin|pregabalin|mesh-list
139059865|NCT01122004|Analgesics|analgesics|mesh-ancestor
139059866|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
139059867|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059868|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059869|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
139059870|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139059871|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139059872|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059873|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139059874|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139059875|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139059876|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059877|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139059879|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139059880|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059881|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
139059882|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
139059883|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
139059884|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059885|NCT01118572|Celecoxib|celecoxib|mesh-list
139059886|NCT01118572|Etodolac|etodolac|mesh-list
139059887|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139059888|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139059889|NCT01118572|Analgesics|analgesics|mesh-ancestor
139059890|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
139059891|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059892|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059893|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139059894|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139059895|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139059896|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139059897|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059898|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059899|NCT03937648|Lasmiditan|lasmiditan|mesh-list
139059900|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139059901|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
139059902|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059903|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059904|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059905|NCT01219036|Budesonide|budesonide|mesh-list
139059906|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139059907|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139059908|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
139059909|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059910|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059911|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139059912|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
139059913|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
139059914|NCT01219036|Hormones|hormones|mesh-ancestor
139059915|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139059916|NCT01124500|Methylphenidate|methylphenidate|mesh-list
139059917|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139059918|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059919|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139059920|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139059921|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139059922|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059923|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
139059924|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059925|NCT01118884|Promethazine|promethazine|mesh-list
139059926|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
139059927|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
139059928|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
139059929|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139059930|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
139059931|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
139059932|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059933|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059934|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059935|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139059936|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139059937|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139059938|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139059939|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
139059940|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
139059941|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
139059942|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059943|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
139059944|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
139059945|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139059946|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
139059947|NCT01119196|Icodextrin|icodextrin|mesh-list
139059948|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139059949|NCT01213888|Trientine|trientine|mesh-list
138696926|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139059950|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
139059951|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
139059952|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059953|NCT01119430|Fluoxetine|fluoxetine|mesh-list
139059954|NCT01119430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139059955|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139059956|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138902817|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
139059957|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059958|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139059959|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
139059960|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059961|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139059962|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
139059963|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139059964|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139059965|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139059966|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059967|NCT02529124|Caseins|caseins|mesh-list
139059968|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
139059969|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
139059970|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059971|NCT03780244|Mannitol|mannitol|mesh-list
139059972|NCT03780244|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139059973|NCT03780244|Diuretics|diuretics|mesh-ancestor
139059974|NCT03780244|Natriuretic Agents|natriuretic agents|mesh-ancestor
139059975|NCT03780244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059976|NCT01119742|Butenafine|butenafine|mesh-list
139059977|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
139059978|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139059979|NCT01216696|Ipilimumab|ipilimumab|mesh-list
139059980|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139059981|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139059982|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139059983|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059984|NCT03937258|Probenecid|probenecid|mesh-list
139059985|NCT03937258|Abrocitinib|abrocitinib|mesh-list
139059986|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
139059987|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
139059988|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139059989|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139059990|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139059991|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059992|NCT01124656|Pioglitazone|pioglitazone|mesh-list
139059993|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
139059994|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139059995|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139059996|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139059997|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139059998|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139059999|NCT01122472|Lenalidomide|lenalidomide|mesh-list
139060000|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
139060001|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060002|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139060003|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139060004|NCT01122472|Growth Substances|growth substances|mesh-ancestor
139060005|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
138902838|NCT00663377|Losartan|losartan|mesh-list
139060006|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060008|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
139060009|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
139060010|NCT03935152|Progestins|progestins|mesh-ancestor
139060011|NCT03935152|Hormones|hormones|mesh-ancestor
139060012|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139060013|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060014|NCT01216852|Losartan|losartan|mesh-list
139060015|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139060016|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139060017|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139060018|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138696982|NCT06087211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139060019|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060020|NCT03933748|Teicoplanin|teicoplanin|mesh-list
139060021|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139060022|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060023|NCT01120366|Methotrexate|methotrexate|mesh-list
139060024|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139060025|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
139060026|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139060027|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060028|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139060029|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
139060030|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060031|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060032|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
139060033|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060034|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139060035|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139060036|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
139060037|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139060038|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139060039|NCT01217086|Infliximab|infliximab|mesh-list
139060040|NCT01217086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139060041|NCT01217086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139060042|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
138253752|NCT04578600|Azacitidine|azacitidine|mesh-list
139060043|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139060045|NCT01120444|Insulin|insulin|mesh-list
139060046|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139060047|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060048|NCT01217398|Bevacizumab|bevacizumab|mesh-list
139060049|NCT01217398|Temozolomide|temozolomide|mesh-list
139060050|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139060051|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060052|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139060053|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139060054|NCT01217398|Growth Substances|growth substances|mesh-ancestor
139060055|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060056|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
139060057|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139060058|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
139060059|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060060|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
139060061|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139060062|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060063|NCT01214746|Atorvastatin|atorvastatin|mesh-list
139060064|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139060065|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139060066|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
139060067|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060068|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139060069|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139060070|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060071|NCT03935074|Melphalan|melphalan|mesh-list
139060072|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139060073|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
139060074|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060075|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060076|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139060077|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139060078|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
139060079|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060080|NCT01217632|Entecavir|entecavir|mesh-list
139060081|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
139060082|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060083|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
139060084|NCT03933280|Nalbuphine|nalbuphine|mesh-list
139060085|NCT03933280|Propofol|propofol|mesh-list
139060086|NCT03933280|Benoxinate|benoxinate|mesh-list
139060087|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139060088|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138810666|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139060089|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060090|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060091|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139060093|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
139060094|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060095|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139060096|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139060097|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139060098|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
139060099|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060100|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060101|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139060102|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
139060103|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
138902898|NCT00669773|Docetaxel|docetaxel|mesh-list
139060105|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139060106|NCT03933280|Narcotics|narcotics|mesh-ancestor
139060107|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
139060108|NCT01120912|Insulin|insulin|mesh-list
139060109|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139060110|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060111|NCT01219582|Metformin|metformin|mesh-list
139060112|NCT01219582|Acarbose|acarbose|mesh-list
138697043|NCT06086288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060113|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139060114|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060115|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139060116|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060117|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060118|NCT03933358|Hormones|hormones|mesh-list
139060119|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139060120|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060121|NCT01122940|Phenytoin|phenytoin|mesh-list
139060122|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
139060123|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139060124|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139060125|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139060126|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060127|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139060128|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139060129|NCT01219816|Epratuzumab|epratuzumab|mesh-list
139060130|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139060131|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060132|NCT01218022|Losartan|losartan|mesh-list
139060133|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139060134|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139060135|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139060136|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139060137|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060138|NCT01121458|Clevidipine|clevidipine|mesh-list
139060139|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139060140|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139060141|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060142|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139060143|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060144|NCT01215214|Midazolam|midazolam|mesh-list
139060145|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139060146|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139060147|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060148|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060149|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139060150|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139060151|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139060152|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139060153|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
139060154|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
139060155|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
139060156|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
139060157|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060158|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060159|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139060160|NCT01125670|Darexaban|darexaban|mesh-list
139060161|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139060163|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139060164|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
139060165|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060166|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060167|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
139060168|NCT03934450|Primaquine|primaquine|mesh-list
139060169|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
139060170|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139060171|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139060172|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060173|NCT01215682|Vitamin D|vitamin d|mesh-list
139060174|NCT01215682|Vitamins|vitamins|mesh-ancestor
139060175|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
139060176|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060177|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139060178|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139060179|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139060180|NCT01123408|Haloperidol|haloperidol|mesh-list
139060181|NCT01123408|Olanzapine|olanzapine|mesh-list
139060182|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
139060183|NCT01123408|Clozapine|clozapine|mesh-list
139060184|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
139060185|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
139060186|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060187|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060188|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139060189|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139060190|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139060191|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060192|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139060193|NCT01123408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139060194|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139060195|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139060196|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060197|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060198|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
139060199|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139060200|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
139060201|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139060202|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139060203|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
139060204|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
139060205|NCT00141297|Palbociclib|palbociclib|mesh-list
139060206|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060207|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139060208|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697107|NCT06085417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139060209|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060210|NCT01123486|Hydromorphone|hydromorphone|mesh-list
139060211|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139060212|NCT01123486|Narcotics|narcotics|mesh-ancestor
139060213|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060214|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060215|NCT01123486|Analgesics|analgesics|mesh-ancestor
139060216|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
139060217|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060218|NCT01123564|Ranibizumab|ranibizumab|mesh-list
139060219|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139060220|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139060221|NCT01123564|Growth Substances|growth substances|mesh-ancestor
139060222|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060223|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
139060224|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060226|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
139060227|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060228|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
139060229|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
139060230|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
139060231|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060232|NCT03932266|Docetaxel|docetaxel|mesh-list
139060233|NCT03932266|Endostar protein|endostar protein|mesh-list
139060234|NCT03932266|Endostatins|endostatins|mesh-list
139060235|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060236|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
139060237|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
139060238|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
139060239|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060240|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139060241|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139060243|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060244|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
139060245|NCT00141219|Pregabalin|pregabalin|mesh-list
139060247|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
139060248|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060249|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060250|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
139060251|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139060252|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139060253|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060254|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139060255|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139060256|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139060257|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060258|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139060259|NCT01222468|Nabilone|nabilone|mesh-list
139060260|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
139060261|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
139060262|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060263|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060264|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139060265|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139060266|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139060267|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060268|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139060269|NCT01220284|Vinorelbine|vinorelbine|mesh-list
139060270|NCT01220284|Satraplatin|satraplatin|mesh-list
138902998|NCT00833040|Sufentanil|sufentanil|mesh-list
139060271|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139060272|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060273|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
139060274|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
139060275|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
139060276|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060277|NCT01127464|Poly ICLC|poly iclc|mesh-list
139060278|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
139060279|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
139060280|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060281|NCT01222780|Vincristine|vincristine|mesh-list
139060282|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139060283|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060284|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
139060285|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
139060286|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
139060287|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253805|NCT04186299|Clonidine|clonidine|mesh-list
139060289|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060290|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139060291|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060292|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060293|NCT01125904|Crizotinib|crizotinib|mesh-list
139060294|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060295|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139060296|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060297|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060298|NCT01125982|Propofol|propofol|mesh-list
139060299|NCT01125982|Desflurane|desflurane|mesh-list
139060300|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139060301|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060302|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060303|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139060304|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
139060305|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
139060306|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139060307|NCT01220362|Fentanyl|fentanyl|mesh-list
139060308|NCT01220362|Bupivacaine|bupivacaine|mesh-list
139060309|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
139060310|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
139060311|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697162|NCT06078228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060312|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810894|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
139060313|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
139060314|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060315|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139060316|NCT01220362|Narcotics|narcotics|mesh-ancestor
139060317|NCT01220362|Analgesics|analgesics|mesh-ancestor
139060318|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139060319|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139060320|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
139060321|NCT01220440|Methylphenidate|methylphenidate|mesh-list
139060322|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
139060323|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139060324|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060325|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139060326|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139060327|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139060328|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060329|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
139060330|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060331|NCT01123876|Veliparib|veliparib|mesh-list
139060332|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139060333|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060334|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060335|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060336|NCT01124032|Methylphenidate|methylphenidate|mesh-list
139060337|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139060338|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060339|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139060340|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139060341|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139060342|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060343|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
139060344|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060345|NCT03934294|Metoclopramide|metoclopramide|mesh-list
139060346|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
139060347|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
139060348|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060349|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060350|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139060351|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139060352|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139060353|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
139060354|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060355|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060356|NCT01218568|Rifaximin|rifaximin|mesh-list
139060357|NCT01218568|Lactulose|lactulose|mesh-list
139060358|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139060359|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060360|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139060361|NCT01127542|Lenalidomide|lenalidomide|mesh-list
138903083|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
139060363|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060364|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139060365|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139060366|NCT01127542|Growth Substances|growth substances|mesh-ancestor
139060367|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
139060368|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060369|NCT01127620|Cetirizine|cetirizine|mesh-list
139060370|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139060371|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139060372|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139060373|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
139060374|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
139060375|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060376|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060377|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060378|NCT01220518|Infliximab|infliximab|mesh-list
139060379|NCT01220518|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139060380|NCT01220518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139060381|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
139060382|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139060383|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139060384|NCT01220596|Interferons|interferons|mesh-list
139060385|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139060386|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
139060387|NCT01220596|Entecavir|entecavir|mesh-list
139060389|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
139060390|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060391|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
139060392|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060393|NCT01218724|Losartan|losartan|mesh-list
139060394|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139060395|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139060396|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138697214|NCT06049160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138697216|NCT06049160|Oxytocics|oxytocics|mesh-ancestor
139060397|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139060398|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139060399|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060400|NCT01218724|Diuretics|diuretics|mesh-ancestor
139060401|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
139060402|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060403|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139060404|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139060405|NCT01126216|Paclitaxel|paclitaxel|mesh-list
139060406|NCT01126216|Cisplatin|cisplatin|mesh-list
139060407|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139060408|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060409|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
139060410|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
139060411|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
139060412|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060413|NCT01329016|Metformin|metformin|mesh-list
139060414|NCT01329016|Glyburide|glyburide|mesh-list
139060415|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139060416|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060417|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
139060418|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139060419|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
139060420|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060421|NCT01223326|Expectorants|expectorants|mesh-ancestor
139060422|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
139060423|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139060424|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
139060425|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060426|NCT01223326|Protective Agents|protective agents|mesh-ancestor
139060427|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060428|NCT01223326|Antidotes|antidotes|mesh-ancestor
139060429|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
139060430|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139060431|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060432|NCT01126294|Melatonin|melatonin|mesh-list
139060433|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
139060434|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060435|NCT01126294|Protective Agents|protective agents|mesh-ancestor
139060436|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060437|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060438|NCT00162266|Abatacept|abatacept|mesh-list
139060439|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139060440|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060441|NCT00162266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139060442|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060443|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139060444|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
139060445|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060446|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139060447|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139060448|NCT01126450|Cetuximab|cetuximab|mesh-list
139060449|NCT01126450|Lenalidomide|lenalidomide|mesh-list
139060450|NCT01126450|Antibodies|antibodies|mesh-list
139060451|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
139060452|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139060453|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
139060454|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060455|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060456|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139060457|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139060458|NCT01126450|Growth Substances|growth substances|mesh-ancestor
139060459|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
139060460|NCT01073384|Beclomethasone|beclomethasone|mesh-list
139060461|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139060462|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
139060463|NCT01073384|Hormones|hormones|mesh-ancestor
139060464|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139060465|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060466|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139060467|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
139060469|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
139060470|NCT01126528|Vitamins|vitamins|mesh-ancestor
139060471|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
139060472|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060473|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139060474|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139060475|NCT00225212|Rituximab|rituximab|mesh-list
139060476|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139060477|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060478|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
139060479|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060480|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139060481|NCT03853330|Bupivacaine|bupivacaine|mesh-list
139060482|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
139060483|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
139060484|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060485|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060486|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
139060487|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060488|NCT01581944|Goserelin|goserelin|mesh-list
139060489|NCT01581944|Hormones|hormones|mesh-list
139060490|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139060491|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060492|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139060493|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060494|NCT01226056|Everolimus|everolimus|mesh-list
139060495|NCT01226056|Sorafenib|sorafenib|mesh-list
139060496|NCT01226056|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139060497|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139060498|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060499|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060500|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139060501|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
139060502|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060503|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060504|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
139060505|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139060506|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060507|NCT01126606|Glycerol|glycerol|mesh-list
139060508|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
139060509|NCT01126606|Protective Agents|protective agents|mesh-ancestor
139060510|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060511|NCT01329406|Milnacipran|milnacipran|mesh-list
139060512|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
139060513|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139060514|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138253892|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139060515|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139060516|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060517|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060518|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060519|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139060520|NCT01329406|Analgesics|analgesics|mesh-ancestor
139060521|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
139060522|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060523|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
139060524|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139060525|NCT01126684|Atorvastatin|atorvastatin|mesh-list
139060526|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139060527|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139060528|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
139060529|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060530|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139060531|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139060532|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060533|NCT01224028|Tacrolimus|tacrolimus|mesh-list
139060534|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139060535|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
139060536|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811116|NCT02752971|Analgesics|analgesics|mesh-ancestor
139060537|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139060539|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060540|NCT01226212|Sulfalene|sulfalene|mesh-list
139060541|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060542|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139060543|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
139060544|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139060545|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139060546|NCT01075490|Clonidine|clonidine|mesh-list
139060547|NCT01075490|Analgesics|analgesics|mesh-ancestor
139060548|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
139060549|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060550|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060551|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139060552|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
139060553|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
139060554|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139060555|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139060556|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139060557|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
139060558|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060559|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060560|NCT01126138|Docetaxel|docetaxel|mesh-list
138903180|NCT00823836|Ropinirole|ropinirole|mesh-list
139060561|NCT01126138|Capecitabine|capecitabine|mesh-list
139060562|NCT01126138|Vinorelbine|vinorelbine|mesh-list
139060563|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060564|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
139060565|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
139060566|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
139060567|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060568|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139060569|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
138697339|NCT05886972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139060570|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139060571|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139060572|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139060573|NCT03930706|Estradiol|estradiol|mesh-list
139060574|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139060575|NCT03930706|Estrogens|estrogens|mesh-ancestor
139060576|NCT03930706|Hormones|hormones|mesh-ancestor
139060577|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139060578|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060579|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139060580|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
139060581|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139060582|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139060583|NCT03932578|Atropine|atropine|mesh-list
139060584|NCT03932578|Metoclopramide|metoclopramide|mesh-list
139060585|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139060586|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139060587|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139060588|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
139060589|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060590|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060591|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139060592|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
139060593|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
139060594|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
139060595|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139060596|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139060597|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
139060598|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060599|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060600|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
139060601|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139060602|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139060603|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139060604|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
139060605|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
139060606|NCT00258440|Hematinics|hematinics|mesh-ancestor
139060607|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
139060608|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139060609|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060610|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139060611|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139060612|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060613|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060615|NCT00224120|Silodosin|silodosin|mesh-list
139060616|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139060617|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139060618|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139060619|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
139060620|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060621|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060622|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060623|NCT00224120|Urological Agents|urological agents|mesh-ancestor
139060624|NCT01226446|Vitamin D|vitamin d|mesh-list
139060625|NCT01226446|Vitamins|vitamins|mesh-ancestor
139060626|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
139060627|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060628|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139060629|NCT01224418|Tacrolimus|tacrolimus|mesh-list
139060630|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139060631|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
139060632|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060633|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139060634|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060635|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060636|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
139060637|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139060638|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139060639|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139060640|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139060641|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060642|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
139060643|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060644|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060645|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139060646|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060647|NCT01129180|Azacitidine|azacitidine|mesh-list
139060648|NCT01129180|Bortezomib|bortezomib|mesh-list
139060649|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139060650|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
139060651|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060652|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060653|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060654|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
139060655|NCT00224042|Hematinics|hematinics|mesh-ancestor
139060656|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
139060657|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060658|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060659|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
139060660|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060661|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139060662|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060663|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060664|NCT01224652|Paclitaxel|paclitaxel|mesh-list
139060665|NCT01224652|Irinotecan|irinotecan|mesh-list
139060666|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139060667|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060668|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
139060669|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
139060670|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
139060671|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060672|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139060673|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139060674|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060675|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
139060676|NCT00160706|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139060677|NCT00160706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139060678|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139060679|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
139060680|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060681|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139060682|NCT01226602|Ticagrelor|ticagrelor|mesh-list
139060683|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139060684|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138903268|NCT00671801|Irinotecan|irinotecan|mesh-list
139060685|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139060686|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139060687|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
139060688|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060689|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060690|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060691|NCT01226680|Tofacitinib|tofacitinib|mesh-list
139060692|NCT01226680|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139060693|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139060694|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060695|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060696|NCT00257192|Ziprasidone|ziprasidone|mesh-list
139060697|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139060698|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
139060699|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060700|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060701|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060702|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139060703|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139060704|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060705|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138697435|NCT05498480|Nivolumab|nivolumab|mesh-list
139060706|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139060707|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
139060708|NCT01224964|Montelukast|montelukast|mesh-list
139060709|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139060710|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
139060711|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139060712|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
139060713|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253918|NCT03636152|Amebicides|amebicides|mesh-ancestor
139060714|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060715|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139060716|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139060717|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060718|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
139060719|NCT03967964|Testosterone|testosterone|mesh-list
139060720|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
139060721|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
139060722|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139060723|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139060724|NCT03967964|Androgens|androgens|mesh-ancestor
139060725|NCT03967964|Hormones|hormones|mesh-ancestor
139060726|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139060727|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060728|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139060729|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060730|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
139060731|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139060732|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
139060733|NCT01129414|Omeprazole|omeprazole|mesh-list
139060734|NCT01129414|Clopidogrel|clopidogrel|mesh-list
139060735|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139060736|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139060737|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139060738|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139060739|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
139060740|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060741|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060742|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060743|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139060744|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139060745|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139060746|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060747|NCT03967886|Esomeprazole|esomeprazole|mesh-list
139060748|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138697457|NCT05488067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060749|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139060750|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139060751|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060752|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060753|NCT03968042|Thiamine|thiamine|mesh-list
139060754|NCT03968042|Edaravone|edaravone|mesh-list
139060755|NCT03968042|Mitogens|mitogens|mesh-list
139060756|NCT03968042|Vitamins|vitamins|mesh-ancestor
139060757|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
139060758|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060759|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
139060760|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060761|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
139060762|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139060763|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
139060764|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139060765|NCT03968042|Protective Agents|protective agents|mesh-ancestor
139060766|NCT01128322|Niacin|niacin|mesh-list
139060767|NCT01128322|Amlodipine|amlodipine|mesh-list
139060768|NCT01128322|Telmisartan|telmisartan|mesh-list
139060769|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139060770|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139060771|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139060772|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060773|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139060774|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060776|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139060777|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139060778|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139060779|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
139060780|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139060781|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
139060782|NCT01128322|Vitamins|vitamins|mesh-ancestor
139060783|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
139060784|NCT01129570|Silybin|silybin|mesh-list
139060785|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139060786|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060787|NCT01129570|Protective Agents|protective agents|mesh-ancestor
139060788|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060789|NCT01073540|Cephalexin|cephalexin|mesh-list
139060790|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139060791|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060792|NCT03740386|Phentolamine|phentolamine|mesh-list
139060793|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139060794|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139060795|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
139060796|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181125|NCT02722564|Ethanol|ethanol|mesh-list
139060797|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060798|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060799|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139060800|NCT03927352|Adalimumab|adalimumab|mesh-list
139060801|NCT03927352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139060802|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139060803|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139060804|NCT01225198|Vitamins|vitamins|mesh-list
139060805|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
139060806|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060807|NCT01226992|Vancomycin|vancomycin|mesh-list
139060808|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139060809|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060810|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
139060811|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139060812|NCT03740464|Lenograstim|lenograstim|mesh-list
139060813|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139060814|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
139060815|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060816|NCT03927118|Dexamethasone|dexamethasone|mesh-list
139060817|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
139060818|NCT03927118|BB 1101|bb 1101|mesh-list
139060819|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139060820|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
139060821|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
139060822|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060823|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060824|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139060825|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
139060826|NCT03927118|Hormones|hormones|mesh-ancestor
139060827|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139060828|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139060829|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060830|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
139060831|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060832|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060833|NCT01227148|Insulin|insulin|mesh-list
139060834|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138811417|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253942|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139060835|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060836|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
139060837|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139060838|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139060839|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
139060840|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139060841|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060842|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139060843|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060844|NCT01128712|Pregabalin|pregabalin|mesh-list
139060845|NCT01128712|Analgesics|analgesics|mesh-ancestor
139060846|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
139060847|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060848|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060849|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
139060850|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139060851|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139060852|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060853|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139060854|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139060855|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139060856|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060857|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139060858|NCT01127386|Lenalidomide|lenalidomide|mesh-list
139060859|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
139060860|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060861|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139060862|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139060863|NCT01127386|Growth Substances|growth substances|mesh-ancestor
139060864|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
139060865|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060866|NCT01130194|Procarbazine|procarbazine|mesh-list
139060867|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697547|NCT05290090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060868|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
139060869|NCT01225744|Irinotecan|irinotecan|mesh-list
139060870|NCT01225744|Cetuximab|cetuximab|mesh-list
139060871|NCT01225744|Tegafur|tegafur|mesh-list
139060872|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060873|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139060874|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139060875|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060876|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060877|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139060878|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139060879|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
139060880|NCT03926806|Vitamins|vitamins|mesh-list
139060881|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
139060882|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
139060883|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060884|NCT03926962|Nafithromycin|nafithromycin|mesh-list
138903413|NCT00677729|Albuterol|albuterol|mesh-list
139060885|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139060886|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060887|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139060889|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060890|NCT03919786|Anesthetics|anesthetics|mesh-list
139060891|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060892|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060893|NCT03924544|Mitomycins|mitomycins|mesh-list
139060894|NCT03924544|Mitomycin|mitomycin|mesh-list
139060895|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139060896|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903482|NCT02627807|Cisplatin|cisplatin|mesh-list
139060897|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
139060898|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060899|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139060900|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060901|NCT01131364|Doxorubicin|doxorubicin|mesh-list
139060902|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139060903|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060904|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139060905|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139060906|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060907|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060908|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
139060909|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138697590|NCT05193227|Lidocaine|lidocaine|mesh-list
139060910|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139060911|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060912|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139060913|NCT02529202|Analgesics|analgesics|mesh-ancestor
139060914|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
139060915|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060916|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139060917|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139060918|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139060919|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
139060920|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060921|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060922|NCT00154310|Cyclosporine|cyclosporine|mesh-list
139060923|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
139060924|NCT00154310|Everolimus|everolimus|mesh-list
139060925|NCT00154310|Cyclosporins|cyclosporins|mesh-list
139060926|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060927|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060928|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139060929|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
139060930|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060931|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
139060932|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060933|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
139060934|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139060935|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139060936|NCT00154310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139060937|NCT00154310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139060938|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060939|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139060940|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139060941|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
139060942|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139060943|NCT03770728|Metformin|metformin|mesh-list
139060944|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
139060945|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139060946|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060947|NCT01132222|Ibuprofen|ibuprofen|mesh-list
139060948|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
139060949|NCT01132222|Ephedrine|ephedrine|mesh-list
139060950|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139060951|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139060952|NCT01132222|Analgesics|analgesics|mesh-ancestor
139060953|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
138253958|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060954|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139060955|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060956|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139060958|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139060959|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060960|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060961|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139060963|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139060964|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
139060965|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
139060966|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139060967|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139060969|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
139060970|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139060971|NCT03926182|Aflutinib|aflutinib|mesh-list
139060972|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139060973|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060974|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060975|NCT01130506|Cytarabine|cytarabine|mesh-list
139060976|NCT01130506|Decitabine|decitabine|mesh-list
139060978|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139060979|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
139060980|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060981|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060982|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
139060983|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139060984|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138811579|NCT06178523|Citric Acid|citric acid|mesh-list
139060985|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
139060986|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139060987|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060988|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139060990|NCT01130662|Midostaurin|midostaurin|mesh-list
139060991|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139060992|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
139060993|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139060994|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139060995|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139060996|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139060997|NCT03925714|Metformin|metformin|mesh-list
139060998|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139060999|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061000|NCT01228552|Ketoprofen|ketoprofen|mesh-list
139061001|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139061002|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139061003|NCT01228552|Analgesics|analgesics|mesh-ancestor
139061004|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
139061005|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061006|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061007|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139061008|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138697644|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139061009|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139061010|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061011|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061012|NCT03919084|Nicotine|nicotine|mesh-list
139061013|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139061014|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
139061015|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061016|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061017|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139061018|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139061019|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
139061020|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904211|NCT05397652|Hemostatics|hemostatics|mesh-ancestor
139061021|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061023|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139061024|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061025|NCT01132768|Atenolol|atenolol|mesh-list
139061026|NCT01132768|Olmesartan|olmesartan|mesh-list
139061027|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139061028|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139061029|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138904256|NCT05340504|Antidotes|antidotes|mesh-ancestor
139061030|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139061031|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061032|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139061034|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
139061035|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061036|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061037|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139061038|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139061039|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139061040|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
139061041|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061042|NCT01230034|Ramipril|ramipril|mesh-list
139061044|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139061045|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
139061046|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061047|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061048|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139061049|NCT03918616|Dopamine|dopamine|mesh-list
139061050|NCT03918616|Memantine|memantine|mesh-list
139061051|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
138697673|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
138697674|NCT04858269|Paclitaxel|paclitaxel|mesh-list
139061052|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139061053|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139061054|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
139061055|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061056|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061057|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061058|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139061059|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139061060|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139061061|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
139061062|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
139061063|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061064|NCT03918616|Protective Agents|protective agents|mesh-ancestor
139061065|NCT01228630|Loratadine|loratadine|mesh-list
139061066|NCT01228630|Fexofenadine|fexofenadine|mesh-list
139061067|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
139061068|NCT01228630|Ephedrine|ephedrine|mesh-list
139061069|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
139061070|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
139061071|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139061072|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139061073|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139061074|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
139061075|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
139061076|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061077|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061078|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061079|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139061080|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
139061081|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061082|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139061083|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
139061084|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
139061085|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139061086|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139061087|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
138697705|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
139061088|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
139061089|NCT01134406|Hylan|hylan|mesh-list
139061091|NCT01134406|Protective Agents|protective agents|mesh-ancestor
139061092|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061093|NCT01231828|Lactulose|lactulose|mesh-list
139061094|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139061095|NCT03923218|Vitamin D|vitamin d|mesh-list
139061096|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
139061097|NCT03923218|Vitamins|vitamins|mesh-ancestor
139061098|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
139061099|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061100|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139061101|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139061102|NCT03923140|Tranilast|tranilast|mesh-list
139061103|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139061104|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139061105|NCT03923140|Analgesics|analgesics|mesh-ancestor
139061106|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
139061107|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061108|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061109|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139061110|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139061111|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139061112|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139061113|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061114|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139061115|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139061116|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
139061117|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
138697743|NCT04645667|Tacrolimus|tacrolimus|mesh-list
139061118|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061119|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139061120|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139061121|NCT01133080|Minocycline|minocycline|mesh-list
139061122|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139061123|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061124|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139061125|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139061126|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
139061127|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
139061128|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061129|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061130|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061131|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138811724|NCT06111443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139061132|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139061133|NCT01585792|Glimepiride|glimepiride|mesh-list
139061134|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139061136|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061137|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139061138|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
139061139|NCT01134484|Thalidomide|thalidomide|mesh-list
139061140|NCT01134484|Dexamethasone|dexamethasone|mesh-list
139061142|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139061143|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
139061144|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
139061145|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061146|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254068|NCT01323569|Nabiximols|nabiximols|mesh-list
139061147|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139061148|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
139061149|NCT01134484|Hormones|hormones|mesh-ancestor
139061150|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139061151|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139061152|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061153|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139061154|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
139061155|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
139061156|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139061157|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061158|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139061159|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139061160|NCT01134484|Growth Substances|growth substances|mesh-ancestor
139061161|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
139061163|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
139061164|NCT01133470|Ephedrine|ephedrine|mesh-list
138905101|NCT05435560|Dexmedetomidine|dexmedetomidine|mesh-list
139061165|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139061166|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139061167|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139061168|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
139061169|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
139061170|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061171|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061172|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061173|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139061174|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
139061175|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061176|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139061177|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
139061178|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
139061179|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139061180|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139061181|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
139061182|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
139061183|NCT01134718|Simeprevir|simeprevir|mesh-list
139061184|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
139061185|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061186|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
139061187|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061188|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061189|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
139061190|NCT03917758|Empagliflozin|empagliflozin|mesh-list
139061191|NCT03917758|Canagliflozin|canagliflozin|mesh-list
139061192|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139061193|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061194|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138905307|NCT00761332|Teriparatide|teriparatide|mesh-list
139061196|NCT01230736|Timolol|timolol|mesh-list
139061197|NCT01230736|Travoprost|travoprost|mesh-list
139061198|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139061199|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139061200|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139061201|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139061202|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
139061203|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061204|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061205|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061206|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139061207|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138905379|NCT04507906|Nivolumab|nivolumab|mesh-list
139061209|NCT01133548|Testosterone|testosterone|mesh-list
139061210|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
139061211|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
139061212|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
139061213|NCT01133548|Androgens|androgens|mesh-ancestor
139061214|NCT01133548|Hormones|hormones|mesh-ancestor
139061215|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139061216|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061217|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139061218|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061219|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
139061220|NCT03917134|Metronidazole|metronidazole|mesh-list
139061221|NCT03917134|Cephalosporins|cephalosporins|mesh-list
139061222|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061223|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139061224|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139061225|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139061226|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139061227|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061228|NCT01231126|Misoprostol|misoprostol|mesh-list
139061229|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139061230|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
139061231|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139061232|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061233|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139061234|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139061235|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
139061236|NCT03769090|Budesonide|budesonide|mesh-list
139061237|NCT03769090|Albuterol|albuterol|mesh-list
139061238|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139061239|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139061240|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
139061241|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905425|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
139061242|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061243|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139061244|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
139061245|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
139061246|NCT03769090|Hormones|hormones|mesh-ancestor
139061247|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139061248|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
139061249|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139061250|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139061251|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139061252|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139061253|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
139061254|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061255|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061256|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139061257|NCT03921736|Perindopril|perindopril|mesh-list
139061258|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138905468|NCT02558218|Hormones|hormones|mesh-ancestor
139061260|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
139061261|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061262|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139061263|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139061264|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061265|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139061267|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061268|NCT05401006|Acitretin|acitretin|mesh-list
139061269|NCT05401006|Keratolytic Agents|keratolytic agents|mesh-ancestor
139061270|NCT05401006|Dermatologic Agents|dermatologic agents|mesh-ancestor
139061271|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
139061272|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061273|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139061274|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
139061275|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139061276|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061277|NCT01131754|Heparin|heparin|mesh-list
139061278|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
139061279|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139061280|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139061281|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061283|NCT01231594|Dabrafenib|dabrafenib|mesh-list
139061284|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
139061285|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139061286|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061287|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061288|NCT01136278|Clonidine|clonidine|mesh-list
139061289|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139061290|NCT01136278|Analgesics|analgesics|mesh-ancestor
139061291|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
139061292|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061293|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061294|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139061295|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
139061296|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
139061297|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139061298|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139061299|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138334314|NCT00728910|Niacin|niacin|mesh-list
139061300|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
139061301|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061302|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061303|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
139061304|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139061305|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
139061306|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139061307|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139061308|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139061309|NCT05402722|Antibodies|antibodies|mesh-list
139061310|NCT05402722|Immunologic Factors|immunologic factors|mesh-ancestor
139061311|NCT05402722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061312|NCT05480488|Midazolam|midazolam|mesh-list
139061313|NCT05480488|Warfarin|warfarin|mesh-list
139061314|NCT05480488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139061315|NCT05480488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139061316|NCT05480488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139061317|NCT05480488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061318|NCT05480488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139061319|NCT05480488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139061320|NCT05480488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139061321|NCT05480488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139061322|NCT05480488|Anesthetics, General|anesthetics, general|mesh-ancestor
139061323|NCT05480488|Anesthetics|anesthetics|mesh-ancestor
139061324|NCT05480488|GABA Modulators|gaba modulators|mesh-ancestor
139061325|NCT05480488|GABA Agents|gaba agents|mesh-ancestor
139061326|NCT05480488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061327|NCT05480488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061328|NCT05480488|Anticoagulants|anticoagulants|mesh-ancestor
139061329|NCT01229332|Carbidopa|carbidopa|mesh-list
139061330|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139061331|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139061332|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
139061333|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061334|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061335|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061336|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139061337|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061338|NCT03921034|Ropivacaine|ropivacaine|mesh-list
139061339|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
139061340|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
139061341|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139061342|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061343|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
139061344|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061345|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
139061346|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139061347|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139061348|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061349|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
139061350|NCT01136590|Coagulants|coagulants|mesh-ancestor
139061351|NCT03920878|Aflibercept|aflibercept|mesh-list
139061352|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139061353|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139061354|NCT03920878|Growth Substances|growth substances|mesh-ancestor
138697901|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
139061355|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061356|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
139061357|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061358|NCT03920644|Scopolamine|scopolamine|mesh-list
139061359|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
139061360|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139061361|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
139061362|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
139061363|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061364|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061365|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139061366|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
139061367|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139061368|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
139061369|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061370|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061371|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139061372|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
139061373|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
139061374|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061375|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139061376|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061377|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061378|NCT01137994|Paclitaxel|paclitaxel|mesh-list
139061379|NCT01137994|Vinorelbine|vinorelbine|mesh-list
139061380|NCT01137994|Docetaxel|docetaxel|mesh-list
139061381|NCT01137994|Trastuzumab|trastuzumab|mesh-list
139061382|NCT01137994|Lapatinib|lapatinib|mesh-list
139061383|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139061384|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061385|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
139061386|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
139061387|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
139061388|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061389|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139061390|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139061391|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061392|NCT01138072|Atorvastatin|atorvastatin|mesh-list
139061393|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139061394|NCT01138072|Simvastatin|simvastatin|mesh-list
139061395|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139061396|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139061397|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
139061398|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061399|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139061400|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139061401|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061402|NCT01131910|Vaccines|vaccines|mesh-list
139061403|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
139061404|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061405|NCT03739606|Antibodies|antibodies|mesh-list
139061406|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
139061407|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139061408|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139061409|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
139061410|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061411|NCT01233622|Vildagliptin|vildagliptin|mesh-list
139061412|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139061413|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061414|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138254112|NCT01323465|Analgesics|analgesics|mesh-ancestor
139061415|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
139061416|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061417|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061418|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
139061419|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
139061420|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061421|NCT01138774|Protective Agents|protective agents|mesh-ancestor
139061422|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061423|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
139061424|NCT01138774|Vitamins|vitamins|mesh-ancestor
139061425|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
139061426|NCT01131988|Tacrolimus|tacrolimus|mesh-list
139061427|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139061428|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
139061429|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061430|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139061431|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061432|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061433|NCT01138852|Ampicillin|ampicillin|mesh-list
139061434|NCT01138852|Cefuroxime|cefuroxime|mesh-list
139061435|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
138812020|NCT05238883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061436|NCT01138852|Sulbactam|sulbactam|mesh-list
139061437|NCT01138852|Sultamicillin|sultamicillin|mesh-list
139061438|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139061439|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061440|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139061441|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061442|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061443|NCT01585870|Sorafenib|sorafenib|mesh-list
139061444|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061445|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139061446|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061447|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061448|NCT05210140|Escitalopram|escitalopram|mesh-list
139061449|NCT05210140|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139061450|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139061451|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139061452|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061453|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061454|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
139061455|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061456|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
139061457|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
139061458|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139061459|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
139061460|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
139061461|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061462|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061463|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061464|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
139061465|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
139061466|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139061467|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139061468|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139061469|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061470|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139061471|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139061472|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061473|NCT05195944|Incretins|incretins|mesh-ancestor
139061475|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139061476|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139061477|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
139061478|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061479|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061480|NCT01236586|Dexamethasone|dexamethasone|mesh-list
139061481|NCT01236586|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139061482|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139061483|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
139061484|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
139061485|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061486|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061487|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139061488|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
139061489|NCT01236586|Hormones|hormones|mesh-ancestor
139061490|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139061491|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139061492|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061493|NCT01236586|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139061494|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061495|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061496|NCT01234792|Nicotine|nicotine|mesh-list
139061497|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139061498|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
138697977|NCT03871036|Paclitaxel|paclitaxel|mesh-list
139061499|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061500|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061501|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139061502|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139061503|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
139061504|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061505|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061506|NCT03467932|Insulin|insulin|mesh-list
139061507|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139061508|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139061509|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061510|NCT01140100|Thiopental|thiopental|mesh-list
139061511|NCT01140100|Propofol|propofol|mesh-list
139061512|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139061513|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139061514|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061515|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139061516|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
139061517|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
139061518|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
139061519|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
139061520|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
139061521|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061522|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061523|NCT01141036|Midazolam|midazolam|mesh-list
139061524|NCT01141036|Propofol|propofol|mesh-list
139061525|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139061526|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138254147|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
139061527|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061528|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139061529|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
139061530|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
139061531|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139061532|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139061533|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139061534|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139061535|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
139061536|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
139061537|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061538|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061539|NCT04906720|Colchicine|colchicine|mesh-list
139061540|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
139061541|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139061542|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
139061543|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
139061544|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
139061545|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061546|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061547|NCT01141192|Vitamin D|vitamin d|mesh-list
139061548|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
139061549|NCT01141192|Vitamins|vitamins|mesh-ancestor
138698009|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138698010|NCT03795311|Bevacizumab|bevacizumab|mesh-list
138698011|NCT03795311|Folfirinox|folfirinox|mesh-list
139061550|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
139061551|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061552|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139061553|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139061554|NCT01144000|Daptomycin|daptomycin|mesh-list
139061555|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139061556|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061557|NCT01140412|Ritonavir|ritonavir|mesh-list
139061558|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
139061559|NCT01140412|Maraviroc|maraviroc|mesh-list
139061560|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139061561|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139061562|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
139061563|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061564|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061565|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139061566|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139061567|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
139061568|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061569|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139061570|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139061571|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139061572|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139061573|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139061574|NCT01234324|Cisplatin|cisplatin|mesh-list
139061575|NCT01234324|Capecitabine|capecitabine|mesh-list
139061576|NCT01234324|Epirubicin|epirubicin|mesh-list
139061577|NCT01234324|Panitumumab|panitumumab|mesh-list
139061578|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061579|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139061580|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
139061581|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061582|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139061583|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139061584|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139061585|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061586|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139061587|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
139061588|NCT02334124|Floxacillin|floxacillin|mesh-list
139061589|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139061590|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061591|NCT01144156|Adalimumab|adalimumab|mesh-list
139061592|NCT01144156|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139061593|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139061594|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139061595|NCT01235260|Becaplermin|becaplermin|mesh-list
139061596|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
139061597|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
139061598|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139061599|NCT01235260|Growth Substances|growth substances|mesh-ancestor
139061600|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061601|NCT01144312|Fentanyl|fentanyl|mesh-list
139061602|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139061603|NCT01144312|Narcotics|narcotics|mesh-ancestor
139061604|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139061605|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061606|NCT01144312|Analgesics|analgesics|mesh-ancestor
138698034|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
138698035|NCT03638297|Antibodies|antibodies|mesh-list
139061607|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
139061608|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061609|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139061610|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139061611|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
139061612|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
139061613|NCT01144390|Methadone|methadone|mesh-list
139061614|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139061615|NCT01144390|Narcotics|narcotics|mesh-ancestor
139061616|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139061617|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061618|NCT01144390|Analgesics|analgesics|mesh-ancestor
139061619|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
139061620|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061621|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
139061622|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
139061623|NCT01329640|Paclitaxel|paclitaxel|mesh-list
139061624|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
139061625|NCT01329640|Trastuzumab|trastuzumab|mesh-list
139061626|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139061627|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061628|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
138906193|NCT00818766|Vancomycin|vancomycin|mesh-list
139061629|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
139061630|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
139061631|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061632|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139061633|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
139061634|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061635|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139061636|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139061637|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
139061638|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139061639|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139061640|NCT05335018|Lenalidomide|lenalidomide|mesh-list
139061641|NCT05335018|Immunologic Factors|immunologic factors|mesh-ancestor
139061642|NCT05335018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061643|NCT05335018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139061644|NCT05335018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139061645|NCT05335018|Growth Substances|growth substances|mesh-ancestor
139061646|NCT05335018|Growth Inhibitors|growth inhibitors|mesh-ancestor
139061647|NCT05335018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061648|NCT00114777|Cyclosporine|cyclosporine|mesh-list
139061649|NCT00114777|Abatacept|abatacept|mesh-list
139061650|NCT00114777|Cyclosporins|cyclosporins|mesh-list
139061651|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061652|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061653|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139061654|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
139061655|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061656|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
139061657|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061658|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
139061659|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139061660|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139061661|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139061662|NCT00114777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139061663|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061664|NCT00139737|Ziprasidone|ziprasidone|mesh-list
139061665|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139061666|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
139061667|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061668|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061669|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061670|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139061671|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139061672|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139061673|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139061674|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139061675|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
139061676|NCT00139659|Insulin|insulin|mesh-list
139061677|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139061678|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139061679|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061680|NCT01076439|Fluticasone|fluticasone|mesh-list
139061681|NCT01076439|Xhance|xhance|mesh-list
139061682|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139061683|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139061684|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139061685|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
139061686|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061687|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061688|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139061689|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
139061690|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
139061691|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139061692|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139061693|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139061694|NCT01076439|Analgesics|analgesics|mesh-ancestor
139061695|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
139061696|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139061697|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139061698|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139061699|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
139061700|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
139061701|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698081|NCT03468985|Nivolumab|nivolumab|mesh-list
138254189|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061702|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061703|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
139061704|NCT03965637|Vitamins|vitamins|mesh-ancestor
139061705|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
139061706|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061707|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
139061708|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061709|NCT03965637|Protective Agents|protective agents|mesh-ancestor
139061710|NCT01078779|Chloroquine|chloroquine|mesh-list
139061711|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
139061712|NCT01078779|Amebicides|amebicides|mesh-ancestor
139061713|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139061714|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139061715|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061716|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
139061717|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139061718|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139061719|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139061720|NCT01078779|Analgesics|analgesics|mesh-ancestor
139061721|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
139061722|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061723|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061724|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139061725|NCT01078779|Filaricides|filaricides|mesh-ancestor
139061726|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
139061727|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
139061728|NCT00114231|Capecitabine|capecitabine|mesh-list
139061729|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
139061730|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139061731|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
139061732|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061733|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061734|NCT00113919|Busulfan|busulfan|mesh-list
139061735|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
139061736|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906225|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
139061737|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139061738|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
139061739|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061740|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139061741|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061742|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139061743|NCT00113841|Curcumin|curcumin|mesh-list
139061744|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139061745|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139061746|NCT00113841|Analgesics|analgesics|mesh-ancestor
139061747|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
139061748|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061749|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061750|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139061751|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139061752|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061753|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061754|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061755|NCT00113607|Dexamethasone|dexamethasone|mesh-list
139061756|NCT00113607|Trabectedin|trabectedin|mesh-list
139061757|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139061758|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
139061759|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
139061760|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061761|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061762|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139061763|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
139061764|NCT00113607|Hormones|hormones|mesh-ancestor
139061765|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139061766|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139061767|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061768|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139061769|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
139061770|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061771|NCT00113529|Sunitinib|sunitinib|mesh-list
139061772|NCT00113529|Gefitinib|gefitinib|mesh-list
139061773|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061774|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139061775|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139061776|NCT00113529|Growth Substances|growth substances|mesh-ancestor
139061777|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061778|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
138698158|NCT03061474|Niacin|niacin|mesh-list
139061779|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139061780|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061781|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061782|NCT01079013|Treosulfan|treosulfan|mesh-list
139061783|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139061784|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
139061785|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061786|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061787|NCT00134901|Memantine|memantine|mesh-list
139061788|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139061789|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139061790|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
139061791|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906246|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061792|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061793|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061794|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139061795|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139061796|NCT01076595|Interferons|interferons|mesh-list
139061797|NCT01076595|Interferon-beta|interferon-beta|mesh-list
139061798|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
139061799|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061800|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
139061801|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061802|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
139061803|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061804|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139061805|NCT00113373|Lapatinib|lapatinib|mesh-list
139061806|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061807|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139061808|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061809|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061810|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139061811|NCT00113295|Paroxetine|paroxetine|mesh-list
139061812|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
139061813|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139061814|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138812406|NCT04292743|Vitamins|vitamins|mesh-ancestor
139061815|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139061816|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139061817|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061818|NCT00113295|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139061819|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139061820|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139061821|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061822|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061823|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
139061824|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139061825|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139061826|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139061827|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061829|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061830|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139061831|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061832|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061833|NCT00427895|Vaccines|vaccines|mesh-list
139061834|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139061836|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061837|NCT01034189|Paclitaxel|paclitaxel|mesh-list
139061838|NCT01034189|Cetuximab|cetuximab|mesh-list
139061839|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139061840|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061841|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
139061842|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
139061843|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
139061844|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061845|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139061846|NCT00425945|Pycnogenols|pycnogenols|mesh-list
139061847|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139061848|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
139061849|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061850|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
138698226|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139061851|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061852|NCT00425945|Protective Agents|protective agents|mesh-ancestor
139061853|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139061854|NCT00121641|Metformin|metformin|mesh-list
139061855|NCT00121641|Saxagliptin|saxagliptin|mesh-list
139061856|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139061857|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061858|NCT00121641|Incretins|incretins|mesh-ancestor
139061859|NCT00121641|Hormones|hormones|mesh-ancestor
139061860|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139061861|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139061862|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
139061863|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061864|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061865|NCT00425555|Panobinostat|panobinostat|mesh-list
139061866|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061867|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139061868|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061869|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061870|NCT00424775|Vorinostat|vorinostat|mesh-list
139061871|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061872|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139061873|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061874|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061875|NCT01034345|Sirolimus|sirolimus|mesh-list
139061876|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
139061877|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139061878|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061879|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139061880|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061881|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
139061882|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139061883|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
139061884|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061885|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061886|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061887|NCT01763866|Atorvastatin|atorvastatin|mesh-list
139061888|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139061891|NCT01763866|Evolocumab|evolocumab|mesh-list
139061892|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139061893|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139061894|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139061895|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
139061896|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698257|NCT02017704|Leucovorin|leucovorin|mesh-list
139061897|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139061898|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139061899|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061900|NCT01763866|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139061901|NCT01763866|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139061902|NCT01763866|Protease Inhibitors|protease inhibitors|mesh-ancestor
139061903|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
139061904|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061905|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
139061906|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139061907|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139061908|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
139061909|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
139061910|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139061911|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061912|NCT01588925|Dexamethasone|dexamethasone|mesh-list
139061913|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
139061914|NCT01588925|BB 1101|bb 1101|mesh-list
139061915|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
139061916|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139061917|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
139061918|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
139061919|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061920|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061921|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139061922|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
139061923|NCT01588925|Hormones|hormones|mesh-ancestor
139061924|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139061925|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139061926|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061927|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
139061928|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061929|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061930|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139061931|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
139061932|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
139061933|NCT01588925|Protective Agents|protective agents|mesh-ancestor
139061934|NCT01238146|Rituximab|rituximab|mesh-list
139061935|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139061936|NCT01238146|Obatoclax|obatoclax|mesh-list
139061937|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139061938|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061939|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
139061940|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061941|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139061942|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139061943|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
139061944|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061945|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061946|NCT01141894|Phenylephrine|phenylephrine|mesh-list
139061947|NCT01141894|Dobutamine|dobutamine|mesh-list
139061948|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
139061949|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
139061950|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139061951|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
138698331|NCT01351103|LGK974|lgk974|mesh-list
139061952|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
139061953|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139061954|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061955|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
139061956|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139061957|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
139061958|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
138254246|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139061959|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139061960|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139061961|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138812549|NCT03646123|Dacarbazine|dacarbazine|mesh-list
139061962|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
139061963|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139061964|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061965|NCT01141894|Protective Agents|protective agents|mesh-ancestor
139061966|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139061967|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139061968|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
139061969|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
139061970|NCT01238224|Tadalafil|tadalafil|mesh-list
139061971|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
139061972|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139061973|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139061974|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061975|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061976|NCT01238224|Urological Agents|urological agents|mesh-ancestor
139061977|NCT01237444|Ritonavir|ritonavir|mesh-list
139061978|NCT01237444|Lopinavir|lopinavir|mesh-list
139061979|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139061980|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139061981|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
139061982|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139061983|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139061984|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139061985|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139061986|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
139061987|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139061988|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139061989|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139061990|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
139061991|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139061992|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139061993|NCT01141972|Vitamin D|vitamin d|mesh-list
139061994|NCT01141972|Vitamins|vitamins|mesh-ancestor
139061995|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
139061996|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139061997|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139061998|NCT04316806|Rifaximin|rifaximin|mesh-list
139061999|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139062000|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062001|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139062002|NCT01145326|Lidocaine|lidocaine|mesh-list
139062003|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
139062004|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
139062005|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139062006|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062007|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
139062008|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062009|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138254251|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139062010|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139062011|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139062012|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139062013|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062014|NCT01144702|Artesunate|artesunate|mesh-list
139062015|NCT01144702|Mefloquine|mefloquine|mesh-list
139062016|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
139062017|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139062018|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139062019|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062020|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062021|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
139062022|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
139062023|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139062024|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
139062025|NCT01145404|Capecitabine|capecitabine|mesh-list
139062026|NCT01145404|Lapatinib|lapatinib|mesh-list
139062027|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139062028|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
139062029|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062030|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062031|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139062032|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062033|NCT01237522|Metformin|metformin|mesh-list
139062034|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139062035|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062036|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
139062037|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139062038|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062039|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062040|NCT04246996|Gentamicins|gentamicins|mesh-list
139062041|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139062042|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062043|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139062044|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062045|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062046|NCT00424463|Edaravone|edaravone|mesh-list
139062047|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139062048|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
139062049|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062050|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139062051|NCT00424463|Protective Agents|protective agents|mesh-ancestor
139062052|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062053|NCT01324115|Nitroarginine|nitroarginine|mesh-list
139062054|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062055|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062056|NCT01037621|Valacyclovir|valacyclovir|mesh-list
139062057|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
139062058|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062059|NCT00424385|Sorafenib|sorafenib|mesh-list
139062060|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
139062061|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062062|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139062063|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062064|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062065|NCT01037699|Hormones|hormones|mesh-list
139062066|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139062067|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139062068|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062069|NCT00423917|Bevacizumab|bevacizumab|mesh-list
139062070|NCT00423917|Fulvestrant|fulvestrant|mesh-list
139062071|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139062072|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062073|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139062074|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139062076|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062077|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
139062078|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139062079|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139062080|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139062081|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
139062082|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139062083|NCT00845026|Olanzapine|olanzapine|mesh-list
139062084|NCT00845026|Risperidone|risperidone|mesh-list
139062085|NCT00845026|Aripiprazole|aripiprazole|mesh-list
139062086|NCT00845026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139062087|NCT00845026|Serotonin Agents|serotonin agents|mesh-ancestor
139062088|NCT00845026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139062089|NCT00845026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906459|NCT05758662|Listerine|listerine|mesh-list
139062090|NCT00845026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062092|NCT00845026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139062093|NCT00845026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139062094|NCT00845026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139062095|NCT00845026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139062096|NCT00845026|Dopamine Agents|dopamine agents|mesh-ancestor
139062097|NCT00845026|Antiemetics|antiemetics|mesh-ancestor
139062098|NCT00845026|Autonomic Agents|autonomic agents|mesh-ancestor
139062099|NCT00845026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062100|NCT00845026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139062101|NCT00845026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139062102|NCT00845026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139062103|NCT00845026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139062104|NCT00845026|Antidepressive Agents|antidepressive agents|mesh-ancestor
139062105|NCT00845026|Dopamine Agonists|dopamine agonists|mesh-ancestor
139062106|NCT00845026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139062107|NCT00845026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139062108|NCT00845026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139062109|NCT00845026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139062110|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139062111|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
139062112|NCT02445131|Idelalisib|idelalisib|mesh-list
139062113|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139062114|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
139062115|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062116|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062117|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139062118|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062119|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
139062120|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062121|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
139062122|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062123|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139062124|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139062125|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
139062126|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062127|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062128|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139062130|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139062131|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139062132|NCT01145950|Analgesics|analgesics|mesh-ancestor
139062133|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
139062134|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062135|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062136|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139062137|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139062138|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139062139|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062140|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
139062141|NCT01238926|Vitamins|vitamins|mesh-list
139062142|NCT01238926|Folic Acid|folic acid|mesh-list
139062143|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
139062144|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
139062145|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
139062146|NCT01238926|Pyridoxal|pyridoxal|mesh-list
139062147|NCT01238926|Pyridoxine|pyridoxine|mesh-list
139062148|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
139062149|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
139062150|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062151|NCT01238926|Hematinics|hematinics|mesh-ancestor
139062152|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139062153|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139062154|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139062155|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
139062156|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062157|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139062158|NCT01142518|Interferons|interferons|mesh-list
139062159|NCT01142518|Interferon-beta|interferon-beta|mesh-list
139062160|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
139062161|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062162|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
139062163|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062164|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
139062165|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062166|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139062167|NCT00423449|Gemcitabine|gemcitabine|mesh-list
139062168|NCT00423449|Vorinostat|vorinostat|mesh-list
139062169|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139062170|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
139062171|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062172|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062173|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139062174|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062175|NCT00423293|Fluorouracil|fluorouracil|mesh-list
139062176|NCT00423293|Mitomycins|mitomycins|mesh-list
139062177|NCT00423293|Mitomycin|mitomycin|mesh-list
139062178|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
139062179|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062180|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139062181|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062182|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062183|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
139062184|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062185|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139062186|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
139062187|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139062188|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062189|NCT00422903|Letrozole|letrozole|mesh-list
139062191|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062192|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139062193|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139062194|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062195|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062196|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139062197|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
139062198|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139062199|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062200|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139062201|NCT00422591|Cytarabine|cytarabine|mesh-list
139062202|NCT00422591|Idarubicin|idarubicin|mesh-list
139062203|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139062204|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
138254293|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
139062205|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062206|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062207|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
139062208|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062209|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062210|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
139062211|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062212|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139062213|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139062214|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139062215|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062216|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
139062217|NCT00422513|Hematinics|hematinics|mesh-ancestor
139062218|NCT00202878|Simvastatin|simvastatin|mesh-list
139062219|NCT00202878|Ezetimibe|ezetimibe|mesh-list
139062220|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
139062221|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139062222|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139062223|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
139062224|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062225|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139062226|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139062227|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062228|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
139062229|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
139062230|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139062231|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062232|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139062233|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139062234|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062235|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062236|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062237|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139062238|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139062239|NCT00260208|Cyclosporine|cyclosporine|mesh-list
139062240|NCT00260208|Tacrolimus|tacrolimus|mesh-list
139062241|NCT00260208|Cyclosporins|cyclosporins|mesh-list
139062242|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062243|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
139062244|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062245|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139062246|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906599|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
139062247|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062248|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
139062249|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062250|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
139062251|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139062252|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
139062253|NCT00202644|Anagrelide|anagrelide|mesh-list
139062254|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062255|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
139062256|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062257|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062258|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139062259|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139062260|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139062261|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139062262|NCT00259740|Denosumab|denosumab|mesh-list
139062263|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138812849|NCT02166463|Prednisone|prednisone|mesh-list
139062264|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062265|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139062266|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139062267|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139062268|NCT01236040|Vaccines|vaccines|mesh-list
139062269|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
139062270|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062271|NCT03812224|Erenumab|erenumab|mesh-list
138254310|NCT00002691|Leucovorin|leucovorin|mesh-list
139062272|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
139062273|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062274|NCT03812224|Analgesics|analgesics|mesh-ancestor
139062275|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
139062276|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062277|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062278|NCT01146028|Tizanidine|tizanidine|mesh-list
139062279|NCT01146028|Analgesics|analgesics|mesh-ancestor
139062280|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
138906643|NCT00777166|Oxytocin|oxytocin|mesh-list
139062281|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062282|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062284|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139062285|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139062286|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
139062287|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
139062288|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139062289|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139062290|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139062291|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
139062292|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139062293|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062294|NCT03530800|Dronabinol|dronabinol|mesh-list
139062295|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
139062296|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062297|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139062298|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139062299|NCT03530800|Analgesics|analgesics|mesh-ancestor
139062300|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
139062301|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062302|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139062303|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139062304|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139062305|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062306|NCT03530800|Hormones|hormones|mesh-ancestor
139062307|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139062308|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
139062309|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139062310|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
139062311|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062312|NCT04982146|Expectorants|expectorants|mesh-ancestor
139062313|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
139062314|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139062315|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
139062316|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062317|NCT04982146|Protective Agents|protective agents|mesh-ancestor
139062318|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062319|NCT04982146|Antidotes|antidotes|mesh-ancestor
139062320|NCT04958746|Propofol|propofol|mesh-list
139062321|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139062322|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139062323|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062324|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139062325|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
139062326|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
139062327|NCT01146106|Pravastatin|pravastatin|mesh-list
139062328|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139062329|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139062330|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
139062331|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062332|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139062333|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139062334|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062335|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
138906723|NCT00768508|Naltrexone|naltrexone|mesh-list
139062336|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139062337|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
139062338|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062339|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
139062340|NCT03431584|Protective Agents|protective agents|mesh-ancestor
139062341|NCT00259272|Olanzapine|olanzapine|mesh-list
139062342|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
139062343|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
139062344|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062345|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062346|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139062347|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139062348|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139062349|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139062350|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139062351|NCT00259272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139062352|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139062353|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139062354|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062355|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139062356|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
139062357|NCT03106324|Lenalidomide|lenalidomide|mesh-list
139062358|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
139062359|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062360|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139062361|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139062362|NCT03106324|Growth Substances|growth substances|mesh-ancestor
139062363|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
139062364|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062365|NCT01147276|Vildagliptin|vildagliptin|mesh-list
139062366|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139062367|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062368|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139062369|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
139062370|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062371|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062372|NCT01239940|Paclitaxel|paclitaxel|mesh-list
139062373|NCT01239940|Everolimus|everolimus|mesh-list
139062374|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139062375|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062376|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
139062377|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
139062378|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
138698668|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139062379|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062380|NCT01239940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139062381|NCT01239940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139062382|NCT01239940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062383|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062384|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
139062385|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062386|NCT02526004|Tobramycin|tobramycin|mesh-list
139062387|NCT02526004|Ceftazidime|ceftazidime|mesh-list
139062388|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139062389|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062390|NCT00421889|Paclitaxel|paclitaxel|mesh-list
139062391|NCT00421889|Carboplatin|carboplatin|mesh-list
139062392|NCT00421889|Belinostat|belinostat|mesh-list
139062393|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139062394|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062395|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
139062396|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
139062397|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
139062398|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062399|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139062400|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062401|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
139062402|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
139062403|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062404|NCT03913468|Protective Agents|protective agents|mesh-ancestor
138254325|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
139062405|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062406|NCT03913468|Vitamins|vitamins|mesh-ancestor
139062407|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
139062408|NCT01147354|Selenium|selenium|mesh-list
139062409|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
138812999|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139062410|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062411|NCT01147354|Protective Agents|protective agents|mesh-ancestor
139062412|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062414|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
139062415|NCT04744480|Anesthetics|anesthetics|mesh-list
139062416|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139062417|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062418|NCT01147432|Capsaicin|capsaicin|mesh-list
139062419|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
139062420|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
139062421|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
139062422|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062423|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062424|NCT01147510|Montelukast|montelukast|mesh-list
139062425|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139062426|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
139062427|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139062428|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
139062429|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139062430|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062431|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139062432|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139062433|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062434|NCT03916432|Sirolimus|sirolimus|mesh-list
139062435|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139062436|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062437|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139062438|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062439|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
139062440|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062441|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
139062442|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062443|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
139062444|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139062445|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062446|NCT00421733|Vitamins|vitamins|mesh-ancestor
139062447|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
139062448|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139062449|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
139062450|NCT00421343|Vitamin D|vitamin d|mesh-list
139062451|NCT00421343|Alendronate|alendronate|mesh-list
139062452|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
139062453|NCT00421343|Calcium|calcium|mesh-list
139062454|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139062455|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062456|NCT00421343|Vitamins|vitamins|mesh-ancestor
139062457|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
139062458|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139062459|NCT00421343|Antacids|antacids|mesh-ancestor
139062460|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062461|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139062462|NCT01147588|Esomeprazole|esomeprazole|mesh-list
139062463|NCT01147588|Omeprazole|omeprazole|mesh-list
139062464|NCT01147588|Lansoprazole|lansoprazole|mesh-list
139062465|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
139062466|NCT01147588|Clopidogrel|clopidogrel|mesh-list
139062467|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139062468|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138254328|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139062469|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139062470|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139062471|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
139062472|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139062473|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062474|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062475|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139062476|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139062477|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139062478|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062479|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
139062480|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062481|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062482|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062483|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139062484|NCT00230178|Allopurinol|allopurinol|mesh-list
138813071|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062485|NCT00230178|Rasburicase|rasburicase|mesh-list
139062486|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
139062487|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062488|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062489|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
139062490|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139062491|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139062492|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
139062493|NCT00230178|Protective Agents|protective agents|mesh-ancestor
139062494|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062495|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
139062496|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139062497|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139062498|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139062499|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139062500|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062501|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
139062502|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139062503|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062504|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139062505|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062507|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
138906946|NCT00666718|Coagulants|coagulants|mesh-ancestor
139062508|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
139062509|NCT01251172|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139062510|NCT01251172|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
139062511|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139062512|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
139062513|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062514|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062515|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139062516|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062517|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
139062518|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062519|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062520|NCT00413777|Tolvaptan|tolvaptan|mesh-list
139062521|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139062522|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062523|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
139062524|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062525|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139062526|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139062527|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139062528|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139062529|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139062530|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
139062531|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139062532|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062533|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062534|NCT01074060|Plerixafor|plerixafor|mesh-list
139062535|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
139062536|NCT01074060|Lenograstim|lenograstim|mesh-list
139062537|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062538|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
139062539|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062540|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139062541|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139062542|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
139062543|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062544|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062545|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139062546|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139062547|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139062548|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139062549|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
139062550|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062551|NCT03915340|Propafenone|propafenone|mesh-list
139062552|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139062553|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139062554|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139062555|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139062556|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062557|NCT01581918|Carbamazepine|carbamazepine|mesh-list
139062558|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
139062559|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
139062560|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139062561|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139062562|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062563|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139062564|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139062565|NCT01581918|Analgesics|analgesics|mesh-ancestor
139062566|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
139062567|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062568|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139062569|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139062570|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062571|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139062572|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139062573|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139062574|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
139062575|NCT01582542|Coagulants|coagulants|mesh-ancestor
139062576|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139062577|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
139062578|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062579|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
139062580|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
139062581|NCT03912766|Coagulants|coagulants|mesh-ancestor
139062582|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139062583|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139062584|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
139062585|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062587|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139062588|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062589|NCT00420641|Paroxetine|paroxetine|mesh-list
139062590|NCT00420641|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139062591|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139062592|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139062593|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062594|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139062595|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
139062596|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062597|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139062598|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
139062599|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139062600|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139062601|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139062602|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062603|NCT00257556|Menotropins|menotropins|mesh-list
139062604|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139062605|NCT00257556|Hormones|hormones|mesh-ancestor
139062606|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139062607|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062608|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139062609|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
139062610|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139062611|NCT03906916|Micafungin|micafungin|mesh-list
139062612|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
139062613|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062614|NCT01250470|Sargramostim|sargramostim|mesh-list
139062615|NCT01250470|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139062616|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
139062617|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062618|NCT01250470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139062619|NCT01250548|Apremilast|apremilast|mesh-list
139062620|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139062621|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139062622|NCT01250548|Analgesics|analgesics|mesh-ancestor
139062623|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
139062624|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062625|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062626|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139062627|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139062628|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138813219|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139062629|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139062630|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062631|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062633|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
139062634|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
139062635|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139062636|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062637|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
139062638|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062639|NCT01251484|Nintedanib|nintedanib|mesh-list
139062640|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062641|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139062642|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062643|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062644|NCT03914638|Albuterol|albuterol|mesh-list
139062645|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139062646|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
139062647|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062648|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062649|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139062650|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
139062651|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
139062652|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139062653|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139062654|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139062655|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139062656|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
139062657|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139062658|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062660|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
139062661|NCT01148446|Rituximab|rituximab|mesh-list
139062662|NCT01148446|Doxorubicin|doxorubicin|mesh-list
139062663|NCT01148446|Vincristine|vincristine|mesh-list
139062664|NCT01148446|Epirubicin|epirubicin|mesh-list
139062665|NCT01148446|Vinblastine|vinblastine|mesh-list
139062666|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062667|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
139062668|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062669|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139062670|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139062671|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
139062672|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062673|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062674|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139062675|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139062676|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139062677|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139062678|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139062679|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062680|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139062681|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
139062682|NCT01148446|Hormones|hormones|mesh-ancestor
139062683|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139062684|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139062685|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139062686|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
139062687|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
139062688|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
139062689|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
139062690|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
138907129|NCT00690911|Adalimumab|adalimumab|mesh-list
139062691|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062693|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062694|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
139062695|NCT03914404|Vitamins|vitamins|mesh-ancestor
139062696|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
139062697|NCT01251640|Gemcitabine|gemcitabine|mesh-list
139062698|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139062699|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
139062700|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062701|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062702|NCT00257166|Ziprasidone|ziprasidone|mesh-list
139062703|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139062704|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
139062705|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139062706|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062707|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062709|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139062710|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139062711|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139062712|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139062714|NCT03914092|Triamcinolone|triamcinolone|mesh-list
139062715|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139062716|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139062717|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139062718|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139062719|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
139062720|NCT03914092|Hormones|hormones|mesh-ancestor
139062721|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139062722|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062723|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062724|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
139062725|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062726|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062727|NCT03913858|Anesthetics|anesthetics|mesh-list
139062728|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139062729|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062730|NCT00227370|Valganciclovir|valganciclovir|mesh-list
139062731|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
139062732|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062733|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139062734|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062735|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139062736|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062737|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062738|NCT01251874|Alovudine|alovudine|mesh-list
139062739|NCT01251874|Carboplatin|carboplatin|mesh-list
139062740|NCT01251874|Veliparib|veliparib|mesh-list
139062741|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062742|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139062743|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062744|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062745|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
139062746|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062747|NCT03911440|Azithromycin|azithromycin|mesh-list
139062748|NCT03911440|Doxycycline|doxycycline|mesh-list
139062749|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139062750|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062751|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
139062752|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139062753|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139062754|NCT00191100|Gemcitabine|gemcitabine|mesh-list
139062755|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062756|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139062757|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
139062758|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062759|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
139062760|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139062761|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139062762|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062763|NCT01252342|Oxytocin|oxytocin|mesh-list
139062764|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
139062765|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139062766|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062767|NCT01254994|Entecavir|entecavir|mesh-list
139062768|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
139062769|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062770|NCT03904732|Aspirin|aspirin|mesh-list
139062771|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139062772|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139062773|NCT03904732|Analgesics|analgesics|mesh-ancestor
139062774|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
139062775|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062776|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062777|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139062778|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138254397|NCT00002715|Hormones|hormones|mesh-ancestor
139062779|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139062780|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139062781|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062782|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139062783|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139062784|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062785|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
139062786|NCT01252420|Enoxaparin|enoxaparin|mesh-list
139062787|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
139062788|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139062789|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139062790|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062791|NCT01149304|Enoxaparin|enoxaparin|mesh-list
139062792|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
139062793|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139062794|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
139062795|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139062796|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139062797|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062798|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138907260|NCT00769522|Rituximab|rituximab|mesh-list
139062799|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062800|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139062801|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139062802|NCT01149304|Protective Agents|protective agents|mesh-ancestor
139062803|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062804|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
139062805|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139062806|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
139062807|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139062808|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139062809|NCT01254526|Paclitaxel|paclitaxel|mesh-list
139062810|NCT01254526|Bevacizumab|bevacizumab|mesh-list
139062811|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139062812|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062813|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
139062814|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
139062815|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
139062816|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062817|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139062818|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139062819|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139062820|NCT01254526|Growth Substances|growth substances|mesh-ancestor
139062821|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062822|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
139062823|NCT01148992|Lofexidine|lofexidine|mesh-list
139062824|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139062825|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139062826|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062827|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
139062828|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062829|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139062830|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139062831|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139062832|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
139062833|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139062834|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062836|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
139062837|NCT03903952|Vitamins|vitamins|mesh-ancestor
139062838|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
139062839|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062840|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
139062841|NCT03903952|Hematinics|hematinics|mesh-ancestor
139062842|NCT00257010|Almotriptan|almotriptan|mesh-list
139062843|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139062844|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
139062845|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139062846|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062847|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062848|NCT03901768|Dexamethasone|dexamethasone|mesh-list
139062849|NCT03901768|Triamcinolone|triamcinolone|mesh-list
139062850|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139062851|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
139062852|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
139062853|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062854|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062855|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139062856|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
139062858|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139062859|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139062860|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062861|NCT03903718|Oseltamivir|oseltamivir|mesh-list
139062862|NCT03903718|MEDI8852|medi8852|mesh-list
139062863|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
139062864|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062865|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062866|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062867|NCT03910504|Rocuronium|rocuronium|mesh-list
139062868|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
139062869|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
139062870|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139062871|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139062872|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062873|NCT03901690|Imiquimod|imiquimod|mesh-list
139062874|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139062875|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
139062876|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062877|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062878|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
139062879|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
139062880|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139062881|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062882|NCT03901378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139062883|NCT03901378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062884|NCT00256854|Ropinirole|ropinirole|mesh-list
138344319|NCT03223025|Hormones|hormones|mesh-list
139062885|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139062886|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139062887|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
139062888|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
139062889|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139062890|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062891|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062892|NCT00189462|Montelukast|montelukast|mesh-list
139062893|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139062894|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
139062895|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139062896|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
139062897|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139062898|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062899|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139062900|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138907367|NCT00695045|Narcotics|narcotics|mesh-ancestor
139062901|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062902|NCT01150318|Iodine|iodine|mesh-list
139062903|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139062904|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062905|NCT01150318|Trace Elements|trace elements|mesh-ancestor
139062906|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
139062907|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062908|NCT05667298|Immunomodulating Agents|immunomodulating agents|mesh-list
139062909|NCT05667298|Immunologic Factors|immunologic factors|mesh-ancestor
139062910|NCT05667298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062911|NCT01256632|Ranibizumab|ranibizumab|mesh-list
139062912|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139062913|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139062914|NCT01256632|Growth Substances|growth substances|mesh-ancestor
139062915|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062916|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
139062917|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062918|NCT00256698|Fulvestrant|fulvestrant|mesh-list
139062919|NCT00256698|Anastrozole|anastrozole|mesh-list
139062920|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139062921|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062922|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139062923|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139062924|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
139062925|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139062926|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062927|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139062928|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139062929|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062930|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062932|NCT01150630|Capecitabine|capecitabine|mesh-list
139062933|NCT01150630|Epirubicin|epirubicin|mesh-list
139062934|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062935|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139062936|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
139062937|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062938|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139062939|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139062940|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139062941|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062942|NCT00189306|Imiquimod|imiquimod|mesh-list
139062943|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139062944|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
139062945|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062946|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062947|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
139062948|NCT03898336|Micronutrients|micronutrients|mesh-list
139062949|NCT03898336|Trace Elements|trace elements|mesh-list
139062950|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062951|NCT03972462|Sirolimus|sirolimus|mesh-list
139062952|NCT03972462|Temsirolimus|temsirolimus|mesh-list
139062953|NCT03972462|MTOR Inhibitors|mtor inhibitors|mesh-list
139062954|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139062955|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139062956|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139062957|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062958|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
139062959|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062960|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
139062961|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062962|NCT03972462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139062963|NCT03972462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062964|NCT03972462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062965|NCT01150786|Selenium|selenium|mesh-list
139062966|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
139062967|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062968|NCT01150786|Protective Agents|protective agents|mesh-ancestor
139062969|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062970|NCT01150786|Trace Elements|trace elements|mesh-ancestor
139062971|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
139062972|NCT03909724|Sunitinib|sunitinib|mesh-list
139062973|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062974|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139062975|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139062976|NCT03909724|Growth Substances|growth substances|mesh-ancestor
139062977|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062979|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139062980|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139062981|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062982|NCT03909646|Fluorouracil|fluorouracil|mesh-list
139062983|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139062984|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139062985|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
139062986|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139062987|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139062988|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139062989|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139062990|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
139062991|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062992|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139062993|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
139062994|NCT01256866|Midazolam|midazolam|mesh-list
139062995|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
139062996|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139062997|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139062998|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139062999|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139063000|NCT01256866|Analgesics|analgesics|mesh-ancestor
139063001|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
139063002|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063003|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139063004|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139063005|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139063006|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
139063007|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063008|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063009|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139063010|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139063011|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138344501|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139063012|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139063013|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139063014|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
139063015|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
139063016|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
139063017|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
139063018|NCT03902782|Dexamethasone|dexamethasone|mesh-list
139063019|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
139063020|NCT03902782|Epinephrine|epinephrine|mesh-list
139063021|NCT03902782|Bupivacaine|bupivacaine|mesh-list
139063022|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139063023|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
139063024|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
139063025|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063026|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063027|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139063028|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
139063029|NCT03902782|Hormones|hormones|mesh-ancestor
139063030|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139063031|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139063032|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063033|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
139063034|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
139063035|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063036|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
139063037|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139063038|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139063039|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
139063040|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063041|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063042|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139063043|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139063044|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139063045|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
139063046|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
139063047|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
139063048|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139063050|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139063051|NCT03908944|Narcotics|narcotics|mesh-ancestor
139063052|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063053|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063054|NCT03908944|Analgesics|analgesics|mesh-ancestor
139063055|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
139063056|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063057|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
139063058|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
139063059|NCT03899506|Midazolam|midazolam|mesh-list
139063060|NCT03899506|Olanzapine|olanzapine|mesh-list
139063061|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139063062|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139063063|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063064|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063065|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139063066|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139063067|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139063068|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139063069|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
139063070|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
139063071|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
139063072|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
139063073|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063074|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063075|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
139063076|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
139063077|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063078|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139063079|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139063080|NCT03899506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139063081|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139063082|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139063083|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
139063084|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
139063085|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139063086|NCT03896932|Antibodies|antibodies|mesh-list
139063087|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
139063088|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139063089|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
139063090|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063091|NCT01257334|Empagliflozin|empagliflozin|mesh-list
139063092|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139063093|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063094|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139063095|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063096|NCT01151176|Insulin|insulin|mesh-list
139063097|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139063098|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139063099|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063100|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
139063101|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139063102|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063103|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139063104|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063105|NCT01257490|Bupropion|bupropion|mesh-list
138699282|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063106|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139063107|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
139063108|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139063109|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139063110|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139063111|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139063112|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063113|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
139063114|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063115|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063116|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139063117|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139063119|NCT03894280|Fluticasone|fluticasone|mesh-list
139063120|NCT03894280|Xhance|xhance|mesh-list
139063121|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139063122|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139063123|NCT03894280|Charcoal|charcoal|mesh-list
139063124|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139063125|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139063126|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
139063127|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063128|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063129|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139063130|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
139063131|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
139063132|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139063133|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139063134|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139063135|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139063136|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
139063137|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063138|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063139|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
139063140|NCT03894280|Hormones|hormones|mesh-ancestor
139063141|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139063142|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
139063143|NCT03894280|Antidotes|antidotes|mesh-ancestor
139063144|NCT03894280|Protective Agents|protective agents|mesh-ancestor
139063145|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
139063146|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139063147|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138344913|NCT01797822|Hormones|hormones|mesh-ancestor
139063148|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063149|NCT01150162|Omeprazole|omeprazole|mesh-list
139063150|NCT01150162|Rebamipide|rebamipide|mesh-list
139063151|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139063152|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139063153|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139063154|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063155|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063156|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
139063157|NCT01150162|Protective Agents|protective agents|mesh-ancestor
139063158|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063159|NCT03893734|Methadone|methadone|mesh-list
139063160|NCT03893734|Hydromorphone|hydromorphone|mesh-list
139063161|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139063162|NCT03893734|Narcotics|narcotics|mesh-ancestor
139063163|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063164|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063165|NCT03893734|Analgesics|analgesics|mesh-ancestor
139063166|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
139063167|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063168|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
139063169|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
139063170|NCT03899194|Escitalopram|escitalopram|mesh-list
139063171|NCT03899194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139063172|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139063173|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139063174|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063175|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063176|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
139063177|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063178|NCT01151800|Benzocaine|benzocaine|mesh-list
139063179|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
139063180|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
139063181|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063182|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063183|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
139063184|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063185|NCT03896074|Bevacizumab|bevacizumab|mesh-list
139063186|NCT03896074|Atezolizumab|atezolizumab|mesh-list
139063187|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139063188|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063189|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139063190|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139063191|NCT03896074|Growth Substances|growth substances|mesh-ancestor
138699359|NCT06021756|Ketamine|ketamine|mesh-list
139063192|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063193|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
139063194|NCT03896074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139063195|NCT03896074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063196|NCT03899038|Anesthetics|anesthetics|mesh-list
139063197|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063198|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063199|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
139063200|NCT01151878|Cathartics|cathartics|mesh-ancestor
139063201|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139063202|NCT03898882|Oxytocin|oxytocin|mesh-list
139063203|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
139063204|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139063205|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063206|NCT01151254|Propofol|propofol|mesh-list
139063207|NCT01151254|Sevoflurane|sevoflurane|mesh-list
139063208|NCT01151254|Isoflurane|isoflurane|mesh-list
139063209|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139063210|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063211|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063212|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139063213|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
139063214|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
139063215|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139063216|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139063217|NCT01255774|Ranibizumab|ranibizumab|mesh-list
139063218|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139063219|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139063220|NCT01255774|Growth Substances|growth substances|mesh-ancestor
139063221|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063222|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
139063223|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063224|NCT01255852|Atorvastatin|atorvastatin|mesh-list
139063225|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138907730|NCT00828672|Bevacizumab|bevacizumab|mesh-list
139063226|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139063227|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
139063228|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063229|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139063230|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139063231|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063232|NCT03895528|Lonafarnib|lonafarnib|mesh-list
139063233|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063234|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063235|NCT01257958|Vitamin D|vitamin d|mesh-list
139063236|NCT01257958|Vitamins|vitamins|mesh-ancestor
139063237|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
139063238|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063239|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139063240|NCT03893032|Modafinil|modafinil|mesh-list
139063241|NCT03893032|Amphetamine|amphetamine|mesh-list
139063242|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139063243|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063244|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139063245|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139063246|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139063247|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063248|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
139063249|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
139063250|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063251|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
139063252|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063253|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
139063254|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139063255|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139063256|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139063257|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139063258|NCT01258036|Hormones|hormones|mesh-list
139063259|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139063260|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063261|NCT03889366|Aprepitant|aprepitant|mesh-list
139063262|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
139063263|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
139063265|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063266|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139063267|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139063268|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138254492|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139063270|NCT03894826|Vorinostat|vorinostat|mesh-list
139063271|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063272|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139063273|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063274|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063275|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
139063276|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139063277|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139063278|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139063279|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138699412|NCT06021210|Letermovir|letermovir|mesh-list
139063280|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063281|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
139063282|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063283|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063284|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139063285|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063286|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
139063287|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063288|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139063289|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063290|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063291|NCT03888664|Interferons|interferons|mesh-list
139063292|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
139063293|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063294|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
139063295|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063296|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
139063297|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063298|NCT01153828|Mupirocin|mupirocin|mesh-list
139063299|NCT01153828|Retapamulin|retapamulin|mesh-list
139063300|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
139063301|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139063302|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063303|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139063304|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813881|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
139063305|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063306|NCT01151722|Bevacizumab|bevacizumab|mesh-list
139063307|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139063308|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063309|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139063310|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138699440|NCT06020963|Tamsulosin|tamsulosin|mesh-list
139063311|NCT01151722|Growth Substances|growth substances|mesh-ancestor
139063312|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063313|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
139063314|NCT01258192|Paclitaxel|paclitaxel|mesh-list
139063315|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139063316|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139063317|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063318|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
139063319|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
139063320|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
139063321|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063322|NCT01326078|Propofol|propofol|mesh-list
139063323|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139063324|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063325|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063326|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139063327|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
139063328|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
139063329|NCT01260376|Acipimox|acipimox|mesh-list
139063330|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139063331|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
139063332|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063333|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139063334|NCT01259050|Copper|copper|mesh-list
139063335|NCT01259050|Trace Elements|trace elements|mesh-ancestor
139063336|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
138907841|NCT00665392|Docetaxel|docetaxel|mesh-list
139063337|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063338|NCT00255840|Ritonavir|ritonavir|mesh-list
139063339|NCT00255840|Lopinavir|lopinavir|mesh-list
139063340|NCT00255840|Lamivudine|lamivudine|mesh-list
139063341|NCT00255840|Nevirapine|nevirapine|mesh-list
139063342|NCT00255840|Stavudine|stavudine|mesh-list
139063343|NCT00255840|Efavirenz|efavirenz|mesh-list
139063344|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139063345|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139063346|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
139063347|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063348|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063349|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139063350|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139063351|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
139063352|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063353|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139063354|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139063355|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139063356|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139063357|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139063358|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139063359|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139063360|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139063361|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139063362|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
139063363|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
139063364|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
139063365|NCT00224874|Etanercept|etanercept|mesh-list
139063366|NCT00224874|Pentostatin|pentostatin|mesh-list
139063367|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
139063368|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139063369|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063370|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139063371|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
139063372|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139063373|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063374|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063375|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063376|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139063377|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139063378|NCT00224874|Analgesics|analgesics|mesh-ancestor
138813956|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
139063379|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
139063380|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063381|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063382|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139063383|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139063384|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139063385|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139063386|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
139063387|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
139063388|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
139063389|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
139063390|NCT03892330|Doxorubicin|doxorubicin|mesh-list
139063391|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139063392|NCT03892330|Vincristine|vincristine|mesh-list
139063393|NCT03892330|Pirarubicin|pirarubicin|mesh-list
139063394|NCT03892330|Epirubicin|epirubicin|mesh-list
139063395|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139063396|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
139063397|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063398|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139063399|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139063400|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
139063401|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063402|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063403|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139063404|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139063405|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139063406|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139063407|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063408|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139063409|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
139063410|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
139063411|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
139063412|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139063413|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063414|NCT00186186|Valproic Acid|valproic acid|mesh-list
139063415|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
139063416|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907916|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
139063417|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063418|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
139063419|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063420|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063421|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
139063422|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139063423|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063424|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139063425|NCT00185640|Cyclosporine|cyclosporine|mesh-list
139063426|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
139063427|NCT00185640|Lenograstim|lenograstim|mesh-list
139063428|NCT00185640|Cyclosporins|cyclosporins|mesh-list
139063429|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
139063430|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139063431|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139063432|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
139063433|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063434|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063435|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063436|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139063437|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
139063438|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063439|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
139063440|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139063441|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139063442|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139063443|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063444|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139063445|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
139063446|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139063447|NCT03885388|Dactinomycin|dactinomycin|mesh-list
139063448|NCT03885388|Methotrexate|methotrexate|mesh-list
139063449|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139063450|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
139063451|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139063452|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063453|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139063454|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
139063455|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063456|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063457|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
139063458|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907947|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
139063459|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139063460|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139063461|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
139063462|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139063463|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139063464|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139063465|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063466|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139063467|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139063469|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139063470|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
139063471|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063472|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063473|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063474|NCT01260610|Tenofovir|tenofovir|mesh-list
139063475|NCT01260610|Telbivudine|telbivudine|mesh-list
139063476|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
139063477|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063478|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139063479|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139063480|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063481|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063482|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139063483|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139063484|NCT01155700|Omalizumab|omalizumab|mesh-list
139063485|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139063486|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139063487|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
139063488|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139063489|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139063490|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
139063491|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063492|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139063493|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139063494|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
139063495|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
139063496|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063497|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063498|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
139063499|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139063500|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063501|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
139063502|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
139063503|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139063504|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063505|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139063506|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063507|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139063508|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
139063509|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063510|NCT03891472|Fluorouracil|fluorouracil|mesh-list
139063511|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
139063512|NCT03891472|Irinotecan|irinotecan|mesh-list
139063513|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
139063514|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063515|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139063516|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063517|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139063518|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
139063519|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063520|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139063521|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139063522|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063523|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
139063524|NCT01262482|Sorafenib|sorafenib|mesh-list
139063525|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063526|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139063527|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063528|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063529|NCT01261078|Epinephrine|epinephrine|mesh-list
139063530|NCT01261078|Racepinephrine|racepinephrine|mesh-list
139063531|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
139063532|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139063533|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139063534|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
139063535|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063536|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063537|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063538|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139063539|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139063540|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
139063541|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063542|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138908012|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
139063543|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
139063544|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
139063545|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
139063546|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139063547|NCT01155934|Risperidone|risperidone|mesh-list
139063548|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139063549|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
139063550|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063551|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063552|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063553|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139063554|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139063555|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063556|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139063557|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139063558|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
139063559|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139063560|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
139063561|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063562|NCT01261156|Diltiazem|diltiazem|mesh-list
139063563|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139063564|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139063565|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139063566|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063567|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139063568|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063569|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
139063570|NCT03884530|Aspirin|aspirin|mesh-list
139063571|NCT03884530|Ticagrelor|ticagrelor|mesh-list
139063572|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139063573|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139063574|NCT03884530|Analgesics|analgesics|mesh-ancestor
139063575|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
139063576|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063577|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908052|NCT04015908|Acetaminophen|acetaminophen|mesh-list
139063578|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139063579|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139063580|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139063581|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139063582|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063583|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138254558|NCT00002775|Estramustine|estramustine|mesh-list
139063584|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139063586|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
139063587|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139063588|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139063589|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139063590|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
139063591|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063592|NCT03891316|Sevoflurane|sevoflurane|mesh-list
139063593|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139063594|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139063595|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
139063596|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
139063597|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063598|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063599|NCT03887260|Fentanyl|fentanyl|mesh-list
139063600|NCT03887260|Morphine|morphine|mesh-list
139063601|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139063602|NCT03887260|Narcotics|narcotics|mesh-ancestor
139063603|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063604|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063605|NCT03887260|Analgesics|analgesics|mesh-ancestor
139063606|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
139063607|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063608|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139063609|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139063610|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
139063611|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
139063612|NCT03883984|Cysteamine|cysteamine|mesh-list
139063613|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
139063614|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063615|NCT01586494|Tramadol|tramadol|mesh-list
139063616|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139063617|NCT01586494|Narcotics|narcotics|mesh-ancestor
138908089|NCT00795496|Histamine|histamine|mesh-list
139063618|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063619|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063620|NCT01586494|Analgesics|analgesics|mesh-ancestor
139063621|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
139063622|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063623|NCT03886948|Mirikizumab|mirikizumab|mesh-list
139063624|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139063625|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139063626|NCT03886948|Analgesics|analgesics|mesh-ancestor
139063627|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
139063628|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063629|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063630|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139063631|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139063632|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139063633|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139063634|NCT01259362|Cocaine|cocaine|mesh-list
139063635|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
139063636|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
139063637|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063638|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063639|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
139063640|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063641|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139063642|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139063643|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139063644|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139063645|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063646|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
139063647|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063648|NCT03891238|Avelumab|avelumab|mesh-list
138908139|NCT02620631|Morphine|morphine|mesh-list
139063649|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139063650|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063651|NCT01261234|Cilostazol|cilostazol|mesh-list
139063652|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139063653|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
139063654|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063655|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063656|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139063657|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
139063658|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139063659|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139063660|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063661|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139063662|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
139063663|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139063664|NCT01261234|Protective Agents|protective agents|mesh-ancestor
139063665|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139063666|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139063667|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063668|NCT01152736|Nicotine|nicotine|mesh-list
139063669|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139063670|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
139063671|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063672|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063673|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139063674|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139063675|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
139063676|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063677|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063678|NCT01261546|Dexamethasone|dexamethasone|mesh-list
139063679|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138814256|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
139063680|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
139063681|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
139063682|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063683|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063684|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139063685|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
139063686|NCT01261546|Hormones|hormones|mesh-ancestor
139063687|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139063688|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139063689|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063690|NCT03883360|Cannabidiol|cannabidiol|mesh-list
139063691|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
139063692|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
139063693|NCT01261702|Analgesics|analgesics|mesh-ancestor
139063694|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
139063695|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063696|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063697|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
139063698|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063699|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139063700|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
139063701|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139063702|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139063703|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063704|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139063705|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
139063706|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139063707|NCT01156246|Metformin|metformin|mesh-list
139063708|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
139063709|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139063710|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063711|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139063712|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063713|NCT03890770|Deucravacitinib|deucravacitinib|mesh-list
139063714|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
139063715|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139063716|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063717|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063718|NCT03883204|Risperidone|risperidone|mesh-list
139063719|NCT03883204|Aripiprazole|aripiprazole|mesh-list
139063720|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139063721|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
139063722|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063723|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699772|NCT05320380|Antimetabolites|antimetabolites|mesh-ancestor
139063724|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063725|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139063726|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139063727|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063728|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139063729|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139063730|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
139063731|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
139063732|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
139063733|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139063734|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139063735|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139063736|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139063737|NCT01263418|Ofatumumab|ofatumumab|mesh-list
139063738|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063739|NCT03882814|Meperidine|meperidine|mesh-list
139063740|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139063741|NCT03882814|Narcotics|narcotics|mesh-ancestor
139063742|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063743|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063744|NCT03882814|Analgesics|analgesics|mesh-ancestor
139063745|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
139063746|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063747|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139063748|NCT03647566|Listerine|listerine|mesh-list
139063749|NCT03647566|Fluorides|fluorides|mesh-list
139063750|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
139063751|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
139063752|NCT03647566|Protective Agents|protective agents|mesh-ancestor
139063753|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063754|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139063756|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
139063757|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
139063758|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139063759|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139063760|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063761|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063762|NCT01156636|Urological Agents|urological agents|mesh-ancestor
139063763|NCT03889288|Analgesics|analgesics|mesh-list
139063764|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
139063765|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063766|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063767|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
139063768|NCT01153204|Citric Acid|citric acid|mesh-list
139063769|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
139063770|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
139063771|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139063772|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
139063773|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
139063774|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063775|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
139063776|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139063777|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139063778|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063779|NCT01153204|Urological Agents|urological agents|mesh-ancestor
139063780|NCT03760666|Ribavirin|ribavirin|mesh-list
139063781|NCT03760666|Brequinar|brequinar|mesh-list
139063782|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
139063783|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063784|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
139063785|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063786|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063787|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063788|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139063789|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
139063790|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063791|NCT01263574|Ethanol|ethanol|mesh-list
139063792|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139063793|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063794|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063795|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063796|NCT03464734|Paclitaxel|paclitaxel|mesh-list
139063797|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
139063798|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139063799|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139063800|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063801|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
139063802|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
139063803|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
139063804|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063805|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139063806|NCT03464734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139063807|NCT01156948|Misoprostol|misoprostol|mesh-list
139063808|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139063809|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
139063810|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139063811|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063812|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139063813|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139063814|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
139063815|NCT01157026|Tamoxifen|tamoxifen|mesh-list
139063816|NCT01157026|Tocotrienols|tocotrienols|mesh-list
139063817|NCT01157026|Vitamin E|vitamin e|mesh-list
139063818|NCT01157026|Tocopherols|tocopherols|mesh-list
139063819|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139063820|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
138908323|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139063821|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139063822|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063823|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139063825|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139063826|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139063827|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139063828|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
139063829|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063830|NCT01157026|Protective Agents|protective agents|mesh-ancestor
139063831|NCT01157026|Vitamins|vitamins|mesh-ancestor
139063832|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
139063833|NCT01263652|Dipyrone|dipyrone|mesh-list
139063834|NCT01263652|Diclofenac|diclofenac|mesh-list
139063835|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
139063836|NCT01263652|Tramadol|tramadol|mesh-list
139063837|NCT01263652|Orphenadrine|orphenadrine|mesh-list
139063838|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139063839|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139063840|NCT01263652|Analgesics|analgesics|mesh-ancestor
139063841|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
138254610|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063842|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063843|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063844|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139063845|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139063846|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139063847|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063848|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063849|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139063850|NCT01263652|Narcotics|narcotics|mesh-ancestor
139063851|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139063852|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
139063853|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139063854|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139063855|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139063856|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139063857|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
139063858|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
139063859|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139063860|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139063861|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
139063862|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063863|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
139063864|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139063865|NCT03881644|Sumatriptan|sumatriptan|mesh-list
139063866|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
139063867|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139063868|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139063869|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139063870|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
139063871|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063872|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063873|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063874|NCT03881644|Growth Substances|growth substances|mesh-ancestor
139063875|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
139063877|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139063878|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139063879|NCT01259830|Analgesics|analgesics|mesh-ancestor
139063880|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
139063881|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063882|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063883|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139063884|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139063885|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139063886|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139063887|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063888|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063889|NCT00224484|Vaccines|vaccines|mesh-list
139063890|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
139063891|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063892|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
139063893|NCT01265680|Hematinics|hematinics|mesh-ancestor
139063894|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
139063895|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139063897|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139063898|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139063899|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063900|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063901|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063902|NCT01157572|Metoprolol|metoprolol|mesh-list
139063903|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139063904|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138814483|NCT02713191|Midazolam|midazolam|mesh-list
139063905|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
139063906|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
139063907|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063908|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063909|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139063910|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139063911|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139063912|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
139063913|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063914|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063915|NCT01074372|Alirocumab|alirocumab|mesh-list
139063916|NCT01074372|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139063917|NCT01074372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139063918|NCT01074372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138908588|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139063920|NCT01074372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063921|NCT01074372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139063922|NCT01074372|Protease Inhibitors|protease inhibitors|mesh-ancestor
139063923|NCT01074372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063924|NCT01074372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139063925|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139063926|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139063927|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063928|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139063929|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063930|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063931|NCT00254982|Infliximab|infliximab|mesh-list
139063932|NCT00254982|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139063933|NCT00254982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139063934|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
139063935|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139063936|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139063937|NCT01586572|Vaccines|vaccines|mesh-list
139063938|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
139063939|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063940|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
139063941|NCT00224016|Oxybutynin|oxybutynin|mesh-list
139063942|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
139063943|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
139063944|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139063945|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063946|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139063947|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139063948|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
139063949|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063950|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063951|NCT00224016|Urological Agents|urological agents|mesh-ancestor
139063952|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139063953|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063954|NCT02527174|Cytarabine|cytarabine|mesh-list
139063955|NCT02527174|Idarubicin|idarubicin|mesh-list
139063956|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139063957|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
139063958|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063959|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063960|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
139063961|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139063962|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139063963|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
139063964|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063965|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139063966|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139063967|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139063968|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139063969|NCT01161940|Nizatidine|nizatidine|mesh-list
139063970|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139063971|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139063972|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
139063973|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
139063974|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
139063975|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139063976|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063977|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063978|NCT01160068|Metformin|metformin|mesh-list
139063979|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139063980|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139063982|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
139063983|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139063984|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
139063985|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
139063986|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
139063987|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139063988|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063989|NCT03876886|Paclitaxel|paclitaxel|mesh-list
139063990|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139063991|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
139063992|NCT03876886|Carboplatin|carboplatin|mesh-list
139063993|NCT03876886|Epirubicin|epirubicin|mesh-list
138560792|NCT04885530|Xhance|xhance|mesh-list
139063994|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139063995|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139063996|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
139063997|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
139063998|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
139063999|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064000|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139064001|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
139064002|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064003|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139064004|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139064005|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
139064006|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139064007|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139064008|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139064009|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139064010|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064011|NCT01266772|Budesonide|budesonide|mesh-list
139064012|NCT01266772|Montelukast|montelukast|mesh-list
139064013|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138908789|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
139064014|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139064015|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
139064016|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064017|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064018|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139064019|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
139064021|NCT01266772|Hormones|hormones|mesh-ancestor
139064022|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139064023|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139064024|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
139064025|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139064026|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139064027|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064028|NCT01264354|Adefovir|adefovir|mesh-list
139064029|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139064030|NCT01264354|Clevudine|clevudine|mesh-list
139064031|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
139064032|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064033|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139064034|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139064035|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064036|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064037|NCT01264432|Veliparib|veliparib|mesh-list
139064038|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139064039|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064040|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064041|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064042|NCT02527096|Lamivudine|lamivudine|mesh-list
139064043|NCT02527096|Dolutegravir|dolutegravir|mesh-list
139064044|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139064045|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139064046|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064047|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064048|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
139064049|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064050|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139064051|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139064052|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139064053|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139064054|NCT01160302|Curcumin|curcumin|mesh-list
139064055|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139064056|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139064058|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
139064059|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064060|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064061|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064062|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139064063|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064064|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064065|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064066|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
139064067|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139064068|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139064069|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
139064070|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908966|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064071|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064072|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064073|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
139064074|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
139064075|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064076|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
139064077|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139064078|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
139064079|NCT01268176|Vitamin D|vitamin d|mesh-list
139064080|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
139064081|NCT01268176|Vitamins|vitamins|mesh-ancestor
139064082|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
139064083|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064084|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139064085|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139064086|NCT01264588|Calcium|calcium|mesh-list
139064087|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139064088|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064089|NCT01158274|Capecitabine|capecitabine|mesh-list
139085258|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909011|NCT00798772|Micronutrients|micronutrients|mesh-list
139064090|NCT01158274|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139064091|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139064092|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
139064093|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064094|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064095|NCT01158274|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139064096|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064097|NCT01267084|Ketoconazole|ketoconazole|mesh-list
139064098|NCT01267084|Dexamethasone|dexamethasone|mesh-list
139064099|NCT01267084|Trabectedin|trabectedin|mesh-list
139064100|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064101|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
139064102|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
139064103|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064104|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254826|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139064105|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138909135|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
139064106|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
139064107|NCT01267084|Hormones|hormones|mesh-ancestor
139064108|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139064109|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139064110|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064111|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
139064112|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064113|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139064114|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139064115|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064116|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064117|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139064118|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
139064119|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139064120|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139064121|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
139064122|NCT01264822|Rabeprazole|rabeprazole|mesh-list
139064123|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139064124|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139064125|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138814727|NCT02776527|Apatinib|apatinib|mesh-list
139064127|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064128|NCT03876574|Dexamethasone|dexamethasone|mesh-list
139064129|NCT03876574|Gemcitabine|gemcitabine|mesh-list
139064130|NCT03876574|Floxuridine|floxuridine|mesh-list
139064131|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064132|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
139064133|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
139064134|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064135|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064136|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139064137|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
138700079|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
139064138|NCT03876574|Hormones|hormones|mesh-ancestor
139064139|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139064140|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139064141|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064142|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139064143|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
139064144|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064145|NCT01161082|Alirocumab|alirocumab|mesh-list
139064146|NCT01161082|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139064147|NCT01161082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139064148|NCT01161082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139064149|NCT01161082|Antimetabolites|antimetabolites|mesh-ancestor
139064150|NCT01161082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064151|NCT01161082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139064152|NCT01161082|Protease Inhibitors|protease inhibitors|mesh-ancestor
139064153|NCT01161082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064154|NCT01161082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139064155|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
139064156|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
139064157|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
139064158|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139064159|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064160|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
139064161|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064163|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
139064164|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139064165|NCT01267396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139064166|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139064167|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139064168|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064169|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064170|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
139064171|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064172|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
139064173|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139064174|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139064175|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
139064176|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064177|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139064178|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139064179|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064180|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064181|NCT01161316|Cetuximab|cetuximab|mesh-list
139064182|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139064183|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064184|NCT01161550|Cytarabine|cytarabine|mesh-list
139064185|NCT01161550|Tretinoin|tretinoin|mesh-list
139064186|NCT01161550|Cladribine|cladribine|mesh-list
139064187|NCT01161550|Midostaurin|midostaurin|mesh-list
139064188|NCT01161550|Lenograstim|lenograstim|mesh-list
139064189|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139064190|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
138254965|NCT02219581|Hormones|hormones|mesh-ancestor
139064191|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064192|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064193|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
138909233|NCT05757336|Antimetabolites|antimetabolites|mesh-ancestor
139064194|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064195|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139064196|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
139064197|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064198|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139064199|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
139064200|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
139064201|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139064202|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064204|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
139064205|NCT01159210|Coagulants|coagulants|mesh-ancestor
139064206|NCT03879460|Naltrexone|naltrexone|mesh-list
139064207|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139064208|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139064209|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064210|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
139064211|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064212|NCT03877120|Diazepam|diazepam|mesh-list
139064213|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
139064214|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139064215|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139064216|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064217|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139064218|NCT03877120|Analgesics|analgesics|mesh-ancestor
139064219|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
139064220|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064221|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139064222|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139064223|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139064224|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
139064225|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064226|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064227|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139064228|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
139064229|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
139064230|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
139064231|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139064232|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139064233|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139064234|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139064235|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139064236|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139064237|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139064238|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
139064239|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
139064240|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
139064241|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
139064242|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
139064243|NCT03879382|Fludarabine|fludarabine|mesh-list
139064244|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139064245|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
139064246|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064247|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139064248|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139064249|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
139064250|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064251|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064252|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139064253|NCT01166932|Amoxicillin|amoxicillin|mesh-list
139064254|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
139064255|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
139064256|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
139064257|NCT01166932|Oxacillin|oxacillin|mesh-list
139064258|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139064259|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064260|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064261|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064262|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139064263|NCT01167010|Budesonide|budesonide|mesh-list
139064264|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
139064265|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064266|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139064267|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
139064268|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064269|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064270|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139064271|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
139064272|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
139064273|NCT01167010|Hormones|hormones|mesh-ancestor
139064274|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139064275|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139064276|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139064277|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139064278|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
139064279|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255101|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139064280|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064281|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139064282|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
139064283|NCT01280188|Coagulants|coagulants|mesh-ancestor
139064284|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139064285|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
139064286|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064287|NCT03871972|Sirolimus|sirolimus|mesh-list
139064288|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139064289|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064290|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139064291|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064292|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
139064293|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139064294|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
139064295|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064296|NCT01165060|Bezafibrate|bezafibrate|mesh-list
139064297|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139064298|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
139064299|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064300|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139064301|NCT01165294|Ketamine|ketamine|mesh-list
139064302|NCT01165294|Analgesics|analgesics|mesh-ancestor
139064303|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
139064304|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064305|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064306|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139064307|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139064308|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
139064309|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
139064310|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139064311|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139064312|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138255151|NCT00000321|Desipramine|desipramine|mesh-list
139064313|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064314|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064316|NCT01165372|Piperaquine|piperaquine|mesh-list
139064317|NCT01165372|Artenimol|artenimol|mesh-list
139064319|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139064320|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139064321|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064322|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064323|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
139064324|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
139064325|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139064326|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
139064327|NCT01280734|Melatonin|melatonin|mesh-list
139064328|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
139064329|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064330|NCT01280734|Protective Agents|protective agents|mesh-ancestor
139064331|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064332|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139064333|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139064334|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139064335|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064336|NCT01587430|Cytarabine|cytarabine|mesh-list
139064337|NCT01587430|Daunorubicin|daunorubicin|mesh-list
139064338|NCT01587430|Idarubicin|idarubicin|mesh-list
139064339|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
139064340|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139064341|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909749|NCT00789646|Lidocaine|lidocaine|mesh-list
139064342|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139064343|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139064344|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064345|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064346|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139064347|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
139064348|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
139064349|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064350|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139064351|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
139064352|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064353|NCT01587430|Analgesics|analgesics|mesh-ancestor
139064354|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
139064355|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064356|NCT03874000|Metformin|metformin|mesh-list
139064357|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139064358|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064359|NCT03757234|Levofloxacin|levofloxacin|mesh-list
139064360|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139064361|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064362|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139064363|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139064364|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139064365|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064366|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064367|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064368|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139064369|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139064370|NCT03874156|Atorvastatin|atorvastatin|mesh-list
139064371|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139064372|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139064373|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
139064374|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909928|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064375|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139064376|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139064377|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064378|NCT01167478|Caffeine|caffeine|mesh-list
139064379|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139064380|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064381|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139064382|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064383|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064384|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139064385|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139064386|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
139064387|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064388|NCT01587196|Naltrexone|naltrexone|mesh-list
139064389|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139064390|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139064391|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064392|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
139064393|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064394|NCT01281514|Carboplatin|carboplatin|mesh-list
139064395|NCT01281514|Doxorubicin|doxorubicin|mesh-list
139064396|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139064398|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064399|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139064400|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139064401|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139064403|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064404|NCT01281514|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139064405|NCT01281514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139064406|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139064407|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
139064408|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064409|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
139064410|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
139064411|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064412|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139064413|NCT00223080|Antacids|antacids|mesh-ancestor
139064414|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064415|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139064416|NCT03971604|Vitamins|vitamins|mesh-list
139064417|NCT03971604|Vitamin E|vitamin e|mesh-list
139064418|NCT03971604|Vitamin A|vitamin a|mesh-list
139064419|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
139064420|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064421|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
139064422|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064423|NCT03971604|Protective Agents|protective agents|mesh-ancestor
139064424|NCT02531490|Labetalol|labetalol|mesh-list
139064425|NCT02531490|Methyldopa|methyldopa|mesh-list
139064426|NCT02531490|Nifedipine|nifedipine|mesh-list
139064427|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139064428|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139064429|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064430|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139064431|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064432|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
139064433|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
139064434|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139064435|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139064436|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139064437|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
139064438|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064439|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139064440|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
139064441|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
139064442|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064443|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139064444|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139064445|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
139064446|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139064447|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139064448|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139064451|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139064452|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139064453|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064454|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
139064455|NCT03871114|Hormones|hormones|mesh-ancestor
139064456|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139064457|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064458|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139064459|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
139064460|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064461|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064462|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
139064463|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139064464|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139064465|NCT01281748|Prednisolone|prednisolone|mesh-list
139064466|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
139064467|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139064468|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
139064469|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064470|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
139064471|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
139064472|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064473|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064474|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139064475|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
139064476|NCT01281748|Hormones|hormones|mesh-ancestor
139064477|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139064478|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139064479|NCT01281748|Protective Agents|protective agents|mesh-ancestor
139064480|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139064481|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064482|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
139064483|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139064485|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
139064486|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139064487|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
139064488|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
139064489|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064490|NCT01273402|Antibodies|antibodies|mesh-list
139064491|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
139064492|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
139064493|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
139064494|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064495|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
139064496|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139064497|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
139064498|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064499|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064500|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139064501|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
139064502|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139064503|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
139064504|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064505|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064506|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139064507|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
139064508|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
139064509|NCT03873298|Protective Agents|protective agents|mesh-ancestor
139064510|NCT00184002|Prednisone|prednisone|mesh-list
139064511|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
139064512|NCT00184002|Doxorubicin|doxorubicin|mesh-list
139064513|NCT00184002|Vincristine|vincristine|mesh-list
139064514|NCT00184002|Rituximab|rituximab|mesh-list
139064515|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139064516|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
139064517|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064518|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139064519|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139064520|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
139064521|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064522|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064523|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139064524|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139064525|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139064526|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139064527|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064528|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064529|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
139064531|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139064532|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139064533|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139064534|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
139064535|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
139064536|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
139064537|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139064538|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
139064539|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139064540|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139064541|NCT01167946|Prednisolone|prednisolone|mesh-list
139064542|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
139064543|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139064544|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
139064545|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064546|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
139064547|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
139064548|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064549|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064550|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139064551|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
139064552|NCT01167946|Hormones|hormones|mesh-ancestor
138770220|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064553|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139064554|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139064555|NCT01167946|Protective Agents|protective agents|mesh-ancestor
139064556|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139064557|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064559|NCT01275508|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139064560|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064561|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139064562|NCT01073670|Acetaminophen|acetaminophen|mesh-list
139064563|NCT01073670|Indomethacin|indomethacin|mesh-list
139064564|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139064565|NCT01073670|Analgesics|analgesics|mesh-ancestor
139064566|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
139064567|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064568|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064569|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
139064570|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139064571|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064572|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139064573|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
139064574|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
139064575|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139064576|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139064577|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064578|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064579|NCT03971370|Vaccines|vaccines|mesh-list
138815159|NCT03460522|Immunotoxins|immunotoxins|mesh-ancestor
139064580|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
139064581|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064582|NCT01168336|Betahistine|betahistine|mesh-list
139064583|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
139064584|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
139064585|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
139064586|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064587|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064588|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064589|NCT00165672|Rabeprazole|rabeprazole|mesh-list
139064590|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139064591|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139064592|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139064593|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064594|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064595|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
139064596|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139064597|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
139064598|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700393|NCT01237951|Melphalan|melphalan|mesh-list
139064599|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
139064600|NCT03870646|Protective Agents|protective agents|mesh-ancestor
139064601|NCT01168492|Ketamine|ketamine|mesh-list
139064602|NCT01168492|Analgesics|analgesics|mesh-ancestor
139064603|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
139064604|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064605|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064606|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139064607|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139064608|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
139064609|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
139064610|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139064611|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139064612|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139064613|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064614|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064616|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139064617|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064618|NCT01278082|Budesonide|budesonide|mesh-list
139064619|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064620|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139064621|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
139064622|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064623|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064624|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139064625|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
139064626|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
139064627|NCT01278082|Hormones|hormones|mesh-ancestor
139064628|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139064629|NCT03870256|Misoprostol|misoprostol|mesh-list
139064630|NCT03870256|Carbetocin|carbetocin|mesh-list
139064631|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139064632|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
139064633|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139064634|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064635|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139064636|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139064637|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
139064638|NCT01166542|Paclitaxel|paclitaxel|mesh-list
139064639|NCT01166542|Carboplatin|carboplatin|mesh-list
139064640|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139064641|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064642|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
139064643|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
139064644|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
139064645|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064646|NCT00169104|Trastuzumab|trastuzumab|mesh-list
139064647|NCT00169104|Vinorelbine|vinorelbine|mesh-list
139064648|NCT00169104|Lenograstim|lenograstim|mesh-list
139064649|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139064650|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064651|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139064653|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064654|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138815232|NCT02692599|Vaccines|vaccines|mesh-list
139064655|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
139064656|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
139064657|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
139064658|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064659|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
139064660|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139064661|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139064662|NCT03872830|Analgesics|analgesics|mesh-ancestor
139064663|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
139064664|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064665|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064666|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064667|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139064668|NCT02526316|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139064669|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
139064670|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139064671|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
139064672|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064673|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139064674|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
139064675|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139064676|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138910546|NCT00705692|Levamisole|levamisole|mesh-list
139064677|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139064678|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139064679|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064680|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
139064681|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
139064682|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139064683|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
139064684|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139064685|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064687|NCT00163020|Hormones|hormones|mesh-ancestor
139064688|NCT01168804|Dexamethasone|dexamethasone|mesh-list
139064689|NCT01168804|Bortezomib|bortezomib|mesh-list
139064690|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139064691|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064692|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
139064693|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
139064694|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064695|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064696|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139064697|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
139064698|NCT01168804|Hormones|hormones|mesh-ancestor
139064699|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700453|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064700|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139064701|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064702|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139064703|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
138910592|NCT03537924|Diuretics|diuretics|mesh-ancestor
139064704|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064705|NCT03873532|Capecitabine|capecitabine|mesh-list
139064706|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139064707|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
139064708|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064709|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064710|NCT01282528|Infliximab|infliximab|mesh-list
139064711|NCT01282528|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138910641|NCT00796107|Letrozole|letrozole|mesh-list
139064712|NCT01282528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064713|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
139064714|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139064715|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139064716|NCT01169506|Silicon|silicon|mesh-list
139064717|NCT01169506|Trace Elements|trace elements|mesh-ancestor
139064718|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
139064719|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064721|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
139064722|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064723|NCT01169740|Protective Agents|protective agents|mesh-ancestor
139064724|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064725|NCT01169584|Molgramostim|molgramostim|mesh-list
139064726|NCT01169584|Sargramostim|sargramostim|mesh-list
139064727|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
139064728|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064729|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064730|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
139064731|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139064732|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064733|NCT01282762|Vaccines|vaccines|mesh-list
139064734|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
139064735|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064736|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139064737|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139064738|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139064739|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
139064740|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064741|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064742|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064744|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
139064745|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064746|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139064747|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064748|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064749|NCT01172626|Valproic Acid|valproic acid|mesh-list
139064750|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
139064751|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064752|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064753|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
139064754|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064755|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064756|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
139064757|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139064758|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139064759|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139064760|NCT01172782|Hydromorphone|hydromorphone|mesh-list
139064761|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139064762|NCT01172782|Narcotics|narcotics|mesh-ancestor
138910891|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064763|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139064764|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064766|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
139064767|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064768|NCT03866746|Aflibercept|aflibercept|mesh-list
139064769|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139064770|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139064772|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064773|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
139064774|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064775|NCT03869398|Calcitriol|calcitriol|mesh-list
139064776|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139064777|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064778|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138700510|NCT01237678|Carboplatin|carboplatin|mesh-list
139064779|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138911017|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064780|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064782|NCT03869398|Vitamins|vitamins|mesh-ancestor
139064783|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
139064784|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139064785|NCT01170052|Sirolimus|sirolimus|mesh-list
139064786|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139064787|NCT01170052|Temsirolimus|temsirolimus|mesh-list
139064788|NCT01170052|MTOR Inhibitors|mtor inhibitors|mesh-list
139064789|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139064790|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
139064791|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064792|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064793|NCT01170052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139064794|NCT01170052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064795|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139064796|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
139064797|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064798|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139064799|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064800|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139064801|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
138815378|NCT00614679|Tigecycline|tigecycline|mesh-list
139064802|NCT01284478|Dexamethasone|dexamethasone|mesh-list
139064803|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064805|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
139064806|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064807|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064808|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139064809|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
139064810|NCT01284478|Hormones|hormones|mesh-ancestor
139064811|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139064812|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138700550|NCT01237327|Exemestane|exemestane|mesh-list
139064813|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064814|NCT00252720|Candesartan|candesartan|mesh-list
139064815|NCT00252720|Candesartan cilexetil|candesartan cilexetil|mesh-list
138911152|NCT02603445|Idelalisib|idelalisib|mesh-list
139064816|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139064817|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138770221|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138255911|NCT02987270|Artenimol|artenimol|mesh-list
139064818|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139064819|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064820|NCT01284556|Phenobarbital|phenobarbital|mesh-list
139064821|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
139064822|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139064823|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139064824|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064825|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139064826|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139064827|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064828|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064829|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
139064830|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
139064831|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138911260|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
139064832|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139064833|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139064834|NCT01170130|Lidocaine|lidocaine|mesh-list
139064835|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
139064836|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
139064837|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139064838|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064839|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
139064840|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064841|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139064842|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139064843|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138700593|NCT04647344|Paclitaxel|paclitaxel|mesh-list
139064844|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139064845|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064846|NCT03868852|Apatinib|apatinib|mesh-list
139064847|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911332|NCT00815516|Amphotericin B|amphotericin b|mesh-list
139064848|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139064849|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064850|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064851|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
139064852|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139064853|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
139064855|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139064856|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139064857|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
139085259|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064858|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064859|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064860|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139064861|NCT01163500|Ubiquinone|ubiquinone|mesh-list
139064862|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
139064863|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
139064864|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064865|NCT01163500|Vitamins|vitamins|mesh-ancestor
139064866|NCT01163734|Ranolazine|ranolazine|mesh-list
139064867|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139064868|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139064869|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064870|NCT01284868|Propranolol|propranolol|mesh-list
139064871|NCT01284868|Bisoprolol|bisoprolol|mesh-list
139064872|NCT01284868|Mirabegron|mirabegron|mesh-list
139064873|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139064874|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139064875|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
139064876|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085260|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139064877|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064878|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064879|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139064880|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139064881|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
139064882|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139064883|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139064884|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138911585|NCT00810862|Lactitol|lactitol|mesh-list
139064885|NCT01284868|Urological Agents|urological agents|mesh-ancestor
139064886|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
139064887|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
139064888|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064889|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139064890|NCT01170442|Vitamin D|vitamin d|mesh-list
139064892|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
138256039|NCT04699383|Allopurinol|allopurinol|mesh-list
139064893|NCT01170442|Vitamins|vitamins|mesh-list
139064894|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
139064895|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064896|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139064897|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139064898|NCT00252564|Leucovorin|leucovorin|mesh-list
139064899|NCT00252564|Bevacizumab|bevacizumab|mesh-list
139064900|NCT00252564|Cetuximab|cetuximab|mesh-list
139064901|NCT00252564|Fluorouracil|fluorouracil|mesh-list
139064902|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
139064903|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139064904|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064905|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139064906|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139064907|NCT00252564|Growth Substances|growth substances|mesh-ancestor
139064908|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064909|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
139064910|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
139064911|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064912|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139064913|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139064914|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
139064915|NCT00252564|Antidotes|antidotes|mesh-ancestor
139064916|NCT00252564|Protective Agents|protective agents|mesh-ancestor
139064917|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
139064918|NCT00252564|Vitamins|vitamins|mesh-ancestor
139064919|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
139064920|NCT01284946|Deferasirox|deferasirox|mesh-list
139064921|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139064922|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
139064923|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
139064924|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064925|NCT01173562|Mebendazole|mebendazole|mesh-list
139064926|NCT01173562|Piperazine|piperazine|mesh-list
139064927|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
139064928|NCT01173562|DMP 777|dmp 777|mesh-list
139064929|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
139064930|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
138700664|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139064931|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139064932|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139064933|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
139064934|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
139064935|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
139064936|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064937|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139064938|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064939|NCT00166296|Escitalopram|escitalopram|mesh-list
139064940|NCT00166296|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139064941|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139064942|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139064943|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064944|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064945|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
139064946|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064947|NCT01173640|Midazolam|midazolam|mesh-list
139064948|NCT01173640|Resveratrol|resveratrol|mesh-list
139064949|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139064950|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139064951|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139064952|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815526|NCT03387657|Diuretics|diuretics|mesh-ancestor
139064954|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139064955|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139064956|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139064957|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
139064959|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
139064960|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
139064961|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064962|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064963|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
139064964|NCT01173640|Protective Agents|protective agents|mesh-ancestor
139064965|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139064966|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139064967|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139064968|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
139064969|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064970|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139064971|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
139064972|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139064973|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139064974|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139064975|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139064976|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139064977|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
139064978|NCT03868306|Chrysarobin|chrysarobin|mesh-list
139064979|NCT03868306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139064980|NCT03868306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139064981|NCT03868306|Analgesics|analgesics|mesh-ancestor
139064982|NCT03868306|Sensory System Agents|sensory system agents|mesh-ancestor
139064983|NCT03868306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139064984|NCT03868306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139064985|NCT03868306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139064986|NCT03868306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139064987|NCT01164046|Vitamin K|vitamin k|mesh-list
139064988|NCT01164046|Heparin|heparin|mesh-list
139064989|NCT01164046|Enoxaparin|enoxaparin|mesh-list
139064990|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139064991|NCT01164046|Tinzaparin|tinzaparin|mesh-list
139064992|NCT01164046|Dalteparin|dalteparin|mesh-list
139064993|NCT01164046|Nadroparin|nadroparin|mesh-list
139064994|NCT01164046|Reviparin|reviparin|mesh-list
139064995|NCT01164046|Warfarin|warfarin|mesh-list
139064996|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
139064997|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
139064998|NCT01164046|Bemiparin|bemiparin|mesh-list
139064999|NCT01164046|Certoparin|certoparin|mesh-list
139065000|NCT01164046|Vitamins|vitamins|mesh-ancestor
139065001|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
139065002|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065003|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
139065004|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139065005|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139065006|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065007|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139065008|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
139065009|NCT01164046|Coagulants|coagulants|mesh-ancestor
139065010|NCT01075464|Paclitaxel|paclitaxel|mesh-list
139065011|NCT01075464|Bevacizumab|bevacizumab|mesh-list
139065012|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139065013|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065014|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
139065015|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
139065016|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
139065017|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065018|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139065019|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139065020|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139065021|NCT01075464|Growth Substances|growth substances|mesh-ancestor
139065022|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065023|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
139065024|NCT01074996|Leucovorin|leucovorin|mesh-list
138256226|NCT05738564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139065026|NCT01074996|Protective Agents|protective agents|mesh-ancestor
139065027|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065028|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
139065029|NCT01074996|Vitamins|vitamins|mesh-ancestor
139065030|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
139065031|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
139065032|NCT00160524|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138700716|NCT00558662|Monensin|monensin|mesh-list
139065033|NCT00160524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139065034|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139065035|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
139065036|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065037|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139065038|NCT01077570|Repaglinide|repaglinide|mesh-list
139065039|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139065040|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065041|NCT01075698|Telmisartan|telmisartan|mesh-list
139065042|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139065043|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139065044|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139065045|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065046|NCT00159822|Voriconazole|voriconazole|mesh-list
139065047|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
139065048|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065049|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139065050|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139065051|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065052|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065053|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139065054|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
139065055|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700740|NCT02906163|Gefitinib|gefitinib|mesh-list
139065056|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065057|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139065058|NCT00158262|Propranolol|propranolol|mesh-list
139065059|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139065060|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139065061|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
139065062|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065063|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065064|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065065|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139065066|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139065067|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
139065068|NCT03868072|Tofacitinib|tofacitinib|mesh-list
139065069|NCT03868072|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139065070|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139065071|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065072|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065073|NCT02526394|Vaccines|vaccines|mesh-list
139065074|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
139065075|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065076|NCT01283932|Pantoprazole|pantoprazole|mesh-list
139065077|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139065078|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065079|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139065080|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065081|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065082|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139065083|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139065084|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065085|NCT01171378|Ofatumumab|ofatumumab|mesh-list
139065086|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065087|NCT01171456|Metformin|metformin|mesh-list
139065088|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139065089|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065090|NCT03865888|Cyclosporine|cyclosporine|mesh-list
139065091|NCT03865888|Tacrolimus|tacrolimus|mesh-list
139065092|NCT03865888|Cyclosporins|cyclosporins|mesh-list
138912309|NCT00791778|Sorafenib|sorafenib|mesh-list
139065093|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139065094|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
139065095|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065096|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139065097|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065098|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065099|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
139065100|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065101|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
139065102|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139065103|NCT01284166|Timolol|timolol|mesh-list
139065104|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139065105|NCT01284166|Dorzolamide|dorzolamide|mesh-list
139065106|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139065107|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139065108|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139065109|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139065110|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
139065111|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065112|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065113|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065114|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139065115|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139065116|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139065117|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139065118|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139065119|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139065120|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065121|NCT01285414|Temozolomide|temozolomide|mesh-list
139065122|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139065124|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065125|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065126|NCT01172002|Azathioprine|azathioprine|mesh-list
139065127|NCT01172002|Leflunomide|leflunomide|mesh-list
139065128|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
139065129|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065130|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139065131|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065132|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139065133|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
139065134|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065135|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139065136|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065137|NCT03867994|Carvedilol|carvedilol|mesh-list
139065138|NCT03867994|Atorvastatin|atorvastatin|mesh-list
139065139|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139065140|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139065141|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
139065142|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065143|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138912460|NCT00816244|Atorvastatin|atorvastatin|mesh-list
139065144|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139065145|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065146|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139065147|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139065148|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
139065149|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256319|NCT01707043|Betamethasone|betamethasone|mesh-list
139065150|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065151|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139065152|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
139065153|NCT03867994|Protective Agents|protective agents|mesh-ancestor
139065154|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139065155|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139065156|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139065157|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
139065158|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139065159|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139065160|NCT01172236|Lactoferrin|lactoferrin|mesh-list
139065161|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065162|NCT02525848|Dexamethasone|dexamethasone|mesh-list
139065163|NCT02525848|Gabapentin|gabapentin|mesh-list
139065164|NCT02525848|Aprepitant|aprepitant|mesh-list
139065165|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139065166|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
139065167|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
139065168|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065169|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065170|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065171|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
139065172|NCT02525848|Hormones|hormones|mesh-ancestor
139065173|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139065174|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139065175|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065176|NCT02525848|Analgesics|analgesics|mesh-ancestor
139065177|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
139065178|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
139065179|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139065180|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139065181|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139065183|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139065184|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139065185|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065186|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065187|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
139065188|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139065189|NCT01269112|Citric Acid|citric acid|mesh-list
139065190|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
139065192|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139065193|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
139065194|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
139065195|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065196|NCT01174420|Mitomycins|mitomycins|mesh-list
139065197|NCT01174420|Mitomycin|mitomycin|mesh-list
139065198|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139065199|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065200|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
139065201|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065202|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139065203|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065204|NCT01164826|Nabumetone|nabumetone|mesh-list
139065205|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139065206|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139065207|NCT01164826|Analgesics|analgesics|mesh-ancestor
139065208|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
139065209|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065210|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065211|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139065212|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139065213|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139065214|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139065215|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065216|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065217|NCT01172392|Interferons|interferons|mesh-list
139065218|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
139065219|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
139065220|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139065221|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065222|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
138912625|NCT00642460|Methotrexate|methotrexate|mesh-list
139065223|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065224|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
139065225|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065226|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
139065227|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139065228|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065229|NCT03864016|Sufentanil|sufentanil|mesh-list
139065230|NCT03864016|Dsuvia|dsuvia|mesh-list
139065231|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
139065232|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139065233|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065234|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139065235|NCT03864016|Narcotics|narcotics|mesh-ancestor
139065236|NCT03864016|Analgesics|analgesics|mesh-ancestor
139065237|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
139065238|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065239|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139065240|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139065241|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
139065242|NCT03860662|Baclofen|baclofen|mesh-list
139065243|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139065244|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065245|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139065246|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065247|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139065248|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
139065249|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
139065250|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065251|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065252|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
139065253|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
139065254|NCT01177852|Promethazine|promethazine|mesh-list
139065255|NCT01177852|Brompheniramine|brompheniramine|mesh-list
139065256|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
139065257|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
139065259|NCT01177852|Dipropizine|dipropizine|mesh-list
139065260|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065261|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139065262|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139065263|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139065264|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065265|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
139065266|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
139065267|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
139065268|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065269|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
139065270|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
139065271|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065272|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139065273|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
139065274|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
139065275|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065276|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139065277|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
139065278|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
139065279|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139065280|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139065281|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
139065282|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
139065283|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139065284|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138912725|NCT00641056|Exenatide|exenatide|mesh-list
139065285|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
139065286|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
139065287|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
139065288|NCT03863392|Misoprostol|misoprostol|mesh-list
139065289|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139065290|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
139065291|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139065292|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065293|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139065294|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065295|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
139065296|NCT01175200|Lansoprazole|lansoprazole|mesh-list
138256619|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
139065297|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
139065298|NCT01175200|Clopidogrel|clopidogrel|mesh-list
139065299|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
139065300|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139065301|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139065302|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139065303|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139065304|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
139065305|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065306|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065307|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065308|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139065309|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065310|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139065311|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065312|NCT03863626|Furosemide|furosemide|mesh-list
139065313|NCT03863626|Diuretics|diuretics|mesh-ancestor
139065314|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
139065315|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065316|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139065317|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139065318|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065319|NCT01178320|Niacin|niacin|mesh-list
139065320|NCT01178320|Niacinamide|niacinamide|mesh-list
139065321|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
139065322|NCT01178320|Simvastatin|simvastatin|mesh-list
139065323|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139065324|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139065325|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
139065326|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065327|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139065328|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139065329|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065330|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
139065331|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
139065333|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
139065334|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065335|NCT01175512|Naltrexone|naltrexone|mesh-list
139065336|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139065337|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139065338|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065339|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
139065340|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065341|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
139065342|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139065343|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065344|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065345|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139065346|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139065347|NCT03859570|Protective Agents|protective agents|mesh-ancestor
139065348|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065349|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
139065350|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139065352|NCT03745222|Tislelizumab|tislelizumab|mesh-list
139065353|NCT03745222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139065354|NCT03745222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065355|NCT01286584|Varenicline|varenicline|mesh-list
139065356|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139065357|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139065358|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
139065359|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065360|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065361|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065362|NCT03743038|Minocycline|minocycline|mesh-list
139065363|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139065364|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065365|NCT03864250|Prednisone|prednisone|mesh-list
139065366|NCT03864250|Tacrolimus|tacrolimus|mesh-list
139065367|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139065368|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
139065369|NCT03864250|Hormones|hormones|mesh-ancestor
139065370|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139065371|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065372|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139065373|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065374|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139065375|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
139065376|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139065377|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065378|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065379|NCT01175746|Nicardipine|nicardipine|mesh-list
139065380|NCT01175746|Remifentanil|remifentanil|mesh-list
139065381|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138256774|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
139065382|NCT01175746|Narcotics|narcotics|mesh-ancestor
139065383|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139065384|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065385|NCT01175746|Analgesics|analgesics|mesh-ancestor
139065386|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
139065387|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065388|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139065389|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139065390|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139065391|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065392|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139065393|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
139065395|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139065396|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065397|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139065398|NCT01174810|Incretins|incretins|mesh-ancestor
139065399|NCT01174810|Hormones|hormones|mesh-ancestor
139065400|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139065401|NCT01178710|Simvastatin|simvastatin|mesh-list
139065402|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139065403|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139065404|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
139065405|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065406|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139065407|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139065408|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065409|NCT01174888|Cytarabine|cytarabine|mesh-list
139065410|NCT01174888|Etoposide|etoposide|mesh-list
139065411|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
139065412|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
139065413|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
139065414|NCT01174888|Bortezomib|bortezomib|mesh-list
139065415|NCT01174888|Midostaurin|midostaurin|mesh-list
139065416|NCT01174888|Staurosporine|staurosporine|mesh-list
139065417|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139065418|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065419|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139065420|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139065421|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065422|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065423|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139065424|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
139065425|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
139065426|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065427|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139065428|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
139065429|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065430|NCT01174888|Analgesics|analgesics|mesh-ancestor
139065431|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
139065432|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065433|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
139065434|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
139065435|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
139065436|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
139065437|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
139065438|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139065439|NCT01178788|Progesterone|progesterone|mesh-list
139065440|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
139065441|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
139065442|NCT01178788|Progestins|progestins|mesh-ancestor
139065443|NCT01178788|Hormones|hormones|mesh-ancestor
139065444|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139065445|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065446|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139065447|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
139065448|NCT00153816|Vitamin D|vitamin d|mesh-list
139065449|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
139065450|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
139065451|NCT00153816|Calcium|calcium|mesh-list
139065452|NCT00153816|Vitamins|vitamins|mesh-ancestor
139065453|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
139065454|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065455|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139065456|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139065457|NCT00153816|Antacids|antacids|mesh-ancestor
139065458|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065459|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065460|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
139065461|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
138256927|NCT02975141|Afatinib|afatinib|mesh-list
139065462|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065463|NCT01077648|Trastuzumab|trastuzumab|mesh-list
139065464|NCT01077648|Lapatinib|lapatinib|mesh-list
139065465|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139065466|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065467|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139065468|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065469|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065470|NCT00151476|Celecoxib|celecoxib|mesh-list
139065471|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139065472|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139065473|NCT00151476|Analgesics|analgesics|mesh-ancestor
139065474|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
139065475|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065476|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065477|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139065478|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139065479|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139065480|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139065481|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065482|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816053|NCT01016912|Ribavirin|ribavirin|mesh-list
139065483|NCT01077726|Capecitabine|capecitabine|mesh-list
139065484|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139065485|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
139065486|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065488|NCT01179100|Lidocaine|lidocaine|mesh-list
139065489|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
139065490|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
139065491|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139065492|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065493|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
139065494|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065495|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139065496|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139065497|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139065498|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139065499|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065500|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
139065501|NCT03864172|Calcium|calcium|mesh-list
139065502|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139065503|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065504|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139065505|NCT02525302|Halofuginone|halofuginone|mesh-list
139065506|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065507|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
139065508|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139065509|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139065510|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065511|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139065512|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065513|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912951|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
139065515|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139065516|NCT02525302|Growth Substances|growth substances|mesh-ancestor
139065517|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065518|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
139065519|NCT01286194|Rabeprazole|rabeprazole|mesh-list
139065520|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139065521|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065522|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138701117|NCT00559676|Vitamins|vitamins|mesh-ancestor
139065523|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065524|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065526|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139065527|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139065528|NCT01179256|Analgesics|analgesics|mesh-ancestor
139065529|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
139065530|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065531|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065532|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139065533|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139065534|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065535|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065536|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065537|NCT01179412|Iodine|iodine|mesh-list
139065538|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
139065539|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
139065540|NCT01179412|Povidone|povidone|mesh-list
138912976|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065541|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139065542|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065543|NCT01179412|Trace Elements|trace elements|mesh-ancestor
139065544|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
139065545|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065546|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
139065547|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
139065548|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139065549|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139065550|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065551|NCT03862768|Sunitinib|sunitinib|mesh-list
139065552|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
139065553|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257060|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139065554|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138701162|NCT04680819|Propolis|propolis|mesh-list
139065555|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138816133|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
139065557|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065558|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
139065559|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139065560|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065561|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065562|NCT03862456|Azithromycin|azithromycin|mesh-list
139065563|NCT03862456|Metronidazole|metronidazole|mesh-list
139065564|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139065565|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065566|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139065567|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139065568|NCT03859102|Acetaminophen|acetaminophen|mesh-list
139065569|NCT03859102|Dexamethasone|dexamethasone|mesh-list
139065570|NCT03859102|Gabapentin|gabapentin|mesh-list
139065571|NCT03859102|Ondansetron|ondansetron|mesh-list
139065572|NCT03859102|Anesthetics|anesthetics|mesh-list
139065573|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
139065574|NCT03859102|Lansoprazole|lansoprazole|mesh-list
139065575|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
139065576|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139065577|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
139065579|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138257088|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
139065580|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065581|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065582|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
139065583|NCT03859102|Hormones|hormones|mesh-ancestor
139065584|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139065585|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139065586|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349431|NCT02684136|Suvorexant|suvorexant|mesh-list
139065587|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139065588|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139065589|NCT03859102|Analgesics|analgesics|mesh-ancestor
139065590|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
139065591|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
139065592|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
139065593|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139065594|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139065595|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139065596|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139065597|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138913065|NCT00640042|Analgesics|analgesics|mesh-ancestor
139065598|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065599|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065600|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
139065601|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
139065602|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
139065603|NCT03859102|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139065604|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138913130|NCT05753696|Losartan|losartan|mesh-list
139065606|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139065607|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138913187|NCT00806624|Warfarin|warfarin|mesh-list
139065608|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065609|NCT00149994|Cyclosporine|cyclosporine|mesh-list
139065610|NCT00149994|Prednisone|prednisone|mesh-list
139065611|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
139065612|NCT00149994|Tacrolimus|tacrolimus|mesh-list
139065613|NCT00149994|Cyclosporins|cyclosporins|mesh-list
139065614|NCT00149994|Basiliximab|basiliximab|mesh-list
139065615|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139065616|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
139065617|NCT00149994|Hormones|hormones|mesh-ancestor
139065618|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139065619|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065620|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139065621|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065622|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139065623|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
138913270|NCT02549326|Vitamin D|vitamin d|mesh-list
139065624|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139065625|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065626|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065627|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
139065628|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065629|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
138816208|NCT04298684|Metformin|metformin|mesh-list
139065630|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139065631|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
139065632|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
139065633|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913383|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
139065634|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065635|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139065637|NCT01179646|Pantoprazole|pantoprazole|mesh-list
139065638|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139065639|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065640|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139065641|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065642|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065643|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
139065644|NCT01075776|Acetylcholine|acetylcholine|mesh-list
139065645|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
139065646|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139065647|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
139065648|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065649|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065650|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065651|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
139065652|NCT01079910|Fluorides|fluorides|mesh-list
139065653|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
139065654|NCT01079910|Protective Agents|protective agents|mesh-ancestor
139065655|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065656|NCT01286896|Sunitinib|sunitinib|mesh-list
139065657|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065658|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139065659|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139065660|NCT01286896|Growth Substances|growth substances|mesh-ancestor
139065661|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065662|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
139065663|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139065664|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065665|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065666|NCT03857854|Pirfenidone|pirfenidone|mesh-list
139065667|NCT03857854|Analgesics|analgesics|mesh-ancestor
139065668|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
139065669|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065670|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065671|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139065672|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139065673|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139065674|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139065675|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065677|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139065678|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
139065679|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
139065680|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139065681|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065682|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139065683|NCT01287052|Analgesics|analgesics|mesh-ancestor
139065684|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
139065685|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065686|NCT01288924|Parecoxib|parecoxib|mesh-list
138913870|NCT04102566|Ibuprofen|ibuprofen|mesh-list
139065687|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139065688|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139065689|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065690|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065691|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139065692|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138257270|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065693|NCT01288924|Analgesics|analgesics|mesh-ancestor
139065694|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
139065695|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065696|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065697|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139065698|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139065699|NCT01179724|Pantoprazole|pantoprazole|mesh-list
139065700|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139065701|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139065702|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065703|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065704|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065705|NCT03862612|Anesthetics|anesthetics|mesh-list
139065706|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139065707|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065708|NCT01287130|Cetuximab|cetuximab|mesh-list
139065709|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139065710|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065711|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
139065712|NCT00149214|Docetaxel|docetaxel|mesh-list
139065713|NCT00149214|Doxorubicin|doxorubicin|mesh-list
139065715|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139065716|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
139065717|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065718|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139065719|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138914062|NCT00838240|Idarubicin|idarubicin|mesh-list
139065721|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065722|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065723|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139065724|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
139065725|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
139065726|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
139065727|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139065728|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139065729|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139065730|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065731|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139065732|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139065733|NCT03034018|Suvorexant|suvorexant|mesh-list
139065734|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139065735|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139065736|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138914202|NCT00840112|Vitamins|vitamins|mesh-ancestor
139065738|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
139065739|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065740|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065741|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
139065742|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
139065743|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
139065744|NCT02525458|Protective Agents|protective agents|mesh-ancestor
139065745|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065746|NCT02555254|Methamphetamine|methamphetamine|mesh-list
139065747|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139065748|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065749|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
139065750|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
139065751|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065752|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
139065753|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914255|NCT00840346|Panobinostat|panobinostat|mesh-list
139065754|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065755|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
139065756|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139065757|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139065758|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139065759|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139065760|NCT00114972|Paclitaxel|paclitaxel|mesh-list
139065761|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139065762|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139065763|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065764|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
139065765|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
139065766|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
139065767|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065768|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
139065769|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
139065770|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
139065771|NCT02444728|Azathioprine|azathioprine|mesh-list
139065772|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139065773|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
139065774|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065775|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139065776|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139065777|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
139065778|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065779|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065780|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139065781|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139065782|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
139065783|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
139065784|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138257439|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139065785|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065786|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
139065787|NCT02444728|Hormones|hormones|mesh-ancestor
139065788|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139065789|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138701373|NCT02904369|Tenofovir|tenofovir|mesh-list
139065790|NCT02444728|Protective Agents|protective agents|mesh-ancestor
139065791|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
138566526|NCT05633966|Hormones|hormones|mesh-list
139065792|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139065793|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139065794|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065795|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065796|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
139065797|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139065799|NCT00129402|Ezetimibe|ezetimibe|mesh-list
139065800|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139065801|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139065802|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
139065803|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065804|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139065805|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139065806|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065807|NCT03739528|Levofloxacin|levofloxacin|mesh-list
139065808|NCT03739528|Ofloxacin|ofloxacin|mesh-list
139065809|NCT03739528|Tobramycin|tobramycin|mesh-list
139065810|NCT03739528|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
139065811|NCT03739528|Dexamethasone|dexamethasone|mesh-list
139065812|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
139065813|NCT03739528|BB 1101|bb 1101|mesh-list
139065814|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139065815|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
139065816|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
139065817|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065818|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065819|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065820|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
139065821|NCT03739528|Hormones|hormones|mesh-ancestor
139065822|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139065823|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139065824|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065825|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
139065826|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065827|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065828|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139065829|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065830|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139065831|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139065832|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138701404|NCT02894892|Antacids|antacids|mesh-ancestor
139065833|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139065834|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139065835|NCT03739528|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139065836|NCT03739528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139065837|NCT03857386|Anesthetics|anesthetics|mesh-list
139065838|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139065839|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065840|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138257537|NCT00003141|Carboplatin|carboplatin|mesh-list
139065841|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
139065842|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139065843|NCT01289236|Milnacipran|milnacipran|mesh-list
139065844|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
139065845|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139065846|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139065847|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139065848|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065849|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065850|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065851|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139065852|NCT01289236|Analgesics|analgesics|mesh-ancestor
139065853|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
139065854|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065855|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
139065856|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139065857|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
139065858|NCT01289938|Promethazine|promethazine|mesh-list
139065859|NCT01289938|Metoclopramide|metoclopramide|mesh-list
139065860|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139065861|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139065862|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138257588|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
139065863|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065864|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
139065865|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
139065866|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
139065867|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065868|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
139065870|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065871|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139065872|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
139065873|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
139065874|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065875|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065876|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139065877|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
139065878|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
139065879|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139065880|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139065881|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
139065883|NCT00114738|Bortezomib|bortezomib|mesh-list
139065884|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139065885|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065886|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
139065887|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065888|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139065889|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
139065890|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139065891|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139065892|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139065893|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139065894|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065895|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
139065896|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065897|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065898|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138701468|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
139065899|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065900|NCT01180426|Tosedostat|tosedostat|mesh-list
139065901|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065902|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065904|NCT00148122|Capecitabine|capecitabine|mesh-list
139065905|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065906|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
139065907|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
138915047|NCT04104984|Progesterone|progesterone|mesh-list
139065908|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
139065909|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065910|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139065911|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
139065912|NCT01182142|Capecitabine|capecitabine|mesh-list
139065913|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139065914|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
139065915|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065916|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065917|NCT01180816|Temozolomide|temozolomide|mesh-list
139065918|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139065919|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
139065920|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065921|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065922|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
139065923|NCT01287598|Midazolam|midazolam|mesh-list
139065924|NCT01287598|Omeprazole|omeprazole|mesh-list
139065925|NCT01287598|Warfarin|warfarin|mesh-list
139065926|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139065927|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139065928|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139065929|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065930|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139065931|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139065932|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139065933|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139065934|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
139065936|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
139065937|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
139065938|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065939|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065940|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
139065941|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139065942|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139065943|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139065944|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065945|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139065947|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
139065948|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
139065949|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139065950|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065951|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138701518|NCT04633733|Tacrolimus|tacrolimus|mesh-list
139065952|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139065953|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139065954|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
139065955|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065956|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257745|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139065957|NCT01290172|Somatostatin|somatostatin|mesh-list
139065958|NCT01290172|Hormones|hormones|mesh-ancestor
139065959|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139065960|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065961|NCT03861598|Carvedilol|carvedilol|mesh-list
139065962|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139065963|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139065964|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
139065965|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139065966|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065967|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065968|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139065969|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
139065970|NCT03861598|Protective Agents|protective agents|mesh-ancestor
139065971|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139065972|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139065973|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139065974|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
139065975|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139065976|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139065977|NCT01184482|Cetuximab|cetuximab|mesh-list
139065978|NCT01184482|Lapatinib|lapatinib|mesh-list
139065979|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139065980|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139065981|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139065982|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139065983|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065985|NCT01184560|Sibutramine|sibutramine|mesh-list
139065986|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915491|NCT04097847|Vitamin E|vitamin e|mesh-list
139065987|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139065988|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139065989|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138701542|NCT05427903|Autonomic Agents|autonomic agents|mesh-ancestor
139065990|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
139065991|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139065992|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
139065993|NCT01184638|Propofol|propofol|mesh-list
139065994|NCT01184638|Sevoflurane|sevoflurane|mesh-list
139065995|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139065996|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139065997|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139065998|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139065999|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
139066000|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
139066001|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138915631|NCT00831701|Urological Agents|urological agents|mesh-ancestor
139066002|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139066003|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
139066004|NCT01290328|Hematinics|hematinics|mesh-ancestor
139066005|NCT01184716|Vitamin D|vitamin d|mesh-list
139066006|NCT01184716|Vitamins|vitamins|mesh-ancestor
139066007|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
138915700|NCT00916890|Analgesics|analgesics|mesh-ancestor
139066008|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066009|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139066010|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
139066011|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
139066012|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
139066013|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066014|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066015|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
139066016|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066017|NCT01587508|Meloxicam|meloxicam|mesh-list
139066018|NCT01587508|Amitriptyline|amitriptyline|mesh-list
139066019|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
139066020|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139066021|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139066022|NCT01587508|Analgesics|analgesics|mesh-ancestor
139066023|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
139066024|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066025|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066026|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139066027|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139066028|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139066029|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139066030|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066031|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066032|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139066033|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
139066034|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139066035|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139066036|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139066037|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138701579|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066038|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066039|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139066040|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139066041|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139066042|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
139066043|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066044|NCT00147498|Tofacitinib|tofacitinib|mesh-list
139066045|NCT00147498|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139066046|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139066047|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066048|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066049|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139066050|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
139066051|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066052|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066053|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139066054|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066055|NCT01080066|Cetuximab|cetuximab|mesh-list
139066056|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139066057|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066058|NCT01185184|Tofacitinib|tofacitinib|mesh-list
139066059|NCT01185184|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139066060|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139066061|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066062|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066063|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
139066064|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139066065|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139066066|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066067|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
139066068|NCT00113568|Coagulants|coagulants|mesh-ancestor
139066069|NCT01185262|Rituximab|rituximab|mesh-list
139066070|NCT01185262|Lenalidomide|lenalidomide|mesh-list
139066071|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139066072|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066073|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
139066074|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066075|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139066076|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139066077|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139066078|NCT01185262|Growth Substances|growth substances|mesh-ancestor
139066079|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
139066080|NCT00113490|Palivizumab|palivizumab|mesh-list
139066081|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
139066082|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139066084|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139066085|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
139066087|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139066088|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066089|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139066090|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066092|NCT01185418|Risperidone|risperidone|mesh-list
139066093|NCT01185418|Aripiprazole|aripiprazole|mesh-list
139066094|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
139066095|NCT01185418|Amisulpride|amisulpride|mesh-list
139066096|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139066097|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
139066098|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066099|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066100|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066101|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139066102|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139066103|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066104|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139066105|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139066106|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
139066107|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
139066108|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
139066109|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139066110|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138916132|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139066111|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139066112|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139066113|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
139066114|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
139066115|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066116|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139066117|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139066118|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139066119|NCT01185574|Vitamin D|vitamin d|mesh-list
139066120|NCT01185574|Vitamins|vitamins|mesh-ancestor
139066121|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
139066122|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066123|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139066124|NCT03861364|Propofol|propofol|mesh-list
139066125|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139066126|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066127|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066128|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139066129|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
139066130|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
139066131|NCT01185808|Vitamin D|vitamin d|mesh-list
138257948|NCT01783561|Caffeine|caffeine|mesh-list
139066133|NCT01185808|Cholecalciferol|cholecalciferol|mesh-list
139066134|NCT01185808|Vitamins|vitamins|mesh-list
139066135|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
139066136|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066137|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139066138|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139066139|NCT01183624|Analgesics|analgesics|mesh-list
139066140|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
139066141|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066142|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066143|NCT01291186|Epinephrine|epinephrine|mesh-list
139066144|NCT01291186|Racepinephrine|racepinephrine|mesh-list
138701626|NCT01225549|Budesonide|budesonide|mesh-list
139066145|NCT01291186|Bupivacaine|bupivacaine|mesh-list
139066146|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
139066147|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
139066148|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
139066149|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066150|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066151|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
139066152|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066153|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139066154|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139066155|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
139066156|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066157|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066158|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139066159|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139066161|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139066162|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
139066164|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
139066165|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139066166|NCT04979338|Bupivacaine|bupivacaine|mesh-list
139066167|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
139066168|NCT04979338|Anesthetics|anesthetics|mesh-list
139066169|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066170|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066171|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
139066172|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066173|NCT01177306|Guanfacine|guanfacine|mesh-list
139066174|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139066175|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139066176|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139066177|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139066178|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
138916433|NCT02597322|Axitinib|axitinib|mesh-list
139066179|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066180|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066181|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066183|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066184|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
139066185|NCT03854812|Fentanyl|fentanyl|mesh-list
139066186|NCT03854812|Propofol|propofol|mesh-list
139066187|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139066188|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066189|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066190|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139066191|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
139066192|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
139066193|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139066194|NCT03854812|Narcotics|narcotics|mesh-ancestor
139066195|NCT03854812|Analgesics|analgesics|mesh-ancestor
139066196|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
138258027|NCT02115997|Hormones|hormones|mesh-ancestor
139066198|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139066199|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139066200|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
139066201|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139066202|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139066203|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066204|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139066205|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
139066206|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139066208|NCT01186120|Everolimus|everolimus|mesh-list
139066209|NCT01186120|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139066210|NCT01186120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139066211|NCT01186120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066212|NCT01186120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066213|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139066214|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
139066215|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066216|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066217|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139066218|NCT03855826|Amiodarone|amiodarone|mesh-list
139066219|NCT03855826|Nifekalant|nifekalant|mesh-list
139066220|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139066221|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
139066222|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139066223|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139066224|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066225|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139066226|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138701687|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
139066227|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139066228|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066229|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139066230|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139066231|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139066232|NCT01184404|Bosentan|bosentan|mesh-list
139066233|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138916669|NCT00731679|Rifaximin|rifaximin|mesh-list
139066234|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139066235|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066236|NCT01186588|Canagliflozin|canagliflozin|mesh-list
139066237|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139066238|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066239|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139066240|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066241|NCT03854266|Heparin|heparin|mesh-list
139066242|NCT03854266|Calcium heparin|calcium heparin|mesh-list
139066243|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139066244|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
139066245|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139066246|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139085261|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139066247|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066248|NCT01187992|Atorvastatin|atorvastatin|mesh-list
139066249|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139066250|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139066251|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
139066252|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066253|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139066254|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139066255|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066256|NCT01191034|Imiquimod|imiquimod|mesh-list
139066257|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139066258|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
139066259|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066260|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066261|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
139066262|NCT01188148|Memantine|memantine|mesh-list
139066263|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139066264|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139066265|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
139066266|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066267|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066268|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066269|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139066270|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139066271|NCT01187212|Cisplatin|cisplatin|mesh-list
139066272|NCT01187212|Capecitabine|capecitabine|mesh-list
139066273|NCT01187212|Sorafenib|sorafenib|mesh-list
139066274|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066275|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139066276|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
139066277|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066278|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139066279|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066280|NCT03849508|Phenylephrine|phenylephrine|mesh-list
139066281|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
139066282|NCT03849508|Norepinephrine|norepinephrine|mesh-list
139066283|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139066285|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
139066286|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066287|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066288|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
139066289|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139066290|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
139066291|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
139066292|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139066293|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139066294|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139066295|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
139066296|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066297|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066298|NCT03849508|Protective Agents|protective agents|mesh-ancestor
139066299|NCT03849664|Niacinamide|niacinamide|mesh-list
139066300|NCT03849664|Niacin|niacin|mesh-list
139066301|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
139066302|NCT03849664|Riboflavin|riboflavin|mesh-list
139066303|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
139066304|NCT03849664|Povidone|povidone|mesh-list
139066305|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139066306|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066307|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
139066308|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
139066309|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
139066310|NCT03849664|Vitamins|vitamins|mesh-ancestor
139066311|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
139066312|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139066313|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
139066314|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066315|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139066316|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
139066317|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139066318|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
139066319|NCT01293838|Escitalopram|escitalopram|mesh-list
139066320|NCT01293838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139066321|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139066322|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139066323|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066324|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066325|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
139066326|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066327|NCT01188304|Aspirin|aspirin|mesh-list
139066328|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139066329|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139066330|NCT01188304|Analgesics|analgesics|mesh-ancestor
139066331|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
139066332|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066333|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066334|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139066335|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139066336|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139066337|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139066338|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066339|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139066340|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139066341|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066342|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
139066343|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
139066344|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
139066345|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139066346|NCT02524444|Mefloquine|mefloquine|mesh-list
139066347|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
139066348|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139066349|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139066350|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139066351|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139066352|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066353|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066354|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139066355|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
139066356|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139066357|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
139066358|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066359|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066360|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139066361|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
139066362|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139066363|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
139066364|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066365|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066366|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139066367|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
139066368|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
139066369|NCT03853642|Protective Agents|protective agents|mesh-ancestor
138917213|NCT00801632|Prednisone|prednisone|mesh-list
139066370|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
139066371|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139066372|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
139066373|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066374|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066375|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139066376|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
139066377|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139066378|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139066379|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139066380|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
139066381|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085262|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
139066382|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066384|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139066385|NCT01291654|Analgesics|analgesics|mesh-ancestor
139066386|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
139066387|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066388|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066389|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
139066390|NCT03853096|Cefazolin|cefazolin|mesh-list
139066391|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138917343|NCT00800540|Timolol|timolol|mesh-list
139066392|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139066393|NCT05671276|Aspirin|aspirin|mesh-list
139066394|NCT05671276|Rivaroxaban|rivaroxaban|mesh-list
139066395|NCT05671276|Clopidogrel|clopidogrel|mesh-list
139066396|NCT05671276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139066397|NCT05671276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139066398|NCT05671276|Analgesics|analgesics|mesh-ancestor
139066399|NCT05671276|Sensory System Agents|sensory system agents|mesh-ancestor
138701814|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139066400|NCT05671276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066401|NCT05671276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066402|NCT05671276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139066403|NCT05671276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139066404|NCT05671276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139066405|NCT05671276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139066406|NCT05671276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066407|NCT05671276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139066408|NCT05671276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139066409|NCT05671276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066410|NCT05671276|Antipyretics|antipyretics|mesh-ancestor
139066411|NCT05671276|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139066412|NCT05671276|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139066413|NCT05671276|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139066414|NCT05671276|Purinergic Agents|purinergic agents|mesh-ancestor
139066415|NCT05671276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066416|NCT05671276|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139066417|NCT05671276|Antithrombins|antithrombins|mesh-ancestor
139066418|NCT05671276|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139066419|NCT05671276|Protease Inhibitors|protease inhibitors|mesh-ancestor
139066420|NCT05671276|Anticoagulants|anticoagulants|mesh-ancestor
139066421|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139066422|NCT03852160|Mirtazapine|mirtazapine|mesh-list
139066423|NCT03852160|Trazodone|trazodone|mesh-list
139066424|NCT03852160|Agomelatine|agomelatine|mesh-list
139066425|NCT03852160|Bupropion|bupropion|mesh-list
139066426|NCT03852160|Sertraline|sertraline|mesh-list
139066427|NCT03852160|Esketamine|esketamine|mesh-list
139066428|NCT03852160|Escitalopram|escitalopram|mesh-list
139066429|NCT03852160|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139066430|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139066431|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139066432|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066433|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066434|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
139066435|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066436|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066437|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139066438|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
139066439|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139066440|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139066441|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
138258236|NCT02471651|Hormones|hormones|mesh-ancestor
139066442|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139066443|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139066444|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701841|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139066445|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139066446|NCT03852160|Analgesics|analgesics|mesh-ancestor
139066447|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
139066448|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139066449|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
139066450|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
139066451|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139066452|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139066453|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066454|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138817024|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066455|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139066456|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139066457|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
139066458|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139066459|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139066460|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139066461|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139066463|NCT02524210|Rabeprazole|rabeprazole|mesh-list
139066464|NCT02524210|Dabigatran|dabigatran|mesh-list
138917638|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
139066465|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139066466|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139066467|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139066468|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066469|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066470|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
139066471|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139066472|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
139066473|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
139066474|NCT03847792|Dexamethasone|dexamethasone|mesh-list
139066475|NCT03847792|Fentanyl|fentanyl|mesh-list
139066476|NCT03847792|Bupivacaine|bupivacaine|mesh-list
138917776|NCT02603822|Analgesics|analgesics|mesh-ancestor
139066477|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139066478|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
139066479|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
139066480|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066481|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066482|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139066483|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
139066484|NCT03847792|Hormones|hormones|mesh-ancestor
139066485|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139066486|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139066487|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066488|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
139066489|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
139066490|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066491|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
138917852|NCT00791258|Amlodipine|amlodipine|mesh-list
139066492|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139066493|NCT03847792|Narcotics|narcotics|mesh-ancestor
139066494|NCT03847792|Analgesics|analgesics|mesh-ancestor
139066495|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139066496|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139066497|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
139066498|NCT01294618|Interferons|interferons|mesh-list
139066499|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066500|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
139066501|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139066502|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
139066503|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
138917904|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
139066504|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139066505|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139066506|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066507|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066508|NCT01194232|Urological Agents|urological agents|mesh-ancestor
139066509|NCT01296334|Morphine|morphine|mesh-list
139066510|NCT01296334|Buprenorphine|buprenorphine|mesh-list
139066511|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139066512|NCT01296334|Narcotics|narcotics|mesh-ancestor
139066513|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066514|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066515|NCT01296334|Analgesics|analgesics|mesh-ancestor
139066516|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
139066517|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066518|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139066519|NCT03847558|Hormones|hormones|mesh-list
139066520|NCT03847558|Testosterone|testosterone|mesh-list
139066521|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138770222|NCT02658721|Narcotics|narcotics|mesh-ancestor
139066522|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139066523|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066524|NCT03847558|Androgens|androgens|mesh-ancestor
139066525|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
139066526|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
139066527|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
139066528|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139066529|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139066530|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066531|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066532|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066533|NCT01292356|Cetuximab|cetuximab|mesh-list
139066534|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139066535|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066536|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139066537|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
139066538|NCT03847246|Entecavir|entecavir|mesh-list
139066539|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
139066540|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139066541|NCT03849196|Bisacodyl|bisacodyl|mesh-list
139066542|NCT03849196|Cathartics|cathartics|mesh-ancestor
139066543|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139066544|NCT03849196|Laxatives|laxatives|mesh-ancestor
139066545|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
139066546|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
139066547|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139066548|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
139066549|NCT01296802|Fenfluramine|fenfluramine|mesh-list
139066550|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
139066551|NCT01296802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139066552|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139066553|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139066554|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066555|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066556|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
139066557|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066558|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139066559|NCT01296958|Niclosamide|niclosamide|mesh-list
139066560|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
139066561|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139066562|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
139066563|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139066564|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139066565|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
139066566|NCT01295086|Docetaxel|docetaxel|mesh-list
139066567|NCT01295086|Capecitabine|capecitabine|mesh-list
139066568|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
139066569|NCT01295086|Trastuzumab|trastuzumab|mesh-list
139066570|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066571|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
139066572|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
139066573|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
139066574|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066575|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138258353|NCT02416193|Vitamin D|vitamin d|mesh-list
139066576|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
139066577|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139066578|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
139066579|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139066580|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
139066581|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066582|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066583|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139066584|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
139066585|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
139066586|NCT01194700|Hormones|hormones|mesh-ancestor
139066587|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139066588|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
139066589|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139066590|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
139066591|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139066592|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139066593|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139066594|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066595|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066596|NCT01194778|Vitamins|vitamins|mesh-list
139066597|NCT01194778|Vitamin K|vitamin k|mesh-list
139066598|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
139066599|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
139066600|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
139066601|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066602|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139066603|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139066604|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066605|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
139066606|NCT01194778|Coagulants|coagulants|mesh-ancestor
138258370|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139066607|NCT01194934|Lenograstim|lenograstim|mesh-list
139066608|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139066609|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
139066610|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066612|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139066613|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066614|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066615|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
139066616|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918628|NCT04107194|Antacids|antacids|mesh-ancestor
139066617|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066618|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
139066621|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
139066622|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139066623|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066624|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139066625|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138770223|NCT02658721|Analgesics|analgesics|mesh-ancestor
138258413|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139066626|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066628|NCT03848806|Vitamins|vitamins|mesh-ancestor
139066629|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
139066630|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139066631|NCT01189864|Diclofenac|diclofenac|mesh-list
139066632|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
139066633|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139066634|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
139066635|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139066636|NCT01189864|Prednisolone|prednisolone|mesh-list
139066637|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139066638|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
138701938|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
139066639|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139066640|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139066641|NCT01189864|Analgesics|analgesics|mesh-ancestor
139066642|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
139066643|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066644|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066645|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139066646|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139066647|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139066648|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066649|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066650|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
139066651|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
139066652|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139066653|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
139066654|NCT01189864|Hormones|hormones|mesh-ancestor
139066655|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139066656|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139066657|NCT01189864|Protective Agents|protective agents|mesh-ancestor
138918736|NCT05324163|Sensory System Agents|sensory system agents|mesh-ancestor
139066659|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258529|NCT05324995|Celecoxib|celecoxib|mesh-list
139066660|NCT01195246|Vaccines|vaccines|mesh-list
139066661|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
139066662|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918794|NCT00729690|Pregabalin|pregabalin|mesh-list
139066664|NCT01191892|Gemcitabine|gemcitabine|mesh-list
139066665|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066666|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139066667|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
139066668|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066669|NCT01293058|Naloxone|naloxone|mesh-list
139066670|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139066671|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066672|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
139066673|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066674|NCT01195324|Canagliflozin|canagliflozin|mesh-list
139066675|NCT01195324|Warfarin|warfarin|mesh-list
139066676|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
139066677|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139066678|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066679|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139066680|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066681|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
139066682|NCT01293136|Narcotics|narcotics|mesh-ancestor
139066683|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066684|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066686|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
138817251|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
139066687|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066688|NCT01293292|Teriparatide|teriparatide|mesh-list
139066689|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139066690|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918924|NCT00774800|Insulin|insulin|mesh-list
139066691|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139066692|NCT01195714|Ofatumumab|ofatumumab|mesh-list
139066693|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066694|NCT01190722|Diclofenac|diclofenac|mesh-list
139066695|NCT01190722|Etoricoxib|etoricoxib|mesh-list
139066696|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139066697|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139066698|NCT01190722|Analgesics|analgesics|mesh-ancestor
139066699|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
139066700|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066701|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066702|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139066703|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139066704|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139066705|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919057|NCT00766142|Vitamins|vitamins|mesh-ancestor
139066706|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066707|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139066708|NCT01196260|Capecitabine|capecitabine|mesh-list
139066709|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
139066710|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139066711|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
138258631|NCT05747521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258638|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
139066712|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066713|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066714|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
139066715|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066716|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139066717|NCT01193296|Vildagliptin|vildagliptin|mesh-list
139066718|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139066719|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066720|NCT01193296|Incretins|incretins|mesh-ancestor
139066721|NCT01193296|Hormones|hormones|mesh-ancestor
139066722|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139066723|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139066724|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
139066725|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066726|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066727|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
139066728|NCT01197040|Prednisone|prednisone|mesh-list
139066729|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139066730|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
139066731|NCT01197040|Hormones|hormones|mesh-ancestor
139066732|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139066733|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066734|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139066735|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066736|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139066737|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139066738|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
139066739|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139066740|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139066741|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066742|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066743|NCT01193452|Leucovorin|leucovorin|mesh-list
139066744|NCT01193452|Fluorouracil|fluorouracil|mesh-list
139066745|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
139066746|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
139066747|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066748|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138702065|NCT02901288|Levofloxacin|levofloxacin|mesh-list
139066749|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066750|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139066751|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
139066752|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066753|NCT01193452|Antidotes|antidotes|mesh-ancestor
139066754|NCT01193452|Protective Agents|protective agents|mesh-ancestor
139066755|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
139066757|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
139066758|NCT05670886|Carbetocin|carbetocin|mesh-list
138817335|NCT02586649|Bromides|bromides|mesh-list
139066759|NCT05670886|Oxytocics|oxytocics|mesh-ancestor
139066760|NCT05670886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139066761|NCT05670886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066762|NCT01295632|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
139066763|NCT01295632|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139066764|NCT01295632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066765|NCT01295632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066766|NCT03844594|Eptifibatide|eptifibatide|mesh-list
139066767|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139066768|NCT03848182|Gemcitabine|gemcitabine|mesh-list
139066769|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139066770|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
139066771|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066772|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066774|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139066775|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139066776|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
139066777|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139066778|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
139066779|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
139066780|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139066781|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
139066782|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066783|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066784|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139066785|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
138919425|NCT02586987|Durvalumab|durvalumab|mesh-list
139066786|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139066787|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
138788174|NCT00640588|Adefovir|adefovir|mesh-list
139066788|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066789|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066790|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139066791|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
139066792|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
139066793|NCT01295866|Protective Agents|protective agents|mesh-ancestor
139066794|NCT03848104|Cefoxitin|cefoxitin|mesh-list
139066795|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139066796|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139066797|NCT05670808|Epinephrine|epinephrine|mesh-list
139066798|NCT05670808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139066799|NCT05670808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139066800|NCT05670808|Adrenergic Agents|adrenergic agents|mesh-ancestor
139066801|NCT05670808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066802|NCT05670808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066803|NCT05670808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066804|NCT05670808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139066805|NCT05670808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139066806|NCT05670808|Autonomic Agents|autonomic agents|mesh-ancestor
139066807|NCT05670808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066808|NCT05670808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139066809|NCT05670808|Respiratory System Agents|respiratory system agents|mesh-ancestor
139066810|NCT05670808|Mydriatics|mydriatics|mesh-ancestor
139066811|NCT05670808|Sympathomimetics|sympathomimetics|mesh-ancestor
139066812|NCT05670808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139066813|NCT01197664|Fluorouracil|fluorouracil|mesh-list
139066814|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
139066815|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066816|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139066817|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066818|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139066819|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
139066820|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066822|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139066823|NCT01199458|Narcotics|narcotics|mesh-ancestor
139066824|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066825|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066826|NCT01199458|Analgesics|analgesics|mesh-ancestor
139066827|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
139066828|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066829|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139066830|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
139066831|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
139066832|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
139066833|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066834|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139066835|NCT01588522|Calcitriol|calcitriol|mesh-list
139066836|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139066837|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066838|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139066839|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138919539|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
139066840|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066841|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139066844|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139066846|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138919603|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
139066847|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066848|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139066849|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139066850|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066851|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066852|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139066853|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138919663|NCT00761774|Brivaracetam|brivaracetam|mesh-list
139066854|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
139066855|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066856|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066857|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139066858|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
139066859|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066860|NCT03730012|Atezolizumab|atezolizumab|mesh-list
138571754|NCT00133848|Retapamulin|retapamulin|mesh-list
139066861|NCT03730012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139066862|NCT03730012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066863|NCT03730012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139066864|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066865|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
139066866|NCT03844360|Bortezomib|bortezomib|mesh-list
139066867|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
139066868|NCT03844360|Dasatinib|dasatinib|mesh-list
139066869|NCT03844360|Pegaspargase|pegaspargase|mesh-list
139066870|NCT03844360|Lenograstim|lenograstim|mesh-list
139066871|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066872|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139066873|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258922|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138919793|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
139066874|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066875|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139066876|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
139066877|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066878|NCT01198054|Lenalidomide|lenalidomide|mesh-list
139066879|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
139066880|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066881|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139066882|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139066883|NCT01198054|Growth Substances|growth substances|mesh-ancestor
139066884|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
139066885|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066886|NCT01202032|Bevacizumab|bevacizumab|mesh-list
139066887|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139066888|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066889|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139066890|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139066891|NCT01202032|Growth Substances|growth substances|mesh-ancestor
138919859|NCT04454229|Penicillins|penicillins|mesh-list
139066892|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066893|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
139066894|NCT03844984|Lidocaine|lidocaine|mesh-list
139066895|NCT03844984|Midazolam|midazolam|mesh-list
139066896|NCT03844984|Ketamine|ketamine|mesh-list
139066897|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
139066898|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
139066899|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066900|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066901|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
139066902|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066903|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139066904|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139066905|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139066906|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139066907|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066908|NCT03844984|Analgesics|analgesics|mesh-ancestor
139066909|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139066910|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139066911|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
139066912|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139066913|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139066914|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066915|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138788259|NCT00641446|Hormones|hormones|mesh-ancestor
139066916|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139066917|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139066918|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139066919|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139066920|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
139066923|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139066924|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
139066925|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139066926|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139066927|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066928|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139066929|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139066930|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139066931|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066932|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139066933|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139066934|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139066935|NCT01200004|Lenalidomide|lenalidomide|mesh-list
139066936|NCT01200004|Azacitidine|azacitidine|mesh-list
139066937|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
139066938|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066939|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139066940|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139066941|NCT01200004|Growth Substances|growth substances|mesh-ancestor
139066942|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
139066943|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066944|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139066945|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
139066946|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066947|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066949|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
139066950|NCT01198210|Ketamine|ketamine|mesh-list
139066951|NCT01198210|BB 1101|bb 1101|mesh-list
139066952|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139066953|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
139066954|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
139066955|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139066956|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139066957|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139066958|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
139066959|NCT01198210|Hormones|hormones|mesh-ancestor
139066960|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139066961|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139066962|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139066963|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
139066964|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139066965|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139066966|NCT01198210|Analgesics|analgesics|mesh-ancestor
139066967|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
139066968|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139066969|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139066970|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
139066971|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
139066972|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139066973|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139066974|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139066975|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139066977|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
139066978|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139066979|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
139066980|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139066981|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139066982|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259097|NCT00363857|Ropinirole|ropinirole|mesh-list
138920205|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138920206|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138920207|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
138920208|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920209|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920210|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
138920211|NCT02581683|Ropivacaine|ropivacaine|mesh-list
139066983|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139066984|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139066985|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139066986|NCT03843736|Estrogens|estrogens|mesh-ancestor
139066987|NCT03843736|Hormones|hormones|mesh-ancestor
139066988|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139066989|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139066990|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
139066991|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139066992|NCT03843736|Diuretics|diuretics|mesh-ancestor
139066993|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
139066994|NCT01200472|Apremilast|apremilast|mesh-list
139066995|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139066996|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139066997|NCT01200472|Analgesics|analgesics|mesh-ancestor
138920270|NCT00914693|Gestodene|gestodene|mesh-list
139066998|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
139066999|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067000|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067001|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139067002|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139067003|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139067004|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139067005|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067006|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067008|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
139067009|NCT04638790|Dacarbazine|dacarbazine|mesh-list
139067010|NCT04638790|Doxorubicin|doxorubicin|mesh-list
139067011|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139067012|NCT04638790|Etoposide|etoposide|mesh-list
139067013|NCT04638790|Vincristine|vincristine|mesh-list
139067014|NCT04638790|Bleomycin|bleomycin|mesh-list
139067015|NCT04638790|Vinblastine|vinblastine|mesh-list
139067016|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139067017|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
139067018|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920329|NCT05629949|Docetaxel|docetaxel|mesh-list
139067019|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139067020|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139067021|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
139067022|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067023|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067024|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139067025|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139067026|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
139067027|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
139067028|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067029|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139067030|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
139067032|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139067033|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139067034|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139067035|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139067036|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139067037|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067038|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139067040|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
139067041|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
139067043|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139067044|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067045|NCT01200784|Niacinamide|niacinamide|mesh-list
139067046|NCT01200784|Niacin|niacin|mesh-list
139067047|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
139067048|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
139067049|NCT01200784|Vitamins|vitamins|mesh-ancestor
139067050|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
139067051|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067052|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139067053|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
139067054|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067055|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139067056|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
139067057|NCT03841474|Sertraline|sertraline|mesh-list
138259248|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067058|NCT03841474|Escitalopram|escitalopram|mesh-list
138920589|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
139067059|NCT03841474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139067060|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139067061|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139067062|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067063|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067064|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
139067065|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067066|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
139067067|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139067069|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139067070|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067071|NCT05670184|Ethanol|ethanol|mesh-list
139067072|NCT05670184|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
139067073|NCT05670184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139067074|NCT05670184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788387|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067075|NCT05670184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067076|NCT05670184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067077|NCT05670184|Hallucinogens|hallucinogens|mesh-ancestor
139067078|NCT05670184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139067079|NCT05670184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139067080|NCT05670184|Serotonin Agents|serotonin agents|mesh-ancestor
139067081|NCT05670184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067082|NCT05670184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067083|NCT05670184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139067084|NCT03842800|Ketamine|ketamine|mesh-list
139067085|NCT03842800|Analgesics|analgesics|mesh-ancestor
139067086|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
139067087|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067089|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139067090|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139067091|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
139067092|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
138920776|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
139067093|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067094|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139067095|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139067096|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067097|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067098|NCT01202422|Pregabalin|pregabalin|mesh-list
139067099|NCT01202422|Analgesics|analgesics|mesh-ancestor
139067100|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
139067101|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067102|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067103|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
139067104|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139067105|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139067106|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067107|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139067108|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139067109|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139067110|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067111|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139067112|NCT03892018|Paclitaxel|paclitaxel|mesh-list
139067113|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139067114|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067115|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
139067116|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
139067117|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
138788429|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139067118|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067120|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139067121|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067122|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
139067123|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139067124|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139067125|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
139067126|NCT03842488|Darunavir|darunavir|mesh-list
139067127|NCT03842488|Cobicistat|cobicistat|mesh-list
139067128|NCT03842488|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
139067129|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139067130|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139067131|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
139067132|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817714|NCT02874989|Dasatinib|dasatinib|mesh-list
139067133|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139067134|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139067135|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067136|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067137|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139067138|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139067139|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
139067140|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139067141|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139067143|NCT03842254|Hematinics|hematinics|mesh-ancestor
139067144|NCT01201642|Prednisolone|prednisolone|mesh-list
139067145|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139067146|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
139067147|NCT01201642|Hormones|hormones|mesh-ancestor
139067148|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139067149|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067150|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139067151|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067152|NCT05004064|Rituximab|rituximab|mesh-list
139067153|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
139067154|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139067155|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067156|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
139067157|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067158|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139067159|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139067160|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139067161|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
139067162|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067164|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139067165|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067166|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139067167|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139067168|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139067169|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067170|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
139067171|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067173|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139067174|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139067175|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
139067177|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139067178|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139067179|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
139067180|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067181|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139067182|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139067183|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067184|NCT01202890|Bevacizumab|bevacizumab|mesh-list
139067185|NCT01202890|Lenalidomide|lenalidomide|mesh-list
139067186|NCT01202890|Doxorubicin|doxorubicin|mesh-list
139067187|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138921208|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
139067188|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139067189|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067190|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139067191|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139067192|NCT01202890|Growth Substances|growth substances|mesh-ancestor
139067193|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067194|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
139067195|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139067196|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139067197|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139067198|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067199|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067200|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
139067201|NCT01199224|Veliparib|veliparib|mesh-list
139067202|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139067203|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067204|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817776|NCT02583217|Narcotics|narcotics|mesh-ancestor
139067205|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067206|NCT01204138|Apremilast|apremilast|mesh-list
139067207|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139067208|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139067209|NCT01204138|Analgesics|analgesics|mesh-ancestor
139067210|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
139067211|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067212|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259476|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139067213|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139067214|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139067215|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139067216|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139067217|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067218|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067219|NCT01204372|Gemcitabine|gemcitabine|mesh-list
139067220|NCT01204372|Trastuzumab|trastuzumab|mesh-list
139067221|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139067222|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139067223|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
139067224|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067225|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921338|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
139067226|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139067227|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139067228|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067229|NCT01204450|Sirolimus|sirolimus|mesh-list
139067230|NCT01204450|Temsirolimus|temsirolimus|mesh-list
139067231|NCT01204450|MTOR Inhibitors|mtor inhibitors|mesh-list
139067232|NCT01204450|Valproic Acid|valproic acid|mesh-list
139067233|NCT01204450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139067234|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067235|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067236|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139067237|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
138259523|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139067238|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067239|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067240|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139067241|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067242|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138788527|NCT01172288|Expectorants|expectorants|mesh-ancestor
139067243|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
139067244|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
139067246|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067247|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
139067248|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139067249|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067250|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139067251|NCT03834454|Bupivacaine|bupivacaine|mesh-list
139067252|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
139067253|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
139067254|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067255|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067256|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
139067257|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067258|NCT02428270|Trametinib|trametinib|mesh-list
139067259|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067260|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139067261|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067262|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067263|NCT03829930|Entinostat|entinostat|mesh-list
139067264|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067265|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139067266|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196496|NCT00000796|Vitamins|vitamins|mesh-ancestor
139067267|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067268|NCT01203202|Clomipramine|clomipramine|mesh-list
139067269|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139067270|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
139067271|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139067272|NCT01203202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139067273|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138184305|NCT01834235|Paclitaxel|paclitaxel|mesh-list
139067274|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139067275|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067276|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067277|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
139067278|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067279|NCT01298284|Propranolol|propranolol|mesh-list
139067280|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139067281|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139067282|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
139067283|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067284|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067285|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067286|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139067287|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139067288|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
139067289|NCT01204840|Hormones|hormones|mesh-list
139067290|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139067291|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067292|NCT01203358|Beractant|beractant|mesh-list
139067293|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
139067294|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
139067295|NCT03832426|Ritonavir|ritonavir|mesh-list
139067296|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139067297|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139067299|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067300|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067301|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139067302|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139067303|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
139067304|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067305|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139067306|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139067307|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
139067308|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139067309|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
139067310|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067311|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
139067312|NCT03840070|Protective Agents|protective agents|mesh-ancestor
139067313|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
139067314|NCT01203514|Hematinics|hematinics|mesh-ancestor
139067315|NCT01204996|Paclitaxel|paclitaxel|mesh-list
139067316|NCT01204996|Docetaxel|docetaxel|mesh-list
139067317|NCT01204996|Carboplatin|carboplatin|mesh-list
139067318|NCT01204996|Gemcitabine|gemcitabine|mesh-list
139067319|NCT01204996|Doxorubicin|doxorubicin|mesh-list
139067320|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139067321|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138921749|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
139067322|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067323|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
139067324|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
139067325|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
139067326|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067327|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139067328|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
139067329|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139067330|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139067331|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139067332|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067333|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
139067335|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139067336|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139067337|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
139067338|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067339|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067340|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067341|NCT01297192|Urological Agents|urological agents|mesh-ancestor
139067342|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
139067343|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139067344|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139067345|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
139067347|NCT01205074|Propranolol|propranolol|mesh-list
139067348|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139067349|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139067350|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
139067351|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067352|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067353|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067354|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139067355|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139067356|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
139067357|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138922010|NCT05276102|Emollients|emollients|mesh-list
139067358|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067359|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067362|NCT03722524|Indapamide|indapamide|mesh-list
139067363|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
139067364|NCT03722524|Diuretics|diuretics|mesh-list
139067365|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
139067366|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139067367|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139067368|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139067369|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067370|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139067371|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067372|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
139067373|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
139067374|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
138922108|NCT02598830|Vitamin D|vitamin d|mesh-list
139067375|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067376|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139067377|NCT05667220|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139067378|NCT05667220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139067379|NCT05667220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067380|NCT05667220|Incretins|incretins|mesh-ancestor
139067381|NCT05667220|Hormones|hormones|mesh-ancestor
139067382|NCT05667220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139067383|NCT05667220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139067384|NCT05667220|Protease Inhibitors|protease inhibitors|mesh-ancestor
139067385|NCT05667220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922133|NCT05285358|Tubulin Modulators|tubulin modulators|mesh-ancestor
139067386|NCT05667220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067388|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139067389|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
139067390|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067391|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067392|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139067393|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
139067394|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
138922197|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
139067395|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139067396|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139067397|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139067398|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139067399|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
139067400|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067401|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067402|NCT03829150|Amoxicillin|amoxicillin|mesh-list
139067403|NCT03829150|Metronidazole|metronidazole|mesh-list
139067404|NCT03829150|Clarithromycin|clarithromycin|mesh-list
139067405|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
139067406|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139067407|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067408|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139067409|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139067410|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139067411|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067412|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259797|NCT00364871|Naltrexone|naltrexone|mesh-list
139067413|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139067414|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139067415|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139067416|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139067417|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139067418|NCT01205464|Doxycycline|doxycycline|mesh-list
139067419|NCT01205464|Tetracycline|tetracycline|mesh-list
139067420|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139067421|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067422|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
139067423|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139067424|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139067425|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139067426|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067427|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067429|NCT03828838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139067430|NCT03828838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067431|NCT03819010|Letrozole|letrozole|mesh-list
139067432|NCT03819010|Palbociclib|palbociclib|mesh-list
139067433|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067434|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139067435|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139067436|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259844|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139067437|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067438|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139067439|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
139067440|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139067441|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067442|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139067443|NCT03818932|Acetaminophen|acetaminophen|mesh-list
139067445|NCT03818932|Ketorolac|ketorolac|mesh-list
139067446|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139067447|NCT03818932|Diazepam|diazepam|mesh-list
139067448|NCT03818932|Gabapentin|gabapentin|mesh-list
139067449|NCT03818932|Hydrocodone|hydrocodone|mesh-list
139067450|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139067451|NCT03818932|Analgesics|analgesics|mesh-ancestor
139067452|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
139067453|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067454|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067455|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
139067456|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139067457|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139067458|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139067459|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139067460|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139067461|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067462|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067463|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
139067464|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139067465|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139067466|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067467|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138259897|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138259898|NCT04734197|Cyclosporins|cyclosporins|mesh-list
139067468|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138922650|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139067469|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139067470|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067471|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
139067472|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139067473|NCT03818932|Narcotics|narcotics|mesh-ancestor
139067474|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
139067475|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
139067476|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139067477|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
139067478|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
139067479|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139067480|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139067481|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139067482|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139067483|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139067484|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
139067486|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
139067487|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
139067488|NCT01205932|Enoxaparin|enoxaparin|mesh-list
139067489|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
139067490|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139067491|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
139067492|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139067493|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
139067494|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067495|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067496|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
139067497|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139067498|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139067499|NCT01300780|Etoricoxib|etoricoxib|mesh-list
139067500|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139067501|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139067502|NCT01300780|Analgesics|analgesics|mesh-ancestor
138818075|NCT03824587|Calcium, Dietary|calcium, dietary|mesh-list
139067503|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
139067504|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067505|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922923|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
139067506|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138788712|NCT02670616|Rituximab|rituximab|mesh-list
139067507|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139067508|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139067509|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139067510|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067511|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067512|NCT01297816|Minocycline|minocycline|mesh-list
139067513|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139067514|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067516|NCT01297894|Fosfomycin|fosfomycin|mesh-list
139067517|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139067518|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067519|NCT05666362|Benoxinate|benoxinate|mesh-list
139067520|NCT05666362|Anesthetics, Local|anesthetics, local|mesh-ancestor
139067521|NCT05666362|Anesthetics|anesthetics|mesh-ancestor
139067522|NCT05666362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067523|NCT05666362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067524|NCT05666362|Sensory System Agents|sensory system agents|mesh-ancestor
139067525|NCT05666362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067526|NCT01206010|Varenicline|varenicline|mesh-list
139067527|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139067528|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139067529|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
139067530|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138923057|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
139067531|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067532|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067533|NCT05665114|Cytarabine|cytarabine|mesh-list
139067534|NCT05665114|Cyclophosphamide|cyclophosphamide|mesh-list
139067535|NCT05665114|Fludarabine|fludarabine|mesh-list
139067536|NCT05665114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139067537|NCT05665114|Immunologic Factors|immunologic factors|mesh-ancestor
139067538|NCT05665114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259984|NCT02265913|Acyclovir|acyclovir|mesh-list
139067539|NCT05665114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139067540|NCT05665114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139067541|NCT05665114|Alkylating Agents|alkylating agents|mesh-ancestor
139067542|NCT05665114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067543|NCT05665114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067544|NCT05665114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139067545|NCT05665114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139067546|NCT05665114|Antimetabolites|antimetabolites|mesh-ancestor
139067547|NCT05665114|Antiviral Agents|antiviral agents|mesh-ancestor
139067548|NCT05665114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067549|NCT03814642|Esomeprazole|esomeprazole|mesh-list
139067550|NCT03814642|Clopidogrel|clopidogrel|mesh-list
139067551|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139067552|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139067553|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139067554|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139067555|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
138788763|NCT02670772|Tenofovir|tenofovir|mesh-list
139067556|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067557|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067558|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067559|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139067560|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139067561|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139067562|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067563|NCT01299220|Acitretin|acitretin|mesh-list
139067564|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
139067565|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
139067566|NCT03813784|Capecitabine|capecitabine|mesh-list
139067567|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
139067569|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139067570|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
139067571|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067572|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067573|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139067574|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067575|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
139067576|NCT03818308|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
139067577|NCT03818308|Velpatasvir|velpatasvir|mesh-list
139067578|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
139067579|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067580|NCT03827044|Avelumab|avelumab|mesh-list
139067581|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139067582|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067583|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
139067584|NCT00145626|Melphalan|melphalan|mesh-list
139067586|NCT00145626|Fludarabine|fludarabine|mesh-list
139067587|NCT00145626|Antibodies|antibodies|mesh-list
139067588|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139067589|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
139067590|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067591|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139067592|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139067593|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
139067594|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067595|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067596|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138260072|NCT00550459|Tolvaptan|tolvaptan|mesh-list
139067598|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139067599|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
139067600|NCT01206946|Hormones|hormones|mesh-ancestor
139067601|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139067602|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067603|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139067604|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
139067605|NCT03813940|Vaccines|vaccines|mesh-list
139067606|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
139067607|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067608|NCT03967938|Olaparib|olaparib|mesh-list
139067609|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139067610|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067611|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067612|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067613|NCT01299298|Mipomersen|mipomersen|mesh-list
139067614|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139067615|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139067616|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
139067617|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067618|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139067619|NCT00153062|Telmisartan|telmisartan|mesh-list
139067620|NCT00153062|Clopidogrel|clopidogrel|mesh-list
139067621|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
139067622|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139067623|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139067624|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139067625|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139067626|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
139067628|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067629|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788805|NCT00628914|Eszopiclone|eszopiclone|mesh-list
139067630|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139067631|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139067632|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139067633|NCT00145470|Asenapine|asenapine|mesh-list
139067634|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139067635|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139067636|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067637|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067638|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139067639|NCT03813394|Bevacizumab|bevacizumab|mesh-list
139067640|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
139067641|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139067642|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067643|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139067644|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139067645|NCT03813394|Growth Substances|growth substances|mesh-ancestor
139067646|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067647|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
139067648|NCT03813394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139067649|NCT03813394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067650|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139067651|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
139067652|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
139067653|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139067654|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139067655|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067656|NCT03813316|Incretins|incretins|mesh-ancestor
139067657|NCT03813316|Hormones|hormones|mesh-ancestor
139067658|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139067659|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
139067660|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067661|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067662|NCT01301248|Cisplatin|cisplatin|mesh-list
139067664|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067665|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139067666|NCT03817684|BPN14770|bpn14770|mesh-list
139067667|NCT03817684|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
139067668|NCT03817684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139067669|NCT03817684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067670|NCT03817684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067671|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
139067672|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139067673|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067674|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139067675|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067676|NCT01302106|Clofarabine|clofarabine|mesh-list
139067677|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139067678|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
139067679|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067680|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067682|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
139067683|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
138260210|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
139067684|NCT00145158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
139067685|NCT00145158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139067686|NCT00145158|Immunologic Factors|immunologic factors|mesh-ancestor
139067687|NCT00145158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067688|NCT05624008|Methamphetamine|methamphetamine|mesh-list
139067689|NCT05624008|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139067690|NCT05624008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067691|NCT05624008|Sympathomimetics|sympathomimetics|mesh-ancestor
139067692|NCT05624008|Autonomic Agents|autonomic agents|mesh-ancestor
139067693|NCT05624008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067694|NCT05624008|Dopamine Agents|dopamine agents|mesh-ancestor
139067695|NCT05624008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067696|NCT05624008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067697|NCT05624008|Adrenergic Agents|adrenergic agents|mesh-ancestor
139067698|NCT05624008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139067699|NCT05624008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139067701|NCT05624008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139067702|NCT05623852|Fucoidan|fucoidan|mesh-list
139067703|NCT05623852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139067704|NCT05623852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139067705|NCT05623852|Anticoagulants|anticoagulants|mesh-ancestor
139067706|NCT05623852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067707|NCT01302340|Dronabinol|dronabinol|mesh-list
139067708|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
139067709|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067710|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139067711|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139067712|NCT01302340|Analgesics|analgesics|mesh-ancestor
139067713|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
139067714|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067715|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139067716|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139067717|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067718|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067719|NCT01302340|Hormones|hormones|mesh-ancestor
139067720|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139067721|NCT00150800|Brivaracetam|brivaracetam|mesh-list
139067722|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
139067723|NCT03812770|Leucovorin|leucovorin|mesh-list
139067724|NCT03812770|Fluorouracil|fluorouracil|mesh-list
139067725|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
139067726|NCT03812770|Sorafenib|sorafenib|mesh-list
139067727|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
139067728|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067729|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139067730|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067731|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139067732|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
139067733|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067734|NCT03812770|Antidotes|antidotes|mesh-ancestor
139067735|NCT03812770|Protective Agents|protective agents|mesh-ancestor
139067736|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
139067737|NCT03812770|Vitamins|vitamins|mesh-ancestor
139067738|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
139067739|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139067740|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067741|NCT00144300|Pramipexole|pramipexole|mesh-list
139067742|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
139067743|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067744|NCT00144300|Protective Agents|protective agents|mesh-ancestor
139067745|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067746|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139067747|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139067748|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
139067749|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
139067750|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067751|NCT00149630|Disulfiram|disulfiram|mesh-list
139067752|NCT00149630|Methadone|methadone|mesh-list
139067753|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139067754|NCT00149630|Narcotics|narcotics|mesh-ancestor
139067755|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067756|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067757|NCT00149630|Analgesics|analgesics|mesh-ancestor
139067758|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
139067759|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067760|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
139067761|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
139067762|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
139067763|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
139067764|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067765|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067766|NCT01302496|Ipilimumab|ipilimumab|mesh-list
139067767|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139067768|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067769|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139067770|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067771|NCT00127842|Etanercept|etanercept|mesh-list
139067772|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139067773|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139067774|NCT00127842|Analgesics|analgesics|mesh-ancestor
139067775|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
139067776|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067777|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067778|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139067779|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139067780|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139067781|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139067782|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
139067783|NCT01075802|Tamoxifen|tamoxifen|mesh-list
139067784|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139067785|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
139067786|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139067787|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067788|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139067789|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067790|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139067791|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139067792|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139067793|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
139067794|NCT03816592|Anesthetics|anesthetics|mesh-list
139067795|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067796|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067797|NCT03816592|Narcotics|narcotics|mesh-ancestor
139067798|NCT03816592|Analgesics|analgesics|mesh-ancestor
139067799|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
139067800|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067801|NCT01078038|Sirolimus|sirolimus|mesh-list
139067802|NCT01078038|Everolimus|everolimus|mesh-list
139067803|NCT01078038|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139067804|NCT01078038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139067805|NCT01078038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067806|NCT01078038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067807|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139067808|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
139067809|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067810|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067811|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139067812|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067813|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139067814|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
139067815|NCT00223496|Aripiprazole|aripiprazole|mesh-list
139067816|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
139067817|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139067818|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138924112|NCT00737139|Epinephrine|epinephrine|mesh-list
139067819|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139067820|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067821|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067822|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
139067823|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
139067824|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067825|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067826|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139067827|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139067828|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
139067829|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139067830|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139067831|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139067832|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139067833|NCT02531412|Spironolactone|spironolactone|mesh-list
139067834|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139067835|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
139067836|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139067837|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067838|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139067839|NCT02531412|Diuretics|diuretics|mesh-ancestor
139067840|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
139067841|NCT00126672|Sirolimus|sirolimus|mesh-list
139067842|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139067843|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067844|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139067845|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067846|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
139067847|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139067848|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
138924201|NCT00732693|Norethindrone|norethindrone|mesh-list
139067849|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067850|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
139067851|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139067852|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139067853|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
139067854|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067855|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139067857|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
139067858|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
139067859|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
139067860|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067861|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
139067862|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139067863|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139067864|NCT00145496|Olanzapine|olanzapine|mesh-list
139067865|NCT00145496|Asenapine|asenapine|mesh-list
138924294|NCT00738621|Aprepitant|aprepitant|mesh-list
139067866|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
139067867|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
139067868|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067869|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067870|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139067871|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139067872|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139067873|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067874|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139067875|NCT00145496|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139067876|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139067877|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138789140|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139067878|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067879|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139067880|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
139067881|NCT01299922|Cyclosporine|cyclosporine|mesh-list
139067882|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
139067883|NCT01299922|Cyclosporins|cyclosporins|mesh-list
139067884|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067885|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067886|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139067887|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
139067888|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067889|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
139067890|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067891|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
139067892|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139067893|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139067894|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139067895|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067896|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139067897|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
139067898|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139067899|NCT05030818|Aspirin|aspirin|mesh-list
139067900|NCT05030818|Ramipril|ramipril|mesh-list
139067901|NCT05030818|Atorvastatin|atorvastatin|mesh-list
139067902|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139067903|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139067904|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
139067905|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067906|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139067907|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139067908|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576297|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139067909|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139067910|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139067911|NCT05030818|Analgesics|analgesics|mesh-ancestor
139067912|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
139067913|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067914|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067915|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139067916|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924357|NCT04065165|Lanreotide|lanreotide|mesh-list
139067917|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139067918|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139067919|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139067920|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139067922|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139067923|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
139067924|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139067925|NCT01582022|Bupivacaine|bupivacaine|mesh-list
139067926|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
139067927|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
139067928|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067929|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067930|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
139067931|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067932|NCT01582412|Isavuconazole|isavuconazole|mesh-list
139067933|NCT01582412|Digoxin|digoxin|mesh-list
139067934|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139067935|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139067936|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924479|NCT02567955|Vaccines|vaccines|mesh-list
139067937|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067938|NCT01582412|Protective Agents|protective agents|mesh-ancestor
139067939|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067940|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
139067941|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067942|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
139067944|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139067945|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139067946|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139067947|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067948|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067949|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
138260542|NCT05432843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067950|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067951|NCT00126594|Interferons|interferons|mesh-list
139067952|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
139067953|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
139067954|NCT00126594|Sorafenib|sorafenib|mesh-list
139067955|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067956|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
139067957|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139067958|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139067959|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067960|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067961|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
139067962|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067963|NCT01080456|Tacrolimus|tacrolimus|mesh-list
139067964|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139067965|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
139067966|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067967|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139067968|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067969|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067970|NCT03811054|Apatinib|apatinib|mesh-list
138260595|NCT02682563|Gliclazide|gliclazide|mesh-list
139067972|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139067973|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067974|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067975|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
139067976|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139067977|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139067978|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067979|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139067980|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139067981|NCT01075854|Hormones|hormones|mesh-ancestor
139067982|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139067983|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067985|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
139067986|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
139067987|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139067988|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139067989|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
139067990|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139067991|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139067992|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139067993|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139067994|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139067995|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139067996|NCT00142584|Metoprolol|metoprolol|mesh-list
139067997|NCT00142584|Nebivolol|nebivolol|mesh-list
139067998|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139067999|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139068000|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
139068001|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
139068002|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068003|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068004|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139068005|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139068006|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139068007|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
139068008|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139068009|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068010|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
139068011|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139068012|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139068013|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138260646|NCT02268864|Simeprevir|simeprevir|mesh-list
139068014|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
139068015|NCT04848064|Fludarabine|fludarabine|mesh-list
139068016|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
139068017|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
139068018|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
139068019|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139068020|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
139068021|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068022|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068023|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139068024|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
139068025|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068026|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068027|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139068028|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
139068029|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139068030|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139068031|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139068032|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139068033|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068034|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
138789344|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
139068035|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139068036|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068037|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139068038|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068040|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139068041|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
139068042|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068043|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139068044|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068045|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068046|NCT00125190|Mecasermin|mecasermin|mesh-list
139068047|NCT00125190|Growth Substances|growth substances|mesh-ancestor
139068048|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068049|NCT00141726|Etanercept|etanercept|mesh-list
139068050|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139068051|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139068052|NCT00141726|Analgesics|analgesics|mesh-ancestor
139068053|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
139068054|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068055|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068056|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068057|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068058|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138924825|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
139068059|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139068060|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
139068061|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139068062|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139068063|NCT01301716|Paclitaxel|paclitaxel|mesh-list
139068064|NCT01301716|Bevacizumab|bevacizumab|mesh-list
139068065|NCT01301716|Carboplatin|carboplatin|mesh-list
139068066|NCT01301716|Pemetrexed|pemetrexed|mesh-list
139068067|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139068068|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068069|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
139068070|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
139068071|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
139068072|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068073|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139068074|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138924878|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068075|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139068076|NCT01301716|Growth Substances|growth substances|mesh-ancestor
139068077|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068078|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
139068079|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068080|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139068081|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139068082|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
139068083|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
139068084|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138260690|NCT05648526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139068085|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068086|NCT01300312|Diclofenac|diclofenac|mesh-list
139068087|NCT01300312|Eperisone|eperisone|mesh-list
139068088|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139068089|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139068091|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
139068092|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068093|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068094|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068095|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068096|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139068097|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068098|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068099|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
139068100|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139068101|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138818679|NCT06166628|Anesthetics|anesthetics|mesh-ancestor
139068102|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139068103|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139068104|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139068105|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
139068106|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
139068107|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
139068108|NCT01567384|Pemetrexed|pemetrexed|mesh-list
139068109|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068110|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068111|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068112|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139068113|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139068115|NCT01080612|Analgesics|analgesics|mesh-ancestor
139068116|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
139068117|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068118|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068119|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
139068120|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138924997|NCT00738530|Interferons|interferons|mesh-list
139068121|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139068122|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068123|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139068125|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139068126|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139068127|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139068128|NCT03819790|Insulin|insulin|mesh-list
139068129|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139068130|NCT03819790|Metformin|metformin|mesh-list
139068131|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
139068132|NCT03819790|Lixisenatide|lixisenatide|mesh-list
139068133|NCT03819790|Gliclazide|gliclazide|mesh-list
139068134|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139068135|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068136|NCT01560442|Buprenorphine|buprenorphine|mesh-list
139068137|NCT01560442|Methadone|methadone|mesh-list
139068138|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139068139|NCT01560442|Narcotics|narcotics|mesh-ancestor
138260794|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139068140|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139068141|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068142|NCT01560442|Analgesics|analgesics|mesh-ancestor
139068143|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
139068144|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068145|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139068146|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
139068147|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
139068148|NCT00110994|Sorafenib|sorafenib|mesh-list
139068149|NCT00110994|Dacarbazine|dacarbazine|mesh-list
138925107|NCT00697593|Antibodies|antibodies|mesh-list
139068150|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068151|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139068152|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068153|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068155|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
139068156|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
139068157|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139068158|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139068160|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
139068161|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139068162|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
139068163|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068164|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
139068165|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
139068166|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068167|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068168|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139068169|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
139068170|NCT01560052|Hormones|hormones|mesh-ancestor
139068171|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139068172|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139068173|NCT01560052|Protective Agents|protective agents|mesh-ancestor
139068174|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139068175|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068176|NCT05622994|Rimonabant|rimonabant|mesh-list
139068177|NCT05622994|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139068178|NCT05622994|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138260902|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
139068179|NCT05622994|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139068180|NCT05622994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139068181|NCT05622994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789587|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139068183|NCT05622994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139068184|NCT05622994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068185|NCT05622916|Ethanol|ethanol|mesh-list
139068186|NCT05622916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139068187|NCT05622916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068188|NCT05622916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139068189|NCT05622916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068190|NCT03819556|Caseins|caseins|mesh-list
139068191|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
139068192|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
139068193|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068194|NCT03804034|Molybdenum|molybdenum|mesh-list
139068195|NCT03804034|Trace Elements|trace elements|mesh-ancestor
139068196|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
139068197|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068198|NCT04246762|Vitamin K|vitamin k|mesh-list
139068199|NCT04246762|Midazolam|midazolam|mesh-list
139068200|NCT04246762|Caffeine|caffeine|mesh-list
139068202|NCT04246762|Warfarin|warfarin|mesh-list
139068203|NCT04246762|Vitamins|vitamins|mesh-ancestor
139068204|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
139068205|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068206|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139068207|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139068208|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139068209|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139068210|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139068211|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139068212|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139068213|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
139068214|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
139068215|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
139068216|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
139068217|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085263|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139068218|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068219|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
139068220|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139068221|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139068222|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068223|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139068224|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139068225|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
139068226|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139068227|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139068228|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139068229|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139068230|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139068231|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
139068232|NCT04246762|Coagulants|coagulants|mesh-ancestor
139068233|NCT03799120|Tamsulosin|tamsulosin|mesh-list
139068234|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
139068235|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139068236|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139068237|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
139068238|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789624|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
139068239|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068240|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068241|NCT03799120|Urological Agents|urological agents|mesh-ancestor
139068242|NCT03792724|Nivolumab|nivolumab|mesh-list
139068243|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139068244|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068245|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139068246|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068248|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139068249|NCT00144170|Tipranavir|tipranavir|mesh-list
139068250|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
139068251|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139068252|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068253|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068254|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139068255|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139068256|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
139068257|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068258|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139068259|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139068260|NCT00255086|Memantine|memantine|mesh-list
139068261|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139068262|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139068263|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
139068264|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789657|NCT00648154|Letrozole|letrozole|mesh-list
139068265|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068266|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068267|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139068268|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139068269|NCT00110214|Prednisone|prednisone|mesh-list
139068270|NCT00110214|Bevacizumab|bevacizumab|mesh-list
139068271|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139068272|NCT00110214|Docetaxel|docetaxel|mesh-list
139068273|NCT00110214|Antibodies|antibodies|mesh-list
139068274|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
139068275|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139068276|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068277|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139068278|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139068279|NCT00110214|Growth Substances|growth substances|mesh-ancestor
139068280|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068281|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
139068282|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
139068283|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
139068284|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
139068285|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
139068286|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068287|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068288|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
139068289|NCT00110214|Hormones|hormones|mesh-ancestor
139068290|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139068291|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139068292|NCT04176172|Nicotine|nicotine|mesh-list
139068293|NCT04176172|Varenicline|varenicline|mesh-list
139068294|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139068295|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
139068296|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068297|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068298|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139068299|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139068300|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
139068301|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139068302|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068303|NCT03795844|Liver Extracts|liver extracts|mesh-list
139068304|NCT03795844|Hematinics|hematinics|mesh-ancestor
139068305|NCT05669170|Methylphenidate|methylphenidate|mesh-list
139068306|NCT05669170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139068307|NCT05669170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068308|NCT05669170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139068309|NCT05669170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139068310|NCT05669170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139085264|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068311|NCT05669170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068312|NCT05669170|Dopamine Agents|dopamine agents|mesh-ancestor
139068313|NCT05669170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139068314|NCT03799822|Vitamin K|vitamin k|mesh-list
139068315|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
139068316|NCT03799822|Vitamins|vitamins|mesh-ancestor
139068317|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
139068318|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068319|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139068320|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
138577348|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
139068321|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139068322|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
139068323|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068324|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068325|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
139068326|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139068327|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139068328|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
139068329|NCT03799822|Coagulants|coagulants|mesh-ancestor
139068331|NCT03799900|Analgesics|analgesics|mesh-ancestor
139068332|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
139068333|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068334|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068335|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139068336|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139068337|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
139068338|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
139068339|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261261|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068340|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139068341|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139068342|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139068343|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068345|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139068346|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139068347|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068348|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068349|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068350|NCT01304134|Morphine|morphine|mesh-list
139068351|NCT01304134|Oxycodone|oxycodone|mesh-list
139068352|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139068353|NCT01304134|Narcotics|narcotics|mesh-ancestor
139068354|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139068355|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068356|NCT01304134|Analgesics|analgesics|mesh-ancestor
139068357|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
139068358|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068359|NCT00124020|Vancomycin|vancomycin|mesh-list
139068360|NCT00124020|Telavancin|telavancin|mesh-list
139068361|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139068362|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068363|NCT01080846|Misoprostol|misoprostol|mesh-list
139068364|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139068365|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
139068366|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139068367|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261315|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068368|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139068369|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139068370|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
139068371|NCT01076322|Albuterol|albuterol|mesh-list
139068372|NCT01076322|Procaterol|procaterol|mesh-list
139068373|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139068374|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
139068375|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068376|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068377|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139068378|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
139068379|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
139068380|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139068381|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139068382|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139068383|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139068384|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
139068385|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139068386|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068387|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
139068388|NCT03966066|Erythromycin|erythromycin|mesh-list
139068389|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
139068390|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139068391|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
139068392|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139068393|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068394|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139068395|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138261360|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068396|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068397|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068398|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139068399|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
139068400|NCT01304212|Ketorolac|ketorolac|mesh-list
139068401|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139068402|NCT01304212|Epinephrine|epinephrine|mesh-list
139068403|NCT01304212|Racepinephrine|racepinephrine|mesh-list
139068404|NCT01304212|Morphine|morphine|mesh-list
139068405|NCT01304212|Ropivacaine|ropivacaine|mesh-list
139068406|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
139068407|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139068409|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139068410|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068411|NCT01304212|Analgesics|analgesics|mesh-ancestor
139068412|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
139068413|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068414|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
139068415|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
139068416|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138925628|NCT00727532|Sorafenib|sorafenib|mesh-list
139068417|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139068418|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
139068419|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139068420|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068421|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139068422|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139068423|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
139068424|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139068425|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
139068427|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
139068428|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138789861|NCT00852397|Apixaban|apixaban|mesh-list
139068429|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139068430|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139068431|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068432|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068433|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139068434|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068435|NCT00143390|Anastrozole|anastrozole|mesh-list
139068436|NCT00143390|Exemestane|exemestane|mesh-list
139068437|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139068438|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068439|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139068440|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139068441|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068442|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068443|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139068444|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
139068445|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139068446|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068447|NCT03238534|Omeprazole|omeprazole|mesh-list
139068448|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139068449|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139068450|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139068451|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068452|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068453|NCT00141102|Celecoxib|celecoxib|mesh-list
139068454|NCT00141102|Diclofenac|diclofenac|mesh-list
139068455|NCT00141102|Omeprazole|omeprazole|mesh-list
139068456|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139068457|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139068458|NCT00141102|Analgesics|analgesics|mesh-ancestor
139068459|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
139068460|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068461|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068462|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068463|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068464|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139068465|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139068466|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068467|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068468|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139068469|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139068470|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139068471|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139068472|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139068473|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068474|NCT01078428|Petrolatum|petrolatum|mesh-list
139068475|NCT01078428|Emollients|emollients|mesh-ancestor
139068476|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
139068477|NCT01081002|Lidocaine|lidocaine|mesh-list
139068478|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
139068479|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
139068480|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139068481|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068482|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
139068483|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068484|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139068485|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139068486|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139068487|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139068488|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068489|NCT03789058|Ibuprofen|ibuprofen|mesh-list
139068490|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139068491|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139068492|NCT03789058|Analgesics|analgesics|mesh-ancestor
139068493|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
139068494|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068495|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068496|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068497|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068498|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139068499|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068500|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068501|NCT03788902|Methylphenidate|methylphenidate|mesh-list
139068502|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139068503|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068504|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139068505|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139068506|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139068507|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068508|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
139068509|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139068510|NCT05669092|Capecitabine|capecitabine|mesh-list
139068511|NCT05669092|Oxaliplatin|oxaliplatin|mesh-list
139068512|NCT05669092|Irinotecan|irinotecan|mesh-list
139068513|NCT05669092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
139068514|NCT05669092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139068515|NCT05669092|Antimetabolites|antimetabolites|mesh-ancestor
139068516|NCT05669092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068517|NCT05669092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790012|NCT00707083|Hormones|hormones|mesh-ancestor
138926083|NCT00741741|Rilpivirine|rilpivirine|mesh-list
139068518|NCT05669092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139068519|NCT05669092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139068520|NCT05669092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068521|NCT05669092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139068522|NCT00255008|Ribavirin|ribavirin|mesh-list
138261529|NCT01904071|Morphine|morphine|mesh-list
139068523|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139068524|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
139068525|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
139068526|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068527|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
139068528|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068529|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
139068530|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068531|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139068532|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
139068533|NCT03714022|Abatacept|abatacept|mesh-list
139068534|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139068535|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068536|NCT03714022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139068537|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068538|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139068539|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
139068540|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068541|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068542|NCT00143312|Voriconazole|voriconazole|mesh-list
139068543|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
139068544|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068545|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139068546|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139068547|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068548|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068549|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139068550|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
139068551|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139068552|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068553|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139068554|NCT04833946|Andrographolide|andrographolide|mesh-list
139068555|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068556|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139068557|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139068558|NCT04833946|Analgesics|analgesics|mesh-ancestor
138261640|NCT04403711|Analgesics|analgesics|mesh-ancestor
139068559|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
139068560|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068561|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068562|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068564|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139068565|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167526|NCT04146116|Povidone|povidone|mesh-list
139068566|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
139068567|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139068568|NCT01077206|Simvastatin|simvastatin|mesh-list
139068569|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139068570|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139068571|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
139068572|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068573|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139068574|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139068575|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068577|NCT05623540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139068578|NCT05623540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068579|NCT05622838|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
139068580|NCT05622838|Protein C Inhibitor|protein c inhibitor|mesh-list
139068581|NCT05622838|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
139068582|NCT05622838|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139068583|NCT05622838|Protease Inhibitors|protease inhibitors|mesh-ancestor
139068584|NCT05622838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085265|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139068585|NCT05622838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068587|NCT01306318|Eperisone|eperisone|mesh-list
139068588|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139068589|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138261752|NCT05349071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138790121|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
139068591|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
139068592|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068593|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068594|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068595|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068596|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139068597|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068598|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068599|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
139068600|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139068601|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139068602|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139068603|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139068604|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139068605|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
139068606|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
139068607|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
139068608|NCT00254540|Sunitinib|sunitinib|mesh-list
139068609|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068610|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139068611|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139068612|NCT00254540|Growth Substances|growth substances|mesh-ancestor
139068613|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068614|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
138790172|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
139068615|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139068616|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926534|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
139068617|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068618|NCT01326494|Prednisone|prednisone|mesh-list
139068619|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068621|NCT01326494|Hormones|hormones|mesh-ancestor
139068622|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139068623|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926661|NCT00753207|Epirubicin|epirubicin|mesh-list
139068624|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139068625|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068626|NCT01305850|Losartan|losartan|mesh-list
139068627|NCT01305850|Enalapril|enalapril|mesh-list
139068628|NCT01305850|Enalaprilat|enalaprilat|mesh-list
139068629|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139068630|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138261859|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068631|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138790220|NCT00649558|Pioglitazone|pioglitazone|mesh-list
139068632|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139068633|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068634|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139068635|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
139068636|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068637|NCT01306630|Capecitabine|capecitabine|mesh-list
139068638|NCT01306630|Tivozanib|tivozanib|mesh-list
139068639|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139068640|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
139068641|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926717|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
139068642|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068643|NCT01306630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139068644|NCT01306630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068646|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
139068647|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
139068648|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139068649|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139068650|NCT01306708|Analgesics|analgesics|mesh-ancestor
139068651|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
139068652|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068653|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068654|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139068655|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139068656|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139068657|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068658|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
139068659|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139068660|NCT03794518|Pioglitazone|pioglitazone|mesh-list
139068661|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139068662|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068663|NCT05566288|Moxifloxacin|moxifloxacin|mesh-list
139068664|NCT05566288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138926912|NCT00918632|Axitinib|axitinib|mesh-list
139068665|NCT05566288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068666|NCT05566288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139068667|NCT05566288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139068668|NCT05566288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068669|NCT05566288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068670|NCT05566288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068671|NCT03790540|Benzocaine|benzocaine|mesh-list
138261980|NCT04778839|Paclitaxel|paclitaxel|mesh-list
139068672|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
139068673|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
139068674|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139068675|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068676|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
138790335|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
139068677|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068678|NCT03794596|Aspirin|aspirin|mesh-list
139068679|NCT03794596|Avelumab|avelumab|mesh-list
139068680|NCT03794596|Lansoprazole|lansoprazole|mesh-list
139068681|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
139068682|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
139068683|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139068684|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139068685|NCT03794596|Analgesics|analgesics|mesh-ancestor
139068686|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
139068687|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068688|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068689|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068690|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068691|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139068692|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139068693|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927042|NCT02588534|Etanercept|etanercept|mesh-list
139068694|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139068696|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068697|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
139068698|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139068699|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068700|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139068701|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139068702|NCT05571748|Thioctic Acid|thioctic acid|mesh-list
139068703|NCT05571748|Antioxidants|antioxidants|mesh-ancestor
138927093|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139068704|NCT05571748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068705|NCT05571748|Protective Agents|protective agents|mesh-ancestor
139068706|NCT05571748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068707|NCT05571748|Vitamin B Complex|vitamin b complex|mesh-ancestor
139068708|NCT05571748|Vitamins|vitamins|mesh-ancestor
139068709|NCT05571748|Micronutrients|micronutrients|mesh-ancestor
139068710|NCT03790618|Methamphetamine|methamphetamine|mesh-list
139068711|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
139068712|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
139068713|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068714|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139068715|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
139068716|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139068717|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068718|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139068719|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139068720|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139068721|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
139068722|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139068723|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
139068724|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
139068725|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068726|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
139068727|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139068728|NCT03790228|Carboplatin|carboplatin|mesh-list
139068730|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068731|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068732|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068733|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139068734|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139068735|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
139068736|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
139068737|NCT01304836|Prednisolone|prednisolone|mesh-list
139068739|NCT01304836|Basiliximab|basiliximab|mesh-list
139068740|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139068741|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
139068742|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068743|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139068744|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068745|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068746|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139068747|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068748|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139068749|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
139068750|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139068751|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068752|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068753|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
139068754|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
139068755|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068756|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139068757|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
139068758|NCT01304836|Hormones|hormones|mesh-ancestor
139068759|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139068760|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139068761|NCT01304836|Protective Agents|protective agents|mesh-ancestor
139068762|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139068763|NCT01306864|Hemostatics|hemostatics|mesh-list
139068764|NCT01306864|Coagulants|coagulants|mesh-ancestor
139068765|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
139068766|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139068767|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068768|NCT03790384|Mitomycins|mitomycins|mesh-list
139068769|NCT03790384|Mitomycin|mitomycin|mesh-list
139068770|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
139068771|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139068772|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068773|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
139068774|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068775|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139068776|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068777|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139068778|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
139068779|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068780|NCT01307488|Ritonavir|ritonavir|mesh-list
139068781|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139068782|NCT01307488|Lamivudine|lamivudine|mesh-list
139068783|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139068784|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139068785|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
139068786|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068787|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068788|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139068789|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139068790|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
139068791|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068792|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139068793|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139068794|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139068795|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139068796|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
139068797|NCT03790072|Fludarabine|fludarabine|mesh-list
139068798|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139068799|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
138790582|NCT03542266|Azacitidine|azacitidine|mesh-list
139068800|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068801|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068802|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139068803|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
139068804|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068805|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068806|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139068808|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
138927602|NCT00673179|Leucovorin|leucovorin|mesh-list
139068809|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068811|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068812|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139068813|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068814|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068815|NCT00139776|Celecoxib|celecoxib|mesh-list
139068816|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139068817|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139068818|NCT00139776|Analgesics|analgesics|mesh-ancestor
139068819|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
139068820|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068821|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262122|NCT05288075|Antidotes|antidotes|mesh-ancestor
139068822|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068823|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068824|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139068825|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139068826|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068827|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068828|NCT00413699|Tofacitinib|tofacitinib|mesh-list
139068829|NCT00413699|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139068830|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139068831|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068832|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068834|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068835|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139068836|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068837|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068838|NCT03712930|Pamiparib|pamiparib|mesh-list
139068839|NCT03712930|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138262181|NCT00372515|Gefitinib|gefitinib|mesh-list
139068840|NCT03712930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068841|NCT03712930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068842|NCT03712930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068843|NCT00420407|Vasopressins|vasopressins|mesh-list
139068844|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
139068845|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
139068846|NCT00420407|Coagulants|coagulants|mesh-ancestor
139068847|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139068848|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139068849|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
139068850|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068851|NCT03789370|Propofol|propofol|mesh-list
139068852|NCT03789370|Sevoflurane|sevoflurane|mesh-list
139068853|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139068854|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139068856|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139068857|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
138262236|NCT04265053|Hormones|hormones|mesh-ancestor
139068858|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
139068859|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139068860|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139068861|NCT00420095|Insulin|insulin|mesh-list
139068862|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139068863|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
139068864|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139068865|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068866|NCT01038089|Resveratrol|resveratrol|mesh-list
139068867|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
139068868|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068869|NCT01038089|Protective Agents|protective agents|mesh-ancestor
138262292|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138262296|NCT01992523|Ticagrelor|ticagrelor|mesh-list
139068870|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068871|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068872|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139068873|NCT00419393|Levetiracetam|levetiracetam|mesh-list
139068874|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
139068875|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
139068876|NCT01038167|Cyclosporine|cyclosporine|mesh-list
139068878|NCT01038167|Cyclosporins|cyclosporins|mesh-list
139068879|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139068880|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
139068881|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068882|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139068883|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068884|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068885|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
139068886|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068887|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
139068888|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139068889|NCT03787030|Vitamin E|vitamin e|mesh-list
139068890|NCT03787030|Tocopherols|tocopherols|mesh-list
139068891|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
139068893|NCT03787030|Vitamins|vitamins|mesh-ancestor
139068894|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
139068895|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068896|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
139068897|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068898|NCT03787030|Protective Agents|protective agents|mesh-ancestor
138185363|NCT02789410|Morphine|morphine|mesh-list
139068899|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
139068900|NCT03786562|Morphine|morphine|mesh-list
139068901|NCT03786562|Nalbuphine|nalbuphine|mesh-list
139068902|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139068903|NCT03786562|Narcotics|narcotics|mesh-ancestor
139068904|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139068905|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068906|NCT03786562|Analgesics|analgesics|mesh-ancestor
139068907|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
138928134|NCT00768183|Ethanol|ethanol|mesh-list
139068908|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139068910|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
139068911|NCT01305226|Streptokinase|streptokinase|mesh-list
139068912|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139068913|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139068914|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068915|NCT01308268|Ivermectin|ivermectin|mesh-list
139068916|NCT01308268|Albendazole|albendazole|mesh-list
139068917|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139068918|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068919|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
139068920|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
139068921|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139068922|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139068923|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
139068924|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
139068925|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
139068926|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068927|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068928|NCT01308346|Everolimus|everolimus|mesh-list
139068929|NCT01308346|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138928169|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
139068930|NCT01308346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139068932|NCT01308346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068934|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
139068935|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068936|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068937|NCT05694130|Prednisolone|prednisolone|mesh-list
139068938|NCT05694130|Tacrolimus|tacrolimus|mesh-list
139068939|NCT05694130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139068940|NCT05694130|Immunologic Factors|immunologic factors|mesh-ancestor
139068941|NCT05694130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068942|NCT05694130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139068943|NCT05694130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068944|NCT05694130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068945|NCT05694130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139068946|NCT05694130|Glucocorticoids|glucocorticoids|mesh-ancestor
139068947|NCT05694130|Hormones|hormones|mesh-ancestor
139068948|NCT05694130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139068949|NCT05694130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139068950|NCT05694130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068951|NCT00419159|Everolimus|everolimus|mesh-list
139068952|NCT00419159|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139068953|NCT00419159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139068954|NCT00419159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068955|NCT00419159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068956|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139068957|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
139068958|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068959|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068960|NCT03717064|Pitavastatin|pitavastatin|mesh-list
139068961|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139068962|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139068963|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139068964|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
139068965|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068966|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068967|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139068968|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
139068969|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
139068970|NCT02113163|Metformin|metformin|mesh-list
139068971|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
139068972|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139068973|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139068974|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139068975|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139068976|NCT00413153|Ritonavir|ritonavir|mesh-list
139068977|NCT00413153|Lopinavir|lopinavir|mesh-list
139068978|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139068979|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138262583|NCT02896595|Anesthetics|anesthetics|mesh-list
139068980|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139068981|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
139068982|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139068983|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068984|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139068985|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139068986|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
139068987|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139068988|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139068989|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139068990|NCT02107937|Paclitaxel|paclitaxel|mesh-list
139068991|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139068992|NCT02107937|Carboplatin|carboplatin|mesh-list
139068993|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139068994|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139068995|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
139068996|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
139068997|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
139068998|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139068999|NCT01312402|Brinzolamide|brinzolamide|mesh-list
138262628|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139069000|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139069002|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069003|NCT05693428|Propofol|propofol|mesh-list
139069004|NCT05693428|Sevoflurane|sevoflurane|mesh-list
139069005|NCT05693428|Isoflurane|isoflurane|mesh-list
139069006|NCT05693428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138819592|NCT03337087|Antidotes|antidotes|mesh-ancestor
139069007|NCT05693428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069008|NCT05693428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069009|NCT05693428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139069010|NCT05693428|Anesthetics, General|anesthetics, general|mesh-ancestor
139069011|NCT05693428|Anesthetics|anesthetics|mesh-ancestor
139069012|NCT05693428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139069013|NCT05693428|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139069015|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
139069016|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
139069017|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069018|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069019|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139069020|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139069021|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139069022|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069023|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139069024|NCT01561066|Octreotide|octreotide|mesh-list
139069025|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139069026|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139069027|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139069028|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069029|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
139069030|NCT01561066|Coagulants|coagulants|mesh-ancestor
139069031|NCT00419003|Lamotrigine|lamotrigine|mesh-list
139069032|NCT00419003|Ketamine|ketamine|mesh-list
139069033|NCT00419003|Riluzole|riluzole|mesh-list
139069034|NCT00419003|Analgesics|analgesics|mesh-ancestor
139069035|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
139069036|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069037|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069038|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139069039|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139069040|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
139069042|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069043|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139069044|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139069045|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069046|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069047|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
139069048|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139069049|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139069050|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139069051|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139069052|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139069053|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139069054|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138262798|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069055|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139069056|NCT00419003|Protective Agents|protective agents|mesh-ancestor
139069057|NCT00418691|Methylphenidate|methylphenidate|mesh-list
139069058|NCT00418691|Modafinil|modafinil|mesh-list
139069059|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139069060|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069061|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139069062|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139069063|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139069064|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069065|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
139069066|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069067|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
139069068|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139069069|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139069070|NCT03781258|Warfarin|warfarin|mesh-list
139069071|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
139069072|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139069073|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139069074|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139069075|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069076|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069077|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139069078|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138928635|NCT00667251|Paclitaxel|paclitaxel|mesh-list
139069079|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139069080|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
139069081|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069082|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069083|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139069084|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139069085|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
139069086|NCT01308658|Ritonavir|ritonavir|mesh-list
139069087|NCT01308658|Darunavir|darunavir|mesh-list
139069088|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139069089|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139069090|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
139069091|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069092|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069093|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139069094|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139069095|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
139069096|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069097|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139069098|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139069099|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
139069100|NCT03777514|Hematinics|hematinics|mesh-ancestor
139069101|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
139069102|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139069103|NCT03777124|Carboplatin|carboplatin|mesh-list
139069104|NCT03777124|Pemetrexed|pemetrexed|mesh-list
139069105|NCT03777124|Apatinib|apatinib|mesh-list
139069106|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069107|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262903|NCT01962961|Protective Agents|protective agents|mesh-ancestor
139069108|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069109|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139069110|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139069111|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139069112|NCT00418379|Immunomodulating Agents|immunomodulating agents|mesh-list
139069113|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
139069114|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069115|NCT03780556|Lornoxicam|lornoxicam|mesh-list
139069116|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139069117|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139069118|NCT03780556|Analgesics|analgesics|mesh-ancestor
139069119|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
139069120|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069121|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069122|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139069123|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139069124|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
139069125|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139069126|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139069127|NCT00418145|Prednisolone|prednisolone|mesh-list
139069128|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
139069129|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139069130|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
139069131|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139069132|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
139069133|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
138262955|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
139069134|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069135|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069136|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139069137|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
139069138|NCT00418145|Hormones|hormones|mesh-ancestor
139069139|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139069140|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138928850|NCT01022047|Hormones|hormones|mesh-ancestor
139069141|NCT00418145|Protective Agents|protective agents|mesh-ancestor
139069142|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139069143|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069144|NCT03780634|Sorafenib|sorafenib|mesh-list
139069145|NCT03780634|Antibodies|antibodies|mesh-list
139069146|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
139069147|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
139069148|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069149|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069150|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139069151|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069152|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069154|NCT03777280|Chromium|chromium|mesh-list
139069155|NCT03777280|Trace Elements|trace elements|mesh-ancestor
139069156|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
139069157|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069158|NCT02043587|Leucovorin|leucovorin|mesh-list
139069160|NCT02043587|Prednisone|prednisone|mesh-list
139069161|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
139069162|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139069163|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139069164|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139069165|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
139069166|NCT02043587|Rituximab|rituximab|mesh-list
139069167|NCT02043587|Methotrexate|methotrexate|mesh-list
139069168|NCT02043587|Etoposide|etoposide|mesh-list
139069169|NCT02043587|Vincristine|vincristine|mesh-list
139069170|NCT02043587|Daunorubicin|daunorubicin|mesh-list
139069171|NCT02043587|Asparaginase|asparaginase|mesh-list
139069172|NCT02043587|Dasatinib|dasatinib|mesh-list
139069173|NCT02043587|Pegaspargase|pegaspargase|mesh-list
138929047|NCT00781131|Pregabalin|pregabalin|mesh-list
139069174|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139069175|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
139069176|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263063|NCT02006108|Hematinics|hematinics|mesh-ancestor
139069177|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139069178|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139069179|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
139069180|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069181|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791278|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
139069182|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139069183|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139069184|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139069185|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
139069186|NCT02043587|Hormones|hormones|mesh-ancestor
139069187|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139069188|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139069189|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139069190|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
139069191|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138263114|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
139069192|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139069193|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
139069194|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
139069195|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069196|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139069197|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139069198|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139069199|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139069200|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139069201|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
139069202|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069203|NCT02043587|Antidotes|antidotes|mesh-ancestor
139069204|NCT02043587|Protective Agents|protective agents|mesh-ancestor
139069205|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
139069206|NCT02043587|Vitamins|vitamins|mesh-ancestor
139069207|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
139069208|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
139069209|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
139069210|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
139069211|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139069212|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139069213|NCT01561222|Calcitriol|calcitriol|mesh-list
139069214|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139069215|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069216|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139069217|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139069218|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069219|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139069220|NCT01561222|Vitamins|vitamins|mesh-ancestor
139069221|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
139069222|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139069223|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
139069224|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
139069225|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138263227|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
139069226|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139069227|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
139069228|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069229|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069230|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069231|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
139069232|NCT01039025|Melphalan|melphalan|mesh-list
139069233|NCT01039025|Topotecan|topotecan|mesh-list
139069234|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139069235|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
139069236|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069237|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139069238|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139069239|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
139069240|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069241|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069242|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139069243|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139069244|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139069245|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069246|NCT03779776|Vitamins|vitamins|mesh-list
139069247|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
139069248|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069249|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139069250|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069251|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139069252|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069253|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069254|NCT01035593|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
139069255|NCT01035593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
139069256|NCT01035593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139069257|NCT01035593|Immunologic Factors|immunologic factors|mesh-ancestor
139069258|NCT01035593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069259|NCT01317784|Antibodies|antibodies|mesh-list
139069260|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
139069261|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
139069262|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
139069263|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069264|NCT03779464|Gemcitabine|gemcitabine|mesh-list
139069265|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139069266|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
139069267|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069268|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069270|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139069271|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069272|NCT03784378|Agerafenib|agerafenib|mesh-list
139069273|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139069274|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069275|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069276|NCT01314898|Spironolactone|spironolactone|mesh-list
138263398|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
139069277|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139069279|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139069280|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791376|NCT04290936|Tenofovir|tenofovir|mesh-list
139069281|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139069282|NCT01314898|Diuretics|diuretics|mesh-ancestor
139069283|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
139069284|NCT01315912|Letrozole|letrozole|mesh-list
139069285|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069286|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139069287|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139069288|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069289|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069290|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139069291|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
139069292|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139069293|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069294|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
139069295|NCT03778450|Analgesics|analgesics|mesh-list
139069296|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
139069297|NCT03778450|Narcotics|narcotics|mesh-ancestor
139069298|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069299|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069300|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
139069301|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069302|NCT03776500|Macozinone|macozinone|mesh-list
139069303|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
139069304|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929369|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
139069305|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069306|NCT03778138|Pemetrexed|pemetrexed|mesh-list
139069307|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069308|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069309|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069310|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139069311|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139069313|NCT03783754|Telmisartan|telmisartan|mesh-list
139069314|NCT03783754|Indapamide|indapamide|mesh-list
139069315|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139069316|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139069317|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139069318|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069319|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139069320|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069321|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
139069322|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139069323|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139069324|NCT03783754|Diuretics|diuretics|mesh-ancestor
139069325|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
139069326|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139069327|NCT01309438|Erythromycin|erythromycin|mesh-list
139069328|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
139069329|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
139069330|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
139069332|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139069333|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
139069334|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139069335|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
139069336|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069337|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069338|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
139069339|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139069340|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069341|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139069342|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139069344|NCT03776032|Hematinics|hematinics|mesh-ancestor
139069345|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
139069346|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069347|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
139069348|NCT03775876|Propofol|propofol|mesh-list
139069349|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139069350|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069351|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069352|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138791463|NCT05326555|Imidacloprid|imidacloprid|mesh-list
138791464|NCT05326555|Cholinergic Agents|cholinergic agents|mesh-ancestor
138791465|NCT05326555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791466|NCT05326555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791467|NCT05326555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791468|NCT02610829|Vitamin E|vitamin e|mesh-list
138791469|NCT02610829|Tocopherols|tocopherols|mesh-list
139069353|NCT03775876|Analgesics|analgesics|mesh-ancestor
139069354|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
139069355|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069356|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139069357|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139069358|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139069359|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
139069360|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069361|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069362|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139069363|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
139069364|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
139069365|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
139069366|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
139069367|NCT01320514|Coagulants|coagulants|mesh-ancestor
139069368|NCT03773536|Artesunate|artesunate|mesh-list
139069369|NCT03773536|Primaquine|primaquine|mesh-list
139069370|NCT03773536|Amodiaquine|amodiaquine|mesh-list
139069371|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
139069372|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139069374|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069375|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069376|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
139069377|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
139069378|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139069379|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
139069380|NCT01320592|Paclitaxel|paclitaxel|mesh-list
139069381|NCT01320592|Palbociclib|palbociclib|mesh-list
139069382|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139069383|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069384|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
139069385|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
139069386|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
139069387|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069388|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139069389|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791523|NCT00708565|Iloprost|iloprost|mesh-list
139069390|NCT03783676|Remifentanil|remifentanil|mesh-list
139069391|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139069392|NCT03783676|Narcotics|narcotics|mesh-ancestor
139069393|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069394|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069395|NCT03783676|Analgesics|analgesics|mesh-ancestor
139069396|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
139069397|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069398|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
139069399|NCT03783520|Eusol|eusol|mesh-list
139069400|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
139069401|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069402|NCT01320982|Aspirin|aspirin|mesh-list
139069403|NCT01320982|Minocycline|minocycline|mesh-list
139069404|NCT01320982|Pramipexole|pramipexole|mesh-list
139069405|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139069406|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139069407|NCT01320982|Analgesics|analgesics|mesh-ancestor
139069408|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
139069409|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069410|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069411|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139069412|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139069413|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139069415|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069416|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139069417|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139069418|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069419|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
139069420|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139069421|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069422|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
139069423|NCT01320982|Protective Agents|protective agents|mesh-ancestor
139069424|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139069425|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139069426|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
139069427|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
139069428|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069429|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
139069430|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139069431|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139069432|NCT01321138|Morphine|morphine|mesh-list
139069433|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139069434|NCT01321138|Narcotics|narcotics|mesh-ancestor
139069435|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069436|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069437|NCT01321138|Analgesics|analgesics|mesh-ancestor
139069438|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
139069439|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069440|NCT04628572|Ceftazidime|ceftazidime|mesh-list
139069441|NCT04628572|Avibactam|avibactam|mesh-list
139069442|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
139069443|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139069444|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069445|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139069446|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069447|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069448|NCT03772990|Calcium|calcium|mesh-list
139069449|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139069450|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069451|NCT03782662|Itraconazole|itraconazole|mesh-list
139069452|NCT03782662|Rifampin|rifampin|mesh-list
139069453|NCT03782662|Verapamil|verapamil|mesh-list
139069454|NCT03782662|Midazolam|midazolam|mesh-list
139069455|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139069456|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138263897|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069457|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069458|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069459|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139069460|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138929612|NCT02576288|Incretins|incretins|mesh-ancestor
139069461|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139069462|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139069463|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
139069464|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
139069465|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
139069466|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
139069467|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069468|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069469|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
139069470|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069471|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139069472|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139069473|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069474|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139069475|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
139069476|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263956|NCT02877485|Hormones|hormones|mesh-ancestor
139069477|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139069478|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139069479|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
139069480|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139069481|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
139069482|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139069483|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139069484|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139069485|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139069486|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139069487|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139069488|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139069489|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139069490|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139069491|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139069492|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139069493|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
139069494|NCT01309984|Propofol|propofol|mesh-list
139069495|NCT01309984|Fospropofol|fospropofol|mesh-list
139069496|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139069497|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069498|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069499|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139069500|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
139069501|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
139069502|NCT03772054|Propofol|propofol|mesh-list
139069503|NCT03772054|Sevoflurane|sevoflurane|mesh-list
139069504|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138264014|NCT02959853|Anastrozole|anastrozole|mesh-list
139069505|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069506|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069507|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139069509|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
139069510|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139069511|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139069512|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
139069513|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139069514|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069515|NCT03771820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139069516|NCT03771820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069517|NCT05531890|Betamethasone|betamethasone|mesh-list
139069518|NCT05531890|Betamethasone Valerate|betamethasone valerate|mesh-list
139069519|NCT05531890|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
139069520|NCT05531890|Betamethasone benzoate|betamethasone benzoate|mesh-list
139069521|NCT05531890|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139069522|NCT05531890|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
139069523|NCT05531890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139069524|NCT05531890|Glucocorticoids|glucocorticoids|mesh-ancestor
139069525|NCT05531890|Hormones|hormones|mesh-ancestor
139069526|NCT05531890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139069527|NCT05531890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069528|NCT05531890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139069529|NCT05531890|Respiratory System Agents|respiratory system agents|mesh-ancestor
139069530|NCT00123474|Dasatinib|dasatinib|mesh-list
139069531|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069532|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139069533|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069534|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820111|NCT00580801|Interferons|interferons|mesh-list
138791663|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138791664|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139069536|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
139069537|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069538|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139069539|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069540|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069541|NCT03774706|Misoprostol|misoprostol|mesh-list
139069542|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
139069543|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139069544|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139069545|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069546|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
139069547|NCT03774706|Coagulants|coagulants|mesh-ancestor
139069548|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139069549|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
139069550|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139069551|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069552|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139069553|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139069554|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
139069555|NCT03967496|Metformin|metformin|mesh-list
139069556|NCT03967496|Amlodipine|amlodipine|mesh-list
139069557|NCT03967496|Lisinopril|lisinopril|mesh-list
139069558|NCT03967496|Bisoprolol|bisoprolol|mesh-list
139069559|NCT03967496|Hydralazine|hydralazine|mesh-list
139069560|NCT03967496|Anesthetics|anesthetics|mesh-list
139069561|NCT03967496|Atorvastatin|atorvastatin|mesh-list
139069562|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139069563|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069564|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069565|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139069566|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139069567|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
139069568|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069569|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139069570|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139069571|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069572|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139069573|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138685681|NCT02929719|Dapsone|dapsone|mesh-list
139069574|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139069575|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139069576|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
139069577|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139069578|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
139069579|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138929777|NCT00665847|Etravirine|etravirine|mesh-list
139069580|NCT03967496|Protective Agents|protective agents|mesh-ancestor
139069581|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
139069582|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
139069583|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069584|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139069585|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139069586|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139069587|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
139069588|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069589|NCT00412061|Everolimus|everolimus|mesh-list
139069590|NCT00412061|Octreotide|octreotide|mesh-list
139069591|NCT00412061|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139069592|NCT00412061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139069593|NCT00412061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069594|NCT00412061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069595|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139069596|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
139069597|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069598|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069599|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139069600|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139069601|NCT03964350|Ethanol|ethanol|mesh-list
139069602|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139069603|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069604|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069605|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069606|NCT01310452|Insulin|insulin|mesh-list
139069607|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139069608|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
139069609|NCT01310452|Protamines|protamines|mesh-list
139069610|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139069611|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069612|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
139069613|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069614|NCT01310452|Coagulants|coagulants|mesh-ancestor
139069615|NCT01035671|Vitamin E|vitamin e|mesh-list
139069616|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
139069617|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
139069618|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139069619|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
138685712|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685713|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139069620|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069622|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069623|NCT01035671|Vitamins|vitamins|mesh-ancestor
139069624|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
139069625|NCT04560868|Nicotine|nicotine|mesh-list
139069626|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139069627|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
139069628|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069629|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069630|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139069631|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139069632|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
139069633|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069634|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069635|NCT03769402|Citric Acid|citric acid|mesh-list
139069636|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
139069637|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
139069638|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139069639|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
139069640|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
139069641|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069642|NCT00411671|Sorafenib|sorafenib|mesh-list
139069643|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069644|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139069645|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069646|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069647|NCT03770806|Acetaminophen|acetaminophen|mesh-list
139069648|NCT03770806|Celecoxib|celecoxib|mesh-list
139069649|NCT03770806|Oxycodone|oxycodone|mesh-list
139069650|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139069651|NCT03770806|Analgesics|analgesics|mesh-ancestor
139069652|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
139069653|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069654|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069655|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
139069656|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139069657|NCT03770806|Narcotics|narcotics|mesh-ancestor
139069658|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069659|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139069660|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139069661|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139069662|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139069663|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139069664|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929854|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
139069665|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069666|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
139069667|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139069668|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139069669|NCT01039103|Prednisolone|prednisolone|mesh-list
139069670|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
139069671|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139069672|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
139069673|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139069674|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
139069675|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
139069676|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069677|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069678|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139069679|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
139069680|NCT01039103|Hormones|hormones|mesh-ancestor
139069681|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139069682|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139069683|NCT01039103|Protective Agents|protective agents|mesh-ancestor
139069684|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139069685|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820262|NCT01057589|Hematinics|hematinics|mesh-ancestor
139069686|NCT01039181|Vitamin D|vitamin d|mesh-list
139069688|NCT01039181|Vitamins|vitamins|mesh-ancestor
139069689|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
139069690|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069691|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139069692|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139069693|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139069694|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139069695|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069698|NCT03770026|Enclomiphene|enclomiphene|mesh-list
139069699|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
139069700|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139069701|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
139069702|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139069703|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069704|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139069705|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
139069706|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139069707|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139069708|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139069709|NCT03769870|Atorvastatin|atorvastatin|mesh-list
139069710|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139069711|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139069712|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
139069713|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069714|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138685768|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138685769|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139069715|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139069716|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069717|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139069718|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139069719|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069720|NCT01567540|Incretins|incretins|mesh-ancestor
139069721|NCT01567540|Hormones|hormones|mesh-ancestor
138929937|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
139069722|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139069723|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139069724|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
139069725|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069726|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069727|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
139069728|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
139069729|NCT01036841|Coagulants|coagulants|mesh-ancestor
139069730|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139069731|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
139069732|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069733|NCT03709576|Azacitidine|azacitidine|mesh-list
139069734|NCT03709576|Pevonedistat|pevonedistat|mesh-list
139069735|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139069736|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
139069737|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069738|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069739|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069740|NCT00122460|Cisplatin|cisplatin|mesh-list
139069741|NCT00122460|Carboplatin|carboplatin|mesh-list
139069742|NCT00122460|Fluorouracil|fluorouracil|mesh-list
139069743|NCT00122460|Cetuximab|cetuximab|mesh-list
139069744|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069745|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
139069746|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069747|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139069748|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139069749|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
139069750|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069751|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138685799|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138685800|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685801|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138685802|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138685809|NCT02946437|Midazolam|midazolam|mesh-list
139069753|NCT03763396|Posaconazole|posaconazole|mesh-list
139069754|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
139069755|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069756|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139069757|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139069758|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069759|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820340|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
139069760|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139069761|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
139069762|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139069763|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069764|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139069765|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139069766|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139069767|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139069768|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
139069770|NCT01320436|Mesalamine|mesalamine|mesh-list
139069771|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139069772|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139069773|NCT01320436|Analgesics|analgesics|mesh-ancestor
139069774|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
139069775|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069776|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069777|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139069778|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139069779|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069780|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069781|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069782|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
139069783|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139069784|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069785|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
139069786|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069787|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139069788|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069789|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069790|NCT03763084|Acetaminophen|acetaminophen|mesh-list
139069791|NCT03763084|Sufentanil|sufentanil|mesh-list
139069792|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139069794|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
139069795|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069796|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069797|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
139069798|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139069799|NCT03763084|Narcotics|narcotics|mesh-ancestor
139069800|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069801|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139069802|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139069803|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
139069804|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
139069805|NCT01567618|Docetaxel|docetaxel|mesh-list
139069806|NCT01567618|Fluorouracil|fluorouracil|mesh-list
139069807|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069808|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
139069809|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
139069810|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
139069811|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069812|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
139069813|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139069814|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139069815|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
139069816|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069817|NCT04771078|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
139069818|NCT04771078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139069819|NCT04771078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069820|NCT03762928|Efavirenz|efavirenz|mesh-list
139069821|NCT03762928|Midazolam|midazolam|mesh-list
139069822|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139069823|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139069824|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069825|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069826|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139069827|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139069828|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139069829|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139069830|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
139069831|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
139069833|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
139069834|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069835|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069836|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139069837|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139069838|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069839|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
139069840|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069841|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139069842|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138264721|NCT05363501|Naloxone|naloxone|mesh-list
138930168|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
138685860|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139069844|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139069845|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139069846|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139069848|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069849|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
139069850|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
139069851|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
139069852|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069853|NCT00137436|Prednisone|prednisone|mesh-list
139069854|NCT00137436|Docetaxel|docetaxel|mesh-list
139069855|NCT00137436|Sunitinib|sunitinib|mesh-list
139069856|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069857|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
139069858|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
139069859|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
139069860|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069861|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139069862|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
139069863|NCT00137436|Hormones|hormones|mesh-ancestor
139069864|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139069865|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069866|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139069867|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139069868|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139069869|NCT00137436|Growth Substances|growth substances|mesh-ancestor
139069870|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
139069871|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139069872|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069874|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139069875|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139069876|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069877|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139069878|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
139069879|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
139069880|NCT03762382|Tenofovir|tenofovir|mesh-list
139069881|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
139069882|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
139069883|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138930366|NCT00712556|Fluorides|fluorides|mesh-list
139069884|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139069885|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139069886|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069887|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069888|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139069889|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139069890|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139069891|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
139069892|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139069893|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069894|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139069895|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139069896|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139069897|NCT03767920|Dexamethasone|dexamethasone|mesh-list
139069898|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
139069899|NCT03767920|Bupivacaine|bupivacaine|mesh-list
139069901|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139069902|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
139069903|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
139069904|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069905|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685938|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
139069906|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139069907|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
139069908|NCT03767920|Hormones|hormones|mesh-ancestor
139069909|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139069910|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139069911|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069913|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069914|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069915|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
139069916|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
139069917|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138930621|NCT01247324|Interferons|interferons|mesh-list
139069918|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
139069919|NCT03834623|Nivolumab|nivolumab|mesh-list
139069920|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139069921|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069922|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139069923|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069924|NCT03762148|Vitamins|vitamins|mesh-list
139069925|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
139069926|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
139069927|NCT03762148|Iron|iron|mesh-list
139069928|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
139069929|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069930|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
139069931|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069932|NCT03762148|Protective Agents|protective agents|mesh-ancestor
139069933|NCT03762148|Trace Elements|trace elements|mesh-ancestor
139069934|NCT01589159|Capecitabine|capecitabine|mesh-list
139069935|NCT01589159|Etoposide|etoposide|mesh-list
139069936|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139069937|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
139069938|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069939|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069940|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139069941|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139069942|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139069943|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069944|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139069945|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139069946|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
139069947|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139069948|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069949|NCT03937895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139069950|NCT03937895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069951|NCT03767296|Phenylephrine|phenylephrine|mesh-list
139069952|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
139069953|NCT03767296|Ephedrine|ephedrine|mesh-list
139069954|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
139069955|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139069956|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
139069957|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
139069958|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069959|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069960|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
139069961|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139069962|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
139069963|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
139069964|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139069965|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139069966|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139069967|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
139069968|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139069969|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069970|NCT03767296|Protective Agents|protective agents|mesh-ancestor
139069971|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139069972|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139069973|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139069974|NCT00410813|Dasatinib|dasatinib|mesh-list
139069975|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069976|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139069977|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139069978|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069979|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
139069980|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139069981|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138930941|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139069982|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139069983|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139069984|NCT03760978|Analgesics|analgesics|mesh-ancestor
139069985|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
139069986|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139069987|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139069988|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139069989|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139069990|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
139069991|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686069|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686088|NCT02927496|Doxycycline|doxycycline|mesh-list
139069992|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139069994|NCT03766984|Tramadol|tramadol|mesh-list
139069995|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139069996|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139069997|NCT03766984|Analgesics|analgesics|mesh-ancestor
139069998|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
138583033|NCT00142428|Cetuximab|cetuximab|mesh-list
139069999|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139070000|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070001|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139070002|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139070003|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139070004|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070005|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070006|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139070008|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139070009|NCT00405821|Acyclovir|acyclovir|mesh-list
139070010|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
139070011|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070012|NCT03928600|Misoprostol|misoprostol|mesh-list
139070013|NCT03928600|Dinoprostone|dinoprostone|mesh-list
139070014|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139070015|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
139070016|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139070017|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686120|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139070018|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139070019|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139070020|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
139070021|NCT01322152|Capecitabine|capecitabine|mesh-list
139070022|NCT01322152|Irinotecan|irinotecan|mesh-list
139070023|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139070024|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
139070025|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070026|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070027|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139070028|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139070029|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070031|NCT01446016|Docetaxel|docetaxel|mesh-list
139070032|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139070033|NCT01446016|Taxane|taxane|mesh-list
139070034|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139070035|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070036|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
139070037|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
139070038|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
139070039|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070040|NCT00137046|Insulin|insulin|mesh-list
139070041|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139070042|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070043|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070044|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
138362992|NCT03029676|Analgesics|analgesics|mesh-ancestor
139070045|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139070046|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139070047|NCT03760354|Prednisolone|prednisolone|mesh-list
139070048|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
139070049|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139070050|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
139070051|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139070052|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
139070053|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
139070054|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139070055|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070056|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139070057|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
139070059|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139070060|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139070061|NCT03760354|Protective Agents|protective agents|mesh-ancestor
139070062|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139070063|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070064|NCT03760276|Voriconazole|voriconazole|mesh-list
139070065|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
139070066|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070067|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139070068|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139070069|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070070|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070071|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139070072|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
139070073|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139070074|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070075|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139070076|NCT03766594|Folic Acid|folic acid|mesh-list
139070077|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
138264951|NCT02049307|Losartan|losartan|mesh-list
138686216|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139070078|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070079|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
139070080|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139070081|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139070082|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070083|NCT03766594|Urological Agents|urological agents|mesh-ancestor
139070084|NCT03766594|Hematinics|hematinics|mesh-ancestor
139070085|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
139070086|NCT03766594|Vitamins|vitamins|mesh-ancestor
139070087|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
139070088|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070089|NCT00122382|Methotrexate|methotrexate|mesh-list
139070090|NCT00122382|Abatacept|abatacept|mesh-list
139070091|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139070092|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
139070093|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138931568|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070094|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070095|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139070096|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
139070097|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070098|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070099|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
139070100|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070101|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139070102|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070103|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
139070104|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139070105|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139070106|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139070107|NCT00122382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139070108|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
139070109|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
139070110|NCT01028716|Fludarabine|fludarabine|mesh-list
139070111|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
139070112|NCT01028716|Tacrolimus|tacrolimus|mesh-list
139070113|NCT01028716|Lenograstim|lenograstim|mesh-list
139070114|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070115|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
139070116|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070117|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139070118|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139070119|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
139070120|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070121|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070123|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139070124|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
139070125|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139070126|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139070127|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070128|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139070129|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139070130|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
139070131|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139070132|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686313|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138686314|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
138686315|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070134|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138820710|NCT01007942|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139070135|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
139070136|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139070137|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139070138|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070139|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070140|NCT02531724|Protective Agents|protective agents|mesh-ancestor
139070141|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070142|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139070143|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139070144|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139070145|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070146|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139070147|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139070148|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070149|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
139070150|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139070152|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139070153|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070154|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070155|NCT00106704|Incretins|incretins|mesh-ancestor
139070156|NCT00106704|Hormones|hormones|mesh-ancestor
138686345|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
138686346|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686347|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
138686348|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686349|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
138686350|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070157|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139070158|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139070159|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
139070160|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070161|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070163|NCT03759886|Paromomycin|paromomycin|mesh-list
139070164|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070165|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139070166|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139070167|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139070169|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139070170|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
139070171|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139070172|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139070174|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070175|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070176|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139070177|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139070178|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
139070179|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070180|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139070181|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139070182|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
139070183|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070185|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070186|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070188|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070189|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070190|NCT05208268|Rabeprazole|rabeprazole|mesh-list
139070191|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139070192|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139070193|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139070194|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932147|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
139070195|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070197|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
139070198|NCT03759262|Vitamins|vitamins|mesh-ancestor
139070199|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
139070200|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070201|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139070202|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139070203|NCT00135330|Exenatide|exenatide|mesh-list
139070204|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
139070205|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070206|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070207|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139070208|NCT00135330|Incretins|incretins|mesh-ancestor
138820788|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
139070209|NCT00135330|Hormones|hormones|mesh-ancestor
139070210|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139070211|NCT01076478|Cilostazol|cilostazol|mesh-list
139070212|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139070213|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
139070214|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139070215|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070216|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138932277|NCT05764876|Azithromycin|azithromycin|mesh-list
139070217|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
139070218|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139070219|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138686437|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138686438|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138686439|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686440|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
138686441|NCT04231968|Ziresovir|ziresovir|mesh-list
138686442|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
139070220|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070221|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139070222|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
138932342|NCT05610800|Exenatide|exenatide|mesh-list
139070223|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139070224|NCT01076478|Protective Agents|protective agents|mesh-ancestor
139070225|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139070226|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139070227|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070228|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
139070229|NCT01076556|Rituximab|rituximab|mesh-list
139070230|NCT01076556|Alvocidib|alvocidib|mesh-list
138584381|NCT00141011|Ancrod|ancrod|mesh-list
139070232|NCT01076556|Antibodies|antibodies|mesh-list
139070233|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
139070234|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139070235|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070236|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
139070237|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070238|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139070239|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138265157|NCT04652414|Hormones|hormones|mesh-ancestor
139070240|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
139070241|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070242|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070243|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139070245|NCT01076556|Growth Substances|growth substances|mesh-ancestor
139070246|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139070247|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070248|NCT03965442|Esmolol|esmolol|mesh-list
139070249|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139070250|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139070251|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139070252|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
139070253|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686476|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138686477|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
138686483|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
139070254|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070255|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070256|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
139070257|NCT00134082|Rituximab|rituximab|mesh-list
139070258|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070259|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
139070260|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070261|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139070262|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139070263|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
139070264|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070265|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070266|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139070267|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139070268|NCT03765346|Oxycodone|oxycodone|mesh-list
139070269|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139070270|NCT03765346|Narcotics|narcotics|mesh-ancestor
139070271|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139070272|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686516|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070273|NCT03765346|Analgesics|analgesics|mesh-ancestor
139070274|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
139070275|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139070276|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
139070277|NCT01078818|Trace Elements|trace elements|mesh-ancestor
139070278|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
139070279|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070280|NCT01079052|Famotidine|famotidine|mesh-list
139070281|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139070282|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138820867|NCT00996944|Ropinirole|ropinirole|mesh-list
139070283|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138932678|NCT04447092|Leucovorin|leucovorin|mesh-list
139070284|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
139070285|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
139070286|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139070287|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070288|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070289|NCT01326468|Sirolimus|sirolimus|mesh-list
139070290|NCT01326468|Cisplatin|cisplatin|mesh-list
139070291|NCT01326468|Cetuximab|cetuximab|mesh-list
139070292|NCT01326468|Temsirolimus|temsirolimus|mesh-list
139070293|NCT01326468|MTOR Inhibitors|mtor inhibitors|mesh-list
139070294|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070295|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139070296|NCT01326468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139070297|NCT01326468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070298|NCT01326468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070299|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070300|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
139070301|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070302|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139070303|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070304|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139070305|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
139070306|NCT01076634|Insulin|insulin|mesh-list
139070307|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139070308|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
139070309|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070310|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070311|NCT00132678|Risperidone|risperidone|mesh-list
139070312|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139070313|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
139070314|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085266|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139070315|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070316|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070317|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139070318|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139070319|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139070320|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139070321|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139070322|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
139070323|NCT01081548|Atorvastatin|atorvastatin|mesh-list
139070324|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139070325|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139070326|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
138686619|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139070327|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070328|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139070329|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139070330|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070331|NCT00101400|Sorafenib|sorafenib|mesh-list
139070332|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070333|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139070334|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070335|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070336|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
139070337|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139070338|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139070339|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932905|NCT03642990|Niacinamide|niacinamide|mesh-list
139070340|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139070342|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
139070343|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139070344|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139070345|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139070346|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139070347|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
138686668|NCT04000854|Calcium|calcium|mesh-list
139070348|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139070349|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070350|NCT01582932|Calcipotriene|calcipotriene|mesh-list
139070351|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
139070352|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
139070353|NCT03965286|Ledipasvir|ledipasvir|mesh-list
139070354|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
139070355|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
139070356|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070357|NCT01079286|Sirolimus|sirolimus|mesh-list
139070358|NCT01079286|Nelfinavir|nelfinavir|mesh-list
139070359|NCT01079286|Temsirolimus|temsirolimus|mesh-list
139070361|NCT01079286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139070362|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070363|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070364|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070365|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
139070366|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070367|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070368|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139070369|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070370|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139070371|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
138686720|NCT00531557|Ritonavir|ritonavir|mesh-list
138686721|NCT00531557|Darunavir|darunavir|mesh-list
139070372|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139070373|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139070374|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
139070375|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139070376|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139070377|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
139070378|NCT01081704|Ustekinumab|ustekinumab|mesh-list
139070379|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
139070380|NCT00141518|Levodopa|levodopa|mesh-list
139070382|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139070383|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139070384|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139070385|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
139070386|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139070387|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070388|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070389|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139070390|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070391|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139070392|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
139070393|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
139070394|NCT01075880|Interferons|interferons|mesh-list
139070395|NCT01075880|Interferon-beta|interferon-beta|mesh-list
139070396|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
139070397|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070398|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
138686771|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
139070399|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070400|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
139070401|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070402|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139070403|NCT00098748|Maraviroc|maraviroc|mesh-list
139070404|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139070405|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139070406|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070407|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139070408|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139070409|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
139070410|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070411|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139070412|NCT00130520|Bevacizumab|bevacizumab|mesh-list
139070413|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139070414|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139070415|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070416|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139070417|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139070418|NCT00130520|Growth Substances|growth substances|mesh-ancestor
139070419|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070420|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
139070421|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139070422|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070423|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070425|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139070426|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
139070427|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933490|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
139070428|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070429|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
139070430|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
139070431|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139070432|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
139070433|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070435|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139070436|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139070437|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070438|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070439|NCT00253370|Cisplatin|cisplatin|mesh-list
139070440|NCT00253370|Docetaxel|docetaxel|mesh-list
139070441|NCT00253370|Sorafenib|sorafenib|mesh-list
139070442|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070443|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
139070444|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
139070445|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
139070446|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070447|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139070448|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070449|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
139070450|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
139070451|NCT00140426|Risperidone|risperidone|mesh-list
139070452|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139070453|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
139070454|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139070455|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070456|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070457|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139070458|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139070459|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139070460|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139070461|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139070462|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
139070463|NCT03966560|Timolol|timolol|mesh-list
139070464|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139070465|NCT03966560|Bimatoprost|bimatoprost|mesh-list
139070466|NCT03966560|Travoprost|travoprost|mesh-list
139070468|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139070469|NCT03966560|Latanoprost|latanoprost|mesh-list
139070470|NCT03966560|Brinzolamide|brinzolamide|mesh-list
139070471|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139070472|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070473|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070474|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139070475|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139070476|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
139070477|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139070478|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070479|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139070480|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139070481|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139070482|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139070483|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138686915|NCT02942693|Apatinib|apatinib|mesh-list
139070484|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139070485|NCT01072058|Adalimumab|adalimumab|mesh-list
139070486|NCT01072058|Infliximab|infliximab|mesh-list
139070487|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
139070488|NCT01072058|Etanercept|etanercept|mesh-list
139070489|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139070490|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139070491|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
139070492|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139070493|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139070494|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139070495|NCT01072058|Analgesics|analgesics|mesh-ancestor
139070496|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
139070497|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139070498|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070499|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070500|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
139070501|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
139070502|NCT00121134|Bevacizumab|bevacizumab|mesh-list
138265353|NCT02397265|Insulin|insulin|mesh-list
139070503|NCT00121134|Capecitabine|capecitabine|mesh-list
139070504|NCT00121134|Methotrexate|methotrexate|mesh-list
139070505|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070506|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
139070507|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070508|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139070509|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139070510|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
139070511|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070512|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070513|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139070514|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139070515|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139070516|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139070517|NCT00121134|Growth Substances|growth substances|mesh-ancestor
139070518|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
139070519|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139070520|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
139070521|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139070522|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
139070523|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139070524|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
139070525|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070526|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139070527|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139070528|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
139070529|NCT03966378|Calcium|calcium|mesh-list
139070530|NCT03966378|Caseins|caseins|mesh-list
139070531|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139070532|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070533|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
139070534|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
139070535|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070536|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139070537|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070538|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
139070539|NCT03966378|Protective Agents|protective agents|mesh-ancestor
139070540|NCT00119262|Tamoxifen|tamoxifen|mesh-list
138218801|NCT06214078|Niacin|niacin|mesh-list
139070541|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
138265406|NCT05993455|Sotorasib|sotorasib|mesh-list
139070542|NCT00119262|Bevacizumab|bevacizumab|mesh-list
139070543|NCT00119262|Doxorubicin|doxorubicin|mesh-list
139070544|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139070545|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139070546|NCT00119262|Antibodies|antibodies|mesh-list
139070547|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
138934303|NCT00923806|Aldesleukin|aldesleukin|mesh-list
139070548|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139070550|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139070551|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070552|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070553|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070554|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
139070555|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070556|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139070557|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139070558|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
139070559|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139070560|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139070561|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139070563|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
139070564|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139070565|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139070566|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139070567|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070568|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138934428|NCT00856570|Warfarin|warfarin|mesh-list
139070569|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139070570|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
139070571|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139070572|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139085267|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070573|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139070574|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139070575|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139070576|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139070577|NCT00131664|Metformin|metformin|mesh-list
139070578|NCT00131664|Glimepiride|glimepiride|mesh-list
139070579|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
139070580|NCT00131664|Maleic acid|maleic acid|mesh-list
139070581|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070582|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070583|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070584|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070585|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139070586|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070587|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
139070589|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
139070590|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070591|NCT03778996|Sirolimus|sirolimus|mesh-list
139070592|NCT03778996|Phenytoin|phenytoin|mesh-list
139070593|NCT03778996|Methoxsalen|methoxsalen|mesh-list
139070594|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
139070595|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139070596|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138687112|NCT02941367|Metformin|metformin|mesh-list
139070597|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139070598|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070599|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
139070600|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139070601|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
139070602|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070603|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070604|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070605|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
139070606|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138934690|NCT00720512|Vitamins|vitamins|mesh-ancestor
139070607|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139070608|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139070609|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139070610|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139070611|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
139070612|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
139070613|NCT03764722|Simendan|simendan|mesh-list
139070614|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139070615|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
139070616|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139070617|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139070618|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070619|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070620|NCT03764722|Protective Agents|protective agents|mesh-ancestor
139070621|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070622|NCT05024734|Gemcitabine|gemcitabine|mesh-list
139070623|NCT05024734|Docetaxel|docetaxel|mesh-list
139070624|NCT05024734|Epirubicin|epirubicin|mesh-list
139070625|NCT05024734|Mitomycins|mitomycins|mesh-list
139070626|NCT05024734|Mitomycin|mitomycin|mesh-list
139070627|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139070628|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
139070629|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070630|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070631|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
139070632|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
139070633|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
139070634|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139070635|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139070636|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139070637|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265476|NCT05992077|Sofosbuvir|sofosbuvir|mesh-list
139070638|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
139070639|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139070640|NCT03699124|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139070641|NCT03699124|Antiviral Agents|antiviral agents|mesh-ancestor
139070642|NCT03699124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070643|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
139070644|NCT03756220|Thiamine|thiamine|mesh-list
139070645|NCT03756220|Vitamins|vitamins|mesh-ancestor
139070646|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
138934760|NCT03834740|Everolimus|everolimus|mesh-list
139070647|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070648|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
139070649|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070650|NCT03756220|Protective Agents|protective agents|mesh-ancestor
139070651|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
139070652|NCT04980040|Alogliptin|alogliptin|mesh-list
139070653|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070654|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070655|NCT04980040|Incretins|incretins|mesh-ancestor
139070656|NCT04980040|Hormones|hormones|mesh-ancestor
139070657|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138687203|NCT06025773|Antacids|antacids|mesh-ancestor
139070658|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139070659|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
138821250|NCT02576353|Fentanyl|fentanyl|mesh-list
139070660|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070661|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070663|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
139070664|NCT00131352|Protective Agents|protective agents|mesh-ancestor
138934791|NCT00720590|Ritonavir|ritonavir|mesh-list
139070665|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070667|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139070668|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070669|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070670|NCT04633564|Bevacizumab|bevacizumab|mesh-list
139070671|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139070672|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070673|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139070674|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139070675|NCT04633564|Growth Substances|growth substances|mesh-ancestor
139070676|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070677|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
139070678|NCT03756064|Carboplatin|carboplatin|mesh-list
139070679|NCT03756064|Docetaxel|docetaxel|mesh-list
139070680|NCT03756064|Trastuzumab|trastuzumab|mesh-list
139070681|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070682|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
139070683|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
139070684|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
139070685|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070686|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139070687|NCT03764020|Melatonin|melatonin|mesh-list
139070688|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
139070689|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070690|NCT03764020|Protective Agents|protective agents|mesh-ancestor
139070691|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070692|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139070693|NCT00135512|Bupropion|bupropion|mesh-list
139070694|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138687303|NCT06024915|Rifampin|rifampin|mesh-list
139070695|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
139070696|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139070697|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139070698|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139070699|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139070700|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070701|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
139070702|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139070703|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070704|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139070705|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139070706|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070707|NCT00130728|Bevacizumab|bevacizumab|mesh-list
139070708|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139070709|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139070710|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070711|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139070712|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139070713|NCT00130728|Growth Substances|growth substances|mesh-ancestor
139070714|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265533|NCT05988034|Moxifloxacin|moxifloxacin|mesh-list
139070715|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
139070716|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139070717|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070718|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070719|NCT00129974|Gemcitabine|gemcitabine|mesh-list
139070720|NCT00129974|Pemetrexed|pemetrexed|mesh-list
139070721|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139070722|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
138687353|NCT06024213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070723|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070724|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070725|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070726|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139070727|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139070728|NCT03966326|Fentanyl|fentanyl|mesh-list
139070729|NCT03966326|Anesthetics|anesthetics|mesh-list
139070730|NCT03966326|Sevoflurane|sevoflurane|mesh-list
139070731|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139070732|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070733|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139070734|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139070735|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
139070736|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139070738|NCT03966326|Analgesics|analgesics|mesh-ancestor
139070739|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
139070740|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139070741|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139070742|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139070743|NCT00119106|Tenofovir|tenofovir|mesh-list
139070744|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
139070745|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070746|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139070747|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139070748|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070749|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070750|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139070751|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139070753|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139070754|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
139070755|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265567|NCT05987397|Ubiquinone|ubiquinone|mesh-list
139070756|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070757|NCT00135356|Ritonavir|ritonavir|mesh-list
139070758|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139070759|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
139070760|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
139070761|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
139070762|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139070763|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070764|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070765|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139070766|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138935178|NCT04066790|Paclitaxel|paclitaxel|mesh-list
139070767|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
139070768|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070769|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139070770|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139070771|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139070772|NCT00118716|Fluticasone|fluticasone|mesh-list
139070773|NCT00118716|Xhance|xhance|mesh-list
138935190|NCT02571192|Volixibat|volixibat|mesh-list
139070774|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139070775|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139070776|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139070778|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139070779|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070780|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139070781|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
139070782|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
139070783|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138687444|NCT06022614|Analgesics|analgesics|mesh-ancestor
139070784|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139070785|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139070786|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139070787|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
139070788|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139070789|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070790|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
139070791|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139070792|NCT03966950|Melatonin|melatonin|mesh-list
139070793|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
139070794|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070795|NCT03966950|Protective Agents|protective agents|mesh-ancestor
139070796|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265603|NCT05986838|Metformin|metformin|mesh-list
139070797|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139070798|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
139070799|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139070800|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139070801|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070802|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
139070803|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139070804|NCT01076582|Desogestrel|desogestrel|mesh-list
139070805|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139070806|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139070807|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139070808|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
139070809|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139070810|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070811|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139070812|NCT01076582|Estrogens|estrogens|mesh-ancestor
139070814|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139070815|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139070816|NCT01076582|Progestins|progestins|mesh-ancestor
139070817|NCT01081938|Insulin|insulin|mesh-list
139070818|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139070819|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
139070820|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
139070821|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070822|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070823|NCT01082796|Glipizide|glipizide|mesh-list
139070824|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070825|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070826|NCT03763786|Cetrorelix|cetrorelix|mesh-list
139070827|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139070828|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
139070829|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139070830|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070831|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
138265627|NCT05986344|Trace Elements|trace elements|mesh-ancestor
139070832|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139070833|NCT01079364|Insulin|insulin|mesh-list
139070834|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139070835|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
139070836|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
139070837|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
139070838|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139070839|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070840|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070841|NCT01077752|Acetaminophen|acetaminophen|mesh-list
139070842|NCT01077752|Lidocaine|lidocaine|mesh-list
139070843|NCT01077752|Morphine|morphine|mesh-list
139070844|NCT01077752|Ropivacaine|ropivacaine|mesh-list
139070845|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
139070846|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
139070847|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139070848|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070849|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
139070850|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139070851|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139070852|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139070853|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139070854|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139070855|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070856|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138687531|NCT06008405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070857|NCT01077752|Narcotics|narcotics|mesh-ancestor
139070858|NCT01077752|Analgesics|analgesics|mesh-ancestor
139070859|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139070860|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
139070862|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139070863|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
139070864|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139070865|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139070866|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139070867|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139070868|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070869|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
139070870|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139070871|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070872|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139070873|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139070874|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070875|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
139070876|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139070877|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070878|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
139070879|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139070881|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687560|NCT05986136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138687562|NCT05986136|Sensory System Agents|sensory system agents|mesh-ancestor
139070882|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070883|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139070885|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139070886|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
139070887|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070888|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139070889|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138935535|NCT04130204|Colchicine|colchicine|mesh-list
139070890|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
139070891|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
139070892|NCT03963648|Protective Agents|protective agents|mesh-ancestor
139070893|NCT04899232|Antithrombins|antithrombins|mesh-list
139070894|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
139070895|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139070896|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
139070897|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070898|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070899|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
139070900|NCT03757858|Antibodies|antibodies|mesh-list
139070901|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
139070902|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070903|NCT01079676|Lenograstim|lenograstim|mesh-list
139070904|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139070905|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
139070906|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070907|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139070908|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139070909|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138687613|NCT05926427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139070910|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139070911|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070912|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139070913|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139070914|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139070915|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139070916|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
139070917|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139070918|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070919|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139070920|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139070921|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
139070922|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139070923|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139070924|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
139070925|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
139070926|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070927|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070928|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
139070929|NCT04555096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139070930|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
139070931|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070932|NCT04555096|Protective Agents|protective agents|mesh-ancestor
138687658|NCT05911321|Growth Substances|growth substances|mesh-ancestor
139070933|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070934|NCT00097500|Metformin|metformin|mesh-list
139070935|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
139070936|NCT00097500|Exenatide|exenatide|mesh-list
139070937|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139070938|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070939|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139070940|NCT00097500|Incretins|incretins|mesh-ancestor
139070941|NCT00097500|Hormones|hormones|mesh-ancestor
139070942|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139070943|NCT01082484|Treprostinil|treprostinil|mesh-list
139070944|NCT01082484|Iloprost|iloprost|mesh-list
139070945|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139070946|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139070947|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
139070948|NCT05459974|Colchicine|colchicine|mesh-list
139070949|NCT05459974|Gout Suppressants|gout suppressants|mesh-ancestor
139070950|NCT05459974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139070951|NCT05459974|Tubulin Modulators|tubulin modulators|mesh-ancestor
139070952|NCT05459974|Antimitotic Agents|antimitotic agents|mesh-ancestor
139070953|NCT05459974|Mitosis Modulators|mitosis modulators|mesh-ancestor
139070954|NCT05459974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070955|NCT05459974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070956|NCT03754816|Anesthetics|anesthetics|mesh-list
139070957|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
139070958|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139070959|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070960|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
139070961|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
139070962|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139070963|NCT04542694|Favipiravir|favipiravir|mesh-list
139070964|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
139070965|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139070966|NCT03965208|Heparin|heparin|mesh-list
139070967|NCT03965208|Calcium heparin|calcium heparin|mesh-list
139070968|NCT03965208|Bivalirudin|bivalirudin|mesh-list
139070969|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
139070970|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139070971|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139070972|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139070973|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
139070974|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139070975|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
139070976|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139070977|NCT01083264|Gestodene|gestodene|mesh-list
139070978|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139070979|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139070980|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139070981|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
139070982|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139070983|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070984|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139070986|NCT01083264|Progestins|progestins|mesh-ancestor
139070987|NCT01083264|Hormones|hormones|mesh-ancestor
139070988|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139070989|NCT00129116|Vaccines|vaccines|mesh-list
138687763|NCT05839899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139070990|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
139070991|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070992|NCT00117156|Rituximab|rituximab|mesh-list
139070993|NCT00117156|Fludarabine|fludarabine|mesh-list
139070994|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138936042|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
139070995|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139070996|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
139070997|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139070998|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139070999|NCT01083420|Minocycline|minocycline|mesh-list
139071000|NCT01083420|Dexamethasone|dexamethasone|mesh-list
139071001|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139071002|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
139071003|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
139071004|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071005|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071006|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139071007|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
139071008|NCT01083420|Hormones|hormones|mesh-ancestor
139071009|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139071010|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139071011|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071012|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139071013|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071014|NCT00096954|Omalizumab|omalizumab|mesh-list
139071015|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139071016|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139071017|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
139071018|NCT00096486|Everolimus|everolimus|mesh-list
139071019|NCT00096486|Gefitinib|gefitinib|mesh-list
139071020|NCT00096486|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139071021|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138687804|NCT05834569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138265812|NCT05862233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071022|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071023|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071024|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139071025|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
139071026|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071027|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071028|NCT00116844|Valacyclovir|valacyclovir|mesh-list
139071029|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
139071030|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071031|NCT03963336|Acetazolamide|acetazolamide|mesh-list
139071032|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
139071033|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139071034|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071035|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071036|NCT03963336|Diuretics|diuretics|mesh-ancestor
139071037|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
139071038|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071039|NCT00132314|Risperidone|risperidone|mesh-list
139071040|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
139071041|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139071042|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
139071043|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071044|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071045|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071046|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139071047|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071048|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138687852|NCT05701215|Venetoclax|venetoclax|mesh-list
139071049|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139071050|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
139071051|NCT04539262|Remdesivir|remdesivir|mesh-list
139071052|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
139071053|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071054|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
139071055|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071056|NCT04537234|Vaccines|vaccines|mesh-list
139071057|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
139071058|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071059|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
139071060|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
139071061|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
139071062|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
139071063|NCT04537078|Cetrorelix|cetrorelix|mesh-list
139071064|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
139071065|NCT04537078|Progesterone|progesterone|mesh-list
139071067|NCT04537078|Estradiol|estradiol|mesh-list
139071068|NCT04537078|Progestins|progestins|mesh-ancestor
139071069|NCT04537078|Hormones|hormones|mesh-ancestor
139071070|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139071071|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071072|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139071073|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139071074|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
139071075|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139071076|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139071077|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071078|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139071079|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
139071080|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
139071082|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
139071083|NCT04532164|Clotrimazole|clotrimazole|mesh-list
139071085|NCT04532164|Butenafine|butenafine|mesh-list
139071086|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071087|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139071088|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139071089|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139071091|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071092|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139071094|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139071095|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071096|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139071097|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139071099|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
139071100|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071101|NCT04799782|Mirtazapine|mirtazapine|mesh-list
139071102|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
139071103|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139071104|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139071105|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
139071106|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
139071107|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071108|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071109|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265943|NCT05752409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139071110|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139071111|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139071112|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071113|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139071114|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139071115|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139071116|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
139071117|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139071118|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139071119|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
139071120|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139071121|NCT04790812|Acetaminophen|acetaminophen|mesh-list
139071122|NCT04790812|Celecoxib|celecoxib|mesh-list
139071123|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138687935|NCT05526586|Ethanol|ethanol|mesh-list
139071124|NCT04790812|Analgesics|analgesics|mesh-ancestor
139071125|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
139071126|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071127|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071128|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
139071129|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138936650|NCT00734318|Fluticasone|fluticasone|mesh-list
139071130|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139071131|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139071132|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139071133|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139071134|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071135|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071136|NCT03697252|Xanomeline|xanomeline|mesh-list
139071137|NCT03697252|Trospium chloride|trospium chloride|mesh-list
138936705|NCT00728546|Isoniazid|isoniazid|mesh-list
139071138|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
139071139|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
139071140|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071141|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071142|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139071143|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139071144|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
139071145|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071146|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071147|NCT03697252|Urological Agents|urological agents|mesh-ancestor
139071148|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139071149|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139071150|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139071151|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139071152|NCT03701074|Acetaminophen|acetaminophen|mesh-list
139071153|NCT03701074|Ibuprofen|ibuprofen|mesh-list
139071154|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139071155|NCT03701074|Analgesics|analgesics|mesh-ancestor
139071156|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
139071157|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071158|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071159|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
139071160|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139071161|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139071162|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139071163|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139071164|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071165|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071166|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
139071167|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
139071168|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139071169|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139071170|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
139071171|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071172|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139071173|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139071174|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071175|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139071177|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139071178|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139071179|NCT03757156|Analgesics|analgesics|mesh-ancestor
139071180|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
139071181|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071182|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071183|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139071184|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139071185|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139071186|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138688063|NCT05296772|Immunoglobulins|immunoglobulins|mesh-list
138688070|NCT05288374|Celecoxib|celecoxib|mesh-list
139071187|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071188|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139071189|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139071190|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071191|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
139071192|NCT03750916|Docetaxel|docetaxel|mesh-list
138266012|NCT05632133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139071193|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071194|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
139071195|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
139071196|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
139071197|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071198|NCT05322148|Loteprednol Etabonate|loteprednol etabonate|mesh-list
139071199|NCT05322148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139071200|NCT03750760|Atorvastatin|atorvastatin|mesh-list
139071201|NCT03750760|Ezetimibe|ezetimibe|mesh-list
139071202|NCT03750760|Alirocumab|alirocumab|mesh-list
139071203|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139071204|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139071205|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
139071206|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071207|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139071208|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139071210|NCT03750760|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139071211|NCT03750760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139071212|NCT03750760|Protease Inhibitors|protease inhibitors|mesh-ancestor
139071213|NCT01076894|Anesthetics|anesthetics|mesh-list
139071214|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138688119|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071215|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071216|NCT00130832|Vaccines|vaccines|mesh-list
139071217|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
139071218|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071219|NCT00096018|Thalidomide|thalidomide|mesh-list
139071220|NCT00096018|Fludarabine|fludarabine|mesh-list
139071221|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
139071222|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071223|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139071224|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
139071225|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071226|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139071227|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
139071228|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071229|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
139071230|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139071231|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071232|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139071233|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139071235|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
139071236|NCT01079754|Morphine|morphine|mesh-list
139071237|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
139071238|NCT01079754|Narcotics|narcotics|mesh-ancestor
139071239|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138937127|NCT06147648|Tacrolimus|tacrolimus|mesh-list
139071240|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071242|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
139071243|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688170|NCT05149287|Lidocaine|lidocaine|mesh-list
139071245|NCT04701658|Antiviral Agents|antiviral agents|mesh-ancestor
139071246|NCT04701658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071247|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
139071248|NCT01322776|Fludarabine|fludarabine|mesh-list
139071249|NCT01322776|Bortezomib|bortezomib|mesh-list
139071250|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139071251|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
139071252|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071253|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139071254|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139071255|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
139085268|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071256|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071257|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071258|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139071259|NCT00128102|Vorinostat|vorinostat|mesh-list
139071260|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688214|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688215|NCT05100134|Ceritinib|ceritinib|mesh-list
139071261|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139071262|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071263|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071264|NCT03965858|Esketamine|esketamine|mesh-list
139071265|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
139071266|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139071267|NCT04668274|Resveratrol|resveratrol|mesh-list
139071268|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
139071269|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071270|NCT04668274|Protective Agents|protective agents|mesh-ancestor
139071271|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071272|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071273|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139071274|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
139071275|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071276|NCT04406194|Favipiravir|favipiravir|mesh-list
139071277|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
139071278|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071279|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
139071280|NCT03822884|Hematinics|hematinics|mesh-ancestor
139071281|NCT03822416|Nicotine|nicotine|mesh-list
139071282|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139071283|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
138688273|NCT05014776|Tadalafil|tadalafil|mesh-list
139071284|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071285|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071286|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139071287|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139071288|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
139071289|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071290|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071291|NCT04405570|Molnupiravir|molnupiravir|mesh-list
139071292|NCT04405570|Antiviral Agents|antiviral agents|mesh-ancestor
139071293|NCT04405570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071294|NCT00127712|Amiodarone|amiodarone|mesh-list
139071295|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139071296|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
139071297|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139071298|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139071299|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071300|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139071301|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139071302|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139071303|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071304|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139071305|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139071306|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138937444|NCT06087757|Histamine Agents|histamine agents|mesh-ancestor
138266196|NCT05401227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071308|NCT01082744|Ropivacaine|ropivacaine|mesh-list
139071309|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
139071310|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
139071311|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071312|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071313|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
139071314|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071315|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139071316|NCT01082744|Narcotics|narcotics|mesh-ancestor
139071317|NCT01082744|Analgesics|analgesics|mesh-ancestor
139071318|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139071319|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139071320|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
139071321|NCT00096356|Vitamins|vitamins|mesh-list
139071322|NCT00096356|Vitamin E|vitamin e|mesh-list
139071323|NCT00096356|Tocopherols|tocopherols|mesh-list
139071324|NCT00096356|Tocotrienols|tocotrienols|mesh-list
139071325|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
139071326|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
139071327|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071328|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
139071329|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071330|NCT00096356|Protective Agents|protective agents|mesh-ancestor
139071331|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
139071332|NCT03749590|Analgesics|analgesics|mesh-ancestor
139071333|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
139071334|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071335|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071336|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
139071337|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071338|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139071339|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
139071340|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139071341|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138937561|NCT05950646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937562|NCT05950646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138937563|NCT05950646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138937564|NCT05950646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138937565|NCT05950646|Adrenergic Agents|adrenergic agents|mesh-ancestor
138937566|NCT05950646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138937567|NCT05950646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071342|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071343|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139071344|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
139071345|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139071346|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
139071347|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139071348|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071349|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071350|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139071351|NCT01076816|Analgesics|analgesics|mesh-ancestor
139071352|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
139071353|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071354|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138688417|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139071355|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139071356|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139071357|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
139071358|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071359|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071361|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139071362|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
139071363|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071364|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139071365|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071366|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071367|NCT04358068|Azithromycin|azithromycin|mesh-list
139071368|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
139071369|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139071370|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071371|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
139071372|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139071373|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139071374|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071375|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071376|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139071377|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
139071379|NCT00096278|Folic Acid|folic acid|mesh-list
139071380|NCT00096278|Bevacizumab|bevacizumab|mesh-list
139071381|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139071382|NCT00096278|Fluorouracil|fluorouracil|mesh-list
139071383|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
139071384|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
139071385|NCT00096278|Antibodies|antibodies|mesh-list
139071386|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
139071387|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139071388|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
139071389|NCT00096278|Calcium|calcium|mesh-list
139071390|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
139071391|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071392|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139071393|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139071394|NCT00096278|Growth Substances|growth substances|mesh-ancestor
139071395|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071396|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
139071397|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
139071398|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139071399|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139071400|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
139071401|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071402|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139071403|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139071404|NCT00096278|Antidotes|antidotes|mesh-ancestor
139071405|NCT00096278|Protective Agents|protective agents|mesh-ancestor
139071406|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
139071407|NCT00096278|Vitamins|vitamins|mesh-ancestor
139071408|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
138937740|NCT05700721|Niraparib|niraparib|mesh-list
139071409|NCT00096278|Hematinics|hematinics|mesh-ancestor
139071410|NCT00095940|Lapatinib|lapatinib|mesh-list
139071411|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071412|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139071413|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071414|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071415|NCT00114218|Gemcitabine|gemcitabine|mesh-list
139071416|NCT00114218|Docetaxel|docetaxel|mesh-list
139071417|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139071418|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
139071419|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071420|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071421|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
138266318|NCT05301361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071422|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
139071423|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
139071424|NCT01077986|Capecitabine|capecitabine|mesh-list
139071426|NCT01077986|Everolimus|everolimus|mesh-list
138688516|NCT04562558|Antidotes|antidotes|mesh-ancestor
139071427|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139071428|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
139071429|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071430|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071431|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139071432|NCT01077986|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139071433|NCT01077986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139071434|NCT01077986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071435|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139071436|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
139071437|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071439|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139071440|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
139071441|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071442|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071443|NCT01082718|Artesunate|artesunate|mesh-list
139071444|NCT01082718|Mefloquine|mefloquine|mesh-list
139071445|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
139071446|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139071447|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139071448|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071449|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071450|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
139071451|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
139071452|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139071453|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
139071454|NCT04380142|Levodopa|levodopa|mesh-list
139071455|NCT04380142|Carbidopa|carbidopa|mesh-list
139071456|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139071457|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139071458|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
139071459|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071460|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071461|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071462|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139071463|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071464|NCT04336228|Dexetimide|dexetimide|mesh-list
138266348|NCT05186779|Hormones|hormones|mesh-ancestor
139071466|NCT04336228|Escitalopram|escitalopram|mesh-list
138937902|NCT05538702|Menthol|menthol|mesh-list
139071467|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071468|NCT04336228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139071469|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139071470|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138937947|NCT05439564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139071471|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071472|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071473|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
139071474|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139071475|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139071476|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
139071477|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
139071478|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071479|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139071480|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139071481|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
139071482|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139071483|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
139071484|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139071485|NCT03917446|Propofol|propofol|mesh-list
139071486|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139071487|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071488|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071489|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139071490|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
139071491|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
139071492|NCT03748108|Lidocaine|lidocaine|mesh-list
139071493|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
139071494|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
139071495|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071496|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071497|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
139071498|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071499|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139071500|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138938070|NCT05232825|Diphenhydramine|diphenhydramine|mesh-list
139071501|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139071502|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139071503|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071504|NCT04171414|Adalimumab|adalimumab|mesh-list
139071505|NCT04171414|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139071506|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139071507|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139071509|NCT04167670|Clarithromycin|clarithromycin|mesh-list
139071510|NCT04167670|Lansoprazole|lansoprazole|mesh-list
139071511|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
139071512|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139071513|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071514|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139071515|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688641|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139071516|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071517|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139071518|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139071519|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139071520|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139071521|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139071522|NCT00113516|Paclitaxel|paclitaxel|mesh-list
139071523|NCT00113516|Carboplatin|carboplatin|mesh-list
139071524|NCT00113516|Sunitinib|sunitinib|mesh-list
139071525|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139071526|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071527|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
139071528|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
139071529|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
139071530|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071531|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139071532|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139071533|NCT00113516|Growth Substances|growth substances|mesh-ancestor
138938203|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
139071534|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071535|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
139071536|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139071537|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071538|NCT03251326|Propranolol|propranolol|mesh-list
139071539|NCT03251326|Nabilone|nabilone|mesh-list
139071540|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139071541|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139071542|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
139071543|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071544|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071545|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071546|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139071547|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139071548|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
139071549|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
139071550|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
139071551|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071552|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139071553|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139071554|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139071555|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071556|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139071557|NCT04140292|Vitamin D|vitamin d|mesh-list
139071558|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
139071559|NCT04140292|Vitamins|vitamins|mesh-ancestor
139071560|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
138938252|NCT05030441|Ivosidenib|ivosidenib|mesh-list
139071561|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071562|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139071563|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139071564|NCT00127166|Fluticasone|fluticasone|mesh-list
139071565|NCT00127166|Xhance|xhance|mesh-list
139071566|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
139071567|NCT00127166|Montelukast|montelukast|mesh-list
139071568|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139071569|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139071570|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
138938311|NCT04978584|Hormones|hormones|mesh-ancestor
139071571|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071572|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071573|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139071574|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
139071575|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
139071576|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139071577|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139071578|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139071579|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139071580|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
139071581|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071582|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688717|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071583|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139071584|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
139085269|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139071585|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139071586|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139071587|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139071588|NCT00125138|Metylperon|metylperon|mesh-list
139071589|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139071590|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139071591|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071592|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071593|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139071594|NCT04132336|Naproxen|naproxen|mesh-list
139071595|NCT04132336|Caffeine|caffeine|mesh-list
139071596|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139071597|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071598|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139071599|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071600|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071601|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139071602|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138688765|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
139071603|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
139071604|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071605|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139071606|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139071607|NCT04132336|Analgesics|analgesics|mesh-ancestor
139071608|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
139071609|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071610|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139071611|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139071612|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
139071613|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139071615|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
139071616|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071617|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
139071618|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
139071619|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
139071620|NCT03691948|Narcotics|narcotics|mesh-ancestor
139071621|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071622|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071623|NCT03691948|Analgesics|analgesics|mesh-ancestor
139071624|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
139071625|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266557|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
139071626|NCT04124926|Lansoprazole|lansoprazole|mesh-list
139071627|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
139071628|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139071629|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139071630|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139071632|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071633|NCT03746158|Curcumin|curcumin|mesh-list
139071634|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139071635|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139071636|NCT03746158|Analgesics|analgesics|mesh-ancestor
139071637|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
139071638|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071639|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071640|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139071641|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139071642|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071643|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071644|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071645|NCT03747094|Fentanyl|fentanyl|mesh-list
139071646|NCT03747094|Ketamine|ketamine|mesh-list
139071647|NCT03747094|Analgesics|analgesics|mesh-ancestor
139071648|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
139071649|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266595|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071650|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071651|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139071652|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139071653|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
139071654|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
139071655|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071656|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139071657|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139071658|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071659|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071660|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139071661|NCT03747094|Narcotics|narcotics|mesh-ancestor
139071662|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139071663|NCT04105972|Ivacaftor|ivacaftor|mesh-list
139071664|NCT04105972|Elexacaftor|elexacaftor|mesh-list
139071665|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138222125|NCT01491113|Levetiracetam|levetiracetam|mesh-list
139071666|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139071667|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071668|NCT00124982|Abatacept|abatacept|mesh-list
139071669|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
139071670|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139085270|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139071671|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071672|NCT00124982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139071673|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071674|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139071675|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
139071676|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071677|NCT04249336|Listerine|listerine|mesh-list
139071678|NCT04249336|Calcium|calcium|mesh-list
139071679|NCT04249336|Fluorides|fluorides|mesh-list
139071680|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
139071681|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139071682|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071683|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
139071684|NCT04249336|Protective Agents|protective agents|mesh-ancestor
139071685|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139071686|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071687|NCT03752476|Lactams|lactams|mesh-list
139071688|NCT03752476|beta-Lactams|beta-lactams|mesh-list
139071689|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139071690|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071691|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139071692|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138266643|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
139071693|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
139071694|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
139071695|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071696|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
139071697|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071698|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139071699|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071700|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071702|NCT01078142|Rituximab|rituximab|mesh-list
139071703|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139071705|NCT01078142|MTOR Inhibitors|mtor inhibitors|mesh-list
139071706|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139071707|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071708|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
139071709|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071710|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139071711|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139071712|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
138688958|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688959|NCT03767582|Nivolumab|nivolumab|mesh-list
139071713|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071714|NCT01078142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139071715|NCT01078142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071716|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139071717|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139071718|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071719|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139071720|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
139071721|NCT04060654|Buprenorphine|buprenorphine|mesh-list
139071722|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139071723|NCT04060654|Narcotics|narcotics|mesh-ancestor
139071724|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071725|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071726|NCT04060654|Analgesics|analgesics|mesh-ancestor
139071727|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
139071728|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071729|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139071730|NCT00096200|Paclitaxel|paclitaxel|mesh-list
139071731|NCT00096200|Carboplatin|carboplatin|mesh-list
139071732|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139071733|NCT00096200|Sorafenib|sorafenib|mesh-list
139071734|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139071735|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071736|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
138689006|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
138689007|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
139071737|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
139071738|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
139071739|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071740|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139071741|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071743|NCT00096044|Lenalidomide|lenalidomide|mesh-list
139071744|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139071745|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071746|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
139071747|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071748|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138938890|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
139071749|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139071750|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139071751|NCT00096044|Growth Substances|growth substances|mesh-ancestor
139071752|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
139071753|NCT03963128|Vitamin D|vitamin d|mesh-list
139071754|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
139071755|NCT03963128|Vitamins|vitamins|mesh-ancestor
138266706|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139071756|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
139071757|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071758|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139071759|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139071760|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
139071761|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139071762|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
138689058|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689074|NCT03642067|Nivolumab|nivolumab|mesh-list
139071763|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071764|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139071765|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139071766|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139071767|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071768|NCT01083290|Spironolactone|spironolactone|mesh-list
139071769|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139071770|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
139071771|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139071772|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071773|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139071774|NCT01083290|Diuretics|diuretics|mesh-ancestor
139071775|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
139071776|NCT01326650|Vitamin D|vitamin d|mesh-list
139071777|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
139071778|NCT01326650|Cholecalciferol|cholecalciferol|mesh-list
139071779|NCT01326650|Vitamins|vitamins|mesh-list
139071780|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139071781|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
139071782|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071783|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139071784|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139071785|NCT03689374|Insulin|insulin|mesh-list
139071786|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139071787|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
139071788|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
139071789|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139071790|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071791|NCT03745300|Atorvastatin|atorvastatin|mesh-list
138689107|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
139071792|NCT03745300|Simvastatin|simvastatin|mesh-list
139071793|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139071794|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139071796|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071797|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139071798|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139071799|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071800|NCT00112736|Sirolimus|sirolimus|mesh-list
139071801|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139071802|NCT00112736|Temsirolimus|temsirolimus|mesh-list
139071803|NCT00112736|MTOR Inhibitors|mtor inhibitors|mesh-list
139071804|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071805|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139071806|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071807|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071808|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139071809|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
139071810|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071811|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139071812|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139071813|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139071814|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
139071815|NCT04052620|Diclofenac|diclofenac|mesh-list
139071816|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139071817|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139071818|NCT04052620|Analgesics|analgesics|mesh-ancestor
139071819|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
139071820|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071821|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071822|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139071823|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139071824|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139071825|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071826|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071827|NCT00112580|Ipilimumab|ipilimumab|mesh-list
139071828|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139071829|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071830|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139071831|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071832|NCT04238650|Bevacizumab|bevacizumab|mesh-list
139071833|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139071834|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071835|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138266790|NCT04751500|Misoprostol|misoprostol|mesh-list
139071836|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139071837|NCT04238650|Growth Substances|growth substances|mesh-ancestor
139071838|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071839|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
138939040|NCT03510208|Antibodies|antibodies|mesh-list
139071841|NCT04049578|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139071842|NCT04049578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071843|NCT04049578|Natriuretic Agents|natriuretic agents|mesh-ancestor
139071844|NCT04049578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071845|NCT00095498|Denosumab|denosumab|mesh-list
139071846|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139071847|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071848|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
139071849|NCT04237792|Propofol|propofol|mesh-list
139071850|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139071851|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071852|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071853|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139071854|NCT04237792|Analgesics|analgesics|mesh-ancestor
139071855|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
139071856|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071857|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139071858|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139071859|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139071860|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
139071861|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071862|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071863|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139071864|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
139071865|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
139071866|NCT03744988|Androgens|androgens|mesh-list
139071867|NCT03744988|Hormones|hormones|mesh-ancestor
139071868|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139071870|NCT03746782|Thrombin|thrombin|mesh-list
139071871|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
139071872|NCT03746782|Coagulants|coagulants|mesh-ancestor
139071873|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
139071874|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139071875|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139071876|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071878|NCT04024228|Vaccines|vaccines|mesh-list
139071879|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
139071880|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071881|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
139071882|NCT04024228|Coagulants|coagulants|mesh-ancestor
139071883|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
139071884|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139071885|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689240|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138689252|NCT03304080|Trastuzumab|trastuzumab|mesh-list
139071886|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
139071887|NCT04018612|Acetaminophen|acetaminophen|mesh-list
139071888|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139071889|NCT04018612|Analgesics|analgesics|mesh-ancestor
139071890|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
139071891|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071892|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071893|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
139071894|NCT04207840|Epinephrine|epinephrine|mesh-list
139071895|NCT04207840|Racepinephrine|racepinephrine|mesh-list
139071896|NCT04207840|Albuterol|albuterol|mesh-list
139071897|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
139071898|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139071899|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139071900|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
139071901|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071902|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071903|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071904|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139071905|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139071906|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
139071907|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071908|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139071909|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
139071910|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
139071911|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
139071912|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138266878|NCT04660812|Bevacizumab|bevacizumab|mesh-list
139071913|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
139071914|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139071915|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138689297|NCT03267680|Analgesics|analgesics|mesh-ancestor
139071916|NCT03744364|Misoprostol|misoprostol|mesh-list
139071917|NCT03744364|Dinoprostone|dinoprostone|mesh-list
139071918|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139071919|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
139071920|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139071921|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071922|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139071923|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139071924|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
139071925|NCT03744208|Antibodies|antibodies|mesh-list
139071926|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139071927|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
139071928|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071929|NCT05069896|Mirikizumab|mirikizumab|mesh-list
139071930|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139071931|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139071932|NCT05069896|Analgesics|analgesics|mesh-ancestor
139071933|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
139071934|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071935|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071936|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139071937|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139071938|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139071939|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138822517|NCT04095754|Analgesics|analgesics|mesh-ancestor
139071940|NCT01562626|Flucytosine|flucytosine|mesh-list
139071941|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
139071942|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689356|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138689357|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
138689358|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
138689360|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139071943|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
139071944|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071946|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
139071947|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
139071948|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071949|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071950|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139071951|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139071952|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139071953|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071954|NCT04465396|Teduglutide|teduglutide|mesh-list
139071955|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139071956|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139071957|NCT04465396|Protective Agents|protective agents|mesh-ancestor
139071958|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071959|NCT03996694|Oxycodone|oxycodone|mesh-list
139071960|NCT03996694|Buprenorphine|buprenorphine|mesh-list
139071961|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139071962|NCT03996694|Narcotics|narcotics|mesh-ancestor
139071963|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071964|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071965|NCT03996694|Analgesics|analgesics|mesh-ancestor
139071966|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
139071967|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071968|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139071970|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
139071971|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
139071972|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
139071973|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071974|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071975|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
139071976|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139071977|NCT03751228|Deucravacitinib|deucravacitinib|mesh-list
139071978|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
139071979|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139071980|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071981|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071982|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139071983|NCT03656692|Hormones|hormones|mesh-ancestor
138279686|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071984|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139071985|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071986|NCT04439266|Crizotinib|crizotinib|mesh-list
139071987|NCT04439266|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139071988|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139071989|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139071990|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139071991|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139071992|NCT01329796|Lidocaine|lidocaine|mesh-list
139071993|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
139071994|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
139071995|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139071996|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139071997|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
139071998|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139071999|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139072000|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139072001|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138689460|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138689466|NCT02845882|Hormones|hormones|mesh-ancestor
139072002|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139072003|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072004|NCT04428502|Etanercept|etanercept|mesh-list
139072005|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139072006|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139072007|NCT04428502|Analgesics|analgesics|mesh-ancestor
139072008|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
139072009|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072010|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072011|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072012|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072013|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139072014|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072015|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
139072016|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
139072017|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139072018|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072019|NCT03736330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139072020|NCT03736330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072021|NCT04428424|Etanercept|etanercept|mesh-list
138939228|NCT03119012|Aspirin|aspirin|mesh-list
139072022|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139072023|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139072024|NCT04428424|Analgesics|analgesics|mesh-ancestor
139072025|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
139072026|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072027|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072028|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138267027|NCT04352166|Buprenorphine|buprenorphine|mesh-list
139072029|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072030|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138689499|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072031|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072032|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
139072034|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139072035|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139072036|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139072037|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072038|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
139072039|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139072040|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072041|NCT01084044|Urinastatin|urinastatin|mesh-list
139072043|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139072044|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
139072045|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072046|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072047|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
139072048|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072049|NCT01090596|Naproxen|naproxen|mesh-list
139072050|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139072051|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139072052|NCT01090596|Analgesics|analgesics|mesh-ancestor
139072053|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
139072054|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072055|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072056|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072057|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072058|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
139072059|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139072060|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072061|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072062|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139072063|NCT01084122|Hematinics|hematinics|mesh-ancestor
139072064|NCT01084200|Propofol|propofol|mesh-list
139072065|NCT01084200|Sevoflurane|sevoflurane|mesh-list
139072066|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139072067|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139072068|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072069|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139072070|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
138689543|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072071|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
139072072|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139072073|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139072074|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139072075|NCT00094770|Glipizide|glipizide|mesh-list
139072076|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139072077|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072078|NCT00094770|Incretins|incretins|mesh-ancestor
139072079|NCT00094770|Hormones|hormones|mesh-ancestor
139072080|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139072081|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139072082|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
139072083|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939389|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072084|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072085|NCT01087398|Cyclosporine|cyclosporine|mesh-list
139072086|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
139072087|NCT01087398|Busulfan|busulfan|mesh-list
139072088|NCT01087398|Methotrexate|methotrexate|mesh-list
139072089|NCT01087398|Fludarabine|fludarabine|mesh-list
139072090|NCT01087398|Cyclosporins|cyclosporins|mesh-list
138822666|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
139072092|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072093|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
139072094|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072095|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072096|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139072097|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
138267127|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139072098|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072100|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139072101|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139072102|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
139072103|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139072104|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139072105|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
139072106|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
139072107|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072108|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139072109|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139072110|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
139072111|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072112|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139072113|NCT01087476|Doxycycline|doxycycline|mesh-list
139072114|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139072115|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072116|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
139072117|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139072118|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139072119|NCT00069108|Leucovorin|leucovorin|mesh-list
139072120|NCT00069108|Capecitabine|capecitabine|mesh-list
139072121|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
139072122|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139072123|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
139072124|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072125|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072126|NCT00069108|Antidotes|antidotes|mesh-ancestor
139072127|NCT00069108|Protective Agents|protective agents|mesh-ancestor
139072128|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072129|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
139072131|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
139072132|NCT00405587|Vemurafenib|vemurafenib|mesh-list
139072133|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072134|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139072135|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072136|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072137|NCT01040429|Clonidine|clonidine|mesh-list
139072138|NCT01040429|Analgesics|analgesics|mesh-ancestor
139072139|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
138689623|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
139072140|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072141|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072142|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139072143|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
139072144|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
139072145|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139072146|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139072147|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139072148|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
139072149|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139072150|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072151|NCT01039883|Albaconazole|albaconazole|mesh-list
139072152|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
139072153|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072154|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
139072155|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
139072156|NCT00405275|Etanercept|etanercept|mesh-list
139072157|NCT00405275|Methotrexate|methotrexate|mesh-list
139072158|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139072159|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
139072160|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139072161|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072162|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139072163|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
139072164|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072165|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822748|NCT02570971|Mannitol|mannitol|mesh-list
139072166|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
139072167|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072168|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139072169|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072170|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
139072171|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072172|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139072173|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
139072174|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139072175|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139072176|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072177|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139072178|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139072179|NCT00405275|Analgesics|analgesics|mesh-ancestor
139072180|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
139072181|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072182|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072183|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139072184|NCT00404651|Vaccines|vaccines|mesh-list
139072185|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
139072186|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072187|NCT00404495|Irinotecan|irinotecan|mesh-list
138267189|NCT04139304|Cortisone|cortisone|mesh-list
139072188|NCT00404495|Temozolomide|temozolomide|mesh-list
139072189|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139072190|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139072191|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072192|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072193|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072194|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139072195|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
139072196|NCT00409409|Immunomodulating Agents|immunomodulating agents|mesh-list
139072197|NCT00409409|Immunologic Factors|immunologic factors|mesh-ancestor
139072198|NCT00409409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072200|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139072201|NCT00409331|Protective Agents|protective agents|mesh-ancestor
139072202|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072203|NCT00362219|Morphine|morphine|mesh-list
139072204|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139072205|NCT00362219|Narcotics|narcotics|mesh-ancestor
139072206|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139072207|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072208|NCT00362219|Analgesics|analgesics|mesh-ancestor
139072209|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
139072210|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072211|NCT01040585|Linezolid|linezolid|mesh-list
139072212|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139072213|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072214|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139072215|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072216|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072217|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
139072218|NCT01040195|Methotrexate|methotrexate|mesh-list
139072219|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139072220|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
139072221|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139072222|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072223|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139072224|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
139072225|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072226|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072227|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
139072228|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072229|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139072230|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072231|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
139072232|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072233|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139072234|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
139072235|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139072236|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139072237|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072238|NCT01040273|Bupivacaine|bupivacaine|mesh-list
139072239|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
139072240|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
139072241|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139072242|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072243|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
138267286|NCT04043195|Nivolumab|nivolumab|mesh-list
139072244|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072246|NCT00408629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139072247|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072248|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072249|NCT00408317|Pancrelipase|pancrelipase|mesh-list
139072250|NCT00408317|Pancreatin|pancreatin|mesh-list
139072251|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139072252|NCT00112502|Thalidomide|thalidomide|mesh-list
139072253|NCT00112502|Celecoxib|celecoxib|mesh-list
139072254|NCT00112502|Temozolomide|temozolomide|mesh-list
139072255|NCT00112502|Isotretinoin|isotretinoin|mesh-list
139072256|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139072257|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
139072258|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072259|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072260|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139072261|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139072262|NCT00112502|Analgesics|analgesics|mesh-ancestor
139072263|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
139072264|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267327|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
139072265|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072266|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072268|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139072269|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139072270|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939708|NCT01142401|Bortezomib|bortezomib|mesh-list
139072271|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072272|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
139072273|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
139072274|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139072275|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072276|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139072277|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139072278|NCT00112502|Growth Substances|growth substances|mesh-ancestor
139072279|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
139072280|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
139072281|NCT03965546|Sorafenib|sorafenib|mesh-list
139072282|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072283|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139072284|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072285|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072286|NCT01083992|Vitamin D|vitamin d|mesh-list
139072287|NCT01083992|Vildagliptin|vildagliptin|mesh-list
139072288|NCT01083992|Vitamins|vitamins|mesh-ancestor
139072289|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
139072290|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072291|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139072292|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139072293|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139072294|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
139072295|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689923|NCT01044745|Busulfan|busulfan|mesh-list
139072296|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072297|NCT03822182|Dexamethasone|dexamethasone|mesh-list
139072299|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072300|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
139072301|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
138939773|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
138939774|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
138939775|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138939776|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138939777|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138939778|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138939779|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939780|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138939781|NCT00482807|Docetaxel|docetaxel|mesh-list
138939782|NCT00482807|Goserelin|goserelin|mesh-list
138939783|NCT00482807|Bicalutamide|bicalutamide|mesh-list
138939785|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
138939786|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
138939787|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
138939788|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939789|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138939790|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
138939791|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
138939792|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689960|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689962|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138939793|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072302|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072303|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072304|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139072305|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
139072306|NCT03822182|Hormones|hormones|mesh-ancestor
139072307|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139072308|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139072309|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072310|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
139072311|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
139085272|NCT01134848|Secretin|secretin|mesh-list
138939839|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138939840|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138939841|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
138939842|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939843|NCT00740090|Antacids|antacids|mesh-ancestor
138939844|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939845|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939846|NCT00738660|Telmisartan|telmisartan|mesh-list
138939847|NCT00738660|Ramipril|ramipril|mesh-list
138939848|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138180068|NCT00860171|Iodine|iodine|mesh-list
138939849|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138939850|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138939851|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939852|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138939853|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
138939854|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072312|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139072313|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
139072314|NCT01078610|Adalimumab|adalimumab|mesh-list
139072315|NCT01078610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138822910|NCT02866370|Paclitaxel|paclitaxel|mesh-list
139072316|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072317|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072319|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072320|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
139072321|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072322|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139072323|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072324|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072325|NCT03965624|Ixazomib|ixazomib|mesh-list
139072326|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072327|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
139072328|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072329|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072330|NCT01080560|Cyclosporine|cyclosporine|mesh-list
139072331|NCT01080560|Cyclosporins|cyclosporins|mesh-list
139072332|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267447|NCT03872700|Analgesics|analgesics|mesh-ancestor
139072333|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072334|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072335|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
139072336|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072337|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
139072338|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072339|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
139072340|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072341|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139072343|NCT00094328|Bicalutamide|bicalutamide|mesh-list
139072344|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139072345|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072346|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138690072|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
139072347|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139072348|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072349|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072350|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139072351|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
139072352|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139072353|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072354|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
139072356|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139072357|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139072358|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
139072359|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072360|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139072361|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139072362|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072363|NCT00094094|Axitinib|axitinib|mesh-list
139072364|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072365|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139072366|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072367|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072368|NCT03962816|Vaccines|vaccines|mesh-list
139072370|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072371|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
139072372|NCT01080638|Abciximab|abciximab|mesh-list
139072373|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
139072374|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139072375|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139072376|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
139072377|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690099|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072378|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139072379|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072380|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
139072381|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072382|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
139072383|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139072384|NCT01080638|Protective Agents|protective agents|mesh-ancestor
139072385|NCT00110396|Interferons|interferons|mesh-list
139072386|NCT00110396|Interferon-beta|interferon-beta|mesh-list
139072387|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
139072388|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072389|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
139072390|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072391|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
138822968|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072392|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267528|NCT03688464|Protective Agents|protective agents|mesh-ancestor
139072395|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072396|NCT00407537|Amlodipine|amlodipine|mesh-list
139072397|NCT00407537|Atorvastatin|atorvastatin|mesh-list
139072398|NCT00407537|Calcium|calcium|mesh-list
139072399|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139072400|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072401|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139072402|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139072403|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
139072404|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072405|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139072406|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139072407|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072408|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139072409|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139072410|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139072411|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
139072412|NCT00094458|Infliximab|infliximab|mesh-list
139072413|NCT00094458|Azathioprine|azathioprine|mesh-list
139072414|NCT00094458|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139072415|NCT00094458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072416|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
139072417|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139072418|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072420|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072421|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139072422|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072423|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072424|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
139072425|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072426|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139072427|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139072428|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072429|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072430|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139072431|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138940084|NCT00863902|Cetirizine|cetirizine|mesh-list
138690184|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138690185|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138690190|NCT01292473|Omalizumab|omalizumab|mesh-list
139072432|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072433|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
139072434|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139072435|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
139072436|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
139072437|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072439|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139072440|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072441|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139072442|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
139072443|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139072444|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
139072445|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072446|NCT01087632|Folic Acid|folic acid|mesh-list
139072447|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
139072448|NCT01087632|Policosanol|policosanol|mesh-list
139072449|NCT01087632|Red yeast rice|red yeast rice|mesh-list
139072451|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
139072452|NCT01087632|Vitamins|vitamins|mesh-ancestor
139072453|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
139072454|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072455|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139072456|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139072457|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139072458|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
139072459|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072460|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072461|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139072462|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139072463|NCT00394589|Infliximab|infliximab|mesh-list
139072464|NCT00394589|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139072465|NCT00394589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072466|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
139072467|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139072468|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072469|NCT00068406|Cisplatin|cisplatin|mesh-list
139072470|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072471|NCT00403559|Ketoconazole|ketoconazole|mesh-list
139072472|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
139072473|NCT00403559|Antifungal Agents|antifungal agents|mesh-ancestor
139072474|NCT00403559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072475|NCT00403559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139072476|NCT00403559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139072477|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072478|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072479|NCT00403559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139072480|NCT00403559|Hormone Antagonists|hormone antagonists|mesh-ancestor
139072481|NCT00403559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139072482|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072483|NCT00403559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139072484|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139072485|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138690292|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690306|NCT01290679|Ribavirin|ribavirin|mesh-list
139072486|NCT00403559|Analgesics|analgesics|mesh-ancestor
139072487|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
139072488|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072489|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072490|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072491|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
139072492|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072493|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
139072494|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139072495|NCT01087710|Vitamins|vitamins|mesh-list
139072496|NCT01087710|Antioxidants|antioxidants|mesh-list
139072497|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
139072498|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072499|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072500|NCT01087710|Protective Agents|protective agents|mesh-ancestor
139072501|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139072502|NCT00403481|Olmesartan|olmesartan|mesh-list
139072503|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
139072504|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139072505|NCT00403481|Diuretics|diuretics|mesh-ancestor
139072506|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
139072507|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072508|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138267720|NCT03192995|Sensory System Agents|sensory system agents|mesh-ancestor
139072509|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139072510|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072511|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139072512|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139072513|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139072514|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072515|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139072516|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072517|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072518|NCT00394433|Bevacizumab|bevacizumab|mesh-list
139072520|NCT00394433|Docetaxel|docetaxel|mesh-list
139072521|NCT00394433|Irinotecan|irinotecan|mesh-list
138690346|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
138690347|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
139072522|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139072523|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072524|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139072525|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139072526|NCT00394433|Growth Substances|growth substances|mesh-ancestor
139072527|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072528|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
139072529|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
139072530|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
139072531|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
139072532|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072533|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139072534|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139072535|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072536|NCT00092534|Vaccines|vaccines|mesh-list
139072537|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
139072538|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072539|NCT00068250|Rituximab|rituximab|mesh-list
139072540|NCT00068250|Methotrexate|methotrexate|mesh-list
139072541|NCT00068250|Temozolomide|temozolomide|mesh-list
139072542|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139072544|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
139072545|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072546|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072547|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139072548|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
139072549|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139072550|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139072551|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
139072552|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690385|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138690386|NCT01290601|Primaquine|primaquine|mesh-list
138690387|NCT01290601|Tafenoquine|tafenoquine|mesh-list
138690388|NCT01290601|Amebicides|amebicides|mesh-ancestor
138690389|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138690390|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138690391|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690392|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
139072553|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
139072554|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072555|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139072556|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072557|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139072558|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138940419|NCT00864838|Acetazolamide|acetazolamide|mesh-list
138267805|NCT02935361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139072559|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
139072560|NCT03957720|Penicillamine|penicillamine|mesh-list
139072561|NCT03957720|Succimer|succimer|mesh-list
139072562|NCT03957720|Antidotes|antidotes|mesh-ancestor
139072563|NCT03957720|Protective Agents|protective agents|mesh-ancestor
138215393|NCT02248051|CXA-10|cxa-10|mesh-list
139072564|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072565|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
139072566|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
139072567|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072568|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072569|NCT00393029|Aldesleukin|aldesleukin|mesh-list
139072570|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
139072571|NCT00393029|Fludarabine|fludarabine|mesh-list
139072572|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
139072573|NCT00393029|Interleukin-2|interleukin-2|mesh-list
139072574|NCT00393029|Lenograstim|lenograstim|mesh-list
139072575|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072576|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
139072577|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072578|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072579|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139072580|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
139072581|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690424|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690425|NCT04688346|Epinephrine|epinephrine|mesh-list
138181007|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138690427|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138690428|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
138690429|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690430|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690431|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690432|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138690433|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138690434|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
138690435|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690436|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138690437|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
138690438|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
138690439|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
138690440|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138690441|NCT01289821|Leucovorin|leucovorin|mesh-list
138690442|NCT01289821|Folic Acid|folic acid|mesh-list
138690443|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
138690444|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
139072582|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072583|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139072584|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139072585|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
139072586|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139072587|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139072588|NCT00393029|Analgesics|analgesics|mesh-ancestor
139072589|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
139072590|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072591|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139072592|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139072593|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
139072594|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072595|NCT00402233|Pramipexole|pramipexole|mesh-list
138940617|NCT04039126|Povidone|povidone|mesh-list
139072597|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072598|NCT00402233|Protective Agents|protective agents|mesh-ancestor
139072599|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072600|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139072601|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139072602|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
139072603|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
139072604|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267862|NCT02713997|Analgesics|analgesics|mesh-ancestor
139072605|NCT03993431|Methamphetamine|methamphetamine|mesh-list
139072606|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139072607|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072608|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
139072609|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
139072610|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072611|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
138690449|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
138690450|NCT01289821|Vitamins|vitamins|mesh-ancestor
138690451|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
138690466|NCT01289782|Ribavirin|ribavirin|mesh-list
139072612|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139072613|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072614|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
139072615|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138823213|NCT02571517|Hormones|hormones|mesh-ancestor
139072616|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139072617|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139072618|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139072620|NCT00401843|Bortezomib|bortezomib|mesh-list
139072621|NCT00401843|Siltuximab|siltuximab|mesh-list
139072622|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072623|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
139072624|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
139072625|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072626|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072627|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139072628|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
139072629|NCT00401843|Hormones|hormones|mesh-ancestor
139072630|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139072631|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139072632|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072633|NCT00401531|Vaccines|vaccines|mesh-list
139072634|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139072635|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
139072636|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072637|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
139072638|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139072639|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072640|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
139072641|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072642|NCT00400517|Thalidomide|thalidomide|mesh-list
139072643|NCT00400517|Sargramostim|sargramostim|mesh-list
139072644|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072646|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072647|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
139072648|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139072649|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072650|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139072651|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139072652|NCT00400517|Growth Substances|growth substances|mesh-ancestor
139072653|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
139072654|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072655|NCT01044095|Vaccines|vaccines|mesh-list
139072656|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
139072657|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072658|NCT00392171|Temozolomide|temozolomide|mesh-list
139072659|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138690546|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072660|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
139072661|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072662|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072663|NCT00091832|Denosumab|denosumab|mesh-list
139072664|NCT00091832|Diphosphonates|diphosphonates|mesh-list
139072665|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139072666|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072667|NCT00391391|Vaccines|vaccines|mesh-list
139072668|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
139072669|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072671|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139072672|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
139072673|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267926|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
139072674|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072675|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072677|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
139072678|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
139072680|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
139072681|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139072682|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072683|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139072684|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139072685|NCT01044329|Growth Substances|growth substances|mesh-ancestor
139072686|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072687|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
139072688|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072689|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
139072690|NCT01044329|Hormones|hormones|mesh-ancestor
139072691|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139072692|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072694|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690601|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138690602|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
139072695|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072696|NCT00091442|Docetaxel|docetaxel|mesh-list
139072697|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139072698|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072699|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
139072700|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
139072701|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
139072702|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072703|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139072704|NCT00390689|Pramipexole|pramipexole|mesh-list
139072705|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
139072706|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072707|NCT00390689|Protective Agents|protective agents|mesh-ancestor
139072708|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072710|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139072712|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
139072713|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139072714|NCT01079078|Acetaminophen|acetaminophen|mesh-list
139072715|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139072716|NCT01079078|Analgesics|analgesics|mesh-ancestor
139072717|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
139072718|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072719|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072720|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
139072721|NCT00390455|Fulvestrant|fulvestrant|mesh-list
139072722|NCT00390455|Lapatinib|lapatinib|mesh-list
139072723|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139072724|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085273|NCT01134848|Neostigmine|neostigmine|mesh-list
139072725|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139072726|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139072727|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
138690639|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139072728|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139072729|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072730|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139072731|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085274|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139072732|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072733|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
139072734|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139072735|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072736|NCT01583114|Perindopril|perindopril|mesh-list
139072737|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139072738|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
139072739|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072740|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072741|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139072742|NCT01079312|Fentanyl|fentanyl|mesh-list
139072743|NCT01079312|Remifentanil|remifentanil|mesh-list
139072744|NCT01079312|Propofol|propofol|mesh-list
138941268|NCT00881296|Carboplatin|carboplatin|mesh-list
139072745|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
139072746|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139072747|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072748|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139072749|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
139072750|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
139072751|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138690686|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139072752|NCT01079312|Narcotics|narcotics|mesh-ancestor
139072753|NCT01079312|Analgesics|analgesics|mesh-ancestor
139072754|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
139072755|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139072756|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139072758|NCT01044485|Lapatinib|lapatinib|mesh-list
139072759|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072760|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
139072761|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
139072762|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
139072763|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072764|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139072765|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072766|NCT00119678|Prednisone|prednisone|mesh-list
139072767|NCT00119678|Abatacept|abatacept|mesh-list
139072768|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139072769|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
139072770|NCT00119678|Hormones|hormones|mesh-ancestor
139072771|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139072772|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072773|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139072774|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072775|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139072776|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072777|NCT00119678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139072778|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072779|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
138690737|NCT02934035|Fluoxetine|fluoxetine|mesh-list
139072780|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072781|NCT00110084|Paclitaxel|paclitaxel|mesh-list
139072782|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139072783|NCT00110084|Gemcitabine|gemcitabine|mesh-list
139072784|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139072785|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072786|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
139072787|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
139072788|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
139072789|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072790|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139072791|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
139072792|NCT00390221|Daclizumab|daclizumab|mesh-list
139072793|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072794|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
139072795|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072796|NCT00389831|Rotigotine|rotigotine|mesh-list
138268043|NCT02369523|Bupivacaine|bupivacaine|mesh-list
139072797|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
139072798|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
139072799|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139072800|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072801|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072802|NCT00389519|Ramipril|ramipril|mesh-list
139072803|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139072804|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
139072805|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072806|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072807|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139072808|NCT00389441|Axitinib|axitinib|mesh-list
139072809|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072810|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139072811|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835850|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
139072812|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072813|NCT00118898|Ritonavir|ritonavir|mesh-list
139072814|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139072815|NCT00118898|Tenofovir|tenofovir|mesh-list
139072816|NCT00118898|Lamivudine|lamivudine|mesh-list
139072817|NCT00118898|Emtricitabine|emtricitabine|mesh-list
139072818|NCT00118898|Abacavir|abacavir|mesh-list
139072819|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139072820|NCT00118898|Efavirenz|efavirenz|mesh-list
139072821|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
139072822|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139072823|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139072824|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
139072825|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072826|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072827|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139072828|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139072829|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
139072830|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072831|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139072832|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139072833|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139072834|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139072835|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139072836|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139072837|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139072838|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139072839|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139072840|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
138823434|NCT00727207|Everolimus|everolimus|mesh-list
139072841|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
139072842|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138690818|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139072843|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
139072844|NCT01085552|Hematinics|hematinics|mesh-ancestor
139072845|NCT01085708|Rabeprazole|rabeprazole|mesh-list
139072846|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139072847|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139072848|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139072849|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072850|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072851|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139072852|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139072853|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139072854|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
139072856|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072857|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072858|NCT00090584|Urological Agents|urological agents|mesh-ancestor
139072859|NCT01079624|Glucagon|glucagon|mesh-list
139072860|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
139072861|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139072862|NCT01079624|Hormones|hormones|mesh-ancestor
139072863|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139072864|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072865|NCT01079624|Incretins|incretins|mesh-ancestor
139072866|NCT01086020|Atorvastatin|atorvastatin|mesh-list
139072867|NCT01086020|Ezetimibe|ezetimibe|mesh-list
139072868|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139072869|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139072870|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
139072871|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072872|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139072873|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139072874|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072875|NCT03670810|Lasmiditan|lasmiditan|mesh-list
139072876|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139072877|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
139072878|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690865|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690866|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
138690867|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
139072879|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941747|NCT00611884|Insulin|insulin|mesh-list
139072880|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072882|NCT01086254|Iniparib|iniparib|mesh-list
139072883|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072884|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139072885|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
138268103|NCT02043457|Hormones|hormones|mesh-list
139072886|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072887|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139072888|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072890|NCT01086332|Gemcitabine|gemcitabine|mesh-list
139072891|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139072892|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
139072893|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072894|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072895|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139072896|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139072897|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
139072898|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072899|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139072900|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139072901|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
139072902|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072903|NCT01811368|Cyclosporine|cyclosporine|mesh-list
139072904|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
139072905|NCT01811368|Rituximab|rituximab|mesh-list
139072906|NCT01811368|Cyclosporins|cyclosporins|mesh-list
138690902|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139072907|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
139072908|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
139072909|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
139072910|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139072911|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072912|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
139072913|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072914|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139072915|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072916|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072917|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072918|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
139072919|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072920|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
139072921|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139072922|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139072923|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139072924|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
139072925|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139072926|NCT00089648|Sunitinib|sunitinib|mesh-list
139072927|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072928|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139072929|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139072930|NCT00089648|Growth Substances|growth substances|mesh-ancestor
139072931|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072932|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
139072933|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139072934|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072935|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072936|NCT01079702|Capecitabine|capecitabine|mesh-list
139072937|NCT01079702|Everolimus|everolimus|mesh-list
138268184|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
139072938|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139072939|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
139072940|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072941|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072942|NCT01079702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139072943|NCT01079702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138941981|NCT00889642|Lidocaine|lidocaine|mesh-list
139072944|NCT01079702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072945|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139072946|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
139072947|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072949|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139072950|NCT00118040|Protective Agents|protective agents|mesh-ancestor
139072951|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072952|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072953|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139072954|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072955|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139072956|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
139072957|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139072958|NCT00118040|Estrogens|estrogens|mesh-ancestor
139072959|NCT00118040|Hormones|hormones|mesh-ancestor
139072960|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139072961|NCT03961958|Propofol|propofol|mesh-list
139072962|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139072963|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139072964|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072965|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139072966|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
139072967|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
139072968|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
139072969|NCT00389207|Nevirapine|nevirapine|mesh-list
139072970|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139072971|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139072972|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
139072973|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139072974|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268246|NCT01476787|Rituximab|rituximab|mesh-list
139072976|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139072977|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
139072978|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139072979|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139072980|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139072981|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139072982|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139072983|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139072984|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
139072985|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139072986|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139072987|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139072988|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139072989|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072990|NCT00388583|Vaccines|vaccines|mesh-list
139072991|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
139072992|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139072993|NCT00117572|Docetaxel|docetaxel|mesh-list
139072994|NCT00117572|Fluorouracil|fluorouracil|mesh-list
139072995|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
139072996|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139072997|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
139072998|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
139072999|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
139073000|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073001|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
139073002|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138268286|NCT00792662|Methylphenidate|methylphenidate|mesh-list
139073003|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139073004|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
139073005|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073006|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
139073007|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073008|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139073009|NCT00388505|Tobramycin|tobramycin|mesh-list
139073010|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139073011|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073012|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
139073013|NCT00388349|Carmustine|carmustine|mesh-list
139073014|NCT00388349|Gemcitabine|gemcitabine|mesh-list
139073015|NCT00388349|Etoposide|etoposide|mesh-list
139073016|NCT00388349|Vinorelbine|vinorelbine|mesh-list
139073017|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139073018|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
139073019|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073020|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139073021|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139073023|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073024|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073025|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139073026|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139073027|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
139073028|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139073029|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139073030|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139073031|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073032|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
138942248|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
139073033|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
139073034|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
139073035|NCT00117338|Montelukast|montelukast|mesh-list
139073036|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139073037|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
139073038|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139073039|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
139073040|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139073041|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073042|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139073043|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139073044|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073045|NCT00388037|Sunitinib|sunitinib|mesh-list
139073046|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073047|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139073048|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139073049|NCT00388037|Growth Substances|growth substances|mesh-ancestor
139073050|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073051|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
139073052|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139073053|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073054|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073055|NCT00387881|Naproxen|naproxen|mesh-list
139073056|NCT00387881|Sumatriptan|sumatriptan|mesh-list
139073057|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139073058|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139073059|NCT00387881|Analgesics|analgesics|mesh-ancestor
139073060|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
139073061|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073062|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073063|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073064|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139073065|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
139073066|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139073067|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073068|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073069|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139073070|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139073071|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139073072|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
139073073|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139073074|NCT00084656|Ipilimumab|ipilimumab|mesh-list
139085275|NCT01134848|Narcotics|narcotics|mesh-ancestor
139073075|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139073076|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073077|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139073078|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073079|NCT00387647|Azacitidine|azacitidine|mesh-list
139073080|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139073081|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
138942492|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
139073082|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226372|NCT02489448|Tremelimumab|tremelimumab|mesh-list
139073083|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073084|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073085|NCT00386009|Tadalafil|tadalafil|mesh-list
139073086|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
139073087|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139073088|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139073089|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073090|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073091|NCT00386009|Urological Agents|urological agents|mesh-ancestor
139073092|NCT01045889|Prednisone|prednisone|mesh-list
139073093|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
139073094|NCT01045889|Melphalan|melphalan|mesh-list
139073095|NCT01045889|Rituximab|rituximab|mesh-list
139073096|NCT01045889|Etoposide|etoposide|mesh-list
139073098|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139073099|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
139073100|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073101|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138942622|NCT00696774|Analgesics|analgesics|mesh-ancestor
139073102|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138268353|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
139073104|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073105|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073106|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139073107|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138691217|NCT02834559|Heparin|heparin|mesh-list
138691218|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
139073108|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073109|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
139073110|NCT01045889|Hormones|hormones|mesh-ancestor
138942695|NCT00696696|Sorafenib|sorafenib|mesh-list
139073111|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139073112|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139073113|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139073115|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139073116|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073117|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
139073118|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
139073119|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
139073120|NCT00373685|Celecoxib|celecoxib|mesh-list
139073121|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139073122|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139073123|NCT00373685|Analgesics|analgesics|mesh-ancestor
139073124|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
139073125|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073126|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073127|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073128|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139073129|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139073130|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139073131|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073132|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073133|NCT00373529|Clofarabine|clofarabine|mesh-list
139073134|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139073135|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
139073136|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073137|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073139|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139073140|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073141|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139073142|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073143|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
139073144|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
139073145|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
139073146|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139073147|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073148|NCT00385541|Morphine|morphine|mesh-list
139073149|NCT00385541|Hydromorphone|hydromorphone|mesh-list
139073150|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139073151|NCT00385541|Narcotics|narcotics|mesh-ancestor
139073152|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139073153|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073154|NCT00385541|Analgesics|analgesics|mesh-ancestor
139073155|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
139073156|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073157|NCT01046045|Everolimus|everolimus|mesh-list
139073158|NCT01046045|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139073159|NCT01046045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138691268|NCT03981341|Estrogens|estrogens|mesh-list
139073160|NCT01046045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073161|NCT01046045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073162|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139073163|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
139073164|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073165|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073167|NCT01044719|Tobramycin|tobramycin|mesh-list
139073168|NCT01044719|Ceftazidime|ceftazidime|mesh-list
139073169|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139073170|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073171|NCT01045109|Vitamin D|vitamin d|mesh-list
139073172|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
139073173|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
139073174|NCT01045109|Vitamins|vitamins|mesh-list
139073175|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
139073176|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073177|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139073178|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139073179|NCT00094302|Spironolactone|spironolactone|mesh-list
139073180|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
139073181|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
139073182|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139073183|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073184|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139073185|NCT00094302|Diuretics|diuretics|mesh-ancestor
139073186|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
138691292|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139073187|NCT00372905|Rituximab|rituximab|mesh-list
139073188|NCT00372905|Bortezomib|bortezomib|mesh-list
139073189|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139073190|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139073191|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073192|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
139073193|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073194|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139073195|NCT00384839|Azacitidine|azacitidine|mesh-list
139073196|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139073197|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
139073198|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073199|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073200|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073201|NCT01046279|Bevacizumab|bevacizumab|mesh-list
139073202|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139073203|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073204|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139073205|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139073206|NCT01046279|Growth Substances|growth substances|mesh-ancestor
139073207|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073208|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
139073210|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139073211|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
139073212|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073213|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138691338|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073214|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
139073215|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
139073216|NCT00384293|Vitamins|vitamins|mesh-ancestor
139073217|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
139073218|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073219|NCT01087866|Metformin|metformin|mesh-list
139073220|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139073221|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073222|NCT01090830|Paclitaxel|paclitaxel|mesh-list
139073223|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139073224|NCT01090830|Bevacizumab|bevacizumab|mesh-list
139073225|NCT01090830|Carboplatin|carboplatin|mesh-list
139073226|NCT01090830|Belinostat|belinostat|mesh-list
139073227|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139073228|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073229|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
139073230|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
139073231|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
139073232|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073233|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139073234|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139073235|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139073236|NCT01090830|Growth Substances|growth substances|mesh-ancestor
139073237|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073238|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
139073239|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139073240|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073241|NCT01084824|Cantharidin|cantharidin|mesh-list
139073242|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073243|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691386|NCT02921165|Aspirin|aspirin|mesh-list
139073244|NCT01088022|Dexamethasone|dexamethasone|mesh-list
139073245|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
139073246|NCT01088022|Aprepitant|aprepitant|mesh-list
139073247|NCT01088022|Palonosetron|palonosetron|mesh-list
139073248|NCT01088022|BB 1101|bb 1101|mesh-list
139073249|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073250|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
139073251|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
139073252|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073253|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073254|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139073255|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
139073256|NCT01088022|Hormones|hormones|mesh-ancestor
139073257|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139073258|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139073259|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073260|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
139073261|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268475|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
139073262|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073263|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
139073264|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139073265|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139073266|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139073267|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
139073268|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
139073269|NCT00067002|Melphalan|melphalan|mesh-list
139073270|NCT00067002|Thiotepa|thiotepa|mesh-list
139073271|NCT00067002|Rituximab|rituximab|mesh-list
139073272|NCT00067002|Fludarabine|fludarabine|mesh-list
139073273|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
139073274|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138691435|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
138691459|NCT02932566|Pirfenidone|pirfenidone|mesh-list
139073275|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
139073276|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073277|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139073278|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139073279|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
139073280|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073281|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073282|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139073283|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139073284|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139073285|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
139073287|NCT01084902|Brinzolamide|brinzolamide|mesh-list
139073288|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
139073289|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139073290|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138823883|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
139073291|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073292|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073293|NCT01084980|Tacrolimus|tacrolimus|mesh-list
139073294|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139073295|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
139073296|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691479|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073297|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139073298|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073299|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073300|NCT01085058|Lenograstim|lenograstim|mesh-list
139073301|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139073302|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
139073303|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073304|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
139073305|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139073306|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
139073307|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139073308|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073309|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139073310|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139073311|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139073312|NCT01088256|Etoricoxib|etoricoxib|mesh-list
139073313|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139073314|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139073315|NCT01088256|Analgesics|analgesics|mesh-ancestor
139073316|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
139073317|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073318|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073319|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073320|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139073321|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139073322|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139073323|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073324|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073325|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
139073326|NCT01326858|Ketotifen|ketotifen|mesh-list
138691532|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073327|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139073328|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139073329|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139073330|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139073331|NCT01326858|Analgesics|analgesics|mesh-ancestor
139073332|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
139073333|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073334|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073335|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073336|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139073337|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138268559|NCT02802566|Vitamins|vitamins|mesh-list
139073338|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139073339|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139073340|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
139073341|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
139073342|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139073343|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073344|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
139073345|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
139073346|NCT00091572|Temozolomide|temozolomide|mesh-list
139073347|NCT00091572|Dacarbazine|dacarbazine|mesh-list
139073348|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139073349|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
138943493|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139073350|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073351|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073353|NCT01091220|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138943554|NCT00823875|Cilostazol|cilostazol|mesh-list
139073354|NCT01091220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073355|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139073356|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
139073357|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073358|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139073359|NCT00084266|Vancomycin|vancomycin|mesh-list
139073360|NCT00084266|Linezolid|linezolid|mesh-list
139073361|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139073362|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073363|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139073364|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073365|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073366|NCT01086878|Trimethoprim|trimethoprim|mesh-list
139073367|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
139073368|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
139073369|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139073370|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073371|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
139073372|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139073373|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139073374|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139073375|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073376|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073377|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139073378|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139073379|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139073380|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139073381|NCT01086956|Sufentanil|sufentanil|mesh-list
139073382|NCT01086956|Ropivacaine|ropivacaine|mesh-list
139073383|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
139073384|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
139073385|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139073386|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073387|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
139073388|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073389|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139073390|NCT01086956|Narcotics|narcotics|mesh-ancestor
139073391|NCT01086956|Analgesics|analgesics|mesh-ancestor
139073392|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139073393|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139073394|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
139073395|NCT00091026|Bevacizumab|bevacizumab|mesh-list
139073396|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139073397|NCT00091026|Cetuximab|cetuximab|mesh-list
139073398|NCT00091026|Gemcitabine|gemcitabine|mesh-list
139073399|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139073400|NCT00091026|Antibodies|antibodies|mesh-list
139073401|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
139073402|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139073403|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073404|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139073405|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139073406|NCT00091026|Growth Substances|growth substances|mesh-ancestor
139073407|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073408|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
139073409|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
139073410|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139073411|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
139073412|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073413|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139073414|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073415|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
139073416|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073417|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139073418|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073419|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073420|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
139073421|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139073422|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
139073423|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139073424|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
139073425|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073426|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
139073427|NCT00100178|Daclizumab|daclizumab|mesh-list
139073428|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139073429|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073430|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139073431|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
139073432|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139073433|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073434|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073435|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073436|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139073437|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
139073438|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073439|NCT00099632|Ritonavir|ritonavir|mesh-list
139073440|NCT00099632|Lopinavir|lopinavir|mesh-list
139073441|NCT00099632|Tenofovir|tenofovir|mesh-list
139073442|NCT00099632|Lamivudine|lamivudine|mesh-list
139073443|NCT00099632|Emtricitabine|emtricitabine|mesh-list
139073444|NCT00099632|Zidovudine|zidovudine|mesh-list
139073445|NCT00099632|Nevirapine|nevirapine|mesh-list
139073446|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139073447|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139073448|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139073449|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139073450|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
139073451|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073452|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073453|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139073454|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139073455|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
139073456|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073457|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139073458|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139073459|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139073460|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139073461|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
139073462|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139073463|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139073464|NCT01087190|Isoniazid|isoniazid|mesh-list
139073465|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
139073466|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138691704|NCT03673787|Atezolizumab|atezolizumab|mesh-list
139073467|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073468|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
139073469|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139073470|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
139073471|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073472|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139073473|NCT01090466|Sirolimus|sirolimus|mesh-list
139073474|NCT01090466|Gemcitabine|gemcitabine|mesh-list
139073475|NCT01090466|Temsirolimus|temsirolimus|mesh-list
139073476|NCT01090466|MTOR Inhibitors|mtor inhibitors|mesh-list
139073477|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073478|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139073479|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
139073480|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073481|NCT01090466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139073482|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073483|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139073484|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
139073485|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073486|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139073487|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073488|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139073489|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
139073491|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073492|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
139073493|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
139073494|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073495|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073496|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139073497|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
139073498|NCT04116398|Hormones|hormones|mesh-ancestor
139073499|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139073500|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139073501|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073502|NCT00098774|Leucovorin|leucovorin|mesh-list
139073503|NCT00098774|Cytarabine|cytarabine|mesh-list
139073504|NCT00098774|Rituximab|rituximab|mesh-list
139073505|NCT00098774|Methotrexate|methotrexate|mesh-list
138691740|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073506|NCT00098774|Etoposide|etoposide|mesh-list
139073507|NCT00098774|Temozolomide|temozolomide|mesh-list
139073508|NCT00098774|Calcium|calcium|mesh-list
139073509|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
139073510|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139073511|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073512|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
139073513|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073514|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139073515|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139073516|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139073518|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139073519|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139073520|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
139073521|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073522|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
139073523|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073524|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139073525|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139073526|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139073527|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139073528|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139073529|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139073530|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
139073531|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073532|NCT00098774|Antidotes|antidotes|mesh-ancestor
139073533|NCT00098774|Protective Agents|protective agents|mesh-ancestor
139073534|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
138227137|NCT02233751|Hormones|hormones|mesh-ancestor
139073535|NCT00098774|Vitamins|vitamins|mesh-ancestor
139073536|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
139073537|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139073538|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
139073540|NCT01081652|Progestins|progestins|mesh-ancestor
139073541|NCT01081652|Hormones|hormones|mesh-ancestor
139073542|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139073543|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073544|NCT01087580|Prednisone|prednisone|mesh-list
139073545|NCT01087580|Docetaxel|docetaxel|mesh-list
139073546|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073547|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
139073548|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
139073549|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
139073550|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073551|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073552|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
139073554|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139073555|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073556|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139073557|NCT01087658|Calcium|calcium|mesh-list
139073558|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139073559|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073560|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139073561|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139073562|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691827|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
139073563|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
139073565|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
139073566|NCT01090700|Simeprevir|simeprevir|mesh-list
139073567|NCT01090700|Dexetimide|dexetimide|mesh-list
139073568|NCT01090700|Citalopram|citalopram|mesh-list
139073569|NCT01090700|Escitalopram|escitalopram|mesh-list
139073570|NCT01090700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139073571|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139073572|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138944165|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
139073573|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073574|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139073575|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
139073576|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073577|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139073578|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139073579|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
139073580|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
139073581|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073582|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139073583|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139073584|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
139073585|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139073586|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
139073587|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139073588|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
138691871|NCT03685253|Vitamins|vitamins|mesh-ancestor
139073589|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073590|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
139073591|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073592|NCT03957902|Aspirin|aspirin|mesh-list
139073593|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139073594|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139073595|NCT03957902|Analgesics|analgesics|mesh-ancestor
139073596|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
139073597|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073598|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073599|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073600|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139073601|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139073602|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139073603|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073604|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139073605|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139073606|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073607|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
139073608|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139073609|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
139073610|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073611|NCT01046435|Amoxicillin|amoxicillin|mesh-list
139073612|NCT01046435|Metronidazole|metronidazole|mesh-list
139073613|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139073614|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073615|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139073616|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139073617|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
139073618|NCT00858364|Hematinics|hematinics|mesh-ancestor
139073619|NCT00382733|Topotecan|topotecan|mesh-list
139073620|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139073621|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139073622|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073623|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073624|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073626|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073627|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691922|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
139073628|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073629|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139073630|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139073633|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073634|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139073635|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
139073636|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073637|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073638|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139073639|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
139073640|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
139073641|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139073642|NCT03732508|Fluorouracil|fluorouracil|mesh-list
139073643|NCT03732508|Irinotecan|irinotecan|mesh-list
139073644|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
139073645|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073646|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139073647|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073648|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138944687|NCT00927004|Analgesics|analgesics|mesh-ancestor
139073649|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
139073650|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073651|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138691958|NCT05466149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139073652|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139073653|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073654|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139073655|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
139073656|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268777|NCT05717881|Propolis|propolis|mesh-list
139073658|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
139073659|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
139073660|NCT00112437|Calcium|calcium|mesh-list
139073661|NCT00112437|Vitamins|vitamins|mesh-ancestor
139073662|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
139073663|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073664|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139073665|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139073666|NCT00112437|Antacids|antacids|mesh-ancestor
139073667|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073669|NCT03653416|Bupivacaine|bupivacaine|mesh-list
139073670|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
139073671|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
139073672|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139073673|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073674|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
139073675|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073676|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
139073677|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139073678|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
139073679|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073680|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
139073681|NCT01076673|Protective Agents|protective agents|mesh-ancestor
139073682|NCT00119379|Tenofovir|tenofovir|mesh-list
139073683|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
139073684|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268799|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
138268801|NCT02387359|Plecanatide|plecanatide|mesh-list
139073685|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139073686|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139073687|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073688|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073689|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139073690|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139073691|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
139073692|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139073693|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073694|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139073695|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
139073696|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139073697|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073698|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073699|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073701|NCT01079481|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139073702|NCT01079481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139073703|NCT01079481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692055|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
139073704|NCT01079481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945020|NCT01049347|Paroxetine|paroxetine|mesh-list
139073705|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139073706|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
138268847|NCT05664139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073707|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073708|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073709|NCT03964779|Antibodies|antibodies|mesh-list
139073710|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
139073711|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
139073712|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073713|NCT00131937|Sorafenib|sorafenib|mesh-list
139073714|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073715|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139073716|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073717|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073718|NCT01079559|Tobramycin|tobramycin|mesh-list
139073719|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139073720|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073721|NCT00131469|Teriparatide|teriparatide|mesh-list
139073722|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139073723|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073724|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139073725|NCT00372593|Cytarabine|cytarabine|mesh-list
139073726|NCT00372593|Etoposide|etoposide|mesh-list
139073727|NCT00372593|Daunorubicin|daunorubicin|mesh-list
139073728|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
139073729|NCT00372593|Asparaginase|asparaginase|mesh-list
139073730|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
139073731|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139073732|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692110|NCT04261218|Paclitaxel|paclitaxel|mesh-list
138692117|NCT04687449|Curcumin|curcumin|mesh-list
139073733|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139073734|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139073735|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073736|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073737|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139073738|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
139073739|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
139073740|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073741|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139073742|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
139073743|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073744|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139073745|NCT00372593|Analgesics|analgesics|mesh-ancestor
139073746|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
139073747|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073748|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139073750|NCT00372593|Immunoconjugates|immunoconjugates|mesh-ancestor
139073751|NCT01324583|Prednisolone|prednisolone|mesh-list
139073752|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073753|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
139085276|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139073755|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139073756|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073757|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139073758|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073759|NCT00382109|Sirolimus|sirolimus|mesh-list
139073760|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
139073761|NCT00382109|Thiotepa|thiotepa|mesh-list
139073762|NCT00382109|Methotrexate|methotrexate|mesh-list
139073763|NCT00382109|Tacrolimus|tacrolimus|mesh-list
139073764|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139073765|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
139073766|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463662|NCT01946984|Diclofenac|diclofenac|mesh-list
139073767|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139073768|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139073769|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
139073770|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073771|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073772|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139073773|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139073774|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
139073775|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139073776|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139073777|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
139073778|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
139073779|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073780|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139073781|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139073782|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139073783|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139073784|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073785|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139073786|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
139073787|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
139073788|NCT00381797|Bevacizumab|bevacizumab|mesh-list
138268928|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
138692191|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138945283|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
139073789|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139073791|NCT00381797|Camptothecin|camptothecin|mesh-list
139073792|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
139073793|NCT00381797|Antibodies|antibodies|mesh-list
139073794|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
139073795|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139073796|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
139073797|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139073798|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073799|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139073800|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139073801|NCT00381797|Growth Substances|growth substances|mesh-ancestor
139073802|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073803|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
139073804|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
139073805|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139073806|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139073807|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073808|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073809|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139073810|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139073811|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
139073812|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
139073813|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073814|NCT03665038|Brexanolone|brexanolone|mesh-list
139073815|NCT03665038|Neurosteroids|neurosteroids|mesh-ancestor
139073816|NCT03665038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139073817|NCT03665038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073818|NCT03665038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073819|NCT03665038|GABA Modulators|gaba modulators|mesh-ancestor
139073820|NCT03665038|GABA Agents|gaba agents|mesh-ancestor
138227784|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
139073821|NCT03664024|Carboplatin|carboplatin|mesh-list
139073822|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
139073823|NCT03664024|Pemetrexed|pemetrexed|mesh-list
139073824|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945410|NCT01046539|Analgesics|analgesics|mesh-ancestor
139073825|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139073826|NCT03664024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139073827|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073829|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139073830|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139073831|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
139073832|NCT03624946|Antibodies|antibodies|mesh-list
139073833|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
139073834|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139073835|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139073836|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
139073837|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
139073838|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073840|NCT03735082|Carboplatin|carboplatin|mesh-list
139073841|NCT03735082|Apatinib|apatinib|mesh-list
139073842|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139073843|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073844|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
139073845|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
139073846|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
139073847|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073848|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139073849|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073850|NCT00381095|Pregabalin|pregabalin|mesh-list
139073851|NCT00381095|Analgesics|analgesics|mesh-ancestor
139073852|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
139073853|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073854|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073855|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
139073856|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139073857|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139073858|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073859|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139073860|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139073861|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139073862|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139073863|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139073864|NCT03737656|Progesterone|progesterone|mesh-list
139073865|NCT03737656|Progestins|progestins|mesh-ancestor
139073866|NCT03737656|Hormones|hormones|mesh-ancestor
139073867|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139073868|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073869|NCT00112047|Tenofovir|tenofovir|mesh-list
139073870|NCT00112047|Lamivudine|lamivudine|mesh-list
139073871|NCT00112047|Emtricitabine|emtricitabine|mesh-list
139073872|NCT00112047|Zidovudine|zidovudine|mesh-list
139073873|NCT00112047|Efavirenz|efavirenz|mesh-list
139073874|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
139073875|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
139073876|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073877|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139073878|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139073879|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073880|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073881|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139073882|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139073883|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
139073884|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139073885|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139073886|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139073887|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139073888|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139073889|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139073890|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139073891|NCT03658876|Hematinics|hematinics|mesh-ancestor
139073892|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
139073893|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139073894|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073895|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
139073896|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073897|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139073898|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073899|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073901|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139073902|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139073903|NCT03734614|Analgesics|analgesics|mesh-ancestor
139073904|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
139073905|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945633|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139073906|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073907|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073908|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139073909|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139073910|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139073911|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073912|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139073913|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139073914|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139073915|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
139073916|NCT00380393|Vaccines|vaccines|mesh-list
139073917|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
139073918|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073919|NCT00380081|Zolpidem|zolpidem|mesh-list
139073920|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139073921|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139073922|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139073923|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073924|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139073925|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
139073926|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
139073927|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139073928|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073929|NCT03579940|Lasmiditan|lasmiditan|mesh-list
139073930|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139073931|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
139073932|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139073933|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073934|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073935|NCT03732040|Fluorides|fluorides|mesh-list
139073936|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
139073937|NCT03732040|Protective Agents|protective agents|mesh-ancestor
138269015|NCT00003165|Doxorubicin|doxorubicin|mesh-list
139073938|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073940|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139073941|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139073942|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073943|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139073944|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139073945|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
139073946|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073947|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139073949|NCT03615040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139073950|NCT03615040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139073951|NCT03615040|Antiviral Agents|antiviral agents|mesh-ancestor
139073952|NCT03615040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139073953|NCT01090778|Hormones|hormones|mesh-list
139073954|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139073955|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073956|NCT00068588|Capecitabine|capecitabine|mesh-list
139073957|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139073958|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
138692404|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692406|NCT05471453|Vitamin E|vitamin e|mesh-list
139073959|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073960|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073961|NCT01088282|Dipivefrin|dipivefrin|mesh-list
139073962|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139073963|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
139073964|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139073965|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073966|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073967|NCT03963752|Megestrol|megestrol|mesh-list
139073968|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
139073969|NCT03963752|Leuprolide|leuprolide|mesh-list
139073970|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139073971|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139073972|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139073973|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
138824545|NCT02666001|Methadone|methadone|mesh-list
139073974|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139073975|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073976|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138692453|NCT05471063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138692454|NCT05471063|Hormone Antagonists|hormone antagonists|mesh-ancestor
138945792|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
139073977|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139073978|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139073979|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139073980|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
139073981|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139073982|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139073983|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
139073984|NCT01310296|Lofexidine|lofexidine|mesh-list
139073985|NCT01310296|Clonidine|clonidine|mesh-list
138945834|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
139073986|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139073987|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139073988|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139073989|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
139073990|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139073991|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139073992|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139073993|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139073994|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
139073995|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139073996|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139073997|NCT01310296|Analgesics|analgesics|mesh-ancestor
139073998|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
139073999|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
139074000|NCT03734068|Doxorubicin|doxorubicin|mesh-list
139074001|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139074002|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074003|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139074004|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139074005|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074006|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074007|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
139074008|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074009|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
139074010|NCT03575806|Estrogens|estrogens|mesh-ancestor
139074011|NCT03575806|Hormones|hormones|mesh-ancestor
139074012|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139074013|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139074014|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074015|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
139074016|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
139074017|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074018|NCT03729310|Triamcinolone|triamcinolone|mesh-list
139074019|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139074021|NCT03729310|Hormones|hormones|mesh-ancestor
139074022|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269078|NCT00003195|Interferons|interferons|mesh-list
139074023|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074025|NCT03731494|Trace Elements|trace elements|mesh-ancestor
139074026|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
139074027|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074028|NCT00111813|Bortezomib|bortezomib|mesh-list
139074029|NCT00111813|Vorinostat|vorinostat|mesh-list
139074030|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074031|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
139074032|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074033|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074034|NCT00118287|Etanercept|etanercept|mesh-list
139074035|NCT00118287|Azacitidine|azacitidine|mesh-list
139074036|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139074037|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
139074038|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074039|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074040|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692554|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
139074041|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139074042|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139074043|NCT00118287|Analgesics|analgesics|mesh-ancestor
139074044|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
139074045|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074046|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074047|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139074048|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139074049|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139074050|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139074051|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
139074053|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
139074054|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139074055|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074056|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074057|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
139074058|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139074059|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139074060|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074061|NCT01079715|Propranolol|propranolol|mesh-list
139074062|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139074063|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139074064|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
138692597|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228267|NCT02455518|Acetaminophen|acetaminophen|mesh-list
139074065|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074066|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074067|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074068|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139074069|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139074070|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
139074071|NCT00130689|Cetuximab|cetuximab|mesh-list
139074072|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139074073|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074074|NCT01326585|Dexamethasone|dexamethasone|mesh-list
139074075|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
139074076|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
139074077|NCT01326585|BB 1101|bb 1101|mesh-list
138946117|NCT00574119|Spironolactone|spironolactone|mesh-list
139074078|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139074079|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
139074080|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
139074081|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074082|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074083|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139074084|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
139074085|NCT01326585|Hormones|hormones|mesh-ancestor
139074086|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139074087|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139074088|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074089|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
139074090|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692650|NCT05470166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074091|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074092|NCT03964935|Minocycline|minocycline|mesh-list
139074093|NCT03964935|Lycopene|lycopene|mesh-list
139074094|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139074095|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074096|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139074097|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
139074098|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074099|NCT03964935|Protective Agents|protective agents|mesh-ancestor
139074100|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074101|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139074102|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139074103|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074104|NCT03605212|Febuxostat|febuxostat|mesh-list
139074105|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
139074106|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139074107|NCT00117507|Deferasirox|deferasirox|mesh-list
139074108|NCT00117507|Chelating Agents|chelating agents|mesh-list
139074109|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
139074110|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
139074111|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074112|NCT03621046|Zolpidem|zolpidem|mesh-list
139074113|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
139074114|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139074115|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139074116|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074117|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
139074118|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
139074120|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074121|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074122|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
139074123|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139074124|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074125|NCT03603496|Nicotine|nicotine|mesh-list
139074126|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139074127|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
139074128|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074129|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074130|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139074131|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139074132|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
139074133|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074134|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074135|NCT00096135|Leucovorin|leucovorin|mesh-list
139074136|NCT00096135|Cytarabine|cytarabine|mesh-list
139074137|NCT00096135|Dexamethasone|dexamethasone|mesh-list
139074138|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
139074139|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139074140|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139074141|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139074142|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
139074143|NCT00096135|Methotrexate|methotrexate|mesh-list
139074144|NCT00096135|Etoposide|etoposide|mesh-list
139074145|NCT00096135|Vincristine|vincristine|mesh-list
139074146|NCT00096135|Daunorubicin|daunorubicin|mesh-list
139074147|NCT00096135|Asparaginase|asparaginase|mesh-list
139074148|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
139074149|NCT00096135|Pegaspargase|pegaspargase|mesh-list
139074150|NCT00096135|Lenograstim|lenograstim|mesh-list
139074151|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
139074152|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139074153|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
139074154|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074155|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139074156|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139074158|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074159|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074160|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139074161|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139074162|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
139074163|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
139074164|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074165|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139074166|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
139074167|NCT00096135|Hormones|hormones|mesh-ancestor
139074168|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139074169|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139074170|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139074171|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
139074172|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139074173|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139074174|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
139074175|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
139074176|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074177|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139074178|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139074179|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139074180|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139074182|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
139074183|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074184|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139074185|NCT00096135|Antidotes|antidotes|mesh-ancestor
139074186|NCT00096135|Protective Agents|protective agents|mesh-ancestor
138466333|NCT01958684|Copper|copper|mesh-list
139074187|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
139074188|NCT00096135|Vitamins|vitamins|mesh-ancestor
139074189|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
139074190|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
139074191|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
139074192|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
139074193|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139074194|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139074195|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
139074196|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139074197|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139074198|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824777|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
139074199|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074200|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
139074201|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074202|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139074203|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139074205|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139074206|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
139074207|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074209|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
139074210|NCT01080651|Voriconazole|voriconazole|mesh-list
138692830|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138692831|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138692832|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138692833|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138692834|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
138692835|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
138692836|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138692837|NCT00596050|Narcotics|narcotics|mesh-ancestor
138692838|NCT02888899|Loperamide|loperamide|mesh-list
138692839|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
138692840|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
138692841|NCT02888899|Psyllium|psyllium|mesh-list
138692842|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138692843|NCT02888899|Cathartics|cathartics|mesh-ancestor
139074211|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
139074212|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074213|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139074214|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139074215|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074216|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074217|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139074218|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
139074219|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139074220|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074221|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139074222|NCT01080729|Hormones|hormones|mesh-list
139074223|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
139074224|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139074225|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074226|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
139074227|NCT03962907|Mupirocin|mupirocin|mesh-list
139074228|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139074229|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074230|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
139074231|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139074232|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139074233|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074234|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074235|NCT00083889|Interferons|interferons|mesh-list
139074236|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
139074237|NCT00083889|Sunitinib|sunitinib|mesh-list
139074238|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074239|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
139074240|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074241|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
139074242|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074243|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139074244|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139074245|NCT00083889|Growth Substances|growth substances|mesh-ancestor
139074246|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
139074247|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139074248|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074249|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074250|NCT03639532|Tacrine|tacrine|mesh-list
139074251|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139074252|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074253|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074254|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
139074255|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074256|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074257|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139074258|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
139074259|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074260|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
139074261|NCT03571516|Teduglutide|teduglutide|mesh-list
139074262|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139074263|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139074264|NCT03571516|Protective Agents|protective agents|mesh-ancestor
138692917|NCT05312866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138466769|NCT01961856|Ticagrelor|ticagrelor|mesh-list
138692919|NCT05312866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692920|NCT05312866|Anesthetics, Local|anesthetics, local|mesh-ancestor
138692921|NCT05312866|Anesthetics|anesthetics|mesh-ancestor
138692922|NCT05312866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692923|NCT05312866|Sensory System Agents|sensory system agents|mesh-ancestor
138692924|NCT05312866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138692926|NCT05312866|Analgesics|analgesics|mesh-ancestor
139074265|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074266|NCT03600376|Dantrolene|dantrolene|mesh-list
139074267|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
139074268|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074269|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139074270|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074271|NCT03961659|Metformin|metformin|mesh-list
139074272|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
139074273|NCT03961659|Acarbose|acarbose|mesh-list
139074274|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139074275|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074276|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139074277|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074278|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
139074279|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074281|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139074282|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074283|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139074284|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074285|NCT03741309|Calcium|calcium|mesh-list
139074286|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139074287|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074288|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
139074289|NCT00082407|Exenatide|exenatide|mesh-list
139074290|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
139074291|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139074292|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074293|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139074294|NCT00082407|Incretins|incretins|mesh-ancestor
139074295|NCT00082407|Hormones|hormones|mesh-ancestor
139074296|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139074297|NCT01080963|Daptomycin|daptomycin|mesh-list
139074298|NCT01080963|Cefuroxime|cefuroxime|mesh-list
139074299|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
138269256|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
139074300|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139074301|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074302|NCT01083381|Risperidone|risperidone|mesh-list
139074303|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139074304|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
139074305|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074306|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074307|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692957|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074308|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139074309|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139074310|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139074311|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139074312|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139074313|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
139074314|NCT01087359|Melatonin|melatonin|mesh-list
139074315|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
139074316|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074317|NCT01087359|Protective Agents|protective agents|mesh-ancestor
139074318|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074319|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139074320|NCT01087437|Calcium|calcium|mesh-list
139074321|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139074322|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074323|NCT01083537|Paclitaxel|paclitaxel|mesh-list
138692990|NCT05470764|Vasodilator Agents|vasodilator agents|mesh-ancestor
139074324|NCT01083537|Cisplatin|cisplatin|mesh-list
139074325|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139074326|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074327|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
139074328|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
139074329|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
139074330|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074331|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
139074332|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
139074333|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
139074334|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
138947309|NCT00750048|Naloxone|naloxone|mesh-list
139074335|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074336|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
139074337|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139074338|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139074339|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074340|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139074341|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
139074342|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074343|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139074344|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
139074345|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
139074346|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
138824922|NCT00737971|Triamcinolone|triamcinolone|mesh-list
138269282|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139074347|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139074348|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139074349|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139074350|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139074351|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074352|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
139074353|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074354|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074355|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139074356|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074358|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
139074359|NCT03569098|Coagulants|coagulants|mesh-ancestor
139074360|NCT03727282|Dobutamine|dobutamine|mesh-list
139074361|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139074362|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
139074363|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
139074364|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074365|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074366|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
139074367|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139074368|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139074369|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
139074370|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074371|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074372|NCT03727282|Protective Agents|protective agents|mesh-ancestor
139074373|NCT03568942|Gepotidacin|gepotidacin|mesh-list
139074374|NCT03568942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139074375|NCT03568942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074376|NCT03568942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074377|NCT03568942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074378|NCT00110019|Paclitaxel|paclitaxel|mesh-list
139074379|NCT00110019|Carboplatin|carboplatin|mesh-list
139074380|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139074381|NCT00110019|Sorafenib|sorafenib|mesh-list
139074382|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139074383|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074384|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
139074385|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
139074386|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
139074387|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074388|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139074389|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074391|NCT03642262|Expectorants|expectorants|mesh-ancestor
139074392|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
139074393|NCT03727048|Ketorolac|ketorolac|mesh-list
139074394|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
139074395|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139074396|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139074397|NCT03727048|Analgesics|analgesics|mesh-ancestor
139074398|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
139074399|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074400|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074401|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139074402|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139074403|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139074404|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074405|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074406|NCT00095979|Epothilones|epothilones|mesh-list
139074407|NCT00095979|Epothilone B|epothilone b|mesh-list
139074408|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
138693143|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
139074409|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
139074410|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
139074411|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074412|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074413|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139074414|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139074415|NCT01087593|Estradiol|estradiol|mesh-list
139074416|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139074417|NCT01087593|Estrogens|estrogens|mesh-ancestor
139074419|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139074420|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074421|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138947618|NCT00944398|Zinc|zinc|mesh-list
139074422|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
139074423|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139074425|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
139074426|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139074427|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074428|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139074429|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139074430|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074431|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074432|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074433|NCT01087749|Losartan|losartan|mesh-list
138269342|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074434|NCT01087749|Propranolol|propranolol|mesh-list
139074435|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
139074436|NCT01087749|Eprosartan|eprosartan|mesh-list
139074437|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139074438|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139074439|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139074440|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139074441|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074442|NCT01087749|Diuretics|diuretics|mesh-ancestor
139074443|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
139074444|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074445|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
139074446|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139074447|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139074448|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139074449|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
139074450|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074452|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
139074453|NCT00108069|Tamoxifen|tamoxifen|mesh-list
139074454|NCT00108069|Bortezomib|bortezomib|mesh-list
139074455|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074456|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139074457|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
139074458|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139074459|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074460|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139074461|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139074462|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139074463|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139074464|NCT00079274|Leucovorin|leucovorin|mesh-list
139074465|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139074466|NCT00079274|Cetuximab|cetuximab|mesh-list
139074467|NCT00079274|Fluorouracil|fluorouracil|mesh-list
139074468|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
139074469|NCT00079274|Irinotecan|irinotecan|mesh-list
139074470|NCT00079274|Antibodies|antibodies|mesh-list
139074471|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
139074472|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139074473|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
139074474|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
139074475|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693225|NCT05469984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693226|NCT05469984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074476|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947769|NCT00685698|Nemonoxacin|nemonoxacin|mesh-list
139074477|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
139074478|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074479|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139074480|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139074481|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139074482|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139074483|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074484|NCT00079274|Antidotes|antidotes|mesh-ancestor
139074485|NCT00079274|Protective Agents|protective agents|mesh-ancestor
139074486|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
139074487|NCT00079274|Vitamins|vitamins|mesh-ancestor
139074488|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
139074489|NCT01081964|Levofloxacin|levofloxacin|mesh-list
139074490|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
139074491|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139074492|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074493|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139074494|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139074495|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139074496|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074497|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074498|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074499|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139074500|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139074501|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139074502|NCT00079040|Bevacizumab|bevacizumab|mesh-list
139074503|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139074505|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
139074506|NCT00079040|Antibodies|antibodies|mesh-list
139074507|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
139074508|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139074509|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074510|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139074511|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139074512|NCT00079040|Growth Substances|growth substances|mesh-ancestor
139074513|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074514|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
139074515|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
139074516|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139074517|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139074518|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139074519|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074520|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074521|NCT01088516|Ritonavir|ritonavir|mesh-list
139074522|NCT01088516|Lopinavir|lopinavir|mesh-list
139074523|NCT01088516|Zidovudine|zidovudine|mesh-list
139074524|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
139074525|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
139074526|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
139074527|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269400|NCT05327972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074528|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074529|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139074530|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139074531|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
139074532|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074533|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139074534|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139074535|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
139074536|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139074537|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139074538|NCT00078806|Etanercept|etanercept|mesh-list
139074539|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139074540|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139074541|NCT00078806|Analgesics|analgesics|mesh-ancestor
138948226|NCT02656706|Nivolumab|nivolumab|mesh-list
139074542|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
139074543|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074544|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074545|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139074546|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139074547|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139074548|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139074549|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
139074550|NCT00078338|Interferons|interferons|mesh-list
139074551|NCT00078338|Interferon-beta|interferon-beta|mesh-list
139074552|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
139074553|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
139074554|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
139074555|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074556|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
139074557|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074558|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
139074559|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074560|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138948283|NCT00553696|Growth Substances|growth substances|mesh-ancestor
139074561|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139074562|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139074563|NCT01088594|Pioglitazone|pioglitazone|mesh-list
139074564|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
139074565|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139074566|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074567|NCT01082120|Pioglitazone|pioglitazone|mesh-list
139074568|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139074569|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269438|NCT00003231|Docetaxel|docetaxel|mesh-list
139074570|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139074571|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139074572|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
139074573|NCT03808298|Balovaptan|balovaptan|mesh-list
138825147|NCT02647671|Calcium|calcium|mesh-list
139074574|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139074575|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139074576|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074577|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138948405|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
139074578|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139074579|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074580|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074581|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074582|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139074583|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
139074584|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139074585|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074586|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139074587|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139074588|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139074589|NCT03808298|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139074590|NCT03808298|Natriuretic Agents|natriuretic agents|mesh-ancestor
139074591|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139074592|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
139074593|NCT00077636|Ribavirin|ribavirin|mesh-list
139074594|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
139074595|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074596|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
139074597|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074598|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
139074599|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074600|NCT01082198|Vaccines|vaccines|mesh-list
138693465|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
139074601|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
139074602|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
139074603|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074604|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139074606|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
139074607|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139074608|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139074609|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074610|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074611|NCT01091012|Urological Agents|urological agents|mesh-ancestor
139074612|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
139074613|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139074614|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139074615|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139074616|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074617|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139074618|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
139074619|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139074620|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139074621|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
139074622|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074623|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074624|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139074625|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139074626|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
139074627|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139074628|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139074629|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
139074630|NCT01088906|Pemetrexed|pemetrexed|mesh-list
139074632|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074633|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074634|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139074635|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139074636|NCT00095199|Docetaxel|docetaxel|mesh-list
139074637|NCT00095199|Pemetrexed|pemetrexed|mesh-list
139074639|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074640|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
139074641|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
138693508|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074642|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
139074643|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074644|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074645|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138948782|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139074646|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139074647|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139074648|NCT00075764|Fulvestrant|fulvestrant|mesh-list
139074649|NCT00075764|Anastrozole|anastrozole|mesh-list
139074650|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139074651|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074652|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139074653|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138948854|NCT04237012|Dexamethasone|dexamethasone|mesh-list
139074654|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
139074655|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139074656|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074657|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139074658|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139074659|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252851|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
138229617|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
139074660|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074661|NCT03567616|Dexamethasone|dexamethasone|mesh-list
139074662|NCT03567616|Venetoclax|venetoclax|mesh-list
139074663|NCT03567616|Pomalidomide|pomalidomide|mesh-list
139074664|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139074665|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
139074666|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
139074667|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074668|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074669|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139074670|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
139074671|NCT03567616|Hormones|hormones|mesh-ancestor
139074672|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139074673|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139074674|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074675|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
139074676|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139074677|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139074678|NCT03567616|Growth Substances|growth substances|mesh-ancestor
139074679|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
139074680|NCT03567382|Tenofovir|tenofovir|mesh-list
139074681|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
139074682|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074683|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138269533|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269535|NCT03269435|Metoclopramide|metoclopramide|mesh-list
139074684|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139074686|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074687|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139074688|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139074689|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
139074690|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138252897|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139074691|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139074692|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139074693|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139074694|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
139074695|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074696|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074697|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074698|NCT03730714|Epinephrine|epinephrine|mesh-list
139074699|NCT03730714|Racepinephrine|racepinephrine|mesh-list
139074700|NCT03730714|Morphine|morphine|mesh-list
139074701|NCT03730714|Anesthetics|anesthetics|mesh-list
139074702|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
139074703|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
139074704|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139074705|NCT03730714|Narcotics|narcotics|mesh-ancestor
139074706|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139074707|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074708|NCT03730714|Analgesics|analgesics|mesh-ancestor
139074709|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
139074710|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074711|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139074712|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139074713|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
139074714|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074715|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074716|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139074717|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139074718|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
139074719|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139074720|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
139074721|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
139074722|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
138825293|NCT05740657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074723|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139074724|NCT00106353|Temsirolimus|temsirolimus|mesh-list
139074725|NCT00106353|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139074726|NCT00106353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139074727|NCT00106353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269569|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
139074728|NCT00106353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074729|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139074730|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
139074731|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074732|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074734|NCT01087983|Sirolimus|sirolimus|mesh-list
139074735|NCT01087983|Lapatinib|lapatinib|mesh-list
139074736|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139074737|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074738|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139074739|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074740|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139074741|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074742|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
139074743|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139074744|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
139074745|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139074746|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074747|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074748|NCT00080301|Capecitabine|capecitabine|mesh-list
139074749|NCT00080301|Epothilones|epothilones|mesh-list
138949274|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
139074750|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139074751|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
139074752|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074753|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074754|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
139074755|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
139074756|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
139074757|NCT03961503|Vancomycin|vancomycin|mesh-list
139074758|NCT03961503|Daptomycin|daptomycin|mesh-list
139074759|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139074760|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074761|NCT00079677|Modafinil|modafinil|mesh-list
139074762|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139074763|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074764|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138229869|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139074765|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139074766|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139074767|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074768|NCT01081353|Aspirin|aspirin|mesh-list
139074769|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139074770|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139074771|NCT01081353|Analgesics|analgesics|mesh-ancestor
139074772|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
139074773|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074774|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074775|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139074776|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139074777|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139074778|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139074779|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074780|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139074781|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139074782|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074783|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
139074784|NCT00095121|Lamivudine|lamivudine|mesh-list
139074785|NCT00095121|Adefovir|adefovir|mesh-list
139074786|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138253090|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139074787|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139074788|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139074789|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074790|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074791|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
139074792|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074793|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139074794|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139074795|NCT01081431|Lenalidomide|lenalidomide|mesh-list
139074796|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
139074797|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949431|NCT00873483|Gestodene|gestodene|mesh-list
139074798|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139074799|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139074800|NCT01081431|Growth Substances|growth substances|mesh-ancestor
139074801|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
139074802|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074803|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
139074804|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139074805|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
139074806|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074807|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074808|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074809|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
139074811|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139074812|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139074813|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074814|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139074815|NCT01084473|Analgesics|analgesics|mesh-ancestor
139074816|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
139074817|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074818|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139074819|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138253136|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074820|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139074821|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
139074822|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074823|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074824|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139074825|NCT01084473|Narcotics|narcotics|mesh-ancestor
139074826|NCT01088373|Lenalidomide|lenalidomide|mesh-list
139074827|NCT01088373|Azacitidine|azacitidine|mesh-list
139074828|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
139074829|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074830|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139074831|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139074832|NCT01088373|Growth Substances|growth substances|mesh-ancestor
139074833|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
139074834|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074835|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139074836|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
139074837|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074838|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074839|NCT01088451|Insulin|insulin|mesh-list
139074840|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139074841|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074842|NCT00075218|Sunitinib|sunitinib|mesh-list
139074843|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074844|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138253166|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138253167|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
139074845|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139074846|NCT00075218|Growth Substances|growth substances|mesh-ancestor
139074847|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074848|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
139074849|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139074850|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074851|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074852|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
139074853|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139074854|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139074855|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074856|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
139074857|NCT01089140|Coagulants|coagulants|mesh-ancestor
139074858|NCT00094653|Ipilimumab|ipilimumab|mesh-list
139074859|NCT00094653|Vaccines|vaccines|mesh-list
139074860|NCT00094653|Antibodies|antibodies|mesh-list
139074861|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139074862|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
139074863|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074864|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139074865|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074866|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139074867|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074869|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139074870|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139074871|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139074872|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074873|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139074874|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074875|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
139074876|NCT05665348|Bevacizumab|bevacizumab|mesh-list
139074877|NCT05665348|Ipilimumab|ipilimumab|mesh-list
139074878|NCT05665348|Atezolizumab|atezolizumab|mesh-list
139074879|NCT05665348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139074880|NCT05665348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139074881|NCT05665348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074882|NCT05665348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139074883|NCT05665348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138949825|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
139074884|NCT05665348|Growth Substances|growth substances|mesh-ancestor
139074885|NCT05665348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074886|NCT05665348|Growth Inhibitors|growth inhibitors|mesh-ancestor
139074887|NCT05665348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139074888|NCT05665348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074889|NCT05665348|Immunologic Factors|immunologic factors|mesh-ancestor
139074890|NCT03726736|Docetaxel|docetaxel|mesh-list
139074891|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074892|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
139074893|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
139074894|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
138269700|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269703|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
139074895|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074896|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
139074898|NCT03726580|Propofol|propofol|mesh-list
139074899|NCT03726580|Sevoflurane|sevoflurane|mesh-list
139074900|NCT03726580|Isoflurane|isoflurane|mesh-list
139074901|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139074902|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139074903|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074904|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139074905|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
138253275|NCT00002571|Vitamins|vitamins|mesh-ancestor
139074906|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
139074907|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139074908|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139074909|NCT03730558|Aflibercept|aflibercept|mesh-list
139074910|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139074911|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139074912|NCT03730558|Growth Substances|growth substances|mesh-ancestor
139074913|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074914|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
139074915|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139074916|NCT03588910|Acetaminophen|acetaminophen|mesh-list
139074917|NCT03588910|Ibuprofen|ibuprofen|mesh-list
139074918|NCT03588910|Oxycodone|oxycodone|mesh-list
139074919|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139074920|NCT03588910|Analgesics|analgesics|mesh-ancestor
139074921|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
139074922|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950079|NCT04722718|Carboplatin|carboplatin|mesh-list
139074923|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074925|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139074926|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139074927|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139074928|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139074929|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074930|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074931|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139074932|NCT03588910|Narcotics|narcotics|mesh-ancestor
139074933|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139074935|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
139074936|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
138269729|NCT00356395|Ramipril|ramipril|mesh-list
139074937|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139074938|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074939|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
139074940|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074941|NCT00103857|Metformin|metformin|mesh-list
139074942|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
139074943|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139074944|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074945|NCT00103857|Incretins|incretins|mesh-ancestor
139074946|NCT00103857|Hormones|hormones|mesh-ancestor
139074947|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139074948|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139074949|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
139074950|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074951|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074952|NCT03587584|Bupivacaine|bupivacaine|mesh-list
139074953|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
139074954|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
139074955|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139074956|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074957|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
139074958|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074960|NCT03586726|Balovaptan|balovaptan|mesh-list
139074961|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139074962|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
139074963|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139074964|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139074965|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
139074966|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139074967|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074968|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074969|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139074970|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139074971|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138950205|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139074972|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139074973|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138253417|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139074974|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139074975|NCT03586726|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
139074976|NCT03586726|Natriuretic Agents|natriuretic agents|mesh-ancestor
139074977|NCT03586726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074978|NCT03721900|Ketamine|ketamine|mesh-list
139074979|NCT03721900|Analgesics|analgesics|mesh-ancestor
139074980|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
139074981|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139074982|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139074983|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139074984|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139074985|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
139074986|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
139074987|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139074988|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138950327|NCT00546364|Docetaxel|docetaxel|mesh-list
139074989|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139074990|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139074991|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139074992|NCT03585712|Norgestrel|norgestrel|mesh-list
139074993|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139074994|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139074995|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139074996|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
139074997|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139074998|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075000|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139075001|NCT01082510|Tegafur|tegafur|mesh-list
139075002|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139075003|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
139075004|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075005|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075006|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
139075007|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139075008|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139075009|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
139075010|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075011|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075012|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075013|NCT03583372|Urological Agents|urological agents|mesh-ancestor
139075014|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
139075015|NCT01091324|Silymarin|silymarin|mesh-list
139075016|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
139075017|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
139075018|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139075019|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139075020|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075021|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075022|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075023|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
139075024|NCT01091324|Protective Agents|protective agents|mesh-ancestor
139075025|NCT05782426|Paclitaxel|paclitaxel|mesh-list
139075026|NCT05782426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139075028|NCT05782426|Tubulin Modulators|tubulin modulators|mesh-ancestor
139075029|NCT05782426|Antimitotic Agents|antimitotic agents|mesh-ancestor
138253511|NCT05805930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075030|NCT05782426|Mitosis Modulators|mitosis modulators|mesh-ancestor
139075031|NCT05782426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075032|NCT05782348|Listerine|listerine|mesh-list
139075033|NCT05782348|Sodium Fluoride|sodium fluoride|mesh-list
139075034|NCT05782348|Cariostatic Agents|cariostatic agents|mesh-ancestor
139075035|NCT05782348|Protective Agents|protective agents|mesh-ancestor
139075036|NCT05782348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075037|NCT05782348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139075038|NCT05782348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139075040|NCT05782192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139075041|NCT05782192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075042|NCT05782192|Incretins|incretins|mesh-ancestor
139075043|NCT05782192|Hormones|hormones|mesh-ancestor
139085277|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075044|NCT05782192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139075045|NCT05782192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139075046|NCT05782192|Protease Inhibitors|protease inhibitors|mesh-ancestor
139075047|NCT05782192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075048|NCT05782192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075049|NCT05781997|Mydriatics|mydriatics|mesh-list
139075050|NCT05781997|Autonomic Agents|autonomic agents|mesh-ancestor
139075051|NCT05781997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075052|NCT05781997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075053|NCT05781854|Dexmedetomidine|dexmedetomidine|mesh-list
139075054|NCT05781854|Bupivacaine|bupivacaine|mesh-list
139075055|NCT05781854|Anesthetics, Local|anesthetics, local|mesh-ancestor
139075056|NCT05781854|Anesthetics|anesthetics|mesh-ancestor
138253548|NCT05800938|Natriuretic Agents|natriuretic agents|mesh-ancestor
139075057|NCT05781854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139075058|NCT05781854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075059|NCT05781854|Sensory System Agents|sensory system agents|mesh-ancestor
139075060|NCT05781854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075061|NCT05781854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139075062|NCT05781854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139075063|NCT05781854|Analgesics|analgesics|mesh-ancestor
139075064|NCT05781854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139075065|NCT05781854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139075066|NCT05781854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139075067|NCT05781854|Adrenergic Agents|adrenergic agents|mesh-ancestor
139075068|NCT05781854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075069|NCT05781854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075070|NCT05781685|Testosterone|testosterone|mesh-list
139075071|NCT05781685|Androgens|androgens|mesh-ancestor
139075072|NCT05781685|Hormones|hormones|mesh-ancestor
139085279|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
139075073|NCT05781685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139075074|NCT05781685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075076|NCT05781633|Etoposide|etoposide|mesh-list
139075077|NCT05781633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075078|NCT05781633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075079|NCT05781633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139075080|NCT05781633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139075081|NCT05781633|Growth Substances|growth substances|mesh-ancestor
139075082|NCT05781633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075083|NCT05781633|Growth Inhibitors|growth inhibitors|mesh-ancestor
139075084|NCT05781633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139075085|NCT05781633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139075086|NCT05781633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139075087|NCT05781633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075088|NCT05781633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075089|NCT05781529|Hyaluronic Acid|hyaluronic acid|mesh-list
139075090|NCT05781529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139075091|NCT05781529|Immunologic Factors|immunologic factors|mesh-ancestor
139075092|NCT05781529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075093|NCT05781529|Viscosupplements|viscosupplements|mesh-ancestor
138825687|NCT00964886|Benztropine|benztropine|mesh-list
139075094|NCT05781529|Protective Agents|protective agents|mesh-ancestor
139075095|NCT05780554|Cyclophosphamide|cyclophosphamide|mesh-list
139075096|NCT05780554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139075097|NCT05780554|Immunologic Factors|immunologic factors|mesh-ancestor
139075098|NCT05780554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075099|NCT05780554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139075100|NCT05780554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139075101|NCT05780554|Alkylating Agents|alkylating agents|mesh-ancestor
139075102|NCT05780554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075103|NCT05780554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075104|NCT05780554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139075105|NCT05869578|Anesthetics|anesthetics|mesh-list
139075106|NCT05869578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139075107|NCT05869578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075108|NCT05869227|Capecitabine|capecitabine|mesh-list
139075109|NCT05869227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139075110|NCT05869227|Antimetabolites|antimetabolites|mesh-ancestor
139075111|NCT05869227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950945|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
139075112|NCT05869227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075113|NCT05869201|Vaccines|vaccines|mesh-list
139075114|NCT05869201|Immunologic Factors|immunologic factors|mesh-ancestor
139075115|NCT05869201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075116|NCT05869097|Trifluridine|trifluridine|mesh-list
139075117|NCT05869097|Bevacizumab|bevacizumab|mesh-list
139075118|NCT05869097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075119|NCT05869097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075120|NCT05869097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139075121|NCT05869097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139075122|NCT05869097|Growth Substances|growth substances|mesh-ancestor
138951013|NCT04157725|Clomiphene|clomiphene|mesh-list
138951014|NCT04157725|Enclomiphene|enclomiphene|mesh-list
138951015|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
138951016|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139075123|NCT05869097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075125|NCT05869097|Antimetabolites|antimetabolites|mesh-ancestor
138230716|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139075126|NCT05869097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075127|NCT05869097|Antiviral Agents|antiviral agents|mesh-ancestor
139075128|NCT05869097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139075129|NCT05868993|Ropivacaine|ropivacaine|mesh-list
139075130|NCT05868993|Anesthetics, Local|anesthetics, local|mesh-ancestor
139075131|NCT05868993|Anesthetics|anesthetics|mesh-ancestor
139075132|NCT05868993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139075133|NCT05868993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075134|NCT05868993|Sensory System Agents|sensory system agents|mesh-ancestor
139075135|NCT05868993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075136|NCT05868967|Fexuprazan|fexuprazan|mesh-list
139075137|NCT05868967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139075138|NCT05868720|Risperidone|risperidone|mesh-list
139075139|NCT05868720|Aripiprazole|aripiprazole|mesh-list
139075140|NCT05868720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139075141|NCT05868720|Serotonin Agents|serotonin agents|mesh-ancestor
139075142|NCT05868720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075143|NCT05868720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075144|NCT05868720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075145|NCT05868720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139075146|NCT05868720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138253657|NCT05367401|Antimetabolites|antimetabolites|mesh-ancestor
139075147|NCT05868720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139075148|NCT05868720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139075149|NCT05868720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139075150|NCT05868720|Dopamine Agents|dopamine agents|mesh-ancestor
139075151|NCT05868720|Antidepressive Agents|antidepressive agents|mesh-ancestor
139075152|NCT05868720|Dopamine Agonists|dopamine agonists|mesh-ancestor
139075153|NCT05868720|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139075154|NCT05868720|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139075155|NCT05868720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139075156|NCT05868720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139075157|NCT05868395|Rituximab|rituximab|mesh-list
139075158|NCT05868395|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139075159|NCT05868395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075160|NCT05868395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075161|NCT05868395|Immunologic Factors|immunologic factors|mesh-ancestor
139075162|NCT05868395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075163|NCT05868395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139075164|NCT05868395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139075165|NCT05868395|Alkylating Agents|alkylating agents|mesh-ancestor
139075166|NCT05868395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075167|NCT05868317|Fluorouracil|fluorouracil|mesh-list
139075168|NCT05868317|Irinotecan|irinotecan|mesh-list
139075169|NCT05868317|Folfirinox|folfirinox|mesh-list
139075170|NCT05868317|Oxaliplatin|oxaliplatin|mesh-list
139075171|NCT05868317|Antimetabolites|antimetabolites|mesh-ancestor
139075172|NCT05868317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075173|NCT05868317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139075174|NCT05868317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075175|NCT05868317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139075176|NCT05868317|Immunologic Factors|immunologic factors|mesh-ancestor
139075177|NCT05868317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075178|NCT05868317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139075179|NCT05868317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139075180|NCT05868317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075181|NCT05868200|Listerine|listerine|mesh-list
139075182|NCT05868200|Sodium Fluoride|sodium fluoride|mesh-list
139075183|NCT05868200|Cariostatic Agents|cariostatic agents|mesh-ancestor
139075184|NCT05868200|Protective Agents|protective agents|mesh-ancestor
139075185|NCT05868200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075186|NCT05868200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139075187|NCT05868200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139075188|NCT05865080|Ketamine|ketamine|mesh-list
139075189|NCT05865080|Analgesics|analgesics|mesh-ancestor
139075190|NCT05865080|Sensory System Agents|sensory system agents|mesh-ancestor
139075191|NCT05865080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075192|NCT05865080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075193|NCT05865080|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139075194|NCT05865080|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139075195|NCT05865080|Anesthetics, General|anesthetics, general|mesh-ancestor
139075196|NCT05865080|Anesthetics|anesthetics|mesh-ancestor
139075197|NCT05865080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139075198|NCT05865080|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139075199|NCT05865080|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139075200|NCT05865080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075201|NCT05865080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075202|NCT05863286|Botulinum Toxins|botulinum toxins|mesh-list
139075203|NCT05863286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139075204|NCT05863286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
139075205|NCT05863286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139075206|NCT05863286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139075207|NCT05863286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075208|NCT05863286|Cholinergic Agents|cholinergic agents|mesh-ancestor
139075209|NCT05863286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075210|NCT05863286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075211|NCT05863286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139075212|NCT05863286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075213|NCT05768373|Fluorides|fluorides|mesh-list
139075214|NCT05768373|Cariostatic Agents|cariostatic agents|mesh-ancestor
139075215|NCT05768373|Protective Agents|protective agents|mesh-ancestor
139075216|NCT05768373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075217|NCT05734690|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
139075218|NCT05734690|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139075219|NCT05734690|Adrenergic Agents|adrenergic agents|mesh-ancestor
139075220|NCT05734690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075221|NCT05734690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075222|NCT05734690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075223|NCT05733624|Cyclosporine|cyclosporine|mesh-list
139075224|NCT05733624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139075225|NCT05733624|Cyclosporins|cyclosporins|mesh-list
139075226|NCT05733624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075227|NCT05733624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075228|NCT05733624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139075229|NCT05733624|Immunologic Factors|immunologic factors|mesh-ancestor
139075230|NCT05733624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075231|NCT05733624|Antifungal Agents|antifungal agents|mesh-ancestor
139075232|NCT05733624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139075233|NCT05733624|Dermatologic Agents|dermatologic agents|mesh-ancestor
139075234|NCT05733624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139075235|NCT05733624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139075236|NCT05733624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139075237|NCT05642572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139075238|NCT05642572|Osimertinib|osimertinib|mesh-list
139075239|NCT05642572|Ramucirumab|ramucirumab|mesh-list
139075240|NCT05642572|Antibodies|antibodies|mesh-list
139075241|NCT05642572|Immunoglobulins|immunoglobulins|mesh-list
139075242|NCT05642572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139075243|NCT05642572|Lexatumumab|lexatumumab|mesh-list
139075244|NCT05642572|Immunologic Factors|immunologic factors|mesh-ancestor
139075245|NCT05642572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075246|NCT05642572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075247|NCT05642572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139075248|NCT05642572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075249|NCT05642572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075251|NCT05518799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139075252|NCT05518799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139075253|NCT05518799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139075254|NCT05518799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075255|NCT05518799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139075256|NCT05518799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139075257|NCT05518799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139075258|NCT05518799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138951563|NCT00546052|Losartan|losartan|mesh-list
139075259|NCT05518799|Anesthetics, General|anesthetics, general|mesh-ancestor
139075261|NCT05518799|GABA Modulators|gaba modulators|mesh-ancestor
139075262|NCT05518799|GABA Agents|gaba agents|mesh-ancestor
139075263|NCT05518799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075264|NCT05518799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075266|NCT05447702|Cyclophosphamide|cyclophosphamide|mesh-list
139075267|NCT05447702|Apatinib|apatinib|mesh-list
139075268|NCT05447702|Epirubicin|epirubicin|mesh-list
139075269|NCT05447702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139075270|NCT05447702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075271|NCT05447702|Tubulin Modulators|tubulin modulators|mesh-ancestor
139075272|NCT05447702|Antimitotic Agents|antimitotic agents|mesh-ancestor
139075273|NCT05447702|Mitosis Modulators|mitosis modulators|mesh-ancestor
139075274|NCT05447702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075275|NCT05447702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139075276|NCT05447702|Immunologic Factors|immunologic factors|mesh-ancestor
139075277|NCT05447702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075278|NCT05447702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139075279|NCT05447702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139075280|NCT05447702|Alkylating Agents|alkylating agents|mesh-ancestor
139075281|NCT05447702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139075282|NCT05447702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139075283|NCT05447702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075284|NCT05447702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139075285|NCT05447702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139075286|NCT05447702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139075287|NCT05418010|Natalizumab|natalizumab|mesh-list
139075288|NCT05418010|Immunologic Factors|immunologic factors|mesh-ancestor
139075289|NCT05418010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075290|NCT05391971|Bupivacaine|bupivacaine|mesh-list
139075291|NCT05391971|Anesthetics, Local|anesthetics, local|mesh-ancestor
139075292|NCT05391971|Anesthetics|anesthetics|mesh-ancestor
139075293|NCT05391971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139075294|NCT05391971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075295|NCT05391971|Sensory System Agents|sensory system agents|mesh-ancestor
139075296|NCT05391971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075298|NCT05323396|Albendazole|albendazole|mesh-list
139075299|NCT05323396|Praziquantel|praziquantel|mesh-list
139075300|NCT05323396|Antiparasitic Agents|antiparasitic agents|mesh-list
139075301|NCT05323396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139075302|NCT05323396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139075303|NCT05323396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139075304|NCT05323396|Anthelmintics|anthelmintics|mesh-ancestor
139075305|NCT05323396|Anticestodal Agents|anticestodal agents|mesh-ancestor
139075306|NCT05323396|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
139075307|NCT05323396|Tubulin Modulators|tubulin modulators|mesh-ancestor
138269967|NCT05923021|Serotonin Agents|serotonin agents|mesh-ancestor
139075308|NCT05323396|Antimitotic Agents|antimitotic agents|mesh-ancestor
139075309|NCT05323396|Mitosis Modulators|mitosis modulators|mesh-ancestor
138253949|NCT03192397|Fludarabine|fludarabine|mesh-list
139075310|NCT05323396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075311|NCT05323396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075312|NCT05178550|Heparin|heparin|mesh-list
139075313|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
139075314|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139075315|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139075316|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075317|NCT05168566|Maleic acid|maleic acid|mesh-list
139075318|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075319|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075320|NCT05085782|Propranolol|propranolol|mesh-list
139075322|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138951803|NCT00766350|Analgesics|analgesics|mesh-ancestor
139075323|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
139075324|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075325|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075326|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075327|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139075328|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139075329|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
139075330|NCT04732195|Pilocarpine|pilocarpine|mesh-list
139075331|NCT04732195|Miotics|miotics|mesh-ancestor
139075332|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
139075333|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075334|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075335|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139075336|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139075337|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
139075338|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075339|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075340|NCT04704921|Ranibizumab|ranibizumab|mesh-list
139075341|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139075342|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139075343|NCT04704921|Growth Substances|growth substances|mesh-ancestor
139075344|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075345|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
139075346|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075347|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
139075348|NCT04703426|Sargramostim|sargramostim|mesh-list
139075349|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075350|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075351|NCT04703426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139075352|NCT04703426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075353|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
139075354|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075355|NCT04681482|Apixaban|apixaban|mesh-list
139075356|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139075357|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
139075358|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139075359|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
138269997|NCT05922501|Hormones|hormones|mesh-ancestor
139075360|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075361|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075362|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
139075363|NCT04635644|Morphine|morphine|mesh-list
139075364|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139075365|NCT04635644|Narcotics|narcotics|mesh-ancestor
139075366|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139075367|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075368|NCT04635644|Analgesics|analgesics|mesh-ancestor
139075369|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
139075370|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075371|NCT04580277|Tofacitinib|tofacitinib|mesh-list
139075372|NCT04580277|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
139075373|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139075374|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075375|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075376|NCT04571229|Mifamurtide|mifamurtide|mesh-list
139075377|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139075378|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
139075379|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075380|NCT04535713|Gemcitabine|gemcitabine|mesh-list
139075381|NCT04535713|Docetaxel|docetaxel|mesh-list
139075382|NCT04535713|Doxorubicin|doxorubicin|mesh-list
139075383|NCT04535713|Nivolumab|nivolumab|mesh-list
139075384|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139075385|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
139085280|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075386|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075387|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075389|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
139075390|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
139075391|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139075392|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139075393|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139075394|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825970|NCT05972785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139075395|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075396|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139075397|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
139075398|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139075399|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139075400|NCT04526132|Analgesics|analgesics|mesh-ancestor
139075401|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
139075402|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075403|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075404|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139075405|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139075406|NCT04514653|Ranibizumab|ranibizumab|mesh-list
139075407|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138951945|NCT00966316|Aspirin|aspirin|mesh-list
139075408|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139075409|NCT04514653|Growth Substances|growth substances|mesh-ancestor
139075410|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075411|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
139075412|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075413|NCT04505670|Donepezil|donepezil|mesh-list
139075414|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
139075415|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139075416|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075417|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075418|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
139075419|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075420|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075421|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
139075422|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
139075423|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
139075424|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139075425|NCT04505670|Protective Agents|protective agents|mesh-ancestor
139075426|NCT04493320|Levodopa|levodopa|mesh-list
138254136|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139075427|NCT04493320|Carbidopa|carbidopa|mesh-list
139075428|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139075429|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139075430|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139075431|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
139075432|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075433|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075434|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075435|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139075436|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075437|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139075438|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
139075439|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
139075441|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075442|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075443|NCT04417166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139075444|NCT04417166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075445|NCT04189744|Metronidazole|metronidazole|mesh-list
139075446|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
139075447|NCT04189744|Piperaquine|piperaquine|mesh-list
139075448|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
139075449|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
139075450|NCT04189744|Artenimol|artenimol|mesh-list
139075451|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139075452|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139075453|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139075454|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138231647|NCT02620865|Vitamins|vitamins|mesh-ancestor
139075455|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
139075456|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139075457|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075458|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075459|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139075460|NCT04175470|Tocotrienols|tocotrienols|mesh-list
139075461|NCT04175470|Vitamin E|vitamin e|mesh-list
139075462|NCT04175470|Tocopherols|tocopherols|mesh-list
139075463|NCT04175470|Bevacizumab|bevacizumab|mesh-list
139075464|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075465|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075466|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138826052|NCT05930808|Bisoprolol|bisoprolol|mesh-list
139075467|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139075468|NCT04175470|Growth Substances|growth substances|mesh-ancestor
139075469|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075470|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
139075472|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075473|NCT04175470|Protective Agents|protective agents|mesh-ancestor
139075474|NCT04175470|Vitamins|vitamins|mesh-ancestor
139075475|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
139075476|NCT04165330|Nivolumab|nivolumab|mesh-list
139075477|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075478|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952165|NCT00893061|Tamoxifen|tamoxifen|mesh-list
138475558|NCT04278833|Hormones|hormones|mesh-ancestor
139075479|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139075480|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075481|NCT04115878|Oxybutynin|oxybutynin|mesh-list
139075482|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
139075483|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
139075484|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139075485|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139075486|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075487|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
139075488|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952228|NCT00967096|Rifaximin|rifaximin|mesh-list
139075489|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075490|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
139075491|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
139075492|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075493|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139075494|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139075495|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
139075496|NCT04115878|Urological Agents|urological agents|mesh-ancestor
139075497|NCT03965130|Glucagon|glucagon|mesh-list
139075498|NCT03965130|Hormones|hormones|mesh-ancestor
139075499|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139075500|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270141|NCT05920512|Vitamins|vitamins|mesh-ancestor
139075501|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139075502|NCT03900884|Letrozole|letrozole|mesh-list
139075503|NCT03900884|Venetoclax|venetoclax|mesh-list
139075504|NCT03900884|Palbociclib|palbociclib|mesh-list
139075505|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075506|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139075507|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139075508|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075509|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075510|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139075511|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
139075512|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139075513|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075514|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139075515|NCT03761030|Levodopa|levodopa|mesh-list
139075516|NCT03761030|Carbidopa|carbidopa|mesh-list
139075517|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
139075518|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139075519|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139075520|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
139075521|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085281|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139075522|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075523|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075524|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
139075526|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139075527|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
139075528|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
138254335|NCT00002691|Hormones|hormones|mesh-ancestor
139075529|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
139075530|NCT03742505|Vitamin D|vitamin d|mesh-list
139075531|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139075532|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075533|NCT03742505|Vitamins|vitamins|mesh-ancestor
139075534|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
139075535|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139075536|NCT03663205|Cisplatin|cisplatin|mesh-list
139075537|NCT03663205|Carboplatin|carboplatin|mesh-list
139075538|NCT03663205|Pemetrexed|pemetrexed|mesh-list
139075539|NCT03663205|Tislelizumab|tislelizumab|mesh-list
139075540|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075541|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952466|NCT00891033|Bortezomib|bortezomib|mesh-list
139075542|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075543|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138826120|NCT05631795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075544|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139075545|NCT03663205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075546|NCT03572088|Terlipressin|terlipressin|mesh-list
139075547|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139075548|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139075550|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
139075551|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254379|NCT05032807|Cannabidiol|cannabidiol|mesh-list
139075552|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139075553|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139075554|NCT03560934|Analgesics|analgesics|mesh-ancestor
139075555|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
139075556|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075557|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
139075558|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
139075559|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075560|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075561|NCT03560934|Hormones|hormones|mesh-ancestor
139075562|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139075563|NCT03527472|Memantine|memantine|mesh-list
139075564|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139075565|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138254433|NCT04739345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138254435|NCT04739345|Protective Agents|protective agents|mesh-ancestor
139075566|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
139075567|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075568|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075569|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952674|NCT00975910|Lidocaine|lidocaine|mesh-list
139075570|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139075571|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139075573|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
139075574|NCT03477396|Hormones|hormones|mesh-ancestor
139075575|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139075576|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075577|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139075578|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075579|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075580|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139075581|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
139075582|NCT03388788|CGP 12177|cgp 12177|mesh-list
138254499|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075583|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139075584|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139075585|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
139075586|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075587|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075588|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075589|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139075590|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139075591|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
139075592|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
139075593|NCT03240081|Estradiol|estradiol|mesh-list
139075594|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
139075595|NCT03240081|Estrogens|estrogens|mesh-ancestor
139075596|NCT03240081|Hormones|hormones|mesh-ancestor
139085282|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075597|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139075598|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075599|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139075600|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
139075601|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139075602|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139075603|NCT03236857|Venetoclax|venetoclax|mesh-list
139075604|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075605|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138254552|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075606|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
139075607|NCT03097120|Estrogens|estrogens|mesh-list
139075608|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
139075609|NCT03097120|Hormones|hormones|mesh-ancestor
139075610|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139075611|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075612|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139075613|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139075614|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139075615|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
139075616|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138952780|NCT00969904|Antidotes|antidotes|mesh-ancestor
139075617|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139075618|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
139075620|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139075621|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075622|NCT03003520|Prednisone|prednisone|mesh-list
139075623|NCT03003520|Prednisolone|prednisolone|mesh-list
139075624|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
139075625|NCT03003520|Rituximab|rituximab|mesh-list
139075626|NCT03003520|Doxorubicin|doxorubicin|mesh-list
139075627|NCT03003520|Vincristine|vincristine|mesh-list
139075628|NCT03003520|Lenalidomide|lenalidomide|mesh-list
139075629|NCT03003520|Durvalumab|durvalumab|mesh-list
139075630|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139075631|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
139075632|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075633|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139075634|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139075635|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
139075636|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075637|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075638|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139075639|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075640|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139075641|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139075642|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139075643|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075644|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139075645|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
139075646|NCT03003520|Hormones|hormones|mesh-ancestor
139075647|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139075648|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138254657|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
138254658|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139075649|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139075650|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
139075651|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
139075653|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139075654|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139075655|NCT03003520|Growth Substances|growth substances|mesh-ancestor
139075656|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
139075657|NCT02989597|Dexamethasone|dexamethasone|mesh-list
139075658|NCT02989597|Sufentanil|sufentanil|mesh-list
139075659|NCT02989597|Ketamine|ketamine|mesh-list
139075660|NCT02989597|Remifentanil|remifentanil|mesh-list
139075661|NCT02989597|Methadone|methadone|mesh-list
139075662|NCT02989597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139075663|NCT02989597|Antiemetics|antiemetics|mesh-ancestor
139075664|NCT02989597|Autonomic Agents|autonomic agents|mesh-ancestor
139075665|NCT02989597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075666|NCT02989597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075667|NCT02989597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139075668|NCT02989597|Glucocorticoids|glucocorticoids|mesh-ancestor
139075669|NCT02989597|Hormones|hormones|mesh-ancestor
139075670|NCT02989597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139075671|NCT02989597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139075672|NCT02989597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075673|NCT02989597|Analgesics|analgesics|mesh-ancestor
139075674|NCT02989597|Sensory System Agents|sensory system agents|mesh-ancestor
138254708|NCT05447507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139075675|NCT02989597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139075676|NCT02989597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139075677|NCT02989597|Anesthetics, General|anesthetics, general|mesh-ancestor
139075678|NCT02989597|Anesthetics|anesthetics|mesh-ancestor
139075679|NCT02989597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139075680|NCT02989597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139075681|NCT02989597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139075682|NCT02989597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075683|NCT02989597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075684|NCT02989597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139075685|NCT02989597|Narcotics|narcotics|mesh-ancestor
139075686|NCT02989597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139075687|NCT02989597|Antitussive Agents|antitussive agents|mesh-ancestor
139075688|NCT02989597|Respiratory System Agents|respiratory system agents|mesh-ancestor
139075689|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
139075690|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139075691|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139075692|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139075693|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075694|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075695|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075696|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139075697|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
139075698|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139075699|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
139075700|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
139075701|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139075702|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
139075703|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075704|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139075705|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139075706|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
138254755|NCT05749575|Antimitotic Agents|antimitotic agents|mesh-ancestor
139075707|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270365|NCT05672108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075708|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075709|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139075710|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075711|NCT02768701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139075713|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
139075714|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075715|NCT02621944|Protective Agents|protective agents|mesh-ancestor
139075716|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075717|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139075718|NCT02586025|Docetaxel|docetaxel|mesh-list
139075719|NCT02586025|Trastuzumab|trastuzumab|mesh-list
139075720|NCT02586025|Pertuzumab|pertuzumab|mesh-list
138953194|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
139075721|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075722|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
139075723|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
139075724|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
139075725|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075726|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075727|NCT02465164|Oxytocin|oxytocin|mesh-list
139075728|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
139075729|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139075730|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075731|NCT01955512|Clopidogrel|clopidogrel|mesh-list
139075732|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139075733|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
139075734|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
139075735|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139075736|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
139075737|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075738|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075739|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075740|NCT00227617|Leucovorin|leucovorin|mesh-list
139075741|NCT00227617|Bevacizumab|bevacizumab|mesh-list
139075742|NCT00227617|Fluorouracil|fluorouracil|mesh-list
139075743|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
139075744|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075745|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075746|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139075747|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139075748|NCT00227617|Growth Substances|growth substances|mesh-ancestor
139075749|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075750|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
139075751|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
139075752|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075753|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139075754|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139075755|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
139075756|NCT00227617|Antidotes|antidotes|mesh-ancestor
139075757|NCT00227617|Protective Agents|protective agents|mesh-ancestor
139075758|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
139075759|NCT00227617|Vitamins|vitamins|mesh-ancestor
139075760|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
139075761|NCT05710081|Broncho-Vaxom|broncho-vaxom|mesh-list
139075762|NCT05710081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139075763|NCT05710081|Immunologic Factors|immunologic factors|mesh-ancestor
139075764|NCT05710081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075765|NCT05703191|Nitric Oxide|nitric oxide|mesh-list
139075766|NCT05703191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139075767|NCT05703191|Autonomic Agents|autonomic agents|mesh-ancestor
139075768|NCT05703191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075769|NCT05703191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075770|NCT05703191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139075771|NCT05703191|Respiratory System Agents|respiratory system agents|mesh-ancestor
139075772|NCT05703191|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139075773|NCT05703191|Antioxidants|antioxidants|mesh-ancestor
139075774|NCT05703191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254837|NCT05513937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075775|NCT05703191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075776|NCT05703191|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
139075777|NCT05703191|Vasodilator Agents|vasodilator agents|mesh-ancestor
139075778|NCT05703191|Gasotransmitters|gasotransmitters|mesh-ancestor
139075779|NCT05703191|Protective Agents|protective agents|mesh-ancestor
139075780|NCT05657470|Tenecteplase|tenecteplase|mesh-list
139075781|NCT05657470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139075782|NCT05657470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139075783|NCT05657470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075784|NCT05639686|Remifentanil|remifentanil|mesh-list
139075785|NCT05639686|Anesthetics|anesthetics|mesh-list
139075786|NCT05639686|Propofol|propofol|mesh-list
139075787|NCT05639686|Isoflurane|isoflurane|mesh-list
139075788|NCT05639686|Tranexamic Acid|tranexamic acid|mesh-list
139075789|NCT05639686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139075790|NCT05639686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075791|NCT05639686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139075792|NCT05639686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139075793|NCT05639686|Anesthetics, General|anesthetics, general|mesh-ancestor
139075794|NCT05639686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139075795|NCT05639686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139075796|NCT05639686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075797|NCT05639686|Hemostatics|hemostatics|mesh-ancestor
139075798|NCT05639686|Coagulants|coagulants|mesh-ancestor
139075799|NCT05639686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139075800|NCT05639686|Narcotics|narcotics|mesh-ancestor
139075801|NCT05639686|Analgesics|analgesics|mesh-ancestor
139075802|NCT05639686|Sensory System Agents|sensory system agents|mesh-ancestor
139075803|NCT05639686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075804|NCT05639686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139075805|NCT05633576|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139075806|NCT05633576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139075807|NCT05586074|Cytarabine|cytarabine|mesh-list
139075808|NCT05586074|Fludarabine|fludarabine|mesh-list
139075809|NCT05586074|Azacitidine|azacitidine|mesh-list
139075810|NCT05586074|Decitabine|decitabine|mesh-list
139075811|NCT05586074|Idarubicin|idarubicin|mesh-list
139075812|NCT05586074|Lenograstim|lenograstim|mesh-list
139075813|NCT05586074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075814|NCT05586074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139075815|NCT05586074|Antimetabolites|antimetabolites|mesh-ancestor
139075816|NCT05586074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075817|NCT05586074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139075818|NCT05586074|Immunologic Factors|immunologic factors|mesh-ancestor
139075819|NCT05586074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075820|NCT05586074|Antiviral Agents|antiviral agents|mesh-ancestor
139075821|NCT05586074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139075822|NCT05586074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953696|NCT01052623|Estradiol|estradiol|mesh-list
139075823|NCT05586074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139075824|NCT05586074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139075825|NCT05586074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139075826|NCT05586074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139075827|NCT05541146|Paclitaxel|paclitaxel|mesh-list
139075828|NCT05541146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139075829|NCT05541146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075830|NCT05541146|Tubulin Modulators|tubulin modulators|mesh-ancestor
139075831|NCT05541146|Antimitotic Agents|antimitotic agents|mesh-ancestor
138953758|NCT00902967|Atorvastatin|atorvastatin|mesh-list
139075832|NCT05541146|Mitosis Modulators|mitosis modulators|mesh-ancestor
139075833|NCT05541146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075835|NCT05532358|Fluvoxamine|fluvoxamine|mesh-list
139075836|NCT05532358|Caffeine|caffeine|mesh-list
139075837|NCT05532358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139075838|NCT05532358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139075839|NCT05532358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138254927|NCT03762317|Clonidine|clonidine|mesh-list
139075840|NCT05532358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075841|NCT05532358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138953836|NCT00922467|Esmolol|esmolol|mesh-list
139075842|NCT05532358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139075843|NCT05532358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139075844|NCT05532358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139075845|NCT05532358|Anesthetics, General|anesthetics, general|mesh-ancestor
139075847|NCT05532358|GABA Modulators|gaba modulators|mesh-ancestor
139075848|NCT05532358|GABA Agents|gaba agents|mesh-ancestor
139075849|NCT05532358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075850|NCT05532358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075851|NCT05532358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139075852|NCT05532358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139075853|NCT05532358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075854|NCT05532358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139075855|NCT05532358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139075856|NCT05532358|Purinergic Agents|purinergic agents|mesh-ancestor
139075857|NCT05532358|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139075858|NCT05532358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139075859|NCT05532358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139075861|NCT05532358|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139075862|NCT05532358|Antidepressive Agents|antidepressive agents|mesh-ancestor
139075863|NCT05532358|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139075864|NCT05532358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139075865|NCT05532358|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139075866|NCT05525416|Propranolol|propranolol|mesh-list
139075867|NCT05525416|Nitroprusside|nitroprusside|mesh-list
139075868|NCT05525416|Phentolamine|phentolamine|mesh-list
138254964|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
139075869|NCT05525416|Phenylephrine|phenylephrine|mesh-list
139075870|NCT05525416|Oxymetazoline|oxymetazoline|mesh-list
139075871|NCT05525416|Norepinephrine|norepinephrine|mesh-list
139075872|NCT05525416|Synephrine|synephrine|mesh-list
139075873|NCT05525416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139075874|NCT05525416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139075875|NCT05525416|Adrenergic Agents|adrenergic agents|mesh-ancestor
139075876|NCT05525416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075877|NCT05525416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075878|NCT05525416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075879|NCT05525416|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139075880|NCT05525416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139075881|NCT05525416|Vasodilator Agents|vasodilator agents|mesh-ancestor
139075882|NCT05525416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139075883|NCT05525416|Mydriatics|mydriatics|mesh-ancestor
139075884|NCT05525416|Autonomic Agents|autonomic agents|mesh-ancestor
139075885|NCT05525416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139075886|NCT05525416|Sympathomimetics|sympathomimetics|mesh-ancestor
139075887|NCT05525416|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139075888|NCT05525416|Nasal Decongestants|nasal decongestants|mesh-ancestor
139075889|NCT05525416|Respiratory System Agents|respiratory system agents|mesh-ancestor
139075890|NCT05525416|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139075891|NCT05525416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139075892|NCT05525416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139075893|NCT05525416|Protective Agents|protective agents|mesh-ancestor
139075894|NCT05525416|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139075895|NCT05525416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
139075896|NCT05491512|Carboplatin|carboplatin|mesh-list
139075897|NCT05491512|Fluorouracil|fluorouracil|mesh-list
138255009|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
139075899|NCT05491512|Antimetabolites|antimetabolites|mesh-ancestor
139075900|NCT05491512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075901|NCT05491512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139075902|NCT05491512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139075903|NCT05491512|Immunologic Factors|immunologic factors|mesh-ancestor
139075904|NCT05491512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075905|NCT05449405|Chlorpheniramine|chlorpheniramine|mesh-list
139075906|NCT05449405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075907|NCT05449405|Antipruritics|antipruritics|mesh-ancestor
139075908|NCT05449405|Dermatologic Agents|dermatologic agents|mesh-ancestor
139075909|NCT05449405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139075910|NCT05449405|Histamine Antagonists|histamine antagonists|mesh-ancestor
139075911|NCT05449405|Histamine Agents|histamine agents|mesh-ancestor
139075912|NCT05449405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075913|NCT05449405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075914|NCT05449405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139075915|NCT05394740|Leucovorin|leucovorin|mesh-list
139075916|NCT05394740|Capecitabine|capecitabine|mesh-list
139075917|NCT05394740|Fluorouracil|fluorouracil|mesh-list
139075918|NCT05394740|Oxaliplatin|oxaliplatin|mesh-list
139075919|NCT05394740|Nivolumab|nivolumab|mesh-list
138826494|NCT03095612|Docetaxel|docetaxel|mesh-list
139075920|NCT05394740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139075921|NCT05394740|Antimetabolites|antimetabolites|mesh-ancestor
139075922|NCT05394740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075923|NCT05394740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075924|NCT05394740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139075925|NCT05394740|Immunologic Factors|immunologic factors|mesh-ancestor
139075926|NCT05394740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075927|NCT05394740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075928|NCT05394740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139075929|NCT05394740|Antidotes|antidotes|mesh-ancestor
139075930|NCT05394740|Protective Agents|protective agents|mesh-ancestor
139075931|NCT05394740|Vitamin B Complex|vitamin b complex|mesh-ancestor
139075932|NCT05394740|Vitamins|vitamins|mesh-ancestor
139075933|NCT05394740|Micronutrients|micronutrients|mesh-ancestor
138270611|NCT05120141|Listerine|listerine|mesh-list
139075934|NCT05390021|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139075935|NCT05390021|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139075936|NCT05390021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075937|NCT05273996|Bupropion|bupropion|mesh-list
139075938|NCT05273996|Sertraline|sertraline|mesh-list
139075939|NCT05273996|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
139075940|NCT05273996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139075941|NCT05273996|Antidepressive Agents|antidepressive agents|mesh-ancestor
139075942|NCT05273996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139075943|NCT05273996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139075944|NCT05273996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139075945|NCT05273996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139075946|NCT05273996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075947|NCT05273996|Dopamine Agents|dopamine agents|mesh-ancestor
139075948|NCT05273996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139075949|NCT05273996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075950|NCT05273996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139075951|NCT05273996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139075952|NCT05273996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139075953|NCT05273996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139075954|NCT05273996|Serotonin Agents|serotonin agents|mesh-ancestor
139075955|NCT05273996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139075956|NCT05262244|Bevacizumab|bevacizumab|mesh-list
139075957|NCT05262244|Vedolizumab|vedolizumab|mesh-list
139075958|NCT05262244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139075959|NCT05262244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075960|NCT05262244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139075961|NCT05262244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139075962|NCT05262244|Growth Substances|growth substances|mesh-ancestor
139075963|NCT05262244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075964|NCT05262244|Growth Inhibitors|growth inhibitors|mesh-ancestor
139075965|NCT05262244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139075966|NCT05244213|Paclitaxel|paclitaxel|mesh-list
139075967|NCT05244213|Carboplatin|carboplatin|mesh-list
139075968|NCT05244213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138954260|NCT00906867|Miotics|miotics|mesh-ancestor
139075969|NCT05244213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075970|NCT05244213|Tubulin Modulators|tubulin modulators|mesh-ancestor
138255085|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139075971|NCT05244213|Antimitotic Agents|antimitotic agents|mesh-ancestor
139075972|NCT05244213|Mitosis Modulators|mitosis modulators|mesh-ancestor
139075973|NCT05244213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075974|NCT05231148|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139075975|NCT05231148|Calcium|calcium|mesh-list
139075976|NCT05231148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139075977|NCT05231148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075978|NCT05231148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139075979|NCT05169112|Leuprolide|leuprolide|mesh-list
139075980|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139075981|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
139075982|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139075983|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075984|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139075985|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075986|NCT05097209|Cisplatin|cisplatin|mesh-list
139075987|NCT05097209|Gemcitabine|gemcitabine|mesh-list
139075988|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139075989|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139075990|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
139075991|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139075992|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
138826587|NCT02358031|Cetuximab|cetuximab|mesh-list
138954420|NCT00775242|Estradiol|estradiol|mesh-list
139075993|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139075994|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139075996|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
139075997|NCT04991974|Naloxone|naloxone|mesh-list
139075998|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139075999|NCT04991974|Narcotics|narcotics|mesh-ancestor
139076000|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076001|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076002|NCT04991974|Analgesics|analgesics|mesh-ancestor
139076003|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
139076004|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076005|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139076006|NCT04971473|Hormones|hormones|mesh-list
138954472|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139076007|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139076008|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076009|NCT04917692|Empagliflozin|empagliflozin|mesh-list
139076010|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139076011|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076012|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139076013|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076014|NCT04893785|Temozolomide|temozolomide|mesh-list
139076015|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139076016|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
138529663|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
139076017|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076018|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076020|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139076021|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
139076022|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954596|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
138255165|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138233271|NCT04246619|Pregabalin|pregabalin|mesh-list
139076023|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076024|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076026|NCT04862949|Atezolizumab|atezolizumab|mesh-list
139076027|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139076028|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076029|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139076030|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139076031|NCT04862949|Growth Substances|growth substances|mesh-ancestor
139076032|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076033|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
139076034|NCT04862949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139076035|NCT04862949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076036|NCT04781959|Lenograstim|lenograstim|mesh-list
139076037|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139076038|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
139076039|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076040|NCT04729608|Paclitaxel|paclitaxel|mesh-list
139076041|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139076042|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076043|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
139076044|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
139076045|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
139076046|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076047|NCT04652245|Fluticasone|fluticasone|mesh-list
139076048|NCT04652245|Xhance|xhance|mesh-list
139076049|NCT04652245|Azelastine|azelastine|mesh-list
139076050|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076051|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138255217|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139076052|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
139076053|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076054|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076055|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139076056|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
139076057|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
139076058|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139076059|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
139076060|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076061|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076062|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139076063|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139076064|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
139076065|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
139076066|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139076067|NCT04642287|Fluorouracil|fluorouracil|mesh-list
139076068|NCT04642287|Calcipotriene|calcipotriene|mesh-list
139076069|NCT04642287|Petrolatum|petrolatum|mesh-list
139076070|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
139076071|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076072|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139076073|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076074|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139076075|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
138255277|NCT01943864|Trametinib|trametinib|mesh-list
139076076|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076077|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
139076078|NCT04642287|Emollients|emollients|mesh-ancestor
139076079|NCT04635735|Ipilimumab|ipilimumab|mesh-list
139076080|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139076081|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076082|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139076083|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076084|NCT04595513|Sirolimus|sirolimus|mesh-list
139076085|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139076086|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139076087|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139076088|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076089|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
139076090|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139076091|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
139076092|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076093|NCT04543110|Durvalumab|durvalumab|mesh-list
139076094|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139076095|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076096|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
139076097|NCT04487652|Vitamins|vitamins|mesh-ancestor
139076098|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
139076099|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076100|NCT04429334|Nangibotide|nangibotide|mesh-list
139076101|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076102|NCT04408443|Vitamin D|vitamin d|mesh-list
139076103|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
139076104|NCT04408443|Vitamins|vitamins|mesh-ancestor
139076105|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
139076106|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076107|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139076108|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139076109|NCT04405739|Molnupiravir|molnupiravir|mesh-list
139076110|NCT04405739|Antiviral Agents|antiviral agents|mesh-ancestor
139076111|NCT04405739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139076112|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
139076113|NCT04396457|Pemetrexed|pemetrexed|mesh-list
139076114|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139076115|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270730|NCT04736329|Telmisartan|telmisartan|mesh-list
139076116|NCT04396457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139076117|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076118|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076119|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139076120|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139076121|NCT04377204|Lidocaine|lidocaine|mesh-list
139076122|NCT04377204|Bupivacaine|bupivacaine|mesh-list
139076123|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
139076124|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
139076125|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076126|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076127|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
139076128|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076129|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139076130|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139076131|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139076132|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255362|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
139076133|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076134|NCT04346589|Antibodies|antibodies|mesh-list
139076135|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
139076136|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139076137|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
139076138|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076139|NCT05934110|Orlistat|orlistat|mesh-list
139076140|NCT05934110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076141|NCT05934110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076142|NCT05934110|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
139076143|NCT05934110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139076144|NCT05934097|Prednisone|prednisone|mesh-list
139076145|NCT05934097|Cyclophosphamide|cyclophosphamide|mesh-list
139076146|NCT05934097|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139076147|NCT05934097|Rituximab|rituximab|mesh-list
139076148|NCT05934097|Doxorubicin|doxorubicin|mesh-list
139076149|NCT05934097|Vincristine|vincristine|mesh-list
139076150|NCT05934097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139076151|NCT05934097|Immunologic Factors|immunologic factors|mesh-ancestor
139076152|NCT05934097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076153|NCT05934097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139076154|NCT05934097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139076155|NCT05934097|Alkylating Agents|alkylating agents|mesh-ancestor
139076156|NCT05934097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076157|NCT05934097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076158|NCT05934097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139076159|NCT05934097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139076160|NCT05934097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139076161|NCT05934097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139076162|NCT05934097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139076163|NCT05934097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076164|NCT05934097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076165|NCT05934097|Glucocorticoids|glucocorticoids|mesh-ancestor
139076166|NCT05934097|Hormones|hormones|mesh-ancestor
139076167|NCT05934097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139076168|NCT05934097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139076169|NCT05934097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139076170|NCT05934097|Tubulin Modulators|tubulin modulators|mesh-ancestor
139076171|NCT05934097|Antimitotic Agents|antimitotic agents|mesh-ancestor
139076172|NCT05934097|Mitosis Modulators|mitosis modulators|mesh-ancestor
139076173|NCT05934071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
139076174|NCT05934071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076175|NCT05934071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139076176|NCT05934071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076177|NCT05933863|Antibodies|antibodies|mesh-list
139076178|NCT05933863|Immunologic Factors|immunologic factors|mesh-ancestor
139076179|NCT05933863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076180|NCT05933759|Insulin|insulin|mesh-list
139076181|NCT05933759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139076182|NCT05933759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076183|NCT05933486|Pregabalin|pregabalin|mesh-list
139076184|NCT05933486|Analgesics|analgesics|mesh-ancestor
139076185|NCT05933486|Sensory System Agents|sensory system agents|mesh-ancestor
139076186|NCT05933486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076187|NCT05933486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076188|NCT05933486|Anticonvulsants|anticonvulsants|mesh-ancestor
139076189|NCT05933486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139076190|NCT05933486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139076191|NCT05933486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076192|NCT05933486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139076193|NCT05933486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139076194|NCT05933486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139076195|NCT05933486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255443|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138255444|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
139076196|NCT05933486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139076197|NCT05933447|Moxifloxacin|moxifloxacin|mesh-list
139076198|NCT05933447|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
139076199|NCT05933447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139076200|NCT05933447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139076201|NCT05933447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139076202|NCT05933447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139076203|NCT05933447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076204|NCT05933447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076205|NCT05933447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076206|NCT05933447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139076207|NCT05933447|Contraceptive Agents|contraceptive agents|mesh-ancestor
139076208|NCT05933447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139076209|NCT05933447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076210|NCT05933447|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
139076211|NCT05933447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139076212|NCT05933447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139076213|NCT05933213|Mescaline|mescaline|mesh-list
139076214|NCT05933213|Glucocorticoids|glucocorticoids|mesh-list
138826798|NCT00959894|Etravirine|etravirine|mesh-list
139076215|NCT05933213|Hormones|hormones|mesh-ancestor
139076216|NCT05933213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139076217|NCT05933213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270827|NCT04501367|Prednisone|prednisone|mesh-list
139076219|NCT05933213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139076220|NCT05933213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139076221|NCT05933213|Serotonin Agents|serotonin agents|mesh-ancestor
139076222|NCT05933213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139076223|NCT05933213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255485|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076224|NCT05933031|Lansoprazole|lansoprazole|mesh-list
139076225|NCT05933031|Dexlansoprazole|dexlansoprazole|mesh-list
139076226|NCT05933031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139076227|NCT05933031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139076228|NCT05933031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139076229|NCT05933031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076230|NCT05933031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076232|NCT05932849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139076233|NCT05932849|Respiratory System Agents|respiratory system agents|mesh-ancestor
139076234|NCT05932550|Maraviroc|maraviroc|mesh-list
139076235|NCT05932550|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139076236|NCT05932550|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139076237|NCT05932550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076238|NCT05932550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139076239|NCT05932550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139076240|NCT05932550|Antiviral Agents|antiviral agents|mesh-ancestor
139076241|NCT05932550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139076242|NCT05932550|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139076243|NCT05932524|Dexamethasone|dexamethasone|mesh-list
139076244|NCT05932524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076245|NCT05932524|Antiemetics|antiemetics|mesh-ancestor
139076246|NCT05932524|Autonomic Agents|autonomic agents|mesh-ancestor
139076247|NCT05932524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076248|NCT05932524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076249|NCT05932524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139076250|NCT05932524|Glucocorticoids|glucocorticoids|mesh-ancestor
139076251|NCT05932524|Hormones|hormones|mesh-ancestor
138255530|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
139076252|NCT05932524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139076253|NCT05932524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139076254|NCT05932524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076255|NCT05932472|Aspirin|aspirin|mesh-list
138270873|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139076256|NCT05932472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139076257|NCT05932472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139076258|NCT05932472|Analgesics|analgesics|mesh-ancestor
139076259|NCT05932472|Sensory System Agents|sensory system agents|mesh-ancestor
139076260|NCT05932472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076261|NCT05932472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076262|NCT05932472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076263|NCT05932472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139076264|NCT05932472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139076265|NCT05932472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139076266|NCT05932472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076267|NCT05932472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139076268|NCT05932472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139076269|NCT05932472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076270|NCT05932472|Antipyretics|antipyretics|mesh-ancestor
139076271|NCT05932407|Vortioxetine|vortioxetine|mesh-list
139076272|NCT05932407|Antidepressive Agents|antidepressive agents|mesh-ancestor
139076273|NCT05932407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139076274|NCT05932407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139076275|NCT05932407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139076276|NCT05932407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076277|NCT05932407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076278|NCT05932407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139076279|NCT05932407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139076280|NCT05932407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139076281|NCT05932407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076282|NCT05932407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139076283|NCT05932407|Serotonin Agents|serotonin agents|mesh-ancestor
139076284|NCT05932407|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138255578|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
139076285|NCT05932407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139076286|NCT05932407|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139076287|NCT05932407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139076288|NCT05932316|Albuterol|albuterol|mesh-list
139076289|NCT05932316|Bronchodilator Agents|bronchodilator agents|mesh-list
139076290|NCT05932316|Autonomic Agents|autonomic agents|mesh-ancestor
139076291|NCT05932316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076292|NCT05932316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076293|NCT05932316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138270914|NCT04328844|Pemetrexed|pemetrexed|mesh-list
139076294|NCT05932316|Respiratory System Agents|respiratory system agents|mesh-ancestor
139076295|NCT05932316|Tocolytic Agents|tocolytic agents|mesh-ancestor
139076296|NCT05932316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139076297|NCT05932316|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139076298|NCT05932316|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139076299|NCT05932316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139076300|NCT05932316|Adrenergic Agents|adrenergic agents|mesh-ancestor
139076301|NCT05932316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139076302|NCT05932316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076304|NCT05932277|Flurbiprofen|flurbiprofen|mesh-list
139076305|NCT05932277|Midazolam|midazolam|mesh-list
139076306|NCT05932277|Caffeine|caffeine|mesh-list
139076307|NCT05932277|Bupropion|bupropion|mesh-list
139076308|NCT05932277|Omeprazole|omeprazole|mesh-list
139076309|NCT05932277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139076310|NCT05932277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138255615|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076311|NCT05932277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076312|NCT05932277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076314|NCT05932277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139076315|NCT05932277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139076316|NCT05932277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139076317|NCT05932277|Anesthetics, General|anesthetics, general|mesh-ancestor
139076318|NCT05932277|Anesthetics|anesthetics|mesh-ancestor
139076319|NCT05932277|GABA Modulators|gaba modulators|mesh-ancestor
139076320|NCT05932277|GABA Agents|gaba agents|mesh-ancestor
139076321|NCT05932277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139076322|NCT05932277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076323|NCT05932277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139076324|NCT05932277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139076325|NCT05932277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076326|NCT05932277|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
139076327|NCT05932277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
139076328|NCT05932277|Purinergic Agents|purinergic agents|mesh-ancestor
139076329|NCT05932277|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139076330|NCT05932277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139076331|NCT05932277|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139076332|NCT05932277|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139076333|NCT05932277|Antidepressive Agents|antidepressive agents|mesh-ancestor
139076334|NCT05932277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139076335|NCT05932277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139076336|NCT05932277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139076337|NCT05932277|Dopamine Agents|dopamine agents|mesh-ancestor
139076338|NCT05932277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139076339|NCT05932277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139076340|NCT05932277|Analgesics|analgesics|mesh-ancestor
139076341|NCT05932277|Sensory System Agents|sensory system agents|mesh-ancestor
139076342|NCT05932277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076343|NCT05932277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139076344|NCT05932277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139076345|NCT05932277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076346|NCT05932277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139076347|NCT05932277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139076348|NCT05932277|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139076349|NCT05932277|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
139076350|NCT05932277|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
139076351|NCT05932277|Histamine Antagonists|histamine antagonists|mesh-ancestor
139076352|NCT05932277|Histamine Agents|histamine agents|mesh-ancestor
139076353|NCT05932264|Apatinib|apatinib|mesh-list
139076354|NCT05932264|Fluzoparib|fluzoparib|mesh-list
139076355|NCT05932264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076356|NCT05932264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139076357|NCT05932264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076358|NCT05932264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076359|NCT05932264|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139076360|NCT05932186|Anesthetics|anesthetics|mesh-list
139076361|NCT05932186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138956124|NCT00749138|Tamoxifen|tamoxifen|mesh-list
139076362|NCT05932186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076363|NCT05931822|Fluorides|fluorides|mesh-list
139076364|NCT05931822|Fluorides, Topical|fluorides, topical|mesh-list
139076365|NCT05931822|Cariostatic Agents|cariostatic agents|mesh-ancestor
139076366|NCT05931822|Protective Agents|protective agents|mesh-ancestor
139076367|NCT05931822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076369|NCT05931757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076370|NCT05931744|Prednisone|prednisone|mesh-list
139076371|NCT05931744|Budesonide|budesonide|mesh-list
139076372|NCT05931744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076373|NCT05931744|Glucocorticoids|glucocorticoids|mesh-ancestor
139076374|NCT05931744|Hormones|hormones|mesh-ancestor
138956182|NCT00567567|Vitamin A|vitamin a|mesh-list
139076375|NCT05931744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139076376|NCT05931744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255702|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
139076377|NCT05931744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139076378|NCT05931744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076379|NCT05931744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139076380|NCT05931744|Autonomic Agents|autonomic agents|mesh-ancestor
139076381|NCT05931744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076382|NCT05931744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139076383|NCT05931744|Respiratory System Agents|respiratory system agents|mesh-ancestor
139076384|NCT05931718|Epoetin Alfa|epoetin alfa|mesh-list
139076385|NCT05931718|Luspatercept|luspatercept|mesh-list
139076386|NCT05931718|Hematinics|hematinics|mesh-ancestor
139076387|NCT05931484|Gemfibrozil|gemfibrozil|mesh-list
139076388|NCT05931484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139076389|NCT05931484|Antimetabolites|antimetabolites|mesh-ancestor
139076390|NCT05931484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076391|NCT05931484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139076392|NCT05931484|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
139076393|NCT05931484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139076394|NCT05931484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076396|NCT05931458|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139076397|NCT05931458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076398|NCT05931458|Dermatologic Agents|dermatologic agents|mesh-ancestor
138255763|NCT00000621|Tretinoin|tretinoin|mesh-list
139076399|NCT05931458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139076400|NCT05931458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139076401|NCT05931328|Pomalidomide|pomalidomide|mesh-list
139076402|NCT05931328|Thiotepa|thiotepa|mesh-list
139076403|NCT05931328|Immunologic Factors|immunologic factors|mesh-ancestor
139076404|NCT05931328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076405|NCT05931328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139076406|NCT05931328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139076407|NCT05931328|Growth Substances|growth substances|mesh-ancestor
139076408|NCT05931328|Growth Inhibitors|growth inhibitors|mesh-ancestor
139076409|NCT05931328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076410|NCT05931328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139076411|NCT05931328|Alkylating Agents|alkylating agents|mesh-ancestor
139076412|NCT05931328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076413|NCT05931328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139076414|NCT05931328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139076416|NCT05931263|Carmustine|carmustine|mesh-list
139076417|NCT05931263|Melphalan|melphalan|mesh-list
139076418|NCT05931263|Etoposide|etoposide|mesh-list
139076419|NCT05931263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139076420|NCT05931263|Alkylating Agents|alkylating agents|mesh-ancestor
139076421|NCT05931263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076422|NCT05931263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076423|NCT05931263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139076424|NCT05931263|Antimetabolites|antimetabolites|mesh-ancestor
139076425|NCT05931263|Antiviral Agents|antiviral agents|mesh-ancestor
139076426|NCT05931263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139076427|NCT05931263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139076428|NCT05931263|Immunologic Factors|immunologic factors|mesh-ancestor
139076429|NCT05931263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076430|NCT05931263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139076431|NCT05931263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139076432|NCT05931263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139076433|NCT05931263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076434|NCT05931263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139076435|NCT05931224|Antihypertensive Agents|antihypertensive agents|mesh-list
139076436|NCT05931042|Trastuzumab|trastuzumab|mesh-list
139076437|NCT05931042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139076438|NCT05931042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076439|NCT05931029|Ubiquinone|ubiquinone|mesh-list
139076440|NCT05931029|Idebenone|idebenone|mesh-list
139076441|NCT05931029|Antioxidants|antioxidants|mesh-ancestor
139076442|NCT05931029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956498|NCT00932217|Lenograstim|lenograstim|mesh-list
139076443|NCT05931029|Protective Agents|protective agents|mesh-ancestor
139076444|NCT05931029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076445|NCT05931029|Micronutrients|micronutrients|mesh-ancestor
139076446|NCT05930912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138271062|NCT04111978|Letrozole|letrozole|mesh-list
139076448|NCT05930912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138956550|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
139076449|NCT05930912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139076450|NCT05930912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139076451|NCT05930912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076453|NCT05930912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076454|NCT05930912|Analgesics|analgesics|mesh-ancestor
139076455|NCT05930912|Sensory System Agents|sensory system agents|mesh-ancestor
139076456|NCT05930912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076457|NCT05930912|Antidepressive Agents|antidepressive agents|mesh-ancestor
139076458|NCT05930912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139076459|NCT05930912|Dopamine Agents|dopamine agents|mesh-ancestor
139076460|NCT05930912|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139076461|NCT05930912|Serotonin Agents|serotonin agents|mesh-ancestor
139076462|NCT05930665|Bevacizumab|bevacizumab|mesh-list
139076463|NCT05930665|Carboplatin|carboplatin|mesh-list
139076464|NCT05930665|Pemetrexed|pemetrexed|mesh-list
139076465|NCT05930665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138956627|NCT00783900|Metoprolol|metoprolol|mesh-list
139076466|NCT05930665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076467|NCT05930665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139076468|NCT05930665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139076470|NCT05930665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076471|NCT05930665|Growth Inhibitors|growth inhibitors|mesh-ancestor
139076472|NCT05930665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076473|NCT05930665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076474|NCT05930665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139076475|NCT05930665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139076476|NCT05930236|Methylprednisolone|methylprednisolone|mesh-list
139076477|NCT05930236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139076478|NCT05930236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139076479|NCT05930236|Prednisolone|prednisolone|mesh-list
139076480|NCT05930236|Prednisolone acetate|prednisolone acetate|mesh-list
139076481|NCT05930236|Lidocaine|lidocaine|mesh-list
138255896|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076482|NCT05930236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139076483|NCT05930236|Prednisolone phosphate|prednisolone phosphate|mesh-list
139076484|NCT05930236|Anesthetics, Local|anesthetics, local|mesh-ancestor
139076485|NCT05930236|Anesthetics|anesthetics|mesh-ancestor
139076486|NCT05930236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076487|NCT05930236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076488|NCT05930236|Sensory System Agents|sensory system agents|mesh-ancestor
139076489|NCT05930236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076490|NCT05930236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139076491|NCT05930236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139076492|NCT05930236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139076493|NCT05930236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139076494|NCT05930236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076495|NCT05930236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076496|NCT05930236|Antiemetics|antiemetics|mesh-ancestor
139076497|NCT05930236|Autonomic Agents|autonomic agents|mesh-ancestor
139076498|NCT05930236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139076499|NCT05930236|Glucocorticoids|glucocorticoids|mesh-ancestor
139076501|NCT05930236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139076502|NCT05930236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139076503|NCT05930236|Protective Agents|protective agents|mesh-ancestor
138234438|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
139076504|NCT05930236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139076505|NCT05930236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076506|NCT05930080|Celecoxib|celecoxib|mesh-list
139076507|NCT05930080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139076508|NCT05930080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139076509|NCT05930080|Analgesics|analgesics|mesh-ancestor
139076510|NCT05930080|Sensory System Agents|sensory system agents|mesh-ancestor
139076511|NCT05930080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076512|NCT05930080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076513|NCT05930080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076514|NCT05930080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139076515|NCT05930080|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139076516|NCT05930080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139076517|NCT05930080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076518|NCT05930080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076519|NCT05930002|Ivermectin|ivermectin|mesh-list
139076520|NCT05930002|Colchicine|colchicine|mesh-list
139076521|NCT05930002|Gout Suppressants|gout suppressants|mesh-ancestor
139076522|NCT05930002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139076523|NCT05930002|Tubulin Modulators|tubulin modulators|mesh-ancestor
139076525|NCT05930002|Mitosis Modulators|mitosis modulators|mesh-ancestor
139076526|NCT05930002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076527|NCT05930002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076528|NCT05930002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139076529|NCT05930002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139076530|NCT05929092|Cyclophosphamide|cyclophosphamide|mesh-list
139076531|NCT05929092|Busulfan|busulfan|mesh-list
139076532|NCT05929092|Fludarabine|fludarabine|mesh-list
139076533|NCT05929092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139076534|NCT05929092|Immunologic Factors|immunologic factors|mesh-ancestor
138255999|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
139076535|NCT05929092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076536|NCT05929092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139076537|NCT05929092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271129|NCT03901482|Analgesics|analgesics|mesh-ancestor
139076538|NCT05929092|Alkylating Agents|alkylating agents|mesh-ancestor
139076539|NCT05929092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076540|NCT05929092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076541|NCT05929092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139076542|NCT05928897|Disitamab vedotin|disitamab vedotin|mesh-list
139076543|NCT05928897|Immunoconjugates|immunoconjugates|mesh-ancestor
139076544|NCT05928897|Immunologic Factors|immunologic factors|mesh-ancestor
139076545|NCT05928897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076546|NCT05925894|Anesthetics|anesthetics|mesh-list
139076547|NCT05925894|Mydriatics|mydriatics|mesh-list
139076548|NCT05925894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076549|NCT05925894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076550|NCT05925894|Autonomic Agents|autonomic agents|mesh-ancestor
139076551|NCT05925894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076552|NCT05923086|Lidocaine|lidocaine|mesh-list
139076553|NCT05923086|Anesthetics, Local|anesthetics, local|mesh-ancestor
139076554|NCT05923086|Anesthetics|anesthetics|mesh-ancestor
139076555|NCT05923086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076556|NCT05923086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076557|NCT05923086|Sensory System Agents|sensory system agents|mesh-ancestor
139076558|NCT05923086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076559|NCT05923086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139076560|NCT05923086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139076561|NCT05923086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139076562|NCT05923086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138256083|NCT05681702|Aspirin|aspirin|mesh-list
139076563|NCT05923086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076564|NCT05909618|Nivolumab|nivolumab|mesh-list
139076565|NCT05909618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139076566|NCT05909618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139076567|NCT05909618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076568|NCT05909618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138957112|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076569|NCT05909618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076570|NCT05902117|Arginine Vasopressin|arginine vasopressin|mesh-list
139076571|NCT05902117|Hemostatics|hemostatics|mesh-ancestor
139076572|NCT05902117|Coagulants|coagulants|mesh-ancestor
139076573|NCT05902117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139076574|NCT05902117|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
139076575|NCT05902117|Natriuretic Agents|natriuretic agents|mesh-ancestor
139076576|NCT05902117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076577|NCT05899010|Progesterone|progesterone|mesh-list
139076578|NCT05899010|Progestins|progestins|mesh-ancestor
139076579|NCT05899010|Hormones|hormones|mesh-ancestor
139076580|NCT05899010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139076581|NCT05899010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076582|NCT05894564|Fluvoxamine|fluvoxamine|mesh-list
138957169|NCT00326911|Bevacizumab|bevacizumab|mesh-list
139076583|NCT05894564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076584|NCT05894564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076585|NCT05894564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139076586|NCT05894564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139076587|NCT05894564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076588|NCT05894564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076589|NCT05894564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139076590|NCT05894564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139076591|NCT05894564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139076592|NCT05894564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139076593|NCT05894564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139076594|NCT05894564|Serotonin Agents|serotonin agents|mesh-ancestor
139076595|NCT05894564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139076596|NCT05894564|Antidepressive Agents|antidepressive agents|mesh-ancestor
139076597|NCT05894564|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139076598|NCT05894564|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139076599|NCT05894564|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139076600|NCT05877573|Capecitabine|capecitabine|mesh-list
139076601|NCT05877573|Oxaliplatin|oxaliplatin|mesh-list
139076602|NCT05877573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139076603|NCT05877573|Antimetabolites|antimetabolites|mesh-ancestor
138256090|NCT05681702|Sensory System Agents|sensory system agents|mesh-ancestor
138256091|NCT05681702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076604|NCT05877573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076605|NCT05877573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076606|NCT05872542|Listerine|listerine|mesh-list
139076607|NCT05872542|Fluorides|fluorides|mesh-list
139076608|NCT05872542|Sodium Fluoride|sodium fluoride|mesh-list
139076609|NCT05872542|Fluorides, Topical|fluorides, topical|mesh-list
139076610|NCT05872542|Cariostatic Agents|cariostatic agents|mesh-ancestor
139076611|NCT05872542|Protective Agents|protective agents|mesh-ancestor
139076612|NCT05872542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076613|NCT05872542|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139076614|NCT05872542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139076615|NCT05872425|Drospirenone|drospirenone|mesh-list
139076616|NCT05872425|Ethinyl Estradiol|ethinyl estradiol|mesh-list
139076617|NCT05872425|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
139076618|NCT05872425|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139076619|NCT05872425|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139076620|NCT05872425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139076621|NCT05872425|Contraceptive Agents|contraceptive agents|mesh-ancestor
139076622|NCT05872425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139076623|NCT05872425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076624|NCT05872425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139076625|NCT05872425|Estrogens|estrogens|mesh-ancestor
139076626|NCT05872425|Hormones|hormones|mesh-ancestor
139076627|NCT05872425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139076628|NCT05872425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
139076629|NCT05872425|Hormone Antagonists|hormone antagonists|mesh-ancestor
139076630|NCT05872425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139076631|NCT05872425|Diuretics|diuretics|mesh-ancestor
139076632|NCT05872425|Natriuretic Agents|natriuretic agents|mesh-ancestor
139076633|NCT05870709|Valsartan|valsartan|mesh-list
139076634|NCT05870709|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
139076635|NCT05870709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139076636|NCT05870709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139076637|NCT05870709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138271174|NCT03829371|Growth Substances|growth substances|mesh-ancestor
139076638|NCT05870709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076639|NCT05870514|Propofol|propofol|mesh-list
139076640|NCT05870514|Fospropofol|fospropofol|mesh-list
139076641|NCT05870514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139076642|NCT05870514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957344|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139076643|NCT05870514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076644|NCT05870514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139076645|NCT05870514|Anesthetics, General|anesthetics, general|mesh-ancestor
139076646|NCT05870514|Anesthetics|anesthetics|mesh-ancestor
138256117|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076647|NCT05851560|Hyaluronic Acid|hyaluronic acid|mesh-list
139076648|NCT05851560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139076649|NCT05851560|Immunologic Factors|immunologic factors|mesh-ancestor
139076650|NCT05851560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076651|NCT05851560|Viscosupplements|viscosupplements|mesh-ancestor
139076652|NCT05851560|Protective Agents|protective agents|mesh-ancestor
139076653|NCT05810363|Propofol|propofol|mesh-list
139076654|NCT05810363|Etomidate|etomidate|mesh-list
139076655|NCT05810363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139076656|NCT05810363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076657|NCT05810363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076658|NCT05810363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139076659|NCT05810363|Anesthetics, General|anesthetics, general|mesh-ancestor
139076660|NCT05810363|Anesthetics|anesthetics|mesh-ancestor
138827247|NCT00739648|Levofloxacin|levofloxacin|mesh-list
139076661|NCT05803148|Midodrine|midodrine|mesh-list
139076662|NCT05803148|Sympathomimetics|sympathomimetics|mesh-ancestor
139076663|NCT05803148|Autonomic Agents|autonomic agents|mesh-ancestor
139076664|NCT05803148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076665|NCT05803148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076666|NCT05803148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139076667|NCT05803148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
139076668|NCT05803148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139076669|NCT05803148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139076670|NCT05803148|Adrenergic Agents|adrenergic agents|mesh-ancestor
139076671|NCT05803148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139076672|NCT05803148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076673|NCT05802849|Acetazolamide|acetazolamide|mesh-list
139076674|NCT05802849|Anticonvulsants|anticonvulsants|mesh-ancestor
139076675|NCT05802849|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
139076676|NCT05802849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076677|NCT05802849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076678|NCT05802849|Diuretics|diuretics|mesh-ancestor
139076679|NCT05802849|Natriuretic Agents|natriuretic agents|mesh-ancestor
139076680|NCT05802849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076681|NCT05748366|Analgesics|analgesics|mesh-list
139076682|NCT05748366|Sensory System Agents|sensory system agents|mesh-ancestor
139076683|NCT05748366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076684|NCT05748366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256196|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076685|NCT05738161|Cisplatin|cisplatin|mesh-list
139076686|NCT05738161|Gemcitabine|gemcitabine|mesh-list
139076687|NCT05738161|Magrolimab|magrolimab|mesh-list
139076688|NCT05738161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076689|NCT05738161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139076690|NCT05738161|Antimetabolites|antimetabolites|mesh-ancestor
139076691|NCT05738161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076692|NCT05738161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139076693|NCT05723055|Nivolumab|nivolumab|mesh-list
139076694|NCT05723055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139076695|NCT05723055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076696|NCT05723055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139076697|NCT05723055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076698|NCT05709977|Histamine Antagonists|histamine antagonists|mesh-list
139076699|NCT05709977|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
139076700|NCT05709977|Histamine Agents|histamine agents|mesh-ancestor
139076701|NCT05709977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138957497|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
139076702|NCT05709977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076703|NCT05709977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076704|NCT05705804|Atorvastatin|atorvastatin|mesh-list
139076705|NCT05705804|Pitavastatin|pitavastatin|mesh-list
139076706|NCT05705804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139076707|NCT05705804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138271317|NCT03439865|Ivacaftor|ivacaftor|mesh-list
139076708|NCT05705804|Antimetabolites|antimetabolites|mesh-ancestor
139076709|NCT05705804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957560|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
139076710|NCT05705804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139076711|NCT05705804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
139076712|NCT05705804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076713|NCT05703659|Sulfalene|sulfalene|mesh-list
139076714|NCT05703659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139076715|NCT05703659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139076716|NCT05703659|Antimalarials|antimalarials|mesh-ancestor
139076717|NCT05703659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139076718|NCT05703659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139076719|NCT05636787|Melphalan|melphalan|mesh-list
139076720|NCT05636787|Treosulfan|treosulfan|mesh-list
138957694|NCT00755924|Acetic Acid|acetic acid|mesh-list
139076721|NCT05636787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139076722|NCT05636787|Alkylating Agents|alkylating agents|mesh-ancestor
139076723|NCT05636787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076724|NCT05636787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076725|NCT05636787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139076726|NCT05636787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139076727|NCT05636787|Immunologic Factors|immunologic factors|mesh-ancestor
139076728|NCT05636787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076729|NCT05631912|Cyclophosphamide|cyclophosphamide|mesh-list
139076730|NCT05631912|Fludarabine|fludarabine|mesh-list
139076731|NCT05631912|Fludarabine phosphate|fludarabine phosphate|mesh-list
139076732|NCT05631912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139076733|NCT05631912|Immunologic Factors|immunologic factors|mesh-ancestor
138256301|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139076734|NCT05631912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076735|NCT05631912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139076736|NCT05631912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139076737|NCT05631912|Alkylating Agents|alkylating agents|mesh-ancestor
138957828|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
139076738|NCT05631912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076739|NCT05631912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076740|NCT05631912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139076741|NCT05631912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139076742|NCT05631912|Antimetabolites|antimetabolites|mesh-ancestor
139076744|NCT05615948|Analgesics|analgesics|mesh-ancestor
139076745|NCT05615948|Sensory System Agents|sensory system agents|mesh-ancestor
139076746|NCT05615948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076747|NCT05615948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076748|NCT05615948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076749|NCT05615948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139076750|NCT05615948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139076751|NCT05615948|Anesthetics, General|anesthetics, general|mesh-ancestor
139076752|NCT05615948|Anesthetics|anesthetics|mesh-ancestor
139076753|NCT05615948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076754|NCT05615948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139076755|NCT05615948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138256354|NCT03634917|Acamprosate|acamprosate|mesh-list
139076756|NCT05615948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139076757|NCT05614349|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
139076758|NCT05614349|Antiviral Agents|antiviral agents|mesh-ancestor
138957958|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139076759|NCT05614349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139076761|NCT05595460|Etoposide|etoposide|mesh-list
139076762|NCT05595460|Atezolizumab|atezolizumab|mesh-list
139076763|NCT05595460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076764|NCT05595460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139076765|NCT05595460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139076766|NCT05595460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139076767|NCT05595460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076768|NCT05595460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076769|NCT05595460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139076770|NCT05595460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139076771|NCT05594667|Psilocybin|psilocybin|mesh-list
139076772|NCT05594667|Hallucinogens|hallucinogens|mesh-ancestor
139076773|NCT05594667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076774|NCT05594667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139076775|NCT05589818|Pembrolizumab|pembrolizumab|mesh-list
139076776|NCT05589818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139076777|NCT05589818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076778|NCT05589818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139076779|NCT05589818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076780|NCT05573360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139076783|NCT05571319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139076784|NCT05571319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076785|NCT05542615|Pirfenidone|pirfenidone|mesh-list
139076786|NCT05542615|Analgesics|analgesics|mesh-ancestor
139076787|NCT05542615|Sensory System Agents|sensory system agents|mesh-ancestor
139076788|NCT05542615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076789|NCT05542615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076790|NCT05542615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139076791|NCT05542615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139076792|NCT05542615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076793|NCT05542615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139076794|NCT05542615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076795|NCT05532163|Natalizumab|natalizumab|mesh-list
139076796|NCT05532163|Immunologic Factors|immunologic factors|mesh-ancestor
139076797|NCT05532163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076798|NCT05510141|Nitrous Oxide|nitrous oxide|mesh-list
139076799|NCT05510141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139076800|NCT05510141|Anesthetics, General|anesthetics, general|mesh-ancestor
139076801|NCT05510141|Anesthetics|anesthetics|mesh-ancestor
139076802|NCT05510141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076803|NCT05510141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076804|NCT05510141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139076805|NCT05510141|Analgesics|analgesics|mesh-ancestor
139076806|NCT05510141|Sensory System Agents|sensory system agents|mesh-ancestor
139076807|NCT05510141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076808|NCT05501600|Lidocaine|lidocaine|mesh-list
138827398|NCT00921505|Acetaminophen|acetaminophen|mesh-list
139076809|NCT05501600|Anesthetics, Local|anesthetics, local|mesh-ancestor
139076810|NCT05501600|Anesthetics|anesthetics|mesh-ancestor
139076811|NCT05501600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076812|NCT05501600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076813|NCT05501600|Sensory System Agents|sensory system agents|mesh-ancestor
139076814|NCT05501600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076815|NCT05501600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138958124|NCT05360602|Antioxidants|antioxidants|mesh-ancestor
139076816|NCT05501600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139076817|NCT05501600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139076818|NCT05501600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139076819|NCT05501600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271427|NCT03126539|Sulforaphane|sulforaphane|mesh-list
139076826|NCT05416658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076827|NCT05416658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076828|NCT05416658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139076829|NCT05416021|Dapivirine|dapivirine|mesh-list
139076830|NCT05416021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139076831|NCT05416021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139076832|NCT05416021|Antiviral Agents|antiviral agents|mesh-ancestor
139076833|NCT05416021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139076834|NCT05393271|Midazolam|midazolam|mesh-list
139076835|NCT05393271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139076836|NCT05393271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138256584|NCT04195256|Ketamine|ketamine|mesh-list
139076837|NCT05393271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076838|NCT05393271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076839|NCT05393271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139076840|NCT05393271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139076841|NCT05393271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139076842|NCT05393271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139076843|NCT05393271|Anesthetics, General|anesthetics, general|mesh-ancestor
139076844|NCT05393271|Anesthetics|anesthetics|mesh-ancestor
139076845|NCT05393271|GABA Modulators|gaba modulators|mesh-ancestor
139076846|NCT05393271|GABA Agents|gaba agents|mesh-ancestor
139076848|NCT05393271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076849|NCT05363553|Caseins|caseins|mesh-list
139076850|NCT05363553|Chelating Agents|chelating agents|mesh-ancestor
139076851|NCT05363553|Sequestering Agents|sequestering agents|mesh-ancestor
139076852|NCT05363553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076853|NCT05332561|Trastuzumab|trastuzumab|mesh-list
139076854|NCT05332561|Atezolizumab|atezolizumab|mesh-list
139076855|NCT05332561|Pertuzumab|pertuzumab|mesh-list
139076856|NCT05332561|Olaparib|olaparib|mesh-list
139076857|NCT05332561|Ipatasertib|ipatasertib|mesh-list
139076858|NCT05332561|Inavolisib|inavolisib|mesh-list
139076859|NCT05332561|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
139076860|NCT05332561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139076861|NCT05332561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076862|NCT05332561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139076863|NCT05332561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076864|NCT05332561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139076865|NCT05332561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076866|NCT05332561|Immunoconjugates|immunoconjugates|mesh-ancestor
139076867|NCT05332561|Immunologic Factors|immunologic factors|mesh-ancestor
139076868|NCT05332561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076869|NCT05332561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139076870|NCT05332561|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
139076871|NCT05303935|Quetiapine Fumarate|quetiapine fumarate|mesh-list
139076872|NCT05303935|Antidepressive Agents|antidepressive agents|mesh-ancestor
139076873|NCT05303935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139076874|NCT05303935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139076875|NCT05303935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139076876|NCT05303935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076877|NCT05303935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076878|NCT05298449|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
139076879|NCT05298449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
139076880|NCT05298449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
139076881|NCT05298449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076882|NCT05298449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076883|NCT05298449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139076884|NCT05298449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139076885|NCT05298449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076886|NCT05298449|Cholinergic Agents|cholinergic agents|mesh-ancestor
139076887|NCT05298449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139076889|NCT05296837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139076890|NCT05296837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139076891|NCT05296837|Antimalarials|antimalarials|mesh-ancestor
139076892|NCT05296837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139076893|NCT05296837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139076894|NCT05291130|Vitamin E|vitamin e|mesh-list
139076895|NCT05291130|Vitamins|vitamins|mesh-ancestor
139076896|NCT05291130|Micronutrients|micronutrients|mesh-ancestor
139076897|NCT05291130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076898|NCT05291130|Antioxidants|antioxidants|mesh-ancestor
139076899|NCT05291130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076900|NCT05291130|Protective Agents|protective agents|mesh-ancestor
139076901|NCT05243797|Lenalidomide|lenalidomide|mesh-list
139076902|NCT05243797|Immunologic Factors|immunologic factors|mesh-ancestor
139076903|NCT05243797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076904|NCT05243797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139076905|NCT05243797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139076906|NCT05243797|Growth Substances|growth substances|mesh-ancestor
139076907|NCT05243797|Growth Inhibitors|growth inhibitors|mesh-ancestor
139076908|NCT05243797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139076909|NCT05206266|Turmeric extract|turmeric extract|mesh-list
139076910|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
139076911|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076912|NCT05206266|Protective Agents|protective agents|mesh-ancestor
138271489|NCT02949700|Metformin|metformin|mesh-list
138271490|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139076914|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
139076915|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139076916|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
139076917|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076918|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
139076919|NCT05188898|Protective Agents|protective agents|mesh-ancestor
139076920|NCT05169268|Aripiprazole|aripiprazole|mesh-list
139076921|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
139076922|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
139076923|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139076924|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139076925|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139076926|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076927|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076928|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
139076929|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
139076930|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139076931|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076932|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139076933|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139076934|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
139076935|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139076936|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139076937|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139076938|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139076939|NCT05166746|Clindamycin|clindamycin|mesh-list
139076940|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
139076941|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
139076942|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139076943|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139076944|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139076945|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076946|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076947|NCT05160298|Ropivacaine|ropivacaine|mesh-list
139076948|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
139076949|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
139076950|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076951|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076952|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
139076953|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076955|NCT05155579|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139076956|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
139076957|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076958|NCT05143281|Dexamethasone|dexamethasone|mesh-list
138827551|NCT00958568|Olanzapine|olanzapine|mesh-list
139076959|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
139076960|NCT05143281|BB 1101|bb 1101|mesh-list
139076961|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076962|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
139076963|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
139076964|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076965|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076966|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139076967|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
139076968|NCT05143281|Hormones|hormones|mesh-ancestor
139076969|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139076970|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139076971|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256763|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076972|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
139076973|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076974|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076975|NCT05117710|Ebselen|ebselen|mesh-list
139076976|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139076977|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139076978|NCT05117710|Analgesics|analgesics|mesh-ancestor
139076979|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
139076980|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139076981|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076982|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139076983|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139076984|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139076985|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139076986|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
139076987|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139076988|NCT05117710|Protective Agents|protective agents|mesh-ancestor
139076989|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139076990|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139076991|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139076992|NCT05105022|Propofol|propofol|mesh-list
139076993|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138958505|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139076994|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139076995|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139076996|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139076997|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
139076998|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
138958549|NCT00794976|Dexamethasone|dexamethasone|mesh-list
139076999|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
139077000|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139077001|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
139077002|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077003|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
139077004|NCT05099718|Protective Agents|protective agents|mesh-ancestor
139077005|NCT05096468|Pregabalin|pregabalin|mesh-list
139077007|NCT05096468|Esketamine|esketamine|mesh-list
139077008|NCT05096468|Analgesics|analgesics|mesh-ancestor
139077009|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
139077010|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256852|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256853|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139077011|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077012|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139077013|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139077014|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
139077015|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
139077016|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139077017|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139077018|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139077019|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139077020|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077021|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
139077022|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139077023|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139077024|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139077025|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138256906|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139077026|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139077027|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139077028|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
139077029|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
139077030|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077031|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077032|NCT05085028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138271576|NCT02359175|Analgesics|analgesics|mesh-ancestor
139077033|NCT05085028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077034|NCT05084365|Sulforaphane|sulforaphane|mesh-list
139077035|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
139077036|NCT05084365|Protective Agents|protective agents|mesh-ancestor
139077037|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077038|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077039|NCT05079789|Amiloride|amiloride|mesh-list
139077040|NCT05079789|Furosemide|furosemide|mesh-list
139077041|NCT05079789|Diuretics|diuretics|mesh-ancestor
139077042|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
139077043|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077044|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
139077045|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139077046|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077047|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
139077048|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139077049|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
139077050|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
139077051|NCT05025423|Venetoclax|venetoclax|mesh-list
139077052|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139077053|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077054|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139077055|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
139077056|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077057|NCT05023993|Niacinamide|niacinamide|mesh-list
139077058|NCT05023993|Niacin|niacin|mesh-list
139077059|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
139077060|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
139077061|NCT05023993|Vitamins|vitamins|mesh-ancestor
139077062|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
139077063|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077064|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139077065|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
139077066|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077067|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139077068|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
139077069|NCT05021926|Lidocaine|lidocaine|mesh-list
139077070|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
139077071|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
139077072|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
139077073|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139077074|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077075|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
139077076|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077077|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139077078|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139077079|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139077080|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139077081|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077082|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139077083|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
139077084|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
139077085|NCT05021926|Protective Agents|protective agents|mesh-ancestor
139077087|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
139077088|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
139077089|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
139077090|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139077091|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077092|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
139077093|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077094|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139077095|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139077096|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139077097|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139077098|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077099|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139077100|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
139077101|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
139077102|NCT05021913|Protective Agents|protective agents|mesh-ancestor
139077103|NCT04999241|Infliximab|infliximab|mesh-list
139077104|NCT04999241|Mesalamine|mesalamine|mesh-list
139077105|NCT04999241|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139077106|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139077107|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
139077108|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138827692|NCT00743587|Naproxen|naproxen|mesh-list
139077109|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139077110|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139077111|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139077112|NCT04999241|Analgesics|analgesics|mesh-ancestor
139077113|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
139077114|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077115|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077117|NCT04992065|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139077118|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139077119|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139077120|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
139077121|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077122|NCT04992065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139077123|NCT04992065|Protease Inhibitors|protease inhibitors|mesh-ancestor
139077124|NCT04992065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271714|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
139077125|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139077126|NCT04906096|GDC-0084|gdc-0084|mesh-list
139077127|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077128|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077129|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
139077130|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
139077131|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077132|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
139077133|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139077134|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139077135|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077136|NCT04898114|Urological Agents|urological agents|mesh-ancestor
139077137|NCT04898114|Analgesics|analgesics|mesh-ancestor
139077138|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
139077139|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077140|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077141|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
139077142|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139077143|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139077144|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
139077145|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139077146|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139077147|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139077148|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
139077149|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139077150|NCT04897217|Megestrol|megestrol|mesh-list
139077151|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
139077152|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
139077153|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
139077154|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
139077155|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139077156|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077157|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
139077158|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138257147|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257148|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257149|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257150|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257151|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
138257152|NCT00002955|Antidotes|antidotes|mesh-ancestor
138257153|NCT00002955|Protective Agents|protective agents|mesh-ancestor
138257154|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
138257155|NCT00002955|Vitamins|vitamins|mesh-ancestor
138257156|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
139077159|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
139077160|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
139077161|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139077162|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077163|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
139077164|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139077165|NCT04870203|Adalimumab|adalimumab|mesh-list
139077166|NCT04870203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139077167|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139077168|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139077169|NCT04867707|Zanamivir|zanamivir|mesh-list
139077170|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
139077171|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139077172|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271755|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
139077173|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077174|NCT04860661|Esketamine|esketamine|mesh-list
139077175|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
139077176|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139077177|NCT04853199|Quercetin|quercetin|mesh-list
139077178|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
139077179|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077180|NCT04853199|Protective Agents|protective agents|mesh-ancestor
139077181|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257204|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257205|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138257206|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139077182|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139077183|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139077184|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077185|NCT04801485|Inositol|inositol|mesh-list
139077186|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
139077187|NCT04801485|Vitamins|vitamins|mesh-ancestor
139077188|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
139077189|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077190|NCT04753970|Cilostazol|cilostazol|mesh-list
139077191|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139077192|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
139077193|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077194|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077195|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139077196|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
139077197|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139077198|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139077199|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077200|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139077201|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
139077202|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139077203|NCT04753970|Protective Agents|protective agents|mesh-ancestor
139077204|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139077205|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139077206|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077207|NCT04741204|Metformin|metformin|mesh-list
139077208|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139077209|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077210|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
139077211|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139077212|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077213|NCT04725188|Docetaxel|docetaxel|mesh-list
139077214|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
139077215|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077216|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
139077217|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
139077218|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257302|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257303|NCT00003063|Leucovorin|leucovorin|mesh-list
138257304|NCT00003063|Interferons|interferons|mesh-list
138257305|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
138257306|NCT00003063|Levamisole|levamisole|mesh-list
138257307|NCT00003063|Fluorouracil|fluorouracil|mesh-list
138257308|NCT00003063|Calcium|calcium|mesh-list
138257309|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
138257310|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138479395|NCT02039453|Fentanyl|fentanyl|mesh-list
138257311|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257313|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257314|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257315|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257316|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257317|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
138257318|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
138257319|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139077219|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077220|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077221|NCT04725188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139077222|NCT04723394|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
139077224|NCT04723394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139077225|NCT04722523|Carboplatin|carboplatin|mesh-list
139077226|NCT04722523|Docetaxel|docetaxel|mesh-list
139077227|NCT04722523|Cetuximab|cetuximab|mesh-list
139077228|NCT04722523|Cemiplimab|cemiplimab|mesh-list
139077229|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077230|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
139077231|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
139077232|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
139077233|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077234|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138479417|NCT02039869|Sucralfate|sucralfate|mesh-list
138257350|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
138257351|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
138257352|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138257353|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
138257354|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138257355|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257356|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
138257357|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138257358|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138257359|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138257360|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138257361|NCT00003087|Paclitaxel|paclitaxel|mesh-list
138257362|NCT00003087|Cisplatin|cisplatin|mesh-list
138257363|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257364|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257365|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257366|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257367|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257368|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257370|NCT00003093|Carboplatin|carboplatin|mesh-list
138257371|NCT00003093|Doxorubicin|doxorubicin|mesh-list
138257372|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138257373|NCT00003093|Etoposide|etoposide|mesh-list
139077236|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
139077237|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077238|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139077239|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139077240|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139077241|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077242|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
139077243|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139077244|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139077245|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139077246|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
139077247|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
139077248|NCT04613206|Vaccines|vaccines|mesh-list
138271813|NCT01079780|Ramucirumab|ramucirumab|mesh-list
139077250|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077251|NCT04590508|Xanthohumol|xanthohumol|mesh-list
139077252|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077253|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139077254|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139077255|NCT04590508|Growth Substances|growth substances|mesh-ancestor
139077256|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077257|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
139077258|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
139077259|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139077260|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
139077261|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077262|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
139077263|NCT04557527|Protective Agents|protective agents|mesh-ancestor
139077265|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
139077267|NCT04532606|Anesthetics|anesthetics|mesh-list
139077268|NCT04532606|Propofol|propofol|mesh-list
139077269|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139077270|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077271|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139077272|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139077273|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
139077274|NCT04513145|Ropivacaine|ropivacaine|mesh-list
139077275|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
139077276|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
139077277|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139077278|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077279|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
139077280|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077281|NCT04460885|Insulin|insulin|mesh-list
139077282|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139077283|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
139077284|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139077285|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077286|NCT04459715|Cisplatin|cisplatin|mesh-list
139077287|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077288|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
139077289|NCT04417192|Olaparib|olaparib|mesh-list
138271873|NCT00779194|Sirolimus|sirolimus|mesh-list
139077290|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077291|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077292|NCT04417192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139077293|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077294|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139077295|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077297|NCT04409002|Dostarlimab|dostarlimab|mesh-list
139077298|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139077299|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257490|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138257491|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139077300|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077301|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077302|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
139077303|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139077304|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077305|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077306|NCT04343885|Docetaxel|docetaxel|mesh-list
139077307|NCT04343885|177Lu-PSMA-617|177lu-psma-617|mesh-list
139077308|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077309|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
139077310|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
139077311|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
139077312|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077313|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139077314|NCT04338061|Teriflunomide|teriflunomide|mesh-list
139077315|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139077316|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139077317|NCT04338061|Analgesics|analgesics|mesh-ancestor
139077318|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
139077319|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077320|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077321|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138257552|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139077322|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139077323|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139077324|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
139077325|NCT04310995|Nicorandil|nicorandil|mesh-list
139077326|NCT04310995|Diltiazem|diltiazem|mesh-list
139077327|NCT04310995|Isosorbide|isosorbide|mesh-list
139077328|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
139077329|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
139077330|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139077331|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139077332|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139077333|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077334|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139077335|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077336|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
139077337|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
139077338|NCT04310995|Diuretics|diuretics|mesh-ancestor
139077339|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
139077340|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
139077341|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139077342|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
139077343|NCT04310995|Vitamins|vitamins|mesh-ancestor
139077344|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
139077345|NCT04302324|Clarithromycin|clarithromycin|mesh-list
139077346|NCT04302324|Dexamethasone|dexamethasone|mesh-list
139077347|NCT04302324|Daratumumab|daratumumab|mesh-list
139077348|NCT04302324|Pomalidomide|pomalidomide|mesh-list
139077349|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139077350|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
139077351|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
139077352|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077353|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077354|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139077355|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
139077356|NCT04302324|Hormones|hormones|mesh-ancestor
139077357|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139077358|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139077359|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077360|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139077361|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139077362|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
139077363|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077364|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077365|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139077366|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139077367|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
139077368|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139077369|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139077370|NCT04302324|Growth Substances|growth substances|mesh-ancestor
139077371|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
139077372|NCT04270175|Dexamethasone|dexamethasone|mesh-list
139077373|NCT04270175|Daratumumab|daratumumab|mesh-list
139077374|NCT04270175|Pomalidomide|pomalidomide|mesh-list
139077375|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139077376|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
139077377|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
139077378|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077379|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077380|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139077381|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
139077382|NCT04270175|Hormones|hormones|mesh-ancestor
139077383|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139077384|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139077385|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077386|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
139077387|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139077388|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139077389|NCT04270175|Growth Substances|growth substances|mesh-ancestor
139077390|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
139077392|NCT04267549|Apatinib|apatinib|mesh-list
139077393|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139077394|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077395|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
139077396|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257648|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077397|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
139077398|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077399|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139077400|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077401|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
139077402|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
139077403|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139077404|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
139077405|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077406|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
139077407|NCT04262336|Protective Agents|protective agents|mesh-ancestor
139077408|NCT04262336|Antidotes|antidotes|mesh-ancestor
139077409|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
139077410|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077411|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
139077412|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139077413|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139077414|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
139077415|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
139077417|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077418|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077419|NCT04235959|Tirzepatide|tirzepatide|mesh-list
139077420|NCT04235959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138257683|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138257684|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139077421|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077422|NCT04235959|Incretins|incretins|mesh-ancestor
139077423|NCT04235959|Hormones|hormones|mesh-ancestor
139077424|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139077425|NCT04235101|Trastuzumab|trastuzumab|mesh-list
139077426|NCT04235101|Niraparib|niraparib|mesh-list
139077427|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077428|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077429|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139077430|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077431|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077432|NCT04182360|Carbetocin|carbetocin|mesh-list
139077433|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
139077434|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139077435|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077436|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
139077437|NCT04147533|Dasatinib|dasatinib|mesh-list
139077438|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077439|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139077440|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077441|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077442|NCT04112368|Estradiol|estradiol|mesh-list
139077443|NCT04112368|Progesterone|progesterone|mesh-list
139077444|NCT04112368|Estrogens|estrogens|mesh-ancestor
139077445|NCT04112368|Hormones|hormones|mesh-ancestor
139077446|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139077447|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077448|NCT04112368|Progestins|progestins|mesh-ancestor
139077449|NCT04088188|Cisplatin|cisplatin|mesh-list
138257742|NCT04005079|Hormones|hormones|mesh-ancestor
139077450|NCT04088188|Gemcitabine|gemcitabine|mesh-list
139077451|NCT04088188|Ivosidenib|ivosidenib|mesh-list
139077452|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077453|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139077454|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
139077455|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077456|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959593|NCT00655746|Dasatinib|dasatinib|mesh-list
139077457|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
139077458|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
139077459|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139077460|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077461|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077462|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
139077463|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
139077464|NCT04062123|Fentanyl|fentanyl|mesh-list
139077465|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
139077466|NCT04062123|Propofol|propofol|mesh-list
139077467|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139077468|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139077469|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077470|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139077471|NCT04062123|Analgesics|analgesics|mesh-ancestor
139077472|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
139077473|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077474|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139077475|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139077476|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139077477|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
139077478|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139077479|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077480|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139077481|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
139077482|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
139077483|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139077484|NCT04062123|Narcotics|narcotics|mesh-ancestor
139077485|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139077486|NCT04059562|Irinotecan|irinotecan|mesh-list
138828063|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
139077487|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139077488|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139077489|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077490|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077491|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077492|NCT03992261|Halobetasol|halobetasol|mesh-list
139077493|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139077494|NCT03991884|Prednisone|prednisone|mesh-list
139077495|NCT03991884|Cortisone|cortisone|mesh-list
139077496|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
139077497|NCT03991884|Doxorubicin|doxorubicin|mesh-list
139077498|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139077499|NCT03991884|Etoposide|etoposide|mesh-list
139077500|NCT03991884|Vincristine|vincristine|mesh-list
139077501|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
139077502|NCT03991884|Daunorubicin|daunorubicin|mesh-list
139077503|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
139077504|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
139077505|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139077506|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
139077507|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077508|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139077509|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139077510|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
139077511|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077512|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257847|NCT01769365|Amoxicillin|amoxicillin|mesh-list
139077513|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139077514|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139077515|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139077516|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139077517|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077518|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139077519|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
138959904|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139077521|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139077522|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139077523|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139077524|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
139077525|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
139077526|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257874|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
139077527|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
139077528|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
138271991|NCT00274924|Prednisone|prednisone|mesh-list
139077529|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077530|NCT03991884|Immunotoxins|immunotoxins|mesh-ancestor
139077531|NCT03991884|Immunoconjugates|immunoconjugates|mesh-ancestor
139077532|NCT03984565|Cannabidiol|cannabidiol|mesh-list
139077533|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
139077534|NCT03978039|Immunomodulating Agents|immunomodulating agents|mesh-list
139077535|NCT03978039|Immunologic Factors|immunologic factors|mesh-ancestor
139077536|NCT03978039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077537|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
139077538|NCT03890289|Idelalisib|idelalisib|mesh-list
139077539|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077540|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077541|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077542|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077543|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
139077544|NCT03825289|Trametinib|trametinib|mesh-list
139077545|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
139077546|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139077547|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139077548|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139077549|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077550|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077551|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139077552|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077553|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139077554|NCT03800602|Metformin|metformin|mesh-list
139077555|NCT03800602|Nivolumab|nivolumab|mesh-list
139077556|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139077557|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077558|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077559|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077560|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139077561|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077562|NCT03779191|Bevacizumab|bevacizumab|mesh-list
139077563|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077564|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077565|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139077567|NCT03779191|Growth Substances|growth substances|mesh-ancestor
138272034|NCT00096174|Cisplatin|cisplatin|mesh-list
139077568|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077569|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
139077570|NCT03775902|Nicorandil|nicorandil|mesh-list
139077571|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139077572|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139077573|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
139077574|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
139077575|NCT03775902|Vitamins|vitamins|mesh-ancestor
139077576|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
139077577|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077578|NCT03743662|Bevacizumab|bevacizumab|mesh-list
139077579|NCT03743662|Nivolumab|nivolumab|mesh-list
139077580|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077581|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077582|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139077583|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139077584|NCT03743662|Growth Substances|growth substances|mesh-ancestor
139077585|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077586|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
139077587|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139077588|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077589|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
139077590|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
139077591|NCT03712878|Tacrolimus|tacrolimus|mesh-list
139077592|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139077593|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
139077594|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077595|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139077596|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139077597|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
139077598|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077599|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077600|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139077601|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139077602|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077603|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139077604|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139077605|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
139077606|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139077607|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139077608|NCT03651206|Niraparib|niraparib|mesh-list
139077609|NCT03651206|Dostarlimab|dostarlimab|mesh-list
139077610|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139077611|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077612|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077613|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077614|NCT03485417|Aripiprazole|aripiprazole|mesh-list
139077615|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
139077616|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
139077617|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139077618|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139077619|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138258025|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139077620|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139077621|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077622|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
139077623|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
139077624|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139077625|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077626|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139077627|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139077628|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
139077629|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139077630|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139077631|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139077632|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139077633|NCT03485274|Vortioxetine|vortioxetine|mesh-list
139077634|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
139077635|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139077636|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139077637|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139077638|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258069|NCT01789255|Tacrolimus|tacrolimus|mesh-list
139077639|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077640|NCT03485274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139077641|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138960388|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
139077642|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139077643|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077644|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139077645|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
139077646|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139077647|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138272105|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
139077648|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
139077650|NCT03434028|Norepinephrine|norepinephrine|mesh-list
139077651|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138960442|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139077652|NCT03434028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139077653|NCT03434028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139077654|NCT03434028|Adrenergic Agents|adrenergic agents|mesh-ancestor
139077655|NCT03434028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139077656|NCT03434028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077657|NCT03434028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077658|NCT03434028|Sympathomimetics|sympathomimetics|mesh-ancestor
139077659|NCT03434028|Autonomic Agents|autonomic agents|mesh-ancestor
138960505|NCT05355610|Dexamethasone|dexamethasone|mesh-list
139077660|NCT03434028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077661|NCT03404960|Nivolumab|nivolumab|mesh-list
139077662|NCT03404960|Ipilimumab|ipilimumab|mesh-list
139077663|NCT03404960|Niraparib|niraparib|mesh-list
139077664|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077665|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077666|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139077667|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077668|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
139077669|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077670|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
139077671|NCT03393845|Fulvestrant|fulvestrant|mesh-list
139077672|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077673|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077674|NCT03393845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138960574|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138960575|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
138960576|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
138960577|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960578|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
138960579|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960580|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960590|NCT00776282|Loratadine|loratadine|mesh-list
138960591|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
138960592|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
139077675|NCT03393845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077676|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139077677|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
139077678|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139077679|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
139077680|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139077681|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077682|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
139077683|NCT03391466|Fludarabine|fludarabine|mesh-list
139077684|NCT03391466|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
139077685|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139077686|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
139077687|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077688|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139077689|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139077690|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
139077691|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077692|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077693|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139077694|NCT03391466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077695|NCT03391427|Lidocaine|lidocaine|mesh-list
139077696|NCT03391427|Ketamine|ketamine|mesh-list
139077697|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
139077698|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
139077699|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139077700|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077701|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
139077702|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258138|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
139077703|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138612594|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
139077704|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139077705|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139077706|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139077707|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077708|NCT03391427|Analgesics|analgesics|mesh-ancestor
139077709|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139077710|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139077711|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
139077712|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139077713|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139077714|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139077715|NCT03290950|Dexamethasone|dexamethasone|mesh-list
139077716|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
139077717|NCT03290950|Lenalidomide|lenalidomide|mesh-list
139077718|NCT03290950|Daratumumab|daratumumab|mesh-list
139077719|NCT03290950|BB 1101|bb 1101|mesh-list
139077720|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139077721|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
139077722|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
139077723|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077724|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960682|NCT00776516|Rifampin|rifampin|mesh-list
139077725|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139077726|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
139077727|NCT03290950|Hormones|hormones|mesh-ancestor
139077728|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139077729|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139077730|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077731|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
139077732|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077733|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077734|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
139077735|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139077736|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139077737|NCT03290950|Growth Substances|growth substances|mesh-ancestor
138258192|NCT01800877|Phenylephrine|phenylephrine|mesh-list
139077738|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
139077739|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
139077740|NCT03264404|Azacitidine|azacitidine|mesh-list
139077741|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077742|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077743|NCT03264404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139077744|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077745|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139077746|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
139077747|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077748|NCT03241745|Nivolumab|nivolumab|mesh-list
139077749|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077750|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077751|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139077752|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077753|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
139077754|NCT03129555|Apixaban|apixaban|mesh-list
139077755|NCT03129555|Edoxaban|edoxaban|mesh-list
139077756|NCT03129555|Dabigatran|dabigatran|mesh-list
139077757|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139077758|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
139077759|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139077760|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
139077761|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077762|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077763|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
139077764|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
139077765|NCT03129490|Apixaban|apixaban|mesh-list
139077766|NCT03129490|Edoxaban|edoxaban|mesh-list
139077767|NCT03129490|Dabigatran|dabigatran|mesh-list
139077768|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
139077769|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
139077770|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139077771|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
139077772|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077773|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077774|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
139077775|NCT03121014|Methotrexate|methotrexate|mesh-list
138272193|NCT00003389|Prednisone|prednisone|mesh-list
139077776|NCT03121014|Fludarabine|fludarabine|mesh-list
139077777|NCT03121014|Busulfan|busulfan|mesh-list
139077778|NCT03121014|Tacrolimus|tacrolimus|mesh-list
139077779|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
139077780|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139077781|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
139077782|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139077783|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077784|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139077785|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
138258285|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
139077786|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077787|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077788|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
139077789|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077790|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138960775|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077791|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139077792|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
139077793|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139077794|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139077795|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139077796|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
139077797|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139077798|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139077799|NCT03118570|Vitamin D|vitamin d|mesh-list
139077800|NCT03118570|Zoledronic Acid|zoledronic acid|mesh-list
139077801|NCT03118570|Calcium|calcium|mesh-list
139077802|NCT03118570|Vitamins|vitamins|mesh-ancestor
139077803|NCT03118570|Micronutrients|micronutrients|mesh-ancestor
139077804|NCT03118570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077805|NCT03118570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139077806|NCT03118570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139077807|NCT03076320|Adapalene|adapalene|mesh-list
139077808|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
139077809|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
138258336|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138258342|NCT01804075|Morphine|morphine|mesh-list
139077810|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139077811|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139077812|NCT03076320|Analgesics|analgesics|mesh-ancestor
139077813|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
139077814|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077815|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077816|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139077817|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139077818|NCT03066739|Remifentanil|remifentanil|mesh-list
139077819|NCT03066739|Naloxone|naloxone|mesh-list
139077820|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139077821|NCT03066739|Narcotics|narcotics|mesh-ancestor
139077822|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139077823|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077824|NCT03066739|Analgesics|analgesics|mesh-ancestor
139077825|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
139077826|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077827|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139077828|NCT03033303|Isotretinoin|isotretinoin|mesh-list
139077829|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
139077830|NCT03009981|Prednisone|prednisone|mesh-list
139077831|NCT03009981|Leuprolide|leuprolide|mesh-list
139077832|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
139077833|NCT03009981|Bicalutamide|bicalutamide|mesh-list
138706487|NCT02910050|Letrozole|letrozole|mesh-list
139077834|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139077835|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
139077836|NCT03009981|Hormones|hormones|mesh-ancestor
139077837|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139077838|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077839|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139077840|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077841|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
139077842|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
139077843|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139077844|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139077845|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077846|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077847|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
139077848|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139077849|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
139077850|NCT03009240|Decitabine|decitabine|mesh-list
139077851|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
139077852|NCT03009240|Pevonedistat|pevonedistat|mesh-list
139077853|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139077854|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
139077855|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077856|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077857|NCT02971683|Abatacept|abatacept|mesh-list
139077858|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139077859|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706612|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
139077860|NCT02971683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138258437|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
138258438|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
139077861|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077862|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139077863|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
139077864|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077865|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139077866|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
139077867|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139077869|NCT02950051|Fludarabine|fludarabine|mesh-list
139077870|NCT02950051|Venetoclax|venetoclax|mesh-list
139077871|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
139077872|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139077874|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077875|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139077876|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139077877|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
139077878|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077879|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077880|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139077881|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077882|NCT02921022|Paclitaxel|paclitaxel|mesh-list
139077883|NCT02921022|Gemcitabine|gemcitabine|mesh-list
139077884|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139077885|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077886|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
139077887|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
138258488|NCT02533505|Hormones|hormones|mesh-ancestor
139077888|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
139077889|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077890|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139077891|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
139077892|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
139077893|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077894|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077895|NCT02918162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139077896|NCT02918162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077897|NCT02899299|Carboplatin|carboplatin|mesh-list
139077898|NCT02899299|Nivolumab|nivolumab|mesh-list
139077899|NCT02899299|Pemetrexed|pemetrexed|mesh-list
139077900|NCT02899299|Ipilimumab|ipilimumab|mesh-list
139077901|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077902|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077903|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139077904|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077905|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077906|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139077907|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139077908|NCT02899195|Durvalumab|durvalumab|mesh-list
139077909|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077910|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077911|NCT02833233|Nivolumab|nivolumab|mesh-list
139077912|NCT02833233|Ipilimumab|ipilimumab|mesh-list
139077913|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077914|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272303|NCT03994705|Fludarabine|fludarabine|mesh-list
139077915|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139077916|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077917|NCT02814916|Dalbavancin|dalbavancin|mesh-list
139077918|NCT02814916|Teicoplanin|teicoplanin|mesh-list
139077919|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139077920|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139077921|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
139077922|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
139077923|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
139077924|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139077925|NCT02804594|Expectorants|expectorants|mesh-ancestor
139077926|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
139077927|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139077928|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
139077929|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077930|NCT02804594|Protective Agents|protective agents|mesh-ancestor
139077931|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077932|NCT02804594|Antidotes|antidotes|mesh-ancestor
139077934|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
139077935|NCT02728050|Sorafenib|sorafenib|mesh-list
139077936|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
139077937|NCT02728050|Cladribine|cladribine|mesh-list
139077938|NCT02728050|Lenograstim|lenograstim|mesh-list
139077939|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139077940|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
139077941|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077942|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077943|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
139077944|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139077945|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139077946|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
138258580|NCT02534129|Petrolatum|petrolatum|mesh-list
139077947|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077948|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139077949|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139077950|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139077951|NCT02728050|Analgesics|analgesics|mesh-ancestor
139077952|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
139077953|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139077954|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139077955|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139077956|NCT02598349|Capecitabine|capecitabine|mesh-list
139077957|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139077958|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
139077959|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077960|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077962|NCT02581943|Carboplatin|carboplatin|mesh-list
139077963|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
139077964|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139077965|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139077966|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077967|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
138258627|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077968|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
139077969|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
139077970|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706951|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
139077971|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077972|NCT02581943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139077974|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139077975|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077976|NCT02527200|Incretins|incretins|mesh-ancestor
139077977|NCT02527200|Hormones|hormones|mesh-ancestor
139077978|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139077979|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
139077980|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
139077981|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139077982|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077983|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
139077984|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139077985|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077986|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
139077987|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
138258682|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077988|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139077989|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
139077990|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139077991|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139077992|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139077993|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
139077994|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139077995|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139077996|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139077997|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139077998|NCT02414269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139077999|NCT02341989|Carboplatin|carboplatin|mesh-list
139078000|NCT02341989|Etoposide|etoposide|mesh-list
139078001|NCT02341989|Bleomycin|bleomycin|mesh-list
139078002|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078003|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139078004|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139078005|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139078006|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707113|NCT00533312|Niacin|niacin|mesh-list
139078007|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078008|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138258735|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078009|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139078010|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139078011|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078012|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
139078013|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078014|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707147|NCT04668456|Lidocaine|lidocaine|mesh-list
139078015|NCT02267603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139078016|NCT02267603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078017|NCT02244125|Dexamethasone|dexamethasone|mesh-list
139078018|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
139078019|NCT02244125|Pomalidomide|pomalidomide|mesh-list
139078020|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078021|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
139078022|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078023|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139078024|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139078025|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
139078026|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078027|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078028|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139078029|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139078030|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
139078031|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
139078032|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078033|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139078034|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
139078035|NCT02244125|Hormones|hormones|mesh-ancestor
139078036|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139078037|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139078038|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138258788|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
138258789|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
139078039|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139078040|NCT02244125|Growth Substances|growth substances|mesh-ancestor
139078041|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
139078042|NCT02243878|Ranibizumab|ranibizumab|mesh-list
139078043|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138707192|NCT00556413|Vitamins|vitamins|mesh-ancestor
139078044|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139078045|NCT02243878|Growth Substances|growth substances|mesh-ancestor
139078046|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078047|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
139078048|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078049|NCT02199236|Capecitabine|capecitabine|mesh-list
139078050|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139078051|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
139078052|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078053|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078054|NCT02157051|Vaccines|vaccines|mesh-list
139078055|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
139078056|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078057|NCT01935089|Interferons|interferons|mesh-list
139078058|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
139078059|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
139078060|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
139078062|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
139078063|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139078064|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
139078065|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078066|NCT01803152|Gemcitabine|gemcitabine|mesh-list
139078067|NCT01803152|Imiquimod|imiquimod|mesh-list
139078068|NCT01803152|Vaccines|vaccines|mesh-list
139078069|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
139078070|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078071|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139078072|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
139078073|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078074|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078075|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139078076|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
139078078|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139078079|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078080|NCT01773707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078081|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078082|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078083|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
139078084|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078085|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139078086|NCT01628640|Interferons|interferons|mesh-list
139078087|NCT01628640|Interferon-beta|interferon-beta|mesh-list
139078088|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078090|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139078091|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
139078092|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078093|NCT01504815|Cisplatin|cisplatin|mesh-list
139078094|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078095|NCT01334944|Ibuprofen|ibuprofen|mesh-list
139078096|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138258875|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
139078097|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139078098|NCT01334944|Analgesics|analgesics|mesh-ancestor
139078099|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
139078100|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078101|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078102|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139078103|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139078104|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139078105|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078106|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078107|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
139078108|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078109|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
139078110|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078111|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138707708|NCT01183390|Anastrozole|anastrozole|mesh-list
139078112|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139078113|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
139078114|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078115|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078116|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139078117|NCT00810732|Nifedipine|nifedipine|mesh-list
139078118|NCT00810732|Sitaxsentan|sitaxsentan|mesh-list
139078119|NCT00810732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139078120|NCT00810732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139078121|NCT00810732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078122|NCT00810732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139078123|NCT00810732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078124|NCT00810732|Vasodilator Agents|vasodilator agents|mesh-ancestor
139078125|NCT00810732|Tocolytic Agents|tocolytic agents|mesh-ancestor
139078126|NCT00810732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138707850|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
139078127|NCT00810732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
139078128|NCT00719888|Cyclosporine|cyclosporine|mesh-list
139078129|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
139078130|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
139078131|NCT00719888|Thiotepa|thiotepa|mesh-list
139078132|NCT00719888|Fludarabine|fludarabine|mesh-list
139078133|NCT00719888|Cyclosporins|cyclosporins|mesh-list
139078134|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078135|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
139078136|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078137|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258984|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139078138|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139078139|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
139078140|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078141|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078142|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139078143|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078144|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
139078145|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139078146|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
139078147|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139078148|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139078149|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139078150|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
139078151|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139078152|NCT00571727|Mecasermin|mecasermin|mesh-list
139078153|NCT00571727|Growth Substances|growth substances|mesh-ancestor
139078154|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078155|NCT00427349|Octreotide|octreotide|mesh-list
139078156|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
139078157|NCT00427349|Imetelstat|imetelstat|mesh-list
139078158|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139078159|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139078160|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078161|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139078162|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078163|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078164|NCT00309985|Docetaxel|docetaxel|mesh-list
139078165|NCT00309985|Androgens|androgens|mesh-list
139078166|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078167|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
138707918|NCT02462811|Anesthetics|anesthetics|mesh-ancestor
139078168|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
139078169|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
139078170|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078172|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139078173|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078174|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
139078175|NCT00200174|Exemestane|exemestane|mesh-list
139078176|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078177|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
139078178|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139078179|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078180|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078181|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139078182|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
138707956|NCT00538499|Fentanyl|fentanyl|mesh-list
139078183|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139078184|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259084|NCT02562755|Sorafenib|sorafenib|mesh-list
139078185|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139078186|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139078187|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139078188|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
139078189|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
139078190|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
139078191|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078192|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078193|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139078194|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138708011|NCT00538811|Ribavirin|ribavirin|mesh-list
139078195|NCT00195091|Growth Substances|growth substances|mesh-ancestor
139078196|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078197|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
139078198|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078199|NCT00098787|Leucovorin|leucovorin|mesh-list
139078200|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
139078201|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
139078202|NCT00098787|Bevacizumab|bevacizumab|mesh-list
139078203|NCT00098787|Fluorouracil|fluorouracil|mesh-list
139078204|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
139078205|NCT00098787|Irinotecan|irinotecan|mesh-list
139078206|NCT00098787|Camptothecin|camptothecin|mesh-list
139078207|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
139078208|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138259135|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139078209|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078210|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139078211|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139078212|NCT00098787|Growth Substances|growth substances|mesh-ancestor
139078213|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078214|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
139078215|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
139078216|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078217|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139078218|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078219|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
139078220|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139078221|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139078224|NCT00098787|Protective Agents|protective agents|mesh-ancestor
139078225|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
139078226|NCT00098787|Vitamins|vitamins|mesh-ancestor
139078227|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
139078228|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139078229|NCT00075946|Rituximab|rituximab|mesh-list
139078230|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078231|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078232|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
139078233|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078234|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139078235|NCT00074165|Cytarabine|cytarabine|mesh-list
139078236|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
139078237|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
139078238|NCT00074165|Rituximab|rituximab|mesh-list
139078239|NCT00074165|Carboplatin|carboplatin|mesh-list
139078240|NCT00074165|Etoposide|etoposide|mesh-list
139078241|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
139078242|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138828808|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139078243|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
139078244|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078245|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139078246|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139078247|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
139078248|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078249|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078250|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138272556|NCT01640184|Vitamin D|vitamin d|mesh-list
139078251|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078252|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139078254|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139078255|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078256|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139078257|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
139078258|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
139078259|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139078260|NCT00074165|Antidotes|antidotes|mesh-ancestor
139078261|NCT00074165|Protective Agents|protective agents|mesh-ancestor
139078262|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
139078263|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
139078264|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139078265|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
139078266|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
139078267|NCT00059930|Leucovorin|leucovorin|mesh-list
139078268|NCT00059930|Dexamethasone|dexamethasone|mesh-list
139078269|NCT00059930|Fluorouracil|fluorouracil|mesh-list
139078270|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
139078271|NCT00059930|Floxuridine|floxuridine|mesh-list
139078272|NCT00059930|Calcium|calcium|mesh-list
139078273|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
139078274|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139078275|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
139078276|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
139078277|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078278|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078279|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139078280|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
139078281|NCT00059930|Hormones|hormones|mesh-ancestor
139078282|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139078283|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139078284|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480750|NCT00005925|Muscimol|muscimol|mesh-list
139078285|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139078286|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
139078287|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078288|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139078289|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078290|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
139078292|NCT00059930|Protective Agents|protective agents|mesh-ancestor
139078293|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
139078294|NCT00059930|Vitamins|vitamins|mesh-ancestor
139078295|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
139078296|NCT00057876|Gemcitabine|gemcitabine|mesh-list
139078297|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139078298|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
139078299|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078300|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078301|NCT00057837|Cisplatin|cisplatin|mesh-list
139078302|NCT00057837|Irinotecan|irinotecan|mesh-list
139078303|NCT00057837|Etoposide|etoposide|mesh-list
139078304|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
139078305|NCT00057837|Topotecan|topotecan|mesh-list
139078306|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
139078307|NCT00057837|Camptothecin|camptothecin|mesh-list
139078308|NCT00057837|Lenograstim|lenograstim|mesh-list
139078309|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078310|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139078311|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139078312|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078313|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708427|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139078314|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139078315|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139078316|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139078317|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
139078318|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078319|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
138272658|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
138708476|NCT00542984|Katacalcin|katacalcin|mesh-list
139078321|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
139078322|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
139078323|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
139078325|NCT00046930|Daunorubicin|daunorubicin|mesh-list
139078326|NCT00046930|Molgramostim|molgramostim|mesh-list
139078327|NCT00046930|Lenograstim|lenograstim|mesh-list
139078328|NCT00046930|Sargramostim|sargramostim|mesh-list
139078329|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139078330|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
139078331|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078332|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259403|NCT02592629|Lidocaine|lidocaine|mesh-list
139078333|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
139078334|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139078335|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078336|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
139078337|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078338|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139078339|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139078340|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139078341|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139078342|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078344|NCT00042939|Irinotecan|irinotecan|mesh-list
139078345|NCT00042939|Cetuximab|cetuximab|mesh-list
139078346|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078347|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
139078348|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
139078349|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
139078350|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078351|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139078352|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139078353|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078354|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078355|NCT00008385|Selenium|selenium|mesh-list
139078356|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
139078357|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078358|NCT00008385|Protective Agents|protective agents|mesh-ancestor
139078359|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078360|NCT00008385|Trace Elements|trace elements|mesh-ancestor
139078361|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
139078362|NCT00003927|Paclitaxel|paclitaxel|mesh-list
139078363|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
139078364|NCT00003927|Doxorubicin|doxorubicin|mesh-list
139078365|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139078366|NCT00003927|Amifostine|amifostine|mesh-list
139078367|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139078368|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259459|NCT00553501|Rituximab|rituximab|mesh-list
139078369|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
139078370|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
139078371|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
139078372|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078373|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078374|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
139078375|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078376|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139078377|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139078378|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
139078379|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139078380|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139078381|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139078382|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138259481|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139078383|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078384|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
139078385|NCT00003927|Protective Agents|protective agents|mesh-ancestor
139078386|NCT00003910|Prednisone|prednisone|mesh-list
139078387|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
139078388|NCT00003910|Methotrexate|methotrexate|mesh-list
139078389|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078390|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
139078391|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078392|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139078393|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139078394|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
138708643|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139078395|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078396|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078397|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139078399|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
139078400|NCT00003910|Hormones|hormones|mesh-ancestor
139078401|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139078402|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139078403|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138272714|NCT05334108|Ecopipam|ecopipam|mesh-list
139078406|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139078407|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
139078408|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
139078409|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078410|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139078411|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139078412|NCT00003907|Cisplatin|cisplatin|mesh-list
139078413|NCT00003907|Doxorubicin|doxorubicin|mesh-list
139078414|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139078415|NCT00003907|Mitomycins|mitomycins|mesh-list
139078416|NCT00003907|Mitomycin|mitomycin|mesh-list
139078417|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078418|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139078419|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139078420|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139078421|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078422|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078423|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
139078424|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139078425|NCT04331067|Paclitaxel|paclitaxel|mesh-list
139078426|NCT04331067|Carboplatin|carboplatin|mesh-list
139078427|NCT04331067|Nivolumab|nivolumab|mesh-list
139078428|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139078429|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078430|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
139078431|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
139078432|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
139078433|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078434|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078435|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139078436|NCT04329221|Calcitriol|calcitriol|mesh-list
139078437|NCT04329221|Fluorouracil|fluorouracil|mesh-list
139078438|NCT04329221|Calcipotriene|calcipotriene|mesh-list
139078439|NCT04329221|Petrolatum|petrolatum|mesh-list
139078440|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
139078441|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078442|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139078443|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078444|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078445|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
139078446|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078447|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
139078448|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139078449|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139078450|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139078451|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139078452|NCT04329221|Vitamins|vitamins|mesh-ancestor
139078453|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
139078454|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139078455|NCT04329221|Emollients|emollients|mesh-ancestor
139078456|NCT04316013|Lidocaine|lidocaine|mesh-list
139078457|NCT04316013|Propofol|propofol|mesh-list
139078458|NCT04316013|Sevoflurane|sevoflurane|mesh-list
139078459|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
139078460|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
139078461|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138708942|NCT05704829|Immunoconjugates|immunoconjugates|mesh-ancestor
139078462|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078463|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
139078464|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078465|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139078466|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139078467|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139078468|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139078469|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078470|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139078471|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138259636|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139078472|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
139078473|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139078474|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
139078475|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
139078476|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
139078477|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139078478|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078479|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078480|NCT04264897|Metformin|metformin|mesh-list
139078481|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139078482|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078483|NCT04225026|Manganese|manganese|mesh-list
138259677|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
139078484|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
139078485|NCT04225026|Trace Elements|trace elements|mesh-ancestor
139078486|NCT04225026|Micronutrients|micronutrients|mesh-ancestor
139078487|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078488|NCT04225026|Free Radical Scavengers|free radical scavengers|mesh-ancestor
139078490|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078491|NCT04225026|Protective Agents|protective agents|mesh-ancestor
139078492|NCT04177108|Paclitaxel|paclitaxel|mesh-list
139078493|NCT04177108|Atezolizumab|atezolizumab|mesh-list
139078494|NCT04177108|Ipatasertib|ipatasertib|mesh-list
139078495|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139078496|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139078497|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078498|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
139078499|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
139078500|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
139078501|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078502|NCT04177108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139078503|NCT04177108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078504|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
139078505|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078506|NCT04177108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139078507|NCT04177108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078508|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
139078509|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139078511|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078512|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
139078513|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
139078514|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139078515|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
139078516|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
139078517|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139078518|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139078519|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078520|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139078521|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078522|NCT04111627|Analgesics|analgesics|mesh-ancestor
139078523|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
139078524|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078525|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
139078526|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139078527|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
139078528|NCT04090710|Nivolumab|nivolumab|mesh-list
139078529|NCT04090710|Ipilimumab|ipilimumab|mesh-list
139078530|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078531|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078532|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139078533|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078534|NCT04069312|Azithromycin|azithromycin|mesh-list
138709321|NCT02918409|Tobramycin|tobramycin|mesh-list
138259786|NCT05452577|Estazolam|estazolam|mesh-list
139078535|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139078536|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139078537|NCT03982277|Rifampin|rifampin|mesh-list
139078538|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
139078539|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
139078540|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139078541|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139078542|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
139078543|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139078544|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078545|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078546|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139078547|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139078548|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
139078549|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
139078550|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
139078551|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139078553|NCT03955978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078554|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
139078555|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
139078556|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078557|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
139078558|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078559|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139078560|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139078561|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
139078562|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078563|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078564|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138259835|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
139078565|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078566|NCT03918499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139078567|NCT03815890|Nivolumab|nivolumab|mesh-list
139078568|NCT03815890|Ipilimumab|ipilimumab|mesh-list
139078569|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078570|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078571|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139078572|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078573|NCT03711474|Dexamethasone|dexamethasone|mesh-list
139078574|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139078575|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
139078576|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
139078577|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709577|NCT00545870|Growth Substances|growth substances|mesh-ancestor
139078578|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078579|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139078580|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
139078581|NCT03711474|Hormones|hormones|mesh-ancestor
139078582|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139078583|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139078584|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078585|NCT03482024|Tirzepatide|tirzepatide|mesh-list
139078586|NCT03482024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138709642|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078587|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078588|NCT03482024|Incretins|incretins|mesh-ancestor
139078589|NCT03482024|Hormones|hormones|mesh-ancestor
139078590|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139078591|NCT03423199|Tamoxifen|tamoxifen|mesh-list
139078592|NCT03423199|Goserelin|goserelin|mesh-list
139078593|NCT03423199|Palbociclib|palbociclib|mesh-list
139078594|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
139078595|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
138272836|NCT05430048|Hemostatics|hemostatics|mesh-ancestor
139078596|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139078597|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078598|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139078599|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078600|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
139078601|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
139078602|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139078603|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139078604|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078605|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078606|NCT03423147|Chlorhexidine|chlorhexidine|mesh-list
139078607|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
139078608|NCT03423147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139078609|NCT03423147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139078610|NCT03423147|Disinfectants|disinfectants|mesh-ancestor
139078611|NCT03423147|Dermatologic Agents|dermatologic agents|mesh-ancestor
139078612|NCT03418532|Osimertinib|osimertinib|mesh-list
139078613|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078614|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139078615|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078616|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259926|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139078617|NCT03417401|Plasminogen|plasminogen|mesh-list
139078618|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
139078619|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139078620|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139078621|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078622|NCT03322631|Tirzepatide|tirzepatide|mesh-list
139078623|NCT03322631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139078624|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078625|NCT03322631|Incretins|incretins|mesh-ancestor
139078626|NCT03322631|Hormones|hormones|mesh-ancestor
139078627|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139078628|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
139078629|NCT03290612|Vitamins|vitamins|mesh-ancestor
139078630|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
138709906|NCT04643691|Losartan|losartan|mesh-list
139078631|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078632|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
139078633|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078634|NCT03290612|Protective Agents|protective agents|mesh-ancestor
139078635|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
139078636|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078637|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078638|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
139078639|NCT03057795|Nivolumab|nivolumab|mesh-list
139078640|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
139078641|NCT03057795|Antibodies|antibodies|mesh-list
139078642|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
139078643|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139078644|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
139078645|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
139078646|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078647|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078648|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139078649|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259976|NCT02264353|Donepezil|donepezil|mesh-list
139078650|NCT03057795|Immunotoxins|immunotoxins|mesh-ancestor
139078651|NCT03018704|Topiramate|topiramate|mesh-list
139078652|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
139078653|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139078654|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078655|NCT02978612|Capecitabine|capecitabine|mesh-list
139078656|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139078657|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
139078658|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078659|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078660|NCT02970500|Methylphenidate|methylphenidate|mesh-list
138710101|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
139078661|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139078662|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078663|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139078664|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139078665|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138260020|NCT04992143|Sorafenib|sorafenib|mesh-list
139078666|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078667|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
139078668|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139078669|NCT02951130|Milrinone|milrinone|mesh-list
139078670|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139078671|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
139078672|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
139078673|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
139078674|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139078675|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078676|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078677|NCT02951130|Protective Agents|protective agents|mesh-ancestor
139078678|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078679|NCT02617407|Listerine|listerine|mesh-list
139078680|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
139078681|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
139078682|NCT02617407|Protective Agents|protective agents|mesh-ancestor
139078683|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078684|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139078685|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138710222|NCT00561522|Capecitabine|capecitabine|mesh-list
139078686|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
139078687|NCT02537509|Vitamin D|vitamin d|mesh-list
139078688|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139078689|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078691|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
139078692|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139078693|NCT02490878|Bevacizumab|bevacizumab|mesh-list
139078694|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078695|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078696|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139078697|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139078698|NCT02490878|Growth Substances|growth substances|mesh-ancestor
139078699|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078700|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
139078701|NCT02332850|Dexamethasone|dexamethasone|mesh-list
139078702|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139078703|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
139078704|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
139078705|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078706|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078707|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139078708|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
139078709|NCT02332850|Hormones|hormones|mesh-ancestor
139078710|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139078711|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139078712|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078713|NCT02262325|Etoposide|etoposide|mesh-list
139078714|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
139078715|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078716|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139078717|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139078718|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139078719|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078720|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078721|NCT02205762|Cytarabine|cytarabine|mesh-list
139078722|NCT02205762|Prednisone|prednisone|mesh-list
139078723|NCT02205762|Indomethacin|indomethacin|mesh-list
139078724|NCT02205762|Methotrexate|methotrexate|mesh-list
139078725|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
139078726|NCT02205762|Vinblastine|vinblastine|mesh-list
139078727|NCT02205762|Cladribine|cladribine|mesh-list
139078728|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
139078729|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
139078730|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
139078731|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
139078732|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139078734|NCT02205762|Hormones|hormones|mesh-ancestor
139078735|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139078736|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078737|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139078738|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078739|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139078740|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
139078741|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139078742|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139078743|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
139078744|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078745|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
139078746|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078747|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139078748|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078749|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
139078750|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260166|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139078751|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139078752|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
139078753|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139078754|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139078755|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
139078756|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
139078757|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
139078758|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139078759|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139078761|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
139078762|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078763|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
139078764|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
139078765|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139078766|NCT01996267|Paclitaxel|paclitaxel|mesh-list
139078767|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
139078768|NCT01996267|Carboplatin|carboplatin|mesh-list
138829344|NCT00747799|Sorafenib|sorafenib|mesh-list
139078769|NCT01996267|Fluorouracil|fluorouracil|mesh-list
139078770|NCT01996267|Trastuzumab|trastuzumab|mesh-list
139078771|NCT01996267|Pertuzumab|pertuzumab|mesh-list
138272976|NCT02975258|Miotics|miotics|mesh-ancestor
139078772|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138710666|NCT04653792|Pregabalin|pregabalin|mesh-list
139078773|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078774|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
139078775|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
139078776|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
139078777|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078778|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078779|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
139078780|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078781|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139078782|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139078783|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
139078784|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139078785|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
139078786|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138260216|NCT02641691|Leucovorin|leucovorin|mesh-list
139078787|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078788|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
139078789|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139078790|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
139078791|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078792|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
139078793|NCT01934218|Protective Agents|protective agents|mesh-ancestor
139078794|NCT01898117|Paclitaxel|paclitaxel|mesh-list
139078795|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139078796|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
139078797|NCT01898117|Carboplatin|carboplatin|mesh-list
139078798|NCT01898117|Atezolizumab|atezolizumab|mesh-list
139078799|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
139078800|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139078801|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078802|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
139078803|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
139078804|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
139078805|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078806|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139078807|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
139078808|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078809|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139078810|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139078811|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
139078812|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
139078813|NCT01898117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139078814|NCT01898117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078815|NCT01233635|Losartan|losartan|mesh-list
139078816|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138710851|NCT02902523|Tenofovir|tenofovir|mesh-list
138260253|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260257|NCT03750071|Avelumab|avelumab|mesh-list
139078817|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139078818|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139078819|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139078820|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078821|NCT00385606|Rofecoxib|rofecoxib|mesh-list
139078822|NCT00385606|Gemcitabine|gemcitabine|mesh-list
139078823|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138710911|NCT00553553|Morphine|morphine|mesh-list
139078824|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139078825|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
139078826|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078827|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139078828|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139078829|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078830|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139078831|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139078832|NCT00385606|Analgesics|analgesics|mesh-ancestor
139078833|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
139078834|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078835|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078836|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138710967|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
139078837|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139078839|NCT03721744|Gemcitabine|gemcitabine|mesh-list
138260298|NCT02164955|Growth Substances|growth substances|mesh-ancestor
138260299|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
138260300|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260301|NCT01943461|Avelumab|avelumab|mesh-list
138260302|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138260303|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138481404|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
138260304|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260305|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
138260306|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260307|NCT00422435|Paclitaxel|paclitaxel|mesh-list
139078840|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139078841|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139078842|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
139078843|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
139078844|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
139078845|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078846|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139078848|NCT01589354|Ropivacaine|ropivacaine|mesh-list
139078849|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
139078850|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
139078851|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139078852|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078853|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
139078854|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078855|NCT01583660|Acetaminophen|acetaminophen|mesh-list
139078856|NCT01583660|Celecoxib|celecoxib|mesh-list
139078857|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
139078858|NCT01583660|Oxycodone|oxycodone|mesh-list
138260349|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138260351|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
139078859|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139078860|NCT01583660|Analgesics|analgesics|mesh-ancestor
139078861|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
139078862|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078863|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078864|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
139078865|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139078866|NCT01583660|Narcotics|narcotics|mesh-ancestor
139078867|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139078868|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139078869|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139078870|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139078871|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
139078872|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139078873|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078874|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078875|NCT01089218|Amoxicillin|amoxicillin|mesh-list
139078876|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
139078877|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
139078878|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
139078879|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139078880|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139078881|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
139078882|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260401|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
138260402|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078883|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078884|NCT03957668|Lactulose|lactulose|mesh-list
139078885|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
139078886|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139078887|NCT03957668|Laxatives|laxatives|mesh-ancestor
139078888|NCT01089452|Amlodipine|amlodipine|mesh-list
139078889|NCT01089452|Olmesartan|olmesartan|mesh-list
139078890|NCT01089452|Perindopril|perindopril|mesh-list
139078891|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139078892|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139078893|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139078894|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078895|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139078896|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078897|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
139078898|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139078899|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
139078900|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
139078901|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
139078902|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078903|NCT04880980|Itraconazole|itraconazole|mesh-list
139078904|NCT04880980|Terbinafine|terbinafine|mesh-list
139078905|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
139078906|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139078907|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139078908|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139078909|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078910|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078911|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139078912|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
139078913|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138273098|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
139078914|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078915|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139078916|NCT01583504|Anesthetics|anesthetics|mesh-list
139078917|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
139078918|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139078919|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078920|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
139078921|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078922|NCT01583036|Digoxin|digoxin|mesh-list
139078923|NCT01583036|Ezogabine|ezogabine|mesh-list
139078924|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139078925|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139078926|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078927|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078928|NCT01583036|Protective Agents|protective agents|mesh-ancestor
139078929|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078930|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
139078931|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139078932|NCT01091792|Bevacizumab|bevacizumab|mesh-list
139078933|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139078934|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711401|NCT05419583|Aspirin|aspirin|mesh-list
139078935|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139078936|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139078937|NCT01091792|Growth Substances|growth substances|mesh-ancestor
139078938|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078939|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
138260502|NCT04878198|Melatonin|melatonin|mesh-list
139078940|NCT03510910|Acetaminophen|acetaminophen|mesh-list
139078941|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139078942|NCT03510910|Analgesics|analgesics|mesh-ancestor
139078943|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
139078944|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078945|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078946|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
139078947|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
139078948|NCT01091870|Citric Acid|citric acid|mesh-list
139078949|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
139078950|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
139078951|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
139078953|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
139078954|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078955|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
139078956|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
139078957|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139078958|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139078959|NCT01091870|Urological Agents|urological agents|mesh-ancestor
139078961|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
139078962|NCT03509350|Thiamine|thiamine|mesh-list
139078963|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
139078964|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
139078965|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
139078966|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
139078967|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
138260539|NCT05432843|Pregabalin|pregabalin|mesh-list
139078968|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078969|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139078970|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
139078971|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139078972|NCT03509350|Protective Agents|protective agents|mesh-ancestor
139078973|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
139078974|NCT03478696|Budesonide|budesonide|mesh-list
139078975|NCT03478696|Albuterol|albuterol|mesh-list
139078976|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
139078977|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
139078978|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
139078979|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139078980|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
139078981|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
139078982|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139078983|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078984|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
139078985|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
139078986|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
139078987|NCT03478696|Hormones|hormones|mesh-ancestor
139078988|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139078989|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
139078990|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
139078991|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139078992|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
139078993|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273173|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139078994|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260588|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
139078995|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
139078996|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139078997|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
139078998|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
139078999|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139079001|NCT00072176|Temsirolimus|temsirolimus|mesh-list
139079002|NCT00072176|MTOR Inhibitors|mtor inhibitors|mesh-list
139079003|NCT00072176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139079004|NCT00072176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139079005|NCT00072176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139079006|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139079007|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
139079008|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139079009|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139079010|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138901106|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901107|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
138901108|NCT00686686|Infliximab|infliximab|mesh-list
138901109|NCT00686686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138901110|NCT00686686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138901111|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
138901112|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138260633|NCT05648994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138260634|NCT05648994|Immunologic Factors|immunologic factors|mesh-ancestor
138901113|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138901114|NCT02637167|Rifaximin|rifaximin|mesh-list
138901115|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138901116|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553134|NCT00274612|Ramipril|ramipril|mesh-list
138901117|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138901118|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138901119|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138901120|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901121|NCT00655109|Fluticasone|fluticasone|mesh-list
138901122|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138901123|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
138901124|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138901125|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138901126|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
138901127|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901128|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901129|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138901130|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
138260699|NCT02705807|Tezosentan|tezosentan|mesh-list
138901131|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
138901132|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138901133|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138901134|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138901135|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138901136|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138901138|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
138901139|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138901140|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138901141|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138901142|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
138901143|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
138901144|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709246|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901145|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901147|NCT02632877|Ketanserin|ketanserin|mesh-list
138901148|NCT02632877|Analgesics|analgesics|mesh-ancestor
138901149|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
138901150|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901151|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901152|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138901153|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138901154|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138901155|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138901156|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901157|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138901158|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138901159|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138901161|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901162|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901164|NCT00656123|Molgramostim|molgramostim|mesh-list
138901165|NCT00656123|Sargramostim|sargramostim|mesh-list
138901166|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
138901167|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901168|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138901169|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138901170|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138901171|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
138901172|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901173|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901174|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138901175|NCT04163471|Hemostatics|hemostatics|mesh-list
138901176|NCT04163471|Coagulants|coagulants|mesh-ancestor
138901177|NCT00657449|Valdecoxib|valdecoxib|mesh-list
138901178|NCT00657449|Rofecoxib|rofecoxib|mesh-list
138901179|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138901180|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138901181|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901182|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901183|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138901184|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138260775|NCT03649061|Etanercept|etanercept|mesh-list
138260776|NCT03649061|Leflunomide|leflunomide|mesh-list
138901185|NCT00657449|Analgesics|analgesics|mesh-ancestor
138901186|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
138901187|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791979|NCT00657514|Ranolazine|ranolazine|mesh-list
138901188|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901189|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138901190|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138901192|NCT04160195|Fludarabine|fludarabine|mesh-list
138901193|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138901194|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
138901195|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901196|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138901197|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138901198|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
138901199|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901200|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901201|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138901202|NCT00911261|Oxymorphone|oxymorphone|mesh-list
138901203|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138901204|NCT00911261|Narcotics|narcotics|mesh-ancestor
138901205|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138901206|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901207|NCT00911261|Analgesics|analgesics|mesh-ancestor
138901208|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
138260825|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
138260835|NCT05544786|Ritonavir|ritonavir|mesh-list
138901209|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770241|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
138901210|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138901211|NCT00686374|Adalimumab|adalimumab|mesh-list
138901212|NCT00686374|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138901213|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138901214|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138901215|NCT00750178|Vorinostat|vorinostat|mesh-list
138901216|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901217|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138901218|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901219|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901220|NCT00750334|Clofarabine|clofarabine|mesh-list
138792088|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
138901221|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138901222|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
138901223|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901224|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901225|NCT00745186|Glucagon|glucagon|mesh-list
138901226|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138901227|NCT00745186|Hormones|hormones|mesh-ancestor
138901228|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138901229|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901230|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
138901231|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138901232|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
138901233|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901234|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
138401312|NCT01554813|Vaccines|vaccines|mesh-list
138901235|NCT00750724|Protective Agents|protective agents|mesh-ancestor
138901237|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901238|NCT00752596|Azimilide|azimilide|mesh-list
138260888|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
138901239|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138901240|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138901241|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138901242|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901243|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138901244|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901245|NCT00750802|Lorazepam|lorazepam|mesh-list
138901246|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
138901247|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
138901248|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
138901249|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901250|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901251|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138901252|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138507243|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
138901253|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138901254|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138901255|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138901256|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138901257|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
138901258|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
138901259|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901260|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901261|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138901262|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
138901263|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138901264|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138901265|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138901266|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138901267|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901268|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
138901270|NCT00683878|Pioglitazone|pioglitazone|mesh-list
138901271|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
138901272|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
138901273|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138901274|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901275|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138901276|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901277|NCT00884741|Bevacizumab|bevacizumab|mesh-list
138901278|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138901279|NCT00884741|Temozolomide|temozolomide|mesh-list
138901280|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
138901281|NCT00884741|Antibodies|antibodies|mesh-list
138260970|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260972|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
138901282|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
138901283|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138901284|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
138901285|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901286|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138901287|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138901288|NCT00884741|Growth Substances|growth substances|mesh-ancestor
138901289|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901290|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
138901291|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
138901292|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138901293|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
138901294|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901295|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138901296|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138901297|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138901298|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
138901299|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901300|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138901301|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138901302|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901303|NCT04159649|Letrozole|letrozole|mesh-list
138901304|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901305|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138901306|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138901307|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481947|NCT00006240|Hormones|hormones|mesh-ancestor
138901308|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901309|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138901310|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
138383030|NCT06076772|Denosumab|denosumab|mesh-list
138901311|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138901312|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901313|NCT00880763|Interferons|interferons|mesh-list
138901314|NCT00880763|Ribavirin|ribavirin|mesh-list
138901315|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901316|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
138901317|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901318|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
138901319|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901320|NCT00884273|Goserelin|goserelin|mesh-list
138261072|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138261073|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
138901321|NCT00884273|Bicalutamide|bicalutamide|mesh-list
138507247|NCT00392106|Amiodarone|amiodarone|mesh-list
138901322|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138901323|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901324|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
138901325|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
138901326|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792290|NCT02876549|Primaquine|primaquine|mesh-list
138901327|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901328|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
138901329|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138901330|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138442574|NCT01809171|Vitamin D|vitamin d|mesh-list
138901331|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901332|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138901333|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138901334|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
138709247|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
138901335|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901336|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138901337|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
138901338|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138901339|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138901340|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901341|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901342|NCT00657839|Urological Agents|urological agents|mesh-ancestor
138901343|NCT00884117|Oseltamivir|oseltamivir|mesh-list
138901344|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
138901345|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261135|NCT02588027|Ibuprofen|ibuprofen|mesh-list
138901346|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901347|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901348|NCT04159181|Lactulose|lactulose|mesh-list
138901349|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
138901350|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138901351|NCT04159181|Cathartics|cathartics|mesh-ancestor
138901352|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
138901353|NCT00884039|Anecortave|anecortave|mesh-list
138901354|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138901355|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138901356|NCT00884039|Growth Substances|growth substances|mesh-ancestor
138901357|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901358|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
138901359|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901360|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138901361|NCT00657995|Pancrelipase|pancrelipase|mesh-list
138901362|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138901363|NCT02632565|Lidocaine|lidocaine|mesh-list
138901365|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
138901366|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261177|NCT05431673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138901367|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901368|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
138901369|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901370|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138901371|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138901372|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138901373|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138901374|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901375|NCT04158947|Trastuzumab|trastuzumab|mesh-list
138901376|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138901377|NCT04158947|Afatinib|afatinib|mesh-list
138507253|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138901378|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138901379|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901380|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138901381|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901382|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901383|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
138901384|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
138901385|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
138901386|NCT04158947|Immunotoxins|immunotoxins|mesh-ancestor
138901387|NCT04158947|Immunoconjugates|immunoconjugates|mesh-ancestor
138901388|NCT04158947|Immunologic Factors|immunologic factors|mesh-ancestor
138901389|NCT04158947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901390|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138901391|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
138901392|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138901393|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
138901394|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901395|NCT04163237|Sorafenib|sorafenib|mesh-list
138901396|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901397|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138901398|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261235|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
138261236|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138901399|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901400|NCT00880685|Memantine|memantine|mesh-list
138901402|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138901403|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
138901404|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901405|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901406|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901407|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138901408|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138901409|NCT02612298|Metoprolol|metoprolol|mesh-list
138901410|NCT02612298|Arotinolol|arotinolol|mesh-list
138553421|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138901411|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138901412|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138901413|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
138901414|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
138901415|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901416|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901417|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138901418|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138901419|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138901420|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
138901421|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901422|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901423|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138901424|NCT00880607|Morphine|morphine|mesh-list
138901425|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138901426|NCT00880607|Narcotics|narcotics|mesh-ancestor
138901427|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138901428|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901429|NCT00880607|Analgesics|analgesics|mesh-ancestor
138901430|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
138901431|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901432|NCT00656435|Bevacizumab|bevacizumab|mesh-list
138261334|NCT05364515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138901433|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138901434|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901435|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138901436|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138901437|NCT00656435|Growth Substances|growth substances|mesh-ancestor
138901438|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792759|NCT06199102|Micronutrients|micronutrients|mesh-ancestor
138901439|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
138901440|NCT02636231|Endostatins|endostatins|mesh-list
138901441|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138901442|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138901443|NCT02636231|Growth Substances|growth substances|mesh-ancestor
138901444|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901445|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
138901446|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901447|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138901448|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138901449|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138901450|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
138261397|NCT05451719|Antimetabolites|antimetabolites|mesh-ancestor
138901451|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901452|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138901453|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138901454|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901455|NCT00656591|Methotrexate|methotrexate|mesh-list
138901456|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138901457|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
138901458|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138901459|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901460|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138901461|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
138901462|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901463|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901464|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
138901465|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901466|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138901467|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138901468|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
138901469|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138901470|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138901471|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138901472|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138901473|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138901474|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138901475|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901476|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901477|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792907|NCT06075771|Levodopa|levodopa|mesh-list
138261448|NCT05448989|Cholinergic Agents|cholinergic agents|mesh-ancestor
138261449|NCT05448989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901478|NCT00658931|Analgesics|analgesics|mesh-ancestor
138901479|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
138901480|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901481|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
138901482|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138901483|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
138901484|NCT00834912|Tramadol|tramadol|mesh-list
138901485|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138901486|NCT00834912|Narcotics|narcotics|mesh-ancestor
138553493|NCT00279565|Interferons|interferons|mesh-list
138901487|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138901488|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901490|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
138901491|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901492|NCT02535689|Tofacitinib|tofacitinib|mesh-list
138901493|NCT02535689|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138901494|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138901495|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901496|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901497|NCT02632331|Gabapentin|gabapentin|mesh-list
138901498|NCT02632331|Analgesics|analgesics|mesh-ancestor
138901499|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
138901500|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901501|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901502|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
138901503|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138901504|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138901505|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138901506|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138901507|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138901508|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138901509|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901510|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901511|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
138901512|NCT04162535|Lidocaine|lidocaine|mesh-list
138901514|NCT04162535|Anesthetics|anesthetics|mesh-list
138901515|NCT04162535|Sevoflurane|sevoflurane|mesh-list
138901516|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
138901517|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
138901518|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138901519|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901520|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
138901521|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901522|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138901523|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138901524|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138901525|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138901526|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901527|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138901528|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
138901529|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138901530|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138793067|NCT06011772|Vitamins|vitamins|mesh-ancestor
138901531|NCT02632019|Gemcitabine|gemcitabine|mesh-list
138901532|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138901533|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
138261544|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138901534|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901535|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901536|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138901537|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
138901538|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
138901539|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138901540|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138901541|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138901542|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138901543|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901544|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901545|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901546|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
138901548|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138901549|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
138901550|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901551|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901552|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138901553|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138901554|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
138901555|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901556|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901558|NCT00659399|Fondaparinux|fondaparinux|mesh-list
138901559|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138901560|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
138901562|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
138901563|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901564|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901565|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
138442907|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
138901566|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138901567|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138901569|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138901570|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901571|NCT00911339|Atorvastatin|atorvastatin|mesh-list
138901572|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138901573|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138901574|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
138901575|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901576|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138901577|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138901578|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901579|NCT05863195|Leucovorin|leucovorin|mesh-list
138901580|NCT05863195|Bevacizumab|bevacizumab|mesh-list
138901581|NCT05863195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138901582|NCT05863195|Cetuximab|cetuximab|mesh-list
138901583|NCT05863195|Panitumumab|panitumumab|mesh-list
138901584|NCT05863195|Fluorouracil|fluorouracil|mesh-list
138901585|NCT05863195|Oxaliplatin|oxaliplatin|mesh-list
138901586|NCT05863195|Irinotecan|irinotecan|mesh-list
138901587|NCT05863195|Floxuridine|floxuridine|mesh-list
138901588|NCT05863195|Endothelial Growth Factors|endothelial growth factors|mesh-list
138901589|NCT05863195|Antibodies|antibodies|mesh-list
138901590|NCT05863195|Immunoglobulins|immunoglobulins|mesh-list
138901591|NCT05863195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138901592|NCT05863195|Immunoglobulin G|immunoglobulin g|mesh-list
138901593|NCT05863195|Deoxyuridine|deoxyuridine|mesh-list
138261651|NCT01911169|Vitamins|vitamins|mesh-list
138901594|NCT05863195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901595|NCT05863195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138901596|NCT05863195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138901597|NCT05863195|Growth Substances|growth substances|mesh-ancestor
138901598|NCT05863195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901599|NCT05863195|Growth Inhibitors|growth inhibitors|mesh-ancestor
138901600|NCT05863195|Immunologic Factors|immunologic factors|mesh-ancestor
138901601|NCT05863195|Antimetabolites|antimetabolites|mesh-ancestor
138901602|NCT05863195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901603|NCT05863195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138901604|NCT05863195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138901605|NCT05863195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138901606|NCT05863195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138901607|NCT05863195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901608|NCT05863195|Antidotes|antidotes|mesh-ancestor
138901609|NCT05863195|Protective Agents|protective agents|mesh-ancestor
138901610|NCT05863195|Vitamin B Complex|vitamin b complex|mesh-ancestor
138901611|NCT05863195|Vitamins|vitamins|mesh-ancestor
138901612|NCT05863195|Micronutrients|micronutrients|mesh-ancestor
138901613|NCT05862753|Etomidate|etomidate|mesh-list
138901614|NCT05862753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138261679|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901615|NCT05862753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138901616|NCT05862753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901617|NCT05862753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138901618|NCT05862753|Anesthetics, General|anesthetics, general|mesh-ancestor
138901619|NCT05862753|Anesthetics|anesthetics|mesh-ancestor
138901620|NCT05862714|Itraconazole|itraconazole|mesh-list
138793199|NCT05774951|Tamoxifen|tamoxifen|mesh-list
138901621|NCT05862714|Fluconazole|fluconazole|mesh-list
138901622|NCT05862714|Antifungal Agents|antifungal agents|mesh-ancestor
138901623|NCT05862714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901624|NCT05862714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138901625|NCT05862714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138793245|NCT05691478|Cisplatin|cisplatin|mesh-list
138901626|NCT05862714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901627|NCT05862714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901628|NCT05862714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138901629|NCT05862714|Hormone Antagonists|hormone antagonists|mesh-ancestor
138901630|NCT05862714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138901631|NCT05862714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901632|NCT05862714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138901633|NCT05862714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138901634|NCT05862714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138901635|NCT05862701|Permethrin|permethrin|mesh-list
138901636|NCT05862701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901637|NCT05862701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901638|NCT05862519|Testosterone|testosterone|mesh-list
138901639|NCT05862519|Androgens|androgens|mesh-ancestor
138901640|NCT05862519|Hormones|hormones|mesh-ancestor
138901641|NCT05862519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138901642|NCT05862519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901643|NCT05862428|Misoprostol|misoprostol|mesh-list
138901644|NCT05862428|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138901645|NCT05862428|Abortifacient Agents|abortifacient agents|mesh-ancestor
138901646|NCT05862428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138793407|NCT05287568|Cc-486|cc-486|mesh-list
138901647|NCT05862428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901648|NCT05862428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138901649|NCT05862428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138901650|NCT05862428|Oxytocics|oxytocics|mesh-ancestor
138901651|NCT05862402|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138901652|NCT05862402|Gentamicins|gentamicins|mesh-list
138901653|NCT05862402|Meropenem|meropenem|mesh-list
138901654|NCT05862402|Imipenem|imipenem|mesh-list
138901655|NCT05862402|Amikacin|amikacin|mesh-list
138901656|NCT05862402|Ceftazidime|ceftazidime|mesh-list
138901657|NCT05862402|Colistin|colistin|mesh-list
138901658|NCT05862402|Tigecycline|tigecycline|mesh-list
138901659|NCT05862402|Avibactam|avibactam|mesh-list
138793439|NCT05256225|Pertuzumab|pertuzumab|mesh-list
138261779|NCT05738317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138901660|NCT05862402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138901661|NCT05862402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901662|NCT05862402|Antitubercular Agents|antitubercular agents|mesh-ancestor
138901663|NCT05862402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138901664|NCT05862402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901665|NCT05862402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901666|NCT05862402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138901667|NCT05862220|Fibrin fragment D|fibrin fragment d|mesh-list
138901668|NCT05862220|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138901669|NCT05862220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138901670|NCT05862220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901671|NCT05862220|Hemostatics|hemostatics|mesh-ancestor
138901672|NCT05862220|Coagulants|coagulants|mesh-ancestor
138901673|NCT05862064|Paclitaxel|paclitaxel|mesh-list
138901674|NCT05862064|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138901675|NCT05862064|Cyclophosphamide|cyclophosphamide|mesh-list
138901677|NCT05862064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138901678|NCT05862064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901679|NCT05862064|Tubulin Modulators|tubulin modulators|mesh-ancestor
138901680|NCT05862064|Antimitotic Agents|antimitotic agents|mesh-ancestor
138901681|NCT05862064|Mitosis Modulators|mitosis modulators|mesh-ancestor
138901682|NCT05862064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901684|NCT05862064|Immunologic Factors|immunologic factors|mesh-ancestor
138901685|NCT05862064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901686|NCT05862064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138901687|NCT05862064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138901688|NCT05862064|Alkylating Agents|alkylating agents|mesh-ancestor
138901689|NCT05862064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138901690|NCT05862064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138901691|NCT05862064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138901692|NCT05862064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138901693|NCT05862064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901694|NCT05861791|Ketorolac|ketorolac|mesh-list
138901695|NCT05861791|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138901696|NCT05861791|Fentanyl|fentanyl|mesh-list
138901697|NCT05861791|Nefopam|nefopam|mesh-list
138901698|NCT05861791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138901699|NCT05861791|Narcotics|narcotics|mesh-ancestor
138261892|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
138901700|NCT05861791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138901701|NCT05861791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901702|NCT05861791|Analgesics|analgesics|mesh-ancestor
138901703|NCT05861791|Sensory System Agents|sensory system agents|mesh-ancestor
138793636|NCT04791176|Lenvatinib|lenvatinib|mesh-list
138901704|NCT05861791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901705|NCT05861791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138901706|NCT05861791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138901707|NCT05861791|Anesthetics, General|anesthetics, general|mesh-ancestor
138901708|NCT05861791|Anesthetics|anesthetics|mesh-ancestor
138901709|NCT05861791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138901710|NCT05861791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138901711|NCT05861791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138901712|NCT05861791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138901713|NCT05861791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138901714|NCT05861791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901715|NCT05861791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901717|NCT05861713|Antiemetics|antiemetics|mesh-ancestor
138901718|NCT05861713|Autonomic Agents|autonomic agents|mesh-ancestor
138901719|NCT05861713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901720|NCT05861713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901721|NCT05861713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138901722|NCT05861713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138901723|NCT05861713|Histamine Antagonists|histamine antagonists|mesh-ancestor
138901724|NCT05861713|Histamine Agents|histamine agents|mesh-ancestor
138901725|NCT05861713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901726|NCT05861713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901727|NCT05861687|Amoxicillin|amoxicillin|mesh-list
138901728|NCT05861687|Clarithromycin|clarithromycin|mesh-list
138901729|NCT05861687|Esomeprazole|esomeprazole|mesh-list
138901730|NCT05861687|Lansoprazole|lansoprazole|mesh-list
138901731|NCT05861687|Dexlansoprazole|dexlansoprazole|mesh-list
138901732|NCT05861687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138901733|NCT05861687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901734|NCT05861687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138901735|NCT05861687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138901736|NCT05861687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138901737|NCT05861687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901738|NCT05861687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901739|NCT05861687|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138901740|NCT05861687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138901741|NCT05861687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138901742|NCT05861648|Folic Acid|folic acid|mesh-list
138901743|NCT05861648|Hematinics|hematinics|mesh-ancestor
138901744|NCT05861648|Vitamin B Complex|vitamin b complex|mesh-ancestor
138901745|NCT05861648|Vitamins|vitamins|mesh-ancestor
138901746|NCT05861648|Micronutrients|micronutrients|mesh-ancestor
138770242|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
138901747|NCT05861648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901748|NCT05861635|Tislelizumab|tislelizumab|mesh-list
138901749|NCT05861635|Disitamab vedotin|disitamab vedotin|mesh-list
138901750|NCT05861635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138262012|NCT00371813|Varenicline|varenicline|mesh-list
138901751|NCT05861635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901752|NCT05861635|Immunoconjugates|immunoconjugates|mesh-ancestor
138901753|NCT05861635|Immunologic Factors|immunologic factors|mesh-ancestor
138901754|NCT05861635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901755|NCT05861609|Analgesics|analgesics|mesh-list
138901756|NCT05861609|Sensory System Agents|sensory system agents|mesh-ancestor
138901757|NCT05861609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901758|NCT05861609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901759|NCT05773326|Sirolimus|sirolimus|mesh-list
138901760|NCT05773326|Temsirolimus|temsirolimus|mesh-list
138901761|NCT05773326|MTOR Inhibitors|mtor inhibitors|mesh-list
138901762|NCT05773326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138901763|NCT05773326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901764|NCT05773326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901765|NCT05773326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138901766|NCT05773326|Immunologic Factors|immunologic factors|mesh-ancestor
138901767|NCT05773326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901768|NCT05773326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901769|NCT05773326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138901770|NCT05773326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901771|NCT05773326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138901772|NCT05773326|Antifungal Agents|antifungal agents|mesh-ancestor
138901773|NCT05765071|Botulinum Toxins|botulinum toxins|mesh-list
138901774|NCT05765071|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138901775|NCT05765071|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138262048|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138901776|NCT05765071|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138901777|NCT05765071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138901778|NCT05765071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901779|NCT05765071|Cholinergic Agents|cholinergic agents|mesh-ancestor
138901780|NCT05765071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901781|NCT05765071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901782|NCT05765071|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138901783|NCT05765071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901784|NCT05686564|Choline|choline|mesh-list
138901785|NCT05686564|Lipotropic Agents|lipotropic agents|mesh-ancestor
138901786|NCT05686564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138901787|NCT05686564|Antimetabolites|antimetabolites|mesh-ancestor
138901788|NCT05686564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507309|NCT00056329|Vitamin E|vitamin e|mesh-list
138901789|NCT05686564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138553796|NCT00416962|Amantadine|amantadine|mesh-list
138901790|NCT05686564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138901791|NCT05686564|Nootropic Agents|nootropic agents|mesh-ancestor
138901792|NCT05671900|Gemcitabine|gemcitabine|mesh-list
138901793|NCT05671900|Docetaxel|docetaxel|mesh-list
138901794|NCT05671900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138901795|NCT05671900|Antimetabolites|antimetabolites|mesh-ancestor
138901796|NCT05671900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901797|NCT05671900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901798|NCT05671900|Tubulin Modulators|tubulin modulators|mesh-ancestor
138901799|NCT05671900|Antimitotic Agents|antimitotic agents|mesh-ancestor
138901800|NCT05671900|Mitosis Modulators|mitosis modulators|mesh-ancestor
138901801|NCT05489185|Tranexamic Acid|tranexamic acid|mesh-list
138901802|NCT05489185|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138901803|NCT05489185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138901804|NCT05489185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901805|NCT05489185|Hemostatics|hemostatics|mesh-ancestor
138901806|NCT05489185|Coagulants|coagulants|mesh-ancestor
138901807|NCT05465304|Azithromycin|azithromycin|mesh-list
138901808|NCT05465304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138901809|NCT05465304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901810|NCT05458024|Vitamin D|vitamin d|mesh-list
138901811|NCT05458024|Ergocalciferols|ergocalciferols|mesh-list
138901812|NCT05458024|Cholecalciferol|cholecalciferol|mesh-list
138901813|NCT05458024|Vitamins|vitamins|mesh-list
138901814|NCT05458024|Micronutrients|micronutrients|mesh-ancestor
138901815|NCT05458024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901816|NCT05458024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138901817|NCT05458024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138901818|NCT05370313|Nicotine|nicotine|mesh-list
138901819|NCT05370313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138901820|NCT05370313|Autonomic Agents|autonomic agents|mesh-ancestor
138901821|NCT05370313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901822|NCT05370313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901823|NCT05370313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138901824|NCT05370313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138901825|NCT05370313|Cholinergic Agents|cholinergic agents|mesh-ancestor
138901826|NCT05370313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901827|NCT05370313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901828|NCT05357768|Formaldehyde|formaldehyde|mesh-list
138901829|NCT05357768|Disinfectants|disinfectants|mesh-ancestor
138901830|NCT05357768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901831|NCT05324449|Cannabidiol|cannabidiol|mesh-list
138901832|NCT05324449|Anticonvulsants|anticonvulsants|mesh-ancestor
138901833|NCT05304871|Cefazolin|cefazolin|mesh-list
138901834|NCT05304871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138901835|NCT05304871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901836|NCT05281406|Carboplatin|carboplatin|mesh-list
138901837|NCT05281406|Pemetrexed|pemetrexed|mesh-list
138901838|NCT05281406|Osimertinib|osimertinib|mesh-list
138901839|NCT05281406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901840|NCT05281406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901841|NCT05281406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901842|NCT05281406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138901843|NCT05281406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138901844|NCT05281406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138901845|NCT05265299|Aspirin|aspirin|mesh-list
138901846|NCT05265299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138901847|NCT05265299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138901848|NCT05265299|Analgesics|analgesics|mesh-ancestor
138901849|NCT05265299|Sensory System Agents|sensory system agents|mesh-ancestor
138901850|NCT05265299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901851|NCT05265299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901852|NCT05265299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138901853|NCT05265299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138901854|NCT05265299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138901855|NCT05265299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138507395|NCT00057031|Calcitriol|calcitriol|mesh-list
138901856|NCT05265299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901857|NCT05265299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138901858|NCT05265299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138901859|NCT05265299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901861|NCT05233722|Sirolimus|sirolimus|mesh-list
138901862|NCT05233722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901863|NCT05233722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138901864|NCT05233722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553870|NCT00076544|Ziconotide|ziconotide|mesh-list
138901865|NCT05233722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138901866|NCT05233722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901867|NCT05233722|Antifungal Agents|antifungal agents|mesh-ancestor
138901868|NCT05233722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138901869|NCT05233722|Immunologic Factors|immunologic factors|mesh-ancestor
138901870|NCT05221892|Thiamine|thiamine|mesh-list
138901871|NCT05221892|Pyridoxine|pyridoxine|mesh-list
138901872|NCT05221892|Vitamin B 12|vitamin b 12|mesh-list
138901873|NCT05221892|Hydroxocobalamin|hydroxocobalamin|mesh-list
138901874|NCT05221892|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
138901875|NCT05221892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901876|NCT05221892|Vitamin B Complex|vitamin b complex|mesh-ancestor
138901878|NCT05221892|Micronutrients|micronutrients|mesh-ancestor
138901879|NCT05221892|Hematinics|hematinics|mesh-ancestor
138901880|NCT05221892|GABA Agents|gaba agents|mesh-ancestor
138901881|NCT05221892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508065|NCT06196580|Repaglinide|repaglinide|mesh-list
138262323|NCT01387763|Interferons|interferons|mesh-list
138901882|NCT05221892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901883|NCT05045794|Liver Extracts|liver extracts|mesh-list
138901884|NCT05045794|Hematinics|hematinics|mesh-ancestor
138901885|NCT05044936|Cannabidiol|cannabidiol|mesh-list
138901886|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
138901887|NCT05033743|Secnidazole|secnidazole|mesh-list
138901888|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138901889|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138901890|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901891|NCT05021900|Tenalisib|tenalisib|mesh-list
138901892|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138901893|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901894|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901895|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
138901896|NCT05014646|Leflunomide|leflunomide|mesh-list
138901897|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901898|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901899|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138901900|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
138901901|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901902|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138901903|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138901904|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
138901905|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138901907|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138901908|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
138901909|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901910|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901911|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138901912|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138901913|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
138901914|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185412|NCT01723553|Corticosterone|corticosterone|mesh-list
138901915|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901916|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
138901918|NCT04942340|Atipamezole|atipamezole|mesh-list
138901919|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138901920|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138901921|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901922|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138901923|NCT04942340|Analgesics|analgesics|mesh-ancestor
138901924|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
138901925|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138509274|NCT04650581|Fulvestrant|fulvestrant|mesh-list
138901926|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138901927|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138262417|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901928|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138443383|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
138901930|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901931|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901932|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138901933|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138509572|NCT04169828|Antidotes|antidotes|mesh-ancestor
138901934|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901935|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138901936|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138901937|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
138901938|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138901939|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138901940|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138901941|NCT04905654|Cromakalim|cromakalim|mesh-list
138794368|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901942|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138901943|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138509852|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
138901945|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262481|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
138510004|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138901946|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901947|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138510315|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
138901948|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
138901949|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
138901950|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
138901951|NCT04857398|Insulin|insulin|mesh-list
138901952|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138901953|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901954|NCT04826432|Pasireotide|pasireotide|mesh-list
138901955|NCT04826432|Hormones|hormones|mesh-ancestor
138901956|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138901957|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901959|NCT04812548|Venetoclax|venetoclax|mesh-list
138901960|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138901961|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
138901962|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901963|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901964|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901965|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138901966|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138901967|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901968|NCT04698525|Valproic Acid|valproic acid|mesh-list
138901969|NCT04698525|Memantine|memantine|mesh-list
138901970|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138901971|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138901972|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
138901973|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901974|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901975|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901976|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138901977|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138901978|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
138901979|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901980|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
138901981|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
138901982|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138901983|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138901984|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138901985|NCT04667104|Tenofovir|tenofovir|mesh-list
138901986|NCT04667104|Entecavir|entecavir|mesh-list
138901987|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138901988|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
138901989|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901990|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138901991|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138901992|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443467|NCT01814514|Timolol|timolol|mesh-list
138901993|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901994|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138262589|NCT04147351|Bevacizumab|bevacizumab|mesh-list
138901995|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138901996|NCT04659369|Nivolumab|nivolumab|mesh-list
138901997|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794543|NCT02890355|Vitamins|vitamins|mesh-ancestor
138901998|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901999|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138902000|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902001|NCT04651439|Lenograstim|lenograstim|mesh-list
138902002|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138902003|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
138902004|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902005|NCT04635774|Insulin|insulin|mesh-list
138902006|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138902007|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902008|NCT04634799|Plasminogen|plasminogen|mesh-list
138902009|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
138902010|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
138902011|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138902012|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138902013|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262638|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
138262639|NCT02896907|Irinotecan|irinotecan|mesh-list
138262640|NCT02896907|Camptothecin|camptothecin|mesh-list
138554019|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138902014|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138902015|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
138902016|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902017|NCT04603365|Temozolomide|temozolomide|mesh-list
138902018|NCT04603365|Pamiparib|pamiparib|mesh-list
138902019|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138384412|NCT04199767|Insulin|insulin|mesh-list
138902020|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138902021|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
138330368|NCT04304274|Analgesics|analgesics|mesh-ancestor
138902022|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902023|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902024|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902025|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
138902026|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
138902027|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138902028|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138902029|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
138902030|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902033|NCT04560660|Analgesics|analgesics|mesh-ancestor
138902034|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
138902035|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902036|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902037|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138902038|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138902039|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
138902040|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
138262695|NCT04492358|Hormones|hormones|mesh-ancestor
138902041|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138902042|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138902043|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138902044|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138902045|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902046|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138902047|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138902048|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138902049|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138902050|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138902051|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
138902052|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
138902053|NCT04556526|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138902054|NCT04556526|Antiviral Agents|antiviral agents|mesh-ancestor
138902055|NCT04556526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902056|NCT04478617|Metronidazole|metronidazole|mesh-list
138902057|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902058|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138902059|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138262747|NCT02902913|Ibuprofen|ibuprofen|mesh-list
138902060|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138902061|NCT04424966|Infigratinib|infigratinib|mesh-list
138902062|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902064|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138902065|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902066|NCT04340258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138902067|NCT04340258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902068|NCT04301271|Simvastatin|simvastatin|mesh-list
138902069|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138902070|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138902071|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
138902072|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902073|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138902074|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138902075|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902076|NCT04228783|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138902077|NCT04228783|Antiviral Agents|antiviral agents|mesh-ancestor
138794754|NCT02311933|Tamoxifen|tamoxifen|mesh-list
138902078|NCT04228783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902079|NCT04188119|Aspirin|aspirin|mesh-list
138902080|NCT04188119|Avelumab|avelumab|mesh-list
138902081|NCT04188119|Lansoprazole|lansoprazole|mesh-list
138902082|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
138262796|NCT02815709|Analgesics|analgesics|mesh-ancestor
138262799|NCT02912195|Lidocaine|lidocaine|mesh-list
138902083|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138902084|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138902085|NCT04188119|Analgesics|analgesics|mesh-ancestor
138902086|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
138902087|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902088|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902089|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138554092|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
138902090|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138902091|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138902092|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138902093|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902094|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138902096|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902097|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
138902098|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138902099|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902100|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138902101|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138902102|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138262838|NCT01990898|Cyclosporine|cyclosporine|mesh-list
138902105|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
138902106|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138902107|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
138902108|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138902109|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
138902110|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902111|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902112|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
138902113|NCT04138394|Vitamins|vitamins|mesh-ancestor
138902114|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
138902115|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902116|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
138902117|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902118|NCT04138394|Protective Agents|protective agents|mesh-ancestor
138902119|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
138902120|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
138902121|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902122|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138902123|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902124|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902125|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138262938|NCT01967641|Naloxone|naloxone|mesh-list
138902126|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
138902127|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902129|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
138902130|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
138902131|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138902132|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902133|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
138902134|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902135|NCT03977363|Anticoagulants|anticoagulants|mesh-list
138902136|NCT03950674|Folic Acid|folic acid|mesh-list
138902137|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
138902138|NCT03950674|Dexamethasone|dexamethasone|mesh-list
138902139|NCT03950674|Carboplatin|carboplatin|mesh-list
138902140|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
138902141|NCT03950674|Pemetrexed|pemetrexed|mesh-list
138902142|NCT03950674|Vitamins|vitamins|mesh-ancestor
138902143|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
138902144|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902145|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138902146|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
138902147|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
138902148|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443667|NCT01816191|Diltiazem|diltiazem|mesh-list
138902149|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138902150|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
138902152|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138902153|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138902154|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902155|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138902156|NCT03950674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138902157|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902158|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902159|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138902160|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138902161|NCT03950674|Hematinics|hematinics|mesh-ancestor
138902162|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
138902163|NCT03911661|Warfarin|warfarin|mesh-list
138902164|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
138902165|NCT03909477|Xenon|xenon|mesh-list
138263006|NCT01965002|Enoxaparin|enoxaparin|mesh-list
138902166|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138902167|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
138554165|NCT00283543|Carmustine|carmustine|mesh-list
138902168|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
138902169|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138510458|NCT00062023|Analgesics|analgesics|mesh-ancestor
138902170|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902173|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902174|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138902175|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902176|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902178|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138902179|NCT03851159|Diuretics|diuretics|mesh-ancestor
138902180|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
138902181|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902182|NCT03711604|Tenalisib|tenalisib|mesh-list
138902183|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138902184|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902185|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902186|NCT03708627|Bimatoprost|bimatoprost|mesh-list
138902187|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138902188|NCT03702621|Bupivacaine|bupivacaine|mesh-list
138902189|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
138902190|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
138263053|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263054|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902191|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138902192|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902193|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
138902194|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902195|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138902196|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138902197|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902198|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
138902199|NCT03684876|Diuretics|diuretics|mesh-list
138902200|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
138902201|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902202|NCT03655665|Ofloxacin|ofloxacin|mesh-list
138902203|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138902204|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795084|NCT01844505|Nivolumab|nivolumab|mesh-list
138902206|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138902207|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138902208|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902209|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902210|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902211|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138795144|NCT01371981|Cytarabine|cytarabine|mesh-list
138902212|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138902213|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
138902214|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138902215|NCT03604627|Calcium|calcium|mesh-list
138263101|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138263109|NCT02916407|Sevoflurane|sevoflurane|mesh-list
138902216|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138902217|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902218|NCT03516656|Heparin|heparin|mesh-list
138902219|NCT03516656|Calcium heparin|calcium heparin|mesh-list
138902220|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
138902221|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138902222|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138902223|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902224|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
138443815|NCT01817257|Heparin|heparin|mesh-list
138902225|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138902226|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902227|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138902228|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902229|NCT03245008|Fasinumab|fasinumab|mesh-list
138902230|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138902231|NCT03245008|Analgesics|analgesics|mesh-ancestor
138263144|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
138263145|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138902232|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
138902233|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902234|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902235|NCT03203473|Nivolumab|nivolumab|mesh-list
138902236|NCT03203473|Ipilimumab|ipilimumab|mesh-list
138902237|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138902238|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902239|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138902240|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902241|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
138902242|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
138902244|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330593|NCT05766605|Antidotes|antidotes|mesh-ancestor
138902245|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902246|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
138902247|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138902248|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138443861|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138902249|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902250|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
138902251|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
138795287|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
138902252|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138902253|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138902254|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902255|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902256|NCT03142568|Urological Agents|urological agents|mesh-ancestor
138902257|NCT03115567|Triamcinolone|triamcinolone|mesh-list
138795323|NCT00980460|MTOR Inhibitors|mtor inhibitors|mesh-list
138902258|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138902259|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
138902260|NCT03115567|Hormones|hormones|mesh-ancestor
138902261|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138902262|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902263|NCT02982902|Immunomodulating Agents|immunomodulating agents|mesh-list
138902264|NCT02982902|Immunologic Factors|immunologic factors|mesh-ancestor
138902265|NCT02982902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902266|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
138902267|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138902268|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902269|NCT02971761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138902270|NCT02971761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902271|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
138902272|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138902273|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902274|NCT02964559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138902275|NCT02964559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902276|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138902277|NCT02893293|Hematinics|hematinics|mesh-ancestor
138902278|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138902279|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138902280|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138902281|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138902282|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
138902283|NCT02578680|Folic Acid|folic acid|mesh-list
138902284|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
138902285|NCT02578680|Dexamethasone|dexamethasone|mesh-list
138902286|NCT02578680|Carboplatin|carboplatin|mesh-list
138902287|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
138902288|NCT02578680|Pemetrexed|pemetrexed|mesh-list
138902289|NCT02578680|Vitamins|vitamins|mesh-ancestor
138902290|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
138902291|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902292|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138902293|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
138902294|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
138795458|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
138902295|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902296|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138902297|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
138902299|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138902300|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138902301|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902302|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138902303|NCT02578680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138902304|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902305|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902306|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138902307|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138902308|NCT02578680|Hematinics|hematinics|mesh-ancestor
138902309|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
138902310|NCT02385266|Cycloserine|cycloserine|mesh-list
138902311|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138902312|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902313|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138902314|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
138902315|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138902316|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
138902317|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902319|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902320|NCT02251431|Exenatide|exenatide|mesh-list
138902321|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138902322|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902323|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138902324|NCT02251431|Incretins|incretins|mesh-ancestor
138902325|NCT02251431|Hormones|hormones|mesh-ancestor
138902326|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138902327|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138902328|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138902329|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
138902330|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
138902331|NCT01494441|Calcium|calcium|mesh-list
138902332|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138902333|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902334|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138902335|NCT01367002|Paclitaxel|paclitaxel|mesh-list
138902336|NCT01367002|Carboplatin|carboplatin|mesh-list
138902337|NCT01367002|Trastuzumab|trastuzumab|mesh-list
138902338|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138902339|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902340|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
138902341|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
138902342|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
138902343|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902344|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138902345|NCT00858273|Insulin|insulin|mesh-list
138902346|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138902347|NCT00858273|Antioxidants|antioxidants|mesh-list
138902348|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138902349|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902350|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902351|NCT00858273|Protective Agents|protective agents|mesh-ancestor
138902352|NCT04158167|Oxytocin|oxytocin|mesh-list
138902353|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
138902354|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138902355|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902356|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138902357|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138263391|NCT02938949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263393|NCT02025439|Amantadine|amantadine|mesh-list
138902358|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138902359|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138902360|NCT02635607|Ganirelix|ganirelix|mesh-list
138902361|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
138902362|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138902363|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
138902364|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138902365|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902366|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138902367|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138902368|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902369|NCT02635607|Hormones|hormones|mesh-ancestor
138902370|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138902371|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
138902372|NCT00660257|Vaccines|vaccines|mesh-list
138902373|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
138902374|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902375|NCT00844428|Eculizumab|eculizumab|mesh-list
138902376|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138902377|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138902378|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
138902379|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902380|NCT00660335|Secretin|secretin|mesh-list
138902381|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138902382|NCT00660335|Hormones|hormones|mesh-ancestor
138902383|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138902384|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902386|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138902387|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
138902388|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
138902389|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902390|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
138902391|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138263448|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138902392|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
138902393|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902394|NCT00834834|Fluoxetine|fluoxetine|mesh-list
138902395|NCT00834834|Citalopram|citalopram|mesh-list
138902396|NCT00834834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138902397|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138902398|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138902399|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902400|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138902401|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
138902402|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902403|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138902404|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
138902405|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138902406|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138902407|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138902408|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902409|NCT00834366|Tramadol|tramadol|mesh-list
138902410|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138902411|NCT00834366|Narcotics|narcotics|mesh-ancestor
138902412|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138902413|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902414|NCT00834366|Analgesics|analgesics|mesh-ancestor
138902415|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
138902416|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902417|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
138902418|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138902419|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902420|NCT00660647|Adalimumab|adalimumab|mesh-list
138902421|NCT00660647|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138902422|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138902423|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138902424|NCT04156451|Furosemide|furosemide|mesh-list
138902425|NCT04156451|Diuretics|diuretics|mesh-ancestor
138902426|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
138902427|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902428|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138902429|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138902430|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902431|NCT00660725|Gemcitabine|gemcitabine|mesh-list
138902432|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
138902433|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138902434|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
138902435|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902436|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902437|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138902438|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138902439|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138902440|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138902441|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902442|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138902443|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902444|NCT00844194|Analgesics|analgesics|mesh-ancestor
138902445|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
138902446|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902447|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
138902448|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138902449|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
138902450|NCT00660803|Fulvestrant|fulvestrant|mesh-list
138902451|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138902452|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902453|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138902454|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138902455|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
138902456|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138902457|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902458|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138902459|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
138902460|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138902461|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138902462|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902463|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902464|NCT00661115|Urological Agents|urological agents|mesh-ancestor
138902466|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
138902467|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902468|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138263522|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138902469|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138902470|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902471|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902472|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138902473|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138902474|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
138902475|NCT00665717|Pravastatin|pravastatin|mesh-list
138902476|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138902477|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138902478|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
138902479|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902480|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138902481|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138902482|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902483|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902484|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138902485|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138902486|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
138902487|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138902488|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138902489|NCT02611596|Ranolazine|ranolazine|mesh-list
138902490|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138902491|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138902492|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902493|NCT00661349|Ritonavir|ritonavir|mesh-list
138902494|NCT00661349|Lopinavir|lopinavir|mesh-list
138902495|NCT00661349|Nevirapine|nevirapine|mesh-list
138902496|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138263554|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138902497|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138902498|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
138902500|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902501|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138902502|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138902503|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
138902504|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902505|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138902506|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138902507|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138902508|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138902509|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138902510|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138902511|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138902512|NCT00665873|Amoxicillin|amoxicillin|mesh-list
138902513|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
138902514|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
138902515|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138902516|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902517|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
138902518|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902519|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902520|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138902521|NCT00707850|Ribavirin|ribavirin|mesh-list
138902522|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138902523|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
138902524|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
138902525|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902526|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
138902527|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902528|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
138902529|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902530|NCT00665951|Ritonavir|ritonavir|mesh-list
138902531|NCT00665951|Lopinavir|lopinavir|mesh-list
138902532|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138902534|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
138902535|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902536|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902537|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138902538|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138902539|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
138902540|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902541|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138902542|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138902543|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138902544|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138902545|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
138902546|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902547|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902549|NCT00878969|Ramipril|ramipril|mesh-list
138902550|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138902551|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138902552|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138902553|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138902554|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902555|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
138902556|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902558|NCT00843492|Nadroparin|nadroparin|mesh-list
138263661|NCT01985581|Guanfacine|guanfacine|mesh-list
138902559|NCT00843492|Fondaparinux|fondaparinux|mesh-list
138902560|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138902561|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
138902562|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138902563|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
138902564|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796322|NCT05281562|Vitamins|vitamins|mesh-ancestor
138902565|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902566|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
138902567|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138902568|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138902569|NCT00666107|Vaccines|vaccines|mesh-list
138902570|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
138902571|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902572|NCT00666185|Fluconazole|fluconazole|mesh-list
138902573|NCT00666185|Micafungin|micafungin|mesh-list
138902574|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
138902575|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902576|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138902577|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138902578|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902579|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902580|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138902581|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
138902582|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138902583|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902584|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138902585|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138902587|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138902588|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138902589|NCT00913224|Analgesics|analgesics|mesh-ancestor
138263693|NCT03930745|TOL-463|tol-463|mesh-list
138902590|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
138902591|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902592|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902593|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138902594|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138902595|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138902596|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796572|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
138902597|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902598|NCT00666341|Immunomodulating Agents|immunomodulating agents|mesh-list
138902600|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902601|NCT00661973|Budesonide|budesonide|mesh-list
138902602|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138902603|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138902604|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
138902605|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902606|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902607|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138902608|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
138902609|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
138902610|NCT00661973|Hormones|hormones|mesh-ancestor
138902611|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138554619|NCT00111150|Tenofovir|tenofovir|mesh-list
138902612|NCT00666575|Gabapentin|gabapentin|mesh-list
138902613|NCT00666575|Analgesics|analgesics|mesh-ancestor
138902614|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
138902615|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902616|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902617|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
138902618|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138902619|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138902620|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138902621|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138902622|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138902623|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138902624|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138902625|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902626|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
138902627|NCT00666653|Pramipexole|pramipexole|mesh-list
138902628|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
138902629|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902630|NCT00666653|Protective Agents|protective agents|mesh-ancestor
138902631|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902632|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138796694|NCT03055507|Analgesics|analgesics|mesh-ancestor
138902634|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
138902635|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
138263786|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902636|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138902638|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
138902639|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138902640|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
138902641|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138902642|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138902643|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902644|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902645|NCT00666809|Urological Agents|urological agents|mesh-ancestor
138902646|NCT00666887|Minocycline|minocycline|mesh-list
138902647|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138902648|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902649|NCT02631473|Ritonavir|ritonavir|mesh-list
138902650|NCT02631473|Lopinavir|lopinavir|mesh-list
138902651|NCT02631473|Efavirenz|efavirenz|mesh-list
138902652|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138902653|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138902654|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
138902655|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902656|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902657|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138902658|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138902659|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
138902660|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902661|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138902662|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138902663|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138902664|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138444259|NCT01820442|Clonidine|clonidine|mesh-list
138902665|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138902666|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138902667|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138902668|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138902669|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138902670|NCT00825162|Vaccines|vaccines|mesh-list
138902671|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
138902672|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902673|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138902674|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
138902675|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138902676|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138902677|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902678|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902679|NCT00662441|Urological Agents|urological agents|mesh-ancestor
138902680|NCT00911573|Vancomycin|vancomycin|mesh-list
138902681|NCT00911573|Clindamycin|clindamycin|mesh-list
138902682|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
138902683|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
138554684|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
138902684|NCT00911573|Tigecycline|tigecycline|mesh-list
138902685|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138902686|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902687|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138902688|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902689|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902691|NCT00667433|Emtricitabine|emtricitabine|mesh-list
138902692|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
138902693|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138902694|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
138902695|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138263887|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902696|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138796994|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138902697|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138902698|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902699|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902700|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138902701|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138902702|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138902703|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138902704|NCT00662519|Lenograstim|lenograstim|mesh-list
138902705|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138902706|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
138902707|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902708|NCT00667901|Riluzole|riluzole|mesh-list
138902709|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
138902710|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138902711|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138902712|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138902713|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902714|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902715|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138902716|NCT00667901|Protective Agents|protective agents|mesh-ancestor
138902717|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138902718|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
138902719|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138902720|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138263930|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902721|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902722|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902723|NCT00667979|Urological Agents|urological agents|mesh-ancestor
138902724|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138902725|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
138902726|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138902727|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138902728|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902729|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902730|NCT00668057|Urological Agents|urological agents|mesh-ancestor
138902731|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138902732|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
138902733|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138902734|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138902735|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902736|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902737|NCT00668135|Urological Agents|urological agents|mesh-ancestor
138902739|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
138902740|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
138902741|NCT04155983|Ropivacaine|ropivacaine|mesh-list
138902742|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
138902743|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
138902744|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138902745|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902746|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
138902747|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902748|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138902749|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138902750|NCT00668603|Estradiol|estradiol|mesh-list
138902751|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138902752|NCT00668603|Estrogens|estrogens|mesh-ancestor
138902753|NCT00668603|Hormones|hormones|mesh-ancestor
138263976|NCT03028025|Hemostatics|hemostatics|mesh-list
138902754|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138902755|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902756|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138902757|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
138902758|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138902759|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138902761|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138902762|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902764|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138902765|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
138902766|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138902767|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138902768|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902769|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138902770|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138902771|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138902772|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902773|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138264025|NCT00374465|Verapamil|verapamil|mesh-list
138902774|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138902775|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138902776|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138902777|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138902778|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138902779|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138902780|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902781|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138902782|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138902783|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138902784|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
138902785|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138902786|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902787|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138902788|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138902789|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
138902790|NCT00663221|Vitamin D|vitamin d|mesh-list
138902791|NCT00663221|Calcium|calcium|mesh-list
138902792|NCT00663221|Vitamins|vitamins|mesh-ancestor
138902793|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
138902794|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902795|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138902796|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138902797|NCT00824850|Vaccines|vaccines|mesh-list
138902798|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138902799|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
138902800|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902801|NCT00596687|Insulin|insulin|mesh-list
138902802|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138902803|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
138902804|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
138902805|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138902806|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902807|NCT02631239|Dexamethasone|dexamethasone|mesh-list
138902808|NCT02631239|Methotrexate|methotrexate|mesh-list
138902809|NCT02631239|Etoposide|etoposide|mesh-list
138902810|NCT02631239|Pegaspargase|pegaspargase|mesh-list
138902811|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138902812|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
138902813|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
138902814|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902815|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902816|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138902818|NCT02631239|Hormones|hormones|mesh-ancestor
138902819|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138902820|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138797528|NCT01126580|Metformin|metformin|mesh-list
138902821|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902822|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138902823|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
138902824|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138902825|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138902826|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
138902827|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902828|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
138902829|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902830|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138554833|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902831|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138902832|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
138902834|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138902835|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138902836|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138902837|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138902839|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138902840|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138902841|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138902842|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138902843|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902844|NCT00669149|Aspirin|aspirin|mesh-list
138902845|NCT00669149|Heparin|heparin|mesh-list
138902846|NCT00669149|Enoxaparin|enoxaparin|mesh-list
138902847|NCT00669149|Bivalirudin|bivalirudin|mesh-list
138902848|NCT00669149|Clopidogrel|clopidogrel|mesh-list
138902849|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138902850|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138902851|NCT00669149|Analgesics|analgesics|mesh-ancestor
138902852|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
138902853|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902854|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902855|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138902856|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138902857|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138902858|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138902859|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902860|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138902861|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138902862|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902863|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
138902864|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138902865|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138902866|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138902867|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
138902868|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138902869|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
138902870|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
138902871|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138902872|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
138902873|NCT00663455|Cyclosporine|cyclosporine|mesh-list
138902874|NCT00663455|Cyclosporins|cyclosporins|mesh-list
138902875|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902876|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264161|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138902877|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138902878|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
138902879|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902880|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
138902881|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902882|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
138902883|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138902884|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138902885|NCT00669695|Atorvastatin|atorvastatin|mesh-list
138902886|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138902887|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138902888|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
138902889|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902890|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138902891|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138902892|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902893|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138902894|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902895|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138902896|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902897|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264196|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138902899|NCT00669773|Doxorubicin|doxorubicin|mesh-list
138797775|NCT02860494|Everolimus|everolimus|mesh-list
138902900|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138902901|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902902|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
138902903|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
138902904|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
138902905|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902906|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138902908|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138902909|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902910|NCT00824616|Insulin|insulin|mesh-list
138902911|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138797812|NCT04304807|Protective Agents|protective agents|mesh-ancestor
138902912|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902914|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
138902915|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138902916|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138902917|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902918|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902919|NCT00663845|Urological Agents|urological agents|mesh-ancestor
138902920|NCT00708240|Escitalopram|escitalopram|mesh-list
138902921|NCT00708240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138902922|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138902923|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138902924|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902925|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138902926|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
138902927|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902928|NCT04155515|Ribavirin|ribavirin|mesh-list
138902929|NCT04155515|Yimitasvir|yimitasvir|mesh-list
138902930|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
138902931|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902932|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
138902933|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902934|NCT00664001|Antioxidants|antioxidants|mesh-list
138902935|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264245|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902936|NCT00664001|Protective Agents|protective agents|mesh-ancestor
138902937|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902938|NCT00824382|Olodaterol|olodaterol|mesh-list
138902939|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138902940|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
138902941|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902942|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902943|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138902944|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
138902945|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138902946|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138902947|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
138902948|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138902949|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902950|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138902951|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138902952|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138902953|NCT00708318|Fentanyl|fentanyl|mesh-list
138902954|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138902955|NCT00708318|Narcotics|narcotics|mesh-ancestor
138797988|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902956|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138902957|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902958|NCT00708318|Analgesics|analgesics|mesh-ancestor
138902959|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
138902960|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902961|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138902962|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138902963|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
138902964|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
138902965|NCT00670475|Piroxicam|piroxicam|mesh-list
138902966|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138902967|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138902968|NCT00670475|Analgesics|analgesics|mesh-ancestor
138902969|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
138902970|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902971|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902972|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138902973|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138902974|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138902975|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902976|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902977|NCT04154033|Naltrexone|naltrexone|mesh-list
138902978|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138902979|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138902980|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138902981|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
138902982|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138902984|NCT05530356|Anticoagulants|anticoagulants|mesh-ancestor
138902985|NCT05530356|Plasma Substitutes|plasma substitutes|mesh-ancestor
138798114|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138902986|NCT05530356|Blood Substitutes|blood substitutes|mesh-ancestor
138902987|NCT00664313|Linezolid|linezolid|mesh-list
138902988|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138902989|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138902990|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138902991|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902992|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902993|NCT00670553|Panobinostat|panobinostat|mesh-list
138902994|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138902995|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138902996|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138902997|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138902999|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138903000|NCT00833040|Narcotics|narcotics|mesh-ancestor
138798175|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903001|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138903002|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903004|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
138903005|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903006|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138903007|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138798234|NCT00808639|Doxorubicin|doxorubicin|mesh-list
138903008|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
138903009|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
138903010|NCT02629835|Dexamethasone|dexamethasone|mesh-list
138903011|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
138903012|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138903013|NCT02629835|BB 1101|bb 1101|mesh-list
138264377|NCT02039947|Trametinib|trametinib|mesh-list
138903014|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138903015|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
138903016|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
138903017|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798302|NCT00907803|Tecovirimat|tecovirimat|mesh-list
138903019|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138903020|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
138903021|NCT02629835|Hormones|hormones|mesh-ancestor
138903022|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264431|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
138903023|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138903024|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903025|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
138903026|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903027|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903028|NCT00664469|Atorvastatin|atorvastatin|mesh-list
138903029|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138903030|NCT00664469|Simvastatin|simvastatin|mesh-list
138903031|NCT00664469|Ezetimibe|ezetimibe|mesh-list
138903032|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138903033|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138903034|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
138903035|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903036|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138903037|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138903038|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903039|NCT00843024|Naproxen|naproxen|mesh-list
138903040|NCT00843024|Sumatriptan|sumatriptan|mesh-list
138903041|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138903042|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138903043|NCT00843024|Analgesics|analgesics|mesh-ancestor
138903044|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
138903045|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903046|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903047|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138903048|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138903049|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
138903050|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138903051|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903052|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903053|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138903054|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138903055|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138903056|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
138903057|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903058|NCT04154813|Topiramate|topiramate|mesh-list
138903059|NCT04154813|Fluoxetine|fluoxetine|mesh-list
138903060|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
138903061|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138903062|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903063|NCT04154813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138903064|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138903065|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903066|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903067|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903068|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
138903069|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138903070|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
138903071|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138903072|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138903073|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138903074|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903075|NCT00664703|Methylphenidate|methylphenidate|mesh-list
138903077|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138903078|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903079|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138903080|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138903081|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903082|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903084|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903085|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138903086|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
138903087|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903088|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138903089|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138903090|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
138903091|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
138903092|NCT00670787|Losartan|losartan|mesh-list
138903093|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138903094|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138903095|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138903096|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138903097|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138903098|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903100|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
138903101|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903102|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138903103|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903104|NCT00664781|Rucaparib|rucaparib|mesh-list
138903105|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138903106|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903107|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903108|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903109|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
138903110|NCT00832650|Fesoterodine|fesoterodine|mesh-list
138903111|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138903112|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138903113|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
138903114|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903115|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903116|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903117|NCT00832650|Urological Agents|urological agents|mesh-ancestor
138903118|NCT00708396|Escitalopram|escitalopram|mesh-list
138798797|NCT00590317|Ondansetron|ondansetron|mesh-list
138903119|NCT00708396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138903120|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138903121|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903122|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903124|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
138903125|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555133|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
138903126|NCT00665093|Insulin|insulin|mesh-list
138903127|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138903128|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
138903129|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
138903130|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
138903131|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138903132|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138903133|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903134|NCT00595517|Esomeprazole|esomeprazole|mesh-list
138903135|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138903136|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138903137|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138903138|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903139|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903140|NCT00911651|Bromides|bromides|mesh-list
138903141|NCT00911651|Albuterol|albuterol|mesh-list
138903142|NCT00911651|Ipratropium|ipratropium|mesh-list
138903143|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
138903144|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138903145|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
138903146|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264623|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138264624|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
138903147|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903148|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138903149|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
138798986|NCT05751967|Fenofibrate|fenofibrate|mesh-list
138903151|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138903152|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138903153|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138903154|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138903155|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
138903156|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903157|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903158|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138903159|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
138903160|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
138903161|NCT00665327|Levofloxacin|levofloxacin|mesh-list
138903162|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138903163|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138903164|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903165|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138903166|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138903167|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903168|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903169|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903170|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138903171|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
138903172|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138903173|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264670|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138903174|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138445083|NCT01826149|Propofol|propofol|mesh-list
138903175|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138903176|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138903177|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138903178|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138903179|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138903181|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138903182|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138903183|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
138903184|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
138903185|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903186|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903187|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903188|NCT04154735|Rifaximin|rifaximin|mesh-list
138903189|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
138903190|NCT04154735|Fludarabine|fludarabine|mesh-list
138903191|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
138903192|NCT04154735|Tacrolimus|tacrolimus|mesh-list
138903193|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138903194|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
138903195|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903196|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138903197|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138903198|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
138903199|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903200|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264716|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
138903201|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138903202|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138903203|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903204|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138903205|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138903206|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903207|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138903209|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138903210|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138903211|NCT00705042|Analgesics|analgesics|mesh-ancestor
138903212|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
138903213|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903214|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903215|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138903216|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138903217|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138903218|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138903219|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
138903220|NCT00879437|Bevacizumab|bevacizumab|mesh-list
138903221|NCT00879437|Valproic Acid|valproic acid|mesh-list
138903222|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138903223|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903224|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138903225|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138903226|NCT00879437|Growth Substances|growth substances|mesh-ancestor
138799287|NCT02857686|Anesthetics|anesthetics|mesh-list
138903227|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903228|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
138903229|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
138903230|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903231|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903232|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
138903233|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903234|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
138903235|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138903236|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138903237|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138264766|NCT02068027|Clonidine|clonidine|mesh-list
138903238|NCT00665639|Caspofungin|caspofungin|mesh-list
138903239|NCT00665639|Micafungin|micafungin|mesh-list
138903240|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
138903241|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903242|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903243|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903244|NCT04153253|Aflibercept|aflibercept|mesh-list
138903245|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138903246|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138903247|NCT04153253|Growth Substances|growth substances|mesh-ancestor
138903248|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903249|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
138903250|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903251|NCT00671645|Bevacizumab|bevacizumab|mesh-list
138903252|NCT00671645|Capecitabine|capecitabine|mesh-list
138903254|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903255|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138903256|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138903257|NCT00671645|Growth Substances|growth substances|mesh-ancestor
138903258|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903259|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
138903260|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138903261|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
138903262|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903263|NCT02629523|Afatinib|afatinib|mesh-list
138903264|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903265|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138903266|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445223|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
138903267|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903270|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138903271|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138903272|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903273|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903274|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903275|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
138903276|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903278|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138903279|NCT00671801|Growth Substances|growth substances|mesh-ancestor
138903280|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
138264801|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
138903281|NCT00676559|Ranibizumab|ranibizumab|mesh-list
138903282|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138903283|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138903284|NCT00676559|Growth Substances|growth substances|mesh-ancestor
138903285|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903286|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
138903287|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903289|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138903290|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903291|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903292|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138903293|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903294|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
138903295|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
138903296|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138903297|NCT00676637|Timolol|timolol|mesh-list
138903298|NCT00676637|Travoprost|travoprost|mesh-list
138903299|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138903300|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138903301|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138799588|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
138903303|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
138903304|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903305|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903306|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903307|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138903308|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138903309|NCT00672347|Clonidine|clonidine|mesh-list
138903310|NCT00672347|Morphine|morphine|mesh-list
138903311|NCT00672347|Bupivacaine|bupivacaine|mesh-list
138903312|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
138903313|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
138903314|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138903315|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903316|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
138903317|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903318|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138903319|NCT00672347|Narcotics|narcotics|mesh-ancestor
138903320|NCT00672347|Analgesics|analgesics|mesh-ancestor
138903321|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138903322|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
138903323|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
138903324|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138903325|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138903326|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138903327|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
138903328|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264838|NCT02393378|Vitamins|vitamins|mesh-ancestor
138903329|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903330|NCT00676871|Blinatumomab|blinatumomab|mesh-list
138903331|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903332|NCT00677027|Lentinan|lentinan|mesh-list
138903333|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138903334|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
138638343|NCT01683682|Carboplatin|carboplatin|mesh-list
138903335|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903336|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903337|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
138903338|NCT00595127|Fludarabine|fludarabine|mesh-list
138903339|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138903340|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
138799838|NCT00903357|Vitamins|vitamins|mesh-ancestor
138903341|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903342|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138903343|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138903344|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
138903345|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903346|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903347|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138903348|NCT00672659|Dexetimide|dexetimide|mesh-list
138903349|NCT00672659|Pipamperone|pipamperone|mesh-list
138903350|NCT00672659|Citalopram|citalopram|mesh-list
138903351|NCT00672659|Escitalopram|escitalopram|mesh-list
138903352|NCT00672659|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138264886|NCT02069041|Vitamins|vitamins|mesh-ancestor
138903353|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138903354|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903355|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903356|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903357|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
138903358|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903359|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138903360|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
138903361|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138903362|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138903363|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138903364|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
138903365|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
138903366|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903367|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138903368|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138903369|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
138903370|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138903371|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138903372|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138903373|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138903374|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138903375|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138903376|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264915|NCT00355862|Temsirolimus|temsirolimus|mesh-list
138903377|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138903378|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138903379|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903380|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903381|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
138903382|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903383|NCT00677261|Anesthetics|anesthetics|mesh-list
138903384|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
138903385|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138903386|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903387|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
138903388|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903389|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
138903390|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138903391|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138903392|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903393|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
138903394|NCT00912119|Coagulants|coagulants|mesh-ancestor
138903395|NCT00677339|Vitamin D|vitamin d|mesh-list
138903396|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
138903397|NCT00677339|Cholecalciferol|cholecalciferol|mesh-list
138903398|NCT00677339|Vitamins|vitamins|mesh-list
138903399|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
138903400|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903401|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138903402|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138903404|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903405|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903406|NCT00673205|Bicalutamide|bicalutamide|mesh-list
138903407|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
138903408|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
138903409|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264968|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138264969|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
138264970|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
138264971|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
138264972|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138264973|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
138264974|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
138264975|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264976|NCT02049385|Diazoxide|diazoxide|mesh-list
138264977|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138903410|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903411|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903412|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138903414|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138903415|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
138903416|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903417|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903418|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138800187|NCT02848209|Phenol|phenol|mesh-list
138903419|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
138903421|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138903422|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138903423|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138903424|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138903425|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
138903426|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903427|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903428|NCT02628197|Vitamin D|vitamin d|mesh-list
138903429|NCT02628197|Calcium|calcium|mesh-list
138903430|NCT02628197|Vitamins|vitamins|mesh-ancestor
138903431|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
138903432|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903433|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138903434|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138903435|NCT00673829|Interleukin-2|interleukin-2|mesh-list
138903436|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903437|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138903438|NCT00673829|Analgesics|analgesics|mesh-ancestor
138903439|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
138903440|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903441|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903442|NCT04152629|Methylphenidate|methylphenidate|mesh-list
138903443|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138903444|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138903445|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800265|NCT02690883|Exenatide|exenatide|mesh-list
138903446|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138903447|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138903448|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903449|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903450|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
138903451|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903453|NCT02535299|Liraglutide|liraglutide|mesh-list
138903454|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138903455|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903456|NCT02535299|Incretins|incretins|mesh-ancestor
138903457|NCT02535299|Hormones|hormones|mesh-ancestor
138903458|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138903459|NCT00674063|Alefacept|alefacept|mesh-list
138903460|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
138903461|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
138903462|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903463|NCT04151459|Metformin|metformin|mesh-list
138903464|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138903465|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903466|NCT00674141|Dexamethasone|dexamethasone|mesh-list
138903467|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138903468|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
138903469|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
138903470|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903471|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903472|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138903473|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
138903474|NCT00674141|Hormones|hormones|mesh-ancestor
138903475|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138903476|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138903477|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903478|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138903479|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
138903480|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903481|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138903483|NCT02627807|Gemcitabine|gemcitabine|mesh-list
138903484|NCT02627807|Docetaxel|docetaxel|mesh-list
138903485|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903486|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138903487|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
138903488|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903489|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
138903490|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
138903491|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
138903492|NCT00678431|Resveratrol|resveratrol|mesh-list
138903493|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
138903494|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903495|NCT00678431|Protective Agents|protective agents|mesh-ancestor
138903496|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903497|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903498|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138903499|NCT00678509|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138903500|NCT00678509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138903501|NCT00678509|Immunologic Factors|immunologic factors|mesh-ancestor
138903502|NCT00678509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903504|NCT00674687|Analgesics|analgesics|mesh-ancestor
138903505|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
138903506|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903507|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903508|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
138903509|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138903510|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138903511|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138903512|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138903513|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138903514|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138903515|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903516|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903517|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
138903518|NCT00656747|Amoxicillin|amoxicillin|mesh-list
138903519|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
138903520|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
138903521|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
138903522|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138903523|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138903524|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138903525|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903526|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138903527|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138903528|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903529|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903530|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903531|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138903532|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
138903533|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138903534|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903535|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138903536|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138903537|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138903538|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138903539|NCT00678743|Simvastatin|simvastatin|mesh-list
138903540|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138903541|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138903542|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
138903543|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903544|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138903545|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138903546|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903547|NCT04152317|Misoprostol|misoprostol|mesh-list
138903548|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138903549|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
138903550|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138903551|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903552|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138903553|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138903554|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
138903555|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138903556|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
138903557|NCT02628665|Trioxsalen|trioxsalen|mesh-list
138903559|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903560|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
138903561|NCT00678977|Gemcitabine|gemcitabine|mesh-list
138903562|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903563|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138903564|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
138903565|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331952|NCT04355520|Fulvestrant|fulvestrant|mesh-list
138903566|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138903567|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138903568|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903569|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138903570|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
138903571|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138903572|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138903573|NCT00674999|Bacitracin|bacitracin|mesh-list
138903574|NCT00674999|Nystatin|nystatin|mesh-list
138903575|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138903576|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903577|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138903578|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
138903579|NCT00674999|Ionophores|ionophores|mesh-ancestor
138903580|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903581|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903582|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
138903583|NCT00882713|Hematinics|hematinics|mesh-ancestor
138800901|NCT00684268|Silybin|silybin|mesh-list
138903585|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138903586|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
138903587|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903588|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903589|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138903590|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
138903591|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138903592|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138903593|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903594|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903595|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138903596|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138903597|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
138903598|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903599|NCT04151381|Protective Agents|protective agents|mesh-ancestor
138903601|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138903602|NCT00809133|Bevacizumab|bevacizumab|mesh-list
138903603|NCT00809133|Carboplatin|carboplatin|mesh-list
138903604|NCT00809133|Afatinib|afatinib|mesh-list
138903605|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138903606|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903607|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
138903608|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
138903609|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
138903610|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903611|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138903612|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138903613|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138903614|NCT00809133|Growth Substances|growth substances|mesh-ancestor
138903615|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800999|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
138903616|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
138903617|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138903618|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903619|NCT00912275|Vinorelbine|vinorelbine|mesh-list
138903620|NCT00912275|Lapatinib|lapatinib|mesh-list
138903621|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138903622|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903623|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
138903624|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
138903625|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
138903626|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903627|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138903628|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903629|NCT00882557|Daptomycin|daptomycin|mesh-list
138903630|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138903631|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903633|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
138903634|NCT02627573|Busulfan|busulfan|mesh-list
138903635|NCT02627573|Fludarabine|fludarabine|mesh-list
138903636|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
138903637|NCT02627573|Tacrolimus|tacrolimus|mesh-list
138903638|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
138903639|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138903640|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
138903641|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903642|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138903643|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138903644|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
138903645|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903646|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903647|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138903648|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138903649|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
138903650|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138903651|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903652|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138903653|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138903654|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
138903655|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138903656|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903658|NCT00675545|Docetaxel|docetaxel|mesh-list
138903659|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903660|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
138903661|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
138903663|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903664|NCT00679523|Tavaborole|tavaborole|mesh-list
138903665|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138903666|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
138903667|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903668|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
138903669|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138903670|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903671|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138903672|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138903673|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903674|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903675|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903676|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
138903677|NCT00808899|Doxorubicin|doxorubicin|mesh-list
138903678|NCT00808899|Irinotecan|irinotecan|mesh-list
138903679|NCT00808899|Etoposide|etoposide|mesh-list
138903680|NCT00808899|Topotecan|topotecan|mesh-list
138903681|NCT00808899|Tretinoin|tretinoin|mesh-list
138903682|NCT00808899|Temsirolimus|temsirolimus|mesh-list
138903683|NCT00808899|Isotretinoin|isotretinoin|mesh-list
138903684|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138903686|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903687|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138903688|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138903689|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
138903690|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903691|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903692|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138903693|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138903694|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138903695|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138903696|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903697|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138903698|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138903699|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
138903700|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
138265208|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138903701|NCT00808899|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138903702|NCT00808899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138903703|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
138903704|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138903705|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138903706|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903707|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138903708|NCT00808665|Analgesics|analgesics|mesh-ancestor
138903709|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
138903710|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903711|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138903712|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138903713|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138903714|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
138903715|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903716|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903718|NCT00808509|Methotrexate|methotrexate|mesh-list
138903719|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138903720|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
138903721|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138903722|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903723|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138903725|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903726|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903727|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
138903728|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903729|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138903730|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138903731|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
138903732|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138903733|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138903734|NCT00808509|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138903735|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138903736|NCT00807573|Paclitaxel|paclitaxel|mesh-list
138903737|NCT00807573|Bevacizumab|bevacizumab|mesh-list
138903738|NCT00807573|Pemetrexed|pemetrexed|mesh-list
138903739|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138903740|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903741|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
138265255|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
138903742|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
138903743|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
138903744|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903745|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138903746|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138903747|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138903748|NCT00807573|Growth Substances|growth substances|mesh-ancestor
138903749|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903750|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
138903751|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903752|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138903753|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138903754|NCT00842712|Cisplatin|cisplatin|mesh-list
138801394|NCT04137640|Docetaxel|docetaxel|mesh-list
138903755|NCT00842712|Gemcitabine|gemcitabine|mesh-list
138903756|NCT00842712|Cetuximab|cetuximab|mesh-list
138903757|NCT00842712|Vinorelbine|vinorelbine|mesh-list
138903758|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903759|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138903760|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
138903761|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903762|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138903763|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138903764|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
138903765|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
138903766|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
138903767|NCT00705120|Cyclosporine|cyclosporine|mesh-list
138903768|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
138903769|NCT00705120|Busulfan|busulfan|mesh-list
138903770|NCT00705120|Cyclosporins|cyclosporins|mesh-list
138903771|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138903772|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
138903773|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903774|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138903776|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
138903777|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903778|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903779|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138903780|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903781|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
138903782|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903783|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
138265283|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903784|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138903785|NCT00842244|Capecitabine|capecitabine|mesh-list
138903786|NCT00842244|Axitinib|axitinib|mesh-list
138903787|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903788|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138903789|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
138903790|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903791|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138903792|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903793|NCT00832416|Tramadol|tramadol|mesh-list
138903794|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138903795|NCT00832416|Narcotics|narcotics|mesh-ancestor
138903796|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138903797|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903798|NCT00832416|Analgesics|analgesics|mesh-ancestor
138903799|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
138903800|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903801|NCT00705198|Temozolomide|temozolomide|mesh-list
138903802|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138903803|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
138903804|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903805|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903807|NCT00702936|Ramipril|ramipril|mesh-list
138903808|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138903809|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138903810|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138903811|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903812|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138903813|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
138179015|NCT05741021|Paclitaxel|paclitaxel|mesh-list
138903814|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903815|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138903816|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138903817|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138903818|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903819|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903820|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903821|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903822|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
138903823|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138903824|NCT00683644|Zinc|zinc|mesh-list
138903825|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
138903826|NCT00683644|Trace Elements|trace elements|mesh-ancestor
138903827|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
138903828|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903829|NCT00683644|Astringents|astringents|mesh-ancestor
138903830|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
138903831|NCT00753064|Prazosin|prazosin|mesh-list
138903832|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138903833|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138903834|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138903835|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138903836|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
138903837|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903838|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903839|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903840|NCT00751738|Azimilide|azimilide|mesh-list
138903841|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138903842|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138903843|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903844|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903845|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138265362|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
138903846|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903847|NCT04060264|Eculizumab|eculizumab|mesh-list
138903848|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138903849|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138903850|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
138903851|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903852|NCT00684814|Zolpidem|zolpidem|mesh-list
138903853|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138903854|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138903855|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138903856|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903857|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138903859|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
138903860|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903861|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903862|NCT00576472|Methylphenidate|methylphenidate|mesh-list
138903863|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138903864|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903865|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138903866|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138903867|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903868|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903869|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
138903870|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903871|NCT00823212|Aspirin|aspirin|mesh-list
138903872|NCT00823212|Ticlopidine|ticlopidine|mesh-list
138903873|NCT00823212|Clopidogrel|clopidogrel|mesh-list
138903874|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138903875|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138903877|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
138903878|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903879|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903880|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138903881|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138903882|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138903883|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138903884|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903885|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138903886|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138903887|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903888|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
138903889|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138903890|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138903891|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138903892|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
138903893|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138903894|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138903895|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138903896|NCT02561494|Nefopam|nefopam|mesh-list
138903897|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138903898|NCT02561494|Analgesics|analgesics|mesh-ancestor
138903899|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
138903900|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903901|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903902|NCT05958693|Lumefantrine|lumefantrine|mesh-list
138903903|NCT05958693|Artemether|artemether|mesh-list
138903904|NCT05958693|Primaquine|primaquine|mesh-list
138903905|NCT05958693|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138903906|NCT05958693|Antimalarials|antimalarials|mesh-ancestor
138903907|NCT05958693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138903908|NCT05958693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138903909|NCT05958693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903910|NCT05958589|Levobupivacaine|levobupivacaine|mesh-list
138903911|NCT05958589|Anesthetics|anesthetics|mesh-ancestor
138903912|NCT05958589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445586|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138903913|NCT05958589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903914|NCT05958589|Anesthetics, Local|anesthetics, local|mesh-ancestor
138903915|NCT05958589|Sensory System Agents|sensory system agents|mesh-ancestor
138903916|NCT05958589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903917|NCT05958277|Vitamins|vitamins|mesh-list
138903918|NCT05958277|Vitamin B 12|vitamin b 12|mesh-list
138903919|NCT05958277|Niacinamide|niacinamide|mesh-list
138903920|NCT05958277|Vitamin B Complex|vitamin b complex|mesh-list
138903921|NCT05958277|Micronutrients|micronutrients|mesh-ancestor
138903922|NCT05958277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903923|NCT05958173|Capsaicin|capsaicin|mesh-list
138903924|NCT05958173|Piperine|piperine|mesh-list
138903925|NCT05958173|Antipruritics|antipruritics|mesh-ancestor
138903926|NCT05958173|Dermatologic Agents|dermatologic agents|mesh-ancestor
138903927|NCT05958173|Sensory System Agents|sensory system agents|mesh-ancestor
138903928|NCT05958173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903929|NCT05958173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903930|NCT05958173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138903932|NCT05958173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903933|NCT05958160|Topiramate|topiramate|mesh-list
138903934|NCT05958160|Anticonvulsants|anticonvulsants|mesh-ancestor
138903935|NCT05958160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138265435|NCT05992987|Purinergic Agonists|purinergic agonists|mesh-ancestor
138903936|NCT05958160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903937|NCT05958069|Minocycline|minocycline|mesh-list
138903938|NCT05958069|Anticonvulsants|anticonvulsants|mesh-list
138903939|NCT05958069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138332328|NCT04335786|Valsartan|valsartan|mesh-list
138903941|NCT05957991|Metformin|metformin|mesh-list
138903942|NCT05957991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138903943|NCT05957991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903944|NCT05957913|Tenofovir|tenofovir|mesh-list
138903945|NCT05957913|Emtricitabine|emtricitabine|mesh-list
138903946|NCT05957913|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138903947|NCT05957913|Antiviral Agents|antiviral agents|mesh-ancestor
138903948|NCT05957913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903949|NCT05957913|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138903950|NCT05957913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138903952|NCT05957913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903953|NCT05957913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138903954|NCT05957913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138903955|NCT05957887|Dapagliflozin|dapagliflozin|mesh-list
138903956|NCT05957887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138903957|NCT05957887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903958|NCT05957887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138903959|NCT05957887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903960|NCT05957666|Misoprostol|misoprostol|mesh-list
138903961|NCT05957666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138903962|NCT05957666|Abortifacient Agents|abortifacient agents|mesh-ancestor
138903963|NCT05957666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138903964|NCT05957666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903965|NCT05957666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138903966|NCT05957666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138903967|NCT05957666|Oxytocics|oxytocics|mesh-ancestor
138903968|NCT05957653|Lidocaine|lidocaine|mesh-list
138903969|NCT05957653|Sufentanil|sufentanil|mesh-list
138903970|NCT05957653|Anesthetics, Local|anesthetics, local|mesh-ancestor
138903971|NCT05957653|Anesthetics|anesthetics|mesh-ancestor
138903972|NCT05957653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138801792|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138903973|NCT05957653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138903974|NCT05957653|Sensory System Agents|sensory system agents|mesh-ancestor
138903975|NCT05957653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138903976|NCT05957653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138903977|NCT05957653|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138903978|NCT05957653|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138903979|NCT05957653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138903980|NCT05957653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903981|NCT05957653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138903982|NCT05957653|Narcotics|narcotics|mesh-ancestor
138903983|NCT05957653|Analgesics|analgesics|mesh-ancestor
138903984|NCT05957653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138903985|NCT05957653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138903986|NCT05957653|Anesthetics, General|anesthetics, general|mesh-ancestor
138903987|NCT05957510|Carboplatin|carboplatin|mesh-list
138903988|NCT05957510|Etoposide|etoposide|mesh-list
138903989|NCT05957510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138903990|NCT05957510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138903991|NCT05957510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138903992|NCT05957510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138903993|NCT05957510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138903994|NCT05957510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138903995|NCT05957432|Amoxicillin|amoxicillin|mesh-list
138903996|NCT05957432|Clarithromycin|clarithromycin|mesh-list
138903997|NCT05957432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138903998|NCT05957432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138903999|NCT05957432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138904000|NCT05957432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904001|NCT05957432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904002|NCT05957432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138904003|NCT05957432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138904004|NCT05957328|Ascorbic Acid|ascorbic acid|mesh-list
138904005|NCT05957328|Antioxidants|antioxidants|mesh-ancestor
138904006|NCT05957328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904007|NCT05957328|Protective Agents|protective agents|mesh-ancestor
138904008|NCT05957328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904009|NCT05957328|Vitamins|vitamins|mesh-ancestor
138904010|NCT05957328|Micronutrients|micronutrients|mesh-ancestor
138904011|NCT05957302|Fentanyl|fentanyl|mesh-list
138904012|NCT05957302|Ketamine|ketamine|mesh-list
138904013|NCT05957302|Analgesics|analgesics|mesh-ancestor
138904014|NCT05957302|Sensory System Agents|sensory system agents|mesh-ancestor
138904016|NCT05957302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904017|NCT05957302|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138904018|NCT05957302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138904019|NCT05957302|Anesthetics, General|anesthetics, general|mesh-ancestor
138904020|NCT05957302|Anesthetics|anesthetics|mesh-ancestor
138904021|NCT05957302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138904022|NCT05957302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138904023|NCT05957302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138904024|NCT05957302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904025|NCT05957302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904026|NCT05957302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138904027|NCT05957302|Narcotics|narcotics|mesh-ancestor
138904028|NCT05957302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138904029|NCT05957250|FAPI-46|fapi-46|mesh-list
138801940|NCT02622334|Latanoprost|latanoprost|mesh-list
138904030|NCT05957250|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138904031|NCT05957250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904033|NCT05957094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138904034|NCT05957094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138904035|NCT05957094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138904036|NCT05957094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904037|NCT05957094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904038|NCT05957094|Serotonin Agents|serotonin agents|mesh-ancestor
138904039|NCT05957094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904040|NCT05957094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138904041|NCT05957094|Antidepressive Agents|antidepressive agents|mesh-ancestor
138904042|NCT05957094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138904043|NCT05956899|Ondansetron|ondansetron|mesh-list
138904044|NCT05956899|Palonosetron|palonosetron|mesh-list
138904045|NCT05956899|Antiemetics|antiemetics|mesh-ancestor
138904046|NCT05956899|Autonomic Agents|autonomic agents|mesh-ancestor
138904047|NCT05956899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904048|NCT05956899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904049|NCT05956899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138904050|NCT05956899|Antipruritics|antipruritics|mesh-ancestor
138904051|NCT05956899|Dermatologic Agents|dermatologic agents|mesh-ancestor
138904052|NCT05956899|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138904053|NCT05956899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138904054|NCT05956899|Serotonin Agents|serotonin agents|mesh-ancestor
138904055|NCT05956899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904056|NCT05956899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904057|NCT05951712|Acetylcysteine|acetylcysteine|mesh-list
138904058|NCT05951712|Simethicone|simethicone|mesh-list
138904059|NCT05951712|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138904060|NCT05951712|Antiviral Agents|antiviral agents|mesh-ancestor
138904061|NCT05951712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904062|NCT05951712|Expectorants|expectorants|mesh-ancestor
138904063|NCT05951712|Respiratory System Agents|respiratory system agents|mesh-ancestor
138904064|NCT05951712|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138904065|NCT05951712|Antioxidants|antioxidants|mesh-ancestor
138904066|NCT05951712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904067|NCT05951712|Protective Agents|protective agents|mesh-ancestor
138904068|NCT05951712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904069|NCT05951712|Antidotes|antidotes|mesh-ancestor
138904070|NCT05951712|Antifoaming Agents|antifoaming agents|mesh-ancestor
138904071|NCT05951712|Emollients|emollients|mesh-ancestor
138904072|NCT05951712|Dermatologic Agents|dermatologic agents|mesh-ancestor
138904073|NCT05951595|Artesunate|artesunate|mesh-list
138904074|NCT05951595|Lumefantrine|lumefantrine|mesh-list
138904075|NCT05951595|Artemether|artemether|mesh-list
138904076|NCT05951595|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138904077|NCT05951595|Amodiaquine|amodiaquine|mesh-list
138904078|NCT05951595|Antimalarials|antimalarials|mesh-ancestor
138904079|NCT05951595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138904080|NCT05951595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138265525|NCT05988684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138265528|NCT05988177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138904081|NCT05951595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904082|NCT05951595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904083|NCT05951595|Antiviral Agents|antiviral agents|mesh-ancestor
138904084|NCT05951595|Schistosomicides|schistosomicides|mesh-ancestor
138904085|NCT05951595|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138904086|NCT05951595|Anthelmintics|anthelmintics|mesh-ancestor
138904087|NCT05929157|Artesunate|artesunate|mesh-list
138904088|NCT05929157|Pyronaridine|pyronaridine|mesh-list
138904089|NCT05929157|Antimalarials|antimalarials|mesh-ancestor
138904090|NCT05929157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138802054|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
138904091|NCT05929157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138904092|NCT05929157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904093|NCT05929157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904094|NCT05929157|Antiviral Agents|antiviral agents|mesh-ancestor
138904095|NCT05929157|Schistosomicides|schistosomicides|mesh-ancestor
138904096|NCT05929157|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138904097|NCT05929157|Anthelmintics|anthelmintics|mesh-ancestor
138556113|NCT04718038|Cetuximab|cetuximab|mesh-list
138904098|NCT05861167|Ustekinumab|ustekinumab|mesh-list
138904099|NCT05861167|Dermatologic Agents|dermatologic agents|mesh-ancestor
138904100|NCT05828459|Paclitaxel|paclitaxel|mesh-list
138904101|NCT05828459|Bevacizumab|bevacizumab|mesh-list
138904102|NCT05828459|Lenalidomide|lenalidomide|mesh-list
138904103|NCT05828459|Pomalidomide|pomalidomide|mesh-list
138904104|NCT05828459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138904105|NCT05828459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904106|NCT05828459|Tubulin Modulators|tubulin modulators|mesh-ancestor
138904107|NCT05828459|Antimitotic Agents|antimitotic agents|mesh-ancestor
138904108|NCT05828459|Mitosis Modulators|mitosis modulators|mesh-ancestor
138265552|NCT05987696|Cyclophosphamide|cyclophosphamide|mesh-list
138904109|NCT05828459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904110|NCT05828459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904111|NCT05828459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138904112|NCT05828459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138904113|NCT05828459|Growth Substances|growth substances|mesh-ancestor
138904114|NCT05828459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904115|NCT05828459|Growth Inhibitors|growth inhibitors|mesh-ancestor
138904116|NCT05828459|Immunologic Factors|immunologic factors|mesh-ancestor
138904117|NCT05809895|Paclitaxel|paclitaxel|mesh-list
138904118|NCT05809895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138904119|NCT05809895|Carboplatin|carboplatin|mesh-list
138904120|NCT05809895|Gemcitabine|gemcitabine|mesh-list
138904121|NCT05809895|Pembrolizumab|pembrolizumab|mesh-list
138904122|NCT05809895|Tislelizumab|tislelizumab|mesh-list
138904123|NCT05809895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138904124|NCT05809895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904125|NCT05809895|Tubulin Modulators|tubulin modulators|mesh-ancestor
138904126|NCT05809895|Antimitotic Agents|antimitotic agents|mesh-ancestor
138904127|NCT05809895|Mitosis Modulators|mitosis modulators|mesh-ancestor
138904128|NCT05809895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904129|NCT05809895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138904130|NCT05809895|Antimetabolites|antimetabolites|mesh-ancestor
138904131|NCT05809895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904132|NCT05809895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138904133|NCT05791097|Paclitaxel|paclitaxel|mesh-list
138904134|NCT05791097|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138904135|NCT05791097|Carboplatin|carboplatin|mesh-list
138904136|NCT05791097|Pembrolizumab|pembrolizumab|mesh-list
138904137|NCT05791097|Pemetrexed|pemetrexed|mesh-list
138904138|NCT05791097|Tislelizumab|tislelizumab|mesh-list
138904139|NCT05791097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138904140|NCT05791097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904141|NCT05791097|Tubulin Modulators|tubulin modulators|mesh-ancestor
138904142|NCT05791097|Antimitotic Agents|antimitotic agents|mesh-ancestor
138904143|NCT05791097|Mitosis Modulators|mitosis modulators|mesh-ancestor
138904144|NCT05791097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802115|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138904145|NCT05791097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904147|NCT05791097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904148|NCT05791097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138904149|NCT05791097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138904150|NCT05664659|Misoprostol|misoprostol|mesh-list
138904151|NCT05664659|Oxytocin|oxytocin|mesh-list
138904152|NCT05664659|Carbetocin|carbetocin|mesh-list
138904153|NCT05664659|Oxytocics|oxytocics|mesh-ancestor
138904154|NCT05664659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138904155|NCT05664659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904156|NCT05664659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138904157|NCT05664659|Abortifacient Agents|abortifacient agents|mesh-ancestor
138904158|NCT05664659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138904159|NCT05664659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138904160|NCT05627479|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138904161|NCT05626478|Dexamethasone|dexamethasone|mesh-list
138904162|NCT05626478|Prednisolone|prednisolone|mesh-list
138904163|NCT05626478|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138904164|NCT05626478|Methylprednisolone|methylprednisolone|mesh-list
138904165|NCT05626478|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138904166|NCT05626478|Prednisolone acetate|prednisolone acetate|mesh-list
138904167|NCT05626478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138904168|NCT05626478|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138904169|NCT05626478|Prednisolone phosphate|prednisolone phosphate|mesh-list
138904170|NCT05626478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138904171|NCT05626478|Antiemetics|antiemetics|mesh-ancestor
138904172|NCT05626478|Autonomic Agents|autonomic agents|mesh-ancestor
138904173|NCT05626478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904174|NCT05626478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904175|NCT05626478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138904176|NCT05626478|Glucocorticoids|glucocorticoids|mesh-ancestor
138904178|NCT05626478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138556186|NCT00080327|Aripiprazole|aripiprazole|mesh-list
138904179|NCT05626478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138904180|NCT05626478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904181|NCT05626478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138265642|NCT05986071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138265643|NCT05986071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265644|NCT05986071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138265645|NCT05986071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138265646|NCT05986071|Hormone Antagonists|hormone antagonists|mesh-ancestor
138265647|NCT05986071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138265649|NCT05985798|Chlorotrianisene|chlorotrianisene|mesh-list
138904182|NCT05626478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138904183|NCT05626478|Protective Agents|protective agents|mesh-ancestor
138904184|NCT05600309|Pembrolizumab|pembrolizumab|mesh-list
138904185|NCT05600309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904186|NCT05600309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904187|NCT05600309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138904188|NCT05600309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904189|NCT05481645|Paclitaxel|paclitaxel|mesh-list
138904190|NCT05481645|Docetaxel|docetaxel|mesh-list
138904191|NCT05481645|Carboplatin|carboplatin|mesh-list
138904192|NCT05481645|Gemcitabine|gemcitabine|mesh-list
138904193|NCT05481645|Doxorubicin|doxorubicin|mesh-list
138904195|NCT05481645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138904196|NCT05481645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904197|NCT05481645|Tubulin Modulators|tubulin modulators|mesh-ancestor
138904198|NCT05481645|Antimitotic Agents|antimitotic agents|mesh-ancestor
138904199|NCT05481645|Mitosis Modulators|mitosis modulators|mesh-ancestor
138904200|NCT05481645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904201|NCT05481645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138904202|NCT05481645|Antimetabolites|antimetabolites|mesh-ancestor
138904203|NCT05481645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138904204|NCT05481645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138904205|NCT05481645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138904206|NCT05481645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904207|NCT05397652|Tranexamic Acid|tranexamic acid|mesh-list
138904208|NCT05397652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138904209|NCT05397652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138904210|NCT05397652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904212|NCT05397652|Coagulants|coagulants|mesh-ancestor
138904213|NCT05397405|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
138904214|NCT05397405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138904215|NCT05397405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138904216|NCT05397405|Antimetabolites|antimetabolites|mesh-ancestor
138904217|NCT05397405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904218|NCT05397405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138904219|NCT05397405|Protease Inhibitors|protease inhibitors|mesh-ancestor
138904220|NCT05397405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904221|NCT05397405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138904222|NCT05345522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138904223|NCT05345522|Antibodies|antibodies|mesh-list
138904224|NCT05345522|Immunoglobulins|immunoglobulins|mesh-list
138904225|NCT05345522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138904226|NCT05345522|Immunologic Factors|immunologic factors|mesh-ancestor
138904227|NCT05345522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904228|NCT05345522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904229|NCT05342584|Cytarabine|cytarabine|mesh-list
138904230|NCT05342584|Daunorubicin|daunorubicin|mesh-list
138904231|NCT05342584|Venetoclax|venetoclax|mesh-list
138904232|NCT05342584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138904233|NCT05342584|Antimetabolites|antimetabolites|mesh-ancestor
138904234|NCT05342584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904235|NCT05342584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904236|NCT05342584|Antiviral Agents|antiviral agents|mesh-ancestor
138904237|NCT05342584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904238|NCT05342584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138904239|NCT05342584|Immunologic Factors|immunologic factors|mesh-ancestor
138904240|NCT05342584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904241|NCT05342584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138904242|NCT05342584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138904243|NCT05342584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138904244|NCT05342584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904245|NCT05340504|Acetylcysteine|acetylcysteine|mesh-list
138904246|NCT05340504|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138904247|NCT05340504|Antiviral Agents|antiviral agents|mesh-ancestor
138904248|NCT05340504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904249|NCT05340504|Expectorants|expectorants|mesh-ancestor
138904250|NCT05340504|Respiratory System Agents|respiratory system agents|mesh-ancestor
138904251|NCT05340504|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138556262|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904252|NCT05340504|Antioxidants|antioxidants|mesh-ancestor
138904253|NCT05340504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904254|NCT05340504|Protective Agents|protective agents|mesh-ancestor
138904255|NCT05340504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904257|NCT05338658|Pembrolizumab|pembrolizumab|mesh-list
138904258|NCT05338658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904259|NCT05338658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904260|NCT05338658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138904261|NCT05338658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904262|NCT05333549|Istradefylline|istradefylline|mesh-list
138904263|NCT05333549|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138904264|NCT05333549|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138904265|NCT05333549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138904266|NCT05333549|Purinergic Agents|purinergic agents|mesh-ancestor
138904267|NCT05333549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904268|NCT05333549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904269|NCT05333549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904270|NCT05278715|Carboplatin|carboplatin|mesh-list
138904271|NCT05278715|Vincristine|vincristine|mesh-list
138904272|NCT05278715|Endostatins|endostatins|mesh-list
138904273|NCT05278715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904274|NCT05278715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138904275|NCT05278715|Tubulin Modulators|tubulin modulators|mesh-ancestor
138904276|NCT05278715|Antimitotic Agents|antimitotic agents|mesh-ancestor
138904277|NCT05278715|Mitosis Modulators|mitosis modulators|mesh-ancestor
138904278|NCT05278715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904279|NCT05278715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138904280|NCT05278715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138904281|NCT05278715|Growth Substances|growth substances|mesh-ancestor
138904282|NCT05278715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904283|NCT05278715|Growth Inhibitors|growth inhibitors|mesh-ancestor
138904284|NCT05262738|Misoprostol|misoprostol|mesh-list
138904285|NCT05262738|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138904286|NCT05262738|Abortifacient Agents|abortifacient agents|mesh-ancestor
138904287|NCT05262738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138904288|NCT05262738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904289|NCT05262738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138904290|NCT05262738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138904291|NCT05262738|Oxytocics|oxytocics|mesh-ancestor
138904292|NCT05256719|Abatacept|abatacept|mesh-list
138904293|NCT05256719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138904294|NCT05256719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904295|NCT05256719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904296|NCT05256719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904297|NCT05256719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138904298|NCT05256719|Immunologic Factors|immunologic factors|mesh-ancestor
138904299|NCT05256719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904300|NCT05256719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138904301|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
138904302|NCT05152901|Epinephrine|epinephrine|mesh-list
138904303|NCT05152901|Racepinephrine|racepinephrine|mesh-list
138904304|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
138904305|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138265729|NCT05955222|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138904306|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138904307|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
138904308|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904309|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904310|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904311|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138904312|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138904313|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
138904314|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904315|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138904316|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
138904318|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
138904319|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138904320|NCT05124080|Deucravacitinib|deucravacitinib|mesh-list
138904321|NCT05124080|Dermatologic Agents|dermatologic agents|mesh-ancestor
138904322|NCT05124080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138904323|NCT05124080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904324|NCT05124080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904325|NCT05074433|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
138904326|NCT05074433|Antiviral Agents|antiviral agents|mesh-ancestor
138904327|NCT05074433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904330|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
138904331|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904332|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904333|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
138904334|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138904336|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138904337|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138904338|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138904339|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138904340|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904341|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904342|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
138904343|NCT04952571|Bevacizumab|bevacizumab|mesh-list
138904344|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904345|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904346|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138904347|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138904348|NCT04952571|Growth Substances|growth substances|mesh-ancestor
138904349|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904350|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
138904351|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138904352|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904353|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904354|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
138904355|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138904356|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
138904357|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
138904358|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904359|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904360|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904361|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138904362|NCT04940390|Analgesics|analgesics|mesh-ancestor
138904363|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
138904364|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904365|NCT04939142|Dexamethasone|dexamethasone|mesh-list
138904366|NCT04939142|Dexamethasone acetate|dexamethasone acetate|mesh-list
138904367|NCT04939142|Bortezomib|bortezomib|mesh-list
138904368|NCT04939142|BB 1101|bb 1101|mesh-list
138904369|NCT04939142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138904370|NCT04939142|Antiemetics|antiemetics|mesh-ancestor
138904371|NCT04939142|Autonomic Agents|autonomic agents|mesh-ancestor
138904372|NCT04939142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904373|NCT04939142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904374|NCT04939142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138904375|NCT04939142|Glucocorticoids|glucocorticoids|mesh-ancestor
138904376|NCT04939142|Hormones|hormones|mesh-ancestor
138904377|NCT04939142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138802644|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
138904378|NCT04939142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138904379|NCT04939142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904380|NCT04939142|Protease Inhibitors|protease inhibitors|mesh-ancestor
138904381|NCT04939142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904382|NCT04939142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904383|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
138904384|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
138904385|NCT04722354|Growth Substances|growth substances|mesh-ancestor
138904386|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904387|NCT04721977|Capecitabine|capecitabine|mesh-list
138904388|NCT04721977|Trastuzumab|trastuzumab|mesh-list
138904389|NCT04721977|Tucatinib|tucatinib|mesh-list
138904390|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138904391|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
138904392|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904394|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904395|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138904396|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904397|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138904398|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904399|NCT04607954|Durvalumab|durvalumab|mesh-list
138904400|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
138904401|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138904402|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
138904403|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904404|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904405|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
138904406|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904407|NCT04585841|Cannabidiol|cannabidiol|mesh-list
138904408|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
138904409|NCT04583007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138904410|NCT04583007|Immunologic Factors|immunologic factors|mesh-ancestor
138904411|NCT04583007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904412|NCT04557020|Gemcitabine|gemcitabine|mesh-list
138904413|NCT04557020|Antibodies|antibodies|mesh-list
138904414|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
138904415|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904416|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904417|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138904419|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904420|NCT04521140|Dexamethasone|dexamethasone|mesh-list
138904421|NCT04521140|Prednisolone|prednisolone|mesh-list
138904422|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138904423|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
138904424|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138904425|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
138904426|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138904427|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
138904428|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138904429|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
138904430|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
138904431|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904432|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904433|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138904434|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
138904435|NCT04521140|Hormones|hormones|mesh-ancestor
138265837|NCT05840861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904436|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138904437|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138904438|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904439|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138904440|NCT04521140|Protective Agents|protective agents|mesh-ancestor
138904441|NCT04507178|Nadroparin|nadroparin|mesh-list
138904442|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
138904443|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138904444|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138904445|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904446|NCT04485949|Temozolomide|temozolomide|mesh-list
138904447|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138904448|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
138904449|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904450|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904451|NCT04449861|Durvalumab|durvalumab|mesh-list
138904452|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904453|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904454|NCT04392375|Nifedipine|nifedipine|mesh-list
138904455|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138904456|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138904457|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904458|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138904459|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904460|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
138904461|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
138904462|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138904463|NCT04314570|Ropivacaine|ropivacaine|mesh-list
138904464|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
138904465|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
138332854|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
138904466|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138904467|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904468|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
138904469|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904470|NCT04278573|Vitamin D|vitamin d|mesh-list
138904471|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
138904472|NCT04278573|Vitamins|vitamins|mesh-ancestor
138904473|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
138904474|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904475|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138904476|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138904477|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
138904478|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138904479|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138904480|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904481|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
138904482|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
138904483|NCT04201197|Dronabinol|dronabinol|mesh-list
138904484|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
138904485|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904486|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138904487|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138904488|NCT04201197|Analgesics|analgesics|mesh-ancestor
138904489|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
138904490|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904491|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138904492|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138904493|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904494|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904495|NCT04201197|Hormones|hormones|mesh-ancestor
138904496|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138904497|NCT04107740|TA 0910|ta 0910|mesh-list
138904498|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
138904499|NCT04104139|Trifluridine|trifluridine|mesh-list
138904500|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
138904501|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904502|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
138904503|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904504|NCT04085315|Osimertinib|osimertinib|mesh-list
138904505|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904506|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138904507|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770243|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138904508|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904509|NCT04028050|Carboplatin|carboplatin|mesh-list
138904510|NCT04028050|Etoposide|etoposide|mesh-list
138904511|NCT04028050|Atezolizumab|atezolizumab|mesh-list
138904512|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802881|NCT02876354|Vitamin K|vitamin k|mesh-list
138904514|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138904515|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138904516|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904517|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904518|NCT04028050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138904519|NCT04028050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138265912|NCT05758831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904520|NCT04016805|Venetoclax|venetoclax|mesh-list
138904521|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
138904522|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904523|NCT03972527|Analgesics|analgesics|mesh-list
138904524|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
138904525|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904526|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904527|NCT03968393|Rivaroxaban|rivaroxaban|mesh-list
138904528|NCT03968393|Apixaban|apixaban|mesh-list
138904529|NCT03968393|Edoxaban|edoxaban|mesh-list
138904530|NCT03968393|Dabigatran|dabigatran|mesh-list
138904531|NCT03968393|Anticoagulants|anticoagulants|mesh-list
138904532|NCT03968393|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138904533|NCT03968393|Antithrombins|antithrombins|mesh-ancestor
138904534|NCT03968393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138904535|NCT03968393|Protease Inhibitors|protease inhibitors|mesh-ancestor
138904536|NCT03968393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904537|NCT03968393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904538|NCT03959358|Lenalidomide|lenalidomide|mesh-list
138904539|NCT03959358|Pomalidomide|pomalidomide|mesh-list
138904540|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
138904541|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904542|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138904543|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138904544|NCT03959358|Growth Substances|growth substances|mesh-ancestor
138904545|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
138904546|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904547|NCT03714308|Aflibercept|aflibercept|mesh-list
138904548|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138904549|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138904550|NCT03714308|Growth Substances|growth substances|mesh-ancestor
138904551|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904552|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
138904553|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904554|NCT03702270|Penicillins|penicillins|mesh-list
138904555|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138904556|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904558|NCT03580369|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138904559|NCT03580369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138904560|NCT03580369|Respiratory System Agents|respiratory system agents|mesh-ancestor
138904562|NCT03554083|Vemurafenib|vemurafenib|mesh-list
138904563|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138904564|NCT03554083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138904565|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904566|NCT03554083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904567|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904568|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
138904569|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904570|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138904571|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904572|NCT03479476|Metformin|metformin|mesh-list
138904573|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138904574|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904575|NCT03399539|Dexamethasone|dexamethasone|mesh-list
138904576|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
138904577|NCT03399539|Venetoclax|venetoclax|mesh-list
138904578|NCT03399539|Ixazomib|ixazomib|mesh-list
138904579|NCT03399539|Ichthammol|ichthammol|mesh-list
138904580|NCT03399539|BB 1101|bb 1101|mesh-list
138904581|NCT03399539|Glycine|glycine|mesh-list
138904582|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138904583|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
138904584|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
138904585|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904586|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904587|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138904588|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
138904589|NCT03399539|Hormones|hormones|mesh-ancestor
138904590|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138904591|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138904592|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904593|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904594|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
138904595|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904596|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
138904597|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
138904598|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904599|NCT03358706|Vitamin K|vitamin k|mesh-list
138904600|NCT03358706|Midazolam|midazolam|mesh-list
138904601|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
138904602|NCT03358706|Caffeine|caffeine|mesh-list
138904603|NCT03358706|Ustekinumab|ustekinumab|mesh-list
138904604|NCT03358706|Omeprazole|omeprazole|mesh-list
138904605|NCT03358706|Warfarin|warfarin|mesh-list
138904606|NCT03358706|Vitamins|vitamins|mesh-ancestor
138904607|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
138904608|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904609|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138904610|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138904611|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138904612|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138904613|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138904614|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138904615|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138904616|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
138904617|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
138904618|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
138904619|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
138265961|NCT05715411|Sympathomimetics|sympathomimetics|mesh-ancestor
138904620|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904621|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904623|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138904624|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138904625|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904626|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138904627|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138904628|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
138904629|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138904630|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138904631|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138904632|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
138904633|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138904634|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138904635|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
138904636|NCT03358706|Coagulants|coagulants|mesh-ancestor
138803232|NCT04111159|Propofol|propofol|mesh-list
138904637|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
138904638|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
138904639|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138904640|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138904642|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138904643|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138904644|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138904645|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
138904646|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904647|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904648|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904649|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
138904650|NCT03331289|Exenatide|exenatide|mesh-list
138904651|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138904652|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904653|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138904654|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904655|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138904656|NCT03331289|Incretins|incretins|mesh-ancestor
138904657|NCT03331289|Hormones|hormones|mesh-ancestor
138904658|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138904659|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
138904660|NCT03215810|Nivolumab|nivolumab|mesh-list
138904661|NCT03215810|Fludarabine|fludarabine|mesh-list
138904662|NCT03215810|Interleukin-2|interleukin-2|mesh-list
138904663|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138904664|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
138904665|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904666|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138904667|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138904668|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
138904669|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904670|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904671|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138904672|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904673|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138904674|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138904676|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
138904677|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904678|NCT03036930|Vaccines|vaccines|mesh-list
138904679|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
138904680|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904681|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
138904682|NCT03032406|Everolimus|everolimus|mesh-list
138904683|NCT03032406|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138904684|NCT03032406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138904685|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904686|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904687|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138904688|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
138904689|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904690|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904691|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
138904692|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138904693|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138904694|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904695|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138904697|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904698|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904699|NCT02977468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138904700|NCT02977468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904701|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
138904702|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
138904703|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904704|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138904705|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
138904706|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904707|NCT02891538|Protective Agents|protective agents|mesh-ancestor
138904708|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904709|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138556720|NCT00302536|Tacrolimus|tacrolimus|mesh-list
138904710|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138904711|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904712|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138904713|NCT02817659|Glucagon|glucagon|mesh-list
138904714|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138904715|NCT02817659|Hormones|hormones|mesh-ancestor
138709208|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904716|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138904717|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904718|NCT02565628|PF-06669571|pf-06669571|mesh-list
138904719|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
138904720|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
138904721|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803558|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
138904722|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904723|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904724|NCT02486640|Interferons|interferons|mesh-list
138904725|NCT02486640|Interferon-beta|interferon-beta|mesh-list
138904726|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
138904727|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904728|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
138904729|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904730|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
138904731|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904732|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138904733|NCT02330991|Temozolomide|temozolomide|mesh-list
138904734|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138904735|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
138904736|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904737|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904738|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
138904739|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138904740|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
138904741|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138904742|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
138904743|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904744|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904745|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
138904746|NCT01321567|Rabeprazole|rabeprazole|mesh-list
138904747|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138904748|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138904749|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138904750|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904751|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904752|NCT01290445|Varenicline|varenicline|mesh-list
138904753|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138904754|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138904755|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
138904756|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904757|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904758|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904759|NCT01251718|Donepezil|donepezil|mesh-list
138904760|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138904761|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904762|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904763|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
138904764|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904765|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904766|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
138904767|NCT00581828|Vitamin D|vitamin d|mesh-list
138904768|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
138904769|NCT00581828|Cholecalciferol|cholecalciferol|mesh-list
138904770|NCT00581828|Vitamins|vitamins|mesh-list
138904771|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
138904772|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266093|NCT05510427|Growth Substances|growth substances|mesh-ancestor
138904773|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138904774|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138904775|NCT00220337|Lacosamide|lacosamide|mesh-list
138904776|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
138904777|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138904778|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138904779|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138904780|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904781|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138904782|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138904783|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
138556791|NCT00418366|Incretins|incretins|mesh-ancestor
138904784|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
138904785|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
138904786|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904787|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
138904788|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
138904789|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138904790|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138904791|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904792|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138904793|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904794|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138904796|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
138904797|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904798|NCT00755950|Protective Agents|protective agents|mesh-ancestor
138904799|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904800|NCT00705354|Bacitracin|bacitracin|mesh-list
138904801|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138904802|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904803|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138266138|NCT05470283|Furosemide|furosemide|mesh-list
138904804|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
138904805|NCT00575380|Azithromycin|azithromycin|mesh-list
138904806|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138904807|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138904808|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138904809|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138904810|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904811|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138904812|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138904813|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904814|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904815|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904816|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138904817|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
138904818|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138904819|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904820|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138904821|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138904822|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138904823|NCT00840996|Lidocaine|lidocaine|mesh-list
138904824|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
138904825|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
138904826|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138904827|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904828|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
138904829|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904830|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138904831|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138904832|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138904833|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138904834|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266181|NCT05414240|Ibudilast|ibudilast|mesh-list
138904835|NCT00756184|Travoprost|travoprost|mesh-list
138904836|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138904837|NCT00756340|Bevacizumab|bevacizumab|mesh-list
138904838|NCT00756340|Everolimus|everolimus|mesh-list
138904839|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138904840|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904841|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138904842|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138904843|NCT00756340|Growth Substances|growth substances|mesh-ancestor
138904844|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904845|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
138904846|NCT00756340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138904847|NCT00756340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138904848|NCT00756340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904849|NCT00756340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904850|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138904851|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
138904852|NCT00705510|Cyclosporine|cyclosporine|mesh-list
138904853|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138904854|NCT00705510|Cyclosporins|cyclosporins|mesh-list
138904855|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904856|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904857|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138904858|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
138904859|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904860|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
138904861|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904862|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
138904863|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138904864|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138904865|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138904866|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138904867|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
138904868|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904869|NCT00680836|Rifaximin|rifaximin|mesh-list
138904870|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138904871|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904872|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138904873|NCT05428306|Acetaminophen|acetaminophen|mesh-list
138904874|NCT05428306|Ibuprofen|ibuprofen|mesh-list
138904875|NCT05428306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138904876|NCT05428306|Analgesics|analgesics|mesh-ancestor
138904877|NCT05428306|Sensory System Agents|sensory system agents|mesh-ancestor
138904878|NCT05428306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904879|NCT05428306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904880|NCT05428306|Antipyretics|antipyretics|mesh-ancestor
138904881|NCT05428306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138904882|NCT05428306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138803880|NCT04468815|Esomeprazole|esomeprazole|mesh-list
138904883|NCT05428306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138904884|NCT05428306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138904885|NCT05428306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904886|NCT05428306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904887|NCT05424796|Hemostatics|hemostatics|mesh-list
138904888|NCT05424796|Coagulants|coagulants|mesh-ancestor
138904889|NCT00757198|Remifentanil|remifentanil|mesh-list
138904890|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138904891|NCT00757198|Narcotics|narcotics|mesh-ancestor
138904892|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138904893|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904894|NCT00757198|Analgesics|analgesics|mesh-ancestor
138904895|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
138904896|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904897|NCT00679432|Budesonide|budesonide|mesh-list
138904898|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138904899|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138904900|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
138904901|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904902|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904903|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138904904|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
138904905|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
138904906|NCT00679432|Hormones|hormones|mesh-ancestor
138904907|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138904908|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
138904909|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138904910|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138904911|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904912|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
138904913|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
138904914|NCT04050826|Lidocaine|lidocaine|mesh-list
138904915|NCT04050826|Prilocaine|prilocaine|mesh-list
138904916|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
138904917|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
138904918|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138904919|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904920|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
138904921|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904922|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138904923|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138904924|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138904925|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138904926|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904927|NCT00757978|Memantine|memantine|mesh-list
138904928|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138904929|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138904930|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
138904931|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138904932|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904933|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904934|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138904935|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138904936|NCT00754702|Vinorelbine|vinorelbine|mesh-list
138904937|NCT00754702|Lapatinib|lapatinib|mesh-list
138904938|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138904939|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904940|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
138904941|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
138904942|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
138904943|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904944|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138904945|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904946|NCT00754780|Pirfenidone|pirfenidone|mesh-list
138904947|NCT00754780|Analgesics|analgesics|mesh-ancestor
138904948|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
138904949|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138904951|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138904952|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138904953|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138904954|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138904955|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904956|NCT00822900|Progesterone|progesterone|mesh-list
138904957|NCT00822900|Progestins|progestins|mesh-ancestor
138904958|NCT00822900|Hormones|hormones|mesh-ancestor
138904959|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138904960|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904961|NCT00682786|Fluorouracil|fluorouracil|mesh-list
138904962|NCT00682786|Irinotecan|irinotecan|mesh-list
138904963|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
138904964|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904965|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138904966|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904967|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138904968|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
138904969|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904970|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138904971|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138904972|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904973|NCT00840450|Paclitaxel|paclitaxel|mesh-list
138904974|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138904975|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
138904976|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138904977|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904978|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
138904979|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
138904980|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
138904981|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904982|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138904983|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904984|NCT00754858|Belotecan|belotecan|mesh-list
138640434|NCT00258245|Bortezomib|bortezomib|mesh-list
138904985|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138904986|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138904987|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138904988|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138904989|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138904990|NCT00755014|Ethanol|ethanol|mesh-list
138904991|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138904992|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138904993|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266338|NCT05257018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138904994|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138904995|NCT00705588|Tadalafil|tadalafil|mesh-list
138904996|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138904997|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
138904998|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138904999|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138905000|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905001|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905002|NCT00705588|Urological Agents|urological agents|mesh-ancestor
138905003|NCT00755170|Bevacizumab|bevacizumab|mesh-list
138905004|NCT00755170|Vinorelbine|vinorelbine|mesh-list
138905005|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138905006|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804033|NCT00851890|Interferons|interferons|mesh-list
138557011|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
138905007|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138905008|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138905009|NCT00755170|Growth Substances|growth substances|mesh-ancestor
138905010|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905011|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
138905012|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138905013|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
138905014|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
138905015|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
138905016|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905018|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
138905019|NCT00705822|Docetaxel|docetaxel|mesh-list
138905020|NCT00705822|Estramustine|estramustine|mesh-list
138905021|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905022|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
138905023|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
138905024|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
138905025|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905026|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905027|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
138905028|NCT00705822|Hormones|hormones|mesh-ancestor
138905029|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138905030|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905031|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138709209|NCT04381091|Idebenone|idebenone|mesh-list
138905032|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138905033|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
138905034|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
138905035|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138905036|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905037|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138905038|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138905039|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905040|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905041|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905042|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138905043|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138905044|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138905045|NCT00703170|Sirolimus|sirolimus|mesh-list
138905046|NCT00703170|Doxorubicin|doxorubicin|mesh-list
138905047|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138905048|NCT00703170|Temsirolimus|temsirolimus|mesh-list
138905049|NCT00703170|MTOR Inhibitors|mtor inhibitors|mesh-list
138905050|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138905051|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905052|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138905053|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138905054|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905055|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905056|NCT00703170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138905057|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138905058|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
138905059|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905060|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138905061|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905062|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
138905063|NCT00758134|Trastuzumab|trastuzumab|mesh-list
138905064|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138905065|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905066|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
138905067|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138905068|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905069|NCT02560636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138905070|NCT02560636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905072|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
138905073|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905074|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
138905075|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
138905076|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138905077|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
138905078|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905079|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905080|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138905081|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
138905082|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138905083|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138905084|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138905085|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
138905086|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905087|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905088|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
138905089|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138905090|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
138905091|NCT00758368|Apomorphine|apomorphine|mesh-list
138905092|NCT00758368|Emetics|emetics|mesh-ancestor
138905093|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905094|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
138709210|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
138905095|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905096|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138905097|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
138905098|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
138905099|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905100|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905102|NCT05435560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138905103|NCT05435560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138905104|NCT05435560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905105|NCT05435560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138905106|NCT05435560|Analgesics|analgesics|mesh-ancestor
138905107|NCT05435560|Sensory System Agents|sensory system agents|mesh-ancestor
138905108|NCT05435560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905109|NCT05435560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138905110|NCT05435560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138905111|NCT05435560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138905112|NCT05435560|Adrenergic Agents|adrenergic agents|mesh-ancestor
138905113|NCT05435560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905114|NCT05435560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905115|NCT00680992|Denosumab|denosumab|mesh-list
138905116|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
138905117|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
138905118|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
138905119|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905120|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138905121|NCT02559154|Thalidomide|thalidomide|mesh-list
138905122|NCT02559154|Dexamethasone|dexamethasone|mesh-list
138905123|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
138905124|NCT02559154|Doxorubicin|doxorubicin|mesh-list
138905125|NCT02559154|Bortezomib|bortezomib|mesh-list
138905126|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138905127|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
138905128|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905129|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138905130|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138905131|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
138804218|NCT05306379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138905132|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905133|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905134|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138905135|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905137|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
138905138|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905139|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138905140|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
138905141|NCT02559154|Hormones|hormones|mesh-ancestor
138905142|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138905143|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138905144|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138905145|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138905146|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138905147|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905148|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
138905149|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138905150|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905151|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138905152|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138905153|NCT02559154|Growth Substances|growth substances|mesh-ancestor
138905154|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
138905155|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
138905157|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804343|NCT02838615|Hormones|hormones|mesh-ancestor
138905158|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138905160|NCT05747469|Anesthetics, Local|anesthetics, local|mesh-list
138905161|NCT05747469|Anesthetics|anesthetics|mesh-list
138905162|NCT05747469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138905163|NCT05747469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905164|NCT05747469|Sensory System Agents|sensory system agents|mesh-ancestor
138905165|NCT05747469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905166|NCT05747469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138905167|NCT05747469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138905168|NCT05747469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138905169|NCT05747469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138905170|NCT05747469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905171|NCT00804843|Niacin|niacin|mesh-list
138905172|NCT00804843|Atorvastatin|atorvastatin|mesh-list
138905173|NCT00804843|Simvastatin|simvastatin|mesh-list
138905174|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138905175|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138905176|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
138905177|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804378|NCT04248621|Bicalutamide|bicalutamide|mesh-list
138905178|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138905179|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138905181|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
138905182|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
138905183|NCT00804843|Vitamins|vitamins|mesh-ancestor
138905184|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
138905185|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905186|NCT00822120|Prednisone|prednisone|mesh-list
138905187|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
138905188|NCT00822120|Dacarbazine|dacarbazine|mesh-list
138905189|NCT00822120|Doxorubicin|doxorubicin|mesh-list
138905190|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138905191|NCT00822120|Etoposide|etoposide|mesh-list
138905192|NCT00822120|Vincristine|vincristine|mesh-list
138905193|NCT00822120|Bleomycin|bleomycin|mesh-list
138905194|NCT00822120|Vinblastine|vinblastine|mesh-list
138905195|NCT00822120|Procarbazine|procarbazine|mesh-list
138905196|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138905197|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
138905198|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905199|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138905200|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138905201|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
138905202|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905203|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905204|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138905205|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138266552|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
138905206|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138905207|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138905208|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905209|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905210|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
138905211|NCT00822120|Hormones|hormones|mesh-ancestor
138905212|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138510474|NCT00062062|Paclitaxel|paclitaxel|mesh-list
138905213|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138905214|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138905215|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
138905216|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
138905217|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
138905218|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
138905220|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138905221|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
138905222|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905223|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905224|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138905225|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
138905226|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
138905227|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138905228|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138905229|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
138905230|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
138905231|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905232|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905233|NCT00678652|Vaccines|vaccines|mesh-list
138905234|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
138905235|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905236|NCT02607657|Eplerenone|eplerenone|mesh-list
138905237|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138905238|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
138905239|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138905240|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905241|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138905242|NCT02607657|Diuretics|diuretics|mesh-ancestor
138905243|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
138905244|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138905245|NCT00574912|Insulin|insulin|mesh-list
138905246|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138905247|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
138905248|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138905249|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905250|NCT00922896|Gemcitabine|gemcitabine|mesh-list
138905251|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138905252|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905253|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138905254|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
138905255|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905256|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138905257|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905259|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
138905260|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138905261|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138905262|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905263|NCT00804141|Bromides|bromides|mesh-list
138905264|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
138905265|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
138905266|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138905267|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905268|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
138905269|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905270|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
138905271|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905272|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138905273|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905274|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905275|NCT02607579|Ropivacaine|ropivacaine|mesh-list
138905276|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
138905277|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
138905278|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266635|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
138266636|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266637|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138266638|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
138266639|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138266640|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138266641|NCT04965077|Antibodies|antibodies|mesh-list
138266642|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138266644|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266661|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
138266662|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138266663|NCT04953962|Nivolumab|nivolumab|mesh-list
138266664|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266665|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266666|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138266667|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905279|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905280|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
138905281|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905282|NCT03539367|Acetazolamide|acetazolamide|mesh-list
138905283|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
138905284|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138905285|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510475|NCT00062062|Carboplatin|carboplatin|mesh-list
138905286|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905287|NCT03539367|Diuretics|diuretics|mesh-ancestor
138905288|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
138905289|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905290|NCT03416361|Vitamin D|vitamin d|mesh-list
138905291|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
138905292|NCT03416361|Vitamins|vitamins|mesh-ancestor
138905293|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
138905294|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905295|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138905296|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138905297|NCT00761254|Domperidone|domperidone|mesh-list
138905298|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
138905299|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
138905300|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804580|NCT00703690|Fenofibrate|fenofibrate|mesh-list
138905301|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905302|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138905303|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138905304|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
138557308|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
138905305|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905306|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905308|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138905309|NCT00761332|Diphosphonates|diphosphonates|mesh-list
138905310|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138905311|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905312|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138905313|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138905314|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
138905315|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138905316|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138905317|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138905318|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138905319|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
138905320|NCT03321201|Coagulants|coagulants|mesh-ancestor
138905321|NCT02612220|Hemostatics|hemostatics|mesh-list
138905322|NCT02612220|Coagulants|coagulants|mesh-ancestor
138905323|NCT04627246|Vaccines|vaccines|mesh-list
138905324|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
138905325|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905326|NCT00761644|Sirolimus|sirolimus|mesh-list
138905327|NCT00761644|Bevacizumab|bevacizumab|mesh-list
138905328|NCT00761644|Doxorubicin|doxorubicin|mesh-list
138905329|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138905330|NCT00761644|Temsirolimus|temsirolimus|mesh-list
138905331|NCT00761644|MTOR Inhibitors|mtor inhibitors|mesh-list
138905332|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138905333|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905334|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138804615|NCT00782509|Olodaterol|olodaterol|mesh-list
138905335|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138905336|NCT00761644|Growth Substances|growth substances|mesh-ancestor
138905337|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905338|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
138905339|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138905340|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138905341|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138905342|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905343|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905344|NCT00761644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138905345|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138905346|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
138905347|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138905348|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905349|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
138905350|NCT02559388|Montelukast|montelukast|mesh-list
138905351|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138905352|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
138905353|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138905354|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
138905355|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138905356|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905357|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138905358|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138905359|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905361|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138905362|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138905363|NCT03168256|Analgesics|analgesics|mesh-ancestor
138905364|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
138905365|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905366|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905367|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905368|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138905369|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138905370|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138905371|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905372|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905373|NCT00761722|Azacitidine|azacitidine|mesh-list
138905374|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138905375|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
138905376|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905377|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905378|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905380|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138905382|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138905383|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905384|NCT00762190|Insulin|insulin|mesh-list
138905385|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138905386|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138905387|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905388|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
138905389|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138905390|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905391|NCT00762658|Betamethasone|betamethasone|mesh-list
138266743|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266744|NCT04826133|Calcitriol|calcitriol|mesh-list
138905392|NCT00762658|Tacrolimus|tacrolimus|mesh-list
138905393|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138905394|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138905395|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
138905396|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905397|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138905398|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804688|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138905399|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905400|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905401|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
138905402|NCT00762658|Hormones|hormones|mesh-ancestor
138905403|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138905404|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138905405|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
138905406|NCT02558452|Tacrolimus|tacrolimus|mesh-list
138905407|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138905408|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
138905409|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905410|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138905411|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905412|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905413|NCT00762736|Pioglitazone|pioglitazone|mesh-list
138905414|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138905415|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138905416|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905417|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138905418|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138905419|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905420|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
138905421|NCT02915224|Chlorambucil|chlorambucil|mesh-list
138905422|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138905423|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445803|NCT01839344|Acarbose|acarbose|mesh-list
138804737|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266787|NCT04751500|Metronidazole|metronidazole|mesh-list
138266788|NCT04751500|Clindamycin|clindamycin|mesh-list
138266791|NCT04751500|Mifepristone|mifepristone|mesh-list
138905424|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138905426|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905427|NCT02813824|Aspirin|aspirin|mesh-list
138905428|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
138905429|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138905430|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138905431|NCT02813824|Analgesics|analgesics|mesh-ancestor
138905432|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
138905433|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905434|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905435|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905436|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138905437|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138905438|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138905439|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905440|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138905441|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138905442|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905443|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
138905444|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138905445|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138905446|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905447|NCT00673894|Incretins|incretins|mesh-ancestor
138905448|NCT00673894|Hormones|hormones|mesh-ancestor
138905449|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138804783|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
138905450|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138905451|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
138905452|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905453|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905454|NCT00763204|Betamethasone|betamethasone|mesh-list
138905455|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138905456|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905457|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
138905459|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138905460|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905461|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138905462|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
138905463|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
138905464|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905465|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138905466|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905467|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
138905469|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138905470|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905471|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138905472|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138905473|NCT00763438|Sertindole|sertindole|mesh-list
138905474|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138905475|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138905476|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138905477|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905478|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138905479|NCT02559232|Anticoagulants|anticoagulants|mesh-list
138905480|NCT00763906|Norepinephrine|norepinephrine|mesh-list
138905481|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138905482|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138905483|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
138905484|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905485|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905486|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905487|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
138905488|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
138905489|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905490|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138905491|NCT00764062|Amoxicillin|amoxicillin|mesh-list
138905492|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138905493|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905494|NCT00758914|Vitamin E|vitamin e|mesh-list
138905495|NCT00758914|Vitamins|vitamins|mesh-ancestor
138905496|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
138905497|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905498|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
138905499|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905500|NCT00758914|Protective Agents|protective agents|mesh-ancestor
138905501|NCT00759070|Ritonavir|ritonavir|mesh-list
138905502|NCT00759070|Lopinavir|lopinavir|mesh-list
138905503|NCT00759070|Tenofovir|tenofovir|mesh-list
138905504|NCT00759070|Emtricitabine|emtricitabine|mesh-list
138905505|NCT00759070|Efavirenz|efavirenz|mesh-list
138905506|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138905507|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138905508|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
138905509|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905510|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905511|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138905512|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138905513|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
138905514|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905515|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138905516|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138905517|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138905518|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138905519|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138905520|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138905521|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138905522|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138905523|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138905524|NCT00764140|Mitogens|mitogens|mesh-list
138905525|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
138804919|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
138905526|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905528|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
138905529|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138905530|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138905531|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138905532|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138905533|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905534|NCT00672958|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138905535|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138905536|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138905537|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905539|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
138905540|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138905541|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138905542|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138905543|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138905545|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138905546|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905547|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905548|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
138905549|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905550|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905551|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138905552|NCT00759226|Leucovorin|leucovorin|mesh-list
138905553|NCT00759226|Folic Acid|folic acid|mesh-list
138905554|NCT00759226|Cisplatin|cisplatin|mesh-list
138905555|NCT00759226|Gemcitabine|gemcitabine|mesh-list
138905556|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
138905557|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905558|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138905559|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
138709248|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138905560|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905561|NCT00759226|Antidotes|antidotes|mesh-ancestor
138905562|NCT00759226|Protective Agents|protective agents|mesh-ancestor
138905563|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905564|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
138905565|NCT00759226|Vitamins|vitamins|mesh-ancestor
138905566|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
138905567|NCT00759226|Hematinics|hematinics|mesh-ancestor
138905568|NCT00672646|Naproxen|naproxen|mesh-list
138905569|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138905570|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138905571|NCT00672646|Analgesics|analgesics|mesh-ancestor
138905572|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
138905573|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905574|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905575|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905576|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138905577|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
138905578|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138905579|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905580|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905582|NCT00759460|Sertindole|sertindole|mesh-list
138905583|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
138905584|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
138905585|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905586|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905587|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138905588|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138905589|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138445867|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
138905590|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138905591|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138905592|NCT00759460|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138905593|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138905594|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138905595|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905596|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905597|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
138905598|NCT00765154|Ritonavir|ritonavir|mesh-list
138905599|NCT00765154|Darunavir|darunavir|mesh-list
138905600|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138905601|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138557619|NCT00308269|Folic Acid|folic acid|mesh-list
138905603|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709249|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
138905604|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905605|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138905606|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138905607|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
138905608|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905609|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138905610|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138905611|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138905612|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
138905613|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138905614|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138905615|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138905616|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138905617|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905618|NCT00770302|Saxagliptin|saxagliptin|mesh-list
138905619|NCT00770302|Incretins|incretins|mesh-ancestor
138905620|NCT00770302|Hormones|hormones|mesh-ancestor
138905621|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138905622|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905623|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138905624|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
138905625|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905626|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905627|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138905628|NCT02557984|Naltrexone|naltrexone|mesh-list
138905629|NCT02557984|Amisulpride|amisulpride|mesh-list
138905630|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138905631|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138905632|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905633|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
138905634|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905635|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138905636|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138905637|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138905638|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138905639|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138905640|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
138905641|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905642|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905643|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138905644|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
138905645|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138905646|NCT00759928|Sorafenib|sorafenib|mesh-list
138905647|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805319|NCT00637884|Fexofenadine|fexofenadine|mesh-list
138905648|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138905649|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905650|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905651|NCT00670930|Omalizumab|omalizumab|mesh-list
138905652|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138905653|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138445879|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
138905654|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
138905655|NCT00770536|Doxorubicin|doxorubicin|mesh-list
138905656|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138905658|NCT00770536|Trebananib|trebananib|mesh-list
138905659|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138905660|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905661|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138905662|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138905663|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905664|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905665|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138905666|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138905667|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138905668|NCT00770536|Growth Substances|growth substances|mesh-ancestor
138905669|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905670|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
138905671|NCT00771004|Pioglitazone|pioglitazone|mesh-list
138905672|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138905673|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905674|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
138905675|NCT00674362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138805381|NCT00779467|Fentanyl|fentanyl|mesh-list
138905676|NCT00674362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905677|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138905678|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
138905679|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905680|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138905681|NCT00820950|Betamethasone|betamethasone|mesh-list
138905682|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
138905683|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138905684|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
138905685|NCT00820950|Calcipotriene|calcipotriene|mesh-list
138905686|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138905687|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905688|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
138905690|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138905691|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905692|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138905693|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
138905694|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
138905695|NCT00765934|Lidocaine|lidocaine|mesh-list
138905696|NCT00765934|Tetracaine|tetracaine|mesh-list
138905697|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
138905698|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
138905699|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138905700|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267131|NCT04205552|Nivolumab|nivolumab|mesh-list
138905701|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
138905702|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905703|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138905704|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138905705|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138905706|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138905707|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905708|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
138905709|NCT04049344|Decitabine|decitabine|mesh-list
138905710|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905711|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138905712|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
138905713|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905714|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905715|NCT00670306|Cetrorelix|cetrorelix|mesh-list
138805477|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
138905716|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138905717|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
138905718|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138905719|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905720|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
138905721|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138905722|NCT00709254|Fentanyl|fentanyl|mesh-list
138905723|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138905724|NCT00709254|Narcotics|narcotics|mesh-ancestor
138905725|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445885|NCT01840800|Ropivacaine|ropivacaine|mesh-list
138805532|NCT00916045|Vidarabine|vidarabine|mesh-list
138905726|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905727|NCT00709254|Analgesics|analgesics|mesh-ancestor
138334114|NCT00706446|Xhance|xhance|mesh-list
138905728|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
138905729|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905730|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138905731|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138905733|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
138905734|NCT00760318|Levetiracetam|levetiracetam|mesh-list
138905735|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
138905736|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
138905737|NCT00591630|Cytarabine|cytarabine|mesh-list
138905738|NCT00591630|Rituximab|rituximab|mesh-list
138905739|NCT00591630|Etoposide|etoposide|mesh-list
138905740|NCT00591630|Melphalan|melphalan|mesh-list
138905741|NCT00591630|Carmustine|carmustine|mesh-list
138905742|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138905743|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905744|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
138905745|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905746|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138905747|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138905748|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138905749|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138905750|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905751|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905752|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138905753|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
138905754|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
138905755|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905756|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138905757|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138905758|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
138905759|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138905760|NCT00771394|Tamsulosin|tamsulosin|mesh-list
138905761|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
138905762|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138905763|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138905764|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138905765|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
138905766|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905767|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905768|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905769|NCT00771394|Urological Agents|urological agents|mesh-ancestor
138905770|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138905771|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138905772|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
138905773|NCT00670228|Insulin|insulin|mesh-list
138905774|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138905775|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
138905776|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
138905777|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138905778|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905779|NCT00766246|Bevacizumab|bevacizumab|mesh-list
138905780|NCT00766246|Carboplatin|carboplatin|mesh-list
138267214|NCT04139304|Hormones|hormones|mesh-ancestor
138905781|NCT00766246|Docetaxel|docetaxel|mesh-list
138905782|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138905783|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905784|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138905785|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138905787|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905788|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
138905789|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
138905790|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
138905791|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
138905792|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905793|NCT00766402|Acetaminophen|acetaminophen|mesh-list
138905794|NCT00766402|Diclofenac|diclofenac|mesh-list
138905795|NCT00766402|Tramadol|tramadol|mesh-list
138905796|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138905797|NCT00766402|Analgesics|analgesics|mesh-ancestor
138905798|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
138905799|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905800|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905801|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
138905802|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138905803|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905804|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138905805|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138905806|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905807|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905808|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138905810|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138905811|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138905812|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905813|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905814|NCT00760864|Methotrexate|methotrexate|mesh-list
138905815|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138905816|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
138267234|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905817|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138905818|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905819|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138905820|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
138905821|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905822|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905823|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
138905824|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905825|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138905826|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138905828|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138905829|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138905830|NCT00766480|Fluorouracil|fluorouracil|mesh-list
138905831|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905832|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
138905833|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905834|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138905835|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138905836|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
138905837|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905839|NCT00772174|Pioglitazone|pioglitazone|mesh-list
138905840|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138267275|NCT04093596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267276|NCT04091750|Nivolumab|nivolumab|mesh-list
138905841|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905842|NCT00772564|Atorvastatin|atorvastatin|mesh-list
138905843|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138905844|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138905845|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
138905846|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905847|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138905848|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138905849|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905850|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138905851|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138905852|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138905853|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138905854|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905855|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905856|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905857|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138905858|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
138905859|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138905860|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
138905861|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138905862|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138905863|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
138905864|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905865|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138905866|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138905867|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905868|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905869|NCT00775294|Maraviroc|maraviroc|mesh-list
138905870|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138905871|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138905872|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905873|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138905874|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138905875|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
138905876|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905878|NCT00772798|Paclitaxel|paclitaxel|mesh-list
138905879|NCT00772798|Carboplatin|carboplatin|mesh-list
138905880|NCT00772798|Vorinostat|vorinostat|mesh-list
138905881|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138905882|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905883|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
138905884|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
138905885|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
138905886|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905887|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138905888|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905889|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
138905890|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138905891|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138905892|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138905893|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
138905894|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905895|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905896|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905897|NCT00775372|Clarithromycin|clarithromycin|mesh-list
138905898|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138905899|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905900|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138905901|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905902|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905903|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138905904|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138905906|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138905907|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905909|NCT04047940|Valsartan|valsartan|mesh-list
138905910|NCT04047940|Atorvastatin|atorvastatin|mesh-list
138905911|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138267375|NCT03961698|Paclitaxel|paclitaxel|mesh-list
138905912|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905913|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138905914|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138905915|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
138709250|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905916|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905917|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138905918|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138905919|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905920|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138905921|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138905922|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138905923|NCT00773188|Bevacizumab|bevacizumab|mesh-list
138905924|NCT00773188|Vinorelbine|vinorelbine|mesh-list
138905925|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138905926|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138905927|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138905928|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138905929|NCT00773188|Growth Substances|growth substances|mesh-ancestor
138905930|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905931|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
138905932|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138905933|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
138905934|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
138905935|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
138709251|NCT03798639|Nivolumab|nivolumab|mesh-list
138905936|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905937|NCT00767260|Insulin|insulin|mesh-list
138905938|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138905939|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905940|NCT00767494|Travoprost|travoprost|mesh-list
138905941|NCT00767494|Brinzolamide|brinzolamide|mesh-list
138905942|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138267427|NCT03908736|Picolinic acid|picolinic acid|mesh-list
138267429|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
138905943|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138905944|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905945|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905946|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
138905947|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138905948|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
138905949|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905950|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905952|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
138905953|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138905954|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
138905955|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905956|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905957|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138905958|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
138905959|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
138905960|NCT00773578|Protective Agents|protective agents|mesh-ancestor
138905961|NCT00775762|Aspirin|aspirin|mesh-list
138905962|NCT00775762|Clopidogrel|clopidogrel|mesh-list
138905963|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138905964|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138905965|NCT00775762|Analgesics|analgesics|mesh-ancestor
138905966|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
138905967|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138905968|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138905969|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138905970|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138905971|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138557991|NCT00310531|Estradiol|estradiol|mesh-list
138905972|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138905973|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905974|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138905975|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138905976|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905977|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
138905978|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138905979|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138905980|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138905981|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
138905982|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138905983|NCT00775840|Candesartan|candesartan|mesh-list
138905984|NCT00775840|Candesartan cilexetil|candesartan cilexetil|mesh-list
138905985|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138905986|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138905987|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138905988|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905989|NCT00775918|Doxycycline|doxycycline|mesh-list
138905990|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138905991|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138905992|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
138905993|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138905994|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138905995|NCT00878189|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
138905996|NCT00878189|Nirogacestat|nirogacestat|mesh-list
138445910|NCT01841099|Analgesics|analgesics|mesh-ancestor
138905997|NCT00878189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138905998|NCT00878189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138905999|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
138906000|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
138906001|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138906002|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138906003|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138906004|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906005|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138906006|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
138906007|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
138906008|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906009|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906010|NCT00773812|Mecamylamine|mecamylamine|mesh-list
138906011|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138906012|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138906013|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
138906014|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906015|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906016|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138906017|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138906018|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
138709252|NCT03798639|Ipilimumab|ipilimumab|mesh-list
138906019|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770244|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138906020|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906021|NCT00767728|Mesalamine|mesalamine|mesh-list
138906022|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138906023|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138906024|NCT00767728|Analgesics|analgesics|mesh-ancestor
138906025|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
138906026|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906027|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906028|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138906029|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138906030|NCT00776074|Leuprolide|leuprolide|mesh-list
138906031|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138906032|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
138906033|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138906034|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906035|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138906036|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906038|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138906039|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138906040|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138906041|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138906042|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
138906043|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906044|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558065|NCT00311116|Vitamin E|vitamin e|mesh-list
138906045|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906046|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
138906047|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138906048|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
138906049|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138906050|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906051|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138906052|NCT00668200|Vitamin D|vitamin d|mesh-list
138906053|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
138906054|NCT00668200|Calcium|calcium|mesh-list
138906055|NCT00668200|Vitamins|vitamins|mesh-ancestor
138906056|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
138906057|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906058|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138906059|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138906060|NCT00679601|Tavaborole|tavaborole|mesh-list
138906061|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
138906062|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906063|NCT00675779|Atorvastatin|atorvastatin|mesh-list
138806700|NCT02806791|Lenograstim|lenograstim|mesh-list
138906064|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
138906065|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
138906067|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138906068|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138906069|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
138267592|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
138906070|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906071|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138906072|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138906073|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906074|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138806765|NCT05461339|Ranibizumab|ranibizumab|mesh-list
138906075|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906076|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138906077|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138906078|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138906079|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138906080|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906081|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
138906082|NCT00774280|Busulfan|busulfan|mesh-list
138906083|NCT00774280|Fludarabine|fludarabine|mesh-list
138906084|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138906085|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
138446022|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
138906086|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806819|NCT02799615|Infliximab|infliximab|mesh-list
138906087|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138906088|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138906089|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
138906090|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906091|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906092|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138906093|NCT04151147|Mitogens|mitogens|mesh-list
138906094|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
138906095|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906096|NCT00774358|Aldesleukin|aldesleukin|mesh-list
138906098|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906099|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138906100|NCT00774358|Analgesics|analgesics|mesh-ancestor
138906101|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
138906102|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906103|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906104|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138906105|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138267635|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138906106|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
138906107|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906108|NCT02627417|Dapsone|dapsone|mesh-list
138906109|NCT02627417|Prednisone|prednisone|mesh-list
138906110|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138906111|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
138906112|NCT02627417|Hormones|hormones|mesh-ancestor
138906113|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138906114|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906115|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138906116|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906117|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906118|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
138906119|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138906120|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138906121|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138906122|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906123|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906124|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
138906125|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138906127|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138906128|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906129|NCT00838578|Irinotecan|irinotecan|mesh-list
138906130|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138906131|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138906132|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906133|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906134|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906135|NCT02634515|Insulin|insulin|mesh-list
138906136|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138906137|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138906138|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906139|NCT00705900|Calcipotriene|calcipotriene|mesh-list
138906140|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
138906141|NCT00679835|Daptomycin|daptomycin|mesh-list
138906142|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138906143|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906144|NCT00774904|Losartan|losartan|mesh-list
138906145|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138906146|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138906147|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138906148|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138906149|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906150|NCT00829296|Metoprolol|metoprolol|mesh-list
138906151|NCT00829296|Nebivolol|nebivolol|mesh-list
138906152|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138906153|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138446085|NCT01842139|Laxatives|laxatives|mesh-ancestor
138906154|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
138906155|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
138906156|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906157|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906158|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138906159|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138906160|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138906161|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
138906162|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906163|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906164|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
138906165|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138906166|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138906167|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138906168|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
138906169|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
138906170|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906171|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138906172|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906173|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138906174|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
138906175|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906176|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138906177|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267708|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
138906179|NCT00881621|Lapatinib|lapatinib|mesh-list
138906180|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138906181|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
138906182|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906183|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906184|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138906185|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906186|NCT02634281|Varenicline|varenicline|mesh-list
138906187|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138906188|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138906189|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
138906190|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906191|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906192|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558215|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
138906196|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906197|NCT00779350|Sertraline|sertraline|mesh-list
138807246|NCT05804305|Misoprostol|misoprostol|mesh-list
138906198|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
138906199|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138906200|NCT00779350|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138906201|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138906202|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138906203|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906204|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906205|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
138906206|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906207|NCT00705978|Pancreatin|pancreatin|mesh-list
138906208|NCT00705978|Pancrelipase|pancrelipase|mesh-list
138906209|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906210|NCT02556970|Acetaminophen|acetaminophen|mesh-list
138906211|NCT02556970|Diclofenac|diclofenac|mesh-list
138906212|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
138906213|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138906214|NCT02556970|Analgesics|analgesics|mesh-ancestor
138906215|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
138906216|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906217|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906218|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
138906219|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138906220|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138906221|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138906222|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138906223|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709253|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138906224|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906226|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
138906227|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138906228|NCT00594815|Leucovorin|leucovorin|mesh-list
138906229|NCT00594815|Cytarabine|cytarabine|mesh-list
138906230|NCT00594815|Rituximab|rituximab|mesh-list
138906231|NCT00594815|Methotrexate|methotrexate|mesh-list
138906232|NCT00594815|Vincristine|vincristine|mesh-list
138906233|NCT00594815|Procarbazine|procarbazine|mesh-list
138906234|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138906235|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906236|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
138906237|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906238|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138906239|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138906240|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
138906241|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138906242|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138906243|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
138906244|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906245|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
138906247|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138906248|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138906249|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138906250|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
138906251|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906252|NCT00594815|Antidotes|antidotes|mesh-ancestor
138906253|NCT00594815|Protective Agents|protective agents|mesh-ancestor
138906254|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
138906255|NCT00594815|Vitamins|vitamins|mesh-ancestor
138906256|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
138906257|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138906258|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
138906259|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
138906260|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
138906261|NCT00776542|Minocycline|minocycline|mesh-list
138807479|NCT05484349|Tizanidine|tizanidine|mesh-list
138906262|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138906263|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906264|NCT00776620|Glimepiride|glimepiride|mesh-list
138906265|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138906266|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138906267|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906268|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138906269|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
138906270|NCT00776698|Bevacizumab|bevacizumab|mesh-list
138906271|NCT00776698|Etoposide|etoposide|mesh-list
138906272|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138906273|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906274|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138906275|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138906276|NCT00776698|Growth Substances|growth substances|mesh-ancestor
138906277|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906278|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
138906279|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138906280|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138906281|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138906282|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906283|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906285|NCT04150757|Analgesics|analgesics|mesh-ancestor
138906286|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
138906287|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906288|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906289|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138906290|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138267825|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906291|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
138906292|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
138906293|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138906294|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138906295|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138906296|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906297|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906298|NCT04150367|Rifampin|rifampin|mesh-list
138906299|NCT04150367|Isoniazid|isoniazid|mesh-list
138906300|NCT04150367|Ethambutol|ethambutol|mesh-list
138906301|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138906302|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138906303|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
138906304|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138906305|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906306|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
138906307|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138906308|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906309|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906310|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138906311|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138906312|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138906313|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138906314|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138906315|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138906316|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138906317|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138906318|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
138906319|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138906320|NCT02634203|Riociguat|riociguat|mesh-list
138906321|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
138906322|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906324|NCT00681005|Pantoprazole|pantoprazole|mesh-list
138906325|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138906326|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906327|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138906328|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906329|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906330|NCT02633969|Indomethacin|indomethacin|mesh-list
138906331|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138906332|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138906333|NCT02633969|Analgesics|analgesics|mesh-ancestor
138906334|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
138906335|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267929|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267930|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138267931|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
138267933|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138267934|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138267935|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267936|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
138267937|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267938|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267939|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
138267940|NCT02511067|Ranibizumab|ranibizumab|mesh-list
138267941|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138267942|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138267943|NCT02511067|Growth Substances|growth substances|mesh-ancestor
138267944|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267945|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
138267946|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906336|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906337|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138906338|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138906339|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
138906340|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
138770245|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
138906341|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138906342|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138906343|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558363|NCT00293332|Bevacizumab|bevacizumab|mesh-list
138906344|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906346|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138906347|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
138906348|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906349|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906350|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138906351|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
138906353|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138906354|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138906355|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138906356|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138906357|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
138906358|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906359|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906360|NCT00820170|Paclitaxel|paclitaxel|mesh-list
138906361|NCT00820170|Dasatinib|dasatinib|mesh-list
138906362|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138393218|NCT01513941|Ribavirin|ribavirin|mesh-list
138906363|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906364|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
138906365|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
138906366|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
138906367|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267978|NCT02458274|Dimercaprol|dimercaprol|mesh-list
138267979|NCT02458274|Chelating Agents|chelating agents|mesh-ancestor
138267980|NCT02458274|Sequestering Agents|sequestering agents|mesh-ancestor
138906368|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138906369|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906370|NCT02627027|Metformin|metformin|mesh-list
138906371|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138906372|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906373|NCT00709332|Folic Acid|folic acid|mesh-list
138906374|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138906375|NCT00709332|Norgestimate|norgestimate|mesh-list
138906376|NCT00709332|Estradiol|estradiol|mesh-list
138906377|NCT00709332|Estrogens|estrogens|mesh-ancestor
138906378|NCT00709332|Hormones|hormones|mesh-ancestor
138906379|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138906380|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906381|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138906382|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
138906383|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138906384|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138906385|NCT00709332|Hematinics|hematinics|mesh-ancestor
138906386|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
138906387|NCT00709332|Vitamins|vitamins|mesh-ancestor
138906388|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
138906389|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138906390|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138906391|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138906392|NCT00684905|Leuprolide|leuprolide|mesh-list
138906393|NCT00684905|Bicalutamide|bicalutamide|mesh-list
138906394|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138906395|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
138906396|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138906397|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906398|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138906399|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906400|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
138906401|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
138268018|NCT02402439|Pancreatin|pancreatin|mesh-list
138906402|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138906403|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
138906405|NCT00685061|Daclizumab|daclizumab|mesh-list
138906406|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
138906407|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906408|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138906409|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138906410|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906411|NCT02633813|Naftifine|naftifine|mesh-list
138906412|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
138906413|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906415|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138906416|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
138906417|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906418|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906419|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138906420|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
138906421|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
138906422|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138906423|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138906424|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138906425|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138906426|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
138906427|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268063|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906428|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906430|NCT02626247|Vitamins|vitamins|mesh-ancestor
138906431|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
138906432|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906433|NCT00828984|Laxatives|laxatives|mesh-list
138906434|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138906435|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906436|NCT00819390|Chloroquine|chloroquine|mesh-list
138906437|NCT00819390|Amebicides|amebicides|mesh-ancestor
138906438|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138906439|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138906441|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
138906442|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138906443|NCT00876395|Paclitaxel|paclitaxel|mesh-list
138906444|NCT00876395|Trastuzumab|trastuzumab|mesh-list
138906445|NCT00876395|Everolimus|everolimus|mesh-list
138906446|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138906447|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906448|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
138906449|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
138906450|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
138906451|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906452|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138906453|NCT00876395|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138906454|NCT00876395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138906455|NCT00876395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906456|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138376078|NCT01437982|Hormones|hormones|mesh-ancestor
138906457|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
138906458|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906460|NCT05758662|Fluorides|fluorides|mesh-list
138906461|NCT05758662|Sodium Fluoride|sodium fluoride|mesh-list
138906462|NCT05758662|Cariostatic Agents|cariostatic agents|mesh-ancestor
138906463|NCT05758662|Protective Agents|protective agents|mesh-ancestor
138906464|NCT05758662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906465|NCT05758662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138906466|NCT05758662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906467|NCT02633657|Gabapentin|gabapentin|mesh-list
138906468|NCT02633657|Analgesics|analgesics|mesh-ancestor
138906469|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
138906470|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906471|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906472|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
138906473|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138906474|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138906475|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138906477|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138906478|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138906479|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906480|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906481|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
138906482|NCT02626169|Clopidogrel|clopidogrel|mesh-list
138906483|NCT02626169|Ticagrelor|ticagrelor|mesh-list
138906484|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138906485|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138906486|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138906487|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138906488|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
138906489|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906490|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906491|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906493|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906494|NCT04148183|Metformin|metformin|mesh-list
138906495|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
138446673|NCT01845363|Cefazolin|cefazolin|mesh-list
138906496|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138906497|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906498|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138906499|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138906500|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138906501|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
138906502|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906503|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138906504|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138906505|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906506|NCT02633579|Erythromycin|erythromycin|mesh-list
138906507|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
138906508|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138906509|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
138906510|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
138906511|NCT02633579|Atropine|atropine|mesh-list
138906512|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138906513|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138906514|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138906515|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
138906516|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906517|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906518|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138906519|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
138906520|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
138906521|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
138906522|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138906523|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138808516|NCT02611804|Analgesics|analgesics|mesh-ancestor
138906524|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
138906525|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906526|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906527|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138906528|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906529|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906530|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138906531|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906532|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
138906533|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138906534|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
138906535|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268255|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138906536|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906537|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138906538|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
138906539|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138906540|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138906541|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138906542|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
138906543|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906544|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906545|NCT00685607|Simethicone|simethicone|mesh-list
138906546|NCT00685607|Loperamide|loperamide|mesh-list
138906547|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
138906548|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906549|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
138906550|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906552|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
138906553|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
138906554|NCT00657059|Prednisone|prednisone|mesh-list
138906555|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
138906556|NCT00657059|Irbesartan|irbesartan|mesh-list
138906557|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138906558|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
138906559|NCT00657059|Hormones|hormones|mesh-ancestor
138906560|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138906561|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906562|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138906563|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906564|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138906565|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138906566|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
138906567|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138906568|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906569|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906570|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906571|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
138906573|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906574|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906575|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138906576|NCT00657059|Protective Agents|protective agents|mesh-ancestor
138446740|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
138906577|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138906578|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138906579|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138906580|NCT00667732|Exenatide|exenatide|mesh-list
138906581|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138906582|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906583|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138906584|NCT00667732|Incretins|incretins|mesh-ancestor
138906585|NCT00667732|Hormones|hormones|mesh-ancestor
138906586|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138906587|NCT04161209|Citalopram|citalopram|mesh-list
138906588|NCT04161209|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138906589|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138906590|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138906591|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906592|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906593|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
138906594|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906595|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138906596|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
138906597|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138906598|NCT04161053|Rifaximin|rifaximin|mesh-list
138906600|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138906601|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906602|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906603|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138906604|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138906605|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
138906606|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138906607|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138906608|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
138906609|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906610|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906611|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138906612|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
138906613|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138906614|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138906615|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138906616|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
138906617|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808857|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138906618|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906619|NCT00681785|Dalteparin|dalteparin|mesh-list
138906620|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138906621|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
138906622|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138906623|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138906624|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906625|NCT00671788|Dasatinib|dasatinib|mesh-list
138906626|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906627|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138906628|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808923|NCT02848950|Metformin|metformin|mesh-list
138906629|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906631|NCT02626481|Daratumumab|daratumumab|mesh-list
138906632|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138906633|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
138906634|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
138906635|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906636|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906637|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906638|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
138906639|NCT02626481|Hormones|hormones|mesh-ancestor
138446826|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
138268387|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
138906640|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138906641|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138906642|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906645|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138906646|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906647|NCT00681941|Sevelamer|sevelamer|mesh-list
138906648|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
138906649|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
138906650|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906651|NCT00657137|Capecitabine|capecitabine|mesh-list
138906652|NCT00657137|Lapatinib|lapatinib|mesh-list
138906653|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138906654|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
138906655|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906656|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906657|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138906658|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906659|NCT00777244|Mitotane|mitotane|mesh-list
138906660|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138906661|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268439|NCT00006436|Tubulin Modulators|tubulin modulators|mesh-ancestor
138906662|NCT04160897|Tenofovir|tenofovir|mesh-list
138906663|NCT04160897|Entecavir|entecavir|mesh-list
138906664|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
138906665|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906666|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138809044|NCT00902304|Diuretics|diuretics|mesh-ancestor
138906667|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138906668|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906669|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906670|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138906671|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138906673|NCT00777322|Dextrans|dextrans|mesh-list
138906674|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
138906675|NCT00777322|Vitamins|vitamins|mesh-ancestor
138906676|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
138906677|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906678|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138906679|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
138906680|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
138906681|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
138906682|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
138906683|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138906684|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
138809092|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
138906685|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138906686|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138906687|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906688|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906689|NCT00682019|Urological Agents|urological agents|mesh-ancestor
138906690|NCT00779896|Tazarotene|tazarotene|mesh-list
138906691|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
138906692|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
138906693|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138906694|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138906695|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138906696|NCT02556268|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
138906697|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
138906699|NCT02556268|Riociguat|riociguat|mesh-list
138906700|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
138906701|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
138906702|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906703|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
138906704|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906705|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138906706|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138906707|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906708|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138906709|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138906710|NCT00875615|Carboplatin|carboplatin|mesh-list
138906711|NCT00875615|Sorafenib|sorafenib|mesh-list
138906712|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906713|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138268535|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906714|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906715|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906716|NCT02626559|Bupivacaine|bupivacaine|mesh-list
138906717|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
138906718|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
138906719|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138906720|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906721|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
138906722|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906724|NCT00768508|Ondansetron|ondansetron|mesh-list
138906725|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138906726|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138809269|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
138906727|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906728|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
138906729|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906730|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
138906731|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
138906732|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906733|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
138906734|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
138906735|NCT00768508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138906736|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138906737|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
138906738|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906739|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906740|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
138906741|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138906742|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138906743|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138906744|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138906745|NCT00777478|Sunitinib|sunitinib|mesh-list
138906746|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906747|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138906748|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138906749|NCT00777478|Growth Substances|growth substances|mesh-ancestor
138906750|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906751|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
138906752|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138906753|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906754|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906755|NCT00780598|Tosedostat|tosedostat|mesh-list
138906756|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906757|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906758|NCT00780754|Dutasteride|dutasteride|mesh-list
138906759|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138906760|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138906761|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906762|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906763|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
138906764|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138906765|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906766|NCT00780832|Caffeine|caffeine|mesh-list
138906767|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138906768|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138906769|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906770|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138906771|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906772|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906773|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138906774|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138906775|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
138906776|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906777|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
138906779|NCT00597701|Baclofen|baclofen|mesh-list
138906780|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138906781|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906782|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138906783|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906785|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
138906786|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
138906787|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906788|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268697|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268698|NCT02363803|Lidocaine|lidocaine|mesh-list
138268699|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
138268700|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
138268701|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138268702|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906789|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
138906790|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
138558813|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138906791|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
138906792|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906793|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138906794|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138906795|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138906796|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138906797|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138906798|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
138906799|NCT02556658|Anesthetics|anesthetics|mesh-list
138906800|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138906801|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906802|NCT00682721|Valacyclovir|valacyclovir|mesh-list
138268738|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906803|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
138906804|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906805|NCT02556814|Dexamethasone|dexamethasone|mesh-list
138906806|NCT02556814|Caffeic acid|caffeic acid|mesh-list
138906807|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138906808|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
138906809|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
138906810|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906811|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906812|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906814|NCT02556814|Hormones|hormones|mesh-ancestor
138906815|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138906816|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138906817|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906818|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
138446950|NCT01847768|Sequestering Agents|sequestering agents|mesh-ancestor
138906819|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906820|NCT02556814|Protective Agents|protective agents|mesh-ancestor
138906821|NCT00682955|Zinc|zinc|mesh-list
138906822|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
138906823|NCT00682955|Trace Elements|trace elements|mesh-ancestor
138906824|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
138906825|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906826|NCT00682955|Astringents|astringents|mesh-ancestor
138906827|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
138906828|NCT00686621|Posaconazole|posaconazole|mesh-list
138809764|NCT02599675|Vitamin D|vitamin d|mesh-list
138906829|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
138906830|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906831|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138906832|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138906833|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138906834|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138906835|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138906836|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906837|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906838|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138906839|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
138906840|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138906841|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906842|NCT00683111|Esomeprazole|esomeprazole|mesh-list
138906843|NCT00683111|Famotidine|famotidine|mesh-list
138906844|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138906845|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906846|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138906847|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906848|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906849|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138906850|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
138906851|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
138906852|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906853|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906854|NCT04138901|Ropivacaine|ropivacaine|mesh-list
138906855|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
138906856|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
138906857|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138906858|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906859|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
138906860|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906861|NCT00922649|Insulin|insulin|mesh-list
138906862|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138906863|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906864|NCT04142411|Insulin|insulin|mesh-list
138906865|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138906866|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
138906867|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138906868|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906869|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138268845|NCT05664139|Paclitaxel|paclitaxel|mesh-list
138906870|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
138906871|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
138906872|NCT04142411|Protective Agents|protective agents|mesh-ancestor
138906873|NCT00683189|Warfarin|warfarin|mesh-list
138906874|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
138906875|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
138906876|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906877|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
138906878|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138906879|NCT00667576|Protective Agents|protective agents|mesh-ancestor
138906880|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906881|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138906882|NCT04141787|Cefazolin|cefazolin|mesh-list
138906883|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
138906884|NCT04141787|Daptomycin|daptomycin|mesh-list
138906885|NCT04141787|Cloxacillin|cloxacillin|mesh-list
138906886|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906887|NCT02557594|Tenofovir|tenofovir|mesh-list
138906888|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
138906889|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138906890|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138906891|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138906892|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906893|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906894|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138906895|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138906896|NCT00687011|Dexamethasone|dexamethasone|mesh-list
138906897|NCT00687011|Palonosetron|palonosetron|mesh-list
138906898|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138906899|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
138906900|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
138268882|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
138906901|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906902|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906903|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906904|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
138906905|NCT00687011|Hormones|hormones|mesh-ancestor
138906906|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138906907|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138906908|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138906909|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138906910|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138906911|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
138906912|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906913|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906914|NCT00683267|Capsaicin|capsaicin|mesh-list
138906915|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
138906916|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
138906917|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
138906918|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906919|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906920|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138906921|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138906922|NCT00687245|Esomeprazole|esomeprazole|mesh-list
138906923|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138906924|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138906925|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138906926|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906927|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906928|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138906929|NCT00690521|Metolazone|metolazone|mesh-list
138906930|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138906931|NCT00690521|Diuretics|diuretics|mesh-ancestor
138906932|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
138906933|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906934|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138906935|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138906936|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906937|NCT00666718|Insulin|insulin|mesh-list
138906939|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
138906940|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
138906941|NCT00666718|Protamines|protamines|mesh-list
138906942|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138906943|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906944|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
138906945|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906947|NCT00683735|Metformin|metformin|mesh-list
138906948|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138906949|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138906950|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906951|NCT00683735|Incretins|incretins|mesh-ancestor
138906952|NCT00683735|Hormones|hormones|mesh-ancestor
138906953|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269037|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
138906954|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138906955|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
138906956|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906957|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906958|NCT04139681|Menthol|menthol|mesh-list
138906959|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
138906960|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
138906961|NCT04047394|Rasburicase|rasburicase|mesh-list
138906962|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
138906963|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138906964|NCT02625779|Valproic Acid|valproic acid|mesh-list
138906965|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
138906966|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906967|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906969|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906970|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906971|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
138906972|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138906973|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138906974|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138906975|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
138906976|NCT00667420|Epirubicin|epirubicin|mesh-list
138906977|NCT00667420|Panitumumab|panitumumab|mesh-list
138906978|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810287|NCT02767245|Thiamine|thiamine|mesh-list
138906979|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906980|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138906981|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138906982|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138906983|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138906984|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138906986|NCT04141319|Epinephrine|epinephrine|mesh-list
138906987|NCT04141319|Ropivacaine|ropivacaine|mesh-list
138906988|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
138906989|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
138906990|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138906991|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138906992|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
138906993|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138906994|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138906996|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
138906997|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138906998|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138906999|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138907000|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138907001|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
138907002|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138907003|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
138907004|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
138907005|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
138907006|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138907007|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138907008|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138907009|NCT04141319|Analgesics|analgesics|mesh-ancestor
138907010|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138907011|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907012|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138907013|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907015|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138907016|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
138907017|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138907018|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907019|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907020|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138810473|NCT04223973|Insulin|insulin|mesh-list
138907021|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138907022|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138907023|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138907024|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
138907025|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
138907026|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
138907027|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138907028|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907029|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138907030|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
138907031|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138907032|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907033|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907034|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907035|NCT00778024|Fluoxetine|fluoxetine|mesh-list
138907036|NCT00778024|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138907037|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138907038|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138269188|NCT00003213|Hormones|hormones|mesh-ancestor
138907039|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907040|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138907041|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
138907042|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907043|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138907044|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
138907045|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138907046|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138907047|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138907048|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907049|NCT00853658|Enalapril|enalapril|mesh-list
138907050|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138907051|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
138907052|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907053|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269245|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138907054|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138907055|NCT00690677|Panobinostat|panobinostat|mesh-list
138907056|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907057|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138907058|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810569|NCT02765373|Letrozole|letrozole|mesh-list
138907059|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907060|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138907062|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138907063|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
138907064|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
138907065|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907066|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907067|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138907068|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
138907069|NCT00781300|Hormones|hormones|mesh-ancestor
138907070|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138907071|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138907072|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907073|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138907075|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138907076|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138907077|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138907078|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907079|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
138907080|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907081|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138907082|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
138907083|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907084|NCT00666562|Protective Agents|protective agents|mesh-ancestor
138907085|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907086|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138907087|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138907088|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907089|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138907090|NCT00769054|Ropivacaine|ropivacaine|mesh-list
138907091|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
138907092|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
138907093|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138907094|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907095|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
138907096|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907097|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
138907098|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138907099|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
138907100|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907101|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907102|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138907103|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
138907104|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907105|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907106|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138907107|NCT00666328|Clevidipine|clevidipine|mesh-list
138907108|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138907109|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138907110|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907111|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138907112|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907113|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138907114|NCT00778180|Furosemide|furosemide|mesh-list
138188147|NCT04352959|Betadex|betadex|mesh-list
138907115|NCT00778180|Diuretics|diuretics|mesh-ancestor
138907116|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
138907117|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907118|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138907119|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138907120|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907121|NCT00769210|Simvastatin|simvastatin|mesh-list
138810724|NCT02764749|Phenol|phenol|mesh-list
138907122|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138907123|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138907124|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
138907125|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907126|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138907127|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138907128|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907130|NCT00690911|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138907131|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138907132|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907133|NCT00781846|Sirolimus|sirolimus|mesh-list
138907134|NCT00781846|Bevacizumab|bevacizumab|mesh-list
138269401|NCT03256253|Pregabalin|pregabalin|mesh-list
138907135|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138907136|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907137|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138907138|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138907139|NCT00781846|Growth Substances|growth substances|mesh-ancestor
138907140|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907141|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
138907142|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138907143|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907144|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138907145|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
138907146|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138907147|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
138907149|NCT00853580|L 647318|l 647318|mesh-list
138907150|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
138907151|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138907152|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138907153|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
138907154|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907155|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138907156|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138907157|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810805|NCT02758509|Ritonavir|ritonavir|mesh-list
138907158|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
138907159|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
138907160|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138907161|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138907162|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907163|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138907164|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138907165|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907166|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907167|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269454|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907168|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138559184|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
138907169|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
138907170|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138907171|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907172|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138907173|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138907174|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138907175|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138907176|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138907177|NCT00778414|Amoxicillin|amoxicillin|mesh-list
138907178|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
138907179|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
138907180|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138907181|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138907182|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907183|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907184|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907185|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138907186|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
138907187|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
138907188|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
138907189|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907190|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
138907191|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907192|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
138907193|NCT00769288|Growth Substances|growth substances|mesh-ancestor
138907194|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907195|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
138907196|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138907197|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907198|NCT00688805|Propranolol|propranolol|mesh-list
138907199|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138907200|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138907201|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
138907202|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138907203|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907204|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907205|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138907206|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138269495|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907207|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
138907208|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
138907209|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
138907210|NCT04136639|Fluorides|fluorides|mesh-list
138907211|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
138907212|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
138907213|NCT04136639|Protective Agents|protective agents|mesh-ancestor
138907214|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907215|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811010|NCT05429775|Budesonide|budesonide|mesh-list
138907216|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138907217|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907219|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907220|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138907221|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138907222|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
138907223|NCT02613026|Docetaxel|docetaxel|mesh-list
138907224|NCT02613026|Pirarubicin|pirarubicin|mesh-list
138907225|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138907226|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
138907227|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907228|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907229|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138907230|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
138907231|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907232|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907233|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138907234|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
138907235|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
138907236|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
138907237|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138907239|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138907240|NCT00778726|Diuretics|diuretics|mesh-ancestor
138907241|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
138447343|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
138907242|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907243|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138269525|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138907244|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138907245|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907246|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138907248|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907249|NCT00688883|Fludarabine|fludarabine|mesh-list
138907250|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
138907251|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907252|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138907253|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
138907254|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907255|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138907256|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
138907257|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907258|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
138907259|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138907261|NCT00769522|Fludarabine|fludarabine|mesh-list
138907262|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138907263|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
138907264|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907265|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907266|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138907267|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
138907268|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907269|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907270|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138907271|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138907272|NCT00688961|Aspirin|aspirin|mesh-list
138907273|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138907274|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138907275|NCT00688961|Analgesics|analgesics|mesh-ancestor
138907276|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
138907277|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907278|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907279|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138907280|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907281|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138907282|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138907283|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269565|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
138907284|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138907285|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138907286|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907287|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
138907288|NCT00782470|Factor VIII|factor viii|mesh-list
138907289|NCT00782470|Coagulants|coagulants|mesh-ancestor
138907290|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
138907291|NCT00865280|Linezolid|linezolid|mesh-list
138907292|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138907293|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907294|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138907295|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138907296|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907297|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907298|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907299|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138907300|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138907301|NCT00782548|Morphine|morphine|mesh-list
138907302|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138907303|NCT00782548|Narcotics|narcotics|mesh-ancestor
138907304|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138907305|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907306|NCT00782548|Analgesics|analgesics|mesh-ancestor
138907307|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
138907308|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907309|NCT00689195|Curcumin|curcumin|mesh-list
138907310|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138907311|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138907312|NCT00689195|Analgesics|analgesics|mesh-ancestor
138907313|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
138907314|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907315|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907316|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138907317|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907318|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907319|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907320|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907321|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138907322|NCT00865124|Spironolactone|spironolactone|mesh-list
138907323|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138907324|NCT00865124|Diuretics|diuretics|mesh-ancestor
138907325|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
138447410|NCT01851265|Olaparib|olaparib|mesh-list
138907326|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907327|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138907328|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138907329|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907330|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138907331|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
138907332|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138907333|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138907334|NCT00691067|Mifepristone|mifepristone|mesh-list
138907335|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138907336|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
138907337|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138907338|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907339|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138907340|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138907341|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138907342|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
138907343|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138907344|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138907345|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
138907346|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138907347|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
138907348|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138269642|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269643|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907349|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138907350|NCT00691145|Tacrolimus|tacrolimus|mesh-list
138907351|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138907352|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
138907353|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907354|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138907355|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907356|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907357|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138907358|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138907359|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138907360|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
138907361|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138907362|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907363|NCT00694967|Progestins|progestins|mesh-ancestor
138907364|NCT00694967|Hormones|hormones|mesh-ancestor
138907365|NCT00695045|Morphine|morphine|mesh-list
138907366|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138907368|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138907369|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907370|NCT00695045|Analgesics|analgesics|mesh-ancestor
138907371|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
138907372|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907373|NCT02624453|Fluconazole|fluconazole|mesh-list
138907374|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138907375|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
138907376|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907377|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138907378|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138907379|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907380|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907381|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138907382|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
138811438|NCT02612116|Ticagrelor|ticagrelor|mesh-list
138907383|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138907384|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907385|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138907386|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138907387|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
138907388|NCT00819234|Pramlintide|pramlintide|mesh-list
138907389|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138907390|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907392|NCT00695201|Irinotecan|irinotecan|mesh-list
138907393|NCT00695201|Floxuridine|floxuridine|mesh-list
138907394|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907395|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138907396|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138907397|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907398|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907399|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138907400|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
138907401|NCT00689585|Ethosuximide|ethosuximide|mesh-list
138907402|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
138907403|NCT00783016|Morphine|morphine|mesh-list
138907404|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138907405|NCT00783016|Narcotics|narcotics|mesh-ancestor
138907406|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138907407|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907408|NCT00783016|Analgesics|analgesics|mesh-ancestor
138907409|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
138269727|NCT00356395|Candesartan|candesartan|mesh-list
138907410|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907411|NCT00769990|Genistein|genistein|mesh-list
138907412|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138907413|NCT00769990|Protective Agents|protective agents|mesh-ancestor
138907414|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907415|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907416|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138907417|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907418|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907419|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
138907420|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138907421|NCT00769990|Estrogens|estrogens|mesh-ancestor
138907422|NCT00769990|Hormones|hormones|mesh-ancestor
138907423|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138907424|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
138907425|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138907426|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138907427|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
138907428|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907429|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138907430|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138907431|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907432|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907433|NCT02555800|Cidofovir|cidofovir|mesh-list
138907434|NCT02555800|Bevacizumab|bevacizumab|mesh-list
138907435|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138907436|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811557|NCT06178627|Flucytosine|flucytosine|mesh-list
138907438|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138907440|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907441|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
138907442|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
138907443|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907444|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907445|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907446|NCT00783172|Gemcitabine|gemcitabine|mesh-list
138907447|NCT00783172|Mitogens|mitogens|mesh-list
138907448|NCT00783172|Enkephalins|enkephalins|mesh-list
138907449|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138907450|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
138907451|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907452|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907453|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907454|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
138907455|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138907456|NCT00783250|Albuterol|albuterol|mesh-list
138269811|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138269814|NCT05210582|Afamelanotide|afamelanotide|mesh-list
138907457|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
138907458|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138907459|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
138907460|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907461|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907462|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138907463|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
138907464|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
138907465|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138907466|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
138907467|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138907468|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907469|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
138907470|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138907471|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138907472|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138907473|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138907474|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
138907475|NCT02555644|Cetuximab|cetuximab|mesh-list
138907476|NCT02555644|Prexasertib|prexasertib|mesh-list
138907477|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907478|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138907479|NCT02555644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138907480|NCT02555644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907481|NCT02555644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907482|NCT00871403|Pemetrexed|pemetrexed|mesh-list
138907483|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907484|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907485|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269870|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907486|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138907487|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138907488|NCT00691379|Paclitaxel|paclitaxel|mesh-list
138907489|NCT00691379|Bevacizumab|bevacizumab|mesh-list
138907490|NCT00691379|Carboplatin|carboplatin|mesh-list
138907491|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138907492|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907493|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
138907494|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
138907495|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
138811783|NCT05917340|Isoniazid|isoniazid|mesh-list
138907496|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907497|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138907498|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138907499|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138907500|NCT00691379|Growth Substances|growth substances|mesh-ancestor
138907501|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907502|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
138907503|NCT02624531|Cisplatin|cisplatin|mesh-list
138907504|NCT02624531|Taxane|taxane|mesh-list
138907505|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907506|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
138907507|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138907508|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
138907509|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907510|NCT04136015|Dasatinib|dasatinib|mesh-list
138907511|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907512|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138907513|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907514|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907516|NCT02624063|Simeprevir|simeprevir|mesh-list
138907517|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
138907518|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907519|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
138907520|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907521|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907522|NCT05298683|Acetaminophen|acetaminophen|mesh-list
138907523|NCT05298683|Diphenhydramine|diphenhydramine|mesh-list
138907524|NCT05298683|Promethazine|promethazine|mesh-list
138907525|NCT05298683|Dexamethasone|dexamethasone|mesh-list
138907526|NCT05298683|Pomalidomide|pomalidomide|mesh-list
138907527|NCT05298683|Ranitidine|ranitidine|mesh-list
138907528|NCT05298683|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138907529|NCT05298683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138907530|NCT05298683|Antiemetics|antiemetics|mesh-ancestor
138907531|NCT05298683|Autonomic Agents|autonomic agents|mesh-ancestor
138907532|NCT05298683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811897|NCT05718024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811898|NCT05718024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138811899|NCT05718024|Anesthetics, General|anesthetics, general|mesh-ancestor
138811900|NCT05718024|Anesthetics|anesthetics|mesh-ancestor
138811901|NCT05718024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138811902|NCT05718024|Narcotics|narcotics|mesh-ancestor
138811903|NCT05718024|Antidepressive Agents|antidepressive agents|mesh-ancestor
138811904|NCT05718024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138811905|NCT05700266|Aspirin|aspirin|mesh-list
138811906|NCT05700266|Rivaroxaban|rivaroxaban|mesh-list
138907533|NCT05298683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907534|NCT05298683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138907535|NCT05298683|Glucocorticoids|glucocorticoids|mesh-ancestor
138907536|NCT05298683|Hormones|hormones|mesh-ancestor
138907537|NCT05298683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138447571|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
138907538|NCT05298683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138907539|NCT05298683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269969|NCT05922839|Zanubrutinib|zanubrutinib|mesh-list
138907540|NCT05298683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138907541|NCT05298683|Analgesics|analgesics|mesh-ancestor
138907542|NCT05298683|Sensory System Agents|sensory system agents|mesh-ancestor
138907543|NCT05298683|Antipyretics|antipyretics|mesh-ancestor
138907544|NCT05298683|Immunologic Factors|immunologic factors|mesh-ancestor
138907545|NCT05298683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138907546|NCT05298683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138907547|NCT05298683|Growth Substances|growth substances|mesh-ancestor
138907548|NCT05298683|Growth Inhibitors|growth inhibitors|mesh-ancestor
138907549|NCT05298683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138907550|NCT05298683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138907551|NCT05298683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138907552|NCT05298683|Anesthetics, Local|anesthetics, local|mesh-ancestor
138907553|NCT05298683|Anesthetics|anesthetics|mesh-ancestor
138907554|NCT05298683|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138907555|NCT05298683|Histamine Antagonists|histamine antagonists|mesh-ancestor
138907556|NCT05298683|Histamine Agents|histamine agents|mesh-ancestor
138907557|NCT05298683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138812017|NCT05279937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812018|NCT05238883|Tislelizumab|tislelizumab|mesh-list
138812019|NCT05238883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812021|NCT05179499|Norepinephrine|norepinephrine|mesh-list
138812022|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138907558|NCT05298683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907559|NCT05298683|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138907560|NCT05298683|Antipruritics|antipruritics|mesh-ancestor
138907561|NCT05298683|Dermatologic Agents|dermatologic agents|mesh-ancestor
138907562|NCT05298683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138907563|NCT05298683|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138907564|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
138907565|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
138907566|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138907567|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138907568|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907569|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907570|NCT00853112|Urological Agents|urological agents|mesh-ancestor
138907571|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
138270013|NCT05922384|Melphalan|melphalan|mesh-list
138907572|NCT02624141|Hematinics|hematinics|mesh-ancestor
138907573|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
138907574|NCT00691613|Hematinics|hematinics|mesh-ancestor
138907575|NCT00460603|Bevacizumab|bevacizumab|mesh-list
138907577|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138907578|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907579|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138907580|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138907581|NCT00460603|Growth Substances|growth substances|mesh-ancestor
138907582|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907583|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
138907584|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138907585|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907586|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907587|NCT00696059|Adalimumab|adalimumab|mesh-list
138907588|NCT00696059|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138907589|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138907590|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907592|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138907593|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138907594|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138812141|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812142|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812143|NCT04965090|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138812144|NCT04965090|Lazertinib|lazertinib|mesh-list
138812145|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138812146|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812147|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812148|NCT04965090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812149|NCT04965090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812150|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
138812170|NCT04903119|Trametinib|trametinib|mesh-list
138907595|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
138907596|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
138907597|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270046|NCT05921370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138907598|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907599|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138907600|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138907601|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
138907602|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138907603|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907604|NCT00700544|Norethandrolone|norethandrolone|mesh-list
138907605|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
138907606|NCT00700544|Hormones|hormones|mesh-ancestor
138907607|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138907608|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907609|NCT02612792|Atorvastatin|atorvastatin|mesh-list
138907610|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138907611|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138907612|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
138907613|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907614|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138907615|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138907616|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907618|NCT00662038|Analgesics|analgesics|mesh-ancestor
138907619|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
138907620|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907621|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907622|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138907623|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138907624|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138907625|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907626|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907627|NCT00701792|Liver Extracts|liver extracts|mesh-list
138907628|NCT00701792|Hematinics|hematinics|mesh-ancestor
138907629|NCT00784498|Midazolam|midazolam|mesh-list
138907630|NCT00784498|Ketamine|ketamine|mesh-list
138907631|NCT00784498|Propofol|propofol|mesh-list
138907632|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138907633|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138907634|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907635|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138907636|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
138907637|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
138907638|NCT00784498|Analgesics|analgesics|mesh-ancestor
138464217|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
138907639|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
138907640|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907641|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138907642|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138907643|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138907644|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138907645|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447687|NCT01852994|Androgens|androgens|mesh-ancestor
138907646|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138907647|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138907648|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138907649|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138270132|NCT05920512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138907650|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
138907651|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
138812299|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812300|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138907653|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138907654|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
138907655|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138907656|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138907657|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907658|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907659|NCT01022983|Protective Agents|protective agents|mesh-ancestor
138907660|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907661|NCT00912860|Interferons|interferons|mesh-list
138907662|NCT00912860|Interferon-beta|interferon-beta|mesh-list
138907663|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
138907664|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907665|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
138907666|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907667|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
138907668|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907669|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138907670|NCT02623673|Dexamethasone|dexamethasone|mesh-list
138907671|NCT02623673|Bevacizumab|bevacizumab|mesh-list
138907672|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138907673|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907674|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138907675|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138907676|NCT02623673|Growth Substances|growth substances|mesh-ancestor
138907677|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907678|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
138907679|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138907680|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
138907681|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
138907682|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907683|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138270181|NCT05897268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907684|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
138907685|NCT02623673|Hormones|hormones|mesh-ancestor
138907686|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138907687|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138907688|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
138907689|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138559722|NCT05997693|Ticagrelor|ticagrelor|mesh-list
138907690|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
138907691|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138907692|NCT00459979|Sunitinib|sunitinib|mesh-list
138907694|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138907695|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138907696|NCT00459979|Growth Substances|growth substances|mesh-ancestor
138907697|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907698|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
138907699|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138907700|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907701|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907702|NCT00783484|Maraviroc|maraviroc|mesh-list
138907703|NCT00783484|Darunavir|darunavir|mesh-list
138907704|NCT00783484|Midazolam|midazolam|mesh-list
138907705|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138270222|NCT05883852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907706|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138907707|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138907708|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907709|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138907710|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138907711|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138907712|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138907713|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
138907714|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
138907715|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
138907716|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
138907717|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138907718|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907719|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138907720|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138907721|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138907722|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138907723|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
138907724|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907725|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138907726|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138907727|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138907728|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
138907729|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907731|NCT00828672|Capecitabine|capecitabine|mesh-list
138907732|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
138907733|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138907734|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907735|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138907736|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138907737|NCT00828672|Growth Substances|growth substances|mesh-ancestor
138907738|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907739|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
138907740|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138907741|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
138907742|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907743|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138907744|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138907745|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907746|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907747|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138907748|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
138907749|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138907750|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907751|NCT00873119|Paclitaxel|paclitaxel|mesh-list
138907752|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138907753|NCT00873119|Carboplatin|carboplatin|mesh-list
138907754|NCT00873119|Belinostat|belinostat|mesh-list
138907755|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138907756|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907757|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
138907758|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
138907759|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
138907760|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907761|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138907762|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907763|NCT00661726|Decitabine|decitabine|mesh-list
138907764|NCT00661726|Azacitidine|azacitidine|mesh-list
138907765|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138907766|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
138559779|NCT05997238|Triamcinolone|triamcinolone|mesh-list
138907767|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907768|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907769|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907770|NCT00706680|Cyclosporine|cyclosporine|mesh-list
138907771|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
138907773|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138907774|NCT00706680|Cyclosporins|cyclosporins|mesh-list
138907775|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
138907776|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138907777|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
138907778|NCT00706680|Hormones|hormones|mesh-ancestor
138270313|NCT05796791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138270315|NCT05759364|Papaverine|papaverine|mesh-list
138907779|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138907780|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907781|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138907782|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907783|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907784|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907786|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
138907787|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
138907788|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907789|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
138907790|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907791|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138907792|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138907793|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138907794|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
138907795|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138907796|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138907797|NCT00706680|Protective Agents|protective agents|mesh-ancestor
138907798|NCT02624999|Cisplatin|cisplatin|mesh-list
138907799|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907800|NCT02612480|Aspirin|aspirin|mesh-list
138907801|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
138907802|NCT02612480|Clopidogrel|clopidogrel|mesh-list
138907803|NCT02612480|Ticagrelor|ticagrelor|mesh-list
138907804|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138907805|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138907806|NCT02612480|Analgesics|analgesics|mesh-ancestor
138907807|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
138907808|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270352|NCT05693454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138270353|NCT05693454|Narcotics|narcotics|mesh-ancestor
138907809|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907810|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138907811|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907812|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138907813|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138907814|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907815|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138907816|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138907817|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907818|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
138907819|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138907820|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138907821|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138907822|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
138270400|NCT05601700|Paclitaxel|paclitaxel|mesh-list
138907823|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138907824|NCT00784966|Etanercept|etanercept|mesh-list
138907825|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138907826|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138907827|NCT00784966|Analgesics|analgesics|mesh-ancestor
138907828|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
138907829|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907830|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907831|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138907832|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907833|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138907834|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138907835|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
138907836|NCT02623595|Molgramostim|molgramostim|mesh-list
138907837|NCT02623595|Sargramostim|sargramostim|mesh-list
138907838|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
138907839|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907840|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559872|NCT05995314|Caffeine|caffeine|mesh-list
138907842|NCT00665392|Fluorouracil|fluorouracil|mesh-list
138907843|NCT00665392|Cetuximab|cetuximab|mesh-list
138907844|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907845|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
138907846|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
138907847|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
138907848|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270458|NCT05403138|Daratumumab|daratumumab|mesh-list
138270459|NCT05403138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907849|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
138907850|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138907851|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138907852|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
138907853|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907854|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138907855|NCT00851630|Lamivudine|lamivudine|mesh-list
138907856|NCT00851630|Zidovudine|zidovudine|mesh-list
138907857|NCT00851630|Abacavir|abacavir|mesh-list
138907858|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138907859|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138907860|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907861|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907862|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
138907863|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907864|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138907865|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138907866|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
138907867|NCT00459667|Interferons|interferons|mesh-list
138907868|NCT00459667|Interferon-beta|interferon-beta|mesh-list
138907869|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
138907870|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812853|NCT02166463|Prednisolone|prednisolone|mesh-list
138907871|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
138907872|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907873|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
138907874|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907875|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138907877|NCT02621255|Anesthetics|anesthetics|mesh-list
138447916|NCT01854749|Cisplatin|cisplatin|mesh-list
138907878|NCT02621255|Sevoflurane|sevoflurane|mesh-list
138907879|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
138270507|NCT05340465|Anticoagulants|anticoagulants|mesh-ancestor
138270510|NCT05303090|Lenvatinib|lenvatinib|mesh-list
138907880|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138907881|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907882|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
138907883|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907884|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138907885|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138907886|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
138907887|NCT00828204|Interferons|interferons|mesh-list
138907888|NCT00828204|Interferon-beta|interferon-beta|mesh-list
138907889|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
138907890|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907891|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
138907892|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138907893|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
138907894|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907895|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138907896|NCT00696215|Rasagiline|rasagiline|mesh-list
138907897|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138907898|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907899|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907900|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138907901|NCT00696215|Protective Agents|protective agents|mesh-ancestor
138907902|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907903|NCT00784186|Misoprostol|misoprostol|mesh-list
138907904|NCT00784186|Mifepristone|mifepristone|mesh-list
138907905|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138907906|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
138907907|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138907908|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907909|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138907910|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138907911|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
138812903|NCT02118467|Phenylephrine|phenylephrine|mesh-list
138907912|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138907913|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138907914|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138907915|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138907917|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138559937|NCT05980546|Hormones|hormones|mesh-ancestor
138907918|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138907919|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
138907920|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138907921|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
138907922|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138907923|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138907925|NCT00851552|Doxorubicin|doxorubicin|mesh-list
138907926|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138907927|NCT00851552|Bortezomib|bortezomib|mesh-list
138907928|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138907929|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907930|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
138907931|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907932|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907933|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138907934|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138907935|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138907936|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907937|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907938|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
138907939|NCT00785122|Molgramostim|molgramostim|mesh-list
138907940|NCT00785122|Imiquimod|imiquimod|mesh-list
138907941|NCT00785122|Sargramostim|sargramostim|mesh-list
138907942|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138907943|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
138812940|NCT02000622|Olaparib|olaparib|mesh-list
138907944|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907945|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138907946|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138447995|NCT01855321|Vitamin D|vitamin d|mesh-list
138907948|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907949|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907950|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138907951|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138907952|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
138907953|NCT04116554|Bupivacaine|bupivacaine|mesh-list
138907954|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
138907955|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
138812980|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138907956|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138907957|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907958|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
138907959|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138907960|NCT00700856|Pioglitazone|pioglitazone|mesh-list
138907961|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138907962|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907963|NCT00790114|Midazolam|midazolam|mesh-list
138907964|NCT00790114|Caffeine|caffeine|mesh-list
138907965|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138907966|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138907967|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138907968|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138907970|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138907971|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138907972|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138907973|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
138907974|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
138907975|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
138907976|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
138907977|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138907978|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907979|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138907980|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138907981|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138907982|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138907983|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138907984|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
138907985|NCT01023139|Sibutramine|sibutramine|mesh-list
138270628|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
138907986|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
138907987|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138907988|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
138907989|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138907990|NCT00459043|Docetaxel|docetaxel|mesh-list
138907991|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138907992|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
138907993|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
138907994|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
138907995|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138907996|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
138907997|NCT00795262|Quinapril|quinapril|mesh-list
138907998|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
138907999|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908000|NCT00795262|Protective Agents|protective agents|mesh-ancestor
138908001|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908002|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
138908003|NCT00795262|Vitamins|vitamins|mesh-ancestor
138908004|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
138908005|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138908006|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
138908007|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908008|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138908009|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
138448047|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
138908010|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138908011|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138908013|NCT00817206|Tacrolimus|tacrolimus|mesh-list
138908014|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138908015|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
138908016|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908017|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138908018|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908019|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908020|NCT02611518|Metformin|metformin|mesh-list
138908021|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138908022|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138908023|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908024|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138908025|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138908026|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
138908027|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908028|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138908029|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138908030|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908031|NCT01023607|Atorvastatin|atorvastatin|mesh-list
138908032|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138908033|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138908034|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138908035|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
138908036|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908037|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138908038|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138908039|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813145|NCT00740779|Silodosin|silodosin|mesh-list
138908040|NCT00665002|Sargramostim|sargramostim|mesh-list
138908041|NCT00665002|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138908042|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
138908043|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908044|NCT00665002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138908045|NCT00660010|Leuprolide|leuprolide|mesh-list
138908046|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138908047|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
138908048|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138908049|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908050|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138908051|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908053|NCT04015908|Celecoxib|celecoxib|mesh-list
138908054|NCT04015908|Pregabalin|pregabalin|mesh-list
138270703|NCT04806919|Hormones|hormones|mesh-ancestor
138908055|NCT04015908|Oxycodone|oxycodone|mesh-list
138908056|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138908057|NCT04015908|Analgesics|analgesics|mesh-ancestor
138908058|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
138908059|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908060|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908061|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
138908062|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
138908063|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138813197|NCT00734929|Aprepitant|aprepitant|mesh-list
138908064|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138908065|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908066|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138908067|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138908068|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138908069|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138908070|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138908071|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138908072|NCT04015908|Narcotics|narcotics|mesh-ancestor
138908073|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138908074|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138908075|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138908076|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138908077|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138908078|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908080|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
138908081|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138908082|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908083|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908084|NCT00873041|Deferasirox|deferasirox|mesh-list
138908085|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138908086|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
138448127|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
138908087|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
138270751|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138908088|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908090|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
138908091|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
138908092|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908093|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908094|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908095|NCT00795574|Infliximab|infliximab|mesh-list
138908096|NCT00795574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138908097|NCT00795574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138908098|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
138908099|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138908100|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138908101|NCT00785434|Escitalopram|escitalopram|mesh-list
138908102|NCT00785434|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138908103|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138908104|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138908105|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908106|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908107|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
138908108|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908109|NCT00790894|Epothilones|epothilones|mesh-list
138908110|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
138908111|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
138908112|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
138908113|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908114|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908116|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908117|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138908118|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138908119|NCT02623127|Growth Substances|growth substances|mesh-ancestor
138908120|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448170|NCT01856205|Antibodies|antibodies|mesh-list
138908121|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
138908122|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138908123|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908124|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908127|NCT05263492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138908128|NCT05263492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908129|NCT05263492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138908130|NCT05263492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908131|NCT05263492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138908132|NCT05263492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908133|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
138908134|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138908135|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
138908136|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908137|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
138908138|NCT04134611|Protective Agents|protective agents|mesh-ancestor
138908140|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138908141|NCT02620631|Narcotics|narcotics|mesh-ancestor
138908142|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138908143|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560158|NCT05722340|Anesthetics|anesthetics|mesh-list
138908145|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
138908146|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908147|NCT04030572|Clonidine|clonidine|mesh-list
138908148|NCT04030572|Analgesics|analgesics|mesh-ancestor
138908149|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
138908150|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908151|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908152|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138908153|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
138908154|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
138908155|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138908156|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138908157|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138908158|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
138908159|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908160|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908161|NCT00795808|Metformin|metformin|mesh-list
138908162|NCT00795808|Clomiphene|clomiphene|mesh-list
138908163|NCT00795808|Enclomiphene|enclomiphene|mesh-list
138908164|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
138908165|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138908166|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908167|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138908168|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
138908169|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138908170|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138908171|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
138908172|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138908173|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138908174|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138908175|NCT04135781|Paclitaxel|paclitaxel|mesh-list
138908176|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138908177|NCT04135781|Capecitabine|capecitabine|mesh-list
138908178|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
138908179|NCT04135781|Tegafur|tegafur|mesh-list
138908180|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138908181|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908182|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
138908183|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
138908184|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
138908185|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908186|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138908187|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
138908188|NCT04135313|Capecitabine|capecitabine|mesh-list
138908189|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
138908190|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138336596|NCT01024686|Vaccines|vaccines|mesh-list
138908191|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
138908192|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908193|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908194|NCT00692159|Pemetrexed|pemetrexed|mesh-list
138908195|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908196|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908197|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908198|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138908199|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138908200|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
138908201|NCT00692315|Vitamins|vitamins|mesh-ancestor
138908202|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
138813547|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138908203|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908204|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
138908205|NCT02623049|Anticoagulants|anticoagulants|mesh-list
138908206|NCT02608944|Adenosine|adenosine|mesh-list
138908207|NCT02608944|Regadenoson|regadenoson|mesh-list
138908208|NCT02608944|Analgesics|analgesics|mesh-ancestor
138908209|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
138908210|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908211|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908212|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138908213|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
138908214|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138908215|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
138908216|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
138908217|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138560234|NCT05688085|Vasodilator Agents|vasodilator agents|mesh-ancestor
138908218|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908219|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138908220|NCT00913614|SR 46349B|sr 46349b|mesh-list
138908221|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138908222|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138270918|NCT04328844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908223|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908224|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138908225|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138908226|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
138908227|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908228|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908229|NCT00664534|Insulin|insulin|mesh-list
138908230|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138908231|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
138908232|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
138908233|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138908234|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908235|NCT00913848|Valproic Acid|valproic acid|mesh-list
138908236|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
138908237|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908238|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908239|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
138908240|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908241|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908242|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
138908243|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138908244|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138908245|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138908246|NCT02620163|Amlodipine|amlodipine|mesh-list
138908247|NCT02620163|Telmisartan|telmisartan|mesh-list
138908248|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
138908249|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138908250|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138908251|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138908252|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138908253|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908254|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138908255|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908256|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
138270959|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
138908257|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138908258|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138908259|NCT02620163|Diuretics|diuretics|mesh-ancestor
138908260|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
138908261|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138908262|NCT05758116|Tislelizumab|tislelizumab|mesh-list
138908263|NCT05758116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138908264|NCT05758116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908265|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
138908266|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138908267|NCT00570310|Pregabalin|pregabalin|mesh-list
138908268|NCT00570310|Analgesics|analgesics|mesh-ancestor
138908269|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
138908270|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908271|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908272|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
138908273|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138908274|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138908275|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908276|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138908277|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138908278|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138813724|NCT02733237|Oxytocin|oxytocin|mesh-list
138908279|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138908280|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138908281|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
138908282|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
138908283|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138908284|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138908285|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908286|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
138908287|NCT00664066|Hematinics|hematinics|mesh-ancestor
138908288|NCT02619929|Vinorelbine|vinorelbine|mesh-list
138908289|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138908290|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908291|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
138908292|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
138908293|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
138908294|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908295|NCT00796198|Latanoprost|latanoprost|mesh-list
138908296|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138908297|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138908298|NCT02622503|Rituximab|rituximab|mesh-list
138908299|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138908300|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908301|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
138908302|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908303|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138908304|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138908305|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
138908306|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908307|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138908308|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138908309|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138908310|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138908311|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908312|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138908313|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138908314|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138908315|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
138908316|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908317|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908318|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138908319|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138908320|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
138908321|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138908322|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138448350|NCT01857193|Everolimus|everolimus|mesh-list
138908324|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138908325|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908326|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138908327|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138908328|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138908329|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
138908330|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908331|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908332|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138908333|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138908334|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
138908335|NCT00786058|Fluorouracil|fluorouracil|mesh-list
138908336|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
138908337|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908338|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138908339|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908340|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138908341|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
138908342|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908344|NCT00871169|Irinotecan|irinotecan|mesh-list
138908345|NCT00871169|Cetuximab|cetuximab|mesh-list
138908346|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271045|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271047|NCT04158440|Paclitaxel|paclitaxel|mesh-list
138908347|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138908348|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138908349|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908350|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908351|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138908352|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138908353|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138908354|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138908355|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138908356|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908357|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138908358|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138908359|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138908360|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
138908361|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908362|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908363|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138908364|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138560377|NCT05512039|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138908365|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
138908367|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138908368|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138908369|NCT00814632|Analgesics|analgesics|mesh-ancestor
138908370|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
138908371|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908372|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908373|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138908374|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138908375|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138908376|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138908377|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908378|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908379|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138908380|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138908381|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138908382|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
138908383|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908384|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138908385|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138908386|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908387|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
138908388|NCT02554942|Hematinics|hematinics|mesh-ancestor
138908389|NCT02619773|Mupirocin|mupirocin|mesh-list
138908390|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138908391|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138908392|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138908393|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908394|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908395|NCT02555488|Methylene Blue|methylene blue|mesh-list
138908396|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908397|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908398|NCT02554864|Lidocaine|lidocaine|mesh-list
138908399|NCT02554864|Ropivacaine|ropivacaine|mesh-list
138908400|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
138908401|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
138908402|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138271115|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138908403|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908404|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
138908405|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908406|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138908407|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138908408|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138908409|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138908410|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908411|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
138908412|NCT00851318|Methotrexate|methotrexate|mesh-list
138908413|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138908414|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
138908415|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138908416|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908417|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138908418|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
138908419|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908420|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908421|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
138908422|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908423|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138908424|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138908425|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
138908426|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138908427|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138908428|NCT00851318|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138908429|NCT00851318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138908430|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
138908432|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138908433|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138908434|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908435|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138908436|NCT00786370|Analgesics|analgesics|mesh-ancestor
138908437|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
138908438|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908439|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138908440|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138908441|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138908442|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
138908443|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908444|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908445|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138908446|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
138908448|NCT00796900|Dantrolene|dantrolene|mesh-list
138908449|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138908450|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908451|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138908452|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908453|NCT00791830|Irbesartan|irbesartan|mesh-list
138908454|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138908455|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138908456|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138908457|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908459|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138908460|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138908461|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
138908462|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908463|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908464|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908465|NCT00786448|Urological Agents|urological agents|mesh-ancestor
138908466|NCT04137653|Paclitaxel|paclitaxel|mesh-list
138908467|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138908468|NCT04137653|Carboplatin|carboplatin|mesh-list
138908469|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138908470|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908471|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
138908472|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
138908473|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
138908474|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908475|NCT00797056|Aspirin|aspirin|mesh-list
138908476|NCT00797056|Clopidogrel|clopidogrel|mesh-list
138908477|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138908478|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138908479|NCT00797056|Analgesics|analgesics|mesh-ancestor
138908480|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
138908481|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908482|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908483|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138908484|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138908485|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138908486|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138908487|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908488|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138908489|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138908490|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908491|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
138908492|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138908493|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138908494|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138908495|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
138908496|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908497|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
138908498|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
138908499|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
138908500|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138271237|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
138271238|NCT03631784|Pemetrexed|pemetrexed|mesh-list
138908501|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138908502|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908503|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908504|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908505|NCT00697151|Aspirin|aspirin|mesh-list
138908506|NCT00697151|Warfarin|warfarin|mesh-list
138908507|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138908508|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138908509|NCT00697151|Analgesics|analgesics|mesh-ancestor
138908510|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
138908511|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908512|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908513|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138908514|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138908515|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138908516|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138908517|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908518|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138908519|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138908520|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908521|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
138908522|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
138908523|NCT02621957|Pravastatin|pravastatin|mesh-list
138908524|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138908525|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138908526|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
138908527|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908528|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138908529|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138814281|NCT00806026|Pregabalin|pregabalin|mesh-list
138908530|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908531|NCT00851084|Leucovorin|leucovorin|mesh-list
138908532|NCT00851084|Folic Acid|folic acid|mesh-list
138908533|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
138908534|NCT00851084|Aflibercept|aflibercept|mesh-list
138908535|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
138908536|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908537|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138908538|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138908539|NCT00851084|Growth Substances|growth substances|mesh-ancestor
138908540|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908541|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
138908542|NCT00851084|Antidotes|antidotes|mesh-ancestor
138908543|NCT00851084|Protective Agents|protective agents|mesh-ancestor
138908544|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
138908545|NCT00851084|Vitamins|vitamins|mesh-ancestor
138271282|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138908546|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
138908547|NCT00851084|Hematinics|hematinics|mesh-ancestor
138908548|NCT02617199|Fentanyl|fentanyl|mesh-list
138908549|NCT02617199|Analgesics|analgesics|mesh-list
138908550|NCT02617199|Ropivacaine|ropivacaine|mesh-list
138908551|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
138908552|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138908553|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908554|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
138908555|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
138908556|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908557|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138908558|NCT02617199|Narcotics|narcotics|mesh-ancestor
138908559|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138908560|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138908561|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
138908563|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
138908564|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
138908565|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908566|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908567|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138908568|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138908569|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138908570|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
138908571|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908572|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271311|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908573|NCT02619149|Tazobactam|tazobactam|mesh-list
138908574|NCT02619149|Piperacillin|piperacillin|mesh-list
138908575|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138908576|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138908577|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138908578|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138908579|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908580|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908581|NCT04134065|Vitamin D|vitamin d|mesh-list
138908582|NCT04134065|Vitamins|vitamins|mesh-ancestor
138908583|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
138908584|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908585|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138908586|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
138560599|NCT05290129|Oxytocics|oxytocics|mesh-ancestor
138908587|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138448467|NCT01857817|Etodolac|etodolac|mesh-list
138908589|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908590|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
138908591|NCT02616731|Coagulants|coagulants|mesh-ancestor
138908592|NCT00850460|Atorvastatin|atorvastatin|mesh-list
138908593|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138908594|NCT00850460|Simvastatin|simvastatin|mesh-list
138908595|NCT00850460|Pravastatin|pravastatin|mesh-list
138271358|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271359|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
138271360|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271361|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138271362|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138271363|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138271364|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138271365|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271366|NCT03248167|Cannabidiol|cannabidiol|mesh-list
138271367|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
138271368|NCT03243552|Levodopa|levodopa|mesh-list
138271369|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138271370|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138271371|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
138271372|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138271373|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271374|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271376|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138271377|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
138271378|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138271379|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
138271382|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
138908596|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138908597|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138908598|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
138908599|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908600|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138908601|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138908603|NCT00661492|Cetuximab|cetuximab|mesh-list
138908604|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
138908605|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138908606|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908607|NCT00661492|Analgesics|analgesics|mesh-ancestor
138908608|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
138908609|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908610|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908611|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138908612|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138908613|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908614|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908615|NCT00693251|Sirolimus|sirolimus|mesh-list
138908616|NCT00693251|Paclitaxel|paclitaxel|mesh-list
138908617|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138908618|NCT00693251|Everolimus|everolimus|mesh-list
138908619|NCT00693251|Temsirolimus|temsirolimus|mesh-list
138908620|NCT00693251|MTOR Inhibitors|mtor inhibitors|mesh-list
138908621|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138908622|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908623|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
138908624|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
138908625|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
138908626|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908627|NCT00693251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138908628|NCT00693251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908629|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138908630|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
138271413|NCT03144804|Lamivudine|lamivudine|mesh-list
138271414|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138271415|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138271416|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908631|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908632|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138908633|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138908634|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138908635|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
138908637|NCT00792376|Etoricoxib|etoricoxib|mesh-list
138908638|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138908639|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138271452|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
138908640|NCT00792376|Analgesics|analgesics|mesh-ancestor
138908641|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
138908642|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908643|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908644|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138908645|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138908646|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138908647|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908648|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908649|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138908650|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138908651|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138908652|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138271519|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908653|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138908654|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908655|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138908656|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138908658|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
138908659|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908660|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908661|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138908662|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138560675|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138908663|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
138908664|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
138908665|NCT00814320|Antibodies|antibodies|mesh-list
138908666|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
138908667|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138908668|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138271581|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
138908669|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
138908670|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
138908671|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908672|NCT00869999|Rituximab|rituximab|mesh-list
138908673|NCT00869999|Everolimus|everolimus|mesh-list
138908674|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138908675|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908676|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
138908677|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908678|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138908679|NCT00869999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138908680|NCT00869999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138908681|NCT00869999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908682|NCT00869999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908683|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138908684|NCT04030988|Dexamethasone|dexamethasone|mesh-list
138908685|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138908686|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
138908687|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
138908688|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908689|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908690|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138908691|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
138908692|NCT04030988|Hormones|hormones|mesh-ancestor
138908693|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138908694|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138908695|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908696|NCT00703352|Eplerenone|eplerenone|mesh-list
138908697|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138908698|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
138908699|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138908700|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908701|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138908702|NCT00703352|Diuretics|diuretics|mesh-ancestor
138908703|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
138908704|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138908705|NCT00703430|Memantine|memantine|mesh-list
138908706|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138908707|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138908708|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
138908709|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908710|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908711|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814762|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
138908712|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138908713|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138908714|NCT00797836|Interferons|interferons|mesh-list
138271680|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
138271684|NCT01390584|Etoposide|etoposide|mesh-list
138908715|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908716|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
138908717|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138908718|NCT00693407|Capsaicin|capsaicin|mesh-list
138908719|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
138908720|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
138908721|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
138908722|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908723|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908724|NCT02618603|Triamcinolone|triamcinolone|mesh-list
138908725|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138448539|NCT01858025|Mitomycins|mitomycins|mesh-list
138908726|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138908727|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
138908728|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138908729|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138908730|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138908731|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138908732|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138908733|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908734|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
138814826|NCT00585325|Lidocaine|lidocaine|mesh-list
138908735|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908736|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908737|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138908738|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
138908739|NCT02618603|Hormones|hormones|mesh-ancestor
138908740|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138908741|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138908742|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
138908743|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908744|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138908745|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908746|NCT02616497|Aspirin|aspirin|mesh-list
138908747|NCT02616497|Triflusal|triflusal|mesh-list
138908748|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138908749|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138908750|NCT02616497|Analgesics|analgesics|mesh-ancestor
138908751|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
138908752|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908753|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908754|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138908755|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138908756|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138908757|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138908758|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908759|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138908760|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138908761|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271799|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138908762|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
138908763|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138908764|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908765|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138908766|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908767|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908768|NCT05755854|Cyclophosphamide|cyclophosphamide|mesh-list
138908769|NCT05755854|Fludarabine|fludarabine|mesh-list
138908770|NCT05755854|Fludarabine phosphate|fludarabine phosphate|mesh-list
138908771|NCT05755854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138908772|NCT05755854|Immunologic Factors|immunologic factors|mesh-ancestor
138908773|NCT05755854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908774|NCT05755854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138908775|NCT05755854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138908776|NCT05755854|Alkylating Agents|alkylating agents|mesh-ancestor
138908777|NCT05755854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908778|NCT05755854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908779|NCT05755854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138510496|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
138908780|NCT05755854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138908782|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
138908783|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908784|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138908785|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908786|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271842|NCT01063179|Growth Substances|growth substances|mesh-ancestor
138908787|NCT02616419|Lidocaine|lidocaine|mesh-list
138448576|NCT01858090|Metoclopramide|metoclopramide|mesh-list
138908788|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
138908790|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138908791|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908792|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
138908793|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908794|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138908795|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138908796|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138908797|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138908798|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908799|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
138908800|NCT00798070|Fluorouracil|fluorouracil|mesh-list
138908801|NCT00798070|Docetaxel|docetaxel|mesh-list
138908802|NCT00798070|Epirubicin|epirubicin|mesh-list
138908803|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271891|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138908804|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
138908805|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908806|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138908807|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138908808|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
138908809|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908810|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560829|NCT04872790|Prednisone|prednisone|mesh-list
138908811|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138908812|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
138908813|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138908814|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
138908815|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
138908816|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
138908817|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138908818|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138908819|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138908820|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908821|NCT00809328|Azithromycin|azithromycin|mesh-list
138908822|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138908823|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138271950|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
138908824|NCT00798148|Carboplatin|carboplatin|mesh-list
138908825|NCT00798148|Etoposide|etoposide|mesh-list
138908826|NCT00798148|Melphalan|melphalan|mesh-list
138908827|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908828|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138908829|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138908830|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138908831|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908832|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908833|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138908834|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
138908835|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138908836|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138908837|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
138908838|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908839|NCT00787462|Pregabalin|pregabalin|mesh-list
138908840|NCT00787462|Analgesics|analgesics|mesh-ancestor
138908841|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
138908842|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908843|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908844|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
138908845|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138908846|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138908847|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908848|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138908849|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138908850|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138908851|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138908852|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138908853|NCT00792766|Everolimus|everolimus|mesh-list
138908854|NCT00792766|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138908855|NCT00792766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138908856|NCT00792766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272018|NCT00274924|Hormones|hormones|mesh-ancestor
138908857|NCT00792766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908858|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138908859|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
138908860|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908861|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908862|NCT00798460|Lamivudine|lamivudine|mesh-list
138908863|NCT00798460|Adefovir|adefovir|mesh-list
138908864|NCT00798460|Clevudine|clevudine|mesh-list
138908865|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138908866|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138908867|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908868|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908869|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
138908870|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138908871|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138908872|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138908873|NCT02615873|Levodopa|levodopa|mesh-list
138908874|NCT02615873|Carbidopa|carbidopa|mesh-list
138908875|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138908876|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138908877|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138908878|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
138908879|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908880|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908881|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908882|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138272060|NCT00071981|Vaccines|vaccines|mesh-list
138908883|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908884|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138908885|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
138908886|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
138908887|NCT00814164|Daunorubicin|daunorubicin|mesh-list
138908888|NCT00814164|Clofarabine|clofarabine|mesh-list
138908889|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138908890|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815252|NCT03292666|Dabigatran|dabigatran|mesh-list
138908891|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138908892|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138908893|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908894|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908895|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138908896|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
138908897|NCT02609334|Pemirolast|pemirolast|mesh-list
138908898|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
138908899|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
138908900|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908901|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908902|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908903|NCT00659230|Dopamine|dopamine|mesh-list
138908904|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138908905|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
138908906|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
138908907|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908908|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908909|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
138908910|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908911|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908912|NCT00659230|Protective Agents|protective agents|mesh-ancestor
138908913|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
138908914|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138908915|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
138815375|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
138272096|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272097|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908916|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138908917|NCT00809094|Expectorants|expectorants|mesh-ancestor
138908918|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
138908919|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138908920|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
138908921|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908922|NCT00809094|Protective Agents|protective agents|mesh-ancestor
138908923|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908924|NCT00809094|Antidotes|antidotes|mesh-ancestor
138908925|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138908926|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
138908927|NCT02615639|Entecavir|entecavir|mesh-list
138908928|NCT02615639|Telbivudine|telbivudine|mesh-list
138908929|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
138908930|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138908931|NCT02615639|Vaccines|vaccines|mesh-list
138908932|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
138908933|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908934|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
138908935|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138908936|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138908937|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908938|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908939|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908940|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
138908941|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138908942|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138908943|NCT00798616|Prednisolone|prednisolone|mesh-list
138908944|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
138908945|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138908946|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
138908947|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138908948|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
138908949|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
138908950|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908951|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908952|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138908953|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
138908954|NCT00798616|Hormones|hormones|mesh-ancestor
138908955|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138908956|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138908957|NCT00798616|Protective Agents|protective agents|mesh-ancestor
138908958|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138908959|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908960|NCT02618057|Levofloxacin|levofloxacin|mesh-list
138908961|NCT02618057|Prednisolone|prednisolone|mesh-list
138908962|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138908963|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
138908964|NCT02618057|Hormones|hormones|mesh-ancestor
138908965|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138815549|NCT00724243|Infliximab|infliximab|mesh-list
138908967|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138272194|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
138908968|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138908969|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138908970|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138908971|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138908972|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138908973|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138908974|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138908975|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908976|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138908977|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138908978|NCT04137029|Bromides|bromides|mesh-list
138908979|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
138908980|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
138908981|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138908982|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
138908983|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138908984|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138908985|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138908986|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
138908987|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138815675|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
138908988|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138908989|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138908990|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
138908991|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138908992|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138908993|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
138908994|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138908995|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
138908996|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
138908997|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
138908998|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138908999|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138909000|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
138909001|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815744|NCT01743651|GABA Agents|gaba agents|mesh-ancestor
138909002|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138272243|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909003|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138909004|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909005|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909006|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138909007|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909008|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138909009|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909010|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909012|NCT00798772|Trace Elements|trace elements|mesh-list
138909013|NCT00798772|Antioxidants|antioxidants|mesh-list
138909014|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909015|NCT00798772|Protective Agents|protective agents|mesh-ancestor
138909016|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909017|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138909018|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138909019|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
138909020|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909021|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909022|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
138909023|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
138909024|NCT02615561|Vitamins|vitamins|mesh-ancestor
138909025|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
138909026|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909027|NCT00793234|Enoxaparin|enoxaparin|mesh-list
138909028|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
138909029|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138909030|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138909031|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909032|NCT00697775|Vaccines|vaccines|mesh-list
138909033|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
138909034|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272282|NCT02259348|Analgesics|analgesics|mesh-ancestor
138909035|NCT04133051|Bupivacaine|bupivacaine|mesh-list
138909036|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
138909038|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138909039|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909040|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
138909041|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909042|NCT00788242|Insulin|insulin|mesh-list
138909043|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138909044|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909045|NCT04031027|Apremilast|apremilast|mesh-list
138909046|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138909047|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138909048|NCT04031027|Analgesics|analgesics|mesh-ancestor
138909049|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
138909050|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909051|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909052|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909053|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138909054|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138909055|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138909056|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909057|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909058|NCT02609802|Sevoflurane|sevoflurane|mesh-list
138909059|NCT02609802|Desflurane|desflurane|mesh-list
138909060|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138909061|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138909062|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
138909063|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
138909064|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138272333|NCT04332809|Gentamicins|gentamicins|mesh-list
138909065|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909066|NCT02609646|Vancomycin|vancomycin|mesh-list
138909067|NCT02609646|Meropenem|meropenem|mesh-list
138909068|NCT02609646|Tazobactam|tazobactam|mesh-list
138909069|NCT02609646|Linezolid|linezolid|mesh-list
138909070|NCT02609646|Piperacillin|piperacillin|mesh-list
138909071|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138909072|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138909073|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138909074|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138909075|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816041|NCT00588640|Methadone|methadone|mesh-list
138909076|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909077|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138909078|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
138909079|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138909080|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
138909081|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909082|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
138909083|NCT02610504|Protective Agents|protective agents|mesh-ancestor
138909084|NCT04132583|Diclofenac|diclofenac|mesh-list
138909085|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138909086|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138909087|NCT04132583|Analgesics|analgesics|mesh-ancestor
138909088|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
138909089|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909090|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909091|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909092|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272405|NCT04926233|Olodaterol|olodaterol|mesh-list
138909093|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138909094|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909095|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909096|NCT05754762|Remifentanil|remifentanil|mesh-list
138909097|NCT05754762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138909098|NCT05754762|Narcotics|narcotics|mesh-ancestor
138909099|NCT05754762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138909100|NCT05754762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909101|NCT05754762|Analgesics|analgesics|mesh-ancestor
138909102|NCT05754762|Sensory System Agents|sensory system agents|mesh-ancestor
138909103|NCT05754762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909104|NCT05326152|Immunomodulating Agents|immunomodulating agents|mesh-list
138909105|NCT05326152|Immunologic Factors|immunologic factors|mesh-ancestor
138909106|NCT05326152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909107|NCT00914004|Desipramine|desipramine|mesh-list
138272432|NCT02258334|Vaccines|vaccines|mesh-list
138909108|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138909109|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
138909110|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138909111|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909112|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909113|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138909114|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138909115|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138909116|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
138909117|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138909118|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909119|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
138909120|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909121|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138909122|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909123|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909124|NCT02608710|Verinurad|verinurad|mesh-list
138909125|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
138909126|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138909127|NCT04030260|Antibodies|antibodies|mesh-list
138909128|NCT04030260|Immunoglobulins|immunoglobulins|mesh-list
138909129|NCT04030260|Immunologic Factors|immunologic factors|mesh-ancestor
138909130|NCT04030260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909131|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
138909132|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138909133|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138909134|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909136|NCT00697385|Coagulants|coagulants|mesh-ancestor
138909137|NCT00451555|Fulvestrant|fulvestrant|mesh-list
138909138|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138909139|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909140|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138909141|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138909142|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
138909143|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138816362|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138909144|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909146|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138909147|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
138909148|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138909149|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138909150|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
138909151|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
138909152|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
138909153|NCT05754684|Aldesleukin|aldesleukin|mesh-list
138909154|NCT05754684|Interleukin-2|interleukin-2|mesh-list
138909155|NCT05754684|Molgramostim|molgramostim|mesh-list
138272543|NCT02256540|Estrogens|estrogens|mesh-ancestor
138909156|NCT05754684|Dinutuximab|dinutuximab|mesh-list
138909157|NCT05754684|Spironolactone|spironolactone|mesh-list
138909158|NCT05754684|Sargramostim|sargramostim|mesh-list
138909159|NCT05754684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909160|NCT05754684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138909161|NCT05754684|Analgesics|analgesics|mesh-ancestor
138909162|NCT05754684|Sensory System Agents|sensory system agents|mesh-ancestor
138909163|NCT05754684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909164|NCT05754684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909165|NCT05754684|Immunologic Factors|immunologic factors|mesh-ancestor
138909166|NCT05754684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138909167|NCT05754684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138909168|NCT05754684|Antiviral Agents|antiviral agents|mesh-ancestor
138909169|NCT05754684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138909170|NCT05754684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138909171|NCT05754684|Hormone Antagonists|hormone antagonists|mesh-ancestor
138909172|NCT05754684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138909173|NCT05754684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138909174|NCT05754684|Diuretics|diuretics|mesh-ancestor
138909175|NCT05754684|Natriuretic Agents|natriuretic agents|mesh-ancestor
138909176|NCT00694187|Zaleplon|zaleplon|mesh-list
138909177|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
138816468|NCT00914836|Betamethasone|betamethasone|mesh-list
138909178|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138909179|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138909180|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909181|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
138909182|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
138909183|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138909184|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909185|NCT02617121|Gabapentin|gabapentin|mesh-list
138909186|NCT02617121|Ramosetron|ramosetron|mesh-list
138909187|NCT02617121|Analgesics|analgesics|mesh-ancestor
138909188|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
138909189|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909190|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909191|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
138909192|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138909193|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138909194|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138909195|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138909196|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138909197|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138816532|NCT00787930|Valproic Acid|valproic acid|mesh-list
138909198|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138909199|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909201|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
138909202|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
138909203|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138909204|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138909205|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
138909206|NCT02609490|Olmesartan|olmesartan|mesh-list
138909207|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138909208|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138909209|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138909210|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138909211|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138909212|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909213|NCT02610348|Vaccines|vaccines|mesh-list
138909214|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138909215|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
138909216|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909217|NCT05757336|Paclitaxel|paclitaxel|mesh-list
138909218|NCT05757336|Bevacizumab|bevacizumab|mesh-list
138909219|NCT05757336|Gemcitabine|gemcitabine|mesh-list
138909220|NCT05757336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138909221|NCT05757336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909222|NCT05757336|Tubulin Modulators|tubulin modulators|mesh-ancestor
138909223|NCT05757336|Antimitotic Agents|antimitotic agents|mesh-ancestor
138909224|NCT05757336|Mitosis Modulators|mitosis modulators|mesh-ancestor
138909225|NCT05757336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909226|NCT05757336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138909227|NCT05757336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138909228|NCT05757336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138909229|NCT05757336|Growth Substances|growth substances|mesh-ancestor
138909230|NCT05757336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909231|NCT05757336|Growth Inhibitors|growth inhibitors|mesh-ancestor
138909232|NCT05757336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138909234|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138909235|NCT00871871|Isosorbide|isosorbide|mesh-list
138909236|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138909237|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138909238|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138909239|NCT00871871|Diuretics|diuretics|mesh-ancestor
138909240|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
138909241|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909242|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138909243|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138909244|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909245|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138909246|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
138909247|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138909248|NCT02608788|Ketorolac|ketorolac|mesh-list
138909249|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138909250|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138909251|NCT02608788|Analgesics|analgesics|mesh-ancestor
138909252|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
138909253|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909254|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909255|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909256|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138909257|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138909258|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770246|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138909259|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909260|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
138909261|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138909262|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
138909264|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909265|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138909267|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
138909268|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909269|NCT00866723|Bevacizumab|bevacizumab|mesh-list
138909270|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138909271|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909272|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138909273|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138909274|NCT00866723|Growth Substances|growth substances|mesh-ancestor
138909275|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909276|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
138909277|NCT02613455|Triamcinolone|triamcinolone|mesh-list
138909278|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138909279|NCT02613455|Lidocaine|lidocaine|mesh-list
138909280|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
138909281|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
138909282|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138909283|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909284|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
138272793|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909285|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909286|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138909287|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138909288|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138909289|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138909290|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909291|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909292|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
138909293|NCT02613455|Hormones|hormones|mesh-ancestor
138909294|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138909295|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138909296|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
138909297|NCT00703586|Maraviroc|maraviroc|mesh-list
138909299|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138909300|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909301|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138909302|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138272837|NCT05430048|Coagulants|coagulants|mesh-ancestor
138272840|NCT02975570|Levofloxacin|levofloxacin|mesh-list
138909303|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
138909304|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816856|NCT02703051|Lenograstim|lenograstim|mesh-list
138909305|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138909306|NCT04130399|Folfirinox|folfirinox|mesh-list
138909307|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909308|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
138909309|NCT00849056|Incretins|incretins|mesh-ancestor
138909310|NCT00849056|Hormones|hormones|mesh-ancestor
138909311|NCT00849056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138909312|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909313|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138909314|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
138909315|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138909316|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138909317|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138909318|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138909319|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909320|NCT00706862|Lactoferrin|lactoferrin|mesh-list
138909321|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
138909322|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909323|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138909324|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138909325|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138909326|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138909327|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
138909328|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909329|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138909330|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138909331|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909332|NCT00837434|Adalimumab|adalimumab|mesh-list
138909334|NCT00837434|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138909335|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909336|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138909337|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138909338|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138909339|NCT00837434|Analgesics|analgesics|mesh-ancestor
138909340|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
138909341|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909342|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909343|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138909344|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138909345|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
138909346|NCT00703742|Escitalopram|escitalopram|mesh-list
138909347|NCT00703742|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138909348|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138909349|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138909350|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909351|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272946|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138909352|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
138909353|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909354|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138909355|NCT00702182|Vinorelbine|vinorelbine|mesh-list
138909356|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909357|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138909358|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817043|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909359|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909360|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138909361|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
138909362|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
138909363|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
138909365|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138909366|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
138909367|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709254|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909368|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909369|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138909371|NCT00702416|Fentanyl|fentanyl|mesh-list
138909372|NCT00702416|Morphine|morphine|mesh-list
138909373|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
138909374|NCT00702416|Narcotics|narcotics|mesh-list
138909375|NCT00702416|Analgesics|analgesics|mesh-list
138909376|NCT00702416|Anesthetics|anesthetics|mesh-list
138909377|NCT00702416|Ropivacaine|ropivacaine|mesh-list
138909378|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
138909379|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138909380|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909381|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
138909382|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909383|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138909384|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138909385|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
138909386|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138909387|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
138909388|NCT00827918|Olanzapine|olanzapine|mesh-list
138909389|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
138909390|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
138909391|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909392|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909393|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138909394|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138909395|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138909396|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138909397|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138909398|NCT00827918|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138909399|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138909400|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138909401|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909402|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138909403|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
138909404|NCT00813150|Dexamethasone|dexamethasone|mesh-list
138909405|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
138909406|NCT00813150|Bortezomib|bortezomib|mesh-list
138817285|NCT02698995|Narcotics|narcotics|mesh-ancestor
138909407|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138909408|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
138909409|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909410|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138909411|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138909412|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
138909413|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909414|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909415|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138909416|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909417|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
138909418|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
138909419|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909420|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138909421|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
138909422|NCT00813150|Hormones|hormones|mesh-ancestor
138909423|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138909424|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138909425|NCT00807846|Celecoxib|celecoxib|mesh-list
138909426|NCT00807846|Naproxen|naproxen|mesh-list
138909427|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138909428|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138909429|NCT00807846|Analgesics|analgesics|mesh-ancestor
138909430|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
138909431|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273102|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
138909432|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909433|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909434|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138909435|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138909436|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138909437|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909438|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909439|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
138909440|NCT00810108|Ritonavir|ritonavir|mesh-list
138909441|NCT00810108|Lopinavir|lopinavir|mesh-list
138909442|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138909443|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138909444|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
138909445|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909446|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909447|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138909448|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138909449|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
138909450|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138909451|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138909452|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138909453|NCT00827606|Atorvastatin|atorvastatin|mesh-list
138909454|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138909455|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138909456|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
138909457|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909458|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138909459|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138909460|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909461|NCT04016220|Budesonide|budesonide|mesh-list
138909462|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909463|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138909464|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
138909465|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909466|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909467|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138909468|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
138909469|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
138909470|NCT04016220|Hormones|hormones|mesh-ancestor
138909471|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138909472|NCT00663052|Etanercept|etanercept|mesh-list
138273201|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138909473|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138909474|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138909475|NCT00663052|Analgesics|analgesics|mesh-ancestor
138909476|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
138909477|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909478|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909479|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909480|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138909481|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138909482|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138909483|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
138273254|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138909484|NCT05599880|Bortezomib|bortezomib|mesh-list
138909485|NCT05599880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909486|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138909487|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909488|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138909489|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909490|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909491|NCT00826748|Beclomethasone|beclomethasone|mesh-list
138909492|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909493|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
138909494|NCT00826748|Hormones|hormones|mesh-ancestor
138909495|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138909496|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909497|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138909498|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
138909500|NCT00922844|Isoflurane|isoflurane|mesh-list
138909501|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138909502|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138909503|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
138909504|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
138909505|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138909506|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909507|NCT00707330|Clarithromycin|clarithromycin|mesh-list
138909508|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138909509|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138909510|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138909511|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909512|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909513|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138909514|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138909516|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909517|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138909518|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909519|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909521|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
138909522|NCT00788320|Vitamins|vitamins|mesh-ancestor
138909523|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
138909524|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909525|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138909526|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138909527|NCT00807144|Tacrolimus|tacrolimus|mesh-list
138909528|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138909529|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
138909530|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909531|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138909532|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909533|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909534|NCT00799240|Cisplatin|cisplatin|mesh-list
138909535|NCT00799240|Pemetrexed|pemetrexed|mesh-list
138909536|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138909537|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909538|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909539|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909540|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138909541|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138909542|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
138909543|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909544|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
138909546|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909547|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
138909548|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138909549|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138909550|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138909551|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909552|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138909553|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138909554|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138909555|NCT00844844|Eculizumab|eculizumab|mesh-list
138909556|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138909557|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138909558|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
138909559|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909560|NCT05748054|Fluorides|fluorides|mesh-list
138909561|NCT05748054|Cariostatic Agents|cariostatic agents|mesh-ancestor
138273410|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
138273411|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
138909562|NCT05748054|Protective Agents|protective agents|mesh-ancestor
138909563|NCT05748054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909564|NCT00702572|Paclitaxel|paclitaxel|mesh-list
138909565|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138909566|NCT00702572|Bevacizumab|bevacizumab|mesh-list
138909567|NCT00702572|Carboplatin|carboplatin|mesh-list
138909568|NCT00702572|Vorinostat|vorinostat|mesh-list
138909569|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138817954|NCT01010126|Growth Substances|growth substances|mesh-ancestor
138909570|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909571|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
138909572|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
138909573|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
138909574|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909575|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138909576|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138818009|NCT00617955|Aprotinin|aprotinin|mesh-list
138909577|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138909578|NCT00702572|Growth Substances|growth substances|mesh-ancestor
138909579|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909580|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
138909581|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138909582|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909584|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138909585|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
138909586|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909587|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909588|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138818077|NCT03824587|Calcium|calcium|mesh-list
138909589|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138909590|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
138909591|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138909592|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909593|NCT00836810|Prednisone|prednisone|mesh-list
138909594|NCT00836810|Prednisolone|prednisolone|mesh-list
138909595|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909596|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
138909597|NCT00836810|Hormones|hormones|mesh-ancestor
138709255|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138909598|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138909599|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909600|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138909601|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909602|NCT00658684|Fesoterodine|fesoterodine|mesh-list
138909603|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138909604|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138909605|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
138909606|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818204|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
138909607|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909608|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909609|NCT00658684|Urological Agents|urological agents|mesh-ancestor
138909610|NCT00660400|Azacitidine|azacitidine|mesh-list
138909611|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138909612|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
138909613|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909614|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909615|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909617|NCT00826514|Analgesics|analgesics|mesh-ancestor
138909618|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
138909619|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909620|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909621|NCT00800566|Clofarabine|clofarabine|mesh-list
138909622|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138909623|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
138909624|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909625|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909626|NCT00793858|Ciclesonide|ciclesonide|mesh-list
138909627|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
138909628|NCT00793858|Hormones|hormones|mesh-ancestor
138909629|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138909630|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909631|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138909632|NCT00800722|Sirolimus|sirolimus|mesh-list
138909633|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138909634|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138909635|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138909636|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909637|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
138909638|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138909639|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
138909640|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909642|NCT00826280|Regadenoson|regadenoson|mesh-list
138909643|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138909644|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909645|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138909646|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909647|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909648|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138909649|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138909650|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
138909651|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138909652|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138909653|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138909654|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
138909655|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138909656|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138909657|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138909658|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
138909659|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909660|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138909661|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138909662|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909663|NCT00703898|Nevirapine|nevirapine|mesh-list
138909664|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138909665|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138909666|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909667|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909668|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
138909669|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138909670|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138909671|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138909672|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138909673|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138909674|NCT00801034|Calcium|calcium|mesh-list
138909675|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138909676|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909677|NCT04130477|Nickel|nickel|mesh-list
138909678|NCT04130477|Trace Elements|trace elements|mesh-ancestor
138909679|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
138909680|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909681|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
138909682|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138909683|NCT00702728|Furosemide|furosemide|mesh-list
138909684|NCT00702728|Diuretics|diuretics|mesh-ancestor
138909685|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
138909686|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909687|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138909688|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138273734|NCT05723341|Morphine|morphine|mesh-list
138909689|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909690|NCT04132115|Vancomycin|vancomycin|mesh-list
138909691|NCT04132115|Gentamicins|gentamicins|mesh-list
138909692|NCT04132115|Meropenem|meropenem|mesh-list
138909693|NCT04132115|Tazobactam|tazobactam|mesh-list
138909694|NCT04132115|Linezolid|linezolid|mesh-list
138909695|NCT04132115|Piperacillin|piperacillin|mesh-list
138909696|NCT04132115|Daptomycin|daptomycin|mesh-list
138909697|NCT04132115|Amikacin|amikacin|mesh-list
138909698|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138909699|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
138909700|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
138909701|NCT04132115|Acyclovir|acyclovir|mesh-list
138909702|NCT04132115|Ganciclovir|ganciclovir|mesh-list
138909703|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138818640|NCT06180083|Dermatologic Agents|dermatologic agents|mesh-ancestor
138909704|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138909705|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138909706|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909707|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909708|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138909709|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
138909710|NCT00801268|Emodin|emodin|mesh-list
138909711|NCT00801268|Cathartics|cathartics|mesh-ancestor
138909712|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138909713|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138909714|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909715|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909718|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138909719|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138909720|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138909721|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138909722|NCT02614937|Growth Substances|growth substances|mesh-ancestor
138909723|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909724|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
138909725|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909726|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138909727|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138909728|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138909729|NCT02614937|Protective Agents|protective agents|mesh-ancestor
138909730|NCT00707642|Vaccines|vaccines|mesh-list
138909731|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
138909732|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909734|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138909735|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138909736|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138909737|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138909738|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138909739|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909740|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909741|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909742|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138909743|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
138909744|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138909745|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909746|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138909747|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138909748|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138818888|NCT05738291|Antimetabolites|antimetabolites|mesh-ancestor
138909750|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
138909751|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
138909752|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138909753|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909754|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
138909755|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909756|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138380257|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
138909757|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138909758|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138909759|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138909760|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909761|NCT00856973|Eszopiclone|eszopiclone|mesh-list
138909762|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138909763|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138909764|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909765|NCT00794638|Rituximab|rituximab|mesh-list
138909766|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138909767|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138909768|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909769|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
138909770|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909771|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138909772|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138909773|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
138909774|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273947|NCT03042468|177Lu-PSMA-617|177lu-psma-617|mesh-list
138909775|NCT00801580|Doxorubicin|doxorubicin|mesh-list
138909776|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138909777|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138909778|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909779|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138909780|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138909781|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909782|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909784|NCT00805194|Nintedanib|nintedanib|mesh-list
138909785|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909786|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
138909787|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
138909788|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
138909789|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909790|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138909791|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909793|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138274003|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
138274007|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138909794|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138909795|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138909796|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
138909797|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909798|NCT00801736|Paclitaxel|paclitaxel|mesh-list
138909799|NCT00801736|Cisplatin|cisplatin|mesh-list
138909800|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138909801|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909802|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
138909803|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
138909804|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
138909805|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909806|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
138909807|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138909808|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138909809|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909810|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
138909811|NCT02606994|Lidocaine|lidocaine|mesh-list
138909812|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
138909813|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
138909814|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138909815|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909816|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
138909817|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909818|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138909819|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138909820|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138909821|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138909822|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909823|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138909824|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138909825|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
138909826|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
138909827|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138909828|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138909829|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
138909830|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
138909831|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138909832|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138909833|NCT00844376|Atorvastatin|atorvastatin|mesh-list
138909834|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138909835|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138909836|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
138909837|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909838|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138909839|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138909840|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909841|NCT04046302|Dinoprostone|dinoprostone|mesh-list
138909842|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
138909843|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138909844|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909845|NCT00914394|Phenylephrine|phenylephrine|mesh-list
138909846|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
138909847|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138909848|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138909849|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
138274102|NCT05648058|Histamine Antagonists|histamine antagonists|mesh-ancestor
138909850|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
138909851|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909852|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909853|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
138909854|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138909855|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
138909856|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
138909857|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138909858|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138909859|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138909860|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
138909861|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138909862|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909863|NCT00914394|Protective Agents|protective agents|mesh-ancestor
138909864|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909865|NCT04045678|Rotigotine|rotigotine|mesh-list
138909866|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
138909867|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
138909868|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138909869|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909870|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909872|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
138909873|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
138909874|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909875|NCT00795106|Capsaicin|capsaicin|mesh-list
138909876|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
138909877|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
138909878|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
138909879|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909880|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909881|NCT00589290|Belinostat|belinostat|mesh-list
138909882|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909883|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138909884|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909885|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274160|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
138909886|NCT00802048|Ropivacaine|ropivacaine|mesh-list
138909887|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
138909888|NCT00802048|Anesthetics|anesthetics|mesh-list
138909889|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138819505|NCT03798626|Leucovorin|leucovorin|mesh-list
138909890|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338315|NCT01147302|Complement C1s|complement c1s|mesh-list
138909891|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
138909892|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909893|NCT00809536|Metformin|metformin|mesh-list
138909894|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138909895|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909896|NCT00809692|Histamine|histamine|mesh-list
138909897|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
138909898|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
138909899|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
138909900|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138909901|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909902|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909903|NCT00843284|Pregabalin|pregabalin|mesh-list
138274194|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138909904|NCT00843284|Analgesics|analgesics|mesh-ancestor
138909905|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
138909906|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909907|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909908|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
138909909|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138909910|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138909911|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909912|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138909913|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138909914|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138819565|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
138909915|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138909916|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138909917|NCT00802282|Psilocybin|psilocybin|mesh-list
138909918|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
138909919|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909920|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138909921|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
138909922|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138909923|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909924|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138909925|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
138909926|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138909927|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138909929|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909931|NCT00825812|Neostigmine|neostigmine|mesh-list
138909932|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138909933|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138909934|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138909935|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
138909936|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909937|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909938|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138909939|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
138909940|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
138909941|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
138909942|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138819684|NCT02967692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819685|NCT02967692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819686|NCT02967692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138909943|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138909944|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
138909945|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138909946|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909947|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138909948|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138909949|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138909950|NCT00802594|Pafuramidine|pafuramidine|mesh-list
138909951|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138909952|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138909953|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138909954|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274308|NCT00361933|Valganciclovir|valganciclovir|mesh-list
138909955|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138909957|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138909958|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138909959|NCT00802828|Famotidine|famotidine|mesh-list
138909960|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138909961|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138909962|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138909963|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
138909965|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138909966|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909967|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909969|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138909970|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909971|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138909972|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138909973|NCT00802906|Growth Substances|growth substances|mesh-ancestor
138909974|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909975|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
138909976|NCT00803218|Fluticasone|fluticasone|mesh-list
138909977|NCT00803218|Xhance|xhance|mesh-list
138909978|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138909979|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138909980|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
138909981|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138909982|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138909983|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138909984|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
138909986|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138909987|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
138909988|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138909989|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138274347|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
138274348|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
138909990|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909991|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
138909992|NCT00824564|Coagulants|coagulants|mesh-ancestor
138909994|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138909995|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138909996|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138909997|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138909998|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138909999|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
138910000|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910001|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
138910002|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
138819989|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
138910003|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910004|NCT00803530|Protective Agents|protective agents|mesh-ancestor
138910005|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910006|NCT00803530|Vitamins|vitamins|mesh-ancestor
138910007|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
138910008|NCT00803764|Naproxen|naproxen|mesh-list
138562033|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138910009|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138910010|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138910011|NCT00803764|Analgesics|analgesics|mesh-ancestor
138910012|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
138910013|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910014|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910015|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138910016|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138910017|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
138910018|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138910019|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910020|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910021|NCT00704366|Saracatinib|saracatinib|mesh-list
138910022|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910023|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910024|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910025|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138910026|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138910027|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138910028|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138910029|NCT00803842|Doxycycline|doxycycline|mesh-list
138910030|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138910031|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910032|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
138910033|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138910034|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138910035|NCT00658528|Esomeprazole|esomeprazole|mesh-list
138910036|NCT00658528|Rabeprazole|rabeprazole|mesh-list
138910037|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138910038|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138910039|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138910040|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910041|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910043|NCT00856583|Sertindole|sertindole|mesh-list
138910044|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138910045|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
138910046|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820243|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138910047|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910048|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910049|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138910050|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138910051|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138910052|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138820314|NCT04209699|Famotidine|famotidine|mesh-list
138910053|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138910054|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
138910055|NCT00803244|Immunomodulating Agents|immunomodulating agents|mesh-list
138910056|NCT00803244|Immunologic Factors|immunologic factors|mesh-ancestor
138910057|NCT00803244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910058|NCT05753280|Vitamin D|vitamin d|mesh-list
138910059|NCT05753280|Vitamins|vitamins|mesh-ancestor
138910060|NCT05753280|Micronutrients|micronutrients|mesh-ancestor
138910061|NCT05753280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910062|NCT05753280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138910063|NCT00824408|Pemetrexed|pemetrexed|mesh-list
138910064|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910065|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910066|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910067|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138910068|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138910070|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138910071|NCT02611700|Cisplatin|cisplatin|mesh-list
138910072|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
138910073|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138910074|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910075|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
138910076|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
138274485|NCT03518034|Testosterone|testosterone|mesh-list
138910077|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
138910078|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910079|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138910080|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138910082|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138910083|NCT00708344|Diuretics|diuretics|mesh-ancestor
138910084|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
138910085|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910087|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138820507|NCT00621387|Roxithromycin|roxithromycin|mesh-list
138910088|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910089|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138910090|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138820574|NCT04138641|Cangrelor|cangrelor|mesh-list
138910092|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910093|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138910094|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910095|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910096|NCT00834080|Naltrexone|naltrexone|mesh-list
138910097|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138910098|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138274538|NCT03661645|Dexamethasone|dexamethasone|mesh-list
138910099|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910100|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
138910101|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910102|NCT00823472|Ganirelix|ganirelix|mesh-list
138910103|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
138910104|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820641|NCT00612261|Triamcinolone|triamcinolone|mesh-list
138910105|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910107|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138910108|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910109|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138910110|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
138910111|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138910112|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138910113|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138910114|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
138910115|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138910116|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910117|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910118|NCT04130087|Selegiline|selegiline|mesh-list
138910119|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
138910120|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138274581|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
138910121|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138910122|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138910123|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138910124|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910125|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910126|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138910127|NCT04130087|Protective Agents|protective agents|mesh-ancestor
138910128|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910129|NCT00652366|Gemcitabine|gemcitabine|mesh-list
138910130|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138910131|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138910132|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
138910133|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910134|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910135|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138910136|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910137|NCT00841568|Tolvaptan|tolvaptan|mesh-list
138910138|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138910139|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910140|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
138910141|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910142|NCT00855959|Budesonide|budesonide|mesh-list
138274636|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
138910143|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138910144|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138910145|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
138910146|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910147|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910148|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138910149|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
138910150|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
138910151|NCT00855959|Hormones|hormones|mesh-ancestor
138910152|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138910153|NCT00704600|Nelfinavir|nelfinavir|mesh-list
138910154|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138910155|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138910156|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
138910157|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910158|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910159|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138820958|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
138910160|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138910161|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
138910162|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910163|NCT00699881|Cetuximab|cetuximab|mesh-list
138910164|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138910165|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910166|NCT00708578|Metformin|metformin|mesh-list
138910167|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
138821031|NCT00996476|Simeprevir|simeprevir|mesh-list
138910168|NCT00708578|Glimepiride|glimepiride|mesh-list
138910169|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138910170|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274690|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
138910171|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138910172|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138910173|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
138910174|NCT00704678|Sevelamer|sevelamer|mesh-list
138910175|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
138910176|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
138910177|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910178|NCT00708656|Mesalamine|mesalamine|mesh-list
138910179|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138910180|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138910181|NCT00708656|Analgesics|analgesics|mesh-ancestor
138910182|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
138821155|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
138910183|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910184|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910185|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138910186|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138910187|NCT00913328|Montelukast|montelukast|mesh-list
138910188|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138910190|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138910191|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
138821223|NCT00709423|Moxaverine|moxaverine|mesh-list
138274743|NCT00383487|Vitamins|vitamins|mesh-ancestor
138910192|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138910193|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910194|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138910195|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138910196|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910197|NCT00804310|Lapatinib|lapatinib|mesh-list
138910198|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910199|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138910200|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910201|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910203|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
138910204|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
138910205|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138910206|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910207|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
138910208|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910209|NCT00708812|Paclitaxel|paclitaxel|mesh-list
138910210|NCT00708812|Carboplatin|carboplatin|mesh-list
138910211|NCT00708812|Endostar protein|endostar protein|mesh-list
138910212|NCT00708812|Endostatins|endostatins|mesh-list
138910213|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138910214|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910215|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
138910216|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
138910217|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
138274791|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138910218|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821354|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138910219|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138910220|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138910221|NCT00708812|Growth Substances|growth substances|mesh-ancestor
138910222|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910223|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
138910224|NCT04127747|Rituximab|rituximab|mesh-list
138910225|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138910226|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910227|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
138910228|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910229|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138910230|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
138910231|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138910232|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138449084|NCT01861015|Vasopressins|vasopressins|mesh-list
138910233|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138910234|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138910235|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910236|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
138910237|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138910238|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910239|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138910240|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910241|NCT00822770|Plerixafor|plerixafor|mesh-list
138910242|NCT00822770|Fludarabine|fludarabine|mesh-list
138910243|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
138910244|NCT00822770|Busulfan|busulfan|mesh-list
138910245|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
138910246|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138910247|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910248|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138910249|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
138910250|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910251|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138910252|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
138910253|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910254|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
138910255|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910256|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
138910257|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138910258|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138910259|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138821527|NCT01013753|Olodaterol|olodaterol|mesh-list
138910261|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138910262|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138910263|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910264|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138910265|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
138821599|NCT01013597|Panobinostat|panobinostat|mesh-list
138910266|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138910267|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138910268|NCT02607111|Dalteparin|dalteparin|mesh-list
138910269|NCT02607111|Tinzaparin|tinzaparin|mesh-list
138274891|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
138910270|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138910271|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
138910272|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138910273|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138910274|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910275|NCT00703196|Folic Acid|folic acid|mesh-list
138910276|NCT00703196|Hematinics|hematinics|mesh-ancestor
138910277|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
138910278|NCT00703196|Vitamins|vitamins|mesh-ancestor
138910279|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
138910280|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910281|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
138910282|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138910283|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
138910284|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910285|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910286|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
138910287|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910288|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
138910289|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
138910290|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138910291|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138910292|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910293|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910294|NCT00914277|Urological Agents|urological agents|mesh-ancestor
138910295|NCT00704756|Ribavirin|ribavirin|mesh-list
138910296|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138910297|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
138910298|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
138274937|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138910299|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910300|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
138910301|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910302|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
138910303|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910304|NCT00806442|Borage oil|borage oil|mesh-list
138910305|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138910306|NCT02608242|Amlodipine|amlodipine|mesh-list
138910307|NCT02608242|Telmisartan|telmisartan|mesh-list
138910308|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138910309|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138910310|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138910311|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138910312|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138910313|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910314|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138910315|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910317|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138910318|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138910319|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
138910320|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138910321|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138910322|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910323|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138910324|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138910325|NCT02607696|Zolpidem|zolpidem|mesh-list
138910326|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138910327|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138910328|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138910329|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274995|NCT00002835|Vitamins|vitamins|mesh-ancestor
138910330|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138910331|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
138910332|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
138910333|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138910334|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910335|NCT00839852|Cariprazine|cariprazine|mesh-list
138910336|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138910338|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138910339|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910340|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138910341|NCT02604849|Gentamicins|gentamicins|mesh-list
138910342|NCT02604849|Neomycin|neomycin|mesh-list
138910343|NCT02604849|Streptomycin|streptomycin|mesh-list
138910344|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138910345|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910346|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138910347|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910348|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910349|NCT00709046|Pantoprazole|pantoprazole|mesh-list
138910350|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138910351|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138910352|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138910353|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910354|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910355|NCT00820898|Gemcitabine|gemcitabine|mesh-list
138910356|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138910357|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
138910358|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910359|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910360|NCT00865709|Leucovorin|leucovorin|mesh-list
138910361|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
138910362|NCT00865709|Fluorouracil|fluorouracil|mesh-list
138910363|NCT00865709|Sorafenib|sorafenib|mesh-list
138910364|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
138910365|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910366|NCT00865709|Antidotes|antidotes|mesh-ancestor
138910367|NCT00865709|Protective Agents|protective agents|mesh-ancestor
138910368|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910369|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
138910370|NCT00865709|Vitamins|vitamins|mesh-ancestor
138910371|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
138910372|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
138910373|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910374|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138910375|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138910376|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
138910377|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138910378|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910380|NCT00839306|Ranitidine|ranitidine|mesh-list
138910381|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138910382|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138910383|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138910384|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138910385|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910386|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910387|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138910388|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
138910389|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
138910390|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138910391|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910392|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138910393|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138910394|NCT00839072|Trazodone|trazodone|mesh-list
138910395|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138910396|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138910397|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138910398|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910399|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138910400|NCT00839072|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138910401|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138910402|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138910403|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910404|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138910405|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
138910406|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138910407|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
138910408|NCT00704990|Vitamins|vitamins|mesh-list
138910409|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
138910410|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
138910411|NCT00704990|Pyridoxal|pyridoxal|mesh-list
138910412|NCT00704990|Pyridoxine|pyridoxine|mesh-list
138910413|NCT00704990|Zinc|zinc|mesh-list
138910414|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
138910415|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
138910416|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910417|NCT00704990|Trace Elements|trace elements|mesh-ancestor
138910418|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
138910419|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910420|NCT00704990|Protective Agents|protective agents|mesh-ancestor
138910421|NCT02607774|Midazolam|midazolam|mesh-list
138910422|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138910423|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138910424|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138910425|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910426|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138910427|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138910428|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138910429|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138910430|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
138910431|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
138910432|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
138910433|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
138910434|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138910435|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910436|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
138910437|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
138910438|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138910439|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910440|NCT00838916|Incretins|incretins|mesh-ancestor
138910441|NCT00838916|Hormones|hormones|mesh-ancestor
138910442|NCT00838916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138910443|NCT00838682|Omeprazole|omeprazole|mesh-list
138822127|NCT00717379|Hormones|hormones|mesh-ancestor
138910445|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138910446|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138910447|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138910448|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910449|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910450|NCT00913484|Disulfiram|disulfiram|mesh-list
138910451|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138910452|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138910453|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910454|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910455|NCT00803712|Vitamin D|vitamin d|mesh-list
138910456|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
138910457|NCT00803712|Cholecalciferol|cholecalciferol|mesh-list
138910458|NCT00803712|Vitamins|vitamins|mesh-list
138910459|NCT00803712|Cinacalcet|cinacalcet|mesh-list
138910460|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
138910461|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910462|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138910463|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138910464|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138910465|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
138910466|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138910467|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
138910468|NCT00803634|Diltiazem|diltiazem|mesh-list
138910469|NCT00803634|Nitroprusside|nitroprusside|mesh-list
138910470|NCT00803634|Nicardipine|nicardipine|mesh-list
138910471|NCT00803634|Clevidipine|clevidipine|mesh-list
138910472|NCT00803634|Isosorbide|isosorbide|mesh-list
138910473|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138910474|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
138910475|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
138910476|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138910477|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138910478|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910479|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138822294|NCT00639873|Analgesics|analgesics|mesh-ancestor
138910480|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910481|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138910482|NCT00803634|Diuretics|diuretics|mesh-ancestor
138910483|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
138910484|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138910485|NCT00838526|Rabeprazole|rabeprazole|mesh-list
138910486|NCT00838526|Ranitidine|ranitidine|mesh-list
138910487|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138910488|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138910489|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138910490|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138910491|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910492|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910493|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138910494|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
138910495|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
138910496|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138910497|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910498|NCT00914472|Heparin|heparin|mesh-list
138910499|NCT00914472|Calcium heparin|calcium heparin|mesh-list
138910500|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
138910501|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138910502|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138910503|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910504|NCT02611466|Naproxen|naproxen|mesh-list
138910505|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138910506|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138910507|NCT02611466|Analgesics|analgesics|mesh-ancestor
138910508|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
138910509|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910510|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910511|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138910512|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138910513|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
138910514|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138910515|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910516|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910517|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
138910518|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
138910519|NCT02610920|Iron|iron|mesh-list
138910520|NCT02610920|Trace Elements|trace elements|mesh-ancestor
138910521|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
138910522|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910523|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138910524|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138910525|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138910526|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
138910527|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910528|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138910529|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138822467|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138910530|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910531|NCT00818168|Infliximab|infliximab|mesh-list
138910532|NCT00818168|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138910533|NCT00818168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138910534|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
138910535|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138562563|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
138910536|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138910537|NCT02607540|Cisplatin|cisplatin|mesh-list
138910538|NCT02607540|Fluorouracil|fluorouracil|mesh-list
138910539|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910540|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
138910541|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822530|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138910542|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138910543|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138910544|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
138910545|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910547|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138910548|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
138910549|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910550|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
138910551|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
138910552|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138910553|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910554|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138910555|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
138910556|NCT00705770|Anecortave|anecortave|mesh-list
138910557|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138910558|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138910559|NCT00705770|Growth Substances|growth substances|mesh-ancestor
138910560|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910561|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
138910562|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275388|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
138910563|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138910564|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
138910565|NCT00796653|Olodaterol|olodaterol|mesh-list
138910566|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138910567|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
138910568|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910569|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910570|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138822593|NCT00720421|Lorazepam|lorazepam|mesh-list
138910571|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
138910572|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138910573|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138910574|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138910575|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
138910576|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138910577|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910578|NCT00806286|Paclitaxel|paclitaxel|mesh-list
138910579|NCT00806286|Carboplatin|carboplatin|mesh-list
138910580|NCT00806286|Efatutazone|efatutazone|mesh-list
138822636|NCT02570581|Furosemide|furosemide|mesh-list
138910581|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138910582|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910583|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
138910584|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
138910585|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
138910586|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910588|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
138910589|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138910590|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449231|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138910591|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910593|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
138910594|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910595|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138910596|NCT00590538|Genistein|genistein|mesh-list
138910597|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910598|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138910599|NCT00590538|Protective Agents|protective agents|mesh-ancestor
138910600|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910601|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138910602|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275487|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910603|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910604|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
138910605|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138910606|NCT00590538|Estrogens|estrogens|mesh-ancestor
138910608|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138910609|NCT02608320|Fentanyl|fentanyl|mesh-list
138910610|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138910611|NCT02608320|Narcotics|narcotics|mesh-ancestor
138910612|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138910613|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910614|NCT02608320|Analgesics|analgesics|mesh-ancestor
138910615|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
138910616|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910617|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138910618|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138910619|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
138910620|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
138910621|NCT05728788|Antineoplastic Agents|antineoplastic agents|mesh-list
138910622|NCT02608164|Vitamin D|vitamin d|mesh-list
138910623|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
138910624|NCT02608164|Vitamins|vitamins|mesh-ancestor
138910625|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
138910626|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910627|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138910628|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138910629|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138275542|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275544|NCT00004887|Vinblastine|vinblastine|mesh-list
138275545|NCT00004887|Carboplatin|carboplatin|mesh-list
138275546|NCT00004887|Ifosfamide|ifosfamide|mesh-list
138275547|NCT00004887|Mitomycins|mitomycins|mesh-list
138275548|NCT00004887|Mitomycin|mitomycin|mesh-list
138275553|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275556|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
138910630|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
138910631|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
138910633|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
138910634|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910636|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
138910637|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138910638|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
138449260|NCT01862523|Capsaicin|capsaicin|mesh-list
138910639|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910640|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275594|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275599|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910642|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910643|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138910644|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138910645|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910646|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910647|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138910648|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
138910649|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138910650|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910651|NCT00805740|Caspofungin|caspofungin|mesh-list
138910652|NCT00805740|Anidulafungin|anidulafungin|mesh-list
138910653|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
138910654|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910655|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910656|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275658|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275659|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138275660|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275661|NCT00003633|Prednisone|prednisone|mesh-list
138275662|NCT00003633|Docetaxel|docetaxel|mesh-list
138275663|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
138275664|NCT00003633|Estramustine|estramustine|mesh-list
138275665|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910657|NCT05613075|Hyaluronic Acid|hyaluronic acid|mesh-list
138910658|NCT05613075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138910659|NCT05613075|Immunologic Factors|immunologic factors|mesh-ancestor
138910660|NCT05613075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910661|NCT05613075|Viscosupplements|viscosupplements|mesh-ancestor
138910662|NCT05613075|Protective Agents|protective agents|mesh-ancestor
138910663|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138910664|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
138910665|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138910666|NCT01227876|Prednisolone|prednisolone|mesh-list
138910667|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
138910668|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138910669|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
138910670|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138910671|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
138910672|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
138910673|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910674|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910675|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138910676|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
138910677|NCT01227876|Hormones|hormones|mesh-ancestor
138910678|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138275712|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275713|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275714|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275715|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275716|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381538|NCT02715609|Copper|copper|mesh-list
138910679|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138910680|NCT01227876|Protective Agents|protective agents|mesh-ancestor
138910681|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138910682|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910683|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
138910684|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138910685|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910686|NCT05297292|Ranibizumab|ranibizumab|mesh-list
138910687|NCT05297292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138823014|NCT00640575|Lidocaine|lidocaine|mesh-list
138562711|NCT03690544|Analgesics|analgesics|mesh-ancestor
138910689|NCT05297292|Growth Substances|growth substances|mesh-ancestor
138910690|NCT05297292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910691|NCT05297292|Growth Inhibitors|growth inhibitors|mesh-ancestor
138910692|NCT05297292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910694|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138910695|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
138910696|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
138910697|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138910698|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910699|NCT02607072|Aspirin|aspirin|mesh-list
138910700|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138910701|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138910702|NCT02607072|Analgesics|analgesics|mesh-ancestor
138910703|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
138449289|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
138910704|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910705|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823059|NCT04183881|Brodalumab|brodalumab|mesh-list
138910706|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138910707|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138910708|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138910709|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138910710|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910711|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138910712|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138910713|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910714|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
138910715|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138910716|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910717|NCT04110093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138910718|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910720|NCT00588237|Bevacizumab|bevacizumab|mesh-list
138910721|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138910722|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910723|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
138910724|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
138910725|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
138910726|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275818|NCT00004107|Epratuzumab|epratuzumab|mesh-list
138910727|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138910728|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138910729|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138910730|NCT00588237|Growth Substances|growth substances|mesh-ancestor
138910731|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910732|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
138910733|NCT02605746|Ceritinib|ceritinib|mesh-list
138910734|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910735|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138910736|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910737|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910738|NCT04109859|Methylene Blue|methylene blue|mesh-list
138910739|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910740|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910741|NCT00790023|Ciclesonide|ciclesonide|mesh-list
138910742|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
138910743|NCT00790023|Hormones|hormones|mesh-ancestor
138910744|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138910745|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910746|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138910747|NCT00588822|Rituximab|rituximab|mesh-list
138910748|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138910749|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910750|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
138910751|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910752|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138910754|NCT05563467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138910755|NCT05563467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910756|NCT05563467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138910757|NCT05563467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275880|NCT00384657|Hematinics|hematinics|mesh-ancestor
138910758|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138910759|NCT00589914|Risperidone|risperidone|mesh-list
138910760|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138910761|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138910762|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138910763|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823435|NCT00727207|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138910764|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138910765|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138910766|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138910767|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
138910768|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138910769|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910770|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138910771|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138910772|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
138910773|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138910774|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138910775|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138910776|NCT00789555|Analgesics|analgesics|mesh-ancestor
138910777|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
138910778|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910779|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275909|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275910|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275911|NCT00004179|Prednisone|prednisone|mesh-list
138275912|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
138275913|NCT00004179|Rituximab|rituximab|mesh-list
138275914|NCT00004179|Doxorubicin|doxorubicin|mesh-list
138275915|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138275917|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138910780|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138910781|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138910782|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138910783|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138910784|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138910785|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
138910786|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
138910787|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823557|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
138910788|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910789|NCT03770455|Avelumab|avelumab|mesh-list
138910790|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138910791|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910792|NCT01026337|Sunitinib|sunitinib|mesh-list
138910793|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910794|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138910795|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138910796|NCT01026337|Growth Substances|growth substances|mesh-ancestor
138910797|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910798|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
138910799|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138910800|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910801|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910802|NCT03746275|Aspirin|aspirin|mesh-list
138910803|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
138275957|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
138910804|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138910805|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138910806|NCT03746275|Analgesics|analgesics|mesh-ancestor
138910807|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
138910808|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910809|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910810|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823623|NCT00586690|Antibodies|antibodies|mesh-list
138910812|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138910813|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138910814|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910815|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138910816|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138910817|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910818|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
138910819|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138910820|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
138910821|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138910822|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
138910823|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
138910824|NCT01026415|Rifampin|rifampin|mesh-list
138910825|NCT01026415|Ketoconazole|ketoconazole|mesh-list
138910826|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138910827|NCT01026415|Midazolam|midazolam|mesh-list
138910828|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138910829|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138910830|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138910831|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138910832|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910833|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138910834|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138910835|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138910836|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138562875|NCT00123318|Cisplatin|cisplatin|mesh-list
138910837|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
138910838|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
138910839|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
138910840|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
138910841|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449301|NCT01862978|Heparin|heparin|mesh-list
138910842|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910843|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138910844|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
138910845|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138910846|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910847|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
138910848|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138910849|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910850|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138910851|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138910852|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138910853|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138910854|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138823790|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276058|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
138910855|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138910856|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138910857|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910859|NCT01026415|Immunoconjugates|immunoconjugates|mesh-ancestor
138910860|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
138910861|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
138910862|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138910863|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138910864|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138910865|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
138910866|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138910867|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138910868|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138910869|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
138910870|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910871|NCT02604966|Artesunate|artesunate|mesh-list
138910872|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
138910873|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138910874|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138910875|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276104|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138910876|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910877|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
138910878|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
138910879|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138910880|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
138910881|NCT00914160|Diclofenac|diclofenac|mesh-list
138910882|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138910883|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138910884|NCT00914160|Analgesics|analgesics|mesh-ancestor
138910885|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
138910886|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910887|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910888|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138910889|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138910890|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138910892|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910893|NCT00450619|Metronidazole|metronidazole|mesh-list
138910894|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
138910895|NCT00450619|Vaccines|vaccines|mesh-list
138276158|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
138276159|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322615|NCT00084864|Calcitriol|calcitriol|mesh-list
138276160|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276161|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
138276162|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276163|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138276164|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381776|NCT01267812|Rituximab|rituximab|mesh-list
138276167|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138276168|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138910897|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
138910898|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910899|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910900|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138910901|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138910902|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138910903|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138910904|NCT00450619|Analgesics|analgesics|mesh-ancestor
138910905|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
138910906|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910907|NCT00802074|Ritonavir|ritonavir|mesh-list
138910908|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
138910909|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
138910910|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138910911|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138910912|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
138910913|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276204|NCT00004311|Diuretics|diuretics|mesh-ancestor
138276205|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
138276207|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
138276208|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
138276209|NCT00004317|Spiramycin|spiramycin|mesh-list
138276210|NCT00004317|Calcium|calcium|mesh-list
138276211|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
138276212|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138276213|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276214|NCT00004317|Antidotes|antidotes|mesh-ancestor
138276215|NCT00004317|Protective Agents|protective agents|mesh-ancestor
138276216|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
138276217|NCT00004317|Vitamins|vitamins|mesh-ancestor
138276218|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
138276228|NCT00005091|Exatecan|exatecan|mesh-list
138910914|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910915|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138910916|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138910917|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
138910918|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138910919|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138910920|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138910921|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138910922|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138910923|NCT04112394|Anesthetics|anesthetics|mesh-list
138910924|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
138276254|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
138910925|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138910926|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910927|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
138910928|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910929|NCT00450385|Prednisone|prednisone|mesh-list
138910930|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
138910931|NCT00450385|Rituximab|rituximab|mesh-list
138910932|NCT00450385|Doxorubicin|doxorubicin|mesh-list
138910933|NCT00450385|Vincristine|vincristine|mesh-list
138910934|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276466|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
138276495|NCT00385125|Rituximab|rituximab|mesh-list
138910935|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
138910936|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910937|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138910938|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138910940|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910941|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910943|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138910944|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138910945|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138276683|NCT00004755|Allopurinol|allopurinol|mesh-list
138910946|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138910947|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910948|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138910950|NCT00450385|Hormones|hormones|mesh-ancestor
138910951|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400386|NCT01548066|Valproic Acid|valproic acid|mesh-list
138276829|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
138910952|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138910953|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138910954|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
138910955|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
138910956|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
138910957|NCT00588354|Triamcinolone|triamcinolone|mesh-list
138910958|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138910959|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138910960|NCT00588354|Lidocaine|lidocaine|mesh-list
138910961|NCT00588354|Clonidine|clonidine|mesh-list
138276905|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138276913|NCT02247349|Nivolumab|nivolumab|mesh-list
138910962|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138910963|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
138910964|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
138910965|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138910966|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138910967|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
138910968|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138910969|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138277116|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
138910970|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138910971|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138910972|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138277196|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910973|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910974|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138910975|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
138910976|NCT00588354|Hormones|hormones|mesh-ancestor
138910977|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138910978|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138910979|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
138910980|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910981|NCT00588354|Analgesics|analgesics|mesh-ancestor
138910982|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138910983|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
138910984|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
138910985|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138910986|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138563009|NCT00315211|Docetaxel|docetaxel|mesh-list
138910987|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138910988|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
138910989|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138910990|NCT00449761|Panobinostat|panobinostat|mesh-list
138910991|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138910992|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138910993|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138910994|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138910995|NCT00800982|Etanercept|etanercept|mesh-list
138910996|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138910997|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138910998|NCT00800982|Analgesics|analgesics|mesh-ancestor
138910999|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
138911000|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911001|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911002|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138911003|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138911004|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138911005|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138911006|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
138911007|NCT01019395|Daptomycin|daptomycin|mesh-list
138911008|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138911009|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911010|NCT00830960|Clopidogrel|clopidogrel|mesh-list
138911011|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138911012|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138911013|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138911014|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138277552|NCT02523235|Ropivacaine|ropivacaine|mesh-list
138911015|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138911016|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
138449350|NCT01863225|Atorvastatin|atorvastatin|mesh-list
138911018|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911019|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911020|NCT01026961|Acetaminophen|acetaminophen|mesh-list
138911021|NCT01026961|Dimethindene|dimethindene|mesh-list
138911022|NCT01026961|Phenylephrine|phenylephrine|mesh-list
138911023|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
138911024|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138911025|NCT01026961|Analgesics|analgesics|mesh-ancestor
138911026|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
138911027|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911028|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911030|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911031|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138911032|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
138911033|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
138911034|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
138911035|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138911036|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
138911037|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
138277890|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
138911038|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138911039|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138911040|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138911041|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
138911042|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911043|NCT01026961|Protective Agents|protective agents|mesh-ancestor
138278048|NCT02568644|Ketoprofen|ketoprofen|mesh-list
138911044|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
138911045|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
138911046|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138911047|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
138911048|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
138911049|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138911050|NCT01566253|Acetaminophen|acetaminophen|mesh-list
138911051|NCT01566253|Ketoprofen|ketoprofen|mesh-list
138911052|NCT01566253|Morphine|morphine|mesh-list
138911053|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138911054|NCT01566253|Narcotics|narcotics|mesh-ancestor
138382809|NCT01468480|Calcium|calcium|mesh-list
138911055|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138911056|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911057|NCT01566253|Analgesics|analgesics|mesh-ancestor
138911058|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
138278329|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
138911059|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911060|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138911061|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
138911062|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138563085|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138911063|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138911064|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138911065|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138911066|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911067|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911069|NCT03849313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138911070|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138911071|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138911072|NCT04111614|Tofacitinib|tofacitinib|mesh-list
138911073|NCT04111614|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138911074|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138911075|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824491|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138278399|NCT05360030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138911076|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911077|NCT01023919|Sirolimus|sirolimus|mesh-list
138911078|NCT01023919|Paclitaxel|paclitaxel|mesh-list
138278457|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911079|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138911080|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911081|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
138911082|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
138911083|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
138278597|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278599|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138911084|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911085|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138911086|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911087|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138911088|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
138911089|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138911090|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
138911091|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911092|NCT04028622|Anesthetics|anesthetics|mesh-list
138911093|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138911094|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911096|NCT00830804|Darunavir|darunavir|mesh-list
138911097|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
138911098|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138911099|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138911100|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
138911101|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911102|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824677|NCT02662725|Ipilimumab|ipilimumab|mesh-list
138911103|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138911104|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138911105|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
138911106|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911107|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138278812|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
138278813|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
138911108|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138911109|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138911110|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138911111|NCT00789477|Aflibercept|aflibercept|mesh-list
138911112|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138911113|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138911114|NCT00789477|Growth Substances|growth substances|mesh-ancestor
138911115|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278875|NCT02565901|Docetaxel|docetaxel|mesh-list
138278888|NCT03926624|Cytarabine|cytarabine|mesh-list
138911116|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
138911117|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911118|NCT01024075|Dexamethasone|dexamethasone|mesh-list
138911119|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138911120|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
138911121|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
138911122|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911123|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911124|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138911125|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
138279019|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138911127|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138911128|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138911129|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911130|NCT05756348|Protective Agents|protective agents|mesh-list
138911131|NCT05756348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911132|NCT00913874|Valproic Acid|valproic acid|mesh-list
138911133|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
138911134|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911135|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911136|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
138911137|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911138|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911140|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138911141|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138911142|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138911143|NCT00796614|Tamsulosin|tamsulosin|mesh-list
138279303|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
138911144|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138911145|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138911146|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138911147|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
138911148|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279452|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138911149|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911150|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911151|NCT00796614|Urological Agents|urological agents|mesh-ancestor
138279526|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
138911153|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911154|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824858|NCT00712543|Lactulose|lactulose|mesh-list
138911155|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911157|NCT02603679|Paclitaxel|paclitaxel|mesh-list
138911158|NCT02603679|Letrozole|letrozole|mesh-list
138911159|NCT02603679|Palbociclib|palbociclib|mesh-list
138911160|NCT02603679|Anastrozole|anastrozole|mesh-list
138911161|NCT02603679|Exemestane|exemestane|mesh-list
138911162|NCT02603679|Goserelin|goserelin|mesh-list
138911163|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138911164|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138911165|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911166|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
138911167|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
138911168|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
138911169|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911170|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138911171|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911172|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138911173|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
138824912|NCT02653833|Tadalafil|tadalafil|mesh-list
138911174|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138911175|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911176|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138911177|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138911178|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138911179|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138911180|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138279895|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911181|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
138911182|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
138911183|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911184|NCT02605434|Levodopa|levodopa|mesh-list
138911185|NCT02605434|Carbidopa|carbidopa|mesh-list
138911186|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138911187|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138911188|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138911189|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
138911190|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911191|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911192|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279957|NCT02641561|Analgesics|analgesics|mesh-ancestor
138911193|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138911194|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911195|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138911196|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
138911197|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
138911198|NCT05758298|Nicotine|nicotine|mesh-list
138911199|NCT05758298|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138911200|NCT05758298|Autonomic Agents|autonomic agents|mesh-ancestor
138911201|NCT05758298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911202|NCT05758298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911203|NCT05758298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138911204|NCT05758298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138911205|NCT05758298|Cholinergic Agents|cholinergic agents|mesh-ancestor
138911206|NCT05758298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911207|NCT05758298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280021|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
138911209|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138911210|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138911211|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138911212|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911213|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138911214|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825163|NCT02647515|Ranibizumab|ranibizumab|mesh-list
138911215|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
138911216|NCT00811928|Fluconazole|fluconazole|mesh-list
138911217|NCT00811928|Posaconazole|posaconazole|mesh-list
138911218|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
138911219|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911220|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138911221|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138911222|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911223|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911224|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138911225|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
138911226|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138911227|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911228|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138911229|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138911231|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138911232|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138911233|NCT00448669|Tenofovir|tenofovir|mesh-list
138911234|NCT00448669|Emtricitabine|emtricitabine|mesh-list
138911235|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
138911236|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911237|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138911238|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138911239|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280134|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
138280135|NCT02201784|Ropivacaine|ropivacaine|mesh-list
138280136|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
138911240|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911241|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138911242|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138911243|NCT00591734|Bevacizumab|bevacizumab|mesh-list
138911244|NCT00591734|Everolimus|everolimus|mesh-list
138911245|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138911246|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911247|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138911248|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138911249|NCT00591734|Growth Substances|growth substances|mesh-ancestor
138911250|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911251|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
138911252|NCT00591734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138911253|NCT00591734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138911254|NCT00591734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280199|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911255|NCT00591734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911256|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138911257|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
138911258|NCT00848549|Carbamazepine|carbamazepine|mesh-list
138911259|NCT00848549|Zonisamide|zonisamide|mesh-list
138911261|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
138911262|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138911263|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138911264|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911265|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138911266|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138911267|NCT00848549|Analgesics|analgesics|mesh-ancestor
138911268|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
138911269|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911270|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138911271|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138911272|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911273|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138911274|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138911275|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138911276|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138911277|NCT00788151|Vaccines|vaccines|mesh-list
138911278|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138911279|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
138911280|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911281|NCT04116359|Cisplatin|cisplatin|mesh-list
138911282|NCT04116359|Etoposide|etoposide|mesh-list
138911283|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
138911284|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
138911285|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911286|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138911287|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138280321|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911288|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138911290|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911291|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
138911292|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
138911293|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
138911294|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
138911295|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
138911296|NCT04118153|Abatacept|abatacept|mesh-list
138911297|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138911298|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911299|NCT04118153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138911300|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911301|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138911302|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
138280379|NCT05587621|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138911303|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911306|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
138911307|NCT00848393|Citric Acid|citric acid|mesh-list
138911308|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
138911309|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138911310|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138911311|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911312|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138911313|NCT00848393|Analgesics|analgesics|mesh-ancestor
138911314|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
138911315|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911316|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138911317|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138280442|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138911318|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138911319|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
138911320|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911321|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911322|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138911323|NCT00848393|Narcotics|narcotics|mesh-ancestor
138911324|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138911325|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138911326|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
138911327|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
138911328|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
138280498|NCT02690948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280499|NCT02698735|Gentamicins|gentamicins|mesh-list
138280500|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138280501|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280502|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138280503|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280505|NCT02691416|Propofol|propofol|mesh-list
138911329|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138911330|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
138911331|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
138911333|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138911334|NCT00815516|Micafungin|micafungin|mesh-list
138911335|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
138911336|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
138911337|NCT00815516|Amebicides|amebicides|mesh-ancestor
138911338|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138911339|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138911340|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384288|NCT04470609|Vaccines|vaccines|mesh-list
138280557|NCT02697188|Androgens|androgens|mesh-ancestor
138280562|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911341|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138911342|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
138911343|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138911344|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138911345|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138911346|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
138911347|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911348|NCT00787917|Omalizumab|omalizumab|mesh-list
138911349|NCT00787917|Itraconazole|itraconazole|mesh-list
138911350|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
138911351|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911352|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138911353|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138911354|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911355|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911356|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138911357|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
138911358|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138911359|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280686|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911360|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138911361|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138911362|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138911363|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
138911364|NCT05758064|Dydrogesterone|dydrogesterone|mesh-list
138911365|NCT05758064|Progestins|progestins|mesh-ancestor
138911366|NCT05758064|Hormones|hormones|mesh-ancestor
138911367|NCT05758064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138911368|NCT05758064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911369|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138911370|NCT00829244|Hormones|hormones|mesh-ancestor
138911371|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138911372|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911373|NCT00787605|Amlodipine|amlodipine|mesh-list
138911374|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138911375|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138911376|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138911377|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138911378|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911379|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138911380|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280749|NCT02664961|Growth Substances|growth substances|mesh-ancestor
138911381|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
138911383|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
138911384|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138911385|NCT00448591|Bevacizumab|bevacizumab|mesh-list
138911386|NCT00448591|Taxane|taxane|mesh-list
138911387|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138911388|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911389|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138911390|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138911391|NCT00448591|Growth Substances|growth substances|mesh-ancestor
138911392|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911393|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
138911394|NCT00787527|Prednisone|prednisone|mesh-list
138911395|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
138911396|NCT00787527|Doxorubicin|doxorubicin|mesh-list
138911397|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138911398|NCT00787527|Vincristine|vincristine|mesh-list
138911399|NCT00787527|Vorinostat|vorinostat|mesh-list
138911400|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138911402|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911403|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138280871|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911404|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138911405|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
138911406|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911407|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911408|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138911409|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138911410|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138911411|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138911412|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911413|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138911415|NCT00787527|Hormones|hormones|mesh-ancestor
138911416|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138911417|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138280943|NCT02736175|Hormones|hormones|mesh-ancestor
138911418|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138911419|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
138911420|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
138911421|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
138280995|NCT05424523|Omalizumab|omalizumab|mesh-list
138911422|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138911423|NCT00804388|Vitamin E|vitamin e|mesh-list
138911424|NCT00804388|Vitamins|vitamins|mesh-ancestor
138911425|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
138911426|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911427|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
138911428|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911429|NCT00804388|Protective Agents|protective agents|mesh-ancestor
138911430|NCT00806962|Vaccines|vaccines|mesh-list
138911431|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
138911432|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911433|NCT02553226|Oxytocin|oxytocin|mesh-list
138911434|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
138911435|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138911436|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911437|NCT00810316|Clonazepam|clonazepam|mesh-list
138911438|NCT00810316|Alprazolam|alprazolam|mesh-list
138911439|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138281288|NCT05441150|Ketamine|ketamine|mesh-list
138911440|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138911441|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911442|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138911443|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138911444|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138911445|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
138911446|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
138911447|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911448|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911449|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
138911450|NCT00448435|Fluticasone|fluticasone|mesh-list
138911451|NCT00448435|Xhance|xhance|mesh-list
138911452|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138911453|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138911454|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339866|NCT01434342|Nicotine|nicotine|mesh-list
138911455|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138826128|NCT05480384|Trastuzumab|trastuzumab|mesh-list
138911456|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
138911457|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911458|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911459|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138911460|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
138911461|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
138911462|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138911463|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138911464|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138911465|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138911466|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
138826191|NCT05238207|Psyllium|psyllium|mesh-list
138911467|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911468|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911471|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138911472|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
138911473|NCT00804622|Tenofovir|tenofovir|mesh-list
138911474|NCT00804622|Telbivudine|telbivudine|mesh-list
138281551|NCT00370370|Hormones|hormones|mesh-ancestor
138911475|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
138911476|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911477|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138911478|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138911479|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911480|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911481|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138911482|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138911483|NCT02603055|Vaccines|vaccines|mesh-list
138911484|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
138281764|NCT00370760|Hormones|hormones|mesh-ancestor
138911485|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911486|NCT02602743|Ketamine|ketamine|mesh-list
138911487|NCT02602743|Remifentanil|remifentanil|mesh-list
138911488|NCT02602743|Propofol|propofol|mesh-list
138911489|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138911490|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138911491|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911492|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138911493|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
138911494|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
138911495|NCT02602743|Analgesics|analgesics|mesh-ancestor
138911496|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
138911497|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911498|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138911499|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138911500|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138911501|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911502|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911503|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138911504|NCT02602743|Narcotics|narcotics|mesh-ancestor
138911505|NCT00807118|Fesoterodine|fesoterodine|mesh-list
138911506|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138911507|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138911508|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
138911509|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911510|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911511|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911512|NCT00807118|Urological Agents|urological agents|mesh-ancestor
138911513|NCT00448279|Trastuzumab|trastuzumab|mesh-list
138911514|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826440|NCT03542175|Rucaparib|rucaparib|mesh-list
138826441|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138826442|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282032|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138826443|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826444|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826445|NCT03519230|Pamiparib|pamiparib|mesh-list
138826446|NCT03519230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138826447|NCT03519230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911515|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911517|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911518|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138911519|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138911520|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911521|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911522|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138911523|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
138911524|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138911525|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911526|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
138911527|NCT00807196|Rituximab|rituximab|mesh-list
138911528|NCT00807196|Fludarabine|fludarabine|mesh-list
138282317|NCT04064684|Glucocorticoids|glucocorticoids|mesh-ancestor
138911529|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138911530|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
138449436|NCT01863602|Lamotrigine|lamotrigine|mesh-list
138911531|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911532|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138911533|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138911534|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
138911535|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911536|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911537|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138911538|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138911539|NCT00448123|Tamsulosin|tamsulosin|mesh-list
138911540|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138911541|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138911542|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138911543|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
138911544|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911545|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911546|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911547|NCT00448123|Urological Agents|urological agents|mesh-ancestor
138282678|NCT02885636|Albuterol|albuterol|mesh-list
138911548|NCT00804934|Ranibizumab|ranibizumab|mesh-list
138911549|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138911550|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138911551|NCT00804934|Growth Substances|growth substances|mesh-ancestor
138911552|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911553|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
138282814|NCT02790788|Prednisolone|prednisolone|mesh-list
138911554|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911556|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826758|NCT04019782|Hylan|hylan|mesh-list
138911557|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
138911558|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
138911559|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
138911560|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911561|NCT00447499|Lanreotide|lanreotide|mesh-list
138911562|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911563|NCT00805090|Itraconazole|itraconazole|mesh-list
138911564|NCT00805090|Diclofenac|diclofenac|mesh-list
138911565|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138911566|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138911567|NCT00805090|Analgesics|analgesics|mesh-ancestor
138911568|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
138911569|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911570|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911571|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138911572|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138911573|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138911574|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911575|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911576|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
138911577|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911578|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138911579|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138826825|NCT00746590|Tretazicar|tretazicar|mesh-list
138911580|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138911581|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
138702623|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138911582|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138911583|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138911584|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
138911586|NCT00810862|Cathartics|cathartics|mesh-ancestor
138911587|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138911588|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138911589|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138911590|NCT00810862|Analgesics|analgesics|mesh-ancestor
138911591|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
138911592|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138826889|NCT01012973|Aflibercept|aflibercept|mesh-list
138326951|NCT00103116|Vaccines|vaccines|mesh-list
138911593|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911594|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138702834|NCT04798287|Golimumab|golimumab|mesh-list
138911595|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138911596|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
138911597|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138911598|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
138911599|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138911600|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911601|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911602|NCT00800436|Trastuzumab|trastuzumab|mesh-list
138911603|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138911604|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911605|NCT00810940|Mannitol|mannitol|mesh-list
138703042|NCT01709214|Oxycodone|oxycodone|mesh-list
138911606|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138911607|NCT00810940|Diuretics|diuretics|mesh-ancestor
138911608|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
138911609|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911610|NCT00655564|Alefacept|alefacept|mesh-list
138703180|NCT02915354|Etanercept|etanercept|mesh-list
138911611|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
138911612|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
138911613|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911614|NCT00447421|Pemetrexed|pemetrexed|mesh-list
138911615|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911616|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703376|NCT02063295|CKD732|ckd732|mesh-list
138911617|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911618|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138703399|NCT02052648|Bevacizumab|bevacizumab|mesh-list
138911619|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138911620|NCT00651118|Fluticasone|fluticasone|mesh-list
138911621|NCT00651118|Xhance|xhance|mesh-list
138911623|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138911624|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138911625|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
138911626|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911627|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911628|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138911629|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
138911630|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
138911631|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138703626|NCT01973049|Ribavirin|ribavirin|mesh-list
138703685|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
138911632|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138911633|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911634|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911635|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138911636|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138703774|NCT06227065|Gemcitabine|gemcitabine|mesh-list
138911637|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
138911638|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
138911639|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911640|NCT00447265|Etanercept|etanercept|mesh-list
138911641|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138911642|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138911643|NCT00447265|Analgesics|analgesics|mesh-ancestor
138911644|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
138911645|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911646|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911648|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138421922|NCT01688362|Hormones|hormones|mesh-ancestor
138911649|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138911650|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138911651|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
138911652|NCT03641755|Olaparib|olaparib|mesh-list
138911653|NCT03641755|Sapacitabine|sapacitabine|mesh-list
138911654|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138911655|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911656|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911657|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911658|NCT00657358|Lidocaine|lidocaine|mesh-list
138911659|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
138911660|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
138911661|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138911662|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911663|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
138422026|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138911664|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911665|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138911666|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138911667|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138911668|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138911669|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911671|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138911672|NCT00800202|Paclitaxel|paclitaxel|mesh-list
138911673|NCT00800202|Bevacizumab|bevacizumab|mesh-list
138911674|NCT00800202|Carboplatin|carboplatin|mesh-list
138911675|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138911676|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138911677|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911678|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
138911679|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
138911680|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
138422294|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138911681|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911682|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138911683|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138911684|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138911685|NCT00800202|Growth Substances|growth substances|mesh-ancestor
138911686|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911687|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
138911688|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138827258|NCT01032239|Baclofen|baclofen|mesh-list
138911689|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911690|NCT00811096|Chloroquine|chloroquine|mesh-list
138911691|NCT00811096|Tinidazole|tinidazole|mesh-list
138911692|NCT00811096|Amebicides|amebicides|mesh-ancestor
138911693|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138911694|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138911695|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911696|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
138911697|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138911698|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
138911699|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911700|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138911701|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138911702|NCT05146804|Sulforaphane|sulforaphane|mesh-list
138911703|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138911704|NCT05146804|Protective Agents|protective agents|mesh-ancestor
138422674|NCT05290948|Growth Substances|growth substances|mesh-ancestor
138911705|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911706|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911707|NCT00655486|Lacosamide|lacosamide|mesh-list
138911708|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
138911709|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138911710|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138422744|NCT05291910|Mitosis Modulators|mitosis modulators|mesh-ancestor
138911711|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138911712|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911713|NCT04111302|Dezocine|dezocine|mesh-list
138911714|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138911715|NCT04111302|Narcotics|narcotics|mesh-ancestor
138911716|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138911717|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911718|NCT04111302|Analgesics|analgesics|mesh-ancestor
138911719|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
138911720|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911721|NCT04111848|Ketamine|ketamine|mesh-list
138911722|NCT04111848|Analgesics|analgesics|mesh-ancestor
138911723|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
138911724|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911725|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911726|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138827375|NCT04284098|Analgesics|analgesics|mesh-ancestor
138911727|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138911728|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
138911729|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
138911730|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138911731|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138911732|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138911733|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911734|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911735|NCT00457015|Ecallantide|ecallantide|mesh-list
138911736|NCT00457015|Analgesics|analgesics|mesh-ancestor
138911737|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
138911738|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911739|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911740|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138911741|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138911742|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138911743|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138911744|NCT00654940|Pregabalin|pregabalin|mesh-list
138911745|NCT00654940|Analgesics|analgesics|mesh-ancestor
138911746|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
138911747|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911748|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911749|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
138911750|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138911751|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138911752|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911753|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138911754|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138911755|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138911756|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138911757|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138911758|NCT00588666|Bevacizumab|bevacizumab|mesh-list
138911759|NCT00588666|Carboplatin|carboplatin|mesh-list
138911760|NCT00588666|Gemcitabine|gemcitabine|mesh-list
138911761|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138911762|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911763|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138911764|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138911765|NCT00588666|Growth Substances|growth substances|mesh-ancestor
138911766|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911767|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
138911768|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138911769|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
138911770|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911771|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
138911772|NCT00805558|Metronidazole|metronidazole|mesh-list
138911773|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
138911774|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138911775|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138911776|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911777|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138911778|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138382450|NCT01464476|Azimilide|azimilide|mesh-list
138911779|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911780|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423510|NCT04294147|Erenumab|erenumab|mesh-list
138911781|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911782|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138911783|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
138423585|NCT04133922|Insulin|insulin|mesh-list
138911784|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138911785|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911786|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138911787|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138911788|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138911789|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138911790|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138911791|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138911792|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138911793|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
138911794|NCT01019785|Vitamin D|vitamin d|mesh-list
138911795|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138911796|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911797|NCT01019785|Vitamins|vitamins|mesh-ancestor
138911798|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
138911799|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138911800|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
138911801|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138911802|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138911803|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911804|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
138911805|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911806|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911807|NCT01024543|Phenylephrine|phenylephrine|mesh-list
138911808|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
138911809|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
138563840|NCT00324688|Tenofovir|tenofovir|mesh-list
138911810|NCT01024543|Giapreza|giapreza|mesh-list
138911811|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
138911812|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138911813|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
138911814|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
138911815|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911816|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911817|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
138911818|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138911819|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
138911820|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
138911821|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138911822|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138911823|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138911824|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
138911825|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911826|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911827|NCT01024543|Protective Agents|protective agents|mesh-ancestor
138911828|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138911829|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
138911830|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911831|NCT00811330|Atorvastatin|atorvastatin|mesh-list
138911832|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138911833|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138911834|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
138911835|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911836|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138911837|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138423979|NCT05297903|Immunologic Factors|immunologic factors|mesh-ancestor
138911838|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911840|NCT00811408|Carboplatin|carboplatin|mesh-list
138911841|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827843|NCT01005329|Paclitaxel|paclitaxel|mesh-list
138911842|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
138911843|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911844|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770248|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138911845|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911846|NCT00446797|Celecoxib|celecoxib|mesh-list
138911847|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138911848|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138911849|NCT00446797|Analgesics|analgesics|mesh-ancestor
138911850|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
138911851|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911852|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911853|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138911854|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138911855|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138911856|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138911857|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911858|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911859|NCT00855335|Ritonavir|ritonavir|mesh-list
138911860|NCT00855335|Darunavir|darunavir|mesh-list
138911861|NCT00855335|Cobicistat|cobicistat|mesh-list
138911862|NCT00855335|Rilpivirine|rilpivirine|mesh-list
138911863|NCT00855335|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
138911864|NCT00855335|Etravirine|etravirine|mesh-list
138424330|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
138911865|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138911866|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138911867|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
138424402|NCT02237820|Hormones|hormones|mesh-ancestor
138911868|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911869|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911870|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138911871|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138911872|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
138911873|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911874|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138911875|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138911876|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138911877|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138911878|NCT00811486|Spironolactone|spironolactone|mesh-list
138911879|NCT00811486|Conivaptan|conivaptan|mesh-list
138911880|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138424543|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138911882|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138911883|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424610|NCT03760835|Hormones|hormones|mesh-ancestor
138911884|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138911885|NCT00811486|Diuretics|diuretics|mesh-ancestor
138911886|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
138911887|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138911888|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911889|NCT04114188|Prednisolone|prednisolone|mesh-list
138911890|NCT04114188|Infliximab|infliximab|mesh-list
138911891|NCT04114188|Tacrolimus|tacrolimus|mesh-list
138911892|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
138911893|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138911894|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
138911895|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138911896|NCT04114188|Antibodies|antibodies|mesh-list
138911897|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138911898|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
138424756|NCT03500549|Eculizumab|eculizumab|mesh-list
138424817|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911899|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911900|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138911901|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911902|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911903|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138911904|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
138911905|NCT04114188|Hormones|hormones|mesh-ancestor
138911906|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138911907|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138911908|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911909|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138911910|NCT04114188|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138911911|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
138911912|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138911913|NCT00811876|Leuprolide|leuprolide|mesh-list
138911914|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138911915|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
138911916|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138911917|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424959|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
138424965|NCT03850483|PF-06700841|pf-06700841|mesh-list
138425025|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138911918|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138911919|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911920|NCT00915252|Cytarabine|cytarabine|mesh-list
138911921|NCT00915252|Azacitidine|azacitidine|mesh-list
138911922|NCT00915252|Daunorubicin|daunorubicin|mesh-list
138425105|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911923|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138911924|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
138425174|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
138911925|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911926|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138911927|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
138911928|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138911929|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138911930|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
138911931|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911932|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911933|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138911934|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138911935|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138911936|NCT00593489|Insulin|insulin|mesh-list
138911937|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138911938|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911939|NCT00446641|Cilostazol|cilostazol|mesh-list
138911940|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138911941|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
138911942|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911943|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911944|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138911945|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
138425397|NCT02367794|Paclitaxel|paclitaxel|mesh-list
138911946|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138911947|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138911948|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911949|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138911950|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
138911951|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138911952|NCT00446641|Protective Agents|protective agents|mesh-ancestor
138911953|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138911954|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138911955|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425535|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911956|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138911957|NCT00646282|Vitamins|vitamins|mesh-ancestor
138911958|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
138911959|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911960|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138911961|NCT00792636|Naproxen|naproxen|mesh-list
138911962|NCT00792636|Sumatriptan|sumatriptan|mesh-list
138828462|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
138911963|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138425603|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
138911964|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138911965|NCT00792636|Analgesics|analgesics|mesh-ancestor
138911966|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
138911967|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138911968|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911969|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138911970|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138911971|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
138911972|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138911973|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138911974|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911975|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138911976|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138911977|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138911978|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
138911979|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138911980|NCT00446563|Losartan|losartan|mesh-list
138911981|NCT00446563|Amlodipine|amlodipine|mesh-list
138911982|NCT00446563|Valsartan|valsartan|mesh-list
138911983|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138911984|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138911985|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138911986|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138911987|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138911988|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138911989|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138911990|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
138911991|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138911992|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138911993|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138911995|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
138911996|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138911997|NCT00650806|Canagliflozin|canagliflozin|mesh-list
138911998|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138911999|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912000|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138912001|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912002|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138912003|NCT00863057|Methadone|methadone|mesh-list
138912004|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138912005|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138912006|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138828714|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912007|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392904|NCT01512017|Emollients|emollients|mesh-ancestor
138912008|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912009|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912010|NCT00863057|Analgesics|analgesics|mesh-ancestor
138912011|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
138912012|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912013|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
138912014|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138912015|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
138912016|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138912017|NCT00863057|Narcotics|narcotics|mesh-ancestor
138912018|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138912019|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
138912020|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
138912021|NCT00814216|Fluticasone|fluticasone|mesh-list
138912022|NCT00814216|Xhance|xhance|mesh-list
138912023|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138912024|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138912025|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
138912026|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912027|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912028|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138912029|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
138912030|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
138912031|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138912032|NCT00829166|Capecitabine|capecitabine|mesh-list
138912033|NCT00829166|Trastuzumab|trastuzumab|mesh-list
138912034|NCT00829166|Lapatinib|lapatinib|mesh-list
138564064|NCT00318838|Azimilide|azimilide|mesh-list
138912035|NCT00829166|Maytansine|maytansine|mesh-list
138912036|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138912037|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138912038|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
138912039|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912040|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912041|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138912042|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138912043|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912044|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138912045|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
138912046|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
138912047|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
138912048|NCT00829166|Immunotoxins|immunotoxins|mesh-ancestor
138912049|NCT00829166|Immunoconjugates|immunoconjugates|mesh-ancestor
138912050|NCT00829166|Immunologic Factors|immunologic factors|mesh-ancestor
138912051|NCT00829166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912052|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
138912053|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138912054|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912056|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138912057|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138912058|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
138912059|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
138912060|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912061|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912062|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912063|NCT00808054|Lidocaine|lidocaine|mesh-list
138912064|NCT00808054|Prilocaine|prilocaine|mesh-list
138912065|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
138912066|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
138912067|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138912068|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912069|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
138912070|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912071|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138912072|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138912073|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138912074|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138912075|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912076|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
138912077|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
138912078|NCT00814528|Imiquimod|imiquimod|mesh-list
138912079|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138912080|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
138912081|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912082|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912083|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
138912084|NCT00814606|Ribavirin|ribavirin|mesh-list
138912085|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138912086|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
138912087|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912088|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
138912089|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912091|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
138912092|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912093|NCT00654238|Sorafenib|sorafenib|mesh-list
138912094|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912095|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138912096|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912097|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912098|NCT00862979|Cyclosporine|cyclosporine|mesh-list
138912099|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
138912100|NCT00862979|Everolimus|everolimus|mesh-list
138912101|NCT00862979|Tacrolimus|tacrolimus|mesh-list
138912102|NCT00862979|Cyclosporins|cyclosporins|mesh-list
138912103|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138912104|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
138912105|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912106|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138912107|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912108|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912109|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
138564135|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912110|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912111|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
138912112|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138912113|NCT00862979|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138912114|NCT00862979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138912115|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912116|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138912117|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138912118|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
138912119|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138912120|NCT02605356|Dexamethasone|dexamethasone|mesh-list
138426001|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912122|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138912123|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138912124|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
138912125|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
138912126|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912127|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912128|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138912129|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
138912130|NCT02605356|Hormones|hormones|mesh-ancestor
138912131|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138912132|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138912133|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912134|NCT00812266|Carboplatin|carboplatin|mesh-list
138912135|NCT00812266|Etoposide|etoposide|mesh-list
138912136|NCT00812266|Topotecan|topotecan|mesh-list
138912137|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912138|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138912139|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138912140|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138912141|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912142|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912143|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138912144|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138912145|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138912146|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
138912147|NCT04113954|Prilocaine|prilocaine|mesh-list
138912148|NCT04113954|Mepivacaine|mepivacaine|mesh-list
138912149|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
138912150|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
138912151|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138912152|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912153|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
138912154|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912155|NCT00812344|Ketoconazole|ketoconazole|mesh-list
138912156|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
138912157|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912158|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138912159|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138912160|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912161|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449549|NCT01864161|Iron|iron|mesh-list
138912162|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138912163|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
138160839|NCT00357331|Expectorants|expectorants|mesh-ancestor
138912164|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138912165|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912166|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138912167|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
138912168|NCT00446251|Rituximab|rituximab|mesh-list
138912169|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138912170|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912171|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
138912172|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912173|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138912174|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138912175|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138912176|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
138912177|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138912178|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912179|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426143|NCT01696630|Desflurane|desflurane|mesh-list
138912180|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912181|NCT00812422|Ibuprofen|ibuprofen|mesh-list
138912182|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138564212|NCT00400088|Paroxetine|paroxetine|mesh-list
138912183|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138912184|NCT00812422|Analgesics|analgesics|mesh-ancestor
138912185|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
138912186|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912187|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912188|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138912189|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138912190|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138912191|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829478|NCT00748345|Caspofungin|caspofungin|mesh-list
138912192|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912193|NCT04110834|Itraconazole|itraconazole|mesh-list
138912194|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
138912195|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
138912196|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912197|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138912198|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138426201|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
138912199|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912200|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912201|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138912202|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
138912203|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138912204|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912205|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138912206|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
138912208|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138912209|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912210|NCT00812578|Vitamins|vitamins|mesh-ancestor
138912211|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
138912212|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138912213|NCT00796224|Azithromycin|azithromycin|mesh-list
138912214|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138912215|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912216|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
138912217|NCT00808366|Clotrimazole|clotrimazole|mesh-list
138912218|NCT00808366|Miconazole|miconazole|mesh-list
138912219|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
138912220|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912221|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138912222|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138912223|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138912224|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912225|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912226|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138912227|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
138912228|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138912229|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426249|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
138912230|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138912231|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138912232|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
138912233|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
138912234|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138912235|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912236|NCT02551276|Albuterol|albuterol|mesh-list
138912237|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138912238|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
138912239|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912240|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912241|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138912242|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
138912243|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
138912244|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138770249|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
138912245|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138912246|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138912247|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138912248|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
138912249|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912250|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912251|NCT00848081|Tadalafil|tadalafil|mesh-list
138912252|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
138912253|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138912254|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138912255|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912256|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912257|NCT00848081|Urological Agents|urological agents|mesh-ancestor
138912258|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
138912259|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912261|NCT04111380|Cisplatin|cisplatin|mesh-list
138912262|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138912263|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912264|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
138912265|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
138912266|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
138829809|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138426336|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912267|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912269|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138912270|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138912271|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
138912272|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138912273|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138912274|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138912275|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138912276|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138912277|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
138912278|NCT04117919|Hormones|hormones|mesh-ancestor
138912279|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138912280|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912281|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138912282|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
138912283|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912284|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912285|NCT00701285|Pravastatin|pravastatin|mesh-list
138912286|NCT00701285|Pitavastatin|pitavastatin|mesh-list
138912287|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138912288|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138912289|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
138912290|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912291|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138912292|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138912293|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912294|NCT02604498|Nemonoxacin|nemonoxacin|mesh-list
138912295|NCT02604498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138912296|NCT02604498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912297|NCT00700037|Atorvastatin|atorvastatin|mesh-list
138912298|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138912299|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138912300|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
138912301|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912302|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138912303|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138912304|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912305|NCT00815542|Dinoprostone|dinoprostone|mesh-list
138912306|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
138912307|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138912308|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912310|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912311|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138912312|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912313|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912314|NCT02604576|Bromopride|bromopride|mesh-list
138912315|NCT02604576|Metoclopramide|metoclopramide|mesh-list
138912316|NCT02604576|Simethicone|simethicone|mesh-list
138912317|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
138912318|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912319|NCT02604576|Emollients|emollients|mesh-ancestor
138912320|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
138912321|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
138912322|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
138912323|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912324|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912325|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138912326|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138912327|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
138912328|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912329|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138912331|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138564358|NCT00124332|Rimonabant|rimonabant|mesh-list
138912332|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
138912333|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
138426517|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
138912334|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
138912335|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
138912336|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138912337|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912338|NCT00795132|Cyclosporine|cyclosporine|mesh-list
138912339|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
138912340|NCT00795132|Fludarabine|fludarabine|mesh-list
138912341|NCT00795132|Busulfan|busulfan|mesh-list
138912342|NCT00795132|Cyclosporins|cyclosporins|mesh-list
138912343|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
138912344|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138912345|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912346|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912347|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138912348|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
138830241|NCT05340205|Misoprostol|misoprostol|mesh-list
138912349|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912351|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
138912352|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912353|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
138912354|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138912355|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138912356|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138912357|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138912358|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
138912359|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138912360|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
138912361|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138912362|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138912363|NCT02604420|Eculizumab|eculizumab|mesh-list
138830315|NCT05039944|Irinotecan|irinotecan|mesh-list
138912364|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138912365|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138912366|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
138912367|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912368|NCT04110210|Morphine|morphine|mesh-list
138912369|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138912370|NCT04110210|Narcotics|narcotics|mesh-ancestor
138912371|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138912372|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912373|NCT04110210|Analgesics|analgesics|mesh-ancestor
138912374|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
138912375|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912376|NCT00647296|Pramipexole|pramipexole|mesh-list
138912377|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
138912378|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912379|NCT00647296|Protective Agents|protective agents|mesh-ancestor
138912380|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912381|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138912382|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138912383|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
138912384|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
138912385|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912386|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138912387|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
138912388|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912389|NCT00646906|Aspirin|aspirin|mesh-list
138912390|NCT00646906|Acetaminophen|acetaminophen|mesh-list
138912391|NCT00646906|Ibuprofen|ibuprofen|mesh-list
138912392|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138912393|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138912394|NCT00646906|Analgesics|analgesics|mesh-ancestor
138912395|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
138912396|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912397|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912398|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138912399|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138912400|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138912401|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138426617|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912402|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912403|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138912404|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138912405|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912406|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
138912407|NCT00813436|Oxytocin|oxytocin|mesh-list
138912408|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
138912409|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138912410|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912411|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138912412|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138912413|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138912414|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
138912415|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912416|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138912417|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138912419|NCT00815854|Folic Acid|folic acid|mesh-list
138912420|NCT00815854|Hematinics|hematinics|mesh-ancestor
138912421|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
138912422|NCT00815854|Vitamins|vitamins|mesh-ancestor
138912423|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
138912424|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912425|NCT00817648|Risperidone|risperidone|mesh-list
138912426|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138912427|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138912428|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
138912429|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912430|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912431|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912432|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138912433|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138912434|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138912435|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138912436|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138912437|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
138912438|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
138912439|NCT00829010|Vaccines|vaccines|mesh-list
138912440|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138912441|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
138912442|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912443|NCT00644332|Ranolazine|ranolazine|mesh-list
138830606|NCT00678379|Analgesics|analgesics|mesh-ancestor
138912444|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138912445|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138912446|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912447|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
138912448|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
138912449|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138912450|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138912451|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912452|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912453|NCT00808912|Urological Agents|urological agents|mesh-ancestor
138912454|NCT02551042|Factor VIII|factor viii|mesh-list
138912455|NCT02551042|Coagulants|coagulants|mesh-ancestor
138912456|NCT00445939|Adalimumab|adalimumab|mesh-list
138912457|NCT00445939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138912458|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138912459|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138912461|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138912462|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138912463|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
138912464|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912465|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138912466|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138912467|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912468|NCT00817960|Methylphenidate|methylphenidate|mesh-list
138912469|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138830726|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
138912470|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912471|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138912472|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138912473|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138426744|NCT01700426|Vitamin E|vitamin e|mesh-list
138912474|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912475|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
138912476|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912477|NCT00818038|Natalizumab|natalizumab|mesh-list
138912478|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
138912479|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830788|NCT00603824|PENTA|penta|mesh-list
138912480|NCT00482053|Acetaminophen|acetaminophen|mesh-list
138912481|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
138912482|NCT00482053|Promethazine|promethazine|mesh-list
138564505|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138912483|NCT00482053|Cyclosporine|cyclosporine|mesh-list
138912484|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
138912485|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
138912486|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138912487|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
138912488|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
138912489|NCT00482053|Carmustine|carmustine|mesh-list
138912490|NCT00482053|Rituximab|rituximab|mesh-list
138912491|NCT00482053|Etoposide|etoposide|mesh-list
138912492|NCT00482053|Cyclosporins|cyclosporins|mesh-list
138912493|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138912494|NCT00482053|Lenograstim|lenograstim|mesh-list
138912495|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138912496|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
138912497|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912498|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138912499|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138912500|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
138912501|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912502|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912503|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138912504|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138912505|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138912506|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138912507|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138912508|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912509|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138912510|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
138912511|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912512|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
138912513|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138912514|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138912515|NCT00482053|Analgesics|analgesics|mesh-ancestor
138912516|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
138912517|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912518|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
138912519|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138912520|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138912521|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
138830973|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138912522|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138912523|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138912524|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
138912525|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
138912526|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138912527|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
138912528|NCT00482053|Hormones|hormones|mesh-ancestor
138912529|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138912530|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138912531|NCT00482053|Protective Agents|protective agents|mesh-ancestor
138912532|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138912533|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138912534|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138912535|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138912536|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
138912537|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
138912538|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138912539|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
138912540|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
138912541|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912542|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138912543|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
138912544|NCT00455923|Fluticasone|fluticasone|mesh-list
138912545|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138912546|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138912547|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
138912548|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912549|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912550|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138426962|NCT01701778|Analgesics|analgesics|mesh-ancestor
138912551|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
138912552|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
138912554|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138912555|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
138912556|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138912557|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
138912558|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138912559|NCT00642616|Insulin|insulin|mesh-list
138912560|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138912561|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912562|NCT00809068|Tibolone|tibolone|mesh-list
138912563|NCT00809068|Fenofibrate|fenofibrate|mesh-list
138912564|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138912565|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
138912566|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912567|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138912568|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
138912569|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
138912570|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138912571|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912572|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138427014|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138912573|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138912574|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912575|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138912576|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
138912577|NCT00809068|Hormones|hormones|mesh-ancestor
138912578|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138912579|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138912580|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
138912581|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
138912582|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138912583|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138912584|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912585|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912586|NCT01027117|Urological Agents|urological agents|mesh-ancestor
138912587|NCT03995563|Dexamethasone|dexamethasone|mesh-list
138912588|NCT03995563|Ropivacaine|ropivacaine|mesh-list
138912589|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138912590|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
138912591|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
138831210|NCT05305248|Dexmedetomidine|dexmedetomidine|mesh-list
138912592|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912593|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912594|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138912595|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
138912596|NCT03995563|Hormones|hormones|mesh-ancestor
138912597|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138912598|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138912599|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912600|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
138912601|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
138912602|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138912603|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
138912604|NCT00445003|Triamcinolone|triamcinolone|mesh-list
138912605|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138912606|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138912607|NCT00445003|Ranibizumab|ranibizumab|mesh-list
138912608|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138912609|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138912610|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138912611|NCT00445003|Growth Substances|growth substances|mesh-ancestor
138912612|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912613|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
138912614|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912615|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138912616|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
138912617|NCT00445003|Hormones|hormones|mesh-ancestor
138912618|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138912619|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138912621|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912622|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912623|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138912624|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138449753|NCT01865916|Vitamins|vitamins|mesh-ancestor
138912626|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138912627|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
138912628|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138912629|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912630|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138912631|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
138912632|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912633|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912634|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
138912635|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912636|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138912637|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138912638|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
138912639|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138912640|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138912641|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138912642|NCT00642460|Analgesics|analgesics|mesh-ancestor
138912643|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
138912644|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912645|NCT00814658|Nimodipine|nimodipine|mesh-list
138912646|NCT00814658|Galantamine|galantamine|mesh-list
138912647|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138912648|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912649|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912650|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
138912651|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912652|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912654|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
138912655|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912656|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
138912657|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138912658|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138912659|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138912660|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138912661|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
138912662|NCT00816634|Paclitaxel|paclitaxel|mesh-list
138912663|NCT00816634|Capecitabine|capecitabine|mesh-list
138912664|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138912665|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912666|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
138449788|NCT01866254|Morphine|morphine|mesh-list
138912667|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
138912668|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
138912669|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912670|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138912671|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
138427246|NCT01703624|Bromides|bromides|mesh-list
138912672|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
138912673|NCT00642304|Hematinics|hematinics|mesh-ancestor
138912674|NCT00814580|Oxycodone|oxycodone|mesh-list
138912675|NCT00814580|Tapentadol|tapentadol|mesh-list
138912676|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138912677|NCT00814580|Narcotics|narcotics|mesh-ancestor
138912678|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138912679|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912681|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
138912682|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912683|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138912684|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138912685|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138912686|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912687|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
138912688|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912689|NCT00643162|Escitalopram|escitalopram|mesh-list
138912690|NCT00643162|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138912691|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138912692|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138912693|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912694|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138427273|NCT01703754|Ifosfamide|ifosfamide|mesh-list
138912695|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
138912696|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912697|NCT00814502|Zolpidem|zolpidem|mesh-list
138912698|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138912699|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138912700|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138912701|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912702|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138912703|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
138912704|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
138912705|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912706|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912707|NCT00653224|Levocetirizine|levocetirizine|mesh-list
138912708|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138912710|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
138912711|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
138912712|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912713|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912714|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912715|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138912716|NCT00444925|Fesoterodine|fesoterodine|mesh-list
138912717|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138912718|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138912719|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
138912720|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912721|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831676|NCT01845337|Capecitabine|capecitabine|mesh-list
138912722|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912723|NCT00444925|Urological Agents|urological agents|mesh-ancestor
138912724|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
138912726|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138912727|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912728|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138912729|NCT00641056|Incretins|incretins|mesh-ancestor
138912730|NCT00641056|Hormones|hormones|mesh-ancestor
138912731|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138912732|NCT00569374|Modafinil|modafinil|mesh-list
138912733|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138912734|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912735|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138912736|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138912737|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138912738|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912739|NCT00828464|Clobetasol|clobetasol|mesh-list
138912740|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138912741|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
138912742|NCT00828464|Hormones|hormones|mesh-ancestor
138912743|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138912744|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912745|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
138912746|NCT00816712|Testosterone|testosterone|mesh-list
138912747|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
138912748|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
138912749|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138912751|NCT00816712|Hormones|hormones|mesh-ancestor
138912752|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138912753|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912754|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138449818|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
138912755|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912756|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
138912757|NCT00818194|Cyclosporine|cyclosporine|mesh-list
138912758|NCT00818194|Tacrolimus|tacrolimus|mesh-list
138912759|NCT00818194|Cyclosporins|cyclosporins|mesh-list
138912760|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138912761|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
138912762|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912763|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138912764|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912765|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912766|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
138912767|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912768|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
138912769|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138912770|NCT02610686|Chloroquine|chloroquine|mesh-list
138912771|NCT02610686|Amebicides|amebicides|mesh-ancestor
138912772|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138912773|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138912774|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912775|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
138912776|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138912777|NCT00816790|Tazobactam|tazobactam|mesh-list
138912778|NCT00816790|Piperacillin|piperacillin|mesh-list
138831830|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427414|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138912779|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138912780|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138912781|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912782|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138912784|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912785|NCT00818350|Sunitinib|sunitinib|mesh-list
138912786|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912787|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138912788|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138912789|NCT00818350|Growth Substances|growth substances|mesh-ancestor
138912790|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912791|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
138912792|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138912793|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912794|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912795|NCT00810602|Vorinostat|vorinostat|mesh-list
138912796|NCT00810602|Tacrolimus|tacrolimus|mesh-list
138912797|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138912798|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
138912799|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912800|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138912801|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912802|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912803|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912804|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138912805|NCT00816868|Capecitabine|capecitabine|mesh-list
138912806|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138912807|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138912808|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
138912809|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912810|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912811|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138912812|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912813|NCT00791700|Maraviroc|maraviroc|mesh-list
138912814|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138912815|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138912816|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912817|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138912818|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138912819|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
138912820|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912821|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138912822|NCT00628108|Levocetirizine|levocetirizine|mesh-list
138912823|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138912824|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138912825|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
138912826|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
138912827|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912828|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912829|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912830|NCT00821392|Febuxostat|febuxostat|mesh-list
138912831|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
138912832|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138912833|NCT00591578|Valsartan|valsartan|mesh-list
138912834|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138912835|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138912836|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138912837|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138912838|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912839|NCT00797862|Amlodipine|amlodipine|mesh-list
138912840|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138912841|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138912842|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138912843|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138912844|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912845|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138912846|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912847|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
138912848|NCT00797862|Diuretics|diuretics|mesh-ancestor
138912849|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
138912850|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138912851|NCT00817258|Cisplatin|cisplatin|mesh-list
138912852|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912853|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
138912854|NCT00794820|Rituximab|rituximab|mesh-list
138912855|NCT00794820|Fludarabine|fludarabine|mesh-list
138912856|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
138912857|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138912858|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
138912859|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912860|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138912861|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138912862|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
138912863|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912864|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912865|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138912866|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138912867|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138912868|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
138912870|NCT00455533|Epothilones|epothilones|mesh-list
138912871|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
138912872|NCT00455533|Doxorubicin|doxorubicin|mesh-list
138912873|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138912874|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912875|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
138912876|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
138912877|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
138912878|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912879|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138912880|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
138912881|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912882|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138912883|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138912884|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
138912885|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138912886|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138912887|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138912888|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138912889|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912890|NCT00818584|Micafungin|micafungin|mesh-list
138912891|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
138912892|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912893|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138912894|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912895|NCT00923000|Morphine|morphine|mesh-list
138912896|NCT00923000|Nalbuphine|nalbuphine|mesh-list
138912897|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138912898|NCT00923000|Narcotics|narcotics|mesh-ancestor
138912899|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138912900|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912901|NCT00923000|Analgesics|analgesics|mesh-ancestor
138912902|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
138912903|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138912904|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
138912905|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912906|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
138912907|NCT00642850|Hematinics|hematinics|mesh-ancestor
138912908|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138912909|NCT00913952|Clomipramine|clomipramine|mesh-list
138912910|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138912911|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
138912912|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138832317|NCT00668707|Melatonin|melatonin|mesh-list
138912913|NCT00913952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138912914|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138912915|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138912916|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912917|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912918|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
138912919|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912920|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138912921|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138912922|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138912923|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912924|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
138912925|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
138912926|NCT03840811|Cefixime|cefixime|mesh-list
138912927|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138912928|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138912929|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138912930|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138912931|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912932|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912933|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427702|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
138912934|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138912935|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138912937|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
138912938|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
138912939|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510526|NCT00062179|Celecoxib|celecoxib|mesh-list
138912940|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912941|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138912942|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138912943|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138912944|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138912945|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138770250|NCT00629967|Interferons|interferons|mesh-list
138912946|NCT00640510|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138912947|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138912948|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138912949|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912950|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912953|NCT00913718|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138832370|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
138912954|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138912955|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138912956|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912957|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912958|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
138912959|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912960|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138912961|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
138912962|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138912963|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138912964|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138912965|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912966|NCT00813800|Varenicline|varenicline|mesh-list
138912967|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138832402|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
138912969|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
138912970|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138912971|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832460|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
138912972|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912973|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
138912974|NCT00627016|Lansoprazole|lansoprazole|mesh-list
138912975|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138912977|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138912978|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912979|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912980|NCT00794664|Mipomersen|mipomersen|mesh-list
138912981|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138912982|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138912983|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
138912984|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912985|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138912986|NCT00444535|Bevacizumab|bevacizumab|mesh-list
138912987|NCT00444535|Lapatinib|lapatinib|mesh-list
138912988|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138912989|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138912990|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138912991|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138912992|NCT00444535|Growth Substances|growth substances|mesh-ancestor
138912993|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138912994|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
138912995|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138912996|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138912997|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138912999|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138913000|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913001|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
138913002|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
138913003|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
138913004|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913005|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
138913006|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138913007|NCT00826306|Protective Agents|protective agents|mesh-ancestor
138913008|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913009|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
138913010|NCT05753852|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
138913011|NCT05753852|Antiviral Agents|antiviral agents|mesh-ancestor
138913012|NCT05753852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138913013|NCT05753852|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138427922|NCT01707953|Midodrine|midodrine|mesh-list
138913014|NCT05753852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138913015|NCT00821782|Azithromycin|azithromycin|mesh-list
138913016|NCT00821782|Levofloxacin|levofloxacin|mesh-list
138913017|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138913018|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138913019|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138913020|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138913021|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138913022|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832714|NCT03866668|Esomeprazole|esomeprazole|mesh-list
138913023|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913024|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913025|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138913026|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138913027|NCT00847613|Tofacitinib|tofacitinib|mesh-list
138913028|NCT00847613|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138913029|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138913030|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913031|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913032|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
138913033|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138913034|NCT00807092|Insulin|insulin|mesh-list
138913035|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138913036|NCT00807092|Metformin|metformin|mesh-list
138913037|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
138913038|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
138913039|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138427984|NCT01708447|Lidocaine|lidocaine|mesh-list
138913040|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138913041|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913042|NCT04112550|Acetaminophen|acetaminophen|mesh-list
138913043|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138913044|NCT04112550|Oxycodone|oxycodone|mesh-list
138913045|NCT04112550|Methadone|methadone|mesh-list
138913046|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138913047|NCT04112550|Analgesics|analgesics|mesh-ancestor
138913048|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
138913049|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913050|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913051|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
138913052|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138913053|NCT04112550|Narcotics|narcotics|mesh-ancestor
138913054|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913055|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
138913056|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
138913057|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138913058|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138913059|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138913060|NCT00640042|Morphine|morphine|mesh-list
138913061|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138913062|NCT00640042|Narcotics|narcotics|mesh-ancestor
138770251|NCT00629967|Ribavirin|ribavirin|mesh-list
138913063|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913064|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832813|NCT00769405|Fluorouracil|fluorouracil|mesh-list
138913066|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
138913067|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913068|NCT00807014|Adapalene|adapalene|mesh-list
138913069|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138913070|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138913071|NCT00807014|Analgesics|analgesics|mesh-ancestor
138913072|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
138913073|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913074|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913075|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138913076|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138913077|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
138565101|NCT00419731|Naltrexone|naltrexone|mesh-list
138913078|NCT00794040|Methylphenidate|methylphenidate|mesh-list
138913079|NCT00794040|Citalopram|citalopram|mesh-list
138913080|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138913081|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913082|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138913083|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138913084|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138428074|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
138913085|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913086|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
138832886|NCT02579902|Vitamin D|vitamin d|mesh-list
138913087|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913088|NCT00794040|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138913089|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
138913090|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138913091|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
138913092|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138913093|NCT04109742|Curcumin|curcumin|mesh-list
138913094|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138913095|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138913096|NCT04109742|Analgesics|analgesics|mesh-ancestor
138913097|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
138913098|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913099|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913100|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138913101|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138913102|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913103|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913104|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913105|NCT00813488|Fentanyl|fentanyl|mesh-list
138913106|NCT00813488|Oxycodone|oxycodone|mesh-list
138913107|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138913108|NCT00813488|Narcotics|narcotics|mesh-ancestor
138913109|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913110|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913111|NCT00813488|Analgesics|analgesics|mesh-ancestor
138833105|NCT00934700|Xenon|xenon|mesh-list
138913112|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
138913113|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913114|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138913115|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138913117|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
138913118|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138913119|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138913120|NCT00797316|Diuretics|diuretics|mesh-ancestor
138913121|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
138913122|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913123|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138913124|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138913125|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913126|NCT05640336|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138913127|NCT05640336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138913128|NCT05640336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138913129|NCT05640336|Antitubercular Agents|antitubercular agents|mesh-ancestor
138913131|NCT05753696|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138913132|NCT05753696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138913133|NCT05753696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138913134|NCT05753696|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138913135|NCT05753696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138913136|NCT05753696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913137|NCT04107480|Dopamine|dopamine|mesh-list
138913138|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
138913139|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138913140|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
138913141|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
138913142|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913143|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913144|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
138913145|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913146|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913147|NCT04107480|Protective Agents|protective agents|mesh-ancestor
138913148|NCT00915408|Dexamethasone|dexamethasone|mesh-list
138913149|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
138913150|NCT00915408|Lenalidomide|lenalidomide|mesh-list
138913151|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138913152|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
138913153|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913154|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138913155|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138913156|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
138913157|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913158|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913159|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138913160|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138913161|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
138913162|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
138913163|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913164|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138913165|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
138913167|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138913168|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138913169|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138913170|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138913171|NCT00915408|Growth Substances|growth substances|mesh-ancestor
138913172|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
138913173|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
138913174|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138913175|NCT00791076|Hormones|hormones|mesh-ancestor
138913176|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138913177|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913178|NCT02610062|AGS67E|ags67e|mesh-list
138913179|NCT02610062|Immunoconjugates|immunoconjugates|mesh-ancestor
138913180|NCT02610062|Immunologic Factors|immunologic factors|mesh-ancestor
138913181|NCT02610062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913182|NCT00625378|Sorafenib|sorafenib|mesh-list
138913183|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913184|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138395673|NCT05249309|Ketamine|ketamine|mesh-list
138913185|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913186|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913188|NCT00806624|Edoxaban|edoxaban|mesh-list
138913189|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
138913190|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138913191|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
138913192|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138913193|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
138913194|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913195|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913196|NCT00624832|Omalizumab|omalizumab|mesh-list
138913197|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138913198|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138913199|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
138913200|NCT00826852|Carboplatin|carboplatin|mesh-list
138913201|NCT00826852|Docetaxel|docetaxel|mesh-list
138913202|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913203|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
138913204|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
138913205|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
138913206|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913207|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
138913209|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913210|NCT00826930|Protective Agents|protective agents|mesh-ancestor
138913211|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913212|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138428244|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
138913213|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913214|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
138913215|NCT00913796|Diuretics|diuretics|mesh-ancestor
138913216|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
138913217|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913218|NCT00913796|Expectorants|expectorants|mesh-ancestor
138913219|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
138913220|NCT00633880|Droxidopa|droxidopa|mesh-list
138913221|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138913222|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138913223|NCT04029428|Octreotide|octreotide|mesh-list
138913224|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138913225|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138913226|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913227|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138913228|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138913229|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565250|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138913230|NCT00819520|Ivermectin|ivermectin|mesh-list
138913231|NCT00819520|Malathion|malathion|mesh-list
138913232|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138913233|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138913234|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138913235|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428288|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913236|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913237|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
138913238|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913239|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913240|NCT00631696|Pregabalin|pregabalin|mesh-list
138913241|NCT00631696|Analgesics|analgesics|mesh-ancestor
138913242|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
138913243|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913244|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913245|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
138833478|NCT00785395|Oxytocin|oxytocin|mesh-list
138913246|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138913247|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138913248|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913249|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138913250|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138913251|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138913252|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913253|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138913254|NCT02608112|Methotrexate|methotrexate|mesh-list
138913255|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138913256|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
138913257|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138913258|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913259|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138913260|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
138913261|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913262|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913263|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
138913264|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913265|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138913266|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138913267|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
138913268|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138913269|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138913271|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
138913272|NCT02549326|Vitamins|vitamins|mesh-ancestor
138913273|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
138913274|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913275|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138913276|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138913277|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
138913278|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138913279|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
138913280|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913281|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913282|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138913283|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
138913284|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138913285|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
138913286|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913287|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913288|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138913289|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
138913290|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
138913291|NCT00819676|Protective Agents|protective agents|mesh-ancestor
138913292|NCT00827320|Levetiracetam|levetiracetam|mesh-list
138913293|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
138913294|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
138913295|NCT00819754|Bevacizumab|bevacizumab|mesh-list
138913296|NCT00819754|Capecitabine|capecitabine|mesh-list
138913297|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
138913298|NCT00819754|Irinotecan|irinotecan|mesh-list
138913299|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138913300|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913301|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138913302|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138913303|NCT00819754|Growth Substances|growth substances|mesh-ancestor
138913304|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565330|NCT00331708|Artesunate|artesunate|mesh-list
138913305|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
138913306|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138913307|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
138913308|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913309|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138913310|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138913311|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913312|NCT00819988|Pregabalin|pregabalin|mesh-list
138913313|NCT00819988|Analgesics|analgesics|mesh-ancestor
138770252|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
138913314|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
138913315|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913316|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913317|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
138913318|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138913319|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138913320|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913321|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138913322|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138913323|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138913324|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913325|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138913326|NCT00827554|Nadroparin|nadroparin|mesh-list
138913327|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
138913328|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138913329|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138913330|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913331|NCT00847145|Vaccines|vaccines|mesh-list
138913332|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
138913333|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913334|NCT00701597|Bosentan|bosentan|mesh-list
138913335|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138913336|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138913337|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913338|NCT00700193|Vaccines|vaccines|mesh-list
138913339|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
138913340|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913341|NCT00846521|Acarbose|acarbose|mesh-list
138913342|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138913343|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913344|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913345|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138913346|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913347|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138913348|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138913349|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138913350|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138913351|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138913352|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
138913353|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913354|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913355|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913356|NCT00862823|Tenofovir|tenofovir|mesh-list
138913357|NCT00862823|Emtricitabine|emtricitabine|mesh-list
138913358|NCT00862823|Efavirenz|efavirenz|mesh-list
138913359|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
138913360|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138913361|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138913362|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138913363|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913364|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913365|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138913366|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138913367|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138913368|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138913369|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138913370|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138913371|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138913372|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138913374|NCT00790842|Lenalidomide|lenalidomide|mesh-list
138913375|NCT00790842|Heparin|heparin|mesh-list
138913376|NCT00790842|Calcium heparin|calcium heparin|mesh-list
138913377|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138913378|NCT00790842|Tinzaparin|tinzaparin|mesh-list
138913379|NCT00790842|Dalteparin|dalteparin|mesh-list
138913380|NCT00790842|Anticoagulants|anticoagulants|mesh-list
138913381|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138913382|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
138913384|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913385|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913386|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138913387|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
138913388|NCT00790842|Hormones|hormones|mesh-ancestor
138428524|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138913389|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138913390|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138913391|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913392|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138913393|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138913394|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913395|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
138913396|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138913397|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138913398|NCT00790842|Growth Substances|growth substances|mesh-ancestor
138913399|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
138913400|NCT04104204|Morphine|morphine|mesh-list
138913401|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138913402|NCT04104204|Narcotics|narcotics|mesh-ancestor
138913403|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913404|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913405|NCT04104204|Analgesics|analgesics|mesh-ancestor
138913406|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
138913407|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913408|NCT00574288|Dexamethasone|dexamethasone|mesh-list
138913409|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
138913410|NCT00574288|Daratumumab|daratumumab|mesh-list
138913411|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138913412|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138913413|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
138913414|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
138913415|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913416|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913417|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138913418|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
138913419|NCT00574288|Hormones|hormones|mesh-ancestor
138913420|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138913421|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138833839|NCT01000337|Propofol|propofol|mesh-list
138913422|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913423|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138913424|NCT00574288|Protective Agents|protective agents|mesh-ancestor
138913425|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
138913426|NCT00790452|Aspirin|aspirin|mesh-list
138913427|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138913428|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138913429|NCT00790452|Analgesics|analgesics|mesh-ancestor
138913430|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
138913431|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913432|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913433|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138913434|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138913435|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138913436|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138913437|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913438|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138913439|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138913440|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913441|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
138913442|NCT00823030|Lidocaine|lidocaine|mesh-list
138913443|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
138913444|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
138913445|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913446|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913447|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
138913448|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913449|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138913450|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138913451|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138913452|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138341880|NCT05607342|SR 142801|sr 142801|mesh-list
138833937|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833938|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
138833939|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
138833940|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833941|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138833942|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
138833943|NCT00595335|Hormones|hormones|mesh-ancestor
138913453|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913455|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138913456|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913457|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
138913458|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
138913459|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
138913460|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913461|NCT00626392|Aspirin|aspirin|mesh-list
138913462|NCT00626392|Niacin|niacin|mesh-list
138913463|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138913464|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138913465|NCT00626392|Analgesics|analgesics|mesh-ancestor
138913466|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
138913467|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913468|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913469|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138913470|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138913471|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138913472|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138913473|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913474|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138913475|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138913476|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913477|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
138913478|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138913479|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
138913480|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138913481|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
138913482|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
138913484|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
138834143|NCT00996593|Iodine|iodine|mesh-list
138913485|NCT00820690|Paclitaxel|paclitaxel|mesh-list
138913486|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
138913487|NCT00820690|Doxorubicin|doxorubicin|mesh-list
138913488|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138913489|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913490|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
138913491|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
138913492|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
138913493|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913494|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138913495|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
138913496|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913497|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138913498|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138913499|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
138913500|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138913501|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138913502|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138913503|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138913504|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913505|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138913506|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913507|NCT00624052|Amlodipine|amlodipine|mesh-list
138913508|NCT00624052|Telmisartan|telmisartan|mesh-list
138913509|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138913510|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138913511|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138913512|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913513|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138913514|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913515|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
138913516|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138913517|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138913519|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138913520|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138913521|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138913522|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913523|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
138913524|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138913525|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
138913526|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913527|NCT04044430|Nivolumab|nivolumab|mesh-list
138913528|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138913530|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138913531|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913532|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138913533|NCT00821158|Antioxidants|antioxidants|mesh-list
138913534|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913535|NCT00821158|Protective Agents|protective agents|mesh-ancestor
138913536|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913538|NCT00828646|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138913539|NCT00828646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913540|NCT00828646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913541|NCT02548936|Simvastatin|simvastatin|mesh-list
138913542|NCT02548936|Ezetimibe|ezetimibe|mesh-list
138913543|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138913544|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138834373|NCT00788749|Hormones|hormones|mesh-ancestor
138913545|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138913546|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
138913547|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913548|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138913549|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138913550|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913551|NCT00828802|Lenalidomide|lenalidomide|mesh-list
138913552|NCT00828802|Decitabine|decitabine|mesh-list
138913553|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
138913554|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913555|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138913556|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138913557|NCT00828802|Growth Substances|growth substances|mesh-ancestor
138913558|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
138913559|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913560|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138913561|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
138913562|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913563|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913564|NCT00785577|Pregabalin|pregabalin|mesh-list
138913565|NCT00785577|Analgesics|analgesics|mesh-ancestor
138913566|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
138913567|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913568|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913569|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
138913570|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138913571|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138913572|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913573|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138913574|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138913575|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138913576|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913577|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138913578|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
138913579|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138913580|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
138913581|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913582|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
138913583|NCT00830830|Protective Agents|protective agents|mesh-ancestor
138913585|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138913586|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
138913587|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913588|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913589|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913590|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138913591|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138913592|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913593|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138913594|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138913595|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
138913596|NCT02548780|Doxorubicin|doxorubicin|mesh-list
138913597|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138913598|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913599|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138913600|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138913601|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913602|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913604|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138913605|NCT04105023|Protective Agents|protective agents|mesh-ancestor
138913606|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913607|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913608|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138913609|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913610|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913611|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
138913612|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138913613|NCT04105023|Estrogens|estrogens|mesh-ancestor
138913614|NCT04105023|Hormones|hormones|mesh-ancestor
138913615|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138913616|NCT04104867|Domperidone|domperidone|mesh-list
138913617|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
138913618|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
138913619|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913620|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913621|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138913622|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138913623|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
138913624|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913625|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913626|NCT00789828|Everolimus|everolimus|mesh-list
138913627|NCT00789828|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138913628|NCT00789828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138913629|NCT00789828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913630|NCT00789828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913631|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138913632|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
138913633|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913634|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913635|NCT02550262|Fentanyl|fentanyl|mesh-list
138913636|NCT02550262|Bupivacaine|bupivacaine|mesh-list
138913637|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
138913638|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
138913639|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913640|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913641|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
138913642|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913643|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138913644|NCT02550262|Narcotics|narcotics|mesh-ancestor
138913645|NCT02550262|Analgesics|analgesics|mesh-ancestor
138913646|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138913647|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138913648|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
138913649|NCT02550418|Budesonide|budesonide|mesh-list
138486661|NCT00001474|Interleukin-2|interleukin-2|mesh-list
138913650|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138913651|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138913652|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
138913653|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913654|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913655|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138913656|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
138913657|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
138913658|NCT02550418|Hormones|hormones|mesh-ancestor
138913659|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138913660|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138913661|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138913663|NCT00829114|Estradiol|estradiol|mesh-list
138913664|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138913665|NCT00829114|Estrogens|estrogens|mesh-ancestor
138913666|NCT00829114|Hormones|hormones|mesh-ancestor
138913667|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138913668|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913669|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138913670|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
138913671|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138913672|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138913673|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138913674|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138913675|NCT00790296|Hormones|hormones|mesh-list
138188570|NCT03743103|Nitroprusside|nitroprusside|mesh-list
138913676|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
138913677|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138913678|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913680|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
138913681|NCT00623194|Insulin|insulin|mesh-list
138913682|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138913683|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
138913684|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
138913685|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138913686|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913687|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138913688|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
138913689|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
138913690|NCT02548468|Fludarabine|fludarabine|mesh-list
138913691|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
138913692|NCT02548468|Tacrolimus|tacrolimus|mesh-list
138913693|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138913694|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
138913695|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913696|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138913697|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138913698|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
138913699|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913700|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913701|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138913702|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138913703|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
138913704|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138913705|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138913706|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913707|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138913708|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138913709|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
138913710|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138913711|NCT00829660|Acarbose|acarbose|mesh-list
138913712|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138913713|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913714|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913715|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138913716|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913717|NCT00915564|Simeprevir|simeprevir|mesh-list
138913718|NCT00915564|Methadone|methadone|mesh-list
138913719|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138913720|NCT00915564|Narcotics|narcotics|mesh-ancestor
138913721|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913722|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913723|NCT00915564|Analgesics|analgesics|mesh-ancestor
138913724|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
138913725|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913726|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
138913727|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
138913729|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138913730|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
138913731|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913732|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913733|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
138913734|NCT02603406|Hematinics|hematinics|mesh-ancestor
138913735|NCT04106700|Apixaban|apixaban|mesh-list
138913736|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138913737|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
138913738|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138913739|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
138913740|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913741|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913742|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
138913743|NCT00831376|Albuterol|albuterol|mesh-list
138913744|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138913745|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
138913746|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913747|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913748|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138913749|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
138913750|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
138913751|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138188643|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
138913752|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138913753|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138913754|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138913755|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
138913756|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913757|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913758|NCT02602470|Metronidazole|metronidazole|mesh-list
138913759|NCT02602470|Azelaic acid|azelaic acid|mesh-list
138913760|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138913761|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138913762|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138913763|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138913764|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138913765|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138913766|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138913767|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138913768|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138913769|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
138913770|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913771|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913772|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913773|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913774|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
138913776|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
138913777|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
138913778|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
138913779|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138913780|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913781|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913782|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913783|NCT00824200|Urological Agents|urological agents|mesh-ancestor
138913784|NCT00829894|Risperidone|risperidone|mesh-list
138913785|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138913786|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
138913787|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913788|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913789|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913790|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138913791|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138913792|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913793|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138913794|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138913795|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
138913796|NCT00622726|Bevacizumab|bevacizumab|mesh-list
138913797|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138913798|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913799|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138913800|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138913801|NCT00622726|Growth Substances|growth substances|mesh-ancestor
138913802|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913803|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
138913804|NCT00830050|Naproxen|naproxen|mesh-list
138913805|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138913806|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138913807|NCT00830050|Analgesics|analgesics|mesh-ancestor
138913808|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
138913809|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913810|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913811|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138913812|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138913813|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
138913814|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138913815|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913816|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913817|NCT00623428|Ribavirin|ribavirin|mesh-list
138913818|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138913819|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
138913820|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913821|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
138913822|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138913823|NCT00824668|Insulin|insulin|mesh-list
138913824|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138913825|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
138913826|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
138565852|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
138913827|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
138913828|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138913829|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
138913830|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138913831|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913832|NCT00832234|Dexamethasone|dexamethasone|mesh-list
138913833|NCT00832234|Rituximab|rituximab|mesh-list
138913834|NCT00832234|Bortezomib|bortezomib|mesh-list
138913835|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138913836|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
138913837|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
138913838|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913839|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388169|NCT01487564|Analgesics|analgesics|mesh-ancestor
138913840|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138913841|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
138913842|NCT00832234|Hormones|hormones|mesh-ancestor
138913843|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138913844|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138913845|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913846|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138913847|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
138913848|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138913849|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
138913850|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
138913851|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913852|NCT05036980|Protective Agents|protective agents|mesh-ancestor
138913853|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913854|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138913855|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913856|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138913857|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
138913858|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138913859|NCT00837850|Protective Agents|protective agents|mesh-ancestor
138913860|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913861|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138913862|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138913863|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138913864|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913865|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138913866|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138913867|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
138913868|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913869|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913871|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138913872|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138913873|NCT04102566|Analgesics|analgesics|mesh-ancestor
138913874|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
138913875|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913876|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835093|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
138913877|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138913878|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138913879|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138913880|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913881|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913882|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
138913883|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
138913884|NCT04102176|Protective Agents|protective agents|mesh-ancestor
138913885|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913886|NCT00783432|Azelastine|azelastine|mesh-list
138913887|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138913888|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
138913889|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913890|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429272|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
138913891|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138913892|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
138913893|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138913894|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913895|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913896|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138913897|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138913898|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138913899|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
138913900|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
138913901|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913902|NCT00789360|Loxapine|loxapine|mesh-list
138913903|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138913904|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138913905|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913906|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913907|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138913908|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138913909|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
138913910|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913911|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913912|NCT00782418|Exenatide|exenatide|mesh-list
138913913|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138913914|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913915|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138913916|NCT00782418|Incretins|incretins|mesh-ancestor
138913917|NCT00782418|Hormones|hormones|mesh-ancestor
138913918|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138913919|NCT00782340|Droxidopa|droxidopa|mesh-list
138913920|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138913921|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138913922|NCT00774852|Prednisone|prednisone|mesh-list
138913923|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
138913924|NCT00774852|Abatacept|abatacept|mesh-list
138913925|NCT00774852|Azathioprine|azathioprine|mesh-list
138913926|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138913928|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913929|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138913930|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138913931|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
138913932|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913933|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913934|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138913935|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138835250|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
138913936|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
138913937|NCT00774852|Hormones|hormones|mesh-ancestor
138913938|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138913939|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138913940|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138913941|NCT00774852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138913942|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
138913943|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138913944|NCT00774306|Phenytoin|phenytoin|mesh-list
138913945|NCT00774306|Levetiracetam|levetiracetam|mesh-list
138913946|NCT00774306|Valproic Acid|valproic acid|mesh-list
138913947|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
138913948|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
138913949|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913950|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913951|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
138913952|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138913953|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913954|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
138913955|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138913956|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138913957|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138913958|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138913959|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138913960|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138913961|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138913962|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138913963|NCT04105764|Bromides|bromides|mesh-list
138913964|NCT04105764|Rocuronium|rocuronium|mesh-list
138913965|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
138913966|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
138913967|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138913968|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138429416|NCT01716416|Cetuximab|cetuximab|mesh-list
138913969|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913970|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913972|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138913973|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138913974|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138913975|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913976|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138913977|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913980|NCT00773838|Bortezomib|bortezomib|mesh-list
138913981|NCT00773838|Vorinostat|vorinostat|mesh-list
138913982|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138913983|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
138913984|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
138913985|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138913986|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913987|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138913988|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
138913989|NCT00773838|Hormones|hormones|mesh-ancestor
138913990|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138913991|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138913992|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138913993|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138913994|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138913995|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138913996|NCT00787644|Pioglitazone|pioglitazone|mesh-list
138429455|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138429457|NCT01716637|Etanercept|etanercept|mesh-list
138913997|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138913998|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138913999|NCT02602002|Remifentanil|remifentanil|mesh-list
138914000|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138914001|NCT02602002|Narcotics|narcotics|mesh-ancestor
138914002|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138914003|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914005|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
138914006|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914007|NCT00787566|Granisetron|granisetron|mesh-list
138914008|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
138914009|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
138914010|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914011|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914012|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138914013|NCT00787566|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138914014|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138914015|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
138914016|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914017|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914018|NCT02602938|Aspirin|aspirin|mesh-list
138914019|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138914020|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138914021|NCT02602938|Analgesics|analgesics|mesh-ancestor
138914022|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
138914023|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914024|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914025|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138914026|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914027|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138914028|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138914029|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914030|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138914031|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138914032|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914033|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
138914034|NCT00787254|Lansoprazole|lansoprazole|mesh-list
138914035|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
138914036|NCT00787254|Gefarnate|gefarnate|mesh-list
138914037|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138914038|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138914039|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138914040|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914041|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914042|NCT00922402|Insulin|insulin|mesh-list
138914043|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138914044|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914045|NCT04105374|Flucytosine|flucytosine|mesh-list
138914046|NCT04105374|Temozolomide|temozolomide|mesh-list
138914047|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138914048|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
138566077|NCT03002103|Paclitaxel|paclitaxel|mesh-list
138914049|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914050|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914051|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
138914052|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914053|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
138914054|NCT04102878|Anesthetics|anesthetics|mesh-list
138914055|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
138914056|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429622|NCT01717846|Abatacept|abatacept|mesh-list
138914057|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914058|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
138914059|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914061|NCT00838240|Clofarabine|clofarabine|mesh-list
138914063|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138914064|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
138914065|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914066|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914067|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
138914068|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914069|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138914070|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
138914071|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914072|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138914073|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138914074|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138914075|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914076|NCT00773292|Cyclosporine|cyclosporine|mesh-list
138914077|NCT00773292|Cyclosporins|cyclosporins|mesh-list
138914078|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914079|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914080|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138914081|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
138914082|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914083|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
138914084|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914085|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
138429670|NCT01718093|Metformin|metformin|mesh-list
138914086|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914087|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138914088|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
138914089|NCT00838396|Baclofen|baclofen|mesh-list
138914090|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138914091|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914092|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138835556|NCT00686985|Carboplatin|carboplatin|mesh-list
138914093|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914094|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138914095|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
138914096|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
138914097|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914098|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914099|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
138914100|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138914101|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914102|NCT00833326|Docetaxel|docetaxel|mesh-list
138914103|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
138914104|NCT00833326|Mitogens|mitogens|mesh-list
138429717|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
138914105|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914106|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
138914107|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
138914108|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914109|NCT00833404|Nicotine|nicotine|mesh-list
138914110|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138914111|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
138914112|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914113|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914114|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138429766|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
138914115|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138914116|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
138914117|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914118|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914119|NCT00621322|Vaccines|vaccines|mesh-list
138914120|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
138914121|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914122|NCT00839488|Pantoprazole|pantoprazole|mesh-list
138914123|NCT00839488|Famotidine|famotidine|mesh-list
138914124|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138914125|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138914126|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138914127|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914128|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914129|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138914130|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
138914131|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
138914132|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914133|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914134|NCT00834184|Nikkomycin|nikkomycin|mesh-list
138914135|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
138914136|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914137|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914138|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914139|NCT00834262|Insulin|insulin|mesh-list
138914140|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138914141|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
138914142|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
138914143|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138914144|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
138429836|NCT01718678|Melatonin|melatonin|mesh-list
138914145|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138914146|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138914147|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914148|NCT00853385|Adalimumab|adalimumab|mesh-list
138914149|NCT00853385|Tofacitinib|tofacitinib|mesh-list
138914150|NCT00853385|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138914151|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138914152|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914153|NCT00853385|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138914154|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138835656|NCT00689169|Cytarabine|cytarabine|mesh-list
138914156|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914157|NCT00622336|Lenalidomide|lenalidomide|mesh-list
138914158|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
138914159|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914160|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138914161|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138914162|NCT00622336|Growth Substances|growth substances|mesh-ancestor
138914163|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
138914164|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914165|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138914166|NCT00846365|Olmesartan|olmesartan|mesh-list
138914167|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138914168|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
138914169|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138914170|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138914171|NCT00846365|Diuretics|diuretics|mesh-ancestor
138914172|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
138914173|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429878|NCT01718951|Pamidronate|pamidronate|mesh-list
138914174|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138914175|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138914176|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914177|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138914178|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138914179|NCT00834730|Ketamine|ketamine|mesh-list
138914180|NCT00834730|Analgesics|analgesics|mesh-ancestor
138914181|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
138914182|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914183|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914184|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138914185|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138914186|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
138914187|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
138914188|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138914189|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138914190|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138914191|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914192|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914194|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
138914195|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138914196|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914197|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
138914198|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566221|NCT01946477|Growth Substances|growth substances|mesh-ancestor
138914200|NCT00840112|Tocopherols|tocopherols|mesh-list
138914201|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
138914203|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
138914204|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914205|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
138835731|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138914206|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914207|NCT00840112|Protective Agents|protective agents|mesh-ancestor
138914208|NCT04101474|Ketamine|ketamine|mesh-list
138914209|NCT04101474|Analgesics|analgesics|mesh-ancestor
138914210|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
138914211|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914212|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914213|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138914214|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138914215|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
138914216|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
138914217|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138914218|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138914219|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138914220|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914221|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914222|NCT04101708|Amoxicillin|amoxicillin|mesh-list
138914223|NCT04101708|Clarithromycin|clarithromycin|mesh-list
138914224|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138914225|NCT04101708|Lansoprazole|lansoprazole|mesh-list
138914226|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
138914227|NCT04101708|Bismuth|bismuth|mesh-list
138914228|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138914229|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914230|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138914231|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914232|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914233|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138914234|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138914235|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138914236|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138914237|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138914238|NCT04101708|Antacids|antacids|mesh-ancestor
138914239|NCT00779142|Methotrexate|methotrexate|mesh-list
138914240|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138914241|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
138914242|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138914243|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914244|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138914245|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
138914246|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914247|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914248|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
138914249|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914250|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138914251|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138914252|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
138914253|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914254|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138914256|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914257|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138914258|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835877|NCT05833815|Everolimus|everolimus|mesh-list
138914259|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914260|NCT04105140|Oxytocin|oxytocin|mesh-list
138914261|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
138430024|NCT01719835|Prednisolone|prednisolone|mesh-list
138914262|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138914263|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914264|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
138914265|NCT00840580|Levofloxacin|levofloxacin|mesh-list
138914266|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138914267|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138914268|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138914269|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138914270|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914271|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138914272|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138914273|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914274|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914275|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914276|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138914277|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
138914278|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138914279|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914280|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138914281|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138914282|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138914283|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138914284|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138914285|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138914286|NCT00773136|Bimatoprost|bimatoprost|mesh-list
138914287|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138914288|NCT02602860|Levetiracetam|levetiracetam|mesh-list
138914289|NCT02602860|Brivaracetam|brivaracetam|mesh-list
138914290|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
138914291|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
138914292|NCT00825058|Paroxetine|paroxetine|mesh-list
138914293|NCT00825058|Amibegron|amibegron|mesh-list
138914294|NCT00825058|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138914295|NCT00825058|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138914296|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138914297|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138835948|NCT05832619|Serotonin|serotonin|mesh-list
138914298|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914299|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914300|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
138914301|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914302|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138914303|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
138914304|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138914305|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138914306|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138914307|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914308|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138914309|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138914310|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
138914311|NCT00825058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138914312|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
138914313|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138914314|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914315|NCT00835744|Clomiphene|clomiphene|mesh-list
138914316|NCT00835744|Enclomiphene|enclomiphene|mesh-list
138914317|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
138914318|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138914319|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
138914320|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138914321|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914322|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138914323|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
138914324|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138914325|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138914326|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138914327|NCT00778830|Cetuximab|cetuximab|mesh-list
138914328|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138914329|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914330|NCT00772668|Prednisone|prednisone|mesh-list
138914331|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
138914333|NCT00772668|Bortezomib|bortezomib|mesh-list
138914334|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138914335|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
138914336|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914337|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914338|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138914339|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
138914340|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914341|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914342|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138189244|NCT01000285|Hormones|hormones|mesh-ancestor
138914343|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138836114|NCT05594615|Antimetabolites|antimetabolites|mesh-ancestor
138914344|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138914346|NCT00772668|Hormones|hormones|mesh-ancestor
138914347|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566371|NCT05936671|Anesthetics, General|anesthetics, general|mesh-ancestor
138914348|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138914349|NCT00786474|Dalteparin|dalteparin|mesh-list
138914350|NCT00786474|Tinzaparin|tinzaparin|mesh-list
138914351|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138914352|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
138914353|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138914354|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138914355|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914357|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138914358|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138914359|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138914360|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914361|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138914362|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
138914363|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
138914364|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914365|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914366|NCT00701909|Ketamine|ketamine|mesh-list
138914367|NCT00701909|Morphine|morphine|mesh-list
138914368|NCT00701909|Analgesics|analgesics|mesh-ancestor
138914369|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
138914370|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914371|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914372|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138914373|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138914374|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
138914375|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
138914376|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138914377|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138914378|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138914379|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914380|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914381|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138914382|NCT00701909|Narcotics|narcotics|mesh-ancestor
138914383|NCT00699023|Simvastatin|simvastatin|mesh-list
138914384|NCT00699023|Ezetimibe|ezetimibe|mesh-list
138914385|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138914386|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138914387|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
138914388|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914389|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138914390|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138914391|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914392|NCT00853229|Pregabalin|pregabalin|mesh-list
138914393|NCT00853229|Analgesics|analgesics|mesh-ancestor
138914394|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
138914395|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914396|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914397|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
138914398|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138914399|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138914400|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914401|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138914402|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138914403|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138914404|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138914405|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138914406|NCT00853073|Bevacizumab|bevacizumab|mesh-list
138836295|NCT04902885|Carboplatin|carboplatin|mesh-list
138914407|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138914408|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914409|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138914410|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138914412|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914413|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
138914414|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
138430342|NCT01730612|Glycine|glycine|mesh-list
138189325|NCT03210376|Neostigmine|neostigmine|mesh-list
138914415|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138914416|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138914417|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914418|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
138914419|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914420|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566451|NCT05794997|Sympatholytics|sympatholytics|mesh-ancestor
138914421|NCT04120337|Lidocaine|lidocaine|mesh-list
138914422|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
138914423|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
138914424|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138914425|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914426|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
138914427|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914428|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138914429|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138914430|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138914431|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138914432|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914433|NCT00592319|Celecoxib|celecoxib|mesh-list
138914434|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138914435|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138914436|NCT00592319|Analgesics|analgesics|mesh-ancestor
138914437|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
138914438|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399334|NCT01541072|Lenograstim|lenograstim|mesh-list
138914439|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914440|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138914441|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914442|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138836399|NCT03067051|Verteporfin|verteporfin|mesh-list
138914443|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138914444|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914445|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914446|NCT00862121|Mesalamine|mesalamine|mesh-list
138914447|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138914448|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138914450|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
138914451|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914452|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914453|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138914454|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914455|NCT00784719|Cyclosporine|cyclosporine|mesh-list
138914456|NCT00784719|Cyclosporins|cyclosporins|mesh-list
138914457|NCT00784719|Tofacitinib|tofacitinib|mesh-list
138914458|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836514|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914459|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914460|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138914461|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
138914462|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914463|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
138914464|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914465|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
138914466|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914467|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138914468|NCT00784719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138914469|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138914470|NCT00852917|Tramadol|tramadol|mesh-list
138914471|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138914472|NCT00852917|Narcotics|narcotics|mesh-ancestor
138914473|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138914474|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914475|NCT00852917|Analgesics|analgesics|mesh-ancestor
138914476|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
138914477|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914478|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138914479|NCT00700583|Terazosin|terazosin|mesh-list
138430463|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
138914480|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138914481|NCT00700583|Diuretics|diuretics|mesh-ancestor
138914483|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914484|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138914485|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138189394|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138914486|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914487|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138914489|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138914490|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
138914491|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914492|NCT00700583|Urological Agents|urological agents|mesh-ancestor
138914493|NCT00913055|Octreotide|octreotide|mesh-list
138914494|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138914495|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138914496|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914497|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138914498|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138914499|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914500|NCT00845429|Vaccines|vaccines|mesh-list
138914501|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
138914502|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914503|NCT00844883|Sorafenib|sorafenib|mesh-list
138914504|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914505|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138914506|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914507|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914508|NCT00851903|Metformin|metformin|mesh-list
138914509|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
138914510|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138914511|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138914512|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914514|NCT00851903|Hormones|hormones|mesh-ancestor
138914515|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138914516|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138914517|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
138914518|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914519|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914520|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
138914521|NCT00587457|Immunotoxins|immunotoxins|mesh-ancestor
138914522|NCT00587457|Immunoconjugates|immunoconjugates|mesh-ancestor
138914523|NCT00587457|Immunologic Factors|immunologic factors|mesh-ancestor
138914524|NCT00587457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914525|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914526|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
138914527|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138914528|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138914529|NCT04099563|Abrocitinib|abrocitinib|mesh-list
138914530|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138914531|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914532|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914533|NCT00767325|Methotrexate|methotrexate|mesh-list
138914534|NCT00767325|Abatacept|abatacept|mesh-list
138914535|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138914536|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
138914537|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138914538|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914539|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138914540|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
138914541|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914542|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914543|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
138914544|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914545|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138914546|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138914547|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
138914548|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138837036|NCT00917462|Sorafenib|sorafenib|mesh-list
138914549|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138914550|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138914551|NCT00767325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138914553|NCT00851591|Cathartics|cathartics|mesh-ancestor
138914554|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138914555|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
138914556|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138914557|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138837086|NCT00979901|Loratadine|loratadine|mesh-list
138914558|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914559|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138450370|NCT01868880|Bisoprolol|bisoprolol|mesh-list
138914560|NCT02612363|Analgesics|analgesics|mesh-ancestor
138914561|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
138914562|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914563|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138914564|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138566983|NCT03426891|Vorinostat|vorinostat|mesh-list
138914565|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138914566|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
138914567|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914568|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914569|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138914570|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138914571|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138914572|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138914573|NCT00912899|Noscapine|noscapine|mesh-list
138914574|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
138914575|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
138914576|NCT00700895|Warfarin|warfarin|mesh-list
138914577|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
138914578|NCT00861341|Aspirin|aspirin|mesh-list
138914579|NCT00861341|Pioglitazone|pioglitazone|mesh-list
138914580|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138914581|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138914582|NCT00861341|Analgesics|analgesics|mesh-ancestor
138914583|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
138914584|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914585|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914586|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138914587|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914588|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138914589|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138914590|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914591|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138430613|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
138914592|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138914593|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914594|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
138914595|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138914597|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138914598|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914599|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138914600|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138914601|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138914602|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914603|NCT00850499|Rituximab|rituximab|mesh-list
138914604|NCT00850499|Fludarabine|fludarabine|mesh-list
138914605|NCT00850499|Bortezomib|bortezomib|mesh-list
138914606|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138914607|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914608|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
138914609|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914610|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914611|NCT00844805|Infliximab|infliximab|mesh-list
138914612|NCT00844805|Naproxen|naproxen|mesh-list
138914613|NCT00844805|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138914614|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138914615|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
138914616|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138914617|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567175|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914618|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138914619|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138914621|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
138914622|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914623|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914624|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
138914625|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138914626|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914627|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914628|NCT00765999|Linaclotide|linaclotide|mesh-list
138914629|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138914630|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
138914631|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914632|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138914633|NCT04099407|Pirfenidone|pirfenidone|mesh-list
138914634|NCT04099407|Analgesics|analgesics|mesh-ancestor
138914635|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
138914636|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914637|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914638|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138914639|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138914640|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138914641|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914642|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914643|NCT00765063|Dalteparin|dalteparin|mesh-list
138914644|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
138914645|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138914646|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138914647|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914649|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
138914650|NCT00764517|Rituximab|rituximab|mesh-list
138914651|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138914652|NCT00764517|Vorinostat|vorinostat|mesh-list
138914653|NCT00764517|Cladribine|cladribine|mesh-list
138914654|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
138914655|NCT00764517|Antibodies|antibodies|mesh-list
138914656|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
138914657|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138914658|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
138914659|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914660|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914661|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914662|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138914663|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914664|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914665|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138914666|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138914667|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
138914668|NCT00764361|Doxycycline|doxycycline|mesh-list
138914669|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138914670|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914671|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
138914672|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138914673|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138914674|NCT00763971|Methylphenidate|methylphenidate|mesh-list
138914675|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138914676|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138914677|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914678|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138914679|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138914680|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138914681|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914682|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
138914683|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914684|NCT00763815|Metformin|metformin|mesh-list
138914685|NCT00763815|Pioglitazone|pioglitazone|mesh-list
138914686|NCT00763815|Lixisenatide|lixisenatide|mesh-list
138914687|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138914688|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914689|NCT00763269|Silicon|silicon|mesh-list
138914690|NCT00763269|Triclosan|triclosan|mesh-list
138914691|NCT00763269|Fluorides|fluorides|mesh-list
138914692|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
138914693|NCT00763269|Protective Agents|protective agents|mesh-ancestor
138914694|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430716|NCT01733043|Analgesics|analgesics|mesh-ancestor
138914695|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138914696|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138770253|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
138914697|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138914698|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138914699|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
138914700|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914701|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138914702|NCT00763269|Trace Elements|trace elements|mesh-ancestor
138914703|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
138914705|NCT00763035|Regadenoson|regadenoson|mesh-list
138914706|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138914707|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
138914708|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
138914709|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914710|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914711|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138914712|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138914713|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138914714|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
138914715|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914716|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914717|NCT00763035|Protective Agents|protective agents|mesh-ancestor
138914718|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138914719|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138914720|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
138914721|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
138914722|NCT00844649|Paclitaxel|paclitaxel|mesh-list
138914723|NCT00844649|Gemcitabine|gemcitabine|mesh-list
138914724|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138914725|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138914726|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914727|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
138914728|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
138914729|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
138914730|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914731|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138914732|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
138914733|NCT04098861|Timolol|timolol|mesh-list
138914734|NCT04098861|Latanoprost|latanoprost|mesh-list
138430811|NCT01733823|Nimorazole|nimorazole|mesh-list
138914735|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138914736|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138914737|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
138914738|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914739|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914740|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914741|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138914742|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138914743|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138914744|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138914745|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
138914746|NCT00850343|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138914747|NCT00850343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138914748|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138914749|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
138914750|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914751|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914752|NCT00849875|Dacarbazine|dacarbazine|mesh-list
138914753|NCT00849875|Imidazole|imidazole|mesh-list
138914754|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138914755|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
138914756|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914757|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567545|NCT00334360|Buspirone|buspirone|mesh-list
138914758|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914759|NCT00844415|Dabigatran|dabigatran|mesh-list
138914760|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
138914761|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138914762|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
138914763|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914764|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914765|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
138914766|NCT00843635|Tadalafil|tadalafil|mesh-list
138914767|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
138914768|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138914769|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138914770|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914771|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914772|NCT00843635|Urological Agents|urological agents|mesh-ancestor
138914773|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
138914774|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
138914775|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138914776|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138914777|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914778|NCT04116827|Tamoxifen|tamoxifen|mesh-list
138914779|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138914780|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
138914781|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138914782|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914783|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138914784|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914785|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138567608|NCT00127569|Rituximab|rituximab|mesh-list
138914786|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138914787|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138914788|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
138914789|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138914790|NCT00849017|Incretins|incretins|mesh-ancestor
138914792|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566829|NCT04293393|Taxane|taxane|mesh-list
138566858|NCT04285567|Rituximab|rituximab|mesh-list
138914793|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914794|NCT00842309|Cycloserine|cycloserine|mesh-list
138914795|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138914796|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914797|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138567651|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138914798|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
138914799|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138914800|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
138914801|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914803|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138914804|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
138914805|NCT00842153|Hormones|hormones|mesh-ancestor
138914806|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138914807|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709211|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709212|NCT04381091|Protective Agents|protective agents|mesh-ancestor
138914808|NCT00762411|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
138914809|NCT00762411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138914810|NCT00762411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567781|NCT00089570|Terlipressin|terlipressin|mesh-list
138914811|NCT00762411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914813|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
138914814|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914815|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138914816|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
138914817|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914818|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
138914819|NCT02602704|Calcium|calcium|mesh-list
138567847|NCT00343135|Amoxicillin|amoxicillin|mesh-list
138914820|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138914821|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914822|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138914823|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138914824|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
138914825|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138914826|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138914827|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138914828|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
138914829|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
138914830|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
138914831|NCT00703313|Levofloxacin|levofloxacin|mesh-list
138914832|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
138914833|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138914834|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138914835|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138914836|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138914837|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914838|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138914839|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138914840|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914841|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914842|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914843|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138914844|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
138914845|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138914846|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914847|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138914848|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138914849|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138914850|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138914851|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138914852|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138914853|NCT00703079|Octreotide|octreotide|mesh-list
138914854|NCT00703079|Lanreotide|lanreotide|mesh-list
138914855|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138914856|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138914857|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914858|NCT00840827|Cyclosporine|cyclosporine|mesh-list
138914859|NCT00840827|Lenalidomide|lenalidomide|mesh-list
138914860|NCT00840827|Cyclosporins|cyclosporins|mesh-list
138914861|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914862|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568033|NCT00344227|Ranibizumab|ranibizumab|mesh-list
138914863|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138566903|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
138914864|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
138914865|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914866|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
138914867|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914868|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
138914869|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914870|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138914871|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138914872|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138914873|NCT00840827|Growth Substances|growth substances|mesh-ancestor
138914874|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
138914875|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914876|NCT00703469|Nivolumab|nivolumab|mesh-list
138914877|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138914878|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914879|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138914880|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914881|NCT02612207|Bilirubin|bilirubin|mesh-list
138914882|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
138914883|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914884|NCT02612207|Protective Agents|protective agents|mesh-ancestor
138914885|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914886|NCT00859937|Dasatinib|dasatinib|mesh-list
138914887|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914888|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138914889|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914890|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914891|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138914892|NCT04030715|Bismuth|bismuth|mesh-list
138914893|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914894|NCT04030715|Antacids|antacids|mesh-ancestor
138914895|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914896|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138914897|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138914898|NCT00592007|Fulvestrant|fulvestrant|mesh-list
138914899|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914900|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138914901|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914902|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914903|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138431029|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
138914904|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138914905|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138914906|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
138914907|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138914908|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914909|NCT00839423|Vortioxetine|vortioxetine|mesh-list
138914910|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138914911|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138914912|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138914913|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138914914|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914915|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914916|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568193|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138914917|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138914918|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
138914919|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138914920|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138914921|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138914922|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138914923|NCT00839423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138914924|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
138568268|NCT00345202|Atorvastatin|atorvastatin|mesh-list
138914925|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138914926|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138914927|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138914928|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138914930|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
138914931|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138914932|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
138914933|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566975|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914934|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914936|NCT00703625|Docetaxel|docetaxel|mesh-list
138914937|NCT00703625|Temsirolimus|temsirolimus|mesh-list
138914938|NCT00703625|MTOR Inhibitors|mtor inhibitors|mesh-list
138914939|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914940|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
138914941|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
138914942|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
138568325|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138914943|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914944|NCT00703625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138914945|NCT00703625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914946|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138914947|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
138914948|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914949|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138914950|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138914951|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138914952|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
138914953|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138914954|NCT00703703|Darifenacin|darifenacin|mesh-list
138914955|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138914956|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138914957|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
138914958|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138914959|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914960|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914961|NCT00703703|Urological Agents|urological agents|mesh-ancestor
138914963|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138914964|NCT00859313|Narcotics|narcotics|mesh-ancestor
138914965|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138914966|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914967|NCT00859313|Analgesics|analgesics|mesh-ancestor
138568394|NCT00346294|Etanercept|etanercept|mesh-list
138914968|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
138914969|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914970|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138914971|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138914972|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
138914973|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
138914974|NCT02611973|Aspirin|aspirin|mesh-list
138914975|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
138914976|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138914977|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138914978|NCT02611973|Analgesics|analgesics|mesh-ancestor
138914979|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
138914980|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138914981|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138914982|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138568434|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
138914983|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138914984|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138914985|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138914986|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138914987|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138914988|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138914989|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138914990|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
138914991|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138914992|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
138914993|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138914994|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138914995|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138914996|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
138914997|NCT00836927|Sirolimus|sirolimus|mesh-list
138770254|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138914998|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138914999|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915000|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138915001|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915002|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
138915003|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138915004|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
138915005|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915006|NCT00703235|Bevacizumab|bevacizumab|mesh-list
138915007|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138915008|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915009|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138915010|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138915011|NCT00703235|Growth Substances|growth substances|mesh-ancestor
138915012|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915013|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
138915014|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138915016|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
138915017|NCT00768300|Ambrisentan|ambrisentan|mesh-list
138915018|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138915019|NCT00768222|Triclosan|triclosan|mesh-list
138915020|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138915021|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915022|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138915023|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138915024|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
138431113|NCT01736020|Ketamine|ketamine|mesh-list
138915025|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915026|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138915027|NCT00768144|Sunitinib|sunitinib|mesh-list
138915028|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915029|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138915030|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138915031|NCT00768144|Growth Substances|growth substances|mesh-ancestor
138915032|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915033|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
138915034|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138915035|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915036|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915037|NCT00784836|Interferons|interferons|mesh-list
138915038|NCT00784836|Interferon-beta|interferon-beta|mesh-list
138915039|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
138915040|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915041|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
138915042|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915043|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
138568619|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915044|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915045|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138915046|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
138915048|NCT04104984|Progestins|progestins|mesh-ancestor
138915049|NCT04104984|Hormones|hormones|mesh-ancestor
138915050|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915051|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915052|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138915053|NCT00767520|Dasatinib|dasatinib|mesh-list
138915054|NCT00767520|Exemestane|exemestane|mesh-list
138915055|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915056|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138915057|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915058|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915059|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138915060|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138915061|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138915062|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
138915063|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915064|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915065|NCT00858845|Clonidine|clonidine|mesh-list
138915066|NCT00858845|Analgesics|analgesics|mesh-ancestor
138915067|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
138915068|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915069|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915070|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138915071|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
138915073|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138915074|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138915075|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138915076|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
138915077|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138915078|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915079|NCT00770562|Dexamethasone|dexamethasone|mesh-list
138915080|NCT00770562|Rituximab|rituximab|mesh-list
138915081|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138915082|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
138567137|NCT01291719|Insulin|insulin|mesh-list
138915083|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
138915084|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915085|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915086|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138915087|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
138915088|NCT00770562|Hormones|hormones|mesh-ancestor
138915089|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915090|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138915091|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915092|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138915093|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
138915094|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138915095|NCT00836693|Tadalafil|tadalafil|mesh-list
138915096|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
138915097|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138915098|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138915099|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915100|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915101|NCT00836693|Urological Agents|urological agents|mesh-ancestor
138915102|NCT00770484|Propranolol|propranolol|mesh-list
138915103|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138915104|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138915105|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
138915106|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138915107|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915108|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915109|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138431250|NCT01736813|Maraviroc|maraviroc|mesh-list
138915110|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138915111|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
138915112|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138915113|NCT00835679|Cetuximab|cetuximab|mesh-list
138915114|NCT00835679|Dasatinib|dasatinib|mesh-list
138915115|NCT00835679|Antibodies|antibodies|mesh-list
138915116|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
138915117|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138915118|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
138915119|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915120|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915121|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138915122|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915123|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915124|NCT00766506|Fentanyl|fentanyl|mesh-list
138915126|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138915127|NCT00766506|Narcotics|narcotics|mesh-ancestor
138915128|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138915129|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915130|NCT00766506|Analgesics|analgesics|mesh-ancestor
138915131|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
138915132|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915133|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138915134|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138915135|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
138915136|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
138915137|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
138915138|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138568801|NCT04705129|Tislelizumab|tislelizumab|mesh-list
138915139|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915140|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915141|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138915142|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138915143|NCT00770328|Protective Agents|protective agents|mesh-ancestor
138915144|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915145|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
138915147|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
138915148|NCT05500092|Cisplatin|cisplatin|mesh-list
138915149|NCT05500092|Gemcitabine|gemcitabine|mesh-list
138915150|NCT05500092|Docetaxel|docetaxel|mesh-list
138915151|NCT05500092|Nivolumab|nivolumab|mesh-list
138915152|NCT05500092|Pemetrexed|pemetrexed|mesh-list
138915153|NCT05500092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915154|NCT05500092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138915155|NCT05500092|Antimetabolites|antimetabolites|mesh-ancestor
138915156|NCT05500092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915157|NCT05500092|Tubulin Modulators|tubulin modulators|mesh-ancestor
138915158|NCT05500092|Antimitotic Agents|antimitotic agents|mesh-ancestor
138915159|NCT05500092|Mitosis Modulators|mitosis modulators|mesh-ancestor
138915160|NCT05500092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138915162|NCT05500092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915163|NCT05500092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138915164|NCT05500092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138915165|NCT00916500|Cisplatin|cisplatin|mesh-list
138915166|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915167|NCT03110094|Adalimumab|adalimumab|mesh-list
138915168|NCT03110094|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138915169|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138915170|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138915171|NCT02600988|Vitamin D|vitamin d|mesh-list
138915172|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
138915173|NCT02600988|Cholecalciferol|cholecalciferol|mesh-list
138915174|NCT02600988|Vitamins|vitamins|mesh-list
138915175|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
138915176|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915177|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138915178|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138915179|NCT04097574|Menthol|menthol|mesh-list
138915180|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
138915181|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
138915182|NCT00766038|Hormones|hormones|mesh-list
138709213|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915183|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915184|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915185|NCT00765882|Linaclotide|linaclotide|mesh-list
138915186|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138431327|NCT01737346|Lomustine|lomustine|mesh-list
138915187|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
138915188|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915189|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138915190|NCT00913367|Insulin|insulin|mesh-list
138915191|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138915192|NCT00913367|Metformin|metformin|mesh-list
138915193|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
138915194|NCT00913367|Glimepiride|glimepiride|mesh-list
138915195|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138915196|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915197|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138915198|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138915199|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
138915200|NCT00828113|Varenicline|varenicline|mesh-list
138915201|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138915202|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138915203|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
138915204|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138915205|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915206|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915207|NCT00707135|Sirolimus|sirolimus|mesh-list
138915208|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138915209|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915210|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138915211|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915212|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
138915213|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138915214|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
138915215|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915216|NCT00769704|Molgramostim|molgramostim|mesh-list
138915217|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138915218|NCT00769704|Sargramostim|sargramostim|mesh-list
138915219|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
138569116|NCT00092339|Valdecoxib|valdecoxib|mesh-list
138915221|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915222|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138915223|NCT00818753|Heparin|heparin|mesh-list
138915224|NCT00818753|Calcium heparin|calcium heparin|mesh-list
138915225|NCT00818753|Dabigatran|dabigatran|mesh-list
138915226|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
138915227|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138915228|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138915229|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915230|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
138915231|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138915232|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
138915233|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915234|NCT00704249|Nevirapine|nevirapine|mesh-list
138915235|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138915236|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138915237|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915238|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915239|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
138915240|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915241|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138915242|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138915243|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138915244|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138915245|NCT00765726|Factor VIII|factor viii|mesh-list
138915246|NCT00765726|Coagulants|coagulants|mesh-ancestor
138915247|NCT04100226|Vitamin D|vitamin d|mesh-list
138915248|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
138915249|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
138915251|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
138915252|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915253|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138915254|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138915255|NCT04100226|Antacids|antacids|mesh-ancestor
138915256|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915257|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138915258|NCT00765336|Minocycline|minocycline|mesh-list
138915259|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138915260|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915262|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138915263|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
138915264|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915265|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915266|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138915267|NCT00818519|Diuretics|diuretics|mesh-ancestor
138915268|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
138915269|NCT00827567|Everolimus|everolimus|mesh-list
138915270|NCT00827567|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138915271|NCT00827567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138915272|NCT00827567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915273|NCT00827567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915274|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138915275|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
138915276|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915277|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915278|NCT00765102|Bortezomib|bortezomib|mesh-list
138915279|NCT00765102|Romidepsin|romidepsin|mesh-list
138915280|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915281|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138915282|NCT00765102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138915283|NCT00765102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915284|NCT00765102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915285|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138915286|NCT00809354|Tanezumab|tanezumab|mesh-list
138915287|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138915288|NCT00809354|Analgesics|analgesics|mesh-ancestor
138915289|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
138431440|NCT01738178|Caffeine|caffeine|mesh-list
138915290|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915291|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915292|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138915294|NCT00834899|Eptifibatide|eptifibatide|mesh-list
138915295|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138915296|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
138915297|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138915298|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138915299|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
138915300|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915301|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138915303|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915304|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915305|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138915306|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138915307|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915308|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138915309|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138915310|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138915311|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915312|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
138915313|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138915314|NCT03990896|Talazoparib|talazoparib|mesh-list
138709214|NCT04225312|Natalizumab|natalizumab|mesh-list
138915315|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138915316|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915317|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915318|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915319|NCT00756444|Panitumumab|panitumumab|mesh-list
138915320|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915321|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138915322|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138915323|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138915324|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915325|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138915326|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138915327|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138915328|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915329|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
138915330|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138915331|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
138915332|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915333|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138915334|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138915335|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915336|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915337|NCT00764478|Asenapine|asenapine|mesh-list
138915338|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138915339|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138915340|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138915341|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915342|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138915343|NCT00805766|Infliximab|infliximab|mesh-list
138915344|NCT00805766|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138915345|NCT00805766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138915346|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
138915347|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138915348|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138915350|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138915351|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
138915352|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915353|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915354|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138915355|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915356|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138915357|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138915358|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138915359|NCT03908060|Morphine|morphine|mesh-list
138915360|NCT03908060|Methadone|methadone|mesh-list
138915361|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138915362|NCT03908060|Narcotics|narcotics|mesh-ancestor
138915363|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138915364|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915365|NCT03908060|Analgesics|analgesics|mesh-ancestor
138915366|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
138915367|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915368|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
138915369|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
138915370|NCT00752856|Ritonavir|ritonavir|mesh-list
138915371|NCT00752856|Lopinavir|lopinavir|mesh-list
138915372|NCT00752856|Tenofovir|tenofovir|mesh-list
138915373|NCT00752856|Emtricitabine|emtricitabine|mesh-list
138915374|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
138915375|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138915376|NCT00752856|Efavirenz|efavirenz|mesh-list
138915377|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138915378|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138915379|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
138915380|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915381|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915382|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138915383|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138915384|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
138915385|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915386|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138915387|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138915388|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138915389|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138915390|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138915391|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138915392|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138915393|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138915394|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138915395|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138915396|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138915397|NCT00805142|Tapentadol|tapentadol|mesh-list
138915398|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138915399|NCT00805142|Narcotics|narcotics|mesh-ancestor
138915400|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138915401|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915402|NCT00805142|Analgesics|analgesics|mesh-ancestor
138915403|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
138431619|NCT01739413|Anesthetics|anesthetics|mesh-list
138915404|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915405|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138915406|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138569751|NCT00095966|Gemcitabine|gemcitabine|mesh-list
138915407|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138915408|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915410|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138915411|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138915412|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
138915413|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915414|NCT00761319|Travoprost|travoprost|mesh-list
138915415|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138915416|NCT00761319|Latanoprost|latanoprost|mesh-list
138915417|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138915418|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138915419|NCT00704639|Carboplatin|carboplatin|mesh-list
138915420|NCT00704639|Cetuximab|cetuximab|mesh-list
138915421|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915422|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138915423|NCT00826943|Cetirizine|cetirizine|mesh-list
138915424|NCT00826943|Levocetirizine|levocetirizine|mesh-list
138915425|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138915426|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138915427|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138915428|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
138915429|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
138915430|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450533|NCT01871480|Gefitinib|gefitinib|mesh-list
138915431|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915432|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915433|NCT00707369|Amoxicillin|amoxicillin|mesh-list
138915434|NCT00707369|Metronidazole|metronidazole|mesh-list
138915435|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138915436|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915437|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138915438|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138915439|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138915440|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138915441|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915442|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138915443|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915444|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915445|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
138915446|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915448|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
138915449|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915450|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138915451|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138915452|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138915453|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138915454|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138915455|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915456|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915457|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138915458|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
138567499|NCT00333931|Phenytoin|phenytoin|mesh-list
138915459|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915460|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915462|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138915463|NCT00759915|Narcotics|narcotics|mesh-ancestor
138915464|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138915465|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915466|NCT00759915|Analgesics|analgesics|mesh-ancestor
138915467|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
138915468|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915469|NCT00759759|Morphine|morphine|mesh-list
138915470|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138915471|NCT00759759|Narcotics|narcotics|mesh-ancestor
138915472|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138915473|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915474|NCT00759759|Analgesics|analgesics|mesh-ancestor
138915475|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
138915476|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915477|NCT00759681|Thrombin|thrombin|mesh-list
138915478|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
138915479|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
138915480|NCT00759681|Coagulants|coagulants|mesh-ancestor
138915481|NCT00826241|Temozolomide|temozolomide|mesh-list
138915482|NCT00826241|Lapatinib|lapatinib|mesh-list
138915483|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138915484|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
138915485|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915486|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915487|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138915488|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915489|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
138915490|NCT04097847|Tocopherols|tocopherols|mesh-list
138915492|NCT04097847|Tocotrienols|tocotrienols|mesh-list
138915493|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
138915494|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
138915495|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138915496|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915497|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915498|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138915499|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138915500|NCT04097847|Protective Agents|protective agents|mesh-ancestor
138570108|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915502|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
138915503|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138915504|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
138915505|NCT04097847|Vitamins|vitamins|mesh-ancestor
138915506|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
138709215|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
138915507|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138915508|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
138915509|NCT00762372|Sevoflurane|sevoflurane|mesh-list
138915510|NCT00762372|Desflurane|desflurane|mesh-list
138915511|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138915512|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138915513|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
138915514|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
138915515|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138915516|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915517|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138915518|NCT00762372|Analgesics|analgesics|mesh-ancestor
138915519|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
138570245|NCT04711044|Menthol|menthol|mesh-list
138915520|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915523|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138915524|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915525|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
138915526|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
138915527|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
138915528|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915529|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138915530|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138915531|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138915532|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915533|NCT00833027|Incretins|incretins|mesh-ancestor
138915534|NCT00833027|Hormones|hormones|mesh-ancestor
138915535|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915536|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138915537|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
138915538|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915539|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915540|NCT00752622|Infliximab|infliximab|mesh-list
138915541|NCT00752622|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138915542|NCT00752622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138915543|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
138915544|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138915545|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138915546|NCT00754650|Bevacizumab|bevacizumab|mesh-list
138915547|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138915548|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915549|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138915550|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138915551|NCT00754650|Growth Substances|growth substances|mesh-ancestor
138915552|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915553|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
138915554|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138915555|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915556|NCT00825305|Vaccines|vaccines|mesh-list
138915557|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
138915558|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915559|NCT00754572|Methotrexate|methotrexate|mesh-list
138915560|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138915561|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
138450560|NCT01871662|Interferons|interferons|mesh-list
138915562|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138915563|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915564|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138915565|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
138915566|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915567|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915569|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915570|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138915571|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138915572|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
138915573|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138915574|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138915575|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
138915576|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915577|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138915578|NCT04095312|Pancrelipase|pancrelipase|mesh-list
138431820|NCT01741077|Folic Acid|folic acid|mesh-list
138915579|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138915580|NCT04095390|Capecitabine|capecitabine|mesh-list
138915581|NCT04095390|Letrozole|letrozole|mesh-list
138915582|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138915583|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
138915584|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915585|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915586|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138915587|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138915588|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915589|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138915590|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
138915591|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915592|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915593|NCT00708149|Lansoprazole|lansoprazole|mesh-list
138915594|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
138915596|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138915597|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138570605|NCT00131430|Hormones|hormones|mesh-ancestor
138915598|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915599|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915600|NCT04016051|Clarithromycin|clarithromycin|mesh-list
138915601|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138915602|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915603|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138915604|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915605|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915606|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138915607|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138915608|NCT00761514|Adalimumab|adalimumab|mesh-list
138915609|NCT00761514|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138915610|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138915611|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138915612|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
138915613|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138915614|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431875|NCT01741493|Upadacitinib|upadacitinib|mesh-list
138915615|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138915616|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915617|NCT00758043|Ribavirin|ribavirin|mesh-list
138570734|NCT00099008|Genistein|genistein|mesh-list
138915618|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138915620|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915621|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
138915622|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915623|NCT00831701|Tamsulosin|tamsulosin|mesh-list
138915624|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138915625|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138915626|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138915627|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
138915628|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450563|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
138915629|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915630|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915632|NCT00705419|Tenofovir|tenofovir|mesh-list
138915633|NCT00705419|Emtricitabine|emtricitabine|mesh-list
138915634|NCT00705419|Maleic acid|maleic acid|mesh-list
138915635|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
138915636|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915637|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138915638|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138915639|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915640|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915641|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138915642|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138915643|NCT05425355|Acetaminophen|acetaminophen|mesh-list
138915644|NCT05425355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138915645|NCT05425355|Analgesics|analgesics|mesh-ancestor
138915646|NCT05425355|Sensory System Agents|sensory system agents|mesh-ancestor
138915647|NCT05425355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915648|NCT05425355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915649|NCT05425355|Antipyretics|antipyretics|mesh-ancestor
138915650|NCT04093713|Nordefrin|nordefrin|mesh-list
138915651|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138915652|NCT00831311|Vaccines|vaccines|mesh-list
138915653|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
138915654|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915655|NCT00831233|Goserelin|goserelin|mesh-list
138915656|NCT00831233|Bicalutamide|bicalutamide|mesh-list
138915657|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138915658|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915659|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
138915660|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
138431950|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
138915661|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915662|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915663|NCT05438277|Methylprednisolone|methylprednisolone|mesh-list
138915664|NCT05438277|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138915665|NCT05438277|Triamcinolone|triamcinolone|mesh-list
138915666|NCT05438277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138915667|NCT05438277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138915668|NCT05438277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138915669|NCT05438277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138915670|NCT05438277|Antiemetics|antiemetics|mesh-ancestor
138915671|NCT05438277|Autonomic Agents|autonomic agents|mesh-ancestor
138915672|NCT05438277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915673|NCT05438277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915674|NCT05438277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138915675|NCT05438277|Glucocorticoids|glucocorticoids|mesh-ancestor
138915676|NCT05438277|Hormones|hormones|mesh-ancestor
138709216|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915677|NCT05438277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915678|NCT05438277|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138915679|NCT05438277|Protective Agents|protective agents|mesh-ancestor
138915680|NCT05438277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138915681|NCT05438277|Immunologic Factors|immunologic factors|mesh-ancestor
138915682|NCT05438277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915683|NCT05438277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915685|NCT00761280|Carmustine|carmustine|mesh-list
138915686|NCT00761280|Lomustine|lomustine|mesh-list
138915687|NCT00761280|Trabedersen|trabedersen|mesh-list
138915688|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138915689|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
138915690|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915691|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915692|NCT00916890|Fentanyl|fentanyl|mesh-list
138915693|NCT00916890|Morphine|morphine|mesh-list
138915694|NCT00916890|Oxycodone|oxycodone|mesh-list
138915695|NCT00916890|Buprenorphine|buprenorphine|mesh-list
138915696|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138915697|NCT00916890|Narcotics|narcotics|mesh-ancestor
138915698|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138915699|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915701|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
138571102|NCT00100646|Ritonavir|ritonavir|mesh-list
138915702|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915703|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138915704|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138915705|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
138915706|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
138915707|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138915708|NCT02599701|Gabapentin|gabapentin|mesh-list
138915709|NCT02599701|Analgesics|analgesics|mesh-ancestor
138432012|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
138915710|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
138915711|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915712|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915713|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
138915714|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138915715|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138915716|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138915717|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138915718|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138915719|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138915720|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138915721|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915722|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
138915723|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138709217|NCT04209205|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138915724|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138915725|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138915726|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138915727|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915728|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138915729|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915730|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
138915731|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138915732|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
138709218|NCT04209205|Immunologic Factors|immunologic factors|mesh-ancestor
138915733|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138915734|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
138915735|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915736|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138915737|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138915738|NCT00760266|Diuretics|diuretics|mesh-ancestor
138915739|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
138915740|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915741|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138915742|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138915743|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915745|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138915746|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
138915747|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915748|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915749|NCT00759954|Morphine|morphine|mesh-list
138915750|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138915751|NCT00759954|Narcotics|narcotics|mesh-ancestor
138571348|NCT00135759|Naltrexone|naltrexone|mesh-list
138915752|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138915753|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915754|NCT00759954|Analgesics|analgesics|mesh-ancestor
138915755|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
138915756|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915757|NCT00804908|Temozolomide|temozolomide|mesh-list
138915758|NCT00804908|Veliparib|veliparib|mesh-list
138915759|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138567856|NCT00343174|Ancrod|ancrod|mesh-list
138915760|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
138915761|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915762|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915763|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138915764|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915765|NCT02608034|Itraconazole|itraconazole|mesh-list
138915766|NCT02608034|Rifampin|rifampin|mesh-list
138915767|NCT02608034|Vemurafenib|vemurafenib|mesh-list
138915768|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
138915769|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915770|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138915771|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138915772|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915773|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915774|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138915775|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
138915776|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915777|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915778|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138915779|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138915780|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
138915781|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138915782|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
138915783|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138915784|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138915785|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138915786|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138915787|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138915788|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138915789|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138915790|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915791|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138915792|NCT00589784|Sunitinib|sunitinib|mesh-list
138915793|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
138915794|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915795|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138915796|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138915797|NCT00589784|Growth Substances|growth substances|mesh-ancestor
138915798|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915799|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
138915800|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138915801|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915802|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915803|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138915804|NCT05742854|Oxytocin|oxytocin|mesh-list
138915805|NCT05742854|Carbetocin|carbetocin|mesh-list
138915806|NCT05742854|Oxytocics|oxytocics|mesh-ancestor
138915807|NCT05742854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138915808|NCT05742854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915809|NCT00823979|Etravirine|etravirine|mesh-list
138915810|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138915811|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138915812|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915813|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915814|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
138915816|NCT04094766|Immunomodulating Agents|immunomodulating agents|mesh-list
138915817|NCT04094766|Immunologic Factors|immunologic factors|mesh-ancestor
138915818|NCT04094766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915819|NCT02606864|Nifurtimox|nifurtimox|mesh-list
138915820|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138915821|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138915822|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138915823|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915824|NCT00823901|Clindamycin|clindamycin|mesh-list
138915825|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
138915826|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
138915827|NCT00823901|Tretinoin|tretinoin|mesh-list
138915828|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138915829|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915830|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138915831|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915832|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915833|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915834|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
138915835|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
138915837|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138915838|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
138915839|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915840|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915841|NCT02926898|Fenfluramine|fenfluramine|mesh-list
138915842|NCT02926898|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138915843|NCT02926898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138915844|NCT02926898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138915845|NCT02926898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915846|NCT02926898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138915847|NCT02926898|Serotonin Agents|serotonin agents|mesh-ancestor
138915848|NCT02926898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915850|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138915851|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915852|NCT00816023|Ecallantide|ecallantide|mesh-list
138915853|NCT00816023|Analgesics|analgesics|mesh-ancestor
138915854|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
138915855|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915856|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915857|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138915858|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138915859|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138915860|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138915861|NCT00815633|Alefacept|alefacept|mesh-list
138915862|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
138571616|NCT00136344|Levofloxacin|levofloxacin|mesh-list
138915863|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
138915864|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915865|NCT02610881|Iron|iron|mesh-list
138915866|NCT02610881|Trace Elements|trace elements|mesh-list
138915867|NCT02610881|Folic Acid|folic acid|mesh-list
138915868|NCT02610881|Micronutrients|micronutrients|mesh-list
138915869|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915870|NCT02610881|Hematinics|hematinics|mesh-ancestor
138915871|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
138915872|NCT02610881|Vitamins|vitamins|mesh-ancestor
138915873|NCT00830765|Progesterone|progesterone|mesh-list
138915874|NCT00830765|Progestins|progestins|mesh-ancestor
138915875|NCT00830765|Hormones|hormones|mesh-ancestor
138915876|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915877|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915878|NCT04093206|Vitamins|vitamins|mesh-list
138915879|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
138915880|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
138915881|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915882|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
138915883|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915884|NCT04093206|Protective Agents|protective agents|mesh-ancestor
138915885|NCT00830375|Memantine|memantine|mesh-list
138915886|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138915887|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138915888|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
138915889|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138915890|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915891|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915892|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138915893|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138915894|NCT00708539|Progesterone|progesterone|mesh-list
138915895|NCT00708539|Progestins|progestins|mesh-ancestor
138915896|NCT00708539|Hormones|hormones|mesh-ancestor
138915897|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138915898|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915899|NCT00914420|Trapidil|trapidil|mesh-list
138915900|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138915901|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915902|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915903|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138915904|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
138915905|NCT04094532|Bupivacaine|bupivacaine|mesh-list
138915906|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
138915907|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
138915908|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138915909|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915910|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
138915911|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138915912|NCT00708773|Irinotecan|irinotecan|mesh-list
138915913|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138915914|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138915915|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915916|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915917|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138915918|NCT05758259|Vitamin D|vitamin d|mesh-list
138915919|NCT05758259|Ergocalciferols|ergocalciferols|mesh-list
138915920|NCT05758259|Cholecalciferol|cholecalciferol|mesh-list
138915921|NCT05758259|Vitamins|vitamins|mesh-list
138915922|NCT05758259|Micronutrients|micronutrients|mesh-ancestor
138915923|NCT05758259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432229|NCT01743157|Ipilimumab|ipilimumab|mesh-list
138915924|NCT05758259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138915925|NCT05758259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138915926|NCT00803738|Terconazole|terconazole|mesh-list
138915927|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
138915928|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915929|NCT00591266|Amlodipine|amlodipine|mesh-list
138915930|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138915931|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138915932|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138915933|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138915934|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915935|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138915936|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704033|NCT06205407|Spironolactone|spironolactone|mesh-list
138915937|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
138915938|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138915939|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138915940|NCT04093050|Vasopressins|vasopressins|mesh-list
138915941|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
138915942|NCT04093050|Coagulants|coagulants|mesh-ancestor
138915943|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138915944|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138915945|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
138915946|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915947|NCT00758394|Listerine|listerine|mesh-list
138915948|NCT00758394|Triclosan|triclosan|mesh-list
138915949|NCT00758394|Fluorides|fluorides|mesh-list
138915950|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
138915951|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
138915952|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
138450617|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138915953|NCT00758394|Protective Agents|protective agents|mesh-ancestor
138915954|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915955|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138571808|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
138915956|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138915957|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138915958|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138915959|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
138915960|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915961|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138915962|NCT04450394|Insulin|insulin|mesh-list
138915963|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138915964|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915965|NCT00758160|Methylphenidate|methylphenidate|mesh-list
138915966|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138915967|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915968|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138915969|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138915970|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138915971|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915972|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
138915973|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138915975|NCT02606552|Clopidogrel|clopidogrel|mesh-list
138915976|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138915977|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138915978|NCT02606552|Analgesics|analgesics|mesh-ancestor
138915979|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
138915980|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571862|NCT00404040|Lactulose|lactulose|mesh-list
138915981|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138915982|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138915983|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568023|NCT00344149|Rituximab|rituximab|mesh-list
138915984|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138915985|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138915986|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138915987|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138915988|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138915989|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915990|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
138915991|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138915992|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138915993|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138915994|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
138915995|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138915996|NCT02608736|Valproic Acid|valproic acid|mesh-list
138915997|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
138915998|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138915999|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916000|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
138916001|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916002|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916003|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
138916004|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138916005|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916006|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138916007|NCT02607410|Insulin|insulin|mesh-list
138916008|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138916009|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138916010|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
138432311|NCT01743690|Hormones|hormones|mesh-ancestor
138916011|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
138916012|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
138916013|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
138916014|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138916015|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138916016|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916017|NCT02607410|Incretins|incretins|mesh-ancestor
138916018|NCT02607410|Hormones|hormones|mesh-ancestor
138916019|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138916020|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
138916021|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916022|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916024|NCT05693090|Tipifarnib|tipifarnib|mesh-list
138916025|NCT05693090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916026|NCT05693090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138916027|NCT05693090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916028|NCT05693090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916029|NCT00751296|Lenalidomide|lenalidomide|mesh-list
138916030|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
138916031|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916032|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138572013|NCT00134394|Tacrolimus|tacrolimus|mesh-list
138916033|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138916034|NCT00751296|Growth Substances|growth substances|mesh-ancestor
138916035|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
138916036|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916037|NCT04093518|Estradiol|estradiol|mesh-list
138916038|NCT04093518|Estrogens|estrogens|mesh-ancestor
138916040|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138916041|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916042|NCT02606084|Esketamine|esketamine|mesh-list
138916043|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
138916044|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138916045|NCT02607488|Lidocaine|lidocaine|mesh-list
138916046|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
138916047|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
138916048|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916049|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572079|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916050|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
138916051|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916052|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138916053|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138916054|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138916055|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138916056|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916057|NCT00914498|Lidocaine|lidocaine|mesh-list
138916058|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
138916059|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
138916060|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916061|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916062|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
138916063|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916064|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138916065|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138916066|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138916067|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138916068|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916069|NCT00751881|Teriflunomide|teriflunomide|mesh-list
138916070|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138916071|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138916072|NCT00751881|Analgesics|analgesics|mesh-ancestor
138916073|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
138916074|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916075|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916076|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138916077|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138916078|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138916079|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
138916080|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
138916081|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138916082|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916083|NCT02599779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138916084|NCT02599779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916085|NCT02597556|Albendazole|albendazole|mesh-list
138916086|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
138916087|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138916088|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916089|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
138916090|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138916091|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138916092|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
138916093|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
138916094|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
138916095|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916096|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916097|NCT02599857|Bisoprolol|bisoprolol|mesh-list
138916098|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138916099|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
138916100|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
138916101|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916102|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916103|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138916104|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138916105|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138916107|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916108|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916109|NCT02599623|Anesthetics|anesthetics|mesh-list
138916110|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916111|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916112|NCT02597400|Metformin|metformin|mesh-list
138916113|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138916114|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916115|NCT00830063|Naproxen|naproxen|mesh-list
138916116|NCT00830063|Tanezumab|tanezumab|mesh-list
138916117|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138916118|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138916119|NCT00830063|Analgesics|analgesics|mesh-ancestor
138916120|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
138916121|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916122|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916123|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138916125|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
138916126|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138916127|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916128|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916129|NCT04092621|Amiodarone|amiodarone|mesh-list
138916130|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138916131|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
138432467|NCT01744379|Lesinurad|lesinurad|mesh-list
138450653|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916133|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138916134|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916135|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138916136|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138916137|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138916138|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916139|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138916140|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138916141|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138916142|NCT00751101|Nicotine|nicotine|mesh-list
138916143|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138916144|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
138916145|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916146|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572511|NCT00436033|Milnacipran|milnacipran|mesh-list
138916147|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138916148|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138916149|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
138916150|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916151|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916153|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138916154|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138916155|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138916156|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138916157|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138916158|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916159|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
138916160|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916161|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
138916162|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
138916163|NCT02598414|Protective Agents|protective agents|mesh-ancestor
138916164|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916165|NCT04020003|Simendan|simendan|mesh-list
138916166|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138916167|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
138916168|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138916169|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138916170|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916171|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916172|NCT04020003|Protective Agents|protective agents|mesh-ancestor
138916173|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916175|NCT03977142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138916177|NCT03977142|Analgesics|analgesics|mesh-ancestor
138916178|NCT03977142|Sensory System Agents|sensory system agents|mesh-ancestor
138916179|NCT03977142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916180|NCT03977142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916181|NCT03977142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138916182|NCT03977142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138916183|NCT00751023|Modafinil|modafinil|mesh-list
138916184|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138572757|NCT00438178|Obatoclax|obatoclax|mesh-list
138916185|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916187|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138916188|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138916189|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916190|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
138916191|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138916192|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138916193|NCT04091412|Protective Agents|protective agents|mesh-ancestor
138916194|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916195|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138916196|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138572822|NCT00106886|Folic Acid|folic acid|mesh-list
138916197|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138916198|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
138916199|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916200|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916201|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916202|NCT02599311|Urological Agents|urological agents|mesh-ancestor
138916203|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
138916204|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138916205|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138916206|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138432535|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916207|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916208|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138916209|NCT00591773|Diuretics|diuretics|mesh-ancestor
138916210|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
138916211|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916212|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138916213|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138916214|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
138916215|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138916216|NCT00750867|Antibodies|antibodies|mesh-list
138916217|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
138916218|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138916219|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
138916220|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916221|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
138916222|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
138916223|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916224|NCT04091763|Polidocanol|polidocanol|mesh-list
138916225|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138916226|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138916227|NCT00829829|Rilonacept|rilonacept|mesh-list
138916228|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138916229|NCT00829439|Levodopa|levodopa|mesh-list
138916230|NCT00829439|Carbidopa|carbidopa|mesh-list
138916231|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138916232|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138916233|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
138916234|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432579|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916235|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916236|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916237|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138916238|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916239|NCT02599077|Dienogest|dienogest|mesh-list
138916240|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
138916241|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138916242|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
138916243|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138916244|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916245|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138916246|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138916248|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138916249|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138916250|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
138916251|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138916252|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138573136|NCT00142896|Morphine|morphine|mesh-list
138916253|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916254|NCT00829283|Orlistat|orlistat|mesh-list
138916255|NCT00829283|Sibutramine|sibutramine|mesh-list
138916256|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916257|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916259|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138916260|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
138916261|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138916262|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
138916263|NCT05758025|Parathyroid Hormone|parathyroid hormone|mesh-list
138916264|NCT05758025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138573202|NCT00441415|Adapalene|adapalene|mesh-list
138372609|NCT01419353|Estradiol|estradiol|mesh-list
138916265|NCT05758025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916266|NCT00706277|Fentanyl|fentanyl|mesh-list
138916267|NCT00706277|Remifentanil|remifentanil|mesh-list
138916268|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
138916269|NCT00706277|Propofol|propofol|mesh-list
138916270|NCT00706277|Sevoflurane|sevoflurane|mesh-list
138916271|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138916272|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916273|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916274|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138916275|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
138916276|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
138916277|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138916278|NCT00706277|Narcotics|narcotics|mesh-ancestor
138916279|NCT00706277|Analgesics|analgesics|mesh-ancestor
138916280|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
138916281|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916282|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138916283|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138916284|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138916285|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138916287|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138916288|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
138916289|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916290|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916291|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138573341|NCT03278938|Bupropion|bupropion|mesh-list
138916292|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138916293|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
138916294|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916295|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916296|NCT00821327|Gemcitabine|gemcitabine|mesh-list
138916297|NCT00821327|Sunitinib|sunitinib|mesh-list
138916298|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916299|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138916300|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
138573384|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138573390|NCT00442741|Omeprazole|omeprazole|mesh-list
138432667|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138916301|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916302|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138916303|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138916304|NCT00821327|Growth Substances|growth substances|mesh-ancestor
138916305|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916306|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
138916307|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138916308|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916309|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138916310|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
138916311|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916312|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138916313|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138916314|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
138916315|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916316|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916317|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138916318|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
138916319|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138916320|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138916321|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138916322|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
138916323|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916324|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916325|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138916326|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
138916327|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916328|NCT02611505|Esketamine|esketamine|mesh-list
138916329|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
138916330|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138916331|NCT00743652|Vaccines|vaccines|mesh-list
138191249|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
138916332|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138916334|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916335|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
138916336|NCT00748215|Loperamide|loperamide|mesh-list
138916337|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
138916338|NCT00748215|Calcium|calcium|mesh-list
138916339|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138916340|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916341|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138916342|NCT00917163|Sirolimus|sirolimus|mesh-list
138916343|NCT00917163|Everolimus|everolimus|mesh-list
138916344|NCT00917163|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138916345|NCT00917163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138916346|NCT00917163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916347|NCT00917163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916348|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138916349|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
138916350|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916351|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916352|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138568406|NCT00346489|Fluorouracil|fluorouracil|mesh-list
138916353|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916354|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138916355|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
138916356|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138916357|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916358|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138916359|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916360|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916361|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
138916362|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138916363|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138916364|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
138916365|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916366|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138916367|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138916368|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916369|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916370|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
138916371|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138916372|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916373|NCT04091178|Vitamin D|vitamin d|mesh-list
138916374|NCT04091178|Vitamins|vitamins|mesh-ancestor
138916375|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
138916376|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916377|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138916378|NCT00917358|Interferons|interferons|mesh-list
138916379|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
138916380|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
138916381|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138916382|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916383|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
138916384|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916385|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
138916386|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916387|NCT00743340|Emtricitabine|emtricitabine|mesh-list
138916388|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
138916389|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916390|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138916391|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138916392|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916393|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916394|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138916395|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138916396|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138916397|NCT00749190|Empagliflozin|empagliflozin|mesh-list
138916398|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138249976|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138916399|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916400|NCT00749190|Incretins|incretins|mesh-ancestor
138916402|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138916403|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138916404|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
138916405|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191339|NCT03034733|Hormones|hormones|mesh-ancestor
138916406|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916407|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138573652|NCT00443950|Etanercept|etanercept|mesh-list
138916409|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138916411|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916412|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916413|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916414|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138916415|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138916416|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138573716|NCT00451594|Hormones|hormones|mesh-ancestor
138916417|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138916418|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138916419|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
138916421|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138916422|NCT02597166|Ledipasvir|ledipasvir|mesh-list
138916423|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
138916424|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916425|NCT00743106|Fenoldopam|fenoldopam|mesh-list
138450734|NCT01872013|ASP7991|asp7991|mesh-list
138916426|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138916427|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
138916428|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
138916429|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
138916430|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916431|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916432|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916434|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916435|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138916436|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916437|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916438|NCT00738699|Paclitaxel|paclitaxel|mesh-list
138916439|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138916440|NCT00738699|Farletuzumab|farletuzumab|mesh-list
138916441|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138916442|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916443|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
138916444|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
138916445|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
138916446|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916448|NCT00814307|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138916449|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138916450|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573904|NCT00452569|Thalidomide|thalidomide|mesh-list
138916451|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916452|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
138916453|NCT02596776|Propranolol|propranolol|mesh-list
138916454|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138916455|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138916456|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
138916457|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916458|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916459|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916460|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138916461|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138916462|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
138916463|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916464|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138916465|NCT02596776|Protective Agents|protective agents|mesh-ancestor
138916466|NCT00748098|Gabapentin|gabapentin|mesh-list
138916467|NCT00748098|Analgesics|analgesics|mesh-ancestor
138916468|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
138916469|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916470|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916471|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
138916472|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138916473|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138916474|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916475|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138916476|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138916477|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138916478|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916479|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916480|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
138916481|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138916482|NCT00813995|Metformin|metformin|mesh-list
138916483|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138916484|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916485|NCT00813995|Incretins|incretins|mesh-ancestor
138916486|NCT00813995|Hormones|hormones|mesh-ancestor
138574087|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138916487|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138916488|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138916489|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
138916490|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916491|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916492|NCT00737529|Lenalidomide|lenalidomide|mesh-list
138916493|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
138916494|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916495|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138916496|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138916497|NCT00737529|Growth Substances|growth substances|mesh-ancestor
138916498|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
138916499|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916500|NCT00813917|Varenicline|varenicline|mesh-list
138916501|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138916502|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138916503|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
138916504|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916505|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916506|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916507|NCT02598102|Diclofenac|diclofenac|mesh-list
138916508|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138916509|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138916510|NCT02598102|Analgesics|analgesics|mesh-ancestor
138916511|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
138916512|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916513|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916514|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138916515|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138916516|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138916517|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916518|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916519|NCT02610647|Anesthetics|anesthetics|mesh-list
138916520|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916521|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916522|NCT02595918|Nivolumab|nivolumab|mesh-list
138916523|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138916524|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916525|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138916526|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916527|NCT02595840|Pemetrexed|pemetrexed|mesh-list
138916528|NCT02595840|Afatinib|afatinib|mesh-list
138916529|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916530|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916531|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916532|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138916533|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138916534|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138916535|NCT02594241|Prednisolone|prednisolone|mesh-list
138916536|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138916537|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
138916538|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138916539|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
138432946|NCT01747590|Zolpidem|zolpidem|mesh-list
138916540|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138916541|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
138916542|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138916543|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
138916544|NCT02594241|Hormones|hormones|mesh-ancestor
138916545|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138916546|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916547|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138916548|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916550|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
138916551|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916552|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138916553|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138916554|NCT02594241|Protective Agents|protective agents|mesh-ancestor
138916555|NCT00585975|Bromfenac|bromfenac|mesh-list
138916556|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138916557|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138916558|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138916559|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138916560|NCT00585975|Analgesics|analgesics|mesh-ancestor
138916561|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
138916562|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916564|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138916565|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138916566|NCT00918021|Olanzapine|olanzapine|mesh-list
138916567|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
138916568|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
138916569|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432989|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
138916570|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916571|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138916572|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138916573|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138916574|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916575|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138574446|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138916576|NCT00918021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138916577|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138916578|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138916579|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916580|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916581|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
138916582|NCT00585585|Betahistine|betahistine|mesh-list
138916583|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
138916584|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
138916585|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
138916586|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916587|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916588|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916589|NCT02593695|Fluoxetine|fluoxetine|mesh-list
138916590|NCT02593695|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138916591|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138916592|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709219|NCT04209205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916593|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916594|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916595|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
138916596|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916597|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138916598|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
138916599|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138916600|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138916601|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138916602|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916603|NCT00734097|Esomeprazole|esomeprazole|mesh-list
138916604|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138916605|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138916606|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138916607|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916608|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916609|NCT00819767|Valsartan|valsartan|mesh-list
138916610|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138916611|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138916612|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138916613|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916614|NCT04088175|Menthol|menthol|mesh-list
138916615|NCT04088175|Nicotine|nicotine|mesh-list
138916616|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138916617|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
138916618|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916619|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916620|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138916621|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138916622|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
138916623|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916624|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916625|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
138916626|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
138916627|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
138916628|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138916629|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
138916630|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138916631|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
138916632|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138916633|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
138916634|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138916636|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916637|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916638|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916639|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138433098|NCT01748344|Cetirizine|cetirizine|mesh-list
138916640|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138916641|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138916642|NCT00732069|Valsartan|valsartan|mesh-list
138916643|NCT00732069|Ramipril|ramipril|mesh-list
138916644|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138916645|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138916646|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138916647|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916648|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138916649|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
138916650|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916651|NCT02593383|Clindamycin|clindamycin|mesh-list
138916652|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
138916653|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
138916654|NCT02593383|Adapalene|adapalene|mesh-list
138916655|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138916656|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916657|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138916658|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916659|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916660|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138916661|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138916662|NCT02593383|Analgesics|analgesics|mesh-ancestor
138916663|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
138916664|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916665|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916666|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138916667|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138916668|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
138916670|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138433108|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
138916671|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916672|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138916673|NCT02609087|Propofol|propofol|mesh-list
138916674|NCT02609087|Sevoflurane|sevoflurane|mesh-list
138916675|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138916676|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916677|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916678|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138916679|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
138916680|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
138916681|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138916682|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138916683|NCT00731133|Disulfiram|disulfiram|mesh-list
138916684|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138916685|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138916686|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916687|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916688|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138916689|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138916690|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916691|NCT00730275|Incretins|incretins|mesh-ancestor
138916692|NCT00730275|Hormones|hormones|mesh-ancestor
138916693|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138916694|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138916695|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
138916696|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916697|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916698|NCT04793711|Decanoic acid|decanoic acid|mesh-list
138916699|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
138916700|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916701|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
138916702|NCT00729651|Vitamin D|vitamin d|mesh-list
138916703|NCT00729651|Alendronate|alendronate|mesh-list
138916704|NCT00729651|Calcium|calcium|mesh-list
138916705|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138916706|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916707|NCT00729651|Vitamins|vitamins|mesh-ancestor
138916708|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
138916709|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138916710|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
138916711|NCT00729183|Vitamin D|vitamin d|mesh-list
138916712|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
138916713|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
138916714|NCT00729183|Calcium|calcium|mesh-list
138916715|NCT00729183|Vitamins|vitamins|mesh-ancestor
138916716|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
138916717|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916718|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138916719|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138916720|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916721|NCT00729183|Antacids|antacids|mesh-ancestor
138916722|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138916723|NCT00811733|Ofatumumab|ofatumumab|mesh-list
138916724|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916725|NCT00728949|Tamoxifen|tamoxifen|mesh-list
138916726|NCT00728949|Letrozole|letrozole|mesh-list
138916727|NCT00728949|Fulvestrant|fulvestrant|mesh-list
138916728|NCT00728949|Anastrozole|anastrozole|mesh-list
138916729|NCT00728949|Exemestane|exemestane|mesh-list
138916730|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138916731|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916732|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138916733|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138916734|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916735|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916736|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138916737|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
138770255|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916738|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138916739|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916740|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138916741|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138916742|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138916743|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138916744|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138916745|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
138916747|NCT00918177|Carbidopa|carbidopa|mesh-list
138916748|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138916749|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138916750|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138916751|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
138916752|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916753|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916754|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916755|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138916756|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916757|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138916758|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
138916759|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
138916760|NCT00728481|Budesonide|budesonide|mesh-list
138916761|NCT00728481|Esomeprazole|esomeprazole|mesh-list
138916762|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138916763|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138916764|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
138916765|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916766|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916767|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138916768|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
138916769|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
138916770|NCT00728481|Hormones|hormones|mesh-ancestor
138916771|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138916772|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138916773|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138916774|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138916775|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916776|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916777|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
138916778|NCT02593227|Vaccines|vaccines|mesh-list
138916779|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
138916780|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916781|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138916782|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138916783|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138916784|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
138916785|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916786|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916787|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138916788|NCT04030481|Anesthetics|anesthetics|mesh-list
138916789|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916790|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916791|NCT02592915|Clonidine|clonidine|mesh-list
138916792|NCT02592915|Anesthetics|anesthetics|mesh-list
138916793|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916794|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916795|NCT02592915|Analgesics|analgesics|mesh-ancestor
138916796|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
138916797|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916798|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138916799|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
138916800|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
138568850|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
138916801|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138916802|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138916803|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138916804|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
138916805|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916806|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916807|NCT00727311|Ribavirin|ribavirin|mesh-list
138916808|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138916809|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
138916810|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
138916811|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916812|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
138916813|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916814|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
138916815|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916816|NCT00726999|Morphine|morphine|mesh-list
138916817|NCT00726999|Gabapentin|gabapentin|mesh-list
138916818|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138916819|NCT00726999|Narcotics|narcotics|mesh-ancestor
138916820|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916821|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916822|NCT00726999|Analgesics|analgesics|mesh-ancestor
138916823|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
138916824|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916825|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
138916826|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138916827|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138916828|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138916829|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138916830|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138916831|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916832|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916833|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
138916834|NCT00585351|Ranitidine|ranitidine|mesh-list
138916835|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138916836|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138916837|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138916838|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138916839|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
138574957|NCT00348985|Bortezomib|bortezomib|mesh-list
138916840|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
138916841|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916842|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916843|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916844|NCT00726609|Posaconazole|posaconazole|mesh-list
138916845|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
138916846|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138916847|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138916848|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138916849|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138916850|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138916851|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138916852|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916853|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916854|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138916855|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
138916856|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138916857|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916858|NCT00808028|Vaccines|vaccines|mesh-list
138916859|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
138916860|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916861|NCT03466346|Fluoxetine|fluoxetine|mesh-list
138916862|NCT03466346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138916863|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138916864|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575012|NCT04729140|Ivermectin|ivermectin|mesh-list
138916865|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916866|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916867|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
138916868|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433352|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
138916869|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138916870|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
138916871|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138916872|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138568925|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138916873|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138916874|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916875|NCT05754242|Ascorbic Acid|ascorbic acid|mesh-list
138916876|NCT05754242|Vitamins|vitamins|mesh-ancestor
138916877|NCT05754242|Micronutrients|micronutrients|mesh-ancestor
138916878|NCT05754242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916879|NCT05754242|Antioxidants|antioxidants|mesh-ancestor
138916880|NCT05754242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916881|NCT05754242|Protective Agents|protective agents|mesh-ancestor
138916882|NCT00809783|Tanezumab|tanezumab|mesh-list
138916883|NCT00809783|Analgesics|analgesics|mesh-ancestor
138916884|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
138916885|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916886|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916887|NCT05675462|Lenvatinib|lenvatinib|mesh-list
138916888|NCT05675462|Tislelizumab|tislelizumab|mesh-list
138916889|NCT05675462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916890|NCT05675462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138916891|NCT05675462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916892|NCT05675462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916893|NCT05675462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138916894|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
138916895|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138916896|NCT02608658|Antibodies|antibodies|mesh-list
138916897|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
138916898|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916899|NCT00807248|Gaboxadol|gaboxadol|mesh-list
138916900|NCT00807248|Dexetimide|dexetimide|mesh-list
138916901|NCT00807248|Citalopram|citalopram|mesh-list
138916902|NCT00807248|Escitalopram|escitalopram|mesh-list
138916903|NCT00807248|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138433403|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
138916904|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138916905|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138916906|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916907|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916908|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
138916909|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916910|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138916911|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138916912|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
138916913|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
138450834|NCT01872702|Artenimol|artenimol|mesh-list
138916914|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916915|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138916916|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138916917|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
138916918|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138916919|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
138916920|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138916921|NCT00807248|Analgesics|analgesics|mesh-ancestor
138916922|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
138916923|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
138916924|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
138916925|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
138916927|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138916928|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138916929|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
138916930|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
138916931|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
138916932|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916933|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138916934|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138916935|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575089|NCT00349726|Inositol|inositol|mesh-list
138916936|NCT05297669|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
138916937|NCT05297669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138916938|NCT05297669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138916939|NCT05297669|Analgesics|analgesics|mesh-ancestor
138916940|NCT05297669|Sensory System Agents|sensory system agents|mesh-ancestor
138916941|NCT05297669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916942|NCT05297669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916943|NCT05297669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138916944|NCT05297669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138916945|NCT00589628|Infliximab|infliximab|mesh-list
138916946|NCT00589628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138916947|NCT00589628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138569001|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138916949|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138916950|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138916951|NCT05754983|Immunomodulating Agents|immunomodulating agents|mesh-list
138916952|NCT05754983|Immunologic Factors|immunologic factors|mesh-ancestor
138916953|NCT05754983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916954|NCT00914576|Vitamins|vitamins|mesh-list
138916955|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
138916956|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916957|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
138916958|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138916959|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
138916960|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916961|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916962|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138916963|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
138916964|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138916965|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138916966|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138916967|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
138916968|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138916969|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916970|NCT02605772|Metformin|metformin|mesh-list
138916971|NCT02605772|Saxagliptin|saxagliptin|mesh-list
138916972|NCT02605772|Acarbose|acarbose|mesh-list
138916973|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138916974|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916975|NCT02605772|Incretins|incretins|mesh-ancestor
138916976|NCT02605772|Hormones|hormones|mesh-ancestor
138916977|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138916978|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138916979|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
138916980|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138916981|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916982|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138916983|NCT04115462|Morphine|morphine|mesh-list
138916984|NCT04115462|Histamine|histamine|mesh-list
138916985|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
138916986|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138916987|NCT04115462|Narcotics|narcotics|mesh-ancestor
138916988|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138916989|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138916990|NCT04115462|Analgesics|analgesics|mesh-ancestor
138916991|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
138916992|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138916993|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
138916994|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
138191986|NCT00957359|Niacin|niacin|mesh-list
138916996|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138916997|NCT02605460|Plerixafor|plerixafor|mesh-list
138916998|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
138916999|NCT02605460|Busulfan|busulfan|mesh-list
138917000|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138917001|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
138917002|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917003|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138917004|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138917005|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
138917006|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917007|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917008|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138917009|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138917010|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138917011|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
138917012|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917013|NCT00797108|Amoxicillin|amoxicillin|mesh-list
138917014|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
138917015|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
138917016|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
138917017|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138917018|NCT00797108|Lactams|lactams|mesh-list
138917019|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138917020|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917021|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138917022|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569080|NCT00092300|Valdecoxib|valdecoxib|mesh-list
138917023|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917025|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
138917026|NCT00742560|Lenalidomide|lenalidomide|mesh-list
138917027|NCT00742560|Elotuzumab|elotuzumab|mesh-list
138917028|NCT00742560|BB 1101|bb 1101|mesh-list
138917029|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138917030|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
138917031|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
138917032|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917033|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917034|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138917035|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
138917036|NCT00742560|Hormones|hormones|mesh-ancestor
138917037|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138917038|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138917039|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433581|NCT06176157|Ergocalciferols|ergocalciferols|mesh-list
138433582|NCT06176157|Cholecalciferol|cholecalciferol|mesh-list
138433583|NCT06176157|Vitamins|vitamins|mesh-list
138433584|NCT06176157|Micronutrients|micronutrients|mesh-ancestor
138433585|NCT06176157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433586|NCT06176157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138917040|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
138917041|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917042|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917043|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
138917044|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138917045|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138917046|NCT00742560|Growth Substances|growth substances|mesh-ancestor
138917047|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
138917048|NCT00796718|Capecitabine|capecitabine|mesh-list
138917049|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138917050|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
138917051|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917052|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917053|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
138917054|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138917055|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138917056|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
138917057|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917058|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138917059|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138917060|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917061|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917062|NCT04025840|Dexamethasone|dexamethasone|mesh-list
138917063|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
138917064|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138917065|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
138917066|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
138917067|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917068|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917069|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138917070|NCT04025840|Hormones|hormones|mesh-ancestor
138917071|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138917072|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138917073|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917075|NCT00589472|Leuprolide|leuprolide|mesh-list
138917076|NCT00589472|Goserelin|goserelin|mesh-list
138917077|NCT00589472|Bicalutamide|bicalutamide|mesh-list
138917078|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917079|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138917080|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917081|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917082|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138917083|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
138917084|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138917085|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917086|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138917087|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
138917088|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
138917089|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138917090|NCT02608931|Dronabinol|dronabinol|mesh-list
138917091|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
138917092|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917093|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138917094|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138917095|NCT02608931|Analgesics|analgesics|mesh-ancestor
138917096|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
138917097|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917098|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138917099|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138917100|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917101|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917102|NCT02608931|Hormones|hormones|mesh-ancestor
138917103|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138917104|NCT00744978|Varenicline|varenicline|mesh-list
138917105|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138917106|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138917107|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
138917108|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917109|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917110|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917111|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
138917112|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138917113|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
138709220|NCT04129086|Ketamine|ketamine|mesh-list
138917114|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917115|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
138917116|NCT02595606|Protective Agents|protective agents|mesh-ancestor
138917117|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
138917118|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
138917119|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138917120|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138917121|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
138917122|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917123|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917124|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917125|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917126|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138917127|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917128|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138917129|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138917130|NCT00739596|Amlodipine|amlodipine|mesh-list
138917131|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138917132|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138917133|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138917134|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138917135|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917136|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138917137|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917138|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
138917139|NCT00739596|Diuretics|diuretics|mesh-ancestor
138917140|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
138917141|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138917142|NCT00742326|Pioglitazone|pioglitazone|mesh-list
138917143|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138917144|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917146|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138917147|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
138917148|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917149|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917150|NCT00811187|Lidocaine|lidocaine|mesh-list
138917151|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
138917152|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
138917153|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138917154|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917155|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
138917156|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917157|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138917158|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138917159|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138917160|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138917161|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917162|NCT00917748|Docetaxel|docetaxel|mesh-list
138917163|NCT00917748|Modafinil|modafinil|mesh-list
138917164|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917165|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
138917166|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
138917167|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
138917168|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917169|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138917170|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917171|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138917172|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138917173|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138917174|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
138917175|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138917176|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917177|NCT00591149|Docetaxel|docetaxel|mesh-list
138917178|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
138917179|NCT00591149|Cetuximab|cetuximab|mesh-list
138917180|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917181|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
138917182|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
138917183|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
138917184|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917185|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138917186|NCT00735072|Maraviroc|maraviroc|mesh-list
138917187|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138917188|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138917189|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917190|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138575422|NCT00351715|Methadone|methadone|mesh-list
138917192|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
138917193|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917194|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138917195|NCT00793598|Brincidofovir|brincidofovir|mesh-list
138917196|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
138917197|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917198|NCT04115072|Praziquantel|praziquantel|mesh-list
138917199|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
138917200|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138917201|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917202|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
138917203|NCT00796562|Busulfan|busulfan|mesh-list
138917204|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138917205|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
138917206|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917207|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138917208|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138917209|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
138917210|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917211|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917212|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138917214|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
138575475|NCT00351910|Analgesics|analgesics|mesh-ancestor
138917215|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
138917216|NCT00801632|Rituximab|rituximab|mesh-list
138917217|NCT00801632|Tacrolimus|tacrolimus|mesh-list
138917218|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138917219|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
138917220|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917221|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138917222|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138917223|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
138917224|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917225|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917226|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138917227|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138917228|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138917229|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
138917231|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138917232|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138917233|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138917234|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917235|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
138917236|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
138917237|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917238|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138917239|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138917240|NCT00801632|Protective Agents|protective agents|mesh-ancestor
138917241|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
138917242|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138917243|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138917244|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
138917245|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575516|NCT00352300|Paclitaxel|paclitaxel|mesh-list
138917246|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917247|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138917248|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
138917249|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138917250|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
138917251|NCT04111484|Protective Agents|protective agents|mesh-ancestor
138917252|NCT04111328|Sufentanil|sufentanil|mesh-list
138917253|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
138917255|NCT04111328|Hydromorphone|hydromorphone|mesh-list
138917256|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138917257|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138917258|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917259|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138917260|NCT04111328|Analgesics|analgesics|mesh-ancestor
138917261|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
138917262|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917263|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138917264|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138917265|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138917266|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
138434029|NCT05656027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138917267|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917268|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917269|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138917270|NCT04111328|Narcotics|narcotics|mesh-ancestor
138917271|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138917272|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138917273|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
138917274|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
138917275|NCT00806819|Folic Acid|folic acid|mesh-list
138917276|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
138917277|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
138917278|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
138917279|NCT00806819|Dexamethasone|dexamethasone|mesh-list
138917280|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
138917281|NCT00806819|Pemetrexed|pemetrexed|mesh-list
138917282|NCT00806819|Nintedanib|nintedanib|mesh-list
138917283|NCT00806819|BB 1101|bb 1101|mesh-list
138917284|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138917285|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
138917286|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
138917287|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917288|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917289|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138917290|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
138917291|NCT00806819|Hormones|hormones|mesh-ancestor
138917292|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138917293|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138917294|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917295|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
138917296|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917297|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917298|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138917299|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138917300|NCT00806819|Hematinics|hematinics|mesh-ancestor
138917301|NCT00806819|Vitamins|vitamins|mesh-ancestor
138917302|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
138917303|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138917304|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
138917305|NCT04109534|Miotics|miotics|mesh-ancestor
138917306|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
138917307|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917308|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917309|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138917310|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138917311|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
138917312|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138917313|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138917314|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
138917315|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917316|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917317|NCT05326139|Tranexamic Acid|tranexamic acid|mesh-list
138917318|NCT05326139|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138917319|NCT05326139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138917320|NCT05326139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569381|NCT00093743|Cyclosporins|cyclosporins|mesh-list
138917321|NCT05326139|Hemostatics|hemostatics|mesh-ancestor
138917322|NCT05326139|Coagulants|coagulants|mesh-ancestor
138917323|NCT02605694|Prednisone|prednisone|mesh-list
138917324|NCT02605694|Rituximab|rituximab|mesh-list
138917325|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138917326|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917327|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
138917328|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917329|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138917330|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138917331|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
138917332|NCT02605694|Hormones|hormones|mesh-ancestor
138917333|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138917335|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
138917336|NCT02604134|Fluorides|fluorides|mesh-list
138917337|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
138917338|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
138917339|NCT02604134|Protective Agents|protective agents|mesh-ancestor
138450944|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138917340|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917341|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138917342|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917344|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138917345|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138917346|NCT00800540|Brinzolamide|brinzolamide|mesh-list
138917347|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138917348|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138917349|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138917350|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
138917351|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917352|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917353|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917354|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138917355|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138917356|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138917357|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138917358|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138917359|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138917360|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917361|NCT00796328|Phenylephrine|phenylephrine|mesh-list
138917362|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
138575710|NCT00112892|Irinotecan|irinotecan|mesh-list
138917363|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138917365|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
138917366|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917367|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917368|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
138917369|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138510546|NCT00062257|Irofulven|irofulven|mesh-list
138917370|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
138917371|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
138917372|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138917373|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138917374|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138434266|NCT05231629|Hormones|hormones|mesh-ancestor
138917375|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
138917376|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917377|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917378|NCT00796328|Protective Agents|protective agents|mesh-ancestor
138917379|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
138917380|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138917381|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138917382|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917383|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
138917384|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
138917385|NCT04110860|Voriconazole|voriconazole|mesh-list
138917386|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
138917387|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917388|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138917389|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138917390|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917391|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917392|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138917393|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
138917394|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138917395|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917396|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138917397|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
138917398|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138917399|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917401|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138917402|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
138917403|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917404|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917405|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138917406|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138917407|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
138917408|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138434311|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
138917409|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917410|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
138917411|NCT00915200|Silybin|silybin|mesh-list
138917412|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138917413|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
138917414|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917415|NCT00915200|Expectorants|expectorants|mesh-ancestor
138917416|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
138917417|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138917418|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
138917419|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917420|NCT00915200|Protective Agents|protective agents|mesh-ancestor
138917421|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917422|NCT00915200|Antidotes|antidotes|mesh-ancestor
138917423|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138917424|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917425|NCT00588146|Interferons|interferons|mesh-list
138917426|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
138917427|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
138917428|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138917429|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917430|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
138917431|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917432|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
138917433|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917434|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138917435|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
138917436|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917438|NCT00799058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138917439|NCT00799058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138917440|NCT00799058|Antiviral Agents|antiviral agents|mesh-ancestor
138917441|NCT00799058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917442|NCT00725985|Cladribine|cladribine|mesh-list
138917443|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917445|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
138917446|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917447|NCT00793910|Gabapentin|gabapentin|mesh-list
138917448|NCT00793910|Analgesics|analgesics|mesh-ancestor
138917449|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
138917450|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917451|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917452|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
138917453|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138917454|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138917455|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138917456|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138917457|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138917458|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138917459|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917460|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917461|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
138917462|NCT01019941|Docetaxel|docetaxel|mesh-list
138917463|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917464|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
138917465|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
138917466|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
138917467|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917468|NCT04113668|Diflunisal|diflunisal|mesh-list
138917469|NCT04113668|Deucravacitinib|deucravacitinib|mesh-list
138917470|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
138917471|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138917472|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917473|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917474|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138917476|NCT04113668|Analgesics|analgesics|mesh-ancestor
138917477|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
138917478|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917479|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434401|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
138434402|NCT05062044|Vitamins|vitamins|mesh-ancestor
138434403|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
138434404|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917480|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138917481|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138917482|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138917483|NCT00444145|Lansoprazole|lansoprazole|mesh-list
138917484|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138917485|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138917486|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138917487|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917488|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917489|NCT04107896|Tamsulosin|tamsulosin|mesh-list
138917490|NCT04107896|Silodosin|silodosin|mesh-list
138917491|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138917492|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138917493|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138917494|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
138917495|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917496|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917497|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917498|NCT04107896|Urological Agents|urological agents|mesh-ancestor
138917499|NCT01024777|Vitamin D|vitamin d|mesh-list
138917500|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
138917501|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
138917502|NCT01024777|Vitamins|vitamins|mesh-list
138917503|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
138709221|NCT04129086|Analgesics|analgesics|mesh-ancestor
138917504|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917505|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138917506|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138917507|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138917508|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
138917509|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138917510|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
138917511|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138917512|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138917513|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138917514|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138917515|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917516|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917517|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917518|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
138917519|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138917520|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138434455|NCT04965155|Hormones|hormones|mesh-ancestor
138917521|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138917522|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917523|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138917524|NCT00725205|Ribavirin|ribavirin|mesh-list
138917525|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138917526|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
138917527|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
138917528|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917529|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
138917530|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917531|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
138917532|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917533|NCT00443755|Metformin|metformin|mesh-list
138917534|NCT00443755|Pioglitazone|pioglitazone|mesh-list
138575909|NCT00444379|Ritonavir|ritonavir|mesh-list
138917535|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138917536|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917537|NCT00724971|Rituximab|rituximab|mesh-list
138917538|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138917539|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138917540|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917541|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
138917542|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917543|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138917544|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138917545|NCT00724971|Immunotoxins|immunotoxins|mesh-ancestor
138917546|NCT00724971|Immunoconjugates|immunoconjugates|mesh-ancestor
138917547|NCT00443599|Insulin|insulin|mesh-list
138917548|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138917549|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138917550|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917551|NCT04107428|Somatostatin|somatostatin|mesh-list
138917552|NCT04107428|Hormones|hormones|mesh-ancestor
138917553|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138917554|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917555|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
138917556|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138917557|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138917558|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917559|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138917560|NCT00455143|Analgesics|analgesics|mesh-ancestor
138917561|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
138917562|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917563|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138917564|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138917565|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138917566|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
138917567|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917568|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917569|NCT00724893|Interferons|interferons|mesh-list
138917570|NCT00724893|Ribavirin|ribavirin|mesh-list
138917571|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
138917572|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
138917573|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138917574|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917575|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
138917576|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917577|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
138917578|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917579|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
138917580|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917581|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138917582|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138917583|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
138917584|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138917585|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138917586|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138917587|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138917588|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917589|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138917590|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138917591|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138917592|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
138917593|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917594|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917595|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138917596|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138917597|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
138917598|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138917599|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138917600|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
138917601|NCT00724815|Sumatriptan|sumatriptan|mesh-list
138917602|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138917603|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138917604|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138917605|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
138575991|NCT05594121|Narcotics|narcotics|mesh-ancestor
138917606|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917607|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917608|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917610|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138917611|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138917612|NCT00798590|Hormones|hormones|mesh-ancestor
138917613|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138917614|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917615|NCT00798590|Incretins|incretins|mesh-ancestor
138917616|NCT00481195|Modafinil|modafinil|mesh-list
138917617|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138917618|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917619|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138917620|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138917621|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138917622|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917623|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
138917624|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917625|NCT01027429|Amoxicillin|amoxicillin|mesh-list
138917626|NCT01027429|Gentamicins|gentamicins|mesh-list
138917627|NCT01027429|Penicillins|penicillins|mesh-list
138917628|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
138917629|NCT01027429|Penicillin G|penicillin g|mesh-list
138917630|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138917631|NCT01027429|Procaine|procaine|mesh-list
138917632|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138917633|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917634|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138917635|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917636|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917637|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
138917639|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138917640|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917641|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
138917642|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917643|NCT01020253|Alendronate|alendronate|mesh-list
138917644|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
138917645|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138917646|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138917647|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917648|NCT01020253|Vitamins|vitamins|mesh-ancestor
138917649|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
138917650|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
138917651|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917652|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
138917653|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138917654|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138917655|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917656|NCT00454207|Urological Agents|urological agents|mesh-ancestor
138917657|NCT01020331|Memantine|memantine|mesh-list
138917658|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138917659|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138917660|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
138917661|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917662|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917663|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917664|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138917665|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138917666|NCT00738894|Dipyridamole|dipyridamole|mesh-list
138917667|NCT00738894|Clopidogrel|clopidogrel|mesh-list
138917668|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576064|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917669|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917670|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138917671|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917672|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138917673|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138917674|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138917675|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
138917676|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917677|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138917678|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
138917681|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138917682|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917683|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
138917684|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917685|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138917686|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917687|NCT02593734|Olanzapine|olanzapine|mesh-list
138917688|NCT02593734|Risperidone|risperidone|mesh-list
138917689|NCT02593734|Fluoxetine|fluoxetine|mesh-list
138917690|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138917691|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
138917692|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917693|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917694|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917695|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138917696|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138917697|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138569760|NCT01803594|Niacin|niacin|mesh-list
138917700|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
138917701|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
138917702|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
138917703|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917704|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138917705|NCT02593734|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138917706|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138451039|NCT05854849|Gemcitabine|gemcitabine|mesh-list
138917707|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138917708|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138917709|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
138917710|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138917711|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138917712|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917713|NCT00798434|Fesoterodine|fesoterodine|mesh-list
138917714|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138917715|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138917716|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
138917717|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917718|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917719|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917721|NCT04106804|Abatacept|abatacept|mesh-list
138917722|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138917723|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917724|NCT04106804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138917725|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917726|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138917727|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
138917728|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917729|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138917730|NCT00791648|Atorvastatin|atorvastatin|mesh-list
138917731|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138917732|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138917733|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
138917734|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917735|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138917736|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138917737|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917739|NCT05366595|Astringents|astringents|mesh-ancestor
138917740|NCT05366595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917741|NCT05366595|Dermatologic Agents|dermatologic agents|mesh-ancestor
138917742|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138917743|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
138917744|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917745|NCT04017338|Ezetimibe|ezetimibe|mesh-list
138917746|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138917747|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138917748|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
138917749|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917750|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138917751|NCT04106726|Ivermectin|ivermectin|mesh-list
138917752|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138917753|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917754|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
138917755|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138917756|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138917757|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917758|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138917759|NCT00723957|Paclitaxel|paclitaxel|mesh-list
138917760|NCT00723957|Carboplatin|carboplatin|mesh-list
138917761|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138917762|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917763|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
138917764|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
138917765|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
138917766|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917767|NCT02603822|Indomethacin|indomethacin|mesh-list
138917768|NCT02603822|Mannitol|mannitol|mesh-list
138917769|NCT02603822|Lactulose|lactulose|mesh-list
138917770|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138917771|NCT02603822|Diuretics|diuretics|mesh-ancestor
138917772|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
138917774|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138917775|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138917777|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
138917778|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917779|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138917780|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138917781|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
138917782|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
138917783|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138917784|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138917785|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917786|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917787|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138917788|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
138917789|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
138917790|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917791|NCT00723801|Losartan|losartan|mesh-list
138917792|NCT00723801|Atenolol|atenolol|mesh-list
138917793|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138917794|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138917795|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138917796|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138917797|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917798|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
138917799|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
138917800|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917801|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917802|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138917803|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138917804|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138917805|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
138917806|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917807|NCT00797966|Fluoxetine|fluoxetine|mesh-list
138917808|NCT00797966|Paroxetine|paroxetine|mesh-list
138917809|NCT00797966|Sertraline|sertraline|mesh-list
138917810|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138917811|NCT00797966|Escitalopram|escitalopram|mesh-list
138917812|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
138917813|NCT00797966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138917814|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138192748|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
138917815|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138917816|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917817|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917818|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
138917819|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917820|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138917821|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
138917822|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138917823|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138917824|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138917825|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917826|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138917827|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
138917828|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
138917829|NCT00723255|Sirolimus|sirolimus|mesh-list
138917830|NCT00723255|Bevacizumab|bevacizumab|mesh-list
138917831|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138917832|NCT00723255|Temsirolimus|temsirolimus|mesh-list
138917833|NCT00723255|MTOR Inhibitors|mtor inhibitors|mesh-list
138917834|NCT00723255|Antibodies|antibodies|mesh-list
138917835|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
138917836|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138917837|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917838|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138917839|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138917840|NCT00723255|Growth Substances|growth substances|mesh-ancestor
138917841|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917842|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
138917843|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
138917844|NCT00723255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138917845|NCT00723255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569905|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
138917846|NCT00723255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917847|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138917848|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138917849|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917850|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138917851|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
138917853|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138917854|NCT00791258|Olmesartan|olmesartan|mesh-list
138917855|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138917856|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138917857|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138917858|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138917859|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917860|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138917861|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917862|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
138917863|NCT00791258|Diuretics|diuretics|mesh-ancestor
138917864|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
138917865|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138917866|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138917867|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138917868|NCT00808067|Dabigatran|dabigatran|mesh-list
138917869|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
138917870|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138917871|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
138917872|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917873|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917874|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
138917875|NCT00723021|Zileuton|zileuton|mesh-list
138917876|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138917877|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138917878|NCT00723021|Analgesics|analgesics|mesh-ancestor
138917879|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
138576386|NCT00401856|Diuretics|diuretics|mesh-ancestor
138917880|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917881|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917882|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138917883|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138917884|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138917885|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917886|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917887|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138917888|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
138917889|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138917890|NCT04309409|Nivolumab|nivolumab|mesh-list
138917891|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138917892|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435033|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
138917893|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138917894|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917895|NCT04086537|Hepcidins|hepcidins|mesh-list
138917896|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917897|NCT02608619|Choline|choline|mesh-list
138917898|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
138917899|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138917900|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
138917901|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917902|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138917903|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138917905|NCT02591667|Bevacizumab|bevacizumab|mesh-list
138917906|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138917907|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917908|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138917909|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138917910|NCT02591667|Growth Substances|growth substances|mesh-ancestor
138917911|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917912|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
138917913|NCT00807599|Dexamethasone|dexamethasone|mesh-list
138917914|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
138917915|NCT00807599|Lenalidomide|lenalidomide|mesh-list
138917916|NCT00807599|Melphalan|melphalan|mesh-list
138917917|NCT00807599|BB 1101|bb 1101|mesh-list
138917918|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138917919|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
138917920|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
138917921|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917922|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917923|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138435091|NCT03169972|BAX 855|bax 855|mesh-list
138917924|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
138917925|NCT00807599|Hormones|hormones|mesh-ancestor
138917926|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138917927|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138917928|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917929|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
138917930|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138917931|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917932|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
138917933|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138917934|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138917936|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
138917937|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138917938|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
138917939|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138917940|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138917941|NCT00788372|Fentanyl|fentanyl|mesh-list
138917942|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138917943|NCT00788372|Narcotics|narcotics|mesh-ancestor
138917944|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138917945|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917946|NCT00788372|Analgesics|analgesics|mesh-ancestor
138917947|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
138917948|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917949|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138917950|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138917951|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
138917952|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
138917953|NCT00738582|Pemetrexed|pemetrexed|mesh-list
138917954|NCT00738582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138917955|NCT00738582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435130|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138917956|NCT00738582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917957|NCT00738582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138917958|NCT00738582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138917959|NCT05753657|Pioglitazone|pioglitazone|mesh-list
138917960|NCT05753657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138917961|NCT05753657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917962|NCT00720759|Cycloserine|cycloserine|mesh-list
138917963|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138917964|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917965|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138917966|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
138917967|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138451075|NCT05854082|Lidocaine|lidocaine|mesh-list
138917968|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
138917969|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917970|NCT00918411|Ramosetron|ramosetron|mesh-list
138917971|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
138917972|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
138917973|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917974|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917975|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138917976|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138917977|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
138917978|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138917979|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917980|NCT00810407|Rifabutin|rifabutin|mesh-list
138917981|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138917982|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138917983|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138917984|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
138917985|NCT00720057|Naproxen|naproxen|mesh-list
138917986|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138917987|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138917988|NCT00720057|Analgesics|analgesics|mesh-ancestor
138917989|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
138917990|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138917991|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138917992|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138917993|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138917994|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
138917995|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138917997|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138917998|NCT00790868|Cycloserine|cycloserine|mesh-list
138917999|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138918000|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918001|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138918002|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
138918003|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138918004|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
138435167|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918005|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918006|NCT00719901|Bortezomib|bortezomib|mesh-list
138918007|NCT00719901|Obatoclax|obatoclax|mesh-list
138918008|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918009|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576609|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138918010|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918011|NCT02603276|Red yeast rice|red yeast rice|mesh-list
138918012|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138918013|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138918014|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138918015|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
138918016|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918017|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918018|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138918019|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138918020|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
138918021|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918022|NCT00807365|Hormones|hormones|mesh-list
138918023|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
138918024|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918025|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918026|NCT02609711|Candesartan|candesartan|mesh-list
138918027|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
138918028|NCT02609711|Atorvastatin|atorvastatin|mesh-list
138918029|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138918030|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138918031|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
138918032|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918033|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138918034|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138918035|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918036|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138435196|NCT02531854|Pemetrexed|pemetrexed|mesh-list
138918037|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138918038|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138918039|NCT04016207|Guanfacine|guanfacine|mesh-list
138918040|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138918041|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138918042|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138918043|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138918044|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
138918045|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576665|NCT00450736|Celecoxib|celecoxib|mesh-list
138918046|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918047|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918049|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138918050|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
138918051|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138918052|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918053|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
138918054|NCT00734604|Tadalafil|tadalafil|mesh-list
138918055|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918056|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
138918057|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138918058|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138918059|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918060|NCT00734604|Urological Agents|urological agents|mesh-ancestor
138918061|NCT00590681|Bevacizumab|bevacizumab|mesh-list
138918062|NCT00590681|Temozolomide|temozolomide|mesh-list
138918063|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138918064|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918065|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138918066|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138918067|NCT00590681|Growth Substances|growth substances|mesh-ancestor
138570143|NCT00130884|Simendan|simendan|mesh-list
138435231|NCT01950520|Pindolol|pindolol|mesh-list
138918068|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918069|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
138918070|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138918071|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
138918072|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918073|NCT00727272|Quinine|quinine|mesh-list
138918074|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
138918075|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138918076|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138918077|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918078|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138918079|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918080|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138918081|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918082|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138918083|NCT00727272|Analgesics|analgesics|mesh-ancestor
138918084|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
138918085|NCT02609477|Phentermine|phentermine|mesh-list
138918086|NCT02609477|Istradefylline|istradefylline|mesh-list
138918087|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138918088|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918089|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
138918090|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138918091|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
138918092|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
138918093|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918094|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
138918095|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918096|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918097|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138918098|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138918099|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138918100|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
138918101|NCT02592720|Tenecteplase|tenecteplase|mesh-list
138918102|NCT02592720|Tirofiban|tirofiban|mesh-list
138918103|NCT02592720|Bivalirudin|bivalirudin|mesh-list
138918104|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138918105|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138918106|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918107|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
138918108|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138918109|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
138918110|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918111|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
138918112|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138918113|NCT02608073|Capecitabine|capecitabine|mesh-list
138918114|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918115|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138918116|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
138918117|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918118|NCT04041791|Amoxicillin|amoxicillin|mesh-list
138918119|NCT04041791|Gentamicins|gentamicins|mesh-list
138918120|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
138918121|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
138918122|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
138918123|NCT04041791|Penicillins|penicillins|mesh-list
138918124|NCT04041791|Ampicillin|ampicillin|mesh-list
138918125|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138918126|NCT04041791|Penicillin G|penicillin g|mesh-list
138918127|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138918128|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
138918129|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138918130|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918131|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138576793|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138918132|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918133|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918134|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138918135|NCT02605226|Bicalutamide|bicalutamide|mesh-list
138918136|NCT02605226|Hormones|hormones|mesh-list
138918137|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138918138|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918139|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918140|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
138918141|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
138918142|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918143|NCT04088448|Metformin|metformin|mesh-list
138918144|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138918145|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918146|NCT00806351|Caspofungin|caspofungin|mesh-list
138918147|NCT00806351|Anidulafungin|anidulafungin|mesh-list
138918148|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
138918149|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918150|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918151|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918152|NCT03995251|Testosterone|testosterone|mesh-list
138918153|NCT03995251|Androgens|androgens|mesh-ancestor
138918154|NCT03995251|Hormones|hormones|mesh-ancestor
138918155|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918156|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918157|NCT01031017|Progesterone|progesterone|mesh-list
138918158|NCT01031017|Progestins|progestins|mesh-ancestor
138918159|NCT01031017|Hormones|hormones|mesh-ancestor
138918160|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918161|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918162|NCT03742531|Oxytocin|oxytocin|mesh-list
138918163|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
138918164|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138918165|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918167|NCT00733902|Analgesics|analgesics|mesh-ancestor
138918168|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
138918169|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918170|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918171|NCT05737355|Red yeast rice|red yeast rice|mesh-list
138918172|NCT05737355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138918173|NCT05737355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138918174|NCT05737355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138918175|NCT05737355|Antimetabolites|antimetabolites|mesh-ancestor
138918176|NCT05737355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918177|NCT05737355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918178|NCT05737355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138918179|NCT03540017|Cisplatin|cisplatin|mesh-list
138918180|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918181|NCT02606981|Vitamins|vitamins|mesh-list
138918182|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
138918183|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
138918184|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918185|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
138918186|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918187|NCT02606981|Protective Agents|protective agents|mesh-ancestor
138918188|NCT00914888|Metronidazole|metronidazole|mesh-list
138918189|NCT00914888|Clarithromycin|clarithromycin|mesh-list
138918190|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
138918191|NCT00914888|Tigecycline|tigecycline|mesh-list
138918192|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435412|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138435413|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138435414|NCT00217737|Growth Substances|growth substances|mesh-ancestor
138435416|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
138918193|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138918194|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138918195|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138918196|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138918197|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918198|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918199|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138918200|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138918201|NCT02603198|Epinephrine|epinephrine|mesh-list
138918202|NCT02603198|Nordefrin|nordefrin|mesh-list
138918203|NCT02603198|Anesthetics|anesthetics|mesh-list
138918204|NCT02603198|Mepivacaine|mepivacaine|mesh-list
138918205|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138918206|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918207|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138918208|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138918209|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
138918210|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918211|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918212|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138918213|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138918214|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
138918215|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918216|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138918217|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
138918218|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
138918219|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
138918220|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138918221|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
138918222|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
138918223|NCT00719043|Vaccines|vaccines|mesh-list
138918224|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
138918225|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918226|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
138918227|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138918228|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
138918229|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138918230|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
138918231|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918232|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918233|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
138918234|NCT00718887|Entecavir|entecavir|mesh-list
138918235|NCT00718887|Adefovir|adefovir|mesh-list
138918236|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
138918237|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918238|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138918239|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138918240|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918241|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918242|NCT00786188|Paroxetine|paroxetine|mesh-list
138918243|NCT00786188|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138918244|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138918245|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138576978|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
138918246|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918247|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918248|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
138918249|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918250|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138918251|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
138918252|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138918253|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138918254|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138918255|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918256|NCT00733824|Plerixafor|plerixafor|mesh-list
138918257|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138918258|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138918259|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
138918260|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918261|NCT00718809|Saracatinib|saracatinib|mesh-list
138918262|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918263|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918264|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918265|NCT00585039|Albuterol|albuterol|mesh-list
138918266|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138918267|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
138918268|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918269|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918270|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138918271|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
138918272|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
138918273|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138918274|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138918275|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138918276|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138918277|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
138918279|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918280|NCT04085913|Lidocaine|lidocaine|mesh-list
138918281|NCT04085913|Epinephrine|epinephrine|mesh-list
138918282|NCT04085913|Racepinephrine|racepinephrine|mesh-list
138918283|NCT04085913|Bupivacaine|bupivacaine|mesh-list
138918284|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
138918285|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
138918286|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
138918287|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138918288|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918289|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
138918290|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918291|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138918292|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138918293|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138570357|NCT00433069|Ribavirin|ribavirin|mesh-list
138918294|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138918295|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918296|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138918297|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138918298|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
138918299|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918300|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138918301|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138918302|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
138918303|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138918304|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
138918305|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
138918306|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
138918307|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138918308|NCT00806195|Vaccines|vaccines|mesh-list
138918309|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138577069|NCT00461422|Ganirelix|ganirelix|mesh-list
138918310|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
138918311|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918312|NCT05728151|Epinephrine|epinephrine|mesh-list
138918313|NCT05728151|Levobupivacaine|levobupivacaine|mesh-list
138918314|NCT05728151|Carticaine|carticaine|mesh-list
138918315|NCT05728151|Mepivacaine|mepivacaine|mesh-list
138918316|NCT05728151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138918317|NCT05728151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138918318|NCT05728151|Adrenergic Agents|adrenergic agents|mesh-ancestor
138918319|NCT05728151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918320|NCT05728151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918321|NCT05728151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918322|NCT05728151|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138918323|NCT05728151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138918324|NCT05728151|Autonomic Agents|autonomic agents|mesh-ancestor
138918325|NCT05728151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918326|NCT05728151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138510561|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918327|NCT05728151|Respiratory System Agents|respiratory system agents|mesh-ancestor
138918328|NCT05728151|Mydriatics|mydriatics|mesh-ancestor
138918329|NCT05728151|Sympathomimetics|sympathomimetics|mesh-ancestor
138918330|NCT05728151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138918331|NCT05728151|Anesthetics, Local|anesthetics, local|mesh-ancestor
138918332|NCT05728151|Anesthetics|anesthetics|mesh-ancestor
138918333|NCT05728151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138918334|NCT05728151|Sensory System Agents|sensory system agents|mesh-ancestor
138918335|NCT00733746|Gemcitabine|gemcitabine|mesh-list
138918336|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138918337|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138918338|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
138918339|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918340|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918341|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138918342|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918343|NCT03422705|Lisinopril|lisinopril|mesh-list
138918344|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138918345|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
138918346|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918347|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918348|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138918349|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138918350|NCT03422705|Protective Agents|protective agents|mesh-ancestor
138918351|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918352|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138918353|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138918354|NCT02607293|Hormones|hormones|mesh-ancestor
138918355|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918356|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918357|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
138918358|NCT02607371|Apixaban|apixaban|mesh-list
138918359|NCT02607371|Edoxaban|edoxaban|mesh-list
138918360|NCT02607371|Dabigatran|dabigatran|mesh-list
138918361|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138918362|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
138918363|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138918364|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
138918365|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918366|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918367|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
138918368|NCT04085757|Dinoprostone|dinoprostone|mesh-list
138918369|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
138918370|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138918371|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918372|NCT00727194|Eculizumab|eculizumab|mesh-list
138918373|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138918374|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138918375|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
138918376|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918377|NCT00717093|Varenicline|varenicline|mesh-list
138918378|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138918379|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138918380|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
138918381|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918382|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918383|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918384|NCT00716859|Timolol|timolol|mesh-list
138918385|NCT00716859|Latanoprost|latanoprost|mesh-list
138918386|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138918387|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138918388|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
138918389|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435665|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918390|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918391|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918392|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138918393|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138918394|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138918395|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138918397|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138918398|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138918399|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
138918400|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918401|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138918402|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138918403|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918404|NCT00589667|Gemcitabine|gemcitabine|mesh-list
138918405|NCT00589667|Pemetrexed|pemetrexed|mesh-list
138918406|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138918407|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
138918408|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577349|NCT00463957|Tadalafil|tadalafil|mesh-list
138918409|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918410|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918411|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138918412|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138918413|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138918414|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138918415|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138918416|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918417|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918418|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
138918419|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918420|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138918421|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138435715|NCT01752322|Lidocaine|lidocaine|mesh-list
138918422|NCT05752799|Analgesics, Opioid|analgesics, opioid|mesh-list
138918423|NCT05752799|Anesthetics|anesthetics|mesh-list
138918424|NCT05752799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138918425|NCT05752799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918426|NCT05752799|Narcotics|narcotics|mesh-ancestor
138918427|NCT05752799|Analgesics|analgesics|mesh-ancestor
138918428|NCT05752799|Sensory System Agents|sensory system agents|mesh-ancestor
138918429|NCT05752799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918431|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
138918432|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138918433|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
138918434|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918435|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918436|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138918437|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
138918438|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
138577389|NCT00116493|Folic Acid|folic acid|mesh-list
138918439|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138918440|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
138918441|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918442|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918443|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
138918444|NCT00732498|Cytarabine|cytarabine|mesh-list
138918445|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
138918446|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138918447|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138918448|NCT00732498|Prednisolone|prednisolone|mesh-list
138918449|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
138918450|NCT00732498|Rituximab|rituximab|mesh-list
138918451|NCT00732498|Etoposide|etoposide|mesh-list
138435754|NCT01752790|Azathioprine|azathioprine|mesh-list
138918452|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138918453|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138918454|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
138918455|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138918456|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918457|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
138918458|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918459|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138918460|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138918461|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138918462|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138918463|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918464|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918465|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138918466|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
138918467|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
138918468|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918469|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138918470|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138918471|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
138918472|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
138918473|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918474|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138918476|NCT00732498|Hormones|hormones|mesh-ancestor
138918477|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918478|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138918479|NCT00732498|Protective Agents|protective agents|mesh-ancestor
138918480|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138918482|NCT00790400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138918483|NCT00790400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138918484|NCT00790400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918485|NCT00790400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918486|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138918487|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
138918488|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918489|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918490|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138918491|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138918492|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138918493|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138918494|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918495|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138918496|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138918497|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138918498|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
138918499|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918500|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918501|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138918502|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138918503|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
138918504|NCT02602652|Vaccines|vaccines|mesh-list
138918505|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
138918506|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918507|NCT02593500|Budesonide|budesonide|mesh-list
138918508|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138918509|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138918510|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
138918511|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918512|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918513|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138918514|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
138918515|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
138918516|NCT02593500|Hormones|hormones|mesh-ancestor
138918517|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918518|NCT02594358|Caffeine|caffeine|mesh-list
138918519|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138918520|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918521|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138918522|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918523|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918524|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138918525|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138918526|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
138918527|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918528|NCT00785486|Quinine|quinine|mesh-list
138918529|NCT00785486|Midazolam|midazolam|mesh-list
138918530|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138918531|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138918532|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138918533|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918534|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138918535|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138918536|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138918537|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138918538|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
138918539|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
138918540|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
138918541|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
138918542|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918543|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918544|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
138451173|NCT05736952|Topotecan|topotecan|mesh-list
138918545|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138918546|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138918547|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918548|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138918549|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138435888|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138918550|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918551|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138918552|NCT00785486|Analgesics|analgesics|mesh-ancestor
138918553|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
138918554|NCT00917904|Dapivirine|dapivirine|mesh-list
138918555|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138918556|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138918557|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
138918558|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918559|NCT00589979|Lidocaine|lidocaine|mesh-list
138918560|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
138918561|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
138918562|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138918563|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918564|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
138918565|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918566|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138918567|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138918568|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138918569|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138918570|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918571|NCT02590653|Atorvastatin|atorvastatin|mesh-list
138918572|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138918573|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138918574|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
138918575|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918576|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138918577|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138918578|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918579|NCT00915746|Ketoconazole|ketoconazole|mesh-list
138918580|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
138918581|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918582|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138918583|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138577546|NCT00116727|Etanercept|etanercept|mesh-list
138918584|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918585|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918586|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138918587|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
138918588|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918589|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918590|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138918591|NCT00736944|Cisplatin|cisplatin|mesh-list
138918592|NCT00736944|Cetuximab|cetuximab|mesh-list
138918593|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138918594|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918595|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138918596|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
138918597|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138918598|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918599|NCT04084977|Antibodies|antibodies|mesh-list
138918600|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
138918601|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918602|NCT04107194|Amoxicillin|amoxicillin|mesh-list
138918603|NCT04107194|Metronidazole|metronidazole|mesh-list
138918604|NCT04107194|Clarithromycin|clarithromycin|mesh-list
138918605|NCT04107194|Levofloxacin|levofloxacin|mesh-list
138918606|NCT04107194|Tetracycline|tetracycline|mesh-list
138918607|NCT04107194|Rifabutin|rifabutin|mesh-list
138918608|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138918609|NCT04107194|Pantoprazole|pantoprazole|mesh-list
138918610|NCT04107194|Bismuth|bismuth|mesh-list
138918611|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138918612|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918613|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138918614|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138918615|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138918616|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918617|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918618|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138436029|NCT01755299|Caffeine|caffeine|mesh-list
138918619|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138918620|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138918621|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138918622|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138918624|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138918625|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138918626|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138918627|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138918629|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138918630|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
138918631|NCT02590263|Temozolomide|temozolomide|mesh-list
138918632|NCT02590263|ABT-414|abt-414|mesh-list
138918633|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138918634|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
138918635|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918636|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918637|NCT02590263|Immunoconjugates|immunoconjugates|mesh-ancestor
138918638|NCT02590263|Immunologic Factors|immunologic factors|mesh-ancestor
138918639|NCT02590263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918640|NCT00736476|Vaccines|vaccines|mesh-list
138918641|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
138918642|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918643|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
138918644|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138577636|NCT03270553|Metformin|metformin|mesh-list
138918645|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918646|NCT04019496|Calcitonin|calcitonin|mesh-list
138918647|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
138918648|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138918649|NCT04019496|Antibodies|antibodies|mesh-list
138918650|NCT04019496|Katacalcin|katacalcin|mesh-list
138918651|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
138918652|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436082|NCT01755494|Metformin|metformin|mesh-list
138918653|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138918654|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138918655|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
138918656|NCT00918489|Vorinostat|vorinostat|mesh-list
138918657|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918658|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138918659|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918660|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918661|NCT02604992|Dronabinol|dronabinol|mesh-list
138918662|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
138918663|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918664|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138918665|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138918666|NCT02604992|Analgesics|analgesics|mesh-ancestor
138918667|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
138918668|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918669|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138918670|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138918672|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918674|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918675|NCT03899597|Oxytocin|oxytocin|mesh-list
138918676|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
138918677|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138918678|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918679|NCT00714285|Vaccines|vaccines|mesh-list
138918680|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
138436135|NCT01755572|Hormones|hormones|mesh-ancestor
138918681|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918682|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
138918683|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138918684|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
138918685|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918686|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918687|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138918688|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
138918689|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
138918690|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138918691|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
138918692|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918693|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918694|NCT04015557|Acetaminophen|acetaminophen|mesh-list
138918695|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
138918696|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138918697|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138918698|NCT04015557|Analgesics|analgesics|mesh-ancestor
138918699|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
138918700|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918701|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918702|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
138918703|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
138918704|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918705|NCT04015557|Expectorants|expectorants|mesh-ancestor
138918706|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
138918707|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138918708|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
138709222|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
138577733|NCT00475072|Ribavirin|ribavirin|mesh-list
138918709|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918710|NCT04015557|Protective Agents|protective agents|mesh-ancestor
138918711|NCT04015557|Antidotes|antidotes|mesh-ancestor
138918712|NCT00784784|Zanamivir|zanamivir|mesh-list
138918713|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
138918714|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918715|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918716|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918717|NCT00587288|Reslizumab|reslizumab|mesh-list
138918718|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138918719|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
138918720|NCT00800735|Interferons|interferons|mesh-list
138918721|NCT00800735|Ribavirin|ribavirin|mesh-list
138918722|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
138918723|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
138918724|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138918725|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918726|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
138918727|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918728|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
138918729|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918730|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
138436227|NCT01756183|Paclitaxel|paclitaxel|mesh-list
138918731|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918732|NCT05324163|Celecoxib|celecoxib|mesh-list
138918733|NCT05324163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138918734|NCT05324163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138918735|NCT05324163|Analgesics|analgesics|mesh-ancestor
138918737|NCT05324163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918738|NCT05324163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918739|NCT05324163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138918740|NCT05324163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138918741|NCT05324163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138918742|NCT05324163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138918743|NCT05324163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918744|NCT05324163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918745|NCT00730158|Irinotecan|irinotecan|mesh-list
138918746|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138918747|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138918748|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918749|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918750|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918752|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
138918753|NCT04114643|Coagulants|coagulants|mesh-ancestor
138918754|NCT02989662|Mifepristone|mifepristone|mesh-list
138918755|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138918756|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
138918757|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138918758|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918759|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138436272|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
138436273|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
138918761|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138918762|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
138918763|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138918764|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138918765|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
138918766|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918767|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
138918768|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138918769|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138918770|NCT00784550|Fluticasone|fluticasone|mesh-list
138918771|NCT00784550|Xhance|xhance|mesh-list
138918772|NCT00784550|Bromides|bromides|mesh-list
138918773|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
138918774|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138918775|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138918776|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138918777|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
138918778|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918779|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918780|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138918781|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
138918782|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
138918783|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138918784|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
138918785|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138918786|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
138918787|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918788|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918789|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138918790|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138918791|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138918792|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
138918793|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
138918795|NCT00729690|Analgesics|analgesics|mesh-ancestor
138918796|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
138918797|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918798|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918799|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
138918800|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138918801|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138918802|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918803|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138918804|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138918805|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138918806|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138918807|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138918808|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
138918809|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138918810|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138918811|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918812|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138918813|NCT04027829|Analgesics|analgesics|mesh-ancestor
138918814|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
138918815|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918816|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138918817|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138918818|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138918819|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
138918820|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918821|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918822|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138918823|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138918824|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138918825|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138918826|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918827|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138918828|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138918829|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138918830|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
138918831|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918832|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918833|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138918834|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138918835|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
138918837|NCT00729612|Carboplatin|carboplatin|mesh-list
138918838|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138918839|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138918840|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918841|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
138918842|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
138918843|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
138918844|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918845|NCT05684913|Hemostatics|hemostatics|mesh-list
138918846|NCT05684913|Coagulants|coagulants|mesh-ancestor
138918847|NCT00585546|Clenbuterol|clenbuterol|mesh-list
138918848|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138918849|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138918850|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
138918851|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918852|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918853|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918854|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138918855|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
138918856|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918857|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138918858|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
138918859|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
138918860|NCT00768248|Ropivacaine|ropivacaine|mesh-list
138918861|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
138918862|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
138918863|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138918864|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918865|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
138918866|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918867|NCT02589717|Atezolizumab|atezolizumab|mesh-list
138918868|NCT02589717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138918869|NCT02589717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918870|NCT02589717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138918871|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918872|NCT02602028|Colchicine|colchicine|mesh-list
138918873|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
138918874|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138918875|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
138918876|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
138918877|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
138918878|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918879|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918880|NCT04103684|Dexamethasone|dexamethasone|mesh-list
138918881|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
138918882|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138918883|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138918884|NCT04103684|Prednisolone|prednisolone|mesh-list
138918885|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
138918886|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138918887|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
138918888|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138918889|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
138918890|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
138918891|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918892|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918893|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138918894|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
138918895|NCT04103684|Hormones|hormones|mesh-ancestor
138571023|NCT00132444|UC-781|uc-781|mesh-list
138918896|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918897|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138918898|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918899|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138918900|NCT04103684|Protective Agents|protective agents|mesh-ancestor
138918901|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138918902|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138918903|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918904|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
138918905|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138918906|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138918907|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
138918908|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138918909|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918910|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138918911|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138918912|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138918913|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138918914|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138918915|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138918916|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138918917|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918918|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918919|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918920|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
138918921|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138918922|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
138918923|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918925|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138918927|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138918928|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918929|NCT00439309|Thrombin|thrombin|mesh-list
138918930|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
138918931|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
138918932|NCT00439309|Coagulants|coagulants|mesh-ancestor
138918933|NCT00479167|Bortezomib|bortezomib|mesh-list
138918934|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
138918935|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918936|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
138918937|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138918938|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138918939|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138918940|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138918941|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918942|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
138918943|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918944|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918945|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138918946|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918947|NCT00725010|Temozolomide|temozolomide|mesh-list
138578009|NCT00117767|Terbinafine|terbinafine|mesh-list
138918948|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138918949|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
138918950|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918951|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918952|NCT05216055|Dexamethasone|dexamethasone|mesh-list
138918953|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
138918954|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
138918955|NCT05216055|Bupivacaine|bupivacaine|mesh-list
138918956|NCT05216055|Ropivacaine|ropivacaine|mesh-list
138918957|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138918958|NCT05216055|BB 1101|bb 1101|mesh-list
138918959|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138918960|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
138918961|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
138918962|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138918963|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918964|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138918965|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
138918966|NCT05216055|Hormones|hormones|mesh-ancestor
138918967|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138918968|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138918969|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138918970|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
138918971|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
138918972|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138918973|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
138918974|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138918975|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138918976|NCT05216055|Analgesics|analgesics|mesh-ancestor
138918977|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138918978|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138918979|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138918980|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
138918981|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138918982|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138918983|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
138918984|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138918985|NCT00767000|Metformin|metformin|mesh-list
138918986|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
138918987|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138436562|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138918988|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918989|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138918990|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138918991|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138918992|NCT00724932|Atropine|atropine|mesh-list
138918993|NCT00724932|Bromides|bromides|mesh-list
138918994|NCT00724932|Rocuronium|rocuronium|mesh-list
138918995|NCT00724932|Neostigmine|neostigmine|mesh-list
138918996|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
138918997|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138918998|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138919000|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919001|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919002|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138919003|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138919004|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138919005|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
138919006|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138919007|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
138919008|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
138919009|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
138919010|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138919011|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138919012|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
138919013|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919014|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919015|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138919016|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919017|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138919018|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138919019|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138919020|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919021|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919022|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138919023|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
138919024|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138919025|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919026|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138919028|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
138919029|NCT04083807|Coagulants|coagulants|mesh-ancestor
138919030|NCT05163483|Bevacizumab|bevacizumab|mesh-list
138919031|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138919032|NCT05163483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138919033|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919034|NCT05163483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138919035|NCT05163483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138919036|NCT05163483|Growth Substances|growth substances|mesh-ancestor
138919037|NCT05163483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919038|NCT05163483|Growth Inhibitors|growth inhibitors|mesh-ancestor
138919039|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919040|NCT00766142|Leucovorin|leucovorin|mesh-list
138919041|NCT00766142|Fluorouracil|fluorouracil|mesh-list
138919042|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
138919043|NCT00766142|Cetuximab|cetuximab|mesh-list
138919044|NCT00766142|Calcium|calcium|mesh-list
138919045|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
138919046|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138919047|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919048|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
138919049|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919050|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138919051|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919052|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138919053|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
138919054|NCT00766142|Antidotes|antidotes|mesh-ancestor
138919055|NCT00766142|Protective Agents|protective agents|mesh-ancestor
138919056|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
138919058|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
138919059|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138919060|NCT00916526|Mannitol|mannitol|mesh-list
138919061|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138919062|NCT00916526|Diuretics|diuretics|mesh-ancestor
138578199|NCT00478543|Furosemide|furosemide|mesh-list
138919063|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
138919064|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919065|NCT00724854|Ribavirin|ribavirin|mesh-list
138919066|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138919067|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
138919068|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
138919069|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919070|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
138919071|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919072|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
138919073|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919074|NCT04083651|Bromides|bromides|mesh-list
138919075|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
138919076|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
138919077|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138919078|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919079|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
138919080|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919082|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138919083|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138919084|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
138919085|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919086|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138919087|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138919088|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919089|NCT04087746|Ranibizumab|ranibizumab|mesh-list
138919090|NCT04087746|Aflibercept|aflibercept|mesh-list
138919091|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138919092|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138919093|NCT04087746|Growth Substances|growth substances|mesh-ancestor
138919094|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919095|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
138919096|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919097|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138919098|NCT04083417|Penicillins|penicillins|mesh-list
138919099|NCT04083417|Penicillin V|penicillin v|mesh-list
138919100|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919101|NCT02588937|Entecavir|entecavir|mesh-list
138919102|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
138919103|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919104|NCT04083105|Midazolam|midazolam|mesh-list
138919105|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
138919106|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138436680|NCT01758380|Vildagliptin|vildagliptin|mesh-list
138919107|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138919108|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138919109|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919110|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138919111|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138919112|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138919113|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138919114|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
138919115|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
138919116|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
138919117|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
138919118|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919119|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919120|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138919121|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138919122|NCT04083105|Analgesics|analgesics|mesh-ancestor
138919123|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
138919124|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919126|NCT00735696|Carboplatin|carboplatin|mesh-list
138919127|NCT00735696|Ramucirumab|ramucirumab|mesh-list
138919128|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138919129|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919130|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
138919131|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
138919132|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
138919133|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919135|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919136|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
138919137|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919138|NCT02588547|Granisetron|granisetron|mesh-list
138919139|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
138919140|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
138919141|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919142|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919143|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138919144|NCT02588547|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138919145|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138919146|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
138919147|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919148|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919149|NCT00478231|Maraviroc|maraviroc|mesh-list
138919150|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138919151|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138194106|NCT01455506|Busulfan|busulfan|mesh-list
138919152|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919153|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138919154|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138919155|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
138919156|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919157|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138919158|NCT00474175|Benzocaine|benzocaine|mesh-list
138919159|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
138919160|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
138919161|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138919162|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919163|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
138919164|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919165|NCT03002389|Fluticasone|fluticasone|mesh-list
138919166|NCT03002389|Xhance|xhance|mesh-list
138919167|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138919168|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138919169|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
138578329|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919170|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919171|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919172|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138919173|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
138919174|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
138919175|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138919176|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138919177|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
138919178|NCT04082949|Coagulants|coagulants|mesh-ancestor
138919180|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138919181|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138919182|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919183|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138919184|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
138919185|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
138919186|NCT03537391|Fluorides|fluorides|mesh-list
138919187|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
138919188|NCT03537391|Protective Agents|protective agents|mesh-ancestor
138919189|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451285|NCT05528198|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138919190|NCT04082715|Celecoxib|celecoxib|mesh-list
138919191|NCT04082715|Levodopa|levodopa|mesh-list
138919192|NCT04082715|Carbidopa|carbidopa|mesh-list
138919193|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138919194|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138919195|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138919196|NCT04082715|Analgesics|analgesics|mesh-ancestor
138919197|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
138578373|NCT00480142|Oxycodone|oxycodone|mesh-list
138919198|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919199|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919200|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138919201|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138919202|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138919203|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138919204|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919205|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919206|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138919207|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138919208|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
138919209|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919210|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138919211|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138919212|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
138919213|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
138919214|NCT00443209|Rizatriptan|rizatriptan|mesh-list
138919215|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138919216|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
138919217|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919218|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919219|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919220|NCT02588235|Atorvastatin|atorvastatin|mesh-list
138919221|NCT02588235|Ezetimibe|ezetimibe|mesh-list
138919222|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138919223|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138919224|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
138919225|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919226|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138919227|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138919229|NCT01020955|Mecasermin|mecasermin|mesh-list
138919230|NCT01020955|Growth Substances|growth substances|mesh-ancestor
138919231|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919232|NCT04082793|Diclofenac|diclofenac|mesh-list
138770256|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
138919233|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138919234|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138919235|NCT04082793|Analgesics|analgesics|mesh-ancestor
138919236|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
138919237|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919238|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919240|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138919241|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138919242|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919243|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919244|NCT00439231|Lenalidomide|lenalidomide|mesh-list
138919245|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
138919246|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919247|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138919248|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138919249|NCT00439231|Growth Substances|growth substances|mesh-ancestor
138919250|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
138919251|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919252|NCT00783692|Vedolizumab|vedolizumab|mesh-list
138919253|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138919254|NCT04992273|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
138919255|NCT04992273|Antiviral Agents|antiviral agents|mesh-ancestor
138919256|NCT04992273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919257|NCT00783224|Fluticasone|fluticasone|mesh-list
138919258|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
138919259|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138919260|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138919261|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
138919262|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919263|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919264|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138919265|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
138919266|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
138919267|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138919268|NCT04102124|Fluzoparib|fluzoparib|mesh-list
138919269|NCT04102124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138919270|NCT04102124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919271|NCT04102124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919272|NCT04102124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919273|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138919274|NCT04082559|Metronidazole|metronidazole|mesh-list
138919275|NCT04082559|Doxycycline|doxycycline|mesh-list
138571338|NCT00101894|Panitumumab|panitumumab|mesh-list
138919276|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
138919277|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138919278|NCT04082559|Complement Factor H|complement factor h|mesh-list
138919279|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919280|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
138919281|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138919282|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138919283|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
138919284|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138919285|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138919286|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919287|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919288|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919289|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138919290|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138919291|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138919292|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138919293|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
138919294|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919295|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
138919296|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138919297|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138919298|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919299|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
138919300|NCT02587845|Coagulants|coagulants|mesh-ancestor
138919301|NCT00765674|Amlodipine|amlodipine|mesh-list
138919303|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138919304|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138919305|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138919306|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919307|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138919308|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919309|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
138919310|NCT00765674|Diuretics|diuretics|mesh-ancestor
138919311|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
138919312|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138919313|NCT00586898|Ketoconazole|ketoconazole|mesh-list
138919314|NCT00586898|Bicalutamide|bicalutamide|mesh-list
138919315|NCT00586898|Testosterone|testosterone|mesh-list
138919316|NCT00586898|Estrogens|estrogens|mesh-list
138919317|NCT00586898|Androgens|androgens|mesh-ancestor
138919318|NCT00586898|Hormones|hormones|mesh-ancestor
138919319|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138919320|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919321|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919322|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
138919323|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919324|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138919325|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138919326|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919327|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919328|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138919330|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138919331|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
138919332|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
138919333|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138919334|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919335|NCT02587455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138919336|NCT02587455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919337|NCT04099238|Warfarin|warfarin|mesh-list
138919338|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
138919339|NCT04099238|Dabigatran|dabigatran|mesh-list
138919340|NCT04099238|Apixaban|apixaban|mesh-list
138919341|NCT04099238|Anticoagulants|anticoagulants|mesh-list
138919342|NCT04099238|Edoxaban|edoxaban|mesh-list
138919343|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
138919344|NCT04099238|Phenindione|phenindione|mesh-list
138919345|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138919346|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
138919347|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138919348|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
138919349|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919350|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919351|NCT04101812|Doxorubicin|doxorubicin|mesh-list
138919352|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138578582|NCT00481273|Azacitidine|azacitidine|mesh-list
138919353|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138919354|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919355|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138436948|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
138919356|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138919357|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919358|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919359|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138919360|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138919361|NCT04923867|Estradiol|estradiol|mesh-list
138919362|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138919363|NCT04923867|Estrogens|estrogens|mesh-ancestor
138919364|NCT04923867|Hormones|hormones|mesh-ancestor
138919365|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138919366|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919367|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138919368|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
138919369|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138919370|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138919371|NCT02587533|Dopamine|dopamine|mesh-list
138919372|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138919373|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
138919374|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
138919375|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919376|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919378|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919379|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919380|NCT02587533|Protective Agents|protective agents|mesh-ancestor
138919381|NCT04847661|Mefloquine|mefloquine|mesh-list
138578650|NCT00481819|Tacrolimus|tacrolimus|mesh-list
138919382|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
138919383|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138919384|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138919385|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919386|NCT00919815|Cyclosporine|cyclosporine|mesh-list
138919387|NCT00919815|Prednisolone|prednisolone|mesh-list
138919388|NCT00919815|Cyclosporins|cyclosporins|mesh-list
138436985|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436986|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436987|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
138436988|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436989|NCT01760174|Bupivacaine|bupivacaine|mesh-list
138436990|NCT01760174|Ropivacaine|ropivacaine|mesh-list
138436991|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
138436992|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
138436993|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436994|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436995|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
138436996|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138337081|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138376396|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238122|NCT06096779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138238129|NCT06094010|Baloxavir|baloxavir|mesh-list
138919389|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919390|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919391|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138919392|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
138919393|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919394|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
138919395|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578685|NCT00481975|Hormones|hormones|mesh-ancestor
138919397|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138919398|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138437035|NCT01760252|Capecitabine|capecitabine|mesh-list
138919399|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138437036|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
138437037|NCT01760252|Irinotecan|irinotecan|mesh-list
138437038|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138437039|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
138437040|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437041|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437042|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138437043|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138437044|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437045|NCT01760278|Cetrorelix|cetrorelix|mesh-list
138919400|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
138919401|NCT00919815|Hormones|hormones|mesh-ancestor
138919402|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138919403|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138919404|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919405|NCT00796991|Paclitaxel|paclitaxel|mesh-list
138919406|NCT00796991|Carboplatin|carboplatin|mesh-list
138919407|NCT00796991|Ipilimumab|ipilimumab|mesh-list
138919408|NCT00796991|Dacarbazine|dacarbazine|mesh-list
138919409|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138919410|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919411|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
138919412|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
138919413|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
138919414|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919415|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138919416|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138919417|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138919418|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
138919419|NCT04112147|Ubiquinone|ubiquinone|mesh-list
138919420|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
138919421|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919422|NCT00914771|Vaccines|vaccines|mesh-list
138919423|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
138919424|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919426|NCT02586987|Tremelimumab|tremelimumab|mesh-list
138919427|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138571492|NCT00135954|Hormones|hormones|mesh-ancestor
138919428|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919429|NCT02586753|Paclitaxel|paclitaxel|mesh-list
138919430|NCT02586753|Cisplatin|cisplatin|mesh-list
138404581|NCT01573663|Dipropizine|dipropizine|mesh-list
138919431|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138919432|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919433|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
138919434|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
138919435|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
138919436|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919437|NCT00799487|Methylphenidate|methylphenidate|mesh-list
138919438|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138919439|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919440|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138919441|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138919442|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138919443|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919444|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
138919445|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919446|NCT00799409|Methylphenidate|methylphenidate|mesh-list
138919447|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138919448|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919449|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138194389|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138919451|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709223|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919452|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919453|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
138919454|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919456|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138919457|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
138919458|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919459|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919460|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138919461|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
138919462|NCT01558115|Denosumab|denosumab|mesh-list
138919463|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138919464|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919465|NCT02605265|Capecitabine|capecitabine|mesh-list
138919466|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
138919467|NCT02605265|Irinotecan|irinotecan|mesh-list
138919468|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138919469|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
138919470|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919471|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919472|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138919473|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138919474|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919475|NCT04101500|Aminophylline|aminophylline|mesh-list
138919476|NCT04101500|Bromides|bromides|mesh-list
138919477|NCT04101500|Ipratropium|ipratropium|mesh-list
138919478|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
138919479|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138919480|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
138919481|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919482|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919483|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138919484|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
138919485|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138919486|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
138919487|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919488|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919489|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138919490|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138919491|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919492|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138919493|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138919494|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
138919495|NCT04101500|Protective Agents|protective agents|mesh-ancestor
138919496|NCT02586441|Bromides|bromides|mesh-list
138919497|NCT02586441|Propofol|propofol|mesh-list
138919498|NCT02586441|Rocuronium|rocuronium|mesh-list
138919499|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138919500|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138919501|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919502|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138919503|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
138919504|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
138919505|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
138919506|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138919507|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138919508|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138919509|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919510|NCT02586363|Entecavir|entecavir|mesh-list
138919511|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
138919512|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919513|NCT02586129|Metformin|metformin|mesh-list
138919514|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138919515|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138919516|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919517|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138919518|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138919519|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
138919520|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919521|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138919522|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138919523|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919524|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
138919525|NCT04081077|Linezolid|linezolid|mesh-list
138919526|NCT04081077|Bedaquiline|bedaquiline|mesh-list
138919527|NCT04081077|Clofazimine|clofazimine|mesh-list
138451377|NCT05221229|Liraglutide|liraglutide|mesh-list
138919528|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138919529|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919530|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138919531|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138919532|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919533|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919534|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919535|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138919536|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
138919537|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138919538|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
138919540|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
138919541|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138919542|NCT02586051|Antibodies|antibodies|mesh-list
138919543|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
138919544|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138919545|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
138919546|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919547|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138919548|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919549|NCT00763958|Buprenorphine|buprenorphine|mesh-list
138919550|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138919551|NCT00763958|Narcotics|narcotics|mesh-ancestor
138919552|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138919553|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919554|NCT00763958|Analgesics|analgesics|mesh-ancestor
138919555|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
138919556|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919557|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138919558|NCT04101578|Cyclosporine|cyclosporine|mesh-list
138919559|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
138437251|NCT01761201|Levofloxacin|levofloxacin|mesh-list
138919560|NCT04101578|Prednisone|prednisone|mesh-list
138919561|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
138919562|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
138919563|NCT04101578|Methotrexate|methotrexate|mesh-list
138919564|NCT04101578|Azathioprine|azathioprine|mesh-list
138919565|NCT04101578|Bromides|bromides|mesh-list
138919566|NCT04101578|Tacrolimus|tacrolimus|mesh-list
138919567|NCT04101578|Cyclosporins|cyclosporins|mesh-list
138919568|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138919569|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
138919570|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138919571|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
138919572|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138919573|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138919574|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
138919575|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919576|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138919577|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138919578|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
138919579|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919580|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919581|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138919582|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138919583|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
138919585|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138919586|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138919587|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138919588|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
138919589|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138919590|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138919591|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
138451414|NCT05047952|Vortioxetine|vortioxetine|mesh-list
138919592|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
138919593|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919594|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138919595|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138919596|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138919597|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
138919598|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919599|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138919600|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138919601|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
138919602|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138919604|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
138919605|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919606|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138919607|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138919609|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
138919610|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138919611|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
138919612|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919613|NCT00763256|Triclosan|triclosan|mesh-list
138919614|NCT00763256|Fluorides|fluorides|mesh-list
138919615|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
138919616|NCT00763256|Protective Agents|protective agents|mesh-ancestor
138919617|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919618|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138919619|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919620|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138919621|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138919622|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
138919623|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919624|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138919625|NCT02585973|Cisplatin|cisplatin|mesh-list
138919626|NCT02585973|Adavosertib|adavosertib|mesh-list
138919627|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919628|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919629|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919630|NCT00920283|Cobalt|cobalt|mesh-list
138919631|NCT00920283|Trace Elements|trace elements|mesh-ancestor
138919632|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
138919633|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919634|NCT00583947|Albuterol|albuterol|mesh-list
138919635|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
138919636|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138919637|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
138919638|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437334|NCT01761656|Atorvastatin|atorvastatin|mesh-list
138919639|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919640|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138919641|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
138919642|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
138919643|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138919644|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138919645|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138919646|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138919647|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
138919648|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919649|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919650|NCT00772928|Vaccines|vaccines|mesh-list
138919651|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138919652|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
138919653|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919654|NCT00762164|Simvastatin|simvastatin|mesh-list
138919655|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138571704|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
138919656|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138919657|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138919658|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
138919659|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919660|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138709224|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919661|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138919662|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919664|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
138919665|NCT04080375|Dinoprostone|dinoprostone|mesh-list
138919666|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
138919667|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138919668|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919669|NCT00781274|Ribavirin|ribavirin|mesh-list
138919670|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138919671|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
138919672|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919673|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
138919674|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919675|NCT05520177|Ranibizumab|ranibizumab|mesh-list
138919676|NCT05520177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138919677|NCT05520177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138919678|NCT05520177|Growth Substances|growth substances|mesh-ancestor
138919679|NCT05520177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919680|NCT05520177|Growth Inhibitors|growth inhibitors|mesh-ancestor
138919681|NCT05520177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919683|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138919684|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
138919685|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
138919686|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919687|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
138919688|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919689|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
138919690|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919691|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
138919692|NCT02584881|Narcotics|narcotics|mesh-ancestor
138919693|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138919694|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919695|NCT02584881|Analgesics|analgesics|mesh-ancestor
138919696|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
138919697|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919698|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138919699|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
138919700|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919701|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138919702|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138919703|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919704|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919705|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919706|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138919707|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138919708|NCT00761306|Vortioxetine|vortioxetine|mesh-list
138919709|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
138919710|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138919711|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138919712|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138919713|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138919714|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919715|NCT00761306|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138919716|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138919717|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138919718|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919719|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919720|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
138919721|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138919722|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138919723|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138919724|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138919725|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
138919726|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138919727|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
138919728|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919729|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437445|NCT01762319|Pyridoxal|pyridoxal|mesh-list
138919730|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138919731|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
138919732|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
138919733|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138919734|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
138919735|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919736|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919738|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138919739|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
138919740|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138919741|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919742|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138919743|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919744|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138919745|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138919746|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138919747|NCT00761150|Acetaminophen|acetaminophen|mesh-list
138919748|NCT00761150|Hydrocodone|hydrocodone|mesh-list
138919749|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138919750|NCT00761150|Analgesics|analgesics|mesh-ancestor
138919751|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
138919752|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919753|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919754|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
138919755|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138919756|NCT00761150|Narcotics|narcotics|mesh-ancestor
138919757|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138919758|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
138919759|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
138919760|NCT00583557|Belimumab|belimumab|mesh-list
138919761|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138919762|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
138919763|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919764|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
138919765|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138919766|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138919767|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919768|NCT00760838|Azithromycin|azithromycin|mesh-list
138919769|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138919770|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919771|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
138919772|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138919773|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138919774|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138919775|NCT02584335|Lidocaine|lidocaine|mesh-list
138919776|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138919777|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
138919779|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138919780|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919781|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
138919782|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919783|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138919784|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138919785|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138919786|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138919787|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919788|NCT00437281|Pregabalin|pregabalin|mesh-list
138919789|NCT00437281|Analgesics|analgesics|mesh-ancestor
138919790|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
138919791|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919792|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919794|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138919795|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138919796|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919797|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138919798|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138919799|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138919800|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138571855|NCT00103805|Levodopa|levodopa|mesh-list
138919802|NCT04544007|Poly ICLC|poly iclc|mesh-list
138919803|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
138919804|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
138919805|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919806|NCT05468073|Aldesleukin|aldesleukin|mesh-list
138919807|NCT05468073|Interleukin-2|interleukin-2|mesh-list
138919808|NCT05468073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919809|NCT05468073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138437619|NCT01762995|Calcium|calcium|mesh-list
138919810|NCT05468073|Analgesics|analgesics|mesh-ancestor
138919811|NCT05468073|Sensory System Agents|sensory system agents|mesh-ancestor
138919812|NCT05468073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919813|NCT05468073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919814|NCT05468073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138919815|NCT05468073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138919816|NCT05468073|Antiviral Agents|antiviral agents|mesh-ancestor
138919817|NCT05468073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919818|NCT05674695|Omalizumab|omalizumab|mesh-list
138919819|NCT05674695|Cyclosporine|cyclosporine|mesh-list
138919820|NCT05674695|Methotrexate|methotrexate|mesh-list
138919821|NCT05674695|Upadacitinib|upadacitinib|mesh-list
138919823|NCT05674695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138919824|NCT05674695|Abortifacient Agents|abortifacient agents|mesh-ancestor
138919825|NCT05674695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138919826|NCT05674695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919827|NCT05674695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138919828|NCT05674695|Antimetabolites|antimetabolites|mesh-ancestor
138919829|NCT05674695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919830|NCT05674695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919831|NCT05674695|Dermatologic Agents|dermatologic agents|mesh-ancestor
138919832|NCT05674695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919833|NCT05674695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138919834|NCT05674695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138919835|NCT05674695|Immunologic Factors|immunologic factors|mesh-ancestor
138919836|NCT05674695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138919837|NCT05674695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138919838|NCT05674695|Antifungal Agents|antifungal agents|mesh-ancestor
138919839|NCT05674695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919840|NCT05674695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138919841|NCT05674695|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138919842|NCT05674695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138919843|NCT05674695|Respiratory System Agents|respiratory system agents|mesh-ancestor
138919844|NCT05674695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138919845|NCT05674695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138919847|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138919848|NCT02596269|Analgesics|analgesics|mesh-ancestor
138919849|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
138919850|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919851|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919852|NCT00741039|Vaccines|vaccines|mesh-list
138919853|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138919854|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
138919855|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919856|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138919857|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138919858|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919860|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138919861|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919862|NCT04078659|Lidocaine|lidocaine|mesh-list
138919863|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
138919864|NCT04078659|Fentanyl|fentanyl|mesh-list
138919865|NCT04078659|Propofol|propofol|mesh-list
138919866|NCT04078659|Atracurium|atracurium|mesh-list
138919867|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
138919868|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
138919869|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138571903|NCT00136734|Methylphenidate|methylphenidate|mesh-list
138919870|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919871|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
138919872|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919873|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138919874|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138919875|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138919876|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138919877|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919878|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138919879|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138919880|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
138919881|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138919883|NCT04078659|Analgesics|analgesics|mesh-ancestor
138919884|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138919885|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
138919886|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138919887|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138919888|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
138919889|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138919890|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138919891|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138919892|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138919893|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138919894|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138919895|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
138919896|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919897|NCT02583243|Buprenorphine|buprenorphine|mesh-list
138919898|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138919899|NCT02583243|Narcotics|narcotics|mesh-ancestor
138919900|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138919901|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919902|NCT02583243|Analgesics|analgesics|mesh-ancestor
138919903|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
138919904|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919905|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138919906|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138919907|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138919908|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138919909|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138919910|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919911|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919912|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919913|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
138919914|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138919915|NCT00760214|Ramipril|ramipril|mesh-list
138919916|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138919917|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138919918|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
138919919|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919920|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919921|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138919922|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138919923|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138919924|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138919925|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
138919926|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138919927|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919928|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138919930|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
138919931|NCT00638391|Anastrozole|anastrozole|mesh-list
138919932|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138919933|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919934|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138919935|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138919936|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919937|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919938|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138919939|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
138919940|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138919941|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919942|NCT02583633|Nifedipine|nifedipine|mesh-list
138919943|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
138919944|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138437765|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
138919945|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138919946|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919947|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138919948|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919949|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
138919950|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
138919951|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138919952|NCT02582307|Acetaminophen|acetaminophen|mesh-list
138919953|NCT02582307|Scopolamine|scopolamine|mesh-list
138919954|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
138919956|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138919957|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
138919958|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138919959|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919960|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
138919961|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138919962|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
138919963|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
138919965|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
138919966|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138919967|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
138919968|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138919969|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919970|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138919971|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
138919972|NCT02689245|Tenofovir|tenofovir|mesh-list
138919973|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
138919974|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919975|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138919976|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138919977|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919978|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919979|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138919980|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138437814|NCT01764451|Simvastatin|simvastatin|mesh-list
138919981|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
138919982|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138919983|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138919984|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138919985|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919986|NCT00772148|Tacrolimus|tacrolimus|mesh-list
138919987|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138919988|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
138919989|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138919990|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138437849|NCT01764581|Tacrolimus|tacrolimus|mesh-list
138919991|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579365|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138919992|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138919993|NCT02689089|Rifapentine|rifapentine|mesh-list
138919994|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138919995|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
138919996|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138919997|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138919998|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
138919999|NCT00759902|Morphine|morphine|mesh-list
138920000|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138920001|NCT00759902|Narcotics|narcotics|mesh-ancestor
138920002|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138920003|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920004|NCT00759902|Analgesics|analgesics|mesh-ancestor
138920005|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
138920006|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920007|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
138920008|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
138920009|NCT04077957|Etanercept|etanercept|mesh-list
138920010|NCT04077957|Methotrexate|methotrexate|mesh-list
138920011|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138920012|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
138920013|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138920014|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920015|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138920016|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
138920017|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920018|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920019|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
138920020|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920021|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138920022|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138920023|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
138920024|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138920025|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138920026|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
138920027|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138920028|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138920029|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920030|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138920031|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138920032|NCT04077957|Analgesics|analgesics|mesh-ancestor
138920033|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
138920034|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920035|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138920036|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138920037|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
138920038|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920039|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138920040|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
138920041|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
138920042|NCT04102670|Protective Agents|protective agents|mesh-ancestor
138451487|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138920043|NCT04114097|Betamethasone|betamethasone|mesh-list
138920044|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
138920045|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138920046|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
138920048|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138920049|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138920050|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
138920051|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920052|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138920053|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920054|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920055|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138920056|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
138920057|NCT04114097|Hormones|hormones|mesh-ancestor
138920058|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138920059|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138920060|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
138920061|NCT00772070|Vaccines|vaccines|mesh-list
138920062|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
138920063|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920064|NCT00796757|Interferons|interferons|mesh-list
138438019|NCT01765738|Rifampin|rifampin|mesh-list
138920065|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
138920066|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
138920067|NCT00796757|Bevacizumab|bevacizumab|mesh-list
138920068|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138920069|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920070|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138920071|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138920072|NCT00796757|Growth Substances|growth substances|mesh-ancestor
138920073|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920074|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
138920075|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
138920076|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920077|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
138920078|NCT00759356|Morphine|morphine|mesh-list
138920079|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138920080|NCT00759356|Narcotics|narcotics|mesh-ancestor
138920081|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138920082|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920083|NCT00759356|Analgesics|analgesics|mesh-ancestor
138920084|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
138920085|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920086|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138920087|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138920088|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920089|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920090|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138920091|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709225|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138920092|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920093|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
138920094|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920095|NCT04102592|Permethrin|permethrin|mesh-list
138920096|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920097|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920098|NCT04113551|Guanfacine|guanfacine|mesh-list
138572131|NCT00137358|Amifostine|amifostine|mesh-list
138920100|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138920101|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138920102|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138920103|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138920104|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920105|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
138920106|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920107|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920108|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138920109|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138920110|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
138920111|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138920112|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138920113|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138920114|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138920115|NCT00798317|Plasminogen|plasminogen|mesh-list
138920116|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138920117|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138920118|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920119|NCT00771914|Aspirin|aspirin|mesh-list
138920120|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138920121|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138920122|NCT00771914|Analgesics|analgesics|mesh-ancestor
138920123|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
138920124|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579534|NCT01242631|Everolimus|everolimus|mesh-list
138920125|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920126|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138920127|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138920128|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138920129|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138920130|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920131|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138920132|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138920133|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920134|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
138920135|NCT00779324|Amantadine|amantadine|mesh-list
138920136|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138920137|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138920138|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
138920139|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920140|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
138920141|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920142|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920143|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920144|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138920145|NCT00779324|Analgesics|analgesics|mesh-ancestor
138920146|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
138920147|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920148|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
138920149|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138920150|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138438158|NCT01766375|Cyclosporine|cyclosporine|mesh-list
138920151|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579575|NCT00122018|Expectorants|expectorants|mesh-ancestor
138920152|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
138920153|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
138920154|NCT02581761|Misoprostol|misoprostol|mesh-list
138920155|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138920156|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
138920157|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138920158|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920159|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138920160|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138920161|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
138920162|NCT00771758|Oxycodone|oxycodone|mesh-list
138920163|NCT00771758|Tapentadol|tapentadol|mesh-list
138920164|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138920165|NCT00771758|Narcotics|narcotics|mesh-ancestor
138920166|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138920167|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920168|NCT00771758|Analgesics|analgesics|mesh-ancestor
138920169|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
138920170|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920171|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138920172|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138920173|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138920174|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920175|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
138920176|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920177|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
138920178|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138920179|NCT02581371|Protective Agents|protective agents|mesh-ancestor
138920180|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920181|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
138920182|NCT02688465|Apomorphine|apomorphine|mesh-list
138920183|NCT02688465|Emetics|emetics|mesh-ancestor
138920184|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920185|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
138920186|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920187|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138920188|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
138920189|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
138920190|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920191|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920192|NCT00758498|Modafinil|modafinil|mesh-list
138920194|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920195|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138920196|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138920197|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138920198|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920200|NCT00798161|Linagliptin|linagliptin|mesh-list
138920201|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138920202|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920203|NCT00798161|Incretins|incretins|mesh-ancestor
138920204|NCT00798161|Hormones|hormones|mesh-ancestor
138451532|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
138920212|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
138920213|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
138920214|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138920215|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920216|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
138920217|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920218|NCT02581683|Analgesics|analgesics|mesh-ancestor
138920219|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138920220|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
138920221|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138920222|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138920223|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920224|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138920225|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
138920226|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138920234|NCT04076709|Anesthetics|anesthetics|mesh-list
138920235|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138920236|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920237|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
138920238|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138920239|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138920240|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920241|NCT04115423|Adalimumab|adalimumab|mesh-list
138920242|NCT04115423|Infliximab|infliximab|mesh-list
138920243|NCT04115423|Golimumab|golimumab|mesh-list
138920244|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
138920245|NCT04115423|Etanercept|etanercept|mesh-list
138920246|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138920247|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138920248|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
138920249|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138920250|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138920251|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138920253|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
138920254|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920255|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920256|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138920257|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
138920258|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138920259|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
138920260|NCT04113005|Coagulants|coagulants|mesh-ancestor
138920261|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138920262|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
138920263|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920264|NCT00588341|Temozolomide|temozolomide|mesh-list
138920265|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138920266|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
138920267|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451555|NCT04720326|Tacrolimus|tacrolimus|mesh-list
138920268|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920269|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138920271|NCT00914693|Femovan|femovan|mesh-list
138920272|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138920273|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138920274|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138920275|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
138920276|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138920277|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920278|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138920279|NCT00914693|Estrogens|estrogens|mesh-ancestor
138920280|NCT00914693|Hormones|hormones|mesh-ancestor
138920281|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138920282|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138920283|NCT00914693|Progestins|progestins|mesh-ancestor
138920284|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138920285|NCT00915083|Amrubicin|amrubicin|mesh-list
138920286|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920287|NCT00802529|Gentamicins|gentamicins|mesh-list
138920288|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
138920289|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138920290|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138920291|NCT00802529|Prednisolone|prednisolone|mesh-list
138920292|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
138920293|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138920294|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
138920295|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138920296|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
138920297|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
138920298|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438251|NCT01767090|Leuprolide|leuprolide|mesh-list
138920299|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920300|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138920301|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
138920302|NCT00802529|Hormones|hormones|mesh-ancestor
138920303|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138920304|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138920305|NCT00802529|Protective Agents|protective agents|mesh-ancestor
138920306|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138920307|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920308|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138920309|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920310|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138920311|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920312|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920313|NCT02605811|Temozolomide|temozolomide|mesh-list
138920314|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138920315|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
138920316|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920317|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920318|NCT00758264|Vaccines|vaccines|mesh-list
138920319|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138572355|NCT00434824|Hormones|hormones|mesh-ancestor
138920320|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
138920321|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920322|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
138920323|NCT04027517|Hematinics|hematinics|mesh-ancestor
138920324|NCT00588731|Cannabidiol|cannabidiol|mesh-list
138920325|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
138920326|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
138920327|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
138920328|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920330|NCT05629949|Trastuzumab|trastuzumab|mesh-list
138920331|NCT05629949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920332|NCT05629949|Tubulin Modulators|tubulin modulators|mesh-ancestor
138920333|NCT05629949|Antimitotic Agents|antimitotic agents|mesh-ancestor
138920334|NCT05629949|Mitosis Modulators|mitosis modulators|mesh-ancestor
138920335|NCT05629949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920336|NCT05629949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138920337|NCT05628233|Azasetron|azasetron|mesh-list
138920338|NCT05628233|Antiemetics|antiemetics|mesh-ancestor
138920339|NCT05628233|Autonomic Agents|autonomic agents|mesh-ancestor
138195287|NCT05586620|Mitomycins|mitomycins|mesh-list
138920340|NCT05628233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920341|NCT05628233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920342|NCT05628233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138920343|NCT05628233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138920344|NCT05628233|Serotonin Agents|serotonin agents|mesh-ancestor
138920345|NCT05628233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920346|NCT05628233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920347|NCT04109261|Palbociclib|palbociclib|mesh-list
138920348|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920349|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138920350|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920351|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920352|NCT04109339|Oxytocin|oxytocin|mesh-list
138920353|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
138920354|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138920355|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920356|NCT00757172|Docetaxel|docetaxel|mesh-list
138920357|NCT00757172|Panitumumab|panitumumab|mesh-list
138920358|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920359|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
138920360|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
138920361|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
138920362|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920363|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138920364|NCT00797225|Leuprolide|leuprolide|mesh-list
138920365|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138920366|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
138920367|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138920368|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579833|NCT00492388|Ketamine|ketamine|mesh-list
138920369|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138438316|NCT01767454|Ipilimumab|ipilimumab|mesh-list
138920370|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920371|NCT05277285|Sodium thiosulfate|sodium thiosulfate|mesh-list
138920372|NCT05277285|Antidotes|antidotes|mesh-ancestor
138920373|NCT05277285|Protective Agents|protective agents|mesh-ancestor
138920374|NCT05277285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920375|NCT05277285|Antioxidants|antioxidants|mesh-ancestor
138920376|NCT05277285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920377|NCT05277285|Antitubercular Agents|antitubercular agents|mesh-ancestor
138920378|NCT05277285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138920379|NCT05277285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451580|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
138920380|NCT05277285|Chelating Agents|chelating agents|mesh-ancestor
138920381|NCT05277285|Sequestering Agents|sequestering agents|mesh-ancestor
138920382|NCT04110665|Acetaminophen|acetaminophen|mesh-list
138920383|NCT04110665|Morphine|morphine|mesh-list
138920384|NCT04110665|Oxycodone|oxycodone|mesh-list
138920385|NCT04110665|Tramadol|tramadol|mesh-list
138920386|NCT04110665|Nefopam|nefopam|mesh-list
138920387|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138920388|NCT04110665|Narcotics|narcotics|mesh-ancestor
138920389|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138920390|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920391|NCT04110665|Analgesics|analgesics|mesh-ancestor
138920392|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
138920393|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920394|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138920395|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
138920396|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138920397|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
138920398|NCT00638859|Telithromycin|telithromycin|mesh-list
138920399|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138920400|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920401|NCT02537847|Ertapenem|ertapenem|mesh-list
138920402|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
138920403|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
138920404|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138920405|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920406|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138920407|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920408|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920409|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138920410|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138920411|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920412|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
138920413|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138920414|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920415|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920416|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138920417|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138920418|NCT02687841|Protective Agents|protective agents|mesh-ancestor
138920419|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920420|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
138920421|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138920422|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
138920423|NCT00778622|Metformin|metformin|mesh-list
138920424|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138920425|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920426|NCT00777920|Ambrisentan|ambrisentan|mesh-list
138920427|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138920428|NCT04236141|Rituximab|rituximab|mesh-list
138920429|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138920430|NCT04236141|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138920431|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138920432|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920433|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
138920434|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920435|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138438396|NCT01768078|Hormones|hormones|mesh-ancestor
138438401|NCT01768182|Leucovorin|leucovorin|mesh-list
138920436|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138920437|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
138920438|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920439|NCT04236141|Immunoconjugates|immunoconjugates|mesh-ancestor
138920440|NCT04097444|Leucovorin|leucovorin|mesh-list
138920441|NCT04097444|Bevacizumab|bevacizumab|mesh-list
138920442|NCT04097444|Capecitabine|capecitabine|mesh-list
138920443|NCT04097444|Fluorouracil|fluorouracil|mesh-list
138920444|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
138920445|NCT04097444|Irinotecan|irinotecan|mesh-list
138920446|NCT04097444|Calcium|calcium|mesh-list
138920447|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
138920448|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138920449|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920450|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138920451|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138920452|NCT04097444|Growth Substances|growth substances|mesh-ancestor
138920453|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920454|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
138920455|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138920456|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138920457|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
138920458|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920459|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138920460|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
138920461|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138920462|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138920463|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920464|NCT04097444|Antidotes|antidotes|mesh-ancestor
138920465|NCT04097444|Protective Agents|protective agents|mesh-ancestor
138920466|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
138920467|NCT04097444|Vitamins|vitamins|mesh-ancestor
138920468|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
138920469|NCT04097288|Dexetimide|dexetimide|mesh-list
138920470|NCT04097288|Citalopram|citalopram|mesh-list
138920471|NCT04097288|Reboxetine|reboxetine|mesh-list
138572505|NCT00435955|Rituximab|rituximab|mesh-list
138920472|NCT04097288|Escitalopram|escitalopram|mesh-list
138920473|NCT04097288|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138920474|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138920475|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138920476|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920477|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920478|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
138920479|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920480|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138920481|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
138920482|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138920483|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138920484|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138920485|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
138920486|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
138920487|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920488|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138920489|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138920490|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
138920491|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138920492|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
138920493|NCT04219449|Protein C|protein c|mesh-list
138920494|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
138920495|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138920496|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138920497|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920498|NCT04209855|Paclitaxel|paclitaxel|mesh-list
138920499|NCT04209855|Maytansine|maytansine|mesh-list
138920500|NCT04209855|Doxorubicin|doxorubicin|mesh-list
138580002|NCT00126698|Trimethoprim|trimethoprim|mesh-list
138920501|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138920502|NCT04209855|Topotecan|topotecan|mesh-list
138920503|NCT04209855|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
138438489|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
138920504|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138920505|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920506|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
138920507|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
138920508|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
138920509|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920510|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138920511|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138920512|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138920513|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920514|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138920515|NCT04209855|Immunoconjugates|immunoconjugates|mesh-ancestor
138920516|NCT04209855|Immunologic Factors|immunologic factors|mesh-ancestor
138920517|NCT04209855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920518|NCT00756938|Losartan|losartan|mesh-list
138920519|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138920520|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138920521|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138920522|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138920523|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920524|NCT04076865|Lidocaine|lidocaine|mesh-list
138920525|NCT04076865|Histamine|histamine|mesh-list
138920526|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
138920527|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
138580046|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
138920528|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138920529|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920530|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
138920531|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920532|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138920533|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138920534|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138920535|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138920536|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920537|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
138920538|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
138920539|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920541|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920542|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138920543|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920544|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920545|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
138920546|NCT02604719|Ethamsylate|ethamsylate|mesh-list
138920547|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138920548|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138920549|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920550|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
138920552|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
138920553|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
138920554|NCT02604797|Sufentanil|sufentanil|mesh-list
138920555|NCT02604797|Dsuvia|dsuvia|mesh-list
138920556|NCT02604797|Nalbuphine|nalbuphine|mesh-list
138920557|NCT02604797|Ramosetron|ramosetron|mesh-list
138920558|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138920559|NCT02604797|Narcotics|narcotics|mesh-ancestor
138920560|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138920561|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920562|NCT02604797|Analgesics|analgesics|mesh-ancestor
138920563|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
138920564|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920565|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138920566|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138920567|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
138920569|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138920570|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138920571|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138920572|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138920573|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138920574|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920575|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920576|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
138920577|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
138920578|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138920579|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138920580|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
138920581|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920582|NCT00777608|Donepezil|donepezil|mesh-list
138920583|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138920584|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920585|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920586|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
138920587|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451622|NCT04062656|Nivolumab|nivolumab|mesh-list
138920588|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920590|NCT00792935|Metformin|metformin|mesh-list
138920591|NCT00792935|Glimepiride|glimepiride|mesh-list
138920592|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138920593|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438623|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
138920594|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138920595|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138920596|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
138920598|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138920599|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920600|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138920601|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138920602|NCT03904563|Growth Substances|growth substances|mesh-ancestor
138920603|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920604|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
138920605|NCT00770510|Zolpidem|zolpidem|mesh-list
138920606|NCT00770510|Eszopiclone|eszopiclone|mesh-list
138920607|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138920608|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138920609|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138920610|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920611|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138920612|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
138920613|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
138920614|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920615|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920616|NCT04077255|Paclitaxel|paclitaxel|mesh-list
138920617|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138920618|NCT04077255|Antibodies|antibodies|mesh-list
138920619|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138920620|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920621|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
138920622|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
138920623|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
138920624|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920625|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
138920626|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920627|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138920628|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138920629|NCT00770432|Laxatives|laxatives|mesh-ancestor
138920630|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138920631|NCT00792701|Gemcitabine|gemcitabine|mesh-list
138920632|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920633|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138920634|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
138920635|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920636|NCT03772353|Letrozole|letrozole|mesh-list
138920637|NCT03772353|Fulvestrant|fulvestrant|mesh-list
138920638|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920639|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138920640|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138920641|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920642|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920643|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138920644|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
138920645|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138920646|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920647|NCT03772353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138920648|NCT03772353|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138920650|NCT05559983|Vaccines|vaccines|mesh-list
138920651|NCT05559983|Immunologic Factors|immunologic factors|mesh-ancestor
138920652|NCT05559983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920653|NCT05559983|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138920654|NCT05559983|Antacids|antacids|mesh-ancestor
138920655|NCT05559983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920656|NCT05559983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138920657|NCT03765567|Vancomycin|vancomycin|mesh-list
138920658|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138920659|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920660|NCT00777296|Amikacin|amikacin|mesh-list
138920661|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138920662|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920663|NCT00756470|Paclitaxel|paclitaxel|mesh-list
138920664|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
138920665|NCT00756470|Fluorouracil|fluorouracil|mesh-list
138920666|NCT00756470|Epirubicin|epirubicin|mesh-list
138920667|NCT00756470|Lapatinib|lapatinib|mesh-list
138920668|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138920669|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920670|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
138920671|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
138920672|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
138580270|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920673|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920674|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138920675|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
138920676|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920677|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138920678|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138920679|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
138920680|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138920681|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
138920682|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138920683|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138920684|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138920685|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138580323|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138920686|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920687|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138920688|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
138920689|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138920690|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920691|NCT00727506|Afatinib|afatinib|mesh-list
138920692|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920693|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138920694|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920695|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920696|NCT00789815|Midazolam|midazolam|mesh-list
138920697|NCT00789815|Propofol|propofol|mesh-list
138920698|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138920699|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138920700|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920701|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138920702|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
138920703|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
138920704|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138920706|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138920707|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138920708|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
138920709|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
138920710|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920711|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920713|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
138920714|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920715|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138920716|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138920717|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920718|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920720|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
138920721|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138920722|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920723|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138920724|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138920725|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138920726|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138920727|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
138920728|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920729|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138920730|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
138920731|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138920732|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920733|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138920734|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138920735|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920736|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920737|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920738|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
138920739|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138920740|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920741|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920743|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138920744|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920745|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138920746|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
138920747|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138920748|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920749|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920750|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920751|NCT05600387|Empagliflozin|empagliflozin|mesh-list
138920752|NCT05600387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138920753|NCT05600387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920754|NCT05600387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138920755|NCT05600387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920756|NCT00721110|Lidocaine|lidocaine|mesh-list
138920757|NCT00721110|Ketamine|ketamine|mesh-list
138920758|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
138920759|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
138920760|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138920761|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920762|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
138920763|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920764|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138920765|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138920766|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138920767|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138920768|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920769|NCT00721110|Analgesics|analgesics|mesh-ancestor
138920770|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138920771|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138920772|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
138580644|NCT00498901|Letrozole|letrozole|mesh-list
138920773|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138920774|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138920775|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920777|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
138920778|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
138920779|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138920780|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920781|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
138920782|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138920783|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138920784|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138920785|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920786|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920787|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920788|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138920789|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
138920790|NCT00791999|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138920791|NCT00791999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138920792|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138920793|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
138920794|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920795|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138920796|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
138920797|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138920799|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
138920800|NCT04033263|Protective Agents|protective agents|mesh-ancestor
138920801|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920802|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138920803|NCT04075227|Dexamethasone|dexamethasone|mesh-list
138920804|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138920805|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
138920806|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
138920807|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920808|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920809|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138920810|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
138920811|NCT04075227|Hormones|hormones|mesh-ancestor
138920812|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138920813|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138920814|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920815|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138920816|NCT00585078|Capecitabine|capecitabine|mesh-list
138920817|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
138920818|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138920820|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920821|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920822|NCT00720876|Rituximab|rituximab|mesh-list
138920823|NCT00720876|Vorinostat|vorinostat|mesh-list
138920824|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138920825|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920826|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
138438989|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
138920827|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920828|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138920829|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138920830|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920831|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920832|NCT00789581|Paclitaxel|paclitaxel|mesh-list
138920833|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
138920834|NCT00789581|Doxorubicin|doxorubicin|mesh-list
138920836|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138920837|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920838|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
138920839|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
138920840|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
138920841|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920842|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138920843|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
138920844|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920845|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138920846|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138920847|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
138920848|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138920849|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138920850|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138581001|NCT00501514|Hormones|hormones|mesh-list
138920851|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138920852|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920853|NCT00717756|Lenalidomide|lenalidomide|mesh-list
138920854|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
138920855|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920856|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138920857|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138920858|NCT00717756|Growth Substances|growth substances|mesh-ancestor
138920859|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
138920860|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920861|NCT04111289|Tirofiban|tirofiban|mesh-list
138920862|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138920863|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138510576|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138920864|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920865|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138920867|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138920868|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920869|NCT05674539|Vidarabine|vidarabine|mesh-list
138920870|NCT05674539|Fludarabine|fludarabine|mesh-list
138920871|NCT05674539|Fludarabine phosphate|fludarabine phosphate|mesh-list
138920872|NCT05674539|Melphalan|melphalan|mesh-list
138920873|NCT05674539|Busulfan|busulfan|mesh-list
138920874|NCT05674539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920875|NCT05674539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138920876|NCT05674539|Antimetabolites|antimetabolites|mesh-ancestor
138920877|NCT05674539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920878|NCT05674539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138920879|NCT05674539|Immunologic Factors|immunologic factors|mesh-ancestor
138920880|NCT05674539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920881|NCT05674539|Antiviral Agents|antiviral agents|mesh-ancestor
138920882|NCT05674539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920883|NCT05674539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138920884|NCT05674539|Alkylating Agents|alkylating agents|mesh-ancestor
138920885|NCT05674539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138920886|NCT00717522|Pomalidomide|pomalidomide|mesh-list
138920887|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
138920888|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920889|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138920890|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138920891|NCT00717522|Growth Substances|growth substances|mesh-ancestor
138920892|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
138920893|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920894|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
138920895|NCT00791921|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138439074|NCT01771406|Nebivolol|nebivolol|mesh-list
138920896|NCT00791921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138920897|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138920898|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
138920899|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920900|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138920901|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138920902|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920903|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138920904|NCT03475953|Avelumab|avelumab|mesh-list
138920905|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138920906|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138920907|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920908|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
138920909|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920910|NCT00582933|Vidarabine|vidarabine|mesh-list
138920911|NCT00582933|Fludarabine|fludarabine|mesh-list
138920912|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
138920913|NCT00582933|Melphalan|melphalan|mesh-list
138920914|NCT00582933|Busulfan|busulfan|mesh-list
138920915|NCT00582933|Lenograstim|lenograstim|mesh-list
138920916|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920917|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138920919|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920920|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138920921|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
138920922|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920923|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
138920924|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138920925|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138920926|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138920927|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
138581213|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
138920928|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138920929|NCT00791765|Etanercept|etanercept|mesh-list
138920930|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138920931|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138920932|NCT00791765|Analgesics|analgesics|mesh-ancestor
138920933|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
138920934|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920935|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920936|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138920937|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138920938|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138195876|NCT00932152|Bevacizumab|bevacizumab|mesh-list
138920939|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138920940|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
138920941|NCT00789191|Metformin|metformin|mesh-list
138920942|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138920943|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
138920944|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138920945|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920946|NCT00789191|Incretins|incretins|mesh-ancestor
138920947|NCT00789191|Hormones|hormones|mesh-ancestor
138920948|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138581340|NCT01247311|Cholecalciferol|cholecalciferol|mesh-list
138920949|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138920950|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
138920951|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138920952|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920953|NCT02603315|Mitogens|mitogens|mesh-list
138920954|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
138920955|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
138920956|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920957|NCT02603315|Growth Substances|growth substances|mesh-ancestor
138920958|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920959|NCT00789035|Metformin|metformin|mesh-list
138920960|NCT00789035|Empagliflozin|empagliflozin|mesh-list
138920961|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138920962|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451682|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
138920963|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138920964|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920965|NCT04108013|Paclitaxel|paclitaxel|mesh-list
138920966|NCT04108013|Carboplatin|carboplatin|mesh-list
138920967|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138920968|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138920969|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
138920970|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
138920971|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
138920972|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920973|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
138920974|NCT04105985|Tetracaine|tetracaine|mesh-list
138920975|NCT04105985|Carticaine|carticaine|mesh-list
138920976|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
138581473|NCT01249690|Bortezomib|bortezomib|mesh-list
138920977|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
138920978|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138920979|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920980|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
138920981|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138920982|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138920983|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138920984|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
138920985|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920986|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138920987|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
138920988|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
138920989|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
138920990|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138920991|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
138920992|NCT04074213|Clozapine|clozapine|mesh-list
138920993|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138920994|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
138920995|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138920996|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581523|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
138920997|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138920998|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138920999|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138921000|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138573025|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921001|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138921002|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
138921003|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
138921004|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138921005|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138921007|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
138921008|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921009|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138921010|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
138921011|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921012|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
138921013|NCT04110587|Protective Agents|protective agents|mesh-ancestor
138921014|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
138921015|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921016|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
138921017|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138921018|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921019|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
138921020|NCT02579733|Azathioprine|azathioprine|mesh-list
138921022|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921023|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138921024|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921025|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138921026|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
138921027|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921028|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138921029|NCT03326193|Bevacizumab|bevacizumab|mesh-list
138921030|NCT03326193|Niraparib|niraparib|mesh-list
138921031|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138921032|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921033|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138921034|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138921035|NCT03326193|Growth Substances|growth substances|mesh-ancestor
138921036|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921037|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
138921038|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138921039|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921040|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921041|NCT02517099|Azithromycin|azithromycin|mesh-list
138921042|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138921043|NCT02517099|Beclomethasone|beclomethasone|mesh-list
138921044|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138921045|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921046|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138921047|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921048|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921049|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138921050|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
138921051|NCT02517099|Hormones|hormones|mesh-ancestor
138709226|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138921052|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138921053|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921054|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138921055|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
138921056|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
138921057|NCT02473263|Tazobactam|tazobactam|mesh-list
138921058|NCT02473263|Piperacillin|piperacillin|mesh-list
138921059|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138921060|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
138921061|NCT02473263|Norepinephrine|norepinephrine|mesh-list
138921062|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138921063|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138921064|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138921065|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
138921066|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921067|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921068|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581901|NCT00139815|Enoxaparin|enoxaparin|mesh-list
138921069|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
138921070|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
138921071|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921072|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138921073|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138921074|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138573104|NCT00440284|Insulin|insulin|mesh-list
138921075|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138921076|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921077|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
138921078|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
138921079|NCT03249831|Pentostatin|pentostatin|mesh-list
138921080|NCT03249831|Tacrolimus|tacrolimus|mesh-list
138921081|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
138921082|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138921083|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138921084|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
138921085|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921086|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138921087|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138581960|NCT00139854|Alprazolam|alprazolam|mesh-list
138921088|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
138921089|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921090|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921091|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138921092|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138921093|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921094|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138921095|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138921096|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
138921097|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138921098|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921099|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138921100|NCT03222609|Navitoclax|navitoclax|mesh-list
138921101|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921102|NCT00437203|Gemcitabine|gemcitabine|mesh-list
138921103|NCT00437203|PF 00477736|pf 00477736|mesh-list
138921104|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138582008|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
138921105|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
138921106|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921107|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921108|NCT00437203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138921109|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921110|NCT02419287|Crizotinib|crizotinib|mesh-list
138921111|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921112|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138921113|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921114|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921115|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138709227|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
138921116|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138921117|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138921118|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138921119|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921120|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921121|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921122|NCT00437125|Analgesics|analgesics|mesh-ancestor
138921123|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
138921124|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921125|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
138921126|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138921127|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
138921128|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138921129|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138921130|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
138921131|NCT01028287|Hormones|hormones|mesh-ancestor
138921132|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138921133|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921134|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709228|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
138921135|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921136|NCT01028443|Cyclosporine|cyclosporine|mesh-list
138921137|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
138921138|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921139|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
138921140|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921141|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921142|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138921143|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
138921144|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921145|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138921146|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138921147|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
138921148|NCT03116997|Neostigmine|neostigmine|mesh-list
138921149|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138921150|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921151|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582265|NCT00140712|Ropinirole|ropinirole|mesh-list
138921152|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
138921153|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921154|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921155|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138921156|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
138921157|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921158|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138921160|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138921161|NCT02600780|Allopurinol|allopurinol|mesh-list
138921162|NCT02600780|Febuxostat|febuxostat|mesh-list
138921163|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
138921164|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921165|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921166|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
138921167|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138921168|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138921169|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
138921170|NCT02600780|Protective Agents|protective agents|mesh-ancestor
138921171|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921172|NCT00582309|Insulin|insulin|mesh-list
138921173|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138921174|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138921175|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921176|NCT00443053|PENTA|penta|mesh-list
138921177|NCT00443053|Fondaparinux|fondaparinux|mesh-list
138921178|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138921179|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
138921180|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138921181|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
138921182|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921183|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921184|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
138921185|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138921186|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138921187|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138921188|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138921189|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
138921190|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138921191|NCT00720798|Analgesics|analgesics|mesh-ancestor
138921192|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
138921193|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921194|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921195|NCT01816971|Dexamethasone|dexamethasone|mesh-list
138921196|NCT01816971|Lenalidomide|lenalidomide|mesh-list
138921197|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138921198|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
138921199|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
138921200|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921201|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921202|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138921203|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
138709229|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921205|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138921206|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138921207|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921209|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138921210|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138921211|NCT01816971|Growth Substances|growth substances|mesh-ancestor
138921212|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
138921213|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
138921214|NCT01021267|Urological Agents|urological agents|mesh-ancestor
138921215|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
138921216|NCT00717366|Hematinics|hematinics|mesh-ancestor
138921217|NCT02939989|Ribavirin|ribavirin|mesh-list
138921218|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
138921219|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
138921220|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921221|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
138921222|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921223|NCT04096742|Tretinoin|tretinoin|mesh-list
138921224|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921225|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
138921226|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
138921227|NCT04085640|Ropivacaine|ropivacaine|mesh-list
138921228|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
138921229|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
138921230|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921231|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921232|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
138921233|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921234|NCT01031719|Vaccines|vaccines|mesh-list
138921235|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
138196175|NCT05286190|Sensory System Agents|sensory system agents|mesh-ancestor
138921236|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921237|NCT00723606|Haloperidol|haloperidol|mesh-list
138921238|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
138921239|NCT00723606|Ziprasidone|ziprasidone|mesh-list
138921240|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
138921241|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
138921242|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921243|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921244|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138921245|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138921246|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138921247|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921248|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138921249|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138921250|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
138921251|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921252|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921253|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138921254|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138921255|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
138921256|NCT01021501|Nifedipine|nifedipine|mesh-list
138921257|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138582459|NCT00133172|Prednisone|prednisone|mesh-list
138921258|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138921259|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921260|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138921261|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921262|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
138921263|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
138921264|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138921265|NCT01021579|Metformin|metformin|mesh-list
138921266|NCT01021579|Simvastatin|simvastatin|mesh-list
138921267|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138921268|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921269|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138582522|NCT00141258|Pregabalin|pregabalin|mesh-list
138921270|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138921271|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
138921272|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921273|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138921274|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138921275|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921276|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138921277|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138921278|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921279|NCT01021735|Adalimumab|adalimumab|mesh-list
138921280|NCT01021735|Etanercept|etanercept|mesh-list
138921281|NCT01021735|Rituximab|rituximab|mesh-list
138921282|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138921283|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921284|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
138582579|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138921285|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921286|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138921287|NCT01021735|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138921288|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138921289|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138921290|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138921291|NCT01021735|Analgesics|analgesics|mesh-ancestor
138921292|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
138921293|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921294|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138921295|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138921296|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
138921297|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138921298|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
138921299|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138921300|NCT00436501|Docetaxel|docetaxel|mesh-list
138921301|NCT00436501|Aflibercept|aflibercept|mesh-list
138921302|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
138921303|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921304|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
138921305|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
138921306|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
138921307|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921308|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138921309|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138921311|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921312|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
138921314|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138921315|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921316|NCT00755846|Incretins|incretins|mesh-ancestor
138921317|NCT00755846|Hormones|hormones|mesh-ancestor
138921318|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138921319|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138921320|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
138921321|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921322|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921323|NCT03850093|Bisoprolol|bisoprolol|mesh-list
138921324|NCT03850093|Gabapentin|gabapentin|mesh-list
138921325|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921326|NCT03850093|Analgesics|analgesics|mesh-ancestor
138921327|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
138921328|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921329|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
138921330|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138921331|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138921332|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921333|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138921334|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138921335|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138921336|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921337|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921339|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138921340|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
138921341|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
138439584|NCT01775839|Aspirin|aspirin|mesh-list
138921342|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138921343|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138921344|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138921345|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
138921346|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
138921348|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138582814|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138921349|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138921350|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
138921351|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921352|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921353|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138921354|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
138921355|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
138921356|NCT00442117|Hormones|hormones|mesh-ancestor
138709230|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138921357|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138921358|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
138921359|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138921360|NCT00752726|Orlistat|orlistat|mesh-list
138921361|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921362|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921363|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138921364|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138921365|NCT04072263|Interferons|interferons|mesh-list
138921366|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
138921367|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
138921368|NCT04072263|Paclitaxel|paclitaxel|mesh-list
138921369|NCT04072263|Carboplatin|carboplatin|mesh-list
138921370|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138921371|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921372|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
138921373|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
138921374|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
138921375|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573392|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138921376|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
138921377|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921378|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
138921379|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921380|NCT00441727|Esomeprazole|esomeprazole|mesh-list
138921381|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138921382|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138921383|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138921384|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921385|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921387|NCT00770120|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138921388|NCT00770120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138921389|NCT00770120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921390|NCT00770120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921391|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138921392|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
138921393|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921394|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921395|NCT03996655|Neostigmine|neostigmine|mesh-list
138921396|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138921397|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921398|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921399|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
138921400|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921401|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921402|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138921403|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
138921404|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921405|NCT01032109|Bevacizumab|bevacizumab|mesh-list
138921406|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138921407|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921408|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138921409|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138921410|NCT01032109|Growth Substances|growth substances|mesh-ancestor
138921411|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921412|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
138921413|NCT04100330|Cytarabine|cytarabine|mesh-list
138921414|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138921415|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
138921416|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921417|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921418|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
138921419|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921420|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138921421|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
138921422|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921423|NCT00436345|Remifentanil|remifentanil|mesh-list
138921424|NCT00436345|Propofol|propofol|mesh-list
138921425|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138921426|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921427|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921428|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138921429|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
138921430|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
138921431|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138921432|NCT00436345|Narcotics|narcotics|mesh-ancestor
138921433|NCT00436345|Analgesics|analgesics|mesh-ancestor
138921434|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
138921435|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921436|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138921437|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138921438|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138921439|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
138921440|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921441|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921442|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138921443|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138921444|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
138921445|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921446|NCT01032187|Amphotericin B|amphotericin b|mesh-list
138921447|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138921448|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
138921449|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138921450|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
138921451|NCT01032187|Amebicides|amebicides|mesh-ancestor
138573472|NCT00138567|Vildagliptin|vildagliptin|mesh-list
138921452|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138921453|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138921454|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921455|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138921456|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
138921457|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138921458|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138921460|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138921461|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
138921463|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138921464|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921465|NCT00768560|Nifedipine|nifedipine|mesh-list
138921466|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138921467|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709231|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138921468|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921469|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138921470|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921471|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
138921472|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
138921473|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138921475|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138921476|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138921477|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138921478|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921479|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921480|NCT00754442|Teriparatide|teriparatide|mesh-list
138921481|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138921482|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921483|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138921484|NCT00754052|Donepezil|donepezil|mesh-list
138921485|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138921486|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921487|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921488|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
138921489|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921490|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921491|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
138921492|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138921493|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
138921494|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138921495|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138921496|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138921497|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921498|NCT02927067|Valganciclovir|valganciclovir|mesh-list
138583420|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
138921499|NCT02927067|Maribavir|maribavir|mesh-list
138921500|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
138921501|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921502|NCT02600468|Abatacept|abatacept|mesh-list
138921503|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138921504|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921505|NCT02600468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138921506|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921507|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138921508|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
138921509|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451818|NCT02685605|Temozolomide|temozolomide|mesh-list
138921510|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138921511|NCT02598596|Azathioprine|azathioprine|mesh-list
138921512|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
138709232|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921513|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921514|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138921515|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921516|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138921517|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
138921518|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921519|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138921521|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
138439835|NCT01778192|Cathartics|cathartics|mesh-ancestor
138921522|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138921523|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921524|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138921525|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138921526|NCT00586508|Growth Substances|growth substances|mesh-ancestor
138583537|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138921527|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921528|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
138921529|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
138921530|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921531|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
138921533|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
138921534|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
138921535|NCT00723528|Ustekinumab|ustekinumab|mesh-list
138921536|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
138921537|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138921538|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
138921539|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138921540|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
138921541|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138583599|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921542|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921543|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138921544|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138921545|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439901|NCT01778803|Paclitaxel|paclitaxel|mesh-list
138921546|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138921547|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921548|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138921549|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138921550|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
138921551|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921553|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921554|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138921555|NCT00723450|Lamotrigine|lamotrigine|mesh-list
138921556|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
138921557|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138921558|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138921559|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921560|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138921561|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921562|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138921563|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138451829|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
138921564|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921565|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138921566|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138921568|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138921569|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
138921570|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138921571|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
138921572|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921573|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921574|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
138921575|NCT00751400|Naproxen|naproxen|mesh-list
138921576|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138921577|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138921578|NCT00751400|Analgesics|analgesics|mesh-ancestor
138921579|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
138921580|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921581|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921582|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138921583|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138921584|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
138921585|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138921586|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921587|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921588|NCT00585312|Celecoxib|celecoxib|mesh-list
138583768|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
138921589|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138921590|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138921591|NCT00585312|Analgesics|analgesics|mesh-ancestor
138921592|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
138921593|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921594|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921595|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138921596|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138921597|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138921598|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138921599|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921600|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921602|NCT00753506|Artemisinin|artemisinin|mesh-list
138921603|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
138921604|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138921605|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138921606|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921607|NCT00720096|Doxorubicin|doxorubicin|mesh-list
138921608|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138921609|NCT00720096|Topotecan|topotecan|mesh-list
138921610|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138921611|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921612|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138921613|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138921614|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583892|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138921615|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451849|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
138921616|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138921617|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
138921618|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
138921619|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921620|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921621|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921622|NCT02577783|Dexamethasone|dexamethasone|mesh-list
138921623|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
138921624|NCT02577783|Doxorubicin|doxorubicin|mesh-list
138921625|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138921626|NCT02577783|BB 1101|bb 1101|mesh-list
138921627|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138921628|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
138921629|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
138921630|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921631|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921632|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138921633|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
138921634|NCT02577783|Hormones|hormones|mesh-ancestor
138921635|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138921636|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138921637|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921638|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
138921639|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583949|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138921640|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921642|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138921643|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138921644|NCT00918450|Navitoclax|navitoclax|mesh-list
138921645|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921646|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
138440024|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
138921647|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138921648|NCT02591628|Diuretics|diuretics|mesh-ancestor
138921649|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
138921650|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921651|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138921652|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138921653|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921654|NCT04090112|Lidocaine|lidocaine|mesh-list
138921655|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
138921656|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
138921657|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921658|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921659|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
138921660|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921661|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138921662|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138921663|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138921664|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138921665|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921666|NCT00747344|Ustekinumab|ustekinumab|mesh-list
138921667|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
138921668|NCT00580983|Paclitaxel|paclitaxel|mesh-list
138921669|NCT00580983|Carboplatin|carboplatin|mesh-list
138921670|NCT00580983|Fluorouracil|fluorouracil|mesh-list
138921671|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138921672|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921673|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
138573689|NCT00108797|Coagulants|coagulants|mesh-ancestor
138921674|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
138921675|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
138440059|NCT01779843|Cytarabine|cytarabine|mesh-list
138921676|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921677|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
138921678|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138921679|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138921680|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
138921681|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921682|NCT02576223|Ropivacaine|ropivacaine|mesh-list
138921683|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
138921684|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
138921685|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921686|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921687|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
138921688|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921689|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
138921690|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138921691|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138921692|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
138921693|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379017|NCT05841420|Paclitaxel|paclitaxel|mesh-list
138921694|NCT02577393|Protective Agents|protective agents|mesh-ancestor
138921695|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921696|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138921697|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138921698|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921699|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138921701|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138921702|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921703|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138921704|NCT00753896|Incretins|incretins|mesh-ancestor
138921705|NCT00753896|Hormones|hormones|mesh-ancestor
138921706|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138921707|NCT02597114|Insulin|insulin|mesh-list
138921708|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138921709|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138921710|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921711|NCT00743444|Lesogaberan|lesogaberan|mesh-list
138921712|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138921713|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138921714|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
138921715|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
138921716|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921717|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921718|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921719|NCT00743366|Riboflavin|riboflavin|mesh-list
138921720|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138921721|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
138921722|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138921723|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138921724|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138921725|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921726|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921727|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
138921728|NCT00743366|Vitamins|vitamins|mesh-ancestor
138921729|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
138921730|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138921731|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
138921732|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
138921733|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
138921734|NCT01760655|Busulfan|busulfan|mesh-list
138921735|NCT01760655|Methyl Methanesulfonate|methyl methanesulfonate|mesh-list
138921736|NCT01760655|Fludarabine|fludarabine|mesh-list
138921737|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
138921739|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138921740|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
138921741|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921742|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138921743|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138921744|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
138921745|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921746|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921747|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138921748|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138921750|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921751|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138921752|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921753|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138921754|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138921755|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
138921756|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138921758|NCT00743288|Panobinostat|panobinostat|mesh-list
138921759|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138921760|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
138921761|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921762|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921763|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138921764|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138921765|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
138921766|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921767|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138921768|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921769|NCT02579187|Anesthetics|anesthetics|mesh-list
138921770|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921771|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921772|NCT02598440|Alendronate|alendronate|mesh-list
138921773|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
138921774|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138921775|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921776|NCT00750308|Ramipril|ramipril|mesh-list
138921777|NCT00750308|Tadalafil|tadalafil|mesh-list
138921778|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
138921779|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138921780|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138921781|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921782|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921783|NCT00750308|Urological Agents|urological agents|mesh-ancestor
138921784|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138921785|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
138921786|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138921787|NCT05392790|Calcium|calcium|mesh-list
138921788|NCT05392790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138921789|NCT05392790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921790|NCT02597036|Zansecimab|zansecimab|mesh-list
138921791|NCT02597036|Paclitaxel|paclitaxel|mesh-list
138921792|NCT02597036|Ramucirumab|ramucirumab|mesh-list
138921793|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138921794|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921795|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
138921796|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
138921797|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
138921798|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921799|NCT02597036|Antiviral Agents|antiviral agents|mesh-ancestor
138921800|NCT02597036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921801|NCT04071639|Ubiquinone|ubiquinone|mesh-list
138921802|NCT04071639|Haloperidol|haloperidol|mesh-list
138921803|NCT04071639|Risperidone|risperidone|mesh-list
138921804|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
138921805|NCT04071639|Sertraline|sertraline|mesh-list
138921806|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
138921807|NCT04071639|Idebenone|idebenone|mesh-list
138921808|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138921809|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
138451891|NCT01900574|Golimumab|golimumab|mesh-list
138921810|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921811|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921812|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921813|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138921814|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138921815|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921816|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138921817|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138921818|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
138921819|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
138921820|NCT04071639|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138921821|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138921822|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138921824|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
138921825|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921826|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138921827|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138921828|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
138921829|NCT04071639|Protective Agents|protective agents|mesh-ancestor
138921830|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
138921831|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138921832|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
138921834|NCT04089176|Carbetocin|carbetocin|mesh-list
138921835|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
138921836|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138921837|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921838|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
138921839|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138584488|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921840|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921841|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138921842|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921843|NCT00749684|Interferons|interferons|mesh-list
138921844|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138921845|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
138921846|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921847|NCT02575755|Azithromycin|azithromycin|mesh-list
138921848|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
138921849|NCT02575755|Piperaquine|piperaquine|mesh-list
138921850|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
138921851|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138921852|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138921853|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921854|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
138921855|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138921856|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138921857|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138921858|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921859|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440419|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
138921860|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138921861|NCT00746798|Vaccines|vaccines|mesh-list
138921862|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
138921863|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921864|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138921865|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138921866|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138921867|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138921868|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921869|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
138921870|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584606|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
138921871|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921872|NCT01298193|Phenothiazine|phenothiazine|mesh-list
138921873|NCT01298193|Droperidol|droperidol|mesh-list
138921874|NCT01298193|Haloperidol|haloperidol|mesh-list
138921875|NCT01298193|Aprepitant|aprepitant|mesh-list
138921876|NCT01298193|Metoclopramide|metoclopramide|mesh-list
138921877|NCT01298193|Domperidone|domperidone|mesh-list
138921878|NCT01298193|Alizapride|alizapride|mesh-list
138921879|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
138921880|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
138921881|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
138440460|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921882|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921883|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921884|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138921885|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138921886|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921887|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921888|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138921889|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138921890|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921891|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138921892|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138921893|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
138921894|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138921895|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138921896|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138921897|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138921898|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
138921899|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138921900|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138921901|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921902|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
138921903|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921904|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
138921905|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138510581|NCT04733625|Vitamin D|vitamin d|mesh-list
138440526|NCT01783340|Azithromycin|azithromycin|mesh-list
138921906|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138921907|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921908|NCT02590536|Urological Agents|urological agents|mesh-ancestor
138921910|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138921911|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
138921912|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584781|NCT00141791|Etanercept|etanercept|mesh-list
138921913|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921914|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138921915|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
138921916|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138921917|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921918|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921919|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138921920|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138921921|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138921922|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
138921924|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921925|NCT02578953|Dutasteride|dutasteride|mesh-list
138921926|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138440563|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
138921927|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138921928|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138921929|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921930|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
138921931|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138921932|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921933|NCT02578719|Bupivacaine|bupivacaine|mesh-list
138584929|NCT04514419|Docetaxel|docetaxel|mesh-list
138921934|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
138921935|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
138921936|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921937|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921938|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
138921939|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921940|NCT00742508|Carvedilol|carvedilol|mesh-list
138921941|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138921942|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138921943|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
138921944|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138921945|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921946|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921947|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138921948|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
138921949|NCT00742508|Protective Agents|protective agents|mesh-ancestor
138921950|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138921951|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138921952|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138921953|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
138921954|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138440618|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
138921955|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138921956|NCT02590614|Vitamin D|vitamin d|mesh-list
138921957|NCT02590614|Vitamins|vitamins|mesh-ancestor
138921958|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
138921959|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921960|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138921961|NCT02575443|Rocuronium|rocuronium|mesh-list
138921962|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138921963|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138921964|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138921965|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921966|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921967|NCT02596334|Lamivudine|lamivudine|mesh-list
138921968|NCT02596334|Abacavir|abacavir|mesh-list
138921969|NCT02596334|Dolutegravir|dolutegravir|mesh-list
138921970|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138921971|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138921972|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585106|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921973|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138921974|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
138921975|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138921976|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138921977|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138921978|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138921979|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138921980|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
138921981|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
138921982|NCT00719706|Vitamins|vitamins|mesh-ancestor
138921983|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
138921984|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921985|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
138921986|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
138921987|NCT02575521|Propofol|propofol|mesh-list
138921988|NCT02575521|Sevoflurane|sevoflurane|mesh-list
138921989|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138921990|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138921991|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138921992|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138921993|NCT02575521|Analgesics|analgesics|mesh-ancestor
138921994|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
138921995|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138921996|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138921997|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138921998|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138921999|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
138922000|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922001|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922002|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138922003|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
138922005|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138922006|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138922007|NCT02576457|BMS-936559|bms-936559|mesh-list
138451917|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138922008|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922009|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922011|NCT05276102|Dermatologic Agents|dermatologic agents|mesh-ancestor
138922012|NCT01192971|Apatinib|apatinib|mesh-list
138922013|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922014|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138922015|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922016|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922017|NCT00719472|Antipyretics|antipyretics|mesh-list
138922018|NCT00719472|Prednisone|prednisone|mesh-list
138922019|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
138922020|NCT00719472|Rituximab|rituximab|mesh-list
138922021|NCT00719472|Doxorubicin|doxorubicin|mesh-list
138922022|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138922023|NCT00719472|Vincristine|vincristine|mesh-list
138922024|NCT00719472|Analgesics|analgesics|mesh-list
138922025|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
138922026|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138922027|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138922028|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
138922029|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922030|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138922031|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138922032|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
138922033|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922034|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922035|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138440706|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138922036|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922037|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138922038|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138922039|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138922040|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922041|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922042|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
138922043|NCT00719472|Hormones|hormones|mesh-ancestor
138922044|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138922045|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138922046|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138922047|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
138922048|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
138922049|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
138922050|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
138585401|NCT00506623|Irinotecan|irinotecan|mesh-list
138922051|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922052|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
138922053|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922055|NCT00579501|Trabectedin|trabectedin|mesh-list
138922056|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922057|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
138440749|NCT01785043|Hormones|hormones|mesh-ancestor
138922058|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
138922059|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922060|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922061|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138922062|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
138922063|NCT00579501|Hormones|hormones|mesh-ancestor
138922064|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138922065|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138922066|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922067|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138922068|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
138922069|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922070|NCT02576301|Cytarabine|cytarabine|mesh-list
138922071|NCT02576301|Combretastatin|combretastatin|mesh-list
138922072|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138922074|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922075|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922076|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
138922077|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922078|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138922079|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
138922080|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922081|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138922082|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
138922083|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
138922084|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
138922085|NCT04086186|Bupivacaine|bupivacaine|mesh-list
138922086|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
138922087|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
138922088|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138922089|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922090|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
138922091|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922092|NCT00741338|Cyclosporine|cyclosporine|mesh-list
138922093|NCT00741338|Azathioprine|azathioprine|mesh-list
138922094|NCT00741338|Cyclosporins|cyclosporins|mesh-list
138922095|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922096|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922097|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138922098|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
138922099|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922100|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
138922101|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922102|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
138922103|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138922104|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138922105|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
138922106|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138922107|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922109|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
138922111|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
138922112|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922113|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138922114|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138922115|NCT02578251|Acetaminophen|acetaminophen|mesh-list
138922116|NCT02578251|Meperidine|meperidine|mesh-list
138922117|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138922118|NCT02578251|Analgesics|analgesics|mesh-ancestor
138922119|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
138922120|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922121|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922122|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
138922123|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138922124|NCT02578251|Narcotics|narcotics|mesh-ancestor
138922125|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138922126|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138922127|NCT05285358|Paclitaxel|paclitaxel|mesh-list
138922128|NCT05285358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138922129|NCT05285358|Cisplatin|cisplatin|mesh-list
138922130|NCT05285358|Gemcitabine|gemcitabine|mesh-list
138922131|NCT05285358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138922132|NCT05285358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451940|NCT00444093|Loperamide|loperamide|mesh-list
138922134|NCT05285358|Antimitotic Agents|antimitotic agents|mesh-ancestor
138922136|NCT05285358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922137|NCT05285358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138922139|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
138922140|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
138922141|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138922142|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
138922143|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922144|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922145|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138922146|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
138922147|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138922148|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138922149|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138922150|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
138922151|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138585764|NCT00148395|Mitomycin|mitomycin|mesh-list
138922152|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922153|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922154|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
138922155|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138922157|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
138922158|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922159|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922160|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922161|NCT00709449|Papaverine|papaverine|mesh-list
138922162|NCT00709449|Moxaverine|moxaverine|mesh-list
138922163|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
138922164|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
138922165|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922166|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922167|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138922168|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922169|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922170|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
138922171|NCT00709449|Urological Agents|urological agents|mesh-ancestor
138922172|NCT00746252|Risperidone|risperidone|mesh-list
138922173|NCT00746252|Aripiprazole|aripiprazole|mesh-list
138922174|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138922175|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
138922176|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922177|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922178|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922179|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138922180|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138922181|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138922182|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138922183|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138922184|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
138922185|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
138922186|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
138922187|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138922188|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138922189|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138922190|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138922191|NCT02574975|Budesonide|budesonide|mesh-list
138922192|NCT02574975|Adenosine|adenosine|mesh-list
138922193|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
138922194|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
138922195|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922196|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138922198|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440981|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922199|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922200|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138922201|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
138922202|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
138922203|NCT02574975|Hormones|hormones|mesh-ancestor
138922204|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138922205|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138922206|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138922207|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138922208|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
138922209|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922210|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922211|NCT02574975|Analgesics|analgesics|mesh-ancestor
138922212|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
138922213|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138922214|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
138922215|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138922216|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
138922217|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
138922219|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138922220|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138922221|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138922222|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138922223|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
138922224|NCT00718770|Bexarotene|bexarotene|mesh-list
138922225|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922226|NCT04084158|Paclitaxel|paclitaxel|mesh-list
138922227|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138922228|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138922229|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922230|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
138922231|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
138922232|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
138922233|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922234|NCT00714519|Castor Oil|castor oil|mesh-list
138922235|NCT00714519|Cathartics|cathartics|mesh-ancestor
138922236|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138922237|NCT00714948|Gemcitabine|gemcitabine|mesh-list
138922238|NCT00714948|Sorafenib|sorafenib|mesh-list
138922239|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922240|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138922241|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
138922242|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586055|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
138922243|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138922245|NCT00714714|Adapalene|adapalene|mesh-list
138922246|NCT00714714|Tretinoin|tretinoin|mesh-list
138922247|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922248|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
138922249|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
138922250|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138922251|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138922252|NCT00714714|Analgesics|analgesics|mesh-ancestor
138922253|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
138586113|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
138922254|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922255|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922256|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922257|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138922258|NCT00441337|Nivolumab|nivolumab|mesh-list
138922259|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922260|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922261|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138922262|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922263|NCT00578877|Nonoxynol|nonoxynol|mesh-list
138922264|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138922265|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138922266|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922267|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138922268|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
138586188|NCT00467467|Alfuzosin|alfuzosin|mesh-list
138922269|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138922270|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138922272|NCT02573727|Epinephrine|epinephrine|mesh-list
138922273|NCT02573727|Racepinephrine|racepinephrine|mesh-list
138922274|NCT02573727|Norepinephrine|norepinephrine|mesh-list
138922275|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
138922276|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138922278|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
138922279|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922280|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262688|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
138922281|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922282|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138922283|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138922285|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922286|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138922287|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
138922289|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
138922290|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138922291|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138922292|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
138922293|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
138922294|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138922295|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138922296|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922297|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138922298|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
138922299|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922300|NCT00918528|Mitomycins|mitomycins|mesh-list
138922301|NCT00918528|Mitomycin|mitomycin|mesh-list
138922302|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138922303|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922304|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
138922305|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922306|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138922307|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922308|NCT00468481|Drospirenone|drospirenone|mesh-list
138922309|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138922310|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138922311|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138922312|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138922313|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138922314|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
138922315|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138922316|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922317|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138922318|NCT00468481|Estrogens|estrogens|mesh-ancestor
138922319|NCT00468481|Hormones|hormones|mesh-ancestor
138922320|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138922321|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138922322|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
138922323|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138922324|NCT00468481|Diuretics|diuretics|mesh-ancestor
138922325|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
138922326|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
138922327|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138922328|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922329|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
138922330|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922331|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
138922332|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922333|NCT03949153|Nivolumab|nivolumab|mesh-list
138922334|NCT03949153|Ipilimumab|ipilimumab|mesh-list
138922335|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922336|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922337|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138922338|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922339|NCT00709917|Repaglinide|repaglinide|mesh-list
138922340|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138586445|NCT06182735|Fludarabine|fludarabine|mesh-list
138922342|NCT02574741|Aripiprazole|aripiprazole|mesh-list
138922343|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
138922344|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138922345|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138922346|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138922347|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586474|NCT06182176|Pyrimethamine|pyrimethamine|mesh-list
138922348|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922349|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
138922350|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
138922351|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922352|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922353|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138197320|NCT04331470|Hormones|hormones|mesh-ancestor
138922354|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138922355|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
138922356|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138922357|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138922358|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138922359|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138922360|NCT00468169|Cetuximab|cetuximab|mesh-list
138922361|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
138922362|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922363|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922364|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
138922365|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922366|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922367|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138922368|NCT02589444|Vitamin D|vitamin d|mesh-list
138922369|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
138922370|NCT02589444|Vitamins|vitamins|mesh-ancestor
138922371|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
138922372|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922373|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138922374|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138922375|NCT05325684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138922376|NCT05325684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922377|NCT05325684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922378|NCT05325684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922379|NCT00435487|Heparin|heparin|mesh-list
138922381|NCT00435487|Dalteparin|dalteparin|mesh-list
138922382|NCT00435487|Tinzaparin|tinzaparin|mesh-list
138922383|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138922384|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
138922385|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138586672|NCT06181032|Apatinib|apatinib|mesh-list
138922386|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138922387|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922388|NCT02589678|Vaccines|vaccines|mesh-list
138922389|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
138922390|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922391|NCT02591004|Nifedipine|nifedipine|mesh-list
138922392|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138922393|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138922394|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922395|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138922396|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922397|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
138922398|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
138922399|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138922400|NCT05310786|Analgesics, Opioid|analgesics, opioid|mesh-list
138922401|NCT05310786|Narcotics|narcotics|mesh-ancestor
138922402|NCT05310786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586797|NCT06172764|Vitamin D|vitamin d|mesh-list
138922403|NCT05310786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922404|NCT05310786|Analgesics|analgesics|mesh-ancestor
138922405|NCT05310786|Sensory System Agents|sensory system agents|mesh-ancestor
138922406|NCT05310786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922407|NCT04085562|Amlodipine|amlodipine|mesh-list
138922408|NCT04085562|Bisoprolol|bisoprolol|mesh-list
138922409|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138922410|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138922411|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138922412|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922413|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138922414|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586867|NCT06143306|Anesthetics|anesthetics|mesh-ancestor
138922415|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
138922417|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
138922418|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922419|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138922420|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138922421|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138922422|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
138922423|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922424|NCT05683626|Adalimumab|adalimumab|mesh-list
138922425|NCT05683626|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138922426|NCT05683626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922427|NCT05683626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138922428|NCT02588196|Dexamethasone|dexamethasone|mesh-list
138922429|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
138922431|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922432|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
138922433|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
138922434|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922435|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922436|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138922437|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
138922438|NCT02588196|Hormones|hormones|mesh-ancestor
138922439|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138922440|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138922441|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922442|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
138922443|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922444|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922445|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138922446|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
138922447|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922448|NCT00579345|Vaccines|vaccines|mesh-list
138452009|NCT01873339|Midazolam|midazolam|mesh-list
138922449|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
138922450|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922451|NCT00715377|Benztropine|benztropine|mesh-list
138922452|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138586989|NCT06015880|Growth Inhibitors|growth inhibitors|mesh-ancestor
138922453|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138922454|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
138922455|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
138922456|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922457|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922458|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138922459|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138922460|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
138922461|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922462|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922463|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138922464|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138922465|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138922466|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
138922467|NCT00715455|Heparin|heparin|mesh-list
138922468|NCT00715455|Calcium heparin|calcium heparin|mesh-list
138922469|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
138922470|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138922471|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138922472|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922473|NCT02574663|Leucovorin|leucovorin|mesh-list
138922474|NCT02574663|Folic Acid|folic acid|mesh-list
138922475|NCT02574663|Paclitaxel|paclitaxel|mesh-list
138922476|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138922477|NCT02574663|Bevacizumab|bevacizumab|mesh-list
138922478|NCT02574663|Gemcitabine|gemcitabine|mesh-list
138922479|NCT02574663|Fluorouracil|fluorouracil|mesh-list
138922480|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
138922481|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
138922482|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138922483|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922484|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
138922485|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
138922486|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
138922487|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922488|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922489|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138922490|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138922491|NCT02574663|Growth Substances|growth substances|mesh-ancestor
138922492|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922493|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
138922494|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138922495|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
138922496|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138922497|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
138922498|NCT02574663|Antidotes|antidotes|mesh-ancestor
138922499|NCT02574663|Protective Agents|protective agents|mesh-ancestor
138922500|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
138922501|NCT02574663|Vitamins|vitamins|mesh-ancestor
138922502|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
138922503|NCT02574663|Hematinics|hematinics|mesh-ancestor
138574506|NCT03274102|Vaccines|vaccines|mesh-list
138922504|NCT04069845|Doxorubicin|doxorubicin|mesh-list
138587173|NCT05851898|Analgesics|analgesics|mesh-ancestor
138922506|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138922507|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922508|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138922510|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922511|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922512|NCT00715689|Hormones|hormones|mesh-list
138922513|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138922514|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922515|NCT00919542|Cyclosporine|cyclosporine|mesh-list
138922516|NCT00919542|Prednisolone|prednisolone|mesh-list
138922517|NCT00919542|Cyclosporins|cyclosporins|mesh-list
138922518|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922519|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922520|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138922521|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
138922522|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922523|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
138922524|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922525|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
138922526|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138922527|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138922528|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922529|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
138922530|NCT00919542|Hormones|hormones|mesh-ancestor
138922531|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138922532|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138922533|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922534|NCT00719121|Adapalene|adapalene|mesh-list
138922535|NCT00719121|R 115866|r 115866|mesh-list
138587291|NCT05721170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922536|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138922537|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138922539|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
138922540|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922541|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922542|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922543|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138922544|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
138587346|NCT05553938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922545|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138922546|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922547|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922549|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922550|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922551|NCT02589288|Ropivacaine|ropivacaine|mesh-list
138922552|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
138922553|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
138922554|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138922555|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922556|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
138922557|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922558|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
138922559|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138922560|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
138922561|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922562|NCT00716001|Expectorants|expectorants|mesh-ancestor
138922563|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
138922564|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138922565|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
138922566|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922567|NCT00716001|Protective Agents|protective agents|mesh-ancestor
138922568|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922569|NCT00716001|Antidotes|antidotes|mesh-ancestor
138922570|NCT00710229|Bevacizumab|bevacizumab|mesh-list
138922571|NCT00710229|Ranibizumab|ranibizumab|mesh-list
138922572|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922573|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922574|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138922575|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138922576|NCT00710229|Growth Substances|growth substances|mesh-ancestor
138922577|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922578|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
138922579|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
138922581|NCT05192460|Vaccines|vaccines|mesh-list
138922582|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
138574578|NCT00457678|Dexamethasone|dexamethasone|mesh-list
138922583|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922584|NCT00719433|Armin|armin|mesh-list
138922585|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138922586|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922587|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922588|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
138922589|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922590|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922591|NCT04978272|Piperaquine|piperaquine|mesh-list
138922592|NCT04978272|Artenimol|artenimol|mesh-list
138922593|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
138922594|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138922595|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138922596|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922597|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
138922598|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138922599|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138922600|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922601|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138922602|NCT04973124|Analgesics|analgesics|mesh-ancestor
138922603|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
138922604|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922605|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138922606|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138922607|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138922608|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
138922609|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922610|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922611|NCT04971720|Valsartan|valsartan|mesh-list
138922612|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138922613|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138922614|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138922615|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138922616|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922617|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
138922618|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922619|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
138922620|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138922621|NCT00719745|Tacrolimus|tacrolimus|mesh-list
138922622|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138922623|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
138922624|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922625|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138922626|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922627|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922628|NCT02587416|Atorvastatin|atorvastatin|mesh-list
138922629|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138922630|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138922631|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
138922632|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922633|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138922634|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138922635|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922636|NCT00719823|Maraviroc|maraviroc|mesh-list
138922637|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138922638|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138922639|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922640|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138922641|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138922642|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
138922643|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922644|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138922645|NCT00919776|Cyclosporine|cyclosporine|mesh-list
138922646|NCT00919776|Prednisolone|prednisolone|mesh-list
138922647|NCT00919776|Cyclosporins|cyclosporins|mesh-list
138922648|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922649|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452043|NCT01873443|Rituximab|rituximab|mesh-list
138922651|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
138922652|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922653|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
138922654|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922655|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
138922656|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138922657|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138922658|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922659|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
138922661|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138922662|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138922663|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922664|NCT00720135|Rituximab|rituximab|mesh-list
138922665|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138922666|NCT00720135|Interleukin-2|interleukin-2|mesh-list
138922667|NCT00720135|Antibodies|antibodies|mesh-list
138922668|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
138922669|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138922670|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
138922671|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922672|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922673|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138922674|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138922675|NCT00720135|Analgesics|analgesics|mesh-ancestor
138922676|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
138922677|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922678|NCT02588118|Propofol|propofol|mesh-list
138922679|NCT02588118|Cisatracurium|cisatracurium|mesh-list
138922680|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138922681|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138587767|NCT04992507|Anesthetics|anesthetics|mesh-list
138922682|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922683|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138922684|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
138922685|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
138922686|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138922687|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138922688|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922689|NCT00716391|Cisplatin|cisplatin|mesh-list
138922690|NCT00716391|Cetuximab|cetuximab|mesh-list
138922691|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922692|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922693|NCT00716469|Talaporfin|talaporfin|mesh-list
138922694|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922695|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138922696|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
138922697|NCT04082598|Amoxicillin|amoxicillin|mesh-list
138922698|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
138922699|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
138441398|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
138922700|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138922701|NCT04082598|Lactoferrin|lactoferrin|mesh-list
138922702|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138922703|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922704|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138922705|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922706|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922707|NCT00716547|Celecoxib|celecoxib|mesh-list
138922708|NCT00716547|Ketoprofen|ketoprofen|mesh-list
138922709|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138922710|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138922711|NCT00716547|Analgesics|analgesics|mesh-ancestor
138922712|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
138922713|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922714|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922715|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922716|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138922717|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138922718|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138922719|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922720|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922721|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138922722|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
138922723|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
138922724|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138922725|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
138922726|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922727|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
138922728|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922729|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922730|NCT00720291|Metronidazole|metronidazole|mesh-list
138922731|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922732|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138922733|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138922734|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138922735|NCT00578643|Cyclosporine|cyclosporine|mesh-list
138922736|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
138922737|NCT00578643|Busulfan|busulfan|mesh-list
138922738|NCT00578643|Fludarabine|fludarabine|mesh-list
138922739|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
138922740|NCT00578643|Cyclosporins|cyclosporins|mesh-list
138922741|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138922742|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
138922743|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922744|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138922745|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138922746|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
138922747|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922748|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922749|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138922750|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922751|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
138587966|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
138922752|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922753|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
138922754|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138922755|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922756|NCT04082286|Antibodies|antibodies|mesh-list
138922757|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138922758|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
138922759|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922760|NCT00720447|Cytarabine|cytarabine|mesh-list
138922761|NCT00720447|Etoposide|etoposide|mesh-list
138922762|NCT00720447|Melphalan|melphalan|mesh-list
138922763|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
138922764|NCT00720447|Carmustine|carmustine|mesh-list
138922765|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138922766|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922767|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138922768|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138922769|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922770|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922771|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138922772|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
138922773|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
138922774|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922775|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138922776|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
138922777|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922778|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138922779|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
138922780|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138922781|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922782|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
138922783|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138922784|NCT04828824|Norgestimate|norgestimate|mesh-list
138922785|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138922786|NCT04828824|Estradiol|estradiol|mesh-list
138922787|NCT04828824|Estrogens|estrogens|mesh-ancestor
138922788|NCT04828824|Hormones|hormones|mesh-ancestor
138922789|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138922790|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588093|NCT04375605|Antidotes|antidotes|mesh-ancestor
138922791|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138922792|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
138922793|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138922794|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138922795|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138922796|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138922797|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138922798|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138922799|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922800|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138922801|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138922802|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922803|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922804|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922805|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138922807|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138922808|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922809|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
138922810|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922813|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138922814|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922815|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
138922816|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922817|NCT02588742|Melatonin|melatonin|mesh-list
138922818|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
138922819|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922820|NCT02588742|Protective Agents|protective agents|mesh-ancestor
138922821|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922822|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138922823|NCT00720603|Plerixafor|plerixafor|mesh-list
138922824|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138922825|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138922826|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
138922827|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922828|NCT04936854|Sirolimus|sirolimus|mesh-list
138922829|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
138922830|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138922831|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138922833|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
138922834|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138922835|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
138922836|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138922837|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922838|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138922839|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922840|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
138922841|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138922842|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
138922843|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922844|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922845|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
138922846|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
138922847|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922848|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138922849|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
138922850|NCT04936854|Hormones|hormones|mesh-ancestor
138922851|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138922852|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138922853|NCT04936854|Protective Agents|protective agents|mesh-ancestor
138588190|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922854|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138922855|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
138922856|NCT00711789|Giapreza|giapreza|mesh-list
138922857|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
138922858|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138922859|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138922860|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
138441518|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138922861|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922862|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922863|NCT00741260|Capecitabine|capecitabine|mesh-list
138922864|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138922865|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
138922866|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922867|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922868|NCT02587260|Clopidogrel|clopidogrel|mesh-list
138922869|NCT02587260|Ticagrelor|ticagrelor|mesh-list
138922870|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138922871|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138588247|NCT04031508|SMOFlipid|smoflipid|mesh-list
138922872|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138922873|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138922874|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138922875|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
138922876|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922877|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922878|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922879|NCT02596256|Docetaxel|docetaxel|mesh-list
138922880|NCT02596256|Apatinib|apatinib|mesh-list
138922881|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922882|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
138922883|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
138922884|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
138574879|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
138922885|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922886|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138922888|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
138922889|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138922890|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138922891|NCT00717561|Amoxicillin|amoxicillin|mesh-list
138922892|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
138922893|NCT00717561|Azithromycin|azithromycin|mesh-list
138922894|NCT00717561|Clarithromycin|clarithromycin|mesh-list
138922895|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
138922896|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
138922897|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
138922898|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138922899|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138922900|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138922901|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922902|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138922903|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138922904|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922905|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441574|NCT01794429|Exenatide|exenatide|mesh-list
138922906|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922907|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138922908|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
138588299|NCT03918252|Ipilimumab|ipilimumab|mesh-list
138922909|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138922910|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922911|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138922912|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138922913|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138922914|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138922915|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138922916|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138922917|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138922919|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
138452075|NCT01873768|Coagulants|coagulants|mesh-ancestor
138922920|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138922921|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138922922|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922924|NCT00720915|Coagulants|coagulants|mesh-ancestor
138922925|NCT00712101|Abciximab|abciximab|mesh-list
138922926|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
138922927|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138922928|NCT00712257|Heparin|heparin|mesh-list
138922929|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
138922930|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138922931|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138588398|NCT03637660|Penicillin G|penicillin g|mesh-list
138922932|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922933|NCT00740792|Fluticasone|fluticasone|mesh-list
138922934|NCT00740792|Xhance|xhance|mesh-list
138922935|NCT00740792|Azelastine|azelastine|mesh-list
138922936|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138922937|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138922938|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
138922939|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138922940|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588474|NCT03331341|Imidazole|imidazole|mesh-list
138922941|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138922942|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
138922943|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
138922944|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138922945|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138922946|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922947|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922948|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138922949|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138922950|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
138922951|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
138922952|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138922953|NCT00721305|Lovastatin|lovastatin|mesh-list
138922954|NCT00721305|L 647318|l 647318|mesh-list
138922955|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
138922956|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138922957|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138922958|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
138922959|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922960|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138922961|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138922962|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922963|NCT00717951|Capecitabine|capecitabine|mesh-list
138922964|NCT00717951|Docetaxel|docetaxel|mesh-list
138922965|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922966|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138922967|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
138922968|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922969|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
138922970|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
138922971|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
138922972|NCT02572947|Dolutegravir|dolutegravir|mesh-list
138922974|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138922975|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922976|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922977|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138922978|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138922979|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
138922980|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922981|NCT00712491|Sirolimus|sirolimus|mesh-list
138922982|NCT00712491|Temsirolimus|temsirolimus|mesh-list
138922983|NCT00712491|MTOR Inhibitors|mtor inhibitors|mesh-list
138922984|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138922985|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138922986|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138922987|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138922988|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
138922989|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138922990|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
138922991|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138922992|NCT00712491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138922993|NCT00712491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138922994|NCT00712491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138922995|NCT04083066|Cytarabine|cytarabine|mesh-list
138922996|NCT04083066|Dexamethasone|dexamethasone|mesh-list
138922997|NCT04083066|Rituximab|rituximab|mesh-list
138922998|NCT04083066|Methotrexate|methotrexate|mesh-list
138922999|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138923000|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
138923001|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
138923002|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923003|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923004|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138923005|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
138923006|NCT04083066|Hormones|hormones|mesh-ancestor
138923007|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138923008|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138923009|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923010|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138923011|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
138923012|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138923013|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138923014|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
138923015|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138923016|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138923017|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
138923018|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923019|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
138923020|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923021|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138923022|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138923023|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138923024|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
138923025|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923026|NCT05683782|Chitosan|chitosan|mesh-list
138923027|NCT05683782|Epoetin Alfa|epoetin alfa|mesh-list
138923028|NCT05683782|Hematinics|hematinics|mesh-ancestor
138923029|NCT05683782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138923030|NCT05683782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138923031|NCT05683782|Antimetabolites|antimetabolites|mesh-ancestor
138923032|NCT05683782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923033|NCT05683782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138923034|NCT05683782|Chelating Agents|chelating agents|mesh-ancestor
138923035|NCT05683782|Sequestering Agents|sequestering agents|mesh-ancestor
138923036|NCT05683782|Hemostatics|hemostatics|mesh-ancestor
138923038|NCT00740714|Vitamins|vitamins|mesh-list
138923039|NCT00740714|Vitamin E|vitamin e|mesh-list
138923040|NCT00740714|Tocopherols|tocopherols|mesh-list
138923041|NCT00740714|Tocotrienols|tocotrienols|mesh-list
138923042|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
138923043|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
138923044|NCT00740714|Ubiquinone|ubiquinone|mesh-list
138923045|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
138923046|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923047|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
138923048|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923049|NCT00740714|Protective Agents|protective agents|mesh-ancestor
138923050|NCT00721773|Valsartan|valsartan|mesh-list
138923051|NCT00721773|Benazepril|benazepril|mesh-list
138441663|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
138923052|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138923053|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138923054|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138923055|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923056|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138923058|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923059|NCT04070469|Amoxicillin|amoxicillin|mesh-list
138923060|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138923061|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923062|NCT00712647|Beta Carotene|beta carotene|mesh-list
138923063|NCT00712647|Vitamin A|vitamin a|mesh-list
138923064|NCT00712647|Carotenoids|carotenoids|mesh-list
138923065|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
138923066|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923067|NCT00712647|Protective Agents|protective agents|mesh-ancestor
138923068|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923069|NCT00712647|Provitamins|provitamins|mesh-ancestor
138923070|NCT00712647|Vitamins|vitamins|mesh-ancestor
138923071|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
138923072|NCT00788957|Panitumumab|panitumumab|mesh-list
138923073|NCT00788957|Rilotumumab|rilotumumab|mesh-list
138923074|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138923075|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923076|NCT04067817|Phenylephrine|phenylephrine|mesh-list
138923077|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
138923078|NCT04067817|Norepinephrine|norepinephrine|mesh-list
138923079|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138923080|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138923081|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
138923082|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
138923083|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923084|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923085|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
138923086|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
138923087|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
138923088|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138923089|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138588807|NCT01955460|Fludarabine|fludarabine|mesh-list
138923090|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138923091|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
138923092|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138923093|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923094|NCT04067817|Protective Agents|protective agents|mesh-ancestor
138923095|NCT00740636|Temozolomide|temozolomide|mesh-list
138923096|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138923097|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
138923098|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923099|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923100|NCT02603159|Capecitabine|capecitabine|mesh-list
138923101|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138923102|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
138923103|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923104|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923105|NCT02595554|Paclitaxel|paclitaxel|mesh-list
138923106|NCT02595554|Cisplatin|cisplatin|mesh-list
138923107|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138510588|NCT00062686|Lapatinib|lapatinib|mesh-list
138510591|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923108|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923109|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
138923110|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
138923111|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
138511191|NCT00070174|Cytarabine|cytarabine|mesh-list
138511262|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
138770257|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923112|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923113|NCT04069065|Tacrolimus|tacrolimus|mesh-list
138511409|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923114|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588849|NCT01756456|Mitogens|mitogens|mesh-list
138923115|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
138923116|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511711|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
138923117|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138923118|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138512079|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
138923119|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923120|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
138923122|NCT04070391|Pyridoxine|pyridoxine|mesh-list
138512383|NCT00078988|Etoposide|etoposide|mesh-list
138512527|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923125|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138512600|NCT00079924|Teriparatide|teriparatide|mesh-list
138923126|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
138923127|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138923128|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138512818|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138512894|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
138923129|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138923130|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
138513194|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923131|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138513269|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
138923132|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138513414|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513487|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923133|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923134|NCT00795509|Urological Agents|urological agents|mesh-ancestor
138923135|NCT02603003|Pemetrexed|pemetrexed|mesh-list
138923136|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923137|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923138|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923139|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138923140|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138923141|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138923142|NCT02603081|Ebselen|ebselen|mesh-list
138513780|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
138513930|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
138923143|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138923144|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138923145|NCT02603081|Analgesics|analgesics|mesh-ancestor
138923146|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
138514079|NCT00141544|Estrogens|estrogens|mesh-list
138923147|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923149|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138514445|NCT00144274|Ambroxol|ambroxol|mesh-list
138923150|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138923152|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138514742|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138923154|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923155|NCT02603081|Protective Agents|protective agents|mesh-ancestor
138923156|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138923157|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923158|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138923159|NCT00787787|Capecitabine|capecitabine|mesh-list
138923160|NCT00787787|Sunitinib|sunitinib|mesh-list
138923161|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138923162|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
138923163|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923164|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923165|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138923166|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138923167|NCT00787787|Growth Substances|growth substances|mesh-ancestor
138514951|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138923168|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923169|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
138923170|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138923171|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923172|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
138923173|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138923175|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
138923176|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138923177|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
138923178|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923179|NCT00915239|Pantoprazole|pantoprazole|mesh-list
138923180|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138923181|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138516084|NCT00276900|Sertraline|sertraline|mesh-list
138516218|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923182|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138923183|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589140|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
138923184|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923185|NCT00722631|Pioglitazone|pioglitazone|mesh-list
138923186|NCT00722631|Glimepiride|glimepiride|mesh-list
138923187|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138923188|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575183|NCT00114192|Thalidomide|thalidomide|mesh-list
138923189|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138923190|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138923193|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
138517568|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
138517640|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923194|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923195|NCT02604095|Protective Agents|protective agents|mesh-ancestor
138923196|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923197|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138923198|NCT02571543|Ibuprofen|ibuprofen|mesh-list
138518171|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
138923199|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138518252|NCT02971878|Vitamins|vitamins|mesh-ancestor
138518350|NCT00023361|Rifabutin|rifabutin|mesh-list
138923200|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138923201|NCT02571543|Analgesics|analgesics|mesh-ancestor
138923202|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
138589255|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138518709|NCT00025467|Thalidomide|thalidomide|mesh-list
138923203|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138518847|NCT00026364|Antidotes|antidotes|mesh-ancestor
138923204|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923205|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138923206|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138519301|NCT00028782|Etanidazole|etanidazole|mesh-list
138519375|NCT00029250|Protective Agents|protective agents|mesh-ancestor
138923207|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138923208|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519598|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138519673|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923209|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923211|NCT04107779|Nicotine|nicotine|mesh-list
138923212|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138441759|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138923214|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923215|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923216|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138923217|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138923218|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
138923219|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138923220|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923221|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
138923222|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
138923224|NCT04067505|Warfarin|warfarin|mesh-list
138923225|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
138923226|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
138923227|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138923228|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
138923229|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138923230|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
138923231|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589371|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
138923232|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923233|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138520249|NCT00033306|Irinotecan|irinotecan|mesh-list
138923234|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138923235|NCT00794963|Metformin|metformin|mesh-list
138923236|NCT00794963|Orlistat|orlistat|mesh-list
138923237|NCT00794963|Irbesartan|irbesartan|mesh-list
138520473|NCT00034359|Lamivudine|lamivudine|mesh-list
138923238|NCT00794963|Fenofibrate|fenofibrate|mesh-list
138923239|NCT00794963|Pravastatin|pravastatin|mesh-list
138923241|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923242|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138520910|NCT00036348|Aripiprazole|aripiprazole|mesh-list
138923243|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
138520982|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138923244|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923245|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138923246|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138521202|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138521279|NCT00847223|Tipifarnib|tipifarnib|mesh-list
138521353|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138923247|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138923248|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923249|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138521652|NCT00276497|Pioglitazone|pioglitazone|mesh-list
138521723|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521793|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521944|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138923250|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138522091|NCT00129155|Treosulfan|treosulfan|mesh-list
138522167|NCT00038376|Interferons|interferons|mesh-list
138522315|NCT05744674|Anesthetics, Local|anesthetics, local|mesh-ancestor
138923251|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138923252|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138923253|NCT00713271|AZD-3199|azd-3199|mesh-list
138923254|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138923255|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138923256|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138923257|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
138923258|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138923259|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923260|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923261|NCT05673135|Antihypertensive Agents|antihypertensive agents|mesh-list
138523288|NCT05768282|Hormones|hormones|mesh-ancestor
138923262|NCT00722709|Ropivacaine|ropivacaine|mesh-list
138923263|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
138523513|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
138589546|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138662525|NCT06189209|Tenalisib|tenalisib|mesh-list
138923265|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138923266|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923267|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
138923268|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923269|NCT04105205|Apramycin|apramycin|mesh-list
138524111|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
138524186|NCT00019136|Aldesleukin|aldesleukin|mesh-list
138923270|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138923271|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923272|NCT00794573|Varenicline|varenicline|mesh-list
138923273|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138923274|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138923275|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
138923276|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138923277|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923278|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923280|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
138923281|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923282|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138923283|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138923284|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923285|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923286|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138923287|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138524476|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
138923289|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
138923290|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923291|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138923292|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138923293|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923294|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923295|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138923296|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
138923297|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138923298|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923299|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138923300|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
138923301|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138923302|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
138923303|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923304|NCT02586636|Metformin|metformin|mesh-list
138923305|NCT02586636|Omeprazole|omeprazole|mesh-list
138923306|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138923307|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923308|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138923309|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138923310|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138923311|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923312|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923313|NCT00713739|Prazosin|prazosin|mesh-list
138923314|NCT00713739|Doxazosin|doxazosin|mesh-list
138923315|NCT00713739|Nifedipine|nifedipine|mesh-list
138923316|NCT00713739|Alfuzosin|alfuzosin|mesh-list
138923317|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138923318|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138923319|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923320|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138923321|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923322|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
138923323|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
138923324|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138923325|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138923326|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138923327|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138923328|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138923329|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
138923330|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138923331|NCT00713739|Urological Agents|urological agents|mesh-ancestor
138923332|NCT02595476|Remifentanil|remifentanil|mesh-list
138923333|NCT02595476|Propofol|propofol|mesh-list
138923334|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138923335|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138923336|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923337|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138923338|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
138575332|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
138923340|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138923341|NCT02595476|Narcotics|narcotics|mesh-ancestor
138923342|NCT02595476|Analgesics|analgesics|mesh-ancestor
138923343|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
138923344|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923345|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
138923346|NCT02586402|Hematinics|hematinics|mesh-ancestor
138923347|NCT00734630|Losartan|losartan|mesh-list
138923348|NCT00734630|Lisinopril|lisinopril|mesh-list
138923349|NCT00734630|Nebivolol|nebivolol|mesh-list
138923350|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138923351|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138923352|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138923353|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138923354|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923355|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138923356|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
138923357|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923358|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138923359|NCT00734630|Protective Agents|protective agents|mesh-ancestor
138923360|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923361|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
138923362|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138923363|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138923364|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138923365|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
138923366|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138923367|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
138923368|NCT02586246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138923369|NCT02586246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138923370|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138923371|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
138923372|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923373|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138923374|NCT00920244|Atropine|atropine|mesh-list
138923375|NCT00920244|Amiodarone|amiodarone|mesh-list
138923376|NCT00920244|Epinephrine|epinephrine|mesh-list
138923377|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138923378|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138923379|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
138923380|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441861|NCT01800708|Prednisolone|prednisolone|mesh-list
138923381|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923382|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923383|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138923384|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138923385|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
138923386|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923387|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138923388|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
138923389|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
138923390|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
138923391|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138923392|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138923393|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138923394|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
138923395|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138923396|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138923397|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
138923398|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
138923399|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138923400|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138923401|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138923402|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138923403|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138923404|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923405|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138923406|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138923407|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138923408|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138923409|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
138923410|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923411|NCT00723879|Ribavirin|ribavirin|mesh-list
138923412|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138923413|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
138923414|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923415|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
138923416|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923418|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138923419|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923420|NCT00435409|Capecitabine|capecitabine|mesh-list
138923421|NCT00435409|Sunitinib|sunitinib|mesh-list
138923422|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138923423|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
138923424|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923425|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923426|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138923427|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138923428|NCT00435409|Growth Substances|growth substances|mesh-ancestor
138923429|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923430|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
138923431|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138923432|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923433|NCT00724035|Midazolam|midazolam|mesh-list
138923434|NCT00724035|Fentanyl|fentanyl|mesh-list
138923435|NCT00724035|Analgesics|analgesics|mesh-list
138923436|NCT00724035|Anesthetics|anesthetics|mesh-list
138923437|NCT00724035|Ropivacaine|ropivacaine|mesh-list
138923438|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
138923439|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138923440|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923441|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
138923442|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923443|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138923444|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138923445|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138923446|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138923447|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138923448|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138923449|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
138923450|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
138923451|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
138923453|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923454|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138923455|NCT00724035|Narcotics|narcotics|mesh-ancestor
138923456|NCT04126824|Triamcinolone|triamcinolone|mesh-list
138923457|NCT04126824|Bupivacaine|bupivacaine|mesh-list
138923458|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
138923459|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
138923460|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138923461|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590130|NCT00158847|Xhance|xhance|mesh-list
138923462|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
138923463|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923464|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138923465|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
138923466|NCT04126824|Hormones|hormones|mesh-ancestor
138923467|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138923468|NCT00724113|Lidocaine|lidocaine|mesh-list
138923469|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
138923470|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
138923471|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138923472|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923473|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
138923474|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923475|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138923476|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138923477|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138923478|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138923479|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923480|NCT04070001|Ibuprofen|ibuprofen|mesh-list
138923481|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138923482|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138923483|NCT04070001|Analgesics|analgesics|mesh-ancestor
138923484|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
138590175|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
138923485|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923486|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923487|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138923488|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138923489|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138923490|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923491|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923492|NCT00435019|Insulin|insulin|mesh-list
138923493|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138923494|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
138923495|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
138923496|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
138923498|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
138923499|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138923500|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923501|NCT00724581|Amiodarone|amiodarone|mesh-list
138923502|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138923503|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
138923504|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138923505|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138923506|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923507|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138923508|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138923509|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138923510|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923511|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138923512|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138923513|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138923514|NCT02570841|Capsaicin|capsaicin|mesh-list
138923515|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
138923516|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
138923517|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
138923518|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923519|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923520|NCT00577863|Teriparatide|teriparatide|mesh-list
138923521|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138923522|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923523|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138923524|NCT04956627|Itraconazole|itraconazole|mesh-list
138923525|NCT04956627|Phenytoin|phenytoin|mesh-list
138923526|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
138923527|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
138923528|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923529|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138382485|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
138923530|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138923531|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923532|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923533|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138923534|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
138923535|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138923536|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923537|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138923538|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
138923539|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138923540|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138923541|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138923542|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138923543|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138923544|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138923546|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138923547|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138923548|NCT00920088|Ritonavir|ritonavir|mesh-list
138923549|NCT00920088|Lopinavir|lopinavir|mesh-list
138923550|NCT00920088|Darunavir|darunavir|mesh-list
138923551|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
138923552|NCT00920088|Midazolam|midazolam|mesh-list
138923553|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
138923554|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138923555|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138923556|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138923557|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923558|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138923559|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138923560|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138923561|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138923562|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
138923563|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
138923564|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
138923565|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
138923566|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138923567|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923568|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138923569|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138923570|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
138923571|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923572|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138923573|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138923574|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
138923575|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923576|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138923577|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138923578|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
138923579|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
138441969|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
138923580|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138923581|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138923582|NCT00920088|Analgesics|analgesics|mesh-ancestor
138923583|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
138923584|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198486|NCT01661790|Bevacizumab|bevacizumab|mesh-list
138923585|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138923586|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138923587|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138923588|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138923589|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138923590|NCT04018833|Ranibizumab|ranibizumab|mesh-list
138923591|NCT04018833|Aflibercept|aflibercept|mesh-list
138923592|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138923593|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138923594|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138923595|NCT04018833|Growth Substances|growth substances|mesh-ancestor
138923596|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923597|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
138923598|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923599|NCT04066803|Folic Acid|folic acid|mesh-list
138923600|NCT04066803|Hematinics|hematinics|mesh-ancestor
138923601|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
138923602|NCT04066803|Vitamins|vitamins|mesh-ancestor
138923603|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
138923604|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923605|NCT00725439|R 115866|r 115866|mesh-list
138923606|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138923607|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923608|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923609|NCT03205761|Olaparib|olaparib|mesh-list
138923610|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138923611|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923612|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923613|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923614|NCT00725517|Icodextrin|icodextrin|mesh-list
138923615|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
138923616|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138923618|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138923619|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
138923620|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923621|NCT00794417|Pemetrexed|pemetrexed|mesh-list
138923622|NCT00794417|Aflibercept|aflibercept|mesh-list
138923623|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923624|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923625|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923626|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138923627|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138441995|NCT01802268|Sirolimus|sirolimus|mesh-list
138923628|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138923629|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138923630|NCT00794417|Growth Substances|growth substances|mesh-ancestor
138923631|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923632|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
138923633|NCT04483206|Melphalan|melphalan|mesh-list
138575636|NCT00112775|Dasatinib|dasatinib|mesh-list
138923634|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138923635|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
138923636|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923637|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923638|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138923639|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138923640|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
138923641|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452215|NCT01874847|Melatonin|melatonin|mesh-list
138923642|NCT00725829|Simvastatin|simvastatin|mesh-list
138923643|NCT00725829|Ezetimibe|ezetimibe|mesh-list
138923644|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138923645|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138923646|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
138923647|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923648|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138923649|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138923650|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923651|NCT02583438|Saxagliptin|saxagliptin|mesh-list
138923652|NCT02583438|Incretins|incretins|mesh-ancestor
138923653|NCT02583438|Hormones|hormones|mesh-ancestor
138923654|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138923655|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923656|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138923657|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
138442019|NCT01802489|Diuretics|diuretics|mesh-ancestor
138923658|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923659|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923660|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138923661|NCT02603861|Modafinil|modafinil|mesh-list
138923662|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138923663|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923664|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138923665|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138923666|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138923667|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923668|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
138923669|NCT02569905|Parecoxib|parecoxib|mesh-list
138923670|NCT02569905|Analgesics|analgesics|mesh-ancestor
138923671|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
138923672|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923673|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923674|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138923675|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138923676|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138923677|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138923678|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138923679|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923680|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923681|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138923682|NCT02603783|Capsaicin|capsaicin|mesh-list
138923683|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
138923684|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
138923685|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
138923686|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923687|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923688|NCT04110275|Plasminogen|plasminogen|mesh-list
138923689|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138923690|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138923691|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138923692|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923693|NCT04250883|Iodine|iodine|mesh-list
138923694|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138923695|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923696|NCT04250883|Trace Elements|trace elements|mesh-ancestor
138923697|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
138923698|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923699|NCT04469634|Antibodies|antibodies|mesh-list
138923700|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
138923701|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923702|NCT04465500|Androgens|androgens|mesh-list
138923703|NCT04465500|Hormones|hormones|mesh-ancestor
138923704|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138923705|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923706|NCT04080726|Esomeprazole|esomeprazole|mesh-list
138923707|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138923708|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138923709|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138923710|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923711|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923712|NCT02583516|Vemurafenib|vemurafenib|mesh-list
138923713|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923714|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138923715|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590822|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138923716|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923717|NCT00790907|Heparin|heparin|mesh-list
138923718|NCT00790907|PENTA|penta|mesh-list
138923719|NCT00790907|Fondaparinux|fondaparinux|mesh-list
138923720|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
138923721|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138923722|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138923723|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923724|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138923725|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
138590890|NCT05861063|Lidocaine|lidocaine|mesh-list
138923726|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138923727|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
138923728|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923729|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138442102|NCT01802645|Vitamins|vitamins|mesh-ancestor
138923730|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138923731|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
138923732|NCT04066179|Prednisolone|prednisolone|mesh-list
138923734|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
138923735|NCT04066179|Hormones|hormones|mesh-ancestor
138923736|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138923737|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923738|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138923739|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923740|NCT04110119|Diclofenac|diclofenac|mesh-list
138923741|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138923742|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138923743|NCT04110119|Analgesics|analgesics|mesh-ancestor
138923744|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
138590952|NCT05860153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138923745|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923746|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923747|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138923748|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138923749|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138923750|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923751|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923752|NCT00726687|Capecitabine|capecitabine|mesh-list
138923753|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138923754|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
138923755|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923756|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923757|NCT00727077|Interferons|interferons|mesh-list
138923758|NCT00727077|Ribavirin|ribavirin|mesh-list
138923759|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
138923760|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
138923761|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923762|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
138923763|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923764|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
138923765|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923766|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
138923767|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923768|NCT04080336|Misoprostol|misoprostol|mesh-list
138923769|NCT04080336|Dinoprostone|dinoprostone|mesh-list
138923770|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138923771|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
138923772|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138923773|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442148|NCT01802944|Insulin|insulin|mesh-list
138923774|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138923775|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138923776|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
138923777|NCT00793871|Sunitinib|sunitinib|mesh-list
138923778|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923779|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138923780|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138923781|NCT00793871|Growth Substances|growth substances|mesh-ancestor
138923782|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923783|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
138923784|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138923785|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923786|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923787|NCT00727233|Sorafenib|sorafenib|mesh-list
138923788|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923789|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138923790|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923791|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923792|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
138923793|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138923794|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923795|NCT04066257|Metronidazole|metronidazole|mesh-list
138923796|NCT04066257|Tetracycline|tetracycline|mesh-list
138923797|NCT04066257|Bismuth|bismuth|mesh-list
138923798|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923799|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138923800|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138923801|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138923802|NCT04066257|Antacids|antacids|mesh-ancestor
138923803|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923804|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138923805|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138923806|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923807|NCT03655821|Pemetrexed|pemetrexed|mesh-list
138923808|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923809|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923810|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923811|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138923812|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138923813|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
138923814|NCT04524702|Paclitaxel|paclitaxel|mesh-list
138923815|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138923816|NCT04524702|Gemcitabine|gemcitabine|mesh-list
138923817|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138442161|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138923818|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923819|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
138923820|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
138923821|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
138923822|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923823|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138923824|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
138923825|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
138923826|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138923827|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138923828|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923829|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923830|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138923831|NCT00730197|Albuterol|albuterol|mesh-list
138923832|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138923833|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
138923834|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923835|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923836|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138923837|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
138923838|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
138923839|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138923840|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138923841|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138923842|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138923843|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
138923844|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138923845|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923846|NCT00727545|Chelating Agents|chelating agents|mesh-list
138923847|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
138923848|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923849|NCT02582892|Vitamin D|vitamin d|mesh-list
138923850|NCT02582892|Vitamins|vitamins|mesh-ancestor
138923851|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
138923852|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923853|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138923854|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
138923855|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
138923856|NCT00730509|Vitamins|vitamins|mesh-ancestor
138923857|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
138923858|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923859|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
138923860|NCT00730509|Hematinics|hematinics|mesh-ancestor
138923861|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
138923862|NCT02582736|Haloperidol|haloperidol|mesh-list
138575856|NCT00426049|Everolimus|everolimus|mesh-list
138923863|NCT02582736|Pimozide|pimozide|mesh-list
138923864|NCT02582736|Olanzapine|olanzapine|mesh-list
138923865|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
138923866|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
138923867|NCT02582736|Risperidone|risperidone|mesh-list
138923868|NCT02582736|Aripiprazole|aripiprazole|mesh-list
138923869|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138591295|NCT04898231|Hormones|hormones|mesh-ancestor
138923870|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138923871|NCT02582736|Ziprasidone|ziprasidone|mesh-list
138923872|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
138923873|NCT02582736|Clozapine|clozapine|mesh-list
138923874|NCT02582736|Loxapine|loxapine|mesh-list
138923875|NCT02582736|Perphenazine|perphenazine|mesh-list
138923876|NCT02582736|Fluphenazine|fluphenazine|mesh-list
138923877|NCT02582736|Thioridazine|thioridazine|mesh-list
138923878|NCT02582736|Flupenthixol|flupenthixol|mesh-list
138923879|NCT02582736|Clopenthixol|clopenthixol|mesh-list
138923880|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
138923881|NCT02582736|Fluspirilene|fluspirilene|mesh-list
138923882|NCT02582736|Thiothixene|thiothixene|mesh-list
138923883|NCT02582736|Mesoridazine|mesoridazine|mesh-list
138923884|NCT02582736|Chlormezanone|chlormezanone|mesh-list
138923885|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
138923886|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138591343|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591344|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138591345|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138591346|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138591347|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138591348|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138591349|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138591350|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138591351|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138591352|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
138591353|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138591363|NCT04775381|Vitamin D|vitamin d|mesh-list
138591364|NCT04775381|Vitamins|vitamins|mesh-ancestor
138591365|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
138591366|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591369|NCT04721873|Phentermine|phentermine|mesh-list
138923887|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
138923888|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138923889|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923890|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923891|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138923892|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138923893|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138923894|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138923895|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
138923896|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
138923897|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
138923898|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923899|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138923900|NCT02582736|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138923901|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138923902|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138923903|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
138923904|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
138923905|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138923906|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138452263|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
138923907|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138923908|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138923909|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138923910|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
138923911|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
138923912|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138923913|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
138923914|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138923915|NCT02582736|Analgesics|analgesics|mesh-ancestor
138923916|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
138923917|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138923918|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138923919|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138923920|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
138923921|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138923922|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138923923|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138923924|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138923925|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138923926|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923927|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923928|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923929|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138923930|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
138923931|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138923932|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923933|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138923934|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138923935|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138575933|NCT00444418|Naltrexone|naltrexone|mesh-list
138923936|NCT00735345|Docetaxel|docetaxel|mesh-list
138923937|NCT00735345|Cetuximab|cetuximab|mesh-list
138923938|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923939|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
138923940|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
138923941|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
138923942|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923943|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138923944|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
138923945|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138923946|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923947|NCT00727935|Lidocaine|lidocaine|mesh-list
138923948|NCT00727935|Ropivacaine|ropivacaine|mesh-list
138923949|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
138923950|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
138923951|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138923952|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923953|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
138923954|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923955|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138923956|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138923957|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138923958|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138923959|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923960|NCT00728013|Atorvastatin|atorvastatin|mesh-list
138923961|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138923962|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138923963|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
138923964|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923965|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138923966|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138923967|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923968|NCT00577707|Pemetrexed|pemetrexed|mesh-list
138923969|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138923970|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923971|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923972|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923973|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138923974|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138923975|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138923976|NCT00730821|Nintedanib|nintedanib|mesh-list
138923977|NCT00730821|Afatinib|afatinib|mesh-list
138591625|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138923978|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138923979|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138923980|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138923981|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923982|NCT00728559|Bupivacaine|bupivacaine|mesh-list
138923983|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
138923984|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
138923985|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138923986|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138923987|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
138442295|NCT01804374|Sorafenib|sorafenib|mesh-list
138923988|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138923990|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
138923991|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138923992|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138923993|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138923994|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
138923995|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138923996|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138923997|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
138923998|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138923999|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924000|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924001|NCT04064619|Urological Agents|urological agents|mesh-ancestor
138924002|NCT00730977|Mannitol|mannitol|mesh-list
138924003|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138924004|NCT00730977|Diuretics|diuretics|mesh-ancestor
138924005|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
138924006|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924007|NCT00728715|Budesonide|budesonide|mesh-list
138924008|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
138924009|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138591747|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
138924010|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138924011|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
138924012|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924013|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924014|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138924015|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
138924016|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
138924017|NCT00728715|Hormones|hormones|mesh-ancestor
138924018|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138924019|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138924020|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138924021|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138924022|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
138924023|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924024|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924025|NCT00731289|Triamcinolone|triamcinolone|mesh-list
138924026|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138924027|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138924028|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
138924029|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138924030|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924031|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
138924032|NCT00731289|Hormones|hormones|mesh-ancestor
138452276|NCT01875263|Levofloxacin|levofloxacin|mesh-list
138924033|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138924034|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924035|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138924036|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
138924037|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924038|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924039|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138924041|NCT00731289|Protective Agents|protective agents|mesh-ancestor
138924042|NCT00736515|Insulin|insulin|mesh-list
138924043|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138924044|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
138924045|NCT00736515|Gliclazide|gliclazide|mesh-list
138924046|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138924047|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924048|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138924049|NCT00731367|Laxatives|laxatives|mesh-ancestor
138924050|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138924051|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138924052|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138924053|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924054|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138924055|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
138924056|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924057|NCT05601531|Calcitriol|calcitriol|mesh-list
138924058|NCT05601531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138924059|NCT05601531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924060|NCT05601531|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138924061|NCT05601531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138924062|NCT05601531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924063|NCT05601531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138924064|NCT05601531|Vitamins|vitamins|mesh-ancestor
138924065|NCT05601531|Micronutrients|micronutrients|mesh-ancestor
138924066|NCT05601531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138924067|NCT02569125|Everolimus|everolimus|mesh-list
138924068|NCT02569125|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138924069|NCT02569125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138924070|NCT02569125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924071|NCT02569125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924072|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138924074|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924075|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924076|NCT00731601|Pantoprazole|pantoprazole|mesh-list
138924077|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138924078|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138592028|NCT00166842|Cyclosporine|cyclosporine|mesh-list
138924079|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138924080|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924081|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924083|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138924084|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138924085|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924086|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924087|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
138924088|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138924089|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138924090|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138924091|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
138924092|NCT00736983|Adalimumab|adalimumab|mesh-list
138924093|NCT00736983|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138924094|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924095|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924096|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138924097|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138924098|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138924099|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138924100|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924101|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924102|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924103|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138924104|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138924105|NCT00729339|Mosapride|mosapride|mesh-list
138924106|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138924107|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138924108|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
138924109|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924110|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924111|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924113|NCT00737139|Bupivacaine|bupivacaine|mesh-list
138924114|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138924115|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138924116|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
138924117|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138442357|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138924118|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924119|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924120|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138924121|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138924122|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
138924123|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924124|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138924125|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
138924126|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
138924127|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
138924128|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138924129|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
138924130|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
138924131|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138924132|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
138924133|NCT00732147|Pramlintide|pramlintide|mesh-list
138924134|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138924135|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924136|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
138924137|NCT02569515|Hematinics|hematinics|mesh-ancestor
138924138|NCT00737373|Leucovorin|leucovorin|mesh-list
138924139|NCT00737373|Folic Acid|folic acid|mesh-list
138924140|NCT00737373|Docetaxel|docetaxel|mesh-list
138924141|NCT00737373|Fluorouracil|fluorouracil|mesh-list
138924142|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
138924143|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
138924144|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924145|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
138924146|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
138924147|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
138924148|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924149|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
138924150|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138924151|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138924152|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
138924153|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924154|NCT00737373|Antidotes|antidotes|mesh-ancestor
138924155|NCT00737373|Protective Agents|protective agents|mesh-ancestor
138924156|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
138924158|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
138924159|NCT00737373|Hematinics|hematinics|mesh-ancestor
138924160|NCT00729495|Celecoxib|celecoxib|mesh-list
138924161|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138924162|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138924163|NCT00729495|Analgesics|analgesics|mesh-ancestor
138924164|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
138576151|NCT00446212|Propofol|propofol|mesh-list
138592232|NCT00152022|Amphetamine|amphetamine|mesh-list
138924165|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924166|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924167|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924168|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924169|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138924170|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138924171|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924172|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924173|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
138924175|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
138924176|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138924177|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
138924178|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924180|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138924181|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
138924182|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924183|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924184|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138924185|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
138924186|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138924187|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
138924188|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924189|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924190|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138924191|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
138924192|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138924193|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
138924194|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924195|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924196|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138924197|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
138924198|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
138924199|NCT00732537|Protective Agents|protective agents|mesh-ancestor
138924200|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138924202|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
138924203|NCT00732693|Estradiol|estradiol|mesh-list
138924204|NCT00732693|Progesterone|progesterone|mesh-list
138924205|NCT00732693|Estrogens|estrogens|mesh-ancestor
138924206|NCT00732693|Hormones|hormones|mesh-ancestor
138924207|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138924208|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924209|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138442418|NCT01807767|Everolimus|everolimus|mesh-list
138592373|NCT04186013|Atezolizumab|atezolizumab|mesh-list
138924210|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
138924211|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138924212|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138924213|NCT00732693|Progestins|progestins|mesh-ancestor
138924214|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138924215|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138924216|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138924217|NCT00729963|Sibutramine|sibutramine|mesh-list
138924218|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
138924219|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138924220|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
138924221|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138924222|NCT00737997|Morphine|morphine|mesh-list
138924223|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138924224|NCT00737997|Narcotics|narcotics|mesh-ancestor
138924225|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138924226|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924227|NCT00737997|Analgesics|analgesics|mesh-ancestor
138924228|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
138924229|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924230|NCT00732927|Aspirin|aspirin|mesh-list
138924231|NCT00732927|Parnaparin|parnaparin|mesh-list
138924232|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138924233|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138924234|NCT00732927|Analgesics|analgesics|mesh-ancestor
138924235|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
138924236|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924237|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924238|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924239|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924240|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138924241|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138924242|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924243|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138924244|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138924245|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924246|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
138924247|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
138924248|NCT00733083|Dexamethasone|dexamethasone|mesh-list
138924250|NCT00733083|Oxycodone|oxycodone|mesh-list
138924251|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924252|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
138924253|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
138924254|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924255|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924256|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138924257|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
138924258|NCT00733083|Hormones|hormones|mesh-ancestor
138524546|NCT00020501|Calcium|calcium|mesh-list
138924259|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138452421|NCT01876433|Mirabegron|mirabegron|mesh-list
138592605|NCT00523666|Galantamine|galantamine|mesh-list
138924260|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138924261|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924262|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138924263|NCT00733083|Narcotics|narcotics|mesh-ancestor
138924264|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138924265|NCT00733083|Analgesics|analgesics|mesh-ancestor
138924266|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
138924267|NCT00712335|Fluticasone|fluticasone|mesh-list
138924269|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138924270|NCT00712335|Montelukast|montelukast|mesh-list
138924271|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
138924272|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924273|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138924274|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
138924275|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924276|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924277|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138924278|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
138924279|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
138924280|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138924281|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138924282|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138924283|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138924284|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
138924285|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924286|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924287|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
138924288|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138592801|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
138924289|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138924290|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138924291|NCT00738621|Dexamethasone|dexamethasone|mesh-list
138924292|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
138924293|NCT00738621|Ondansetron|ondansetron|mesh-list
138924295|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
138924296|NCT00738621|BB 1101|bb 1101|mesh-list
138924297|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138442488|NCT01808300|Vitamins|vitamins|mesh-ancestor
138924298|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
138924299|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
138924300|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592860|NCT02946814|Listerine|listerine|mesh-list
138924301|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924302|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138924303|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
138924304|NCT00738621|Hormones|hormones|mesh-ancestor
138924305|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138924306|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138924307|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924308|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
138924309|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924310|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924311|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
138924312|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
138924313|NCT00738621|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138924314|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138924315|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
138924316|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924317|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138924318|NCT00733239|Cycloserine|cycloserine|mesh-list
138452439|NCT01876563|Vitamin D|vitamin d|mesh-list
138924319|NCT00733239|Verapamil|verapamil|mesh-list
138924320|NCT00733239|Diltiazem|diltiazem|mesh-list
138924321|NCT00733239|Isradipine|isradipine|mesh-list
138924322|NCT00733239|Nifedipine|nifedipine|mesh-list
138924323|NCT00733239|Gabapentin|gabapentin|mesh-list
138924324|NCT00733239|Naloxone|naloxone|mesh-list
138924325|NCT00733239|Analgesics|analgesics|mesh-ancestor
138924326|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
138924327|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924328|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924329|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
138924330|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138924331|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138924332|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138924333|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138924334|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138924335|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138924336|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924337|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924338|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
138924339|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138924340|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138924341|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138924342|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138924343|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
138924344|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
138924345|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138924346|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138924347|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593036|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
138924348|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138924349|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
138924350|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138924351|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
138924352|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138924353|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138924354|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
138924355|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138924356|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924358|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924359|NCT00577629|Cytarabine|cytarabine|mesh-list
138924360|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
138924361|NCT00577629|Rituximab|rituximab|mesh-list
138924362|NCT00577629|Doxorubicin|doxorubicin|mesh-list
138924363|NCT00577629|Etoposide|etoposide|mesh-list
138924364|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138924365|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
138924366|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924367|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924368|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138924369|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
138924370|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924371|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924372|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138593105|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924373|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138924374|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138924375|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138924376|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138924377|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924378|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138924379|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138924380|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
138924381|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
138924382|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138924383|NCT00733317|Budesonide|budesonide|mesh-list
138924384|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924385|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138924386|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
138593158|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138924387|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924388|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924389|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138924390|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
138924391|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
138924392|NCT00733317|Hormones|hormones|mesh-ancestor
138924393|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138924394|NCT02568735|Etoricoxib|etoricoxib|mesh-list
138924395|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138924396|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138924397|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138924399|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
138924400|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924401|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924402|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924403|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924404|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138924405|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138924406|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924407|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924408|NCT00733473|Budesonide|budesonide|mesh-list
138924409|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924410|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138924411|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
138593282|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
138924412|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924413|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924414|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138924415|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
138924416|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
138924418|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138442581|NCT01809184|Insulin|insulin|mesh-list
138924419|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138924420|NCT00710385|Buprenorphine|buprenorphine|mesh-list
138924421|NCT00710385|Heroin|heroin|mesh-list
138924422|NCT00710385|Naloxone|naloxone|mesh-list
138593340|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138924423|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138924424|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924425|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
138924426|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924427|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138924428|NCT00710385|Narcotics|narcotics|mesh-ancestor
138924429|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138924430|NCT00710385|Analgesics|analgesics|mesh-ancestor
138924431|NCT04063527|Paclitaxel|paclitaxel|mesh-list
138924432|NCT04063527|Carboplatin|carboplatin|mesh-list
138924433|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138924434|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924435|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
138924436|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
138924437|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
138924438|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924439|NCT00738777|Tamoxifen|tamoxifen|mesh-list
138924440|NCT00738777|Fulvestrant|fulvestrant|mesh-list
138924441|NCT00738777|Anastrozole|anastrozole|mesh-list
138924442|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138924443|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
138924444|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138924445|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924446|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138924447|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924448|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138924449|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138924450|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138924451|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138924452|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138924453|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138593404|NCT04692376|Hormones|hormones|mesh-ancestor
138924454|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924455|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924456|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
138924457|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138924458|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924459|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138924460|NCT04063449|Endostar protein|endostar protein|mesh-list
138924461|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924462|NCT04063449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138593447|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138924463|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924464|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138924465|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138924466|NCT04063449|Growth Substances|growth substances|mesh-ancestor
138924467|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924468|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
138924469|NCT00700011|Clofarabine|clofarabine|mesh-list
138924470|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138924471|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
138924472|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924473|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924474|NCT05512767|Capecitabine|capecitabine|mesh-list
138924475|NCT05512767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138924476|NCT05512767|Antimetabolites|antimetabolites|mesh-ancestor
138924477|NCT05512767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452506|NCT01877122|Ibuprofen|ibuprofen|mesh-list
138924478|NCT05512767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924480|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
138924481|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924482|NCT02568423|Mirikizumab|mirikizumab|mesh-list
138924483|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138924484|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138924485|NCT02568423|Analgesics|analgesics|mesh-ancestor
138924486|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
138924487|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924488|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924489|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924490|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924491|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138924492|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138924493|NCT00921063|Alprazolam|alprazolam|mesh-list
138924494|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138924495|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138924496|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924497|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138924498|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138924499|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138924500|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
138924501|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
138924502|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924503|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924504|NCT00707031|Metformin|metformin|mesh-list
138924505|NCT00707031|Exenatide|exenatide|mesh-list
138924506|NCT00707031|Lixisenatide|lixisenatide|mesh-list
138924507|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138924508|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924509|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138924510|NCT00707031|Incretins|incretins|mesh-ancestor
138924511|NCT00707031|Hormones|hormones|mesh-ancestor
138924512|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138924513|NCT00711477|Naltrexone|naltrexone|mesh-list
138924514|NCT00711477|Bupropion|bupropion|mesh-list
138924515|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138924516|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138924517|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924518|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
138924519|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924520|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138924521|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
138924522|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138924523|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138924524|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138924525|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138924526|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924527|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
138924528|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924529|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138924530|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138924531|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924532|NCT00734474|Metformin|metformin|mesh-list
138924533|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138924534|NCT00734474|Dulaglutide|dulaglutide|mesh-list
138924535|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138924536|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924537|NCT00734474|Incretins|incretins|mesh-ancestor
138924538|NCT00734474|Hormones|hormones|mesh-ancestor
138924539|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138924540|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138924541|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
138924542|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924543|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924544|NCT00583362|Belimumab|belimumab|mesh-list
138593741|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924545|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138452518|NCT01877226|Tapentadol|tapentadol|mesh-list
138924546|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
138924547|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924548|NCT00577473|Mesalamine|mesalamine|mesh-list
138924549|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138924550|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138924551|NCT00577473|Analgesics|analgesics|mesh-ancestor
138924552|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
138924553|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924554|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924555|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924556|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924557|NCT00740103|Semapimod|semapimod|mesh-list
138924558|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138924559|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138924560|NCT00740103|Analgesics|analgesics|mesh-ancestor
138924561|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
138924562|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924563|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924564|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924565|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924566|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138924567|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
138924568|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
138924569|NCT02583828|Letrozole|letrozole|mesh-list
138924570|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138924571|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
138924572|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924573|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924574|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138924575|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
138924576|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924577|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593815|NCT00168870|Treosulfan|treosulfan|mesh-list
138924578|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138924579|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138924580|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138924581|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924582|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138924583|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
138924584|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138924585|NCT02568111|Interferons|interferons|mesh-list
138924586|NCT02568111|Interferon-beta|interferon-beta|mesh-list
138924587|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
138924588|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138924589|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924590|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
138924591|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138924592|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
138924593|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924594|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138924595|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138924596|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138924597|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138924598|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
138924599|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593846|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
138924600|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924601|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138924602|NCT00785291|Paclitaxel|paclitaxel|mesh-list
138924603|NCT00785291|Epothilones|epothilones|mesh-list
138924604|NCT00785291|Epothilone B|epothilone b|mesh-list
138924605|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138924606|NCT00785291|Bevacizumab|bevacizumab|mesh-list
138924607|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138924608|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
138924609|NCT00785291|Antibodies|antibodies|mesh-list
138924610|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
138924611|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138924612|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
138924613|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138924614|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924615|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
138924616|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
138924617|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
138924618|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924619|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138924620|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138924621|NCT00785291|Growth Substances|growth substances|mesh-ancestor
138924622|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924623|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
138593900|NCT00531895|Analgesics|analgesics|mesh-ancestor
138924624|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
138924626|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
138924627|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138924628|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138924629|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924630|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138924631|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924632|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138924633|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
138924634|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
138924635|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924636|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
138924637|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
138924638|NCT04063839|Grazoprevir|grazoprevir|mesh-list
138924639|NCT04063839|Ledipasvir|ledipasvir|mesh-list
138924640|NCT04063839|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138924641|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
138924642|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138924643|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
138924644|NCT00785213|Quinine|quinine|mesh-list
138924645|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138924646|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924647|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
138924648|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138924649|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138452538|NCT01877577|Vitamin D|vitamin d|mesh-list
138924650|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138924651|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138924652|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138924653|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924654|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138924655|NCT00785213|Analgesics|analgesics|mesh-ancestor
138924656|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
138924657|NCT02583594|Loratadine|loratadine|mesh-list
138924658|NCT02583594|Acyclovir|acyclovir|mesh-list
138924659|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
138924660|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
138924661|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
138924662|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924663|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
138924664|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
138924665|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594068|NCT02942758|Tretinoin|tretinoin|mesh-list
138924666|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924667|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138924668|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
138924669|NCT02583594|Hormones|hormones|mesh-ancestor
138924670|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138924671|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138924672|NCT02583594|Protective Agents|protective agents|mesh-ancestor
138924673|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442765|NCT01810601|Progesterone|progesterone|mesh-list
138442767|NCT01810601|Hormones|hormones|mesh-ancestor
138924674|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138924675|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
138594137|NCT00146042|Erythromycin|erythromycin|mesh-list
138924676|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138924677|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
138924678|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
138924679|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138924680|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138924681|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138594202|NCT00146120|Etoposide|etoposide|mesh-list
138924682|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
138924683|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
138924684|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924685|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924686|NCT00740415|Dexamethasone|dexamethasone|mesh-list
138924687|NCT00740415|Rituximab|rituximab|mesh-list
138924688|NCT00740415|Bortezomib|bortezomib|mesh-list
138924689|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138924690|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924691|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
138924692|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
138594264|NCT02277067|Carbetocin|carbetocin|mesh-list
138924693|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924694|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924695|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138924696|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
138924697|NCT00740415|Hormones|hormones|mesh-ancestor
138924698|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138924699|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138924700|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924701|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138924702|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
138924703|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924704|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138924705|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
138924706|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924707|NCT00734162|Tenofovir|tenofovir|mesh-list
138924708|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
138924709|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138924710|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138924711|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138924712|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924713|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924715|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138924716|NCT00740493|Warfarin|warfarin|mesh-list
138924717|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
138924718|NCT00740571|Pregabalin|pregabalin|mesh-list
138924719|NCT00740571|Amitriptyline|amitriptyline|mesh-list
138924720|NCT00740571|Analgesics|analgesics|mesh-ancestor
138924721|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
138924722|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924723|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924724|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
138924725|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138924726|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138924727|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924728|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138924729|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138924730|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138924731|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138924732|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138924733|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138924734|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
138924735|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138924736|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138924737|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138924738|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
138924739|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924741|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
138924742|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924743|NCT02595242|Prednisone|prednisone|mesh-list
138924744|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
138924745|NCT02595242|Vincristine|vincristine|mesh-list
138924746|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138924747|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
138924748|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924749|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924750|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138924751|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
138924752|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924753|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924754|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138924755|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138924756|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
138924757|NCT02595242|Hormones|hormones|mesh-ancestor
138770258|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
138594494|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138924758|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138924759|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138924760|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138924761|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
138924762|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
138924763|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
138924764|NCT04487106|Azacitidine|azacitidine|mesh-list
138924765|NCT04487106|Venetoclax|venetoclax|mesh-list
138924766|NCT04487106|Trametinib|trametinib|mesh-list
138924767|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138924768|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
138924769|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924770|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924771|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924772|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138924774|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
138924775|NCT02568033|Paclitaxel|paclitaxel|mesh-list
138924776|NCT02568033|Docetaxel|docetaxel|mesh-list
138924777|NCT02568033|Carboplatin|carboplatin|mesh-list
138924778|NCT02568033|Pemetrexed|pemetrexed|mesh-list
138442832|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
138924779|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138924780|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924781|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
138924782|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
138924783|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
138199751|NCT01004939|PENTA|penta|mesh-list
138924784|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924786|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138924787|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138924788|NCT00582972|Omeprazole|omeprazole|mesh-list
138924789|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138924790|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138924791|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138924792|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924793|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924794|NCT05224401|Amoxicillin|amoxicillin|mesh-list
138924795|NCT05224401|Ciprofloxacin|ciprofloxacin|mesh-list
138924796|NCT05224401|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138924797|NCT05224401|Clavulanic Acids|clavulanic acids|mesh-list
138924798|NCT05224401|Clavulanic Acid|clavulanic acid|mesh-list
138924799|NCT05224401|Ertapenem|ertapenem|mesh-list
138924800|NCT05224401|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
138924801|NCT05224401|Trimethoprim|trimethoprim|mesh-list
138924802|NCT05224401|Sulfamethoxazole|sulfamethoxazole|mesh-list
138924803|NCT05224401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138924804|NCT05224401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138924805|NCT05224401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138924806|NCT05224401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138924807|NCT05224401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924808|NCT05224401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924809|NCT05224401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924810|NCT05224401|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138924811|NCT05224401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138924812|NCT05224401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138924813|NCT05224401|Antimalarials|antimalarials|mesh-ancestor
138924814|NCT05224401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138924815|NCT05224401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138594669|NCT02938507|Solabegron|solabegron|mesh-list
138924816|NCT05224401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138924817|NCT05224401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138924818|NCT05224401|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138924819|NCT05224401|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138924821|NCT00918086|Vitamins|vitamins|mesh-ancestor
138924822|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
138924823|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924824|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138924826|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
138924827|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
138924828|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138924829|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924830|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
138924831|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924832|NCT04366908|Calcifediol|calcifediol|mesh-list
138924833|NCT04366908|Vitamins|vitamins|mesh-ancestor
138924834|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
138924835|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924836|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138924837|NCT00711243|Docetaxel|docetaxel|mesh-list
138924838|NCT00711243|Fluorouracil|fluorouracil|mesh-list
138924839|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
138924840|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924841|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
138924842|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
138924843|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
138924844|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924845|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
138594726|NCT02941510|Hormones|hormones|mesh-ancestor
138924846|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138924847|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138924848|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
138924849|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924850|NCT04366518|Scopolamine|scopolamine|mesh-list
138924852|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138924853|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138924854|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924855|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924856|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
138924857|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924858|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924859|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138924860|NCT04366518|Protective Agents|protective agents|mesh-ancestor
138924861|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138924863|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
138924866|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
138924867|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138924868|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138924869|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
138924870|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
138924871|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138924872|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
138924873|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924874|NCT04076436|Fosfomycin|fosfomycin|mesh-list
138924875|NCT04076436|Lactams|lactams|mesh-list
138924876|NCT04076436|beta-Lactams|beta-lactams|mesh-list
138924877|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452615|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
138924897|NCT00732992|Sunitinib|sunitinib|mesh-list
138924898|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924899|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138924900|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924901|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138924902|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138924903|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138924904|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138442875|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
138924905|NCT00732992|Growth Substances|growth substances|mesh-ancestor
138924906|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924907|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
138924908|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138924909|NCT00741195|Bevacizumab|bevacizumab|mesh-list
138924910|NCT00741195|Docetaxel|docetaxel|mesh-list
138924911|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138924912|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924913|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138924914|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138924915|NCT00741195|Growth Substances|growth substances|mesh-ancestor
138924916|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924917|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
138924918|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
138924919|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
138924920|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
138924921|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924922|NCT05338632|Naloxone|naloxone|mesh-list
138924923|NCT05338632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138924924|NCT05338632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924925|NCT05338632|Sensory System Agents|sensory system agents|mesh-ancestor
138924926|NCT05338632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924928|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
138924929|NCT00732758|Vitamins|vitamins|mesh-ancestor
138924930|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
138924931|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924932|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138924933|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138924934|NCT00741351|Fentanyl|fentanyl|mesh-list
138924935|NCT00741351|Remifentanil|remifentanil|mesh-list
138924936|NCT00741351|Propofol|propofol|mesh-list
138452648|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
138924938|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138924939|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138924940|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924941|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138924942|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
138924943|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
138924944|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138924945|NCT00741351|Narcotics|narcotics|mesh-ancestor
138924946|NCT00741351|Analgesics|analgesics|mesh-ancestor
138924947|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
138924948|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924949|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138924950|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138924951|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138924952|NCT02582190|Colchicine|colchicine|mesh-list
138924953|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
138924954|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924955|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
138924956|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
138924957|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
138924958|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924959|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138924960|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138924961|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138924962|NCT05742243|Insulin|insulin|mesh-list
138924963|NCT05742243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138924964|NCT05742243|Abatacept|abatacept|mesh-list
138924965|NCT05742243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138924966|NCT05742243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924967|NCT05742243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138594985|NCT00175734|Chrysarobin|chrysarobin|mesh-list
138924968|NCT05742243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924969|NCT05742243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138924971|NCT05742243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138924972|NCT05742243|Immunologic Factors|immunologic factors|mesh-ancestor
138924973|NCT05742243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138924974|NCT04076748|Sufentanil|sufentanil|mesh-list
138924975|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138924976|NCT04076748|Narcotics|narcotics|mesh-ancestor
138924977|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138924978|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924979|NCT04076748|Analgesics|analgesics|mesh-ancestor
138924980|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
138924981|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924982|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138924983|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138924984|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
138924985|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
138924986|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
138924987|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138924988|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138924989|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138924990|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138924991|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138924992|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
138924993|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138924994|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138924995|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138924996|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138924998|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
138924999|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
138925000|NCT00738530|Bevacizumab|bevacizumab|mesh-list
138925001|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138925002|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925003|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138925004|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138925006|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925007|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
138925008|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
138925009|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925010|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
138925011|NCT00711009|Ritonavir|ritonavir|mesh-list
138925012|NCT00711009|Lopinavir|lopinavir|mesh-list
138925013|NCT00711009|Tenofovir|tenofovir|mesh-list
138925014|NCT00711009|Emtricitabine|emtricitabine|mesh-list
138925015|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
138925016|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138925017|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138925018|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138925019|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
138925020|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925021|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925022|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138925023|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138925024|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
138925025|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925026|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138925027|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138925028|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138925029|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138925030|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138925031|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138925032|NCT00921219|Ivermectin|ivermectin|mesh-list
138925033|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138925034|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925035|NCT02567331|Capecitabine|capecitabine|mesh-list
138925036|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138925037|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
138925038|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925039|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925040|NCT00577005|Levetiracetam|levetiracetam|mesh-list
138925041|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
138925042|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
138925043|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
138925044|NCT02581566|Bupivacaine|bupivacaine|mesh-list
138925045|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
138925046|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
138925047|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925048|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925049|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
138925050|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925051|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138442961|NCT01812122|Glimepiride|glimepiride|mesh-list
138925052|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138925053|NCT02581566|Analgesics|analgesics|mesh-ancestor
138925054|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138925055|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138925056|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138925057|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
138925058|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925059|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925060|NCT00698841|Cetuximab|cetuximab|mesh-list
138925061|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138925062|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925063|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
138925064|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138925065|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138925066|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925067|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138925068|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925069|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138925070|NCT04062357|Lidocaine|lidocaine|mesh-list
138925071|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
138925072|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
138925073|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925074|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925075|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
138925076|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925077|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138925078|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138925079|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138925080|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138925081|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925082|NCT05190120|Ropivacaine|ropivacaine|mesh-list
138925083|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
138925084|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
138925085|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925086|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925087|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
138925088|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925090|NCT00738374|Chlorambucil|chlorambucil|mesh-list
138925091|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138925092|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925093|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
138925094|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925095|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138925096|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138925097|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
138925098|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925100|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138925101|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
138452710|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
138925102|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138925103|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
138925104|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925105|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925106|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
138925108|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138925109|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
138925110|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925111|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138925112|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138925113|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138925114|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595347|NCT02917525|Vitamin K|vitamin k|mesh-list
138925115|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925116|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138925117|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138925118|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925119|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
138925120|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925121|NCT04445025|Leuprolide|leuprolide|mesh-list
138925122|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138925123|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
138925124|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138925125|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925126|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138925127|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925128|NCT02580474|Asunaprevir|asunaprevir|mesh-list
138925129|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
138925130|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925131|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925132|NCT00738062|Droxidopa|droxidopa|mesh-list
138925133|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138925134|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138925135|NCT04156074|Vitamin D|vitamin d|mesh-list
138925136|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
138925137|NCT04156074|Cholecalciferol|cholecalciferol|mesh-list
138925138|NCT04156074|Vitamins|vitamins|mesh-list
138925139|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
138925140|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595477|NCT02916121|Folic Acid|folic acid|mesh-list
138925141|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138925142|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138925144|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
138925145|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
138925146|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925147|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925148|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
138925149|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925150|NCT04064073|Metformin|metformin|mesh-list
138925151|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138925152|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925153|NCT04137354|Vitamins|vitamins|mesh-list
138925155|NCT04137354|Iron|iron|mesh-list
138925156|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
138925157|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
138925158|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925159|NCT04137354|Trace Elements|trace elements|mesh-ancestor
138925160|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
138925161|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925162|NCT04137354|Protective Agents|protective agents|mesh-ancestor
138925163|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138925164|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925165|NCT04902729|Oxytocin|oxytocin|mesh-list
138925166|NCT04902729|Carbetocin|carbetocin|mesh-list
138925167|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
138925168|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138595665|NCT05780424|Remdesivir|remdesivir|mesh-list
138925169|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925170|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
138925171|NCT00698685|Pentostatin|pentostatin|mesh-list
138925172|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138925173|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925174|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138925175|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925176|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925177|NCT00737438|Bevacizumab|bevacizumab|mesh-list
138925178|NCT00737438|Docetaxel|docetaxel|mesh-list
138925179|NCT00737438|Capecitabine|capecitabine|mesh-list
138925180|NCT00737438|Irinotecan|irinotecan|mesh-list
138925181|NCT00737438|Epirubicin|epirubicin|mesh-list
138595736|NCT05355935|Moxifloxacin|moxifloxacin|mesh-list
138925182|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138925183|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925184|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138925185|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138925186|NCT00737438|Growth Substances|growth substances|mesh-ancestor
138925187|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925188|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
138925189|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
138925190|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
138925191|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
138925192|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925193|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138925194|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
138925195|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138925196|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138925197|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925198|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138925199|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138925200|NCT00737048|Acetaminophen|acetaminophen|mesh-list
138925201|NCT00737048|Tramadol|tramadol|mesh-list
138925202|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138925203|NCT00737048|Analgesics|analgesics|mesh-ancestor
138925204|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
138595861|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925205|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925206|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925207|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
138925208|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138925209|NCT00737048|Narcotics|narcotics|mesh-ancestor
138925210|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925211|NCT02593448|Anesthetics|anesthetics|mesh-list
138925212|NCT02593448|Propofol|propofol|mesh-list
138452751|NCT01879033|Insulin|insulin|mesh-list
138925213|NCT02593448|Sevoflurane|sevoflurane|mesh-list
138925214|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925215|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925216|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138925218|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
138925219|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138925220|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138925221|NCT02592746|Capecitabine|capecitabine|mesh-list
138925222|NCT02592746|Palbociclib|palbociclib|mesh-list
138925223|NCT02592746|Leuprolide|leuprolide|mesh-list
138925224|NCT02592746|Exemestane|exemestane|mesh-list
138925225|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138595986|NCT04511247|Sirolimus|sirolimus|mesh-list
138925226|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
138577197|NCT00462553|Growth Substances|growth substances|mesh-ancestor
138925227|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925228|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925229|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138925230|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925231|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138925232|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
138925233|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138925234|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443072|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
138925235|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138925236|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138925237|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138925238|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138925239|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
138925240|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138925241|NCT00731120|Vortioxetine|vortioxetine|mesh-list
138925242|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
138925243|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138925244|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138925245|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138925246|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925247|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925248|NCT00731120|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138925249|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138925250|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138925251|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925252|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925253|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
138925254|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138925255|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138925256|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138925257|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138925258|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
138925259|NCT02580006|Hematinics|hematinics|mesh-ancestor
138925260|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138452764|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138925261|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138925262|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596053|NCT04236609|Sirolimus|sirolimus|mesh-list
138925263|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
138925264|NCT02787642|Olaparib|olaparib|mesh-list
138925265|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138925266|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925267|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925268|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925269|NCT04075188|Aflibercept|aflibercept|mesh-list
138925270|NCT04075188|Verteporfin|verteporfin|mesh-list
138925271|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138925272|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138443097|NCT01812954|Acitretin|acitretin|mesh-list
138925273|NCT04075188|Growth Substances|growth substances|mesh-ancestor
138925274|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925275|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
138925276|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925277|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138925278|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
138925279|NCT00726986|Etoposide|etoposide|mesh-list
138925280|NCT00726986|Sorafenib|sorafenib|mesh-list
138925281|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925282|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138925283|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138925284|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138925285|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596089|NCT04127786|Vaccines|vaccines|mesh-list
138925286|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925287|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138925288|NCT00696657|Liraglutide|liraglutide|mesh-list
138925289|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138925290|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925291|NCT00696657|Incretins|incretins|mesh-ancestor
138925292|NCT00696657|Hormones|hormones|mesh-ancestor
138925293|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138925294|NCT00726752|Axitinib|axitinib|mesh-list
138925295|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925296|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138925297|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925298|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925299|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
138925300|NCT02594462|Etonogestrel|etonogestrel|mesh-list
138925301|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138925302|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577313|NCT00463762|Sulbactam|sulbactam|mesh-list
138925303|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138925304|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138925305|NCT02664558|Ubenimex|ubenimex|mesh-list
138596143|NCT03762096|Resveratrol|resveratrol|mesh-list
138925306|NCT02664558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138925307|NCT02664558|Immunologic Factors|immunologic factors|mesh-ancestor
138925308|NCT02664558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925309|NCT02664558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138925310|NCT02664558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443130|NCT01813162|Tenofovir|tenofovir|mesh-list
138925311|NCT02664558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138925312|NCT02664558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925313|NCT02664558|Protease Inhibitors|protease inhibitors|mesh-ancestor
138925314|NCT02664558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925315|NCT02664558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925316|NCT02664558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138925317|NCT02664558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138925318|NCT02664558|Antiviral Agents|antiviral agents|mesh-ancestor
138925320|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138925321|NCT02566707|Dolutegravir|dolutegravir|mesh-list
138925322|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138925323|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138925325|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925326|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
138925327|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925328|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138925329|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138925330|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138925331|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138925332|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
138925333|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138925334|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138925335|NCT04063683|Paclitaxel|paclitaxel|mesh-list
138925336|NCT04063683|Cisplatin|cisplatin|mesh-list
138925337|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138925338|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925339|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
138925340|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
138925341|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
138925342|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925343|NCT00921531|Thalidomide|thalidomide|mesh-list
138925344|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138925345|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
138925346|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925347|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
138596310|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925348|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138925349|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925350|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138925351|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138925352|NCT00921531|Growth Substances|growth substances|mesh-ancestor
138925353|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
138925354|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925355|NCT00730028|Clindamycin|clindamycin|mesh-list
138925356|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
138925357|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
138925358|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138925359|NCT00730028|Trimethoprim|trimethoprim|mesh-list
138925360|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
138925361|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138925362|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925363|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138925364|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925365|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925366|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138925367|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
138925368|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138925369|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138925370|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138925371|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138925372|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138925373|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138925374|NCT04088084|Palmidrol|palmidrol|mesh-list
138925375|NCT04088084|Analgesics|analgesics|mesh-ancestor
138925376|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
138925377|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925378|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925379|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138925381|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138925382|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138925383|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
138925384|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925385|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138925386|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138925387|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925388|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925390|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138925391|NCT02593370|Lidocaine|lidocaine|mesh-list
138925392|NCT02593370|Epinephrine|epinephrine|mesh-list
138925393|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138925394|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
138925395|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
138443206|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
138925396|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925397|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925398|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
138596560|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
138925399|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925400|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138925401|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138925402|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138925403|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138925404|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925405|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138925406|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138925407|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
138925408|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925409|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138925410|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138925411|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
138925412|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138925413|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
138925414|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
138925415|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
138925416|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138925417|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
138925418|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
138925419|NCT00918320|Temozolomide|temozolomide|mesh-list
138925420|NCT00918320|Topotecan|topotecan|mesh-list
138925421|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138925422|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
138925423|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925424|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925425|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138925426|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138925427|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925428|NCT00729560|Flutamide|flutamide|mesh-list
138925429|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
138925430|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
138925431|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138925432|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925433|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138925434|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925435|NCT00736190|Tenofovir|tenofovir|mesh-list
138925436|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
138925437|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925438|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138452900|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
138925439|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138925440|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273040|NCT02976272|Bortezomib|bortezomib|mesh-list
138925441|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925442|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138925443|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138443240|NCT01813643|Risperidone|risperidone|mesh-list
138925444|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138925445|NCT00729326|Exenatide|exenatide|mesh-list
138925446|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138925447|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925448|NCT00729326|Incretins|incretins|mesh-ancestor
138925449|NCT00729326|Hormones|hormones|mesh-ancestor
138577440|NCT00464971|Estradiol|estradiol|mesh-list
138925450|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138925451|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138925452|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
138925453|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925454|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925455|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138925456|NCT02565303|Ropivacaine|ropivacaine|mesh-list
138925457|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
138925458|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
138925459|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925460|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925461|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
138925462|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925463|NCT00698451|Bevacizumab|bevacizumab|mesh-list
138925464|NCT00698451|Carboplatin|carboplatin|mesh-list
138925465|NCT00698451|Doxorubicin|doxorubicin|mesh-list
138925466|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138925467|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138925468|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925469|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138925470|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138925471|NCT00698451|Growth Substances|growth substances|mesh-ancestor
138925472|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925473|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
138925474|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138925475|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138925476|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138925477|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925478|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925479|NCT03980925|Carboplatin|carboplatin|mesh-list
138925480|NCT03980925|Nivolumab|nivolumab|mesh-list
138925481|NCT03980925|Etoposide|etoposide|mesh-list
138925482|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925483|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138925484|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138925485|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925486|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138925487|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138925488|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138925489|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925490|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
138925491|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138925492|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138925493|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138925494|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
138925495|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138925496|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
138925497|NCT02565693|Aspirin|aspirin|mesh-list
138925498|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
138925499|NCT02565693|Dipyridamole|dipyridamole|mesh-list
138925500|NCT02565693|Apixaban|apixaban|mesh-list
138925501|NCT02565693|Clopidogrel|clopidogrel|mesh-list
138925502|NCT02565693|Calcium|calcium|mesh-list
138925503|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138925504|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925505|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138925506|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138925507|NCT02565693|Analgesics|analgesics|mesh-ancestor
138925508|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
138925509|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925510|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138925511|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138925512|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138925513|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138925514|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925515|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138925516|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138925517|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925518|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
138925519|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138596756|NCT02712814|Estrogens|estrogens|mesh-list
138925520|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138925521|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138925522|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
138925523|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925524|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138925525|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
138925526|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138925527|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
138925528|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
138925529|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138925530|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
138925532|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138925533|NCT04061655|Trace Elements|trace elements|mesh-ancestor
138925534|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
138925535|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925537|NCT04061265|Lidocaine|lidocaine|mesh-list
138925538|NCT04061265|Epinephrine|epinephrine|mesh-list
138925539|NCT04061265|Carticaine|carticaine|mesh-list
138925540|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
138925541|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
138925542|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925543|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925544|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
138925545|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925546|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138925547|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138925548|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138925549|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138925550|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925551|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138925552|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138925553|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
138925554|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596880|NCT03777904|Iron|iron|mesh-list
138925555|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138925556|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138925557|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
138925558|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138925559|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
138925560|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
138925561|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
138925562|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138925563|NCT02592980|Warfarin|warfarin|mesh-list
138925564|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
138925565|NCT00727844|Linezolid|linezolid|mesh-list
138925566|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138925567|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925568|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138925569|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925570|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925571|NCT00735878|Carboplatin|carboplatin|mesh-list
138925572|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925573|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138925574|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
138925575|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138925576|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138925577|NCT00695955|Diuretics|diuretics|mesh-ancestor
138925578|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
138925579|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925580|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138925581|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138925582|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925583|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138925584|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138925585|NCT00693225|Omeprazole|omeprazole|mesh-list
138925586|NCT00693225|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
138925587|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138925588|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138925589|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138925590|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925591|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925592|NCT00735644|Vaccines|vaccines|mesh-list
138925593|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
138925594|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925595|NCT02591888|Bupivacaine|bupivacaine|mesh-list
138925596|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
138925597|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
138925598|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925599|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925600|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
138925601|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925602|NCT00724958|Infliximab|infliximab|mesh-list
138925603|NCT00724958|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138925604|NCT00724958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138925605|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
138925606|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138925607|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138925608|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
138925609|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138925610|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
138925611|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925612|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
138925613|NCT04088006|Protective Agents|protective agents|mesh-ancestor
138925615|NCT00695565|Analgesics|analgesics|mesh-ancestor
138925616|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
138925617|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925618|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925619|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138925620|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
138925621|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
138925622|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138925623|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138596943|NCT04723836|Riboflavin|riboflavin|mesh-list
138925624|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138925625|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
138925626|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925627|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925629|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925630|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138925631|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925632|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925634|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138925635|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
138925636|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925637|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925638|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925639|NCT00720902|Hormones|hormones|mesh-list
138596986|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
138925640|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
138925641|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138925642|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925644|NCT02592278|Fluorides|fluorides|mesh-list
138925645|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
138925646|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
138925647|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
138925648|NCT02592278|Protective Agents|protective agents|mesh-ancestor
138925649|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925650|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138925651|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925652|NCT00695019|Interferons|interferons|mesh-list
138925653|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
138925654|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
138925655|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138925656|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925657|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
138597053|NCT05467384|Amlodipine|amlodipine|mesh-list
138925658|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925659|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
138925660|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925661|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138925662|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
138925663|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925664|NCT00742911|Copper|copper|mesh-list
138925665|NCT00742911|Disulfiram|disulfiram|mesh-list
138925666|NCT00742911|Trace Elements|trace elements|mesh-ancestor
138925667|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
138925668|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925669|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138925670|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138925671|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925672|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925673|NCT00694707|Risperidone|risperidone|mesh-list
138925674|NCT00694707|Cariprazine|cariprazine|mesh-list
138925675|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138925676|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
138925678|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925679|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925680|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138925681|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138925682|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138597167|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138925683|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138200594|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
138925684|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138925685|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
138925686|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
138925688|NCT00692913|Alendronate|alendronate|mesh-list
138925689|NCT00692913|Calcium|calcium|mesh-list
138925690|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138925691|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925692|NCT00692913|Vitamins|vitamins|mesh-ancestor
138925693|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
138925694|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138925695|NCT00694551|Poly I-C|poly i-c|mesh-list
138925696|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138925697|NCT00694551|Vaccines|vaccines|mesh-list
138925698|NCT00694551|Poly ICLC|poly iclc|mesh-list
138925699|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
138925700|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925701|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
138925702|NCT00694551|Laxatives|laxatives|mesh-ancestor
138925703|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138925704|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
138925705|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925706|NCT02603705|Oxycodone|oxycodone|mesh-list
138925707|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138925708|NCT02603705|Narcotics|narcotics|mesh-ancestor
138925709|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925710|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925711|NCT02603705|Analgesics|analgesics|mesh-ancestor
138925712|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
138925713|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925714|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138925715|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
138453013|NCT01881347|Resveratrol|resveratrol|mesh-list
138925716|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138925717|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925718|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138925719|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138925720|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138925721|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925722|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
138925723|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925724|NCT00915785|Azacitidine|azacitidine|mesh-list
138925725|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138925726|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
138925727|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925728|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925729|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925730|NCT00776009|Methylphenidate|methylphenidate|mesh-list
138925731|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
138925732|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138925733|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925734|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138925735|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138925736|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138925737|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925738|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
138597268|NCT00532675|Lenalidomide|lenalidomide|mesh-list
138925739|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925740|NCT00720356|Bevacizumab|bevacizumab|mesh-list
138925741|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138925742|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138925743|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925744|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138925745|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138925746|NCT00720356|Growth Substances|growth substances|mesh-ancestor
138925747|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925748|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
138925749|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138925750|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925751|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925752|NCT00745953|Valsartan|valsartan|mesh-list
138925753|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138925754|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138925755|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138925756|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138925757|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925758|NCT00745953|Diuretics|diuretics|mesh-ancestor
138925759|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
138925760|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925761|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138925762|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138925763|NCT00720278|Azelastine|azelastine|mesh-list
138925764|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138925765|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
138925766|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925767|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925768|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138925769|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
138925770|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138925771|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925772|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925773|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138925774|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138925775|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138925776|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
138925777|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
138925778|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925779|NCT00746031|Goserelin|goserelin|mesh-list
138925780|NCT00746031|Cetrorelix|cetrorelix|mesh-list
138925781|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138925782|NCT00746031|Hormones|hormones|mesh-ancestor
138925783|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138925784|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925785|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138925786|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925787|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138925788|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
138925789|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138925790|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
138925791|NCT00720122|Insulin|insulin|mesh-list
138925792|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138925793|NCT00720122|Mitogens|mitogens|mesh-list
138925795|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138925796|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925797|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
138925798|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925799|NCT00720122|Growth Substances|growth substances|mesh-ancestor
138925800|NCT00743847|Varenicline|varenicline|mesh-list
138925801|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138925802|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138925803|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
138925804|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925805|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925806|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925807|NCT00717860|Caspofungin|caspofungin|mesh-list
138925808|NCT00717860|Micafungin|micafungin|mesh-list
138925809|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
138925810|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925811|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925812|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925813|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
138925814|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138597433|NCT04687111|Valsartan|valsartan|mesh-list
138925815|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138925816|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
138925817|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925818|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138925819|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138925820|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925821|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925822|NCT02592122|Bromides|bromides|mesh-list
138925823|NCT02592122|Albuterol|albuterol|mesh-list
138925824|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
138925825|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138925826|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
138925827|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925828|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925829|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138925830|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
138925831|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
138925832|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138925833|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138925834|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138925835|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138925836|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
138925837|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925838|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925839|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
138925840|NCT00923637|Pemetrexed|pemetrexed|mesh-list
138925841|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925842|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925843|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925844|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138925845|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138925846|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
138925847|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138925848|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925849|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138925850|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
138925851|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138925852|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925853|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925854|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925855|NCT01090089|Dexamethasone|dexamethasone|mesh-list
138925856|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
138925857|NCT01090089|Lenalidomide|lenalidomide|mesh-list
138925858|NCT01090089|BB 1101|bb 1101|mesh-list
138925859|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138925860|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
138925861|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
138925862|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925863|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925864|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138925865|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
138925866|NCT01090089|Hormones|hormones|mesh-ancestor
138925867|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138925868|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138925869|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925870|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
138925871|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925872|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925873|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
138925874|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138925875|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138925876|NCT01090089|Growth Substances|growth substances|mesh-ancestor
138925877|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
138925878|NCT00689793|Iron|iron|mesh-list
138925879|NCT00689793|Trace Elements|trace elements|mesh-ancestor
138925880|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
138925881|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925882|NCT04086290|Androgens|androgens|mesh-list
138925883|NCT04086290|Hormones|hormones|mesh-ancestor
138925884|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138925885|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925886|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
138925887|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138925888|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138925889|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
138925890|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
138925891|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925892|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925893|NCT02563353|Teriparatide|teriparatide|mesh-list
138925894|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138925895|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925896|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138925897|NCT00688701|Lixisenatide|lixisenatide|mesh-list
138925898|NCT00688701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138925899|NCT00688701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925900|NCT00744549|Vitamin D|vitamin d|mesh-list
138925901|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
138925902|NCT00744549|Vitamins|vitamins|mesh-list
138925903|NCT00744549|Vitamin E|vitamin e|mesh-list
138925904|NCT00744549|Selenium|selenium|mesh-list
138925905|NCT00744549|Lycopene|lycopene|mesh-list
138925906|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
138925907|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200818|NCT00002704|Vitamins|vitamins|mesh-ancestor
138925908|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138925909|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138925911|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925912|NCT00744549|Protective Agents|protective agents|mesh-ancestor
138925913|NCT00744549|Trace Elements|trace elements|mesh-ancestor
138925914|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138925915|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138925916|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138925917|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925918|NCT00746655|Cisplatin|cisplatin|mesh-list
138925919|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925920|NCT00741429|Insulin|insulin|mesh-list
138925921|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138925922|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925923|NCT00741507|Ethanol|ethanol|mesh-list
138925924|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138925925|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925926|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925927|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925928|NCT00688623|Everolimus|everolimus|mesh-list
138925929|NCT00688623|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138925930|NCT00688623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138925931|NCT00688623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138925932|NCT00688623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925933|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138925934|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
138925935|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925936|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925937|NCT02563821|Clonidine|clonidine|mesh-list
138925938|NCT02563821|Sufentanil|sufentanil|mesh-list
138925939|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
138925940|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138925941|NCT02563821|Narcotics|narcotics|mesh-ancestor
138925942|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138925943|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925944|NCT02563821|Analgesics|analgesics|mesh-ancestor
138925945|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
138925946|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925947|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138925948|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138925949|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
138925950|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
138925951|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138925952|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
138925953|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
138925954|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138925955|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138925956|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138925957|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
138925958|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138925959|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925960|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
138925961|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
138925962|NCT00717236|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138925963|NCT00717236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138925964|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138925965|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
138925966|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925967|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138925968|NCT04085354|Vitamins|vitamins|mesh-list
138925969|NCT04085354|Folic Acid|folic acid|mesh-list
138925970|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
138925971|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
138925972|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
138925973|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925974|NCT04085354|Hematinics|hematinics|mesh-ancestor
138211899|NCT00385580|Dasatinib|dasatinib|mesh-list
138925975|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
138577949|NCT03277261|Analgesics|analgesics|mesh-ancestor
138925976|NCT00719810|Tigecycline|tigecycline|mesh-list
138925977|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
138925978|NCT00719810|Delafloxacin|delafloxacin|mesh-list
138925979|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138925980|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925981|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138925982|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524549|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925983|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138925984|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138925986|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
138925987|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
138925988|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138925989|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
138925990|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138925991|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
138925992|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138925993|NCT00688545|Celecoxib|celecoxib|mesh-list
138925994|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138925995|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138925996|NCT00688545|Analgesics|analgesics|mesh-ancestor
138925997|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
138925998|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138925999|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926000|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926001|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138926002|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138926003|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138926004|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926005|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926006|NCT04060407|Nivolumab|nivolumab|mesh-list
138926007|NCT04060407|Ipilimumab|ipilimumab|mesh-list
138926008|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138926009|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926010|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138926011|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926012|NCT00741585|Atenolol|atenolol|mesh-list
138926013|NCT00741585|Amlodipine|amlodipine|mesh-list
138926014|NCT00741585|Valsartan|valsartan|mesh-list
138926015|NCT00741585|Telmisartan|telmisartan|mesh-list
138926016|NCT00741585|Carvedilol|carvedilol|mesh-list
138926017|NCT00741585|Candesartan|candesartan|mesh-list
138926018|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
138926019|NCT00741585|Ramipril|ramipril|mesh-list
138926020|NCT00741585|Olmesartan|olmesartan|mesh-list
138926021|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138926022|NCT00741585|Enalapril|enalapril|mesh-list
138926023|NCT00741585|Enalaprilat|enalaprilat|mesh-list
138926024|NCT00741585|Lisinopril|lisinopril|mesh-list
138926025|NCT00741585|Irbesartan|irbesartan|mesh-list
138926026|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
138926027|NCT00741585|Quinapril|quinapril|mesh-list
138926028|NCT00741585|Lercanidipine|lercanidipine|mesh-list
138926029|NCT00741585|Manidipine|manidipine|mesh-list
138926030|NCT00741585|Doxazosin|doxazosin|mesh-list
138926031|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138926032|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138926033|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926034|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138926035|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926036|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
138926037|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138926038|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138926039|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138926040|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138926041|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
138926042|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926043|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
138926044|NCT00741585|Protective Agents|protective agents|mesh-ancestor
138926045|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138926046|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138926047|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138926048|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
138926049|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926050|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138926051|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138926052|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
138926053|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
138926054|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926055|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138926056|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
138926057|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
138926058|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138926059|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138443569|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
138926061|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926062|NCT00746967|Urological Agents|urological agents|mesh-ancestor
138926063|NCT02563041|Heparin|heparin|mesh-list
138926064|NCT02563041|Calcium heparin|calcium heparin|mesh-list
138926065|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
138926066|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926067|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138926068|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138926069|NCT00741663|Furosemide|furosemide|mesh-list
138926070|NCT00741663|Spironolactone|spironolactone|mesh-list
138926071|NCT00741663|Diuretics|diuretics|mesh-ancestor
138926072|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
138926073|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926074|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138926075|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138926076|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926077|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138926078|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
138926079|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138926080|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138926081|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
138453085|NCT01882179|Hormones|hormones|mesh-ancestor
138926082|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138926084|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138926085|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138926086|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926087|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926088|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
138926089|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926090|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138926091|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138926092|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138926093|NCT00745173|Estrogens|estrogens|mesh-ancestor
138926094|NCT00745173|Hormones|hormones|mesh-ancestor
138926095|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138926096|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926097|NCT04060095|Anesthetics|anesthetics|mesh-list
138926098|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138926099|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926100|NCT00741897|Fexofenadine|fexofenadine|mesh-list
138926101|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138926102|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138926103|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138926104|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
138926105|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
138926106|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926107|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926108|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926109|NCT00745407|Fenofibrate|fenofibrate|mesh-list
138926110|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138926111|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
138597878|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
138926112|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926113|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138926114|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
138926115|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138926116|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926118|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138926119|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926120|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
138926122|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
138926123|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926124|NCT00742287|Protective Agents|protective agents|mesh-ancestor
138926125|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926126|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138926127|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138926128|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926129|NCT00747669|Lidocaine|lidocaine|mesh-list
138926130|NCT00747669|Tetracaine|tetracaine|mesh-list
138926131|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
138926132|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
138926133|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138926134|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926135|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
138926136|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926137|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138926138|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138926139|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138926140|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138926141|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926143|NCT00690573|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138926144|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926145|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138926146|NCT00719264|Interferons|interferons|mesh-list
138926147|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
138926148|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
138926149|NCT00719264|Bevacizumab|bevacizumab|mesh-list
138926151|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138926152|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926153|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138926154|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138926155|NCT00719264|Growth Substances|growth substances|mesh-ancestor
138926156|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926157|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
138926158|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
138926159|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926160|NCT00719264|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138926161|NCT00719264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138926162|NCT00719264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926163|NCT00719264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926164|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138926165|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
138926166|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138926167|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138926168|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138926169|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138926170|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926171|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
138926172|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926173|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926174|NCT00751959|Poractant alfa|poractant alfa|mesh-list
138926175|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138926176|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
138926177|NCT00723554|Iloprost|iloprost|mesh-list
138926178|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138926179|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
138926180|NCT00687219|Ribavirin|ribavirin|mesh-list
138926181|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138926182|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
138926183|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926184|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
138926185|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926186|NCT04085120|Dexamethasone|dexamethasone|mesh-list
138926187|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
138926188|NCT04085120|Lidocaine|lidocaine|mesh-list
138926189|NCT04085120|Ropivacaine|ropivacaine|mesh-list
138926190|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926191|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
138926192|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
138926193|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926194|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926195|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138926196|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
138926197|NCT04085120|Hormones|hormones|mesh-ancestor
138926198|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138926199|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138926200|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926201|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
138578172|NCT00478504|Clomiphene|clomiphene|mesh-list
138926202|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
138926203|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138926204|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
138926205|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138926206|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138598215|NCT00153881|Carboplatin|carboplatin|mesh-list
138926207|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138926209|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926210|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138926211|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138926212|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
138926213|NCT02562183|Kallikreins|kallikreins|mesh-list
138926214|NCT02562183|Coagulants|coagulants|mesh-ancestor
138341685|NCT01562886|Rilpivirine|rilpivirine|mesh-list
138926215|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
138926216|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
138926217|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138926218|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926219|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138926220|NCT00723398|Pitavastatin|pitavastatin|mesh-list
138926221|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138926222|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138926223|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138926224|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
138926225|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926226|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926227|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138926228|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138926229|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
138926230|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138926231|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926232|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138926233|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138926234|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138926235|NCT00716456|Cetuximab|cetuximab|mesh-list
138926236|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138926237|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138926238|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926239|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138926240|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926241|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926242|NCT00684645|Sunitinib|sunitinib|mesh-list
138926243|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926244|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138926245|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138926246|NCT00684645|Growth Substances|growth substances|mesh-ancestor
138926247|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926248|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
138926249|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138926250|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926251|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926252|NCT00752037|Ritonavir|ritonavir|mesh-list
138926253|NCT00752037|Lopinavir|lopinavir|mesh-list
138926254|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
138926255|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138926256|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138926257|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
138926258|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926259|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926260|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138926261|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138926262|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
138926263|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926264|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138926265|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138926266|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138926267|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138926268|NCT00716144|R 115866|r 115866|mesh-list
138926269|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138926270|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926271|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926272|NCT00752115|Paclitaxel|paclitaxel|mesh-list
138926273|NCT00752115|Carboplatin|carboplatin|mesh-list
138926274|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
138926275|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138578257|NCT00479206|Artesunate|artesunate|mesh-list
138926276|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926277|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
138926278|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
138926279|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
138926280|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926282|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138926283|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138926284|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926285|NCT00752115|Urological Agents|urological agents|mesh-ancestor
138926286|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
138926287|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
138926288|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138926289|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926290|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138926291|NCT00749385|Naproxen|naproxen|mesh-list
138926292|NCT00749385|Esomeprazole|esomeprazole|mesh-list
138926293|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138926294|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138926295|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138926296|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926297|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926298|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138926299|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138926300|NCT00749385|Analgesics|analgesics|mesh-ancestor
138926301|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
138926302|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926303|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926304|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926305|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138926306|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
138926307|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138926308|NCT00748059|Propranolol|propranolol|mesh-list
138926309|NCT00748059|Atropine|atropine|mesh-list
138926310|NCT00748059|Clonidine|clonidine|mesh-list
138926311|NCT00748059|Nitroprusside|nitroprusside|mesh-list
138926312|NCT00748059|Methyldopa|methyldopa|mesh-list
138926313|NCT00748059|Phenylephrine|phenylephrine|mesh-list
138926314|NCT00748059|Isoproterenol|isoproterenol|mesh-list
138926315|NCT00748059|Metoclopramide|metoclopramide|mesh-list
138926316|NCT00748059|Yohimbine|yohimbine|mesh-list
138926317|NCT00748059|Tyramine|tyramine|mesh-list
138926318|NCT00748059|Edrophonium|edrophonium|mesh-list
138926319|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138926320|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138926321|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
138926322|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926323|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926324|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926325|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138926326|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138926327|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
138926328|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138926329|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
138926330|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
138926331|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926332|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
138926333|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138926334|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
138926335|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
138926336|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138926337|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138926338|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138926339|NCT00748059|Protective Agents|protective agents|mesh-ancestor
138926340|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138926341|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138926342|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138926343|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
138926344|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138926345|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138926346|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
138926347|NCT00748059|Analgesics|analgesics|mesh-ancestor
138926348|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
138926349|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
138926350|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138926351|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
138926352|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138926353|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138926354|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138926355|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
138926356|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138926357|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138926358|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138926359|NCT00748059|Urological Agents|urological agents|mesh-ancestor
138926360|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138926361|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138926362|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138926363|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138926364|NCT00748059|Antidotes|antidotes|mesh-ancestor
138926365|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138926366|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926367|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
138926368|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138926369|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138926370|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926372|NCT00576381|Analgesics|analgesics|mesh-ancestor
138926373|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
138926374|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926375|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138926376|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138926377|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138926378|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
138926379|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926380|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926381|NCT02562417|Dexamethasone|dexamethasone|mesh-list
138598718|NCT02918110|Misoprostol|misoprostol|mesh-list
138926382|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926384|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
138926385|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926386|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926387|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138926388|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
138926389|NCT02562417|Hormones|hormones|mesh-ancestor
138926390|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138926391|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138926392|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926393|NCT00749619|Taurolidine|taurolidine|mesh-list
138926394|NCT00749619|Heparin|heparin|mesh-list
138926395|NCT00749619|Calcium heparin|calcium heparin|mesh-list
138926396|NCT00749619|Citric Acid|citric acid|mesh-list
138926397|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
138926398|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138926399|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
138926400|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138926401|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
138926402|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
138926403|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926404|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138453139|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
138926405|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138926406|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926407|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138926408|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926410|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138926411|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138926412|NCT00748371|Analgesics|analgesics|mesh-ancestor
138926413|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
138926414|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926415|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926416|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926417|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138926418|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138926419|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138926420|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926421|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138926422|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138926423|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926424|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
138926425|NCT00749853|Buserelin|buserelin|mesh-list
138926426|NCT00749853|Hormones|hormones|mesh-list
138926427|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138926428|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138926429|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926430|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138926431|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
138926432|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138926433|NCT00684567|Temozolomide|temozolomide|mesh-list
138926434|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138926435|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
138926436|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926438|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138926439|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138926440|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138926441|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138926442|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926443|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138926444|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138926445|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138926446|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
138926447|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926448|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926449|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138926450|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138926451|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
138926452|NCT04053621|Thiamine|thiamine|mesh-list
138926453|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
138926454|NCT04053621|Metformin|metformin|mesh-list
138926455|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138926456|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926457|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
138926458|NCT04053621|Vitamins|vitamins|mesh-ancestor
138926459|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
138926460|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
138926461|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926462|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138926463|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926464|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926465|NCT02562651|Doxycycline|doxycycline|mesh-list
138926466|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138926467|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926468|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
138926469|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138926470|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138926471|NCT00748527|Carboplatin|carboplatin|mesh-list
138926472|NCT00748527|Decitabine|decitabine|mesh-list
138926473|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926474|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138926475|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
138926476|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926477|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926478|NCT00686829|Maleic acid|maleic acid|mesh-list
138926479|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926480|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926481|NCT00687297|Carboplatin|carboplatin|mesh-list
138926482|NCT00687297|Docetaxel|docetaxel|mesh-list
138926483|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926484|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
138926485|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
138926486|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
138926487|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926488|NCT00684177|Retapamulin|retapamulin|mesh-list
138926489|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138926490|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926491|NCT00752661|Tramadol|tramadol|mesh-list
138926492|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138926493|NCT00752661|Narcotics|narcotics|mesh-ancestor
138926494|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138926495|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926496|NCT00752661|Analgesics|analgesics|mesh-ancestor
138926497|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
138926498|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926499|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
138926500|NCT00576303|Hematinics|hematinics|mesh-ancestor
138926501|NCT00752739|Selenium|selenium|mesh-list
138926502|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
138926503|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926504|NCT00752739|Protective Agents|protective agents|mesh-ancestor
138926505|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926506|NCT00752739|Trace Elements|trace elements|mesh-ancestor
138926507|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
138926508|NCT00755781|Cyclosporine|cyclosporine|mesh-list
138926509|NCT00755781|Cyclosporins|cyclosporins|mesh-list
138926510|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926511|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926512|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138926513|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
138926514|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926515|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
138926516|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926517|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
138599112|NCT02500147|Metformin|metformin|mesh-list
138926518|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138926519|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138926520|NCT00755859|Prednisone|prednisone|mesh-list
138926521|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138926522|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138926523|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
138926524|NCT00755859|Prednisolone|prednisolone|mesh-list
138926525|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
138926526|NCT00755859|Azathioprine|azathioprine|mesh-list
138926527|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138926528|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
138926529|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
138926530|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926531|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138926532|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926533|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138926535|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926536|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138926537|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926538|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
138926540|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138926541|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138926542|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138926543|NCT00755859|Protective Agents|protective agents|mesh-ancestor
138926544|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
138926545|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
138926546|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926547|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138926548|NCT00686517|Interferons|interferons|mesh-list
138926549|NCT00686517|Ribavirin|ribavirin|mesh-list
138926550|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
138926551|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
138926552|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138926553|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926554|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
138926555|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926556|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
138926557|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926558|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
138926559|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926560|NCT00571701|Celecoxib|celecoxib|mesh-list
138926561|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138926562|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138926563|NCT00571701|Analgesics|analgesics|mesh-ancestor
138926564|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
138926565|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926566|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926567|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926568|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138926569|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138926570|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138926571|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926572|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926573|NCT00686127|Lidocaine|lidocaine|mesh-list
138926574|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
138926575|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
138926576|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138926577|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926578|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
138926579|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926580|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138926581|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138926582|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138599284|NCT05469880|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138926583|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138926584|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926586|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138926587|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138926588|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
138926589|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138926590|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926591|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138926592|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
138926593|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926594|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926595|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
138926596|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926597|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138926598|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138926599|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
138926600|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138926601|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138926603|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926604|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
138926605|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
138926606|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
138926607|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926609|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926610|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
138926611|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926612|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926613|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138926614|NCT00750399|Ranibizumab|ranibizumab|mesh-list
138926615|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138926616|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138926617|NCT00750399|Growth Substances|growth substances|mesh-ancestor
138926618|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926619|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
138926620|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926621|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138926622|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138926623|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138926625|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926626|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138926627|NCT00718640|Dexamethasone|dexamethasone|mesh-list
138926628|NCT00718640|Bortezomib|bortezomib|mesh-list
138926629|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926630|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
138926631|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
138926632|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926633|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926634|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138926635|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
138926636|NCT00718640|Hormones|hormones|mesh-ancestor
138926637|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138926638|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138926639|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926640|NCT00753051|Haloperidol|haloperidol|mesh-list
138926641|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
138926642|NCT00753051|Clozapine|clozapine|mesh-list
138926643|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
138926644|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
138926645|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926646|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926647|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138926648|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138926649|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138926650|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138926651|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138926652|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138926653|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
138926654|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926655|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926657|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138926659|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
138926660|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
138926662|NCT00753207|Lapatinib|lapatinib|mesh-list
138926663|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138926664|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926665|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138926666|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138926667|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443872|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138926668|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926669|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138926670|NCT00715910|Vaccines|vaccines|mesh-list
138926671|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
138599639|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
138926672|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926673|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138926675|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
138926676|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926677|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138926678|NCT00718328|Simvastatin|simvastatin|mesh-list
138926679|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138926680|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138926681|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
138926682|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926683|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138926684|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138926685|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926686|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138926687|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138926688|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138926689|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138926690|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926691|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926692|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926693|NCT02590874|Analgesics|analgesics|mesh-ancestor
138926694|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
138926695|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926696|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
138926697|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138926698|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
138926699|NCT00715520|Levodopa|levodopa|mesh-list
138926700|NCT00715520|Carbidopa|carbidopa|mesh-list
138926701|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138926702|NCT00715520|Methylphenidate|methylphenidate|mesh-list
138926703|NCT00715520|Amphetamine|amphetamine|mesh-list
138926704|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138926705|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926706|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138926707|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138926708|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138926709|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926710|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
138443904|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926711|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926712|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138926713|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138926714|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138926715|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599755|NCT00189657|Irinotecan|irinotecan|mesh-list
138926716|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
138926718|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926719|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
138926720|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138926721|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138926722|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
138926723|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
138926724|NCT00756873|Etoricoxib|etoricoxib|mesh-list
138926725|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138926726|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138926727|NCT00756873|Analgesics|analgesics|mesh-ancestor
138926728|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
138578709|NCT00117936|Mitogens|mitogens|mesh-list
138926729|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926730|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926731|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926732|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138926733|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138926734|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138926735|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926736|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926737|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138926738|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138926739|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926741|NCT00790205|Hormones|hormones|mesh-ancestor
138599863|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
138926742|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138926743|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138926744|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
138926745|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926746|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926748|NCT04056039|Atorvastatin|atorvastatin|mesh-list
138385618|NCT01470742|Capecitabine|capecitabine|mesh-list
138926749|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138926750|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138926751|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
138926752|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926753|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138926754|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138926755|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926756|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
138926757|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138926758|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
138926759|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
138926760|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
138926761|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926762|NCT00715208|Prednisone|prednisone|mesh-list
138926763|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
138926764|NCT00715208|Rituximab|rituximab|mesh-list
138926765|NCT00715208|Doxorubicin|doxorubicin|mesh-list
138926766|NCT00715208|Bortezomib|bortezomib|mesh-list
138926767|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138926768|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
138926769|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926770|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138926771|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138926772|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
138926773|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926774|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926775|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138926776|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138926777|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138926778|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138926779|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138926780|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926781|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926782|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
138926783|NCT00715208|Hormones|hormones|mesh-ancestor
138600052|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926784|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138926785|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138926787|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
138926788|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926789|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
138926790|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138926791|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138926792|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138926793|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138443953|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138926794|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926795|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
138926796|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926797|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926798|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138926799|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926800|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
138926801|NCT02589782|Linezolid|linezolid|mesh-list
138578778|NCT00483028|Donepezil|donepezil|mesh-list
138926802|NCT02589782|Bedaquiline|bedaquiline|mesh-list
138926804|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138201733|NCT01250899|Vitamin D|vitamin d|mesh-list
138926805|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926806|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138926807|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138926808|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926809|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926810|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926811|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138926812|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
138926813|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926814|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
138926815|NCT00918554|Methotrexate|methotrexate|mesh-list
138600114|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
138926816|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138926817|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
138926818|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138926819|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926820|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138926821|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
138926822|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926823|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926824|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
138926825|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926826|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138926827|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138926828|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
138926829|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138444010|NCT01818869|Adenosine|adenosine|mesh-list
138926830|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138926832|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
138926833|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138926834|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926835|NCT00768053|Etanercept|etanercept|mesh-list
138926836|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138926837|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138926838|NCT00768053|Analgesics|analgesics|mesh-ancestor
138926839|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
138926840|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926841|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926842|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926843|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138926844|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138926845|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138926846|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
138926847|NCT00683475|Prednisone|prednisone|mesh-list
138926848|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
138926849|NCT00683475|Ramucirumab|ramucirumab|mesh-list
138926850|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138926851|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138926852|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
138926853|NCT00683475|Hormones|hormones|mesh-ancestor
138926854|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138926855|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926856|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138926857|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600219|NCT00537121|Leucovorin|leucovorin|mesh-list
138926858|NCT00683475|Analgesics|analgesics|mesh-ancestor
138926859|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
138926860|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926861|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138926862|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138926863|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926864|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926865|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
138926866|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138926867|NCT02589158|Darunavir|darunavir|mesh-list
138926868|NCT02589158|Cobicistat|cobicistat|mesh-list
138926869|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138926870|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138926871|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
138926872|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926873|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926874|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138926875|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138926876|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
138926877|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926878|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138926879|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138926881|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138926882|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926883|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138926884|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138926885|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138926886|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926887|NCT00757029|Norepinephrine|norepinephrine|mesh-list
138926888|NCT00757029|Methylphenidate|methylphenidate|mesh-list
138926889|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138926890|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926891|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138926892|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138926893|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138926894|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926895|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
138926896|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926897|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138926898|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138926899|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
138926900|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
138926901|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
138926902|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926903|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138926904|NCT04101929|Irinotecan|irinotecan|mesh-list
138926905|NCT04101929|Apatinib|apatinib|mesh-list
138926906|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138926907|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138926908|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926909|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600458|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138926911|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138926913|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926914|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138926915|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926916|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926917|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
138926918|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138926919|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
138926920|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600514|NCT00540787|Sotalol|sotalol|mesh-list
138926921|NCT00751257|Expectorants|expectorants|mesh-ancestor
138926922|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
138926923|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138926924|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
138926925|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926926|NCT00751257|Protective Agents|protective agents|mesh-ancestor
138926927|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926928|NCT00751257|Antidotes|antidotes|mesh-ancestor
138926929|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
138926930|NCT00757185|Testosterone|testosterone|mesh-list
138926931|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
138926932|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
138926933|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138926934|NCT00757185|Ganirelix|ganirelix|mesh-list
138926935|NCT00757185|Androgens|androgens|mesh-ancestor
138926936|NCT00757185|Hormones|hormones|mesh-ancestor
138926937|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138926938|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926939|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138926940|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926941|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
138926942|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
138926943|NCT00751491|Clopidogrel|clopidogrel|mesh-list
138926944|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138926945|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138926946|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138926947|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138926948|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
138600635|NCT00159536|Metformin|metformin|mesh-list
138926949|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926950|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926951|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926952|NCT02561169|Oseltamivir|oseltamivir|mesh-list
138926953|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
138926954|NCT02561169|Antacids|antacids|mesh-ancestor
138926955|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926956|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138926957|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
138926958|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138926959|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138926960|NCT00753597|Rituximab|rituximab|mesh-list
138926961|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138926962|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926963|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
138926964|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926965|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138926966|NCT00757419|Lesogaberan|lesogaberan|mesh-list
138926967|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138926968|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138926969|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
138926970|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
138926971|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926972|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926973|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926974|NCT00757731|Milnacipran|milnacipran|mesh-list
138926975|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
138444057|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926976|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138926977|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138926978|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138926979|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926980|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138926981|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138926982|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138926983|NCT00757731|Analgesics|analgesics|mesh-ancestor
138926984|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
138926985|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138926986|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
138926987|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138926988|NCT00753909|Paclitaxel|paclitaxel|mesh-list
138926989|NCT00753909|Bevacizumab|bevacizumab|mesh-list
138926990|NCT00753909|Carboplatin|carboplatin|mesh-list
138926991|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138926992|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138926993|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
138926994|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
138926995|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
138926996|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138926997|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138926998|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138926999|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138927000|NCT00753909|Growth Substances|growth substances|mesh-ancestor
138927001|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927002|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
138927003|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
138927004|NCT02560155|Mupirocin|mupirocin|mesh-list
138927005|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138927006|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138927007|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
138927008|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138927009|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138927010|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927011|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927013|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
138927014|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927015|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138927016|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
138927017|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927018|NCT05266040|Valacyclovir|valacyclovir|mesh-list
138444110|NCT01819402|Pioglitazone|pioglitazone|mesh-list
138927019|NCT05266040|Antiviral Agents|antiviral agents|mesh-ancestor
138927020|NCT05266040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138927021|NCT00773747|Bortezomib|bortezomib|mesh-list
138927022|NCT00773747|Vorinostat|vorinostat|mesh-list
138927023|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927024|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138927025|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578997|NCT00484510|Vitamins|vitamins|mesh-ancestor
138927026|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927027|NCT00784277|Oxycodone|oxycodone|mesh-list
138927028|NCT00784277|Tapentadol|tapentadol|mesh-list
138927030|NCT00784277|Narcotics|narcotics|mesh-ancestor
138927031|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138927032|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927033|NCT00784277|Analgesics|analgesics|mesh-ancestor
138927034|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
138927035|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927036|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138600856|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927037|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138927038|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138927039|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927040|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
138927041|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927043|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138927044|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138927045|NCT02588534|Analgesics|analgesics|mesh-ancestor
138927046|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
138927047|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927048|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927049|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138927050|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138927051|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138927052|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138927053|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
138927054|NCT00682929|Dronabinol|dronabinol|mesh-list
138444129|NCT01819610|Ketorolac|ketorolac|mesh-list
138927055|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
138927056|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927057|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138927058|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138927060|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
138927061|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927062|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138927063|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138927064|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927065|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927066|NCT00682929|Hormones|hormones|mesh-ancestor
138927067|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138927068|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
138927069|NCT00758199|Prednisolone|prednisolone|mesh-list
138927070|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138927071|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
138927072|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138927073|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
138927074|NCT00758199|Bromfenac|bromfenac|mesh-list
138927075|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138927076|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138927077|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
138927078|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138927079|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
138927080|NCT00758199|Hormones|hormones|mesh-ancestor
138927081|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138927082|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927083|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138927084|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927085|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
138927086|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
138927087|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927088|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138927089|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138927090|NCT00758199|Protective Agents|protective agents|mesh-ancestor
138927091|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138927092|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453288|NCT01884298|Lidocaine|lidocaine|mesh-list
138927094|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138927095|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927096|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927098|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
138927099|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138927100|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138927101|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138927103|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138927104|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138927105|NCT00758199|Analgesics|analgesics|mesh-ancestor
138927106|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
138927107|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138927108|NCT05683808|Apixaban|apixaban|mesh-list
138927109|NCT05683808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138927110|NCT05683808|Antithrombins|antithrombins|mesh-ancestor
138927111|NCT05683808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138927112|NCT05683808|Protease Inhibitors|protease inhibitors|mesh-ancestor
138927113|NCT05683808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927114|NCT05683808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927115|NCT05683808|Anticoagulants|anticoagulants|mesh-ancestor
138927116|NCT00680745|Metformin|metformin|mesh-list
138927117|NCT00680745|Pioglitazone|pioglitazone|mesh-list
138927118|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
138927119|NCT00680745|Glimepiride|glimepiride|mesh-list
138927120|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
138927121|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138927122|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927123|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138927124|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927125|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138927126|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138927127|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
138927128|NCT05434377|Vitamin D|vitamin d|mesh-list
138927129|NCT05434377|Ergocalciferols|ergocalciferols|mesh-list
138927130|NCT05434377|Vitamins|vitamins|mesh-ancestor
138927131|NCT05434377|Micronutrients|micronutrients|mesh-ancestor
138927132|NCT05434377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927133|NCT05434377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138927134|NCT05434377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138927135|NCT05428293|Acetaminophen|acetaminophen|mesh-list
138927136|NCT05428293|Ibuprofen|ibuprofen|mesh-list
138927137|NCT05428293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138927138|NCT05428293|Analgesics|analgesics|mesh-ancestor
138927139|NCT05428293|Sensory System Agents|sensory system agents|mesh-ancestor
138927140|NCT05428293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927141|NCT05428293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927142|NCT05428293|Antipyretics|antipyretics|mesh-ancestor
138601119|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444250|NCT01820325|Paclitaxel|paclitaxel|mesh-list
138927143|NCT05428293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138927144|NCT05428293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138927145|NCT05428293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138927146|NCT05428293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138927147|NCT05428293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927148|NCT05428293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927149|NCT05427825|Anesthetics|anesthetics|mesh-list
138927150|NCT05427825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138927151|NCT05427825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927152|NCT00680121|Benphothiamine|benphothiamine|mesh-list
138927153|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138927154|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
138927155|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927156|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
138927157|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
138927158|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927159|NCT00754689|Metformin|metformin|mesh-list
138927160|NCT00754689|Rimonabant|rimonabant|mesh-list
138927161|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138927162|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927163|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138927164|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138927165|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138927166|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927167|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927168|NCT00754689|Hormones|hormones|mesh-ancestor
138927169|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138927170|NCT00767819|Everolimus|everolimus|mesh-list
138601232|NCT00160355|Fludarabine|fludarabine|mesh-list
138927171|NCT00767819|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138579142|NCT00118794|Lumefantrine|lumefantrine|mesh-list
138927172|NCT00767819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138927173|NCT00767819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927174|NCT00767819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927175|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138444296|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
138927177|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927178|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927179|NCT00758277|Levetiracetam|levetiracetam|mesh-list
138927180|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
138927181|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
138927182|NCT00584870|Naproxen|naproxen|mesh-list
138927183|NCT00584870|Tanezumab|tanezumab|mesh-list
138927184|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138927185|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138927186|NCT00584870|Analgesics|analgesics|mesh-ancestor
138927187|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
138927188|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927189|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927190|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138927191|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138927192|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
138927193|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138927194|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927195|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927196|NCT00679341|Docetaxel|docetaxel|mesh-list
138927197|NCT00679341|Trastuzumab|trastuzumab|mesh-list
138927198|NCT00679341|Maytansine|maytansine|mesh-list
138927199|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138927200|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601355|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
138927201|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
138927202|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
138927203|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
138927204|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927205|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138927206|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138927207|NCT00679341|Immunotoxins|immunotoxins|mesh-ancestor
138927208|NCT00679341|Immunoconjugates|immunoconjugates|mesh-ancestor
138927209|NCT00679341|Immunologic Factors|immunologic factors|mesh-ancestor
138927210|NCT00679341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927211|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
138927212|NCT00680043|Hematinics|hematinics|mesh-ancestor
138927213|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138927214|NCT00682539|Triamcinolone|triamcinolone|mesh-list
138927215|NCT00682539|Bevacizumab|bevacizumab|mesh-list
138927216|NCT00682539|Ranibizumab|ranibizumab|mesh-list
138927217|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138927218|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927219|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138927220|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138927221|NCT00682539|Growth Substances|growth substances|mesh-ancestor
138601414|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
138927222|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927223|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
138927224|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138927225|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
138927226|NCT00682539|Hormones|hormones|mesh-ancestor
138927227|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138927228|NCT00682461|Nicotine|nicotine|mesh-list
138927229|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138927230|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
138927231|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927232|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927233|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138927234|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138927235|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
138927236|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927237|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927238|NCT00921765|Ketamine|ketamine|mesh-list
138927239|NCT00921765|Naloxone|naloxone|mesh-list
138927240|NCT00921765|Analgesics|analgesics|mesh-ancestor
138444371|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
138927241|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
138927242|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927243|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927244|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138927245|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138927246|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
138927247|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
138927248|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138927249|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138927250|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138927251|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927252|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927253|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138927254|NCT05435781|Hydrocortisone|hydrocortisone|mesh-list
138927255|NCT05435781|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138927256|NCT05435781|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138927257|NCT05435781|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138601467|NCT00547144|Gemcitabine|gemcitabine|mesh-list
138927258|NCT05435781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138927259|NCT00755157|Bevacizumab|bevacizumab|mesh-list
138927260|NCT00755157|Docetaxel|docetaxel|mesh-list
138927261|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138444414|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
138927262|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927263|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138927264|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138927265|NCT00755157|Growth Substances|growth substances|mesh-ancestor
138927266|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927267|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
138927268|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
138927269|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
138927270|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
138927271|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927272|NCT00919880|Paclitaxel|paclitaxel|mesh-list
138927273|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138927274|NCT00919880|Carboplatin|carboplatin|mesh-list
138927275|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138927276|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927277|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
138927278|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
138927279|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
138927280|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927281|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
138927282|NCT00755313|Carboplatin|carboplatin|mesh-list
138927283|NCT00755313|Docetaxel|docetaxel|mesh-list
138927284|NCT00755313|Doxorubicin|doxorubicin|mesh-list
138927285|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138927286|NCT00755313|Trastuzumab|trastuzumab|mesh-list
138927287|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138927288|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138927289|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138927290|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
138927291|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927292|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138927293|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138927294|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
138927295|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927296|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927297|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138927298|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
138927299|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
138927300|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
138927301|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138927302|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138927303|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138927304|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927305|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138927306|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138927307|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138927308|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138927309|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
138927310|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138927311|NCT04082858|Midazolam|midazolam|mesh-list
138927312|NCT04082858|Ketamine|ketamine|mesh-list
138927313|NCT04082858|Analgesics|analgesics|mesh-ancestor
138927314|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
138927315|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927316|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927317|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138927318|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138927319|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
138927320|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
138927321|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138927322|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138927323|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138927324|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927325|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927326|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138927327|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138927328|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138927329|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138927330|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138927331|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
138927332|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
138927333|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
138927334|NCT00919022|Cyproterone|cyproterone|mesh-list
138927335|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
138927336|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
138927337|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138927338|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927339|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927340|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138927341|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
138927342|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138927343|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
138927344|NCT05122221|Fludarabine|fludarabine|mesh-list
138927345|NCT05122221|Interleukin-2|interleukin-2|mesh-list
138927346|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138927347|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
138927348|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927349|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138927350|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138927351|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
138927352|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927353|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927354|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138927355|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138927356|NCT05122221|Analgesics|analgesics|mesh-ancestor
138927357|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
138927358|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927359|NCT03802305|Anesthetics|anesthetics|mesh-list
138927360|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138927361|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927362|NCT02587052|Tacrolimus|tacrolimus|mesh-list
138927363|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138927364|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
138927365|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927366|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138927367|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927368|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927369|NCT02587130|Ketamine|ketamine|mesh-list
138927370|NCT02587130|Analgesics|analgesics|mesh-ancestor
138927371|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
138927372|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927373|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601711|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927374|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138927375|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138927376|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
138927377|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
138927378|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138927379|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138927380|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138927381|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927382|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927383|NCT02559141|Dobutamine|dobutamine|mesh-list
138927385|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138927386|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138927387|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
138927388|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927389|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927390|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927391|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
138927392|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
138927393|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927394|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138927395|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138601837|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927396|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138927397|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138927398|NCT02559141|Protective Agents|protective agents|mesh-ancestor
138927399|NCT02561013|Monensin|monensin|mesh-list
138927400|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
138927401|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138927403|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138927404|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
138927405|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
138927406|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
138927407|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927408|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927409|NCT02561013|Ionophores|ionophores|mesh-ancestor
138927410|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138927411|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
138927412|NCT00678795|Nabiximols|nabiximols|mesh-list
138927413|NCT00678795|Analgesics|analgesics|mesh-ancestor
138927414|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
138927415|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927416|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927417|NCT03417687|Xenon|xenon|mesh-list
138927418|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138927419|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
138927420|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
138927421|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138927422|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927423|NCT04767698|Belimumab|belimumab|mesh-list
138927424|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
138927425|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138927426|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
138927427|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927428|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138927429|NCT03205137|Amlodipine|amlodipine|mesh-list
138927430|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138927431|NCT03205137|Telmisartan|telmisartan|mesh-list
138927432|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138927433|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
138927434|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138927435|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138601965|NCT00161720|Protein C|protein c|mesh-list
138927436|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138927437|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927438|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138927439|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927440|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
138927441|NCT03205137|Diuretics|diuretics|mesh-ancestor
138602010|NCT00551122|Paclitaxel|paclitaxel|mesh-list
138927443|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138927444|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138927445|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138927446|NCT00678561|Tofacitinib|tofacitinib|mesh-list
138927447|NCT00678561|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138927448|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138927449|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927450|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927451|NCT04081376|Hydromorphone|hydromorphone|mesh-list
138927452|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138927453|NCT04081376|Narcotics|narcotics|mesh-ancestor
138927454|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138927455|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927456|NCT04081376|Analgesics|analgesics|mesh-ancestor
138927457|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
138927458|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927459|NCT02584400|Imidazole|imidazole|mesh-list
138927460|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927461|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927462|NCT02586194|Peficitinib|peficitinib|mesh-list
138927463|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927464|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927465|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138927466|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
138927467|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927468|NCT00761241|Interferons|interferons|mesh-list
138927469|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
138927470|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138927471|NCT00761241|Gemcitabine|gemcitabine|mesh-list
138927473|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
138927474|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138927475|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
138927476|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927477|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927478|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
138927479|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
138927480|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
138927481|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
138927482|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138927483|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
138927484|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927486|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138927487|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138927488|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138927489|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
138602200|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
138927490|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
138927491|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927492|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927493|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927494|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138927495|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138927496|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927497|NCT02981979|Prednisone|prednisone|mesh-list
138927498|NCT02981979|Leflunomide|leflunomide|mesh-list
138927499|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138927500|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
138927501|NCT02981979|Hormones|hormones|mesh-ancestor
138927502|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138927503|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602252|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138927504|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138927505|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927506|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927507|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927508|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138927509|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
138927510|NCT04049409|Trastuzumab|trastuzumab|mesh-list
138927511|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138927512|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927513|NCT00920660|Prednisolone|prednisolone|mesh-list
138927514|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138927515|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
138927517|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138927518|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927519|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138927520|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927521|NCT02583464|Tenofovir|tenofovir|mesh-list
138927522|NCT02583464|Emtricitabine|emtricitabine|mesh-list
138927523|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
138927524|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138927525|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138927526|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138927527|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927528|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927529|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138927530|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138927531|NCT00675597|Bevacizumab|bevacizumab|mesh-list
138927532|NCT00675597|Docetaxel|docetaxel|mesh-list
138927533|NCT00675597|Vinorelbine|vinorelbine|mesh-list
138927534|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138927535|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927536|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138927537|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138927538|NCT00675597|Growth Substances|growth substances|mesh-ancestor
138927539|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453355|NCT01884506|Iron|iron|mesh-list
138927540|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
138927541|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
138927542|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
138927543|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
138927544|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927545|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138927547|NCT02677545|Clopidogrel|clopidogrel|mesh-list
138927548|NCT02677545|Ticagrelor|ticagrelor|mesh-list
138602495|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927549|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138927550|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138927552|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
138927553|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927554|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927556|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138927557|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138927558|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138927559|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927560|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138927561|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138927562|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927564|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138927565|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138927566|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138927567|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
138927568|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927569|NCT04079426|Dimercaprol|dimercaprol|mesh-list
138927570|NCT04079426|Chelating Agents|chelating agents|mesh-ancestor
138927571|NCT04079426|Sequestering Agents|sequestering agents|mesh-ancestor
138927572|NCT04079426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927573|NCT00675441|Lenalidomide|lenalidomide|mesh-list
138927574|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
138927575|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927576|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138927577|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138927578|NCT00675441|Growth Substances|growth substances|mesh-ancestor
138602635|NCT00163358|Hormones|hormones|mesh-ancestor
138927579|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
138927580|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927581|NCT02559297|Sevoflurane|sevoflurane|mesh-list
138927582|NCT02559297|Desflurane|desflurane|mesh-list
138927583|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138927584|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138927585|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
138927587|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138927588|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927589|NCT02558517|Prednisone|prednisone|mesh-list
138927590|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138927591|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
138927592|NCT02558517|Hormones|hormones|mesh-ancestor
138927593|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138927594|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927595|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138927596|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602749|NCT05807945|Ropivacaine|ropivacaine|mesh-list
138927597|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138927598|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927599|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138927600|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927601|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927603|NCT00673179|Gemcitabine|gemcitabine|mesh-list
138927604|NCT00673179|Doxorubicin|doxorubicin|mesh-list
138927605|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138927606|NCT00673179|Methotrexate|methotrexate|mesh-list
138927607|NCT00673179|Ifosfamide|ifosfamide|mesh-list
138927608|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
138927609|NCT00673179|Razoxane|razoxane|mesh-list
138927610|NCT00673179|Sargramostim|sargramostim|mesh-list
138927611|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927612|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138927613|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
138602815|NCT05807347|Antimetabolites|antimetabolites|mesh-ancestor
138927614|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927615|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138927616|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138927617|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138927618|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927619|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138927620|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
138927621|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138602874|NCT05709509|Gout Suppressants|gout suppressants|mesh-ancestor
138927622|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927623|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
138927624|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138927625|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138927626|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
138927627|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138927628|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138927629|NCT00673179|Antidotes|antidotes|mesh-ancestor
138927630|NCT00673179|Protective Agents|protective agents|mesh-ancestor
138927631|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
138927633|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
138927634|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138927635|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
138927636|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138927637|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
138927638|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
138927639|NCT00758433|Capsaicin|capsaicin|mesh-list
138927640|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
138927641|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
138927642|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
138927643|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603004|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
138927644|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927645|NCT00584012|Docetaxel|docetaxel|mesh-list
138927646|NCT00584012|Lovastatin|lovastatin|mesh-list
138927647|NCT00584012|L 647318|l 647318|mesh-list
138927648|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
138927649|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927650|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
138927651|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
138927652|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
138927653|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927654|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138444712|NCT01823159|Ezogabine|ezogabine|mesh-list
138927655|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138927656|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
138927657|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138927658|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138927659|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927660|NCT05435846|Trametinib|trametinib|mesh-list
138927661|NCT05435846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927662|NCT05435846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138927663|NCT05435846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927664|NCT05435846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927665|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138927666|NCT00920270|Colistin|colistin|mesh-list
138927667|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138927668|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
138927669|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138927670|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
138927671|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138927672|NCT02585882|Fluorides|fluorides|mesh-list
138927673|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
138927674|NCT02585882|Protective Agents|protective agents|mesh-ancestor
138927675|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927676|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138927677|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138927678|NCT02584010|Silicon|silicon|mesh-list
138927679|NCT02584010|Trace Elements|trace elements|mesh-ancestor
138927680|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
138927681|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927682|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
138927683|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138927684|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927685|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138927686|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927688|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
138927689|NCT02582996|Metoclopramide|metoclopramide|mesh-list
138927690|NCT02582996|Caffeine|caffeine|mesh-list
138927691|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138927692|NCT02582996|Analgesics|analgesics|mesh-ancestor
138927693|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
138927694|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927695|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927696|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
138927697|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138927698|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138927699|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927700|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579660|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138927701|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138927702|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138927704|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927705|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
138927706|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
138927707|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138927708|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138927709|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138927710|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
138927711|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138927712|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
138927713|NCT02585570|Phenylephrine|phenylephrine|mesh-list
138927714|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
138927715|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138927716|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
138927717|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
138927718|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927719|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927720|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
138927721|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138603316|NCT03311555|Androgens|androgens|mesh-list
138927722|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
138927723|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
138927724|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138927725|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138927726|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138927727|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
138927728|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927729|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927730|NCT02585570|Protective Agents|protective agents|mesh-ancestor
138927731|NCT02583854|Hemostatics|hemostatics|mesh-list
138927732|NCT02583854|Coagulants|coagulants|mesh-ancestor
138927734|NCT00764907|Cytarabine|cytarabine|mesh-list
138927735|NCT00764907|Dexamethasone|dexamethasone|mesh-list
138927736|NCT00764907|Prednisone|prednisone|mesh-list
138927737|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
138927738|NCT00764907|Ifosfamide|ifosfamide|mesh-list
138927739|NCT00764907|Doxorubicin|doxorubicin|mesh-list
138927740|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138927741|NCT00764907|Methotrexate|methotrexate|mesh-list
138927742|NCT00764907|Etoposide|etoposide|mesh-list
138927743|NCT00764907|Vincristine|vincristine|mesh-list
138927744|NCT00764907|Daunorubicin|daunorubicin|mesh-list
138927745|NCT00764907|Asparaginase|asparaginase|mesh-list
138927746|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
138927747|NCT00764907|Thioguanine|thioguanine|mesh-list
138927748|NCT00764907|Vindesine|vindesine|mesh-list
138927749|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
138927750|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138927751|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
138927752|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927753|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138927754|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138927755|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
138927756|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927757|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927758|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138927759|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138927760|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
138927761|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
138927762|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927763|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138927764|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
138927765|NCT00764907|Hormones|hormones|mesh-ancestor
138927766|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138927767|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138927768|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138927769|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138927770|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138927771|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927772|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138927773|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
138927774|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138927775|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138444833|NCT01824433|Fluoxetine|fluoxetine|mesh-list
138927776|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
138927777|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
138927778|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138927779|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138927780|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138579735|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138927781|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
138927782|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138927783|NCT00764907|Antidotes|antidotes|mesh-ancestor
138927784|NCT00764907|Protective Agents|protective agents|mesh-ancestor
138927785|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
138927786|NCT00764907|Vitamins|vitamins|mesh-ancestor
138927787|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
138927788|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603616|NCT00193323|Gemcitabine|gemcitabine|mesh-list
138927789|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
138927790|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
138927791|NCT02583698|Carvedilol|carvedilol|mesh-list
138927792|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138927793|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138927794|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
138927795|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927796|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927797|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927798|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138927799|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
138927800|NCT02583698|Protective Agents|protective agents|mesh-ancestor
138927801|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138453421|NCT01884896|Metoprolol|metoprolol|mesh-list
138927802|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138927803|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138927804|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
138927805|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138927806|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138927807|NCT00762099|Pregabalin|pregabalin|mesh-list
138927808|NCT00762099|Analgesics|analgesics|mesh-ancestor
138927809|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
138927810|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927811|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927812|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
138927813|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138927814|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138927815|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927816|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138927817|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138927818|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138927819|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138927820|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138927822|NCT00762255|Irinotecan|irinotecan|mesh-list
138927823|NCT00762255|Vorinostat|vorinostat|mesh-list
138927824|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138927825|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927826|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138927827|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138927828|NCT00762255|Growth Substances|growth substances|mesh-ancestor
138927829|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927830|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
138927831|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138927832|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138927833|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927834|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927835|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138927836|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138927837|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138927838|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138927839|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
138927840|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138927841|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138927842|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138927843|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138927844|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927845|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
138927846|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927847|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927848|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138927849|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927850|NCT05332730|Golimumab|golimumab|mesh-list
138927851|NCT05332730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138927852|NCT05332730|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138927853|NCT05332730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138927854|NCT05332730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138927855|NCT05332730|Immunologic Factors|immunologic factors|mesh-ancestor
138579813|NCT00491998|Entacapone|entacapone|mesh-list
138927856|NCT05332730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927858|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138927859|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138927860|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138927861|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
138927862|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927863|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927864|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927865|NCT02581826|Urological Agents|urological agents|mesh-ancestor
138603799|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138927866|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138927867|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
138927869|NCT04340882|Ramucirumab|ramucirumab|mesh-list
138927870|NCT04340882|Antibodies|antibodies|mesh-list
138927871|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
138927872|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138927873|NCT04340882|Lexatumumab|lexatumumab|mesh-list
138927874|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
138927875|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927876|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927877|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
138927878|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
138927879|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
138927880|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927881|NCT04340882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138927882|NCT00765921|Ranibizumab|ranibizumab|mesh-list
138927883|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138927884|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138927885|NCT00765921|Growth Substances|growth substances|mesh-ancestor
138927886|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927887|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
138927888|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603831|NCT00164840|Esomeprazole|esomeprazole|mesh-list
138927889|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138927890|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138927891|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138927892|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
138927893|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138927894|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927895|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
138927896|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927897|NCT00766155|Capecitabine|capecitabine|mesh-list
138927898|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
138927899|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138927900|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
138603878|NCT04682782|Esketamine|esketamine|mesh-list
138927901|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927903|NCT00762567|Phenylephrine|phenylephrine|mesh-list
138927904|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
138927905|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
138927906|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138927907|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
138927908|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
138927909|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927910|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927911|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
138927912|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138927913|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
138927914|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138927915|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138927916|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138927917|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
138927918|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927919|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927920|NCT00762567|Protective Agents|protective agents|mesh-ancestor
138927921|NCT04338620|Paclitaxel|paclitaxel|mesh-list
138927922|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138927923|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138927924|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927925|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
138453434|NCT01884909|Metoprolol|metoprolol|mesh-list
138927926|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
138927927|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
138927928|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927929|NCT00923234|Lenalidomide|lenalidomide|mesh-list
138927930|NCT00923234|Azacitidine|azacitidine|mesh-list
138579888|NCT00492661|Tacrolimus|tacrolimus|mesh-list
138927931|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
138927932|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927933|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138927934|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138927935|NCT00923234|Growth Substances|growth substances|mesh-ancestor
138927936|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
138927937|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138927938|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138927939|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
138927940|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927942|NCT00674661|Riboflavin|riboflavin|mesh-list
138927943|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138927944|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138927945|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
138927946|NCT00674661|Vitamins|vitamins|mesh-ancestor
138927947|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
138927948|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927949|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138927950|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
138927951|NCT00766545|Cilostazol|cilostazol|mesh-list
138927952|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138927953|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
138927954|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927955|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927956|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138927957|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
138927958|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138927959|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138927960|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927961|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138927962|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
138927963|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138927964|NCT00766545|Protective Agents|protective agents|mesh-ancestor
138927965|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138927966|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138927967|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138927969|NCT02558205|Hematinics|hematinics|mesh-ancestor
138927970|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
138927971|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138927972|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138927973|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138927974|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138927975|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138927976|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
138927977|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138927978|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927979|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138927980|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927981|NCT00766857|Insulin|insulin|mesh-list
138927982|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138927983|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
138927984|NCT00766857|Exenatide|exenatide|mesh-list
138927985|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138927986|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927987|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138927988|NCT00766857|Incretins|incretins|mesh-ancestor
138927989|NCT00766857|Hormones|hormones|mesh-ancestor
138927990|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138927991|NCT02558283|Lidocaine|lidocaine|mesh-list
138927992|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
138927993|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
138927994|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138927995|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138927996|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
138927997|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138927998|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138927999|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138928000|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138604222|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
138928001|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138928002|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928003|NCT00767091|Rivastigmine|rivastigmine|mesh-list
138928004|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
138928005|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928006|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928007|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
138928008|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928009|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928010|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138928011|NCT00767091|Protective Agents|protective agents|mesh-ancestor
138928012|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
138928013|NCT00767169|Pamidronate|pamidronate|mesh-list
138444960|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928014|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138928015|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928016|NCT05256381|Pembrolizumab|pembrolizumab|mesh-list
138928017|NCT05256381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138928018|NCT05256381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928019|NCT05256381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138928020|NCT05256381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928022|NCT00767481|Brinzolamide|brinzolamide|mesh-list
138928023|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138928024|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138928025|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928026|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928027|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
138928028|NCT00671931|Propofol|propofol|mesh-list
138928029|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138928030|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138928031|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928032|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138928033|NCT00671931|Analgesics|analgesics|mesh-ancestor
138928034|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
138928035|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928036|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138928037|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138928038|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138928039|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
138928040|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928041|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928042|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138928044|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
138928045|NCT00767559|PENTA|penta|mesh-list
138928046|NCT00767559|Warfarin|warfarin|mesh-list
138928047|NCT00767559|Fondaparinux|fondaparinux|mesh-list
138928048|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
138928049|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138928050|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
138928051|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138928052|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
138928053|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928054|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928055|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138928056|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138928057|NCT00767715|Haloperidol|haloperidol|mesh-list
138928058|NCT00767715|Olanzapine|olanzapine|mesh-list
138928059|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
138928060|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
138928061|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
138928062|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928063|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928064|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138928065|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138928066|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138928067|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138928068|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138928069|NCT00767715|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138928070|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138928071|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138928072|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928073|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928074|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
138928075|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138928076|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
138928077|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138928078|NCT00762957|Metformin|metformin|mesh-list
138928079|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138928080|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928081|NCT00759993|Chromium|chromium|mesh-list
138203008|NCT01260649|Ketamine|ketamine|mesh-list
138928083|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
138928084|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928085|NCT00673881|Choline|choline|mesh-list
138928086|NCT00673881|Fenofibrate|fenofibrate|mesh-list
138928087|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138928088|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
138928089|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928090|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138928091|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
138604514|NCT00167375|Eszopiclone|eszopiclone|mesh-list
138928092|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138928093|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
138928094|NCT00763347|Alogliptin|alogliptin|mesh-list
138928095|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138928096|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928097|NCT00763347|Incretins|incretins|mesh-ancestor
138928098|NCT00763347|Hormones|hormones|mesh-ancestor
138928099|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138928100|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138928101|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
138928102|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928103|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928104|NCT00767871|Escitalopram|escitalopram|mesh-list
138928105|NCT00767871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138669010|NCT00439712|Levocetirizine|levocetirizine|mesh-list
138928106|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138928107|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138928108|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928109|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928110|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
138928111|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928112|NCT00760149|Rifampin|rifampin|mesh-list
138928113|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138928114|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
138604629|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
138928115|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138928116|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928117|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
138928118|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138928119|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928120|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928121|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138928122|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138928123|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138928124|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138928125|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138928126|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138928127|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138928128|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
138928129|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138928130|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138928131|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138928132|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138928133|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928136|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138928137|NCT00768183|Narcotics|narcotics|mesh-ancestor
138928138|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138928139|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928140|NCT00768183|Analgesics|analgesics|mesh-ancestor
138928141|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
138928142|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928143|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138928144|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928145|NCT02557581|Terbutaline|terbutaline|mesh-list
138928146|NCT02557581|Clenbuterol|clenbuterol|mesh-list
138928147|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138928148|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
138445050|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
138928149|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928150|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928151|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138928152|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
138928153|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
138580109|NCT00494338|Docetaxel|docetaxel|mesh-list
138928154|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
138928155|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138928156|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138928157|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138928158|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138928159|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
138928160|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928161|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928162|NCT04077944|Trace Elements|trace elements|mesh-list
138928163|NCT04077944|Micronutrients|micronutrients|mesh-list
138928164|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928165|NCT02558751|Vaccines|vaccines|mesh-list
138453468|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
138928166|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138928167|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
138928168|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928170|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
138928171|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138928172|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138928173|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928174|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604885|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
138928175|NCT00768573|Urological Agents|urological agents|mesh-ancestor
138928176|NCT02558361|Apremilast|apremilast|mesh-list
138928177|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138928178|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138928179|NCT02558361|Analgesics|analgesics|mesh-ancestor
138928180|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
138928181|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928182|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928183|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138928184|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138928185|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138928186|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138928187|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928188|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928189|NCT02558595|Niacinamide|niacinamide|mesh-list
138928191|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
138928192|NCT02558595|Vitamins|vitamins|mesh-ancestor
138928193|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
138928194|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928195|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
138928196|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138928197|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
138928198|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928199|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138928200|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
138928201|NCT00760695|Dronabinol|dronabinol|mesh-list
138928202|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
138445072|NCT01825993|Morphine|morphine|mesh-list
138928203|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928204|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138928205|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138928206|NCT00760695|Analgesics|analgesics|mesh-ancestor
138928207|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
138928208|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928209|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138928210|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138928211|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928212|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928213|NCT00760695|Hormones|hormones|mesh-ancestor
138928214|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138928215|NCT02582372|Fentanyl|fentanyl|mesh-list
138928216|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
138928217|NCT02582372|Bupivacaine|bupivacaine|mesh-list
138928218|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
138928219|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
138928220|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605068|NCT05880459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138928221|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928222|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
138928223|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928224|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138928225|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138928226|NCT02582372|Analgesics|analgesics|mesh-ancestor
138928227|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138928229|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138928231|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928232|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928233|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138928234|NCT02582372|Narcotics|narcotics|mesh-ancestor
138928235|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138605128|NCT05755048|Immunotoxins|immunotoxins|mesh-ancestor
138928236|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138928237|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
138928238|NCT00768729|Sirolimus|sirolimus|mesh-list
138928239|NCT00768729|Azathioprine|azathioprine|mesh-list
138928240|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138928241|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928242|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138928243|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928244|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
138928245|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138928246|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
138928247|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928248|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928249|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
138928250|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138605181|NCT05365451|Histamine Agents|histamine agents|mesh-ancestor
138928251|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138928252|NCT00768963|Ranibizumab|ranibizumab|mesh-list
138928253|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138928254|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138928255|NCT00768963|Growth Substances|growth substances|mesh-ancestor
138928256|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928257|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
138928258|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928259|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
138928260|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138928261|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928262|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138928263|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138928264|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928265|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928266|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928268|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138928269|NCT00770445|Metformin|metformin|mesh-list
138928270|NCT00770445|Pioglitazone|pioglitazone|mesh-list
138928271|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138928272|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928273|NCT04077398|Ropivacaine|ropivacaine|mesh-list
138928274|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
138928275|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
138928276|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138928277|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928278|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
138928279|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928280|NCT04048707|Octreotide|octreotide|mesh-list
138928281|NCT04048707|Midodrine|midodrine|mesh-list
138928282|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
138928283|NCT04048707|Giapreza|giapreza|mesh-list
138928284|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
138928285|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138928286|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138928287|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928288|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
138928289|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
138928290|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605362|NCT04507503|Futibatinib|futibatinib|mesh-list
138928291|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928292|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138928293|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138928294|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138928295|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138928296|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
138928297|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928298|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928299|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138928300|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
138605432|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138928301|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928303|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138928304|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138928305|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138928306|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138928307|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928308|NCT00770835|Metformin|metformin|mesh-list
138928309|NCT00770835|Pioglitazone|pioglitazone|mesh-list
138928310|NCT00770835|Glyburide|glyburide|mesh-list
138928311|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138928312|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928313|NCT00769587|Thalidomide|thalidomide|mesh-list
138928314|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138670262|NCT00442845|Atorvastatin|atorvastatin|mesh-list
138928315|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
138928316|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928317|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
138928318|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138928319|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928320|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138928321|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138928322|NCT00769587|Growth Substances|growth substances|mesh-ancestor
138605567|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
138928323|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
138928324|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928325|NCT00570921|Everolimus|everolimus|mesh-list
138928326|NCT00570921|Fulvestrant|fulvestrant|mesh-list
138928327|NCT00570921|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138928328|NCT00570921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138928329|NCT00570921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928330|NCT00570921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928331|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138928332|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
138928333|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928334|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928335|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138928336|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138928337|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138928338|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
138928339|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138928340|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138928341|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138928342|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138928343|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928344|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
138928345|NCT04048317|Doxorubicin|doxorubicin|mesh-list
138928346|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138928347|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
138928348|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138453547|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
138928349|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928350|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138445143|NCT01827007|Polygeline|polygeline|mesh-list
138928351|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138928352|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928353|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928355|NCT04353986|Ledipasvir|ledipasvir|mesh-list
138928356|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138928357|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
138928358|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928359|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138928360|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138928361|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928362|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138928363|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
138928364|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928365|NCT00771147|Sorafenib|sorafenib|mesh-list
138928366|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928367|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138928368|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928369|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928370|NCT04155710|Interleukin-2|interleukin-2|mesh-list
138928371|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928372|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138928373|NCT04155710|Analgesics|analgesics|mesh-ancestor
138928374|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
138928375|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928376|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928377|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138928378|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
138928379|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138928380|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
138928381|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138928382|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928383|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138928384|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138928385|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138928386|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928387|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138605740|NCT02903719|Ropivacaine|ropivacaine|mesh-list
138928388|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138928389|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138928390|NCT00775125|Ritonavir|ritonavir|mesh-list
138928391|NCT00775125|Darunavir|darunavir|mesh-list
138928392|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
138928393|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138928394|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138928395|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
138928396|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928397|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928398|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138928399|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138928400|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
138928401|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928402|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138928403|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138928404|NCT02557503|Fluorouracil|fluorouracil|mesh-list
138928405|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
138928406|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
138928407|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928408|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138928409|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928410|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138928411|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
138928412|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928413|NCT00764439|Nicotine|nicotine|mesh-list
138445205|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
138928414|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138928415|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
138928416|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928417|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928418|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138928419|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138928420|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
138928421|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928422|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928424|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138928425|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138928426|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928427|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
138928428|NCT00771303|Coagulants|coagulants|mesh-ancestor
138928429|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
138928430|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138928431|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928432|NCT00771459|Ropivacaine|ropivacaine|mesh-list
138928433|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
138928434|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
138928435|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138928436|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928437|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
138928438|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928439|NCT00775359|Fenofibrate|fenofibrate|mesh-list
138928440|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138928441|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
138928442|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928443|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138928444|NCT05338502|Omeprazole|omeprazole|mesh-list
138928445|NCT05338502|Ranitidine|ranitidine|mesh-list
138928446|NCT05338502|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138928447|NCT05338502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138928448|NCT05338502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138453566|NCT01886001|Povidone|povidone|mesh-list
138928449|NCT05338502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138928451|NCT05338502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928452|NCT05338502|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138928453|NCT05338502|Histamine Antagonists|histamine antagonists|mesh-ancestor
138928454|NCT05338502|Histamine Agents|histamine agents|mesh-ancestor
138928455|NCT05338502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928456|NCT05338502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928457|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
138928458|NCT02557269|Azelastine|azelastine|mesh-list
138928459|NCT02557269|Prednisolone|prednisolone|mesh-list
138928460|NCT02557269|Xylometazoline|xylometazoline|mesh-list
138928461|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138928462|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
138928463|NCT02557269|Hormones|hormones|mesh-ancestor
138928464|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138928465|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928466|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138928467|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928468|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
138928469|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928470|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
138928472|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138928473|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138928474|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
138928475|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138928476|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928477|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928478|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138928479|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138928480|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
138928481|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
138928482|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928483|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
138928484|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138928485|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
138928486|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138928487|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138928488|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
138928489|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138928490|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928491|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138445284|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
138928492|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138928493|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138928494|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138928495|NCT02556411|Estrogens|estrogens|mesh-ancestor
138928496|NCT02556411|Hormones|hormones|mesh-ancestor
138638032|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138928497|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138928498|NCT04085276|Paclitaxel|paclitaxel|mesh-list
138928499|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138928500|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138928501|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928502|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
138928503|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
138928504|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
138928505|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928506|NCT00775827|Fenofibrate|fenofibrate|mesh-list
138928507|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138928508|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
138928509|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928510|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138928511|NCT00775905|Amlodipine|amlodipine|mesh-list
138606228|NCT00196599|Efavirenz|efavirenz|mesh-list
138928512|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138928513|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138928514|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138928515|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928516|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138928517|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928518|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
138928519|NCT00772161|Methylphenidate|methylphenidate|mesh-list
138928520|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138928521|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928522|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138928523|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138928524|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138928525|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928526|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
138928527|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928528|NCT00776139|Cetirizine|cetirizine|mesh-list
138928529|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138928530|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138928531|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138928532|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
138928533|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
138928534|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928535|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928536|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928537|NCT00779493|Curcumin|curcumin|mesh-list
138928538|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928539|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138928540|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138928541|NCT00779493|Analgesics|analgesics|mesh-ancestor
138928542|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
138928543|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928544|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138928545|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138928546|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928547|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928548|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928549|NCT02580344|Ibuprofen|ibuprofen|mesh-list
138606469|NCT00196872|Epirubicin|epirubicin|mesh-list
138928550|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138928551|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138928553|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
138928554|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928555|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928556|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138928557|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138638061|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
138928558|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138928559|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928560|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928561|NCT00779649|Bisacodyl|bisacodyl|mesh-list
138928562|NCT00779649|Cathartics|cathartics|mesh-ancestor
138928563|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138928564|NCT00779649|Laxatives|laxatives|mesh-ancestor
138928565|NCT00776217|Loratadine|loratadine|mesh-list
138928566|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
138928567|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
138282870|NCT02783443|Anesthetics|anesthetics|mesh-list
138928568|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138928569|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138928570|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138928571|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
138928572|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
138445362|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
138928573|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928574|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928575|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928576|NCT00667875|Naltrexone|naltrexone|mesh-list
138928577|NCT00667875|Aripiprazole|aripiprazole|mesh-list
138928578|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138928579|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138928580|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928581|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
138928582|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928583|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
138928584|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138928585|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138928586|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138928587|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138928588|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
138928589|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
138928590|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606576|NCT00170729|Hormones|hormones|mesh-ancestor
138928591|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928592|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138928593|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138928594|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
138928595|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138928596|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138928597|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138928598|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138928599|NCT02579642|Ketamine|ketamine|mesh-list
138928600|NCT02579642|Analgesics|analgesics|mesh-ancestor
138928601|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
138928602|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928604|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138928605|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138928606|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
138928607|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
138928608|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138928609|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138928610|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138928611|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928612|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928613|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
138928614|NCT00779805|Ephedrine|ephedrine|mesh-list
138928615|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138928616|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
138928617|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928618|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928619|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138928620|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
138928621|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
138928622|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138928623|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138928624|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
138928625|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
138928626|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928627|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928628|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
138928629|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138928630|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138928631|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928632|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138606737|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928633|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928634|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138928637|NCT00667251|Trastuzumab|trastuzumab|mesh-list
138928638|NCT00667251|Lapatinib|lapatinib|mesh-list
138928639|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138928640|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928641|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
138928642|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
138928643|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
138928644|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928645|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138928646|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138928647|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928648|NCT04063124|Dasatinib|dasatinib|mesh-list
138928649|NCT04063124|Quercetin|quercetin|mesh-list
138928650|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928651|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138928652|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928653|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928654|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
138928655|NCT04063124|Protective Agents|protective agents|mesh-ancestor
138928656|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928657|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
138606802|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
138928658|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138928659|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
138928660|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928661|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928662|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928663|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138928664|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138638088|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
138928665|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928666|NCT00780039|Carboplatin|carboplatin|mesh-list
138928667|NCT00780039|Doxorubicin|doxorubicin|mesh-list
138928668|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138928670|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138928671|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138928672|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138928673|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580630|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928674|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928676|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138928677|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928678|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138928679|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138928680|NCT00776763|Growth Substances|growth substances|mesh-ancestor
138928681|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928682|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
138928683|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
138928684|NCT00772551|Ezetimibe|ezetimibe|mesh-list
138928685|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138928686|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138928687|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
138928688|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928689|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138928690|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138928691|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138445517|NCT01829711|Immunoconjugates|immunoconjugates|mesh-ancestor
138606912|NCT00553930|Ribavirin|ribavirin|mesh-list
138928692|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
138928693|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928694|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138928695|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138928696|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928697|NCT00776841|Cholic Acids|cholic acids|mesh-list
138928698|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
138928699|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138928700|NCT02556879|Liver Extracts|liver extracts|mesh-list
138928701|NCT02556879|Antibodies|antibodies|mesh-list
138928702|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
138928703|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928704|NCT02556879|Hematinics|hematinics|mesh-ancestor
138928705|NCT00772863|Docetaxel|docetaxel|mesh-list
138606965|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
138928706|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928707|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
138928708|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
138928709|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
138928710|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928711|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138928712|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138928713|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
138928714|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928715|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928716|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928717|NCT00667719|Amlodipine|amlodipine|mesh-list
138928718|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138607030|NCT00202293|Olanzapine|olanzapine|mesh-list
138928719|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138928720|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138928721|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138928722|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928723|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138928724|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928725|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
138928726|NCT00667719|Diuretics|diuretics|mesh-ancestor
138928727|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
138928728|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138928729|NCT00669669|Plerixafor|plerixafor|mesh-list
138928730|NCT00669669|Temozolomide|temozolomide|mesh-list
138928731|NCT00669669|Carmustine|carmustine|mesh-list
138928732|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138928733|NCT00669669|Lenograstim|lenograstim|mesh-list
138928734|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138928735|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
138928736|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928737|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138928738|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
138928739|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928740|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928741|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138928742|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138928743|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
138928744|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928745|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928747|NCT02579564|Vinorelbine|vinorelbine|mesh-list
138928748|NCT02579564|Gemcitabine|gemcitabine|mesh-list
138928749|NCT02579564|Pemetrexed|pemetrexed|mesh-list
138928750|NCT02579564|Endostar protein|endostar protein|mesh-list
138928751|NCT02579564|Endostatins|endostatins|mesh-list
138928752|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138928753|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928754|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
138928755|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
138928756|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
138607207|NCT00198237|Docetaxel|docetaxel|mesh-list
138928757|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928758|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138928759|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
138928760|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928761|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138928762|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138928763|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138928764|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138928765|NCT02579564|Growth Substances|growth substances|mesh-ancestor
138928766|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928767|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
138928769|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
138928770|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138928771|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138928772|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138928773|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928774|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138928775|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138928776|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138928777|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138928778|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
138928779|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
138607274|NCT00198393|Gemcitabine|gemcitabine|mesh-list
138928780|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
138928781|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
138928782|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928783|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928784|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
138928785|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
138928786|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138928787|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138928788|NCT00570687|Insulin|insulin|mesh-list
138928789|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138928790|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928791|NCT01021891|Insulin|insulin|mesh-list
138928792|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138928793|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928794|NCT01029223|Metoprolol|metoprolol|mesh-list
138928795|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138928796|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138928797|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
138928798|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
138928799|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928800|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928801|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138607389|NCT02057380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928802|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138928803|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138928804|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
138928805|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928806|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928807|NCT02556723|Aflibercept|aflibercept|mesh-list
138928808|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138928809|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138928810|NCT02556723|Growth Substances|growth substances|mesh-ancestor
138928811|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928812|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
138928813|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928815|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138928816|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138445690|NCT01835418|Amlodipine|amlodipine|mesh-list
138928817|NCT00777543|Analgesics|analgesics|mesh-ancestor
138928819|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928820|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928821|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138928822|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138928823|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
138928824|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138928825|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138928826|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138928827|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138928828|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
138928829|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607524|NCT00410631|Vindesine|vindesine|mesh-list
138928832|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138928833|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
138928834|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928835|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138928836|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607580|NCT01877395|Vaccines|vaccines|mesh-list
138928837|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928838|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
138928839|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138928840|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928841|NCT01022047|Budesonide|budesonide|mesh-list
138928842|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138928843|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138445935|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138928844|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
138928845|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928846|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138314804|NCT01696032|Paclitaxel|paclitaxel|mesh-list
138928847|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138928848|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
138928849|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
138928851|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138928852|NCT01022125|Simeprevir|simeprevir|mesh-list
138928853|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
138928854|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928855|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
138928856|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928857|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928858|NCT05673980|Vitamin D|vitamin d|mesh-list
138928859|NCT05673980|Cholecalciferol|cholecalciferol|mesh-list
138928860|NCT05673980|Ergocalciferols|ergocalciferols|mesh-list
138928861|NCT05673980|Vitamins|vitamins|mesh-ancestor
138928862|NCT05673980|Micronutrients|micronutrients|mesh-ancestor
138928863|NCT05673980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928864|NCT05673980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138928865|NCT05673980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138928866|NCT02581124|Lapatinib|lapatinib|mesh-list
138928867|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928868|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138928869|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928870|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928871|NCT02580968|Flunarizine|flunarizine|mesh-list
138928872|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
138928873|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138928874|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138928875|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607769|NCT01756924|Vancomycin|vancomycin|mesh-list
138928876|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138928877|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928878|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138928879|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
138928880|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
138928881|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928882|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
138928883|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
138928884|NCT00441103|Interferon-beta|interferon-beta|mesh-list
138928885|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138928886|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
138928887|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928888|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928889|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
138928890|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928891|NCT01029613|Adalimumab|adalimumab|mesh-list
138928892|NCT01029613|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138928893|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138928894|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138928895|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
138928896|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
138928897|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928898|NCT03268057|Avelumab|avelumab|mesh-list
138607908|NCT00174356|Paclitaxel|paclitaxel|mesh-list
138928899|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138928900|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928901|NCT01033903|Misoprostol|misoprostol|mesh-list
138928902|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138928903|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
138928904|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138928905|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638168|NCT00281190|Dimercaprol|dimercaprol|mesh-list
138928906|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138928907|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138928908|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
138928909|NCT03281954|Atezolizumab|atezolizumab|mesh-list
138928910|NCT03281954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138607973|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
138928911|NCT03281954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928912|NCT03281954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138928913|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928915|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
138928916|NCT00433537|Rituximab|rituximab|mesh-list
138928917|NCT00433537|Doxorubicin|doxorubicin|mesh-list
138928918|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138928919|NCT00433537|Vincristine|vincristine|mesh-list
138928920|NCT00433537|Bortezomib|bortezomib|mesh-list
138928921|NCT00433537|Lenograstim|lenograstim|mesh-list
138928922|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138928923|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
138446387|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
138446392|NCT01843868|Hormones|hormones|mesh-ancestor
138928924|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928925|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138928926|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138928927|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
138928928|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446450|NCT01844323|Palbociclib|palbociclib|mesh-list
138928929|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928930|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138608098|NCT01652482|Cetuximab|cetuximab|mesh-list
138928931|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138928932|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
138928933|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
138446675|NCT01845376|Anesthetics|anesthetics|mesh-list
138928934|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928935|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138928936|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
138928937|NCT00433537|Hormones|hormones|mesh-ancestor
138608164|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138928938|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138928939|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138928940|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138928941|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138928942|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138928943|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138928944|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928945|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138928946|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138928947|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
138446880|NCT01847339|Bupivacaine|bupivacaine|mesh-list
138928948|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
138928949|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
138928950|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138928951|NCT00570765|Cathartics|cathartics|mesh-ancestor
138928952|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138928953|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138928954|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138928955|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138928956|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447021|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138928957|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928958|NCT05118477|Caffeine|caffeine|mesh-list
138608302|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
138928959|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138928960|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928961|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138928962|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138928963|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928964|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138928965|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138928966|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
138928967|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928968|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138928969|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138928970|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138608367|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138928971|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138928972|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928973|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138928974|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138928975|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928976|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
138928977|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138928978|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138928979|NCT00667095|Protective Agents|protective agents|mesh-ancestor
138928980|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138928982|NCT00777933|Cyclosporine|cyclosporine|mesh-list
138928983|NCT00777933|Tacrolimus|tacrolimus|mesh-list
138928984|NCT00777933|Cyclosporins|cyclosporins|mesh-list
138928985|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138928986|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
138928987|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138928988|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138608501|NCT00554086|Bicalutamide|bicalutamide|mesh-list
138928990|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138928991|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
138928992|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138928993|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
138928994|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138928995|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
138928997|NCT00778011|Ondansetron|ondansetron|mesh-list
138928998|NCT00778011|Metoclopramide|metoclopramide|mesh-list
138928999|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
138929000|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
138929001|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138929002|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929003|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138929004|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
138929005|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
138929006|NCT00778011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138929007|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138929008|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
138608628|NCT00199719|Ribavirin|ribavirin|mesh-list
138929009|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929010|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929011|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138929013|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
138929014|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138929015|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
138929016|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138929017|NCT00778089|Protective Agents|protective agents|mesh-ancestor
138929018|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929019|NCT00433381|Bevacizumab|bevacizumab|mesh-list
138929020|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138929021|NCT00433381|Irinotecan|irinotecan|mesh-list
138929022|NCT00433381|Temozolomide|temozolomide|mesh-list
138929023|NCT00433381|Camptothecin|camptothecin|mesh-list
138929024|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
138929025|NCT00433381|Antibodies|antibodies|mesh-list
138929026|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
138929027|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138929028|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
138929029|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929030|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138929031|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138929032|NCT00433381|Growth Substances|growth substances|mesh-ancestor
138929033|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929034|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
138638193|NCT00252863|Hormones|hormones|mesh-ancestor
138929035|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
138929036|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138929037|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138929038|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929039|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929040|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138447997|NCT01855321|Vitamins|vitamins|mesh-ancestor
138929041|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
138929042|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138929043|NCT00667017|Immunotoxins|immunotoxins|mesh-list
138929044|NCT00667017|Immunoconjugates|immunoconjugates|mesh-ancestor
138929045|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
138929046|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929048|NCT00781131|Analgesics|analgesics|mesh-ancestor
138929049|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
138929050|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138929051|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929052|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
138929053|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138929054|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138929055|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929056|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138929057|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138929058|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138929059|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138929060|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138929061|NCT00778245|Cefprozil|cefprozil|mesh-list
138929062|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929063|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929064|NCT00778401|Gabapentin|gabapentin|mesh-list
138929065|NCT00778401|Analgesics|analgesics|mesh-ancestor
138929066|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
138929067|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138929068|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929069|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
138929070|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138929071|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138929072|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417783|NCT03894904|Heparin|heparin|mesh-list
138929073|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138929074|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138929075|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138929076|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929077|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929078|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
138929079|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
138929080|NCT00666705|Maraviroc|maraviroc|mesh-list
138929081|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138929082|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138929083|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
138929084|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929085|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138929086|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138929087|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929088|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929089|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138929090|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138929091|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138929092|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138929093|NCT04047849|Amoxicillin|amoxicillin|mesh-list
138929094|NCT04047849|Azithromycin|azithromycin|mesh-list
138929095|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929096|NCT00778557|Cefprozil|cefprozil|mesh-list
138929097|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138448729|NCT01858623|Diuretics|diuretics|mesh-ancestor
138929098|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929099|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138929100|NCT00778713|Fosinopril|fosinopril|mesh-list
138929101|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138929102|NCT00778713|Diuretics|diuretics|mesh-ancestor
138929103|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
138929104|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638197|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138929105|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138929106|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138929107|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929108|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138929109|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
138929110|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929111|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
138929112|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138929113|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138929114|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
138929115|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929116|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138929117|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138929118|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929119|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929120|NCT00774111|Dolutegravir|dolutegravir|mesh-list
138929121|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138929122|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138929123|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929124|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929125|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138929126|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138449142|NCT01861535|Imiquimod|imiquimod|mesh-list
138449210|NCT01862120|Interleukin-2|interleukin-2|mesh-list
138929127|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
138929128|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929130|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138929131|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929132|NCT00774189|Clarithromycin|clarithromycin|mesh-list
138929133|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929134|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929135|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138929136|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929137|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929138|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138929139|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138929140|NCT00774423|Riluzole|riluzole|mesh-list
138929141|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
138929142|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138929143|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138608969|NCT00176969|Capsaicin|capsaicin|mesh-list
138929144|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929145|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929146|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929147|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138929148|NCT00774423|Protective Agents|protective agents|mesh-ancestor
138929149|NCT00781521|Ofloxacin|ofloxacin|mesh-list
138929150|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138929151|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929152|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929153|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138929154|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138929155|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929156|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929157|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929158|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138929159|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138929160|NCT00774501|Anesthetics|anesthetics|mesh-list
138929161|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449553|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
138929162|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929163|NCT00784485|Omalizumab|omalizumab|mesh-list
138929164|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138929165|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138929166|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
138929167|NCT00781755|Varenicline|varenicline|mesh-list
138929168|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138609009|NCT00554632|Estradiol|estradiol|mesh-list
138929169|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138929170|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
138929171|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449684|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929172|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929173|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929174|NCT00774735|Dolutegravir|dolutegravir|mesh-list
138929175|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138929176|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138929177|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929178|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929179|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138929180|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138449840|NCT01866605|Midazolam|midazolam|mesh-list
138929181|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
138929182|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929183|NCT00666237|Mitomycins|mitomycins|mesh-list
138929184|NCT00666237|Mitomycin|mitomycin|mesh-list
138929185|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138929186|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929187|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
138929188|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929189|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138929190|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929191|NCT00774813|Citalopram|citalopram|mesh-list
138929192|NCT00774813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138929193|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138929194|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138929195|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929196|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929197|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
138638241|NCT01681966|Ropivacaine|ropivacaine|mesh-list
138929198|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929199|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138929201|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138929202|NCT00784797|Oxytocin|oxytocin|mesh-list
138929203|NCT00784797|Mifepristone|mifepristone|mesh-list
138929204|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
138929205|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138450340|NCT01870219|Ketamine|ketamine|mesh-list
138929206|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929207|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138929208|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
138929209|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138929210|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138929211|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138929212|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
138450610|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929213|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138929214|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138929215|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
138450759|NCT01872351|Protective Agents|protective agents|mesh-ancestor
138929216|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138929217|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
138450832|NCT01872702|Piperaquine|piperaquine|mesh-list
138929218|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138929219|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138929220|NCT00774969|Metronidazole|metronidazole|mesh-list
138929221|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929222|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929223|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138929224|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138929225|NCT00785109|Vitamin K|vitamin k|mesh-list
138929226|NCT00785109|Vitamins|vitamins|mesh-ancestor
138929227|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
138929228|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929229|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138929230|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138405860|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
138929231|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929233|NCT00785109|Coagulants|coagulants|mesh-ancestor
138929234|NCT00662025|Capecitabine|capecitabine|mesh-list
138929235|NCT00662025|Sunitinib|sunitinib|mesh-list
138929236|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138929237|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
138609292|NCT00200655|Pravastatin|pravastatin|mesh-list
138929238|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929239|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929240|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138929241|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138929242|NCT00662025|Growth Substances|growth substances|mesh-ancestor
138929243|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929244|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
138929245|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138451477|NCT04859322|Glucagon|glucagon|mesh-list
138929246|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929248|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138929249|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138929250|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929251|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
138929252|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138929253|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138929254|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138929255|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929256|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138929257|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929258|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138929259|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138929260|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
138929261|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138929262|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138929263|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138929265|NCT00782301|Etravirine|etravirine|mesh-list
138929266|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138451982|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
138929267|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138929268|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929269|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138929270|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138929271|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
138929272|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929273|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138929274|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138929275|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138929276|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929277|NCT00785421|Leucovorin|leucovorin|mesh-list
138929278|NCT00785421|Folic Acid|folic acid|mesh-list
138929279|NCT00785421|Cisplatin|cisplatin|mesh-list
138929280|NCT00785421|Gemcitabine|gemcitabine|mesh-list
138929281|NCT00785421|Enoxaparin|enoxaparin|mesh-list
138929282|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
138929283|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
138929284|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609404|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
138929285|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138929286|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
138929287|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929288|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929290|NCT00785421|Protective Agents|protective agents|mesh-ancestor
138929291|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
138929292|NCT00785421|Vitamins|vitamins|mesh-ancestor
138929293|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
138929294|NCT00785421|Hematinics|hematinics|mesh-ancestor
138929295|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
138929296|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138929297|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138929298|NCT00790179|Ropivacaine|ropivacaine|mesh-list
138929299|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
138929300|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
138929301|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138929302|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929303|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
138452694|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
138929304|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138929305|NCT00790413|Rituximab|rituximab|mesh-list
138929306|NCT00790413|Fludarabine|fludarabine|mesh-list
138929307|NCT00790413|Thiotepa|thiotepa|mesh-list
138929308|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138452768|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929309|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138929310|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929311|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
138929312|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929313|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138929314|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929315|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138638270|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
138929316|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138609591|NCT00408239|Enoxaparin|enoxaparin|mesh-list
138929317|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
138929318|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138929319|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929320|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138929321|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
138929322|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138929323|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138929324|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929325|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929326|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929327|NCT00440947|Ritonavir|ritonavir|mesh-list
138929328|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138929330|NCT00440947|Abacavir|abacavir|mesh-list
138929331|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
138929332|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138929333|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138929334|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
138929335|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929336|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929337|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138929338|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138929339|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
138929340|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138204253|NCT00004102|Leucovorin|leucovorin|mesh-list
138929341|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138929342|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138929343|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138929344|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138929345|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
138929347|NCT00790881|Artemether|artemether|mesh-list
138929348|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138929349|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
138929350|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138929351|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138929352|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929354|NCT01029769|Amisulpride|amisulpride|mesh-list
138929355|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
138929356|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
138929357|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138929358|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929359|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138929360|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138929361|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138929362|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138929363|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138929364|NCT01029769|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138929365|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138929366|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138929367|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929368|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929370|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138929371|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
138929372|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138929373|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
138929375|NCT02557945|Analgesics|analgesics|mesh-ancestor
138929376|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
138929377|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138929378|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929379|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
138929380|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138929381|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138929382|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138929383|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138929384|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138929385|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138929386|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609831|NCT00201630|Alfuzosin|alfuzosin|mesh-list
138929387|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929388|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
138929389|NCT00664521|Rituximab|rituximab|mesh-list
138929390|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138929391|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929392|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
138929393|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929394|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138929395|NCT02581046|Dexamethasone|dexamethasone|mesh-list
138929396|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138929397|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
138929398|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
138929399|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138929400|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929401|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138929402|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
138929403|NCT02581046|Hormones|hormones|mesh-ancestor
138929404|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138929405|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138929406|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929407|NCT00664209|Amoxicillin|amoxicillin|mesh-list
138929408|NCT00664209|Omeprazole|omeprazole|mesh-list
138929409|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929410|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929411|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138929412|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138929413|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138929414|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638312|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138929415|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929416|NCT03192332|Plasminogen|plasminogen|mesh-list
138929417|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138929418|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138929419|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138929420|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929421|NCT02555943|Ritonavir|ritonavir|mesh-list
138929423|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
138929424|NCT02555943|Entecavir|entecavir|mesh-list
138929425|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138929426|NCT02555943|Ledipasvir|ledipasvir|mesh-list
138929427|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138929428|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138929429|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
138929431|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929432|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138929433|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138929434|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
138929435|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929436|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138929437|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138929438|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138929439|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138929441|NCT00782847|Cyproterone|cyproterone|mesh-list
138929442|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
138929443|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
138929444|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138929445|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929446|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929447|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138929448|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
138610053|NCT00561223|Iloprost|iloprost|mesh-list
138929449|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138929450|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138929451|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
138929452|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929453|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
138929454|NCT00440557|Hematinics|hematinics|mesh-ancestor
138929455|NCT01029847|Adalimumab|adalimumab|mesh-list
138929456|NCT01029847|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138929457|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138929458|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138929459|NCT02452268|Spartalizumab|spartalizumab|mesh-list
138929460|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138929461|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929462|NCT02452268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138929463|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929464|NCT02524249|Caffeine|caffeine|mesh-list
138929465|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138929466|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929467|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138929468|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929469|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929470|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138929471|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138929472|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
138929473|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929474|NCT01033981|Sunitinib|sunitinib|mesh-list
138929475|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929476|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138929477|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138929478|NCT01033981|Growth Substances|growth substances|mesh-ancestor
138929479|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929480|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
138929481|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138929482|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929483|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929484|NCT02430194|Interferons|interferons|mesh-list
138929485|NCT02430194|Ritonavir|ritonavir|mesh-list
138929486|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
138929487|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
138929488|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138929489|NCT02430194|Lonafarnib|lonafarnib|mesh-list
138929490|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929491|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
138929492|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929493|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138929494|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138929495|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
138929496|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929497|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929498|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138929499|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138929500|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138929501|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138929502|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
138929503|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929504|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
138929505|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138929506|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929507|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929508|NCT03087656|Levofloxacin|levofloxacin|mesh-list
138929509|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
138929510|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138610373|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
138929511|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929512|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929513|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138929514|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138929515|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929516|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929517|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929518|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138929519|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138929520|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
138929521|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138929522|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929523|NCT04076228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138929524|NCT04076228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929525|NCT02580734|Melatonin|melatonin|mesh-list
138929526|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
138929527|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929528|NCT02580734|Protective Agents|protective agents|mesh-ancestor
138929529|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929530|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138929531|NCT00427999|Pioglitazone|pioglitazone|mesh-list
138929532|NCT00427999|Dexamethasone|dexamethasone|mesh-list
138929533|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
138929534|NCT00427999|Etoricoxib|etoricoxib|mesh-list
138929535|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
138929536|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138929537|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
138929538|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
138929539|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138929540|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929541|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138929542|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
138929544|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138929545|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138929546|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929547|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138929548|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138929549|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929550|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929551|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138929552|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138929553|NCT00427999|Analgesics|analgesics|mesh-ancestor
138929554|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
138929555|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138929556|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138929557|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138929558|NCT04825652|177Lu-PSMA-617|177lu-psma-617|mesh-list
138929559|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138610554|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
138929560|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929561|NCT00661713|Vaccines|vaccines|mesh-list
138929562|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
138929563|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929564|NCT02578472|Zolpidem|zolpidem|mesh-list
138929565|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138929566|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138929567|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138929568|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929569|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138929570|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
138929571|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
138929572|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638377|NCT01684111|Vinorelbine|vinorelbine|mesh-list
138929573|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929574|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138929575|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
138929576|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929578|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138929579|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929580|NCT04072640|Voriconazole|voriconazole|mesh-list
138929581|NCT04072640|Amphotericin B|amphotericin b|mesh-list
138610675|NCT04576975|Analgesics|analgesics|mesh-ancestor
138929582|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138929583|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
138929585|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
138929586|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929587|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138929588|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138929589|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610740|NCT00181181|Atorvastatin|atorvastatin|mesh-list
138929590|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929591|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138453212|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
138929593|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138929594|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929595|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138929596|NCT04072640|Amebicides|amebicides|mesh-ancestor
138929597|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138929598|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138929599|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929600|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138929601|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138929602|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138929603|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
138929604|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138929605|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138929606|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138929607|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138929608|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929609|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138929610|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138929611|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929614|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138929615|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138929616|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
138929617|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929618|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929619|NCT00427921|Adalimumab|adalimumab|mesh-list
138929620|NCT00427921|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138929621|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138929622|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138929623|NCT00432991|Ephedrine|ephedrine|mesh-list
138929624|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138929625|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929626|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
138929627|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
138929628|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138929629|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138929630|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
138929631|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929632|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929633|NCT00580970|Lovastatin|lovastatin|mesh-list
138929634|NCT00580970|L 647318|l 647318|mesh-list
138638446|NCT00416910|Analgesics|analgesics|mesh-ancestor
138929635|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
138929636|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138929637|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138929639|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929640|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138929641|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138929642|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929643|NCT01030081|Amlodipine|amlodipine|mesh-list
138929644|NCT01030081|Nifedipine|nifedipine|mesh-list
138929645|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138929646|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138929647|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138929648|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929649|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138929650|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929652|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
138929653|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138929654|NCT00426751|Abciximab|abciximab|mesh-list
138929655|NCT00426751|Eptifibatide|eptifibatide|mesh-list
138929656|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
138929657|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138929658|NCT02576366|Rifampin|rifampin|mesh-list
138929659|NCT02576366|Voriconazole|voriconazole|mesh-list
138929660|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138929661|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
138929662|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929663|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929664|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
138610965|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
138929665|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138929666|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929667|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929668|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138929669|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138929670|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138929671|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138929672|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138929673|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138929674|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
138929675|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138929676|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138929677|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138929678|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
138929679|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138929680|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929681|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138929682|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138929683|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
138929684|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138929685|NCT04046679|Bleomycin|bleomycin|mesh-list
138929686|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138929687|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929688|NCT00786279|Ethanol|ethanol|mesh-list
138929689|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138929690|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929691|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138929692|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929693|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138929694|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138453261|NCT01884272|Naproxen|naproxen|mesh-list
138929695|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138929696|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138929697|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929698|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138929699|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138929700|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138929701|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
138929702|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929703|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929704|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138929705|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138929706|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
138929707|NCT00791271|Interferons|interferons|mesh-list
138929708|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
138929709|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
138929710|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138929712|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929713|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
138929714|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929715|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
138929716|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929717|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138929718|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
138929719|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929720|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929721|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138929722|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138929723|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138929724|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138929725|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929726|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138929727|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138929728|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138929729|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
138929730|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929731|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929732|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138929733|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138929734|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
138929735|NCT00440401|Hemostatics|hemostatics|mesh-list
138929736|NCT00440401|Thrombin|thrombin|mesh-list
138929737|NCT00440401|Coagulants|coagulants|mesh-ancestor
138929738|NCT00791427|Ranibizumab|ranibizumab|mesh-list
138929739|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138929740|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138453284|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
138929741|NCT00791427|Growth Substances|growth substances|mesh-ancestor
138929742|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929743|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
138929744|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929745|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
138929746|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138929747|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
138929748|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138611407|NCT00182702|Epothilones|epothilones|mesh-list
138929749|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
138929750|NCT00791505|Trimethoprim|trimethoprim|mesh-list
138929751|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
138929752|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929753|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929754|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138929755|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138929756|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929757|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929758|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929759|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138929760|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138929761|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138929762|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
138929763|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138929764|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138929765|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138929766|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138929767|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138929768|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138929769|NCT02598960|Nivolumab|nivolumab|mesh-list
138929770|NCT02598960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138929771|NCT02598960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929772|NCT02598960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138929773|NCT02598960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929774|NCT00426361|Vaccines|vaccines|mesh-list
138929775|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
138929776|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929778|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138611517|NCT00589381|Protective Agents|protective agents|mesh-ancestor
138929779|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138929780|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929781|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929782|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
138929783|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929784|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138929785|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138453313|NCT01884428|Prednisolone|prednisolone|mesh-list
138929786|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929788|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138929789|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
138929791|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929792|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138929793|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
138929794|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138929795|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138929796|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929797|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138929798|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
138929799|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138929800|NCT00783081|Protective Agents|protective agents|mesh-ancestor
138929801|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138929802|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138929803|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929804|NCT00426127|Docetaxel|docetaxel|mesh-list
138929805|NCT00426127|Doxorubicin|doxorubicin|mesh-list
138929806|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138929807|NCT00426127|Enoxaparin|enoxaparin|mesh-list
138929808|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611706|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
138929809|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
138929810|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
138929811|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
138929812|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929813|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138929814|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138929815|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138929816|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929817|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
138929818|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138929819|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138929820|NCT00425503|Bortezomib|bortezomib|mesh-list
138929821|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929822|NCT00786669|Cefixime|cefixime|mesh-list
138929823|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
138929824|NCT00786669|Bevacizumab|bevacizumab|mesh-list
138929825|NCT00786669|Irinotecan|irinotecan|mesh-list
138929826|NCT00786669|Vincristine|vincristine|mesh-list
138929827|NCT00786669|Temozolomide|temozolomide|mesh-list
138929828|NCT00786669|Camptothecin|camptothecin|mesh-list
138929829|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138929830|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929831|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138929832|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138929833|NCT00786669|Growth Substances|growth substances|mesh-ancestor
138929834|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929835|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
138929836|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138929837|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138929838|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929839|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929840|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138929841|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
138929842|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
138929843|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
138929844|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138929845|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
138929846|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929847|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929849|NCT00791739|Trazodone|trazodone|mesh-list
138929850|NCT00791739|Analgesics|analgesics|mesh-ancestor
138612002|NCT00210561|Tramadol|tramadol|mesh-list
138929851|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
138929852|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138929853|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929855|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138929856|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138929857|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929858|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138929859|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138929860|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138929861|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138929862|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138929863|NCT00791739|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138929864|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138929865|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929866|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
138929867|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138929868|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
138929869|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
138929870|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
138929871|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138929872|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138929873|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929874|NCT00430573|Cycloserine|cycloserine|mesh-list
138929875|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138929876|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929877|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138929878|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
138929879|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929880|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
138929881|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929882|NCT00783393|Temozolomide|temozolomide|mesh-list
138929883|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138929884|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
138929885|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929886|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929887|NCT00783471|Docetaxel|docetaxel|mesh-list
138929888|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138929889|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929890|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
138929891|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
138929892|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
138929893|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929894|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138929895|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929896|NCT02460900|Varenicline|varenicline|mesh-list
138929897|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138929898|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138929899|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
138929900|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612086|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
138929901|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929902|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929903|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138929904|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
138929905|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
138929906|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929907|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
138929908|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929909|NCT02554695|Denosumab|denosumab|mesh-list
138929910|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138929911|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929912|NCT00792363|Irinotecan|irinotecan|mesh-list
138929914|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138929915|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138929916|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138929917|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929918|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929919|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138929920|NCT00425113|Metronidazole|metronidazole|mesh-list
138929921|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929922|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138929924|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138929925|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
138929926|NCT03994783|Rituximab|rituximab|mesh-list
138929927|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
138638700|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
138929928|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138929929|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
138612266|NCT00218166|Triazolam|triazolam|mesh-list
138929930|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138248607|NCT04069221|Cobicistat|cobicistat|mesh-list
138929931|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138929932|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929933|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
138929934|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929935|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138929936|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138929938|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
138929939|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138929940|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138929941|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
138929942|NCT03994783|Hormones|hormones|mesh-ancestor
138612333|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138929943|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138929944|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138929945|NCT03994783|Protective Agents|protective agents|mesh-ancestor
138929946|NCT00440011|Bimatoprost|bimatoprost|mesh-list
138929947|NCT00440011|Travoprost|travoprost|mesh-list
138929948|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138929949|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138929950|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138929951|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138929952|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
138929953|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929954|NCT01937468|Interleukin-2|interleukin-2|mesh-list
138929955|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929956|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138929957|NCT01937468|Analgesics|analgesics|mesh-ancestor
138929958|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
138929959|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612399|NCT00185705|Telmisartan|telmisartan|mesh-list
138929960|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929961|NCT00663117|Naltrexone|naltrexone|mesh-list
138929962|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138929963|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138612463|NCT00211419|Triamcinolone|triamcinolone|mesh-list
138929964|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929965|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
138929966|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138929967|NCT04072328|Midazolam|midazolam|mesh-list
138929968|NCT04072328|Propofol|propofol|mesh-list
138929969|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138929970|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138929971|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929972|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138929973|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
138929974|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
138929975|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138929976|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138929977|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138929978|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138929979|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
138929980|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
138929981|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929982|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929984|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
138929985|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138929986|NCT00784017|Asparaginase|asparaginase|mesh-list
138929987|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138929988|NCT04074122|Adenosine|adenosine|mesh-list
138929989|NCT04074122|Isoproterenol|isoproterenol|mesh-list
138929990|NCT04074122|Epinephrine|epinephrine|mesh-list
138929991|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138929992|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138929993|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
138929994|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138929995|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138929996|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138929997|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138929998|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138929999|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
138930000|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930001|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138930002|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
138930003|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
138930004|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
138930005|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138930006|NCT04074122|Analgesics|analgesics|mesh-ancestor
138930007|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
138930008|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138930009|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
138930010|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138930011|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
138930012|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
138930014|NCT04074122|Protective Agents|protective agents|mesh-ancestor
138930015|NCT02578550|Tenofovir|tenofovir|mesh-list
138930016|NCT02578550|Emtricitabine|emtricitabine|mesh-list
138930017|NCT02578550|Darunavir|darunavir|mesh-list
138930018|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138930019|NCT02578550|Cobicistat|cobicistat|mesh-list
138930020|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138930021|NCT02578550|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
138930022|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
138930023|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138930024|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138612715|NCT00212472|Factor VIII|factor viii|mesh-list
138930025|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138930026|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930027|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930028|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138930029|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138930030|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138930031|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138930032|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
138930033|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138930034|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138453444|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
138930036|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138930037|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
138930038|NCT00788463|Hormones|hormones|mesh-ancestor
138930039|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138930040|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612776|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
138930041|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138930042|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
138930044|NCT00579254|Atorvastatin|atorvastatin|mesh-list
138930045|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138930046|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138930047|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
138930048|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930049|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138930050|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138612836|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
138930051|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930052|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138930053|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138930054|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138930055|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138930056|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930057|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
138930058|NCT00793221|Sirolimus|sirolimus|mesh-list
138930059|NCT00793221|Everolimus|everolimus|mesh-list
138930060|NCT00793221|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138930061|NCT00793221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138930062|NCT00793221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930063|NCT00793221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930064|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138930065|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
138930066|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930067|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930068|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138930069|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138930070|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138930071|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
138930072|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
138930073|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138612926|NCT00189371|Paclitaxel|paclitaxel|mesh-list
138930074|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138930075|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138930076|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138930077|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930078|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
138930079|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930080|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930081|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138930082|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930083|NCT01773278|Antioxidants|antioxidants|mesh-list
138930084|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930085|NCT01773278|Protective Agents|protective agents|mesh-ancestor
138930086|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930088|NCT00788931|Trastuzumab|trastuzumab|mesh-list
138930089|NCT00788931|Panobinostat|panobinostat|mesh-list
138930090|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138638772|NCT01687699|Spironolactone|spironolactone|mesh-list
138930091|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613020|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
138930092|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
138930093|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
138930094|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
138930095|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930096|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138613075|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930097|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138930098|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582059|NCT03117309|Nivolumab|nivolumab|mesh-list
138930099|NCT02577848|Liraglutide|liraglutide|mesh-list
138930100|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138930101|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930102|NCT02577848|Incretins|incretins|mesh-ancestor
138930103|NCT02577848|Hormones|hormones|mesh-ancestor
138930104|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138930105|NCT00582426|Octreotide|octreotide|mesh-list
138930106|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138930107|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138930108|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930109|NCT00709982|Folic Acid|folic acid|mesh-list
138930110|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138930111|NCT00709982|Norgestimate|norgestimate|mesh-list
138930112|NCT00709982|Estradiol|estradiol|mesh-list
138930113|NCT00709982|Estrogens|estrogens|mesh-ancestor
138930114|NCT00709982|Hormones|hormones|mesh-ancestor
138930115|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138930116|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930117|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138930118|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
138930119|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138930120|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138930121|NCT00709982|Hematinics|hematinics|mesh-ancestor
138613209|NCT00220350|Leuprolide|leuprolide|mesh-list
138930122|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
138930123|NCT00709982|Vitamins|vitamins|mesh-ancestor
138930124|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
138930125|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138930126|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138930127|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138930128|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
138930129|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138453481|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930130|NCT00710138|Vitamins|vitamins|mesh-list
138930131|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
138930132|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
138930133|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
138930134|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
138930135|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930136|NCT00710138|Hematinics|hematinics|mesh-ancestor
138930137|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
138930138|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138930139|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930141|NCT00710216|Telbivudine|telbivudine|mesh-list
138930142|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138930143|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138930144|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930145|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930146|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
138930147|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138930148|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138930149|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138930150|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
138930151|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
138930152|NCT00773513|Hematinics|hematinics|mesh-ancestor
138930153|NCT00710528|Idelalisib|idelalisib|mesh-list
138930154|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930155|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930156|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930157|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
138930158|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138930159|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930161|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138930162|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
138930163|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138930164|NCT00711308|Vitamin K|vitamin k|mesh-list
138930165|NCT00711308|Tinzaparin|tinzaparin|mesh-list
138930166|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138930167|NCT00711308|Dalteparin|dalteparin|mesh-list
138930169|NCT00711308|Vitamins|vitamins|mesh-ancestor
138930170|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
138930171|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930172|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138930173|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138582143|NCT00131846|Diuretics|diuretics|mesh-list
138930174|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930175|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
138930177|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
138930178|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138930179|NCT02601911|Acetaminophen|acetaminophen|mesh-list
138930180|NCT02601911|Ketorolac|ketorolac|mesh-list
138930181|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138930182|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138930183|NCT02601911|Analgesics|analgesics|mesh-ancestor
138930184|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
138930185|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930186|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930187|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
138453513|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
138930188|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138613510|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138930189|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138930190|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138930191|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138930192|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930193|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930195|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138930196|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
138930197|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930198|NCT02577614|Coagulants|coagulants|mesh-list
138930199|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
138930200|NCT02577458|Everolimus|everolimus|mesh-list
138930201|NCT02577458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138930202|NCT02577458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138930203|NCT02577458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930204|NCT02577458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930205|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138930206|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
138930207|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930208|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930209|NCT00767039|Poractant alfa|poractant alfa|mesh-list
138930212|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
138930213|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138930214|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138930215|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930216|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138930217|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
138930218|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930219|NCT02577770|Caffeine|caffeine|mesh-list
138930220|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138930221|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930222|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138930223|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613789|NCT05840952|Midazolam|midazolam|mesh-list
138930224|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930225|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138930226|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138930227|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
138930228|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930229|NCT00129896|Docetaxel|docetaxel|mesh-list
138930230|NCT00129896|Doxorubicin|doxorubicin|mesh-list
138930231|NCT00129896|Trastuzumab|trastuzumab|mesh-list
138930232|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930233|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
138930234|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
138930235|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
138930236|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613836|NCT05701007|Docetaxel|docetaxel|mesh-list
138930238|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138930239|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138930240|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930241|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138930242|NCT02574338|Alprostadil|alprostadil|mesh-list
138930243|NCT02574338|Misoprostol|misoprostol|mesh-list
138930244|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138930245|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
138930246|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138930247|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930248|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138930249|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138930250|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
138930251|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138930252|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
138930253|NCT02574338|Urological Agents|urological agents|mesh-ancestor
138930255|NCT03070392|Ipilimumab|ipilimumab|mesh-list
138930256|NCT03070392|Dacarbazine|dacarbazine|mesh-list
138930257|NCT03070392|Imidazole|imidazole|mesh-list
138930258|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138930259|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930260|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138930261|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930262|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138930263|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
138930264|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930265|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
138930266|NCT00711698|Narcotics|narcotics|mesh-ancestor
138930267|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138930268|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930269|NCT00711698|Analgesics|analgesics|mesh-ancestor
138930270|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
138930271|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930273|NCT00795171|Sunitinib|sunitinib|mesh-list
138930274|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930275|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
138930276|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
138930277|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
138614023|NCT05244525|Mydriatics|mydriatics|mesh-ancestor
138930278|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930279|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138930280|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138930281|NCT00795171|Growth Substances|growth substances|mesh-ancestor
138930282|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930283|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
138930284|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138930285|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930286|NCT00711854|Rifampin|rifampin|mesh-list
138930287|NCT00711854|Linezolid|linezolid|mesh-list
138930288|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138930289|NCT00711854|Trimethoprim|trimethoprim|mesh-list
138930290|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
138930291|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138930292|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
138930293|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138930294|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138930295|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
138930296|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138930297|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930298|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930299|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138930300|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138930301|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138930302|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138930303|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138930304|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138930305|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138930306|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138930309|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138930310|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138930311|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138930312|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138930313|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138930314|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
138614231|NCT04332874|Dactinomycin|dactinomycin|mesh-list
138930315|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138930316|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930318|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138930319|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138930320|NCT03015792|Dexamethasone|dexamethasone|mesh-list
138930321|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
138930322|NCT03015792|Lenalidomide|lenalidomide|mesh-list
138930323|NCT03015792|Ichthammol|ichthammol|mesh-list
138930324|NCT03015792|BB 1101|bb 1101|mesh-list
138930325|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138930326|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
138930327|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
138930328|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930329|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930330|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138930331|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
138711049|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138638021|NCT00252668|Methotrexate|methotrexate|mesh-list
138930333|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138930334|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138930335|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930336|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
138930337|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930338|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930339|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
138930340|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138930341|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138930342|NCT03015792|Growth Substances|growth substances|mesh-ancestor
138930343|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
138930344|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
138930345|NCT00789165|Quinidine|quinidine|mesh-list
138930346|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138930347|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138930348|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
138930349|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930350|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930351|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930352|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138930353|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
138930354|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138930355|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138638896|NCT00288444|Lonafarnib|lonafarnib|mesh-list
138614340|NCT03782207|Atezolizumab|atezolizumab|mesh-list
138930356|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138930357|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930358|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138930359|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138930360|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
138930361|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138930362|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138930363|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138638049|NCT02271997|Hematinics|hematinics|mesh-ancestor
138930364|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138930365|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138930367|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
138930368|NCT00712556|Protective Agents|protective agents|mesh-ancestor
138930369|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930370|NCT00772967|Naproxen|naproxen|mesh-list
138930371|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138930372|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138930373|NCT00772967|Analgesics|analgesics|mesh-ancestor
138930374|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
138930375|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930376|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930377|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138930378|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138930379|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
138930380|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138930381|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138205286|NCT00004186|Etoposide|etoposide|mesh-list
138930382|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930383|NCT00793377|Tamoxifen|tamoxifen|mesh-list
138930384|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
138930385|NCT00793377|Docetaxel|docetaxel|mesh-list
138930386|NCT00793377|Doxorubicin|doxorubicin|mesh-list
138930387|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138930388|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138930389|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
138930390|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930391|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138930392|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138930393|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
138930394|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930395|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930396|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138930397|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
138930398|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
138930399|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
138930400|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138930401|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138930402|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138930403|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614574|NCT02420717|Rituximab|rituximab|mesh-list
138930404|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138930405|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
138930406|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138930407|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138930408|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138930409|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138412179|NCT01632514|Vitamins|vitamins|mesh-ancestor
138638102|NCT01680796|Hormones|hormones|mesh-ancestor
138930410|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138930411|NCT00662259|Alprazolam|alprazolam|mesh-list
138930412|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138930413|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138315539|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138930414|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930415|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138930416|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138930417|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138930418|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
138930419|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
138930420|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930421|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930422|NCT00712790|Sorafenib|sorafenib|mesh-list
138930423|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930424|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138930425|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930426|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930427|NCT00660699|Gemcitabine|gemcitabine|mesh-list
138930428|NCT00660699|Docetaxel|docetaxel|mesh-list
138930429|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138930430|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
138930431|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930432|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930433|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
138930434|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
138930435|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
138930436|NCT02577068|Propacetamol|propacetamol|mesh-list
138930437|NCT02577068|Nefopam|nefopam|mesh-list
138930438|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138930439|NCT02577068|Analgesics|analgesics|mesh-ancestor
138930440|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
138930441|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930442|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930443|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138930444|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138930445|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138930446|NCT00582114|Atenolol|atenolol|mesh-list
138930447|NCT00582114|Lisinopril|lisinopril|mesh-list
138638131|NCT01680913|Anesthetics|anesthetics|mesh-list
138930448|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138930449|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
138930450|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930451|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930452|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138930453|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138930454|NCT00582114|Protective Agents|protective agents|mesh-ancestor
138930455|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930456|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138930457|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
138930458|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
138930459|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930460|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138930461|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138930462|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138930463|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
138930464|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930465|NCT00582036|Insulin|insulin|mesh-list
138930466|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138930467|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138930468|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930469|NCT00581360|Doxorubicin|doxorubicin|mesh-list
138930470|NCT00581360|Bortezomib|bortezomib|mesh-list
138930471|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138614816|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
138930472|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930473|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138930474|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138582431|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
138930475|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930476|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930477|NCT01650792|Aspirin|aspirin|mesh-list
138930478|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138930479|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138930480|NCT01650792|Analgesics|analgesics|mesh-ancestor
138930481|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
138930482|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930483|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930484|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138930485|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138930486|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138930487|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138930488|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930489|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138930490|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138930491|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614939|NCT00221325|Rituximab|rituximab|mesh-list
138930492|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
138930493|NCT00660387|Levodopa|levodopa|mesh-list
138930494|NCT00660387|Carbidopa|carbidopa|mesh-list
138930495|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138930496|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138930497|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138930498|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
138930499|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930500|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930501|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930502|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138930503|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930504|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138930505|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
138930506|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
138930507|NCT00582738|Everolimus|everolimus|mesh-list
138930508|NCT00582738|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138930509|NCT00582738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138930510|NCT00582738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930511|NCT00582738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930512|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138930513|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
138930514|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930515|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930516|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
138930517|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138615068|NCT00191672|Paclitaxel|paclitaxel|mesh-list
138930518|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138930519|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138930520|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138930521|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138930522|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930523|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930524|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930525|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138930526|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
138930527|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138930528|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930529|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138930530|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138930531|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138930533|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138930534|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
138930535|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
138930536|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
138930537|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138930538|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138214945|NCT02513550|Ixekizumab|ixekizumab|mesh-list
138930539|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930540|NCT00713726|Fentanyl|fentanyl|mesh-list
138930541|NCT00713726|Tramadol|tramadol|mesh-list
138930542|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138930543|NCT00713726|Narcotics|narcotics|mesh-ancestor
138930544|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138638924|NCT00415103|Aprepitant|aprepitant|mesh-list
138930545|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930546|NCT00713726|Analgesics|analgesics|mesh-ancestor
138930547|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
138930548|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930549|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138930550|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138930551|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
138930553|NCT00800553|Donepezil|donepezil|mesh-list
138930554|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138930555|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930556|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930557|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
138930558|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930559|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930560|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
138930561|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
138930562|NCT00793767|Hematinics|hematinics|mesh-ancestor
138930563|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138930564|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138930565|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138930566|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138930567|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930568|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138930569|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138930570|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138930571|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
138930572|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930573|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930574|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138615171|NCT00123890|Aplaviroc|aplaviroc|mesh-list
138930575|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138930576|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
138930577|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
138930578|NCT00793845|Melphalan|melphalan|mesh-list
138930579|NCT00793845|Thiotepa|thiotepa|mesh-list
138930580|NCT00793845|Carboplatin|carboplatin|mesh-list
138930581|NCT00793845|Etoposide|etoposide|mesh-list
138930582|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138930583|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
138930584|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930585|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138930586|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138930587|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
138930588|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930589|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930590|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138930591|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138930592|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138930593|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138930594|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930595|NCT00800709|Memantine|memantine|mesh-list
138930596|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138930597|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138930598|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
138930599|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930600|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930601|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615208|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930602|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138930604|NCT00793923|Dexamethasone|dexamethasone|mesh-list
138930605|NCT00793923|Ranibizumab|ranibizumab|mesh-list
138930606|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138930607|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
138930608|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
138930609|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930610|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930611|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138930612|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
138930613|NCT00793923|Hormones|hormones|mesh-ancestor
138638938|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
138930614|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138930615|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138930616|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930617|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138930618|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138930619|NCT00793923|Growth Substances|growth substances|mesh-ancestor
138930620|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
138930622|NCT01247324|Interferon-beta|interferon-beta|mesh-list
138930623|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
138930624|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
138930625|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930626|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
138930627|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138930628|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
138930629|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930630|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138930631|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138930632|NCT00772577|Ramipril|ramipril|mesh-list
138930633|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138930634|NCT00772577|Diuretics|diuretics|mesh-ancestor
138930635|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
138930636|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638230|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930637|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138930638|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138930639|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930640|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138930641|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
138930642|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930643|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
138930644|NCT02345850|Methotrexate|methotrexate|mesh-list
138930645|NCT02345850|Tacrolimus|tacrolimus|mesh-list
138930646|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138930647|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
138930648|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930649|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138930650|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138930651|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
138930652|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930653|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930654|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138930655|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138930656|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
138930657|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138930658|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138930659|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
138930660|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
138930661|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930662|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138930663|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138930664|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138930665|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
138930666|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
138930667|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930668|NCT04073550|Topotecan|topotecan|mesh-list
138930669|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138930670|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138930671|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930672|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930673|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930674|NCT02576600|Remifentanil|remifentanil|mesh-list
138930675|NCT02576600|Propofol|propofol|mesh-list
138930676|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138930677|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138930678|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930679|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138638949|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
138638260|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138930680|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
138930681|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
138930682|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138930683|NCT02576600|Narcotics|narcotics|mesh-ancestor
138930684|NCT02576600|Analgesics|analgesics|mesh-ancestor
138930685|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
138930686|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930687|NCT02863770|Pancrelipase|pancrelipase|mesh-list
138930688|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138930689|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138930690|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138930691|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138930692|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138930693|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930694|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138930695|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138930696|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138930697|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
138930698|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930699|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930700|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138930701|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138930702|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
138930703|NCT00660309|Irbesartan|irbesartan|mesh-list
138930704|NCT00660309|Captopril|captopril|mesh-list
138930705|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138930706|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138930707|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138930708|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930709|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138930710|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
138930711|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930712|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
138930713|NCT04046133|Capecitabine|capecitabine|mesh-list
138930714|NCT04046133|Mitomycins|mitomycins|mesh-list
138930715|NCT04046133|Mitomycin|mitomycin|mesh-list
138930716|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138930717|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930718|NCT04046133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138930719|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930720|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138930721|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
138930722|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138930723|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
138930724|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138930725|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930726|NCT02573714|Ketamine|ketamine|mesh-list
138930727|NCT02573714|Analgesics|analgesics|mesh-ancestor
138930728|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
138930729|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930730|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930731|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138638286|NCT00287664|Terlipressin|terlipressin|mesh-list
138930732|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138930733|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
138930734|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
138930735|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138930736|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138615447|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138930737|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138930738|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930739|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930740|NCT00794235|Sorafenib|sorafenib|mesh-list
138930741|NCT00794235|Dacarbazine|dacarbazine|mesh-list
138930742|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930743|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138930744|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930745|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930746|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138930747|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
138930748|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
138930749|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138930750|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930751|NCT02575664|Buprenorphine|buprenorphine|mesh-list
138930752|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138930753|NCT02575664|Narcotics|narcotics|mesh-ancestor
138930754|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138930755|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930756|NCT02575664|Analgesics|analgesics|mesh-ancestor
138930757|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
138930758|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930759|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138930760|NCT00796497|Ondansetron|ondansetron|mesh-list
138930761|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
138930762|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
138930763|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930764|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930765|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138930766|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
138930767|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
138930768|NCT00796497|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138615493|NCT00215592|Zonisamide|zonisamide|mesh-list
138930769|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138930770|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
138930771|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638301|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638303|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138930772|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930773|NCT00801177|Necitumumab|necitumumab|mesh-list
138930774|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138930775|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138930777|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
138930778|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930780|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138930781|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138930782|NCT00581100|Analgesics|analgesics|mesh-ancestor
138930783|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
138930784|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930785|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930786|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138930787|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138930788|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138930789|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138930790|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
138930791|NCT00579098|Atorvastatin|atorvastatin|mesh-list
138930792|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138930793|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138930794|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
138930795|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930796|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138930797|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138930798|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930800|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
138930801|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930802|NCT00801255|Lactams|lactams|mesh-list
138930803|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138930804|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138930805|NCT00794625|Valproic Acid|valproic acid|mesh-list
138930806|NCT00794625|Risperidone|risperidone|mesh-list
138615544|NCT00192803|Candesartan|candesartan|mesh-list
138930807|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
138930808|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138930809|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
138930810|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930811|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930812|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930813|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138930814|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138930815|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138930816|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138930817|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138930818|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
138930819|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
138930820|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638334|NCT00253058|Cetirizine|cetirizine|mesh-list
138930821|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
138930822|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
138930823|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138930824|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138930825|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138930826|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138930827|NCT02577432|Fentanyl|fentanyl|mesh-list
138930828|NCT02577432|Bupivacaine|bupivacaine|mesh-list
138930829|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
138930831|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138930832|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930833|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
138930834|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930835|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138930836|NCT02577432|Narcotics|narcotics|mesh-ancestor
138930837|NCT02577432|Analgesics|analgesics|mesh-ancestor
138930838|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138930839|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138930840|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
138582807|NCT00134498|Atorvastatin|atorvastatin|mesh-list
138930841|NCT00794703|Itraconazole|itraconazole|mesh-list
138930842|NCT00794703|Micafungin|micafungin|mesh-list
138930843|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
138930844|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138930845|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138930846|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138930847|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930848|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930849|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138930850|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
138930851|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138930852|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930853|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138930854|NCT00772031|Topiramate|topiramate|mesh-list
138930855|NCT00772031|Propranolol|propranolol|mesh-list
138930856|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138930857|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138930858|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
138930859|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138930860|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930861|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930862|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138930863|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138930864|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
138930865|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
138930866|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138930867|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
138930868|NCT00801411|Docetaxel|docetaxel|mesh-list
138930869|NCT00801411|Doxorubicin|doxorubicin|mesh-list
138930870|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138930871|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138930872|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
138930873|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930874|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138615611|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930875|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138638360|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138930876|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
138930877|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930878|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930879|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138930880|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
138930881|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
138930882|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
138930883|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138930884|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138930885|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138930886|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930888|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930889|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138930890|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930891|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930892|NCT00771953|Docetaxel|docetaxel|mesh-list
138930893|NCT00771953|Pemetrexed|pemetrexed|mesh-list
138930894|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930895|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
138930896|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
138930897|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
138930898|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930899|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930900|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138930901|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138930902|NCT00714584|Naltrexone|naltrexone|mesh-list
138930903|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138930905|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930906|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
138930907|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930908|NCT00621244|Panobinostat|panobinostat|mesh-list
138930909|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930910|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138930911|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930912|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930913|NCT00916409|Temozolomide|temozolomide|mesh-list
138930914|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138930915|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
138930916|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930917|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930918|NCT00714740|Acetazolamide|acetazolamide|mesh-list
138930919|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
138930920|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138930921|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930922|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930923|NCT00714740|Diuretics|diuretics|mesh-ancestor
138930924|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
138930925|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930926|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
138930927|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
138930928|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138930929|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138930930|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930931|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930932|NCT00659529|Urological Agents|urological agents|mesh-ancestor
138930933|NCT02575508|Fluorouracil|fluorouracil|mesh-list
138930934|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
138930936|NCT02575508|Camptothecin|camptothecin|mesh-list
138930937|NCT02575508|Infigratinib|infigratinib|mesh-list
138930938|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
138930939|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930940|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138930942|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138930943|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
138930945|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138930946|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138930947|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930948|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138930949|NCT00795015|Insulin|insulin|mesh-list
138930950|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138930951|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138930952|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930953|NCT00796887|Niacin|niacin|mesh-list
138930954|NCT00796887|Niacinamide|niacinamide|mesh-list
138930955|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
138930956|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138930957|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
138930958|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930959|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138930960|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
138930961|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
138930962|NCT00796887|Vitamins|vitamins|mesh-ancestor
138930963|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
138930964|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930965|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
138930966|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138930967|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930968|NCT00843934|Epirubicin|epirubicin|mesh-list
138930969|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930970|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138930971|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138930972|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138930973|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930974|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930975|NCT00805701|Dutasteride|dutasteride|mesh-list
138930976|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138615735|NCT00215709|Docetaxel|docetaxel|mesh-list
138930977|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138930978|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138930979|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138930981|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138930982|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930984|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138930985|NCT04042948|Analgesics|analgesics|mesh-ancestor
138930986|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
138930987|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138930988|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930989|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
138582959|NCT04725357|Analgesics|analgesics|mesh-ancestor
138930990|NCT00765245|Rituximab|rituximab|mesh-list
138930991|NCT00765245|Lenalidomide|lenalidomide|mesh-list
138930992|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138930993|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138930994|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
138638999|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138930995|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138930996|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138930997|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138930998|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138930999|NCT00765245|Growth Substances|growth substances|mesh-ancestor
138931000|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
138931001|NCT00801879|Mupirocin|mupirocin|mesh-list
138931002|NCT00801879|Calcium|calcium|mesh-list
138931003|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138931004|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931005|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138931006|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931007|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138931008|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931009|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931010|NCT00718484|Doxorubicin|doxorubicin|mesh-list
138931011|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138931012|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
138931013|NCT00718484|Ifosfamide|ifosfamide|mesh-list
138931014|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138931015|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931016|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138931017|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138931018|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931019|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615778|NCT00215865|Ribavirin|ribavirin|mesh-list
138931020|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138931021|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
138931023|NCT00841126|Trace Elements|trace elements|mesh-ancestor
138931024|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
138931025|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931026|NCT00805857|Tipranavir|tipranavir|mesh-list
138931027|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138931028|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138931029|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
138931030|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931031|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
138931032|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138931033|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138931034|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138931035|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
138931036|NCT00801957|Tacrolimus|tacrolimus|mesh-list
138931037|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138931038|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
138931039|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931040|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138931041|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931042|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931043|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138931044|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
138931045|NCT00836134|Bupivacaine|bupivacaine|mesh-list
138931046|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
138931047|NCT00836134|Anesthetics|anesthetics|mesh-list
138931048|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138931049|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931050|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
138931051|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931052|NCT00782795|Pioglitazone|pioglitazone|mesh-list
138931053|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138931054|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931055|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
138931056|NCT02573558|Propofol|propofol|mesh-list
138931057|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138931058|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138931059|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931060|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138931061|NCT02573558|Analgesics|analgesics|mesh-ancestor
138931062|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
138216960|NCT00731198|Drotaverin|drotaverin|mesh-list
138931063|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931064|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138931065|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138931066|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138931067|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
138931068|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138931069|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931070|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138931071|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
138931072|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
138931073|NCT00656799|Bromides|bromides|mesh-list
138931074|NCT00656799|Rocuronium|rocuronium|mesh-list
138931075|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
138931076|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138931077|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138931078|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138931079|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931080|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931082|NCT00764699|Growth Substances|growth substances|mesh-ancestor
138931083|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931084|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138931085|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138931086|NCT00844012|Estradiol|estradiol|mesh-list
138931087|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138931088|NCT00844012|Estrogens|estrogens|mesh-ancestor
138931089|NCT00844012|Hormones|hormones|mesh-ancestor
138931090|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138931091|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931092|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138931093|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
138931094|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138931095|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138931096|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138931097|NCT02574962|Hormones|hormones|mesh-ancestor
138931098|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138931099|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931100|NCT00802035|Baclofen|baclofen|mesh-list
138931101|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138931102|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931103|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138931104|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931105|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138931106|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
138931107|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
138931108|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138931109|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931110|NCT00836212|Efavirenz|efavirenz|mesh-list
138931111|NCT00836212|Lopinavir|lopinavir|mesh-list
138931112|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138931113|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138931114|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931115|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931116|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
138931117|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931118|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138931119|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138638493|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138931120|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138931121|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138931122|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138931123|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138931124|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138931125|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138931126|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
138931127|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138931128|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138615950|NCT00124826|Insulin|insulin|mesh-list
138615951|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138615953|NCT00193739|Paclitaxel|paclitaxel|mesh-list
138931129|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138931130|NCT00782717|Prednisolone|prednisolone|mesh-list
138931131|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138931132|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
138931133|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138931134|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
138931135|NCT00782717|Nepafenac|nepafenac|mesh-list
138931136|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138931137|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
138931138|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138931139|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
138931140|NCT00782717|Hormones|hormones|mesh-ancestor
138931141|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138931142|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931143|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138931144|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931145|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
138931146|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
138931147|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931148|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138931149|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138931150|NCT00782717|Protective Agents|protective agents|mesh-ancestor
138931151|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138931152|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138931153|NCT00782717|Analgesics|analgesics|mesh-ancestor
138931154|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
138931155|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138931156|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
138931157|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138931158|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138931159|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
138931160|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931161|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138931162|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138931163|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931164|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931165|NCT02601677|Fluoxetine|fluoxetine|mesh-list
138931166|NCT02601677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138931167|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138931168|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138931169|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931170|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138931171|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
138931172|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931173|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138931174|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
138931175|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138931176|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138931177|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138931178|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931179|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138931180|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138931181|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138931182|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138931183|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931184|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138931185|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931186|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138931187|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
138931188|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138931189|NCT05479097|Antihypertensive Agents|antihypertensive agents|mesh-list
138931190|NCT00656019|Vitamin D|vitamin d|mesh-list
138931191|NCT00656019|Calcipotriene|calcipotriene|mesh-list
138931192|NCT00656019|Vitamins|vitamins|mesh-ancestor
138931193|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
138206066|NCT00004492|Miconazole|miconazole|mesh-list
138931194|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931195|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138931196|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
138931198|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
138931199|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138931200|NCT00841516|Immunomodulating Agents|immunomodulating agents|mesh-list
138931201|NCT00841516|Immunologic Factors|immunologic factors|mesh-ancestor
138931202|NCT00841516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931203|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
138931204|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
138931205|NCT04068974|Apatinib|apatinib|mesh-list
138931206|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931207|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138931208|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931209|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931210|NCT00836368|Vitamin E|vitamin e|mesh-list
138931211|NCT00836368|Tocopherols|tocopherols|mesh-list
138931212|NCT00836368|Tocotrienols|tocotrienols|mesh-list
138931213|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
138931214|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
138931215|NCT00836368|Vitamins|vitamins|mesh-ancestor
138931216|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
138931217|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931218|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
138931219|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931220|NCT00836368|Protective Agents|protective agents|mesh-ancestor
138931221|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
138931222|NCT00718796|Ubiquinone|ubiquinone|mesh-list
138931223|NCT00718796|Atorvastatin|atorvastatin|mesh-list
138931224|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138931225|NCT00718796|Simvastatin|simvastatin|mesh-list
138931226|NCT00718796|Pravastatin|pravastatin|mesh-list
138931227|NCT00718796|Lovastatin|lovastatin|mesh-list
138931228|NCT00718796|L 647318|l 647318|mesh-list
138931229|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
138931230|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
138931231|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138931232|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
138931233|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931234|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138931235|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138931236|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931237|NCT00718796|Vitamins|vitamins|mesh-ancestor
138931238|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
138931239|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931240|NCT00844168|Sorafenib|sorafenib|mesh-list
138931241|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931242|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138931243|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931244|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931245|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
138931246|NCT00764465|Ritonavir|ritonavir|mesh-list
138931247|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
138931248|NCT00764465|Maraviroc|maraviroc|mesh-list
138931249|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138931250|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138931251|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
138931252|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931253|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931254|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138931255|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138931256|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
138931257|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931258|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138931259|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138931260|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138931261|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138931262|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138931263|NCT00655863|Pioglitazone|pioglitazone|mesh-list
138931264|NCT00655863|Alogliptin|alogliptin|mesh-list
138931265|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138931266|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931267|NCT00655863|Incretins|incretins|mesh-ancestor
138931268|NCT00655863|Hormones|hormones|mesh-ancestor
138931269|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138931270|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138931271|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
138931272|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931273|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931274|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138931275|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
138931276|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138931277|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138931278|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931279|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931280|NCT00718952|Urological Agents|urological agents|mesh-ancestor
138931281|NCT00781937|Liraglutide|liraglutide|mesh-list
138931282|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138931283|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931284|NCT00781937|Incretins|incretins|mesh-ancestor
138931285|NCT00781937|Hormones|hormones|mesh-ancestor
138931286|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138931287|NCT00802581|Anesthetics|anesthetics|mesh-list
138931288|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
138931289|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138931290|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931291|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
138931292|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931293|NCT00719108|Insulin|insulin|mesh-list
138931294|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138931295|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138931296|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931297|NCT00842140|Metformin|metformin|mesh-list
138931298|NCT00842140|Spironolactone|spironolactone|mesh-list
138931299|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
138931300|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
138931301|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138931302|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931303|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138931304|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138931305|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
138931306|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138931307|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138931308|NCT00842140|Diuretics|diuretics|mesh-ancestor
138931309|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
138931310|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138931311|NCT00806169|Triamcinolone|triamcinolone|mesh-list
138931312|NCT00806169|Bevacizumab|bevacizumab|mesh-list
138931313|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138931314|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931315|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138931316|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138931317|NCT00806169|Growth Substances|growth substances|mesh-ancestor
138931318|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931319|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
138931320|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138931321|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
138931322|NCT00806169|Hormones|hormones|mesh-ancestor
138931323|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138638561|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
138931324|NCT00844324|Candesartan|candesartan|mesh-list
138931325|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
138931326|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138931327|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138931328|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138931329|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931330|NCT00802815|Etanercept|etanercept|mesh-list
138931331|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138931332|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138931333|NCT00802815|Analgesics|analgesics|mesh-ancestor
138931334|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
138931335|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931336|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931337|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138616192|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
138931339|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138931340|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138931341|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
138931342|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
138931343|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
138931344|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138931345|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138931346|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931347|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931348|NCT04100759|Urological Agents|urological agents|mesh-ancestor
138931349|NCT00836914|Idelalisib|idelalisib|mesh-list
138931350|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931351|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931352|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931353|NCT00844402|Atorvastatin|atorvastatin|mesh-list
138931354|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138931355|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138931356|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
138931357|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931358|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138931359|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138931360|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931361|NCT00806247|Tapentadol|tapentadol|mesh-list
138292683|NCT00002756|Vitamins|vitamins|mesh-ancestor
138931362|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138931363|NCT00806247|Narcotics|narcotics|mesh-ancestor
138931364|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138931365|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931367|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
138931368|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931369|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138931370|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138931371|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138931372|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931373|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
138931374|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138931375|NCT00797745|Ritonavir|ritonavir|mesh-list
138931376|NCT00797745|Ribavirin|ribavirin|mesh-list
138638589|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138931377|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138931378|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138931379|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138931380|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
138931381|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931382|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931383|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138931384|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138931385|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
138931386|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931387|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138931388|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138931389|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
138931390|NCT00659373|Tamoxifen|tamoxifen|mesh-list
138931391|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138931392|NCT00659373|Exemestane|exemestane|mesh-list
138931393|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138931394|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
138931395|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138931396|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931397|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138931398|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931399|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138931400|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138931401|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138931402|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138931403|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138931404|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931405|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931406|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
138931407|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138931408|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
138931409|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138931410|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138931411|NCT00842452|Topotecan|topotecan|mesh-list
138931412|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138931413|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138931414|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931415|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931416|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931417|NCT02552745|Parecoxib|parecoxib|mesh-list
138931418|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138931419|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138931420|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931421|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931422|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138638607|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931423|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138931424|NCT02552745|Analgesics|analgesics|mesh-ancestor
138931425|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
138931426|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931427|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931428|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138616336|NCT00125684|Morphine|morphine|mesh-list
138931429|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138931430|NCT02547844|Tenofovir|tenofovir|mesh-list
138931431|NCT02547844|Efavirenz|efavirenz|mesh-list
138931432|NCT02547844|Emtricitabine|emtricitabine|mesh-list
138931433|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
138931434|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931435|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138931436|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138931437|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583411|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
138931438|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931439|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138931440|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138931441|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138931442|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138931443|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138931444|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138931445|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138931446|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138931448|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
138931449|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138931450|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
138931451|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138931452|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
138931453|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931454|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931455|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
138931456|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138616375|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
138931457|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138931458|NCT00842686|Bevacizumab|bevacizumab|mesh-list
138638636|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
138931459|NCT00842686|Capecitabine|capecitabine|mesh-list
138931460|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138931461|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931462|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138931463|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138931464|NCT00842686|Growth Substances|growth substances|mesh-ancestor
138639058|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138931465|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931466|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
138931467|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138931468|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
138931469|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931471|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138931472|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138931473|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
138931474|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931475|NCT00803439|Clobetasol|clobetasol|mesh-list
138931476|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138931477|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
138616413|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
138931478|NCT00803439|Hormones|hormones|mesh-ancestor
138931479|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138931480|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931481|NCT00806481|Sevelamer|sevelamer|mesh-list
138931482|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
138931483|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
138931484|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931485|NCT00709436|Ketamine|ketamine|mesh-list
138931486|NCT00709436|Analgesics|analgesics|mesh-ancestor
138931487|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
138931488|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931489|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931490|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138931491|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138931492|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
138931493|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
138931494|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138931495|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138931496|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138931497|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138931498|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931499|NCT00844792|Vitamin D|vitamin d|mesh-list
138931500|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
138931501|NCT00844792|Vitamins|vitamins|mesh-list
138931502|NCT00844792|Vitamin E|vitamin e|mesh-list
138931503|NCT00844792|Selenium|selenium|mesh-list
138931504|NCT00844792|Lycopene|lycopene|mesh-list
138931505|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
138931506|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931507|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138931508|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138931509|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
138931510|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931511|NCT00844792|Protective Agents|protective agents|mesh-ancestor
138638726|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931512|NCT00844792|Trace Elements|trace elements|mesh-ancestor
138616466|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
138931513|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138931514|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138931515|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138931516|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931517|NCT00719420|Amoxicillin|amoxicillin|mesh-list
138931518|NCT00719420|Metronidazole|metronidazole|mesh-list
138931519|NCT00719420|Clarithromycin|clarithromycin|mesh-list
138931520|NCT00719420|Omeprazole|omeprazole|mesh-list
138931521|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138931522|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931523|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138931524|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138931525|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138931526|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138931527|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138931528|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931529|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931530|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138931531|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138931532|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138931533|NCT00803829|Sulfalene|sulfalene|mesh-list
138931534|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931535|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138931536|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
138931537|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138931538|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138931539|NCT00716612|Ubiquinone|ubiquinone|mesh-list
138931540|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
138931541|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
138931542|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931543|NCT00716612|Vitamins|vitamins|mesh-ancestor
138931544|NCT00842920|Simvastatin|simvastatin|mesh-list
138931545|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138931546|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138931547|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
138931548|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616505|NCT00471445|Analgesics|analgesics|mesh-ancestor
138638769|NCT01687582|Hormones|hormones|mesh-ancestor
138931549|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138931550|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138931551|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931553|NCT00842998|Lapatinib|lapatinib|mesh-list
138931554|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138931555|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931556|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138931557|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931558|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931559|NCT00716846|Atorvastatin|atorvastatin|mesh-list
138931560|NCT00716846|Simvastatin|simvastatin|mesh-list
138931561|NCT00716846|Pitavastatin|pitavastatin|mesh-list
138931562|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138931563|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138931564|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
138931565|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931566|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138524573|NCT00020579|Entinostat|entinostat|mesh-list
138639109|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
138931567|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138931569|NCT00620854|Calcitonin|calcitonin|mesh-list
138931570|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
138931571|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138931572|NCT00620854|Katacalcin|katacalcin|mesh-list
138931573|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138931574|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931575|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138931576|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
138931577|NCT00716924|Clopidogrel|clopidogrel|mesh-list
138616556|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
138931578|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138931579|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138931580|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138931581|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138931582|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
138931583|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138931584|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931585|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931586|NCT00430027|Capecitabine|capecitabine|mesh-list
138583558|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
138931587|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
138931588|NCT00430027|Cetuximab|cetuximab|mesh-list
138931589|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138931590|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
138931591|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931592|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931593|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138931594|NCT04766229|Gabapentin|gabapentin|mesh-list
138931595|NCT04766229|Citalopram|citalopram|mesh-list
138931596|NCT04766229|Analgesics|analgesics|mesh-ancestor
138931597|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
138931598|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931599|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931600|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
138931601|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138931602|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138931603|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138931604|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138931605|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138931606|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138931607|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138931608|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931609|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
138931610|NCT04766229|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138616598|NCT00413088|Bemiparin|bemiparin|mesh-list
138931611|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138931612|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138931613|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
138931614|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138931615|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
138931616|NCT04068506|Gabapentin|gabapentin|mesh-list
138931617|NCT04068506|Analgesics|analgesics|mesh-ancestor
138931618|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
138931619|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931620|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931621|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
138931622|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138931623|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138931624|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138931625|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138931626|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138931627|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138931628|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138931629|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931630|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
138931631|NCT00803907|Imiquimod|imiquimod|mesh-list
138931632|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
138931633|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138931634|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931635|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931636|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
138931637|NCT00843154|Candesartan|candesartan|mesh-list
138931638|NCT00843154|Candesartan cilexetil|candesartan cilexetil|mesh-list
138931639|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138931640|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138931641|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138931642|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931644|NCT00429793|Temsirolimus|temsirolimus|mesh-list
138931645|NCT00429793|MTOR Inhibitors|mtor inhibitors|mesh-list
138931646|NCT00429793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138931647|NCT00429793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931648|NCT00429793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931649|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138931650|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
138931651|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931652|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931653|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138931654|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931655|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138931656|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
138931657|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
138931658|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138931659|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138931660|NCT00806871|Prednisolone|prednisolone|mesh-list
138931661|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
138931662|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138931663|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
138931664|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138931665|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
138931666|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
138931667|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931668|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931669|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138931670|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
138931671|NCT00806871|Hormones|hormones|mesh-ancestor
138931672|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138931673|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138931674|NCT00806871|Protective Agents|protective agents|mesh-ancestor
138931675|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138931676|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931677|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
138931678|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138931679|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931680|NCT00798213|Immunotoxins|immunotoxins|mesh-ancestor
138931681|NCT00798213|Immunoconjugates|immunoconjugates|mesh-ancestor
138931682|NCT00798213|Immunologic Factors|immunologic factors|mesh-ancestor
138931683|NCT00798213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931684|NCT04069208|Cytarabine|cytarabine|mesh-list
138931685|NCT04069208|Idarubicin|idarubicin|mesh-list
138931686|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138931687|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
138931688|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931689|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931690|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
138931691|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931692|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138931693|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
138931694|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931695|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138931696|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138931697|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138931698|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931699|NCT00845104|Bevacizumab|bevacizumab|mesh-list
138931700|NCT00845104|Rituximab|rituximab|mesh-list
138931701|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138931702|NCT00845104|Fludarabine|fludarabine|mesh-list
138931703|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
138931704|NCT00845104|Antibodies|antibodies|mesh-list
138931705|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
138931706|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138931707|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931708|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138931709|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138931710|NCT00845104|Growth Substances|growth substances|mesh-ancestor
138931711|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931712|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
138931713|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
138931714|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138206591|NCT00052910|Leucovorin|leucovorin|mesh-list
138931715|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138931717|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931718|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138931719|NCT00763451|Metformin|metformin|mesh-list
138931720|NCT00763451|Lixisenatide|lixisenatide|mesh-list
138931721|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138931722|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931723|NCT00762762|Triclosan|triclosan|mesh-list
138931724|NCT00762762|Fluorides|fluorides|mesh-list
138931725|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
138931726|NCT00762762|Protective Agents|protective agents|mesh-ancestor
138931727|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931728|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138931729|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931730|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138931731|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138931732|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
138931733|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931734|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138931735|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
138931736|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138931737|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138931738|NCT00424489|Prednisolone|prednisolone|mesh-list
138931739|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
138931740|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
138931741|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138931742|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
138931743|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138616834|NCT00195728|Hydrocodone|hydrocodone|mesh-list
138931744|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
138931745|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931746|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138931747|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138931748|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
138931749|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931750|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931751|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138931752|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138931754|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
138931755|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931756|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138931757|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
138931758|NCT00424489|Hormones|hormones|mesh-ancestor
138931759|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138931760|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138931761|NCT00424489|Protective Agents|protective agents|mesh-ancestor
138931762|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138931763|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
138931764|NCT00578864|Doxorubicin|doxorubicin|mesh-list
138931765|NCT00578864|Etoposide|etoposide|mesh-list
138931766|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
138931767|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138931768|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
138931769|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931770|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138931771|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138931772|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
138639061|NCT00288717|Candesartan|candesartan|mesh-list
138931773|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680690|NCT00513162|Etoposide|etoposide|mesh-list
138931774|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931775|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138931776|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138931777|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138931778|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138931779|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931780|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138931781|NCT01034683|Leucovorin|leucovorin|mesh-list
138931782|NCT01034683|Antidotes|antidotes|mesh-ancestor
138931783|NCT01034683|Protective Agents|protective agents|mesh-ancestor
138931784|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931785|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
138931786|NCT01034683|Vitamins|vitamins|mesh-ancestor
138931787|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
138931788|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
138931790|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
138931791|NCT00717470|Tacrolimus|tacrolimus|mesh-list
138931792|NCT00717470|Basiliximab|basiliximab|mesh-list
138931793|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138931794|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
138931795|NCT00717470|Hormones|hormones|mesh-ancestor
138931796|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138931797|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931798|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138931799|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931800|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138931801|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
138931802|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138931803|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931804|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931805|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138931806|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138931807|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
138616925|NCT00202397|Protective Agents|protective agents|mesh-ancestor
138931808|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138931809|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931811|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
138931812|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931813|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138931814|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138931815|NCT00717470|Protective Agents|protective agents|mesh-ancestor
138931816|NCT00631566|Mupirocin|mupirocin|mesh-list
138931817|NCT00631566|Triclosan|triclosan|mesh-list
138931818|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
138931819|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138931820|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931821|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138931822|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931823|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931824|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138931825|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138931826|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138931827|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
138931828|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138931829|NCT00722852|Ketoprofen|ketoprofen|mesh-list
138931830|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138931831|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138931832|NCT00722852|Analgesics|analgesics|mesh-ancestor
138931833|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
138931834|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931835|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931836|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138931837|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138931838|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138616965|NCT00195845|Galantamine|galantamine|mesh-list
138931840|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931841|NCT05657444|Tenecteplase|tenecteplase|mesh-list
138931842|NCT05657444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138931843|NCT05657444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138931844|NCT05657444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931845|NCT04833426|Testosterone|testosterone|mesh-list
138931846|NCT04833426|Androgens|androgens|mesh-ancestor
138931847|NCT04833426|Hormones|hormones|mesh-ancestor
138931848|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138931849|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931850|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138931851|NCT02576964|Capecitabine|capecitabine|mesh-list
138931852|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138931853|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
138931854|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931855|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931856|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
138931857|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138931858|NCT00763139|Pioglitazone|pioglitazone|mesh-list
138931859|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138931860|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931861|NCT01366092|Interleukin-2|interleukin-2|mesh-list
138931862|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931863|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138931865|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
138931866|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931867|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931868|NCT00781859|Plasminogen|plasminogen|mesh-list
138931869|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138931870|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138931871|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931873|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
138931874|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
138931875|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138931876|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931877|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
138931878|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931879|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138931880|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138931881|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138931882|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138639174|NCT01608373|Lidocaine|lidocaine|mesh-list
138931883|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931884|NCT04101383|Insulin|insulin|mesh-list
138931885|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138931886|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
138931887|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138931888|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931889|NCT02576808|Loratadine|loratadine|mesh-list
138931890|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
138931891|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
138931892|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138931893|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138931894|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138931895|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
138639247|NCT00270075|Hematinics|hematinics|mesh-ancestor
138931896|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
138931897|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138931898|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931899|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931900|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
138931901|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
138931902|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931903|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138931904|NCT04073160|Durvalumab|durvalumab|mesh-list
138931905|NCT04073160|Tremelimumab|tremelimumab|mesh-list
138931906|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138931907|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931908|NCT00417079|Prednisone|prednisone|mesh-list
138931909|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
138931910|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138931911|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
138931912|NCT00417079|Hormones|hormones|mesh-ancestor
138931913|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138931914|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931915|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138931916|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138931917|NCT00417079|Analgesics|analgesics|mesh-ancestor
138931918|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
138931919|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931920|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138931921|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138931922|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931923|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931924|NCT00429169|Bupropion|bupropion|mesh-list
138931925|NCT00429169|Paroxetine|paroxetine|mesh-list
138931926|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138931927|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
138931928|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138931929|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138931930|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138931931|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138931932|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931933|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
138931934|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138931935|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931936|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138931937|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138931938|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931939|NCT00429169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138931940|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
138931941|NCT01037491|Aspirin|aspirin|mesh-list
138931942|NCT01037491|Rabeprazole|rabeprazole|mesh-list
138931943|NCT01037491|Clopidogrel|clopidogrel|mesh-list
138931944|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138931945|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138931946|NCT01037491|Analgesics|analgesics|mesh-ancestor
138931947|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
138931948|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931949|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931950|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138931951|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138931952|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138931953|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138931954|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931955|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138931956|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138931957|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138931958|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
138931959|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138639323|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
138931960|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138931961|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138931962|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
138931963|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138931964|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138617144|NCT00196469|Heparin|heparin|mesh-list
138931965|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138931966|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138931967|NCT01033279|Warfarin|warfarin|mesh-list
138931968|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
138931969|NCT02576340|Octylonium|octylonium|mesh-list
138931970|NCT02576340|Bromides|bromides|mesh-list
138931971|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
138931972|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138931973|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138931974|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931975|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138931976|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931977|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138931979|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
138931980|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138931981|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138931982|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138931983|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
138931984|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138931985|NCT02578602|Edetic Acid|edetic acid|mesh-list
138931986|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
138931987|NCT02578602|Antidotes|antidotes|mesh-ancestor
138931988|NCT02578602|Protective Agents|protective agents|mesh-ancestor
138931989|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138931990|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
138931991|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
138931992|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138931993|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138931994|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
138931995|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138931996|NCT00128856|Paclitaxel|paclitaxel|mesh-list
138931997|NCT00128856|Gemcitabine|gemcitabine|mesh-list
138931998|NCT00128856|Doxorubicin|doxorubicin|mesh-list
138931999|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138932000|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932001|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
138617185|NCT00226200|Omalizumab|omalizumab|mesh-list
138932002|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
138932003|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
138932004|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639192|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932005|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138932006|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
138932007|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138932008|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138932009|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138932010|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932011|NCT00128778|Doxorubicin|doxorubicin|mesh-list
138932012|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138932013|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138932014|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932015|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138932016|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138932017|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932018|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932019|NCT00709488|Talaporfin|talaporfin|mesh-list
138617262|NCT00226356|Betaine|betaine|mesh-list
138932020|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932021|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138932022|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
138932023|NCT00714246|Carboplatin|carboplatin|mesh-list
138932024|NCT00714246|Docetaxel|docetaxel|mesh-list
138932025|NCT00714246|Bortezomib|bortezomib|mesh-list
138932026|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639397|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
138932027|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
138932028|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
138932029|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
138932030|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932031|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138932032|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138932033|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932034|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
138932035|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932036|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138932037|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932038|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932039|NCT00709644|Folic Acid|folic acid|mesh-list
138932040|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138932041|NCT00709644|Norgestimate|norgestimate|mesh-list
138932043|NCT00709644|Estrogens|estrogens|mesh-ancestor
138932044|NCT00709644|Hormones|hormones|mesh-ancestor
138932045|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138932046|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932047|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138932048|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
138932049|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138932050|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138932051|NCT00709644|Hematinics|hematinics|mesh-ancestor
138932052|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
138932053|NCT00709644|Vitamins|vitamins|mesh-ancestor
138932054|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
138932055|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138932057|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138932058|NCT00415597|Naltrexone|naltrexone|mesh-list
138932059|NCT00415597|Morphine|morphine|mesh-list
138932060|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138932061|NCT00415597|Narcotics|narcotics|mesh-ancestor
138639444|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
138932062|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138932063|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932064|NCT00415597|Analgesics|analgesics|mesh-ancestor
138932065|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
138932066|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932067|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138932068|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138932069|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
138932071|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
138932072|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932073|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138932074|NCT00714558|Fentanyl|fentanyl|mesh-list
138932075|NCT00714558|Naltrexone|naltrexone|mesh-list
138932076|NCT00714558|Naloxone|naloxone|mesh-list
138932077|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138932078|NCT00714558|Narcotics|narcotics|mesh-ancestor
138932079|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138932080|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932081|NCT00714558|Analgesics|analgesics|mesh-ancestor
138932082|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
138932083|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932084|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138932085|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138932086|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
138932087|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
138932088|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138932089|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138932090|NCT02575638|Camptothecin|camptothecin|mesh-list
138932091|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138932092|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932093|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138932094|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138932095|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932096|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932097|NCT02573610|Levofloxacin|levofloxacin|mesh-list
138932098|NCT02573610|Ofloxacin|ofloxacin|mesh-list
138932099|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138932100|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932101|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138639494|NCT01600456|Sertraline|sertraline|mesh-list
138932102|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138932103|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138932104|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932105|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932106|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932107|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138932108|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138932109|NCT02574468|Dexamethasone|dexamethasone|mesh-list
138932110|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
138932111|NCT02574468|BB 1101|bb 1101|mesh-list
138932112|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138932113|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
138932114|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
138932115|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932116|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932117|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138932118|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
138932119|NCT02574468|Hormones|hormones|mesh-ancestor
138932120|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138932121|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138932122|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932123|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
138932124|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932125|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932126|NCT00710268|Bevacizumab|bevacizumab|mesh-list
138932127|NCT00710268|Olaparib|olaparib|mesh-list
138932128|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138617435|NCT00203372|Docetaxel|docetaxel|mesh-list
138932129|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932130|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138932131|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138932132|NCT00710268|Growth Substances|growth substances|mesh-ancestor
138639527|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639530|NCT01609387|Tocopherols|tocopherols|mesh-list
138932133|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932134|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
138932135|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138932136|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932137|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932139|NCT02575248|Clomiphene|clomiphene|mesh-list
138932140|NCT02575248|Enclomiphene|enclomiphene|mesh-list
138932141|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
138932142|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138932143|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
138932144|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138932145|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932146|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138932148|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138932149|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138932150|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138932151|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138932152|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
138932153|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138932154|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138932155|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138932156|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138932157|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138932158|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932159|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138932160|NCT00710736|Capecitabine|capecitabine|mesh-list
138932161|NCT00710736|Fluorouracil|fluorouracil|mesh-list
138932162|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138932163|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
138932164|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932165|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932166|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138932167|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
138932168|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932169|NCT00620542|Atorvastatin|atorvastatin|mesh-list
138932170|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138932171|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138932172|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138932173|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
138639569|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932174|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932175|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138932176|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138932177|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932178|NCT04070742|Minocycline|minocycline|mesh-list
138932179|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138932180|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932181|NCT00851344|Cetirizine|cetirizine|mesh-list
138932182|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138932183|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138932184|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138932185|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
138932186|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
138932187|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138932188|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932189|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584149|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
138932190|NCT00711204|Donepezil|donepezil|mesh-list
138932191|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138932192|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932193|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617507|NCT00226668|Hormones|hormones|mesh-ancestor
138932194|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
138932195|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138932196|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932197|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
138932198|NCT05810571|Morphine|morphine|mesh-list
138932199|NCT05810571|Remifentanil|remifentanil|mesh-list
138932200|NCT05810571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138932201|NCT05810571|Narcotics|narcotics|mesh-ancestor
138932202|NCT05810571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138207063|NCT03008551|Metformin|metformin|mesh-list
138932203|NCT05810571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932204|NCT05810571|Analgesics|analgesics|mesh-ancestor
138932205|NCT05810571|Sensory System Agents|sensory system agents|mesh-ancestor
138932206|NCT05810571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932207|NCT05810558|Glycine|glycine|mesh-list
138932208|NCT05810558|Glycine Agents|glycine agents|mesh-ancestor
138932209|NCT05810558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639601|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
138932210|NCT05810558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932211|NCT05810558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932212|NCT05810389|Fluorides|fluorides|mesh-list
138932213|NCT05810389|Cariostatic Agents|cariostatic agents|mesh-ancestor
138932214|NCT05810389|Protective Agents|protective agents|mesh-ancestor
138932215|NCT05810389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932216|NCT05809869|Durvalumab|durvalumab|mesh-list
138932217|NCT05809869|Tremelimumab|tremelimumab|mesh-list
138932218|NCT05809869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932219|NCT05809869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932220|NCT05809843|Pancrelipase|pancrelipase|mesh-list
138932221|NCT05809843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138932223|NCT05809804|Antidepressive Agents|antidepressive agents|mesh-ancestor
138932224|NCT05809804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138932225|NCT05809518|Dexmedetomidine|dexmedetomidine|mesh-list
138932226|NCT05809518|Propofol|propofol|mesh-list
138932227|NCT05809518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138932228|NCT05809518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138932229|NCT05809518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932230|NCT05809518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138932231|NCT05809518|Analgesics|analgesics|mesh-ancestor
138932232|NCT05809518|Sensory System Agents|sensory system agents|mesh-ancestor
138932233|NCT05809518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932234|NCT05809518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138932235|NCT05809518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138932236|NCT05809518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138932237|NCT05809518|Adrenergic Agents|adrenergic agents|mesh-ancestor
138932238|NCT05809518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138932239|NCT05809518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932240|NCT05809518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138932241|NCT05809518|Anesthetics, General|anesthetics, general|mesh-ancestor
138932242|NCT05809518|Anesthetics|anesthetics|mesh-ancestor
138932243|NCT05809336|Pembrolizumab|pembrolizumab|mesh-list
138932244|NCT05809336|Atezolizumab|atezolizumab|mesh-list
138932245|NCT05809336|Tislelizumab|tislelizumab|mesh-list
138932246|NCT05809336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138932247|NCT05809336|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138932248|NCT05809336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932249|NCT05809336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617603|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138932250|NCT05809336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932251|NCT05809336|Immunologic Factors|immunologic factors|mesh-ancestor
138932252|NCT05809336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932254|NCT05809024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932255|NCT05809024|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138932256|NCT05809024|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138932257|NCT05809024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932258|NCT05809024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932259|NCT05809024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138932260|NCT05809024|Hormone Antagonists|hormone antagonists|mesh-ancestor
138932261|NCT05809024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138932262|NCT05809024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932263|NCT05808985|Butyric Acid|butyric acid|mesh-list
138932264|NCT05808985|Histamine Antagonists|histamine antagonists|mesh-ancestor
138932265|NCT05808985|Histamine Agents|histamine agents|mesh-ancestor
138932266|NCT05808985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138932267|NCT05808985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932268|NCT05808985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932269|NCT05808946|Thioctic Acid|thioctic acid|mesh-list
138932270|NCT05808946|Antioxidants|antioxidants|mesh-ancestor
138932271|NCT05808946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932272|NCT05808946|Protective Agents|protective agents|mesh-ancestor
138932273|NCT05808946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932274|NCT05808946|Vitamin B Complex|vitamin b complex|mesh-ancestor
138932275|NCT05808946|Vitamins|vitamins|mesh-ancestor
138932276|NCT05808946|Micronutrients|micronutrients|mesh-ancestor
138932279|NCT05764876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138932280|NCT05764876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932281|NCT05764876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138932282|NCT05764876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932283|NCT05764876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932284|NCT05737576|Insulin Aspart|insulin aspart|mesh-list
138932285|NCT05737576|Insulin, Long-Acting|insulin, long-acting|mesh-list
138932286|NCT05737576|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138932287|NCT05737576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138932288|NCT05737576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932289|NCT05720988|Azacitidine|azacitidine|mesh-list
138932290|NCT05720988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138932291|NCT05720988|Antimetabolites|antimetabolites|mesh-ancestor
138932292|NCT05720988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932293|NCT05720988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932294|NCT05720988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932295|NCT05716763|Tramadol|tramadol|mesh-list
138932296|NCT05716763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138932297|NCT05716763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138932298|NCT05716763|Narcotics|narcotics|mesh-ancestor
138932299|NCT05716763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138932300|NCT05716763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932301|NCT05716763|Analgesics|analgesics|mesh-ancestor
138932302|NCT05716763|Sensory System Agents|sensory system agents|mesh-ancestor
138932303|NCT05716763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932304|NCT05716503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138932305|NCT05716503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932306|NCT05648435|Lithium Carbonate|lithium carbonate|mesh-list
138932307|NCT05648435|Antidepressive Agents|antidepressive agents|mesh-ancestor
138932308|NCT05648435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138932309|NCT05648435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932310|NCT05648435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932311|NCT05648435|Antimanic Agents|antimanic agents|mesh-ancestor
138932312|NCT05648435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138932313|NCT05648435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138932314|NCT05648435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932315|NCT05642767|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138932316|NCT05642767|Cetrimonium|cetrimonium|mesh-list
138932317|NCT05642767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932318|NCT05642767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138932319|NCT05624138|Leucovorin|leucovorin|mesh-list
138932320|NCT05624138|Ketotifen|ketotifen|mesh-list
138932321|NCT05624138|Fluorouracil|fluorouracil|mesh-list
138932322|NCT05624138|Oxaliplatin|oxaliplatin|mesh-list
138932323|NCT05624138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932324|NCT05624138|Antimetabolites|antimetabolites|mesh-ancestor
138932325|NCT05624138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932326|NCT05624138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138932327|NCT05624138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932328|NCT05624138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138932329|NCT05624138|Immunologic Factors|immunologic factors|mesh-ancestor
138932330|NCT05624138|Antidotes|antidotes|mesh-ancestor
138932331|NCT05624138|Protective Agents|protective agents|mesh-ancestor
138932332|NCT05624138|Vitamin B Complex|vitamin b complex|mesh-ancestor
138932333|NCT05624138|Vitamins|vitamins|mesh-ancestor
138932334|NCT05624138|Micronutrients|micronutrients|mesh-ancestor
138932335|NCT05624138|Antipruritics|antipruritics|mesh-ancestor
138932336|NCT05624138|Dermatologic Agents|dermatologic agents|mesh-ancestor
138932337|NCT05624138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138932338|NCT05624138|Histamine Antagonists|histamine antagonists|mesh-ancestor
138932339|NCT05624138|Histamine Agents|histamine agents|mesh-ancestor
138932340|NCT05624138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138932341|NCT05624138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138932343|NCT05610800|Nicotine|nicotine|mesh-list
138932344|NCT05610800|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138932345|NCT05610800|Autonomic Agents|autonomic agents|mesh-ancestor
138932346|NCT05610800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617734|NCT00204074|Hormones|hormones|mesh-ancestor
138932347|NCT05610800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932348|NCT05610800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138932349|NCT05610800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138932350|NCT05610800|Cholinergic Agents|cholinergic agents|mesh-ancestor
138932351|NCT05610800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138932352|NCT05610800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932353|NCT05610800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138932354|NCT05610800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138932357|NCT05610800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138932358|NCT05596383|Vitamin D|vitamin d|mesh-list
138932359|NCT05596383|Vitamins|vitamins|mesh-ancestor
138932360|NCT05596383|Micronutrients|micronutrients|mesh-ancestor
138932361|NCT05596383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932362|NCT05596383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138932363|NCT05594745|Lifitegrast|lifitegrast|mesh-list
138932364|NCT05594745|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138932365|NCT05594745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138932366|NCT05568953|Vaccines|vaccines|mesh-list
138932367|NCT05568953|Immunologic Factors|immunologic factors|mesh-ancestor
138932368|NCT05568953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932369|NCT05556200|Apatinib|apatinib|mesh-list
138932370|NCT05556200|Antibodies|antibodies|mesh-list
138932371|NCT05556200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138932372|NCT05556200|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138932373|NCT05556200|Immunologic Factors|immunologic factors|mesh-ancestor
138617779|NCT00227409|Edetic Acid|edetic acid|mesh-list
138932374|NCT05556200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932375|NCT05556200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932376|NCT05556200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138932377|NCT05556200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932378|NCT05556200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932379|NCT05532215|Misoprostol|misoprostol|mesh-list
138932380|NCT05532215|Oxytocin|oxytocin|mesh-list
138932381|NCT05532215|Oxytocics|oxytocics|mesh-ancestor
138932382|NCT05532215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138932383|NCT05532215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932384|NCT05532215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138932385|NCT05532215|Abortifacient Agents|abortifacient agents|mesh-ancestor
138932386|NCT05532215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138932387|NCT05532215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138932388|NCT05516654|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138932389|NCT05516654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932390|NCT05471947|Glycolic acid|glycolic acid|mesh-list
138932391|NCT05471947|Keratolytic Agents|keratolytic agents|mesh-ancestor
138932392|NCT05471947|Dermatologic Agents|dermatologic agents|mesh-ancestor
138932393|NCT05463601|Tamoxifen|tamoxifen|mesh-list
138932394|NCT05463601|Letrozole|letrozole|mesh-list
138932395|NCT05463601|Fulvestrant|fulvestrant|mesh-list
138932396|NCT05463601|Exemestane|exemestane|mesh-list
138932397|NCT05463601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932398|NCT05463601|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138932399|NCT05463601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138932400|NCT05463601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932401|NCT05463601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932402|NCT05463601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138932403|NCT05463601|Hormone Antagonists|hormone antagonists|mesh-ancestor
138932404|NCT05463601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138932405|NCT05463601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932406|NCT05463601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138932407|NCT05463601|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138932408|NCT05463601|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138932409|NCT05463601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138932410|NCT05463601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138932411|NCT05438082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138932412|NCT05438082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617843|NCT00204269|Hormones|hormones|mesh-ancestor
138932413|NCT05395195|Epoetin Alfa|epoetin alfa|mesh-list
138932414|NCT05395195|Hematinics|hematinics|mesh-ancestor
138932415|NCT05391360|Entecavir|entecavir|mesh-list
138932416|NCT05391360|Antiviral Agents|antiviral agents|mesh-ancestor
138932417|NCT05391360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932418|NCT05366764|Albuterol|albuterol|mesh-list
138932419|NCT05366764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138932420|NCT05366764|Autonomic Agents|autonomic agents|mesh-ancestor
138932421|NCT05366764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932422|NCT05366764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932423|NCT05366764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138932424|NCT05366764|Respiratory System Agents|respiratory system agents|mesh-ancestor
138932425|NCT05366764|Tocolytic Agents|tocolytic agents|mesh-ancestor
138932426|NCT05366764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138932427|NCT05366764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138932428|NCT05366764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138932429|NCT05366764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138932430|NCT05366764|Adrenergic Agents|adrenergic agents|mesh-ancestor
138932431|NCT05366764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138932432|NCT05366764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932434|NCT05359835|Calcium|calcium|mesh-list
138932435|NCT05359835|Pentetic Acid|pentetic acid|mesh-list
138932436|NCT05359835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138932437|NCT05359835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932438|NCT05359835|Antidotes|antidotes|mesh-ancestor
138639890|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138932439|NCT05359835|Protective Agents|protective agents|mesh-ancestor
138932440|NCT05359835|Chelating Agents|chelating agents|mesh-ancestor
138932441|NCT05359835|Sequestering Agents|sequestering agents|mesh-ancestor
138932442|NCT05359835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932443|NCT05359835|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138932444|NCT05359835|Anticoagulants|anticoagulants|mesh-ancestor
138932445|NCT05359835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138932446|NCT05303844|Tislelizumab|tislelizumab|mesh-list
138932447|NCT05303844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932448|NCT05303844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932449|NCT05260606|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138932450|NCT05260606|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138932451|NCT05260606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932452|NCT05236946|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138932453|NCT05236946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138932454|NCT05236946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932455|NCT05236946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932457|NCT05222932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932458|NCT05222932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932459|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
138932460|NCT05216419|Vitamin D|vitamin d|mesh-list
138932461|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138932462|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932463|NCT05216419|Vitamins|vitamins|mesh-ancestor
138932464|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
138932465|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138932466|NCT05117034|Morphine|morphine|mesh-list
138932467|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138932468|NCT05117034|Narcotics|narcotics|mesh-ancestor
138932469|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138932470|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932471|NCT05117034|Analgesics|analgesics|mesh-ancestor
138932472|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
138932473|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932474|NCT05093920|Doxorubicin|doxorubicin|mesh-list
138932475|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138932476|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138932477|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639259|NCT04719104|Bilirubin|bilirubin|mesh-list
138932478|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138932479|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138932480|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932481|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932482|NCT05052879|Tadalafil|tadalafil|mesh-list
138932483|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
138932484|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138932485|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138932486|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932487|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932488|NCT05052879|Urological Agents|urological agents|mesh-ancestor
138932489|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
138932490|NCT05049707|Analgesics|analgesics|mesh-ancestor
138932491|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
138932492|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932493|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932494|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
138932495|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138932496|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138932497|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
138932498|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138932499|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138932500|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932501|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138932502|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
138932503|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138207363|NCT01323595|Celecoxib|celecoxib|mesh-list
138932504|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
138932505|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
138932506|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
138932507|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138932508|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138932509|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639975|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
138639978|NCT01601899|Lamivudine|lamivudine|mesh-list
138932510|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932511|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932512|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
138932513|NCT05033483|Trace Elements|trace elements|mesh-ancestor
138932514|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
138932515|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932516|NCT04982913|Oseltamivir|oseltamivir|mesh-list
138932517|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
138932518|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932519|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932520|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932521|NCT04981899|Carboplatin|carboplatin|mesh-list
138932522|NCT04981899|Nivolumab|nivolumab|mesh-list
138932523|NCT04981899|Etoposide|etoposide|mesh-list
138932524|NCT04981899|Ifosfamide|ifosfamide|mesh-list
138932525|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932526|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932527|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138932528|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932529|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138932530|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138932531|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138932532|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932533|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138932534|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
138932535|NCT04929600|Amlodipine|amlodipine|mesh-list
138932536|NCT04929600|Valsartan|valsartan|mesh-list
138932537|NCT04929600|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138932538|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138932539|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138932540|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138932541|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639264|NCT01588795|Vitamin D|vitamin d|mesh-list
138618074|NCT02962518|Hormones|hormones|mesh-ancestor
138932542|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138932543|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932544|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
138932545|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138932546|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138932547|NCT04925648|Dasatinib|dasatinib|mesh-list
138932548|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932549|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138932550|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932551|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932552|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138932553|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932554|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138932555|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932556|NCT04852367|Doxorubicin|doxorubicin|mesh-list
138932557|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138932558|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932559|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138932560|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138932561|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932562|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932563|NCT04824417|Itraconazole|itraconazole|mesh-list
138932564|NCT04824417|Voriconazole|voriconazole|mesh-list
138932565|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
138932566|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932567|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138932568|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138932569|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932570|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932571|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138932572|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
138932573|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138932574|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932575|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138932576|NCT04727996|Tislelizumab|tislelizumab|mesh-list
138932577|NCT04727996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932578|NCT04727996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932579|NCT04720781|Esomeprazole|esomeprazole|mesh-list
138932580|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138932581|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138932582|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138932583|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932584|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932585|NCT04692623|Insulin|insulin|mesh-list
138932586|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138932587|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
138932588|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
138932589|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138932590|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932591|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138932592|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932593|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138932594|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138932595|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932596|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932597|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932598|NCT04690608|Triamcinolone|triamcinolone|mesh-list
138932599|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138932600|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138932601|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138640045|NCT01602406|Trastuzumab|trastuzumab|mesh-list
138932602|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138932603|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
138932604|NCT04690608|Hormones|hormones|mesh-ancestor
138932605|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138932606|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639275|NCT00107614|Rituximab|rituximab|mesh-list
138932607|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138932608|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
138932609|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932610|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932611|NCT04684238|Midazolam|midazolam|mesh-list
138932612|NCT04684238|Isoflurane|isoflurane|mesh-list
138932613|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138932614|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138932615|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138932616|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932617|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138932618|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138932619|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138932620|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138932621|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
138932622|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
138932623|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
138932624|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
138932625|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138932626|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932627|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138932628|NCT04586348|Iodine|iodine|mesh-list
138932629|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
138932630|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138932631|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932632|NCT04586348|Trace Elements|trace elements|mesh-ancestor
138932633|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
138932634|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932635|NCT04577001|Letrozole|letrozole|mesh-list
138932636|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932637|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138932638|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138932639|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932640|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932641|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138932642|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
138932643|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138932644|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932645|NCT04576078|Nefopam|nefopam|mesh-list
138932646|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138640075|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
138932647|NCT04576078|Analgesics|analgesics|mesh-ancestor
138932648|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
138932649|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932650|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932652|NCT04561557|Fludarabine|fludarabine|mesh-list
138932653|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138618310|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
138932654|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
138932655|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618319|NCT00228891|Insulin|insulin|mesh-list
138932656|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138932657|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138932658|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
138932659|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932660|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932661|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138932662|NCT04560127|Apatinib|apatinib|mesh-list
138932663|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932664|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138618379|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932665|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932666|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932667|NCT04536532|Entecavir|entecavir|mesh-list
138932668|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
138932669|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932670|NCT04508634|Metformin|metformin|mesh-list
138932671|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138932672|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932673|NCT04480502|Ipilimumab|ipilimumab|mesh-list
138932674|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932675|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932676|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138932677|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932679|NCT04447092|Paclitaxel|paclitaxel|mesh-list
138932680|NCT04447092|Gemcitabine|gemcitabine|mesh-list
138932681|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
138932682|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
138932683|NCT04447092|Irinotecan|irinotecan|mesh-list
138640094|NCT01602523|Hormones|hormones|mesh-ancestor
138640102|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
138932684|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138932685|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932686|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
138932687|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
138932688|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
138932689|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932691|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
138932692|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932693|NCT04447092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138932694|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138932695|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138932696|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932697|NCT04447092|Antidotes|antidotes|mesh-ancestor
138932698|NCT04447092|Protective Agents|protective agents|mesh-ancestor
138932699|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932700|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
138932701|NCT04447092|Vitamins|vitamins|mesh-ancestor
138932702|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
138932703|NCT04371224|Leucovorin|leucovorin|mesh-list
138932704|NCT04371224|Capecitabine|capecitabine|mesh-list
138932705|NCT04371224|Fluorouracil|fluorouracil|mesh-list
138932706|NCT04371224|Irinotecan|irinotecan|mesh-list
138932707|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138932708|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
138932709|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932710|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932711|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138932712|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
138932713|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932714|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138932715|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138932717|NCT04371224|Antidotes|antidotes|mesh-ancestor
138932718|NCT04371224|Protective Agents|protective agents|mesh-ancestor
138932719|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
138932720|NCT04371224|Vitamins|vitamins|mesh-ancestor
138932721|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
138932722|NCT04306900|Paclitaxel|paclitaxel|mesh-list
138932723|NCT04306900|Docetaxel|docetaxel|mesh-list
138932724|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138932725|NCT04306900|Gemcitabine|gemcitabine|mesh-list
138932726|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
138932727|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138932728|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932729|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
138932730|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
138932731|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
138932732|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932733|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138932734|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
138932735|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932736|NCT04306900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138932737|NCT04288687|Niraparib|niraparib|mesh-list
138932738|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138932739|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932740|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932741|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932742|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
138932743|NCT04231708|Yohimbine|yohimbine|mesh-list
138932744|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138932745|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
138932746|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
138932747|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932748|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932749|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138932750|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138932751|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138932752|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
138932753|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138932754|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932755|NCT04231708|Urological Agents|urological agents|mesh-ancestor
138932756|NCT04218786|Colchicine|colchicine|mesh-list
138932757|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
138932758|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138932759|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
138932760|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
138932761|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
138932762|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932763|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932764|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
138932765|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
138618548|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
138932772|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932773|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138932775|NCT04177758|Vitamins|vitamins|mesh-ancestor
138932776|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
138932777|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932778|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138932804|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932805|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138932806|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138932807|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
138932809|NCT04147208|Entecavir|entecavir|mesh-list
138932810|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138932811|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138932812|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
138932813|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932814|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932815|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138932816|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138932817|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
138932818|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932819|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138932820|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138932821|NCT04003103|Islatravir|islatravir|mesh-list
138932822|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
138932823|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932824|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932825|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932826|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138932827|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138932828|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138932829|NCT03999216|Diuretics|diuretics|mesh-list
138640188|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138932830|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138932831|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
138932832|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
138932833|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932834|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138932835|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932836|NCT03945448|Fluconazole|fluconazole|mesh-list
138932837|NCT03945448|Amphotericin B|amphotericin b|mesh-list
138932838|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138932839|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
138932840|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932841|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138932842|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138932843|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932844|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932845|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138932846|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
138932847|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138932848|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932849|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138932850|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138932851|NCT03945448|Amebicides|amebicides|mesh-ancestor
138932852|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138932853|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138932854|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138932855|NCT03941873|Tislelizumab|tislelizumab|mesh-list
138932856|NCT03941873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932857|NCT03941873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932858|NCT03941587|Aflibercept|aflibercept|mesh-list
138932859|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138932860|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138932861|NCT03941587|Growth Substances|growth substances|mesh-ancestor
138932862|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932863|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
138932864|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932865|NCT03917420|Tenofovir|tenofovir|mesh-list
138932866|NCT03917420|Emtricitabine|emtricitabine|mesh-list
138932867|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138932869|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932870|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138932871|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138932872|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932873|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932874|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138932875|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138932877|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
138932878|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
138932879|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138932880|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932881|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
138932882|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932883|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138932884|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138932885|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138932886|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138932887|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932888|NCT03713528|Vancomycin|vancomycin|mesh-list
138932889|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138932890|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932891|NCT03705845|Tocotrienols|tocotrienols|mesh-list
138932892|NCT03705845|Vitamin E|vitamin e|mesh-list
138932893|NCT03705845|Tocopherols|tocopherols|mesh-list
138932894|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
138932895|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932896|NCT03705845|Protective Agents|protective agents|mesh-ancestor
138932897|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932898|NCT03705845|Vitamins|vitamins|mesh-ancestor
138932899|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
138932900|NCT03669718|Cemiplimab|cemiplimab|mesh-list
138932901|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932902|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932903|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138932904|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932906|NCT03642990|Niacin|niacin|mesh-list
138932907|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
138932908|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
138932909|NCT03642990|Vitamins|vitamins|mesh-ancestor
138932910|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
138932911|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932912|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138932913|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
138932914|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932915|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138932916|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
138932917|NCT03582475|Cisplatin|cisplatin|mesh-list
138932918|NCT03582475|Carboplatin|carboplatin|mesh-list
138932919|NCT03582475|Docetaxel|docetaxel|mesh-list
138932920|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
138932921|NCT03582475|Etoposide|etoposide|mesh-list
138932922|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
138932923|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
138932924|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932925|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
138932926|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
138932927|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
138932928|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932929|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932930|NCT03582475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138932931|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138932932|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138932933|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138932934|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932935|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
138932936|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
138932937|NCT03579784|Paclitaxel|paclitaxel|mesh-list
138932938|NCT03579784|Durvalumab|durvalumab|mesh-list
138932939|NCT03579784|Olaparib|olaparib|mesh-list
138584888|NCT00162669|Bevacizumab|bevacizumab|mesh-list
138932940|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138932941|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932942|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
138932943|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
138932944|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
138640310|NCT00257855|Lamotrigine|lamotrigine|mesh-list
138932945|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932946|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932947|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138932948|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138932949|NCT03553563|Esomeprazole|esomeprazole|mesh-list
138932950|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138932951|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138207806|NCT00128180|Prednisolone|prednisolone|mesh-list
138932952|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138932953|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618847|NCT00207077|Cetuximab|cetuximab|mesh-list
138932954|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932956|NCT06063473|Dermatologic Agents|dermatologic agents|mesh-ancestor
138932957|NCT06063421|Nicotine|nicotine|mesh-list
138932958|NCT06063421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138932959|NCT06063421|Autonomic Agents|autonomic agents|mesh-ancestor
138932960|NCT06063421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932961|NCT06063421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932962|NCT06063421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138932963|NCT06063421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138618911|NCT00233025|Analgesics|analgesics|mesh-ancestor
138932964|NCT06063421|Cholinergic Agents|cholinergic agents|mesh-ancestor
138932965|NCT06063421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138932966|NCT06063421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932967|NCT06063369|Palmidrol|palmidrol|mesh-list
138932968|NCT06063369|Analgesics|analgesics|mesh-ancestor
138932969|NCT06063369|Sensory System Agents|sensory system agents|mesh-ancestor
138932970|NCT06063369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138932971|NCT06063369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932972|NCT06063369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138932973|NCT06063369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138932974|NCT06063369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138932975|NCT06063369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138932976|NCT06063369|Antiviral Agents|antiviral agents|mesh-ancestor
138932977|NCT06063369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138932978|NCT06063369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138932979|NCT06063369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138932980|NCT06063369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223891|NCT00839540|Micafungin|micafungin|mesh-list
138932981|NCT06063369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932982|NCT06063369|Hormones|hormones|mesh-ancestor
138932983|NCT06063369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138932984|NCT06063200|Methylphenidate|methylphenidate|mesh-list
138932985|NCT06063200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138932986|NCT06063200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138932987|NCT06063200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138932988|NCT06063200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138932989|NCT06063200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138932990|NCT06063200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138932991|NCT06063200|Dopamine Agents|dopamine agents|mesh-ancestor
138932992|NCT06063200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138932993|NCT06063070|Bevacizumab|bevacizumab|mesh-list
138932994|NCT06063070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
138932995|NCT06063070|Fluzoparib|fluzoparib|mesh-list
138932996|NCT06063070|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138932997|NCT06063070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138932998|NCT06063070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138932999|NCT06063070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138933000|NCT06063070|Growth Substances|growth substances|mesh-ancestor
138933001|NCT06063070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933002|NCT06063070|Growth Inhibitors|growth inhibitors|mesh-ancestor
138933003|NCT06063070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933004|NCT06063070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933005|NCT06063057|Vaccines|vaccines|mesh-list
138933006|NCT06063057|Immunologic Factors|immunologic factors|mesh-ancestor
138933007|NCT06063057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933008|NCT06063018|Tislelizumab|tislelizumab|mesh-list
138933009|NCT06063018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933010|NCT06063018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933011|NCT06062953|Melatonin|melatonin|mesh-list
138933012|NCT06062953|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138933013|NCT06062953|Antioxidants|antioxidants|mesh-ancestor
138933014|NCT06062953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933015|NCT06062953|Protective Agents|protective agents|mesh-ancestor
138933016|NCT06062953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933017|NCT06062953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138933018|NCT06062953|Antidepressive Agents|antidepressive agents|mesh-ancestor
138933020|NCT06062953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138933021|NCT06062953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138933022|NCT06062875|Adalimumab|adalimumab|mesh-list
138933023|NCT06062875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138933024|NCT06062875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933025|NCT06062875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138933027|NCT06062823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933028|NCT06062823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138933029|NCT06062823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933030|NCT06062823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933031|NCT06062719|Octreotide|octreotide|mesh-list
138933032|NCT06062719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933033|NCT06062719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138933034|NCT06062719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933035|NCT06062498|Palbociclib|palbociclib|mesh-list
138933036|NCT06062498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933037|NCT06062498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138933038|NCT06062498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933039|NCT06062498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933040|NCT06062277|Colchicine|colchicine|mesh-list
138933041|NCT06062277|Gout Suppressants|gout suppressants|mesh-ancestor
138933042|NCT06062277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138933043|NCT06062277|Tubulin Modulators|tubulin modulators|mesh-ancestor
138933044|NCT06062277|Antimitotic Agents|antimitotic agents|mesh-ancestor
138933045|NCT06062277|Mitosis Modulators|mitosis modulators|mesh-ancestor
138933046|NCT06062277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933047|NCT06062277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933048|NCT06060236|Ibuprofen|ibuprofen|mesh-list
138933049|NCT06060236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138933050|NCT06060236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138933051|NCT06060236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138933052|NCT06060236|Analgesics|analgesics|mesh-ancestor
138933053|NCT06060236|Sensory System Agents|sensory system agents|mesh-ancestor
138933054|NCT06060236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933055|NCT06060236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933056|NCT06060236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933057|NCT06060236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138933058|NCT06060236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138933059|NCT06060236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933060|NCT06060236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933061|NCT06049927|Vaccines|vaccines|mesh-list
138933062|NCT06049927|Immunologic Factors|immunologic factors|mesh-ancestor
138933063|NCT06049927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933064|NCT06018467|Niacinamide|niacinamide|mesh-list
138933065|NCT06018467|Niacin|niacin|mesh-list
138933066|NCT06018467|Nicotinic Acids|nicotinic acids|mesh-list
138933067|NCT06018467|Dasatinib|dasatinib|mesh-list
138933068|NCT06018467|Quercetin|quercetin|mesh-list
138933069|NCT06018467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640410|NCT00290901|Celecoxib|celecoxib|mesh-list
138933070|NCT06018467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138933071|NCT06018467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933072|NCT06018467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933073|NCT06018467|Vitamin B Complex|vitamin b complex|mesh-ancestor
138933074|NCT06018467|Vitamins|vitamins|mesh-ancestor
138933075|NCT06018467|Micronutrients|micronutrients|mesh-ancestor
138933076|NCT06018467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933077|NCT06018467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138933078|NCT06018467|Antimetabolites|antimetabolites|mesh-ancestor
138933079|NCT06018467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138933080|NCT06018467|Vasodilator Agents|vasodilator agents|mesh-ancestor
138933081|NCT06018467|Antioxidants|antioxidants|mesh-ancestor
138933082|NCT06018467|Protective Agents|protective agents|mesh-ancestor
138933083|NCT05992896|Bupivacaine|bupivacaine|mesh-list
138933084|NCT05992896|Anesthetics, Local|anesthetics, local|mesh-ancestor
138933085|NCT05992896|Anesthetics|anesthetics|mesh-ancestor
138933086|NCT05992896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138933087|NCT05992896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933088|NCT05992896|Sensory System Agents|sensory system agents|mesh-ancestor
138933089|NCT05992896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933090|NCT05920798|Pembrolizumab|pembrolizumab|mesh-list
138933091|NCT05920798|Vaccines|vaccines|mesh-list
138933092|NCT05920798|Immunologic Factors|immunologic factors|mesh-ancestor
138933093|NCT05920798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933094|NCT05920798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933095|NCT05920798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933096|NCT05920798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138933097|NCT05920798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933098|NCT05907980|Atezolizumab|atezolizumab|mesh-list
138933099|NCT05907980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138639381|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
138933100|NCT05907980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933101|NCT05907980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933102|NCT05907980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933103|NCT05906615|Lidocaine|lidocaine|mesh-list
138933104|NCT05906615|Anesthetics, Local|anesthetics, local|mesh-ancestor
138933105|NCT05906615|Anesthetics|anesthetics|mesh-ancestor
138933106|NCT05906615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138933107|NCT05906615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933108|NCT05906615|Sensory System Agents|sensory system agents|mesh-ancestor
138933109|NCT05906615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933110|NCT05906615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138933111|NCT05906615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138933112|NCT05906615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138619155|NCT01085812|Milnacipran|milnacipran|mesh-list
138933113|NCT05906615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138933114|NCT05906615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933115|NCT05889013|Nitric Oxide|nitric oxide|mesh-list
138933116|NCT05889013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138933117|NCT05889013|Autonomic Agents|autonomic agents|mesh-ancestor
138933118|NCT05889013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933119|NCT05889013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933120|NCT05889013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138933121|NCT05889013|Respiratory System Agents|respiratory system agents|mesh-ancestor
138933122|NCT05889013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138933123|NCT05889013|Antioxidants|antioxidants|mesh-ancestor
138933124|NCT05889013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933125|NCT05889013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138933126|NCT05889013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138933127|NCT05889013|Vasodilator Agents|vasodilator agents|mesh-ancestor
138933128|NCT05889013|Gasotransmitters|gasotransmitters|mesh-ancestor
138933129|NCT05889013|Protective Agents|protective agents|mesh-ancestor
138933130|NCT05880355|Dapansutrile|dapansutrile|mesh-list
138933131|NCT05880355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933132|NCT05879367|Eflornithine|eflornithine|mesh-list
138933133|NCT05879367|Temozolomide|temozolomide|mesh-list
138933134|NCT05879367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138933135|NCT05879367|Alkylating Agents|alkylating agents|mesh-ancestor
138933136|NCT05879367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933137|NCT05879367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933138|NCT05879367|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138933139|NCT05879367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138933140|NCT05879367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138933141|NCT05879367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933142|NCT05879367|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138933143|NCT05879367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933144|NCT05853367|Pembrolizumab|pembrolizumab|mesh-list
138933145|NCT05853367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933146|NCT05853367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933147|NCT05853367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138933148|NCT05853367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933149|NCT05825092|Methyltestosterone|methyltestosterone|mesh-list
138933150|NCT05825092|Testosterone|testosterone|mesh-list
138933151|NCT05825092|Testosterone undecanoate|testosterone undecanoate|mesh-list
138933152|NCT05825092|Testosterone enanthate|testosterone enanthate|mesh-list
138619193|NCT00208442|Diuretics|diuretics|mesh-ancestor
138933153|NCT05825092|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138933154|NCT05825092|Androgens|androgens|mesh-ancestor
138933155|NCT05825092|Hormones|hormones|mesh-ancestor
138933156|NCT05825092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138933157|NCT05825092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933158|NCT05825092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138933159|NCT05825092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933160|NCT05825092|Anabolic Agents|anabolic agents|mesh-ancestor
138933161|NCT05795101|Trastuzumab|trastuzumab|mesh-list
138933162|NCT05795101|Durvalumab|durvalumab|mesh-list
138933163|NCT05795101|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138933164|NCT05795101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138585120|NCT00142727|Methadone|methadone|mesh-list
138933165|NCT05795101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933167|NCT05795101|Immunologic Factors|immunologic factors|mesh-ancestor
138933168|NCT05795101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933169|NCT05782894|Remifentanil|remifentanil|mesh-list
138933170|NCT05782894|Propofol|propofol|mesh-list
138933171|NCT05782894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138933172|NCT05782894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138933173|NCT05782894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524616|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
138933174|NCT05782894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138933175|NCT05782894|Anesthetics, General|anesthetics, general|mesh-ancestor
138933176|NCT05782894|Anesthetics|anesthetics|mesh-ancestor
138933177|NCT05782894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138933178|NCT05782894|Narcotics|narcotics|mesh-ancestor
138933179|NCT05782894|Analgesics|analgesics|mesh-ancestor
138933180|NCT05782894|Sensory System Agents|sensory system agents|mesh-ancestor
138933181|NCT05782894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933183|NCT05765578|Immunologic Factors|immunologic factors|mesh-ancestor
138933184|NCT05765578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933185|NCT05714007|Ferrous succinate|ferrous succinate|mesh-list
138933186|NCT05714007|Hematinics|hematinics|mesh-ancestor
138933187|NCT05713838|Durvalumab|durvalumab|mesh-list
138933188|NCT05713838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933189|NCT05713838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933190|NCT05697809|Dexamethasone|dexamethasone|mesh-list
138933191|NCT05697809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933192|NCT05697809|Antiemetics|antiemetics|mesh-ancestor
138933193|NCT05697809|Autonomic Agents|autonomic agents|mesh-ancestor
138933194|NCT05697809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933195|NCT05697809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933196|NCT05697809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933197|NCT05697809|Glucocorticoids|glucocorticoids|mesh-ancestor
138933198|NCT05697809|Hormones|hormones|mesh-ancestor
138933199|NCT05697809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138933200|NCT05697809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138933201|NCT05697809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933202|NCT05619913|Pembrolizumab|pembrolizumab|mesh-list
138933203|NCT05619913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933204|NCT05619913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933205|NCT05619913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138933206|NCT05619913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933207|NCT05513560|Pentoxifylline|pentoxifylline|mesh-list
138933208|NCT05513560|Ibudilast|ibudilast|mesh-list
138933209|NCT05513560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138933210|NCT05513560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933211|NCT05513560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933212|NCT05513560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138933213|NCT05513560|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138933214|NCT05513560|Protective Agents|protective agents|mesh-ancestor
138933215|NCT05513560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933216|NCT05513560|Vasodilator Agents|vasodilator agents|mesh-ancestor
138933217|NCT05513560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138933218|NCT05513560|Antioxidants|antioxidants|mesh-ancestor
138933219|NCT05513560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138933220|NCT05513560|Autonomic Agents|autonomic agents|mesh-ancestor
138933221|NCT05513560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933222|NCT05513560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138933223|NCT05513560|Respiratory System Agents|respiratory system agents|mesh-ancestor
138933224|NCT05502913|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138933225|NCT05502913|Rifaximin|rifaximin|mesh-list
138933226|NCT05502913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933227|NCT05502913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933228|NCT05412082|Leucovorin|leucovorin|mesh-list
138933229|NCT05412082|Capecitabine|capecitabine|mesh-list
138933230|NCT05412082|Fluorouracil|fluorouracil|mesh-list
138933231|NCT05412082|Oxaliplatin|oxaliplatin|mesh-list
138933232|NCT05412082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138933233|NCT05412082|Antimetabolites|antimetabolites|mesh-ancestor
138933234|NCT05412082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933235|NCT05412082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933236|NCT05412082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138933237|NCT05412082|Immunologic Factors|immunologic factors|mesh-ancestor
138933238|NCT05412082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933239|NCT05412082|Antidotes|antidotes|mesh-ancestor
138585188|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
138933240|NCT05412082|Protective Agents|protective agents|mesh-ancestor
138933241|NCT05412082|Vitamin B Complex|vitamin b complex|mesh-ancestor
138933242|NCT05412082|Vitamins|vitamins|mesh-ancestor
138933243|NCT05412082|Micronutrients|micronutrients|mesh-ancestor
138933244|NCT05372354|Dexamethasone|dexamethasone|mesh-list
138933245|NCT05372354|Trametinib|trametinib|mesh-list
138933246|NCT05372354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933247|NCT05372354|Antiemetics|antiemetics|mesh-ancestor
138933248|NCT05372354|Autonomic Agents|autonomic agents|mesh-ancestor
138933249|NCT05372354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933250|NCT05372354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933252|NCT05372354|Glucocorticoids|glucocorticoids|mesh-ancestor
138933253|NCT05372354|Hormones|hormones|mesh-ancestor
138933254|NCT05372354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138933255|NCT05372354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138933256|NCT05372354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933257|NCT05372354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138933258|NCT05372354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933259|NCT05372354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933260|NCT05214664|Anesthetics|anesthetics|mesh-list
138933261|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138933262|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933263|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138933264|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138933265|NCT05214573|Glucagon|glucagon|mesh-list
138933266|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138933267|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933268|NCT05214573|Hormones|hormones|mesh-ancestor
138933269|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138933270|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933271|NCT05214573|Incretins|incretins|mesh-ancestor
138933272|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
138933273|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933274|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933275|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138933276|NCT05204641|Rifaximin|rifaximin|mesh-list
138933278|NCT05204641|Benserazide|benserazide|mesh-list
138933279|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138933280|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138933281|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
138933282|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138933283|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933284|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933285|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138933286|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933287|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933288|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933289|NCT05186974|Carboplatin|carboplatin|mesh-list
138933290|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
138933291|NCT05186974|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138933292|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933293|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933294|NCT05186974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138933295|NCT05186974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933296|NCT05186974|Immunoconjugates|immunoconjugates|mesh-ancestor
138933297|NCT05186974|Immunologic Factors|immunologic factors|mesh-ancestor
138933298|NCT05186974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933299|NCT05182840|Empagliflozin|empagliflozin|mesh-list
138933300|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138640609|NCT01334710|Sorafenib|sorafenib|mesh-list
138933301|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933302|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138933303|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933304|NCT05144945|Vaccines|vaccines|mesh-list
138933305|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
138619396|NCT00234195|Bupropion|bupropion|mesh-list
138933306|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933308|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933309|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
138933310|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933311|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933312|NCT05101070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138933313|NCT05101070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933314|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138933315|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
138933316|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
138933317|NCT05064332|Estradiol|estradiol|mesh-list
138933318|NCT05064332|Estrogens|estrogens|mesh-ancestor
138933319|NCT05064332|Hormones|hormones|mesh-ancestor
138933320|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138933321|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933322|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138933323|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138933324|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138933325|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138933327|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933328|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138933329|NCT05027308|Protective Agents|protective agents|mesh-ancestor
138933330|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933332|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
138933333|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138933334|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138933335|NCT04976088|Analgesics|analgesics|mesh-ancestor
138933336|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
138933337|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933338|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933339|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933340|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138933341|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138933342|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711050|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640662|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933343|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933344|NCT04874038|Lidocaine|lidocaine|mesh-list
138933345|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
138933346|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
138933347|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138933348|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933349|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
138933350|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933351|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138933352|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138933353|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138933354|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138639427|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
138933355|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933356|NCT04771481|Metoclopramide|metoclopramide|mesh-list
138933357|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
138933358|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
138933359|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933360|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933361|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933362|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138933363|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138933364|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
138933365|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138933366|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933367|NCT04667312|Durvalumab|durvalumab|mesh-list
138933368|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933369|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933370|NCT04650893|Dexamethasone|dexamethasone|mesh-list
138933371|NCT04650893|Ketorolac|ketorolac|mesh-list
138933372|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640693|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
138619537|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
138933373|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
138933374|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
138933375|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933376|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933377|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933378|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
138933379|NCT04650893|Hormones|hormones|mesh-ancestor
138933380|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138933381|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138933382|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933383|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138933384|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138933385|NCT04650893|Analgesics|analgesics|mesh-ancestor
138933386|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
138933387|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138933388|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138933389|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933390|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933391|NCT04611152|Aflibercept|aflibercept|mesh-list
138933392|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138933393|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138933394|NCT04611152|Growth Substances|growth substances|mesh-ancestor
138933395|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933397|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933398|NCT04603937|Aflibercept|aflibercept|mesh-list
138933399|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138933400|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138933401|NCT04603937|Growth Substances|growth substances|mesh-ancestor
138933402|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933403|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
138933404|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933405|NCT04603651|Bamlanivimab|bamlanivimab|mesh-list
138933406|NCT04603651|Antiviral Agents|antiviral agents|mesh-ancestor
138933407|NCT04603651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933408|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138933409|NCT04602975|Vaccines|vaccines|mesh-list
138933410|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
138933411|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933412|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138933413|NCT04602975|Antacids|antacids|mesh-ancestor
138933414|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933415|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933416|NCT04564885|Meloxicam|meloxicam|mesh-list
138933417|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138933418|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138933419|NCT04564885|Analgesics|analgesics|mesh-ancestor
138933420|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
138933421|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933422|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933423|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933424|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138933425|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138933426|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138933427|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933428|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933429|NCT04551547|Vaccines|vaccines|mesh-list
138933430|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
138933431|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933432|NCT04539236|Lenalidomide|lenalidomide|mesh-list
138933433|NCT04539236|Luspatercept|luspatercept|mesh-list
138933434|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
138933435|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933436|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138933437|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138933438|NCT04539236|Growth Substances|growth substances|mesh-ancestor
138933439|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
138933440|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933441|NCT04539236|Hematinics|hematinics|mesh-ancestor
138933442|NCT04520776|Meloxicam|meloxicam|mesh-list
138933443|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138933444|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138933445|NCT04520776|Analgesics|analgesics|mesh-ancestor
138933446|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
138933447|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933448|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933449|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933450|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138933451|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138640771|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933452|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138933453|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933454|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933455|NCT04509102|Adderall|adderall|mesh-list
138933456|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138933457|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933458|NCT04439318|Trametinib|trametinib|mesh-list
138933459|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138933460|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933461|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138619888|NCT04996771|Cisplatin|cisplatin|mesh-list
138933462|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933463|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933464|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138933465|NCT04439318|Protective Agents|protective agents|mesh-ancestor
138933466|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933467|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138933469|NCT04256317|Azacitidine|azacitidine|mesh-list
138933470|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138933471|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
138933472|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933473|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933474|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933475|NCT04217447|Aspirin|aspirin|mesh-list
138933476|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138933477|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138933478|NCT04217447|Analgesics|analgesics|mesh-ancestor
138933479|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
138933480|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933481|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640803|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640804|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
138640805|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640806|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138640807|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138640808|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640809|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138933482|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933483|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138933484|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138933485|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138933486|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933487|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138933488|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138933489|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933491|NCT04210349|Vaccines|vaccines|mesh-list
138933492|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
138933493|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933494|NCT04203901|Nivolumab|nivolumab|mesh-list
138933495|NCT04203901|Ipilimumab|ipilimumab|mesh-list
138933496|NCT04203901|Everolimus|everolimus|mesh-list
138933497|NCT04203901|Lenvatinib|lenvatinib|mesh-list
138933498|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933499|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933500|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138933501|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933502|NCT04203901|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138933503|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138933504|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933505|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138933506|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
138933507|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620070|NCT00237861|Olanzapine|olanzapine|mesh-list
138933508|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
138933509|NCT04198766|Antibodies|antibodies|mesh-list
138933510|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
138933511|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933512|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933513|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933514|NCT04198766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138933515|NCT04198766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933516|NCT04171700|Rucaparib|rucaparib|mesh-list
138933517|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138933518|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933519|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933520|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933521|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
138933523|NCT04096066|Dexamethasone|dexamethasone|mesh-list
138933524|NCT04096066|Lenalidomide|lenalidomide|mesh-list
138711051|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
138418613|NCT06225271|Vitamins|vitamins|mesh-list
138933525|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933526|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
138933527|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
138933528|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933529|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933530|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933531|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
138933532|NCT04096066|Hormones|hormones|mesh-ancestor
138933533|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138933534|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138933535|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933536|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
138933537|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138933538|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138585489|NCT00144209|Levodopa|levodopa|mesh-list
138933539|NCT04096066|Growth Substances|growth substances|mesh-ancestor
138933540|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
138933541|NCT03976258|Naltrexone|naltrexone|mesh-list
138933542|NCT03976258|Buprenorphine|buprenorphine|mesh-list
138933543|NCT03976258|Methadone|methadone|mesh-list
138933544|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138933545|NCT03976258|Heroin|heroin|mesh-list
138933546|NCT03976258|Naloxone|naloxone|mesh-list
138933547|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138933549|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138933550|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933551|NCT03976258|Analgesics|analgesics|mesh-ancestor
138933552|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
138933553|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933554|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138933555|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138933556|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
138933557|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
138933558|NCT03909165|Atropine|atropine|mesh-list
138933560|NCT03909165|Neostigmine|neostigmine|mesh-list
138933561|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138933562|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138933563|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138933564|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
138933565|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933566|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933567|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138933568|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
138933569|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
138933571|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138933572|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138933573|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
138933574|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138933575|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933576|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138933577|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933578|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138933579|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138933580|NCT03784443|Ranibizumab|ranibizumab|mesh-list
138933581|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138933582|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138933583|NCT03784443|Growth Substances|growth substances|mesh-ancestor
138933584|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933585|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
138933586|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933587|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933588|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
138933589|NCT03784443|Hormones|hormones|mesh-ancestor
138620310|NCT00238329|Growth Substances|growth substances|mesh-ancestor
138933590|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138933591|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
138933592|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138933593|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138933594|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138933595|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
138933596|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138933597|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933598|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933599|NCT03512223|Dexamethasone|dexamethasone|mesh-list
138933600|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933601|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
138933602|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
138933603|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933604|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933605|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933606|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
138933607|NCT03512223|Hormones|hormones|mesh-ancestor
138933608|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138933609|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138933610|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933611|NCT03502668|Decitabine|decitabine|mesh-list
138933612|NCT03502668|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138933613|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138933614|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
138585581|NCT00507091|Leucovorin|leucovorin|mesh-list
138933615|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933616|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933617|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933618|NCT03474458|Doxycycline|doxycycline|mesh-list
138933620|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933621|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
138933622|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138933623|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138933624|NCT03386500|Manganese|manganese|mesh-list
138933625|NCT03386500|Trace Elements|trace elements|mesh-ancestor
138933626|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
138933627|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933628|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
138933629|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933630|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933631|NCT03374332|Immunotoxins|immunotoxins|mesh-ancestor
138933632|NCT03374332|Immunoconjugates|immunoconjugates|mesh-ancestor
138933633|NCT03374332|Immunologic Factors|immunologic factors|mesh-ancestor
138933634|NCT03374332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933635|NCT03226418|Cytarabine|cytarabine|mesh-list
138933636|NCT03226418|Azacitidine|azacitidine|mesh-list
138933637|NCT03226418|Decitabine|decitabine|mesh-list
138933638|NCT03226418|Daunorubicin|daunorubicin|mesh-list
138933639|NCT03226418|Venetoclax|venetoclax|mesh-list
138933640|NCT03226418|Idarubicin|idarubicin|mesh-list
138933641|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138933642|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
138640928|NCT00259922|Alvimopan|alvimopan|mesh-list
138933643|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933644|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933645|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
138933646|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933647|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138933648|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
138933649|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933650|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933651|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138933652|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138933653|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138933654|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
138933655|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
138933656|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138933657|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138933658|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933659|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933660|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933661|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138933662|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
138933663|NCT03073785|Capecitabine|capecitabine|mesh-list
138933664|NCT03073785|Fluorouracil|fluorouracil|mesh-list
138933665|NCT03073785|Imidazole|imidazole|mesh-list
138933666|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138933667|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
138933668|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933669|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933670|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138933671|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
138933672|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933673|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138933674|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933675|NCT03066648|Azacitidine|azacitidine|mesh-list
138933676|NCT03066648|Decitabine|decitabine|mesh-list
138933677|NCT03066648|Spartalizumab|spartalizumab|mesh-list
138933678|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138933679|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
138933680|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933681|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933682|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933683|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138933684|NCT03066648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933685|NCT02766465|Sirolimus|sirolimus|mesh-list
138933686|NCT02766465|Methotrexate|methotrexate|mesh-list
138933687|NCT02766465|Fludarabine|fludarabine|mesh-list
138933688|NCT02766465|Melphalan|melphalan|mesh-list
138933689|NCT02766465|Busulfan|busulfan|mesh-list
138933690|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
138933691|NCT02766465|Tacrolimus|tacrolimus|mesh-list
138933692|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138933693|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
138933694|NCT02766465|Lenograstim|lenograstim|mesh-list
138933695|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138639468|NCT00270543|Antidotes|antidotes|mesh-ancestor
138620613|NCT00238914|Naltrexone|naltrexone|mesh-list
138933696|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
138933697|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138933698|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933699|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138933700|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
138933701|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933702|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933703|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
138933704|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933705|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138933706|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138933707|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
138933708|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138933709|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138933710|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138933711|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138933712|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933713|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138933714|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
138933715|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138933716|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
138933717|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138933718|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138933719|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138933720|NCT02743455|Vaccines|vaccines|mesh-list
138933721|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
138933722|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933723|NCT02553447|Vitamin D|vitamin d|mesh-list
138933724|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
138933725|NCT02553447|Vitamins|vitamins|mesh-ancestor
138933726|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
138933727|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933728|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138933729|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138933730|NCT02020707|Paclitaxel|paclitaxel|mesh-list
138419177|NCT06058377|Paclitaxel|paclitaxel|mesh-list
138933731|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138933732|NCT02020707|Bevacizumab|bevacizumab|mesh-list
138933733|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138933734|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
138933735|NCT02020707|Antibodies|antibodies|mesh-list
138933736|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
138933737|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138933738|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
138933739|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138933740|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933741|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
138933742|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
138933743|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
138933744|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933745|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138933746|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138933747|NCT02020707|Growth Substances|growth substances|mesh-ancestor
138933748|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933749|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
138933750|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
138933751|NCT01632436|Pixantrone|pixantrone|mesh-list
138933752|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138933753|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138933754|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933755|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933756|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933757|NCT01594047|Ketamine|ketamine|mesh-list
138933758|NCT01594047|Methadone|methadone|mesh-list
138933759|NCT01594047|Analgesics|analgesics|mesh-ancestor
138933760|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
138933761|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620693|NCT04668469|Vitamins|vitamins|mesh-list
138933762|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933763|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138933764|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138639476|NCT02960919|Amoxicillin|amoxicillin|mesh-list
138933765|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
138933766|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
138933767|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138933768|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138933769|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138419279|NCT06023641|Irinotecan|irinotecan|mesh-list
138933770|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138933771|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933772|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138933773|NCT01594047|Narcotics|narcotics|mesh-ancestor
138933774|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
138933775|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
138933776|NCT01268579|Ribavirin|ribavirin|mesh-list
138933777|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
138933778|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933779|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
138933780|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933782|NCT01165632|Cariostatic Agents|cariostatic agents|mesh-ancestor
138933783|NCT01165632|Protective Agents|protective agents|mesh-ancestor
138933784|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933785|NCT01056523|Cytarabine|cytarabine|mesh-list
138933786|NCT01056523|Ribavirin|ribavirin|mesh-list
138933787|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138933788|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
138933789|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933790|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933791|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
138933792|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933793|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138933794|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
138933795|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933796|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
138933797|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
138933798|NCT00579878|Methotrexate|methotrexate|mesh-list
138933799|NCT00579878|Leflunomide|leflunomide|mesh-list
138933800|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138933801|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
138933802|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138933803|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933804|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138933805|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
138933806|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933807|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933808|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
138933809|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933810|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138933811|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138933812|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
138933813|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138933814|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138640969|NCT00292344|Rifaximin|rifaximin|mesh-list
138640970|NCT00292344|Loperamide|loperamide|mesh-list
138640971|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
138640975|NCT00417768|Plasminogen|plasminogen|mesh-list
138933815|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
138933816|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138933817|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138933818|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933819|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138933820|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138933821|NCT00579878|Analgesics|analgesics|mesh-ancestor
138933822|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
138933823|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933824|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933825|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933826|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
138933827|NCT00554788|Thiotepa|thiotepa|mesh-list
138933828|NCT00554788|Cisplatin|cisplatin|mesh-list
138933829|NCT00554788|Carboplatin|carboplatin|mesh-list
138933830|NCT00554788|Etoposide|etoposide|mesh-list
138933831|NCT00554788|Vincristine|vincristine|mesh-list
138933832|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
138933833|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
138933834|NCT00554788|Lenograstim|lenograstim|mesh-list
138933835|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138620851|NCT00411593|Bortezomib|bortezomib|mesh-list
138933836|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
138933837|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933838|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138933839|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138933840|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
138933841|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933842|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933843|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138933844|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138585798|NCT03451825|Avelumab|avelumab|mesh-list
138933845|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138933846|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138933847|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933848|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138933849|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
138933850|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
138933851|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
138933852|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
138933853|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
138933855|NCT00138216|Vincristine|vincristine|mesh-list
138933856|NCT00138216|Temozolomide|temozolomide|mesh-list
138933857|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138933858|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138933859|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933860|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933861|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933862|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138933863|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
138933864|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
138225821|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
138933865|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
138933866|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138933867|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
138933868|NCT03542760|Methylene Blue|methylene blue|mesh-list
138933869|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933870|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933871|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138933872|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933873|NCT03465540|Dexamethasone|dexamethasone|mesh-list
138933874|NCT03465540|Azacitidine|azacitidine|mesh-list
138933875|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138933876|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
138933877|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
138933878|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933879|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933880|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138933881|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
138933882|NCT03465540|Hormones|hormones|mesh-ancestor
138933883|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138933884|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138933885|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933886|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138933887|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
138933888|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933889|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933890|NCT03368547|Edetic Acid|edetic acid|mesh-list
138933891|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138933892|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
138933893|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
138933894|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933895|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
138933896|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138933897|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138933898|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138933899|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933900|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933901|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933902|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138933904|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138933905|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
138933906|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933907|NCT03152890|Insulin|insulin|mesh-list
138933908|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138933909|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933910|NCT03123029|Venetoclax|venetoclax|mesh-list
138933911|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933912|NCT03048877|Apatinib|apatinib|mesh-list
138933913|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419498|NCT05899127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138933914|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138933915|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933916|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933917|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
138933918|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
138933919|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
138933920|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138933921|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933922|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
138933923|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138933924|NCT02940925|Cisplatin|cisplatin|mesh-list
138933925|NCT02940925|Capecitabine|capecitabine|mesh-list
138933926|NCT02940925|Fluorouracil|fluorouracil|mesh-list
138933927|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933928|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138620963|NCT00239538|Telmisartan|telmisartan|mesh-list
138933930|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933931|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138933932|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
138933933|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933934|NCT02915705|Vitamin D|vitamin d|mesh-list
138933935|NCT02915705|Vitamins|vitamins|mesh-ancestor
138933936|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
138933937|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933938|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138933939|NCT02891278|Cytarabine|cytarabine|mesh-list
138933940|NCT02891278|Sertraline|sertraline|mesh-list
138933941|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138933942|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
138933943|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933944|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933945|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
138933946|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138933947|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138933948|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
138933949|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933950|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
138933951|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138933952|NCT02891278|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138933953|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138933954|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138933955|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138933956|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
138933957|NCT02807181|Cisplatin|cisplatin|mesh-list
138933958|NCT02807181|Gemcitabine|gemcitabine|mesh-list
138933959|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933960|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138933961|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
138933962|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933963|NCT02454543|Androgens|androgens|mesh-list
138933964|NCT02454543|Hormones|hormones|mesh-ancestor
138933965|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138933966|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933967|NCT02384512|Rasagiline|rasagiline|mesh-list
138933968|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138933969|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138933970|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933971|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138933972|NCT02384512|Protective Agents|protective agents|mesh-ancestor
138933973|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933974|NCT02366494|Docetaxel|docetaxel|mesh-list
138933975|NCT02366494|Leuprolide|leuprolide|mesh-list
138933976|NCT02366494|Goserelin|goserelin|mesh-list
138933977|NCT02366494|Bicalutamide|bicalutamide|mesh-list
138933978|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138933979|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138933980|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
138933981|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
138933982|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
138621074|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
138933983|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138933984|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138933985|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
138933986|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138933987|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138933988|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138933989|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
138933990|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
138933991|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138933992|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
138933993|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138933994|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
138933995|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138933996|NCT02157610|Nicotine|nicotine|mesh-list
138585949|NCT05594186|Hemostatics|hemostatics|mesh-ancestor
138641014|NCT00292734|Zolpidem|zolpidem|mesh-list
138933997|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138933998|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
138933999|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934000|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934001|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138934002|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138934003|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
138934004|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934005|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934007|NCT02078869|Progestins|progestins|mesh-ancestor
138934008|NCT02078869|Hormones|hormones|mesh-ancestor
138934009|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138934010|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934011|NCT01946815|Atorvastatin|atorvastatin|mesh-list
138934012|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138934013|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138934014|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
138934015|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934016|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138621164|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934017|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138934018|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934019|NCT01937156|Granisetron|granisetron|mesh-list
138934020|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
138934021|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
138934022|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934023|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934024|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138934025|NCT01937156|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138934026|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138934027|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
138934028|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934029|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934031|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138934032|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138934033|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138419668|NCT05745480|Analgesics|analgesics|mesh-ancestor
138934034|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934035|NCT01718873|Leucovorin|leucovorin|mesh-list
138934036|NCT01718873|Folic Acid|folic acid|mesh-list
138934037|NCT01718873|Bevacizumab|bevacizumab|mesh-list
138934038|NCT01718873|Capecitabine|capecitabine|mesh-list
138934039|NCT01718873|Fluorouracil|fluorouracil|mesh-list
138934040|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
138934041|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
138934042|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138934043|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934044|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138934045|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138934046|NCT01718873|Growth Substances|growth substances|mesh-ancestor
138934047|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934048|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
138934049|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138934050|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
138934051|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934052|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934053|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
138934054|NCT01718873|Antidotes|antidotes|mesh-ancestor
138934055|NCT01718873|Protective Agents|protective agents|mesh-ancestor
138934056|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
138934057|NCT01718873|Vitamins|vitamins|mesh-ancestor
138934058|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
138934060|NCT01424566|Nabiximols|nabiximols|mesh-list
138934061|NCT01424566|Analgesics|analgesics|mesh-ancestor
138934062|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
138934063|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934064|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934065|NCT01367561|Naloxone|naloxone|mesh-list
138934066|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
138934067|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138934068|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934069|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
138586030|NCT00148746|Hormones|hormones|mesh-ancestor
138934070|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934071|NCT01361607|Nabiximols|nabiximols|mesh-list
138934072|NCT01361607|Analgesics|analgesics|mesh-ancestor
138934073|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
138934074|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934075|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934076|NCT01337089|Nabiximols|nabiximols|mesh-list
138934077|NCT01337089|Analgesics|analgesics|mesh-ancestor
138934078|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
138934079|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934080|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934081|NCT01276587|Vitamin D|vitamin d|mesh-list
138934082|NCT01276587|Ergocalciferols|ergocalciferols|mesh-list
138934083|NCT01276587|Cholecalciferol|cholecalciferol|mesh-list
138934084|NCT01276587|Vitamins|vitamins|mesh-list
138934085|NCT01276587|Micronutrients|micronutrients|mesh-ancestor
138934086|NCT01276587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934087|NCT01276587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138934088|NCT01276587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138934089|NCT01217580|Ropivacaine|ropivacaine|mesh-list
138934090|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
138934091|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
138934092|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934093|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934094|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
138934095|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934096|NCT00802646|Epinephrine|epinephrine|mesh-list
138934097|NCT00802646|Fentanyl|fentanyl|mesh-list
138934098|NCT00802646|Bupivacaine|bupivacaine|mesh-list
138934099|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
138934100|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
138934101|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934102|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934103|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
138934104|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934105|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138934107|NCT00802646|Analgesics|analgesics|mesh-ancestor
138934108|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138934109|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138934110|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
138934111|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138934112|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138934113|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
138934114|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934115|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934116|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138934117|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138934118|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
138934119|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138934120|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
138934121|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
138934122|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
138934123|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138934124|NCT00473707|Oxytocin|oxytocin|mesh-list
138934125|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
138934126|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138934127|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934128|NCT00233675|Tiagabine|tiagabine|mesh-list
138934129|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
138934130|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
138934131|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138934132|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138934133|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934134|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
138934135|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934136|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934137|NCT00202774|Capecitabine|capecitabine|mesh-list
138934138|NCT00202774|Fluorouracil|fluorouracil|mesh-list
138934139|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
138934140|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138934141|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
138934142|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934143|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934144|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138419847|NCT05655689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138934145|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
138934146|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934147|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
138934148|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934149|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
138934150|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934151|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138934152|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138934153|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
138621546|NCT04667143|Metformin|metformin|mesh-list
138934154|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934155|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934156|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138934157|NCT00107744|Caseins|caseins|mesh-list
138934158|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
138934159|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
138934160|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934161|NCT00845338|Darifenacin|darifenacin|mesh-list
138934162|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138934163|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138934164|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
138934165|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934166|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934167|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934168|NCT00845338|Urological Agents|urological agents|mesh-ancestor
138934169|NCT00923962|Adenosine|adenosine|mesh-list
138934170|NCT00923962|Glucagon|glucagon|mesh-list
138934171|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138934172|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138934173|NCT00923962|Hormones|hormones|mesh-ancestor
138934174|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138641143|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
138934175|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934176|NCT00923962|Incretins|incretins|mesh-ancestor
138934177|NCT00923962|Analgesics|analgesics|mesh-ancestor
138934178|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
138934179|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934180|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138934181|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
138934182|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138934183|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
138934184|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
138934185|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934186|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934187|NCT02575092|Folic Acid|folic acid|mesh-list
138934188|NCT02575092|Enalapril|enalapril|mesh-list
138934189|NCT02575092|Enalaprilat|enalaprilat|mesh-list
138934190|NCT02575092|Maleic acid|maleic acid|mesh-list
138934191|NCT02575092|Hematinics|hematinics|mesh-ancestor
138621661|NCT00240942|Letrozole|letrozole|mesh-list
138934192|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
138934193|NCT02575092|Vitamins|vitamins|mesh-ancestor
138934194|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
138934195|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934196|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934197|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934198|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138934199|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
138934200|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138934201|NCT04097470|Decitabine|decitabine|mesh-list
138934202|NCT04097470|Midostaurin|midostaurin|mesh-list
138934203|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138934204|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
138934205|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934206|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934207|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934208|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138934209|NCT04041934|Tryptophan|tryptophan|mesh-list
138934210|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138934211|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
138934212|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138934213|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138934214|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138934215|NCT00845572|Risperidone|risperidone|mesh-list
138934216|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138934217|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
138934218|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934219|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934220|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934221|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138934222|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138934223|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934224|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138934225|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138934227|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
138934228|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
138934229|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138934230|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138934231|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
138934232|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138934233|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138934234|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934235|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138934236|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934237|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934238|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138934239|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138934240|NCT04227184|Trospium chloride|trospium chloride|mesh-list
138934241|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
138934242|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
138934243|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934244|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934245|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138934246|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138934247|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
138934248|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934249|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934250|NCT04227184|Urological Agents|urological agents|mesh-ancestor
138934251|NCT04018950|Durlobactam|durlobactam|mesh-list
138934252|NCT04018950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138934253|NCT04018950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934254|NCT04018950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934255|NCT04018950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138934256|NCT04018950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934257|NCT02545972|Tacrolimus|tacrolimus|mesh-list
138934258|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934259|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
138934260|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934261|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138934262|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934263|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934264|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
138934265|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138934266|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934267|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934268|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138934269|NCT00852046|Analgesics|analgesics|mesh-ancestor
138934270|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
138934271|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934272|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138934273|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138934274|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138934275|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
138934276|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934277|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934279|NCT02573064|Colistin|colistin|mesh-list
138934280|NCT02573064|Tigecycline|tigecycline|mesh-list
138934281|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138934282|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934283|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138934284|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934285|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934286|NCT00845884|Bevacizumab|bevacizumab|mesh-list
138934287|NCT00845884|Cisplatin|cisplatin|mesh-list
138934288|NCT00845884|Docetaxel|docetaxel|mesh-list
138934289|NCT00845884|Capecitabine|capecitabine|mesh-list
138934290|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138934291|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934292|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138639553|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934293|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138934294|NCT00845884|Growth Substances|growth substances|mesh-ancestor
138934295|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934296|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
138934297|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
138934298|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
138934299|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
138934300|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934301|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138934302|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
138934305|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138934306|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138934307|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
138934308|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934309|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138934310|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
138934311|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138934312|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
138934313|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138934314|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138934315|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
138934316|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934317|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138934318|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138934319|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934320|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934322|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934323|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934324|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934325|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138934326|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138934327|NCT00712140|Trastuzumab|trastuzumab|mesh-list
138934328|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138934329|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934330|NCT02545738|Liraglutide|liraglutide|mesh-list
138934331|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138934332|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934333|NCT02545738|Incretins|incretins|mesh-ancestor
138934334|NCT02545738|Hormones|hormones|mesh-ancestor
138934335|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138934336|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
138641250|NCT00261365|Ipilimumab|ipilimumab|mesh-list
138934337|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138934338|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
138934339|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934340|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934341|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138934342|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
138934343|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138934345|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934346|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934347|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138934348|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
138934349|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
138934350|NCT00848302|Protective Agents|protective agents|mesh-ancestor
138934351|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
138934352|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934353|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
138934354|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934355|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138934356|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138934357|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
138934358|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934359|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934360|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138934361|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
138934362|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
138934363|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138934364|NCT00712374|Amodiaquine|amodiaquine|mesh-list
138934365|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
138934366|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138934367|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138934368|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934369|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138934370|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934371|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622183|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138934372|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138934373|NCT02573220|Leucovorin|leucovorin|mesh-list
138934374|NCT02573220|Fluorouracil|fluorouracil|mesh-list
138934375|NCT02573220|Irinotecan|irinotecan|mesh-list
138934376|NCT02573220|Cetuximab|cetuximab|mesh-list
138934377|NCT02573220|Camptothecin|camptothecin|mesh-list
138934378|NCT02573220|Calcium|calcium|mesh-list
138934379|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
138934380|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138934381|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934382|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
138934383|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934384|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138934385|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934386|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934387|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
138934388|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138934389|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138934390|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934391|NCT02573220|Antidotes|antidotes|mesh-ancestor
138934392|NCT02573220|Protective Agents|protective agents|mesh-ancestor
138934393|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
138934394|NCT02573220|Vitamins|vitamins|mesh-ancestor
138934395|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
138934396|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138934397|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138934398|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
138934399|NCT00712452|Vinblastine|vinblastine|mesh-list
138934400|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934401|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
138934402|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934403|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138682803|NCT05146895|Imiquimod|imiquimod|mesh-list
138934404|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138934405|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
138934406|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934407|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934408|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138934409|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138934410|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
138934411|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
138934412|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
138934414|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934415|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138934416|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934417|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934418|NCT02544880|Tadalafil|tadalafil|mesh-list
138934419|NCT02544880|Vaccines|vaccines|mesh-list
138934420|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
138934421|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934422|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
138934423|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138934424|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138934425|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934426|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934427|NCT02544880|Urological Agents|urological agents|mesh-ancestor
138934429|NCT00856570|Mirabegron|mirabegron|mesh-list
138934430|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
138934431|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138934432|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138934433|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138934434|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
138934435|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934436|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934437|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934438|NCT00856570|Urological Agents|urological agents|mesh-ancestor
138934439|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
138934440|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138622269|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138934441|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934442|NCT00856804|Ribavirin|ribavirin|mesh-list
138934443|NCT00856804|Thalidomide|thalidomide|mesh-list
138934444|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
138934445|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934446|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
138934447|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934448|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934449|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
138934450|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586402|NCT06183008|Immunoglobulins|immunoglobulins|mesh-list
138934451|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
138934452|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138934453|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138934454|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138934455|NCT00856804|Growth Substances|growth substances|mesh-ancestor
138934456|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
138934457|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934459|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
138934460|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
138934461|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934462|NCT00712686|Olanzapine|olanzapine|mesh-list
138934463|NCT00712686|Aripiprazole|aripiprazole|mesh-list
138934464|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
138934465|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
138934466|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934467|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934468|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138934469|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138934470|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138934471|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934472|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138934473|NCT00712686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138934474|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138934475|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138934476|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934477|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934478|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
138934479|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
138934480|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
138934481|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
138934482|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138934483|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138934484|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138934485|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138934486|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138934487|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138934488|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
138934489|NCT04041856|Povidone|povidone|mesh-list
138934490|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
138934491|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
138934492|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138934493|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934494|NCT00856960|Losartan|losartan|mesh-list
138934495|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138934496|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138934497|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138934498|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138934499|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934500|NCT00712764|Adenosine|adenosine|mesh-list
138934501|NCT00712764|Analgesics|analgesics|mesh-ancestor
138934502|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
138934503|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934504|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934505|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138934506|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
138934507|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138934508|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
138934509|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
138934510|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934511|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934513|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934514|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
138934515|NCT00578786|Ambrisentan|ambrisentan|mesh-list
138934516|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138934517|NCT00424255|Lapatinib|lapatinib|mesh-list
138934518|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934519|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138934520|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934521|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934522|NCT02574156|Insulin|insulin|mesh-list
138934523|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138622472|NCT00559312|Fluticasone|fluticasone|mesh-list
138934524|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934525|NCT00848692|Rituximab|rituximab|mesh-list
138934526|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138934527|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934528|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
138934529|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934531|NCT00848770|Norepinephrine|norepinephrine|mesh-list
138934532|NCT00848770|Esmolol|esmolol|mesh-list
138934533|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138934534|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138934535|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
138934536|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934537|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934538|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641379|NCT00293475|Rituximab|rituximab|mesh-list
138934539|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
138934540|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
138934541|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934542|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138934543|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138934544|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138934545|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138934547|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934548|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138934549|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934550|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934551|NCT00620074|Voriconazole|voriconazole|mesh-list
138934552|NCT00620074|Anidulafungin|anidulafungin|mesh-list
138934553|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
138934554|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934555|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138934556|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138934557|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934558|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934559|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138934561|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138934562|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934563|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138934564|NCT02571296|Progesterone|progesterone|mesh-list
138934565|NCT02571296|Progestins|progestins|mesh-ancestor
138934566|NCT02571296|Hormones|hormones|mesh-ancestor
138934567|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138934568|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934569|NCT00857038|Doxycycline|doxycycline|mesh-list
138934570|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138934571|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934572|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
138934573|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138934574|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138934575|NCT00857116|Albendazole|albendazole|mesh-list
138934576|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
138934577|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138934578|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934579|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
138934580|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138934581|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138934582|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
138934583|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
138934584|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
138934585|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641424|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
138934586|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934587|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
138934588|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138934589|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138934590|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934591|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
138934592|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934593|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934594|NCT00717938|Carboplatin|carboplatin|mesh-list
138934595|NCT00717938|Etoposide|etoposide|mesh-list
138934596|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
138934597|NCT00717938|Cisplatin|cisplatin|mesh-list
138934598|NCT00717938|Enoxaparin|enoxaparin|mesh-list
138934599|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
138934600|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934601|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138934602|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138934603|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138934605|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934606|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
138934607|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138934608|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138934609|NCT00857428|Oxymorphone|oxymorphone|mesh-list
138934610|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138934611|NCT00857428|Narcotics|narcotics|mesh-ancestor
138934612|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934613|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934614|NCT00857428|Analgesics|analgesics|mesh-ancestor
138934615|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
138934616|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934617|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138934618|NCT04018768|Acetaminophen|acetaminophen|mesh-list
138934620|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138934621|NCT04018768|Oxycodone|oxycodone|mesh-list
138934622|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138934623|NCT04018768|Analgesics|analgesics|mesh-ancestor
138934624|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
138934625|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934626|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934627|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
138934628|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138934629|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138934630|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138934631|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138934632|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934633|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934634|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138934635|NCT04018768|Narcotics|narcotics|mesh-ancestor
138934636|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934637|NCT00848848|Vaccines|vaccines|mesh-list
138934638|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
138934639|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934640|NCT02573922|Oxycodone|oxycodone|mesh-list
138934642|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138934643|NCT02573922|Narcotics|narcotics|mesh-ancestor
138934644|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934645|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934646|NCT02573922|Analgesics|analgesics|mesh-ancestor
138934647|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
138934648|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934649|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138934650|NCT00852436|Pregabalin|pregabalin|mesh-list
138934651|NCT00852436|Analgesics|analgesics|mesh-ancestor
138934652|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
138934653|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934654|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622933|NCT00219869|Galantamine|galantamine|mesh-list
138934655|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
138934656|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138934657|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138934658|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934659|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138934660|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138934661|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138934662|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934663|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138934664|NCT00720512|Leucovorin|leucovorin|mesh-list
138934665|NCT00720512|Bevacizumab|bevacizumab|mesh-list
138934666|NCT00720512|Fluorouracil|fluorouracil|mesh-list
138934667|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
138934668|NCT00720512|Irinotecan|irinotecan|mesh-list
138934669|NCT00720512|Calcium|calcium|mesh-list
138934670|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
138934671|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138934672|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934673|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138934674|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138934675|NCT00720512|Growth Substances|growth substances|mesh-ancestor
138934676|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934677|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
138934678|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138934679|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
138934680|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934681|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138934682|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934683|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
138934684|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138934685|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138934686|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934688|NCT00720512|Protective Agents|protective agents|mesh-ancestor
138934689|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
138934691|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
138934692|NCT04069286|Amoxicillin|amoxicillin|mesh-list
138934693|NCT04069286|Omeprazole|omeprazole|mesh-list
138934694|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138934695|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623058|NCT00247026|Vitamins|vitamins|mesh-ancestor
138934697|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138934698|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138934699|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711052|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138934700|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934701|NCT00713622|Zonisamide|zonisamide|mesh-list
138934702|NCT00713622|Valproic Acid|valproic acid|mesh-list
138934703|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
138934704|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934705|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934706|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
138934707|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934708|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934709|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
138934710|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138934711|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934712|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138934713|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138623106|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
138934714|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138934715|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138934716|NCT00718172|Ribavirin|ribavirin|mesh-list
138934717|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
138934718|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934719|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
138934720|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934721|NCT00720018|Sumatriptan|sumatriptan|mesh-list
138934722|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138934723|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138934724|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138934725|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
138934726|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934727|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934728|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934729|NCT00618826|Paclitaxel|paclitaxel|mesh-list
138934730|NCT00618826|Gemcitabine|gemcitabine|mesh-list
138934731|NCT00618826|Bevacizumab|bevacizumab|mesh-list
138934732|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138934733|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934734|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
138934735|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
138934736|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
138934737|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934738|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138934739|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
138934740|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138934741|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138934742|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138934743|NCT00618826|Growth Substances|growth substances|mesh-ancestor
138934744|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934745|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
138934746|NCT00720174|Doxorubicin|doxorubicin|mesh-list
138934747|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138934748|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138934749|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138934750|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934751|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138934752|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138934753|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934754|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934755|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
138934756|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934757|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138934758|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
138934759|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934761|NCT03834740|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138934762|NCT03834740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138934763|NCT03834740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934764|NCT03834740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934765|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934766|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
138934767|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934768|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934769|NCT00849082|Goserelin|goserelin|mesh-list
138934770|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
138934771|NCT00849082|Cyproterone|cyproterone|mesh-list
138934772|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138934773|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934774|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
138934775|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
138623346|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
138934776|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138934777|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934778|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138934779|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
138934780|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138934781|NCT00849160|Darunavir|darunavir|mesh-list
138934782|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138641567|NCT00299520|Linezolid|linezolid|mesh-list
138934783|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138934784|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
138934785|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934786|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934787|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138934788|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138934789|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
138934790|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934792|NCT00720590|Lopinavir|lopinavir|mesh-list
138934793|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138934794|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138934795|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138934796|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
138934797|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934798|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934799|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138934800|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138934801|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
138934802|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934803|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138934804|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138934805|NCT00718406|Metoprolol|metoprolol|mesh-list
138934806|NCT00718406|Morphine|morphine|mesh-list
138934807|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138934808|NCT00718406|Narcotics|narcotics|mesh-ancestor
138934809|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934810|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934811|NCT00718406|Analgesics|analgesics|mesh-ancestor
138934812|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
138934813|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934814|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138934815|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138934816|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
138934817|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
138934818|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138934819|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138934820|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138934821|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
138934822|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934823|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934824|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
138934825|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138934826|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934827|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138934828|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
138934829|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138934830|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934831|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934832|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934834|NCT00720408|Tacrolimus|tacrolimus|mesh-list
138934835|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934836|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
138934837|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934838|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138934839|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934840|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934841|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138623581|NCT00221624|Analgesics|analgesics|mesh-ancestor
138934842|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934843|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138934844|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
138934845|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138934846|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934847|NCT00852670|Ponesimod|ponesimod|mesh-list
138934848|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138934849|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934850|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934851|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
138934852|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934853|NCT00717210|Temozolomide|temozolomide|mesh-list
138934854|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138934855|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
138934856|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934857|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934858|NCT00723086|Docetaxel|docetaxel|mesh-list
138934859|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934860|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
138934861|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
138934862|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
138421444|NCT03317392|Olaparib|olaparib|mesh-list
138934863|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934864|NCT04018378|Varenicline|varenicline|mesh-list
138934865|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138934866|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138934867|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
138934868|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934869|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934870|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934871|NCT00849550|Bevacizumab|bevacizumab|mesh-list
138934872|NCT00849550|Capecitabine|capecitabine|mesh-list
138934873|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
138934874|NCT00849550|Everolimus|everolimus|mesh-list
138934875|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138934876|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934877|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138934878|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138934879|NCT00849550|Growth Substances|growth substances|mesh-ancestor
138934880|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934881|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
138934882|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138934883|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
138934884|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934885|NCT00849550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138934886|NCT00849550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138934887|NCT00849550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934888|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934889|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
138934890|NCT03816488|Metformin|metformin|mesh-list
138934891|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138934892|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138641664|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
138934893|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934894|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138934895|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138934896|NCT03816488|Analgesics|analgesics|mesh-ancestor
138934897|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
138934898|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934899|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138934900|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138934901|NCT00858676|Acarbose|acarbose|mesh-list
138934902|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138934904|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934905|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138934906|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934907|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
138934908|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138934909|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934910|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
138934911|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934912|NCT00723164|Midazolam|midazolam|mesh-list
138934913|NCT00723164|Fentanyl|fentanyl|mesh-list
138934914|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138934915|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138934916|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934917|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934918|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138934919|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138934920|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138934921|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138934922|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
138934923|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
138934924|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
138934925|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
138934926|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934927|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934928|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138934929|NCT00723164|Narcotics|narcotics|mesh-ancestor
138934930|NCT00723164|Analgesics|analgesics|mesh-ancestor
138934931|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
138934932|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934933|NCT00723242|Ribavirin|ribavirin|mesh-list
138934934|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
138934935|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934936|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
138934937|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138934938|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
138934939|NCT02545426|Calcium|calcium|mesh-list
138934940|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138934941|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934942|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138934943|NCT00720824|Anesthetics|anesthetics|mesh-list
138934944|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138934945|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
138934946|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934947|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934948|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
138934949|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138934950|NCT05373134|Pentoxifylline|pentoxifylline|mesh-list
138934951|NCT05373134|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138934952|NCT05373134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934953|NCT05373134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934954|NCT05373134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138934955|NCT05373134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138934956|NCT05373134|Protective Agents|protective agents|mesh-ancestor
138934957|NCT05373134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934958|NCT05373134|Vasodilator Agents|vasodilator agents|mesh-ancestor
138934959|NCT05373134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138934960|NCT05373134|Antioxidants|antioxidants|mesh-ancestor
138934961|NCT00723320|Atorvastatin|atorvastatin|mesh-list
138934962|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138934964|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
138934965|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934966|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138934967|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138934968|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138934970|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138934971|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934972|NCT00578448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138934973|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934974|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138934975|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
138934976|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934977|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138934978|NCT00720564|Temozolomide|temozolomide|mesh-list
138934979|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
138934980|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138934981|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
138934982|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934983|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138934984|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138641785|NCT00264134|Carboplatin|carboplatin|mesh-list
138934985|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138934986|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138934987|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138934988|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138934989|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138934990|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934991|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138934992|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
138934993|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138934994|NCT04067024|Anesthetics|anesthetics|mesh-list
138934995|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138934996|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138934997|NCT00618748|Olanzapine|olanzapine|mesh-list
138934998|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
138934999|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
138935000|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935001|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935002|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138935003|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138935004|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138935005|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138935006|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138935007|NCT00618748|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138935008|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138935009|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138935010|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935011|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138935012|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
138935013|NCT04067102|Paclitaxel|paclitaxel|mesh-list
138935014|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138935015|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
138935016|NCT04067102|Carboplatin|carboplatin|mesh-list
138935017|NCT04067102|Epirubicin|epirubicin|mesh-list
138935018|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138935019|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935020|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
138935021|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
138624065|NCT05950841|Locust bean gum|locust bean gum|mesh-list
138935022|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
138935023|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935024|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138935025|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
138935026|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935027|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138935028|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138935029|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
138935030|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138935031|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138935032|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138935033|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138935034|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935036|NCT05659290|Capecitabine|capecitabine|mesh-list
138935037|NCT05659290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138935038|NCT05659290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935039|NCT05659290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138935040|NCT05659290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138624128|NCT05837845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138624129|NCT05837845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138624130|NCT05837845|Adrenergic Agents|adrenergic agents|mesh-ancestor
138624138|NCT05750992|Fentanyl|fentanyl|mesh-list
138624139|NCT05750992|Meperidine|meperidine|mesh-list
138624140|NCT05750992|Bupivacaine|bupivacaine|mesh-list
138624141|NCT05750992|Anesthetics, Local|anesthetics, local|mesh-ancestor
138624142|NCT05750992|Anesthetics|anesthetics|mesh-ancestor
138935041|NCT05659290|Growth Substances|growth substances|mesh-ancestor
138935042|NCT05659290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935043|NCT05659290|Growth Inhibitors|growth inhibitors|mesh-ancestor
138935044|NCT05659290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138935045|NCT05659290|Antimetabolites|antimetabolites|mesh-ancestor
138935046|NCT05659290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935047|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
138935048|NCT00717678|Tacrolimus|tacrolimus|mesh-list
138935049|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138935050|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
138935051|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935052|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138935053|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935054|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935055|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138935056|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935057|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138935058|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
138935059|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138641896|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138641899|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935060|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935062|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
138935063|NCT02571842|Prednisolone|prednisolone|mesh-list
138935064|NCT02571842|Rituximab|rituximab|mesh-list
138935065|NCT02571842|Enalapril|enalapril|mesh-list
138935066|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138935067|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624253|NCT05536856|Fluorouracil|fluorouracil|mesh-list
138624254|NCT05536856|Antimetabolites|antimetabolites|mesh-ancestor
138624255|NCT05536856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624256|NCT05536856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138624257|NCT05536856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935068|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
138935069|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935070|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138935071|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138935072|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
138935073|NCT02571842|Hormones|hormones|mesh-ancestor
138935074|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138935075|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138935076|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138935077|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
138935078|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935079|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935080|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138935081|NCT02546284|Lenzilumab|lenzilumab|mesh-list
138935082|NCT02546284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138935083|NCT00721448|Ticagrelor|ticagrelor|mesh-list
138935084|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138935085|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138935086|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138641954|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138935087|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138935088|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
138935089|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138935090|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935091|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935092|NCT00853216|Oxycodone|oxycodone|mesh-list
138935093|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138935094|NCT00853216|Narcotics|narcotics|mesh-ancestor
138935095|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138935096|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935097|NCT00853216|Analgesics|analgesics|mesh-ancestor
138935098|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
138935099|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935100|NCT04961528|Terlipressin|terlipressin|mesh-list
138935101|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
138935102|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138935103|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138935104|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935105|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
138935106|NCT04961528|Coagulants|coagulants|mesh-ancestor
138935107|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138935108|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138935109|NCT00721032|Amiodarone|amiodarone|mesh-list
138935110|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138935111|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
138935112|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138935113|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138935114|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935115|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138935116|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138935117|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138935118|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935119|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138935120|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138935121|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138641998|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138935122|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138935124|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138935125|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935126|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935127|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138935128|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138935129|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935130|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
138935131|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138935132|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
138935133|NCT00853294|Hydrocodone|hydrocodone|mesh-list
138935134|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935135|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138935136|NCT00853294|Narcotics|narcotics|mesh-ancestor
138935137|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138935138|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935139|NCT00853294|Analgesics|analgesics|mesh-ancestor
138935140|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
138935141|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935142|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
138642035|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138642054|NCT00265070|Gefitinib|gefitinib|mesh-list
138935143|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
138935144|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
138624552|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
138935145|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
138935146|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138935147|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
138935148|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
138935149|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138935150|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138935151|NCT00717834|Formaldehyde|formaldehyde|mesh-list
138935152|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
138935153|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935154|NCT00658359|Cyclosporine|cyclosporine|mesh-list
138935155|NCT00658359|Cyclosporins|cyclosporins|mesh-list
138935156|NCT00658359|Tofacitinib|tofacitinib|mesh-list
138935157|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935158|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301159|NCT00004003|Gemcitabine|gemcitabine|mesh-list
138624618|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
138624619|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
138624621|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935159|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138935160|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
138935161|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935162|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
138935163|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935164|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
138935165|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138935166|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138935167|NCT00658359|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138935168|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138935169|NCT00853450|Clopidogrel|clopidogrel|mesh-list
138935170|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138935171|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138935172|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138935173|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138935174|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
138935175|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138935176|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935177|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935179|NCT04066790|Trastuzumab|trastuzumab|mesh-list
138935180|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138935181|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935182|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
138935183|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
138935184|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
138624678|NCT04609020|Lidocaine|lidocaine|mesh-list
138935185|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935186|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138935187|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138935188|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
138935189|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
138935191|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138624726|NCT04398537|Hormones|hormones|mesh-ancestor
138935193|NCT00724022|Prednisolone|prednisolone|mesh-list
138935194|NCT00724022|Tacrolimus|tacrolimus|mesh-list
138935195|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
138935196|NCT00724022|Basiliximab|basiliximab|mesh-list
138935197|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138935198|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
138935199|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642126|NCT00265733|Paclitaxel|paclitaxel|mesh-list
138935200|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138935202|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935203|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138935204|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
138935206|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138935207|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138624868|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
138935208|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935209|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138935210|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138935211|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
138935212|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138935213|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935214|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
138935215|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138935216|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935217|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138935218|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138935219|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935220|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935221|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935222|NCT00717990|Bevacizumab|bevacizumab|mesh-list
138935223|NCT00717990|Capecitabine|capecitabine|mesh-list
138935224|NCT00717990|Irinotecan|irinotecan|mesh-list
138642181|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138935225|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138935226|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935227|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138624997|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935228|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138935229|NCT00717990|Growth Substances|growth substances|mesh-ancestor
138935230|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935231|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
138935232|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138935233|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
138935234|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935235|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138935236|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138935237|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935238|NCT02572986|Permethrin|permethrin|mesh-list
138935239|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625060|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625066|NCT03449108|Aldesleukin|aldesleukin|mesh-list
138625067|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
138625068|NCT03449108|Nivolumab|nivolumab|mesh-list
138625069|NCT03449108|Fludarabine|fludarabine|mesh-list
138625070|NCT03449108|Ipilimumab|ipilimumab|mesh-list
138625071|NCT03449108|Interleukin-2|interleukin-2|mesh-list
138935240|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935241|NCT00853684|Capecitabine|capecitabine|mesh-list
138935242|NCT00853684|Endostar protein|endostar protein|mesh-list
138935243|NCT00853684|Endostatins|endostatins|mesh-list
138935244|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138935245|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
138935246|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935247|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935248|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138935249|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138625129|NCT03198078|Aripiprazole|aripiprazole|mesh-list
138935250|NCT00853684|Growth Substances|growth substances|mesh-ancestor
138935251|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935252|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
138935253|NCT00723060|Escitalopram|escitalopram|mesh-list
138935254|NCT00723060|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138935255|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138935256|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138935257|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935258|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138935259|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
138935260|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935261|NCT02571140|Teriparatide|teriparatide|mesh-list
138935262|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
138935263|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138935264|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935265|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138935266|NCT00723216|Enoxaparin|enoxaparin|mesh-list
138935267|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
138935268|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138935269|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138935270|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935271|NCT00724178|Vitamin D|vitamin d|mesh-list
138935272|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
138935273|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
138935274|NCT00724178|Calcium|calcium|mesh-list
138935275|NCT00724178|Vitamins|vitamins|mesh-ancestor
138935276|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
138935277|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935278|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138935279|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138935280|NCT00724178|Antacids|antacids|mesh-ancestor
138935281|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935282|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138935283|NCT02546050|Metformin|metformin|mesh-list
138935284|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138935285|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935286|NCT04800224|Propolis|propolis|mesh-list
138935287|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935288|NCT00718146|Vaccines|vaccines|mesh-list
138935289|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
138935290|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935291|NCT00860626|Interferons|interferons|mesh-list
138935292|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935293|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
138935294|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935295|NCT00724256|Ceftibuten|ceftibuten|mesh-list
138935296|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138935297|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935298|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
138935299|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138935301|NCT01005914|Dexamethasone|dexamethasone|mesh-list
138935302|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
138935303|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138935304|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138935305|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
138935306|NCT01005914|Doxorubicin|doxorubicin|mesh-list
138935307|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138935308|NCT01005914|Methotrexate|methotrexate|mesh-list
138625377|NCT02452918|Warfarin|warfarin|mesh-list
138935309|NCT01005914|Vincristine|vincristine|mesh-list
138935310|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
138935311|NCT01005914|Asparaginase|asparaginase|mesh-list
138935312|NCT01005914|Pegaspargase|pegaspargase|mesh-list
138935313|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138935314|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
138935315|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642315|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138935316|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138935317|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138935318|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
138935319|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935320|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935321|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138935322|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138935323|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
138935325|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935326|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138935327|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
138935328|NCT01005914|Hormones|hormones|mesh-ancestor
138935329|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138935330|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138935331|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138935332|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138935333|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138935334|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935335|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138935336|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
138935337|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138935338|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138935339|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
138935340|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
138935341|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138935342|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138935343|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
138935344|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935345|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138935346|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
138587320|NCT05673811|Paclitaxel|paclitaxel|mesh-list
138935347|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
138935348|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
138935349|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138935350|NCT01005914|Protective Agents|protective agents|mesh-ancestor
138935351|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138935352|NCT00854230|Naltrexone|naltrexone|mesh-list
138935353|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138935354|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138935355|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935356|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
138935357|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935358|NCT00861016|Metoprolol|metoprolol|mesh-list
138935359|NCT00861016|Felodipine|felodipine|mesh-list
138935360|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138935361|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138935362|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
138935363|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
138625648|NCT04615702|Hormones|hormones|mesh-ancestor
138935364|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935365|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935366|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138935367|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138935368|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138935369|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
138642398|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138642399|NCT00266591|Topiramate|topiramate|mesh-list
138935370|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138935371|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935372|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138935373|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138935374|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138935375|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
138935376|NCT00721916|Leucovorin|leucovorin|mesh-list
138935377|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
138935378|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935379|NCT00721916|Antidotes|antidotes|mesh-ancestor
138935380|NCT00721916|Protective Agents|protective agents|mesh-ancestor
138935381|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935382|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
138935383|NCT00721916|Vitamins|vitamins|mesh-ancestor
138935384|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
138935385|NCT00861250|Dexamethasone|dexamethasone|mesh-list
138935386|NCT00861250|Bortezomib|bortezomib|mesh-list
138935387|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138935388|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
138935389|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
138935390|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935391|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935392|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138935393|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
138935395|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138935396|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138935397|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935398|NCT00722150|Artesunate|artesunate|mesh-list
138642446|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138935399|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
138935400|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138935401|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138935402|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935403|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935404|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
138935405|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
138935406|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138935407|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
138935408|NCT00861094|Leucovorin|leucovorin|mesh-list
138935409|NCT00861094|Folic Acid|folic acid|mesh-list
138935410|NCT00861094|Fluorouracil|fluorouracil|mesh-list
138935411|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
138935412|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
138935413|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935414|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
138935415|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935416|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138935417|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138935418|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
138935419|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935420|NCT00861094|Antidotes|antidotes|mesh-ancestor
138625866|NCT00563758|Tegaserod|tegaserod|mesh-list
138935421|NCT00861094|Protective Agents|protective agents|mesh-ancestor
138935422|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
138935424|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
138935425|NCT00861094|Hematinics|hematinics|mesh-ancestor
138935426|NCT00807261|Gemcitabine|gemcitabine|mesh-list
138935427|NCT00807261|Docetaxel|docetaxel|mesh-list
138642493|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935428|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138935429|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
138935430|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935431|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935432|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
138935433|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
138935434|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
138935435|NCT04019106|Budesonide|budesonide|mesh-list
138935436|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138935437|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138935438|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138935439|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
138935440|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935441|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935442|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138935443|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
138935444|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
138935445|NCT04019106|Hormones|hormones|mesh-ancestor
138625988|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935446|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138935447|NCT02571608|Metformin|metformin|mesh-list
138935448|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138642542|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138935449|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935450|NCT00865072|Metformin|metformin|mesh-list
138935451|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138935452|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935453|NCT00804297|Octreotide|octreotide|mesh-list
138935454|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138935455|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138935456|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935457|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
138935458|NCT00861328|Irinotecan|irinotecan|mesh-list
138935459|NCT00861328|Camptothecin|camptothecin|mesh-list
138935460|NCT00861328|ON 01910|on 01910|mesh-list
138935461|NCT00861328|Glycine|glycine|mesh-list
138935462|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935463|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138935464|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138935465|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935466|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935467|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138935468|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138935469|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
138935470|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138935471|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935472|NCT00861406|Interferons|interferons|mesh-list
138935473|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
138935474|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
138935475|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138935476|NCT00861406|Vaccines|vaccines|mesh-list
138935477|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
138626067|NCT00248313|Sirolimus|sirolimus|mesh-list
138935478|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935479|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935480|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
138642592|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138642601|NCT00296127|Celecoxib|celecoxib|mesh-list
138935481|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935482|NCT00865384|Mirtazapine|mirtazapine|mesh-list
138935483|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
138935484|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138935485|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138935486|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
138935487|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
138935488|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138935489|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935490|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935491|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138935492|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138935493|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138935494|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138935495|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138935496|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138935497|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
138935498|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138935499|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138935500|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
138935501|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138935502|NCT00724724|Aspirin|aspirin|mesh-list
138935503|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
138935504|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138935505|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138935506|NCT00724724|Analgesics|analgesics|mesh-ancestor
138642637|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642640|NCT00415922|Carbidopa|carbidopa|mesh-list
138935507|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
138935508|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935509|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935510|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138935511|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138935512|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138935513|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138935514|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935515|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138935516|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138935517|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935518|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
138935519|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138935520|NCT00724724|Protective Agents|protective agents|mesh-ancestor
138935521|NCT00865462|Bupropion|bupropion|mesh-list
138935522|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138935523|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
138935524|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138935525|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138935526|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138935527|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138935528|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935529|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
138935530|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138935531|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935532|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138935533|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138935534|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935536|NCT04130204|Gout Suppressants|gout suppressants|mesh-ancestor
138935537|NCT04130204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138935538|NCT04130204|Tubulin Modulators|tubulin modulators|mesh-ancestor
138935539|NCT04130204|Antimitotic Agents|antimitotic agents|mesh-ancestor
138935540|NCT04130204|Mitosis Modulators|mitosis modulators|mesh-ancestor
138935541|NCT04130204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935542|NCT04130204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935543|NCT00723918|Methadone|methadone|mesh-list
138935544|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138935545|NCT00723918|Narcotics|narcotics|mesh-ancestor
138935546|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138935547|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935548|NCT00723918|Analgesics|analgesics|mesh-ancestor
138935549|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
138935550|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935551|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
138935552|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
138935553|NCT00865540|Prednisolone|prednisolone|mesh-list
138935554|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138935555|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
138935556|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138935557|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
138935558|NCT00865540|Ketorolac|ketorolac|mesh-list
138642727|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138935559|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138935560|NCT00865540|Nepafenac|nepafenac|mesh-list
138935561|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138935562|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
138935563|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138935564|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
138935565|NCT00865540|Hormones|hormones|mesh-ancestor
138935566|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138935567|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935568|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138935569|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935570|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
138935571|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
138935572|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935573|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138935574|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138935575|NCT00865540|Protective Agents|protective agents|mesh-ancestor
138935576|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138935577|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138935578|NCT00865540|Analgesics|analgesics|mesh-ancestor
138935579|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
138935580|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138935581|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138935582|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935583|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935584|NCT00865618|Eplerenone|eplerenone|mesh-list
138935585|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138935586|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
138935587|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138935588|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935589|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138935590|NCT00865618|Diuretics|diuretics|mesh-ancestor
138935591|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
138639918|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
138935592|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138935593|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138935594|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
138935595|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138626515|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138935597|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935598|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935599|NCT00655629|Urological Agents|urological agents|mesh-ancestor
138935600|NCT00865696|Mirtazapine|mirtazapine|mesh-list
138935601|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
138935602|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138935603|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138935604|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
138935605|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
138935606|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626569|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
138935607|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935608|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935609|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138935610|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138935611|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138935612|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138626631|NCT04598191|Iloprost|iloprost|mesh-list
138642832|NCT00268970|Satraplatin|satraplatin|mesh-list
138935613|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138935614|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138935615|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
138935616|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138935617|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138935618|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
138935619|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138935621|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
138935622|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935623|NCT02545114|Tolvaptan|tolvaptan|mesh-list
138935624|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138935625|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935626|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
138935627|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935628|NCT00724880|Clopidogrel|clopidogrel|mesh-list
138935629|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138935630|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138935631|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138935632|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138935633|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
138935634|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138935635|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935636|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935637|NCT00724074|Bupivacaine|bupivacaine|mesh-list
138935638|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
138935639|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
138642874|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138935640|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138935641|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935643|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935644|NCT00854776|Lansoprazole|lansoprazole|mesh-list
138935645|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
138935646|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138935647|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138935648|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138935649|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138935650|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935651|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626913|NCT04593706|BB 1101|bb 1101|mesh-list
138935652|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138935653|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
138935654|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935655|NCT00854776|Antacids|antacids|mesh-ancestor
138935656|NCT00798525|Lepirudin|lepirudin|mesh-list
138935657|NCT00798525|Argatroban|argatroban|mesh-list
138935658|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
138935659|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138935660|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
138935661|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935662|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935664|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138935665|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138935666|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138935667|NCT00861640|Omeprazole|omeprazole|mesh-list
138935668|NCT00861640|Rabeprazole|rabeprazole|mesh-list
138935669|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138935670|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138935671|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138935672|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642923|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
138935673|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935674|NCT00724230|Ribavirin|ribavirin|mesh-list
138935675|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138935676|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
138935677|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
138935678|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935679|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
138935680|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935681|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
138935682|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935683|NCT00725036|Insulin|insulin|mesh-list
138935684|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138935685|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
138935686|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
138935687|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
138935688|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
138935689|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138935690|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935691|NCT00724386|Paclitaxel|paclitaxel|mesh-list
138935692|NCT00724386|Vinorelbine|vinorelbine|mesh-list
138935693|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138935694|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935695|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
138935696|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
138935697|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
138935698|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935699|NCT00865852|Metformin|metformin|mesh-list
138935700|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138935701|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935702|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
138935703|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
138935704|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
138935705|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138935706|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935707|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
138935708|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935709|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138935710|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138935711|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935712|NCT00724542|Voglibose|voglibose|mesh-list
138935713|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138639939|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
138935714|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935715|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138935716|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935717|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935718|NCT00724620|Ribavirin|ribavirin|mesh-list
138935719|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138935720|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
138935721|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935722|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
138935723|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935724|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138935725|NCT00866008|Ganirelix|ganirelix|mesh-list
138935726|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
138935727|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138935728|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
138935729|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138935730|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935731|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138935732|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138935733|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935734|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
138935735|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138935737|NCT02571426|Sevoflurane|sevoflurane|mesh-list
138935738|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138935739|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138935740|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935741|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138935742|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
138935743|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
138935744|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138935745|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138935746|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138935747|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935748|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
138935749|NCT00578292|Busulfan|busulfan|mesh-list
138935750|NCT00578292|Fludarabine|fludarabine|mesh-list
138935751|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
138935752|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138935753|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
138935754|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935755|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138935756|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138935757|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
138935758|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935759|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935760|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138935761|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138935762|NCT00861874|Sirolimus|sirolimus|mesh-list
138935763|NCT00861874|Decitabine|decitabine|mesh-list
138935764|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138935765|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
138935766|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935767|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935768|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627479|NCT04584736|Ezetimibe|ezetimibe|mesh-list
138935769|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138935770|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935771|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138935772|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
138935773|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138935774|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
138935775|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935776|NCT05372874|Antiviral Agents|antiviral agents|mesh-list
138935777|NCT05372874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935778|NCT04067856|Dexamethasone|dexamethasone|mesh-list
138935779|NCT04067856|Bevacizumab|bevacizumab|mesh-list
138935780|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138935781|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935782|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138935783|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138935784|NCT04067856|Growth Substances|growth substances|mesh-ancestor
138935785|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935786|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
138935787|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138935788|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
138935789|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
138935790|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935791|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138935792|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
138935793|NCT04067856|Hormones|hormones|mesh-ancestor
138935794|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138935795|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138935796|NCT04042714|Trifluridine|trifluridine|mesh-list
138935797|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
138935798|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935799|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
138935800|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935801|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138643095|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935802|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935803|NCT00725348|R 115866|r 115866|mesh-list
138935804|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138935805|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935806|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935807|NCT00577772|Rifaximin|rifaximin|mesh-list
138935808|NCT00577772|Lactulose|lactulose|mesh-list
138935809|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138935810|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935811|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138935812|NCT00578136|Bupivacaine|bupivacaine|mesh-list
138935813|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
138935814|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
138935815|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138935816|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935817|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
138935818|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935820|NCT00861952|Emollients|emollients|mesh-ancestor
138935821|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
138935822|NCT00655551|Lacosamide|lacosamide|mesh-list
138935823|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
138935824|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138935825|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138935826|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138935827|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935828|NCT00855088|Ritonavir|ritonavir|mesh-list
138935829|NCT00855088|Darunavir|darunavir|mesh-list
138935830|NCT00855088|Etravirine|etravirine|mesh-list
138935831|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138935832|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138935833|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
138935834|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935835|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935837|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138935838|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
138935839|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935840|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138935841|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138935842|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138935843|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138935844|NCT02553603|Hormones|hormones|mesh-list
138935845|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
138935846|NCT02553603|Tesamorelin|tesamorelin|mesh-list
138935847|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138935848|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627916|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
138935849|NCT02553603|Growth Substances|growth substances|mesh-ancestor
138935850|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138935851|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
138935852|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138935853|NCT00804531|Prednisolone|prednisolone|mesh-list
138935854|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
138935855|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138935856|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
138935857|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138935858|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
138935859|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
138935860|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138935861|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935862|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138935863|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
138935864|NCT00804531|Hormones|hormones|mesh-ancestor
138935865|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138935866|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138935867|NCT00804531|Protective Agents|protective agents|mesh-ancestor
138935868|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138935869|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935870|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
138935871|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138935872|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
138935873|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935874|NCT00866866|Expectorants|expectorants|mesh-ancestor
138935875|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
138935876|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138935877|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
138935878|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935879|NCT00866866|Protective Agents|protective agents|mesh-ancestor
138935880|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935881|NCT00866866|Antidotes|antidotes|mesh-ancestor
138935882|NCT00312728|Bevacizumab|bevacizumab|mesh-list
138935883|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138935884|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935885|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138643239|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935886|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138935887|NCT00312728|Growth Substances|growth substances|mesh-ancestor
138935888|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935889|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
138935890|NCT00804921|Bevacizumab|bevacizumab|mesh-list
138935891|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138935892|NCT00804921|Acetazolamide|acetazolamide|mesh-list
138935893|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138935894|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935895|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138935896|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138935897|NCT00804921|Growth Substances|growth substances|mesh-ancestor
138935898|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935899|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
138935900|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138935901|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138935902|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138935903|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138935904|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
138935905|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138935906|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935907|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
138935908|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138935909|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935910|NCT00804921|Diuretics|diuretics|mesh-ancestor
138935911|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
138639977|NCT01601899|Tenofovir|tenofovir|mesh-list
138935913|NCT00866944|Fluorouracil|fluorouracil|mesh-list
138935914|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
138935915|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138628307|NCT00225173|Hormones|hormones|mesh-ancestor
138935916|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
138935917|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935918|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138935919|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138935920|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138935921|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
138643283|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
138643284|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
138935922|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935924|NCT00866944|Protective Agents|protective agents|mesh-ancestor
138935925|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
138935926|NCT00866944|Vitamins|vitamins|mesh-ancestor
138935927|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
138935928|NCT00577824|Exenatide|exenatide|mesh-list
138935929|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138935930|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935933|NCT00577824|Hormones|hormones|mesh-ancestor
138935934|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138935935|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
138935936|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
138935937|NCT04046289|Calcium|calcium|mesh-list
138935938|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138935939|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935940|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138935941|NCT04046289|Antacids|antacids|mesh-ancestor
138935942|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935943|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138935944|NCT00807807|Folic Acid|folic acid|mesh-list
138935945|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
138935946|NCT00807807|Hematinics|hematinics|mesh-ancestor
138935947|NCT00807807|Vitamins|vitamins|mesh-ancestor
138935948|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
138935949|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935968|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138935969|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
138935970|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138935971|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138935972|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138935973|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138935974|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935975|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138935976|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138639981|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
138416459|NCT01665248|Listerine|listerine|mesh-list
138935977|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138935978|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
138935979|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138935980|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
138935981|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138935982|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
138935983|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138935984|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935985|NCT00730418|Doxazosin|doxazosin|mesh-list
138935986|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138935987|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138935988|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138935989|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138935990|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
138935991|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628674|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935992|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138935993|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138935994|NCT00805233|Bromfenac|bromfenac|mesh-list
138935995|NCT00805233|Ranibizumab|ranibizumab|mesh-list
138935996|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138935997|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138935998|NCT00805233|Growth Substances|growth substances|mesh-ancestor
138935999|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936000|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
138936001|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936002|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138936003|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138936004|NCT00805233|Analgesics|analgesics|mesh-ancestor
138936005|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
138936006|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936007|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936008|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138936009|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
138936010|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138936011|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138936012|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936013|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138936014|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138936015|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
138936016|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936017|NCT00725400|Cetuximab|cetuximab|mesh-list
138936018|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138936019|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936020|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
138936021|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138936022|NCT00798915|Incretins|incretins|mesh-ancestor
138936023|NCT00798915|Hormones|hormones|mesh-ancestor
138936024|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138936025|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936026|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
138936027|NCT00798993|Vitamin D|vitamin d|mesh-list
138936028|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138936029|NCT00798993|Calcifediol|calcifediol|mesh-list
138936030|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138587989|NCT04486352|Ipatasertib|ipatasertib|mesh-list
138936031|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936032|NCT00798993|Vitamins|vitamins|mesh-ancestor
138936033|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
138936034|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138936036|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138936037|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936038|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138936039|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138936040|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138936041|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936043|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936045|NCT00862264|Norflurane|norflurane|mesh-list
138936046|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
138936047|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138936048|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
138936049|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936050|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936051|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138936052|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
138936053|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138936054|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138936055|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138936056|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
138936057|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936058|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936059|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936060|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
138936061|NCT00862264|Hormones|hormones|mesh-ancestor
138936062|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138936063|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
138936064|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138936065|NCT00730574|Vitamins|vitamins|mesh-list
138936066|NCT00730574|Folic Acid|folic acid|mesh-list
138936067|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
138936068|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
138936069|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
138936070|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
138936071|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936072|NCT00730574|Hematinics|hematinics|mesh-ancestor
138936073|NCT00870532|Sorafenib|sorafenib|mesh-list
138628842|NCT00255762|Paclitaxel|paclitaxel|mesh-list
138936075|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936076|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138936077|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643440|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138936078|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936079|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138936080|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
138936081|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
138936082|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
138936083|NCT00725478|Piribedil|piribedil|mesh-list
138936084|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138936085|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138936086|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
138936087|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
138936088|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936089|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936090|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936092|NCT01951274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138936093|NCT01951274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936094|NCT01951274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936095|NCT01951274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936096|NCT03355794|Everolimus|everolimus|mesh-list
138936097|NCT03355794|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138936098|NCT03355794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138936099|NCT03355794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936100|NCT03355794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936101|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138936102|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
138628951|NCT00226694|Citalopram|citalopram|mesh-list
138936103|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936104|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936105|NCT01487174|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138936106|NCT01487174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936107|NCT01487174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138936108|NCT01487174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936109|NCT01487174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936110|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138936111|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138643481|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138936112|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936113|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138936114|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936115|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936116|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
138936117|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936118|NCT00617344|Vaccines|vaccines|mesh-list
138936119|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
138936120|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936121|NCT00862342|Bevacizumab|bevacizumab|mesh-list
138936122|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138936123|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936124|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138629064|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
138936125|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138936126|NCT00862342|Growth Substances|growth substances|mesh-ancestor
138936127|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936128|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
138936129|NCT02544724|Interleukin-12|interleukin-12|mesh-list
138936130|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138936131|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
138936132|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936133|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138936134|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138936135|NCT02544724|Growth Substances|growth substances|mesh-ancestor
138936136|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
138643522|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138936137|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936138|NCT00862420|Ticlopidine|ticlopidine|mesh-list
138936139|NCT00862420|Clopidogrel|clopidogrel|mesh-list
138936140|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138629122|NCT00227747|Capecitabine|capecitabine|mesh-list
138936141|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138936142|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138936143|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138936144|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
138936145|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936146|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936147|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936148|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138936149|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138936150|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138936151|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138936152|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936153|NCT00321698|Docetaxel|docetaxel|mesh-list
138936154|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936155|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
138936156|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
138936158|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936159|NCT02569970|Fluoxetine|fluoxetine|mesh-list
138936160|NCT02569970|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138936161|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138936162|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138936163|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936164|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936165|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
138629244|NCT00236145|Fentanyl|fentanyl|mesh-list
138936166|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936167|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138936168|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
138643569|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936169|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138936170|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138936171|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138936172|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936173|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138936174|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
138936175|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138936176|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138936177|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936178|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936179|NCT00725790|Urological Agents|urological agents|mesh-ancestor
138936180|NCT00731276|Irinotecan|irinotecan|mesh-list
138936181|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138936182|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138936183|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936184|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936185|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936186|NCT00725946|Iodine|iodine|mesh-list
138936187|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
138936188|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138936189|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936190|NCT00725946|Trace Elements|trace elements|mesh-ancestor
138936191|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
138936192|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936193|NCT02569346|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
138936194|NCT02569346|Lamivudine|lamivudine|mesh-list
138936195|NCT02569346|Abacavir|abacavir|mesh-list
138936196|NCT02569346|Dolutegravir|dolutegravir|mesh-list
138936197|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138936198|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138936199|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
138936200|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936201|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138936202|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138936203|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936204|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936205|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138936206|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138936207|NCT00726804|Adalimumab|adalimumab|mesh-list
138936208|NCT00726804|Etanercept|etanercept|mesh-list
138936209|NCT00726804|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138640052|NCT00290628|Melphalan|melphalan|mesh-list
138936210|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936211|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138643611|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138936212|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138936213|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138936214|NCT00726804|Analgesics|analgesics|mesh-ancestor
138936215|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
138936216|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629504|NCT00236301|Estradiol|estradiol|mesh-list
138936217|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936218|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138936219|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138936220|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
138936221|NCT00726960|Buprenorphine|buprenorphine|mesh-list
138936222|NCT00726960|Aprepitant|aprepitant|mesh-list
138936223|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138936224|NCT00726960|Narcotics|narcotics|mesh-ancestor
138936225|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138936226|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936228|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
138936229|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936230|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138936231|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
138936232|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
138936233|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138936234|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138936235|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936236|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936237|NCT00727038|Ranibizumab|ranibizumab|mesh-list
138936238|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138643639|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
138936239|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138936240|NCT00727038|Growth Substances|growth substances|mesh-ancestor
138936241|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936242|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
138936243|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936244|NCT00726258|Ketamine|ketamine|mesh-list
138936245|NCT00726258|Analgesics|analgesics|mesh-ancestor
138936246|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
138936247|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936248|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936249|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138936250|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138936251|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
138936252|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
138936253|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629686|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138936254|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138936255|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138936256|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936257|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936258|NCT02569814|Amlodipine|amlodipine|mesh-list
138936259|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138936260|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138936261|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138936262|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138936263|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936264|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138936265|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936266|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
138936267|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138936268|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138936269|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
138936270|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138936271|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138936272|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936273|NCT00726570|Heparin|heparin|mesh-list
138936274|NCT00726570|Calcium heparin|calcium heparin|mesh-list
138936275|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138936276|NCT00726570|Tinzaparin|tinzaparin|mesh-list
138936277|NCT00726570|Dalteparin|dalteparin|mesh-list
138936278|NCT00726570|Anticoagulants|anticoagulants|mesh-list
138936279|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138936280|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138629813|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138936281|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936282|NCT00726726|Vitamin K|vitamin k|mesh-list
138936283|NCT00726726|Midazolam|midazolam|mesh-list
138936284|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
138936285|NCT00726726|Caffeine|caffeine|mesh-list
138936286|NCT00726726|Omeprazole|omeprazole|mesh-list
138936287|NCT00726726|Warfarin|warfarin|mesh-list
138936288|NCT00726726|BMS 708163|bms 708163|mesh-list
138936289|NCT00726726|Vitamins|vitamins|mesh-ancestor
138936290|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
138936291|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936292|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138936293|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138936294|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138936295|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138936296|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138936297|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138936298|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138936299|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
138936300|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
138936301|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
138936302|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
138936303|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936304|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936305|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
138629937|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936306|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138936307|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138936308|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936309|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138936310|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138936311|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
138936312|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138936313|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138936314|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138936315|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138936316|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138936317|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
138936318|NCT00726726|Coagulants|coagulants|mesh-ancestor
138936319|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
138936320|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
138643724|NCT00418782|Naproxen|naproxen|mesh-list
138936321|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138936322|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138936323|NCT00726726|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138936324|NCT00654381|Inositol|inositol|mesh-list
138936325|NCT00654381|Linagliptin|linagliptin|mesh-list
138936326|NCT00654381|Voglibose|voglibose|mesh-list
138936327|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138936328|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936329|NCT00654381|Incretins|incretins|mesh-ancestor
138936330|NCT00654381|Hormones|hormones|mesh-ancestor
138936331|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138936332|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138936333|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
138936334|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936335|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936336|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138936337|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
138936339|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
138936340|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
138936341|NCT04018482|Povidone|povidone|mesh-list
138936342|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
138936343|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
138936344|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138936345|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936347|NCT00805311|Losartan|losartan|mesh-list
138936348|NCT00805311|Amlodipine|amlodipine|mesh-list
138936349|NCT00805311|Atorvastatin|atorvastatin|mesh-list
138936350|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138936351|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138936352|NCT00805311|Analgesics|analgesics|mesh-ancestor
138936353|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
138936354|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936355|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936356|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936357|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138936358|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138936360|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936361|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138936362|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138936363|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936364|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
138936365|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138936366|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138936367|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
138936368|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138936369|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138936370|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138936371|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138936372|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138936373|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138936374|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
138936375|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138936376|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138936377|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138936378|NCT00732290|Fluoxetine|fluoxetine|mesh-list
138936379|NCT00732290|Clopidogrel|clopidogrel|mesh-list
138936380|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138936381|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138643795|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936382|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138936383|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138936384|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
138936385|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936386|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936387|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936388|NCT00732290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138936389|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138936390|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138936391|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
138936392|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138936393|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
138936394|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138936395|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138936396|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138936398|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138936399|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
138936400|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936401|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
138936402|NCT00732446|Dexamethasone|dexamethasone|mesh-list
138211251|NCT00370838|Analgesics|analgesics|mesh-ancestor
138588380|NCT03647111|Crizotinib|crizotinib|mesh-list
138936404|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138936405|NCT00732446|BB 1101|bb 1101|mesh-list
138936406|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936407|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
138936408|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
138936409|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936410|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936411|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138936412|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
138936413|NCT00732446|Hormones|hormones|mesh-ancestor
138936414|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138936415|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138936416|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936417|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
138936418|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630424|NCT00202163|Androgens|androgens|mesh-ancestor
138936419|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936420|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138936421|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936422|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138936423|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138936424|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138936425|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
138936426|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138936427|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138936428|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138936429|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138936431|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138936432|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936433|NCT00657267|Temozolomide|temozolomide|mesh-list
138936434|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138936435|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
138936436|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936437|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936438|NCT00733850|Gemcitabine|gemcitabine|mesh-list
138936439|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138936440|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
138936441|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936442|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936443|NCT00727766|Clofarabine|clofarabine|mesh-list
138936444|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138936445|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
138936446|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936447|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936448|NCT00799071|Posaconazole|posaconazole|mesh-list
138630558|NCT00477607|Vitamins|vitamins|mesh-ancestor
138936449|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
138238019|NCT06132685|BB 1101|bb 1101|mesh-list
138936450|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936451|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138936452|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138936453|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138936454|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138936455|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138936456|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936457|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936458|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138936459|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
138936460|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138936461|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936462|NCT00732836|Paclitaxel|paclitaxel|mesh-list
138936463|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138936464|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138936465|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936466|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
138936467|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
138936468|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
138936469|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936470|NCT00799149|Etoricoxib|etoricoxib|mesh-list
138936471|NCT00799149|Gabapentin|gabapentin|mesh-list
138936472|NCT00799149|Analgesics|analgesics|mesh-ancestor
138936473|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
138936474|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936475|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936476|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
138936477|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138936478|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138936479|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138936480|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138643919|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936481|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138936482|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138936483|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936484|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936485|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
138936486|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138936487|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138936488|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936489|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138936490|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138936491|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138936492|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936494|NCT00732914|Sunitinib|sunitinib|mesh-list
138936495|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936496|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138936497|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936498|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936499|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138936500|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138936501|NCT00732914|Growth Substances|growth substances|mesh-ancestor
138936502|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936503|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
138936504|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
138936505|NCT00808275|Calcium|calcium|mesh-list
138936506|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138936507|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936508|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138936509|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
138936510|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138936511|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138643959|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
138936512|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138936513|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138936514|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936515|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936516|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936517|NCT00728000|Gemcitabine|gemcitabine|mesh-list
138936518|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
138936519|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138936520|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138936521|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
138936522|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936523|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936524|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138936525|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936526|NCT04065230|Tenofovir|tenofovir|mesh-list
138936527|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
138936528|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936529|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138936530|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138936531|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936532|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936533|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138936534|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138936535|NCT00728078|Thalidomide|thalidomide|mesh-list
138936536|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138936537|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
138936538|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936539|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
138936540|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138936541|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936542|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138936543|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138936544|NCT00728078|Growth Substances|growth substances|mesh-ancestor
138936545|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
138936546|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936547|NCT04066088|Guanfacine|guanfacine|mesh-list
138936548|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138936549|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138936550|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138936551|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138936552|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
138936553|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644006|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
138936554|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936555|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936556|NCT00733148|Insulin|insulin|mesh-list
138936557|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138936558|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936559|NCT00730392|Etanercept|etanercept|mesh-list
138936560|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138936561|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138936562|NCT00730392|Analgesics|analgesics|mesh-ancestor
138936563|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
138936564|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936565|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936566|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936567|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138936568|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138936569|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138936570|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
138936571|NCT01528046|Metformin|metformin|mesh-list
138936572|NCT01528046|Irinotecan|irinotecan|mesh-list
138936573|NCT01528046|Camptothecin|camptothecin|mesh-list
138936574|NCT01528046|Vincristine|vincristine|mesh-list
138936575|NCT01528046|Temozolomide|temozolomide|mesh-list
138630811|NCT04559074|Amlodipine|amlodipine|mesh-list
138936576|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138936577|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936578|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138936579|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138936580|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936581|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936582|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936583|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138936584|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
138644038|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
138936585|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
138640126|NCT00290667|Prednisone|prednisone|mesh-list
138936586|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
138936587|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138936588|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
138936589|NCT00652899|Aldesleukin|aldesleukin|mesh-list
138936590|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
138936591|NCT00652899|Fludarabine|fludarabine|mesh-list
138936592|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
138936593|NCT00652899|Interleukin-2|interleukin-2|mesh-list
138936594|NCT00652899|Allopurinol|allopurinol|mesh-list
138936595|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138936596|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
138936597|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936598|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138936599|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138936600|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
138936601|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936602|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936603|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138936604|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138644079|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138320717|NCT03817320|Vincristine|vincristine|mesh-list
138936605|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
138936606|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
138936607|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936608|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138936610|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
138936611|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936612|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138936613|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138936614|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936615|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
138936616|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138936617|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
138936618|NCT00652899|Protective Agents|protective agents|mesh-ancestor
138936619|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
138936620|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138936621|NCT04066452|Antibodies|antibodies|mesh-list
138936622|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
138936623|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936624|NCT00728520|Azacitidine|azacitidine|mesh-list
138936625|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138936627|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936628|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936629|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936630|NCT04065308|Daratumumab|daratumumab|mesh-list
138936631|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936632|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
138936633|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138936634|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936635|NCT00728156|Clopidogrel|clopidogrel|mesh-list
138936636|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138936637|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138936638|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138936639|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138936640|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
138936641|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936642|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644130|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644132|NCT00274898|Docetaxel|docetaxel|mesh-list
138644134|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
138936643|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936644|NCT02569554|Rabeprazole|rabeprazole|mesh-list
138936645|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138936646|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138936647|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138936648|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936649|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936652|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
138936653|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138936654|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
138936655|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936656|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936657|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138936658|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
138936659|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138936660|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138936661|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138936662|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
138644167|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138644190|NCT00277550|Tegaserod|tegaserod|mesh-list
138936663|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936664|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936665|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936666|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
138936667|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138936668|NCT00733616|Docetaxel|docetaxel|mesh-list
138936669|NCT00733616|Capecitabine|capecitabine|mesh-list
138631168|NCT00259896|Exenatide|exenatide|mesh-list
138936670|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
138936671|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936672|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
138936673|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
138936674|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
138936675|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936676|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138936677|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
138936678|NCT00728832|Morphine|morphine|mesh-list
138936679|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138936680|NCT00728832|Narcotics|narcotics|mesh-ancestor
138936681|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138936682|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936683|NCT00728832|Analgesics|analgesics|mesh-ancestor
138936684|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
138936685|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936686|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138936688|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
138936689|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138936690|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138936691|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138936692|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138936693|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936694|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
138936695|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
138936696|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936697|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644224|NCT00277706|Calcium|calcium|mesh-list
138644225|NCT00277706|Vitamins|vitamins|mesh-ancestor
138936698|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138936699|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138936700|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
138936701|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138936702|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138936703|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138640155|NCT01602757|Lidocaine|lidocaine|mesh-list
138936704|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138936706|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
138936707|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138936708|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936709|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138936710|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138936711|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
138631281|NCT00267540|Vitamins|vitamins|mesh-ancestor
138936712|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936713|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138936714|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138936715|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
138936716|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936717|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138936718|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138936719|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138936720|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
138936721|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644264|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
138936722|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138936723|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138936724|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936725|NCT04066296|Bupivacaine|bupivacaine|mesh-list
138936726|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
138936727|NCT04066296|Anesthetics|anesthetics|mesh-list
138936728|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138936729|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936730|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
138936731|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936732|NCT02341014|Lenalidomide|lenalidomide|mesh-list
138936733|NCT02341014|Romidepsin|romidepsin|mesh-list
138936734|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
138936735|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936736|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138936737|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138936738|NCT02341014|Growth Substances|growth substances|mesh-ancestor
138936739|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
138936740|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936741|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138936742|NCT02341014|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138936743|NCT02341014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936744|NCT02341014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936745|NCT00868426|Budesonide|budesonide|mesh-list
138644321|NCT00278369|Aldesleukin|aldesleukin|mesh-list
138936746|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
138936747|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138936748|NCT00868426|Charcoal|charcoal|mesh-list
138936749|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936750|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138936751|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
138936752|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936753|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936754|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138936755|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
138936756|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
138936757|NCT00868426|Hormones|hormones|mesh-ancestor
138936758|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138936759|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138936760|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138936761|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138936762|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
138936763|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936764|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936765|NCT00868426|Antidotes|antidotes|mesh-ancestor
138936766|NCT00868426|Protective Agents|protective agents|mesh-ancestor
138936767|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
138936768|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
138936769|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936770|NCT00868738|Vitamin D|vitamin d|mesh-list
138936771|NCT00868738|Vitamins|vitamins|mesh-ancestor
138936772|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
138644364|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
138936773|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936774|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138936776|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936778|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138936779|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936780|NCT00868894|Latanoprost|latanoprost|mesh-list
138936781|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138936782|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138936783|NCT00730938|Cefuroxime|cefuroxime|mesh-list
138936784|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
138936785|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138936786|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936787|NCT00712010|Caseins|caseins|mesh-list
138936788|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
138936789|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
138936790|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936791|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
138936792|NCT00731016|Pravastatin|pravastatin|mesh-list
138936793|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138936794|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936795|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138936796|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138936797|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
138644412|NCT00315861|Topotecan|topotecan|mesh-list
138644413|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936798|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936799|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138936800|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138936801|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936802|NCT00799539|Prednisone|prednisone|mesh-list
138936803|NCT00799539|Bortezomib|bortezomib|mesh-list
138936804|NCT00799539|Melphalan|melphalan|mesh-list
138936805|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936806|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
138936807|NCT00799539|Hormones|hormones|mesh-ancestor
138936808|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138936809|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936810|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138936811|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936812|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138936813|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
138936814|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936815|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138936816|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138936817|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
138936818|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
138936819|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
138936820|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138936821|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
138936822|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936823|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138936824|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138936825|NCT00738842|Ticagrelor|ticagrelor|mesh-list
138644465|NCT00279266|Vitamins|vitamins|mesh-ancestor
138936826|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138936827|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138936828|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138936829|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138936830|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
138936831|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936832|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936833|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936834|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
138936835|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138936836|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936837|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138936838|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138936839|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936840|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936841|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936842|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138936843|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138936844|NCT00729222|Rolofylline|rolofylline|mesh-list
138936845|NCT00729222|Diuretics|diuretics|mesh-ancestor
138644510|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138936846|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
138936847|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936848|NCT00808743|Celecoxib|celecoxib|mesh-list
138936849|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138936850|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138936851|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138588829|NCT01902173|Trametinib|trametinib|mesh-list
138936853|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
138936854|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936855|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936856|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936857|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138936858|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138936859|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138936860|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936861|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936862|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138936863|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138936864|NCT00869596|Fluticasone|fluticasone|mesh-list
138936865|NCT00869596|Xhance|xhance|mesh-list
138936866|NCT00869596|Albuterol|albuterol|mesh-list
138936867|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936868|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138936869|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
138936870|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936871|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936872|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138936873|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
138936874|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
138644561|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138936875|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138936877|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138936878|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138936879|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138936880|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138936881|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
138936882|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936883|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936884|NCT03743376|UB-421|ub-421|mesh-list
138936885|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138936886|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
138936887|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138936888|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
138936889|NCT03728478|Etanercept|etanercept|mesh-list
138936890|NCT03728478|Methotrexate|methotrexate|mesh-list
138936891|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138936892|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
138936893|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138936894|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936895|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138936896|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
138936897|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936898|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936899|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
138936900|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936901|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138936902|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138936903|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
138644618|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
138936904|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138936905|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138936906|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138936907|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138936908|NCT03728478|Analgesics|analgesics|mesh-ancestor
138936909|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
138936910|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936911|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936912|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138936913|NCT00653523|Simvastatin|simvastatin|mesh-list
138936914|NCT00653523|Ezetimibe|ezetimibe|mesh-list
138936915|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138936916|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138936917|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
138936918|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936919|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138936920|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138936921|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936922|NCT00808977|Mesalamine|mesalamine|mesh-list
138936923|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138640210|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
138936924|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138936925|NCT00808977|Analgesics|analgesics|mesh-ancestor
138936926|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
138936927|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936928|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936929|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936930|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138936931|NCT00735020|Vaccines|vaccines|mesh-list
138644659|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138936932|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
138936933|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936934|NCT04065906|Methylphenidate|methylphenidate|mesh-list
138936935|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138936936|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138936937|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936938|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138936939|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138936940|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138936941|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936942|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
138936943|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138936944|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138936945|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
138936946|NCT00739388|Azacitidine|azacitidine|mesh-list
138936947|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138936948|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
138936949|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936950|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936951|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936952|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
138936953|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
138936954|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138936955|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138936956|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936957|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936958|NCT00862888|Urological Agents|urological agents|mesh-ancestor
138936959|NCT00729170|Calcium|calcium|mesh-list
138936960|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138936961|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936962|NCT00862966|Heparin|heparin|mesh-list
138644728|NCT00416819|Vitamins|vitamins|mesh-ancestor
138936963|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
138936964|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936965|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138936966|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138936967|NCT02569320|Dexamethasone|dexamethasone|mesh-list
138936968|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
138936969|NCT02569320|Pomalidomide|pomalidomide|mesh-list
138936970|NCT02569320|Ichthammol|ichthammol|mesh-list
138936971|NCT02569320|BB 1101|bb 1101|mesh-list
138936972|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138936973|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138936974|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
138936975|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
138936976|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138936977|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936978|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138936980|NCT02569320|Hormones|hormones|mesh-ancestor
138936981|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138936982|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138936983|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138936984|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
138936985|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138936986|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138936987|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
138936988|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138640244|NCT01603108|Rifaximin|rifaximin|mesh-list
138936989|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138936990|NCT02569320|Growth Substances|growth substances|mesh-ancestor
138936991|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
138936992|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
138936993|NCT00739466|Alendronate|alendronate|mesh-list
138644779|NCT00280358|Xhance|xhance|mesh-list
138936994|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138936995|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138936996|NCT00869908|Insulin|insulin|mesh-list
138936997|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138936998|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
138936999|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
138937000|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138937001|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
138937003|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138937004|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937005|NCT00739622|Rilpivirine|rilpivirine|mesh-list
138937006|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138937007|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138937008|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937009|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937010|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
138937011|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937012|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138937013|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138937014|NCT00731562|Varenicline|varenicline|mesh-list
138937015|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138937016|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138937017|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
138937018|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138937019|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937020|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937021|NCT00870142|Amlodipine|amlodipine|mesh-list
138937022|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138937023|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138937024|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138644796|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
138937025|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937026|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138937027|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937028|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
138937029|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138937030|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138937031|NCT00870220|Estradiol|estradiol|mesh-list
138937032|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138937034|NCT00870220|Hormones|hormones|mesh-ancestor
138937035|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138937036|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937037|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138937038|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
138937039|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138937040|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138937041|NCT00729768|Cyclosporine|cyclosporine|mesh-list
138937042|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
138937043|NCT00729768|Cyclosporins|cyclosporins|mesh-list
138937044|NCT00729768|Basiliximab|basiliximab|mesh-list
138937045|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937046|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937047|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138937048|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
138937049|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937050|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
138937051|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937052|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
138937053|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138937054|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138937055|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138937056|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937057|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138937058|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
138937059|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138937060|NCT00871156|Chloroquine|chloroquine|mesh-list
138937061|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138937062|NCT00871156|Tafenoquine|tafenoquine|mesh-list
138937063|NCT00871156|Amebicides|amebicides|mesh-ancestor
138937064|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138937065|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138937066|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937067|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
138937068|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138937069|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138937070|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138937072|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
138937073|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937074|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937075|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138937076|NCT00871156|Filaricides|filaricides|mesh-ancestor
138937077|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
138937078|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
138937079|NCT00734448|Inositol|inositol|mesh-list
138937080|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
138937081|NCT00734448|Vitamins|vitamins|mesh-ancestor
138937082|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
138937083|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937084|NCT00734526|Temozolomide|temozolomide|mesh-list
138937085|NCT00734526|Sorafenib|sorafenib|mesh-list
138937086|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138937088|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937089|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937090|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138937091|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937092|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138937093|NCT00729404|Gestodene|gestodene|mesh-list
138937094|NCT00729404|Femovan|femovan|mesh-list
138937095|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138937096|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138937097|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138937098|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
138937099|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138937100|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937101|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138937102|NCT00729404|Estrogens|estrogens|mesh-ancestor
138937103|NCT00729404|Hormones|hormones|mesh-ancestor
138937104|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138937105|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138937106|NCT00729404|Progestins|progestins|mesh-ancestor
138937107|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138937108|NCT00731952|Bortezomib|bortezomib|mesh-list
138937109|NCT00731952|Vorinostat|vorinostat|mesh-list
138937110|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937111|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138937112|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937113|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937114|NCT04065932|Deucravacitinib|deucravacitinib|mesh-list
138937115|NCT04065932|Famotidine|famotidine|mesh-list
138937116|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138644926|NCT00317187|Vaccines|vaccines|mesh-list
138937117|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138937118|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138937119|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
138937120|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
138937121|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138937122|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937123|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937124|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
138937125|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138937126|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937128|NCT06147648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138937129|NCT06147648|Immunologic Factors|immunologic factors|mesh-ancestor
138937130|NCT06147648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937131|NCT06147648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138937132|NCT06147648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937133|NCT06147648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937134|NCT06147505|Temozolomide|temozolomide|mesh-list
138937135|NCT06147505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138937136|NCT06147505|Alkylating Agents|alkylating agents|mesh-ancestor
138937137|NCT06147505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937138|NCT06147505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937139|NCT06147375|Cyclosporine|cyclosporine|mesh-list
138937140|NCT06147375|Tacrolimus|tacrolimus|mesh-list
138937141|NCT06147375|Cyclosporins|cyclosporins|mesh-list
138937142|NCT06147375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138937143|NCT06147375|Immunologic Factors|immunologic factors|mesh-ancestor
138644970|NCT00417014|Prednisolone|prednisolone|mesh-list
138937144|NCT06147375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937145|NCT06147375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138937146|NCT06147375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937147|NCT06147375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937148|NCT06147375|Antifungal Agents|antifungal agents|mesh-ancestor
138937149|NCT06147375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937150|NCT06147375|Dermatologic Agents|dermatologic agents|mesh-ancestor
138937151|NCT06147375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138937152|NCT06147232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138937153|NCT06147232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138937154|NCT06147232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937155|NCT06147232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138937156|NCT06147232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937158|NCT06147050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138937159|NCT06147050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937160|NCT06146972|Tofacitinib|tofacitinib|mesh-list
138937161|NCT06146972|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138937162|NCT06146972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138937163|NCT06146972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937164|NCT06146972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937165|NCT06146920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138645014|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138937166|NCT06146920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937167|NCT06146920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138937168|NCT06146920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937169|NCT06146881|Hyaluronic Acid|hyaluronic acid|mesh-list
138937170|NCT06146881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138937171|NCT06146881|Immunologic Factors|immunologic factors|mesh-ancestor
138937172|NCT06146881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937173|NCT06146881|Viscosupplements|viscosupplements|mesh-ancestor
138937174|NCT06146881|Protective Agents|protective agents|mesh-ancestor
138937175|NCT06146842|Bupivacaine|bupivacaine|mesh-list
138937176|NCT06146842|Anesthetics, Local|anesthetics, local|mesh-ancestor
138937177|NCT06146842|Anesthetics|anesthetics|mesh-ancestor
138937178|NCT06146842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138937179|NCT06146842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937181|NCT06146842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937182|NCT06146751|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138937183|NCT06146751|Hematinics|hematinics|mesh-ancestor
138937184|NCT06146751|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138645065|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138937185|NCT06146751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138937186|NCT06146478|Thalidomide|thalidomide|mesh-list
138937187|NCT06146478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138937188|NCT06146478|Immunologic Factors|immunologic factors|mesh-ancestor
138937189|NCT06146478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937190|NCT06146478|Leprostatic Agents|leprostatic agents|mesh-ancestor
138937191|NCT06146478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138937192|NCT06146478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937193|NCT06146478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138937194|NCT06146478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138937195|NCT06146478|Growth Substances|growth substances|mesh-ancestor
138937196|NCT06146478|Growth Inhibitors|growth inhibitors|mesh-ancestor
138632286|NCT00235898|Antidotes|antidotes|mesh-ancestor
138937197|NCT06146478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937198|NCT06146309|Aflibercept|aflibercept|mesh-list
138937199|NCT06146309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138937200|NCT06146309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138937201|NCT06146309|Growth Substances|growth substances|mesh-ancestor
138937202|NCT06146309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937203|NCT06146309|Growth Inhibitors|growth inhibitors|mesh-ancestor
138937204|NCT06146309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937205|NCT06146296|Vitamins|vitamins|mesh-list
138937206|NCT06146296|Ascorbic Acid|ascorbic acid|mesh-list
138937207|NCT06146296|Micronutrients|micronutrients|mesh-ancestor
138937208|NCT06146296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937209|NCT06146296|Antioxidants|antioxidants|mesh-ancestor
138937210|NCT06146296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937211|NCT06146296|Protective Agents|protective agents|mesh-ancestor
138937212|NCT06146192|Colchicine|colchicine|mesh-list
138937213|NCT06146192|Gout Suppressants|gout suppressants|mesh-ancestor
138937214|NCT06146192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138937215|NCT06146192|Tubulin Modulators|tubulin modulators|mesh-ancestor
138937216|NCT06146192|Antimitotic Agents|antimitotic agents|mesh-ancestor
138937217|NCT06146192|Mitosis Modulators|mitosis modulators|mesh-ancestor
138937218|NCT06146192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645120|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
138937219|NCT06146192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937220|NCT06145958|Hormones|hormones|mesh-list
138937221|NCT06145958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138937222|NCT06145958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937223|NCT06145854|Cabotegravir|cabotegravir|mesh-list
138937224|NCT06145854|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138937225|NCT06145854|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138937226|NCT06145854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937227|NCT06145854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937228|NCT06145854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138937229|NCT06145854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138937230|NCT06145854|Antiviral Agents|antiviral agents|mesh-ancestor
138937231|NCT06145854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937233|NCT06145633|Vorinostat|vorinostat|mesh-list
138937234|NCT06145633|Edetic Acid|edetic acid|mesh-list
138937235|NCT06145633|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138937236|NCT06145633|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138937237|NCT06145633|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138937238|NCT06145633|177Lu-PSMA-617|177lu-psma-617|mesh-list
138937239|NCT06145633|Chelating Agents|chelating agents|mesh-ancestor
138937240|NCT06145633|Sequestering Agents|sequestering agents|mesh-ancestor
138937241|NCT06145633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937242|NCT06145633|Anticoagulants|anticoagulants|mesh-ancestor
138937243|NCT06145633|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138937244|NCT06145633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937245|NCT06145633|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138937246|NCT06145633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937247|NCT06145633|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138937248|NCT06145633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937249|NCT06145633|Antimetabolites|antimetabolites|mesh-ancestor
138937250|NCT06145633|Antiviral Agents|antiviral agents|mesh-ancestor
138937251|NCT06145490|Caffeine|caffeine|mesh-list
138937252|NCT06145490|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138937253|NCT06145490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937254|NCT06145490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138640282|NCT00271284|Insulin|insulin|mesh-list
138937255|NCT06145490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937256|NCT06145490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937257|NCT06145490|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138937258|NCT06145490|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138937259|NCT06145490|Purinergic Agents|purinergic agents|mesh-ancestor
138937260|NCT06145490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138937261|NCT06145438|Leuprolide|leuprolide|mesh-list
138937262|NCT06145438|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138937263|NCT06145438|Dienogest|dienogest|mesh-list
138937264|NCT06145438|Medroxyprogesterone|medroxyprogesterone|mesh-list
138937265|NCT06145438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138937266|NCT06145438|Contraceptive Agents|contraceptive agents|mesh-list
138937267|NCT06145438|Contraceptives, Oral|contraceptives, oral|mesh-list
138937268|NCT06145438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138645212|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138937269|NCT06145438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138937270|NCT06145438|Fertility Agents|fertility agents|mesh-ancestor
138937271|NCT06145438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138937272|NCT06145438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937273|NCT06145438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138937274|NCT06145438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937275|NCT06145438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138937276|NCT06145438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138937277|NCT06145438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138937278|NCT06145438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138937279|NCT06145438|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138937280|NCT06145438|Hormone Antagonists|hormone antagonists|mesh-ancestor
138937281|NCT06145438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138937282|NCT06145438|Estrogens|estrogens|mesh-ancestor
138937283|NCT06145438|Hormones|hormones|mesh-ancestor
138937284|NCT06145412|Cisplatin|cisplatin|mesh-list
138937285|NCT06145412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937286|NCT06145399|Deoxyglucose|deoxyglucose|mesh-list
138937287|NCT06145399|Methyltestosterone|methyltestosterone|mesh-list
138937288|NCT06145399|Testosterone|testosterone|mesh-list
138937289|NCT06145399|Testosterone undecanoate|testosterone undecanoate|mesh-list
138937290|NCT06145399|Testosterone enanthate|testosterone enanthate|mesh-list
138937291|NCT06145399|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138937292|NCT06145399|Dihydrotestosterone|dihydrotestosterone|mesh-list
138937293|NCT06145399|Androgens|androgens|mesh-ancestor
138937294|NCT06145399|Hormones|hormones|mesh-ancestor
138937295|NCT06145399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138937296|NCT06145399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632492|NCT00269061|Pioglitazone|pioglitazone|mesh-list
138937297|NCT06145399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138645261|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
138645263|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937298|NCT06145399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937299|NCT06145399|Anabolic Agents|anabolic agents|mesh-ancestor
138589282|NCT00157872|Naproxen|naproxen|mesh-list
138937300|NCT06145399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937301|NCT06145399|Antimetabolites|antimetabolites|mesh-ancestor
138937302|NCT06145399|Antiviral Agents|antiviral agents|mesh-ancestor
138937303|NCT06145399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937304|NCT06145321|Lenograstim|lenograstim|mesh-list
138937305|NCT06145321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138937306|NCT06145321|Immunologic Factors|immunologic factors|mesh-ancestor
138937307|NCT06145321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937308|NCT06145308|Paclitaxel|paclitaxel|mesh-list
138937309|NCT06145308|Apatinib|apatinib|mesh-list
138937310|NCT06145308|Bicalutamide|bicalutamide|mesh-list
138937311|NCT06145308|Vedolizumab|vedolizumab|mesh-list
138937312|NCT06145308|Androgen Antagonists|androgen antagonists|mesh-list
138937313|NCT06145308|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138937314|NCT06145308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138937315|NCT06145308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937316|NCT06145308|Tubulin Modulators|tubulin modulators|mesh-ancestor
138937317|NCT06145308|Antimitotic Agents|antimitotic agents|mesh-ancestor
138937318|NCT06145308|Mitosis Modulators|mitosis modulators|mesh-ancestor
138937319|NCT06145308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937320|NCT06145308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138937321|NCT06145308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937322|NCT06145308|Hormone Antagonists|hormone antagonists|mesh-ancestor
138937323|NCT06145308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138645303|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138937324|NCT06145308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937325|NCT06145308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138937326|NCT06145269|Warfarin|warfarin|mesh-list
138937327|NCT06145269|Rivaroxaban|rivaroxaban|mesh-list
138937328|NCT06145269|Anticoagulants|anticoagulants|mesh-list
138937329|NCT06145269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138937330|NCT06145269|Antithrombins|antithrombins|mesh-ancestor
138937331|NCT06145269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138937332|NCT06145269|Protease Inhibitors|protease inhibitors|mesh-ancestor
138937333|NCT06145269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937334|NCT06145269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937335|NCT06145217|Dasatinib|dasatinib|mesh-list
138937336|NCT06145217|Omeprazole|omeprazole|mesh-list
138937337|NCT06145217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138937338|NCT06145217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138937339|NCT06145217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138937340|NCT06145217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937341|NCT06145217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937342|NCT06145217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937343|NCT06145217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138937344|NCT06145165|Bupivacaine|bupivacaine|mesh-list
138937345|NCT06145165|Ropivacaine|ropivacaine|mesh-list
138937346|NCT06145165|Anesthetics, Local|anesthetics, local|mesh-ancestor
138937347|NCT06145165|Anesthetics|anesthetics|mesh-ancestor
138937348|NCT06145165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138937349|NCT06145165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645347|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138937350|NCT06145165|Sensory System Agents|sensory system agents|mesh-ancestor
138937351|NCT06145165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937352|NCT06143566|Empagliflozin|empagliflozin|mesh-list
138937353|NCT06143566|Losartan|losartan|mesh-list
138937354|NCT06143566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138937355|NCT06143566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138937356|NCT06143566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138937357|NCT06143566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138632583|NCT00269217|Vitamins|vitamins|mesh-ancestor
138937358|NCT06143566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937359|NCT06143566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138937360|NCT06143566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138937361|NCT06143566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937362|NCT06140823|Liver Extracts|liver extracts|mesh-list
138937363|NCT06140823|Hematinics|hematinics|mesh-ancestor
138937364|NCT06135259|Triamcinolone|triamcinolone|mesh-list
138937365|NCT06135259|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138937366|NCT06135259|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138937367|NCT06135259|Epoetin Alfa|epoetin alfa|mesh-list
138937368|NCT06135259|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138937369|NCT06135259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138937370|NCT06135259|Glucocorticoids|glucocorticoids|mesh-ancestor
138937371|NCT06135259|Hormones|hormones|mesh-ancestor
138937372|NCT06135259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138937373|NCT06135259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937374|NCT06135259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138937375|NCT06135259|Immunologic Factors|immunologic factors|mesh-ancestor
138937376|NCT06135259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640301|NCT01603342|Clopidogrel|clopidogrel|mesh-list
138937377|NCT06135259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937379|NCT06134362|Cabotegravir|cabotegravir|mesh-list
138937380|NCT06134362|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138937381|NCT06134362|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138645403|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
138937382|NCT06134362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937383|NCT06134362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937384|NCT06134362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138937385|NCT06134362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138937386|NCT06134362|Antiviral Agents|antiviral agents|mesh-ancestor
138937387|NCT06134362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937388|NCT06132698|Pemetrexed|pemetrexed|mesh-list
138937389|NCT06132698|Tislelizumab|tislelizumab|mesh-list
138937390|NCT06132698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937391|NCT06132698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937392|NCT06132698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937393|NCT06132698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138632624|NCT00261729|Prazosin|prazosin|mesh-list
138937395|NCT06132698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138937396|NCT06129643|Edetic Acid|edetic acid|mesh-list
138937397|NCT06129643|Anticoagulants|anticoagulants|mesh-ancestor
138937398|NCT06129643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138937399|NCT06129643|Chelating Agents|chelating agents|mesh-ancestor
138937400|NCT06129643|Sequestering Agents|sequestering agents|mesh-ancestor
138937401|NCT06129643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937402|NCT06128096|Dapagliflozin|dapagliflozin|mesh-list
138937403|NCT06128096|Empagliflozin|empagliflozin|mesh-list
138937404|NCT06128096|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138937405|NCT06128096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937406|NCT06128096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138937407|NCT06128096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645443|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937408|NCT06117839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138937409|NCT06117839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937410|NCT06116409|Bupivacaine|bupivacaine|mesh-list
138937411|NCT06116409|Anesthetics, Local|anesthetics, local|mesh-ancestor
138937412|NCT06116409|Anesthetics|anesthetics|mesh-ancestor
138937413|NCT06116409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138937414|NCT06116409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937415|NCT06116409|Sensory System Agents|sensory system agents|mesh-ancestor
138937416|NCT06116409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937417|NCT06105983|Rabeprazole|rabeprazole|mesh-list
138937418|NCT06105983|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138937419|NCT06105983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138937420|NCT06105983|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138937421|NCT06105983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937422|NCT06105983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937423|NCT06102057|Immunomodulating Agents|immunomodulating agents|mesh-list
138937424|NCT06102057|Immunologic Factors|immunologic factors|mesh-ancestor
138937425|NCT06102057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937426|NCT06091904|Sufentanil|sufentanil|mesh-list
138937427|NCT06091904|Remifentanil|remifentanil|mesh-list
138937428|NCT06091904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138937429|NCT06091904|Narcotics|narcotics|mesh-ancestor
138937430|NCT06091904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138937431|NCT06091904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937432|NCT06091904|Analgesics|analgesics|mesh-ancestor
138937433|NCT06091904|Sensory System Agents|sensory system agents|mesh-ancestor
138937434|NCT06091904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937435|NCT06091904|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138937436|NCT06091904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138937448|NCT06087757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138937449|NCT06060210|Ketamine|ketamine|mesh-list
138937450|NCT06060210|Analgesics|analgesics|mesh-ancestor
138212293|NCT00466310|Risperidone|risperidone|mesh-list
138937451|NCT06060210|Sensory System Agents|sensory system agents|mesh-ancestor
138937452|NCT06060210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937453|NCT06060210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937454|NCT06060210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138937455|NCT06060210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138937456|NCT06060210|Anesthetics, General|anesthetics, general|mesh-ancestor
138937457|NCT06060210|Anesthetics|anesthetics|mesh-ancestor
138937458|NCT06060210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138937459|NCT06060210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138937460|NCT06060210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138937461|NCT06060210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645543|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138645545|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
138937462|NCT06060210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937473|NCT06049654|Fexofenadine|fexofenadine|mesh-list
138937474|NCT06049654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138937475|NCT06049654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138937476|NCT06049654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138937477|NCT06049654|Histamine Antagonists|histamine antagonists|mesh-ancestor
138937478|NCT06049654|Histamine Agents|histamine agents|mesh-ancestor
138937479|NCT06049654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632764|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138937480|NCT06049654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937481|NCT06049654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937483|NCT06017284|Paclitaxel|paclitaxel|mesh-list
138937484|NCT06017284|Gemcitabine|gemcitabine|mesh-list
138937485|NCT06017284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138937486|NCT06017284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937487|NCT06017284|Tubulin Modulators|tubulin modulators|mesh-ancestor
138937488|NCT06017284|Antimitotic Agents|antimitotic agents|mesh-ancestor
138937489|NCT06017284|Mitosis Modulators|mitosis modulators|mesh-ancestor
138937490|NCT06017284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937491|NCT06017284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138937492|NCT06017284|Antimetabolites|antimetabolites|mesh-ancestor
138645598|NCT00285389|Doxorubicin|doxorubicin|mesh-list
138645609|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
138937493|NCT06017284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138937499|NCT06017284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138937500|NCT06017284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138937501|NCT06017284|Growth Substances|growth substances|mesh-ancestor
138937502|NCT06017284|Growth Inhibitors|growth inhibitors|mesh-ancestor
138937503|NCT06014515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138937504|NCT06014515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138937505|NCT06014515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937519|NCT05991453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937520|NCT05991453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138937521|NCT05991453|Anesthetics, General|anesthetics, general|mesh-ancestor
138937522|NCT05987657|Progesterone|progesterone|mesh-list
138937523|NCT05987657|Progestins|progestins|mesh-ancestor
138937524|NCT05987657|Hormones|hormones|mesh-ancestor
138937525|NCT05987657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138937526|NCT05987657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937527|NCT05983588|Glycerol|glycerol|mesh-list
138937528|NCT05983588|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138937529|NCT05983588|Protective Agents|protective agents|mesh-ancestor
138937530|NCT05983588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937531|NCT05977673|Tislelizumab|tislelizumab|mesh-list
138937532|NCT05977673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138645650|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
138937533|NCT05977673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937534|NCT05977465|Empagliflozin|empagliflozin|mesh-list
138937535|NCT05977465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138937536|NCT05977465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937537|NCT05977465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138937538|NCT05977465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937539|NCT05975554|Interleukin-2|interleukin-2|mesh-list
138937540|NCT05975554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937541|NCT05975554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138937542|NCT05975554|Analgesics|analgesics|mesh-ancestor
138937543|NCT05975554|Sensory System Agents|sensory system agents|mesh-ancestor
138937544|NCT05975554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937545|NCT05975554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937546|NCT05972993|Vaccines|vaccines|mesh-list
138937547|NCT05972993|Immunologic Factors|immunologic factors|mesh-ancestor
138937548|NCT05972993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937549|NCT05965167|Teriparatide|teriparatide|mesh-list
138937550|NCT05965167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138937551|NCT05965167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937552|NCT05965167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138937553|NCT05950646|Dexmedetomidine|dexmedetomidine|mesh-list
138937554|NCT05950646|Esketamine|esketamine|mesh-list
138937555|NCT05950646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138937556|NCT05950646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138937557|NCT05950646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937558|NCT05950646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138937559|NCT05950646|Analgesics|analgesics|mesh-ancestor
138640343|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
138937568|NCT05950646|Antidepressive Agents|antidepressive agents|mesh-ancestor
138937569|NCT05950646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138937571|NCT05949008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138937572|NCT05949008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937573|NCT05944926|Fluoxetine|fluoxetine|mesh-list
138937574|NCT05944926|Antidepressive Agents|antidepressive agents|mesh-list
138937575|NCT05944926|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138937576|NCT05944926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138937577|NCT05944926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138937578|NCT05944926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937579|NCT05944926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138937580|NCT05944926|Serotonin Agents|serotonin agents|mesh-ancestor
138937581|NCT05944926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937582|NCT05944926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138937583|NCT05944926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138937584|NCT05944926|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138937585|NCT05944926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138937586|NCT05944926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937587|NCT05942911|Hydroxychloroquine|hydroxychloroquine|mesh-list
138937588|NCT05942911|Cannabidiol|cannabidiol|mesh-list
138937589|NCT05942911|Antimalarials|antimalarials|mesh-ancestor
138937590|NCT05942911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138937591|NCT05942911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138937592|NCT05942911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937593|NCT05942911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937594|NCT05942911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937595|NCT05942911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138937596|NCT05942911|Anticonvulsants|anticonvulsants|mesh-ancestor
138937597|NCT05940896|Disitamab vedotin|disitamab vedotin|mesh-list
138937598|NCT05940896|Immunoconjugates|immunoconjugates|mesh-ancestor
138937599|NCT05940896|Immunologic Factors|immunologic factors|mesh-ancestor
138937600|NCT05940896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937611|NCT05896033|Antipruritics|antipruritics|mesh-ancestor
138937612|NCT05896033|Dermatologic Agents|dermatologic agents|mesh-ancestor
138937613|NCT05895773|Povidone-Iodine|povidone-iodine|mesh-list
138937614|NCT05895773|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
138937615|NCT05895773|Povidone|povidone|mesh-list
138937616|NCT05895773|Plasma Substitutes|plasma substitutes|mesh-ancestor
138937617|NCT05895773|Blood Substitutes|blood substitutes|mesh-ancestor
138937618|NCT05895773|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138937619|NCT05895773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937620|NCT05895773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138937621|NCT05866354|Tisotumab vedotin|tisotumab vedotin|mesh-list
138937622|NCT05866354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138937623|NCT05866354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937624|NCT05865457|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138937625|NCT05865457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138937626|NCT05865379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138937627|NCT05865379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138937628|NCT05863442|Eculizumab|eculizumab|mesh-list
138937629|NCT05863442|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138632978|NCT00416208|Bortezomib|bortezomib|mesh-list
138937630|NCT05863442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138937631|NCT05863442|Immunologic Factors|immunologic factors|mesh-ancestor
138937632|NCT05863442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937633|NCT05855746|Colchicine|colchicine|mesh-list
138937634|NCT05855746|Gout Suppressants|gout suppressants|mesh-ancestor
138937635|NCT05855746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138937636|NCT05855746|Tubulin Modulators|tubulin modulators|mesh-ancestor
138937637|NCT05855746|Antimitotic Agents|antimitotic agents|mesh-ancestor
138937638|NCT05855746|Mitosis Modulators|mitosis modulators|mesh-ancestor
138937639|NCT05855746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937640|NCT05855746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937641|NCT05827068|Vaccines|vaccines|mesh-list
138645793|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138937642|NCT05827068|Immunologic Factors|immunologic factors|mesh-ancestor
138937643|NCT05827068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937644|NCT05821933|Aflutinib|aflutinib|mesh-list
138937645|NCT05821933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138937646|NCT05821933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937647|NCT05821933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937648|NCT05819853|Metformin|metformin|mesh-list
138937649|NCT05819853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138633035|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
138937650|NCT05819853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937651|NCT05819541|Albuterol|albuterol|mesh-list
138937652|NCT05819541|Montelukast|montelukast|mesh-list
138937653|NCT05819541|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138937654|NCT05819541|Respiratory System Agents|respiratory system agents|mesh-ancestor
138937655|NCT05819541|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138937656|NCT05819541|Hormone Antagonists|hormone antagonists|mesh-ancestor
138937657|NCT05819541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138937658|NCT05819541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937659|NCT05819541|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138937660|NCT05819541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138633093|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
138937661|NCT05819541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937662|NCT05819541|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138937663|NCT05819541|Autonomic Agents|autonomic agents|mesh-ancestor
138937664|NCT05819541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937665|NCT05819541|Tocolytic Agents|tocolytic agents|mesh-ancestor
138937666|NCT05819541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138937667|NCT05819541|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138937668|NCT05819541|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138937669|NCT05819541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138937670|NCT05819541|Adrenergic Agents|adrenergic agents|mesh-ancestor
138937671|NCT05819541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138937672|NCT05815264|Vaccines|vaccines|mesh-list
138937673|NCT05815264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138937674|NCT05815264|Immunologic Factors|immunologic factors|mesh-ancestor
138633155|NCT04538365|Propranolol|propranolol|mesh-list
138937675|NCT05815264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937676|NCT05788458|Bupivacaine|bupivacaine|mesh-list
138937677|NCT05788458|Anesthetics, Local|anesthetics, local|mesh-ancestor
138937678|NCT05788458|Anesthetics|anesthetics|mesh-ancestor
138937679|NCT05788458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138937680|NCT05788458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937681|NCT05788458|Sensory System Agents|sensory system agents|mesh-ancestor
138937682|NCT05788458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937683|NCT05756569|Pembrolizumab|pembrolizumab|mesh-list
138937684|NCT05756569|Immunoconjugates|immunoconjugates|mesh-list
138937685|NCT05756569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138937686|NCT05756569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937687|NCT05756569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138937688|NCT05756569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937689|NCT05756569|Immunologic Factors|immunologic factors|mesh-ancestor
138937690|NCT05756569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937691|NCT05736406|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138937692|NCT05736406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138937693|NCT05736406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138937694|NCT05736406|Dermatologic Agents|dermatologic agents|mesh-ancestor
138937695|NCT05732883|Dexamethasone|dexamethasone|mesh-list
138937696|NCT05732883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138937697|NCT05732883|Antiemetics|antiemetics|mesh-ancestor
138937698|NCT05732883|Autonomic Agents|autonomic agents|mesh-ancestor
138645885|NCT00417326|Sivelestat|sivelestat|mesh-list
138937699|NCT05732883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937700|NCT05732883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937701|NCT05732883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138937702|NCT05732883|Glucocorticoids|glucocorticoids|mesh-ancestor
138937703|NCT05732883|Hormones|hormones|mesh-ancestor
138937704|NCT05732883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138937705|NCT05732883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138937706|NCT05732883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937707|NCT05727189|Idazoxan|idazoxan|mesh-list
138937708|NCT05727189|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138937709|NCT05727189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138937710|NCT05727189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138937711|NCT05727189|Adrenergic Agents|adrenergic agents|mesh-ancestor
138937712|NCT05727189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138937713|NCT05727189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937714|NCT05727189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937715|NCT05704036|Estradiol|estradiol|mesh-list
138937716|NCT05704036|Estrogens|estrogens|mesh-list
138937717|NCT05704036|Progesterone|progesterone|mesh-list
138937718|NCT05704036|Hormones|hormones|mesh-ancestor
138937719|NCT05704036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138937720|NCT05704036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937721|NCT05704036|Progestins|progestins|mesh-ancestor
138937722|NCT05703048|Dexmedetomidine|dexmedetomidine|mesh-list
138640388|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
138937724|NCT05703048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138937725|NCT05703048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138937726|NCT05703048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937727|NCT05703048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138937728|NCT05703048|Analgesics|analgesics|mesh-ancestor
138937729|NCT05703048|Sensory System Agents|sensory system agents|mesh-ancestor
138937730|NCT05703048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937731|NCT05703048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138937732|NCT05703048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138937733|NCT05703048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138937734|NCT05703048|Adrenergic Agents|adrenergic agents|mesh-ancestor
138937735|NCT05703048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138937736|NCT05703048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937737|NCT05703048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138937738|NCT05703048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138937739|NCT05703048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138937741|NCT05700721|Dostarlimab|dostarlimab|mesh-list
138937742|NCT05700721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138937743|NCT05700721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937744|NCT05700721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937745|NCT05700721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937746|NCT05696938|Niacinamide|niacinamide|mesh-list
138937747|NCT05696938|Niacin|niacin|mesh-list
138937748|NCT05696938|Nicotinic Acids|nicotinic acids|mesh-list
138633418|NCT02216227|Iodine|iodine|mesh-list
138937749|NCT05696938|Vitamin B Complex|vitamin b complex|mesh-ancestor
138937750|NCT05696938|Vitamins|vitamins|mesh-ancestor
138937751|NCT05696938|Micronutrients|micronutrients|mesh-ancestor
138937752|NCT05696938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937753|NCT05696938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138937754|NCT05696938|Antimetabolites|antimetabolites|mesh-ancestor
138937755|NCT05696938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937756|NCT05696938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138937757|NCT05696938|Vasodilator Agents|vasodilator agents|mesh-ancestor
138937758|NCT05683171|Rituximab|rituximab|mesh-list
138937759|NCT05683171|Lenalidomide|lenalidomide|mesh-list
138937760|NCT05683171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138937761|NCT05683171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937762|NCT05683171|Immunologic Factors|immunologic factors|mesh-ancestor
138937763|NCT05683171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937764|NCT05683171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138937765|NCT05683171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138937766|NCT05683171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138937767|NCT05683171|Growth Substances|growth substances|mesh-ancestor
138937768|NCT05683171|Growth Inhibitors|growth inhibitors|mesh-ancestor
138937769|NCT05675579|Pembrolizumab|pembrolizumab|mesh-list
138937770|NCT05675579|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138937771|NCT05675579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138937772|NCT05675579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937773|NCT05675579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138937774|NCT05675579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937775|NCT05675579|Immunoconjugates|immunoconjugates|mesh-ancestor
138937776|NCT05675579|Immunologic Factors|immunologic factors|mesh-ancestor
138937777|NCT05675579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937778|NCT05671991|Empagliflozin|empagliflozin|mesh-list
138640427|NCT00258245|Aspirin|aspirin|mesh-list
138937779|NCT05671991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138937780|NCT05671991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937781|NCT05671991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138937782|NCT05671991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937783|NCT05651282|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138937784|NCT05651282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138937785|NCT05651282|Contraceptive Agents|contraceptive agents|mesh-ancestor
138937786|NCT05651282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138937787|NCT05651282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937788|NCT05651282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138937789|NCT05651282|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138937790|NCT05651282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138937791|NCT05651282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937792|NCT05650008|Anesthetics|anesthetics|mesh-list
138937793|NCT05650008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138937794|NCT05650008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937795|NCT05646719|Phentolamine|phentolamine|mesh-list
138937796|NCT05646719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138937797|NCT05646719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138937798|NCT05646719|Pilocarpine|pilocarpine|mesh-list
138937799|NCT05646719|Miotics|miotics|mesh-ancestor
138937800|NCT05646719|Autonomic Agents|autonomic agents|mesh-ancestor
138646015|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138937801|NCT05646719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937802|NCT05646719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937803|NCT05646719|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138937804|NCT05646719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138937805|NCT05646719|Cholinergic Agents|cholinergic agents|mesh-ancestor
138937806|NCT05646719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138937807|NCT05646719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937808|NCT05646719|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138937809|NCT05646719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138937810|NCT05646719|Adrenergic Agents|adrenergic agents|mesh-ancestor
138937811|NCT05646719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138937812|NCT05632809|Durvalumab|durvalumab|mesh-list
138937813|NCT05632809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138937814|NCT05632809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937815|NCT05630781|Suvorexant|suvorexant|mesh-list
138937816|NCT05630781|Methylphenidate|methylphenidate|mesh-list
138937817|NCT05630781|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138937818|NCT05630781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937819|NCT05630781|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138937820|NCT05630781|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138937821|NCT05630781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138646049|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138937822|NCT05630781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937823|NCT05630781|Dopamine Agents|dopamine agents|mesh-ancestor
138937824|NCT05630781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138937825|NCT05630781|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138937826|NCT05630781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138937827|NCT05630781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138937828|NCT05630781|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138937829|NCT05624268|Psilocybin|psilocybin|mesh-list
138937830|NCT05624268|Hallucinogens|hallucinogens|mesh-ancestor
138937831|NCT05624268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937832|NCT05624268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138937833|NCT05610319|Faricimab|faricimab|mesh-list
138937834|NCT05610319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138937835|NCT05610319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138937836|NCT05610319|Growth Substances|growth substances|mesh-ancestor
138937837|NCT05610319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937838|NCT05610319|Growth Inhibitors|growth inhibitors|mesh-ancestor
138937839|NCT05610319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937840|NCT05589896|Mycophenolic Acid|mycophenolic acid|mesh-list
138937841|NCT05589896|Cyclophosphamide|cyclophosphamide|mesh-list
138937842|NCT05589896|Busulfan|busulfan|mesh-list
138937843|NCT05589896|Fludarabine|fludarabine|mesh-list
138937844|NCT05589896|Tacrolimus|tacrolimus|mesh-list
138937845|NCT05589896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138937846|NCT05589896|Immunologic Factors|immunologic factors|mesh-ancestor
138937847|NCT05589896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937848|NCT05589896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138937849|NCT05589896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138937850|NCT05589896|Alkylating Agents|alkylating agents|mesh-ancestor
138937851|NCT05589896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937852|NCT05589896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937853|NCT05589896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138646099|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138937854|NCT05589896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138937855|NCT05589896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937856|NCT05589896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138937857|NCT05589896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138937858|NCT05589896|Antitubercular Agents|antitubercular agents|mesh-ancestor
138937859|NCT05589896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138937860|NCT05589896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937861|NCT05588219|Cisplatin|cisplatin|mesh-list
138937862|NCT05588219|Tislelizumab|tislelizumab|mesh-list
138937863|NCT05588219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138937864|NCT05588219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937865|NCT05588219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138937866|NCT05588219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937867|NCT05585346|Thiamine|thiamine|mesh-list
138937868|NCT05585346|Vitamins|vitamins|mesh-ancestor
138937869|NCT05585346|Micronutrients|micronutrients|mesh-ancestor
138937870|NCT05585346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937871|NCT05585346|Vitamin B Complex|vitamin b complex|mesh-ancestor
138937872|NCT05567406|Belumosudil|belumosudil|mesh-list
138937880|NCT05555706|Antimitotic Agents|antimitotic agents|mesh-ancestor
138937881|NCT05555706|Mitosis Modulators|mitosis modulators|mesh-ancestor
138937882|NCT05555706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633704|NCT00238082|Norflurane|norflurane|mesh-list
138937893|NCT05545384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138937894|NCT05545384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937895|NCT05545384|Immunologic Factors|immunologic factors|mesh-ancestor
138937896|NCT05545384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937897|NCT05545384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138937898|NCT05545384|Antimetabolites|antimetabolites|mesh-ancestor
138937899|NCT05545384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646144|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138646149|NCT00320853|Vitamin D|vitamin d|mesh-list
138937901|NCT05545384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138937903|NCT05538702|Antipruritics|antipruritics|mesh-ancestor
138937904|NCT05538702|Dermatologic Agents|dermatologic agents|mesh-ancestor
138937905|NCT05498155|Durvalumab|durvalumab|mesh-list
138937906|NCT05498155|Olaparib|olaparib|mesh-list
138937907|NCT05498155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138937908|NCT05498155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937909|NCT05498155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138937910|NCT05498155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937911|NCT05498155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937912|NCT05468372|Amphotericin B|amphotericin b|mesh-list
138937913|NCT05468372|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138937914|NCT05468372|Posaconazole|posaconazole|mesh-list
138937915|NCT05468372|Amebicides|amebicides|mesh-ancestor
138937916|NCT05468372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138937917|NCT05468372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138937918|NCT05468372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937919|NCT05468372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138937920|NCT05468372|Antifungal Agents|antifungal agents|mesh-ancestor
138937921|NCT05468372|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138937922|NCT05468372|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138937923|NCT05468372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138937924|NCT05468372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937925|NCT05468372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937926|NCT05468372|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138937927|NCT05468372|Hormone Antagonists|hormone antagonists|mesh-ancestor
138633883|NCT05669079|Decitabine|decitabine|mesh-list
138937928|NCT05468372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138937929|NCT05468372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937931|NCT05443061|Vasodilator Agents|vasodilator agents|mesh-ancestor
138937932|NCT05439564|Dexmedetomidine|dexmedetomidine|mesh-list
138937933|NCT05439564|Morphine|morphine|mesh-list
138646187|NCT00320892|Atropine|atropine|mesh-list
138937934|NCT05439564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138937935|NCT05439564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138937936|NCT05439564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937937|NCT05439564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138937938|NCT05439564|Analgesics|analgesics|mesh-ancestor
138937939|NCT05439564|Sensory System Agents|sensory system agents|mesh-ancestor
138937940|NCT05439564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138937941|NCT05439564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138937942|NCT05439564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138937943|NCT05439564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138937944|NCT05439564|Adrenergic Agents|adrenergic agents|mesh-ancestor
138937945|NCT05439564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138937946|NCT05439564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640474|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
138937948|NCT05439564|Narcotics|narcotics|mesh-ancestor
138937949|NCT05438875|Tretinoin|tretinoin|mesh-list
138937950|NCT05438875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937951|NCT05438875|Keratolytic Agents|keratolytic agents|mesh-ancestor
138937952|NCT05438875|Dermatologic Agents|dermatologic agents|mesh-ancestor
138937954|NCT05421858|Caspofungin|caspofungin|mesh-list
138937955|NCT05421858|Antifungal Agents|antifungal agents|mesh-ancestor
138937956|NCT05421858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138937957|NCT05421858|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138937958|NCT05421858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138937959|NCT05421858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937960|NCT05421858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646228|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937961|NCT05421858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138937962|NCT05421858|Hormone Antagonists|hormone antagonists|mesh-ancestor
138937963|NCT05421858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138937964|NCT05421858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937965|NCT05421858|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138937966|NCT05421858|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138937967|NCT05400603|Zoledronic Acid|zoledronic acid|mesh-list
138937968|NCT05400603|Irinotecan|irinotecan|mesh-list
138937969|NCT05400603|Temozolomide|temozolomide|mesh-list
138937970|NCT05400603|Dinutuximab|dinutuximab|mesh-list
138937971|NCT05400603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138937972|NCT05400603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138937973|NCT05400603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138937974|NCT05400603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937975|NCT05400603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937976|NCT05400603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138937977|NCT05400603|Alkylating Agents|alkylating agents|mesh-ancestor
138937978|NCT05400603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138937979|NCT05400603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937980|NCT05359068|Valsartan|valsartan|mesh-list
138937981|NCT05359068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138937982|NCT05359068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138646276|NCT00288158|Protective Agents|protective agents|mesh-ancestor
138937983|NCT05359068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138937984|NCT05359068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937985|NCT05357027|Cyclophosphamide|cyclophosphamide|mesh-list
138937986|NCT05357027|Fludarabine|fludarabine|mesh-list
138937987|NCT05357027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138937988|NCT05357027|Immunologic Factors|immunologic factors|mesh-ancestor
138937989|NCT05357027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138937990|NCT05357027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138937991|NCT05357027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138937992|NCT05357027|Alkylating Agents|alkylating agents|mesh-ancestor
138937993|NCT05357027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138937994|NCT05357027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138937995|NCT05357027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138937996|NCT05347199|Amisulpride|amisulpride|mesh-list
138937997|NCT05347199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138937998|NCT05347199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138937999|NCT05347199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938000|NCT05347199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938001|NCT05347199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138938002|NCT05347199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138938003|NCT05347199|Dopamine Agents|dopamine agents|mesh-ancestor
138938004|NCT05347199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938005|NCT05347199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938006|NCT05347199|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138938007|NCT05347199|Antidepressive Agents|antidepressive agents|mesh-ancestor
138938008|NCT05346588|Propofol|propofol|mesh-list
138938009|NCT05346588|Anesthetics|anesthetics|mesh-list
138938010|NCT05346588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138938011|NCT05346588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938012|NCT05346588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938013|NCT05346588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138938014|NCT05346588|Anesthetics, General|anesthetics, general|mesh-ancestor
138938015|NCT05340374|177Lu-PSMA-617|177lu-psma-617|mesh-list
138938016|NCT05340374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138938017|NCT05340374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938018|NCT05335356|Ustekinumab|ustekinumab|mesh-list
138938019|NCT05335356|Dermatologic Agents|dermatologic agents|mesh-ancestor
138938020|NCT05292404|Alirocumab|alirocumab|mesh-list
138938021|NCT05292404|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138634164|NCT03373760|Durvalumab|durvalumab|mesh-list
138938022|NCT05292404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138938023|NCT05292404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138938024|NCT05292404|Antimetabolites|antimetabolites|mesh-ancestor
138938025|NCT05292404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938026|NCT05292404|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138938027|NCT05292404|Protease Inhibitors|protease inhibitors|mesh-ancestor
138938028|NCT05292404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938029|NCT05292404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138704059|NCT06199297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704060|NCT06199297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138938030|NCT05292209|Riluzole|riluzole|mesh-list
138938031|NCT05292209|Anticonvulsants|anticonvulsants|mesh-ancestor
138938032|NCT05292209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138938033|NCT05292209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138938034|NCT05292209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938035|NCT05292209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938036|NCT05292209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938037|NCT05292209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138938038|NCT05292209|Protective Agents|protective agents|mesh-ancestor
138938040|NCT05277896|Etomidate|etomidate|mesh-list
138938041|NCT05277896|Analgesics|analgesics|mesh-ancestor
138938042|NCT05277896|Sensory System Agents|sensory system agents|mesh-ancestor
138938043|NCT05277896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938044|NCT05277896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938045|NCT05277896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138938046|NCT05277896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138938047|NCT05277896|Anesthetics, General|anesthetics, general|mesh-ancestor
138938048|NCT05277896|Anesthetics|anesthetics|mesh-ancestor
138938049|NCT05277896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938050|NCT05277896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138938051|NCT05277896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138938052|NCT05277896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938053|NCT05277896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938054|NCT05277896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138938055|NCT05275894|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138938056|NCT05275894|Metronidazole|metronidazole|mesh-list
138938057|NCT05275894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138938058|NCT05275894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138938059|NCT05275894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138938060|NCT05265065|Vaccines|vaccines|mesh-list
138938061|NCT05265065|Immunologic Factors|immunologic factors|mesh-ancestor
138938062|NCT05265065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938063|NCT05255159|Furosemide|furosemide|mesh-list
138938064|NCT05255159|Diuretics|diuretics|mesh-ancestor
138938065|NCT05255159|Natriuretic Agents|natriuretic agents|mesh-ancestor
138640504|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
138938066|NCT05255159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938067|NCT05255159|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138938068|NCT05255159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138938069|NCT05255159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938071|NCT05232825|Promethazine|promethazine|mesh-list
138938072|NCT05232825|Dexamethasone|dexamethasone|mesh-list
138938073|NCT05232825|Methylprednisolone|methylprednisolone|mesh-list
138938074|NCT05232825|Desloratadine|desloratadine|mesh-list
138938075|NCT05232825|Ocrelizumab|ocrelizumab|mesh-list
138938076|NCT05232825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138938077|NCT05232825|Antiemetics|antiemetics|mesh-ancestor
138938078|NCT05232825|Autonomic Agents|autonomic agents|mesh-ancestor
138938079|NCT05232825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938080|NCT05232825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938081|NCT05232825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138938082|NCT05232825|Glucocorticoids|glucocorticoids|mesh-ancestor
138938084|NCT05232825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138938085|NCT05232825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138938086|NCT05232825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938087|NCT05232825|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138938088|NCT05232825|Protective Agents|protective agents|mesh-ancestor
138938089|NCT05232825|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138938090|NCT05232825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138938091|NCT05232825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938092|NCT05232825|Anesthetics, Local|anesthetics, local|mesh-ancestor
138938093|NCT05232825|Anesthetics|anesthetics|mesh-ancestor
138938094|NCT05232825|Sensory System Agents|sensory system agents|mesh-ancestor
138938095|NCT05232825|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138938096|NCT05232825|Histamine Antagonists|histamine antagonists|mesh-ancestor
138938097|NCT05232825|Histamine Agents|histamine agents|mesh-ancestor
138938098|NCT05232825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938099|NCT05232825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938100|NCT05232825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138938101|NCT05232825|Antipruritics|antipruritics|mesh-ancestor
138938102|NCT05232825|Dermatologic Agents|dermatologic agents|mesh-ancestor
138938103|NCT05232825|Immunologic Factors|immunologic factors|mesh-ancestor
138646473|NCT06140134|Hematinics|hematinics|mesh-ancestor
138646475|NCT06140095|Evolocumab|evolocumab|mesh-list
138938104|NCT05232825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138938105|NCT05232825|Cholinergic Agents|cholinergic agents|mesh-ancestor
138938106|NCT05232825|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138938107|NCT05222555|Lenalidomide|lenalidomide|mesh-list
138938108|NCT05222555|Immunologic Factors|immunologic factors|mesh-ancestor
138938109|NCT05222555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938110|NCT05222555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138938111|NCT05222555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138938112|NCT05222555|Growth Substances|growth substances|mesh-ancestor
138938113|NCT05222555|Growth Inhibitors|growth inhibitors|mesh-ancestor
138938114|NCT05222555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938115|NCT05214911|Loratadine|loratadine|mesh-list
138938116|NCT05214911|Prednisolone|prednisolone|mesh-list
138938117|NCT05214911|Desloratadine|desloratadine|mesh-list
138938118|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138938119|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
138938120|NCT05214911|Hormones|hormones|mesh-ancestor
138634460|NCT00414323|Analgesics|analgesics|mesh-ancestor
138938121|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138938122|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938123|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138938124|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938125|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138938126|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
138938127|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938128|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938129|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138938130|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138938131|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
138938132|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
138938133|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
138938134|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
138646542|NCT06139393|Febuxostat|febuxostat|mesh-list
138938135|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138938137|NCT05202080|Narcotics|narcotics|mesh-ancestor
138938138|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938139|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938140|NCT05202080|Analgesics|analgesics|mesh-ancestor
138938141|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
138938142|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938143|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138938144|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
138938145|NCT05199324|Cefazolin|cefazolin|mesh-list
138938146|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
138938147|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138938148|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
138938149|NCT05199324|Trimethoprim|trimethoprim|mesh-list
138938150|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
138938151|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138938152|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138938153|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138938154|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938155|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938156|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938157|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138646577|NCT06139211|Micronutrients|micronutrients|mesh-ancestor
138938158|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138938159|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138938160|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
138938161|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138938162|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138938163|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138938164|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138938165|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138938166|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138938167|NCT05169866|Amiodarone|amiodarone|mesh-list
138938168|NCT05169866|Nifekalant|nifekalant|mesh-list
138938169|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138938170|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
138938171|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138938172|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138938173|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938174|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138938175|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138938176|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138938177|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646640|NCT06138496|Lenvatinib|lenvatinib|mesh-list
138938178|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138938179|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138938180|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138938181|NCT05153239|Irinotecan|irinotecan|mesh-list
138938182|NCT05153239|Topotecan|topotecan|mesh-list
138938183|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138938184|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138938185|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938186|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938187|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938188|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
138938189|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138938190|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938191|NCT05131919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138213042|NCT01471639|Ketorolac|ketorolac|mesh-list
138938192|NCT05131919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938194|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
138687672|NCT05896007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138938195|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138938196|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938197|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938198|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138938199|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138938200|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138938202|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138938204|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938205|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938206|NCT05073692|Liraglutide|liraglutide|mesh-list
138646684|NCT06136754|Fluorides, Topical|fluorides, topical|mesh-list
138646685|NCT06136754|Cariostatic Agents|cariostatic agents|mesh-ancestor
138938207|NCT05073692|Empagliflozin|empagliflozin|mesh-list
138938208|NCT05073692|Exenatide|exenatide|mesh-list
138938209|NCT05073692|Glimepiride|glimepiride|mesh-list
138938210|NCT05073692|Linagliptin|linagliptin|mesh-list
138938211|NCT05073692|Saxagliptin|saxagliptin|mesh-list
138938212|NCT05073692|Alogliptin|alogliptin|mesh-list
138938213|NCT05073692|Glipizide|glipizide|mesh-list
138938214|NCT05073692|Glucagon|glucagon|mesh-list
138938215|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138938216|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138938217|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938218|NCT05073692|Incretins|incretins|mesh-ancestor
138938219|NCT05073692|Hormones|hormones|mesh-ancestor
138711053|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138646728|NCT06103617|Antidotes|antidotes|mesh-ancestor
138938220|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138938221|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138938222|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938223|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138938224|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138938225|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138938226|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
138938227|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138938228|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
138938229|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938230|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138938231|NCT05049525|Itraconazole|itraconazole|mesh-list
138938232|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
138938233|NCT05049525|Terbinafine|terbinafine|mesh-list
138938234|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
138938235|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138938236|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138646792|NCT06002490|Antipyretics|antipyretics|mesh-ancestor
138938237|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138938238|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938239|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938240|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138938241|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
138938242|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138938243|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938244|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138938245|NCT05046314|Vincristine|vincristine|mesh-list
138938246|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138646845|NCT05875441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138938247|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938248|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
138938249|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
138938250|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
138640546|NCT01340014|Brinzolamide|brinzolamide|mesh-list
138938251|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938253|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938254|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938255|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634706|NCT01643278|Ipilimumab|ipilimumab|mesh-list
138938257|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
138938258|NCT05028725|Coagulants|coagulants|mesh-ancestor
138938259|NCT05009992|TIC10 compound|tic10 compound|mesh-list
138938260|NCT05009992|Dopamine|dopamine|mesh-list
138938261|NCT05009992|GDC-0084|gdc-0084|mesh-list
138938262|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138938263|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
138938264|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
138938265|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938266|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938267|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
138938269|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646909|NCT05781217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138646910|NCT05781217|Leuprolide|leuprolide|mesh-list
138938270|NCT05009992|Protective Agents|protective agents|mesh-ancestor
138938271|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938272|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938273|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138938274|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938275|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138938276|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138938277|NCT05001555|Analgesics|analgesics|mesh-ancestor
138938278|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
138938279|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938280|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138938281|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138938282|NCT04978584|Prednisone|prednisone|mesh-list
138938283|NCT04978584|Cortisone|cortisone|mesh-list
138938284|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
138938285|NCT04978584|Rituximab|rituximab|mesh-list
138938286|NCT04978584|Doxorubicin|doxorubicin|mesh-list
138938287|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138938288|NCT04978584|Vincristine|vincristine|mesh-list
138938289|NCT04978584|Lenalidomide|lenalidomide|mesh-list
138938290|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
138646964|NCT05712707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138938291|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138938292|NCT04978584|Antibodies|antibodies|mesh-list
138938293|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
138938294|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138938295|NCT04978584|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138938296|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138938297|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
138938298|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938299|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138938300|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138938301|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
138938302|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938303|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938304|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138938305|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138938306|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138938307|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138938308|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938309|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138938312|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138938313|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138938314|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138938315|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
138938316|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
138938317|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
138938318|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138647018|NCT05541497|Varenicline|varenicline|mesh-list
138938319|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138938320|NCT04978584|Growth Substances|growth substances|mesh-ancestor
138938321|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
138938322|NCT04978584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138938323|NCT04973163|Midazolam|midazolam|mesh-list
138938324|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138938325|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138938326|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938327|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938328|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138938329|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138938330|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138938331|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138938332|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
138938333|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
138938334|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
138938335|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
138938336|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938337|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938338|NCT04971785|Firsocostat|firsocostat|mesh-list
138938339|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938340|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938342|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
138938343|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
138938344|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138938346|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138938347|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
138938348|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938349|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938350|NCT04941716|Venetoclax|venetoclax|mesh-list
138938351|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
138938352|NCT04941716|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138938353|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938354|NCT04941716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138647068|NCT05313620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938355|NCT04941716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938356|NCT04941716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938357|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
138938358|NCT04933331|Fluorides|fluorides|mesh-list
138938359|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
138938360|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
138938361|NCT04933331|Protective Agents|protective agents|mesh-ancestor
138938362|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938363|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138938364|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138938365|NCT04900155|Atorvastatin|atorvastatin|mesh-list
138938366|NCT04900155|Ezetimibe|ezetimibe|mesh-list
138938367|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138938368|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138938369|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
138640594|NCT04709315|Rocuronium|rocuronium|mesh-list
138938370|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938371|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138938372|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138938373|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938374|NCT04896164|Curcumin|curcumin|mesh-list
138938375|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138938376|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138938377|NCT04896164|Analgesics|analgesics|mesh-ancestor
138938378|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
138938379|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938380|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938381|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138938382|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138938383|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938384|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938385|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938386|NCT04862975|Tenofovir|tenofovir|mesh-list
138938387|NCT04862975|Emtricitabine|emtricitabine|mesh-list
138938388|NCT04862975|Efavirenz|efavirenz|mesh-list
138938389|NCT04862975|Dolutegravir|dolutegravir|mesh-list
138938390|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
138938391|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138938392|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138938393|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138938394|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938395|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938396|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138938397|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138938398|NCT04862975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138635060|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
138938399|NCT04862975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138938400|NCT04862975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138938401|NCT04862975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138938402|NCT04862975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138938403|NCT04862975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138938404|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138938405|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138938406|NCT04852068|Vaccines|vaccines|mesh-list
138938407|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
138938408|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938409|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
138938410|NCT04822064|Ketamine|ketamine|mesh-list
138938411|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
138938412|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138635115|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938413|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938414|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647146|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138647147|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138647148|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
138647149|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647150|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647151|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
138647152|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
138647153|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138647155|NCT05036291|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647156|NCT05036291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647157|NCT05036291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647158|NCT05036291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938415|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138938417|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
138524624|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
138938418|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938419|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138635177|NCT00240656|Carvedilol|carvedilol|mesh-list
138938420|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138938421|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138938422|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
138938423|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938424|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938425|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138938426|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138938427|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
138938429|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138938430|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138938431|NCT04821843|Paclitaxel|paclitaxel|mesh-list
138938432|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
138938433|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138938434|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938435|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
138938436|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
138938437|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
138938438|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938439|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138938440|NCT04821817|Rocuronium|rocuronium|mesh-list
138938441|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138938442|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138938443|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138938444|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938445|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938446|NCT04787341|Panitumumab|panitumumab|mesh-list
138938447|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138938448|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647193|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647194|NCT04889664|Ketamine|ketamine|mesh-list
138938449|NCT04786275|Fentanyl|fentanyl|mesh-list
138938450|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138938451|NCT04786275|Narcotics|narcotics|mesh-ancestor
138938452|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938453|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938454|NCT04786275|Analgesics|analgesics|mesh-ancestor
138938455|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
138938456|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938457|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138938458|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138938459|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
138938460|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
138938461|NCT04745026|Cannabidiol|cannabidiol|mesh-list
138938462|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
138938464|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
138635361|NCT01688947|Pregabalin|pregabalin|mesh-list
138938465|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938466|NCT04728932|Simendan|simendan|mesh-list
138938467|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138938468|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
138938469|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138938470|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138938471|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938472|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938473|NCT04728932|Protective Agents|protective agents|mesh-ancestor
138938474|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938475|NCT04712643|Atezolizumab|atezolizumab|mesh-list
138938476|NCT04712643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138938477|NCT04712643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640632|NCT00291213|Levetiracetam|levetiracetam|mesh-list
138938478|NCT04712643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138938479|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938480|NCT04710641|Sorafenib|sorafenib|mesh-list
138938481|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938482|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138938483|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938484|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938485|NCT04707196|Fulvestrant|fulvestrant|mesh-list
138938486|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138938487|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138938488|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938489|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138938490|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138938491|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
138938492|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138938493|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938494|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138938495|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938496|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938497|NCT04667663|Dexamethasone|dexamethasone|mesh-list
138938498|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
138938499|NCT04667663|Daratumumab|daratumumab|mesh-list
138938500|NCT04667663|Pomalidomide|pomalidomide|mesh-list
138938501|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138938502|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
138938503|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938504|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138938505|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138938506|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
138938507|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938508|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938509|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138938510|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138647301|NCT04579380|Tucatinib|tucatinib|mesh-list
138938511|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
138938512|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
138938513|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938514|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138938515|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
138938516|NCT04667663|Hormones|hormones|mesh-ancestor
138938517|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138938518|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138938519|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138938520|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138938521|NCT04667663|Growth Substances|growth substances|mesh-ancestor
138938522|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
138938523|NCT04652076|Paclitaxel|paclitaxel|mesh-list
138938524|NCT04652076|Carboplatin|carboplatin|mesh-list
138938525|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
138938526|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138938527|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938528|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
138938529|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
138938530|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
138938531|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635658|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
138938532|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138938533|NCT04652076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138938534|NCT04632758|Crizotinib|crizotinib|mesh-list
138938535|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938536|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138938537|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938538|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938539|NCT04629209|TIC10 compound|tic10 compound|mesh-list
138938540|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938541|NCT04627285|Lacosamide|lacosamide|mesh-list
138938542|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
138647326|NCT04569747|Tamoxifen|tamoxifen|mesh-list
138938543|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138938544|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138938545|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138938546|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938547|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138938548|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
138938549|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938550|NCT04564339|Ravulizumab|ravulizumab|mesh-list
138938551|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138938552|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138938553|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
138938554|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938555|NCT04552288|Benralizumab|benralizumab|mesh-list
138938556|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138938557|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
138938558|NCT04551963|Clarithromycin|clarithromycin|mesh-list
138938559|NCT04551963|Fluconazole|fluconazole|mesh-list
138938560|NCT04551963|Voriconazole|voriconazole|mesh-list
138938561|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
138938562|NCT04551963|Diltiazem|diltiazem|mesh-list
138938563|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138938564|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138938565|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138938566|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938567|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938568|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138938569|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138938570|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
138938571|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138938572|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138938573|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
138938574|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138938575|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938576|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138938577|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138938578|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938579|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138938580|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138938581|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138635723|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138938582|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138938583|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138938584|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
138938585|NCT04527107|Aflibercept|aflibercept|mesh-list
138938586|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138938587|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138938588|NCT04527107|Growth Substances|growth substances|mesh-ancestor
138938589|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938590|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
138938591|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938592|NCT04502381|Amphotericin B|amphotericin b|mesh-list
138938593|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138938594|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
138938595|NCT04502381|Amebicides|amebicides|mesh-ancestor
138938596|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138938597|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138938598|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138647400|NCT04405167|Lenalidomide|lenalidomide|mesh-list
138938599|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138938600|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
138938601|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138938602|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138938603|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138938604|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938605|NCT04472910|Folfirinox|folfirinox|mesh-list
138938606|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938607|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138938608|NCT04466475|Melphalan|melphalan|mesh-list
138938609|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
138938610|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138938611|NCT04466475|Daratumumab|daratumumab|mesh-list
138938612|NCT04466475|Antibodies|antibodies|mesh-list
138938613|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
138938614|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138938615|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
138938616|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938617|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938618|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138938619|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
138938620|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938621|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138938622|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138938623|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
138635874|NCT00273390|Infliximab|infliximab|mesh-list
138938624|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
138938625|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938626|NCT04375033|Buprenorphine|buprenorphine|mesh-list
138938627|NCT04375033|Naloxone|naloxone|mesh-list
138938628|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138938629|NCT04375033|Narcotics|narcotics|mesh-ancestor
138938630|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938631|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938632|NCT04375033|Analgesics|analgesics|mesh-ancestor
138938633|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
138938634|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938635|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138938636|NCT04356638|Midazolam|midazolam|mesh-list
138938637|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
138635929|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
138938638|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138938639|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938640|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938641|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138938642|NCT04356638|Analgesics|analgesics|mesh-ancestor
138938643|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
138938644|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938645|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138938646|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138938647|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138938648|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
138938649|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938650|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647503|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138938651|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138938652|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138938653|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138938654|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138938655|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138938656|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
138938657|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
138938658|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
138938659|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
138938660|NCT04347434|Atorvastatin|atorvastatin|mesh-list
138938662|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138938663|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138938664|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
138938665|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938666|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138938667|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138938668|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938669|NCT04343170|Folic Acid|folic acid|mesh-list
138938670|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
138938671|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
138938672|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
138938673|NCT04343170|Vitamins|vitamins|mesh-ancestor
138938674|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
138938675|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938676|NCT04343170|Hematinics|hematinics|mesh-ancestor
138938677|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
138938678|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
138938679|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938680|NCT04336046|Bupivacaine|bupivacaine|mesh-list
138938681|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
138938682|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
138938683|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938684|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938685|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
138938686|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938687|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
138938688|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138938689|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938690|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938691|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138938692|NCT04331418|Analgesics|analgesics|mesh-ancestor
138938693|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
138938694|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636047|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
138938695|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138938696|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138938697|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138938698|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
138938699|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938700|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938701|NCT04307511|Aspirin|aspirin|mesh-list
138938702|NCT04307511|Ticagrelor|ticagrelor|mesh-list
138938703|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138938704|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138938706|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
138938707|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938708|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938709|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138185810|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138938710|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138938711|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138938712|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138640685|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138938713|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938714|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138938715|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138938716|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938717|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
138938718|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138938719|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138938720|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138938721|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
138938722|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938723|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
138938724|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138938725|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938726|NCT04301011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138938727|NCT04301011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938729|NCT04227483|Deflazacort|deflazacort|mesh-list
138938730|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138938731|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
138938732|NCT04227483|Hormones|hormones|mesh-ancestor
138938733|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138938734|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938735|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138938736|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938737|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138938738|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
138938739|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
138938740|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138938741|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938742|NCT04219254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138938743|NCT04219254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938744|NCT04200534|Nicotine|nicotine|mesh-list
138938745|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138938746|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
138938747|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938748|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938749|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138938750|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138938751|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
138938752|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938753|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938754|NCT04195633|Cyclosporine|cyclosporine|mesh-list
138938755|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
138938756|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
138938757|NCT04195633|Treosulfan|treosulfan|mesh-list
138938758|NCT04195633|Busulfan|busulfan|mesh-list
138938759|NCT04195633|Fludarabine|fludarabine|mesh-list
138938760|NCT04195633|Cyclosporins|cyclosporins|mesh-list
138938761|NCT04195633|Lenograstim|lenograstim|mesh-list
138938762|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138938763|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
138938764|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938765|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138938766|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138938767|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
138938768|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938769|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938770|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138938771|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138938772|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938773|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
138640711|NCT01332292|Xhance|xhance|mesh-list
138938774|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138938775|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
138938776|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138938777|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138938778|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138938779|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
138938780|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138938781|NCT04189783|Bupivacaine|bupivacaine|mesh-list
138938783|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
138938784|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938785|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938786|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
138938787|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938788|NCT04187352|Cisplatin|cisplatin|mesh-list
138938789|NCT04187352|Fluorouracil|fluorouracil|mesh-list
138938790|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938791|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
138938792|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938793|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138938794|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138938795|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
138938796|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938797|NCT04181606|Esmolol|esmolol|mesh-list
138938798|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138938799|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138938800|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138636447|NCT00274794|Rituximab|rituximab|mesh-list
138938801|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
138938802|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938803|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938804|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938805|NCT04120636|Celecoxib|celecoxib|mesh-list
138938806|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138938807|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138938808|NCT04120636|Analgesics|analgesics|mesh-ancestor
138938809|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
138938810|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938811|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938812|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138938813|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138938814|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138938815|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138938816|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938817|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938819|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
138938820|NCT04120311|BB 1101|bb 1101|mesh-list
138938821|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138938822|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
138938823|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
138938824|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938825|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636556|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
138938827|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
138938828|NCT04120311|Hormones|hormones|mesh-ancestor
138938829|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138938830|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138938831|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938832|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
138938833|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938834|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938835|NCT04116528|Ketamine|ketamine|mesh-list
138938836|NCT04116528|Buprenorphine|buprenorphine|mesh-list
138938837|NCT04116528|Analgesics|analgesics|mesh-ancestor
138938838|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
138938839|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938840|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938841|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138938842|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138938843|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
138938844|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
138938845|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938846|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138938847|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138938848|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938849|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938850|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138186048|NCT04361149|Capsaicin|capsaicin|mesh-list
138938851|NCT04116528|Narcotics|narcotics|mesh-ancestor
138938852|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138938853|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
138938854|NCT04103476|Estrogens|estrogens|mesh-list
138938855|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138938856|NCT04103476|Hormones|hormones|mesh-ancestor
138938857|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138938858|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938859|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138938860|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138938861|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
138938862|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138938863|NCT04045301|Omalizumab|omalizumab|mesh-list
138938864|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138938865|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
138938866|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938867|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138938868|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138938869|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
138938870|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138938871|NCT04017650|Nivolumab|nivolumab|mesh-list
138938872|NCT04017650|Cetuximab|cetuximab|mesh-list
138590861|NCT05861297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938873|NCT04017650|Antibodies|antibodies|mesh-list
138938874|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
138938875|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138938876|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
138938877|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938878|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938879|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138938880|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938881|NCT04005430|Dexamethasone|dexamethasone|mesh-list
138938882|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
138938883|NCT04005430|BB 1101|bb 1101|mesh-list
138938884|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138186088|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138938885|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
138938886|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
138938887|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938888|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938889|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138938891|NCT04005430|Hormones|hormones|mesh-ancestor
138938892|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138938893|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138938894|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938895|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
138938896|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938897|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938898|NCT03998735|Lobeline|lobeline|mesh-list
138938899|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138938900|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
138938901|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938902|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938903|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138938904|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138938905|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
138938906|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138938907|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938908|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
138938909|NCT03958721|Capecitabine|capecitabine|mesh-list
138938910|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138938911|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
138938912|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938913|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938914|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
138938915|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138938916|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
138938917|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938918|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
138938919|NCT03906877|Protective Agents|protective agents|mesh-ancestor
138938920|NCT03901001|Sirolimus|sirolimus|mesh-list
138938921|NCT03901001|Oseltamivir|oseltamivir|mesh-list
138938922|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138938923|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138938924|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138938925|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938926|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
138938927|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138938928|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
138938929|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938930|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938931|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938932|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
138938933|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
138938934|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138938935|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
138938936|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138938937|NCT03900988|Expectorants|expectorants|mesh-ancestor
138938938|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
138636896|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
138938939|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138938940|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
138186173|NCT03008590|Naltrexone|naltrexone|mesh-list
138938941|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938942|NCT03900988|Protective Agents|protective agents|mesh-ancestor
138938943|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938944|NCT03900988|Antidotes|antidotes|mesh-ancestor
138938945|NCT03900377|Rituximab|rituximab|mesh-list
138938946|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138938947|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938948|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
138938949|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938950|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138938951|NCT03824327|Papaverine|papaverine|mesh-list
138938952|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138938953|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938954|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938955|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
138938956|NCT03824327|Urological Agents|urological agents|mesh-ancestor
138938957|NCT03809013|Trastuzumab|trastuzumab|mesh-list
138938958|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138938959|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938960|NCT03802240|Pemetrexed|pemetrexed|mesh-list
138938961|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938962|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938963|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938964|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138938965|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138938966|NCT03796572|Ropivacaine|ropivacaine|mesh-list
138938967|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
138938968|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
138938969|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138938970|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938971|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
138938972|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938974|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138938975|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138938976|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138938977|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938978|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138938979|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
138938980|NCT03734237|Vaccines|vaccines|mesh-list
138938981|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
138938982|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938983|NCT03693872|Dopamine|dopamine|mesh-list
138938984|NCT03693872|Apomorphine|apomorphine|mesh-list
138938985|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
138938986|NCT03693872|Emetics|emetics|mesh-ancestor
138938987|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138938988|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
138938989|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138938990|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138938991|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
138938992|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138317423|NCT02630628|Tacrolimus|tacrolimus|mesh-list
138938993|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138938994|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138938995|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
138938996|NCT03693872|Protective Agents|protective agents|mesh-ancestor
138938997|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138938998|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138938999|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138939000|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138939001|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
138939002|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138939003|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939004|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939005|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
138939006|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939007|NCT03679650|Decitabine|decitabine|mesh-list
138939008|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138939009|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
138939010|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939011|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939012|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939013|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138939014|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138939015|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138939016|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
138939017|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939018|NCT03529201|Fentanyl|fentanyl|mesh-list
138939019|NCT03529201|Oxycodone|oxycodone|mesh-list
138939020|NCT03529201|Sevoflurane|sevoflurane|mesh-list
138939021|NCT03529201|Rocuronium|rocuronium|mesh-list
138939022|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138939023|NCT03529201|Narcotics|narcotics|mesh-ancestor
138939024|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591015|NCT05858918|Clopidogrel|clopidogrel|mesh-list
138637260|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138939025|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939026|NCT03529201|Analgesics|analgesics|mesh-ancestor
138939027|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
138939028|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939029|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138939030|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138939031|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
138939032|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
138939033|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138939034|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138939035|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138939036|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138939037|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138939038|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138939039|NCT03510208|Panitumumab|panitumumab|mesh-list
138939041|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
138939042|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138939043|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
138939044|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939045|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939046|NCT03500380|Capecitabine|capecitabine|mesh-list
138939047|NCT03500380|Lapatinib|lapatinib|mesh-list
138939048|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138939049|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
138939050|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939051|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939052|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138939053|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939054|NCT03496623|Treprostinil|treprostinil|mesh-list
138939055|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138939056|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138939057|NCT03473561|Racecadotril|racecadotril|mesh-list
138939058|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
138939059|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939060|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
138939061|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939062|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939063|NCT03471260|Azacitidine|azacitidine|mesh-list
138939064|NCT03471260|Venetoclax|venetoclax|mesh-list
138939065|NCT03471260|Ivosidenib|ivosidenib|mesh-list
138637437|NCT00416832|Prednisone|prednisone|mesh-list
138939066|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138939067|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
138939068|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939069|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939070|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939071|NCT03466450|Temozolomide|temozolomide|mesh-list
138939072|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138939073|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
138939074|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939075|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939076|NCT03455517|Rituximab|rituximab|mesh-list
138939077|NCT03455517|Venetoclax|venetoclax|mesh-list
138939078|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939079|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939080|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
138939081|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939082|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138939083|NCT03431168|Azithromycin|azithromycin|mesh-list
138939084|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138939085|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138939086|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138939087|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138939088|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
138939089|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138939090|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138939091|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
138939092|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939093|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939094|NCT03419481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138939095|NCT03419481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939096|NCT03404908|Acetaminophen|acetaminophen|mesh-list
138939097|NCT03404908|Dipyrone|dipyrone|mesh-list
138939098|NCT03404908|Ketoprofen|ketoprofen|mesh-list
138939099|NCT03404908|Morphine|morphine|mesh-list
138939100|NCT03404908|Ropivacaine|ropivacaine|mesh-list
138939101|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138939102|NCT03404908|Narcotics|narcotics|mesh-ancestor
138939103|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138939104|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939105|NCT03404908|Analgesics|analgesics|mesh-ancestor
138939106|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
138939107|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939108|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
138939109|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
138939110|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138939111|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
138637691|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
138939112|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138939113|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138939114|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138939115|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138939116|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939117|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939118|NCT03399032|Caspofungin|caspofungin|mesh-list
138939119|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
138939120|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138939121|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939122|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939123|NCT03366272|Rituximab|rituximab|mesh-list
138939124|NCT03366272|Nivolumab|nivolumab|mesh-list
138939125|NCT03366272|Gemcitabine|gemcitabine|mesh-list
138939126|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
138939127|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939128|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939129|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
138939130|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939131|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138939132|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138939133|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
138939134|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939135|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138939136|NCT03363217|Trametinib|trametinib|mesh-list
138939137|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939138|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138939139|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939140|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939141|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138939142|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939143|NCT03313804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939144|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939145|NCT03224507|Dexamethasone|dexamethasone|mesh-list
138939146|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
138939147|NCT03224507|Lenalidomide|lenalidomide|mesh-list
138939148|NCT03224507|Daratumumab|daratumumab|mesh-list
138939149|NCT03224507|BB 1101|bb 1101|mesh-list
138939150|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138939151|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138939152|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
138939153|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
138939154|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939155|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939156|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939157|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
138939158|NCT03224507|Hormones|hormones|mesh-ancestor
138939159|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138939160|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138939161|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939162|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
138939163|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939164|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939165|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
138939166|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138939167|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138939168|NCT03224507|Growth Substances|growth substances|mesh-ancestor
138939169|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
138419069|NCT06144944|Epirubicin|epirubicin|mesh-list
138939170|NCT03215030|Dexamethasone|dexamethasone|mesh-list
138939171|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138939172|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
138939173|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
138939174|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939175|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591162|NCT05457582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138939176|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939177|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
138939179|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138939180|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138939181|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939182|NCT03193190|Leucovorin|leucovorin|mesh-list
138939183|NCT03193190|Paclitaxel|paclitaxel|mesh-list
138939184|NCT03193190|Bevacizumab|bevacizumab|mesh-list
138939185|NCT03193190|Gemcitabine|gemcitabine|mesh-list
138939186|NCT03193190|Fluorouracil|fluorouracil|mesh-list
138939187|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
138939188|NCT03193190|Atezolizumab|atezolizumab|mesh-list
138939189|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138939190|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939191|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
138939192|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
138939193|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
138939194|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939195|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939196|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138939197|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138939198|NCT03193190|Growth Substances|growth substances|mesh-ancestor
138939199|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939200|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
138939201|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138939202|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
138939203|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138939204|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
138939205|NCT03193190|Antidotes|antidotes|mesh-ancestor
138939206|NCT03193190|Protective Agents|protective agents|mesh-ancestor
138939207|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
138939208|NCT03193190|Vitamins|vitamins|mesh-ancestor
138939209|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
138939210|NCT03193190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138939211|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138939212|NCT03169985|Ezetimibe|ezetimibe|mesh-list
138939213|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138939214|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138939215|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
138939216|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939217|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138939218|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138939219|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939220|NCT03153527|Prednisone|prednisone|mesh-list
138939221|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138939222|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
138939223|NCT03153527|Hormones|hormones|mesh-ancestor
138489404|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939224|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138939225|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939226|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138939227|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939229|NCT03119012|Clopidogrel|clopidogrel|mesh-list
138939231|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138939232|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138939233|NCT03119012|Analgesics|analgesics|mesh-ancestor
138939234|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
138939235|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939236|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939237|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138939238|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138939239|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138939240|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138939241|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939242|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138939243|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138186551|NCT05717361|Analgesics|analgesics|mesh-ancestor
138939245|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
138939246|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138939247|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138939248|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138939249|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
138591239|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939250|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138939251|NCT03117010|Dexamethasone|dexamethasone|mesh-list
138939252|NCT03117010|Etoposide|etoposide|mesh-list
138939253|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138939254|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
138939255|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
138939256|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939257|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939258|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939259|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
138939260|NCT03117010|Hormones|hormones|mesh-ancestor
138939261|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640934|NCT00272454|Analgesics|analgesics|mesh-ancestor
138939262|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138939263|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939264|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939265|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939266|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138939267|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138939268|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138939269|NCT03085147|Olaparib|olaparib|mesh-list
138939270|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138186603|NCT04374071|Prednisolone|prednisolone|mesh-list
138939271|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939272|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939273|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939274|NCT03046862|Gemcitabine|gemcitabine|mesh-list
138939275|NCT03046862|Durvalumab|durvalumab|mesh-list
138939276|NCT03046862|Tremelimumab|tremelimumab|mesh-list
138939277|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939278|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138939279|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
138939280|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939281|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939282|NCT03037385|Pralsetinib|pralsetinib|mesh-list
138939283|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939284|NCT03031210|Amoxicillin|amoxicillin|mesh-list
138939285|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138939286|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138939287|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138939288|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138939289|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939290|NCT02988921|Paclitaxel|paclitaxel|mesh-list
138939291|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138939292|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939293|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
138939294|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
138939295|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
138939296|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939297|NCT02981615|Levofloxacin|levofloxacin|mesh-list
138939298|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138939299|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138939300|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138939301|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138939302|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138939303|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939304|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939305|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939306|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138186650|NCT02959840|Metoclopramide|metoclopramide|mesh-list
138939307|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138939308|NCT02944799|Vitamin D|vitamin d|mesh-list
138939309|NCT02944799|Alendronate|alendronate|mesh-list
138939310|NCT02944799|Calcium|calcium|mesh-list
138939311|NCT02944799|Vitamins|vitamins|mesh-ancestor
138939312|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
138524629|NCT02970630|Tacrolimus|tacrolimus|mesh-list
138939313|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939314|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138939315|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138939317|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939318|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138939319|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939320|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939321|NCT02903680|Dexamethasone|dexamethasone|mesh-list
138489744|NCT00015028|Analgesics|analgesics|mesh-ancestor
138939322|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
138939323|NCT02903680|BB 1101|bb 1101|mesh-list
138939324|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138939325|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
138939326|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
138939327|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939328|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489802|NCT00015340|Analgesics|analgesics|mesh-ancestor
138939329|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939330|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
138939331|NCT02903680|Hormones|hormones|mesh-ancestor
138939332|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138939333|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138939334|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939335|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
138939336|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939337|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939338|NCT02864004|Apomorphine|apomorphine|mesh-list
138939339|NCT02864004|Emetics|emetics|mesh-ancestor
138939340|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939341|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
138939342|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939343|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939344|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
138939345|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
138939346|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138489868|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138939347|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939348|NCT02842424|Ramipril|ramipril|mesh-list
138939349|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138939350|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
138939351|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939352|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939353|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138939354|NCT02810743|Olaparib|olaparib|mesh-list
138939355|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138939356|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939357|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939358|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939359|NCT02759835|Osimertinib|osimertinib|mesh-list
138939360|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939361|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138939362|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939363|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939364|NCT02720094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138939365|NCT02720094|Cabotegravir|cabotegravir|mesh-list
138939366|NCT02720094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138939367|NCT02720094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138939368|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939369|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939370|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
138939371|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138939372|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138939373|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138939374|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138186740|NCT02240927|Warfarin|warfarin|mesh-list
138939375|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138939376|NCT02716012|Sorafenib|sorafenib|mesh-list
138939377|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939378|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138939379|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939380|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939381|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
138939382|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939383|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939384|NCT02628067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138939385|NCT02628067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939386|NCT02607722|Nintedanib|nintedanib|mesh-list
138419294|NCT06023641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939387|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939388|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138939390|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939391|NCT02567253|Cisplatin|cisplatin|mesh-list
138939392|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939393|NCT02564068|Oxytocin|oxytocin|mesh-list
138939394|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
138939395|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138939396|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939397|NCT02521493|Cytarabine|cytarabine|mesh-list
138939398|NCT02521493|Etoposide|etoposide|mesh-list
138939399|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
138939400|NCT02521493|Daunorubicin|daunorubicin|mesh-list
138939401|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
138939402|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
138939403|NCT02521493|Asparaginase|asparaginase|mesh-list
138939404|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
138939405|NCT02521493|Thioguanine|thioguanine|mesh-list
138939406|NCT02521493|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
138939407|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
138939408|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138939409|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939410|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138939411|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138186768|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138939412|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939413|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939414|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138939415|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
138939416|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
138939417|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138939418|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138939419|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
138939420|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939421|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138939422|NCT02521493|Analgesics|analgesics|mesh-ancestor
138939423|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
138939424|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939425|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138939426|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
138939427|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
138939428|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
138939429|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
138939430|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
138939431|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
138939432|NCT02419495|Leucovorin|leucovorin|mesh-list
138939433|NCT02419495|Folic Acid|folic acid|mesh-list
138939434|NCT02419495|Paclitaxel|paclitaxel|mesh-list
138939435|NCT02419495|Camptothecin|camptothecin|mesh-list
138939436|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
138939437|NCT02419495|Carboplatin|carboplatin|mesh-list
138939438|NCT02419495|Doxorubicin|doxorubicin|mesh-list
138939439|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138939440|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
138939441|NCT02419495|Capecitabine|capecitabine|mesh-list
138939442|NCT02419495|Fluorouracil|fluorouracil|mesh-list
138939443|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
138939444|NCT02419495|Nivolumab|nivolumab|mesh-list
138939445|NCT02419495|Irinotecan|irinotecan|mesh-list
138939446|NCT02419495|Pemetrexed|pemetrexed|mesh-list
138939447|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138939448|NCT02419495|Ipilimumab|ipilimumab|mesh-list
138939449|NCT02419495|Daunorubicin|daunorubicin|mesh-list
138939450|NCT02419495|Topotecan|topotecan|mesh-list
138939451|NCT02419495|Olaparib|olaparib|mesh-list
138939452|NCT02419495|Calcium|calcium|mesh-list
138939453|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
138939454|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138939455|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186806|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186807|NCT05368857|Afamelanotide|afamelanotide|mesh-list
138939456|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
138939457|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
138939458|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
138939459|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939460|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138939461|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
138939462|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939463|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138939464|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138939465|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
138939466|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138939467|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138939468|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138939469|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138939470|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939471|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939472|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138939473|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138939474|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138939475|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138939477|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138939478|NCT02419495|Antidotes|antidotes|mesh-ancestor
138939479|NCT02419495|Protective Agents|protective agents|mesh-ancestor
138939480|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
138939481|NCT02419495|Vitamins|vitamins|mesh-ancestor
138939482|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
138939483|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138939484|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138939485|NCT02419495|Hematinics|hematinics|mesh-ancestor
138939486|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138939487|NCT02400216|Cholic Acids|cholic acids|mesh-list
138939488|NCT02400216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939489|NCT02385617|Octreotide|octreotide|mesh-list
138939490|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939491|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138939492|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939493|NCT02381249|Octreotide|octreotide|mesh-list
138939494|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939495|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138939496|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939497|NCT02339922|Rituximab|rituximab|mesh-list
138939498|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138939499|NCT02339922|Ixazomib|ixazomib|mesh-list
138939500|NCT02339922|Antibodies|antibodies|mesh-list
138939501|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
138939502|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138939503|NCT02339922|Glycine|glycine|mesh-list
138939504|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
138939505|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939506|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939507|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138186909|NCT05528913|Benralizumab|benralizumab|mesh-list
138939508|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939509|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
138939510|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939511|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
138939512|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138939513|NCT02332356|Adalimumab|adalimumab|mesh-list
138939514|NCT02332356|Infliximab|infliximab|mesh-list
138939515|NCT02332356|Azathioprine|azathioprine|mesh-list
138939516|NCT02332356|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138939517|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138939518|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138939519|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
138939520|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939521|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
138939522|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939523|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138939524|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939525|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138939526|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
138939527|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939528|NCT02193620|Nalbuphine|nalbuphine|mesh-list
138939529|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138939530|NCT02193620|Narcotics|narcotics|mesh-ancestor
138939531|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138939532|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939533|NCT02193620|Analgesics|analgesics|mesh-ancestor
138939534|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
138939535|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939536|NCT02183168|Indomethacin|indomethacin|mesh-list
138939537|NCT02183168|Meloxicam|meloxicam|mesh-list
138939538|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138939539|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138939540|NCT02183168|Analgesics|analgesics|mesh-ancestor
138939541|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
138186950|NCT02242097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138939542|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939543|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939544|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138939545|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138939546|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
138939547|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
138939548|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138939549|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138939550|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939551|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939552|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138939553|NCT02183129|Diclofenac|diclofenac|mesh-list
138939554|NCT02183129|Meloxicam|meloxicam|mesh-list
138939555|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138939556|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138939558|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
138939559|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939560|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939561|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138939562|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138939563|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138939564|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939565|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939566|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138939567|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
138939568|NCT02176967|Carboplatin|carboplatin|mesh-list
138939569|NCT02176967|Doxorubicin|doxorubicin|mesh-list
138939570|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138939571|NCT02176967|Etoposide|etoposide|mesh-list
138939572|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
138939573|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
138939574|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138939575|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
138939576|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939577|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138939578|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138939579|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
138939580|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939581|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939582|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138166919|NCT04192916|Edoxaban|edoxaban|mesh-list
138939583|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138939584|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138939585|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138939586|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939587|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138939588|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
138939589|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
138939590|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
138939591|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
138939592|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
138939593|NCT02133196|Aldesleukin|aldesleukin|mesh-list
138939594|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
138939595|NCT02133196|Fludarabine|fludarabine|mesh-list
138939596|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138939597|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
138939598|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939599|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138939600|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138939601|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
138490576|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138939602|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187039|NCT02242331|Telmisartan|telmisartan|mesh-list
138939603|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939604|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138939605|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138939606|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138939607|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
138939608|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138939609|NCT01843530|Cortisone|cortisone|mesh-list
138939610|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138939611|NCT01720563|Leucovorin|leucovorin|mesh-list
138939612|NCT01720563|Tegafur|tegafur|mesh-list
138939613|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490689|NCT05419921|Lidocaine|lidocaine|mesh-list
138939614|NCT01720563|Antidotes|antidotes|mesh-ancestor
138939615|NCT01720563|Protective Agents|protective agents|mesh-ancestor
138939616|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939617|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
138939619|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
138939620|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138939621|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
138939622|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939623|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
138939624|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138939625|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
138939626|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939627|NCT01502280|Protective Agents|protective agents|mesh-ancestor
138939628|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939629|NCT01502280|Vitamins|vitamins|mesh-ancestor
138939630|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
138591606|NCT03007238|Aldesleukin|aldesleukin|mesh-list
138939631|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138939632|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
138939633|NCT01485809|Gefitinib|gefitinib|mesh-list
138939634|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490708|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
138939635|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138939636|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187079|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138939637|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939638|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
138939639|NCT01413100|Plerixafor|plerixafor|mesh-list
138939640|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
138939641|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
138939642|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138939643|NCT01413100|Lenograstim|lenograstim|mesh-list
138939644|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138939645|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
138939646|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939648|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138939649|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
138939650|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939651|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939652|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138939653|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138939654|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138939655|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138939656|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
138939657|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138939658|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138939659|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939660|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138939661|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138939662|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
138939663|NCT01349959|Azacitidine|azacitidine|mesh-list
138939664|NCT01349959|Entinostat|entinostat|mesh-list
138939665|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138939666|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138939667|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
138939668|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939669|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939670|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939671|NCT01331681|Aflibercept|aflibercept|mesh-list
138939672|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138939673|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138939674|NCT01331681|Growth Substances|growth substances|mesh-ancestor
138939675|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939676|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
138939677|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939678|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
138939679|NCT01286272|Bortezomib|bortezomib|mesh-list
138939680|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138939681|NCT01286272|Ofatumumab|ofatumumab|mesh-list
138939682|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138939683|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138939684|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939685|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138939686|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
138939687|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939688|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138939689|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
138939690|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
138939691|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138939692|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
138939693|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939694|NCT01215136|Paclitaxel|paclitaxel|mesh-list
138939695|NCT01215136|Everolimus|everolimus|mesh-list
138939696|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138939697|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939698|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
138939699|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
138939700|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
138711054|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138939701|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939702|NCT01215136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138939703|NCT01215136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138939704|NCT01215136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939705|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138939706|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
138939707|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939709|NCT01142401|Fulvestrant|fulvestrant|mesh-list
138939710|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939711|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138939712|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138939713|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138939714|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
138939715|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138939716|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939717|NCT01142388|Paclitaxel|paclitaxel|mesh-list
138939718|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138939719|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138939720|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138939721|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939722|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
138939723|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
138939724|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
138939725|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939726|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
138939727|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939729|NCT01134614|Sargramostim|sargramostim|mesh-list
138939730|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939731|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939732|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138939733|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939734|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
138939735|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939736|NCT00870636|Bevacizumab|bevacizumab|mesh-list
138939737|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939738|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939739|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138939740|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138939741|NCT00870636|Growth Substances|growth substances|mesh-ancestor
138939742|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939743|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
138939744|NCT00584532|Genistein|genistein|mesh-list
138939745|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138939746|NCT00584532|Protective Agents|protective agents|mesh-ancestor
138939747|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939748|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939749|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138939750|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939751|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939752|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
138491116|NCT03152149|Fluticasone|fluticasone|mesh-list
138939753|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138939754|NCT00584532|Estrogens|estrogens|mesh-ancestor
138939755|NCT00584532|Hormones|hormones|mesh-ancestor
138939756|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138939757|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
138939758|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
138939759|NCT00525759|Docetaxel|docetaxel|mesh-list
138939760|NCT00525759|Fluorouracil|fluorouracil|mesh-list
138939761|NCT00525759|Epirubicin|epirubicin|mesh-list
138939762|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138939763|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
138939764|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939765|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138939766|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138939767|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
138939768|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939769|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939770|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138939771|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
138939772|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
138939855|NCT00740168|Bevacizumab|bevacizumab|mesh-list
138939856|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939857|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939858|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138939859|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138939860|NCT00740168|Growth Substances|growth substances|mesh-ancestor
138491167|NCT03151603|Fosfomycin|fosfomycin|mesh-list
138939861|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939862|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
138939863|NCT05225974|Liraglutide|liraglutide|mesh-list
138939864|NCT05225974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138939865|NCT05225974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939866|NCT05225974|Incretins|incretins|mesh-ancestor
138939867|NCT05225974|Hormones|hormones|mesh-ancestor
138939868|NCT05225974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138939869|NCT00729638|Lenalidomide|lenalidomide|mesh-list
138939870|NCT00729638|Everolimus|everolimus|mesh-list
138939871|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
138939872|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939873|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138939874|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138939875|NCT00729638|Growth Substances|growth substances|mesh-ancestor
138939876|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
138939877|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939878|NCT00729638|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138939879|NCT00729638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138939880|NCT00729638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939881|NCT00729638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939882|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138939883|NCT00734682|Irinotecan|irinotecan|mesh-list
138939884|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138641104|NCT01331161|Vaccines|vaccines|mesh-list
138939885|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138939886|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939887|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939888|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939889|NCT00732108|Topiramate|topiramate|mesh-list
138939890|NCT00732108|Lactulose|lactulose|mesh-list
138939891|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
138939892|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138939893|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939894|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939895|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
138939896|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
138939897|NCT00876616|Tacrolimus|tacrolimus|mesh-list
138939898|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138939899|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
138939900|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939901|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138939902|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138939903|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
138939904|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939905|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939906|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138939907|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138939908|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138939909|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138939910|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138939911|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
138939912|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138939913|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138939914|NCT05575440|Fluorides|fluorides|mesh-list
138939915|NCT05575440|Cariostatic Agents|cariostatic agents|mesh-ancestor
138939916|NCT05575440|Protective Agents|protective agents|mesh-ancestor
138939917|NCT05575440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939918|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
138939919|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
138939920|NCT00729794|Vasopressins|vasopressins|mesh-list
138939921|NCT00729794|Epinephrine|epinephrine|mesh-list
138187436|NCT02993302|Vitamins|vitamins|mesh-ancestor
138939922|NCT00729794|Racepinephrine|racepinephrine|mesh-list
138939923|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
138939924|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138939925|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
138939926|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
138939927|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939928|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939929|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939930|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
138939931|NCT00729794|Hormones|hormones|mesh-ancestor
138939932|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138939933|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138939934|NCT00729794|Protective Agents|protective agents|mesh-ancestor
138939935|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138939936|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138939937|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
138939938|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138939939|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939940|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138939941|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138939942|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138939943|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
138939944|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
138939945|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
138939946|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138939947|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
138939948|NCT00729794|Coagulants|coagulants|mesh-ancestor
138939949|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138939950|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
138187459|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187470|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138939951|NCT00871546|Bortezomib|bortezomib|mesh-list
138939952|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
138939953|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939954|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939955|NCT00732186|Ipilimumab|ipilimumab|mesh-list
138939956|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939957|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939958|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138939959|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939961|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
138939962|NCT04039828|Trace Elements|trace elements|mesh-ancestor
138939963|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
138939964|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939965|NCT04039828|Astringents|astringents|mesh-ancestor
138939966|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
138939967|NCT00876772|Olanzapine|olanzapine|mesh-list
138939968|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
138939969|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
138939970|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939971|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939972|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138939973|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138939974|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138939975|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138939976|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138939977|NCT00876772|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138939978|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138939979|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138939980|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939981|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138939982|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
138939983|NCT00729950|Ipilimumab|ipilimumab|mesh-list
138491426|NCT01807429|Midazolam|midazolam|mesh-list
138939984|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939985|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939986|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138187507|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
138187522|NCT00923117|Sunitinib|sunitinib|mesh-list
138939987|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138939988|NCT00616018|Acetaminophen|acetaminophen|mesh-list
138939989|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138939990|NCT00616018|Analgesics|analgesics|mesh-ancestor
138939991|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
138939992|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138939993|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138939994|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
138939995|NCT00740948|Rituximab|rituximab|mesh-list
138939996|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138939997|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138939998|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
138939999|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940000|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138940001|NCT00876850|Linezolid|linezolid|mesh-list
138940002|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138940003|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940004|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138940005|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940006|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940007|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138187544|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138187545|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
138940008|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138940009|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138940010|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138940011|NCT05157412|Doxycycline|doxycycline|mesh-list
138940012|NCT05157412|Prednisolone|prednisolone|mesh-list
138940013|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138940014|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
138940015|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138940016|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
138940017|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138940018|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
138940019|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138940020|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
138940022|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138940023|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940024|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138940025|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940027|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
138940028|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940029|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138940030|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138940031|NCT05157412|Protective Agents|protective agents|mesh-ancestor
138940032|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138940033|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940034|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
138940035|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138940036|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138940037|NCT00732420|Topotecan|topotecan|mesh-list
138940038|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138940039|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138940040|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940041|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940042|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940043|NCT00735228|Pancrelipase|pancrelipase|mesh-list
138940044|NCT00735228|Pancreatin|pancreatin|mesh-list
138940045|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138940046|NCT00739128|Vaccines|vaccines|mesh-list
138940047|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
138940048|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940049|NCT00863668|Tenofovir|tenofovir|mesh-list
138940050|NCT00863668|Emtricitabine|emtricitabine|mesh-list
138940051|NCT00863668|Efavirenz|efavirenz|mesh-list
138940052|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
138187595|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
138711055|NCT02900729|Diuretics|diuretics|mesh-ancestor
138187596|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138187609|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
138940053|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138940054|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138940055|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
138940056|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
138940057|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940058|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138940059|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940060|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940061|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138940062|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138491705|NCT01465009|Aspirin|aspirin|mesh-list
138940063|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138940064|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138940065|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138940066|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138940067|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138940068|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138940069|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138940070|NCT00872248|Anesthetics|anesthetics|mesh-list
138940071|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187626|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940072|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940073|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
138940075|NCT00732576|Menaquinone 7|menaquinone 7|mesh-list
138940076|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138940077|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138940078|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940079|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
138940080|NCT00732576|Coagulants|coagulants|mesh-ancestor
138940081|NCT00732576|Vitamins|vitamins|mesh-ancestor
138940082|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
138940083|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592055|NCT00519259|Lobeline|lobeline|mesh-list
138940085|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138940086|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138940087|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138940088|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
138940089|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
138940090|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940091|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940092|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940093|NCT00732810|Capecitabine|capecitabine|mesh-list
138940094|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138940095|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138940096|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
138940097|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187684|NCT03062488|Analgesics|analgesics|mesh-ancestor
138940098|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940099|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138940100|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940101|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
138940102|NCT00732888|Calcium|calcium|mesh-list
138940103|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138940104|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940105|NCT00732888|Antacids|antacids|mesh-ancestor
138940106|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940107|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138940108|NCT00732966|Losartan|losartan|mesh-list
138940109|NCT00732966|Valsartan|valsartan|mesh-list
138940110|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138940111|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138940112|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138940113|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940114|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138940115|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138940116|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
138940117|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138940118|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
138940119|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138940120|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940121|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138940122|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138940123|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940124|NCT00424021|Ambrisentan|ambrisentan|mesh-list
138940125|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138940126|NCT00735930|Lenalidomide|lenalidomide|mesh-list
138940127|NCT00735930|Alvocidib|alvocidib|mesh-list
138940128|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
138940129|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940130|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138940131|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138940132|NCT00735930|Growth Substances|growth substances|mesh-ancestor
138940133|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
138940134|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940135|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138940136|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940137|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940139|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138940140|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138940141|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940142|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
138940143|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940145|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
138940146|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940147|NCT00577460|Protective Agents|protective agents|mesh-ancestor
138940148|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940149|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138940150|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138940151|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
138940152|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
138940153|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940154|NCT00863980|Telmisartan|telmisartan|mesh-list
138940155|NCT00863980|Candesartan|candesartan|mesh-list
138940156|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
138940157|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138940158|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138187797|NCT01575925|BB 1101|bb 1101|mesh-list
138940159|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138940160|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940161|NCT00415519|Edaravone|edaravone|mesh-list
138940162|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138940163|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
138940164|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940165|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138940167|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940168|NCT02568176|Midazolam|midazolam|mesh-list
138940169|NCT02568176|Bupropion|bupropion|mesh-list
138940170|NCT02568176|Esketamine|esketamine|mesh-list
138940171|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138940172|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138940173|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138940174|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940175|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138940176|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138940177|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138940178|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138940179|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
138940180|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
138940181|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
138940182|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
138940183|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940184|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940185|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138940186|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
138940187|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138940188|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138940189|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138940190|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
138940191|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138491950|NCT00846625|Growth Substances|growth substances|mesh-ancestor
138940192|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138940194|NCT00741182|Teriparatide|teriparatide|mesh-list
138940195|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138940196|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940197|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138940198|NCT00423943|Modafinil|modafinil|mesh-list
138940199|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138187826|NCT00936377|Analgesics|analgesics|mesh-ancestor
138940200|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940201|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138940202|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138940203|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138641188|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138940204|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940205|NCT00736346|Paroxetine|paroxetine|mesh-list
138940206|NCT00736346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138940207|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138940208|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138940209|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940210|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940211|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
138940212|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940213|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138940214|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
138940215|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138940216|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138940217|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138940218|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940220|NCT00864058|Analgesics|analgesics|mesh-ancestor
138940221|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
138940222|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940223|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940224|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
138940225|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138940226|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138940227|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138940228|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138940229|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138940230|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138940231|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940232|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940233|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
138940234|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
138940235|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138940236|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
138187860|NCT02982395|Ethanol|ethanol|mesh-list
138940237|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138940238|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940239|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138940240|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138940241|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138940242|NCT00864214|Hormones|hormones|mesh-list
138940243|NCT00864214|Estradiol|estradiol|mesh-list
138492036|NCT00277108|Escitalopram|escitalopram|mesh-list
138940244|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138940245|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940246|NCT00864214|Estrogens|estrogens|mesh-ancestor
138940247|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
138940248|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138940249|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940250|NCT00428389|Rivastigmine|rivastigmine|mesh-list
138940251|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138940252|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940253|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940254|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
138940255|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940256|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940257|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138940258|NCT00428389|Protective Agents|protective agents|mesh-ancestor
138940259|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
138940260|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138940261|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940262|NCT02568488|Metformin|metformin|mesh-list
138940263|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138940264|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940265|NCT01324063|Cytarabine|cytarabine|mesh-list
138940266|NCT01324063|Daunorubicin|daunorubicin|mesh-list
138940267|NCT01324063|Amsacrine|amsacrine|mesh-list
138940268|NCT01324063|Sargramostim|sargramostim|mesh-list
138940269|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138940270|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
138940271|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940272|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940273|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
138940274|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940275|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138940276|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
138940277|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940278|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138940279|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138940280|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138940281|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940282|NCT00864448|Ramipril|ramipril|mesh-list
138940283|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138940284|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
138940285|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940286|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940287|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138940288|NCT00406315|Ziprasidone|ziprasidone|mesh-list
138940289|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138215122|NCT01591837|Vaccines|vaccines|mesh-list
138940290|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
138940291|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940292|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940293|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940294|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138940295|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138940296|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138940297|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138940298|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138940299|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
138940300|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138940301|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
138940302|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138940303|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138940304|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138940305|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711056|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
138187925|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
138940306|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592279|NCT04694092|Landiolol|landiolol|mesh-list
138940307|NCT00864526|Ibuprofen|ibuprofen|mesh-list
138940308|NCT00864526|Oxycodone|oxycodone|mesh-list
138940309|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138940310|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138940311|NCT00864526|Analgesics|analgesics|mesh-ancestor
138940312|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
138940313|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940314|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940315|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138940316|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138940317|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138940318|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940319|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940320|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138940321|NCT00864526|Narcotics|narcotics|mesh-ancestor
138940322|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138940323|NCT00864604|Nabumetone|nabumetone|mesh-list
138940324|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138940325|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138940326|NCT00864604|Analgesics|analgesics|mesh-ancestor
138940327|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
138940328|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940329|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940330|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138940331|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187968|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187969|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187970|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
138940332|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138940333|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138940334|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940335|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940336|NCT04064138|Anesthetics|anesthetics|mesh-list
138940337|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138940338|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940339|NCT01323751|Ricolinostat|ricolinostat|mesh-list
138940340|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940341|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138940342|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492324|NCT02921555|Prednisone|prednisone|mesh-list
138940343|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940345|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940346|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138940347|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940348|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940349|NCT00864760|Gabapentin|gabapentin|mesh-list
138940350|NCT00864760|Analgesics|analgesics|mesh-ancestor
138940351|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
138940352|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138492371|NCT02632760|Hematinics|hematinics|mesh-ancestor
138940353|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940354|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
138940355|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138940356|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138188022|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
138188027|NCT05026905|Vitamins|vitamins|mesh-ancestor
138420162|NCT05428826|Hormones|hormones|mesh-ancestor
138940357|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138940358|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138940359|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138940360|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138940361|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940362|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940364|NCT00710762|Nintedanib|nintedanib|mesh-list
138940365|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940366|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138940367|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940368|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940369|NCT05137912|Immunomodulating Agents|immunomodulating agents|mesh-list
138940370|NCT05137912|Immunologic Factors|immunologic factors|mesh-ancestor
138940371|NCT05137912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940373|NCT00736814|Gemcitabine|gemcitabine|mesh-list
138940374|NCT00736814|Docetaxel|docetaxel|mesh-list
138940375|NCT00736814|Vinorelbine|vinorelbine|mesh-list
138940376|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940377|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138940378|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
138188079|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188091|NCT03073876|Donepezil|donepezil|mesh-list
138940379|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940380|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
138592354|NCT03458923|Diclofenac|diclofenac|mesh-list
138940381|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
138940382|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
138940383|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138940384|NCT04063904|Misoprostol|misoprostol|mesh-list
138940385|NCT04063904|Mifepristone|mifepristone|mesh-list
138940386|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138940387|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
138940388|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138940389|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940390|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138940391|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138940392|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
138940393|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138940394|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138940395|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138940396|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138940397|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
138940398|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138940399|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138940400|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
138940401|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138940402|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
138940403|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138940404|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138940405|NCT00573430|Candesartan|candesartan|mesh-list
138940406|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
138940407|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138940408|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138188137|NCT05394415|Paclitaxel|paclitaxel|mesh-list
138492539|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940409|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138940410|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940412|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138940413|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940414|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138940415|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138940416|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138940417|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940418|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138940420|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138940421|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138940422|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138492604|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
138940423|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138940424|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
138940425|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940426|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940427|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940428|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
138940429|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138940430|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940431|NCT00864838|Diuretics|diuretics|mesh-ancestor
138940432|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
138940433|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138940434|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138940435|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940437|NCT00615550|Progestins|progestins|mesh-ancestor
138940438|NCT00615550|Hormones|hormones|mesh-ancestor
138188174|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
138188178|NCT00375076|Enoxaparin|enoxaparin|mesh-list
138940439|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138940440|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940441|NCT00736164|Selenium|selenium|mesh-list
138940442|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
138940443|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940444|NCT00736164|Protective Agents|protective agents|mesh-ancestor
138940445|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940446|NCT00736164|Trace Elements|trace elements|mesh-ancestor
138940447|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
138940448|NCT00739830|Sirolimus|sirolimus|mesh-list
138940449|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138940450|NCT00739830|Megestrol|megestrol|mesh-list
138940451|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
138940452|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
138940453|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138940454|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138940455|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138940456|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
138940457|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138940458|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940459|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138940460|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138940461|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138940462|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138940463|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940464|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
138940465|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138940466|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138940467|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940468|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138940469|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
138940470|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138940471|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
138940472|NCT00577382|Sunitinib|sunitinib|mesh-list
138940473|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940474|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138940475|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138940476|NCT00577382|Growth Substances|growth substances|mesh-ancestor
138940477|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940478|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
138940479|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138940480|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940481|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940482|NCT00733434|Alprostadil|alprostadil|mesh-list
138940483|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138940484|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
138940485|NCT00733434|Urological Agents|urological agents|mesh-ancestor
138940486|NCT00736320|Vincristine|vincristine|mesh-list
138940487|NCT00736320|Doxorubicin|doxorubicin|mesh-list
138940488|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138940489|NCT00736320|Dacarbazine|dacarbazine|mesh-list
138940490|NCT00736320|Bleomycin|bleomycin|mesh-list
138940491|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138940492|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940493|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
138940494|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
138940495|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
138940496|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940497|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138940498|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138940499|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138940500|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940501|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138940502|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
138940503|NCT04065282|Capecitabine|capecitabine|mesh-list
138940504|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
138940505|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138940506|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
138940507|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940508|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940509|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138940510|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138940511|NCT00873262|Estropipate|estropipate|mesh-list
138940512|NCT00873262|Estradiol|estradiol|mesh-list
138940513|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138940514|NCT00873262|Estrone|estrone|mesh-list
138940515|NCT00873262|Progesterone|progesterone|mesh-list
138940516|NCT00873262|Estrogens|estrogens|mesh-ancestor
138940517|NCT00873262|Hormones|hormones|mesh-ancestor
138492881|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940518|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138940519|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940520|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138940522|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138462808|NCT05303038|Growth Inhibitors|growth inhibitors|mesh-ancestor
138940523|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138940524|NCT00873262|Progestins|progestins|mesh-ancestor
138940525|NCT00736970|Sirolimus|sirolimus|mesh-list
138940526|NCT00736970|Trastuzumab|trastuzumab|mesh-list
138940527|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138940528|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940529|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138940530|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940531|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138940532|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
138940533|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138940534|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
138940535|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940536|NCT00873340|Interferons|interferons|mesh-list
138940537|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
138940538|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940539|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
138940540|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940541|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138940542|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
138940543|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940544|NCT00740064|Lamivudine|lamivudine|mesh-list
138940545|NCT00740064|Abacavir|abacavir|mesh-list
138940546|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
138940547|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138940548|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138940549|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940550|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940551|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
138940552|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940553|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138940554|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138940555|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138940556|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138940557|NCT00614926|Modafinil|modafinil|mesh-list
138462849|NCT04609098|Piperaquine|piperaquine|mesh-list
138462850|NCT04609098|Artenimol|artenimol|mesh-list
138940558|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138940559|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940560|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138940561|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138940562|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138940563|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940564|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
138940565|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
138940566|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138940567|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138940568|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940569|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940570|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940571|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138940573|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138940574|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
138940575|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
138940576|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138940577|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940578|NCT00740142|Lactulose|lactulose|mesh-list
138940579|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
138940580|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138940581|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138940582|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138940583|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940584|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940585|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940586|NCT00873652|Vaccines|vaccines|mesh-list
138940587|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
138940588|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940589|NCT00423319|Enoxaparin|enoxaparin|mesh-list
138940590|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
138940591|NCT00423319|Apixaban|apixaban|mesh-list
138462890|NCT04321551|Hormone Antagonists|hormone antagonists|mesh-ancestor
138462893|NCT04321551|Androgens|androgens|mesh-ancestor
138940592|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
138940593|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138940594|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138940595|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940596|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138940597|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
138940598|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138940599|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
138940600|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940601|NCT05224492|Sulforaphane|sulforaphane|mesh-list
138940602|NCT05224492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138940603|NCT05224492|Protective Agents|protective agents|mesh-ancestor
138940604|NCT05224492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940605|NCT05224492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940606|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138940607|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
138940608|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138940609|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138940610|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138940611|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138940612|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940614|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
138940616|NCT04039126|Tetracycline|tetracycline|mesh-list
138940618|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138940619|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940620|NCT04039126|Trace Elements|trace elements|mesh-ancestor
138940621|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
138940622|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940623|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
138940624|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
138940625|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138940626|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138940627|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940628|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940629|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
138940630|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
138940631|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
138940632|NCT00873808|Tetracycline|tetracycline|mesh-list
138940633|NCT00873808|Demeclocycline|demeclocycline|mesh-list
138940634|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138940635|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493225|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138940636|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138940637|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940638|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138940639|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940640|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940641|NCT04064190|Durvalumab|durvalumab|mesh-list
138940642|NCT04064190|Vactosertib|vactosertib|mesh-list
138940643|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138940644|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940645|NCT04064190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138940646|NCT04064190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940647|NCT04064190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940648|NCT00873886|Oseltamivir|oseltamivir|mesh-list
138940649|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
138940650|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940651|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940652|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940653|NCT00880282|Sirolimus|sirolimus|mesh-list
138940654|NCT00880282|Temsirolimus|temsirolimus|mesh-list
138940655|NCT00880282|MTOR Inhibitors|mtor inhibitors|mesh-list
138940656|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138940657|NCT00880282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138940658|NCT00880282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940659|NCT00880282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940660|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138940661|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
138940662|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940663|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940664|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138940665|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940666|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138940668|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138940669|NCT00874042|Gemcitabine|gemcitabine|mesh-list
138940670|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138940671|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
138940672|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940673|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940674|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
138940675|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138940676|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
138940677|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940678|NCT00736866|Expectorants|expectorants|mesh-ancestor
138940679|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
138940680|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138592652|NCT00512395|Fentanyl|fentanyl|mesh-list
138940682|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940683|NCT00736866|Protective Agents|protective agents|mesh-ancestor
138940684|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940686|NCT00879424|Vitamin D|vitamin d|mesh-list
138940687|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
138940688|NCT00879424|Vitamins|vitamins|mesh-ancestor
138940689|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
138940690|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940691|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138940692|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138940693|NCT00710684|Donepezil|donepezil|mesh-list
138463004|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463011|NCT02625610|Vitamins|vitamins|mesh-ancestor
138940694|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138940695|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940696|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940697|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
138493462|NCT00089206|Sargramostim|sargramostim|mesh-list
138940698|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940699|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940700|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
138940702|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138940703|NCT00710606|Desogestrel|desogestrel|mesh-list
138940704|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138940705|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
138940706|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138940707|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940708|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138940709|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138940710|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138940711|NCT00710606|Estrogens|estrogens|mesh-ancestor
138940712|NCT00710606|Hormones|hormones|mesh-ancestor
138940713|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138940714|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138940715|NCT00710606|Progestins|progestins|mesh-ancestor
138940716|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
138940718|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138940719|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138940720|NCT00713544|Analgesics|analgesics|mesh-ancestor
138940721|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
138940722|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940723|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940724|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463062|NCT05414721|Desflurane|desflurane|mesh-list
138940725|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138940726|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138940727|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138940728|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
138940729|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138940730|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940731|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138940732|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138940733|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
138940734|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940735|NCT00737126|Folic Acid|folic acid|mesh-list
138940736|NCT00737126|Hematinics|hematinics|mesh-ancestor
138940737|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
138940738|NCT00737126|Vitamins|vitamins|mesh-ancestor
138940739|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
138940740|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940741|NCT04063046|Anesthetics|anesthetics|mesh-list
138940742|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138940743|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940744|NCT05529056|Atropine|atropine|mesh-list
138940745|NCT05529056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138493590|NCT00089518|Valsartan|valsartan|mesh-list
138940746|NCT05529056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138940747|NCT05529056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138940748|NCT05529056|Autonomic Agents|autonomic agents|mesh-ancestor
138463096|NCT05413902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138940749|NCT05529056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940750|NCT05529056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940751|NCT05529056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138940752|NCT05529056|Respiratory System Agents|respiratory system agents|mesh-ancestor
138940753|NCT05529056|Mydriatics|mydriatics|mesh-ancestor
138940754|NCT05529056|Parasympatholytics|parasympatholytics|mesh-ancestor
138940755|NCT05529056|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138940756|NCT05529056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138940757|NCT05529056|Cholinergic Agents|cholinergic agents|mesh-ancestor
138940758|NCT05529056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940759|NCT05529056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940760|NCT00740922|Becaplermin|becaplermin|mesh-list
138940761|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
138940762|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
138641340|NCT00298974|Analgesics|analgesics|mesh-ancestor
138493621|NCT00089869|Olanzapine|olanzapine|mesh-list
138940763|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138940764|NCT00740922|Growth Substances|growth substances|mesh-ancestor
138940765|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940766|NCT00741078|Amlodipine|amlodipine|mesh-list
138940767|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138940768|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138940769|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138940770|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940771|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138940772|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940773|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
138940774|NCT02568800|Cefepime|cefepime|mesh-list
138940775|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138940776|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940777|NCT00741234|Azacitidine|azacitidine|mesh-list
138493673|NCT00090727|AQ4N|aq4n|mesh-list
138940778|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138940779|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
138940780|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940781|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940782|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940783|NCT00713258|Alendronate|alendronate|mesh-list
138940785|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
138940786|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138940787|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940788|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138940789|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138940790|NCT00710034|Nicotine|nicotine|mesh-list
138940791|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138940792|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
138940793|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940794|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940795|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138940796|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138940797|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
138940798|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940799|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940800|NCT02567942|Propofol|propofol|mesh-list
138940801|NCT02567942|Sevoflurane|sevoflurane|mesh-list
138940802|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138940803|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138940804|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940805|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138940806|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
138940807|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
138493790|NCT00006203|Naltrexone|naltrexone|mesh-list
138940808|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138940809|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138940810|NCT00414973|Teriparatide|teriparatide|mesh-list
138940812|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
138940813|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138940814|NCT00414973|Katacalcin|katacalcin|mesh-list
138940815|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138940816|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940817|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138940818|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
138940819|NCT00423085|Rivastigmine|rivastigmine|mesh-list
138940820|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138940821|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940822|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940823|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
138940824|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940825|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940826|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138940827|NCT00423085|Protective Agents|protective agents|mesh-ancestor
138592806|NCT02947711|Diltiazem|diltiazem|mesh-list
138940828|NCT00414661|Tofacitinib|tofacitinib|mesh-list
138940829|NCT00414661|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138940830|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138940831|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940832|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940833|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
138940835|NCT01608451|Progesterone|progesterone|mesh-list
138940836|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138940837|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940838|NCT01608451|Vitamins|vitamins|mesh-ancestor
138940839|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
138940840|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138940841|NCT01608451|Progestins|progestins|mesh-ancestor
138940842|NCT01608451|Hormones|hormones|mesh-ancestor
138940843|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138940844|NCT00405067|Ezetimibe|ezetimibe|mesh-list
138940845|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138940846|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138940847|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
138940848|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463226|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463227|NCT04641234|Aflibercept|aflibercept|mesh-list
138384776|NCT02966665|Vitamins|vitamins|mesh-list
138940849|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138940850|NCT00708708|Etanercept|etanercept|mesh-list
138940851|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138940852|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138940853|NCT00708708|Analgesics|analgesics|mesh-ancestor
138940854|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
138940855|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940856|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940857|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138940858|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138940859|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138940860|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138940861|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
138940862|NCT00404755|Bupropion|bupropion|mesh-list
138940863|NCT00404755|Imipramine|imipramine|mesh-list
138940864|NCT00404755|Escitalopram|escitalopram|mesh-list
138940865|NCT00404755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138940866|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138940867|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138940868|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940869|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940870|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
138940871|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463265|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138463266|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
138463267|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138940872|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138940873|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
138940874|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138940875|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138940876|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
138940877|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138494019|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138940878|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138940879|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940880|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138940881|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138940882|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
138940884|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
138940885|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940886|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138940887|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138940888|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138940889|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
138940890|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940891|NCT00737256|Aripiprazole|aripiprazole|mesh-list
138940892|NCT00737256|Perphenazine|perphenazine|mesh-list
138940893|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
138940894|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138940895|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138940896|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138940897|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138940898|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940899|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
138463323|NCT03600818|Prednisone|prednisone|mesh-list
138940900|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
138940901|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138494085|NCT00006239|Tretinoin|tretinoin|mesh-list
138940902|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592875|NCT00524875|Bevacizumab|bevacizumab|mesh-list
138940903|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138940904|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138940905|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
138940906|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138940907|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138940908|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138940909|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138940910|NCT00614614|Vaccines|vaccines|mesh-list
138940911|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
138940912|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940913|NCT00713310|Mesalamine|mesalamine|mesh-list
138940914|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138940915|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138940916|NCT00713310|Analgesics|analgesics|mesh-ancestor
138940917|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
138940918|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940919|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940920|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138940922|NCT05740488|Hormones|hormones|mesh-list
138940923|NCT05740488|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138940924|NCT05740488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138940925|NCT05740488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940926|NCT05742126|Heparin|heparin|mesh-list
138940927|NCT05742126|Calcium heparin|calcium heparin|mesh-list
138463360|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138463364|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940928|NCT05742126|Anticoagulants|anticoagulants|mesh-ancestor
138940929|NCT05742126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138940930|NCT05742126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138940931|NCT05742126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940932|NCT00882856|Bisoprolol|bisoprolol|mesh-list
138940933|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138940934|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
138940935|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
138940936|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940937|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940938|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138940939|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138940940|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138940941|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
138940942|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940943|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940944|NCT00880672|Dutasteride|dutasteride|mesh-list
138494186|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
138940945|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138940946|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138940947|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940948|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940949|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
138463404|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138940950|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138940951|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940952|NCT00737724|Efavirenz|efavirenz|mesh-list
138940953|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138940954|NCT00737724|Isoniazid|isoniazid|mesh-list
138940955|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138940956|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138940957|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940958|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940959|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
138940960|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138940961|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138940962|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138940963|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138940964|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138940965|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138940966|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138940967|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138940968|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138940969|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
138940970|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138940971|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138940972|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138940973|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
138940974|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138940975|NCT00880828|Acetaminophen|acetaminophen|mesh-list
138940976|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138940977|NCT00880828|Analgesics|analgesics|mesh-ancestor
138940978|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
138940979|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940980|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463458|NCT01968213|Rucaparib|rucaparib|mesh-list
138940981|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
138940983|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138940984|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
138940985|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138940986|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138940987|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138940988|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
138940989|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138940990|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138940991|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138940992|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138940993|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138940994|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138940995|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
138940996|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
138940997|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138940998|NCT00874744|Triamcinolone|triamcinolone|mesh-list
138940999|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138941000|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138941001|NCT00874744|Bevacizumab|bevacizumab|mesh-list
138941002|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138941003|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138941004|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941005|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138941006|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138941007|NCT00874744|Growth Substances|growth substances|mesh-ancestor
138941008|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941009|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
138941010|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138941011|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
138941012|NCT00874744|Hormones|hormones|mesh-ancestor
138941013|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138941014|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138941015|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
138941016|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941017|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941018|NCT05736744|Magnesium Sulfate|magnesium sulfate|mesh-list
138941019|NCT05736744|Bromides|bromides|mesh-list
138941020|NCT05736744|Rocuronium|rocuronium|mesh-list
138941021|NCT05736744|Atracurium|atracurium|mesh-list
138941022|NCT05736744|Cisatracurium|cisatracurium|mesh-list
138941023|NCT05736744|Anticonvulsants|anticonvulsants|mesh-ancestor
138941024|NCT05736744|Analgesics|analgesics|mesh-ancestor
138941025|NCT05736744|Sensory System Agents|sensory system agents|mesh-ancestor
138941026|NCT05736744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138385426|NCT01469559|Insulin|insulin|mesh-list
138941027|NCT05736744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941028|NCT05736744|Anesthetics|anesthetics|mesh-ancestor
138941029|NCT05736744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941030|NCT05736744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138941031|NCT05736744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138941032|NCT05736744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138941033|NCT05736744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494461|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138941034|NCT05736744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138941035|NCT05736744|Tocolytic Agents|tocolytic agents|mesh-ancestor
138941036|NCT05736744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138941037|NCT05736744|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138941038|NCT05736744|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138941039|NCT05736744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138941040|NCT05736744|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138941041|NCT05736744|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138941042|NCT05736744|Cholinergic Agents|cholinergic agents|mesh-ancestor
138941043|NCT05736744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941044|NCT00920868|Bevacizumab|bevacizumab|mesh-list
138941045|NCT00920868|Capecitabine|capecitabine|mesh-list
138941046|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
138941047|NCT00920868|Dasatinib|dasatinib|mesh-list
138593026|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138941048|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138941049|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941050|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138941051|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138941052|NCT00920868|Growth Substances|growth substances|mesh-ancestor
138463604|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138463606|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
138941053|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941054|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
138941055|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138941057|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941058|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138941059|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941060|NCT05741814|Propofol|propofol|mesh-list
138941061|NCT05741814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138941062|NCT05741814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941063|NCT05741814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941064|NCT05741814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138941065|NCT05741814|Anesthetics, General|anesthetics, general|mesh-ancestor
138941066|NCT05741814|Anesthetics|anesthetics|mesh-ancestor
138941067|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
138941068|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138941069|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
138941070|NCT04721626|Tetracycline|tetracycline|mesh-list
138941071|NCT04721626|Doxycycline|doxycycline|mesh-list
138941072|NCT04721626|Povidone|povidone|mesh-list
138941073|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138941074|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941075|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
138941076|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
138941077|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
138941078|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
138941079|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138941080|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138941081|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463651|NCT01946906|Rifaximin|rifaximin|mesh-list
138641381|NCT00293475|Carboplatin|carboplatin|mesh-list
138941082|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941083|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
138941084|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138941085|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138941086|NCT00881140|Mifepristone|mifepristone|mesh-list
138941087|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138941088|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
138941089|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138941090|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941091|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138941093|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138941094|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
138941095|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138941096|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138941097|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
138941098|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138941099|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
138941100|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138941101|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138941102|NCT05733078|Vitamins|vitamins|mesh-list
138941105|NCT05733078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941106|NCT05733078|Antioxidants|antioxidants|mesh-ancestor
138941107|NCT05733078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941108|NCT05733078|Protective Agents|protective agents|mesh-ancestor
138941109|NCT00874978|Lenalidomide|lenalidomide|mesh-list
138941110|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
138941111|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941112|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138941113|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138494833|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494834|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463697|NCT01947114|Propofol|propofol|mesh-list
138494835|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138494836|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138171255|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
138494837|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
138494838|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494839|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138494840|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138494841|NCT00006356|Carboplatin|carboplatin|mesh-list
138941115|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
138941116|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941117|NCT00737880|Pancrelipase|pancrelipase|mesh-list
138941118|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138941119|NCT05728632|Nebivolol|nebivolol|mesh-list
138941120|NCT05728632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138941121|NCT05728632|Vasodilator Agents|vasodilator agents|mesh-ancestor
138941122|NCT05728632|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138941123|NCT05728632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138593102|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138941124|NCT05728632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138941126|NCT05728632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941127|NCT05728632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941128|NCT05728632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941129|NCT00612586|Leucovorin|leucovorin|mesh-list
138941130|NCT00612586|Bevacizumab|bevacizumab|mesh-list
138941131|NCT00612586|Fluorouracil|fluorouracil|mesh-list
138941132|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138641396|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
138941133|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941134|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138463739|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941135|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138941136|NCT00612586|Growth Substances|growth substances|mesh-ancestor
138941137|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941138|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
138941139|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
138494960|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
138941140|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941141|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138941142|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138941143|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
138941145|NCT00612586|Protective Agents|protective agents|mesh-ancestor
138941146|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
138941147|NCT00612586|Vitamins|vitamins|mesh-ancestor
138941148|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
138941149|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
138941150|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138941151|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138941152|NCT00614380|Amlodipine|amlodipine|mesh-list
138941153|NCT00614380|Telmisartan|telmisartan|mesh-list
138495007|NCT00100750|Gemcitabine|gemcitabine|mesh-list
138941154|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138941155|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138941156|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138463784|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138941157|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138941158|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941159|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138941160|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941161|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
138941162|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138941163|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138941165|NCT00738192|Sufentanil|sufentanil|mesh-list
138941166|NCT00738192|Dsuvia|dsuvia|mesh-list
138941167|NCT00738192|Butorphanol|butorphanol|mesh-list
138941168|NCT00738192|Citric Acid|citric acid|mesh-list
138941169|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
138941170|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138941171|NCT00738192|Narcotics|narcotics|mesh-ancestor
138941172|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941173|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941174|NCT00738192|Analgesics|analgesics|mesh-ancestor
138941175|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
138941176|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941177|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138941178|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138941179|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
138941180|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
138941181|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
138941182|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138941183|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
138941184|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
138941185|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941186|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
138941187|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
138941188|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138941189|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
138463839|NCT01948024|Asenapine|asenapine|mesh-list
138941190|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138941191|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138941192|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
138941193|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941194|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641427|NCT00299013|Hormones|hormones|mesh-ancestor
138941195|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941196|NCT00884104|Urological Agents|urological agents|mesh-ancestor
138941197|NCT04140214|Carbocysteine|carbocysteine|mesh-list
138941198|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138941199|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941200|NCT04140214|Expectorants|expectorants|mesh-ancestor
138941201|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
138941202|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138941203|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138941204|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138941205|NCT00612508|Etonogestrel|etonogestrel|mesh-list
138941206|NCT00612508|Desogestrel|desogestrel|mesh-list
138941207|NCT00612508|NuvaRing|nuvaring|mesh-list
138941208|NCT00612508|Estradiol|estradiol|mesh-list
138941209|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138941210|NCT00612508|Estrogens|estrogens|mesh-ancestor
138941211|NCT00612508|Hormones|hormones|mesh-ancestor
138495107|NCT00101140|Fludarabine|fludarabine|mesh-list
138941212|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138941213|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941214|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138941215|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
138941216|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138941217|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138463880|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138386286|NCT01475760|Chitosan|chitosan|mesh-list
138941218|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138941219|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138941220|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138941221|NCT00612508|Progestins|progestins|mesh-ancestor
138941222|NCT00881218|Regadenoson|regadenoson|mesh-list
138941223|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138941224|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138941225|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
138941226|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
138941227|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941228|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941229|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941230|NCT00613834|Lidocaine|lidocaine|mesh-list
138941231|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
138941232|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
138941233|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941234|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941235|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
138941236|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941237|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138941238|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138941239|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138941240|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138941241|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941242|NCT00875368|Maraviroc|maraviroc|mesh-list
138941243|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138941244|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138941245|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941246|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138941247|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138941248|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
138941249|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941250|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138941251|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
138941252|NCT03912298|Narcotics|narcotics|mesh-ancestor
138941253|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941254|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941255|NCT03912298|Analgesics|analgesics|mesh-ancestor
138941256|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
138941257|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941259|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941260|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
138641432|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
138941261|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138941262|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
138941263|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138941264|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941265|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138941266|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138941267|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138941269|NCT00881296|Gemcitabine|gemcitabine|mesh-list
138941270|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463968|NCT01948960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941271|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138941272|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
138941273|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941274|NCT00613366|Misoprostol|misoprostol|mesh-list
138941275|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
138941276|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138941277|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
138941278|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138941279|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941280|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138941281|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138941282|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
138941284|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941285|NCT00612352|Ethanol|ethanol|mesh-list
138941286|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138941287|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941288|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941289|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941290|NCT00884416|Sorafenib|sorafenib|mesh-list
138941291|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941292|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138941293|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941294|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941295|NCT00884494|Insulin|insulin|mesh-list
138941296|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138941297|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941298|NCT00881686|Adenosine|adenosine|mesh-list
138941299|NCT00881686|Analgesics|analgesics|mesh-ancestor
138941300|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
138941301|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941302|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941303|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138464019|NCT01949454|Hormones|hormones|mesh-ancestor
138941304|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
138941305|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138941306|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
138941307|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
138941308|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495339|NCT00102778|Ritonavir|ritonavir|mesh-list
138941309|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941310|NCT00885508|Lenalidomide|lenalidomide|mesh-list
138941311|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
138941312|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941313|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138941314|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138941315|NCT00885508|Growth Substances|growth substances|mesh-ancestor
138941316|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
138941317|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941318|NCT02543086|Piperaquine|piperaquine|mesh-list
138941319|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
138941320|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138941321|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138941322|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941323|NCT00885586|Gabapentin|gabapentin|mesh-list
138941324|NCT00885586|Analgesics|analgesics|mesh-ancestor
138941325|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
138941326|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941327|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941328|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
138941329|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138941330|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138941331|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941332|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138941333|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138941334|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138464056|NCT01949675|Vaccines|vaccines|mesh-list
138941335|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941336|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941338|NCT02542930|Thymalfasin|thymalfasin|mesh-list
138941339|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138941340|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
138941341|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941342|NCT00881764|Anesthetics|anesthetics|mesh-list
138941343|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941344|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941345|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
138941346|NCT04038034|Vitamins|vitamins|mesh-ancestor
138941347|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
138941348|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593321|NCT00173862|Gemcitabine|gemcitabine|mesh-list
138941349|NCT04037878|Tramadol|tramadol|mesh-list
138941350|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138941352|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941353|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941354|NCT04037878|Analgesics|analgesics|mesh-ancestor
138941355|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
138941356|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941357|NCT00651261|Cytarabine|cytarabine|mesh-list
138941358|NCT00651261|Dexamethasone|dexamethasone|mesh-list
138941359|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
138941360|NCT00651261|Daunorubicin|daunorubicin|mesh-list
138941361|NCT00651261|Midostaurin|midostaurin|mesh-list
138941362|NCT00651261|BB 1101|bb 1101|mesh-list
138941363|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138941364|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
138941365|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
138941366|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941367|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941368|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138941369|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
138941370|NCT00651261|Hormones|hormones|mesh-ancestor
138941371|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138941372|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138941373|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941374|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138941375|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
138941376|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941377|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
138941378|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941379|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138941380|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
138941381|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138941382|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138941383|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138941384|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941385|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138941386|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
138941387|NCT00885820|Prednisone|prednisone|mesh-list
138941388|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
138941389|NCT00885820|Tacrolimus|tacrolimus|mesh-list
138941390|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138941391|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
138941392|NCT00885820|Hormones|hormones|mesh-ancestor
138464151|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
138941393|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138941394|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941395|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138941396|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941397|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138941398|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
138941399|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138941400|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941401|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941402|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
138941403|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
138941404|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941405|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138216239|NCT00658736|Triamcinolone|triamcinolone|mesh-list
138941406|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138941407|NCT00885820|Protective Agents|protective agents|mesh-ancestor
138941408|NCT02567838|Lidocaine|lidocaine|mesh-list
138941409|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
138941410|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
138941411|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941412|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941413|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
138464200|NCT01950507|Hormones|hormones|mesh-ancestor
138941414|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941415|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138941416|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138941417|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138941418|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138941419|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495660|NCT00006470|Antibodies|antibodies|mesh-list
138941420|NCT00651183|Pramipexole|pramipexole|mesh-list
138941421|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
138941422|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941423|NCT00651183|Protective Agents|protective agents|mesh-ancestor
138941424|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941425|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138941426|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138941427|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
138941428|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
138941429|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941430|NCT00810381|Nitroprusside|nitroprusside|mesh-list
138941432|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138941433|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138941434|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
138941435|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
138941436|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138941437|NCT00810381|Diuretics|diuretics|mesh-ancestor
138941438|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
138464245|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
138464247|NCT01950884|Ezetimibe|ezetimibe|mesh-list
138941439|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941440|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138941441|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941442|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138941443|NCT00800319|ALKS-33|alks-33|mesh-list
138941444|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138941445|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941446|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
138941447|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941448|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138941449|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
138941450|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941451|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
138941452|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138941453|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
138641446|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
138941454|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941455|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138941456|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138941457|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138941458|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941459|NCT00810849|Prednisolone|prednisolone|mesh-list
138941460|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138941461|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
138941462|NCT00810849|Hormones|hormones|mesh-ancestor
138941463|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138941464|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941465|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138941466|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941467|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
138941468|NCT00811005|Methoxsalen|methoxsalen|mesh-list
138941469|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138941470|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
138941471|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138941472|NCT00813735|Dexetimide|dexetimide|mesh-list
138464294|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138941473|NCT00813735|Eszopiclone|eszopiclone|mesh-list
138941474|NCT00813735|Citalopram|citalopram|mesh-list
138941475|NCT00813735|Escitalopram|escitalopram|mesh-list
138495742|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138941476|NCT00813735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138941477|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138941478|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138941479|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941480|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941481|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
138941482|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941483|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138941484|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138941485|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
138941486|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
138941487|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941488|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138941489|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138941490|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
138941491|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138941492|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
138941493|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138941494|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138941495|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941497|NCT00811083|Antidotes|antidotes|mesh-ancestor
138593471|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138941498|NCT00811083|Protective Agents|protective agents|mesh-ancestor
138941499|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941500|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
138941501|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
138941502|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941503|NCT00642759|Paclitaxel|paclitaxel|mesh-list
138941504|NCT00642759|Bevacizumab|bevacizumab|mesh-list
138941505|NCT00642759|Carboplatin|carboplatin|mesh-list
138941506|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138941507|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941508|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
138941509|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
138941510|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
138941511|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941512|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138941513|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138941514|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138464373|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
138941515|NCT00642759|Growth Substances|growth substances|mesh-ancestor
138941516|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941517|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
138941518|NCT00813891|Ranibizumab|ranibizumab|mesh-list
138941519|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138941520|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138941521|NCT00813891|Growth Substances|growth substances|mesh-ancestor
138941522|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941523|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
138941524|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941525|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138941526|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138941527|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138941528|NCT00611026|Fesoterodine|fesoterodine|mesh-list
138941529|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138941530|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138941531|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
138941532|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941533|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941534|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941535|NCT00611026|Urological Agents|urological agents|mesh-ancestor
138941536|NCT02552589|Fluorides|fluorides|mesh-list
138941537|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
138941538|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
138941539|NCT02552589|Protective Agents|protective agents|mesh-ancestor
138941540|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941541|NCT00811239|Antivenins|antivenins|mesh-list
138941542|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
138941543|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941544|NCT00814047|Yohimbine|yohimbine|mesh-list
138941545|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
138464452|NCT01951924|Antibodies|antibodies|mesh-list
138941546|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
138941547|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941548|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941549|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138941550|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138941551|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138941552|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
138941553|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941554|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941556|NCT00814125|Tamoxifen|tamoxifen|mesh-list
138941557|NCT00814125|Anastrozole|anastrozole|mesh-list
138941558|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138941559|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
138941560|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138941561|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941562|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138941563|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941564|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138941565|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138941566|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138941567|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138941568|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138941569|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941570|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941571|NCT00817713|Ivermectin|ivermectin|mesh-list
138941572|NCT00817713|Albendazole|albendazole|mesh-list
138941573|NCT00817713|Praziquantel|praziquantel|mesh-list
138941574|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138941575|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941576|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
138941577|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
138941578|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138941579|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138941580|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
138941581|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
138941582|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
138941583|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941584|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941586|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138941587|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941588|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
138941589|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941590|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138941591|NCT00814281|Montelukast|montelukast|mesh-list
138941592|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138941593|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
138941594|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138941595|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
138464526|NCT05876598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138941596|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138941597|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941598|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138941599|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138941600|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941601|NCT00814359|Benzydamine|benzydamine|mesh-list
138941602|NCT00814359|Sucralfate|sucralfate|mesh-list
138941603|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138941604|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138941605|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138941606|NCT00612040|Insulin|insulin|mesh-list
138941607|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138941608|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
138941609|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
138941610|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
138941611|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138941612|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941613|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
138941614|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
138941615|NCT00422227|Etanercept|etanercept|mesh-list
138941616|NCT00422227|Methotrexate|methotrexate|mesh-list
138941617|NCT00422227|Leflunomide|leflunomide|mesh-list
138941618|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138941619|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
138941620|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138941621|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941622|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138464582|NCT05875714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138941623|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
138641488|NCT00293631|Ketorolac|ketorolac|mesh-list
138941624|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941625|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941626|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
138941627|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941628|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138941629|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138941630|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
138941631|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138941632|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138941633|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
138941634|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138941635|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138941636|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941637|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138941638|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138941639|NCT00422227|Analgesics|analgesics|mesh-ancestor
138941640|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
138941641|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941642|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138941643|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138941644|NCT00811785|Copper|copper|mesh-list
138941645|NCT00811785|Trace Elements|trace elements|mesh-ancestor
138941647|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941648|NCT00814515|Cyclosporine|cyclosporine|mesh-list
138941649|NCT00814515|Cyclosporins|cyclosporins|mesh-list
138941650|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941651|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941652|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138941653|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
138941654|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941655|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
138941656|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941657|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
138941658|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138941659|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138941660|NCT00814593|Carmustine|carmustine|mesh-list
138941661|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138941662|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
138941663|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941664|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941665|NCT00421993|Adapalene|adapalene|mesh-list
138941666|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
138941667|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138941668|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
138941669|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138941670|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138941671|NCT00421993|Analgesics|analgesics|mesh-ancestor
138941672|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
138941673|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941674|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941675|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138941676|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138941677|NCT00884884|Topiramate|topiramate|mesh-list
138941678|NCT00884884|Aripiprazole|aripiprazole|mesh-list
138941679|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
138941680|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138941681|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138941682|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138941683|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941684|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941685|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
138941686|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
138941687|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941688|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941689|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138941690|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138941691|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
138941692|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138941693|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138941694|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138941695|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138941696|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
138941697|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138941698|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
138941699|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941700|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138941701|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941702|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941703|NCT02551029|Capsaicin|capsaicin|mesh-list
138941704|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
138941705|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
138941707|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941708|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941709|NCT00812019|Vaccines|vaccines|mesh-list
138941710|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
138941711|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
138496175|NCT00109135|Hormones|hormones|mesh-ancestor
138941712|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464716|NCT05874674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138941713|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138941714|NCT00413959|Dexamethasone|dexamethasone|mesh-list
138941715|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
138941716|NCT00413959|Rituximab|rituximab|mesh-list
138941717|NCT00413959|Bortezomib|bortezomib|mesh-list
138941718|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138941719|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
138941720|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941721|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138941722|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138941723|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
138941724|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941725|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941726|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138593694|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
138464762|NCT05872412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138941727|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138941729|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
138941730|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941731|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138941732|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
138941733|NCT00413959|Hormones|hormones|mesh-ancestor
138464763|NCT05872412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138941734|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138941735|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138941736|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138941737|NCT00814905|Clindamycin|clindamycin|mesh-list
138941738|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
138941739|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
138941740|NCT00814905|Gentamicins|gentamicins|mesh-list
138941741|NCT00814905|Ampicillin|ampicillin|mesh-list
138941742|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138941743|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941744|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138941745|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941746|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941748|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138941749|NCT00611884|Metformin|metformin|mesh-list
138941750|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
138941751|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
138941752|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138941753|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941754|NCT00611806|Folic Acid|folic acid|mesh-list
138941755|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
138941756|NCT00611806|Hematinics|hematinics|mesh-ancestor
138941757|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
138941758|NCT00611806|Vitamins|vitamins|mesh-ancestor
138941759|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
138941760|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941761|NCT00413413|Amlodipine|amlodipine|mesh-list
138941762|NCT00413413|Valsartan|valsartan|mesh-list
138941763|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138941764|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138941765|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138941766|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941767|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138941768|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941769|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
138941770|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138941771|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138941772|NCT00886132|Sunitinib|sunitinib|mesh-list
138941773|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941774|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138941775|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138941776|NCT00886132|Growth Substances|growth substances|mesh-ancestor
138941777|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941778|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
138941779|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138941780|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941781|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941782|NCT01040455|Lansoprazole|lansoprazole|mesh-list
138941783|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
138941784|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138941785|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138941786|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138464866|NCT05508815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138941787|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941788|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941789|NCT01041235|Docetaxel|docetaxel|mesh-list
138941790|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941791|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
138941792|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
138941793|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
138941794|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941795|NCT01041313|Memantine|memantine|mesh-list
138941796|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138941797|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138593779|NCT00174174|Modafinil|modafinil|mesh-list
138941798|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
138941799|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941800|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941801|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941802|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138941803|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138941805|NCT00610714|Carboplatin|carboplatin|mesh-list
138941806|NCT00610714|Saracatinib|saracatinib|mesh-list
138941807|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138941808|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496319|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138941809|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
138941810|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
138941811|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
138941812|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941813|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941815|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138941816|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
138941817|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941818|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138941819|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138941820|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941821|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941822|NCT00645411|Vaccines|vaccines|mesh-list
138941823|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
138941824|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941825|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
138941826|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138941827|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138941828|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138941829|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138941830|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941831|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
138941832|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941833|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941834|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138941835|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941836|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
138941838|NCT00885274|Antacids|antacids|mesh-ancestor
138941839|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941840|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138941841|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
138941842|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138941843|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
138941844|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
138941845|NCT00402727|Amoxicillin|amoxicillin|mesh-list
138941846|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
138941847|NCT00402727|Tazobactam|tazobactam|mesh-list
138941848|NCT00402727|Piperacillin|piperacillin|mesh-list
138941849|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
138464976|NCT04966546|Memantine|memantine|mesh-list
138941850|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
138941851|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138941852|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138941853|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138941854|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941855|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138941856|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138941857|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941858|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941859|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941860|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138941861|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
138941862|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138941863|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941864|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138941865|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138941866|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138941867|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138941868|NCT00923494|Ropivacaine|ropivacaine|mesh-list
138941869|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
138941870|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
138941871|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138464997|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
138941872|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496480|NCT00111631|Metformin|metformin|mesh-list
138941873|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
138941874|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593845|NCT00168909|Vitamins|vitamins|mesh-ancestor
138941875|NCT00888784|Propranolol|propranolol|mesh-list
138941876|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138941877|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138941878|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
138941879|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941880|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941881|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941882|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138941883|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138941884|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
138941885|NCT00886678|Carboplatin|carboplatin|mesh-list
138941886|NCT00886678|Pemetrexed|pemetrexed|mesh-list
138941887|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941888|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941889|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941890|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138465049|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
138465050|NCT04650698|Coagulants|coagulants|mesh-ancestor
138941891|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138941892|NCT00402337|Linaclotide|linaclotide|mesh-list
138941893|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138941894|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
138941895|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941896|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138941897|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138941898|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138941899|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138941900|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138941901|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941902|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465102|NCT04198805|Tocotrienols|tocotrienols|mesh-list
138941903|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941904|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
138941905|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138941906|NCT00886990|Ritonavir|ritonavir|mesh-list
138941907|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138941908|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138941909|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
138941910|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941911|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941912|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138941913|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138941914|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
138941915|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941916|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138941917|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138941918|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
138941919|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138941920|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
138465170|NCT03649659|Fluorides|fluorides|mesh-list
138941921|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941922|NCT00650091|Expectorants|expectorants|mesh-ancestor
138941923|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
138941924|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138941925|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
138941926|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941927|NCT00650091|Protective Agents|protective agents|mesh-ancestor
138941928|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941929|NCT00650091|Antidotes|antidotes|mesh-ancestor
138941930|NCT00889018|Carboplatin|carboplatin|mesh-list
138941931|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941932|NCT00889096|Propranolol|propranolol|mesh-list
138941933|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138941934|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138941935|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
138941936|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941937|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941938|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941939|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138941940|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138941941|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
138941942|NCT00818103|Interferons|interferons|mesh-list
138941943|NCT00818103|Atorvastatin|atorvastatin|mesh-list
138941944|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941945|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
138941946|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138941947|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138941948|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138593916|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
138941949|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
138941950|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941951|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138941952|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138941953|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941955|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138941956|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
138941960|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138941961|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941962|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941963|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
138941964|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
138941965|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941966|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138941967|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138941968|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
138941969|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138941970|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941971|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138941972|NCT01154335|Everolimus|everolimus|mesh-list
138941973|NCT01154335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138941974|NCT01154335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138941975|NCT01154335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138941976|NCT01154335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941977|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138941978|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
138941979|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941980|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138941982|NCT00889642|Epinephrine|epinephrine|mesh-list
138941983|NCT00889642|Racepinephrine|racepinephrine|mesh-list
138941984|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
138941985|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
138941986|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
138941987|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138941988|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138941989|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
138941990|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138941991|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138941992|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138941993|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138703968|NCT06225349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138703969|NCT06225349|Antacids|antacids|mesh-ancestor
138703983|NCT06224725|Chrysarobin|chrysarobin|mesh-list
138941994|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138941995|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138941996|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138941997|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138941998|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
138941999|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942000|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138942001|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138942002|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
138942003|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138942004|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
138942006|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
138942007|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138942008|NCT02541526|Mirtazapine|mirtazapine|mesh-list
138942009|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
138465317|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138942010|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138704008|NCT06220422|Anticoagulants|anticoagulants|mesh-list
138465318|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496650|NCT00007631|Tretinoin|tretinoin|mesh-list
138942011|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138942012|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
138942013|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
138942014|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942015|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942016|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942017|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138942018|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138942019|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138942020|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138942021|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138942022|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138942023|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
138942024|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138942025|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138942026|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
138942027|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138942028|NCT01037959|Norfloxacin|norfloxacin|mesh-list
138942029|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138942030|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942031|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138942032|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138942033|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942034|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942035|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942036|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138496700|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138942037|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138942038|NCT01038037|Carboplatin|carboplatin|mesh-list
138942039|NCT01038037|Vinorelbine|vinorelbine|mesh-list
138942040|NCT01038037|Panitumumab|panitumumab|mesh-list
138465396|NCT02106572|Mitomycins|mitomycins|mesh-list
138942041|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942042|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138942043|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
138942044|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
138942045|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
138942046|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942047|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138942048|NCT00645099|Olanzapine|olanzapine|mesh-list
138942049|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138942050|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
138942051|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
138942052|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942053|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942054|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138942055|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138942056|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138942057|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138942058|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138942059|NCT00645099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138942060|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138942061|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138942062|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942063|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942064|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
138942065|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138942066|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138942067|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138942068|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138942069|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
138942070|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138465400|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
138942071|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138942072|NCT01038349|Methotrexate|methotrexate|mesh-list
138942073|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138942074|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
138942075|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138942076|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942077|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138942078|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
138942079|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942080|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942081|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
138942082|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942083|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138942084|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138942085|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
138942086|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138942087|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138942088|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
138711057|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138711058|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
138465444|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942089|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
138942090|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138942091|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942092|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138942093|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138942094|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942095|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942097|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138942098|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138942099|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138942100|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
138942101|NCT01038505|Sirolimus|sirolimus|mesh-list
138942102|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
138942103|NCT01038505|Tacrolimus|tacrolimus|mesh-list
138942104|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138942105|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
138942106|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942107|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138942108|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942109|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942110|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138942111|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942112|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138942113|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942114|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
138942115|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138942116|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
138942117|NCT01038583|Aspirin|aspirin|mesh-list
138667382|NCT04703465|Tenofovir|tenofovir|mesh-list
138942118|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138942119|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138942120|NCT01038583|Analgesics|analgesics|mesh-ancestor
138942121|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
138942122|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942123|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942124|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138942125|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138942126|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138942127|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138942128|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942129|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138942130|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138942131|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942132|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
138942133|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
138942134|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138942135|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
138942136|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942137|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942138|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138942139|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
138942140|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138942141|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
138942142|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942143|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942144|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138942145|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
138942146|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
138942147|NCT02551107|Protective Agents|protective agents|mesh-ancestor
138942148|NCT01038661|Docetaxel|docetaxel|mesh-list
138942149|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942150|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
138942151|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
138942152|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
138465542|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138942153|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942154|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
138942155|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
138942156|NCT01038817|Protective Agents|protective agents|mesh-ancestor
138942157|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942158|NCT00420511|Metformin|metformin|mesh-list
138942159|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138942160|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138942161|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942162|NCT00420511|Incretins|incretins|mesh-ancestor
138942163|NCT00420511|Hormones|hormones|mesh-ancestor
138942164|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138942165|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138942166|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
138942167|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594141|NCT00146042|Docetaxel|docetaxel|mesh-list
138942168|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942170|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138942171|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
138942172|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942173|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942174|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138942175|NCT00420199|Abatacept|abatacept|mesh-list
138942176|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138942177|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942178|NCT00420199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138942179|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942180|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138942181|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
138496931|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
138942182|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942184|NCT00649389|Amlodipine|amlodipine|mesh-list
138942185|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138942186|NCT00649389|Olmesartan|olmesartan|mesh-list
138942187|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138942188|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138942189|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138942190|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138942191|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942192|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138942193|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942194|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
138942196|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
138942197|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138942198|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138942199|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138942200|NCT00402103|Amlodipine|amlodipine|mesh-list
138942201|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138942202|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138942203|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138942204|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138942205|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942206|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138942207|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942208|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
138942209|NCT00402103|Diuretics|diuretics|mesh-ancestor
138942210|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
138942211|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138942212|NCT00812175|Sorafenib|sorafenib|mesh-list
138465621|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138465643|NCT01953796|Clomiphene|clomiphene|mesh-list
138942213|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942214|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138942215|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942216|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942217|NCT00815373|Timolol|timolol|mesh-list
138942218|NCT00815373|Dorzolamide|dorzolamide|mesh-list
138942219|NCT00815373|Latanoprost|latanoprost|mesh-list
138942220|NCT00815373|Maleic acid|maleic acid|mesh-list
138942221|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942222|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942223|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138942224|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138942225|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
138942226|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942227|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942228|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138942229|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138942230|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138497115|NCT03007407|Durvalumab|durvalumab|mesh-list
138942231|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138942232|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138942233|NCT00641667|Fentanyl|fentanyl|mesh-list
138942234|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138942235|NCT00641667|Narcotics|narcotics|mesh-ancestor
138942236|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138942237|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942238|NCT00641667|Analgesics|analgesics|mesh-ancestor
138942239|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
138465664|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138942240|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942241|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138942242|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138942243|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
138942244|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
138942245|NCT00704184|Interferons|interferons|mesh-list
138942246|NCT00704184|Ribavirin|ribavirin|mesh-list
138641660|NCT00299676|Galantamine|galantamine|mesh-list
138942247|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942249|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942250|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
138942251|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942252|NCT00641043|Pioglitazone|pioglitazone|mesh-list
138942253|NCT00641043|Linagliptin|linagliptin|mesh-list
138942254|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138942255|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942256|NCT00641043|Incretins|incretins|mesh-ancestor
138942257|NCT00641043|Hormones|hormones|mesh-ancestor
138942258|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138942259|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138942260|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
138942261|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942262|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942263|NCT02567916|Propofol|propofol|mesh-list
138942264|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138942265|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138942266|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942267|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138942268|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
138942269|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
138942270|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138942271|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138942272|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942273|NCT00609622|Bevacizumab|bevacizumab|mesh-list
138942274|NCT00609622|Sunitinib|sunitinib|mesh-list
138942275|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138942276|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942277|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138942278|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138942279|NCT00609622|Growth Substances|growth substances|mesh-ancestor
138942280|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942281|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
138942282|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138942283|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942284|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942285|NCT00818415|Naproxen|naproxen|mesh-list
138942286|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138942287|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138942288|NCT00818415|Analgesics|analgesics|mesh-ancestor
138942289|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
138942290|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942291|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942292|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138942294|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
138942295|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138942296|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942297|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942298|NCT00815841|Methylphenidate|methylphenidate|mesh-list
138942299|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138942300|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942301|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138942302|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138942303|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138942304|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942305|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
138942306|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942307|NCT03897192|Bevacizumab|bevacizumab|mesh-list
138942308|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138942309|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942310|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138465746|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138465747|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138942311|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138942312|NCT03897192|Growth Substances|growth substances|mesh-ancestor
138942313|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942314|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
138942315|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
138942316|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
138942317|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138942318|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
138942319|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942320|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942321|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138942322|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
138942323|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
138942324|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138942325|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
138942326|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138497241|NCT00115648|Zidovudine|zidovudine|mesh-list
138942327|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942328|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138942329|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138942330|NCT00890110|Sunitinib|sunitinib|mesh-list
138942331|NCT00890110|Vaccines|vaccines|mesh-list
138942332|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
138942333|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942334|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942335|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138497278|NCT00008294|Antidotes|antidotes|mesh-ancestor
138465790|NCT01954368|Analgesics|analgesics|mesh-ancestor
138942337|NCT00890110|Growth Substances|growth substances|mesh-ancestor
138942338|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
138942339|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138942340|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942341|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942342|NCT02566824|Methylphenidate|methylphenidate|mesh-list
138942343|NCT02566824|Amphetamine|amphetamine|mesh-list
138942344|NCT02566824|Adderall|adderall|mesh-list
138942345|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
138942346|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138942347|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942348|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138942349|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138942350|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138942351|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942352|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
138942353|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942354|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
138942355|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
138942356|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942357|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
138942358|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138942359|NCT00890188|Thalidomide|thalidomide|mesh-list
138465838|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138465839|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138465840|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
138465841|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138465848|NCT01955070|Ketamine|ketamine|mesh-list
138942360|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138942361|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
138942362|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942363|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
138942364|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138942365|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942366|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138942367|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138942368|NCT00890188|Growth Substances|growth substances|mesh-ancestor
138942369|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
138942370|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942371|NCT05388942|Nitrous Oxide|nitrous oxide|mesh-list
138942372|NCT05388942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138942373|NCT05388942|Anesthetics, General|anesthetics, general|mesh-ancestor
138942374|NCT05388942|Anesthetics|anesthetics|mesh-ancestor
138942375|NCT05388942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138942376|NCT05388942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942377|NCT05388942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138942378|NCT05388942|Analgesics|analgesics|mesh-ancestor
138942379|NCT05388942|Sensory System Agents|sensory system agents|mesh-ancestor
138942380|NCT05388942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942381|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
138942382|NCT04037566|Fludarabine|fludarabine|mesh-list
138942383|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138942384|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
138942385|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942386|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138942387|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138942388|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
138942389|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942390|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942391|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138942392|NCT00888082|Goserelin|goserelin|mesh-list
138942393|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138942394|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942395|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
138942396|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138942397|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
138942398|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942399|NCT00627705|Expectorants|expectorants|mesh-ancestor
138942400|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
138942401|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138942402|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
138942403|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942404|NCT00627705|Protective Agents|protective agents|mesh-ancestor
138942405|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942406|NCT00627705|Antidotes|antidotes|mesh-ancestor
138942407|NCT00610168|Vaccines|vaccines|mesh-list
138942408|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
138942409|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942410|NCT00921102|Atropine|atropine|mesh-list
138942411|NCT00921102|Morphine|morphine|mesh-list
138942412|NCT00921102|Bupivacaine|bupivacaine|mesh-list
138942413|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
138942414|NCT00921102|Anesthetics|anesthetics|mesh-list
138942415|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138942416|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942417|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
138942418|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942419|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138942420|NCT00921102|Narcotics|narcotics|mesh-ancestor
138942421|NCT00921102|Analgesics|analgesics|mesh-ancestor
138942422|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138942423|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138942424|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138942425|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
138942426|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138942427|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
138942428|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
138942429|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
138942430|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138942431|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138942432|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
138497575|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
138942433|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942434|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942435|NCT00890500|Sirolimus|sirolimus|mesh-list
138942436|NCT00890500|Fludarabine|fludarabine|mesh-list
138942437|NCT00890500|Melphalan|melphalan|mesh-list
138942438|NCT00890500|Tacrolimus|tacrolimus|mesh-list
138942439|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138942440|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942441|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942442|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138942443|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
138942444|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942445|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138942446|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942447|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138942448|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138497699|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
138942450|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
138942451|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138942452|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
138942453|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138942454|NCT04061772|Prednisone|prednisone|mesh-list
138942455|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
138942456|NCT04061772|Etoposide|etoposide|mesh-list
138942457|NCT04061772|Bortezomib|bortezomib|mesh-list
138942458|NCT04061772|Epirubicin|epirubicin|mesh-list
138942459|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138942460|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
138942461|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942462|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138942463|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138465975|NCT01955642|Clopidogrel|clopidogrel|mesh-list
138942464|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
138942465|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942466|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942467|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138942468|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138942469|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
138942470|NCT04061772|Hormones|hormones|mesh-ancestor
138497773|NCT00119587|Hematinics|hematinics|mesh-ancestor
138942471|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138942472|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138942473|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138942474|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138942475|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138942476|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942477|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138942478|NCT00644787|Fentanyl|fentanyl|mesh-list
138942479|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138942480|NCT00644787|Narcotics|narcotics|mesh-ancestor
138942481|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138942482|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942483|NCT00644787|Analgesics|analgesics|mesh-ancestor
138942484|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
138497889|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
138942485|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942486|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138942487|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138942488|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
138942489|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
138942490|NCT00821301|Fluphenazine|fluphenazine|mesh-list
138942491|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
138942493|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138942494|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138942495|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138942496|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942497|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138942498|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138942499|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
138942500|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942501|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942502|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
138942503|NCT00699348|Hematinics|hematinics|mesh-ancestor
138942504|NCT00643851|Metformin|metformin|mesh-list
138942505|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
138942506|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138942507|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942508|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138942509|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942510|NCT00821457|Mitogens|mitogens|mesh-list
138942511|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
138942512|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942513|NCT03667690|Fluconazole|fluconazole|mesh-list
138942514|NCT03667690|Caspofungin|caspofungin|mesh-list
138942515|NCT03667690|Rezafungin|rezafungin|mesh-list
138942516|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
138942517|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942518|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138466057|NCT01956006|Milrinone|milrinone|mesh-list
138942519|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138942520|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942521|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942522|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138942523|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
138942524|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138942525|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942526|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138466097|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138942527|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138942529|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138942530|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138942531|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942532|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138942533|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138942534|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
138942535|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942536|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138942537|NCT04062006|Aldesleukin|aldesleukin|mesh-list
138942538|NCT04062006|Interleukin-2|interleukin-2|mesh-list
138942539|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942540|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138942541|NCT04062006|Analgesics|analgesics|mesh-ancestor
138594514|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
138942542|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
138942543|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942544|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942545|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138942546|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138942547|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
138942548|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942549|NCT04872582|Bevacizumab|bevacizumab|mesh-list
138466162|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466163|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942550|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138942551|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138942552|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942553|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138942554|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138942555|NCT04872582|Growth Substances|growth substances|mesh-ancestor
138942556|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942557|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
138942558|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942560|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
138942561|NCT04061538|Trace Elements|trace elements|mesh-ancestor
138942562|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
138942563|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942564|NCT04061538|Astringents|astringents|mesh-ancestor
138942565|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
138942566|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
138942567|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
138942568|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138942569|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138942570|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942571|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942572|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942573|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138942574|NCT00888394|Imidacloprid|imidacloprid|mesh-list
138942575|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
138942576|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942577|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942578|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942579|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
138942580|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138942581|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
138942582|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138942583|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
138942584|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138942585|NCT00627393|Dexamethasone|dexamethasone|mesh-list
138942586|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138942587|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
138942588|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
138942589|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942590|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942591|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138942592|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
138942593|NCT00627393|Hormones|hormones|mesh-ancestor
138942594|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138942595|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138942596|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942597|NCT00822081|Timolol|timolol|mesh-list
138942598|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138942599|NCT00822081|Dorzolamide|dorzolamide|mesh-list
138942600|NCT00822081|Maleic acid|maleic acid|mesh-list
138942601|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
138942602|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942603|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942604|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138942605|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138942606|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
138942607|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942608|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942609|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138942610|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138942611|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138498154|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
138942612|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138942613|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138942614|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138942615|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138942616|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138466326|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138942617|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138942618|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138942619|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942620|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942621|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942623|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
138942624|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942625|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
138942626|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138942627|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
138942628|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
138942629|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138942630|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138942631|NCT00626925|Topiramate|topiramate|mesh-list
138942632|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
138466367|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138942633|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138942634|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942635|NCT00816543|Docetaxel|docetaxel|mesh-list
138942636|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
138942637|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942638|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
138942639|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
138942640|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
138942641|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942642|NCT00698646|Valsartan|valsartan|mesh-list
138942643|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138942644|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138942645|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138942646|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138942647|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942648|NCT00698646|Diuretics|diuretics|mesh-ancestor
138942649|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
138942650|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942651|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138498260|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
138942653|NCT02565888|Ritonavir|ritonavir|mesh-list
138942654|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138942655|NCT02565888|Cobicistat|cobicistat|mesh-list
138942656|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138942657|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138942658|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
138942659|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942660|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942661|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138466427|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942662|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138942663|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
138942664|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942665|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138942666|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138942667|NCT00609466|Morphine|morphine|mesh-list
138942668|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138942669|NCT00609466|Narcotics|narcotics|mesh-ancestor
138942670|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138942671|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498327|NCT00009204|Citalopram|citalopram|mesh-list
138942673|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
138942674|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942675|NCT00822315|Efavirenz|efavirenz|mesh-list
138942676|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
138942677|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138942678|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138942679|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942680|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942681|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
138942682|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942683|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138942684|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138942685|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138942686|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138942687|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138942688|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138942689|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138942690|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138594660|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
138942691|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138942692|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138942693|NCT00696696|Gemcitabine|gemcitabine|mesh-list
138466470|NCT01959386|Trastuzumab|trastuzumab|mesh-list
138466474|NCT01959399|Peficitinib|peficitinib|mesh-list
138942694|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138942696|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138942697|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
138942698|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942699|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138498414|NCT00009672|Morphine|morphine|mesh-list
138942700|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138942701|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942703|NCT00822393|Treosulfan|treosulfan|mesh-list
138942704|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
138942705|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942706|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138942707|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
138942708|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942709|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138942710|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942711|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138942712|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
138942713|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
138498415|NCT00009672|Nortriptyline|nortriptyline|mesh-list
138942714|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138942715|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
138942716|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942717|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138942718|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138942720|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
138942721|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138942722|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138942723|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138942724|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942725|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138942726|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138942727|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466516|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942728|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942729|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942730|NCT02551185|Citarinostat|citarinostat|mesh-list
138942731|NCT02551185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138942732|NCT02551185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942733|NCT02551185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942734|NCT00892996|Dexamethasone|dexamethasone|mesh-list
138942735|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
138942736|NCT00892996|BB 1101|bb 1101|mesh-list
138942737|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138942738|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
138942739|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
138942740|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942741|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942742|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138942743|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
138942744|NCT00892996|Hormones|hormones|mesh-ancestor
138942745|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138942746|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138942747|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942748|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
138942749|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942750|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942751|NCT00891670|Aspirin|aspirin|mesh-list
138942752|NCT00891670|Cilostazol|cilostazol|mesh-list
138942753|NCT00891670|Clopidogrel|clopidogrel|mesh-list
138942754|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138942755|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138942756|NCT00891670|Analgesics|analgesics|mesh-ancestor
138942757|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
138942758|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942759|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942760|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138942761|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138942762|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138942763|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138942764|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942765|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138594739|NCT02940184|Incretins|incretins|mesh-ancestor
138942766|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138942767|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466620|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
138466623|NCT01960595|Fentanyl|fentanyl|mesh-list
138942768|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
138942769|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138942770|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138942771|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138942772|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
138942773|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942774|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138942775|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
138942776|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138942777|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
138942778|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
138942779|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138942780|NCT00891670|Protective Agents|protective agents|mesh-ancestor
138942781|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138942782|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138942783|NCT00699192|Amlodipine|amlodipine|mesh-list
138942784|NCT00699192|Valsartan|valsartan|mesh-list
138942785|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138942786|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138942787|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138498581|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
138942788|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942789|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138942790|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942791|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
138942792|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138466659|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138466661|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942793|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138942794|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138942795|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
138942796|NCT00921180|Entecavir|entecavir|mesh-list
138942797|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
138942798|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942799|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
138942800|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942801|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
138942802|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138942803|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942804|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138942805|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
138942806|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138942807|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942808|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942809|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942810|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138942811|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138466706|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138942812|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138942813|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138942814|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942815|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942816|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942817|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
138942819|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
138942821|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138942822|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138942823|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138942824|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942825|NCT00696384|Diuretics|diuretics|mesh-ancestor
138942826|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
138466768|NCT01961856|Clopidogrel|clopidogrel|mesh-list
138942827|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942828|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138942829|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138942830|NCT01041625|Apremilast|apremilast|mesh-list
138942831|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138942832|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138942833|NCT01041625|Analgesics|analgesics|mesh-ancestor
138942834|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
138942835|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942836|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594809|NCT00169845|Protective Agents|protective agents|mesh-ancestor
138466820|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
138942838|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138942839|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138942840|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138942841|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942842|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942843|NCT02566356|Oxytocin|oxytocin|mesh-list
138942844|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
138942845|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138942846|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942847|NCT00892450|Oxybutynin|oxybutynin|mesh-list
138942848|NCT00892450|Darifenacin|darifenacin|mesh-list
138942849|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
138942851|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942852|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942853|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138942854|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138942855|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
138942856|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942857|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942858|NCT00892450|Urological Agents|urological agents|mesh-ancestor
138942859|NCT01566565|Theophylline|theophylline|mesh-list
138942860|NCT01566565|Bambuterol|bambuterol|mesh-list
138942861|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138942862|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
138942863|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942864|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942865|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138942866|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
138942867|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138942868|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942869|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942870|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
138942871|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138466882|NCT01963390|Testosterone|testosterone|mesh-list
138942872|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138942873|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
138942874|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942875|NCT01039363|Cytarabine|cytarabine|mesh-list
138942876|NCT01039363|Vorinostat|vorinostat|mesh-list
138942877|NCT01039363|Idarubicin|idarubicin|mesh-list
138942878|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
138942879|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138942880|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
138942881|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942882|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942883|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
138942884|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942885|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138942886|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
138942887|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942888|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138942889|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942890|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138942891|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138942892|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138942893|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138942894|NCT01039363|Immunotoxins|immunotoxins|mesh-ancestor
138942895|NCT01039363|Immunoconjugates|immunoconjugates|mesh-ancestor
138942896|NCT01039441|Bupivacaine|bupivacaine|mesh-list
138466923|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138942897|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
138942898|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
138942899|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138942900|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942901|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
138942902|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942903|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138942904|NCT01034917|Etravirine|etravirine|mesh-list
138942905|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
138942906|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138942907|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138942908|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138942909|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942910|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942911|NCT00816699|Anesthetics|anesthetics|mesh-list
138942912|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138942913|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942914|NCT00822549|Morphine|morphine|mesh-list
138942915|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138942916|NCT00822549|Narcotics|narcotics|mesh-ancestor
138942917|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138942918|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942919|NCT00822549|Analgesics|analgesics|mesh-ancestor
138942920|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
138942921|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942922|NCT00819351|Asparaginase|asparaginase|mesh-list
138942923|NCT00819351|Pegaspargase|pegaspargase|mesh-list
138942924|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942925|NCT00699998|Aspirin|aspirin|mesh-list
138942926|NCT00699998|Clopidogrel|clopidogrel|mesh-list
138942928|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138942929|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138942930|NCT00699998|Analgesics|analgesics|mesh-ancestor
138942931|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
138942932|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138942933|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942934|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138942935|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138942936|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138498867|NCT00020800|Rituximab|rituximab|mesh-list
138942937|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138942938|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942939|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138942940|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138942941|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942942|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
138942943|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138942944|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138942945|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138942946|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
138498930|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
138942947|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942948|NCT00696072|Letrozole|letrozole|mesh-list
138942949|NCT00696072|Dasatinib|dasatinib|mesh-list
138942950|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942951|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138942952|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138942953|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942954|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942955|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138942956|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
138942957|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138942958|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942959|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138942960|NCT00816855|Docetaxel|docetaxel|mesh-list
138942961|NCT00816855|Fluorouracil|fluorouracil|mesh-list
138942962|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942963|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
138942964|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
138942965|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
138498995|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942966|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942967|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
138942968|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138942969|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138942970|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
138942971|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942972|NCT00822783|Omalizumab|omalizumab|mesh-list
138942973|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138942974|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138942975|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
138942976|NCT00634647|Prednisone|prednisone|mesh-list
138942977|NCT00634647|Satraplatin|satraplatin|mesh-list
138499053|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138942978|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138942979|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
138467059|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138942980|NCT00634647|Hormones|hormones|mesh-ancestor
138942981|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138942982|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942983|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138942984|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138942985|NCT00576732|Risperidone|risperidone|mesh-list
138942986|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138594977|NCT00148265|Hormones|hormones|mesh-ancestor
138942988|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138942989|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138942990|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138942991|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138942992|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138942993|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138942994|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138942995|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138942996|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
138942997|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138942998|NCT00817011|Mirtazapine|mirtazapine|mesh-list
138942999|NCT00817011|Trazodone|trazodone|mesh-list
138943000|NCT00817011|Bupropion|bupropion|mesh-list
138943001|NCT00817011|Fluoxetine|fluoxetine|mesh-list
138943002|NCT00817011|Paroxetine|paroxetine|mesh-list
138943003|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138943004|NCT00817011|Citalopram|citalopram|mesh-list
138943005|NCT00817011|Sertraline|sertraline|mesh-list
138943006|NCT00817011|Nortriptyline|nortriptyline|mesh-list
138943007|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138943008|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
138943009|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138692955|NCT00596986|Analgesics|analgesics|mesh-ancestor
138943010|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138943011|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138943012|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138943013|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943015|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943016|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943017|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138943018|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138943019|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943020|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138943021|NCT00817011|Analgesics|analgesics|mesh-ancestor
138943022|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
138943023|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943024|NCT00817011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138943025|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
138943026|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138943027|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
138943028|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
138943029|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138943030|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138467154|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138467155|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
138467159|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
138943031|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943032|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138943033|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138499307|NCT00000146|Prednisone|prednisone|mesh-list
138943034|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138943035|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
138943036|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138943037|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138943038|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138943039|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138943040|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138943041|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
138943042|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138943043|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943044|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943045|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138943046|NCT00697788|Analgesics|analgesics|mesh-ancestor
138943047|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
138943048|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943049|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138943050|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138943051|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138943052|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
138943053|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943054|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943055|NCT00400153|Ipratropium|ipratropium|mesh-list
138943056|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138943057|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
138943058|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943059|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595037|NCT02929459|Vitamins|vitamins|mesh-list
138943060|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138943061|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
138467227|NCT01964846|Curcumin|curcumin|mesh-list
138943062|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138943063|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
138943064|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943065|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943066|NCT04062890|Vigabatrin|vigabatrin|mesh-list
138943067|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
138943068|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943069|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943070|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
138943071|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943072|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943073|NCT00817245|Amoxicillin|amoxicillin|mesh-list
138943074|NCT00817245|Metronidazole|metronidazole|mesh-list
138943075|NCT00817245|Omeprazole|omeprazole|mesh-list
138943076|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138943077|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943078|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138943079|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138943080|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138943081|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138943082|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138943083|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943084|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943085|NCT02550483|Beta Carotene|beta carotene|mesh-list
138943086|NCT02550483|Lycopene|lycopene|mesh-list
138943087|NCT02550483|Carotenoids|carotenoids|mesh-list
138943088|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
138943089|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467250|NCT01965041|Aflibercept|aflibercept|mesh-list
138499472|NCT00023335|Isoniazid|isoniazid|mesh-list
138943090|NCT02550483|Protective Agents|protective agents|mesh-ancestor
138943091|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943092|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138943093|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138943094|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138943095|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943097|NCT02550483|Vitamins|vitamins|mesh-ancestor
138943098|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
138943099|NCT04608318|Venetoclax|venetoclax|mesh-list
138943100|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
138943101|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943102|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138943103|NCT04063358|Ranibizumab|ranibizumab|mesh-list
138943104|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138943105|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138943106|NCT04063358|Growth Substances|growth substances|mesh-ancestor
138943107|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943108|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
138943109|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943111|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138943112|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
138943113|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943114|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467295|NCT01965353|Lenalidomide|lenalidomide|mesh-list
138943115|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138943116|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
138943117|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138943118|NCT00419341|Antibodies|antibodies|mesh-list
138943119|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
138943120|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943121|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
138943122|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138943123|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943124|NCT03922620|Bupivacaine|bupivacaine|mesh-list
138943125|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
138943126|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
138943127|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943128|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943129|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
138943130|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943131|NCT00419263|Peramivir|peramivir|mesh-list
138943132|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
138499595|NCT00023725|Semaxinib|semaxinib|mesh-list
138943133|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943134|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943135|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595113|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
138943136|NCT01034995|Escitalopram|escitalopram|mesh-list
138943137|NCT01034995|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138467347|NCT01965626|Hormones|hormones|mesh-ancestor
138943138|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138943139|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138943140|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943141|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943142|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
138943143|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943144|NCT00921414|Rituximab|rituximab|mesh-list
138943145|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138943146|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943147|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
138943148|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943149|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943150|NCT04060914|Clopidogrel|clopidogrel|mesh-list
138943151|NCT04060914|Ticagrelor|ticagrelor|mesh-list
138499636|NCT00000221|Buprenorphine|buprenorphine|mesh-list
138943152|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138943153|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138943154|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138943155|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138943156|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
138943157|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943158|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943159|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943160|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
138467395|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943161|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943162|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138943163|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138943164|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138943165|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138943166|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943167|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
138943168|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943169|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943170|NCT05324904|Vitamin D|vitamin d|mesh-list
138943171|NCT05324904|Acyclovir|acyclovir|mesh-list
138943172|NCT05324904|Vitamins|vitamins|mesh-ancestor
138943173|NCT05324904|Micronutrients|micronutrients|mesh-ancestor
138943174|NCT05324904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943175|NCT05324904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138943176|NCT05324904|Antiviral Agents|antiviral agents|mesh-ancestor
138943177|NCT05324904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943178|NCT02085265|Telmisartan|telmisartan|mesh-list
138943179|NCT02085265|Perindopril|perindopril|mesh-list
138943180|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138943181|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138218031|NCT00782756|Bevacizumab|bevacizumab|mesh-list
138943182|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138943183|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943184|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138943185|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
138943186|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943187|NCT00699842|Lenalidomide|lenalidomide|mesh-list
138943188|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
138943189|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138499751|NCT00000248|Pergolide|pergolide|mesh-list
138943190|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138943191|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138943192|NCT00699842|Growth Substances|growth substances|mesh-ancestor
138943193|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
138943194|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943195|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
138943197|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138943198|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
138943199|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943200|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943201|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138943202|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
138943203|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943204|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943205|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138943206|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138943207|NCT00712712|Acetaminophen|acetaminophen|mesh-list
138595188|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138943209|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138943211|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943212|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943213|NCT00712712|Analgesics|analgesics|mesh-ancestor
138943214|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
138943215|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943216|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138943217|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
138943218|NCT00411151|Sunitinib|sunitinib|mesh-list
138943219|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943220|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138943221|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138943222|NCT00411151|Growth Substances|growth substances|mesh-ancestor
138943223|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943224|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
138943225|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138943226|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943227|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943228|NCT00607048|Paclitaxel|paclitaxel|mesh-list
138943229|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138943230|NCT00607048|Carboplatin|carboplatin|mesh-list
138943231|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138943232|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138943233|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943234|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
138943235|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
138943236|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
138943237|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943238|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
138943239|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943240|NCT04035850|Vortioxetine|vortioxetine|mesh-list
138943241|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
138943242|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138943243|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138467546|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138467547|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467548|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138467549|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467550|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138467551|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467552|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467553|NCT01967199|Paclitaxel|paclitaxel|mesh-list
138396825|NCT01527422|Prednisone|prednisone|mesh-list
138396889|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
138467554|NCT01967199|Everolimus|everolimus|mesh-list
138467555|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138467556|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467557|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
138467558|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
138467559|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
138467561|NCT01967199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138943244|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138943245|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943246|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943247|NCT04035850|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138943248|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138943249|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138943250|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943251|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943252|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
138943253|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138943254|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138943255|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138943256|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138943258|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138943259|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943260|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943261|NCT00895570|Modafinil|modafinil|mesh-list
138943262|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138943263|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943264|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138943265|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138943266|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138943267|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943268|NCT00895648|Pemetrexed|pemetrexed|mesh-list
138943269|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943270|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943271|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943272|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138943273|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138500118|NCT00025519|Tacrolimus|tacrolimus|mesh-list
138943275|NCT00893854|Diclofenac|diclofenac|mesh-list
138943276|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138943277|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
138943278|NCT00893854|Hormones|hormones|mesh-ancestor
138943279|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138595289|NCT00170469|Antacids|antacids|mesh-ancestor
138943280|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943281|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943282|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943283|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138943284|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138943285|NCT00893854|Analgesics|analgesics|mesh-ancestor
138943286|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
138943287|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943288|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943289|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138943290|NCT00895804|Pindolol|pindolol|mesh-list
138943291|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138943292|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138943293|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
138943294|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943295|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943296|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943297|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138943298|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138943299|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
138943300|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
138943301|NCT00895882|Interferons|interferons|mesh-list
138943302|NCT00895882|Ribavirin|ribavirin|mesh-list
138943303|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943304|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
138943305|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943306|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
138943307|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943308|NCT00706706|Sunitinib|sunitinib|mesh-list
138943309|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943310|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138943311|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138943312|NCT00706706|Growth Substances|growth substances|mesh-ancestor
138641897|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138641898|NCT00264446|Eniluracil|eniluracil|mesh-list
138943313|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943314|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
138943315|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138943316|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943317|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943318|NCT00894010|Carbamazepine|carbamazepine|mesh-list
138943319|NCT00894010|Levetiracetam|levetiracetam|mesh-list
138943320|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
138943321|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
138943322|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
138943323|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138943324|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943325|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943326|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138943327|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138943328|NCT00894010|Analgesics|analgesics|mesh-ancestor
138943329|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
138943330|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943331|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138943332|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138943333|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943334|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138467722|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138943335|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138943336|NCT00895960|Temozolomide|temozolomide|mesh-list
138943337|NCT00895960|Dasatinib|dasatinib|mesh-list
138943338|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138943339|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
138943340|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943341|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943342|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138943343|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943344|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
138943345|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138943346|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943347|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138943348|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
138943349|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138943350|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943351|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943352|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595339|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
138943353|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138943354|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138943355|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138943356|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138943358|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138943359|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
138943360|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
138943361|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943362|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943363|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943364|NCT05508776|Moxifloxacin|moxifloxacin|mesh-list
138943365|NCT05508776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138500417|NCT00027391|Albuterol|albuterol|mesh-list
138943366|NCT05508776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943367|NCT05508776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138943368|NCT05508776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138943369|NCT05508776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943370|NCT05508776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943371|NCT05508776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943372|NCT00896428|Gallopamil|gallopamil|mesh-list
138943373|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138943374|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138943375|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641917|NCT00264680|Lamotrigine|lamotrigine|mesh-list
138943376|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138943377|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943378|NCT02962050|Capsaicin|capsaicin|mesh-list
138943379|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
138943380|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
138943381|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
138943382|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943383|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943384|NCT00410605|Dexamethasone|dexamethasone|mesh-list
138943385|NCT00410605|Bevacizumab|bevacizumab|mesh-list
138943386|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138943387|NCT00410605|Lenalidomide|lenalidomide|mesh-list
138943389|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
138943390|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138943391|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943392|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138943393|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138943394|NCT00410605|Growth Substances|growth substances|mesh-ancestor
138943395|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943396|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
138943397|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
138943398|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138943399|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
138943400|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
138943401|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943402|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138943403|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
138943404|NCT00410605|Hormones|hormones|mesh-ancestor
138943405|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138943406|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138943408|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138943409|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
138943410|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138943411|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138943412|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138943413|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943414|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943415|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
138943416|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943417|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943418|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
138943419|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943420|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
138943421|NCT00418717|Etanercept|etanercept|mesh-list
138943422|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138943423|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138595411|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
138943424|NCT00418717|Analgesics|analgesics|mesh-ancestor
138943425|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
138943426|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943427|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943428|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138943429|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943430|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138943431|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138943432|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
138943433|NCT00572572|Aprepitant|aprepitant|mesh-list
138943434|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
138943435|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
138943436|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943437|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943438|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138943439|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138943440|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138500626|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
138943441|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943442|NCT00897130|Azacitidine|azacitidine|mesh-list
138943443|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138943444|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
138943445|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943446|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943447|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943448|NCT00398047|Mitogens|mitogens|mesh-list
138943449|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
138467909|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943450|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943451|NCT00631371|Interferons|interferons|mesh-list
138943452|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
138943453|NCT00631371|Sirolimus|sirolimus|mesh-list
138943454|NCT00631371|Bevacizumab|bevacizumab|mesh-list
138943455|NCT00631371|Temsirolimus|temsirolimus|mesh-list
138943456|NCT00631371|MTOR Inhibitors|mtor inhibitors|mesh-list
138500689|NCT00012051|Hormones|hormones|mesh-ancestor
138943457|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138943458|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943459|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138943460|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138943461|NCT00631371|Growth Substances|growth substances|mesh-ancestor
138943462|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943463|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
138943464|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
138943465|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943466|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
138943467|NCT00631371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138943468|NCT00631371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943469|NCT00631371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943470|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138943471|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138943472|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138943473|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
138943474|NCT00409747|Minocycline|minocycline|mesh-list
138943475|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138943476|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138467951|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138943477|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
138943478|NCT04016740|Ketamine|ketamine|mesh-list
138943479|NCT04016740|Remifentanil|remifentanil|mesh-list
138943480|NCT04016740|Propofol|propofol|mesh-list
138943481|NCT04016740|Ropivacaine|ropivacaine|mesh-list
138943482|NCT04016740|Sevoflurane|sevoflurane|mesh-list
138943483|NCT04016740|Rocuronium|rocuronium|mesh-list
138943484|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138943485|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943486|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943487|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138943488|NCT04016740|Analgesics|analgesics|mesh-ancestor
138943489|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
138943490|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943491|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138943492|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138943494|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
138943495|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595481|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943496|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943497|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138943498|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
138943499|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
138943500|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138943501|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138943502|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138943503|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
138943504|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138943505|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138943506|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138943507|NCT04016740|Narcotics|narcotics|mesh-ancestor
138943508|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138943509|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138943510|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138943511|NCT02540512|Acetaminophen|acetaminophen|mesh-list
138943512|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138943513|NCT02540512|Hydrocodone|hydrocodone|mesh-list
138943514|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138943515|NCT02540512|Analgesics|analgesics|mesh-ancestor
138943516|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
138943517|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943518|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943519|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
138943520|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138943521|NCT02540512|Narcotics|narcotics|mesh-ancestor
138943522|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943523|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
138943524|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
138500857|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
138943525|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138943526|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138468033|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
138468034|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
138943527|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943528|NCT00897520|Interferons|interferons|mesh-list
138943529|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
138943530|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943531|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
138943532|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943533|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
138943534|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943535|NCT00894634|Brompheniramine|brompheniramine|mesh-list
138943536|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943537|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138943538|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
138943539|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
138943540|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943541|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943542|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138943543|NCT00894712|Sulforaphane|sulforaphane|mesh-list
138943544|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138500981|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
138943546|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943547|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943548|NCT00823641|Infliximab|infliximab|mesh-list
138943549|NCT00823641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138943550|NCT00823641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138943551|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
138943552|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138943553|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943555|NCT00823875|Probucol|probucol|mesh-list
138943556|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138943557|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
138943558|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468092|NCT01970280|Enoxaparin|enoxaparin|mesh-list
138943559|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138501033|NCT00012363|Gemcitabine|gemcitabine|mesh-list
138943560|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138943561|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
138943562|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138943563|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138943564|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943565|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138943566|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
138943567|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138943568|NCT00823875|Protective Agents|protective agents|mesh-ancestor
138943569|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138943570|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138943571|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943572|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138501101|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
138943574|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
138943575|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138943576|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
138943577|NCT00397189|Melatonin|melatonin|mesh-list
138943578|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
138943579|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943580|NCT00397189|Protective Agents|protective agents|mesh-ancestor
138943581|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943582|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943583|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
138943584|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138943586|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
138943587|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138943588|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943589|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
138943590|NCT04044651|Nivolumab|nivolumab|mesh-list
138943591|NCT04044651|Lenvatinib|lenvatinib|mesh-list
138943592|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138943593|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943594|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138943595|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943596|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138943597|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943598|NCT00606034|Insulin|insulin|mesh-list
138943599|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138943600|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943601|NCT00819975|Caseins|caseins|mesh-list
138943602|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
138943603|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
138943604|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943605|NCT04044417|Curcumin|curcumin|mesh-list
138943606|NCT04044417|Simvastatin|simvastatin|mesh-list
138943607|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138943608|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138943609|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
138943610|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468182|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
138468189|NCT01971411|Vitamin D|vitamin d|mesh-list
138943611|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138943612|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138943613|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943614|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138943615|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138943616|NCT04044417|Analgesics|analgesics|mesh-ancestor
138943617|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
138943618|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943619|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943620|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138943621|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943622|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230010|NCT02384850|Antidotes|antidotes|mesh-ancestor
138943623|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138943624|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138943625|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138943626|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943627|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943628|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138943629|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138943630|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138943631|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
138943632|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943633|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943634|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138943635|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138943636|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
138943637|NCT00820053|Epirubicin|epirubicin|mesh-list
138943638|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
138943639|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138943640|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943641|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138943642|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138943643|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468227|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138468228|NCT01971632|Narcotics|narcotics|mesh-ancestor
138943644|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943645|NCT00572728|Alovudine|alovudine|mesh-list
138943646|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
138943647|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
138943648|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943649|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
138943650|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943651|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138943652|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138943653|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943654|NCT00699374|Sorafenib|sorafenib|mesh-list
138943655|NCT00699374|Sunitinib|sunitinib|mesh-list
138943656|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943657|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138943658|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943659|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943660|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138943661|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138943662|NCT00699374|Growth Substances|growth substances|mesh-ancestor
138641980|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138943663|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468282|NCT01971801|Vitamin D|vitamin d|mesh-list
138943664|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
138943665|NCT00898534|Chrysarobin|chrysarobin|mesh-list
138943666|NCT00898534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138943667|NCT00898534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138943668|NCT00898534|Analgesics|analgesics|mesh-ancestor
138943669|NCT00898534|Sensory System Agents|sensory system agents|mesh-ancestor
138943670|NCT00898534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943671|NCT00898534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943672|NCT00898534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138943673|NCT00898534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943675|NCT00606892|Varenicline|varenicline|mesh-list
138943676|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138943677|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
138943678|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943679|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943680|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138943681|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138943682|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
138943683|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943684|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943685|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
138943686|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943687|NCT01035853|Colistin|colistin|mesh-list
138943688|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138943689|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943690|NCT01042717|Plerixafor|plerixafor|mesh-list
138943691|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138943692|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138468325|NCT01972269|Lidocaine|lidocaine|mesh-list
138943693|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
138943694|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943695|NCT00898846|Tegafur|tegafur|mesh-list
138943696|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138943697|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
138943698|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943699|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943700|NCT00826371|Ranibizumab|ranibizumab|mesh-list
138943701|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138943702|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138943703|NCT00826371|Growth Substances|growth substances|mesh-ancestor
138943704|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943705|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
138943706|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943707|NCT02540824|Apatinib|apatinib|mesh-list
138943708|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943709|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138943710|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943711|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943712|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
138943713|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138943714|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138943715|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
138943716|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943717|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943718|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943719|NCT00826527|Urological Agents|urological agents|mesh-ancestor
138943720|NCT02550717|Aspirin|aspirin|mesh-list
138943721|NCT02550717|Anticoagulants|anticoagulants|mesh-list
138943722|NCT02550717|Clopidogrel|clopidogrel|mesh-list
138943723|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138943724|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138943725|NCT02550717|Analgesics|analgesics|mesh-ancestor
138943726|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
138943727|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468370|NCT01972711|Amisulpride|amisulpride|mesh-list
138943728|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943729|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138943730|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943731|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138943732|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138943733|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943734|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138943735|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138943736|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943737|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
138943738|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138943739|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138647836|NCT03502018|Bupivacaine|bupivacaine|mesh-list
138943740|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138943741|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
138943742|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138468409|NCT01972984|Anastrozole|anastrozole|mesh-list
138943744|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138943745|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943746|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138943747|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943748|NCT00824811|Fluorometholone|fluorometholone|mesh-list
138943749|NCT00824811|Cyclosporine|cyclosporine|mesh-list
138943750|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138647901|NCT03414983|Vitamins|vitamins|mesh-ancestor
138943751|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
138943753|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943754|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943755|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138943756|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
138943757|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943758|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
138943759|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943760|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
138943761|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943762|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138468464|NCT01973400|Protective Agents|protective agents|mesh-ancestor
138943763|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138943764|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138943765|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
138943766|NCT00824811|Hormones|hormones|mesh-ancestor
138943767|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138943768|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138943769|NCT00606580|Paromomycin|paromomycin|mesh-list
138943770|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138943771|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943772|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138943773|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138943775|NCT02550327|Gemcitabine|gemcitabine|mesh-list
138943776|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138943777|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138943778|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943779|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
138943780|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
138943781|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
138943782|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943783|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138943784|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
138943785|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943786|NCT00825045|Risperidone|risperidone|mesh-list
138648020|NCT03031730|BB 1101|bb 1101|mesh-list
138943787|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138943788|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
138943789|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943790|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642089|NCT00265304|Analgesics|analgesics|mesh-ancestor
138468530|NCT01973816|Cyproterone|cyproterone|mesh-list
138943791|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943792|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138943793|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138943794|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943795|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138943796|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138943797|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
138943798|NCT00606502|Vitamins|vitamins|mesh-list
138943799|NCT00606502|Folic Acid|folic acid|mesh-list
138943800|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
138943801|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
138943802|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138943803|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
138595778|NCT05292339|Analgesics|analgesics|mesh-ancestor
138943805|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943806|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943807|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138943808|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943809|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943810|NCT00606502|Hematinics|hematinics|mesh-ancestor
138943811|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138943812|NCT00825123|Metoprolol|metoprolol|mesh-list
138943813|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138943814|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138943815|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
138943816|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
138943817|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943818|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943819|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138943820|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138943821|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138943822|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
138943823|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943824|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943825|NCT00826839|Leuprolide|leuprolide|mesh-list
138943826|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
138943827|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
138943828|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138943829|NCT00826839|Ganirelix|ganirelix|mesh-list
138943830|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138943831|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943832|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138943833|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
138468609|NCT01974258|Vemurafenib|vemurafenib|mesh-list
138468614|NCT01974297|Atorvastatin|atorvastatin|mesh-list
138943834|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138943835|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943836|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138943837|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
138943838|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138943839|NCT04017988|Ethanol|ethanol|mesh-list
138943840|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138943841|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943842|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943843|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943844|NCT00825201|Paclitaxel|paclitaxel|mesh-list
138943845|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138943846|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138943847|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943848|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
138943849|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
138943850|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
138943851|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943852|NCT00820911|Cyclosporine|cyclosporine|mesh-list
138943853|NCT00820911|Everolimus|everolimus|mesh-list
138943854|NCT00820911|Cyclosporins|cyclosporins|mesh-list
138943855|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943856|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943857|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138943858|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
138943859|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943860|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
138943861|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943862|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
138943863|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943864|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138943865|NCT00820911|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138943866|NCT00820911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138943867|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943868|NCT00605722|Bevacizumab|bevacizumab|mesh-list
138943869|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138943870|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138943871|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943872|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138943873|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138943874|NCT00605722|Growth Substances|growth substances|mesh-ancestor
138468676|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138468678|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
138943875|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943876|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
138943877|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138943878|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943879|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943881|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
138943882|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
138943883|NCT00882076|Clofarabine|clofarabine|mesh-list
138943884|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138943885|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943886|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138943887|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138943888|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943889|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943890|NCT00882076|Analgesics|analgesics|mesh-ancestor
138943891|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
138943892|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943893|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943894|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138943895|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
138943896|NCT00827151|Estrogens|estrogens|mesh-list
138943897|NCT00827151|Hormones|hormones|mesh-ancestor
138943898|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138943899|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943900|NCT00882154|Cefdinir|cefdinir|mesh-list
138943901|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138943902|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943903|NCT00825591|Melatonin|melatonin|mesh-list
138253537|NCT05804747|Edoxaban|edoxaban|mesh-list
138943904|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
138943905|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943906|NCT00825591|Protective Agents|protective agents|mesh-ancestor
138943907|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943908|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138943909|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
138943910|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138943911|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
138943912|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943913|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
138943914|NCT00882232|Protective Agents|protective agents|mesh-ancestor
138943916|NCT00900172|Bevacizumab|bevacizumab|mesh-list
138943917|NCT00900172|Carboplatin|carboplatin|mesh-list
138943918|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138943919|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943920|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
138943921|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
138943922|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
138218778|NCT06214169|Lidocaine|lidocaine|mesh-list
138943923|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943924|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138943925|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138943926|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138943927|NCT00900172|Growth Substances|growth substances|mesh-ancestor
138468753|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138943928|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943929|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
138943930|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
138943931|NCT00605566|Sorafenib|sorafenib|mesh-list
138943932|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138943933|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
138943934|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943935|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138943936|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138943937|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
138468801|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
138468802|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468805|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
138943938|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943939|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943940|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138943941|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138943942|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943943|NCT00882388|Aspirin|aspirin|mesh-list
138943944|NCT00882388|Celecoxib|celecoxib|mesh-list
138943945|NCT00882388|Clopidogrel|clopidogrel|mesh-list
138943946|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138943947|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138943948|NCT00882388|Analgesics|analgesics|mesh-ancestor
138943949|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
138468864|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138468865|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138468866|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
138468867|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
138468868|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
138468869|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
138943950|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138943951|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943952|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138943954|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138943955|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138943956|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943957|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138943958|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138943959|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943960|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
138943961|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138943962|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138943963|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138943964|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
138943965|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138468921|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943966|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138943967|NCT00396877|Clopidogrel|clopidogrel|mesh-list
138642148|NCT00295308|Clonidine|clonidine|mesh-list
138943968|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138943969|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138943970|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138943971|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138943972|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
138943973|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138943974|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943975|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943976|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138943977|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
138943978|NCT00882466|Hematinics|hematinics|mesh-ancestor
138943979|NCT00901498|BMS 708163|bms 708163|mesh-list
138943980|NCT00901498|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138943981|NCT00901498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943982|NCT00901498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943983|NCT00628251|Doxorubicin|doxorubicin|mesh-list
138943984|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138943985|NCT00628251|Olaparib|olaparib|mesh-list
138943986|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138943987|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138943988|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138468982|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138943989|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138943990|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138943991|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138943992|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138943993|NCT01036399|Lenalidomide|lenalidomide|mesh-list
138943994|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
138943995|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138943996|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138943997|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138943998|NCT01036399|Growth Substances|growth substances|mesh-ancestor
138943999|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
138944000|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944002|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
138944003|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944004|NCT00625131|Bupropion|bupropion|mesh-list
138944005|NCT00625131|Nicotine|nicotine|mesh-list
138944006|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138944007|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
138944008|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944009|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944010|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138944011|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138944012|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
138944013|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944014|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944015|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138944016|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
138944017|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138944018|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138469028|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944019|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138944020|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138944021|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
138944022|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138944023|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138944024|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944025|NCT00901732|Calcium|calcium|mesh-list
138944026|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138648759|NCT00291785|Antidotes|antidotes|mesh-ancestor
138944027|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944028|NCT00882700|Cefdinir|cefdinir|mesh-list
138944029|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138944030|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944031|NCT00408499|Cetuximab|cetuximab|mesh-list
138944032|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138944033|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138944034|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944035|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138944036|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944037|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944038|NCT00837369|Regadenoson|regadenoson|mesh-list
138944039|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138944040|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138944041|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
138944042|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
138944043|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944044|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944045|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944046|NCT00900874|Albuterol|albuterol|mesh-list
138944047|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
138944048|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138944049|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
138944050|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944051|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944052|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138944053|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
138944054|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138944055|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138944056|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138944057|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
138944058|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469078|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
138944059|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944060|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
138944061|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138944062|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
138944063|NCT00901888|Nitroprusside|nitroprusside|mesh-list
138944064|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138944065|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
138944066|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138944067|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944068|NCT00908362|Fluticasone|fluticasone|mesh-list
138944069|NCT00908362|Xhance|xhance|mesh-list
138218922|NCT06213077|Nitric Oxide|nitric oxide|mesh-list
138944070|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138944071|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138944072|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138944073|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138944074|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
138944075|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944076|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944077|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138944078|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
138944079|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
138944080|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138944081|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138944082|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138944084|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
138944085|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944086|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944087|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
138944089|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138944090|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
138944091|NCT02549469|Naproxen|naproxen|mesh-list
138944092|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138944093|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138944094|NCT02549469|Analgesics|analgesics|mesh-ancestor
138944095|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
138642174|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
138944096|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944097|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944098|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138944099|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138944100|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
138944101|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138944102|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944103|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944105|NCT02548533|Epinephrine|epinephrine|mesh-list
138944106|NCT02548533|Prilocaine|prilocaine|mesh-list
138944107|NCT02548533|Carticaine|carticaine|mesh-list
138944108|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138944109|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
138944110|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
138944111|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138944112|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944113|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
138944114|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944115|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138944116|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138944117|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138944118|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138649047|NCT00293150|Eplerenone|eplerenone|mesh-list
138944119|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944120|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138944121|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138944122|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
138944123|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944124|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138944125|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138944126|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
138944127|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138944128|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
138944129|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
138944130|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
138944131|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138944132|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138944133|NCT02549391|Cinacalcet|cinacalcet|mesh-list
138944134|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138944135|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944136|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138944137|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
138469139|NCT01978678|Budesonide|budesonide|mesh-list
138944138|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138944139|NCT02538172|Valganciclovir|valganciclovir|mesh-list
138944140|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
138944141|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944142|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
138944143|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
138944144|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
138944145|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138944146|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
138944147|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
138944148|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944149|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944150|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944151|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138944152|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
138944153|NCT00908674|Cyproterone|cyproterone|mesh-list
138944154|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
138944155|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
138944156|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138944157|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944158|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944159|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138944160|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
138944161|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138944162|NCT00621777|Varenicline|varenicline|mesh-list
138944163|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138944164|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138944166|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944167|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944168|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944169|NCT02538718|Ritodrine|ritodrine|mesh-list
138944170|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
138596157|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
138944171|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
138325973|NCT05320692|Apatinib|apatinib|mesh-list
138944172|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944173|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944174|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
138944175|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138944176|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138944177|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138944178|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138944179|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
138944180|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469170|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944181|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944182|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
138944183|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
138944184|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138944185|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138944186|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944187|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944188|NCT00902512|Urological Agents|urological agents|mesh-ancestor
138944190|NCT00827307|Goserelin|goserelin|mesh-list
138944191|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138944192|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
138944193|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138944194|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944195|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138944196|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944197|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138944198|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138944199|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138944200|NCT00837915|Loratadine|loratadine|mesh-list
138944201|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
138944202|NCT00837915|Ephedrine|ephedrine|mesh-list
138944203|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
138326120|NCT04775238|Copper|copper|mesh-list
138944205|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138944206|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138944207|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138944208|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
138944209|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
138944210|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944211|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944212|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944213|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138944214|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
138944215|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944216|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138944217|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
138944218|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
138944219|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138944220|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138944221|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
138944222|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
138944223|NCT00908986|Rituximab|rituximab|mesh-list
138944224|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138944225|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944226|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
138944227|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642188|NCT00295347|Diuretics|diuretics|mesh-ancestor
138944228|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138944229|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
138944230|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138944231|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944232|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
138944233|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138944234|NCT00838071|Antibodies|antibodies|mesh-list
138944235|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
138944236|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944237|NCT02547519|Insulin|insulin|mesh-list
138944238|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138944239|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944240|NCT00909454|Vitamin D|vitamin d|mesh-list
138944241|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
138944242|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
138944243|NCT00909454|Vitamins|vitamins|mesh-list
138944244|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
138944245|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944246|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138944247|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138944248|NCT04035070|Clindamycin|clindamycin|mesh-list
138944249|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
138944250|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
138944251|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138944252|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138944253|NCT04035070|Eusol|eusol|mesh-list
138944254|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138944255|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944256|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138944257|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944258|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944259|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
138944260|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138944261|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138944262|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138944263|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138944264|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138944265|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944266|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944267|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944268|NCT00408421|Analgesics|analgesics|mesh-ancestor
138469226|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944269|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
138944270|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944271|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
138944272|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138944273|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
138944274|NCT00604786|Omalizumab|omalizumab|mesh-list
138944275|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138944276|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138944277|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
138944278|NCT01042873|Dobutamine|dobutamine|mesh-list
138524648|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
138944279|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138944280|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
138944281|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
138944282|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944283|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944284|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138944285|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138944286|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138944287|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
138944288|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944289|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944290|NCT01042873|Protective Agents|protective agents|mesh-ancestor
138642196|NCT00295386|Zopiclone|zopiclone|mesh-list
138944293|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944294|NCT01037023|Topotecan|topotecan|mesh-list
138944295|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138944296|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138944297|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944298|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944299|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944300|NCT00604708|Vaccines|vaccines|mesh-list
138944301|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
138944302|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944303|NCT00909688|BLI-489|bli-489|mesh-list
138469260|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138944304|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138944305|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944306|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138770273|NCT01122264|Tadalafil|tadalafil|mesh-list
138944307|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138944308|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944309|NCT00903214|Riluzole|riluzole|mesh-list
138944310|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
138944311|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138944312|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138944313|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944314|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944315|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944316|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138944317|NCT00903214|Protective Agents|protective agents|mesh-ancestor
138944318|NCT04034836|Parecoxib|parecoxib|mesh-list
138944319|NCT04034836|Ropivacaine|ropivacaine|mesh-list
138944320|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
138944321|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
138944322|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596303|NCT02535832|Pioglitazone|pioglitazone|mesh-list
138944323|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944324|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
138944325|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944326|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138944327|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138944328|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944329|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944330|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138944331|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138944332|NCT04034836|Analgesics|analgesics|mesh-ancestor
138944333|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138944334|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138944335|NCT00407797|Pregabalin|pregabalin|mesh-list
138944336|NCT00407797|Analgesics|analgesics|mesh-ancestor
138944337|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
138944338|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138770332|NCT02654041|Methimazole|methimazole|mesh-list
138944339|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944340|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
138944341|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138944342|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138944343|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469299|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944344|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138944345|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138944346|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138944347|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138944348|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138944349|NCT00903292|Pemetrexed|pemetrexed|mesh-list
138944350|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138944351|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944352|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944353|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944354|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138944355|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138944356|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138944357|NCT00903838|Pramipexole|pramipexole|mesh-list
138944358|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
138944359|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944360|NCT00903838|Protective Agents|protective agents|mesh-ancestor
138944361|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944362|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138944363|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138944364|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
138944365|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
138944366|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944367|NCT00924430|Simvastatin|simvastatin|mesh-list
138944368|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138944369|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138944370|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
138944371|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944372|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138944373|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138944374|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944376|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138944377|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138944378|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
138944379|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944380|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944381|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944382|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138944383|NCT00903994|Ketoprofen|ketoprofen|mesh-list
138469394|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
138944384|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138944385|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138944386|NCT00903994|Analgesics|analgesics|mesh-ancestor
138944387|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
138944388|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944389|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944390|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138944391|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138944392|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138944393|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944394|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596377|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138944396|NCT00924742|Piperacillin|piperacillin|mesh-list
138944397|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138944398|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944399|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138944400|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944401|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944402|NCT00407563|Paclitaxel|paclitaxel|mesh-list
138944403|NCT00407563|Bevacizumab|bevacizumab|mesh-list
138944404|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138944405|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138944406|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944407|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
138944408|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
138944409|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
138944410|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944411|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138944412|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138770543|NCT02650609|Hormones|hormones|mesh-ancestor
138944413|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138944414|NCT00407563|Growth Substances|growth substances|mesh-ancestor
138944415|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944416|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
138944418|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138944419|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944420|NCT01037101|Cycloserine|cycloserine|mesh-list
138944421|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138944422|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944423|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138944424|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
138469443|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
138642209|NCT00295425|Cyclosporine|cyclosporine|mesh-list
138944425|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138944427|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944428|NCT00904306|Chromium|chromium|mesh-list
138944429|NCT00904306|Picolinic acid|picolinic acid|mesh-list
138944430|NCT00904306|Trace Elements|trace elements|mesh-ancestor
138944431|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
138944432|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944433|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138944434|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
138944435|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
138944436|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944437|NCT00623103|Rivastigmine|rivastigmine|mesh-list
138944438|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138944439|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944440|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944441|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
138944442|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944443|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944444|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138944445|NCT00623103|Protective Agents|protective agents|mesh-ancestor
138944446|NCT01043341|Vaccines|vaccines|mesh-list
138944447|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
138944448|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944449|NCT01043419|Xenon|xenon|mesh-list
138944450|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138944451|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
138944452|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
138944453|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138944454|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944455|NCT01037335|Morphine|morphine|mesh-list
138944456|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138944457|NCT01037335|Narcotics|narcotics|mesh-ancestor
138944458|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138944459|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944460|NCT01037335|Analgesics|analgesics|mesh-ancestor
138944461|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
138944462|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944463|NCT04015492|Factor VIII|factor viii|mesh-list
138944464|NCT04015492|BAX 855|bax 855|mesh-list
138944465|NCT04015492|Coagulants|coagulants|mesh-ancestor
138944466|NCT00904462|Lidocaine|lidocaine|mesh-list
138944467|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
138944468|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
138596448|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138944469|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138944470|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944471|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
138944472|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944473|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138944474|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138944475|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138944476|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138944477|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944478|NCT00396565|Olanzapine|olanzapine|mesh-list
138944479|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138944480|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
138944481|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
138944482|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944483|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944484|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138944485|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138944486|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138944487|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138944488|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138944489|NCT00396565|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138944490|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138944491|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138944492|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944493|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944494|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
138944495|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138469517|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138944496|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138944497|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138944498|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138944499|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
138944500|NCT00906880|Eflornithine|eflornithine|mesh-list
138944501|NCT00906880|Nifurtimox|nifurtimox|mesh-list
138944502|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944503|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138944504|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138944505|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138944506|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944507|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138944508|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944509|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944510|NCT00904852|Bevacizumab|bevacizumab|mesh-list
138944511|NCT00904852|Temozolomide|temozolomide|mesh-list
138944512|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138944513|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944514|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138944515|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138944516|NCT00904852|Growth Substances|growth substances|mesh-ancestor
138944517|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944518|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
138944519|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138944520|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
138944521|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944522|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138944523|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138944524|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
138944525|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138944526|NCT00394771|Estradiol|estradiol|mesh-list
138944527|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138944528|NCT00394771|Estrogens|estrogens|mesh-ancestor
138944529|NCT00394771|Hormones|hormones|mesh-ancestor
138944530|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138944531|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944532|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138944533|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
138944534|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138944535|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138944536|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138944537|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138469550|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
138944538|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138944540|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138944541|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138944542|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
138944543|NCT04060836|Factor VIII|factor viii|mesh-list
138944544|NCT04060836|Coagulants|coagulants|mesh-ancestor
138944545|NCT00693420|Bimatoprost|bimatoprost|mesh-list
138642236|NCT00266162|Bosentan|bosentan|mesh-list
138944546|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138944547|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138944548|NCT04034524|Insulin|insulin|mesh-list
138944549|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138944550|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138944551|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944553|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
138944554|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
138944555|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138944556|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944557|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
138944558|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944559|NCT00695136|Donepezil|donepezil|mesh-list
138944560|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138944561|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944562|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944563|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
138944564|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944565|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944566|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
138944567|NCT00921570|Amlodipine|amlodipine|mesh-list
138944568|NCT00921570|Valsartan|valsartan|mesh-list
138944569|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138944570|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138944571|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138944572|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711059|NCT01190410|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138944573|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138944574|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944575|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
138944576|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138944577|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138944578|NCT02710890|Lacosamide|lacosamide|mesh-list
138944579|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
138944580|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138944581|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138944582|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138944583|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944584|NCT00605176|Imiquimod|imiquimod|mesh-list
138944585|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138944586|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
138944587|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944588|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944589|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
138944590|NCT00743028|Navitoclax|navitoclax|mesh-list
138944591|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944592|NCT00926302|Levetiracetam|levetiracetam|mesh-list
138944593|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
138944594|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
138944595|NCT00907036|Cyclosporine|cyclosporine|mesh-list
138944596|NCT00907036|Fludarabine|fludarabine|mesh-list
138944597|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
138944598|NCT00907036|Melphalan|melphalan|mesh-list
138944599|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
138771043|NCT02647489|Antacids|antacids|mesh-ancestor
138944600|NCT00907036|Cyclosporins|cyclosporins|mesh-list
138944601|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944602|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138944603|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
138944604|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944605|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138944606|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
138944607|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944608|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944609|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
138944610|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944611|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
138944612|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138469628|NCT01982799|Narcotics|narcotics|mesh-ancestor
138944613|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138944614|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138944615|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
138944616|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138944617|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138944618|NCT00926614|Pioglitazone|pioglitazone|mesh-list
138944619|NCT00926614|Atorvastatin|atorvastatin|mesh-list
138944620|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138944621|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138944622|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
138944623|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944624|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138944625|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138944626|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944627|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138944628|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944629|NCT00907114|Ketorolac|ketorolac|mesh-list
138944630|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138944631|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138944632|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138944633|NCT00907114|Analgesics|analgesics|mesh-ancestor
138944634|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
138944635|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944636|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944637|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138944638|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138944639|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138944640|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944641|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944642|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
138944643|NCT02564094|Hematinics|hematinics|mesh-ancestor
138944644|NCT00745914|Pioglitazone|pioglitazone|mesh-list
138944645|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138944646|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944647|NCT00746070|Spironolactone|spironolactone|mesh-list
138944648|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138944649|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
138771133|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
138944650|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138944651|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944652|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138469655|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
138944654|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
138944655|NCT00396331|Plerixafor|plerixafor|mesh-list
138944656|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138944657|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138944658|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
138944659|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944660|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
138944661|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
138944662|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138944663|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944664|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944665|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
138944666|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138944667|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138944668|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944669|NCT00926926|Oxybutynin|oxybutynin|mesh-list
138944670|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
138944671|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
138469693|NCT01983449|Hormones|hormones|mesh-ancestor
138944672|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944673|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944674|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138944675|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138944676|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
138944677|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944678|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944679|NCT00926926|Urological Agents|urological agents|mesh-ancestor
138944681|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138944682|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138944683|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944684|NCT00927004|Etoricoxib|etoricoxib|mesh-list
138642246|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138944685|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138944686|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138944688|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
138944689|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944690|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944691|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138944692|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138944693|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138944694|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138944695|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944696|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944698|NCT00931450|Exemestane|exemestane|mesh-list
138944699|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944700|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138944701|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138944702|NCT00931450|Growth Substances|growth substances|mesh-ancestor
138944703|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944704|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
138944705|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138944706|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944707|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944708|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138944709|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138944710|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138944711|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
138944712|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138944713|NCT00928330|Trastuzumab|trastuzumab|mesh-list
138944714|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138944715|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138944716|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944717|NCT00928330|Immunotoxins|immunotoxins|mesh-ancestor
138944718|NCT00928330|Immunoconjugates|immunoconjugates|mesh-ancestor
138944719|NCT00928330|Immunologic Factors|immunologic factors|mesh-ancestor
138944720|NCT00928330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944721|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
138944722|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
138944723|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
138944724|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944725|NCT00928798|Sirolimus|sirolimus|mesh-list
138944726|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138944727|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944728|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138944729|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944730|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
138944731|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138944732|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
138944733|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944734|NCT00931840|Irinotecan|irinotecan|mesh-list
138944735|NCT00931840|Cetuximab|cetuximab|mesh-list
138944736|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138944737|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138944738|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944739|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944740|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944741|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138944742|NCT04034368|Tenofovir|tenofovir|mesh-list
138944743|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
138944744|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944745|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138524659|NCT00020774|Lonafarnib|lonafarnib|mesh-list
138944746|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138642253|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138944748|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944749|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138944750|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138944751|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
138944752|NCT00907270|Vitamin D|vitamin d|mesh-list
138944753|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138944754|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944755|NCT00907270|Vitamins|vitamins|mesh-ancestor
138944756|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
138944757|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138944758|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
138944759|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138944760|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944761|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138944762|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138944763|NCT00907504|Cisplatin|cisplatin|mesh-list
138944764|NCT00907504|Gemcitabine|gemcitabine|mesh-list
138944765|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944766|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138944767|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
138944768|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944769|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
138944770|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138944771|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138944772|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944773|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138944774|NCT00932386|Analgesics|analgesics|mesh-ancestor
138944775|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
138944776|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944777|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138944778|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138944779|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138944780|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
138944781|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944782|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944783|NCT00932542|Lidocaine|lidocaine|mesh-list
138944784|NCT00932542|Prilocaine|prilocaine|mesh-list
138944785|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
138944786|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
138944787|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138944788|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944789|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
138469820|NCT01984008|Antacids|antacids|mesh-ancestor
138944790|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944791|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138944792|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138944793|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138944794|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138944795|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944796|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
138944797|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138944798|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944799|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
138944800|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138944801|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138944802|NCT04014634|Prednisolone|prednisolone|mesh-list
138642265|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
138944803|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
138944804|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138944805|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
138771302|NCT02639767|Pemetrexed|pemetrexed|mesh-list
138944806|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138944807|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
138944808|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
138944809|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944810|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944811|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138944812|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
138944813|NCT04014634|Hormones|hormones|mesh-ancestor
138944814|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138944815|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138944816|NCT04014634|Protective Agents|protective agents|mesh-ancestor
138944817|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138944818|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944819|NCT01043575|Rifampin|rifampin|mesh-list
138944820|NCT01043575|Rifapentine|rifapentine|mesh-list
138944821|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138771316|NCT00960063|Temozolomide|temozolomide|mesh-list
138944822|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
138944823|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138944824|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944825|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
138944826|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138944827|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944828|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944829|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138944830|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138944831|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138944832|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138469872|NCT01984177|Hormones|hormones|mesh-list
138944833|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138944834|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138944835|NCT01045837|Prednisolone|prednisolone|mesh-list
138944836|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138944837|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
138944838|NCT01045837|Hormones|hormones|mesh-ancestor
138944839|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138944840|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944841|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138944842|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944844|NCT00567268|Analgesics|analgesics|mesh-ancestor
138944845|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
138944846|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944847|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944848|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
138944849|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138944850|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138944851|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138944852|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138944853|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138944854|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138944855|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944856|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944857|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
138944858|NCT00907894|Telbivudine|telbivudine|mesh-list
138944859|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
138944860|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944861|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138944862|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642281|NCT00295542|Valsartan|valsartan|mesh-list
138944863|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944864|NCT04014556|Aflibercept|aflibercept|mesh-list
138944865|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138944866|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138469881|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138944867|NCT04014556|Growth Substances|growth substances|mesh-ancestor
138944868|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944869|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
138944870|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944871|NCT00929812|Glucagon|glucagon|mesh-list
138944872|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138944873|NCT00929812|Hormones|hormones|mesh-ancestor
138944874|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138944875|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944876|NCT00907972|Vitamin D|vitamin d|mesh-list
138944877|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
138944878|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
138944879|NCT00907972|Vitamins|vitamins|mesh-list
138944880|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
138944881|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944882|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138944883|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138944884|NCT03799744|Durvalumab|durvalumab|mesh-list
138944885|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138944886|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944887|NCT00933634|Propafenone|propafenone|mesh-list
138944888|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138944889|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138944890|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138944891|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138944892|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944893|NCT00933790|Rifampin|rifampin|mesh-list
138944894|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
138944895|NCT00933790|Ethambutol|ethambutol|mesh-list
138944896|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138944897|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
138771538|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944898|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138944899|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138944900|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
138944901|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138944902|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944903|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469981|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138944904|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138944905|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138944906|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138944907|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138944908|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138944909|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138944911|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
138771588|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138771589|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138771590|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138771591|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138771592|NCT01124838|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138771593|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138944912|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138944913|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138944914|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944915|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138944916|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944917|NCT00930202|Conivaptan|conivaptan|mesh-list
138944918|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138944919|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944920|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
138944921|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944922|NCT00393367|Prednisone|prednisone|mesh-list
138470036|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
138944923|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
138944924|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138944925|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138944926|NCT00393367|Prednisolone|prednisolone|mesh-list
138944927|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
138944928|NCT00393367|Budesonide|budesonide|mesh-list
138944929|NCT00393367|Bromides|bromides|mesh-list
138944930|NCT00393367|Albuterol|albuterol|mesh-list
138944931|NCT00393367|Ipratropium|ipratropium|mesh-list
138944932|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138944933|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
138944934|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138944935|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
138944936|NCT00393367|Hormones|hormones|mesh-ancestor
138944937|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138944938|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944939|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138944940|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944941|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
138944942|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
138944943|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138771651|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944944|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138944945|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138944946|NCT00393367|Protective Agents|protective agents|mesh-ancestor
138944947|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138944948|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138944949|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
138944950|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
138944951|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
138944952|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138944953|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138944954|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138944955|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138944956|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
138944957|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138944958|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944959|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138944960|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
138944962|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138944963|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
138944964|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
138219997|NCT05257083|Antiemetics|antiemetics|mesh-ancestor
138944965|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944966|NCT00392665|Sulindac|sulindac|mesh-list
138944967|NCT00392665|Bevacizumab|bevacizumab|mesh-list
138944968|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138944969|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138944970|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138944971|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138944972|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138944973|NCT00392665|Growth Substances|growth substances|mesh-ancestor
138944974|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944975|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
138944976|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138944977|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944978|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944979|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138944980|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138944981|NCT00392665|Analgesics|analgesics|mesh-ancestor
138944982|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
138944983|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138944984|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138944985|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138944986|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138944987|NCT01043965|Metformin|metformin|mesh-list
138944988|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138944989|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944990|NCT00622869|Everolimus|everolimus|mesh-list
138944991|NCT00622869|Tacrolimus|tacrolimus|mesh-list
138944992|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138944993|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
138642308|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
138944994|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138944995|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138944996|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138944997|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138944998|NCT00622869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138470126|NCT01985854|Propofol|propofol|mesh-list
138944999|NCT00622869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138945000|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945001|NCT00366457|Bevacizumab|bevacizumab|mesh-list
138945002|NCT00366457|Gemcitabine|gemcitabine|mesh-list
138945003|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138945004|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138945005|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945006|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138945007|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138945008|NCT00366457|Growth Substances|growth substances|mesh-ancestor
138945009|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945010|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
138945011|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138945012|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
138945013|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945014|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138945015|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945016|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138945017|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
138945018|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945019|NCT01049347|Amitriptyline|amitriptyline|mesh-list
138945021|NCT01049347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138945022|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138945023|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138945024|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945025|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945026|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
138945027|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945028|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138945029|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
138945030|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138945031|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138945032|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138945034|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138945035|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138945037|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
138945038|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945039|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138945040|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
138945041|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
138945042|NCT01049425|Docetaxel|docetaxel|mesh-list
138945043|NCT01049425|Epirubicin|epirubicin|mesh-list
138945044|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138945045|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
138945046|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945047|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138945048|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138945049|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
138945050|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945051|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945052|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138945053|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
138945054|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
138945055|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
138945056|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138945057|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138945058|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138945059|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945060|NCT00838227|Modafinil|modafinil|mesh-list
138945061|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138945062|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945063|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138945064|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138945065|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138945066|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945067|NCT00366301|Metformin|metformin|mesh-list
138945068|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
138945069|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138945070|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945071|NCT00838305|Citalopram|citalopram|mesh-list
138945072|NCT00838305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138945073|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138470192|NCT01986283|Analgesics|analgesics|mesh-ancestor
138470193|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
138945074|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138945075|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945076|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945077|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
138945078|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945079|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138945080|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
138945081|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138945082|NCT00622713|Rivastigmine|rivastigmine|mesh-list
138945083|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138945084|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945085|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945086|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
138945087|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945088|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945089|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138945090|NCT00622713|Protective Agents|protective agents|mesh-ancestor
138945091|NCT01046227|Vaccines|vaccines|mesh-list
138945092|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
138945093|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945094|NCT00392197|Aripiprazole|aripiprazole|mesh-list
138945095|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
138945096|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138945097|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138945098|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138945099|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138945100|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470231|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470236|NCT01986556|Lesinurad|lesinurad|mesh-list
138945101|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
138945102|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
138945103|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945104|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220161|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945105|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138642323|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138945106|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138945107|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
138945108|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138945109|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138945110|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138945111|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138945112|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138945113|NCT00391807|Norethindrone|norethindrone|mesh-list
138945114|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
138945115|NCT00391807|Estradiol|estradiol|mesh-list
138945116|NCT00391807|Estrogens|estrogens|mesh-ancestor
138945117|NCT00391807|Hormones|hormones|mesh-ancestor
138945118|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138945119|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945120|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138945121|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
138945122|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138945123|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138945124|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138945125|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138772147|NCT02635243|Glucagon|glucagon|mesh-list
138945126|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138945128|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945129|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138945130|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945131|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945132|NCT01046383|Caseins|caseins|mesh-list
138945133|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
138945134|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
138945135|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945136|NCT00831597|Rituximab|rituximab|mesh-list
138945137|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138597114|NCT05466019|Antidotes|antidotes|mesh-ancestor
138945138|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138945139|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945140|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
138945141|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945142|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138945143|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138945144|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
138945145|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945146|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138945147|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138945148|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
138945149|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945150|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945151|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138945152|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
138945153|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138945154|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138945155|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138945156|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
138945157|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945158|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945159|NCT00391027|Insulin|insulin|mesh-list
138945160|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138945161|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
138945162|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138945163|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945164|NCT00622401|Interleukin-12|interleukin-12|mesh-list
138945165|NCT00622401|Vaccines|vaccines|mesh-list
138945166|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
138945167|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945169|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138945170|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138470308|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138470337|NCT01986998|Hormones|hormones|mesh-ancestor
138945171|NCT00622401|Growth Substances|growth substances|mesh-ancestor
138945172|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
138945173|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945174|NCT04018365|Empagliflozin|empagliflozin|mesh-list
138945175|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138945176|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945178|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945179|NCT00828087|Cobalt|cobalt|mesh-list
138945180|NCT00828087|Chromium|chromium|mesh-list
138945181|NCT00828087|Everolimus|everolimus|mesh-list
138945182|NCT00828087|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138945183|NCT00828087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138945184|NCT00828087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945185|NCT00828087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945186|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138945187|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
138945188|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945189|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945190|NCT00828087|Trace Elements|trace elements|mesh-ancestor
138945191|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
138945192|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
138945193|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
138945194|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
138945195|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945196|NCT00839085|Protective Agents|protective agents|mesh-ancestor
138945197|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945198|NCT00839085|Vitamins|vitamins|mesh-ancestor
138945199|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
138945200|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138945201|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945202|NCT00839163|Vitamin K|vitamin k|mesh-list
138945203|NCT00839163|Enoxaparin|enoxaparin|mesh-list
138945204|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
138945205|NCT00839163|Vitamins|vitamins|mesh-ancestor
138945206|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
138945207|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945208|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138945209|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
138945210|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138945211|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
138945212|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945213|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945214|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
138945215|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138945216|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138945217|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138945218|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
138945219|NCT00839163|Coagulants|coagulants|mesh-ancestor
138945220|NCT02549001|Amorolfine|amorolfine|mesh-list
138945221|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
138945222|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945223|NCT00621543|Copper|copper|mesh-list
138945224|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
138945225|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138945226|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
138945227|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138945228|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945229|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138945230|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138945231|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138945232|NCT00621543|Trace Elements|trace elements|mesh-ancestor
138945233|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
138945234|NCT00623805|Bevacizumab|bevacizumab|mesh-list
138945235|NCT00623805|Capecitabine|capecitabine|mesh-list
138945236|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
138945237|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138945238|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945239|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138945240|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138945241|NCT00623805|Growth Substances|growth substances|mesh-ancestor
138945242|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945243|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
138945244|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138945245|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
138711060|NCT01190410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138470392|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138945246|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945247|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
138945249|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138945250|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138945251|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945252|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138945253|NCT02548923|Analgesics|analgesics|mesh-ancestor
138945254|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
138945255|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945256|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138945257|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138945258|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138945259|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
138945260|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945261|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945262|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138945263|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
138945265|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138945266|NCT00832221|Raclopride|raclopride|mesh-list
138945267|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
138945268|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138945269|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138945270|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138945271|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138945272|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945273|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138945274|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
138945275|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945276|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945277|NCT00839397|Paroxetine|paroxetine|mesh-list
138945278|NCT00839397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138945279|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138945280|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138945281|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945282|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945284|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945285|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138945286|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
138945287|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138945288|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138945289|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138945290|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945291|NCT00828477|Nepafenac|nepafenac|mesh-list
138945293|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138945294|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138945295|NCT00828477|Analgesics|analgesics|mesh-ancestor
138945296|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
138945297|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945298|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945299|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138945300|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138945301|NCT00621309|Rifampin|rifampin|mesh-list
138945302|NCT00621309|Rifamycins|rifamycins|mesh-list
138945303|NCT00621309|Sulforaphane|sulforaphane|mesh-list
138945304|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138945305|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
138945306|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138772462|NCT02848612|Heparin|heparin|mesh-list
138945307|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945308|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
138945309|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138945310|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945311|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945312|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138945313|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138772520|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
138945314|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138945315|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138945316|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138945317|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138945318|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138945319|NCT00621309|Protective Agents|protective agents|mesh-ancestor
138945320|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945321|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138772586|NCT00433420|Epirubicin|epirubicin|mesh-list
138945323|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138945324|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945325|NCT00832689|Gemcitabine|gemcitabine|mesh-list
138945326|NCT00832689|Irinotecan|irinotecan|mesh-list
138945327|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138945328|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
138945329|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945330|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945331|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138945332|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138945333|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945334|NCT00567190|Docetaxel|docetaxel|mesh-list
138945335|NCT00567190|Trastuzumab|trastuzumab|mesh-list
138945336|NCT00567190|Pertuzumab|pertuzumab|mesh-list
138945337|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945338|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
138945339|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
138945340|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
138945341|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945342|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138945343|NCT00922389|Lenograstim|lenograstim|mesh-list
138945344|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138945345|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
138945346|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945347|NCT00691938|Decitabine|decitabine|mesh-list
138945348|NCT00691938|Panobinostat|panobinostat|mesh-list
138945349|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138945350|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
138945351|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945352|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945353|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945354|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138945355|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
138945356|NCT00365365|Bevacizumab|bevacizumab|mesh-list
138945357|NCT00365365|Carboplatin|carboplatin|mesh-list
138945359|NCT00365365|Doxorubicin|doxorubicin|mesh-list
138945360|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138945361|NCT00365365|Trastuzumab|trastuzumab|mesh-list
138945362|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138945363|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
138945364|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470495|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
138945365|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138945366|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138945367|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
138945368|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945369|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945370|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138945371|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138772700|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
138945372|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138945373|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138945375|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
138945376|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
138945377|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
138945378|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
138772749|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945379|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138945380|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138945381|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138945382|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945383|NCT01046461|Dexamethasone|dexamethasone|mesh-list
138945384|NCT01046461|Aprepitant|aprepitant|mesh-list
138945385|NCT01046461|Ramosetron|ramosetron|mesh-list
138945386|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138945387|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
138945388|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
138945389|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138772816|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
138945390|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945391|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138945392|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
138945393|NCT01046461|Hormones|hormones|mesh-ancestor
138945394|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138945395|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138945396|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945397|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138945398|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138772881|NCT00885703|Amphotericin B|amphotericin b|mesh-list
138945399|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945400|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138945401|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
138945402|NCT00623727|Factor VIII|factor viii|mesh-list
138945403|NCT00623727|Coagulants|coagulants|mesh-ancestor
138945404|NCT01046539|Buprenorphine|buprenorphine|mesh-list
138945406|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138945407|NCT01046539|Narcotics|narcotics|mesh-ancestor
138642409|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
138945408|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138945409|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945411|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
138945412|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945413|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138945414|NCT01044199|Vaccines|vaccines|mesh-list
138945415|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
138945416|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945417|NCT00828789|Tenofovir|tenofovir|mesh-list
138945418|NCT00828789|Efavirenz|efavirenz|mesh-list
138945419|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
138945420|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945421|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138945422|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138945423|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945424|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945425|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138945426|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138945427|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138945428|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138772943|NCT00655837|Gemcitabine|gemcitabine|mesh-list
138945429|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138945431|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138945432|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138945433|NCT00930358|Anesthetics|anesthetics|mesh-list
138945434|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138945435|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945436|NCT00372775|Sunitinib|sunitinib|mesh-list
138945437|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945438|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138772988|NCT00656773|Sufentanil|sufentanil|mesh-list
138945439|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138945440|NCT00372775|Growth Substances|growth substances|mesh-ancestor
138945441|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945442|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
138945443|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138945444|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945445|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945447|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138945448|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945449|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945450|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138945451|NCT00936676|Protective Agents|protective agents|mesh-ancestor
138945452|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945453|NCT00839787|Morphine|morphine|mesh-list
138945454|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138945455|NCT00839787|Narcotics|narcotics|mesh-ancestor
138945456|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138945457|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945458|NCT00839787|Analgesics|analgesics|mesh-ancestor
138470553|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138945459|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
138945460|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945461|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138945462|NCT00934258|Fenofibrate|fenofibrate|mesh-list
138945463|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138773125|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
138945464|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138945465|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
138945466|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945467|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138945468|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138945469|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945470|NCT00372697|Octreotide|octreotide|mesh-list
138945471|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138945472|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138945473|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945474|NCT00934414|Insulin|insulin|mesh-list
138945475|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138945476|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945477|NCT00930514|Rituximab|rituximab|mesh-list
138945478|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138945479|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945480|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
138945481|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945482|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138945483|NCT00936988|Cinacalcet|cinacalcet|mesh-list
138945484|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138945485|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945486|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138945487|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
138945488|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470581|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
138945489|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138945490|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138945491|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945492|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138945493|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
138945494|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138945495|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138945496|NCT00934570|Metformin|metformin|mesh-list
138945497|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138945498|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945499|NCT00930670|Esomeprazole|esomeprazole|mesh-list
138945500|NCT00930670|Omeprazole|omeprazole|mesh-list
138945501|NCT00930670|Pantoprazole|pantoprazole|mesh-list
138945502|NCT00930670|Ranitidine|ranitidine|mesh-list
138945503|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138945504|NCT00930670|Atorvastatin|atorvastatin|mesh-list
138945505|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138945506|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138945507|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138945509|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945510|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138945511|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138945512|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945513|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138597508|NCT00533065|Donepezil|donepezil|mesh-list
138945514|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138945515|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138945516|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138945517|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
138945518|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
138945519|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945520|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470626|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
138945521|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
138945522|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
138945523|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138773286|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
138945524|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138945525|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945526|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945527|NCT00937144|Urological Agents|urological agents|mesh-ancestor
138945528|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
138945529|NCT00937300|Fludarabine|fludarabine|mesh-list
138945530|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
138945531|NCT00937300|Interleukin-2|interleukin-2|mesh-list
138945532|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138945533|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
138945534|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945535|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138945536|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138945537|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
138945538|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945539|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945540|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138945541|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138945542|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
138470668|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945543|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138945544|NCT00937300|Analgesics|analgesics|mesh-ancestor
138945545|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
138945546|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945547|NCT02226276|Copper|copper|mesh-list
138945548|NCT02226276|Trastuzumab|trastuzumab|mesh-list
138945549|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138945550|NCT02226276|Maytansine|maytansine|mesh-list
138945551|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138945552|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
138945553|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138945554|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945555|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945556|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138945557|NCT02226276|Trace Elements|trace elements|mesh-ancestor
138945558|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
138945559|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945560|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138945561|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
138945562|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
138945563|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
138945564|NCT02226276|Immunotoxins|immunotoxins|mesh-ancestor
138945565|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
138945566|NCT00935116|Etoricoxib|etoricoxib|mesh-list
138945567|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138945568|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138945569|NCT00935116|Analgesics|analgesics|mesh-ancestor
138945570|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
138945571|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945572|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945573|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138945574|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138945575|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138945576|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138945577|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470717|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470718|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
138945578|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945579|NCT00931138|Cytarabine|cytarabine|mesh-list
138945580|NCT00931138|Daunorubicin|daunorubicin|mesh-list
138945581|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138945582|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945583|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138945584|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138945585|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945586|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945587|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138945588|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
138945589|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
138945590|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945591|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138945592|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
138945593|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945594|NCT00935194|Oseltamivir|oseltamivir|mesh-list
138945595|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
138945596|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945597|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945598|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945599|NCT00690378|Imipenem|imipenem|mesh-list
138945600|NCT00690378|Ceftazidime|ceftazidime|mesh-list
138945601|NCT00690378|Avibactam|avibactam|mesh-list
138945602|NCT00690378|Cilastatin|cilastatin|mesh-list
138945603|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138945604|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945605|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
138945606|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945607|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945608|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138945609|NCT00574275|Gemcitabine|gemcitabine|mesh-list
138945610|NCT00574275|Aflibercept|aflibercept|mesh-list
138945611|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138945612|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
138945613|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945614|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945615|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138945616|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138945617|NCT00574275|Growth Substances|growth substances|mesh-ancestor
138945618|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945619|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
138945620|NCT01742832|Citalopram|citalopram|mesh-list
138945621|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138945622|NCT01742832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138945623|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138945624|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138945625|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945626|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945627|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
138945628|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711061|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138945629|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138945630|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
138945631|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138945632|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138642487|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
138945634|NCT00833079|Tacrolimus|tacrolimus|mesh-list
138945635|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138945636|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
138945637|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945638|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138945639|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945640|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945641|NCT00935506|Aspirin|aspirin|mesh-list
138945642|NCT00935506|Clopidogrel|clopidogrel|mesh-list
138773547|NCT00657163|Fluoxetine|fluoxetine|mesh-list
138945643|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138945644|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138945645|NCT00935506|Analgesics|analgesics|mesh-ancestor
138945646|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
138945647|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945648|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945649|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138945650|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138945651|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138945652|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138945653|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945654|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138945655|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138945656|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945657|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
138945658|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138945659|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138945660|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138945661|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
138945662|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470774|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
138945664|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138945665|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138945666|NCT00833157|Analgesics|analgesics|mesh-ancestor
138945667|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
138945668|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945669|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945670|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138945671|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138945672|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138945674|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945675|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
138945676|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138945677|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138945678|NCT00931372|Lixisenatide|lixisenatide|mesh-list
138945679|NCT00931372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138945680|NCT00931372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773632|NCT00894790|Celecoxib|celecoxib|mesh-list
138945681|NCT00829257|Fluticasone|fluticasone|mesh-list
138945682|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138945683|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138945684|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138945685|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
138945686|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945687|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945688|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138945689|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
138945690|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
138945691|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138945692|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
138945693|NCT00829257|Hormones|hormones|mesh-ancestor
138945694|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138945695|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
138470815|NCT01991054|Vitamin D|vitamin d|mesh-list
138945696|NCT03978832|Risperidone|risperidone|mesh-list
138945697|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138945698|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
138945699|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945700|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945701|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945702|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138945703|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138945704|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138945705|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138945706|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138945707|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
138945708|NCT00840333|Levofloxacin|levofloxacin|mesh-list
138945709|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138945710|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945711|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138945712|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138945713|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138945714|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945715|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945716|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945717|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138945718|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138945719|NCT00840489|Ribavirin|ribavirin|mesh-list
138945720|NCT00840489|Colchicine|colchicine|mesh-list
138945721|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
138945722|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945723|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
138945724|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945725|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
138945726|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138945727|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
138773811|NCT00657943|Metformin|metformin|mesh-list
138945728|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
138945729|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
138945730|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945731|NCT00743496|Antibodies|antibodies|mesh-list
138945732|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
138945733|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945734|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138945735|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138945736|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138945737|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138945738|NCT00840645|Mirabegron|mirabegron|mesh-list
138945739|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138945741|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138945742|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
138945743|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945744|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945745|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470853|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470861|NCT01991275|Narcotics|narcotics|mesh-ancestor
138945746|NCT00840645|Urological Agents|urological agents|mesh-ancestor
138945747|NCT00566722|Adalimumab|adalimumab|mesh-list
138945748|NCT00566722|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138945749|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138945750|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138945751|NCT00691704|Prednisone|prednisone|mesh-list
138945752|NCT00691704|Lenalidomide|lenalidomide|mesh-list
138945753|NCT00691704|Bortezomib|bortezomib|mesh-list
138945754|NCT00691704|Melphalan|melphalan|mesh-list
138945755|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138945756|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
138945757|NCT00691704|Hormones|hormones|mesh-ancestor
138945758|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138945759|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945760|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138945761|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945762|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945763|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
138945764|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138945765|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138945766|NCT00691704|Growth Substances|growth substances|mesh-ancestor
138945767|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
138945768|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138945769|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
138945770|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138945771|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138945772|NCT00829647|Lenalidomide|lenalidomide|mesh-list
138945773|NCT00829647|Dasatinib|dasatinib|mesh-list
138945774|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
138945775|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773935|NCT02836288|Ketamine|ketamine|mesh-list
138945776|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138945777|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138945778|NCT00829647|Growth Substances|growth substances|mesh-ancestor
138945779|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
138945780|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945781|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138945782|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945783|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945785|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138945786|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138945787|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945788|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
138945789|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945790|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138642538|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
138945791|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138945793|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945794|NCT00829881|Betahistine|betahistine|mesh-list
138945795|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
138945796|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
138945797|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
138945798|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945799|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945800|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138773990|NCT02835664|Niacin|niacin|mesh-list
138945801|NCT04014244|Triamcinolone|triamcinolone|mesh-list
138945802|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138945803|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138945804|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138945805|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138945806|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
138945807|NCT04014244|Hormones|hormones|mesh-ancestor
138945808|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138945809|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945810|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138945811|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
138945812|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597784|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
138945813|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945814|NCT02548611|Clopidogrel|clopidogrel|mesh-list
138945815|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138945816|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138945817|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138945818|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138945819|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138945820|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
138945821|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945822|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945823|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945824|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
138945825|NCT00937924|Promethazine|promethazine|mesh-list
138470911|NCT01991574|Calcium|calcium|mesh-list
138470912|NCT01991574|Calcium acetate|calcium acetate|mesh-list
138945826|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138945827|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138945828|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138945829|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945830|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
138945831|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
138945832|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
138945833|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945836|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138945837|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138945838|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
138945839|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
138945840|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945841|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945842|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138945843|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
138945844|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
138945845|NCT00743886|Mitogens|mitogens|mesh-list
138945846|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
138945847|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945848|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
138945849|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138945850|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
138945851|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945852|NCT00830193|Expectorants|expectorants|mesh-ancestor
138945853|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
138945854|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138945855|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
138945856|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945857|NCT00830193|Protective Agents|protective agents|mesh-ancestor
138945858|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945859|NCT00830193|Antidotes|antidotes|mesh-ancestor
138945860|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
138945861|NCT00938158|Incretins|incretins|mesh-ancestor
138945862|NCT00938158|Hormones|hormones|mesh-ancestor
138945863|NCT00938158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138945864|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945865|NCT00840957|Infliximab|infliximab|mesh-list
138945867|NCT00840957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138945868|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
138945869|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138945870|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138945871|NCT00743964|Capecitabine|capecitabine|mesh-list
138945872|NCT00743964|Epirubicin|epirubicin|mesh-list
138945873|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945874|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138945875|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
138945876|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945877|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138945878|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138945879|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138945880|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945881|NCT00830349|Risperidone|risperidone|mesh-list
138945882|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138945883|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
138945884|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945885|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945886|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945887|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138945888|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138945889|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138945890|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138470985|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
138945891|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138945892|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
138945893|NCT00841113|Goserelin|goserelin|mesh-list
138945894|NCT00841113|Bicalutamide|bicalutamide|mesh-list
138945895|NCT00841113|Abarelix|abarelix|mesh-list
138945896|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138945897|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945898|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
138642598|NCT00301899|Pertuzumab|pertuzumab|mesh-list
138774391|NCT02885441|Ketorolac|ketorolac|mesh-list
138945899|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
138945900|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138945901|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945902|NCT00830505|Fluticasone|fluticasone|mesh-list
138945903|NCT00830505|Xhance|xhance|mesh-list
138945904|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138945905|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138945906|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138945907|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138945908|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
138945909|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138945910|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945911|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138945912|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
138945913|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
138945914|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138945915|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138945916|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138945917|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138945918|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
138945919|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138945920|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945921|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
138945922|NCT00830505|Hormones|hormones|mesh-ancestor
138945923|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138945925|NCT00566020|Lamotrigine|lamotrigine|mesh-list
138945926|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
138945927|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138945928|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138945929|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945930|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138945931|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945932|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138945933|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138945934|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138945935|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138945936|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138945937|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
138945938|NCT02563782|Tacrolimus|tacrolimus|mesh-list
138945939|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138945940|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
138945941|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138774507|NCT01157351|Perphenazine|perphenazine|mesh-list
138945942|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138945943|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945944|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945945|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138945946|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945947|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138945948|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
138945949|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138945950|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945951|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138945953|NCT00841191|Antibodies|antibodies|mesh-list
138945954|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
138945955|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138945956|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
138945957|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945958|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945959|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
138945960|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
138945961|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
138945962|NCT00843453|Vitamins|vitamins|mesh-ancestor
138945963|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
138945964|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945966|NCT00921726|Oseltamivir|oseltamivir|mesh-list
138945968|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
138945969|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945970|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945971|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945972|NCT00938236|Cyclosporine|cyclosporine|mesh-list
138945973|NCT00938236|Cyclosporins|cyclosporins|mesh-list
138945974|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945975|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138945976|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138945977|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
138945978|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945979|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
138945980|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945981|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
138945982|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138945983|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138945984|NCT00741780|Plerixafor|plerixafor|mesh-list
138945985|NCT00741780|Lenograstim|lenograstim|mesh-list
138774747|NCT05210764|Anesthetics|anesthetics|mesh-list
138945986|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138945987|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
138945988|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138945989|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138945990|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138471049|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138945991|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
138945992|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138945993|NCT00936442|Anastrozole|anastrozole|mesh-list
138945994|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138945995|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138945996|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138945997|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138945998|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138945999|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946000|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138946001|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
138946002|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946003|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946004|NCT00744354|Doxorubicin|doxorubicin|mesh-list
138946005|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138946006|NCT00744354|Bortezomib|bortezomib|mesh-list
138946007|NCT00744354|Vorinostat|vorinostat|mesh-list
138946008|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138946009|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946010|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138946011|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138946012|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471082|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138946013|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946014|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138946015|NCT04043325|Antibodies|antibodies|mesh-list
138946016|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
138642632|NCT00296361|Tacrolimus|tacrolimus|mesh-list
138946017|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946018|NCT00936520|Lifitegrast|lifitegrast|mesh-list
138946019|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138946020|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138946021|NCT00835029|Clotrimazole|clotrimazole|mesh-list
138946022|NCT00835029|Miconazole|miconazole|mesh-list
138946023|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138946024|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138946025|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
138946026|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138946027|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138946028|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946029|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946030|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138946031|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
138946032|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946033|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946034|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138946035|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138946036|NCT00835107|Ziprasidone|ziprasidone|mesh-list
138946037|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138946038|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
138946039|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138774922|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138946040|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946041|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946042|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138946043|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138946044|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946045|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138946046|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138946047|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
138946048|NCT00690612|Candesartan|candesartan|mesh-list
138946049|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
138946050|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138946051|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138946052|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138946053|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946054|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
138946055|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
138946056|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138524696|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946057|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138946058|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946059|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946060|NCT00742014|Urological Agents|urological agents|mesh-ancestor
138946062|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711062|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
138946063|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946064|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138946065|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138946066|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
138946067|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138946068|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138946069|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138946070|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946071|NCT00841581|Ranibizumab|ranibizumab|mesh-list
138946072|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138946073|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138946074|NCT00841581|Growth Substances|growth substances|mesh-ancestor
138946075|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642639|NCT00415922|Levodopa|levodopa|mesh-list
138946076|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
138946077|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946078|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
138946079|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138946080|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
138946081|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946082|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946083|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138946084|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
138946085|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138946086|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138946087|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138775103|NCT00660751|Analgesics|analgesics|mesh-ancestor
138946088|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
138946089|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946090|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946092|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138946093|NCT04249167|Atezolizumab|atezolizumab|mesh-list
138946094|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138946095|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138946096|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946097|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
138946098|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
138946099|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
138946100|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946101|NCT04249167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138946102|NCT04249167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138946103|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
138946104|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946105|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138946106|NCT00621153|Candesartan|candesartan|mesh-list
138946107|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
138946108|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138946109|NCT00621153|Diuretics|diuretics|mesh-ancestor
138946110|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
138946111|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598092|NCT00153491|Artemether|artemether|mesh-list
138642652|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138946112|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138946113|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138471154|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
138471159|NCT01993680|Bromides|bromides|mesh-list
138946114|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138775160|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138946115|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138946116|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138946118|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138946119|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
138946120|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946121|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946122|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138946124|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
138946125|NCT00705614|Infliximab|infliximab|mesh-list
138946126|NCT00705614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138946127|NCT00705614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138946128|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
138946129|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138946130|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138946131|NCT00844155|Oseltamivir|oseltamivir|mesh-list
138946132|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
138946133|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138946134|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946135|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946137|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138946138|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138946139|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946140|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946141|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946142|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
138946143|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
138946144|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946145|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138946146|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946147|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138946148|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138946149|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946150|NCT02547597|Atenolol|atenolol|mesh-list
138946151|NCT02547597|Carvedilol|carvedilol|mesh-list
138946152|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138946153|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138946154|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
138946155|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946156|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946157|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449647|NCT01865175|Iron|iron|mesh-list
138946158|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138946159|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
138946160|NCT02547597|Protective Agents|protective agents|mesh-ancestor
138946161|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138946162|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138946163|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138946164|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
138946165|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138946166|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138946167|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138946168|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
138946169|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
138946170|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946171|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138946172|NCT00842127|Methylphenidate|methylphenidate|mesh-list
138946173|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138946174|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946175|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138642692|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946176|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138946177|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138946178|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946179|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
138946180|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946182|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
138946183|NCT00835965|Aprepitant|aprepitant|mesh-list
138946184|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
138946185|NCT00835965|BB 1101|bb 1101|mesh-list
138946186|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138946187|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
138946188|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
138946189|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946190|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946191|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138946192|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
138946194|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946195|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138946196|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946197|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
138946198|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946199|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946200|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138946201|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946202|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
138946203|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138946204|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138946205|NCT05667740|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138946206|NCT05667740|Immunologic Factors|immunologic factors|mesh-ancestor
138946207|NCT05667740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138775441|NCT01112982|Colchicine|colchicine|mesh-list
138946208|NCT00842205|Interferons|interferons|mesh-list
138946209|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946210|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
138946211|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138946212|NCT00738296|Simvastatin|simvastatin|mesh-list
138946213|NCT00738296|Ezetimibe|ezetimibe|mesh-list
138946214|NCT00738296|Pravastatin|pravastatin|mesh-list
138946215|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138946216|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138946217|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
138946218|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946219|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138946220|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138946221|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946222|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
138946223|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138946224|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946225|NCT02567396|Talazoparib|talazoparib|mesh-list
138946226|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138946227|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138775485|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946228|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946229|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946230|NCT00738452|Antibodies|antibodies|mesh-list
138946231|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138946232|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
138946233|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946234|NCT05667428|Leuprolide|leuprolide|mesh-list
138946235|NCT05667428|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138946236|NCT05667428|Fertility Agents|fertility agents|mesh-ancestor
138946237|NCT05667428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138946238|NCT05667428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946239|NCT05667428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138946240|NCT05667428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946241|NCT05664542|Dexmedetomidine|dexmedetomidine|mesh-list
138946243|NCT05664542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138946244|NCT05664542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946245|NCT05664542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946246|NCT05664542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138946247|NCT05664542|Analgesics|analgesics|mesh-ancestor
138946248|NCT05664542|Sensory System Agents|sensory system agents|mesh-ancestor
138946249|NCT05664542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471286|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138946250|NCT05664542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138946251|NCT05664542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138946252|NCT05664542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138946253|NCT05664542|Adrenergic Agents|adrenergic agents|mesh-ancestor
138946254|NCT05664542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946255|NCT05664542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946256|NCT05664542|Anesthetics, Local|anesthetics, local|mesh-ancestor
138946257|NCT05664542|Anesthetics|anesthetics|mesh-ancestor
138946258|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
138946259|NCT00562978|Etoposide|etoposide|mesh-list
138946260|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138946261|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
138946262|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946263|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138946264|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138946265|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
138946266|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946267|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946268|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138946269|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138946270|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138946271|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138946272|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946273|NCT00842595|Prednisone|prednisone|mesh-list
138946274|NCT00842595|Rituximab|rituximab|mesh-list
138946275|NCT00842595|Vinorelbine|vinorelbine|mesh-list
138946276|NCT00842595|Ifosfamide|ifosfamide|mesh-list
138946277|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
138946278|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138946279|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946280|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
138946281|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946282|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138946283|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138946284|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
138946285|NCT00842595|Hormones|hormones|mesh-ancestor
138946286|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946287|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138946288|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138946289|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
138775647|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
138946290|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
138946291|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
138946292|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946293|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138946294|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
138946296|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
138471335|NCT01995019|Hormones|hormones|mesh-ancestor
138946297|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946298|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138946299|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138946300|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946301|NCT00938626|Antibodies|antibodies|mesh-list
138946302|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138946303|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
138946304|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946305|NCT00836199|Vaccines|vaccines|mesh-list
138946306|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
138946307|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946308|NCT04013386|Dexamethasone|dexamethasone|mesh-list
138946309|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
138946310|NCT04013386|Aprepitant|aprepitant|mesh-list
138946311|NCT04013386|Mirtazapine|mirtazapine|mesh-list
138946312|NCT04013386|BB 1101|bb 1101|mesh-list
138946313|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138946314|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
138946315|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
138946316|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946317|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946318|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138946319|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
138946320|NCT04013386|Hormones|hormones|mesh-ancestor
138946321|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946322|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138946323|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946324|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
138946325|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946326|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946327|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138946328|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946329|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
138946330|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138946331|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138946332|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
138946333|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
138946334|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138946335|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138946336|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946337|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138946338|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138946339|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138946340|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
138471370|NCT01995214|Propofol|propofol|mesh-list
138946341|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138946342|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138946343|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
138946344|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138946345|NCT00940420|Ribavirin|ribavirin|mesh-list
138946347|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
138946348|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
138946349|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946350|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
138946351|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138946352|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
138946353|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946354|NCT00842907|Tretinoin|tretinoin|mesh-list
138946355|NCT00842907|Isotretinoin|isotretinoin|mesh-list
138946356|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946357|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
138946358|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
138946359|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138946360|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138946361|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946362|NCT00940654|Acetaminophen|acetaminophen|mesh-list
138946363|NCT00940654|Antipyretics|antipyretics|mesh-list
138946364|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138946365|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138946366|NCT00940654|Analgesics|analgesics|mesh-ancestor
138946367|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
138946368|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946369|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946370|NCT00843063|Pantoprazole|pantoprazole|mesh-list
138946371|NCT00843063|Famotidine|famotidine|mesh-list
138946372|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138946373|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138946374|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138946375|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946376|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946377|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138946378|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
138946379|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
138946381|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946382|NCT04013464|Escitalopram|escitalopram|mesh-list
138946383|NCT04013464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138946384|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138946385|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138946386|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946387|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946388|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
138946389|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946390|NCT04012918|Capecitabine|capecitabine|mesh-list
138946391|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138946392|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138946393|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
138946394|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946395|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946396|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138946397|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946398|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138946399|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
138775914|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
138775936|NCT04239586|Glyburide|glyburide|mesh-list
138946400|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946401|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946402|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
138946403|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
138946404|NCT00939718|Vitamins|vitamins|mesh-ancestor
138946405|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
138946406|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946407|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
138946408|NCT00939718|Hematinics|hematinics|mesh-ancestor
138946409|NCT00836667|Sertraline|sertraline|mesh-list
138946410|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
138946411|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138946412|NCT00836667|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138946413|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138946414|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138946415|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946416|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946417|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
138946418|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946419|NCT00845559|Exenatide|exenatide|mesh-list
138946420|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138946421|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946422|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138946423|NCT00845559|Incretins|incretins|mesh-ancestor
138946424|NCT00845559|Hormones|hormones|mesh-ancestor
138946425|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946426|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
138946427|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
138946428|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946429|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
138946430|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471428|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138946431|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946432|NCT05107778|Entecavir|entecavir|mesh-list
138946433|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
138946434|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138946435|NCT00372619|Cytarabine|cytarabine|mesh-list
138946436|NCT00372619|Methotrexate|methotrexate|mesh-list
138946437|NCT00372619|Clofarabine|clofarabine|mesh-list
138946438|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138776096|NCT04745728|Prednisone|prednisone|mesh-list
138946439|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
138946440|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138946441|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946442|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138946444|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946445|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946446|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
138946447|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946448|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138946449|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138946450|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
138946451|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138946452|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138946453|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
138946454|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138946455|NCT00851175|Caffeine|caffeine|mesh-list
138946456|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138946457|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138946458|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138946459|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
138946460|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946461|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138946462|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138946464|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138946465|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946466|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138946467|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138946468|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138946469|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
138946470|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946471|NCT02566226|Morphine|morphine|mesh-list
138946472|NCT02566226|Bupivacaine|bupivacaine|mesh-list
138946473|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
138946474|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
138946475|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946476|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946477|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
138471449|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138946478|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946479|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138946480|NCT02566226|Narcotics|narcotics|mesh-ancestor
138946481|NCT02566226|Analgesics|analgesics|mesh-ancestor
138946482|NCT00837135|Vaccines|vaccines|mesh-list
138946483|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
138946484|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946486|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138946487|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138946488|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946489|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946490|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138946491|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
138946492|NCT02546349|Fluticasone|fluticasone|mesh-list
138946493|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
138946494|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138946495|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138946496|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138946497|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138946498|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
138946499|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946500|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946501|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138946502|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
138946503|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
138946504|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138946505|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
138946506|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138946507|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
138946508|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946509|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946510|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138776241|NCT00634192|Tobramycin|tobramycin|mesh-list
138946511|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138946512|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138946513|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
138946516|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946517|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
138946518|NCT00851487|Amoxicillin|amoxicillin|mesh-list
138946519|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138946520|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138946522|NCT00372385|Ribavirin|ribavirin|mesh-list
138946523|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
138946524|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
138946525|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138471537|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
138946526|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946527|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
138946528|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138946529|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
138946530|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946531|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
138946532|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946533|NCT03830281|Insulin|insulin|mesh-list
138946534|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138946536|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138946537|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946538|NCT00563368|Topiramate|topiramate|mesh-list
138946539|NCT00563368|Phentermine|phentermine|mesh-list
138946540|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
138946541|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138946542|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946543|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138946544|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
138946545|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138946546|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
138946547|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
138946548|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946549|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
138946550|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946551|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946552|NCT00390013|Gabapentin|gabapentin|mesh-list
138946553|NCT00390013|Analgesics|analgesics|mesh-ancestor
138946554|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
138946555|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946556|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946557|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
138946558|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138946559|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138946560|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946562|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138946563|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138776526|NCT04237246|Tacrolimus|tacrolimus|mesh-list
138946564|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946565|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946566|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
138946567|NCT00562120|Fexofenadine|fexofenadine|mesh-list
138946568|NCT00562120|Terfenadine|terfenadine|mesh-list
138946569|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138946570|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138946571|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138946572|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
138946573|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
138946574|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946575|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946576|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946577|NCT00561730|Pantoprazole|pantoprazole|mesh-list
138946578|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138776562|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946579|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138946580|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138946581|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946582|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946583|NCT00697112|Sirolimus|sirolimus|mesh-list
138946584|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138946585|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138946586|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138946587|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946588|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
138946589|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138946590|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
138946591|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946592|NCT00621855|Dabigatran|dabigatran|mesh-list
138946593|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
138946594|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138946595|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
138946596|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946597|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946598|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
138946599|NCT00851565|Infliximab|infliximab|mesh-list
138946600|NCT00851565|Antibodies|antibodies|mesh-list
138946601|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
138946602|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946603|NCT00851565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138946604|NCT00851565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138946605|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
138946606|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138946607|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138946608|NCT00561574|Mirtazapine|mirtazapine|mesh-list
138946609|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
138946610|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138946611|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138946612|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
138946613|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
138471615|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946614|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946615|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946616|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946617|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138946618|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138946619|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946620|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138946621|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138946622|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138946623|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
138946624|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138946625|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138946626|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
138946627|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138946628|NCT00619827|Immunomodulating Agents|immunomodulating agents|mesh-list
138946629|NCT00619827|Immunologic Factors|immunologic factors|mesh-ancestor
138946630|NCT00619827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946631|NCT00687804|Ranibizumab|ranibizumab|mesh-list
138946632|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138946633|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138946634|NCT00687804|Growth Substances|growth substances|mesh-ancestor
138413696|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
138946635|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946636|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
138946637|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946638|NCT02563704|Artesunate|artesunate|mesh-list
138946640|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
138946641|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138946642|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138946643|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138642824|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
138946644|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946645|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
138946646|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
138946647|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138946648|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
138946649|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138946650|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946651|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138946652|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946653|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138946654|NCT02563704|Analgesics|analgesics|mesh-ancestor
138946655|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
138471699|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
138471701|NCT01997255|Everolimus|everolimus|mesh-list
138946656|NCT00848523|Panobinostat|panobinostat|mesh-list
138946657|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946658|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138946659|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946660|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946661|NCT00742404|Dexamethasone|dexamethasone|mesh-list
138946662|NCT00742404|Doxorubicin|doxorubicin|mesh-list
138946663|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138946664|NCT00742404|Bortezomib|bortezomib|mesh-list
138946665|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138946666|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
138946667|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
138946668|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946669|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946670|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138946671|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
138946673|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946674|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138946675|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946676|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138946677|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138946678|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138946679|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946680|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946681|NCT00744666|Prednisolone|prednisolone|mesh-list
138946682|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138946683|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138946684|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
138946685|NCT00744666|Hormones|hormones|mesh-ancestor
138946686|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946687|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946688|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138946689|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946690|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138946691|NCT04013620|Abatacept|abatacept|mesh-list
138946692|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138471756|NCT01997762|Resveratrol|resveratrol|mesh-list
138946693|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946694|NCT04013620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138946695|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946696|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138946697|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
138946698|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946699|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138946701|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
138946702|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138946703|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946704|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
138946705|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946706|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138946707|NCT00848679|Lidocaine|lidocaine|mesh-list
138946708|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
138946709|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
138946710|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946711|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946712|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
138946713|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946714|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138776876|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
138946715|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138946716|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138471787|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946717|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138946718|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946719|NCT04012606|Carboplatin|carboplatin|mesh-list
138946720|NCT04012606|Etoposide|etoposide|mesh-list
138946721|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946722|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138946723|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138946724|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138946725|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946726|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946727|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
138946728|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138946729|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138946731|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
138946732|NCT02545959|Rituximab|rituximab|mesh-list
138946733|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138946734|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
138946735|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138946736|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946737|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
138946738|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946739|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138946740|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138946742|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
138946743|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946744|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138946745|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
138946746|NCT02545959|Hormones|hormones|mesh-ancestor
138776982|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138946747|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946748|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138946749|NCT02545959|Protective Agents|protective agents|mesh-ancestor
138946750|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138946751|NCT00744900|Pemetrexed|pemetrexed|mesh-list
138946752|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946753|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946754|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946755|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138946756|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138946757|NCT00727090|Conivaptan|conivaptan|mesh-list
138946758|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138946759|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946760|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
138946761|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946762|NCT00689052|Pramipexole|pramipexole|mesh-list
138946763|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
138946764|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946765|NCT00689052|Protective Agents|protective agents|mesh-ancestor
138946766|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946767|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138777059|NCT02884817|Listerine|listerine|mesh-list
138946768|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138946769|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
138946770|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
138946771|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946772|NCT04012450|Anesthetics|anesthetics|mesh-list
138946773|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946774|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946775|NCT00945022|Anesthetics|anesthetics|mesh-list
138946776|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946777|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946778|NCT02565212|Montelukast|montelukast|mesh-list
138471886|NCT01998503|Dexamethasone|dexamethasone|mesh-list
138946779|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138946780|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
138946781|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138946782|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
138946783|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946784|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946785|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138946786|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138946787|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946788|NCT00747708|Lenograstim|lenograstim|mesh-list
138946789|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138946790|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
138946791|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946792|NCT05602064|Acetaminophen|acetaminophen|mesh-list
138946793|NCT05602064|Ibuprofen|ibuprofen|mesh-list
138946794|NCT05602064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138946795|NCT05602064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138946796|NCT05602064|Analgesics|analgesics|mesh-ancestor
138946797|NCT05602064|Sensory System Agents|sensory system agents|mesh-ancestor
138946798|NCT05602064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946799|NCT05602064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946800|NCT05602064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138946801|NCT05602064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138946802|NCT05602064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138946803|NCT05602064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946804|NCT05602064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946806|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138946807|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
138946808|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946809|NCT02562144|Lidocaine|lidocaine|mesh-list
138946810|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
138946811|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
138471922|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
138946812|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946813|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946814|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
138777224|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946815|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946816|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138946817|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138946818|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138946819|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138946820|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946821|NCT02562300|Misoprostol|misoprostol|mesh-list
138946822|NCT02562300|Oxytocin|oxytocin|mesh-list
138946823|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
138946824|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138946825|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946826|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138946827|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
138946828|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138946829|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138946830|NCT00945178|Naproxen|naproxen|mesh-list
138946831|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138946832|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138946833|NCT00945178|Analgesics|analgesics|mesh-ancestor
138946834|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
138946835|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946836|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946837|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138946838|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138946839|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
138946840|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138946841|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946842|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946843|NCT00749346|Pemetrexed|pemetrexed|mesh-list
138946844|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946845|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946846|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946847|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138946848|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138946849|NCT02562690|Thrombin|thrombin|mesh-list
138946850|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
138946851|NCT02562690|Coagulants|coagulants|mesh-ancestor
138946852|NCT00576758|Rituximab|rituximab|mesh-list
138946853|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
138946854|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138946855|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946856|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
138946857|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946858|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138946859|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138946860|NCT00923676|Fenofibrate|fenofibrate|mesh-list
138946861|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138946862|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138946863|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
138946864|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946865|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138946866|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138946867|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946868|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
138946869|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138946870|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946871|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946872|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138946873|NCT00921284|Analgesics|analgesics|mesh-ancestor
138946874|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
138222091|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
138946875|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946876|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138946877|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138946878|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138946879|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
138946880|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946881|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946882|NCT00749502|Niraparib|niraparib|mesh-list
138472003|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946883|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138777319|NCT00691951|Budesonide|budesonide|mesh-list
138946884|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946885|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946886|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946887|NCT00560794|Blinatumomab|blinatumomab|mesh-list
138946888|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138946889|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946890|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
138946891|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946892|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
138946894|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138946895|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138946896|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946897|NCT00749736|Vitamins|vitamins|mesh-ancestor
138946898|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
138946899|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138946900|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
138946901|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
138946902|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138946903|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138946904|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946905|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946906|NCT00950404|Urological Agents|urological agents|mesh-ancestor
138946907|NCT00749814|Melatonin|melatonin|mesh-list
138946908|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
138946909|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472037|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138946910|NCT00749814|Protective Agents|protective agents|mesh-ancestor
138946911|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946912|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946913|NCT00748176|Anesthetics|anesthetics|mesh-list
138946914|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946915|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946916|NCT00619359|Dexamethasone|dexamethasone|mesh-list
138946917|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
138946918|NCT00619359|Ondansetron|ondansetron|mesh-list
138946919|NCT00619359|Aprepitant|aprepitant|mesh-list
138946920|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
138946921|NCT00619359|BB 1101|bb 1101|mesh-list
138946922|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138946923|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
138946924|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
138946925|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946926|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946927|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138946928|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
138946929|NCT00619359|Hormones|hormones|mesh-ancestor
138598907|NCT04575844|Liraglutide|liraglutide|mesh-list
138946930|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138946931|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138946932|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946933|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
138946934|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946935|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946936|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
138946937|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
138946938|NCT00619359|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138946939|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138946940|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
138777401|NCT00692263|Analgesics|analgesics|mesh-ancestor
138946941|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472085|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138472086|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946942|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138946943|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
138946944|NCT00848991|Propofol|propofol|mesh-list
138946945|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138946946|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138946947|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946948|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138946949|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
138946950|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
138946951|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138946952|NCT00848991|Analgesics|analgesics|mesh-ancestor
138946953|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
138946954|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138946955|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138946956|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138946957|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138946958|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
138946959|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946960|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946961|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138946962|NCT00950794|Tulobuterol|tulobuterol|mesh-list
138946963|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138946964|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
138472124|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138946965|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138777453|NCT01152437|Cetuximab|cetuximab|mesh-list
138946966|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946967|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138946968|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
138946969|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138946970|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138946971|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138946972|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
138946973|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138946974|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946976|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
138946977|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
138946978|NCT00852189|Hematinics|hematinics|mesh-ancestor
138946979|NCT00852189|Vitamins|vitamins|mesh-ancestor
138946980|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
138946981|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138946982|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138946983|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
138946984|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
138946985|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
138946986|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946987|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
138946988|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138946989|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
138946990|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138946991|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138946992|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138946993|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138946994|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138946995|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138946996|NCT00372229|Valganciclovir|valganciclovir|mesh-list
138946997|NCT00372229|Ganciclovir|ganciclovir|mesh-list
138946998|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138946999|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
138947000|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947001|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138947002|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947003|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947005|NCT05301010|Trastuzumab|trastuzumab|mesh-list
138947006|NCT05301010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947007|NCT05301010|Tubulin Modulators|tubulin modulators|mesh-ancestor
138947008|NCT05301010|Antimitotic Agents|antimitotic agents|mesh-ancestor
138947009|NCT05301010|Mitosis Modulators|mitosis modulators|mesh-ancestor
138947010|NCT05301010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947011|NCT05301010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138947012|NCT00855699|Acamprosate|acamprosate|mesh-list
138947013|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138947014|NCT00855777|Ibuprofen|ibuprofen|mesh-list
138947015|NCT00855777|Etoricoxib|etoricoxib|mesh-list
138947016|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138947017|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138947018|NCT00855777|Analgesics|analgesics|mesh-ancestor
138947019|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
138947020|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138947021|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947022|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138947023|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138947024|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138947025|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947026|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947027|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138947028|NCT04012294|Allopurinol|allopurinol|mesh-list
138947029|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
138947030|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947031|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947032|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
138947033|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138947034|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138947035|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
138947036|NCT04012294|Protective Agents|protective agents|mesh-ancestor
138947037|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947038|NCT00849459|Interleukin-12|interleukin-12|mesh-list
138947039|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138947040|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
138947041|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947042|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138947043|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138947044|NCT00849459|Growth Substances|growth substances|mesh-ancestor
138947045|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
138947046|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947047|NCT00852345|Clofazimine|clofazimine|mesh-list
138947048|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138947049|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
138947050|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947051|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947053|NCT00852423|Lumefantrine|lumefantrine|mesh-list
138947055|NCT00852423|Piperaquine|piperaquine|mesh-list
138947056|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138947057|NCT00852423|Amodiaquine|amodiaquine|mesh-list
138947058|NCT00852423|Artenimol|artenimol|mesh-list
138947059|NCT00852423|Mefloquine|mefloquine|mesh-list
138947060|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
138947061|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138947062|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138947063|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947064|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947065|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
138947066|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
138947067|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138947068|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
138947069|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
138947070|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138947071|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947072|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138947073|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
138947074|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947075|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947076|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947077|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947078|NCT00849537|Triamcinolone|triamcinolone|mesh-list
138947079|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138947080|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
138947081|NCT00849537|Hormones|hormones|mesh-ancestor
138947082|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138947083|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947084|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
138947085|NCT01049815|Calcium|calcium|mesh-list
138947087|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138947088|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947089|NCT01049815|Antacids|antacids|mesh-ancestor
138947090|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947091|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138947092|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
138947093|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
138947094|NCT00849615|Leucovorin|leucovorin|mesh-list
138947095|NCT00849615|Folic Acid|folic acid|mesh-list
138947096|NCT00849615|Docetaxel|docetaxel|mesh-list
138947097|NCT00849615|Fluorouracil|fluorouracil|mesh-list
138947098|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
138947099|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
138947100|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947101|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
138947102|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
138947103|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
138947104|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947105|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
138947106|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138947107|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138947108|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
138947109|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947111|NCT00849615|Protective Agents|protective agents|mesh-ancestor
138947112|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
138947113|NCT00849615|Vitamins|vitamins|mesh-ancestor
138947114|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
138947115|NCT00849615|Hematinics|hematinics|mesh-ancestor
138947116|NCT00946036|Sertraline|sertraline|mesh-list
138947117|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
138947118|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138947119|NCT00946036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138777817|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138947120|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138947121|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138947122|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947123|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947124|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
138947125|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947126|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
138947128|NCT00688740|Doxorubicin|doxorubicin|mesh-list
138947129|NCT00688740|Fluorouracil|fluorouracil|mesh-list
138947130|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138947131|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
138472296|NCT02001363|Hormones|hormones|mesh-ancestor
138947132|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947133|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138947134|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138947135|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
138947136|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947137|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947138|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138947139|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
138947140|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
138947141|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
138947142|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138947143|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138947144|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138947145|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947146|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
138947147|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138947149|NCT05323058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138947150|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
138947151|NCT01046773|Vitamin D|vitamin d|mesh-list
138947152|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138947153|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947154|NCT01046773|Vitamins|vitamins|mesh-ancestor
138947155|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
138947156|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138947157|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
138947158|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138947159|NCT00850005|Antibodies|antibodies|mesh-list
138599129|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
138947160|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
138947161|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138947162|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
138947163|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947165|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947166|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947167|NCT00942136|Dolutegravir|dolutegravir|mesh-list
138947169|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138947170|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138947171|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138947172|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947173|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947174|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138947175|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138947176|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138947177|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138947178|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
138947179|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947181|NCT05300932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138642895|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
138947182|NCT05300932|Immunologic Factors|immunologic factors|mesh-ancestor
138947183|NCT05300932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947184|NCT05300932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138416026|NCT01661751|Vaccines|vaccines|mesh-list
138947185|NCT05300932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138947186|NCT05300932|Alkylating Agents|alkylating agents|mesh-ancestor
138947187|NCT05300932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947188|NCT05300932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947189|NCT05300932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138947190|NCT00942214|Natalizumab|natalizumab|mesh-list
138947191|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
138947192|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947193|NCT00850161|Insulin|insulin|mesh-list
138947194|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138947195|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
138947196|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138947197|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947198|NCT00951574|Nadroparin|nadroparin|mesh-list
138947199|NCT00951574|Calcium|calcium|mesh-list
138947200|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138947201|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138777991|NCT02793388|Primaquine|primaquine|mesh-list
138947203|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138947204|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138947205|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947206|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138947207|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
138947208|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
138947209|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947210|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
138947211|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947212|NCT00856089|Retapamulin|retapamulin|mesh-list
138947213|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947214|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947215|NCT00686712|Insulin|insulin|mesh-list
138947216|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138947217|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
138947218|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
138947219|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
138947220|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
138947221|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138947222|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947223|NCT00748644|Rituximab|rituximab|mesh-list
138947224|NCT00748644|Azathioprine|azathioprine|mesh-list
138947225|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138947226|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947227|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
138947228|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947229|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138947230|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
138947231|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947232|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138947233|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138947234|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138947235|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138947236|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947237|NCT00686634|Incretins|incretins|mesh-ancestor
138599204|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
138947238|NCT00686634|Hormones|hormones|mesh-ancestor
138472339|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
138778024|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138947239|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138947240|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138947241|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
138947242|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947243|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947244|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
138947245|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947246|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138947247|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
138947248|NCT00560404|Hematinics|hematinics|mesh-ancestor
138947249|NCT00942526|Nystatin|nystatin|mesh-list
138947250|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947251|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947252|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
138947253|NCT00942526|Ionophores|ionophores|mesh-ancestor
138947254|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138947255|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947256|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
138947257|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138947258|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
138947259|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947260|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
138947261|NCT03967444|Protective Agents|protective agents|mesh-ancestor
138947262|NCT05300854|Anesthetics|anesthetics|mesh-list
138947263|NCT05300854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138947264|NCT05300854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947266|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138947267|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947269|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138947270|NCT00619983|Donepezil|donepezil|mesh-list
138947271|NCT00619983|Analgesics|analgesics|mesh-ancestor
138947272|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
138947273|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138947274|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947275|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
138947276|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138947277|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138947278|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138947279|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138778120|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138947280|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138947281|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138947282|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947283|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947285|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138947286|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138947287|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138947288|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
138947289|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
138947290|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138947291|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947292|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
138947293|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
138947294|NCT00942682|Sorafenib|sorafenib|mesh-list
138947295|NCT00942682|Everolimus|everolimus|mesh-list
138947296|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947297|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138947298|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947299|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947300|NCT00942682|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138947301|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138947302|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
138947303|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947304|NCT00853983|Saracatinib|saracatinib|mesh-list
138947305|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947306|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947307|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947308|NCT00750048|Acetaminophen|acetaminophen|mesh-list
138947310|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138947311|NCT00750048|Analgesics|analgesics|mesh-ancestor
138947312|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
138947313|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138947314|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947315|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
138947316|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138947317|NCT00942838|Cisplatin|cisplatin|mesh-list
138947318|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947319|NCT04057014|Amoxicillin|amoxicillin|mesh-list
138947320|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947321|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947322|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138947323|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947324|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138947325|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947326|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947327|NCT00854139|Cyclosporine|cyclosporine|mesh-list
138947328|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
138947329|NCT00854139|Cyclosporins|cyclosporins|mesh-list
138947330|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138947331|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138947332|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
138947333|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947334|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138947335|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138947336|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
138711063|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947337|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947338|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947339|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138947340|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947341|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
138947342|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947343|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
138947344|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138947345|NCT00755820|Cycloserine|cycloserine|mesh-list
138947346|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138947347|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947348|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138947349|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
138947350|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947351|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
138947352|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947353|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
138947354|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138947355|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947356|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138947357|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
138947358|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947359|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947360|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947361|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947363|NCT00750126|Busulfan|busulfan|mesh-list
138947364|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
138947365|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947366|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947367|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138947368|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
138947369|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947370|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
138947371|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138947372|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138947373|NCT00755976|Sulindac|sulindac|mesh-list
138947375|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138947376|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947377|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138947378|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138947379|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947380|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947381|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138947382|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138947383|NCT00755976|Analgesics|analgesics|mesh-ancestor
138947384|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
138778535|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
138947385|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138947386|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947387|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138947388|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138947389|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138947390|NCT00752310|Darunavir|darunavir|mesh-list
138947391|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138947392|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138947393|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
138947394|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947395|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947396|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138947397|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138947398|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
138947399|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947400|NCT00943462|Temozolomide|temozolomide|mesh-list
138947401|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138947402|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
138947403|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947404|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947405|NCT02560974|Capecitabine|capecitabine|mesh-list
138947406|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
138947407|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138947408|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
138947409|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947410|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947411|NCT00854451|Amoxicillin|amoxicillin|mesh-list
138947412|NCT00854451|Omeprazole|omeprazole|mesh-list
138947413|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947414|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947415|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138947416|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138947417|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138947418|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947419|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947420|NCT00854529|Bevacizumab|bevacizumab|mesh-list
138947421|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138947422|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947423|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138947424|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138947425|NCT00854529|Growth Substances|growth substances|mesh-ancestor
138947426|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947427|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
138947428|NCT00952432|Carbamazepine|carbamazepine|mesh-list
138947429|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
138947430|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
138947431|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138778787|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138947432|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138947433|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947434|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138472429|NCT02002078|Prednisolone|prednisolone|mesh-list
138947435|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138947436|NCT00952432|Analgesics|analgesics|mesh-ancestor
138947437|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
138947438|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138947439|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138947440|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138947441|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947442|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138947443|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138947444|NCT00861315|Amikacin|amikacin|mesh-list
138947445|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947446|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947447|NCT00943540|Lamivudine|lamivudine|mesh-list
138947448|NCT00943540|Emtricitabine|emtricitabine|mesh-list
138947449|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
138947450|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138947451|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138947452|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138947453|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947454|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947455|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
138947456|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947457|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138947458|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138947459|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138947460|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138947461|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138947462|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138947464|NCT00861627|Paclitaxel|paclitaxel|mesh-list
138947465|NCT00861627|Carboplatin|carboplatin|mesh-list
138947466|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138947467|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947468|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
138947469|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
138947470|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
138947471|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947472|NCT00943930|Dronabinol|dronabinol|mesh-list
138947473|NCT00943930|Amphetamine|amphetamine|mesh-list
138947474|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
138947475|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138947476|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947477|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
138947478|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
138947479|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138947480|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
138778964|NCT00887536|Growth Substances|growth substances|mesh-ancestor
138947481|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947482|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947483|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
138947484|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138947485|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138947486|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138947487|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138947488|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
138947489|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138947490|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138947491|NCT00943930|Analgesics|analgesics|mesh-ancestor
138947492|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
138947493|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138947494|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138947495|NCT00943930|Hormones|hormones|mesh-ancestor
138947496|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138947497|NCT00854763|Olmesartan|olmesartan|mesh-list
138947498|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138947499|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138947500|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138947501|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947502|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
138947503|NCT00854841|Dasatinib|dasatinib|mesh-list
138947504|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947505|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138947506|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947507|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947508|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
138947509|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138947510|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138947511|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947512|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138947513|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
138947514|NCT00861783|Irinotecan|irinotecan|mesh-list
138947515|NCT00861783|Camptothecin|camptothecin|mesh-list
138947516|NCT00861783|ON 01910|on 01910|mesh-list
138947517|NCT00861783|Glycine|glycine|mesh-list
138947518|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947519|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138947520|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138947521|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947522|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947523|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138947524|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138947525|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
138947526|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947527|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947528|NCT00947128|Ondansetron|ondansetron|mesh-list
138947529|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
138947530|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
138947531|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138947532|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947533|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138947534|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
138947535|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
138947536|NCT00947128|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138947537|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138599505|NCT00189384|Gentamicins|gentamicins|mesh-list
138947538|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
138947539|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947540|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947541|NCT00861861|Atorvastatin|atorvastatin|mesh-list
138947542|NCT00861861|Pitavastatin|pitavastatin|mesh-list
138947543|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138947544|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138947545|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
138947546|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947547|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138947548|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138947549|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947550|NCT00686166|Capecitabine|capecitabine|mesh-list
138947551|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
138947552|NCT00686166|Cetuximab|cetuximab|mesh-list
138947553|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138947554|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
138947555|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947556|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947557|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138947558|NCT04280536|Trifluridine|trifluridine|mesh-list
138947559|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
138947560|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947561|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
138947562|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947564|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
138947565|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138947566|NCT00944242|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138947567|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138947568|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138947569|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947570|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947571|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
138947572|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947573|NCT00363649|Interferons|interferons|mesh-list
138947574|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
138947575|NCT00363649|Sargramostim|sargramostim|mesh-list
138947576|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947577|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
138947578|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947579|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
138472539|NCT02002598|BB 1101|bb 1101|mesh-list
138947580|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947581|NCT00855153|Cycloserine|cycloserine|mesh-list
138947582|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138947583|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947584|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138947585|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
138947586|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947587|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
138947588|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947589|NCT00952978|Omeprazole|omeprazole|mesh-list
138947590|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138947591|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138947592|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138947593|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947594|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947595|NCT00861939|Bupropion|bupropion|mesh-list
138947596|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138947597|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
138947598|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138947599|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138947600|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138947601|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138947602|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947603|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
138947604|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947605|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947606|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138947607|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138947608|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947609|NCT00953134|Folic Acid|folic acid|mesh-list
138947610|NCT00953134|Micronutrients|micronutrients|mesh-list
138947611|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
138947613|NCT00953134|Hematinics|hematinics|mesh-ancestor
138947614|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
138947615|NCT00953134|Vitamins|vitamins|mesh-ancestor
138947616|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947617|NCT00944398|Vitamins|vitamins|mesh-list
138947619|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
138947620|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
138947621|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
138947622|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947623|NCT00944398|Trace Elements|trace elements|mesh-ancestor
138947624|NCT00944398|Astringents|astringents|mesh-ancestor
138947625|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
138947626|NCT00855387|Pancrelipase|pancrelipase|mesh-list
138947627|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138947628|NCT00947596|Atropine|atropine|mesh-list
138947629|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138947630|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138947631|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138947632|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
138947633|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138947634|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947635|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138472541|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
138947636|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
138947638|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
138947639|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138947640|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138947641|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
138947642|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947643|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947644|NCT00865059|Gabapentin|gabapentin|mesh-list
138947645|NCT00865059|Analgesics|analgesics|mesh-ancestor
138947646|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
138947647|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138947648|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947649|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
138947650|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138947651|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138947652|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138947653|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138947654|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138947655|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138947656|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947657|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947658|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
138947660|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138947661|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
138947662|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947663|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138947664|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947665|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947666|NCT00862095|Topiramate|topiramate|mesh-list
138947667|NCT00862095|Propranolol|propranolol|mesh-list
138947668|NCT00862095|Amitriptyline|amitriptyline|mesh-list
138947669|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138947670|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138947671|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
138947672|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947673|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947674|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947675|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138947676|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138947677|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
138947678|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
138947679|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138947680|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138947681|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
138947682|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138947683|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138947684|NCT00862095|Analgesics|analgesics|mesh-ancestor
138947685|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
138947686|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138947687|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138472560|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138472561|NCT02002663|Prednisolone|prednisolone|mesh-list
138947688|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138947689|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138947690|NCT04054128|Heparin|heparin|mesh-list
138947691|NCT04054128|Calcium heparin|calcium heparin|mesh-list
138947692|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
138947693|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138947694|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138947695|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947696|NCT00865215|Propranolol|propranolol|mesh-list
138947697|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138947698|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138947699|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
138947700|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947701|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947702|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947703|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138947704|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138947705|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
138947707|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138947708|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
138947709|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138947710|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138947711|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138947712|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138947713|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947714|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
138947715|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947716|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643035|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
138947717|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138947718|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138947719|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947720|NCT00865449|Spironolactone|spironolactone|mesh-list
138947721|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138947722|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
138947723|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138947724|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947725|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138947726|NCT00865449|Diuretics|diuretics|mesh-ancestor
138947727|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
138947728|NCT00858195|Indomethacin|indomethacin|mesh-list
138947729|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138947730|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138947731|NCT00858195|Analgesics|analgesics|mesh-ancestor
138947732|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
138947733|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138779466|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
138947734|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947735|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138947736|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138947737|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
138947739|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138947740|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138947741|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947742|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947743|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
138947744|NCT00618813|Ifosfamide|ifosfamide|mesh-list
138947745|NCT00618813|Doxorubicin|doxorubicin|mesh-list
138947746|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138947747|NCT00618813|Etoposide|etoposide|mesh-list
138947748|NCT00618813|Vincristine|vincristine|mesh-list
138947749|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
138947750|NCT00618813|Topotecan|topotecan|mesh-list
138947751|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138947752|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
138947753|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947754|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138947755|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138947756|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
138947757|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947758|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947759|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138947760|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138947761|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138947762|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138947763|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947764|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138947765|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
138947766|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
138947767|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
138947768|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138947770|NCT00685698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947771|NCT00685698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947772|NCT00858429|Capecitabine|capecitabine|mesh-list
138947773|NCT00858429|Doxifluridine|doxifluridine|mesh-list
138472617|NCT02002858|Nicotine|nicotine|mesh-list
138947774|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138947775|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
138947776|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947777|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947778|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138947780|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947781|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
138947782|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138947783|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
138947784|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138947786|NCT02566928|Mupirocin|mupirocin|mesh-list
138947787|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138947788|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947789|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
138947790|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
138947791|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947792|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138947793|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947794|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947795|NCT00865605|Clobetasol|clobetasol|mesh-list
138947796|NCT00865605|Halobetasol|halobetasol|mesh-list
138947797|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138947798|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138947799|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
138947800|NCT00865605|Hormones|hormones|mesh-ancestor
138947801|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138947802|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947803|NCT00956644|Amlodipine|amlodipine|mesh-list
138947804|NCT00956644|Irbesartan|irbesartan|mesh-list
138947805|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138947806|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138947807|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138947808|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947809|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138947810|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947811|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
138947812|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138947813|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138947814|NCT00858663|Everolimus|everolimus|mesh-list
138947815|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947816|NCT00858663|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138947817|NCT00858663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138947818|NCT00858663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643066|NCT00297375|Tramadol|tramadol|mesh-list
138947819|NCT00858663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947820|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138947821|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
138947822|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947823|NCT02544789|Clofarabine|clofarabine|mesh-list
138947824|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138947825|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
138947826|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947827|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947828|NCT02565836|Thrombin|thrombin|mesh-list
138947829|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
138947830|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
138947831|NCT02565836|Coagulants|coagulants|mesh-ancestor
138947832|NCT00865761|Alprazolam|alprazolam|mesh-list
138947833|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138947834|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138947835|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947836|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138599805|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138947837|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138947838|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138947839|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
138947840|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
138947841|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947842|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947843|NCT00865839|Metformin|metformin|mesh-list
138947844|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138947845|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947846|NCT00865917|Metoprolol|metoprolol|mesh-list
138947847|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138947848|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138947849|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138947850|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
138947851|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
138947852|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223074|NCT05946772|Cyclosporine|cyclosporine|mesh-list
138947853|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947854|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138947855|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138947856|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
138947857|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947858|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947859|NCT00696410|Zinc|zinc|mesh-list
138947860|NCT00696410|Trace Elements|trace elements|mesh-ancestor
138947861|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
138947862|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947863|NCT00683904|Carboplatin|carboplatin|mesh-list
138947864|NCT00683904|Epothilones|epothilones|mesh-list
138947865|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947866|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
138947867|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
138947868|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
138947869|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947870|NCT00862329|Caseins|caseins|mesh-list
138947871|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
138947872|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
138711064|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138472668|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138947873|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947874|NCT00866073|Decitabine|decitabine|mesh-list
138947875|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138947876|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
138947877|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947878|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138947879|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947880|NCT00752466|Topiramate|topiramate|mesh-list
138947881|NCT00752466|Flunarizine|flunarizine|mesh-list
138947882|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
138947883|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138947884|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947885|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138947886|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138947887|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947888|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138947889|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138947890|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
138947891|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
138947892|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947893|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
138947894|NCT00957190|Timolol|timolol|mesh-list
138947895|NCT00957190|Dorzolamide|dorzolamide|mesh-list
138947896|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138947897|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138947899|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947900|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947901|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947902|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138947903|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138947904|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138947905|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947906|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138947907|NCT00866229|Simvastatin|simvastatin|mesh-list
138947908|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138947909|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138947910|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
138947911|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947912|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138947913|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138947915|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138947916|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138947917|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947918|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947919|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
138947920|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947921|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947922|NCT00948220|Ribavirin|ribavirin|mesh-list
138947923|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138947924|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
138779729|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
138711065|NCT01190254|Asenapine|asenapine|mesh-list
138472700|NCT02003885|Desflurane|desflurane|mesh-list
138947925|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947926|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
138947927|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947928|NCT00756990|Naltrexone|naltrexone|mesh-list
138947930|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138947931|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947932|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
138947933|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138947934|NCT00957346|Misoprostol|misoprostol|mesh-list
138947935|NCT00957346|Mifepristone|mifepristone|mesh-list
138947936|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138947937|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
138947938|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138947939|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947940|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138947941|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138947942|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
138947943|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138947944|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138947945|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138947946|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138947947|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
138947948|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138779774|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947949|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138947950|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
138947951|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138947952|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
138947953|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138947954|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138947956|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
138947957|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947958|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
138947959|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138779827|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138947960|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947961|NCT00751062|Timolol|timolol|mesh-list
138947962|NCT00751062|Latanoprost|latanoprost|mesh-list
138947963|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138947964|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138947965|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
138947966|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138947967|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947968|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138947969|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138947970|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138947971|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138947972|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138947973|NCT00751374|Gentamicins|gentamicins|mesh-list
138947974|NCT00751374|Mupirocin|mupirocin|mesh-list
138947975|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138947976|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947977|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138947978|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947979|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947980|NCT00954304|Loperamide|loperamide|mesh-list
138947981|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
138947982|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138947983|NCT00363415|Carboplatin|carboplatin|mesh-list
138947984|NCT00363415|Etoposide|etoposide|mesh-list
138947985|NCT00363415|Pemetrexed|pemetrexed|mesh-list
138947986|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599955|NCT00158132|Amantadine|amantadine|mesh-list
138947987|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138947988|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138947989|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138947990|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138947991|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138947992|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138947993|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138947994|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
138947995|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138947996|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138947997|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138947998|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138947999|NCT00752934|Baclofen|baclofen|mesh-list
138948000|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138948001|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948002|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138948003|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948004|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138948005|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
138948006|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
138948007|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948008|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948009|NCT00696020|Bromides|bromides|mesh-list
138948010|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
138948011|NCT00696020|Olodaterol|olodaterol|mesh-list
138948012|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138948013|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
138948014|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948015|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948016|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138948017|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
138948018|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
138948019|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138948020|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
138948021|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948022|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948023|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
138948024|NCT00576576|Atorvastatin|atorvastatin|mesh-list
138948025|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138948026|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138948027|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
138948028|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948029|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138948030|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138948031|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948033|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
138948034|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138948035|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948036|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
138948037|NCT00757458|Propofol|propofol|mesh-list
138948038|NCT00757458|Edetic Acid|edetic acid|mesh-list
138948039|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
138948041|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138948042|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948043|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138948044|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
138948045|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
138948046|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
138948047|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138948048|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
138948049|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
138948050|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948051|NCT00757458|Antidotes|antidotes|mesh-ancestor
138948052|NCT00757458|Protective Agents|protective agents|mesh-ancestor
138948053|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138948054|NCT00923247|Bortezomib|bortezomib|mesh-list
138948055|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948056|NCT02866136|Carboplatin|carboplatin|mesh-list
138948058|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
138948059|NCT02866136|Melphalan|melphalan|mesh-list
138948060|NCT02866136|Vincristine|vincristine|mesh-list
138948061|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948062|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138948063|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138948064|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138948065|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948066|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948067|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138948068|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
138472765|NCT02004314|Chloroquine|chloroquine|mesh-list
138948069|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138948070|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138948071|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
138948072|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948073|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
138948074|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
138948075|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
138948076|NCT00757692|Bicalutamide|bicalutamide|mesh-list
138948077|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
138948078|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
138948079|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138948080|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948081|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948083|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138948084|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138948085|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948086|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138948087|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138948088|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
138948089|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948090|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948091|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138948092|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138948093|NCT02565602|Vitamin D|vitamin d|mesh-list
138948094|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
138948095|NCT02565602|Vitamins|vitamins|mesh-ancestor
138948096|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
138948097|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948098|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138948099|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138948100|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
138948101|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
138948102|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138948103|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138948104|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948105|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948106|NCT00866463|Urological Agents|urological agents|mesh-ancestor
138948107|NCT00695864|Ondansetron|ondansetron|mesh-list
138948108|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
138948109|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
138948110|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472802|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948111|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948112|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138948113|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
138948114|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
138948115|NCT00695864|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138948116|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138948117|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
138948118|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948119|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948120|NCT00684996|Bevacizumab|bevacizumab|mesh-list
138948121|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138948122|NCT00684996|Antibodies|antibodies|mesh-list
138948123|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
138948124|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138948125|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948126|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138948127|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138948128|NCT00684996|Growth Substances|growth substances|mesh-ancestor
138948129|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948130|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
138948131|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
138948133|NCT05325008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138948134|NCT05325008|Antibodies|antibodies|mesh-list
138948135|NCT05325008|gamma-Globulins|gamma-globulins|mesh-list
138948136|NCT05325008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138948137|NCT05325008|Immunologic Factors|immunologic factors|mesh-ancestor
138948138|NCT05325008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948139|NCT00684762|Cilostazol|cilostazol|mesh-list
138948140|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138948141|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
138948142|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948143|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948144|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138948145|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
138948146|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138948147|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138948148|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948149|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138948150|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
138643139|NCT00270647|Vitamins|vitamins|mesh-list
138948151|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138948152|NCT00684762|Protective Agents|protective agents|mesh-ancestor
138948153|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138948154|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138948155|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948157|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138948158|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948159|NCT00695786|Rituximab|rituximab|mesh-list
138948160|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138948161|NCT00695786|Lenalidomide|lenalidomide|mesh-list
138948162|NCT00695786|Antibodies|antibodies|mesh-list
138948163|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
138948164|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138948165|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
138948166|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948167|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948168|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138948169|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138948170|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138948171|NCT00695786|Growth Substances|growth substances|mesh-ancestor
138948172|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
138948173|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138948174|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
138948175|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948176|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138948177|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138948178|NCT00387127|Lapatinib|lapatinib|mesh-list
138948179|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948180|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138948181|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948182|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948183|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138948184|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
138948185|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138948186|NCT00683592|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138948187|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138948188|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138948189|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948190|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948191|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
138948192|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948193|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138948194|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138948195|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
138948196|NCT00695396|Hematinics|hematinics|mesh-ancestor
138948197|NCT00753402|Epinephrine|epinephrine|mesh-list
138472854|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472860|NCT02005302|Vitamin D|vitamin d|mesh-list
138948198|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138948199|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138948200|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
138948201|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948202|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948203|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948204|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138948205|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138948206|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
138948207|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948208|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138948209|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
138948210|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
138948211|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
138948212|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138948213|NCT05434884|Salicylic Acid|salicylic acid|mesh-list
138948214|NCT05434884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948215|NCT05434884|Antifungal Agents|antifungal agents|mesh-ancestor
138948216|NCT05434884|Keratolytic Agents|keratolytic agents|mesh-ancestor
138948217|NCT05434884|Dermatologic Agents|dermatologic agents|mesh-ancestor
138948218|NCT00758004|Atorvastatin|atorvastatin|mesh-list
138643141|NCT00270647|Beta Carotene|beta carotene|mesh-list
138948219|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138948220|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138948221|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
138948222|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948223|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138948224|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138948225|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948227|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138948228|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948229|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138948230|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948232|NCT04049916|Piperaquine|piperaquine|mesh-list
138948233|NCT04049916|Primaquine|primaquine|mesh-list
138948234|NCT04049916|Artenimol|artenimol|mesh-list
138948235|NCT04049916|Pyronaridine|pyronaridine|mesh-list
138948236|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
138948237|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138948238|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138948239|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948240|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948241|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
138948242|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
138948243|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138948244|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
138948245|NCT00753558|Gentamicins|gentamicins|mesh-list
138948246|NCT00753558|Polymyxins|polymyxins|mesh-list
138948247|NCT00753558|Colistin|colistin|mesh-list
138948248|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138948249|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948250|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138948251|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948252|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948253|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
138948254|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138948255|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138948256|NCT00753792|Prednisolone|prednisolone|mesh-list
138948257|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
138948258|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138948259|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
138948260|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138948261|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
138948262|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
138948263|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948264|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948265|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138948266|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
138948267|NCT00753792|Hormones|hormones|mesh-ancestor
138948268|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138948269|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138948270|NCT00753792|Protective Agents|protective agents|mesh-ancestor
138948271|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138948272|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948273|NCT00575094|Tigecycline|tigecycline|mesh-list
138948274|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138948275|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948276|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138948277|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948278|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948279|NCT00553696|Sunitinib|sunitinib|mesh-list
138948280|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948281|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138948282|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138948284|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948285|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
138948286|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138948287|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948288|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948289|NCT05430126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
138948290|NCT05430126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948291|NCT05430126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948292|NCT00958204|Fluoxetine|fluoxetine|mesh-list
138948293|NCT00958204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138948294|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138948295|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138948296|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138780518|NCT00861757|Tadalafil|tadalafil|mesh-list
138948297|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417757|NCT04172363|Octenidine|octenidine|mesh-list
138948298|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
138948299|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948300|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138948301|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
138948302|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138948303|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138948304|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138948306|NCT00617409|Paclitaxel|paclitaxel|mesh-list
138948307|NCT00617409|Tretinoin|tretinoin|mesh-list
138948308|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138948309|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948310|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
138948311|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
138948312|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
138948313|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948314|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
138948315|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
138948316|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138948317|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138948319|NCT00695318|Hormones|hormones|mesh-ancestor
138948320|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138948321|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948322|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138948323|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948324|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138948325|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948326|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948327|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138948328|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948329|NCT05396898|Tacrolimus|tacrolimus|mesh-list
138948330|NCT05396898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138948331|NCT05396898|Immunologic Factors|immunologic factors|mesh-ancestor
138948332|NCT05396898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948333|NCT05396898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138948334|NCT05396898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948335|NCT05396898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948336|NCT00694304|Vortioxetine|vortioxetine|mesh-list
138948337|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
138948338|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138948339|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138948340|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138948341|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138948342|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948343|NCT00694304|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138948344|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138948345|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138948346|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948347|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948348|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
138948349|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138472952|NCT02005757|Analgesics|analgesics|mesh-ancestor
138948350|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138948351|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138948352|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138948353|NCT00866853|Simeprevir|simeprevir|mesh-list
138948354|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
138948355|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948356|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
138948357|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948358|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948359|NCT00682890|Metformin|metformin|mesh-list
138948360|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138948361|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948362|NCT02565368|Metformin|metformin|mesh-list
138948363|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138948364|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948366|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
138948367|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138948368|NCT03992365|Cathartics|cathartics|mesh-ancestor
138948369|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138948370|NCT03992365|Laxatives|laxatives|mesh-ancestor
138948371|NCT00921804|Risperidone|risperidone|mesh-list
138948372|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138948373|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
138948374|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948375|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948376|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948377|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138948378|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138948379|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138948380|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138948381|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138948382|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
138948383|NCT00859911|Micronutrients|micronutrients|mesh-list
138948384|NCT00859911|Trace Elements|trace elements|mesh-list
138948385|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948386|NCT00698516|Bevacizumab|bevacizumab|mesh-list
138948387|NCT00698516|Topotecan|topotecan|mesh-list
138948388|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138948389|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948390|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138948391|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138948392|NCT00698516|Growth Substances|growth substances|mesh-ancestor
138948393|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948394|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
138472974|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138948395|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138948396|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138948397|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948398|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948399|NCT00679302|Trimethoprim|trimethoprim|mesh-list
138948400|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138948401|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
138948402|NCT00679302|Simethicone|simethicone|mesh-list
138948403|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138643184|NCT00298194|Z 338|z 338|mesh-list
138948404|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948406|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138948407|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138948408|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138948409|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948410|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948411|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138948412|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138948413|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138948414|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
138948415|NCT00679302|Emollients|emollients|mesh-ancestor
138948416|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
138948417|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138948418|NCT04011124|Rifampin|rifampin|mesh-list
138948419|NCT04011124|Fluzoparib|fluzoparib|mesh-list
138948420|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138948421|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
138948422|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138948423|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948424|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
138948425|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138948426|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948427|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948428|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138948429|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138948430|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138948431|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138948432|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138948433|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138948434|NCT04011124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138948435|NCT04011124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948436|NCT00862875|Insulin|insulin|mesh-list
138948437|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138948438|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
138948439|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
138948440|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138948441|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948442|NCT02544165|Caffeine|caffeine|mesh-list
138948443|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138948444|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948445|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138948446|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948447|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948448|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138948449|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138948451|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948452|NCT05343156|Dexamethasone|dexamethasone|mesh-list
138948453|NCT05343156|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138948454|NCT05343156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138948455|NCT05343156|Antiemetics|antiemetics|mesh-ancestor
138948456|NCT05343156|Autonomic Agents|autonomic agents|mesh-ancestor
138948457|NCT05343156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138780643|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
138948458|NCT05343156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948459|NCT05343156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138948460|NCT05343156|Glucocorticoids|glucocorticoids|mesh-ancestor
138948461|NCT05343156|Hormones|hormones|mesh-ancestor
138948462|NCT05343156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138948463|NCT05343156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138948464|NCT05343156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948465|NCT05343156|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138948466|NCT00955162|Buprenorphine|buprenorphine|mesh-list
138948467|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138948468|NCT00955162|Naloxone|naloxone|mesh-list
138948469|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138948470|NCT00955162|Narcotics|narcotics|mesh-ancestor
138948471|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138948472|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948473|NCT00955162|Analgesics|analgesics|mesh-ancestor
138948474|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
138948475|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948476|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138948477|NCT00949546|Etanercept|etanercept|mesh-list
138948478|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138948479|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138948480|NCT00949546|Analgesics|analgesics|mesh-ancestor
138948481|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
138948482|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948483|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948484|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138948485|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138948486|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138948487|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138948488|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
138948489|NCT00949624|Docetaxel|docetaxel|mesh-list
138948490|NCT00949624|Axitinib|axitinib|mesh-list
138948491|NCT00949624|Crenolanib|crenolanib|mesh-list
138948492|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948493|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
138948494|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
138948495|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
138948496|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948497|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138948498|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948499|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
138948500|NCT04019379|Calcium|calcium|mesh-list
138948501|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138948502|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948503|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138948504|NCT04005339|Leucovorin|leucovorin|mesh-list
138948505|NCT04005339|Fluorouracil|fluorouracil|mesh-list
138948506|NCT04005339|Irinotecan|irinotecan|mesh-list
138948507|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
138948508|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948509|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138948510|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948511|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138948512|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
138600487|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
138948513|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948514|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138948515|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138948516|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948517|NCT04005339|Antidotes|antidotes|mesh-ancestor
138948518|NCT04005339|Protective Agents|protective agents|mesh-ancestor
138948519|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
138948520|NCT04005339|Vitamins|vitamins|mesh-ancestor
138948521|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
138948522|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
138948523|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138948524|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138524702|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
138948525|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948526|NCT02544243|Gemcitabine|gemcitabine|mesh-list
138948527|NCT02544243|Vinorelbine|vinorelbine|mesh-list
138948528|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948529|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138780715|NCT04312061|Tramadol|tramadol|mesh-list
138948530|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
138948531|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948532|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138948533|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
138948534|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
138948535|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
138948536|NCT04011670|Caffeine|caffeine|mesh-list
138948537|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138948538|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948539|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138948540|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948541|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948542|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138948543|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138948544|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
138948545|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473044|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138948546|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
138948547|NCT01581073|Hematinics|hematinics|mesh-ancestor
138948548|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
138948549|NCT00742820|Calcium|calcium|mesh-list
138948550|NCT00742820|Calcium acetate|calcium acetate|mesh-list
138948551|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138948552|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948553|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138948554|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
138948555|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
138948556|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948557|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138948558|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
138948559|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
138948560|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138948561|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948562|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
138948563|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948564|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138948565|NCT00742976|Insulin|insulin|mesh-list
138948566|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138948567|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
138948568|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
138948569|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
138948570|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
138948571|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138948572|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948573|NCT00955240|Fluorouracil|fluorouracil|mesh-list
138948574|NCT00955240|Cetuximab|cetuximab|mesh-list
138948575|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948576|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
138948577|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948578|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138948579|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138948580|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
138948581|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948582|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138948583|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
138948584|NCT00867867|Trace Elements|trace elements|mesh-ancestor
138948585|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
138948586|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948587|NCT00955318|Apomorphine|apomorphine|mesh-list
138948588|NCT00955318|Emetics|emetics|mesh-ancestor
138948589|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948590|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
138948591|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948592|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138948593|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
138948594|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
138473076|NCT05970627|Oxaliplatin|oxaliplatin|mesh-list
138948595|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948596|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948597|NCT00860223|Digoxin|digoxin|mesh-list
138948598|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138948599|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138948600|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948601|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948602|NCT00860223|Protective Agents|protective agents|mesh-ancestor
138948603|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948604|NCT00698204|Celecoxib|celecoxib|mesh-list
138948605|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138948606|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138948607|NCT00698204|Analgesics|analgesics|mesh-ancestor
138948608|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
138948609|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948610|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948611|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138948612|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138948613|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138948614|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138948615|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948616|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948617|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138948618|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138948619|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138948620|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138948621|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948622|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138948623|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138948625|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138948626|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
138948627|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948628|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948629|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138948630|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138948631|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
138948632|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138948633|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138948634|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
138948635|NCT00863187|Rituximab|rituximab|mesh-list
138948636|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138948637|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948638|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
138948639|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948640|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138948641|NCT00754884|Calcitonin|calcitonin|mesh-list
138948642|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
138948643|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138948644|NCT00754884|Glycerol|glycerol|mesh-list
138948645|NCT00754884|Katacalcin|katacalcin|mesh-list
138948646|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138473098|NCT05970250|Micronutrients|micronutrients|mesh-ancestor
138473099|NCT05970250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948647|NCT00754884|Protective Agents|protective agents|mesh-ancestor
138948648|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948649|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138948650|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138948651|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
138948652|NCT00371761|Interferons|interferons|mesh-list
138948653|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
138948654|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
138948655|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138948657|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138948658|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948659|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
138948660|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948661|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
138948662|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948663|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138948664|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138948665|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948666|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948667|NCT00754962|Protriptyline|protriptyline|mesh-list
138948668|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138948669|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
138948670|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138948671|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138223923|NCT01203722|Tacrolimus|tacrolimus|mesh-list
138948672|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138948673|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138948674|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948675|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
138948676|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948677|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948678|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
138948679|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138948680|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
138948681|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948682|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948683|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138948684|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
138948685|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138948686|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138948687|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138948688|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
138948689|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473119|NCT05969847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948690|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948691|NCT05300386|Escitalopram|escitalopram|mesh-list
138948692|NCT05300386|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138948693|NCT05300386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138948694|NCT05300386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138948695|NCT05300386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948696|NCT05300386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948697|NCT05300386|Serotonin Agents|serotonin agents|mesh-ancestor
138948698|NCT05300386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948699|NCT00863499|Methylphenidate|methylphenidate|mesh-list
138948700|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138948701|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948702|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138948703|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138948704|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138948705|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948706|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
138948707|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948708|NCT00755118|Leucovorin|leucovorin|mesh-list
138948709|NCT00755118|Bevacizumab|bevacizumab|mesh-list
138948710|NCT00755118|Cetuximab|cetuximab|mesh-list
138948711|NCT00755118|Fluorouracil|fluorouracil|mesh-list
138948712|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
138948713|NCT00755118|Irinotecan|irinotecan|mesh-list
138948714|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138948715|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948716|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138948717|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138473147|NCT05969522|Alkylating Agents|alkylating agents|mesh-ancestor
138948718|NCT00755118|Growth Substances|growth substances|mesh-ancestor
138948719|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948720|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
138948721|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
138948722|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948723|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138948724|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138948725|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
138948726|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138948727|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138948728|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948729|NCT00755118|Antidotes|antidotes|mesh-ancestor
138948730|NCT00755118|Protective Agents|protective agents|mesh-ancestor
138948731|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
138948732|NCT00755118|Vitamins|vitamins|mesh-ancestor
138948733|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
138948734|NCT00755352|Pravastatin|pravastatin|mesh-list
138948735|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138948736|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138948737|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138948738|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
138948739|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948740|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138948741|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138948742|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948743|NCT00549640|Methylphenidate|methylphenidate|mesh-list
138948744|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138948745|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948746|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138948747|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138948748|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138948749|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948750|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
138948751|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948752|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
138948753|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
138948754|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138948755|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
138948756|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138948757|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
138948758|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948759|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948760|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
138948762|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
138948763|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
138948764|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138948765|NCT00868413|Rituximab|rituximab|mesh-list
138948766|NCT00868413|Fludarabine|fludarabine|mesh-list
138948767|NCT00868413|Navitoclax|navitoclax|mesh-list
138948768|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138948769|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
138948770|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948771|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138948772|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138948773|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
138948774|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473190|NCT05969119|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138948775|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948776|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138948777|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138948779|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
138948780|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138948781|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138948783|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948784|NCT00868491|Cisplatin|cisplatin|mesh-list
138948785|NCT00868491|Docetaxel|docetaxel|mesh-list
138948786|NCT00868491|Fluorouracil|fluorouracil|mesh-list
138948787|NCT00868491|Cetuximab|cetuximab|mesh-list
138948788|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948789|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
138948790|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
138948791|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
138948792|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948793|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
138948794|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138948795|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138948796|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
138948797|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948798|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138948799|NCT00955630|Ranibizumab|ranibizumab|mesh-list
138948800|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138948801|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138948802|NCT00955630|Growth Substances|growth substances|mesh-ancestor
138948803|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948804|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
138948805|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948806|NCT00868569|Leucovorin|leucovorin|mesh-list
138948807|NCT00868569|Fluorouracil|fluorouracil|mesh-list
138948808|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
138600782|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
138948809|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
138948810|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948811|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138948812|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948813|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138948814|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
138948815|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948817|NCT00868569|Protective Agents|protective agents|mesh-ancestor
138948818|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
138948819|NCT00868569|Vitamins|vitamins|mesh-ancestor
138948820|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
138948821|NCT00863733|Acetic Acid|acetic acid|mesh-list
138948822|NCT00863733|Vadimezan|vadimezan|mesh-list
138948823|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138473209|NCT05968885|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138948824|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948825|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948826|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138948827|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138948829|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138948830|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948831|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138948832|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138948833|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138948834|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
138948835|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948836|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948837|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138948838|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138948839|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
138948840|NCT00860925|Clonidine|clonidine|mesh-list
138948841|NCT00860925|Analgesics|analgesics|mesh-ancestor
138948842|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
138948843|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948844|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138781123|NCT02759926|Analgesics|analgesics|mesh-ancestor
138948845|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138948846|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
138948847|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
138948848|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138948849|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138948850|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138948851|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
138948852|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948853|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948855|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
138948856|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138948857|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
138948858|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
138948859|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948860|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948861|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138948862|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
138948863|NCT04237012|Hormones|hormones|mesh-ancestor
138948864|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138948865|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138948866|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948867|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138948868|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138948869|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138948870|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
138948871|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138948872|NCT00863889|Prednisolone|prednisolone|mesh-list
138948873|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
138948874|NCT00863889|Lidocaine|lidocaine|mesh-list
138948875|NCT00863889|Bupivacaine|bupivacaine|mesh-list
138948876|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138948877|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
138948878|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
138948879|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
138948880|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138948881|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948882|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
138948883|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948884|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138948885|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138948886|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138948887|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138948888|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948889|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138948890|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
138948891|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
138948892|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138948893|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
138948895|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138948896|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138948897|NCT00863889|Protective Agents|protective agents|mesh-ancestor
138948898|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138948899|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138948900|NCT00677352|Sertraline|sertraline|mesh-list
138948901|NCT00677352|Paroxetine|paroxetine|mesh-list
138948902|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
138948903|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138948904|NCT00677352|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138948905|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138948906|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138948907|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948908|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948910|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948911|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138948912|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138948913|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138643270|NCT00271271|Vinorelbine|vinorelbine|mesh-list
138948914|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948915|NCT00864045|Olanzapine|olanzapine|mesh-list
138948916|NCT00864045|Sertindole|sertindole|mesh-list
138948917|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
138948918|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
138948919|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948920|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948921|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138948922|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138948923|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138948924|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138948925|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138948926|NCT00864045|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138948927|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138948928|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138948929|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948930|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948931|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
138948932|NCT00755508|Gabapentin|gabapentin|mesh-list
138948933|NCT00755508|Analgesics|analgesics|mesh-ancestor
138948934|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
138948935|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948936|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948937|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
138948938|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138948939|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138948940|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138948941|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138948942|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138948943|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138948944|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948945|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948946|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
138948947|NCT03680352|Cefepime|cefepime|mesh-list
138948948|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
138948949|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138948950|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138948951|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138948952|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948953|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948954|NCT00864201|Bosentan|bosentan|mesh-list
138948955|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138948956|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138948957|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948958|NCT00864279|Cetirizine|cetirizine|mesh-list
138948959|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138948960|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138948961|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138948962|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
138948963|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
138948964|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948965|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948966|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948967|NCT02559648|Denosumab|denosumab|mesh-list
138948968|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138948969|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948970|NCT00864357|Ibuprofen|ibuprofen|mesh-list
138948971|NCT00864357|Oxycodone|oxycodone|mesh-list
138948972|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138948973|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138948974|NCT00864357|Analgesics|analgesics|mesh-ancestor
138948975|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
138948976|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138948977|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948978|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138948979|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138948980|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138948981|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138948982|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948983|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138948984|NCT00864357|Narcotics|narcotics|mesh-ancestor
138948985|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138948986|NCT00864435|Carvedilol|carvedilol|mesh-list
138948987|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138948988|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138948989|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
138948990|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138948991|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138948992|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138948993|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138948994|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
138948995|NCT00864435|Protective Agents|protective agents|mesh-ancestor
138948996|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138948997|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138948998|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138948999|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
138949000|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138949001|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138949002|NCT00755664|Vitamins|vitamins|mesh-list
138949003|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
138949004|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
138949005|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949006|NCT00956098|Oltipraz|oltipraz|mesh-list
138949007|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
138949008|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949009|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
138473324|NCT05966792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949010|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138949011|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
138949012|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138949013|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138949014|NCT00956098|Protective Agents|protective agents|mesh-ancestor
138949015|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949017|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138949018|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138949019|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949020|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949021|NCT00864591|Adenosine|adenosine|mesh-list
138949022|NCT00864591|Analgesics|analgesics|mesh-ancestor
138949023|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
138949024|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949025|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949026|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138949027|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
138949028|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138949029|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
138949030|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
138949031|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949032|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949033|NCT05350384|Methylprednisolone|methylprednisolone|mesh-list
138949034|NCT05350384|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138949035|NCT05350384|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138949036|NCT05350384|Prednisolone|prednisolone|mesh-list
138949037|NCT05350384|Prednisolone acetate|prednisolone acetate|mesh-list
138643289|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
138949038|NCT05350384|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138949039|NCT05350384|Prednisolone phosphate|prednisolone phosphate|mesh-list
138949040|NCT05350384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138949042|NCT05350384|Autonomic Agents|autonomic agents|mesh-ancestor
138949043|NCT05350384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949044|NCT05350384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949045|NCT05350384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138949046|NCT05350384|Glucocorticoids|glucocorticoids|mesh-ancestor
138949047|NCT05350384|Hormones|hormones|mesh-ancestor
138949048|NCT05350384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138949049|NCT05350384|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138949050|NCT05350384|Protective Agents|protective agents|mesh-ancestor
138949051|NCT05350384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138949052|NCT05350384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949053|NCT00870441|Valacyclovir|valacyclovir|mesh-list
138949054|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
138949055|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949056|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138949057|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
138949058|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473361|NCT05935631|Folic Acid|folic acid|mesh-list
138949059|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138949060|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138949061|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949062|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949063|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138949064|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138949065|NCT00864669|Metformin|metformin|mesh-list
138949066|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138949067|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949068|NCT00864747|Propranolol|propranolol|mesh-list
138949069|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138949070|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138949071|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
138949072|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949073|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949074|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949075|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138949076|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138949077|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
138949078|NCT05279716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138949079|NCT05279716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138949080|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
138949081|NCT02559102|Anesthetics|anesthetics|mesh-list
138949082|NCT02559102|Sevoflurane|sevoflurane|mesh-list
138949083|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138949084|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949085|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138949086|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138949087|NCT02559102|Analgesics|analgesics|mesh-ancestor
138949088|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
138949089|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643303|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
138949090|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138949091|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138949092|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138949093|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
138949094|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949095|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949096|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138949097|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138949098|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
138949099|NCT05348668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138949100|NCT05348668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949101|NCT05348668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138949102|NCT05348668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949103|NCT00864825|Allopurinol|allopurinol|mesh-list
138949104|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
138949105|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949106|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949107|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
138949109|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138949110|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
138949111|NCT00864825|Protective Agents|protective agents|mesh-ancestor
138949112|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949113|NCT00956176|Cidofovir|cidofovir|mesh-list
138949114|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
138949115|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949116|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949117|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949118|NCT00864981|Bupropion|bupropion|mesh-list
138949119|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138949120|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
138949121|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138949122|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138949123|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138949124|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138949125|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949126|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
138949127|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949128|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949129|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138949130|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138949131|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949132|NCT00371683|Enoxaparin|enoxaparin|mesh-list
138949133|NCT00371683|Apixaban|apixaban|mesh-list
138949134|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
138949135|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138949136|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138949137|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949138|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138949139|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
138949140|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138949141|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
138949142|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949143|NCT00876135|Albuterol|albuterol|mesh-list
138949144|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138949145|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
138949146|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949147|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949148|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138949149|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
138949150|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
138949151|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138949152|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138949153|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138949154|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138949155|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
138949156|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949157|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949158|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
138949160|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
138949161|NCT04039815|Vitamins|vitamins|mesh-ancestor
138949162|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
138949163|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949164|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138949165|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
138949166|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
138949167|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949168|NCT04039815|Protective Agents|protective agents|mesh-ancestor
138949169|NCT00870987|Vaccines|vaccines|mesh-list
138949170|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
138949171|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949172|NCT00962026|Rilonacept|rilonacept|mesh-list
138949173|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138949174|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
138949175|NCT00616239|Salicylates|salicylates|mesh-list
138949176|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949177|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
138949178|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
138949179|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
138949180|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138949181|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138949182|NCT00616239|Analgesics|analgesics|mesh-ancestor
138949183|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
138949184|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949185|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949186|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138781695|NCT04217512|Pantoprazole|pantoprazole|mesh-list
138949187|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138949188|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138949189|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949190|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949191|NCT00547534|Rituximab|rituximab|mesh-list
138949192|NCT00547534|Bortezomib|bortezomib|mesh-list
138949193|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138949194|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138949195|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949196|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
138781738|NCT00636142|Infliximab|infliximab|mesh-list
138949197|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949198|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138949199|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138949200|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
138949201|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949202|NCT00871455|Baclofen|baclofen|mesh-list
138949203|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138711066|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138949204|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949205|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138949206|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949207|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138949208|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
138949209|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
138949210|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949211|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949212|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
138949213|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
138949214|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138949215|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138949216|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
138949217|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949218|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
138949219|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949220|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949221|NCT00877149|Telbivudine|telbivudine|mesh-list
138949222|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
138949223|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949224|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138949225|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949226|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949227|NCT00877227|Leucovorin|leucovorin|mesh-list
138949228|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
138949229|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
138949230|NCT00877227|Antidotes|antidotes|mesh-ancestor
138949231|NCT00877227|Protective Agents|protective agents|mesh-ancestor
138949232|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949233|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
138949234|NCT00877227|Vitamins|vitamins|mesh-ancestor
138949235|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
138949236|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
138949237|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138949238|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949239|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138949240|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138949241|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
138949242|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949243|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138949244|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
138949245|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949246|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
138949247|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
138781856|NCT04216888|Ketamine|ketamine|mesh-list
138949248|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949249|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949250|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949251|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
138949253|NCT00877539|Fluticasone|fluticasone|mesh-list
138949255|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138949256|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138601226|NCT03456466|Rituximab|rituximab|mesh-list
138949257|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
138949258|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949259|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949260|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138949261|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
138949262|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
138949263|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138949264|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138949266|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138949267|NCT00872235|Diuretics|diuretics|mesh-ancestor
138949268|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
138949269|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949270|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138949271|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138949272|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949273|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138949275|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949276|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
138949277|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138949278|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138949279|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949280|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
138949281|NCT00872469|Coagulants|coagulants|mesh-ancestor
138949282|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
138949283|NCT00872625|Docetaxel|docetaxel|mesh-list
138949284|NCT00872625|Fluorouracil|fluorouracil|mesh-list
138949285|NCT00872625|Epirubicin|epirubicin|mesh-list
138949286|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138949287|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
138949288|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949289|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138949290|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138949291|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
138949292|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949293|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949294|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138949295|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
138949296|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
138949297|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
138949298|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
138949299|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138949300|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138949301|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138949302|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138949303|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949304|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138949305|NCT00872781|Quinapril|quinapril|mesh-list
138949306|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138949307|NCT00872781|Diuretics|diuretics|mesh-ancestor
138949308|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
138949309|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138782081|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138711067|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138949310|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138949311|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138949312|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949313|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138949314|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
138949315|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949316|NCT00384085|Insulin|insulin|mesh-list
138949317|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138949318|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
138949319|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
138949320|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138949321|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949322|NCT00361231|Bevacizumab|bevacizumab|mesh-list
138949323|NCT00361231|Gemcitabine|gemcitabine|mesh-list
138949324|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
138949325|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138949326|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949327|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138949328|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138949329|NCT00361231|Growth Substances|growth substances|mesh-ancestor
138949330|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949331|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
138949332|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138949333|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
138949334|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949335|NCT00676650|Prednisone|prednisone|mesh-list
138949336|NCT00676650|Sunitinib|sunitinib|mesh-list
138949337|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138949338|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
138949339|NCT00676650|Hormones|hormones|mesh-ancestor
138949340|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138949341|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949342|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138949343|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949344|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138949345|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138949346|NCT00676650|Growth Substances|growth substances|mesh-ancestor
138949347|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
138949348|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138949349|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949350|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949351|NCT01045369|Etravirine|etravirine|mesh-list
138949352|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138949353|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138949354|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949355|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949356|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
138949357|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949358|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
138949359|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138949360|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
138949361|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949362|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949363|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138949364|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
138949365|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
138949366|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138949367|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
138949368|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949369|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949370|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138949371|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949372|NCT00383149|Cetuximab|cetuximab|mesh-list
138949373|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138949374|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949375|NCT00878631|Dextrans|dextrans|mesh-list
138949376|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
138949377|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
138949378|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
138949379|NCT00382993|Naproxen|naproxen|mesh-list
138949380|NCT00382993|Sumatriptan|sumatriptan|mesh-list
138949381|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138949382|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138949383|NCT00382993|Analgesics|analgesics|mesh-ancestor
138949384|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
138949385|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949386|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949387|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138949388|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138949389|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
138949390|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138949391|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949392|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949393|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138949394|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138949395|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138949396|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
138949397|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949398|NCT00760968|Methotrexate|methotrexate|mesh-list
138949399|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138949400|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
138949401|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138949402|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949403|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138949404|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
138949405|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949406|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949407|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
138949408|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949409|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138949410|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138949411|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
138949412|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138473517|NCT05539729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138949413|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138949414|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
138949416|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138949417|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949418|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138949420|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138949421|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138949422|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949424|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138949425|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138949426|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
138949427|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
138949428|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949429|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949430|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138949432|NCT00873483|Femovan|femovan|mesh-list
138949433|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138949434|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138949435|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138949436|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
138949437|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138949438|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949439|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138949440|NCT00873483|Estrogens|estrogens|mesh-ancestor
138949441|NCT00873483|Hormones|hormones|mesh-ancestor
138949442|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138949443|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138949444|NCT00873483|Progestins|progestins|mesh-ancestor
138949445|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138949446|NCT01050517|Ivermectin|ivermectin|mesh-list
138949447|NCT01050517|Albendazole|albendazole|mesh-list
138949449|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138949450|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949451|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
138949452|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
138949453|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138949454|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138949455|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
138949456|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
138949457|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
138949458|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949459|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949461|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138949462|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
138949463|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138949464|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
138949465|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138949466|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949467|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138782451|NCT02731846|Xhance|xhance|mesh-list
138949468|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138949469|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949470|NCT01050595|Naltrexone|naltrexone|mesh-list
138949471|NCT01050595|Bromides|bromides|mesh-list
138949472|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
138949473|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
138949474|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138949475|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949476|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
138949477|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949478|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138601450|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
138949479|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
138949480|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949481|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
138949482|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138949483|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138949484|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949485|NCT00878943|Urological Agents|urological agents|mesh-ancestor
138949486|NCT00873639|Insulin|insulin|mesh-list
138949487|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138949488|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
138949489|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
138949490|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138949491|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949492|NCT00879021|Pregabalin|pregabalin|mesh-list
138949493|NCT00879021|Analgesics|analgesics|mesh-ancestor
138949494|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
138949495|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949496|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949497|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
138949498|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138949499|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138949500|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949501|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138949502|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138949503|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138949504|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138949505|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138949506|NCT00879099|Timolol|timolol|mesh-list
138949507|NCT00879099|Paroxetine|paroxetine|mesh-list
138949508|NCT00879099|Maleic acid|maleic acid|mesh-list
138949509|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949510|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949511|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138949512|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138949513|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
138949514|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949515|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949516|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138949517|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138949518|NCT00879099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138949519|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138949520|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138949521|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
138949522|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138949523|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
138949524|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138949525|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138949526|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138949527|NCT00369655|Aflibercept|aflibercept|mesh-list
138949528|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
138949529|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138949530|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138949531|NCT00369655|Growth Substances|growth substances|mesh-ancestor
138949532|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949533|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
138949534|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949535|NCT00879177|Varenicline|varenicline|mesh-list
138949536|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138949537|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138949538|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
138949539|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949540|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949541|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949542|NCT00676338|Metformin|metformin|mesh-list
138949543|NCT00676338|Pioglitazone|pioglitazone|mesh-list
138949544|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138949545|NCT00676338|Exenatide|exenatide|mesh-list
138949546|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138949547|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949548|NCT00676338|Incretins|incretins|mesh-ancestor
138949549|NCT00676338|Hormones|hormones|mesh-ancestor
138949550|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138949551|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138949552|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
138949553|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949554|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949555|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138949557|NCT02534623|Bupivacaine|bupivacaine|mesh-list
138949558|NCT02534623|Anesthetics|anesthetics|mesh-list
138949559|NCT02534623|Propofol|propofol|mesh-list
138949560|NCT02534623|Sevoflurane|sevoflurane|mesh-list
138949561|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
138949562|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138949563|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949564|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
138949565|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949566|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138949567|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138949568|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
138949569|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138949570|NCT02534623|Narcotics|narcotics|mesh-ancestor
138949571|NCT02534623|Analgesics|analgesics|mesh-ancestor
138949572|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138949573|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138949574|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138949575|NCT00873795|Aripiprazole|aripiprazole|mesh-list
138949576|NCT00873795|Sertraline|sertraline|mesh-list
138949577|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
138949578|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138949579|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138949580|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138949581|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138949582|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949583|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
138949584|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
138473579|NCT05468957|Coagulants|coagulants|mesh-ancestor
138949585|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949586|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949587|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138949588|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138949589|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
138949590|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138949591|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138949592|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138949593|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138949594|NCT00873795|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138949595|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138949596|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138949597|NCT00873951|Caseins|caseins|mesh-list
138949598|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
138949599|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
138949600|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949601|NCT00874107|Paclitaxel|paclitaxel|mesh-list
138949602|NCT00874107|Bevacizumab|bevacizumab|mesh-list
138949603|NCT00874107|Carboplatin|carboplatin|mesh-list
138949604|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138949605|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949606|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
138949607|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
138949608|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
138949609|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949610|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138949611|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138949612|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138949613|NCT00874107|Growth Substances|growth substances|mesh-ancestor
138949614|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949615|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
138949616|NCT00761358|Z 338|z 338|mesh-list
138949617|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138949618|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949619|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949620|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
138949621|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949622|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949623|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138949624|NCT00879723|Vitamins|vitamins|mesh-list
138949625|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
138949626|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949627|NCT00874419|Carboplatin|carboplatin|mesh-list
138949628|NCT00874419|Gemcitabine|gemcitabine|mesh-list
138949629|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138643454|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
138949630|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601609|NCT00191490|Docetaxel|docetaxel|mesh-list
138949631|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138949632|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
138949633|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949634|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138949636|NCT00381043|Acamprosate|acamprosate|mesh-list
138949637|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138949638|NCT01050985|Sirolimus|sirolimus|mesh-list
138949639|NCT01050985|Capecitabine|capecitabine|mesh-list
138949640|NCT01050985|Temsirolimus|temsirolimus|mesh-list
138949641|NCT01050985|MTOR Inhibitors|mtor inhibitors|mesh-list
138473598|NCT05422066|Alkylating Agents|alkylating agents|mesh-ancestor
138949642|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138949643|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
138949644|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949645|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949646|NCT01050985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138949647|NCT01050985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949648|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138949649|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
138949650|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949651|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138949652|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949653|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138949654|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
138949655|NCT00614991|Ritonavir|ritonavir|mesh-list
138949656|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
138949657|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
138949658|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138949659|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138949660|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
138949661|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949662|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949663|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138949664|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138949665|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
138949666|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949667|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138949668|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138949669|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138949670|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138949671|NCT00874575|Vitamin D|vitamin d|mesh-list
138949672|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
138949673|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
138949674|NCT00874575|Vitamins|vitamins|mesh-list
138949675|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
138782785|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
138949677|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138949678|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138949679|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
138949680|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138949681|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
138949682|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138949683|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949684|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138949685|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138949686|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138949687|NCT00369577|Loxapine|loxapine|mesh-list
138949688|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138949689|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138643467|NCT00307632|Estradiol|estradiol|mesh-list
138949690|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138949691|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949692|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138949693|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138949694|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
138949695|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949696|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949697|NCT00879957|Heparin|heparin|mesh-list
138949698|NCT00879957|Calcium heparin|calcium heparin|mesh-list
138949699|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
138949700|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138949701|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138949702|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949703|NCT00874809|Insulin|insulin|mesh-list
138949705|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138949706|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949708|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138949709|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
138949710|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949711|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949712|NCT00678288|Interferons|interferons|mesh-list
138949713|NCT00678288|Sorafenib|sorafenib|mesh-list
138949714|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949715|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
138949716|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949717|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138949718|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949719|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949720|NCT00880815|Rituximab|rituximab|mesh-list
138949721|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138949722|NCT00880815|Methotrexate|methotrexate|mesh-list
138949723|NCT00880815|Fludarabine|fludarabine|mesh-list
138949724|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138949725|NCT00880815|Antibodies|antibodies|mesh-list
138949726|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
138949727|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138949728|NCT00880815|Lenograstim|lenograstim|mesh-list
138949729|NCT00880815|Tacrolimus|tacrolimus|mesh-list
138949730|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
138949731|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138949732|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
138949733|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949734|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949735|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138949736|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138949737|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
138949738|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138949739|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138949740|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
138949741|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949742|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
138949743|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949744|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138949745|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138949746|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138949747|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138949748|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138949749|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138949751|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138949752|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138949753|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138949754|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138949755|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949756|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949757|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949758|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
138949759|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138949760|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
138949761|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949762|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138949763|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949764|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949765|NCT00881127|Cetirizine|cetirizine|mesh-list
138949766|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
138949767|NCT00881127|Ephedrine|ephedrine|mesh-list
138949768|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138949769|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138949770|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138949771|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
138949772|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
138949773|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949774|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949775|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949776|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138949777|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
138949778|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949779|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138949780|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
138949781|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
138949782|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138782963|NCT02717884|Cytarabine|cytarabine|mesh-list
138949783|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138949785|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
138949786|NCT00369265|Lansoprazole|lansoprazole|mesh-list
138949787|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
138949788|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138949789|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138949790|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138949791|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949792|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949794|NCT00875745|Vorinostat|vorinostat|mesh-list
138949795|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949796|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138783011|NCT02882477|Expectorants|expectorants|mesh-ancestor
138949797|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949798|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949799|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138949800|NCT00368875|Paclitaxel|paclitaxel|mesh-list
138949801|NCT00368875|Bevacizumab|bevacizumab|mesh-list
138949802|NCT00368875|Vorinostat|vorinostat|mesh-list
138949803|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138949804|NCT00368875|Antibodies|antibodies|mesh-list
138949805|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
138949806|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138949807|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138949808|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473655|NCT05291364|Dexmedetomidine|dexmedetomidine|mesh-list
138949809|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
138949810|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
138949811|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
138949812|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949813|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138949814|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138949815|NCT00368875|Growth Substances|growth substances|mesh-ancestor
138949816|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949817|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
138949818|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
138949819|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138949820|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949821|NCT00614055|Insulin|insulin|mesh-list
138949822|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138949823|NCT00614055|Metformin|metformin|mesh-list
138949824|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
138949826|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
138949827|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138949828|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138949829|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949830|NCT00613821|Lidocaine|lidocaine|mesh-list
138949831|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
138949832|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
138949833|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138949834|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949835|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
138949836|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949837|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138949838|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138949839|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138949840|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138949841|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949842|NCT00882765|Genistein|genistein|mesh-list
138949843|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138949844|NCT00882765|Protective Agents|protective agents|mesh-ancestor
138949845|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949846|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949847|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138949848|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949849|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949850|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
138949851|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138949852|NCT00882765|Estrogens|estrogens|mesh-ancestor
138949853|NCT00882765|Hormones|hormones|mesh-ancestor
138949854|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138601825|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
138949855|NCT00548548|Bevacizumab|bevacizumab|mesh-list
138949857|NCT00548548|Fluorouracil|fluorouracil|mesh-list
138949858|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138949859|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949860|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138949861|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138949862|NCT00548548|Growth Substances|growth substances|mesh-ancestor
138949863|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949864|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
138949865|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138949866|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
138949867|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949868|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138949869|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
138949870|NCT00613509|Interferons|interferons|mesh-list
138949871|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
138949872|NCT00613509|Vaccines|vaccines|mesh-list
138949873|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949874|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
138949875|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949876|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
138949877|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949878|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
138949879|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
138949880|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949881|NCT00881595|Temozolomide|temozolomide|mesh-list
138949882|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138949883|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
138949884|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949885|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949886|NCT00883155|Bupropion|bupropion|mesh-list
138949887|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138949888|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
138949889|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138949890|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138949891|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138949892|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138949893|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949894|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
138949895|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949896|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949897|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138949898|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138949899|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949900|NCT00881673|Dexamethasone|dexamethasone|mesh-list
138949901|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138949902|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138949903|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138949904|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
138949905|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
138949906|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949907|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949908|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138949909|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
138949910|NCT00881673|Hormones|hormones|mesh-ancestor
138949911|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138949912|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138949913|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949914|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138949915|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138949916|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138949917|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
138949918|NCT04487925|Hormones|hormones|mesh-list
138949919|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138949920|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473692|NCT05280132|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138949921|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949922|NCT00547300|Metoprolol|metoprolol|mesh-list
138949923|NCT00547300|Nebivolol|nebivolol|mesh-list
138949924|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138949925|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138949926|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
138949927|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
138949928|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601904|NCT00161681|Estradiol|estradiol|mesh-list
138949929|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949930|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138949931|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138949932|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138949933|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
138949934|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949935|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949936|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
138949937|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138949938|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138949939|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138949940|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
138949941|NCT00612807|Bupropion|bupropion|mesh-list
138949942|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138949943|NCT00612807|Sertraline|sertraline|mesh-list
138949944|NCT00612807|Nortriptyline|nortriptyline|mesh-list
138949945|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138643512|NCT00307671|Hormones|hormones|mesh-ancestor
138949946|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
138949947|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138949948|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138949949|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138949950|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138949951|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949952|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
138949953|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949954|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949955|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138949956|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138949957|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138949958|NCT00612807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138949959|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
138949960|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138949961|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138949962|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138949963|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138949964|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138949965|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
138949966|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138949967|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138949968|NCT00958750|Minoxidil|minoxidil|mesh-list
138949969|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138949970|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
138949971|NCT00958906|Infliximab|infliximab|mesh-list
138949972|NCT00958906|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138949973|NCT00958906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138949974|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
138949975|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138473721|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
138949976|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138949977|NCT00959062|Clonidine|clonidine|mesh-list
138949978|NCT00959062|Analgesics|analgesics|mesh-ancestor
138949979|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
138949980|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138949981|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949982|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138949983|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
138949984|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
138949985|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138949986|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138949987|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138949988|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
138949989|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138949990|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138949991|NCT04038411|Etoposide|etoposide|mesh-list
138949992|NCT04038411|Lenalidomide|lenalidomide|mesh-list
138949993|NCT04038411|Antibodies|antibodies|mesh-list
138949994|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
138949995|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138949996|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138949997|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138949998|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138949999|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138950000|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950001|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601982|NCT00551005|Celecoxib|celecoxib|mesh-list
138950002|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138950003|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138950004|NCT04038411|Growth Substances|growth substances|mesh-ancestor
138950005|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
138950006|NCT00882375|Nicotine|nicotine|mesh-list
138950007|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138783335|NCT04189666|Melatonin|melatonin|mesh-list
138950009|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950010|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950011|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138950012|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138950013|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
138950014|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138950015|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950016|NCT00882453|Interferons|interferons|mesh-list
138950017|NCT00882453|Interferon-beta|interferon-beta|mesh-list
138950018|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
138950019|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950020|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
138950021|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950022|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
138950023|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950024|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138950025|NCT00882531|Isotretinoin|isotretinoin|mesh-list
138950026|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
138950028|NCT00963274|Romidepsin|romidepsin|mesh-list
138950029|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950030|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138950031|NCT00963274|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138950032|NCT00963274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950033|NCT00963274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950034|NCT00882609|Fluorides|fluorides|mesh-list
138950035|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
138950036|NCT00882609|Protective Agents|protective agents|mesh-ancestor
138950037|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950038|NCT00883623|Lenalidomide|lenalidomide|mesh-list
138950039|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
138950040|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950041|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138950042|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138950043|NCT00883623|Growth Substances|growth substances|mesh-ancestor
138950044|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
138950045|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950046|NCT00959218|Dronabinol|dronabinol|mesh-list
138950047|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
138950048|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950049|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138950050|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138950051|NCT00959218|Analgesics|analgesics|mesh-ancestor
138950052|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
138950053|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950054|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138950055|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138950056|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138950057|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950058|NCT00959218|Hormones|hormones|mesh-ancestor
138950059|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138950060|NCT00678210|Tofacitinib|tofacitinib|mesh-list
138950061|NCT00678210|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138950062|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138950063|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950064|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950065|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138950066|NCT00611715|Letrozole|letrozole|mesh-list
138950067|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950068|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138950069|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950070|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950071|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138950072|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138950073|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138950074|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
138950075|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138950076|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950078|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138950080|NCT04722718|Apatinib|apatinib|mesh-list
138950081|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138950082|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950083|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
138950084|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
138473751|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
138225350|NCT01723202|Trametinib|trametinib|mesh-list
138950085|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
138950086|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950087|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138950088|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950090|NCT00761670|Amisulpride|amisulpride|mesh-list
138950091|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138950092|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
138950093|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138950094|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950095|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950096|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138950097|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138950098|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950099|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138950100|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138950101|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
138950102|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138950103|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
138950104|NCT00963664|Interferons|interferons|mesh-list
138950105|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
138950106|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
138950107|NCT00963664|Lovastatin|lovastatin|mesh-list
138950108|NCT00963664|L 647318|l 647318|mesh-list
138950109|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
138950110|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950111|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
138950112|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950113|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
138950114|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950115|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138950116|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138950117|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
138950118|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950119|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138950120|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138950121|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950123|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
138950124|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138950125|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138950126|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950127|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138950128|NCT00761904|Simvastatin|simvastatin|mesh-list
138950129|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138950130|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138950131|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
138950132|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473781|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138950133|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138950134|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138950135|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950136|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138950137|NCT00761904|Diuretics|diuretics|mesh-ancestor
138950138|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
138950139|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950140|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138950141|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138950142|NCT00963976|Enalapril|enalapril|mesh-list
138950143|NCT00963976|Labetalol|labetalol|mesh-list
138950144|NCT00963976|Hydralazine|hydralazine|mesh-list
138950145|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138950146|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
138950147|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950148|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950149|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138950150|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138602128|NCT00551824|Mitomycins|mitomycins|mesh-list
138950151|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138783594|NCT02724904|Thiotepa|thiotepa|mesh-list
138950152|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
138950153|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138950154|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950155|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
138950156|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
138950157|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950158|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138950159|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138950160|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
138950161|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
138950162|NCT02558868|Irinotecan|irinotecan|mesh-list
138950163|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950164|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138950165|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138783613|NCT00935493|Guanfacine|guanfacine|mesh-list
138950166|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950167|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950169|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138950170|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
138950171|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950172|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950173|NCT00883935|Ritonavir|ritonavir|mesh-list
138950174|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138950175|NCT00883935|Dolutegravir|dolutegravir|mesh-list
138950176|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138473809|NCT04929379|Fenofibrate|fenofibrate|mesh-list
138950177|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138950178|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
138950179|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950180|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950181|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138950182|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138950183|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
138950184|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950185|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138950186|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138950187|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138950188|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138950189|NCT00675948|Nabiximols|nabiximols|mesh-list
138950190|NCT00675948|Analgesics|analgesics|mesh-ancestor
138950191|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
138950192|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950193|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950194|NCT00885885|Panitumumab|panitumumab|mesh-list
138950195|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138950196|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950197|NCT00610935|Peramivir|peramivir|mesh-list
138950198|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
138950199|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950200|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950201|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950202|NCT02303028|Topotecan|topotecan|mesh-list
138950203|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138950204|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138643554|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
138950206|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950207|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950208|NCT02287818|Febuxostat|febuxostat|mesh-list
138950209|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
138950210|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138950211|NCT00762060|Anesthetics|anesthetics|mesh-list
138950212|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
138950213|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950214|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950215|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
138950216|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473838|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950217|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138950219|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
138950220|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138950221|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
138950222|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950223|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950224|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
138950225|NCT00672984|Guanfacine|guanfacine|mesh-list
138950226|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138950227|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950228|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138950229|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138950230|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950231|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950232|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950233|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950234|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138950235|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138950236|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138950237|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138950238|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
138950239|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643568|NCT00281970|Docetaxel|docetaxel|mesh-list
138950240|NCT02543697|Epinephrine|epinephrine|mesh-list
138950241|NCT02543697|Racepinephrine|racepinephrine|mesh-list
138950242|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
138950243|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138950244|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138950245|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
138950246|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138950247|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950248|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473871|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138473873|NCT04882072|Ustekinumab|ustekinumab|mesh-list
138950249|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138950250|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138950251|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
138950252|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950253|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138950254|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
138950255|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
138950256|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
138950257|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138950258|NCT00886275|Midazolam|midazolam|mesh-list
138950259|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
138950260|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138950261|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950262|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784022|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
138950263|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138950264|NCT00886275|Analgesics|analgesics|mesh-ancestor
138950265|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
138950266|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950267|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138950268|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138950269|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138950270|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
138950271|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138950272|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950273|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138950274|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138950275|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138950276|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138950277|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138950278|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
138950279|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
138950280|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
138950281|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
138950282|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
138950283|NCT04017897|Nivolumab|nivolumab|mesh-list
138950284|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138950285|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950286|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138950287|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950288|NCT02542137|Thymalfasin|thymalfasin|mesh-list
138950289|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138950290|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
138473919|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
138950291|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950292|NCT00886509|Lenograstim|lenograstim|mesh-list
138950293|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138950294|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
138950295|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950297|NCT02543385|Esketamine|esketamine|mesh-list
138950298|NCT02543385|Analgesics|analgesics|mesh-ancestor
138950299|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
138950300|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950301|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950302|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138950303|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138950304|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
138950305|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
138950306|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950307|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138784153|NCT02882087|Methotrexate|methotrexate|mesh-list
138950308|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138950309|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138950310|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950313|NCT00884481|Natalizumab|natalizumab|mesh-list
138950314|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
138950315|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950316|NCT02543229|Ranibizumab|ranibizumab|mesh-list
138950318|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138950319|NCT02543229|Growth Substances|growth substances|mesh-ancestor
138950320|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950321|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
138950322|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950323|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
138950325|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138950326|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950328|NCT00546364|Capecitabine|capecitabine|mesh-list
138950330|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950331|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
138950332|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
138950333|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
138950334|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950335|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138950336|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
138950337|NCT00887211|Sirolimus|sirolimus|mesh-list
138950338|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138950339|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950340|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138950341|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950342|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
138950343|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138950344|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
138950345|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950346|NCT00887367|Ethanol|ethanol|mesh-list
138950347|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138950348|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950349|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950350|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950351|NCT00964288|Lidocaine|lidocaine|mesh-list
138950352|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
138950353|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
138950354|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950355|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950356|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
138950357|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950358|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138950359|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138950360|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138950361|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138950362|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950363|NCT05955001|Tadalafil|tadalafil|mesh-list
138950364|NCT05955001|Vasodilator Agents|vasodilator agents|mesh-ancestor
138950365|NCT05955001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138950366|NCT05955001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138950367|NCT05955001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950368|NCT05955001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950369|NCT05955001|Urological Agents|urological agents|mesh-ancestor
138950370|NCT05954897|Lenvatinib|lenvatinib|mesh-list
138950371|NCT05954897|Tislelizumab|tislelizumab|mesh-list
138950372|NCT05954897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950373|NCT05954897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138950374|NCT05954897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950375|NCT05954897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950376|NCT05954897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138950377|NCT05954806|Antivenins|antivenins|mesh-list
138950378|NCT05954806|Immunologic Factors|immunologic factors|mesh-ancestor
138950379|NCT05954806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950380|NCT05954078|Leucovorin|leucovorin|mesh-list
138950381|NCT05954078|Fluorouracil|fluorouracil|mesh-list
138950382|NCT05954078|Oxaliplatin|oxaliplatin|mesh-list
138950383|NCT05954078|Irinotecan|irinotecan|mesh-list
138950384|NCT05954078|Levoleucovorin|levoleucovorin|mesh-list
138950385|NCT05954078|Antimetabolites|antimetabolites|mesh-ancestor
138950386|NCT05954078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950387|NCT05954078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138950388|NCT05954078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950389|NCT05954078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138950390|NCT05954078|Immunologic Factors|immunologic factors|mesh-ancestor
138950391|NCT05954078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950392|NCT05954078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138950393|NCT05954078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138473957|NCT04735523|Dabigatran|dabigatran|mesh-list
138950394|NCT05954078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950395|NCT05954078|Antidotes|antidotes|mesh-ancestor
138950396|NCT05954078|Protective Agents|protective agents|mesh-ancestor
138950397|NCT05954078|Vitamin B Complex|vitamin b complex|mesh-ancestor
138950398|NCT05954078|Vitamins|vitamins|mesh-ancestor
138950399|NCT05954078|Micronutrients|micronutrients|mesh-ancestor
138950400|NCT05953909|Paclitaxel|paclitaxel|mesh-list
138950401|NCT05953909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138950402|NCT05953909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950403|NCT05953909|Tubulin Modulators|tubulin modulators|mesh-ancestor
138950404|NCT05953909|Antimitotic Agents|antimitotic agents|mesh-ancestor
138950405|NCT05953909|Mitosis Modulators|mitosis modulators|mesh-ancestor
138950406|NCT05953909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950407|NCT05953896|Hyaluronic Acid|hyaluronic acid|mesh-list
138950408|NCT05953896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138950409|NCT05953896|Immunologic Factors|immunologic factors|mesh-ancestor
138950410|NCT05953896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950411|NCT05953896|Viscosupplements|viscosupplements|mesh-ancestor
138950412|NCT05953896|Protective Agents|protective agents|mesh-ancestor
138950413|NCT05953714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138950414|NCT05953714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950415|NCT05953675|Ethanol|ethanol|mesh-list
138950416|NCT05953675|Heparin|heparin|mesh-list
138950417|NCT05953675|Anticoagulants|anticoagulants|mesh-ancestor
138950418|NCT05953675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138950419|NCT05953675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138950420|NCT05953675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950421|NCT05953675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138950422|NCT05953675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950423|NCT05953675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950424|NCT05953675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950425|NCT05953376|Calcium, Dietary|calcium, dietary|mesh-list
138950426|NCT05953376|Calcium|calcium|mesh-list
138784472|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
138950427|NCT05953376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138950428|NCT05953376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473991|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473992|NCT04675788|Ibutilide|ibutilide|mesh-list
138950429|NCT05953376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138950430|NCT05953350|Hydroxychloroquine|hydroxychloroquine|mesh-list
138950431|NCT05953350|Palbociclib|palbociclib|mesh-list
138950432|NCT05953350|Antimalarials|antimalarials|mesh-ancestor
138950433|NCT05953350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138950434|NCT05953350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138950435|NCT05953350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950436|NCT05953350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950437|NCT05953350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950438|NCT05953350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138950439|NCT05953350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950440|NCT05953350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138950441|NCT05928312|Oxaliplatin|oxaliplatin|mesh-list
138950442|NCT05928312|Irinotecan|irinotecan|mesh-list
138950443|NCT05928312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950444|NCT05928312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138950445|NCT05928312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138950446|NCT05928312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950447|NCT05928312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950448|NCT05919147|Pioglitazone|pioglitazone|mesh-list
138950449|NCT05919147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138950450|NCT05919147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602416|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138950451|NCT05919030|Paclitaxel|paclitaxel|mesh-list
138950452|NCT05919030|Tislelizumab|tislelizumab|mesh-list
138950453|NCT05919030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138950454|NCT05919030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950455|NCT05919030|Tubulin Modulators|tubulin modulators|mesh-ancestor
138950456|NCT05919030|Antimitotic Agents|antimitotic agents|mesh-ancestor
138950457|NCT05919030|Mitosis Modulators|mitosis modulators|mesh-ancestor
138950458|NCT05919030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950459|NCT05919030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138950460|NCT05917509|Rilpivirine|rilpivirine|mesh-list
138950461|NCT05917509|Cabotegravir|cabotegravir|mesh-list
138950462|NCT05917509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138950463|NCT05917509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138784588|NCT03436498|Insulin|insulin|mesh-list
138950464|NCT05917509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950465|NCT05917509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950466|NCT05917509|Antiviral Agents|antiviral agents|mesh-ancestor
138950467|NCT05917509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950468|NCT05917509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138950469|NCT05917509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138950470|NCT05917509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138950471|NCT05917509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138950472|NCT05895201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138950473|NCT05895201|Cyclophosphamide|cyclophosphamide|mesh-list
138950475|NCT05895201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138950477|NCT05895201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950478|NCT05895201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138950479|NCT05895201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138950480|NCT05895201|Alkylating Agents|alkylating agents|mesh-ancestor
138950481|NCT05895201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950482|NCT05895201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950483|NCT05895201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138950484|NCT05895201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138950485|NCT05895201|Incretins|incretins|mesh-ancestor
138950486|NCT05895201|Hormones|hormones|mesh-ancestor
138950487|NCT05895201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138950488|NCT05895201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138950489|NCT05895201|Protease Inhibitors|protease inhibitors|mesh-ancestor
138950490|NCT05895201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950491|NCT05870956|Nintedanib|nintedanib|mesh-list
138950492|NCT05870956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950493|NCT05870956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138950494|NCT05870956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950495|NCT05870956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950496|NCT05847348|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138950497|NCT05847348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138950498|NCT05847348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950499|NCT05843383|Propofol|propofol|mesh-list
138950500|NCT05843383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138950501|NCT05843383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950502|NCT05843383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138784774|NCT00823576|Ropivacaine|ropivacaine|mesh-list
138950503|NCT05843383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138950505|NCT05843383|Anesthetics|anesthetics|mesh-ancestor
138950506|NCT05836753|Sarecycline|sarecycline|mesh-list
138950507|NCT05836753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138950508|NCT05836753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138474055|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138950509|NCT05836753|Dermatologic Agents|dermatologic agents|mesh-ancestor
138950510|NCT05827211|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138950511|NCT05827211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138950512|NCT05827211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950513|NCT05827211|Antitubercular Agents|antitubercular agents|mesh-ancestor
138950514|NCT05822063|Lidocaine|lidocaine|mesh-list
138950515|NCT05822063|Anesthetics, Local|anesthetics, local|mesh-ancestor
138950516|NCT05822063|Anesthetics|anesthetics|mesh-ancestor
138950517|NCT05822063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950518|NCT05822063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950519|NCT05822063|Sensory System Agents|sensory system agents|mesh-ancestor
138950520|NCT05822063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950521|NCT05822063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138950522|NCT05822063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138950523|NCT05822063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138950524|NCT05822063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138950525|NCT05822063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950526|NCT05820503|Anesthetics|anesthetics|mesh-list
138602494|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
138950527|NCT05820503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950528|NCT05820503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950529|NCT05817097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138950530|NCT05817097|Protease Inhibitors|protease inhibitors|mesh-ancestor
138950531|NCT05817097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950532|NCT05817097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950533|NCT05817097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138950534|NCT05817097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950536|NCT05814354|Gemcitabine|gemcitabine|mesh-list
138950537|NCT05814354|Capecitabine|capecitabine|mesh-list
138950538|NCT05814354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138950539|NCT05814354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950540|NCT05814354|Tubulin Modulators|tubulin modulators|mesh-ancestor
138950541|NCT05814354|Antimitotic Agents|antimitotic agents|mesh-ancestor
138950542|NCT05814354|Mitosis Modulators|mitosis modulators|mesh-ancestor
138474102|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138474104|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950543|NCT05814354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950544|NCT05814354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138950545|NCT05814354|Antimetabolites|antimetabolites|mesh-ancestor
138950546|NCT05794659|Paclitaxel|paclitaxel|mesh-list
138950547|NCT05794659|Carboplatin|carboplatin|mesh-list
138950548|NCT05794659|Molgramostim|molgramostim|mesh-list
138950549|NCT05794659|Sargramostim|sargramostim|mesh-list
138950550|NCT05794659|Immunologic Factors|immunologic factors|mesh-ancestor
138950551|NCT05794659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950552|NCT05794659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138950553|NCT05794659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950554|NCT05794659|Tubulin Modulators|tubulin modulators|mesh-ancestor
138950555|NCT05794659|Antimitotic Agents|antimitotic agents|mesh-ancestor
138950556|NCT05794659|Mitosis Modulators|mitosis modulators|mesh-ancestor
138950557|NCT05794659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950558|NCT05771584|Sargramostim|sargramostim|mesh-list
138950559|NCT05771584|Immunologic Factors|immunologic factors|mesh-ancestor
138950560|NCT05771584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950561|NCT05761041|Listerine|listerine|mesh-list
138950562|NCT05761041|Fluorides|fluorides|mesh-list
138950563|NCT05761041|Sodium Fluoride|sodium fluoride|mesh-list
138950564|NCT05761041|Fluorides, Topical|fluorides, topical|mesh-list
138950565|NCT05761041|Cariostatic Agents|cariostatic agents|mesh-ancestor
138950566|NCT05761041|Protective Agents|protective agents|mesh-ancestor
138950567|NCT05761041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138785055|NCT01107353|Imipramine|imipramine|mesh-list
138950568|NCT05761041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138950569|NCT05761041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950571|NCT05753436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138950572|NCT05753436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138950573|NCT05753436|Analgesics|analgesics|mesh-ancestor
138950574|NCT05753436|Sensory System Agents|sensory system agents|mesh-ancestor
138950575|NCT05753436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950576|NCT05753436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950577|NCT05753436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138950578|NCT05753436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138950579|NCT05753436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950580|NCT05753436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950581|NCT05753436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950582|NCT05750966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138950583|NCT05750966|Ciprofloxacin|ciprofloxacin|mesh-list
138950584|NCT05750966|Gentamicins|gentamicins|mesh-list
138950585|NCT05750966|Ceftriaxone|ceftriaxone|mesh-list
138950586|NCT05750966|Cefuroxime|cefuroxime|mesh-list
138950587|NCT05750966|Cefuroxime axetil|cefuroxime axetil|mesh-list
138950588|NCT05750966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138950589|NCT05750966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950590|NCT05750966|Antitubercular Agents|antitubercular agents|mesh-ancestor
138474141|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138950591|NCT05750966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138950592|NCT05750966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138950593|NCT05750966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950594|NCT05750966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950595|NCT05750966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950596|NCT05750966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138950597|NCT05750966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138602565|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138950598|NCT05750966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138950599|NCT05679921|Pembrolizumab|pembrolizumab|mesh-list
138785178|NCT00193414|Pemetrexed|pemetrexed|mesh-list
138950600|NCT05679921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138950601|NCT05679921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950602|NCT05679921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138950603|NCT05679921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950604|NCT05658380|Atropine|atropine|mesh-list
138950605|NCT05658380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138950606|NCT05658380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138950607|NCT05658380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138950608|NCT05658380|Autonomic Agents|autonomic agents|mesh-ancestor
138950609|NCT05658380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950610|NCT05658380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950611|NCT05658380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138950612|NCT05658380|Respiratory System Agents|respiratory system agents|mesh-ancestor
138950614|NCT05658380|Parasympatholytics|parasympatholytics|mesh-ancestor
138950615|NCT05658380|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138950616|NCT05658380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138950617|NCT05658380|Cholinergic Agents|cholinergic agents|mesh-ancestor
138950618|NCT05658380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138950619|NCT05658380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950620|NCT05551104|Labetalol|labetalol|mesh-list
138950621|NCT05551104|Nifedipine|nifedipine|mesh-list
138950622|NCT05551104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138950623|NCT05551104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138950624|NCT05551104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950625|NCT05551104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138950626|NCT05551104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950627|NCT05551104|Vasodilator Agents|vasodilator agents|mesh-ancestor
138950628|NCT05551104|Tocolytic Agents|tocolytic agents|mesh-ancestor
138950629|NCT05551104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138950630|NCT05551104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138950631|NCT05551104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138950632|NCT05551104|Adrenergic Agents|adrenergic agents|mesh-ancestor
138950633|NCT05551104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138950634|NCT05551104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138950635|NCT05551104|Sympathomimetics|sympathomimetics|mesh-ancestor
138950636|NCT05551104|Autonomic Agents|autonomic agents|mesh-ancestor
138950637|NCT05551104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138785364|NCT02700022|Hormones|hormones|mesh-ancestor
138950638|NCT05551104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138950639|NCT05551104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138950647|NCT05527418|Dasatinib|dasatinib|mesh-list
138474169|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950648|NCT05527418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950649|NCT05527418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138950650|NCT05527418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950651|NCT05527418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950652|NCT05512481|Temozolomide|temozolomide|mesh-list
138950653|NCT05512481|Apatinib|apatinib|mesh-list
138950654|NCT05512481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138950655|NCT05512481|Alkylating Agents|alkylating agents|mesh-ancestor
138950656|NCT05512481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950657|NCT05512481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950658|NCT05512481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138950659|NCT05512481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950660|NCT05473273|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138950661|NCT05473273|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138950662|NCT05473273|Estradiol|estradiol|mesh-list
138950663|NCT05473273|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138950664|NCT05473273|Progesterone|progesterone|mesh-list
138950665|NCT05473273|Estrogens|estrogens|mesh-ancestor
138950666|NCT05473273|Hormones|hormones|mesh-ancestor
138950667|NCT05473273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138950668|NCT05473273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950669|NCT05473273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138950670|NCT05473273|Contraceptive Agents|contraceptive agents|mesh-ancestor
138950671|NCT05473273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138950672|NCT05473273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138950673|NCT05473273|Progestins|progestins|mesh-ancestor
138950674|NCT05464680|Dimercaprol|dimercaprol|mesh-list
138950675|NCT05464680|Chelating Agents|chelating agents|mesh-ancestor
138950676|NCT05464680|Sequestering Agents|sequestering agents|mesh-ancestor
138950677|NCT05464680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950678|NCT05389813|Pregabalin|pregabalin|mesh-list
138950679|NCT05389813|Oxycodone|oxycodone|mesh-list
138950680|NCT05389813|Analgesics|analgesics|mesh-ancestor
138950684|NCT05389813|Anticonvulsants|anticonvulsants|mesh-ancestor
138950685|NCT05389813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138950686|NCT05389813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138950687|NCT05389813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950688|NCT05389813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138950689|NCT05389813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138950690|NCT05389813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138950691|NCT05389813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950692|NCT05389813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138474190|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138474191|NCT04250948|Capecitabine|capecitabine|mesh-list
138950693|NCT05389813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138950694|NCT05389813|Narcotics|narcotics|mesh-ancestor
138950699|NCT05341167|Phenylephrine|phenylephrine|mesh-list
138950700|NCT05341167|Oxymetazoline|oxymetazoline|mesh-list
138950701|NCT05341167|Norepinephrine|norepinephrine|mesh-list
138950702|NCT05341167|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138950703|NCT05341167|Mydriatics|mydriatics|mesh-ancestor
138950704|NCT05341167|Autonomic Agents|autonomic agents|mesh-ancestor
138950705|NCT05341167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950706|NCT05341167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950707|NCT05341167|Sympathomimetics|sympathomimetics|mesh-ancestor
138950708|NCT05341167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138950709|NCT05341167|Nasal Decongestants|nasal decongestants|mesh-ancestor
138950710|NCT05341167|Respiratory System Agents|respiratory system agents|mesh-ancestor
138950711|NCT05341167|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138950712|NCT05341167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138950713|NCT05341167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138950714|NCT05341167|Adrenergic Agents|adrenergic agents|mesh-ancestor
138785596|NCT00918957|Tobramycin|tobramycin|mesh-list
138950715|NCT05341167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138950716|NCT05341167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950717|NCT05341167|Protective Agents|protective agents|mesh-ancestor
138950718|NCT05293132|Coenzyme Q10|coenzyme q10|mesh-list
138950719|NCT05293132|Ubiquinone|ubiquinone|mesh-list
138950720|NCT05293132|Montelukast|montelukast|mesh-list
138950721|NCT05293132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138950722|NCT05293132|Respiratory System Agents|respiratory system agents|mesh-ancestor
138950723|NCT05293132|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138950724|NCT05293132|Hormone Antagonists|hormone antagonists|mesh-ancestor
138950725|NCT05293132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138950726|NCT05293132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950727|NCT05293132|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138950728|NCT05293132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138950729|NCT05293132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950730|NCT05293132|Vitamins|vitamins|mesh-ancestor
138474222|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950731|NCT05293132|Micronutrients|micronutrients|mesh-ancestor
138950732|NCT05288361|Acetylcholine|acetylcholine|mesh-list
138950733|NCT05288361|Vasodilator Agents|vasodilator agents|mesh-ancestor
138950734|NCT05288361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138950735|NCT05288361|Cholinergic Agents|cholinergic agents|mesh-ancestor
138950736|NCT05288361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138785713|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950737|NCT05288361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950738|NCT05288361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950739|NCT05231980|Thioctic Acid|thioctic acid|mesh-list
138950740|NCT05231980|Pentoxifylline|pentoxifylline|mesh-list
138950741|NCT05231980|Clomiphene|clomiphene|mesh-list
138950742|NCT05231980|Enclomiphene|enclomiphene|mesh-list
138950743|NCT05231980|Zuclomiphene|zuclomiphene|mesh-list
138950744|NCT05231980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643674|NCT00273026|Fluticasone|fluticasone|mesh-list
138950745|NCT05231980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138950746|NCT05231980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138785782|NCT02612701|Nicotine|nicotine|mesh-list
138950747|NCT05231980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138950748|NCT05231980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138950749|NCT05231980|Protective Agents|protective agents|mesh-ancestor
138950750|NCT05231980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950751|NCT05231980|Vasodilator Agents|vasodilator agents|mesh-ancestor
138950752|NCT05231980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138950753|NCT05231980|Antioxidants|antioxidants|mesh-ancestor
138950754|NCT05231980|Vitamin B Complex|vitamin b complex|mesh-ancestor
138950755|NCT05231980|Vitamins|vitamins|mesh-ancestor
138950756|NCT05231980|Micronutrients|micronutrients|mesh-ancestor
138950758|NCT05231980|Hormone Antagonists|hormone antagonists|mesh-ancestor
138950759|NCT05231980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138950760|NCT05231980|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138950761|NCT05231980|Fertility Agents|fertility agents|mesh-ancestor
138950762|NCT05231980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138950763|NCT05231980|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138950764|NCT05231980|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138950765|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
138950766|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138950767|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950768|NCT05171062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138785906|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138711068|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950769|NCT05171062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950771|NCT05148962|Immunologic Factors|immunologic factors|mesh-ancestor
138950772|NCT05148962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950774|NCT05140941|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138950775|NCT05140941|Velpatasvir|velpatasvir|mesh-list
138950776|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
138950777|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950778|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
138950779|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138785970|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
138950780|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138950782|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950783|NCT05050305|Dexamethasone|dexamethasone|mesh-list
138950784|NCT05050305|Pomalidomide|pomalidomide|mesh-list
138950785|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138950786|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
138950787|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
138950788|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950789|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950790|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138950791|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
138950792|NCT05050305|Hormones|hormones|mesh-ancestor
138950793|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138950794|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138950795|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950796|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
138950797|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138950798|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138950799|NCT05050305|Growth Substances|growth substances|mesh-ancestor
138950800|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
138950801|NCT05020327|Amoxicillin|amoxicillin|mesh-list
138950802|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138950803|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950804|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
138950805|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138950806|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950811|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950812|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138950814|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138950815|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
138950816|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138950817|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950818|NCT04947527|Fluorides|fluorides|mesh-list
138950819|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
138950820|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
138950821|NCT04947527|Protective Agents|protective agents|mesh-ancestor
138950822|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950823|NCT04939935|Metformin|metformin|mesh-list
138950824|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138950825|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602791|NCT05807542|Paclitaxel|paclitaxel|mesh-list
138474301|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474324|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
138950830|NCT04907214|Empagliflozin|empagliflozin|mesh-list
138950831|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138950832|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950833|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138950834|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950835|NCT04907032|Mirabegron|mirabegron|mesh-list
138786088|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
138950836|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138950837|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138950838|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138950839|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
138950840|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138950841|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950842|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950843|NCT04907032|Urological Agents|urological agents|mesh-ancestor
138950844|NCT04861051|Ketamine|ketamine|mesh-list
138950845|NCT04861051|Analgesics|analgesics|mesh-ancestor
138950846|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
138950847|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950848|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950849|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138950850|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138950851|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
138950852|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
138950853|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950854|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138950855|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138950856|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138950857|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950858|NCT04834375|Dexamethasone|dexamethasone|mesh-list
138950859|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
138950860|NCT04834375|BB 1101|bb 1101|mesh-list
138950861|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138950862|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
138950863|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
138950864|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950865|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950866|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138950867|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
138950868|NCT04834375|Hormones|hormones|mesh-ancestor
138643713|NCT00273299|Valsartan|valsartan|mesh-list
138950869|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138950870|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138950871|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950872|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
138950873|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950874|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950875|NCT04788745|Trimetazidine|trimetazidine|mesh-list
138950876|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
138950877|NCT04712903|Carboplatin|carboplatin|mesh-list
138950878|NCT04712903|Etoposide|etoposide|mesh-list
138950879|NCT04712903|Durvalumab|durvalumab|mesh-list
138950880|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950881|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138950882|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138950883|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138950884|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950885|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474334|NCT04034238|Tofacitinib|tofacitinib|mesh-list
138950886|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138950888|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
138950889|NCT04710927|Protective Agents|protective agents|mesh-ancestor
138950890|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950891|NCT04694976|Vitamin D|vitamin d|mesh-list
138950892|NCT04694976|Vitamins|vitamins|mesh-ancestor
138950893|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
138950894|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950895|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138950896|NCT04683627|Diclofenac|diclofenac|mesh-list
138950897|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138950898|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138950899|NCT04683627|Analgesics|analgesics|mesh-ancestor
138950900|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
138950901|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950902|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950903|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138950904|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138950905|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138950906|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950907|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950908|NCT04657666|Nabiximols|nabiximols|mesh-list
138950910|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
138950911|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950912|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950913|NCT04646967|Acetaminophen|acetaminophen|mesh-list
138950914|NCT04646967|Ibuprofen|ibuprofen|mesh-list
138950915|NCT04646967|Ketorolac|ketorolac|mesh-list
138950916|NCT04646967|Bupivacaine|bupivacaine|mesh-list
138950917|NCT04646967|Sevoflurane|sevoflurane|mesh-list
138950918|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
138474340|NCT04034238|Immunoconjugates|immunoconjugates|mesh-ancestor
138950919|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
138950920|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950921|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950922|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
138950923|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950924|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138950925|NCT04646967|Analgesics|analgesics|mesh-ancestor
138950926|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
138950927|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138950928|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138950929|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138950930|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138950931|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950932|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950933|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138950935|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
138950936|NCT04563754|Proflavine|proflavine|mesh-list
138950937|NCT04563754|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138950938|NCT04563754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138950939|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
138950940|NCT04539249|Pentazocine|pentazocine|mesh-list
138950941|NCT04539249|Analgesics|analgesics|mesh-ancestor
138950942|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
138950943|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138950944|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950946|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138950947|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138950948|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
138950949|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138950950|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138950951|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950952|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138950953|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
138950954|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138950955|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138950956|NCT04539249|Narcotics|narcotics|mesh-ancestor
138950957|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138950958|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138950959|NCT04492891|Cyclosporine|cyclosporine|mesh-list
138950960|NCT04492891|Cyclosporins|cyclosporins|mesh-list
138950961|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950962|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950963|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138950964|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
138950965|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950966|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
138950967|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138474385|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474388|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
138950968|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
138950969|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138950970|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138950971|NCT04449198|Resveratrol|resveratrol|mesh-list
138950972|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
138950973|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950974|NCT04449198|Protective Agents|protective agents|mesh-ancestor
138602949|NCT05617118|GABA Agents|gaba agents|mesh-ancestor
138950975|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950976|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950977|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138950978|NCT04271189|Metformin|metformin|mesh-list
138950979|NCT04271189|Pioglitazone|pioglitazone|mesh-list
138950980|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138950981|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138950982|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138950983|NCT04271189|Incretins|incretins|mesh-ancestor
138950984|NCT04271189|Hormones|hormones|mesh-ancestor
138950985|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138950986|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138950987|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
138950988|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138950989|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950990|NCT04221945|Cisplatin|cisplatin|mesh-list
138950991|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
138950992|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138950993|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138950994|NCT04221945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138950995|NCT04221945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950996|NCT04199325|Uric Acid|uric acid|mesh-list
138950997|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
138950998|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138950999|NCT04199325|Protective Agents|protective agents|mesh-ancestor
138951000|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474413|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474441|NCT03936023|Hormones|hormones|mesh-ancestor
138951001|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138951002|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138951003|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951017|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
138951018|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138951019|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951020|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138951021|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
138951022|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138951023|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138951024|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138951025|NCT04145518|Naproxen|naproxen|mesh-list
138951026|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138951027|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138951028|NCT04145518|Analgesics|analgesics|mesh-ancestor
138951029|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
138951030|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951031|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951032|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138951033|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138951034|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
138951035|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138951036|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951037|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951038|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138951039|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138951040|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951041|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
138951042|NCT04101721|Aflibercept|aflibercept|mesh-list
138951043|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138951044|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138951045|NCT04101721|Growth Substances|growth substances|mesh-ancestor
138951046|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951047|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
138951048|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951050|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138951051|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951052|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
138474452|NCT03878199|Daunorubicin|daunorubicin|mesh-list
138474453|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138951053|NCT03968640|Vitamins|vitamins|mesh-ancestor
138951054|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
138951055|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951056|NCT03948074|Dronabinol|dronabinol|mesh-list
138951057|NCT03948074|Cannabidiol|cannabidiol|mesh-list
138951058|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
138951059|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
138951060|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951061|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138951062|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138951064|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
138951065|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951066|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138951067|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138951068|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951069|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951070|NCT03948074|Hormones|hormones|mesh-ancestor
138951071|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138951072|NCT03939104|Artesunate|artesunate|mesh-list
138951073|NCT03939104|Lumefantrine|lumefantrine|mesh-list
138951074|NCT03939104|Artemether|artemether|mesh-list
138951075|NCT03939104|Piperaquine|piperaquine|mesh-list
138951076|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138951077|NCT03939104|Amodiaquine|amodiaquine|mesh-list
138951078|NCT03939104|Mefloquine|mefloquine|mesh-list
138951079|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
138951080|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138951081|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138951082|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951083|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951084|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
138951085|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
138951086|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138951087|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
138951088|NCT03932318|Azacitidine|azacitidine|mesh-list
138951089|NCT03932318|Venetoclax|venetoclax|mesh-list
138951090|NCT03932318|Lintuzumab|lintuzumab|mesh-list
138951091|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138951092|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
138951093|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951094|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951095|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951096|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138951097|NCT03923725|Artesunate|artesunate|mesh-list
138951098|NCT03923725|Lumefantrine|lumefantrine|mesh-list
138951099|NCT03923725|Artemether|artemether|mesh-list
138951100|NCT03923725|Piperaquine|piperaquine|mesh-list
138951101|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138951102|NCT03923725|Amodiaquine|amodiaquine|mesh-list
138951103|NCT03923725|Mefloquine|mefloquine|mesh-list
138951104|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
138951105|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138951106|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138951107|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951108|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951109|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
138951110|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
138951111|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138951112|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
138951114|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138951115|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
138951116|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951117|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138951118|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138786904|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
138951119|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951121|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
138951122|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
138951123|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951124|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138951126|NCT03809533|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138951127|NCT03809533|Velpatasvir|velpatasvir|mesh-list
138951128|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
138951129|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951130|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
138951131|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138951132|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138951133|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138951134|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
138951135|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138951136|NCT03718234|Hormones|hormones|mesh-ancestor
138951137|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138951138|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951140|NCT03643107|Irofulven|irofulven|mesh-list
138951141|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138951142|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
138474520|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138474524|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138951143|NCT03643107|Hormones|hormones|mesh-ancestor
138951144|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138951145|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951146|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138951147|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951148|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138951149|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
138951150|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951151|NCT03623243|Siponimod|siponimod|mesh-list
138951152|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138951153|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951154|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138951155|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
138951156|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951158|NCT03619707|Progestins|progestins|mesh-ancestor
138951159|NCT03619707|Hormones|hormones|mesh-ancestor
138951160|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138951161|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951162|NCT03597568|Resveratrol|resveratrol|mesh-list
138951163|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
138951164|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951165|NCT03597568|Protective Agents|protective agents|mesh-ancestor
138951166|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951167|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951168|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138951169|NCT03593408|Midazolam|midazolam|mesh-list
138951170|NCT03593408|Fentanyl|fentanyl|mesh-list
138951171|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
138951172|NCT03593408|Morphine|morphine|mesh-list
138951173|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138951174|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138951175|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951176|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138951178|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
138951179|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474555|NCT03573024|Azacitidine|azacitidine|mesh-list
138474556|NCT03573024|Venetoclax|venetoclax|mesh-list
138474557|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138951180|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138951181|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138951182|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138951183|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
138787284|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138951184|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951185|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951186|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138951188|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138951189|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138951190|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138951191|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138951192|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138951193|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
138951194|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
138951195|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
138951196|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
138951197|NCT03572582|Nivolumab|nivolumab|mesh-list
138951198|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138951199|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951200|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138951201|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951202|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138787419|NCT00890266|Vitamins|vitamins|mesh-ancestor
138951203|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951204|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951205|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951206|NCT03432871|Niacinamide|niacinamide|mesh-list
138951207|NCT03432871|Niacin|niacin|mesh-list
138951208|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
138951209|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
138951210|NCT03432871|Vitamins|vitamins|mesh-ancestor
138951212|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951213|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138951214|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
138951215|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951216|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138951217|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
138951218|NCT03399318|Acetaminophen|acetaminophen|mesh-list
138951219|NCT03399318|Ibuprofen|ibuprofen|mesh-list
138951220|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138951221|NCT03399318|Analgesics|analgesics|mesh-ancestor
138951222|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
138951223|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951224|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951225|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
138951226|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138951227|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138951228|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138951229|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138951230|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951231|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951232|NCT03389139|Anesthetics|anesthetics|mesh-list
138951233|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138951234|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951235|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
138951236|NCT03382938|Ropivacaine|ropivacaine|mesh-list
138951237|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138951238|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138951239|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951240|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138951241|NCT03382938|Analgesics|analgesics|mesh-ancestor
138951242|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
138951243|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951244|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138951245|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138951246|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138951247|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
138951248|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951249|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951250|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
138951251|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
138951252|NCT03380468|Pemetrexed|pemetrexed|mesh-list
138951253|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951254|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138501313|NCT00000518|Quinidine|quinidine|mesh-list
138951255|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951256|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138474618|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474619|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951257|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138951258|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
138951259|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951261|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138951262|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
138951263|NCT03236155|Narcotics|narcotics|mesh-ancestor
138951264|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138951265|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951266|NCT03236155|Analgesics|analgesics|mesh-ancestor
138951267|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
138951268|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951269|NCT03177122|Inositol|inositol|mesh-list
138951270|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
138951271|NCT03177122|Vitamins|vitamins|mesh-ancestor
138951272|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
138951273|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951274|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138951275|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
138951276|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138951277|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
138951278|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138951279|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951280|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138951281|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138951282|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951283|NCT03006848|Avelumab|avelumab|mesh-list
138951284|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138951285|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951287|NCT02981069|Exenatide|exenatide|mesh-list
138951288|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138951289|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951290|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138951291|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951292|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138951293|NCT02981069|Incretins|incretins|mesh-ancestor
138951294|NCT02981069|Hormones|hormones|mesh-ancestor
138951295|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474661|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138951296|NCT02980991|Pemetrexed|pemetrexed|mesh-list
138951297|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951298|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951299|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951300|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138951301|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138951302|NCT02923128|Sufentanil|sufentanil|mesh-list
138951303|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
138951304|NCT02923128|Dsuvia|dsuvia|mesh-list
138951305|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138951306|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138951307|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951308|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138951309|NCT02923128|Analgesics|analgesics|mesh-ancestor
138951310|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
138951311|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951312|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138951313|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138951314|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138951315|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
138951316|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951317|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951318|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138951319|NCT02923128|Narcotics|narcotics|mesh-ancestor
138951320|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138951321|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138951322|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
138951323|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
138951324|NCT02839642|Rivastigmine|rivastigmine|mesh-list
138951325|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138951326|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951327|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951328|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
138951329|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951330|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951331|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138951332|NCT02839642|Protective Agents|protective agents|mesh-ancestor
138951333|NCT02810444|Immunoglobulins|immunoglobulins|mesh-list
138951334|NCT02810444|gamma-Globulins|gamma-globulins|mesh-list
138951335|NCT02810444|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138951336|NCT02810444|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138501460|NCT00030862|Irinotecan|irinotecan|mesh-list
138951337|NCT02810444|Immunologic Factors|immunologic factors|mesh-ancestor
138951338|NCT02810444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951339|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
138951340|NCT02612311|Chlorambucil|chlorambucil|mesh-list
138951341|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138951342|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951343|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138951344|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
138951345|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951346|NCT02607319|Bemiparin|bemiparin|mesh-list
138951347|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
138951348|NCT02581085|Tocotrienols|tocotrienols|mesh-list
138951349|NCT02581085|Vitamin E|vitamin e|mesh-list
138951350|NCT02581085|Tocopherols|tocopherols|mesh-list
138951351|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
138951352|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951353|NCT02581085|Protective Agents|protective agents|mesh-ancestor
138951354|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951355|NCT02581085|Vitamins|vitamins|mesh-ancestor
138951356|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
138951357|NCT02575963|Cytarabine|cytarabine|mesh-list
138951358|NCT02575963|Lintuzumab|lintuzumab|mesh-list
138951359|NCT02575963|Furosemide|furosemide|mesh-list
138951360|NCT02575963|Spironolactone|spironolactone|mesh-list
138524712|NCT00040872|Etoposide|etoposide|mesh-list
138951361|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138951362|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
138951363|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951364|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951365|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
138951366|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951367|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138951368|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
138951369|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951370|NCT02575963|Diuretics|diuretics|mesh-ancestor
138951371|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
138951372|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138951373|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138951374|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138951375|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
138951376|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138951377|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138951378|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138951379|NCT02507284|SRX246|srx246|mesh-list
138501628|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
138951380|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138951381|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951382|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
138474724|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951383|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951384|NCT02501096|Pembrolizumab|pembrolizumab|mesh-list
138951386|NCT02501096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138951387|NCT02501096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951388|NCT02501096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138501689|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
138951389|NCT02501096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951390|NCT02501096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138951391|NCT02501096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951392|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138951393|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138951394|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
138951395|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951396|NCT02364089|Epinephrine|epinephrine|mesh-list
138951397|NCT02364089|Racepinephrine|racepinephrine|mesh-list
138951398|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
138951399|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138951400|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138951401|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
138951402|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951403|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951404|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951405|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138951406|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138951407|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
138951408|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951409|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138951410|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
138951411|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
138951412|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
138951413|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138951414|NCT02122562|Ketamine|ketamine|mesh-list
138951415|NCT02122562|Analgesics|analgesics|mesh-ancestor
138951416|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
138951417|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951418|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951419|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138951420|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138951421|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
138951422|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
138951423|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138951424|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138951425|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138951426|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951427|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951428|NCT02115724|Vitamins|vitamins|mesh-list
138951429|NCT02115724|Vitamin E|vitamin e|mesh-list
138951430|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
138474762|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138951431|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
138951432|NCT02115724|Antioxidants|antioxidants|mesh-list
138951433|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
138951434|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951435|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951436|NCT02115724|Protective Agents|protective agents|mesh-ancestor
138951437|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
138951438|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
138951440|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138951441|NCT02036372|Liraglutide|liraglutide|mesh-list
138951442|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138951443|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951444|NCT02036372|Incretins|incretins|mesh-ancestor
138951445|NCT02036372|Hormones|hormones|mesh-ancestor
138951446|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138951447|NCT01633541|Carboplatin|carboplatin|mesh-list
138951448|NCT01633541|Docetaxel|docetaxel|mesh-list
138951449|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138501864|NCT00000611|Vitamin D|vitamin d|mesh-list
138951451|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
138951452|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
138951453|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951454|NCT01399372|Cytarabine|cytarabine|mesh-list
138951455|NCT01399372|Rituximab|rituximab|mesh-list
138951456|NCT01399372|Methotrexate|methotrexate|mesh-list
138951457|NCT01399372|Vincristine|vincristine|mesh-list
138951458|NCT01399372|Procarbazine|procarbazine|mesh-list
138951459|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138951460|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951461|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
138951462|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951463|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138951464|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138951465|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
138951466|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138951467|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138951468|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
138951469|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951470|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
138951471|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951472|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138501988|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
138474807|NCT02506517|Afatinib|afatinib|mesh-list
138951473|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138951474|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138951475|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
138951476|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951477|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138951478|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
138951479|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
138951480|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
138951482|NCT01267604|Melatonin|melatonin|mesh-list
138951483|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
138951484|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951485|NCT01267604|Protective Agents|protective agents|mesh-ancestor
138951486|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951487|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138951488|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
138951489|NCT01267604|Vitamins|vitamins|mesh-ancestor
138951490|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
138951491|NCT01244399|Inositol|inositol|mesh-list
138951492|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
138951493|NCT01244399|Vitamins|vitamins|mesh-ancestor
138951494|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
138951495|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951496|NCT01063517|Paclitaxel|paclitaxel|mesh-list
138951497|NCT01063517|Olaparib|olaparib|mesh-list
138951498|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138951499|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951500|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
138951501|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
138474822|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138474823|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
138951502|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
138951503|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951504|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138951505|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951506|NCT00920621|Vitamin D|vitamin d|mesh-list
138951507|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
138951508|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
138951509|NCT00920621|Vitamins|vitamins|mesh-list
138951510|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
138951511|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138226777|NCT02459964|Analgesics|analgesics|mesh-ancestor
138951512|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138951513|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138951514|NCT00964756|Ganciclovir|ganciclovir|mesh-list
138951515|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138951516|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
138951517|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951518|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138951519|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951520|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951521|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138951523|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138951524|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951525|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
138951526|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
138502237|NCT00389129|Aspirin|aspirin|mesh-list
138951527|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138951528|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138951530|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
138951531|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138951532|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951533|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
138951534|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138951535|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138951536|NCT04017741|Prednisolone|prednisolone|mesh-list
138951537|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
138951538|NCT04017741|Lidocaine|lidocaine|mesh-list
138951539|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138951540|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
138951541|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
138951542|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
138951543|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138951544|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951545|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
138951546|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951547|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138951548|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138951549|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138951550|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138502364|NCT00000674|Vitamins|vitamins|mesh-ancestor
138951551|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951552|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138951553|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
138951554|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
138951555|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138951556|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
138951557|NCT04017741|Hormones|hormones|mesh-ancestor
138951558|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138474870|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951559|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138951560|NCT04017741|Protective Agents|protective agents|mesh-ancestor
138951561|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138951562|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951565|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138951566|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138951567|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138951568|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138951569|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951570|NCT00546052|Diuretics|diuretics|mesh-ancestor
138951571|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
138951572|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951573|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138951574|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138951575|NCT00887601|Donepezil|donepezil|mesh-list
138951576|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138951577|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951578|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951579|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
138951580|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951581|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951582|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
138951583|NCT00887757|Gemcitabine|gemcitabine|mesh-list
138951584|NCT00887757|Navitoclax|navitoclax|mesh-list
138603538|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
138951585|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138951586|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
138951587|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951588|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951589|NCT00965224|Immunomodulating Agents|immunomodulating agents|mesh-list
138951590|NCT00965224|Immunologic Factors|immunologic factors|mesh-ancestor
138951591|NCT00965224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951593|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138951594|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
138951595|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138951596|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138951597|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951598|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138951599|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138951600|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138951601|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951602|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138951603|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138951604|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138951605|NCT00673920|Methotrexate|methotrexate|mesh-list
138951606|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
138951607|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138951608|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
138951609|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138951610|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474886|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474887|NCT01661647|Anesthetics|anesthetics|mesh-list
138951611|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138951612|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
138951613|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951614|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951615|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
138951616|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951617|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138951618|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138502670|NCT00000722|Pentamidine|pentamidine|mesh-list
138951619|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
138951620|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138643862|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
138951621|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138951622|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138951623|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138951624|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
138951625|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951626|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951627|NCT00379795|Ranibizumab|ranibizumab|mesh-list
138951628|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138951629|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138951630|NCT00379795|Growth Substances|growth substances|mesh-ancestor
138951631|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951632|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
138951633|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951634|NCT04588948|Aflibercept|aflibercept|mesh-list
138951635|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138951636|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138951637|NCT04588948|Growth Substances|growth substances|mesh-ancestor
138502809|NCT00014469|Melphalan|melphalan|mesh-list
138951638|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951639|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
138951640|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951641|NCT00765024|Ivermectin|ivermectin|mesh-list
138951642|NCT00765024|Albendazole|albendazole|mesh-list
138951643|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138951644|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951645|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
138951646|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
138951647|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138951648|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138951649|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
138951650|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
138951651|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
138951652|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951653|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951654|NCT02557932|Bismuth|bismuth|mesh-list
138951655|NCT02557932|Antacids|antacids|mesh-ancestor
138951656|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951657|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138951658|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
138474904|NCT00601198|Leucovorin|leucovorin|mesh-list
138474905|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
138951659|NCT00960232|Vitamin D|vitamin d|mesh-list
138951660|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138951661|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951662|NCT00960232|Vitamins|vitamins|mesh-ancestor
138951663|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
138951664|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138951665|NCT00960310|Bicalutamide|bicalutamide|mesh-list
138951666|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
138951667|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
138951668|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138951669|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951670|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951672|NCT00610155|Tramadol|tramadol|mesh-list
138951673|NCT00610155|Analgesics|analgesics|mesh-ancestor
138951674|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
138951675|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951676|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951677|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
138951678|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138951679|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138951680|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951681|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138951682|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138951683|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138951684|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138951685|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138951686|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138951687|NCT00610155|Narcotics|narcotics|mesh-ancestor
138951688|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
138951689|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138951690|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
138951691|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951693|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138951694|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
138951695|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951696|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951697|NCT04488952|Anesthetics|anesthetics|mesh-list
138951698|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138951699|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951700|NCT00888303|Dexamethasone|dexamethasone|mesh-list
138951701|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138951702|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
138951703|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
138951704|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951705|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951706|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138951707|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
138951708|NCT00888303|Hormones|hormones|mesh-ancestor
138951709|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138951710|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138951711|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951712|NCT00967642|Insulin|insulin|mesh-list
138474933|NCT02006745|Ribavirin|ribavirin|mesh-list
138951713|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138951714|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138503110|NCT00036634|Tenofovir|tenofovir|mesh-list
138951715|NCT00674700|Immunomodulating Agents|immunomodulating agents|mesh-list
138951716|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
138951717|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951718|NCT00762918|Vitamin D|vitamin d|mesh-list
138951719|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
138951720|NCT00762918|Vitamins|vitamins|mesh-ancestor
138951721|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
138951722|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951723|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138951724|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138951725|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138951726|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138951727|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138951728|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138951729|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951730|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
138951731|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951732|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951733|NCT00759720|Glyburide|glyburide|mesh-list
138951734|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138951735|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951736|NCT00379639|Gemcitabine|gemcitabine|mesh-list
138951737|NCT00379639|Romidepsin|romidepsin|mesh-list
138951738|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138951739|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
138503237|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
138951740|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951741|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951742|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138951743|NCT00379639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138951744|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951745|NCT00609765|Dexamethasone|dexamethasone|mesh-list
138951746|NCT00609765|Bevacizumab|bevacizumab|mesh-list
138951747|NCT00609765|Doxorubicin|doxorubicin|mesh-list
138951748|NCT00609765|Fluorouracil|fluorouracil|mesh-list
138951749|NCT00609765|Streptozocin|streptozocin|mesh-list
138951750|NCT00609765|Ondansetron|ondansetron|mesh-list
138951751|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138951752|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951753|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138951754|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138951755|NCT00609765|Growth Substances|growth substances|mesh-ancestor
138951756|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951757|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
138951758|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138951759|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
138951760|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
138951761|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474951|NCT02006966|Lidocaine|lidocaine|mesh-list
138951762|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138951763|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
138951764|NCT00609765|Hormones|hormones|mesh-ancestor
138951765|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138951766|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138951767|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138951768|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138951769|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138951770|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951771|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951772|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
138951773|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138951774|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138951775|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
138951776|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
138951777|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
138951778|NCT00609765|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138951779|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138951780|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
138951781|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951782|NCT01051219|Losartan|losartan|mesh-list
138951783|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138951784|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138951785|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138951786|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138951787|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951788|NCT00961324|Insulin|insulin|mesh-list
138951789|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138951790|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
138951791|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138951792|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951793|NCT00766350|Amitriptyline|amitriptyline|mesh-list
138951794|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138951795|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
138951796|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138951797|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138951798|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138951799|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138951800|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951801|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138951802|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138951804|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
138951805|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951806|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138474975|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951807|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138951808|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138951809|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951810|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
138951811|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951812|NCT00889161|Curcumin|curcumin|mesh-list
138951813|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138951814|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138951815|NCT00889161|Analgesics|analgesics|mesh-ancestor
138951816|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
138951817|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951818|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951819|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138951820|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138951821|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951822|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951823|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951824|NCT03992755|Treprostinil|treprostinil|mesh-list
138951825|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138951826|NCT01563328|Dolutegravir|dolutegravir|mesh-list
138951827|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138951828|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138951829|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951830|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951831|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138951832|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138951833|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
138503816|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
138951834|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951835|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
138951836|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138951837|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475003|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
138951838|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138951839|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138951840|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951841|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951842|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951843|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138951844|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138951845|NCT00961480|Metformin|metformin|mesh-list
138951846|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138951847|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138951848|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951849|NCT00961480|Incretins|incretins|mesh-ancestor
138951850|NCT00961480|Hormones|hormones|mesh-ancestor
138951851|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138951852|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138951853|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
138951854|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951855|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951856|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
138951857|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
138951858|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138951859|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
138951860|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138951861|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138951862|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951863|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138951864|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951865|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951866|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138951867|NCT00965926|Mirabegron|mirabegron|mesh-list
138951868|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138951869|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138951870|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138524716|NCT00040872|Antibodies|antibodies|mesh-list
138951871|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
138951872|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951873|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951874|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951875|NCT00965926|Urological Agents|urological agents|mesh-ancestor
138951876|NCT00966004|Mirabegron|mirabegron|mesh-list
138503905|NCT00015873|Hormones|hormones|mesh-ancestor
138951877|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138951878|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138951879|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138951880|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138951881|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
138951882|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951883|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951884|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951885|NCT00966004|Urological Agents|urological agents|mesh-ancestor
138951886|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138951887|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138951888|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
138951890|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138951891|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138951892|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
138951893|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138951894|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951895|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951896|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138951897|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138951898|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
138951899|NCT00889629|Vitamin D|vitamin d|mesh-list
138951900|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
138951901|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138951902|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
138951903|NCT00889629|Vitamins|vitamins|mesh-ancestor
138951904|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
138951905|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951906|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138951907|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138951908|NCT00966160|Ritonavir|ritonavir|mesh-list
138951909|NCT00966160|Lopinavir|lopinavir|mesh-list
138951910|NCT00966160|Lamivudine|lamivudine|mesh-list
138951911|NCT00966160|Zidovudine|zidovudine|mesh-list
138951912|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138951913|NCT00966160|Efavirenz|efavirenz|mesh-list
138951914|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138951915|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138951916|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
138951917|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951918|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951919|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138951920|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138475079|NCT02007915|Pamidronate|pamidronate|mesh-list
138475082|NCT02007928|Olanzapine|olanzapine|mesh-list
138951921|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
138951922|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951923|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138951924|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138504121|NCT00016302|Hormones|hormones|mesh-ancestor
138951925|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138951926|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138951927|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
138951928|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138951929|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138951930|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138951931|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138951932|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138951933|NCT00766818|Lopinavir|lopinavir|mesh-list
138504208|NCT00001190|Deslorelin|deslorelin|mesh-list
138951934|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138951935|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138951937|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951938|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951939|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138951940|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138951941|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
138951942|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951943|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138643971|NCT00274274|Insulin|insulin|mesh-list
138951944|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138951946|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138951947|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138951948|NCT00966316|Analgesics|analgesics|mesh-ancestor
138951949|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
138951950|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951951|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951952|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138951953|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138951954|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138603915|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
138951955|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138951956|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951957|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138951958|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138951959|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951960|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
138475110|NCT02008006|Etoposide|etoposide|mesh-list
138475111|NCT02008006|Melphalan|melphalan|mesh-list
138951961|NCT00892827|Rituximab|rituximab|mesh-list
138951962|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138951963|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951964|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
138951965|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951966|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138951967|NCT00766896|Aspirin|aspirin|mesh-list
138951968|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138951969|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138951970|NCT00766896|Analgesics|analgesics|mesh-ancestor
138951971|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
138951972|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138951973|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951974|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138951975|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138951976|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138951977|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138951978|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951979|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138951980|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138951981|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951982|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
138951983|NCT00763620|Dimercaprol|dimercaprol|mesh-list
138951984|NCT00763620|Chelating Agents|chelating agents|mesh-ancestor
138951985|NCT00763620|Sequestering Agents|sequestering agents|mesh-ancestor
138951986|NCT00763620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951987|NCT00973804|Sirolimus|sirolimus|mesh-list
138951988|NCT00973804|Tacrolimus|tacrolimus|mesh-list
138951989|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138951990|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
138951991|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138951992|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138951993|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138951994|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138951995|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138951996|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138951997|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138951998|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138951999|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
138952000|NCT04018131|Cimetidine|cimetidine|mesh-list
138952001|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138952002|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138952003|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138952004|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
138952005|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
138952006|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952007|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475141|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
138475145|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
138952008|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952009|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138952010|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138952011|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952012|NCT00973882|Carboplatin|carboplatin|mesh-list
138952013|NCT00973882|Etoposide|etoposide|mesh-list
138952014|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952015|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138952016|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138952017|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138952018|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952019|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952020|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138952021|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138952022|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
138952023|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952024|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952025|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138952026|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
138952027|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138952028|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138952030|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
138952031|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952032|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952033|NCT05279482|Methylprednisolone|methylprednisolone|mesh-list
138952034|NCT05279482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138952035|NCT05279482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138952036|NCT05279482|Prednisolone|prednisolone|mesh-list
138952037|NCT05279482|Prednisolone acetate|prednisolone acetate|mesh-list
138952038|NCT05279482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138952039|NCT05279482|Prednisolone phosphate|prednisolone phosphate|mesh-list
138952040|NCT05279482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138952041|NCT05279482|Antiemetics|antiemetics|mesh-ancestor
138952042|NCT05279482|Autonomic Agents|autonomic agents|mesh-ancestor
138952043|NCT05279482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952044|NCT05279482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952045|NCT05279482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138952046|NCT05279482|Glucocorticoids|glucocorticoids|mesh-ancestor
138952047|NCT05279482|Hormones|hormones|mesh-ancestor
138952048|NCT05279482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952049|NCT05279482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138504506|NCT00001322|Leuprolide|leuprolide|mesh-list
138952050|NCT05279482|Protective Agents|protective agents|mesh-ancestor
138952051|NCT05279482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138952052|NCT05279482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952053|NCT00890175|Loxapine|loxapine|mesh-list
138644030|NCT00274430|Dexamethasone|dexamethasone|mesh-list
138952054|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138952055|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138504569|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952056|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138952057|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952058|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138952059|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138952060|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
138952061|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952062|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952063|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138952064|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138952065|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952066|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138952067|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952068|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952069|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138952070|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138952071|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
138952072|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138952073|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138952074|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
138952075|NCT00890253|Prednisone|prednisone|mesh-list
138952076|NCT00890253|Prednisolone|prednisolone|mesh-list
138952078|NCT00890253|Basiliximab|basiliximab|mesh-list
138952079|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138952080|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
138952081|NCT00890253|Hormones|hormones|mesh-ancestor
138952082|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952083|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952084|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138952085|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952086|NCT00890253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138952087|NCT00890253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138952088|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952089|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952090|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138952091|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
138952092|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138952093|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138952094|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
138952095|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138952096|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138952098|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
138952099|NCT00674154|Vitamins|vitamins|mesh-ancestor
138952100|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
138475205|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
138952101|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952102|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138604062|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
138952103|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138952105|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
138952106|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952107|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952108|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
138952109|NCT00767286|Cobalt|cobalt|mesh-list
138952110|NCT00767286|Goserelin|goserelin|mesh-list
138952111|NCT00767286|Flutamide|flutamide|mesh-list
138952112|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138952113|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952114|NCT00767286|Trace Elements|trace elements|mesh-ancestor
138952115|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
138952116|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952117|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
138952118|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
138952119|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952120|NCT00968110|Omalizumab|omalizumab|mesh-list
138952121|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138952122|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138952123|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
138952124|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
138952125|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
138952126|NCT00608517|Fludarabine|fludarabine|mesh-list
138952127|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
138952128|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138952129|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138952130|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
138952131|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952132|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138952133|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138952134|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
138952135|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952136|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952137|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138952138|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138952139|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
138952140|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138952141|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
138952142|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
138952143|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952144|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138952145|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
138952146|NCT00608517|Hormones|hormones|mesh-ancestor
138475226|NCT02008747|Analgesics|analgesics|mesh-ancestor
138952147|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952148|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138952149|NCT00608517|Protective Agents|protective agents|mesh-ancestor
138952150|NCT00966706|Gemcitabine|gemcitabine|mesh-list
138952151|NCT00966706|Docetaxel|docetaxel|mesh-list
138952152|NCT00966706|Capecitabine|capecitabine|mesh-list
138952153|NCT00966706|Epirubicin|epirubicin|mesh-list
138952154|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952155|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138952156|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
138952157|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952158|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
138505020|NCT00042601|Pramlintide|pramlintide|mesh-list
138952159|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
138952160|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
138952161|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138952162|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138952163|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138952164|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952166|NCT00893061|Letrozole|letrozole|mesh-list
138952167|NCT00893061|Anastrozole|anastrozole|mesh-list
138952168|NCT00893061|Exemestane|exemestane|mesh-list
138952169|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952170|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952171|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138952172|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138952173|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952174|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138952175|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
138952176|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952177|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952178|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138952179|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138952180|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138952181|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138952182|NCT00974272|Exenatide|exenatide|mesh-list
138952183|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138952184|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952185|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138952186|NCT00974272|Incretins|incretins|mesh-ancestor
138952187|NCT00974272|Hormones|hormones|mesh-ancestor
138952188|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952189|NCT00974428|Wobenzym|wobenzym|mesh-list
138952190|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138952191|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
138952192|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952193|NCT00974584|Paclitaxel|paclitaxel|mesh-list
138952194|NCT00974584|Bevacizumab|bevacizumab|mesh-list
138952195|NCT00974584|Carboplatin|carboplatin|mesh-list
138952196|NCT00974584|Pemetrexed|pemetrexed|mesh-list
138952197|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138952198|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952199|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
138475253|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
138952200|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
138952201|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
138952202|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952203|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138952204|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138952205|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138952206|NCT00974584|Growth Substances|growth substances|mesh-ancestor
138952207|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138505108|NCT00043069|Estrogens|estrogens|mesh-list
138952208|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
138952209|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952210|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138952211|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138952212|NCT00608205|Fluorouracil|fluorouracil|mesh-list
138952213|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952214|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
138952215|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952216|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138952217|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138952218|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
138952219|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952220|NCT00974740|Atorvastatin|atorvastatin|mesh-list
138952221|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138952222|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138952223|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
138952224|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952225|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138952226|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138952227|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952229|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138952230|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138952231|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138952232|NCT05227300|Lidocaine|lidocaine|mesh-list
138952233|NCT05227300|Epinephrine|epinephrine|mesh-list
138952234|NCT05227300|Anesthetics, Local|anesthetics, local|mesh-ancestor
138952235|NCT05227300|Anesthetics|anesthetics|mesh-ancestor
138505231|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952236|NCT05227300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138952237|NCT05227300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952238|NCT05227300|Sensory System Agents|sensory system agents|mesh-ancestor
138952239|NCT05227300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952240|NCT05227300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138952241|NCT05227300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138952242|NCT05227300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138952243|NCT05227300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138952244|NCT05227300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952245|NCT05227300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138952247|NCT05227300|Adrenergic Agents|adrenergic agents|mesh-ancestor
138952248|NCT05227300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952249|NCT05227300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138952250|NCT05227300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138952251|NCT05227300|Autonomic Agents|autonomic agents|mesh-ancestor
138952252|NCT05227300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138604213|NCT00194727|Capecitabine|capecitabine|mesh-list
138952253|NCT05227300|Respiratory System Agents|respiratory system agents|mesh-ancestor
138952254|NCT05227300|Mydriatics|mydriatics|mesh-ancestor
138952255|NCT05227300|Sympathomimetics|sympathomimetics|mesh-ancestor
138952256|NCT05227300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138952257|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
138952258|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138952259|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
138952260|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952261|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
138952262|NCT00890487|Protective Agents|protective agents|mesh-ancestor
138952263|NCT00890565|Granisetron|granisetron|mesh-list
138952264|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
138952265|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
138952266|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952267|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952268|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138952269|NCT00890565|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138475309|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
138952270|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138952271|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
138952272|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952273|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952275|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138952276|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138952277|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138952278|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138952279|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
138952280|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138505474|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138952281|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952282|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952283|NCT00893217|Interferons|interferons|mesh-list
138952284|NCT00893217|Interferon-beta|interferon-beta|mesh-list
138952285|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
138952286|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952287|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
138644092|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
138952288|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138952289|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
138952290|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952291|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138952292|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
138952293|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138952295|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
138952296|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
138952297|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138952298|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952299|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505610|NCT02970682|Tamoxifen|tamoxifen|mesh-list
138952300|NCT00767598|Urological Agents|urological agents|mesh-ancestor
138952301|NCT00670800|Metformin|metformin|mesh-list
138952302|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138952303|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952304|NCT00764166|Docetaxel|docetaxel|mesh-list
138952305|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138952306|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952307|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
138952308|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
138952309|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
138952310|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952311|NCT00764166|Hormones|hormones|mesh-ancestor
138475352|NCT05777902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475353|NCT05777707|Paclitaxel|paclitaxel|mesh-list
138475354|NCT05777707|Carboplatin|carboplatin|mesh-list
138952312|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952313|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952314|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
138505742|NCT00045877|Aldesleukin|aldesleukin|mesh-list
138952316|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138227595|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952318|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138952319|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952320|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
138952321|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952322|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952323|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138952324|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138505820|NCT00046111|Topotecan|topotecan|mesh-list
138952325|NCT02557542|Polidocanol|polidocanol|mesh-list
138952326|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
138604284|NCT00166595|Risperidone|risperidone|mesh-list
138952327|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138952328|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138952329|NCT00767754|Paroxetine|paroxetine|mesh-list
138952330|NCT00767754|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138952331|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138952332|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138952333|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138505874|NCT00397657|Vitamins|vitamins|mesh-ancestor
138952334|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952335|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
138952336|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952337|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138952338|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
138952339|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138952340|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138952341|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138952342|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952343|NCT00764244|Triamcinolone|triamcinolone|mesh-list
138952344|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138952345|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138952346|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138952347|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138952348|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
138952350|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952351|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952352|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138475384|NCT05777369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952353|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
138952354|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952355|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952357|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138952358|NCT00770640|Pioglitazone|pioglitazone|mesh-list
138952359|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138952360|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952361|NCT00770718|Thrombin|thrombin|mesh-list
138952362|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
138952363|NCT00770718|Coagulants|coagulants|mesh-ancestor
138952364|NCT00770796|Atorvastatin|atorvastatin|mesh-list
138952365|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138952366|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138952367|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
138952368|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952369|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138952370|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138952371|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952372|NCT00545740|Mesalamine|mesalamine|mesh-list
138952373|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138952374|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138952375|NCT00545740|Analgesics|analgesics|mesh-ancestor
138952376|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
138952377|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952378|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952379|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138952380|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138952381|NCT05208190|Clozapine|clozapine|mesh-list
138952382|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138952383|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
138952384|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952385|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952386|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952387|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138952388|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138952389|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138952391|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
138952392|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
138952393|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
138952394|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138475411|NCT05616390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138506113|NCT00047671|Citalopram|citalopram|mesh-list
138952395|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138952397|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
138475412|NCT05616390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138952398|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138952399|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
138952400|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138952401|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
138952402|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
138644131|NCT00274898|Celecoxib|celecoxib|mesh-list
138952403|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952404|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952405|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138952406|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
138952408|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952409|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138952410|NCT00609609|Protective Agents|protective agents|mesh-ancestor
138952411|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138952412|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952413|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138952414|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138506172|NCT00048373|Etanercept|etanercept|mesh-list
138952415|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138952416|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138952417|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506224|NCT00048646|Progesterone|progesterone|mesh-list
138952418|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952419|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952420|NCT00673452|Analgesics|analgesics|mesh-ancestor
138952421|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
138952422|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952423|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
138952424|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138952425|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
138952426|NCT00967174|Nicotine|nicotine|mesh-list
138952427|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138952428|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
138952429|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952430|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952431|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138952432|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138952433|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
138506293|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
138952434|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952435|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952436|NCT00967252|Atorvastatin|atorvastatin|mesh-list
138952437|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138952438|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138952439|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
138952440|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952441|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138952442|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138952443|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952444|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
138952445|NCT00890955|Amrubicin|amrubicin|mesh-list
138952446|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138952447|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
138952448|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952449|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138952450|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138952451|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
138952452|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952453|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952454|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138952455|NCT00975052|Metformin|metformin|mesh-list
138952456|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138952457|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138952458|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952459|NCT00975052|Incretins|incretins|mesh-ancestor
138952460|NCT00975052|Hormones|hormones|mesh-ancestor
138952461|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952462|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138952464|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952465|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952467|NCT00891033|Panobinostat|panobinostat|mesh-list
138952468|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952469|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138952470|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952471|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952472|NCT00770952|Pioglitazone|pioglitazone|mesh-list
138952473|NCT00770952|Glimepiride|glimepiride|mesh-list
138475484|NCT04840472|Panitumumab|panitumumab|mesh-list
138952475|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952476|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138952477|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138952478|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
138952479|NCT00764556|Insulin|insulin|mesh-list
138952480|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138952481|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952482|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
138952483|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138952484|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138952485|NCT00968578|Prednisolone|prednisolone|mesh-list
138952486|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
138952487|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138952488|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
138952489|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138952490|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
138952491|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
138952492|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952493|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952494|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138952495|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
138952497|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952498|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138952499|NCT00968578|Protective Agents|protective agents|mesh-ancestor
138952500|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138952501|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952502|NCT00893373|Sorafenib|sorafenib|mesh-list
138952503|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952504|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138952505|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952506|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952507|NCT00891267|Amlodipine|amlodipine|mesh-list
138952508|NCT00891267|Olmesartan|olmesartan|mesh-list
138952509|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138952510|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138952511|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138952512|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138952513|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952514|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138952515|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952516|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
138952517|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138952518|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138952519|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138952520|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138952521|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952522|NCT00545584|Incretins|incretins|mesh-ancestor
138952523|NCT00545584|Hormones|hormones|mesh-ancestor
138952524|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952525|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138952526|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
138952527|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952528|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952529|NCT00378703|Sirolimus|sirolimus|mesh-list
138952530|NCT00378703|Bevacizumab|bevacizumab|mesh-list
138952531|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138952532|NCT00378703|Sorafenib|sorafenib|mesh-list
138952533|NCT00378703|Temsirolimus|temsirolimus|mesh-list
138952534|NCT00378703|MTOR Inhibitors|mtor inhibitors|mesh-list
138952535|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
138952536|NCT00378703|Antibodies|antibodies|mesh-list
138952537|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
138952538|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138952539|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
138952540|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952541|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138952542|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138952543|NCT00378703|Growth Substances|growth substances|mesh-ancestor
138952544|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952545|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
138952546|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
138952547|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138952548|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952549|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952551|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138952552|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138952553|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
138952554|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138952555|NCT00893451|Vitamin D|vitamin d|mesh-list
138952556|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
138952557|NCT00893451|Vitamins|vitamins|mesh-ancestor
138952558|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
138952559|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952560|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138952561|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138952562|NCT00967408|Escitalopram|escitalopram|mesh-list
138952563|NCT00967408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138952564|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138952565|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138952566|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952567|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952568|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
138952569|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952570|NCT00891423|Meropenem|meropenem|mesh-list
138952571|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138952572|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138952574|NCT04035382|Oxytocin|oxytocin|mesh-list
138952575|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
138952576|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138952577|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952578|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138952579|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
138952580|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138952581|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138952582|NCT02541045|Metadoxine|metadoxine|mesh-list
138952583|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138952584|NCT00891579|Pemetrexed|pemetrexed|mesh-list
138952585|NCT00891579|Gefitinib|gefitinib|mesh-list
138952586|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952587|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506993|NCT00053950|NSC 366140|nsc 366140|mesh-list
138952588|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952589|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138952590|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138952591|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138952592|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
138952593|NCT00968734|Vitamin D|vitamin d|mesh-list
138952594|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138952595|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952596|NCT00968734|Vitamins|vitamins|mesh-ancestor
138952597|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
138952598|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138952599|NCT03620643|Fulvestrant|fulvestrant|mesh-list
138952600|NCT03620643|Crizotinib|crizotinib|mesh-list
138952601|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138952602|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952603|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138952604|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138952605|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
138952606|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952607|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952608|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138952609|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952610|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952612|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
138952613|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138952614|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
138952615|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
138952616|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
138475568|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
138475569|NCT04221087|Dexamethasone|dexamethasone|mesh-list
138952617|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952618|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952619|NCT00893607|Methoxamine|methoxamine|mesh-list
138952620|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
138952621|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
138952622|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952623|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952624|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138952625|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138952626|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138952627|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138952628|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
138952629|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952630|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952632|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952633|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
138952634|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
138952635|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
138952636|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952637|NCT05008354|Pyridoxine|pyridoxine|mesh-list
138952638|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
138952639|NCT05008354|Vitamins|vitamins|mesh-ancestor
138952640|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
138507225|NCT00055822|Antidotes|antidotes|mesh-ancestor
138952641|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952642|NCT00975754|Budesonide|budesonide|mesh-list
138952643|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138952644|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138952645|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
138952646|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952647|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952648|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138952649|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
138952650|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
138952651|NCT00975754|Hormones|hormones|mesh-ancestor
138952652|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952653|NCT01045681|Dexamethasone|dexamethasone|mesh-list
138952654|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
138952655|NCT01045681|Bortezomib|bortezomib|mesh-list
138952656|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138952657|NCT01045681|BB 1101|bb 1101|mesh-list
138952658|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138952659|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
138952660|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
138952661|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952662|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952663|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138952664|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
138952665|NCT01045681|Hormones|hormones|mesh-ancestor
138952666|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138644159|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952667|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138475597|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138952668|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952669|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
138952670|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952671|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952672|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138952673|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
138952675|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
138952676|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
138952677|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138952678|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952679|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
138952680|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952681|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138952682|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138952683|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138952684|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138952685|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952687|NCT03617913|Fluorouracil|fluorouracil|mesh-list
138952688|NCT03617913|Mitomycins|mitomycins|mesh-list
138952689|NCT03617913|Mitomycin|mitomycin|mesh-list
138952690|NCT03617913|Avelumab|avelumab|mesh-list
138952691|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138952692|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952693|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
138952694|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952695|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138952697|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
138952698|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952699|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138952700|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
138952701|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138952702|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952703|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138952704|NCT00975988|Lapatinib|lapatinib|mesh-list
138952705|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952706|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138952707|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952708|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952709|NCT00976066|Naltrexone|naltrexone|mesh-list
138952710|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138952711|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138475624|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
138952712|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952713|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
138952714|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952715|NCT00969592|Insulin|insulin|mesh-list
138952716|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138952717|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
138952718|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
138952719|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138952720|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
138952721|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138952722|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952723|NCT00368641|Icodextrin|icodextrin|mesh-list
138952724|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
138952725|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138952726|NCT00976222|Ranibizumab|ranibizumab|mesh-list
138952727|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138952728|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138952729|NCT00976222|Growth Substances|growth substances|mesh-ancestor
138952730|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952731|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
138952732|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952733|NCT00976300|Cyclosporine|cyclosporine|mesh-list
138952734|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
138952735|NCT00976300|Cyclosporins|cyclosporins|mesh-list
138952736|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138952737|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
138952738|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952739|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138507578|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
138952740|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138952741|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
138952742|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952743|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952744|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138952745|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952746|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
138952747|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138952748|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
138952749|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138952750|NCT00979966|Sirolimus|sirolimus|mesh-list
138952751|NCT00979966|Sunitinib|sunitinib|mesh-list
138952752|NCT00979966|Temsirolimus|temsirolimus|mesh-list
138952753|NCT00979966|MTOR Inhibitors|mtor inhibitors|mesh-list
138952754|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952755|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138507655|NCT00059761|Irinotecan|irinotecan|mesh-list
138952756|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138952757|NCT00979966|Growth Substances|growth substances|mesh-ancestor
138952758|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952759|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
138952760|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138952761|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952762|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952763|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138952765|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138952766|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138952767|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138952768|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
138952769|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
138952770|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138952771|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
138952772|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138952773|NCT00969904|Expectorants|expectorants|mesh-ancestor
138952774|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
138952775|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138952776|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
138952777|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952778|NCT00969904|Protective Agents|protective agents|mesh-ancestor
138644181|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952779|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952781|NCT00976690|Mesalamine|mesalamine|mesh-list
138952782|NCT00976690|Azathioprine|azathioprine|mesh-list
138952783|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
138952784|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952785|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138952786|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952787|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138952788|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
138952789|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952790|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138952791|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138952792|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138952793|NCT00976690|Analgesics|analgesics|mesh-ancestor
138952794|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
138952795|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952796|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138952797|NCT00976768|Fluorouracil|fluorouracil|mesh-list
138952798|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
138952799|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
138952800|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952801|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138952802|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952803|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138952804|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
138952805|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952806|NCT00608985|Zolpidem|zolpidem|mesh-list
138952807|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138952808|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138952809|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138952810|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952811|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138952813|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
138952814|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952815|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952816|NCT00969982|Misoprostol|misoprostol|mesh-list
138952817|NCT00969982|Mifepristone|mifepristone|mesh-list
138475690|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
138952818|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138952819|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
138952820|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138952821|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952823|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138952824|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
138952825|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138952826|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138952827|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138952828|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138952829|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
138952830|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138644209|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138952831|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138952832|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
138952833|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952834|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
138952835|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138952836|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138952837|NCT00970138|Apatinib|apatinib|mesh-list
138952838|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952839|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138952840|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952841|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952842|NCT00892125|Carbamazepine|carbamazepine|mesh-list
138952843|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138952844|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138952845|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138952846|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138508056|NCT06196606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138952847|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952849|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138952850|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138952851|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
138952852|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952853|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952854|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138952855|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138952856|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
138952857|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
138952858|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
138952859|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138952860|NCT00892125|Analgesics|analgesics|mesh-ancestor
138952861|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
138952862|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952863|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138952864|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138952865|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138952866|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138952868|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138952869|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952870|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138952871|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
138952872|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952873|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475706|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138475707|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138952874|NCT00368251|Brivaracetam|brivaracetam|mesh-list
138952875|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
138952876|NCT00893841|Pramipexole|pramipexole|mesh-list
138952877|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138952878|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
138952879|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138952880|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138952881|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138952882|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138952883|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952884|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
138952885|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952886|NCT00893841|Protective Agents|protective agents|mesh-ancestor
138952887|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138952888|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138952889|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
138952890|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
138952891|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952892|NCT00378079|Methadone|methadone|mesh-list
138952893|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138952894|NCT00378079|Narcotics|narcotics|mesh-ancestor
138952895|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138952896|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952897|NCT00378079|Analgesics|analgesics|mesh-ancestor
138952898|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
138952899|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952900|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
138952901|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
138952902|NCT00970450|Acetaminophen|acetaminophen|mesh-list
138952903|NCT00970450|Tropisetron|tropisetron|mesh-list
138952904|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138952905|NCT00970450|Analgesics|analgesics|mesh-ancestor
138952906|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
138952907|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952908|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952909|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
138952910|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
138952911|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
138952912|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138952913|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138952914|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138952915|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
138952916|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952917|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952919|NCT00970528|Voglibose|voglibose|mesh-list
138952920|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138952921|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952922|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952923|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138952924|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952925|NCT00970762|Rocuronium|rocuronium|mesh-list
138952926|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
138952927|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138952928|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138952929|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138952930|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952931|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952932|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138952933|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138952934|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
138952935|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138952936|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952937|NCT00978172|Artesunate|artesunate|mesh-list
138952938|NCT00978172|Mefloquine|mefloquine|mesh-list
138952939|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
138952940|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138952941|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138952942|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138952943|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952944|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
138952945|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
138952946|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138952947|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
138952948|NCT03923530|Eplerenone|eplerenone|mesh-list
138952949|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138952950|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
138952951|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952952|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952953|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138952954|NCT03923530|Diuretics|diuretics|mesh-ancestor
138952955|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
138952956|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138952957|NCT00608907|Rifampin|rifampin|mesh-list
138952958|NCT00608907|Dexamethasone|dexamethasone|mesh-list
138952959|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
138952960|NCT00608907|Bortezomib|bortezomib|mesh-list
138952961|NCT00608907|BB 1101|bb 1101|mesh-list
138952962|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138952963|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
138952964|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
138952965|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138952966|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138952967|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138952968|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
138952969|NCT00608907|Hormones|hormones|mesh-ancestor
138508386|NCT06045247|Prednisone|prednisone|mesh-list
138952970|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138952971|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138952972|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952973|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
138952974|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138952975|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138952976|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138952977|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
138952978|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138952979|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138952980|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
138952981|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138952982|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138952983|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138952984|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138952985|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138952986|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138952987|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138952988|NCT00970996|Interferons|interferons|mesh-list
138952989|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
138952990|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
138952991|NCT00970996|Paclitaxel|paclitaxel|mesh-list
138952992|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138952993|NCT00970996|Cisplatin|cisplatin|mesh-list
138952994|NCT00970996|Temozolomide|temozolomide|mesh-list
138952995|NCT00970996|Interleukin-2|interleukin-2|mesh-list
138952996|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138952997|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138952998|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
138952999|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
138953000|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
138953001|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604960|NCT02903485|Anesthetics|anesthetics|mesh-list
138953003|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953004|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138953005|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
138953006|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
138953007|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953008|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138953009|NCT00970996|Analgesics|analgesics|mesh-ancestor
138953010|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
138953011|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953012|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
138953013|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138953014|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953015|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
138953016|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953017|NCT00869193|Protective Agents|protective agents|mesh-ancestor
138953018|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953019|NCT04009018|Anesthetics|anesthetics|mesh-list
138953020|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138953021|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953022|NCT00869271|Leucovorin|leucovorin|mesh-list
138953023|NCT00869271|Fluorouracil|fluorouracil|mesh-list
138953024|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
138953025|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
138953026|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953027|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138953028|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953029|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138953030|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
138953031|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953032|NCT00869271|Antidotes|antidotes|mesh-ancestor
138953033|NCT00869271|Protective Agents|protective agents|mesh-ancestor
138953034|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
138953035|NCT00869271|Vitamins|vitamins|mesh-ancestor
138953036|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
138953037|NCT00971074|Hylan|hylan|mesh-list
138953038|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
138953039|NCT00971074|Protective Agents|protective agents|mesh-ancestor
138953040|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953041|NCT00971152|Menotropins|menotropins|mesh-list
138953042|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138953043|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
138953044|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138953045|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953046|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
138953047|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138953048|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475758|NCT03289039|Fulvestrant|fulvestrant|mesh-list
138953049|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138953050|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
138953051|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138508674|NCT05657652|Antimetabolites|antimetabolites|mesh-ancestor
138508675|NCT05657652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508687|NCT05642026|Ropivacaine|ropivacaine|mesh-list
138953052|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953053|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953054|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953055|NCT00978328|Oxycodone|oxycodone|mesh-list
138953056|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138953057|NCT00978328|Narcotics|narcotics|mesh-ancestor
138953058|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138953059|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953060|NCT00978328|Analgesics|analgesics|mesh-ancestor
138953061|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
138953062|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953063|NCT00892359|Anidulafungin|anidulafungin|mesh-list
138953064|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
138953065|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953066|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138953068|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138953069|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138953070|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953071|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138953072|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138953073|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138953074|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
138953075|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953076|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508801|NCT05465174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953077|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138953078|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138953079|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
138953080|NCT03992911|Carboplatin|carboplatin|mesh-list
138953081|NCT03992911|Etoposide|etoposide|mesh-list
138953082|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
138953083|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953084|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138953085|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138953086|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138953087|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953088|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953089|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
138953090|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138953091|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
138953092|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953093|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953094|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138953095|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
138953096|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138953097|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138953098|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138953099|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
138953100|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953101|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953102|NCT00377455|Bosentan|bosentan|mesh-list
138953103|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138953104|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138953105|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953106|NCT00895557|Varenicline|varenicline|mesh-list
138953107|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138953108|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138953109|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
138953110|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953111|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953112|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953113|NCT00869973|Dexamethasone|dexamethasone|mesh-list
138953114|NCT00869973|Aprepitant|aprepitant|mesh-list
138953115|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138953116|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
138953117|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
138953118|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953119|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953120|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138953121|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
138953122|NCT00869973|Hormones|hormones|mesh-ancestor
138953123|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138953124|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138953126|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138953127|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953128|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953129|NCT04008784|Triamcinolone|triamcinolone|mesh-list
138953130|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138953131|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138953132|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138953133|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138953134|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
138953135|NCT04008784|Hormones|hormones|mesh-ancestor
138228415|NCT00982592|Protective Agents|protective agents|mesh-ancestor
138953136|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138953137|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953138|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138953139|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
138953140|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953141|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953142|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
138953143|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138953144|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138953145|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138508964|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
138953146|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138953147|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953148|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
138953149|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953150|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953151|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138953152|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953154|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
138953155|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953156|NCT00978718|Protective Agents|protective agents|mesh-ancestor
138953157|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953158|NCT00978718|Trace Elements|trace elements|mesh-ancestor
138953159|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
138953160|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
138953161|NCT00895713|Antibodies|antibodies|mesh-list
138953162|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
138953163|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138953164|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138953165|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
138953166|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953167|NCT01051765|Irinotecan|irinotecan|mesh-list
138953168|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953169|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138953170|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138953171|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953172|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953173|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138953174|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138953175|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953176|NCT00978796|Incretins|incretins|mesh-ancestor
138953177|NCT00978796|Hormones|hormones|mesh-ancestor
138953178|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138953179|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138953180|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
138953181|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953182|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953183|NCT00894231|Levocetirizine|levocetirizine|mesh-list
138953184|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138953185|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138953186|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
138953187|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
138953188|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953189|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953190|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953191|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138475821|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
138953192|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
138953193|NCT03472365|Capecitabine|capecitabine|mesh-list
138953195|NCT03472365|Apatinib|apatinib|mesh-list
138953196|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138953197|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
138953198|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953199|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953200|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138953201|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953202|NCT00894621|Norepinephrine|norepinephrine|mesh-list
138953203|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138953204|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138953205|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
138953206|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953207|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953208|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953210|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
138953211|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953212|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138953213|NCT00376675|Methylphenidate|methylphenidate|mesh-list
138953214|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138953215|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953216|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138953217|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138953218|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138953219|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953220|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
138953221|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953222|NCT00979186|Hemostatics|hemostatics|mesh-list
138953223|NCT00979186|Coagulants|coagulants|mesh-ancestor
138953224|NCT05178628|Paclitaxel|paclitaxel|mesh-list
138953225|NCT05178628|Gemcitabine|gemcitabine|mesh-list
138953226|NCT05178628|Tinzaparin|tinzaparin|mesh-list
138953227|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138953228|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953229|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
138953230|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
138953231|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
138953232|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953233|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138953234|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
138953235|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
138953236|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138953237|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138953238|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138953239|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138953240|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138953241|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138953242|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
138953243|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138953244|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953245|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138953246|NCT00896571|Estrogens|estrogens|mesh-ancestor
138953247|NCT00896571|Hormones|hormones|mesh-ancestor
138953248|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138953249|NCT00896727|Antibodies|antibodies|mesh-list
138953250|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
138475853|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
138475854|NCT02332980|Idelalisib|idelalisib|mesh-list
138475860|NCT02087826|Metformin|metformin|mesh-list
138953251|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953252|NCT00981838|Rituximab|rituximab|mesh-list
138953253|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138953254|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953255|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
138953256|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953257|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138953258|NCT02533765|Olaparib|olaparib|mesh-list
138953259|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138509226|NCT04713098|Coal Tar|coal tar|mesh-list
138953260|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953261|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953262|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953263|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138953264|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953265|NCT00367237|Infliximab|infliximab|mesh-list
138953266|NCT00367237|Methotrexate|methotrexate|mesh-list
138953267|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138953268|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
138953269|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138953270|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953271|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138953272|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
138953273|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953274|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953275|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
138953276|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953277|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138953278|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138953279|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
138953280|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138953281|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138953282|NCT00367237|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138953283|NCT00367237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138953284|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138953286|NCT00901407|Paroxetine|paroxetine|mesh-list
138953287|NCT00901407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138953288|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138953289|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138953290|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953291|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953292|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
138953293|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509430|NCT04310007|Paclitaxel|paclitaxel|mesh-list
138953294|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138953295|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
138953296|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138953297|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138953298|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138953299|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953300|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
138953301|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138953302|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138953303|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138953304|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138953305|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138953306|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138953307|NCT00984724|Nicotine|nicotine|mesh-list
138953308|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138953309|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
138953310|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953311|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953312|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138953313|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138953314|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
138953315|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953316|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953317|NCT00901719|Nitroprusside|nitroprusside|mesh-list
138953318|NCT00901719|Acetylcholine|acetylcholine|mesh-list
138644334|NCT00315549|Penicillins|penicillins|mesh-list
138953319|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138953320|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
138953321|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138953322|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953323|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138953324|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
138953325|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953326|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953327|NCT00972712|Bortezomib|bortezomib|mesh-list
138953328|NCT00972712|Tipifarnib|tipifarnib|mesh-list
138953329|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953330|NCT02539641|Hormones|hormones|mesh-list
138953331|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138953332|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509587|NCT04167033|Hormones|hormones|mesh-list
138953333|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138953334|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138953335|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138953336|NCT00544882|Desogestrel|desogestrel|mesh-list
138953337|NCT00544882|Oviol|oviol|mesh-list
138953338|NCT00544882|Estradiol|estradiol|mesh-list
138953339|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138953340|NCT00544882|Estrogens|estrogens|mesh-ancestor
138953341|NCT00544882|Hormones|hormones|mesh-ancestor
138509650|NCT03984448|Venetoclax|venetoclax|mesh-list
138953342|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138953343|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953344|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138953345|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
138953346|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138953347|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138953348|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138953349|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138953350|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138953351|NCT00544882|Progestins|progestins|mesh-ancestor
138953352|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138953353|NCT04035603|Cycloserine|cycloserine|mesh-list
138509716|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138509717|NCT03875287|Decitabine|decitabine|mesh-list
138509718|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138509719|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
138509720|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138509721|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953354|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138953355|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953356|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138953357|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
138953358|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138953359|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
138953360|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953361|NCT00606801|Galantamine|galantamine|mesh-list
138953362|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138953363|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953364|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953365|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
138953366|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953367|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138509793|NCT03671018|Rituximab|rituximab|mesh-list
138953368|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138953369|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
138953370|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953371|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
138953372|NCT00972790|Bupivacaine|bupivacaine|mesh-list
138953373|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
138953374|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
138605336|NCT04692077|Tenofovir|tenofovir|mesh-list
138953375|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138953376|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953377|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
138953378|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953379|NCT00901875|Buprenorphine|buprenorphine|mesh-list
138953380|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138953381|NCT00901875|Naloxone|naloxone|mesh-list
138953382|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138953383|NCT00901875|Narcotics|narcotics|mesh-ancestor
138953384|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138953385|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953386|NCT00901875|Analgesics|analgesics|mesh-ancestor
138953387|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
138953388|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953389|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138953391|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
138953392|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
138953393|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
138953394|NCT00606177|Aripiprazole|aripiprazole|mesh-list
138953395|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
138953396|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138953397|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138953398|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138953399|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138953400|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953401|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
138953402|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
138953403|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953404|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953405|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138475907|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
138953406|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138953407|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
138953408|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138953409|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138953410|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138953411|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138953412|NCT00985270|Rifampin|rifampin|mesh-list
138953413|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138953414|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
138953415|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138953416|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953418|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138953419|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953420|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953421|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138953422|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138953423|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138953424|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138953425|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138953426|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138953428|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
138953429|NCT00359281|Atorvastatin|atorvastatin|mesh-list
138953430|NCT00359281|Simvastatin|simvastatin|mesh-list
138953431|NCT00359281|Ezetimibe|ezetimibe|mesh-list
138953432|NCT00359281|Fenofibrate|fenofibrate|mesh-list
138953433|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138953434|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138953435|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
138953436|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953437|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138953438|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138953439|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953440|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
138953441|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
138953442|NCT00359281|Vitamins|vitamins|mesh-ancestor
138953443|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
138953444|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953445|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
138953446|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
138953447|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138953448|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138953449|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953450|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138953452|NCT00902031|Senna Extract|senna extract|mesh-list
138953453|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
138953454|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138953455|NCT00902031|Laxatives|laxatives|mesh-ancestor
138953456|NCT00902031|Cathartics|cathartics|mesh-ancestor
138953457|NCT00985348|Levetiracetam|levetiracetam|mesh-list
138953458|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
138953459|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
138953460|NCT00973336|Vitamin D|vitamin d|mesh-list
138953461|NCT00973336|Calcium|calcium|mesh-list
138953462|NCT00973336|Vitamins|vitamins|mesh-ancestor
138953463|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
138953464|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953465|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138953466|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138953467|NCT00902187|Fesoterodine|fesoterodine|mesh-list
138953468|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138953469|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138953470|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
138953471|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953472|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953473|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953474|NCT00902187|Urological Agents|urological agents|mesh-ancestor
138953476|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138953477|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
138953478|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953479|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138953480|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
138953481|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
138953482|NCT01052311|Vitamins|vitamins|mesh-ancestor
138953483|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
138953484|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953485|NCT00988078|Metformin|metformin|mesh-list
138953486|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138953487|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953488|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
138953489|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
138953490|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138953491|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138953492|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953493|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138953494|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138953495|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953496|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953497|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953498|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138953499|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
138953500|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138953501|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953502|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138953503|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138953504|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138953505|NCT00982540|Caspofungin|caspofungin|mesh-list
138953506|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
138953507|NCT00982540|Clotrimazole|clotrimazole|mesh-list
138953508|NCT00982540|Miconazole|miconazole|mesh-list
138953509|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953510|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953511|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953512|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138953513|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138953514|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138953515|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138953516|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
138953517|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138953518|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953519|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138953520|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138953521|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138953522|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138953523|NCT00366535|Neurotropin|neurotropin|mesh-list
138953524|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138953525|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
138953526|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953527|NCT00366535|Analgesics|analgesics|mesh-ancestor
138953528|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
138953529|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953530|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
138953531|NCT00982618|Lidocaine|lidocaine|mesh-list
138953532|NCT00982618|Morphine|morphine|mesh-list
138953533|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
138953534|NCT00982618|Anesthetics|anesthetics|mesh-list
138953535|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138953536|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953537|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
138953538|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953539|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138953540|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138953541|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138953542|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138953543|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953544|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138953545|NCT00982618|Narcotics|narcotics|mesh-ancestor
138953546|NCT00982618|Analgesics|analgesics|mesh-ancestor
138953547|NCT00895167|Curcumin|curcumin|mesh-list
138953548|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138953549|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138953550|NCT00895167|Analgesics|analgesics|mesh-ancestor
138953551|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
138953552|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953553|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953554|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138953555|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138953556|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953557|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138510492|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138953558|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953559|NCT00902421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138953560|NCT00902421|Serotonin|serotonin|mesh-list
138953561|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
138953562|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138953563|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138953564|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953565|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953566|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
138953567|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953568|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138953569|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138953570|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
138953571|NCT00985660|Nisoldipine|nisoldipine|mesh-list
138953572|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138953573|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138953574|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138953575|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953576|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138953577|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953578|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
138953579|NCT00350545|Cyclosporine|cyclosporine|mesh-list
138953580|NCT00350545|Prednisone|prednisone|mesh-list
138953581|NCT00350545|Rituximab|rituximab|mesh-list
138953582|NCT00350545|Tacrolimus|tacrolimus|mesh-list
138953583|NCT00350545|Cyclosporins|cyclosporins|mesh-list
138953584|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138953585|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953586|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
138953587|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953588|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138953589|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138953590|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
138953591|NCT00350545|Hormones|hormones|mesh-ancestor
138510560|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138953592|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138953593|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138953594|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138953595|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138953596|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953597|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953598|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
138605563|NCT03535298|Analgesics|analgesics|mesh-ancestor
138953599|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953600|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
138953601|NCT04006054|Midazolam|midazolam|mesh-list
138953602|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
138953603|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138476011|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138953604|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138510611|NCT00389909|Doxapram|doxapram|mesh-list
138953605|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953606|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138953607|NCT04006054|Analgesics|analgesics|mesh-ancestor
138953608|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
138953609|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953610|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138953611|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138953612|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138953613|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
138953614|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953615|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953616|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138953617|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138953618|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138953619|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138644411|NCT00315861|Pemetrexed|pemetrexed|mesh-list
138953620|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138953621|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
138953622|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
138953623|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
138953624|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
138953625|NCT00897975|Red yeast rice|red yeast rice|mesh-list
138953626|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138953627|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138953628|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138953629|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
138953630|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953631|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953632|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138953633|NCT01052389|Haloperidol|haloperidol|mesh-list
138953634|NCT01052389|Olanzapine|olanzapine|mesh-list
138953635|NCT01052389|Aripiprazole|aripiprazole|mesh-list
138953636|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
138953637|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
138953638|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
138953639|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953640|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953641|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138953642|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138953643|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138953644|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138953645|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138953646|NCT01052389|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138953647|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138953648|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138953649|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953650|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953651|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
138953652|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
138953653|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
138953654|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
138953655|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138953656|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138953657|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138953658|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138953659|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138953660|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138953661|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138953663|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138953664|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138953665|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
138953666|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953668|NCT00349921|Clonidine|clonidine|mesh-list
138953669|NCT00349921|Analgesics|analgesics|mesh-ancestor
138953670|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
138953671|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953672|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953673|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138953674|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
138953675|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
138953676|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138953677|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138953678|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138953679|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
138953680|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953681|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953682|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138953683|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
138953684|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138953685|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
138953686|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
138953687|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138953688|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
138953689|NCT00902655|Coagulants|coagulants|mesh-ancestor
138953690|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138953691|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
138953692|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953694|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138953695|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138953697|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138953698|NCT01052623|Hormones|hormones|mesh-ancestor
138953699|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138510823|NCT00066274|Leucovorin|leucovorin|mesh-list
138953700|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953701|NCT01052623|Estrogens|estrogens|mesh-ancestor
138953702|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138953703|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
138953704|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138953705|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138953706|NCT01052623|Analgesics|analgesics|mesh-ancestor
138953707|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
138953708|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953709|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138953710|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
138953711|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
138953712|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138953713|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138953714|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138953715|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
138953716|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953717|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953718|NCT00902811|Artesunate|artesunate|mesh-list
138953719|NCT00902811|Amodiaquine|amodiaquine|mesh-list
138953720|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
138953721|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138953722|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138953723|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953724|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953725|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
138953726|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
138953727|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138953728|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
138953729|NCT00898287|Gemcitabine|gemcitabine|mesh-list
138953730|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138953731|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
138953732|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953733|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953735|NCT04034823|Trastuzumab|trastuzumab|mesh-list
138953736|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953737|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
138953738|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
138953739|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
138953740|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953741|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138953742|NCT00606021|Pemetrexed|pemetrexed|mesh-list
138953743|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953744|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953745|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953746|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138605716|NCT00799864|Emtricitabine|emtricitabine|mesh-list
138953747|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138953748|NCT00337675|Montelukast|montelukast|mesh-list
138953749|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138953750|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
138953751|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138953752|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
138953753|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138953754|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953755|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138953756|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138510984|NCT02967094|Expectorants|expectorants|mesh-list
138953757|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953759|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138953760|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138953761|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
138953762|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953763|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138953764|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138953765|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953766|NCT00903045|Propiverine|propiverine|mesh-list
138953767|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
138953768|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
138953769|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953770|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953771|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138953772|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138953773|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
138953774|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953775|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953776|NCT00903045|Urological Agents|urological agents|mesh-ancestor
138953777|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138953778|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138953779|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953780|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138953781|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138953782|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138953783|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953784|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
138953785|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953786|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
138953787|NCT04035525|Ubiquinone|ubiquinone|mesh-list
138953788|NCT04035525|Vitamins|vitamins|mesh-ancestor
138953789|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
138953790|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511106|NCT00399061|Cyclosporine|cyclosporine|mesh-list
138953791|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138953792|NCT00905853|Amiodarone|amiodarone|mesh-list
138953793|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
138953794|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138953795|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138953796|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953797|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138953798|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138953799|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138953800|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953801|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138953802|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138953803|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138953805|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138953806|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
138953807|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953808|NCT00905931|Protective Agents|protective agents|mesh-ancestor
138953809|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953810|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138953811|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138953812|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953813|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
138953814|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138953815|NCT04035135|Antibodies|antibodies|mesh-list
138953816|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
138953817|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138953818|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
138953819|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953820|NCT00903279|Retapamulin|retapamulin|mesh-list
138605789|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
138953821|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138953822|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953823|NCT02539017|Immunomodulating Agents|immunomodulating agents|mesh-list
138953824|NCT02539017|Immunologic Factors|immunologic factors|mesh-ancestor
138953825|NCT02539017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953827|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
138953828|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138953829|NCT00605865|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138953830|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138953831|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138953832|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953833|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953834|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
138953835|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138511281|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138953837|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138953838|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138953839|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138953840|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
138953841|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953842|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953843|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953844|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
138953845|NCT00903747|Prucalopride|prucalopride|mesh-list
138953846|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138953847|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953848|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138953849|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138953850|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953851|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953852|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953853|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953854|NCT00903747|Laxatives|laxatives|mesh-ancestor
138953855|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138953856|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138953857|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138953858|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
138953859|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138953860|NCT02538627|Trametinib|trametinib|mesh-list
138953861|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953862|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138953863|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953864|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953865|NCT00903825|Lidocaine|lidocaine|mesh-list
138953866|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
138953867|NCT00903825|Anesthetics|anesthetics|mesh-list
138953868|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138953869|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953870|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
138953871|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953872|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138953873|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138953874|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138953875|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138229165|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138953876|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953877|NCT00904059|Asunaprevir|asunaprevir|mesh-list
138953878|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
138953879|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953880|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953881|NCT00337207|Bevacizumab|bevacizumab|mesh-list
138953882|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138953883|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953884|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138953885|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138953886|NCT00337207|Growth Substances|growth substances|mesh-ancestor
138953887|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953888|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
138953889|NCT01055743|Fluorouracil|fluorouracil|mesh-list
138953890|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
138953891|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953892|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138953893|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953894|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138953895|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
138953896|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953897|NCT00604695|Tenecteplase|tenecteplase|mesh-list
138511419|NCT00071968|Sirolimus|sirolimus|mesh-list
138953898|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138953899|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138953900|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953901|NCT01055821|Interferons|interferons|mesh-list
138953902|NCT01055821|Ribavirin|ribavirin|mesh-list
138953903|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953904|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
138953905|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953906|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
138953907|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953908|NCT00904293|Warfarin|warfarin|mesh-list
138953909|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
138953910|NCT00904449|Oxymorphone|oxymorphone|mesh-list
138953911|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138953912|NCT00904449|Narcotics|narcotics|mesh-ancestor
138953913|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138953914|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953915|NCT00904449|Analgesics|analgesics|mesh-ancestor
138953916|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
138953917|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953918|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138953919|NCT00348595|Lenalidomide|lenalidomide|mesh-list
138953920|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
138953921|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953922|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138953923|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138953924|NCT00348595|Growth Substances|growth substances|mesh-ancestor
138953925|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
138953926|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953927|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
138953928|NCT02538939|Antidotes|antidotes|mesh-ancestor
138953929|NCT02538939|Protective Agents|protective agents|mesh-ancestor
138953930|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953931|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
138953932|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953933|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
138953935|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953936|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
138953937|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
138953938|NCT00904605|Celecoxib|celecoxib|mesh-list
138953939|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138953940|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138953941|NCT00904605|Analgesics|analgesics|mesh-ancestor
138953942|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
138953943|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138953944|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953945|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138953946|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138953947|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138953948|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138953949|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953950|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953953|NCT00905073|Cyclosporins|cyclosporins|mesh-list
138953954|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138511683|NCT00072943|Antibodies|antibodies|mesh-list
138953955|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
138953956|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138953957|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953958|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138953959|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
138953960|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953961|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953962|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
138953963|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953964|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138953965|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138953966|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
138953967|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138953968|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138953969|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
138953970|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138953971|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138953972|NCT00905229|Vitamins|vitamins|mesh-list
138953973|NCT00905229|Vitamin K|vitamin k|mesh-list
138953974|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
138953975|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
138953976|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953977|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138953978|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138953979|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953980|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
138953981|NCT00905229|Coagulants|coagulants|mesh-ancestor
138953982|NCT00905541|Simvastatin|simvastatin|mesh-list
138953983|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138953984|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138953985|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
138711069|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138953986|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138953987|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138644485|NCT00279344|Analgesics|analgesics|mesh-ancestor
138511808|NCT00074191|Hormones|hormones|mesh-ancestor
138953988|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138953989|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138953990|NCT00348283|Adalimumab|adalimumab|mesh-list
138953991|NCT00348283|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138953992|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138953993|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138953994|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
138953995|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138953996|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138953997|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138953998|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
138953999|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138954000|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954001|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954002|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954004|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
138954005|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
138954006|NCT00336583|Etoposide|etoposide|mesh-list
138954007|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954008|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138954009|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138954010|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138954011|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954012|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954013|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138954014|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
138954015|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
138954016|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954017|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138954018|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
138954019|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954020|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138954021|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
138954022|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
138954023|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954024|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138954025|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
138954026|NCT00336583|Hormones|hormones|mesh-ancestor
138954027|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138954029|NCT00336583|Protective Agents|protective agents|mesh-ancestor
138954030|NCT00336505|Clarithromycin|clarithromycin|mesh-list
138954031|NCT00336505|Cethromycin|cethromycin|mesh-list
138954032|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138954033|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954034|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138954035|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954036|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511928|NCT04729595|Tempol|tempol|mesh-list
138954037|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138954038|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138954039|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
138954040|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138954041|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138954042|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954043|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
138606051|NCT02898961|Amikacin|amikacin|mesh-list
138954044|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
138954045|NCT03987529|Propofol|propofol|mesh-list
138954046|NCT03987529|Sevoflurane|sevoflurane|mesh-list
138954047|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138954048|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138954049|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954050|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138954051|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
138954052|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
138954053|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138954054|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138954055|NCT00335959|Capecitabine|capecitabine|mesh-list
138954056|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
138954057|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138954058|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
138954059|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954060|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954061|NCT01053169|Thrombin|thrombin|mesh-list
138954062|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
138954063|NCT01053169|Coagulants|coagulants|mesh-ancestor
138954064|NCT01059331|Pregabalin|pregabalin|mesh-list
138954065|NCT01059331|Analgesics|analgesics|mesh-ancestor
138954066|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
138954067|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954068|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954069|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
138954070|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138954071|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138954072|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954073|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138954074|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138954075|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138954076|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138954077|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138954078|NCT01059955|Dexamethasone|dexamethasone|mesh-list
138954079|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
138954080|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138954081|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138954082|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138954083|NCT01059955|BB 1101|bb 1101|mesh-list
138476200|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
138954084|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138954085|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
138954086|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
138954087|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476206|NCT02011191|Biotin|biotin|mesh-list
138188619|NCT03106870|Insulin|insulin|mesh-list
138954088|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954089|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138954090|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
138954091|NCT01059955|Hormones|hormones|mesh-ancestor
138954092|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138954093|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138954094|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954095|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
138954096|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954097|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954098|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
138954099|NCT01060189|Urinastatin|urinastatin|mesh-list
138954100|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138954101|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138954102|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954103|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
138954104|NCT01060189|Coagulants|coagulants|mesh-ancestor
138954105|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138954106|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138954107|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
138954108|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954109|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138954110|NCT01060267|Erythromycin|erythromycin|mesh-list
138954112|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138954113|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
138954114|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954115|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138954116|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138954117|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954118|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606093|NCT00408174|Analgesics|analgesics|mesh-ancestor
138954119|NCT01060423|Irinotecan|irinotecan|mesh-list
138954120|NCT01060423|Cetuximab|cetuximab|mesh-list
138954121|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138954122|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138954123|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954124|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954125|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954126|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138954127|NCT01060501|Leucovorin|leucovorin|mesh-list
138954129|NCT01060501|Interferons|interferons|mesh-list
138954130|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
138476225|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
138954131|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
138954132|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954133|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
138954134|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954135|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
138954136|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954137|NCT01060501|Antidotes|antidotes|mesh-ancestor
138954138|NCT01060501|Protective Agents|protective agents|mesh-ancestor
138954139|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
138954140|NCT01060501|Vitamins|vitamins|mesh-ancestor
138954141|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
138954142|NCT01060501|Hematinics|hematinics|mesh-ancestor
138954143|NCT00671658|Cytarabine|cytarabine|mesh-list
138954144|NCT00671658|Dexamethasone|dexamethasone|mesh-list
138954145|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
138954146|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138954147|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138954148|NCT00671658|Prednisolone|prednisolone|mesh-list
138954149|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
138954150|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
138954152|NCT00671658|Doxorubicin|doxorubicin|mesh-list
138954153|NCT00671658|Methotrexate|methotrexate|mesh-list
138954154|NCT00671658|Vincristine|vincristine|mesh-list
138954155|NCT00671658|Asparaginase|asparaginase|mesh-list
138954156|NCT00671658|Pegaspargase|pegaspargase|mesh-list
138954157|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138954158|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
138954159|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138954160|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
138954161|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954162|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138954163|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138954164|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
138954165|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954166|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954167|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138954168|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138954169|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
138954170|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
138954171|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954172|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138954173|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
138954174|NCT00671658|Hormones|hormones|mesh-ancestor
138954175|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138954176|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138954177|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138954178|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138954179|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138954180|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138954181|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954182|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138954183|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
138954184|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138954185|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138954186|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
138954187|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
138954188|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138954189|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138954190|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
138954191|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954192|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138954193|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
138954194|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
138954195|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
138954196|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138954197|NCT00671658|Protective Agents|protective agents|mesh-ancestor
138954198|NCT00764712|Insulin|insulin|mesh-list
138954199|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138954200|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954201|NCT00768456|Ropivacaine|ropivacaine|mesh-list
138954202|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
138954203|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
138954204|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138954205|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954206|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
138954207|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954208|NCT00768612|Risperidone|risperidone|mesh-list
138954210|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
138954211|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954212|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954213|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954214|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138954215|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138954216|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138954217|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138954218|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138954219|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
138954220|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
138954221|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954222|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954223|NCT04048200|Fentanyl|fentanyl|mesh-list
138954224|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
138954225|NCT04048200|Ketamine|ketamine|mesh-list
138954226|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
138954227|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138954228|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138954229|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954230|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138954231|NCT04048200|Analgesics|analgesics|mesh-ancestor
138954232|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
138954233|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138512774|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
138954234|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138954235|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138954236|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138954237|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
138954238|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954239|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954240|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138954241|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138954242|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
138954243|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
138512823|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
138954244|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138954245|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138954246|NCT04048200|Narcotics|narcotics|mesh-ancestor
138954247|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138954248|NCT04034589|Fulvestrant|fulvestrant|mesh-list
138954249|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138954250|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954251|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138954252|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138954253|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
138524879|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954254|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138954255|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954256|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138954257|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
138525025|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
138954258|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954259|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
138954261|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
138954262|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954263|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525172|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
138954264|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138954265|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138954266|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
138954267|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138954268|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138954269|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
138954270|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138525388|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138954271|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954273|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
138954274|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954275|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138954276|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138954277|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954278|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644556|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954279|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138954280|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
138954281|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138954282|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954283|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138954285|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
138954286|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954287|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954288|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954289|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138954291|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
138954292|NCT00775086|Estradiol|estradiol|mesh-list
138954293|NCT00775086|Estrogens|estrogens|mesh-ancestor
138526221|NCT00025688|Paclitaxel|paclitaxel|mesh-list
138954294|NCT00775086|Hormones|hormones|mesh-ancestor
138526279|NCT00053976|Prednisolone|prednisolone|mesh-list
138954295|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138954296|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954297|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138476359|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138526502|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954298|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138954299|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138954300|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138954301|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138954302|NCT02557854|Doxorubicin|doxorubicin|mesh-list
138954303|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138954304|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138954305|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954306|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138954307|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138526958|NCT00028847|Cytarabine|cytarabine|mesh-list
138954308|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954309|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954310|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
138954312|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
138954313|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138527170|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
138954314|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954315|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
138954316|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954317|NCT00986050|Sirolimus|sirolimus|mesh-list
138954319|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138954320|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954321|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138954322|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954323|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
138954324|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138954325|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
138954326|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954327|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
138954328|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138954329|NCT00986128|Topiramate|topiramate|mesh-list
138513210|NCT03151434|Hydromorphone|hydromorphone|mesh-list
138954330|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
138954331|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138954332|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954333|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
138954334|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138954335|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
138954336|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954337|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954338|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138954339|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
138954340|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138954342|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954343|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954344|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138954345|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
138954346|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
138954347|NCT00771342|Protective Agents|protective agents|mesh-ancestor
138954348|NCT00775164|Metformin|metformin|mesh-list
138954349|NCT00775164|Pioglitazone|pioglitazone|mesh-list
138954350|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138527390|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954351|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954352|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
138954353|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138954354|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138954355|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
138954356|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954358|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
138954359|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138954360|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
138954361|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
138527647|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
138954362|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954363|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954364|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138954365|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
138954366|NCT04767256|Hormones|hormones|mesh-ancestor
138954367|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138954368|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138954369|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527867|NCT00059943|Docetaxel|docetaxel|mesh-list
138513376|NCT00136825|Expectorants|expectorants|mesh-ancestor
138954371|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138954372|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138954373|NCT04767256|Analgesics|analgesics|mesh-ancestor
138954374|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
138954375|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138528019|NCT00060645|Sirolimus|sirolimus|mesh-list
138954376|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138954377|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138954378|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
138954379|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954380|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954381|NCT00771498|Lopinavir|lopinavir|mesh-list
138954382|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138954383|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138954384|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
138476425|NCT02012322|Ubiquinone|ubiquinone|mesh-list
138954385|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954386|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954387|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138954388|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138954389|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
138954390|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954391|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138954392|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138954393|NCT00986284|Gefitinib|gefitinib|mesh-list
138954394|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954395|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138954396|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138513497|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954397|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954398|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138954399|NCT00988780|Efavirenz|efavirenz|mesh-list
138954400|NCT00988780|Maraviroc|maraviroc|mesh-list
138954401|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138954402|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138954403|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954404|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954405|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
138954406|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954407|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138954408|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138954409|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138954410|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138954411|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138528206|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954412|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138954413|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138954414|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138954415|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138954416|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138954417|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138476451|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
138476452|NCT02012465|Insulin|insulin|mesh-list
138476457|NCT02012517|Cefazolin|cefazolin|mesh-list
138954418|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138954419|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138606393|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
138954421|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138954422|NCT00775242|Estrogens|estrogens|mesh-list
138954423|NCT00775242|Progesterone|progesterone|mesh-list
138954424|NCT00775242|Progestins|progestins|mesh-list
138954425|NCT00775242|Hormones|hormones|mesh-ancestor
138954426|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138954427|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954428|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138954429|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
138954430|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138954431|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138954432|NCT00986518|Immunomodulating Agents|immunomodulating agents|mesh-list
138954433|NCT00986518|Immunologic Factors|immunologic factors|mesh-ancestor
138954434|NCT00986518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954435|NCT00769158|Topiramate|topiramate|mesh-list
138954436|NCT00769158|Naltrexone|naltrexone|mesh-list
138954437|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138954438|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138954439|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954440|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
138954441|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954442|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
138954443|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138954444|NCT00983164|Antioxidants|antioxidants|mesh-list
138528694|NCT00062556|Niacin|niacin|mesh-list
138954445|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954446|NCT00983164|Protective Agents|protective agents|mesh-ancestor
138954447|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954449|NCT00333775|Docetaxel|docetaxel|mesh-list
138513559|NCT00138541|Vildagliptin|vildagliptin|mesh-list
138954450|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138954452|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138954453|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138954454|NCT00333775|Growth Substances|growth substances|mesh-ancestor
138954455|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954456|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
138954457|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
138954458|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
138954459|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
138954460|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954461|NCT03860428|Acetaminophen|acetaminophen|mesh-list
138954462|NCT03860428|Ibuprofen|ibuprofen|mesh-list
138954463|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
138954464|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138954465|NCT03860428|Analgesics|analgesics|mesh-ancestor
138954466|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
138954467|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954468|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954469|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
138644592|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
138954470|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138476489|NCT02012920|Seviteronel|seviteronel|mesh-list
138954471|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138954473|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954474|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954476|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954477|NCT00605475|Metformin|metformin|mesh-list
138954478|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138954479|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954480|NCT00986596|Vitamin D|vitamin d|mesh-list
138954481|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
138954482|NCT00986596|Vitamins|vitamins|mesh-ancestor
138954483|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
138513627|NCT00138970|Daclizumab|daclizumab|mesh-list
138954484|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954485|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138954486|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138954487|NCT00769470|Carboplatin|carboplatin|mesh-list
138954488|NCT00769470|Docetaxel|docetaxel|mesh-list
138954489|NCT00769470|Trastuzumab|trastuzumab|mesh-list
138954490|NCT00769470|Lapatinib|lapatinib|mesh-list
138606467|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954491|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954492|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
138954493|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
138954494|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
138954495|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954496|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138954498|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954499|NCT00605319|Fesoterodine|fesoterodine|mesh-list
138954500|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138954501|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138954502|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
138954503|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138529313|NCT00069888|Docetaxel|docetaxel|mesh-list
138954504|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954505|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954506|NCT00605319|Urological Agents|urological agents|mesh-ancestor
138954507|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138954508|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
138954509|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138954510|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138954511|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138711070|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138954512|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138954513|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954514|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
138954515|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
138954516|NCT00908661|Coagulants|coagulants|mesh-ancestor
138954517|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
138954518|NCT00983398|Carboplatin|carboplatin|mesh-list
138954519|NCT00983398|Melphalan|melphalan|mesh-list
138954520|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
138954521|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138954522|NCT00983398|Mannitol|mannitol|mesh-list
138954523|NCT00983398|Antidotes|antidotes|mesh-list
138954524|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954525|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138954526|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
138954527|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954528|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138954529|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138513822|NCT03150459|Rifaximin|rifaximin|mesh-list
138954530|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
138954531|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954532|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138954534|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
138954535|NCT00983398|Protective Agents|protective agents|mesh-ancestor
138954536|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
138954537|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
138954538|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138954539|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529810|NCT00071097|Darunavir|darunavir|mesh-list
138954540|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
138954541|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
138954542|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
138954543|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138954544|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954545|NCT00769548|Goserelin|goserelin|mesh-list
138954546|NCT00769548|Flutamide|flutamide|mesh-list
138954547|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138954548|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954549|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
138954550|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
138530102|NCT00202696|Nalmefene|nalmefene|mesh-list
138954551|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138954552|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530181|NCT00203320|Etanercept|etanercept|mesh-list
138954553|NCT05277675|Bevacizumab|bevacizumab|mesh-list
138954554|NCT05277675|Tislelizumab|tislelizumab|mesh-list
138954555|NCT05277675|Lenvatinib|lenvatinib|mesh-list
138476541|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513874|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
138954556|NCT05277675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138954557|NCT05277675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954558|NCT05277675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138954559|NCT05277675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138954560|NCT05277675|Growth Substances|growth substances|mesh-ancestor
138954561|NCT05277675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954562|NCT05277675|Growth Inhibitors|growth inhibitors|mesh-ancestor
138954563|NCT05277675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138954564|NCT05277675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954565|NCT05277675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954566|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
138954568|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
138606535|NCT03014635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954569|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954570|NCT03984409|Expectorants|expectorants|mesh-ancestor
138954571|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
138954572|NCT00983554|Anastrozole|anastrozole|mesh-list
138954573|NCT00983554|Testosterone|testosterone|mesh-list
138954574|NCT00983554|Dutasteride|dutasteride|mesh-list
138954575|NCT00983554|Androgens|androgens|mesh-ancestor
138954576|NCT00983554|Hormones|hormones|mesh-ancestor
138954577|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138954578|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954579|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138954580|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954581|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138954582|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138513995|NCT00141193|Celecoxib|celecoxib|mesh-list
138954583|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530682|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138954584|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954585|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
138954586|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138954587|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138954589|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138954591|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138954592|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138954593|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138644614|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
138954594|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138954595|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954597|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
138954598|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138954599|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
138530957|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531027|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138954601|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138531100|NCT00068952|Temozolomide|temozolomide|mesh-list
138954602|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954603|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138954604|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
138954605|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954606|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954608|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
138954609|NCT00332839|Everolimus|everolimus|mesh-list
138954610|NCT00332839|Tacrolimus|tacrolimus|mesh-list
138954611|NCT00332839|Cyclosporins|cyclosporins|mesh-list
138954612|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138954613|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
138954614|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531537|NCT00210301|Modafinil|modafinil|mesh-list
138954615|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138531610|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
138954616|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954617|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954618|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
138954619|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954620|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
138954621|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138954622|NCT00332839|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138476640|NCT02013986|Midazolam|midazolam|mesh-list
138531755|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
138531827|NCT00212212|Protective Agents|protective agents|mesh-ancestor
138954623|NCT00332839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138954625|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138954626|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138954627|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
138954628|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138954629|NCT00927147|Cetuximab|cetuximab|mesh-list
138514301|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
138954630|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138954631|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954632|NCT05712616|Strontium ranelate|strontium ranelate|mesh-list
138954633|NCT05712616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138954634|NCT05712616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954635|NCT00927225|Ropivacaine|ropivacaine|mesh-list
138954636|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
138532181|NCT00215956|Topotecan|topotecan|mesh-list
138954637|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
138954638|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138954639|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954640|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
138954641|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954642|NCT00357097|Ropinirole|ropinirole|mesh-list
138954643|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138954644|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138954645|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
138954646|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
138954647|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532323|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
138532397|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
138954648|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954649|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514507|NCT00404794|Hormones|hormones|mesh-ancestor
138954651|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138954652|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
138532544|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138954653|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954654|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138954655|NCT00983944|Prednisone|prednisone|mesh-list
138954656|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
138954657|NCT00983944|Rituximab|rituximab|mesh-list
138954658|NCT00983944|Doxorubicin|doxorubicin|mesh-list
138954659|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138954661|NCT00983944|Vincristine|vincristine|mesh-list
138954662|NCT00983944|Bleomycin|bleomycin|mesh-list
138954663|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138954664|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
138954665|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532906|NCT00221026|Methoxsalen|methoxsalen|mesh-list
138954666|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138954667|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138532981|NCT00042887|Mitomycins|mitomycins|mesh-list
138954668|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
138954669|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954670|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954671|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138514637|NCT05461807|Rivaroxaban|rivaroxaban|mesh-list
138954672|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138476651|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138954673|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138954675|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138954676|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954677|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138954678|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
138954679|NCT00983944|Hormones|hormones|mesh-ancestor
138514703|NCT02985866|Pancrelipase|pancrelipase|mesh-list
138533330|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954680|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138954681|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138954682|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138954683|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
138954684|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
138954685|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
138954686|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138954687|NCT00927537|Telmisartan|telmisartan|mesh-list
138954688|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138954689|NCT00927537|Diuretics|diuretics|mesh-ancestor
138954690|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
138514787|NCT00393393|Hylan|hylan|mesh-list
138954691|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954692|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138954693|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138954694|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954695|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138954696|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138533843|NCT00043784|Enoxaparin|enoxaparin|mesh-list
138954698|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
138954699|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138954700|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954701|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138954702|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954703|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954704|NCT00909129|Interferons|interferons|mesh-list
138954705|NCT00909129|Ribavirin|ribavirin|mesh-list
138954706|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
138954707|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138514827|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
138954708|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954709|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
138954710|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954711|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
138954712|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954713|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
138534488|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
138954714|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514881|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
138954715|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138476670|NCT02013089|Gefitinib|gefitinib|mesh-list
138954716|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
138954717|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138954718|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138606680|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138954719|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954720|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138954721|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138954722|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138954724|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954725|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138954726|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
138954727|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954728|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954729|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138954730|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138534558|NCT00079170|Docetaxel|docetaxel|mesh-list
138954731|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138954732|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
138954733|NCT00927615|Abciximab|abciximab|mesh-list
138954734|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
138954735|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138954736|NCT03990103|Paclitaxel|paclitaxel|mesh-list
138534688|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
138954737|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138954739|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
138954741|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138954742|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954744|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
138954745|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
138954746|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954747|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138954748|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138954749|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138954750|NCT03990103|Growth Substances|growth substances|mesh-ancestor
138954751|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954752|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
138954753|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138954754|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
138954755|NCT00927693|Calcium|calcium|mesh-list
138535119|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954756|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138954757|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535262|NCT00131755|Diazoxide|diazoxide|mesh-list
138954759|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138954760|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954761|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954762|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
138954763|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954764|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954765|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
138954766|NCT01581151|Dexamethasone|dexamethasone|mesh-list
138954767|NCT01581151|Ranibizumab|ranibizumab|mesh-list
138711071|NCT04620954|Nivolumab|nivolumab|mesh-list
138476698|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
138954768|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138954769|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
138954770|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
138515210|NCT01466088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954771|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954772|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954773|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138954774|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
138954776|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138954777|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138954778|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535472|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
138954780|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138954781|NCT01581151|Growth Substances|growth substances|mesh-ancestor
138954782|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
138954783|NCT01053481|Vitamin D|vitamin d|mesh-list
138954784|NCT01053481|Vitamins|vitamins|mesh-ancestor
138954785|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
138954786|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954787|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138954788|NCT00927771|Azelaic acid|azelaic acid|mesh-list
138954789|NCT00927771|Hydroquinone|hydroquinone|mesh-list
138954790|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954791|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
138954792|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
138954793|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954794|NCT00927771|Protective Agents|protective agents|mesh-ancestor
138606751|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
138954795|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954796|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138954797|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
138954798|NCT01053559|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138954799|NCT01053559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138954800|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138536203|NCT00147355|Acetaminophen|acetaminophen|mesh-list
138954801|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
138954802|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954803|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138954804|NCT01053637|Acetaminophen|acetaminophen|mesh-list
138954805|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138954806|NCT01053637|Hydrocodone|hydrocodone|mesh-list
138954807|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138954808|NCT01053637|Analgesics|analgesics|mesh-ancestor
138954809|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
138954810|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954811|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954812|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
138954813|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138954814|NCT01053637|Narcotics|narcotics|mesh-ancestor
138954815|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138954816|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
138954817|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
138711072|NCT04620954|Oregovomab|oregovomab|mesh-list
138476720|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954818|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138954819|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138954820|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138954821|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
138954822|NCT00928161|Lansoprazole|lansoprazole|mesh-list
138954823|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138954824|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138536478|NCT00148447|Escitalopram|escitalopram|mesh-list
138954825|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138954826|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515528|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954827|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954828|NCT00909519|Naproxen|naproxen|mesh-list
138954829|NCT00909519|Furosemide|furosemide|mesh-list
138954830|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
138954831|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138954832|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138954833|NCT00909519|Analgesics|analgesics|mesh-ancestor
138954834|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
138515594|NCT00847860|Analgesics|analgesics|mesh-ancestor
138954835|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954836|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954837|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138954838|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138954839|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
138954840|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138954841|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954842|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954843|NCT00909519|Diuretics|diuretics|mesh-ancestor
138954844|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
138954845|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138954846|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138954847|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138954848|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138954849|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138515663|NCT00011804|Topiramate|topiramate|mesh-list
138954850|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138954852|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954853|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138954854|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138954855|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954856|NCT00907179|Pemetrexed|pemetrexed|mesh-list
138954857|NCT00907179|Panobinostat|panobinostat|mesh-list
138954858|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476746|NCT02014545|Lucanthone|lucanthone|mesh-list
138954859|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138954860|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954862|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138954863|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138954864|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
138954865|NCT00544648|Paclitaxel|paclitaxel|mesh-list
138954866|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138954867|NCT00544648|Carboplatin|carboplatin|mesh-list
138536740|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
138954868|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138954869|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954870|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
138954871|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
138606826|NCT00171665|Analgesics|analgesics|mesh-ancestor
138954872|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
138954873|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954874|NCT01053871|Midazolam|midazolam|mesh-list
138954875|NCT01053871|Fentanyl|fentanyl|mesh-list
138954876|NCT01053871|Propofol|propofol|mesh-list
138954877|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138954878|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138954879|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954880|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138954881|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
138954882|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
138954883|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138954884|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138954885|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138954886|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138954887|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
138954888|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
138954889|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954890|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954891|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138954892|NCT01053871|Narcotics|narcotics|mesh-ancestor
138954893|NCT01053871|Analgesics|analgesics|mesh-ancestor
138954894|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
138954895|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954896|NCT01053949|Thalidomide|thalidomide|mesh-list
138954897|NCT01053949|Pomalidomide|pomalidomide|mesh-list
138954898|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
138954899|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954900|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138954901|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138954902|NCT01053949|Growth Substances|growth substances|mesh-ancestor
138954903|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
138954904|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138954905|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138954906|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
138954907|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138954908|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138954909|NCT00987376|Choline|choline|mesh-list
138954910|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
138954911|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138954912|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
138954913|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954914|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138954915|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138954916|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
138954917|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
138954918|NCT00987454|Hematinics|hematinics|mesh-ancestor
138954919|NCT04005664|Phenylephrine|phenylephrine|mesh-list
138954920|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
138954921|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138954922|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
138954923|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
138954924|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954925|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954926|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
138954927|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138954928|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
138954929|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
138954930|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138954931|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138954932|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138516021|NCT00013520|Lamivudine|lamivudine|mesh-list
138954933|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
138954934|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954935|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536906|NCT00150631|Candesartan|candesartan|mesh-list
138954936|NCT04005664|Protective Agents|protective agents|mesh-ancestor
138954937|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138954938|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138954939|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138954940|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138954942|NCT00924573|Glimepiride|glimepiride|mesh-list
138954943|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138954944|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954945|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138954946|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138954947|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
138954948|NCT01054027|Phenylephrine|phenylephrine|mesh-list
138954949|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
138954950|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
138954951|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138954952|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
138954953|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
138954954|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954955|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954956|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
138954957|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138954958|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
138954959|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
138954960|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138954961|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138954962|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138954963|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
138954964|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954965|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954966|NCT01054027|Protective Agents|protective agents|mesh-ancestor
138954967|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
138954968|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138954969|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138954970|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
138954972|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138954973|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
138954974|NCT00330343|Naloxone|naloxone|mesh-list
138954975|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138537102|NCT00151489|Pregabalin|pregabalin|mesh-list
138954976|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516134|NCT00276666|Vincristine|vincristine|mesh-list
138954977|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
138954978|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138954980|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
138954981|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138954982|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138954983|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
138954984|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954985|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537161|NCT00406042|Hormones|hormones|mesh-ancestor
138954986|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138954988|NCT00330187|Bupropion|bupropion|mesh-list
138954989|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138954990|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
138954991|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138954992|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138954993|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138954994|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138537208|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138954995|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138954996|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
138954997|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138954998|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138954999|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138516330|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
138955000|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138955001|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955002|NCT00987844|Prucalopride|prucalopride|mesh-list
138955003|NCT00987844|Laxatives|laxatives|mesh-ancestor
138955004|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138955005|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138955006|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138955007|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
138955008|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955009|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955010|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955011|NCT03986905|Scopolamine|scopolamine|mesh-list
138955012|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138955013|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138955014|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
138955015|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
138955016|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955017|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955018|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138955020|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138955021|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
138955022|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955023|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955024|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138955025|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
138955027|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
138955028|NCT00329797|Calcium|calcium|mesh-list
138955029|NCT00329797|Vitamins|vitamins|mesh-ancestor
138955030|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
138955031|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537334|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
138955032|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138537387|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
138955033|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138955034|NCT00541450|Metformin|metformin|mesh-list
138955035|NCT00541450|Pioglitazone|pioglitazone|mesh-list
138955036|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138955037|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138955038|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955039|NCT00541450|Incretins|incretins|mesh-ancestor
138955041|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955042|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138955043|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
138476847|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138955044|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955045|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955046|NCT01056679|Doxorubicin|doxorubicin|mesh-list
138955047|NCT01056679|Lenalidomide|lenalidomide|mesh-list
138955048|NCT01056679|Vinblastine|vinblastine|mesh-list
138955049|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138955050|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955051|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138955052|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138955053|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955054|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955055|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
138955056|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138516591|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
138955057|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138955058|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138955059|NCT01056679|Growth Substances|growth substances|mesh-ancestor
138955060|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
138955061|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138955062|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
138955063|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
138955064|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
138955065|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138955066|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
138955067|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955068|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955069|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138955070|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955071|NCT05709574|Tadalafil|tadalafil|mesh-list
138955072|NCT05709574|Vasodilator Agents|vasodilator agents|mesh-ancestor
138955073|NCT05709574|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138955074|NCT05709574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138955075|NCT05709574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955076|NCT05709574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955077|NCT05709574|Urological Agents|urological agents|mesh-ancestor
138955078|NCT04690504|Melatonin|melatonin|mesh-list
138955079|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
138955080|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955081|NCT04690504|Protective Agents|protective agents|mesh-ancestor
138955082|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537787|NCT00154180|Hormones|hormones|mesh-ancestor
138955083|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138955084|NCT00540124|Tadalafil|tadalafil|mesh-list
138955085|NCT00540124|Tamsulosin|tamsulosin|mesh-list
138955086|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
138955087|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138955088|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138955089|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955090|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955091|NCT00540124|Urological Agents|urological agents|mesh-ancestor
138537858|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
138955092|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138955093|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138955094|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138955095|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
138955096|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955097|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955099|NCT00540046|Trace Elements|trace elements|mesh-ancestor
138395535|NCT05494593|Rituximab|rituximab|mesh-list
138955100|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
138955101|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955102|NCT04613830|Tramadol|tramadol|mesh-list
138955103|NCT04613830|Bupivacaine|bupivacaine|mesh-list
138955104|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
138955105|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
138955106|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138955107|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955108|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
138955109|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955110|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138955111|NCT04613830|Narcotics|narcotics|mesh-ancestor
138955112|NCT04613830|Analgesics|analgesics|mesh-ancestor
138955113|NCT00689936|Thalidomide|thalidomide|mesh-list
138955114|NCT00689936|Dexamethasone|dexamethasone|mesh-list
138955115|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
138955116|NCT00689936|Prednisone|prednisone|mesh-list
138955117|NCT00689936|Lenalidomide|lenalidomide|mesh-list
138955118|NCT00689936|Melphalan|melphalan|mesh-list
138955119|NCT00689936|BB 1101|bb 1101|mesh-list
138955120|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138955121|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
138955122|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
138955123|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955124|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955125|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138955126|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
138955127|NCT00689936|Hormones|hormones|mesh-ancestor
138955128|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955129|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138955130|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955131|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
138955132|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516913|NCT00129597|Ketamine|ketamine|mesh-list
138476901|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
138955133|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955135|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138955136|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138955137|NCT00689936|Growth Substances|growth substances|mesh-ancestor
138955138|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
138955139|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138955140|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
138955141|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138955142|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138955143|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
138955144|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138955145|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955147|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138955148|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138955149|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955150|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
138538169|NCT00156403|Amlodipine|amlodipine|mesh-list
138955151|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955152|NCT05473234|Amoxicillin|amoxicillin|mesh-list
138955154|NCT05473234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138955155|NCT05473234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955156|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
138955157|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138955158|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955159|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138955160|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138955161|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
138955162|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955163|NCT00671034|Cytarabine|cytarabine|mesh-list
138955164|NCT00671034|Dexamethasone|dexamethasone|mesh-list
138955165|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
138955166|NCT00671034|Prednisone|prednisone|mesh-list
138955167|NCT00671034|Cortisone|cortisone|mesh-list
138955168|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
138955169|NCT00671034|Doxorubicin|doxorubicin|mesh-list
138955170|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138955171|NCT00671034|Methotrexate|methotrexate|mesh-list
138955172|NCT00671034|Vincristine|vincristine|mesh-list
138955173|NCT00671034|Daunorubicin|daunorubicin|mesh-list
138955174|NCT00671034|Asparaginase|asparaginase|mesh-list
138955175|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
138955176|NCT00671034|Pegaspargase|pegaspargase|mesh-list
138955177|NCT00671034|Thioguanine|thioguanine|mesh-list
138955178|NCT00671034|BB 1101|bb 1101|mesh-list
138955179|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
138955180|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138955181|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
138955182|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955183|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138955184|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138955185|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
138955186|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955187|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476947|NCT02015728|Dasatinib|dasatinib|mesh-list
138476963|NCT02015923|Panitumumab|panitumumab|mesh-list
138955188|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138955189|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138955190|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
138955191|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
138955192|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955193|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138955194|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
138955195|NCT00671034|Hormones|hormones|mesh-ancestor
138955196|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955197|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138955198|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
138955199|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955200|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138955201|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138955202|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138955203|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138955204|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
138955205|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138955206|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138955207|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
138955208|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
138955209|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138955210|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138955211|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
138955212|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955213|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138955214|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
138955215|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
138538607|NCT00159718|Amlodipine|amlodipine|mesh-list
138955216|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
138955217|NCT04425070|Carboplatin|carboplatin|mesh-list
138955218|NCT04425070|Gemcitabine|gemcitabine|mesh-list
138955219|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
138955220|NCT04425070|Etoposide|etoposide|mesh-list
138955221|NCT04425070|Ifosfamide|ifosfamide|mesh-list
138955222|NCT04425070|Tislelizumab|tislelizumab|mesh-list
138955223|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955224|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138955225|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
138955226|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955227|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138955228|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138955229|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138955230|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955231|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138955232|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
138955233|NCT04425070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138955234|NCT00743678|Cetuximab|cetuximab|mesh-list
138955235|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138955236|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955237|NCT02679508|Lansoprazole|lansoprazole|mesh-list
138955238|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
138955239|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138955240|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138955241|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138955242|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538726|NCT00160342|Estrone|estrone|mesh-list
138955243|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955244|NCT00775632|Cyclosporine|cyclosporine|mesh-list
138955245|NCT00775632|Methotrexate|methotrexate|mesh-list
138955246|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
138955247|NCT00775632|Cyclosporins|cyclosporins|mesh-list
138955248|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138955249|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
138955250|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138955251|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955252|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138955253|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
138955254|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955255|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955256|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
138955257|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138517229|NCT00017459|Vinorelbine|vinorelbine|mesh-list
138955259|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138955260|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
138955261|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138955262|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138955263|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
138955264|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955265|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138955266|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138955267|NCT04047654|Anticoagulants|anticoagulants|mesh-list
138955269|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138955270|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138955271|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955272|NCT04394182|Ritonavir|ritonavir|mesh-list
138955273|NCT04394182|Lopinavir|lopinavir|mesh-list
138955274|NCT04394182|Azithromycin|azithromycin|mesh-list
138955275|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
138955276|NCT04394182|Tazobactam|tazobactam|mesh-list
138539137|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
138955278|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138955279|NCT04394182|Heparin|heparin|mesh-list
138955280|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138955281|NCT04394182|Tinzaparin|tinzaparin|mesh-list
138955282|NCT04394182|Dalteparin|dalteparin|mesh-list
138539350|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138955283|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138955284|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138955285|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
138955286|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955287|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955288|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138955289|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138955291|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138517343|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
138955292|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138955293|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138955295|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138539719|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
138955296|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138955297|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138955299|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138955300|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138539873|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
138955301|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138955302|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138955303|NCT05386576|Venetoclax|venetoclax|mesh-list
138955304|NCT05386576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955305|NCT05325580|Magnesium Sulfate|magnesium sulfate|mesh-list
138955306|NCT05325580|Analgesics|analgesics|mesh-ancestor
138955307|NCT05325580|Sensory System Agents|sensory system agents|mesh-ancestor
138955308|NCT05325580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955309|NCT05325580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955311|NCT05325580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138955312|NCT05325580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138955313|NCT05325580|Anticonvulsants|anticonvulsants|mesh-ancestor
138955314|NCT05325580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138517455|NCT00018954|Methotrexate|methotrexate|mesh-list
138955315|NCT05325580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138955316|NCT05325580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540308|NCT00169546|Xhance|xhance|mesh-list
138955317|NCT05325580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138955318|NCT05325580|Tocolytic Agents|tocolytic agents|mesh-ancestor
138955319|NCT05325580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138955320|NCT00539734|Ranibizumab|ranibizumab|mesh-list
138955321|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138540469|NCT00170989|Valsartan|valsartan|mesh-list
138955322|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138955323|NCT00539734|Growth Substances|growth substances|mesh-ancestor
138955324|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955325|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
138955326|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955328|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607270|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138955330|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138955331|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955332|NCT01093976|Dronabinol|dronabinol|mesh-list
138955333|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
138955334|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955335|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138955336|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138955338|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
138955339|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540806|NCT00056030|Leucovorin|leucovorin|mesh-list
138955340|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138955341|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138955342|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955343|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955344|NCT01093976|Hormones|hormones|mesh-ancestor
138540942|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138955345|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955346|NCT00329719|Sirolimus|sirolimus|mesh-list
138955347|NCT00329719|Sorafenib|sorafenib|mesh-list
138955348|NCT00329719|Temsirolimus|temsirolimus|mesh-list
138955349|NCT00329719|MTOR Inhibitors|mtor inhibitors|mesh-list
138955350|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541017|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138955351|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138955352|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541092|NCT00175630|Bupivacaine|bupivacaine|mesh-list
138955353|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955354|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138955355|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955356|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138955357|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
138955358|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138955359|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
138955360|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955361|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
138955362|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138541379|NCT00177580|Pravastatin|pravastatin|mesh-list
138955363|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
138955364|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
138541455|NCT00408187|Cyclosporine|cyclosporine|mesh-list
138955365|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138955366|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477053|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477054|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138477064|NCT02016417|Cisplatin|cisplatin|mesh-list
138955367|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138955368|NCT04008628|Analgesics|analgesics|mesh-ancestor
138955369|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
138955370|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955371|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
138955372|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138541661|NCT00180037|Vitamins|vitamins|mesh-ancestor
138955373|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138955374|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138955375|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955376|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138955377|NCT00743834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138955378|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138955379|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138955380|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955381|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955383|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138955384|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
138955385|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138955386|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138955387|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955388|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138955389|NCT00743912|Rifaximin|rifaximin|mesh-list
138517659|NCT00020202|Romidepsin|romidepsin|mesh-list
138955391|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542323|NCT00185302|Entinostat|entinostat|mesh-list
138955392|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138955393|NCT04060472|Paclitaxel|paclitaxel|mesh-list
138955394|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
138955395|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138955396|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138955397|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955398|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
138955399|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
138955400|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
138955401|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955402|NCT00329641|Paclitaxel|paclitaxel|mesh-list
138955404|NCT00329641|Sorafenib|sorafenib|mesh-list
138517667|NCT05576675|Hydromorphone|hydromorphone|mesh-list
138955405|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138607360|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
138955406|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955407|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
138542683|NCT00187915|Cyclosporine|cyclosporine|mesh-list
138955408|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
138955409|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
138542753|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955410|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955411|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138955412|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542824|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
138955414|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
138955415|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955416|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955417|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955419|NCT00743990|Menthol|menthol|mesh-list
138477085|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138477086|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
138955420|NCT00743990|Petrolatum|petrolatum|mesh-list
138955422|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
138543103|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955424|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138955425|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955426|NCT00329407|Topiramate|topiramate|mesh-list
138955427|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
138955428|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138955429|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955430|NCT01056757|Ribavirin|ribavirin|mesh-list
138955431|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
138955432|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955433|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
138955434|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955435|NCT01056835|Epoprostenol|epoprostenol|mesh-list
138955437|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138955438|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138955439|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
138955440|NCT03986515|Apatinib|apatinib|mesh-list
138955441|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955442|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138955443|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955444|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955445|NCT00567489|Icodextrin|icodextrin|mesh-list
138955446|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
138955447|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138955448|NCT02538393|Sorafenib|sorafenib|mesh-list
138955449|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955450|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138955451|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955452|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955453|NCT00924963|Lidocaine|lidocaine|mesh-list
138543583|NCT00409591|Ritonavir|ritonavir|mesh-list
138955454|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
138955455|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
138955456|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138955457|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955458|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
138955459|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955460|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138955461|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138955462|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138955463|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138955464|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955465|NCT00669864|Metformin|metformin|mesh-list
138955466|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
138955467|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
138955468|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138955469|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138955470|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477107|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
138955471|NCT00770172|Lenograstim|lenograstim|mesh-list
138955472|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138955473|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
138955474|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955475|NCT00776022|Cetirizine|cetirizine|mesh-list
138955476|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138955477|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138955478|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138955479|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
138955480|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
138607424|NCT02018926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955482|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955483|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955484|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138955485|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138955486|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138955487|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955488|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955489|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
138955490|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955491|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138955492|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138955493|NCT00779220|Methotrexate|methotrexate|mesh-list
138955494|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
138955495|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138955496|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
138955497|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138955498|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955499|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138955500|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
138955501|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955502|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955503|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
138955504|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955505|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138955506|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138955507|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
138955508|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138955509|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138955510|NCT00779376|Zidovudine|zidovudine|mesh-list
138955511|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
138955512|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955513|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138955514|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138955515|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955516|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
138955517|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955518|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138955519|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138955520|NCT00779454|Gemcitabine|gemcitabine|mesh-list
138955521|NCT00779454|Capecitabine|capecitabine|mesh-list
138955522|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
138955523|NCT00779454|Panitumumab|panitumumab|mesh-list
138955524|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138955525|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
138955526|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955527|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955528|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138955530|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
138955531|NCT00773058|Hormones|hormones|mesh-ancestor
138955532|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955533|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955534|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138955535|NCT00776334|Fosinopril|fosinopril|mesh-list
138955536|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138955537|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
138955538|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955539|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955540|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138955541|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138955542|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
138955543|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955544|NCT00667992|Budesonide|budesonide|mesh-list
138955545|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138955546|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138955547|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
138955548|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955549|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955550|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138955551|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
138955552|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
138955553|NCT00667992|Hormones|hormones|mesh-ancestor
138955554|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955555|NCT00776490|Glimepiride|glimepiride|mesh-list
138955556|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138955557|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138955558|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955559|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138955560|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
138955561|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
138955562|NCT00779922|Lenalidomide|lenalidomide|mesh-list
138955563|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
138518036|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
138955564|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955565|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138955566|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138955567|NCT00779922|Growth Substances|growth substances|mesh-ancestor
138955568|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
138955569|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955570|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138518099|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
138955572|NCT00776646|Diuretics|diuretics|mesh-ancestor
138955573|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
138955574|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955575|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138955576|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138955577|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955578|NCT00776724|Docetaxel|docetaxel|mesh-list
138955579|NCT00776724|Epirubicin|epirubicin|mesh-list
138955581|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
138955582|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
138955583|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
138955584|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955585|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138955586|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138955587|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138955588|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955589|NCT00776802|Dexamethasone|dexamethasone|mesh-list
138955590|NCT00776802|Etoposide|etoposide|mesh-list
138955591|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138955592|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
138955593|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
138955594|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955595|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955596|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138955597|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
138955598|NCT00776802|Hormones|hormones|mesh-ancestor
138955599|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955600|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138955601|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955602|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138955603|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138955604|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138955605|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955606|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955607|NCT00773916|Methylphenidate|methylphenidate|mesh-list
138955608|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138955609|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955610|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138955611|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138955612|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138955613|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955614|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
138955615|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955616|NCT00774072|Tobramycin|tobramycin|mesh-list
138518301|NCT00023244|Trimethoprim|trimethoprim|mesh-list
138955617|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138955618|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955619|NCT00780780|Triamcinolone|triamcinolone|mesh-list
138955620|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138955621|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138955622|NCT00780780|Nepafenac|nepafenac|mesh-list
138955623|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138955624|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138955625|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
138955626|NCT00780780|Hormones|hormones|mesh-ancestor
138955627|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955628|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955629|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138955630|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
138955631|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955632|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477173|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138477179|NCT02017392|Lidocaine|lidocaine|mesh-list
138955633|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138955634|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138955635|NCT00780780|Analgesics|analgesics|mesh-ancestor
138955636|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
138955637|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955638|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138955639|NCT00780858|Ganirelix|ganirelix|mesh-list
138955640|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
138955641|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955642|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955643|NCT00777114|Bortezomib|bortezomib|mesh-list
138955644|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955645|NCT00669396|Copper|copper|mesh-list
138955646|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
138955647|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138955648|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
138955649|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138955650|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955651|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138955652|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138955653|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138955654|NCT00669396|Trace Elements|trace elements|mesh-ancestor
138955655|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
138955656|NCT00774462|Rituximab|rituximab|mesh-list
138955657|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138955658|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955659|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
138955660|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955661|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138955662|NCT00669318|Rituximab|rituximab|mesh-list
138955663|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
138955664|NCT00669318|Pentostatin|pentostatin|mesh-list
138955665|NCT00669318|Sargramostim|sargramostim|mesh-list
138955666|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138955667|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955668|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
138955669|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955670|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138955671|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138955672|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955673|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955674|NCT00774540|Ketorolac|ketorolac|mesh-list
138955675|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138955676|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138477193|NCT02017405|Antibodies|antibodies|mesh-list
138955677|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138955678|NCT00774540|Analgesics|analgesics|mesh-ancestor
138955679|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
138955680|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955681|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955682|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138955683|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138955684|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138955685|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955686|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955687|NCT00669240|Varenicline|varenicline|mesh-list
138955688|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138955689|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138955690|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
138955691|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955692|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955693|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955694|NCT00669162|Docetaxel|docetaxel|mesh-list
138955695|NCT00669162|Leuprolide|leuprolide|mesh-list
138955696|NCT00669162|Goserelin|goserelin|mesh-list
138955697|NCT00669162|Bicalutamide|bicalutamide|mesh-list
138955698|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955699|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
138955700|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
138518484|NCT05268185|Vaccines|vaccines|mesh-list
138955701|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
138955702|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955703|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138955704|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
138955705|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138955706|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955707|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138955708|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
138955709|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
138955710|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955711|NCT00774696|Clarithromycin|clarithromycin|mesh-list
138955712|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138955713|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543803|NCT00084201|Amoxicillin|amoxicillin|mesh-list
138955714|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138955715|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955716|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955717|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138955718|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138955719|NCT02556060|Lamotrigine|lamotrigine|mesh-list
138955720|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
138955721|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138955722|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477224|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955723|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955724|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138955725|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955726|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138955727|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138955728|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138955729|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138955730|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138955731|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
138955732|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138955733|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
138955734|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955735|NCT00354770|Expectorants|expectorants|mesh-ancestor
138955736|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
138955737|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138955738|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
138955739|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955740|NCT00354770|Protective Agents|protective agents|mesh-ancestor
138955741|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955742|NCT00354770|Antidotes|antidotes|mesh-ancestor
138955743|NCT00744224|Exenatide|exenatide|mesh-list
138955744|NCT00744224|Prednisolone|prednisolone|mesh-list
138955745|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138955746|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
138955747|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138955748|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
138955749|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138955750|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
138518766|NCT00025740|Clonazepam|clonazepam|mesh-list
138955751|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138955753|NCT00744224|Hormones|hormones|mesh-ancestor
138644852|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138955754|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955755|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955756|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138955757|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955759|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
138955760|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955761|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138955762|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138955763|NCT00744224|Protective Agents|protective agents|mesh-ancestor
138518888|NCT04610684|Carboplatin|carboplatin|mesh-list
138955764|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138955765|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138955766|NCT00744224|Incretins|incretins|mesh-ancestor
138955767|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
138955768|NCT00744302|Calcium|calcium|mesh-list
138955769|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138955770|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955771|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138955772|NCT00666588|Cytarabine|cytarabine|mesh-list
138955773|NCT00666588|Etoposide|etoposide|mesh-list
138955774|NCT00666588|Idarubicin|idarubicin|mesh-list
138955775|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
138955776|NCT00666588|Bortezomib|bortezomib|mesh-list
138955777|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138955778|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955779|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138518974|NCT00027573|Tacrolimus|tacrolimus|mesh-list
138955782|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955783|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138955784|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
138955785|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
138477249|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
138955786|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955787|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138955788|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
138955789|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955790|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138955791|NCT00689390|Ribavirin|ribavirin|mesh-list
138955792|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138955793|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
138955794|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955795|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
138955796|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955797|NCT00567879|Trastuzumab|trastuzumab|mesh-list
138955798|NCT00567879|Panobinostat|panobinostat|mesh-list
138955799|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138955800|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955801|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138955802|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955803|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955804|NCT00781404|Adenosine|adenosine|mesh-list
138955805|NCT00781404|Analgesics|analgesics|mesh-ancestor
138955807|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955808|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955809|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138955810|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
138955811|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138955812|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
138955813|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
138955814|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955815|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955816|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
138955817|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138955818|NCT00777504|Growth Substances|growth substances|mesh-ancestor
138955819|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955820|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
138955821|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955822|NCT00781482|Zolpidem|zolpidem|mesh-list
138955823|NCT00781482|Eszopiclone|eszopiclone|mesh-list
138955824|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138955825|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138955826|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138955827|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955828|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138955829|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
138955830|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
138955831|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955832|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955833|NCT00603915|Carboplatin|carboplatin|mesh-list
138955834|NCT00603915|Gemcitabine|gemcitabine|mesh-list
138955835|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138955836|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955837|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138955838|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
138955839|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543830|NCT00195559|Estrogens|estrogens|mesh-ancestor
138955840|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138955841|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955842|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138955844|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138955845|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
138477262|NCT02018094|Iodine|iodine|mesh-list
138955846|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
138955847|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
138955848|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
138955849|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
138955850|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138955851|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955852|NCT00926055|Simvastatin|simvastatin|mesh-list
138955853|NCT00926055|Ezetimibe|ezetimibe|mesh-list
138955854|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138955855|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138955856|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138955857|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
138519267|NCT03959540|Levodopa|levodopa|mesh-list
138955858|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955859|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138955860|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138955861|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955862|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
138955863|NCT04034199|Denosumab|denosumab|mesh-list
138955864|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138955865|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955866|NCT02538237|Ibuprofen|ibuprofen|mesh-list
138955867|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138955868|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138955869|NCT02538237|Analgesics|analgesics|mesh-ancestor
138955870|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
138955871|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955872|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955873|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138955874|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138955875|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138955876|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955877|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955878|NCT00691028|Infliximab|infliximab|mesh-list
138644889|NCT00280865|Pioglitazone|pioglitazone|mesh-list
138955879|NCT00691028|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138955880|NCT00691028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138955881|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
138955882|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138955883|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138955884|NCT00690794|Travoprost|travoprost|mesh-list
138955885|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138955886|NCT00690794|Latanoprost|latanoprost|mesh-list
138955887|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138955888|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138955889|NCT00666276|Linezolid|linezolid|mesh-list
138955890|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138955891|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477285|NCT02018133|Vitamin D|vitamin d|mesh-list
138955892|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138955893|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955894|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955895|NCT00567255|Naltrexone|naltrexone|mesh-list
138955896|NCT00567255|Bupropion|bupropion|mesh-list
138955897|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138955898|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138519449|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138955899|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955900|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
138955901|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955902|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138955903|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
138955904|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138955905|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138955906|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138955907|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138955908|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955909|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
138955910|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138955911|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138955912|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138955913|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955914|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
138955915|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138955916|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955917|NCT00784446|Bevacizumab|bevacizumab|mesh-list
138955918|NCT00784446|Capecitabine|capecitabine|mesh-list
138955919|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
138955920|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
138955921|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138955922|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955923|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138955924|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138955925|NCT00784446|Growth Substances|growth substances|mesh-ancestor
138955926|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955927|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
138955928|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138955929|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
138955930|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955931|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138955932|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955935|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
138955936|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955937|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138955938|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138955939|NCT00744536|Growth Substances|growth substances|mesh-ancestor
138955940|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
138477305|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
138955941|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955942|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138955943|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
138955944|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955945|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138955946|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138955947|NCT00929799|Hormones|hormones|mesh-list
138955948|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955949|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955951|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138955953|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138955954|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138955955|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955956|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955957|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
138955958|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138955959|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138955960|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138955961|NCT00784680|Tamoxifen|tamoxifen|mesh-list
138955962|NCT00784680|Anastrozole|anastrozole|mesh-list
138955963|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138955964|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
138955965|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138955966|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955967|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138955968|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699463|NCT06020833|Tretinoin|tretinoin|mesh-list
138955969|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138955970|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138955971|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138955972|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138955973|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138955974|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138519881|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
138955975|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955976|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
138955977|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138955978|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955979|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138955980|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955981|NCT02556840|Insulin|insulin|mesh-list
138955982|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138955983|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955984|NCT00929877|Ketoprofen|ketoprofen|mesh-list
138955985|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138955986|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138955987|NCT00929877|Analgesics|analgesics|mesh-ancestor
138955988|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
138955989|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138955990|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138955991|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138955993|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138955994|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138955995|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138955996|NCT00741884|Varenicline|varenicline|mesh-list
138955997|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138955998|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138955999|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
138956000|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956001|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956002|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956004|NCT00931437|Vitamins|vitamins|mesh-ancestor
138956005|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
138956006|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956007|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138956008|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138956009|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956010|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
138956011|NCT00931437|Coagulants|coagulants|mesh-ancestor
138956012|NCT00742040|Captopril|captopril|mesh-list
138956013|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138956014|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
138956015|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956016|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956017|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138956018|NCT00926757|Entecavir|entecavir|mesh-list
138956019|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
138956020|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956021|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
138956022|NCT00782106|Antibodies|antibodies|mesh-list
138956023|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
138956024|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138956025|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138956026|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
138956027|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
138956028|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956029|NCT00929955|Ondansetron|ondansetron|mesh-list
138956030|NCT00929955|Simvastatin|simvastatin|mesh-list
138956031|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138956032|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138956033|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
138956034|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956035|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138956036|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138956037|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956038|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
138956039|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
138956040|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956041|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956042|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138956043|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
138956044|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
138956045|NCT00929955|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138956046|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138956047|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
138956048|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956049|NCT00784914|Sirolimus|sirolimus|mesh-list
138956050|NCT00784914|Temsirolimus|temsirolimus|mesh-list
138956051|NCT00784914|MTOR Inhibitors|mtor inhibitors|mesh-list
138956052|NCT00784914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138956053|NCT00784914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956054|NCT00784914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956055|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138956056|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
138644922|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138477340|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
138956057|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956058|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956059|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138956060|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956061|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138956062|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
138956063|NCT00745004|Ondansetron|ondansetron|mesh-list
138956064|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
138956065|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
138956066|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956067|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956068|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138520255|NCT02984384|Aspirin|aspirin|mesh-list
138956070|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
138956071|NCT00745004|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138956072|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138956073|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
138956074|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956075|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608032|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
138956076|NCT04060550|Omalizumab|omalizumab|mesh-list
138956077|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138956078|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138956079|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
138956081|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138956082|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956083|NCT00667446|Leuprolide|leuprolide|mesh-list
138956084|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138956085|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
138956086|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138520305|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138956087|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956088|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138956089|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956090|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138956091|NCT00777972|Fosinopril|fosinopril|mesh-list
138956092|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138956093|NCT00777972|Diuretics|diuretics|mesh-ancestor
138956094|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
138956095|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956096|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138956097|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138956098|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956099|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138956100|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
138956101|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956102|NCT00778050|Amoxicillin|amoxicillin|mesh-list
138956103|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138956104|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956105|NCT00746486|Budesonide|budesonide|mesh-list
138956106|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138956107|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138956108|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
138956109|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956110|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956111|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138956113|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
138956114|NCT00746486|Hormones|hormones|mesh-ancestor
138956115|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138956116|NCT00778128|Gemcitabine|gemcitabine|mesh-list
138956117|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138956118|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
138956119|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956120|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956121|NCT00778284|Amoxicillin|amoxicillin|mesh-list
138956122|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138956123|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520515|NCT01806857|Quinidine|quinidine|mesh-list
138956125|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138956126|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
138956127|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138956128|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956129|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138956130|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956131|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138956132|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138956133|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138956135|NCT02563340|Bortezomib|bortezomib|mesh-list
138956136|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138956137|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956138|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
138956139|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956140|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138956141|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
138956142|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138956143|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
138956144|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956145|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956146|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138956147|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
138956148|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138956149|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
138956150|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956151|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956152|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138956153|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
138956154|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
138956155|NCT00782652|Protective Agents|protective agents|mesh-ancestor
138956157|NCT00785382|Analgesics|analgesics|mesh-ancestor
138956158|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
138956159|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477387|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956160|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956161|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
138956162|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138956163|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138956164|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543945|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138956165|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138956166|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138956167|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138956168|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138956169|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138956170|NCT00667368|Metronidazole|metronidazole|mesh-list
138956171|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956172|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138956173|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138956174|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138956175|NCT00785460|Benphothiamine|benphothiamine|mesh-list
138956176|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138956177|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
138520665|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
138956178|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956179|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
138956180|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
138956181|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956183|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
138956184|NCT00567567|Melphalan|melphalan|mesh-list
138956185|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
138956186|NCT00567567|Thiotepa|thiotepa|mesh-list
138956187|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138956188|NCT00567567|Cisplatin|cisplatin|mesh-list
138956189|NCT00567567|Carboplatin|carboplatin|mesh-list
138956190|NCT00567567|Doxorubicin|doxorubicin|mesh-list
138956191|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138956192|NCT00567567|Etoposide|etoposide|mesh-list
138956193|NCT00567567|Vincristine|vincristine|mesh-list
138956194|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
138956195|NCT00567567|Topotecan|topotecan|mesh-list
138956196|NCT00567567|Tretinoin|tretinoin|mesh-list
138956197|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
138956198|NCT00567567|Isotretinoin|isotretinoin|mesh-list
138956199|NCT00567567|Lenograstim|lenograstim|mesh-list
138956200|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138956201|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
138956202|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956203|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138956204|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138956205|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
138956206|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956207|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956208|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138956209|NCT00567567|Vitamins|vitamins|mesh-ancestor
138956210|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
138956211|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138477428|NCT02019056|Metadoxine|metadoxine|mesh-list
138956212|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138956213|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138956214|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956215|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138956216|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138956217|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
138956218|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
138956219|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
138520842|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
138956220|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138956221|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
138956222|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
138956223|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
138956224|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
138956225|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138608182|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138956226|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138956227|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138520904|NCT00036309|Analgesics|analgesics|mesh-ancestor
138956228|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956230|NCT00778596|Prednisolone|prednisolone|mesh-list
138956231|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138956232|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
138956233|NCT00778596|Hormones|hormones|mesh-ancestor
138956234|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138956235|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956236|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138956237|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956238|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138956239|NCT00778674|Benazepril|benazepril|mesh-list
138956240|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138956241|NCT00778674|Diuretics|diuretics|mesh-ancestor
138956242|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
138956243|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956244|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138956245|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138956246|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956247|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138956248|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
138956249|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956250|NCT00778752|Lenalidomide|lenalidomide|mesh-list
138956251|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
138956252|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956253|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138956254|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138956255|NCT00778752|Growth Substances|growth substances|mesh-ancestor
138956256|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
138477439|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138477440|NCT02019160|Fluorides|fluorides|mesh-list
138477448|NCT02019186|Vitamin E|vitamin e|mesh-list
138956257|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956258|NCT00926835|Lamotrigine|lamotrigine|mesh-list
138956259|NCT00926835|Dexetimide|dexetimide|mesh-list
138956260|NCT00926835|Aripiprazole|aripiprazole|mesh-list
138956261|NCT00926835|Mirtazapine|mirtazapine|mesh-list
138956262|NCT00926835|Citalopram|citalopram|mesh-list
138956263|NCT00926835|Bupropion|bupropion|mesh-list
138956264|NCT00926835|Paroxetine|paroxetine|mesh-list
138956265|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138956266|NCT00926835|Escitalopram|escitalopram|mesh-list
138956267|NCT00926835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138956268|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138956269|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138956270|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956271|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956272|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
138956273|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956274|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138956275|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138956276|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
138956277|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
138956278|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956279|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138956280|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138956281|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
138956282|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138956283|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
138956284|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138956285|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138956286|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
138956287|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138956288|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138956289|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956290|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138956291|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138956292|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138956294|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138956295|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138956296|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138956297|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138956298|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138956299|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138956300|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138956301|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
138956302|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138521203|NCT00393731|Misoprostol|misoprostol|mesh-list
138956303|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138956304|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138956305|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138956306|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
138956307|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
138956308|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138956309|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138956310|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138956311|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138956312|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
138956313|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138956314|NCT00930033|Sunitinib|sunitinib|mesh-list
138956315|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956316|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138956317|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138956318|NCT00930033|Growth Substances|growth substances|mesh-ancestor
138956319|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956320|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
138956321|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138956322|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956323|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956324|NCT00664560|Celecoxib|celecoxib|mesh-list
138956325|NCT00664560|Antacids|antacids|mesh-list
138956326|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138956327|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138956328|NCT00664560|Analgesics|analgesics|mesh-ancestor
138956329|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
138956330|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956331|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956332|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138956333|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138956334|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138956335|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138956336|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956337|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956338|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138956339|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138956340|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138956341|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138956342|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
138956343|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956344|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138956345|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138956346|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956347|NCT00688688|Mirabegron|mirabegron|mesh-list
138956348|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138956349|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138956350|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138956351|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138477498|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956352|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
138956353|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956354|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956355|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956357|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138956358|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138956359|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
138956361|NCT00930189|Ranibizumab|ranibizumab|mesh-list
138956362|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138956363|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138956364|NCT00930189|Growth Substances|growth substances|mesh-ancestor
138956365|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956366|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
138956367|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956368|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138956369|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
138956370|NCT00930189|Hormones|hormones|mesh-ancestor
138956371|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138956372|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
138956373|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138956374|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138956375|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
138608333|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
138956376|NCT00931827|Etonogestrel|etonogestrel|mesh-list
138644995|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
138956377|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138956378|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
138956379|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138956380|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956381|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138956382|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138956383|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138956384|NCT00778908|Cisplatin|cisplatin|mesh-list
138956385|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956386|NCT02561468|Nefopam|nefopam|mesh-list
138956387|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138956388|NCT02561468|Analgesics|analgesics|mesh-ancestor
138956389|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
138956390|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956391|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956392|NCT02555748|Sunitinib|sunitinib|mesh-list
138956393|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956394|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138956395|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138956396|NCT02555748|Growth Substances|growth substances|mesh-ancestor
138956397|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956398|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
138956399|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138956400|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956401|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956402|NCT00930345|Sunitinib|sunitinib|mesh-list
138956403|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956404|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138543989|NCT00084279|Ribavirin|ribavirin|mesh-list
138956405|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138956406|NCT00930345|Growth Substances|growth substances|mesh-ancestor
138956407|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956408|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
138477515|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956409|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138956410|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956411|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956412|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
138956413|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138956414|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956415|NCT00746720|Etoricoxib|etoricoxib|mesh-list
138956416|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138956417|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138956418|NCT00746720|Analgesics|analgesics|mesh-ancestor
138956419|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
138956420|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956421|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956422|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138956423|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138956424|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138956425|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138956426|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956427|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956428|NCT00686972|Glucagon|glucagon|mesh-list
138644999|NCT00417053|Doxorubicin|doxorubicin|mesh-list
138956429|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138956430|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138956431|NCT00686972|Hormones|hormones|mesh-ancestor
138956432|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138956433|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956434|NCT00686972|Incretins|incretins|mesh-ancestor
138956435|NCT00665652|Lenalidomide|lenalidomide|mesh-list
138956436|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
138956437|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956438|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138956439|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138956440|NCT00665652|Growth Substances|growth substances|mesh-ancestor
138956441|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
138956442|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956443|NCT00752024|Hemostatics|hemostatics|mesh-list
138956444|NCT00752024|Coagulants|coagulants|mesh-ancestor
138956445|NCT00937677|Natalizumab|natalizumab|mesh-list
138956446|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
138956447|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956448|NCT00786240|Fesoterodine|fesoterodine|mesh-list
138197990|NCT00380770|Lamivudine|lamivudine|mesh-list
138956449|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138956450|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138956451|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
138956452|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956453|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956454|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956455|NCT00786240|Urological Agents|urological agents|mesh-ancestor
138956456|NCT04498923|Dexamethasone|dexamethasone|mesh-list
138956457|NCT04498923|Epinephrine|epinephrine|mesh-list
138956458|NCT04498923|Bupivacaine|bupivacaine|mesh-list
138956459|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138956460|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
138956461|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
138956462|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956463|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956464|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138956465|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
138477534|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
138956466|NCT04498923|Hormones|hormones|mesh-ancestor
138544001|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138956467|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138956468|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138956469|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956470|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
138956471|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
138956472|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138956473|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
138956474|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138956475|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138956476|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
138956477|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956478|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956479|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138956480|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138956481|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138956482|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
138956483|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
138956484|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
138956485|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138956486|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
138956487|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138956488|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
138956489|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138956490|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
138956491|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956492|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956493|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
138956494|NCT04046874|Analgesics|analgesics|mesh-list
138956495|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
138956496|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956497|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956499|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138956500|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
138956501|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956502|NCT00786318|Ziprasidone|ziprasidone|mesh-list
138956503|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138956504|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
138956505|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956506|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956507|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956508|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138956509|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138956510|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138956511|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138956512|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138956513|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
138521784|NCT03957057|Iron|iron|mesh-list
138956514|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138956515|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138956516|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138956517|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138956518|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956519|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138956520|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138956521|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138956522|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
138956523|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608492|NCT00175682|Prazosin|prazosin|mesh-list
138956524|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956525|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138956526|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138956527|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
138956528|NCT00937911|Darexaban|darexaban|mesh-list
138956529|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138956530|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
138956531|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138956532|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
138956533|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956534|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956535|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
138956536|NCT00930891|Bevacizumab|bevacizumab|mesh-list
138956537|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138956538|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956539|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138956540|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138956541|NCT00930891|Growth Substances|growth substances|mesh-ancestor
138956542|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956543|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
138956544|NCT00938379|Insect Repellents|insect repellents|mesh-list
138956545|NCT00938379|Protective Agents|protective agents|mesh-ancestor
138956546|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956547|NCT00661830|Gemcitabine|gemcitabine|mesh-list
138956548|NCT00661830|Sorafenib|sorafenib|mesh-list
138956549|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138956551|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956552|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956553|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138956554|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956555|NCT00932529|Olanzapine|olanzapine|mesh-list
138956556|NCT00932529|Risperidone|risperidone|mesh-list
138956557|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138956558|NCT00932529|Ziprasidone|ziprasidone|mesh-list
138956559|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138956560|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
138956561|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956562|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956563|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956564|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138956565|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138956566|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138956567|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138956568|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138956569|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
138956570|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
138521855|NCT00275093|Sirolimus|sirolimus|mesh-list
138956571|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
138956572|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956573|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138956574|NCT00932529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138956575|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138956576|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138956577|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
138956578|NCT00783744|Insulin|insulin|mesh-list
138956579|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138956580|NCT00783744|Metformin|metformin|mesh-list
138956581|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
138956582|NCT00783744|Glimepiride|glimepiride|mesh-list
138956583|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
138956584|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
138956585|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
138956586|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138521886|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
138956587|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956588|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138956589|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138956590|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
138956591|NCT00932607|Immunomodulating Agents|immunomodulating agents|mesh-list
138956592|NCT00932607|Immunologic Factors|immunologic factors|mesh-ancestor
138956593|NCT00932607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956595|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138956596|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138956597|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138956598|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956599|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138956600|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138608554|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956601|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138956602|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138956603|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
138956604|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
138956605|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
138956606|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
138956607|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956608|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956609|NCT00931125|Ranibizumab|ranibizumab|mesh-list
138956610|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138956611|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138956612|NCT00931125|Growth Substances|growth substances|mesh-ancestor
138956613|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956614|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
138956615|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956616|NCT00932763|Amlodipine|amlodipine|mesh-list
138956617|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138321689|NCT04439279|Trametinib|trametinib|mesh-list
138956618|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138956619|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138956620|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956621|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138956622|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956623|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
138956624|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138956625|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
138956626|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956628|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138956629|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138956630|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
138956631|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
138956632|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956633|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522063|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
138956634|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138956635|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138956636|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138956638|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956639|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477581|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956640|NCT00938613|Budesonide|budesonide|mesh-list
138956641|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138956642|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138956643|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
138956644|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956645|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956646|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138956647|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
138956648|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
138956649|NCT00938613|Hormones|hormones|mesh-ancestor
138956650|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138956651|NCT00786552|Paclitaxel|paclitaxel|mesh-list
138956652|NCT00786552|Pemetrexed|pemetrexed|mesh-list
138956653|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138956654|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956655|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
138956656|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
138956657|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
138956658|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956659|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956660|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138956661|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138956662|NCT04047186|Nivolumab|nivolumab|mesh-list
138956663|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138956664|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956665|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138956666|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956667|NCT00931203|Celecoxib|celecoxib|mesh-list
138956668|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138956669|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138956670|NCT00931203|Analgesics|analgesics|mesh-ancestor
138956671|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
138956672|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956673|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956674|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138956675|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138956677|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138956678|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956679|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956680|NCT00565773|Sirolimus|sirolimus|mesh-list
138956681|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
138477601|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138956682|NCT00565773|Abatacept|abatacept|mesh-list
138956683|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138956684|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138522251|NCT05770323|Uric Acid|uric acid|mesh-list
138956685|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138956686|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956687|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
138956688|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138956689|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
138956690|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956691|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956692|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138956693|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138956694|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138956695|NCT00570492|Fluticasone|fluticasone|mesh-list
138956696|NCT00570492|Xhance|xhance|mesh-list
138956697|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138956698|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138956699|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
138956700|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956701|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956702|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138956703|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
138956704|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
138956705|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138956706|NCT00931281|Ritonavir|ritonavir|mesh-list
138956707|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138956708|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138956709|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
138956710|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956711|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956712|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138956713|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138956714|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
138956715|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956716|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138956717|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138956719|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956720|NCT00571922|Acamprosate|acamprosate|mesh-list
138956721|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138522425|NCT05379322|Analgesics|analgesics|mesh-ancestor
138956722|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
138956723|NCT00933231|Prednisone|prednisone|mesh-list
138956724|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
138956725|NCT00933231|Ramipril|ramipril|mesh-list
138956726|NCT00933231|Irbesartan|irbesartan|mesh-list
138956727|NCT00933231|Tacrolimus|tacrolimus|mesh-list
138956728|NCT00933231|Basiliximab|basiliximab|mesh-list
138956729|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138956730|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
138956731|NCT00933231|Hormones|hormones|mesh-ancestor
138956732|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138956733|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956734|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138956735|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956736|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138956737|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
138956738|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138956739|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138522488|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138956740|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956741|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
138956742|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
138956743|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956744|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138956745|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138956746|NCT00933231|Protective Agents|protective agents|mesh-ancestor
138956747|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138956748|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138956749|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
138956750|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138956751|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956752|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138956753|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
138956754|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138522545|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956755|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138956756|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138956757|NCT03489525|Antibodies|antibodies|mesh-list
138956758|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
138956759|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
138956760|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
138956761|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956762|NCT00752180|Insulin|insulin|mesh-list
138956763|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138956764|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138956765|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956766|NCT00784290|Orantinib|orantinib|mesh-list
138956767|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138956768|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956769|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956770|NCT00752414|Levofloxacin|levofloxacin|mesh-list
138956771|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138956772|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956773|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138956774|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138956775|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138956776|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956777|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956778|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956779|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138956780|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138956782|NCT00686894|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138956783|NCT00686894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138956784|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
138956785|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138956786|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138956787|NCT00328627|Pioglitazone|pioglitazone|mesh-list
138956788|NCT00328627|Alogliptin|alogliptin|mesh-list
138956789|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138956790|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956791|NCT00328627|Incretins|incretins|mesh-ancestor
138956792|NCT00328627|Hormones|hormones|mesh-ancestor
138956793|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138956794|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138956795|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
138956796|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956797|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956798|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
138956799|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138956800|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956801|NCT00663858|Cetrorelix|cetrorelix|mesh-list
138956802|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138956803|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
138956804|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138956805|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956806|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
138956807|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138956808|NCT05223400|Clindamycin|clindamycin|mesh-list
138956809|NCT05223400|Clindamycin palmitate|clindamycin palmitate|mesh-list
138956810|NCT05223400|Clindamycin phosphate|clindamycin phosphate|mesh-list
138956811|NCT05223400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138956812|NCT05223400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956813|NCT05223400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138956814|NCT05223400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477691|NCT02020603|Coagulants|coagulants|mesh-ancestor
138477692|NCT02020629|Lixisenatide|lixisenatide|mesh-list
138956815|NCT05223400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956816|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
138956817|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138956818|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
138956819|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956820|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956821|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138956822|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
138956823|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138956824|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
138956825|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956826|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956827|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138956828|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
138956829|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
138956830|NCT00790608|Protective Agents|protective agents|mesh-ancestor
138956831|NCT00749450|Capecitabine|capecitabine|mesh-list
138956832|NCT00749450|Fluorouracil|fluorouracil|mesh-list
138956833|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
138956834|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138956835|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
138956836|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956837|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956838|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138956839|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
138956840|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956841|NCT00795444|Maraviroc|maraviroc|mesh-list
138956842|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138522762|NCT04199026|Sirolimus|sirolimus|mesh-list
138956843|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138956844|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956845|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138956846|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138956847|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
138956848|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956849|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138956851|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138956852|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138956853|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956854|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956855|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
138956856|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956857|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138956858|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138956859|NCT00752648|Simeprevir|simeprevir|mesh-list
138956860|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
138956861|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956862|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
138956863|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956864|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645095|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477726|NCT02021097|Estrogens|estrogens|mesh-ancestor
138477727|NCT02021097|Hormones|hormones|mesh-ancestor
138522888|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138956865|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
138956866|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138956867|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138956868|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956870|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138522949|NCT03176277|Venetoclax|venetoclax|mesh-list
138956871|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956872|NCT01060735|Vitamin D|vitamin d|mesh-list
138956873|NCT01060735|Vitamins|vitamins|mesh-ancestor
138956874|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
138956875|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956876|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138956877|NCT00683774|Diazoxide|diazoxide|mesh-list
138956878|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138956879|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
138956880|NCT00787410|Gefitinib|gefitinib|mesh-list
138956881|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956882|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138956883|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956884|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956885|NCT03989557|Aspirin|aspirin|mesh-list
138956886|NCT03989557|Clopidogrel|clopidogrel|mesh-list
138956887|NCT03989557|Ticagrelor|ticagrelor|mesh-list
138956888|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138956889|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138956890|NCT03989557|Analgesics|analgesics|mesh-ancestor
138956891|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
138956892|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138956893|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956894|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138956895|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138956896|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138956897|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138956898|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956899|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138956900|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138956901|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956902|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
138956903|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138956904|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138956906|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
138477748|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477749|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956907|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956908|NCT00790998|Ivermectin|ivermectin|mesh-list
138956909|NCT00790998|Moxidectin|moxidectin|mesh-list
138956910|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138956911|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138956912|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
138956913|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
138956914|NCT02555046|Anesthetics|anesthetics|mesh-list
138956915|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138956916|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956917|NCT00354679|Bevacizumab|bevacizumab|mesh-list
138956918|NCT00354679|Irinotecan|irinotecan|mesh-list
138956919|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138956920|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956921|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138956922|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138956923|NCT00354679|Growth Substances|growth substances|mesh-ancestor
138956924|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956925|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
138544063|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
138956926|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138956927|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138956928|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956929|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956930|NCT00540514|Paclitaxel|paclitaxel|mesh-list
138956931|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138956932|NCT00540514|Carboplatin|carboplatin|mesh-list
138956933|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138956934|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956935|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
138956936|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
138956937|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
138956938|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956939|NCT00663702|Abatacept|abatacept|mesh-list
138956940|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138956941|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956942|NCT00663702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138956943|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956944|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138956945|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
138956946|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956947|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138956948|NCT02022592|Midazolam|midazolam|mesh-list
138956949|NCT02022592|Lormetazepam|lormetazepam|mesh-list
138956950|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138956951|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138956952|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138956953|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956954|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138956955|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138956956|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138956957|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138956958|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
138956959|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
138956960|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
138956961|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
138956962|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138956963|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956964|NCT00683618|Atorvastatin|atorvastatin|mesh-list
138956965|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138956966|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138956967|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138956968|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
138956969|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138956970|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138956971|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138956972|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138956973|NCT00795678|Paclitaxel|paclitaxel|mesh-list
138956974|NCT00795678|Vinorelbine|vinorelbine|mesh-list
138956975|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138956976|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
138956977|NCT00795678|Gemcitabine|gemcitabine|mesh-list
138956978|NCT00795678|Doxorubicin|doxorubicin|mesh-list
138544074|NCT00084396|Letrozole|letrozole|mesh-list
138956979|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138956980|NCT00795678|Capecitabine|capecitabine|mesh-list
138956981|NCT00795678|Trastuzumab|trastuzumab|mesh-list
138956982|NCT00795678|Lapatinib|lapatinib|mesh-list
138956983|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138956984|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138956985|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
138956986|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
138956987|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
138956988|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477809|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477810|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138956989|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138956990|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
138956991|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138956992|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138956993|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138956994|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
138956995|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138956996|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138956997|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
138956998|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138956999|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138957000|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138957001|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957002|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138957003|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138957005|NCT00753038|Carboplatin|carboplatin|mesh-list
138957006|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138957007|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957008|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
138957009|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
138957010|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
138957011|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957012|NCT00795756|Cytarabine|cytarabine|mesh-list
138957013|NCT00795756|Methotrexate|methotrexate|mesh-list
138957014|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138957015|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
138957016|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138957017|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957018|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138957019|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
138957020|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957021|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957022|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
138957023|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957024|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138957025|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138957026|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
138957027|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138957028|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138957029|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
138957030|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957031|NCT04058522|Triamcinolone|triamcinolone|mesh-list
138957032|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138477847|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477848|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
138477849|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957033|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
138957034|NCT04058522|Hormones|hormones|mesh-ancestor
138957035|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138957036|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957037|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138957038|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138957039|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138957040|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957041|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957042|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138957043|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138957044|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138957045|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
138957046|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138957047|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957048|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138957049|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138957050|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
138957051|NCT01563952|Sirolimus|sirolimus|mesh-list
138957052|NCT01563952|Umirolimus|umirolimus|mesh-list
138957053|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138957054|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645131|NCT00317811|Bortezomib|bortezomib|mesh-list
138957055|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138957056|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957057|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
138957058|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138957059|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
138957060|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957061|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957062|NCT00795912|Atorvastatin|atorvastatin|mesh-list
138957063|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138957064|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138957065|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
138957066|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957067|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138957068|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138957069|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957070|NCT00788034|Vortioxetine|vortioxetine|mesh-list
138957071|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
138957072|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138957073|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138957074|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138957075|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957076|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957077|NCT00788034|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138477878|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138957078|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138957079|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138957080|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957081|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138957083|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138957084|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138957085|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138957086|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138957087|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
138957088|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138957089|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
138957090|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138957091|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957092|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138957094|NCT00688064|Adapalene|adapalene|mesh-list
138957095|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138957096|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957097|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
138957098|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138957099|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138957100|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138957101|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138957102|NCT00688064|Analgesics|analgesics|mesh-ancestor
138957103|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
138957104|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957105|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957106|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957107|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138957108|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
138957109|NCT00788112|Vorinostat|vorinostat|mesh-list
138957110|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957111|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138957113|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957114|NCT00749918|Vitamin D|vitamin d|mesh-list
138957115|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
138957116|NCT00749918|Vitamins|vitamins|mesh-ancestor
138957117|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
138957118|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957119|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138957120|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138957121|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
138957122|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957123|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
138957124|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138957125|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138957126|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957127|NCT04058132|Urological Agents|urological agents|mesh-ancestor
138957128|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138957129|NCT00791544|Sorafenib|sorafenib|mesh-list
138957130|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701091|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
138957131|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138957132|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957133|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957134|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138957135|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138957136|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138957137|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
138957138|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957139|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138957140|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138957141|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957143|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138957144|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138957145|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
138957146|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957147|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138957148|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138957149|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957150|NCT00683384|Etanercept|etanercept|mesh-list
138957151|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138957152|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138957153|NCT00683384|Analgesics|analgesics|mesh-ancestor
138957154|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
138957155|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957156|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957157|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957158|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138957159|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138957160|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138957161|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
138957162|NCT00753740|Camptothecin|camptothecin|mesh-list
138957163|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138957165|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138957166|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138957168|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957170|NCT00326911|Cetuximab|cetuximab|mesh-list
138957171|NCT00326911|Gemcitabine|gemcitabine|mesh-list
138957172|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138477934|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957173|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957174|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138957175|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138957176|NCT00326911|Growth Substances|growth substances|mesh-ancestor
138957177|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957178|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
138957179|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138957180|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
138957181|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957182|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138957183|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138957184|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138957185|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957186|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957187|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138957188|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138957189|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138957190|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
138957191|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138957192|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957193|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138957194|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138957195|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
138957196|NCT00747110|Budesonide|budesonide|mesh-list
138957197|NCT00747110|Mesalamine|mesalamine|mesh-list
138609156|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138523901|NCT02571881|Naloxone|naloxone|mesh-list
138957198|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957199|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138957201|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957202|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138523980|NCT00038766|Semapimod|semapimod|mesh-list
138957203|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138957204|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
138957205|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
138957206|NCT00747110|Hormones|hormones|mesh-ancestor
138957207|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138957208|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138957209|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138957210|NCT00747110|Analgesics|analgesics|mesh-ancestor
138957211|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
138957212|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138957213|NCT00796458|Docetaxel|docetaxel|mesh-list
138957214|NCT00796458|Hormones|hormones|mesh-list
138957215|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957216|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
138957217|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
138477967|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138957218|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
138957219|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957220|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138957221|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957222|NCT04046016|Paclitaxel|paclitaxel|mesh-list
138957223|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138524038|NCT00042393|Adefovir|adefovir|mesh-list
138957224|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957225|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
138957226|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
138957227|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
138957228|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957229|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
138957230|NCT01057615|Vitamins|vitamins|mesh-ancestor
138957231|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
138544128|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
138957233|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
138957234|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957235|NCT01057615|Protective Agents|protective agents|mesh-ancestor
138957236|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
138957237|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138957238|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
138957239|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957240|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957241|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138957242|NCT00788424|Protective Agents|protective agents|mesh-ancestor
138957243|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138957244|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138957245|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957246|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957247|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
138957248|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957249|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
138957250|NCT00791856|Testosterone|testosterone|mesh-list
138957251|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
138957252|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
138957253|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138957254|NCT00791856|Androgens|androgens|mesh-ancestor
138957256|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138957257|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957258|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138957259|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957260|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
138957261|NCT00796692|Heparin|heparin|mesh-list
138957262|NCT00796692|Calcium heparin|calcium heparin|mesh-list
138957263|NCT00796692|Nadroparin|nadroparin|mesh-list
138957264|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
138477998|NCT02022722|Bupivacaine|bupivacaine|mesh-list
138957265|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138957266|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138957267|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957268|NCT00540436|Ambrisentan|ambrisentan|mesh-list
138957269|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138957270|NCT00788580|Sirolimus|sirolimus|mesh-list
138957271|NCT00788580|Temsirolimus|temsirolimus|mesh-list
138957272|NCT00788580|MTOR Inhibitors|mtor inhibitors|mesh-list
138957273|NCT00788580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138957275|NCT00788580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957276|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138957277|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
138957278|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957279|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957280|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138957281|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957282|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138957283|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
138957284|NCT00792012|Temozolomide|temozolomide|mesh-list
138957285|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138957286|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
138957287|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957288|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957289|NCT00990418|Fentanyl|fentanyl|mesh-list
138957290|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138957291|NCT00990418|Narcotics|narcotics|mesh-ancestor
138957292|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957293|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957294|NCT00990418|Analgesics|analgesics|mesh-ancestor
138957295|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
138957296|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957297|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138957298|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138957299|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
138957300|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
138957301|NCT02562950|Midazolam|midazolam|mesh-list
138957302|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138957303|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138957304|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957305|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957306|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138957307|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138957308|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138957309|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138957310|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
138957311|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
138957312|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
138957313|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
138478023|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138478024|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957314|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138957315|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957316|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138957317|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138957318|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138957319|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138524247|NCT00019409|Cytarabine|cytarabine|mesh-list
138957320|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957321|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138957322|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957323|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138957324|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
138957325|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138957326|NCT00687440|Docetaxel|docetaxel|mesh-list
138957327|NCT00687440|Doxorubicin|doxorubicin|mesh-list
138957328|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138957329|NCT00687440|Trastuzumab|trastuzumab|mesh-list
138957330|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957331|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
138957332|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
138957333|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
138524298|NCT00019487|Aldesleukin|aldesleukin|mesh-list
138957334|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957335|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138957336|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138957337|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138957338|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957339|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138957340|NCT02554734|Levodopa|levodopa|mesh-list
138957341|NCT02554734|Carbidopa|carbidopa|mesh-list
138957342|NCT02554734|Entacapone|entacapone|mesh-list
138957343|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138957345|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
138957346|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138957347|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957348|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957349|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138957350|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957351|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138957352|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
138957354|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138957355|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
138957356|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957357|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138957358|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138478049|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
138957359|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
138957360|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957361|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957362|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138957363|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138957365|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957366|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
138957367|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138957368|NCT00755066|Fluticasone|fluticasone|mesh-list
138957369|NCT00755066|Xhance|xhance|mesh-list
138957370|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957371|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138957372|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
138957373|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957374|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957375|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138957376|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
138957377|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
138957378|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138957379|NCT00990574|Anesthetics|anesthetics|mesh-list
138957380|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957381|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957382|NCT00659490|Naproxen|naproxen|mesh-list
138957383|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138957384|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138957385|NCT00659490|Analgesics|analgesics|mesh-ancestor
138957386|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
138957387|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957388|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957389|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957390|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138957391|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
138957392|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138957393|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957394|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957395|NCT00792246|Voriconazole|voriconazole|mesh-list
138957396|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
138957397|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957398|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138478076|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957399|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138957400|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957401|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957402|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138957403|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
138957404|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138957405|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957406|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138957408|NCT00539500|Etoposide|etoposide|mesh-list
138957409|NCT00539500|Melphalan|melphalan|mesh-list
138957410|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957411|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138213856|NCT03243890|Vitamin K|vitamin k|mesh-list
138957412|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138957413|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138957414|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957415|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957416|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138957417|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
138957418|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138957419|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138957420|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
138957422|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138957424|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957426|NCT00792324|Etravirine|etravirine|mesh-list
138957427|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138957428|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138957429|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957430|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957431|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
138957432|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957433|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138957434|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138957435|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138957436|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138957437|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138957438|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138957439|NCT00990808|Atorvastatin|atorvastatin|mesh-list
138957440|NCT00990808|Anacetrapib|anacetrapib|mesh-list
138957441|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138957442|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138957443|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
138478113|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138957444|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645255|NCT00311688|Analgesics|analgesics|mesh-ancestor
138957445|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138957446|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138957447|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957449|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138957450|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957451|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957452|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138957453|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
138957454|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
138957455|NCT00682448|Metformin|metformin|mesh-list
138957456|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138957457|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957458|NCT04003792|Bevacizumab|bevacizumab|mesh-list
138957459|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
138957460|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138957461|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957462|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138957463|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138957464|NCT04003792|Growth Substances|growth substances|mesh-ancestor
138957465|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957466|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
138957467|NCT00990886|Oxybutynin|oxybutynin|mesh-list
138957468|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
138957469|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
138957470|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957471|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957472|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138957473|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138957474|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
138957475|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138957476|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957477|NCT00990886|Urological Agents|urological agents|mesh-ancestor
138957478|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
138957479|NCT00797394|Urological Agents|urological agents|mesh-ancestor
138957480|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138957481|NCT00681824|Thrombin|thrombin|mesh-list
138957483|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
138957484|NCT00681824|Coagulants|coagulants|mesh-ancestor
138957485|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138957486|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138957487|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
138957488|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957489|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957490|NCT00797472|Bleomycin|bleomycin|mesh-list
138957491|NCT00797472|Dacarbazine|dacarbazine|mesh-list
138957492|NCT00797472|Vinblastine|vinblastine|mesh-list
138957493|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138957494|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219820|NCT05400369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138219821|NCT05362760|Fulvestrant|fulvestrant|mesh-list
138219822|NCT05362760|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138219823|NCT05362760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138219824|NCT05362760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219826|NCT05362760|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138957495|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957496|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138957498|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138957499|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
138957500|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
138957501|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
138957502|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138957503|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
138957504|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138524695|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138957505|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138957506|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138957507|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957508|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957509|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
138957510|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138957511|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
138957512|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957513|NCT00539188|Expectorants|expectorants|mesh-ancestor
138957514|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
138957515|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138957516|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
138957517|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957518|NCT00539188|Protective Agents|protective agents|mesh-ancestor
138957519|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957520|NCT00539188|Antidotes|antidotes|mesh-ancestor
138957521|NCT00681590|Vitamin D|vitamin d|mesh-list
138957522|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
138957523|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
138957524|NCT00681590|Vitamins|vitamins|mesh-list
138957525|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
138957526|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957527|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138478170|NCT02023710|Carboplatin|carboplatin|mesh-list
138478173|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
138957528|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138957529|NCT05359432|Empagliflozin|empagliflozin|mesh-list
138957530|NCT05359432|Vildagliptin|vildagliptin|mesh-list
138957531|NCT05359432|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138524801|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138957532|NCT05359432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957533|NCT05359432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138957534|NCT05359432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957535|NCT05359432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138957536|NCT05359432|Protease Inhibitors|protease inhibitors|mesh-ancestor
138957537|NCT05359432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957538|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138957539|NCT00755534|Capecitabine|capecitabine|mesh-list
138957540|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
138957541|NCT00755534|Irinotecan|irinotecan|mesh-list
138957542|NCT00755534|Cetuximab|cetuximab|mesh-list
138957543|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138957544|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
138957545|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957546|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957547|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138957548|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138957549|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957550|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138957551|NCT00326599|Carboplatin|carboplatin|mesh-list
138957552|NCT00326599|Gemcitabine|gemcitabine|mesh-list
138957553|NCT00326599|Cediranib|cediranib|mesh-list
138957554|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957555|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138957556|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
138957557|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957558|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957559|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138957561|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138957562|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
138957563|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957564|NCT00750386|Paclitaxel|paclitaxel|mesh-list
138957565|NCT00750386|Carboplatin|carboplatin|mesh-list
138957566|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138957567|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957568|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
138957569|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
138957570|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
138957571|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957572|NCT00539032|Vaccines|vaccines|mesh-list
138957573|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
138478204|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478206|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138957574|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957575|NCT00685802|Cilostazol|cilostazol|mesh-list
138957576|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138957577|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
138957578|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957579|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957580|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138957581|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
138957582|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138957583|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138957584|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957585|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138957586|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
138957587|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138957588|NCT00685802|Protective Agents|protective agents|mesh-ancestor
138524991|NCT00049374|Hormones|hormones|mesh-ancestor
138957589|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138957590|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138957591|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957592|NCT01054651|Artesunate|artesunate|mesh-list
138957593|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
138478235|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138478244|NCT02024217|Tegafur|tegafur|mesh-list
138957594|NCT01054651|Sulfalene|sulfalene|mesh-list
138957595|NCT01054651|Praziquantel|praziquantel|mesh-list
138957596|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
138957597|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138957598|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138957599|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957600|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957601|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
138957602|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
138957603|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138957604|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
138957605|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138957606|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957607|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957608|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138957609|NCT00792714|Mannitol|mannitol|mesh-list
138957610|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138957611|NCT00792714|Diuretics|diuretics|mesh-ancestor
138957612|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
138957613|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957614|NCT04961554|Anesthetics|anesthetics|mesh-list
138957615|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957616|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957617|NCT00354601|Docetaxel|docetaxel|mesh-list
138957618|NCT00354601|Capecitabine|capecitabine|mesh-list
138957619|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957620|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
138957621|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
138957622|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
138645314|NCT00283790|Zolpidem|zolpidem|mesh-list
138957623|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957624|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138957625|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
138957626|NCT01563640|Permethrin|permethrin|mesh-list
138957627|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957628|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957629|NCT00750620|Mirabegron|mirabegron|mesh-list
138957630|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138957631|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138957632|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138957633|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
138957634|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138957635|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525232|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
138957636|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957637|NCT00750620|Urological Agents|urological agents|mesh-ancestor
138957639|NCT03827473|Prednisone|prednisone|mesh-list
138957640|NCT03827473|Cortisone|cortisone|mesh-list
138957641|NCT03827473|Docetaxel|docetaxel|mesh-list
138957642|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
138957643|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
138957644|NCT03827473|Hormones|hormones|mesh-list
138478339|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138478340|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
138478341|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138478355|NCT02024659|Budesonide|budesonide|mesh-list
138957645|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138957646|NCT03827473|Androgens|androgens|mesh-list
138957647|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
138957648|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957649|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
138957650|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
138957651|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
138957652|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957653|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957654|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
138957655|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138957656|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957657|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138957658|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138957659|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957660|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
138957661|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138957662|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
138957663|NCT03827473|Protective Agents|protective agents|mesh-ancestor
138957664|NCT03827473|Vitamins|vitamins|mesh-ancestor
138957665|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
138957666|NCT03827473|Estrogens|estrogens|mesh-ancestor
138957667|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
138957668|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
138957669|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
138957670|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138957671|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138957672|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957673|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957674|NCT00800592|Urological Agents|urological agents|mesh-ancestor
138957675|NCT00797784|Etanercept|etanercept|mesh-list
138957676|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138957678|NCT00797784|Analgesics|analgesics|mesh-ancestor
138957679|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
138957680|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957681|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957682|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957683|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138957684|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138957685|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138957686|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
138957687|NCT00747968|Exenatide|exenatide|mesh-list
138957688|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138957689|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957690|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138957691|NCT00747968|Incretins|incretins|mesh-ancestor
138957692|NCT00747968|Hormones|hormones|mesh-ancestor
138525484|NCT00051285|Enoximone|enoximone|mesh-list
138957693|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138957695|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138957696|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957697|NCT00800748|Ribavirin|ribavirin|mesh-list
138957698|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138957699|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
138957700|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957701|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
138957702|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957703|NCT00798252|Paclitaxel|paclitaxel|mesh-list
138957704|NCT00798252|Docetaxel|docetaxel|mesh-list
138957705|NCT00798252|Doxorubicin|doxorubicin|mesh-list
138957706|NCT00798252|Capecitabine|capecitabine|mesh-list
138957707|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138957708|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957709|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
138957710|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
138957711|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
138957712|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957713|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138957714|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138957715|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138957716|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957717|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138957718|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
138957719|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138957720|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957722|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138957723|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138957724|NCT00326209|Analgesics|analgesics|mesh-ancestor
138957725|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
138957726|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957727|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957728|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957729|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138957730|NCT00537940|Pregabalin|pregabalin|mesh-list
138957731|NCT00537940|Gabapentin|gabapentin|mesh-list
138957732|NCT00537940|Analgesics|analgesics|mesh-ancestor
138957733|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
138957734|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957735|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478413|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478414|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138957736|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
138957737|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138957738|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138957739|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957740|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138957741|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138957742|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138957743|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957744|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138957745|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138957746|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138957747|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138957749|NCT00661362|Metformin|metformin|mesh-list
138957750|NCT00661362|Saxagliptin|saxagliptin|mesh-list
138957751|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138957752|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957753|NCT00661362|Incretins|incretins|mesh-ancestor
138957754|NCT00661362|Hormones|hormones|mesh-ancestor
138957755|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138957756|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138957757|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
138957758|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957759|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957760|NCT00748202|Complement C1s|complement c1s|mesh-list
138478448|NCT02025218|Gefitinib|gefitinib|mesh-list
138478453|NCT02025348|Metoprolol|metoprolol|mesh-list
138957761|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138957762|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138957763|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
138957764|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957765|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138525722|NCT00024518|Interferons|interferons|mesh-list
138957766|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138957767|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138957768|NCT00325897|Azithromycin|azithromycin|mesh-list
138957769|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957770|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
138957771|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138957772|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957773|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957774|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138957775|NCT00800826|Analgesics|analgesics|mesh-ancestor
138957776|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
138957777|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957778|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138957779|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138957780|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138478496|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138478497|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
138957781|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
138957782|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138957783|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957784|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
138957785|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138957786|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957787|NCT03989089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138957788|NCT03989089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957789|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
138957790|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
138957791|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138957792|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138957793|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957794|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957795|NCT00793338|Urological Agents|urological agents|mesh-ancestor
138957796|NCT00344773|Gefitinib|gefitinib|mesh-list
138957797|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957798|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138609751|NCT00201357|Growth Substances|growth substances|mesh-ancestor
138957799|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957800|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957802|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138957803|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138957804|NCT02554344|Analgesics|analgesics|mesh-ancestor
138957805|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
138957806|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957807|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957808|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957809|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138957810|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957811|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957812|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957813|NCT01055041|Budesonide|budesonide|mesh-list
138957814|NCT01055041|Doxofylline|doxofylline|mesh-list
138957815|NCT01055041|Montelukast|montelukast|mesh-list
138525835|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
138957816|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957817|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138957818|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
138957819|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957820|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478547|NCT02025855|Analgesics|analgesics|mesh-ancestor
138957821|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138957822|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
138957823|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
138957824|NCT01055041|Hormones|hormones|mesh-ancestor
138957825|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138957826|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138957827|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
138957829|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138957830|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957831|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
138957832|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138957833|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957834|NCT00325819|Acetaminophen|acetaminophen|mesh-list
138957835|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138957836|NCT00325819|Analgesics|analgesics|mesh-ancestor
138957837|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
138957838|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957839|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957840|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
138957841|NCT00748358|Sunitinib|sunitinib|mesh-list
138957842|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957843|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138957844|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138957845|NCT00748358|Growth Substances|growth substances|mesh-ancestor
138957846|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957847|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
138957848|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138957849|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957850|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957851|NCT00748436|Betahistine|betahistine|mesh-list
138957852|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
138957853|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
138957855|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138957856|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957857|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957858|NCT00756860|Sevelamer|sevelamer|mesh-list
138957859|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
138957860|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
138525910|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138957861|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957862|NCT00757016|Triamcinolone|triamcinolone|mesh-list
138478583|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138478584|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
138957863|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138957864|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138957865|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138957866|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957867|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
138957868|NCT00757016|Hormones|hormones|mesh-ancestor
138957869|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138957870|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957871|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138957872|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
138957873|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957874|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957875|NCT00687362|Infliximab|infliximab|mesh-list
138957876|NCT00687362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138957877|NCT00687362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957878|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
138957879|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138957880|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138957881|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138957882|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138957883|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
138957884|NCT00751478|Naltrexone|naltrexone|mesh-list
138957885|NCT00751478|Morphine|morphine|mesh-list
138957886|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138957887|NCT00751478|Narcotics|narcotics|mesh-ancestor
138957888|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957889|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957890|NCT00751478|Analgesics|analgesics|mesh-ancestor
138957891|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
138957892|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957893|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138957894|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138957895|NCT00751556|Naproxen|naproxen|mesh-list
138957896|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138957897|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138957898|NCT00751556|Analgesics|analgesics|mesh-ancestor
138957899|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
138957900|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957901|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957902|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138957903|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138957904|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
138957905|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138957906|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957907|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957908|NCT00685334|Olanzapine|olanzapine|mesh-list
138478615|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138957909|NCT00685334|Aripiprazole|aripiprazole|mesh-list
138957910|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
138957911|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
138957912|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138957913|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957914|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138957915|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138957916|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138957917|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138957918|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138957919|NCT00685334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138957920|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138957921|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138957922|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957923|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138957925|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
138957926|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
138957927|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
138957928|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138957929|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138957930|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138957931|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138478644|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478646|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
138957932|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138957933|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138957934|NCT00801294|Nintedanib|nintedanib|mesh-list
138957935|NCT00801294|Afatinib|afatinib|mesh-list
138957936|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957937|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138957939|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957940|NCT04013919|Insulin|insulin|mesh-list
138957941|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138957942|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138957943|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957944|NCT00344461|Tenofovir|tenofovir|mesh-list
138957945|NCT00344461|Nevirapine|nevirapine|mesh-list
138957946|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
138957947|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957948|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138957949|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138957950|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957951|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957952|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138957953|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138957954|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138957955|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138957957|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
138957959|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957960|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
138957961|NCT00537394|Maraviroc|maraviroc|mesh-list
138957962|NCT00537394|Darunavir|darunavir|mesh-list
138957963|NCT00537394|Tipranavir|tipranavir|mesh-list
138957964|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
138957965|NCT00537394|Etravirine|etravirine|mesh-list
138957966|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138957967|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138957968|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
138957969|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138957970|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138957971|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138957972|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957973|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957974|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138957975|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138957976|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138957977|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138957978|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138957979|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
138957980|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138957981|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138957982|NCT00933309|Metformin|metformin|mesh-list
138957983|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
138957984|NCT00933309|Exemestane|exemestane|mesh-list
138957985|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138957986|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138957987|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138957988|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138957989|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138957990|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138957991|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138957992|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138957993|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
138957994|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138957995|NCT00352885|Escitalopram|escitalopram|mesh-list
138957996|NCT00352885|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138957997|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138957998|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138957999|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958000|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138958001|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
138526339|NCT00026195|Irinotecan|irinotecan|mesh-list
138958002|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958003|NCT00933387|Paclitaxel|paclitaxel|mesh-list
138958004|NCT00933387|Cetuximab|cetuximab|mesh-list
138958005|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138958006|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958007|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
138958008|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
138958009|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
138958010|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958011|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138958012|NCT00660660|Esomeprazole|esomeprazole|mesh-list
138958013|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138958014|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958015|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138958016|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958017|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958020|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
138526443|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958021|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645361|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958022|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609975|NCT04630288|Clopidogrel|clopidogrel|mesh-list
138958023|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
138958024|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138958025|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138958026|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138958027|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138958028|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138958029|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138958030|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138958031|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958032|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
138958033|NCT00933465|Loperamide|loperamide|mesh-list
138958034|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
138958035|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958037|NCT00757874|Tacrolimus|tacrolimus|mesh-list
138958038|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958039|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
138958040|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958041|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138958042|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958043|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958044|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138958045|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
138958046|NCT00757874|Hormones|hormones|mesh-ancestor
138958047|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138958048|NCT00344305|Vaccines|vaccines|mesh-list
138958049|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
138958050|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958051|NCT00933777|Everolimus|everolimus|mesh-list
138958052|NCT00933777|Sorafenib|sorafenib|mesh-list
138958053|NCT00933777|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138958054|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138958055|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958056|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958057|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138478768|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478769|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958058|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
138958059|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958060|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958061|NCT00801450|Triamcinolone|triamcinolone|mesh-list
138958062|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138958063|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138958064|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138958065|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138958066|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
138958067|NCT00801450|Hormones|hormones|mesh-ancestor
138958068|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138958069|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958070|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958071|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
138958072|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958073|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958074|NCT00660816|Docetaxel|docetaxel|mesh-list
138958075|NCT00660816|Pemetrexed|pemetrexed|mesh-list
138958076|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138526578|NCT00055341|Ribavirin|ribavirin|mesh-list
138958077|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958078|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
138958079|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
138958080|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
138958081|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958082|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958083|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138958084|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138958085|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138958086|NCT00801528|Diclofenac|diclofenac|mesh-list
138958087|NCT00801528|Ropivacaine|ropivacaine|mesh-list
138958088|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
138958089|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
138958090|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138958091|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958092|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
138958093|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958094|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138958095|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138958096|NCT00801528|Analgesics|analgesics|mesh-ancestor
138958097|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138958098|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138958099|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138958100|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711073|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138478802|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958101|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958102|NCT01060891|Colistin|colistin|mesh-list
138958103|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138958104|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138958105|NCT04003402|Ethanol|ethanol|mesh-list
138958106|NCT04003402|ASP8062|asp8062|mesh-list
138958107|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138958108|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138958109|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138958110|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958111|NCT04003402|Analgesics|analgesics|mesh-ancestor
138958112|NCT04003402|Sensory System Agents|sensory system agents|mesh-ancestor
138958113|NCT04003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958114|NCT04003402|GABA Modulators|gaba modulators|mesh-ancestor
138958115|NCT04003402|GABA Agents|gaba agents|mesh-ancestor
138958116|NCT04003402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138958117|NCT04003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958119|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958120|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138958121|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958122|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958123|NCT05360602|Thioctic Acid|thioctic acid|mesh-list
138645393|NCT00283985|Hormones|hormones|mesh-ancestor
138958125|NCT05360602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958126|NCT05360602|Protective Agents|protective agents|mesh-ancestor
138958127|NCT05360602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958128|NCT05360602|Vitamin B Complex|vitamin b complex|mesh-ancestor
138958129|NCT05360602|Vitamins|vitamins|mesh-ancestor
138958130|NCT05360602|Micronutrients|micronutrients|mesh-ancestor
138958131|NCT00991744|Cytarabine|cytarabine|mesh-list
138958132|NCT00991744|Cortisone|cortisone|mesh-list
138958133|NCT00991744|Prednisolone|prednisolone|mesh-list
138958134|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138958135|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
138958136|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138958137|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
138958138|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138958139|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
138958140|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138478834|NCT02027493|Interferons|interferons|mesh-list
138958141|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
138958142|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958143|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958145|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138958146|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958147|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
138958148|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958149|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138958150|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
138958151|NCT00991744|Hormones|hormones|mesh-ancestor
138526915|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
138958152|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138958153|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138958154|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
138958155|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
138958156|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958157|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958158|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138958159|NCT00991744|Protective Agents|protective agents|mesh-ancestor
138958160|NCT00798876|Vitamin E|vitamin e|mesh-list
138958161|NCT00798876|Vitamins|vitamins|mesh-ancestor
138958162|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
138958163|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958164|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
138958165|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958166|NCT00798876|Protective Agents|protective agents|mesh-ancestor
138958167|NCT00989404|Zanamivir|zanamivir|mesh-list
138958168|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
138958169|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138958170|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958171|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958172|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138610127|NCT00575419|Antidotes|antidotes|mesh-ancestor
138958173|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138958174|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138958175|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138958176|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958177|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138958178|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138958179|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138958180|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
138958181|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138958182|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958183|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138958184|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138478871|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478872|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958185|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
138958186|NCT00991822|Timolol|timolol|mesh-list
138958187|NCT00991822|Dorzolamide|dorzolamide|mesh-list
138958188|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138958189|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138958190|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
138527034|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
138958191|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138958192|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958193|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958194|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138958195|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138958196|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138958197|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958198|NCT00798954|Sirolimus|sirolimus|mesh-list
138958199|NCT00798954|Paclitaxel|paclitaxel|mesh-list
138958200|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138958201|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958202|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
138958203|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
138958204|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
138958205|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958206|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138958207|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138478900|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138478901|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
138958208|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138958209|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
138958210|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958211|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
138527095|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
138958212|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958213|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138958214|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138958215|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138958216|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
138958217|NCT00934167|Heparin|heparin|mesh-list
138958218|NCT00934167|Calcium heparin|calcium heparin|mesh-list
138958219|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
138958220|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138958221|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138544263|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138958222|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958224|NCT00801606|Trace Elements|trace elements|mesh-list
138958225|NCT00801606|Micronutrients|micronutrients|mesh-list
138958226|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958227|NCT00934245|Vaccines|vaccines|mesh-list
138958228|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
138958229|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958230|NCT02560688|Clopidogrel|clopidogrel|mesh-list
138958231|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138958232|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138527223|NCT00030056|Molgramostim|molgramostim|mesh-list
138958233|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138478948|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958234|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138958235|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
138958236|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138958237|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958238|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958239|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
138958240|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
138958241|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
138958242|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958243|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
138958244|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958245|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138958246|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138958247|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
138958248|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610201|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
138958249|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958250|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138958251|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138958252|NCT00934323|Metformin|metformin|mesh-list
138958253|NCT00934323|Glimepiride|glimepiride|mesh-list
138958254|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138958255|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958256|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138958257|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958258|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
138958259|NCT00575666|Insulin|insulin|mesh-list
138958260|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138958261|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958262|NCT00934479|Lubiprostone|lubiprostone|mesh-list
138958263|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138958264|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138958265|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958266|NCT00658632|Esomeprazole|esomeprazole|mesh-list
138958267|NCT00658632|Rabeprazole|rabeprazole|mesh-list
138958268|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138958269|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958270|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138958271|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958272|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958273|NCT00677534|Vitamin D|vitamin d|mesh-list
138958274|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
138478996|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
138478999|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958275|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
138958277|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
138958278|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958279|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138958280|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138958281|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
138958282|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
138958283|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
138958284|NCT00660348|Morphine|morphine|mesh-list
138958285|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138958286|NCT00660348|Narcotics|narcotics|mesh-ancestor
138958287|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138527386|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
138958288|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958289|NCT00660348|Analgesics|analgesics|mesh-ancestor
138958290|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
138958291|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958292|NCT03734198|Daratumumab|daratumumab|mesh-list
138958293|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138958294|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958295|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
138958296|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958297|NCT01564108|Ranibizumab|ranibizumab|mesh-list
138958298|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138958299|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138958300|NCT01564108|Growth Substances|growth substances|mesh-ancestor
138958301|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958302|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
138958303|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958304|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
138958305|NCT00801918|Ifosfamide|ifosfamide|mesh-list
138958306|NCT00801918|Etoposide|etoposide|mesh-list
138958307|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
138958308|NCT00801918|Interleukin-2|interleukin-2|mesh-list
138958309|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958310|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
138958311|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958312|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138958313|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138958314|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
138479028|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
138479029|NCT02028819|Dolutegravir|dolutegravir|mesh-list
138479030|NCT02028819|Ibalizumab|ibalizumab|mesh-list
138958315|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958316|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958317|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138958318|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138958319|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138958320|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138958321|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958322|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138958323|NCT00801918|Analgesics|analgesics|mesh-ancestor
138958324|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
138958325|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958326|NCT00799188|Everolimus|everolimus|mesh-list
138958327|NCT00799188|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138958328|NCT00799188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138958329|NCT00799188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958330|NCT00799188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958331|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958332|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
138958333|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958334|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958335|NCT00571688|Risperidone|risperidone|mesh-list
138958336|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138958337|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
138958338|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138958339|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958340|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958341|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138958342|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138527563|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
138958343|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138958344|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138958345|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138479073|NCT02029118|Aspirin|aspirin|mesh-list
138958346|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
138544277|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958347|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
138958348|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
138958349|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958351|NCT05408104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138958352|NCT05408104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958353|NCT05408104|Natriuretic Agents|natriuretic agents|mesh-ancestor
138958354|NCT05408104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958355|NCT00343291|Paclitaxel|paclitaxel|mesh-list
138958356|NCT00343291|Bevacizumab|bevacizumab|mesh-list
138958357|NCT00343291|Carboplatin|carboplatin|mesh-list
138958358|NCT00343291|Cetuximab|cetuximab|mesh-list
138958359|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138958360|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958361|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
138958362|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
138958363|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
138958364|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958365|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138958366|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138958367|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138958368|NCT00343291|Growth Substances|growth substances|mesh-ancestor
138958369|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958370|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
138958371|NCT05407870|Propofol|propofol|mesh-list
138958372|NCT05407870|Etomidate|etomidate|mesh-list
138958373|NCT05407870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138958374|NCT05407870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138958375|NCT05407870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958376|NCT05407870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138958377|NCT05407870|Anesthetics, General|anesthetics, general|mesh-ancestor
138958378|NCT05407870|Anesthetics|anesthetics|mesh-ancestor
138958379|NCT03988231|Enoxaparin|enoxaparin|mesh-list
138958380|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
138958381|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138958382|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138958383|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958384|NCT00658788|Calcitriol|calcitriol|mesh-list
138958385|NCT00658788|Clobetasol|clobetasol|mesh-list
138527755|NCT00031850|Goserelin|goserelin|mesh-list
138958386|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138479108|NCT02029313|Montelukast|montelukast|mesh-list
138958387|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958388|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138958389|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138958390|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958391|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138958392|NCT00658788|Vitamins|vitamins|mesh-ancestor
138958393|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
138958394|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138958395|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138958396|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
138958397|NCT00658788|Hormones|hormones|mesh-ancestor
138958398|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610350|NCT00187083|Dexamethasone|dexamethasone|mesh-list
138958400|NCT01060969|Tadalafil|tadalafil|mesh-list
138958401|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
138958402|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138958403|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138958404|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544289|NCT00198094|Alprazolam|alprazolam|mesh-list
138958405|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958406|NCT01060969|Urological Agents|urological agents|mesh-ancestor
138958407|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
138958408|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138958409|NCT01060969|Diuretics|diuretics|mesh-ancestor
138958410|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
138958411|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958412|NCT05407246|Hemay005|hemay005|mesh-list
138958413|NCT05407246|Dermatologic Agents|dermatologic agents|mesh-ancestor
138958414|NCT05407246|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138958415|NCT05407246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138958416|NCT05407246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958417|NCT05407246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958418|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138958419|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
138958420|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958421|NCT00799890|Protective Agents|protective agents|mesh-ancestor
138958422|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958423|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138479137|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479138|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138958424|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138958425|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958426|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138958427|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
138958428|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138958429|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958430|NCT00802308|Morphine|morphine|mesh-list
138958431|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138958432|NCT00802308|Narcotics|narcotics|mesh-ancestor
138645474|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958433|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138958434|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527847|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
138958435|NCT00802308|Analgesics|analgesics|mesh-ancestor
138479172|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138479173|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958436|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
138958437|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958438|NCT00562965|Dexamethasone|dexamethasone|mesh-list
138958439|NCT00562965|Prednisone|prednisone|mesh-list
138958440|NCT00562965|Prednisolone|prednisolone|mesh-list
138958441|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
138958442|NCT00562965|Rituximab|rituximab|mesh-list
138958443|NCT00562965|Fludarabine|fludarabine|mesh-list
138958444|NCT00562965|Vincristine|vincristine|mesh-list
138958445|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
138958446|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138958447|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958448|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
138958449|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958450|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138958451|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138958452|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
138958453|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958454|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958455|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138958456|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138958457|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
138958458|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
138958459|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958460|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958461|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
138958462|NCT00562965|Hormones|hormones|mesh-ancestor
138958463|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138958464|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138958465|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138958466|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138958467|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
138958468|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
138958469|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
138958470|NCT00562965|Analgesics|analgesics|mesh-ancestor
138958471|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
138958472|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138958473|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138610441|NCT00187122|Hormones|hormones|mesh-ancestor
138958474|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958475|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138958476|NCT00562965|Immunotoxins|immunotoxins|mesh-ancestor
138958477|NCT00562965|Immunoconjugates|immunoconjugates|mesh-ancestor
138958478|NCT05406934|Infliximab|infliximab|mesh-list
138958479|NCT05406934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138958480|NCT05406934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138958481|NCT05406934|Dermatologic Agents|dermatologic agents|mesh-ancestor
138479236|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479237|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958482|NCT05406934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958483|NCT05406934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138958484|NCT00794898|Infliximab|infliximab|mesh-list
138958485|NCT00794898|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138958486|NCT00794898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138958487|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
138958488|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958489|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138958490|NCT00800280|Cimetidine|cimetidine|mesh-list
138958491|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138958492|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958493|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138528028|NCT00060684|Dexamethasone|dexamethasone|mesh-list
138958494|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
138958495|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
138958496|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138958497|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958498|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958499|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138958500|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138958501|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958502|NCT00800358|Calcitriol|calcitriol|mesh-list
138958503|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138958504|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958506|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138528072|NCT00060918|Metoprolol|metoprolol|mesh-list
138958507|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958508|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138958509|NCT00800358|Vitamins|vitamins|mesh-ancestor
138958510|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
138958511|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138958512|NCT00934713|Montelukast|montelukast|mesh-list
138958513|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138958514|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
138958515|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138958516|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
138958517|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138958518|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528130|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
138958519|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138479268|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
138958520|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138958521|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958523|NCT01057849|Risperidone|risperidone|mesh-list
138958524|NCT01057849|Aripiprazole|aripiprazole|mesh-list
138958525|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138958526|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
138958527|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138958528|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544322|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138958529|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958530|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138528193|NCT00061113|Fluoxetine|fluoxetine|mesh-list
138958532|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138958533|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138958534|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138958535|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
138958536|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
138958537|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
138958538|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958539|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958540|NCT01057849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138958541|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138958542|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138958543|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
138958544|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
138958545|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138958546|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138958547|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138958548|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138958550|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
138958551|NCT00794976|BB 1101|bb 1101|mesh-list
138958552|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138958553|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
138958554|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
138958555|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958556|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958557|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958558|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
138958559|NCT00794976|Hormones|hormones|mesh-ancestor
138479299|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
138479304|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138958560|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138958561|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138958562|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958563|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
138958564|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958565|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958566|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138958568|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138958569|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958570|NCT00939939|Incretins|incretins|mesh-ancestor
138958571|NCT00939939|Hormones|hormones|mesh-ancestor
138958572|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138958573|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138958574|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
138958575|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958576|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958577|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138958578|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958579|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
138958580|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138958581|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138958582|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958583|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958584|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
138958585|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958587|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
138958588|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138958589|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958590|NCT04978012|Fluzoparib|fluzoparib|mesh-list
138958591|NCT04978012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138958592|NCT04978012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958593|NCT04978012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958594|NCT04978012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958597|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138958598|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138958599|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
138479333|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138958600|NCT00803166|Hormones|hormones|mesh-ancestor
138958601|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138958602|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958603|NCT00324961|Adefovir|adefovir|mesh-list
138958604|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138958605|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
138958606|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645604|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
138958607|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138958608|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138422116|NCT01690637|Oseltamivir|oseltamivir|mesh-list
138958610|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958611|NCT00935415|Montelukast|montelukast|mesh-list
138958612|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138958613|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
138958614|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138958615|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
138958616|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138528549|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
138958617|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958618|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138958619|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138958620|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958621|NCT00935571|Remifentanil|remifentanil|mesh-list
138958622|NCT00935571|Propofol|propofol|mesh-list
138958623|NCT00935571|Sevoflurane|sevoflurane|mesh-list
138958624|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138958625|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138958626|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958627|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138958628|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
138958629|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
138958630|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138958631|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138958632|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138479370|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958633|NCT00935571|Narcotics|narcotics|mesh-ancestor
138958634|NCT00935571|Analgesics|analgesics|mesh-ancestor
138958635|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
138958636|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958637|NCT00324649|Lamivudine|lamivudine|mesh-list
138958638|NCT00324649|Zidovudine|zidovudine|mesh-list
138958639|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138544344|NCT00084708|Vitamins|vitamins|mesh-ancestor
138958640|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138958641|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138958642|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958643|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958644|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
138958645|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138958646|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138958647|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138958648|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
138958649|NCT03743259|Charcoal|charcoal|mesh-list
138958650|NCT03743259|Antidotes|antidotes|mesh-ancestor
138958651|NCT03743259|Protective Agents|protective agents|mesh-ancestor
138958652|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958653|NCT03983239|Efavirenz|efavirenz|mesh-list
138958654|NCT03983239|Rifampin|rifampin|mesh-list
138958655|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138958656|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138958657|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958658|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958659|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
138958660|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138958661|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138958662|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138958663|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138958664|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138958665|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138958666|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138958667|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138958668|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
138958669|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138479412|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479413|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138479423|NCT02040064|Gefitinib|gefitinib|mesh-list
138958670|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
138958671|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138958672|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138958673|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138958674|NCT00935805|Insulin|insulin|mesh-list
138958675|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138958676|NCT00935805|Metformin|metformin|mesh-list
138958677|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
138958678|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
138958679|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
138958680|NCT00935805|Glyburide|glyburide|mesh-list
138958681|NCT00935805|Propranolol|propranolol|mesh-list
138958682|NCT00935805|Amlodipine|amlodipine|mesh-list
138958683|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138958684|NCT00935805|Captopril|captopril|mesh-list
138958685|NCT00935805|Diuretics|diuretics|mesh-list
138958686|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138958687|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958688|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138958689|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138958690|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138958691|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958692|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138958693|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
138958694|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
138958695|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138958696|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138958697|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138958698|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
138958699|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138958700|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138958701|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138958702|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
138958703|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958704|NCT00935961|Docetaxel|docetaxel|mesh-list
138479450|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
138958705|NCT00935961|Everolimus|everolimus|mesh-list
138958706|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958707|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
138958708|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
138958709|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
138528687|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
138958710|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958711|NCT00935961|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138958712|NCT00935961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138958713|NCT00935961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958714|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958715|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
138958716|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958717|NCT01055431|Iron|iron|mesh-list
138958718|NCT01055431|Trace Elements|trace elements|mesh-ancestor
138958719|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
138958720|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958721|NCT00803556|Paclitaxel|paclitaxel|mesh-list
138958722|NCT00803556|Trastuzumab|trastuzumab|mesh-list
138958723|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138958724|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958725|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
138958726|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
138958727|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
138958728|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958729|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138958730|NCT00936195|Ritonavir|ritonavir|mesh-list
138958731|NCT00936195|Lopinavir|lopinavir|mesh-list
138958732|NCT00936195|Tenofovir|tenofovir|mesh-list
138958733|NCT00936195|Lamivudine|lamivudine|mesh-list
138958734|NCT00936195|Emtricitabine|emtricitabine|mesh-list
138958735|NCT00936195|Zidovudine|zidovudine|mesh-list
138958736|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138958737|NCT00936195|Efavirenz|efavirenz|mesh-list
138958738|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138958739|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138958740|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
138958741|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958742|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958743|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138958744|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138958745|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
138958746|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138958747|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138958748|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138958749|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138958750|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138958751|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
138958752|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138958753|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138958754|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138958755|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138958756|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138958758|NCT00680186|Dabigatran|dabigatran|mesh-list
138958759|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
138958760|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
138958761|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138958762|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
138958763|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958764|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958766|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138958767|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
138958768|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958769|NCT00936429|Antacids|antacids|mesh-ancestor
138958770|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958771|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958772|NCT00656292|Simvastatin|simvastatin|mesh-list
138958773|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138958774|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138958776|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958777|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138958778|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138958779|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958780|NCT00352417|Atreleuton|atreleuton|mesh-list
138958781|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138528909|NCT02967276|Hormones|hormones|mesh-ancestor
138958782|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958783|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958784|NCT00944541|Maraviroc|maraviroc|mesh-list
138958785|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138958786|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138645696|NCT00319566|Estrogens|estrogens|mesh-ancestor
138479600|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
138958787|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958788|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138528978|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
138958789|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138958790|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
138958791|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138958792|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138958793|NCT00944619|Insulin|insulin|mesh-list
138958794|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138958795|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958796|NCT00323869|Bevacizumab|bevacizumab|mesh-list
138958797|NCT00323869|Carboplatin|carboplatin|mesh-list
138958798|NCT00323869|Gemcitabine|gemcitabine|mesh-list
138958799|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138958800|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529055|NCT00064428|PENTA|penta|mesh-list
138958801|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138958802|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138958803|NCT00323869|Growth Substances|growth substances|mesh-ancestor
138958804|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958805|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
138958806|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138958807|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
138958808|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479639|NCT02041143|Caseins|caseins|mesh-list
138958809|NCT00323557|Molgramostim|molgramostim|mesh-list
138958810|NCT00323557|Sargramostim|sargramostim|mesh-list
138958811|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138958812|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
138958813|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958814|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958815|NCT00558363|Dutasteride|dutasteride|mesh-list
138958816|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138958817|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138529175|NCT00038090|Thalidomide|thalidomide|mesh-list
138958818|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958819|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958820|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
138958821|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138958822|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958823|NCT00323479|Anastrozole|anastrozole|mesh-list
138958824|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138958825|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958826|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138958827|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138958828|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958829|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958830|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138958831|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
138958832|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138958833|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958834|NCT00352105|Fluorouracil|fluorouracil|mesh-list
138958835|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958836|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
138958837|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958838|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138958839|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958840|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
138958841|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958842|NCT03988075|Acetaminophen|acetaminophen|mesh-list
138958843|NCT03988075|Ibuprofen|ibuprofen|mesh-list
138958844|NCT03988075|Hydrocodone|hydrocodone|mesh-list
138479691|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
138958845|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138958846|NCT03988075|Analgesics|analgesics|mesh-ancestor
138958847|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
138958848|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958849|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958850|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
138958851|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138958852|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138958853|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138958854|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138529243|NCT00038246|Paclitaxel|paclitaxel|mesh-list
138958855|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958856|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958857|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138958858|NCT03988075|Narcotics|narcotics|mesh-ancestor
138958859|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138958860|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
138958861|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
138958862|NCT00944853|Zinc|zinc|mesh-list
138958863|NCT00944853|Trace Elements|trace elements|mesh-ancestor
138958864|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
138958865|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958866|NCT03985891|Antibodies|antibodies|mesh-list
138958867|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138958868|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
138958869|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958870|NCT00350779|Metformin|metformin|mesh-list
138958871|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138958872|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
138958873|NCT00350779|Glipizide|glipizide|mesh-list
138958874|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138958875|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958876|NCT00350779|Incretins|incretins|mesh-ancestor
138958877|NCT00350779|Hormones|hormones|mesh-ancestor
138958878|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138958879|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138958880|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
138958881|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958882|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958884|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958885|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138958886|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958887|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958888|NCT00676520|Everolimus|everolimus|mesh-list
138958889|NCT00676520|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138958890|NCT00676520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138958891|NCT00676520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958892|NCT00676520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479729|NCT02042196|Cetrorelix|cetrorelix|mesh-list
138958893|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958894|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
138958895|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958896|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958897|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
138958898|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138958899|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
138958900|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958901|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
138958902|NCT02559908|Protective Agents|protective agents|mesh-ancestor
138958903|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138958904|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138958905|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138958906|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138958907|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958908|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138958909|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958910|NCT00322621|Analgesics|analgesics|mesh-ancestor
138958911|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
138958912|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958913|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
138958914|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138958915|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
138958917|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138958918|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138958919|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
138958920|NCT00809718|Rifapentine|rifapentine|mesh-list
138958921|NCT00809718|Rifampin|rifampin|mesh-list
138958922|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138958923|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138958924|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
138958925|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138958926|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138958927|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138958928|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138958929|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958930|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138958931|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
138958932|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138958933|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
138958934|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138958935|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138958936|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138958937|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138958938|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138958939|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138958940|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138958941|NCT05427266|Bupivacaine|bupivacaine|mesh-list
138958942|NCT05427266|Anesthetics, Local|anesthetics, local|mesh-ancestor
138479753|NCT02042573|Sertraline|sertraline|mesh-list
138958943|NCT05427266|Anesthetics|anesthetics|mesh-ancestor
138958944|NCT05427266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138958945|NCT05427266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958946|NCT05427266|Sensory System Agents|sensory system agents|mesh-ancestor
138958947|NCT05427266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138958949|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138958950|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
138958951|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958952|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138958953|NCT00656058|Montelukast|montelukast|mesh-list
138958954|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138958955|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
138958956|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138958957|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
138958958|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138958959|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958960|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138529586|NCT00070434|Fluorouracil|fluorouracil|mesh-list
138958961|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138958962|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958963|NCT00537316|Infliximab|infliximab|mesh-list
138958964|NCT00537316|Azathioprine|azathioprine|mesh-list
138958965|NCT00537316|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138958966|NCT00537316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138958967|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
138958968|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138958969|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138958970|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
138958971|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958972|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138479776|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958973|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138958974|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138958975|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
138958976|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958977|NCT00803868|Varenicline|varenicline|mesh-list
138958978|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138958979|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138958980|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
138958981|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138958982|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138958983|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958984|NCT00655980|Folic Acid|folic acid|mesh-list
138958985|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
138958986|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
138958987|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
138958988|NCT00655980|Vitamins|vitamins|mesh-ancestor
138958989|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
138958990|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138958991|NCT00655980|Hematinics|hematinics|mesh-ancestor
138958992|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
138958993|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138958994|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
138958995|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
138958996|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138958997|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138958998|NCT00655980|Analgesics|analgesics|mesh-ancestor
138958999|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
138959000|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959001|NCT01063621|Apomorphine|apomorphine|mesh-list
138959003|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959004|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
138959005|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959006|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138959007|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
138959008|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
138959009|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959010|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959011|NCT02533141|Simvastatin|simvastatin|mesh-list
138959012|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138959013|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138959014|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
138529674|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
138959015|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959016|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138959017|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138959018|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959019|NCT00809796|Pentamidine|pentamidine|mesh-list
138959020|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
138959021|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138959022|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138479819|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
138959023|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138959024|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138959025|NCT05589454|Calcium, Dietary|calcium, dietary|mesh-list
138959027|NCT05589454|Calcium|calcium|mesh-list
138959028|NCT05589454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138959029|NCT05589454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959030|NCT05589454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138959031|NCT05589454|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138959032|NCT05589454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138959033|NCT05589454|Antimetabolites|antimetabolites|mesh-ancestor
138959034|NCT05589454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959035|NCT05589454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138959036|NCT05589454|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138959037|NCT05589454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959038|NCT00803946|Ibuprofen|ibuprofen|mesh-list
138959039|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138959040|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138959041|NCT00803946|Analgesics|analgesics|mesh-ancestor
138959042|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
138959043|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959044|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959045|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138959046|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138959047|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138959048|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959049|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959050|NCT00676130|Trimethoprim|trimethoprim|mesh-list
138959051|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138959052|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
138959053|NCT00676130|Cephalexin|cephalexin|mesh-list
138479847|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479848|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138959054|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138959055|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138959056|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
138959057|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138959058|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138959059|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138959060|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959061|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959062|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138959063|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138959064|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138959065|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138959066|NCT00809874|Caseins|caseins|mesh-list
138959067|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
138959068|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
138959069|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611023|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959070|NCT05436002|Hyaluronic Acid|hyaluronic acid|mesh-list
138959071|NCT05436002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138959072|NCT05436002|Immunologic Factors|immunologic factors|mesh-ancestor
138959073|NCT05436002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959074|NCT05436002|Viscosupplements|viscosupplements|mesh-ancestor
138959075|NCT05436002|Protective Agents|protective agents|mesh-ancestor
138959076|NCT02560376|Exenatide|exenatide|mesh-list
138959077|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138959078|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959079|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138959080|NCT02560376|Incretins|incretins|mesh-ancestor
138959081|NCT02560376|Hormones|hormones|mesh-ancestor
138959082|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138959083|NCT00535288|Mirtazapine|mirtazapine|mesh-list
138529988|NCT00144703|Sirolimus|sirolimus|mesh-list
138959084|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959085|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
138959086|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138959087|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138959088|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
138959089|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
138959090|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959091|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959092|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138959093|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138959094|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138959095|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138959096|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138959097|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138959098|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
138959099|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138959100|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138959102|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138479890|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
138479891|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
138959104|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138959105|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138959106|NCT00921830|Analgesics|analgesics|mesh-ancestor
138959107|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
138959108|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959109|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530107|NCT00038636|Ritonavir|ritonavir|mesh-list
138959110|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138959111|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138959112|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138959113|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959114|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959115|NCT02560220|Mitomycins|mitomycins|mesh-list
138959116|NCT02560220|Mitomycin|mitomycin|mesh-list
138959117|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138959118|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959119|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
138530162|NCT00203281|Tacrolimus|tacrolimus|mesh-list
138959120|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959121|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138959122|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959123|NCT05356078|Antidepressive Agents|antidepressive agents|mesh-list
138959124|NCT05356078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138959125|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
138959126|NCT04836832|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138959127|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959128|NCT04836832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138959129|NCT04836832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959130|NCT04836832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959131|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
138959132|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
138959133|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138959134|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959135|NCT02783300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138959136|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959137|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959138|NCT00675506|Hormones|hormones|mesh-list
138959139|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
138530224|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
138959140|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138959141|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959142|NCT05435378|Vitamins|vitamins|mesh-list
138959143|NCT05435378|Folic Acid|folic acid|mesh-list
138959144|NCT05435378|Niacinamide|niacinamide|mesh-list
138959145|NCT05435378|Vitamin B Complex|vitamin b complex|mesh-list
138959146|NCT05435378|Micronutrients|micronutrients|mesh-ancestor
138479912|NCT02043912|Haloperidol|haloperidol|mesh-list
138479913|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
138959147|NCT05435378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959148|NCT05435378|Hematinics|hematinics|mesh-ancestor
138959149|NCT03895840|Triamcinolone|triamcinolone|mesh-list
138959150|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138959151|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138959152|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138959153|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138959154|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
138959155|NCT03895840|Hormones|hormones|mesh-ancestor
138959156|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138959157|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959158|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138959159|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
138959160|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959161|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959162|NCT00310375|Ezogabine|ezogabine|mesh-list
138959163|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
138959164|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138959165|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959166|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
138959167|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138959168|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138959169|NCT00309907|Prednisolone|prednisolone|mesh-list
138959170|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
138959171|NCT00309907|Etanercept|etanercept|mesh-list
138959172|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138959173|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
138959174|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138959175|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
138959176|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
138959177|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959178|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959179|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138959180|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
138959181|NCT00309907|Hormones|hormones|mesh-ancestor
138959182|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138959183|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138959184|NCT00309907|Protective Agents|protective agents|mesh-ancestor
138959185|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138959186|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959187|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138959188|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138959189|NCT00309907|Analgesics|analgesics|mesh-ancestor
138959190|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
138959191|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138959192|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138959193|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
138959194|NCT00655824|Ofatumumab|ofatumumab|mesh-list
138959195|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959196|NCT03985969|Indomethacin|indomethacin|mesh-list
138479940|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959197|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138959198|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138959199|NCT03985969|Analgesics|analgesics|mesh-ancestor
138959200|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
138645898|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
138959201|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959202|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959203|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138959204|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138959205|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
138959206|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
138959207|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138959208|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138959209|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959210|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959211|NCT01061437|Lansoprazole|lansoprazole|mesh-list
138959212|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
138959213|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138959214|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138530442|NCT00072228|Gemcitabine|gemcitabine|mesh-list
138959215|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138959216|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959217|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611179|NCT00587119|Budesonide|budesonide|mesh-list
138959219|NCT00575588|Saxagliptin|saxagliptin|mesh-list
138959220|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138959221|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959222|NCT00575588|Incretins|incretins|mesh-ancestor
138959223|NCT00575588|Hormones|hormones|mesh-ancestor
138959224|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138206797|NCT02762669|Oxytocin|oxytocin|mesh-list
138959225|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138959226|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
138959227|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959228|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959230|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138959231|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138959232|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
138959233|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959234|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959235|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959236|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138959237|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138959238|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
138959239|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138959240|NCT00810030|Hematinics|hematinics|mesh-ancestor
138959241|NCT00675428|Natalizumab|natalizumab|mesh-list
138959242|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
138959243|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959244|NCT00760916|Treprostinil|treprostinil|mesh-list
138959245|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138959246|NCT00761228|Apomorphine|apomorphine|mesh-list
138959247|NCT00761228|Emetics|emetics|mesh-ancestor
138959248|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959249|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
138959250|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959251|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138959252|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
138959253|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
138959254|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645911|NCT00417404|Protective Agents|protective agents|mesh-ancestor
138959255|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959256|NCT00758732|Carboplatin|carboplatin|mesh-list
138959257|NCT00758732|Docetaxel|docetaxel|mesh-list
138959258|NCT00758732|Doxorubicin|doxorubicin|mesh-list
138959259|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138959260|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959261|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
138959262|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
138959263|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
138959264|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959265|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138959266|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138959267|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138959268|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959269|NCT02559674|Paclitaxel|paclitaxel|mesh-list
138959270|NCT02559674|Gemcitabine|gemcitabine|mesh-list
138959271|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138959272|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530690|NCT00411190|Analgesics|analgesics|mesh-ancestor
138959273|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
138959274|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
138959275|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
138959276|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959277|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138959278|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
138959279|NCT00761540|Liraglutide|liraglutide|mesh-list
138959280|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138959281|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959282|NCT00761540|Incretins|incretins|mesh-ancestor
138959283|NCT00761540|Hormones|hormones|mesh-ancestor
138959284|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138959285|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138959286|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138959287|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138959288|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138959289|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455941|NCT01909037|Analgesics|analgesics|mesh-ancestor
138959290|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959291|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959292|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138530745|NCT00206635|Interferons|interferons|mesh-list
138959294|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138959295|NCT00759200|Interferons|interferons|mesh-list
138959296|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
138959297|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
138959298|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959299|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
138959300|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138959301|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
138959302|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959303|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
138959305|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138959306|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959307|NCT01299753|Propranolol|propranolol|mesh-list
138959308|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138530798|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
138959309|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138959310|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
138959311|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959312|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959313|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959314|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138959315|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138959316|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
138959317|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
138959318|NCT02559440|Phenylephrine|phenylephrine|mesh-list
138959319|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
138530865|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
138959320|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138959321|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
138959322|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138959323|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138959324|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138959325|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
138959326|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959327|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959328|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959329|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
138959330|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
138959331|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959332|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
138959333|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138959334|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
138959335|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138959336|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
138959337|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138959338|NCT02559440|Protective Agents|protective agents|mesh-ancestor
138959339|NCT00674570|Cycloserine|cycloserine|mesh-list
138959340|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
138959341|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138959342|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138959343|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530996|NCT00208039|Calfactant|calfactant|mesh-list
138959344|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138959345|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
138959346|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138959348|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959349|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
138959350|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959351|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138959352|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959353|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959354|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
138959355|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959356|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959357|NCT00940719|Vitamin D|vitamin d|mesh-list
138959358|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
138959359|NCT00940719|Vitamins|vitamins|mesh-ancestor
138959360|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
138959361|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531051|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138959362|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138959363|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138959365|NCT00940953|Budesonide|budesonide|mesh-list
138959366|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138959367|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138959368|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
138959369|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959370|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959371|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138959372|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
138959374|NCT00940953|Hormones|hormones|mesh-ancestor
138959375|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138959376|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138959377|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959378|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959379|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138959380|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138959381|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138959382|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
138959383|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
138959384|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959385|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
138959386|NCT00759824|Doxorubicin|doxorubicin|mesh-list
138959387|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138959388|NCT00759824|Vindesine|vindesine|mesh-list
138959389|NCT00759824|Valproic Acid|valproic acid|mesh-list
138959390|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138959391|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
138959392|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959393|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138959394|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138959395|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
138959396|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959397|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959398|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138959399|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138959400|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138959401|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138959402|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959403|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
138959404|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
138959405|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959406|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
138959407|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138959408|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138959409|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138959410|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138959411|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
138959412|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
138959413|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
138959414|NCT00561951|Fesoterodine|fesoterodine|mesh-list
138959415|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138959416|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138531168|NCT00208819|Olanzapine|olanzapine|mesh-list
138959417|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
138959418|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959419|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959420|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959421|NCT00561951|Urological Agents|urological agents|mesh-ancestor
138959422|NCT00762398|Chrysarobin|chrysarobin|mesh-list
138959423|NCT00762398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138959424|NCT00762398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138959425|NCT00762398|Analgesics|analgesics|mesh-ancestor
138959426|NCT00762398|Sensory System Agents|sensory system agents|mesh-ancestor
138959427|NCT00762398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959428|NCT00762398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959429|NCT00762398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138959430|NCT00762398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138959431|NCT04552886|Immunomodulating Agents|immunomodulating agents|mesh-list
138959432|NCT04552886|Immunologic Factors|immunologic factors|mesh-ancestor
138959433|NCT04552886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959434|NCT00762632|Everolimus|everolimus|mesh-list
138959435|NCT00762632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138959436|NCT00762632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138959437|NCT00762632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959438|NCT00762632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959439|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138959440|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
138959441|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959442|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959443|NCT00322387|Plerixafor|plerixafor|mesh-list
138959444|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138611401|NCT00216762|Rituximab|rituximab|mesh-list
138959445|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138959446|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
138959447|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138959448|NCT00561015|Ribavirin|ribavirin|mesh-list
138959449|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
138959450|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138959451|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
138959452|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959453|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
138959454|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138959455|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959456|NCT04012047|Cromakalim|cromakalim|mesh-list
138959457|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138959458|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138959459|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
138959460|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959461|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959462|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138959463|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
138959464|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
138959465|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
138959466|NCT00941265|Levodopa|levodopa|mesh-list
138959467|NCT00941265|Benserazide|benserazide|mesh-list
138959468|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138959469|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138959470|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
138959471|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959472|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959473|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959474|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959476|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138959477|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138959478|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138959479|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
138959480|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959481|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959482|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959483|NCT00941343|Urological Agents|urological agents|mesh-ancestor
138959484|NCT00561795|Paclitaxel|paclitaxel|mesh-list
138959485|NCT00561795|Carboplatin|carboplatin|mesh-list
138959486|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138959487|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959488|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
138959489|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
138959490|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
138531369|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
138959491|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959492|NCT00652626|Azacitidine|azacitidine|mesh-list
138959493|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138959494|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
138959495|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959496|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959497|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959498|NCT00560703|Doxycycline|doxycycline|mesh-list
138959499|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138959500|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138959501|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
138959502|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138959503|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138959504|NCT00308737|Insulin|insulin|mesh-list
138959505|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138959506|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959507|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138959508|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
138959509|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959510|NCT00941499|Leucovorin|leucovorin|mesh-list
138508260|NCT06167317|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138508261|NCT06167317|Immunoconjugates|immunoconjugates|mesh-ancestor
138508262|NCT06167317|Immunologic Factors|immunologic factors|mesh-ancestor
138508263|NCT06167317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959511|NCT00941499|Bevacizumab|bevacizumab|mesh-list
138959512|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138959513|NCT00941499|Cetuximab|cetuximab|mesh-list
138959514|NCT00941499|Fluorouracil|fluorouracil|mesh-list
138959515|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
138959516|NCT00941499|Antibodies|antibodies|mesh-list
138959517|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
138959518|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138959519|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611473|NCT00182741|Calcitriol|calcitriol|mesh-list
138959520|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138959521|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138959522|NCT00941499|Growth Substances|growth substances|mesh-ancestor
138959523|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959524|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
138959525|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
138959527|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959528|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138959529|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138959530|NCT00941499|Antidotes|antidotes|mesh-ancestor
138959531|NCT00941499|Protective Agents|protective agents|mesh-ancestor
138959532|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
138959533|NCT00941499|Vitamins|vitamins|mesh-ancestor
138959534|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
138959535|NCT04752384|Buprenorphine|buprenorphine|mesh-list
138959536|NCT04752384|Tramadol|tramadol|mesh-list
138959537|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138959538|NCT04752384|Narcotics|narcotics|mesh-ancestor
138959539|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138959540|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959541|NCT04752384|Analgesics|analgesics|mesh-ancestor
138959542|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
138959543|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959544|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138959545|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
138959546|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
138959547|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138959549|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959550|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959551|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138959552|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
138959553|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138959554|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
138959555|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959556|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959557|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138959558|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
138959559|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
138959560|NCT00945789|Protective Agents|protective agents|mesh-ancestor
138959561|NCT00945789|Hematinics|hematinics|mesh-ancestor
138959562|NCT00941811|Imiquimod|imiquimod|mesh-list
138959563|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138959564|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
138531611|NCT00041327|Hormones|hormones|mesh-ancestor
138959565|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959566|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959567|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
138959568|NCT02553018|Methotrexate|methotrexate|mesh-list
138959569|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138959570|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
138959571|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138959572|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959573|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138959574|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
138959575|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959576|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959577|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
138959578|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959579|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138959580|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138959581|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
138959582|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138959583|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138959584|NCT00941967|Gemcitabine|gemcitabine|mesh-list
138959585|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
138959586|NCT00941967|Sorafenib|sorafenib|mesh-list
138959587|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138959588|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
138959589|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959590|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959591|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138959592|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959594|NCT00655746|Omeprazole|omeprazole|mesh-list
138959595|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138611547|NCT00216879|Calcipotriene|calcipotriene|mesh-list
138959596|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138959597|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138959598|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959599|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959600|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959601|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138959602|NCT00338455|Dobutamine|dobutamine|mesh-list
138959603|NCT00338455|Milrinone|milrinone|mesh-list
138959604|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138959605|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138959606|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
138959607|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
138959608|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959609|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959610|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138959611|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138959612|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138959613|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
138959614|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531784|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138959615|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959616|NCT00338455|Protective Agents|protective agents|mesh-ancestor
138959617|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138959618|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
138959619|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138959620|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138959621|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959622|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
138959624|NCT00678392|Axitinib|axitinib|mesh-list
138959625|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959626|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138959627|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544486|NCT00199186|Methotrexate|methotrexate|mesh-list
138959628|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959629|NCT00950391|Tacrolimus|tacrolimus|mesh-list
138959630|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138959631|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
138959632|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959633|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138959634|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959635|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959637|NCT00804336|Pasireotide|pasireotide|mesh-list
138959638|NCT00804336|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138959639|NCT00804336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138959640|NCT00804336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959641|NCT00804336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959642|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138959643|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
138959644|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959645|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959646|NCT00804336|Hormones|hormones|mesh-ancestor
138959647|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138959648|NCT00942201|Dexamethasone|dexamethasone|mesh-list
138959649|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
138959650|NCT00942201|BB 1101|bb 1101|mesh-list
138959651|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138959652|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
138959653|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
138959654|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959655|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959656|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138959657|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
138959658|NCT00942201|Hormones|hormones|mesh-ancestor
138646053|NCT00313833|Analgesics|analgesics|mesh-ancestor
138959659|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138959660|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138959661|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959662|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
138959663|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959664|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959665|NCT00942435|Darexaban|darexaban|mesh-list
138959666|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138959667|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
138959668|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138531896|NCT00213265|Vaccines|vaccines|mesh-list
138959669|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
138959670|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959671|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959672|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
138959674|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
138959675|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959677|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
138959678|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
138959679|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138959680|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959681|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
138959682|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959683|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138959684|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138959685|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138959686|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138531933|NCT00213694|Analgesics|analgesics|mesh-ancestor
138959687|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959689|NCT00942591|Interferon-beta|interferon-beta|mesh-list
138959690|NCT00942591|Atorvastatin|atorvastatin|mesh-list
138959691|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
138959692|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959693|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
138959694|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138959695|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138959696|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138959697|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
138959698|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959699|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138959700|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138959701|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959702|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
138959703|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959704|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138959706|NCT00946335|Veliparib|veliparib|mesh-list
138646059|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138959707|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138959708|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
138959709|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959710|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959711|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138959712|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959713|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
138959714|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138959715|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959716|NCT00762944|Cimetidine|cimetidine|mesh-list
138959717|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138959718|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138959719|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138959720|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
138959721|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
138959722|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959723|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532040|NCT00214864|Capecitabine|capecitabine|mesh-list
138959724|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959725|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138959726|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138959727|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959728|NCT00760448|Insulin|insulin|mesh-list
138959729|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138959730|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
138959731|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
138959733|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
138959734|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138959735|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959736|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138959737|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138959738|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138959739|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138959740|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959741|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959742|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959743|NCT00763178|Analgesics|analgesics|mesh-ancestor
138959744|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
138611693|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138959745|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959746|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
138959747|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138959748|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
138959749|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
138959750|NCT00308581|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138959751|NCT00308581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138959752|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138959753|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
138959754|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959755|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138959757|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138959758|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959759|NCT00658320|Cyclosporine|cyclosporine|mesh-list
138959760|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
138959761|NCT00658320|Everolimus|everolimus|mesh-list
138959762|NCT00658320|Cyclosporins|cyclosporins|mesh-list
138959763|NCT00658320|Basiliximab|basiliximab|mesh-list
138959764|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959765|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959766|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138959767|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
138508455|NCT05998642|Immunologic Factors|immunologic factors|mesh-ancestor
138959768|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959769|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
138959770|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138959771|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
138959772|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138959773|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138532284|NCT00216463|Mipomersen|mipomersen|mesh-list
138959774|NCT00658320|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138959775|NCT00658320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138959776|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959777|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138959778|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138959779|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
138959780|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138959781|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
138959782|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138959783|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959784|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138532342|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138959785|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959786|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138959787|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
138959788|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
138959789|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138959790|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138959791|NCT00806754|Ciclesonide|ciclesonide|mesh-list
138959792|NCT00806754|Azelastine|azelastine|mesh-list
138959793|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
138959794|NCT00806754|Hormones|hormones|mesh-ancestor
138959795|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138959796|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959797|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138959798|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138959799|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
138959800|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959801|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138959802|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
138959803|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138959804|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959805|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959806|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138959807|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138959808|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
138959809|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
138959810|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959811|NCT00764816|Caseins|caseins|mesh-list
138959812|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
138959813|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
138959814|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959815|NCT00322153|Memantine|memantine|mesh-list
138959816|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138959817|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138959818|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
138959819|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959820|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959821|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959822|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138959823|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138959824|NCT00806910|Conivaptan|conivaptan|mesh-list
138959825|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138959826|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959827|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
138959828|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959829|NCT00807066|Gefitinib|gefitinib|mesh-list
138959830|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959831|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138959832|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959833|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959834|NCT00804960|Letrozole|letrozole|mesh-list
138959835|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959836|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138646096|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
138959837|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138959838|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959839|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959840|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138508523|NCT05870579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138508524|NCT05856526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138508529|NCT05837455|Anastrozole|anastrozole|mesh-list
138508530|NCT05837455|Taxane|taxane|mesh-list
138508533|NCT05837455|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138959841|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
138959842|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138959843|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959844|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
138959845|NCT00805116|Vitamins|vitamins|mesh-ancestor
138959846|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
138959847|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959848|NCT03985735|Anesthetics|anesthetics|mesh-list
138959849|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138959850|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959851|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138959852|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138959853|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959854|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138959855|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138959856|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138959857|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959859|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959860|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138959861|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138959862|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138959863|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138959864|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
138959865|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138959866|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
138959867|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138959868|NCT00672620|Vortioxetine|vortioxetine|mesh-list
138959869|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138959870|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138959871|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138959872|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959873|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959874|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959875|NCT00672620|Analgesics|analgesics|mesh-ancestor
138959876|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
138959877|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959878|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
138959879|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138959880|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
138959881|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138959882|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138959883|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138959884|NCT00672620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138959885|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
138959886|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138959887|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138532762|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
138959888|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138959889|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138959891|NCT00764972|Vinorelbine|vinorelbine|mesh-list
138959892|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959893|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138959895|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959896|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138959897|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
138959898|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
138959899|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
138959900|NCT00673790|Losartan|losartan|mesh-list
138959901|NCT00673790|Lisinopril|lisinopril|mesh-list
138959902|NCT00673790|Nebivolol|nebivolol|mesh-list
138959903|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138532827|NCT00412555|Oseltamivir|oseltamivir|mesh-list
138959905|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138959906|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138959907|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959908|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138959909|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
138959910|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959911|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138959912|NCT00673790|Protective Agents|protective agents|mesh-ancestor
138959913|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959914|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
138959915|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138959916|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138959918|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
138959919|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138959920|NCT00763646|Docetaxel|docetaxel|mesh-list
138959921|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959922|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
138959923|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
138959924|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
138959925|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959926|NCT00763880|Lidocaine|lidocaine|mesh-list
138959927|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
138959928|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
138959929|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532938|NCT00221260|Anesthetics|anesthetics|mesh-list
138959930|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959931|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
138959932|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138959933|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138959934|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138959935|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138959936|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138959937|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959938|NCT00657150|Enoxaparin|enoxaparin|mesh-list
138959939|NCT00657150|Dabigatran|dabigatran|mesh-list
138959940|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
138959941|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138959942|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138959943|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959944|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
138959945|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138959946|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
138959947|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959948|NCT00770354|Letrozole|letrozole|mesh-list
138959949|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959950|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138533060|NCT02965443|Incretins|incretins|mesh-ancestor
138959951|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138959952|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959953|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959954|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138959955|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
138544528|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138959956|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138959957|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959958|NCT00670748|Aldesleukin|aldesleukin|mesh-list
138959959|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
138959960|NCT00670748|Fludarabine|fludarabine|mesh-list
138959961|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
138959962|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138959963|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
138959964|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138959965|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138611918|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
138959966|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138959967|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
138959968|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959969|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138959970|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138508624|NCT05701059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138959971|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138959972|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
138959973|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138959974|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138959975|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
138959976|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138959977|NCT00646776|Ritonavir|ritonavir|mesh-list
138959978|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138959979|NCT00646776|Rifabutin|rifabutin|mesh-list
138959980|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138959981|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138959982|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
138959983|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138959984|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959985|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138959986|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138959987|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
138959988|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138959989|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138959990|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138959991|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138959992|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138959993|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
138959994|NCT02558114|Ribavirin|ribavirin|mesh-list
138959995|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
138959996|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138959997|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
138959998|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138959999|NCT00770666|Bupropion|bupropion|mesh-list
138960000|NCT00770666|Nicotine|nicotine|mesh-list
138960001|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138960002|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
138960003|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960004|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960005|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138960006|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138960007|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
138960008|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960009|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960010|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138960011|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
138960012|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138960013|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138960014|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138960015|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138960016|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
138960017|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138960018|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138960019|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960020|NCT00764036|Artesunate|artesunate|mesh-list
138960021|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
138960022|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138960023|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138960024|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960025|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960026|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
138960027|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
138960028|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138960029|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
138960030|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138960031|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960033|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138960034|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138960035|NCT00811200|Ranibizumab|ranibizumab|mesh-list
138960036|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138960037|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138960038|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138960039|NCT00811200|Growth Substances|growth substances|mesh-ancestor
138960040|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960041|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
138960042|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960043|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138960044|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
138960045|NCT00811200|Hormones|hormones|mesh-ancestor
138960046|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138960047|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138960048|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
138960049|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960050|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960051|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
138960053|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138960054|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138960055|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
138960056|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960057|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138960058|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138960059|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960060|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138960061|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960062|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138960063|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
138960064|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138960065|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960066|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138960067|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138960068|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138960069|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960070|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960071|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138960072|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138960073|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138960074|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
138960075|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960076|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960077|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138960078|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138960079|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
138960080|NCT00770744|Olanzapine|olanzapine|mesh-list
138960081|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
138960082|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
138960083|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960084|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960085|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138960086|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138960087|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138960088|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960089|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138960090|NCT00770744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138960091|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138235397|NCT02735187|Vitamin D|vitamin d|mesh-list
138960092|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138960093|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960094|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960095|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
138960097|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
138960098|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960099|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138960100|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138960101|NCT00655668|Growth Substances|growth substances|mesh-ancestor
138960102|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
138960103|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960104|NCT00770900|Montelukast|montelukast|mesh-list
138960105|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138960106|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
138960107|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138960108|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
138960109|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138960110|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960111|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138960112|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138960113|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960114|NCT00766220|Irinotecan|irinotecan|mesh-list
138960115|NCT00766220|Cetuximab|cetuximab|mesh-list
138960116|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138960117|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138960118|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960119|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960120|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960121|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138960122|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
138960123|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
138960124|NCT00770978|Cephalosporins|cephalosporins|mesh-list
138960125|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138960126|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960127|NCT00764426|Ethanol|ethanol|mesh-list
138960128|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138960129|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960130|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960131|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960132|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
138960133|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
138960134|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
138960135|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
138960136|NCT00764582|Levofloxacin|levofloxacin|mesh-list
138544570|NCT00199576|Hormones|hormones|mesh-ancestor
138960137|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138960138|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138960139|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138960140|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960141|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138960142|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138960143|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960144|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960145|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960146|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138960147|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138960148|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138960149|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
138960150|NCT04048226|Ketamine|ketamine|mesh-list
138960151|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138960152|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960153|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960154|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138960155|NCT04048226|Analgesics|analgesics|mesh-ancestor
138960156|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
138960157|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960158|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138960159|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138960160|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138960161|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
138960162|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960163|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960164|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138960165|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138960167|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
138960168|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138960169|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138960170|NCT00811746|Eszopiclone|eszopiclone|mesh-list
138960171|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138960172|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960173|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960174|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
138960175|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
138960176|NCT04048070|Sufentanil|sufentanil|mesh-list
138960177|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138960178|NCT04048070|Narcotics|narcotics|mesh-ancestor
138960179|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960180|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960181|NCT04048070|Analgesics|analgesics|mesh-ancestor
138960182|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
138960183|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960184|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138960185|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138960186|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
138960187|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
138960188|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138960189|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138960190|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138960191|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138960192|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138960193|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960194|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960196|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138960197|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544576|NCT00084942|Gemcitabine|gemcitabine|mesh-list
138960198|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960199|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
138960200|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960201|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960202|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
138960204|NCT00811980|Linezolid|linezolid|mesh-list
138960205|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138960206|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960207|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138960208|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960209|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960210|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138960211|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
138960212|NCT00775034|Coagulants|coagulants|mesh-ancestor
138960213|NCT00813696|Gemcitabine|gemcitabine|mesh-list
138960214|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960215|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138960216|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
138960217|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960218|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
138960219|NCT00813774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138960220|NCT00813774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138960221|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138960222|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
138960223|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960224|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138960226|NCT02557490|Raltitrexed|raltitrexed|mesh-list
138960227|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960228|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138960229|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
138960230|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960231|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138960232|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960234|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138960235|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138960236|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138960237|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138960238|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138960239|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960240|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
138960241|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960242|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960243|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138960244|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960245|NCT00807534|Bromides|bromides|mesh-list
138960246|NCT00807534|Ipratropium|ipratropium|mesh-list
138960247|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
138960248|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138960249|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
138960250|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960251|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960252|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138960253|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
138960254|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138544590|NCT00084981|Decitabine|decitabine|mesh-list
138508791|NCT05472779|Contraceptive Agents|contraceptive agents|mesh-ancestor
138960255|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
138960256|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960257|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960258|NCT05589064|Vitamin D|vitamin d|mesh-list
138960259|NCT05589064|Cholecalciferol|cholecalciferol|mesh-list
138960260|NCT05589064|Vitamins|vitamins|mesh-ancestor
138960261|NCT05589064|Micronutrients|micronutrients|mesh-ancestor
138960262|NCT05589064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960263|NCT05589064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138960264|NCT05589064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138960266|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138960267|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
138960268|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960269|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138960270|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960271|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960272|NCT05355844|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138960273|NCT05355844|Dermatologic Agents|dermatologic agents|mesh-ancestor
138960274|NCT00814008|Insulin|insulin|mesh-list
138960275|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138960276|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960277|NCT00814086|Paclitaxel|paclitaxel|mesh-list
138960278|NCT00814086|Cisplatin|cisplatin|mesh-list
138960279|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138960280|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960281|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
138960282|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
138960283|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
138960284|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960285|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138960286|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138533998|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138960287|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138960288|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138960289|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960290|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960291|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960292|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
138960293|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138960295|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138960296|NCT00654732|Doxorubicin|doxorubicin|mesh-list
138960297|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138960298|NCT00654732|Dacarbazine|dacarbazine|mesh-list
138960299|NCT00654732|Bleomycin|bleomycin|mesh-list
138960300|NCT00654732|Vinblastine|vinblastine|mesh-list
138960301|NCT00654732|Antibodies|antibodies|mesh-list
138960302|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
138960303|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138534094|NCT00078351|Hylan|hylan|mesh-list
138960304|NCT00654732|Imidazole|imidazole|mesh-list
138960305|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
138960306|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960307|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960308|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138960309|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138960310|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138960311|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138960312|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960313|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960314|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138960315|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
138960316|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138960317|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
138960318|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
138960319|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
138960320|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
138960321|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138960322|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
138534117|NCT00044486|Posaconazole|posaconazole|mesh-list
138960323|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960324|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960325|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138960326|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
138960327|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138960328|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
138960329|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960330|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960331|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138508853|NCT05388006|Durvalumab|durvalumab|mesh-list
138960332|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
138960333|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
138960334|NCT00771368|Protective Agents|protective agents|mesh-ancestor
138960335|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
138960336|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
138960337|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138612302|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
138960338|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960339|NCT00771680|Insulin|insulin|mesh-list
138960340|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138960341|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
138960342|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
138960343|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138960344|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
138960345|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
138960346|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138960347|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138960348|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960349|NCT00767468|Sorafenib|sorafenib|mesh-list
138960350|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960351|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138960352|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960353|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960354|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
138960355|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138534182|NCT00044720|Sirolimus|sirolimus|mesh-list
138960356|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
138960357|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960358|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
138960359|NCT00669032|Protective Agents|protective agents|mesh-ancestor
138960360|NCT00775580|Atenolol|atenolol|mesh-list
138960361|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138960362|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138960363|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
138960364|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
138960365|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960366|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960367|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138960368|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138960369|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138960370|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
138960371|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960372|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960373|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
138960374|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138960375|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138508885|NCT05279833|Dronedarone|dronedarone|mesh-list
138960376|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960377|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
138960378|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960379|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960380|NCT00654498|Pramipexole|pramipexole|mesh-list
138960381|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
138534211|NCT00078858|Fludarabine|fludarabine|mesh-list
138960382|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960383|NCT00654498|Protective Agents|protective agents|mesh-ancestor
138960384|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960385|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138960386|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138960387|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
138960389|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960390|NCT00670046|Valproic Acid|valproic acid|mesh-list
138960391|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
138960392|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960393|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960395|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960396|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960397|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
138960398|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138960399|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960400|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138960401|NCT00560391|Dexamethasone|dexamethasone|mesh-list
138960402|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
138960403|NCT00560391|Lenalidomide|lenalidomide|mesh-list
138960404|NCT00560391|Dasatinib|dasatinib|mesh-list
138960405|NCT00560391|BB 1101|bb 1101|mesh-list
138960406|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138960407|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
138960408|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
138960409|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960410|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960411|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138960412|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
138960413|NCT00560391|Hormones|hormones|mesh-ancestor
138960414|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138960415|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138960416|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960417|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
138960418|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960419|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960420|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
138960421|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138534259|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138960422|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138960423|NCT00560391|Growth Substances|growth substances|mesh-ancestor
138960424|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
138960425|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138960426|NCT00775736|Insulin|insulin|mesh-list
138960427|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138960428|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
138960429|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
138508914|NCT05260008|Autonomic Agents|autonomic agents|mesh-ancestor
138960430|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138960431|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
138960432|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138960433|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138960434|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960435|NCT00537238|Pregabalin|pregabalin|mesh-list
138960436|NCT00537238|Levetiracetam|levetiracetam|mesh-list
138960437|NCT00537238|Analgesics|analgesics|mesh-ancestor
138960438|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
138960439|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960440|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960441|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
138960443|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138960444|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960445|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138960446|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138960447|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138960448|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960449|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138960450|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
138960451|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
138960452|NCT03982771|Bortezomib|bortezomib|mesh-list
138960453|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138960454|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
138960455|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960456|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138960457|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138960458|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
138960459|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960460|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960461|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138534299|NCT04457557|Ropivacaine|ropivacaine|mesh-list
138960462|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138960463|NCT00775814|Candesartan|candesartan|mesh-list
138960464|NCT00775814|Candesartan cilexetil|candesartan cilexetil|mesh-list
138960465|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138960466|NCT00775814|Diuretics|diuretics|mesh-ancestor
138960467|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
138960468|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960469|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138960470|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138960471|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960472|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138960473|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138960474|NCT00942747|Sirolimus|sirolimus|mesh-list
138960475|NCT00942747|Temsirolimus|temsirolimus|mesh-list
138960476|NCT00942747|MTOR Inhibitors|mtor inhibitors|mesh-list
138960477|NCT00942747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138960478|NCT00942747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960479|NCT00942747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960480|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138960481|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
138960482|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960483|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960484|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138960485|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960486|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138960487|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
138960488|NCT00946491|Haloperidol|haloperidol|mesh-list
138960489|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
138960490|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
138960491|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
138960492|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960493|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960494|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138960495|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138960496|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138960497|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960498|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138960499|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138960500|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
138960501|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960502|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960503|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138960504|NCT05355610|Gentamicins|gentamicins|mesh-list
138960506|NCT05355610|Dexamethasone acetate|dexamethasone acetate|mesh-list
138960508|NCT05355610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138960509|NCT05355610|Antiemetics|antiemetics|mesh-ancestor
138960510|NCT05355610|Autonomic Agents|autonomic agents|mesh-ancestor
138960511|NCT05355610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960512|NCT05355610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960513|NCT05355610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138960514|NCT05355610|Glucocorticoids|glucocorticoids|mesh-ancestor
138960515|NCT05355610|Hormones|hormones|mesh-ancestor
138960516|NCT05355610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138960517|NCT05355610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138960518|NCT05355610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960519|NCT05355610|Protease Inhibitors|protease inhibitors|mesh-ancestor
138960520|NCT05355610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960521|NCT05355610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960522|NCT05355610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138960523|NCT05355610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960524|NCT05355610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138960525|NCT00552669|Sirolimus|sirolimus|mesh-list
138960526|NCT00552669|Paclitaxel|paclitaxel|mesh-list
138960527|NCT00552669|Temsirolimus|temsirolimus|mesh-list
138960528|NCT00552669|MTOR Inhibitors|mtor inhibitors|mesh-list
138534438|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
138960529|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138960530|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960532|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
138960533|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
138960534|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960535|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138960536|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960537|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138960538|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
138960539|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138960540|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
138960541|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960542|NCT00552669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138960543|NCT00552669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960544|NCT00943059|Acipimox|acipimox|mesh-list
138960545|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138960546|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
138960547|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960548|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138960549|NCT00943137|Fluorouracil|fluorouracil|mesh-list
138960550|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
138960551|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960552|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138960553|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960554|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138960555|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
138960556|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960557|NCT00772616|Sufentanil|sufentanil|mesh-list
138960558|NCT00772616|Remifentanil|remifentanil|mesh-list
138960559|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138960560|NCT00772616|Narcotics|narcotics|mesh-ancestor
138960561|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960562|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960564|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
138534542|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
138960565|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960566|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138960567|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138960568|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
138960569|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
138960570|NCT00768404|Phentermine|phentermine|mesh-list
138960571|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138960572|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960573|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
138960594|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138960595|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138960596|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
138960597|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
138960598|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960599|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960600|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960602|NCT00943293|Melphalan|melphalan|mesh-list
138960603|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
138960604|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960605|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960606|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138960607|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
138960608|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960609|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138960610|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
138960611|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138509028|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138960612|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138960613|NCT00776360|Oxytocin|oxytocin|mesh-list
138960614|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
138960615|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138960616|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960618|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138960619|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138960620|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
138960621|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
138960622|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960623|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960624|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138960625|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138960626|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138960627|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
138960628|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960629|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960630|NCT03041740|Perflubron|perflubron|mesh-list
138960631|NCT03041740|Bromides|bromides|mesh-list
138960632|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
138960633|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138960634|NCT00772694|Sorafenib|sorafenib|mesh-list
138960635|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960636|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138960637|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960638|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960640|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
138960641|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960643|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960644|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138960645|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960646|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960647|NCT00952029|Leucovorin|leucovorin|mesh-list
138960648|NCT00952029|Bevacizumab|bevacizumab|mesh-list
138960649|NCT00952029|Fluorouracil|fluorouracil|mesh-list
138960650|NCT00952029|Irinotecan|irinotecan|mesh-list
138960651|NCT00952029|Calcium|calcium|mesh-list
138960652|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
138960653|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138960654|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960655|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138960656|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138960657|NCT00952029|Growth Substances|growth substances|mesh-ancestor
138960658|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960659|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
138960660|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138960661|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
138235963|NCT02682381|Teduglutide|teduglutide|mesh-list
138960662|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960663|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138960664|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138960665|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
138960666|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138960668|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960669|NCT00952029|Antidotes|antidotes|mesh-ancestor
138960670|NCT00952029|Protective Agents|protective agents|mesh-ancestor
138960671|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
138960672|NCT00952029|Vitamins|vitamins|mesh-ancestor
138960673|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
138960674|NCT00667862|Panobinostat|panobinostat|mesh-list
138960675|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960676|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138960677|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960678|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960679|NCT00952185|Antibodies|antibodies|mesh-list
138960680|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
138960681|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960683|NCT00776516|Mirabegron|mirabegron|mesh-list
138960684|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138960685|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
138960686|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138960687|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960688|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
138960689|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138960690|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960691|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960692|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138960693|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138960694|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138960695|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138960696|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138960697|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138960698|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138960699|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138960700|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138960701|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
138960702|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960703|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960704|NCT00776516|Urological Agents|urological agents|mesh-ancestor
138960705|NCT00768638|Atorvastatin|atorvastatin|mesh-list
138960706|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138960707|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138960708|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
138960709|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960710|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138612672|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
138960711|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138960712|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960713|NCT02557958|Azithromycin|azithromycin|mesh-list
138960714|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138960715|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138960717|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138960718|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
138960719|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960720|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960721|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138960722|NCT00535132|Risperidone|risperidone|mesh-list
138960723|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138960724|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138960725|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
138960726|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138960727|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960728|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960729|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138960730|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138960731|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960732|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138960733|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138960734|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
138960735|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138960736|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138960737|NCT00570908|Capecitabine|capecitabine|mesh-list
138960738|NCT00570908|Sunitinib|sunitinib|mesh-list
138960739|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138960740|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
138960741|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960742|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138960743|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138960744|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138960745|NCT00570908|Growth Substances|growth substances|mesh-ancestor
138960746|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960747|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
138960748|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138960749|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960750|NCT00773084|Lisinopril|lisinopril|mesh-list
138960751|NCT00773084|Spironolactone|spironolactone|mesh-list
138960752|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138960753|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
138960754|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138960755|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960756|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138960757|NCT00773084|Diuretics|diuretics|mesh-ancestor
138960758|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
138960759|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138960760|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
138960761|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960762|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960763|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138960764|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138960765|NCT00773084|Protective Agents|protective agents|mesh-ancestor
138960766|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
138960767|NCT00321919|Hematinics|hematinics|mesh-ancestor
138960768|NCT00781391|Warfarin|warfarin|mesh-list
138960769|NCT00781391|Edoxaban|edoxaban|mesh-list
138960770|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
138960771|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138960772|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
138960773|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138960774|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
138646326|NCT00288431|Sirolimus|sirolimus|mesh-list
138960776|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960777|NCT00534976|Montelukast|montelukast|mesh-list
138960778|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138960779|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
138960780|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138960781|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
138960782|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138960783|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612745|NCT00188630|Antidotes|antidotes|mesh-ancestor
138960784|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138960785|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138960786|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960787|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138509160|NCT04852887|Tamoxifen|tamoxifen|mesh-list
138960788|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
138960789|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138960790|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138960791|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138960792|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138960793|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960795|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138960796|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
138960797|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138960798|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138960799|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138960800|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
138960801|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138960802|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138960803|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138960804|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138960805|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
138535153|NCT00132613|Bleomycin|bleomycin|mesh-list
138960806|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138960807|NCT00776828|Protective Agents|protective agents|mesh-ancestor
138960808|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138960809|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138960810|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960811|NCT01063933|Peramivir|peramivir|mesh-list
138960812|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
138960813|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138509201|NCT04770272|Paclitaxel|paclitaxel|mesh-list
138960814|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138960815|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612969|NCT00220155|Gemcitabine|gemcitabine|mesh-list
138613115|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613192|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
138613730|NCT05925686|Tramadol|tramadol|mesh-list
138613929|NCT05487586|Avibactam|avibactam|mesh-list
138614307|NCT03905603|Cosyntropin|cosyntropin|mesh-list
138614381|NCT03605342|Analgesics|analgesics|mesh-ancestor
138614455|NCT03255915|Tenofovir|tenofovir|mesh-list
138614756|NCT01375140|Hormones|hormones|mesh-ancestor
138615055|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138615356|NCT00215202|Gefitinib|gefitinib|mesh-list
138615645|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138615947|NCT00193700|Hormones|hormones|mesh-ancestor
138616318|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535197|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
138616543|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138617228|NCT00196586|Ribavirin|ribavirin|mesh-list
138617295|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617369|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617458|NCT00226551|Isoproterenol|isoproterenol|mesh-list
138617516|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
138617673|NCT00203801|Artesunate|artesunate|mesh-list
138619389|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
138619682|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
138620005|NCT00234819|Estrogens|estrogens|mesh-list
138620288|NCT00211328|Anecortave|anecortave|mesh-list
138620446|NCT05428072|Antipyretics|antipyretics|mesh-ancestor
138620741|NCT00211952|Celecoxib|celecoxib|mesh-list
138621148|NCT00214058|Docetaxel|docetaxel|mesh-list
138621183|NCT00214331|Azithromycin|azithromycin|mesh-list
138621632|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
138621705|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138621928|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
138622085|NCT00241527|Esomeprazole|esomeprazole|mesh-list
138622249|NCT00217568|Docetaxel|docetaxel|mesh-list
138622384|NCT00218075|Levodopa|levodopa|mesh-list
138622461|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
138622753|NCT00219323|Omalizumab|omalizumab|mesh-list
138623795|NCT06171269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624246|NCT05557110|Blinatumomab|blinatumomab|mesh-list
138624395|NCT05221645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138624468|NCT05096169|Citric Acid|citric acid|mesh-list
138624617|NCT04756037|Relugolix|relugolix|mesh-list
138624691|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138624844|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138624917|NCT03951649|Acetaminophen|acetaminophen|mesh-list
138625216|NCT02883062|Atezolizumab|atezolizumab|mesh-list
138625747|NCT04613284|Endostatins|endostatins|mesh-list
138626265|NCT04605952|Antibodies|antibodies|mesh-list
138626633|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
138626862|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
138627775|NCT00415116|Carboplatin|carboplatin|mesh-list
138627989|NCT00570622|Pioglitazone|pioglitazone|mesh-list
138628137|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628358|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
138628433|NCT00574015|Analgesics|analgesics|mesh-ancestor
138628585|NCT00255372|Lactulose|lactulose|mesh-list
138628658|NCT04573855|Antibodies|antibodies|mesh-list
138628889|NCT00413504|PENTA|penta|mesh-list
138629020|NCT00227357|Naloxone|naloxone|mesh-list
138629173|NCT00236028|Infliximab|infliximab|mesh-list
138629323|NCT00191854|Paclitaxel|paclitaxel|mesh-list
138629399|NCT00191191|Pemetrexed|pemetrexed|mesh-list
138629471|NCT00256932|Alvimopan|alvimopan|mesh-list
138629624|NCT00193219|Growth Substances|growth substances|mesh-ancestor
138629770|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138230112|NCT02246816|Opium|opium|mesh-list
138630373|NCT00171301|Deferasirox|deferasirox|mesh-list
138630975|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
138631051|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138631352|NCT00233558|Methotrexate|methotrexate|mesh-list
138631647|NCT00234572|Lanreotide|lanreotide|mesh-list
138631874|NCT00235157|Sirolimus|sirolimus|mesh-list
138632249|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632547|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
138633064|NCT04538521|Niacin|niacin|mesh-list
138633070|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
138633604|NCT00263094|Rofecoxib|rofecoxib|mesh-list
138634201|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634649|NCT02278861|Protective Agents|protective agents|mesh-ancestor
138634872|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
138635169|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138635317|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
138635411|NCT01689298|Oxytocin|oxytocin|mesh-list
138636432|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138636508|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
138636667|NCT00277602|Riluzole|riluzole|mesh-list
138637855|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
138637930|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
138638460|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138638544|NCT04527679|Lenvatinib|lenvatinib|mesh-list
138638609|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138638764|NCT01687582|Liraglutide|liraglutide|mesh-list
138638984|NCT00288522|Lanreotide|lanreotide|mesh-list
138639211|NCT00254930|Risperidone|risperidone|mesh-list
138639280|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138639355|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
138639509|NCT00256100|PENTA|penta|mesh-list
138640036|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
138640261|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641623|NCT00263003|Irbesartan|irbesartan|mesh-list
138641698|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
138642012|NCT00265031|Prednisone|prednisone|mesh-list
138642662|NCT00416039|Midazolam|midazolam|mesh-list
138642734|NCT00296712|Dexetimide|dexetimide|mesh-list
138643182|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
138643710|NCT00313950|Vaccines|vaccines|mesh-list
138643859|NCT00273962|Albuterol|albuterol|mesh-list
138644008|NCT00274352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138644154|NCT00308880|Coagulants|coagulants|mesh-ancestor
138644304|NCT00278330|Alvocidib|alvocidib|mesh-list
138644607|NCT00316407|Paclitaxel|paclitaxel|mesh-list
138644765|NCT00280280|Baclofen|baclofen|mesh-list
138644907|NCT00281255|Dobutamine|dobutamine|mesh-list
138645130|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
138645282|NCT00283556|Irinotecan|irinotecan|mesh-list
138645352|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
138645654|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
138646527|NCT06139419|Paclitaxel|paclitaxel|mesh-list
138646889|NCT05799144|Pembrolizumab|pembrolizumab|mesh-list
138647259|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
138647564|NCT03961919|Treosulfan|treosulfan|mesh-list
138648238|NCT01572506|Biotin|biotin|mesh-list
138648565|NCT00303537|Metformin|metformin|mesh-list
138648702|NCT00324480|Vorinostat|vorinostat|mesh-list
138649887|NCT00298415|Carboplatin|carboplatin|mesh-list
138649963|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138650336|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
138650975|NCT00333021|PENTA|penta|mesh-list
138651607|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
138651758|NCT00336141|Vorinostat|vorinostat|mesh-list
138652047|NCT00337623|Prednisolone|prednisolone|mesh-list
138652949|NCT00313001|Incretins|incretins|mesh-ancestor
138653327|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
138653474|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138653624|NCT06164275|Doxorubicin|doxorubicin|mesh-list
138654000|NCT05676294|Olanzapine|olanzapine|mesh-list
138654297|NCT05159934|Nicotine|nicotine|mesh-list
138654372|NCT04865289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138654763|NCT03206671|Hormones|hormones|mesh-ancestor
138655199|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
138655580|NCT02959749|Growth Substances|growth substances|mesh-ancestor
138656104|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
138656178|NCT00331188|Vapreotide|vapreotide|mesh-list
138656709|NCT00354198|Hormones|hormones|mesh-ancestor
138656994|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138657153|NCT00432432|Infliximab|infliximab|mesh-list
138657445|NCT01055028|Paclitaxel|paclitaxel|mesh-list
138657512|NCT00428883|Protective Agents|protective agents|mesh-ancestor
138657669|NCT00328718|Xhance|xhance|mesh-list
138658554|NCT00333164|Cilostazol|cilostazol|mesh-list
138658622|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
138658774|NCT00334256|Tenofovir|tenofovir|mesh-list
138659218|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138660112|NCT00343733|Narcotics|narcotics|mesh-ancestor
138660194|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
138660492|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138660562|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138660859|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661307|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138661385|NCT00351884|Vildagliptin|vildagliptin|mesh-list
138661606|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
138661682|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
138662206|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
138662654|NCT06188143|Acetaminophen|acetaminophen|mesh-list
138662726|NCT06187584|Antitussive Agents|antitussive agents|mesh-ancestor
138706422|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
138706423|NCT04676997|Epirubicin|epirubicin|mesh-list
138706424|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138706425|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706426|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
138706427|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
138706428|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
138706429|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706430|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706431|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
138706432|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706433|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138706434|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138706435|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
138706436|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138706437|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138706438|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138706439|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138706440|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706441|NCT02910206|Sufentanil|sufentanil|mesh-list
138706442|NCT02910206|Propofol|propofol|mesh-list
138706443|NCT02910206|Etomidate|etomidate|mesh-list
138706444|NCT02910206|Cisatracurium|cisatracurium|mesh-list
138706445|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138706446|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138706447|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706448|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138706449|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
138706450|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
138706451|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138706452|NCT02910206|Narcotics|narcotics|mesh-ancestor
138706453|NCT02910206|Analgesics|analgesics|mesh-ancestor
138706454|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
138706455|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706456|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138706457|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138706458|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138706459|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
138706461|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
138706462|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138706463|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706464|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
138544676|NCT02962804|Nivolumab|nivolumab|mesh-list
138706465|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706467|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138706468|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138706469|NCT02909972|Cytarabine|cytarabine|mesh-list
138706470|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138706471|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
138509403|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706472|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706473|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706474|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
138706475|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706476|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706477|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
138706478|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706479|NCT00555594|Bevacizumab|bevacizumab|mesh-list
138535637|NCT00047294|Celecoxib|celecoxib|mesh-list
138646369|NCT00417677|Temsirolimus|temsirolimus|mesh-list
138706480|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138706481|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706482|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138706483|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138706484|NCT00555594|Growth Substances|growth substances|mesh-ancestor
138706485|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706486|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
138706488|NCT02910050|Anastrozole|anastrozole|mesh-list
138706490|NCT02910050|Bicalutamide|bicalutamide|mesh-list
138706491|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138706492|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706493|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138706494|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706495|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706496|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138706497|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
138706498|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138706499|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706500|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138706501|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
138706502|NCT02909933|Metformin|metformin|mesh-list
138706503|NCT02909933|Liraglutide|liraglutide|mesh-list
138706504|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138706505|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706506|NCT02909933|Incretins|incretins|mesh-ancestor
138706507|NCT02909933|Hormones|hormones|mesh-ancestor
138706508|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138706509|NCT02910245|Prednisone|prednisone|mesh-list
138706510|NCT02910245|Mesalamine|mesalamine|mesh-list
138706511|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
138706512|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138706513|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
138706514|NCT02910245|Hormones|hormones|mesh-ancestor
138709233|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706515|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138706516|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706517|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138706518|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706519|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
138706520|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706521|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138706522|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706523|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
138706524|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138706525|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706526|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138706527|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138706528|NCT02910245|Analgesics|analgesics|mesh-ancestor
138706529|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
138706530|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706532|NCT01185340|Serotonin|serotonin|mesh-list
138706533|NCT01185340|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138706534|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138706535|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
138706536|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709234|NCT04062448|Rituximab|rituximab|mesh-list
138706537|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706538|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706539|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138706540|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138706541|NCT01959282|Niacinamide|niacinamide|mesh-list
138706542|NCT01959282|Peficitinib|peficitinib|mesh-list
138706543|NCT01959282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706544|NCT01959282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706545|NCT01959282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706546|NCT01959282|Immunologic Factors|immunologic factors|mesh-ancestor
138706547|NCT01959282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706548|NCT01959282|Vitamin B Complex|vitamin b complex|mesh-ancestor
138706549|NCT01959282|Vitamins|vitamins|mesh-ancestor
138706550|NCT01959282|Micronutrients|micronutrients|mesh-ancestor
138706551|NCT01185301|Adalimumab|adalimumab|mesh-list
138706552|NCT01185301|Methotrexate|methotrexate|mesh-list
138706553|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138706554|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
138706555|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138706556|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706557|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138706558|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
138706559|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706560|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706561|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
138706562|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706563|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138706564|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535905|NCT00145639|Ifosfamide|ifosfamide|mesh-list
138706566|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138706567|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138706568|NCT01185301|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138706569|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138706570|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138706571|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
138509502|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
138706572|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138706573|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706574|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706575|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
138706576|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706577|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138706578|NCT01940991|Botulinum Toxins|botulinum toxins|mesh-list
138706579|NCT01940991|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138706580|NCT01940991|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138706581|NCT01940991|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138706582|NCT01940991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138706583|NCT01940991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706584|NCT01940991|Cholinergic Agents|cholinergic agents|mesh-ancestor
138706585|NCT01940991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138706586|NCT01940991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706587|NCT01940991|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138706588|NCT01940991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706589|NCT02909465|Midazolam|midazolam|mesh-list
138706590|NCT02909465|Ketamine|ketamine|mesh-list
138706591|NCT02909465|Haloperidol|haloperidol|mesh-list
138706592|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
138706593|NCT02909465|Analgesics|analgesics|mesh-ancestor
138706594|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
138706595|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706596|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706597|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138706599|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
138706600|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
138646394|NCT00288470|Hylan|hylan|mesh-list
138706601|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138706602|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138706603|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138706604|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138706605|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706606|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138706607|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138706608|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138706609|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138706610|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138509552|NCT04169828|Leucovorin|leucovorin|mesh-list
138706611|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
138706613|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
138706614|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
138706615|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138706616|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138706617|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138706618|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
138706619|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138706620|NCT04312555|Alprostadil|alprostadil|mesh-list
138706621|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138706622|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
138706623|NCT04312555|Urological Agents|urological agents|mesh-ancestor
138706624|NCT01184989|Dabigatran|dabigatran|mesh-list
138706625|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
138706626|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138706627|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
138706628|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706629|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706630|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
138706631|NCT04674423|Tenofovir|tenofovir|mesh-list
138706632|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
138706633|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706634|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138536140|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
138706635|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138706636|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706637|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706638|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138706639|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138706640|NCT00555867|Anastrozole|anastrozole|mesh-list
138706641|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138706642|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706643|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138706644|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138706645|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706646|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706647|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138706648|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
138706649|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138509584|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
138706650|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706651|NCT00555984|Remifentanil|remifentanil|mesh-list
138706652|NCT00555984|Propofol|propofol|mesh-list
138706653|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
138706654|NCT00555984|Anesthetics|anesthetics|mesh-list
138706655|NCT00555984|Sevoflurane|sevoflurane|mesh-list
138536262|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138706656|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138706657|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138706658|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706659|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
138706660|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138706661|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138706662|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138706663|NCT00555984|Narcotics|narcotics|mesh-ancestor
138706664|NCT00555984|Analgesics|analgesics|mesh-ancestor
138706665|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
138706666|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706667|NCT03457337|Gefitinib|gefitinib|mesh-list
138706668|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706669|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138706670|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706671|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706672|NCT01908738|Lidocaine|lidocaine|mesh-list
138706673|NCT01908738|Anesthetics, Local|anesthetics, local|mesh-ancestor
138706674|NCT01908738|Anesthetics|anesthetics|mesh-ancestor
138536324|NCT00147784|Interferons|interferons|mesh-list
138706675|NCT01908738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138706676|NCT01908738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706677|NCT01908738|Sensory System Agents|sensory system agents|mesh-ancestor
138509623|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
138706678|NCT01908738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706679|NCT01908738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138706680|NCT01908738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138706681|NCT01908738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138706682|NCT01908738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138706683|NCT01908738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706684|NCT04673955|Cetuximab|cetuximab|mesh-list
138706685|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138706686|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706687|NCT01904409|Rifaximin|rifaximin|mesh-list
138706688|NCT01904409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138706689|NCT01904409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706690|NCT01904409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138706691|NCT01902381|Thioctic Acid|thioctic acid|mesh-list
138706692|NCT01902381|Antioxidants|antioxidants|mesh-ancestor
138706693|NCT01902381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706694|NCT01902381|Protective Agents|protective agents|mesh-ancestor
138706695|NCT01902381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706696|NCT01902381|Vitamin B Complex|vitamin b complex|mesh-ancestor
138706697|NCT01902381|Vitamins|vitamins|mesh-ancestor
138706698|NCT01902381|Micronutrients|micronutrients|mesh-ancestor
138706699|NCT04673799|Denosumab|denosumab|mesh-list
138706700|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138706701|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706702|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
138706703|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
138706704|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
138706705|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706706|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
138706707|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138706708|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706709|NCT01871415|Metformin|metformin|mesh-list
138706710|NCT01871415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138706711|NCT01871415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706712|NCT05189717|Everolimus|everolimus|mesh-list
138706713|NCT05189717|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138706714|NCT05189717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138706715|NCT05189717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138509670|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
138706716|NCT05189717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706717|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706718|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
138706719|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663025|NCT06140966|Etoposide|etoposide|mesh-list
138706720|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706721|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138706723|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706724|NCT02277197|Cetuximab|cetuximab|mesh-list
138706725|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138706726|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706727|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
138706728|NCT00555087|Testosterone|testosterone|mesh-list
138706729|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
138706730|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
138706731|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138706732|NCT00555087|Androgens|androgens|mesh-ancestor
138706733|NCT00555087|Hormones|hormones|mesh-ancestor
138646415|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
138544708|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138706734|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138706735|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706736|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138706737|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706738|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
138706739|NCT04673214|Acetaminophen|acetaminophen|mesh-list
138706740|NCT04673214|Azithromycin|azithromycin|mesh-list
138706741|NCT04673214|Ivermectin|ivermectin|mesh-list
138706742|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138706743|NCT04673214|Analgesics|analgesics|mesh-ancestor
138706744|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
138706745|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706746|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706747|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
138706748|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138706749|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706750|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138706751|NCT00556023|Gemcitabine|gemcitabine|mesh-list
138706752|NCT00556023|Tremelimumab|tremelimumab|mesh-list
138706753|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138706754|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
138706755|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706756|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706757|NCT05011214|Ketamine|ketamine|mesh-list
138706758|NCT05011214|Sevoflurane|sevoflurane|mesh-list
138706759|NCT05011214|Esketamine|esketamine|mesh-list
138706760|NCT05011214|Analgesics|analgesics|mesh-ancestor
138706761|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
138706762|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706763|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706764|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138706765|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138706766|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
138706767|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
138706768|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138706769|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138706770|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138706771|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138706772|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536526|NCT00148681|Vinorelbine|vinorelbine|mesh-list
138706773|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138706774|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138706775|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
138706776|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138706777|NCT00556062|Vaccines|vaccines|mesh-list
138706778|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
138706779|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706780|NCT04676763|Histamine|histamine|mesh-list
138706781|NCT04676763|Substance P|substance p|mesh-list
138706782|NCT04676763|Neurokinin A|neurokinin a|mesh-list
138706783|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
138706784|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
138706785|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138706786|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706787|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706788|NCT04672707|Bromhexine|bromhexine|mesh-list
138706789|NCT04672707|Expectorants|expectorants|mesh-ancestor
138706790|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
138706791|NCT04932083|Midazolam|midazolam|mesh-list
138706792|NCT04932083|Fentanyl|fentanyl|mesh-list
138706793|NCT04932083|Nalbuphine|nalbuphine|mesh-list
138706794|NCT04932083|Bupivacaine|bupivacaine|mesh-list
138706795|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
138706796|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
138706797|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138706798|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706799|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
138706800|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706801|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138706802|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138706803|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138706804|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138706805|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138706806|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138706807|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
138706808|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
138706809|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
138706810|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138706811|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706812|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138706813|NCT04932083|Narcotics|narcotics|mesh-ancestor
138706814|NCT04932083|Analgesics|analgesics|mesh-ancestor
138706816|NCT01825980|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138706817|NCT01825980|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138706818|NCT01825980|Protease Inhibitors|protease inhibitors|mesh-ancestor
138706819|NCT01825980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706820|NCT01825980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706821|NCT01825980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138706822|NCT01825980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138706823|NCT01825980|Antiviral Agents|antiviral agents|mesh-ancestor
138706824|NCT01825980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706825|NCT01825980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138509796|NCT03671018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706826|NCT01825980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138706827|NCT04672317|Immunomodulating Agents|immunomodulating agents|mesh-list
138646459|NCT06140238|Parecoxib|parecoxib|mesh-list
138706828|NCT04672317|Immunologic Factors|immunologic factors|mesh-ancestor
138706829|NCT04672317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706830|NCT01655225|Pemetrexed|pemetrexed|mesh-list
138706831|NCT01655225|Letrozole|letrozole|mesh-list
138706832|NCT01655225|Fulvestrant|fulvestrant|mesh-list
138706833|NCT01655225|Midazolam|midazolam|mesh-list
138706834|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706835|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138706836|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138706837|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138706838|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706839|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138706840|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138706841|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138706842|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138706843|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
138706845|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
138706846|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
138706847|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138706848|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706849|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706850|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138706851|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138706852|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138706853|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138706854|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138706855|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
138706856|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138706857|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138706858|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138706860|NCT01818921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138706861|NCT01818921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138706862|NCT01818921|Growth Substances|growth substances|mesh-ancestor
138706863|NCT01818921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706864|NCT01818921|Growth Inhibitors|growth inhibitors|mesh-ancestor
138706865|NCT01818921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706867|NCT01810575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138706868|NCT01810575|Vasodilator Agents|vasodilator agents|mesh-ancestor
138706869|NCT01810575|Urological Agents|urological agents|mesh-ancestor
138706870|NCT01785771|Exenatide|exenatide|mesh-list
138706871|NCT01785771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138706872|NCT01785771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706873|NCT01785771|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138706874|NCT01785771|Incretins|incretins|mesh-ancestor
138706875|NCT01785771|Hormones|hormones|mesh-ancestor
138706876|NCT01785771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138706877|NCT01784874|Vaccines|vaccines|mesh-list
138706878|NCT01784874|Immunologic Factors|immunologic factors|mesh-ancestor
138706879|NCT01784874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706880|NCT04607252|Metformin|metformin|mesh-list
138706881|NCT04607252|Megestrol|megestrol|mesh-list
138706882|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
138706883|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138706884|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706885|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138706886|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138706887|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138706888|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
138706889|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138706890|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138706891|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138706892|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138706893|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706894|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
138646480|NCT06140095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138536932|NCT00150670|Cisplatin|cisplatin|mesh-list
138706895|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138706896|NCT01782729|Tacrolimus|tacrolimus|mesh-list
138706897|NCT01782729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706898|NCT01782729|Immunologic Factors|immunologic factors|mesh-ancestor
138706899|NCT01782729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706900|NCT01782729|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138706901|NCT01782729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706902|NCT01782729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706903|NCT01780428|Acetaminophen|acetaminophen|mesh-list
138706904|NCT01780428|Promethazine|promethazine|mesh-list
138706905|NCT01780428|Diphenhydramine|diphenhydramine|mesh-list
138706906|NCT01780428|Hydrocodone|hydrocodone|mesh-list
138706907|NCT01780428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138706908|NCT01780428|Analgesics|analgesics|mesh-ancestor
138706909|NCT01780428|Sensory System Agents|sensory system agents|mesh-ancestor
138706910|NCT01780428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706911|NCT01780428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706912|NCT01780428|Antipyretics|antipyretics|mesh-ancestor
138706913|NCT01780428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138706914|NCT01780428|Narcotics|narcotics|mesh-ancestor
138706915|NCT01780428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138706916|NCT01780428|Antitussive Agents|antitussive agents|mesh-ancestor
138706917|NCT01780428|Respiratory System Agents|respiratory system agents|mesh-ancestor
138706918|NCT01780428|Antipruritics|antipruritics|mesh-ancestor
138706919|NCT01780428|Dermatologic Agents|dermatologic agents|mesh-ancestor
138706920|NCT01780428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138706921|NCT01780428|Histamine Antagonists|histamine antagonists|mesh-ancestor
138706922|NCT01780428|Histamine Agents|histamine agents|mesh-ancestor
138706923|NCT01780428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138706924|NCT01780428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706925|NCT01780428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138706926|NCT01780428|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138706927|NCT01780428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138706928|NCT01780428|Anesthetics, Local|anesthetics, local|mesh-ancestor
138706930|NCT01780428|Antiemetics|antiemetics|mesh-ancestor
138537057|NCT00049751|Adalimumab|adalimumab|mesh-list
138706931|NCT01780428|Autonomic Agents|autonomic agents|mesh-ancestor
138706932|NCT01780428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138706933|NCT04671420|Rituximab|rituximab|mesh-list
138706934|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138706935|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706936|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
138706937|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706938|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138706939|NCT04573556|Lemborexant|lemborexant|mesh-list
138706940|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138706941|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537096|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138706942|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706943|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138706944|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138706945|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138706946|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706947|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
138706948|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138706949|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
138537192|NCT00151528|Pregabalin|pregabalin|mesh-list
138706950|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706952|NCT04671108|Protective Agents|protective agents|mesh-ancestor
138706953|NCT01779453|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138706954|NCT01779453|Atorvastatin|atorvastatin|mesh-list
138706955|NCT01779453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138706956|NCT01779453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138706957|NCT01779453|Antimetabolites|antimetabolites|mesh-ancestor
138537227|NCT00151567|Tamsulosin|tamsulosin|mesh-list
138706958|NCT01779453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706959|NCT01779453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138706960|NCT01779453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138706961|NCT01779453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706962|NCT01779453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138706963|NCT01779453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706964|NCT01776606|Botulinum Toxins|botulinum toxins|mesh-list
138706965|NCT01776606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138706966|NCT01776606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138706967|NCT01776606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138510023|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706968|NCT01776606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138706969|NCT01776606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706970|NCT01776606|Cholinergic Agents|cholinergic agents|mesh-ancestor
138706971|NCT01776606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138706972|NCT01776606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706973|NCT01776606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138706974|NCT01776606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706975|NCT01774578|Gemcitabine|gemcitabine|mesh-list
138706976|NCT01774578|Docetaxel|docetaxel|mesh-list
138706977|NCT01774578|Pemetrexed|pemetrexed|mesh-list
138706978|NCT01774578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138706979|NCT01774578|Antimetabolites|antimetabolites|mesh-ancestor
138706980|NCT01774578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706981|NCT01774578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706982|NCT01774578|Tubulin Modulators|tubulin modulators|mesh-ancestor
138706983|NCT01774578|Antimitotic Agents|antimitotic agents|mesh-ancestor
138706984|NCT01774578|Mitosis Modulators|mitosis modulators|mesh-ancestor
138537372|NCT00082836|Rituximab|rituximab|mesh-list
138706985|NCT01774578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706986|NCT01774578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138706987|NCT01774578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138706988|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
138706989|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138544761|NCT00200941|Topiramate|topiramate|mesh-list
138706990|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
138706991|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706992|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
138706993|NCT04670601|Analgesics|analgesics|mesh-ancestor
138706994|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
138706995|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138706996|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706997|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138706998|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138706999|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138707000|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138707001|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138707002|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707003|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707004|NCT04670913|Apatinib|apatinib|mesh-list
138707005|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707006|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138707007|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707008|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707009|NCT04671069|Clopidogrel|clopidogrel|mesh-list
138510073|NCT02539537|Leucovorin|leucovorin|mesh-list
138707010|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138707011|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138707012|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138707013|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138707014|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
138707015|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707016|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707017|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707018|NCT04322123|Azithromycin|azithromycin|mesh-list
138707019|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
138707020|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138707021|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707023|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138663324|NCT05891093|Exemestane|exemestane|mesh-list
138707024|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138707025|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707026|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707027|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138707028|NCT04259138|Vedolizumab|vedolizumab|mesh-list
138707029|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138707030|NCT01741155|Docetaxel|docetaxel|mesh-list
138707031|NCT01741155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707032|NCT01741155|Tubulin Modulators|tubulin modulators|mesh-ancestor
138707033|NCT01741155|Antimitotic Agents|antimitotic agents|mesh-ancestor
138707034|NCT01741155|Mitosis Modulators|mitosis modulators|mesh-ancestor
138707035|NCT01741155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707036|NCT04244630|Antioxidants|antioxidants|mesh-list
138707037|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707038|NCT04244630|Protective Agents|protective agents|mesh-ancestor
138707039|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707040|NCT04239053|Bupivacaine|bupivacaine|mesh-list
138707041|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
138707042|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
138707043|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138510105|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
138707044|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427661|NCT01706315|Gepotidacin|gepotidacin|mesh-list
138707045|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
138707046|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707047|NCT01718145|Ribavirin|ribavirin|mesh-list
138707048|NCT01718145|Asunaprevir|asunaprevir|mesh-list
138707049|NCT01718145|Antimetabolites|antimetabolites|mesh-ancestor
138707050|NCT01718145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707051|NCT01718145|Antiviral Agents|antiviral agents|mesh-ancestor
138707052|NCT01718145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707053|NCT01718145|Protease Inhibitors|protease inhibitors|mesh-ancestor
138707054|NCT01718145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707055|NCT00556257|Cyclosporine|cyclosporine|mesh-list
138707056|NCT00556257|Cyclosporins|cyclosporins|mesh-list
138707057|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707058|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707059|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138707060|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
138707061|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707062|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
138707063|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707064|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
138707065|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138707066|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138707067|NCT01712451|Fluticasone|fluticasone|mesh-list
138707069|NCT01712451|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138707070|NCT01712451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138707071|NCT01712451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138707072|NCT01712451|Autonomic Agents|autonomic agents|mesh-ancestor
138707073|NCT01712451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707074|NCT01712451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138510146|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138510148|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
138707075|NCT01712451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138707076|NCT01712451|Respiratory System Agents|respiratory system agents|mesh-ancestor
138707077|NCT01712451|Dermatologic Agents|dermatologic agents|mesh-ancestor
138707078|NCT01712451|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138707079|NCT01712451|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138707080|NCT01712451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138707081|NCT01712451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138707082|NCT01712451|Adrenergic Agents|adrenergic agents|mesh-ancestor
138707083|NCT01712451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707084|NCT01712451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707085|NCT01712217|Crizotinib|crizotinib|mesh-list
138707086|NCT01712217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707087|NCT01712217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138707088|NCT01712217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707089|NCT01712217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707090|NCT04669821|Propofol|propofol|mesh-list
138707091|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138707092|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138707093|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707094|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138707095|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
138707096|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
138707097|NCT00532025|Sorafenib|sorafenib|mesh-list
138707098|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707099|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138663398|NCT05855200|Dostarlimab|dostarlimab|mesh-list
138707100|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707101|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707102|NCT04669392|Ethanol|ethanol|mesh-list
138707103|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138707104|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707105|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138707106|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707107|NCT00532142|Triamcinolone|triamcinolone|mesh-list
138707108|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138707109|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
138707110|NCT00532142|Hormones|hormones|mesh-ancestor
138707111|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138707112|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707114|NCT00533312|Niacinamide|niacinamide|mesh-list
138707115|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
138707116|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138707117|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
138707118|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707119|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138707120|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
138707121|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
138707122|NCT00533312|Vitamins|vitamins|mesh-ancestor
138707123|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
138707124|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707125|NCT00533390|Efavirenz|efavirenz|mesh-list
138707126|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138707127|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138707128|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707129|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707130|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
138707131|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707132|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138707133|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138707134|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138707135|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138707136|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138707137|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138707139|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138707140|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707141|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138707142|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138707143|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709235|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138707144|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510227|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
138707145|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
138510236|NCT01659151|Analgesics|analgesics|mesh-ancestor
138707146|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707148|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
138707149|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
138707150|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
138707151|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544812|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
138707152|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707153|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
138707154|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707155|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138707156|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138707157|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138707158|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138707159|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707161|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138707162|NCT04668456|Analgesics|analgesics|mesh-ancestor
138707163|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138707164|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138707165|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138707166|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
138707167|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707168|NCT04668417|Vaccines|vaccines|mesh-list
138707169|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
138707170|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707171|NCT00556413|Leucovorin|leucovorin|mesh-list
138663475|NCT05806346|Hemostatics|hemostatics|mesh-ancestor
138707172|NCT00556413|Fluorouracil|fluorouracil|mesh-list
138707173|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
138707174|NCT00556413|Irinotecan|irinotecan|mesh-list
138707175|NCT00556413|Cetuximab|cetuximab|mesh-list
138707176|NCT00556413|Calcium|calcium|mesh-list
138707177|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
138707178|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138707179|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707180|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
138707181|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707182|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138707183|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707184|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138707185|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
138707186|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138707187|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138707188|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707189|NCT00556413|Antidotes|antidotes|mesh-ancestor
138707190|NCT00556413|Protective Agents|protective agents|mesh-ancestor
138707191|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
138707193|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
138707194|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138707195|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
138707196|NCT04668690|Analgesics|analgesics|mesh-ancestor
138707197|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
138707198|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707199|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707200|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707201|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138707202|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138707203|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707204|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707206|NCT00533585|Bevacizumab|bevacizumab|mesh-list
138707207|NCT00533585|Carboplatin|carboplatin|mesh-list
138707208|NCT00533585|Sorafenib|sorafenib|mesh-list
138707209|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138707210|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707211|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
138707212|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
138707213|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
138707214|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707215|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138707216|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138707217|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138707218|NCT00533585|Growth Substances|growth substances|mesh-ancestor
138707219|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707220|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
138707221|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138707222|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707224|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
138707225|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
138707226|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
138707227|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138707228|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707229|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
138707230|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707231|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138707232|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138707233|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138510297|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138510298|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
138510299|NCT01228331|Hormones|hormones|mesh-ancestor
138510301|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138707234|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138707235|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707236|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138707237|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138707238|NCT04659057|Analgesics|analgesics|mesh-ancestor
138707239|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138707240|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138707241|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138707242|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
138707243|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707244|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138707245|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138663549|NCT05756621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138707246|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
138707247|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707249|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707250|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138707252|NCT00533858|Lacidipine|lacidipine|mesh-list
138707253|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138707254|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138707255|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138707256|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138707257|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707258|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138707259|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138707260|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138707261|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707262|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
138188338|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707263|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138707264|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
138707265|NCT04658355|Povidone|povidone|mesh-list
138707266|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138707267|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707268|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
138707269|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
138707270|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
138707271|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
138707272|NCT00533936|Paclitaxel|paclitaxel|mesh-list
138707273|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
138707274|NCT00533936|Doxorubicin|doxorubicin|mesh-list
138707275|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138707276|NCT00533936|Fluorouracil|fluorouracil|mesh-list
138707278|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138707279|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707280|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
138707281|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
138707282|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
138707283|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707284|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138707285|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
138707286|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707287|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138707288|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138707289|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
138707290|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138707291|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138707292|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138707293|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138707294|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707295|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
138707296|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138707297|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138707298|NCT00557544|Ketoprofen|ketoprofen|mesh-list
138707299|NCT00557544|Metoclopramide|metoclopramide|mesh-list
138707300|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
138707301|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
138707302|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707303|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707304|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138707305|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138707306|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138707307|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
138707308|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707309|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707310|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138707311|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138707312|NCT00557544|Analgesics|analgesics|mesh-ancestor
138707313|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
138707314|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138510373|NCT00061750|Siderophores|siderophores|mesh-ancestor
138707315|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138707316|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138707317|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707318|NCT04667910|Ranibizumab|ranibizumab|mesh-list
138707319|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138663630|NCT05676112|Pirfenidone|pirfenidone|mesh-list
138538421|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707320|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138707321|NCT04667910|Growth Substances|growth substances|mesh-ancestor
138707322|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707323|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
138707324|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707325|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138707326|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
138707327|NCT00556608|Hylan|hylan|mesh-list
138707328|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138707329|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
138707330|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707331|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
138707332|NCT00556608|Protective Agents|protective agents|mesh-ancestor
138707333|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
138707334|NCT00534287|Meropenem|meropenem|mesh-list
138707335|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138707336|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138707337|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707338|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138707339|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138707340|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707341|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707342|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707343|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138707344|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
138707345|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138707346|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707347|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138707348|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138707349|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138707350|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
138707351|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138707352|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707353|NCT04168502|Immunotoxins|immunotoxins|mesh-ancestor
138707354|NCT04168502|Immunoconjugates|immunoconjugates|mesh-ancestor
138707355|NCT04168502|Immunologic Factors|immunologic factors|mesh-ancestor
138707356|NCT04168502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707357|NCT01215916|Pemetrexed|pemetrexed|mesh-list
138707358|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707359|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544908|NCT00048828|Olanzapine|olanzapine|mesh-list
138707360|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707361|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138707362|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138707363|NCT01184872|Vancomycin|vancomycin|mesh-list
138707364|NCT01184872|Daptomycin|daptomycin|mesh-list
138707365|NCT01184872|Penicillins|penicillins|mesh-list
138707366|NCT01184872|Floxacillin|floxacillin|mesh-list
138707367|NCT01184872|Cloxacillin|cloxacillin|mesh-list
138707368|NCT01184872|Oxacillin|oxacillin|mesh-list
138707369|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138707370|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707371|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
138707372|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138510453|NCT00062023|Aspirin|aspirin|mesh-list
138707373|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138707374|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
138707375|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707376|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707377|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707378|NCT01215721|Urological Agents|urological agents|mesh-ancestor
138707379|NCT00534677|Octreotide|octreotide|mesh-list
138707380|NCT00534677|Terlipressin|terlipressin|mesh-list
138707381|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138707382|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138707383|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707384|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138707385|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138707386|NCT00556959|Clonidine|clonidine|mesh-list
138707387|NCT00556959|Analgesics|analgesics|mesh-ancestor
138707388|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
138707389|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707390|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707391|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138707392|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
138707393|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
138707394|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138707395|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138707396|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138707397|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
138707398|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707399|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707400|NCT01184326|Everolimus|everolimus|mesh-list
138707401|NCT01184326|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138707402|NCT01184326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138707403|NCT01184326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707404|NCT01184326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707405|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138707406|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
138707407|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707408|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707409|NCT01215253|Ranolazine|ranolazine|mesh-list
138538699|NCT00160186|Pancreatin|pancreatin|mesh-list
138707410|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138707411|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138707412|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707413|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
138707414|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707415|NCT03813875|Midazolam|midazolam|mesh-list
138707416|NCT03813875|Fentanyl|fentanyl|mesh-list
138707417|NCT03813875|Alfentanil|alfentanil|mesh-list
138707418|NCT03813875|Propofol|propofol|mesh-list
138707419|NCT03813875|Sevoflurane|sevoflurane|mesh-list
138707420|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138707421|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138707422|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707423|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138707424|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
138707425|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
138707426|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138707427|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138707428|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138707429|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138707430|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
138707431|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
138707432|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707433|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707434|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138707435|NCT03813875|Narcotics|narcotics|mesh-ancestor
138707436|NCT03813875|Analgesics|analgesics|mesh-ancestor
138707437|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
138707438|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707439|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138707440|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138707441|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138707442|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707443|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138707444|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707445|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707446|NCT05449522|Vitamin D|vitamin d|mesh-list
138707448|NCT05449522|Micronutrients|micronutrients|mesh-ancestor
138707449|NCT05449522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707450|NCT05449522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138707451|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138707452|NCT03737981|Venetoclax|venetoclax|mesh-list
138707453|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
138707454|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707455|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138707456|NCT04665141|Omalizumab|omalizumab|mesh-list
138707457|NCT04665141|Benralizumab|benralizumab|mesh-list
138707458|NCT04665141|Reslizumab|reslizumab|mesh-list
138707459|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138707460|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138510534|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510535|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138190068|NCT01921790|Hormones|hormones|mesh-ancestor
138190154|NCT03496324|Ibuprofen|ibuprofen|mesh-list
138510536|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138510537|NCT00062179|Analgesics|analgesics|mesh-ancestor
138510538|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
138190355|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
138190512|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
138190584|NCT01110187|Lacosamide|lacosamide|mesh-list
138190729|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
138707461|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
138707462|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
138707463|NCT04665063|Fludarabine|fludarabine|mesh-list
138707464|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138707465|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
138544957|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
138707466|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707467|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138707468|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138707469|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
138707470|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707471|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707472|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138707473|NCT04664595|Propofol|propofol|mesh-list
138707474|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138707475|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138707476|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707477|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138707478|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
138707479|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
138707480|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138707481|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
138707482|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707483|NCT03580148|Cortisone|cortisone|mesh-list
138707484|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138707485|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138707486|NCT04664517|Anesthetics|anesthetics|mesh-list
138707487|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138707488|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230608|NCT01150760|Alvimopan|alvimopan|mesh-list
138707489|NCT01215097|Linagliptin|linagliptin|mesh-list
138707490|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138707491|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707492|NCT01215097|Incretins|incretins|mesh-ancestor
138707493|NCT01215097|Hormones|hormones|mesh-ancestor
138707494|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138707495|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138707496|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
138510575|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
138195580|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
138195728|NCT01006018|Hormones|hormones|mesh-ancestor
138707497|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707498|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707499|NCT03527576|Dexamethasone|dexamethasone|mesh-list
138707500|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138707501|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
138707502|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
138707503|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707504|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707505|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138707506|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
138707507|NCT03527576|Hormones|hormones|mesh-ancestor
138707508|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138707509|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138707511|NCT04664010|Vitamins|vitamins|mesh-list
138707512|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
138707513|NCT04664010|Interferons|interferons|mesh-list
138707514|NCT04664010|Ribavirin|ribavirin|mesh-list
138707515|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
138707516|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138707517|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
138707518|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707519|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707520|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
138707521|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707522|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
138707523|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707524|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
138707525|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
138707526|NCT04664010|Protective Agents|protective agents|mesh-ancestor
138707527|NCT04664127|Valacyclovir|valacyclovir|mesh-list
138707528|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
138707529|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707530|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138707531|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138707532|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138707533|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138707534|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707535|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707536|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707537|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138707538|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
138707539|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138707540|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
138707541|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138707542|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707543|NCT04663386|Budesonide|budesonide|mesh-list
138707544|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
138707545|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138707546|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138545013|NCT00222547|Vitamin A|vitamin a|mesh-list
138707547|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
138707548|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707549|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707550|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138707551|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
138707552|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
138707553|NCT04663386|Hormones|hormones|mesh-ancestor
138707554|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138707555|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138707556|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138707557|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138707558|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
138707559|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707560|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707562|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138707563|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
138707564|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
138707565|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707566|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707567|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138707568|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
138707569|NCT04663269|Hormones|hormones|mesh-ancestor
138707570|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138707571|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138707572|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707573|NCT03303339|Cytarabine|cytarabine|mesh-list
138707574|NCT03303339|Decitabine|decitabine|mesh-list
138707575|NCT03303339|Onvansertib|onvansertib|mesh-list
138707576|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138707577|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
138707578|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707579|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707580|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
138707581|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707582|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138707583|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
138707584|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707585|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707586|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138707587|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138707588|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707589|NCT03299946|Nivolumab|nivolumab|mesh-list
138707590|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138707591|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707592|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138707593|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707594|NCT00535340|Amibegron|amibegron|mesh-list
138707595|NCT00535340|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138707596|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138707597|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138707598|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
138707599|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707600|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707601|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707602|NCT00535340|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138707604|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707605|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138707606|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138707607|NCT00535379|Growth Substances|growth substances|mesh-ancestor
138707608|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707609|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
138707610|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138707611|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707612|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707613|NCT00535418|Letrozole|letrozole|mesh-list
138707614|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707616|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138707617|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709236|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707618|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707619|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138707620|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
138707621|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138707622|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663926|NCT05521087|Fludarabine|fludarabine|mesh-list
138707624|NCT04679064|Bevacizumab|bevacizumab|mesh-list
138707625|NCT04679064|Gemcitabine|gemcitabine|mesh-list
138707626|NCT04679064|Doxorubicin|doxorubicin|mesh-list
138707627|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138707628|NCT04679064|Topotecan|topotecan|mesh-list
138707630|NCT04679064|Dostarlimab|dostarlimab|mesh-list
138707631|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138707632|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707633|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
138707634|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
138707635|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
138707636|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707637|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138707638|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138707639|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138707640|NCT04679064|Growth Substances|growth substances|mesh-ancestor
138539586|NCT00165178|Hormones|hormones|mesh-ancestor
138707641|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707642|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
138707643|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138707644|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
138707645|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138707646|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138707647|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138707648|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707649|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138707650|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138707651|NCT01183780|Leucovorin|leucovorin|mesh-list
138707652|NCT01183780|Folic Acid|folic acid|mesh-list
138707653|NCT01183780|Fluorouracil|fluorouracil|mesh-list
138707654|NCT01183780|Irinotecan|irinotecan|mesh-list
138707655|NCT01183780|Ramucirumab|ramucirumab|mesh-list
138707656|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
138707657|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
138707658|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707659|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138707660|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707661|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138707662|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
138707663|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707664|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138707665|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138707666|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707667|NCT01183780|Antidotes|antidotes|mesh-ancestor
138707668|NCT01183780|Protective Agents|protective agents|mesh-ancestor
138707669|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
138707670|NCT01183780|Vitamins|vitamins|mesh-ancestor
138707671|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
138707672|NCT01183780|Hematinics|hematinics|mesh-ancestor
138707673|NCT04679103|Eculizumab|eculizumab|mesh-list
138539701|NCT00165568|Bevacizumab|bevacizumab|mesh-list
138707674|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138707675|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138707676|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
138707677|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707678|NCT00535574|Bexarotene|bexarotene|mesh-list
138707679|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707680|NCT04678830|Leronlimab|leronlimab|mesh-list
138707681|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138707682|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138707683|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707684|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138707685|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138707686|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
138707687|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707688|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138707689|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
138707690|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138707691|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138707692|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
138707693|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707694|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707695|NCT03245021|Rituximab|rituximab|mesh-list
138707696|NCT03245021|Nivolumab|nivolumab|mesh-list
138707697|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138707698|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707699|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
138539765|NCT00054197|Paclitaxel|paclitaxel|mesh-list
138707700|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707701|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138707702|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138707703|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707705|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
138707706|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707707|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138707709|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138707710|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707711|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138707712|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138707713|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707714|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707715|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138707716|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
138707717|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138707718|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707719|NCT02887807|Cyclosporine|cyclosporine|mesh-list
138707720|NCT02887807|Cyclosporins|cyclosporins|mesh-list
138707721|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707722|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707723|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138707724|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
138707725|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707726|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
138707727|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707728|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
138707729|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138707730|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138707731|NCT04663035|Tislelizumab|tislelizumab|mesh-list
138707732|NCT04663035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138707733|NCT04663035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707734|NCT03098589|Lenalidomide|lenalidomide|mesh-list
138707735|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
138707736|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707737|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138707738|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138707739|NCT03098589|Growth Substances|growth substances|mesh-ancestor
138707740|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
138707741|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707742|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
138707743|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138707744|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138707745|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707746|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138707747|NCT04662177|Analgesics|analgesics|mesh-ancestor
138707748|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
138510696|NCT00392418|Micronutrients|micronutrients|mesh-list
138707749|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707750|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138545047|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
138707751|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138707752|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138707753|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
138707754|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707755|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707756|NCT03026517|Phenformin|phenformin|mesh-list
138707757|NCT03026517|Trametinib|trametinib|mesh-list
138707758|NCT03026517|Dabrafenib|dabrafenib|mesh-list
138707759|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707760|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138707761|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707762|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707763|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138707764|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707765|NCT00537953|Miltefosine|miltefosine|mesh-list
138707766|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138707767|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
138707768|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707769|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707770|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138707771|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138707772|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
138707773|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707774|NCT05226299|Capsaicin|capsaicin|mesh-list
138707775|NCT05226299|Antipruritics|antipruritics|mesh-ancestor
138707776|NCT05226299|Dermatologic Agents|dermatologic agents|mesh-ancestor
138707777|NCT05226299|Sensory System Agents|sensory system agents|mesh-ancestor
138707778|NCT05226299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707779|NCT05226299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707781|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138540054|NCT00407251|Epothilone B|epothilone b|mesh-list
138707782|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707783|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138707784|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138707785|NCT00557232|Growth Substances|growth substances|mesh-ancestor
138707786|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707787|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
138707788|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
138707789|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138707790|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138707791|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138510725|NCT00064636|Bortezomib|bortezomib|mesh-list
138707793|NCT02797119|Coagulants|coagulants|mesh-ancestor
138707794|NCT05161208|Varenicline|varenicline|mesh-list
138707795|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138707796|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138707797|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
138707798|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707799|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707800|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707801|NCT00538070|Glycine|glycine|mesh-list
138707802|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
138707803|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707804|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707805|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707806|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
138707807|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707808|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138707809|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707810|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707811|NCT00538148|Telithromycin|telithromycin|mesh-list
138707812|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138707813|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707814|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
138707815|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707816|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
138707817|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
138707818|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
138707819|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138707820|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138707821|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707822|NCT00538187|Bortezomib|bortezomib|mesh-list
138707823|NCT00538187|Obatoclax|obatoclax|mesh-list
138707824|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707825|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707826|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707827|NCT04661709|Aspirin|aspirin|mesh-list
138707828|NCT04661709|Metoprolol|metoprolol|mesh-list
138707829|NCT04661709|Isosorbide|isosorbide|mesh-list
138707830|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138707831|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138707833|NCT04661709|Trimetazidine|trimetazidine|mesh-list
138707834|NCT04661709|Clopidogrel|clopidogrel|mesh-list
138707835|NCT04661709|Atorvastatin|atorvastatin|mesh-list
138707836|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707837|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138707838|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138707839|NCT04661709|Analgesics|analgesics|mesh-ancestor
138707840|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
138707841|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707842|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138707843|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138707844|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138707845|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138707846|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707847|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138707848|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138707849|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707851|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138707852|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138707853|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
138707854|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138707855|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138707856|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138707857|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138707858|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138707859|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
138707860|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545089|NCT00223054|Everolimus|everolimus|mesh-list
138707861|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138707862|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138707863|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
138707864|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
138707865|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138707866|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138707867|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138707868|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
138707869|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138707870|NCT04661709|Diuretics|diuretics|mesh-ancestor
138707871|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
138707872|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
138707873|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138707874|NCT02466867|Naftifine|naftifine|mesh-list
138707875|NCT02466867|Antifungal Agents|antifungal agents|mesh-ancestor
138707876|NCT02466867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707877|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
138707878|NCT00538265|Tacrolimus|tacrolimus|mesh-list
138707879|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
138707880|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138707881|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
138510779|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138707882|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707883|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138707884|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707885|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707886|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138707887|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707888|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138707889|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
138707890|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138707891|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707892|NCT02462811|Acetaminophen|acetaminophen|mesh-list
138707893|NCT02462811|Promethazine|promethazine|mesh-list
138707894|NCT02462811|Diphenhydramine|diphenhydramine|mesh-list
138707895|NCT02462811|Hydrocodone|hydrocodone|mesh-list
138707896|NCT02462811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138707897|NCT02462811|Analgesics|analgesics|mesh-ancestor
138707898|NCT02462811|Sensory System Agents|sensory system agents|mesh-ancestor
138707899|NCT02462811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707900|NCT02462811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707901|NCT02462811|Antipyretics|antipyretics|mesh-ancestor
138707903|NCT02462811|Narcotics|narcotics|mesh-ancestor
138707904|NCT02462811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138707905|NCT02462811|Antitussive Agents|antitussive agents|mesh-ancestor
138707906|NCT02462811|Respiratory System Agents|respiratory system agents|mesh-ancestor
138707907|NCT02462811|Antipruritics|antipruritics|mesh-ancestor
138707908|NCT02462811|Dermatologic Agents|dermatologic agents|mesh-ancestor
138707909|NCT02462811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138707910|NCT02462811|Histamine Antagonists|histamine antagonists|mesh-ancestor
138707911|NCT02462811|Histamine Agents|histamine agents|mesh-ancestor
138707912|NCT02462811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707913|NCT02462811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707914|NCT02462811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138707915|NCT02462811|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138707916|NCT02462811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138707917|NCT02462811|Anesthetics, Local|anesthetics, local|mesh-ancestor
138707919|NCT02462811|Antiemetics|antiemetics|mesh-ancestor
138707920|NCT02462811|Autonomic Agents|autonomic agents|mesh-ancestor
138707921|NCT02462811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138707922|NCT00538382|Artesunate|artesunate|mesh-list
138707923|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
138707924|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138707925|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138540438|NCT00170794|Everolimus|everolimus|mesh-list
138707926|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138707927|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707928|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
138707929|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
138707930|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138707931|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
138707933|NCT00538421|Sevoflurane|sevoflurane|mesh-list
138707934|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138707935|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138707936|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707937|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138707938|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
138707939|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
138707940|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138707941|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138707942|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
138707943|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138510820|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
138707944|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138707945|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707946|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138707947|NCT04661475|Analgesics|analgesics|mesh-ancestor
138707948|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
138707949|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707950|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138707951|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138707952|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138707953|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
138707954|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138707955|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707957|NCT00538499|Bupivacaine|bupivacaine|mesh-list
138707958|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
138707959|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
138707960|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138707961|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707962|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
138707963|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707964|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138707965|NCT00538499|Narcotics|narcotics|mesh-ancestor
138707966|NCT00538499|Analgesics|analgesics|mesh-ancestor
138707967|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138707968|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138707969|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
138707970|NCT00538538|Ranibizumab|ranibizumab|mesh-list
138707971|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138707972|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138707973|NCT00538538|Growth Substances|growth substances|mesh-ancestor
138707974|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707975|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
138707976|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138707978|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138707979|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138707981|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
138707982|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138707983|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707984|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138707985|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138707986|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138707987|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138707988|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138707989|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707991|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138707992|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138707993|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138707994|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138707995|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138707996|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138707997|NCT00538694|Daptomycin|daptomycin|mesh-list
138707998|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138707999|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708000|NCT02436096|Cyclobenzaprine|cyclobenzaprine|mesh-list
138708001|NCT02436096|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138708002|NCT02436096|Antidepressive Agents|antidepressive agents|mesh-ancestor
138708003|NCT02436096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138664301|NCT05123599|Tenofovir|tenofovir|mesh-list
138708004|NCT02436096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138708005|NCT02436096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708006|NCT02436096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138708007|NCT02436096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708008|NCT02436096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138708009|NCT02436096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138708012|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
138708013|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
138708014|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
138708015|NCT00538811|Amantadine|amantadine|mesh-list
138708016|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708017|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
138708018|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708019|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
138708020|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708021|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
138708022|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708023|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138709237|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
138708024|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138708025|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
138708026|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138708027|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138708028|NCT00538811|Analgesics|analgesics|mesh-ancestor
138708029|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
138708030|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708031|NCT04660773|Pregabalin|pregabalin|mesh-list
138708032|NCT04660773|Analgesics|analgesics|mesh-ancestor
138708033|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
138708034|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708035|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708036|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
138708037|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138708038|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138708039|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708040|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138708041|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138708042|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138708043|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138708044|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138708045|NCT00538889|Citalopram|citalopram|mesh-list
138708046|NCT00538889|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138708047|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138708048|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138708049|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708050|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138708051|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
138708052|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708053|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138708054|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
138708055|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138708056|NCT02413827|Ipilimumab|ipilimumab|mesh-list
138708057|NCT02413827|Poly ICLC|poly iclc|mesh-list
138708058|NCT02413827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138708059|NCT02413827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138708060|NCT02413827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708061|NCT02413827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138708062|NCT02413827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708063|NCT02413827|Interferon Inducers|interferon inducers|mesh-ancestor
138708064|NCT02413827|Immunologic Factors|immunologic factors|mesh-ancestor
138708065|NCT02413827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708066|NCT00538967|Doxycycline|doxycycline|mesh-list
138646735|NCT06096025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138708067|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138708068|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708069|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
138708070|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138708071|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138708072|NCT00539123|Buprenorphine|buprenorphine|mesh-list
138708073|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138708074|NCT00539123|Narcotics|narcotics|mesh-ancestor
138708075|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138708076|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708077|NCT00539123|Analgesics|analgesics|mesh-ancestor
138708078|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
138708079|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708081|NCT02382510|Tiotropium Bromide|tiotropium bromide|mesh-list
138708082|NCT02382510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138708083|NCT02382510|Autonomic Agents|autonomic agents|mesh-ancestor
138708084|NCT02382510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708085|NCT02382510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708086|NCT02382510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138708087|NCT02382510|Respiratory System Agents|respiratory system agents|mesh-ancestor
138708088|NCT02382510|Parasympatholytics|parasympatholytics|mesh-ancestor
138708089|NCT02382510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138708090|NCT02382510|Cholinergic Agents|cholinergic agents|mesh-ancestor
138708091|NCT02382510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138708092|NCT02382510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708093|NCT00539396|Insulin|insulin|mesh-list
138708094|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138708095|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708096|NCT00539435|Insulin|insulin|mesh-list
138708097|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
138708098|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138708099|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708100|NCT00539630|Docetaxel|docetaxel|mesh-list
138708101|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708102|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
138708103|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
138708104|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
138708105|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708106|NCT04660461|Lansoprazole|lansoprazole|mesh-list
138708107|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
138708108|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138708109|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138708110|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138708111|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708112|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708113|NCT00539669|Docetaxel|docetaxel|mesh-list
138708114|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708115|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
138708116|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
138708117|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
138708118|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708119|NCT00554424|Lidocaine|lidocaine|mesh-list
138708120|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
138708121|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
138708122|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138708123|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708124|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
138708125|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708126|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138708127|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138708128|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138708129|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138540902|NCT00174577|Risperidone|risperidone|mesh-list
138708130|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708131|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
138708132|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138708133|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708134|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138708135|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138708136|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
138708137|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708138|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
138708139|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708140|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708141|NCT00539786|Rabeprazole|rabeprazole|mesh-list
138708142|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138708143|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138708144|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138708145|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708146|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708147|NCT00540098|Paroxetine|paroxetine|mesh-list
138708148|NCT00540098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138708149|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138708150|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138510904|NCT04235673|Melatonin|melatonin|mesh-list
138708151|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237986|NCT06137469|Acetaminophen|acetaminophen|mesh-list
138708152|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138708153|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
138708154|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708155|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138708156|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
138708157|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138708158|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138708159|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138708160|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708161|NCT00540137|Ritonavir|ritonavir|mesh-list
138708162|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138708163|NCT00540137|Nevirapine|nevirapine|mesh-list
138708164|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138708165|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138708166|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
138708167|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708168|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708169|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138708170|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138708171|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
138708172|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708173|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138708174|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138708175|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138708176|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138708177|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138708178|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138708179|NCT04660110|Piperaquine|piperaquine|mesh-list
138708180|NCT04660110|Artenimol|artenimol|mesh-list
138708181|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
138708182|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138708183|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138708184|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708185|NCT02336685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138708186|NCT02336685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708187|NCT02336685|Immunologic Factors|immunologic factors|mesh-ancestor
138708188|NCT00540410|Artesunate|artesunate|mesh-list
138708189|NCT00540410|Lumefantrine|lumefantrine|mesh-list
138708190|NCT00540410|Amodiaquine|amodiaquine|mesh-list
138708191|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138708192|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
138708193|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138708194|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138708195|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708196|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708197|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
138708198|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
138708199|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138708200|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
138708201|NCT00540527|Plasminogen|plasminogen|mesh-list
138708202|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138708203|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138708204|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138708205|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708206|NCT00540605|Tenofovir|tenofovir|mesh-list
138708208|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708209|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138708210|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138708211|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708212|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708213|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138708214|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138708215|NCT04659915|Metformin|metformin|mesh-list
138708216|NCT04659915|Prednisone|prednisone|mesh-list
138708217|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138708218|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708219|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138708220|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
138708221|NCT04659915|Hormones|hormones|mesh-ancestor
138708222|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138708223|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138708224|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708225|NCT00557427|Fluoxetine|fluoxetine|mesh-list
138708226|NCT00557427|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138708227|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138708228|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138708229|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708230|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138708231|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
138708232|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708233|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138708234|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
138708235|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138708236|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138708237|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138708238|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708239|NCT00540800|Docetaxel|docetaxel|mesh-list
138708240|NCT00540800|Capecitabine|capecitabine|mesh-list
138708241|NCT00540800|Epirubicin|epirubicin|mesh-list
138708242|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708243|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
138708244|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
138708245|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
138708246|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708247|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138708248|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
138708249|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138708250|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138708251|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138708252|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708253|NCT00540956|Cytarabine|cytarabine|mesh-list
138708254|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138541396|NCT00177853|Celecoxib|celecoxib|mesh-list
138708255|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
138646777|NCT06002490|Aspirin|aspirin|mesh-list
138510957|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
138708256|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708257|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708258|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
138708259|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708260|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138708261|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
138708262|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708263|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
138708264|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
138708265|NCT00541073|Pemetrexed|pemetrexed|mesh-list
138708266|NCT00541073|Vitamins|vitamins|mesh-ancestor
138708267|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
138708268|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708269|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708270|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708271|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708272|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138708273|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138708274|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
138708275|NCT00541073|Hematinics|hematinics|mesh-ancestor
138708276|NCT00541112|Leucovorin|leucovorin|mesh-list
138708277|NCT00541112|Capecitabine|capecitabine|mesh-list
138708278|NCT00541112|Fluorouracil|fluorouracil|mesh-list
138708279|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
138708280|NCT00541112|Cetuximab|cetuximab|mesh-list
138708282|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
138708283|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138708284|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708285|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138708286|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
138708287|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708288|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708289|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138708290|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
138708291|NCT00541112|Antidotes|antidotes|mesh-ancestor
138708292|NCT00541112|Protective Agents|protective agents|mesh-ancestor
138708293|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
138708294|NCT00541112|Vitamins|vitamins|mesh-ancestor
138708295|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
138708296|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138708297|NCT04659525|Ezetimibe|ezetimibe|mesh-list
138708298|NCT04659525|Evolocumab|evolocumab|mesh-list
138708299|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138708300|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138708301|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
138708302|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708303|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138708304|NCT04659525|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138708305|NCT04659525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138708306|NCT04659525|Protease Inhibitors|protease inhibitors|mesh-ancestor
138708307|NCT04659525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708309|NCT02333643|Furosemide|furosemide|mesh-list
138708310|NCT02333643|Diuretics|diuretics|mesh-ancestor
138708311|NCT02333643|Natriuretic Agents|natriuretic agents|mesh-ancestor
138708312|NCT02333643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708313|NCT02333643|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138708314|NCT02333643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138708315|NCT02333643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708316|NCT02333643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138708317|NCT02333643|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138708318|NCT02333643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708319|NCT02333643|Protective Agents|protective agents|mesh-ancestor
138708321|NCT00541463|Indinavir|indinavir|mesh-list
138708322|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708323|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138708324|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138708325|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
138708326|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708327|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138708328|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138708329|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
138708330|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708331|NCT02324985|Ibuprofen|ibuprofen|mesh-list
138708332|NCT02324985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138708333|NCT02324985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138708334|NCT02324985|Analgesics|analgesics|mesh-ancestor
138708335|NCT02324985|Sensory System Agents|sensory system agents|mesh-ancestor
138708336|NCT02324985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708337|NCT02324985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708338|NCT02324985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138708340|NCT02324985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138708341|NCT02324985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708342|NCT02324985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708343|NCT04659642|Fentanyl|fentanyl|mesh-list
138708344|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
138708345|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138708346|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138708347|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708348|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138708350|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
138708351|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708352|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138708353|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138708354|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138708355|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
138708356|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138708357|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708358|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138541795|NCT00181597|Trilostane|trilostane|mesh-list
138708359|NCT04659642|Narcotics|narcotics|mesh-ancestor
138708360|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138708361|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138708362|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
138708363|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
138708364|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
138708365|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
138708366|NCT00541814|Cyclosporine|cyclosporine|mesh-list
138708367|NCT00541814|Cyclosporins|cyclosporins|mesh-list
138708368|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708369|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708370|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138708371|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
138708372|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708373|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
138708374|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708375|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
138708376|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138708377|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138708378|NCT00541853|Candesartan|candesartan|mesh-list
138708379|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
138708380|NCT00541853|Cilnidipine|cilnidipine|mesh-list
138664687|NCT04742959|Paclitaxel|paclitaxel|mesh-list
138708381|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138708382|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138708383|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138708384|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708385|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138708386|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138646795|NCT05969795|Hormones|hormones|mesh-ancestor
138708387|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138708388|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708389|NCT02301234|Celecoxib|celecoxib|mesh-list
138541913|NCT00182533|Sertraline|sertraline|mesh-list
138708390|NCT02301234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138708391|NCT02301234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138708392|NCT02301234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138708393|NCT02301234|Analgesics|analgesics|mesh-ancestor
138708394|NCT02301234|Sensory System Agents|sensory system agents|mesh-ancestor
138708395|NCT02301234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708396|NCT02301234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708397|NCT02301234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138708399|NCT02301234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138708400|NCT02301234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138708401|NCT02301234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541974|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138708402|NCT02301234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708403|NCT02301234|Immunologic Factors|immunologic factors|mesh-ancestor
138708404|NCT02300142|Vaccines|vaccines|mesh-list
138708405|NCT02300142|Immunologic Factors|immunologic factors|mesh-ancestor
138708406|NCT02300142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708407|NCT01214668|Doxorubicin|doxorubicin|mesh-list
138708408|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138708409|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138708410|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542042|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
138708411|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138708412|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138708413|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708414|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708415|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138708416|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
138708417|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138708418|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
138708419|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138708420|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708421|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138708422|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138708423|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708424|NCT00542165|Alfuzosin|alfuzosin|mesh-list
138708425|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138708426|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138646806|NCT05931302|FAPI-46|fapi-46|mesh-list
138708428|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
138708429|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138708430|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542178|NCT00058097|Tipifarnib|tipifarnib|mesh-list
138708431|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708432|NCT00542165|Urological Agents|urological agents|mesh-ancestor
138708433|NCT00542243|Finasteride|finasteride|mesh-list
138708434|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138708435|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138708436|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708437|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708438|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
138708439|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138708440|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708441|NCT00542243|Urological Agents|urological agents|mesh-ancestor
138708442|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
138708443|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138708444|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708445|NCT00542555|Naproxen|naproxen|mesh-list
138708446|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
138708447|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138708448|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138708449|NCT00542555|Analgesics|analgesics|mesh-ancestor
138708450|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
138708451|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708452|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708453|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138708454|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138708455|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
138708456|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138708457|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708458|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708459|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138708460|NCT00542711|Curcumin|curcumin|mesh-list
138708461|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138708462|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138708463|NCT00542711|Analgesics|analgesics|mesh-ancestor
138708464|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
138708465|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708466|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708467|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138708468|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138708469|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708470|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708471|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708473|NCT00542984|Calcitonin|calcitonin|mesh-list
138708474|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
138708475|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138511073|NCT00068653|Celecoxib|celecoxib|mesh-list
138708477|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138708478|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708479|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138708480|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
138708481|NCT02257983|Ubiquinone|ubiquinone|mesh-list
138708482|NCT02257983|Micronutrients|micronutrients|mesh-ancestor
138708483|NCT02257983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708484|NCT00543023|Teriparatide|teriparatide|mesh-list
138708485|NCT00543023|Calcitonin|calcitonin|mesh-list
138708486|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
138708487|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138708488|NCT00543023|Katacalcin|katacalcin|mesh-list
138708489|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138708490|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708491|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138708492|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
138708493|NCT04648917|Caffeic acid|caffeic acid|mesh-list
138708494|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
138708495|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708496|NCT04648917|Protective Agents|protective agents|mesh-ancestor
138708497|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708498|NCT00543179|Lanreotide|lanreotide|mesh-list
138708499|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708500|NCT00543218|Teriparatide|teriparatide|mesh-list
138708501|NCT00543218|Calcitonin|calcitonin|mesh-list
138708502|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
138708503|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138708504|NCT00543218|Katacalcin|katacalcin|mesh-list
138708505|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138708506|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542328|NCT03784014|Durvalumab|durvalumab|mesh-list
138708507|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138708508|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
138708509|NCT02252835|Colchicine|colchicine|mesh-list
138708510|NCT02252835|Febuxostat|febuxostat|mesh-list
138708511|NCT02252835|Gout Suppressants|gout suppressants|mesh-ancestor
138708512|NCT02252835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138708513|NCT02252835|Tubulin Modulators|tubulin modulators|mesh-ancestor
138708514|NCT02252835|Antimitotic Agents|antimitotic agents|mesh-ancestor
138708515|NCT02252835|Mitosis Modulators|mitosis modulators|mesh-ancestor
138708516|NCT02252835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708518|NCT03456752|Dexamethasone|dexamethasone|mesh-list
138708519|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138708520|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
138708521|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
138708522|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708523|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708524|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138708525|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
138664829|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
138708526|NCT03456752|Hormones|hormones|mesh-ancestor
138708527|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138708528|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138708529|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708530|NCT03456713|Mirikizumab|mirikizumab|mesh-list
138542456|NCT00409201|Reboxetine|reboxetine|mesh-list
138708531|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138708532|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138708534|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
138708535|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708536|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708537|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138708538|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138708539|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138708540|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138708541|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138708542|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
138708543|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708544|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138708545|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
138708546|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138708547|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708548|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138708549|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138708550|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138708551|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
138708552|NCT04648332|Bupivacaine|bupivacaine|mesh-list
138708553|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
138708554|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
138708555|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138708556|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708557|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
138708558|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708559|NCT00543335|Sorafenib|sorafenib|mesh-list
138708560|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708561|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138708562|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708563|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708564|NCT00543413|Enalapril|enalapril|mesh-list
138708565|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138708566|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
138708567|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708568|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708569|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138708570|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138708571|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
138708572|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138708573|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138708574|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138708575|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138708576|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708577|NCT00543608|Vancomycin|vancomycin|mesh-list
138708578|NCT00543608|Iclaprim|iclaprim|mesh-list
138708579|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138708580|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708581|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138708582|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708583|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708584|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138708585|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708586|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138708587|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708588|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708589|NCT00543647|Fenofibrate|fenofibrate|mesh-list
138708590|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138708591|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
138708592|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708593|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138708594|NCT04647669|Interferons|interferons|mesh-list
138708595|NCT04647669|Interferon-beta|interferon-beta|mesh-list
138708596|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
138708597|NCT04647669|Remdesivir|remdesivir|mesh-list
138708598|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
138708599|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708600|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
138708601|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708602|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
138708603|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708604|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138708606|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708607|NCT00543686|Fluticasone|fluticasone|mesh-list
138708608|NCT00543686|Montelukast|montelukast|mesh-list
138708609|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138708610|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138708611|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
138708612|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708613|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708614|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138708615|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
138708616|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
138708617|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138708618|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138708619|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
138708620|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138708621|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138708622|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138708623|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708624|NCT00543842|Bevacizumab|bevacizumab|mesh-list
138708625|NCT00543842|Capecitabine|capecitabine|mesh-list
138708626|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138708627|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138708628|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708629|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138708630|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138708631|NCT00543842|Growth Substances|growth substances|mesh-ancestor
138708632|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708633|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
138708634|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138708635|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
138708636|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708637|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138708638|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708639|NCT04638816|Lidocaine|lidocaine|mesh-list
138708640|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
138708641|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
138708642|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
138708644|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708645|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
138708646|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708647|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138708648|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138708649|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138708650|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138708651|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708652|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138708653|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
138708654|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
138708655|NCT04638816|Protective Agents|protective agents|mesh-ancestor
138708656|NCT00543959|Pioglitazone|pioglitazone|mesh-list
138708657|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138708658|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708659|NCT00544037|Interferons|interferons|mesh-list
138708660|NCT00544037|Interferon-beta|interferon-beta|mesh-list
138708661|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
138708662|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708663|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
138708664|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708665|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
138708666|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708667|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138708668|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
138708669|NCT00544154|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138708670|NCT00544154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138708671|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138708672|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
138708673|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708674|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138708675|NCT04638582|Paclitaxel|paclitaxel|mesh-list
138708676|NCT04638582|Carboplatin|carboplatin|mesh-list
138708677|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
138708678|NCT04638582|Pemetrexed|pemetrexed|mesh-list
138708679|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138708680|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708681|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
138708682|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
138708683|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
138708684|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708685|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138708686|NCT04638582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138708688|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138708689|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138708690|NCT00544193|Gemcitabine|gemcitabine|mesh-list
138708691|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138708692|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
138708693|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708694|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708695|NCT00544232|Paclitaxel|paclitaxel|mesh-list
138708696|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138708697|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
138708698|NCT00544232|Methotrexate|methotrexate|mesh-list
138708699|NCT00544232|Epirubicin|epirubicin|mesh-list
138708700|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
138708701|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138708702|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542891|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
138708703|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
138708704|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
138708705|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
138708706|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708707|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138708708|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
138708709|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708710|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138708711|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138708712|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
138708713|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138708714|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138708715|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
138708716|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138708717|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138708718|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
138708719|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
138708720|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708721|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138708722|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138708723|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138708724|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138708725|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138708727|NCT01191268|Insulin|insulin|mesh-list
138708728|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138708729|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
138708730|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
138708731|NCT01191268|Dulaglutide|dulaglutide|mesh-list
138708732|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138708733|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708734|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
138708735|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138708736|NCT00544349|Leucovorin|leucovorin|mesh-list
138708737|NCT00544349|Fluorouracil|fluorouracil|mesh-list
138708738|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
138708739|NCT00544349|Cetuximab|cetuximab|mesh-list
138708741|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
138708742|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138708743|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708744|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
138708745|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708746|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138708747|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708748|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138708749|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
138708750|NCT00544349|Antidotes|antidotes|mesh-ancestor
138708751|NCT00544349|Protective Agents|protective agents|mesh-ancestor
138708752|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
138708753|NCT00544349|Vitamins|vitamins|mesh-ancestor
138708754|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
138708755|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138708756|NCT01191190|Ofatumumab|ofatumumab|mesh-list
138708757|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708758|NCT00544388|Levocetirizine|levocetirizine|mesh-list
138708759|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138708760|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138708761|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
138708762|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
138708763|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138708764|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708765|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708766|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
138708767|NCT00544505|Fluorouracil|fluorouracil|mesh-list
138708768|NCT00544505|Epirubicin|epirubicin|mesh-list
138708769|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138708770|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
138543182|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138708771|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708772|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138708773|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138708774|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
138708775|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708776|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708777|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138708778|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
138708779|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138708780|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138708781|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138708782|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138708783|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708784|NCT00544700|Bevacizumab|bevacizumab|mesh-list
138708785|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138708786|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708787|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138708788|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138708789|NCT00544700|Growth Substances|growth substances|mesh-ancestor
138708790|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708791|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
138708792|NCT05824481|Lenvatinib|lenvatinib|mesh-list
138708793|NCT05824481|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138708794|NCT05824481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708795|NCT05824481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138708796|NCT05824481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708797|NCT05824481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708798|NCT05824468|Lenvatinib|lenvatinib|mesh-list
138708799|NCT05824468|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138708800|NCT05824468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708801|NCT05824468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138708802|NCT05824468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708803|NCT05824468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708805|NCT05824455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138511299|NCT00070486|Celecoxib|celecoxib|mesh-list
138708806|NCT05824455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138708807|NCT05824455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708808|NCT05824455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708809|NCT05824455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708810|NCT05824390|Rituximab|rituximab|mesh-list
138708811|NCT05824390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138708812|NCT05824390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708813|NCT05824390|Immunologic Factors|immunologic factors|mesh-ancestor
138708814|NCT05824390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708815|NCT05824390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138708816|NCT05824312|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138708817|NCT05824312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138708818|NCT05824312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708819|NCT05824312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708820|NCT05824156|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
138708821|NCT05824156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708822|NCT05823883|Metformin|metformin|mesh-list
138708823|NCT05823883|Empagliflozin|empagliflozin|mesh-list
138219550|NCT05723601|Estrogens|estrogens|mesh-ancestor
138708824|NCT05823883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138708825|NCT05823883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708826|NCT05823883|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138708827|NCT05823883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665127|NCT04461639|Factor VIII|factor viii|mesh-list
138708828|NCT05823870|Metformin|metformin|mesh-list
138708829|NCT05823870|Empagliflozin|empagliflozin|mesh-list
138708830|NCT05823870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138708831|NCT05823870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708832|NCT05823870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138708833|NCT05823870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708834|NCT05823701|Azacitidine|azacitidine|mesh-list
138708835|NCT05823701|Mitoxantrone|mitoxantrone|mesh-list
138708836|NCT05823701|Obinutuzumab|obinutuzumab|mesh-list
138708837|NCT05823701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138708838|NCT05823701|Antimetabolites|antimetabolites|mesh-ancestor
138708839|NCT05823701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708840|NCT05823701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708841|NCT05823701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708842|NCT05823701|Analgesics|analgesics|mesh-ancestor
138708843|NCT05823701|Sensory System Agents|sensory system agents|mesh-ancestor
138708844|NCT05823701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708845|NCT05823701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708846|NCT05823701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138708847|NCT05823701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138708848|NCT05823701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138708849|NCT05823168|Anticonvulsants|anticonvulsants|mesh-list
138708850|NCT05823155|Penicillins|penicillins|mesh-list
138708851|NCT05823155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138708852|NCT05823155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138708853|NCT05822882|Anesthetics|anesthetics|mesh-list
138545274|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138708854|NCT05822882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138708855|NCT05822882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708856|NCT05822713|Amisulpride|amisulpride|mesh-list
138708857|NCT05822713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138708858|NCT05822713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138708859|NCT05822713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138708860|NCT05822713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708861|NCT05822713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138708862|NCT05822713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138708863|NCT05822713|Dopamine Agents|dopamine agents|mesh-ancestor
138708864|NCT05822713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138708865|NCT05822713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708866|NCT05822713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138708867|NCT05822713|Antidepressive Agents|antidepressive agents|mesh-ancestor
138708868|NCT05822674|Metformin|metformin|mesh-list
138708869|NCT05822674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138708870|NCT05822674|Empagliflozin|empagliflozin|mesh-list
138708871|NCT05822674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138708872|NCT05822674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708873|NCT05822674|Incretins|incretins|mesh-ancestor
138708874|NCT05822674|Hormones|hormones|mesh-ancestor
138708875|NCT05822674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138708876|NCT05822674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138708877|NCT05822674|Protease Inhibitors|protease inhibitors|mesh-ancestor
138708878|NCT05822674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708879|NCT05822674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708880|NCT05822674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138708883|NCT05817474|Tranexamic Acid|tranexamic acid|mesh-list
138708884|NCT05817474|Anesthetics, Local|anesthetics, local|mesh-ancestor
138708886|NCT05817474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138708887|NCT05817474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708888|NCT05817474|Sensory System Agents|sensory system agents|mesh-ancestor
138708889|NCT05817474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708890|NCT05817474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138708891|NCT05817474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138708892|NCT05817474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138708893|NCT05817474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138708894|NCT05817474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708895|NCT05817474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138708896|NCT05817474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138708897|NCT05817474|Hemostatics|hemostatics|mesh-ancestor
138708898|NCT05817474|Coagulants|coagulants|mesh-ancestor
138708899|NCT05780567|Tamoxifen|tamoxifen|mesh-list
138708900|NCT05780567|Letrozole|letrozole|mesh-list
138708901|NCT05780567|Anastrozole|anastrozole|mesh-list
138708902|NCT05780567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708903|NCT05780567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138708904|NCT05780567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138708905|NCT05780567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708906|NCT05780567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708907|NCT05780567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138708908|NCT05780567|Hormone Antagonists|hormone antagonists|mesh-ancestor
138708909|NCT05780567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138708910|NCT05780567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708911|NCT05780567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138708912|NCT05780567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138708913|NCT05780567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138708914|NCT05780567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138708915|NCT05751629|Bevacizumab|bevacizumab|mesh-list
138708916|NCT05751629|Niraparib|niraparib|mesh-list
138708917|NCT05751629|Dostarlimab|dostarlimab|mesh-list
138708918|NCT05751629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138708919|NCT05751629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708920|NCT05751629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138708921|NCT05751629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138708922|NCT05751629|Growth Substances|growth substances|mesh-ancestor
138708923|NCT05751629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708924|NCT05751629|Growth Inhibitors|growth inhibitors|mesh-ancestor
138708925|NCT05751629|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138708926|NCT05751629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708927|NCT05751629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708929|NCT05736640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138708930|NCT05736640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708931|NCT05728294|Ropivacaine|ropivacaine|mesh-list
138708932|NCT05728294|Anesthetics, Local|anesthetics, local|mesh-ancestor
138708933|NCT05728294|Anesthetics|anesthetics|mesh-ancestor
138708934|NCT05728294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138708935|NCT05728294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708936|NCT05728294|Sensory System Agents|sensory system agents|mesh-ancestor
138708937|NCT05728294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708938|NCT05704829|Trastuzumab|trastuzumab|mesh-list
138708939|NCT05704829|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138646987|NCT05645900|Vaccines|vaccines|mesh-list
138708940|NCT05704829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138708941|NCT05704829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708943|NCT05704829|Immunologic Factors|immunologic factors|mesh-ancestor
138708944|NCT05704829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708946|NCT05564221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138708947|NCT05564221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138511373|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138708948|NCT05564221|Respiratory System Agents|respiratory system agents|mesh-ancestor
138708949|NCT05491200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138708950|NCT05491200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138708951|NCT05490888|Terlipressin|terlipressin|mesh-list
138708952|NCT05490888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138708953|NCT05490888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138708954|NCT05410301|Bevacizumab|bevacizumab|mesh-list
138708955|NCT05410301|Lomustine|lomustine|mesh-list
138708956|NCT05410301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138708957|NCT05410301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138708958|NCT05410301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138708959|NCT05410301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138708960|NCT05410301|Growth Substances|growth substances|mesh-ancestor
138708961|NCT05410301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543697|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
138708962|NCT05410301|Growth Inhibitors|growth inhibitors|mesh-ancestor
138708963|NCT05410301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138708964|NCT05410301|Alkylating Agents|alkylating agents|mesh-ancestor
138708965|NCT05410301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708966|NCT05297578|Vaccines|vaccines|mesh-list
138708967|NCT05297578|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138708968|NCT05297578|Immunologic Factors|immunologic factors|mesh-ancestor
138708969|NCT05297578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708970|NCT05065294|Psilocybin|psilocybin|mesh-list
138708971|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138708972|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
138708973|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708974|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138708975|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138665287|NCT04182672|FX006|fx006|mesh-list
138708976|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
138708977|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138708978|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138708979|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138708980|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
138708981|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138708982|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138708983|NCT05058287|Prednisolone|prednisolone|mesh-list
138708984|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
138708985|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138708986|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
138708987|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138708988|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
138708989|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
138708990|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138708991|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138708992|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138708993|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
138708994|NCT05058287|Hormones|hormones|mesh-ancestor
138708995|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138708996|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138708997|NCT05058287|Protective Agents|protective agents|mesh-ancestor
138708998|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138708999|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709000|NCT04968899|Dexamethasone|dexamethasone|mesh-list
138709001|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
138709002|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138709003|NCT04968899|Antibodies|antibodies|mesh-list
138709004|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
138709005|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138709006|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138709007|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
138709008|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
138709009|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543752|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709010|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709011|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138709012|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
138709013|NCT04968899|Hormones|hormones|mesh-ancestor
138709014|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138709015|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138709016|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709017|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
138709018|NCT04965818|Futibatinib|futibatinib|mesh-list
138543773|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
138709019|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709020|NCT04941105|Evolocumab|evolocumab|mesh-list
138709021|NCT04941105|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138709022|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138709023|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138709024|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
138709025|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709026|NCT04941105|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138709027|NCT04941105|Protease Inhibitors|protease inhibitors|mesh-ancestor
138709028|NCT04941105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709029|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138709030|NCT04873102|Danazol|danazol|mesh-list
138709031|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138709032|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
138709033|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138709034|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709035|NCT04860141|Gabapentin|gabapentin|mesh-list
138709036|NCT04860141|Analgesics|analgesics|mesh-ancestor
138231112|NCT05785195|Gasotransmitters|gasotransmitters|mesh-ancestor
138709037|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
138709038|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709039|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709040|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
138709041|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138709042|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138709043|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138709044|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138709045|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138709046|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138709047|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709048|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709049|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
138709050|NCT04823156|Calcium|calcium|mesh-list
138709051|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138709052|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709054|NCT04813653|Dexamethasone|dexamethasone|mesh-list
138709055|NCT04813653|Cyclosporins|cyclosporins|mesh-list
138709056|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138709057|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
138709058|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
138709059|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545310|NCT00224185|Dimercaprol|dimercaprol|mesh-list
138709060|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709061|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138709062|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
138709063|NCT04813653|Hormones|hormones|mesh-ancestor
138709064|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138709065|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138709066|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709067|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709068|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709069|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138709070|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
138709071|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
138709072|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138709073|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
138709074|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138709075|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138709076|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
138709077|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138709078|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138709079|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709080|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
138709081|NCT04803747|Coagulants|coagulants|mesh-ancestor
138709082|NCT04790474|Dexamethasone|dexamethasone|mesh-list
138709083|NCT04790474|Pomalidomide|pomalidomide|mesh-list
138709084|NCT04790474|Ixazomib|ixazomib|mesh-list
138709085|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138709086|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
138709087|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
138709088|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709089|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709090|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138709091|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
138709092|NCT04790474|Hormones|hormones|mesh-ancestor
138709093|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138709094|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138709095|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709096|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
138709097|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138709098|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138709099|NCT04790474|Growth Substances|growth substances|mesh-ancestor
138709100|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
138709101|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
138709102|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709103|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709104|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
138709105|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138709106|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709107|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
138709108|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709109|NCT04718025|Aspirin|aspirin|mesh-list
138709110|NCT04718025|Ticagrelor|ticagrelor|mesh-list
138709111|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138709112|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138709113|NCT04718025|Analgesics|analgesics|mesh-ancestor
138709114|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
138709115|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709116|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709117|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138709118|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138709119|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138709120|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138709121|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709122|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138709123|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138709124|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709125|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
138709126|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138709127|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138709128|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138709129|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
138709130|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709131|NCT04666948|Vancomycin|vancomycin|mesh-list
138709132|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138709133|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138709134|NCT04609176|Apatinib|apatinib|mesh-list
138709135|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709136|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138709137|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709138|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709139|NCT04562090|Mirabegron|mirabegron|mesh-list
138544021|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
138709140|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138709141|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138709142|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138709143|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
138709144|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709145|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709146|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709147|NCT04562090|Urological Agents|urological agents|mesh-ancestor
138709148|NCT04557189|Ondansetron|ondansetron|mesh-list
138709149|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
138709150|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
138709151|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709152|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709153|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138709154|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
138709155|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
138709156|NCT04557189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138709157|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138709158|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
138709159|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544052|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138709160|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709161|NCT04530838|Vaccines|vaccines|mesh-list
138709162|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138709163|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
138709164|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709165|NCT04442919|Morphine|morphine|mesh-list
138709167|NCT04442919|Ticagrelor|ticagrelor|mesh-list
138709168|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138709169|NCT04442919|Narcotics|narcotics|mesh-ancestor
138709170|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138709171|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138709172|NCT04442919|Analgesics|analgesics|mesh-ancestor
138709173|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
138709174|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138709175|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138709176|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138709177|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138709178|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138709179|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
138709180|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544177|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
138709181|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709182|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138709183|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
138709184|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
138709185|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
138709186|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138709187|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709188|NCT04435197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138709189|NCT04435197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138709190|NCT04424901|Dipyridamole|dipyridamole|mesh-list
138709191|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138709192|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138709193|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138511500|NCT04730596|Analgesics|analgesics|mesh-ancestor
138709194|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138709195|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
138709196|NCT04415060|Sevoflurane|sevoflurane|mesh-list
138709197|NCT04415060|Isoflurane|isoflurane|mesh-list
138709198|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138709199|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138709200|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
138665507|NCT04034927|Tremelimumab|tremelimumab|mesh-list
139085283|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085284|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
139085285|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085286|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139085287|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
139085288|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139085289|NCT01134848|Hormones|hormones|mesh-ancestor
139085290|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139085291|NCT03926000|Pregabalin|pregabalin|mesh-list
139085292|NCT03926000|Analgesics|analgesics|mesh-ancestor
139085293|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
139085294|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085295|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085296|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
139085297|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139085298|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139085299|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085300|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139085301|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139085302|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139085303|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139085304|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139085305|NCT01134926|Misoprostol|misoprostol|mesh-list
139085306|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139085307|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
139085308|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139085309|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085310|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139085311|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139085312|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
139085313|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
139085314|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
139085315|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139085316|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085317|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
139085318|NCT01228136|Coagulants|coagulants|mesh-ancestor
139085319|NCT03140176|Sunitinib|sunitinib|mesh-list
139085320|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085321|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139085322|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138544333|NCT00084708|Hormones|hormones|mesh-ancestor
139085323|NCT03140176|Growth Substances|growth substances|mesh-ancestor
139085324|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085325|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
139085326|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139085327|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085328|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085329|NCT04259164|Mometasone Furoate|mometasone furoate|mesh-list
139085330|NCT04259164|Glycopyrrolate|glycopyrrolate|mesh-list
139085331|NCT04259164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139085332|NCT04259164|Dermatologic Agents|dermatologic agents|mesh-ancestor
139085333|NCT04259164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139085334|NCT04259164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139085335|NCT04259164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138544395|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
139085336|NCT04259164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139085338|NCT04259164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085339|NCT04259164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085340|NCT04259164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085341|NCT01230476|Cetuximab|cetuximab|mesh-list
139085342|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139085343|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085344|NCT01135472|Esomeprazole|esomeprazole|mesh-list
139085345|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139085346|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139085347|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139085348|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085349|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085350|NCT01133210|Maraviroc|maraviroc|mesh-list
139085351|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
139085352|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
139085353|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085354|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139085355|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139085356|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
139085357|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085358|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
139085359|NCT01135550|Dexamethasone|dexamethasone|mesh-list
139085360|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
139085361|NCT01135550|BB 1101|bb 1101|mesh-list
138544464|NCT00199147|Cytarabine|cytarabine|mesh-list
139085362|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139085363|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
139085364|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
139085365|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085366|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085367|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138511567|NCT00072319|Paclitaxel|paclitaxel|mesh-list
139085368|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
139085370|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139085371|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139085372|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085373|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
139085374|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085375|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085376|NCT05401370|Methylene Blue|methylene blue|mesh-list
139085377|NCT05401370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085378|NCT05401370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085379|NCT01131026|Amoxicillin|amoxicillin|mesh-list
139085380|NCT01131026|Levofloxacin|levofloxacin|mesh-list
139085381|NCT01131026|Lansoprazole|lansoprazole|mesh-list
139085382|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
139085383|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139085384|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085385|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
139085386|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139085387|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139085388|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085389|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085390|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085391|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
139085392|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139085393|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139085394|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139085395|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139085396|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
139085397|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139085398|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085399|NCT01133366|Warfarin|warfarin|mesh-list
139085400|NCT01133366|Mipomersen|mipomersen|mesh-list
139085401|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
139085402|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139085403|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139085404|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
139085405|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085406|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139085407|NCT01232270|Propofol|propofol|mesh-list
139085408|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139085409|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139085410|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085411|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139085412|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
139085413|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
139085415|NCT05400902|Tislelizumab|tislelizumab|mesh-list
139085416|NCT05400902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085417|NCT05400902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139085418|NCT05400902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085419|NCT05400902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085420|NCT05400902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139085421|NCT01233206|Metformin|metformin|mesh-list
139085422|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139085423|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085424|NCT00369941|Tenofovir|tenofovir|mesh-list
139085425|NCT00369941|Emtricitabine|emtricitabine|mesh-list
139085426|NCT00369941|Efavirenz|efavirenz|mesh-list
139085427|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
139085428|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
139085430|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085431|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
139085432|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139085433|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085434|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085435|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
139085436|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
139085437|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
139085438|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139085439|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
139085440|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
139085441|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
139085442|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
139085443|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
139085444|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
139085445|NCT01133444|Finasteride|finasteride|mesh-list
139085446|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
139085447|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139085448|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085449|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085450|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
139085451|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139085452|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085453|NCT01133444|Urological Agents|urological agents|mesh-ancestor
139085454|NCT01137656|Acetylcholine|acetylcholine|mesh-list
139085455|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
139085456|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139085457|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
138544869|NCT00221611|Baclofen|baclofen|mesh-list
139085458|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138511605|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085459|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085460|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085461|NCT00369785|Donepezil|donepezil|mesh-list
139085462|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139085463|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085464|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085465|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
139085466|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085467|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085468|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
139085469|NCT05476562|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
139085470|NCT05476562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139085471|NCT05476562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085472|NCT05476562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085473|NCT01136252|Adalimumab|adalimumab|mesh-list
139085474|NCT01136252|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139085475|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138280160|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139085476|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139085477|NCT00369707|Rituximab|rituximab|mesh-list
139085478|NCT00369707|Bortezomib|bortezomib|mesh-list
139085479|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139085480|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085481|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
139085482|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085483|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139085484|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
139085485|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
139085486|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
139085487|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
139085488|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085489|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280222|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139085490|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544939|NCT00221845|Telmisartan|telmisartan|mesh-list
139085491|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139085492|NCT01233362|Vaccines|vaccines|mesh-list
139085493|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
139085494|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085495|NCT01136642|Nicotine|nicotine|mesh-list
139085496|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
139085497|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
139085498|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085499|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085500|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139085501|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139085502|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
139085503|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085504|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085506|NCT00369629|Pemetrexed|pemetrexed|mesh-list
139085507|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139085508|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
139085509|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085510|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085511|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085512|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139085513|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139085514|NCT01133600|Vancomycin|vancomycin|mesh-list
139085515|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139085516|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085517|NCT01133912|Paclitaxel|paclitaxel|mesh-list
139085518|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139085519|NCT01133912|Gemcitabine|gemcitabine|mesh-list
139085520|NCT01133912|Lapatinib|lapatinib|mesh-list
139085521|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139085522|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085523|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
138280343|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085524|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
139085525|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
139085526|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085527|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139085529|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139085530|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085531|NCT05320094|Sorbitol|sorbitol|mesh-list
139085532|NCT05320094|Charcoal|charcoal|mesh-list
139085533|NCT05320094|Antidotes|antidotes|mesh-ancestor
139085534|NCT05320094|Protective Agents|protective agents|mesh-ancestor
139085535|NCT05320094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085536|NCT05320094|Cathartics|cathartics|mesh-ancestor
139085537|NCT05320094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139085538|NCT01233752|Morphine|morphine|mesh-list
139085539|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139085540|NCT01233752|Narcotics|narcotics|mesh-ancestor
138545020|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
139085541|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138511671|NCT00072865|Carboplatin|carboplatin|mesh-list
139085542|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085543|NCT01233752|Analgesics|analgesics|mesh-ancestor
139085544|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
139085545|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085546|NCT01140620|Ketamine|ketamine|mesh-list
139085547|NCT01140620|Risperidone|risperidone|mesh-list
139085548|NCT01140620|Analgesics|analgesics|mesh-ancestor
138545068|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085549|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
139085550|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085551|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085552|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139085553|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139085554|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
139085555|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
139085556|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139085557|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139085558|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139085559|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085560|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085561|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139085562|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
139085563|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139085564|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139085565|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139085566|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139085567|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
139085568|NCT01140932|Prednisolone|prednisolone|mesh-list
139085569|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
139085570|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
139085571|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
139085572|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
139085573|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
139085574|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
139085575|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138545200|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
138280448|NCT02643979|Ketamine|ketamine|mesh-list
138836152|NCT05594602|Adrenergic Agents|adrenergic agents|mesh-ancestor
139085577|NCT01140932|Hormones|hormones|mesh-ancestor
139085578|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139085579|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085580|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139085581|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085582|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
139085583|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
139085584|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085585|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139085586|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139085587|NCT01140932|Protective Agents|protective agents|mesh-ancestor
138511703|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085588|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
139085589|NCT01138904|Irinotecan|irinotecan|mesh-list
139085590|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085591|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139085592|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139085593|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085594|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085595|NCT04582448|Insulin|insulin|mesh-list
139085596|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139085597|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085598|NCT01139138|Irinotecan|irinotecan|mesh-list
139085599|NCT01139138|Everolimus|everolimus|mesh-list
139085600|NCT01139138|Panitumumab|panitumumab|mesh-list
139085601|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139085602|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139085603|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085604|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085605|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085606|NCT01139138|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139085607|NCT01139138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139085609|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
139085610|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085611|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139085613|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
139085614|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
139085615|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
139085616|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
139085617|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
138709201|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
138239284|NCT05369832|Ozanimod|ozanimod|mesh-list
139085618|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
139085619|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
139085620|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139085621|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085622|NCT05308888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
139085623|NCT05308888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
139085624|NCT05308888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085625|NCT01231490|Naproxen|naproxen|mesh-list
139085626|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139085627|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139085628|NCT01231490|Analgesics|analgesics|mesh-ancestor
139085629|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
139085630|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085631|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085632|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139085633|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139085634|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
139085635|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139085636|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545485|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
139085637|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085638|NCT01141244|Sirolimus|sirolimus|mesh-list
139085639|NCT01141244|Irinotecan|irinotecan|mesh-list
139085640|NCT01141244|Temozolomide|temozolomide|mesh-list
138280539|NCT02674412|Buspirone|buspirone|mesh-list
139085641|NCT01141244|Temsirolimus|temsirolimus|mesh-list
139085642|NCT01141244|MTOR Inhibitors|mtor inhibitors|mesh-list
139085643|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139085644|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139085645|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085646|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085647|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085648|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139085649|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
139085650|NCT01141244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139085651|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139085652|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
139085653|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085654|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139085655|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085656|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139085657|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
139085658|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
139085659|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
139085660|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139085661|NCT01141556|Selenium|selenium|mesh-list
139085662|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
139085663|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085664|NCT01141556|Protective Agents|protective agents|mesh-ancestor
139085665|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085666|NCT01141556|Trace Elements|trace elements|mesh-ancestor
139085667|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
139085668|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
139085669|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
139085670|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
139085671|NCT03638440|Naloxegol|naloxegol|mesh-list
139085672|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
139085673|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545679|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139085674|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
139085675|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085676|NCT01719640|Insulin|insulin|mesh-list
139085677|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139085678|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085679|NCT02439658|Sotalol|sotalol|mesh-list
139085680|NCT02439658|Dofetilide|dofetilide|mesh-list
139085681|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138545733|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
139085682|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139085683|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
139085684|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085685|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085686|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085687|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139085688|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
139085689|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
139085690|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085691|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
139085692|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139085694|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
138511811|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085695|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085696|NCT04895098|Ezetimibe|ezetimibe|mesh-list
139085697|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
139085698|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139085699|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139085700|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
139085701|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085702|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139085703|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085705|NCT00318461|Liraglutide|liraglutide|mesh-list
139085706|NCT00318461|Glimepiride|glimepiride|mesh-list
139085707|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139085708|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085709|NCT00318461|Incretins|incretins|mesh-ancestor
139085710|NCT00318461|Hormones|hormones|mesh-ancestor
139085711|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138280735|NCT02710526|Buprenorphine|buprenorphine|mesh-list
138280736|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139085712|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139085713|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139085714|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
139085715|NCT01142258|Trazodone|trazodone|mesh-list
139085716|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138431652|NCT01739582|Enclomiphene|enclomiphene|mesh-list
139085717|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139085718|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139085719|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085720|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139085721|NCT01142258|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139085722|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139085723|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139085724|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085725|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836316|NCT04525274|Ketamine|ketamine|mesh-list
139085726|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
139085727|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139085728|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
139085729|NCT01139840|Vitamin D|vitamin d|mesh-list
139085730|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
139085731|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
139085732|NCT01139840|Vitamins|vitamins|mesh-list
139085733|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
139085734|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085735|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139085736|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139085737|NCT02945410|Vitamin D|vitamin d|mesh-list
139085738|NCT02945410|Calcium|calcium|mesh-list
139085739|NCT02945410|Vitamins|vitamins|mesh-ancestor
139085740|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
139085741|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085742|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139085743|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139085745|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
139085746|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
139085747|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139085748|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085749|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
139085750|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085751|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139085752|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
139085753|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
139085754|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139085755|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085756|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
139085757|NCT01140074|Astringents|astringents|mesh-ancestor
139085758|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085759|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
139085760|NCT01142414|Fluorouracil|fluorouracil|mesh-list
138280841|NCT02731820|Vitamins|vitamins|mesh-ancestor
138280847|NCT02731820|Antacids|antacids|mesh-ancestor
139085761|NCT01142414|Panitumumab|panitumumab|mesh-list
139085762|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085763|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
139085764|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085765|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138546033|NCT00227734|Capecitabine|capecitabine|mesh-list
139085766|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139085767|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
139085768|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085769|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139085770|NCT01236482|Oxytocin|oxytocin|mesh-list
139085771|NCT01236482|Ergonovine|ergonovine|mesh-list
139085772|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
139085773|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139085774|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085775|NCT01142492|Interferons|interferons|mesh-list
139085776|NCT01142492|Interferon-beta|interferon-beta|mesh-list
139085777|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
139085778|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085779|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
139085780|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085781|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
139085782|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085783|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139085784|NCT01234142|Varenicline|varenicline|mesh-list
139085785|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
139085786|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139085787|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
139085788|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085789|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085790|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085792|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
139085793|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
139085794|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085796|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
139085797|NCT01142648|Neostigmine|neostigmine|mesh-list
139085798|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
139085799|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085800|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085801|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
139085802|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085803|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085805|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
138546222|NCT00228358|Immunoconjugates|immunoconjugates|mesh-ancestor
139085806|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085807|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
139085808|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
139085809|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
139085810|NCT02143726|Everolimus|everolimus|mesh-list
139085811|NCT02143726|Sorafenib|sorafenib|mesh-list
139085812|NCT02143726|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138280949|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
139085813|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139085814|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085815|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085816|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139085818|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085819|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085820|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
139085821|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085822|NCT02088112|Durvalumab|durvalumab|mesh-list
139085823|NCT02088112|Gefitinib|gefitinib|mesh-list
139085824|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139085825|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085826|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139085827|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138511898|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138511901|NCT00074776|Lamotrigine|lamotrigine|mesh-list
139085828|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085829|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
139085830|NCT01144910|Miotics|miotics|mesh-ancestor
139085831|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
139085832|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281000|NCT05442931|Pregabalin|pregabalin|mesh-list
139085833|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085834|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
139085835|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
139085836|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
139085837|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
139085838|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
139085839|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
139085840|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085841|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085842|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
139085843|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
139085844|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085845|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
139085846|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139085847|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138546347|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085848|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085849|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
139085850|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085852|NCT05308342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139085853|NCT05308342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085854|NCT03332212|Empagliflozin|empagliflozin|mesh-list
139085855|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
139085856|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085857|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139085858|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085859|NCT01144988|Bevacizumab|bevacizumab|mesh-list
139085860|NCT01144988|Irinotecan|irinotecan|mesh-list
139085861|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139085862|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085863|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
139085864|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
139085865|NCT01144988|Growth Substances|growth substances|mesh-ancestor
139085866|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085867|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
139085868|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
139085869|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139085870|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085871|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085872|NCT03331666|Evolocumab|evolocumab|mesh-list
139085873|NCT03331666|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
139085874|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
139085875|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139085876|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
139085877|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085878|NCT03331666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
139085879|NCT03331666|Protease Inhibitors|protease inhibitors|mesh-ancestor
139085880|NCT03331666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085881|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139085883|NCT04828538|Vitamins|vitamins|mesh-list
139085884|NCT04828538|Folic Acid|folic acid|mesh-list
139085885|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
139085886|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
139085887|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281094|NCT03113695|Lenalidomide|lenalidomide|mesh-list
139085888|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139085890|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
139085891|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
139085892|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
139085893|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085894|NCT03638206|Immunomodulating Agents|immunomodulating agents|mesh-list
139085895|NCT03638206|Immunologic Factors|immunologic factors|mesh-ancestor
139085896|NCT03638206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085897|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
139085898|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139085899|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085900|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
139085901|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139085902|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
139085903|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085904|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085905|NCT01234454|Olanzapine|olanzapine|mesh-list
139085906|NCT01234454|Risperidone|risperidone|mesh-list
139085907|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139085908|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
138250236|NCT01621737|Oxytocin|oxytocin|mesh-list
139085909|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085910|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085911|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085912|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139085913|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139085914|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139085915|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138254192|NCT00002643|Cobalt|cobalt|mesh-list
139085916|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139085919|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
139085920|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085921|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139085922|NCT01234454|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139085923|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139085924|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139085925|NCT01145456|Gemcitabine|gemcitabine|mesh-list
139085926|NCT01145456|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
139085927|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138709202|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139085929|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085930|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085931|NCT01145456|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
139085932|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085933|NCT04939636|Vitamin D|vitamin d|mesh-list
139085934|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
139085935|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
139085936|NCT04939636|Vitamins|vitamins|mesh-list
139085937|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
139085938|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085939|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139085940|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139085941|NCT01238276|Cefazolin|cefazolin|mesh-list
139085942|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139085943|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085944|NCT01145534|Glyburide|glyburide|mesh-list
139085945|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139085946|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085947|NCT01145612|Losartan|losartan|mesh-list
139085948|NCT01145612|Atenolol|atenolol|mesh-list
139085949|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
139085950|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139085951|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
139085953|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085954|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
139085955|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
139085956|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085957|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085958|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
139085959|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
139085960|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
139085961|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
139085962|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085963|NCT05293366|Dermatologic Agents|dermatologic agents|mesh-list
139085964|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
139085965|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
139085966|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085968|NCT01143584|Cabergoline|cabergoline|mesh-list
139085969|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
139085970|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
139085971|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
139085972|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
139085973|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139085974|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085975|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
139085976|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139085977|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085978|NCT01143584|Protective Agents|protective agents|mesh-ancestor
139085979|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139085980|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139085981|NCT01145846|Cytarabine|cytarabine|mesh-list
139085982|NCT01145846|Daunorubicin|daunorubicin|mesh-list
139085983|NCT01145846|Idarubicin|idarubicin|mesh-list
139085984|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139085985|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
139085986|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139085987|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139085988|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
139085989|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139085990|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546838|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
139085991|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
138281361|NCT05447936|Vitamin D|vitamin d|mesh-list
139085992|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139085993|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139085994|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
139085995|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139085996|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139085997|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
139085998|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
139085999|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086000|NCT03134456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
139086001|NCT03134456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086002|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
139086003|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
139086004|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086005|NCT05173688|Propofol|propofol|mesh-list
139086006|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139086007|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086008|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086009|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139086010|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
139086011|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
139086012|NCT01146548|Fluoxetine|fluoxetine|mesh-list
139086013|NCT01146548|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139086014|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139086015|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139086016|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086017|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086018|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
139086019|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086020|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139086021|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
139086022|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138836606|NCT00200200|Bevacizumab|bevacizumab|mesh-list
139086023|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139086024|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139086025|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086027|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
139086028|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138512080|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086029|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
139086031|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
139086032|NCT01312714|Vitamins|vitamins|mesh-ancestor
139086033|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
139086034|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086035|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139086036|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139086037|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
139086038|NCT04188028|Paroxetine|paroxetine|mesh-list
139086039|NCT04188028|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
139086040|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
139086041|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139086042|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086043|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086044|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
139086045|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086046|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
139086047|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
139086048|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139086049|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
139086050|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139086051|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086052|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
139086053|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
139086054|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139086055|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139086056|NCT01312792|Ampicillin|ampicillin|mesh-list
139086057|NCT01312792|Cephradine|cephradine|mesh-list
139086058|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139086059|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086060|NCT03523000|Fentanyl|fentanyl|mesh-list
139086061|NCT03523000|Bupivacaine|bupivacaine|mesh-list
139086062|NCT03523000|Anesthetics, Local|anesthetics, local|mesh-ancestor
139086063|NCT03523000|Anesthetics|anesthetics|mesh-ancestor
139086064|NCT03523000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086065|NCT03523000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086066|NCT03523000|Sensory System Agents|sensory system agents|mesh-ancestor
139086067|NCT03523000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086068|NCT03523000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139086069|NCT03523000|Narcotics|narcotics|mesh-ancestor
139086070|NCT03523000|Analgesics|analgesics|mesh-ancestor
139086071|NCT03523000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138512111|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
139086072|NCT03523000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139086073|NCT03523000|Anesthetics, General|anesthetics, general|mesh-ancestor
139086074|NCT04705480|Pregabalin|pregabalin|mesh-list
139086075|NCT04705480|Gabapentin|gabapentin|mesh-list
139086076|NCT04705480|Analgesics|analgesics|mesh-ancestor
139086077|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
139086078|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086079|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086080|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
139086081|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139086082|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139086083|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086084|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139086085|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139086086|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139086087|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086088|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139086089|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139086090|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139086091|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086092|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
139086093|NCT01238978|Vildagliptin|vildagliptin|mesh-list
139086094|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139086095|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086096|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
139086097|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
139086098|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281629|NCT05454332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
139086099|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086100|NCT00318149|Vaccines|vaccines|mesh-list
139086101|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
139086102|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086103|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
139086104|NCT04648696|Vancomycin|vancomycin|mesh-list
139086105|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
139086106|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086107|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
139086108|NCT01236716|Paclitaxel|paclitaxel|mesh-list
139086109|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
139086110|NCT01236716|Carboplatin|carboplatin|mesh-list
139086111|NCT01236716|Gemcitabine|gemcitabine|mesh-list
139086112|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
139086113|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086114|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
139086115|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
139086116|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
139086117|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086118|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139086119|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
139086120|NCT04154800|Itraconazole|itraconazole|mesh-list
139086121|NCT04154800|Diltiazem|diltiazem|mesh-list
139086122|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
139086123|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086124|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
139086125|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
139086126|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086127|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086128|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
139086129|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
139086130|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139086131|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086132|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
139086133|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139086134|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
139086135|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138547131|NCT00233623|Antidotes|antidotes|mesh-ancestor
139086136|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139086137|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
139086138|NCT01048229|Pramipexole|pramipexole|mesh-list
139086139|NCT01048229|Rasagiline|rasagiline|mesh-list
139086140|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
139086141|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086142|NCT01048229|Protective Agents|protective agents|mesh-ancestor
139086143|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086144|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
139086145|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
139086146|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
139086147|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
139086148|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086149|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
139086150|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086151|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
139086152|NCT01048307|Polihexanide|polihexanide|mesh-list
139086154|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
139086155|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139086156|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
139086157|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
139086158|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
139086159|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086160|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
139086161|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
139086162|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086163|NCT02049905|Gemcitabine|gemcitabine|mesh-list
139086164|NCT02049905|Docetaxel|docetaxel|mesh-list
139086165|NCT02049905|Doxorubicin|doxorubicin|mesh-list
139086166|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
139086167|NCT02049905|Ifosfamide|ifosfamide|mesh-list
139086168|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
138547251|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
139086169|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138836756|NCT00594165|Rotigotine|rotigotine|mesh-list
139086170|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
139086171|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086172|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086173|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
139086174|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
139086175|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
139086176|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139086177|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138281716|NCT04891718|Nivolumab|nivolumab|mesh-list
139086178|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
139086179|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086180|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
139086181|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
139086182|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
139086183|NCT01062191|Laxatives|laxatives|mesh-ancestor
139086184|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138547305|NCT00234871|Verapamil|verapamil|mesh-list
139086186|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
139086187|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
139086188|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
139086189|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
139086190|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086191|NCT01239368|Sirolimus|sirolimus|mesh-list
139086192|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
139086193|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086194|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
139086195|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086196|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
139086197|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086198|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
139086199|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139086201|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
139086202|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139086203|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139086204|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139086205|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
139086206|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086207|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086208|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086209|NCT01146626|Vitamin D|vitamin d|mesh-list
139086210|NCT01146626|Ribavirin|ribavirin|mesh-list
139086211|NCT01146626|Vitamins|vitamins|mesh-ancestor
139086212|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
139086213|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086214|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139086215|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
139086216|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086217|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
139086218|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086219|NCT02924324|Propofol|propofol|mesh-list
139086220|NCT02924324|Ropivacaine|ropivacaine|mesh-list
138281751|NCT00370760|Dexamethasone|dexamethasone|mesh-list
139086221|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139086222|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086223|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086224|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139086226|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
139086227|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
139086228|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
139086229|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086230|NCT05137574|Ketamine|ketamine|mesh-list
139086231|NCT05137574|Propofol|propofol|mesh-list
139086232|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139086233|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086234|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086235|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139086236|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
139086237|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
139086238|NCT05137574|Analgesics|analgesics|mesh-ancestor
139086239|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
139086240|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086241|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139086242|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139086243|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139086244|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086245|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086246|NCT01236950|Listerine|listerine|mesh-list
138281788|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
139086247|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
139086248|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086250|NCT04971746|Nintedanib|nintedanib|mesh-list
139086251|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086252|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139086254|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086255|NCT04971746|Analgesics|analgesics|mesh-ancestor
139086256|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
139086257|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086258|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086259|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139086260|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139086261|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139086262|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139086263|NCT00369161|Everolimus|everolimus|mesh-list
139086264|NCT00369161|Tacrolimus|tacrolimus|mesh-list
139086265|NCT00369161|Basiliximab|basiliximab|mesh-list
139086266|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139086267|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
139086268|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086269|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
139086270|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086271|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086272|NCT00369161|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
139086273|NCT00369161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138281837|NCT00370669|Triamcinolone|triamcinolone|mesh-list
139086274|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086275|NCT01143974|Pemetrexed|pemetrexed|mesh-list
139086276|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086277|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086278|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086279|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139086280|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139086281|NCT00337571|Aripiprazole|aripiprazole|mesh-list
139086282|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
139086283|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139086284|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
139086285|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139086286|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086287|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086288|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
139086289|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
139086290|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086291|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086292|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
139086293|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
139086294|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
139086295|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
139086296|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
139086297|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
139086298|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
139086299|NCT01247870|Metformin|metformin|mesh-list
139086300|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139086301|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086302|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
139086303|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
139086304|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086305|NCT03985319|Esomeprazole|esomeprazole|mesh-list
139086306|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
139086307|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
139086308|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
139086309|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086310|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086311|NCT01237028|Calcitriol|calcitriol|mesh-list
139086312|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
139086313|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086314|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
139086315|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
139086316|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086317|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
139086319|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
139086320|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139086321|NCT01240850|Prednisone|prednisone|mesh-list
139086322|NCT01240850|Methotrexate|methotrexate|mesh-list
139086323|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138547778|NCT00098124|Analgesics|analgesics|mesh-ancestor
139086324|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
139086326|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
139086327|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086328|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
139086329|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086330|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
139086331|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
139086332|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
139086333|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139086334|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
139086335|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086336|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
139086337|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086338|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
139086339|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139086340|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
139086341|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139086342|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
139086343|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
139086344|NCT04813016|Tramadol|tramadol|mesh-list
139086345|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139086346|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086347|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086348|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139086349|NCT04813016|Analgesics|analgesics|mesh-ancestor
139086350|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
139086351|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086352|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
139086353|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
139086354|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
139086355|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
139086356|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086357|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086358|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139086359|NCT04813016|Narcotics|narcotics|mesh-ancestor
139086360|NCT00368927|Sulindac|sulindac|mesh-list
139086361|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139086362|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139086363|NCT00368927|Analgesics|analgesics|mesh-ancestor
139086364|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
139086365|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086366|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086367|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139086368|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139086369|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086370|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
139086371|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086372|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086373|NCT01242410|Silicon|silicon|mesh-list
139086374|NCT01242410|Trace Elements|trace elements|mesh-ancestor
139086375|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
139086376|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086377|NCT02655692|Ketamine|ketamine|mesh-list
139086378|NCT02655692|Analgesics|analgesics|mesh-ancestor
139086379|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
139086380|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086381|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086382|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
139086383|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139086384|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
139086385|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
139086386|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086387|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
139086388|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
139086389|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086390|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086391|NCT01237262|Adalimumab|adalimumab|mesh-list
139086392|NCT01237262|Infliximab|infliximab|mesh-list
139086393|NCT01237262|Etanercept|etanercept|mesh-list
139086394|NCT01237262|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
139086395|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
139086396|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
139086397|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
139086399|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
139086400|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
139086402|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
139086403|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086404|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548064|NCT02961829|Niacinamide|niacinamide|mesh-list
139086405|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139086406|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
139086407|NCT01329770|Vitamins|vitamins|mesh-list
139086408|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
139086409|NCT01329770|Vitamin E|vitamin e|mesh-list
139086410|NCT01329770|Tocopherols|tocopherols|mesh-list
139086411|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
139086412|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
139086413|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086414|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
139086415|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086416|NCT01329770|Protective Agents|protective agents|mesh-ancestor
139086417|NCT00316589|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
139086419|NCT00316589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
139086420|NCT01048385|Ubiquinone|ubiquinone|mesh-list
139086421|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
139086422|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
139086423|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086424|NCT01048385|Vitamins|vitamins|mesh-ancestor
139086425|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
139086426|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138512291|NCT04711213|Hormones|hormones|mesh-ancestor
139086427|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086428|NCT03916250|Petrolatum|petrolatum|mesh-list
139086429|NCT03916250|PF-06700841|pf-06700841|mesh-list
139086430|NCT03916250|Emollients|emollients|mesh-ancestor
139086431|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
139086432|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
139086433|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
139086434|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086435|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
139086436|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
139086437|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086438|NCT03916406|Midazolam|midazolam|mesh-list
139086439|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138548244|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
139086440|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
139086441|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086442|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086443|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
139086444|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
139086445|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
139086446|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
139086447|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
139086448|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
139086449|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
139086450|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
139086451|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
139086452|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086453|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
139086454|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
139086455|NCT00316277|Narcotics|narcotics|mesh-ancestor
139086456|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
139086457|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086458|NCT00316277|Analgesics|analgesics|mesh-ancestor
139086459|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
139086460|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
139086461|NCT01249352|Fluorouracil|fluorouracil|mesh-list
139086462|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
139086463|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
139086464|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
139086465|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
139086466|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
139086467|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
139086468|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
139086469|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
139086470|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138837047|NCT02619513|Analgesics|analgesics|mesh-ancestor
139086471|NCT03912974|Escitalopram|escitalopram|mesh-list
139086472|NCT03912974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138566955|NCT03464942|Atezolizumab|atezolizumab|mesh-list
138567026|NCT03228394|GABA Modulators|gaba modulators|mesh-ancestor
138787632|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282089|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
138787633|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787634|NCT04314674|Mannitol|mannitol|mesh-list
138787635|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138787636|NCT04314674|Diuretics|diuretics|mesh-ancestor
138787637|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
138787638|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787639|NCT00639262|Temozolomide|temozolomide|mesh-list
138787640|NCT00639262|Sorafenib|sorafenib|mesh-list
138567181|NCT00729300|Disulfiram|disulfiram|mesh-list
138787641|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138787642|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
138787643|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787644|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567314|NCT00125307|Tacrolimus|tacrolimus|mesh-list
138787645|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138787646|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787647|NCT02885558|Efonidipine|efonidipine|mesh-list
138787648|NCT02885558|Nifedipine|nifedipine|mesh-list
138567603|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138787649|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138567755|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
138567827|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138787650|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138787651|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787652|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138568357|NCT00345826|Dasatinib|dasatinib|mesh-list
138787653|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787654|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
138787655|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
138787656|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138787657|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138787658|NCT02885558|Diuretics|diuretics|mesh-ancestor
138787659|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
138787661|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
138787662|NCT01008150|Doxorubicin|doxorubicin|mesh-list
138787663|NCT01008150|Trastuzumab|trastuzumab|mesh-list
138569101|NCT00428428|Isoproterenol|isoproterenol|mesh-list
138569241|NCT00093509|Mesna|mesna|mesh-list
138569250|NCT00093509|Protective Agents|protective agents|mesh-ancestor
138569327|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138569422|NCT00094289|Disulfiram|disulfiram|mesh-list
138282126|NCT05320718|Anesthetics, Local|anesthetics, local|mesh-ancestor
138787664|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138787665|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787666|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
138787667|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
138787668|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
138787669|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787670|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138787671|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
138570225|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138570748|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
138787672|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570827|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
138787673|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138787674|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138787675|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
138787676|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138787677|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138571119|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
138571269|NCT00133185|Telmisartan|telmisartan|mesh-list
138571343|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571427|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787678|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138571643|NCT00136383|Paroxetine|paroxetine|mesh-list
138571716|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
138571767|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138787679|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138571924|NCT00136851|Amlodipine|amlodipine|mesh-list
138787680|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787681|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138787682|NCT04186936|Simethicone|simethicone|mesh-list
138787683|NCT04186936|Loperamide|loperamide|mesh-list
138787684|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
138787685|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138787686|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
138572360|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
138787687|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787688|NCT04186936|Emollients|emollients|mesh-ancestor
138787689|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
138572888|NCT00439426|Capecitabine|capecitabine|mesh-list
138787690|NCT02689180|Furosemide|furosemide|mesh-list
138787691|NCT02689180|Diuretics|diuretics|mesh-ancestor
138573180|NCT00440869|Expectorants|expectorants|mesh-ancestor
138787692|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
138787693|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787694|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138462162|NCT01944033|Terbutaline|terbutaline|mesh-list
138787695|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138574056|NCT00143559|Antibodies|antibodies|mesh-list
138574060|NCT00453778|Xhance|xhance|mesh-list
138574133|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138574207|NCT00143715|Vitamins|vitamins|mesh-ancestor
138787696|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787697|NCT02689336|Temozolomide|temozolomide|mesh-list
138787698|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138574359|NCT00113100|Ethanol|ethanol|mesh-list
138574502|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787699|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138787700|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
138787701|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787702|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787703|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138787704|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787705|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138787706|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138787707|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
138574575|NCT00110864|Insulin|insulin|mesh-list
138787709|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787710|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138787711|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
138787712|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138787713|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
138787714|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787715|NCT04294056|Propofol|propofol|mesh-list
138512435|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
138787716|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138787717|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138787718|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787720|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
138787721|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
138787722|NCT04186702|Ranibizumab|ranibizumab|mesh-list
138787723|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138787724|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138787725|NCT04186702|Growth Substances|growth substances|mesh-ancestor
138787726|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574869|NCT00348244|Ketorolac|ketorolac|mesh-list
138574927|NCT00144456|Vitamins|vitamins|mesh-ancestor
138787727|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
138787728|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575251|NCT00111956|Etanercept|etanercept|mesh-list
138787729|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
138787730|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
138787731|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138787732|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138787733|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787734|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
138787735|NCT04187014|Coagulants|coagulants|mesh-ancestor
138787736|NCT02686840|Misoprostol|misoprostol|mesh-list
138787737|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138787738|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
138787739|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138787740|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787741|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138787742|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138787743|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
138787744|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138787745|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138787746|NCT00638482|Diuretics|diuretics|mesh-ancestor
138787747|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
138787748|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787749|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138787750|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138787751|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787752|NCT00638560|Vitamins|vitamins|mesh-list
138787753|NCT00638560|Vitamin E|vitamin e|mesh-list
138787754|NCT00638560|Antioxidants|antioxidants|mesh-list
138787755|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
138575797|NCT00114933|Lopinavir|lopinavir|mesh-list
138575947|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
138787756|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576018|NCT00445081|Hormones|hormones|mesh-ancestor
138576090|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576166|NCT00446368|Everolimus|everolimus|mesh-list
138576239|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138787757|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787758|NCT00638560|Protective Agents|protective agents|mesh-ancestor
138787760|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
138576780|NCT00458731|Cediranib|cediranib|mesh-list
138787761|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138787762|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
138787763|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138787764|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138787765|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787767|NCT02684812|Coagulants|coagulants|mesh-ancestor
138787769|NCT01004250|Pemetrexed|pemetrexed|mesh-list
138787770|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138787771|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577807|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138787772|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138787773|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138787774|NCT01004250|Growth Substances|growth substances|mesh-ancestor
138578180|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138578253|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138787775|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787777|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787778|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578567|NCT01240252|Insulin|insulin|mesh-list
138578629|NCT00481663|Incretins|incretins|mesh-ancestor
138787779|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138787780|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138787781|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138787782|NCT02688634|Amoxicillin|amoxicillin|mesh-list
138578925|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
138787783|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138787784|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
138787785|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138787786|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
138579212|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
138787787|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138787788|NCT00639496|Expectorants|expectorants|mesh-ancestor
138579511|NCT00145314|Antidotes|antidotes|mesh-ancestor
138579657|NCT00490243|Budesonide|budesonide|mesh-list
138579809|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
138579886|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138579959|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
138256435|NCT05033756|Olaparib|olaparib|mesh-list
138256659|NCT01715233|Vitamins|vitamins|mesh-ancestor
138787789|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
138580401|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
138787790|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138787792|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787793|NCT00639496|Protective Agents|protective agents|mesh-ancestor
138787794|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787795|NCT00639496|Antidotes|antidotes|mesh-ancestor
138787796|NCT00639574|Nefopam|nefopam|mesh-list
138580923|NCT01245946|Doxycycline|doxycycline|mesh-list
138787797|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138787798|NCT00639574|Analgesics|analgesics|mesh-ancestor
138581294|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
138787799|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
138581527|NCT00405444|Fentanyl|fentanyl|mesh-list
138787800|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787802|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
138581812|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138581971|NCT00131144|Octreotide|octreotide|mesh-list
138582034|NCT00139971|Antimetabolites|antimetabolites|mesh-ancestor
138787803|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787804|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138787805|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582348|NCT00132821|Bupropion|bupropion|mesh-list
138787806|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787807|NCT01004172|Bevacizumab|bevacizumab|mesh-list
138787808|NCT01004172|Trastuzumab|trastuzumab|mesh-list
138787809|NCT01004172|Carboplatin|carboplatin|mesh-list
138787810|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138582778|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
138787811|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582929|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138787812|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138787813|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138583528|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
138583685|NCT00138242|Carboplatin|carboplatin|mesh-list
138787814|NCT01004172|Growth Substances|growth substances|mesh-ancestor
138787815|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583828|NCT00154401|Hormones|hormones|mesh-ancestor
138787816|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
138787817|NCT02688322|Sulbactam|sulbactam|mesh-list
138787818|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138787819|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583964|NCT00161304|Androgens|androgens|mesh-ancestor
138787820|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138787821|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584551|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
138584697|NCT00141596|Diuretics|diuretics|mesh-ancestor
138584926|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138787822|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787823|NCT02685748|Aspirin|aspirin|mesh-list
138787824|NCT02685748|Pantoprazole|pantoprazole|mesh-list
138787825|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138787826|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138787827|NCT02685748|Analgesics|analgesics|mesh-ancestor
138787828|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
138787829|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585597|NCT00507091|Vitamins|vitamins|mesh-ancestor
138585673|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138787830|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585825|NCT00507403|Infliximab|infliximab|mesh-list
138585903|NCT00507832|Analgesics|analgesics|mesh-ancestor
138585976|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138787831|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138787832|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138787833|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138787834|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138586513|NCT06182098|Anesthetics|anesthetics|mesh-ancestor
138586732|NCT06180941|Tocolytic Agents|tocolytic agents|mesh-ancestor
138787835|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282340|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787836|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138787837|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138787839|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
138787840|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138587408|NCT05511025|Acetaminophen|acetaminophen|mesh-list
138787841|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138587558|NCT05302388|Prednisolone|prednisolone|mesh-list
138787842|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138787843|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
138787844|NCT02685670|Fludarabine|fludarabine|mesh-list
138787845|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138787846|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
138588082|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787847|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588385|NCT03646994|Crizotinib|crizotinib|mesh-list
138588462|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138588546|NCT03132454|Dexamethasone|dexamethasone|mesh-list
138282394|NCT04507022|Estradiol|estradiol|mesh-list
138787849|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138787850|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
138588684|NCT02728102|Vaccines|vaccines|mesh-list
138588759|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138588909|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588987|NCT00600496|Sirolimus|sirolimus|mesh-list
138787851|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787852|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589135|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589207|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138787853|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138787854|NCT02687932|Valsartan|valsartan|mesh-list
138589283|NCT00157872|Rofecoxib|rofecoxib|mesh-list
138589355|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138589652|NCT00337792|Lorazepam|lorazepam|mesh-list
138589653|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138589883|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
138589884|NCT00158574|Proguanil|proguanil|mesh-list
138589957|NCT00473005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138787855|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138787856|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138549480|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
138787857|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138787858|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138787859|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590105|NCT00510250|Sorafenib|sorafenib|mesh-list
138787861|NCT00641602|Lansoprazole|lansoprazole|mesh-list
138787862|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
138787863|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138787864|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138590392|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138787865|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138590472|NCT00513487|Miotics|miotics|mesh-ancestor
138512508|NCT00079261|Hormones|hormones|mesh-ancestor
138787866|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590617|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
138590687|NCT00515788|Cytarabine|cytarabine|mesh-list
138590761|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
138591067|NCT05731596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591142|NCT05576792|Growth Substances|growth substances|mesh-ancestor
138787867|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591368|NCT04721873|Topiramate|topiramate|mesh-list
138787869|NCT05663944|Liver Extracts|liver extracts|mesh-list
138787870|NCT05663944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138787871|NCT05663944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591591|NCT03123913|Hormones|hormones|mesh-ancestor
138787872|NCT05663944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138591808|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138591881|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
138787873|NCT05663944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787874|NCT05663944|Antifungal Agents|antifungal agents|mesh-ancestor
138787875|NCT05663944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138787876|NCT05663944|Immunologic Factors|immunologic factors|mesh-ancestor
138787877|NCT05663944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787878|NCT05663944|Hematinics|hematinics|mesh-ancestor
138787879|NCT02682862|Bromides|bromides|mesh-list
138787880|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
138787881|NCT02682862|Olodaterol|olodaterol|mesh-list
138282486|NCT04061330|Analgesics|analgesics|mesh-ancestor
138787882|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138787883|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
138592097|NCT02948998|Spironolactone|spironolactone|mesh-list
138787884|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787885|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787886|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138787887|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
138787888|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
138592537|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
138592691|NCT00512668|Temsirolimus|temsirolimus|mesh-list
138787889|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138787890|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
138549655|NCT00250120|Rubitecan|rubitecan|mesh-list
138787891|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592989|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
138593063|NCT00525694|Cocaine|cocaine|mesh-list
138593213|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138593285|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138593358|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
138787892|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787893|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
138787895|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138787896|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138593733|NCT00531544|Sunitinib|sunitinib|mesh-list
138787897|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
138282545|NCT04430959|Candesartan|candesartan|mesh-list
138787898|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138787899|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594103|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
138787900|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787901|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138787902|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138787905|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138787906|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138787907|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138787908|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
138787909|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
138787910|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138787911|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787912|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787913|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138787914|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
138787915|NCT02680600|Cefepime|cefepime|mesh-list
138787916|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138787917|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138787918|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138787919|NCT04182724|Paclitaxel|paclitaxel|mesh-list
138787920|NCT04182724|Apatinib|apatinib|mesh-list
138787921|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138787922|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282637|NCT00373412|Vaccines|vaccines|mesh-list
138787923|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
138787924|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
138787925|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
138787926|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787927|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138787928|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787929|NCT04184518|Durvalumab|durvalumab|mesh-list
138787930|NCT04184518|Cediranib|cediranib|mesh-list
138787931|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138787932|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787933|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787934|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787935|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138787936|NCT01174238|Paclitaxel|paclitaxel|mesh-list
138787937|NCT01174238|Carboplatin|carboplatin|mesh-list
138787938|NCT01174238|Axitinib|axitinib|mesh-list
138787939|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138787940|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787941|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
138787942|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
138787943|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
138787944|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787945|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138787946|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138787947|NCT02928406|Atezolizumab|atezolizumab|mesh-list
138787948|NCT02928406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138787949|NCT02928406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787950|NCT02928406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138787951|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138787952|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
138787953|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
138787954|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
138787955|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138787956|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787957|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
138787958|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787959|NCT01161446|Antibodies|antibodies|mesh-list
138787960|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
138787961|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
138787962|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787963|NCT00641680|Fluticasone|fluticasone|mesh-list
138787964|NCT00641680|Xhance|xhance|mesh-list
138787965|NCT00641680|Budesonide|budesonide|mesh-list
138787966|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138787967|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138787968|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
138595471|NCT02916160|Valsartan|valsartan|mesh-list
138787969|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138787970|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595682|NCT05774405|Contraceptive Agents|contraceptive agents|mesh-ancestor
138595761|NCT05292339|Triamcinolone|triamcinolone|mesh-list
138595909|NCT04792502|Lenalidomide|lenalidomide|mesh-list
138787971|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138787972|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
138596592|NCT02913430|Tamoxifen|tamoxifen|mesh-list
138787975|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
138596794|NCT02911480|Oxytocin|oxytocin|mesh-list
138596795|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
138596866|NCT00150761|Levocetirizine|levocetirizine|mesh-list
138596870|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
138596939|NCT00532207|Teriparatide|teriparatide|mesh-list
138787977|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138787978|NCT01174004|Pimavanserin|pimavanserin|mesh-list
138787979|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138787980|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138787981|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138787982|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138787983|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138550081|NCT04719715|Antibodies|antibodies|mesh-list
138787984|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787985|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138696766|NCT04683237|Incretins|incretins|mesh-ancestor
138787986|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138597161|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597226|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597300|NCT05308030|Protease Inhibitors|protease inhibitors|mesh-ancestor
138597373|NCT00164736|Ritonavir|ritonavir|mesh-list
138787987|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138597451|NCT00533026|Warfarin|warfarin|mesh-list
138787988|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
138787989|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597813|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138597889|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
138598036|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138787990|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138787991|NCT01173692|Minocycline|minocycline|mesh-list
138787992|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138598190|NCT00153764|Vitamins|vitamins|mesh-list
138787993|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138787994|NCT00641758|Pycnogenols|pycnogenols|mesh-list
138598487|NCT02921659|Niacinamide|niacinamide|mesh-list
138598630|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138787995|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138787996|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
138787997|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138787998|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
138787999|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788000|NCT00641758|Protective Agents|protective agents|mesh-ancestor
138788001|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138788002|NCT00640276|Pitavastatin|pitavastatin|mesh-list
138598856|NCT00533416|ON 01910|on 01910|mesh-list
138598925|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
138788003|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138788004|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138788005|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138788006|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
138788007|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788008|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788009|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138788010|NCT02680132|Esomeprazole|esomeprazole|mesh-list
138788011|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138788012|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138788013|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138550262|NCT00253903|SR 46349B|sr 46349b|mesh-list
138788014|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788015|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788017|NCT02683564|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138599510|NCT00189384|Penicillin G|penicillin g|mesh-list
138788019|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
138788020|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138788021|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138788022|NCT01101035|Allopurinol|allopurinol|mesh-list
138788023|NCT01101035|Febuxostat|febuxostat|mesh-list
138788024|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
138600030|NCT00158405|Efavirenz|efavirenz|mesh-list
138788025|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788027|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
138788029|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138788030|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
138788031|NCT01101035|Protective Agents|protective agents|mesh-ancestor
138788032|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788033|NCT01160822|Naproxen|naproxen|mesh-list
138788034|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138600852|NCT00542893|Oblimersen|oblimersen|mesh-list
138601004|NCT00543634|Estrogens|estrogens|mesh-ancestor
138601066|NCT00544219|Prednisone|prednisone|mesh-list
138601135|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601208|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138601282|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138601433|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601506|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601582|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601656|NCT00548509|Coagulants|coagulants|mesh-ancestor
138601732|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788035|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138788036|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138788037|NCT01160822|Analgesics|analgesics|mesh-ancestor
138788038|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
138788039|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602102|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138602182|NCT00162188|Efavirenz|efavirenz|mesh-list
138788040|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788041|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138788042|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138602403|NCT03970330|Naltrexone|naltrexone|mesh-list
138788043|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
138602541|NCT00192660|Didanosine|didanosine|mesh-list
138602615|NCT02556931|Fludarabine|fludarabine|mesh-list
138788044|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138788045|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603063|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138788046|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788047|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
138788048|NCT01006980|Dacarbazine|dacarbazine|mesh-list
138788049|NCT01006980|Vemurafenib|vemurafenib|mesh-list
138512658|NCT00080158|Mirtazapine|mirtazapine|mesh-list
138788050|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138788051|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
138788052|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788053|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788054|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138788055|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788056|NCT04296240|Capecitabine|capecitabine|mesh-list
138788057|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
138788058|NCT04296240|Antiemetics|antiemetics|mesh-list
138788059|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138788060|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
138788061|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788062|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788063|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
138273482|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
138788064|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788065|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788066|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138788067|NCT04205058|Caffeine|caffeine|mesh-list
138788068|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138603955|NCT00165347|Vatalanib|vatalanib|mesh-list
138788069|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788070|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138788071|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788072|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788073|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138788074|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138788075|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
138788076|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788077|NCT04183738|Ritonavir|ritonavir|mesh-list
138788078|NCT04183738|Darunavir|darunavir|mesh-list
138788079|NCT04183738|Dolutegravir|dolutegravir|mesh-list
138788080|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138788081|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138788082|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
138788083|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788084|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788085|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138788086|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138788087|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
138788088|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788089|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138788090|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138788091|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138788092|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138604158|NCT00166127|Simendan|simendan|mesh-list
138788094|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
138788095|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
138788096|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788097|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788098|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
138788099|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788102|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138788103|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138788104|NCT00640432|Analgesics|analgesics|mesh-ancestor
138788105|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
138604497|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138788106|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788107|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788108|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138788109|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138788110|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138788111|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138788112|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788113|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788114|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138788115|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138604580|NCT00167648|Leuprolide|leuprolide|mesh-list
138788116|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138788117|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
138604783|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138604934|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
138605012|NCT05994742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138711074|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788118|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605232|NCT05073679|Naltrexone|naltrexone|mesh-list
138605309|NCT04796948|Irinotecan|irinotecan|mesh-list
138788119|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138605385|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138788120|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138788121|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788122|NCT00641212|Budesonide|budesonide|mesh-list
138605532|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
138788123|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138788124|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138788125|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
138605759|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
138605832|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
138550724|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
138788126|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606210|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
138788127|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788128|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138788129|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
138788130|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
138788131|NCT00641212|Hormones|hormones|mesh-ancestor
138606429|NCT00409890|Scopolamine|scopolamine|mesh-list
138788132|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138788134|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138788135|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
138788136|NCT02681848|Nicotine|nicotine|mesh-list
138788137|NCT02681848|Varenicline|varenicline|mesh-list
138788138|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138788139|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
138788140|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788141|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788142|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138788143|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138606575|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
138606638|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
138788144|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
138788145|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606777|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138788146|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788147|NCT00997386|Melphalan|melphalan|mesh-list
138788148|NCT00997386|Busulfan|busulfan|mesh-list
138788149|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
138607003|NCT00180024|Irbesartan|irbesartan|mesh-list
138607071|NCT00172367|Lycopene|lycopene|mesh-list
138607149|NCT00198159|Gefitinib|gefitinib|mesh-list
138607218|NCT00198354|Carboplatin|carboplatin|mesh-list
138788150|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138607448|NCT01978366|Halofuginone|halofuginone|mesh-list
138788152|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788153|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788154|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138607897|NCT01719016|Analgesics|analgesics|mesh-ancestor
138607972|NCT00203814|Artesunate|artesunate|mesh-list
138608061|NCT01660633|Melphalan|melphalan|mesh-list
138608134|NCT00555334|Lamivudine|lamivudine|mesh-list
138608200|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
138788155|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138788156|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
138608578|NCT00199602|Heparin|heparin|mesh-list
138788157|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608875|NCT00554476|Triamcinolone|triamcinolone|mesh-list
138608950|NCT02296645|Ethanol|ethanol|mesh-list
138609100|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788158|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138788160|NCT02679820|Trace Elements|trace elements|mesh-ancestor
138788161|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
138609244|NCT04654819|Anesthetics|anesthetics|mesh-list
138609318|NCT00200694|Diuretics|diuretics|mesh-ancestor
138609387|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609461|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138788162|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788164|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138609985|NCT00561028|Antibodies|antibodies|mesh-list
138788165|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138788166|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
138610285|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
138610440|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
138788167|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788168|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788169|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138610813|NCT04576390|Ondansetron|ondansetron|mesh-list
138788170|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
138610899|NCT00411372|Xhance|xhance|mesh-list
138788171|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
138887311|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887312|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887313|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138887314|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611551|NCT00216879|Hormones|hormones|mesh-ancestor
138611692|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
138280236|NCT02244164|Exenatide|exenatide|mesh-list
138887316|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138887317|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138887318|NCT01002703|Growth Substances|growth substances|mesh-ancestor
138887319|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
138887320|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138887321|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
138887322|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887323|NCT02639234|Nivolumab|nivolumab|mesh-list
138612362|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
138612444|NCT00218361|Hydromorphone|hydromorphone|mesh-list
138887324|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138612510|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
138887325|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887326|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138887327|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612734|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
138887328|NCT00654290|Propranolol|propranolol|mesh-list
138887329|NCT00654290|Amiodarone|amiodarone|mesh-list
138887330|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138612960|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
138887331|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138887332|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
138887333|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613493|NCT00191243|Docetaxel|docetaxel|mesh-list
138887334|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887335|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887336|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138887337|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138887338|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
138613912|NCT05501821|Pembrolizumab|pembrolizumab|mesh-list
138887339|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138614215|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
138887340|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138887341|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138614433|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
138887342|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138614585|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138887343|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138887344|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887345|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138887346|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138887347|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138887349|NCT02713139|Clotrimazole|clotrimazole|mesh-list
138887350|NCT02713139|Miconazole|miconazole|mesh-list
138887351|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138887352|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138887353|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138887354|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138887355|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138887356|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
138887357|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138887358|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138887359|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887360|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887361|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138887362|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
138512816|NCT00080977|Aldesleukin|aldesleukin|mesh-list
138887363|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887364|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887365|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138887366|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138887367|NCT01005121|Colchicine|colchicine|mesh-list
138551250|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
138887369|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138887370|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
138887371|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
138887372|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
138887373|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887374|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887375|NCT02711579|Celecoxib|celecoxib|mesh-list
138887376|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138887377|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138887378|NCT02711579|Analgesics|analgesics|mesh-ancestor
138887379|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
138887380|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887381|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887382|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138887383|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138887384|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138887385|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138887386|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887387|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887388|NCT00611195|Remifentanil|remifentanil|mesh-list
138887389|NCT00611195|Propofol|propofol|mesh-list
138887390|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138887391|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138615809|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615881|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138887392|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887393|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138887394|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
138887395|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
138887396|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138887398|NCT00611195|Analgesics|analgesics|mesh-ancestor
138887399|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
138887400|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616205|NCT00194402|Niacin|niacin|mesh-list
138887401|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138551371|NCT00261820|Sirolimus|sirolimus|mesh-list
138887402|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138887403|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
138887404|NCT01008709|Hormones|hormones|mesh-ancestor
138512845|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
138887405|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138616498|NCT00206973|Mannitol|mannitol|mesh-list
138887406|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887407|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616613|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
138887408|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887409|NCT02615574|Interferons|interferons|mesh-list
138887410|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138617064|NCT00202787|Antidotes|antidotes|mesh-ancestor
138887413|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
138617510|NCT00208572|Citalopram|citalopram|mesh-list
138887414|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617733|NCT00204074|Estrogens|estrogens|mesh-ancestor
138617807|NCT00227448|Midodrine|midodrine|mesh-list
138887415|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887417|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618107|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138618185|NCT00231582|Paclitaxel|paclitaxel|mesh-list
138618258|NCT00199004|Methotrexate|methotrexate|mesh-list
138618336|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
138618409|NCT00204893|Calcium|calcium|mesh-list
138618487|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618779|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
138618933|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
138887418|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138887420|NCT02615574|Analgesics|analgesics|mesh-ancestor
138887421|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
138887422|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887423|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138887424|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138887425|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138619362|NCT00209222|Etoposide|etoposide|mesh-list
138887426|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138887427|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619588|NCT01081132|Guanfacine|guanfacine|mesh-list
138887428|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887429|NCT02708693|Triamcinolone|triamcinolone|mesh-list
138887430|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138619882|NCT01059903|Rotigotine|rotigotine|mesh-list
138887431|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138887432|NCT02708693|Lidocaine|lidocaine|mesh-list
138620102|NCT00237900|Antidotes|antidotes|mesh-ancestor
138887433|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138887434|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
138887436|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138620629|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887437|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620859|NCT00239382|Meloxicam|meloxicam|mesh-list
138887438|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
138620926|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138621004|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
138621073|NCT00243672|Atorvastatin|atorvastatin|mesh-list
138887439|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621302|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138887440|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138621444|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
138551613|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138887441|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138887442|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138621594|NCT00557011|Amphetamine|amphetamine|mesh-list
138887443|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138621818|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
138622115|NCT00558181|Prednisolone|prednisolone|mesh-list
138622193|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622268|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138622422|NCT00245934|Etanercept|etanercept|mesh-list
138622495|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622574|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
138622790|NCT00219440|Metformin|metformin|mesh-list
138622863|NCT04626193|Levofloxacin|levofloxacin|mesh-list
138622937|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
138887444|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887445|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138887446|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
138887447|NCT02708693|Hormones|hormones|mesh-ancestor
138623232|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138623381|NCT00243399|Oxandrolone|oxandrolone|mesh-list
138623454|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
138623525|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
138623600|NCT06178146|Prednisone|prednisone|mesh-list
138623601|NCT06178146|Cortisone|cortisone|mesh-list
138887448|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887449|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138887450|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
138887451|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623970|NCT06015750|Antimetabolites|antimetabolites|mesh-ancestor
138624047|NCT05988671|Glucocorticoids|glucocorticoids|mesh-ancestor
138887452|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138887453|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138887454|NCT02638922|Trisequens|trisequens|mesh-list
138887455|NCT02638922|Norethindrone|norethindrone|mesh-list
138887456|NCT02638922|Estradiol|estradiol|mesh-list
138887457|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138887458|NCT02638922|Estrogens|estrogens|mesh-ancestor
138887459|NCT02638922|Hormones|hormones|mesh-ancestor
138624273|NCT05452772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138624413|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
138624418|NCT05136846|Paclitaxel|paclitaxel|mesh-list
138624487|NCT05089708|Trifarotene|trifarotene|mesh-list
138624488|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
138887460|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887461|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887462|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138887463|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
138887464|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138887465|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138887466|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138887467|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138512900|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887468|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138887471|NCT01005199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138887472|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138887473|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887474|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887475|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138887476|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
138887477|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887478|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887479|NCT02711189|Oxytocin|oxytocin|mesh-list
138887480|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
138887481|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138887482|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887483|NCT02635802|Lidocaine|lidocaine|mesh-list
138887484|NCT02635802|Midazolam|midazolam|mesh-list
138887485|NCT02635802|Remifentanil|remifentanil|mesh-list
138887486|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
138887487|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
138887488|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887489|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887490|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
138887491|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625059|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
138625286|NCT02727803|Fludarabine|fludarabine|mesh-list
138302228|NCT00003343|Hormones|hormones|mesh-ancestor
138887492|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138887493|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138887494|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138702736|NCT02927951|Pregabalin|pregabalin|mesh-list
138887495|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138887496|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887497|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138887498|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138887499|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138887500|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138887501|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138887502|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138887503|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
138887504|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
138887505|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
138887506|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625818|NCT00248157|Octreotide|octreotide|mesh-list
138887507|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138887509|NCT02635802|Analgesics|analgesics|mesh-ancestor
138626048|NCT04609033|Ketamine|ketamine|mesh-list
138887510|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138887511|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
138887512|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887514|NCT00657410|Prednisone|prednisone|mesh-list
138887515|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138887516|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
138887517|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
138887518|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626480|NCT00252408|Hormones|hormones|mesh-list
138887519|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626759|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
138626830|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138626908|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138626981|NCT04484363|Azacitidine|azacitidine|mesh-list
138627054|NCT00253227|Galantamine|galantamine|mesh-list
138887520|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138887521|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
138627500|NCT04584307|Growth Substances|growth substances|mesh-ancestor
138627651|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
138627725|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627799|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138627955|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
138628103|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
138628174|NCT00572182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628248|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628322|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138628469|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
138628542|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138628545|NCT03453346|Ribavirin|ribavirin|mesh-list
138628615|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138887523|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887524|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138551888|NCT00102141|Estradiol|estradiol|mesh-list
138887525|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887527|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138887528|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138887529|NCT01009021|Analgesics|analgesics|mesh-ancestor
138887530|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
138887531|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887532|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887534|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138887535|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138887536|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887537|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887538|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
138887539|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138887540|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887541|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887542|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138887543|NCT01005433|Analgesics|analgesics|mesh-ancestor
138887544|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
138887545|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887546|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138887547|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138887548|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138887549|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
138887550|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887551|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887552|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138887553|NCT00654446|Simvastatin|simvastatin|mesh-list
138887554|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138628808|NCT04572373|SMOFlipid|smoflipid|mesh-list
138887555|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138887556|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
138887557|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887558|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138629400|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887559|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138551981|NCT00102258|Hormones|hormones|mesh-list
138887560|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887561|NCT01003483|Orlistat|orlistat|mesh-list
138887562|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629699|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
138629925|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138630076|NCT00200681|Bortezomib|bortezomib|mesh-list
138630148|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887563|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630224|NCT00201695|Dexamethasone|dexamethasone|mesh-list
138887564|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138887567|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138887568|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
138630672|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
138630746|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
138887569|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
138887571|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887572|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887573|NCT01009177|Bosentan|bosentan|mesh-list
138887574|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138887575|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138887576|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887577|NCT00598832|Adapalene|adapalene|mesh-list
138630896|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
138887578|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138887579|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138887580|NCT00598832|Analgesics|analgesics|mesh-ancestor
138887581|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
138552061|NCT00268177|Xhance|xhance|mesh-list
138887582|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887583|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887584|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138887585|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138887586|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
138631478|NCT00556270|Fentanyl|fentanyl|mesh-list
138887587|NCT01003561|Anesthetics|anesthetics|mesh-list
138887588|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887589|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632003|NCT00268515|Cyclosporins|cyclosporins|mesh-list
138887591|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
138887592|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138887593|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
138632570|NCT00269217|Niacin|niacin|mesh-list
138887594|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138887595|NCT04459871|Thrombin|thrombin|mesh-list
138887596|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
138887597|NCT04459871|Coagulants|coagulants|mesh-ancestor
138887598|NCT02708459|Morphine|morphine|mesh-list
138887599|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138887600|NCT02708459|Narcotics|narcotics|mesh-ancestor
138887601|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887602|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887603|NCT02708459|Analgesics|analgesics|mesh-ancestor
138887604|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
138632825|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
138702797|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
138633039|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138633192|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138887605|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887606|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
138887607|NCT01005979|Rituximab|rituximab|mesh-list
138887608|NCT01005979|Lenalidomide|lenalidomide|mesh-list
138887609|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138887610|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
138887611|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887612|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138887613|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138887614|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
138709203|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887615|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887616|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887617|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138887618|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138702833|NCT04798287|Infliximab|infliximab|mesh-list
138887619|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138887620|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138887621|NCT01005979|Growth Substances|growth substances|mesh-ancestor
138887622|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
138887623|NCT00913029|Timolol|timolol|mesh-list
138887624|NCT00913029|Latanoprost|latanoprost|mesh-list
138887625|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138887626|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138887627|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
138887628|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138709204|NCT04410445|Nivolumab|nivolumab|mesh-list
138887629|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633269|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887630|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633400|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
138887631|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138887632|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138887633|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138887634|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138887636|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138887637|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
138887638|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138887639|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887640|NCT00853125|Sunitinib|sunitinib|mesh-list
138887641|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887642|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138633465|NCT04535518|Aspirin|aspirin|mesh-list
138887643|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138887644|NCT00853125|Growth Substances|growth substances|mesh-ancestor
138887645|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887646|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
138887647|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138887648|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887649|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887651|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138887652|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138887653|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138887654|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887655|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138887656|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887657|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
138887658|NCT02710877|Sufentanil|sufentanil|mesh-list
138887659|NCT02710877|Dsuvia|dsuvia|mesh-list
138887660|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
138887661|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138887662|NCT02710877|Narcotics|narcotics|mesh-ancestor
138228849|NCT02175212|Androgens|androgens|mesh-list
138887663|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887664|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887665|NCT02710877|Analgesics|analgesics|mesh-ancestor
138887666|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
138887667|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887668|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138887669|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138887670|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
138887671|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
138887672|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
138887673|NCT00530023|Insulin|insulin|mesh-list
138887674|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138887675|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887676|NCT02707445|Clopidogrel|clopidogrel|mesh-list
138887677|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138887678|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138887679|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138887680|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138887681|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
138887682|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702928|NCT02191878|TKM-080301|tkm-080301|mesh-list
138887683|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887684|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887685|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
138887686|NCT03999775|Vitamin D|vitamin d|mesh-list
138887687|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
138887689|NCT03999775|Vitamins|vitamins|mesh-list
138887690|NCT03999775|Calcium|calcium|mesh-list
138887692|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887693|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138887694|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138887695|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138887696|NCT02706977|Carbidopa|carbidopa|mesh-list
138887697|NCT02706977|Levodopa|levodopa|mesh-list
138887698|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138887699|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
138887700|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439701|NCT01776853|Levan|levan|mesh-list
138887701|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138887702|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138887703|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
138887704|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
138887705|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887706|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887707|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138887708|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887709|NCT02707211|Antibodies|antibodies|mesh-list
138887710|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
138887711|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
138552781|NCT00272116|Vitamins|vitamins|mesh-list
138887712|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887713|NCT01006525|Zolpidem|zolpidem|mesh-list
138887714|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138887715|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138887716|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887717|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887718|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138887719|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
138887720|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
138633838|NCT05841160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138633972|NCT04923776|Carboplatin|carboplatin|mesh-list
138887721|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887722|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887724|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
138887725|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
138887726|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887727|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138887729|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138634638|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138887730|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887732|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138634935|NCT01647412|Analgesics|analgesics|mesh-ancestor
138635010|NCT01648036|Dalteparin|dalteparin|mesh-list
138635157|NCT00240617|Analgesics|analgesics|mesh-ancestor
138635231|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138635456|NCT02279602|Tubulin Modulators|tubulin modulators|mesh-ancestor
138887733|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887734|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138887735|NCT02706509|Narcotics|narcotics|mesh-ancestor
138887736|NCT02706509|Analgesics|analgesics|mesh-ancestor
138887737|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
138887738|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887739|NCT02710409|Vaccines|vaccines|mesh-list
138636192|NCT00244556|Etanercept|etanercept|mesh-list
138887740|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
138702998|NCT02125266|Methotrexate|methotrexate|mesh-list
138887741|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887743|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
138887744|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
138887745|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138887746|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887747|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
138636783|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138887748|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887749|NCT04318210|Tenofovir|tenofovir|mesh-list
138887750|NCT04318210|Emtricitabine|emtricitabine|mesh-list
138887751|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
138552971|NCT00273559|Hormones|hormones|mesh-ancestor
138887752|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138887753|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138637156|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
138637223|NCT00249782|Dapsone|dapsone|mesh-list
138887754|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138887755|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637603|NCT01641406|Growth Substances|growth substances|mesh-ancestor
138637832|NCT00287157|Tizanidine|tizanidine|mesh-list
138637897|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887756|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887758|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138887759|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138887760|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
138887761|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703066|NCT02916251|Glucagon|glucagon|mesh-list
138887762|NCT00870870|Carboplatin|carboplatin|mesh-list
138887763|NCT00870870|Gemcitabine|gemcitabine|mesh-list
138887764|NCT00870870|Cetuximab|cetuximab|mesh-list
138887765|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138887766|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887767|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138887768|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
138887769|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887770|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138553094|NCT00274495|Ribavirin|ribavirin|mesh-list
138887771|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
138887772|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887773|NCT00731926|Vitamins|vitamins|mesh-list
138887774|NCT00731926|Vitamin E|vitamin e|mesh-list
138887775|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
138887776|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887777|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
138887778|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887779|NCT00731926|Protective Agents|protective agents|mesh-ancestor
138887780|NCT00732082|Gemcitabine|gemcitabine|mesh-list
138887781|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138887782|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
138513132|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138887783|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887784|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887785|NCT00611741|Furosemide|furosemide|mesh-list
138887786|NCT00611741|Diuretics|diuretics|mesh-ancestor
138887787|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
138887788|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887789|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138887790|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138887791|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539931|NCT00054587|Docetaxel|docetaxel|mesh-list
138887792|NCT04134468|Gemcitabine|gemcitabine|mesh-list
138887793|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138887794|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138887795|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
138887796|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887797|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887798|NCT02709863|Propofol|propofol|mesh-list
138887799|NCT02709863|Sevoflurane|sevoflurane|mesh-list
138887800|NCT02709863|Desflurane|desflurane|mesh-list
138887801|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138887802|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887803|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703163|NCT02092935|Vancomycin|vancomycin|mesh-list
138887804|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138887805|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
138887806|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
138887807|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138887808|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138295416|NCT00003044|Cisplatin|cisplatin|mesh-list
138887809|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
138887810|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138887811|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887812|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138887813|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887814|NCT02619786|Colistin|colistin|mesh-list
138887815|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138887816|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138887817|NCT00697086|Dronedarone|dronedarone|mesh-list
138887818|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138887819|NCT04066660|Fucoidan|fucoidan|mesh-list
138887820|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138887821|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138887822|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
138887823|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887824|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
138887825|NCT00697164|Hematinics|hematinics|mesh-ancestor
138887826|NCT00694980|Etrolizumab|etrolizumab|mesh-list
138887827|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138887828|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
138887829|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887830|NCT00612755|Ribavirin|ribavirin|mesh-list
138887831|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138887832|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
138887833|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887834|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
138887835|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138887836|NCT04132674|Tenofovir|tenofovir|mesh-list
138887837|NCT04132674|Emtricitabine|emtricitabine|mesh-list
138887838|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138703224|NCT01658826|Pritelivir|pritelivir|mesh-list
138887839|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
138887840|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138887841|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138887842|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138887843|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887844|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887845|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138887846|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138887847|NCT00612287|Buprenorphine|buprenorphine|mesh-list
138887848|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138887849|NCT00612287|Narcotics|narcotics|mesh-ancestor
138887850|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887851|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887852|NCT00612287|Analgesics|analgesics|mesh-ancestor
138887853|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
138887854|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887855|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138887856|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
138887857|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
138887858|NCT00732784|Calcium|calcium|mesh-list
138887859|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138887860|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887861|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887862|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138887863|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887864|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887865|NCT00732784|Antacids|antacids|mesh-ancestor
138887866|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138887867|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
138887868|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
138887869|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138887870|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887871|NCT02947126|Antidotes|antidotes|mesh-ancestor
138887872|NCT02947126|Protective Agents|protective agents|mesh-ancestor
138887873|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887874|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
138703259|NCT02081118|Exenatide|exenatide|mesh-list
138513211|NCT03151434|Bupivacaine|bupivacaine|mesh-list
138887875|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
138887876|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138887877|NCT04492553|Testosterone|testosterone|mesh-list
138887878|NCT04492553|Androgens|androgens|mesh-ancestor
138887879|NCT04492553|Hormones|hormones|mesh-ancestor
138887880|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887881|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887883|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138887884|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138887885|NCT01007539|Choline|choline|mesh-list
138887886|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138887887|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
138887888|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138887889|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
138887890|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887891|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138887892|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138887893|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
138887894|NCT04951817|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138553402|NCT00278824|Analgesics|analgesics|mesh-ancestor
138887895|NCT04951817|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138887896|NCT04951817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887897|NCT04137185|Hormones|hormones|mesh-list
138887898|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887899|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887900|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
138887901|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138887902|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887903|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138887904|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138887905|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138887906|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138887907|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887908|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887909|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887910|NCT00529789|Analgesics|analgesics|mesh-ancestor
138887911|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
138887912|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887913|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
138887914|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138887915|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
138703290|NCT01628094|Ribavirin|ribavirin|mesh-list
138553473|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
138887916|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138887917|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138887918|NCT00611819|Interferons|interferons|mesh-list
138887919|NCT00611819|Ribavirin|ribavirin|mesh-list
138887920|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138887921|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
138887922|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887923|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
138887924|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138887925|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
138887926|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887927|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
138887928|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887929|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
138887930|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138887931|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887932|NCT02619162|Letrozole|letrozole|mesh-list
138887933|NCT02619162|Nintedanib|nintedanib|mesh-list
138887934|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138887935|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138887936|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138887937|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887938|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703333|NCT02063997|Colchicine|colchicine|mesh-list
138887939|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138887940|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
138887941|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887942|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887943|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138887945|NCT04018690|Ropivacaine|ropivacaine|mesh-list
138887946|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
138887947|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
138887948|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887949|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887950|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
138887951|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887952|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138887953|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
138887954|NCT04018690|Hormones|hormones|mesh-ancestor
138887955|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138887956|NCT00697866|Vaccines|vaccines|mesh-list
138887957|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
138887958|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887959|NCT00733564|Lidocaine|lidocaine|mesh-list
138887960|NCT00733564|Propofol|propofol|mesh-list
138887961|NCT00733564|Sevoflurane|sevoflurane|mesh-list
138887962|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
138887963|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
138887964|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887965|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887966|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
138887967|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138887968|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138887969|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138300922|NCT00003943|Paclitaxel|paclitaxel|mesh-list
138887970|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138887971|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138887972|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887973|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138887974|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138887975|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
138887976|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138887977|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138887978|NCT00727870|Glycerol|glycerol|mesh-list
138887979|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138887980|NCT00727870|Protective Agents|protective agents|mesh-ancestor
138887981|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887982|NCT01007695|Valproic Acid|valproic acid|mesh-list
138887983|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
138887984|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138887985|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138887986|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
138887987|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138887988|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887989|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
138887990|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138887991|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887992|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138887993|NCT02709473|Remifentanil|remifentanil|mesh-list
138887994|NCT02709473|Propofol|propofol|mesh-list
138887995|NCT02709473|Rocuronium|rocuronium|mesh-list
138887996|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138887997|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138887998|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138887999|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138888000|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
138888001|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
138888002|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138888003|NCT02709473|Narcotics|narcotics|mesh-ancestor
138888004|NCT02709473|Analgesics|analgesics|mesh-ancestor
138888005|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
138888006|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888007|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138888008|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138888009|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138888010|NCT00866658|Lixisenatide|lixisenatide|mesh-list
138888011|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138888012|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888014|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
138888015|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888016|NCT02615340|Protective Agents|protective agents|mesh-ancestor
138888017|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888018|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888019|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
138888020|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888021|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
138888022|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888023|NCT04899791|Protective Agents|protective agents|mesh-ancestor
138888024|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888025|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138888026|NCT02615106|Endostar protein|endostar protein|mesh-list
138888027|NCT02615106|Endostatins|endostatins|mesh-list
138888028|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138888029|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138888030|NCT02615106|Growth Substances|growth substances|mesh-ancestor
138888031|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513324|NCT03151161|Pemetrexed|pemetrexed|mesh-list
138888032|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
138888033|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888034|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
138888035|NCT04930237|Bisacodyl|bisacodyl|mesh-list
138888036|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
138888037|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
138888038|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138888039|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
138888040|NCT04930237|Calcium|calcium|mesh-list
138888041|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138888042|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888043|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888044|NCT04930237|Cathartics|cathartics|mesh-ancestor
138888045|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138888046|NCT04930237|Laxatives|laxatives|mesh-ancestor
138888047|NCT04930237|Antacids|antacids|mesh-ancestor
138888048|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138888049|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
138888050|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888051|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
138888052|NCT02615262|Dexamethasone|dexamethasone|mesh-list
138888053|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138888054|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
138888055|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
138888056|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888057|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888058|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138888059|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
138888060|NCT02615262|Hormones|hormones|mesh-ancestor
138888061|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138888062|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138888063|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888064|NCT00733720|Naltrexone|naltrexone|mesh-list
138888065|NCT00733720|Buprenorphine|buprenorphine|mesh-list
138888066|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138888067|NCT00733720|Naloxone|naloxone|mesh-list
138888068|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138888069|NCT00733720|Narcotics|narcotics|mesh-ancestor
138553977|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
138888070|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888071|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888072|NCT00733720|Analgesics|analgesics|mesh-ancestor
138888073|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
138513363|NCT00136786|Memantine|memantine|mesh-list
138888074|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888075|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138888076|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138888077|NCT04134312|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138888078|NCT04134312|Antiviral Agents|antiviral agents|mesh-ancestor
138888079|NCT04134312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888080|NCT02624388|Genistein|genistein|mesh-list
138888081|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138888082|NCT02624388|Protective Agents|protective agents|mesh-ancestor
138888083|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888084|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888085|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138888086|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888087|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888088|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
138888089|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138888090|NCT02624388|Estrogens|estrogens|mesh-ancestor
138888091|NCT02624388|Hormones|hormones|mesh-ancestor
138888092|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138888093|NCT00727948|Aspirin|aspirin|mesh-list
138888094|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138888095|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138888096|NCT00727948|Analgesics|analgesics|mesh-ancestor
138888097|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
138888098|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888099|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888100|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138888101|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138888102|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138888103|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138888104|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888105|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138888106|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138888107|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888108|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
138888109|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138888110|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
138888111|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138888112|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
138888113|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138554157|NCT00417157|Ganirelix|ganirelix|mesh-list
138888114|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888115|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138888116|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138888117|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888118|NCT05580016|Plasminogen|plasminogen|mesh-list
138888119|NCT05580016|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138888120|NCT05580016|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138888121|NCT05580016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888122|NCT05730673|Leronlimab|leronlimab|mesh-list
138888123|NCT05730673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138888124|NCT05730673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138888125|NCT05730673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888126|NCT05730673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138888127|NCT05730673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138888128|NCT05730673|Antiviral Agents|antiviral agents|mesh-ancestor
138888129|NCT05730673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888130|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
138703589|NCT04675944|Zamicastat|zamicastat|mesh-list
138888131|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138888132|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
138888133|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888134|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888135|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138888136|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
138888137|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138888138|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
138888139|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888140|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888141|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138888142|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
138888143|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
138888144|NCT04134078|Protective Agents|protective agents|mesh-ancestor
138888146|NCT00738556|Paclitaxel|paclitaxel|mesh-list
138888147|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138888148|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888149|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
138888150|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
138888151|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
138888152|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888153|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138888154|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888155|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138888156|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
138888157|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138888158|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
138888159|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888160|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
138888161|NCT00597584|Hematinics|hematinics|mesh-ancestor
138888162|NCT00529633|Thalidomide|thalidomide|mesh-list
138888163|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138888164|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
138888165|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888166|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
138888167|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138380507|NCT03522246|Nivolumab|nivolumab|mesh-list
138888169|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138888170|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138888171|NCT00529633|Growth Substances|growth substances|mesh-ancestor
138888172|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
138888173|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888174|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138888175|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
138888176|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888177|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138888178|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138888180|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138888181|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
138888182|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888183|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
138888184|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138888185|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888186|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138888187|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138888188|NCT00657488|Growth Substances|growth substances|mesh-ancestor
138888189|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
138888190|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888191|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138888192|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138888193|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138888194|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138888195|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888196|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
138888197|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888198|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888199|NCT00712270|Risperidone|risperidone|mesh-list
138888200|NCT00712270|Aripiprazole|aripiprazole|mesh-list
138888201|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138888202|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
138888203|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888204|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703674|NCT02910518|Hormones|hormones|mesh-ancestor
138888205|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888206|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138888207|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138888208|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888209|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138888210|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138888212|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
138888213|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
138554718|NCT00077948|Enoximone|enoximone|mesh-list
138888214|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138888215|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138888216|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138888217|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138888218|NCT03860597|Memantine|memantine|mesh-list
138888219|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138888220|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138888221|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
138554783|NCT00287521|Timolol|timolol|mesh-list
138888222|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888223|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888224|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888225|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138888226|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138888227|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138888228|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138888229|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138888230|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
138888231|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888232|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888233|NCT00695604|Fluticasone|fluticasone|mesh-list
138888234|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138888235|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138888236|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
138888237|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888238|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888239|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138888240|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
138888241|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
138888242|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138888243|NCT00654524|Vitamin D|vitamin d|mesh-list
138888244|NCT00654524|Goserelin|goserelin|mesh-list
138888245|NCT00654524|Hormones|hormones|mesh-list
138888246|NCT00654524|Vitamins|vitamins|mesh-ancestor
138888247|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
138888248|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703710|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138888249|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138888250|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138888251|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138888252|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888253|NCT05260619|Lenalidomide|lenalidomide|mesh-list
138888254|NCT05260619|Immunologic Factors|immunologic factors|mesh-ancestor
138888255|NCT05260619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888256|NCT05260619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138888257|NCT05260619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138554917|NCT00399425|Tinzaparin|tinzaparin|mesh-list
138888258|NCT05260619|Growth Substances|growth substances|mesh-ancestor
138888259|NCT05260619|Growth Inhibitors|growth inhibitors|mesh-ancestor
138888260|NCT05260619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888262|NCT00695682|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138888263|NCT00695682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138888264|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
138888265|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138888266|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138888267|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138888268|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138888269|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888270|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
138888271|NCT03828773|Fluconazole|fluconazole|mesh-list
138888272|NCT03828773|Posaconazole|posaconazole|mesh-list
138888273|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
138888274|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888275|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138888276|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138888277|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888278|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888279|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138888280|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
138888281|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138888282|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888283|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138888284|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138888285|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138888286|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138888287|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138888288|NCT00530257|Methylphenidate|methylphenidate|mesh-list
138888289|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138888290|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888291|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138888292|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138555028|NCT00290017|Pemetrexed|pemetrexed|mesh-list
138888293|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138888294|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888295|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
138888296|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888297|NCT00738868|Cetuximab|cetuximab|mesh-list
138888298|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138888299|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888300|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138888301|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
138888302|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138888303|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138888304|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888305|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888306|NCT00657644|Urological Agents|urological agents|mesh-ancestor
138888307|NCT00869778|Vaccines|vaccines|mesh-list
138888308|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
138888309|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888310|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
138888311|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138888312|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138888313|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138888314|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
138888315|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888316|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888317|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888318|NCT04162028|Ketamine|ketamine|mesh-list
138888319|NCT04162028|Analgesics|analgesics|mesh-ancestor
138888320|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
138888321|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888322|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888323|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138888324|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138888325|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
138888326|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
138888327|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888328|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138888329|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138888330|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138703775|NCT06227065|Docetaxel|docetaxel|mesh-list
138888331|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888332|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
138555131|NCT02960815|Imiquimod|imiquimod|mesh-list
138888334|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138888335|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138888336|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888337|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
138888338|NCT00656786|Coagulants|coagulants|mesh-ancestor
138888339|NCT00656786|Vitamins|vitamins|mesh-ancestor
138888340|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
138888341|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888342|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
138888343|NCT01008631|Antidotes|antidotes|mesh-ancestor
138888344|NCT01008631|Protective Agents|protective agents|mesh-ancestor
138888345|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888346|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
138888347|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888348|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
138888349|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138888350|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888351|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
138888352|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
138888353|NCT00734890|Bevacizumab|bevacizumab|mesh-list
138888354|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138888355|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138513598|NCT03150732|Nalbuphine|nalbuphine|mesh-list
138888356|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138888357|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138888358|NCT00734890|Growth Substances|growth substances|mesh-ancestor
138888359|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888360|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
138888361|NCT05325190|Granisetron|granisetron|mesh-list
138888362|NCT05325190|Antiemetics|antiemetics|mesh-ancestor
138888363|NCT05325190|Autonomic Agents|autonomic agents|mesh-ancestor
138888364|NCT05325190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888365|NCT05325190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888366|NCT05325190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138888367|NCT05325190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138888368|NCT05325190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138888369|NCT05325190|Serotonin Agents|serotonin agents|mesh-ancestor
138888370|NCT05325190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888371|NCT05325190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888372|NCT02624310|Droxidopa|droxidopa|mesh-list
138888373|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138888374|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138888375|NCT00612521|Adenosine|adenosine|mesh-list
138888376|NCT00612521|Analgesics|analgesics|mesh-ancestor
138888377|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
138888378|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888379|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888380|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138888381|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
138888382|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138888383|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
138888384|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
138888385|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888386|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888387|NCT00735124|Gabapentin|gabapentin|mesh-list
138888388|NCT00735124|Analgesics|analgesics|mesh-ancestor
138888389|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
138888390|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888391|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888392|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
138888393|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138888394|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138888395|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888396|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138888397|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138888398|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138888399|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888400|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888402|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
138888403|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138888404|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138888405|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138888406|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138555363|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888407|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888408|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
138888409|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888410|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888411|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138888412|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888413|NCT04246541|Acetaminophen|acetaminophen|mesh-list
138888414|NCT04246541|Ketorolac|ketorolac|mesh-list
138888415|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138888416|NCT04246541|Oxycodone|oxycodone|mesh-list
138888417|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138888418|NCT04246541|Analgesics|analgesics|mesh-ancestor
138888419|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
138888420|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888421|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888422|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
138888423|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138888424|NCT04246541|Narcotics|narcotics|mesh-ancestor
138888425|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888426|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138888427|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138888428|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138888429|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138888430|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888431|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888432|NCT04902859|Clonidine|clonidine|mesh-list
138555479|NCT00079118|Docetaxel|docetaxel|mesh-list
138888434|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
138888435|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888436|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888437|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138888438|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
138888439|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
138888440|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138888441|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138888442|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138888443|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
138888444|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888445|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888446|NCT05227313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138555559|NCT00130156|Doxazosin|doxazosin|mesh-list
138888447|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138888448|NCT04180943|Bupivacaine|bupivacaine|mesh-list
138888449|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
138888450|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
138888451|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888452|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888453|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
138888454|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888455|NCT05011357|Phenylephrine|phenylephrine|mesh-list
138888456|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
138888457|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138888458|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
138888459|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
138703922|NCT06225570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888460|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888461|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888462|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
138888463|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138888464|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
138888465|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
138888466|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138888467|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138888468|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138888469|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
138888470|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888471|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888472|NCT05011357|Protective Agents|protective agents|mesh-ancestor
138888474|NCT00711880|Analgesics|analgesics|mesh-ancestor
138888475|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
138888476|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888477|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888478|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
138888479|NCT02693483|Povidone|povidone|mesh-list
138888480|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
138888481|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
138888482|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138888483|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888484|NCT04873063|Beclomethasone|beclomethasone|mesh-list
138888485|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138888486|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
138888487|NCT04873063|Hormones|hormones|mesh-ancestor
138888488|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138888489|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888490|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138888491|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
138888492|NCT00739414|Panobinostat|panobinostat|mesh-list
138888493|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421845|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
138888494|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138888495|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888496|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888497|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
138888498|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
138888499|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138888500|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888501|NCT00735280|Heparin|heparin|mesh-list
138888502|NCT00735280|Calcium heparin|calcium heparin|mesh-list
138555726|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
138888503|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
138888504|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138888505|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138888506|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888507|NCT00612989|Temozolomide|temozolomide|mesh-list
138888508|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138888509|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138888510|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
138888514|NCT04929067|Immunomodulating Agents|immunomodulating agents|mesh-list
138888515|NCT04929067|Immunologic Factors|immunologic factors|mesh-ancestor
138888516|NCT04929067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888517|NCT05215405|Venetoclax|venetoclax|mesh-list
138888518|NCT05215405|Navitoclax|navitoclax|mesh-list
138888519|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888520|NCT00613067|Escitalopram|escitalopram|mesh-list
138888521|NCT00613067|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138888522|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138888523|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138888524|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888525|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888526|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
138888527|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138513724|NCT00139360|Bevacizumab|bevacizumab|mesh-list
138888551|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555833|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138888552|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138888553|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888554|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888555|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138888556|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138888557|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
138888558|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888559|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138888560|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
138888561|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138888562|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
138888563|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888564|NCT00529399|Antacids|antacids|mesh-ancestor
138888565|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888566|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138888567|NCT05268419|Ethanol|ethanol|mesh-list
138888568|NCT05268419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138888569|NCT05268419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888570|NCT05268419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888571|NCT05268419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888572|NCT00852969|Niacin|niacin|mesh-list
138888573|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138888574|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
138888575|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888576|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138888577|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
138888578|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
138888580|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
138888581|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888582|NCT00613457|Cytarabine|cytarabine|mesh-list
138888583|NCT00613457|Dexamethasone|dexamethasone|mesh-list
138888584|NCT00613457|Prednisone|prednisone|mesh-list
138888585|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
138888586|NCT00613457|Ifosfamide|ifosfamide|mesh-list
138888587|NCT00613457|Doxorubicin|doxorubicin|mesh-list
138888588|NCT00613457|Methotrexate|methotrexate|mesh-list
138888589|NCT00613457|Etoposide|etoposide|mesh-list
138888590|NCT00613457|Vincristine|vincristine|mesh-list
138888591|NCT00613457|Daunorubicin|daunorubicin|mesh-list
138888592|NCT00613457|Asparaginase|asparaginase|mesh-list
138888593|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
138888594|NCT00613457|Thioguanine|thioguanine|mesh-list
138888595|NCT00613457|Vindesine|vindesine|mesh-list
138888596|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138888597|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
138888598|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888599|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138888600|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138888601|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
138888602|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556030|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888603|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888604|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138888605|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138888606|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
138888607|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
138888608|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888609|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138888610|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
138888611|NCT00613457|Hormones|hormones|mesh-ancestor
138888612|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138888613|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138888614|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138888615|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138888616|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138888617|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556134|NCT00300937|Ubiquinone|ubiquinone|mesh-list
138888618|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138888619|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
138888620|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138888621|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138888622|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
138888623|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
138556208|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
138888624|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138888625|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138888626|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138888627|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
138888628|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888629|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
138888630|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
138888631|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
138888633|NCT04131582|Empagliflozin|empagliflozin|mesh-list
138888634|NCT04131582|Linagliptin|linagliptin|mesh-list
138888635|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138888636|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888637|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138888638|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888639|NCT04131582|Incretins|incretins|mesh-ancestor
138888641|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138888642|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138888643|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
138888644|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888645|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138888646|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
138888647|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138888648|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138888649|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138888650|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888651|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888652|NCT00695994|Carboplatin|carboplatin|mesh-list
138888654|NCT00695994|Docetaxel|docetaxel|mesh-list
138888655|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888656|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138888657|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
138888658|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888659|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
138888660|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
138888661|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
138888662|NCT00711802|Daptomycin|daptomycin|mesh-list
138888663|NCT00711802|Cloxacillin|cloxacillin|mesh-list
138888664|NCT00711802|Oxacillin|oxacillin|mesh-list
138888665|NCT00711802|Nafcillin|nafcillin|mesh-list
138888666|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138888667|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888668|NCT00851877|Paclitaxel|paclitaxel|mesh-list
138888669|NCT00851877|Cetuximab|cetuximab|mesh-list
138888670|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138888671|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888672|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
138888673|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
138888674|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
138888675|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888676|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138888677|NCT00613223|Etoposide|etoposide|mesh-list
138888678|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
138888679|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138888680|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888681|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138556397|NCT00080678|Docetaxel|docetaxel|mesh-list
138888682|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138888683|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888684|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888685|NCT00882908|Ribavirin|ribavirin|mesh-list
138888686|NCT00882908|Simeprevir|simeprevir|mesh-list
138888687|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
138888688|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888689|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
138888690|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138540823|NCT00056030|Vitamins|vitamins|mesh-ancestor
138888691|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
138888692|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888693|NCT03580967|Vortioxetine|vortioxetine|mesh-list
138888694|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
138888695|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138888696|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138888697|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138888698|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888699|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888700|NCT03580967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138513804|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
138888701|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138888702|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138888703|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888704|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888705|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
138888706|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138888707|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138888708|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138888709|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138888711|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138888712|NCT00851799|Darunavir|darunavir|mesh-list
138888713|NCT00851799|Tenofovir|tenofovir|mesh-list
138888714|NCT00851799|Emtricitabine|emtricitabine|mesh-list
138888715|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
138888716|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138888717|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138888718|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138888719|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
138888720|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888721|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888722|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138888723|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138888724|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
138888725|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888726|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138704956|NCT05422794|Paclitaxel|paclitaxel|mesh-list
138888727|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138888728|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138888729|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138422419|NCT01693081|Emetics|emetics|mesh-ancestor
138513840|NCT00140101|Paclitaxel|paclitaxel|mesh-list
138888730|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138888731|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138888733|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138888734|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138888735|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888736|NCT04117191|Tryptophan|tryptophan|mesh-list
138888737|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138888738|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
138888739|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138888740|NCT00520975|Paclitaxel|paclitaxel|mesh-list
138888741|NCT00520975|Bevacizumab|bevacizumab|mesh-list
138888742|NCT00520975|Carboplatin|carboplatin|mesh-list
138888743|NCT00520975|Trastuzumab|trastuzumab|mesh-list
138556618|NCT00301951|Fludarabine|fludarabine|mesh-list
138888744|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138888746|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
138888747|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138888748|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138888749|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888750|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
138888751|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
138888752|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
138888753|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888754|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138888755|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138888756|NCT00520975|Growth Substances|growth substances|mesh-ancestor
138888757|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888758|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
138888759|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
138888760|NCT00614159|Ketamine|ketamine|mesh-list
138888761|NCT00614159|Propofol|propofol|mesh-list
138556672|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
138888763|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888764|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888765|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138888767|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
138888768|NCT00614159|Analgesics|analgesics|mesh-ancestor
138888769|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
138513882|NCT00140452|Thalidomide|thalidomide|mesh-list
138888770|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888771|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138888772|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138888773|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138888774|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888775|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888777|NCT05042531|Dasatinib|dasatinib|mesh-list
138888778|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138888779|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
138888780|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888781|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888782|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888783|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138888784|NCT00851721|Factor VIII|factor viii|mesh-list
138888785|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
138888786|NCT00851721|Coagulants|coagulants|mesh-ancestor
138888788|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
138888789|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138888790|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888791|NCT02634476|Ethanol|ethanol|mesh-list
138888792|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138888793|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888794|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888795|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888796|NCT04385303|Lorecivivint|lorecivivint|mesh-list
138888797|NCT04385303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138888798|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138888799|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138888800|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138888801|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
138711075|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138888802|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888803|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138888804|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138888805|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888806|NCT00740194|Estradiol|estradiol|mesh-list
138888807|NCT00740194|Estrogens|estrogens|mesh-ancestor
138888808|NCT00740194|Hormones|hormones|mesh-ancestor
138422561|NCT05288816|Ravulizumab|ravulizumab|mesh-list
138888809|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138888810|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888811|NCT04159142|Paclitaxel|paclitaxel|mesh-list
138888812|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138888813|NCT04159142|Carboplatin|carboplatin|mesh-list
138888814|NCT04159142|Capecitabine|capecitabine|mesh-list
138888815|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138888816|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888817|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
138888818|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
138888819|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
138888820|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888821|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138888822|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
138888823|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138888824|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
138888825|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138888826|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138888827|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888828|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888829|NCT00654680|Urological Agents|urological agents|mesh-ancestor
138888830|NCT00520741|Lacosamide|lacosamide|mesh-list
138888831|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
138422621|NCT05291455|Lacosamide|lacosamide|mesh-list
138888832|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138556899|NCT00303277|Simvastatin|simvastatin|mesh-list
138888833|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138888834|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138888835|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888836|NCT00729118|Lenalidomide|lenalidomide|mesh-list
138888837|NCT00729118|Vorinostat|vorinostat|mesh-list
138888838|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
138888839|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888840|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138888841|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138556970|NCT00120432|Phenylephrine|phenylephrine|mesh-list
138888842|NCT00729118|Growth Substances|growth substances|mesh-ancestor
138540967|NCT00056264|Infliximab|infliximab|mesh-list
138888843|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
138888844|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888845|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138888846|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888847|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888848|NCT04064632|Darunavir|darunavir|mesh-list
138888849|NCT04064632|Cobicistat|cobicistat|mesh-list
138888850|NCT04064632|Rilpivirine|rilpivirine|mesh-list
138888851|NCT04064632|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
138888852|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138888853|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138888854|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
138888855|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888856|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888857|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138888858|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138888859|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
138888860|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888861|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138888862|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138888863|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138888864|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138888866|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138888867|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
138888868|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138888869|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138888870|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138888871|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888872|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888873|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
138888874|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
138888875|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888876|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138888877|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138888878|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
138888879|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888880|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888881|NCT00882362|Aripiprazole|aripiprazole|mesh-list
138888882|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
138888883|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138888884|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138888885|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138888886|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888887|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888888|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
138888889|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
138888890|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138888891|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888892|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138888893|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138888894|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
138888895|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138888897|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138888898|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138888899|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
138888900|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138888901|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138888902|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
138888903|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888904|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138888905|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138557073|NCT00120471|Tenofovir|tenofovir|mesh-list
138888906|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888907|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888908|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138888909|NCT00636935|Clindamycin|clindamycin|mesh-list
138888910|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
138888911|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
138888912|NCT00636935|Dapsone|dapsone|mesh-list
138888913|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138888914|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138888915|NCT00636935|Primaquine|primaquine|mesh-list
138888916|NCT00636935|Trimethoprim|trimethoprim|mesh-list
138888917|NCT00636935|Atovaquone|atovaquone|mesh-list
138888919|NCT00636935|Prednisone|prednisone|mesh-list
138888920|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138888921|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
138888922|NCT00636935|Hormones|hormones|mesh-ancestor
138888923|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138888924|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888925|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138888926|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888927|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888928|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
138888929|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138888930|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138888931|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888932|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
138888933|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138888934|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138888935|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138888936|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138888937|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138888938|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138888939|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138888940|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
138888941|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
138888942|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138888943|NCT00654758|Paclitaxel|paclitaxel|mesh-list
138888944|NCT00654758|Carboplatin|carboplatin|mesh-list
138888945|NCT00654758|Volociximab|volociximab|mesh-list
138888946|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138888947|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138888948|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888949|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
138888950|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
138888951|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
138888952|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888953|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138888954|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138888955|NCT00654758|Growth Substances|growth substances|mesh-ancestor
138888956|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888957|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
138888958|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
138888960|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138888961|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888962|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
138888963|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138888964|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888965|NCT00613613|Fenofibrate|fenofibrate|mesh-list
138888966|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138888967|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
138888968|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888969|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138888970|NCT04298099|Ropivacaine|ropivacaine|mesh-list
138888971|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
138888972|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
138888973|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138888974|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888975|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
138888976|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888977|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138888978|NCT00850395|Maraviroc|maraviroc|mesh-list
138888979|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138888980|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138557296|NCT00087867|Bortezomib|bortezomib|mesh-list
138422835|NCT05294484|Natriuretic Agents|natriuretic agents|mesh-ancestor
138888981|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138888982|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138888983|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138888984|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
138888985|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138888986|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138888987|NCT04188431|Dexamethasone|dexamethasone|mesh-list
138888988|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138888989|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
138888990|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
138888991|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138888992|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138888993|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138888994|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
138888995|NCT04188431|Hormones|hormones|mesh-ancestor
138888996|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138888997|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138888998|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138888999|NCT03630809|Vaccines|vaccines|mesh-list
138889000|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
138422890|NCT05293704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138889001|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889002|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
138889003|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
138889004|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138889005|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709205|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138889006|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889007|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138889008|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889009|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138889010|NCT00736294|Ramipril|ramipril|mesh-list
138889011|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138889012|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
138889013|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889014|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889015|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138889016|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
138889018|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889019|NCT00512707|Androgens|androgens|mesh-ancestor
138889020|NCT00512707|Hormones|hormones|mesh-ancestor
138889021|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889022|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889023|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
138889024|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138889025|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138889026|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889027|NCT00512707|Urological Agents|urological agents|mesh-ancestor
138889028|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138889029|NCT03471767|Dextromethorphan|dextromethorphan|mesh-list
138889031|NCT03471767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138889032|NCT03471767|Antidepressive Agents|antidepressive agents|mesh-ancestor
138889033|NCT03471767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138889034|NCT03471767|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138889035|NCT03471767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138889036|NCT03471767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138889037|NCT03471767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889038|NCT03471767|Dopamine Agents|dopamine agents|mesh-ancestor
138889039|NCT03471767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138889040|NCT03471767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889041|NCT03471767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138889042|NCT03471767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138889043|NCT03471767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889044|NCT03471767|Antitussive Agents|antitussive agents|mesh-ancestor
138422948|NCT05296005|Micronutrients|micronutrients|mesh-ancestor
138889045|NCT03471767|Respiratory System Agents|respiratory system agents|mesh-ancestor
138889046|NCT03471767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138889047|NCT03471767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138889048|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138889049|NCT00849693|Fluoxetine|fluoxetine|mesh-list
138889050|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138889051|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138889052|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138889053|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889054|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557598|NCT05446142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889055|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889056|NCT00849693|Analgesics|analgesics|mesh-ancestor
138889057|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
138889058|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889059|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
138889060|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138889061|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
138889062|NCT00849693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138889063|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
138541193|NCT00176020|Niacin|niacin|mesh-list
138889064|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138889065|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138889066|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138889067|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889068|NCT00736606|Simvastatin|simvastatin|mesh-list
138889069|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138889070|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138889071|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
138889072|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889073|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138889074|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138423045|NCT05264584|Febuxostat|febuxostat|mesh-list
138889075|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889076|NCT00527605|Dutasteride|dutasteride|mesh-list
138889077|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138889078|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138889079|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889080|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557632|NCT00308425|Valsartan|valsartan|mesh-list
138889081|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
138889082|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889083|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514221|NCT00142948|Naltrexone|naltrexone|mesh-list
138889084|NCT00741052|Azithromycin|azithromycin|mesh-list
138889085|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
138889086|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138889087|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138889088|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138889089|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138889090|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889091|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889092|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889093|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138889094|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138889095|NCT04116411|Valganciclovir|valganciclovir|mesh-list
138889096|NCT04116411|Temozolomide|temozolomide|mesh-list
138889097|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138889098|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
138889099|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889100|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889101|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
138889102|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138889103|NCT00706953|Doxorubicin|doxorubicin|mesh-list
138889104|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138889105|NCT00706953|Bortezomib|bortezomib|mesh-list
138889106|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138889107|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557734|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
138889108|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138889109|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138889110|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889111|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889112|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
138889113|NCT03462017|Acetylcholine|acetylcholine|mesh-list
138889115|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138889116|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138889117|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557798|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138889118|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889119|NCT03462017|Urological Agents|urological agents|mesh-ancestor
138889120|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138889121|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
138889122|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138889123|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889124|NCT00913419|Amitriptyline|amitriptyline|mesh-list
138889125|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
138889126|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138889127|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
138557864|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
138889129|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138889130|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889131|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138557943|NCT00121095|Docetaxel|docetaxel|mesh-list
138889132|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138514292|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
138889133|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138889134|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138889135|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138889136|NCT00913419|Analgesics|analgesics|mesh-ancestor
138889137|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
138889138|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138889139|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138889141|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889142|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
138889143|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138889144|NCT00711412|Capecitabine|capecitabine|mesh-list
138889145|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
138889146|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138889147|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
138558001|NCT00309673|Lidocaine|lidocaine|mesh-list
138889148|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889149|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889150|NCT01840007|Metformin|metformin|mesh-list
138889151|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138889152|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889153|NCT03746951|Ropivacaine|ropivacaine|mesh-list
138889154|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
138889155|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
138889156|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138889157|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889158|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
138889159|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889160|NCT00577408|Naltrexone|naltrexone|mesh-list
138889161|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138889162|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138889163|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889164|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
138889165|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889166|NCT03391193|Vaccines|vaccines|mesh-list
138889167|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
138889168|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889170|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
138889171|NCT00741364|Vitamins|vitamins|mesh-ancestor
138889172|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
138889173|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889174|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138889175|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138889176|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138889177|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
138889178|NCT00614471|Entecavir|entecavir|mesh-list
138889179|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
138889180|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138889181|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
138889182|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889183|NCT05742256|Sufentanil|sufentanil|mesh-list
138889184|NCT05742256|Oxycodone|oxycodone|mesh-list
138889185|NCT05742256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138889186|NCT05742256|Narcotics|narcotics|mesh-ancestor
138889187|NCT05742256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138889188|NCT05742256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889189|NCT05742256|Analgesics|analgesics|mesh-ancestor
138889190|NCT05742256|Sensory System Agents|sensory system agents|mesh-ancestor
138514401|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
138423257|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138889191|NCT05742256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889192|NCT05742256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138889193|NCT05742256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138558170|NCT00311857|Cetuximab|cetuximab|mesh-list
138889194|NCT05742256|Anesthetics, General|anesthetics, general|mesh-ancestor
138889195|NCT05742256|Anesthetics|anesthetics|mesh-ancestor
138889196|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138889197|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
138889198|NCT00713596|Coagulants|coagulants|mesh-ancestor
138889199|NCT00729664|Atezolizumab|atezolizumab|mesh-list
138889200|NCT00729664|BMS-936559|bms-936559|mesh-list
138889201|NCT00729664|Antibodies|antibodies|mesh-list
138889202|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
138889203|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138889204|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
138889205|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889206|NCT00729664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138889207|NCT00729664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889208|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138889209|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889210|NCT04229615|Apatinib|apatinib|mesh-list
138889211|NCT04229615|Fluzoparib|fluzoparib|mesh-list
138889212|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889213|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138889214|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889215|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889216|NCT04229615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138889217|NCT00881894|Rotigotine|rotigotine|mesh-list
138889218|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
138889219|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
138889220|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138889221|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889222|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889224|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138889225|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138889226|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
138889228|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
138889229|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138514448|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
138889230|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138889232|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
138889233|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138889234|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138889235|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889236|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
138889237|NCT00827931|Coagulants|coagulants|mesh-ancestor
138889238|NCT04158674|Simendan|simendan|mesh-list
138889239|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138889240|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
138889241|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138889242|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138889243|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889244|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889245|NCT04158674|Protective Agents|protective agents|mesh-ancestor
138637977|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
138889246|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889247|NCT00526669|Capecitabine|capecitabine|mesh-list
138889248|NCT00526669|Lapatinib|lapatinib|mesh-list
138423324|NCT04767503|Propofol|propofol|mesh-list
138889249|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138889251|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889252|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889253|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138889254|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889255|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
138889256|NCT03640949|Vasopressins|vasopressins|mesh-list
138889257|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
138889258|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138889259|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
138889260|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
138889261|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889262|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889263|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138889264|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
138889265|NCT03640949|Hormones|hormones|mesh-ancestor
138889266|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889267|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138889268|NCT03640949|Protective Agents|protective agents|mesh-ancestor
138889269|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
138889270|NCT03640949|Coagulants|coagulants|mesh-ancestor
138889271|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138889272|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138889273|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
138889274|NCT00827775|Carvedilol|carvedilol|mesh-list
138889275|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138889276|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138889277|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
138889278|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138889279|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889280|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889281|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138889282|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
138889283|NCT00827775|Protective Agents|protective agents|mesh-ancestor
138889284|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138889285|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138889286|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138889287|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
138889288|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138889289|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138889290|NCT02544308|Dexamethasone|dexamethasone|mesh-list
138889291|NCT02544308|Lenalidomide|lenalidomide|mesh-list
138889292|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138889293|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
138889294|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
138889295|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889296|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889297|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138889298|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
138889300|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889301|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138889302|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889303|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
138889304|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138889305|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138889306|NCT02544308|Growth Substances|growth substances|mesh-ancestor
138889307|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
138889309|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
138889310|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138889311|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138558812|NCT00296179|Zolpidem|zolpidem|mesh-list
138889312|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889313|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889314|NCT00707187|Urological Agents|urological agents|mesh-ancestor
138889315|NCT03998761|Progesterone|progesterone|mesh-list
138889316|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
138889317|NCT03998761|Progestins|progestins|mesh-ancestor
138889318|NCT03998761|Hormones|hormones|mesh-ancestor
138889319|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889320|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889321|NCT00658580|Etoposide|etoposide|mesh-list
138889322|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
138889323|NCT00658580|Epirubicin|epirubicin|mesh-list
138889324|NCT00658580|Ifosfamide|ifosfamide|mesh-list
138889325|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889326|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138889327|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138889328|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138889329|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889330|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889331|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138889332|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138889333|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
138889334|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138889335|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889336|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138889337|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889338|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889339|NCT03435107|Durvalumab|durvalumab|mesh-list
138889340|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138889341|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889342|NCT03612791|Atezolizumab|atezolizumab|mesh-list
138889343|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889344|NCT03612791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138889345|NCT03612791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889346|NCT03612791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138889347|NCT00827541|Tigecycline|tigecycline|mesh-list
138889348|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138889349|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138889350|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138889351|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889352|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889353|NCT03916601|Insulin|insulin|mesh-list
138889354|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138889355|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
138889356|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
138889357|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138889358|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138889359|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889360|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138889361|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138889362|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138889363|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138889364|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889365|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138889366|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138559055|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
138889367|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138889368|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
138889369|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138889370|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889371|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138889372|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138889373|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
138889374|NCT00707421|Fluorometholone|fluorometholone|mesh-list
138889375|NCT00707421|Ketorolac|ketorolac|mesh-list
138889376|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138889377|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138889378|NCT00707421|Analgesics|analgesics|mesh-ancestor
138889379|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
138889380|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889381|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889382|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138889383|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138889384|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138889385|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889386|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889387|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
138889388|NCT00707421|Hormones|hormones|mesh-ancestor
138889389|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889390|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138889391|NCT03570437|Paclitaxel|paclitaxel|mesh-list
138889392|NCT03570437|Olaparib|olaparib|mesh-list
138889393|NCT03570437|Cediranib|cediranib|mesh-list
138889394|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138889395|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889396|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
138889397|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
138889398|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
138423542|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
138889399|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889400|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138889401|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889402|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138889403|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138889405|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889406|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138889407|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889408|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889409|NCT03632213|Losartan|losartan|mesh-list
138889410|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138889411|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138514589|NCT01807377|Midazolam|midazolam|mesh-list
138889412|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138889413|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138889414|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889415|NCT00825825|Citalopram|citalopram|mesh-list
138889416|NCT00825825|Escitalopram|escitalopram|mesh-list
138889417|NCT00825825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138889418|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138889419|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138889420|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559236|NCT00323011|Vitamins|vitamins|mesh-ancestor
138889421|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138889422|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
138889423|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889424|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138889425|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
138889426|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138770224|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138709206|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138709207|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138889427|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138889428|NCT03802487|Charcoal|charcoal|mesh-list
138889429|NCT03802487|Antidotes|antidotes|mesh-ancestor
138889430|NCT03802487|Protective Agents|protective agents|mesh-ancestor
138889431|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889432|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138889433|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889434|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138889435|NCT00880334|Docetaxel|docetaxel|mesh-list
138889436|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889437|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
138889438|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
138889439|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
138889440|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889441|NCT00658892|Antibodies|antibodies|mesh-list
138889442|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
138889443|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889444|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138889445|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
138559419|NCT06002659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138889446|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138889447|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138889448|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889449|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889450|NCT00654914|Urological Agents|urological agents|mesh-ancestor
138889451|NCT00865566|Vaccines|vaccines|mesh-list
138889452|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
138514600|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
138889453|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889454|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
138889455|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889456|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889457|NCT00659048|Ciclesonide|ciclesonide|mesh-list
138889458|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
138889459|NCT00659048|Hormones|hormones|mesh-ancestor
138889460|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889461|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889462|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138889463|NCT02623920|Rituximab|rituximab|mesh-list
138889464|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138423646|NCT03984890|Vitamin D|vitamin d|mesh-list
138889465|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138889466|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138889467|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889468|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
138889469|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889470|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138889471|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138889472|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
138889473|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889474|NCT02623920|Immunotoxins|immunotoxins|mesh-ancestor
138889475|NCT02623920|Immunoconjugates|immunoconjugates|mesh-ancestor
138889476|NCT00525499|Androgens|androgens|mesh-list
138889477|NCT00525499|Hormones|hormones|mesh-ancestor
138889478|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889479|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889480|NCT04576546|Inositol|inositol|mesh-list
138889481|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
138889482|NCT04576546|Vitamins|vitamins|mesh-ancestor
138889483|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
138889484|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889485|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
138889486|NCT02617680|Desflurane|desflurane|mesh-list
138559604|NCT05999227|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138889487|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138423676|NCT05802303|Estradiol|estradiol|mesh-list
138889488|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
138889489|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889490|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889491|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138889492|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
138889493|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138889494|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
138889495|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889496|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138889497|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138889498|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
138889499|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
138889500|NCT02617680|Protective Agents|protective agents|mesh-ancestor
138559663|NCT05998421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138559664|NCT05998421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138559665|NCT05998421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559666|NCT05998421|Antipyretics|antipyretics|mesh-ancestor
138559667|NCT05998421|Anticoagulants|anticoagulants|mesh-ancestor
138559668|NCT05998356|Anesthetics|anesthetics|mesh-list
138559669|NCT05998356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138559671|NCT05998226|Anti-Infective Agents|anti-infective agents|mesh-list
138889501|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138889502|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
138889503|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
138889504|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138889505|NCT02568280|Insulin|insulin|mesh-list
138889506|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138889507|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
138889508|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
138889509|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138889510|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138889511|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889512|NCT00525265|Tolvaptan|tolvaptan|mesh-list
138889513|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138889514|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889515|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
138889516|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889517|NCT04158830|Aspirin|aspirin|mesh-list
138889518|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138889519|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138889520|NCT04158830|Analgesics|analgesics|mesh-ancestor
138889521|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
138889522|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889523|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889524|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138889525|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138889526|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138889527|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138889528|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889529|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138889530|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138889531|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889532|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
138889533|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
138889534|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
138889535|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138889536|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138889537|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889538|NCT02617758|Fentanyl|fentanyl|mesh-list
138889539|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138889540|NCT02617758|Narcotics|narcotics|mesh-ancestor
138889541|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138889542|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889543|NCT02617758|Analgesics|analgesics|mesh-ancestor
138889544|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
138889545|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889546|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138889547|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138889548|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
138889549|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
138889550|NCT00737542|Lidocaine|lidocaine|mesh-list
138889551|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
138889552|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
138889553|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138889554|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889555|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
138889556|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889557|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138889558|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138889559|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138889560|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138889561|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889562|NCT00865098|Cetuximab|cetuximab|mesh-list
138889563|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138889564|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889565|NCT00880100|Pancrelipase|pancrelipase|mesh-list
138889566|NCT00880100|Pancreatin|pancreatin|mesh-list
138889567|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138889568|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
138889569|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
138889570|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138889571|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138889572|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889573|NCT00659594|Ciclesonide|ciclesonide|mesh-list
138889574|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
138889575|NCT00659594|Hormones|hormones|mesh-ancestor
138889576|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889577|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889578|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138889579|NCT00659750|Ciclesonide|ciclesonide|mesh-list
138889580|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
138889581|NCT00659750|Hormones|hormones|mesh-ancestor
138889582|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889583|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889584|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138889585|NCT00697476|Topotecan|topotecan|mesh-list
138889586|NCT00697476|Vorinostat|vorinostat|mesh-list
138889587|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138889588|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138889589|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889590|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889591|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889592|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138889593|NCT00660062|Dexetimide|dexetimide|mesh-list
138889594|NCT00660062|Citalopram|citalopram|mesh-list
138889595|NCT00660062|Nortriptyline|nortriptyline|mesh-list
138889596|NCT00660062|Escitalopram|escitalopram|mesh-list
138889597|NCT00660062|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138889598|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138559870|NCT05995392|Diuretics|diuretics|mesh-ancestor
138889599|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138889600|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889601|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138889602|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
138889603|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889604|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138889605|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138889606|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
138889607|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
138889608|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889609|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138889610|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138889611|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
138889612|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138889613|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
138889614|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138889615|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138889616|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138889617|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
138889618|NCT04063540|Amiloride|amiloride|mesh-list
138889619|NCT04063540|Diuretics|diuretics|mesh-ancestor
138889620|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
138889621|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889622|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138889623|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138889624|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138889625|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889626|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138889627|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138889628|NCT04161560|Cetuximab|cetuximab|mesh-list
138889629|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138889630|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889631|NCT00518011|Gemcitabine|gemcitabine|mesh-list
138889632|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138889633|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138889634|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
138559914|NCT05990985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889635|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889636|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889637|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138889638|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889640|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
138889641|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138889642|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138889643|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889644|NCT02633930|Amoxicillin|amoxicillin|mesh-list
138889645|NCT02633930|Clarithromycin|clarithromycin|mesh-list
138889646|NCT02633930|Lansoprazole|lansoprazole|mesh-list
138889647|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
138889648|NCT02633930|Bismuth|bismuth|mesh-list
138889649|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138889650|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138889651|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138889652|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138514683|NCT01806948|Ramosetron|ramosetron|mesh-list
138889653|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889654|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138560021|NCT05925023|Sirolimus|sirolimus|mesh-list
138889655|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138889656|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138889657|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138889658|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138541785|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
138889659|NCT02633930|Antacids|antacids|mesh-ancestor
138889660|NCT00698334|Rifampin|rifampin|mesh-list
138889661|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
138889662|NCT00698334|Ethambutol|ethambutol|mesh-list
138889663|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138889664|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
138889665|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138889666|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138889667|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
138560108|NCT05826964|Hormones|hormones|mesh-ancestor
138889668|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138889669|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889670|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889671|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138889672|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138889673|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138889674|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138889675|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138889676|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138889677|NCT04161482|Furosemide|furosemide|mesh-list
138889679|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
138889680|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889681|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138889682|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138889683|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889684|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
138889685|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138889686|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889687|NCT02633696|Silybin|silybin|mesh-list
138889688|NCT02633696|Silymarin|silymarin|mesh-list
138889689|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
138889690|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889691|NCT02633696|Protective Agents|protective agents|mesh-ancestor
138889692|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889693|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138889694|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889695|NCT02633852|Aflibercept|aflibercept|mesh-list
138889696|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138889697|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138889698|NCT02633852|Growth Substances|growth substances|mesh-ancestor
138889699|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889700|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
138889701|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889702|NCT02633774|Propafenone|propafenone|mesh-list
138889703|NCT02633774|Apixaban|apixaban|mesh-list
138889704|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138889705|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
138889706|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138889707|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
138889708|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889709|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889710|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
138889711|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138889712|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138889713|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138560276|NCT05663073|Vasodilator Agents|vasodilator agents|mesh-ancestor
138889714|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138889715|NCT02633618|Neurotropin|neurotropin|mesh-list
138889716|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138889717|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
138889718|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889719|NCT02633618|Analgesics|analgesics|mesh-ancestor
138889720|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
138889721|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889722|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
138889723|NCT00865020|Telmisartan|telmisartan|mesh-list
138889724|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138889725|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138889726|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138889727|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889728|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
138889729|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889730|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
138889731|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138889732|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138889733|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889734|NCT00517933|Urological Agents|urological agents|mesh-ancestor
138889735|NCT02633384|Sorbitol|sorbitol|mesh-list
138889736|NCT02633384|SMOFlipid|smoflipid|mesh-list
138889737|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138889738|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138889739|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138889740|NCT02633384|Cathartics|cathartics|mesh-ancestor
138889741|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138889742|NCT02633462|Inositol|inositol|mesh-list
138889743|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
138889744|NCT02633462|Vitamins|vitamins|mesh-ancestor
138889745|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
138889746|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889747|NCT02638064|Surgiflo|surgiflo|mesh-list
138889748|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
138889749|NCT02638064|Coagulants|coagulants|mesh-ancestor
138889750|NCT00655148|Vaccines|vaccines|mesh-list
138889751|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
138560323|NCT05579574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138889752|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889753|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138889755|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
138889756|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889757|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889758|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138889759|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
138889760|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
138889761|NCT00857766|Hormones|hormones|mesh-ancestor
138889762|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889763|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
138889764|NCT04161404|Metformin|metformin|mesh-list
138889765|NCT04161404|Andrographolide|andrographolide|mesh-list
138889766|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138889767|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889768|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138889769|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138889770|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138889772|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
138889773|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889774|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138889775|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138889776|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138889777|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560359|NCT05540522|Vaccines|vaccines|mesh-list
138889779|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138889781|NCT00517699|Rituximab|rituximab|mesh-list
138889782|NCT00517699|Methotrexate|methotrexate|mesh-list
138889783|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138889784|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889785|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
138889786|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889787|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138889788|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138889789|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
138889790|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138889791|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138889792|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
138889793|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889794|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
138889795|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889796|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138889797|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138889798|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138889799|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
138889800|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138889801|NCT04161014|Nintedanib|nintedanib|mesh-list
138889802|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889803|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138424192|NCT03961360|Aspirin|aspirin|mesh-list
138889829|NCT00699504|Cangrelor|cangrelor|mesh-list
138889830|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138889831|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138889832|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138889833|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138889834|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889835|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889836|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889837|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560407|NCT05475665|Irbesartan|irbesartan|mesh-list
138889838|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138889839|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138889840|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138889841|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138889842|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
138889843|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138889846|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
138889847|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138889848|NCT02997605|Hormones|hormones|mesh-ancestor
138889849|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889850|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889851|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138889852|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889853|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
138889854|NCT03767543|Lixisenatide|lixisenatide|mesh-list
138889855|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138889856|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889857|NCT00857454|Testosterone|testosterone|mesh-list
138889858|NCT00857454|Androgens|androgens|mesh-ancestor
138889859|NCT00857454|Hormones|hormones|mesh-ancestor
138889860|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889861|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889862|NCT00660140|Carboplatin|carboplatin|mesh-list
138889863|NCT00660140|Gemcitabine|gemcitabine|mesh-list
138889864|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889865|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138889866|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
138889867|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889868|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
138889869|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138889870|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889871|NCT00525031|Interferons|interferons|mesh-list
138889872|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
138889873|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
138889874|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138889875|NCT00525031|Temozolomide|temozolomide|mesh-list
138889876|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889877|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
138889878|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138514791|NCT00405262|Ketorolac|ketorolac|mesh-list
138889879|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138889880|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
138889881|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889882|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
138889883|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889884|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
138889885|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
138889886|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
138889887|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138889888|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889889|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138889890|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138889891|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
138889893|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138889894|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138889895|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889896|NCT00524173|Tenofovir|tenofovir|mesh-list
138889897|NCT00524173|Emtricitabine|emtricitabine|mesh-list
138889898|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
138889899|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138889900|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138889901|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138889902|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889903|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889904|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138889905|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138889906|NCT02704481|Misoprostol|misoprostol|mesh-list
138889907|NCT02704481|Mifepristone|mifepristone|mesh-list
138424378|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
138889908|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138889910|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138889911|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889912|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138889913|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138889914|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
138889915|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138706057|NCT03173950|Nivolumab|nivolumab|mesh-list
138889916|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138889917|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138889918|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138889919|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
138424444|NCT01817751|Sorafenib|sorafenib|mesh-list
138889920|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138560482|NCT05384496|Nivolumab|nivolumab|mesh-list
138889921|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138889922|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
138889923|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138889924|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
138889925|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138889926|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138889928|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138889929|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138889930|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
138889931|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138889932|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889933|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889934|NCT02614482|Urological Agents|urological agents|mesh-ancestor
138889936|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138889937|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889938|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
138889939|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138889940|NCT00879710|Simvastatin|simvastatin|mesh-list
138889941|NCT00879710|Ezetimibe|ezetimibe|mesh-list
138889942|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138889943|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138889944|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
138424530|NCT03785106|Vitamins|vitamins|mesh-list
138889945|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889946|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138889947|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138889948|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889949|NCT02703857|Cefoxitin|cefoxitin|mesh-list
138889950|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138889951|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138889952|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
138889953|NCT02623062|Antacids|antacids|mesh-ancestor
138889954|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889955|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138889956|NCT00597506|Bevacizumab|bevacizumab|mesh-list
138889957|NCT00597506|Everolimus|everolimus|mesh-list
138889958|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138889959|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889960|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138889961|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138889962|NCT00597506|Growth Substances|growth substances|mesh-ancestor
138889963|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889964|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
138889965|NCT00597506|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138889966|NCT00597506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138889967|NCT00597506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889968|NCT00597506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889969|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138889970|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
138889972|NCT03393611|Fludarabine|fludarabine|mesh-list
138889973|NCT03393611|Melphalan|melphalan|mesh-list
138889974|NCT03393611|Daunorubicin|daunorubicin|mesh-list
138889975|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
138889976|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889977|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138889978|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
138889979|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138889980|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138889981|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
138514826|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138889982|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138889983|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
138889984|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138889985|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138889986|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
138889987|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138889988|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138889989|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138889990|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138889991|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138889992|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
138889993|NCT04032548|Propolis|propolis|mesh-list
138889994|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138889995|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138889996|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
138889997|NCT04032236|Caffeine|caffeine|mesh-list
138889998|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138889999|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890000|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138890001|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890002|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890003|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138890004|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138890005|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
138890006|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138890007|NCT02313389|Rituximab|rituximab|mesh-list
138890008|NCT02313389|Methotrexate|methotrexate|mesh-list
138890009|NCT02313389|Temozolomide|temozolomide|mesh-list
138890010|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138890011|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890012|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
138890013|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890014|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138890015|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138890016|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
138890017|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138890018|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138890019|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
138890020|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890021|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
138890022|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890023|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138890024|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138890025|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138890026|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138890027|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
138890028|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138890029|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
138890030|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890031|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
138890032|NCT02632916|Denosumab|denosumab|mesh-list
138890033|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138890035|NCT00881504|Bevacizumab|bevacizumab|mesh-list
138890036|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138890037|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890038|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138890039|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138890040|NCT00881504|Growth Substances|growth substances|mesh-ancestor
138890041|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890042|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
138890043|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138890044|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138890045|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138890046|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
138890047|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890048|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138890049|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138890050|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890051|NCT02131493|Gemcitabine|gemcitabine|mesh-list
138890052|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138890053|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
138890054|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890055|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890056|NCT02096159|Trimethoprim|trimethoprim|mesh-list
138514885|NCT04341181|Immunologic Factors|immunologic factors|mesh-ancestor
138890057|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138890058|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
138890059|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138890060|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138890061|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
138890062|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138890063|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138890064|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138890065|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890066|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890067|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138890068|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138890069|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138890070|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138890071|NCT02632136|Bupivacaine|bupivacaine|mesh-list
138890072|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
138890073|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
138890074|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138890075|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890076|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
138890077|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138890078|NCT00660920|Ponatinib|ponatinib|mesh-list
138890079|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890080|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138890081|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890082|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890083|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
138890084|NCT01936831|Pyridoxal|pyridoxal|mesh-list
138890085|NCT01936831|Pyridoxine|pyridoxine|mesh-list
138890086|NCT01936831|Isoniazid|isoniazid|mesh-list
138890087|NCT01936831|Vitamins|vitamins|mesh-ancestor
138890088|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
138890089|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890090|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
138890091|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
138890092|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138890093|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138890094|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138890095|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138890096|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
138890097|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890098|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138890099|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
138890100|NCT00615173|Azathioprine|azathioprine|mesh-list
138890101|NCT00615173|Tacrolimus|tacrolimus|mesh-list
138514947|NCT00405418|Insulin|insulin|mesh-list
138890102|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138890103|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
138890104|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890105|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138890106|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138890107|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
138890108|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890109|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890110|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138890111|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138890112|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890113|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
138890114|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138890115|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138560869|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560870|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138560871|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
138560872|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560890|NCT04757883|Antibodies|antibodies|mesh-list
138560891|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
138560892|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560893|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
138560894|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
138560895|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138560896|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560897|NCT04712942|Azacitidine|azacitidine|mesh-list
138560898|NCT04712942|Pevonedistat|pevonedistat|mesh-list
138560899|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138560900|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
138560901|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560902|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890116|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
138890117|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138890118|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138890119|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890120|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890121|NCT00660998|Urological Agents|urological agents|mesh-ancestor
138890123|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890124|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138890125|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890126|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890127|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
138890128|NCT01455389|Promethazine|promethazine|mesh-list
138890129|NCT01455389|Dexamethasone|dexamethasone|mesh-list
138424832|NCT05438108|Bevacizumab|bevacizumab|mesh-list
138890130|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138890131|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138890132|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
138890133|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
138890134|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138890135|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890136|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138890137|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
138890138|NCT01455389|Hormones|hormones|mesh-ancestor
138890139|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138890140|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138890141|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890142|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138890143|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890144|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890145|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138890146|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138890147|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138890148|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
138890149|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
138890150|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
138890151|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138890152|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
138890153|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
138890154|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138890156|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
138890157|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
138890158|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138890159|NCT00661076|Adefovir|adefovir|mesh-list
138890160|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138890161|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
138890162|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138890163|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138890164|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138890165|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890166|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890167|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
138515013|NCT01903421|Propofol|propofol|mesh-list
138890168|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138890169|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138890170|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
138560966|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890171|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138890172|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138890173|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890174|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890175|NCT00661700|Urological Agents|urological agents|mesh-ancestor
138890176|NCT00613769|Metronidazole|metronidazole|mesh-list
138890177|NCT00613769|Trimethoprim|trimethoprim|mesh-list
138890178|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
138890179|NCT00613769|Cefuroxime|cefuroxime|mesh-list
138890180|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
138890181|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138890182|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138890183|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138890184|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138890185|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138890186|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138890187|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
138890188|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138890189|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890190|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890191|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138890192|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138890193|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138890194|NCT00661154|Bevacizumab|bevacizumab|mesh-list
138890195|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138890196|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890197|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138890198|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138890199|NCT00661154|Growth Substances|growth substances|mesh-ancestor
138890200|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890201|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
138890202|NCT00523705|Escitalopram|escitalopram|mesh-list
138489284|NCT01929811|Metformin|metformin|mesh-list
138890203|NCT00523705|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138489432|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138890204|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138890205|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138489655|NCT00005987|Etoposide|etoposide|mesh-list
138489727|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890206|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490332|NCT00001524|Thalidomide|thalidomide|mesh-list
138890208|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
138890209|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890210|NCT00193427|Carboplatin|carboplatin|mesh-list
138890211|NCT00193427|Gemcitabine|gemcitabine|mesh-list
138890212|NCT00193427|Docetaxel|docetaxel|mesh-list
138890213|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890214|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138890215|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
138890216|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890217|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
138890218|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
138490478|NCT00018148|Nortriptyline|nortriptyline|mesh-list
138890219|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
138890220|NCT00665678|Paroxetine|paroxetine|mesh-list
138890221|NCT00665678|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138890222|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138890223|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138490762|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138890224|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890225|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138890226|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
138457844|NCT01924676|Analgesics|analgesics|mesh-ancestor
138890227|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890228|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138491282|NCT05605665|Analgesics|analgesics|mesh-ancestor
138890229|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
138491428|NCT01807429|Morphine|morphine|mesh-list
138890231|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138890232|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138890233|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890234|NCT00523549|Amlodipine|amlodipine|mesh-list
138890235|NCT00523549|Valsartan|valsartan|mesh-list
138561058|NCT04533451|Carboplatin|carboplatin|mesh-list
138890236|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138492021|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
138890237|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138890238|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138890239|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492248|NCT00276172|Natalizumab|natalizumab|mesh-list
138425087|NCT00496795|Docetaxel|docetaxel|mesh-list
138492393|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
138890240|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138890241|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890242|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
138492922|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890243|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138890244|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138493145|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
138890245|NCT04215653|Rabeprazole|rabeprazole|mesh-list
138493530|NCT02965261|Fluoxetine|fluoxetine|mesh-list
138890246|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138890247|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138493898|NCT00092287|Octreotide|octreotide|mesh-list
138515114|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
138890248|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138890249|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890250|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890251|NCT02706119|Insulin|insulin|mesh-list
138890252|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138890253|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
138542386|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
138890255|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494641|NCT00400387|Pyridoxine|pyridoxine|mesh-list
138890256|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
138494794|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
138890257|NCT02631668|Hematinics|hematinics|mesh-ancestor
138890258|NCT00665756|Mitomycins|mitomycins|mesh-list
138495013|NCT00006377|Paclitaxel|paclitaxel|mesh-list
138890259|NCT00665756|Mitomycin|mitomycin|mesh-list
138890260|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138890261|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890262|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
138495684|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138425141|NCT03126812|Paclitaxel|paclitaxel|mesh-list
138495911|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
138495988|NCT04712396|Itraconazole|itraconazole|mesh-list
138561090|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
138561091|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138561092|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138561093|NCT04526197|Growth Substances|growth substances|mesh-ancestor
138561094|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
138561095|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496060|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496280|NCT00110032|Etanidazole|etanidazole|mesh-list
138890263|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890264|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138890265|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890266|NCT00661856|Genistein|genistein|mesh-list
138496670|NCT00112645|Melphalan|melphalan|mesh-list
138890267|NCT00661856|Daidzein|daidzein|mesh-list
138496880|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138497031|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138890268|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138890269|NCT00661856|Protective Agents|protective agents|mesh-ancestor
138497335|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138497408|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138890270|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138497634|NCT00118222|Trioxsalen|trioxsalen|mesh-list
138890271|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890272|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138890273|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138498022|NCT04711096|Bupivacaine|bupivacaine|mesh-list
138498086|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138890274|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138498235|NCT00819780|Bevacizumab|bevacizumab|mesh-list
138498308|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
138890275|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
138498404|NCT00128323|Nystatin|nystatin|mesh-list
138890276|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138498636|NCT00019786|Melphalan|melphalan|mesh-list
138890278|NCT00661856|Hormones|hormones|mesh-ancestor
138498750|NCT00020371|Lenograstim|lenograstim|mesh-list
138498825|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
138498899|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138498974|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138499048|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138890279|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138890281|NCT04215731|Bevacizumab|bevacizumab|mesh-list
138890282|NCT04215731|Fluorouracil|fluorouracil|mesh-list
138890284|NCT04215731|Irinotecan|irinotecan|mesh-list
138890285|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
138499572|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
138890286|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138890287|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138499800|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
138499875|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138500029|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
138890288|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138890289|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138890290|NCT04215731|Growth Substances|growth substances|mesh-ancestor
138890291|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890292|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
138890293|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
138890294|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890295|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138890296|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138890297|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
138890298|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138890299|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138890300|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890301|NCT04215731|Antidotes|antidotes|mesh-ancestor
138890302|NCT04215731|Protective Agents|protective agents|mesh-ancestor
138890303|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
138890304|NCT04215731|Vitamins|vitamins|mesh-ancestor
138890305|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
138890306|NCT00665834|Atorvastatin|atorvastatin|mesh-list
138890308|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138890309|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138890310|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
138890311|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890312|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138500243|NCT00000419|Estrogens|estrogens|mesh-ancestor
138500387|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
138500459|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890313|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138500765|NCT00012090|Goserelin|goserelin|mesh-list
138500913|NCT00000485|Diuretics|diuretics|mesh-list
138890314|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890315|NCT02704013|Oxybutynin|oxybutynin|mesh-list
138501136|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
138890316|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
138890318|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138890319|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890320|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138515185|NCT01466244|Cetuximab|cetuximab|mesh-list
138890321|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138501886|NCT00033046|Modafinil|modafinil|mesh-list
138890322|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
138502106|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
138502178|NCT02971423|Imipenem|imipenem|mesh-list
138502251|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890323|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138890324|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890325|NCT02704013|Urological Agents|urological agents|mesh-ancestor
138890326|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
138890327|NCT00665990|Bevacizumab|bevacizumab|mesh-list
138890328|NCT00665990|Sorafenib|sorafenib|mesh-list
138890329|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138890330|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
138890331|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890332|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138890333|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138890334|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
138890335|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890336|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890337|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138561213|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
138890338|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138890339|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138890340|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138890341|NCT00665990|Growth Substances|growth substances|mesh-ancestor
138890342|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
138890343|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138890344|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890345|NCT00666068|Hormones|hormones|mesh-list
138890346|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138890347|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
138502401|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138502453|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138502535|NCT00000689|Antidotes|antidotes|mesh-ancestor
138425335|NCT02499367|Doxorubicin|doxorubicin|mesh-list
138502757|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138502830|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138502906|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138503054|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138503205|NCT00037063|Vitamins|vitamins|mesh-ancestor
138503206|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
138503280|NCT00037219|Anidulafungin|anidulafungin|mesh-list
138503354|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138503369|NCT00037804|Irinotecan|irinotecan|mesh-list
138503652|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
138503653|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
138503964|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138504035|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
138504197|NCT00016380|Hormones|hormones|mesh-ancestor
138709238|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561250|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
138561251|NCT04227275|Fludarabine|fludarabine|mesh-list
138561252|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138561253|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138561254|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
138561255|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561256|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561264|NCT04222023|Antibodies|antibodies|mesh-list
138890348|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138890349|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890350|NCT00700102|Bevacizumab|bevacizumab|mesh-list
138890351|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138504556|NCT00039832|Reteplase|reteplase|mesh-list
138890352|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890353|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138504721|NCT00040690|Vitamins|vitamins|mesh-ancestor
138890354|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138504859|NCT00017472|Antibodies|antibodies|mesh-list
138504933|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
138890355|NCT00700102|Growth Substances|growth substances|mesh-ancestor
138890356|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890357|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
138890358|NCT02705729|Methamphetamine|methamphetamine|mesh-list
138890360|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890361|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
138890362|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
138890363|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138890364|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
138890365|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138890366|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890367|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
138890368|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138890369|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138890370|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138890371|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138890372|NCT02705573|Mannitol|mannitol|mesh-list
138890373|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138890374|NCT02705573|Diuretics|diuretics|mesh-ancestor
138890375|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
138890376|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890377|NCT00613847|Trastuzumab|trastuzumab|mesh-list
138890378|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138890379|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138890380|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890381|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890382|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
138890383|NCT00516295|Bevacizumab|bevacizumab|mesh-list
138890384|NCT00516295|Vincristine|vincristine|mesh-list
138890385|NCT00516295|Topotecan|topotecan|mesh-list
138890386|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138890387|NCT00516295|Antibodies|antibodies|mesh-list
138890388|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
138890389|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138890390|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138890391|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
138890392|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890393|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138890394|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138890395|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
138890396|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890397|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890398|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138890399|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138890400|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138890401|NCT00516295|Growth Substances|growth substances|mesh-ancestor
138890402|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
138890403|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138890404|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
138890405|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
138890406|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
138890407|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138890408|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138890409|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890411|NCT03362099|Varenicline|varenicline|mesh-list
138890412|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138890413|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
138890414|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138890415|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138890416|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138890417|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138890418|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890419|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
138890420|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138890421|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890422|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138890423|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138890425|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138890426|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138890427|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
138890428|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
138890429|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138890430|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
138890431|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138890432|NCT02705651|Somatostatin|somatostatin|mesh-list
138890434|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138890435|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890436|NCT00738088|Gliclazide|gliclazide|mesh-list
138890437|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138890438|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890439|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
138890440|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138890441|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
138890442|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
138890443|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138890444|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890445|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138890446|NCT02703233|Analgesics|analgesics|mesh-ancestor
138890447|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
138890448|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138890449|NCT04062760|Diuretics|diuretics|mesh-list
138890450|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
138890451|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890452|NCT02702843|Xenon|xenon|mesh-list
138890453|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138890454|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
138890455|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
138890456|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138890457|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890458|NCT00516139|Lamotrigine|lamotrigine|mesh-list
138890459|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
138890460|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138890461|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138890462|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890463|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138890464|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890465|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138890466|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138890467|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138890468|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138890469|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138890470|NCT02704715|Anesthetics|anesthetics|mesh-list
138890471|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138890472|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890473|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
138890474|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138890475|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138890476|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
138890477|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138890478|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138890480|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890481|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890483|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138890484|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138890485|NCT00615875|Analgesics|analgesics|mesh-ancestor
138425557|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
138890486|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
138890487|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138890488|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890489|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138890490|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138890491|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
138890492|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138890493|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138505839|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138890494|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890495|NCT02630888|Memantine|memantine|mesh-list
138890496|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138890497|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138890498|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
138515333|NCT00009893|Leucovorin|leucovorin|mesh-list
138890499|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138890500|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890501|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890502|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138890503|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138890504|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
138890505|NCT00666302|Tacrolimus|tacrolimus|mesh-list
138890506|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138890507|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
138890508|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890509|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138890510|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890511|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890512|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138890513|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138890514|NCT00666302|Analgesics|analgesics|mesh-ancestor
138890515|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
138890516|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138890517|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138890518|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138890519|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
138890520|NCT00671372|Bevacizumab|bevacizumab|mesh-list
138890521|NCT00671372|Cetuximab|cetuximab|mesh-list
138890522|NCT00671372|Irinotecan|irinotecan|mesh-list
138425604|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
138890523|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138890524|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890525|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138890526|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138890527|NCT00671372|Growth Substances|growth substances|mesh-ancestor
138890528|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890529|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
138890530|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138890531|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138890532|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890533|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890534|NCT00856986|Metformin|metformin|mesh-list
138890535|NCT00856986|Liraglutide|liraglutide|mesh-list
138890536|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
138890537|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138890538|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890539|NCT00856986|Incretins|incretins|mesh-ancestor
138890540|NCT00856986|Hormones|hormones|mesh-ancestor
138890541|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138890542|NCT00666692|Paclitaxel|paclitaxel|mesh-list
138890543|NCT00666692|Bevacizumab|bevacizumab|mesh-list
138890544|NCT00666692|Carboplatin|carboplatin|mesh-list
138890545|NCT00666692|Volociximab|volociximab|mesh-list
138890546|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138890547|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138890548|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890549|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
138890550|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
138890551|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
138890552|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890553|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138890554|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138890555|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138890556|NCT00666692|Growth Substances|growth substances|mesh-ancestor
138890557|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890558|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
138890559|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
138890560|NCT00707746|Mipomersen|mipomersen|mesh-list
138890561|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138890562|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138890563|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
138709239|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138890564|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890565|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138890567|NCT00666770|Analgesics|analgesics|mesh-ancestor
138890568|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
138890569|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138890570|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890571|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
138890572|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138515412|NCT01465113|Vitamin D|vitamin d|mesh-list
138890573|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138890574|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138890575|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138890576|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138890577|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138890578|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138890579|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890580|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
138890581|NCT04188353|Mannitol|mannitol|mesh-list
138890582|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138890583|NCT04188353|Diuretics|diuretics|mesh-ancestor
138890584|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
138890585|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890586|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
138890587|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
138890588|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890589|NCT02630420|Cetuximab|cetuximab|mesh-list
138890590|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138890591|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890592|NCT00667082|Vorinostat|vorinostat|mesh-list
138890593|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138890594|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
138425745|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890595|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890597|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890598|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
138890599|NCT05343299|Lidocaine|lidocaine|mesh-list
138890600|NCT05343299|Ropivacaine|ropivacaine|mesh-list
138890601|NCT05343299|Anesthetics|anesthetics|mesh-list
138890602|NCT05343299|Anesthetics, Local|anesthetics, local|mesh-ancestor
138890603|NCT05343299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138890604|NCT05343299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890605|NCT05343299|Sensory System Agents|sensory system agents|mesh-ancestor
138890606|NCT05343299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138890607|NCT05343299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138890608|NCT05343299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138890609|NCT05343299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138890610|NCT05343299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138890611|NCT05343299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890612|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
138890613|NCT00667160|Tacrolimus|tacrolimus|mesh-list
138890614|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138890615|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
138890616|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890617|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138425797|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
138890618|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890619|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138515445|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
138890620|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138890621|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138890622|NCT00667160|Analgesics|analgesics|mesh-ancestor
138890623|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
138890624|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138890626|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138890627|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
138890629|NCT02701673|Gemcitabine|gemcitabine|mesh-list
138890630|NCT02701673|Azacitidine|azacitidine|mesh-list
138890631|NCT02701673|Melphalan|melphalan|mesh-list
138890632|NCT02701673|Busulfan|busulfan|mesh-list
138890633|NCT02701673|Belinostat|belinostat|mesh-list
138890634|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138890635|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
138890636|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890637|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890638|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890639|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138890640|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
138890641|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138890642|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138890643|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
138890644|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890645|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
138890646|NCT02701673|Vitamins|vitamins|mesh-ancestor
138890647|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
138890648|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138890649|NCT00522379|Rotigotine|rotigotine|mesh-list
138890650|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
138890651|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
138890652|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138890653|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890654|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890656|NCT00856830|Irinotecan|irinotecan|mesh-list
138890657|NCT00856830|Etoposide|etoposide|mesh-list
138890658|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138890659|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890660|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138890661|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138890662|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890663|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890664|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138890665|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138890666|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138890667|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
138890668|NCT02614404|Piperaquine|piperaquine|mesh-list
138890669|NCT02614404|Artenimol|artenimol|mesh-list
138890670|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
138890671|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890672|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138890673|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890674|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890675|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
138890676|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138890677|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138890678|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138890679|NCT00522301|Sorafenib|sorafenib|mesh-list
138890680|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890681|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138890682|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890683|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890684|NCT00662636|Dasatinib|dasatinib|mesh-list
138890685|NCT00662636|Lapatinib|lapatinib|mesh-list
138890686|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890687|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138890688|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890689|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890690|NCT00506389|Mirtazapine|mirtazapine|mesh-list
138890691|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
138890692|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138890693|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138890694|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
138890695|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
138890696|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138890697|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890698|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890699|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138890700|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138561727|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
138890701|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138890702|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138890703|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138890705|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
138890706|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138890707|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138890709|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138890710|NCT00667472|Ranibizumab|ranibizumab|mesh-list
138890711|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138890712|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138890713|NCT00667472|Growth Substances|growth substances|mesh-ancestor
138890714|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890715|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
138515495|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138515513|NCT01464606|Ifosfamide|ifosfamide|mesh-list
138890716|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890717|NCT00662714|Insulin|insulin|mesh-list
138890718|NCT00662714|Repaglinide|repaglinide|mesh-list
138890719|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138890720|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
138384936|NCT02471144|Etanercept|etanercept|mesh-list
138890722|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890723|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138890724|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
138890725|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138890726|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138890727|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890728|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890729|NCT00668018|Urological Agents|urological agents|mesh-ancestor
138890730|NCT00871338|Vaccines|vaccines|mesh-list
138890731|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138890732|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
138890733|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890734|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
138890735|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138890736|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
138890737|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890738|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
138890739|NCT04130100|Protective Agents|protective agents|mesh-ancestor
138890740|NCT00597116|Vinorelbine|vinorelbine|mesh-list
138890741|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138890742|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890743|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
138890744|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
138890745|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
138890746|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890747|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138890748|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
138890749|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138890750|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138890751|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890752|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890753|NCT00668096|Urological Agents|urological agents|mesh-ancestor
138890754|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138890755|NCT03252587|Deucravacitinib|deucravacitinib|mesh-list
138890756|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
138561766|NCT03283384|Letrozole|letrozole|mesh-list
138890757|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138890759|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890761|NCT02630264|Endostatins|endostatins|mesh-list
138890762|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138890763|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890764|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
138890765|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
138890766|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
138890767|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890768|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138515554|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138890769|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138890770|NCT02630264|Growth Substances|growth substances|mesh-ancestor
138890771|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890772|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
138426010|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
138890773|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
138890774|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
138542931|NCT00189397|Azathioprine|azathioprine|mesh-list
138890775|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
138890776|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138890777|NCT00668330|Calcium|calcium|mesh-list
138890778|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138890779|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890780|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138890781|NCT00668330|Vitamins|vitamins|mesh-ancestor
138890782|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
138890783|NCT01012687|Perindopril|perindopril|mesh-list
138890784|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138890785|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
138890786|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890787|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890788|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138890789|NCT00662948|Rituximab|rituximab|mesh-list
138890790|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138890791|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890792|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
138890793|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890794|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138890795|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
138890796|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138890797|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
138890798|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138890799|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
138890800|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890801|NCT00672464|Metformin|metformin|mesh-list
138890802|NCT00672464|Olanzapine|olanzapine|mesh-list
138890803|NCT00672464|Simvastatin|simvastatin|mesh-list
138890804|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138890805|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890806|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138890807|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138890808|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
138890809|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890810|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138890811|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138890812|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890813|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
138890814|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
138890815|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138890816|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138890817|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138890818|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138890819|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138890820|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138890821|NCT00672464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138890822|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138890823|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138426125|NCT01696617|Aripiprazole|aripiprazole|mesh-list
138890825|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
138890826|NCT02701595|Amoxicillin|amoxicillin|mesh-list
138890827|NCT02701595|Vancomycin|vancomycin|mesh-list
138890828|NCT02701595|Gentamicins|gentamicins|mesh-list
138890829|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
138890830|NCT02701595|Penicillins|penicillins|mesh-list
138890832|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138890833|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
138890834|NCT02701595|Netilmicin|netilmicin|mesh-list
138890835|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138890836|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138890837|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138890838|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890839|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890840|NCT02698553|Bupropion|bupropion|mesh-list
138890841|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138890842|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
138890843|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138890844|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138890845|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138890846|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138890847|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890848|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
138890849|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138890850|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890851|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138890852|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138890853|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890854|NCT00663182|Entecavir|entecavir|mesh-list
138890855|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
138890856|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138890857|NCT00616031|Paclitaxel|paclitaxel|mesh-list
138890858|NCT00616031|Carboplatin|carboplatin|mesh-list
138890859|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
138890860|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138890861|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890862|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
138890863|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
138890864|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
138890865|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890866|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
138890867|NCT04213937|Paclitaxel|paclitaxel|mesh-list
138890868|NCT04213937|Topotecan|topotecan|mesh-list
138890869|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138890870|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890871|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
138890872|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
138890873|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
138890874|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890875|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138890876|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138890877|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890878|NCT02701517|Cyclosporine|cyclosporine|mesh-list
138890879|NCT02701517|Methotrexate|methotrexate|mesh-list
138890880|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
138890881|NCT02701517|Cyclosporins|cyclosporins|mesh-list
138890882|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138890883|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
138890884|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138890885|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561850|NCT03118492|Fludarabine|fludarabine|mesh-list
138890886|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138890887|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
138890888|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890889|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890890|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
138890891|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890892|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138890893|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138890894|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
138890895|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138890896|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138890897|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
138890898|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138890899|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138890900|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138890901|NCT02630108|Epirubicin|epirubicin|mesh-list
138890902|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
138890903|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138890904|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890905|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138890906|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138890907|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890908|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890909|NCT00505921|Cytarabine|cytarabine|mesh-list
138890910|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
138890911|NCT00505921|Melphalan|melphalan|mesh-list
138890912|NCT00505921|Carmustine|carmustine|mesh-list
138890913|NCT00505921|Fludarabine|fludarabine|mesh-list
138890914|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
138890915|NCT00505921|Etoposide|etoposide|mesh-list
138890916|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
138890917|NCT00505921|Molgramostim|molgramostim|mesh-list
138890918|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
138890919|NCT00505921|Sargramostim|sargramostim|mesh-list
138890920|NCT00505921|Lenograstim|lenograstim|mesh-list
138890921|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138890922|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
138890923|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890924|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138890925|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138890926|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
138890927|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890928|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138890929|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138890930|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138890931|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
138890932|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
138890933|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138890934|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138890935|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138890936|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138890937|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890938|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138890939|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138890940|NCT00669344|Rivastigmine|rivastigmine|mesh-list
138890941|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138890942|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138890943|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890944|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
138890945|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138890946|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890947|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138890948|NCT00669344|Protective Agents|protective agents|mesh-ancestor
138890949|NCT02701127|Niacinamide|niacinamide|mesh-list
138890951|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
138890952|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
138890954|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
138890955|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890956|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138890957|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
138890958|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138890959|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138890960|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
138890961|NCT02700893|Atropine|atropine|mesh-list
138890962|NCT02700893|Sufentanil|sufentanil|mesh-list
138890963|NCT02700893|Propofol|propofol|mesh-list
138890964|NCT02700893|Atracurium|atracurium|mesh-list
138890965|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138890966|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138890967|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890968|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138890969|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
138890970|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
138890971|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138890972|NCT02700893|Narcotics|narcotics|mesh-ancestor
138890973|NCT02700893|Analgesics|analgesics|mesh-ancestor
138890974|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
138890975|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138890976|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138890977|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138890978|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138890979|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
138561910|NCT02885753|Antimetabolites|antimetabolites|mesh-ancestor
138890980|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138890981|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
138890983|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
138890984|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138890985|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138890986|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
138890987|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138515759|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138890988|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426406|NCT01698476|Vitamin D|vitamin d|mesh-list
138890989|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138890990|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138890991|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138890992|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138890993|NCT04213781|Sufentanil|sufentanil|mesh-list
138890994|NCT04213781|Propofol|propofol|mesh-list
138890995|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138890996|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138890997|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138890998|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138890999|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
138891000|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
138891001|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138891002|NCT04213781|Narcotics|narcotics|mesh-ancestor
138891003|NCT04213781|Analgesics|analgesics|mesh-ancestor
138891004|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
138891005|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891006|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138891007|NCT00505687|Rotigotine|rotigotine|mesh-list
138891008|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
138891010|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891011|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891012|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891013|NCT00669656|Vitamin D|vitamin d|mesh-list
138891014|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
138891015|NCT00669656|Vitamins|vitamins|mesh-list
138891016|NCT00669656|Vitamin E|vitamin e|mesh-list
138891017|NCT00669656|Tocopherols|tocopherols|mesh-list
138891018|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
138891019|NCT00669656|Selenium|selenium|mesh-list
138891020|NCT00669656|Lycopene|lycopene|mesh-list
138891021|NCT00669656|Daidzein|daidzein|mesh-list
138891022|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
138891023|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891024|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138891025|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138515791|NCT00012350|Tipifarnib|tipifarnib|mesh-list
138891026|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
138891027|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891028|NCT00669656|Protective Agents|protective agents|mesh-ancestor
138891029|NCT00669656|Trace Elements|trace elements|mesh-ancestor
138891030|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138891031|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138891032|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138891033|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891034|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
138891035|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138891036|NCT00669656|Estrogens|estrogens|mesh-ancestor
138891037|NCT00669656|Hormones|hormones|mesh-ancestor
138891038|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138891039|NCT00672776|Paroxetine|paroxetine|mesh-list
138891040|NCT00672776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138891041|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138891042|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709240|NCT04000555|Vancomycin|vancomycin|mesh-list
138891043|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891044|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891046|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891047|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138891048|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
138891049|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138891050|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138891051|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138891052|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891053|NCT00616187|Interferons|interferons|mesh-list
138891054|NCT00616187|Interferon-beta|interferon-beta|mesh-list
138891055|NCT00616187|Atorvastatin|atorvastatin|mesh-list
138891056|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891057|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
138891058|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891059|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138891060|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138891061|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
138891062|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891063|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138891064|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138891065|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891066|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
138891067|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891068|NCT00663338|Rotigotine|rotigotine|mesh-list
138891069|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
138891070|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
138891071|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891072|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891073|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891074|NCT02992015|Gemcitabine|gemcitabine|mesh-list
138891075|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138562045|NCT02046395|Amlodipine|amlodipine|mesh-list
138891076|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
138891077|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891078|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891080|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138891081|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138891082|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
138891083|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
138891085|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891086|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891087|NCT00669812|Cytarabine|cytarabine|mesh-list
138891088|NCT00669812|Prednisolone|prednisolone|mesh-list
138891089|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
138891090|NCT00669812|Melphalan|melphalan|mesh-list
138891091|NCT00669812|Ifosfamide|ifosfamide|mesh-list
138891092|NCT00669812|Carmustine|carmustine|mesh-list
138891093|NCT00669812|Doxorubicin|doxorubicin|mesh-list
138891094|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138891095|NCT00669812|Methotrexate|methotrexate|mesh-list
138891096|NCT00669812|Etoposide|etoposide|mesh-list
138891097|NCT00669812|Vincristine|vincristine|mesh-list
138891098|NCT00669812|Epirubicin|epirubicin|mesh-list
138426533|NCT01699360|Cyclosporine|cyclosporine|mesh-list
138891100|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
138891101|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891102|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138891103|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138891104|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
138891105|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891106|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891107|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138891108|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138891109|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138891110|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138891111|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891112|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138891113|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
138891114|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138891115|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138891116|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
138891117|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
138891118|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138891119|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138891120|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138891121|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
138891122|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891123|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
138891124|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
138891125|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
138891126|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138891127|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
138891128|NCT00669812|Hormones|hormones|mesh-ancestor
138891129|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138891130|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138891131|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138891132|NCT02697851|Cobicistat|cobicistat|mesh-list
138891133|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
138891134|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138891135|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138891136|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138891138|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
138891139|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138891140|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891141|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138891142|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138891143|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138891144|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138891145|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138891146|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
138891147|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891148|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891149|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138891150|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138891151|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
138891152|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891153|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138543279|NCT00191425|Teriparatide|teriparatide|mesh-list
138891154|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138891155|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138891156|NCT02697851|Estrogens|estrogens|mesh-ancestor
138891157|NCT02697851|Hormones|hormones|mesh-ancestor
138891158|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138891159|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138891160|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138891161|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138891162|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138891163|NCT01012843|Amoxicillin|amoxicillin|mesh-list
138891164|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
138891165|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
138891166|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138891167|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138891168|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891169|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138891170|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891171|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891172|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
138891173|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
138891174|NCT00669890|Busulfan|busulfan|mesh-list
138891175|NCT00669890|Methotrexate|methotrexate|mesh-list
138891176|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
138891177|NCT00669890|Tacrolimus|tacrolimus|mesh-list
138891178|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
138891179|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138891180|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
138891181|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891182|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138891183|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138891184|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
138891185|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891186|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891187|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138891188|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138891189|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
138891190|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138891191|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138891192|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
138891193|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
138891194|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891195|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138891196|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138891197|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138891198|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138891199|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138891200|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
138891201|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138891202|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891203|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138891204|NCT00669890|Immunotoxins|immunotoxins|mesh-ancestor
138891205|NCT00669890|Immunoconjugates|immunoconjugates|mesh-ancestor
138891206|NCT02697929|Neostigmine|neostigmine|mesh-list
138891207|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138891208|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891209|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891210|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
138515969|NCT00846144|Copper|copper|mesh-list
138891211|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891212|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891213|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138891214|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
138891215|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891216|NCT00505375|Abatacept|abatacept|mesh-list
138891217|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138891218|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891219|NCT00505375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138891220|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891221|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138891222|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
138562258|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
138891223|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891224|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138891225|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
138891226|NCT02700347|Allopurinol|allopurinol|mesh-list
138891227|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
138891228|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891229|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891230|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
138891231|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138891232|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138891233|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
138891234|NCT02700347|Protective Agents|protective agents|mesh-ancestor
138891235|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891236|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
138891237|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138891238|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891239|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
138891240|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138891241|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891242|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138891243|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
138891244|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138891245|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891246|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891247|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426699|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
138891248|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138562301|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
138891249|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
138891250|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138891251|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138891252|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138891253|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138891254|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891255|NCT00673088|Ropinirole|ropinirole|mesh-list
138891256|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138891257|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138891258|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
138891259|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
138891260|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891261|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891262|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891263|NCT00504829|Atorvastatin|atorvastatin|mesh-list
138891264|NCT00504829|Fenofibrate|fenofibrate|mesh-list
138891265|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138891266|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138891267|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
138891268|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891269|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138891270|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138891271|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891272|NCT02701205|Etanercept|etanercept|mesh-list
138891273|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138891274|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138891275|NCT02701205|Analgesics|analgesics|mesh-ancestor
138891276|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
138891277|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891278|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891279|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138426718|NCT01700400|Carboplatin|carboplatin|mesh-list
138891280|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138891281|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138891282|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138891283|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
138891284|NCT00670436|Paclitaxel|paclitaxel|mesh-list
138891285|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138891286|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138891287|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891288|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
138891289|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
138891290|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
138891291|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891292|NCT02699879|Pirfenidone|pirfenidone|mesh-list
138891293|NCT02699879|Analgesics|analgesics|mesh-ancestor
138891294|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
138891295|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891296|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891297|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138891298|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138891299|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138891300|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138891301|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891302|NCT02699723|Itraconazole|itraconazole|mesh-list
138891303|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
138891304|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
138891305|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891306|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138891307|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138891308|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891309|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891310|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138891311|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
138770226|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138891312|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138891313|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891314|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138891315|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891318|NCT02699645|Indapamide|indapamide|mesh-list
138891319|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138891320|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138891321|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138891322|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891323|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138891324|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891325|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
138891326|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138891327|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138891328|NCT02699645|Diuretics|diuretics|mesh-ancestor
138891329|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
138891330|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138891331|NCT04152434|Erenumab|erenumab|mesh-list
138891332|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138891333|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891334|NCT04152434|Analgesics|analgesics|mesh-ancestor
138891335|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
138891336|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891337|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891338|NCT00615797|Penicillins|penicillins|mesh-list
138891339|NCT00615797|Penicillin V|penicillin v|mesh-list
138891340|NCT00615797|Haloperidol|haloperidol|mesh-list
138891341|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
138891342|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
138891343|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138891344|NCT00615797|Antibodies|antibodies|mesh-list
138891345|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
138891346|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138891347|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
138891348|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891349|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
138891350|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
138891351|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891352|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138891353|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138891354|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138891355|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138891356|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138891357|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138891358|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
138891359|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891360|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891361|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138891362|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138891363|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891364|NCT00705016|Fluorouracil|fluorouracil|mesh-list
138891366|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891367|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
138891368|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891369|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138891370|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138891371|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
138891372|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891373|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138891374|NCT00595868|Varenicline|varenicline|mesh-list
138891375|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138891376|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138891377|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
138891378|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138516165|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
138891379|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891380|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891381|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
138891382|NCT02699801|Propofol|propofol|mesh-list
138891383|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138891384|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138891385|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891386|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138891387|NCT02699801|Analgesics|analgesics|mesh-ancestor
138891388|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
138891389|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891390|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138891391|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138891392|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138891393|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
138891394|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891395|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891396|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138891397|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
138891398|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
138891399|NCT02727907|Interferons|interferons|mesh-list
138891400|NCT02727907|Interferon-beta|interferon-beta|mesh-list
138891401|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
138891402|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891403|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
138891404|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891405|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
138891406|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891407|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138891408|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138891409|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
138891410|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138891411|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138891412|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891413|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891414|NCT00663728|Urological Agents|urological agents|mesh-ancestor
138891415|NCT01009801|Doxorubicin|doxorubicin|mesh-list
138891417|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138891418|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891419|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138891420|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138891421|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891422|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891424|NCT01009801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138891425|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138891426|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
138516219|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
138891427|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891428|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138891429|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138891430|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138891431|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138891432|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891433|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891434|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891435|NCT00617045|Analgesics|analgesics|mesh-ancestor
138891436|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
138891437|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891438|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
138891439|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138891440|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
138891441|NCT02629718|Paclitaxel|paclitaxel|mesh-list
138891442|NCT02629718|Carboplatin|carboplatin|mesh-list
138891443|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138891444|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891445|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
138891446|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
138891447|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
138891448|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891449|NCT01009879|Etanercept|etanercept|mesh-list
138891450|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138891451|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138891452|NCT01009879|Analgesics|analgesics|mesh-ancestor
138891453|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
138891454|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891455|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891457|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138891458|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138891459|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562559|NCT00313690|Docetaxel|docetaxel|mesh-list
138891460|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
138891461|NCT01009957|Everolimus|everolimus|mesh-list
138891462|NCT01009957|MTOR Inhibitors|mtor inhibitors|mesh-list
138891463|NCT01009957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138891464|NCT01009957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891465|NCT01009957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891466|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138891467|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
138891468|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891469|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891470|NCT04062370|Ranibizumab|ranibizumab|mesh-list
138891471|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138891472|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138891473|NCT04062370|Growth Substances|growth substances|mesh-ancestor
138891474|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891475|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
138891476|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891477|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
138891478|NCT01015183|Astringents|astringents|mesh-ancestor
138891479|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891480|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
138891481|NCT00856284|Metformin|metformin|mesh-list
138891482|NCT00856284|Alogliptin|alogliptin|mesh-list
138891483|NCT00856284|Glipizide|glipizide|mesh-list
138891484|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138891485|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891486|NCT00856284|Incretins|incretins|mesh-ancestor
138891487|NCT00856284|Hormones|hormones|mesh-ancestor
138770227|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138891488|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138891489|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138891490|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
138891491|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891492|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891494|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891495|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138562591|NCT00122733|Loxapine|loxapine|mesh-list
138891496|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891497|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891498|NCT01013155|Perindopril|perindopril|mesh-list
138891499|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138891500|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
138891501|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891502|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891503|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138891504|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
138891505|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138891506|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891507|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138891508|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138891509|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891510|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891511|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891512|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138891513|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138891515|NCT01015339|Capecitabine|capecitabine|mesh-list
138891516|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138891517|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891518|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
138891519|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
138891520|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
138891521|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891522|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138891523|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
138891524|NCT02622906|Pasireotide|pasireotide|mesh-list
138891526|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138543638|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
138891527|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891529|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
138891530|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
138891531|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891532|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138891533|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
138891534|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138891535|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138891536|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138891537|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138891538|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891539|NCT01015417|Amoxicillin|amoxicillin|mesh-list
138891540|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138891541|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
138891542|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
138891543|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138891544|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891545|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138891546|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891547|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891548|NCT04061824|Olmesartan|olmesartan|mesh-list
138891549|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
138891550|NCT04061824|Giapreza|giapreza|mesh-list
138891551|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138891552|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
138891553|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138891554|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138891555|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138891556|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
138891557|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891558|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138891559|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138891560|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891561|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138891562|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138562687|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
138891563|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138891564|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138891565|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
138891567|NCT04212533|Vitamins|vitamins|mesh-ancestor
138891568|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
138891569|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891570|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138891571|NCT04155554|Tenofovir|tenofovir|mesh-list
138891572|NCT04155554|Lamivudine|lamivudine|mesh-list
138505970|NCT00001784|Mexiletine|mexiletine|mesh-list
138891573|NCT04155554|Emtricitabine|emtricitabine|mesh-list
138891574|NCT04155554|Dolutegravir|dolutegravir|mesh-list
138891575|NCT04155554|Abacavir|abacavir|mesh-list
138891576|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138891577|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
138891578|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891579|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138891580|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138891582|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891583|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138891584|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138891585|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138891586|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138891587|NCT00663884|Voglibose|voglibose|mesh-list
138891588|NCT00663884|Mitiglinide|mitiglinide|mesh-list
138891589|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138891590|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891591|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138891592|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891593|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891594|NCT00856206|Rilonacept|rilonacept|mesh-list
138891595|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138891596|NCT03997279|Amoxicillin|amoxicillin|mesh-list
138891597|NCT03997279|Metronidazole|metronidazole|mesh-list
138891598|NCT03997279|Clarithromycin|clarithromycin|mesh-list
138891599|NCT03997279|Rabeprazole|rabeprazole|mesh-list
138891600|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138891601|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891602|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138891603|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138891604|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138891605|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891606|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891607|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138891608|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138891609|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138891610|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138891611|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138891613|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138891614|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891615|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891616|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
138891617|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891618|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891619|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138891620|NCT00593112|Methylphenidate|methylphenidate|mesh-list
138891621|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138891622|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891623|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138891624|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138891625|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138891626|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891627|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
138891628|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891629|NCT05323565|Dexamethasone|dexamethasone|mesh-list
138891630|NCT05323565|Dexmedetomidine|dexmedetomidine|mesh-list
138891631|NCT05323565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138891632|NCT05323565|Antiemetics|antiemetics|mesh-ancestor
138891633|NCT05323565|Autonomic Agents|autonomic agents|mesh-ancestor
138891634|NCT05323565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427261|NCT01703637|Hormones|hormones|mesh-ancestor
138891635|NCT05323565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891636|NCT05323565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138891637|NCT05323565|Glucocorticoids|glucocorticoids|mesh-ancestor
138891638|NCT05323565|Hormones|hormones|mesh-ancestor
138891639|NCT05323565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138891640|NCT05323565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138891641|NCT05323565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891642|NCT05323565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891643|NCT05323565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138891644|NCT05323565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138891645|NCT05323565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138891646|NCT05323565|Analgesics|analgesics|mesh-ancestor
138891647|NCT05323565|Sensory System Agents|sensory system agents|mesh-ancestor
138891648|NCT05323565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138891649|NCT05323565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138891650|NCT05323565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138891651|NCT05323565|Adrenergic Agents|adrenergic agents|mesh-ancestor
138891652|NCT05323565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891653|NCT01015495|Ranibizumab|ranibizumab|mesh-list
138891654|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138891655|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138891656|NCT01015495|Growth Substances|growth substances|mesh-ancestor
138891657|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891658|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
138891659|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891661|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
138891662|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138770228|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138891664|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891665|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138891666|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138891667|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
138891668|NCT00699894|Ondansetron|ondansetron|mesh-list
138891669|NCT00699894|Aprepitant|aprepitant|mesh-list
138891670|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
138891671|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
138891672|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891673|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891674|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138891675|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
138891676|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
138891677|NCT00699894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138891678|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138891679|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
138891680|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891681|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891682|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138891683|NCT00664196|Hormones|hormones|mesh-list
138891684|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138891685|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891686|NCT00616499|Gefitinib|gefitinib|mesh-list
138516413|NCT00015548|Citalopram|citalopram|mesh-list
138891687|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891688|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138891689|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891690|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891691|NCT02614248|Protective Agents|protective agents|mesh-list
138891692|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891693|NCT00491179|Interferons|interferons|mesh-list
138891694|NCT00491179|Ribavirin|ribavirin|mesh-list
138891695|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
138891696|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
138891697|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138891698|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891699|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
138891700|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891701|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
138891702|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891703|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
138891704|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891705|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
138891706|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
138891707|NCT04502095|Levofloxacin|levofloxacin|mesh-list
138891709|NCT04502095|Trimethoprim|trimethoprim|mesh-list
138505981|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138562849|NCT01691833|Vitamin D|vitamin d|mesh-list
138891710|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138891711|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
138891712|NCT04502095|Clindamycin|clindamycin|mesh-list
138891713|NCT04502095|Ertapenem|ertapenem|mesh-list
138891714|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
138891715|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138891716|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891717|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138891718|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138891719|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138891720|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891721|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891722|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891723|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138891724|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138891725|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138891726|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
138891727|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138891728|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138891729|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138891730|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138891731|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138891733|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891734|NCT00503581|Megestrol|megestrol|mesh-list
138891735|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
138891736|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138891737|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138891738|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138891739|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
138891740|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138891741|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891742|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138891743|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138891744|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138891745|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891746|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
138891747|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138891748|NCT00677144|Capecitabine|capecitabine|mesh-list
138891749|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
138891750|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138891751|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
138891752|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891753|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891754|NCT00703534|Lesogaberan|lesogaberan|mesh-list
138891755|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138891756|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138891757|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
138891758|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
138891759|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891760|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891761|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891763|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138891764|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138516475|NCT00275457|Pramipexole|pramipexole|mesh-list
138891765|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
138891766|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891767|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138891768|NCT00863772|Tanezumab|tanezumab|mesh-list
138891769|NCT00863772|Analgesics|analgesics|mesh-ancestor
138891770|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
138891771|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891772|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891773|NCT01010425|Hormones|hormones|mesh-list
138891774|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138891775|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891776|NCT00677300|Ritonavir|ritonavir|mesh-list
138891777|NCT00677300|Darunavir|darunavir|mesh-list
138891778|NCT00677300|Tenofovir|tenofovir|mesh-list
138891779|NCT00677300|Emtricitabine|emtricitabine|mesh-list
138891780|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
138891781|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138891782|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138891783|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
138891784|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891785|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891786|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138891787|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138891788|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
138891789|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891790|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138891791|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138891792|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138891793|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138891794|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138891795|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138891796|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138891798|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138891799|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891800|NCT02628392|Incretins|incretins|mesh-ancestor
138891801|NCT02628392|Hormones|hormones|mesh-ancestor
138891802|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138891803|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138891804|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
138891805|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138516509|NCT00015821|Growth Substances|growth substances|mesh-ancestor
138516512|NCT00275184|Metoclopramide|metoclopramide|mesh-list
138891806|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891807|NCT00664586|Masoprocol|masoprocol|mesh-list
138891808|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
138891809|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891810|NCT00664586|Protective Agents|protective agents|mesh-ancestor
138891811|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891812|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138891813|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891814|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138891815|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138891816|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138891817|NCT00664586|Analgesics|analgesics|mesh-ancestor
138891818|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
138891819|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891820|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138891821|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138891822|NCT00502801|Doripenem|doripenem|mesh-list
138891823|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138891824|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891825|NCT04154852|Folic Acid|folic acid|mesh-list
138891826|NCT04154852|Adalimumab|adalimumab|mesh-list
138891827|NCT04154852|Methotrexate|methotrexate|mesh-list
138891828|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138891829|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
138891830|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138563000|NCT00327925|Antibodies|antibodies|mesh-list
138891831|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891832|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138891833|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
138891834|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891835|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891836|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
138891837|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891838|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138891839|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138891840|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
138891841|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138891842|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138891843|NCT04154852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138891844|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138891845|NCT04154852|Hematinics|hematinics|mesh-ancestor
138891846|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
138891848|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
138891849|NCT00921154|Ivermectin|ivermectin|mesh-list
138891850|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138891851|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138516544|NCT00015899|Lonafarnib|lonafarnib|mesh-list
138891852|NCT01015651|Remifentanil|remifentanil|mesh-list
138891853|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138891854|NCT01015651|Narcotics|narcotics|mesh-ancestor
138891855|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138891856|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891857|NCT01015651|Analgesics|analgesics|mesh-ancestor
138891858|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
138891859|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891860|NCT00674414|Trastuzumab|trastuzumab|mesh-list
138891861|NCT00674414|Everolimus|everolimus|mesh-list
138770229|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891862|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138891863|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891864|NCT00674414|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138891865|NCT00674414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138891866|NCT00674414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891867|NCT00674414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891868|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138891869|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
138891870|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891871|NCT05272930|Dienogest|dienogest|mesh-list
138563096|NCT00092313|Acetaminophen|acetaminophen|mesh-list
138891872|NCT05272930|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138891873|NCT05272930|Contraceptive Agents|contraceptive agents|mesh-ancestor
138891874|NCT05272930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138891875|NCT05272930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891876|NCT05272930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138891877|NCT05272930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138891878|NCT05272930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138891879|NCT05272930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138891880|NCT05272930|Hormone Antagonists|hormone antagonists|mesh-ancestor
138891881|NCT05272930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138891882|NCT05272930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138891883|NCT05272930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891884|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138891886|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891887|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138891888|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891889|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891890|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138891891|NCT02566096|Morphine|morphine|mesh-list
138891892|NCT02566096|Bupivacaine|bupivacaine|mesh-list
138891893|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
138891894|NCT02566096|Anesthetics|anesthetics|mesh-list
138891895|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138891896|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891897|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
138891898|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891899|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138891900|NCT02566096|Narcotics|narcotics|mesh-ancestor
138891901|NCT02566096|Analgesics|analgesics|mesh-ancestor
138891902|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138891903|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138891904|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
138891905|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
138891906|NCT02628860|Hematinics|hematinics|mesh-ancestor
138891907|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138891908|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891909|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891910|NCT00855738|Topiramate|topiramate|mesh-list
138891911|NCT00855738|Pregabalin|pregabalin|mesh-list
138891912|NCT00855738|Lamotrigine|lamotrigine|mesh-list
138891913|NCT00855738|Zonisamide|zonisamide|mesh-list
138891914|NCT00855738|Gabapentin|gabapentin|mesh-list
138891915|NCT00855738|Levetiracetam|levetiracetam|mesh-list
138891916|NCT00855738|Tiagabine|tiagabine|mesh-list
138891917|NCT00855738|Analgesics|analgesics|mesh-ancestor
138891918|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
138891919|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891920|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891921|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
138891922|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138505999|NCT00046969|Cisplatin|cisplatin|mesh-list
138891923|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138891924|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891925|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138891927|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138770230|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
138891928|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138891929|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138891930|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138891931|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138891932|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891933|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
138891934|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138891935|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
138891936|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138891937|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138891938|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
138891939|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138891940|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
138891941|NCT02628002|Regadenoson|regadenoson|mesh-list
138891942|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138891943|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138891944|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
138891945|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
138891946|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138891947|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891948|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891949|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138891950|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
138891951|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138891952|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138891953|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891954|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891955|NCT00665054|Urological Agents|urological agents|mesh-ancestor
138891956|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
138891957|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
138891958|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891959|NCT02622672|Vitamins|vitamins|mesh-ancestor
138891960|NCT06157359|Ropivacaine|ropivacaine|mesh-list
138891961|NCT06157359|Anesthetics, Local|anesthetics, local|mesh-ancestor
138891962|NCT06157359|Anesthetics|anesthetics|mesh-ancestor
138891963|NCT06157359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138891964|NCT06157359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891965|NCT06157359|Sensory System Agents|sensory system agents|mesh-ancestor
138891966|NCT06157359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891967|NCT06157320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138891968|NCT06157320|Norepinephrine|norepinephrine|mesh-list
138891969|NCT06157320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138891970|NCT06157320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138891971|NCT06157320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138891972|NCT06157320|Adrenergic Agents|adrenergic agents|mesh-ancestor
138891973|NCT06157320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770231|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
138516654|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
138891974|NCT06157320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891975|NCT06157320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891977|NCT06157320|Autonomic Agents|autonomic agents|mesh-ancestor
138891978|NCT06157320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138891979|NCT06157320|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138891980|NCT06157255|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138891982|NCT06157151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138891983|NCT06157151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138891984|NCT06157151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138891985|NCT06157151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891986|NCT06157099|Atorvastatin|atorvastatin|mesh-list
138891987|NCT06157099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138891988|NCT06157099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138891989|NCT06157099|Antimetabolites|antimetabolites|mesh-ancestor
138891990|NCT06157099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138891991|NCT06157099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138891992|NCT06157099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138891993|NCT06157099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138891994|NCT06157008|Anesthetics|anesthetics|mesh-list
138891995|NCT06157008|Anesthetics, General|anesthetics, general|mesh-list
138891996|NCT06157008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138891997|NCT06157008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138891998|NCT06156995|Mosapride|mosapride|mesh-list
138891999|NCT06156995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138892000|NCT06156995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138892001|NCT06156995|Serotonin Agents|serotonin agents|mesh-ancestor
138892002|NCT06156995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138892003|NCT06156995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892004|NCT06156995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427873|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
138892005|NCT06156878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138892006|NCT06156878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892007|NCT06156878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892008|NCT06156878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892009|NCT06156761|Capecitabine|capecitabine|mesh-list
138892010|NCT06156761|Mitoxantrone|mitoxantrone|mesh-list
138516678|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
138892011|NCT06156761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138892012|NCT06156761|Antimetabolites|antimetabolites|mesh-ancestor
138892013|NCT06156761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892014|NCT06156761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892015|NCT06156761|Analgesics|analgesics|mesh-ancestor
138892016|NCT06156761|Sensory System Agents|sensory system agents|mesh-ancestor
138892017|NCT06156761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892018|NCT06156761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892019|NCT06156761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138892020|NCT06156761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138892021|NCT06156761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892022|NCT06156709|Anesthetics|anesthetics|mesh-list
138892023|NCT06156709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892024|NCT06156709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892025|NCT06156592|Anesthetics|anesthetics|mesh-list
138892026|NCT06156592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892027|NCT06156592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892028|NCT06156579|Decitabine|decitabine|mesh-list
138892029|NCT06156579|Venetoclax|venetoclax|mesh-list
138892030|NCT06156579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138892031|NCT06156579|Antimetabolites|antimetabolites|mesh-ancestor
138892032|NCT06156579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892033|NCT06156579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892034|NCT06156579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892035|NCT06156566|Tecovirimat|tecovirimat|mesh-list
138892036|NCT06156566|Antiviral Agents|antiviral agents|mesh-ancestor
138892037|NCT06156566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892038|NCT06156527|Bevacizumab|bevacizumab|mesh-list
138892039|NCT06156527|Lazertinib|lazertinib|mesh-list
138892040|NCT06156527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892041|NCT06156527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892042|NCT06156527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138892043|NCT06156527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138892044|NCT06156527|Growth Substances|growth substances|mesh-ancestor
138892045|NCT06156527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892046|NCT06156527|Growth Inhibitors|growth inhibitors|mesh-ancestor
138892047|NCT06156527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138892048|NCT06156527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892049|NCT06156527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892050|NCT06156085|Amoxicillin|amoxicillin|mesh-list
138892051|NCT06156085|Metronidazole|metronidazole|mesh-list
138892052|NCT06156085|Clarithromycin|clarithromycin|mesh-list
138892053|NCT06156085|Lansoprazole|lansoprazole|mesh-list
138892054|NCT06156085|Dexlansoprazole|dexlansoprazole|mesh-list
138892055|NCT06156085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138892056|NCT06156085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892057|NCT06156085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138892058|NCT06156085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138892059|NCT06156085|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138892060|NCT06156085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892061|NCT06156085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892062|NCT06156085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138892063|NCT06156085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138892064|NCT06156085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138892065|NCT06156085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138892066|NCT06156085|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138892068|NCT06156059|Antioxidants|antioxidants|mesh-ancestor
138892069|NCT06156059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892070|NCT06156059|Protective Agents|protective agents|mesh-ancestor
138892071|NCT06156059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892072|NCT06156059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892073|NCT06155981|Cocaine|cocaine|mesh-list
138892074|NCT06155981|Anesthetics, Local|anesthetics, local|mesh-ancestor
138892075|NCT06155981|Anesthetics|anesthetics|mesh-ancestor
138892076|NCT06155981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892077|NCT06155981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892078|NCT06155981|Sensory System Agents|sensory system agents|mesh-ancestor
138892079|NCT06155981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892080|NCT06155981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138892081|NCT06155981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138892082|NCT06155981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138892083|NCT06155981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138892084|NCT06155981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892085|NCT06155981|Dopamine Agents|dopamine agents|mesh-ancestor
138892086|NCT06155981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138892087|NCT06155955|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138892088|NCT06155955|Immunologic Factors|immunologic factors|mesh-ancestor
138892089|NCT06155955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892091|NCT06155916|Analgesics|analgesics|mesh-ancestor
138892092|NCT06155916|Sensory System Agents|sensory system agents|mesh-ancestor
138892093|NCT06155916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892094|NCT06155916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892095|NCT06155916|Anticonvulsants|anticonvulsants|mesh-ancestor
138892096|NCT06155916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138892097|NCT06155916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138892098|NCT06155916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892099|NCT06155916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138892100|NCT06155916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138892101|NCT06155916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138892102|NCT06155916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892104|NCT06155903|Anesthetics|anesthetics|mesh-list
138892105|NCT06155903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892106|NCT06155903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892107|NCT06151171|Coenzyme Q10|coenzyme q10|mesh-list
138892108|NCT06151171|Vitamins|vitamins|mesh-ancestor
138892109|NCT06151171|Micronutrients|micronutrients|mesh-ancestor
138892110|NCT06151171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892111|NCT06139380|Ketamine|ketamine|mesh-list
138892112|NCT06139380|Analgesics|analgesics|mesh-ancestor
138892113|NCT06139380|Sensory System Agents|sensory system agents|mesh-ancestor
138892114|NCT06139380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892115|NCT06139380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892116|NCT06139380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138892117|NCT06139380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138892118|NCT06139380|Anesthetics, General|anesthetics, general|mesh-ancestor
138892119|NCT06139380|Anesthetics|anesthetics|mesh-ancestor
138892120|NCT06139380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892121|NCT06139380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138892122|NCT06139380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138892123|NCT06139380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138892124|NCT06139380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892126|NCT06134375|Capecitabine|capecitabine|mesh-list
138892127|NCT06134375|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138892128|NCT06134375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892129|NCT06134375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892130|NCT06134375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138506013|NCT04733781|Epinephrine|epinephrine|mesh-list
138892131|NCT06134375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892132|NCT06134375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138892133|NCT06134375|Antimetabolites|antimetabolites|mesh-ancestor
138892134|NCT06134375|Chelating Agents|chelating agents|mesh-ancestor
138892135|NCT06134375|Sequestering Agents|sequestering agents|mesh-ancestor
138892136|NCT06134375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892137|NCT06134375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138892138|NCT06134375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138892139|NCT06134375|Growth Substances|growth substances|mesh-ancestor
138892140|NCT06134375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892141|NCT06134375|Growth Inhibitors|growth inhibitors|mesh-ancestor
138892142|NCT06109506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138892143|NCT06109506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892145|NCT06099184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138892146|NCT06099184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138892147|NCT06099184|Growth Substances|growth substances|mesh-ancestor
138892148|NCT06099184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892149|NCT06099184|Growth Inhibitors|growth inhibitors|mesh-ancestor
138892150|NCT06099184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892151|NCT06094660|Phenol|phenol|mesh-list
138892152|NCT06094660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138892153|NCT06094660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892154|NCT06094660|Disinfectants|disinfectants|mesh-ancestor
138892155|NCT06094660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138892156|NCT06094660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138892157|NCT06093945|Omeprazole|omeprazole|mesh-list
138892158|NCT06093945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138892159|NCT06093945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138892160|NCT06093945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138892161|NCT06093945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428023|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
138892162|NCT06093945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892163|NCT06070116|Ivermectin|ivermectin|mesh-list
138892164|NCT06070116|Albendazole|albendazole|mesh-list
138892165|NCT06070116|Moxidectin|moxidectin|mesh-list
138892166|NCT06070116|Diethylcarbamazine|diethylcarbamazine|mesh-list
138892167|NCT06070116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138892168|NCT06070116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892169|NCT06070116|Anthelmintics|anthelmintics|mesh-ancestor
138892170|NCT06070116|Anticestodal Agents|anticestodal agents|mesh-ancestor
138892171|NCT06070116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138892172|NCT06070116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138892173|NCT06070116|Tubulin Modulators|tubulin modulators|mesh-ancestor
138892174|NCT06070116|Antimitotic Agents|antimitotic agents|mesh-ancestor
138892175|NCT06070116|Mitosis Modulators|mitosis modulators|mesh-ancestor
138892176|NCT06070116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892177|NCT06070116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892178|NCT06070116|Antinematodal Agents|antinematodal agents|mesh-ancestor
138892180|NCT06070116|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138892181|NCT06070116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892182|NCT06036511|Ketamine|ketamine|mesh-list
138892183|NCT06036511|Analgesics|analgesics|mesh-ancestor
138892184|NCT06036511|Sensory System Agents|sensory system agents|mesh-ancestor
138892185|NCT06036511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892186|NCT06036511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892187|NCT06036511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138892188|NCT06036511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138892189|NCT06036511|Anesthetics, General|anesthetics, general|mesh-ancestor
138892190|NCT06036511|Anesthetics|anesthetics|mesh-ancestor
138892191|NCT06036511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892192|NCT06036511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138892193|NCT06036511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138892194|NCT06036511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563673|NCT00324025|Efungumab|efungumab|mesh-list
138892195|NCT06036511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892196|NCT06024889|Furosemide|furosemide|mesh-list
138892197|NCT06024889|Diuretics|diuretics|mesh-ancestor
138892198|NCT06024889|Natriuretic Agents|natriuretic agents|mesh-ancestor
138892199|NCT06024889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892200|NCT06024889|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138892201|NCT06024889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138516864|NCT00129948|Troxacitabine|troxacitabine|mesh-list
138892202|NCT06024889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892203|NCT06019728|Acetaminophen|acetaminophen|mesh-list
138892204|NCT06019728|Diphenhydramine|diphenhydramine|mesh-list
138892205|NCT06019728|Promethazine|promethazine|mesh-list
138892206|NCT06019728|Dexamethasone|dexamethasone|mesh-list
138892207|NCT06019728|Montelukast|montelukast|mesh-list
138892208|NCT06019728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138892209|NCT06019728|Antiemetics|antiemetics|mesh-ancestor
138892210|NCT06019728|Autonomic Agents|autonomic agents|mesh-ancestor
138892211|NCT06019728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892212|NCT06019728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892213|NCT06019728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138892214|NCT06019728|Glucocorticoids|glucocorticoids|mesh-ancestor
138892215|NCT06019728|Hormones|hormones|mesh-ancestor
138892216|NCT06019728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138892217|NCT06019728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138892218|NCT06019728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892219|NCT06019728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138892220|NCT06019728|Analgesics|analgesics|mesh-ancestor
138892221|NCT06019728|Sensory System Agents|sensory system agents|mesh-ancestor
138892222|NCT06019728|Antipyretics|antipyretics|mesh-ancestor
138892223|NCT06019728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138892224|NCT06019728|Respiratory System Agents|respiratory system agents|mesh-ancestor
138892225|NCT06019728|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138892226|NCT06019728|Hormone Antagonists|hormone antagonists|mesh-ancestor
138892227|NCT06019728|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138892228|NCT06019728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138892229|NCT06019728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892230|NCT06019728|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138892231|NCT06019728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138892232|NCT06019728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892233|NCT06019728|Anesthetics, Local|anesthetics, local|mesh-ancestor
138892235|NCT06019728|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138892236|NCT06019728|Histamine Antagonists|histamine antagonists|mesh-ancestor
138892237|NCT06019728|Histamine Agents|histamine agents|mesh-ancestor
138892238|NCT06019728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138892239|NCT06019728|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138892240|NCT06019728|Antipruritics|antipruritics|mesh-ancestor
138892241|NCT06019728|Dermatologic Agents|dermatologic agents|mesh-ancestor
138892242|NCT06016634|Alendronate|alendronate|mesh-list
138892243|NCT06016634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138892244|NCT06016634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892245|NCT06005662|Buprenorphine|buprenorphine|mesh-list
138892246|NCT06005662|Psilocybin|psilocybin|mesh-list
138892247|NCT06005662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138892248|NCT06005662|Narcotics|narcotics|mesh-ancestor
138892249|NCT06005662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892250|NCT06005662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892251|NCT06005662|Analgesics|analgesics|mesh-ancestor
138563785|NCT00093288|Bupropion|bupropion|mesh-list
138892252|NCT06005662|Sensory System Agents|sensory system agents|mesh-ancestor
138892253|NCT06005662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892254|NCT06005662|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138892255|NCT06005662|Hallucinogens|hallucinogens|mesh-ancestor
138892256|NCT06005662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138892257|NCT05996471|Cabotegravir|cabotegravir|mesh-list
138892258|NCT05996471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138892259|NCT05996471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138892260|NCT05996471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770232|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138892261|NCT05996471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892262|NCT05996471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138892263|NCT05996471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138892264|NCT05996471|Antiviral Agents|antiviral agents|mesh-ancestor
138892265|NCT05996471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892266|NCT05974345|Ezetimibe|ezetimibe|mesh-list
138892267|NCT05974345|Evolocumab|evolocumab|mesh-list
138892268|NCT05974345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138892269|NCT05974345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138892270|NCT05974345|Antimetabolites|antimetabolites|mesh-ancestor
138892271|NCT05974345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892272|NCT05974345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138892273|NCT05974345|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138892274|NCT05974345|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138892275|NCT05974345|Protease Inhibitors|protease inhibitors|mesh-ancestor
138892276|NCT05974345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892277|NCT05963984|Fulvestrant|fulvestrant|mesh-list
138892278|NCT05963984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138892279|NCT05963984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544323|NCT00084708|Calcitriol|calcitriol|mesh-list
138892280|NCT05963984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138892281|NCT05963984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138892282|NCT05963984|Hormone Antagonists|hormone antagonists|mesh-ancestor
138892283|NCT05963984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138892284|NCT05963984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892285|NCT05952557|Tamoxifen|tamoxifen|mesh-list
138892286|NCT05952557|Letrozole|letrozole|mesh-list
138892287|NCT05952557|Anastrozole|anastrozole|mesh-list
138892288|NCT05952557|Exemestane|exemestane|mesh-list
138892289|NCT05952557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892290|NCT05952557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138892291|NCT05952557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138892292|NCT05952557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892293|NCT05952557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892294|NCT05952557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138892296|NCT05952557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138892297|NCT05952557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892298|NCT05952557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138892299|NCT05952557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138892300|NCT05952557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138892301|NCT05952557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138892302|NCT05952024|Rituximab|rituximab|mesh-list
138892303|NCT05952024|Acalabrutinib|acalabrutinib|mesh-list
138892304|NCT05952024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892305|NCT05952024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892306|NCT05952024|Immunologic Factors|immunologic factors|mesh-ancestor
138892307|NCT05952024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892308|NCT05952024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138892309|NCT05938725|Cyclophosphamide|cyclophosphamide|mesh-list
138892310|NCT05938725|Fludarabine|fludarabine|mesh-list
138892311|NCT05938725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138892312|NCT05938725|Immunologic Factors|immunologic factors|mesh-ancestor
138892313|NCT05938725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892314|NCT05938725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138892315|NCT05938725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138892316|NCT05938725|Alkylating Agents|alkylating agents|mesh-ancestor
138892317|NCT05938725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892318|NCT05938725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428239|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
138892319|NCT05938725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138892320|NCT05930028|Atorvastatin|atorvastatin|mesh-list
138892321|NCT05930028|Ezetimibe|ezetimibe|mesh-list
138892322|NCT05930028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138892323|NCT05930028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138892324|NCT05930028|Antimetabolites|antimetabolites|mesh-ancestor
138892325|NCT05930028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892326|NCT05930028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138892327|NCT05930028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138892328|NCT05930028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892329|NCT05915182|Budesonide|budesonide|mesh-list
138892330|NCT05915182|Glycopyrrolate|glycopyrrolate|mesh-list
138892331|NCT05915182|Bromides|bromides|mesh-list
138892332|NCT05915182|Formoterol Fumarate|formoterol fumarate|mesh-list
138892333|NCT05915182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138892334|NCT05915182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138892335|NCT05915182|Autonomic Agents|autonomic agents|mesh-ancestor
138892336|NCT05915182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892337|NCT05915182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892338|NCT05915182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138892339|NCT05915182|Respiratory System Agents|respiratory system agents|mesh-ancestor
138892340|NCT05915182|Glucocorticoids|glucocorticoids|mesh-ancestor
138892341|NCT05915182|Hormones|hormones|mesh-ancestor
138892342|NCT05915182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138892343|NCT05915182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138892344|NCT05915182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138892345|NCT05915182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138892346|NCT05915182|Adrenergic Agents|adrenergic agents|mesh-ancestor
138892347|NCT05915182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138892348|NCT05915182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892349|NCT05915182|Anticonvulsants|anticonvulsants|mesh-ancestor
138892350|NCT05915182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138892351|NCT05915182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138892352|NCT05915182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138892353|NCT05915182|Cholinergic Agents|cholinergic agents|mesh-ancestor
138892354|NCT05899140|Clindamycin|clindamycin|mesh-list
138892355|NCT05899140|Clindamycin palmitate|clindamycin palmitate|mesh-list
138892356|NCT05899140|Clindamycin phosphate|clindamycin phosphate|mesh-list
138892357|NCT05899140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138892358|NCT05899140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892359|NCT05899140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138892360|NCT05899140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892361|NCT05899140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892362|NCT05893108|Triamcinolone|triamcinolone|mesh-list
138892363|NCT05893108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138892364|NCT05893108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138892365|NCT05893108|Losartan|losartan|mesh-list
138892366|NCT05893108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138892367|NCT05893108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138892368|NCT05893108|Glucocorticoids|glucocorticoids|mesh-ancestor
138892369|NCT05893108|Hormones|hormones|mesh-ancestor
138892370|NCT05893108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138892371|NCT05893108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892372|NCT05893108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138892373|NCT05893108|Immunologic Factors|immunologic factors|mesh-ancestor
138892374|NCT05893108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892375|NCT05893108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892376|NCT05893108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138892377|NCT05893108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138892378|NCT05893108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138892379|NCT05893108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138892381|NCT05878093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138892382|NCT05878093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138892383|NCT05878093|Autonomic Agents|autonomic agents|mesh-ancestor
138892384|NCT05878093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892385|NCT05878093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138517052|NCT00017108|Chlorambucil|chlorambucil|mesh-list
138892386|NCT05878093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138892387|NCT05878093|Respiratory System Agents|respiratory system agents|mesh-ancestor
138892388|NCT05878093|Glucocorticoids|glucocorticoids|mesh-ancestor
138892389|NCT05878093|Hormones|hormones|mesh-ancestor
138892390|NCT05878093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138892391|NCT05874921|Mitomycins|mitomycins|mesh-list
138892392|NCT05874921|Mitomycin|mitomycin|mesh-list
138892393|NCT05874921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138892394|NCT05874921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892395|NCT05874921|Alkylating Agents|alkylating agents|mesh-ancestor
138892396|NCT05874921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892397|NCT05874921|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138892398|NCT05874921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892399|NCT05842330|Methylphenidate|methylphenidate|mesh-list
138892400|NCT05842330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138892401|NCT05842330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506042|NCT00047203|Alvocidib|alvocidib|mesh-list
138892402|NCT05842330|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138892403|NCT05842330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138892404|NCT05842330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138892405|NCT05842330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892406|NCT05842330|Dopamine Agents|dopamine agents|mesh-ancestor
138892407|NCT05842330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138892408|NCT05829655|Suvorexant|suvorexant|mesh-list
138892409|NCT05829655|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138892410|NCT05829655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138892411|NCT05829655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892412|NCT05829655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892413|NCT05829655|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138892414|NCT05829655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138892415|NCT05829655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892417|NCT05794230|Immunologic Factors|immunologic factors|mesh-ancestor
138892418|NCT05794230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892419|NCT05788679|Azacitidine|azacitidine|mesh-list
138517092|NCT00129207|Bortezomib|bortezomib|mesh-list
138892420|NCT05788679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138892421|NCT05788679|Antimetabolites|antimetabolites|mesh-ancestor
138892422|NCT05788679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892423|NCT05788679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892424|NCT05788679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892425|NCT05774639|Omalizumab|omalizumab|mesh-list
138892426|NCT05774639|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138364491|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
138892427|NCT05774639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138892428|NCT05774639|Respiratory System Agents|respiratory system agents|mesh-ancestor
138892429|NCT05702853|Cyclophosphamide|cyclophosphamide|mesh-list
138892430|NCT05702853|Fludarabine|fludarabine|mesh-list
138892431|NCT05702853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138892432|NCT05702853|Immunologic Factors|immunologic factors|mesh-ancestor
138892433|NCT05702853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892434|NCT05702853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138892435|NCT05702853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138892436|NCT05702853|Alkylating Agents|alkylating agents|mesh-ancestor
138892437|NCT05702853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892438|NCT05702853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892439|NCT05702853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138892440|NCT05674526|Cetuximab|cetuximab|mesh-list
138892441|NCT05674526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892442|NCT05674526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892443|NCT05650697|Cannabidiol|cannabidiol|mesh-list
138892444|NCT05650697|Anticonvulsants|anticonvulsants|mesh-ancestor
138892445|NCT05625373|Vancomycin|vancomycin|mesh-list
138892446|NCT05625373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138892447|NCT05625373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892448|NCT05620914|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
138892449|NCT05620914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892450|NCT05620914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892451|NCT05619627|Dexmedetomidine|dexmedetomidine|mesh-list
138892452|NCT05619627|Anesthetics|anesthetics|mesh-list
138892453|NCT05619627|Anesthetics, General|anesthetics, general|mesh-list
138892454|NCT05619627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138892455|NCT05619627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892456|NCT05619627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892457|NCT05619627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138892458|NCT05619627|Analgesics|analgesics|mesh-ancestor
138892459|NCT05619627|Sensory System Agents|sensory system agents|mesh-ancestor
138892460|NCT05619627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138517149|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
138892461|NCT05619627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138892462|NCT05619627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138892463|NCT05619627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138892464|NCT05619627|Adrenergic Agents|adrenergic agents|mesh-ancestor
138892465|NCT05619627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138892466|NCT05619627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892468|NCT05605366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138892469|NCT05605366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892470|NCT05588388|Bevacizumab|bevacizumab|mesh-list
138892471|NCT05588388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892472|NCT05588388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892473|NCT05588388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138892474|NCT05588388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138892475|NCT05588388|Growth Substances|growth substances|mesh-ancestor
138892476|NCT05588388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892477|NCT05588388|Growth Inhibitors|growth inhibitors|mesh-ancestor
138892478|NCT05575167|Vitamin D|vitamin d|mesh-list
138892480|NCT05575167|Zoledronic Acid|zoledronic acid|mesh-list
138892481|NCT05575167|Vitamins|vitamins|mesh-ancestor
138892482|NCT05575167|Micronutrients|micronutrients|mesh-ancestor
138892483|NCT05575167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892484|NCT05575167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138892485|NCT05564637|Treprostinil|treprostinil|mesh-list
138892486|NCT05564637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138892487|NCT05513625|Pritelivir|pritelivir|mesh-list
138892488|NCT05513625|Antiviral Agents|antiviral agents|mesh-ancestor
138892489|NCT05513625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892490|NCT05513625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892491|NCT05513625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892492|NCT05495061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138892493|NCT05495061|Latanoprost|latanoprost|mesh-list
138892494|NCT05495061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138892495|NCT05464810|Letrozole|letrozole|mesh-list
138892496|NCT05464810|Simvastatin|simvastatin|mesh-list
138892497|NCT05464810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138892498|NCT05464810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138892499|NCT05464810|Antimetabolites|antimetabolites|mesh-ancestor
138517168|NCT00128895|Azathioprine|azathioprine|mesh-list
138892500|NCT05464810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892501|NCT05464810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138892502|NCT05464810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138892503|NCT05464810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892504|NCT05464810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544542|NCT00199264|Albaconazole|albaconazole|mesh-list
138892505|NCT05464810|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138892506|NCT05464810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138892507|NCT05464810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138892508|NCT05464810|Hormone Antagonists|hormone antagonists|mesh-ancestor
138892509|NCT05464810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138892510|NCT05464810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892512|NCT05450042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138770233|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
138892513|NCT05450042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892514|NCT05450042|Tubulin Modulators|tubulin modulators|mesh-ancestor
138892515|NCT05450042|Antimitotic Agents|antimitotic agents|mesh-ancestor
138892516|NCT05450042|Mitosis Modulators|mitosis modulators|mesh-ancestor
138892517|NCT05450042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892518|NCT05445856|Fentanyl|fentanyl|mesh-list
138892519|NCT05445856|Methadone|methadone|mesh-list
138892520|NCT05445856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138892521|NCT05445856|Narcotics|narcotics|mesh-ancestor
138892522|NCT05445856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892523|NCT05445856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892524|NCT05445856|Analgesics|analgesics|mesh-ancestor
138892525|NCT05445856|Sensory System Agents|sensory system agents|mesh-ancestor
138892526|NCT05445856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892527|NCT05445856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138892528|NCT05445856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138892529|NCT05445856|Anesthetics, General|anesthetics, general|mesh-ancestor
138892530|NCT05445856|Anesthetics|anesthetics|mesh-ancestor
138892531|NCT05445856|Antitussive Agents|antitussive agents|mesh-ancestor
138892532|NCT05445856|Respiratory System Agents|respiratory system agents|mesh-ancestor
138892533|NCT05379686|Glucagon|glucagon|mesh-list
138564163|NCT00085163|Antidotes|antidotes|mesh-ancestor
138892534|NCT05379686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138892535|NCT05379686|Hormones|hormones|mesh-ancestor
138892536|NCT05379686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138892537|NCT05379686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892538|NCT05361486|Primaquine|primaquine|mesh-list
138892539|NCT05361486|Tafenoquine|tafenoquine|mesh-list
138892540|NCT05361486|Antimalarials|antimalarials|mesh-ancestor
138892541|NCT05361486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138892542|NCT05361486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138892543|NCT05361486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892544|NCT05304767|Xanomeline|xanomeline|mesh-list
138892545|NCT05304767|Trospium chloride|trospium chloride|mesh-list
138892546|NCT05304767|Parasympatholytics|parasympatholytics|mesh-ancestor
138892547|NCT05304767|Autonomic Agents|autonomic agents|mesh-ancestor
138892548|NCT05304767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892549|NCT05304767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892550|NCT05304767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138892551|NCT05304767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138892552|NCT05304767|Cholinergic Agents|cholinergic agents|mesh-ancestor
138892553|NCT05304767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138892554|NCT05304767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892555|NCT05304767|Urological Agents|urological agents|mesh-ancestor
138892556|NCT05304767|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138892557|NCT05304767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138892558|NCT05304767|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138428606|NCT01711905|Vitamin D|vitamin d|mesh-list
138892560|NCT05292664|Leucovorin|leucovorin|mesh-list
138892561|NCT05292664|Cytarabine|cytarabine|mesh-list
138892562|NCT05292664|Dexamethasone|dexamethasone|mesh-list
138892563|NCT05292664|Dexamethasone acetate|dexamethasone acetate|mesh-list
138892564|NCT05292664|Hydrocortisone|hydrocortisone|mesh-list
138892565|NCT05292664|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138892566|NCT05292664|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138892567|NCT05292664|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138892568|NCT05292664|Cortisone|cortisone|mesh-list
138892570|NCT05292664|Methotrexate|methotrexate|mesh-list
138892571|NCT05292664|Vincristine|vincristine|mesh-list
138892572|NCT05292664|Azacitidine|azacitidine|mesh-list
138892573|NCT05292664|Venetoclax|venetoclax|mesh-list
138892574|NCT05292664|Asparaginase|asparaginase|mesh-list
138892575|NCT05292664|Dexrazoxane|dexrazoxane|mesh-list
138892576|NCT05292664|Razoxane|razoxane|mesh-list
138892577|NCT05292664|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138892578|NCT05292664|BB 1101|bb 1101|mesh-list
138892579|NCT05292664|Levoleucovorin|levoleucovorin|mesh-list
138892580|NCT05292664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138892581|NCT05292664|Antiemetics|antiemetics|mesh-ancestor
138892582|NCT05292664|Autonomic Agents|autonomic agents|mesh-ancestor
138892583|NCT05292664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892584|NCT05292664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892586|NCT05292664|Glucocorticoids|glucocorticoids|mesh-ancestor
138892587|NCT05292664|Hormones|hormones|mesh-ancestor
138892588|NCT05292664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138892589|NCT05292664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138892590|NCT05292664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892591|NCT05292664|Protease Inhibitors|protease inhibitors|mesh-ancestor
138892592|NCT05292664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892593|NCT05292664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892594|NCT05292664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138892595|NCT05292664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138892596|NCT05292664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138892597|NCT05292664|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138892598|NCT05292664|Abortifacient Agents|abortifacient agents|mesh-ancestor
138892599|NCT05292664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138892600|NCT05292664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138892602|NCT05292664|Dermatologic Agents|dermatologic agents|mesh-ancestor
138892603|NCT05292664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138892604|NCT05292664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138892605|NCT05292664|Immunologic Factors|immunologic factors|mesh-ancestor
138892606|NCT05292664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138564244|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138892607|NCT05292664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138892608|NCT05292664|Antiviral Agents|antiviral agents|mesh-ancestor
138892609|NCT05292664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892610|NCT05292664|Antidotes|antidotes|mesh-ancestor
138892611|NCT05292664|Protective Agents|protective agents|mesh-ancestor
138892612|NCT05292664|Vitamin B Complex|vitamin b complex|mesh-ancestor
138892613|NCT05292664|Vitamins|vitamins|mesh-ancestor
138892614|NCT05292664|Micronutrients|micronutrients|mesh-ancestor
138892615|NCT05292664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138892616|NCT05292664|Tubulin Modulators|tubulin modulators|mesh-ancestor
138892617|NCT05292664|Antimitotic Agents|antimitotic agents|mesh-ancestor
138892618|NCT05292664|Mitosis Modulators|mitosis modulators|mesh-ancestor
138892619|NCT05292664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138892620|NCT05257590|Nivolumab|nivolumab|mesh-list
138892621|NCT05257590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892622|NCT05257590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892623|NCT05257590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138892624|NCT05257590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892625|NCT05244057|Interferons|interferons|mesh-list
138892626|NCT05244057|Tenofovir|tenofovir|mesh-list
138892627|NCT05244057|Interferon-alpha|interferon-alpha|mesh-list
138892628|NCT05244057|Interferon alpha-2|interferon alpha-2|mesh-list
138892629|NCT05244057|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138892630|NCT05244057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892631|NCT05244057|Antiviral Agents|antiviral agents|mesh-ancestor
138892632|NCT05244057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892633|NCT05244057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138892634|NCT05244057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138892635|NCT05244057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892636|NCT05244057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892637|NCT05244057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138892638|NCT05244057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138892639|NCT05244057|Immunologic Factors|immunologic factors|mesh-ancestor
138892640|NCT05244057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892641|NCT05239533|Nivolumab|nivolumab|mesh-list
138892642|NCT05239533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138517315|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
138892643|NCT05239533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892644|NCT05239533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892645|NCT05239533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138892646|NCT05239533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892647|NCT05239533|Immunologic Factors|immunologic factors|mesh-ancestor
138892648|NCT05239533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892649|NCT05229003|Irinotecan|irinotecan|mesh-list
138892650|NCT05229003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138892651|NCT05229003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138892652|NCT05229003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564283|NCT00085358|Paclitaxel|paclitaxel|mesh-list
138892653|NCT05229003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892654|NCT05229003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892656|NCT05220462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138892657|NCT05220462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138892658|NCT05220462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892659|NCT05220462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892660|NCT05220462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138892661|NCT05220462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138892662|NCT05220462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138892663|NCT05220462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138892664|NCT05220462|Anesthetics, General|anesthetics, general|mesh-ancestor
138892665|NCT05220462|Anesthetics|anesthetics|mesh-ancestor
138892666|NCT05220462|GABA Modulators|gaba modulators|mesh-ancestor
138892667|NCT05220462|GABA Agents|gaba agents|mesh-ancestor
138892668|NCT05220462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138892669|NCT05220462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892670|NCT05205603|Infliximab|infliximab|mesh-list
138892671|NCT05205603|Mesalamine|mesalamine|mesh-list
138892672|NCT05205603|Vedolizumab|vedolizumab|mesh-list
138892673|NCT05205603|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138892674|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138892675|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
138892676|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138892677|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138892678|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138892679|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138892680|NCT05205603|Analgesics|analgesics|mesh-ancestor
138892681|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
138892682|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428700|NCT01712464|Oxytocin|oxytocin|mesh-list
138892683|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892684|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
138892685|NCT05181527|Serotonin|serotonin|mesh-list
138892686|NCT05181527|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138892687|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
138892688|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
138892689|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138892690|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138892691|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138892692|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892693|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892694|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138892695|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
138892696|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138892697|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138892698|NCT05171777|Atezolizumab|atezolizumab|mesh-list
138892699|NCT05171777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138892700|NCT05171777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445562|NCT01830153|Everolimus|everolimus|mesh-list
138892701|NCT05171777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892702|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892704|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138892705|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
138892706|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892707|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138892708|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892709|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892710|NCT05093790|Aspirin|aspirin|mesh-list
138892711|NCT05093790|Ticagrelor|ticagrelor|mesh-list
138892712|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138892713|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138892714|NCT05093790|Analgesics|analgesics|mesh-ancestor
138892715|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
138892716|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892717|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892718|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138892719|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138892720|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138892721|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138892722|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892723|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138892724|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138892725|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892726|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
138892727|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138892728|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138892729|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138892730|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
138892731|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544769|NCT00201331|Leucovorin|leucovorin|mesh-list
138892733|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138892735|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138892736|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892737|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138892738|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138892739|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138564465|NCT00320359|Cisplatin|cisplatin|mesh-list
138892740|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138892741|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
138892742|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138892743|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892744|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892745|NCT05018221|Vitamins|vitamins|mesh-list
138892746|NCT05018221|Vitamin K|vitamin k|mesh-list
138892747|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
138892748|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
138892749|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
138892750|NCT05018221|Citric Acid|citric acid|mesh-list
138892751|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
138892752|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
138892753|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892754|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
138892755|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138892756|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
138892757|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
138506068|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
138892758|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892759|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138892760|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138892761|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
138892762|NCT05018221|Coagulants|coagulants|mesh-ancestor
138892763|NCT05018221|Antidotes|antidotes|mesh-ancestor
138892764|NCT05018221|Protective Agents|protective agents|mesh-ancestor
138892765|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
138892766|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
138892767|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138892768|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892769|NCT05018221|Cathartics|cathartics|mesh-ancestor
138892770|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138892771|NCT04984837|Gemcitabine|gemcitabine|mesh-list
138892772|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
138892773|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138892774|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
138892775|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892776|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892777|NCT04983095|Hormones|hormones|mesh-list
138892778|NCT04983095|Androgens|androgens|mesh-list
138892779|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
138892780|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138892781|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892782|NCT04952753|Leucovorin|leucovorin|mesh-list
138892783|NCT04952753|Bevacizumab|bevacizumab|mesh-list
138892784|NCT04952753|Tislelizumab|tislelizumab|mesh-list
138892786|NCT04952753|Irinotecan|irinotecan|mesh-list
138892787|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
138892788|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892789|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892790|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138892791|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138892792|NCT04952753|Growth Substances|growth substances|mesh-ancestor
138892793|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892794|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
138892795|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138892796|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138892797|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892798|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892799|NCT04952753|Antidotes|antidotes|mesh-ancestor
138892800|NCT04952753|Protective Agents|protective agents|mesh-ancestor
138892801|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
138892802|NCT04952753|Vitamins|vitamins|mesh-ancestor
138892803|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
138892804|NCT04940052|Trametinib|trametinib|mesh-list
138892805|NCT04940052|Dabrafenib|dabrafenib|mesh-list
138544840|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
138892806|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892807|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138892808|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892809|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892811|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
138892812|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892813|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138892814|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138892815|NCT04920539|Analgesics|analgesics|mesh-ancestor
138892816|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
138892817|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892818|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138892819|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138892820|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138892821|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892822|NCT04920539|Hormones|hormones|mesh-ancestor
138892823|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138892824|NCT04915612|Cytarabine|cytarabine|mesh-list
138892825|NCT04915612|Daunorubicin|daunorubicin|mesh-list
138892826|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
138892827|NCT04915612|Calicheamicins|calicheamicins|mesh-list
138892828|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138892829|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
138892830|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892831|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892832|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
138892833|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892834|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138892835|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
138892836|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892837|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138892838|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138892839|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138892840|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564595|NCT00086177|Progesterone|progesterone|mesh-list
138892841|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892843|NCT04915612|Immunoconjugates|immunoconjugates|mesh-ancestor
138892844|NCT04894994|Ipilimumab|ipilimumab|mesh-list
138892845|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892846|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892847|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138892848|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892849|NCT04891770|Tenofovir|tenofovir|mesh-list
138892850|NCT04891770|Nivolumab|nivolumab|mesh-list
138564653|NCT00086333|Docetaxel|docetaxel|mesh-list
138892851|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892852|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892853|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138892854|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892855|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
138892856|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892857|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138892858|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138892859|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892860|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138892861|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138892862|NCT04836910|Metformin|metformin|mesh-list
138892863|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
138892864|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
138892865|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138892866|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138892867|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892868|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138892869|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138892870|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
138892871|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138892872|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892873|NCT04785820|Nivolumab|nivolumab|mesh-list
138892874|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138564780|NCT05457751|Rocuronium|rocuronium|mesh-list
138892875|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892876|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138892877|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892878|NCT04776252|Islatravir|islatravir|mesh-list
138892879|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
138892880|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544924|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
138892881|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892882|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892883|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138892884|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138892886|NCT04774419|Dostarlimab|dostarlimab|mesh-list
138892887|NCT04774419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892888|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
138892889|NCT04773392|Prednisone|prednisone|mesh-list
138892890|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
138892891|NCT04773392|Azathioprine|azathioprine|mesh-list
138892892|NCT04773392|Tacrolimus|tacrolimus|mesh-list
138892893|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
138892894|NCT04773392|Basiliximab|basiliximab|mesh-list
138892895|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138892896|NCT04773392|Antimetabolites|antimetabolites|mesh-list
138892897|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138892898|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
138892899|NCT04773392|Hormones|hormones|mesh-ancestor
138892900|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138892901|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892902|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138892903|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892904|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138892905|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
138892906|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138892907|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892908|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892909|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138892910|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138892911|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
138892912|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138892913|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138892914|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
138892915|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
138892916|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892917|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138892918|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138892919|NCT04773392|Protective Agents|protective agents|mesh-ancestor
138892920|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138429052|NCT01714193|Canagliflozin|canagliflozin|mesh-list
138892922|NCT04726085|Ibuprofen|ibuprofen|mesh-list
138892923|NCT04726085|Indomethacin|indomethacin|mesh-list
138892924|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138892925|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138892926|NCT04726085|Analgesics|analgesics|mesh-ancestor
138892927|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
138892928|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892929|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892930|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138892931|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138892932|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138892933|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892934|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892935|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
138892936|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
138892937|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138892938|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
138892939|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892940|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892941|NCT04713514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138892942|NCT04713514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892943|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
138892944|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892945|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892946|NCT04680910|Propofol|propofol|mesh-list
138892947|NCT04680910|Anesthetics|anesthetics|mesh-list
138892948|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138892949|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138892950|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892951|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138892952|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
138892954|NCT04622007|Pemetrexed|pemetrexed|mesh-list
138892955|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892956|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892957|NCT04622007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138892958|NCT04622007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892959|NCT04622007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138892960|NCT04622007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138770234|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
138892961|NCT04622007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138892962|NCT04620759|Psilocybin|psilocybin|mesh-list
138892963|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138892964|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
138892965|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892966|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138892967|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138892968|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
138892969|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138517620|NCT00019773|Capecitabine|capecitabine|mesh-list
138892970|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892971|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138892972|NCT04613492|Durvalumab|durvalumab|mesh-list
138892973|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138892974|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138892975|NCT04547153|Docetaxel|docetaxel|mesh-list
138892976|NCT04547153|Fluorouracil|fluorouracil|mesh-list
138892977|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138360313|NCT00381654|MP 412|mp 412|mesh-list
138892978|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
138892979|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
138892980|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
138892981|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892982|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
138892983|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138892984|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138892985|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
138892986|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138892987|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138892988|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
138892989|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
138892990|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138892991|NCT04537026|Dexamethasone|dexamethasone|mesh-list
138892992|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
138892993|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138892994|NCT04537026|BB 1101|bb 1101|mesh-list
138892995|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138892996|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
138892997|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
138892998|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138892999|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893000|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138893001|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
138893002|NCT04537026|Hormones|hormones|mesh-ancestor
138893003|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138893004|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138893005|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893006|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
138893007|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893008|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893009|NCT04526730|Nivolumab|nivolumab|mesh-list
138893010|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893011|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893012|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893013|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893014|NCT04524000|Fulvestrant|fulvestrant|mesh-list
138893015|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138893016|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893017|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138893018|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138893019|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
138893020|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138893021|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893022|NCT04512235|Dexamethasone|dexamethasone|mesh-list
138893023|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
138893024|NCT04512235|Bortezomib|bortezomib|mesh-list
138893025|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138893026|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
138893027|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893028|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138893029|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138893030|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
138545062|NCT00222976|Naproxen|naproxen|mesh-list
138893031|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893032|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893033|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138893034|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138893036|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
138893037|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893038|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138893039|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
138893040|NCT04512235|Hormones|hormones|mesh-ancestor
138893041|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138893042|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138893043|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
138893044|NCT04509115|Narcotics|narcotics|mesh-ancestor
138893045|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138893046|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893047|NCT04509115|Analgesics|analgesics|mesh-ancestor
138893048|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
138893049|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893050|NCT04503668|Dexamethasone|dexamethasone|mesh-list
138893051|NCT04503668|Ondansetron|ondansetron|mesh-list
138893052|NCT04503668|Olanzapine|olanzapine|mesh-list
138893053|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
138893054|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
138893055|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
138893056|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138893057|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
138893058|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
138893059|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893060|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893061|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138893062|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
138893063|NCT04503668|Hormones|hormones|mesh-ancestor
138893064|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138517737|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138893065|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138893066|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893067|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
138893068|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
138893069|NCT04503668|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138893070|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138893071|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
138893072|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138893073|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893074|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138893075|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138893076|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138893077|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138893078|NCT04503668|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138893079|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138565103|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138893080|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138893081|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138893083|NCT04469075|Clindamycin|clindamycin|mesh-list
138893084|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
138893085|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
138893086|NCT04469075|Triamcinolone|triamcinolone|mesh-list
138893087|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138893088|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138893089|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138893090|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138893091|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
138893093|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138893094|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893095|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138893096|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
138893097|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893098|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893099|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138893100|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893101|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138893102|NCT04463615|Leflunomide|leflunomide|mesh-list
138893103|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893104|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893105|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138893106|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
138893107|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893108|NCT04449549|Paclitaxel|paclitaxel|mesh-list
138429312|NCT01715584|Analgesics|analgesics|mesh-ancestor
138893109|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138893110|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893111|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
138893112|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
138893113|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
138893114|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893115|NCT04444492|Ranibizumab|ranibizumab|mesh-list
138893116|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138893117|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138893118|NCT04444492|Growth Substances|growth substances|mesh-ancestor
138893119|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893120|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
138893121|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893122|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
138893123|NCT04393350|Lenvatinib|lenvatinib|mesh-list
138893124|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893125|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893126|NCT04393350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893127|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893128|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138893129|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893130|NCT04361058|Nivolumab|nivolumab|mesh-list
138893131|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893132|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893133|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138565187|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893134|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893135|NCT04341155|Dexamethasone|dexamethasone|mesh-list
138893136|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
138893137|NCT04341155|BB 1101|bb 1101|mesh-list
138893138|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138893139|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
138893140|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
138893141|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893142|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893143|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138893144|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
138893145|NCT04341155|Hormones|hormones|mesh-ancestor
138893146|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138893147|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138893148|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893149|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
138893150|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893151|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893152|NCT04339036|Capecitabine|capecitabine|mesh-list
138893153|NCT04339036|Temozolomide|temozolomide|mesh-list
138893154|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893155|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
138893156|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893157|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893158|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138893159|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
138893160|NCT04332068|Ivermectin|ivermectin|mesh-list
138893161|NCT04332068|Permethrin|permethrin|mesh-list
138893162|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138893163|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893164|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893165|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893166|NCT04315558|Bromides|bromides|mesh-list
138893167|NCT04315558|Ipratropium|ipratropium|mesh-list
138893168|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
138893169|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138893170|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
138893171|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893172|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893173|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138893174|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
138893175|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138893176|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
138545217|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138893177|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138893178|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893180|NCT04292873|Vitamins|vitamins|mesh-ancestor
138893181|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
138893182|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893183|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138565286|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
138893185|NCT04269200|Carboplatin|carboplatin|mesh-list
138893186|NCT04269200|Durvalumab|durvalumab|mesh-list
138893187|NCT04269200|Olaparib|olaparib|mesh-list
138893188|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138893189|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138893190|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893191|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
138893192|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
138893193|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
138893194|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893195|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138194308|NCT04281420|Niacin|niacin|mesh-list
138893196|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
138893197|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893198|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138893199|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893200|NCT04262154|Prednisone|prednisone|mesh-list
138893201|NCT04262154|Atezolizumab|atezolizumab|mesh-list
138893202|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565348|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
138893203|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
138893204|NCT04262154|Hormones|hormones|mesh-ancestor
138893205|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138893206|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893207|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138893208|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893209|NCT04262154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893210|NCT04262154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893211|NCT04262154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893212|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
138893213|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893214|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893215|NCT04262089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893216|NCT04262089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893217|NCT04251533|Paclitaxel|paclitaxel|mesh-list
138893218|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138893219|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893220|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
138893221|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
138893222|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
138893223|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893224|NCT04225598|Buprenorphine|buprenorphine|mesh-list
138893225|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138893226|NCT04225598|Narcotics|narcotics|mesh-ancestor
138893227|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138893228|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893229|NCT04225598|Analgesics|analgesics|mesh-ancestor
138893230|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
138429419|NCT01716442|Rituximab|rituximab|mesh-list
138893231|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893232|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138893233|NCT04217694|Memantine|memantine|mesh-list
138893234|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138893235|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138893236|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
138893237|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138893238|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893239|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893240|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138893241|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138893242|NCT04216524|Cytarabine|cytarabine|mesh-list
138893243|NCT04216524|Dexamethasone|dexamethasone|mesh-list
138893244|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
138893245|NCT04216524|Prednisone|prednisone|mesh-list
138893246|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
138893247|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138893248|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138893249|NCT04216524|Prednisolone|prednisolone|mesh-list
138893250|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
138893251|NCT04216524|Cortisone|cortisone|mesh-list
138893252|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
138893253|NCT04216524|Rituximab|rituximab|mesh-list
138545288|NCT00085527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893254|NCT04216524|Doxorubicin|doxorubicin|mesh-list
138893255|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138893256|NCT04216524|Methotrexate|methotrexate|mesh-list
138893257|NCT04216524|Vincristine|vincristine|mesh-list
138893258|NCT04216524|Daunorubicin|daunorubicin|mesh-list
138893259|NCT04216524|Venetoclax|venetoclax|mesh-list
138893260|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
138893261|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138893262|NCT04216524|Antibodies|antibodies|mesh-list
138893263|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
138893264|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138893265|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138893266|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
138893267|NCT04216524|BB 1101|bb 1101|mesh-list
138893268|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138893269|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
138893270|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893271|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138893272|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138893273|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
138893274|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893275|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893276|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138893277|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138893278|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
138893279|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
138893280|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893281|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138893282|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
138893283|NCT04216524|Hormones|hormones|mesh-ancestor
138893284|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138893285|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138893286|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
138893287|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893288|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138893289|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138893290|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138893291|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138893292|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
138893293|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138893294|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893295|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
138893296|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
138893297|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138893298|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138893299|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
138893300|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893301|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138893302|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
138893303|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
138893304|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
138893305|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138893306|NCT04216524|Protective Agents|protective agents|mesh-ancestor
138893307|NCT04214626|Prednisone|prednisone|mesh-list
138893308|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
138893309|NCT04214626|Rituximab|rituximab|mesh-list
138893310|NCT04214626|Methotrexate|methotrexate|mesh-list
138893311|NCT04214626|Vincristine|vincristine|mesh-list
138893312|NCT04214626|Lenalidomide|lenalidomide|mesh-list
138893313|NCT04214626|Epirubicin|epirubicin|mesh-list
138893314|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138893315|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
138893316|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893317|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138893318|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138893319|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
138893320|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893321|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893322|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138893323|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893324|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138893325|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
138893326|NCT04214626|Hormones|hormones|mesh-ancestor
138893327|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138893328|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138893329|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138893330|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
138893331|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138893332|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893333|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
138893334|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
138565571|NCT05831267|Hemostatics|hemostatics|mesh-ancestor
138893335|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893336|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138893337|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138893338|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138893339|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
138893340|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
138893341|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
138893342|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138893343|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138893344|NCT04214626|Growth Substances|growth substances|mesh-ancestor
138893345|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
138893346|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138893347|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138893348|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138893349|NCT04196868|Metformin|metformin|mesh-list
138893350|NCT04196868|Methotrexate|methotrexate|mesh-list
138517976|NCT00021528|Buspirone|buspirone|mesh-list
138893351|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138893352|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893353|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138893354|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
138893355|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138893356|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893357|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
138893358|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893359|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893360|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
138893361|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893362|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138893363|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138893364|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
138893365|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138893366|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138893368|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
138893369|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893370|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
138893371|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893372|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893373|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138893374|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
138893375|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893376|NCT04140162|Dexamethasone|dexamethasone|mesh-list
138893377|NCT04140162|Lenalidomide|lenalidomide|mesh-list
138893378|NCT04140162|Bortezomib|bortezomib|mesh-list
138893379|NCT04140162|Daratumumab|daratumumab|mesh-list
138893380|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138893381|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
138893382|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
138893383|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893384|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893385|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138893386|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
138893387|NCT04140162|Hormones|hormones|mesh-ancestor
138893388|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138893389|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138893390|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893391|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
138893392|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138893393|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138893394|NCT04140162|Growth Substances|growth substances|mesh-ancestor
138893395|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
138893397|NCT04038346|Naproxen|naproxen|mesh-list
138893398|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138893399|NCT04038346|Analgesics|analgesics|mesh-ancestor
138893400|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
138893401|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893402|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893403|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
138893404|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138893405|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138893406|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138893407|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
138893408|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138893410|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893411|NCT04037176|Omalizumab|omalizumab|mesh-list
138893412|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138893413|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138893414|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
138893415|NCT04036305|Lidocaine|lidocaine|mesh-list
138893416|NCT04036305|Bupivacaine|bupivacaine|mesh-list
138893417|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
138565744|NCT05167734|Dextrans|dextrans|mesh-list
138893418|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
138893419|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138893420|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893421|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
138893422|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893423|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138893424|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138893425|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138893426|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138893427|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893428|NCT03980509|Curcumin|curcumin|mesh-list
138518049|NCT00022152|Vinorelbine|vinorelbine|mesh-list
138893429|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138893430|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138893431|NCT03980509|Analgesics|analgesics|mesh-ancestor
138893432|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
138893433|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893434|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893435|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138893436|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138893437|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893438|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429653|NCT01717963|Naloxone|naloxone|mesh-list
138893439|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893440|NCT03967977|Carboplatin|carboplatin|mesh-list
138893441|NCT03967977|Gemcitabine|gemcitabine|mesh-list
138893442|NCT03967977|Tislelizumab|tislelizumab|mesh-list
138893443|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893444|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893445|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
138893446|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893447|NCT03967977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893448|NCT03896269|Cytarabine|cytarabine|mesh-list
138893449|NCT03896269|Daunorubicin|daunorubicin|mesh-list
138893450|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893451|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
138893452|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893453|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893454|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
138893455|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893456|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138893457|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
138893458|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893459|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138893460|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138893461|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138893462|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893463|NCT03865940|Lidocaine|lidocaine|mesh-list
138893464|NCT03865940|Guanfacine|guanfacine|mesh-list
138518085|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138429701|NCT01718288|Aspirin|aspirin|mesh-list
138893465|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
138893466|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
138893467|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138893468|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893469|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
138893470|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893471|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138893472|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138893473|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138893474|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138893475|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893476|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138893477|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138893478|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138893479|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138893480|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
138893481|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138893482|NCT03820193|Acetaminophen|acetaminophen|mesh-list
138893483|NCT03820193|Celecoxib|celecoxib|mesh-list
138893484|NCT03820193|Ketorolac|ketorolac|mesh-list
138565877|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
138893485|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138893486|NCT03820193|Diazepam|diazepam|mesh-list
138893487|NCT03820193|Gabapentin|gabapentin|mesh-list
138893489|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138893490|NCT03820193|Analgesics|analgesics|mesh-ancestor
138893491|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
138893492|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893493|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893494|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
138893495|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138893496|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138893497|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138893498|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138893499|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138893500|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893501|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893502|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
138893503|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138893504|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138893505|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138893506|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138893507|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138893508|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138893509|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138893510|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
138893511|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138893513|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
138893514|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
138429796|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138893515|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138893516|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
138893517|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
138893518|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138893519|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138893520|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138893521|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138893522|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138893523|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
138893524|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
138893525|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
138893526|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
138893527|NCT03800693|Leucovorin|leucovorin|mesh-list
138893528|NCT03800693|Fluorouracil|fluorouracil|mesh-list
138893529|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
138566008|NCT03498261|Gabapentin|gabapentin|mesh-list
138893530|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
138518167|NCT00022737|Pegaspargase|pegaspargase|mesh-list
138893531|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893532|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893533|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893534|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138893535|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
138893536|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893537|NCT03800693|Antidotes|antidotes|mesh-ancestor
138893538|NCT03800693|Protective Agents|protective agents|mesh-ancestor
138893539|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
138893540|NCT03800693|Vitamins|vitamins|mesh-ancestor
138893541|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
138893542|NCT03778931|Fulvestrant|fulvestrant|mesh-list
138566035|NCT03191864|Xhance|xhance|mesh-list
138893543|NCT03778931|Anastrozole|anastrozole|mesh-list
138893544|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138893545|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893546|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138893547|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138893548|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
138770235|NCT02658721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138893549|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138893550|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893551|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138893552|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138893553|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893554|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893555|NCT03763643|Rituximab|rituximab|mesh-list
138893556|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893557|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893558|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
138893559|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893561|NCT03753204|Furosemide|furosemide|mesh-list
138893562|NCT03753204|Diuretics|diuretics|mesh-ancestor
138893563|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
138893564|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566107|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
138893565|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138893566|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138893567|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893568|NCT03751709|Blinatumomab|blinatumomab|mesh-list
138893569|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893570|NCT03735979|Argatroban|argatroban|mesh-list
138893571|NCT03735979|Eptifibatide|eptifibatide|mesh-list
138893572|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
138893573|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138893574|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
138893575|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893576|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893577|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
138893578|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138893579|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
138893580|NCT03732352|Osimertinib|osimertinib|mesh-list
138893581|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138893582|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138893583|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893584|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893585|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138893586|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893587|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
138893588|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
138893589|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893590|NCT03706690|Durvalumab|durvalumab|mesh-list
138893591|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893592|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893593|NCT03676764|Azithromycin|azithromycin|mesh-list
138893594|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138893595|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893596|NCT03672539|Cytarabine|cytarabine|mesh-list
138893597|NCT03672539|Daunorubicin|daunorubicin|mesh-list
138893598|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
138893599|NCT03672539|Calicheamicins|calicheamicins|mesh-list
138893600|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893601|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
138893602|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893603|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893604|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
138893605|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893606|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138893607|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
138893608|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893609|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138893610|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138893611|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138893612|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893613|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893614|NCT03672539|Immunotoxins|immunotoxins|mesh-ancestor
138893615|NCT03672539|Immunoconjugates|immunoconjugates|mesh-ancestor
138893617|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893618|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893619|NCT03650387|Lidocaine|lidocaine|mesh-list
138893620|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
138893621|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
138893622|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138893623|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893624|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
138893625|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893626|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138893627|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138893628|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138893629|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138893630|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893631|NCT03638141|Durvalumab|durvalumab|mesh-list
138893632|NCT03638141|Ipilimumab|ipilimumab|mesh-list
138893633|NCT03638141|Tremelimumab|tremelimumab|mesh-list
138893634|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138893635|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893636|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893637|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
138893638|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893639|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893640|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893641|NCT03629171|Cytarabine|cytarabine|mesh-list
138893642|NCT03629171|Daunorubicin|daunorubicin|mesh-list
138893643|NCT03629171|Venetoclax|venetoclax|mesh-list
138893644|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893645|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
138893646|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893647|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893648|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
138893649|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893650|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138893651|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
138893652|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893653|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138893655|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138893656|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893657|NCT03618758|Paclitaxel|paclitaxel|mesh-list
138893658|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138893659|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893660|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
138893661|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
138893662|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
138893663|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893664|NCT03618550|Gemcitabine|gemcitabine|mesh-list
138893665|NCT03618550|Doxorubicin|doxorubicin|mesh-list
138893666|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138566390|NCT05921968|Iron|iron|mesh-list
138893667|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
138893668|NCT03618550|Vinorelbine|vinorelbine|mesh-list
138893669|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893670|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
138893671|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893672|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893673|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138893674|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138893675|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138518341|NCT00023283|Buprenorphine|buprenorphine|mesh-list
138893676|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893677|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893678|NCT03618550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893679|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138893680|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
138893681|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
138893682|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
138893683|NCT03611738|Docetaxel|docetaxel|mesh-list
138893684|NCT03611738|Ceritinib|ceritinib|mesh-list
138893685|NCT03611738|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138893686|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893687|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
138893688|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
138893689|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
138893690|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566424|NCT05846750|Growth Substances|growth substances|mesh-ancestor
138893691|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138893692|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893694|NCT03595917|Dasatinib|dasatinib|mesh-list
138893695|NCT03595917|Blinatumomab|blinatumomab|mesh-list
138893696|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138893697|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
138893698|NCT03595917|Hormones|hormones|mesh-ancestor
138893699|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138893700|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893701|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138893702|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893703|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138893704|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893705|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893706|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
138893707|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893708|NCT03524235|Rituximab|rituximab|mesh-list
138893709|NCT03524235|Fludarabine|fludarabine|mesh-list
138893710|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138893711|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893712|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893713|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
138893714|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893715|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138893716|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893717|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138893718|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
138518368|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
138893720|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138893721|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893722|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893723|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893724|NCT03461445|Tacrolimus|tacrolimus|mesh-list
138893725|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138893726|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
138893727|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893728|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138893729|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893730|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893731|NCT03439046|Letrozole|letrozole|mesh-list
138893732|NCT03439046|Fulvestrant|fulvestrant|mesh-list
138893733|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893734|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138893735|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138893736|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893737|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893738|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138893739|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
138893740|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566529|NCT05614089|Insulin|insulin|mesh-list
138893741|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893742|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138893743|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138893745|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893746|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893747|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893748|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893749|NCT03386578|Tenofovir|tenofovir|mesh-list
138893750|NCT03386578|Emtricitabine|emtricitabine|mesh-list
138893751|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138893752|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
138893753|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893754|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138893755|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138893756|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893757|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893758|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138893759|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138893760|NCT03334617|Trastuzumab|trastuzumab|mesh-list
138893761|NCT03334617|Durvalumab|durvalumab|mesh-list
138893762|NCT03334617|Olaparib|olaparib|mesh-list
138893763|NCT03334617|Cediranib|cediranib|mesh-list
138893764|NCT03334617|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138893765|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893766|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893767|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138893768|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893769|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566575|NCT05381948|Aflibercept|aflibercept|mesh-list
138893770|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138893771|NCT03334617|Immunoconjugates|immunoconjugates|mesh-ancestor
138893772|NCT03334617|Immunologic Factors|immunologic factors|mesh-ancestor
138893773|NCT03334617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893774|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
138893775|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138893776|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138893777|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138893778|NCT03298802|Diuretics|diuretics|mesh-ancestor
138893779|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
138893780|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893781|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138893782|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138893783|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893784|NCT03202316|Atezolizumab|atezolizumab|mesh-list
138893785|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138893786|NCT03202316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893787|NCT03202316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893788|NCT03202316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893789|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893790|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
138893791|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893792|NCT03173248|Azacitidine|azacitidine|mesh-list
138893793|NCT03173248|Ivosidenib|ivosidenib|mesh-list
138566623|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
138893794|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893795|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
138893796|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893797|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893798|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893799|NCT03164616|Cisplatin|cisplatin|mesh-list
138893800|NCT03164616|Carboplatin|carboplatin|mesh-list
138893801|NCT03164616|Gemcitabine|gemcitabine|mesh-list
138893802|NCT03164616|Pemetrexed|pemetrexed|mesh-list
138893803|NCT03164616|Durvalumab|durvalumab|mesh-list
138893804|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138893805|NCT03164616|Tremelimumab|tremelimumab|mesh-list
138893806|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893807|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893808|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
138566668|NCT05059600|Pregnanolone|pregnanolone|mesh-list
138893809|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893810|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893811|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138893812|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138893813|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893816|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893817|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
138893818|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
138893819|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893820|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
138893821|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893822|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893823|NCT03095781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893824|NCT03095781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893825|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
138893826|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893827|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893828|NCT03064490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893829|NCT03064490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893830|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138893831|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
138893832|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893833|NCT02887248|Paclitaxel|paclitaxel|mesh-list
138893834|NCT02887248|Gemcitabine|gemcitabine|mesh-list
138893835|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138566727|NCT04716413|Analgesics|analgesics|mesh-ancestor
138893836|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893837|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
138518470|NCT00023907|Paclitaxel|paclitaxel|mesh-list
138893838|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
138893839|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
138893840|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893841|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893842|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
138893843|NCT02873962|Bevacizumab|bevacizumab|mesh-list
138893844|NCT02873962|Nivolumab|nivolumab|mesh-list
138893845|NCT02873962|Rucaparib|rucaparib|mesh-list
138893846|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893847|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893848|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138893849|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138893850|NCT02873962|Growth Substances|growth substances|mesh-ancestor
138893851|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893852|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
138893853|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138893854|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893855|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138893856|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893858|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893859|NCT02843074|Dexamethasone|dexamethasone|mesh-list
138893860|NCT02843074|Lenalidomide|lenalidomide|mesh-list
138893861|NCT02843074|Elotuzumab|elotuzumab|mesh-list
138893862|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138893863|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
138893864|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
138893865|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893866|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893867|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138893868|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
138893869|NCT02843074|Hormones|hormones|mesh-ancestor
138893870|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138893871|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138893872|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566776|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138893873|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
138893874|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138893875|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138893876|NCT02843074|Growth Substances|growth substances|mesh-ancestor
138893877|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
138893879|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893880|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138893881|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893882|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893883|NCT02707042|Amoxicillin|amoxicillin|mesh-list
138893884|NCT02707042|Azithromycin|azithromycin|mesh-list
138893885|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138893886|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893887|NCT02649673|Topotecan|topotecan|mesh-list
138893888|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138893889|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138893890|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893891|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566816|NCT04313790|Heparin|heparin|mesh-list
138893892|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893893|NCT02642094|Sirolimus|sirolimus|mesh-list
138893894|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138893895|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138893896|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138893897|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893898|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
138893899|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138893900|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
138893901|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893902|NCT02636582|Molgramostim|molgramostim|mesh-list
138893903|NCT02636582|Vaccines|vaccines|mesh-list
138893904|NCT02636582|Sargramostim|sargramostim|mesh-list
138893905|NCT02636582|Immunologic Factors|immunologic factors|mesh-ancestor
138893906|NCT02636582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893907|NCT02636582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893908|NCT02627443|Carboplatin|carboplatin|mesh-list
138893909|NCT02627443|Gemcitabine|gemcitabine|mesh-list
138893910|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893911|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893912|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
138566881|NCT04263896|Laxatives|laxatives|mesh-ancestor
138893913|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893914|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
138893915|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138893916|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893917|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138518552|NCT00024531|Calcium|calcium|mesh-list
138893918|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893919|NCT02598726|Curcumin|curcumin|mesh-list
138893920|NCT02598726|Piperine|piperine|mesh-list
138893921|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138893922|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138893923|NCT02598726|Analgesics|analgesics|mesh-ancestor
138893924|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
138893925|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893926|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893927|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138893928|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138893929|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893930|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893931|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893932|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138545961|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
138893933|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138893934|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138893936|NCT02509546|Analgesics|analgesics|mesh-ancestor
138893937|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
138893938|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138893939|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893940|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138893941|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
138893942|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138893943|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
138893944|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
138893945|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770236|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138893946|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893947|NCT02501954|Paclitaxel|paclitaxel|mesh-list
138893949|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138893950|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893951|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
138893952|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
138893953|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
138893954|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893955|NCT02473497|Crizotinib|crizotinib|mesh-list
138893956|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893957|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138893958|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138893959|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893960|NCT02435849|Tisagenlecleucel|tisagenlecleucel|mesh-list
138693539|NCT05567367|Vasodilator Agents|vasodilator agents|mesh-ancestor
138893961|NCT02435849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893962|NCT02435849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893963|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
138893964|NCT02394834|Leucovorin|leucovorin|mesh-list
138893965|NCT02394834|Bevacizumab|bevacizumab|mesh-list
138893966|NCT02394834|Panitumumab|panitumumab|mesh-list
138893967|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
138893968|NCT02394834|Fluorouracil|fluorouracil|mesh-list
138893969|NCT02394834|Calcium|calcium|mesh-list
138893970|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
138893971|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138893972|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893973|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138893974|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138893975|NCT02394834|Growth Substances|growth substances|mesh-ancestor
138893976|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138893977|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
138893978|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138893979|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138893980|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
138893981|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893982|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893983|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138893984|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
138893985|NCT02394834|Antidotes|antidotes|mesh-ancestor
138893986|NCT02394834|Protective Agents|protective agents|mesh-ancestor
138893987|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
138893988|NCT02394834|Vitamins|vitamins|mesh-ancestor
138893989|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
138893990|NCT02170090|Gemcitabine|gemcitabine|mesh-list
138893991|NCT02170090|Capecitabine|capecitabine|mesh-list
138893992|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138893993|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138893994|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
138893995|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138893996|NCT02143466|Durvalumab|durvalumab|mesh-list
138893997|NCT02143466|Osimertinib|osimertinib|mesh-list
138893998|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138893999|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138894000|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894001|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
138894002|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894003|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138894004|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546036|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138894005|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894006|NCT02073994|Ivosidenib|ivosidenib|mesh-list
138894007|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894008|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894009|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894010|NCT01947023|Lapatinib|lapatinib|mesh-list
138894011|NCT01947023|Dabrafenib|dabrafenib|mesh-list
138894012|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894013|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138369743|NCT01400867|Vancomycin|vancomycin|mesh-list
138894014|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894015|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894016|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
138894017|NCT01897454|Leucovorin|leucovorin|mesh-list
138894018|NCT01897454|Folic Acid|folic acid|mesh-list
138894019|NCT01897454|Gemcitabine|gemcitabine|mesh-list
138894020|NCT01897454|Fluorouracil|fluorouracil|mesh-list
138894022|NCT01897454|Irinotecan|irinotecan|mesh-list
138894023|NCT01897454|Camptothecin|camptothecin|mesh-list
138894024|NCT01897454|Calcium|calcium|mesh-list
138894025|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
138894026|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138894027|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
138894028|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894029|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894030|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138894031|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894032|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138894033|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138894034|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
138894035|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138518645|NCT00025272|Carboplatin|carboplatin|mesh-list
138894036|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138894037|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894038|NCT01897454|Antidotes|antidotes|mesh-ancestor
138894039|NCT01897454|Protective Agents|protective agents|mesh-ancestor
138894040|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
138894042|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
138894043|NCT01897454|Hematinics|hematinics|mesh-ancestor
138894044|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138894045|NCT01865110|Prednisone|prednisone|mesh-list
138894046|NCT01865110|Rituximab|rituximab|mesh-list
138894047|NCT01865110|Lenalidomide|lenalidomide|mesh-list
138894048|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
138894049|NCT01865110|Vincristine|vincristine|mesh-list
138894050|NCT01865110|Doxorubicin|doxorubicin|mesh-list
138894051|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138693746|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
138894053|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
138894054|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894055|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138894056|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138894057|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138894058|NCT01865110|Growth Substances|growth substances|mesh-ancestor
138894059|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
138894060|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138894061|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138894062|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
138894063|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894064|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138894065|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138894066|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
138894067|NCT01865110|Hormones|hormones|mesh-ancestor
138770237|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
138894068|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138894069|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138894070|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138894071|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
138894072|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
138894073|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
138894074|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138894075|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138894076|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138894077|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894078|NCT01856023|Aldesleukin|aldesleukin|mesh-list
138894079|NCT01856023|Ipilimumab|ipilimumab|mesh-list
138894080|NCT01856023|Interleukin-2|interleukin-2|mesh-list
138894081|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138546113|NCT02962492|Incretins|incretins|mesh-ancestor
138894082|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894083|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138693854|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894084|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894085|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138894087|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
138894088|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894089|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894091|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138894092|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
138894093|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138894094|NCT01815359|Leucovorin|leucovorin|mesh-list
138894095|NCT01815359|Mitomycins|mitomycins|mesh-list
138894096|NCT01815359|Mitomycin|mitomycin|mesh-list
138894097|NCT01815359|Antidotes|antidotes|mesh-ancestor
138894098|NCT01815359|Protective Agents|protective agents|mesh-ancestor
138894099|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894100|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
138894101|NCT01815359|Vitamins|vitamins|mesh-ancestor
138894102|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
138894103|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138894104|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894105|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
138894106|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894107|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138894108|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894109|NCT01791478|Letrozole|letrozole|mesh-list
138894110|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
138894111|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894112|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138518741|NCT00025584|Bortezomib|bortezomib|mesh-list
138894113|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138894114|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430569|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138894115|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894116|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138894117|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
138894118|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138894119|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894120|NCT01787487|Azacitidine|azacitidine|mesh-list
138894121|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138894122|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
138894123|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894124|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894125|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894126|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
138894127|NCT01751425|Dasatinib|dasatinib|mesh-list
138894128|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138894129|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894130|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138894131|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894132|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894133|NCT01393756|Lenalidomide|lenalidomide|mesh-list
138894134|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
138894135|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894136|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138894137|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138894138|NCT01393756|Growth Substances|growth substances|mesh-ancestor
138894139|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
138894140|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894141|NCT01364597|Brivaracetam|brivaracetam|mesh-list
138894142|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
138894143|NCT01311648|Factor VIII|factor viii|mesh-list
138894144|NCT01311648|Coagulants|coagulants|mesh-ancestor
138894145|NCT00758342|Travoprost|travoprost|mesh-list
138894146|NCT00758342|Brinzolamide|brinzolamide|mesh-list
138894147|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138518752|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138894148|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138894149|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894150|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894151|NCT00470704|Trastuzumab|trastuzumab|mesh-list
138894152|NCT00470704|Lapatinib|lapatinib|mesh-list
138894153|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138894154|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138506175|NCT00048373|Analgesics|analgesics|mesh-ancestor
138894156|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894157|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894158|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
138894159|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138894160|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
138894161|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894162|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894163|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138894164|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
138894165|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
138894166|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138894167|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
138894168|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894169|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894170|NCT04152356|Sorafenib|sorafenib|mesh-list
138894171|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894172|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138894173|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894174|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894175|NCT04271956|Tislelizumab|tislelizumab|mesh-list
138894176|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
138894177|NCT04271956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138894178|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894179|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138894180|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894181|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894183|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138894184|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
138894185|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138894186|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138894187|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894188|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894189|NCT00678236|Gentamicins|gentamicins|mesh-list
138894190|NCT00678236|Cimetidine|cimetidine|mesh-list
138894191|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138894192|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138894193|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138894194|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
138894195|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
138894196|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894197|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894198|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894199|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138894200|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138894201|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894202|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138894203|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138894204|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138894205|NCT00678314|Ropivacaine|ropivacaine|mesh-list
138894206|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
138894207|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
138894208|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138894209|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894210|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
138894211|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894212|NCT02566720|Amantadine|amantadine|mesh-list
138894213|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138894214|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138894215|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
138894216|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138894217|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
138894218|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894219|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894220|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894221|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138894222|NCT02566720|Analgesics|analgesics|mesh-ancestor
138894223|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
138894224|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894225|NCT00675194|Capecitabine|capecitabine|mesh-list
138894226|NCT00675194|Irinotecan|irinotecan|mesh-list
138894227|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894228|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138894229|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
138894230|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894231|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138894232|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138894233|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894234|NCT00665522|Fentanyl|fentanyl|mesh-list
138894235|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138894236|NCT00665522|Narcotics|narcotics|mesh-ancestor
138430764|NCT01733459|Metformin|metformin|mesh-list
138894237|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138894238|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894239|NCT00665522|Analgesics|analgesics|mesh-ancestor
138894240|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
138894241|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894242|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138894243|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138894244|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
138894245|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
138894246|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
138894247|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138894248|NCT00678626|Docetaxel|docetaxel|mesh-list
138894249|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894250|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
138894251|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
138894252|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
138894253|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894254|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138894255|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
138894256|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138518848|NCT00026364|Protective Agents|protective agents|mesh-ancestor
138894257|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138894258|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894259|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894260|NCT00678704|Urological Agents|urological agents|mesh-ancestor
138894261|NCT00678782|Etanercept|etanercept|mesh-list
138894262|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138894263|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138894264|NCT00678782|Analgesics|analgesics|mesh-ancestor
138894265|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
138894266|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894267|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894268|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138894269|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138894270|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138894271|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138894272|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
138894273|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
138894274|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138894275|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894276|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138894277|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894278|NCT04061200|Empagliflozin|empagliflozin|mesh-list
138894279|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138894280|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894281|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138894282|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894283|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
138894284|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138694269|NCT03268382|Doxorubicin|doxorubicin|mesh-list
138894285|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894286|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138894287|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894288|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894289|NCT02565862|Metformin|metformin|mesh-list
138430861|NCT01734057|Rituximab|rituximab|mesh-list
138894290|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138894291|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894292|NCT04060888|Ustekinumab|ustekinumab|mesh-list
138894293|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
138894294|NCT00879398|Fesoterodine|fesoterodine|mesh-list
138894295|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138894296|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138894297|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
138894298|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894299|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894300|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894301|NCT00879398|Urological Agents|urological agents|mesh-ancestor
138894302|NCT00679250|Cetirizine|cetirizine|mesh-list
138894303|NCT00679250|Levocetirizine|levocetirizine|mesh-list
138894304|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138894305|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138894306|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
138894307|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
138894308|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894309|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894310|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430905|NCT01734408|Antacids|antacids|mesh-ancestor
138894313|NCT00696436|Olmesartan|olmesartan|mesh-list
138894314|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138894315|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138894316|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138894317|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138894318|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894319|NCT00878072|Famciclovir|famciclovir|mesh-list
138894320|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
138894321|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138894322|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138894323|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894324|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894325|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
138894326|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138894327|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894328|NCT03045341|Naltrexone|naltrexone|mesh-list
138894329|NCT03045341|Bupropion|bupropion|mesh-list
138894330|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138894331|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138894332|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138518938|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138894333|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
138894334|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430955|NCT01735006|Vaccines|vaccines|mesh-list
138894335|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138894336|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
138894337|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138894338|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138894339|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138894340|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138894341|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894342|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
138894343|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894344|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138894345|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138894346|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894347|NCT00679484|Candesartan|candesartan|mesh-list
138894348|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
138894349|NCT00679484|Olmesartan|olmesartan|mesh-list
138894350|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138894351|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138894352|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138894353|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138894354|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894355|NCT00679640|Candesartan|candesartan|mesh-list
138894356|NCT00679640|Candesartan cilexetil|candesartan cilexetil|mesh-list
138894357|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138506191|NCT05641337|Incretins|incretins|mesh-ancestor
138894358|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138894359|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138894360|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894361|NCT00921388|Varenicline|varenicline|mesh-list
138894362|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138894363|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138431027|NCT01735344|Lisinopril|lisinopril|mesh-list
138894364|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
138894365|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894366|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894367|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894368|NCT04212065|Buprenorphine|buprenorphine|mesh-list
138894369|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138894370|NCT04212065|Narcotics|narcotics|mesh-ancestor
138894371|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138894372|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894373|NCT04212065|Analgesics|analgesics|mesh-ancestor
138894374|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
138894375|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894376|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138894377|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
138894378|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138894379|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138894380|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
138894381|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138546407|NCT00229684|Pioglitazone|pioglitazone|mesh-list
138894382|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138894383|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138894385|NCT00617513|Laxatives|laxatives|mesh-ancestor
138894386|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138894387|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138519016|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138894388|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138894389|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
138894390|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894391|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894392|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894393|NCT02627222|Vitamin A|vitamin a|mesh-list
138894394|NCT02627222|Provitamins|provitamins|mesh-list
138894395|NCT02627222|Vitamins|vitamins|mesh-ancestor
138894396|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
138894398|NCT00684476|Immunomodulating Agents|immunomodulating agents|mesh-list
138894399|NCT00684476|Immunologic Factors|immunologic factors|mesh-ancestor
138894400|NCT00684476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894401|NCT00594854|Diclofenac|diclofenac|mesh-list
138894402|NCT00594854|Arthrotec|arthrotec|mesh-list
138894403|NCT00594854|Misoprostol|misoprostol|mesh-list
138694524|NCT00539448|Insulin|insulin|mesh-list
138894404|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138894405|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
138894406|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138894407|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894408|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138894409|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138894411|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138894412|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138894413|NCT00594854|Analgesics|analgesics|mesh-ancestor
138894414|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
138894415|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894416|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138894417|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138894418|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138431087|NCT01735747|Nedaplatin|nedaplatin|mesh-list
138894419|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894420|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894421|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138894422|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138894424|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138894425|NCT00684632|Narcotics|narcotics|mesh-ancestor
138894426|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138894427|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894428|NCT00684632|Analgesics|analgesics|mesh-ancestor
138894429|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
138506196|NCT05641337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894430|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894431|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138894432|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138894433|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
138894434|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
138894435|NCT00855582|Tadalafil|tadalafil|mesh-list
138894436|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
138894437|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138894438|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138894439|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894440|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894441|NCT00855582|Urological Agents|urological agents|mesh-ancestor
138894442|NCT00619541|Fluorouracil|fluorouracil|mesh-list
138894443|NCT00619541|Sorafenib|sorafenib|mesh-list
138894444|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
138894445|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894446|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138894447|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894448|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138894449|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
138894450|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894451|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138894452|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894453|NCT00680498|Ranibizumab|ranibizumab|mesh-list
138894454|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138894455|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138894456|NCT00680498|Growth Substances|growth substances|mesh-ancestor
138694689|NCT04681937|Hormones|hormones|mesh-ancestor
138894457|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894458|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
138894459|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894460|NCT00684866|Albuterol|albuterol|mesh-list
138894461|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138894462|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
138894463|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894464|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894465|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138699223|NCT01239472|Everolimus|everolimus|mesh-list
138894466|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
138894467|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
138894468|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138894469|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138894470|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138894471|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138894472|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
138894473|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894474|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894475|NCT00854724|Puerarin|puerarin|mesh-list
138894477|NCT00619697|Insulin|insulin|mesh-list
138894478|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138894479|NCT00619697|Metformin|metformin|mesh-list
138894480|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
138894481|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
138894482|NCT00619697|Glimepiride|glimepiride|mesh-list
138894483|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
138894484|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138894485|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138894486|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894487|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138894488|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138894489|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
138894490|NCT00680654|Riociguat|riociguat|mesh-list
138894491|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
138894492|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894493|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138894494|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138894495|NCT00680732|Folic Acid|folic acid|mesh-list
138894496|NCT00680732|Micronutrients|micronutrients|mesh-list
138894497|NCT00680732|Trace Elements|trace elements|mesh-list
138894498|NCT00680732|Chloroquine|chloroquine|mesh-list
138894499|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
138894501|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
138894502|NCT00680732|Vitamins|vitamins|mesh-ancestor
138894503|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894504|NCT00680732|Amebicides|amebicides|mesh-ancestor
138894505|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138894506|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138894507|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138894508|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
138894509|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138894510|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138894511|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894512|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894513|NCT00698932|Saxagliptin|saxagliptin|mesh-list
138894514|NCT00698932|Incretins|incretins|mesh-ancestor
138894515|NCT00698932|Hormones|hormones|mesh-ancestor
138894516|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138894517|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694797|NCT02908412|Bupivacaine|bupivacaine|mesh-list
138894518|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138894519|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
138894520|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894521|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894522|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138894523|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
138894525|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
138519194|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138894526|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138894527|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
138894528|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894529|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894530|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138894531|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
138894532|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
138894533|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138894534|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138894535|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138894536|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138894537|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
138894538|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894539|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894540|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
138894541|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
138894542|NCT02566252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138894543|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138894544|NCT00823719|Ofatumumab|ofatumumab|mesh-list
138894545|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138894546|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894547|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
138894548|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894549|NCT03953170|Teduglutide|teduglutide|mesh-list
138894550|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138894551|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138894552|NCT03953170|Protective Agents|protective agents|mesh-ancestor
138894553|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894554|NCT00708591|Sirolimus|sirolimus|mesh-list
138894555|NCT00708591|Ketoconazole|ketoconazole|mesh-list
138894556|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138894557|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138894558|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138894559|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894560|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
138894561|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138894562|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
138894563|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894564|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894565|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894566|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138894567|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138894568|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138894569|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
138894570|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138894571|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138894572|NCT04595266|Leucovorin|leucovorin|mesh-list
138894573|NCT04595266|Bevacizumab|bevacizumab|mesh-list
138894574|NCT04595266|Fluorouracil|fluorouracil|mesh-list
138894575|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
138894576|NCT04595266|Irinotecan|irinotecan|mesh-list
138894577|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138894578|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894579|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138894580|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138894581|NCT04595266|Growth Substances|growth substances|mesh-ancestor
138894582|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894583|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
138894584|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
138894585|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894586|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138894587|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138894588|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
138894589|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138894590|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138894591|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894592|NCT04595266|Antidotes|antidotes|mesh-ancestor
138894593|NCT04595266|Protective Agents|protective agents|mesh-ancestor
138894594|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
138894595|NCT04595266|Vitamins|vitamins|mesh-ancestor
138894596|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
138894597|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
138894598|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138894599|NCT00708747|Antibodies|antibodies|mesh-list
138894600|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
138894601|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894602|NCT00685022|Albuterol|albuterol|mesh-list
138894603|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138894605|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894606|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894607|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138894608|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
138894609|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
138894610|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138894611|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138894612|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138894613|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138894614|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
138894615|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894616|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894618|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
138894619|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894620|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
138894621|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138894622|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138894623|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
138894624|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894625|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894626|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894627|NCT00685100|Triamcinolone|triamcinolone|mesh-list
138894628|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138894629|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
138894630|NCT00685100|Hormones|hormones|mesh-ancestor
138894631|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138894632|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894633|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
138894634|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138894635|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138894636|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138894637|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138894638|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894639|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894640|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894641|NCT00637091|Irinotecan|irinotecan|mesh-list
138894642|NCT00637091|Cetuximab|cetuximab|mesh-list
138894643|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138894644|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138894645|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894646|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894647|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894648|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138894649|NCT04213391|Sulforaphane|sulforaphane|mesh-list
138894650|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138894651|NCT04213391|Protective Agents|protective agents|mesh-ancestor
138894652|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894653|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894654|NCT00709137|Amiloride|amiloride|mesh-list
138894655|NCT00709137|Spironolactone|spironolactone|mesh-list
138894656|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138894657|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
138894658|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138894659|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894660|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138894661|NCT00709137|Diuretics|diuretics|mesh-ancestor
138894662|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
138894663|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138894664|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138431393|NCT01737918|Urological Agents|urological agents|mesh-ancestor
138894665|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138894666|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519289|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
138894667|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138894668|NCT04150172|Rebamipide|rebamipide|mesh-list
138894669|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138894670|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138894671|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
138894672|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894673|NCT04150172|Protective Agents|protective agents|mesh-ancestor
138894674|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894675|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894676|NCT02325011|Fluconazole|fluconazole|mesh-list
138894677|NCT02325011|Nabiximols|nabiximols|mesh-list
138894678|NCT02325011|Dronabinol|dronabinol|mesh-list
138894679|NCT02325011|Cannabidiol|cannabidiol|mesh-list
138894680|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
138894681|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138894682|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138894683|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138546712|NCT00231634|Topiramate|topiramate|mesh-list
138894684|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894685|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894686|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138894687|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
138894688|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138894689|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894690|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138894691|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138894693|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
138894694|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894695|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
138894696|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
138894697|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138894698|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138894699|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138894700|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138894701|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894702|NCT02325011|Hormones|hormones|mesh-ancestor
138894704|NCT00577096|Dexamethasone|dexamethasone|mesh-list
138894705|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
138894706|NCT00577096|Melphalan|melphalan|mesh-list
138894707|NCT00577096|Cisplatin|cisplatin|mesh-list
138894708|NCT00577096|Doxorubicin|doxorubicin|mesh-list
138894709|NCT00577096|Etoposide|etoposide|mesh-list
138894710|NCT00577096|Vincristine|vincristine|mesh-list
138894711|NCT00577096|Heparin|heparin|mesh-list
138894712|NCT00577096|Calcium heparin|calcium heparin|mesh-list
138894713|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138894714|NCT00577096|Tinzaparin|tinzaparin|mesh-list
138894715|NCT00577096|Dalteparin|dalteparin|mesh-list
138894716|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
138894717|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138894718|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
138894719|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894720|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138894721|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138894722|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
138894723|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894724|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894725|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138894726|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138894728|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
138894729|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894730|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138894731|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
138894732|NCT00577096|Hormones|hormones|mesh-ancestor
138894733|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138894734|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138894735|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894736|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138894737|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138894738|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138695076|NCT00535119|Paclitaxel|paclitaxel|mesh-list
138519363|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
138894739|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138431515|NCT01738763|Vitamins|vitamins|mesh-ancestor
138894740|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
138894741|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
138894742|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
138894743|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
138894744|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138894745|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138894746|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
138894747|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138894748|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138894749|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138894750|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138894751|NCT00577096|Growth Substances|growth substances|mesh-ancestor
138894752|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
138894753|NCT00577096|Hematinics|hematinics|mesh-ancestor
138894754|NCT02625506|Tramadol|tramadol|mesh-list
138894755|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
138894756|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138894757|NCT02625506|Narcotics|narcotics|mesh-ancestor
138894758|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138894759|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894760|NCT02625506|Analgesics|analgesics|mesh-ancestor
138894761|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
138894762|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894763|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
138894764|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
138894765|NCT04209959|Nifekalant|nifekalant|mesh-list
138894766|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138894767|NCT04209803|Minoxidil|minoxidil|mesh-list
138894768|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138894769|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
138894770|NCT02567032|Oxytocin|oxytocin|mesh-list
138894771|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
138894772|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138894773|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894774|NCT00618059|Pilocarpine|pilocarpine|mesh-list
138894775|NCT00618059|Miotics|miotics|mesh-ancestor
138894776|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
138894777|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894778|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894779|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138894780|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138894781|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
138894782|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894783|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894786|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138894787|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138894788|NCT00863304|Analgesics|analgesics|mesh-ancestor
138894789|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
138894790|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894791|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894792|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138894793|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138894794|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
138894795|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138894796|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894797|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894798|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
138894799|NCT00695110|Testosterone|testosterone|mesh-list
138894800|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
138894801|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
138894802|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138894803|NCT00695110|Androgens|androgens|mesh-ancestor
138894804|NCT00695110|Hormones|hormones|mesh-ancestor
138894805|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138894806|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894807|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138894808|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894809|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
138894810|NCT03264352|Amlodipine|amlodipine|mesh-list
138894811|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138894812|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138894813|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138894814|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894815|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138894816|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894817|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
138894818|NCT04897919|Lumefantrine|lumefantrine|mesh-list
138894819|NCT04897919|Artemether|artemether|mesh-list
138894820|NCT04897919|Piperaquine|piperaquine|mesh-list
138894821|NCT04897919|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138894822|NCT04897919|Artenimol|artenimol|mesh-list
138894823|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
138894824|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138894825|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138894826|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138894827|NCT00594386|Rotigotine|rotigotine|mesh-list
138894828|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
138894829|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
138894830|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894831|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894832|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894833|NCT00690560|Prednisone|prednisone|mesh-list
138894834|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
138894835|NCT00690560|Rituximab|rituximab|mesh-list
138894836|NCT00690560|Doxorubicin|doxorubicin|mesh-list
138894837|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138894838|NCT00690560|Vincristine|vincristine|mesh-list
138894839|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138894840|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
138894841|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894842|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138894843|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138894844|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
138894845|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894846|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894847|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138894848|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138519484|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138894849|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138894850|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138894851|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138894852|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894853|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138894854|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
138894855|NCT00690560|Hormones|hormones|mesh-ancestor
138894856|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138894857|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138894858|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138894859|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
138894860|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
138894861|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
138894862|NCT00742690|Terlipressin|terlipressin|mesh-list
138894863|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138894864|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138894865|NCT00742768|Vitamins|vitamins|mesh-list
138894866|NCT00742768|Vitamin K|vitamin k|mesh-list
138894867|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
138894868|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
138894869|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894870|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138894871|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138894872|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894873|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
138894874|NCT00742768|Coagulants|coagulants|mesh-ancestor
138894875|NCT00862992|Cariprazine|cariprazine|mesh-list
138894876|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138894877|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138894878|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138894879|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894880|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138894881|NCT02565316|Sertraline|sertraline|mesh-list
138894882|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
138894883|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138894884|NCT02565316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138894885|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138894886|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138894887|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894888|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894889|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
138894890|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894891|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138894892|NCT00742846|Triamcinolone|triamcinolone|mesh-list
138894893|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138894894|NCT00742846|Lidocaine|lidocaine|mesh-list
138431744|NCT01740271|Epirubicin|epirubicin|mesh-list
138519526|NCT00030459|Mitomycins|mitomycins|mesh-list
138894895|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138894896|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
138894897|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
138894898|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138894899|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894900|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
138894901|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894902|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138894903|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138894904|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138894905|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138894906|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894907|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138894908|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
138894909|NCT00742846|Hormones|hormones|mesh-ancestor
138894910|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138546937|NCT02958566|Hydromorphone|hydromorphone|mesh-list
138894911|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138894912|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
138894913|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894914|NCT00690872|Carboplatin|carboplatin|mesh-list
138894915|NCT00690872|Gemcitabine|gemcitabine|mesh-list
138894916|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138894917|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138894918|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
138894919|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894922|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138894923|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138894924|NCT00694096|Growth Substances|growth substances|mesh-ancestor
138894925|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894926|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
138894927|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138894928|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894929|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894930|NCT04808531|Oxycodone|oxycodone|mesh-list
138894931|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138894932|NCT04808531|Narcotics|narcotics|mesh-ancestor
138894933|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138894934|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894935|NCT04808531|Analgesics|analgesics|mesh-ancestor
138894936|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
138894937|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894938|NCT00690950|Dutasteride|dutasteride|mesh-list
138894939|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138894940|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138894941|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894942|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894943|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
138894944|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431843|NCT01741285|Beclomethasone|beclomethasone|mesh-list
138894945|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894947|NCT02622126|Ephedrine|ephedrine|mesh-list
138894948|NCT02622126|Morphine|morphine|mesh-list
138894949|NCT02622126|Bupivacaine|bupivacaine|mesh-list
138894950|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
138894951|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
138894952|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138894953|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894954|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
138894955|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894956|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138894957|NCT02622126|Narcotics|narcotics|mesh-ancestor
138894958|NCT02622126|Analgesics|analgesics|mesh-ancestor
138894959|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138894960|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138894961|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138894962|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
138894963|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138894964|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
138894965|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
138894966|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
138894967|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138894968|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138894969|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
138894970|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138894971|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894972|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138894973|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
138894974|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138894975|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
138894976|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
138894977|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138894978|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894979|NCT00685568|Celecoxib|celecoxib|mesh-list
138519582|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
138894980|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138894981|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138894982|NCT00685568|Analgesics|analgesics|mesh-ancestor
138894983|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
138894984|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138894985|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894986|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138894987|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138894988|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138894989|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138894990|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138894991|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138894992|NCT02626208|ST 1435|st 1435|mesh-list
138894993|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
138894994|NCT02626208|Estradiol|estradiol|mesh-list
138894995|NCT02626208|Estrogens|estrogens|mesh-ancestor
138894996|NCT02626208|Hormones|hormones|mesh-ancestor
138894997|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138894998|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138894999|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138895000|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138895001|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138895002|NCT04210739|Betamethasone|betamethasone|mesh-list
138895003|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
138895004|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138895005|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
138895006|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138895007|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
138895008|NCT04210739|Hormones|hormones|mesh-ancestor
138895009|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138895010|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895011|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138895012|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138895013|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
138895014|NCT00696540|Albuterol|albuterol|mesh-list
138895015|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138895016|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
138895017|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895018|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895019|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138895020|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
138895021|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
138895022|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138895023|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138895024|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138895025|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138895026|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
138895027|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895028|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895029|NCT04212845|Dexamethasone|dexamethasone|mesh-list
138895030|NCT04212845|Bupivacaine|bupivacaine|mesh-list
138895031|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138895032|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
138895033|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
138895034|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895035|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895036|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138895037|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
138895038|NCT04212845|Hormones|hormones|mesh-ancestor
138695436|NCT03556696|Analgesics|analgesics|mesh-ancestor
138895039|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138895040|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138895041|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895042|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
138895044|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895045|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
138895047|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
138895048|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
138895049|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
138895050|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
138895051|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138895052|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895053|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
138895054|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138895055|NCT00685958|Enoxaparin|enoxaparin|mesh-list
138895056|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
138895057|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138895058|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138895059|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895061|NCT04138472|Fentanyl|fentanyl|mesh-list
138895062|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
138895063|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
138895064|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
138699366|NCT06021756|Anesthetics, General|anesthetics, general|mesh-ancestor
138895065|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895066|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895067|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
138895068|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895069|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138895070|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138895071|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138895072|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138895073|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895074|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138895075|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138895076|NCT04138472|Analgesics|analgesics|mesh-ancestor
138895077|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138895078|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138895079|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138895080|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
138895081|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895082|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138895083|NCT04138472|Narcotics|narcotics|mesh-ancestor
138895084|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138895085|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138895086|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
138895087|NCT00620789|Dexetimide|dexetimide|mesh-list
138895088|NCT00620789|Citalopram|citalopram|mesh-list
138895089|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
138895090|NCT00620789|Escitalopram|escitalopram|mesh-list
138895091|NCT00620789|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138895092|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138519679|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
138895093|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138895094|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895095|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895096|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
138895097|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895098|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138895099|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138895100|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
138895101|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
138895102|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895103|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138895104|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138895105|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
138895106|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138895107|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138372143|NCT01416558|Paclitaxel|paclitaxel|mesh-list
138895108|NCT00691184|Terbinafine|terbinafine|mesh-list
138895109|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
138895110|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895111|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895112|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895113|NCT00854100|Cariprazine|cariprazine|mesh-list
138895114|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
138895115|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138895116|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138895117|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138895118|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895119|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895120|NCT00691262|Tacrolimus|tacrolimus|mesh-list
138895121|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138695570|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
138895122|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
138895123|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895124|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138895125|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895126|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895127|NCT00620867|Ibuprofen|ibuprofen|mesh-list
138895128|NCT00620867|Celecoxib|celecoxib|mesh-list
138895129|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138895130|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138895131|NCT00620867|Analgesics|analgesics|mesh-ancestor
138895132|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
138895133|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895134|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547150|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
138895135|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138895136|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138895137|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138895138|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895139|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895140|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138895141|NCT04271917|Acetaminophen|acetaminophen|mesh-list
138895142|NCT04271917|Ibuprofen|ibuprofen|mesh-list
138895143|NCT04271917|Cannabidiol|cannabidiol|mesh-list
138895144|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138895145|NCT04271917|Analgesics|analgesics|mesh-ancestor
138895146|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
138895147|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895148|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895149|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
138895150|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138895151|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138895152|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138895153|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138895154|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895155|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519763|NCT04711668|Lidocaine|lidocaine|mesh-list
138895156|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
138895157|NCT04122222|Vaccines|vaccines|mesh-list
138895158|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
138895159|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895160|NCT00686114|Paclitaxel|paclitaxel|mesh-list
138895161|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138895162|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138895163|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895164|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
138895165|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
138895166|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
138895167|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895168|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138895169|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895171|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895172|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895173|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138895174|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138895175|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138895176|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
138895177|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138895178|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
138895179|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138895180|NCT00698724|Prednisolone|prednisolone|mesh-list
138895181|NCT00698724|Bromfenac|bromfenac|mesh-list
138895182|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138895183|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
138895184|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138895185|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
138895186|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
138895187|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895188|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895189|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138895190|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
138895191|NCT00698724|Hormones|hormones|mesh-ancestor
138895192|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138895194|NCT00698724|Protective Agents|protective agents|mesh-ancestor
138895195|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138895196|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895197|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138895198|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138895199|NCT00698724|Analgesics|analgesics|mesh-ancestor
138895200|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
138895201|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138895202|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
138895203|NCT00686192|Calcium|calcium|mesh-list
138895204|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138895205|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895206|NCT00686192|Antacids|antacids|mesh-ancestor
138547226|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895207|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895208|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138895209|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
138895210|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138895211|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138895212|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895213|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
138895214|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
138895215|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
138895216|NCT00922610|Hematinics|hematinics|mesh-ancestor
138895217|NCT04117698|Ethambutol|ethambutol|mesh-list
138895218|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
138895219|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138895220|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895221|NCT04118322|Peppermint oil|peppermint oil|mesh-list
138895222|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
138895223|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
138895224|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895225|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895226|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138895227|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
138895228|NCT00698802|Insulin|insulin|mesh-list
138895229|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138895230|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138895231|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895232|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138895233|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
138895234|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138895235|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138895236|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138895237|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895238|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895240|NCT02621970|Docetaxel|docetaxel|mesh-list
138895241|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895242|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
138895243|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
138895244|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
138895245|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895246|NCT00820755|Cetuximab|cetuximab|mesh-list
138895247|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138895248|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895249|NCT00700128|Frovatriptan|frovatriptan|mesh-list
138895250|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138895251|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
138895252|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895253|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895254|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895255|NCT04660097|Etoposide|etoposide|mesh-list
138895256|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
138895257|NCT04660097|Durvalumab|durvalumab|mesh-list
138895258|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138895259|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138895260|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895261|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138895262|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138895263|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895264|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432433|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138895265|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138895266|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
138895267|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895270|NCT00621101|MTOR Inhibitors|mtor inhibitors|mesh-list
138895271|NCT00621101|Ezetimibe|ezetimibe|mesh-list
138895272|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138895273|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895274|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138895275|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895276|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
138895277|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138895278|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
138895279|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895280|NCT00621101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138895281|NCT00621101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895282|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895283|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138895284|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138895285|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
138895286|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138895287|NCT00709215|Cordycepin|cordycepin|mesh-list
138895288|NCT00709215|Pentostatin|pentostatin|mesh-list
138895289|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895290|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138895291|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895292|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895293|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
138895294|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895295|NCT00699036|Metformin|metformin|mesh-list
138895296|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
138895297|NCT00699036|Losartan|losartan|mesh-list
138895298|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138895299|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895300|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138895301|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138895302|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138895303|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138895304|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138519928|NCT02971644|Cobalt|cobalt|mesh-list
138895305|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138895306|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
138895307|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895308|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138895309|NCT00819741|Metformin|metformin|mesh-list
138895310|NCT00819741|Repaglinide|repaglinide|mesh-list
138895311|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138895312|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895313|NCT04208555|Terconazole|terconazole|mesh-list
138895314|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
138895315|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895316|NCT00621725|Cediranib|cediranib|mesh-list
138895317|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895318|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138895319|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895320|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895321|NCT00862134|Docetaxel|docetaxel|mesh-list
138895322|NCT00862134|Lenograstim|lenograstim|mesh-list
138895323|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895324|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
138895325|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
138895326|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
138895327|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895328|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138895329|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
138895330|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895332|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138895333|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138895334|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
138895335|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895336|NCT00618527|Interferons|interferons|mesh-list
138895337|NCT00618527|Interferon-beta|interferon-beta|mesh-list
138895338|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
138895339|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
138895340|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895341|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
138895342|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895343|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138895344|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138895345|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
138895346|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138895347|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895348|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895349|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
138895350|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895351|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138895352|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138895353|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138895354|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138895355|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138895356|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
138895357|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138895358|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895359|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
138895360|NCT04115982|Vitamin D|vitamin d|mesh-list
138895361|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138895362|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895363|NCT04115982|Vitamins|vitamins|mesh-ancestor
138895365|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138895366|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
138895367|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138895368|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138895369|NCT01010581|Folic Acid|folic acid|mesh-list
138895370|NCT01010581|Methotrexate|methotrexate|mesh-list
138895371|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138895372|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
138895373|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138895374|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520014|NCT03151499|Rifampin|rifampin|mesh-list
138895375|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138895376|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
138895377|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895378|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895379|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
138895380|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895381|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138895382|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138895383|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
138895384|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138895385|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138895386|NCT01010581|Hematinics|hematinics|mesh-ancestor
138895387|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
138895388|NCT01010581|Vitamins|vitamins|mesh-ancestor
138895389|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
138895391|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138895392|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138895393|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895394|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895395|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138895396|NCT04208945|Colistin|colistin|mesh-list
138895397|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138895398|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895399|NCT01016041|Paclitaxel|paclitaxel|mesh-list
138895400|NCT01016041|Everolimus|everolimus|mesh-list
138506278|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
138895401|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138895403|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
138895404|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
138895405|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
138895406|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895407|NCT01016041|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138895408|NCT01016041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138895409|NCT01016041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895410|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138895411|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
138895412|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895413|NCT00622115|Enoxaparin|enoxaparin|mesh-list
138895414|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
138895415|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138520036|NCT00032019|Etoposide|etoposide|mesh-list
138895416|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138895417|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895418|NCT02696837|Rocuronium|rocuronium|mesh-list
138895419|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138895420|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138895421|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138895422|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895423|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895424|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
138895425|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138895426|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
138895427|NCT00490555|Testosterone|testosterone|mesh-list
138895428|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
138895429|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
138895430|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138895431|NCT00490555|Dutasteride|dutasteride|mesh-list
138895432|NCT00490555|Androgens|androgens|mesh-ancestor
138895433|NCT00490555|Hormones|hormones|mesh-ancestor
138895434|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138895435|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895436|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138895437|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895438|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
138895439|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138895440|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138895441|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895442|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895443|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
138895444|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138895445|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138895446|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138895447|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
138895448|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138895449|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138895450|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138895451|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138895453|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138895454|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138895455|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895456|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138895457|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138895458|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895459|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895460|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895461|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138895462|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
138895463|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138895464|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895465|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138895466|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138895467|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138895468|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138895469|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
138895470|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895472|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895473|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
138895474|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
138895475|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
138895476|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895477|NCT05368961|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
138895478|NCT05368961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138895479|NCT05368961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895480|NCT05368961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895481|NCT05368961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138895482|NCT02626754|Sunitinib|sunitinib|mesh-list
138895483|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895484|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138895485|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138895486|NCT02626754|Growth Substances|growth substances|mesh-ancestor
138895487|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895488|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
138895489|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138895490|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433035|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138895491|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895492|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
138895493|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138895494|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895495|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138520117|NCT04712279|Ivermectin|ivermectin|mesh-list
138895496|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138895497|NCT00691886|Analgesics|analgesics|mesh-ancestor
138895498|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
138895499|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895500|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138895501|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138895502|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138895503|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
138895504|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895505|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895506|NCT04138004|Lubiprostone|lubiprostone|mesh-list
138895507|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138895508|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138895509|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895510|NCT00621491|Warfarin|warfarin|mesh-list
138547524|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
138895512|NCT00622349|Cisplatin|cisplatin|mesh-list
138895513|NCT00622349|Gemcitabine|gemcitabine|mesh-list
138895514|NCT00622349|Docetaxel|docetaxel|mesh-list
138895515|NCT00622349|Ifosfamide|ifosfamide|mesh-list
138895516|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
138895517|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895518|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138895519|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
138895520|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895521|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
138895522|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
138895523|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
138895524|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138895525|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
138895526|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
138895527|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138895528|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138895529|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
138895530|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895531|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138895532|NCT05368181|Methylprednisolone|methylprednisolone|mesh-list
138895533|NCT05368181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138895534|NCT05368181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138696237|NCT05080530|Vitamin D|vitamin d|mesh-list
138506295|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
138895536|NCT05368181|Prednisolone acetate|prednisolone acetate|mesh-list
138895537|NCT05368181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138895538|NCT05368181|Prednisolone phosphate|prednisolone phosphate|mesh-list
138895539|NCT05368181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138895540|NCT05368181|Antiemetics|antiemetics|mesh-ancestor
138895541|NCT05368181|Autonomic Agents|autonomic agents|mesh-ancestor
138895542|NCT05368181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895543|NCT05368181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895544|NCT05368181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138895545|NCT05368181|Glucocorticoids|glucocorticoids|mesh-ancestor
138895546|NCT05368181|Hormones|hormones|mesh-ancestor
138895547|NCT05368181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138895548|NCT05368181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138895549|NCT05368181|Protective Agents|protective agents|mesh-ancestor
138895550|NCT05368181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138895551|NCT05368181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895552|NCT05662163|Anesthetics|anesthetics|mesh-list
138895553|NCT05662163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895554|NCT05662163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895555|NCT02666105|Exemestane|exemestane|mesh-list
138895556|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895557|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138895558|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138895559|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895560|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895561|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138895562|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
138895563|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138520189|NCT00033033|Reserpine|reserpine|mesh-list
138895564|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895565|NCT04138238|Sirolimus|sirolimus|mesh-list
138895566|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138895567|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895568|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138895569|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895570|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
138895571|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138895572|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
138895573|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895574|NCT00622817|Epinephrine|epinephrine|mesh-list
138895575|NCT00622817|Xylometazoline|xylometazoline|mesh-list
138895576|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138895577|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138895578|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
138895579|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895580|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895581|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895582|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138895583|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138895584|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
138547602|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895585|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895586|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138895587|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
138895589|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
138895590|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138895591|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
138895592|NCT00692120|Vitamin D|vitamin d|mesh-list
138895593|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
138895594|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
138895595|NCT00692120|Vitamins|vitamins|mesh-list
138895596|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
138895597|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895598|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138895599|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138895600|NCT00819585|Colchicine|colchicine|mesh-list
138895601|NCT00819585|Allopurinol|allopurinol|mesh-list
138895602|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138895603|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
138895604|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138895605|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
138895606|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
138895607|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
138895608|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895609|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895610|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
138895611|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895612|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138895614|NCT00819585|Protective Agents|protective agents|mesh-ancestor
138895615|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895616|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
138895617|NCT00687206|Valsartan|valsartan|mesh-list
138895618|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138895619|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138895620|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138895621|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895622|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
138895623|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138895624|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895625|NCT02358395|Sorafenib|sorafenib|mesh-list
138699616|NCT05669833|Golimumab|golimumab|mesh-list
138895626|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895627|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138895628|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895629|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895630|NCT00692354|Tosedostat|tosedostat|mesh-list
138895631|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895632|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895633|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138895634|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
138895635|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895636|NCT03928847|Protective Agents|protective agents|mesh-ancestor
138895637|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895638|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138895639|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138895640|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895641|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138895642|NCT02624726|Leucovorin|leucovorin|mesh-list
138895643|NCT02624726|Fluorouracil|fluorouracil|mesh-list
138895644|NCT02624726|Irinotecan|irinotecan|mesh-list
138895645|NCT02624726|Aflibercept|aflibercept|mesh-list
138895646|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
138895647|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
138895648|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895649|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138895650|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895651|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138895652|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
138895653|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895654|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138895655|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138895656|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895657|NCT02624726|Antidotes|antidotes|mesh-ancestor
138895658|NCT02624726|Protective Agents|protective agents|mesh-ancestor
138895659|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
138895660|NCT02624726|Vitamins|vitamins|mesh-ancestor
138895661|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
138895662|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138895663|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138895664|NCT02624726|Growth Substances|growth substances|mesh-ancestor
138895665|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
138895666|NCT00681746|Flumazenil|flumazenil|mesh-list
138895667|NCT00681746|Antidotes|antidotes|mesh-ancestor
138895668|NCT00681746|Protective Agents|protective agents|mesh-ancestor
138895669|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895670|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
138895671|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
138895672|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895673|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895674|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138895675|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
138696365|NCT02339129|Ibuprofen|ibuprofen|mesh-list
138895676|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895677|NCT00819039|Ondansetron|ondansetron|mesh-list
138895679|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
138895680|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
138895681|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895682|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895683|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138895684|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
138895685|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
138895686|NCT00819039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138895687|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138895688|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
138895689|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433498|NCT06176560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138895690|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895691|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138895693|NCT00692510|Midazolam|midazolam|mesh-list
138895694|NCT00692510|Caffeine|caffeine|mesh-list
138895695|NCT00692510|Bupropion|bupropion|mesh-list
138895696|NCT00692510|Omeprazole|omeprazole|mesh-list
138895697|NCT00692510|Bilirubin|bilirubin|mesh-list
138895698|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138895699|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138895700|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895701|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895702|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138895703|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138895704|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138895705|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138895706|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
138895707|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
138895708|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
138895709|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
138895710|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895711|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895712|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138895713|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138520422|NCT00034125|Tamoxifen|tamoxifen|mesh-list
138895714|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895715|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138895716|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138895717|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
138895718|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138895719|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138895720|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138895721|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138895722|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
138895723|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138895724|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138895725|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138895726|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
138895727|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138696419|NCT02302079|Growth Inhibitors|growth inhibitors|mesh-ancestor
138895728|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138895729|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138895730|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
138895731|NCT00692510|Protective Agents|protective agents|mesh-ancestor
138895732|NCT00500539|Omalizumab|omalizumab|mesh-list
138895733|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138895734|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138895735|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
138895736|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
138895737|NCT00687518|Hematinics|hematinics|mesh-ancestor
138895738|NCT02303795|Warfarin|warfarin|mesh-list
138895739|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
138895740|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
138895741|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138895742|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
138895743|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138895744|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
138895745|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895746|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895748|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
138895749|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
138895750|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895751|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895752|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
138895753|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895754|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138895755|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
138895756|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138895757|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138895758|NCT00818883|Diuretics|diuretics|mesh-ancestor
138895759|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
138895760|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696439|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138895761|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138895762|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138895763|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895764|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138895765|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138895766|NCT01014481|Tenofovir|tenofovir|mesh-list
138895767|NCT01014481|Lamivudine|lamivudine|mesh-list
138895768|NCT01014481|Efavirenz|efavirenz|mesh-list
138895769|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
138895770|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895771|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138433726|NCT06152172|Cyclophosphamide|cyclophosphamide|mesh-list
138895773|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895774|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895775|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138895776|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138895777|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138895778|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138895779|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138895780|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138895781|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138895782|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138895784|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
138895785|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138895786|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895787|NCT02167763|Trace Elements|trace elements|mesh-ancestor
138895788|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
138895789|NCT00508027|Simvastatin|simvastatin|mesh-list
138895790|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138895791|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138895792|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
138895793|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895794|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138895795|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138895796|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895797|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138895798|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138895799|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138895800|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895801|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895802|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138895803|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138895804|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138895805|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138895806|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
138895807|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895808|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895809|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138895810|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138547830|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
138895811|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
138895812|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138895813|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138895814|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
138895815|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138895816|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138895817|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895818|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138895819|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138895820|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138895821|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895822|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
138895823|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895825|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
138895826|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
138895827|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895828|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895829|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
138895830|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895831|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138895832|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138895833|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138895834|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138895835|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895836|NCT04185857|Olmesartan|olmesartan|mesh-list
138895837|NCT04185857|Canrenone|canrenone|mesh-list
138895838|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138895839|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138895840|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138895841|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895842|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138895843|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
138696584|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138895844|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138895845|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895846|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138895848|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
138895849|NCT01016509|Insulin|insulin|mesh-list
138895850|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138895851|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138895852|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895853|NCT00639119|Ropinirole|ropinirole|mesh-list
138895854|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138895855|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138895856|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
138895857|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
138895858|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895859|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895860|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895861|NCT01010893|Vaccines|vaccines|mesh-list
138895862|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
138895863|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895864|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138895865|NCT01011127|Pravastatin|pravastatin|mesh-list
138895866|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138895867|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138895868|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
138895869|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895870|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138895871|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138895872|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895873|NCT00912548|Tamoxifen|tamoxifen|mesh-list
138895874|NCT00912548|Goserelin|goserelin|mesh-list
138895875|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138895876|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
138895877|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138506320|NCT05576181|Etoposide|etoposide|mesh-list
138895879|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138895880|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895881|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138895882|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138895883|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138895885|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138895886|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895887|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138895888|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138895889|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895890|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895891|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138895892|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
138895893|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138895894|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895895|NCT00681980|Valproic Acid|valproic acid|mesh-list
138895896|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
138895897|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895898|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895899|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
138895900|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895901|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895902|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
138895903|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138895904|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895905|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138895906|NCT00692900|Docetaxel|docetaxel|mesh-list
138895908|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895909|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
138895910|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
138895911|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
138895912|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895913|NCT00489853|Budesonide|budesonide|mesh-list
138895914|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
138895915|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138895916|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138895917|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
138895918|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895919|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895920|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138895921|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
138895922|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
138895923|NCT00489853|Hormones|hormones|mesh-ancestor
138895924|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138895925|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138895926|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138895927|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138895928|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
138895929|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895930|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895931|NCT00682136|Ropivacaine|ropivacaine|mesh-list
138895932|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
138895933|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
138895934|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138895935|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895936|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
138895937|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895938|NCT00693056|beta-Lactams|beta-lactams|mesh-list
138895939|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138895940|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895941|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
138895942|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138895943|NCT04145336|Indomethacin|indomethacin|mesh-list
138895944|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138895945|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138895946|NCT04145336|Analgesics|analgesics|mesh-ancestor
138895947|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
138895948|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138895949|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895950|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138895951|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138895952|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
138895953|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
138433946|NCT05757466|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138895954|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138895955|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138895956|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895957|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895960|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895961|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138895962|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138895963|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138895964|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895965|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138895966|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
138895967|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138895968|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895969|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138895970|NCT02687009|Niclosamide|niclosamide|mesh-list
138895971|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
138895972|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138895973|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
138895974|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138895975|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138895976|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
138895977|NCT00693212|Methylphenidate|methylphenidate|mesh-list
138895978|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138895979|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895980|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138895981|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138895982|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138895983|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895984|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
138895985|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895986|NCT00688298|Imidacloprid|imidacloprid|mesh-list
138895987|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
138895988|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138895989|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138895990|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138895992|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
138895993|NCT00499603|Fluorouracil|fluorouracil|mesh-list
138895994|NCT00499603|Epirubicin|epirubicin|mesh-list
138895995|NCT00499603|Everolimus|everolimus|mesh-list
138895996|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138895997|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138895998|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
138895999|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
138896000|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
138896001|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896002|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138896003|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
138896004|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896005|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138896006|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138896007|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
138896008|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138896009|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
138896010|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138896011|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138896012|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138896013|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138896014|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896015|NCT00499603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138896016|NCT00499603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138896017|NCT01946711|Budesonide|budesonide|mesh-list
138520693|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138896018|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138896019|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138896020|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
138896021|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896022|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896023|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138896024|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
138896025|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
138896026|NCT01946711|Hormones|hormones|mesh-ancestor
138896027|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138896028|NCT00693446|Sirolimus|sirolimus|mesh-list
138896029|NCT00693446|Tacrolimus|tacrolimus|mesh-list
138896030|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138896031|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
138896032|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896033|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138896034|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896035|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896036|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138896037|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138896038|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138896039|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896040|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
138896041|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
138896042|NCT00693524|Prednisone|prednisone|mesh-list
138896043|NCT00693524|Tacrolimus|tacrolimus|mesh-list
138896044|NCT00693524|Daclizumab|daclizumab|mesh-list
138896045|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138896046|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
138896047|NCT00693524|Hormones|hormones|mesh-ancestor
138896048|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138896049|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896050|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138896051|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896052|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138896053|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
138896054|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138896055|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896056|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896057|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138896058|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138896059|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
138896060|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138434064|NCT05615636|Lenalidomide|lenalidomide|mesh-list
138896061|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138520740|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
138896062|NCT00693602|Asparaginase|asparaginase|mesh-list
138896063|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896064|NCT00682214|Vitamin D|vitamin d|mesh-list
138896065|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
138896066|NCT00682214|Vitamins|vitamins|mesh-ancestor
138896067|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
138896068|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896069|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138896070|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138896071|NCT00693680|Imipramine|imipramine|mesh-list
138896072|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138896073|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
138896075|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138896076|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138896077|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138896078|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896079|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
138896080|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896081|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896082|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
138896083|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138896084|NCT00682292|Daclizumab|daclizumab|mesh-list
138896085|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
138896086|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896087|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138896088|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138896089|NCT00810069|Escitalopram|escitalopram|mesh-list
138896090|NCT00810069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138896091|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138896092|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138896093|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896094|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896095|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
138520766|NCT01805726|Alfentanil|alfentanil|mesh-list
138896096|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896097|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896098|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
138896099|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138896100|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138896101|NCT00810069|Analgesics|analgesics|mesh-ancestor
138896102|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
138896103|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
138896105|NCT00693758|Analgesics|analgesics|mesh-ancestor
138896106|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
138896107|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896108|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896109|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138896110|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
138896111|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138896112|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
138896113|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
138896114|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138770238|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138896115|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896116|NCT02625740|Paclitaxel|paclitaxel|mesh-list
138896117|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138896118|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896119|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
138896120|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
138896121|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
138896122|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896123|NCT00688922|Pravastatin|pravastatin|mesh-list
138896124|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138896125|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138896126|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
138696885|NCT04662788|Antibodies|antibodies|mesh-list
138896127|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896128|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138896129|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138896130|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896131|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138896132|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138896133|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896134|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896135|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138896136|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138896137|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896138|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
138896139|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896140|NCT02626364|Crenolanib|crenolanib|mesh-list
138896141|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896142|NCT00694460|Vaccines|vaccines|mesh-list
138896143|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
138896144|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896145|NCT04776525|Doxorubicin|doxorubicin|mesh-list
138896146|NCT04776525|Ifosfamide|ifosfamide|mesh-list
138896147|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138896148|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896149|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138896150|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138896151|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324489|NCT04394598|Irinotecan|irinotecan|mesh-list
138896152|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896153|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138896155|NCT00689000|Tosedostat|tosedostat|mesh-list
138896156|NCT00689000|Glycine|glycine|mesh-list
138896157|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896158|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896159|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
138896160|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896161|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896162|NCT00489541|Paclitaxel|paclitaxel|mesh-list
138896163|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138896164|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896165|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
138896166|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
138896167|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
138896168|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896169|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
138896170|NCT00689156|Docetaxel|docetaxel|mesh-list
138896171|NCT00689156|Epirubicin|epirubicin|mesh-list
138896172|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138896173|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
138896174|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896175|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138896176|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138548198|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896177|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
138896178|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896179|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896180|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138896181|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
138896182|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
138896183|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
138896184|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138896185|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138896186|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138896187|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896188|NCT01016821|Oxycodone|oxycodone|mesh-list
138896189|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138896190|NCT01016821|Narcotics|narcotics|mesh-ancestor
138896191|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138896192|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896193|NCT01016821|Analgesics|analgesics|mesh-ancestor
138896194|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
138896195|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896196|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
138896197|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
138896198|NCT01011205|Tacrolimus|tacrolimus|mesh-list
138896199|NCT01011205|Basiliximab|basiliximab|mesh-list
138896200|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138896201|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
138896202|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896203|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138896204|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896205|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896206|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138896207|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896208|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138896209|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
138896210|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138896211|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138896212|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138896213|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
138896214|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
138896215|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896216|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138896217|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
138896218|NCT01011205|Hormones|hormones|mesh-ancestor
138896219|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138896220|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138896221|NCT01011205|Protective Agents|protective agents|mesh-ancestor
138896223|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138896224|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896225|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896226|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
138896227|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896228|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896230|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
138896231|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896232|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
138896233|NCT01014559|Oxycodone|oxycodone|mesh-list
138896234|NCT01014559|Naloxone|naloxone|mesh-list
138896235|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138896236|NCT01014559|Narcotics|narcotics|mesh-ancestor
138896237|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138896238|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896239|NCT01014559|Analgesics|analgesics|mesh-ancestor
138896240|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
138896241|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896242|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138896243|NCT00853242|Sevelamer|sevelamer|mesh-list
138896244|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
138896245|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
138896246|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896247|NCT02609061|Alendronate|alendronate|mesh-list
138896248|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138896249|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896250|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138896251|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138896252|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548269|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138896253|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
138896254|NCT00694694|Azithromycin|azithromycin|mesh-list
138896255|NCT00694694|Artesunate|artesunate|mesh-list
138896257|NCT00694694|Artemether|artemether|mesh-list
138896258|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138896259|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138896260|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138896261|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
138896262|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138896263|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138520928|NCT00036387|Infliximab|infliximab|mesh-list
138896264|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896265|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
138896266|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
138896267|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138896268|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
138896269|NCT00700362|Insulin|insulin|mesh-list
138896270|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138896271|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896272|NCT04136600|Antibodies|antibodies|mesh-list
138896273|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
138896274|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896275|NCT00809757|Albuterol|albuterol|mesh-list
138896276|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138896277|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
138896278|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896279|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896280|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138896281|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
138896282|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
138896283|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138896284|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138896285|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138896286|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138896287|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
138896288|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896289|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896290|NCT00594464|Rotigotine|rotigotine|mesh-list
138896291|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
138896292|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
138896293|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896294|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896295|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896297|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138896298|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138896299|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138896300|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138896301|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896302|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
138896303|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896304|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896305|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138896306|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896307|NCT05326269|Terbutaline|terbutaline|mesh-list
138697095|NCT06085417|Anesthetics, Local|anesthetics, local|mesh-ancestor
138896308|NCT05326269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138896309|NCT05326269|Autonomic Agents|autonomic agents|mesh-ancestor
138896310|NCT05326269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896311|NCT05326269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896312|NCT05326269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138896313|NCT05326269|Respiratory System Agents|respiratory system agents|mesh-ancestor
138896314|NCT05326269|Sympathomimetics|sympathomimetics|mesh-ancestor
138896315|NCT05326269|Tocolytic Agents|tocolytic agents|mesh-ancestor
138896316|NCT05326269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138896317|NCT05326269|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138896318|NCT05326269|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138896319|NCT05326269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138896320|NCT05326269|Adrenergic Agents|adrenergic agents|mesh-ancestor
138896321|NCT05326269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896322|NCT05326269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896323|NCT02624570|Midostaurin|midostaurin|mesh-list
138896324|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896325|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138896326|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896327|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896328|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
138896329|NCT04665453|Melatonin|melatonin|mesh-list
138896330|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138896331|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138896332|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896334|NCT04665453|Analgesics|analgesics|mesh-ancestor
138896335|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
138896336|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896337|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138896338|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138896339|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138896340|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
138896341|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896342|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896343|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
138896344|NCT04665453|Protective Agents|protective agents|mesh-ancestor
138896345|NCT00695240|Bupivacaine|bupivacaine|mesh-list
138896346|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
138896347|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
138896348|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138896349|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896350|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
138520959|NCT01466231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138896351|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896352|NCT00689702|Capecitabine|capecitabine|mesh-list
138896353|NCT00689702|Cetuximab|cetuximab|mesh-list
138896354|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138896355|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
138896356|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896357|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896358|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138896359|NCT00689780|Midazolam|midazolam|mesh-list
138896360|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138896361|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138506364|NCT02970409|Heparin|heparin|mesh-list
138896362|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138896363|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896365|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138896366|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138896367|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138896368|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
138896369|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
138896371|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
138896372|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896373|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896374|NCT00689858|Cilostazol|cilostazol|mesh-list
138896375|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138896376|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
138896377|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896378|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896379|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138896380|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
138896381|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138896382|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138896383|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896384|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138896385|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
138896386|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138896387|NCT00689858|Protective Agents|protective agents|mesh-ancestor
138896388|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138896389|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138896390|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896391|NCT00695630|Flumazenil|flumazenil|mesh-list
138896392|NCT00695630|Antidotes|antidotes|mesh-ancestor
138896393|NCT00695630|Protective Agents|protective agents|mesh-ancestor
138896394|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896395|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
138896396|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
138896397|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896398|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896399|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138896400|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138896401|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138896402|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138896403|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896404|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138896405|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138896406|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138896407|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138896408|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
138896409|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896410|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896411|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138896412|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138896413|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
138896414|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138896415|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138896416|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
138896417|NCT00690014|Probenecid|probenecid|mesh-list
138896418|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
138896419|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
138896420|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138896421|NCT00683306|Gefitinib|gefitinib|mesh-list
138896422|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896423|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138896424|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896425|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896426|NCT01475123|Nicorandil|nicorandil|mesh-list
138896427|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138896428|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138896429|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
138896430|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
138896431|NCT01475123|Vitamins|vitamins|mesh-ancestor
138896432|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
138896433|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896434|NCT04208399|JNJ-56136379|jnj-56136379|mesh-list
138896435|NCT04208399|Antiviral Agents|antiviral agents|mesh-ancestor
138896436|NCT04208399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138896437|NCT00912392|Carboplatin|carboplatin|mesh-list
138896438|NCT00912392|Etoposide|etoposide|mesh-list
138896439|NCT00912392|Endostar protein|endostar protein|mesh-list
138896440|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896441|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138896442|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138896443|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138896444|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896445|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896446|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138896447|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138896448|NCT00912392|Growth Substances|growth substances|mesh-ancestor
138896449|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896450|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
138896451|NCT00690170|Ketamine|ketamine|mesh-list
138896452|NCT00690170|Nicotine|nicotine|mesh-list
138896453|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138896454|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
138896455|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138521017|NCT00396513|Metformin|metformin|mesh-list
138896456|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896457|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138896458|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138896459|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
138896460|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896461|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896462|NCT00690170|Analgesics|analgesics|mesh-ancestor
138896463|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
138896464|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138896465|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138896466|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
138896467|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
138896468|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138896469|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138896470|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138896471|NCT00689624|Leucovorin|leucovorin|mesh-list
138896472|NCT00689624|Fluorouracil|fluorouracil|mesh-list
138896473|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
138896474|NCT00689624|Irinotecan|irinotecan|mesh-list
138896475|NCT00689624|Cetuximab|cetuximab|mesh-list
138896476|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
138896477|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896478|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138896479|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896480|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138548505|NCT00241423|Exenatide|exenatide|mesh-list
138896481|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
138896482|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896483|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138896484|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138896485|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896486|NCT00689624|Antidotes|antidotes|mesh-ancestor
138697338|NCT05886972|Propofol|propofol|mesh-list
138896487|NCT00689624|Protective Agents|protective agents|mesh-ancestor
138896488|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
138896489|NCT00689624|Vitamins|vitamins|mesh-ancestor
138896490|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
138896491|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138896492|NCT00696098|Butyric Acid|butyric acid|mesh-list
138896493|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
138896494|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
138896495|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896496|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896497|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896498|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
138896499|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138896500|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896501|NCT00684164|Conivaptan|conivaptan|mesh-list
138896502|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138896503|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896504|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
138896505|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896506|NCT04135508|Adalimumab|adalimumab|mesh-list
138896507|NCT04135508|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138896508|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138896509|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138896510|NCT02616770|Perflubron|perflubron|mesh-list
138896511|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138896512|NCT00499369|Leucovorin|leucovorin|mesh-list
138896513|NCT00499369|Bevacizumab|bevacizumab|mesh-list
138896514|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138896515|NCT00499369|Cetuximab|cetuximab|mesh-list
138896516|NCT00499369|Fluorouracil|fluorouracil|mesh-list
138896517|NCT00499369|Irinotecan|irinotecan|mesh-list
138896518|NCT00499369|Antibodies|antibodies|mesh-list
138896519|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
138896520|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138896522|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896523|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138896524|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138896525|NCT00499369|Growth Substances|growth substances|mesh-ancestor
138896526|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896527|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
138896528|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
138896529|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
138896530|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896531|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138896532|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138896533|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138896534|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138896535|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896536|NCT00499369|Antidotes|antidotes|mesh-ancestor
138896537|NCT00499369|Protective Agents|protective agents|mesh-ancestor
138896538|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
138896539|NCT00499369|Vitamins|vitamins|mesh-ancestor
138896540|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
138896541|NCT02616692|Sorafenib|sorafenib|mesh-list
138896542|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896543|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138896544|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896545|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896546|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
138896547|NCT01014637|Clotrimazole|clotrimazole|mesh-list
138896549|NCT01014637|Amorolfine|amorolfine|mesh-list
138896550|NCT01014637|Ciclopirox|ciclopirox|mesh-list
138896551|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
138697442|NCT05490511|Tacrolimus|tacrolimus|mesh-list
138896552|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138896553|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138896554|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138896555|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138896556|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896557|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896558|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138896560|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138896561|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896562|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138896563|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138896564|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
138896565|NCT00696566|Rifampin|rifampin|mesh-list
138896566|NCT00696566|Clopidogrel|clopidogrel|mesh-list
138896567|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138896568|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138896569|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138896570|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138896571|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
138896572|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896573|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896574|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896575|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138896576|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
138896577|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138896578|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138896579|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
138896580|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138896581|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896582|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138896583|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138896584|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138896585|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138896586|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138896587|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138896588|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
138896589|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138896591|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138896592|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896593|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
138896594|NCT01017133|Protective Agents|protective agents|mesh-ancestor
138896595|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896596|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
138896597|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
138896598|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138896600|NCT00869258|Capecitabine|capecitabine|mesh-list
138896601|NCT00869258|Docetaxel|docetaxel|mesh-list
138896602|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138896603|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
138896604|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896605|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896606|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
138896607|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
138896608|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
138896610|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138896611|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435271|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
138896612|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138896613|NCT01017367|Antibodies|antibodies|mesh-list
138896614|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
138896615|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896616|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138896617|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138896618|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138896619|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
138896620|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896621|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896622|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138896623|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138896624|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
138896625|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138896627|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138896628|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896629|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
138896630|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
138896631|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
138896632|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896633|NCT02616848|Everolimus|everolimus|mesh-list
138896634|NCT02616848|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138896635|NCT02616848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138896636|NCT02616848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896637|NCT02616848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896638|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138896639|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
138896640|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896641|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896642|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138896643|NCT02620124|Hormones|hormones|mesh-list
138896644|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138896645|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896646|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
138896647|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138896648|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
138896649|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138896650|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138896651|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138896652|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896654|NCT04134650|Linagliptin|linagliptin|mesh-list
138896655|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138896656|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896657|NCT04134650|Incretins|incretins|mesh-ancestor
138896658|NCT04134650|Hormones|hormones|mesh-ancestor
138896659|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138896660|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138896661|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
138896662|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896663|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896664|NCT00488683|Vaccines|vaccines|mesh-list
138896665|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
138896666|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896667|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
138896668|NCT02563288|Esmolol|esmolol|mesh-list
138896669|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
138896671|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
138896672|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
138896673|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138896674|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138896675|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896676|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138896677|NCT02563288|Analgesics|analgesics|mesh-ancestor
138896678|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
138896679|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896680|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138896681|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896682|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896683|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138896684|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138896685|NCT00711269|Risperidone|risperidone|mesh-list
138896686|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138896687|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138896688|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
138896689|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896690|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896691|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896692|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138896693|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138896694|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138896695|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138896696|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138896697|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
138896698|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138896699|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138896700|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138896701|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
138896702|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138896703|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138896705|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138896706|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138896707|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
138896708|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
138896709|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896710|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896711|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896712|NCT00286169|Amrubicin|amrubicin|mesh-list
138896713|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896714|NCT00693472|Propranolol|propranolol|mesh-list
138896715|NCT00693472|Haloperidol|haloperidol|mesh-list
138896716|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
138896717|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138896718|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
138896719|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
138896720|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896721|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896722|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138896723|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138896724|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138896725|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138896726|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138896727|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138896728|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
138896729|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896730|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896731|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138896732|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
138896733|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138896734|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138896735|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
138521194|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
138896736|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138896737|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138896738|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
138896740|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138896741|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138896742|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138896743|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896744|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138896745|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896746|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
138896747|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138896748|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138896749|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138896750|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
138896751|NCT00746746|Interferons|interferons|mesh-list
138896752|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
138896753|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
138896754|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138896755|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896756|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
138896757|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138896758|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
138896759|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896760|NCT00498355|Ranibizumab|ranibizumab|mesh-list
138896761|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138896762|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138435524|NCT01750762|Lenalidomide|lenalidomide|mesh-list
138896764|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896765|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
138896766|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896767|NCT04539223|Evolocumab|evolocumab|mesh-list
138896768|NCT04539223|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138896769|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138896770|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138896771|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
138896772|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896773|NCT04539223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138896774|NCT04539223|Protease Inhibitors|protease inhibitors|mesh-ancestor
138896775|NCT04539223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896776|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138896777|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138896778|NCT01011751|Leuprolide|leuprolide|mesh-list
138548795|NCT00099333|Incretins|incretins|mesh-ancestor
138896779|NCT01011751|Flutamide|flutamide|mesh-list
138896781|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138896782|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
138896783|NCT01011751|Cyproterone|cyproterone|mesh-list
138896784|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138896785|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138896786|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138896787|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896788|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896789|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697792|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
138896790|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138896791|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
138896792|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138896793|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138896794|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138896795|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138896796|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
138896797|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138896798|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138896799|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138896800|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138896801|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138896802|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896803|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138896804|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
138896805|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
138896806|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
138896807|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138896808|NCT02686619|Cyclosporine|cyclosporine|mesh-list
138896809|NCT02686619|Sirolimus|sirolimus|mesh-list
138896810|NCT02686619|Prednisolone|prednisolone|mesh-list
138896811|NCT02686619|Cyclosporins|cyclosporins|mesh-list
138896812|NCT02686619|Daclizumab|daclizumab|mesh-list
138896813|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896814|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896815|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138896816|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
138896817|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896818|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
138896819|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138896820|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
138896821|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138896822|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138896823|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138896825|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896826|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138896827|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
138896828|NCT02686619|Hormones|hormones|mesh-ancestor
138521266|NCT00847418|Esketamine|esketamine|mesh-list
138896829|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138896830|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138896831|NCT00688636|Infliximab|infliximab|mesh-list
138506425|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
138896832|NCT00688636|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138896833|NCT00688636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138896834|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
138896835|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138896836|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138896837|NCT00870740|Daclizumab|daclizumab|mesh-list
138896838|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138896839|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
138896840|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896841|NCT02686853|Amphotericin B|amphotericin b|mesh-list
138896842|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138896843|NCT02686853|Amebicides|amebicides|mesh-ancestor
138896844|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138896845|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138896846|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138896847|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138896848|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
138896849|NCT01017679|Gefitinib|gefitinib|mesh-list
138896850|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896851|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138896852|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896853|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896854|NCT04130672|Hemostatics|hemostatics|mesh-list
138896855|NCT04130672|Coagulants|coagulants|mesh-ancestor
138896856|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
138896857|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138896858|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896859|NCT02685449|Insulin|insulin|mesh-list
138896860|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138896861|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
138896862|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
138896863|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
138896864|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138896865|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896866|NCT00697034|Capsaicin|capsaicin|mesh-list
138896867|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
138896868|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
138896869|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
138896870|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896871|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896872|NCT00506779|Paclitaxel|paclitaxel|mesh-list
138896873|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
138896874|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138896875|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896876|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
138896877|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
138521281|NCT05433207|Eldecalcitol|eldecalcitol|mesh-list
138896878|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
138896879|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896880|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138896881|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435767|NCT01752959|Esmolol|esmolol|mesh-list
138896882|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
138896883|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138896884|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
138896885|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
138896886|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138896887|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896888|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138896889|NCT04185233|Analgesics|analgesics|mesh-ancestor
138896890|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
138896891|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896892|NCT04185077|Heparin|heparin|mesh-list
138896893|NCT04185077|Calcium heparin|calcium heparin|mesh-list
138896894|NCT04185077|Bivalirudin|bivalirudin|mesh-list
138896895|NCT04185077|Antithrombins|antithrombins|mesh-list
138896896|NCT04185077|Thrombin|thrombin|mesh-list
138896897|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
138896898|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138896899|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138896900|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896901|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
138896902|NCT04185077|Coagulants|coagulants|mesh-ancestor
138896903|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138896904|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
138896905|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896906|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
138896907|NCT02686385|Prednisolone|prednisolone|mesh-list
138896908|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138896909|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138896910|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
138896911|NCT02686385|Hormones|hormones|mesh-ancestor
138896912|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138896913|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896914|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138521302|NCT00846989|Latanoprost|latanoprost|mesh-list
138896915|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896916|NCT02686385|Protective Agents|protective agents|mesh-ancestor
138435820|NCT01753375|Vitamin D|vitamin d|mesh-list
138896918|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138896919|NCT02686385|Expectorants|expectorants|mesh-ancestor
138896920|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
138896921|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138896922|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
138896923|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896924|NCT02686385|Antidotes|antidotes|mesh-ancestor
138896925|NCT02686151|Dexamethasone|dexamethasone|mesh-list
138896926|NCT02686151|Letrozole|letrozole|mesh-list
138896927|NCT02686151|Polygeline|polygeline|mesh-list
138896928|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138896929|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
138896930|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
138896931|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138896932|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896933|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138896934|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
138896936|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138896937|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138896938|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896939|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138896940|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138896941|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896942|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896943|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138896944|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
138896945|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
138896946|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
138896947|NCT00868790|Metformin|metformin|mesh-list
138896948|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138896949|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896950|NCT00496483|Tacrolimus|tacrolimus|mesh-list
138896951|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138896952|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
138896953|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896954|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138896955|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896956|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896957|NCT02614352|Candesartan|candesartan|mesh-list
138435905|NCT01754285|Octreotide|octreotide|mesh-list
138896958|NCT02614352|Candesartan cilexetil|candesartan cilexetil|mesh-list
138896959|NCT02614352|Atorvastatin|atorvastatin|mesh-list
138896960|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138896961|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138896962|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
138896963|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896964|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138521338|NCT00396747|Protective Agents|protective agents|mesh-ancestor
138896965|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138896966|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896967|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138896968|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138896969|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138896970|NCT01018225|Darifenacin|darifenacin|mesh-list
138896971|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138896972|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138896973|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
138896974|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138896975|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506433|NCT00389636|Becaplermin|becaplermin|mesh-list
138435972|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
138896976|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896977|NCT01018225|Urological Agents|urological agents|mesh-ancestor
138896978|NCT03528551|Factor VIII|factor viii|mesh-list
138896979|NCT03528551|Coagulants|coagulants|mesh-ancestor
138896980|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
138698138|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
138896981|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138896982|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896983|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
138896984|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138896985|NCT01012063|Hematinics|hematinics|mesh-ancestor
138896986|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138896987|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
138896988|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138896989|NCT02685059|Paclitaxel|paclitaxel|mesh-list
138896990|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
138896991|NCT02685059|Durvalumab|durvalumab|mesh-list
138896992|NCT02685059|Epirubicin|epirubicin|mesh-list
138896993|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138896994|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138896995|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
138896996|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
138896997|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
138896998|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138896999|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138897000|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
138897001|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897002|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897003|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138897004|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
138897005|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138897006|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138436016|NCT01755182|Hormones|hormones|mesh-ancestor
138897007|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138549021|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
138897008|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138897009|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138897010|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897011|NCT00603239|Exenatide|exenatide|mesh-list
138897012|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138897013|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897014|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138897015|NCT00603239|Incretins|incretins|mesh-ancestor
138897016|NCT00603239|Hormones|hormones|mesh-ancestor
138897017|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138897018|NCT00699114|Acetaminophen|acetaminophen|mesh-list
138897019|NCT00699114|Ibuprofen|ibuprofen|mesh-list
138897020|NCT00699114|Codeine|codeine|mesh-list
138897021|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138897022|NCT00699114|Analgesics|analgesics|mesh-ancestor
138897023|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
138897024|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698238|NCT02136147|Methylphenidate|methylphenidate|mesh-list
138897025|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897027|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138897028|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138897029|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897030|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138897031|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897032|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897033|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138897034|NCT00699114|Narcotics|narcotics|mesh-ancestor
138897035|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897036|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
138897037|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
138897038|NCT00639587|Cetirizine|cetirizine|mesh-list
138897039|NCT00639587|Ketotifen|ketotifen|mesh-list
138897040|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138506439|NCT00050206|Olanzapine|olanzapine|mesh-list
138897041|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138897042|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138897043|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
138897044|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
138897045|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897046|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897047|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897048|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
138897049|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
138897050|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
138897051|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
138897052|NCT00852540|Linezolid|linezolid|mesh-list
138897053|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138897054|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138897055|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138897056|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897057|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897058|NCT00701298|Interferons|interferons|mesh-list
138897059|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
138897060|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
138897061|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138897062|NCT00701298|Decitabine|decitabine|mesh-list
138897063|NCT00701298|Azacitidine|azacitidine|mesh-list
138897064|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897065|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
138897066|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138897067|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
138897068|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897069|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138897070|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
138897071|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897072|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897073|NCT00860574|Methotrexate|methotrexate|mesh-list
138897074|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
138897075|NCT00860574|Fludarabine|fludarabine|mesh-list
138897076|NCT00860574|Treosulfan|treosulfan|mesh-list
138897077|NCT00860574|Tacrolimus|tacrolimus|mesh-list
138897078|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138897079|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
138897080|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138897081|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897082|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138897083|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
138897084|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897085|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897086|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
138897087|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897088|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138897089|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138897090|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
138897091|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897092|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138897093|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138897094|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138897095|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
138897096|NCT00496015|Acetaminophen|acetaminophen|mesh-list
138897097|NCT00496015|Vaccines|vaccines|mesh-list
138897098|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138897099|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
138897100|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897101|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138897102|NCT00496015|Analgesics|analgesics|mesh-ancestor
138897103|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
138897104|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897105|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
138897106|NCT01018381|Ethanol|ethanol|mesh-list
138897107|NCT01018381|Entecavir|entecavir|mesh-list
138897108|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138897109|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138897110|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897111|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897112|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
138897113|NCT00487825|Methotrexate|methotrexate|mesh-list
138897114|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138897115|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
138897116|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138897117|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897118|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138897119|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
138897120|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897121|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897122|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
138897123|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897124|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138897125|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138897126|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
138897127|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897128|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138897129|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138897130|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
138897131|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138897133|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897134|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
138897135|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
138897136|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
138897137|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897138|NCT00487435|Tapentadol|tapentadol|mesh-list
138897139|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138897140|NCT00487435|Narcotics|narcotics|mesh-ancestor
138436335|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
138897141|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897142|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897143|NCT00487435|Analgesics|analgesics|mesh-ancestor
138897144|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
138897145|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897146|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138897147|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138897148|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138897149|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897150|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
138897151|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897152|NCT00495625|Sunitinib|sunitinib|mesh-list
138897153|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897154|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138897155|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138897156|NCT00495625|Growth Substances|growth substances|mesh-ancestor
138897157|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897158|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
138897159|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138506455|NCT00050245|Rituximab|rituximab|mesh-list
138897160|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897161|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897163|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138897164|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138897165|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138897166|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897167|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138897168|NCT00847626|Diuretics|diuretics|mesh-ancestor
138897169|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
138897170|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897171|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138897172|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138897173|NCT04115904|Ibuprofen|ibuprofen|mesh-list
138897174|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138897175|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138897176|NCT04115904|Analgesics|analgesics|mesh-ancestor
138897177|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
138897178|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897179|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897180|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138897181|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897182|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138897183|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897184|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897185|NCT05297994|Vaccines|vaccines|mesh-list
138897186|NCT05297994|Immunologic Factors|immunologic factors|mesh-ancestor
138897187|NCT05297994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521489|NCT04888377|Aspirin|aspirin|mesh-list
138897188|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
138897189|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
138897190|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138897191|NCT00860262|Amlodipine|amlodipine|mesh-list
138897192|NCT00860262|Telmisartan|telmisartan|mesh-list
138897193|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138698535|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
138897194|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138897195|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138897196|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138897197|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897198|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138897199|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897200|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
138897201|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138897202|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138897203|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
138897204|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138897205|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897207|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138897208|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138897209|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
138897210|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897211|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897212|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897213|NCT00701532|Modafinil|modafinil|mesh-list
138897214|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138897215|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897216|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138897217|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138897218|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138897219|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897220|NCT00846768|Olodaterol|olodaterol|mesh-list
138897221|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138897222|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
138897223|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897224|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897225|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138897226|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
138897227|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138897228|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138506475|NCT00050362|Analgesics|analgesics|mesh-ancestor
138897229|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138549244|NCT00424801|Lercanidipine|lercanidipine|mesh-list
138897230|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138897231|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897232|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698629|NCT00541125|Growth Substances|growth substances|mesh-ancestor
138897233|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897234|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
138897236|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138897237|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138897238|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138897239|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897240|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897241|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138897242|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138897243|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138897244|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
138436513|NCT01757756|Midazolam|midazolam|mesh-list
138897245|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897246|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897247|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138897248|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138897249|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
138897250|NCT00699426|Esomeprazole|esomeprazole|mesh-list
138897251|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138897252|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138897253|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138897254|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897255|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897256|NCT00593606|Rotigotine|rotigotine|mesh-list
138897257|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
138897258|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
138897259|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521545|NCT00276848|Vidarabine|vidarabine|mesh-list
138897260|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897261|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897262|NCT02614118|Acetaminophen|acetaminophen|mesh-list
138897263|NCT02614118|Ketorolac|ketorolac|mesh-list
138897264|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138897265|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138897266|NCT02614118|Analgesics|analgesics|mesh-ancestor
138897267|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
138897268|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897269|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897270|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
138897271|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138436571|NCT01758029|Testosterone|testosterone|mesh-list
138698674|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
138897272|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138897273|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897274|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138897275|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897276|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897277|NCT04134416|Donepezil|donepezil|mesh-list
138897278|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138506478|NCT00050401|Vancomycin|vancomycin|mesh-list
138897279|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897280|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897281|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
138897282|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138521585|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
138897283|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897284|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
138897285|NCT04134182|Nivolumab|nivolumab|mesh-list
138897286|NCT04134182|Ipilimumab|ipilimumab|mesh-list
138897287|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138897288|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897289|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138897290|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897291|NCT00870584|Omalizumab|omalizumab|mesh-list
138897292|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138897293|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138897294|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
138897295|NCT02614508|Ofatumumab|ofatumumab|mesh-list
138897296|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138897297|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698713|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
138897298|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
138897299|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897300|NCT02616068|Loxoprofen|loxoprofen|mesh-list
138897301|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138897302|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138897303|NCT02616068|Analgesics|analgesics|mesh-ancestor
138897304|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
138897305|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897306|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897307|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138897308|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897309|NCT04127084|Empagliflozin|empagliflozin|mesh-list
138897310|NCT04127084|Canagliflozin|canagliflozin|mesh-list
138521633|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138897311|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138897312|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897313|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138897314|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897315|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138897316|NCT00870194|Exenatide|exenatide|mesh-list
138897317|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138897318|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897319|NCT00870194|Incretins|incretins|mesh-ancestor
138897320|NCT00870194|Hormones|hormones|mesh-ancestor
138897321|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138897322|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138897323|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
138897324|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897325|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897326|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138897327|NCT00690430|Octreotide|octreotide|mesh-list
138897328|NCT00690430|Pasireotide|pasireotide|mesh-list
138897329|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138897330|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138897331|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897332|NCT00690430|Hormones|hormones|mesh-ancestor
138897333|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138897334|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897335|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138897336|NCT04126304|Azithromycin|azithromycin|mesh-list
138897337|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138897339|NCT02563054|Fluorouracil|fluorouracil|mesh-list
138897340|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897341|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138897342|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
138897343|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897344|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138897345|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
138897346|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897347|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
138897348|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138897349|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138897350|NCT00743470|Ritonavir|ritonavir|mesh-list
138897351|NCT00743470|Lopinavir|lopinavir|mesh-list
138897352|NCT00743470|Rifabutin|rifabutin|mesh-list
138897353|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138897354|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138897355|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
138897356|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897357|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897358|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138897359|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138897360|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
138897361|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138897362|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138897363|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138897364|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138897365|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138897366|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
138897367|NCT00688324|Acamprosate|acamprosate|mesh-list
138897368|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138897369|NCT02619578|Remifentanil|remifentanil|mesh-list
138897370|NCT02619578|Propofol|propofol|mesh-list
138436703|NCT01758627|Icodextrin|icodextrin|mesh-list
138897371|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
138897372|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138897373|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897374|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897375|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138897376|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
138897377|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
138897378|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138521726|NCT00275951|Cetuximab|cetuximab|mesh-list
138897379|NCT02619578|Narcotics|narcotics|mesh-ancestor
138897380|NCT02619578|Analgesics|analgesics|mesh-ancestor
138897381|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
138897382|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698845|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897383|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138897384|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138897385|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138897386|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138897387|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138897388|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
138897389|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897390|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897392|NCT02615912|Cathartics|cathartics|mesh-ancestor
138897393|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138897394|NCT04123652|Lidocaine|lidocaine|mesh-list
138897395|NCT04123652|Ketamine|ketamine|mesh-list
138897396|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
138897397|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
138897398|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897399|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897400|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
138897401|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897402|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138897403|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138897404|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138897405|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138897406|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897407|NCT04123652|Analgesics|analgesics|mesh-ancestor
138897408|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138897409|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138897410|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
138198141|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138521762|NCT00275756|Timolol|timolol|mesh-list
138897411|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138897412|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138897413|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897414|NCT00862940|Memantine|memantine|mesh-list
138897415|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138897416|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138897417|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
138897418|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138436790|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
138897419|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897420|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897421|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138897422|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138897423|NCT04122716|Liraglutide|liraglutide|mesh-list
138897424|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138897425|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897426|NCT04122716|Incretins|incretins|mesh-ancestor
138897427|NCT04122716|Hormones|hormones|mesh-ancestor
138897428|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138897430|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
138897431|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138897432|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138897433|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897434|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897435|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897436|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138897437|NCT00868166|Protective Agents|protective agents|mesh-ancestor
138897438|NCT00858780|Etanercept|etanercept|mesh-list
138897439|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138897440|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138897441|NCT00858780|Analgesics|analgesics|mesh-ancestor
138897442|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
138897443|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897444|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897445|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138897446|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897447|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138897448|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138897449|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
138897450|NCT02619266|Megestrol|megestrol|mesh-list
138897451|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
138897452|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138897453|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138897454|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138897455|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
138897456|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138897457|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897458|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138897459|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138897460|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138897461|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897462|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
138897463|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138897465|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138897466|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
138897467|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138897468|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
138897469|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138897470|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897471|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138897472|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138897473|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897475|NCT02619032|Remifentanil|remifentanil|mesh-list
138897476|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138897477|NCT02619032|Narcotics|narcotics|mesh-ancestor
138897478|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897479|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897480|NCT02619032|Analgesics|analgesics|mesh-ancestor
138897481|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
138897482|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897483|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138897484|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138897485|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
138897486|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
138897487|NCT00858234|Bortezomib|bortezomib|mesh-list
138897488|NCT00858234|Vorinostat|vorinostat|mesh-list
138897489|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897490|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138897491|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897492|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897493|NCT00697814|Clomiphene|clomiphene|mesh-list
138897494|NCT00697814|Enclomiphene|enclomiphene|mesh-list
138897495|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
138897496|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138897497|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
138709241|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138897498|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138897499|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897500|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138897501|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
138897502|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138897503|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138897504|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138897505|NCT00862082|Sorafenib|sorafenib|mesh-list
138897506|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138897507|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897508|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138897509|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897510|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138506547|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897511|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138897513|NCT00692770|Sorafenib|sorafenib|mesh-list
138897514|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897515|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138897516|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897517|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897518|NCT00867308|Lenalidomide|lenalidomide|mesh-list
138897519|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
138897520|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897521|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138897522|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138897523|NCT00867308|Growth Substances|growth substances|mesh-ancestor
138897524|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
138897525|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897526|NCT00849186|Sunitinib|sunitinib|mesh-list
138549542|NCT02967224|Insulin|insulin|mesh-list
138897528|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138897529|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138897530|NCT00849186|Growth Substances|growth substances|mesh-ancestor
138897531|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897532|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
138897533|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138897534|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897535|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897536|NCT02618876|Nalbuphine|nalbuphine|mesh-list
138897537|NCT02618876|Bupivacaine|bupivacaine|mesh-list
138897538|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
138897539|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
138897540|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897541|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897542|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
138897543|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897544|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138897545|NCT02618876|Narcotics|narcotics|mesh-ancestor
138897546|NCT02618876|Analgesics|analgesics|mesh-ancestor
138897547|NCT04119752|Curcumin|curcumin|mesh-list
138897548|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138897549|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138897550|NCT04119752|Analgesics|analgesics|mesh-ancestor
138897551|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
138897552|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897553|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897554|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138897555|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897556|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897557|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897558|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897559|NCT00866918|Vitamins|vitamins|mesh-list
138897560|NCT00866918|Vitamin A|vitamin a|mesh-list
138897561|NCT00866918|Cytarabine|cytarabine|mesh-list
138897562|NCT00866918|Methotrexate|methotrexate|mesh-list
138897563|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
138897564|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
138897565|NCT00866918|Idarubicin|idarubicin|mesh-list
138897566|NCT00866918|Tretinoin|tretinoin|mesh-list
138897567|NCT00866918|Retinol palmitate|retinol palmitate|mesh-list
138897568|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
138897569|NCT00866918|Micronutrients|micronutrients|mesh-ancestor
138897570|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897571|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138897572|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
138897573|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138897574|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138897576|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897577|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897578|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
138897579|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897580|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138897581|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138897582|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
138897583|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897584|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138897585|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
138897586|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138897587|NCT00866918|Analgesics|analgesics|mesh-ancestor
138897588|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
138897589|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897590|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138897591|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138897592|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138897593|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
138897595|NCT00866918|Protective Agents|protective agents|mesh-ancestor
138897596|NCT00866918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138897597|NCT00861692|Argatroban|argatroban|mesh-list
138897598|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
138897599|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138897600|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
138897601|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897602|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897603|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
138897604|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138897605|NCT02689037|Aspirin|aspirin|mesh-list
138897606|NCT02689037|Clopidogrel|clopidogrel|mesh-list
138699232|NCT00544284|Temozolomide|temozolomide|mesh-list
138897607|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138897608|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138897609|NCT02689037|Analgesics|analgesics|mesh-ancestor
138897610|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
138897611|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897612|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897613|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138437144|NCT01760694|Leucovorin|leucovorin|mesh-list
138897615|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138897616|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138897617|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897618|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138897619|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138897620|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897621|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
138897622|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138897623|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138897624|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138897625|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
138897626|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897627|NCT04184921|Aspirin|aspirin|mesh-list
138897628|NCT04184921|Osimertinib|osimertinib|mesh-list
138897629|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138897630|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138897631|NCT04184921|Analgesics|analgesics|mesh-ancestor
138897632|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
138897633|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897634|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897635|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138897636|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897637|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138897638|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138897639|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897640|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138897641|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138897642|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897643|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
138897644|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897645|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138897646|NCT00602927|Varenicline|varenicline|mesh-list
138897647|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138897648|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138897649|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
138897650|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897651|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897652|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897653|NCT00639743|Tenecteplase|tenecteplase|mesh-list
138897654|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138897655|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138897656|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897657|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
138897658|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138897659|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
138897660|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138897661|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897662|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897663|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
138897664|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138897665|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699310|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
138897666|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897667|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138897668|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138897669|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138897670|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897671|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138897672|NCT02688803|Paclitaxel|paclitaxel|mesh-list
138897673|NCT02688803|Docetaxel|docetaxel|mesh-list
138897674|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138897675|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
138897676|NCT02688803|Doxorubicin|doxorubicin|mesh-list
138549715|NCT00250315|Dobutamine|dobutamine|mesh-list
138897677|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138897678|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138897679|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897680|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
138897681|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
138897682|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
138897683|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897684|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138897685|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
138897686|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897687|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897688|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138897689|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
138897690|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138897691|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138897692|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138897693|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138897694|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897695|NCT02684669|Naloxone|naloxone|mesh-list
138897696|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138897697|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897698|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
138897699|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699352|NCT06021912|Immunomodulating Agents|immunomodulating agents|mesh-list
138699353|NCT06021912|Immunologic Factors|immunologic factors|mesh-ancestor
138897701|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138897702|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
138897703|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
138897704|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897705|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897706|NCT00861614|Ipilimumab|ipilimumab|mesh-list
138897707|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138897708|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897709|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138897710|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897711|NCT00861380|Vaccines|vaccines|mesh-list
138897712|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138897713|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
138897714|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897715|NCT00495391|Ribavirin|ribavirin|mesh-list
138897716|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138897717|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
138897718|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
138897719|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897720|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
138897721|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138897723|NCT04378621|Adalimumab|adalimumab|mesh-list
138897724|NCT04378621|Infliximab|infliximab|mesh-list
138897725|NCT04378621|Golimumab|golimumab|mesh-list
138897726|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
138897727|NCT04378621|Etanercept|etanercept|mesh-list
138897728|NCT04378621|Tofacitinib|tofacitinib|mesh-list
138897729|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138897730|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138897731|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138897732|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897733|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
138897734|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138897735|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138897736|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138897737|NCT04378621|Analgesics|analgesics|mesh-ancestor
138897738|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
138897739|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897740|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897741|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138897742|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
138897743|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138699394|NCT06021587|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138699402|NCT06021522|Ecopipam|ecopipam|mesh-list
138897744|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897745|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897746|NCT00869960|Ritonavir|ritonavir|mesh-list
138897747|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138897748|NCT00869960|Tenofovir|tenofovir|mesh-list
138897749|NCT00869960|Emtricitabine|emtricitabine|mesh-list
138897750|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138897751|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138506613|NCT00398008|Naltrexone|naltrexone|mesh-list
138897752|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
138897753|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437372|NCT01761994|Analgesics|analgesics|mesh-ancestor
138897754|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897755|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138897756|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138897757|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
138897758|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138897759|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138345210|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
138897760|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138897761|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138897762|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138897763|NCT02618564|Sennosides|sennosides|mesh-list
138897764|NCT02618564|Laxatives|laxatives|mesh-ancestor
138897765|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138897766|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
138897767|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138897768|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138897769|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897770|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
138897771|NCT02615366|Coagulants|coagulants|mesh-ancestor
138897772|NCT00699296|Panobinostat|panobinostat|mesh-list
138897773|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897774|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138897775|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897776|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897777|NCT00494299|Sorafenib|sorafenib|mesh-list
138897778|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437415|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
138897779|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138897781|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897782|NCT05298176|Carboplatin|carboplatin|mesh-list
138897783|NCT05298176|Pemetrexed|pemetrexed|mesh-list
138897784|NCT05298176|Osimertinib|osimertinib|mesh-list
138897785|NCT05298176|Afatinib|afatinib|mesh-list
138897786|NCT05298176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897787|NCT05298176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897788|NCT05298176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897789|NCT05298176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138897790|NCT05298176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138897791|NCT05298176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138897792|NCT02615288|Vitamin D|vitamin d|mesh-list
138897793|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
138897794|NCT02615288|Vitamins|vitamins|mesh-ancestor
138897795|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
138897796|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897797|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138897798|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138897799|NCT02618096|Oxytocin|oxytocin|mesh-list
138897800|NCT02618096|Dinoprostone|dinoprostone|mesh-list
138897801|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
138897802|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138437468|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
138897803|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897804|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
138897805|NCT04134026|Hematinics|hematinics|mesh-ancestor
138897806|NCT02963831|Cyclophosphamide|cyclophosphamide|mesh-list
138897807|NCT02963831|Durvalumab|durvalumab|mesh-list
138897808|NCT02963831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138897809|NCT02963831|Immunologic Factors|immunologic factors|mesh-ancestor
138897810|NCT02963831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897811|NCT02963831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897812|NCT02963831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138897813|NCT02963831|Alkylating Agents|alkylating agents|mesh-ancestor
138897814|NCT02963831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897815|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897816|NCT02963831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138897817|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138897818|NCT00859898|Metformin|metformin|mesh-list
138897819|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
138897820|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138897821|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897822|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138897823|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897824|NCT00638729|Clonidine|clonidine|mesh-list
138897825|NCT00638729|Midazolam|midazolam|mesh-list
138897826|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138897827|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138897828|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549839|NCT00251056|Mannitol|mannitol|mesh-list
138897829|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437522|NCT01762657|Cyclosporine|cyclosporine|mesh-list
138897830|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138897831|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138897832|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138897833|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138897834|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
138897835|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
138897836|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
138897837|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
138897838|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897839|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897840|NCT00638729|Analgesics|analgesics|mesh-ancestor
138897841|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
138897842|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897843|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138897844|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
138897845|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
138897846|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138897847|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138897848|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138897849|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
138897850|NCT00697892|Ritonavir|ritonavir|mesh-list
138897851|NCT00697892|Lopinavir|lopinavir|mesh-list
138897852|NCT00697892|Efavirenz|efavirenz|mesh-list
138897853|NCT00697892|Lumefantrine|lumefantrine|mesh-list
138897854|NCT00697892|Artemether|artemether|mesh-list
138897855|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138897856|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138897857|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138897858|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
138897859|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897860|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897861|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138897862|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138897863|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
138897864|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138897865|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138897866|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138897867|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138897868|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138897869|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138897870|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138897871|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138897872|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138897873|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138897874|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
138897875|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138897876|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138897877|NCT00699452|Candesartan|candesartan|mesh-list
138897878|NCT00699452|Candesartan cilexetil|candesartan cilexetil|mesh-list
138897879|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138897880|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138897881|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138897882|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897883|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
138897885|NCT02683733|Mesalamine|mesalamine|mesh-list
138897886|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138897887|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138897888|NCT02683733|Analgesics|analgesics|mesh-ancestor
138897889|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
138897890|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897891|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897892|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138897893|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138897894|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897895|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897896|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897897|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
138897898|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138897899|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138897900|NCT02683655|Apatinib|apatinib|mesh-list
138897901|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897902|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138897903|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897904|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897905|NCT00494221|Leucovorin|leucovorin|mesh-list
138897906|NCT00494221|Fluorouracil|fluorouracil|mesh-list
138416857|NCT01668043|UB-421|ub-421|mesh-list
138897907|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
138897908|NCT00494221|Cediranib|cediranib|mesh-list
138897909|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
138897910|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
138897911|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897912|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138897913|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897914|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138897915|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
138897916|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699723|NCT05481684|Hormones|hormones|mesh-ancestor
138897917|NCT00494221|Antidotes|antidotes|mesh-ancestor
138897918|NCT00494221|Protective Agents|protective agents|mesh-ancestor
138897919|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
138897920|NCT00494221|Vitamins|vitamins|mesh-ancestor
138897921|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
138506658|NCT05573958|Purinergic Agents|purinergic agents|mesh-ancestor
138897922|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138897923|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897924|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
138897925|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138897926|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897927|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897928|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138897929|NCT00909935|Analgesics|analgesics|mesh-ancestor
138897930|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
138897931|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897932|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138897933|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138897934|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138897935|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
138897936|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897937|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897938|NCT00857948|Ivermectin|ivermectin|mesh-list
138897939|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138897940|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138897941|NCT02688491|Sunitinib|sunitinib|mesh-list
138897942|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897943|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138897944|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138897945|NCT02688491|Growth Substances|growth substances|mesh-ancestor
138897946|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897947|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
138897948|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138897949|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138897950|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897951|NCT00857792|Regadenoson|regadenoson|mesh-list
138897952|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138897953|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138897954|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
138897955|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
138897956|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897957|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897958|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897959|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
138897960|NCT02613494|Scopolamine|scopolamine|mesh-list
138897961|NCT02613494|Bromides|bromides|mesh-list
138897962|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138897963|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
138897964|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138897965|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138897966|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138897967|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
138897968|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897969|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897970|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897972|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
138897973|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138897974|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138897975|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
138897976|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
138897977|NCT00699530|Cabergoline|cabergoline|mesh-list
138897978|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138897979|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138897981|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
138897982|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138897983|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897984|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897985|NCT02617862|Anesthetics|anesthetics|mesh-list
138897986|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138897987|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138897988|NCT00601835|Vaccines|vaccines|mesh-list
138897989|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
138897990|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138506686|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138897991|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138897992|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138897993|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138897994|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897995|NCT00697502|Capecitabine|capecitabine|mesh-list
138897996|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138897997|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
138897998|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138897999|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898000|NCT00857246|Irinotecan|irinotecan|mesh-list
138898001|NCT00857246|Cetuximab|cetuximab|mesh-list
138898002|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898003|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138898004|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138898005|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898006|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898007|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138898008|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
138898009|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
138898010|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138898011|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898012|NCT00640679|Clopidogrel|clopidogrel|mesh-list
138898013|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138898014|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138898015|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138898016|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138898017|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
138898018|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898019|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898020|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898021|NCT02682953|Plerixafor|plerixafor|mesh-list
138898022|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138898023|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138898024|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
138898025|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898026|NCT02683031|Ionophores|ionophores|mesh-list
138898027|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138898028|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898029|NCT04184141|Alprazolam|alprazolam|mesh-list
138898030|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
138898031|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138898032|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898033|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898034|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138898035|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138898036|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138898037|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
138898038|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
138898039|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898040|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898041|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
138898042|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
138898043|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138898044|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
138898046|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138898047|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
138898048|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138898049|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898050|NCT00640991|Insulin|insulin|mesh-list
138898051|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
138898052|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
138550064|NCT00399152|Sunitinib|sunitinib|mesh-list
138898053|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138898054|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898055|NCT00638807|Celecoxib|celecoxib|mesh-list
138898056|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138898057|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138898058|NCT00638807|Analgesics|analgesics|mesh-ancestor
138898059|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
138898060|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138506692|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138898061|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898062|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138898063|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138898064|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138898065|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138898066|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898067|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898068|NCT00856856|Everolimus|everolimus|mesh-list
138898069|NCT00856856|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138522382|NCT05453955|Propofol|propofol|mesh-list
138898070|NCT00856856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138898071|NCT00856856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898072|NCT00856856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898073|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138898074|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
138437875|NCT01764867|Mirtazapine|mirtazapine|mesh-list
138898075|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898076|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898077|NCT00782327|Losartan|losartan|mesh-list
138898078|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138898079|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138898080|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138898081|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138898082|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898083|NCT00559091|Ribavirin|ribavirin|mesh-list
138898084|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
138898085|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898086|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
138898087|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898088|NCT02682017|Fucoidan|fucoidan|mesh-list
138898089|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138898090|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138898091|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
138898092|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898093|NCT00603473|Gabapentin|gabapentin|mesh-list
138898094|NCT00603473|Analgesics|analgesics|mesh-ancestor
138898095|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
138898096|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898097|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898098|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
138898099|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138898100|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138898101|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898102|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138437918|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138898103|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138898104|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138898105|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898106|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898107|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
138898108|NCT02688023|Leucovorin|leucovorin|mesh-list
138898109|NCT02688023|Capecitabine|capecitabine|mesh-list
138898110|NCT02688023|Fluorouracil|fluorouracil|mesh-list
138898111|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
138898113|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138898114|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
138898115|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898116|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898117|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138898118|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
138898119|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898120|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138898121|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138898122|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898123|NCT02688023|Antidotes|antidotes|mesh-ancestor
138898124|NCT02688023|Protective Agents|protective agents|mesh-ancestor
138898125|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
138898126|NCT02688023|Vitamins|vitamins|mesh-ancestor
138898127|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
138898128|NCT00910013|Ropivacaine|ropivacaine|mesh-list
138898129|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
138898131|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138437961|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
138898132|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898134|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898135|NCT04182191|Tenoxicam|tenoxicam|mesh-list
138898136|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138898137|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138898138|NCT04182191|Analgesics|analgesics|mesh-ancestor
138898139|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
138898140|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898141|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898142|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138898143|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138898144|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138898145|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898146|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898147|NCT02680379|Minocycline|minocycline|mesh-list
138898148|NCT02680379|Lovastatin|lovastatin|mesh-list
138898149|NCT02680379|L 647318|l 647318|mesh-list
138898150|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
138898151|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138898152|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898153|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138898154|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138898155|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
138898156|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522440|NCT05298696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138898157|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138898158|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138898159|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898160|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
138898161|NCT03996421|Trace Elements|trace elements|mesh-ancestor
138898162|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
138898163|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898164|NCT00641693|Budesonide|budesonide|mesh-list
138898165|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138898166|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138898167|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
138898168|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898169|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898170|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138898171|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
138898172|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
138898173|NCT00641693|Hormones|hormones|mesh-ancestor
138700146|NCT03730181|Isoniazid|isoniazid|mesh-list
138898174|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138898176|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138898177|NCT02687867|Vitamin K|vitamin k|mesh-list
138898178|NCT02687867|Dabigatran|dabigatran|mesh-list
138898179|NCT02687867|Vitamins|vitamins|mesh-ancestor
138898180|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
138898181|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898182|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
138898183|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138898184|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
138898185|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898186|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898187|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
138898188|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138898189|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138898190|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
138898191|NCT02687867|Coagulants|coagulants|mesh-ancestor
138898192|NCT02681783|Aflibercept|aflibercept|mesh-list
138898193|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138898194|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138898195|NCT02681783|Growth Substances|growth substances|mesh-ancestor
138898196|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898197|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
138898198|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898200|NCT00486811|Tapentadol|tapentadol|mesh-list
138898201|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138898202|NCT00486811|Narcotics|narcotics|mesh-ancestor
138898203|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898204|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898205|NCT00486811|Analgesics|analgesics|mesh-ancestor
138898206|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
138898207|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898208|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138898209|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138898210|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138898211|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898212|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
138898213|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898214|NCT00921700|Acetaminophen|acetaminophen|mesh-list
138898215|NCT00921700|Ibuprofen|ibuprofen|mesh-list
138898216|NCT00921700|Codeine|codeine|mesh-list
138898217|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138898218|NCT00921700|Analgesics|analgesics|mesh-ancestor
138898219|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
138898220|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438112|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138898221|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898222|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
138898223|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138898224|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138898225|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138898226|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138898227|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898228|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898229|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138898230|NCT00921700|Narcotics|narcotics|mesh-ancestor
138898231|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898232|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
138898233|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
138898234|NCT02678195|Amoxicillin|amoxicillin|mesh-list
138898235|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138898236|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898237|NCT03996577|Lidocaine|lidocaine|mesh-list
138898238|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
138898239|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
138898240|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898241|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326569|NCT00253890|Trazodone|trazodone|mesh-list
138898242|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
138898243|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898244|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138898245|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138898246|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138898247|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138898248|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138522505|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
138898250|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138898251|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
138898252|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898253|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898254|NCT00921622|Vitamin D|vitamin d|mesh-list
138898255|NCT00921622|Vitamins|vitamins|mesh-list
138898256|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
138898257|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898258|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138898259|NCT02681471|Mannitol|mannitol|mesh-list
138898260|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138898261|NCT02681471|Diuretics|diuretics|mesh-ancestor
138898262|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
138898263|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898264|NCT00642395|Bortezomib|bortezomib|mesh-list
138898265|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898266|NCT01018615|Silymarin|silymarin|mesh-list
138898267|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
138898268|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898269|NCT01018615|Protective Agents|protective agents|mesh-ancestor
138898270|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898271|NCT00743782|Hormones|hormones|mesh-list
138898272|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
138898273|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138898274|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898275|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138898276|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
138898277|NCT02678117|Pregabalin|pregabalin|mesh-list
138898278|NCT02678117|Analgesics|analgesics|mesh-ancestor
138898279|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
138898280|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898281|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898282|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
138898283|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138898284|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138898285|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898286|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138898287|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138898288|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138898289|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898290|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138898291|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
138898292|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138898293|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
138898294|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138898295|NCT01018849|Vitamin D|vitamin d|mesh-list
138898296|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
138898297|NCT01018849|Vitamins|vitamins|mesh-ancestor
138898298|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
138898299|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898300|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138898301|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138898302|NCT04102319|Hepcidins|hepcidins|mesh-list
138898303|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898304|NCT00743860|Darapladib|darapladib|mesh-list
138898305|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138898306|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700290|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
138506745|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138898307|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898308|NCT00747526|Rabeprazole|rabeprazole|mesh-list
138898309|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138898310|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138898311|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138898312|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898313|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898314|NCT00747604|Mecasermin|mecasermin|mesh-list
138898315|NCT00747604|Growth Substances|growth substances|mesh-ancestor
138898316|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898318|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138898319|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
138898320|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
138898321|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898322|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898323|NCT00466921|Lenalidomide|lenalidomide|mesh-list
138898324|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
138898325|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898326|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138898327|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138898328|NCT00466921|Growth Substances|growth substances|mesh-ancestor
138898329|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
138898330|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898331|NCT00601523|Pramipexole|pramipexole|mesh-list
138898332|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
138898333|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898334|NCT00601523|Protective Agents|protective agents|mesh-ancestor
138898335|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898336|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138898337|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138898338|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
138898339|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
138898340|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898341|NCT00466687|Bevacizumab|bevacizumab|mesh-list
138898342|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138898343|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138898344|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898345|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138898346|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138898347|NCT00466687|Growth Substances|growth substances|mesh-ancestor
138898348|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898349|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
138898350|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138898351|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898352|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898353|NCT01759459|Lidocaine|lidocaine|mesh-list
138898354|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
138898355|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
138898356|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898357|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898358|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
138898359|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898361|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138898362|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138898363|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138438326|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138898364|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898365|NCT02562742|Ribavirin|ribavirin|mesh-list
138898366|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
138898367|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898369|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898370|NCT00744016|Mesalamine|mesalamine|mesh-list
138898371|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138898372|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138898373|NCT00744016|Analgesics|analgesics|mesh-ancestor
138898374|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
138898375|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898376|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898377|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138898379|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
138898380|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138898381|NCT04182737|Antibodies|antibodies|mesh-list
138898382|NCT04182737|Immunoglobulin M|immunoglobulin m|mesh-list
138898383|NCT04182737|Immunoglobulin A|immunoglobulin a|mesh-list
138898384|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
138898385|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898386|NCT04181645|Paclitaxel|paclitaxel|mesh-list
138898387|NCT04181645|Gemcitabine|gemcitabine|mesh-list
138898388|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138898389|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898390|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
138898391|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
138898392|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
138898393|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898394|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138898395|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
138898396|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
138898397|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
138438374|NCT01767610|Infliximab|infliximab|mesh-list
138898398|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
138898399|NCT02679833|Vitamins|vitamins|mesh-ancestor
138898400|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
138898401|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898402|NCT02679833|Hematinics|hematinics|mesh-ancestor
138898403|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
138898404|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138898405|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
138898406|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138898407|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898408|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898409|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
138898411|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898412|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898413|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138522627|NCT04629534|Vitamin D|vitamin d|mesh-list
138898414|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138438427|NCT01768260|Aspirin|aspirin|mesh-list
138898415|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138898416|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898417|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138898419|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
138898420|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138898421|NCT02677571|Narcotics|narcotics|mesh-ancestor
138898422|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898423|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898424|NCT02677571|Analgesics|analgesics|mesh-ancestor
138898425|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
138898426|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898427|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
138898428|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
138898429|NCT04181567|Agomelatine|agomelatine|mesh-list
138898430|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138506766|NCT00052468|Paclitaxel|paclitaxel|mesh-list
138898431|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898432|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898433|NCT05664191|Simendan|simendan|mesh-list
138898434|NCT05664191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138898435|NCT05664191|Vasodilator Agents|vasodilator agents|mesh-ancestor
138898436|NCT05664191|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138898437|NCT05664191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138898438|NCT05664191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898439|NCT05664191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898440|NCT05664191|Protective Agents|protective agents|mesh-ancestor
138898441|NCT05664191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898442|NCT02676011|Atropine|atropine|mesh-list
138898443|NCT02676011|Succinylcholine|succinylcholine|mesh-list
138898444|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138898445|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138700536|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
138898446|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138898448|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898449|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898450|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138898451|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
138898452|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
138898453|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
138898454|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138898455|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138898456|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
138898457|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898458|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898459|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138898460|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138898461|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138898462|NCT05663255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138898463|NCT05663255|Azithromycin|azithromycin|mesh-list
138898464|NCT05663255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898465|NCT02678975|Copper|copper|mesh-list
138898466|NCT02678975|Temozolomide|temozolomide|mesh-list
138898467|NCT02678975|Lomustine|lomustine|mesh-list
138898468|NCT02678975|Disulfiram|disulfiram|mesh-list
138898469|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
138898470|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138898471|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898472|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898473|NCT02678975|Trace Elements|trace elements|mesh-ancestor
138898474|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
138898475|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898476|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138898477|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138898478|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898479|NCT02677415|Anesthetics|anesthetics|mesh-list
138898480|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
138898481|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898482|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898483|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
138898484|NCT00454051|Omalizumab|omalizumab|mesh-list
138898485|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138898486|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138898487|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
138898488|NCT04181489|Prednisolone|prednisolone|mesh-list
138898489|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
138898490|NCT04181489|Rituximab|rituximab|mesh-list
138898491|NCT04181489|Doxorubicin|doxorubicin|mesh-list
138898492|NCT04181489|Vincristine|vincristine|mesh-list
138898493|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138898494|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
138898495|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898496|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138898497|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138898498|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
138898499|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898500|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898501|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138898502|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138898503|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138898504|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138898505|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138898506|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898507|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138898508|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
138898509|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
138898510|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
138898511|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138898512|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
138898513|NCT04181489|Hormones|hormones|mesh-ancestor
138898514|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138898515|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138898516|NCT02537561|Cisplatin|cisplatin|mesh-list
138898517|NCT02537561|Gemcitabine|gemcitabine|mesh-list
138898518|NCT02537561|Talazoparib|talazoparib|mesh-list
138898519|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898520|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138898521|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
138898522|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898523|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138898525|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
138898526|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138898527|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
138898528|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700667|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
138898529|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898530|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138898531|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
138898532|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
138898533|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138898534|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
138898535|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898536|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898537|NCT02679131|Belinostat|belinostat|mesh-list
138898538|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898539|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138898540|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898541|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898542|NCT00484939|Bevacizumab|bevacizumab|mesh-list
138898543|NCT00484939|Capecitabine|capecitabine|mesh-list
138898544|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138898545|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898546|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138898547|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138898548|NCT00484939|Growth Substances|growth substances|mesh-ancestor
138898549|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898550|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
138898551|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138898552|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
138898553|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898554|NCT00642161|Budesonide|budesonide|mesh-list
138898555|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138898556|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138898557|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
138898558|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898559|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898560|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138898561|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
138898562|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
138898563|NCT00642161|Hormones|hormones|mesh-ancestor
138898564|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138898565|NCT05663177|Vinorelbine|vinorelbine|mesh-list
138898566|NCT05663177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138898567|NCT05663177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898568|NCT05663177|Tubulin Modulators|tubulin modulators|mesh-ancestor
138898569|NCT05663177|Antimitotic Agents|antimitotic agents|mesh-ancestor
138898570|NCT05663177|Mitosis Modulators|mitosis modulators|mesh-ancestor
138898571|NCT05663177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898572|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
138898573|NCT00642551|Vitamin K|vitamin k|mesh-list
138898574|NCT00642551|Menaquinone 7|menaquinone 7|mesh-list
138898575|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138898576|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138898577|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898578|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
138898579|NCT00642551|Coagulants|coagulants|mesh-ancestor
138898580|NCT00642551|Vitamins|vitamins|mesh-ancestor
138898581|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
138898582|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550593|NCT00415285|Docetaxel|docetaxel|mesh-list
138898583|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138898584|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138898585|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898586|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138898587|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138898588|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138898589|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898590|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
138898591|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898592|NCT00643409|Azithromycin|azithromycin|mesh-list
138898593|NCT00643409|Levofloxacin|levofloxacin|mesh-list
138898594|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138898595|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898596|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138898597|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138898598|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138898599|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898600|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898601|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898602|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138898603|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138898604|NCT04180007|Apatinib|apatinib|mesh-list
138898605|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898606|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138898607|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898608|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898609|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138898610|NCT02675309|Simvastatin|simvastatin|mesh-list
138898611|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138898612|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138898613|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
138898614|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898615|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138898616|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138898617|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898619|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138898620|NCT01025245|Narcotics|narcotics|mesh-ancestor
138898621|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898622|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898623|NCT01025245|Analgesics|analgesics|mesh-ancestor
138898624|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
138898625|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898626|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138898627|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138898628|NCT02677259|Estradiol|estradiol|mesh-list
138898629|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138898630|NCT02677259|Progesterone|progesterone|mesh-list
138898631|NCT02677259|Estrogens|estrogens|mesh-ancestor
138898632|NCT02677259|Hormones|hormones|mesh-ancestor
138438738|NCT01769651|Narcotics|narcotics|mesh-ancestor
138898633|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138898634|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898635|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138522876|NCT03759938|Apixaban|apixaban|mesh-list
138898636|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
138898637|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138898638|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138898639|NCT02677259|Progestins|progestins|mesh-ancestor
138898640|NCT02675387|Lidocaine|lidocaine|mesh-list
138898641|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
138898642|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
138898643|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898644|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898645|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
138898646|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898647|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138898648|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138898649|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138898650|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138898651|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898652|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
138898653|NCT02678507|Narcotics|narcotics|mesh-ancestor
138898654|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138550665|NCT00100737|Rituximab|rituximab|mesh-list
138898655|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898656|NCT02678507|Analgesics|analgesics|mesh-ancestor
138898657|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
138898658|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898659|NCT00464737|Rotigotine|rotigotine|mesh-list
138898660|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
138898661|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
138898662|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898663|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898664|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898665|NCT02678585|Lidocaine|lidocaine|mesh-list
138898666|NCT02678585|Nalbuphine|nalbuphine|mesh-list
138898667|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
138898668|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
138898669|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898670|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138522900|NCT03492125|Rituximab|rituximab|mesh-list
138898671|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
138898672|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898673|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138898674|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138898675|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138898676|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138898677|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898678|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138898679|NCT02678585|Narcotics|narcotics|mesh-ancestor
138898680|NCT02678585|Analgesics|analgesics|mesh-ancestor
138898681|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
138898682|NCT00453349|Metronidazole|metronidazole|mesh-list
138898683|NCT00453349|Levofloxacin|levofloxacin|mesh-list
138898684|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138898685|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138898686|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898687|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138898688|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138898689|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898690|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898691|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898692|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138898693|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
138898694|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138898695|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898696|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138898697|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138898698|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138898699|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138898700|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138898701|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138898702|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138898703|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138898704|NCT02675153|Sirolimus|sirolimus|mesh-list
138898705|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138898706|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898707|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138898708|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898709|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
138898710|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138898711|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
138898712|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898713|NCT04179617|Nicotine|nicotine|mesh-list
138898714|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138898715|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
138898716|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898717|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898718|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138898719|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138898720|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
138898721|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898722|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898723|NCT00464269|Brivaracetam|brivaracetam|mesh-list
138898724|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
138898725|NCT00642863|Vitamin D|vitamin d|mesh-list
138550741|NCT00070538|Cytarabine|cytarabine|mesh-list
138898726|NCT00642863|Vitamins|vitamins|mesh-list
138898727|NCT00642863|Vitamin A|vitamin a|mesh-list
138898728|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
138898729|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
138898730|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898731|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
138898732|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898733|NCT00642863|Protective Agents|protective agents|mesh-ancestor
138898734|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138898735|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898736|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138898737|NCT02674997|Factor VIII|factor viii|mesh-list
138898738|NCT02674997|Coagulants|coagulants|mesh-ancestor
138898739|NCT04178291|Erythritol|erythritol|mesh-list
138898740|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
138898741|NCT00643643|Maraviroc|maraviroc|mesh-list
138898742|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138898743|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138898744|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898746|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138898747|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
138898748|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898749|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138898750|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
138898751|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138898752|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898753|NCT02676869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138898754|NCT02676869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898755|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
138898756|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138898757|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138898758|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138898759|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138898760|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898761|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
138898762|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898763|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898764|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138898765|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898767|NCT05584319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138898768|NCT05584319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898769|NCT05584319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138898770|NCT05584319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898771|NCT02676323|Leucovorin|leucovorin|mesh-list
138898772|NCT02676323|Cytarabine|cytarabine|mesh-list
138898773|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
138898774|NCT02676323|Methotrexate|methotrexate|mesh-list
138898775|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
138898776|NCT02676323|Fludarabine|fludarabine|mesh-list
138898777|NCT02676323|Panobinostat|panobinostat|mesh-list
138898778|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
138898779|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898780|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138898781|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
138898782|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138898783|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138898784|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
138898785|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898786|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898787|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
138898788|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898789|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138898790|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138898791|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
138898792|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138898793|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138898794|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
138898795|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898796|NCT02676323|Antidotes|antidotes|mesh-ancestor
138898797|NCT02676323|Protective Agents|protective agents|mesh-ancestor
138898798|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
138898799|NCT02676323|Vitamins|vitamins|mesh-ancestor
138898800|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
138898801|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138898802|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138898803|NCT00643799|Celecoxib|celecoxib|mesh-list
138898804|NCT00643799|Naproxen|naproxen|mesh-list
138898805|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138898806|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138898807|NCT00643799|Analgesics|analgesics|mesh-ancestor
138898808|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
138898809|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898810|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898811|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138898812|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138898813|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138898814|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138898815|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898816|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898817|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
138898818|NCT05348213|Decitabine|decitabine|mesh-list
138898819|NCT05348213|Pomalidomide|pomalidomide|mesh-list
138898820|NCT05348213|Zanubrutinib|zanubrutinib|mesh-list
138898821|NCT05348213|Tofacitinib|tofacitinib|mesh-list
138898822|NCT05348213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138898823|NCT05348213|Antimetabolites|antimetabolites|mesh-ancestor
138898824|NCT05348213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898825|NCT05348213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898826|NCT05348213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898827|NCT05348213|Immunologic Factors|immunologic factors|mesh-ancestor
138701193|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
138898828|NCT05348213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898829|NCT05348213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138898830|NCT05348213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138898831|NCT05348213|Growth Substances|growth substances|mesh-ancestor
138898832|NCT05348213|Growth Inhibitors|growth inhibitors|mesh-ancestor
138898833|NCT05348213|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138898834|NCT05348213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138898835|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
138898836|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898838|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
138898839|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138898840|NCT04179071|Famotidine|famotidine|mesh-list
138898841|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138898842|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138898843|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138898844|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
138898845|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
138898846|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898847|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898848|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898849|NCT02674139|Copper|copper|mesh-list
138898850|NCT02674139|Trace Elements|trace elements|mesh-ancestor
138898851|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
138898852|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898853|NCT00484315|Paclitaxel|paclitaxel|mesh-list
138898854|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138898855|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138898856|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898857|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
138898858|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
138898859|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
138898860|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898861|NCT01019083|Zinc|zinc|mesh-list
138898862|NCT01019083|Albendazole|albendazole|mesh-list
138898863|NCT01019083|Secnidazole|secnidazole|mesh-list
138898864|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
138898865|NCT01019083|Trace Elements|trace elements|mesh-ancestor
138898866|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
138898867|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898868|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
138898869|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138898870|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898871|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
138898872|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138898873|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138898874|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
138898875|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
138898876|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
138898877|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898878|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898879|NCT01019083|Astringents|astringents|mesh-ancestor
138898880|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
138898881|NCT00463801|Daptomycin|daptomycin|mesh-list
138898882|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138898883|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898884|NCT02672345|Sevoflurane|sevoflurane|mesh-list
138898885|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138898886|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138898887|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
138898888|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
138898889|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898890|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898891|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
138898892|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138898893|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898894|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898895|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138898896|NCT02537249|Analgesics|analgesics|mesh-ancestor
138898897|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
138898898|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898899|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138898900|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138898901|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138898902|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
138898903|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138898904|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898905|NCT00644111|Hydromorphone|hydromorphone|mesh-list
138898906|NCT00644111|Bupivacaine|bupivacaine|mesh-list
138898907|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
138898908|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
138898909|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138898910|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898911|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
138898912|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138898913|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138898914|NCT00644111|Narcotics|narcotics|mesh-ancestor
138898915|NCT00644111|Analgesics|analgesics|mesh-ancestor
138898916|NCT00644891|Amoxicillin|amoxicillin|mesh-list
138898917|NCT00644891|Cefdinir|cefdinir|mesh-list
138898918|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138898919|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898920|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138898921|NCT04178057|Antibodies|antibodies|mesh-list
138898922|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
138898923|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138898924|NCT04178057|Mitogens|mitogens|mesh-list
138898925|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
138898926|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
138898927|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898928|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898929|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
138898930|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898931|NCT04178057|Growth Substances|growth substances|mesh-ancestor
138898932|NCT04177043|Antibodies|antibodies|mesh-list
138898933|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
138438976|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
138898934|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
138898935|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898936|NCT02670785|Estradiol|estradiol|mesh-list
138898937|NCT02670785|Estrogens|estrogens|mesh-ancestor
138898938|NCT02670785|Hormones|hormones|mesh-ancestor
138898939|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138898940|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898941|NCT02670317|Prednisone|prednisone|mesh-list
138898942|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
138898943|NCT02670317|Doxorubicin|doxorubicin|mesh-list
138898944|NCT02670317|Vincristine|vincristine|mesh-list
138898945|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
138898946|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138898948|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898949|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138898950|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138898951|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
138898952|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898953|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898954|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138898955|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138898956|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138898957|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138898958|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898959|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138898960|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
138898961|NCT02670317|Hormones|hormones|mesh-ancestor
138709242|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898962|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138898963|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138898964|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138898965|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
138898966|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
138898967|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
138898968|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138898969|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
138898970|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138898971|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
138898972|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898973|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
138898974|NCT02671565|Protective Agents|protective agents|mesh-ancestor
138898976|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138898977|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
138898978|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138898979|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
138898980|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898981|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898982|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
138898983|NCT04175171|Trastuzumab|trastuzumab|mesh-list
138898984|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138898985|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898986|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
138898987|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138898988|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138898989|NCT00645125|Amoxicillin|amoxicillin|mesh-list
138898990|NCT00645125|Cefdinir|cefdinir|mesh-list
138898991|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138898992|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138898993|NCT02669459|Imiquimod|imiquimod|mesh-list
138898994|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138898995|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
138898996|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138898997|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138898998|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
138898999|NCT04176887|Phenytoin|phenytoin|mesh-list
138899000|NCT04176887|Levetiracetam|levetiracetam|mesh-list
138899001|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
138899002|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
138899003|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138899004|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138899005|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138899006|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899007|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138899008|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138899009|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138899010|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138899011|NCT00645203|Cefdinir|cefdinir|mesh-list
138899012|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138899013|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138899014|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
138899015|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138523090|NCT01969227|Ketamine|ketamine|mesh-list
138899016|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138899017|NCT02669303|Prednisolone|prednisolone|mesh-list
138899018|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
138899019|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138899020|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
138701531|NCT05427903|Carticaine|carticaine|mesh-list
138899021|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138899022|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
138899023|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
138899024|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899025|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899026|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138899027|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
138899028|NCT02669303|Hormones|hormones|mesh-ancestor
138899029|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138899030|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138899031|NCT02669303|Protective Agents|protective agents|mesh-ancestor
138899032|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138899033|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899034|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138899035|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138551024|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
138523126|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899036|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138899037|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
138899038|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899039|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899040|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899041|NCT00645281|Urological Agents|urological agents|mesh-ancestor
138899042|NCT02668679|Hormones|hormones|mesh-list
138899043|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138899044|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899045|NCT00645437|Levofloxacin|levofloxacin|mesh-list
138899046|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138899047|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138899048|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138899049|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138899050|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138899051|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899052|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899053|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899054|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138899055|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138899056|NCT02537171|Apatinib|apatinib|mesh-list
138899057|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899058|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138899060|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899061|NCT00645515|Risperidone|risperidone|mesh-list
138899062|NCT00645515|Ziprasidone|ziprasidone|mesh-list
138899063|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138899064|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
138899065|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899066|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899067|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899068|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138327394|NCT00299988|Antibodies|antibodies|mesh-list
138899069|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138899070|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899071|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138899072|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138899074|NCT00644735|Esomeprazole|esomeprazole|mesh-list
138899075|NCT00644735|Lansoprazole|lansoprazole|mesh-list
138899076|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
138899077|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138899078|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138899079|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138899080|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899081|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899082|NCT02667743|Paclitaxel|paclitaxel|mesh-list
138899083|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138899084|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138899085|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899086|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
138899087|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
138899088|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
138899089|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899090|NCT02666651|Tolvaptan|tolvaptan|mesh-list
138899091|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138709243|NCT03994393|Durvalumab|durvalumab|mesh-list
138899092|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899093|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
138899094|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899096|NCT02671175|Artenimol|artenimol|mesh-list
138899097|NCT02671175|Artemisinins|artemisinins|mesh-list
138899098|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
138899099|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138899100|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138899101|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138899102|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138899103|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138899104|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138899105|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
138899106|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551104|NCT00259441|Simvastatin|simvastatin|mesh-list
138899107|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138899108|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138899110|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
138899111|NCT02667197|Narcotics|narcotics|mesh-ancestor
138899112|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899113|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899114|NCT02667197|Analgesics|analgesics|mesh-ancestor
138899115|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
138899116|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899117|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
138899118|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
138899119|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138899120|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
138899121|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899122|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899123|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138899124|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
138899125|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138899126|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138899127|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138899128|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
138899129|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899130|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899131|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
138899132|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138899133|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
138899134|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138899135|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
138899136|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
138899137|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899138|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899139|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138439208|NCT01772381|Dexamethasone|dexamethasone|mesh-list
138899140|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138899141|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
138899142|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899143|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899144|NCT00646841|Doxazosin|doxazosin|mesh-list
138899145|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138899146|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138899147|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138899148|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138701778|NCT03277430|Tacrolimus|tacrolimus|mesh-list
138899149|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
138899150|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899151|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899152|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899153|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
138899154|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899155|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899156|NCT00484159|Lidocaine|lidocaine|mesh-list
138899157|NCT00484159|Bupivacaine|bupivacaine|mesh-list
138899158|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
138899159|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
138899160|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899161|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899162|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
138899163|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899164|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138460102|NCT04380857|Hormones|hormones|mesh-ancestor
138899165|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138899166|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138899167|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138899168|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899169|NCT02666417|Iron|iron|mesh-list
138899170|NCT02666417|Trace Elements|trace elements|mesh-ancestor
138899171|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
138899172|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899173|NCT00910637|Gestodene|gestodene|mesh-list
138899174|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138899175|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138899176|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138899177|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
138899178|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138899179|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899180|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138551172|NCT00105144|Caspofungin|caspofungin|mesh-list
138899181|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138899182|NCT00910637|Progestins|progestins|mesh-ancestor
138899183|NCT00910637|Hormones|hormones|mesh-ancestor
138899184|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138899185|NCT00462865|Bevacizumab|bevacizumab|mesh-list
138899186|NCT00462865|Gemcitabine|gemcitabine|mesh-list
138899187|NCT00462865|Capecitabine|capecitabine|mesh-list
138899188|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138899189|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899190|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138899191|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138439298|NCT01773044|Lidocaine|lidocaine|mesh-list
138899192|NCT00462865|Growth Substances|growth substances|mesh-ancestor
138899193|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899194|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
138899195|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138899196|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
138899197|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899198|NCT02667353|Anesthetics|anesthetics|mesh-list
138899199|NCT02667353|Etomidate|etomidate|mesh-list
138899200|NCT02667353|Succinylcholine|succinylcholine|mesh-list
138899201|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899202|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899203|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138899204|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138899205|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
138899206|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138899207|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138899208|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138899209|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899210|NCT00462709|Complement C1s|complement c1s|mesh-list
138899211|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138899212|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138899213|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
138899214|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899215|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138899216|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138899217|NCT02664857|Vitamin D|vitamin d|mesh-list
138899218|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
138899219|NCT02664857|Cholecalciferol|cholecalciferol|mesh-list
138899220|NCT02664857|Vitamins|vitamins|mesh-list
138899221|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
138899222|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899223|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138899224|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138899225|NCT02665871|Vaccines|vaccines|mesh-list
138899226|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
138899227|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899228|NCT00647543|Atorvastatin|atorvastatin|mesh-list
138899229|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138899230|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138899231|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
138899232|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899233|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138899234|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138899235|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899236|NCT00647621|Phenytoin|phenytoin|mesh-list
138899237|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
138899238|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138899239|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138899240|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138899241|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899242|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138899243|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138899244|NCT00461305|Drospirenone|drospirenone|mesh-list
138899245|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138899246|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
138899247|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138899248|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899249|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138899250|NCT00461305|Diuretics|diuretics|mesh-ancestor
138899251|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
138899252|NCT01022671|Belotecan|belotecan|mesh-list
138701904|NCT00447473|Ketoconazole|ketoconazole|mesh-list
138899253|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138899254|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138899255|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138506915|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138899256|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899257|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899259|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
138899260|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899261|NCT00645905|Adalimumab|adalimumab|mesh-list
138899262|NCT00645905|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138899263|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138899264|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138899265|NCT00647777|Olanzapine|olanzapine|mesh-list
138899266|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
138899267|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
138899268|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899269|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899270|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138899271|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138899272|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138899273|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899274|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138899275|NCT00647777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138899276|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138899277|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138899278|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899279|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899280|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
138899281|NCT04173611|Bupivacaine|bupivacaine|mesh-list
138899282|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
138899283|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
138899284|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899285|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899286|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
138899287|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899288|NCT02665637|Trastuzumab|trastuzumab|mesh-list
138899289|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138899290|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899291|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138899292|NCT00648011|Quinapril|quinapril|mesh-list
138899293|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138899294|NCT00648011|Diuretics|diuretics|mesh-ancestor
138899295|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
138899296|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899297|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138899298|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138709244|NCT03994393|Tremelimumab|tremelimumab|mesh-list
138899299|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899300|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138899301|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
138899302|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899303|NCT00646529|Budesonide|budesonide|mesh-list
138899304|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
138899305|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138899306|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138899307|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138899308|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
138899309|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899310|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899311|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138899312|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
138899313|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
138899314|NCT00646529|Hormones|hormones|mesh-ancestor
138899315|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138899316|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138899317|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138899318|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138899319|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
138899320|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899321|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899322|NCT00646607|Leucovorin|leucovorin|mesh-list
138899323|NCT00646607|Fluorouracil|fluorouracil|mesh-list
138899324|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
138899325|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
138899326|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
138899327|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899328|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138899329|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899330|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138899331|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
138899332|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899333|NCT00646607|Antidotes|antidotes|mesh-ancestor
138899334|NCT00646607|Protective Agents|protective agents|mesh-ancestor
138701971|NCT00448214|Warfarin|warfarin|mesh-list
138899335|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
138899337|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
138899338|NCT00856544|Tofacitinib|tofacitinib|mesh-list
138439393|NCT01773616|Hormones|hormones|mesh-ancestor
138899339|NCT00856544|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138899340|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138899341|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899342|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899343|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138899344|NCT00648323|Doxazosin|doxazosin|mesh-list
138899345|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138899346|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138899347|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138899348|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138899349|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
138899350|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523404|NCT05423769|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138899351|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899352|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899353|NCT00856388|Fludarabine|fludarabine|mesh-list
138899354|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
138899355|NCT00856388|Melphalan|melphalan|mesh-list
138899356|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
138899357|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138899358|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
138899359|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899360|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138899361|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
138702004|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
138899362|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899363|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138899364|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
138899365|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899366|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138899367|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
138899368|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138899369|NCT00648401|Verapamil|verapamil|mesh-list
138899370|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138899371|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138899372|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138899373|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899374|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138899375|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899376|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
138899377|NCT02663999|Diazepam|diazepam|mesh-list
138899378|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138899379|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
138899380|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
138899381|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
138899382|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899383|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899384|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138899385|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138899386|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899387|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138899388|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138899389|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138899390|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138899391|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138899392|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138439454|NCT01774474|Dexamethasone|dexamethasone|mesh-list
138899393|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
138899394|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
138899395|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
138899396|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
138899397|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899398|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899399|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
138899400|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
138899401|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138899402|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899403|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899404|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
138899405|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138899406|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138702051|NCT04698941|Paclitaxel|paclitaxel|mesh-list
138899407|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899409|NCT04171739|Olorofim|olorofim|mesh-list
138899410|NCT04171739|Rifampin|rifampin|mesh-list
138899411|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
138899412|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138899413|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138899414|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138899415|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523502|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899416|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899417|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138899418|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
138899419|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138899420|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899421|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138899422|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138899423|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
138899424|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138899425|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
138899426|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138449765|NCT01866059|Calcium|calcium|mesh-list
138899427|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138899428|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138899429|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138899430|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138899431|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138899432|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138899434|NCT02656121|Clomiphene|clomiphene|mesh-list
138899435|NCT02656121|Vitamins|vitamins|mesh-ancestor
138899436|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
138899437|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899438|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138899439|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138899440|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
138899441|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138899442|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138899443|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
138899444|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138439555|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138899445|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138899446|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138899447|NCT00648713|Terbinafine|terbinafine|mesh-list
138899448|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
138899449|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138899450|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899451|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899452|NCT00649883|Vaccines|vaccines|mesh-list
138899453|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
138788210|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
138523538|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
138899454|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899455|NCT00648791|Finasteride|finasteride|mesh-list
138899456|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138899457|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138899458|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899459|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899460|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
138899461|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138899462|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899463|NCT00648791|Urological Agents|urological agents|mesh-ancestor
138899464|NCT00649181|Metolazone|metolazone|mesh-list
138899465|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138899466|NCT00649181|Diuretics|diuretics|mesh-ancestor
138899467|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
138899468|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899469|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138899470|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138439610|NCT01775891|Flecainide|flecainide|mesh-list
138899471|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899473|NCT02655965|Ropivacaine|ropivacaine|mesh-list
138899474|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
138899475|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
138899476|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899477|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899478|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
138899479|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899480|NCT02655965|Analgesics|analgesics|mesh-ancestor
138899481|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138899482|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
138899483|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
138899484|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138899485|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138899486|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138899487|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
138899488|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788258|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
138899489|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899490|NCT04170179|Lenvatinib|lenvatinib|mesh-list
138899491|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138523573|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
138899492|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138899493|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899494|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899495|NCT02659085|Ketamine|ketamine|mesh-list
138899496|NCT02659085|Analgesics|analgesics|mesh-ancestor
138899497|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
138899498|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899499|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899500|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138899501|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138899502|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
138899503|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
138899504|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899505|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138899506|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138899507|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899508|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899509|NCT04171193|Isoflurane|isoflurane|mesh-list
138899510|NCT04171193|Sertraline|sertraline|mesh-list
138899511|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
138899512|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138899513|NCT04171193|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138899514|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138899515|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138899516|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899517|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899518|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
138899519|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899520|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138899521|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
138899522|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
138899523|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899524|NCT02663141|Bevacizumab|bevacizumab|mesh-list
138899525|NCT02663141|Losartan|losartan|mesh-list
138899526|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138899527|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899528|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138899529|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138899530|NCT02663141|Growth Substances|growth substances|mesh-ancestor
138899531|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899532|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
138899533|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138899534|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138899535|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138899536|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138439697|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138899537|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899538|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
138899539|NCT04171349|Carticaine|carticaine|mesh-list
138899540|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138899541|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899542|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899543|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138899544|NCT04171349|Analgesics|analgesics|mesh-ancestor
138899545|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
138899546|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899547|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138899548|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138551559|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
138899549|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138899550|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
138899551|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899552|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899553|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
138899554|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
138899555|NCT00650039|Valdecoxib|valdecoxib|mesh-list
138899556|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138899557|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138899558|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899559|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899560|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138899561|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138899562|NCT00650039|Analgesics|analgesics|mesh-ancestor
138899563|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
138899564|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899565|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899566|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439739|NCT01777477|Amebicides|amebicides|mesh-ancestor
138899567|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138899569|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
138899570|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
138899571|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899572|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899573|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138899574|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138899575|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
138899576|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899577|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899578|NCT00649259|Urological Agents|urological agents|mesh-ancestor
138899579|NCT02658773|Lidocaine|lidocaine|mesh-list
138899580|NCT02658773|Prilocaine|prilocaine|mesh-list
138899581|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138899582|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
138899583|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
138899584|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899585|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899586|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
138899587|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899588|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138899589|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138899590|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138899591|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138899592|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899593|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138899594|NCT00648869|Metformin|metformin|mesh-list
138899595|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138899596|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899597|NCT04169945|Erythritol|erythritol|mesh-list
138899598|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
138899599|NCT04169867|Nivolumab|nivolumab|mesh-list
138899600|NCT04169867|Ipilimumab|ipilimumab|mesh-list
138899601|NCT04169867|Atezolizumab|atezolizumab|mesh-list
138899602|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138899603|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899604|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138899605|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899606|NCT02655029|Amlodipine|amlodipine|mesh-list
138899607|NCT02655029|Perindopril|perindopril|mesh-list
138899608|NCT02655029|Indapamide|indapamide|mesh-list
138899609|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138899610|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138899611|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138899612|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138507008|NCT00054340|Busulfan|busulfan|mesh-list
138899613|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138899614|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899615|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
138899616|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138899617|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
138899618|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899619|NCT02655029|Diuretics|diuretics|mesh-ancestor
138899620|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
138899621|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138899622|NCT02536859|Insulin|insulin|mesh-list
138899623|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138899625|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138899626|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899627|NCT02536937|Eliglustat|eliglustat|mesh-list
138899628|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899629|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899630|NCT02654405|Butyric Acid|butyric acid|mesh-list
138899631|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
138523644|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138523645|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
138523646|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138523647|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
138523648|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138523649|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
138523650|NCT04323657|Fludarabine|fludarabine|mesh-list
138523660|NCT04318691|Dimercaprol|dimercaprol|mesh-list
138899632|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
138899633|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899634|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899635|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899637|NCT00649415|Piroxicam|piroxicam|mesh-list
138899638|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138899639|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138899640|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899641|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899642|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138899643|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138899644|NCT00649415|Analgesics|analgesics|mesh-ancestor
138899645|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
138899646|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899647|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899648|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138899649|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138899650|NCT00650117|Fentanyl|fentanyl|mesh-list
138899651|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138899652|NCT00650117|Narcotics|narcotics|mesh-ancestor
138899653|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899654|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899655|NCT00650117|Analgesics|analgesics|mesh-ancestor
138899656|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
138899657|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899658|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138899659|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138899660|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
138899661|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
138523687|NCT04189107|Dexamethasone|dexamethasone|mesh-list
138523688|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
138523689|NCT04189107|BB 1101|bb 1101|mesh-list
138523690|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138523691|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
138523692|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
138523693|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899662|NCT00648947|Clopidogrel|clopidogrel|mesh-list
138899663|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138899664|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138899665|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138899666|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138899667|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
138899668|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899669|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899670|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899671|NCT00649493|Rabeprazole|rabeprazole|mesh-list
138899672|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138398902|NCT01538771|Hematinics|hematinics|mesh-ancestor
138899673|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138899674|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138899675|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899676|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899677|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
138899678|NCT02654093|Vitamin D|vitamin d|mesh-list
138899679|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138899680|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138899681|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899682|NCT02654093|Vitamins|vitamins|mesh-ancestor
138899683|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
138899684|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138788576|NCT02672566|Enoxaparin|enoxaparin|mesh-list
138899685|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138899686|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
138899687|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138899688|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138899689|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138899690|NCT04168619|Methotrexate|methotrexate|mesh-list
138899691|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138899692|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
138899693|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138523728|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
138899694|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899695|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138899696|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
138899697|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899698|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899699|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
138899700|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899701|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138899702|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138899703|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
138899704|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138899705|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138899707|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
138899708|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138899709|NCT00650195|Metolazone|metolazone|mesh-list
138899710|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138899711|NCT00650195|Diuretics|diuretics|mesh-ancestor
138899712|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
138899713|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899714|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138899715|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138899716|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899717|NCT04170959|Metformin|metformin|mesh-list
138899718|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138899719|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899720|NCT00848354|Etanercept|etanercept|mesh-list
138899721|NCT00848354|Methotrexate|methotrexate|mesh-list
138899722|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138899723|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
138440090|NCT01779921|Thrombin|thrombin|mesh-list
138899724|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138899725|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899726|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138899727|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
138899728|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899729|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899730|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
138899731|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899732|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138899733|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138899734|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
138899735|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138523760|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138899736|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138899737|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138899738|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138899739|NCT00848354|Analgesics|analgesics|mesh-ancestor
138899740|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
138899741|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899742|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138899743|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138899744|NCT00600821|Paclitaxel|paclitaxel|mesh-list
138440153|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
138899746|NCT00600821|Bevacizumab|bevacizumab|mesh-list
138899747|NCT00600821|Carboplatin|carboplatin|mesh-list
138899748|NCT00600821|Axitinib|axitinib|mesh-list
138899749|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138899750|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899751|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
138899752|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
138899753|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
138899754|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899755|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138899756|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138899757|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138899758|NCT00600821|Growth Substances|growth substances|mesh-ancestor
138899759|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899760|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
138899761|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138899762|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899763|NCT00699764|Vaccines|vaccines|mesh-list
138899764|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
138899765|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899766|NCT02653703|Ethanol|ethanol|mesh-list
138899767|NCT02653703|Menthol|menthol|mesh-list
138899768|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138899769|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138899770|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899771|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899772|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
138899773|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
138899774|NCT00649571|Doxycycline|doxycycline|mesh-list
138899775|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138899776|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788775|NCT02667730|Celecoxib|celecoxib|mesh-list
138899777|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
138899778|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138899779|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138899780|NCT02662283|Acteoside|acteoside|mesh-list
138899781|NCT02662283|Prednisolone|prednisolone|mesh-list
138523790|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
138899782|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138899783|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
138899784|NCT02662283|Hormones|hormones|mesh-ancestor
138899785|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138899786|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899787|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138899788|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899789|NCT02662283|Protective Agents|protective agents|mesh-ancestor
138899790|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138899791|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138899792|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
138788829|NCT02870634|Trace Elements|trace elements|mesh-ancestor
138899793|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899795|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
138899796|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138899797|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
138899798|NCT02657603|Lidocaine|lidocaine|mesh-list
138899799|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
138899801|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899802|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899803|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
138899804|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899805|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138899806|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138899807|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138899808|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138899809|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899810|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138899811|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
138899812|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
138899813|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899814|NCT00649649|Quinapril|quinapril|mesh-list
138899815|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138899816|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
138899817|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899818|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899819|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138899820|NCT02657291|Ropivacaine|ropivacaine|mesh-list
138899821|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
138899822|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
138899823|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899824|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899825|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
138899826|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899827|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138899828|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
138899829|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138899830|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138899831|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138899832|NCT02661893|Rifampin|rifampin|mesh-list
138899833|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138899834|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
138899835|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138899836|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138899837|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
138899838|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138899839|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899840|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899841|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138899842|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138899843|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138899844|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138899845|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138899846|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138899847|NCT00855920|Indomethacin|indomethacin|mesh-list
138899848|NCT00855920|Rilonacept|rilonacept|mesh-list
138899849|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138899850|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138899851|NCT00855920|Analgesics|analgesics|mesh-ancestor
138899852|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
138899853|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899854|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899855|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138899856|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138899857|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
138899858|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
138899859|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138899860|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138899861|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899862|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899863|NCT02657213|Insulin|insulin|mesh-list
138899864|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138899865|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138899866|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899867|NCT00649727|Oxybutynin|oxybutynin|mesh-list
138899868|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
138899869|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
138899870|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138899871|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789068|NCT02666716|Fluconazole|fluconazole|mesh-list
138899872|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138899873|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138899875|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138523845|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899876|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899877|NCT00649727|Urological Agents|urological agents|mesh-ancestor
138899878|NCT00650273|Azithromycin|azithromycin|mesh-list
138899879|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138899880|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138899881|NCT00698126|Insulin|insulin|mesh-list
138899882|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138899883|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
138899884|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
138899885|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138899886|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899887|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
138899888|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
138899889|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899890|NCT02656901|Anesthetics|anesthetics|mesh-list
138899891|NCT02656901|Sevoflurane|sevoflurane|mesh-list
138899892|NCT02656901|Desflurane|desflurane|mesh-list
138899893|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899894|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899895|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138899896|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138899897|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
138899898|NCT00847886|Methotrexate|methotrexate|mesh-list
138899899|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138899900|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
138899902|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899903|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138899904|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
138440382|NCT01782287|Vaccines|vaccines|mesh-list
138702093|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138899905|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899906|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899907|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
138899908|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899909|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138899910|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138899911|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
138899912|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138899913|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138899914|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
138899916|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138899917|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138523873|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
138899918|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138899919|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899920|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899921|NCT02656979|Latanoprost|latanoprost|mesh-list
138899922|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138899923|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138899924|NCT04017455|Bevacizumab|bevacizumab|mesh-list
138899925|NCT04017455|Atezolizumab|atezolizumab|mesh-list
138899926|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138899927|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899928|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138899929|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138899930|NCT04017455|Growth Substances|growth substances|mesh-ancestor
138899931|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899932|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
138899933|NCT04017455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138899934|NCT04017455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899936|NCT05298020|Gemcitabine|gemcitabine|mesh-list
138899937|NCT05298020|Endostar protein|endostar protein|mesh-list
138899938|NCT05298020|Endostatins|endostatins|mesh-list
138899939|NCT05298020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138899940|NCT05298020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899941|NCT05298020|Tubulin Modulators|tubulin modulators|mesh-ancestor
138899942|NCT05298020|Antimitotic Agents|antimitotic agents|mesh-ancestor
138899943|NCT05298020|Mitosis Modulators|mitosis modulators|mesh-ancestor
138899944|NCT05298020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138523909|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138899945|NCT05298020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138899946|NCT05298020|Antimetabolites|antimetabolites|mesh-ancestor
138899947|NCT05298020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450174|NCT01869569|Pregabalin|pregabalin|mesh-list
138899948|NCT05298020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138899949|NCT05298020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138899950|NCT05298020|Growth Substances|growth substances|mesh-ancestor
138899951|NCT05298020|Growth Inhibitors|growth inhibitors|mesh-ancestor
138899952|NCT04170647|Plasminogen|plasminogen|mesh-list
138899953|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138899954|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138899955|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899956|NCT02661347|Risperidone|risperidone|mesh-list
138899957|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138899958|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
138899959|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899960|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899961|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899962|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138507102|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
138899963|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138899964|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138899965|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138899966|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138899967|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
138899968|NCT00649805|Verapamil|verapamil|mesh-list
138899969|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138899970|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138899971|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138899972|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899973|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138899974|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899975|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
138899976|NCT02656589|Capecitabine|capecitabine|mesh-list
138899977|NCT02656589|Trastuzumab|trastuzumab|mesh-list
138899978|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138899979|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
138899980|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138899981|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899982|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138899983|NCT00600353|Dexamethasone|dexamethasone|mesh-list
138899984|NCT00600353|Aprepitant|aprepitant|mesh-list
138899986|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138899987|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
138899988|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
138899989|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138523957|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138899990|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138899991|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138899992|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
138899994|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138899995|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138899996|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138899997|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138899998|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138899999|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900000|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138900001|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138900002|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
138900003|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
138900005|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138900006|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900007|NCT02661191|Vitamins|vitamins|mesh-ancestor
138900008|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
138900009|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138900010|NCT00691210|Niacinamide|niacinamide|mesh-list
138900012|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
138900013|NCT00691210|Etoposide|etoposide|mesh-list
138900014|NCT00691210|Vorinostat|vorinostat|mesh-list
138900015|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138900016|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900017|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138900018|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138900019|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900020|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900021|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138900022|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
138900023|NCT00691210|Vitamins|vitamins|mesh-ancestor
138900024|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
138900025|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900026|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138900027|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
138900028|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138900029|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
138900030|NCT02652065|Acetylcholine|acetylcholine|mesh-list
138900031|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
138900032|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138900033|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
138900034|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138900035|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900036|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900038|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138900039|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
138900040|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138900041|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900042|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900043|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138900044|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138900045|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900046|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138900047|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138900048|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
138900049|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
138900050|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900051|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900052|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138900053|NCT00691132|Protective Agents|protective agents|mesh-ancestor
138900054|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900055|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900056|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
138900057|NCT02651753|Atorvastatin|atorvastatin|mesh-list
138440678|NCT01784549|Docetaxel|docetaxel|mesh-list
138900058|NCT02651753|Fenofibrate|fenofibrate|mesh-list
138900059|NCT02651753|Calcium|calcium|mesh-list
138900060|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138900061|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900062|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138900063|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138900065|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
138900066|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900067|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138900068|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138900069|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900070|NCT00855218|Sorafenib|sorafenib|mesh-list
138900071|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900072|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138900073|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138524019|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138900074|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900076|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
138900077|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900078|NCT02651519|Ropivacaine|ropivacaine|mesh-list
138900079|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
138900080|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
138900081|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900082|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900083|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
138900084|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900085|NCT02651441|Gemcitabine|gemcitabine|mesh-list
138900086|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900087|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138900089|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900090|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
138900091|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138900092|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
138900093|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900094|NCT01063348|Expectorants|expectorants|mesh-ancestor
138900095|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
138900096|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138900097|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
138900098|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900099|NCT01063348|Protective Agents|protective agents|mesh-ancestor
138328460|NCT00373386|Hormones|hormones|mesh-list
138900100|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900102|NCT00855062|Minocycline|minocycline|mesh-list
138900103|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138900104|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900105|NCT00744250|Pancrelipase|pancrelipase|mesh-list
138900106|NCT00744250|Pancreatin|pancreatin|mesh-list
138900107|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138900108|NCT02651207|Lidocaine|lidocaine|mesh-list
138900109|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
138900110|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
138900111|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
138900112|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
138900113|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900114|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900115|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
138900116|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900117|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138900118|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138900119|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138900120|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138900121|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900122|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138900124|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138900125|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
138900126|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900127|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900128|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900129|NCT00600119|Naloxegol|naloxegol|mesh-list
138900130|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138900131|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900132|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
138900133|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900134|NCT00866294|Paroxetine|paroxetine|mesh-list
138900135|NCT00866294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138900136|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138900137|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138900138|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900139|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138900140|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
138900141|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900142|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138900143|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
138552148|NCT00268333|Antidotes|antidotes|mesh-ancestor
138900144|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138900145|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138789526|NCT00702793|Varenicline|varenicline|mesh-list
138900146|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138900147|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900148|NCT00649103|Quinapril|quinapril|mesh-list
138900149|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138900150|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
138900151|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900152|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900153|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138900154|NCT02660177|Dipyrone|dipyrone|mesh-list
138900155|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138900156|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138900157|NCT02660177|Analgesics|analgesics|mesh-ancestor
138900158|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
138900159|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900160|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900161|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138900162|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138900163|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
138900164|NCT00701246|Folic Acid|folic acid|mesh-list
138900165|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
138900166|NCT00701246|Hematinics|hematinics|mesh-ancestor
138900167|NCT00701246|Vitamins|vitamins|mesh-ancestor
138900168|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
138900169|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900170|NCT02648711|Leucovorin|leucovorin|mesh-list
138507128|NCT00055120|Ritonavir|ritonavir|mesh-list
138900171|NCT02648711|Bevacizumab|bevacizumab|mesh-list
138900172|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
138900173|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138900174|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900175|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138900176|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138900177|NCT02648711|Growth Substances|growth substances|mesh-ancestor
138900178|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900179|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
138900180|NCT02648711|Antidotes|antidotes|mesh-ancestor
138900181|NCT02648711|Protective Agents|protective agents|mesh-ancestor
138900182|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
138900184|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
138900185|NCT00854360|Beclomethasone|beclomethasone|mesh-list
138789637|NCT00648076|Valproic Acid|valproic acid|mesh-list
138900186|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138900187|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
138900188|NCT00854360|Hormones|hormones|mesh-ancestor
138900189|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138900190|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900191|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138900192|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
138900193|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
138900194|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138900195|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900196|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138900197|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138900198|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900199|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900200|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900201|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138900202|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138900203|NCT02648633|Nivolumab|nivolumab|mesh-list
138900204|NCT02648633|Valproic Acid|valproic acid|mesh-list
138900205|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138900206|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440833|NCT01785589|Adenosine|adenosine|mesh-list
138900207|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138900208|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900209|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
138900210|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900211|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
138900212|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138900213|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900214|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
138900215|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138900216|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900217|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138900218|NCT00853970|Bromfenac|bromfenac|mesh-list
138900219|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138900220|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138900221|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138900222|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138900223|NCT00853970|Analgesics|analgesics|mesh-ancestor
138900224|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
138900225|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900226|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900227|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138900228|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138900229|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138900230|NCT00651287|Quinapril|quinapril|mesh-list
138900231|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138900232|NCT00651287|Diuretics|diuretics|mesh-ancestor
138900233|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
138900234|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900235|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138900236|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138900237|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900238|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138900239|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
138900240|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900241|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138900242|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138900243|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900244|NCT02650427|Incretins|incretins|mesh-ancestor
138900245|NCT02650427|Hormones|hormones|mesh-ancestor
138900246|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138900247|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138900248|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
138900249|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900250|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900251|NCT02644811|Anesthetics|anesthetics|mesh-list
138900252|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900253|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900254|NCT00651443|Galiximab|galiximab|mesh-list
138900255|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138900256|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900257|NCT00650897|Escitalopram|escitalopram|mesh-list
138900258|NCT00650897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138900259|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138900260|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138900261|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900262|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138900263|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
138900264|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900265|NCT02644499|Folic Acid|folic acid|mesh-list
138900266|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
138900267|NCT02644499|Prednisolone|prednisolone|mesh-list
138900268|NCT02644499|Methotrexate|methotrexate|mesh-list
138524234|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524235|NCT00019331|Aldesleukin|aldesleukin|mesh-list
138900269|NCT02644499|Leflunomide|leflunomide|mesh-list
138789852|NCT01155284|Hormones|hormones|mesh-ancestor
138900270|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
138900271|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138900272|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
138900273|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138900274|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900275|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138900276|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
138900277|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900278|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900279|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
138900280|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900281|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138900282|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138900283|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
138900284|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138900285|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138900286|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138524275|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138900287|NCT02644499|Hormones|hormones|mesh-ancestor
138900288|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138900289|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138900290|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
138900291|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138900292|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138900293|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900294|NCT02644499|Hematinics|hematinics|mesh-ancestor
138900295|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
138900297|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
138900298|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
138900299|NCT00652691|Carboplatin|carboplatin|mesh-list
138900300|NCT00652691|Topotecan|topotecan|mesh-list
138900301|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138900303|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900304|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138900305|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138900306|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
138900307|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900308|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900309|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138900310|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138900311|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138900312|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900313|NCT02649179|Ropivacaine|ropivacaine|mesh-list
138900314|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
138900315|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
138789949|NCT00700687|Aspirin|aspirin|mesh-list
138900316|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900317|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900318|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
138900319|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900320|NCT02644577|Metformin|metformin|mesh-list
138900321|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138900322|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900323|NCT02644421|Lidocaine|lidocaine|mesh-list
138900324|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
138900325|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
138900326|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900327|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900328|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
138900329|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900330|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138900331|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138900332|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138900333|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138900334|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900335|NCT00651599|Drospirenone|drospirenone|mesh-list
138900336|NCT00651599|Estradiol|estradiol|mesh-list
138900337|NCT00651599|Estrogens|estrogens|mesh-ancestor
138900338|NCT00651599|Hormones|hormones|mesh-ancestor
138900339|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138900340|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900341|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138900342|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
138900343|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138900344|NCT00651599|Diuretics|diuretics|mesh-ancestor
138900345|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
138900346|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138900347|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138900348|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138900349|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
138900350|NCT02536391|Ipatasertib|ipatasertib|mesh-list
138900351|NCT02536391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900352|NCT02536391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138900353|NCT02536391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900354|NCT02536391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900355|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138900356|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138790047|NCT04116931|Clopidogrel|clopidogrel|mesh-list
138900357|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
138900358|NCT00651131|Daptomycin|daptomycin|mesh-list
138900359|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138900360|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900361|NCT04167137|Atezolizumab|atezolizumab|mesh-list
138900362|NCT04167137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138900363|NCT04167137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900364|NCT04167137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138900365|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900366|NCT02649413|Prednisone|prednisone|mesh-list
138900367|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138900368|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
138900369|NCT02649413|Hormones|hormones|mesh-ancestor
138709245|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138900370|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138900371|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900372|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138900375|NCT02643563|Bupivacaine|bupivacaine|mesh-list
138900376|NCT02643563|Ropivacaine|ropivacaine|mesh-list
138900377|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
138900378|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
138900379|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900380|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900381|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
138900382|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900383|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138900384|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138900385|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
138900386|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138900387|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900388|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138900389|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138900390|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
138900391|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138900392|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
138900393|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
138900394|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
138900395|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138900396|NCT00651209|Tenofovir|tenofovir|mesh-list
138900397|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
138900398|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900399|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138900400|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138790160|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
138900402|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900403|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138900404|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138900405|NCT00652925|Celecoxib|celecoxib|mesh-list
138900406|NCT00652925|Naproxen|naproxen|mesh-list
138900407|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138900408|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138900409|NCT00652925|Analgesics|analgesics|mesh-ancestor
138900410|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
138900411|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900412|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900413|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138900414|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138900415|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138900416|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138900417|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900418|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900419|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
138900420|NCT00653003|Leflunomide|leflunomide|mesh-list
138900421|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900422|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900423|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138900424|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
138900425|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900426|NCT02643719|Topiramate|topiramate|mesh-list
138900427|NCT02643719|Naproxen|naproxen|mesh-list
138900428|NCT02643719|Sumatriptan|sumatriptan|mesh-list
138900429|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138900430|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138900431|NCT02643719|Analgesics|analgesics|mesh-ancestor
138900432|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
138900433|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900434|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900437|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
138900438|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138900439|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900440|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900441|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
138900442|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138900443|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138900444|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138900445|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138900446|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
138900447|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138900448|NCT02649101|Thalidomide|thalidomide|mesh-list
138900449|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138900450|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
138900451|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900452|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
138900453|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138900454|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900455|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138900456|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138900457|NCT02649101|Growth Substances|growth substances|mesh-ancestor
138524512|NCT00040014|Exemestane|exemestane|mesh-list
138900458|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
138900459|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900460|NCT00700154|Insulin|insulin|mesh-list
138900461|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138900462|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
138900463|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138900464|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900465|NCT00651911|Rasburicase|rasburicase|mesh-list
138900466|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
138900467|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138900468|NCT02643407|Docetaxel|docetaxel|mesh-list
138900469|NCT02643407|Nedaplatin|nedaplatin|mesh-list
138900470|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900471|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
138900472|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
138900473|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
138900474|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900475|NCT02643329|Gliclazide|gliclazide|mesh-list
138900476|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138900477|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900478|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
138900479|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138900480|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900481|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900482|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138900483|NCT02643017|Analgesics|analgesics|mesh-ancestor
138900484|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
138900485|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900486|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138900487|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138900488|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138900489|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
138900490|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138900491|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900492|NCT02643173|Anesthetics|anesthetics|mesh-list
138900493|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
138900494|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900495|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900496|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
138900497|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
138900498|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138900499|NCT02646137|Estrogens|estrogens|mesh-ancestor
138900501|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138900502|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900503|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138900504|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900505|NCT00653549|Torsemide|torsemide|mesh-list
138900506|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138900507|NCT00653549|Diuretics|diuretics|mesh-ancestor
138900508|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
138900509|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900510|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138900511|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138900512|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900513|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
138900514|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
138900515|NCT02642861|Calcium|calcium|mesh-list
138900516|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138524557|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138900517|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552529|NCT00269932|Levofloxacin|levofloxacin|mesh-list
138900519|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900520|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138900521|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138900522|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
138900523|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138900524|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138900525|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138900526|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900527|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138900528|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900529|NCT02641457|Ranibizumab|ranibizumab|mesh-list
138900530|NCT02641457|Aflibercept|aflibercept|mesh-list
138900531|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138900532|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138900533|NCT02641457|Growth Substances|growth substances|mesh-ancestor
138900534|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900535|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
138900536|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900537|NCT02642939|Mifepristone|mifepristone|mesh-list
138900538|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138900539|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
138900540|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138900541|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790390|NCT00600028|Thalidomide|thalidomide|mesh-list
138900542|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138900543|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138900544|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138900545|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
138900546|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138900547|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138900548|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
138900549|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138900550|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
138900551|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138900552|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138900553|NCT02641301|Morphine|morphine|mesh-list
138900554|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138900555|NCT02641301|Narcotics|narcotics|mesh-ancestor
138441306|NCT01788969|Escitalopram|escitalopram|mesh-list
138900556|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900557|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900558|NCT02641301|Analgesics|analgesics|mesh-ancestor
138900559|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
138900560|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900561|NCT02640989|Vaccines|vaccines|mesh-list
138900562|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
138900563|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900564|NCT02645747|Aflibercept|aflibercept|mesh-list
138900565|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138900566|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138900567|NCT02645747|Growth Substances|growth substances|mesh-ancestor
138900568|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900569|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
138900570|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900571|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
138900572|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138900573|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900574|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
138900575|NCT00653315|Tramadol|tramadol|mesh-list
138900576|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138900577|NCT00653315|Narcotics|narcotics|mesh-ancestor
138900578|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900579|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900580|NCT00653315|Analgesics|analgesics|mesh-ancestor
138900581|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
138900582|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900583|NCT02640833|Venetoclax|venetoclax|mesh-list
138900584|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900585|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
138900586|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
138900587|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138900588|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138900589|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900590|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900591|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138552599|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
138900592|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138900593|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900594|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900596|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900597|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900598|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138900599|NCT02645903|Narcotics|narcotics|mesh-ancestor
138900600|NCT02645903|Analgesics|analgesics|mesh-ancestor
138900601|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
138900602|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900603|NCT02645981|Sorafenib|sorafenib|mesh-list
138900604|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900605|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138900606|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900607|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900608|NCT02535767|Primaquine|primaquine|mesh-list
138900609|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
138900610|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138900611|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138900612|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900613|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
138900614|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900615|NCT02640365|Leucovorin|leucovorin|mesh-list
138900616|NCT02640365|Bevacizumab|bevacizumab|mesh-list
138900617|NCT02640365|Irinotecan|irinotecan|mesh-list
138900618|NCT02640365|Camptothecin|camptothecin|mesh-list
138900619|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138900620|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900621|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138900622|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138900623|NCT02640365|Growth Substances|growth substances|mesh-ancestor
138900624|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900625|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
138900626|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138900627|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138900628|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900629|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900630|NCT02640365|Antidotes|antidotes|mesh-ancestor
138900631|NCT02640365|Protective Agents|protective agents|mesh-ancestor
138900632|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
138900633|NCT02640365|Vitamins|vitamins|mesh-ancestor
138900634|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
138900635|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138900636|NCT02642003|Lenograstim|lenograstim|mesh-list
138900637|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138900639|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900640|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
138900641|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138900642|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
138900643|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138900644|NCT00652379|Octreotide|octreotide|mesh-list
138900645|NCT00652379|Lanreotide|lanreotide|mesh-list
138900646|NCT00652379|Somatostatin|somatostatin|mesh-list
138900647|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138790578|NCT02644720|Hormones|hormones|mesh-ancestor
138900648|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138900649|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900651|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138900652|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900654|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138900655|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138900656|NCT04164797|Growth Substances|growth substances|mesh-ancestor
138900657|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900658|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
138900659|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900660|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
138900661|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
138900662|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138900663|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138900664|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900665|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900666|NCT00654017|Urological Agents|urological agents|mesh-ancestor
138900667|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
138900668|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138900669|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138900670|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900671|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
138900672|NCT02639819|Coagulants|coagulants|mesh-ancestor
138900673|NCT02639741|Vitamins|vitamins|mesh-list
138900674|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
138900675|NCT02639741|Melatonin|melatonin|mesh-list
138900676|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
138900677|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900678|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
138900679|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900680|NCT02639741|Protective Agents|protective agents|mesh-ancestor
138900681|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900682|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
138900683|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138900684|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
138900685|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138900686|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138900687|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900688|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138900689|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900690|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138790693|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900691|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900693|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138900694|NCT00654173|Simvastatin|simvastatin|mesh-list
138900695|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138900696|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138900697|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
138900698|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900699|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138900700|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138900701|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900702|NCT02645279|Midazolam|midazolam|mesh-list
138900703|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138900704|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138900705|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138507182|NCT00055549|Lorazepam|lorazepam|mesh-list
138900706|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900707|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138900708|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138900709|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138900710|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138219426|NCT05776524|Paclitaxel|paclitaxel|mesh-list
138900711|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
138900712|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
138900713|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
138900714|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
138900715|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138900716|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900717|NCT04164329|Anesthetics|anesthetics|mesh-list
138900718|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
138900719|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900720|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900721|NCT02639039|Cortisone|cortisone|mesh-list
138900722|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138900723|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138900724|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138900725|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138900726|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
138900727|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900728|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138900729|NCT02562664|Metformin|metformin|mesh-list
138900730|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138900731|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900732|NCT00654407|Atorvastatin|atorvastatin|mesh-list
138900733|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138900734|NCT00654407|Simvastatin|simvastatin|mesh-list
138900735|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138900736|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138900737|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
138900738|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900739|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138900740|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138900741|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900743|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138900744|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138552749|NCT00271414|Analgesics|analgesics|mesh-ancestor
138900745|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900746|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
138900747|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
138524691|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
138900748|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
138900749|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900750|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138900751|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138900753|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138900754|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
138900755|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138900756|NCT00744406|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138900757|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138900758|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138441632|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
138900759|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900760|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138900761|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
138900762|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900763|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138900764|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138900766|NCT00690820|Pancreatin|pancreatin|mesh-list
138900767|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138900768|NCT02562508|Vaccines|vaccines|mesh-list
138900769|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
138900770|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900771|NCT00689338|Fluconazole|fluconazole|mesh-list
138900772|NCT00689338|Voriconazole|voriconazole|mesh-list
138900773|NCT00689338|Anidulafungin|anidulafungin|mesh-list
138900774|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
138900776|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138900777|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138900778|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900779|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900780|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138900781|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
138900782|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138900783|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900784|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138790891|NCT00653848|Docetaxel|docetaxel|mesh-list
138900785|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138900786|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138900787|NCT00686998|Olanzapine|olanzapine|mesh-list
138900788|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
138900789|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
138900790|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900791|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900792|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138900793|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138900794|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138441732|NCT01799863|Analgesics|analgesics|mesh-ancestor
138900795|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138900796|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138900797|NCT00686998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138900798|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138900799|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138900800|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900801|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138900802|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
138900803|NCT00744640|Gemcitabine|gemcitabine|mesh-list
138900804|NCT00744640|Capecitabine|capecitabine|mesh-list
138900805|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
138900806|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138900807|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
138900808|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900809|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900810|NCT00848718|Paclitaxel|paclitaxel|mesh-list
138900811|NCT00848718|Docetaxel|docetaxel|mesh-list
138900812|NCT00848718|Carboplatin|carboplatin|mesh-list
138900813|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138900814|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138900815|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900816|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
138900817|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
138900818|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
138770239|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138900819|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900820|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138900821|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900823|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138900824|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900826|NCT00883337|Interferon-beta|interferon-beta|mesh-list
138900827|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
138900828|NCT00883337|Teriflunomide|teriflunomide|mesh-list
138900829|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900830|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
138900831|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900832|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138900833|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138900834|NCT00883337|Analgesics|analgesics|mesh-ancestor
138900835|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
138900836|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138900837|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900838|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138900839|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138900840|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138900841|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
138900842|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138900844|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900845|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138900846|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900847|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900848|NCT00654485|Atorvastatin|atorvastatin|mesh-list
138900849|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138900850|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138900851|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138900852|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
138900853|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900854|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138524726|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900855|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138900856|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900857|NCT00837876|Sorafenib|sorafenib|mesh-list
138900858|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900859|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138900860|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138770240|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
138900861|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900862|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
138900863|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
138900864|NCT00655421|Coagulants|coagulants|mesh-ancestor
138900865|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
138900866|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900867|NCT00707070|Acitretin|acitretin|mesh-list
138900868|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138900869|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
138900870|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900871|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
138900872|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
138900873|NCT00686920|Rifaximin|rifaximin|mesh-list
138900874|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138900875|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900876|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138900877|NCT02562118|Letrozole|letrozole|mesh-list
138900878|NCT02562118|Lenvatinib|lenvatinib|mesh-list
138900879|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900880|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138900881|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138900882|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900883|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900884|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138900885|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
138900886|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138900887|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900888|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138900889|NCT00744718|Bevacizumab|bevacizumab|mesh-list
138900890|NCT00744718|Carboplatin|carboplatin|mesh-list
138900891|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138900892|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552914|NCT00074828|Enoxaparin|enoxaparin|mesh-list
138900893|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138900894|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138900895|NCT00744718|Growth Substances|growth substances|mesh-ancestor
138900896|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900897|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
138900898|NCT00845832|Rituximab|rituximab|mesh-list
138900899|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138900900|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441880|NCT01800799|Celecoxib|celecoxib|mesh-list
138900901|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
138900902|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900903|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138900904|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
138900905|NCT00703482|Ubiquinone|ubiquinone|mesh-list
138900906|NCT00703482|Fenofibrate|fenofibrate|mesh-list
138900907|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138900908|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
138900909|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900910|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138900912|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
138900913|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791149|NCT02641990|Hormones|hormones|mesh-ancestor
138900914|NCT00885755|Capecitabine|capecitabine|mesh-list
138900915|NCT00885755|Trastuzumab|trastuzumab|mesh-list
138900916|NCT00885755|Taxane|taxane|mesh-list
138900917|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138900918|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
138900919|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900920|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900921|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138900922|NCT00749710|Clopidogrel|clopidogrel|mesh-list
138900923|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138900924|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138900925|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138791211|NCT02885948|Naloxone|naloxone|mesh-list
138900926|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138900927|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
138900928|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138900929|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900930|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900931|NCT00749866|Gentamicins|gentamicins|mesh-list
138900932|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138900933|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900934|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138900935|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900936|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900937|NCT04058236|Polygeline|polygeline|mesh-list
138900938|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
138900939|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
138900940|NCT00742066|Felodipine|felodipine|mesh-list
138900941|NCT00742066|Irbesartan|irbesartan|mesh-list
138900942|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138900943|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138900944|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138900945|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900946|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138900947|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138900948|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138900949|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138900950|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900952|NCT00742144|Ofatumumab|ofatumumab|mesh-list
138900953|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900954|NCT00845676|Interferons|interferons|mesh-list
138900955|NCT00845676|Ribavirin|ribavirin|mesh-list
138900956|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
138900957|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
138900958|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138900960|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
138900961|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138900962|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
138900963|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900964|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
138900965|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900966|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
138552975|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900967|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138900968|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
138900969|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138900970|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138900971|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138900972|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
138900973|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900974|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900975|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138900976|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
138900977|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138900978|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138900980|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138524832|NCT00021398|Calcium|calcium|mesh-list
138900981|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138900982|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138900983|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
138900984|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900985|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138900986|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138900987|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900988|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138900989|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138900990|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138900991|NCT00655655|Everolimus|everolimus|mesh-list
138900992|NCT00655655|Vatalanib|vatalanib|mesh-list
138900993|NCT00655655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138900994|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138900995|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138900996|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138900997|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138900998|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
138900999|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138524865|NCT00021671|Metronidazole|metronidazole|mesh-list
138901000|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901001|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
138901002|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901003|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901004|NCT00837330|Ranibizumab|ranibizumab|mesh-list
138901005|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138901006|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138901007|NCT00837330|Growth Substances|growth substances|mesh-ancestor
138901008|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901009|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
138901010|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901011|NCT00703638|Pemetrexed|pemetrexed|mesh-list
138901012|NCT00703638|Sorafenib|sorafenib|mesh-list
138901013|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901014|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901015|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901016|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138901017|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138901018|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138901019|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
138901020|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138901021|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
138901022|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901023|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
138901024|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901025|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138901026|NCT00885365|Tobramycin|tobramycin|mesh-list
138901027|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138401004|NCT01551719|Linezolid|linezolid|mesh-list
138901028|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901029|NCT00827112|Ritonavir|ritonavir|mesh-list
138901030|NCT00827112|Lopinavir|lopinavir|mesh-list
138901031|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138901032|NCT00827112|Darunavir|darunavir|mesh-list
138901033|NCT00827112|Tenofovir|tenofovir|mesh-list
138901034|NCT00827112|Emtricitabine|emtricitabine|mesh-list
138901035|NCT00827112|Maraviroc|maraviroc|mesh-list
138901036|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138901037|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138901038|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
138791476|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
138901039|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138901040|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901041|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138901042|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138901043|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
138901044|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901045|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138901046|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138901047|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138901048|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138901049|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138901050|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138901051|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138901052|NCT00689104|Mirabegron|mirabegron|mesh-list
138901053|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138901054|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138901055|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138901056|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138901057|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
138901058|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901059|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901060|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901061|NCT00689104|Urological Agents|urological agents|mesh-ancestor
138901062|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138901063|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138901064|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
138901065|NCT00702156|Bisoprolol|bisoprolol|mesh-list
138901066|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138901067|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
138901068|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
138901069|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138901070|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901071|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138901072|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138901073|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138901074|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
138901075|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901076|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901077|NCT02638415|Carvedilol|carvedilol|mesh-list
138901078|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138901079|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138901080|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
138901081|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138901082|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901083|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138901084|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138901086|NCT02638415|Protective Agents|protective agents|mesh-ancestor
138901087|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138901088|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138901089|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138901090|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
138901091|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138901092|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138901093|NCT00703872|Interferons|interferons|mesh-list
138901094|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138901095|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
138901096|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138901097|NCT00689026|Lubiprostone|lubiprostone|mesh-list
138901098|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138901099|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138901100|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138901101|NCT00598559|Acetaminophen|acetaminophen|mesh-list
138901102|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138901103|NCT00598559|Analgesics|analgesics|mesh-ancestor
138901104|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
138901105|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791620|NCT00978120|Vaccines|vaccines|mesh-list
138496442|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496443|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496444|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
138496445|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
138496446|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138496447|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
138496448|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138496449|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496450|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496451|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138496452|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
138496453|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138496454|NCT00111280|Etravirine|etravirine|mesh-list
138496455|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138496456|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138496457|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496458|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496459|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
138496460|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496461|NCT00111319|Bortezomib|bortezomib|mesh-list
138496462|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496463|NCT00111397|Interferons|interferons|mesh-list
138496464|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
138496465|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496466|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
138496467|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496468|NCT00111436|Etanercept|etanercept|mesh-list
138496469|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138496470|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138496471|NCT00111436|Analgesics|analgesics|mesh-ancestor
138496472|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
138496473|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496474|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496475|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138496476|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138496477|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138496478|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496479|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
138692195|NCT05132153|Milrinone|milrinone|mesh-list
138496481|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138496482|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138496483|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496484|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
138496485|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496486|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496487|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138496488|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
138496489|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496490|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496491|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138496492|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496493|NCT00111748|Thalidomide|thalidomide|mesh-list
138496494|NCT00111748|Dexamethasone|dexamethasone|mesh-list
138496495|NCT00111748|Bortezomib|bortezomib|mesh-list
138496496|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138496497|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
138496498|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
138496499|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496500|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496501|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138496502|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
138496503|NCT00111748|Hormones|hormones|mesh-ancestor
138496504|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138496505|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138496506|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496507|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496508|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
138496509|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
138496510|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138496511|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496512|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138496513|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138496514|NCT00111748|Growth Substances|growth substances|mesh-ancestor
138496515|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
138496516|NCT00111787|Paclitaxel|paclitaxel|mesh-list
138496517|NCT00111787|Lapatinib|lapatinib|mesh-list
138496518|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138496519|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496520|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
138496521|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
138496522|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
138496523|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496524|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138496525|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496526|NCT00111904|Paclitaxel|paclitaxel|mesh-list
138496527|NCT00111904|genexol-PM|genexol-pm|mesh-list
138496528|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138496529|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496530|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
138496531|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
138496532|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
138496533|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496534|NCT00111943|Tenofovir|tenofovir|mesh-list
138496535|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
138496536|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496537|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138496538|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138496539|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496540|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496541|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138496542|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138496543|NCT00401596|Omalizumab|omalizumab|mesh-list
138496544|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138685691|NCT02929524|Ketamine|ketamine|mesh-list
138496545|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138496546|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
138496547|NCT00401635|Carboplatin|carboplatin|mesh-list
138496548|NCT00401635|Doxorubicin|doxorubicin|mesh-list
138496549|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138496550|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496551|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138803849|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
138281074|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
138803850|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138803852|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138803853|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138803854|NCT04260828|Analgesics|analgesics|mesh-ancestor
138803855|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
138803856|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803857|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803858|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138803859|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803860|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138803861|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138181338|NCT01832623|Vitamin D|vitamin d|mesh-list
138803862|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803863|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138803864|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138803865|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803866|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
138803867|NCT00928746|Bromides|bromides|mesh-list
138803868|NCT00928746|Ipratropium|ipratropium|mesh-list
138803869|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
138803870|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138803871|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
138803872|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803873|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803874|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138803875|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
138803876|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138803877|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
138803878|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803879|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281120|NCT05243953|Autonomic Agents|autonomic agents|mesh-ancestor
138803882|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138479989|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138803883|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138803884|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803885|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803886|NCT00610584|Cetirizine|cetirizine|mesh-list
138803887|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138803889|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138803890|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
138803891|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
138803892|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803893|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803894|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803895|NCT00894543|Escitalopram|escitalopram|mesh-list
138803896|NCT00894543|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138281165|NCT05172817|Adalimumab|adalimumab|mesh-list
138803897|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138803898|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138803899|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803900|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803901|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
138803902|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803903|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138803904|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138803905|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803906|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138803907|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138803908|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138803909|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803910|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
138803911|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803912|NCT00853372|Sunitinib|sunitinib|mesh-list
138803913|NCT00853372|Trebananib|trebananib|mesh-list
138803914|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
138803915|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803916|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138803917|NCT00853372|Growth Substances|growth substances|mesh-ancestor
138803918|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803919|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
138803920|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138803921|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803922|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480028|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138480030|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
138803923|NCT02836977|Tegafur|tegafur|mesh-list
138281223|NCT04338919|Ticagrelor|ticagrelor|mesh-list
138803924|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138803925|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
138803926|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803927|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803929|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138803930|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138803931|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138803932|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
138803933|NCT00922116|Hematinics|hematinics|mesh-ancestor
138181411|NCT05394142|Pioglitazone|pioglitazone|mesh-list
138803934|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
138803935|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138803936|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
138803937|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803938|NCT04260516|Expectorants|expectorants|mesh-ancestor
138803939|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
138803940|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138803941|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
138803942|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803943|NCT04260516|Protective Agents|protective agents|mesh-ancestor
138803944|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803945|NCT04260516|Antidotes|antidotes|mesh-ancestor
138803946|NCT00921024|Ceftazidime|ceftazidime|mesh-list
138803947|NCT00921024|Ceftolozane|ceftolozane|mesh-list
138803948|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138803949|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803950|NCT00928668|Olodaterol|olodaterol|mesh-list
138803951|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138803952|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
138803953|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803954|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803955|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138803956|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
138803957|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
138480060|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
138480061|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138803958|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138803959|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803960|NCT00700492|Progesterone|progesterone|mesh-list
138803961|NCT00700492|Progestins|progestins|mesh-ancestor
138803962|NCT00700492|Hormones|hormones|mesh-ancestor
138803963|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138803964|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803965|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
138803966|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138803967|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803968|NCT00703300|Bortezomib|bortezomib|mesh-list
138803969|NCT00703300|Decitabine|decitabine|mesh-list
138803970|NCT00703300|Azacitidine|azacitidine|mesh-list
138803971|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803972|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138803973|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
138803974|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803975|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803976|NCT00703378|Docetaxel|docetaxel|mesh-list
138803977|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803978|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
138803979|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
138803980|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
138803981|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803982|NCT00852202|Cariprazine|cariprazine|mesh-list
138803983|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138803984|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138803985|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803986|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803987|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138803988|NCT01074008|Ritonavir|ritonavir|mesh-list
138803989|NCT01074008|Ribavirin|ribavirin|mesh-list
138803990|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138803991|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138480099|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
138480100|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803992|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138803993|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
138803994|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464105|NCT01949818|Hormones|hormones|mesh-ancestor
138803995|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803996|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138803997|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138803998|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
138803999|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804000|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138804001|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138804002|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
138804003|NCT02613052|Propofol|propofol|mesh-list
138804004|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138804005|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138804006|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804007|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138804008|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
138804009|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
138804010|NCT01073930|Bisacodyl|bisacodyl|mesh-list
138804011|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
138804012|NCT01073930|Cathartics|cathartics|mesh-ancestor
138804013|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138804014|NCT01073930|Laxatives|laxatives|mesh-ancestor
138804015|NCT01073618|Voriconazole|voriconazole|mesh-list
138804016|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
138804017|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804018|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138804019|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138804020|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804021|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804022|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138804023|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
138804024|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138804025|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804026|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138804027|NCT00789373|Pemetrexed|pemetrexed|mesh-list
138480141|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138480145|NCT02045693|Buprenorphine|buprenorphine|mesh-list
138804028|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804029|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804030|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804031|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138804032|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138804034|NCT00851890|Ribavirin|ribavirin|mesh-list
138804035|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804036|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
138804037|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804038|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
138804039|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804040|NCT00592072|Decanoic acid|decanoic acid|mesh-list
138804041|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
138804042|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804043|NCT00626288|Mesalamine|mesalamine|mesh-list
138804044|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138804045|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138804046|NCT00626288|Analgesics|analgesics|mesh-ancestor
138804047|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
138804048|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804049|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804050|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138804051|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138804052|NCT00792571|Epoprostenol|epoprostenol|mesh-list
138804053|NCT00792571|Beraprost|beraprost|mesh-list
138804054|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138804055|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
138804056|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138804057|NCT00794365|Varenicline|varenicline|mesh-list
138804058|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138804059|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138804060|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
138804061|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640449|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804062|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804063|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804065|NCT01067144|Lorazepam|lorazepam|mesh-list
138804066|NCT01067144|Analgesics|analgesics|mesh-ancestor
138804067|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
138804068|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804069|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804070|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
138804071|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138804072|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138804073|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138804074|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138480179|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
138804075|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138804076|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138804077|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138804078|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804079|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
138804080|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
138804081|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
138804082|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138804083|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138804084|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
138804085|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
138804086|NCT01078298|Varenicline|varenicline|mesh-list
138181571|NCT01834885|Hormones|hormones|mesh-ancestor
138804087|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138281500|NCT02618720|Ornidazole|ornidazole|mesh-list
138804088|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138804089|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
138804090|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138804091|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804092|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804093|NCT00788593|Pancreatin|pancreatin|mesh-list
138804094|NCT00788593|Pancrelipase|pancrelipase|mesh-list
138804095|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138804096|NCT04106011|Gabapentin|gabapentin|mesh-list
138804097|NCT04106011|Analgesics|analgesics|mesh-ancestor
138804098|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
138804099|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804100|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804101|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
138804102|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138804103|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138804104|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138804105|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138804106|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138804107|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138804108|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138804109|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804110|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
138804111|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138804112|NCT02875886|Amiloride|amiloride|mesh-list
138804113|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138804114|NCT02875886|Diuretics|diuretics|mesh-ancestor
138804115|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
138480205|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
138804116|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804117|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138804118|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138804119|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804120|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138804121|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138804122|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138804123|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138804125|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138804126|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138804127|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138804128|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
138804129|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138804130|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804131|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804132|NCT00793819|Urological Agents|urological agents|mesh-ancestor
138804133|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138804134|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804135|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
138804136|NCT02836821|Rifampin|rifampin|mesh-list
138804137|NCT02836821|Apatinib|apatinib|mesh-list
138804138|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804139|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138804140|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804141|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804142|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138804143|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
138804144|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138804145|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804146|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
138804147|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138804148|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138804149|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138804150|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138804151|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138804152|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138804153|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138804154|NCT02836743|Melatonin|melatonin|mesh-list
138804155|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
138480237|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804156|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804157|NCT02836743|Protective Agents|protective agents|mesh-ancestor
138804158|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181642|NCT01839097|Hormones|hormones|mesh-ancestor
138804159|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138804160|NCT04255368|Choline|choline|mesh-list
138804161|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
138804162|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138804163|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
138804164|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804165|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138804166|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138804167|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
138804168|NCT00610818|Mitogens|mitogens|mesh-list
138804169|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
138804170|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804171|NCT00787891|Rabeprazole|rabeprazole|mesh-list
138464213|NCT01950546|Fluorides|fluorides|mesh-list
138804172|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138804173|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138804174|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138804176|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804177|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138804178|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138804180|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138804181|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138804182|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804183|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804184|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
138804185|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804186|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138804187|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138804188|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138804189|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138804190|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
138804191|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138804192|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138804193|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
138804194|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138804195|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
138804196|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138804197|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281702|NCT01628874|Lidocaine|lidocaine|mesh-list
138480267|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138804198|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804199|NCT02836509|Acetaminophen|acetaminophen|mesh-list
138804201|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138804202|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138804203|NCT02836509|Analgesics|analgesics|mesh-ancestor
138804204|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
138804205|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804206|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804207|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138804208|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138804209|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138804210|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804211|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804212|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
138804213|NCT05306379|Simvastatin|simvastatin|mesh-list
138804214|NCT05306379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138804215|NCT05306379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138804216|NCT05306379|Antimetabolites|antimetabolites|mesh-ancestor
138804217|NCT05306379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804219|NCT05306379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138804220|NCT05306379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804221|NCT05304663|Lomustine|lomustine|mesh-list
138804222|NCT05304663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138804223|NCT05304663|Alkylating Agents|alkylating agents|mesh-ancestor
138804224|NCT05304663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804225|NCT05304663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804226|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
138804227|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138804228|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804229|NCT04109755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138804230|NCT04109755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804231|NCT04248309|Progesterone|progesterone|mesh-list
138804232|NCT04248309|Progestins|progestins|mesh-ancestor
138804233|NCT04248309|Hormones|hormones|mesh-ancestor
138804234|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138804235|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804236|NCT00892281|Doxycycline|doxycycline|mesh-list
138804237|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138804238|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804239|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
138804240|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138804241|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138804242|NCT02836353|Rifaximin|rifaximin|mesh-list
138804243|NCT02836353|Somatostatin|somatostatin|mesh-list
138804244|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138804245|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804246|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138804247|NCT02836353|Hormones|hormones|mesh-ancestor
138804248|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138804249|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804250|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
138804251|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138804252|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138804253|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804254|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138804255|NCT02836431|Analgesics|analgesics|mesh-ancestor
138804256|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
138804257|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804258|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138804259|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138804260|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138804261|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
138804262|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138804263|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804265|NCT05326425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138804266|NCT05326425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804267|NCT05326425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804268|NCT00784693|Tanezumab|tanezumab|mesh-list
138804269|NCT00784693|Analgesics|analgesics|mesh-ancestor
138804270|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
138804271|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804272|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804273|NCT00915811|Fludarabine|fludarabine|mesh-list
138804274|NCT00915811|Busulfan|busulfan|mesh-list
138804275|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
138804276|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138804277|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480336|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138804278|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804279|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138804280|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
138804281|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281830|NCT05450419|Vitamin D|vitamin d|mesh-list
138804283|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138804284|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138804285|NCT00892047|Aripiprazole|aripiprazole|mesh-list
138804286|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138804287|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
138804288|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138804289|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138804290|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138804291|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138804292|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804293|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
138804294|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
138804295|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138804296|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804297|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138804298|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138804299|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
138804300|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138804301|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138804302|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138181779|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804303|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138804304|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138804305|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138804306|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138804307|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138804308|NCT02835729|Cytarabine|cytarabine|mesh-list
138804309|NCT02835729|Idarubicin|idarubicin|mesh-list
138804310|NCT02835729|Tryptophan|tryptophan|mesh-list
138804311|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138804312|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
138804313|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804314|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804315|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
138804316|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804317|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138804318|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
138804319|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804320|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138640523|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
138804321|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138804322|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138804323|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804324|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138804325|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
138804326|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138480371|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804327|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
138804328|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804329|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804331|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804332|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138804333|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804334|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804335|NCT02838615|Dexamethasone|dexamethasone|mesh-list
138804336|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138804337|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
138804338|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
138804339|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804340|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804341|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138804342|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
138804344|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138804345|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138804346|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804347|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
138804348|NCT02838225|Docetaxel|docetaxel|mesh-list
138804349|NCT02838225|Doxorubicin|doxorubicin|mesh-list
138804350|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138804351|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138804352|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
138804353|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281925|NCT02754518|Valsartan|valsartan|mesh-list
138804354|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138804355|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138804356|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
138804357|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804358|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804359|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138804360|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
138804361|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
138804362|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
138804363|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138804364|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138804365|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138804366|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804368|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138804369|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
138804370|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138804371|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480389|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138804372|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138804373|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804374|NCT04248621|Goserelin|goserelin|mesh-list
138804375|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138804376|NCT04248621|Leuprolide|leuprolide|mesh-list
138804377|NCT04248621|Flutamide|flutamide|mesh-list
138181861|NCT04956484|Belimumab|belimumab|mesh-list
138804379|NCT04248621|Androgens|androgens|mesh-list
138804380|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
138804381|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138804382|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804383|NCT04248621|Hormones|hormones|mesh-ancestor
138804384|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138804385|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804386|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
138804387|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
138804388|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138804389|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
138804390|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138804391|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138804392|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138804393|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
138804394|NCT00784459|Abatacept|abatacept|mesh-list
138804395|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138804396|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804397|NCT00784459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138480419|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138480420|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138480425|NCT02047136|Histamine|histamine|mesh-list
138804398|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804399|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138804400|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
138804401|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804402|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138804403|NCT02835183|Insulin|insulin|mesh-list
138804404|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138804405|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804406|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
138804407|NCT02602483|Ibuprofen|ibuprofen|mesh-list
138804408|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138804409|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138804410|NCT02602483|Analgesics|analgesics|mesh-ancestor
138804411|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
138804412|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138480466|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138480467|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480478|NCT02047175|Vitamins|vitamins|mesh-ancestor
138804413|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804414|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138804415|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138804416|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138804417|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804418|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804419|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
138640607|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
138804420|NCT02602483|Protective Agents|protective agents|mesh-ancestor
138804421|NCT02602483|Vitamins|vitamins|mesh-ancestor
138804422|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
138804423|NCT00784147|Ibalizumab|ibalizumab|mesh-list
138804424|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138804425|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138804426|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138804427|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
138804428|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804429|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
138804430|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804431|NCT04260360|Docetaxel|docetaxel|mesh-list
138804432|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804433|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
138804435|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
138804436|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804437|NCT04254822|Carvedilol|carvedilol|mesh-list
138804438|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138804439|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138804440|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
138804441|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138480525|NCT00005823|Analgesics|analgesics|mesh-ancestor
138480526|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
138480527|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804442|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804443|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804444|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138804445|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
138804446|NCT04254822|Protective Agents|protective agents|mesh-ancestor
138804447|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138804448|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138804449|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138804450|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
138804451|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138804452|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138181935|NCT01838707|Fentanyl|fentanyl|mesh-list
138804453|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
138804454|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138804455|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804456|NCT00891813|Vitamins|vitamins|mesh-ancestor
138804457|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
138804458|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138804459|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
138804460|NCT04255056|Epirubicin|epirubicin|mesh-list
138804461|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138480572|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138480573|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
138804462|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
138804463|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804464|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138804465|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138804466|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
138804467|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804468|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804469|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138640620|NCT00271713|Calcium|calcium|mesh-list
138804471|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138804472|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138804473|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804474|NCT00783835|Methylphenidate|methylphenidate|mesh-list
138804475|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138804476|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804477|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138804478|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138804479|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138480626|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480627|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138804480|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804481|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
138804482|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138804483|NCT04254744|Sevoflurane|sevoflurane|mesh-list
138804484|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138804485|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138804486|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
138804487|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
138804488|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138804489|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804490|NCT02831361|Metformin|metformin|mesh-list
138804491|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138804492|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804493|NCT04103905|Antibodies|antibodies|mesh-list
138480682|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480683|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480684|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
138480689|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
138804494|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138804495|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
138804496|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804497|NCT02831205|Cobalt|cobalt|mesh-list
138804498|NCT02831205|Chromium|chromium|mesh-list
138804499|NCT02831205|Everolimus|everolimus|mesh-list
138804500|NCT02831205|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138804501|NCT02831205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138804502|NCT02831205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804503|NCT02831205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804504|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138804505|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
138804506|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804507|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804508|NCT02831205|Trace Elements|trace elements|mesh-ancestor
138804509|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
138804510|NCT00783289|Benralizumab|benralizumab|mesh-list
138804511|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138804512|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
138804513|NCT02828163|Triamcinolone|triamcinolone|mesh-list
138804514|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138804515|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138804516|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138480742|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
138804517|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138804518|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
138804519|NCT02828163|Hormones|hormones|mesh-ancestor
138464384|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804520|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138804521|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804522|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138804523|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
138804524|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480797|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138480798|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138804525|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804526|NCT04107805|Midazolam|midazolam|mesh-list
138804527|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138182005|NCT01721707|Latanoprost|latanoprost|mesh-list
138804528|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138804529|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138804530|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804531|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138804532|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138282186|NCT02192970|Bevacizumab|bevacizumab|mesh-list
138804533|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138804534|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138804535|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
138804537|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
138804538|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
138804539|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138804540|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804541|NCT02833155|Exemestane|exemestane|mesh-list
138804542|NCT02833155|Entinostat|entinostat|mesh-list
138804543|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804544|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138804545|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138480863|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
138480864|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
138480866|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138480872|NCT00005964|Prednisone|prednisone|mesh-list
138804546|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804547|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804548|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138804549|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
138804550|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138804551|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804552|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138804553|NCT04672460|Talazoparib|talazoparib|mesh-list
138804554|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138804555|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282245|NCT02747186|Lidocaine|lidocaine|mesh-list
138804556|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804557|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804558|NCT00847912|Fluorouracil|fluorouracil|mesh-list
138804559|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
138804560|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804561|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138804562|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804563|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138804564|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
138480916|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480917|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
138804565|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804566|NCT00850564|Hormones|hormones|mesh-list
138804567|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
138804568|NCT00850564|Tesamorelin|tesamorelin|mesh-list
138804569|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138804570|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804571|NCT00850564|Growth Substances|growth substances|mesh-ancestor
138804572|NCT00837148|Sorafenib|sorafenib|mesh-list
138804573|NCT00837148|Dacarbazine|dacarbazine|mesh-list
138804574|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804575|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138804576|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480972|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480973|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480974|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138480975|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
138480980|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
138804577|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804578|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138804579|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
138804581|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138804582|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
138804583|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804584|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138804585|NCT05297968|Oseltamivir|oseltamivir|mesh-list
138804586|NCT05297968|Antiviral Agents|antiviral agents|mesh-ancestor
138804587|NCT05297968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804588|NCT05297968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804589|NCT05297968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804591|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
138804592|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
138804593|NCT02613130|Protective Agents|protective agents|mesh-ancestor
138804594|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804595|NCT00849472|Paclitaxel|paclitaxel|mesh-list
138640657|NCT00291369|Interferons|interferons|mesh-list
138804597|NCT00849472|Doxorubicin|doxorubicin|mesh-list
138804598|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138804599|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804600|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
138804601|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
138804602|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
138804603|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804604|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138804605|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
138804606|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804607|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138464436|NCT01951911|Ketamine|ketamine|mesh-list
138804608|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138804609|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
138804610|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138804611|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138804612|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138804613|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138481085|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138481086|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
138481095|NCT00006009|Visilizumab|visilizumab|mesh-list
138804614|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804616|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138804617|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
138804618|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804619|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804620|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138804621|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
138804622|NCT00701428|Losartan|losartan|mesh-list
138804623|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138804624|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138804625|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138804626|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138804627|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804628|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138804629|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138481149|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
138481151|NCT00006024|Temozolomide|temozolomide|mesh-list
138804630|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804631|NCT00848926|Immunotoxins|immunotoxins|mesh-ancestor
138804632|NCT00848926|Immunoconjugates|immunoconjugates|mesh-ancestor
138804633|NCT00848926|Immunologic Factors|immunologic factors|mesh-ancestor
138804634|NCT00848926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804635|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
138804637|NCT00706888|Pyridoxine|pyridoxine|mesh-list
138804638|NCT00706888|Vitamins|vitamins|mesh-ancestor
138804639|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
138804640|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804641|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
138804642|NCT05019534|Cetuximab|cetuximab|mesh-list
138804643|NCT05019534|Vemurafenib|vemurafenib|mesh-list
138804644|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138804645|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804646|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138804647|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804648|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804649|NCT04254042|Perindopril|perindopril|mesh-list
138464472|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804650|NCT04254042|Zofenopril|zofenopril|mesh-list
138804651|NCT04254042|Captopril|captopril|mesh-list
138804652|NCT04254042|Calcium|calcium|mesh-list
138804653|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138481206|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804654|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804655|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138804656|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
138282368|NCT02973776|Hormones|hormones|mesh-ancestor
138804657|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804658|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804659|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138804660|NCT00918138|Metformin|metformin|mesh-list
138804661|NCT00918138|Saxagliptin|saxagliptin|mesh-list
138804662|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138804663|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804664|NCT00918138|Incretins|incretins|mesh-ancestor
138804665|NCT00918138|Hormones|hormones|mesh-ancestor
138804666|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138804667|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138804668|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
138804669|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804670|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481259|NCT00386802|Miconazole|miconazole|mesh-list
138804671|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138804672|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138804673|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804674|NCT00782275|Sirolimus|sirolimus|mesh-list
138804675|NCT00782275|Bevacizumab|bevacizumab|mesh-list
138804676|NCT00782275|Temsirolimus|temsirolimus|mesh-list
138804677|NCT00782275|MTOR Inhibitors|mtor inhibitors|mesh-list
138182162|NCT04687800|Hormones|hormones|mesh-ancestor
138804678|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138804679|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804680|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138804681|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138804682|NCT00782275|Growth Substances|growth substances|mesh-ancestor
138804683|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804684|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
138804685|NCT00782275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138804686|NCT00782275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282399|NCT04507022|Hormones|hormones|mesh-ancestor
138804687|NCT00782275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804689|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
138804690|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138804691|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804692|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138804693|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
138804695|NCT00791557|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138481376|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804696|NCT00791557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138804697|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
138804698|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138804699|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138804701|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804702|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138804703|NCT05176314|Pirtobrutinib|pirtobrutinib|mesh-list
138804704|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138804705|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138804706|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
138804707|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804708|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138804709|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138804710|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804711|NCT05176314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138804712|NCT00920556|Bortezomib|bortezomib|mesh-list
138804713|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804715|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138804716|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
138804717|NCT04901676|Leronlimab|leronlimab|mesh-list
138804718|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138804719|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138804720|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804721|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138804722|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138804723|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
138804724|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804725|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
138804726|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138804727|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804728|NCT02603965|Copper|copper|mesh-list
138804729|NCT02603965|Trace Elements|trace elements|mesh-ancestor
138804730|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
138804731|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804733|NCT00918684|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138804734|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138464543|NCT05876585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138804735|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138804736|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804738|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
138804739|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804740|NCT00919854|Ritonavir|ritonavir|mesh-list
138804741|NCT00919854|Darunavir|darunavir|mesh-list
138804742|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138804743|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138804744|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
138804745|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804746|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804747|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138481477|NCT03002259|Dexamethasone|dexamethasone|mesh-list
138804748|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138804749|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
138804750|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804751|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138182238|NCT02153489|Bromides|bromides|mesh-list
138804752|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138804753|NCT04669782|Teriparatide|teriparatide|mesh-list
138804754|NCT04669782|Vitamin K|vitamin k|mesh-list
138804755|NCT04669782|Vitamins|vitamins|mesh-ancestor
138804756|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
138804757|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804758|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138804759|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138804760|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804762|NCT04669782|Coagulants|coagulants|mesh-ancestor
138804763|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138804764|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138804765|NCT00891735|Ranibizumab|ranibizumab|mesh-list
138804766|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138481538|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804767|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138804768|NCT00891735|Growth Substances|growth substances|mesh-ancestor
138804769|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804770|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
138804771|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804772|NCT04252248|Decitabine|decitabine|mesh-list
138804773|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138804774|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
138804775|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804776|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804777|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804778|NCT04247373|Ropivacaine|ropivacaine|mesh-list
138804779|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
138804780|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
138804781|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138481595|NCT00006051|Fluorouracil|fluorouracil|mesh-list
138481607|NCT00006054|Busulfan|busulfan|mesh-list
138804782|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804784|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804785|NCT02832999|Liraglutide|liraglutide|mesh-list
138804786|NCT02832999|Vildagliptin|vildagliptin|mesh-list
138804787|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138804788|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804789|NCT02832999|Incretins|incretins|mesh-ancestor
138804790|NCT02832999|Hormones|hormones|mesh-ancestor
138804791|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138804792|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138804793|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
138804794|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804795|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804796|NCT04245033|Piperaquine|piperaquine|mesh-list
138804797|NCT04245033|Artenimol|artenimol|mesh-list
138804798|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
138804799|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138160324|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804800|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138804801|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804802|NCT00915018|Paclitaxel|paclitaxel|mesh-list
138804803|NCT00915018|Trastuzumab|trastuzumab|mesh-list
138804804|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138804805|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138804806|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804807|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
138804808|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
138804809|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
138804810|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804811|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138804813|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138804814|NCT04246905|Protective Agents|protective agents|mesh-ancestor
138804815|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804816|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804817|NCT02830347|Amoxicillin|amoxicillin|mesh-list
138804818|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138804819|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804820|NCT00916578|Capecitabine|capecitabine|mesh-list
138804821|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138804822|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
138481721|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138160411|NCT04005599|Analgesics|analgesics|mesh-ancestor
138481722|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
138481724|NCT00006114|Vinorelbine|vinorelbine|mesh-list
138804823|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804824|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804825|NCT04675866|Paclitaxel|paclitaxel|mesh-list
138804826|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138804827|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138804828|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804829|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
138464598|NCT05875610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138804830|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
138804831|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
138804832|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804833|NCT02829879|Listerine|listerine|mesh-list
138804834|NCT02829879|Fluorides|fluorides|mesh-list
138804835|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
138804836|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
138804837|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
138804838|NCT02829879|Protective Agents|protective agents|mesh-ancestor
138804839|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804840|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138804841|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804842|NCT05246007|Dexmedetomidine|dexmedetomidine|mesh-list
138804843|NCT05246007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138804844|NCT05246007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138481770|NCT00006126|Fludarabine|fludarabine|mesh-list
138804845|NCT05246007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804846|NCT05246007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138804847|NCT05246007|Analgesics|analgesics|mesh-ancestor
138804848|NCT05246007|Sensory System Agents|sensory system agents|mesh-ancestor
138804849|NCT05246007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804850|NCT05246007|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138804851|NCT05246007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138804852|NCT05246007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138804853|NCT05246007|Adrenergic Agents|adrenergic agents|mesh-ancestor
138804854|NCT05246007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138804855|NCT05246007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804856|NCT00914940|Fludarabine|fludarabine|mesh-list
138804857|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
138804858|NCT00914940|Thiotepa|thiotepa|mesh-list
138804859|NCT00914940|Tacrolimus|tacrolimus|mesh-list
138804860|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804861|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138804862|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
138804863|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804864|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138804865|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
138804866|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804867|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138804868|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804869|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138804870|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
138804871|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138804872|NCT00835978|Axitinib|axitinib|mesh-list
138804873|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804874|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138481822|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138481833|NCT00006174|Letrozole|letrozole|mesh-list
138804875|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804876|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804877|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138804878|NCT01077518|Ofatumumab|ofatumumab|mesh-list
138804879|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138804880|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138804881|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
138804882|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804883|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804884|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
138804885|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804886|NCT04203186|Lumefantrine|lumefantrine|mesh-list
138804887|NCT04203186|Artemether|artemether|mesh-list
138804888|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138804889|NCT04203186|Atovaquone|atovaquone|mesh-list
138804890|NCT04203186|Proguanil|proguanil|mesh-list
138804891|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138804892|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
138804893|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138804894|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138804895|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804896|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804897|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804898|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
138804899|NCT00835120|Pioglitazone|pioglitazone|mesh-list
138804900|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138804901|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804902|NCT00914316|Ranolazine|ranolazine|mesh-list
138804903|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138804904|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138804905|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804906|NCT00701740|Isotretinoin|isotretinoin|mesh-list
138804907|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
138804908|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
138804909|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
138804910|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138804911|NCT00701740|Protective Agents|protective agents|mesh-ancestor
138804912|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138481864|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138804913|NCT04938882|Lidocaine|lidocaine|mesh-list
138804914|NCT04938882|Ropivacaine|ropivacaine|mesh-list
138804915|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
138804916|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
138804917|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138804918|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804920|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804921|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138804922|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138804923|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138804924|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138804925|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804926|NCT00704080|Temozolomide|temozolomide|mesh-list
138804927|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138804928|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
138804929|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804930|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804931|NCT05253066|Docetaxel|docetaxel|mesh-list
138804932|NCT05253066|Epirubicin|epirubicin|mesh-list
138804933|NCT05253066|Exemestane|exemestane|mesh-list
138804934|NCT05253066|Goserelin|goserelin|mesh-list
138481899|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138804935|NCT05253066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640752|NCT00291720|Diuretics|diuretics|mesh-ancestor
138804936|NCT05253066|Tubulin Modulators|tubulin modulators|mesh-ancestor
138804937|NCT05253066|Antimitotic Agents|antimitotic agents|mesh-ancestor
138804938|NCT05253066|Mitosis Modulators|mitosis modulators|mesh-ancestor
138804939|NCT05253066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804940|NCT05253066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138804941|NCT05253066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138804942|NCT05253066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138804943|NCT05253066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804944|NCT05253066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138804945|NCT05253066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138804946|NCT05253066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138804947|NCT05253066|Hormone Antagonists|hormone antagonists|mesh-ancestor
138804948|NCT05253066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138804949|NCT05253066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804950|NCT05253066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138804951|NCT04303598|Tenofovir|tenofovir|mesh-list
138804952|NCT04303598|Lamivudine|lamivudine|mesh-list
138804953|NCT04303598|Efavirenz|efavirenz|mesh-list
138804954|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
138804955|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138804956|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138804957|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138804958|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804959|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481949|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138804960|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138804961|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138804962|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138804963|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138804964|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138804965|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138804966|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138702187|NCT00449501|Hormones|hormones|mesh-ancestor
138804967|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138804968|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
138804969|NCT04636086|Vitamin D|vitamin d|mesh-list
138804970|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138804971|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804972|NCT04636086|Vitamins|vitamins|mesh-ancestor
138804973|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
138804974|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138804975|NCT00827242|Tadalafil|tadalafil|mesh-list
138804976|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
138464691|NCT05874778|Tubulin Modulators|tubulin modulators|mesh-ancestor
138804977|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138804978|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138804979|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138804980|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804981|NCT00827242|Urological Agents|urological agents|mesh-ancestor
138804982|NCT01077362|Ustekinumab|ustekinumab|mesh-list
138804983|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
138804984|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
138804985|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138804986|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
138804987|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138804988|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138804989|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138804990|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
138804991|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
138804992|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138804993|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
138804994|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138804995|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138804996|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
138804997|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138804998|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138804999|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805000|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805001|NCT00707278|Capecitabine|capecitabine|mesh-list
138805002|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
138805003|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138805004|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
138805005|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805006|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805007|NCT01077284|Allopurinol|allopurinol|mesh-list
138805008|NCT01077284|Febuxostat|febuxostat|mesh-list
138805009|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
138805010|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805011|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805012|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
138805013|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138805014|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138805015|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
138805016|NCT01077284|Protective Agents|protective agents|mesh-ancestor
138805017|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805019|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138805020|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138805021|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
138805022|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805023|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138805024|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138805025|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805026|NCT00704392|XL647|xl647|mesh-list
138805027|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805028|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138805029|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805030|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805031|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
138805032|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138805033|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
138702332|NCT00450008|Growth Substances|growth substances|mesh-ancestor
138805034|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805035|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
138805036|NCT04103125|Protective Agents|protective agents|mesh-ancestor
138805037|NCT00826618|Ranibizumab|ranibizumab|mesh-list
138805038|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138805039|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138805040|NCT00826618|Growth Substances|growth substances|mesh-ancestor
138805041|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805042|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
138805043|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805044|NCT02876822|Vitamin D|vitamin d|mesh-list
138805045|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
138805046|NCT02876822|Vitamins|vitamins|mesh-ancestor
138805047|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
138805048|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805049|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138805050|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138805051|NCT00826540|Bevacizumab|bevacizumab|mesh-list
138640794|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138805052|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138805055|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
138805056|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138805057|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805058|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138805059|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138805060|NCT00826540|Growth Substances|growth substances|mesh-ancestor
138805061|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805062|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
138805063|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
138805064|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138805065|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805066|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805067|NCT04303130|Endostar protein|endostar protein|mesh-list
138805068|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138805069|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138805070|NCT04303130|Growth Substances|growth substances|mesh-ancestor
138805071|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805072|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
138805073|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805074|NCT00626600|Oxycodone|oxycodone|mesh-list
138805075|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138805076|NCT00626600|Narcotics|narcotics|mesh-ancestor
138805077|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805078|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805079|NCT00626600|Analgesics|analgesics|mesh-ancestor
138805080|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
138805081|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805082|NCT00707512|Natalizumab|natalizumab|mesh-list
138805083|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
138805084|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805085|NCT00704548|Simvastatin|simvastatin|mesh-list
138805086|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138805087|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138805088|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
138805089|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805090|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138805091|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138805092|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805093|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138805094|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138702437|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
138805095|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138805096|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138805097|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805098|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805099|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805100|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138805101|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
138805102|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138805103|NCT00846040|Fallypride|fallypride|mesh-list
138805104|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138805105|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138640816|NCT00272064|Insulin|insulin|mesh-list
138805106|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
138805107|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805108|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805109|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805110|NCT02611336|Tadalafil|tadalafil|mesh-list
138805111|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
138805112|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138805113|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138805114|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805115|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805116|NCT02611336|Urological Agents|urological agents|mesh-ancestor
138805117|NCT00704704|Thalidomide|thalidomide|mesh-list
138805118|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138805119|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
138805120|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805121|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
138805122|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138805123|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138805124|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138805125|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138182610|NCT05530122|Golimumab|golimumab|mesh-list
138805126|NCT00704704|Growth Substances|growth substances|mesh-ancestor
138805127|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
138805128|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805129|NCT00707824|Nalbuphine|nalbuphine|mesh-list
138805130|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138805131|NCT00707824|Narcotics|narcotics|mesh-ancestor
138702534|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138805132|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805133|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805135|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
138805136|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805137|NCT00826228|Teriparatide|teriparatide|mesh-list
138805138|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138805139|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805140|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138805141|NCT00791479|Dulaglutide|dulaglutide|mesh-list
138805142|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138161174|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
138805143|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805144|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138805145|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138805146|NCT02831751|Vaccines|vaccines|mesh-list
138805147|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
138805148|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805149|NCT00913458|Etanercept|etanercept|mesh-list
138805150|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138805151|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138805152|NCT00913458|Analgesics|analgesics|mesh-ancestor
138805153|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
138805154|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805155|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805156|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138805157|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138805159|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138805160|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
138805161|NCT05208333|Albendazole|albendazole|mesh-list
138805162|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
138805163|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138805164|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138805165|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
138805166|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138805167|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138805168|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
138805169|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
138805170|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
138805171|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805172|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805173|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138805174|NCT04309773|Bezafibrate|bezafibrate|mesh-list
138805175|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138482258|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138805176|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138805177|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138805178|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
138805179|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805180|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138805181|NCT02829333|Anesthetics|anesthetics|mesh-list
138805182|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805183|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805184|NCT05251662|Bevacizumab|bevacizumab|mesh-list
138805185|NCT05251662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138805186|NCT05251662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805187|NCT05251662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138805188|NCT05251662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138805189|NCT05251662|Growth Substances|growth substances|mesh-ancestor
138805190|NCT05251662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805191|NCT05251662|Growth Inhibitors|growth inhibitors|mesh-ancestor
138805192|NCT02829177|Allopurinol|allopurinol|mesh-list
138805193|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
138805194|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805195|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805196|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
138805197|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138805198|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138805199|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
138805200|NCT02829177|Protective Agents|protective agents|mesh-ancestor
138805201|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482304|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805202|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
138805203|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138805204|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138805205|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138805206|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138464738|NCT05874518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138805207|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805208|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
138805209|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805210|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805211|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138640836|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
138805212|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805213|NCT04244097|Bupivacaine|bupivacaine|mesh-list
138805214|NCT04244097|Neostigmine|neostigmine|mesh-list
138805215|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
138805216|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
138805217|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805218|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805219|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
138805220|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805221|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138805222|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805223|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805224|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
138805225|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805226|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138805227|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
138805228|NCT00785629|Calcium|calcium|mesh-list
138805229|NCT00785629|Sevelamer|sevelamer|mesh-list
138805230|NCT00785629|Calcium acetate|calcium acetate|mesh-list
138805231|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138805232|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805233|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
138805234|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
138805235|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805236|NCT00915733|Aspirin|aspirin|mesh-list
138805237|NCT00915733|Cilostazol|cilostazol|mesh-list
138805238|NCT00915733|Clopidogrel|clopidogrel|mesh-list
138805239|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138805240|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138805241|NCT00915733|Analgesics|analgesics|mesh-ancestor
138805242|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
138805243|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805244|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805245|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138805246|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138805247|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138805248|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138805249|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805250|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138805251|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138805252|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805253|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
138805254|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138805255|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138805256|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138805257|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
138805258|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805259|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138805260|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
138805261|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138805262|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
138805263|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
138805264|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138805265|NCT00915733|Protective Agents|protective agents|mesh-ancestor
138805266|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138805267|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138805268|NCT00913770|Buprenorphine|buprenorphine|mesh-list
138805269|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138805270|NCT00913770|Narcotics|narcotics|mesh-ancestor
138805271|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138640844|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
138805272|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805273|NCT00913770|Analgesics|analgesics|mesh-ancestor
138805274|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
138805275|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805276|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138805278|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805279|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138805280|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138805281|NCT00912912|Growth Substances|growth substances|mesh-ancestor
138805282|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805283|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
138805284|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138805285|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805286|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805287|NCT00913692|Glycine|glycine|mesh-list
138805288|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
138805289|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138482436|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
138805290|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805291|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805292|NCT00784927|Dexamethasone|dexamethasone|mesh-list
138805293|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
138805294|NCT00784927|Rituximab|rituximab|mesh-list
138805295|NCT00784927|Lenalidomide|lenalidomide|mesh-list
138805296|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138805297|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
138805298|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805299|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702815|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805300|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138805301|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
138805302|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805303|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805304|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138805305|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138805306|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
138805307|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
138805308|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805309|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138805310|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
138805312|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138805313|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138805314|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138805315|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138805316|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138805317|NCT00784927|Growth Substances|growth substances|mesh-ancestor
138805318|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
138805320|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138805321|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138805322|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138805323|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
138805324|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
138805325|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805326|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805327|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805329|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
138805330|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138805331|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138805332|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138805333|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805334|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805335|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138805336|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
138805337|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138805338|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805339|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138805340|NCT04834206|Docetaxel|docetaxel|mesh-list
138805341|NCT04834206|Fluorouracil|fluorouracil|mesh-list
138805342|NCT04834206|Nedaplatin|nedaplatin|mesh-list
138805343|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805344|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
138805345|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
138805346|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
138805347|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805348|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
138805349|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138805350|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138805351|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
138805352|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805354|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
138805355|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
138805356|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
138805357|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805358|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805359|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138805360|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138805361|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138805362|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805363|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138805364|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138805365|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
138805366|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805367|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805368|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138805369|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
138805370|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138805371|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
138805372|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805373|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805374|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138805375|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
138805376|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
138805377|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138805378|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
138805379|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640873|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805380|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805382|NCT00779467|Bupivacaine|bupivacaine|mesh-list
138805383|NCT00779467|Neostigmine|neostigmine|mesh-list
138805384|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
138805385|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
138805386|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805387|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805388|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
138805389|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805390|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138805391|NCT00779467|Narcotics|narcotics|mesh-ancestor
138805392|NCT00779467|Analgesics|analgesics|mesh-ancestor
138805393|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138805394|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138805395|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
138805396|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138805397|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805398|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805399|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
138805400|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805401|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138805402|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
138805403|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
138805404|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
138482627|NCT00005977|Etoposide|etoposide|mesh-list
138805405|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805406|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
138805407|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805408|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805410|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138805411|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138805412|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138805413|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805414|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138805415|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805416|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
138805417|NCT04173312|Bupivacaine|bupivacaine|mesh-list
138805418|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
138805419|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
138805420|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805421|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805422|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
138805423|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805425|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805426|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138805427|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138805428|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805429|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805430|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138805431|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
138805432|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138805433|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805434|NCT00632268|Leucovorin|leucovorin|mesh-list
138805435|NCT00632268|Everolimus|everolimus|mesh-list
138805436|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805437|NCT00632268|Antidotes|antidotes|mesh-ancestor
138805438|NCT00632268|Protective Agents|protective agents|mesh-ancestor
138805439|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805440|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
138805441|NCT00632268|Vitamins|vitamins|mesh-ancestor
138805442|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
138805443|NCT00632268|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138352321|NCT03219294|Bromides|bromides|mesh-list
138805444|NCT00632268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138805445|NCT00632268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805446|NCT00632268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805447|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138805448|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
138805449|NCT04145076|Citalopram|citalopram|mesh-list
138805450|NCT04145076|Tianeptine|tianeptine|mesh-list
138805451|NCT04145076|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138805452|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138805453|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138805454|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805455|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805456|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
138482709|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
138805457|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805458|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138805459|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
138805460|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138805461|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138805462|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
138805463|NCT00707902|Lidocaine|lidocaine|mesh-list
138805464|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
138805465|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
138805466|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805467|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805468|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
138805469|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805470|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138805471|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138703085|NCT02916173|Hormones|hormones|mesh-list
138805472|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138805473|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138464856|NCT05574712|Hormone Antagonists|hormone antagonists|mesh-ancestor
138805474|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805475|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138805476|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138805478|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
138805479|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138805480|NCT00833794|Tramadol|tramadol|mesh-list
138805481|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138805482|NCT00833794|Narcotics|narcotics|mesh-ancestor
138805483|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805484|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805485|NCT00833794|Analgesics|analgesics|mesh-ancestor
138805486|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
138805487|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805488|NCT00778375|Cytarabine|cytarabine|mesh-list
138805489|NCT00778375|Decitabine|decitabine|mesh-list
138805490|NCT00778375|Clofarabine|clofarabine|mesh-list
138805491|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138805492|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
138805493|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805494|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805495|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
138805496|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138805497|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138805498|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
138182987|NCT05515770|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138805499|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805501|NCT04102267|Epinephrine|epinephrine|mesh-list
138805502|NCT04102267|Bupivacaine|bupivacaine|mesh-list
138805503|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
138805504|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
138805505|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805506|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805507|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
138805508|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805509|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138805511|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
138805512|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805513|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805514|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138805515|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138805516|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
138805517|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138805518|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
138805519|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
138805520|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
138805521|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138805522|NCT00777829|Zolpidem|zolpidem|mesh-list
138805523|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138805524|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138805525|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805526|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805527|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138805528|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
138805529|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
138805530|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805531|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805533|NCT00916045|Cyclosporine|cyclosporine|mesh-list
138805534|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
138805535|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
138805536|NCT00916045|Melphalan|melphalan|mesh-list
138805537|NCT00916045|Busulfan|busulfan|mesh-list
138805538|NCT00916045|Thiotepa|thiotepa|mesh-list
138805539|NCT00916045|Fludarabine|fludarabine|mesh-list
138805540|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
138805541|NCT00916045|Cyclosporins|cyclosporins|mesh-list
138805542|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
138805543|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138805544|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138805545|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
138805546|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805547|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138805548|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138805549|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
138805550|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482926|NCT00006363|Analgesics|analgesics|mesh-ancestor
138805551|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805552|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138805553|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138419064|NCT06144944|Paclitaxel|paclitaxel|mesh-list
138805554|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
138805555|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
138703168|NCT01666977|Pemetrexed|pemetrexed|mesh-list
138805556|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138805557|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805558|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
138805559|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
138805560|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138805561|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138805562|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138805563|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
138805564|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138805565|NCT00916123|Prednisone|prednisone|mesh-list
138805566|NCT00916123|Docetaxel|docetaxel|mesh-list
138805567|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805568|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
138805569|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
138805570|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
138805571|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805572|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138805573|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
138805574|NCT00916123|Hormones|hormones|mesh-ancestor
138805575|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138805576|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805577|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138805578|NCT00916201|Cannabidiol|cannabidiol|mesh-list
138805579|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
138805580|NCT00833638|Tadalafil|tadalafil|mesh-list
138805581|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
138805582|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138805583|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138805584|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805585|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805586|NCT00833638|Urological Agents|urological agents|mesh-ancestor
138805587|NCT01041404|Capecitabine|capecitabine|mesh-list
138805588|NCT01041404|Fluorouracil|fluorouracil|mesh-list
138805589|NCT01041404|Trastuzumab|trastuzumab|mesh-list
138805590|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805591|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138805592|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
138703195|NCT01661634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805593|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805594|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138805595|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
138805596|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805597|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138805598|NCT00777049|Panobinostat|panobinostat|mesh-list
138805599|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805600|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138805601|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805602|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805603|NCT00774787|Imiquimod|imiquimod|mesh-list
138805604|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138805605|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
138805606|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805607|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805608|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
138805609|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
138805610|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805611|NCT01040780|Gefitinib|gefitinib|mesh-list
138805612|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805613|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138805614|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805615|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805616|NCT04303988|Bevacizumab|bevacizumab|mesh-list
138805617|NCT04303988|Carboplatin|carboplatin|mesh-list
138805618|NCT04303988|Temozolomide|temozolomide|mesh-list
138805619|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138805620|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805621|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138805622|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138805623|NCT04303988|Growth Substances|growth substances|mesh-ancestor
138805624|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805625|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
138805626|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138805627|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
138805628|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805629|NCT01059812|Insulin|insulin|mesh-list
138805630|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138805631|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
138805632|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
138805633|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138805634|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
138805635|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138805636|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138805637|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805638|NCT00888615|Paclitaxel|paclitaxel|mesh-list
138805639|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138805640|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138483059|NCT05660200|Iron|iron|mesh-list
138805641|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805642|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
138805643|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
138805644|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
138805645|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805646|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
138805647|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
138805648|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138805649|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138805650|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
138805651|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805653|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
138805654|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805655|NCT00833560|Dexamethasone|dexamethasone|mesh-list
138805656|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
138805657|NCT00833560|Bortezomib|bortezomib|mesh-list
138805658|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138805660|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805661|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138805662|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138805663|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
138805664|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805665|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805666|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138805667|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138805668|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
138805669|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
138805670|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805671|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138805672|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
138805673|NCT00833560|Hormones|hormones|mesh-ancestor
138640944|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138805674|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138805675|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138805676|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
138805678|NCT04242927|Niacinamide|niacinamide|mesh-list
138805679|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
138805680|NCT04242927|Vitamins|vitamins|mesh-ancestor
138805681|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
138805682|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805683|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138805684|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
138805685|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805686|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138805687|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
138805688|NCT00887679|Escitalopram|escitalopram|mesh-list
138805689|NCT00887679|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138805690|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138805691|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138805692|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805693|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805694|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
138805695|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805697|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805698|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138805699|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805700|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805701|NCT00833482|Ritonavir|ritonavir|mesh-list
138805702|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138805703|NCT00833482|Voriconazole|voriconazole|mesh-list
138805704|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138805705|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138805706|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
138805707|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805708|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805709|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138805710|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138805711|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
138805712|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138805713|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138805714|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138805715|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
138703372|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
138805716|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138805717|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138805718|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
138805719|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138805720|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805722|NCT00845182|Exenatide|exenatide|mesh-list
138805723|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138805724|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805725|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138805727|NCT00845182|Hormones|hormones|mesh-ancestor
138805728|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138805729|NCT00833248|Goserelin|goserelin|mesh-list
138805730|NCT00833248|Bicalutamide|bicalutamide|mesh-list
138805731|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138805732|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805733|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
138805734|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
138805735|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138805736|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805737|NCT00702130|Pravastatin|pravastatin|mesh-list
138805738|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138805739|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138805740|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
138805741|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805742|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138805743|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138805744|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805745|NCT00823264|Charcoal|charcoal|mesh-list
138805746|NCT00823264|Antidotes|antidotes|mesh-ancestor
138805747|NCT00823264|Protective Agents|protective agents|mesh-ancestor
138805748|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805749|NCT04241211|Denosumab|denosumab|mesh-list
138805750|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138805751|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805752|NCT00702442|Droperidol|droperidol|mesh-list
138805753|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138805754|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
138805755|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
138805756|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805757|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805758|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138805759|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138805760|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138805761|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805762|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138805763|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138805764|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138703420|NCT02044341|Benzocaine|benzocaine|mesh-list
138805765|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
138805766|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805767|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805769|NCT02612272|Betamethasone|betamethasone|mesh-list
138805770|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138805771|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138805772|NCT02612272|Analgesics|analgesics|mesh-ancestor
138805773|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
138805774|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805775|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805776|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138805777|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138805778|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138805779|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805780|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805781|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
138805782|NCT02612272|Hormones|hormones|mesh-ancestor
138805783|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138805784|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138805785|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
138805786|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138805787|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138805788|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805789|NCT00832624|Incretins|incretins|mesh-ancestor
138805790|NCT00832624|Hormones|hormones|mesh-ancestor
138805791|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138805793|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
138805794|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805795|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805796|NCT00913120|Enoxaparin|enoxaparin|mesh-list
138805797|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
138805798|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138640966|NCT00260039|Vaccines|vaccines|mesh-list
138805799|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138805800|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805802|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138805803|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
138805804|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805805|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805806|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138805807|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
138805808|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138805809|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138483199|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138805810|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805811|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138805812|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
138805813|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138805814|NCT00822172|Protective Agents|protective agents|mesh-ancestor
138805815|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138805816|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138805817|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805818|NCT00832000|Mexiletine|mexiletine|mesh-list
138805819|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138805820|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138805821|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138805822|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138805823|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805824|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
138805825|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
138805826|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138805827|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
138805828|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138805829|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
138805830|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
138805831|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
138805832|NCT04166292|Lidocaine|lidocaine|mesh-list
138805833|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
138805834|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
138805835|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805836|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805837|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
138805838|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805839|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138805840|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138805841|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138805842|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138805843|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805844|NCT04099771|Ketamine|ketamine|mesh-list
138805845|NCT04099771|Analgesics|analgesics|mesh-ancestor
138805846|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
138805847|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805848|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805849|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138805850|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138805851|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
138805852|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
138805853|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805854|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138805855|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138805856|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805857|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805858|NCT00768469|Paclitaxel|paclitaxel|mesh-list
138805859|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138805860|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805861|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
138805862|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
138805863|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
138805864|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805866|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138805867|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138805868|NCT02825121|Trace Elements|trace elements|mesh-ancestor
138805869|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
138805870|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805871|NCT02825199|Caffeine|caffeine|mesh-list
138805872|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138805873|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805874|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138805875|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805876|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805877|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138805878|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138805879|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
138805880|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805882|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138805883|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805884|NCT02824965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138805885|NCT02824965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483282|NCT00006465|Irinotecan|irinotecan|mesh-list
138805887|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805888|NCT02826759|Insulin|insulin|mesh-list
138805889|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138805890|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805891|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138805892|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
138805893|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138805894|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
138805895|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805896|NCT02826837|Bevacizumab|bevacizumab|mesh-list
138805897|NCT02826837|Cetuximab|cetuximab|mesh-list
138805898|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138805899|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805900|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138464958|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138805901|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138805902|NCT02826837|Growth Substances|growth substances|mesh-ancestor
138805903|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805904|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
138805905|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138805906|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
138805907|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138805908|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
138805909|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138805910|NCT02823483|Protective Agents|protective agents|mesh-ancestor
138805911|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805912|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
138805913|NCT04848597|Paclitaxel|paclitaxel|mesh-list
138805914|NCT04848597|Antibodies|antibodies|mesh-list
138805915|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138805916|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138805917|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805918|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
138805919|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
138805920|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
138805921|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805922|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805923|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
138805924|NCT05660811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138805925|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
138805926|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138805927|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805928|NCT02823405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138805929|NCT02823405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805931|NCT02823249|Tryptophan|tryptophan|mesh-list
138483322|NCT04201834|Risperidone|risperidone|mesh-list
138805932|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138805933|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
138805934|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138805935|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
138805936|NCT00768079|Benralizumab|benralizumab|mesh-list
138805937|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138805938|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
138805939|NCT02603575|Caspofungin|caspofungin|mesh-list
138805940|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
138805941|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
138805942|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
138805943|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138805944|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
138805945|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
138805946|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138805947|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805948|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138805949|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
138805950|NCT02603575|Hormones|hormones|mesh-ancestor
138805951|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138805952|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138805953|NCT02603575|Protective Agents|protective agents|mesh-ancestor
138805954|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
138805955|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138805956|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805957|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805958|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138805959|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
138805960|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
138805961|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138805962|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805963|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805964|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
138805965|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138805966|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138805967|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805968|NCT02822157|Paclitaxel|paclitaxel|mesh-list
138805969|NCT02822157|Carboplatin|carboplatin|mesh-list
138805970|NCT02822157|Gemcitabine|gemcitabine|mesh-list
138805971|NCT02822157|Doxorubicin|doxorubicin|mesh-list
138805972|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138805973|NCT02822157|Topotecan|topotecan|mesh-list
138805974|NCT02822157|Olaparib|olaparib|mesh-list
138805975|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138805976|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138805977|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
138805978|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
138805979|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
138805980|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805981|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138805982|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
138805983|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138805984|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138805985|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138805986|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138805987|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138805988|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138805989|NCT02822937|Triazolam|triazolam|mesh-list
138805990|NCT02822937|Methylphenidate|methylphenidate|mesh-list
138805991|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138805992|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138805993|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138805994|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138805995|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138805996|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138805997|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
138805998|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138805999|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138806000|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138806001|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138806002|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806003|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138806004|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
138806005|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
138806006|NCT04200885|Dexamethasone|dexamethasone|mesh-list
138806007|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138806008|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138806009|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138806010|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
138806011|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
138806012|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806013|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806014|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138806015|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
138703665|NCT02910518|Calcium heparin|calcium heparin|mesh-list
138806017|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138806018|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138806019|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483371|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138806020|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138806021|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138183510|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138806023|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
138806024|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806025|NCT05659251|Paclitaxel|paclitaxel|mesh-list
138806026|NCT05659251|Carboplatin|carboplatin|mesh-list
138806027|NCT05659251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138806028|NCT05659251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806029|NCT05659251|Tubulin Modulators|tubulin modulators|mesh-ancestor
138806030|NCT05659251|Antimitotic Agents|antimitotic agents|mesh-ancestor
138806031|NCT05659251|Mitosis Modulators|mitosis modulators|mesh-ancestor
138806032|NCT05659251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806033|NCT00766831|Hydromorphone|hydromorphone|mesh-list
138806034|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138806035|NCT00766831|Narcotics|narcotics|mesh-ancestor
138806036|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806037|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806038|NCT00766831|Analgesics|analgesics|mesh-ancestor
138806039|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
138806040|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806041|NCT02821689|Pirfenidone|pirfenidone|mesh-list
138806042|NCT02821689|Analgesics|analgesics|mesh-ancestor
138806043|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
138806044|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806045|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806046|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138806047|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138703711|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138380565|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
138703712|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
138703744|NCT06227221|Sorafenib|sorafenib|mesh-list
138806048|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138806049|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806050|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806052|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
138806053|NCT05659407|Rituximab|rituximab|mesh-list
138806054|NCT05659407|Belimumab|belimumab|mesh-list
138806055|NCT05659407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138806056|NCT05659407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806057|NCT05659407|Immunologic Factors|immunologic factors|mesh-ancestor
138806058|NCT05659407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806059|NCT05659407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806060|NCT05659407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138806061|NCT00766675|Acetaminophen|acetaminophen|mesh-list
138806062|NCT00766675|Tramadol|tramadol|mesh-list
138806063|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138806064|NCT00766675|Analgesics|analgesics|mesh-ancestor
138806065|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
138806066|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806067|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806068|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
138806069|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138806070|NCT00766675|Narcotics|narcotics|mesh-ancestor
138806071|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806072|NCT02820441|Zopiclone|zopiclone|mesh-list
138806073|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138806074|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806075|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806076|NCT02821377|Furosemide|furosemide|mesh-list
138806077|NCT02821377|Diuretics|diuretics|mesh-ancestor
138806078|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
138806079|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806080|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138806081|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138806082|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806083|NCT02820987|Meropenem|meropenem|mesh-list
138806086|NCT02820987|Cefepime|cefepime|mesh-list
138806087|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138806088|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138806089|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138806090|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138806091|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806092|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806093|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
138806094|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138806095|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
138806096|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
138806097|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
138483429|NCT00006519|Capravirine|capravirine|mesh-list
138806098|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138806099|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806100|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138806101|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806102|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806103|NCT02818881|Methamphetamine|methamphetamine|mesh-list
138806104|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138806105|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806106|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
138806107|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
138806108|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806109|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
138806110|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138806111|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806112|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
138806113|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138806114|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138806115|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138806116|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138806118|NCT02818803|Miconazole|miconazole|mesh-list
138703804|NCT06226532|Lidocaine|lidocaine|mesh-list
138703805|NCT06226532|Anesthetics, Local|anesthetics, local|mesh-ancestor
138703806|NCT06226532|Anesthetics|anesthetics|mesh-ancestor
138703807|NCT06226532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138703808|NCT06226532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806125|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138806126|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
138806127|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138806128|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806129|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138806130|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138806131|NCT02818725|Cisplatin|cisplatin|mesh-list
138806132|NCT02818725|Doxorubicin|doxorubicin|mesh-list
138806133|NCT02818725|Methotrexate|methotrexate|mesh-list
138806134|NCT02818725|Panitumumab|panitumumab|mesh-list
138465026|NCT04660760|Paclitaxel|paclitaxel|mesh-list
138806135|NCT02818725|Vinblastine|vinblastine|mesh-list
138806136|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806137|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138806138|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138806139|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138806140|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806141|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806142|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138806143|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
138806144|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138806145|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483466|NCT00006669|Etoposide|etoposide|mesh-list
138806146|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138806147|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
138806148|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
138806149|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138806150|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138806151|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
138806152|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806153|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138806154|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138703843|NCT06225999|Leucovorin|leucovorin|mesh-list
138703844|NCT06225999|Fluorouracil|fluorouracil|mesh-list
138703845|NCT06225999|Oxaliplatin|oxaliplatin|mesh-list
138703846|NCT06225999|Irinotecan|irinotecan|mesh-list
138806155|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138806156|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
138806157|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
138806158|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
138806159|NCT02820051|Lidocaine|lidocaine|mesh-list
138806160|NCT02820051|Midazolam|midazolam|mesh-list
138806161|NCT02820051|Nalbuphine|nalbuphine|mesh-list
138806162|NCT02820051|Propofol|propofol|mesh-list
138806163|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
138806164|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
138806165|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806166|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806167|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
138806168|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806169|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138806170|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138806171|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138806172|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138806173|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806174|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138806175|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138806176|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
138806177|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138806178|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138806179|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138806180|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138806181|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
138806182|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
138806183|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138806184|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138806185|NCT02820051|Narcotics|narcotics|mesh-ancestor
138806186|NCT02820051|Analgesics|analgesics|mesh-ancestor
138806187|NCT02817243|Simvastatin|simvastatin|mesh-list
138806188|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138806189|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138806190|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
138806191|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806192|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138703875|NCT06225895|Sensory System Agents|sensory system agents|mesh-ancestor
138806193|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138806194|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806196|NCT00766363|Donepezil|donepezil|mesh-list
138483489|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
138806197|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138806198|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806199|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806200|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
138806201|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138806202|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806203|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
138806204|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138806205|NCT00766363|Protective Agents|protective agents|mesh-ancestor
138806206|NCT02636946|Bimatoprost|bimatoprost|mesh-list
138806207|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138806208|NCT02819661|Morphine|morphine|mesh-list
138806209|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806210|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806211|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138806212|NCT02819661|Narcotics|narcotics|mesh-ancestor
138806213|NCT02819661|Analgesics|analgesics|mesh-ancestor
138806214|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
138806215|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806216|NCT00765817|Exenatide|exenatide|mesh-list
138806217|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138806218|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806219|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138806220|NCT00765817|Incretins|incretins|mesh-ancestor
138806221|NCT00765817|Hormones|hormones|mesh-ancestor
138806222|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138806223|NCT02818491|Dexamethasone|dexamethasone|mesh-list
138806224|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
138806225|NCT02818491|Ropivacaine|ropivacaine|mesh-list
138806226|NCT02818491|BB 1101|bb 1101|mesh-list
138806227|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138806228|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
138806229|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
138806230|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806231|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806232|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138806233|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
138806234|NCT02818491|Hormones|hormones|mesh-ancestor
138806235|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138703911|NCT06225596|Avelumab|avelumab|mesh-list
138703912|NCT06225596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703913|NCT06225596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138703914|NCT06225596|Antimetabolites|antimetabolites|mesh-ancestor
138703915|NCT06225596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353619|NCT00577356|Docetaxel|docetaxel|mesh-list
138703916|NCT06225596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138703926|NCT06225544|Lumasiran|lumasiran|mesh-list
138806236|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138465079|NCT04237103|Methotrexate|methotrexate|mesh-list
138806237|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806238|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
138483510|NCT00006747|Etoposide|etoposide|mesh-list
138806239|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806240|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806241|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
138806242|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
138806243|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806244|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
138806245|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
138806246|NCT02816853|Domperidone|domperidone|mesh-list
138806247|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138806248|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138183736|NCT04382027|Vitamins|vitamins|mesh-list
138806249|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138806250|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138806251|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806252|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806253|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806254|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806255|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
138806256|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
138806257|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806258|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138806260|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
138806261|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138806262|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
138806263|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
138806264|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138806265|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138806266|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138806267|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806268|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138806269|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138806270|NCT00772447|Vancomycin|vancomycin|mesh-list
138806271|NCT00772447|Daptomycin|daptomycin|mesh-list
138806272|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138483539|NCT00006786|Leucovorin|leucovorin|mesh-list
138806273|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138806274|NCT04238169|Bevacizumab|bevacizumab|mesh-list
138806275|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138806276|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806277|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138806278|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138806279|NCT04238169|Growth Substances|growth substances|mesh-ancestor
138806280|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806281|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
138806282|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138806283|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
138806284|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806285|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138806286|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138806287|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138806288|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
138806289|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138806290|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806291|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138806292|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138806293|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138806294|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138806295|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138806296|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138806297|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138806298|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138806299|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138806300|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
138806301|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138806302|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138806303|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138806304|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806305|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806306|NCT02817477|Ketamine|ketamine|mesh-list
138806307|NCT02817477|Morphine|morphine|mesh-list
138806308|NCT02817477|Analgesics|analgesics|mesh-ancestor
138806309|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
138806310|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806311|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806312|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138806313|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138806314|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
138806315|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
138806316|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806317|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138806318|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138806319|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138806320|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806321|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138806322|NCT02817477|Narcotics|narcotics|mesh-ancestor
138806323|NCT02819115|Vaccines|vaccines|mesh-list
138806324|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
138806325|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806326|NCT04099069|Anesthetics|anesthetics|mesh-list
138806327|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806328|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806329|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138806330|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138806331|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138806332|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806333|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806334|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138806335|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138483627|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
138806336|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806337|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
138806338|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138806339|NCT04101019|Lidocaine|lidocaine|mesh-list
138806340|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
138806341|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
138806342|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806343|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806344|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
138806345|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806346|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138806347|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138806348|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138806349|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138806350|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806351|NCT02817321|Morphine|morphine|mesh-list
138421886|NCT01687517|Vaccines|vaccines|mesh-list
138806352|NCT02817321|Ropivacaine|ropivacaine|mesh-list
138806353|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138806354|NCT02817321|Narcotics|narcotics|mesh-ancestor
138806355|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806356|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806357|NCT02817321|Analgesics|analgesics|mesh-ancestor
138806358|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
138806359|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806360|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
138465099|NCT04198805|Vitamins|vitamins|mesh-list
138465100|NCT04198805|Vitamin E|vitamin e|mesh-list
138806361|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
138806362|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
138806363|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138806364|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806365|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
138806366|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138806367|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806368|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
138806369|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138806370|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138806371|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138806373|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
138806374|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
138806375|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806376|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
138806377|NCT00843856|Tacrolimus|tacrolimus|mesh-list
138806378|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138806379|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
138806380|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806381|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138806382|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806383|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806384|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138806385|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806386|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138806387|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
138806388|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138806389|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138806390|NCT04480125|Azacitidine|azacitidine|mesh-list
138806391|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138806392|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
138806393|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806394|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806395|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806396|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
138806397|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138806398|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
138806399|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806400|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
138806402|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
138164986|NCT05630846|Vaccines|vaccines|mesh-list
138806403|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
138806404|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138806405|NCT00705796|Androgens|androgens|mesh-ancestor
138806406|NCT00705796|Hormones|hormones|mesh-ancestor
138806407|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138806408|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806409|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138806410|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806411|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
138806412|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
138806413|NCT00843778|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138806414|NCT00843778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138806415|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138806416|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
138806417|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806418|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806420|NCT05631249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138806421|NCT05631249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806422|NCT05631249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138806423|NCT05631249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806424|NCT05629923|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
138806425|NCT05629923|Antiviral Agents|antiviral agents|mesh-ancestor
138806426|NCT05629923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138806427|NCT00820222|Capecitabine|capecitabine|mesh-list
138806428|NCT00820222|Trastuzumab|trastuzumab|mesh-list
138806429|NCT00820222|Lapatinib|lapatinib|mesh-list
138806430|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138806431|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
138806432|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806433|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806434|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138806435|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138806436|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806437|NCT02815449|Iron|iron|mesh-list
138806438|NCT02815449|Trace Elements|trace elements|mesh-ancestor
138806439|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
138806440|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806441|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
138806442|NCT01039688|Tofacitinib|tofacitinib|mesh-list
138806443|NCT01039688|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138806444|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138806445|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483741|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138806446|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806447|NCT02237508|Budesonide|budesonide|mesh-list
138806448|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
138806449|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138806450|NCT02237508|Charcoal|charcoal|mesh-list
138806451|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138806452|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138806453|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
138806454|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806455|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806456|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138806457|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
138806458|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
138806459|NCT02237508|Hormones|hormones|mesh-ancestor
138806460|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138806461|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138806462|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138806463|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138806464|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
138806465|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138806466|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806467|NCT02237508|Antidotes|antidotes|mesh-ancestor
138806468|NCT02237508|Protective Agents|protective agents|mesh-ancestor
138806469|NCT02809755|Lidocaine|lidocaine|mesh-list
138806470|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
138806472|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806473|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806474|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
138806475|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806476|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138806477|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138806478|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138806479|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138806480|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806481|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
138806482|NCT02812719|Salicylates|salicylates|mesh-list
138806483|NCT02812719|Glycolic acid|glycolic acid|mesh-list
138806484|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138806485|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
138806486|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
138806487|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
138806488|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138806489|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138806490|NCT02812719|Analgesics|analgesics|mesh-ancestor
138806491|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
138806492|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806493|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806494|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138806495|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806496|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138806497|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806498|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806499|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
138806500|NCT02876978|Fludarabine|fludarabine|mesh-list
138806501|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138806502|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
138806503|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806504|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806505|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138806506|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
138806507|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806508|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806509|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138806510|NCT00909480|Insulin|insulin|mesh-list
138806511|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138806512|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
138806513|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
138806514|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138806515|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806516|NCT05642715|Varenicline|varenicline|mesh-list
138465168|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806517|NCT05642715|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138806518|NCT05642715|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138806519|NCT05642715|Cholinergic Agents|cholinergic agents|mesh-ancestor
138806520|NCT05642715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138806521|NCT05642715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806522|NCT05642715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806524|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138806525|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138806526|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806527|NCT02812641|Bevacizumab|bevacizumab|mesh-list
138806528|NCT02812641|Cisplatin|cisplatin|mesh-list
138806529|NCT02812641|Fluorouracil|fluorouracil|mesh-list
138806530|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138806531|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806532|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138806533|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138806534|NCT02812641|Growth Substances|growth substances|mesh-ancestor
138806535|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806536|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
138806537|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
138806538|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806539|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138806540|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138806541|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
138806542|NCT01058096|Cariprazine|cariprazine|mesh-list
138806543|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138806544|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138806545|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806546|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806547|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138806549|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138806550|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138806551|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806552|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
138806553|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806554|NCT01038128|Memantine|memantine|mesh-list
138806555|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138806556|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138806557|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
138806558|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138806559|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806560|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806561|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138806562|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138806563|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
138806564|NCT04303520|Fludarabine|fludarabine|mesh-list
138806565|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138806566|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
138806567|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806568|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806569|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138806570|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
138806571|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806572|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806573|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138806574|NCT02562378|Doxorubicin|doxorubicin|mesh-list
138806575|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138806576|NCT02562378|Trastuzumab|trastuzumab|mesh-list
138465182|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138806577|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138806578|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806579|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138806580|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138806581|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806582|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806583|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138806584|NCT00842530|Vaccines|vaccines|mesh-list
138806585|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
138806586|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806587|NCT05580510|Empagliflozin|empagliflozin|mesh-list
138806588|NCT05580510|Valsartan|valsartan|mesh-list
138806589|NCT05580510|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138806590|NCT05580510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138806591|NCT05580510|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138806592|NCT05580510|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138806593|NCT05580510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806594|NCT05580510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138483960|NCT00006208|Efavirenz|efavirenz|mesh-list
138806595|NCT05580510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138806596|NCT05580510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806597|NCT02811627|Memantine|memantine|mesh-list
138806598|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138806599|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138806600|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
138806601|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138806602|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806603|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806604|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138806605|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138806606|NCT00634413|Budesonide|budesonide|mesh-list
138806607|NCT00634413|Theophylline|theophylline|mesh-list
138806608|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138806609|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138806610|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
138806611|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806612|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806613|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138806614|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
138806615|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
138806616|NCT00634413|Hormones|hormones|mesh-ancestor
138806617|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138806618|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138806619|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184108|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
138806620|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806622|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138806623|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138806624|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
138806625|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138806626|NCT02815059|Prednisone|prednisone|mesh-list
138806627|NCT02815059|Dasatinib|dasatinib|mesh-list
138806628|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138806629|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
138806630|NCT02815059|Hormones|hormones|mesh-ancestor
138806631|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138483998|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
138806632|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806633|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138806634|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806635|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138806636|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806637|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806638|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
138806639|NCT00819910|Fenofibrate|fenofibrate|mesh-list
138806640|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138806641|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806642|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138806643|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
138806644|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806645|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138806646|NCT02808117|Micronutrients|micronutrients|mesh-list
138806647|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806648|NCT04321395|Vigabatrin|vigabatrin|mesh-list
138806649|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
138806650|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806651|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806652|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
138806653|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138806654|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806655|NCT02814669|Atezolizumab|atezolizumab|mesh-list
138806656|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138806657|NCT02814669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138806658|NCT02814669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806659|NCT02814669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138806660|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806661|NCT02808741|Olorofim|olorofim|mesh-list
138806662|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
138806663|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138806664|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138806665|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138806666|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138806667|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138806668|NCT02807415|Ivacaftor|ivacaftor|mesh-list
138806669|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138806670|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138806671|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806672|NCT02804841|Vitamin D|vitamin d|mesh-list
138806673|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
138806674|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
138806675|NCT02804841|Vitamins|vitamins|mesh-list
138806676|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
138806677|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806678|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138806679|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138806680|NCT00634491|Acetazolamide|acetazolamide|mesh-list
138806681|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
138806682|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138806683|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806684|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806685|NCT00634491|Diuretics|diuretics|mesh-ancestor
138806686|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
138806687|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806688|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
138806689|NCT02807103|Rituximab|rituximab|mesh-list
138806690|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138806691|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
138806692|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806693|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138465215|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
138806694|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138806695|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
138806696|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806697|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806698|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138806699|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138806701|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138806702|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
138806703|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806705|NCT00830128|Analgesics|analgesics|mesh-ancestor
138806706|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
138806707|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806708|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806709|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
138806710|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138806711|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138806712|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806713|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138806714|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138806715|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138806716|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806717|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138806718|NCT05498103|Methazolamide|methazolamide|mesh-list
138806719|NCT05498103|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138806720|NCT05498103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806721|NCT05498103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806722|NCT05498103|Diuretics|diuretics|mesh-ancestor
138806723|NCT05498103|Natriuretic Agents|natriuretic agents|mesh-ancestor
138806724|NCT05498103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806725|NCT00771667|Ustekinumab|ustekinumab|mesh-list
138806726|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
138806727|NCT03893175|Acetaminophen|acetaminophen|mesh-list
138806728|NCT03893175|Ibuprofen|ibuprofen|mesh-list
138806729|NCT03893175|Oxycodone|oxycodone|mesh-list
138806730|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138806731|NCT03893175|Analgesics|analgesics|mesh-ancestor
138806732|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
138806733|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806734|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806735|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
138806736|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138806737|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138806738|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806739|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138806740|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806741|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806742|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138806743|NCT03893175|Narcotics|narcotics|mesh-ancestor
138806744|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806746|NCT04236453|Emtricitabine|emtricitabine|mesh-list
138806747|NCT04236453|Darunavir|darunavir|mesh-list
138806748|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138806749|NCT04236453|Cobicistat|cobicistat|mesh-list
138806750|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138806751|NCT04236453|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
138806752|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
138806753|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138806754|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138806755|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138806756|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806757|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806758|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138806759|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138806760|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138806761|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138806762|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
138806763|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138806764|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138806766|NCT05461339|Antibodies|antibodies|mesh-list
138806767|NCT05461339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138806768|NCT05461339|Immunologic Factors|immunologic factors|mesh-ancestor
138806769|NCT05461339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806770|NCT05461339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138806771|NCT05461339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138806772|NCT05461339|Growth Substances|growth substances|mesh-ancestor
138806773|NCT05461339|Growth Inhibitors|growth inhibitors|mesh-ancestor
138806774|NCT05461339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806775|NCT03409848|Nivolumab|nivolumab|mesh-list
138806776|NCT03409848|Ipilimumab|ipilimumab|mesh-list
138806777|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138806778|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806779|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138806780|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806781|NCT00763555|Calcitriol|calcitriol|mesh-list
138806782|NCT00763555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138806783|NCT00763555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806784|NCT00763555|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138806785|NCT00763555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138806786|NCT00763555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806787|NCT00763555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138806788|NCT00763555|Vitamins|vitamins|mesh-ancestor
138806789|NCT00763555|Micronutrients|micronutrients|mesh-ancestor
138806790|NCT00763555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138806792|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
138806793|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138806794|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806795|NCT00763321|Acetaminophen|acetaminophen|mesh-list
138806796|NCT00763321|Hydrocodone|hydrocodone|mesh-list
138806797|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138806798|NCT00763321|Analgesics|analgesics|mesh-ancestor
138806799|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
138806800|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806801|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806802|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
138806803|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138806804|NCT00763321|Narcotics|narcotics|mesh-ancestor
138806805|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806806|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
138806807|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
138806808|NCT02799927|Calcium|calcium|mesh-list
138806809|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138806810|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806811|NCT00770653|Metformin|metformin|mesh-list
138806812|NCT00770653|Pioglitazone|pioglitazone|mesh-list
138806813|NCT00770653|Glimepiride|glimepiride|mesh-list
138806814|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138806815|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465245|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
138806816|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138806817|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138806818|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
138806820|NCT02799615|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138806821|NCT02799615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138806822|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
138806823|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138806824|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806825|NCT00819052|Nevirapine|nevirapine|mesh-list
138806826|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138806827|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138806828|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806829|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806830|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
138806831|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138806832|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138806833|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138806834|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138806835|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138806836|NCT00763009|Dipyridamole|dipyridamole|mesh-list
138806837|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138806838|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806839|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806840|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138806841|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
138806842|NCT02799459|Anesthetics|anesthetics|mesh-list
138806843|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138806844|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806845|NCT05477589|Cyclophosphamide|cyclophosphamide|mesh-list
138806846|NCT05477589|Melphalan|melphalan|mesh-list
138806847|NCT05477589|Busulfan|busulfan|mesh-list
138806848|NCT05477589|Fludarabine|fludarabine|mesh-list
138806849|NCT05477589|Clofarabine|clofarabine|mesh-list
138806850|NCT05477589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138806851|NCT05477589|Immunologic Factors|immunologic factors|mesh-ancestor
138806852|NCT05477589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641361|NCT00293436|Analgesics|analgesics|mesh-ancestor
138806853|NCT05477589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806854|NCT05477589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138806855|NCT05477589|Alkylating Agents|alkylating agents|mesh-ancestor
138806856|NCT05477589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806857|NCT05477589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806858|NCT05477589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138806859|NCT05477589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138806860|NCT05477589|Antimetabolites|antimetabolites|mesh-ancestor
138806861|NCT00841672|Amlodipine|amlodipine|mesh-list
138806862|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138806863|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138806864|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138806865|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806866|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138806867|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806868|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
138806869|NCT05549115|Amoxicillin|amoxicillin|mesh-list
138806870|NCT05549115|Clarithromycin|clarithromycin|mesh-list
138806871|NCT05549115|Levofloxacin|levofloxacin|mesh-list
138806872|NCT05549115|Ofloxacin|ofloxacin|mesh-list
138806873|NCT05549115|Furazolidone|furazolidone|mesh-list
138806874|NCT05549115|Bismuth|bismuth|mesh-list
138806875|NCT05549115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138806876|NCT05549115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138806877|NCT05549115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138806879|NCT05549115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806880|NCT05549115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138806881|NCT05549115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138806882|NCT05549115|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138806883|NCT05549115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138806884|NCT05549115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138806885|NCT05549115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806886|NCT05549115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138806887|NCT05549115|Antacids|antacids|mesh-ancestor
138806888|NCT05549115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138806889|NCT05549115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138806890|NCT05549115|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138806891|NCT05549115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138806892|NCT05549115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138806893|NCT05549115|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138806894|NCT04236219|Rasburicase|rasburicase|mesh-list
138806895|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
138806896|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806897|NCT00908232|Dexamethasone|dexamethasone|mesh-list
138806898|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
138806899|NCT00908232|Lenalidomide|lenalidomide|mesh-list
138806900|NCT00908232|Bortezomib|bortezomib|mesh-list
138806901|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138806902|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
138806903|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806904|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806905|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138806906|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
138806907|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806908|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806909|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138806910|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138806911|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
138806912|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
138806913|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422352|NCT01692483|Prednisone|prednisone|mesh-list
138806914|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138806915|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
138806917|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138806918|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138806919|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138806920|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138806921|NCT00908232|Growth Substances|growth substances|mesh-ancestor
138806922|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
138806924|NCT00770341|Daptomycin|daptomycin|mesh-list
138806925|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138806926|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138806927|NCT05472753|Selenium|selenium|mesh-list
138806928|NCT05472753|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
138806929|NCT05472753|Curcumin|curcumin|mesh-list
138806930|NCT05472753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138806931|NCT05472753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138806932|NCT05472753|Analgesics|analgesics|mesh-ancestor
138806933|NCT05472753|Sensory System Agents|sensory system agents|mesh-ancestor
138806934|NCT05472753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806935|NCT05472753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806936|NCT05472753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138806937|NCT05472753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806938|NCT05472753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806939|NCT05472753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806940|NCT05472753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806941|NCT05472753|Antioxidants|antioxidants|mesh-ancestor
138806942|NCT05472753|Protective Agents|protective agents|mesh-ancestor
138806943|NCT05472753|Trace Elements|trace elements|mesh-ancestor
138806944|NCT05472753|Micronutrients|micronutrients|mesh-ancestor
138806945|NCT05472753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138806946|NCT05472753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138806947|NCT02799147|Fludarabine|fludarabine|mesh-list
138806948|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
138806949|NCT02799147|Busulfan|busulfan|mesh-list
138422388|NCT01692834|Cyclosporine|cyclosporine|mesh-list
138806950|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138806951|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806952|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138806954|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806955|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138806956|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
138806957|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806958|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
138806959|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138806960|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138806961|NCT02798913|Clopidogrel|clopidogrel|mesh-list
138806962|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138806963|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138806964|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138806965|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138806966|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
138806967|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138806968|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806969|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806970|NCT00762463|Celecoxib|celecoxib|mesh-list
138806971|NCT00762463|Diclofenac|diclofenac|mesh-list
138806972|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138806973|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138806975|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
138806976|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138806977|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806978|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138806979|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138806980|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138806981|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138806982|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806983|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806984|NCT00906282|Carboplatin|carboplatin|mesh-list
138806985|NCT00906282|Pemetrexed|pemetrexed|mesh-list
138806986|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138806987|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138806988|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806990|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138806991|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
138806992|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138806993|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806994|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138806995|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138806997|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
138806998|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138806999|NCT02798367|Protective Agents|protective agents|mesh-ancestor
138807000|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807001|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138807002|NCT00762229|Ezetimibe|ezetimibe|mesh-list
138807003|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138807004|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138807005|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
138807006|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807007|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138807008|NCT00907374|Benazepril|benazepril|mesh-list
138465282|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
138807009|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138807010|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
138807011|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807012|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807013|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138807014|NCT02805231|Vitamin D|vitamin d|mesh-list
138807015|NCT02805231|Vitamins|vitamins|mesh-ancestor
138807016|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
138807017|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807018|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138807019|NCT03230604|Z 350|z 350|mesh-list
138807020|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138807021|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138807022|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807023|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807024|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
138807025|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138807026|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807027|NCT02798055|Bosentan|bosentan|mesh-list
138422463|NCT01693328|Analgesics|analgesics|mesh-ancestor
138807028|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138807029|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138807030|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807031|NCT05331768|Terlipressin|terlipressin|mesh-list
138807032|NCT05331768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138807033|NCT05331768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138807034|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
138807035|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138807036|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807037|NCT02640222|Vitamin K|vitamin k|mesh-list
138807038|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
138807039|NCT02640222|Apixaban|apixaban|mesh-list
138807040|NCT02640222|Dabigatran|dabigatran|mesh-list
138807041|NCT02640222|Vitamins|vitamins|mesh-ancestor
138807042|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
138807043|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807044|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138807045|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
138807046|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138807047|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
138807048|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807049|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807050|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
138807051|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138807052|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138807053|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
138807054|NCT02640222|Coagulants|coagulants|mesh-ancestor
138807055|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138807056|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
138807057|NCT00818662|Antibodies|antibodies|mesh-list
138807058|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
138807059|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138807060|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138807061|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
138422498|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422499|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138422500|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138422501|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422502|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422503|NCT01693640|Abatacept|abatacept|mesh-list
138422504|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138422505|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422506|NCT01693640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138328201|NCT00310050|Pemetrexed|pemetrexed|mesh-list
138422507|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422512|NCT01693679|Lamivudine|lamivudine|mesh-list
138807062|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
138807063|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807064|NCT03983031|Rituximab|rituximab|mesh-list
138807065|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138807066|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807067|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
138807068|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807069|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138807070|NCT00703066|Vaccines|vaccines|mesh-list
138807071|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
138465293|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
138807072|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807074|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138807075|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138807076|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
138807077|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807078|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807079|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138807080|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
138807081|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
138807082|NCT00762073|Hormones|hormones|mesh-ancestor
138807083|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138807084|NCT00913588|Fluoxetine|fluoxetine|mesh-list
138807085|NCT00913588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138807086|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138807087|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138807088|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807089|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807090|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
138422539|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807091|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807092|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138807093|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
138807094|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138484445|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807095|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138807096|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138807097|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807098|NCT02797587|Nicotine|nicotine|mesh-list
138807099|NCT02797587|Varenicline|varenicline|mesh-list
138807100|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138807101|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
138807102|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807103|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807104|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138807105|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138807106|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
138807107|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807108|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807109|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138807110|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138807111|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138807112|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138807113|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807114|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138807115|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138807116|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138807117|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
138807118|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807119|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807120|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138807121|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138807122|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
138807123|NCT00761527|Desloratadine|desloratadine|mesh-list
138807124|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138807125|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
138807126|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807127|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807128|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422583|NCT05288725|Hormones|hormones|mesh-ancestor
138807129|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138807130|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138807131|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
138807132|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
138807133|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
138807134|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138807135|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138807136|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138807137|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138807138|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138807139|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807140|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
138807141|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807142|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807143|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138807144|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807145|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
138807146|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138807147|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138807148|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807149|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
138807150|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
138807151|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
138807152|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807153|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
138807154|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
138807155|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
138807156|NCT02797041|Bortezomib|bortezomib|mesh-list
138807157|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807158|NCT02794779|Oxytocin|oxytocin|mesh-list
138807159|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
138807160|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138807161|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807162|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
138807163|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138807164|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807165|NCT05805098|Cytarabine|cytarabine|mesh-list
138807166|NCT05805098|Venetoclax|venetoclax|mesh-list
138807167|NCT05805098|Homoharringtonine|homoharringtonine|mesh-list
138807168|NCT05805098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138807169|NCT05805098|Antimetabolites|antimetabolites|mesh-ancestor
138807170|NCT05805098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807171|NCT05805098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807172|NCT05805098|Antiviral Agents|antiviral agents|mesh-ancestor
138465336|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
138807173|NCT05805098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807174|NCT05805098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138807175|NCT05805098|Immunologic Factors|immunologic factors|mesh-ancestor
138807176|NCT05805098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807177|NCT05805098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138807178|NCT05805098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138807179|NCT05805098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807180|NCT05804903|Fexofenadine|fexofenadine|mesh-list
138807181|NCT05804903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138807182|NCT05804903|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138807183|NCT05804903|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138807184|NCT05804903|Histamine Antagonists|histamine antagonists|mesh-ancestor
138807186|NCT05804903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807187|NCT05804903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807188|NCT05804903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807190|NCT05804734|Anticoagulants|anticoagulants|mesh-list
138807191|NCT05804734|Vitamins|vitamins|mesh-ancestor
138807192|NCT05804734|Micronutrients|micronutrients|mesh-ancestor
138807193|NCT05804734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807194|NCT05804734|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138807195|NCT05804734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138807196|NCT05804734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807197|NCT05804734|Hemostatics|hemostatics|mesh-ancestor
138807198|NCT05804734|Coagulants|coagulants|mesh-ancestor
138807199|NCT05804721|Aripiprazole|aripiprazole|mesh-list
138807200|NCT05804721|Antidepressive Agents|antidepressive agents|mesh-ancestor
138807201|NCT05804721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138807202|NCT05804721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138807203|NCT05804721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138807204|NCT05804721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138807205|NCT05804721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807206|NCT05804721|Dopamine Agonists|dopamine agonists|mesh-ancestor
138807207|NCT05804721|Dopamine Agents|dopamine agents|mesh-ancestor
138807208|NCT05804721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807209|NCT05804721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807210|NCT05804721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138807211|NCT05804721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138807212|NCT05804721|Serotonin Agents|serotonin agents|mesh-ancestor
138807213|NCT05804721|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138807214|NCT05804721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138807215|NCT05804721|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138807216|NCT05804721|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138807217|NCT05804630|Lidocaine|lidocaine|mesh-list
138807218|NCT05804630|Anesthetics|anesthetics|mesh-list
138807219|NCT05804630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138807220|NCT05804630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807222|NCT05804630|Sensory System Agents|sensory system agents|mesh-ancestor
138807223|NCT05804630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807224|NCT05804630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138807225|NCT05804630|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138807226|NCT05804630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138807227|NCT05804630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138807228|NCT05804630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807229|NCT05804591|Pregabalin|pregabalin|mesh-list
138807230|NCT05804591|Analgesics|analgesics|mesh-ancestor
138807231|NCT05804591|Sensory System Agents|sensory system agents|mesh-ancestor
138807232|NCT05804591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807233|NCT05804591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807234|NCT05804591|Anticonvulsants|anticonvulsants|mesh-ancestor
138807235|NCT05804591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138807236|NCT05804591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138807237|NCT05804591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807238|NCT05804591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138807239|NCT05804591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138807240|NCT05804591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138807241|NCT05804591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138807242|NCT05804591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138807243|NCT05804370|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138807244|NCT05804370|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138807245|NCT05804370|Dermatologic Agents|dermatologic agents|mesh-ancestor
138422685|NCT05290935|Antibodies|antibodies|mesh-list
138807247|NCT05804305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138807248|NCT05804305|Abortifacient Agents|abortifacient agents|mesh-ancestor
138807249|NCT05804305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138807250|NCT05804305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807251|NCT05804305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138807252|NCT05804305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138807253|NCT05804305|Oxytocics|oxytocics|mesh-ancestor
138807254|NCT05803863|Atropine|atropine|mesh-list
138807255|NCT05803863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138807256|NCT05803863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138807257|NCT05803863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138807258|NCT05803863|Autonomic Agents|autonomic agents|mesh-ancestor
138807259|NCT05803863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807260|NCT05803863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807261|NCT05803863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138807262|NCT05803863|Respiratory System Agents|respiratory system agents|mesh-ancestor
138807263|NCT05803863|Mydriatics|mydriatics|mesh-ancestor
138807264|NCT05803863|Parasympatholytics|parasympatholytics|mesh-ancestor
138807265|NCT05803863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138807266|NCT05803863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138807267|NCT05803863|Cholinergic Agents|cholinergic agents|mesh-ancestor
138807268|NCT05803863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807269|NCT05803863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807270|NCT05803746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138807271|NCT05803746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138807272|NCT05803746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807273|NCT05803642|Haloperidol|haloperidol|mesh-list
138807274|NCT05803642|Olanzapine|olanzapine|mesh-list
138807275|NCT05803642|Haloperidol decanoate|haloperidol decanoate|mesh-list
138807276|NCT05803642|Antiemetics|antiemetics|mesh-ancestor
138807277|NCT05803642|Autonomic Agents|autonomic agents|mesh-ancestor
138807278|NCT05803642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807279|NCT05803642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807280|NCT05803642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138807289|NCT05803642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807290|NCT05803642|Serotonin Agents|serotonin agents|mesh-ancestor
138807291|NCT05803642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138807292|NCT05803642|Dopamine Agents|dopamine agents|mesh-ancestor
138807293|NCT05803642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138807294|NCT05803590|Chlorhexidine|chlorhexidine|mesh-list
138807295|NCT05803590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138807296|NCT05803590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807297|NCT05803590|Disinfectants|disinfectants|mesh-ancestor
138390027|NCT01498406|Vitamin D|vitamin d|mesh-list
138807298|NCT05803135|Tofacitinib|tofacitinib|mesh-list
138807299|NCT05803135|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138807300|NCT05803135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138807301|NCT05803135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807302|NCT05803135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807313|NCT05803070|Cetirizine|cetirizine|mesh-list
138807314|NCT05803070|Betamethasone|betamethasone|mesh-list
138807315|NCT05803070|Betamethasone Valerate|betamethasone valerate|mesh-list
138807316|NCT05803070|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138807317|NCT05803070|Betamethasone benzoate|betamethasone benzoate|mesh-list
138807318|NCT05803070|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138807319|NCT05803070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138807320|NCT05803070|Glucocorticoids|glucocorticoids|mesh-ancestor
138807321|NCT05803070|Hormones|hormones|mesh-ancestor
138807322|NCT05803070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138807323|NCT05803070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807324|NCT05803070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138807325|NCT05803070|Respiratory System Agents|respiratory system agents|mesh-ancestor
138807326|NCT05803070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138807327|NCT05803070|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138807328|NCT05803070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138807329|NCT05803070|Histamine Antagonists|histamine antagonists|mesh-ancestor
138807330|NCT05803070|Histamine Agents|histamine agents|mesh-ancestor
138807331|NCT05803070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807332|NCT05803070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807333|NCT05803031|Tea Tree Oil|tea tree oil|mesh-list
138807334|NCT05803031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138807335|NCT05803031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807336|NCT05802992|Dexamethasone|dexamethasone|mesh-list
138807337|NCT05802992|Dexamethasone acetate|dexamethasone acetate|mesh-list
138807338|NCT05802992|Lenalidomide|lenalidomide|mesh-list
138807339|NCT05802992|Colchicine|colchicine|mesh-list
138807340|NCT05802992|BB 1101|bb 1101|mesh-list
138807341|NCT05802992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138807342|NCT05802992|Antiemetics|antiemetics|mesh-ancestor
138807343|NCT05802992|Autonomic Agents|autonomic agents|mesh-ancestor
138807344|NCT05802992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807345|NCT05802992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807346|NCT05802992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138807347|NCT05802992|Glucocorticoids|glucocorticoids|mesh-ancestor
138807348|NCT05802992|Hormones|hormones|mesh-ancestor
138807349|NCT05802992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138807350|NCT05802992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138807351|NCT05802992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807352|NCT05802992|Protease Inhibitors|protease inhibitors|mesh-ancestor
138807353|NCT05802992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807354|NCT05802992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807355|NCT05802992|Immunologic Factors|immunologic factors|mesh-ancestor
138807356|NCT05802992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138807357|NCT05802992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138807358|NCT05802992|Growth Substances|growth substances|mesh-ancestor
138807359|NCT05802992|Growth Inhibitors|growth inhibitors|mesh-ancestor
138807360|NCT05802992|Gout Suppressants|gout suppressants|mesh-ancestor
138807361|NCT05802992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138807362|NCT05802992|Tubulin Modulators|tubulin modulators|mesh-ancestor
138807363|NCT05802992|Antimitotic Agents|antimitotic agents|mesh-ancestor
138807364|NCT05802992|Mitosis Modulators|mitosis modulators|mesh-ancestor
138484709|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
138807365|NCT05802979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-list
138184857|NCT03835871|Beclomethasone|beclomethasone|mesh-list
138807366|NCT05802888|Amoxicillin|amoxicillin|mesh-list
138807367|NCT05802888|Tetracycline|tetracycline|mesh-list
138807368|NCT05802888|Esomeprazole|esomeprazole|mesh-list
138807370|NCT05802888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138807371|NCT05802888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807372|NCT05802888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138807373|NCT05802888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138807374|NCT05802888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138807375|NCT05802888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807376|NCT05802888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807377|NCT05802888|Antacids|antacids|mesh-ancestor
138807378|NCT05802888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138807379|NCT05802862|Insulin|insulin|mesh-list
138807380|NCT05802862|Insulin Aspart|insulin aspart|mesh-list
138807381|NCT05802862|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138807382|NCT05802862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138807383|NCT05802862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807384|NCT05800574|Cisplatin|cisplatin|mesh-list
138807385|NCT05800574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807386|NCT05776290|Hyaluronic Acid|hyaluronic acid|mesh-list
138807387|NCT05776290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138807388|NCT05776290|Immunologic Factors|immunologic factors|mesh-ancestor
138807389|NCT05776290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807390|NCT05776290|Viscosupplements|viscosupplements|mesh-ancestor
138807391|NCT05776290|Protective Agents|protective agents|mesh-ancestor
138807392|NCT05765227|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138807393|NCT05765227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138807394|NCT05765227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807395|NCT05761444|Atorvastatin|atorvastatin|mesh-list
138807396|NCT05761444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138807397|NCT05761444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138807398|NCT05761444|Antimetabolites|antimetabolites|mesh-ancestor
138807399|NCT05761444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807400|NCT05761444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138807401|NCT05761444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138807402|NCT05761444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807403|NCT05758948|Formaldehyde|formaldehyde|mesh-list
138807404|NCT05758948|Disinfectants|disinfectants|mesh-ancestor
138807405|NCT05758948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807406|NCT05757791|Empagliflozin|empagliflozin|mesh-list
138807407|NCT05757791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138807408|NCT05757791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807409|NCT05757791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138807410|NCT05757791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807412|NCT05728775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138807413|NCT05728775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138807414|NCT05728775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807415|NCT05728775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138807416|NCT05728775|Anesthetics, General|anesthetics, general|mesh-ancestor
138807417|NCT05728775|Anesthetics|anesthetics|mesh-ancestor
138807418|NCT05715671|Esketamine|esketamine|mesh-list
138807419|NCT05715671|Antidepressive Agents|antidepressive agents|mesh-ancestor
138807420|NCT05715671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138807421|NCT05705089|Warfarin|warfarin|mesh-list
138807422|NCT05705089|Rivaroxaban|rivaroxaban|mesh-list
138807423|NCT05705089|Anticoagulants|anticoagulants|mesh-ancestor
138807424|NCT05705089|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138807425|NCT05705089|Antithrombins|antithrombins|mesh-ancestor
138807426|NCT05705089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138807427|NCT05705089|Protease Inhibitors|protease inhibitors|mesh-ancestor
138807428|NCT05705089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807429|NCT05705089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807430|NCT05672901|Estradiol|estradiol|mesh-list
138807431|NCT05672901|Estrogens|estrogens|mesh-ancestor
138807432|NCT05672901|Hormones|hormones|mesh-ancestor
138807433|NCT05672901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138807434|NCT05672901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807435|NCT05671822|Capecitabine|capecitabine|mesh-list
138807436|NCT05671822|Oxaliplatin|oxaliplatin|mesh-list
138807437|NCT05671822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138807438|NCT05671822|Antimetabolites|antimetabolites|mesh-ancestor
138807439|NCT05671822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807440|NCT05671822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807441|NCT05649540|Amoxicillin|amoxicillin|mesh-list
138807442|NCT05649540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138807443|NCT05649540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807444|NCT05646693|Sertraline|sertraline|mesh-list
138807445|NCT05646693|Magnesium Oxide|magnesium oxide|mesh-list
138807446|NCT05646693|Antidepressive Agents|antidepressive agents|mesh-ancestor
138807447|NCT05646693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138807448|NCT05646693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138807449|NCT05646693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138807450|NCT05646693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138807451|NCT05646693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807452|NCT05646693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807453|NCT05646693|Serotonin Agents|serotonin agents|mesh-ancestor
138807454|NCT05646693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807455|NCT05646693|Antacids|antacids|mesh-ancestor
138807456|NCT05646693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138807457|NCT05616624|Gemcitabine|gemcitabine|mesh-list
138807458|NCT05616624|Docetaxel|docetaxel|mesh-list
138807459|NCT05616624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138807460|NCT05616624|Antimetabolites|antimetabolites|mesh-ancestor
138807461|NCT05616624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807462|NCT05616624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807463|NCT05616624|Tubulin Modulators|tubulin modulators|mesh-ancestor
138807464|NCT05616624|Antimitotic Agents|antimitotic agents|mesh-ancestor
138807465|NCT05616624|Mitosis Modulators|mitosis modulators|mesh-ancestor
138807466|NCT05601817|Tocopherols|tocopherols|mesh-list
138807467|NCT05601817|Vitamin E|vitamin e|mesh-list
138807468|NCT05601817|alpha-Tocopherol|alpha-tocopherol|mesh-list
138807469|NCT05601817|Antioxidants|antioxidants|mesh-ancestor
138807470|NCT05601817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807471|NCT05601817|Protective Agents|protective agents|mesh-ancestor
138807472|NCT05601817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807473|NCT05601817|Vitamins|vitamins|mesh-ancestor
138807474|NCT05601817|Micronutrients|micronutrients|mesh-ancestor
138807475|NCT05513469|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138807476|NCT05513469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138807477|NCT05513469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807478|NCT05484349|Clonidine|clonidine|mesh-list
138465405|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138807480|NCT05484349|Analgesics|analgesics|mesh-ancestor
138807481|NCT05484349|Sensory System Agents|sensory system agents|mesh-ancestor
138807482|NCT05484349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807483|NCT05484349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807484|NCT05484349|Anticonvulsants|anticonvulsants|mesh-ancestor
138807485|NCT05484349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138807486|NCT05484349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138807487|NCT05484349|Parasympatholytics|parasympatholytics|mesh-ancestor
138807488|NCT05484349|Autonomic Agents|autonomic agents|mesh-ancestor
138807489|NCT05484349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138807490|NCT05484349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138807491|NCT05484349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138807492|NCT05484349|Adrenergic Agents|adrenergic agents|mesh-ancestor
138807493|NCT05484349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807494|NCT05484349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807495|NCT05484349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138807496|NCT05484349|Sympatholytics|sympatholytics|mesh-ancestor
138807497|NCT05470244|Analgesics|analgesics|mesh-list
138807498|NCT05470244|Sensory System Agents|sensory system agents|mesh-ancestor
138807499|NCT05470244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807500|NCT05470244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807501|NCT05449548|Lenalidomide|lenalidomide|mesh-list
138807502|NCT05449548|Immunologic Factors|immunologic factors|mesh-ancestor
138807503|NCT05449548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807504|NCT05449548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138807505|NCT05449548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138807506|NCT05449548|Growth Substances|growth substances|mesh-ancestor
138807507|NCT05449548|Growth Inhibitors|growth inhibitors|mesh-ancestor
138807508|NCT05449548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807509|NCT05438264|Donepezil|donepezil|mesh-list
138807510|NCT05438264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138807511|NCT05438264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807512|NCT05438264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807513|NCT05438264|Cholinergic Agents|cholinergic agents|mesh-ancestor
138807514|NCT05438264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807515|NCT05438264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807516|NCT05438264|Nootropic Agents|nootropic agents|mesh-ancestor
138807517|NCT05355857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138807518|NCT05355857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138807519|NCT05355857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807520|NCT05350085|Midazolam|midazolam|mesh-list
138807521|NCT05350085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138807522|NCT05350085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138807523|NCT05350085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138807524|NCT05350085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807525|NCT05350085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138807526|NCT05350085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138807527|NCT05350085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138807528|NCT05350085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138807529|NCT05350085|Anesthetics, General|anesthetics, general|mesh-ancestor
138807530|NCT05350085|Anesthetics|anesthetics|mesh-ancestor
138807531|NCT05350085|GABA Modulators|gaba modulators|mesh-ancestor
138807532|NCT05350085|GABA Agents|gaba agents|mesh-ancestor
138807533|NCT05350085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807534|NCT05350085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807535|NCT05313308|Midazolam|midazolam|mesh-list
138807536|NCT05313308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138807537|NCT05313308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138807538|NCT05313308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138465427|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138807539|NCT05313308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807540|NCT05313308|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138807541|NCT05313308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138807542|NCT05313308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138807543|NCT05313308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138807544|NCT05313308|Anesthetics, General|anesthetics, general|mesh-ancestor
138807545|NCT05313308|Anesthetics|anesthetics|mesh-ancestor
138807546|NCT05313308|GABA Modulators|gaba modulators|mesh-ancestor
138807547|NCT05313308|GABA Agents|gaba agents|mesh-ancestor
138807548|NCT05313308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807549|NCT05313308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807550|NCT05273359|Benralizumab|benralizumab|mesh-list
138807551|NCT05273359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138807552|NCT05273359|Respiratory System Agents|respiratory system agents|mesh-ancestor
138807553|NCT05169905|Vaccines|vaccines|mesh-list
138807554|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
138807555|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807556|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
138807557|NCT05163223|Capecitabine|capecitabine|mesh-list
138807558|NCT05163223|Sargramostim|sargramostim|mesh-list
138807559|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138807560|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807561|NCT05163223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138807562|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807563|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138807564|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
138807565|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
138807566|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807567|NCT05101122|Dronabinol|dronabinol|mesh-list
138807568|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138807569|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138807570|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138807571|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138807572|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807573|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
138807574|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807575|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807576|NCT05101122|Hallucinogens|hallucinogens|mesh-ancestor
138807577|NCT05101122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138807578|NCT05101122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138807579|NCT05101122|Analgesics|analgesics|mesh-ancestor
138807580|NCT05101122|Sensory System Agents|sensory system agents|mesh-ancestor
138807581|NCT05101122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807582|NCT05101122|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138807583|NCT05101122|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138807584|NCT05101122|Hormones|hormones|mesh-ancestor
138807585|NCT05101122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138807586|NCT05087771|Naltrexone|naltrexone|mesh-list
138807587|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138807588|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138807589|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807590|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
138807591|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807592|NCT05084235|Empagliflozin|empagliflozin|mesh-list
138807593|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138421437|NCT03377023|Nintedanib|nintedanib|mesh-list
138807594|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807595|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138185085|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
138807596|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807598|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807599|NCT05042973|Empagliflozin|empagliflozin|mesh-list
138465442|NCT01004731|Gemcitabine|gemcitabine|mesh-list
138807600|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138807601|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807602|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138807603|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807604|NCT05030272|Nicotine|nicotine|mesh-list
138807605|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138807606|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
138807607|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807608|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807609|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138807610|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138807611|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
138807612|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807613|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807614|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138807615|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138807616|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807617|NCT04954365|Amisulpride|amisulpride|mesh-list
138807618|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138807619|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138807620|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138807621|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807622|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138807623|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138807624|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
138807625|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807626|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807627|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138807628|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
138807629|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
138807630|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
138807631|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138807632|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
138807633|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807635|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138807636|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
138807637|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807638|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807639|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138807640|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138807641|NCT04920617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138807642|NCT04860804|Aspirin|aspirin|mesh-list
138807643|NCT04860804|Ketamine|ketamine|mesh-list
138807644|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138807645|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138807646|NCT04860804|Analgesics|analgesics|mesh-ancestor
138807647|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
138807648|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807649|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807650|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138807651|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138807652|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138807653|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138807654|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807655|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138807656|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138807657|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807658|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
138807659|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138807660|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138807661|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
138807662|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
138807663|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138807664|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138807665|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138807666|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807667|NCT04817345|Plerixafor|plerixafor|mesh-list
138185155|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807668|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138807669|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138807670|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
138807671|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807672|NCT04764396|Heparin|heparin|mesh-list
138807673|NCT04764396|Calcium heparin|calcium heparin|mesh-list
138807674|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
138807675|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138422953|NCT05294900|Paclitaxel|paclitaxel|mesh-list
138807676|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138807677|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807678|NCT04684589|Tadalafil|tadalafil|mesh-list
138485082|NCT00008281|Calcium|calcium|mesh-list
138807679|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
138807680|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138807681|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138807682|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807683|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807684|NCT04684589|Urological Agents|urological agents|mesh-ancestor
138807685|NCT04527289|Amantadine|amantadine|mesh-list
138807686|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138807687|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138807688|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
138807689|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641657|NCT00294099|Antacids|antacids|mesh-ancestor
138807690|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
138807691|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807692|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807693|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807694|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138807695|NCT04527289|Analgesics|analgesics|mesh-ancestor
138807696|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
138807697|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807698|NCT04505735|Corticosterone|corticosterone|mesh-list
138807699|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138807700|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
138807701|NCT04460872|Testosterone|testosterone|mesh-list
138807702|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
138807703|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
138807704|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138807705|NCT04460872|Androgens|androgens|mesh-ancestor
138807706|NCT04460872|Hormones|hormones|mesh-ancestor
138485101|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138807707|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138807708|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807709|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138807710|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807711|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
138807712|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
138465479|NCT00129090|Rituximab|rituximab|mesh-list
138807713|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
138807714|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
138807715|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138807716|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807717|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
138807718|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807719|NCT04413617|Tofacitinib|tofacitinib|mesh-list
138807720|NCT04413617|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138807721|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138807722|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807723|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807724|NCT04218565|Golimumab|golimumab|mesh-list
138807725|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138807726|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138807727|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138807728|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
138807729|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807730|NCT04129502|Carboplatin|carboplatin|mesh-list
138807731|NCT04129502|Pemetrexed|pemetrexed|mesh-list
138807732|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807733|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807734|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807735|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138807736|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138807737|NCT04055116|Lidocaine|lidocaine|mesh-list
138807738|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
138807739|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
138807740|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138807741|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807742|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
138807744|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138807745|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138807746|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138807747|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138807748|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807750|NCT04045028|Atezolizumab|atezolizumab|mesh-list
138807751|NCT04045028|Daratumumab|daratumumab|mesh-list
138807752|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138807753|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807754|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
138807755|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807756|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138807757|NCT04045028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138807758|NCT04045028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807759|NCT03990623|Liver Extracts|liver extracts|mesh-list
138807760|NCT03990623|Hematinics|hematinics|mesh-ancestor
138807761|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138807762|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138807763|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
138807764|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138807765|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807766|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138807767|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138807768|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138485214|NCT00000136|Foscarnet|foscarnet|mesh-list
138807769|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807770|NCT03867500|Niacin|niacin|mesh-list
138807771|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138807772|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
138807773|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807774|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138807775|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
138807776|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
138807777|NCT03867500|Vitamins|vitamins|mesh-ancestor
138807778|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
138807779|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807780|NCT03781986|Carboplatin|carboplatin|mesh-list
138807781|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807782|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
138807783|NCT03743402|Narcotics|narcotics|mesh-ancestor
138807784|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138807785|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807786|NCT03743402|Analgesics|analgesics|mesh-ancestor
138807787|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
138807788|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807789|NCT03735433|Aspirin|aspirin|mesh-list
138807790|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138807791|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138807792|NCT03735433|Analgesics|analgesics|mesh-ancestor
138807793|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
138807794|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138807795|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807796|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138807797|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138807798|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138807799|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138807800|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807801|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138807802|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138807803|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807804|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
138807805|NCT03562416|Nintedanib|nintedanib|mesh-list
138807806|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807807|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138807808|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807809|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807810|NCT03512262|Abaloparatide|abaloparatide|mesh-list
138807811|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
138807812|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138807813|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807814|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138807815|NCT03396211|Nivolumab|nivolumab|mesh-list
138807816|NCT03396211|Apatinib|apatinib|mesh-list
138807817|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138807818|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807819|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138807820|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807821|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138807822|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807823|NCT03301896|Spartalizumab|spartalizumab|mesh-list
138807824|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138807825|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807826|NCT03301896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138807827|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807828|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
138807829|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138807830|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423031|NCT05267431|Antioxidants|antioxidants|mesh-ancestor
138807831|NCT03260322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138807832|NCT03260322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807833|NCT03218085|Tenofovir|tenofovir|mesh-list
138807834|NCT03218085|Emtricitabine|emtricitabine|mesh-list
138807835|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
138485282|NCT00000175|Testosterone|testosterone|mesh-list
138807836|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807837|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138807838|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138807839|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807840|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807841|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138807842|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138807843|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
138807844|NCT03197077|Desogestrel|desogestrel|mesh-list
138807845|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
138807846|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138807847|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138807848|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138807849|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807851|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138807852|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138807853|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138807854|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138807855|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138807856|NCT03197077|Progestins|progestins|mesh-ancestor
138807857|NCT03078855|Vitamin D|vitamin d|mesh-list
138807858|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
138807859|NCT03078855|Rituximab|rituximab|mesh-list
138807860|NCT03078855|Vitamins|vitamins|mesh-ancestor
138807861|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
138807862|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807863|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138807864|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807865|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
138807866|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138807867|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138807868|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138807869|NCT03007979|Letrozole|letrozole|mesh-list
138807870|NCT03007979|Fulvestrant|fulvestrant|mesh-list
138807871|NCT03007979|Palbociclib|palbociclib|mesh-list
138807872|NCT03007979|Goserelin|goserelin|mesh-list
138807873|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807874|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138807875|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138807876|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423049|NCT05264584|Expectorants|expectorants|mesh-ancestor
138807877|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807879|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
138807880|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138807881|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807882|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138807883|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138807884|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138807885|NCT02912572|Avelumab|avelumab|mesh-list
138807886|NCT02912572|Axitinib|axitinib|mesh-list
138807887|NCT02912572|Talazoparib|talazoparib|mesh-list
138807888|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138807889|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807890|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138807891|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807892|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807893|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138807894|NCT02867813|Evolocumab|evolocumab|mesh-list
138807895|NCT02867813|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138807896|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138807897|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138485371|NCT00388479|Alvimopan|alvimopan|mesh-list
138807898|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
138807899|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807900|NCT02867813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138807901|NCT02867813|Protease Inhibitors|protease inhibitors|mesh-ancestor
138807902|NCT02867813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807903|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138807904|NCT02737787|Nivolumab|nivolumab|mesh-list
138807905|NCT02737787|Vaccines|vaccines|mesh-list
138807907|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807908|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138807909|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807910|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138807911|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807912|NCT02494570|Sirolimus|sirolimus|mesh-list
138807913|NCT02494570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138807914|NCT02494570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807915|NCT02494570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138807916|NCT02494570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807917|NCT02494570|Antifungal Agents|antifungal agents|mesh-ancestor
138807918|NCT02494570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138807919|NCT02494570|Immunologic Factors|immunologic factors|mesh-ancestor
138807920|NCT02494570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807921|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
138807922|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138807923|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807924|NCT02437071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138807925|NCT02437071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807926|NCT02341274|Tacrolimus|tacrolimus|mesh-list
138807927|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138807928|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
138807929|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807930|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138807931|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807932|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807933|NCT02231879|Plerixafor|plerixafor|mesh-list
138807934|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138807935|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138423090|NCT05220826|Ethanol|ethanol|mesh-list
138807936|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
138807937|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138807938|NCT01968460|Pramipexole|pramipexole|mesh-list
138807939|NCT01968460|Rasagiline|rasagiline|mesh-list
138807940|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
138807941|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807942|NCT01968460|Protective Agents|protective agents|mesh-ancestor
138807943|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807944|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138807945|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138807946|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
138807947|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
138807948|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138807949|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138807950|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807951|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138807952|NCT01712490|Doxorubicin|doxorubicin|mesh-list
138807953|NCT01712490|Bleomycin|bleomycin|mesh-list
138807954|NCT01712490|Dacarbazine|dacarbazine|mesh-list
138807955|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138807956|NCT01712490|Vinblastine|vinblastine|mesh-list
138807957|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138807958|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807959|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138807960|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138807961|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807962|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807963|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138807964|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
138807965|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138807966|NCT01712490|Immunotoxins|immunotoxins|mesh-ancestor
138807967|NCT01712490|Immunoconjugates|immunoconjugates|mesh-ancestor
138807968|NCT01712490|Immunologic Factors|immunologic factors|mesh-ancestor
138807969|NCT01712490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807970|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138807971|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
138807972|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
138807973|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
138807974|NCT01527747|Saxagliptin|saxagliptin|mesh-list
138807975|NCT01527747|Incretins|incretins|mesh-ancestor
138807976|NCT01527747|Hormones|hormones|mesh-ancestor
138807977|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138807978|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807979|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138807980|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
138807981|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138807982|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138807983|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138807984|NCT01439802|Copper|copper|mesh-list
138807985|NCT01439802|Trace Elements|trace elements|mesh-ancestor
138807986|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
138807987|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807988|NCT00646230|Fenretinide|fenretinide|mesh-list
138807989|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138807990|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138807991|NCT00646230|Protective Agents|protective agents|mesh-ancestor
138807992|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138807993|NCT00544414|Leucovorin|leucovorin|mesh-list
138807994|NCT00544414|Gemcitabine|gemcitabine|mesh-list
138807995|NCT00544414|Docetaxel|docetaxel|mesh-list
138807996|NCT00544414|Fluorouracil|fluorouracil|mesh-list
138807997|NCT00544414|Calcium|calcium|mesh-list
138807998|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
138807999|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808000|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138808001|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
138808002|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808003|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
138808004|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
138808005|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
138808006|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138808007|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808008|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138808009|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
138808010|NCT00544414|Antidotes|antidotes|mesh-ancestor
138808011|NCT00544414|Protective Agents|protective agents|mesh-ancestor
138808012|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
138808013|NCT00544414|Vitamins|vitamins|mesh-ancestor
138808014|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
138808015|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138808016|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138808017|NCT00816556|Estradiol|estradiol|mesh-list
138808018|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138465545|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138808019|NCT00816556|Estrogens|estrogens|mesh-ancestor
138808020|NCT00816556|Hormones|hormones|mesh-ancestor
138808021|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138808022|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808023|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138808024|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
138808025|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138808026|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138808027|NCT04100473|Insulin|insulin|mesh-list
138808028|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138641839|NCT00294567|Amlodipine|amlodipine|mesh-list
138808029|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
138808030|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138808031|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808032|NCT02796807|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138808033|NCT02796807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138808034|NCT02796807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808035|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138808036|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138808037|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138808038|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138808039|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808040|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
138808041|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808042|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808043|NCT00760669|Infliximab|infliximab|mesh-list
138808044|NCT00760669|Methotrexate|methotrexate|mesh-list
138808045|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138808046|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
138808047|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138808048|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808049|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138808050|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
138808051|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808052|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808053|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
138808054|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808055|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138808056|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138808057|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
138808058|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808059|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138808060|NCT00760669|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138808061|NCT00760669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138808062|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138808063|NCT02796183|Bevacizumab|bevacizumab|mesh-list
138808064|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138808065|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808066|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138808067|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138808068|NCT02796183|Growth Substances|growth substances|mesh-ancestor
138808069|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808070|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
138808071|NCT02796105|Ganirelix|ganirelix|mesh-list
138808072|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
138808073|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138808074|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808075|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138808076|NCT02795949|Amoxicillin|amoxicillin|mesh-list
138808077|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
138808078|NCT02795949|Meropenem|meropenem|mesh-list
138808079|NCT02795949|Tazobactam|tazobactam|mesh-list
138808080|NCT02795949|Piperacillin|piperacillin|mesh-list
138808081|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
138808082|NCT02795949|Imipenem|imipenem|mesh-list
138808083|NCT02795949|Ceftazidime|ceftazidime|mesh-list
138808084|NCT02795949|Ampicillin|ampicillin|mesh-list
138808085|NCT02795949|Cefepime|cefepime|mesh-list
138808086|NCT02795949|Ertapenem|ertapenem|mesh-list
138808087|NCT02795949|Cefuroxime|cefuroxime|mesh-list
138808088|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138808089|NCT02795949|Lactams|lactams|mesh-list
138808090|NCT02795949|Aztreonam|aztreonam|mesh-list
138808091|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138808092|NCT02795949|beta-Lactams|beta-lactams|mesh-list
138808093|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138808094|NCT02795949|Trimethoprim|trimethoprim|mesh-list
138808095|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
138808096|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808097|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
138808098|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138808099|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138808100|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808101|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808102|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808103|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138808104|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138808105|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138808106|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138808107|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
138808108|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138808109|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138808110|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138808111|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138808112|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138808113|NCT00769483|Gemcitabine|gemcitabine|mesh-list
138808114|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138808115|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138808116|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
138808117|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808118|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808119|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138808120|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808121|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
138808122|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138808123|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
138808124|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808125|NCT02794389|Expectorants|expectorants|mesh-ancestor
138808126|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
138808127|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138808128|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
138485654|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138808129|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808130|NCT02794389|Protective Agents|protective agents|mesh-ancestor
138808131|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808132|NCT02794389|Antidotes|antidotes|mesh-ancestor
138808133|NCT02601703|Tacrolimus|tacrolimus|mesh-list
138808134|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138808135|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
138465589|NCT01953744|Fluconazole|fluconazole|mesh-list
138423231|NCT04989621|Rituximab|rituximab|mesh-list
138808136|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808137|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138808138|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808139|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808140|NCT04234191|Buprenorphine|buprenorphine|mesh-list
138808141|NCT04234191|Hydromorphone|hydromorphone|mesh-list
138808142|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138808143|NCT04234191|Naloxone|naloxone|mesh-list
138808144|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138808145|NCT04234191|Narcotics|narcotics|mesh-ancestor
138808146|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808147|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808148|NCT04234191|Analgesics|analgesics|mesh-ancestor
138808149|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
138808150|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808151|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138808152|NCT02801799|Ropivacaine|ropivacaine|mesh-list
138808153|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
138808154|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
138808155|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808156|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808157|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
138808158|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485707|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138808159|NCT02690103|Ribavirin|ribavirin|mesh-list
138808160|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
138808161|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808162|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
138808163|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808164|NCT02790099|Morphine|morphine|mesh-list
138808165|NCT02790099|Bupivacaine|bupivacaine|mesh-list
138808166|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
138808167|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
138808168|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808169|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808170|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
138808171|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808172|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138808173|NCT02790099|Narcotics|narcotics|mesh-ancestor
138808174|NCT02790099|Analgesics|analgesics|mesh-ancestor
138808175|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
138808176|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138808177|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
138808178|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808179|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
138808180|NCT02790177|Protective Agents|protective agents|mesh-ancestor
138808181|NCT04100083|Spironolactone|spironolactone|mesh-list
138808182|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138808183|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
138808184|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138808185|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808186|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138808187|NCT04100083|Diuretics|diuretics|mesh-ancestor
138808188|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
138808189|NCT02794155|Insulin|insulin|mesh-list
138808190|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138808191|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
138808192|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138808193|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808194|NCT02793843|Dexamethasone|dexamethasone|mesh-list
138808195|NCT02793843|Ondansetron|ondansetron|mesh-list
138808196|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138808197|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
138808198|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
138808199|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808200|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808202|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
138808203|NCT02793843|Hormones|hormones|mesh-ancestor
138808204|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138808205|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138808206|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808207|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808208|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
138808209|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
138808210|NCT02793843|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138808211|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138808212|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
138808213|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808214|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
138808215|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
138808216|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808217|NCT02793687|Protective Agents|protective agents|mesh-ancestor
138808218|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808219|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138808220|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138808221|NCT02801487|Cisplatin|cisplatin|mesh-list
138808222|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808223|NCT02793765|Docetaxel|docetaxel|mesh-list
138808224|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808225|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
138808226|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
138808227|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
138808228|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808229|NCT02793219|Docetaxel|docetaxel|mesh-list
138808230|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808231|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
138808232|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
138808233|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
138808234|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808235|NCT02801409|Anesthetics|anesthetics|mesh-list
138808236|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808237|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808238|NCT03787251|Apatinib|apatinib|mesh-list
138808239|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808240|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138808241|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808242|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808243|NCT02789865|Metronidazole|metronidazole|mesh-list
138808244|NCT02789865|Levofloxacin|levofloxacin|mesh-list
138808246|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808247|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138808248|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138808249|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138808250|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138808251|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138808252|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138808253|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808254|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808255|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808256|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138808257|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138808258|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
138808259|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138808260|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
138808261|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808262|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
138808263|NCT02792673|Protective Agents|protective agents|mesh-ancestor
138808264|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
138808265|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138808266|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
138808267|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808268|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138808269|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
138808270|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138808271|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
138808272|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808273|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808274|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138808275|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
138808276|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808277|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808278|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138808280|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
138808281|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
138808282|NCT02535936|Anesthetics|anesthetics|mesh-list
138808283|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808284|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808285|NCT05332470|Lamivudine|lamivudine|mesh-list
138808286|NCT05332470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138808287|NCT05332470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138808288|NCT05332470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808289|NCT05332470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808290|NCT05332470|Antiviral Agents|antiviral agents|mesh-ancestor
138808291|NCT05332470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808292|NCT05332470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138808293|NCT05332470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138808294|NCT02791815|Selexipag|selexipag|mesh-list
138808295|NCT02791815|Midazolam|midazolam|mesh-list
138808296|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138808297|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138808298|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808299|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808300|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138808301|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138808302|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138808303|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138808304|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
138808305|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
138808306|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
138808307|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
138808308|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641931|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
138485934|NCT00000793|Analgesics|analgesics|mesh-ancestor
138808309|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808310|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138808311|NCT02389374|Chloroquine|chloroquine|mesh-list
138808312|NCT02389374|Lumefantrine|lumefantrine|mesh-list
138808313|NCT02389374|Artemether|artemether|mesh-list
138808314|NCT02389374|Primaquine|primaquine|mesh-list
138808315|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138808316|NCT02389374|Amebicides|amebicides|mesh-ancestor
138808317|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138808318|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138808319|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808320|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
138808321|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808322|NCT02789475|Amlodipine|amlodipine|mesh-list
138808323|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138808324|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138808325|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138808326|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138808327|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808328|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138808329|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808330|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
138808331|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138808332|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138808333|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
138808334|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138485990|NCT00000826|Fluconazole|fluconazole|mesh-list
138808335|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138808336|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808337|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
138808338|NCT04202484|Tegafur|tegafur|mesh-list
138808339|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808340|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138808341|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
138808342|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808343|NCT02790957|Plerixafor|plerixafor|mesh-list
138808344|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138808345|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138808346|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
138808347|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808348|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138808349|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
138808350|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138808351|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138808352|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808353|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138808354|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138808355|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138808356|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808357|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
138808358|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808359|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
138486036|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
138808360|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138808361|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808362|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138808363|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808364|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
138641942|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808365|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138808366|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808367|NCT03753243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138808368|NCT03753243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808370|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
138808371|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
138808372|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808373|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808374|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
138808375|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808377|NCT02789397|Azathioprine|azathioprine|mesh-list
138808378|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138808379|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808380|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
138808381|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808382|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808383|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
138808384|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808385|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138808386|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138808388|NCT00816166|Clopidogrel|clopidogrel|mesh-list
138808389|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138808390|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138808391|NCT00816166|Analgesics|analgesics|mesh-ancestor
138808392|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
138808393|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138165653|NCT05672225|Analgesics|analgesics|mesh-ancestor
138808394|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808395|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138808396|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808397|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138808398|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138808399|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808400|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138808401|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138808402|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808403|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
138808404|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138808405|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138808406|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138808407|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
138808408|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808410|NCT02788851|Methylphenidate|methylphenidate|mesh-list
138808411|NCT02788851|Amphetamine|amphetamine|mesh-list
138808412|NCT02788851|Adderall|adderall|mesh-list
138808413|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
138808414|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138808415|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138808416|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808417|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138808418|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138808419|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641958|NCT00264914|Satavaptan|satavaptan|mesh-list
138486213|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808420|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185909|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
138808422|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808423|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
138808424|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
138808425|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808426|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
138808427|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138808428|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138808429|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138808430|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138808431|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138808432|NCT02786823|Folic Acid|folic acid|mesh-list
138808433|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
138808434|NCT02786823|Metformin|metformin|mesh-list
138808435|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138808436|NCT02786823|Vitamins|vitamins|mesh-ancestor
138808437|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
138808438|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808439|NCT02786823|Hematinics|hematinics|mesh-ancestor
138808440|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
138808441|NCT05332314|Ibuprofen|ibuprofen|mesh-list
138808442|NCT05332314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138808443|NCT05332314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138808444|NCT05332314|Analgesics|analgesics|mesh-ancestor
138808445|NCT05332314|Sensory System Agents|sensory system agents|mesh-ancestor
138808446|NCT05332314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808447|NCT05332314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486277|NCT00000985|Acyclovir|acyclovir|mesh-list
138808448|NCT05332314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138808449|NCT05332314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808450|NCT05332314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138808451|NCT05332314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808452|NCT05332314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808453|NCT00815308|Paclitaxel|paclitaxel|mesh-list
138808454|NCT00815308|Cetuximab|cetuximab|mesh-list
138808455|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138808456|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808457|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
138808458|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
138808459|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
138808460|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808461|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138808462|NCT01039376|Ofatumumab|ofatumumab|mesh-list
138808463|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808464|NCT02610712|Ketamine|ketamine|mesh-list
138808465|NCT02610712|Analgesics|analgesics|mesh-ancestor
138808466|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
138808467|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808468|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808469|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138808470|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138808471|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
138808472|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
138808473|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808474|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138808475|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138808476|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808477|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808478|NCT00905034|Dexamethasone|dexamethasone|mesh-list
138808479|NCT00905034|Rituximab|rituximab|mesh-list
138808480|NCT00905034|Methotrexate|methotrexate|mesh-list
138808481|NCT00905034|Vincristine|vincristine|mesh-list
138808482|NCT00905034|Asparaginase|asparaginase|mesh-list
138808483|NCT00905034|Pegaspargase|pegaspargase|mesh-list
138808484|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138808485|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
138808486|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
138808487|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808488|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808489|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138808490|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
138808491|NCT00905034|Hormones|hormones|mesh-ancestor
138808492|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138808493|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138808494|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808495|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138808496|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
138185984|NCT02158273|Fenofibrate|fenofibrate|mesh-list
138808497|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808498|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138808499|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
138808500|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138808501|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138808502|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
138808503|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808504|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
138808505|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808506|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138808507|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138808508|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138808509|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138808510|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
138808511|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
138808512|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
138808514|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138808515|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138808517|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
138808518|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808519|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808520|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138808521|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808522|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138808523|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808524|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808525|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
138808526|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138808527|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138808528|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
138808529|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
138808530|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808531|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808532|NCT02611492|Cytarabine|cytarabine|mesh-list
138808533|NCT02611492|Dexamethasone|dexamethasone|mesh-list
138808534|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138808535|NCT02611492|Methotrexate|methotrexate|mesh-list
138808536|NCT02611492|Vincristine|vincristine|mesh-list
138808537|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
138808538|NCT02611492|Lenograstim|lenograstim|mesh-list
138808539|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138423610|NCT04012177|Niacin|niacin|mesh-list
138808541|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
138808542|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808543|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808544|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138808545|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
138808546|NCT02611492|Hormones|hormones|mesh-ancestor
138808547|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138808548|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138808549|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808550|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138808551|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
138808552|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138808553|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138808554|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
138486409|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808555|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808556|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
138465688|NCT01953952|Cisplatin|cisplatin|mesh-list
138808557|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808558|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138808559|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138808560|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
138808561|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808562|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138808563|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138808564|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
138808565|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
138808566|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
138808567|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138808568|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
138808569|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808570|NCT00706576|Mitogens|mitogens|mesh-list
138808571|NCT00706576|Enkephalins|enkephalins|mesh-list
138808572|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808573|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
138808574|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808575|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808576|NCT00828568|Imiquimod|imiquimod|mesh-list
138808577|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138808578|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
138808579|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808580|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808581|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
138808582|NCT01038752|Suramin|suramin|mesh-list
138808583|NCT01038752|Carboplatin|carboplatin|mesh-list
138808584|NCT01038752|Docetaxel|docetaxel|mesh-list
138808585|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808586|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
138808587|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
138808588|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
138808589|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423624|NCT04012177|Vitamins|vitamins|mesh-ancestor
138808590|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
138642014|NCT00265031|Etoposide|etoposide|mesh-list
138808591|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
138808592|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138808593|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808594|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138808595|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138808596|NCT00903630|Doxorubicin|doxorubicin|mesh-list
138808597|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138808598|NCT00903630|Lenalidomide|lenalidomide|mesh-list
138808599|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138808600|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808601|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138808602|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138808603|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486561|NCT00001213|Cysteamine|cysteamine|mesh-list
138808604|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808605|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
138808606|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808607|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138808608|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138808609|NCT00903630|Growth Substances|growth substances|mesh-ancestor
138808610|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
138808611|NCT04302584|Vasopressins|vasopressins|mesh-list
138808612|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
138808613|NCT04302584|Norepinephrine|norepinephrine|mesh-list
138808614|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138808615|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138808616|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
138808617|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808618|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808619|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808620|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
138808621|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
138808622|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808623|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138808624|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
138808625|NCT04302584|Coagulants|coagulants|mesh-ancestor
138808626|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138808627|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
138808628|NCT00703144|Tazobactam|tazobactam|mesh-list
138808630|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138808631|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138808632|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808633|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138808634|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808635|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808636|NCT01054820|Diclofenac|diclofenac|mesh-list
138808637|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
138808638|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138808639|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138808640|NCT01054820|Analgesics|analgesics|mesh-ancestor
138808641|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
138808642|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808643|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808644|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138808645|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808646|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138808647|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808648|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808649|NCT02874248|Drospirenone|drospirenone|mesh-list
138808650|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138808651|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
138808652|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138808653|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486678|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
138808654|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138808655|NCT02874248|Diuretics|diuretics|mesh-ancestor
138808656|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
138808657|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138808658|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808659|NCT02788305|Misoprostol|misoprostol|mesh-list
138808660|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138808661|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
138808662|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138808663|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808664|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138808665|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138808666|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
138808668|NCT05758012|Carbetocin|carbetocin|mesh-list
138808669|NCT05758012|Oxytocics|oxytocics|mesh-ancestor
138808670|NCT05758012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138808671|NCT05758012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808672|NCT02786667|Rotigotine|rotigotine|mesh-list
138808673|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
138808674|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
138808675|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808676|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808677|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808678|NCT00913276|Propofol|propofol|mesh-list
138808679|NCT00913276|Sevoflurane|sevoflurane|mesh-list
138808680|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138808681|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808682|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808683|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138423678|NCT05802303|Estrogens|estrogens|mesh-ancestor
138808684|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
138808685|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
138808686|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138808687|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138808688|NCT04302116|Prednisolone|prednisolone|mesh-list
138808689|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138808690|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
138808691|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138808692|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
138808693|NCT04302116|Vigabatrin|vigabatrin|mesh-list
138808694|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138808695|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
138808696|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138808697|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
138808698|NCT04302116|Hormones|hormones|mesh-ancestor
138808699|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138808700|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808701|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138808702|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808703|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
138808704|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
138808705|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808706|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138808707|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138808708|NCT04302116|Protective Agents|protective agents|mesh-ancestor
138808709|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
138808710|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808711|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808712|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
138808713|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808714|NCT05756998|Copper|copper|mesh-list
138808715|NCT05756998|Trace Elements|trace elements|mesh-ancestor
138808716|NCT05756998|Micronutrients|micronutrients|mesh-ancestor
138808717|NCT05756998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808718|NCT02890212|Selenium|selenium|mesh-list
138808719|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
138486773|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138808720|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808721|NCT02890212|Protective Agents|protective agents|mesh-ancestor
138808722|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808723|NCT02890212|Trace Elements|trace elements|mesh-ancestor
138808724|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
138808725|NCT05387577|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138808726|NCT05387577|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138808727|NCT05387577|Estradiol|estradiol|mesh-list
138808728|NCT05387577|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138808729|NCT05387577|Estrogens|estrogens|mesh-ancestor
138808730|NCT05387577|Hormones|hormones|mesh-ancestor
138808731|NCT05387577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138808732|NCT05387577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808733|NCT05387577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138808734|NCT05387577|Contraceptive Agents|contraceptive agents|mesh-ancestor
138808735|NCT05387577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138808736|NCT05387577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138808737|NCT01372254|Nicotine|nicotine|mesh-list
138808738|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138808739|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
138808740|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808741|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808742|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138808743|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138808744|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
138808745|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465720|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808746|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808747|NCT02785653|Sevoflurane|sevoflurane|mesh-list
138808748|NCT02785653|Rocuronium|rocuronium|mesh-list
138808749|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138808750|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138808751|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
138808752|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
138808753|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808754|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808755|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138808756|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138808757|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138808758|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808759|NCT02787447|Gefitinib|gefitinib|mesh-list
138808760|NCT02787447|Thymalfasin|thymalfasin|mesh-list
138808761|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642136|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
138808762|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138808763|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808764|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808765|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138808766|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
138486891|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
138808767|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808768|NCT00904722|Rituximab|rituximab|mesh-list
138808769|NCT00904722|Pidilizumab|pidilizumab|mesh-list
138808770|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138808771|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808772|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
138808773|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808774|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808775|NCT02909361|Fulvestrant|fulvestrant|mesh-list
138808776|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138808777|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808778|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138808779|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138808780|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
138808781|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138808782|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808783|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
138808784|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138808785|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
138808786|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
138808787|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808788|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808789|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138808790|NCT04301024|Analgesics|analgesics|mesh-ancestor
138808791|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
138808792|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808793|NCT01340430|Trastuzumab|trastuzumab|mesh-list
138808794|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138808795|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808796|NCT01029782|Cefazolin|cefazolin|mesh-list
138808797|NCT01029782|Cephalexin|cephalexin|mesh-list
138808798|NCT01029782|Probenecid|probenecid|mesh-list
138808799|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138808800|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808801|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
138808802|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
138808803|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808804|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138808805|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138486926|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138808806|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138465734|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138391544|NCT01505777|Mosapride|mosapride|mesh-list
138808807|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808808|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
138808809|NCT02849730|Fentanyl|fentanyl|mesh-list
138808810|NCT02849730|Analgesics|analgesics|mesh-list
138808811|NCT02849730|Ropivacaine|ropivacaine|mesh-list
138808812|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
138808813|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
138808814|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808815|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808816|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
138808817|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808818|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138808819|NCT02849730|Narcotics|narcotics|mesh-ancestor
138808820|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138808821|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138808822|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
138808823|NCT02849340|Immunomodulating Agents|immunomodulating agents|mesh-list
138808824|NCT02849340|Immunologic Factors|immunologic factors|mesh-ancestor
138808825|NCT02849340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808826|NCT03936192|Meloxicam|meloxicam|mesh-list
138808827|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138808828|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138808829|NCT03936192|Analgesics|analgesics|mesh-ancestor
138808830|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
138808831|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808832|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808833|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138808834|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808835|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138808836|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138808837|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808838|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808839|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138808840|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808841|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138808842|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808843|NCT02786979|Aspirin|aspirin|mesh-list
138808844|NCT02786979|Beraprost|beraprost|mesh-list
138808845|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138808846|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138808847|NCT02786979|Analgesics|analgesics|mesh-ancestor
138808848|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
138808849|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808850|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808851|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138808852|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808853|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138808854|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138465750|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808855|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487021|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808856|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138808858|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808859|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
138808860|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
138808861|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
138808862|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138808863|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808864|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
138808865|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
138808866|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138808867|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808868|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138808869|NCT00221988|Levetiracetam|levetiracetam|mesh-list
138808870|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
138808871|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
138808872|NCT02341911|Carboplatin|carboplatin|mesh-list
138808873|NCT02341911|Gemcitabine|gemcitabine|mesh-list
138808874|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186365|NCT01042925|Paclitaxel|paclitaxel|mesh-list
138808875|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138808876|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
138808877|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808878|NCT02847000|Decitabine|decitabine|mesh-list
138808879|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
138808880|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138808881|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
138808882|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808883|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808884|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808885|NCT02784327|Ropivacaine|ropivacaine|mesh-list
138808886|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
138808887|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
138808888|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808889|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808890|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
138808891|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808892|NCT02845050|Cisplatin|cisplatin|mesh-list
138808893|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808894|NCT02690922|Dexamethasone|dexamethasone|mesh-list
138808895|NCT02690922|Prednisone|prednisone|mesh-list
138808896|NCT02690922|Methotrexate|methotrexate|mesh-list
138808897|NCT02690922|Dasatinib|dasatinib|mesh-list
138808898|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138808899|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
138808900|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
138808901|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808902|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808903|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138808904|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
138808905|NCT02690922|Hormones|hormones|mesh-ancestor
138808906|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138808907|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138808908|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808909|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138808910|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
138808911|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138808912|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138808913|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
138465773|NCT01954290|Diuretics|diuretics|mesh-ancestor
138808914|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808915|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
138808916|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808917|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138808918|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138808919|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
138808920|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138808921|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138808922|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138808924|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138808925|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808926|NCT04202406|Acetaminophen|acetaminophen|mesh-list
138808927|NCT04202406|Codeine|codeine|mesh-list
138808928|NCT04202406|Caffeine|caffeine|mesh-list
138808929|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138808930|NCT04202406|Analgesics|analgesics|mesh-ancestor
138808931|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
138808932|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808933|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808934|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
138808935|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138808936|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138808937|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808938|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808939|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138808940|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138808941|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
138808942|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808943|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138808944|NCT04202406|Narcotics|narcotics|mesh-ancestor
138808945|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138808946|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
138808947|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
138808948|NCT02846766|Lenvatinib|lenvatinib|mesh-list
138808949|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186431|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
138808950|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138808951|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808952|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808953|NCT00839956|Bortezomib|bortezomib|mesh-list
138808954|NCT00839956|Vorinostat|vorinostat|mesh-list
138808955|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808956|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138808957|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808958|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808959|NCT00839800|Terbutaline|terbutaline|mesh-list
138808960|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138808961|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138808962|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
138808963|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138808964|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
138808965|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138808966|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808967|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
138808968|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
138808969|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138808970|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138808971|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138808972|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138808973|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
138423834|NCT05800197|Contraceptive Agents|contraceptive agents|mesh-ancestor
138808974|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138808975|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808976|NCT00867321|Bevacizumab|bevacizumab|mesh-list
138808977|NCT00867321|Sorafenib|sorafenib|mesh-list
138808978|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138808979|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808980|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138808981|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138808982|NCT00867321|Growth Substances|growth substances|mesh-ancestor
138808983|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808984|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
138808985|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138808986|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138808987|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138808988|NCT00913666|Interferons|interferons|mesh-list
138808989|NCT00913666|Interferon-beta|interferon-beta|mesh-list
138808990|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
138808991|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138808992|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
138808993|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138808994|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
138808995|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808996|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138808997|NCT05308095|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138808998|NCT05308095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138808999|NCT02601157|Aspirin|aspirin|mesh-list
138809000|NCT02601157|Clopidogrel|clopidogrel|mesh-list
138809001|NCT02601157|Ticagrelor|ticagrelor|mesh-list
138809002|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138809003|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138809004|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138809005|NCT02601157|Analgesics|analgesics|mesh-ancestor
138809006|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
138809007|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809008|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809009|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138809010|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138809011|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138809012|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138809013|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809014|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138809015|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138809016|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809017|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
138809018|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138809019|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138809020|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138809021|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
138809022|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809023|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
138809024|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138186509|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
138809025|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
138809026|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138809027|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
138809028|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809029|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809030|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
138809031|NCT00902304|Amlodipine|amlodipine|mesh-list
138809032|NCT00902304|Valsartan|valsartan|mesh-list
138809033|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138809034|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
138809035|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138809036|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138809037|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138809038|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809039|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138809040|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809041|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
138809042|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138809043|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138809045|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
138809046|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138809047|NCT02784795|Carboplatin|carboplatin|mesh-list
138809048|NCT02784795|Gemcitabine|gemcitabine|mesh-list
138809049|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809050|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138809051|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
138809052|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809053|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138809054|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
138809055|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809057|NCT02848794|Apatinib|apatinib|mesh-list
138809058|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138809059|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138809060|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809061|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809062|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809063|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138809064|NCT04096027|Cabergoline|cabergoline|mesh-list
138809065|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138809066|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138809067|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
138809068|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
138809069|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809070|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809071|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809073|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138809074|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
138809075|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
138809076|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809077|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
138809078|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138809079|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138809080|NCT00638079|Megestrol|megestrol|mesh-list
138809081|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
138809082|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138809083|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138809084|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138809085|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
138809086|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138809087|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465815|NCT01954784|Cyclosporins|cyclosporins|mesh-list
138809088|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138809089|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138809090|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138809091|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809093|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138809094|NCT00759031|Listerine|listerine|mesh-list
138809095|NCT00759031|Triclosan|triclosan|mesh-list
138809096|NCT00759031|Fluorides|fluorides|mesh-list
138809097|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
138809098|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
138809099|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
138809100|NCT00759031|Protective Agents|protective agents|mesh-ancestor
138186577|NCT00014495|Cytarabine|cytarabine|mesh-list
138487474|NCT00000639|Amebicides|amebicides|mesh-ancestor
138809101|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809102|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138809103|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809104|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138809105|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138809106|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
138809107|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809108|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138809109|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
138809110|NCT04197219|Axitinib|axitinib|mesh-list
138809111|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138642317|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
138809112|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809113|NCT04197219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138423911|NCT05657925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138809114|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809115|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138809116|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809117|NCT04834908|Immune Sera|immune sera|mesh-list
138809118|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
138809119|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809120|NCT02512497|Fludarabine|fludarabine|mesh-list
138809121|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
138809122|NCT02512497|Busulfan|busulfan|mesh-list
138809123|NCT02512497|Romidepsin|romidepsin|mesh-list
138809124|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
138809125|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138809126|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809127|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138809128|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
138809129|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809130|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138809131|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
138809132|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809133|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
138809134|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138809135|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138809136|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138809137|NCT02512497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138809138|NCT02512497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809139|NCT00916669|Etoposide|etoposide|mesh-list
138809140|NCT00916669|Enoxaparin|enoxaparin|mesh-list
138809141|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
138809142|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809143|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138809144|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138809145|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138809146|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809147|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809148|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
138809149|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138809150|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138809151|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
138809153|NCT02784015|Ifosfamide|ifosfamide|mesh-list
138809154|NCT02784015|Thiotepa|thiotepa|mesh-list
138809155|NCT02784015|Carboplatin|carboplatin|mesh-list
138809156|NCT02784015|Doxorubicin|doxorubicin|mesh-list
138809157|NCT02784015|Etoposide|etoposide|mesh-list
138809158|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138809159|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
138809160|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809161|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138809162|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138809163|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
138809164|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809165|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809166|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138809167|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138809168|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138809169|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138809170|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809171|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138809172|NCT02601235|Pyrilamine|pyrilamine|mesh-list
138809173|NCT02601235|Phenylephrine|phenylephrine|mesh-list
138809174|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
138809175|NCT02601235|Naphazoline|naphazoline|mesh-list
138186655|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138809176|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809177|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138809178|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138809179|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
138809180|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809181|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809182|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
138809183|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
138809184|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809185|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
138809186|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138809187|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
138809188|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138809189|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
138809190|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138809191|NCT02601235|Protective Agents|protective agents|mesh-ancestor
138809192|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138809193|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138809194|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138809195|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138809196|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
138809197|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
138809198|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138809199|NCT02783937|Lenograstim|lenograstim|mesh-list
138809200|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138809201|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
138809202|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809203|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
138809204|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138809205|NCT02846142|Estradiol|estradiol|mesh-list
138809206|NCT02846142|Estrogens|estrogens|mesh-ancestor
138809207|NCT02846142|Hormones|hormones|mesh-ancestor
138809208|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138809209|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809210|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138809211|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
138487771|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
138809212|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138809213|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138809214|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138809215|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138809216|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138809217|NCT00757783|Ritonavir|ritonavir|mesh-list
138809218|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138809219|NCT00757783|Darunavir|darunavir|mesh-list
138809220|NCT00757783|Tenofovir|tenofovir|mesh-list
138809221|NCT00757783|Emtricitabine|emtricitabine|mesh-list
138809222|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138809223|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138809224|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
138809225|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809226|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809227|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138809228|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138809229|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
138809230|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809231|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138809232|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138809233|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138809234|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138809235|NCT05242926|Docetaxel|docetaxel|mesh-list
138809236|NCT05242926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809237|NCT05242926|Tubulin Modulators|tubulin modulators|mesh-ancestor
138809238|NCT05242926|Antimitotic Agents|antimitotic agents|mesh-ancestor
138809239|NCT05242926|Mitosis Modulators|mitosis modulators|mesh-ancestor
138809240|NCT05242926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809241|NCT02782221|Hormones|hormones|mesh-list
138809242|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138809243|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809244|NCT04231617|Glyburide|glyburide|mesh-list
138809245|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138424007|NCT05219799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138809246|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809247|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138809248|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138809249|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138809250|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138809251|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809252|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138809253|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138809254|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138809255|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
138809256|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809257|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809258|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138809259|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138809260|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
138809261|NCT02845908|Leucovorin|leucovorin|mesh-list
138809262|NCT02845908|Fluorouracil|fluorouracil|mesh-list
138809263|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
138809264|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
138809265|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809266|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138465875|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138809267|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809268|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138809270|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809271|NCT02845908|Antidotes|antidotes|mesh-ancestor
138809272|NCT02845908|Protective Agents|protective agents|mesh-ancestor
138809273|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
138809274|NCT02845908|Vitamins|vitamins|mesh-ancestor
138809275|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
138809276|NCT02784483|Atezolizumab|atezolizumab|mesh-list
138809277|NCT02784483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138424036|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138809278|NCT02784483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809279|NCT02784483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138809280|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809281|NCT02784561|Cytarabine|cytarabine|mesh-list
138809282|NCT02784561|Fludarabine|fludarabine|mesh-list
138809283|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
138809284|NCT02784561|Busulfan|busulfan|mesh-list
138809285|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
138809286|NCT02784561|Lenograstim|lenograstim|mesh-list
138809287|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809288|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138809289|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
138809290|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809291|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138809292|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
138809293|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809294|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
138809295|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809296|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
138809297|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138809298|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138809299|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138809300|NCT00757627|Etoricoxib|etoricoxib|mesh-list
138809301|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138809302|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138809303|NCT00757627|Analgesics|analgesics|mesh-ancestor
138809304|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
138809305|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809306|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809307|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138809308|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138809309|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138809310|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138809311|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809312|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809313|NCT02600455|Abatacept|abatacept|mesh-list
138809314|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138809315|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809316|NCT02600455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138809317|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487914|NCT03801031|Lidocaine|lidocaine|mesh-list
138809318|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138809319|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
138642414|NCT00295776|Lamotrigine|lamotrigine|mesh-list
138809320|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809321|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138809322|NCT01023308|Dexamethasone|dexamethasone|mesh-list
138809323|NCT01023308|Bortezomib|bortezomib|mesh-list
138809324|NCT01023308|Panobinostat|panobinostat|mesh-list
138809325|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138809326|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
138809327|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
138809328|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809329|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809330|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138809331|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
138809332|NCT01023308|Hormones|hormones|mesh-ancestor
138809333|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138809334|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138809335|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809336|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138809337|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809338|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809339|NCT02781909|Ibuprofen|ibuprofen|mesh-list
138809340|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138809341|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138809342|NCT02781909|Analgesics|analgesics|mesh-ancestor
138809343|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
138809344|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809345|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809346|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138809347|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138809348|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138809349|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809350|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809351|NCT01022996|Everolimus|everolimus|mesh-list
138809352|NCT01022996|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138809353|NCT01022996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138809354|NCT01022996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809355|NCT01022996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809356|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138809357|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
138809358|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809359|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424127|NCT04549792|Ustekinumab|ustekinumab|mesh-list
138809360|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
138809361|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138809362|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138809363|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809364|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
138809365|NCT02781597|Coagulants|coagulants|mesh-ancestor
138809366|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138809367|NCT00757237|Tobramycin|tobramycin|mesh-list
138809368|NCT00757237|Aztreonam|aztreonam|mesh-list
138809369|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138809370|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138809371|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809372|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
138809373|NCT01029392|Vitamin D|vitamin d|mesh-list
138809374|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
138809375|NCT01029392|Vitamins|vitamins|mesh-ancestor
138809376|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
138809377|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809378|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138487987|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
138809379|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138809380|NCT02781753|Interferons|interferons|mesh-list
138809381|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
138809382|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
138809383|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809384|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
138809385|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809386|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
138809387|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809389|NCT00903006|Fulvestrant|fulvestrant|mesh-list
138809390|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809391|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138809392|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809393|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809394|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138809395|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138809397|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
138809398|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138809399|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809400|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
138809401|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138809402|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
138809403|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809404|NCT00839332|Gemcitabine|gemcitabine|mesh-list
138809405|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138809406|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
138809407|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809408|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809409|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
138809410|NCT04095169|Complement C3|complement c3|mesh-list
138809411|NCT04095169|Complement C3d|complement c3d|mesh-list
138809412|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
138809413|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809414|NCT05241912|Dobutamine|dobutamine|mesh-list
138809415|NCT05241912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138809416|NCT05241912|Sympathomimetics|sympathomimetics|mesh-ancestor
138809417|NCT05241912|Autonomic Agents|autonomic agents|mesh-ancestor
138809418|NCT05241912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809419|NCT05241912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809420|NCT05241912|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138809421|NCT05241912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138488046|NCT00390871|Fentanyl|fentanyl|mesh-list
138809422|NCT05241912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138809423|NCT05241912|Adrenergic Agents|adrenergic agents|mesh-ancestor
138809424|NCT05241912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809425|NCT05241912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809426|NCT05241912|Protective Agents|protective agents|mesh-ancestor
138809427|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
138809428|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138424187|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809429|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809430|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138809431|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809433|NCT04229355|Lenvatinib|lenvatinib|mesh-list
138809434|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
138809435|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138809436|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809437|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138809438|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809439|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809440|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138809441|NCT04229355|Estrogens|estrogens|mesh-ancestor
138809442|NCT04229355|Hormones|hormones|mesh-ancestor
138465917|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138809443|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138809444|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809445|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138809446|NCT04229355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138809447|NCT02848170|Olmesartan|olmesartan|mesh-list
138809448|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138809449|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138809450|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138809451|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138809452|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809453|NCT05341401|Prednisolone|prednisolone|mesh-list
138809454|NCT05341401|Budesonide|budesonide|mesh-list
138809455|NCT05341401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138809456|NCT05341401|Glucocorticoids|glucocorticoids|mesh-ancestor
138809457|NCT05341401|Hormones|hormones|mesh-ancestor
138809458|NCT05341401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138809459|NCT05341401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809460|NCT05341401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138809461|NCT05341401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809462|NCT05341401|Autonomic Agents|autonomic agents|mesh-ancestor
138809463|NCT05341401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809464|NCT05341401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138809465|NCT05341401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138809466|NCT05341401|Respiratory System Agents|respiratory system agents|mesh-ancestor
138809467|NCT05340153|Lumefantrine|lumefantrine|mesh-list
138809468|NCT05340153|Artemether|artemether|mesh-list
138809469|NCT05340153|Piperaquine|piperaquine|mesh-list
138809470|NCT05340153|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138809471|NCT05340153|Artenimol|artenimol|mesh-list
138809472|NCT05340153|Antimalarials|antimalarials|mesh-ancestor
138809473|NCT05340153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138809474|NCT05340153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138424229|NCT03749187|Temozolomide|temozolomide|mesh-list
138809475|NCT05340153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809476|NCT05078502|Vitamin D|vitamin d|mesh-list
138809477|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
138809478|NCT05078502|Vitamins|vitamins|mesh-ancestor
138809479|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
138809480|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809481|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138809482|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138809483|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
138809484|NCT02844894|Esmolol|esmolol|mesh-list
138809485|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138642461|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
138809486|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138809487|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809488|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138809489|NCT02844894|Analgesics|analgesics|mesh-ancestor
138809490|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
138809491|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809492|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138809493|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138809494|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138809495|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
138809496|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809497|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809498|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138809499|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138809500|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138809501|NCT04778904|Nivolumab|nivolumab|mesh-list
138809502|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138809503|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809504|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138809505|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809506|NCT00634725|Gemcitabine|gemcitabine|mesh-list
138809507|NCT00634725|Capecitabine|capecitabine|mesh-list
138809508|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138809509|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138809510|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
138809511|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809512|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809513|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138809514|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809515|NCT05325489|Budesonide|budesonide|mesh-list
138809516|NCT05325489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138809517|NCT05325489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138809518|NCT05325489|Autonomic Agents|autonomic agents|mesh-ancestor
138809519|NCT05325489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809520|NCT05325489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809521|NCT05325489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138424254|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138809522|NCT05325489|Respiratory System Agents|respiratory system agents|mesh-ancestor
138809523|NCT05325489|Glucocorticoids|glucocorticoids|mesh-ancestor
138809524|NCT05325489|Hormones|hormones|mesh-ancestor
138809525|NCT05325489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138809526|NCT00902538|Amlodipine|amlodipine|mesh-list
138809527|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138809528|NCT00902538|Olmesartan|olmesartan|mesh-list
138809529|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138809530|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138809531|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138809532|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138809533|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809534|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138809535|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809536|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
138809537|NCT00902538|Diuretics|diuretics|mesh-ancestor
138809538|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
138809539|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138809540|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138809541|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138809542|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
138809543|NCT02780505|Vitamins|vitamins|mesh-ancestor
138809544|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
138809545|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809546|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
138809547|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809548|NCT02780505|Protective Agents|protective agents|mesh-ancestor
138809549|NCT02690844|Clonazepam|clonazepam|mesh-list
138809550|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
138809551|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
138809552|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
138809553|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809554|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809555|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809556|NCT04201860|Hemostatics|hemostatics|mesh-list
138809557|NCT04201860|Coagulants|coagulants|mesh-ancestor
138809558|NCT02847702|Naproxen|naproxen|mesh-list
138809559|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138809560|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138809561|NCT02847702|Analgesics|analgesics|mesh-ancestor
138809562|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
138809563|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809564|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809565|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138809566|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138465950|NCT01955252|Azithromycin|azithromycin|mesh-list
138809567|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
138809568|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138809569|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809570|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809571|NCT02779413|Insulin|insulin|mesh-list
138809572|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138809573|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809574|NCT04887402|Clomiphene|clomiphene|mesh-list
138809575|NCT04887402|Enclomiphene|enclomiphene|mesh-list
138809576|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
138809577|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138809578|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
138809579|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138809580|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809581|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138809582|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
138809583|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138809584|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138809585|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138809586|NCT04793568|Interferons|interferons|mesh-list
138809587|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
138809588|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809589|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
138809590|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809592|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138809593|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809594|NCT05339217|Aldesleukin|aldesleukin|mesh-list
138809595|NCT05339217|Interleukin-2|interleukin-2|mesh-list
138809596|NCT05339217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809597|NCT05339217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138809598|NCT05339217|Analgesics|analgesics|mesh-ancestor
138809599|NCT05339217|Sensory System Agents|sensory system agents|mesh-ancestor
138809600|NCT05339217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809601|NCT05339217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809602|NCT05339217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138809603|NCT05339217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138809604|NCT05339217|Antiviral Agents|antiviral agents|mesh-ancestor
138809605|NCT05339217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809606|NCT04793490|Acetaminophen|acetaminophen|mesh-list
138809607|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138809608|NCT04793490|Analgesics|analgesics|mesh-ancestor
138809609|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
138809610|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138488156|NCT00000906|Ritonavir|ritonavir|mesh-list
138809611|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809612|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
138809613|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
138809614|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138809615|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138809616|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809617|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138809618|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138642549|NCT00267332|Modafinil|modafinil|mesh-list
138809619|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809620|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809621|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809622|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138809623|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
138809624|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138465956|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
138465963|NCT01955421|Gefitinib|gefitinib|mesh-list
138809625|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424298|NCT03560752|Vaccines|vaccines|mesh-list
138809626|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138809627|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138809628|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138809629|NCT05319093|Ozanimod|ozanimod|mesh-list
138809630|NCT05319093|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138809631|NCT05319093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809632|NCT05319093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138809633|NCT05319093|Immunologic Factors|immunologic factors|mesh-ancestor
138809634|NCT05319093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809635|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
138809637|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
138809638|NCT00752557|Cholecalciferol|cholecalciferol|mesh-list
138809639|NCT00752557|Diphosphonates|diphosphonates|mesh-list
138809640|NCT00752557|Vitamins|vitamins|mesh-list
138809641|NCT00752557|Calcium|calcium|mesh-list
138809642|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
138809643|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809644|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138809645|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138809646|NCT04570176|Epinephrine|epinephrine|mesh-list
138809647|NCT04570176|Racepinephrine|racepinephrine|mesh-list
138809648|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
138809649|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138809650|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138809651|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
138809652|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809653|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809654|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809655|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138809656|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138809657|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
138809658|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809659|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138809660|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
138809661|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
138809662|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
138809663|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138809664|NCT00751218|Cetirizine|cetirizine|mesh-list
138809665|NCT00751218|Desloratadine|desloratadine|mesh-list
138642597|NCT00301899|Trastuzumab|trastuzumab|mesh-list
138809666|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138424324|NCT03227705|Progesterone|progesterone|mesh-list
138809667|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138809668|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138809669|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
138809670|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
138809671|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809672|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809673|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809674|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138809675|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
138809676|NCT02779569|Decitabine|decitabine|mesh-list
138809677|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138809678|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
138809679|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809680|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809681|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809682|NCT04095013|Fentanyl|fentanyl|mesh-list
138809683|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
138809684|NCT04095013|Bupivacaine|bupivacaine|mesh-list
138809685|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
138809686|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
138809687|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138809688|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809689|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
138809690|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809691|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138809692|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138809693|NCT04095013|Analgesics|analgesics|mesh-ancestor
138809694|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138809695|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138809696|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138809697|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
138809698|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809699|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809700|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138809701|NCT04095013|Narcotics|narcotics|mesh-ancestor
138809702|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138809703|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138809704|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
138809705|NCT02779881|Caseins|caseins|mesh-list
138809707|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
138809708|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809709|NCT00651378|Atorvastatin|atorvastatin|mesh-list
138809710|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138809711|NCT00651378|Ezetimibe|ezetimibe|mesh-list
138809712|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138809713|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138809714|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
138809715|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809716|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138809717|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138809718|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809719|NCT00747643|Varenicline|varenicline|mesh-list
138809720|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138809721|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138809722|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
138809723|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809724|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809725|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809726|NCT00627692|Prucalopride|prucalopride|mesh-list
138809727|NCT00627692|Laxatives|laxatives|mesh-ancestor
138809728|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138809729|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138809730|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138809731|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
138809732|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809733|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809734|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809735|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
138809736|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138809737|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809738|NCT04301882|Interferons|interferons|mesh-list
138809739|NCT04301882|Ribavirin|ribavirin|mesh-list
138809740|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
138809741|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809742|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809743|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
138809744|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809745|NCT04300322|Progesterone|progesterone|mesh-list
138809746|NCT04300322|Progestins|progestins|mesh-ancestor
138809747|NCT04300322|Hormones|hormones|mesh-ancestor
138809748|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138809749|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809750|NCT01022762|Repaglinide|repaglinide|mesh-list
138809751|NCT01022762|Gliclazide|gliclazide|mesh-list
138809752|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138809753|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809754|NCT00311844|Desloratadine|desloratadine|mesh-list
138809755|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138809756|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
138809757|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809758|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809759|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424398|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809760|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138809761|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138809762|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
138809763|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
138809765|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
138809766|NCT02599675|Vitamins|vitamins|mesh-ancestor
138809767|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
138809768|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809769|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138809770|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138809771|NCT02778789|Adalimumab|adalimumab|mesh-list
138809772|NCT02778789|Infliximab|infliximab|mesh-list
138809773|NCT02778789|Golimumab|golimumab|mesh-list
138809774|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
138809775|NCT02778789|Etanercept|etanercept|mesh-list
138809776|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138809777|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138809778|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187252|NCT04361513|Bupivacaine|bupivacaine|mesh-list
138809779|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
138809780|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138809781|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138809782|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138809783|NCT02778789|Analgesics|analgesics|mesh-ancestor
138809784|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
138809785|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809786|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809787|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138809788|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
138809789|NCT00212784|Olanzapine|olanzapine|mesh-list
138809790|NCT00212784|Asenapine|asenapine|mesh-list
138809791|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
138809792|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
138809793|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809794|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809795|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138809796|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138809797|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138809798|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138809799|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138809800|NCT00212784|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138809801|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138809802|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138809803|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809804|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809805|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
138809806|NCT00751933|Vaccines|vaccines|mesh-list
138809807|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
138809808|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809809|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
138809810|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
138809811|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809812|NCT02778945|Rocuronium|rocuronium|mesh-list
138809813|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138809814|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138809815|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138809816|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809817|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809818|NCT02721342|Ramipril|ramipril|mesh-list
138809819|NCT02721342|Irbesartan|irbesartan|mesh-list
138809820|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138809821|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
138809822|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809823|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809824|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138809825|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138809826|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138809827|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
138809828|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138809829|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809830|NCT02779101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138809831|NCT02779101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809832|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
138809833|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
138809834|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
138809835|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809836|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809837|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138809838|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138809839|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138809840|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138809841|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138809842|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138809844|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809845|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809846|NCT05335278|Nintedanib|nintedanib|mesh-list
138809847|NCT05335278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809848|NCT05335278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138809849|NCT05335278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809850|NCT05335278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809851|NCT00092898|Ezetimibe|ezetimibe|mesh-list
138809852|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138809853|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138809854|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
138809855|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809856|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138809857|NCT04094467|Leuprolide|leuprolide|mesh-list
138809858|NCT04094467|Cetrorelix|cetrorelix|mesh-list
138809859|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138809860|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
138809861|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138809862|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809863|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138809864|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809865|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
138809866|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138809867|NCT00092820|Ezetimibe|ezetimibe|mesh-list
138809868|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138809869|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138809870|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
138809871|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809872|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138809873|NCT00092742|Diclofenac|diclofenac|mesh-list
138809874|NCT00092742|Etoricoxib|etoricoxib|mesh-list
138809875|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138809876|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138809877|NCT00092742|Analgesics|analgesics|mesh-ancestor
138809878|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
138809879|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466003|NCT01955759|Amiodarone|amiodarone|mesh-list
138809880|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809881|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138809882|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138809883|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138809884|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809885|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809886|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138809887|NCT02844270|Sirolimus|sirolimus|mesh-list
138809888|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138809889|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809890|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138809891|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809892|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
138809893|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138809894|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
138809895|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809896|NCT00634959|Maraviroc|maraviroc|mesh-list
138809897|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138809898|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138809899|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642655|NCT00415961|Paclitaxel|paclitaxel|mesh-list
138809900|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138809901|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138809902|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
138809903|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138809904|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138809905|NCT02598427|Trastuzumab|trastuzumab|mesh-list
138809906|NCT02598427|Pertuzumab|pertuzumab|mesh-list
138809907|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138809908|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809909|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138809910|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138809911|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138809912|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
138809913|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809914|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138809915|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138809916|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809917|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
138809918|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
138809919|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
138809920|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809921|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
138809922|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138809923|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809925|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138809926|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
138809927|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809928|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809929|NCT00586495|Sorafenib|sorafenib|mesh-list
138809930|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809931|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138809932|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809933|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809934|NCT02776137|Docetaxel|docetaxel|mesh-list
138809935|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809936|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
138809937|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
138809938|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
138809939|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809940|NCT01027754|Varenicline|varenicline|mesh-list
138809941|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138642679|NCT00296478|Hormones|hormones|mesh-ancestor
138809942|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138809943|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
138809944|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809945|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809946|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809947|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
138809948|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138809949|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138809950|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809951|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138809952|NCT02773017|Analgesics|analgesics|mesh-ancestor
138809953|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
138809954|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138809955|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138809956|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138809957|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138809958|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
138809959|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138809960|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809961|NCT02776059|Prednisolone|prednisolone|mesh-list
138809962|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138809963|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
138809964|NCT02776059|Hormones|hormones|mesh-ancestor
138809965|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138809966|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809967|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138809968|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809970|NCT00774930|Somatostatin|somatostatin|mesh-list
138809971|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809972|NCT00774930|Hormones|hormones|mesh-ancestor
138809973|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138809974|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809975|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138809976|NCT02841774|Pravastatin|pravastatin|mesh-list
138809977|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138809978|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138809979|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
138809980|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809981|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138809982|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138809983|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809984|NCT02772237|Riboflavin|riboflavin|mesh-list
138809985|NCT02772237|Vitamins|vitamins|mesh-ancestor
138809986|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
138809987|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138809988|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
138809989|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138809990|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
138809991|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138809992|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138809993|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138809994|NCT01316250|Imatinib Mesylate|imatinib mesylate|mesh-list
138809995|NCT01316250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138809996|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138809997|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138809998|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138809999|NCT02771925|Gabapentin|gabapentin|mesh-list
138810000|NCT02771925|Analgesics|analgesics|mesh-ancestor
138810001|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
138187472|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138810002|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810003|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810004|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
138810005|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138810006|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138810007|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810008|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138810009|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138488580|NCT00005858|Immunoconjugates|immunoconjugates|mesh-ancestor
138810010|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138810011|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810012|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810013|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
138810014|NCT03205956|Levodopa|levodopa|mesh-list
138810015|NCT03205956|Carbidopa|carbidopa|mesh-list
138810016|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138810017|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138810018|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
138810019|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424505|NCT03861377|Remifentanil|remifentanil|mesh-list
138810020|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810021|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810022|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138810024|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
138810025|NCT02840994|Nivolumab|nivolumab|mesh-list
138810026|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138810027|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642748|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
138810028|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138810029|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810030|NCT02771457|Infliximab|infliximab|mesh-list
138810031|NCT02771457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138810032|NCT02771457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138810033|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
138810034|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810035|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138810036|NCT02843802|Immunomodulating Agents|immunomodulating agents|mesh-list
138810037|NCT02843802|Immunologic Factors|immunologic factors|mesh-ancestor
138810038|NCT02843802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810039|NCT02771379|Idebenone|idebenone|mesh-list
138810040|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
138810041|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810042|NCT02771379|Protective Agents|protective agents|mesh-ancestor
138488630|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138810043|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810044|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
138810045|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138810046|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
138810047|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138810048|NCT02844114|Cisplatin|cisplatin|mesh-list
138810049|NCT02844114|Gemcitabine|gemcitabine|mesh-list
138810050|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810051|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138810052|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
138810053|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810054|NCT02696733|Cephalosporins|cephalosporins|mesh-list
138810055|NCT02696733|Lidocaine|lidocaine|mesh-list
138810056|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
138810057|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
138810058|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810059|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810060|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
138810061|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810062|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138810063|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138810064|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138810065|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138810066|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810067|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138810068|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810069|NCT00897390|Metformin|metformin|mesh-list
138810070|NCT00897390|Saxagliptin|saxagliptin|mesh-list
138810071|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138810072|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810073|NCT00897390|Incretins|incretins|mesh-ancestor
138810074|NCT00897390|Hormones|hormones|mesh-ancestor
138810075|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138187551|NCT00975637|Brodalumab|brodalumab|mesh-list
138810076|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138810077|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
138810078|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810079|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810080|NCT01034462|Milnacipran|milnacipran|mesh-list
138810081|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
138810082|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138488671|NCT00005867|Prednisolone|prednisolone|mesh-list
138810083|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138810084|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138810085|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810086|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810087|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810088|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
138810089|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138810090|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138810091|NCT01034462|Analgesics|analgesics|mesh-ancestor
138810092|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
138810093|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810094|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138810095|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
138810096|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810097|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
138810098|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138810099|NCT02774811|Bimatoprost|bimatoprost|mesh-list
138810100|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138810101|NCT00817050|Fluticasone|fluticasone|mesh-list
138810102|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
138810103|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138810104|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138810105|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
138810106|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810107|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810108|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138810109|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
138810110|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
138810111|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138810112|NCT04224831|Mitogens|mitogens|mesh-list
138810113|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
138466067|NCT01956201|Atorvastatin|atorvastatin|mesh-list
138810114|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810115|NCT00816972|Loratadine|loratadine|mesh-list
138810116|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
138810117|NCT00816972|Oxybutynin|oxybutynin|mesh-list
138810118|NCT00816972|Desloratadine|desloratadine|mesh-list
138810119|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
138810120|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
138810121|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810122|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810123|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138810124|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138810125|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
138810126|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810127|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810128|NCT00816972|Urological Agents|urological agents|mesh-ancestor
138810129|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138810130|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810131|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138810132|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138810133|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
138810134|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
138810135|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
138810136|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
138810137|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138810138|NCT02774499|Methadone|methadone|mesh-list
138810139|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138810140|NCT02774499|Narcotics|narcotics|mesh-ancestor
138810141|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810142|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810143|NCT02774499|Analgesics|analgesics|mesh-ancestor
138810144|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
138642791|NCT00296790|Zolpidem|zolpidem|mesh-list
138810145|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810146|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
138810147|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
138810148|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138810149|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138810150|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
138810151|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810152|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810153|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810154|NCT02774187|Leucovorin|leucovorin|mesh-list
138810155|NCT02774187|Fluorouracil|fluorouracil|mesh-list
138810156|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
138810157|NCT02774187|Sorafenib|sorafenib|mesh-list
138810158|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
138810159|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810160|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138810161|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810162|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138810163|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
138424571|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138810164|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810165|NCT02774187|Antidotes|antidotes|mesh-ancestor
138810166|NCT02774187|Protective Agents|protective agents|mesh-ancestor
138810167|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
138810168|NCT02774187|Vitamins|vitamins|mesh-ancestor
138810169|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
138810170|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138466076|NCT01956305|Metformin|metformin|mesh-list
138810171|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810172|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
138810173|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138810174|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810175|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810176|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138810177|NCT02773797|Analgesics|analgesics|mesh-ancestor
138810178|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
138810179|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810180|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138642796|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138810181|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138810182|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138810183|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
138810184|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810185|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810186|NCT02773875|Pancrelipase|pancrelipase|mesh-list
138810187|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810188|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
138810189|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138810190|NCT02768961|Ledipasvir|ledipasvir|mesh-list
138810191|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
138810192|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810193|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
138810194|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138810195|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138810196|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138810197|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138810198|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810199|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
138810200|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810201|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810202|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138810203|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810204|NCT02768805|Vaccines|vaccines|mesh-list
138810205|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
138810206|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810207|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138810208|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
138810209|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138810210|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
138810211|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810212|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
138810213|NCT02773251|Protective Agents|protective agents|mesh-ancestor
138810214|NCT02773251|Laxatives|laxatives|mesh-ancestor
138810215|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810216|NCT02768649|Risperidone|risperidone|mesh-list
138810217|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138810218|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
138810219|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810220|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810221|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810222|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138810223|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138810224|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187725|NCT01014403|Enoxaparin|enoxaparin|mesh-list
138810225|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138810226|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138810228|NCT04224675|Atenolol|atenolol|mesh-list
138810229|NCT04224675|Captopril|captopril|mesh-list
138810230|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138810231|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138810232|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
138810233|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
138810234|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810235|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810236|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138810237|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138810238|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138810239|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
138810241|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810242|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138810243|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
138810244|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810245|NCT02768493|Ropivacaine|ropivacaine|mesh-list
138810246|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
138810247|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
138810248|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810249|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810250|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
138810251|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810252|NCT02768415|Apatinib|apatinib|mesh-list
138810253|NCT02768415|Vinorelbine|vinorelbine|mesh-list
138810254|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810255|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138810256|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810257|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810258|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138810259|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
138810260|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
138810261|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
138810262|NCT02773095|Lactitol|lactitol|mesh-list
138810263|NCT02773095|Cathartics|cathartics|mesh-ancestor
138810264|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810265|NCT02768337|Afatinib|afatinib|mesh-list
138810266|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810267|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138810268|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810269|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810270|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
138810271|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138810272|NCT02768571|Protective Agents|protective agents|mesh-ancestor
138810273|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810274|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
138810275|NCT02767713|Dexamethasone|dexamethasone|mesh-list
138810276|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138810277|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
138810278|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
138810279|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810280|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810281|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810282|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
138810283|NCT02767713|Hormones|hormones|mesh-ancestor
138810284|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138810285|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138810286|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810288|NCT02767245|Vitamins|vitamins|mesh-ancestor
138810289|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
138810290|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810291|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
138810292|NCT02767401|Aspirin|aspirin|mesh-list
138810293|NCT02767401|Metoprolol|metoprolol|mesh-list
138810294|NCT02767401|Clopidogrel|clopidogrel|mesh-list
138810295|NCT02767401|Ticagrelor|ticagrelor|mesh-list
138810296|NCT02767401|Atorvastatin|atorvastatin|mesh-list
138810297|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138810298|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138810299|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138810300|NCT02767401|Analgesics|analgesics|mesh-ancestor
138810301|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
138810302|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810303|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810304|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138810305|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138810306|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138810307|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138810308|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810309|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138810310|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138424670|NCT03649802|Vitamin D|vitamin d|mesh-list
138810311|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810313|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138810314|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138810315|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
138810316|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138810317|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138810318|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138810319|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138810320|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138810321|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
138810322|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810323|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138810324|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138810325|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
138810326|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
138810327|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138810328|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138810329|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138810330|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
138810331|NCT02767479|Esomeprazole|esomeprazole|mesh-list
138810332|NCT02767479|Rabeprazole|rabeprazole|mesh-list
138810333|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138810334|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810335|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138810336|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810337|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810338|NCT02767635|Triamcinolone|triamcinolone|mesh-list
138810339|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138810340|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138810341|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138810342|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138810343|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138810344|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138810345|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810346|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810347|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138810348|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138810349|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810350|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
138489035|NCT00010231|Calcitriol|calcitriol|mesh-list
138810351|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810352|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138810353|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
138810354|NCT02767635|Hormones|hormones|mesh-ancestor
138810355|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138810356|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138810357|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
138810358|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810359|NCT04224441|Temozolomide|temozolomide|mesh-list
138810360|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
138810361|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138810362|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
138642970|NCT00418431|Bevacizumab|bevacizumab|mesh-list
138810363|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810364|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810365|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
138810366|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
138810367|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810368|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810369|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810370|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138810371|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138810372|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810373|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138810374|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138810375|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
138810376|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810377|NCT02767089|Prednisone|prednisone|mesh-list
138810378|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138810379|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
138810380|NCT02767089|Hormones|hormones|mesh-ancestor
138810381|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138810382|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810383|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138810384|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810385|NCT02766855|Cysteamine|cysteamine|mesh-list
138810386|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138810387|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810388|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138810389|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138810390|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
138810391|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138810392|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810393|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138810394|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138810395|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138810396|NCT02762253|Riboflavin|riboflavin|mesh-list
138810397|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
138810398|NCT02762253|Vitamins|vitamins|mesh-ancestor
138810399|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
138810400|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810401|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138810402|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
138810403|NCT00746941|Mefloquine|mefloquine|mesh-list
138810404|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
138810405|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138810406|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138810407|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810408|NCT04532463|Fluconazole|fluconazole|mesh-list
138810409|NCT04532463|Amphotericin B|amphotericin b|mesh-list
138810410|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138810412|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
138810413|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810414|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138810415|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138810417|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810418|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138810419|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
138810420|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138810421|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810422|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138810423|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138810424|NCT04532463|Amebicides|amebicides|mesh-ancestor
138810425|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138810426|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138810427|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138810428|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
138810429|NCT04091815|Anesthetics|anesthetics|mesh-list
138810430|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810431|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810432|NCT00746785|Olanzapine|olanzapine|mesh-list
138810433|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
138810434|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
138810435|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643053|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
138489101|NCT00001191|Omeprazole|omeprazole|mesh-list
138810436|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810437|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810438|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138810439|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138810440|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810441|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138810442|NCT00746785|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138810443|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138810444|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138424733|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810445|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810446|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810447|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
138810448|NCT04090021|Amoxicillin|amoxicillin|mesh-list
138810449|NCT04090021|Metronidazole|metronidazole|mesh-list
138810450|NCT04090021|Clarithromycin|clarithromycin|mesh-list
138810451|NCT04090021|Levofloxacin|levofloxacin|mesh-list
138810453|NCT04090021|Esomeprazole|esomeprazole|mesh-list
138810454|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138810455|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810456|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138810457|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138810458|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138810459|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810460|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138810461|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810462|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810463|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138810464|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138810465|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138466156|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138810466|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138810467|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138810468|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138810469|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810470|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138810471|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138810472|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
138810474|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138810475|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810476|NCT00750919|Mirtazapine|mirtazapine|mesh-list
138810477|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
138810478|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138810479|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138810480|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
138810481|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
138810482|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424774|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138810483|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810484|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810486|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138810487|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810488|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138810489|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138810490|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138643111|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
138810491|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
138810492|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138810493|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138810494|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
138810495|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138810496|NCT02761161|Mianserin|mianserin|mesh-list
138810497|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138810498|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138810499|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
138810500|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810501|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810502|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810503|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138810504|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
138810505|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
138810506|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138810507|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
138810508|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138810509|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
138810510|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138810511|NCT02761395|Deferasirox|deferasirox|mesh-list
138810512|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138810513|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
138810514|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
138810515|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810516|NCT02761317|Bisacodyl|bisacodyl|mesh-list
138187996|NCT04772547|Vigabatrin|vigabatrin|mesh-list
138187997|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
138187998|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187999|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188000|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
138188001|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188002|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188003|NCT05028153|Azithromycin|azithromycin|mesh-list
138188004|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138188007|NCT03126760|Hormones|hormones|mesh-ancestor
138810517|NCT02761317|Cathartics|cathartics|mesh-ancestor
138466174|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
138810518|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810519|NCT02761317|Laxatives|laxatives|mesh-ancestor
138810520|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138810521|NCT00746551|Hematinics|hematinics|mesh-ancestor
138810522|NCT02696577|Aspirin|aspirin|mesh-list
138810523|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138810524|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138810525|NCT02696577|Analgesics|analgesics|mesh-ancestor
138810526|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
138810527|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810528|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810529|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138810530|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138810531|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138810532|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138810533|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810534|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138810535|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138810536|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810537|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
138810538|NCT04222491|Immunomodulating Agents|immunomodulating agents|mesh-list
138810539|NCT04222491|Immunologic Factors|immunologic factors|mesh-ancestor
138810540|NCT04222491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810541|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
138810542|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
138810543|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138810544|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643123|NCT00297765|Tacrolimus|tacrolimus|mesh-list
138810545|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810546|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
138810547|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138810548|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810549|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810550|NCT04223739|Amiodarone|amiodarone|mesh-list
138810551|NCT04223739|Landiolol|landiolol|mesh-list
138810552|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138810553|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
138810554|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138810555|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138810556|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810557|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138810558|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138810559|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138810560|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810561|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138810562|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138810563|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138810564|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138810565|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138810566|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
138810567|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810568|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810570|NCT02765373|Anastrozole|anastrozole|mesh-list
138810571|NCT02765373|Exemestane|exemestane|mesh-list
138810572|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810573|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138810574|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138810575|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810576|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810577|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138810578|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
138810579|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138810580|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810581|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138810582|NCT02760615|Losartan|losartan|mesh-list
138810583|NCT02760615|Midazolam|midazolam|mesh-list
138810584|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
138810585|NCT02760615|Caffeine|caffeine|mesh-list
138810586|NCT02760615|Omeprazole|omeprazole|mesh-list
138810587|NCT02760615|Vedolizumab|vedolizumab|mesh-list
138810588|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138810589|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138188071|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
138810590|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810591|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810592|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138810593|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138810594|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138810595|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138810596|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
138810597|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
138810598|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
138810599|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
138810600|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810601|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810602|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138810603|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138810604|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138810605|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138810606|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138810607|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138810608|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810609|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138810610|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138810611|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
138810612|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138810613|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810614|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138810615|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
138810616|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
138810617|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138810618|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138810620|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138810621|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
138810622|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
138810623|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810624|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466206|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138810625|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810626|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
138810627|NCT02760459|Hormones|hormones|mesh-ancestor
138810628|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138810629|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138810630|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810631|NCT02765217|Amoxicillin|amoxicillin|mesh-list
138810632|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
138810633|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
138810634|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138810635|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138810636|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810637|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318230|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138810638|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810639|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138810640|NCT02760381|Acetic Acid|acetic acid|mesh-list
138810641|NCT02760381|Retinol acetate|retinol acetate|mesh-list
138810642|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138810643|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810644|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138810645|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
138810646|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810647|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138810648|NCT02760381|Protective Agents|protective agents|mesh-ancestor
138810649|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810650|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
138810651|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138810652|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810653|NCT02760225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138810654|NCT02760225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810655|NCT00744757|Decitabine|decitabine|mesh-list
138810656|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138810657|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
138810658|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810659|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810660|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810661|NCT00917527|Atorvastatin|atorvastatin|mesh-list
138810662|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138810663|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138810664|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
138810665|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810667|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138810668|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810669|NCT00745849|Esomeprazole|esomeprazole|mesh-list
138810670|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138810671|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810672|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138810673|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810674|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810676|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
138810677|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810678|NCT04112277|Morphine|morphine|mesh-list
138810679|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138810680|NCT04112277|Narcotics|narcotics|mesh-ancestor
138810681|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810682|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810683|NCT04112277|Analgesics|analgesics|mesh-ancestor
138810684|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
138810685|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810686|NCT00749203|Midazolam|midazolam|mesh-list
138810687|NCT00749203|Ketamine|ketamine|mesh-list
138810688|NCT00749203|Analgesics|analgesics|mesh-ancestor
138810689|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
138810690|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810691|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810692|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138810693|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138810694|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
138810695|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
138810696|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810697|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138810698|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138810699|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810700|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810701|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138810702|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138810703|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138810704|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138810705|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138810706|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
138810707|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
138810708|NCT02764515|Methotrexate|methotrexate|mesh-list
138810709|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138810710|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
138810711|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138810712|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810713|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138810714|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
138810715|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810716|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466260|NCT01957631|Bupivacaine|bupivacaine|mesh-list
138466264|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
138810717|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
138810718|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810719|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138810720|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138810722|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138810723|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138810725|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138810726|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810727|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
138810728|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138810729|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138318352|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138318353|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
138318354|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
138810730|NCT02764359|Vancomycin|vancomycin|mesh-list
138810731|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138810732|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810733|NCT02764125|Levodopa|levodopa|mesh-list
138810734|NCT02764125|Carbidopa|carbidopa|mesh-list
138810735|NCT02764125|Entacapone|entacapone|mesh-list
138810736|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138810737|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138188219|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
138810738|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
138810739|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810740|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810741|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810742|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138810743|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810744|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138810745|NCT02764281|Dexamethasone|dexamethasone|mesh-list
138810746|NCT02764281|Methotrexate|methotrexate|mesh-list
138810747|NCT02764281|Etoposide|etoposide|mesh-list
138810748|NCT02764281|Pegaspargase|pegaspargase|mesh-list
138810749|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138810750|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
138810751|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
138810752|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810753|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810754|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810755|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
138810756|NCT02764281|Hormones|hormones|mesh-ancestor
138810757|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138810758|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138810759|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810760|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810761|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810762|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138810763|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
138810764|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138810765|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138810766|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
138810767|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
138810768|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138810769|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138810770|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
138810771|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138810772|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138810773|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138318400|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138318402|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138318403|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138318404|NCT01403610|Growth Substances|growth substances|mesh-ancestor
138318405|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318406|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
138318407|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138318408|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
138318409|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318410|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138318411|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
138318412|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810774|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138810775|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138810776|NCT02763969|Interferons|interferons|mesh-list
138810777|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
138810778|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
138810779|NCT02763969|Ustekinumab|ustekinumab|mesh-list
138810780|NCT02763969|Famotidine|famotidine|mesh-list
138810781|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810782|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
138810783|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810784|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
138810785|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810786|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
138810787|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138643181|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
138810788|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138810789|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138810790|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
138810791|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
138810792|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810793|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810794|NCT04660929|Pembrolizumab|pembrolizumab|mesh-list
138810795|NCT04660929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138810796|NCT04660929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810797|NCT04660929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138810798|NCT04660929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810799|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
138810800|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138810801|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810802|NCT02758587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138810803|NCT02758587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810806|NCT02758509|Ribavirin|ribavirin|mesh-list
138810807|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
138810808|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
138810809|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
138810810|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138810811|NCT02758509|Ledipasvir|ledipasvir|mesh-list
138810812|NCT02758509|Simeprevir|simeprevir|mesh-list
138810813|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138810814|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810815|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
138810816|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318419|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138318420|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318421|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138318422|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
138318423|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138318424|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138318426|NCT01402284|Lenalidomide|lenalidomide|mesh-list
138318430|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318431|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318432|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138318434|NCT01402284|Hormones|hormones|mesh-ancestor
138304101|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
138304102|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304103|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
138810817|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138810818|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138810819|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
138810820|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810821|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810822|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138810823|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138810824|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138466288|NCT01957852|Thrombin|thrombin|mesh-list
138810825|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138810826|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
138810827|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
138810828|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810829|NCT02762955|Adalimumab|adalimumab|mesh-list
138810830|NCT02762955|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138810831|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138810832|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138810833|NCT04191681|Valsartan|valsartan|mesh-list
138810834|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138810835|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138810836|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138810837|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138810838|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810839|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138810840|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138810841|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810842|NCT02752503|Nalmefene|nalmefene|mesh-list
138810843|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138810844|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810845|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
138810846|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810847|NCT04479579|Apixaban|apixaban|mesh-list
138425002|NCT02663908|Leuprolide|leuprolide|mesh-list
138810848|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138810849|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
138318435|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138318436|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138318437|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318438|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
138318439|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138318440|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138318441|NCT01402284|Growth Substances|growth substances|mesh-ancestor
138318442|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
138318443|NCT01388790|Cetuximab|cetuximab|mesh-list
138318444|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318445|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138318446|NCT01388478|Pramipexole|pramipexole|mesh-list
138318449|NCT01388478|Protective Agents|protective agents|mesh-ancestor
138810850|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138810851|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
138810852|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810853|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810854|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
138810855|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
138810856|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138810857|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810858|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810859|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138810860|NCT02757495|Analgesics|analgesics|mesh-ancestor
138810861|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
138810862|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810863|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138810864|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138810865|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138810866|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
138810867|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810868|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810869|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
138810870|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810871|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
138810872|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
138810873|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
138810874|NCT02752113|Metformin|metformin|mesh-list
138810875|NCT02752113|Empagliflozin|empagliflozin|mesh-list
138810876|NCT02752113|Linagliptin|linagliptin|mesh-list
138810877|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138810878|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810879|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138810880|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810881|NCT02752113|Incretins|incretins|mesh-ancestor
138810883|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138810884|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138810885|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
138810886|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810887|NCT02756715|Propofol|propofol|mesh-list
138810888|NCT02756715|Desflurane|desflurane|mesh-list
138810889|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138810890|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138318461|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138810891|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810892|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138810893|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
138810895|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138810896|NCT04221321|Atorvastatin|atorvastatin|mesh-list
138810897|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138425047|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
138810898|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138810899|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
138810900|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810901|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138810902|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138810903|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810904|NCT02755857|Itraconazole|itraconazole|mesh-list
138810905|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
138810906|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810907|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138810908|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138810909|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810910|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810911|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138810912|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
138810913|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138810914|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810915|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138810916|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
138810917|NCT02755545|Adapalene|adapalene|mesh-list
138810918|NCT02755545|Salicylates|salicylates|mesh-list
138810919|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138810920|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138810921|NCT02755545|Analgesics|analgesics|mesh-ancestor
138810922|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
138810923|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138810924|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425059|NCT01555541|Ofatumumab|ofatumumab|mesh-list
138810925|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138810926|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138810927|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
138810928|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810929|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
138810930|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
138810931|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138810932|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810933|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810934|NCT02695797|Prednisolone|prednisolone|mesh-list
138810935|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138810936|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
138810937|NCT02695797|Hormones|hormones|mesh-ancestor
138810938|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138810939|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810940|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138810941|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810942|NCT02755311|Cisplatin|cisplatin|mesh-list
138810943|NCT02755311|Carboplatin|carboplatin|mesh-list
138318462|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318463|NCT01400412|Ritonavir|ritonavir|mesh-list
138318464|NCT01400412|Darunavir|darunavir|mesh-list
138304214|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
138304215|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138304216|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
138810944|NCT02755311|Fluorouracil|fluorouracil|mesh-list
138810945|NCT02755311|Epirubicin|epirubicin|mesh-list
138810946|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
138810947|NCT02755311|Pirarubicin|pirarubicin|mesh-list
138810948|NCT02755311|Doxorubicin|doxorubicin|mesh-list
138810949|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
138810950|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810951|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
138810952|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810953|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138810954|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138810955|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
138810956|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810957|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138810958|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138810959|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138810960|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138810961|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
138810962|NCT02755311|Coagulants|coagulants|mesh-ancestor
138810963|NCT04554771|Paclitaxel|paclitaxel|mesh-list
138810964|NCT04554771|Carboplatin|carboplatin|mesh-list
138810965|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138810966|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810967|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
138810968|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
138810969|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
138810970|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810972|NCT04090801|Minoxidil|minoxidil|mesh-list
138810973|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138810974|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138810975|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138810976|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810977|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138810978|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
138810979|NCT04089631|Capecitabine|capecitabine|mesh-list
138810980|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138810981|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
138810982|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810983|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138810984|NCT00917059|Bupropion|bupropion|mesh-list
138810985|NCT00917059|Escitalopram|escitalopram|mesh-list
138318466|NCT01400412|Emtricitabine|emtricitabine|mesh-list
138318467|NCT01400412|Maraviroc|maraviroc|mesh-list
138318468|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138318469|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138318470|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
138318472|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318474|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138318475|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
138318476|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318477|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138318478|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138318479|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138304270|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138304298|NCT01967628|Vitamin D|vitamin d|mesh-list
138810986|NCT00917059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138810987|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138810988|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138810989|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138810990|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138810991|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
138810992|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138810993|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138810994|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
138810995|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138810996|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138810997|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
138810998|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138810999|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138811000|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811001|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
138811002|NCT02754687|Nandrolone|nandrolone|mesh-list
138811003|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
138811004|NCT02754687|Androgens|androgens|mesh-ancestor
138811005|NCT02754687|Hormones|hormones|mesh-ancestor
138811006|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138811007|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811008|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
138811009|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138811011|NCT05429775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138811012|NCT05429775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138811013|NCT05429775|Autonomic Agents|autonomic agents|mesh-ancestor
138811014|NCT05429775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811015|NCT05429775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811016|NCT05429775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138811017|NCT05429775|Respiratory System Agents|respiratory system agents|mesh-ancestor
138811018|NCT05429775|Glucocorticoids|glucocorticoids|mesh-ancestor
138811019|NCT05429775|Hormones|hormones|mesh-ancestor
138811020|NCT05429775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138811021|NCT04220073|Antibodies|antibodies|mesh-list
138811022|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138318480|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138318481|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138318482|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138318483|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138318484|NCT01422876|Linagliptin|linagliptin|mesh-list
138318485|NCT01422876|Empagliflozin|empagliflozin|mesh-list
138318486|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138318487|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318488|NCT01422876|Incretins|incretins|mesh-ancestor
138304305|NCT01998906|Paclitaxel|paclitaxel|mesh-list
138811023|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
138811024|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811025|NCT05429151|Acyclovir|acyclovir|mesh-list
138811026|NCT05429151|Antiviral Agents|antiviral agents|mesh-ancestor
138811027|NCT05429151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811028|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
138811029|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138811030|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138811031|NCT04219995|Prednisolone|prednisolone|mesh-list
138811032|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
138811033|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138811034|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
138811035|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138811036|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
138811037|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
138811038|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811039|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811040|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138811041|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
138811042|NCT04219995|Hormones|hormones|mesh-ancestor
138811043|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138811044|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138811045|NCT04219995|Protective Agents|protective agents|mesh-ancestor
138811046|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138811047|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811048|NCT04200417|Mitomycins|mitomycins|mesh-list
138811049|NCT04200417|Mitomycin|mitomycin|mesh-list
138811050|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
138811051|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138811052|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138649759|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138649760|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
138649761|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811053|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
138811054|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811055|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138811056|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811057|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
138811058|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138811059|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138811060|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811061|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138811063|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
138466362|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138811064|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811065|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138811066|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138811067|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138811068|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
138811069|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138811070|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811071|NCT02695641|Bevacizumab|bevacizumab|mesh-list
138811072|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138811073|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811074|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138811075|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138811076|NCT02695641|Growth Substances|growth substances|mesh-ancestor
138811077|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811078|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
138811079|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
138811080|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138811081|NCT02750475|Protective Agents|protective agents|mesh-ancestor
138811082|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811083|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
138811085|NCT04217265|Misoprostol|misoprostol|mesh-list
138811086|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811087|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138811088|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138811089|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811090|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811091|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138811092|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
138811093|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138811094|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425214|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
138811095|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138811096|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
138811097|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138649806|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
138811098|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138811099|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138811100|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
138811101|NCT00635973|Gefitinib|gefitinib|mesh-list
138811102|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811103|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138811104|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811105|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811106|NCT02752971|Diclofenac|diclofenac|mesh-list
138811107|NCT02752971|Bupivacaine|bupivacaine|mesh-list
138811108|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
138811109|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
138811110|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138811111|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811112|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
138811113|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811114|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138811115|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138811117|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138811118|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811119|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138811120|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466383|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811121|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811122|NCT02750163|Acetaminophen|acetaminophen|mesh-list
138811123|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138811124|NCT02750163|Analgesics|analgesics|mesh-ancestor
138811125|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
138811126|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811127|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811128|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
138811129|NCT04217421|Allopurinol|allopurinol|mesh-list
138811130|NCT04217421|Mannitol|mannitol|mesh-list
138643286|NCT00271349|Budesonide|budesonide|mesh-list
138811131|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
138811132|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811133|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811134|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
138811135|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138425242|NCT02865187|Vitamins|vitamins|mesh-ancestor
138811136|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138811137|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
138811138|NCT04217421|Protective Agents|protective agents|mesh-ancestor
138649831|NCT04718714|Midazolam|midazolam|mesh-list
138811139|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811140|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138811141|NCT04217421|Diuretics|diuretics|mesh-ancestor
138811142|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
138811143|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
138811145|NCT04036929|Hormones|hormones|mesh-ancestor
138811146|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138811147|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811148|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138811149|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138811150|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
138811151|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138811152|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138811153|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811154|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
138811155|NCT04218981|Paroxetine|paroxetine|mesh-list
138811156|NCT04218981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138811157|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138811158|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138811159|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811160|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138811161|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
138811162|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811163|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138811164|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
138811165|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138811166|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138466402|NCT01959022|Doxazosin|doxazosin|mesh-list
138811167|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138811168|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811169|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138811170|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138811171|NCT04218513|Edaravone|edaravone|mesh-list
138811172|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138811173|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
138811174|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811175|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138811176|NCT04218513|Protective Agents|protective agents|mesh-ancestor
138649865|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138811177|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811178|NCT04218435|Valsartan|valsartan|mesh-list
138811179|NCT04218435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138811180|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138811181|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138811182|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138811183|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811185|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138811186|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138811187|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138811188|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811189|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
138811190|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643300|NCT00306696|Furosemide|furosemide|mesh-list
138811191|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811192|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138811193|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
138811194|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811196|NCT04138875|Immunoconjugates|immunoconjugates|mesh-ancestor
138811197|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138811198|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
138811199|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811200|NCT02695563|Lactoferrin|lactoferrin|mesh-list
138811201|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811202|NCT02747823|Bevacizumab|bevacizumab|mesh-list
138811203|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138811204|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811205|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138811206|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138811207|NCT02747823|Growth Substances|growth substances|mesh-ancestor
138811208|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811209|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
138811210|NCT02747511|Haloperidol|haloperidol|mesh-list
138811211|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
138811212|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
138811213|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
138811214|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811215|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811216|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138811217|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138649907|NCT00298571|Epinephrine|epinephrine|mesh-list
138811218|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138811219|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138811220|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138811221|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138811222|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
138811223|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138811224|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811225|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138811226|NCT04217733|Ethosuximide|ethosuximide|mesh-list
138811227|NCT04217733|Mebeverine|mebeverine|mesh-list
138811228|NCT04217733|Alverine|alverine|mesh-list
138811229|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
138811230|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
138811231|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
138811232|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811233|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811234|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138811235|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
138811236|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811237|NCT02746185|Heparin|heparin|mesh-list
138811238|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138811239|NCT02746185|Tinzaparin|tinzaparin|mesh-list
138811240|NCT02746185|Dalteparin|dalteparin|mesh-list
138811241|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
138811242|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
138811243|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138811244|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138811245|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811246|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138811247|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
138811248|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138811249|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
138811250|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811251|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
138811252|NCT02742051|Fluorouracil|fluorouracil|mesh-list
138811253|NCT02742051|Everolimus|everolimus|mesh-list
138811254|NCT02742051|Letrozole|letrozole|mesh-list
138811255|NCT02742051|Epirubicin|epirubicin|mesh-list
138811256|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138811257|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
138811258|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811259|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811260|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138811261|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
138811262|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649936|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
138811263|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811264|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138811265|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
138811266|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138811267|NCT02742051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138811268|NCT02742051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138811269|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811270|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138811271|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138811272|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138811273|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
138811274|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138811275|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138811276|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138811277|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138811278|NCT02741817|Aspirin|aspirin|mesh-list
138811279|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138811280|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138811281|NCT02741817|Analgesics|analgesics|mesh-ancestor
138811282|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
138811283|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811284|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811285|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138811286|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811287|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138811288|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138811289|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811290|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138811291|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138811292|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811293|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
138811294|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
138811295|NCT02745873|Vitamins|vitamins|mesh-ancestor
138811296|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
138811297|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811298|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
138811299|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811300|NCT02745873|Protective Agents|protective agents|mesh-ancestor
138811301|NCT02745639|Capecitabine|capecitabine|mesh-list
138811302|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
138811303|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138811304|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
138811305|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811306|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811307|NCT02745717|Cyclosporine|cyclosporine|mesh-list
138811308|NCT02745717|Cyclosporins|cyclosporins|mesh-list
138811309|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
138811310|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138811311|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811312|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811313|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138811314|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
138811315|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466481|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811317|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811318|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
138811319|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811320|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138811321|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
138811322|NCT02745561|Endostatins|endostatins|mesh-list
138811323|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811324|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138811325|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138811326|NCT02745561|Growth Substances|growth substances|mesh-ancestor
138811327|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811328|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
138811329|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
138811330|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138811331|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811332|NCT02745093|Misoprostol|misoprostol|mesh-list
138811333|NCT02745093|Mifepristone|mifepristone|mesh-list
138811334|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138650005|NCT05455944|Pregabalin|pregabalin|mesh-list
138811335|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
138811336|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138811337|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811338|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138811339|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138811340|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
138811341|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138811342|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138811343|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138811344|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138811345|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
138811346|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138811347|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138811348|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
138811349|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138811350|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
138811351|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138811352|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138811354|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138811355|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
138811356|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811357|NCT02741115|Udenafil|udenafil|mesh-list
138811358|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138811359|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138811360|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811361|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811362|NCT02740803|Listerine|listerine|mesh-list
138811363|NCT02740803|Fluorides|fluorides|mesh-list
138811364|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
138811365|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
138811366|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
138811367|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
138811368|NCT02740803|Protective Agents|protective agents|mesh-ancestor
138811369|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811370|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138811371|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811372|NCT02740647|Amoxicillin|amoxicillin|mesh-list
138811373|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
138811374|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
138811375|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138811376|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138811377|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811378|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138811379|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811380|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811381|NCT03737253|Menotropins|menotropins|mesh-list
138811382|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138811383|NCT03737253|Hormones|hormones|mesh-ancestor
138811384|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138811385|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811386|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138811387|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
138811388|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138811389|NCT00812968|Lenalidomide|lenalidomide|mesh-list
138811390|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
138811391|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811392|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138811393|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138811394|NCT00812968|Growth Substances|growth substances|mesh-ancestor
138811395|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
138811396|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811397|NCT02744703|Capecitabine|capecitabine|mesh-list
138811398|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138811399|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138811400|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
138811401|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811402|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811403|NCT02744937|Aspirin|aspirin|mesh-list
138811404|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138811405|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138811406|NCT02744937|Analgesics|analgesics|mesh-ancestor
138811407|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
138811408|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811409|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811410|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138811411|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811412|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138811413|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138811414|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811415|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138811416|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138650095|NCT01539447|Naproxen|naproxen|mesh-list
138811418|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
138811419|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138811420|NCT02744625|Propofol|propofol|mesh-list
138811421|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138811422|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138811423|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811424|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138811425|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
138811427|NCT02610556|Cisplatin|cisplatin|mesh-list
138811428|NCT02610556|Docetaxel|docetaxel|mesh-list
138811429|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811430|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
138811431|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
138811432|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
138811433|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811434|NCT02740101|Oxytocin|oxytocin|mesh-list
138811435|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
138811436|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138811437|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811439|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138811440|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138811441|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138811442|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138811443|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
138811444|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138811445|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811446|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811447|NCT00813748|Omalizumab|omalizumab|mesh-list
138811448|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138811449|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138811450|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
138811451|NCT00813592|Pasireotide|pasireotide|mesh-list
138811452|NCT00813592|Hormones|hormones|mesh-ancestor
138811453|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138811454|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811455|NCT02739633|Paclitaxel|paclitaxel|mesh-list
138811456|NCT02739633|genexol-PM|genexol-pm|mesh-list
138811457|NCT02739633|Gemcitabine|gemcitabine|mesh-list
138811458|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138811459|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811460|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
138811461|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
138811462|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
138811463|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811464|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138811465|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
138811466|NCT02739477|Favipiravir|favipiravir|mesh-list
138811467|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
138811468|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811469|NCT02739399|Phenylephrine|phenylephrine|mesh-list
138811470|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
138811471|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138811472|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
138811473|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
138811474|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811475|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811476|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
138811477|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138811478|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
138811479|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
138811480|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138811481|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138811482|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138811483|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
138811484|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138811485|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811486|NCT02739399|Protective Agents|protective agents|mesh-ancestor
138811487|NCT02743065|Doxorubicin|doxorubicin|mesh-list
138811488|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138811489|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811490|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138811491|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138811492|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811493|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811495|NCT06179056|Doxycycline|doxycycline|mesh-list
138811496|NCT06179056|Acetylcysteine|acetylcysteine|mesh-list
138811497|NCT06179056|Salicylic Acid|salicylic acid|mesh-list
138811498|NCT06179056|Salicylates|salicylates|mesh-list
138811499|NCT06179056|Isotretinoin|isotretinoin|mesh-list
138811500|NCT06179056|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138811501|NCT06179056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138811502|NCT06179056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811503|NCT06179056|Antimalarials|antimalarials|mesh-ancestor
138811504|NCT06179056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138811505|NCT06179056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138811506|NCT06179056|Antiviral Agents|antiviral agents|mesh-ancestor
138811507|NCT06179056|Expectorants|expectorants|mesh-ancestor
138811508|NCT06179056|Respiratory System Agents|respiratory system agents|mesh-ancestor
138811509|NCT06179056|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138811510|NCT06179056|Antioxidants|antioxidants|mesh-ancestor
138811511|NCT06179056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811512|NCT06179056|Protective Agents|protective agents|mesh-ancestor
138811513|NCT06179056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811514|NCT06179056|Antidotes|antidotes|mesh-ancestor
138811515|NCT06179056|Dermatologic Agents|dermatologic agents|mesh-ancestor
138811516|NCT06179056|Antifungal Agents|antifungal agents|mesh-ancestor
138811517|NCT06179056|Keratolytic Agents|keratolytic agents|mesh-ancestor
138811518|NCT06179056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138811519|NCT06179056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138811520|NCT06179056|Analgesics|analgesics|mesh-ancestor
138811521|NCT06179056|Sensory System Agents|sensory system agents|mesh-ancestor
138811522|NCT06179056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811523|NCT06179056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138811524|NCT06179056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811525|NCT06179056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138811526|NCT06179056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811527|NCT06179004|Bupivacaine|bupivacaine|mesh-list
138811528|NCT06179004|Anesthetics, Local|anesthetics, local|mesh-ancestor
138811529|NCT06179004|Anesthetics|anesthetics|mesh-ancestor
138811530|NCT06179004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138811531|NCT06179004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811532|NCT06179004|Sensory System Agents|sensory system agents|mesh-ancestor
138811533|NCT06179004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811535|NCT06178926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138811536|NCT06178926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138811537|NCT06178926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811538|NCT06178926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138811539|NCT06178926|Anesthetics, General|anesthetics, general|mesh-ancestor
138811540|NCT06178926|Anesthetics|anesthetics|mesh-ancestor
138811541|NCT06178874|Insulin|insulin|mesh-list
138811542|NCT06178874|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138811543|NCT06178874|Insulin Glargine|insulin glargine|mesh-list
138811544|NCT06178874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138811545|NCT06178874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811546|NCT06178848|Propofol|propofol|mesh-list
138811547|NCT06178848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138811548|NCT06178848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138811549|NCT06178848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811550|NCT06178848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138811551|NCT06178848|Anesthetics, General|anesthetics, general|mesh-ancestor
138811552|NCT06178848|Anesthetics|anesthetics|mesh-ancestor
138811553|NCT06178835|Epoetin Alfa|epoetin alfa|mesh-list
138811554|NCT06178835|Hematinics|hematinics|mesh-ancestor
138811555|NCT06178627|Amphotericin B|amphotericin b|mesh-list
138811556|NCT06178627|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138811558|NCT06178627|Amebicides|amebicides|mesh-ancestor
138811559|NCT06178627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138811560|NCT06178627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138811561|NCT06178627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811562|NCT06178627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138811563|NCT06178627|Antifungal Agents|antifungal agents|mesh-ancestor
138811564|NCT06178627|Antimetabolites|antimetabolites|mesh-ancestor
138811565|NCT06178627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811566|NCT06178588|Camptothecin|camptothecin|mesh-list
138811567|NCT06178588|Irinotecan|irinotecan|mesh-list
138811568|NCT06178588|Immunoconjugates|immunoconjugates|mesh-list
138811569|NCT06178588|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138811570|NCT06178588|Immunologic Factors|immunologic factors|mesh-ancestor
138811571|NCT06178588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811572|NCT06178588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138811573|NCT06178588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811574|NCT06178588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138811575|NCT06178588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138811576|NCT06178588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650236|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811577|NCT06178588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811578|NCT06178523|Sildenafil Citrate|sildenafil citrate|mesh-list
138811580|NCT06178523|Sodium Citrate|sodium citrate|mesh-list
138811581|NCT06178523|Clomiphene|clomiphene|mesh-list
138811582|NCT06178523|Enclomiphene|enclomiphene|mesh-list
138811583|NCT06178523|Zuclomiphene|zuclomiphene|mesh-list
138811584|NCT06178523|Anticoagulants|anticoagulants|mesh-ancestor
138811585|NCT06178523|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138811586|NCT06178523|Chelating Agents|chelating agents|mesh-ancestor
138811587|NCT06178523|Sequestering Agents|sequestering agents|mesh-ancestor
138811588|NCT06178523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811589|NCT06178523|Vasodilator Agents|vasodilator agents|mesh-ancestor
138811590|NCT06178523|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138811591|NCT06178523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138811592|NCT06178523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811593|NCT06178523|Urological Agents|urological agents|mesh-ancestor
138811594|NCT06178523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138811595|NCT06178523|Hormone Antagonists|hormone antagonists|mesh-ancestor
138811596|NCT06178523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138811597|NCT06178523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811598|NCT06178523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138811599|NCT06178523|Fertility Agents|fertility agents|mesh-ancestor
138811600|NCT06178523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138811601|NCT06178523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138811602|NCT06178523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138811603|NCT06178445|Pembrolizumab|pembrolizumab|mesh-list
138811604|NCT06178445|Trastuzumab|trastuzumab|mesh-list
138811605|NCT06178445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138811606|NCT06178445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811607|NCT06178445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138811608|NCT06178445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811609|NCT06173466|Dexamethasone|dexamethasone|mesh-list
138811610|NCT06173466|Bupivacaine|bupivacaine|mesh-list
138811611|NCT06173466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138811612|NCT06173466|Antiemetics|antiemetics|mesh-ancestor
138811613|NCT06173466|Autonomic Agents|autonomic agents|mesh-ancestor
138811614|NCT06173466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811615|NCT06173466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811616|NCT06173466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138811617|NCT06173466|Glucocorticoids|glucocorticoids|mesh-ancestor
138811619|NCT06173466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138811620|NCT06173466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138811621|NCT06173466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811622|NCT06173466|Anesthetics, Local|anesthetics, local|mesh-ancestor
138811623|NCT06173466|Anesthetics|anesthetics|mesh-ancestor
138811624|NCT06173466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138811625|NCT06173466|Sensory System Agents|sensory system agents|mesh-ancestor
138811626|NCT06169046|Clenbuterol|clenbuterol|mesh-list
138811627|NCT06169046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138811628|NCT06169046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138811629|NCT06169046|Adrenergic Agents|adrenergic agents|mesh-ancestor
138811630|NCT06169046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138811631|NCT06169046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811632|NCT06169046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811633|NCT06169046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138811634|NCT06169046|Autonomic Agents|autonomic agents|mesh-ancestor
138811635|NCT06169046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811636|NCT06169046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138425587|NCT01863186|Analgesics|analgesics|mesh-ancestor
138811637|NCT06169046|Respiratory System Agents|respiratory system agents|mesh-ancestor
138811638|NCT06169046|Sympathomimetics|sympathomimetics|mesh-ancestor
138811639|NCT06166498|Artesunate|artesunate|mesh-list
138811640|NCT06166498|Pyrimethamine|pyrimethamine|mesh-list
138811641|NCT06166498|Sulfadoxine|sulfadoxine|mesh-list
138811642|NCT06166498|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138811643|NCT06166498|Antimalarials|antimalarials|mesh-ancestor
138811644|NCT06166498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138811645|NCT06166498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138811646|NCT06166498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811647|NCT06166498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811648|NCT06166498|Antiviral Agents|antiviral agents|mesh-ancestor
138811649|NCT06166498|Schistosomicides|schistosomicides|mesh-ancestor
138811650|NCT06166498|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138811651|NCT06166498|Anthelmintics|anthelmintics|mesh-ancestor
138811652|NCT06166498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138811653|NCT06166498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811654|NCT06166498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811655|NCT06166498|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138811656|NCT06163352|Dopamine|dopamine|mesh-list
138811657|NCT06163352|Norepinephrine|norepinephrine|mesh-list
138811658|NCT06163352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138811659|NCT06163352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138811660|NCT06163352|Adrenergic Agents|adrenergic agents|mesh-ancestor
138811661|NCT06163352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138811662|NCT06163352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811663|NCT06163352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811664|NCT06163352|Sympathomimetics|sympathomimetics|mesh-ancestor
138811665|NCT06163352|Autonomic Agents|autonomic agents|mesh-ancestor
138811666|NCT06163352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811667|NCT06163352|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138811668|NCT06163352|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138811669|NCT06163352|Dopamine Agents|dopamine agents|mesh-ancestor
138811670|NCT06163352|Protective Agents|protective agents|mesh-ancestor
138811671|NCT06159777|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138811672|NCT06159777|Laxatives|laxatives|mesh-ancestor
138811673|NCT06159777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138811674|NCT06157086|Ofatumumab|ofatumumab|mesh-list
138811675|NCT06157086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811677|NCT06151847|Fludarabine|fludarabine|mesh-list
138811678|NCT06151847|Interleukin-2|interleukin-2|mesh-list
138811679|NCT06151847|Mitogens|mitogens|mesh-list
138811680|NCT06151847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138811681|NCT06151847|Immunologic Factors|immunologic factors|mesh-ancestor
138811682|NCT06151847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811683|NCT06151847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811684|NCT06151847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138811685|NCT06151847|Alkylating Agents|alkylating agents|mesh-ancestor
138811686|NCT06151847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811687|NCT06151847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811688|NCT06151847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138811689|NCT06151847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138811690|NCT06151847|Analgesics|analgesics|mesh-ancestor
138811691|NCT06151847|Sensory System Agents|sensory system agents|mesh-ancestor
138811692|NCT06151847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811693|NCT06151847|Mitosis Modulators|mitosis modulators|mesh-ancestor
138811694|NCT06150014|Tenofovir|tenofovir|mesh-list
138811695|NCT06150014|Entecavir|entecavir|mesh-list
138811696|NCT06150014|Antiviral Agents|antiviral agents|mesh-ancestor
138811697|NCT06150014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811698|NCT06150014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138811701|NCT06150014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811703|NCT06150014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138811704|NCT06135103|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138811705|NCT06135103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138811706|NCT06135103|Vasodilator Agents|vasodilator agents|mesh-ancestor
138811707|NCT06123338|Pembrolizumab|pembrolizumab|mesh-list
138811708|NCT06123338|Trastuzumab|trastuzumab|mesh-list
138811709|NCT06123338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138811710|NCT06123338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811711|NCT06123338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138811712|NCT06123338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811713|NCT06114407|Tofacitinib|tofacitinib|mesh-list
138811714|NCT06114407|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138811715|NCT06114407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138811716|NCT06114407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811717|NCT06114407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463695|NCT01947114|Ketamine|ketamine|mesh-list
138811721|NCT06111443|Dapagliflozin|dapagliflozin|mesh-list
138811722|NCT06111443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138811723|NCT06111443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811725|NCT06111443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811726|NCT06082167|Pembrolizumab|pembrolizumab|mesh-list
138811727|NCT06082167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138811728|NCT06082167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811729|NCT06082167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138811730|NCT06082167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811731|NCT06077877|Niraparib|niraparib|mesh-list
138811732|NCT06077877|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138811733|NCT06077877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811734|NCT06077877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811735|NCT06077877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811736|NCT06069869|Iron|iron|mesh-list
138811737|NCT06069869|Trace Elements|trace elements|mesh-list
138811738|NCT06069869|Micronutrients|micronutrients|mesh-list
138811739|NCT06069869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811740|NCT06017479|Levofloxacin|levofloxacin|mesh-list
138811741|NCT06017479|Fosfomycin|fosfomycin|mesh-list
138811742|NCT06017479|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138811743|NCT06017479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811744|NCT06017479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138811745|NCT06017479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138811746|NCT06017479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138811747|NCT06017479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811748|NCT06017479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811749|NCT06017479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811750|NCT06017479|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138811751|NCT06017479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138425714|NCT01150045|Vitamins|vitamins|mesh-ancestor
138811752|NCT06016920|Pembrolizumab|pembrolizumab|mesh-list
138811753|NCT06016920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138811754|NCT06016920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811755|NCT06016920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138811756|NCT06016920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650339|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
138811757|NCT05995444|Moxifloxacin|moxifloxacin|mesh-list
138811758|NCT05995444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138811759|NCT05995444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811760|NCT05995444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138811761|NCT05995444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138811762|NCT05995444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811763|NCT05995444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811764|NCT05995444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811765|NCT05975268|Antibodies|antibodies|mesh-list
138811766|NCT05975268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138811767|NCT05975268|Immunologic Factors|immunologic factors|mesh-ancestor
138811768|NCT05975268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811769|NCT05932667|Fulvestrant|fulvestrant|mesh-list
138811770|NCT05932667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138811771|NCT05932667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811772|NCT05932667|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138811773|NCT05932667|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138811774|NCT05932667|Hormone Antagonists|hormone antagonists|mesh-ancestor
138811775|NCT05932667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138811776|NCT05932667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811777|NCT05930938|Cetuximab|cetuximab|mesh-list
138811778|NCT05930938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138811779|NCT05930938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811780|NCT05917340|Aspirin|aspirin|mesh-list
138811781|NCT05917340|Moxifloxacin|moxifloxacin|mesh-list
138811782|NCT05917340|Rifampin|rifampin|mesh-list
138811784|NCT05917340|Pyrazinamide|pyrazinamide|mesh-list
138811785|NCT05917340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138811786|NCT05917340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138811787|NCT05917340|Analgesics|analgesics|mesh-ancestor
138811788|NCT05917340|Sensory System Agents|sensory system agents|mesh-ancestor
138811789|NCT05917340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811790|NCT05917340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811791|NCT05917340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138811792|NCT05917340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811793|NCT05917340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138811794|NCT05917340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138643453|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811795|NCT05917340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811796|NCT05917340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138811797|NCT05917340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138811798|NCT05917340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811800|NCT05917340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138811801|NCT05917340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811802|NCT05917340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138811803|NCT05917340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138811804|NCT05917340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811805|NCT05917340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138811806|NCT05917340|Antitubercular Agents|antitubercular agents|mesh-ancestor
138811807|NCT05917340|Leprostatic Agents|leprostatic agents|mesh-ancestor
138811808|NCT05917340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138811809|NCT05917340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138811810|NCT05917340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138811811|NCT05917340|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138425729|NCT01098032|Expectorants|expectorants|mesh-ancestor
138650395|NCT00328302|Candesartan|candesartan|mesh-list
138811812|NCT05917340|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138811813|NCT05917340|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138811814|NCT05917340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138811815|NCT05917340|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138811817|NCT05917340|Antimetabolites|antimetabolites|mesh-ancestor
138811818|NCT05917340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138811819|NCT05902819|Minocycline|minocycline|mesh-list
138811820|NCT05902819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138650413|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
138650415|NCT00302705|Valsartan|valsartan|mesh-list
138811821|NCT05902819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811822|NCT05901051|Amoxicillin|amoxicillin|mesh-list
138811823|NCT05901051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138811824|NCT05901051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811825|NCT05840510|Sirolimus|sirolimus|mesh-list
138811826|NCT05840510|Adagrasib|adagrasib|mesh-list
138811827|NCT05840510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138811828|NCT05840510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138811829|NCT05840510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138811830|NCT05840510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811831|NCT05840510|Antifungal Agents|antifungal agents|mesh-ancestor
138811832|NCT05840510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138811833|NCT05840510|Immunologic Factors|immunologic factors|mesh-ancestor
138811834|NCT05840510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811835|NCT05827978|Vaccines|vaccines|mesh-list
138811836|NCT05827978|Immunologic Factors|immunologic factors|mesh-ancestor
138811837|NCT05827978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811838|NCT05827055|Paclitaxel|paclitaxel|mesh-list
138811839|NCT05827055|Gemcitabine|gemcitabine|mesh-list
138811840|NCT05827055|Proglumide|proglumide|mesh-list
138811841|NCT05827055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138811842|NCT05827055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811843|NCT05827055|Tubulin Modulators|tubulin modulators|mesh-ancestor
138643466|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138811845|NCT05827055|Mitosis Modulators|mitosis modulators|mesh-ancestor
138811846|NCT05827055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811847|NCT05827055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138811848|NCT05827055|Antimetabolites|antimetabolites|mesh-ancestor
138811849|NCT05827055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138811850|NCT05827055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138811851|NCT05798156|Rituximab|rituximab|mesh-list
138811852|NCT05798156|Obinutuzumab|obinutuzumab|mesh-list
138811853|NCT05798156|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138811854|NCT05798156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138811855|NCT05798156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811856|NCT05798156|Immunologic Factors|immunologic factors|mesh-ancestor
138811857|NCT05798156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811858|NCT05798156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811859|NCT05798156|Immunoconjugates|immunoconjugates|mesh-ancestor
138811860|NCT05778825|Minoxidil|minoxidil|mesh-list
138811861|NCT05778825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138811862|NCT05778825|Vasodilator Agents|vasodilator agents|mesh-ancestor
138811864|NCT05774899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811865|NCT05774899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138811866|NCT05774899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650477|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811867|NCT05774899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811868|NCT05767047|Apremilast|apremilast|mesh-list
138811869|NCT05767047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138811870|NCT05767047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138811871|NCT05767047|Analgesics|analgesics|mesh-ancestor
138811872|NCT05767047|Sensory System Agents|sensory system agents|mesh-ancestor
138811873|NCT05767047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811874|NCT05767047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811875|NCT05767047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138811876|NCT05767047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811877|NCT05767047|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138811878|NCT05767047|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138811879|NCT05767047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811880|NCT05767047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811881|NCT05718024|Dexmedetomidine|dexmedetomidine|mesh-list
138811882|NCT05718024|Remifentanil|remifentanil|mesh-list
138811883|NCT05718024|Propofol|propofol|mesh-list
138811884|NCT05718024|Esketamine|esketamine|mesh-list
138811885|NCT05718024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138811886|NCT05718024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138811887|NCT05718024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811888|NCT05718024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138811889|NCT05718024|Analgesics|analgesics|mesh-ancestor
138811890|NCT05718024|Sensory System Agents|sensory system agents|mesh-ancestor
138811891|NCT05718024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811892|NCT05718024|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138811893|NCT05718024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138811894|NCT05718024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138811895|NCT05718024|Adrenergic Agents|adrenergic agents|mesh-ancestor
138811896|NCT05718024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138811907|NCT05700266|Clopidogrel|clopidogrel|mesh-list
138811908|NCT05700266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138811909|NCT05700266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138811910|NCT05700266|Analgesics|analgesics|mesh-ancestor
138643491|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
138811911|NCT05700266|Sensory System Agents|sensory system agents|mesh-ancestor
138811912|NCT05700266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138811913|NCT05700266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811914|NCT05700266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138811915|NCT05700266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811916|NCT05700266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138811917|NCT05700266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138811918|NCT05700266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811919|NCT05700266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138650509|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
138811920|NCT05700266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138811921|NCT05700266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138811922|NCT05700266|Antipyretics|antipyretics|mesh-ancestor
138811923|NCT05700266|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138811924|NCT05700266|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138811925|NCT05700266|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138811926|NCT05700266|Purinergic Agents|purinergic agents|mesh-ancestor
138811927|NCT05700266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138811928|NCT05700266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138811929|NCT05700266|Antithrombins|antithrombins|mesh-ancestor
138811930|NCT05700266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138811931|NCT05700266|Protease Inhibitors|protease inhibitors|mesh-ancestor
138811932|NCT05700266|Anticoagulants|anticoagulants|mesh-ancestor
138811943|NCT05671757|Daratumumab|daratumumab|mesh-list
138463922|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
138811944|NCT05671757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138811945|NCT05671757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811946|NCT05671757|Immunologic Factors|immunologic factors|mesh-ancestor
138811947|NCT05671757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811948|NCT05661149|Insulin|insulin|mesh-list
138811949|NCT05661149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138811950|NCT05661149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811951|NCT05546515|Suvorexant|suvorexant|mesh-list
138811952|NCT05546515|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-list
138811953|NCT05546515|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138811954|NCT05546515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138811955|NCT05546515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138811956|NCT05546515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811957|NCT05546515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138811958|NCT05546515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811959|NCT05451849|Cyclophosphamide|cyclophosphamide|mesh-list
138811960|NCT05451849|Fludarabine|fludarabine|mesh-list
138811961|NCT05451849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138811962|NCT05451849|Immunologic Factors|immunologic factors|mesh-ancestor
138811963|NCT05451849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811964|NCT05451849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138811965|NCT05451849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138811966|NCT05451849|Alkylating Agents|alkylating agents|mesh-ancestor
138811967|NCT05451849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811968|NCT05451849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811969|NCT05451849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138811970|NCT05438329|Pembrolizumab|pembrolizumab|mesh-list
138643501|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138811971|NCT05438329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138811972|NCT05438329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138811973|NCT05438329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138811974|NCT05438329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811975|NCT05416125|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138811976|NCT05416125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138811977|NCT05416125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811978|NCT05416125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138650540|NCT00419835|Losartan|losartan|mesh-list
138811979|NCT05416125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138425796|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138811980|NCT05416125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138811981|NCT05416125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811982|NCT05416125|Dopamine Agents|dopamine agents|mesh-ancestor
138811983|NCT05416125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138811984|NCT05315648|Anesthetics|anesthetics|mesh-list
138811985|NCT05315648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138811986|NCT05315648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138811987|NCT05304455|Heparin|heparin|mesh-list
138811988|NCT05304455|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138811989|NCT05304455|Tinzaparin|tinzaparin|mesh-list
138811990|NCT05304455|Dalteparin|dalteparin|mesh-list
138811991|NCT05304455|Dipyridamole|dipyridamole|mesh-list
138811992|NCT05304455|Apixaban|apixaban|mesh-list
138811993|NCT05304455|Anticoagulants|anticoagulants|mesh-ancestor
138811994|NCT05304455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138811995|NCT05304455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138811996|NCT05304455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138811997|NCT05304455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138811998|NCT05304455|Antithrombins|antithrombins|mesh-ancestor
138811999|NCT05304455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138812000|NCT05304455|Protease Inhibitors|protease inhibitors|mesh-ancestor
138812001|NCT05304455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812002|NCT05304455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138812003|NCT05304455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138812004|NCT05304455|Vasodilator Agents|vasodilator agents|mesh-ancestor
138812005|NCT05279937|Lidocaine|lidocaine|mesh-list
138812006|NCT05279937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138812007|NCT05279937|Anesthetics, Local|anesthetics, local|mesh-ancestor
138812008|NCT05279937|Anesthetics|anesthetics|mesh-ancestor
138812009|NCT05279937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138812010|NCT05279937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812011|NCT05279937|Sensory System Agents|sensory system agents|mesh-ancestor
138812012|NCT05279937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812013|NCT05279937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138812014|NCT05279937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138812015|NCT05279937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138812016|NCT05279937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138466698|NCT01961453|Isosorbide|isosorbide|mesh-list
138812023|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138812024|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
138650559|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
138812025|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138812026|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812027|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812028|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
138812029|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
138812030|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812031|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138812032|NCT05157126|Gentamicins|gentamicins|mesh-list
138812033|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138812034|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138812035|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138812036|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812037|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812039|NCT05153668|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138812040|NCT05153668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138812041|NCT05153668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812042|NCT05153668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812043|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138812044|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
138812045|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812046|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812047|NCT05119855|Vaccines|vaccines|mesh-list
138812048|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
138812049|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812055|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
138812056|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138812057|NCT05058872|Estradiol|estradiol|mesh-list
138812058|NCT05058872|Estrogens|estrogens|mesh-ancestor
138812059|NCT05058872|Hormones|hormones|mesh-ancestor
138812060|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138812061|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812062|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138812063|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
138812064|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138812065|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138812066|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138812067|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138812068|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138812069|NCT05049057|Erenumab|erenumab|mesh-list
138812070|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138812071|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812072|NCT05049057|Analgesics|analgesics|mesh-ancestor
138812073|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
138812074|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812075|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812076|NCT05042128|Paclitaxel|paclitaxel|mesh-list
138812077|NCT05042128|Gemcitabine|gemcitabine|mesh-list
138466710|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138812078|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138812079|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812080|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
138812081|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
138812082|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
138812083|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812084|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138812085|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
138812086|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
138812087|NCT05040568|Fludarabine|fludarabine|mesh-list
138812088|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
138812089|NCT05040568|Cetuximab|cetuximab|mesh-list
138812090|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138812091|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
138812092|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812093|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138812094|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138812095|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
138812096|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812097|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812098|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138812099|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138812100|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
138812101|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812102|NCT05033080|Ivacaftor|ivacaftor|mesh-list
138812103|NCT05033080|Elexacaftor|elexacaftor|mesh-list
138812104|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138812105|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138812106|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812107|NCT05022901|Melphalan|melphalan|mesh-list
138812108|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138812109|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
138812110|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812111|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812112|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138812113|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138812114|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
138812115|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812116|NCT05010122|Decitabine|decitabine|mesh-list
138812117|NCT05010122|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138812118|NCT05010122|Venetoclax|venetoclax|mesh-list
138812119|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138812120|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
138812121|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812122|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812123|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812124|NCT04989946|Nivolumab|nivolumab|mesh-list
138812125|NCT04989946|Cemiplimab|cemiplimab|mesh-list
138812126|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812127|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650619|NCT00304226|Amlodipine|amlodipine|mesh-list
138650620|NCT00304226|Valsartan|valsartan|mesh-list
138812128|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138812129|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812130|NCT04966702|Ivermectin|ivermectin|mesh-list
138812131|NCT04966702|Albendazole|albendazole|mesh-list
138812132|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138812133|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138812134|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
138812135|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
138812136|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138812137|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138812138|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
138812139|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
138812140|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
138466724|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812151|NCT04933084|Narcotics|narcotics|mesh-ancestor
138812152|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138812153|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812154|NCT04933084|Analgesics|analgesics|mesh-ancestor
138812155|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
138812156|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812168|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138812169|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138812171|NCT04903119|Dabrafenib|dabrafenib|mesh-list
138812172|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812173|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138812181|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138812182|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812183|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138812184|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812186|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
138812187|NCT04777643|Cannabidiol|cannabidiol|mesh-list
138812188|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
138812189|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
138812190|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138812191|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138812192|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138812193|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138812194|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138812195|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812196|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
138650642|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812197|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138812198|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812199|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138812200|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812208|NCT04746235|Decitabine|decitabine|mesh-list
138812209|NCT04746235|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138812210|NCT04746235|Venetoclax|venetoclax|mesh-list
138812211|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138812212|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
138812213|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812214|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812215|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812216|NCT04714190|Paclitaxel|paclitaxel|mesh-list
138812217|NCT04714190|Irinotecan|irinotecan|mesh-list
138812218|NCT04714190|Apatinib|apatinib|mesh-list
138812219|NCT04714190|Trastuzumab|trastuzumab|mesh-list
138812220|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138812221|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812222|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
138812223|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
138812224|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
138812225|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812226|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138812227|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138812228|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812229|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138812230|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812231|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
138812232|NCT04664972|Docetaxel|docetaxel|mesh-list
138812233|NCT04664972|Doxorubicin|doxorubicin|mesh-list
138812234|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138812235|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
138812236|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650680|NCT00304499|Urological Agents|urological agents|mesh-ancestor
138812237|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138812238|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138812239|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
138812240|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812241|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812242|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138812243|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
138812244|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
138812245|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
138812246|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138812247|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138425910|NCT01694576|Paclitaxel|paclitaxel|mesh-list
138812248|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138643593|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
138812249|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812250|NCT04655755|Decitabine|decitabine|mesh-list
138812251|NCT04655755|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138812252|NCT04655755|Venetoclax|venetoclax|mesh-list
138812253|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138812254|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
138812255|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812256|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812257|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812258|NCT04645550|Aspirin|aspirin|mesh-list
138812259|NCT04645550|Heparin|heparin|mesh-list
138812260|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138812261|NCT04645550|Tinzaparin|tinzaparin|mesh-list
138812262|NCT04645550|Dalteparin|dalteparin|mesh-list
138812263|NCT04645550|Dipyridamole|dipyridamole|mesh-list
138812264|NCT04645550|Warfarin|warfarin|mesh-list
138812265|NCT04645550|Apixaban|apixaban|mesh-list
138812266|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138812267|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138650723|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
138812268|NCT04645550|Analgesics|analgesics|mesh-ancestor
138812269|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
138812270|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812271|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812272|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138812273|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138812274|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138812275|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138812276|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812277|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138812278|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138812279|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812280|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
138812281|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
138812282|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138812283|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
138812284|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138812285|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
138812286|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138812287|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
138812288|NCT04592744|Vasopressins|vasopressins|mesh-list
138812289|NCT04592744|Epinephrine|epinephrine|mesh-list
138812290|NCT04592744|Norepinephrine|norepinephrine|mesh-list
138812291|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
138812292|NCT04592744|Giapreza|giapreza|mesh-list
138812293|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
138812294|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138812295|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138812296|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
138812297|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138812298|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466782|NCT01962116|Calcium heparin|calcium heparin|mesh-list
138812301|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138812302|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
138425950|NCT01695005|Hormones|hormones|mesh-ancestor
138650770|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812303|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812304|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138812305|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
138812306|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
138812307|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
138812308|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138812309|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
138812310|NCT04592744|Coagulants|coagulants|mesh-ancestor
138812311|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138812312|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
138812313|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138812314|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
138812315|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812316|NCT04592237|Carboplatin|carboplatin|mesh-list
138812317|NCT04592237|Niraparib|niraparib|mesh-list
138812318|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812319|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138812320|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812321|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812322|NCT04588285|Ambroxol|ambroxol|mesh-list
138812323|NCT04588285|Expectorants|expectorants|mesh-ancestor
138812324|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
138812325|NCT04567160|Propofol|propofol|mesh-list
138812326|NCT04567160|Sevoflurane|sevoflurane|mesh-list
138812327|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138812328|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138812329|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812330|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138812331|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
138812332|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
138812333|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138812334|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138812335|NCT04530058|Metformin|metformin|mesh-list
138812336|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138812337|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812338|NCT04526236|Methadone|methadone|mesh-list
138812339|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138812340|NCT04526236|Narcotics|narcotics|mesh-ancestor
138812341|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138812342|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812343|NCT04526236|Analgesics|analgesics|mesh-ancestor
138812344|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
138812345|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812346|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
138812347|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
138812350|NCT04521348|Antibodies|antibodies|mesh-list
138812351|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
138812352|NCT04521348|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138650809|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812353|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
138812354|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812355|NCT04521348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138812356|NCT04521348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812357|NCT04521348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812358|NCT04477486|Venetoclax|venetoclax|mesh-list
138812359|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812360|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138812361|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138812362|NCT04457596|Trastuzumab|trastuzumab|mesh-list
138812363|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138812364|NCT04457596|Maytansine|maytansine|mesh-list
138812365|NCT04457596|Tucatinib|tucatinib|mesh-list
138812366|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812367|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812368|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138812369|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
138812370|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
138812371|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
138812372|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812373|NCT04457596|Immunotoxins|immunotoxins|mesh-ancestor
138812374|NCT04457596|Immunoconjugates|immunoconjugates|mesh-ancestor
138812375|NCT04457596|Immunologic Factors|immunologic factors|mesh-ancestor
138812376|NCT04457596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812377|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138812378|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812379|NCT04425629|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
138812380|NCT04425629|Antiviral Agents|antiviral agents|mesh-ancestor
138812381|NCT04425629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138812382|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
138812383|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812384|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812385|NCT04317066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138812386|NCT04317066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812387|NCT04292743|Leucovorin|leucovorin|mesh-list
138812388|NCT04292743|Fluorouracil|fluorouracil|mesh-list
138812389|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
138812390|NCT04292743|Irinotecan|irinotecan|mesh-list
138812391|NCT04292743|Folfirinox|folfirinox|mesh-list
138812392|NCT04292743|Eryaspase|eryaspase|mesh-list
138812393|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
138812394|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812395|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138812396|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812397|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138812398|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
138650844|NCT00304850|Ketamine|ketamine|mesh-list
138812399|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812400|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138812401|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138812402|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812403|NCT04292743|Antidotes|antidotes|mesh-ancestor
138812404|NCT04292743|Protective Agents|protective agents|mesh-ancestor
138812405|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
138812407|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
138812408|NCT04267939|Niraparib|niraparib|mesh-list
138812409|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138812410|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812411|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812412|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812413|NCT04251819|Baclofen|baclofen|mesh-list
138812414|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138812415|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812416|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138812417|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812418|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138812419|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
138812420|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
138812421|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138812422|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812423|NCT04232969|Exenatide|exenatide|mesh-list
138812424|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138812425|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812426|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138812427|NCT04232969|Incretins|incretins|mesh-ancestor
138812428|NCT04232969|Hormones|hormones|mesh-ancestor
138812429|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138812430|NCT04230148|Triclabendazole|triclabendazole|mesh-list
138812431|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138812432|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
138812433|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138812434|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138812435|NCT04091022|Eflornithine|eflornithine|mesh-list
138812436|NCT04091022|Diclofenac|diclofenac|mesh-list
138812437|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138812438|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138812439|NCT04091022|Analgesics|analgesics|mesh-ancestor
138812440|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
138812441|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812442|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812443|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138812444|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138812445|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138812446|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812447|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650864|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138812448|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812449|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138812450|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138812451|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138812452|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426089|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
138812453|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138812455|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
138812456|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
138812457|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812458|NCT04028063|Doxorubicin|doxorubicin|mesh-list
138812459|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138812460|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812461|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138812462|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138812463|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812464|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812465|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
138812466|NCT04024462|Docetaxel|docetaxel|mesh-list
138812467|NCT04024462|Doxorubicin|doxorubicin|mesh-list
138812468|NCT04024462|Trastuzumab|trastuzumab|mesh-list
138812469|NCT04024462|Pertuzumab|pertuzumab|mesh-list
138812470|NCT04024462|Hormones|hormones|mesh-list
138812471|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138812472|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
138812473|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812474|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138812475|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138812476|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
138812477|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812478|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812479|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138812480|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
138812481|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
138812482|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
138812483|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138812484|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138812485|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138812486|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812487|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812488|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138812490|NCT03964532|Talazoparib|talazoparib|mesh-list
138812491|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812492|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812493|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138812494|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812495|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812496|NCT03934372|Ponatinib|ponatinib|mesh-list
138812497|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812498|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138812499|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812500|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812501|NCT03929601|Rituximab|rituximab|mesh-list
138812502|NCT03929601|Abatacept|abatacept|mesh-list
138812503|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812504|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138650910|NCT00329394|Ketamine|ketamine|mesh-list
138812505|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
138812506|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812507|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138812508|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138812509|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812510|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138812511|NCT03854903|Fulvestrant|fulvestrant|mesh-list
138812512|NCT03854903|Palbociclib|palbociclib|mesh-list
138812513|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138812514|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812515|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138812516|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138812517|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
138812518|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138812519|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812520|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138812521|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812522|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812523|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
138812524|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138812525|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138812526|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812527|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
138812528|NCT03849443|Coagulants|coagulants|mesh-ancestor
138812529|NCT03843359|Dostarlimab|dostarlimab|mesh-list
138812530|NCT03843359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812531|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138812532|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
138812533|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812534|NCT03803202|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138812535|NCT03803202|Immunologic Factors|immunologic factors|mesh-ancestor
138812536|NCT03803202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812537|NCT03692325|Nivolumab|nivolumab|mesh-list
138812538|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812539|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812540|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138812541|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812542|NCT03662659|Nivolumab|nivolumab|mesh-list
138812543|NCT03662659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812544|NCT03662659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812545|NCT03662659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138812546|NCT03662659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812547|NCT03646123|Doxorubicin|doxorubicin|mesh-list
138812548|NCT03646123|Nivolumab|nivolumab|mesh-list
138812550|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138812551|NCT03646123|Vinblastine|vinblastine|mesh-list
138812552|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138812553|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643672|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
138812554|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138812555|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138812556|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812557|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812558|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812559|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138812560|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138812561|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
138812562|NCT03646123|Immunotoxins|immunotoxins|mesh-ancestor
138812563|NCT03646123|Immunoconjugates|immunoconjugates|mesh-ancestor
138812564|NCT03646123|Immunologic Factors|immunologic factors|mesh-ancestor
138812565|NCT03646123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812566|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138812567|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
138812568|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
138812569|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
138812570|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
138812572|NCT03642509|Edoxaban|edoxaban|mesh-list
138812573|NCT03642509|Dabigatran|dabigatran|mesh-list
138812574|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138812575|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
138812576|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138812577|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
138812578|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812579|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812580|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
138812581|NCT03641560|Androgens|androgens|mesh-list
138812582|NCT03641560|Hormones|hormones|mesh-ancestor
138812583|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138812584|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812585|NCT03640481|Belumosudil|belumosudil|mesh-list
138426207|NCT01697059|Amoxicillin|amoxicillin|mesh-list
138812586|NCT03640481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138812587|NCT03640481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466871|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
138650940|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
138812588|NCT03640481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812589|NCT03603808|Vaccines|vaccines|mesh-list
138812590|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
138812591|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812592|NCT03564691|Paclitaxel|paclitaxel|mesh-list
138812593|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138812594|NCT03564691|Cisplatin|cisplatin|mesh-list
138812595|NCT03564691|Carboplatin|carboplatin|mesh-list
138812596|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
138812597|NCT03564691|Pemetrexed|pemetrexed|mesh-list
138812598|NCT03564691|Lenvatinib|lenvatinib|mesh-list
138812599|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138812600|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812601|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
138812602|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
138812603|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
138812604|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812605|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812606|NCT03564691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138812607|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812608|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138812609|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138812610|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138812611|NCT03554317|Nivolumab|nivolumab|mesh-list
138812612|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
138812613|NCT03554317|Testosterone|testosterone|mesh-list
138812614|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
138812616|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138812617|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812618|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812619|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138812620|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812621|NCT03554317|Androgens|androgens|mesh-ancestor
138812622|NCT03554317|Hormones|hormones|mesh-ancestor
138812623|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138812624|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812625|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138812626|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
138812627|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
138812628|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812629|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812630|NCT03454451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138650983|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
138812631|NCT03454451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812632|NCT03384654|Cytarabine|cytarabine|mesh-list
138812633|NCT03384654|Prednisone|prednisone|mesh-list
138812634|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
138812635|NCT03384654|Doxorubicin|doxorubicin|mesh-list
138812636|NCT03384654|Methotrexate|methotrexate|mesh-list
138812637|NCT03384654|Vincristine|vincristine|mesh-list
138812638|NCT03384654|Asparaginase|asparaginase|mesh-list
138812640|NCT03384654|Daratumumab|daratumumab|mesh-list
138812641|NCT03384654|Pegaspargase|pegaspargase|mesh-list
138812642|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138812643|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
138812644|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466891|NCT01963442|Lactams|lactams|mesh-list
138812645|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138812646|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138812647|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
138812648|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812649|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812650|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138812651|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138812652|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138812653|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138812654|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812655|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138812656|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
138812657|NCT03384654|Hormones|hormones|mesh-ancestor
138812658|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138812659|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138812660|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138812661|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
138812662|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138812663|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138812664|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
138812665|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
138812666|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138812667|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138812668|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
138643698|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138812669|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138812670|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138812671|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
138812672|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
138812673|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
138812674|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
138812675|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812676|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812677|NCT03319940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138812678|NCT03319940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812679|NCT03219268|Margetuximab|margetuximab|mesh-list
138812680|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812681|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
138812682|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812683|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812684|NCT03153202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138812685|NCT03153202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812686|NCT03108131|Atezolizumab|atezolizumab|mesh-list
138812687|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138812688|NCT03108131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138812689|NCT03108131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812690|NCT03108131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812691|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812692|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
138812693|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812694|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138812695|NCT03087071|Panitumumab|panitumumab|mesh-list
138812696|NCT03087071|Trametinib|trametinib|mesh-list
138812697|NCT03087071|Antibodies|antibodies|mesh-list
138812698|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
138464662|NCT05874882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138812699|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138812700|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
138812701|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812702|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812703|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138812704|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812705|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812706|NCT03085485|Ivacaftor|ivacaftor|mesh-list
138812707|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138812708|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138812709|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812710|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
138812711|NCT03071861|Hematinics|hematinics|mesh-ancestor
138812712|NCT03043872|Carboplatin|carboplatin|mesh-list
138651052|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812713|NCT03043872|Etoposide|etoposide|mesh-list
138812714|NCT03043872|Durvalumab|durvalumab|mesh-list
138812715|NCT03043872|Tremelimumab|tremelimumab|mesh-list
138812716|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812717|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138812718|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138812719|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138812720|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812721|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812722|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812723|NCT03015610|Lansoprazole|lansoprazole|mesh-list
138812725|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138812726|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138812727|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138812728|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812729|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812730|NCT03012529|Riboflavin|riboflavin|mesh-list
138812731|NCT03012529|Rifampin|rifampin|mesh-list
138812732|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138812733|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
138812734|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138812735|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138812737|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138812738|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812739|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812740|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138812741|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138812742|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138812743|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138812744|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138812745|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138812746|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
138812747|NCT03012529|Vitamins|vitamins|mesh-ancestor
138812748|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
138812749|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812750|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138812751|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
138812752|NCT03005860|Fentanyl|fentanyl|mesh-list
138812753|NCT03005860|Propofol|propofol|mesh-list
138812754|NCT03005860|Sevoflurane|sevoflurane|mesh-list
138812755|NCT03005860|Atracurium|atracurium|mesh-list
138812756|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138812757|NCT03005860|Narcotics|narcotics|mesh-ancestor
138812758|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138812759|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812760|NCT03005860|Analgesics|analgesics|mesh-ancestor
138812761|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
138812762|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812763|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138812764|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138812765|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
138812766|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
138812767|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812768|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138812769|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138812770|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138812771|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138812772|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138812773|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138812774|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138812775|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
138812776|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138812777|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138812778|NCT02928224|Leucovorin|leucovorin|mesh-list
138812779|NCT02928224|Folic Acid|folic acid|mesh-list
138812780|NCT02928224|Fluorouracil|fluorouracil|mesh-list
138812781|NCT02928224|Irinotecan|irinotecan|mesh-list
138812782|NCT02928224|Cetuximab|cetuximab|mesh-list
138812783|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
138812784|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
138812785|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426384|NCT01698164|Estradiol|estradiol|mesh-list
138812786|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138812787|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812788|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138812789|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
138812790|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812791|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138812792|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138812793|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812794|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812795|NCT02928224|Antidotes|antidotes|mesh-ancestor
138812796|NCT02928224|Protective Agents|protective agents|mesh-ancestor
138812797|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
138812798|NCT02928224|Vitamins|vitamins|mesh-ancestor
138812799|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
138812800|NCT02928224|Hematinics|hematinics|mesh-ancestor
138812801|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138812802|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138812803|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138812804|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138812805|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812806|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812807|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
138812808|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138812809|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138812810|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138812811|NCT02788474|Nintedanib|nintedanib|mesh-list
138812812|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812813|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138812814|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651107|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
138651108|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138651110|NCT00329823|Etanercept|etanercept|mesh-list
138812815|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812816|NCT02720445|Nicotine|nicotine|mesh-list
138812817|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138812818|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
138812819|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812820|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812821|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138812822|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138812823|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
138812824|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138812825|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812826|NCT02678572|Melphalan|melphalan|mesh-list
138812827|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138812828|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
138426394|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138812829|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812830|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812831|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138812832|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138812833|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
138812834|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812836|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812837|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812838|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138812839|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812840|NCT02293655|Methylphenidate|methylphenidate|mesh-list
138812841|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138812842|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812843|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138812844|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138812845|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138812846|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464818|NCT05786040|Rituximab|rituximab|mesh-list
138812847|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
138812848|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138812850|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
138812851|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138466984|NCT01963910|Mannitol|mannitol|mesh-list
138812852|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138812854|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
138812855|NCT02166463|Cortisone|cortisone|mesh-list
138812856|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
138812857|NCT02166463|Doxorubicin|doxorubicin|mesh-list
138812858|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138812859|NCT02166463|Etoposide|etoposide|mesh-list
138812860|NCT02166463|Vincristine|vincristine|mesh-list
138812861|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
138812862|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138812863|NCT02166463|Bleomycin|bleomycin|mesh-list
138812864|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
138812865|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138812866|NCT02166463|Antibodies|antibodies|mesh-list
138812867|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
138812868|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138812869|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138812870|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
138812871|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
138812872|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138812873|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
138812874|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812875|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138812876|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138812877|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
138812878|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812879|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812880|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138426425|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
138812881|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138812882|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138812883|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138812885|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138812886|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
138812887|NCT02166463|Hormones|hormones|mesh-ancestor
138812888|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138812889|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138812890|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138812891|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
138812892|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
138812893|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
138812894|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
138812895|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
138812896|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812897|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138812898|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138812899|NCT02166463|Protective Agents|protective agents|mesh-ancestor
138812900|NCT02166463|Immunotoxins|immunotoxins|mesh-ancestor
138467000|NCT01964001|Vitamins|vitamins|mesh-list
138812901|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
138812902|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
138812904|NCT02118467|Vasopressins|vasopressins|mesh-list
138812905|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
138812906|NCT02118467|Epinephrine|epinephrine|mesh-list
138812907|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
138812908|NCT02118467|Norepinephrine|norepinephrine|mesh-list
138812909|NCT02118467|Synephrine|synephrine|mesh-list
138812910|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138812911|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138812912|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
138812913|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138812914|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812915|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812916|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138812917|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138812918|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
138812919|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812920|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138812921|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
138812922|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
138812923|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
138812924|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138812925|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138812926|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
138426449|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138812927|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138812928|NCT02118467|Protective Agents|protective agents|mesh-ancestor
138812930|NCT02118467|Coagulants|coagulants|mesh-ancestor
138812931|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138812932|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
138812933|NCT02101034|Cetuximab|cetuximab|mesh-list
138812934|NCT02101034|Palbociclib|palbociclib|mesh-list
138812935|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138812936|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812937|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138812938|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812939|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812941|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138812942|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812943|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812944|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812945|NCT00965991|Metformin|metformin|mesh-list
138812946|NCT00965991|Glyburide|glyburide|mesh-list
138812947|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138812948|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812949|NCT00798135|Itraconazole|itraconazole|mesh-list
138812950|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
138812951|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138812952|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138812953|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138812954|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812955|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812956|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138812957|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
138812958|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138643845|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
138812959|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812960|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138812961|NCT00782574|Olaparib|olaparib|mesh-list
138812962|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812963|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138812964|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426481|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138812965|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812966|NCT00579969|Timolol|timolol|mesh-list
138812967|NCT00579969|Latanoprost|latanoprost|mesh-list
138812968|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138812969|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138812970|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
138812971|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138812972|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812973|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812974|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138812975|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138812976|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138812977|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138812978|NCT00135226|Aspirin|aspirin|mesh-list
138812979|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138812981|NCT00135226|Analgesics|analgesics|mesh-ancestor
138812982|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
138812983|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138812984|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812985|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138812986|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138812987|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138812988|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138812989|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138812990|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138812991|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138812992|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138812993|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
138812994|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138812995|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
138812996|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138812997|NCT02742675|Leuprolide|leuprolide|mesh-list
138812998|NCT02742675|Goserelin|goserelin|mesh-list
138464967|NCT04994431|Tamsulosin|tamsulosin|mesh-list
138813000|NCT02742675|Flutamide|flutamide|mesh-list
138813001|NCT02742675|Bicalutamide|bicalutamide|mesh-list
138813002|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138813003|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
138813004|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138813005|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813006|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138813007|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813008|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
138813010|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813011|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
138813012|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138813013|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
138813014|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138813015|NCT00812812|Paroxetine|paroxetine|mesh-list
138813016|NCT00812812|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138813017|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138813018|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138813019|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813020|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813021|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
138813022|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813023|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138813024|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
138813025|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138813026|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138813027|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138813028|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813029|NCT02742285|Lumefantrine|lumefantrine|mesh-list
138813030|NCT02742285|Artemether|artemether|mesh-list
138813031|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138813032|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
138813033|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138813034|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138813035|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813036|NCT03673527|Tacrolimus|tacrolimus|mesh-list
138813037|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138813038|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
138813039|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813040|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138813041|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813042|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813043|NCT02738931|Lamivudine|lamivudine|mesh-list
138813044|NCT02738931|Dolutegravir|dolutegravir|mesh-list
138813045|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138813046|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138813047|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813048|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813049|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
138813050|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813051|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138813052|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138813053|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138813054|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138813055|NCT02738619|Vitamin D|vitamin d|mesh-list
138813056|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
138813057|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
138813058|NCT02738619|Vitamins|vitamins|mesh-list
138813059|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
138813060|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813061|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138813062|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138813064|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138813065|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813066|NCT04016116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138813067|NCT04016116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813068|NCT02736591|Hormones|hormones|mesh-list
138813069|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
138813070|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138465032|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138813072|NCT02736513|Osimertinib|osimertinib|mesh-list
138813073|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467115|NCT01964391|Docetaxel|docetaxel|mesh-list
138467116|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
138813074|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138813075|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813076|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813077|NCT02736435|Leuprolide|leuprolide|mesh-list
138813078|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138651286|NCT00451373|Vancomycin|vancomycin|mesh-list
138813079|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
138813080|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138813081|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813082|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138813083|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813084|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138813085|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
138813086|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138813087|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
138813088|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813089|NCT00748189|Ofatumumab|ofatumumab|mesh-list
138813090|NCT00748189|Chlorambucil|chlorambucil|mesh-list
138813091|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813092|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138813093|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
138813094|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813095|NCT02609230|TIC10 compound|tic10 compound|mesh-list
138813096|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813097|NCT00913822|Desipramine|desipramine|mesh-list
138813098|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138813099|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
138813100|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138813101|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813102|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813103|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138813104|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138813105|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138813106|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
138813107|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813108|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813109|NCT02736123|Nivolumab|nivolumab|mesh-list
138813110|NCT02736123|Ipilimumab|ipilimumab|mesh-list
138813111|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138813112|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813113|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138467158|NCT01964573|Rotigotine|rotigotine|mesh-list
138813114|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813116|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138813117|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138813118|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138813119|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138813120|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
138813121|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813122|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813123|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813124|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
138813125|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138813126|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138813127|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813128|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
138813129|NCT02738073|Coagulants|coagulants|mesh-ancestor
138813130|NCT03967483|Indomethacin|indomethacin|mesh-list
138813131|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138426615|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138813132|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138813133|NCT03967483|Analgesics|analgesics|mesh-ancestor
138813134|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
138813135|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813136|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813137|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138813138|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138813139|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
138813140|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
138813141|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138813142|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138813143|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813144|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813146|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138813147|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138813148|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138813149|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
138813150|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813151|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813152|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813153|NCT00740779|Urological Agents|urological agents|mesh-ancestor
138813155|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
138813156|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813157|NCT01026818|Tadalafil|tadalafil|mesh-list
138813158|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
138813159|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138813160|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138813161|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813162|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813163|NCT01026818|Urological Agents|urological agents|mesh-ancestor
138813164|NCT02593747|Loratadine|loratadine|mesh-list
138813165|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
138813166|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
138813167|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138813168|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138813169|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138813170|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
138813171|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
138813172|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813173|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813174|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813175|NCT00743509|Sirolimus|sirolimus|mesh-list
138813176|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
138813177|NCT00743509|Temsirolimus|temsirolimus|mesh-list
138813178|NCT00743509|MTOR Inhibitors|mtor inhibitors|mesh-list
138813179|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138813180|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
138813181|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813182|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138813183|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138813184|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
138813185|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813186|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813187|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138813188|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138813189|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813190|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138813191|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
138813192|NCT00743509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138813193|NCT00743509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813195|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
138813196|NCT00734929|Ondansetron|ondansetron|mesh-list
138813198|NCT00734929|BB 1101|bb 1101|mesh-list
138813199|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138813200|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
138813201|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
138813202|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813203|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813204|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138813205|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
138813206|NCT00734929|Hormones|hormones|mesh-ancestor
138813207|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813208|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138813209|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813210|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
138813211|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813212|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813213|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
138813214|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
138813215|NCT00734929|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138813216|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138813217|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
138813218|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813220|NCT00734851|Docetaxel|docetaxel|mesh-list
138813221|NCT00734851|Sunitinib|sunitinib|mesh-list
138813222|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813223|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
138651368|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138813224|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
138813225|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
138813226|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813227|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138813228|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138813229|NCT00734851|Growth Substances|growth substances|mesh-ancestor
138813230|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813231|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
138813232|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138813233|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813234|NCT00734617|Nicotine|nicotine|mesh-list
138813235|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138467199|NCT01964781|Epinephrine|epinephrine|mesh-list
138813236|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
138813237|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813238|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813239|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138813240|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138813241|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
138813242|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813243|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813244|NCT00743431|Doxorubicin|doxorubicin|mesh-list
138813245|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138813246|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813247|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138813248|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138813249|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813250|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813251|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
138813252|NCT02737605|Esketamine|esketamine|mesh-list
138813253|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138813254|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813255|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138813256|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138813257|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813258|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813259|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813260|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
138813262|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
138813263|NCT02737371|Clotrimazole|clotrimazole|mesh-list
138813264|NCT02737371|Miconazole|miconazole|mesh-list
138813265|NCT02737371|Olorofim|olorofim|mesh-list
138467221|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
138813266|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813267|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138813268|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138813269|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138813270|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813271|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813272|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138813273|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
138813274|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813275|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813276|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138813277|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138813278|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
138813279|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
138813280|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
138426743|NCT01700426|Vitamins|vitamins|mesh-list
138813281|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813282|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813283|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
138813284|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813285|NCT00734539|Fluconazole|fluconazole|mesh-list
138813286|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
138813287|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813288|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138813289|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138813290|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465258|NCT02866747|Durvalumab|durvalumab|mesh-list
138813291|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813292|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138813293|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
138813294|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813295|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813296|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138813297|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138813298|NCT02737059|Codeine|codeine|mesh-list
138813299|NCT02737059|Naloxegol|naloxegol|mesh-list
138813300|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138813301|NCT02737059|Narcotics|narcotics|mesh-ancestor
138813302|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813303|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813304|NCT02737059|Analgesics|analgesics|mesh-ancestor
138813305|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
138813306|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644011|NCT00314652|Buprenorphine|buprenorphine|mesh-list
138813307|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
138813308|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
138813309|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138813310|NCT02731911|Dexamethasone|dexamethasone|mesh-list
138813311|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138813312|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
138813313|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
138813314|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813315|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813316|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138813317|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
138813318|NCT02731911|Hormones|hormones|mesh-ancestor
138813319|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813320|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138813321|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813322|NCT04089163|Flucytosine|flucytosine|mesh-list
138813323|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
138813324|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813325|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
138813326|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813327|NCT00743197|Aspirin|aspirin|mesh-list
138813328|NCT00743197|Lisinopril|lisinopril|mesh-list
138813329|NCT00743197|Simvastatin|simvastatin|mesh-list
138813330|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138813331|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138813332|NCT00743197|Analgesics|analgesics|mesh-ancestor
138813333|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
138813334|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813335|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813336|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138813337|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138813338|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138813339|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138651453|NCT04698512|Sirolimus|sirolimus|mesh-list
138813340|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813341|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138813342|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138813343|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813344|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
138813345|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138813346|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138813347|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
138813348|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138813349|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138813350|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138813351|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
138813352|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138813353|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138813354|NCT00743197|Protective Agents|protective agents|mesh-ancestor
138813355|NCT02731287|Timolol|timolol|mesh-list
138813356|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813357|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138813358|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138813359|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
138426824|NCT01700881|Protective Agents|protective agents|mesh-ancestor
138813360|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813361|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813362|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138813363|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138813365|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
138813366|NCT02735343|Analgesics|analgesics|mesh-ancestor
138813367|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
138813368|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813369|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813370|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138813371|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138813372|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
138813373|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
138813374|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813375|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138813376|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138813377|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813378|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813379|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
138813380|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
138813381|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138813382|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138813383|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138813384|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138813385|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138813386|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
138813387|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
138813388|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813389|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138813390|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651508|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138813391|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813392|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
138813393|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813394|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813395|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138813396|NCT00734071|Vortioxetine|vortioxetine|mesh-list
138813397|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
138813398|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138813399|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138813400|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138813401|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813402|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813403|NCT00734071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138813404|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138813406|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813407|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813408|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
138813409|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138813410|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138813411|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138813412|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138813413|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
138813414|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138813415|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813416|NCT04188951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138813417|NCT04188951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813418|NCT00739297|Montelukast|montelukast|mesh-list
138813419|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138813420|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
138813421|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138813422|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
138813423|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813424|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813425|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138813426|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138813427|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813428|NCT05430243|Empagliflozin|empagliflozin|mesh-list
138813429|NCT05430243|Diuretics|diuretics|mesh-list
138813430|NCT05430243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138813431|NCT05430243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813432|NCT05430243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138813433|NCT05430243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813434|NCT05430243|Natriuretic Agents|natriuretic agents|mesh-ancestor
138813435|NCT02730117|Cephalosporins|cephalosporins|mesh-list
138813436|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138813437|NCT02730117|Dobutamine|dobutamine|mesh-list
138813438|NCT02730117|Dopamine|dopamine|mesh-list
138813439|NCT02730117|Milrinone|milrinone|mesh-list
138813440|NCT02730117|Norepinephrine|norepinephrine|mesh-list
138813441|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138813442|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138813443|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138813444|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
138813445|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813446|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813447|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813448|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
138813449|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
138813450|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813451|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138651569|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
138813452|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138813453|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138813454|NCT02730117|Protective Agents|protective agents|mesh-ancestor
138813455|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
138813456|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138813457|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
138813458|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138813459|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138813460|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813461|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813462|NCT02595463|Lidocaine|lidocaine|mesh-list
138813463|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
138813464|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
138813465|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813466|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813467|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
138813468|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813469|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138813470|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138813471|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138813472|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138813473|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813474|NCT02593669|Dexamethasone|dexamethasone|mesh-list
138813475|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138813476|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
138813477|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
138813478|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813479|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813480|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138644084|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
138813482|NCT02593669|Hormones|hormones|mesh-ancestor
138813483|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813484|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138813485|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813486|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138813487|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138813488|NCT02729961|Ceritinib|ceritinib|mesh-list
138813489|NCT02729961|Antibodies|antibodies|mesh-list
138813490|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
138813491|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138813492|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
138813493|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
138813494|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813495|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813496|NCT02729961|Immunotoxins|immunotoxins|mesh-ancestor
138426984|NCT01701856|Interferons|interferons|mesh-list
138813497|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138813498|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813499|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813500|NCT02735031|Exenatide|exenatide|mesh-list
138813501|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138813502|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813503|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138813504|NCT02735031|Incretins|incretins|mesh-ancestor
138813505|NCT02735031|Hormones|hormones|mesh-ancestor
138813506|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813507|NCT02595541|Milrinone|milrinone|mesh-list
138813508|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
138813509|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
138813510|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138813511|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138813512|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813513|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813514|NCT02595541|Urological Agents|urological agents|mesh-ancestor
138813515|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138813516|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138813517|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138813518|NCT02595541|Protective Agents|protective agents|mesh-ancestor
138813519|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427021|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
138813520|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138813521|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813522|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138813523|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813524|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813525|NCT01026194|Pioglitazone|pioglitazone|mesh-list
138813526|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138813527|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813528|NCT02734875|Anticoagulants|anticoagulants|mesh-list
138813529|NCT04088461|Metformin|metformin|mesh-list
138813530|NCT04088461|Linagliptin|linagliptin|mesh-list
138813531|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138813532|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813533|NCT04088461|Incretins|incretins|mesh-ancestor
138813534|NCT04088461|Hormones|hormones|mesh-ancestor
138813535|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813536|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138813537|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
138813538|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813539|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813540|NCT00811954|Ritonavir|ritonavir|mesh-list
138813541|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138813542|NCT00811954|Darunavir|darunavir|mesh-list
138813543|NCT00811954|Tenofovir|tenofovir|mesh-list
138813544|NCT00811954|Emtricitabine|emtricitabine|mesh-list
138813545|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
138651641|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138813546|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138467326|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
138813548|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138813549|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
138813550|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813551|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813552|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138813553|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138813554|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
138813555|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813556|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138813557|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138813558|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138813559|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138813560|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138813561|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138813562|NCT00917839|Lamotrigine|lamotrigine|mesh-list
138813563|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
138813564|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138813565|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138813566|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813567|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138813568|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813569|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138813570|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138813571|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813572|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138813573|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138813574|NCT01032200|Modafinil|modafinil|mesh-list
138813575|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138813576|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813577|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138813578|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138813579|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138813580|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813581|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
138813582|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138813583|NCT00586105|Sorafenib|sorafenib|mesh-list
138813584|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813585|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138813586|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813587|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813588|NCT00743119|Dronabinol|dronabinol|mesh-list
138813589|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
138813590|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813591|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138813592|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138813593|NCT00743119|Analgesics|analgesics|mesh-ancestor
138813594|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
138813595|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813596|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138813597|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138813598|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813599|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813600|NCT00743119|Hormones|hormones|mesh-ancestor
138813601|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813602|NCT02610010|Cisplatin|cisplatin|mesh-list
138813603|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813604|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
138813605|NCT02610088|Gliclazide|gliclazide|mesh-list
138813606|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138813607|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813609|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813610|NCT02734407|Aflibercept|aflibercept|mesh-list
138813611|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138813612|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138813613|NCT02734407|Growth Substances|growth substances|mesh-ancestor
138813614|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813615|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
138813616|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813617|NCT02734173|Ritonavir|ritonavir|mesh-list
138813618|NCT02734173|Ribavirin|ribavirin|mesh-list
138813619|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138813620|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138813621|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
138813622|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427133|NCT01702714|Carboplatin|carboplatin|mesh-list
138813623|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813624|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138813625|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138813626|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
138813627|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813628|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138813629|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138813630|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
138813631|NCT05297422|Ketamine|ketamine|mesh-list
138813632|NCT05297422|Ropivacaine|ropivacaine|mesh-list
138813633|NCT05297422|Analgesics|analgesics|mesh-ancestor
138813634|NCT05297422|Sensory System Agents|sensory system agents|mesh-ancestor
138813635|NCT05297422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813636|NCT05297422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813637|NCT05297422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138813638|NCT05297422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138813639|NCT05297422|Anesthetics, General|anesthetics, general|mesh-ancestor
138813640|NCT05297422|Anesthetics|anesthetics|mesh-ancestor
138813641|NCT05297422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813642|NCT05297422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138813643|NCT05297422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138813644|NCT05297422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813645|NCT05297422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813646|NCT05297422|Anesthetics, Local|anesthetics, local|mesh-ancestor
138813647|NCT00813124|Fludarabine|fludarabine|mesh-list
138813648|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
138813649|NCT00813124|Azacitidine|azacitidine|mesh-list
138813650|NCT00813124|Busulfan|busulfan|mesh-list
138813651|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
138813652|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138813653|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813654|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138813655|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
138813656|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813657|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138813658|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
138813659|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467361|NCT01965405|Bupropion|bupropion|mesh-list
138813660|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813661|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
138813662|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138813663|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138813664|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138813666|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
138813667|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813668|NCT02594761|Trastuzumab|trastuzumab|mesh-list
138813669|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138813670|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813671|NCT02728947|Rotigotine|rotigotine|mesh-list
138813672|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
138813673|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
138813674|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813675|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813676|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813677|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138813678|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813679|NCT02733705|Fentanyl|fentanyl|mesh-list
138813680|NCT02733705|Propofol|propofol|mesh-list
138813681|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138813682|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813683|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813684|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138813685|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
138813686|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
138813687|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138813688|NCT02733705|Narcotics|narcotics|mesh-ancestor
138813689|NCT02733705|Analgesics|analgesics|mesh-ancestor
138813690|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
138813691|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813692|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138813693|NCT02597257|Lidocaine|lidocaine|mesh-list
138813694|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
138813695|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
138813696|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813697|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813698|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
138651735|NCT00335673|Irbesartan|irbesartan|mesh-list
138813699|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813700|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138813701|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138813702|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138813703|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138813704|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813705|NCT02596555|Dabigatran|dabigatran|mesh-list
138813706|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
138813707|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138813708|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
138813709|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813710|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813711|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
138813712|NCT02733471|Lidocaine|lidocaine|mesh-list
138813713|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
138813714|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
138813715|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813716|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813717|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
138813718|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813719|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138467384|NCT01966055|Solithromycin|solithromycin|mesh-list
138813720|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138813721|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138813722|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138813723|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813725|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
138813726|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138813727|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813728|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
138813729|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
138813730|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
138813731|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813732|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813733|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
138813734|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813735|NCT00811720|Nalmefene|nalmefene|mesh-list
138813736|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138813737|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813738|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
138813739|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813740|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138813741|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813742|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813743|NCT00811642|Posaconazole|posaconazole|mesh-list
138651763|NCT00336219|Pantoprazole|pantoprazole|mesh-list
138813744|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
138813745|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813746|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138813747|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138813748|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138427256|NCT01703637|Vildagliptin|vildagliptin|mesh-list
138813749|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138813750|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138813751|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813752|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813753|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138813754|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
138813755|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813756|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813757|NCT02609152|Esmolol|esmolol|mesh-list
138813758|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138813759|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138813760|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138813761|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
138813762|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813763|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813764|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813765|NCT02733393|Lidocaine|lidocaine|mesh-list
138813766|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
138813767|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
138813768|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813769|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813770|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
138813771|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813772|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138813773|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138813774|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138813775|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138813776|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813777|NCT00809926|Valsartan|valsartan|mesh-list
138813778|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138813779|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138813780|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138813781|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813782|NCT02728245|Dienogest|dienogest|mesh-list
138813783|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138813784|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
138651777|NCT00453908|Urological Agents|urological agents|mesh-ancestor
138813785|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138813786|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813787|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138813788|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138813789|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138813790|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138813791|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
138813792|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813793|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138813794|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813795|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138813796|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138813797|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813798|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
138813799|NCT05753722|Pembrolizumab|pembrolizumab|mesh-list
138813800|NCT05753722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138813801|NCT05753722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813802|NCT05753722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138813803|NCT05753722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813804|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
138465785|NCT01954368|Sufentanil|sufentanil|mesh-list
138813805|NCT02727621|Propofol|propofol|mesh-list
138813806|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138813807|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813808|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813809|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138813810|NCT02727621|Analgesics|analgesics|mesh-ancestor
138813811|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
138813812|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813813|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138813814|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138813815|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138813816|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
138813817|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813818|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813819|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138813820|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
138813821|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
138813822|NCT02608606|Tacrolimus|tacrolimus|mesh-list
138813823|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138813824|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
138813825|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813826|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138813827|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813828|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813829|NCT02608918|BMS-955176|bms-955176|mesh-list
138813830|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138813831|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138813832|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
138813833|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813834|NCT02727309|Apatinib|apatinib|mesh-list
138813835|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813836|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138813837|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813838|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813839|NCT05755750|Genipin|genipin|mesh-list
138813840|NCT05755750|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138813841|NCT05755750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138813842|NCT02732067|Anesthetics|anesthetics|mesh-list
138813843|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813844|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813845|NCT02609932|Interferons|interferons|mesh-list
138813846|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
138813847|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813848|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
138813849|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138813850|NCT02726919|Clobazam|clobazam|mesh-list
138813851|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
138813852|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138813853|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138813854|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467464|NCT01966575|Progestins|progestins|mesh-list
138813855|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813856|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138813857|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138813858|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
138813859|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
138813860|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813861|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813862|NCT05753566|Androgens|androgens|mesh-list
138813863|NCT05753566|Hormones|hormones|mesh-ancestor
138813864|NCT05753566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813865|NCT05753566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813866|NCT00590824|Interleukin-2|interleukin-2|mesh-list
138813867|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813868|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138813869|NCT00590824|Analgesics|analgesics|mesh-ancestor
138813870|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
138813871|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813872|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813873|NCT02720991|Misoprostol|misoprostol|mesh-list
138813874|NCT02720991|Mifepristone|mifepristone|mesh-list
138813875|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138813876|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
138813877|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138813878|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813879|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138813880|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138813882|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138813883|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138813884|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138813885|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138813886|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
138813887|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138813888|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138813889|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
138813890|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138813891|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
138813892|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138813893|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138813895|NCT02720601|Irinotecan|irinotecan|mesh-list
138813896|NCT02720601|Camptothecin|camptothecin|mesh-list
138813897|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138813898|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
138813899|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813900|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813901|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138813902|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138813903|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813904|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138813905|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
138813906|NCT00590590|Promethazine|promethazine|mesh-list
138813907|NCT00590590|Lidocaine|lidocaine|mesh-list
138813908|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
138813909|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
138813910|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813911|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813912|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
138813913|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813914|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138813915|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138813916|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138813917|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138813918|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813919|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138813920|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138813921|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
138813922|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
138813923|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138813924|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138813925|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
138813926|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
138813927|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813928|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138813929|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
138813930|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
138813931|NCT02720367|Gemcitabine|gemcitabine|mesh-list
138813932|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138813933|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
138813934|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813935|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813936|NCT02693769|Fluticasone|fluticasone|mesh-list
138813937|NCT02693769|Xhance|xhance|mesh-list
138813938|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
138813939|NCT02693769|Bromides|bromides|mesh-list
138813940|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
138813941|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138813942|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138813943|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
138813944|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813945|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813946|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138813947|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
138467506|NCT01966783|Hormones|hormones|mesh-ancestor
138813948|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
138813949|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138813950|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138813951|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138813952|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138813953|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
138465933|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
138813954|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813955|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813957|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138813958|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138813959|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138813960|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
138813961|NCT02725359|Tizanidine|tizanidine|mesh-list
138813962|NCT02725359|Bupivacaine|bupivacaine|mesh-list
138813963|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
138813964|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
138813965|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138813966|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651903|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138813967|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
138813968|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138813969|NCT02725359|Analgesics|analgesics|mesh-ancestor
138813970|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
138813971|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138813972|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138813973|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
138813974|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
138813975|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138813976|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138813977|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138813978|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
138813979|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813980|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813981|NCT00731731|Temozolomide|temozolomide|mesh-list
138813982|NCT00731731|Vorinostat|vorinostat|mesh-list
138813983|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138813984|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
138813985|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813986|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138813987|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138813988|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138813989|NCT02719431|Warfarin|warfarin|mesh-list
138813990|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
138813991|NCT00806494|Fesoterodine|fesoterodine|mesh-list
138813992|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138813993|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138813994|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
138813995|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138813996|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138813997|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138813998|NCT00806494|Urological Agents|urological agents|mesh-ancestor
138813999|NCT00806416|Vitamin D|vitamin d|mesh-list
138814000|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
138814001|NCT00806416|Alendronate|alendronate|mesh-list
138814002|NCT00806416|Vitamins|vitamins|mesh-ancestor
138814003|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
138814004|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814005|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138814006|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138814007|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138814008|NCT00811252|Vortioxetine|vortioxetine|mesh-list
138814009|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138814010|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138814011|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138814012|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814013|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651922|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138814014|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814015|NCT00811252|Analgesics|analgesics|mesh-ancestor
138814016|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
138814017|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814018|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
138814019|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138814020|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
138814021|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138814022|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138814023|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814024|NCT00811252|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138814025|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
138466033|NCT01955824|Lidocaine|lidocaine|mesh-list
138814026|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138814027|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138814028|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138427508|NCT01705041|Liver Extracts|liver extracts|mesh-list
138814030|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138814031|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
138814032|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814033|NCT00736957|Acetaminophen|acetaminophen|mesh-list
138814034|NCT00736957|Tramadol|tramadol|mesh-list
138814035|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138814036|NCT00736957|Analgesics|analgesics|mesh-ancestor
138814037|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
138814038|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814039|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814040|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
138814041|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138814042|NCT00736957|Narcotics|narcotics|mesh-ancestor
138814043|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814044|NCT05294523|Rocuronium|rocuronium|mesh-list
138814045|NCT05294523|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138814046|NCT05294523|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138814047|NCT05294523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138814048|NCT05294523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814049|NCT05294523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814050|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
138814051|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138814052|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814053|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138814054|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814055|NCT02718261|Pantoprazole|pantoprazole|mesh-list
138814056|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138814057|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138814058|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138814059|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814060|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814061|NCT00806260|Ethanol|ethanol|mesh-list
138814062|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138814063|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814064|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814065|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814066|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138814067|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
138814068|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138814069|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814070|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
138814071|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138814072|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138814073|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
138814074|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814075|NCT02723487|Bupivacaine|bupivacaine|mesh-list
138814076|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
138814077|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
138814078|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814079|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814080|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
138814081|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814082|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
138814083|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
138814084|NCT02717871|Levofloxacin|levofloxacin|mesh-list
138814086|NCT02717871|Gentamicins|gentamicins|mesh-list
138814087|NCT02717871|Cefazolin|cefazolin|mesh-list
138814088|NCT02717871|Tobramycin|tobramycin|mesh-list
138814089|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
138814090|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
138814091|NCT02717871|Besifloxacin|besifloxacin|mesh-list
138814092|NCT02717871|Prednisolone|prednisolone|mesh-list
138814093|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138814094|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
138814095|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138814096|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
138814097|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138814098|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138814099|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
138814100|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
138814101|NCT02717871|Mydriatics|mydriatics|mesh-list
138814102|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138814103|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
138814104|NCT02717871|Hormones|hormones|mesh-ancestor
138814105|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138814106|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814107|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138814108|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814109|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
138814110|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
138814111|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814112|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138814113|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138814114|NCT02717871|Protective Agents|protective agents|mesh-ancestor
138814115|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138814116|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814117|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138814118|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138814119|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814120|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814121|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138814122|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138814123|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138814124|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138814125|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138814126|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138814127|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
138814128|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138814129|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138814130|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
138814131|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814132|NCT02723253|Raltitrexed|raltitrexed|mesh-list
138814133|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814134|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138814135|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
138814136|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814137|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138814138|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814139|NCT00730405|Albaconazole|albaconazole|mesh-list
138814140|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
138814141|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814142|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
138814143|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138814144|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814145|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
138814146|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814147|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
138814149|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138814150|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
138814151|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
138814152|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814153|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814154|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138814155|NCT00736645|Selenium|selenium|mesh-list
138814156|NCT00736645|Finasteride|finasteride|mesh-list
138814157|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138814158|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138814159|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814160|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814161|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
138814162|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138814163|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814164|NCT00736645|Urological Agents|urological agents|mesh-ancestor
138814165|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
138814166|NCT00736645|Protective Agents|protective agents|mesh-ancestor
138814167|NCT00736645|Trace Elements|trace elements|mesh-ancestor
138814168|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
138814169|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
138814170|NCT00736489|AZD-3199|azd-3199|mesh-list
138814171|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138814172|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
138814173|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467567|NCT01967251|Udenafil|udenafil|mesh-list
138814174|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814175|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138814176|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
138651986|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814177|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138814178|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138814179|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138814180|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
138814181|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814182|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814183|NCT02716233|Pegaspargase|pegaspargase|mesh-list
138814185|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814186|NCT01999569|Letrozole|letrozole|mesh-list
138814187|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814188|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138814189|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138814190|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814191|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814192|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138814193|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
138814194|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138814195|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814196|NCT04087915|Evolocumab|evolocumab|mesh-list
138814197|NCT04087915|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138814198|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138814199|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138814200|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
138814201|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814202|NCT04087915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138814203|NCT04087915|Protease Inhibitors|protease inhibitors|mesh-ancestor
138814204|NCT04087915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814205|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138814206|NCT02715687|Amiodarone|amiodarone|mesh-list
138814207|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138814208|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
138814209|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138814210|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138814211|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814212|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138814213|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138814214|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138814215|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814216|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138814217|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138814218|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138814219|NCT02715531|Leucovorin|leucovorin|mesh-list
138814220|NCT02715531|Paclitaxel|paclitaxel|mesh-list
138814221|NCT02715531|Bevacizumab|bevacizumab|mesh-list
138814222|NCT02715531|Gemcitabine|gemcitabine|mesh-list
138814223|NCT02715531|Capecitabine|capecitabine|mesh-list
138814224|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
138814225|NCT02715531|Atezolizumab|atezolizumab|mesh-list
138814226|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138814227|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814228|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
138814229|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
138814230|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
138814231|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814232|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138814233|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138814234|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138467598|NCT01967459|Vitamins|vitamins|mesh-ancestor
138814235|NCT02715531|Growth Substances|growth substances|mesh-ancestor
138814236|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814237|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
138814238|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138814239|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
138814240|NCT02715531|Antidotes|antidotes|mesh-ancestor
138814241|NCT02715531|Protective Agents|protective agents|mesh-ancestor
138814242|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
138814243|NCT02715531|Vitamins|vitamins|mesh-ancestor
138814244|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
138814245|NCT02715531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138814246|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
138814247|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138644286|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138814248|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814249|NCT04037085|Ketamine|ketamine|mesh-list
138814250|NCT04037085|Analgesics|analgesics|mesh-ancestor
138814251|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
138814252|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814253|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814254|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138814255|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138814257|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
138814258|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814259|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138814260|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138814261|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814262|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814263|NCT00914056|Lactulose|lactulose|mesh-list
138814264|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138814265|NCT00730171|Linaclotide|linaclotide|mesh-list
138814266|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138814267|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
138814268|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814269|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138814270|NCT04787835|Anesthetics|anesthetics|mesh-list
138814271|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
138814272|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814273|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814274|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
138814275|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814276|NCT00730015|Linaclotide|linaclotide|mesh-list
138467613|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138814277|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138814278|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
138814279|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814280|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138814282|NCT00806026|Pramipexole|pramipexole|mesh-list
138814283|NCT00806026|Analgesics|analgesics|mesh-ancestor
138814284|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
138814285|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814286|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814287|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
138814288|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138814289|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138814290|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814291|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138814292|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138814293|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138814294|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814295|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138814296|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
138814297|NCT00806026|Protective Agents|protective agents|mesh-ancestor
138814298|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138814299|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138814300|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
138814301|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
138814302|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814303|NCT04227093|Acetazolamide|acetazolamide|mesh-list
138814304|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
138814305|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138814307|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814308|NCT04227093|Diuretics|diuretics|mesh-ancestor
138814309|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
138814310|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814311|NCT00805792|Donepezil|donepezil|mesh-list
138814312|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138814313|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814314|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814315|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
138814316|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814317|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814318|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
138814319|NCT04777929|Progesterone|progesterone|mesh-list
138814320|NCT04777929|Estrogens|estrogens|mesh-list
138814321|NCT04777929|Progestins|progestins|mesh-ancestor
138814322|NCT04777929|Hormones|hormones|mesh-ancestor
138814323|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138814324|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814325|NCT00590044|Insulin|insulin|mesh-list
138814326|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138814327|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
138814328|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
138814329|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138814330|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814331|NCT02714361|Vitamin D|vitamin d|mesh-list
138814332|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
138814333|NCT02714361|Vitamins|vitamins|mesh-ancestor
138814334|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
138814335|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814336|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138814337|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138814338|NCT00248703|Docetaxel|docetaxel|mesh-list
138814339|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814340|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
138814341|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
138814342|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
138814343|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814344|NCT02713893|Econazole|econazole|mesh-list
138814345|NCT02713893|Benzydamine|benzydamine|mesh-list
138814346|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138814347|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
138814348|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814349|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138814350|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138814351|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814352|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814353|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138814354|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
138814355|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138814356|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814357|NCT00729937|Clindamycin|clindamycin|mesh-list
138814358|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
138814359|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
138814360|NCT00729937|Cephalexin|cephalexin|mesh-list
138814361|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138814362|NCT00729937|Trimethoprim|trimethoprim|mesh-list
138814363|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
138814364|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138814365|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814366|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138814367|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814368|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814369|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138814370|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
138467674|NCT01967875|Docetaxel|docetaxel|mesh-list
138814371|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138814372|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138814373|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138814374|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138814375|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138814376|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138814377|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
138814378|NCT00729859|Anastrozole|anastrozole|mesh-list
138814379|NCT00729859|Testosterone|testosterone|mesh-list
138814380|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
138814381|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
138814382|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138814383|NCT00729859|Acyline|acyline|mesh-list
138814384|NCT00729859|Androgens|androgens|mesh-ancestor
138814385|NCT00729859|Hormones|hormones|mesh-ancestor
138814386|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138814387|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814388|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138814389|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814390|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
138814391|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138814392|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138814393|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814394|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814395|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138814396|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
138814397|NCT00810394|Sorafenib|sorafenib|mesh-list
138814398|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814399|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138814400|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814401|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814402|NCT00736333|Doxorubicin|doxorubicin|mesh-list
138814403|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138814404|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138814405|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814406|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138814407|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138814408|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814409|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814410|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138814411|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
138814412|NCT00736255|Nicotine|nicotine|mesh-list
138814413|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138814415|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814416|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814417|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138814418|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138814419|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
138814420|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814421|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814422|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138814423|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138814424|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138814425|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138814426|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
138814427|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138814428|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138814429|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814430|NCT00808444|Vaccines|vaccines|mesh-list
138814431|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138814432|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
138814433|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814434|NCT00914134|Levodopa|levodopa|mesh-list
138814435|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138814436|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138814437|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
138814438|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814439|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814440|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814441|NCT05754736|Bevacizumab|bevacizumab|mesh-list
138814442|NCT05754736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138814443|NCT05754736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814444|NCT05754736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138814445|NCT05754736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138814446|NCT05754736|Growth Substances|growth substances|mesh-ancestor
138814447|NCT05754736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814448|NCT05754736|Growth Inhibitors|growth inhibitors|mesh-ancestor
138814449|NCT00742027|Panobinostat|panobinostat|mesh-list
138814450|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814451|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138814452|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814453|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814455|NCT02609698|Clopidogrel|clopidogrel|mesh-list
138814456|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138814457|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138814458|NCT02609698|Analgesics|analgesics|mesh-ancestor
138814459|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
138814460|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814461|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814462|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138814463|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138814464|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138814465|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138814466|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814467|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138814468|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138814469|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814470|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
138814471|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138814472|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138814473|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138814474|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
138814475|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814476|NCT05750134|Pancrelipase|pancrelipase|mesh-list
138814477|NCT05750134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138814478|NCT05749822|Fenofibrate|fenofibrate|mesh-list
138814479|NCT05749822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138814480|NCT05749822|Antimetabolites|antimetabolites|mesh-ancestor
138814481|NCT05749822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814482|NCT05749822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138814484|NCT02713191|Fentanyl|fentanyl|mesh-list
138814485|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
138814486|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138814487|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814488|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814489|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138814490|NCT02713191|Analgesics|analgesics|mesh-ancestor
138814491|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
138814492|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814493|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138814494|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138814495|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138814496|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
138814497|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814498|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814499|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138644397|NCT00309543|Leucovorin|leucovorin|mesh-list
138814500|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138814501|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138814502|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138814503|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138814504|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
138814505|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
138814506|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
138814507|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
138814508|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138814509|NCT02713191|Narcotics|narcotics|mesh-ancestor
138814511|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138814512|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138814513|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814514|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138814515|NCT05754502|Trastuzumab|trastuzumab|mesh-list
138814516|NCT05754502|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138814518|NCT05754502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138814519|NCT05754502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814520|NCT05754502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138814521|NCT05754502|Tubulin Modulators|tubulin modulators|mesh-ancestor
138814522|NCT05754502|Antimitotic Agents|antimitotic agents|mesh-ancestor
138814523|NCT05754502|Mitosis Modulators|mitosis modulators|mesh-ancestor
138814524|NCT05754502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814525|NCT05754502|Immunotoxins|immunotoxins|mesh-ancestor
138814526|NCT05754502|Immunoconjugates|immunoconjugates|mesh-ancestor
138814527|NCT05754502|Immunologic Factors|immunologic factors|mesh-ancestor
138652245|NCT00308438|Teduglutide|teduglutide|mesh-list
138814528|NCT05754502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814529|NCT02712957|Naproxen|naproxen|mesh-list
138814530|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138814531|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138814532|NCT02712957|Analgesics|analgesics|mesh-ancestor
138814533|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
138814534|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814535|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814536|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138814537|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138814538|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
138814539|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138814540|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814541|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814542|NCT04226625|Propofol|propofol|mesh-list
138814543|NCT04226625|Desflurane|desflurane|mesh-list
138814544|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138467744|NCT01968044|Hormones|hormones|mesh-ancestor
138427804|NCT01707342|Simeprevir|simeprevir|mesh-list
138814545|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814546|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814547|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138814548|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
138814549|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
138814550|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138814551|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
138814552|NCT02777619|Propofol|propofol|mesh-list
138814553|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138814554|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814555|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814556|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138814557|NCT02777619|Analgesics|analgesics|mesh-ancestor
138814558|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
138814559|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814560|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138814561|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138814562|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138814563|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
138814564|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814565|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814566|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138814567|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
138814568|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
138814569|NCT05754424|Insulin Aspart|insulin aspart|mesh-list
138814570|NCT05754424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138814571|NCT05754424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814572|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138814573|NCT00636831|Cefazolin|cefazolin|mesh-list
138814574|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814575|NCT04193631|Cannabidiol|cannabidiol|mesh-list
138814576|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
138814577|NCT04856631|Cetuximab|cetuximab|mesh-list
138814578|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138814579|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814580|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
138814581|NCT00808210|Infliximab|infliximab|mesh-list
138814582|NCT00808210|Methotrexate|methotrexate|mesh-list
138814583|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
138814584|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138814585|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
138814586|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138814587|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814588|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138814589|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
138814590|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814591|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814592|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
138814593|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814594|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138467751|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
138427845|NCT01707407|Analgesics|analgesics|mesh-ancestor
138814595|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138814596|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
138644463|NCT00279266|Thiamine|thiamine|mesh-list
138814597|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138814598|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138814599|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138814600|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
138814601|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
138814602|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814603|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138814604|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
138814605|NCT00808210|Hormones|hormones|mesh-ancestor
138814606|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138814607|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138814608|NCT00808210|Protective Agents|protective agents|mesh-ancestor
138814609|NCT00808210|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138814610|NCT02777229|Tenofovir|tenofovir|mesh-list
138814611|NCT02777229|Lamivudine|lamivudine|mesh-list
138814612|NCT02777229|Efavirenz|efavirenz|mesh-list
138814613|NCT02777229|Dolutegravir|dolutegravir|mesh-list
138814614|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
138814615|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814616|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138814617|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138814618|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814619|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814620|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138814621|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138814622|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138814623|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138814624|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138814625|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138814626|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138814627|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138814628|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138814629|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138466603|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
138814630|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138814631|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
138427872|NCT01707732|Enoxaparin|enoxaparin|mesh-list
138814632|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814633|NCT00635037|Bupivacaine|bupivacaine|mesh-list
138814634|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
138814635|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
138814636|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814637|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814638|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
138814639|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814640|NCT02777151|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
138814641|NCT02777151|Atoltivimab|atoltivimab|mesh-list
138814642|NCT02777151|Antiviral Agents|antiviral agents|mesh-ancestor
138814643|NCT02777151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814644|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
138814645|NCT02777073|Liraglutide|liraglutide|mesh-list
138814646|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138814647|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814648|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138814649|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814650|NCT02777073|Incretins|incretins|mesh-ancestor
138814651|NCT02777073|Hormones|hormones|mesh-ancestor
138814652|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138814653|NCT02711865|Antibodies|antibodies|mesh-list
138814654|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
138814655|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814656|NCT02711943|Levofloxacin|levofloxacin|mesh-list
138814657|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138814658|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814659|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138814660|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138814661|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138814662|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814663|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814664|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814665|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138814666|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138814667|NCT02776761|Vaccines|vaccines|mesh-list
138814668|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
138814669|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814670|NCT00736099|Pioglitazone|pioglitazone|mesh-list
138814671|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138814672|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814673|NCT02711241|Dipyrone|dipyrone|mesh-list
138814674|NCT02711241|Papaverine|papaverine|mesh-list
138814675|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138814676|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138814677|NCT02711241|Analgesics|analgesics|mesh-ancestor
138814678|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
138814679|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814680|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814681|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138814682|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138814683|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
138814684|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138814685|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814686|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814687|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
138814688|NCT02711241|Urological Agents|urological agents|mesh-ancestor
138814689|NCT02711007|Apatinib|apatinib|mesh-list
138814690|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814691|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138814692|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814693|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814694|NCT02710539|Amlodipine|amlodipine|mesh-list
138814695|NCT02710539|Perindopril|perindopril|mesh-list
138814696|NCT02710539|Indapamide|indapamide|mesh-list
138814697|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138814698|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138814699|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138814700|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814701|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138814702|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814703|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
138814704|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138814705|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
138814706|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814707|NCT02710539|Diuretics|diuretics|mesh-ancestor
138814708|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
138814709|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138814710|NCT00735709|Vortioxetine|vortioxetine|mesh-list
138814711|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
138814712|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138814713|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138259254|NCT01837069|Metoprolol|metoprolol|mesh-list
138814714|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138814715|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814716|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814717|NCT00735709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138814718|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138814719|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138814720|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814721|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814722|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
138814723|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138814724|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138814725|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138814726|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138814728|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814729|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138814730|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814731|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814732|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
138814733|NCT00729157|Aflibercept|aflibercept|mesh-list
138814734|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
138814735|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138814736|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138814737|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138814738|NCT00729157|Growth Substances|growth substances|mesh-ancestor
138814739|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814740|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
138814741|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814742|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814743|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138814744|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
138814745|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
138814746|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814747|NCT02710305|Lidocaine|lidocaine|mesh-list
138814748|NCT02710305|Scopolamine|scopolamine|mesh-list
138814749|NCT02710305|Bromides|bromides|mesh-list
138814750|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138814751|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
138814752|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
138814753|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467826|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138814754|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814755|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
138814756|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814757|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138814758|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138814759|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138814760|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138814761|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814763|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138814764|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
138163270|NCT04241601|Aldesleukin|aldesleukin|mesh-list
138814765|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
138814766|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138814767|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
138814768|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138814769|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
138814770|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814771|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138814772|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
138814773|NCT02708511|Copper|copper|mesh-list
138814774|NCT02708511|Trace Elements|trace elements|mesh-ancestor
138814775|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
138814776|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814777|NCT00728689|Tecovirimat|tecovirimat|mesh-list
138814778|NCT00728689|Antiviral Agents|antiviral agents|mesh-ancestor
138814779|NCT00728689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814780|NCT02596243|Vaccines|vaccines|mesh-list
138814781|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
138814782|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814783|NCT02717091|Paclitaxel|paclitaxel|mesh-list
138814784|NCT02717091|Gemcitabine|gemcitabine|mesh-list
138814785|NCT02717091|Folfirinox|folfirinox|mesh-list
138814786|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138814787|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814788|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
138814789|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
138428008|NCT01708642|Epinephrine|epinephrine|mesh-list
138814790|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
138814791|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814792|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138814793|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
138814794|NCT00726895|Quinine|quinine|mesh-list
138814795|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
138814796|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138814797|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138814798|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814799|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138814800|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814801|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138814802|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814803|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138814805|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
138814806|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138814807|NCT02593201|Cefazolin|cefazolin|mesh-list
138814808|NCT02593201|Ceftazidime|ceftazidime|mesh-list
138814809|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138814810|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814811|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
138814812|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
138652388|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138814813|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138814814|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814815|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814816|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138814817|NCT02707809|Analgesics|analgesics|mesh-ancestor
138814818|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
138814819|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467841|NCT01968915|Paclitaxel|paclitaxel|mesh-list
138814820|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138814821|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138814822|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138814823|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
138814824|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814825|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814827|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
138814828|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
138814829|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814830|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814831|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
138814832|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814833|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138814834|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138814835|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138814836|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138814837|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814839|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138814840|NCT02716857|Narcotics|narcotics|mesh-ancestor
138814841|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138814842|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814843|NCT02716857|Analgesics|analgesics|mesh-ancestor
138814844|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
138814845|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814846|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138814847|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
138814848|NCT00917761|Entecavir|entecavir|mesh-list
138814849|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
138814850|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814851|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
138814852|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814853|NCT02709603|Scopolamine|scopolamine|mesh-list
138814854|NCT02709603|Bromides|bromides|mesh-list
138814855|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138814856|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
138814857|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138814858|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
138814859|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
138814860|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814861|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814862|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138814864|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138814865|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
138814866|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814867|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814868|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138814869|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
138814870|NCT00611793|Bevacizumab|bevacizumab|mesh-list
138652420|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138814871|NCT00611793|Vatalanib|vatalanib|mesh-list
138467855|NCT01969019|Prednisone|prednisone|mesh-list
138814872|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138814873|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814874|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138814875|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138814876|NCT00611793|Growth Substances|growth substances|mesh-ancestor
138814877|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814878|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
138814879|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138814880|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814881|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814882|NCT00611871|Propranolol|propranolol|mesh-list
138814883|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138814884|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138814885|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
138814886|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814887|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814888|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814889|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138814890|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138814891|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
138814892|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
138814893|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138814894|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
138814895|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814896|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
138814897|NCT02709525|Protective Agents|protective agents|mesh-ancestor
138814898|NCT05087589|Tofacitinib|tofacitinib|mesh-list
138814899|NCT05087589|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138814900|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138814901|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814902|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814903|NCT00612651|Temozolomide|temozolomide|mesh-list
138814904|NCT00612651|Lonafarnib|lonafarnib|mesh-list
138814905|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138814906|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
138814907|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814908|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814909|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814910|NCT00918307|Varenicline|varenicline|mesh-list
138814911|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138814912|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138814913|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
138814914|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814915|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814916|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814917|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138814918|NCT00741013|Protein C|protein c|mesh-list
138814919|NCT00741013|Lovastatin|lovastatin|mesh-list
138814920|NCT00741013|L 647318|l 647318|mesh-list
138814921|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
138814922|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138814923|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138814924|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
138814925|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814926|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138814927|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138644587|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
138814928|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814930|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138814931|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138814932|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814933|NCT04087759|Bedaquiline|bedaquiline|mesh-list
138814934|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
138814935|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
138814936|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138814937|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138814938|NCT00740857|Ibuprofen|ibuprofen|mesh-list
138814939|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138814940|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138814941|NCT00740857|Analgesics|analgesics|mesh-ancestor
138814942|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
138814943|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138814944|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814945|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138814946|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138814947|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138814948|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138814949|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814950|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
138814951|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138814952|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
138814953|NCT00808132|Estrogens|estrogens|mesh-list
138814954|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138814955|NCT00808132|Hormones|hormones|mesh-ancestor
138814956|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138814957|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814958|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138814959|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138814960|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138814961|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
138814962|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138814963|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138814964|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138814965|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138814966|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138652470|NCT00309920|Docetaxel|docetaxel|mesh-list
138814967|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814968|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138814969|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138814970|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
138814971|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138814972|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
138814973|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138814974|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
138814975|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814976|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138814977|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138814978|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
138814979|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814980|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814981|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138814982|NCT00914368|Clopidogrel|clopidogrel|mesh-list
138814983|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138814984|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138814985|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138814986|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138814987|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
138814988|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138814989|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814990|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138814992|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
138814993|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138814994|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138814995|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
138814996|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
138814997|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
138814998|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138814999|NCT02692989|Anesthetics|anesthetics|mesh-list
138815000|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138815001|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815002|NCT04882293|Atorvastatin|atorvastatin|mesh-list
138815003|NCT04882293|Fenofibrate|fenofibrate|mesh-list
138815004|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138815005|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138815006|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
138815007|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815008|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138815009|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138815010|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815011|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
138815012|NCT02608060|Hematinics|hematinics|mesh-ancestor
138467932|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138467941|NCT01969617|Naltrexone|naltrexone|mesh-list
138815013|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
138815014|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138815015|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138815016|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815017|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
138815018|NCT04085575|Coagulants|coagulants|mesh-ancestor
138815019|NCT00585169|Memantine|memantine|mesh-list
138815020|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138815021|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138815022|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
138815023|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815024|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815025|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815026|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138815027|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138815028|NCT00807742|Nicotine|nicotine|mesh-list
138815029|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138815030|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
138815031|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815032|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815033|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138815034|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138815035|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
138815036|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815037|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815038|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
138815039|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138815040|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815041|NCT05738434|Apatinib|apatinib|mesh-list
138815042|NCT05738434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815043|NCT05738434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138815044|NCT05738434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815045|NCT05738434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815047|NCT00803452|Doxycycline|doxycycline|mesh-list
138815048|NCT00803452|Minocycline|minocycline|mesh-list
138815049|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138815050|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815051|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
138815052|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138815053|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138815054|NCT04546113|Ropivacaine|ropivacaine|mesh-list
138815055|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
138815056|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
138815057|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138815058|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815059|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
138815060|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815061|NCT05737342|Red yeast rice|red yeast rice|mesh-list
138815062|NCT05737342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138815063|NCT05737342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138652509|NCT00310154|Docetaxel|docetaxel|mesh-list
138815064|NCT05737342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138815065|NCT05737342|Antimetabolites|antimetabolites|mesh-ancestor
138815066|NCT05737342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815067|NCT05737342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815068|NCT05737342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138815069|NCT00914212|Sibutramine|sibutramine|mesh-list
138815070|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
138815071|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138815072|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
138815073|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138815074|NCT04456023|Tisagenlecleucel|tisagenlecleucel|mesh-list
138815075|NCT04456023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138815076|NCT04456023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815078|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
138428309|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138815079|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815080|NCT04188483|Protective Agents|protective agents|mesh-ancestor
138815081|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815082|NCT04188483|Trace Elements|trace elements|mesh-ancestor
138815083|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
138815084|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138815085|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
138815086|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815088|NCT00717067|Saquinavir|saquinavir|mesh-list
138815089|NCT00717067|Maraviroc|maraviroc|mesh-list
138815090|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138815091|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138815092|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
138815093|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815094|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815095|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138815096|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138815097|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
138815098|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815099|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138815100|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138815101|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138815102|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138815103|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138815104|NCT04393311|Urinastatin|urinastatin|mesh-list
138815105|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138815106|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138815107|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
138815108|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428358|NCT01710722|Ephedrine|ephedrine|mesh-list
138815109|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815110|NCT02607436|Aspirin|aspirin|mesh-list
138815111|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
138815112|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138815113|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138815114|NCT02607436|Analgesics|analgesics|mesh-ancestor
138815115|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
138815116|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815117|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815118|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138815119|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138652532|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138815120|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138815121|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138815122|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815123|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138815124|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138815125|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815126|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
138815127|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138815128|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
138815129|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815130|NCT02607592|Pemetrexed|pemetrexed|mesh-list
138815131|NCT02607592|Nedaplatin|nedaplatin|mesh-list
138815132|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815133|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815134|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815135|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138815136|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138815137|NCT04356339|Interferons|interferons|mesh-list
138815138|NCT04356339|Interferon-beta|interferon-beta|mesh-list
138815139|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
138815140|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815141|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
138815142|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815143|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
138815144|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815145|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138815146|NCT04331145|Ticagrelor|ticagrelor|mesh-list
138815147|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138815148|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138815149|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138815150|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138815151|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
138815152|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815153|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815154|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815155|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138815156|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138815157|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815158|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138815160|NCT03460522|Immunoconjugates|immunoconjugates|mesh-ancestor
138815161|NCT03460522|Immunologic Factors|immunologic factors|mesh-ancestor
138815162|NCT03460522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815163|NCT02605720|Piperaquine|piperaquine|mesh-list
138815164|NCT02605720|Artenimol|artenimol|mesh-list
138815165|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
138815166|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138815167|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138815168|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815170|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138815171|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
138815172|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815173|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
138815174|NCT04188561|Protective Agents|protective agents|mesh-ancestor
138815175|NCT00588952|Ketamine|ketamine|mesh-list
138815176|NCT00588952|Analgesics|analgesics|mesh-ancestor
138815177|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
138815178|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815179|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815180|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138815181|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138815182|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
138815184|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138815185|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138815186|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138815187|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815188|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815189|NCT04885257|Methylphenidate|methylphenidate|mesh-list
138815190|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138815191|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815192|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138815193|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138815194|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138815195|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815196|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
138815197|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815198|NCT00802360|Menotropins|menotropins|mesh-list
138467989|NCT01969695|Venetoclax|venetoclax|mesh-list
138815200|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138815201|NCT00802360|Ganirelix|ganirelix|mesh-list
138815202|NCT00802360|Progestins|progestins|mesh-ancestor
138815203|NCT00802360|Hormones|hormones|mesh-ancestor
138815204|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138815205|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815206|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
138815207|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138815208|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
138815209|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138815210|NCT04811625|Aspirin|aspirin|mesh-list
138815211|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138815212|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138815213|NCT04811625|Analgesics|analgesics|mesh-ancestor
138815214|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
138815215|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815216|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815217|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138815218|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138815219|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138815220|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138815221|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644650|NCT00310128|Cytarabine|cytarabine|mesh-list
138815222|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138815223|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138815224|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815225|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
138815226|NCT02764593|Nivolumab|nivolumab|mesh-list
138815227|NCT02764593|Cetuximab|cetuximab|mesh-list
138815228|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815229|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138815230|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138815231|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815233|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
138652565|NCT00310583|Pregabalin|pregabalin|mesh-list
138815234|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815235|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138815236|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
138815237|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815238|NCT02606266|Valganciclovir|valganciclovir|mesh-list
138815239|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
138815240|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815241|NCT04115020|Naltrexone|naltrexone|mesh-list
138815242|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138815243|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138815244|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815245|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
138815246|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815247|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
138815248|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138815249|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815250|NCT03292666|Warfarin|warfarin|mesh-list
138815251|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
138815253|NCT03292666|Apixaban|apixaban|mesh-list
138815254|NCT03292666|Anticoagulants|anticoagulants|mesh-list
138815255|NCT03292666|Edoxaban|edoxaban|mesh-list
138815256|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138815257|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
138815258|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138815259|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
138815260|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815261|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815262|NCT02707653|Misoprostol|misoprostol|mesh-list
138815263|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138815264|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
138815265|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138815266|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815267|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138815268|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138815269|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
138815270|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138815271|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138815272|NCT03901131|Norethindrone|norethindrone|mesh-list
138815273|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
138815274|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
138815275|NCT03901131|Estradiol|estradiol|mesh-list
138815276|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138815277|NCT03901131|Estrogens|estrogens|mesh-ancestor
138815278|NCT03901131|Hormones|hormones|mesh-ancestor
138815279|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138815280|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815281|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138815282|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
138815283|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138815284|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138815285|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138815286|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138815287|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138815288|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
138815289|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138815290|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
138815291|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815292|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
138815293|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138815294|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815295|NCT03868839|Telmisartan|telmisartan|mesh-list
138815296|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138815297|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138815298|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138815299|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815301|NCT00589420|Sorafenib|sorafenib|mesh-list
138815302|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815303|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
138815304|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
138815305|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
138815306|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815307|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138815308|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815310|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138815311|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815312|NCT04114630|Analgesics|analgesics|mesh-ancestor
138815313|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
138468019|NCT01969942|Melphalan|melphalan|mesh-list
138815314|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815315|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815316|NCT00914524|Olmesartan|olmesartan|mesh-list
138815317|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138815318|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138815319|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138815320|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138815321|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815322|NCT03787095|Cemiplimab|cemiplimab|mesh-list
138815323|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138815324|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815325|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
138815326|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138815327|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138815328|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815329|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138815330|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815331|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138815332|NCT00796978|Trastuzumab|trastuzumab|mesh-list
138815333|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138652613|NCT00421083|Tadalafil|tadalafil|mesh-list
138815334|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815335|NCT03779295|Clindamycin|clindamycin|mesh-list
138815336|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
138815337|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
138815338|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138815339|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138428653|NCT01712139|Irbesartan|irbesartan|mesh-list
138815340|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138815341|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815342|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815344|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
138815345|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644694|NCT00316563|Hormones|hormones|mesh-ancestor
138815346|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138815347|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138815348|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815349|NCT03746769|Gastrins|gastrins|mesh-list
138815350|NCT03746769|Hormones|hormones|mesh-ancestor
138815351|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138815352|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815353|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
138815354|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138815355|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815356|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815357|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138815358|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138815359|NCT00796822|Protective Agents|protective agents|mesh-ancestor
138815360|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815361|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
138815362|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138815363|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
138815364|NCT03822507|Cinacalcet|cinacalcet|mesh-list
138815365|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138815366|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815367|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138815368|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
138815369|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138815370|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
138815371|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138815372|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138815373|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138815374|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815376|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815377|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815379|NCT00614679|Heparin|heparin|mesh-list
138815380|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
138815381|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138815382|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138815383|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815384|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138815385|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815386|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138815387|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815388|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138815389|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138815390|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815391|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138815392|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815393|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
138815394|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138815395|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815397|NCT01024946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138815398|NCT01024946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138815399|NCT01024946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815400|NCT01024946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815401|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138815402|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
138815403|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815404|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815405|NCT00724867|Belimumab|belimumab|mesh-list
138815406|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138815407|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
138815408|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815409|NCT00627536|Mitogens|mitogens|mesh-list
138815410|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
138815411|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815412|NCT00724711|Tenofovir|tenofovir|mesh-list
138815413|NCT00724711|Lamivudine|lamivudine|mesh-list
138815414|NCT00724711|Emtricitabine|emtricitabine|mesh-list
138815415|NCT00724711|Abacavir|abacavir|mesh-list
138815416|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
138815417|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815418|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138815419|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138815420|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815421|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815422|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138815423|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138815424|NCT00721279|Pramipexole|pramipexole|mesh-list
138815425|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
138815426|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815427|NCT00721279|Protective Agents|protective agents|mesh-ancestor
138815428|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815429|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138815431|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
138815432|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
138815433|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815434|NCT01030952|Acarbose|acarbose|mesh-list
138815435|NCT01030952|Nateglinide|nateglinide|mesh-list
138815436|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138815437|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815438|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815439|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138815440|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815441|NCT03611751|Apremilast|apremilast|mesh-list
138815442|NCT03611751|Deucravacitinib|deucravacitinib|mesh-list
138815443|NCT03611751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138815444|NCT03611751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138815445|NCT03611751|Analgesics|analgesics|mesh-ancestor
138815446|NCT03611751|Sensory System Agents|sensory system agents|mesh-ancestor
138815447|NCT03611751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815448|NCT03611751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815449|NCT03611751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138815450|NCT03611751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138467486|NCT01966692|Xhance|xhance|mesh-list
138815451|NCT03611751|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138815452|NCT03611751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138815453|NCT03611751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815454|NCT03611751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815455|NCT03611751|Dermatologic Agents|dermatologic agents|mesh-ancestor
138815456|NCT03611751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138815457|NCT00613743|Morphine|morphine|mesh-list
138815458|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138815459|NCT00613743|Narcotics|narcotics|mesh-ancestor
138815460|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138815461|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815462|NCT00613743|Analgesics|analgesics|mesh-ancestor
138815463|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
138815464|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815465|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
138815466|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138815467|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
138815468|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815469|NCT00614757|Expectorants|expectorants|mesh-ancestor
138815470|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
138815471|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138815472|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
138815473|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815474|NCT00614757|Protective Agents|protective agents|mesh-ancestor
138815475|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815476|NCT00614757|Antidotes|antidotes|mesh-ancestor
138815477|NCT02692365|Manganese|manganese|mesh-list
138652679|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138815478|NCT02692365|Trace Elements|trace elements|mesh-ancestor
138815479|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
138815480|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815481|NCT03492099|Buprenorphine|buprenorphine|mesh-list
138815482|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138815483|NCT03492099|Narcotics|narcotics|mesh-ancestor
138815484|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138815485|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815486|NCT03492099|Analgesics|analgesics|mesh-ancestor
138815487|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
138815488|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815489|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138815490|NCT03481959|Methylphenidate|methylphenidate|mesh-list
138815491|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138815492|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815493|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138468062|NCT01970072|Midazolam|midazolam|mesh-list
138815494|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138815495|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138815496|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815497|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
138815498|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815499|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138815500|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138815501|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138815502|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
138815503|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815504|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138815505|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138815506|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815508|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138815509|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138815510|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815511|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138815512|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815513|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138815515|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138815516|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
138815517|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815518|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815519|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138815520|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138815521|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138815522|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815523|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138815524|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138815525|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138815527|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
138815528|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815529|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138815530|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138815531|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815532|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138815533|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138815534|NCT00720499|Bromides|bromides|mesh-list
138815535|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
138815536|NCT00720499|Olodaterol|olodaterol|mesh-list
138815537|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138815538|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
138815539|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815540|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815541|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138815542|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
138815543|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
138815544|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138815545|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
138815546|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138468071|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
138815547|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815548|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
138815550|NCT00724243|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138815551|NCT00724243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138815552|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
138815553|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138815554|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138815555|NCT02590705|Lidocaine|lidocaine|mesh-list
138815556|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
138815557|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
138815558|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138815559|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815560|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
138815561|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815562|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138815563|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138815564|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138815565|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138815566|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815567|NCT00720343|Choline|choline|mesh-list
138815568|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
138815569|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138815570|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
138815571|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815572|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138815573|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138815574|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
138815575|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
138815577|NCT00720109|Folic Acid|folic acid|mesh-list
138815578|NCT00720109|Cytarabine|cytarabine|mesh-list
138815579|NCT00720109|Dexamethasone|dexamethasone|mesh-list
138815580|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
138815581|NCT00720109|Prednisone|prednisone|mesh-list
138815582|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
138815583|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138815584|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138815586|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
138815587|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
138815588|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138815589|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138815590|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138815591|NCT00720109|Cortisone|cortisone|mesh-list
138815592|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
138815593|NCT00720109|Ifosfamide|ifosfamide|mesh-list
138815594|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
138815595|NCT00720109|Methotrexate|methotrexate|mesh-list
138815596|NCT00720109|Etoposide|etoposide|mesh-list
138815597|NCT00720109|Vincristine|vincristine|mesh-list
138815598|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
138815599|NCT00720109|Daunorubicin|daunorubicin|mesh-list
138815600|NCT00720109|Asparaginase|asparaginase|mesh-list
138815601|NCT00720109|Dasatinib|dasatinib|mesh-list
138815602|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
138815603|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
138815604|NCT00720109|Pegaspargase|pegaspargase|mesh-list
138815605|NCT00720109|Lenograstim|lenograstim|mesh-list
138815606|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138815607|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
138815608|NCT00720109|BB 1101|bb 1101|mesh-list
138815609|NCT00720109|Calcium|calcium|mesh-list
138815610|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
138815611|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138815612|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
138815613|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815614|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138815615|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138815616|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
138815617|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815618|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815619|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138815620|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138815621|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
138815622|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
138815623|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815624|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138815625|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
138815626|NCT00720109|Hormones|hormones|mesh-ancestor
138815627|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138815628|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138815629|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
138815630|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815631|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138815632|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138815633|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138815634|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
138815635|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138815636|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138815637|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
138815638|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
138815639|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138815640|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138815641|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138644834|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815642|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138815643|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138815645|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815646|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138815647|NCT00720109|Antidotes|antidotes|mesh-ancestor
138815648|NCT00720109|Protective Agents|protective agents|mesh-ancestor
138815649|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
138815650|NCT00720109|Vitamins|vitamins|mesh-ancestor
138815651|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
138815652|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
138815653|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
138815654|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
138815655|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138815656|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138815657|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138815658|NCT00720109|Hematinics|hematinics|mesh-ancestor
138815659|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
138815660|NCT02590627|Lumefantrine|lumefantrine|mesh-list
138815661|NCT02590627|Artemether|artemether|mesh-list
138815662|NCT02590627|Piperaquine|piperaquine|mesh-list
138815663|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138815664|NCT02590627|Artenimol|artenimol|mesh-list
138815665|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
138815666|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138815667|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138815668|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815669|NCT01015118|Paclitaxel|paclitaxel|mesh-list
138815670|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138815671|NCT01015118|Carboplatin|carboplatin|mesh-list
138815672|NCT01015118|Nintedanib|nintedanib|mesh-list
138815673|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138468109|NCT01970579|Paclitaxel|paclitaxel|mesh-list
138815674|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365401|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
138815676|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
138815677|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
138815678|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815679|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138815680|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815681|NCT02415153|Pomalidomide|pomalidomide|mesh-list
138815682|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
138815683|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815684|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138815685|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138815686|NCT02415153|Growth Substances|growth substances|mesh-ancestor
138815687|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
138815688|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815689|NCT00628160|Terlipressin|terlipressin|mesh-list
138815690|NCT00628160|Dopamine|dopamine|mesh-list
138815691|NCT00628160|Norepinephrine|norepinephrine|mesh-list
138815692|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
138815693|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138815694|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138815695|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815696|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815697|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815698|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
138815699|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
138815700|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815701|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138815702|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138815703|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138815704|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
138815705|NCT00628160|Protective Agents|protective agents|mesh-ancestor
138815706|NCT02274285|Vaccines|vaccines|mesh-list
138815707|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
138815708|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815709|NCT00614835|Gemcitabine|gemcitabine|mesh-list
138815710|NCT00614835|Docetaxel|docetaxel|mesh-list
138815711|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138815712|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
138815713|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815714|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815715|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
138815716|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
138815717|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
138815718|NCT00715429|Vitamin D|vitamin d|mesh-list
138815719|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
138815720|NCT00715429|Vitamins|vitamins|mesh-ancestor
138815721|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
138815722|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815723|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138815724|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138815725|NCT02606032|Metronidazole|metronidazole|mesh-list
138815726|NCT02606032|Doxycycline|doxycycline|mesh-list
138815727|NCT02606032|Terbinafine|terbinafine|mesh-list
138815728|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815729|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138815730|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138815731|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138815732|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
138815733|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
138815734|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815735|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815736|NCT02145507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138815737|NCT01743651|Baclofen|baclofen|mesh-list
138815738|NCT01743651|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138815739|NCT01743651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815740|NCT01743651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138468126|NCT01970800|Hormones|hormones|mesh-list
138815741|NCT01743651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815742|NCT01743651|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138815743|NCT01743651|GABA Agonists|gaba agonists|mesh-ancestor
138815745|NCT01743651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652794|NCT00311987|Hormones|hormones|mesh-ancestor
138815746|NCT01743651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815747|NCT00715117|Naltrexone|naltrexone|mesh-list
138815748|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138815749|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138815750|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815751|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
138815752|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815753|NCT00723229|Acyclovir|acyclovir|mesh-list
138815754|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
138815755|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815756|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
138815757|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138815758|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815759|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815760|NCT01030718|Dasatinib|dasatinib|mesh-list
138815761|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815762|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138815763|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815764|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815765|NCT00722761|Drospirenone|drospirenone|mesh-list
138815766|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138815767|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138815769|NCT00722761|Estrogens|estrogens|mesh-ancestor
138815770|NCT00722761|Hormones|hormones|mesh-ancestor
138815771|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138815772|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815773|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138815774|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
138815775|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138815776|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138815777|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138815778|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138815779|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138815780|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
138815781|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138815782|NCT00722761|Diuretics|diuretics|mesh-ancestor
138815783|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
138815784|NCT00628238|Rituximab|rituximab|mesh-list
138815785|NCT00628238|Lenalidomide|lenalidomide|mesh-list
138815786|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138815787|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815788|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
138815789|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815790|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138815791|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138815792|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138815793|NCT00628238|Growth Substances|growth substances|mesh-ancestor
138815794|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
138815795|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138815796|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138815797|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
138815798|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138815799|NCT01019486|Regadenoson|regadenoson|mesh-list
138815800|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138815801|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138815802|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138815803|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
138815804|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
138815805|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815806|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815807|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815808|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138815809|NCT02803203|Bevacizumab|bevacizumab|mesh-list
138815810|NCT02803203|Osimertinib|osimertinib|mesh-list
138815811|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138815813|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138644892|NCT00317031|Naltrexone|naltrexone|mesh-list
138815814|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138815815|NCT02803203|Growth Substances|growth substances|mesh-ancestor
138815816|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815817|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
138815818|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138815819|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815820|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815822|NCT00714493|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138815823|NCT00714493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138815824|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
138815825|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138815826|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138815827|NCT01013870|Atorvastatin|atorvastatin|mesh-list
138815828|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138467778|NCT01968564|Curcumin|curcumin|mesh-list
138815829|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138815830|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
138815831|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815832|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138815833|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138815834|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815835|NCT05020184|Cimetidine|cimetidine|mesh-list
138815836|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138815837|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138815838|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138815839|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
138815840|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
138815841|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815842|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815843|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815844|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138815845|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138815846|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815847|NCT00628316|Caffeine|caffeine|mesh-list
138652837|NCT00312260|Gabapentin|gabapentin|mesh-list
138815848|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138815849|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815850|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138815851|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815852|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815853|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138815854|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138815855|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
138815856|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815858|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138815859|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
138815860|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815861|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815862|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138815863|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
138815864|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138815865|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815866|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815867|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138815868|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138815869|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138815870|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
138815871|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
138815872|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815873|NCT01018394|Nicotine|nicotine|mesh-list
138815874|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138815875|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
138815876|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815877|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815878|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138815879|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138815880|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
138815881|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815882|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815883|NCT04301336|Zinc|zinc|mesh-list
138815884|NCT04301336|Folic Acid|folic acid|mesh-list
138815885|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
138815886|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
138815887|NCT04301336|Morphine|morphine|mesh-list
138815888|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
138815889|NCT04301336|Simvastatin|simvastatin|mesh-list
138815890|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138815891|NCT04301336|Narcotics|narcotics|mesh-ancestor
138815892|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138815893|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815894|NCT04301336|Analgesics|analgesics|mesh-ancestor
138815895|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
138815896|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815897|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138815898|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138815899|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
138815900|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815901|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138815902|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138815903|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815904|NCT04301336|Trace Elements|trace elements|mesh-ancestor
138815905|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
138815906|NCT04301336|Hematinics|hematinics|mesh-ancestor
138815907|NCT04301336|Vitamins|vitamins|mesh-ancestor
138815908|NCT04301336|Astringents|astringents|mesh-ancestor
138815909|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
138815910|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815911|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
138815912|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138815913|NCT00627848|Rivastigmine|rivastigmine|mesh-list
138815914|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138815915|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468153|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138815916|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815917|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
138815918|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815919|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815920|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138815921|NCT00627848|Protective Agents|protective agents|mesh-ancestor
138815922|NCT04299854|Dinoprostone|dinoprostone|mesh-list
138815923|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
138815924|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138815925|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815926|NCT01017146|Tazarotene|tazarotene|mesh-list
138815927|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
138815928|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
138815929|NCT02872064|Verteporfin|verteporfin|mesh-list
138815930|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138815931|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
138815932|NCT01010750|Amphetamine|amphetamine|mesh-list
138815933|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138815934|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138815935|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815936|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
138815937|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
138815938|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138815939|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
138815940|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815941|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815942|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
138815943|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138815944|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138815945|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138815946|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138815947|NCT01012622|Methylphenidate|methylphenidate|mesh-list
138815948|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138815949|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815950|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138815951|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138815952|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138815953|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815954|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
138815955|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138815956|NCT00722371|Metformin|metformin|mesh-list
138815958|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138815959|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138815960|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815962|NCT00722371|Hormones|hormones|mesh-ancestor
138815963|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138815964|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138815965|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
138815966|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815967|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815968|NCT02871986|Estrogens|estrogens|mesh-list
138815969|NCT02871986|Hormones|hormones|mesh-ancestor
138815970|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138815971|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815972|NCT00722137|Prednisone|prednisone|mesh-list
138815973|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
138815974|NCT00722137|Rituximab|rituximab|mesh-list
138467935|NCT01969357|Hormones|hormones|mesh-ancestor
138815975|NCT00722137|Doxorubicin|doxorubicin|mesh-list
138815976|NCT00722137|Vincristine|vincristine|mesh-list
138815977|NCT00722137|Bortezomib|bortezomib|mesh-list
138815978|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138815979|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
138815980|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138815981|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138815982|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138815983|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
138815984|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138815985|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138815986|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138815987|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138815988|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138815989|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138815990|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138815991|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138815992|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138815993|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
138815994|NCT00722137|Hormones|hormones|mesh-ancestor
138815995|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138815996|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138815997|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138815998|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
138815999|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
138816000|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
138816001|NCT04114396|Antibodies|antibodies|mesh-list
138816002|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
138816003|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816004|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
138816005|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
138816006|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
138816007|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138816008|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138816009|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429119|NCT01714427|Dexamethasone|dexamethasone|mesh-list
138816010|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138652895|NCT00312533|Hylan|hylan|mesh-list
138816011|NCT00796666|Urological Agents|urological agents|mesh-ancestor
138816012|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138816013|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138816014|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138816015|NCT00799708|Estradiol|estradiol|mesh-list
138816016|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138816017|NCT00799708|Estrogens|estrogens|mesh-ancestor
138816018|NCT00799708|Hormones|hormones|mesh-ancestor
138816019|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138816020|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816021|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138816022|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
138816023|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138816024|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138816025|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
138816026|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
138816027|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
138816028|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138816029|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138816030|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816031|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816032|NCT00796510|Urological Agents|urological agents|mesh-ancestor
138816033|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138816034|NCT04111432|Vaccines|vaccines|mesh-list
138816035|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
138816036|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816037|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
138816038|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138816039|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138816040|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816042|NCT00588640|D-methadone|d-methadone|mesh-list
138816043|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138816044|NCT00588640|Narcotics|narcotics|mesh-ancestor
138816045|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816046|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816047|NCT00588640|Analgesics|analgesics|mesh-ancestor
138816048|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
138816049|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816050|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
138816051|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
138816052|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138816054|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138652923|NCT00347685|Tramadol|tramadol|mesh-list
138816055|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
138816056|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816057|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
138816058|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816059|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
138816060|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
138816061|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816062|NCT00802672|Ciclopirox|ciclopirox|mesh-list
138816063|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
138816064|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816065|NCT04113772|Nitisinone|nitisinone|mesh-list
138816066|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816067|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816068|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
138816069|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
138816070|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816071|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138816072|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816073|NCT04115800|Sirolimus|sirolimus|mesh-list
138816074|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138816075|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816076|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138816077|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816078|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
138816079|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138816080|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
138816081|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816082|NCT04115410|Cisplatin|cisplatin|mesh-list
138816083|NCT04115410|Carboplatin|carboplatin|mesh-list
138816084|NCT04115410|Gemcitabine|gemcitabine|mesh-list
138816085|NCT04115410|Docetaxel|docetaxel|mesh-list
138816086|NCT04115410|Pemetrexed|pemetrexed|mesh-list
138816087|NCT04115410|Vinorelbine|vinorelbine|mesh-list
138816089|NCT04115410|Mitomycins|mitomycins|mesh-list
138816090|NCT04115410|Mitomycin|mitomycin|mesh-list
138816091|NCT04115410|Osimertinib|osimertinib|mesh-list
138816092|NCT04115410|Afatinib|afatinib|mesh-list
138816093|NCT04115410|Vinblastine|vinblastine|mesh-list
138816094|NCT04115410|Crizotinib|crizotinib|mesh-list
138816095|NCT04115410|Ceritinib|ceritinib|mesh-list
138816096|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
138816097|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138816098|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138816099|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
138816100|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816101|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
138816102|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
138816103|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
138816104|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816105|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138816106|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138816107|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138468202|NCT01971450|Iloprost|iloprost|mesh-list
138816108|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138816109|NCT04115410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138816110|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138816111|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
138816112|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138816113|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816114|NCT02604784|Cisplatin|cisplatin|mesh-list
138816115|NCT02604784|Doxorubicin|doxorubicin|mesh-list
138816116|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138816117|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
138816118|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816119|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138816120|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138816121|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138816122|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816123|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816124|NCT04110808|Phentolamine|phentolamine|mesh-list
138816125|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
138816126|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
138816127|NCT04110808|Anesthetics|anesthetics|mesh-list
138816128|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816129|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816130|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
138816131|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138816132|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138816134|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816135|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816136|NCT00714259|Fludarabine|fludarabine|mesh-list
138816137|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816138|NCT00796120|Doxorubicin|doxorubicin|mesh-list
138816139|NCT00796120|Ifosfamide|ifosfamide|mesh-list
138816140|NCT00796120|Trabectedin|trabectedin|mesh-list
138816141|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138816142|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816143|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138816144|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138816145|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816146|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816147|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138816148|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
138816149|NCT00795886|Sirolimus|sirolimus|mesh-list
138816150|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138429207|NCT01714908|Etoposide|etoposide|mesh-list
138816152|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138816153|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816155|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138816156|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
138816157|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816158|NCT04110418|Terlipressin|terlipressin|mesh-list
138816159|NCT04110418|Methylene Blue|methylene blue|mesh-list
138816160|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816161|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816162|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138816163|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138816164|NCT02589457|Tenofovir|tenofovir|mesh-list
138816165|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
138816166|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816167|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138652967|NCT00347724|Narcotics|narcotics|mesh-ancestor
138816168|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138816169|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468225|NCT01971632|Oxycodone|oxycodone|mesh-list
138816170|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816171|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138816172|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138816173|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
138816174|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138816175|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816176|NCT05310643|Nivolumab|nivolumab|mesh-list
138816177|NCT05310643|Ipilimumab|ipilimumab|mesh-list
138816178|NCT05310643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138816179|NCT05310643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816180|NCT05310643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138816181|NCT05310643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816182|NCT05257213|Heparin|heparin|mesh-list
138816183|NCT05257213|Anticoagulants|anticoagulants|mesh-ancestor
138816184|NCT05257213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138816185|NCT05257213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138816186|NCT05257213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816187|NCT00918853|Pancrelipase|pancrelipase|mesh-list
138816188|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138816189|NCT01016600|Lenalidomide|lenalidomide|mesh-list
138816190|NCT01016600|Azacitidine|azacitidine|mesh-list
138816191|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
138816192|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816193|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138816194|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138816195|NCT01016600|Growth Substances|growth substances|mesh-ancestor
138816196|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
138429227|NCT01715142|Paclitaxel|paclitaxel|mesh-list
138816197|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816198|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138816199|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
138816200|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816201|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816202|NCT05175235|Pembrolizumab|pembrolizumab|mesh-list
138816203|NCT05175235|Nivolumab|nivolumab|mesh-list
138816204|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138816205|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816206|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138816207|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816209|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138816210|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138816211|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816212|NCT04298684|Incretins|incretins|mesh-ancestor
138816213|NCT04298684|Hormones|hormones|mesh-ancestor
138816214|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138816215|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138816216|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
138816217|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816218|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816219|NCT04298372|Lenalidomide|lenalidomide|mesh-list
138816220|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
138816221|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816222|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138816223|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138816224|NCT04298372|Growth Substances|growth substances|mesh-ancestor
138816225|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
138816226|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816227|NCT01010204|Varenicline|varenicline|mesh-list
138816228|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138816229|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138816230|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
138816231|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816232|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816233|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816234|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
138816235|NCT00718549|Rituximab|rituximab|mesh-list
138816236|NCT00718549|Cladribine|cladribine|mesh-list
138816237|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138816238|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
138816239|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816240|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138816241|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138816242|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
138429255|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816243|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816244|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816245|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138816246|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138816248|NCT00793624|Olodaterol|olodaterol|mesh-list
138816249|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138816250|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
138816251|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816252|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816253|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138816254|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
138816255|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138816256|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138816257|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138816258|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
138816259|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816260|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816261|NCT00919243|Prednisone|prednisone|mesh-list
138816262|NCT00919243|Allopurinol|allopurinol|mesh-list
138816263|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138816264|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
138816265|NCT00919243|Hormones|hormones|mesh-ancestor
138816266|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138816267|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816268|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138816269|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816270|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
138816271|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816272|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816273|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
138816274|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138816275|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138816276|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
138816277|NCT00919243|Protective Agents|protective agents|mesh-ancestor
138816278|NCT00794950|Sunitinib|sunitinib|mesh-list
138816279|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816280|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138816281|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138816282|NCT00794950|Growth Substances|growth substances|mesh-ancestor
138816283|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816284|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
138816285|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138816286|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816287|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816288|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138816289|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
138816290|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
138816291|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138816292|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
138816293|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138816294|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138816295|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
138816296|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816297|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816299|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816300|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138816301|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138816302|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816303|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816304|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138816305|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
138816306|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138816307|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816308|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138816309|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138816310|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138816311|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816312|NCT00798694|Travoprost|travoprost|mesh-list
138816313|NCT00798694|Latanoprost|latanoprost|mesh-list
138816314|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138816315|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138816316|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138816317|NCT00718315|Erythromycin|erythromycin|mesh-list
138816318|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
138816319|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138816320|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
138816321|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
138816322|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138816323|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816324|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138816325|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816326|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816327|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138816328|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816329|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138816330|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138816331|NCT00798304|Vaccines|vaccines|mesh-list
138816332|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
138816333|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816334|NCT04109872|Lenalidomide|lenalidomide|mesh-list
138816335|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
138816336|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816337|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138816338|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138816339|NCT04109872|Growth Substances|growth substances|mesh-ancestor
138816340|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
138816341|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816342|NCT00793780|Naltrexone|naltrexone|mesh-list
138816343|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138816344|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138816345|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816346|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
138816347|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816348|NCT04107220|Valsartan|valsartan|mesh-list
138816349|NCT04107220|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138816350|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138816351|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138816352|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138816353|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816354|NCT02591017|Ketamine|ketamine|mesh-list
138816355|NCT02591017|Morphine|morphine|mesh-list
138816356|NCT02591017|Chitosan|chitosan|mesh-list
138816357|NCT02591017|Analgesics|analgesics|mesh-ancestor
138816358|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
138816359|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816360|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816361|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138468249|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
138816363|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
138816364|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
138816365|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816366|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138816367|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138816368|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816369|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816370|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138816371|NCT02591017|Narcotics|narcotics|mesh-ancestor
138816372|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138816373|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138816374|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
138816375|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138816376|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
138816377|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
138816378|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
138816379|NCT02591017|Coagulants|coagulants|mesh-ancestor
138816380|NCT02591095|Navitoclax|navitoclax|mesh-list
138816381|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816382|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
138816383|NCT02588755|Tegafur|tegafur|mesh-list
138816384|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138816385|NCT02588755|Estrogens|estrogens|mesh-ancestor
138816386|NCT02588755|Hormones|hormones|mesh-ancestor
138816387|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138816388|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816389|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138816390|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816391|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138816392|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
138816393|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816394|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138816395|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
138653107|NCT00348192|Donepezil|donepezil|mesh-list
138816396|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816397|NCT02643303|Durvalumab|durvalumab|mesh-list
138816398|NCT02643303|Tremelimumab|tremelimumab|mesh-list
138816399|NCT02643303|Poly ICLC|poly iclc|mesh-list
138816400|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138816401|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816402|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
138816403|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
138816404|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816405|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
138816406|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138816407|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138816408|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816409|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
138816410|NCT00615147|Coagulants|coagulants|mesh-ancestor
138816411|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138816412|NCT01029717|Minocycline|minocycline|mesh-list
138816413|NCT01029717|Rifampin|rifampin|mesh-list
138816414|NCT01029717|Heparin|heparin|mesh-list
138816415|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816416|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138816417|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
138816418|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
138816419|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138816420|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138816421|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816422|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
138816423|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138816424|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816425|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138816426|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138816427|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138816428|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138816429|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138816430|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138816431|NCT00790036|Everolimus|everolimus|mesh-list
138816432|NCT00790036|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138816433|NCT00790036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138816434|NCT00790036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816435|NCT00790036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816436|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138816437|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
138816438|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816439|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816440|NCT05563168|Diltiazem|diltiazem|mesh-list
138816441|NCT05563168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138816442|NCT05563168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138816443|NCT05563168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138816444|NCT05563168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816445|NCT05563168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138816446|NCT05563168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816447|NCT05563168|Vasodilator Agents|vasodilator agents|mesh-ancestor
138816448|NCT00789958|Gemcitabine|gemcitabine|mesh-list
138816449|NCT00789958|Capecitabine|capecitabine|mesh-list
138816450|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138816451|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
138816452|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653139|NCT00343980|Glimepiride|glimepiride|mesh-list
138816453|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816454|NCT00789880|Vitamin D|vitamin d|mesh-list
138816455|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
138816456|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
138816457|NCT00789880|Vitamins|vitamins|mesh-list
138816458|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
138816459|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816460|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138816461|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138816462|NCT00915616|Melatonin|melatonin|mesh-list
138816463|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
138816464|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816466|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816467|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816469|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
138816470|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138816471|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
138816472|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
138816473|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138816474|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138816475|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
138816476|NCT00914836|Hormones|hormones|mesh-ancestor
138816477|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138816478|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816479|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138816480|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
138816481|NCT04106752|Caffeine|caffeine|mesh-list
138816482|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138816483|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816484|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138816485|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816486|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816487|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138816488|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138816489|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
138816490|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816491|NCT00792298|Suvorexant|suvorexant|mesh-list
138816492|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138816493|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138816494|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816495|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816496|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138816497|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816498|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816499|NCT02603068|Treprostinil|treprostinil|mesh-list
138816500|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138816501|NCT00718081|Sufentanil|sufentanil|mesh-list
138816502|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138468516|NCT01973790|Z 338|z 338|mesh-list
138816503|NCT00718081|Narcotics|narcotics|mesh-ancestor
138816504|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816505|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816506|NCT00718081|Analgesics|analgesics|mesh-ancestor
138816507|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
138816508|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816509|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138816510|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138816511|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
138816512|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
138816513|NCT00788710|Etoricoxib|etoricoxib|mesh-list
138816514|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138816515|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138816516|NCT00788710|Analgesics|analgesics|mesh-ancestor
138816517|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
138816518|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816519|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816520|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138816521|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138816522|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138816523|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138816524|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816525|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816526|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138816527|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
138816528|NCT04083625|Carbetocin|carbetocin|mesh-list
138816529|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
138816530|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138816531|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816533|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
138816534|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816535|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816536|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
138816537|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816538|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816539|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
138816540|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138645210|NCT00318084|Esomeprazole|esomeprazole|mesh-list
138816541|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816542|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138816543|NCT04106050|Lidocaine|lidocaine|mesh-list
138816544|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
138816545|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
138816546|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816547|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816548|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
138816549|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816550|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138816551|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138816552|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138816553|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138816554|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816555|NCT00588094|Rituximab|rituximab|mesh-list
138816556|NCT00588094|Carboplatin|carboplatin|mesh-list
138816557|NCT00588094|Etoposide|etoposide|mesh-list
138816558|NCT00588094|Ifosfamide|ifosfamide|mesh-list
138816559|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138816560|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816561|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
138816562|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816563|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138816564|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138816565|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138816566|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138816567|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816568|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816569|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138816570|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
138816571|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138816572|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
138816573|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816574|NCT00482157|Vitamin D|vitamin d|mesh-list
138816575|NCT00482157|Calcitriol|calcitriol|mesh-list
138816576|NCT00482157|Vitamins|vitamins|mesh-ancestor
138816577|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
138468528|NCT01973816|Estradiol|estradiol|mesh-list
138816578|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816579|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138816580|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138816581|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138816582|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138816583|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468319|NCT01972230|Narcotics|narcotics|mesh-ancestor
138816584|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138816585|NCT02706015|Dipyrone|dipyrone|mesh-list
138816586|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
138816587|NCT02706015|Caffeine|caffeine|mesh-list
138816588|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138816589|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816590|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138816591|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816592|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816593|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138816594|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138816595|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
138816596|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645232|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138816597|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138816598|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138816600|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
138816601|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816602|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138816603|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138816604|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
138816605|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138816606|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
138816607|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
138816608|NCT02707575|Ranibizumab|ranibizumab|mesh-list
138816609|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138816610|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138816611|NCT02707575|Growth Substances|growth substances|mesh-ancestor
138816612|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816613|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
138816614|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816615|NCT00919399|Tamoxifen|tamoxifen|mesh-list
138816616|NCT00919399|Exemestane|exemestane|mesh-list
138816617|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138816618|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
138816619|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138816620|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816621|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138816622|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816623|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138816624|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138816625|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138816626|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138816627|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138816628|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816629|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816630|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138816631|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138816632|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816633|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138816634|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138816635|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138816636|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816637|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
138816638|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816639|NCT02588287|Tenofovir|tenofovir|mesh-list
138816640|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
138816641|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816642|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138816643|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138816644|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816645|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816646|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138816647|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138816648|NCT02707107|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
138468602|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
138816649|NCT02707107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138816650|NCT02707107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816651|NCT02707263|Heparin|heparin|mesh-list
138816652|NCT02707263|Calcium heparin|calcium heparin|mesh-list
138816653|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
138816654|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138816655|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138816656|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816657|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138816658|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138816659|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138816660|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
138816661|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816662|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138816663|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138816664|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816665|NCT00615303|Simethicone|simethicone|mesh-list
138816666|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
138816667|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816668|NCT00615303|Emollients|emollients|mesh-ancestor
138816669|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
138816670|NCT00787150|Warfarin|warfarin|mesh-list
138816671|NCT00787150|Apixaban|apixaban|mesh-list
138816672|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
138816673|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138816674|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
138816675|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138816676|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
138816677|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468377|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
138816678|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816679|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138816680|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138816681|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816682|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138816683|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138816684|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816685|NCT00786838|Trabectedin|trabectedin|mesh-list
138816686|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138653252|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816687|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
138816688|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816689|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816690|NCT02604004|Lamivudine|lamivudine|mesh-list
138816691|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138816692|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138816693|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816694|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816695|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
138816696|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816697|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138816698|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138816699|NCT05095207|Bicalutamide|bicalutamide|mesh-list
138816700|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
138816701|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
138816702|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138816703|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816704|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816705|NCT03354039|Tamoxifen|tamoxifen|mesh-list
138816706|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138816707|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
138816708|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138816709|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816710|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138816711|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816712|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138816713|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138816714|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138816715|NCT04105426|Antioxidants|antioxidants|mesh-list
138816716|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816717|NCT04105426|Protective Agents|protective agents|mesh-ancestor
138816718|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816720|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138468677|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816721|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138816722|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138816723|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138816724|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138816725|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
138816726|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816727|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816728|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138816729|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
138816730|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
138816731|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
138816732|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138816733|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138816734|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
138816735|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816736|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816737|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
138816738|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
138816739|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138816740|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138816741|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138816742|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138816743|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816744|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
138816745|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816746|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816747|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138816748|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816749|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138816750|NCT02704767|Apatinib|apatinib|mesh-list
138816751|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138816752|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816753|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138816754|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816755|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816756|NCT02587273|Fentanyl|fentanyl|mesh-list
138816757|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138816758|NCT02587273|Narcotics|narcotics|mesh-ancestor
138816759|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816760|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816761|NCT02587273|Analgesics|analgesics|mesh-ancestor
138816762|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
138816763|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816764|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138816765|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138816766|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
138816767|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
138816768|NCT02704299|Immunomodulating Agents|immunomodulating agents|mesh-list
138816769|NCT02704299|Immunologic Factors|immunologic factors|mesh-ancestor
138816770|NCT02704299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816771|NCT02587741|Metformin|metformin|mesh-list
138816772|NCT02587741|Acarbose|acarbose|mesh-list
138816773|NCT02587741|Gliclazide|gliclazide|mesh-list
138816774|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138816775|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138816776|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816777|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138816778|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816779|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816780|NCT02703363|Minocycline|minocycline|mesh-list
138816781|NCT02703363|Celecoxib|celecoxib|mesh-list
138816782|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138816783|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138816784|NCT02703363|Analgesics|analgesics|mesh-ancestor
138816785|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
138816786|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816787|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816788|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138816789|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138468412|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138816790|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138816791|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138816792|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816793|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816794|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138816795|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816796|NCT00615381|Insulin|insulin|mesh-list
138816797|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138816798|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138816799|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816800|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
138816801|NCT00785980|Quinine|quinine|mesh-list
138816802|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138816803|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816804|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138816805|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138816806|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816807|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816808|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816809|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138816810|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138816811|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
138816812|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138816813|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138816814|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138816815|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816816|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138816817|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816818|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138816819|NCT00785980|Analgesics|analgesics|mesh-ancestor
138816820|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
138816822|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
138816823|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
138816824|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
138816825|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138816826|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
138816827|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
138816828|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816829|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816830|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816831|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138816832|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138816833|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138816834|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816835|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
138816836|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
138816837|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
138816838|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816839|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
138816840|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
138816841|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138816842|NCT00915694|Nelfinavir|nelfinavir|mesh-list
138816843|NCT00915694|Temozolomide|temozolomide|mesh-list
138816844|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138816845|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
138816846|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816847|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138816848|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138816849|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138816850|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
138816851|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816852|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138816853|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138816854|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
138816855|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816857|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138816858|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
138816859|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816860|NCT00785512|Nebivolol|nebivolol|mesh-list
138816861|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138816862|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
138816863|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138816864|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138816865|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138816866|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
138816867|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816868|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816869|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816871|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138816872|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138816873|NCT02702817|Analgesics|analgesics|mesh-ancestor
138816874|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
138816875|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653350|NCT02960126|Aspirin|aspirin|mesh-list
138816876|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816877|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138816878|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138816879|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
138816880|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138816881|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816882|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816883|NCT02702739|Ribavirin|ribavirin|mesh-list
138816884|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
138816885|NCT02702739|Simeprevir|simeprevir|mesh-list
138816886|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
138816887|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816888|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
138816889|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816890|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
138816891|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816892|NCT02602444|Ticagrelor|ticagrelor|mesh-list
138816893|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138816894|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138816895|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138816896|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138816897|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
138816898|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816899|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816900|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816901|NCT02702661|Anesthetics|anesthetics|mesh-list
138816902|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
138816903|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
138816904|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816905|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816906|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
138816907|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816908|NCT02702349|Penicillins|penicillins|mesh-list
138816909|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138816910|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138816911|NCT04104334|Remifentanil|remifentanil|mesh-list
138816912|NCT04104334|Desflurane|desflurane|mesh-list
138816913|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
138816914|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816915|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816916|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138816917|NCT04104334|Narcotics|narcotics|mesh-ancestor
138816918|NCT04104334|Analgesics|analgesics|mesh-ancestor
138816919|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
138816920|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816921|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138816922|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
138816923|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138816924|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138816925|NCT02602600|Liraglutide|liraglutide|mesh-list
138816926|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138645348|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
138816927|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816928|NCT02602600|Incretins|incretins|mesh-ancestor
138816929|NCT02602600|Hormones|hormones|mesh-ancestor
138816930|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138816931|NCT00615615|Levetiracetam|levetiracetam|mesh-list
138816932|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
138816933|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
138816934|NCT00784810|Acetaminophen|acetaminophen|mesh-list
138816935|NCT00784810|Oxycodone|oxycodone|mesh-list
138816936|NCT00784810|Codeine|codeine|mesh-list
138816937|NCT00784810|Naloxone|naloxone|mesh-list
138816938|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138816939|NCT00784810|Analgesics|analgesics|mesh-ancestor
138816940|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
138816941|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816942|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816943|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
138816944|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138816945|NCT00784810|Narcotics|narcotics|mesh-ancestor
138816946|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816947|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138468894|NCT01976195|Hormones|hormones|mesh-ancestor
138816948|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
138816949|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
138816950|NCT02603770|Lovastatin|lovastatin|mesh-list
138816951|NCT02603770|L 647318|l 647318|mesh-list
138816952|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
138816953|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138816954|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138816955|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
138816956|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816957|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138816958|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138816959|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138816960|NCT04081909|Fentanyl|fentanyl|mesh-list
138816961|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
138816962|NCT04081909|Ketamine|ketamine|mesh-list
138816963|NCT04081909|Remifentanil|remifentanil|mesh-list
138816964|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138816965|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138816966|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816967|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138816968|NCT04081909|Analgesics|analgesics|mesh-ancestor
138816969|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
138653423|NCT00349089|Pemetrexed|pemetrexed|mesh-list
138816970|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138816971|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138816972|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138816973|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138816974|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
138816975|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138816976|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816977|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138816978|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138816979|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
138816980|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
138816981|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138816982|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138816983|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138816984|NCT04081909|Narcotics|narcotics|mesh-ancestor
138816985|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138816986|NCT03272217|Bevacizumab|bevacizumab|mesh-list
138816987|NCT03272217|Atezolizumab|atezolizumab|mesh-list
138468444|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
138816988|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138816989|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645359|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
138816990|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138816991|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138816992|NCT03272217|Growth Substances|growth substances|mesh-ancestor
138816993|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138816994|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
138816995|NCT03272217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138816996|NCT03272217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138816997|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138816998|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138816999|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817000|NCT00915382|Cisplatin|cisplatin|mesh-list
138817001|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817002|NCT05344443|Lemborexant|lemborexant|mesh-list
138817003|NCT05344443|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138817004|NCT05344443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817005|NCT05344443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817006|NCT05344443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138817007|NCT05344443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138817008|NCT05344443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817009|NCT05344443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817010|NCT00919555|Pioglitazone|pioglitazone|mesh-list
138817011|NCT00919555|Tretinoin|tretinoin|mesh-list
138817012|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138817013|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817014|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817015|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
138817016|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
138817017|NCT02979093|Oxytocin|oxytocin|mesh-list
138817018|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
138817019|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138817020|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817021|NCT02588131|Durvalumab|durvalumab|mesh-list
138817022|NCT02588131|Tremelimumab|tremelimumab|mesh-list
138817023|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138817025|NCT04766983|Dimercaprol|dimercaprol|mesh-list
138817026|NCT04766983|Chelating Agents|chelating agents|mesh-ancestor
138817027|NCT04766983|Sequestering Agents|sequestering agents|mesh-ancestor
138817028|NCT04766983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817029|NCT04766437|Ticagrelor|ticagrelor|mesh-list
138817030|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138817031|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138817032|NCT04766437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138817033|NCT04766437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138817034|NCT04766437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138817035|NCT04766437|Purinergic Agents|purinergic agents|mesh-ancestor
138817036|NCT04766437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817037|NCT04766437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817038|NCT04766437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817039|NCT00776230|Vaccines|vaccines|mesh-list
138817040|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
138817041|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817042|NCT02586259|Budesonide|budesonide|mesh-list
138468451|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
138817044|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138817045|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
138645372|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817046|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817047|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817048|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138817049|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
138817050|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
138817052|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138817053|NCT00775606|Ritonavir|ritonavir|mesh-list
138817054|NCT00775606|Lopinavir|lopinavir|mesh-list
138817055|NCT00775606|Efavirenz|efavirenz|mesh-list
138817056|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138817057|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138817058|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
138817059|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817060|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817061|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138817062|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138817063|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
138817064|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817065|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138817066|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138817067|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138817068|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138817069|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138817070|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138817071|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138817072|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138817073|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138817074|NCT04761601|Paclitaxel|paclitaxel|mesh-list
138817075|NCT04761601|Gemcitabine|gemcitabine|mesh-list
138817076|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138817077|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817078|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
138817079|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
138817080|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
138817081|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817082|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138817083|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
138817084|NCT02960763|Aripiprazole|aripiprazole|mesh-list
138817085|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
138817086|NCT02960763|Bupropion|bupropion|mesh-list
138817087|NCT02960763|Nortriptyline|nortriptyline|mesh-list
138817088|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138468471|NCT01973504|Analgesics|analgesics|mesh-ancestor
138817089|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
138817090|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138817091|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138817092|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138817093|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138817094|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817095|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
138817096|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817097|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817098|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138817099|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138817100|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817101|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138817102|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138817103|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817104|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
138645392|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
138817105|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138817106|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138817107|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
138817108|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138817109|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138817110|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138817111|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138817112|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
138817113|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138817114|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138817115|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
138817116|NCT00775528|Pancrelipase|pancrelipase|mesh-list
138817117|NCT00775528|Pancreatin|pancreatin|mesh-list
138817118|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138817119|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138817120|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138817121|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138817122|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138817123|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817124|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817125|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817126|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138817127|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
138817128|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138817129|NCT02701179|Lidocaine|lidocaine|mesh-list
138817130|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138817131|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
138817132|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
138429685|NCT01718236|Rocuronium|rocuronium|mesh-list
138653528|NCT00349245|Narcotics|narcotics|mesh-ancestor
138817133|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817134|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817135|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
138817136|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817137|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138817138|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138817139|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138817140|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138817141|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817142|NCT02586961|Betamethasone|betamethasone|mesh-list
138817143|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
138817144|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138817145|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
138817146|NCT02586961|Epinephrine|epinephrine|mesh-list
138817147|NCT02586961|Racepinephrine|racepinephrine|mesh-list
138817148|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138817149|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
138817150|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138817151|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
138817152|NCT02586961|Hormones|hormones|mesh-ancestor
138817153|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138817154|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817155|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138817156|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
138817157|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138817158|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138817159|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
138817160|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817161|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817162|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138817163|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138817164|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
138817165|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817166|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
138817167|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
138817168|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138817169|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138817170|NCT02700711|Methylphenidate|methylphenidate|mesh-list
138817171|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138817172|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817173|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138817174|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138817175|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138817176|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817177|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
138817178|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817179|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138817180|NCT02700711|Analgesics|analgesics|mesh-ancestor
138817181|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
138817182|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817183|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
138817184|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138817185|NCT04215159|Gemcitabine|gemcitabine|mesh-list
138817186|NCT04215159|Trastuzumab|trastuzumab|mesh-list
138817187|NCT04215159|Irinotecan|irinotecan|mesh-list
138817188|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138817189|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
138817190|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817191|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817192|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138817193|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138817194|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138817195|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817196|NCT00775450|Vaccines|vaccines|mesh-list
138817197|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
138817198|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817199|NCT02700477|Fenugreek seed meal|fenugreek seed meal|mesh-list
138817200|NCT02700477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138817201|NCT02700477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817202|NCT02699385|Domperidone|domperidone|mesh-list
138817203|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
138653607|NCT06164327|Oxaliplatin|oxaliplatin|mesh-list
138817204|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
138817205|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817206|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817207|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138817208|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138817209|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
138817210|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817211|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817212|NCT02700087|Famotidine|famotidine|mesh-list
138817213|NCT02700087|Ranitidine|ranitidine|mesh-list
138817214|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138817215|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138817216|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138817217|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138817218|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
138817219|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
138817220|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817221|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817222|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817223|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
138817224|NCT02586181|Vitamin D|vitamin d|mesh-list
138817225|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
138817226|NCT02586181|Cholecalciferol|cholecalciferol|mesh-list
138817227|NCT02586181|Vitamins|vitamins|mesh-list
138817228|NCT02586181|Folic Acid|folic acid|mesh-list
138817229|NCT02586181|Calcium|calcium|mesh-list
138817230|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
138817231|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817232|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138817233|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138817234|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
138817235|NCT02586181|Hematinics|hematinics|mesh-ancestor
138817236|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
138429745|NCT01718327|Sunitinib|sunitinib|mesh-list
138817237|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138817238|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817240|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138817241|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817242|NCT03236805|Ketamine|ketamine|mesh-list
138817243|NCT03236805|Morphine|morphine|mesh-list
138817244|NCT03236805|Analgesics|analgesics|mesh-ancestor
138817245|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
138817246|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817247|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817248|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138817249|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138817250|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
138817252|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817253|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138817254|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138817255|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817256|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817257|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138817258|NCT03236805|Narcotics|narcotics|mesh-ancestor
138817259|NCT02698995|Acetaminophen|acetaminophen|mesh-list
138817260|NCT02698995|Dexamethasone|dexamethasone|mesh-list
138817261|NCT02698995|Lidocaine|lidocaine|mesh-list
138817262|NCT02698995|Morphine|morphine|mesh-list
138817263|NCT02698995|Ropivacaine|ropivacaine|mesh-list
138817264|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138817265|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
138817266|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
138817267|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817268|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817269|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138817270|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
138817271|NCT02698995|Hormones|hormones|mesh-ancestor
138817272|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138817273|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138653699|NCT06163755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653700|NCT06163729|Paclitaxel|paclitaxel|mesh-list
138653701|NCT06163729|Oxaliplatin|oxaliplatin|mesh-list
138653702|NCT06163729|Apatinib|apatinib|mesh-list
138653703|NCT06163729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138653704|NCT06163729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138653705|NCT06163729|Tubulin Modulators|tubulin modulators|mesh-ancestor
138653706|NCT06163729|Antimitotic Agents|antimitotic agents|mesh-ancestor
138653707|NCT06163729|Mitosis Modulators|mitosis modulators|mesh-ancestor
138653708|NCT06163729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653709|NCT06163729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138264403|NCT02996591|Hormones|hormones|mesh-ancestor
138817274|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817275|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
138817276|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
138817277|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817278|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
138817279|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138817280|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138817281|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138817282|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138817283|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429781|NCT01718496|Morphine|morphine|mesh-list
138817284|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138817286|NCT02698995|Analgesics|analgesics|mesh-ancestor
138817287|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138817288|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
138817289|NCT00920101|Atorvastatin|atorvastatin|mesh-list
138817290|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138817291|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138817292|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
138817293|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817294|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138653740|NCT06153394|Tinzaparin|tinzaparin|mesh-list
138817295|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138817296|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817297|NCT00616785|Irinotecan|irinotecan|mesh-list
138817298|NCT00616785|Etoposide|etoposide|mesh-list
138817299|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817300|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138817301|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138817302|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817303|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817304|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138817305|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138817306|NCT00616005|Irinotecan|irinotecan|mesh-list
138817307|NCT00616005|Temozolomide|temozolomide|mesh-list
138817308|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138817309|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138817310|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817311|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817312|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817313|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138817314|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
138817315|NCT02698527|Lidocaine|lidocaine|mesh-list
138817316|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
138817317|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
138817318|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817319|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817320|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
138469270|NCT01979965|Ranolazine|ranolazine|mesh-list
138817321|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817322|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138817323|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138817324|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138817325|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138817326|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817327|NCT04215237|Atorvastatin|atorvastatin|mesh-list
138817328|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138817329|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138817330|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
138817331|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817332|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138817333|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138817334|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817336|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
138817337|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138817338|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138817339|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
138817340|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817341|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817342|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138653902|NCT05930613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138653903|NCT05903807|FAPI-46|fapi-46|mesh-list
138817343|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
138817344|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
138817345|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
138817346|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817347|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817348|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
138817349|NCT04213833|Lidocaine|lidocaine|mesh-list
138817350|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
138817351|NCT04213833|Propofol|propofol|mesh-list
138817352|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
138817353|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
138817354|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817355|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817356|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
138817357|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817358|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138817359|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138817360|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138817361|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138817362|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817363|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138817364|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138817365|NCT04213833|Analgesics|analgesics|mesh-ancestor
138817366|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138817367|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138817368|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138817369|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
138817370|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817371|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138817372|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
138817373|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
138817374|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138817375|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817376|NCT00783796|Everolimus|everolimus|mesh-list
138817377|NCT00783796|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138817378|NCT00783796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138817379|NCT00783796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817380|NCT00783796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817381|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138817382|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
138817383|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817384|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817385|NCT00637065|Bosentan|bosentan|mesh-list
138817386|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138817387|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138817388|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817389|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
138817390|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
138817391|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138817392|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138469348|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
138817393|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138817394|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817395|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138817396|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138817397|NCT04079647|Immunomodulating Agents|immunomodulating agents|mesh-list
138817398|NCT04079647|Immunologic Factors|immunologic factors|mesh-ancestor
138817399|NCT04079647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817400|NCT00617253|Sunitinib|sunitinib|mesh-list
138817401|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817402|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138817403|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138817404|NCT00617253|Growth Substances|growth substances|mesh-ancestor
138817405|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817406|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
138817407|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138817408|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817409|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817410|NCT02585947|Tenofovir|tenofovir|mesh-list
138645463|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
138817412|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817413|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138817414|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138817415|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817416|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817417|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138817418|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138817419|NCT02607891|Cannabidiol|cannabidiol|mesh-list
138817420|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
138817421|NCT02607813|Spartalizumab|spartalizumab|mesh-list
138817422|NCT02607813|Naporafenib|naporafenib|mesh-list
138654053|NCT05621616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138817423|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138817424|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817425|NCT02607813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138817426|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817427|NCT02607813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138817428|NCT02607813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817429|NCT04079725|Mitomycins|mitomycins|mesh-list
138817430|NCT04079725|Mitomycin|mitomycin|mesh-list
138817431|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138817432|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817433|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
138817434|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817435|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138817436|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817437|NCT00783718|Vedolizumab|vedolizumab|mesh-list
138817438|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138817439|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138817440|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817441|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138654104|NCT05479123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138817442|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138817443|NCT04213287|Analgesics|analgesics|mesh-ancestor
138817444|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
138817445|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817446|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138817447|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138817448|NCT02585791|Glycerol|glycerol|mesh-list
138817449|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138817450|NCT02585791|Protective Agents|protective agents|mesh-ancestor
138817451|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817452|NCT04913389|Acetazolamide|acetazolamide|mesh-list
138817453|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
138817454|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138817455|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817456|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817457|NCT04913389|Diuretics|diuretics|mesh-ancestor
138817458|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
138817459|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817460|NCT04904965|Propofol|propofol|mesh-list
138817461|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138817462|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817463|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817464|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138817465|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
138817466|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
138817467|NCT00617565|Insulin|insulin|mesh-list
138817468|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138817469|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
138817470|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
138817471|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138817472|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817473|NCT04079413|Insulin|insulin|mesh-list
138817474|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138817475|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
138817476|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
138817477|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138817478|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138817479|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817480|NCT00915460|Interferons|interferons|mesh-list
138817481|NCT00915460|Interferon-beta|interferon-beta|mesh-list
138817482|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
138817483|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817484|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
138817485|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817486|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
138817487|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817488|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138817489|NCT00617643|Nevirapine|nevirapine|mesh-list
138817490|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138817491|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138817492|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817493|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817494|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
138817495|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817496|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138817497|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138817498|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138817499|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138817500|NCT02584075|Metformin|metformin|mesh-list
138817501|NCT02584075|Exenatide|exenatide|mesh-list
138817502|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138817503|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817504|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138817505|NCT02584075|Incretins|incretins|mesh-ancestor
138817506|NCT02584075|Hormones|hormones|mesh-ancestor
138817507|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138817508|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
138817509|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
138817510|NCT02585479|Pirarubicin|pirarubicin|mesh-list
138817511|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
138817512|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817513|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
138817514|NCT02585479|Coagulants|coagulants|mesh-ancestor
138817515|NCT00583453|Celecoxib|celecoxib|mesh-list
138817516|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138817517|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138817518|NCT00583453|Analgesics|analgesics|mesh-ancestor
138817519|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
138817520|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817521|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817522|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138817523|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138817524|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138817525|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138654253|NCT05211336|Venetoclax|venetoclax|mesh-list
138817526|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817527|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817528|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138817529|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
138817530|NCT02584231|Coagulants|coagulants|mesh-ancestor
138817531|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138817532|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
138817533|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817534|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
138817535|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138817536|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138817537|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817538|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
138817539|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817540|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817541|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138817542|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
138817543|NCT02584153|Coagulants|coagulants|mesh-ancestor
138817544|NCT02585401|Aflibercept|aflibercept|mesh-list
138817545|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138817546|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138817547|NCT02585401|Growth Substances|growth substances|mesh-ancestor
138645527|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138817548|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817549|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
138817550|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817551|NCT04080349|Misoprostol|misoprostol|mesh-list
138817552|NCT04080349|Dinoprostone|dinoprostone|mesh-list
138817553|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138817554|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
138817555|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138817556|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817558|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138817559|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
138817560|NCT02585011|Epinephrine|epinephrine|mesh-list
138817561|NCT02585011|Ropivacaine|ropivacaine|mesh-list
138817562|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
138817563|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
138817564|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817565|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817566|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
138817567|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817568|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138817569|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138817570|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
138817571|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817572|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817573|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138817574|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138817575|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
138817576|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138817577|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
138817578|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
138817579|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
138817580|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138817581|NCT00920725|Insulin|insulin|mesh-list
138817582|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138817583|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
138817584|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138817585|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817586|NCT02583451|Lemborexant|lemborexant|mesh-list
138817587|NCT02583451|Zopiclone|zopiclone|mesh-list
138817588|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138817589|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817590|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817591|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138817592|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138817593|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817594|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817595|NCT05435911|Propofol|propofol|mesh-list
138817596|NCT05435911|Flumazenil|flumazenil|mesh-list
138817597|NCT05435911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138817598|NCT05435911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817599|NCT05435911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817600|NCT05435911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138817601|NCT05435911|Anesthetics, General|anesthetics, general|mesh-ancestor
138817602|NCT05435911|Anesthetics|anesthetics|mesh-ancestor
138817603|NCT05435911|Antidotes|antidotes|mesh-ancestor
138817604|NCT05435911|Protective Agents|protective agents|mesh-ancestor
138817605|NCT05435911|GABA Modulators|gaba modulators|mesh-ancestor
138817606|NCT05435911|GABA Agents|gaba agents|mesh-ancestor
138817607|NCT05435911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817608|NCT05435911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817609|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138817610|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
138817611|NCT02583685|Ribavirin|ribavirin|mesh-list
138817612|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138817613|NCT02583685|Simeprevir|simeprevir|mesh-list
138817614|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
138817615|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817616|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
138817617|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817618|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
138817619|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817620|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
138817621|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817622|NCT04606771|Osimertinib|osimertinib|mesh-list
138817623|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817624|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138817625|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817626|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817627|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138817628|NCT04504123|Doxycycline|doxycycline|mesh-list
138817629|NCT04504123|Tetracycline|tetracycline|mesh-list
138817630|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817631|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
138817632|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138817633|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138817634|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138817635|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817636|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817637|NCT02584543|Vaccines|vaccines|mesh-list
138817638|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
138817639|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817640|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138817641|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138817642|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138817643|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
138817644|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138817645|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817646|NCT04077853|Progestins|progestins|mesh-ancestor
138817647|NCT04077853|Hormones|hormones|mesh-ancestor
138817648|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138817649|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138817650|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138817651|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138817652|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138817653|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817654|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
138817655|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429934|NCT01719302|Gemcitabine|gemcitabine|mesh-list
138817656|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817657|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138817659|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138817660|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
138817661|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138817662|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817663|NCT05674669|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
138817664|NCT05674669|Hallucinogens|hallucinogens|mesh-ancestor
138817665|NCT05674669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817666|NCT05674669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138817667|NCT05674669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138817668|NCT05674669|Serotonin Agents|serotonin agents|mesh-ancestor
138817669|NCT05674669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817670|NCT05674669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817671|NCT05674669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138817672|NCT02581501|Gemcitabine|gemcitabine|mesh-list
138817673|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138817674|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138817675|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
138817676|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817677|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817679|NCT01072175|Dabrafenib|dabrafenib|mesh-list
138817680|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817681|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138817682|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817683|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817684|NCT04078711|Losartan|losartan|mesh-list
138817685|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138817686|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138817687|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138817688|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138817689|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817690|NCT04304573|Calcium|calcium|mesh-list
138817691|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138817692|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817693|NCT04426669|Aldesleukin|aldesleukin|mesh-list
138817694|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
138817695|NCT04426669|Fludarabine|fludarabine|mesh-list
138817696|NCT04426669|Interleukin-2|interleukin-2|mesh-list
138817697|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138468627|NCT01974375|Micafungin|micafungin|mesh-list
138429962|NCT01719601|Tapentadol|tapentadol|mesh-list
138817698|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
138817699|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817700|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138817701|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138817702|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
138817703|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817704|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817705|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138817706|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138817707|NCT04426669|Analgesics|analgesics|mesh-ancestor
138817708|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
138817709|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817710|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138817711|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138817712|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
138817713|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817715|NCT02874989|Quercetin|quercetin|mesh-list
138817716|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817717|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138817718|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817719|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817720|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
138817721|NCT02874989|Protective Agents|protective agents|mesh-ancestor
138817722|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817723|NCT01071317|Naproxen|naproxen|mesh-list
138817724|NCT01071317|Sumatriptan|sumatriptan|mesh-list
138817725|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138817726|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138817727|NCT01071317|Analgesics|analgesics|mesh-ancestor
138654646|NCT03587272|Sirolimus|sirolimus|mesh-list
138817728|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
138817729|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817730|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817731|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138817732|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138817733|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
138817734|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138817735|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817736|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817737|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138429986|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138817738|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138817739|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138817740|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
138817741|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817742|NCT00783094|Tadalafil|tadalafil|mesh-list
138817743|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
138817744|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138817745|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138817746|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817747|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817748|NCT00783094|Urological Agents|urological agents|mesh-ancestor
138817749|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
138817750|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
138817751|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138817752|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817753|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817754|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
138817755|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138817756|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817757|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817758|NCT02583217|Ketamine|ketamine|mesh-list
138817759|NCT02583217|Remifentanil|remifentanil|mesh-list
138817760|NCT02583217|Propofol|propofol|mesh-list
138817761|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138468640|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
138817762|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817763|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817764|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138817765|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
138817766|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
138817767|NCT02583217|Analgesics|analgesics|mesh-ancestor
138817768|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
138817769|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817770|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138469725|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
138817771|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138817772|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138817773|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817774|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817775|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138817777|NCT00774046|Cytarabine|cytarabine|mesh-list
138817778|NCT00774046|Etoposide|etoposide|mesh-list
138817779|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
138817780|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138817781|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817782|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138817783|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138817784|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817785|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817786|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138817787|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
138817788|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
138817789|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138654733|NCT03309007|Antacids|antacids|mesh-ancestor
138817790|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138817791|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
138817792|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817793|NCT00774046|Analgesics|analgesics|mesh-ancestor
138817794|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
138817795|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817796|NCT01046903|Dalteparin|dalteparin|mesh-list
138817797|NCT01046903|Tinzaparin|tinzaparin|mesh-list
138817798|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138817799|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
138817800|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138817801|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138817802|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817803|NCT02581423|Capecitabine|capecitabine|mesh-list
138817804|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138817805|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
138817806|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817807|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817808|NCT04102072|Dobutamine|dobutamine|mesh-list
138817809|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138817810|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
138817811|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
138817812|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817813|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817814|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138817815|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138817816|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138817817|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
138817818|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817819|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817820|NCT04102072|Protective Agents|protective agents|mesh-ancestor
138817821|NCT02875457|Cisplatin|cisplatin|mesh-list
138817822|NCT02875457|Etoposide|etoposide|mesh-list
138817823|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
138817824|NCT02875457|Apatinib|apatinib|mesh-list
138817825|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817826|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138817827|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138817828|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138817829|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817830|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817831|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138817832|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
138817833|NCT00773968|Hematinics|hematinics|mesh-ancestor
138817834|NCT04060381|Ibuprofen|ibuprofen|mesh-list
138817835|NCT04060381|Dopamine|dopamine|mesh-list
138817836|NCT04060381|Epinephrine|epinephrine|mesh-list
138817837|NCT04060381|Norepinephrine|norepinephrine|mesh-list
138817838|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138817839|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138817840|NCT04060381|Analgesics|analgesics|mesh-ancestor
138654847|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817841|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
138817842|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817843|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817844|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138817845|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138817846|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138817847|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817848|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817849|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138817850|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138817851|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
138817852|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817853|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138817854|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138817855|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
138817856|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138817857|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
138817859|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
138817860|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138817861|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138817862|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
138817863|NCT04060381|Protective Agents|protective agents|mesh-ancestor
138817865|NCT00782626|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138817866|NCT00782626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138817867|NCT00782626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817868|NCT00782626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817869|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138817870|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
138654962|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817871|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817872|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817873|NCT04076371|Olanzapine|olanzapine|mesh-list
138817874|NCT04076371|Risperidone|risperidone|mesh-list
138817875|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138817876|NCT04076371|Ziprasidone|ziprasidone|mesh-list
138817877|NCT04076371|Sertraline|sertraline|mesh-list
138817878|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138817879|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
138817880|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138817881|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817882|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817883|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138817884|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138817885|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138817886|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138817887|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138817888|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
138817889|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
138817890|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
138817891|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817892|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138817893|NCT04076371|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138817894|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138817895|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138817896|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
138817897|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138817898|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138817899|NCT01071083|Interferons|interferons|mesh-list
138817900|NCT01071083|Interferon-beta|interferon-beta|mesh-list
138817901|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
138817902|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
138817903|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
138817905|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
138817906|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817907|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
138817908|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817909|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138817910|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
138817911|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
138817912|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138817913|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817914|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138817915|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
138817917|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138817918|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138817919|NCT01071083|Protective Agents|protective agents|mesh-ancestor
138817920|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
138817921|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138817922|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138817923|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138817924|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138817925|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817926|NCT04078399|Interferons|interferons|mesh-list
138817927|NCT04078399|Azacitidine|azacitidine|mesh-list
138817928|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817929|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
138817930|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817931|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138817932|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
138817933|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817934|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817935|NCT05189509|Plasminogen|plasminogen|mesh-list
138817936|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138817937|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138817938|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138817939|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817940|NCT03897751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138817941|NCT01010126|Sirolimus|sirolimus|mesh-list
138817942|NCT01010126|Bevacizumab|bevacizumab|mesh-list
138817943|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138817944|NCT01010126|Temsirolimus|temsirolimus|mesh-list
138817945|NCT01010126|MTOR Inhibitors|mtor inhibitors|mesh-list
138817946|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
138817947|NCT01010126|Antibodies|antibodies|mesh-list
138817948|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
138655163|NCT00316472|Niacin|niacin|mesh-list
138817949|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138817950|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
138817951|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400748|NCT01550055|Irinotecan|irinotecan|mesh-list
138817952|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138817953|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138817955|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817956|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
138817957|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
138817958|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138817959|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138817960|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138817961|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
138817962|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138817963|NCT01010126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138817964|NCT01010126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817965|NCT01010126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817966|NCT04076137|Decitabine|decitabine|mesh-list
138817967|NCT04076137|Antibodies|antibodies|mesh-list
138817968|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138817969|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
138817970|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817971|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138817972|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
138817973|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645661|NCT00285623|Thrombin|thrombin|mesh-list
138817974|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817975|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817976|NCT03879577|Tamoxifen|tamoxifen|mesh-list
138817977|NCT03879577|Docetaxel|docetaxel|mesh-list
138817978|NCT03879577|Trastuzumab|trastuzumab|mesh-list
138817979|NCT03879577|Letrozole|letrozole|mesh-list
138817980|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138817981|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
138817982|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
138817983|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
138817984|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138817985|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138817986|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138817987|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138817988|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138817989|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138817990|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
138817991|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138817992|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138817993|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138817994|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138817995|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138817996|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138817997|NCT00617877|Losartan|losartan|mesh-list
138469956|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138817998|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138817999|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138818000|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138818001|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138818002|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138818003|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818004|NCT00617877|Diuretics|diuretics|mesh-ancestor
138818005|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
138818006|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818007|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138818008|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138818010|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818012|NCT00617955|Coagulants|coagulants|mesh-ancestor
138818013|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138655352|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
138818014|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138818015|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
138818016|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818017|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
138818018|NCT02582437|Narcotics|narcotics|mesh-ancestor
138818019|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818020|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818021|NCT02582437|Analgesics|analgesics|mesh-ancestor
138818022|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
138818023|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818024|NCT05674201|Dexmedetomidine|dexmedetomidine|mesh-list
138818025|NCT05674201|Remifentanil|remifentanil|mesh-list
138818026|NCT05674201|Propofol|propofol|mesh-list
138818027|NCT05674201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138818028|NCT05674201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138655440|NCT00317759|Fludarabine|fludarabine|mesh-list
138818029|NCT05674201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818030|NCT05674201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138818031|NCT05674201|Analgesics|analgesics|mesh-ancestor
138818032|NCT05674201|Sensory System Agents|sensory system agents|mesh-ancestor
138818033|NCT05674201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818034|NCT05674201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138818035|NCT05674201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138818036|NCT05674201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138818037|NCT05674201|Adrenergic Agents|adrenergic agents|mesh-ancestor
138818038|NCT05674201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818039|NCT05674201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818040|NCT05674201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138270898|NCT04330248|Carbamazepine|carbamazepine|mesh-list
138818041|NCT05674201|Anesthetics, General|anesthetics, general|mesh-ancestor
138818042|NCT05674201|Anesthetics|anesthetics|mesh-ancestor
138818043|NCT05674201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138818044|NCT05674201|Narcotics|narcotics|mesh-ancestor
138818045|NCT01070303|Adalimumab|adalimumab|mesh-list
138818046|NCT01070303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138818047|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818048|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138818049|NCT00618111|Granisetron|granisetron|mesh-list
138818050|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
138818051|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
138818052|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818053|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818054|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138818055|NCT00618111|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138818056|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138818057|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
138818058|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818059|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818060|NCT01009814|Ritonavir|ritonavir|mesh-list
138818061|NCT01009814|Fostemsavir|fostemsavir|mesh-list
138818062|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138818063|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138818064|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
138818065|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818066|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818067|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138818068|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138818069|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
138818070|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138818071|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138655543|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
138818072|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138470039|NCT01985594|Hormones|hormones|mesh-ancestor
138818073|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138818074|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138818076|NCT03824587|Calcium Carbonate|calcium carbonate|mesh-list
138818078|NCT03824587|Sevelamer|sevelamer|mesh-list
138818079|NCT03824587|Calcium acetate|calcium acetate|mesh-list
138818080|NCT03824587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138818081|NCT03824587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818082|NCT03824587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138818083|NCT03824587|Chelating Agents|chelating agents|mesh-ancestor
138818084|NCT03824587|Sequestering Agents|sequestering agents|mesh-ancestor
138818085|NCT03824587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818086|NCT03824587|Antacids|antacids|mesh-ancestor
138818087|NCT03824587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138818088|NCT00773734|Thalidomide|thalidomide|mesh-list
138818089|NCT00773734|Apremilast|apremilast|mesh-list
138818090|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138818091|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138818092|NCT00773734|Analgesics|analgesics|mesh-ancestor
138818093|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
138818094|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818095|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818096|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818097|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138818098|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138818099|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138818100|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818101|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818102|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138818103|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
138818104|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
138818105|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138818106|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138818107|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138818108|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138818109|NCT00773734|Growth Substances|growth substances|mesh-ancestor
138818110|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
138818111|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818112|NCT04297202|Apatinib|apatinib|mesh-list
138818113|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818114|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138818115|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818116|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818117|NCT02691897|Melatonin|melatonin|mesh-list
138818118|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
138818119|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818120|NCT02691897|Protective Agents|protective agents|mesh-ancestor
138818121|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818122|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818123|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
138818124|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138818125|NCT01009580|Insulin|insulin|mesh-list
138818126|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138818127|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
138818128|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
138818129|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138818130|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
138818131|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138818132|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138818133|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818134|NCT01009346|Cisplatin|cisplatin|mesh-list
138818135|NCT01009346|Carboplatin|carboplatin|mesh-list
138818136|NCT01009346|Cetuximab|cetuximab|mesh-list
138818137|NCT01009346|Everolimus|everolimus|mesh-list
138818138|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818139|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138818140|NCT01009346|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138818141|NCT01009346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138655630|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818142|NCT01009346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818143|NCT01009346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818144|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138818145|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
138818146|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818147|NCT04101682|Bupivacaine|bupivacaine|mesh-list
138818148|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
138818149|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
138818150|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818151|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818152|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
138818153|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818154|NCT01001702|Aripiprazole|aripiprazole|mesh-list
138818155|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
138818156|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138818157|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138818158|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138818159|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818160|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655672|NCT00421473|Atovaquone|atovaquone|mesh-list
138818161|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
138818162|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
138818163|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645688|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
138818164|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818165|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138818166|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138818167|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
138818168|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138818169|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138818170|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138818171|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138818172|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
138818173|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138818174|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818175|NCT00618345|Everolimus|everolimus|mesh-list
138818176|NCT00618345|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138818177|NCT00618345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138818178|NCT00618345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818179|NCT00618345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818180|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138818181|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
138818182|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818183|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818184|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
138818185|NCT02601898|Progesterone|progesterone|mesh-list
138818186|NCT02601898|Progestins|progestins|mesh-ancestor
138818187|NCT02601898|Hormones|hormones|mesh-ancestor
138818188|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138818189|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818190|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
138818191|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818192|NCT02601898|Protective Agents|protective agents|mesh-ancestor
138818193|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
138818194|NCT02601898|Vitamins|vitamins|mesh-ancestor
138818195|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
138818196|NCT00618423|Ketamine|ketamine|mesh-list
138818197|NCT00618423|Analgesics|analgesics|mesh-ancestor
138818198|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
138818199|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818200|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818201|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138818202|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138818203|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
138818205|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818206|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138818207|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138818208|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818209|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818210|NCT04101760|Lenograstim|lenograstim|mesh-list
138818211|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138818212|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
138818213|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818214|NCT00616551|Octreotide|octreotide|mesh-list
138818215|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138818216|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138818217|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818218|NCT04214145|Phenylephrine|phenylephrine|mesh-list
138818219|NCT04214145|Vasopressins|vasopressins|mesh-list
138818220|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
138818221|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
138818222|NCT04214145|Norepinephrine|norepinephrine|mesh-list
138818223|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138818224|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
138818225|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
138818226|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818227|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430187|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
138818228|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
138818229|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138818230|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
138818231|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
138645700|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
138818232|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138818233|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138818234|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138818235|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
138818236|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818237|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818238|NCT04214145|Protective Agents|protective agents|mesh-ancestor
138818239|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
138818240|NCT04214145|Coagulants|coagulants|mesh-ancestor
138818241|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138818242|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
138818243|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
138818244|NCT04212429|Levofloxacin|levofloxacin|mesh-list
138818245|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138818246|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138818247|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138818248|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138818249|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138818250|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138818251|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818252|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818253|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818254|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138818255|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138818256|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138818257|NCT01068665|Insulin|insulin|mesh-list
138818258|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138818259|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
138818260|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138818261|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818262|NCT00618501|Leucovorin|leucovorin|mesh-list
138818263|NCT00618501|Cytarabine|cytarabine|mesh-list
138818264|NCT00618501|Prednisolone|prednisolone|mesh-list
138818265|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
138818266|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138818267|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138818268|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138818269|NCT00618501|Methotrexate|methotrexate|mesh-list
138818271|NCT00618501|Vincristine|vincristine|mesh-list
138818272|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
138818273|NCT00618501|Daunorubicin|daunorubicin|mesh-list
138818274|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
138818275|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818276|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138818277|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
138818278|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138818279|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138818280|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
138818281|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818282|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818283|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
138818284|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818285|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138818286|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138818287|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
138818288|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138818289|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138818290|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138818291|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138818292|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138818293|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
138818294|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138656048|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818295|NCT00618501|Antidotes|antidotes|mesh-ancestor
138818296|NCT00618501|Protective Agents|protective agents|mesh-ancestor
138818297|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
138818298|NCT00618501|Vitamins|vitamins|mesh-ancestor
138818299|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
138818300|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
138818301|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
138818302|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
138818303|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818304|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
138818305|NCT00618501|Hormones|hormones|mesh-ancestor
138818306|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138818307|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138818308|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138818309|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138818310|NCT00772954|Vaccines|vaccines|mesh-list
138818311|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
138818312|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818313|NCT05322681|Pregabalin|pregabalin|mesh-list
138818314|NCT05322681|Analgesics|analgesics|mesh-ancestor
138818315|NCT05322681|Sensory System Agents|sensory system agents|mesh-ancestor
138818316|NCT05322681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818317|NCT05322681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818318|NCT05322681|Anticonvulsants|anticonvulsants|mesh-ancestor
138818319|NCT05322681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138818320|NCT05322681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138818321|NCT05322681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818322|NCT05322681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138645747|NCT00286130|Vitamins|vitamins|mesh-ancestor
138818323|NCT05322681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138818324|NCT05322681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138818325|NCT05322681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818326|NCT05322681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138818327|NCT05322603|Diclofenac|diclofenac|mesh-list
138818328|NCT05322603|Morphine|morphine|mesh-list
138818329|NCT05322603|Analgesics|analgesics|mesh-list
138818330|NCT05322603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
138818331|NCT05322603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138818333|NCT05322603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818334|NCT05322603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818335|NCT05322603|Sensory System Agents|sensory system agents|mesh-ancestor
138818336|NCT05322603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818337|NCT05322603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138818338|NCT05322603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818339|NCT05322603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138818340|NCT05322603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138818341|NCT05322603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818342|NCT05322603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818343|NCT00618579|Warfarin|warfarin|mesh-list
138818344|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
138818345|NCT00781768|Ondansetron|ondansetron|mesh-list
138818346|NCT00781768|Aprepitant|aprepitant|mesh-list
138818347|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
138818348|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
138818349|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818350|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818351|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138656236|NCT00322985|Lenalidomide|lenalidomide|mesh-list
138818352|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
138818353|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
138645771|NCT00319800|Irinotecan|irinotecan|mesh-list
138818354|NCT00781768|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138818355|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138818356|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
138818357|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818358|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818359|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138818360|NCT01005680|Gemcitabine|gemcitabine|mesh-list
138818361|NCT01005680|Pemetrexed|pemetrexed|mesh-list
138818362|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818363|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138818364|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
138818365|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818366|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818367|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138818368|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138818369|NCT04101370|Bosentan|bosentan|mesh-list
138818370|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138818371|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138818372|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818373|NCT04188249|Golimumab|golimumab|mesh-list
138818374|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138818375|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818376|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138818377|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
138818378|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818379|NCT01005602|Digoxin|digoxin|mesh-list
138818380|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138818381|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138818382|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818383|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818384|NCT01005602|Protective Agents|protective agents|mesh-ancestor
138818385|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818386|NCT05490940|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138818387|NCT05490940|Hemostatics|hemostatics|mesh-ancestor
138818388|NCT05490940|Coagulants|coagulants|mesh-ancestor
138818389|NCT04304261|Metformin|metformin|mesh-list
138818390|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
138818391|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138818392|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818393|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138818394|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818395|NCT00768430|Midazolam|midazolam|mesh-list
138818396|NCT00768430|Ketamine|ketamine|mesh-list
138818397|NCT00768430|Analgesics|analgesics|mesh-ancestor
138818398|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
138818399|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468757|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138656331|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
138818400|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818401|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138818402|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138818403|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
138818404|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
138818405|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818406|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138818407|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138818408|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818409|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818410|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138818411|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138818412|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138818413|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138818414|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138818415|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
138818416|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
138818417|NCT04101136|Atorvastatin|atorvastatin|mesh-list
138818418|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138818419|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138818420|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
138818421|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430290|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
138818422|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138818423|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138818424|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818425|NCT00618969|Busulfan|busulfan|mesh-list
138818426|NCT00618969|Melphalan|melphalan|mesh-list
138818427|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
138818428|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818429|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138818430|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
138818431|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818432|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138818433|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818434|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138818435|NCT01064297|Lamotrigine|lamotrigine|mesh-list
138818436|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
138818437|NCT01064297|Valproic Acid|valproic acid|mesh-list
138818438|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138818439|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138818440|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818441|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138818442|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818443|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138818444|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138818445|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818446|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138818447|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138818448|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818449|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
138818450|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818451|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
138818452|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
138818453|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
138818454|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
138818455|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138818456|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468770|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
138818457|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138818458|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138818459|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138818460|NCT00582907|Rilonacept|rilonacept|mesh-list
138818461|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818462|NCT01062113|Celecoxib|celecoxib|mesh-list
138818463|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138818464|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138818465|NCT01062113|Analgesics|analgesics|mesh-ancestor
138818466|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
138818467|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818468|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818469|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818470|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138818471|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138818472|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138818473|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818474|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818475|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138818476|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138818477|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
138818478|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818480|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
138818481|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818482|NCT01038869|Azelaic acid|azelaic acid|mesh-list
138818483|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818484|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
138818485|NCT02580331|Metformin|metformin|mesh-list
138818486|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138818487|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818488|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138818489|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138818490|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138818491|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138818492|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818493|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818494|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818495|NCT00767806|Analgesics|analgesics|mesh-ancestor
138656679|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
138818496|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
138818497|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818498|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
138818499|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138818500|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
138818501|NCT00780910|Ribavirin|ribavirin|mesh-list
138818502|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138818503|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
138818504|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818505|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
138818506|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138818507|NCT02582203|Vancomycin|vancomycin|mesh-list
138818508|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138818509|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138818510|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138818511|NCT05035927|Psilocybin|psilocybin|mesh-list
138818512|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
138656729|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138818513|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818514|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138818515|NCT00771472|Vorinostat|vorinostat|mesh-list
138818516|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818517|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138818518|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818519|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818520|NCT00771316|Meropenem|meropenem|mesh-list
138818521|NCT00771316|Ertapenem|ertapenem|mesh-list
138818522|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138818523|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470480|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
138818525|NCT06184698|Bevacizumab|bevacizumab|mesh-list
138818526|NCT06184698|Fluorouracil|fluorouracil|mesh-list
138818527|NCT06184698|Irinotecan|irinotecan|mesh-list
138818528|NCT06184698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138818529|NCT06184698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818530|NCT06184698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138818531|NCT06184698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138818532|NCT06184698|Growth Substances|growth substances|mesh-ancestor
138818533|NCT06184698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818534|NCT06184698|Growth Inhibitors|growth inhibitors|mesh-ancestor
138818535|NCT06184698|Antimetabolites|antimetabolites|mesh-ancestor
138430341|NCT01730612|Histamine|histamine|mesh-list
138818536|NCT06184698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818537|NCT06184698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138818538|NCT06184698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138818539|NCT06184698|Immunologic Factors|immunologic factors|mesh-ancestor
138818540|NCT06184698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138818541|NCT06184698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138818542|NCT06184698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818543|NCT06184698|Antidotes|antidotes|mesh-ancestor
138818544|NCT06184698|Protective Agents|protective agents|mesh-ancestor
138818545|NCT06184698|Vitamin B Complex|vitamin b complex|mesh-ancestor
138818546|NCT06184698|Vitamins|vitamins|mesh-ancestor
138818547|NCT06184698|Micronutrients|micronutrients|mesh-ancestor
138818548|NCT06184685|Diclofenac|diclofenac|mesh-list
138818549|NCT06184685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138818550|NCT06184685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138818551|NCT06184685|Analgesics|analgesics|mesh-ancestor
138818552|NCT06184685|Sensory System Agents|sensory system agents|mesh-ancestor
138818553|NCT06184685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656912|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818554|NCT06184685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818555|NCT06184685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818556|NCT06184685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138818557|NCT06184685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138818558|NCT06184685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818559|NCT06184685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818560|NCT06184373|Chrysarobin|chrysarobin|mesh-list
138818561|NCT06184373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138818562|NCT06184373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138818563|NCT06184373|Analgesics|analgesics|mesh-ancestor
138818564|NCT06184373|Sensory System Agents|sensory system agents|mesh-ancestor
138818565|NCT06184373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818566|NCT06184373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818567|NCT06184373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818568|NCT06184373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138818569|NCT06184334|Tadalafil|tadalafil|mesh-list
138818570|NCT06184334|Mirabegron|mirabegron|mesh-list
138818571|NCT06184334|Vasodilator Agents|vasodilator agents|mesh-ancestor
138818572|NCT06184334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138818573|NCT06184334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138818574|NCT06184334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818575|NCT06184334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818576|NCT06184334|Urological Agents|urological agents|mesh-ancestor
138818577|NCT06184334|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138818578|NCT06184334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138818579|NCT06184334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138818580|NCT06184334|Adrenergic Agents|adrenergic agents|mesh-ancestor
138818581|NCT06184334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818582|NCT06184334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818583|NCT06184321|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138818584|NCT06184321|Plasminogen|plasminogen|mesh-list
138818585|NCT06184321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138818586|NCT06184321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138818587|NCT06184321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818588|NCT06184139|Misoprostol|misoprostol|mesh-list
138818589|NCT06184139|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138818590|NCT06184139|Abortifacient Agents|abortifacient agents|mesh-ancestor
138818591|NCT06184139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138818592|NCT06184139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818593|NCT06184139|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138818594|NCT06184139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138818595|NCT06184139|Oxytocics|oxytocics|mesh-ancestor
138818596|NCT06183918|Tranexamic Acid|tranexamic acid|mesh-list
138818597|NCT06183918|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138818598|NCT06183918|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138818599|NCT06183918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818600|NCT06183918|Hemostatics|hemostatics|mesh-ancestor
138818601|NCT06183918|Coagulants|coagulants|mesh-ancestor
138818603|NCT06183892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138818604|NCT06183892|Immunologic Factors|immunologic factors|mesh-ancestor
138818605|NCT06183892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818606|NCT06183892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138818607|NCT06183892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818608|NCT06183892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818609|NCT06183749|Anesthetics|anesthetics|mesh-list
138818610|NCT06183749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818611|NCT06183749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818613|NCT06182592|Daunorubicin|daunorubicin|mesh-list
138818614|NCT06182592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138818615|NCT06182592|Antimetabolites|antimetabolites|mesh-ancestor
138818616|NCT06182592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818617|NCT06182592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818618|NCT06182592|Antiviral Agents|antiviral agents|mesh-ancestor
138818619|NCT06182592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138818620|NCT06182592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138818621|NCT06182592|Immunologic Factors|immunologic factors|mesh-ancestor
138818622|NCT06182592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645894|NCT00320229|Abciximab|abciximab|mesh-list
138818623|NCT06182592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138818624|NCT06182592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138818625|NCT06182592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138818626|NCT06182592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818627|NCT06180096|Riociguat|riociguat|mesh-list
138818628|NCT06180096|Enzyme Activators|enzyme activators|mesh-ancestor
138818629|NCT06180096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818630|NCT06180083|Fluticasone|fluticasone|mesh-list
138818631|NCT06180083|Xhance|xhance|mesh-list
138818632|NCT06180083|Azelastine|azelastine|mesh-list
138818633|NCT06180083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818634|NCT06180083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138818635|NCT06180083|Autonomic Agents|autonomic agents|mesh-ancestor
138430392|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138818636|NCT06180083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468825|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
138818637|NCT06180083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818638|NCT06180083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138818639|NCT06180083|Respiratory System Agents|respiratory system agents|mesh-ancestor
138818641|NCT06180083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138818642|NCT06180083|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138818643|NCT06180083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818644|NCT06180083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818645|NCT06180083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138818646|NCT06180083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138818647|NCT06180083|Histamine Antagonists|histamine antagonists|mesh-ancestor
138818648|NCT06180083|Histamine Agents|histamine agents|mesh-ancestor
138818649|NCT06180083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818650|NCT06180057|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138818651|NCT06180057|Cathartics|cathartics|mesh-ancestor
138818652|NCT06180057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138818653|NCT06177483|Curcumin|curcumin|mesh-list
138818654|NCT06177483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138818655|NCT06177483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138818656|NCT06177483|Analgesics|analgesics|mesh-ancestor
138818657|NCT06177483|Sensory System Agents|sensory system agents|mesh-ancestor
138818658|NCT06177483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818659|NCT06177483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818660|NCT06177483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138657262|NCT00432549|Topiramate|topiramate|mesh-list
138818661|NCT06177483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138818662|NCT06177483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818663|NCT06177483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818664|NCT06177483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818665|NCT06173869|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138818666|NCT06173869|Hormones|hormones|mesh-ancestor
138818667|NCT06173869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138818668|NCT06173869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818669|NCT06167785|Tislelizumab|tislelizumab|mesh-list
138818670|NCT06167785|Zanubrutinib|zanubrutinib|mesh-list
138818671|NCT06167785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138818672|NCT06167785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818673|NCT06167785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138818674|NCT06167785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645920|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
138818675|NCT06167785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818677|NCT06166628|Bupivacaine|bupivacaine|mesh-list
138818678|NCT06166628|Anesthetics, Local|anesthetics, local|mesh-ancestor
138818680|NCT06166628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818681|NCT06166628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818682|NCT06166628|Sensory System Agents|sensory system agents|mesh-ancestor
138818683|NCT06166628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818684|NCT06166628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138818685|NCT06166628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138818686|NCT06166628|Disinfectants|disinfectants|mesh-ancestor
138818687|NCT06166628|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138818688|NCT06166628|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138818689|NCT06154447|Itraconazole|itraconazole|mesh-list
138818690|NCT06154447|Midazolam|midazolam|mesh-list
138657315|NCT00432627|Deferasirox|deferasirox|mesh-list
138818691|NCT06154447|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138818692|NCT06154447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138430413|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138818704|NCT06154447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818705|NCT06154447|Antifungal Agents|antifungal agents|mesh-ancestor
138818706|NCT06154447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138818707|NCT06154447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138818708|NCT06154447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138818709|NCT06154447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818710|NCT06154447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138818711|NCT06154447|Hormone Antagonists|hormone antagonists|mesh-ancestor
138657354|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138818712|NCT06154447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138818713|NCT06154447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138818714|NCT06149559|Rozanolixizumab|rozanolixizumab|mesh-list
138818715|NCT06149559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138818716|NCT06149559|Immunologic Factors|immunologic factors|mesh-ancestor
138818717|NCT06149559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818718|NCT06149507|Acetaminophen|acetaminophen|mesh-list
138818720|NCT06149507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138818721|NCT06149507|Analgesics|analgesics|mesh-ancestor
138818722|NCT06149507|Sensory System Agents|sensory system agents|mesh-ancestor
138818723|NCT06149507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818724|NCT06149507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818725|NCT06149507|Antipyretics|antipyretics|mesh-ancestor
138818726|NCT06149507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138818727|NCT06149507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818728|NCT06149507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138818729|NCT06149507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138818730|NCT06149507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657417|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
138818731|NCT06149507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818743|NCT06075147|Aflibercept|aflibercept|mesh-list
138818744|NCT06075147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138818745|NCT06075147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138818746|NCT06075147|Growth Substances|growth substances|mesh-ancestor
138818747|NCT06075147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818748|NCT06075147|Growth Inhibitors|growth inhibitors|mesh-ancestor
138818749|NCT06075147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818750|NCT06070610|Pirfenidone|pirfenidone|mesh-list
138818751|NCT06070610|Nintedanib|nintedanib|mesh-list
138818752|NCT06070610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818753|NCT06070610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138818754|NCT06070610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818755|NCT06070610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818756|NCT06070610|Analgesics|analgesics|mesh-ancestor
138818757|NCT06070610|Sensory System Agents|sensory system agents|mesh-ancestor
138818758|NCT06070610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818759|NCT06070610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818760|NCT06070610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138818761|NCT06070610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138818762|NCT06070610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818763|NCT06070610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138818764|NCT06068764|Propofol|propofol|mesh-list
138818765|NCT06068764|Etomidate|etomidate|mesh-list
138818766|NCT06068764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138818767|NCT06068764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818768|NCT06068764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818769|NCT06068764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138818770|NCT06068764|Anesthetics, General|anesthetics, general|mesh-ancestor
138818771|NCT06068764|Anesthetics|anesthetics|mesh-ancestor
138818772|NCT06067919|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138818773|NCT06067919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138818774|NCT06043674|Atezolizumab|atezolizumab|mesh-list
138818775|NCT06043674|Obinutuzumab|obinutuzumab|mesh-list
138818776|NCT06043674|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138818777|NCT06043674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138818778|NCT06043674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818779|NCT06043674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138818780|NCT06043674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818781|NCT06043674|Immunoconjugates|immunoconjugates|mesh-ancestor
138818782|NCT06043674|Immunologic Factors|immunologic factors|mesh-ancestor
138818783|NCT06043674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818784|NCT06020118|Vaccines|vaccines|mesh-list
138818785|NCT06020118|Immunologic Factors|immunologic factors|mesh-ancestor
138818786|NCT06020118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818787|NCT06007586|Aprepitant|aprepitant|mesh-list
138818788|NCT06007586|Antiemetics|antiemetics|mesh-ancestor
138818789|NCT06007586|Autonomic Agents|autonomic agents|mesh-ancestor
138818790|NCT06007586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818791|NCT06007586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818792|NCT06007586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138818793|NCT06007586|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138818794|NCT06007586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818795|NCT06007586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818796|NCT06003283|Rituximab|rituximab|mesh-list
138818797|NCT06003283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138818798|NCT06003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818799|NCT06003283|Immunologic Factors|immunologic factors|mesh-ancestor
138818800|NCT06003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818801|NCT06003283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138818802|NCT05930171|Acetaminophen|acetaminophen|mesh-list
138818803|NCT05930171|Bupivacaine|bupivacaine|mesh-list
138818804|NCT05930171|Anesthetics, Local|anesthetics, local|mesh-ancestor
138818805|NCT05930171|Anesthetics|anesthetics|mesh-ancestor
138818806|NCT05930171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818807|NCT05930171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818808|NCT05930171|Sensory System Agents|sensory system agents|mesh-ancestor
138818809|NCT05930171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818810|NCT05930171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138818811|NCT05930171|Analgesics|analgesics|mesh-ancestor
138818813|NCT05912244|Nivolumab|nivolumab|mesh-list
138818814|NCT05912244|Relatlimab|relatlimab|mesh-list
138818815|NCT05912244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138818816|NCT05912244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818817|NCT05912244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138818818|NCT05912244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818819|NCT05900388|Rivaroxaban|rivaroxaban|mesh-list
138818820|NCT05900388|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138818821|NCT05900388|Antithrombins|antithrombins|mesh-ancestor
138818822|NCT05900388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138818823|NCT05900388|Protease Inhibitors|protease inhibitors|mesh-ancestor
138818824|NCT05900388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818825|NCT05900388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818826|NCT05900388|Anticoagulants|anticoagulants|mesh-ancestor
138470785|NCT01990807|Idarubicin|idarubicin|mesh-list
138818827|NCT05871606|Nitrous Oxide|nitrous oxide|mesh-list
138818828|NCT05871606|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138818829|NCT05871606|Anesthetics, General|anesthetics, general|mesh-ancestor
138818830|NCT05871606|Anesthetics|anesthetics|mesh-ancestor
138818831|NCT05871606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818832|NCT05871606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818833|NCT05871606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138818834|NCT05871606|Analgesics|analgesics|mesh-ancestor
138818835|NCT05871606|Sensory System Agents|sensory system agents|mesh-ancestor
138818836|NCT05871606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818837|NCT05853458|Hydroxyurea|hydroxyurea|mesh-list
138818838|NCT05853458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818839|NCT05853458|Antisickling Agents|antisickling agents|mesh-ancestor
138818840|NCT05853458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818841|NCT05853458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818842|NCT05853458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138818843|NCT05850520|Aflibercept|aflibercept|mesh-list
138818844|NCT05850520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138818845|NCT05850520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138818846|NCT05850520|Growth Substances|growth substances|mesh-ancestor
138818847|NCT05850520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818848|NCT05850520|Growth Inhibitors|growth inhibitors|mesh-ancestor
138818849|NCT05850520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818850|NCT05844332|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138818851|NCT05844332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138818852|NCT05844332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818853|NCT05772871|Levamisole|levamisole|mesh-list
138818854|NCT05772871|Prednisone|prednisone|mesh-list
138818855|NCT05772871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138818856|NCT05772871|Glucocorticoids|glucocorticoids|mesh-ancestor
138818857|NCT05772871|Hormones|hormones|mesh-ancestor
138818858|NCT05772871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138818859|NCT05772871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818860|NCT05772871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138818861|NCT05772871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818862|NCT05772871|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138818863|NCT05772871|Immunologic Factors|immunologic factors|mesh-ancestor
138818864|NCT05772871|Antinematodal Agents|antinematodal agents|mesh-ancestor
138818865|NCT05772871|Anthelmintics|anthelmintics|mesh-ancestor
138818866|NCT05772871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138818867|NCT05772871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138818868|NCT05772871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138818869|NCT05738291|Digoxin|digoxin|mesh-list
138818870|NCT05738291|Midazolam|midazolam|mesh-list
138818871|NCT05738291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138646105|NCT00287651|Insulin|insulin|mesh-list
138818872|NCT05738291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138818873|NCT05738291|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138818874|NCT05738291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138818875|NCT05738291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818876|NCT05738291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138818877|NCT05738291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138818878|NCT05738291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138818879|NCT05738291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138818880|NCT05738291|Anesthetics, General|anesthetics, general|mesh-ancestor
138818882|NCT05738291|GABA Modulators|gaba modulators|mesh-ancestor
138818883|NCT05738291|GABA Agents|gaba agents|mesh-ancestor
138818884|NCT05738291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818885|NCT05738291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818886|NCT05738291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138818887|NCT05738291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138818889|NCT05738291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138818890|NCT05738291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138818891|NCT05738291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818892|NCT05738291|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138818893|NCT05738291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138818894|NCT05738291|Protective Agents|protective agents|mesh-ancestor
138818896|NCT05718882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818897|NCT05718882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138818898|NCT05718882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818899|NCT05718882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818900|NCT05714839|Dexamethasone|dexamethasone|mesh-list
138818901|NCT05714839|Lenalidomide|lenalidomide|mesh-list
138818902|NCT05714839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138470859|NCT01991275|Morphine|morphine|mesh-list
138818903|NCT05714839|Antiemetics|antiemetics|mesh-ancestor
138818904|NCT05714839|Autonomic Agents|autonomic agents|mesh-ancestor
138818905|NCT05714839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138818906|NCT05714839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818907|NCT05714839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138818908|NCT05714839|Glucocorticoids|glucocorticoids|mesh-ancestor
138818909|NCT05714839|Hormones|hormones|mesh-ancestor
138818910|NCT05714839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138818911|NCT05714839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138818912|NCT05714839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818913|NCT05714839|Immunologic Factors|immunologic factors|mesh-ancestor
138818914|NCT05714839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138818915|NCT05714839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138818916|NCT05714839|Growth Substances|growth substances|mesh-ancestor
138818917|NCT05714839|Growth Inhibitors|growth inhibitors|mesh-ancestor
138818918|NCT05712278|Cytarabine|cytarabine|mesh-list
138818919|NCT05712278|Fludarabine|fludarabine|mesh-list
138818920|NCT05712278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818921|NCT05712278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138818922|NCT05712278|Antimetabolites|antimetabolites|mesh-ancestor
138430476|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
138818923|NCT05712278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818924|NCT05712278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138818925|NCT05712278|Immunologic Factors|immunologic factors|mesh-ancestor
138818926|NCT05712278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818927|NCT05712278|Antiviral Agents|antiviral agents|mesh-ancestor
138818928|NCT05712278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138818929|NCT05707351|Factor VIII|factor viii|mesh-list
138818930|NCT05707351|BAX 855|bax 855|mesh-list
138818931|NCT05707351|Coagulants|coagulants|mesh-ancestor
138818932|NCT05659914|Durvalumab|durvalumab|mesh-list
138818933|NCT05659914|Olaparib|olaparib|mesh-list
138818934|NCT05659914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138818935|NCT05659914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818936|NCT05659914|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138818937|NCT05659914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818938|NCT05659914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818939|NCT05603910|Pembrolizumab|pembrolizumab|mesh-list
138818940|NCT05603910|Lenvatinib|lenvatinib|mesh-list
138818941|NCT05603910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138818942|NCT05603910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658110|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818943|NCT05603910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138818944|NCT05603910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818945|NCT05603910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138818946|NCT05603910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818947|NCT05566301|Clopidogrel|clopidogrel|mesh-list
138818948|NCT05566301|Ticagrelor|ticagrelor|mesh-list
138818949|NCT05566301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138818950|NCT05566301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138818951|NCT05566301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138818952|NCT05566301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138818953|NCT05566301|Purinergic Agents|purinergic agents|mesh-ancestor
138658197|NCT00331214|Hormones|hormones|mesh-ancestor
138818954|NCT05566301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818955|NCT05566301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818956|NCT05566301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818957|NCT05553704|Metformin|metformin|mesh-list
138818958|NCT05553704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138818959|NCT05553704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818960|NCT05545280|Glycopyrrolate|glycopyrrolate|mesh-list
138818961|NCT05545280|Neostigmine|neostigmine|mesh-list
138818962|NCT05545280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138818963|NCT05545280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138818964|NCT05545280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818965|NCT05545280|Cholinergic Agents|cholinergic agents|mesh-ancestor
138818966|NCT05545280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138818967|NCT05545280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818974|NCT05526157|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138818976|NCT05526157|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138818977|NCT05526157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138818978|NCT05526157|Hormones|hormones|mesh-ancestor
138646135|NCT00320814|Aflibercept|aflibercept|mesh-list
138818979|NCT05526157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138818980|NCT05526157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138818981|NCT05526157|Incretins|incretins|mesh-ancestor
138818982|NCT05526157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818983|NCT05526157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138818984|NCT05498766|Capecitabine|capecitabine|mesh-list
138818985|NCT05498766|Tegafur|tegafur|mesh-list
138818986|NCT05498766|Oxaliplatin|oxaliplatin|mesh-list
138818987|NCT05498766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138818988|NCT05498766|Antimetabolites|antimetabolites|mesh-ancestor
138818989|NCT05498766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138818990|NCT05498766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138818997|NCT05393713|Antibodies|antibodies|mesh-list
138818998|NCT05393713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138818999|NCT05393713|Immunologic Factors|immunologic factors|mesh-ancestor
138819000|NCT05393713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819002|NCT05337540|Viscosupplements|viscosupplements|mesh-ancestor
138819003|NCT05337540|Protective Agents|protective agents|mesh-ancestor
138819004|NCT05337540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819005|NCT05323149|Tranexamic Acid|tranexamic acid|mesh-list
138819006|NCT05323149|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138819007|NCT05323149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138819008|NCT05323149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819010|NCT05323149|Coagulants|coagulants|mesh-ancestor
138819011|NCT05322577|Nivolumab|nivolumab|mesh-list
138819012|NCT05322577|Bemarituzumab|bemarituzumab|mesh-list
138819013|NCT05322577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819014|NCT05322577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819015|NCT05322577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138819016|NCT05322577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819017|NCT05293080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138819018|NCT05262400|Letrozole|letrozole|mesh-list
138819019|NCT05262400|Fulvestrant|fulvestrant|mesh-list
138819020|NCT05262400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819021|NCT05262400|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138819022|NCT05262400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138819023|NCT05262400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819024|NCT05262400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430543|NCT01731756|Salicylates|salicylates|mesh-list
138819026|NCT05262400|Hormone Antagonists|hormone antagonists|mesh-ancestor
138819027|NCT05262400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138819028|NCT05262400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819029|NCT05262400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138819030|NCT05262400|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138819031|NCT05218499|Doxorubicin|doxorubicin|mesh-list
138658410|NCT00435435|Acamprosate|acamprosate|mesh-list
138658415|NCT00332540|Timolol|timolol|mesh-list
138819032|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138819033|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819034|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138819035|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138819036|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819037|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819038|NCT05209867|Cannabidiol|cannabidiol|mesh-list
138819039|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
138819040|NCT05201547|Paclitaxel|paclitaxel|mesh-list
138819041|NCT05201547|Carboplatin|carboplatin|mesh-list
138819042|NCT05201547|Dostarlimab|dostarlimab|mesh-list
138819043|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138819044|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819045|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
138819046|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
138819047|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
138819048|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819049|NCT05196815|Dobutamine|dobutamine|mesh-list
138658467|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138819050|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138819051|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
138819052|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
138819053|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138819054|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819055|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138819056|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138819057|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138819058|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
138819059|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138819060|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819061|NCT05196815|Protective Agents|protective agents|mesh-ancestor
138819062|NCT05177484|Ferric maltol|ferric maltol|mesh-list
138819063|NCT05177484|Hematinics|hematinics|mesh-ancestor
138819064|NCT05161195|Tamoxifen|tamoxifen|mesh-list
138819065|NCT05161195|Letrozole|letrozole|mesh-list
138819066|NCT05161195|Fulvestrant|fulvestrant|mesh-list
138819067|NCT05161195|Anastrozole|anastrozole|mesh-list
138819068|NCT05161195|Goserelin|goserelin|mesh-list
138819069|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819070|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138819071|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138819072|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819073|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819074|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138819075|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
138819076|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138819077|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819078|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138819079|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138658581|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138819080|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138819081|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138819082|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138819083|NCT05149638|Cosyntropin|cosyntropin|mesh-list
138819084|NCT05149638|Hormones|hormones|mesh-ancestor
138819085|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138819086|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819087|NCT05118724|Atezolizumab|atezolizumab|mesh-list
138430546|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
138819088|NCT05118724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138819089|NCT05118724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819090|NCT05118724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819091|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819092|NCT04991480|Niraparib|niraparib|mesh-list
138819093|NCT04991480|Talazoparib|talazoparib|mesh-list
138658636|NCT00333632|Analgesics|analgesics|mesh-ancestor
138819094|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138819095|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819096|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819097|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819098|NCT04972123|Phenylephrine|phenylephrine|mesh-list
138819099|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
138819100|NCT04972123|Caffeine|caffeine|mesh-list
138819101|NCT04972123|Capsaicin|capsaicin|mesh-list
138819102|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138819103|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819104|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138819105|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819106|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819107|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138819108|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138819109|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
138819110|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138819111|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138819112|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
138819113|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
138819114|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138819115|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
138658703|NCT00432315|Docetaxel|docetaxel|mesh-list
138819116|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138819117|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
138819118|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
138819119|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138819120|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138819121|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138819122|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
138819123|NCT04972123|Protective Agents|protective agents|mesh-ancestor
138819124|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
138819125|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
138819126|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
138819127|NCT04935359|Paclitaxel|paclitaxel|mesh-list
138819128|NCT04935359|Gemcitabine|gemcitabine|mesh-list
138819129|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138819130|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819131|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
138819132|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
138819133|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
138819134|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819135|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819136|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
138819137|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138819138|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138819139|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138819140|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819141|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819142|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
138819143|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138819144|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138819145|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138819146|NCT04895709|Docetaxel|docetaxel|mesh-list
138819147|NCT04895709|Nivolumab|nivolumab|mesh-list
138819148|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819149|NCT04895709|Tubulin Modulators|tubulin modulators|mesh-ancestor
138430563|NCT01731795|BB 1101|bb 1101|mesh-list
138819150|NCT04895709|Antimitotic Agents|antimitotic agents|mesh-ancestor
138819151|NCT04895709|Mitosis Modulators|mitosis modulators|mesh-ancestor
138819152|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819153|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819154|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138819156|NCT04884035|Prednisolone|prednisolone|mesh-list
138819157|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
138819158|NCT04884035|Rituximab|rituximab|mesh-list
138819159|NCT04884035|Doxorubicin|doxorubicin|mesh-list
138819160|NCT04884035|Vincristine|vincristine|mesh-list
138819161|NCT04884035|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138819162|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138819163|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
138819164|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819165|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138819166|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138819167|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
138819168|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819169|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819170|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138819171|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819172|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138819173|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138819174|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138819175|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819176|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138819178|NCT04884035|Hormones|hormones|mesh-ancestor
138819179|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138819180|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138819181|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138819182|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
138819183|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
138819184|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
138819185|NCT04884035|Immunoconjugates|immunoconjugates|mesh-ancestor
138819186|NCT04835233|Methyldopa|methyldopa|mesh-list
138819187|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138819188|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
138819189|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
138819190|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138819191|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819192|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138819193|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138819194|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138819195|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
138819196|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138704045|NCT06199466|Paclitaxel|paclitaxel|mesh-list
138819198|NCT04827953|Paclitaxel|paclitaxel|mesh-list
138819199|NCT04827953|Gemcitabine|gemcitabine|mesh-list
138819200|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138819201|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819202|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
138819203|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
138819204|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
138819205|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819206|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819207|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
138819208|NCT04772079|Deucravacitinib|deucravacitinib|mesh-list
138819209|NCT04772079|Dermatologic Agents|dermatologic agents|mesh-ancestor
138819210|NCT04772079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138819211|NCT04772079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819212|NCT04772079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819213|NCT04756232|Mecamylamine|mecamylamine|mesh-list
138819214|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138819215|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138819216|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
138819217|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138819218|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819219|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138819220|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138819221|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
138819222|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138819223|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819224|NCT04738942|Vedolizumab|vedolizumab|mesh-list
138819225|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138819226|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
138819227|NCT04676412|Lenvatinib|lenvatinib|mesh-list
138819228|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819229|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819230|NCT04676412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138819231|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819232|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138819233|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819234|NCT04641975|Mirabegron|mirabegron|mesh-list
138704073|NCT06190093|Growth Substances|growth substances|mesh-ancestor
138659085|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138819235|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138819236|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138819237|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138819238|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
138819239|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138819240|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819241|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819242|NCT04641975|Urological Agents|urological agents|mesh-ancestor
138819244|NCT04624204|Etoposide|etoposide|mesh-list
138819245|NCT04624204|Olaparib|olaparib|mesh-list
138819246|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138430618|NCT01732224|Tenofovir|tenofovir|mesh-list
138819247|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819248|NCT04624204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138659135|NCT00437697|Dalteparin|dalteparin|mesh-list
138819249|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819250|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138819251|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138819252|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138819253|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819254|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138819255|NCT04617002|TIC10 compound|tic10 compound|mesh-list
138819256|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819258|NCT04550260|Capecitabine|capecitabine|mesh-list
138819259|NCT04550260|Fluorouracil|fluorouracil|mesh-list
138819260|NCT04550260|Durvalumab|durvalumab|mesh-list
138819261|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819262|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819263|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
138819264|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819265|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138819266|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
138819267|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659261|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138659262|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
138819268|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819269|NCT04527432|Antibodies|antibodies|mesh-list
138819270|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
138819271|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819272|NCT04494958|Palbociclib|palbociclib|mesh-list
138819273|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819274|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138819275|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819276|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819277|NCT04492033|Paclitaxel|paclitaxel|mesh-list
138819278|NCT04492033|Irinotecan|irinotecan|mesh-list
138819279|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138819280|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819281|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
138819282|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
138819283|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
138819284|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819285|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138659336|NCT00444717|Pitavastatin|pitavastatin|mesh-list
138819286|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138819287|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819288|NCT04483505|Fulvestrant|fulvestrant|mesh-list
138819289|NCT04483505|Palbociclib|palbociclib|mesh-list
138819290|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138819291|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819292|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138819293|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138819294|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
138819295|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138819296|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819297|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138819298|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659380|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
138819299|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819300|NCT04447768|Venetoclax|venetoclax|mesh-list
138819301|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
138819302|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819303|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819305|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138819306|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
138819307|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138819308|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
138659453|NCT00444873|Lanreotide|lanreotide|mesh-list
138819309|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819310|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819311|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
138819312|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
138819313|NCT04326673|Testosterone|testosterone|mesh-list
138819314|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
138819315|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
138819316|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138819317|NCT04326673|Androgens|androgens|mesh-ancestor
138819318|NCT04326673|Hormones|hormones|mesh-ancestor
138819319|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138646404|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
138819320|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819321|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138819322|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819323|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
138819324|NCT04300309|Lumefantrine|lumefantrine|mesh-list
138819325|NCT04300309|Artemether|artemether|mesh-list
138819326|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
138819327|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138819328|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138819329|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138819330|NCT04234022|Pomalidomide|pomalidomide|mesh-list
138819331|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
138819332|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819333|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138819334|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138819335|NCT04234022|Growth Substances|growth substances|mesh-ancestor
138819336|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
138819337|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819338|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
138819339|NCT04233866|Leucovorin|leucovorin|mesh-list
138819340|NCT04233866|Folic Acid|folic acid|mesh-list
138819341|NCT04233866|Paclitaxel|paclitaxel|mesh-list
138819342|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138819343|NCT04233866|Gemcitabine|gemcitabine|mesh-list
138819344|NCT04233866|Fluorouracil|fluorouracil|mesh-list
138819345|NCT04233866|Irinotecan|irinotecan|mesh-list
138819346|NCT04233866|Calcium|calcium|mesh-list
138819347|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
138819348|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138819349|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819350|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
138282213|NCT04336891|Testosterone|testosterone|mesh-list
138471307|NCT01995006|Naproxen|naproxen|mesh-list
138819351|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
138819352|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
138819353|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819354|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819355|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
138819356|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138819357|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819358|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138819359|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138819360|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
138430644|NCT01732367|Tenofovir|tenofovir|mesh-list
138819361|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138819362|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138819363|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819364|NCT04233866|Antidotes|antidotes|mesh-ancestor
138819365|NCT04233866|Protective Agents|protective agents|mesh-ancestor
138819366|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
138819367|NCT04233866|Vitamins|vitamins|mesh-ancestor
138819368|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
138819369|NCT04233866|Hematinics|hematinics|mesh-ancestor
138819370|NCT04228042|Infigratinib|infigratinib|mesh-list
138819371|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819372|NCT04212013|Rituximab|rituximab|mesh-list
138819373|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819374|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819375|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
138819376|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819377|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138819378|NCT04207060|Indomethacin|indomethacin|mesh-list
138819379|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138819380|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138819381|NCT04207060|Analgesics|analgesics|mesh-ancestor
138819382|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
138819383|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138819384|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819385|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138819386|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138819387|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
138819388|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
138819389|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138819390|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138819391|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819392|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819393|NCT04196010|Cytarabine|cytarabine|mesh-list
138819394|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
138819395|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
138819396|NCT04196010|Cladribine|cladribine|mesh-list
138819397|NCT04196010|Lenograstim|lenograstim|mesh-list
138819398|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138646472|NCT06140134|Liver Extracts|liver extracts|mesh-list
138819399|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
138341702|NCT01564914|Growth Substances|growth substances|mesh-ancestor
138819400|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819401|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819402|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
138819403|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138819404|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138819405|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
138819406|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819407|NCT04196010|Analgesics|analgesics|mesh-ancestor
138819408|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
138819409|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138819410|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138819411|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138819412|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819413|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138819415|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819416|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819417|NCT04160546|Aspirin|aspirin|mesh-list
138819418|NCT04160546|Ponatinib|ponatinib|mesh-list
138819419|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138819420|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138819421|NCT04160546|Analgesics|analgesics|mesh-ancestor
138819422|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
138819423|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138819424|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819425|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138819426|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138819427|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138819428|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138819429|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819430|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138819431|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138819432|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819433|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
138819434|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659896|NCT00446784|Methotrexate|methotrexate|mesh-list
138819435|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138819436|NCT04151940|Immunomodulating Agents|immunomodulating agents|mesh-list
138819437|NCT04151940|Immunologic Factors|immunologic factors|mesh-ancestor
138819438|NCT04151940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819439|NCT04134000|Atezolizumab|atezolizumab|mesh-list
138819440|NCT04134000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138819441|NCT04134000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819442|NCT04134000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819443|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819444|NCT04091386|Factor VIII|factor viii|mesh-list
138819445|NCT04091386|Coagulants|coagulants|mesh-ancestor
138819446|NCT04032704|Pembrolizumab|pembrolizumab|mesh-list
138819447|NCT04032704|SGN-LIV1A|sgn-liv1a|mesh-list
138659952|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
138819448|NCT04032704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819449|NCT04032704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819450|NCT04032704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138646513|NCT06139926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138819451|NCT04032704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819452|NCT04032704|Immunoconjugates|immunoconjugates|mesh-ancestor
138819453|NCT04032704|Immunologic Factors|immunologic factors|mesh-ancestor
138819454|NCT04032704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819455|NCT04019288|Durvalumab|durvalumab|mesh-list
138819456|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
138819457|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138819458|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
138819459|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819460|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819461|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
138819462|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819463|NCT03984188|Theophylline|theophylline|mesh-list
138819464|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138819465|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
138819466|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138819467|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819468|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138819469|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
138819470|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138819471|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819472|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819473|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
138819474|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138819475|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138819476|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
138819477|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138819478|NCT03975829|Trametinib|trametinib|mesh-list
138819479|NCT03975829|Dabrafenib|dabrafenib|mesh-list
138819480|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819481|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138819482|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819483|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819484|NCT03841058|Abaloparatide|abaloparatide|mesh-list
138819485|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138819486|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819487|NCT03824106|Vitamin D|vitamin d|mesh-list
138819488|NCT03824106|Vitamins|vitamins|mesh-ancestor
138819489|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
138819490|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819491|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138819492|NCT03822468|Letrozole|letrozole|mesh-list
138819493|NCT03822468|Anastrozole|anastrozole|mesh-list
138819494|NCT03822468|Goserelin|goserelin|mesh-list
138819495|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819496|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138660144|NCT00344006|Artesunate|artesunate|mesh-list
138819497|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138819498|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819499|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819500|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138819501|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
138819502|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138819503|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819504|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138819506|NCT03798626|Paclitaxel|paclitaxel|mesh-list
138819507|NCT03798626|Bevacizumab|bevacizumab|mesh-list
138819508|NCT03798626|Fluorouracil|fluorouracil|mesh-list
138819509|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
138819510|NCT03798626|Irinotecan|irinotecan|mesh-list
138819511|NCT03798626|Ramucirumab|ramucirumab|mesh-list
138819512|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
138819513|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138819514|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819515|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
138819516|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
138819517|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
138819518|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819519|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819520|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138819521|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138819522|NCT03798626|Growth Substances|growth substances|mesh-ancestor
138819523|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819524|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
138819525|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
138819526|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819527|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138819528|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
138819529|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138819530|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138819531|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819532|NCT03798626|Antidotes|antidotes|mesh-ancestor
138819533|NCT03798626|Protective Agents|protective agents|mesh-ancestor
138819534|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
138819535|NCT03798626|Vitamins|vitamins|mesh-ancestor
138819536|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
138819537|NCT03635021|Bevacizumab|bevacizumab|mesh-list
138819538|NCT03635021|Panitumumab|panitumumab|mesh-list
138819539|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138660248|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
138819540|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819541|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138819542|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138819543|NCT03635021|Growth Substances|growth substances|mesh-ancestor
138819544|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819545|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
138819546|NCT03631199|Paclitaxel|paclitaxel|mesh-list
138819547|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138819548|NCT03631199|Carboplatin|carboplatin|mesh-list
138819549|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
138819550|NCT03631199|Pemetrexed|pemetrexed|mesh-list
138819551|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138819552|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138819553|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819554|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
138819555|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
138819556|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
138819557|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819558|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819559|NCT03631199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138819560|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819561|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138819562|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138819563|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
138819564|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469027|NCT01977235|Irinotecan|irinotecan|mesh-list
138819566|NCT03439137|Hematinics|hematinics|mesh-ancestor
138819567|NCT03425201|Niraparib|niraparib|mesh-list
138819568|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138819569|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819570|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819571|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819572|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
138819573|NCT03337087|Leucovorin|leucovorin|mesh-list
138819574|NCT03337087|Folic Acid|folic acid|mesh-list
138646634|NCT06138509|Serotonin|serotonin|mesh-list
138819576|NCT03337087|Irinotecan|irinotecan|mesh-list
138819577|NCT03337087|Rucaparib|rucaparib|mesh-list
138819578|NCT03337087|Calcium|calcium|mesh-list
138819579|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
138819580|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138819581|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819582|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138819583|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
138819584|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819585|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819586|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819587|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138819588|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
138819589|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138819590|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138819591|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819593|NCT03337087|Protective Agents|protective agents|mesh-ancestor
138819594|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
138819595|NCT03337087|Vitamins|vitamins|mesh-ancestor
138819596|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
138819597|NCT03337087|Hematinics|hematinics|mesh-ancestor
138819598|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138819599|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
138819600|NCT03329196|Hematinics|hematinics|mesh-ancestor
138819601|NCT03318900|Aldesleukin|aldesleukin|mesh-list
138819602|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
138819603|NCT03318900|Interleukin-2|interleukin-2|mesh-list
138819604|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138819605|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
138819606|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138819607|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
138819608|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819609|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138819610|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138819611|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
138819612|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819613|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819614|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138819615|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138819616|NCT03318900|Analgesics|analgesics|mesh-ancestor
138819617|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
138819618|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138819619|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138819620|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138819621|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
138819622|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138819623|NCT03315364|Paclitaxel|paclitaxel|mesh-list
138819624|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138819625|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138819626|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819627|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
138819628|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
138819629|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
138819630|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819631|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
138819632|NCT03263559|Thiotepa|thiotepa|mesh-list
138819633|NCT03263559|Fludarabine|fludarabine|mesh-list
138819634|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
138819635|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
138819636|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138819637|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
138819638|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819639|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138819640|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138819641|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
138819642|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819643|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819644|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138819645|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
138819646|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819647|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138819648|NCT03101995|Gemcitabine|gemcitabine|mesh-list
138819649|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819650|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
138819651|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430736|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
138819652|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819653|NCT03093922|Gemcitabine|gemcitabine|mesh-list
138819654|NCT03093922|Atezolizumab|atezolizumab|mesh-list
138819655|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819656|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819657|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
138819658|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819659|NCT03093922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138819660|NCT03093922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819661|NCT03056755|Letrozole|letrozole|mesh-list
138819662|NCT03056755|Fulvestrant|fulvestrant|mesh-list
138819663|NCT03056755|Leuprolide|leuprolide|mesh-list
138819664|NCT03056755|Goserelin|goserelin|mesh-list
138819665|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819666|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138819667|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138819668|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819669|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819670|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138819671|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
138819672|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138819673|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819674|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138819675|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138819676|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138819677|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
138819678|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138819679|NCT02967692|Trametinib|trametinib|mesh-list
138819680|NCT02967692|Dabrafenib|dabrafenib|mesh-list
138819681|NCT02967692|Spartalizumab|spartalizumab|mesh-list
138819682|NCT02967692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819683|NCT02967692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138819687|NCT02967692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819688|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
138819689|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819690|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819691|NCT02949219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138819692|NCT02949219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819693|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
138819694|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819695|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819696|NCT02907099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138819697|NCT02907099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138660697|NCT00455286|Hormones|hormones|mesh-ancestor
138819698|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
138819699|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819700|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819701|NCT02892201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138819702|NCT02892201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819703|NCT02873195|Bevacizumab|bevacizumab|mesh-list
138819704|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138819705|NCT02873195|Atezolizumab|atezolizumab|mesh-list
138819706|NCT02873195|Capecitabine|capecitabine|mesh-list
138660745|NCT00347555|Antacids|antacids|mesh-ancestor
138819707|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
138819708|NCT02873195|Antibodies|antibodies|mesh-list
138819709|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
138819710|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138819711|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
138819712|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819713|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138819714|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138819715|NCT02873195|Growth Substances|growth substances|mesh-ancestor
138819716|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819717|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
138819718|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
138819719|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819720|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
138819721|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819722|NCT02873195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138819723|NCT02584933|Ceritinib|ceritinib|mesh-list
138819724|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819725|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138819726|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819727|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819731|NCT02252887|Gemcitabine|gemcitabine|mesh-list
138819732|NCT02252887|Trastuzumab|trastuzumab|mesh-list
138819733|NCT02252887|Pertuzumab|pertuzumab|mesh-list
138471689|NCT01997203|Vitamin D|vitamin d|mesh-list
138819734|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819735|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
138819736|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819737|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469071|NCT01978301|Hormones|hormones|mesh-ancestor
138819738|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819739|NCT02205047|Capecitabine|capecitabine|mesh-list
138819740|NCT02205047|Fluorouracil|fluorouracil|mesh-list
138819741|NCT02205047|Trastuzumab|trastuzumab|mesh-list
138819742|NCT02205047|Pertuzumab|pertuzumab|mesh-list
138819743|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819744|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819745|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
138819746|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819747|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138819748|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
138819749|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819750|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819751|NCT02185560|Sorafenib|sorafenib|mesh-list
138819752|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819753|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138660823|NCT00348062|Bimatoprost|bimatoprost|mesh-list
138819754|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819755|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819756|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
138819757|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
138819758|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138819759|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138819760|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138819761|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819762|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819763|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138819764|NCT02008656|Leucovorin|leucovorin|mesh-list
138819765|NCT02008656|Capecitabine|capecitabine|mesh-list
138819766|NCT02008656|Fluorouracil|fluorouracil|mesh-list
138819767|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
138819768|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819770|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819771|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819772|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138819773|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
138819774|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819775|NCT02008656|Antidotes|antidotes|mesh-ancestor
138819776|NCT02008656|Protective Agents|protective agents|mesh-ancestor
138819777|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
138819778|NCT02008656|Vitamins|vitamins|mesh-ancestor
138819779|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
138819780|NCT01825603|Cisplatin|cisplatin|mesh-list
138819781|NCT01825603|Gemcitabine|gemcitabine|mesh-list
138819782|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819783|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819784|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
138819785|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819786|NCT01065454|Riociguat|riociguat|mesh-list
138819787|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
138819788|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819789|NCT00775463|Treprostinil|treprostinil|mesh-list
138819790|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138819791|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138819792|NCT00406640|Escitalopram|escitalopram|mesh-list
138819793|NCT00406640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138819794|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138819795|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138819796|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819797|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138819798|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
138819799|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819800|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
138819801|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138819802|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138819803|NCT00229931|Triamcinolone|triamcinolone|mesh-list
138819804|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138819805|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138819806|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138819807|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471763|NCT01997775|Metformin|metformin|mesh-list
138819808|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
138819809|NCT00229931|Hormones|hormones|mesh-ancestor
138819810|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138819811|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819812|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138819813|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
138819814|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819815|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819816|NCT00150969|Vitamin K|vitamin k|mesh-list
138819817|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
138819818|NCT00150969|Vitamins|vitamins|mesh-ancestor
138819819|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
138819820|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819821|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138819822|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138819823|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819824|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
138819825|NCT00150969|Coagulants|coagulants|mesh-ancestor
138819826|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138819827|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138819828|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
138819829|NCT00770770|Hormones|hormones|mesh-ancestor
138532529|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819830|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138819831|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819832|NCT00766636|Gemcitabine|gemcitabine|mesh-list
138819833|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138819834|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819835|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
138819836|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819837|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819838|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138819839|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819840|NCT02581969|Factor VIII|factor viii|mesh-list
138819841|NCT02581969|Coagulants|coagulants|mesh-ancestor
138819842|NCT00770692|Eszopiclone|eszopiclone|mesh-list
138819843|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138819844|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138819845|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819846|NCT02816203|Hemostatics|hemostatics|mesh-list
138819847|NCT02816203|Coagulants|coagulants|mesh-ancestor
138819848|NCT04099732|Dabigatran|dabigatran|mesh-list
138819849|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138819850|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138819851|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138819852|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
138819853|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819854|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138819855|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138819856|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819857|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
138819858|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138819859|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
138819860|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
138819861|NCT03183115|Lugol's solution|lugol's solution|mesh-list
138819862|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
138819863|NCT03183115|Coagulants|coagulants|mesh-ancestor
138819864|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138819865|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
138819866|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138819867|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
138819868|NCT02743819|Ipilimumab|ipilimumab|mesh-list
138819869|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819870|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819871|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138819872|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819873|NCT04074421|Rifaximin|rifaximin|mesh-list
138819874|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138819875|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138819876|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138819877|NCT02579707|Ivosidenib|ivosidenib|mesh-list
138819878|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819879|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819880|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819881|NCT02713009|Vitamin D|vitamin d|mesh-list
138819883|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
138819884|NCT02713009|Vitamins|vitamins|mesh-list
138819885|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
138819886|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819887|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138819888|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138819889|NCT03085225|Durvalumab|durvalumab|mesh-list
138819890|NCT03085225|Trabectedin|trabectedin|mesh-list
138819891|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819892|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819893|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138819894|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
138819895|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819896|NCT02705287|Vitamin D|vitamin d|mesh-list
138819897|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
138819898|NCT02705287|Cholecalciferol|cholecalciferol|mesh-list
138819899|NCT02705287|Vitamins|vitamins|mesh-list
138819900|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
138819901|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819902|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138819903|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138819904|NCT04295408|Ropivacaine|ropivacaine|mesh-list
138819905|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
138819906|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
138819907|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138819908|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819909|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
138819910|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138819911|NCT02578537|Clopidogrel|clopidogrel|mesh-list
138819912|NCT02578537|Ticagrelor|ticagrelor|mesh-list
138819913|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138819914|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138819915|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138819916|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138819917|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
138532530|NCT00042029|Aprepitant|aprepitant|mesh-list
138819918|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138819919|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819920|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819921|NCT03011671|Temozolomide|temozolomide|mesh-list
138819922|NCT03011671|Acetazolamide|acetazolamide|mesh-list
138819923|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138469113|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
138819924|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
138819925|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819926|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819927|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
138819928|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138819929|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819930|NCT03011671|Diuretics|diuretics|mesh-ancestor
138819931|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
138819932|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819933|NCT00628706|Dronabinol|dronabinol|mesh-list
138819934|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
138646949|NCT05745467|Povidone|povidone|mesh-list
138819935|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819936|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138819937|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138819938|NCT00628706|Analgesics|analgesics|mesh-ancestor
138819939|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
138819940|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138819941|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138819942|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138430837|NCT01733979|Iron|iron|mesh-list
138819943|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138819944|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819946|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138819947|NCT01001234|Rizatriptan|rizatriptan|mesh-list
138819948|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138819949|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
138819950|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138819951|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819952|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819953|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
138819954|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138819955|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819956|NCT04073953|Primaquine|primaquine|mesh-list
138819957|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
138819958|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138819959|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138819960|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138819961|NCT01004432|Golimumab|golimumab|mesh-list
138819962|NCT01004432|Methotrexate|methotrexate|mesh-list
138661196|NCT04699110|Adenosine|adenosine|mesh-list
138819963|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138819964|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138819965|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
138819966|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138819967|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819968|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138819969|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
138819970|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819971|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819972|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
138819973|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138819974|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138819975|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138819976|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
138819977|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138819978|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138819979|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138819980|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138819981|NCT02576275|Rituximab|rituximab|mesh-list
138819982|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138819983|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138819984|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138819985|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
138819986|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138819987|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138819988|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138469125|NCT01978496|Eletriptan|eletriptan|mesh-list
138430838|NCT01733979|Trace Elements|trace elements|mesh-ancestor
138819990|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138819991|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
138819992|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138819993|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138819994|NCT01000610|Prednisolone|prednisolone|mesh-list
138819995|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
138819996|NCT01000610|Rituximab|rituximab|mesh-list
138819997|NCT01000610|Methotrexate|methotrexate|mesh-list
138819998|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138819999|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
138820000|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138820001|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820002|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
138661309|NCT00351026|Methadone|methadone|mesh-list
138820003|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820004|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138820005|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138820006|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
138820007|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138820008|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138820009|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
138820010|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820011|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
138820012|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820013|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138820014|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138820015|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138820016|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138820017|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
138820018|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
138820019|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820020|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138820021|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
138820022|NCT01000610|Hormones|hormones|mesh-ancestor
138820023|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820025|NCT01000610|Protective Agents|protective agents|mesh-ancestor
138820026|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138820027|NCT02523469|Nivolumab|nivolumab|mesh-list
138820028|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138820029|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820030|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138820031|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820033|NCT00586924|Immunotoxins|immunotoxins|mesh-ancestor
138820034|NCT00586924|Immunoconjugates|immunoconjugates|mesh-ancestor
138820035|NCT00586924|Immunologic Factors|immunologic factors|mesh-ancestor
138820036|NCT00586924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820037|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820038|NCT01000376|Ketoconazole|ketoconazole|mesh-list
138820039|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
138820040|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820041|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138820042|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138820043|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820044|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820045|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138820046|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
138820047|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138430912|NCT01734564|Poly I-C|poly i-c|mesh-list
138820048|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820049|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138820050|NCT01038635|Lenalidomide|lenalidomide|mesh-list
138820051|NCT01038635|Azacitidine|azacitidine|mesh-list
138820052|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
138820053|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820054|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138820055|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138820056|NCT01038635|Growth Substances|growth substances|mesh-ancestor
138820057|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
138820058|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820059|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138820060|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
138820061|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820062|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820063|NCT00619203|Acetaminophen|acetaminophen|mesh-list
138820064|NCT00619203|Glycerol|glycerol|mesh-list
138820065|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138820066|NCT00619203|Analgesics|analgesics|mesh-ancestor
138820067|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
138820068|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820069|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820070|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
138820071|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138820072|NCT00619203|Protective Agents|protective agents|mesh-ancestor
138820073|NCT04072471|Lesinurad|lesinurad|mesh-list
138820074|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
138820075|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138820076|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
138820077|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138647009|NCT05585151|Protease Inhibitors|protease inhibitors|mesh-ancestor
138820078|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138820079|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820080|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138532531|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
138820081|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138820082|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138820083|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820084|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
138820085|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820086|NCT01812603|Nabiximols|nabiximols|mesh-list
138820087|NCT01812603|Analgesics|analgesics|mesh-ancestor
138820088|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
138820089|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820090|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820091|NCT04211805|Tenofovir|tenofovir|mesh-list
138820092|NCT04211805|Vaccines|vaccines|mesh-list
138820093|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
138820094|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820095|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
138820096|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820097|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138820098|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138820099|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820100|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820101|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138661582|NCT00466518|Incretins|incretins|mesh-ancestor
138820102|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138820103|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
138820104|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
138820105|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138820106|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138820107|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472060|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
138820108|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820109|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820110|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138820113|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
138820114|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
138820115|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138820116|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820117|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
138820118|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138661626|NCT00458250|Cyclosporins|cyclosporins|mesh-list
138820119|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
138820120|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820121|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
138820122|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820123|NCT00619671|Rituximab|rituximab|mesh-list
138820124|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138820125|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820126|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
138820127|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820128|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138820129|NCT00628550|Vasopressins|vasopressins|mesh-list
138820130|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
138820131|NCT00628550|Epinephrine|epinephrine|mesh-list
138820132|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138820133|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138647042|NCT05435547|Antiemetics|antiemetics|mesh-ancestor
138820134|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
138820135|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820136|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820137|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661685|NCT00458328|Z 338|z 338|mesh-list
138820138|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138820139|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138820140|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
138820141|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820142|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138820143|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
138820144|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
138820145|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
138820146|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138820147|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
138820148|NCT00628550|Coagulants|coagulants|mesh-ancestor
138820149|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138820150|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
138820151|NCT01059539|Cariprazine|cariprazine|mesh-list
138820152|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138820153|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138820154|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138820155|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820156|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138820157|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
138820158|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138820159|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
138820160|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820161|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820162|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138820163|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
138820164|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
138820165|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138820166|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
138820167|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820168|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820170|NCT02576119|BMS-955176|bms-955176|mesh-list
138820171|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138820172|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820173|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138820174|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138820175|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820176|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820177|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820178|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138820179|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138820180|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
138472136|NCT02000401|Ketorolac|ketorolac|mesh-list
138820181|NCT02871518|Cisplatin|cisplatin|mesh-list
138820182|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820183|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
138661792|NCT00354458|Rolofylline|rolofylline|mesh-list
138820184|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138820185|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138820186|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
138820187|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820188|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138820189|NCT00770224|Prednisone|prednisone|mesh-list
138820190|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
138820191|NCT00770224|Rituximab|rituximab|mesh-list
138820193|NCT00770224|Vincristine|vincristine|mesh-list
138820194|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
138820195|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138820196|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
138820197|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820198|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138820199|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138820200|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
138820201|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820202|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820203|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138820204|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138820205|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138820206|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138820207|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138820208|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820209|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138820210|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
138820211|NCT00770224|Hormones|hormones|mesh-ancestor
138820212|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820213|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138820214|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138820215|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
138820216|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
138820217|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
138820218|NCT02389465|Celecoxib|celecoxib|mesh-list
138820219|NCT02389465|Dexetimide|dexetimide|mesh-list
138820220|NCT02389465|Citalopram|citalopram|mesh-list
138820221|NCT02389465|Escitalopram|escitalopram|mesh-list
138820222|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138820223|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138820224|NCT02389465|Analgesics|analgesics|mesh-ancestor
138820225|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
138820226|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820227|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820228|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138820229|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138820230|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138820231|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138820232|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820233|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820234|NCT02389465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138820235|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138820236|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138820237|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820238|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
138820239|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138820240|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138820241|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
138820242|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
138820244|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138820245|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
138820246|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138820247|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
138820248|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138820250|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
138820252|NCT01057589|Cetuximab|cetuximab|mesh-list
138820253|NCT01057589|Vitamins|vitamins|mesh-ancestor
138820254|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
138820255|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820256|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820257|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820258|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820259|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138820260|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138820261|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138820263|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
138820264|NCT02575885|Nicotine|nicotine|mesh-list
138820265|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138820266|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
138820267|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820268|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820269|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138820270|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138820271|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
138820272|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820273|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820274|NCT02575729|Betamethasone|betamethasone|mesh-list
138820275|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
138820276|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138820277|NCT02575729|Hormones|hormones|mesh-ancestor
138532532|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
138820278|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820279|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820280|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138820281|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
138820282|NCT02575651|Fluzoparib|fluzoparib|mesh-list
138820283|NCT02575651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138820284|NCT02575651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820285|NCT02575651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820286|NCT02575651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820287|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
138820288|NCT01716117|Antacids|antacids|mesh-ancestor
138820289|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820290|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138820291|NCT00579553|Progesterone|progesterone|mesh-list
138820292|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138431135|NCT01736033|Tamsulosin|tamsulosin|mesh-list
138820293|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138820294|NCT00579553|Progestins|progestins|mesh-ancestor
138820295|NCT00579553|Hormones|hormones|mesh-ancestor
138820296|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820297|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820298|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138820299|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
138820300|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
138820301|NCT04209933|Bismuth|bismuth|mesh-list
138820302|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820303|NCT04209933|Antacids|antacids|mesh-ancestor
138820304|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138820305|NCT04209933|Diuretics|diuretics|mesh-ancestor
138820306|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
138820307|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820308|NCT04209933|Expectorants|expectorants|mesh-ancestor
138820309|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
138820310|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138820311|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
138820312|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820313|NCT04209699|Deucravacitinib|deucravacitinib|mesh-list
138662081|NCT00468351|Bevacizumab|bevacizumab|mesh-list
138820315|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138820316|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138820317|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138820318|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
138820319|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
138820320|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820321|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820322|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820323|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
138820324|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138820325|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820326|NCT00620295|Gemcitabine|gemcitabine|mesh-list
138820327|NCT00620295|Bortezomib|bortezomib|mesh-list
138820328|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138820329|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
138820330|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820331|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820332|NCT00581893|Phenytoin|phenytoin|mesh-list
138820333|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
138820334|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138820335|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138820336|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138820337|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820338|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138820339|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138820341|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138820342|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820343|NCT04211103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138820344|NCT04211103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820345|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138647127|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
138820346|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820347|NCT02334865|Lenalidomide|lenalidomide|mesh-list
138820348|NCT02334865|Sargramostim|sargramostim|mesh-list
138820349|NCT02334865|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138820350|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
138820351|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
138820352|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820353|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138820354|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138820356|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
138662179|NCT00427271|Aspirin|aspirin|mesh-list
138820357|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820358|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138820359|NCT04073719|Acetic Acid|acetic acid|mesh-list
138820360|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138820361|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820362|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
138820363|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138820364|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138820365|NCT00379431|Prednisolone|prednisolone|mesh-list
138820366|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
138820367|NCT00379431|Rituximab|rituximab|mesh-list
138820368|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138820369|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
138820370|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138820371|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820372|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
138820373|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820374|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138820375|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138820376|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
138820377|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
138820378|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469186|NCT01978873|Vitamins|vitamins|mesh-ancestor
138820379|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138820380|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
138820381|NCT00379431|Hormones|hormones|mesh-ancestor
138820382|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820383|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138820384|NCT00379431|Protective Agents|protective agents|mesh-ancestor
138820385|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138820386|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
138820387|NCT04954989|Hematinics|hematinics|mesh-ancestor
138820388|NCT00621699|Ezetimibe|ezetimibe|mesh-list
138820389|NCT00621699|Tacrolimus|tacrolimus|mesh-list
138820390|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138820391|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
138820392|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820393|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138820394|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820395|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820396|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138820397|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138820398|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
138820399|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138820400|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138647154|NCT05036291|Sotorasib|sotorasib|mesh-list
138820401|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138820402|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
138820403|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820404|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820405|NCT00770146|Mipomersen|mipomersen|mesh-list
138820406|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138820407|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138820408|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
138820409|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820410|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138820411|NCT00915850|Cisplatin|cisplatin|mesh-list
138820412|NCT00915850|Docetaxel|docetaxel|mesh-list
138820413|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820414|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
138820415|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
138820416|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
138820417|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820418|NCT04208763|Imipenem|imipenem|mesh-list
138820419|NCT04208763|Colistin|colistin|mesh-list
138820420|NCT04208763|Tigecycline|tigecycline|mesh-list
138820421|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138820422|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820423|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138820424|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820425|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820426|NCT00620919|Secretin|secretin|mesh-list
138820427|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138820428|NCT00620919|Hormones|hormones|mesh-ancestor
138820429|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820430|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820431|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
138820432|NCT00916552|Hematinics|hematinics|mesh-ancestor
138820433|NCT03950037|Albendazole|albendazole|mesh-list
138820434|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
138820435|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138820436|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820437|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
138820438|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138820439|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138820440|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
138820441|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
138820442|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
138820443|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820444|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820445|NCT04188171|Polidocanol|polidocanol|mesh-list
138820446|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138820447|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138820449|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
138820450|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
138820451|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138820452|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820453|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
138820454|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820455|NCT00622011|Risperidone|risperidone|mesh-list
138820456|NCT00622011|Zotepine|zotepine|mesh-list
138820457|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138820458|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
138820459|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820460|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820461|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820462|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138820463|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138820464|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138820465|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138820466|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138820467|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
138820468|NCT04208373|Itraconazole|itraconazole|mesh-list
138820469|NCT04208373|Etravirine|etravirine|mesh-list
138820470|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
138820471|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820472|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138820473|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138820474|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820475|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820476|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138662411|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
138820477|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
138820478|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431381|NCT01737671|Antidotes|antidotes|mesh-ancestor
138820479|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820480|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138820481|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138820482|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138820483|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
138820484|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138820485|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
138820486|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138820487|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138820488|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138820489|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138820490|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820491|NCT01056341|Propranolol|propranolol|mesh-list
138820492|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138820493|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138820494|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
138820495|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138662483|NCT00429065|Rituximab|rituximab|mesh-list
138820496|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820497|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820498|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138820499|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138820500|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
138820501|NCT00999518|Tanezumab|tanezumab|mesh-list
138820502|NCT00999518|Analgesics|analgesics|mesh-ancestor
138820503|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
138820504|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820505|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820506|NCT00621387|Ofloxacin|ofloxacin|mesh-list
138820508|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138820509|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820510|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138820511|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138820512|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138820513|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820514|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820515|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820516|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138820517|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138820518|NCT02873273|Dexamethasone|dexamethasone|mesh-list
138820519|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138820520|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
138431427|NCT01738100|Narcotics|narcotics|mesh-ancestor
138820522|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820523|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820524|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138820525|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
138820526|NCT02873273|Hormones|hormones|mesh-ancestor
138820527|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820528|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138820529|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820530|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
138820531|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820532|NCT01056263|Axitinib|axitinib|mesh-list
138820533|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820534|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138820535|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820536|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820537|NCT00637143|Cyclosporine|cyclosporine|mesh-list
138820538|NCT00637143|Tacrolimus|tacrolimus|mesh-list
138820539|NCT00637143|Cyclosporins|cyclosporins|mesh-list
138820540|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138820541|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
138820542|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820543|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138820544|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820545|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820546|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
138820547|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820548|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
138820550|NCT01056107|Glucagon|glucagon|mesh-list
138820551|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138820552|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138820553|NCT01056107|Hormones|hormones|mesh-ancestor
138820554|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820555|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820556|NCT01056107|Incretins|incretins|mesh-ancestor
138820557|NCT03548805|Mitomycins|mitomycins|mesh-list
138820558|NCT03548805|Mitomycin|mitomycin|mesh-list
138820559|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138820560|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820561|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
138820562|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431581|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138820563|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138820564|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820566|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138820567|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138820568|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138820569|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138820570|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
138820571|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820572|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820573|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820575|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138820576|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138820577|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138820578|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138820579|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
138820580|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820581|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820582|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820583|NCT01003184|Exenatide|exenatide|mesh-list
138820584|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
138820585|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138820586|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820587|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138820588|NCT01003184|Incretins|incretins|mesh-ancestor
138820589|NCT01003184|Hormones|hormones|mesh-ancestor
138820590|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820591|NCT01008410|Budesonide|budesonide|mesh-list
138820592|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138820593|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138820594|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
138820595|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820596|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820597|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138820598|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
138820599|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
138820600|NCT01008410|Hormones|hormones|mesh-ancestor
138820601|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820602|NCT00627653|Fenofibrate|fenofibrate|mesh-list
138820603|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138820604|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
138820605|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820606|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138820607|NCT02347917|Pemetrexed|pemetrexed|mesh-list
138820608|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820609|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820610|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820611|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138820612|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138431772|NCT01740921|Aspirin|aspirin|mesh-list
138820613|NCT01972035|Valacyclovir|valacyclovir|mesh-list
138820614|NCT01972035|Valganciclovir|valganciclovir|mesh-list
138820615|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
138820616|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820617|NCT00622479|Sorafenib|sorafenib|mesh-list
138820618|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820619|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138820620|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820621|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820622|NCT01207011|Docetaxel|docetaxel|mesh-list
138820623|NCT01207011|Amrubicin|amrubicin|mesh-list
138820624|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820625|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
138820626|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
138820627|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
138820628|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820629|NCT05264805|Bupivacaine|bupivacaine|mesh-list
138820630|NCT05264805|Anesthetics, Local|anesthetics, local|mesh-ancestor
138820631|NCT05264805|Anesthetics|anesthetics|mesh-ancestor
138820632|NCT05264805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138820633|NCT05264805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820634|NCT05264805|Sensory System Agents|sensory system agents|mesh-ancestor
138472587|NCT02002715|Budesonide|budesonide|mesh-list
138820635|NCT05264805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820636|NCT05264493|Naloxone|naloxone|mesh-list
138820637|NCT05264493|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138820638|NCT05264493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820639|NCT05264493|Sensory System Agents|sensory system agents|mesh-ancestor
138820640|NCT05264493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820642|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138820643|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138820644|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138820645|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138820646|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
138820647|NCT00612261|Hormones|hormones|mesh-ancestor
138820648|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820649|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820650|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138820651|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
138820652|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820653|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820654|NCT00636909|Cyclosporine|cyclosporine|mesh-list
138820655|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
138820656|NCT00636909|Methotrexate|methotrexate|mesh-list
138820657|NCT00636909|Fludarabine|fludarabine|mesh-list
138820658|NCT00636909|Cyclosporins|cyclosporins|mesh-list
138820659|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138820660|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
138820661|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820662|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138820663|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138820664|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
138532533|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820665|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820666|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820667|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138820668|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138820669|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
138820670|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138820671|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138820672|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
138820673|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
138820674|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820675|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138820676|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138820677|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
138820678|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820679|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138313832|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138820680|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138820681|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138820682|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647311|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820683|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138820684|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138820685|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138820686|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138820687|NCT02697045|Aripiprazole|aripiprazole|mesh-list
138820688|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
138820689|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138820690|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138820691|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138820692|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138820693|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820694|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
138820695|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
138820696|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820697|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820698|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138469233|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138820699|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138820700|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
138820701|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138662799|NCT06187090|Hormones|hormones|mesh-ancestor
138820702|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138820703|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138820704|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138820705|NCT01007942|Trastuzumab|trastuzumab|mesh-list
138820706|NCT01007942|Everolimus|everolimus|mesh-list
138820707|NCT01007942|Vinorelbine|vinorelbine|mesh-list
138820708|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138820709|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820711|NCT01007942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138820712|NCT01007942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820713|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820714|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138820715|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
138820716|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820717|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138820718|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
138820719|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
138820720|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
138820721|NCT01023035|Ribavirin|ribavirin|mesh-list
138820722|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138820723|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
138820724|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
138662888|NCT06186596|Hormones|hormones|mesh-ancestor
138820725|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820726|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
138820727|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820728|NCT01023035|Hematinics|hematinics|mesh-ancestor
138820729|NCT01028651|Treprostinil|treprostinil|mesh-list
138820730|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138820731|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
138820732|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138820733|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138820734|NCT00627731|Prednisolone|prednisolone|mesh-list
138820735|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
138820736|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138820737|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
138820738|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138820739|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
138820740|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
138820741|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820742|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820743|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138820744|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
138820745|NCT00627731|Hormones|hormones|mesh-ancestor
138532534|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820746|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820747|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138820748|NCT00627731|Protective Agents|protective agents|mesh-ancestor
138820749|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138820750|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820751|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138820752|NCT01028027|Tobramycin|tobramycin|mesh-list
138820753|NCT01028027|Dexamethasone|dexamethasone|mesh-list
138820754|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138820755|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
138820756|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
138820757|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820758|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820759|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138432154|NCT01742793|Romidepsin|romidepsin|mesh-list
138820760|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
138820761|NCT01028027|Hormones|hormones|mesh-ancestor
138820762|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820763|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138820764|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820765|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138820766|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820767|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138820768|NCT01007552|Bevacizumab|bevacizumab|mesh-list
138820769|NCT01007552|Gemcitabine|gemcitabine|mesh-list
138820770|NCT01007552|Capecitabine|capecitabine|mesh-list
138820771|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138820772|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820773|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138820774|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138820775|NCT01007552|Growth Substances|growth substances|mesh-ancestor
138820776|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820777|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
138820778|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138820779|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
138432203|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138820780|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820781|NCT02870036|Leucovorin|leucovorin|mesh-list
138820782|NCT02870036|Thalidomide|thalidomide|mesh-list
138820783|NCT02870036|Fluorouracil|fluorouracil|mesh-list
138820784|NCT02870036|Calcium|calcium|mesh-list
138820785|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
138820786|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138820787|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820789|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820790|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138820791|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820792|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138820793|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
138820794|NCT02870036|Antidotes|antidotes|mesh-ancestor
138820795|NCT02870036|Protective Agents|protective agents|mesh-ancestor
138820796|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
138820797|NCT02870036|Vitamins|vitamins|mesh-ancestor
138820798|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
138820799|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
138820800|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138820801|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138663143|NCT06088030|Arsenic Trioxide|arsenic trioxide|mesh-list
138820802|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138820803|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138820804|NCT02870036|Growth Substances|growth substances|mesh-ancestor
138820805|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
138820806|NCT04296422|Ibuprofen|ibuprofen|mesh-list
138820807|NCT04296422|Diclofenac|diclofenac|mesh-list
138820808|NCT04296422|Naproxen|naproxen|mesh-list
138820809|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138820810|NCT04296422|Piroxicam|piroxicam|mesh-list
138820811|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
138820812|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
138820813|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138820814|NCT04296422|Analgesics|analgesics|mesh-ancestor
138820815|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
138820816|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820817|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820818|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138820819|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138820820|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138820821|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820822|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820823|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
138820824|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138820825|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138820826|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
138820827|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
138820829|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138820830|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820831|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138820832|NCT00998738|Analgesics|analgesics|mesh-ancestor
138820833|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
138820834|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820835|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
138820836|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138820837|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138820838|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
138820839|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138820840|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138820841|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820842|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
138820843|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138820844|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138820845|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663254|NCT06002607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138663255|NCT06002607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138663256|NCT06002607|Antitubercular Agents|antitubercular agents|mesh-ancestor
138663257|NCT05981118|Betamethasone|betamethasone|mesh-list
138663264|NCT05981118|Hormones|hormones|mesh-ancestor
138820846|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138820847|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820848|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820849|NCT04296578|Selenious Acid|selenious acid|mesh-list
138820850|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
138820851|NCT04296578|Prednisone|prednisone|mesh-list
138820852|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
138820853|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138820854|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
138820855|NCT04296578|Hormones|hormones|mesh-ancestor
138820856|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820857|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820858|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138820859|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472815|NCT02004860|Ciclopirox|ciclopirox|mesh-list
138820860|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138820861|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820862|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820863|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
138820864|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138820865|NCT04296578|Trace Elements|trace elements|mesh-ancestor
138820866|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
138820868|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138820869|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138820870|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
138820871|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
138820872|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647428|NCT04340947|Nicotine|nicotine|mesh-list
138820873|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820874|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820875|NCT01027949|Treprostinil|treprostinil|mesh-list
138820876|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138820877|NCT01038323|Milnacipran|milnacipran|mesh-list
138820878|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
138432258|NCT01743300|Sunitinib|sunitinib|mesh-list
138820879|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138820880|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138820881|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138820882|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820883|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820884|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820885|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138820886|NCT01038323|Analgesics|analgesics|mesh-ancestor
138820887|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
138820888|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138820889|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
138820890|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138820891|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
138820892|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138820893|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820894|NCT04301375|Paclitaxel|paclitaxel|mesh-list
138820895|NCT04301375|Trastuzumab|trastuzumab|mesh-list
138820896|NCT04301375|Pertuzumab|pertuzumab|mesh-list
138820897|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138820898|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820899|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
138820900|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
138820901|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
138820902|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820903|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138820904|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
138820905|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138820906|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820907|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138820908|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
138820909|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
138820910|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820911|NCT01025843|Candesartan|candesartan|mesh-list
138820912|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
138820913|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138820914|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138820915|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138820916|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820917|NCT02873351|Levodopa|levodopa|mesh-list
138820918|NCT02873351|Carbidopa|carbidopa|mesh-list
138820919|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138820920|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138820921|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138820922|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
138820923|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138820924|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820925|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820926|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138820927|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820928|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138820929|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
138820930|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
138820933|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138820934|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
138820935|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138820936|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820937|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138820938|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
138820939|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820940|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820941|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
138820943|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138820944|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138820945|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
138820946|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138820947|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138820948|NCT04299971|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138820949|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138820950|NCT01020305|Sirolimus|sirolimus|mesh-list
138820951|NCT01020305|Temsirolimus|temsirolimus|mesh-list
138820952|NCT01020305|MTOR Inhibitors|mtor inhibitors|mesh-list
138820953|NCT01020305|Bicalutamide|bicalutamide|mesh-list
138820954|NCT01020305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138820955|NCT01020305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820956|NCT01020305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820957|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138820959|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820960|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138820961|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138820962|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138820963|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138820964|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
138820965|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
138820966|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
138820967|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138820968|NCT00627575|Lamotrigine|lamotrigine|mesh-list
138820969|NCT00627575|Phenytoin|phenytoin|mesh-list
138820970|NCT00627575|Atorvastatin|atorvastatin|mesh-list
138820971|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138820972|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138820973|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
138820974|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820975|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138820976|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138820977|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138820978|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
138820979|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138647470|NCT04198506|Tacrolimus|tacrolimus|mesh-list
138820980|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138820981|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138820982|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138820983|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138820984|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138820985|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138820986|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138820987|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138820988|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138820989|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138663644|NCT05672342|Dronabinol|dronabinol|mesh-list
138820990|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138820991|NCT00627809|Streptokinase|streptokinase|mesh-list
138820992|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138820993|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138820994|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138820995|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138820996|NCT02872649|Warfarin|warfarin|mesh-list
138820997|NCT02872649|Dabigatran|dabigatran|mesh-list
138820998|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
138820999|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
138821000|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
138821001|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138821002|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
138821003|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821004|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821005|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138821006|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
138821007|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138821008|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138821009|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138821010|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
138821011|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138821012|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821014|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138821015|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138821016|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138821017|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821018|NCT01018511|Tamsulosin|tamsulosin|mesh-list
138821019|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
138821020|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138821021|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138821022|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138821023|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
138821024|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821025|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821026|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821027|NCT01018511|Urological Agents|urological agents|mesh-ancestor
138821028|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138821029|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138821030|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
138821032|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
138647497|NCT04126135|Nicotine|nicotine|mesh-list
138821033|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821034|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
138821035|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821036|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821037|NCT02269267|Imatinib Mesylate|imatinib mesylate|mesh-list
138821038|NCT02269267|Dasatinib|dasatinib|mesh-list
138821039|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
138821040|NCT02269267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821041|NCT02269267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138821042|NCT02269267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821043|NCT02269267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821044|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
138663713|NCT05656599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663714|NCT05656599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663715|NCT05656599|Antiviral Agents|antiviral agents|mesh-ancestor
138663716|NCT05656599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138663722|NCT05642078|Vaccines|vaccines|mesh-list
138663723|NCT05642078|Immunologic Factors|immunologic factors|mesh-ancestor
138821045|NCT02269267|Protective Agents|protective agents|mesh-ancestor
138821046|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821047|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138821048|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138821049|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821050|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
138821051|NCT02575261|Immunomodulating Agents|immunomodulating agents|mesh-list
138821052|NCT02575261|Immunologic Factors|immunologic factors|mesh-ancestor
138821053|NCT02575261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821054|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
138821055|NCT01017731|Promethazine|promethazine|mesh-list
138821056|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
138821057|NCT01017731|Ramucirumab|ramucirumab|mesh-list
138821059|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821060|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138821061|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138821062|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821063|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821064|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821065|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821066|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138821067|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138821068|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821069|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
138821070|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
138821071|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
138821072|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821073|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
138821074|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
138821075|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138821076|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138821077|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
138821078|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
138647507|NCT04116541|Trametinib|trametinib|mesh-list
138821079|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821080|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138821081|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
138821082|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
138821083|NCT02575183|Varenicline|varenicline|mesh-list
138821084|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138821085|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138821086|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
138821087|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821088|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821089|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821090|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
138821091|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138821092|NCT00779584|Gemcitabine|gemcitabine|mesh-list
138821093|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138821094|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
138821095|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821096|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821097|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138821098|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
138821099|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138821100|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138821101|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138821102|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821103|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821104|NCT01385059|Axitinib|axitinib|mesh-list
138821105|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821106|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138821107|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821108|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821111|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
138821112|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138821113|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
138821114|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821115|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138821116|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
138821117|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
138821118|NCT00769132|Vitamins|vitamins|mesh-ancestor
138821119|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
138821120|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821121|NCT04070755|Minocycline|minocycline|mesh-list
138432829|NCT01746992|Prednisone|prednisone|mesh-list
138821122|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138821123|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821125|NCT04100434|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138821126|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138821127|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138821128|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
138821129|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821130|NCT04100434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138821131|NCT04100434|Protease Inhibitors|protease inhibitors|mesh-ancestor
138821132|NCT04100434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821133|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138821134|NCT00991952|Irinotecan|irinotecan|mesh-list
138821135|NCT00991952|Alvocidib|alvocidib|mesh-list
138821136|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138821137|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138821138|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821139|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821140|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821141|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
138821142|NCT00991952|Growth Substances|growth substances|mesh-ancestor
138821143|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821144|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138821145|NCT00779038|Fentanyl|fentanyl|mesh-list
138821146|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138821147|NCT00779038|Narcotics|narcotics|mesh-ancestor
138821148|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821149|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821150|NCT00779038|Analgesics|analgesics|mesh-ancestor
138821151|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
138821152|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821153|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138473115|NCT05969847|Oxaliplatin|oxaliplatin|mesh-list
138821154|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138821156|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
138821157|NCT04292990|Fentanyl|fentanyl|mesh-list
138821158|NCT04292990|Morphine|morphine|mesh-list
138821160|NCT04292990|Narcotics|narcotics|mesh-ancestor
138821161|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821162|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821163|NCT04292990|Analgesics|analgesics|mesh-ancestor
138821164|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
138821165|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821166|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138821167|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138821168|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
138821169|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
138821170|NCT02868632|Durvalumab|durvalumab|mesh-list
138821171|NCT02868632|Tremelimumab|tremelimumab|mesh-list
138821172|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138821173|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821174|NCT04021498|Simvastatin|simvastatin|mesh-list
138821175|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138647569|NCT03947385|Crizotinib|crizotinib|mesh-list
138663979|NCT05491317|Pembrolizumab|pembrolizumab|mesh-list
138821176|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138821177|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
138821178|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821179|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138821180|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138821181|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821182|NCT00994682|Pioglitazone|pioglitazone|mesh-list
138821183|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138821184|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821186|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138821187|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
138821188|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138821189|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138821190|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138821191|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138821192|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821193|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
138821194|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821195|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432885|NCT01747135|Betadex|betadex|mesh-list
138821197|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138821198|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821199|NCT04292444|Oxytocin|oxytocin|mesh-list
138821200|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
138821201|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138821202|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821203|NCT01017575|Ribavirin|ribavirin|mesh-list
138821204|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138821205|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
138821206|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821207|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
138821208|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821209|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138821210|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
138821211|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138821212|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821213|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138821214|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138821215|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138821216|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821217|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
138821218|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821219|NCT01253161|Pasireotide|pasireotide|mesh-list
138821220|NCT01253161|Hormones|hormones|mesh-ancestor
138821221|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469319|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138821222|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647592|NCT03929718|Spironolactone|spironolactone|mesh-list
138821224|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
138821225|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
138821226|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821227|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821228|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138821229|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
138821230|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138821231|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821232|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821233|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138821234|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138821235|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138821236|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821237|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138821238|NCT02576665|Flucytosine|flucytosine|mesh-list
138821239|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
138821240|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821241|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
138821242|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821243|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
138821244|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821245|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
138821246|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138821247|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138821248|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821249|NCT00627965|Urological Agents|urological agents|mesh-ancestor
138821251|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138821252|NCT02576353|Narcotics|narcotics|mesh-ancestor
138821253|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821254|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821255|NCT02576353|Analgesics|analgesics|mesh-ancestor
138821256|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
138821257|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821258|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138821259|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138821260|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
138821261|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
138821262|NCT01016015|Sirolimus|sirolimus|mesh-list
138821263|NCT01016015|Temsirolimus|temsirolimus|mesh-list
138821264|NCT01016015|MTOR Inhibitors|mtor inhibitors|mesh-list
138821265|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138432994|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821266|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138821267|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821268|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138821269|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821270|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
138821271|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138821272|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
138821273|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821274|NCT01016015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138821275|NCT01016015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821276|NCT01016015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821277|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
138821278|NCT00628043|Hematinics|hematinics|mesh-ancestor
138821279|NCT00709657|Bevacizumab|bevacizumab|mesh-list
138821280|NCT00709657|Ranibizumab|ranibizumab|mesh-list
138821281|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138821282|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821283|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138821284|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138821285|NCT00709657|Growth Substances|growth substances|mesh-ancestor
138821286|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821287|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
138821288|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
138821289|NCT04073173|Analgesics|analgesics|mesh-list
138821290|NCT04073173|Narcotics|narcotics|mesh-ancestor
138821291|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821292|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821293|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
138821294|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821295|NCT00628121|Cetrorelix|cetrorelix|mesh-list
138821296|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138821297|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
138821298|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138821299|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821300|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
138433045|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138821301|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138821302|NCT00709969|Lumefantrine|lumefantrine|mesh-list
138821303|NCT00709969|Artemether|artemether|mesh-list
138821304|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138821305|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
138821306|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138821307|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138821308|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821309|NCT00710125|Doxorubicin|doxorubicin|mesh-list
138821310|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138821311|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821312|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138821313|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138821314|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821315|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821316|NCT02573701|Risperidone|risperidone|mesh-list
138821317|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
138821318|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138821319|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
138821320|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821321|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821322|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821323|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138821324|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821325|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138821326|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138821327|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
138821329|NCT01017029|Everolimus|everolimus|mesh-list
138821330|NCT01017029|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138821331|NCT01017029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138821332|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821333|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821334|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138821335|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
138821336|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821337|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821338|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138821339|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138821340|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
138821341|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138433129|NCT01748422|Capsaicin|capsaicin|mesh-list
138821342|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821343|NCT00714649|Cetuximab|cetuximab|mesh-list
138821344|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138821345|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821346|NCT00710359|Vitamins|vitamins|mesh-list
138821347|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
138821348|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
138821349|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
138821350|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
138821351|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821352|NCT00710359|Hematinics|hematinics|mesh-ancestor
138821353|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138821355|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
138821356|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821357|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138821358|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138821359|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
138433207|NCT01748721|Antibodies|antibodies|mesh-list
138821361|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821362|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821363|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
138821364|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138821365|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821366|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821367|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138821368|NCT00710437|Analgesics|analgesics|mesh-ancestor
138821369|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
138821370|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821371|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138821372|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138821373|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138821374|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
138821375|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821376|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821377|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
138821378|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138821379|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
138821380|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138821381|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821382|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138821383|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138821384|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138821386|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138821387|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821388|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138821389|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821390|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
138821391|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138821392|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
138664441|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664442|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138664443|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138664444|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138664445|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138664446|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138664447|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
138664448|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138664449|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138664450|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138664451|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138664452|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664453|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
138664454|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138664455|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664456|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138664457|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199823|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
138664486|NCT04973345|Terbutaline|terbutaline|mesh-list
138664487|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138664488|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
138199864|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
138664489|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138664490|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138664491|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138821393|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821394|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
138821395|NCT00710827|Androgens|androgens|mesh-ancestor
138821396|NCT00710827|Hormones|hormones|mesh-ancestor
138821397|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138821398|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821399|NCT01034657|Panobinostat|panobinostat|mesh-list
138821400|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
138821401|NCT01034657|Hematinics|hematinics|mesh-ancestor
138821402|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821403|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138821404|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821405|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821407|NCT01014767|Dactinomycin|dactinomycin|mesh-list
138647716|NCT03859973|BI 425809|bi 425809|mesh-list
138821409|NCT01014767|Temozolomide|temozolomide|mesh-list
138821410|NCT01014767|Cisplatin|cisplatin|mesh-list
138821411|NCT01014767|Carboplatin|carboplatin|mesh-list
138821412|NCT01014767|Doxorubicin|doxorubicin|mesh-list
138821413|NCT01014767|Methotrexate|methotrexate|mesh-list
138821414|NCT01014767|Irinotecan|irinotecan|mesh-list
138821415|NCT01014767|Etoposide|etoposide|mesh-list
138821416|NCT01014767|Vincristine|vincristine|mesh-list
138821417|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138821418|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
138821419|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821420|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138821421|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138821422|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
138821423|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821424|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821425|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138821426|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138821427|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138664550|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
138821428|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138821429|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821430|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138821431|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
138433423|NCT01749579|Propofol|propofol|mesh-list
138821432|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138821433|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138821434|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
138821435|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
138821436|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138821437|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138821438|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138821439|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138821440|NCT01014767|Antidotes|antidotes|mesh-ancestor
138821441|NCT01014767|Protective Agents|protective agents|mesh-ancestor
138821442|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
138821443|NCT01014767|Vitamins|vitamins|mesh-ancestor
138821444|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
138821445|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
138821446|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
138821447|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
138821448|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138821449|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821450|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138821451|NCT01014689|Lymecycline|lymecycline|mesh-list
138821452|NCT01014689|Adapalene|adapalene|mesh-list
138821453|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138821454|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138821455|NCT01014689|Analgesics|analgesics|mesh-ancestor
138821456|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
138821457|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821458|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821459|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138821460|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138647731|NCT03718065|Lofexidine|lofexidine|mesh-list
138821461|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
138821462|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138821463|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821465|NCT01014533|Analgesics|analgesics|mesh-ancestor
138821466|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
138821467|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821468|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821469|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
138821470|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138821471|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138821472|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821473|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138821474|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138821475|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138821476|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821477|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821478|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
138821479|NCT02013427|Naproxen|naproxen|mesh-list
138821480|NCT02013427|Omeprazole|omeprazole|mesh-list
138821481|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138821482|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138821483|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138821484|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821485|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821486|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138821487|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138821488|NCT02013427|Analgesics|analgesics|mesh-ancestor
138821489|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
138821490|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821491|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821492|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138821493|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138821494|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
138821495|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138821496|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
138821497|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138821498|NCT01014143|Triclosan|triclosan|mesh-list
138821499|NCT01014143|Fluorides|fluorides|mesh-list
138821500|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
138821501|NCT01014143|Protective Agents|protective agents|mesh-ancestor
138821502|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821503|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138821504|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821505|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
138821506|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
138821507|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138821508|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138821509|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
138821510|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821511|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138664763|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
138664764|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
138664765|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138664766|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138664767|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138664775|NCT04663347|Cytarabine|cytarabine|mesh-list
138664776|NCT04663347|Dexamethasone|dexamethasone|mesh-list
138821512|NCT00714961|Clopidogrel|clopidogrel|mesh-list
138821513|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138821514|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138821515|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138821516|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138821517|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
138821518|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821519|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821520|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821521|NCT02574403|Eculizumab|eculizumab|mesh-list
138821522|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138821523|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138821524|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
138821525|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821526|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
138821528|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138821529|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
138821530|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821531|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821532|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138821533|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
138821534|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138821535|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138821536|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138821537|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
138821538|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821539|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821540|NCT00715039|Lorazepam|lorazepam|mesh-list
138821541|NCT00715039|Paroxetine|paroxetine|mesh-list
138821542|NCT00715039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138821543|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138821544|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138821545|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433588|NCT06176144|Sevoflurane|sevoflurane|mesh-list
138821546|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821547|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
138821548|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821549|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138821550|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
138821551|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138821552|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138821553|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138821554|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821555|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
138647777|NCT03598595|Docetaxel|docetaxel|mesh-list
138821556|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
138821557|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
138821558|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821559|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138821560|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138821561|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821562|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138821563|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138821564|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
138821565|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
138821566|NCT00711295|Vaccines|vaccines|mesh-list
138821567|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
138821568|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821569|NCT02871869|Buformin|buformin|mesh-list
138821570|NCT02871869|Prednisone|prednisone|mesh-list
138821571|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
138821572|NCT02871869|Rituximab|rituximab|mesh-list
138821573|NCT02871869|Epirubicin|epirubicin|mesh-list
138821574|NCT02871869|Vindesine|vindesine|mesh-list
138821575|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138821576|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
138821577|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821578|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138821579|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138821580|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
138433647|NCT06175702|Antimetabolites|antimetabolites|mesh-ancestor
138821581|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821582|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821583|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138821584|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138821585|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138821586|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
138821587|NCT02871869|Hormones|hormones|mesh-ancestor
138821588|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138821589|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138821590|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138821591|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138821592|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138821593|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469399|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
138200520|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664977|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664978|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664979|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
138664980|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138664981|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
138664982|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138664983|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138664984|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138664985|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138287370|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138664986|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665006|NCT04542824|Prednisone|prednisone|mesh-list
138665007|NCT04542824|Cyclophosphamide|cyclophosphamide|mesh-list
138665008|NCT04542824|Rituximab|rituximab|mesh-list
138665009|NCT04542824|Gemcitabine|gemcitabine|mesh-list
138665010|NCT04542824|Doxorubicin|doxorubicin|mesh-list
138665011|NCT04542824|Oxaliplatin|oxaliplatin|mesh-list
138665012|NCT04542824|Vincristine|vincristine|mesh-list
138821594|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138821595|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
138821596|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
138821597|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
138821598|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138433724|NCT06162611|Hormones|hormones|mesh-ancestor
138821600|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821601|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138821602|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821603|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821605|NCT00715273|Niacinamide|niacinamide|mesh-list
138821606|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
138821607|NCT00715273|Atorvastatin|atorvastatin|mesh-list
138821608|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138821609|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138473561|NCT05469893|Lenalidomide|lenalidomide|mesh-list
138821610|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138821611|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
138433766|NCT06109402|Mitosis Modulators|mitosis modulators|mesh-ancestor
138821612|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665023|NCT04542824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138821613|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138821614|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138821615|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821616|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
138821617|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
138821619|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
138821620|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821621|NCT01013285|Bevacizumab|bevacizumab|mesh-list
138821622|NCT01013285|Temozolomide|temozolomide|mesh-list
138821623|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138821624|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821625|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138821626|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138821627|NCT01013285|Growth Substances|growth substances|mesh-ancestor
138821628|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821629|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
138821630|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138821631|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
138433829|NCT05996133|Dexamethasone|dexamethasone|mesh-list
138433830|NCT05996133|Epinephrine|epinephrine|mesh-list
138433831|NCT05996133|Bupivacaine|bupivacaine|mesh-list
138433832|NCT05996133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138821632|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821633|NCT00715351|Insulin|insulin|mesh-list
138821634|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138821635|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
138821636|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
138821637|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
138821638|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
138821639|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138821640|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821641|NCT00711841|Dexamethasone|dexamethasone|mesh-list
138821642|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
138665133|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138665134|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138665135|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138665136|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665137|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200731|NCT05271292|Chiauranib|chiauranib|mesh-list
138665139|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138665145|NCT04418154|Paclitaxel|paclitaxel|mesh-list
138821643|NCT00711841|BB 1101|bb 1101|mesh-list
138821644|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138821645|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
138821646|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
138821647|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821648|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821649|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138821650|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
138821651|NCT00711841|Hormones|hormones|mesh-ancestor
138821652|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138821653|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138821654|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821655|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
138821656|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821657|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821658|NCT00711919|Pitavastatin|pitavastatin|mesh-list
138821659|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138821660|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138821661|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138821662|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
138821663|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821664|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821665|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138821666|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
138200820|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
138665212|NCT04284839|Warfarin|warfarin|mesh-list
138665213|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
138665214|NCT04284839|Dabigatran|dabigatran|mesh-list
138665215|NCT04284839|Apixaban|apixaban|mesh-list
138665216|NCT04284839|Edoxaban|edoxaban|mesh-list
138665217|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
138665218|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138665219|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
138665220|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138665221|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
138665222|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138665224|NCT04273945|Macitentan|macitentan|mesh-list
138821667|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
138821668|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138821669|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138821670|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821671|NCT00712465|Digoxin|digoxin|mesh-list
138821672|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138821673|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138821674|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821675|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821676|NCT00712465|Protective Agents|protective agents|mesh-ancestor
138821677|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821678|NCT00715975|Clobetasol|clobetasol|mesh-list
138821679|NCT00715975|Halobetasol|halobetasol|mesh-list
138434005|NCT05696613|Immunologic Factors|immunologic factors|mesh-ancestor
138821680|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138821681|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
138821682|NCT00715975|Hormones|hormones|mesh-ancestor
138665249|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665257|NCT04209595|Rucaparib|rucaparib|mesh-list
138821683|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473654|NCT05291364|Ethanol|ethanol|mesh-list
138821684|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821685|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138821686|NCT02572687|Durvalumab|durvalumab|mesh-list
138821687|NCT02572687|Ramucirumab|ramucirumab|mesh-list
138821688|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138821689|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821690|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138821691|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138821692|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138821693|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138821694|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138821695|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
138821696|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821697|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821698|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821699|NCT00603447|Dexamethasone|dexamethasone|mesh-list
138821700|NCT00603447|Lenalidomide|lenalidomide|mesh-list
138821701|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138821702|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
138821703|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
138469414|NCT01980966|Oseltamivir|oseltamivir|mesh-list
138821704|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821705|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821706|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138821707|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
138821708|NCT00603447|Hormones|hormones|mesh-ancestor
138821709|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138821710|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138821711|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821712|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
138821713|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138821714|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138821715|NCT00603447|Growth Substances|growth substances|mesh-ancestor
138821716|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
138821717|NCT00718705|Josamycin|josamycin|mesh-list
138821718|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138821719|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821720|NCT00639015|Phenylephrine|phenylephrine|mesh-list
138821721|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
138821722|NCT00639015|Norepinephrine|norepinephrine|mesh-list
138647858|NCT03441048|Cytarabine|cytarabine|mesh-list
138821723|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138821724|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
138821725|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
138821726|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821727|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821728|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
138821729|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138821730|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
138821731|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
138821732|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138821733|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138821734|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138821735|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
138821736|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138434059|NCT05634369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138821737|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821738|NCT00639015|Protective Agents|protective agents|mesh-ancestor
138821739|NCT00712855|Sorafenib|sorafenib|mesh-list
138821740|NCT00712855|Mapatumumab|mapatumumab|mesh-list
138821741|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821742|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138821743|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821744|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821745|NCT02537925|Celecoxib|celecoxib|mesh-list
138821746|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
138821747|NCT02537925|Nedaplatin|nedaplatin|mesh-list
138821748|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138821749|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138821750|NCT02537925|Analgesics|analgesics|mesh-ancestor
138821751|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
138821752|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821753|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821754|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138821755|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138821756|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138821757|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821758|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821759|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821760|NCT00713011|Nifedipine|nifedipine|mesh-list
138821761|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138821762|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138821763|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821764|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138821765|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821766|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
138821767|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
138821768|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138821769|NCT04185675|Anesthetics|anesthetics|mesh-list
138821770|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821771|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821772|NCT04208061|Ritonavir|ritonavir|mesh-list
138821773|NCT04208061|Darunavir|darunavir|mesh-list
138821774|NCT04208061|Dabigatran|dabigatran|mesh-list
138821775|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138821776|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138821779|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821780|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138821781|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138821782|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
138821783|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821784|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138821785|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138821786|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
138821787|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138821788|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
138821789|NCT00988208|Prednisone|prednisone|mesh-list
138821790|NCT00988208|Docetaxel|docetaxel|mesh-list
138821791|NCT00988208|Lenalidomide|lenalidomide|mesh-list
138821792|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821793|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
138821794|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
138821795|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
138821796|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821797|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138821798|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
138821799|NCT00988208|Hormones|hormones|mesh-ancestor
138821800|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138821801|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821802|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138821803|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
138821804|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138821805|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138821806|NCT00988208|Growth Substances|growth substances|mesh-ancestor
138821807|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
138821808|NCT00639249|SA 4503|sa 4503|mesh-list
138821809|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
138821810|NCT04185831|Everolimus|everolimus|mesh-list
138821811|NCT04185831|Atezolizumab|atezolizumab|mesh-list
138821812|NCT04185831|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138821813|NCT04185831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138821814|NCT04185831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821815|NCT04185831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821816|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138821817|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
138821818|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434279|NCT05231629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138434280|NCT05231629|Growth Substances|growth substances|mesh-ancestor
138434281|NCT05231629|Growth Inhibitors|growth inhibitors|mesh-ancestor
138434282|NCT05173298|Bevacizumab|bevacizumab|mesh-list
138434283|NCT05173298|Atezolizumab|atezolizumab|mesh-list
138434284|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434285|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434286|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138821819|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821820|NCT04185831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138821821|NCT04185831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138821823|NCT02686983|Anesthetics|anesthetics|mesh-list
138821824|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
138821825|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821826|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821827|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
138821828|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821829|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138821830|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
138821831|NCT02686983|Hormones|hormones|mesh-ancestor
138821832|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138821833|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138821834|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
138821835|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
138821836|NCT02686905|Vitamin D|vitamin d|mesh-list
138821837|NCT02686905|Vitamins|vitamins|mesh-list
138821838|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
138821839|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
138821840|NCT02686905|Calcium|calcium|mesh-list
138821841|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
138821842|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821843|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138821844|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138821845|NCT02686905|Hematinics|hematinics|mesh-ancestor
138821846|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
138821847|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
138821848|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821849|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
138821850|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138821851|NCT00990704|Protective Agents|protective agents|mesh-ancestor
138821852|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821853|NCT00639327|Irinotecan|irinotecan|mesh-list
138821854|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138821855|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138821856|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821857|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821858|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821859|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138821860|NCT04089553|Durvalumab|durvalumab|mesh-list
138821861|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138821862|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821863|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
138821864|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821865|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138821866|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821867|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821868|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
138821869|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138821870|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821871|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138821873|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
138821874|NCT02686827|Vitamins|vitamins|mesh-ancestor
138821875|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
138821876|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821877|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138821878|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138821879|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
138821880|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138821881|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821882|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
138821883|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821884|NCT00713167|Protective Agents|protective agents|mesh-ancestor
138469483|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
138821885|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821886|NCT00716521|Zolpidem|zolpidem|mesh-list
138821887|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138821888|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138821889|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138665985|NCT03414502|Analgesics|analgesics|mesh-ancestor
138821890|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821891|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138821892|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
138821893|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
138821894|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138821895|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821896|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
138821897|NCT00993668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138821898|NCT00993668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138821899|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138821900|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
138821901|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821903|NCT00778102|Leucovorin|leucovorin|mesh-list
138821904|NCT00778102|Bevacizumab|bevacizumab|mesh-list
138821905|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
138821906|NCT00778102|Irinotecan|irinotecan|mesh-list
138821907|NCT00778102|Fluorouracil|fluorouracil|mesh-list
138821908|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
138821909|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138821910|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821911|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138821912|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138821913|NCT00778102|Growth Substances|growth substances|mesh-ancestor
138821914|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821915|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
138821916|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138821917|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138821918|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821919|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821920|NCT00778102|Antidotes|antidotes|mesh-ancestor
138821921|NCT00778102|Protective Agents|protective agents|mesh-ancestor
138821922|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
138821923|NCT00778102|Vitamins|vitamins|mesh-ancestor
138821924|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
138821925|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
138821926|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138821927|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138821928|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
138821929|NCT00713557|Tirofiban|tirofiban|mesh-list
138821930|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138821931|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138821932|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821933|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138821934|NCT00719095|Naltrexone|naltrexone|mesh-list
138821935|NCT00719095|Buprenorphine|buprenorphine|mesh-list
138821936|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138821937|NCT00719095|Narcotics|narcotics|mesh-ancestor
138821938|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821939|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821940|NCT00719095|Analgesics|analgesics|mesh-ancestor
138821941|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
138469489|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821942|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821943|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138821944|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138821945|NCT00916630|Pemetrexed|pemetrexed|mesh-list
138821946|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821947|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666161|NCT03178149|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138666162|NCT03178149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138821948|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821949|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138821950|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138821951|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
138821952|NCT02572375|Codeine|codeine|mesh-list
138821954|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
138821955|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138821956|NCT02572375|Narcotics|narcotics|mesh-ancestor
138821957|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138821958|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821959|NCT02572375|Analgesics|analgesics|mesh-ancestor
138821960|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
138821961|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138821962|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
138821963|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
138821964|NCT02572375|Expectorants|expectorants|mesh-ancestor
138821965|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138821966|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138821967|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
138821968|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647968|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138821969|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821970|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
138821971|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138821972|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
138666213|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
138666214|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
138821973|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
138821974|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
138821975|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138821976|NCT00716911|Ganciclovir|ganciclovir|mesh-list
138821977|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138821978|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
138821979|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138821980|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138821981|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138821982|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821983|NCT00612495|Fluorouracil|fluorouracil|mesh-list
138821984|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
138821985|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
138821986|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138821987|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138821988|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138821989|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138821990|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
138821991|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821992|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
138821993|NCT00719173|Aprepitant|aprepitant|mesh-list
138821994|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138821995|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
138821996|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138821997|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138821998|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138821999|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
138822000|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822001|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822002|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138822003|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
138822004|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
138469513|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
138822005|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822006|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138822007|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138822008|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822009|NCT00756886|Atorvastatin|atorvastatin|mesh-list
138822010|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138822011|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138822012|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
138666320|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822013|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822014|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138822015|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138822016|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822017|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138822018|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138822019|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138822020|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
138822021|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822022|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822023|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138822024|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138822025|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
138822026|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822028|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138822029|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822030|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138822031|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822032|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822033|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138822034|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138822035|NCT00984620|Interferons|interferons|mesh-list
138822036|NCT00984620|Ribavirin|ribavirin|mesh-list
138822037|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
138822038|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822039|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
138822040|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822041|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
138822042|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822043|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
138434779|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
138822044|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822046|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
138822047|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138822048|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138822049|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822050|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138822051|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822052|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138822053|NCT00639483|Celecoxib|celecoxib|mesh-list
138822054|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138822055|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138822056|NCT00639483|Analgesics|analgesics|mesh-ancestor
138822057|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
138822058|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822059|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822060|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138822061|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138822062|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138822063|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138822064|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469518|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
138822065|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822066|NCT00777946|Amlodipine|amlodipine|mesh-list
138822067|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138822068|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138822069|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138822070|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822071|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138822072|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822073|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
138822074|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
138822075|NCT02686047|Hylan|hylan|mesh-list
138822076|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138822077|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
138666462|NCT02354014|Bedaquiline|bedaquiline|mesh-list
138822078|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822079|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
138822080|NCT02686047|Protective Agents|protective agents|mesh-ancestor
138822081|NCT00713947|Amoxicillin|amoxicillin|mesh-list
138822082|NCT00713947|Metronidazole|metronidazole|mesh-list
138822083|NCT00713947|Clarithromycin|clarithromycin|mesh-list
138822084|NCT00713947|Pantoprazole|pantoprazole|mesh-list
138822085|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138822086|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822087|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138434928|NCT03736720|Vitamins|vitamins|mesh-ancestor
138822088|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138822089|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138822090|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822091|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822092|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138822093|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138822094|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138822095|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138822096|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138822097|NCT00990314|Epoprostenol|epoprostenol|mesh-list
138822098|NCT00990314|Beraprost|beraprost|mesh-list
138822099|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138822100|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
138822101|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138822102|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
138822103|NCT00909831|Sirolimus|sirolimus|mesh-list
138822104|NCT00909831|Temsirolimus|temsirolimus|mesh-list
138822105|NCT00909831|MTOR Inhibitors|mtor inhibitors|mesh-list
138822106|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
138822107|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138822108|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138822109|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822110|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822111|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822112|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138822113|NCT00909831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138822114|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138822115|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
138822116|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822117|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822118|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138822119|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138822120|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
138822122|NCT00717379|Prednisone|prednisone|mesh-list
138822123|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
138822124|NCT00717379|Tacrolimus|tacrolimus|mesh-list
138822125|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138822126|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
138822128|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138822129|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822130|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138822131|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822132|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138822133|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
138822134|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138822135|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822136|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822137|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138822138|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138648041|NCT03004287|Thalidomide|thalidomide|mesh-list
138822139|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
138822140|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138822141|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822142|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
138822143|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
138822144|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138374777|NCT01429701|Gentamicins|gentamicins|mesh-list
138822145|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138822146|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138822147|NCT00717379|Protective Agents|protective agents|mesh-ancestor
138822148|NCT02867306|Methotrexate|methotrexate|mesh-list
138822149|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138822150|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
138822151|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138822152|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822153|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138822154|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
138822155|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822156|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822157|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
138822158|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822159|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138822160|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138822161|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
138822162|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138469546|NCT01982019|Hormones|hormones|mesh-list
138822163|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138822164|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
138822165|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138822166|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
138822167|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138822168|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822169|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138822170|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138822171|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138822172|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
138822173|NCT02685657|Docetaxel|docetaxel|mesh-list
138648065|NCT03004287|Hormones|hormones|mesh-ancestor
138822174|NCT02685657|Doxorubicin|doxorubicin|mesh-list
138822175|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138822176|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
138822177|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822178|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138822179|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138822180|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
138822181|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822182|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822183|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138822184|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
138822185|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
138822186|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
138822187|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138822188|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138822189|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138822190|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822192|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138822193|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138822194|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822195|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
138822196|NCT04290884|Coagulants|coagulants|mesh-ancestor
138822197|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
138822198|NCT00719407|Hematinics|hematinics|mesh-ancestor
138822199|NCT00714025|Everolimus|everolimus|mesh-list
138822200|NCT00714025|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138822201|NCT00714025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138822202|NCT00714025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822203|NCT00714025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822204|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138822206|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822207|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822208|NCT02685345|Firuglipel|firuglipel|mesh-list
138822209|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138822210|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822211|NCT02869100|Listerine|listerine|mesh-list
138822212|NCT02869100|Fluorides|fluorides|mesh-list
138474166|NCT04288089|Palbociclib|palbociclib|mesh-list
138822213|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
138822214|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
138822215|NCT02869100|Protective Agents|protective agents|mesh-ancestor
138822216|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822217|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138822218|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822219|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
138822220|NCT04096768|Ketamine|ketamine|mesh-list
138822221|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138822222|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138822223|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822224|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138822225|NCT04096768|Analgesics|analgesics|mesh-ancestor
138822226|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
138822227|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822228|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138822229|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138822230|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138822231|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
138822232|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822233|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822234|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138822235|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138822236|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
138822237|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
138822238|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138822239|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138822240|NCT00714103|Adenosine|adenosine|mesh-list
138822241|NCT00714103|Analgesics|analgesics|mesh-ancestor
138822242|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
138822243|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822244|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822245|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138822246|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
138822247|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138822248|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
138822249|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
138822250|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822251|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822252|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
138822253|NCT00714181|Temozolomide|temozolomide|mesh-list
138822254|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138822255|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
138822256|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822257|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822258|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
138822259|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138666798|NCT00904202|Analgesics|analgesics|mesh-ancestor
138822260|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138822261|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822262|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822263|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138822264|NCT02600806|Azithromycin|azithromycin|mesh-list
138822265|NCT02600806|Levofloxacin|levofloxacin|mesh-list
138822266|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138822267|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822268|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138822269|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138822270|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138822271|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822272|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822273|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822274|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138822275|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138822276|NCT00639873|Doxycycline|doxycycline|mesh-list
138822277|NCT00639873|Artesunate|artesunate|mesh-list
138822278|NCT00639873|Quinine|quinine|mesh-list
138822279|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138822280|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822281|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
138822282|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138822283|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138822284|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822285|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
138474236|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822286|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
138822287|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138822288|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
138822289|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138822290|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822291|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138822292|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822293|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138822295|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
138822296|NCT04291118|Budesonide|budesonide|mesh-list
138822297|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138822298|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138822299|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
138822300|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822301|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822302|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138324842|NCT01450176|Analgesics|analgesics|mesh-ancestor
138822303|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
138822305|NCT04291118|Hormones|hormones|mesh-ancestor
138822306|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138822307|NCT02868944|Sufentanil|sufentanil|mesh-list
138822308|NCT02868944|Morphine|morphine|mesh-list
138822309|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
138822310|NCT02868944|Anesthetics|anesthetics|mesh-list
138822311|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
138822312|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138822313|NCT02868944|Narcotics|narcotics|mesh-ancestor
138822314|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138822315|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822316|NCT02868944|Analgesics|analgesics|mesh-ancestor
138822317|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
138822318|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822319|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138822320|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138822321|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
138822322|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138822323|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138822324|NCT00722839|Vaccines|vaccines|mesh-list
138822325|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
138822326|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822327|NCT04096690|Pegaspargase|pegaspargase|mesh-list
138822328|NCT04096690|Antibodies|antibodies|mesh-list
138822329|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138822330|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
138822331|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822332|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822333|NCT00719797|Leucovorin|leucovorin|mesh-list
138822334|NCT00719797|Bevacizumab|bevacizumab|mesh-list
138822335|NCT00719797|Fluorouracil|fluorouracil|mesh-list
138822336|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
138822337|NCT00719797|Irinotecan|irinotecan|mesh-list
138822338|NCT00719797|Calcium|calcium|mesh-list
138822339|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
138822340|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138822341|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822342|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138822343|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138822344|NCT00719797|Growth Substances|growth substances|mesh-ancestor
138822345|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822346|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
138822347|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138822348|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
138822349|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822350|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138822351|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138822352|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
138648189|NCT02176148|Hormones|hormones|mesh-ancestor
138822353|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138822354|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138822355|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822356|NCT00719797|Antidotes|antidotes|mesh-ancestor
138822357|NCT00719797|Protective Agents|protective agents|mesh-ancestor
138822358|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
138822359|NCT00719797|Vitamins|vitamins|mesh-ancestor
138822360|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
138822361|NCT00979628|Insulin|insulin|mesh-list
138822362|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138822363|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
138822364|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
138822365|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138822366|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822367|NCT00719875|Vorinostat|vorinostat|mesh-list
138666992|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
138822368|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138822369|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822370|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822371|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822372|NCT02685111|Lenograstim|lenograstim|mesh-list
138822373|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138822374|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
138822375|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822376|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138822377|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138822378|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822379|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138822380|NCT00717925|Immunotoxins|immunotoxins|mesh-ancestor
138822381|NCT00717925|Immunoconjugates|immunoconjugates|mesh-ancestor
138822382|NCT00717925|Immunologic Factors|immunologic factors|mesh-ancestor
138822383|NCT00717925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822384|NCT03258723|Metformin|metformin|mesh-list
138822385|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138822386|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822387|NCT00640029|Meloxicam|meloxicam|mesh-list
138822388|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138822389|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138822390|NCT00640029|Analgesics|analgesics|mesh-ancestor
138822391|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
138822392|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435283|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138822393|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822394|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138822395|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138822396|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138822397|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138822398|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822399|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822400|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
138822401|NCT02684799|Omeprazole|omeprazole|mesh-list
138822402|NCT02684799|Famotidine|famotidine|mesh-list
138822403|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138822404|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138822405|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138822406|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822407|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822408|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138822409|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
138822410|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
138822411|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822412|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822413|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138822414|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138822415|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138822416|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
138822417|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822418|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
138822419|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822420|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822421|NCT00992108|Lidocaine|lidocaine|mesh-list
138822422|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
138822423|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
138822424|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138822425|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822426|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
138822427|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822428|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138822429|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138822430|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138822431|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138822432|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822433|NCT00752986|Fulvestrant|fulvestrant|mesh-list
138822434|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138822435|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822436|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138822437|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138822438|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
138822439|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138822440|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822441|NCT02684487|Vitamin D|vitamin d|mesh-list
138822442|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
138822443|NCT02684487|Vitamins|vitamins|mesh-ancestor
138822444|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
138822445|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822446|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138822447|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138822448|NCT02684409|Sumatriptan|sumatriptan|mesh-list
138822449|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138822450|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138822451|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138822452|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
138822453|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822454|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822455|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822456|NCT00762892|Tenofovir|tenofovir|mesh-list
138822457|NCT00762892|Emtricitabine|emtricitabine|mesh-list
138822458|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
138822459|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138822460|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138822461|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
138822462|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469626|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
138822463|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138203279|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
138822464|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138822465|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822466|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822468|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138822469|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138822470|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138822471|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138822472|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138822473|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
138822474|NCT04290572|Isotretinoin|isotretinoin|mesh-list
138822475|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
138822476|NCT04069429|Heparin|heparin|mesh-list
138822477|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
138822478|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138822479|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138822480|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822481|NCT00755716|Topiramate|topiramate|mesh-list
138822482|NCT00755716|Nicotine|nicotine|mesh-list
138822483|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138822484|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
138822485|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822486|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822487|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138822488|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138822489|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
138822490|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822491|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822492|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
138648273|NCT01059825|Metformin|metformin|mesh-list
138822494|NCT00629252|Risperidone|risperidone|mesh-list
138822495|NCT00629252|Sertindole|sertindole|mesh-list
138822496|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138822497|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
138822498|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822499|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822500|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822501|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138822502|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138822503|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138822504|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138822505|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138822506|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
138822507|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
138822508|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138822509|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822510|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822511|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
138822512|NCT04095754|Anesthetics|anesthetics|mesh-list
138822513|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138822514|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822515|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138822516|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138822518|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
138822519|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822520|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138822521|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138435617|NCT01751347|Bupivacaine|bupivacaine|mesh-list
138822522|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138822523|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
138822524|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822525|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822527|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138822528|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
138822529|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822531|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822532|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822533|NCT02600650|Testosterone|testosterone|mesh-list
138822534|NCT02600650|Androgens|androgens|mesh-ancestor
138822535|NCT02600650|Hormones|hormones|mesh-ancestor
138822536|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138822537|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822538|NCT03084471|Durvalumab|durvalumab|mesh-list
138822539|NCT03084471|Tremelimumab|tremelimumab|mesh-list
138822540|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138822541|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138822542|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822543|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
138822544|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822545|NCT00718471|Heparin|heparin|mesh-list
138822546|NCT00718471|Enoxaparin|enoxaparin|mesh-list
138822547|NCT00718471|Calcium heparin|calcium heparin|mesh-list
138822548|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
138822549|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138822550|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138822551|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822552|NCT00723307|Metformin|metformin|mesh-list
138822553|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138822554|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822555|NCT00723385|Vitamin D|vitamin d|mesh-list
138822556|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
138822557|NCT00723385|Vitamins|vitamins|mesh-ancestor
138822558|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
138822559|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822560|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138822561|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138822562|NCT00754936|Escitalopram|escitalopram|mesh-list
138435727|NCT01752517|Vinorelbine|vinorelbine|mesh-list
138822563|NCT00754936|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138822564|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138822565|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138822566|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822567|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822568|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
138822569|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822570|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
138822571|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
138435782|NCT01752998|Narcotics|narcotics|mesh-ancestor
138822572|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138822573|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138822574|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822575|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138822576|NCT02684019|Analgesics|analgesics|mesh-ancestor
138822577|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
138822578|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822579|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138822580|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138822581|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138435848|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
138822582|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
138822583|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822584|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822585|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
138822586|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138822587|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
138822588|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138667273|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138822589|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138474538|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469671|NCT01983137|Analgesics|analgesics|mesh-ancestor
138822590|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138822591|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
138648314|NCT00323154|Analgesics|analgesics|mesh-ancestor
138822592|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138822594|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
138822595|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
138822596|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
138822597|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822598|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822599|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138822600|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138822601|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138822602|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138822603|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138822604|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138822605|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
138822606|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
138822607|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822608|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822609|NCT02689713|Voriconazole|voriconazole|mesh-list
138822610|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
138822611|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822612|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138822613|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138822614|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822615|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822616|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138822617|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
138822618|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138822619|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822620|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138822622|NCT02601508|Atracurium|atracurium|mesh-list
138822623|NCT02601508|Cisatracurium|cisatracurium|mesh-list
138822624|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138822625|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138822626|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138822627|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822628|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822629|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138822630|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138822631|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
138822632|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822633|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822634|NCT02570581|Acetaminophen|acetaminophen|mesh-list
138822635|NCT02570581|Ramipril|ramipril|mesh-list
138822637|NCT02570581|Memantine|memantine|mesh-list
138822638|NCT02570581|Alprazolam|alprazolam|mesh-list
138822639|NCT02570581|Zopiclone|zopiclone|mesh-list
138822640|NCT02570581|Oxazepam|oxazepam|mesh-list
138822641|NCT02570581|Donepezil|donepezil|mesh-list
138822642|NCT02570581|Clopidogrel|clopidogrel|mesh-list
138822643|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138822644|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138822645|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138822646|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138822647|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
138822648|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822649|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822650|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822651|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138822652|NCT02570581|Analgesics|analgesics|mesh-ancestor
138822653|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
138822654|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822655|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
138822656|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138822657|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822658|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
138822659|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
138822660|NCT02570581|Diuretics|diuretics|mesh-ancestor
138822661|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
138822662|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138822663|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138822664|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138822665|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138822667|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138822668|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138822669|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138822670|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
138822671|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138822672|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138822673|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138822674|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138822675|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138822676|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138822677|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
138822678|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
138822680|NCT00640263|Lopinavir|lopinavir|mesh-list
138822681|NCT00640263|Lamivudine|lamivudine|mesh-list
138822682|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138822683|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138822684|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
138822685|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822686|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822687|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138822688|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138822689|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
138822690|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822691|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138822692|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138822693|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138822694|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138822695|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138822696|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
138822697|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138822698|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
138822699|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822701|NCT02865668|Canagliflozin|canagliflozin|mesh-list
138822702|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138822703|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822704|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138822705|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822706|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
138822707|NCT02867930|Ketamine|ketamine|mesh-list
138822708|NCT02867930|Propofol|propofol|mesh-list
138822709|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138648482|NCT00290108|Propofol|propofol|mesh-list
138822710|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138822711|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822712|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138822713|NCT02867930|Analgesics|analgesics|mesh-ancestor
138667435|NCT00462696|Docetaxel|docetaxel|mesh-list
138822714|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
138822715|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822716|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138822717|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138822718|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138822719|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
138822720|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822721|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822722|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138822723|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
138822724|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
138822725|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138822726|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138822727|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138822728|NCT02570893|Paclitaxel|paclitaxel|mesh-list
138822729|NCT02570893|Carboplatin|carboplatin|mesh-list
138822730|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138822731|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822732|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
138822733|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
138822734|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
138822735|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822736|NCT02538081|Risperidone|risperidone|mesh-list
138822737|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138822738|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
138474688|NCT02916771|Hormones|hormones|mesh-ancestor
138822739|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822740|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822741|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822742|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138822743|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138822744|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138822745|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138822746|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138822747|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
138822749|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138822750|NCT02570971|Diuretics|diuretics|mesh-ancestor
138822751|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
138822752|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822753|NCT02866214|Febuxostat|febuxostat|mesh-list
138822754|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
138822755|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138822756|NCT02866448|Aspirin|aspirin|mesh-list
138822757|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138822758|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138822759|NCT02866448|Analgesics|analgesics|mesh-ancestor
138822760|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
138822761|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822762|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822763|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138822764|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138822765|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138822766|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138822767|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822768|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138822769|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138822770|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822772|NCT00578227|Vaccines|vaccines|mesh-list
138822773|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
138822774|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822775|NCT00720577|Pioglitazone|pioglitazone|mesh-list
138822776|NCT00720577|Losartan|losartan|mesh-list
138822777|NCT00720577|Simvastatin|simvastatin|mesh-list
138822778|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138822779|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138822780|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
138822781|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822782|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138822783|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138822784|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822785|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138822786|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822787|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138822788|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138822789|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138822790|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138822791|NCT05373277|Ticagrelor|ticagrelor|mesh-list
138822792|NCT05373277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138822793|NCT05373277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138822794|NCT05373277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138822795|NCT05373277|Antimetabolites|antimetabolites|mesh-ancestor
138822796|NCT05373277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822797|NCT05373277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138822798|NCT05373277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138667563|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138667567|NCT00471549|Simvastatin|simvastatin|mesh-list
138822799|NCT05373277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822800|NCT05373277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138822801|NCT05373277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138822802|NCT05373277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138822803|NCT05373277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138822804|NCT05373277|Purinergic Agents|purinergic agents|mesh-ancestor
138822805|NCT05373277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822806|NCT05373277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822807|NCT00724321|Iloprost|iloprost|mesh-list
138822808|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138822809|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
138822810|NCT00720811|Acetaminophen|acetaminophen|mesh-list
138822811|NCT00720811|Amoxicillin|amoxicillin|mesh-list
138822812|NCT00720811|Lumefantrine|lumefantrine|mesh-list
138822813|NCT00720811|Artemether|artemether|mesh-list
138648561|NCT00324129|Mocetinostat|mocetinostat|mesh-list
138822814|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138822815|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138822816|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822817|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138822818|NCT00720811|Analgesics|analgesics|mesh-ancestor
138822819|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
138822820|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822821|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822823|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
138822824|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138822825|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138822826|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
138469729|NCT01983527|Protective Agents|protective agents|mesh-ancestor
138822827|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138822828|NCT00577993|Interferons|interferons|mesh-list
138822829|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
138822830|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
138822831|NCT00577993|Dexamethasone|dexamethasone|mesh-list
138822832|NCT00577993|Prednisone|prednisone|mesh-list
138822833|NCT00577993|Prednisolone|prednisolone|mesh-list
138822834|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138822835|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
138822836|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138822837|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
138822838|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
138822839|NCT00577993|Rituximab|rituximab|mesh-list
138822840|NCT00577993|Doxorubicin|doxorubicin|mesh-list
138822841|NCT00577993|Fludarabine|fludarabine|mesh-list
138822842|NCT00577993|Etoposide|etoposide|mesh-list
138822843|NCT00577993|Vincristine|vincristine|mesh-list
138822844|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
138822845|NCT00577993|Bleomycin|bleomycin|mesh-list
138822846|NCT00577993|Procarbazine|procarbazine|mesh-list
138822847|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138822848|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
138822849|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138822850|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
138822851|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822852|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138822853|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138822854|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
138648584|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822855|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822856|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822857|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138822858|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138822859|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
138822860|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
138822861|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822862|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138822863|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
138822864|NCT00577993|Hormones|hormones|mesh-ancestor
138822865|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138822866|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138822867|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822868|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138822869|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138822870|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138822871|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138822872|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138822873|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
138822874|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822875|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
138667650|NCT00463515|Gemcitabine|gemcitabine|mesh-list
138822876|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
138822877|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
138667651|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138667652|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138822878|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138822879|NCT00577993|Protective Agents|protective agents|mesh-ancestor
138822880|NCT00577993|Analgesics|analgesics|mesh-ancestor
138822881|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
138822882|NCT00975806|Lenalidomide|lenalidomide|mesh-list
138822883|NCT00975806|Sunitinib|sunitinib|mesh-list
138822884|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
138822885|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822886|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138469756|NCT01983735|Vitamins|vitamins|mesh-ancestor
138822887|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138822888|NCT00975806|Growth Substances|growth substances|mesh-ancestor
138822889|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
138822890|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822891|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138822892|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822893|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822894|NCT00721201|Mifepristone|mifepristone|mesh-list
138822895|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138822896|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
138822897|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138822898|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138648632|NCT00324363|Exenatide|exenatide|mesh-list
138822899|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138822900|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138822901|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138822902|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
138822903|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138822904|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138822905|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
138822906|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138822907|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
138822908|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138822909|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138822911|NCT02866370|Carboplatin|carboplatin|mesh-list
138822912|NCT02866370|Doxorubicin|doxorubicin|mesh-list
138822913|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138822914|NCT02866370|Topotecan|topotecan|mesh-list
138822915|NCT02866370|Nintedanib|nintedanib|mesh-list
138822916|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138822917|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822918|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
138822919|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
138822920|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
138822921|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822922|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138822923|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138822924|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138822925|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822926|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138822927|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138822929|NCT00978068|Lopinavir|lopinavir|mesh-list
138822930|NCT00978068|Nevirapine|nevirapine|mesh-list
138822931|NCT00978068|Efavirenz|efavirenz|mesh-list
138822932|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138822933|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138822934|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138822935|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
138822936|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822937|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822938|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138822939|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138822940|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
138822941|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822942|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138667700|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822943|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138822944|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138822945|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138822946|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138822947|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138822948|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138822949|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138822950|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
138822951|NCT00629642|Oxybutynin|oxybutynin|mesh-list
138822952|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138822953|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138822954|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
138822955|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138822956|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138648649|NCT00303771|Leucovorin|leucovorin|mesh-list
138822957|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822958|NCT00629642|Urological Agents|urological agents|mesh-ancestor
138822959|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
138822960|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
138822961|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138822962|NCT02865356|Cyclosporine|cyclosporine|mesh-list
138822963|NCT02865356|Cyclosporins|cyclosporins|mesh-list
138822964|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138822965|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822966|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138822967|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
138822969|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
138667759|NCT00463671|Antidotes|antidotes|mesh-ancestor
138822970|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138822971|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
138822972|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138822973|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138822974|NCT04287842|Sevoflurane|sevoflurane|mesh-list
138822975|NCT04287842|Desflurane|desflurane|mesh-list
138822976|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138822977|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138822978|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
138822979|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
138822980|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138822981|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822982|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
138822983|NCT00721747|Docetaxel|docetaxel|mesh-list
138822984|NCT00721747|Doxorubicin|doxorubicin|mesh-list
138822985|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138822986|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138822987|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
138822988|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138822989|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138822990|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138822991|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
138822992|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138822993|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138822994|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138822995|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
138822996|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
138822997|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
138822998|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138822999|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138823000|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138823001|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823002|NCT00603525|Ofatumumab|ofatumumab|mesh-list
138823003|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823004|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138823005|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
138823006|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823007|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138823008|NCT02689401|Hematinics|hematinics|mesh-ancestor
138823009|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138648666|NCT00303771|Protective Agents|protective agents|mesh-ancestor
138823010|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138823012|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138823013|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138823015|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138823016|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
138823017|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
138667835|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138667847|NCT00464256|Rimonabant|rimonabant|mesh-list
138823018|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138823019|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823020|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
138823021|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823022|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138823023|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138823024|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138823025|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138823026|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823027|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823028|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
138823029|NCT00640575|Hormones|hormones|mesh-ancestor
138823030|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138823031|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138823032|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
138823033|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823034|NCT04067791|Melatonin|melatonin|mesh-list
138823035|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
138823036|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823037|NCT04067791|Protective Agents|protective agents|mesh-ancestor
138823038|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823039|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138823040|NCT00762034|Paclitaxel|paclitaxel|mesh-list
138823041|NCT00762034|Bevacizumab|bevacizumab|mesh-list
138823042|NCT00762034|Carboplatin|carboplatin|mesh-list
138823043|NCT00762034|Pemetrexed|pemetrexed|mesh-list
138823044|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138823045|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823046|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
138823047|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
138823048|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
138469821|NCT01984073|Niacin|niacin|mesh-list
138823049|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823050|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138823051|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138823052|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138823053|NCT00762034|Growth Substances|growth substances|mesh-ancestor
138823054|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823055|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
138823056|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823057|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138823058|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138823060|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
138823061|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
138823062|NCT04093648|Fludarabine|fludarabine|mesh-list
138667933|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
138823063|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138823064|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
138823065|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823066|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823067|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138823068|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
138823069|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823070|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823071|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138823072|NCT04184115|Scopolamine|scopolamine|mesh-list
138823073|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138823074|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
138823075|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
138823076|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823077|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823078|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138823079|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
138823080|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138823081|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
138823082|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823083|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823084|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138823085|NCT00722215|Nifedipine|nifedipine|mesh-list
138823086|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
138823087|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138823088|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138823089|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823090|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138823091|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823092|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
138823093|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
138823094|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138823095|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138823096|NCT00640809|Ibuprofen|ibuprofen|mesh-list
138823097|NCT00640809|Celecoxib|celecoxib|mesh-list
138823098|NCT00640809|Omeprazole|omeprazole|mesh-list
138823099|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138823100|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138823101|NCT00640809|Analgesics|analgesics|mesh-ancestor
138823102|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
138823103|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823104|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823105|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823106|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823107|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138823109|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823110|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138823111|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138823112|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138823113|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138823114|NCT00754624|Insulin|insulin|mesh-list
138823115|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138475060|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
138823116|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823117|NCT00722293|Doxorubicin|doxorubicin|mesh-list
138823118|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138823119|NCT00722293|Epirubicin|epirubicin|mesh-list
138823120|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138823121|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823122|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138823123|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138823124|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823125|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823126|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
138823127|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138823128|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823129|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138823130|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823131|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
138823132|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138823133|NCT02683005|Ledipasvir|ledipasvir|mesh-list
138823134|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
138823135|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823136|NCT03583957|Caffeine|caffeine|mesh-list
138823137|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138823138|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823139|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138823141|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823142|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138823143|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138823144|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
138823145|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823146|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
138823147|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
138823148|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138823149|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138823150|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
138823151|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823152|NCT02571283|Epinephrine|epinephrine|mesh-list
138823153|NCT02571283|Bupivacaine|bupivacaine|mesh-list
138823154|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
138823155|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
138823156|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138823157|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823158|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
138823159|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823160|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823161|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
138823162|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138823163|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138823164|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
138823166|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138668101|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138823167|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138823168|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138469852|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
138823169|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
138823170|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
138823171|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
138823172|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138823173|NCT02682693|Denosumab|denosumab|mesh-list
138823174|NCT02682693|Paclitaxel|paclitaxel|mesh-list
138823175|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
138823176|NCT02682693|Carboplatin|carboplatin|mesh-list
138823177|NCT02682693|Trastuzumab|trastuzumab|mesh-list
138823178|NCT02682693|Epirubicin|epirubicin|mesh-list
138823179|NCT02682693|Pertuzumab|pertuzumab|mesh-list
138823180|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138823181|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823182|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
138823183|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
138823184|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
138823185|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823186|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138823187|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
138823188|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823189|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823190|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138823191|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
138823192|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138823193|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138823194|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138823195|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138823196|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138823197|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823198|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138823199|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
138823200|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138823201|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138823202|NCT02571517|Prednisolone|prednisolone|mesh-list
138823203|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
138823204|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138823205|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
138823206|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
138823207|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823208|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
138436474|NCT01757262|Clopidogrel|clopidogrel|mesh-list
138823209|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
138823210|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823211|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823212|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138823214|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138823215|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138823216|NCT02571517|Protective Agents|protective agents|mesh-ancestor
138823217|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138823218|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823219|NCT00586846|Doxorubicin|doxorubicin|mesh-list
138823220|NCT00586846|Methotrexate|methotrexate|mesh-list
138823221|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823222|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138823223|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138823224|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138823225|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823226|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823227|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138823228|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
138823229|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138823230|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823231|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138823233|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
138823234|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138823235|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138823236|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
138823237|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823238|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138823239|NCT04144465|Phenylephrine|phenylephrine|mesh-list
138823240|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
138823241|NCT04144465|Norepinephrine|norepinephrine|mesh-list
138823242|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138823243|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
138823244|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
138823245|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823246|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823247|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
138823248|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138823249|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
138823250|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
138823251|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138823252|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138823253|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138823254|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
138823255|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823256|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823257|NCT04144465|Protective Agents|protective agents|mesh-ancestor
138823258|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
138823259|NCT00754390|Calcium|calcium|mesh-list
138823260|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138823261|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823262|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138823263|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
138823264|NCT04066621|Sulbactam|sulbactam|mesh-list
138823265|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138823266|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138668307|NCT00481572|Terlipressin|terlipressin|mesh-list
138823267|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138823268|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823269|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823270|NCT00629564|Esomeprazole|esomeprazole|mesh-list
138823271|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138823272|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138823273|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138823274|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823275|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823276|NCT02865824|Aspirin|aspirin|mesh-list
138823277|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138823278|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138823279|NCT02865824|Analgesics|analgesics|mesh-ancestor
138823280|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
138823281|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823282|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823283|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823284|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823285|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138823286|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138823287|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823288|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138823289|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138823290|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823291|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
138823292|NCT02570035|Mirabegron|mirabegron|mesh-list
138823293|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138823294|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138823295|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138823296|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
138823297|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823298|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823299|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823300|NCT02570035|Urological Agents|urological agents|mesh-ancestor
138823301|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
138823302|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138823303|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823304|NCT04098796|Antibodies|antibodies|mesh-list
138668344|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138823305|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
138823306|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823307|NCT00522145|XL647|xl647|mesh-list
138823308|NCT00522145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823309|NCT00522145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138823310|NCT00522145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823311|NCT00522145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823312|NCT00726973|Ranibizumab|ranibizumab|mesh-list
138823313|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138823314|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138823315|NCT00726973|Growth Substances|growth substances|mesh-ancestor
138823316|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823317|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
138823318|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823319|NCT02571361|Acetaminophen|acetaminophen|mesh-list
138823320|NCT02571361|Ibuprofen|ibuprofen|mesh-list
138823321|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138823322|NCT02571361|Analgesics|analgesics|mesh-ancestor
138823323|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
138823324|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823325|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668395|NCT00436787|PENTA|penta|mesh-list
138823326|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
138823327|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138823328|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823329|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823330|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138823331|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823332|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823333|NCT04290104|Ampicillin|ampicillin|mesh-list
138823334|NCT04290104|Sulbactam|sulbactam|mesh-list
138823335|NCT04290104|Sultamicillin|sultamicillin|mesh-list
138823336|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138823337|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823338|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138823339|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823340|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823341|NCT02571205|Testosterone|testosterone|mesh-list
138823342|NCT02571205|Androgens|androgens|mesh-ancestor
138823343|NCT02571205|Hormones|hormones|mesh-ancestor
138823344|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138823345|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823346|NCT04290026|Metoclopramide|metoclopramide|mesh-list
138823347|NCT04290026|Granisetron|granisetron|mesh-list
138823348|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
138823349|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
138823350|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823351|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823353|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138823354|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138823355|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
138823356|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532535|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138668412|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823357|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823358|NCT04290026|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138823359|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138823360|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
138823361|NCT00640887|Ritonavir|ritonavir|mesh-list
138823362|NCT00640887|Lopinavir|lopinavir|mesh-list
138823363|NCT00640887|Nevirapine|nevirapine|mesh-list
138823364|NCT00640887|Efavirenz|efavirenz|mesh-list
138823365|NCT00640887|Rifabutin|rifabutin|mesh-list
138823366|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138823367|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138823368|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
138823369|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823370|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823371|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138823372|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138823373|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
138823374|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823375|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138823376|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138823377|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138823378|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138823379|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138823380|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138823381|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138823382|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138823383|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138823384|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138668448|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138823385|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138823386|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
138823387|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
138823388|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
138823389|NCT00730093|Vitamins|vitamins|mesh-ancestor
138823390|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
138823391|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823392|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
138436655|NCT01758263|Metoprolol|metoprolol|mesh-list
138823393|NCT00730093|Hematinics|hematinics|mesh-ancestor
138823394|NCT00727129|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138823395|NCT00727129|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138823396|NCT00727129|Estradiol|estradiol|mesh-list
138823397|NCT00727129|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138823398|NCT00727129|Estrogens|estrogens|mesh-ancestor
138823399|NCT00727129|Hormones|hormones|mesh-ancestor
138823400|NCT00727129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138823401|NCT00727129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823402|NCT00727129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138823403|NCT00727129|Contraceptive Agents|contraceptive agents|mesh-ancestor
138823404|NCT00727129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138823405|NCT00727129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138823406|NCT04183725|Oseltamivir|oseltamivir|mesh-list
138823407|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
138668548|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668549|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
138823408|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823409|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436679|NCT01758380|Metformin|metformin|mesh-list
138823410|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823411|NCT00730249|Methylphenidate|methylphenidate|mesh-list
138823412|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138823413|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823414|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138668619|NCT04701320|Methamphetamine|methamphetamine|mesh-list
138823415|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138648874|NCT00304434|Probenecid|probenecid|mesh-list
138823416|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138823417|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823418|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
138823419|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823420|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138823421|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138823422|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823423|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138823424|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823425|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823426|NCT01632657|Sumatriptan|sumatriptan|mesh-list
138823427|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138823428|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138823429|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138823430|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
138823431|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823432|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436738|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
138823433|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823436|NCT00727207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138823437|NCT00727207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823438|NCT00727207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823439|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138823440|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
138823441|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823442|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823443|NCT02682459|Lisinopril|lisinopril|mesh-list
138823444|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138823445|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
138823446|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823447|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823448|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138823449|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138823450|NCT02682459|Protective Agents|protective agents|mesh-ancestor
138823451|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823452|NCT02620579|Propranolol|propranolol|mesh-list
138823453|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138823454|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138823455|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
138823456|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823457|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823458|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823459|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138823460|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138823461|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
138823462|NCT02682225|Ketamine|ketamine|mesh-list
138823463|NCT02682225|Esketamine|esketamine|mesh-list
138823464|NCT02682225|Analgesics|analgesics|mesh-ancestor
138823465|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
138823466|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823467|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823468|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138823469|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138668735|NCT00475059|Cimetidine|cimetidine|mesh-list
138823470|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
138823471|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
138823472|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138823473|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138823474|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138823475|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823476|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823477|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
138823478|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138823479|NCT04066231|Erythromycin|erythromycin|mesh-list
138823480|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
138823481|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138823482|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
138823483|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
138823484|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138823486|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138823487|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138823488|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823489|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823490|NCT04183491|Interferons|interferons|mesh-list
138823491|NCT04183491|Interferon-beta|interferon-beta|mesh-list
138823492|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
138823493|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823494|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
138823495|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823496|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
138823497|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823498|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138823499|NCT03702283|Penicillins|penicillins|mesh-list
138823500|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138823501|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823502|NCT00727753|Bevacizumab|bevacizumab|mesh-list
138823503|NCT00727753|Ranibizumab|ranibizumab|mesh-list
138823504|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138823505|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823506|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138823507|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138823508|NCT00727753|Growth Substances|growth substances|mesh-ancestor
138823509|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823510|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
138823511|NCT00727831|Leucovorin|leucovorin|mesh-list
138823512|NCT00727831|Methotrexate|methotrexate|mesh-list
138823513|NCT00727831|Calcium|calcium|mesh-list
138823514|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
138823515|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138823516|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823517|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138823518|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
138823519|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138823520|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138823521|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
138823522|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823523|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823524|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
138823525|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823526|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138823527|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138436810|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
138823528|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
138823529|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823530|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138823532|NCT00727831|Protective Agents|protective agents|mesh-ancestor
138823533|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
138823534|NCT00727831|Vitamins|vitamins|mesh-ancestor
138823535|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
138823536|NCT00727987|Golimumab|golimumab|mesh-list
138823537|NCT00727987|Methotrexate|methotrexate|mesh-list
138823538|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138823539|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
138823540|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138823541|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823542|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138823543|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
138668876|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138823544|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823545|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823546|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
138823547|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823548|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138823549|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138823550|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
138823551|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823552|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138823553|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138823554|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823555|NCT02681913|Adenosine|adenosine|mesh-list
138823556|NCT02681913|Analgesics|analgesics|mesh-ancestor
138823558|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823559|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823560|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138823561|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
138823562|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138823563|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
138823564|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
138823565|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823566|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823567|NCT02681679|Bromfenac|bromfenac|mesh-list
138823568|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138823569|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138823570|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138823571|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138823572|NCT02681679|Analgesics|analgesics|mesh-ancestor
138823573|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
138823574|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823575|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823576|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823577|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823578|NCT04183257|Vitamin D|vitamin d|mesh-list
138823579|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
138823580|NCT04183257|Cholecalciferol|cholecalciferol|mesh-list
138823581|NCT04183257|Vitamins|vitamins|mesh-list
138823582|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
138823583|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823584|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138823585|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138823586|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
138823587|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138823588|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138823589|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823590|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138823591|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138648988|NCT00292799|Metformin|metformin|mesh-list
138823592|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
138823593|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138823594|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
138823595|NCT00641589|Hematinics|hematinics|mesh-ancestor
138823597|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138823598|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138823599|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823600|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138823601|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
138823602|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
138823603|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138823604|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
138823605|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823606|NCT02680977|Levodopa|levodopa|mesh-list
138823607|NCT02680977|Benserazide|benserazide|mesh-list
138823608|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138823609|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138823610|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
138823611|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823612|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823613|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823614|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823615|NCT00734695|Vitamins|vitamins|mesh-list
138823616|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
138823617|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
138823618|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823619|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
138823620|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823621|NCT00734695|Protective Agents|protective agents|mesh-ancestor
138823622|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138823624|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
138823625|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138823626|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
138823627|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823628|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823629|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
138823630|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138823631|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
138823632|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823634|NCT00728611|Protective Agents|protective agents|mesh-ancestor
138823635|NCT05663775|Mesalamine|mesalamine|mesh-list
138823636|NCT05663775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138823637|NCT05663775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138823638|NCT05663775|Analgesics|analgesics|mesh-ancestor
138823639|NCT05663775|Sensory System Agents|sensory system agents|mesh-ancestor
138823640|NCT05663775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823641|NCT05663775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823642|NCT05663775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823643|NCT05663775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823644|NCT00909987|Bevacizumab|bevacizumab|mesh-list
138823645|NCT00909987|Capecitabine|capecitabine|mesh-list
138823646|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
138823647|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138823648|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823649|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138823650|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138823651|NCT00909987|Growth Substances|growth substances|mesh-ancestor
138823652|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823653|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
138823654|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138823655|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
138823656|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823657|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138823658|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
138823659|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823660|NCT00760474|Pregabalin|pregabalin|mesh-list
138823661|NCT00760474|Analgesics|analgesics|mesh-ancestor
138823662|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
138823663|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823664|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823665|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
138823666|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138823667|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138823668|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823669|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138823670|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138823671|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138469941|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
138823672|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138823673|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138823674|NCT02680119|Esomeprazole|esomeprazole|mesh-list
138823675|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138823676|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138823677|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138823679|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823680|NCT00734773|Cytarabine|cytarabine|mesh-list
138823681|NCT00734773|Rituximab|rituximab|mesh-list
138823682|NCT00734773|Methotrexate|methotrexate|mesh-list
138823683|NCT00734773|Vincristine|vincristine|mesh-list
138823684|NCT00734773|Procarbazine|procarbazine|mesh-list
138823685|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
138823686|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138823687|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823688|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
138823689|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823690|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823691|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138823692|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
138823693|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138823694|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138823695|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
138823696|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823697|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
138823698|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823699|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138823700|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138823701|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138823702|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
138823703|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823704|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138823705|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
138823706|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
138823707|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
138823708|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138823709|NCT04289090|Propofol|propofol|mesh-list
138823710|NCT04289090|Sevoflurane|sevoflurane|mesh-list
138823711|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138823712|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138823713|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823714|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138823715|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
138823716|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
138823717|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138823718|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138475663|NCT03984357|Antibodies|antibodies|mesh-list
138823719|NCT00975416|Oxytocin|oxytocin|mesh-list
138823720|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
138823721|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138823722|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823723|NCT02679963|Olaparib|olaparib|mesh-list
138823724|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138823725|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823726|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823727|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823728|NCT00760084|Decitabine|decitabine|mesh-list
138823729|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138823730|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
138823731|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823732|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823733|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823734|NCT00735241|Leucovorin|leucovorin|mesh-list
138823735|NCT00735241|Folic Acid|folic acid|mesh-list
138823736|NCT00735241|Bevacizumab|bevacizumab|mesh-list
138823737|NCT00735241|Fluorouracil|fluorouracil|mesh-list
138823738|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
138823739|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
138823740|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138823741|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823742|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138823743|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138823744|NCT00735241|Growth Substances|growth substances|mesh-ancestor
138823745|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823746|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
138823747|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
138823748|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823749|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138823750|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138823751|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
138823752|NCT00735241|Antidotes|antidotes|mesh-ancestor
138823753|NCT00735241|Protective Agents|protective agents|mesh-ancestor
138823754|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
138823755|NCT00735241|Vitamins|vitamins|mesh-ancestor
138823756|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
138823757|NCT00735241|Hematinics|hematinics|mesh-ancestor
138823758|NCT00729313|Lanreotide|lanreotide|mesh-list
138823759|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823760|NCT00641979|Budesonide|budesonide|mesh-list
138823761|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823762|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138823763|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
138823764|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823765|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823766|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138823767|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
138823768|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
138823769|NCT00641979|Hormones|hormones|mesh-ancestor
138823770|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138823771|NCT02679339|Lidocaine|lidocaine|mesh-list
138823772|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
138823773|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
138823774|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138823775|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823776|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
138823777|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823778|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138823779|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138823780|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138823781|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138669349|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823782|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823783|NCT02679261|Atorvastatin|atorvastatin|mesh-list
138823784|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138823785|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138823786|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
138823787|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469979|NCT01985152|Choline|choline|mesh-list
138823788|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138823789|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138823792|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823793|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823794|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823795|NCT02678949|Fluticasone|fluticasone|mesh-list
138823796|NCT02678949|Xhance|xhance|mesh-list
138823797|NCT02678949|Albuterol|albuterol|mesh-list
138823798|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823799|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138823800|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
138823801|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823802|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823803|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138823804|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
138823805|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
138823806|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138669406|NCT03279146|Tenofovir|tenofovir|mesh-list
138823807|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
138823808|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138823809|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138823810|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138823811|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138823812|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
138823813|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823814|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138649119|NCT00304980|Artemether|artemether|mesh-list
138823816|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
138823817|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138823818|NCT00642135|Tropicamide|tropicamide|mesh-list
138823819|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138823820|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
138823821|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
138823822|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437081|NCT01760564|Miglustat|miglustat|mesh-list
138823823|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823824|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
138823825|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138823826|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
138823827|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
138669452|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138823828|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138823829|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138823830|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138823831|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
138823832|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823833|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823834|NCT00642135|Protective Agents|protective agents|mesh-ancestor
138823835|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138823836|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138823837|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138823838|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
138823839|NCT00642291|Emtricitabine|emtricitabine|mesh-list
138823840|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
138823841|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823842|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138823843|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138823844|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823845|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823846|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138823847|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138823848|NCT02600260|Enoxaparin|enoxaparin|mesh-list
138823849|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
138823850|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
138823851|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138823852|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138823853|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823855|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
138823856|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823857|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
138823858|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823859|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
138823860|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823861|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
138823862|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138823863|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138823864|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823865|NCT04179747|Urological Agents|urological agents|mesh-ancestor
138823866|NCT02675205|Aspirin|aspirin|mesh-list
138823867|NCT02675205|Clopidogrel|clopidogrel|mesh-list
138823868|NCT02675205|Ticagrelor|ticagrelor|mesh-list
138823869|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138823870|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138823871|NCT02675205|Analgesics|analgesics|mesh-ancestor
138823872|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
138823873|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823874|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823875|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823876|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823877|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138823878|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138823879|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823880|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138823881|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138823882|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823884|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138669551|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
138823885|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138823886|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138823887|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
138823888|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823889|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
138823890|NCT00753454|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138823891|NCT00753454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823892|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138823893|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
138669592|NCT03271983|Metronidazole|metronidazole|mesh-list
138823894|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823895|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823896|NCT00643539|Azithromycin|azithromycin|mesh-list
138823897|NCT00643539|Amoxicillin|amoxicillin|mesh-list
138823898|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138823900|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
138823901|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138823902|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138823903|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138823904|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138823905|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138823906|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138823907|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138823908|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823909|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823910|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823911|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138823912|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
138823913|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138823914|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823915|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138823916|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138823917|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138823918|NCT00910065|Aspirin|aspirin|mesh-list
138823919|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
138823920|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138823921|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138823922|NCT00910065|Analgesics|analgesics|mesh-ancestor
138823923|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
138437107|NCT01760642|Rifampin|rifampin|mesh-list
138823924|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823925|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823926|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823927|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823928|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138823929|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138823930|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823931|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138823932|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138823933|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823934|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
138823935|NCT02601040|Vaccines|vaccines|mesh-list
138823936|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
138823937|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823938|NCT04179513|Methotrexate|methotrexate|mesh-list
138823939|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138823940|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
138823941|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138823942|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823943|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138823944|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
138823945|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823946|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823947|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
138823948|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823949|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138823950|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138823951|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
138823952|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823953|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138823954|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
138823955|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138823956|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138823957|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823958|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138823959|NCT02675049|Analgesics|analgesics|mesh-ancestor
138823960|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
138823961|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823962|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138823963|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138823964|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138470044|NCT01985724|Fluorouracil|fluorouracil|mesh-list
138823965|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
138823966|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823967|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823968|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
138823969|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
138823970|NCT02674737|Tramadol|tramadol|mesh-list
138823971|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138823972|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138823973|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823974|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138823975|NCT02674737|Analgesics|analgesics|mesh-ancestor
138649260|NCT00294359|Growth Substances|growth substances|mesh-ancestor
138823976|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
138823977|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138823978|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138823979|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138823980|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138823981|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
138823982|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138823983|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138823984|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138823985|NCT02674737|Narcotics|narcotics|mesh-ancestor
138437180|NCT01760824|Esomeprazole|esomeprazole|mesh-list
138823986|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138823987|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138823988|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138823989|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138823990|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138823991|NCT02674893|Liraglutide|liraglutide|mesh-list
138823992|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138823993|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138823994|NCT02674893|Incretins|incretins|mesh-ancestor
138823995|NCT02674893|Hormones|hormones|mesh-ancestor
138823996|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138823997|NCT02717455|Panobinostat|panobinostat|mesh-list
138823998|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138823999|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138824000|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824001|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824002|NCT02674581|Fostemsavir|fostemsavir|mesh-list
138824003|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138669791|NCT00441246|Expectorants|expectorants|mesh-ancestor
138824004|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138824005|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
138824006|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824007|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138824008|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138824009|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824010|NCT04065919|Epinephrine|epinephrine|mesh-list
138824011|NCT04065919|Bupivacaine|bupivacaine|mesh-list
138824012|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
138824013|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
138824014|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824015|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824016|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
138824017|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138475969|NCT00538031|Celecoxib|celecoxib|mesh-list
138824018|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138824019|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138824020|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
138824021|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824022|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824023|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138824024|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138649303|NCT00294593|Leucovorin|leucovorin|mesh-list
138824025|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
138824026|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138824027|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
138824028|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
138824029|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
138824030|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138824031|NCT04065529|Zinc|zinc|mesh-list
138824032|NCT04065529|Trace Elements|trace elements|mesh-ancestor
138824033|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
138824034|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824035|NCT04179045|Sirolimus|sirolimus|mesh-list
138824036|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138824037|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824038|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138824039|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824040|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
138824041|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138824042|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
138824043|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824044|NCT00970268|Bromides|bromides|mesh-list
138824045|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
138824046|NCT02674113|Bupivacaine|bupivacaine|mesh-list
138824047|NCT02674113|Anesthetics|anesthetics|mesh-list
138824048|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
138824049|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824050|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824051|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
138824052|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824053|NCT00644085|Aspirin|aspirin|mesh-list
138669881|NCT02274051|Kinetin|kinetin|mesh-list
138824054|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138824055|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138824056|NCT00644085|Analgesics|analgesics|mesh-ancestor
138824057|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
138824058|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824059|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824060|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138824061|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138824062|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138824063|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138824064|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824065|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138824066|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138824067|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824068|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
138824069|NCT00731575|Prednisolone|prednisolone|mesh-list
138824070|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138824071|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
138669927|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
138669928|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
138824072|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138824073|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
138824074|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138824075|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
138824076|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138824077|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
138824078|NCT00731575|Hormones|hormones|mesh-ancestor
138824079|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138824080|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824081|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138824082|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824083|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
138824084|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
138824085|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824086|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138824087|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138824088|NCT00731575|Protective Agents|protective agents|mesh-ancestor
138824089|NCT02674191|Clindamycin|clindamycin|mesh-list
138824090|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
138824091|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
138824092|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
138824093|NCT02674191|Mepivacaine|mepivacaine|mesh-list
138824094|NCT02674191|Benzocaine|benzocaine|mesh-list
138824095|NCT02674191|Povidone|povidone|mesh-list
138824096|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138824097|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824098|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138824099|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824100|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824101|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
138824102|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
138824103|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138824104|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
138824105|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
138824106|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138669984|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138824107|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824108|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
138824109|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824110|NCT00736021|Escitalopram|escitalopram|mesh-list
138824111|NCT00736021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138824112|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138824113|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138824114|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824115|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824116|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
138824117|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824118|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
138824119|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138824120|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138824121|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824122|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
138824123|NCT04178655|Coagulants|coagulants|mesh-ancestor
138824124|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
138824125|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138824126|NCT00738517|Antibodies|antibodies|mesh-list
138824127|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
138824128|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824129|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138824130|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138824131|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138824132|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824133|NCT00738595|Nicotine|nicotine|mesh-list
138824134|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138824135|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
138824136|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824137|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824138|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138824139|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138824140|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
138824141|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824142|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824143|NCT05273775|Vitamin K|vitamin k|mesh-list
138824144|NCT05273775|Vitamin K 1|vitamin k 1|mesh-list
138824145|NCT05273775|Digoxin|digoxin|mesh-list
138824146|NCT05273775|Midazolam|midazolam|mesh-list
138824147|NCT05273775|Omeprazole|omeprazole|mesh-list
138824148|NCT05273775|Warfarin|warfarin|mesh-list
138824149|NCT05273775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138670067|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824150|NCT05273775|Vitamins|vitamins|mesh-ancestor
138824151|NCT05273775|Micronutrients|micronutrients|mesh-ancestor
138824152|NCT05273775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824153|NCT05273775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138824155|NCT05273775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824156|NCT05273775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138824157|NCT05273775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138824158|NCT05273775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138824159|NCT05273775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138824160|NCT05273775|Anesthetics, General|anesthetics, general|mesh-ancestor
138824161|NCT05273775|Anesthetics|anesthetics|mesh-ancestor
138824162|NCT05273775|GABA Modulators|gaba modulators|mesh-ancestor
138824163|NCT05273775|GABA Agents|gaba agents|mesh-ancestor
138824164|NCT05273775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824165|NCT05273775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824166|NCT05273775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138824167|NCT05273775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138824168|NCT05273775|Antimetabolites|antimetabolites|mesh-ancestor
138824169|NCT05273775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138824170|NCT05273775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138824171|NCT05273775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824172|NCT05273775|Anticoagulants|anticoagulants|mesh-ancestor
138824173|NCT05273775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138824174|NCT05273775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138824175|NCT05273775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138824176|NCT05273775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138824177|NCT05273775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138824178|NCT05273775|Protective Agents|protective agents|mesh-ancestor
138824179|NCT05273775|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138824180|NCT05273775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138824181|NCT05273775|Hemostatics|hemostatics|mesh-ancestor
138824182|NCT05273775|Coagulants|coagulants|mesh-ancestor
138824183|NCT02671851|Acetaminophen|acetaminophen|mesh-list
138824184|NCT02671851|Dipyrone|dipyrone|mesh-list
138824185|NCT02671851|Fentanyl|fentanyl|mesh-list
138824186|NCT02671851|Tramadol|tramadol|mesh-list
138824187|NCT02671851|Bupivacaine|bupivacaine|mesh-list
138824188|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
138824189|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
138824190|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824191|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824192|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
138824193|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824194|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138824195|NCT02671851|Narcotics|narcotics|mesh-ancestor
138824196|NCT02671851|Analgesics|analgesics|mesh-ancestor
138824197|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138824198|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138824199|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
138824200|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138824201|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
138670233|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
138824202|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138824203|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138824204|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138824205|NCT02671695|Amlodipine|amlodipine|mesh-list
138824206|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138824207|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138437369|NCT01761994|Nafamostat|nafamostat|mesh-list
138824208|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138824209|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824210|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138824211|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824212|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
138824213|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
138824214|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
138824215|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138824216|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138824217|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824218|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824219|NCT00644631|Urological Agents|urological agents|mesh-ancestor
138824220|NCT02671383|Lopinavir|lopinavir|mesh-list
138824221|NCT02671383|Darunavir|darunavir|mesh-list
138824222|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138824223|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138824224|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
138824225|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824226|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824227|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138824228|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138824229|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
138824230|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824231|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138824232|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138824233|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138824234|NCT00738751|Panobinostat|panobinostat|mesh-list
138824235|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138824236|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824237|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138824238|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824239|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824240|NCT05243823|Estradiol|estradiol|mesh-list
138824241|NCT05243823|Estrogens|estrogens|mesh-ancestor
138824242|NCT05243823|Hormones|hormones|mesh-ancestor
138824243|NCT05243823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138824244|NCT05243823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824245|NCT00736801|Fluticasone|fluticasone|mesh-list
138824246|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138824247|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138824248|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138824249|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
138824250|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824251|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824252|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138824253|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
138824254|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
138824255|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138824256|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138824257|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138824258|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138824259|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
138824260|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824261|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824262|NCT00738829|Rituximab|rituximab|mesh-list
138824263|NCT00738829|Fludarabine|fludarabine|mesh-list
138824264|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
138824265|NCT00738829|Lenalidomide|lenalidomide|mesh-list
138824266|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138824267|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824268|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
138670345|NCT00480558|Vaccines|vaccines|mesh-list
138824269|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824270|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138824271|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138824272|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
138824273|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824274|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138824275|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138824276|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138824277|NCT00738829|Growth Substances|growth substances|mesh-ancestor
138824278|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
138824279|NCT02671227|Bupivacaine|bupivacaine|mesh-list
138824280|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
138824281|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
138824282|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824283|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824284|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
138824285|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824286|NCT00644709|Atorvastatin|atorvastatin|mesh-list
138824287|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138824288|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138824289|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
138824290|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824291|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138824292|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138824293|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824294|NCT00738985|Simvastatin|simvastatin|mesh-list
138824295|NCT00738985|Ezetimibe|ezetimibe|mesh-list
138824296|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138824297|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138824298|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138824299|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
138470142|NCT01986036|Calcium|calcium|mesh-list
138824300|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824301|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138437407|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138824302|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138824304|NCT05216211|Bupivacaine|bupivacaine|mesh-list
138824305|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
138824306|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
138824307|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138670395|NCT00456482|Hormones|hormones|mesh-ancestor
138824308|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824309|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
138824310|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824311|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138824312|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138824313|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824314|NCT00732121|Incretins|incretins|mesh-ancestor
138824315|NCT00732121|Hormones|hormones|mesh-ancestor
138824316|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138824317|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138824318|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
138824319|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824320|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824321|NCT02537223|Cisplatin|cisplatin|mesh-list
138824322|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824324|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824325|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138824326|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824327|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824328|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
138824329|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138670411|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824330|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138824331|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138824332|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138824333|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138824334|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824335|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138824336|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824337|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824338|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
138824339|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138824340|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138824341|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138824342|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138824343|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138824344|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824346|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824347|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824348|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138824349|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824350|NCT00737113|Hormones|hormones|mesh-list
138824351|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138824352|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824353|NCT00737191|Olanzapine|olanzapine|mesh-list
138824354|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
138824355|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
138824356|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824357|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824358|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138824359|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138824360|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138824361|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824362|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138824363|NCT00737191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138824364|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138824365|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138824366|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824367|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824368|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
138824369|NCT04175067|Antioxidants|antioxidants|mesh-list
138824370|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824371|NCT04175067|Protective Agents|protective agents|mesh-ancestor
138824372|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824373|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
138824374|NCT00758602|Tacrolimus|tacrolimus|mesh-list
138824375|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138824376|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
138824377|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824378|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138824379|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824380|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824381|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138824382|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824383|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138824384|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
138824385|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138824386|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824387|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
138824388|NCT02667561|Testosterone|testosterone|mesh-list
138824389|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
138824390|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
138437464|NCT01762332|Analgesics|analgesics|mesh-ancestor
138824391|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138824392|NCT02667561|Androgens|androgens|mesh-ancestor
138824394|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138824395|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824396|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138824397|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824398|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
138824400|NCT00732511|Carvedilol|carvedilol|mesh-list
138824401|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138824402|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138824403|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
138824404|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
138824405|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824406|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824407|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138824408|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138824409|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138824410|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
138824411|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824412|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824413|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
138824414|NCT00732511|Protective Agents|protective agents|mesh-ancestor
138824415|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138824416|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138824417|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138824418|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
138824419|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138824420|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138824421|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
138824422|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138824423|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
138824424|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824425|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824426|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138824427|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
138824428|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138437497|NCT01762540|Calcium|calcium|mesh-list
138824430|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824431|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470176|NCT01986218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138670528|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138824432|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138824433|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
138824434|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
138824435|NCT00739531|Protective Agents|protective agents|mesh-ancestor
138824436|NCT00739609|Tryptophan|tryptophan|mesh-list
138824437|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138824438|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
138824439|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138824440|NCT00645723|Colistin|colistin|mesh-list
138824441|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138824442|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824443|NCT00711529|Gabapentin|gabapentin|mesh-list
138824444|NCT00711529|Analgesics|analgesics|mesh-ancestor
138824445|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
138824446|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824447|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824448|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
138824449|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138824450|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138824451|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824452|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138824453|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138824454|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138824455|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824456|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824457|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
138824458|NCT00732589|Lidocaine|lidocaine|mesh-list
138824459|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
138824460|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
138824461|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824462|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824463|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
138824464|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824465|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138824466|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138824467|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138824468|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138824469|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824471|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
138824472|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
138824473|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138824474|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
138824475|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
138824476|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824477|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
138824478|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138824479|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824480|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138649668|NCT00296894|Adalimumab|adalimumab|mesh-list
138824481|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
138824482|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138824483|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824484|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824485|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824486|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
138824487|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138824488|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138824489|NCT02666703|Prednisolone|prednisolone|mesh-list
138824490|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
138824492|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
138824493|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138824494|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
138824495|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
138824496|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824497|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824498|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138824499|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
138824500|NCT02666703|Hormones|hormones|mesh-ancestor
138824501|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138824502|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138824503|NCT02666703|Protective Agents|protective agents|mesh-ancestor
138670603|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670604|NCT00458042|Treprostinil|treprostinil|mesh-list
138824504|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138824505|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824506|NCT04174131|Lidocaine|lidocaine|mesh-list
138649689|NCT00296972|Interferons|interferons|mesh-list
138824507|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
138824508|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
138824509|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
138824510|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824511|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824512|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
138824513|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824514|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138824515|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138824516|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138824517|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138824518|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824519|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138824520|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
138824521|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
138824522|NCT04174131|Protective Agents|protective agents|mesh-ancestor
138824523|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
138824524|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138824525|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824526|NCT00646035|Vitamins|vitamins|mesh-ancestor
138824527|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
138824528|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138824529|NCT00646191|Adalimumab|adalimumab|mesh-list
138824530|NCT00646191|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138824531|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138824532|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138824533|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
138824534|NCT02666157|Apixaban|apixaban|mesh-list
138824535|NCT02666157|Dabigatran|dabigatran|mesh-list
138824536|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138824537|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
138824538|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138824539|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
138824540|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824541|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824542|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
138824543|NCT02666001|Fostemsavir|fostemsavir|mesh-list
138824544|NCT02666001|Buprenorphine|buprenorphine|mesh-list
138824546|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138824547|NCT02666001|Narcotics|narcotics|mesh-ancestor
138824548|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824549|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670714|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
138824550|NCT02666001|Analgesics|analgesics|mesh-ancestor
138824551|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
138824552|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824553|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138824554|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
138824555|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
138824556|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138824557|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138824558|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
138824559|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824560|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138824561|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138824562|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824563|NCT02665845|Mesalamine|mesalamine|mesh-list
138824564|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138649777|NCT04333134|Fluzoparib|fluzoparib|mesh-list
138824565|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138824566|NCT02665845|Analgesics|analgesics|mesh-ancestor
138824567|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
138824568|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824569|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824570|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138824571|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138824572|NCT00646425|Basiliximab|basiliximab|mesh-list
138824573|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138824574|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
138824575|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824576|NCT02665533|Dexamethasone|dexamethasone|mesh-list
138824577|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
138824578|NCT02665533|Diclofenac|diclofenac|mesh-list
138824579|NCT02665533|Codeine|codeine|mesh-list
138824580|NCT02665533|BB 1101|bb 1101|mesh-list
138824581|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138824582|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
138824583|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
138824584|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824585|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824586|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138824587|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
138824588|NCT02665533|Hormones|hormones|mesh-ancestor
138824589|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138824590|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138824591|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824592|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
138824593|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824594|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824595|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138824596|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138824597|NCT02665533|Analgesics|analgesics|mesh-ancestor
138824598|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
138824599|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138670792|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824600|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138824601|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138824602|NCT02665533|Narcotics|narcotics|mesh-ancestor
138824603|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824604|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
138824605|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
138824606|NCT00646503|Telbivudine|telbivudine|mesh-list
138824607|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
138824608|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824609|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138824610|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824611|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824612|NCT04173039|Antibodies|antibodies|mesh-list
138824613|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
138824614|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824615|NCT00646659|Carboplatin|carboplatin|mesh-list
138824616|NCT00646659|Docetaxel|docetaxel|mesh-list
138824617|NCT00646659|Fluorouracil|fluorouracil|mesh-list
138824619|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670839|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
138824620|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
138824621|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
138824622|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
138824623|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824624|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
138824625|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138824626|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138824627|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
138824628|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824629|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138824630|NCT00648531|Balsalazide|balsalazide|mesh-list
138670892|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138670893|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
138824631|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138824632|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138824633|NCT00648531|Analgesics|analgesics|mesh-ancestor
138824634|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
138824635|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824636|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824637|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138824638|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138824639|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138824640|NCT00648765|Anagrelide|anagrelide|mesh-list
138824641|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138824642|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138824643|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824644|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138824645|NCT00648843|Oxybutynin|oxybutynin|mesh-list
138824646|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
138824647|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
138824648|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138670958|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824649|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824650|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138824651|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138824653|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138670959|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138670967|NCT00495729|Simvastatin|simvastatin|mesh-list
138824654|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824655|NCT00648843|Urological Agents|urological agents|mesh-ancestor
138824656|NCT02662959|Irinotecan|irinotecan|mesh-list
138824657|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138824658|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138824659|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824660|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824661|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824662|NCT02662647|Cytarabine|cytarabine|mesh-list
138824663|NCT02662647|Decitabine|decitabine|mesh-list
138824664|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
138824665|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138824666|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
138824667|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824668|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824669|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
138824670|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824671|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138824672|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
138824673|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824674|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824675|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138824676|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138824678|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138824679|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138671008|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
138671010|NCT00496002|Clevudine|clevudine|mesh-list
138671011|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
138824680|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138824681|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824682|NCT00648921|Olanzapine|olanzapine|mesh-list
138824683|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
138824684|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
138824685|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824686|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824687|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138824688|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138824689|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138824690|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824692|NCT00648921|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138824693|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138824694|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138476648|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
138824695|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824696|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824697|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
138824698|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
138824699|NCT02662491|Vitamin D|vitamin d|mesh-list
138824700|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
138824701|NCT02662491|Cholecalciferol|cholecalciferol|mesh-list
138824702|NCT02662491|Vitamins|vitamins|mesh-list
138824703|NCT02662491|Calcium|calcium|mesh-list
138824704|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
138824705|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824706|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138824707|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138824708|NCT00648999|Ritonavir|ritonavir|mesh-list
138824709|NCT00648999|Lopinavir|lopinavir|mesh-list
138671057|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
138824710|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138824711|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138824712|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
138824713|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824714|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824715|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138824716|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138824717|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
138824718|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824719|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138824720|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138824721|NCT02661711|Aflibercept|aflibercept|mesh-list
138824722|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138824723|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138824724|NCT02661711|Growth Substances|growth substances|mesh-ancestor
138824725|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824726|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
138824727|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824728|NCT02661789|Goserelin|goserelin|mesh-list
138824729|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138824730|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824731|NCT02661477|Interferons|interferons|mesh-list
138824732|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
138824733|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
138824734|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824735|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
138824736|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824737|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
138824738|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824739|NCT00649077|Meloxicam|meloxicam|mesh-list
138824740|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138824741|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138824742|NCT00649077|Analgesics|analgesics|mesh-ancestor
138824743|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
138824744|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824745|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824746|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138824747|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138824748|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138824749|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138824750|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824751|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824752|NCT02656251|Ethanol|ethanol|mesh-list
138824753|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
138824754|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138824755|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138824756|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824757|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824758|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824759|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
138824760|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
138824761|NCT02656095|Heparin|heparin|mesh-list
138824762|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
138824763|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138824764|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138824765|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824766|NCT00649935|Azithromycin|azithromycin|mesh-list
138824767|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138476724|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
138824768|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824769|NCT02655705|Cyclosporine|cyclosporine|mesh-list
138824770|NCT02655705|Methotrexate|methotrexate|mesh-list
138824771|NCT02655705|Cyclosporins|cyclosporins|mesh-list
138671148|NCT00496392|Narcotics|narcotics|mesh-ancestor
138671152|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
138824772|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138824773|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
138824774|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138824775|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824776|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138824778|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824779|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824780|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
138824781|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824782|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138824783|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138824784|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
138824785|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138824786|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138824787|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
138824788|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824789|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138824790|NCT02655471|Zidovudine|zidovudine|mesh-list
138824791|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
138824792|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
138824793|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824794|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138824795|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138824796|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824797|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
138671188|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138671189|NCT00496704|Gemcitabine|gemcitabine|mesh-list
138671190|NCT00496704|Capecitabine|capecitabine|mesh-list
138671191|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
138824798|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824799|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138824800|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138824801|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138824802|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138824803|NCT00650013|Midodrine|midodrine|mesh-list
138824804|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
138824805|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
138824806|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824807|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824808|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138650066|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
138824809|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138824810|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138824811|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138824812|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
138824813|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824814|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824815|NCT00712933|Belimumab|belimumab|mesh-list
138824816|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138824817|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
138824818|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824819|NCT02654847|Norepinephrine|norepinephrine|mesh-list
138824820|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138824821|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138824822|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
138824823|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824824|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824825|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824826|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
138824827|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
138671235|NCT03273296|Azithromycin|azithromycin|mesh-list
138671236|NCT03273296|Vancomycin|vancomycin|mesh-list
138671237|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138437770|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
138824828|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824829|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138824830|NCT02536209|Oxycodone|oxycodone|mesh-list
138824831|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138824832|NCT02536209|Narcotics|narcotics|mesh-ancestor
138824833|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138824834|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824835|NCT02536209|Analgesics|analgesics|mesh-ancestor
138824836|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
138824837|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824838|NCT00732745|Docetaxel|docetaxel|mesh-list
138824839|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
138824840|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824841|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
138824842|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
138824843|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
138824844|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824845|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
138824846|NCT00737815|Cathartics|cathartics|mesh-ancestor
138824847|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138824848|NCT02654379|Rituximab|rituximab|mesh-list
138824849|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138824850|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824851|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
138824852|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824853|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138824854|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138824855|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
138824856|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
138671277|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
138671278|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138671279|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
138671280|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138671281|NCT00223028|Sirolimus|sirolimus|mesh-list
138671282|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138824857|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824859|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138824860|NCT00650169|Clopidogrel|clopidogrel|mesh-list
138824861|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138824862|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138824863|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138824864|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138824865|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
138824866|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824867|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824868|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824869|NCT04064125|Minocycline|minocycline|mesh-list
138824870|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138824871|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824872|NCT00740389|Etravirine|etravirine|mesh-list
138824873|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138824874|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138824875|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824876|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671318|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138671321|NCT00489840|Anecortave|anecortave|mesh-list
138824877|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
138824878|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824879|NCT00740467|Cyclosporine|cyclosporine|mesh-list
138824880|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
138824881|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
138824882|NCT00740467|Busulfan|busulfan|mesh-list
138824883|NCT00740467|Fludarabine|fludarabine|mesh-list
138824884|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
138824885|NCT00740467|Cyclosporins|cyclosporins|mesh-list
138824886|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138824887|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138824888|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
138824889|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824890|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138824891|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138824892|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
138824893|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824894|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824895|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138824896|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138824897|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
138824898|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824899|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
138824900|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824901|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
138824902|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138671376|NCT00466154|Aspirin|aspirin|mesh-list
138824903|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138824904|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138824905|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
138824906|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138824907|NCT00740545|Enoxaparin|enoxaparin|mesh-list
138824908|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
138824909|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138824910|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138824911|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824913|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
138824914|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138824915|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138824916|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824917|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437842|NCT01764555|Acetaminophen|acetaminophen|mesh-list
138824918|NCT02653833|Urological Agents|urological agents|mesh-ancestor
138824919|NCT00733057|Minocycline|minocycline|mesh-list
138824920|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138824921|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824923|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138824924|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138824925|NCT00737971|Bevacizumab|bevacizumab|mesh-list
138824926|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138824927|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138824928|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138824929|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138824930|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138824931|NCT00737971|Growth Substances|growth substances|mesh-ancestor
138824932|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824933|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
138671421|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138824934|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138824935|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
138824936|NCT00737971|Hormones|hormones|mesh-ancestor
138824937|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138824938|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138824939|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
138824940|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824941|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824942|NCT00650247|Sumatriptan|sumatriptan|mesh-list
138824943|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138824944|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138824945|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138824946|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
138824947|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138824948|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824949|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824950|NCT02568709|Oxytocin|oxytocin|mesh-list
138824951|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
138824952|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138824953|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824954|NCT02653209|Pioglitazone|pioglitazone|mesh-list
138824955|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138824956|NCT02653209|Canagliflozin|canagliflozin|mesh-list
138824957|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138824958|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824959|NCT02653209|Incretins|incretins|mesh-ancestor
138824960|NCT02653209|Hormones|hormones|mesh-ancestor
138437865|NCT01764750|Vancomycin|vancomycin|mesh-list
138671464|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
138671466|NCT00490737|Daptomycin|daptomycin|mesh-list
138532536|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138824961|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138824962|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138824964|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824965|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824966|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138824967|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138824968|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138824969|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138824970|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824971|NCT02653131|Incretins|incretins|mesh-ancestor
138824972|NCT02653131|Hormones|hormones|mesh-ancestor
138824973|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138824974|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
138824975|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824976|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824977|NCT02652585|Naltrexone|naltrexone|mesh-list
138437904|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
138824978|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138824979|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138824980|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138824981|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
138824982|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138824983|NCT00741169|Rifampin|rifampin|mesh-list
138824984|NCT00741169|Simeprevir|simeprevir|mesh-list
138671508|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138824985|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138824986|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
138824987|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138824988|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138824989|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
138824990|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138824991|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138824992|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138824993|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138824994|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138824995|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138824996|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138824997|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138824998|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138824999|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
138825000|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
138825001|NCT00741325|Plerixafor|plerixafor|mesh-list
138825002|NCT00741325|Lenograstim|lenograstim|mesh-list
138825003|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138825004|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
138825005|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825006|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138825007|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138825008|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
138825009|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825010|NCT02652741|Enalapril|enalapril|mesh-list
138825011|NCT02652741|Enalaprilat|enalaprilat|mesh-list
138671558|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138671559|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138671560|NCT00464165|Rimonabant|rimonabant|mesh-list
138825012|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138825014|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825015|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825016|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138825017|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
138825018|NCT02652507|Ketamine|ketamine|mesh-list
138825019|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138825020|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138825021|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825022|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138825023|NCT02652507|Analgesics|analgesics|mesh-ancestor
138825024|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
138825025|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825026|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138825027|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138825028|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138825029|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
138470324|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138825030|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138825031|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825032|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138825033|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138825034|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
138825035|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
138825036|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138825037|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138825038|NCT02652273|Abatacept|abatacept|mesh-list
138825039|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138671602|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138671604|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138825040|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825041|NCT02652273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138825042|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825043|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138825044|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
138825045|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825046|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138825048|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
138825049|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138825050|NCT00650325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138825051|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138825052|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138825053|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825054|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138825055|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
138825056|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825057|NCT00650403|Paroxetine|paroxetine|mesh-list
138825058|NCT00650403|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138825059|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138825060|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138825061|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825062|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138825063|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
138825064|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825065|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138671646|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
138671647|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825066|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
138477019|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
138825067|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138825068|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138825069|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138825070|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825071|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138825072|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138825073|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
138825074|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825075|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825076|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138825077|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
138825078|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138825079|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138825080|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138825081|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
138825082|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650256|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825083|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825084|NCT00920803|Resveratrol|resveratrol|mesh-list
138825085|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
138825086|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825087|NCT00920803|Protective Agents|protective agents|mesh-ancestor
138825088|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825089|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825090|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138825091|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
138825092|NCT04316169|Letrozole|letrozole|mesh-list
138671692|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138825093|NCT04316169|Fulvestrant|fulvestrant|mesh-list
138671693|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825094|NCT04316169|Anastrozole|anastrozole|mesh-list
138825095|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825096|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138825097|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138825098|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825099|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825100|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138825101|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
138825102|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138825103|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825104|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
138825105|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138825106|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138825107|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825108|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138825109|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138825110|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138671735|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825111|NCT05740969|Fluorouracil|fluorouracil|mesh-list
138825112|NCT05740969|Imiquimod|imiquimod|mesh-list
138825113|NCT05740969|Melatonin|melatonin|mesh-list
138825114|NCT05740969|Antimetabolites|antimetabolites|mesh-ancestor
138671736|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825115|NCT05740969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138671737|NCT04397302|Valsartan|valsartan|mesh-list
138825116|NCT05740969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138825117|NCT05740969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825118|NCT05740969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138825119|NCT05740969|Immunologic Factors|immunologic factors|mesh-ancestor
138825120|NCT05740969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825121|NCT05740969|Antioxidants|antioxidants|mesh-ancestor
138825122|NCT05740969|Protective Agents|protective agents|mesh-ancestor
138825123|NCT05740969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138825124|NCT05740969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138825125|NCT05740969|Interferon Inducers|interferon inducers|mesh-ancestor
138825126|NCT02568241|Interferons|interferons|mesh-list
138825127|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
138825128|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
138825129|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825130|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
138825131|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825132|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
138825133|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825134|NCT05551897|Itraconazole|itraconazole|mesh-list
138825135|NCT05551897|Antifungal Agents|antifungal agents|mesh-ancestor
138825136|NCT05551897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825137|NCT05551897|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138825138|NCT05551897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138825139|NCT05551897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825140|NCT05551897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477094|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
138825141|NCT05551897|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138825142|NCT05551897|Hormone Antagonists|hormone antagonists|mesh-ancestor
138825143|NCT05551897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138825144|NCT05551897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825145|NCT05551897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138825146|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
138825148|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138825149|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825150|NCT02647671|Antacids|antacids|mesh-ancestor
138671784|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138825151|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825152|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138825153|NCT04578613|Rituximab|rituximab|mesh-list
138825154|NCT04578613|Chlorambucil|chlorambucil|mesh-list
138825155|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138825156|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825157|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
138825158|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825159|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138825160|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138825161|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
138825162|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825164|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138825165|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138825166|NCT02647515|Growth Substances|growth substances|mesh-ancestor
138825167|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825168|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
138825169|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825170|NCT03818763|Factor VIII|factor viii|mesh-list
138825171|NCT03818763|Coagulants|coagulants|mesh-ancestor
138825172|NCT02647047|Acetaminophen|acetaminophen|mesh-list
138825173|NCT02647047|Ketorolac|ketorolac|mesh-list
138825174|NCT02647047|Sufentanil|sufentanil|mesh-list
138825175|NCT02647047|Ropivacaine|ropivacaine|mesh-list
138825176|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
138825177|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
138825178|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138825179|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825180|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
138825181|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138671822|NCT00467012|Growth Substances|growth substances|mesh-ancestor
138825182|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138825183|NCT02647047|Analgesics|analgesics|mesh-ancestor
138825184|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
138825185|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138825186|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138825187|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138825188|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138825189|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825190|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825191|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138825192|NCT02647047|Narcotics|narcotics|mesh-ancestor
138825193|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138825194|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138825195|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
138825196|NCT00651651|Budesonide|budesonide|mesh-list
138825197|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
138825198|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138825199|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138671867|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825200|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
138671868|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138671869|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138671870|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138671871|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
138671872|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138671873|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138671874|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138207344|NCT01323517|Dactinomycin|dactinomycin|mesh-list
138825201|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825202|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825203|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138825204|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
138825205|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
138825206|NCT00651651|Hormones|hormones|mesh-ancestor
138825207|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138825208|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138825209|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138825210|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138825211|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
138825212|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138825213|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138477169|NCT02017314|Analgesics|analgesics|mesh-ancestor
138825214|NCT00709111|Maraviroc|maraviroc|mesh-list
138825215|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138825216|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138470356|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825217|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825218|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138825219|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138825220|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
138825221|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825222|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138825224|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138825225|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138825226|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138825227|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138825228|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825229|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
138825230|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138671916|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
138825231|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825232|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138825233|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825234|NCT02646735|Fulvestrant|fulvestrant|mesh-list
138825235|NCT02646735|Exemestane|exemestane|mesh-list
138825236|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138825237|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825238|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138825239|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138825240|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
138825241|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138825242|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825243|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138825244|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138825245|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825246|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825247|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138825248|NCT02646657|Vedolizumab|vedolizumab|mesh-list
138825249|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138825250|NCT00652041|Thalidomide|thalidomide|mesh-list
138825251|NCT00652041|Bortezomib|bortezomib|mesh-list
138825252|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825253|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138825254|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
138825255|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825256|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
138825257|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138825258|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470367|NCT01987297|Cytarabine|cytarabine|mesh-list
138825259|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138825260|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138438226|NCT01766843|Charcoal|charcoal|mesh-list
138825261|NCT00652041|Growth Substances|growth substances|mesh-ancestor
138825262|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
138825263|NCT02646111|Ribavirin|ribavirin|mesh-list
138825264|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
138825265|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825266|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
138825267|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825268|NCT00652119|Paclitaxel|paclitaxel|mesh-list
138825269|NCT00652119|Bevacizumab|bevacizumab|mesh-list
138825270|NCT00652119|Carboplatin|carboplatin|mesh-list
138825271|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138825272|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825273|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
138825274|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
138825275|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
138825276|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825277|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138825278|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138825279|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138825280|NCT00652119|Growth Substances|growth substances|mesh-ancestor
138825281|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825282|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
138825284|NCT05740657|Sufentanil|sufentanil|mesh-list
138825285|NCT05740657|Morphine|morphine|mesh-list
138825286|NCT05740657|Remifentanil|remifentanil|mesh-list
138825287|NCT05740657|Oxycodone|oxycodone|mesh-list
138825288|NCT05740657|Hydromorphone|hydromorphone|mesh-list
138825289|NCT05740657|Alfentanil|alfentanil|mesh-list
138825290|NCT05740657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138825291|NCT05740657|Narcotics|narcotics|mesh-ancestor
138825292|NCT05740657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138825294|NCT05740657|Analgesics|analgesics|mesh-ancestor
138825295|NCT05740657|Sensory System Agents|sensory system agents|mesh-ancestor
138825296|NCT05740657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825297|NCT05740657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138825298|NCT05740657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138825299|NCT05740657|Anesthetics, General|anesthetics, general|mesh-ancestor
138825300|NCT05740657|Anesthetics|anesthetics|mesh-ancestor
138825301|NCT02646267|Warfarin|warfarin|mesh-list
138825302|NCT02646267|Dabigatran|dabigatran|mesh-list
138825303|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
138825304|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
138825305|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138671988|NCT00491907|Folic Acid|folic acid|mesh-list
138825306|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
138671989|NCT00491907|Hematinics|hematinics|mesh-ancestor
138825307|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825308|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825309|NCT02646189|Interferons|interferons|mesh-list
138825310|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
138825311|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
138825312|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138825313|NCT02646189|REP 2139|rep 2139|mesh-list
138825314|NCT02646189|Thymalfasin|thymalfasin|mesh-list
138825315|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825316|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
138825317|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825318|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
138825319|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825320|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138825321|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
138825322|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138825323|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138825324|NCT02645565|Prednisolone|prednisolone|mesh-list
138825325|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
138825326|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
138825327|NCT02645565|Azathioprine|azathioprine|mesh-list
138825328|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138825329|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
138825330|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138825331|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
138825332|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825333|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138672034|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
138825334|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138825335|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
138825336|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825337|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672040|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
138825338|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138825339|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138825341|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
138825342|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825343|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138825344|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
138825346|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138825347|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138825348|NCT02645565|Protective Agents|protective agents|mesh-ancestor
138825349|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138825350|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
138825351|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138825352|NCT00699907|Flutamide|flutamide|mesh-list
138825353|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
138825354|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
138825355|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138825356|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825357|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138825358|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825359|NCT00599313|Sunitinib|sunitinib|mesh-list
138825360|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825361|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138825362|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138825363|NCT00599313|Growth Substances|growth substances|mesh-ancestor
138825364|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825365|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
138825366|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138825367|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825368|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825369|NCT00708175|Pioglitazone|pioglitazone|mesh-list
138825370|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138825371|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825372|NCT05740345|Metformin|metformin|mesh-list
138825373|NCT05740345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138825374|NCT05740345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825375|NCT02641431|Ajmaline|ajmaline|mesh-list
138825376|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138825377|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138825378|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138438338|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
138825379|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138672077|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138825380|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825381|NCT00733525|Fluoxetine|fluoxetine|mesh-list
138825382|NCT00733525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138825383|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138825384|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138825385|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825386|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138825387|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
138825388|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825389|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138650401|NCT00328380|Rifaximin|rifaximin|mesh-list
138825390|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
138672112|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672113|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672114|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138825391|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138672115|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138825392|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138825393|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138825394|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825395|NCT02567149|Cidofovir|cidofovir|mesh-list
138825396|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
138825397|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825398|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825399|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825400|NCT00707239|Imipenem|imipenem|mesh-list
138825401|NCT00707239|Tigecycline|tigecycline|mesh-list
138825402|NCT00707239|Cilastatin|cilastatin|mesh-list
138825403|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138825404|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825405|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138825406|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825407|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672170|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672171|NCT00592618|Protective Agents|protective agents|mesh-ancestor
138672172|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825408|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
138825409|NCT00968708|Alogliptin|alogliptin|mesh-list
138825410|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138825411|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825412|NCT00968708|Incretins|incretins|mesh-ancestor
138825413|NCT00968708|Hormones|hormones|mesh-ancestor
138825414|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138825415|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138825416|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
138825417|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825418|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825419|NCT05417269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138825420|NCT05417269|Dermatologic Agents|dermatologic agents|mesh-ancestor
138825421|NCT05417269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138825422|NCT05417269|Immunologic Factors|immunologic factors|mesh-ancestor
138825423|NCT05417269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825424|NCT04062565|Treprostinil|treprostinil|mesh-list
138825425|NCT04062565|Riociguat|riociguat|mesh-list
138825426|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138825427|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
138825428|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825429|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
138825430|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138825431|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
138825432|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
138825433|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138825434|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825435|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138672225|NCT00593008|Temsirolimus|temsirolimus|mesh-list
138825436|NCT00967694|Analgesics|analgesics|mesh-ancestor
138825437|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
138825438|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825439|NCT04288700|Timolol|timolol|mesh-list
138825440|NCT04288700|Propranolol|propranolol|mesh-list
138825441|NCT04288700|Captopril|captopril|mesh-list
138825442|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138825443|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138825444|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825445|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825446|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138825447|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138825448|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
138825449|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138825450|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825451|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138825452|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138825453|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
138825454|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138825455|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
138825456|NCT02863406|Dimercaprol|dimercaprol|mesh-list
138825457|NCT02863406|Chelating Agents|chelating agents|mesh-ancestor
138825458|NCT02863406|Sequestering Agents|sequestering agents|mesh-ancestor
138825459|NCT02863406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825460|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
138825461|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672269|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825462|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825463|NCT00629720|Alfuzosin|alfuzosin|mesh-list
138672270|NCT05654194|Azacitidine|azacitidine|mesh-list
138672271|NCT05654194|Venetoclax|venetoclax|mesh-list
138825464|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138825465|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138825466|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138825467|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
138825468|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138825469|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825470|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825471|NCT00629720|Urological Agents|urological agents|mesh-ancestor
138825472|NCT00967616|Leucovorin|leucovorin|mesh-list
138825473|NCT00967616|Fluorouracil|fluorouracil|mesh-list
138825474|NCT00967616|Irinotecan|irinotecan|mesh-list
138825475|NCT00967616|Efatutazone|efatutazone|mesh-list
138825476|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
138825477|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
138825478|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825479|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138825480|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825481|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138825482|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
138825483|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825484|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138825485|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138825486|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825487|NCT00967616|Antidotes|antidotes|mesh-ancestor
138825488|NCT00967616|Protective Agents|protective agents|mesh-ancestor
138672319|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672320|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825489|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
138825490|NCT00967616|Vitamins|vitamins|mesh-ancestor
138825491|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
138825492|NCT04288232|Aflibercept|aflibercept|mesh-list
138825493|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138825494|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138825495|NCT04288232|Growth Substances|growth substances|mesh-ancestor
138825496|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825497|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
138825498|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825499|NCT02864264|Interferons|interferons|mesh-list
138825500|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
138470454|NCT01988311|Psilocybin|psilocybin|mesh-list
138825501|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825502|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
138825503|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825504|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
138825505|NCT02640417|Vitamins|vitamins|mesh-ancestor
138825506|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
138825507|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825509|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
138825510|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138672366|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
138672367|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825511|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138825512|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825513|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825514|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
138825515|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
138825516|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138825517|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
138672368|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825518|NCT00653757|Leuprolide|leuprolide|mesh-list
138825519|NCT00653757|Goserelin|goserelin|mesh-list
138825520|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138825521|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
138825522|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138825523|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825524|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138825525|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825526|NCT00654225|Atorvastatin|atorvastatin|mesh-list
138825527|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138825528|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138825529|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138825530|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
138825531|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825532|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138825533|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138825534|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825535|NCT00974090|Glimepiride|glimepiride|mesh-list
138825536|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138825537|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138825538|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825539|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138825540|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
138672406|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825541|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138825542|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138825543|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138825544|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
138825545|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825546|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138825547|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138825548|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825549|NCT02639091|Pemetrexed|pemetrexed|mesh-list
138825550|NCT02639091|Anetumab ravtansine|anetumab ravtansine|mesh-list
138825551|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825552|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825553|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825554|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138825555|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138825556|NCT02639091|Immunoconjugates|immunoconjugates|mesh-ancestor
138825557|NCT02639091|Immunologic Factors|immunologic factors|mesh-ancestor
138825558|NCT02639091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825559|NCT00654459|Policosanol|policosanol|mesh-list
138825560|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138825561|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138825562|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
138825563|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825564|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138825565|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138825566|NCT00654537|Atorvastatin|atorvastatin|mesh-list
138825567|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138825568|NCT00654537|Simvastatin|simvastatin|mesh-list
138825569|NCT00654537|Pravastatin|pravastatin|mesh-list
138672462|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825570|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138825571|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138825572|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
138825573|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825574|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138825575|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138825576|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825577|NCT02638857|Epirubicin|epirubicin|mesh-list
138825578|NCT02638857|Mitomycins|mitomycins|mesh-list
138825579|NCT02638857|Mitomycin|mitomycin|mesh-list
138825580|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
138825581|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138825582|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825583|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138825584|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138825585|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825586|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825587|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
138825588|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138825589|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
138825590|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138825591|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138825592|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825593|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138825594|NCT02638545|Analgesics|analgesics|mesh-ancestor
138825595|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
138825596|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825597|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138825598|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138825599|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138825600|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
138825601|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532537|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138672504|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138672505|NCT00473915|Fluticasone|fluticasone|mesh-list
138672507|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138672509|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
138825602|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825603|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
138825604|NCT02638233|Ledipasvir|ledipasvir|mesh-list
138438493|NCT01768351|Calcitriol|calcitriol|mesh-list
138825605|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
138825606|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825607|NCT04285268|Rituximab|rituximab|mesh-list
138825608|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138825609|NCT04285268|Bortezomib|bortezomib|mesh-list
138825610|NCT04285268|Venetoclax|venetoclax|mesh-list
138825611|NCT04285268|Antibodies|antibodies|mesh-list
138672550|NCT00500058|Rituximab|rituximab|mesh-list
138825612|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
138825613|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138825614|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
138825615|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825616|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825617|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138825618|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138825619|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825620|NCT01842399|Resveratrol|resveratrol|mesh-list
138825621|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
138825622|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825623|NCT01842399|Protective Agents|protective agents|mesh-ancestor
138825624|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825625|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825626|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138825627|NCT00970502|Celecoxib|celecoxib|mesh-list
138825628|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138825629|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825630|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138825631|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825632|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825633|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138825634|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138825635|NCT00970502|Analgesics|analgesics|mesh-ancestor
138825636|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
138825637|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825638|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825639|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138825640|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138825641|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138825642|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138825643|NCT02635893|Cycloserine|cycloserine|mesh-list
138825644|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138825645|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825646|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138825647|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
138825648|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138672611|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
138672612|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672613|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
138672614|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672615|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
138825649|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
138825650|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825651|NCT02567773|Itraconazole|itraconazole|mesh-list
138825652|NCT02567773|GSK2881078|gsk2881078|mesh-list
138825653|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
138825654|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825655|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138825656|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138825657|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825658|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825659|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138825660|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
138825661|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138825662|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825663|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138825664|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
138825665|NCT02567773|Hormones|hormones|mesh-ancestor
138825666|NCT00967226|Prednisolone|prednisolone|mesh-list
138825667|NCT00967226|Propranolol|propranolol|mesh-list
138825668|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
138825669|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138825670|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
138825671|NCT00967226|Hormones|hormones|mesh-ancestor
138825672|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138825673|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825674|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138825675|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825676|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138825677|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138825678|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
138825679|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138825680|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672645|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138672646|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456197|NCT01910545|OTS167|ots167|mesh-list
138825681|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138825682|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138825683|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
138825684|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138825685|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138825686|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138825688|NCT00964886|Desipramine|desipramine|mesh-list
138825689|NCT00964886|Clomipramine|clomipramine|mesh-list
138327174|NCT00226590|Paclitaxel|paclitaxel|mesh-list
138825690|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138825691|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
138825692|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138825693|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825694|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825695|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138825696|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138438554|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825697|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138825698|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
138825699|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138825700|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825701|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138825702|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138825703|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
138825705|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825706|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138825707|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138825708|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
138825709|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138825710|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
138825711|NCT00964886|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138825712|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
138825713|NCT02861222|Doxorubicin|doxorubicin|mesh-list
138825714|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138825715|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825716|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138672686|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
138825717|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138672687|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
138825718|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825719|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825720|NCT04062019|Aldesleukin|aldesleukin|mesh-list
138825721|NCT04062019|Interleukin-2|interleukin-2|mesh-list
138825722|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825723|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138825724|NCT04062019|Analgesics|analgesics|mesh-ancestor
138825725|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
138825726|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825727|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825728|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138825729|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138825730|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
138825731|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825732|NCT04061863|Nivolumab|nivolumab|mesh-list
138825733|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138825734|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825735|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138825736|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825737|NCT02861378|Phentolamine|phentolamine|mesh-list
138825738|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138825739|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138825740|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
138825741|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138825742|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825743|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470508|NCT01988896|Atezolizumab|atezolizumab|mesh-list
138825744|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138825745|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
138825746|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138825747|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138825749|NCT00705757|Travoprost|travoprost|mesh-list
138825750|NCT00705757|Latanoprost|latanoprost|mesh-list
138825751|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138825752|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138825753|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138825754|NCT04284644|Propofol|propofol|mesh-list
138672723|NCT01243827|Protective Agents|protective agents|mesh-ancestor
138672724|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138825755|NCT04284644|Sevoflurane|sevoflurane|mesh-list
138672734|NCT00500409|Vitamin D|vitamin d|mesh-list
138825756|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138825757|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138825758|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825759|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138825760|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
138825761|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
138825762|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138825763|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138825764|NCT05330143|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138825765|NCT05330143|Antiviral Agents|antiviral agents|mesh-ancestor
138825766|NCT05330143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825767|NCT04284722|Metformin|metformin|mesh-list
138825768|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138825769|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825770|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
138825771|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
138825772|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138825773|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138825774|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825775|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825776|NCT04283240|Urological Agents|urological agents|mesh-ancestor
138825777|NCT03588884|Cholecalciferol|cholecalciferol|mesh-list
138825778|NCT03588884|Vitamin D|vitamin d|mesh-list
138825779|NCT03588884|Calcifediol|calcifediol|mesh-list
138825780|NCT03588884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138825781|NCT03588884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825782|NCT03588884|Vitamins|vitamins|mesh-ancestor
138825783|NCT03588884|Micronutrients|micronutrients|mesh-ancestor
138825784|NCT03588884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138825785|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138825786|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138825787|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
138825788|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138825789|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
138825790|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138825791|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825792|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138825793|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138825794|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825795|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
138825796|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
138825797|NCT04283162|Calcium|calcium|mesh-list
138825798|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138825799|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672759|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
138672761|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
138672762|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
138825800|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138825802|NCT04283162|Coagulants|coagulants|mesh-ancestor
138825803|NCT00758524|Eplerenone|eplerenone|mesh-list
138672763|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138825804|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138825805|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
138825806|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138825807|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825808|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138825809|NCT00758524|Diuretics|diuretics|mesh-ancestor
138825810|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
138825811|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138825812|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
138650515|NCT00419718|Insulin|insulin|mesh-list
138825813|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138825814|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
138825815|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138825816|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825817|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138825818|NCT00757588|Insulin|insulin|mesh-list
138477766|NCT02021240|Ketamine|ketamine|mesh-list
138825819|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138825820|NCT00757588|Saxagliptin|saxagliptin|mesh-list
138825821|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138825822|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825823|NCT00757588|Incretins|incretins|mesh-ancestor
138825824|NCT00757588|Hormones|hormones|mesh-ancestor
138825825|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138825826|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138825827|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
138672785|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138825828|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672786|NCT00493389|Hormones|hormones|mesh-list
138672790|NCT01605994|Antacids|antacids|mesh-list
138825829|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825830|NCT00917254|Enoxaparin|enoxaparin|mesh-list
138825831|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
138825832|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138825833|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138825834|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825835|NCT02599792|Ivacaftor|ivacaftor|mesh-list
138825836|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138825837|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138825838|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825839|NCT00705679|Tenofovir|tenofovir|mesh-list
138825840|NCT00705679|Emtricitabine|emtricitabine|mesh-list
138825841|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138825842|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
138825843|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438618|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
138825844|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138825845|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138672832|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
138672833|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138825846|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825847|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825848|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138825849|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138825850|NCT04092868|Protamines|protamines|mesh-list
138825851|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
138825852|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825853|NCT04092868|Coagulants|coagulants|mesh-ancestor
138825854|NCT00916942|Lidocaine|lidocaine|mesh-list
138825855|NCT00916942|Prilocaine|prilocaine|mesh-list
138825856|NCT00916942|Capsaicin|capsaicin|mesh-list
138825857|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
138825858|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
138825859|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138825860|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825861|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
138825862|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825863|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138825864|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138825865|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138825866|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138438649|NCT01768988|Analgesics|analgesics|mesh-ancestor
138825867|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825868|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
138825869|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
138825871|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
138825872|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138825873|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138825874|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825876|NCT00751114|Hormones|hormones|mesh-ancestor
138825877|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138825878|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138825879|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
138825880|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138672885|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138672886|NCT01244100|Analgesics|analgesics|mesh-ancestor
138672887|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
138672888|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138825881|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825882|NCT00960440|Tofacitinib|tofacitinib|mesh-list
138825883|NCT00960440|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138825884|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138825885|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825886|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825887|NCT04092478|Anesthetics|anesthetics|mesh-list
138825888|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138825889|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825890|NCT02598466|Abatacept|abatacept|mesh-list
138825891|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138825892|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825893|NCT02598466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138825894|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825895|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138825896|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
138825897|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825898|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138825899|NCT05973370|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138825900|NCT05973370|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138825901|NCT05973370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138825902|NCT05973318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138672924|NCT00469781|Protective Agents|protective agents|mesh-ancestor
138825903|NCT05973318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138825904|NCT05973305|Dorzolamide|dorzolamide|mesh-list
138825905|NCT05973305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138825906|NCT05973305|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138825907|NCT05973305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825908|NCT05973305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825909|NCT05973253|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138825910|NCT05973253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138825911|NCT05973253|Contraceptive Agents|contraceptive agents|mesh-ancestor
138825912|NCT05973253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138825913|NCT05973253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825914|NCT05973253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138672974|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672975|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
138672976|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
138672977|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138672978|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
138825915|NCT05973253|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138825916|NCT05973253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138825917|NCT05973253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825918|NCT05973188|Warfarin|warfarin|mesh-list
138825919|NCT05973188|Rivaroxaban|rivaroxaban|mesh-list
138825920|NCT05973188|Apixaban|apixaban|mesh-list
138825921|NCT05973188|Anticoagulants|anticoagulants|mesh-ancestor
138825922|NCT05973188|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138825923|NCT05973188|Antithrombins|antithrombins|mesh-ancestor
138825924|NCT05973188|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138825925|NCT05973188|Protease Inhibitors|protease inhibitors|mesh-ancestor
138825926|NCT05973188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825927|NCT05973188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825928|NCT05973071|Contraceptive Agents|contraceptive agents|mesh-list
138825929|NCT05973071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138825930|NCT05973071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673029|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825932|NCT05972967|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138825933|NCT05972967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138825934|NCT05972967|Immunologic Factors|immunologic factors|mesh-ancestor
138825935|NCT05972967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825936|NCT05972928|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138825937|NCT05972928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138825938|NCT05972928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825939|NCT05972928|Incretins|incretins|mesh-ancestor
138825940|NCT05972928|Hormones|hormones|mesh-ancestor
138825941|NCT05972928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138825942|NCT05972928|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138825943|NCT05972928|Protease Inhibitors|protease inhibitors|mesh-ancestor
138825944|NCT05972928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138825945|NCT05972928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673088|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
138825946|NCT05972902|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138825947|NCT05972902|Cetrorelix|cetrorelix|mesh-list
138825948|NCT05972902|Dydrogesterone|dydrogesterone|mesh-list
138825949|NCT05972902|Luteolytic Agents|luteolytic agents|mesh-ancestor
138825950|NCT05972902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138825951|NCT05972902|Contraceptive Agents|contraceptive agents|mesh-ancestor
138825952|NCT05972902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138825953|NCT05972902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825954|NCT05972902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138825955|NCT05972902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138825956|NCT05972902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138825957|NCT05972902|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138825958|NCT05972902|Fertility Agents|fertility agents|mesh-ancestor
138825959|NCT05972902|Hormone Antagonists|hormone antagonists|mesh-ancestor
138825960|NCT05972902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673144|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138825962|NCT05972902|Hormones|hormones|mesh-ancestor
138825963|NCT05972785|Calcium Channel Blockers|calcium channel blockers|mesh-list
138673145|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138825964|NCT05972785|Calcium|calcium|mesh-list
138825965|NCT05972785|Diuretics|diuretics|mesh-list
138825966|NCT05972785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138825967|NCT05972785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138825968|NCT05972785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825969|NCT05972785|Natriuretic Agents|natriuretic agents|mesh-ancestor
138825971|NCT05972785|Adrenergic Agents|adrenergic agents|mesh-ancestor
138825972|NCT05972785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138825973|NCT05972785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138825974|NCT05972785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138825975|NCT05972603|Vancomycin|vancomycin|mesh-list
138825976|NCT05972603|Povidone-Iodine|povidone-iodine|mesh-list
138825977|NCT05972603|Povidone|povidone|mesh-list
138825978|NCT05972603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138825979|NCT05972603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825980|NCT05972603|Plasma Substitutes|plasma substitutes|mesh-ancestor
138825981|NCT05972603|Blood Substitutes|blood substitutes|mesh-ancestor
138825982|NCT05972603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138825983|NCT05972434|Sunscreening Agents|sunscreening agents|mesh-list
138825984|NCT05972434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138825985|NCT05972434|Protective Agents|protective agents|mesh-ancestor
138825986|NCT05972434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825987|NCT05972434|Dermatologic Agents|dermatologic agents|mesh-ancestor
138825988|NCT05971680|Vitamins|vitamins|mesh-list
138825989|NCT05971680|Thiamine|thiamine|mesh-list
138825990|NCT05971680|Vitamin B Complex|vitamin b complex|mesh-list
138673200|NCT00501579|Difluprednate|difluprednate|mesh-list
138825991|NCT05971680|Contraceptive Agents|contraceptive agents|mesh-list
138825992|NCT05971680|Micronutrients|micronutrients|mesh-ancestor
138673201|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138673202|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
138825993|NCT05971680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138825994|NCT05971680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138825995|NCT05971654|Azithromycin|azithromycin|mesh-list
138825996|NCT05971654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138825997|NCT05971654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138825998|NCT05971563|Caseins|caseins|mesh-list
138825999|NCT05971563|Chelating Agents|chelating agents|mesh-ancestor
138826000|NCT05971563|Sequestering Agents|sequestering agents|mesh-ancestor
138826001|NCT05971563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826002|NCT05971550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138826003|NCT05971550|Ceftriaxone|ceftriaxone|mesh-list
138826004|NCT05971550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826005|NCT05971537|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138826006|NCT05971537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138826007|NCT05971537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826008|NCT05971537|Antitubercular Agents|antitubercular agents|mesh-ancestor
138826009|NCT05971394|Sirolimus|sirolimus|mesh-list
138826010|NCT05971394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138826011|NCT05971394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826012|NCT05971394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138826013|NCT05971394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826014|NCT05971394|Antifungal Agents|antifungal agents|mesh-ancestor
138826015|NCT05971394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138826016|NCT05971394|Immunologic Factors|immunologic factors|mesh-ancestor
138826017|NCT05971394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826018|NCT05971355|Emollients|emollients|mesh-list
138826019|NCT05971355|Dermatologic Agents|dermatologic agents|mesh-ancestor
138826020|NCT05971186|Ibuprofen|ibuprofen|mesh-list
138826021|NCT05971186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138826022|NCT05971186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138673245|NCT00600691|Urological Agents|urological agents|mesh-ancestor
138826023|NCT05971186|Analgesics|analgesics|mesh-ancestor
138826024|NCT05971186|Sensory System Agents|sensory system agents|mesh-ancestor
138826025|NCT05971186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138826026|NCT05971186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826027|NCT05971186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138826028|NCT05971186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138826029|NCT05971186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138826030|NCT05971186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826031|NCT05971186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826032|NCT05971004|Methylprednisolone|methylprednisolone|mesh-list
138826033|NCT05971004|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138826034|NCT05971004|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138826035|NCT05971004|Prednisolone|prednisolone|mesh-list
138826036|NCT05971004|Prednisolone acetate|prednisolone acetate|mesh-list
138826037|NCT05971004|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138826038|NCT05971004|Prednisolone phosphate|prednisolone phosphate|mesh-list
138826039|NCT05971004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138826040|NCT05971004|Antiemetics|antiemetics|mesh-ancestor
138826041|NCT05971004|Autonomic Agents|autonomic agents|mesh-ancestor
138826042|NCT05971004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138826043|NCT05971004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826044|NCT05971004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138826045|NCT05971004|Glucocorticoids|glucocorticoids|mesh-ancestor
138826047|NCT05971004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138826048|NCT05971004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138826049|NCT05971004|Protective Agents|protective agents|mesh-ancestor
138826050|NCT05971004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138826051|NCT05971004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826053|NCT05930808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138826054|NCT05930808|Sympatholytics|sympatholytics|mesh-ancestor
138826055|NCT05930808|Autonomic Agents|autonomic agents|mesh-ancestor
138826056|NCT05930808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138826057|NCT05930808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673285|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
138826058|NCT05930808|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138470580|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
138826059|NCT05930808|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138826060|NCT05930808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138826061|NCT05930808|Adrenergic Agents|adrenergic agents|mesh-ancestor
138826062|NCT05930808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826063|NCT05930808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826065|NCT05924256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138826066|NCT05924256|Fertility Agents|fertility agents|mesh-ancestor
138826067|NCT05924256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138826068|NCT05924256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826069|NCT05924256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138826070|NCT05924256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826072|NCT05916352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138208138|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
138673335|NCT00501657|Incretins|incretins|mesh-ancestor
138826073|NCT05916352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826074|NCT05916352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138826075|NCT05916352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826076|NCT05916352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826077|NCT05916352|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138826078|NCT05916352|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138826079|NCT05916352|Purinergic Agents|purinergic agents|mesh-ancestor
138826080|NCT05916352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826081|NCT05813964|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138826082|NCT05813964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138826083|NCT05813964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138826084|NCT05813964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138826085|NCT05813964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826086|NCT05813964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826087|NCT05813964|Antiviral Agents|antiviral agents|mesh-ancestor
138826088|NCT05813964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826089|NCT05813964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138826090|NCT05813964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138826091|NCT05739006|Pembrolizumab|pembrolizumab|mesh-list
138826092|NCT05739006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826093|NCT05739006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826094|NCT05739006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138826095|NCT05739006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826096|NCT05700630|Vorinostat|vorinostat|mesh-list
138826097|NCT05700630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826098|NCT05700630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138826099|NCT05700630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826100|NCT05700630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826101|NCT05695027|Niacinamide|niacinamide|mesh-list
138826102|NCT05695027|Niacin|niacin|mesh-list
138826103|NCT05695027|Nicotinic Acids|nicotinic acids|mesh-list
138826104|NCT05695027|Vitamin B Complex|vitamin b complex|mesh-ancestor
138826105|NCT05695027|Vitamins|vitamins|mesh-ancestor
138673386|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138673387|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138673388|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
138826106|NCT05695027|Micronutrients|micronutrients|mesh-ancestor
138826107|NCT05695027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826108|NCT05695027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138826109|NCT05695027|Antimetabolites|antimetabolites|mesh-ancestor
138826110|NCT05695027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826111|NCT05695027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138826112|NCT05695027|Vasodilator Agents|vasodilator agents|mesh-ancestor
138826113|NCT05631795|Fulvestrant|fulvestrant|mesh-list
138826114|NCT05631795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138826115|NCT05631795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826116|NCT05631795|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138826117|NCT05631795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138826118|NCT05631795|Hormone Antagonists|hormone antagonists|mesh-ancestor
138826119|NCT05631795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138826121|NCT05597462|Minocycline|minocycline|mesh-list
138826122|NCT05597462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138826123|NCT05597462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826124|NCT05484687|Anesthetics|anesthetics|mesh-list
138826125|NCT05484687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138826126|NCT05484687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826127|NCT05480384|Nivolumab|nivolumab|mesh-list
138826129|NCT05480384|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138826130|NCT05480384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826131|NCT05480384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826132|NCT05480384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138826133|NCT05480384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826134|NCT05480384|Immunoconjugates|immunoconjugates|mesh-ancestor
138673421|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138673422|NCT00601510|Capecitabine|capecitabine|mesh-list
138350202|NCT06084507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138826135|NCT05480384|Immunologic Factors|immunologic factors|mesh-ancestor
138673423|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
138673424|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826136|NCT05480384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826137|NCT05469412|Midazolam|midazolam|mesh-list
138826138|NCT05469412|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138826139|NCT05469412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138826140|NCT05469412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138826141|NCT05469412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826142|NCT05469412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138826143|NCT05469412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138826144|NCT05469412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138826145|NCT05469412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138826146|NCT05469412|Anesthetics, General|anesthetics, general|mesh-ancestor
138826147|NCT05469412|Anesthetics|anesthetics|mesh-ancestor
138826148|NCT05469412|GABA Modulators|gaba modulators|mesh-ancestor
138826149|NCT05469412|GABA Agents|gaba agents|mesh-ancestor
138826150|NCT05469412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826151|NCT05469412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826152|NCT05343455|Doxycycline|doxycycline|mesh-list
138826153|NCT05343455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138826154|NCT05343455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826155|NCT05343455|Antimalarials|antimalarials|mesh-ancestor
138826156|NCT05343455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138826157|NCT05343455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138826158|NCT05327686|Pembrolizumab|pembrolizumab|mesh-list
138826160|NCT05327686|Ipilimumab|ipilimumab|mesh-list
138826161|NCT05327686|Avelumab|avelumab|mesh-list
138826162|NCT05327686|Lenvatinib|lenvatinib|mesh-list
138826163|NCT05327686|Axitinib|axitinib|mesh-list
138826164|NCT05327686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138673461|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826165|NCT05327686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138673462|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673463|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
138826166|NCT05327686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826167|NCT05327686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138826168|NCT05327686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826169|NCT05327686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138673464|NCT00470405|Pemetrexed|pemetrexed|mesh-list
138826170|NCT05327686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650604|NCT00303836|Analgesics|analgesics|mesh-ancestor
138826172|NCT05327686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826173|NCT05303324|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138826174|NCT05303324|Choline|choline|mesh-list
138826175|NCT05303324|Lipotropic Agents|lipotropic agents|mesh-ancestor
138826176|NCT05303324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138826177|NCT05303324|Antimetabolites|antimetabolites|mesh-ancestor
138438957|NCT01770444|Cytarabine|cytarabine|mesh-list
138826178|NCT05303324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826179|NCT05303324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138826180|NCT05303324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138826181|NCT05303324|Nootropic Agents|nootropic agents|mesh-ancestor
138826182|NCT05303324|Chelating Agents|chelating agents|mesh-ancestor
138826183|NCT05303324|Sequestering Agents|sequestering agents|mesh-ancestor
138826184|NCT05303324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826185|NCT05303324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138826186|NCT05303324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138826187|NCT05303324|Growth Substances|growth substances|mesh-ancestor
138826188|NCT05303324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826189|NCT05303324|Growth Inhibitors|growth inhibitors|mesh-ancestor
138826190|NCT05303324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826192|NCT05238207|Cathartics|cathartics|mesh-ancestor
138826193|NCT05238207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138826194|NCT05213104|Flecainide|flecainide|mesh-list
138826195|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138826196|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138826197|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138826198|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138826199|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826200|NCT05195177|Anesthetics|anesthetics|mesh-list
138826201|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
138826202|NCT05195177|Histamine|histamine|mesh-list
138826203|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
138826204|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138826205|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138826206|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826207|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
138826208|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138826209|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
138826210|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
138673500|NCT00470483|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138826211|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826212|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826213|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
138826214|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826215|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826216|NCT05165433|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138826217|NCT05165433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826218|NCT05150431|Parecoxib|parecoxib|mesh-list
138826219|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138826220|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138826221|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826222|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826223|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138826224|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138826225|NCT05150431|Analgesics|analgesics|mesh-ancestor
138826226|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
138826227|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138826228|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826229|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138438995|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
138438996|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138826230|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138826231|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
138826232|NCT05077527|Fludarabine|fludarabine|mesh-list
138826233|NCT05077527|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138826234|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138826235|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
138826236|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826237|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138826238|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138673533|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826239|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
138826240|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826241|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826242|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138826243|NCT05077527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826244|NCT05013502|Empagliflozin|empagliflozin|mesh-list
138826245|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138826246|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826247|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138826248|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826250|NCT05007392|Dotinurad|dotinurad|mesh-list
138826251|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
138826252|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138470610|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138826253|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
138826254|NCT04909853|Ritonavir|ritonavir|mesh-list
138826255|NCT04909853|Nirmatrelvir|nirmatrelvir|mesh-list
138826256|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138826257|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138826258|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
138826259|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826260|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826261|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138826262|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138826263|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
138826264|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826265|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138826266|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138826267|NCT04733534|Dasatinib|dasatinib|mesh-list
138478232|NCT02024022|Cathartics|cathartics|mesh-ancestor
138826269|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673576|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673577|NCT00470561|Aspirin|aspirin|mesh-list
138673578|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138826270|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138673579|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138826271|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826272|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826273|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
138826274|NCT04733534|Protective Agents|protective agents|mesh-ancestor
138826275|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826276|NCT04727307|Bevacizumab|bevacizumab|mesh-list
138826277|NCT04727307|Atezolizumab|atezolizumab|mesh-list
138826278|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138826279|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826280|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826281|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138826282|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138826283|NCT04727307|Growth Substances|growth substances|mesh-ancestor
138826284|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826285|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
138826286|NCT04727307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138826287|NCT04727307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826288|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
138826289|NCT04683939|Paclitaxel|paclitaxel|mesh-list
138826290|NCT04683939|Gemcitabine|gemcitabine|mesh-list
138826291|NCT04683939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138826292|NCT04683939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826293|NCT04683939|Tubulin Modulators|tubulin modulators|mesh-ancestor
138826294|NCT04683939|Antimitotic Agents|antimitotic agents|mesh-ancestor
138826295|NCT04683939|Mitosis Modulators|mitosis modulators|mesh-ancestor
138826296|NCT04683939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826297|NCT04683939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138826299|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
138826300|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826301|NCT04669002|Olaparib|olaparib|mesh-list
138826302|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138826303|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826304|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826305|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826306|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
138826307|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138826308|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826309|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138826310|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673615|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
138673616|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673617|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
138826311|NCT04528173|Ketorolac|ketorolac|mesh-list
138826312|NCT04528173|Fentanyl|fentanyl|mesh-list
138673618|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138826313|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
138826314|NCT04528173|Morphine|morphine|mesh-list
138826315|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138826316|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138826317|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826318|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138826319|NCT04528173|Analgesics|analgesics|mesh-ancestor
138826320|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
138826321|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439049|NCT01771185|Metformin|metformin|mesh-list
138826322|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138826323|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138826325|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
138826326|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826327|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826328|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138826329|NCT04528173|Narcotics|narcotics|mesh-ancestor
138826330|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138826331|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138826332|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
138826333|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
138826334|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138826335|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138826336|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138826337|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138826338|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826339|NCT04519944|Edoxaban|edoxaban|mesh-list
138478295|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138826340|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138826341|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
138826342|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138826343|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
138826344|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826345|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650650|NCT00332397|Sirolimus|sirolimus|mesh-list
138673644|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
138673645|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
138826347|NCT04430452|Durvalumab|durvalumab|mesh-list
138673647|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138826348|NCT04430452|Ipilimumab|ipilimumab|mesh-list
138826349|NCT04430452|Tremelimumab|tremelimumab|mesh-list
138826350|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
138826351|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138826352|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
138826353|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826354|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826355|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
138826356|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826357|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138826358|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826359|NCT04353661|Azithromycin|azithromycin|mesh-list
138826360|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138826361|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826362|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
138826363|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138826364|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
138826365|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826366|NCT04154982|Expectorants|expectorants|mesh-ancestor
138826367|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
138826368|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138826369|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
138439070|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
138826370|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470639|NCT01989884|IDN 5109|idn 5109|mesh-list
138826372|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826373|NCT04154982|Antidotes|antidotes|mesh-ancestor
138826374|NCT04113616|Cytarabine|cytarabine|mesh-list
138826375|NCT04113616|Decitabine|decitabine|mesh-list
138826376|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138826377|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
138826378|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826379|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826380|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
138826381|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826382|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138826383|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
138826384|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826385|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826387|NCT04040231|Sargramostim|sargramostim|mesh-list
138826388|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826389|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826390|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138826391|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826392|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
138826393|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673679|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826394|NCT04026256|Denosumab|denosumab|mesh-list
138826395|NCT04026256|Teriparatide|teriparatide|mesh-list
138826396|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138826397|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826398|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138826399|NCT03928288|Cabergoline|cabergoline|mesh-list
138826400|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138826401|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138826402|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
138826403|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
138826404|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826405|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826406|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826407|NCT03789604|Antibodies|antibodies|mesh-list
138826409|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
138826410|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826411|NCT03767348|Nivolumab|nivolumab|mesh-list
138826412|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826413|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826414|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138826415|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826416|NCT03735420|Xanthohumol|xanthohumol|mesh-list
138826417|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673708|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138826418|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138826419|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138826420|NCT03735420|Growth Substances|growth substances|mesh-ancestor
138826421|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826422|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
138826423|NCT03662074|Gemcitabine|gemcitabine|mesh-list
138826424|NCT03662074|Nivolumab|nivolumab|mesh-list
138826425|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138826426|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
138826427|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826428|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826429|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826430|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138826432|NCT03602859|Dostarlimab|dostarlimab|mesh-list
138826433|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138826434|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826435|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826436|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826437|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138826438|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138826439|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
138826448|NCT03519230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826449|NCT03519230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826458|NCT03402503|Montelukast|montelukast|mesh-list
138826459|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138826460|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
138826461|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138826462|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
138673762|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138673763|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
138673764|NCT01324999|Tadalafil|tadalafil|mesh-list
138673771|NCT01324570|Buprenorphine|buprenorphine|mesh-list
138826463|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138826464|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826465|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138826466|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138826467|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826468|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138826469|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
138826470|NCT03389412|Coagulants|coagulants|mesh-ancestor
138826471|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138826472|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
138826473|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826474|NCT03327805|Choline|choline|mesh-list
138826475|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
138826476|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138826477|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
138826478|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826479|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138826480|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138826481|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
138826482|NCT03260023|Avelumab|avelumab|mesh-list
138826483|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826484|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826485|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
138826486|NCT03220477|Guadecitabine|guadecitabine|mesh-list
138826487|NCT03220477|Mocetinostat|mocetinostat|mesh-list
138826488|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138650742|NCT00304655|Aripiprazole|aripiprazole|mesh-list
138826489|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826490|NCT03220477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138826491|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826492|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138826493|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826495|NCT03095612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826496|NCT03095612|Tubulin Modulators|tubulin modulators|mesh-ancestor
138673806|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138673807|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
138673808|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138826497|NCT03095612|Antimitotic Agents|antimitotic agents|mesh-ancestor
138826498|NCT03095612|Mitosis Modulators|mitosis modulators|mesh-ancestor
138826499|NCT03095612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826500|NCT03028350|Ifetroban|ifetroban|mesh-list
138826501|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138826502|NCT02918370|Aripiprazole|aripiprazole|mesh-list
138826503|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
138826504|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138826505|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138826506|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138826507|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138826508|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826509|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
138826510|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
138826511|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826512|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826513|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138826514|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138826515|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
138826516|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138826517|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138826518|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138826519|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138826521|NCT02914405|Dinutuximab|dinutuximab|mesh-list
138826522|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
138826523|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
138826524|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826525|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826526|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138826527|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826528|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
138826529|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673844|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138673845|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826530|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
138826531|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138826532|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138826533|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826534|NCT02723955|Paclitaxel|paclitaxel|mesh-list
138826535|NCT02723955|Docetaxel|docetaxel|mesh-list
138826536|NCT02723955|Carboplatin|carboplatin|mesh-list
138826537|NCT02723955|Gemcitabine|gemcitabine|mesh-list
138826538|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
138826539|NCT02723955|Fluorouracil|fluorouracil|mesh-list
138826540|NCT02723955|Pemetrexed|pemetrexed|mesh-list
138826541|NCT02723955|Dostarlimab|dostarlimab|mesh-list
138826542|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138826543|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826544|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
138826545|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
138826546|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
138650745|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138826547|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826548|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138826549|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
138826550|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826551|NCT02723955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138826552|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138826553|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
138826554|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826555|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826556|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138826557|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138826559|NCT02632175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138826560|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138826561|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138826562|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
138826563|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
138673884|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138673885|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138826564|NCT02566304|Fludarabine|fludarabine|mesh-list
138826565|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
138673886|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
138826566|NCT02566304|Tacrolimus|tacrolimus|mesh-list
138826567|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138826568|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
138826569|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826570|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138826571|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138470669|NCT01990079|Bupropion|bupropion|mesh-list
138826572|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
138439183|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138826573|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826574|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826575|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138826576|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138826577|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
138826578|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826579|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138826580|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826581|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138826582|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138826583|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
138826584|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138826585|NCT02358031|Carboplatin|carboplatin|mesh-list
138826586|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
138826588|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138673922|NCT00472004|Estrogens|estrogens|mesh-ancestor
138673923|NCT00472004|Hormones|hormones|mesh-ancestor
138673924|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138826589|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826590|NCT02358031|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138826591|NCT02358031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826592|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
138826593|NCT01946529|Temozolomide|temozolomide|mesh-list
138826595|NCT01946529|Bevacizumab|bevacizumab|mesh-list
138826596|NCT01946529|Doxorubicin|doxorubicin|mesh-list
138826597|NCT01946529|Etoposide|etoposide|mesh-list
138826598|NCT01946529|Vincristine|vincristine|mesh-list
138826599|NCT01946529|Sorafenib|sorafenib|mesh-list
138826600|NCT01946529|Temsirolimus|temsirolimus|mesh-list
138826601|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138826602|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
138826603|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826604|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138826605|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138826606|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
138826607|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826608|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826609|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138826610|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826611|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138826612|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138826613|NCT01946529|Growth Substances|growth substances|mesh-ancestor
138826614|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
138826615|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138826616|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138826617|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138826618|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826619|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138826620|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
138826621|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
138826622|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
138826623|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138826624|NCT01946529|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138826625|NCT00878254|Leucovorin|leucovorin|mesh-list
138673971|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138457434|NCT01918150|Cobalt|cobalt|mesh-list
138673973|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
138826626|NCT00878254|Cytarabine|cytarabine|mesh-list
138826627|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
138826628|NCT00878254|Ifosfamide|ifosfamide|mesh-list
138826629|NCT00878254|Rituximab|rituximab|mesh-list
138826630|NCT00878254|Doxorubicin|doxorubicin|mesh-list
138826631|NCT00878254|Methotrexate|methotrexate|mesh-list
138826632|NCT00878254|Etoposide|etoposide|mesh-list
138826633|NCT00878254|Vincristine|vincristine|mesh-list
138439210|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
138826634|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138826636|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826637|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138826638|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138826639|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
138826640|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826641|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826642|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138826643|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826644|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138826645|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138826646|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138826647|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826648|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138826649|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
138826650|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138826651|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138826652|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
138826653|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
138826654|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138826655|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138674009|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
138674010|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
138350814|NCT04013542|Nivolumab|nivolumab|mesh-list
138826656|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138826657|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
138826658|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826659|NCT00878254|Antidotes|antidotes|mesh-ancestor
138826660|NCT00878254|Protective Agents|protective agents|mesh-ancestor
138826661|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
138826662|NCT00878254|Vitamins|vitamins|mesh-ancestor
138826663|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
138826664|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
138826665|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
138826666|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
138826667|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
138826668|NCT00813423|Sunitinib|sunitinib|mesh-list
138826669|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826670|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138826671|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138826672|NCT00813423|Growth Substances|growth substances|mesh-ancestor
138826673|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826674|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
138826675|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138826676|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674051|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674052|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674053|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138674054|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
138826677|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826678|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
138826679|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138826680|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138826681|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826682|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138826683|NCT00146562|Paclitaxel|paclitaxel|mesh-list
138826684|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
138826685|NCT00146562|Doxorubicin|doxorubicin|mesh-list
138826686|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
138826687|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138826688|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826689|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
138826690|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
138826691|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
138826692|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826693|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138826694|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
138470686|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
138826695|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826696|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138826697|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138826698|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
138826699|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138826700|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138826701|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138826702|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138826703|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826704|NCT00146562|Hematinics|hematinics|mesh-ancestor
138826705|NCT04089592|Fentanyl|fentanyl|mesh-list
138826706|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
138826707|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138826708|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138826709|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826710|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138826711|NCT04089592|Analgesics|analgesics|mesh-ancestor
138826712|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
138826713|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138826714|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138826715|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138826716|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138826717|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
138826718|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826719|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826720|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138826721|NCT04089592|Narcotics|narcotics|mesh-ancestor
138826722|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138674102|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674104|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674105|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138826723|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138674106|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
138674107|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
138674108|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826724|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
138826725|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
138826726|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
138826727|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826728|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138826729|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826730|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826731|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138826732|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138826733|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138826734|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138439249|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138826735|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826736|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826737|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826738|NCT00961298|Analgesics|analgesics|mesh-ancestor
138826739|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
138826740|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138826741|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
138826742|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138826743|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
138826744|NCT00744328|Sertraline|sertraline|mesh-list
138826745|NCT00744328|Estradiol|estradiol|mesh-list
138826746|NCT00744328|Estrogens|estrogens|mesh-ancestor
138826747|NCT00744328|Hormones|hormones|mesh-ancestor
138826748|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138826749|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826750|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
138826751|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138674123|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138674124|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674125|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138417196|NCT01670812|Rituximab|rituximab|mesh-list
138674126|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826752|NCT00744328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138826753|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138826754|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138826755|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826756|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826757|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
138826759|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
138826760|NCT04019782|Protective Agents|protective agents|mesh-ancestor
138826761|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826762|NCT02599480|Mirabegron|mirabegron|mesh-list
138826763|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138826764|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138826765|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138826766|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
138826767|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826768|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826769|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826770|NCT02599480|Urological Agents|urological agents|mesh-ancestor
138826771|NCT03245840|Budesonide|budesonide|mesh-list
138826772|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138826773|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138826774|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
138826775|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138826776|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826777|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138826778|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
138826779|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
138826780|NCT03245840|Hormones|hormones|mesh-ancestor
138674165|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
138674166|NCT01244334|Difluprednate|difluprednate|mesh-list
138674167|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138826781|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138826782|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
138826783|NCT04091698|Ubiquinone|ubiquinone|mesh-list
138826784|NCT04091698|Vitamins|vitamins|mesh-ancestor
138826785|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
138826786|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826787|NCT04281290|Bleomycin|bleomycin|mesh-list
138826788|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138826789|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826790|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
138826791|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138650812|NCT00304811|Vancomycin|vancomycin|mesh-list
138826792|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826793|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826794|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826795|NCT00959894|Tenofovir|tenofovir|mesh-list
138826796|NCT00959894|Emtricitabine|emtricitabine|mesh-list
138826797|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138826799|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
138826800|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826801|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138826802|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138826803|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826804|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826805|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138826806|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138826807|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
138826808|NCT02599168|Propofol|propofol|mesh-list
138826809|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138826810|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138826811|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826812|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138674204|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138826813|NCT02599168|Analgesics|analgesics|mesh-ancestor
138826814|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
138826815|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138826816|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138826817|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138826818|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138826819|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
138826820|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826821|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826822|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138826823|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
138826824|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
138826826|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826827|NCT01032629|Canagliflozin|canagliflozin|mesh-list
138826828|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138826829|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826830|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138826831|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826832|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138826833|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138826834|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138826835|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138826836|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138826837|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
138826838|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439291|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
138826839|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826840|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826841|NCT00749944|Varenicline|varenicline|mesh-list
138826842|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138826843|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138826844|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
138826845|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826846|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826847|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826848|NCT02597140|Lidocaine|lidocaine|mesh-list
138826849|NCT02597140|Propofol|propofol|mesh-list
138674251|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138674252|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138826850|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
138826851|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
138826852|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138826853|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826854|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
138826855|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138826856|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138826857|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138826858|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138826859|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138826860|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826861|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138826862|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138826863|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
138826864|NCT02598310|Paclitaxel|paclitaxel|mesh-list
138826865|NCT02598310|Trastuzumab|trastuzumab|mesh-list
138826866|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138826867|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826868|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
138826869|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
138826870|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
138826871|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826872|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138674287|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
138674288|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138674289|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674290|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138674291|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
138826873|NCT04091074|Clopidogrel|clopidogrel|mesh-list
138826874|NCT04091074|Ticagrelor|ticagrelor|mesh-list
138674292|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
138674293|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
138826875|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138826876|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138826877|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138826878|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138826879|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
138826880|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138826881|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826882|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826883|NCT00749398|Infliximab|infliximab|mesh-list
138439314|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138826884|NCT00749398|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138826886|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
138826887|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138826888|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138826890|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138826891|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138826892|NCT01012973|Growth Substances|growth substances|mesh-ancestor
138826893|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826894|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
138826895|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826896|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
138826897|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
138826898|NCT03974464|Coagulants|coagulants|mesh-ancestor
138826899|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138826900|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138826901|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
138826902|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826903|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
138826904|NCT00742924|Leucovorin|leucovorin|mesh-list
138826905|NCT00742924|Cisplatin|cisplatin|mesh-list
138826906|NCT00742924|Doxorubicin|doxorubicin|mesh-list
138826907|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138826909|NCT00742924|Etoposide|etoposide|mesh-list
138826910|NCT00742924|Ifosfamide|ifosfamide|mesh-list
138826911|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
138826912|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
138826913|NCT00742924|Razoxane|razoxane|mesh-list
138826914|NCT00742924|Imidazole|imidazole|mesh-list
138826915|NCT00742924|Lenograstim|lenograstim|mesh-list
138826916|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
138674329|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674331|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
138826917|NCT00742924|Mesna|mesna|mesh-list
138826918|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826919|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138826920|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138826921|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138826922|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826923|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826924|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826925|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138826926|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
138826927|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138826928|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138826929|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
138826930|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
138826931|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138826932|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138826933|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
138826934|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138826935|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138826936|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138826937|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138826938|NCT00742924|Antidotes|antidotes|mesh-ancestor
138826939|NCT00742924|Protective Agents|protective agents|mesh-ancestor
138826940|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
138478892|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826941|NCT00742924|Vitamins|vitamins|mesh-ancestor
138826942|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
138826943|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138826944|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
138826945|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138674364|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138826946|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138826947|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
138826948|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
138826949|NCT02596984|Caspofungin|caspofungin|mesh-list
138826950|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
138826951|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826952|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826953|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826954|NCT00698815|Pemetrexed|pemetrexed|mesh-list
138826955|NCT00698815|Sunitinib|sunitinib|mesh-list
138826956|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826957|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826958|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826959|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138826960|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138826961|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138826962|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138826963|NCT00698815|Growth Substances|growth substances|mesh-ancestor
138826964|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826965|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
138826966|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138826967|NCT02599090|Temozolomide|temozolomide|mesh-list
138826968|NCT02599090|Sorafenib|sorafenib|mesh-list
138826969|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138826970|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
138338910|NCT01263132|Vitamins|vitamins|mesh-ancestor
138826971|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826972|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826973|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138826974|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138826975|NCT00745498|Bevacizumab|bevacizumab|mesh-list
138826976|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138826977|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138826978|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138826979|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138826980|NCT00745498|Growth Substances|growth substances|mesh-ancestor
138826981|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138826982|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
138826983|NCT02596828|Sirolimus|sirolimus|mesh-list
138826984|NCT02596828|Irinotecan|irinotecan|mesh-list
138826985|NCT02596828|Temozolomide|temozolomide|mesh-list
138826986|NCT02596828|Dasatinib|dasatinib|mesh-list
138826987|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138826988|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138674411|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826989|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674412|NCT00472823|Vitamin D|vitamin d|mesh-list
138674413|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
138826990|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138826991|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138674414|NCT00472823|Calcium|calcium|mesh-list
138674415|NCT00472823|Vitamins|vitamins|mesh-ancestor
138826992|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138826993|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
138826994|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138826995|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138826996|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138826997|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
138826998|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138826999|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
138827000|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827001|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138827002|NCT03896815|INCB054329|incb054329|mesh-list
138827003|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827004|NCT02598856|Naloxone|naloxone|mesh-list
138827005|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138827006|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827007|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
138827008|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827009|NCT02597998|BI 409306|bi 409306|mesh-list
138827010|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138827011|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827012|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827013|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
138827014|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138827015|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827016|NCT00576901|Bevacizumab|bevacizumab|mesh-list
138827017|NCT00576901|Docetaxel|docetaxel|mesh-list
138827018|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138827019|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827020|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138827021|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138827022|NCT00576901|Growth Substances|growth substances|mesh-ancestor
138827023|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827024|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
138827025|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
138674436|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827026|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
138650866|NCT00305201|Pravastatin|pravastatin|mesh-list
138827027|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
138827028|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827029|NCT00699283|Brivaracetam|brivaracetam|mesh-list
138827030|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
138827031|NCT04062721|Immunomodulating Agents|immunomodulating agents|mesh-list
138827032|NCT04062721|Immunologic Factors|immunologic factors|mesh-ancestor
138827033|NCT04062721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827034|NCT01023815|Cyclosporine|cyclosporine|mesh-list
138827035|NCT01023815|Everolimus|everolimus|mesh-list
138827036|NCT01023815|Cyclosporins|cyclosporins|mesh-list
138827037|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827038|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827039|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138674478|NCT05645029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138827040|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
138827041|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674479|NCT05645029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138674480|NCT05645029|Disinfectants|disinfectants|mesh-ancestor
138460118|NCT04265274|Copper|copper|mesh-list
138827042|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
138827043|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827044|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
138827045|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138827046|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138827047|NCT01023815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138827048|NCT01023815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138827049|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827051|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827052|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
138827053|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
138827054|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
138827055|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827056|NCT01023659|Bupropion|bupropion|mesh-list
138827057|NCT01023659|Varenicline|varenicline|mesh-list
138827058|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138827059|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
138827060|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138827061|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138827062|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138827063|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138827064|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827065|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
138827066|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827067|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138460269|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
138827068|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138827069|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138827070|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827071|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138827072|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138827073|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
138827074|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
138827075|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138827076|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138827077|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827078|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
138827079|NCT00740116|Coagulants|coagulants|mesh-ancestor
138827080|NCT02567461|Aspirin|aspirin|mesh-list
138827081|NCT02567461|Edoxaban|edoxaban|mesh-list
138827082|NCT02567461|Clopidogrel|clopidogrel|mesh-list
138827083|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138827084|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138827085|NCT02567461|Analgesics|analgesics|mesh-ancestor
138827086|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
138827087|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827088|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827089|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138827090|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138827091|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138827092|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138827093|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674575|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138827094|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138827095|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138479038|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827096|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827097|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
138439558|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138827098|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138827099|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138827100|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138827101|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
138827102|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827103|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138827104|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
138827105|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138827106|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
138827107|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
138827108|NCT00698581|Brivaracetam|brivaracetam|mesh-list
138827109|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
138827110|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
138827111|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
138827112|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138827113|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138827114|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827115|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827116|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827117|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138674620|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138827118|NCT01023581|Metformin|metformin|mesh-list
138827119|NCT01023581|Alogliptin|alogliptin|mesh-list
138827120|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138827121|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827122|NCT01023581|Incretins|incretins|mesh-ancestor
138827123|NCT01023581|Hormones|hormones|mesh-ancestor
138827124|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138827125|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138827126|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
138827127|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827128|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827129|NCT05571787|Rabeprazole|rabeprazole|mesh-list
138827130|NCT05571787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138827131|NCT05571787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138827132|NCT05571787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138827133|NCT05571787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439583|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827134|NCT05571787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827136|NCT04063189|Dexamethasone|dexamethasone|mesh-list
138827137|NCT04063189|Lenalidomide|lenalidomide|mesh-list
138827138|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138827139|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
138827140|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
138827141|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827142|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827143|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138827144|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
138827145|NCT04063189|Hormones|hormones|mesh-ancestor
138827146|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138827147|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138827148|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827149|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
138827150|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138674669|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
138674670|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138674681|NCT04697537|Ropivacaine|ropivacaine|mesh-list
138827151|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138827152|NCT04063189|Growth Substances|growth substances|mesh-ancestor
138827153|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
138827154|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138827155|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827156|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138827157|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827158|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827159|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138827160|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138827161|NCT02567929|Propofol|propofol|mesh-list
138827162|NCT02567929|Sevoflurane|sevoflurane|mesh-list
138827163|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138827164|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138827165|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827166|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138827167|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
138827168|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
138827169|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138827170|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138827171|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138827173|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138827174|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138827175|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827176|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138827177|NCT00962780|Vaccines|vaccines|mesh-list
138827178|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138827179|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
138827180|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827181|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138827182|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138827183|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827184|NCT02567851|Immunotoxins|immunotoxins|mesh-ancestor
138827185|NCT02567851|Immunoconjugates|immunoconjugates|mesh-ancestor
138827186|NCT02567851|Immunologic Factors|immunologic factors|mesh-ancestor
138827187|NCT02567851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827188|NCT00739882|Antibodies|antibodies|mesh-list
138827189|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138827190|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
138827191|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827192|NCT00961220|Carmustine|carmustine|mesh-list
138827193|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138827194|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138827195|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
138827196|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827197|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827198|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827199|NCT00734656|Ethanol|ethanol|mesh-list
138827200|NCT00734656|Dutasteride|dutasteride|mesh-list
138827201|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138827202|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827203|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138827204|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827205|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138827206|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138827207|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827208|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827209|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
138827210|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138674755|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827212|NCT04644289|Olaparib|olaparib|mesh-list
138674756|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674757|NCT00504933|Cetirizine|cetirizine|mesh-list
138674777|NCT01313221|Etanercept|etanercept|mesh-list
138827213|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138827214|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827215|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138827216|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827217|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827218|NCT02565979|Resveratrol|resveratrol|mesh-list
138827219|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
138827220|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827221|NCT02565979|Protective Agents|protective agents|mesh-ancestor
138827222|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827223|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827224|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138827225|NCT04062175|Azithromycin|azithromycin|mesh-list
138827226|NCT04062175|Cephalosporins|cephalosporins|mesh-list
138827227|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138827228|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827229|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
138827230|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138827231|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138827232|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138827233|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138827234|NCT04391569|Ganaxolone|ganaxolone|mesh-list
138827235|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
138827236|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827237|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827238|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827239|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
138827240|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
138827241|NCT05324917|Rituximab|rituximab|mesh-list
138827242|NCT05324917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138827243|NCT05324917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827244|NCT05324917|Immunologic Factors|immunologic factors|mesh-ancestor
138827245|NCT05324917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827246|NCT05324917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138827248|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138827249|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827250|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138827251|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138827252|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138827253|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827254|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827255|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827256|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138827257|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138827259|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138827260|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827261|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138827262|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827263|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138827264|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
138827265|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
138827266|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827267|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827268|NCT02871713|Morphine|morphine|mesh-list
138827269|NCT02871713|Ropivacaine|ropivacaine|mesh-list
138827270|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138827271|NCT02871713|Narcotics|narcotics|mesh-ancestor
138827272|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138827273|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827274|NCT02871713|Analgesics|analgesics|mesh-ancestor
138827275|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
138827276|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827277|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
138827278|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
138827279|NCT04342975|Niacinamide|niacinamide|mesh-list
138827280|NCT04342975|Niacin|niacin|mesh-list
138827281|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
138827282|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
138827283|NCT04342975|Vitamins|vitamins|mesh-ancestor
138827284|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
138827285|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827286|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138674837|NCT00480272|Adalimumab|adalimumab|mesh-list
138674838|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138827287|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
138827288|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827289|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138827290|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
138827291|NCT00734578|Guanfacine|guanfacine|mesh-list
138827292|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138439750|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138827293|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138827294|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138827295|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138827296|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
138827297|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827298|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827299|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827300|NCT00637715|Alfuzosin|alfuzosin|mesh-list
138827301|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138827302|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138827303|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138827304|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
138827305|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827306|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827307|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470822|NCT01991119|Dronedarone|dronedarone|mesh-list
138827308|NCT00637715|Urological Agents|urological agents|mesh-ancestor
138827309|NCT02596282|Anesthetics|anesthetics|mesh-list
138827310|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138827311|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827312|NCT02593708|Paclitaxel|paclitaxel|mesh-list
138827313|NCT02593708|Trastuzumab|trastuzumab|mesh-list
138827314|NCT02593708|Pertuzumab|pertuzumab|mesh-list
138827315|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138827316|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827317|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
138827318|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
138827319|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
138827320|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674871|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138674872|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138674873|NCT00482183|Pioglitazone|pioglitazone|mesh-list
138827321|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138827322|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
138827323|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138827324|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
138827325|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827326|NCT00696787|Pregabalin|pregabalin|mesh-list
138827327|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138827329|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
138827330|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827331|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827332|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
138827333|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138827334|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138827335|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827336|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138674909|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
138827337|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138827338|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138827339|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138827340|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138827341|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138827342|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138827343|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827344|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
138827345|NCT01012037|Linagliptin|linagliptin|mesh-list
138827346|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138827347|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827348|NCT01012037|Incretins|incretins|mesh-ancestor
138827349|NCT01012037|Hormones|hormones|mesh-ancestor
138827350|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138827351|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138827352|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
138827353|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827354|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827355|NCT00630110|Docetaxel|docetaxel|mesh-list
138827356|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827357|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
138827358|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
138827359|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
138827360|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827362|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138827363|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827364|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827365|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
138827366|NCT04284098|Bupivacaine|bupivacaine|mesh-list
138827367|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
138827368|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
138827369|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138827370|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827371|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
138827372|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827373|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138827374|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138827376|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138827377|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138827378|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138827379|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
138827380|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827381|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827382|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138827383|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138827384|NCT00733954|Clobetasol|clobetasol|mesh-list
138827385|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138827386|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
138827387|NCT00733954|Hormones|hormones|mesh-ancestor
138827388|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138827389|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827390|NCT02595268|Pitavastatin|pitavastatin|mesh-list
138827391|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138827392|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138827393|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138827395|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674956|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138674957|NCT00482261|Growth Substances|growth substances|mesh-ancestor
138674958|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
138827396|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827397|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138827399|NCT00921505|Ibuprofen|ibuprofen|mesh-list
138827400|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138827401|NCT00921505|Analgesics|analgesics|mesh-ancestor
138827402|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
138827403|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827404|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827405|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
138827406|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138827407|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138674985|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
138674986|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138674988|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
138827408|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138439852|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
138827409|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138827410|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827411|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827412|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138827413|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138827414|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827415|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138827416|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
138827417|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827418|NCT04298021|Durvalumab|durvalumab|mesh-list
138827419|NCT04298021|Olaparib|olaparib|mesh-list
138827420|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138827421|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827422|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138827423|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827424|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827425|NCT02595190|Gabapentin|gabapentin|mesh-list
138827426|NCT02595190|Tramadol|tramadol|mesh-list
138827427|NCT02595190|Analgesics|analgesics|mesh-ancestor
138827428|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
138827429|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827430|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827431|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
138827432|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138827433|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138827434|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138827435|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138827436|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138827437|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138827438|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827439|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827440|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
138827441|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138827442|NCT02595190|Narcotics|narcotics|mesh-ancestor
138827443|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138827444|NCT04061473|Empagliflozin|empagliflozin|mesh-list
138827445|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138675045|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138827446|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827447|NCT04061473|Incretins|incretins|mesh-ancestor
138827448|NCT04061473|Hormones|hormones|mesh-ancestor
138827449|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339155|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
138827450|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138827451|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
138650965|NCT00305513|Caffeine|caffeine|mesh-list
138827452|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827453|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827454|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138827455|NCT00733408|Paclitaxel|paclitaxel|mesh-list
138827456|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138827457|NCT00733408|Bevacizumab|bevacizumab|mesh-list
138827458|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138827459|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138827460|NCT00733408|Antibodies|antibodies|mesh-list
138827461|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
138827462|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138827463|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138827464|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827465|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
138827466|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
138479416|NCT02039869|Omeprazole|omeprazole|mesh-list
138827467|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
138827468|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827469|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138827470|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138827471|NCT00733408|Growth Substances|growth substances|mesh-ancestor
138827472|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675079|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675081|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138827473|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
138827474|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
138827475|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138827476|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827477|NCT04296383|Azithromycin|azithromycin|mesh-list
138827478|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138827479|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827480|NCT00576823|Alfuzosin|alfuzosin|mesh-list
138827481|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138827482|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138827483|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138827484|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
138827485|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439908|NCT01778842|Clopidogrel|clopidogrel|mesh-list
138827486|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827487|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827489|NCT00732940|Belimumab|belimumab|mesh-list
138827490|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138827491|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
138827492|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827494|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
138827495|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138827496|NCT00962390|Estrogens|estrogens|mesh-ancestor
138827497|NCT00962390|Hormones|hormones|mesh-ancestor
138827498|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138827499|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827500|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138827501|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138827502|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138827503|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138827504|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675119|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675121|NCT00481013|Valproic Acid|valproic acid|mesh-list
138827505|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827506|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827507|NCT00960986|Analgesics|analgesics|mesh-ancestor
138827508|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
138827509|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827510|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
138827511|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138827512|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
138827513|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138827514|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827515|NCT00958880|Yohimbine|yohimbine|mesh-list
138827516|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
138827517|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
138827518|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827519|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827520|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138827521|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138827522|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138827523|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
138827524|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827525|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827526|NCT00958880|Urological Agents|urological agents|mesh-ancestor
138827527|NCT02595034|Clindamycin|clindamycin|mesh-list
138827528|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
138827529|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
138827531|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138827532|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827533|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138827534|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827535|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827536|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
138827537|NCT00958724|Vinorelbine|vinorelbine|mesh-list
138827538|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138827539|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479490|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
138827540|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
138827541|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
138827542|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
138827543|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827544|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138675229|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138675230|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675231|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
138675239|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138827545|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
138827546|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138827547|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138827548|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827549|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827550|NCT00738400|Urological Agents|urological agents|mesh-ancestor
138827552|NCT00958568|Fluoxetine|fluoxetine|mesh-list
138827553|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
138827554|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
138827555|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827556|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827557|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138827558|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138827559|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138827560|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138827561|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138827562|NCT00958568|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138827563|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138827564|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138650998|NCT00329589|Bortezomib|bortezomib|mesh-list
138827565|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827566|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827567|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
138827568|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138827569|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
138827570|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138827571|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138827572|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827573|NCT00630500|Memantine|memantine|mesh-list
138827574|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138827575|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138827576|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
138827577|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827578|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827579|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827580|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138827581|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138675263|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675264|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138827582|NCT02858804|Cytarabine|cytarabine|mesh-list
138827583|NCT02858804|Thalidomide|thalidomide|mesh-list
138827584|NCT02858804|Dexamethasone|dexamethasone|mesh-list
138827585|NCT02858804|Prednisone|prednisone|mesh-list
138827586|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
138827587|NCT02858804|Rituximab|rituximab|mesh-list
138827588|NCT02858804|Doxorubicin|doxorubicin|mesh-list
138827589|NCT02858804|Etoposide|etoposide|mesh-list
138827590|NCT02858804|Vincristine|vincristine|mesh-list
138827591|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138827592|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
138827593|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827594|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138827595|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138827596|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
138827597|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827598|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827599|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138827600|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138827601|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
138827602|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
138470908|NCT01991561|Antacids|antacids|mesh-ancestor
138827603|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827604|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138827605|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
138827606|NCT02858804|Hormones|hormones|mesh-ancestor
138827607|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138827608|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138827609|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138827610|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138827611|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138827612|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138827613|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827614|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138827615|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138827616|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
138827617|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
138827618|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675290|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138827619|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
138675291|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138440003|NCT01779479|Paclitaxel|paclitaxel|mesh-list
138827620|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
138827621|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
138827622|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
138827623|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138827624|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138827625|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138827626|NCT02858804|Growth Substances|growth substances|mesh-ancestor
138827627|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
138827628|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
138827629|NCT00958256|Rituximab|rituximab|mesh-list
138827630|NCT00958256|Bortezomib|bortezomib|mesh-list
138827631|NCT00958256|Lenograstim|lenograstim|mesh-list
138827632|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138827633|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
138827634|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827635|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138827636|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138827637|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
138827638|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827639|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827640|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138827641|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138827642|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138827643|NCT01006265|Ponesimod|ponesimod|mesh-list
138827644|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138827645|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827646|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138827647|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
138827648|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827649|NCT02861690|Paclitaxel|paclitaxel|mesh-list
138827650|NCT02861690|Nedaplatin|nedaplatin|mesh-list
138827651|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138827652|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827653|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
138827654|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
138827655|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
138827656|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827657|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
138827658|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138827659|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827660|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138827661|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827662|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
138675324|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138675325|NCT00483093|Cisplatin|cisplatin|mesh-list
138675326|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827663|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138827664|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827665|NCT00628667|Esomeprazole|esomeprazole|mesh-list
138827666|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138827667|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138827668|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138827669|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827670|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827671|NCT02858258|Rituximab|rituximab|mesh-list
138827672|NCT02858258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138827673|NCT02858258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827674|NCT02858258|Immunologic Factors|immunologic factors|mesh-ancestor
138827675|NCT02858258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827676|NCT02858258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138827677|NCT01008995|Ustekinumab|ustekinumab|mesh-list
138827678|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
138827679|NCT04295993|Norepinephrine|norepinephrine|mesh-list
138827680|NCT04295993|Methylene Blue|methylene blue|mesh-list
138827681|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138827682|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138827683|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
138827684|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138651037|NCT00305708|Busulfan|busulfan|mesh-list
138827685|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827687|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
138827688|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
138827689|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827690|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138827691|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827693|NCT00743587|Oxycodone|oxycodone|mesh-list
138827694|NCT00743587|Tramadol|tramadol|mesh-list
138827695|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138827696|NCT00743587|Narcotics|narcotics|mesh-ancestor
138827697|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138827698|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827699|NCT00743587|Analgesics|analgesics|mesh-ancestor
138827700|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
138827701|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827702|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138827703|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138827704|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138827705|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138827706|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
138827707|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138827708|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827709|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827710|NCT00957944|Rotigotine|rotigotine|mesh-list
138827711|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
138827712|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
138827713|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827714|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675424|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138675429|NCT00483795|Citric Acid|citric acid|mesh-list
138827715|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827716|NCT02871323|Durvalumab|durvalumab|mesh-list
138827717|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
138827718|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138827720|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138827721|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827722|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
138827723|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827724|NCT04296149|Octreotide|octreotide|mesh-list
138827725|NCT04296149|Edotreotide|edotreotide|mesh-list
138827726|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138827727|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138827728|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827729|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138827730|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827731|NCT01005875|Sorafenib|sorafenib|mesh-list
138827732|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827733|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138827734|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827735|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827736|NCT02701088|Mitomycins|mitomycins|mesh-list
138827737|NCT02701088|Mitomycin|mitomycin|mesh-list
138827738|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138827739|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827740|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
138827741|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827742|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138827743|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827744|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
138827745|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138827746|NCT04279106|Listerine|listerine|mesh-list
138827747|NCT04279106|Fluorides|fluorides|mesh-list
138827748|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
138827749|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
138827750|NCT04279106|Protective Agents|protective agents|mesh-ancestor
138827751|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827752|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138827753|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827754|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
138827755|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
138827756|NCT00743743|Resveratrol|resveratrol|mesh-list
138827757|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
138675459|NCT05644210|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138827758|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827759|NCT00743743|Protective Agents|protective agents|mesh-ancestor
138827760|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827761|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827762|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138827763|NCT01005719|Omeprazole|omeprazole|mesh-list
138479717|NCT02041767|Ertapenem|ertapenem|mesh-list
138827764|NCT01005719|Lansoprazole|lansoprazole|mesh-list
138827765|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
138827766|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138827767|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138827768|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138827769|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827770|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827771|NCT02856854|Cocaine|cocaine|mesh-list
138827772|NCT02856854|Oxazepam|oxazepam|mesh-list
138827773|NCT02856854|Metyrapone|metyrapone|mesh-list
138827774|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
138827775|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
138827776|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138827777|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827778|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
138827779|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827780|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138827781|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138827782|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138827783|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138827784|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827785|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
138827786|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827787|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
138827788|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827789|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138827790|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138827791|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138827792|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138827793|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
138675489|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
138675490|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827794|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
138827795|NCT02857166|Antibodies|antibodies|mesh-list
138827796|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138827797|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
138827798|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827799|NCT02856932|Methamphetamine|methamphetamine|mesh-list
138827800|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138827801|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827802|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
138827803|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
138440116|NCT01780233|Analgesics|analgesics|mesh-ancestor
138827804|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827805|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
138827806|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827807|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827808|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
138827809|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138827810|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138827811|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138827812|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138827813|NCT02563951|Granisetron|granisetron|mesh-list
138827814|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
138827815|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
138827816|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827817|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827818|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138827819|NCT02563951|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138827820|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138827821|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
138827822|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675530|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138827823|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827824|NCT00953576|Ketoconazole|ketoconazole|mesh-list
138827825|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
138827826|NCT00953576|Lapatinib|lapatinib|mesh-list
138827827|NCT00953576|Dutasteride|dutasteride|mesh-list
138827828|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138827829|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827830|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138827831|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827832|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827833|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
138827834|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827835|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138827836|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138827837|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138827838|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
138479798|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
138827839|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138827840|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827841|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138827842|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138827844|NCT01005329|Bevacizumab|bevacizumab|mesh-list
138827845|NCT01005329|Cisplatin|cisplatin|mesh-list
138827846|NCT01005329|Carboplatin|carboplatin|mesh-list
138827847|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138827848|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138827849|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
138827850|NCT01005329|Antibodies|antibodies|mesh-list
138827851|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
138827852|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138827853|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
138827854|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138827855|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827856|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
138651086|NCT00333294|Gefitinib|gefitinib|mesh-list
138827857|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
138827858|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
138827859|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827860|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138827861|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138827862|NCT01005329|Growth Substances|growth substances|mesh-ancestor
138827863|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827864|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
138827865|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
138827866|NCT00921349|Nadolol|nadolol|mesh-list
138675568|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138675569|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827867|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138827868|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138827869|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
138827870|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827871|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827872|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827873|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138827874|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138827875|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
138827876|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
138827877|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827878|NCT01005251|Lesogaberan|lesogaberan|mesh-list
138827879|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138827880|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138827881|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
138827882|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
138827883|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827884|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827885|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827886|NCT03048578|Liraglutide|liraglutide|mesh-list
138827887|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138827888|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827889|NCT03048578|Incretins|incretins|mesh-ancestor
138827890|NCT03048578|Hormones|hormones|mesh-ancestor
138827891|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138827892|NCT02856776|Vitamin D|vitamin d|mesh-list
138827893|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
138827894|NCT02856776|Vitamins|vitamins|mesh-ancestor
138827895|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
138827896|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827897|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138827898|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138827899|NCT04296851|Niclosamide|niclosamide|mesh-list
138827900|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
138827901|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138827902|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
138827903|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138675602|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
138827904|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827905|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
138675603|NCT00484068|Enalapril|enalapril|mesh-list
138827906|NCT02858024|Dapivirine|dapivirine|mesh-list
138827907|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138827908|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138827909|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
138827910|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138827911|NCT02857946|Linagliptin|linagliptin|mesh-list
138827912|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138827913|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138479876|NCT02043717|Vitamin D|vitamin d|mesh-list
138827915|NCT02857946|Hormones|hormones|mesh-ancestor
138827916|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138827917|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138827918|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
138827919|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827920|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827921|NCT02857712|Axitinib|axitinib|mesh-list
138827922|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827923|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138827924|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827925|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827926|NCT00696241|Olmesartan|olmesartan|mesh-list
138827927|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138827928|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138827929|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138827930|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138827931|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138827932|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675638|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138827933|NCT00630968|Levetiracetam|levetiracetam|mesh-list
138827934|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
138827935|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
138827936|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
138827937|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
138827938|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827939|NCT00689611|Bupropion|bupropion|mesh-list
138827940|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138827941|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
138827942|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138827943|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138827944|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138827945|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138827946|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827947|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
138827948|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827949|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827950|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138827951|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138827952|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827953|NCT02563795|Fentanyl|fentanyl|mesh-list
138827954|NCT02563795|Bupivacaine|bupivacaine|mesh-list
138827955|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
138827956|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
138827957|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138827959|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
138827960|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138827961|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138827962|NCT02563795|Narcotics|narcotics|mesh-ancestor
138827963|NCT02563795|Analgesics|analgesics|mesh-ancestor
138827964|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138827965|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138827966|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
138827967|NCT04281680|Octreotide|octreotide|mesh-list
138827968|NCT04281680|Pasireotide|pasireotide|mesh-list
138827969|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138675680|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138827970|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138827971|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138675681|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827972|NCT04281680|Hormones|hormones|mesh-ancestor
138675682|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827973|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138827974|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827976|NCT00744445|Hematinics|hematinics|mesh-ancestor
138827977|NCT02854748|Empagliflozin|empagliflozin|mesh-list
138827978|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138827979|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827980|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138827981|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827982|NCT03881917|Cystatins|cystatins|mesh-list
138827983|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138827984|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
138827985|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138827986|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827987|NCT00744679|Natalizumab|natalizumab|mesh-list
138827988|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
138827989|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138827990|NCT04060459|Paclitaxel|paclitaxel|mesh-list
138827991|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138827992|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138827993|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
138827994|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
138827995|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
138827996|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138827997|NCT01007435|Methotrexate|methotrexate|mesh-list
138827998|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138827999|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
138828000|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138828001|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828002|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138828003|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
138440303|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828004|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828005|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828006|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
138828007|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828008|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138828009|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138828010|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
138828011|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138828012|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138828013|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
138828014|NCT00948896|Piperaquine|piperaquine|mesh-list
138828015|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
138828016|NCT00948896|Trimethoprim|trimethoprim|mesh-list
138828017|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138828018|NCT00948896|Artenimol|artenimol|mesh-list
138828019|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138828020|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
138828021|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
138828022|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138828023|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138828024|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828025|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138828026|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828027|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651130|NCT00306137|Aprotinin|aprotinin|mesh-list
138828028|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138828029|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138828030|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138828031|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138828032|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138828033|NCT01004159|Irinotecan|irinotecan|mesh-list
138828034|NCT01004159|Cetuximab|cetuximab|mesh-list
138828035|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138828036|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138828037|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828038|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828039|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828040|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138828041|NCT00948818|Linaclotide|linaclotide|mesh-list
138828042|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138828043|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
138828044|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828045|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138828046|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138675750|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
138440339|NCT01781897|Mosapride|mosapride|mesh-list
138828047|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138828048|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138828049|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828050|NCT00948506|Cidofovir|cidofovir|mesh-list
138675751|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
138828051|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
138675752|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828052|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828053|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828054|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828055|NCT00689221|Temozolomide|temozolomide|mesh-list
138828056|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138828057|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
138828058|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828059|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828060|NCT04060771|Dexamethasone|dexamethasone|mesh-list
138828061|NCT04060771|Palonosetron|palonosetron|mesh-list
138480034|NCT02044952|Mesalamine|mesalamine|mesh-list
138828062|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138828064|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
138828065|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828066|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828067|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138828068|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
138828069|NCT04060771|Hormones|hormones|mesh-ancestor
138828070|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138828071|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138828072|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828073|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138828074|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138828075|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
138828076|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828077|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828078|NCT00744913|Nicotine|nicotine|mesh-list
138828079|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138828080|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
138828081|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828082|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440363|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
138828083|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138828084|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138828085|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
138828086|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828087|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828088|NCT01875445|Inositol|inositol|mesh-list
138828089|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
138828090|NCT01875445|Vitamins|vitamins|mesh-ancestor
138828091|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
138828092|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828093|NCT00745069|Tapentadol|tapentadol|mesh-list
138828094|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138828095|NCT00745069|Narcotics|narcotics|mesh-ancestor
138828096|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138828097|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828098|NCT00745069|Analgesics|analgesics|mesh-ancestor
138828099|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
138828100|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828101|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138828102|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138828103|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138828104|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828105|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
138828106|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828107|NCT00745147|Laxatives|laxatives|mesh-list
138828108|NCT00745147|Lactulose|lactulose|mesh-list
138828109|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138828110|NCT00688909|Letrozole|letrozole|mesh-list
138828111|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828112|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138828113|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138828114|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828115|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828116|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138828117|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
138440400|NCT01782560|Omeprazole|omeprazole|mesh-list
138440412|NCT01782612|Analgesics|analgesics|mesh-list
138828118|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138828119|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828121|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138828122|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
138828123|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828124|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828125|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
138828127|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138828128|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
138828129|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828130|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828131|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138828132|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
138828133|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138828134|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
138828135|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828136|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675811|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
138675812|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138675813|NCT00484575|Propofol|propofol|mesh-list
138828137|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138828138|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
138828139|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
138828140|NCT00948194|Protective Agents|protective agents|mesh-ancestor
138828141|NCT00691483|Varenicline|varenicline|mesh-list
138828142|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138828143|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138828144|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
138828145|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828146|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828147|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828148|NCT00691093|Fesoterodine|fesoterodine|mesh-list
138828149|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138828150|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138828151|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
138675845|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675849|NCT00484731|Bupivacaine|bupivacaine|mesh-list
138828152|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828153|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828154|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828155|NCT00691093|Urological Agents|urological agents|mesh-ancestor
138828156|NCT03646825|Antioxidants|antioxidants|mesh-list
138828157|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828158|NCT03646825|Protective Agents|protective agents|mesh-ancestor
138828159|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828160|NCT00745225|Pioglitazone|pioglitazone|mesh-list
138828161|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138828162|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828163|NCT02856542|Betamethasone|betamethasone|mesh-list
138828164|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
138828165|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138828166|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
138828167|NCT02856542|Calcipotriene|calcipotriene|mesh-list
138828168|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138828169|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138828170|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
138828171|NCT02856542|Hormones|hormones|mesh-ancestor
138828172|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138828173|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828174|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138828175|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
138828176|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
138828177|NCT00688753|Everolimus|everolimus|mesh-list
138828178|NCT00688753|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138828179|NCT00688753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138828180|NCT00688753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828181|NCT00688753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828182|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138675906|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675908|NCT00484926|Aspirin|aspirin|mesh-list
138828183|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
138828184|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828185|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828187|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138828188|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828189|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138828190|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138828191|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138828192|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828193|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828194|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828195|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138828196|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138828197|NCT02856230|Paclitaxel|paclitaxel|mesh-list
138828198|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138828199|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828200|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
138828201|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
138828202|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
138828203|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828204|NCT00631124|Drospirenone|drospirenone|mesh-list
138828205|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138828206|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138480165|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
138828207|NCT00631124|Estradiol|estradiol|mesh-list
138828208|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138828209|NCT00631124|Estrogens|estrogens|mesh-ancestor
138828210|NCT00631124|Hormones|hormones|mesh-ancestor
138828211|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138828212|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828213|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138828214|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
138828215|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138828216|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138828217|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138828218|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
138828219|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138828220|NCT00631124|Diuretics|diuretics|mesh-ancestor
138828221|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
138828222|NCT02855684|Insulin|insulin|mesh-list
138828223|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138828224|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
138828225|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138828226|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828227|NCT01667744|Citalopram|citalopram|mesh-list
138828228|NCT01667744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138675948|NCT00489398|Epinastine|epinastine|mesh-list
138675949|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138675950|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138828229|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138828230|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138828231|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828232|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828233|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
138828234|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828235|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138828236|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
138828237|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138828238|NCT04274270|Endostar protein|endostar protein|mesh-list
138828239|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138828240|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138828241|NCT04274270|Growth Substances|growth substances|mesh-ancestor
138828242|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828243|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
138828244|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828245|NCT02855294|Drospirenone|drospirenone|mesh-list
138828246|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138828247|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
138440509|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
138828248|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138828249|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828250|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138828252|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
138828253|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138828254|NCT00950690|Latanoprost|latanoprost|mesh-list
138828255|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138828256|NCT02855138|Isotretinoin|isotretinoin|mesh-list
138828257|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
138828258|NCT00694369|Acetaminophen|acetaminophen|mesh-list
138828259|NCT00694369|Ibuprofen|ibuprofen|mesh-list
138828260|NCT00694369|Etoricoxib|etoricoxib|mesh-list
138675975|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138675976|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138675981|NCT00485121|Ezetimibe|ezetimibe|mesh-list
138828261|NCT00694369|Codeine|codeine|mesh-list
138828262|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138828263|NCT00694369|Analgesics|analgesics|mesh-ancestor
138828264|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
138828265|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828266|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828267|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
138828268|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138828269|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138828270|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138828271|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138828272|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828273|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828274|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138828275|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138828276|NCT00694369|Narcotics|narcotics|mesh-ancestor
138828277|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138828278|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
138828279|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
138828280|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
138828281|NCT00745693|BQ 788|bq 788|mesh-list
138828282|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138828283|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138480275|NCT02046486|Ticagrelor|ticagrelor|mesh-list
138828284|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828285|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138828286|NCT02563405|Doxazosin|doxazosin|mesh-list
138828287|NCT02563405|Nifedipine|nifedipine|mesh-list
138828288|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138676015|NCT00485030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676016|NCT00485030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828289|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676017|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138828290|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828291|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138828292|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828293|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
138828294|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
138828295|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138828296|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138828297|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138828298|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138828299|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138828300|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
138828301|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828302|NCT00513019|Lamotrigine|lamotrigine|mesh-list
138828303|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
138828304|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138828305|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138828306|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828307|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138828308|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828309|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138828310|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138828311|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138828312|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138828313|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138828314|NCT00053677|Naltrexone|naltrexone|mesh-list
138828315|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138676059|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
138828316|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138676060|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828317|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676061|NCT00485277|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138676062|NCT00485277|Antiviral Agents|antiviral agents|mesh-ancestor
138676063|NCT00485277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828318|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
138828319|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828320|NCT00954512|Leucovorin|leucovorin|mesh-list
138828321|NCT00954512|Folic Acid|folic acid|mesh-list
138828322|NCT00954512|Carboplatin|carboplatin|mesh-list
138828323|NCT00954512|Gemcitabine|gemcitabine|mesh-list
138828324|NCT00954512|Trastuzumab|trastuzumab|mesh-list
138828325|NCT00954512|Irinotecan|irinotecan|mesh-list
138828326|NCT00954512|Cetuximab|cetuximab|mesh-list
138828327|NCT00954512|Everolimus|everolimus|mesh-list
138828328|NCT00954512|Epirubicin|epirubicin|mesh-list
138828329|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
138828330|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828331|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828332|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138828333|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
138828334|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138828335|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138828336|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138828337|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828338|NCT00954512|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138828339|NCT00954512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138828340|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138828341|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
138828342|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828343|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138828344|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138828345|NCT00954512|Antidotes|antidotes|mesh-ancestor
138676102|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
138676103|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828346|NCT00954512|Protective Agents|protective agents|mesh-ancestor
138828347|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
138828348|NCT00954512|Vitamins|vitamins|mesh-ancestor
138828349|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
138828350|NCT00954512|Hematinics|hematinics|mesh-ancestor
138828351|NCT00691015|Cytarabine|cytarabine|mesh-list
138828352|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
138828353|NCT00691015|Melphalan|melphalan|mesh-list
138676106|NCT00489593|Olanzapine|olanzapine|mesh-list
138828354|NCT00691015|Busulfan|busulfan|mesh-list
138828355|NCT00691015|Carmustine|carmustine|mesh-list
138828356|NCT00691015|Rituximab|rituximab|mesh-list
138480314|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
138828357|NCT00691015|Fludarabine|fludarabine|mesh-list
138828358|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
138828359|NCT00691015|Etoposide|etoposide|mesh-list
138828360|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
138828361|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138828362|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138828363|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
138828364|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828365|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138828366|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138828367|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
138828368|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828369|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828370|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138828371|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138828372|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138828373|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
138828374|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138828375|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138828376|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138828377|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676138|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138828378|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
138828379|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138676139|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138676150|NCT04697511|Midazolam|midazolam|mesh-list
138828380|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
138828381|NCT00950300|Docetaxel|docetaxel|mesh-list
138828382|NCT00950300|Fluorouracil|fluorouracil|mesh-list
138828383|NCT00950300|Trastuzumab|trastuzumab|mesh-list
138828384|NCT00950300|Epirubicin|epirubicin|mesh-list
138828385|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138828386|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
138828387|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828388|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138828389|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138828390|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
138828391|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828392|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828393|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138828395|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
138676181|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138676182|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138828396|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
138828397|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
138676183|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
138828398|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138828399|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138828400|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138828401|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138828402|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138828403|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828404|NCT00949988|Rituximab|rituximab|mesh-list
138828405|NCT00949988|Dasatinib|dasatinib|mesh-list
138828406|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138828407|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828408|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
138828409|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828410|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138828411|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138828412|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828413|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828414|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138828415|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138828416|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828417|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138828418|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
138828419|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828420|NCT02593474|Naltrexone|naltrexone|mesh-list
138828421|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138828422|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138828423|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676239|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138676240|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138676241|NCT00489944|Growth Substances|growth substances|mesh-ancestor
138828424|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
138828425|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828426|NCT00687193|Tofacitinib|tofacitinib|mesh-list
138828427|NCT00687193|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138828428|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138828429|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828430|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828432|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138828433|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828434|NCT00730912|Loratadine|loratadine|mesh-list
138828435|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
138828436|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
138828437|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138828438|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138828439|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138828440|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
138828441|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
138828442|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828443|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828444|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828445|NCT00730756|Fluticasone|fluticasone|mesh-list
138828446|NCT00730756|Xhance|xhance|mesh-list
138828447|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138828448|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138828449|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
138828450|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828451|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828452|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138828453|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
138828454|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
138828455|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138828456|NCT00730132|Ezetimibe|ezetimibe|mesh-list
138828457|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138828458|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138828459|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
138828460|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828461|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138828463|NCT00737464|Hematinics|hematinics|mesh-ancestor
138828464|NCT00729586|Tamoxifen|tamoxifen|mesh-list
138676283|NCT00490178|Metformin|metformin|mesh-list
138676284|NCT00490178|Fenofibrate|fenofibrate|mesh-list
138676285|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138828465|NCT00729586|Sirolimus|sirolimus|mesh-list
138676286|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828466|NCT00729586|Temsirolimus|temsirolimus|mesh-list
138828467|NCT00729586|Megestrol|megestrol|mesh-list
138828468|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
138170230|NCT00660985|Adapalene|adapalene|mesh-list
138828469|NCT00729586|MTOR Inhibitors|mtor inhibitors|mesh-list
138828470|NCT00729586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828471|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138828472|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828473|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138828474|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828475|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
138828476|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138828477|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
138828478|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828479|NCT00729586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138828480|NCT00729586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828481|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138828482|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
138828483|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138828484|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138828485|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138828486|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138828487|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138828488|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138828489|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138828490|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138828491|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
138828492|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138828493|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138676311|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138676312|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138676313|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676314|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
138828494|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138828495|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
138828496|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138828497|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138828498|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828499|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138828500|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828501|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828502|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138828503|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138828504|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138828505|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
138828506|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828507|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138828508|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138480458|NCT02047175|Niacin|niacin|mesh-list
138828509|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828510|NCT02593162|Ribavirin|ribavirin|mesh-list
138828511|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
138828512|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828513|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
138828514|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828516|NCT00686959|Etoposide|etoposide|mesh-list
138828517|NCT00686959|Vinorelbine|vinorelbine|mesh-list
138828518|NCT00686959|Carboplatin|carboplatin|mesh-list
138828519|NCT00686959|Pemetrexed|pemetrexed|mesh-list
138828520|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138828521|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828522|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
138676352|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676353|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676354|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676355|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
138170613|NCT00006110|Paclitaxel|paclitaxel|mesh-list
138828523|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
138828524|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
138828525|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828526|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138828527|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138828528|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828529|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138828530|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138828531|NCT04088110|Trastuzumab|trastuzumab|mesh-list
138828532|NCT04088110|Letrozole|letrozole|mesh-list
138828533|NCT04088110|Anastrozole|anastrozole|mesh-list
138828534|NCT04088110|Exemestane|exemestane|mesh-list
138828535|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138828536|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138828537|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828538|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138828539|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828540|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828541|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138651294|NCT00451412|Calcium heparin|calcium heparin|mesh-list
138828542|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
138828543|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138828544|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828545|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138828546|NCT04088266|Buprenorphine|buprenorphine|mesh-list
138828547|NCT04088266|Naloxone|naloxone|mesh-list
138828548|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138828549|NCT04088266|Narcotics|narcotics|mesh-ancestor
138828550|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138828551|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828552|NCT04088266|Analgesics|analgesics|mesh-ancestor
138828553|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
138828554|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828555|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138828556|NCT05311579|Niraparib|niraparib|mesh-list
138828557|NCT05311579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138828558|NCT05311579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828559|NCT05311579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828560|NCT05311579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828561|NCT00602342|Terbinafine|terbinafine|mesh-list
138828562|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
138828563|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828564|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828565|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828566|NCT00602498|Clarithromycin|clarithromycin|mesh-list
138676389|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
138676390|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828567|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138828568|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828569|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138828570|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828571|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828572|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138828573|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138828574|NCT00749359|Paroxetine|paroxetine|mesh-list
138828575|NCT00749359|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138828576|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138828577|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138828578|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828579|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828580|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
138828581|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828582|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138828583|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
138828584|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138828585|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138828586|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138828587|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828588|NCT00946088|Progesterone|progesterone|mesh-list
138828589|NCT00946088|Progestins|progestins|mesh-ancestor
138828590|NCT00946088|Hormones|hormones|mesh-ancestor
138828591|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138828592|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828593|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
138828594|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138828595|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828596|NCT00736996|Pioglitazone|pioglitazone|mesh-list
138828597|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138828598|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828599|NCT00741949|Propofol|propofol|mesh-list
138676417|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138676418|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676419|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651307|NCT00330525|Sibutramine|sibutramine|mesh-list
138828600|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138828601|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138828602|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828603|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138828604|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
138828605|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
138828606|NCT01410344|Vidarabine|vidarabine|mesh-list
138828607|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
138828608|NCT01410344|Melphalan|melphalan|mesh-list
138828609|NCT01410344|Busulfan|busulfan|mesh-list
138828610|NCT01410344|Fludarabine|fludarabine|mesh-list
138828611|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
138828612|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138828613|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
138828614|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828615|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138828616|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138676454|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138828617|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
138676455|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138828618|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828619|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828620|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138828621|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138828622|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
138828623|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
138828624|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828625|NCT02594410|Lercanidipine|lercanidipine|mesh-list
138828626|NCT02594410|Clopidogrel|clopidogrel|mesh-list
138828627|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138828628|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138440879|NCT01785797|Silicon|silicon|mesh-list
138828629|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138828630|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138828632|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828633|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828634|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828635|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138828636|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138828637|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138828638|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138828639|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138828640|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
138828641|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138828642|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138828643|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138828644|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138828645|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828647|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138828648|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138828649|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
138676508|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676509|NCT00486369|Calcitonin|calcitonin|mesh-list
138676510|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
138676511|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138828650|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828651|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828652|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828653|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138828654|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138828655|NCT00630890|Capecitabine|capecitabine|mesh-list
138828656|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138828657|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
138828658|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828659|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828660|NCT00728494|Ribavirin|ribavirin|mesh-list
138828661|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138828662|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
138828663|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
138828664|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828665|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
138828666|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828667|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
138828668|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828669|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
138828670|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138828671|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138828672|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828673|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138828674|NCT02854904|Analgesics|analgesics|mesh-ancestor
138828675|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
138828676|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828677|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138676547|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676548|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676549|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138676550|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138676551|NCT00491114|Gemcitabine|gemcitabine|mesh-list
138676552|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138676553|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
138171324|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138676554|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676555|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828678|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138828679|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138828680|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
138828681|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828682|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828683|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
138828684|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138828685|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
138828686|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138828687|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
138828688|NCT00941330|Docetaxel|docetaxel|mesh-list
138828689|NCT00941330|Exemestane|exemestane|mesh-list
138828690|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138676581|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138828691|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
138828692|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676582|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828693|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138828694|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138828695|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
138828696|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828697|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828698|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138828699|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
138828700|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
138828701|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
138828702|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138828703|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138828704|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828705|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138828706|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
138828707|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138828708|NCT00686881|Interferons|interferons|mesh-list
138828709|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
138828710|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
138828711|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138828712|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828713|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
138828715|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
138828716|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828717|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138828718|NCT02857244|Modafinil|modafinil|mesh-list
138828719|NCT02857244|Donepezil|donepezil|mesh-list
138828720|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138828721|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138828722|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138828723|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676637|NCT05643586|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138676638|NCT05643586|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138676639|NCT05643586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138828724|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828725|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828726|NCT02857244|Analgesics|analgesics|mesh-ancestor
138828727|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
138828728|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828729|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
138828730|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138828731|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
138828732|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138828733|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828734|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
138828736|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138828737|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138828738|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138828739|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138828740|NCT04273256|Inositol|inositol|mesh-list
138828741|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
138828742|NCT04273256|Vitamins|vitamins|mesh-ancestor
138828743|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
138828744|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828745|NCT00921661|Aflibercept|aflibercept|mesh-list
138828746|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138828747|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138828748|NCT00921661|Growth Substances|growth substances|mesh-ancestor
138828749|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828750|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
138828751|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828752|NCT04088032|Durvalumab|durvalumab|mesh-list
138828753|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138676678|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138676679|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
138828754|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138676682|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
138828755|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828756|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138828757|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828758|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828759|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138828760|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
138828761|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138828762|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828763|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
138828764|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
138828765|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828766|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828767|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828768|NCT00735904|Gemcitabine|gemcitabine|mesh-list
138828769|NCT00735904|Axitinib|axitinib|mesh-list
138828770|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828771|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138828772|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
138828773|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828774|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138828775|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828776|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
138828777|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
138828778|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138828779|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138828780|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828781|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
138828782|NCT02561923|Coagulants|coagulants|mesh-ancestor
138828783|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138828784|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
138828785|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138676723|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676724|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138828786|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
138828787|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828789|NCT00918190|Dexamethasone|dexamethasone|mesh-list
138828790|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
138828791|NCT00918190|Midazolam|midazolam|mesh-list
138828792|NCT00918190|Ondansetron|ondansetron|mesh-list
138828793|NCT00918190|BB 1101|bb 1101|mesh-list
138828794|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138828795|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
138828796|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
138828797|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828798|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828799|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138828800|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
138828801|NCT00918190|Hormones|hormones|mesh-ancestor
138828802|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138828803|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138828804|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828805|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
138828806|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828807|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480763|NCT00005931|Semaxinib|semaxinib|mesh-list
138828809|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138828810|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138828811|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138828812|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138828813|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138828814|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138828815|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
138828816|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
138828817|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
138828818|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
138828819|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828820|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
138828821|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
138828822|NCT00918190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138651387|NCT00330993|Misoprostol|misoprostol|mesh-list
138828823|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138828824|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
138828825|NCT02563327|Pyridoxine|pyridoxine|mesh-list
138676765|NCT00491426|Acyclovir|acyclovir|mesh-list
138676766|NCT00491426|Ampicillin|ampicillin|mesh-list
138676767|NCT00491426|Caspofungin|caspofungin|mesh-list
138828826|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
138828827|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
138676780|NCT01300546|Naproxen|naproxen|mesh-list
138828828|NCT02563327|Rifampin|rifampin|mesh-list
138828829|NCT02563327|Isoniazid|isoniazid|mesh-list
138828830|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
138828831|NCT02563327|Ethambutol|ethambutol|mesh-list
138828832|NCT02563327|Rifapentine|rifapentine|mesh-list
138828833|NCT02563327|Vitamins|vitamins|mesh-ancestor
138828834|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
138828835|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828836|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138828837|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828838|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138828839|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138828840|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676799|NCT00487110|Acetaminophen|acetaminophen|mesh-list
138676800|NCT00487110|Tropisetron|tropisetron|mesh-list
138676801|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138676802|NCT00487110|Analgesics|analgesics|mesh-ancestor
138676803|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
138828841|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828842|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828843|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
138828844|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138828845|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
138828846|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
138828847|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138828848|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138828849|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138828850|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138828851|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138828852|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138828853|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138828854|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138828855|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138828856|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
138828857|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138828858|NCT00918034|Talaporfin|talaporfin|mesh-list
138828859|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828860|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138828861|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
138828862|NCT02593942|Remifentanil|remifentanil|mesh-list
138828863|NCT02593942|Propofol|propofol|mesh-list
138828864|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138828865|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138828866|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828867|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138828868|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
138828869|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
138828870|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138828871|NCT02593942|Narcotics|narcotics|mesh-ancestor
138828872|NCT02593942|Analgesics|analgesics|mesh-ancestor
138828873|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
138828874|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828875|NCT00742339|Octreotide|octreotide|mesh-list
138828876|NCT00742339|Terlipressin|terlipressin|mesh-list
138828877|NCT00742339|Midodrine|midodrine|mesh-list
138828878|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138828879|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138828880|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828881|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
138828882|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
138828883|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828884|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676858|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
138828885|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138828886|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138828887|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138828888|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138828889|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
138828890|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828891|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828892|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138828894|NCT02592772|Nicotine|nicotine|mesh-list
138828895|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138828896|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
138828897|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828898|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828900|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138828901|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
138828902|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828903|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828904|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
138828905|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
138828906|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
138828907|NCT00631202|Hematinics|hematinics|mesh-ancestor
138828908|NCT02851784|Immunomodulating Agents|immunomodulating agents|mesh-list
138828909|NCT02851784|Immunologic Factors|immunologic factors|mesh-ancestor
138828910|NCT02851784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828911|NCT00721630|Capecitabine|capecitabine|mesh-list
138828912|NCT00721630|Lapatinib|lapatinib|mesh-list
138828913|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138828914|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
138828915|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828916|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441175|NCT01788254|Talinolol|talinolol|mesh-list
138828917|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138828918|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828919|NCT00686725|Temozolomide|temozolomide|mesh-list
138828920|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138828921|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
138828922|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828923|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138828924|NCT04055623|Aldesleukin|aldesleukin|mesh-list
138828925|NCT04055623|Interleukin-2|interleukin-2|mesh-list
138828926|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676887|NCT05641909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138676888|NCT05641909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138828927|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138828928|NCT04055623|Analgesics|analgesics|mesh-ancestor
138676889|NCT05641909|Anesthetics, General|anesthetics, general|mesh-ancestor
138828929|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
138828930|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828931|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828932|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138828933|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138828934|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
138828935|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828936|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138828937|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138828938|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138828939|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
138828940|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828941|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138828942|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138828943|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828944|NCT00727246|Choline|choline|mesh-list
138828945|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138828946|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
138828947|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138828948|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
138828949|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828950|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138828951|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138828952|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
138828953|NCT05381558|Triamcinolone|triamcinolone|mesh-list
138651403|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
138828954|NCT05381558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138828955|NCT05381558|Glucocorticoids|glucocorticoids|mesh-ancestor
138828956|NCT05381558|Hormones|hormones|mesh-ancestor
138828957|NCT05381558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138828958|NCT05381558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828959|NCT04055233|Biguanides|biguanides|mesh-list
138828960|NCT04055233|Polihexanide|polihexanide|mesh-list
138828961|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828962|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
138828963|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138828964|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676921|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138828965|NCT04268966|Brincidofovir|brincidofovir|mesh-list
138676922|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138828966|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
138828967|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138828968|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
138828969|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138828970|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138828971|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828972|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138828973|NCT04269278|Analgesics|analgesics|mesh-ancestor
138828974|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
138828975|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828976|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138828977|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138828978|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138828979|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
138828980|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138828981|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828982|NCT02853578|Budesonide|budesonide|mesh-list
138828983|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138828984|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138828985|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
138828986|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138828987|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138828988|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138828989|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
138828990|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
138828991|NCT02853578|Hormones|hormones|mesh-ancestor
138828992|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138828993|NCT02592694|Tenecteplase|tenecteplase|mesh-list
138828994|NCT02592694|Tirofiban|tirofiban|mesh-list
138828995|NCT02592694|Bivalirudin|bivalirudin|mesh-list
138828996|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138828997|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138828998|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138828999|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
138829000|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138829001|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
138829002|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829003|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
138829004|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138829005|NCT02591836|Atorvastatin|atorvastatin|mesh-list
138829006|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138829007|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138829008|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
138829009|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829010|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138829011|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138829012|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829013|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
138829014|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138829015|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
138829016|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829017|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829018|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138829019|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
138829020|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138829021|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
138829022|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829023|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829024|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138829025|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
138829026|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
138829027|NCT02851472|Protective Agents|protective agents|mesh-ancestor
138829028|NCT00687973|Atenolol|atenolol|mesh-list
138829029|NCT00687973|Amlodipine|amlodipine|mesh-list
138829030|NCT00687973|Valsartan|valsartan|mesh-list
138829031|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138829032|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138829033|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138829034|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829035|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138829036|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829037|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
138829038|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138829039|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138829040|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138829041|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
138829042|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
138829043|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829044|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138676996|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138676997|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138676998|NCT01242228|Incretins|incretins|mesh-ancestor
138829045|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138829046|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138829047|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
138829048|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829049|NCT00747097|Gemcitabine|gemcitabine|mesh-list
138829050|NCT00747097|Cetuximab|cetuximab|mesh-list
138829051|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138829052|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
138829053|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829054|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829055|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138829056|NCT00747331|Fenoldopam|fenoldopam|mesh-list
138829057|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138829058|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
138829059|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
138829060|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
138829061|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829062|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829063|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829064|NCT00747409|Insulin|insulin|mesh-list
138829065|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138829066|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
138829067|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
138829068|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
138829069|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138829070|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
138829071|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
138677024|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138677026|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
138677027|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138829072|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
138829073|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138829074|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829075|NCT00752011|Carboplatin|carboplatin|mesh-list
138829076|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829077|NCT00721396|Vaccines|vaccines|mesh-list
138829078|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138829079|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
138829080|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829081|NCT00943826|Bevacizumab|bevacizumab|mesh-list
138829082|NCT00943826|Temozolomide|temozolomide|mesh-list
138829083|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138829084|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829085|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138829086|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138829087|NCT00943826|Growth Substances|growth substances|mesh-ancestor
138829088|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829089|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
138829090|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138829091|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
138829092|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829093|NCT04268888|Nivolumab|nivolumab|mesh-list
138829094|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
138829095|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138829096|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829097|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138829098|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829099|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138829100|NCT04268888|Estrogens|estrogens|mesh-ancestor
138677072|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138677079|NCT00487773|Hormones|hormones|mesh-ancestor
138829101|NCT04268888|Hormones|hormones|mesh-ancestor
138829102|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138829103|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829104|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138829105|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138829106|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829107|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138829108|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829109|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481064|NCT00006000|Irinotecan|irinotecan|mesh-list
138829110|NCT02851394|Tramadol|tramadol|mesh-list
138829111|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
138829112|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138829113|NCT02851394|Narcotics|narcotics|mesh-ancestor
138829114|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138829115|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829116|NCT02851394|Analgesics|analgesics|mesh-ancestor
138829117|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
138829118|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829119|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
138829120|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
138829121|NCT00603434|Methylphenidate|methylphenidate|mesh-list
138829122|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138829123|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829124|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138829125|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138829126|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138829127|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829128|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
138829129|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829130|NCT01004003|Sorafenib|sorafenib|mesh-list
138677116|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829131|NCT01004003|Nintedanib|nintedanib|mesh-list
138677125|NCT01299805|Vortioxetine|vortioxetine|mesh-list
138829132|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829133|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138829134|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829135|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829136|NCT00943670|Trastuzumab|trastuzumab|mesh-list
138829137|NCT00943670|Pertuzumab|pertuzumab|mesh-list
138829138|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138829139|NCT00943670|Maytansine|maytansine|mesh-list
138829140|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138829141|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829142|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138829143|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
138829144|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
138829145|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
138829146|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829147|NCT00943670|Immunotoxins|immunotoxins|mesh-ancestor
138829148|NCT00943670|Immunoconjugates|immunoconjugates|mesh-ancestor
138829149|NCT00943670|Immunologic Factors|immunologic factors|mesh-ancestor
138829150|NCT00943670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829151|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
138829152|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138829153|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829154|NCT02851004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138829155|NCT02851004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829156|NCT00938366|Cladribine|cladribine|mesh-list
138829157|NCT00938366|Pantoprazole|pantoprazole|mesh-list
138829158|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138829159|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138829160|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138829161|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829162|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829163|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829164|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138829165|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
138829166|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829167|NCT00943592|Melphalan|melphalan|mesh-list
138677155|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138677156|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
138677157|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829168|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
138829169|NCT00943592|Clofarabine|clofarabine|mesh-list
138829170|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138441396|NCT01789437|Dexamethasone|dexamethasone|mesh-list
138829171|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
138829172|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829173|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829174|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138829175|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138829176|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
138829177|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829178|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138829179|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138829180|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
138829183|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
138829184|NCT00943124|Simvastatin|simvastatin|mesh-list
138829185|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138829186|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138829187|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
138677193|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138677194|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138829188|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829189|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138677213|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
138829190|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138829191|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829192|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
138829193|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
138829194|NCT00943124|Vitamins|vitamins|mesh-ancestor
138829195|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
138829196|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829197|NCT00940316|Irinotecan|irinotecan|mesh-list
138829198|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138829199|NCT00940316|Panitumumab|panitumumab|mesh-list
138829200|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138829201|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138829202|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829203|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829204|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829205|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138829206|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138829207|NCT02850848|Entecavir|entecavir|mesh-list
138829208|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
138829209|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138829210|NCT05381168|Calcium, Dietary|calcium, dietary|mesh-list
138829211|NCT05381168|Calcium Carbonate|calcium carbonate|mesh-list
138829213|NCT05381168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138829214|NCT05381168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829215|NCT05381168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138829216|NCT05381168|Antacids|antacids|mesh-ancestor
138829217|NCT05381168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829218|NCT05381168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138829219|NCT00726388|Diclofenac|diclofenac|mesh-list
138677245|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211078|NCT00481091|Navitoclax|navitoclax|mesh-list
138677246|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138829220|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138829221|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138829222|NCT00726388|Analgesics|analgesics|mesh-ancestor
138829223|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
138829224|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829225|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829226|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138829227|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138829228|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138829229|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829230|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829231|NCT00572455|Latanoprost|latanoprost|mesh-list
138829232|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138829233|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138829234|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138829235|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138829236|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
138829237|NCT00686335|Prednisone|prednisone|mesh-list
138829238|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138829239|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
138829240|NCT00686335|Hormones|hormones|mesh-ancestor
138829241|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138829242|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829243|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138829244|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829245|NCT00685945|Isosorbide|isosorbide|mesh-list
138829246|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138829247|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138829248|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
138829249|NCT00685945|Bradykinin|bradykinin|mesh-list
138829250|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138829251|NCT00685945|Kininogens|kininogens|mesh-list
138829252|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
138829253|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138829254|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138211126|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
138677359|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677360|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677361|NCT01243970|Protective Agents|protective agents|mesh-ancestor
138829255|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829256|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677363|NCT04515576|Dulaglutide|dulaglutide|mesh-list
138829257|NCT00685945|Urological Agents|urological agents|mesh-ancestor
138829258|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138829259|NCT00685945|Diuretics|diuretics|mesh-ancestor
138829260|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
138829261|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829262|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138829263|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138829264|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
138829265|NCT00747487|Idebenone|idebenone|mesh-list
138829266|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
138829267|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829268|NCT00747487|Protective Agents|protective agents|mesh-ancestor
138829269|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829270|NCT00750217|Buprenorphine|buprenorphine|mesh-list
138829271|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138829272|NCT00750217|Narcotics|narcotics|mesh-ancestor
138677392|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138677393|NCT01244204|Vitamin D|vitamin d|mesh-list
138677394|NCT01244204|Vitamins|vitamins|mesh-ancestor
138829273|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138829274|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829275|NCT00750217|Analgesics|analgesics|mesh-ancestor
138829276|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
138829277|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829278|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138829279|NCT00687739|Leuprolide|leuprolide|mesh-list
138829280|NCT00687739|Estradiol|estradiol|mesh-list
138829281|NCT00687739|Estrogens|estrogens|mesh-ancestor
138829282|NCT00687739|Hormones|hormones|mesh-ancestor
138829283|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138829284|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829285|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138829286|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138829287|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
138829288|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138829289|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829291|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
138829292|NCT00752401|Vitamins|vitamins|mesh-ancestor
138829293|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
138829294|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829295|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138829296|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138829297|NCT00750451|Heparin|heparin|mesh-list
138829298|NCT00750451|Enoxaparin|enoxaparin|mesh-list
138829299|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138829301|NCT00750451|Dalteparin|dalteparin|mesh-list
138829302|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
138829303|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
138829304|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138829305|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138829306|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829307|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
138829308|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138829309|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138829310|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829311|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138677455|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
138829312|NCT00747721|Analgesics|analgesics|mesh-ancestor
138677467|NCT00496223|Sunitinib|sunitinib|mesh-list
138829313|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
138829314|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829315|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138829316|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138829317|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138829318|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
138829319|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829320|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829321|NCT01006889|Exenatide|exenatide|mesh-list
138829322|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138829323|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829324|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138829325|NCT01006889|Incretins|incretins|mesh-ancestor
138829326|NCT01006889|Hormones|hormones|mesh-ancestor
138829327|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138829328|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
138829329|NCT02561767|Tacrolimus|tacrolimus|mesh-list
138829330|NCT02561767|Basiliximab|basiliximab|mesh-list
138829331|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138829332|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
138829333|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829334|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138829335|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829336|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829337|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138829338|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829339|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138829340|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
138441516|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677492|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677494|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
138829341|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138829342|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138829343|NCT00747799|Fluorouracil|fluorouracil|mesh-list
138829345|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829346|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
138829347|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829348|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138829349|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138829350|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
138829351|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829352|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138829353|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829354|NCT04294823|Esomeprazole|esomeprazole|mesh-list
138829355|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138829356|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138829357|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138829358|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829359|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829360|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138829361|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829362|NCT04294511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138829363|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829364|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
138829365|NCT01001429|Propofol|propofol|mesh-list
138829366|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138829367|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138829368|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829369|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138829370|NCT01001429|Analgesics|analgesics|mesh-ancestor
138829371|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
138829372|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138677536|NCT01296412|Liraglutide|liraglutide|mesh-list
138677537|NCT01296412|Glimepiride|glimepiride|mesh-list
138677538|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138829373|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138829374|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138829375|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138829376|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
138829377|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829378|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829379|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138829380|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
138829381|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
138829382|NCT01000961|Cysteamine|cysteamine|mesh-list
138829383|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138829384|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829385|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138829386|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138829387|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138829388|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138829389|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829390|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829391|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829392|NCT01000805|Analgesics|analgesics|mesh-ancestor
138829393|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
138829394|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829395|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
138829396|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138829397|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
138829398|NCT00684307|Vitamin K|vitamin k|mesh-list
138829399|NCT00684307|Warfarin|warfarin|mesh-list
138829400|NCT00684307|Vitamins|vitamins|mesh-ancestor
138829401|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
138829402|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829403|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
138829404|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138829405|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138829406|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829407|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
138829408|NCT00684307|Coagulants|coagulants|mesh-ancestor
138829409|NCT00683917|Leuprolide|leuprolide|mesh-list
138829410|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138829411|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
138829412|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138829413|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677576|NCT02591199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138677578|NCT02591199|Anticoagulants|anticoagulants|mesh-ancestor
138829414|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138829415|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829416|NCT00750529|Donepezil|donepezil|mesh-list
138829417|NCT00750529|Galantamine|galantamine|mesh-list
138829418|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138829419|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829420|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829421|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
138829422|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829423|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829424|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
138829425|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138829426|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
138829427|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441581|NCT01795248|Liraglutide|liraglutide|mesh-list
138829428|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
138829429|NCT00747877|Melphalan|melphalan|mesh-list
138829430|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138677608|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
138677609|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138829431|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
138677610|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138677611|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138829432|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829433|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138829434|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138677612|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
138677613|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677614|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
138677615|NCT02595489|Vitamin D|vitamin d|mesh-list
138677616|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
138677617|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
138677618|NCT02595489|Vitamins|vitamins|mesh-list
138677619|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
138677620|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138677621|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138677622|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138677623|NCT00497003|Metoprolol|metoprolol|mesh-list
138677624|NCT00497003|Carvedilol|carvedilol|mesh-list
138677625|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138677626|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138677627|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
138829435|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
138829436|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829437|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829438|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138829439|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
138677643|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138829440|NCT00750763|Cathartics|cathartics|mesh-ancestor
138829441|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138829442|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
138829443|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
138829444|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138829445|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138829446|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138829447|NCT00752635|Norgestimate|norgestimate|mesh-list
138829448|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138829449|NCT00752635|Estradiol|estradiol|mesh-list
138829450|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138829451|NCT00752635|Cyproterone|cyproterone|mesh-list
138829452|NCT00752635|Estrogens|estrogens|mesh-ancestor
138829453|NCT00752635|Hormones|hormones|mesh-ancestor
138471300|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
138471301|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
138829454|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138829455|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829456|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138829457|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
138829458|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138829459|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138651570|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
138677709|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138829460|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138677710|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
138677711|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829461|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138829462|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
138829463|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
138829464|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829465|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138829466|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138829467|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138829468|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138829469|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138829470|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138829471|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829472|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829473|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138829475|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
138677758|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138677759|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677761|NCT05146674|Urological Agents|urological agents|mesh-ancestor
138829476|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
138829477|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
138829479|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
138829480|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138829481|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829482|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829483|NCT00752869|Dutasteride|dutasteride|mesh-list
138829484|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138829485|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138829486|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829487|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829488|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
138829489|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138829490|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829491|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
138829492|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138829493|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138829494|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138677821|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138829495|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
138829496|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138829497|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138829498|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138829499|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829500|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829501|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138829502|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138829503|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
138441651|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138829504|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
138829505|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138829506|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
138829507|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829508|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829509|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138829510|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
138829511|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138829512|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
138677876|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677877|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138677878|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138829513|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829514|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829515|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138829516|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
138829517|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
138829518|NCT00748423|Protective Agents|protective agents|mesh-ancestor
138829519|NCT00687271|Atorvastatin|atorvastatin|mesh-list
138829521|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138829522|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829523|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138829524|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138829525|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
138829526|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829527|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138829528|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138829529|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829530|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
138829531|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138829532|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829533|NCT02562625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138829534|NCT02562625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829535|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
138829536|NCT00752947|Metronidazole|metronidazole|mesh-list
138829537|NCT00752947|Levofloxacin|levofloxacin|mesh-list
138829538|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138829539|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138829540|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138829541|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138829542|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829543|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829544|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829545|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138829546|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138829547|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138829548|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138829549|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138677928|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138677929|NCT05143125|Decitabine|decitabine|mesh-list
138677930|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138829550|NCT04614545|Phentermine|phentermine|mesh-list
138829551|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138829552|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829553|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
138829554|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138829555|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
138829556|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
138829557|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829558|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
138677964|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829559|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829560|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829561|NCT01031381|Bevacizumab|bevacizumab|mesh-list
138829562|NCT01031381|Everolimus|everolimus|mesh-list
138829563|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138829564|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829565|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138829566|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138829567|NCT01031381|Growth Substances|growth substances|mesh-ancestor
138829568|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829569|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
138829570|NCT01031381|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138829571|NCT01031381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138829572|NCT01031381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651599|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829573|NCT01031381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829574|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138829575|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
138829576|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138829577|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
138829578|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829580|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138829581|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138829582|NCT00751699|Analgesics|analgesics|mesh-ancestor
138829583|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
138441715|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
138829584|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829585|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829586|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678029|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678030|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
138678031|NCT05145543|Dexamethasone|dexamethasone|mesh-list
138678032|NCT05145543|Fentanyl|fentanyl|mesh-list
138678033|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
138172693|NCT03401060|Denosumab|denosumab|mesh-list
138678035|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
138354874|NCT00002046|Zidovudine|zidovudine|mesh-list
138829587|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138829588|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
138829589|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
138829590|NCT00753103|Prednisolone|prednisolone|mesh-list
138829591|NCT00753103|Infliximab|infliximab|mesh-list
138829592|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
138829593|NCT00753103|Azathioprine|azathioprine|mesh-list
138829594|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138829595|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
138829596|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829597|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138829598|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138829599|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
138829600|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829601|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829602|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138829603|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138829604|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138829605|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
138829606|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138829607|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138829608|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829609|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138829610|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
138829611|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
138829612|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829613|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138829614|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
138829615|NCT00753103|Hormones|hormones|mesh-ancestor
138829616|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441750|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829617|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138829618|NCT00753103|Protective Agents|protective agents|mesh-ancestor
138678069|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211465|NCT05299398|Trazodone|trazodone|mesh-list
138471354|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829619|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138678070|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138678071|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138829620|NCT00753103|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138829621|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
138829622|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
138829623|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138829624|NCT00748891|Cediranib|cediranib|mesh-list
138829625|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829626|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138829627|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829628|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829629|NCT00685165|Primidone|primidone|mesh-list
138829630|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
138829631|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
138829632|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
138829633|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829634|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829635|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829636|NCT00749047|Pioglitazone|pioglitazone|mesh-list
138678106|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138678107|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
138829637|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138829638|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829639|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
138829640|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138829641|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
138829642|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
138829643|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138829644|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829645|NCT00753493|Topiramate|topiramate|mesh-list
138829646|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
138829647|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138829648|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829649|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
138829650|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138829651|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138829652|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829653|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829654|NCT00753571|Protective Agents|protective agents|mesh-ancestor
138829655|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829656|NCT00753727|Sunitinib|sunitinib|mesh-list
138829657|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829658|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138829659|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138829660|NCT00753727|Growth Substances|growth substances|mesh-ancestor
138829661|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829662|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
138829663|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138829664|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829665|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829666|NCT00755989|Morphine|morphine|mesh-list
138829667|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138829668|NCT00755989|Narcotics|narcotics|mesh-ancestor
138829669|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138829670|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829671|NCT00755989|Analgesics|analgesics|mesh-ancestor
138829672|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
138829673|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829674|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138829675|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
138829676|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829677|NCT04053205|Paclitaxel|paclitaxel|mesh-list
138829678|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138829679|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829680|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
138829681|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
138829682|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
138829683|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829684|NCT02559973|Buprenorphine|buprenorphine|mesh-list
138829685|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138829686|NCT02559973|Naloxone|naloxone|mesh-list
138678162|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
138829687|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138678163|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138829688|NCT02559973|Narcotics|narcotics|mesh-ancestor
138829689|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138829690|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829691|NCT02559973|Analgesics|analgesics|mesh-ancestor
138829692|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
138829693|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441833|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
138829694|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138829695|NCT00753883|Simvastatin|simvastatin|mesh-list
138829696|NCT00753883|Ezetimibe|ezetimibe|mesh-list
138651635|NCT00335088|Trace Elements|trace elements|mesh-ancestor
138829697|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138829698|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138829699|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
138829700|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829701|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138829702|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138829703|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829704|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
138829705|NCT00720382|Azelastine|azelastine|mesh-list
138829706|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138829707|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
138829708|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138829709|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138829710|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
138829711|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829712|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829713|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138829714|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
138829715|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138829716|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829717|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829718|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138829719|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138829720|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
138829721|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
138829722|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829723|NCT00754039|Fenofibrate|fenofibrate|mesh-list
138829724|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138829725|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138678187|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
138678188|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829726|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
138829727|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829728|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138829729|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138829730|NCT02560909|Vaccines|vaccines|mesh-list
138829731|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
138829732|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829733|NCT02592226|Anesthetics|anesthetics|mesh-list
138829734|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138829735|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829736|NCT00756301|Lidocaine|lidocaine|mesh-list
138829737|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
138829738|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
138829739|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471388|NCT01995331|Cyclosporins|cyclosporins|mesh-list
138829740|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829741|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
138829742|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829743|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138829744|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138829745|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138441863|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138829746|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138829747|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829748|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
138829750|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829751|NCT00720226|Losartan|losartan|mesh-list
138651646|NCT00335166|Pramipexole|pramipexole|mesh-list
138829753|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138829754|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138829755|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138829756|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829757|NCT00725920|Topiramate|topiramate|mesh-list
138829758|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
138829759|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138829760|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829761|NCT00725842|Ribavirin|ribavirin|mesh-list
138829762|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
138829763|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138829764|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
138678220|NCT01246622|Growth Substances|growth substances|mesh-ancestor
138829765|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829766|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
138829767|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138829768|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829769|NCT04051723|Dexamethasone|dexamethasone|mesh-list
138829770|NCT04051723|Ropivacaine|ropivacaine|mesh-list
138829771|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138829772|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
138829773|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
138829774|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829775|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829776|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138829777|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
138829778|NCT04051723|Hormones|hormones|mesh-ancestor
138829779|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138829780|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138829781|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829782|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
138678253|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138829783|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
138829784|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138829785|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
138829786|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
138829787|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
138829788|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138829789|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138829790|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138829791|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829792|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138829793|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138829795|NCT00756847|Carboplatin|carboplatin|mesh-list
138829796|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138829797|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829798|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
138829799|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
138829800|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
138829801|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829802|NCT04051567|Aspirin|aspirin|mesh-list
138829803|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138829804|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138829805|NCT04051567|Analgesics|analgesics|mesh-ancestor
138829806|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
138829807|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829808|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829810|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138829811|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138651667|NCT00453050|Imiquimod|imiquimod|mesh-list
138829812|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138829813|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829814|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138829815|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138829816|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829817|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
138829818|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
138829819|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138829820|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138829821|NCT00757315|Triamcinolone|triamcinolone|mesh-list
138829822|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138829823|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138829824|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138829825|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138829826|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
138678307|NCT06155279|Pemetrexed|pemetrexed|mesh-list
138829827|NCT00757315|Hormones|hormones|mesh-ancestor
138829828|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138829829|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829830|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138829831|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
138829832|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829833|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829834|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
138829835|NCT00757393|Vitamin D|vitamin d|mesh-list
138829836|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
138829837|NCT00757393|Cholecalciferol|cholecalciferol|mesh-list
138829838|NCT00757393|Vitamins|vitamins|mesh-list
138829839|NCT00757393|Calcium|calcium|mesh-list
138829840|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
138829841|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829842|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138829843|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138829844|NCT00754351|Bevacizumab|bevacizumab|mesh-list
138829845|NCT00754351|Gemcitabine|gemcitabine|mesh-list
138829846|NCT00754351|Docetaxel|docetaxel|mesh-list
138829847|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138829848|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829849|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138829850|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138829851|NCT00754351|Growth Substances|growth substances|mesh-ancestor
138829852|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829853|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
138829854|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138829855|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
138829856|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829857|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
138829858|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
138829859|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
138829860|NCT00754429|Losartan|losartan|mesh-list
138829861|NCT00754429|Amlodipine|amlodipine|mesh-list
138829862|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138829863|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138829864|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138471406|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138829865|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829866|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138829867|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829868|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
138829869|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138829870|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138829871|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138829872|NCT00754507|Atorvastatin|atorvastatin|mesh-list
138829873|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138829874|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138678338|NCT06154590|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138678339|NCT06154590|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138829875|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138829876|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
138829877|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441944|NCT01801410|Misoprostol|misoprostol|mesh-list
138829878|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138829879|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138829880|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829881|NCT00725608|Buprenorphine|buprenorphine|mesh-list
138829882|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138829883|NCT00725608|Naloxone|naloxone|mesh-list
138829884|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138829885|NCT00725608|Narcotics|narcotics|mesh-ancestor
138829886|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138829887|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829888|NCT00725608|Analgesics|analgesics|mesh-ancestor
138829889|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
138829890|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829891|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138829892|NCT00725452|Infliximab|infliximab|mesh-list
138829893|NCT00725452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138829894|NCT00725452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138829895|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
138829896|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138829897|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138829898|NCT00725296|Infliximab|infliximab|mesh-list
138829899|NCT00725296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138829900|NCT00725296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138829901|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
138829902|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138829903|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138829904|NCT00585052|Paclitaxel|paclitaxel|mesh-list
138829905|NCT00585052|Lovastatin|lovastatin|mesh-list
138829906|NCT00585052|L 647318|l 647318|mesh-list
138829907|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
138829908|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138829909|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829910|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
138678360|NCT06154200|Androgens|androgens|mesh-list
138678361|NCT06154200|Hormones|hormones|mesh-ancestor
138678362|NCT06154200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138678363|NCT06154200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678364|NCT06145360|Metformin|metformin|mesh-list
138678365|NCT06145360|Empagliflozin|empagliflozin|mesh-list
138678366|NCT06145360|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138829911|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
138829912|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
138829913|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829914|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138829915|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138829916|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
138829917|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138829918|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138829919|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829920|NCT00724282|Eszopiclone|eszopiclone|mesh-list
138829921|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138829922|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138829923|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829924|NCT04086238|Decitabine|decitabine|mesh-list
138829925|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
138829926|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138829927|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
138471423|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138651696|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138829928|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829929|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829930|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138829931|NCT00724126|Rifaximin|rifaximin|mesh-list
138829932|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138829933|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138829934|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138481893|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138829935|NCT00723892|Ribavirin|ribavirin|mesh-list
138829936|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138829937|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
138829938|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
138829939|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829940|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
138829941|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138829942|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
138829943|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829944|NCT04086940|Esmolol|esmolol|mesh-list
138829945|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138829946|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138829947|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138829948|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
138829949|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829950|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678402|NCT06039566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138678403|NCT06039566|Expectorants|expectorants|mesh-ancestor
138678404|NCT06039566|Respiratory System Agents|respiratory system agents|mesh-ancestor
138829951|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829952|NCT02590900|Acetaminophen|acetaminophen|mesh-list
138829953|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138829954|NCT02590900|Analgesics|analgesics|mesh-ancestor
138829955|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
138829956|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829957|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829958|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
138829959|NCT02591914|Bevacizumab|bevacizumab|mesh-list
138829960|NCT02591914|Ranibizumab|ranibizumab|mesh-list
138829961|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138829962|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138829963|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138829964|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138829965|NCT02591914|Growth Substances|growth substances|mesh-ancestor
138829966|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829967|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
138829968|NCT00723190|Clonidine|clonidine|mesh-list
138829969|NCT00723190|Analgesics|analgesics|mesh-ancestor
138829970|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
138829971|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138829972|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829973|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138829974|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
138829975|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
138829976|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138829977|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138651717|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
138829978|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138829979|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
138829980|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138829981|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138829982|NCT00722800|Drospirenone|drospirenone|mesh-list
138829983|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138829984|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138829985|NCT00722800|Estradiol|estradiol|mesh-list
138829986|NCT00722800|Estrogens|estrogens|mesh-ancestor
138829987|NCT00722800|Hormones|hormones|mesh-ancestor
138829988|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138829989|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138829990|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138829991|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
138829992|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138829993|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138829994|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138829995|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138829996|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138829997|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
138211626|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138678433|NCT06018727|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138678434|NCT06018727|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138678435|NCT06018727|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138678436|NCT06018727|Adrenergic Agents|adrenergic agents|mesh-ancestor
138678437|NCT06018727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678438|NCT06018727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678439|NCT06018727|Urological Agents|urological agents|mesh-ancestor
138829998|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138829999|NCT00722800|Diuretics|diuretics|mesh-ancestor
138830000|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
138830001|NCT00741598|Galantamine|galantamine|mesh-list
138830002|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138830003|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830004|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830005|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
138830006|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138830007|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830008|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138830009|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
138481994|NCT00006258|Etoposide|etoposide|mesh-list
138830010|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830011|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
138830012|NCT03947632|Chrysarobin|chrysarobin|mesh-list
138830013|NCT03947632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138830014|NCT03947632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138830015|NCT03947632|Analgesics|analgesics|mesh-ancestor
138830016|NCT03947632|Sensory System Agents|sensory system agents|mesh-ancestor
138830017|NCT03947632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830018|NCT03947632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830019|NCT03947632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138830020|NCT03947632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138830021|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
138830022|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138830023|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138830024|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830025|NCT04085770|Vitamins|vitamins|mesh-ancestor
138830026|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
138830027|NCT00741286|Aspirin|aspirin|mesh-list
138830028|NCT00741286|Cilostazol|cilostazol|mesh-list
138830029|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138830030|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138830031|NCT00741286|Analgesics|analgesics|mesh-ancestor
138830032|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
138830033|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830034|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678450|NCT05929664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830035|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138830036|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138830037|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138830038|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138830039|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830040|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138830041|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138830042|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830043|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
138830044|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138830045|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
138830046|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138830047|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
138830048|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
138830049|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138830050|NCT00741286|Protective Agents|protective agents|mesh-ancestor
138830051|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138830052|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138830053|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138830054|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830055|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138830056|NCT00716092|Linagliptin|linagliptin|mesh-list
138830057|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138678488|NCT05851508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678489|NCT05851508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138830058|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830059|NCT00716092|Incretins|incretins|mesh-ancestor
138678490|NCT05851508|Glucocorticoids|glucocorticoids|mesh-ancestor
138678491|NCT05851508|Hormones|hormones|mesh-ancestor
138830061|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830062|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138830063|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
138830064|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830065|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830066|NCT02590510|Methotrexate|methotrexate|mesh-list
138830067|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138830068|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
138830069|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138830070|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830071|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138830072|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
138830073|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830074|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830075|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
138830076|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830077|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138830078|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138830079|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
138830080|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138830081|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138830082|NCT00919204|Axitinib|axitinib|mesh-list
138830083|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482039|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138830084|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138830085|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830086|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830087|NCT00715624|Metformin|metformin|mesh-list
138830088|NCT00715624|Lixisenatide|lixisenatide|mesh-list
138830089|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138830090|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830091|NCT00919282|Leucovorin|leucovorin|mesh-list
138830092|NCT00919282|Folic Acid|folic acid|mesh-list
138830093|NCT00919282|Gemcitabine|gemcitabine|mesh-list
138830095|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138830096|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
138830097|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830098|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830099|NCT00919282|Antidotes|antidotes|mesh-ancestor
138830100|NCT00919282|Protective Agents|protective agents|mesh-ancestor
138830101|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830102|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
138830103|NCT00919282|Vitamins|vitamins|mesh-ancestor
138830104|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
138830105|NCT00919282|Hematinics|hematinics|mesh-ancestor
138830106|NCT00757549|Cetuximab|cetuximab|mesh-list
138830107|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138678535|NCT05750264|Sensory System Agents|sensory system agents|mesh-ancestor
138830108|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830109|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138830110|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138678536|NCT05750264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138678537|NCT05750264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830111|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830112|NCT00576199|Bevacizumab|bevacizumab|mesh-list
138830113|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138830114|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830115|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138830116|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138830117|NCT00576199|Growth Substances|growth substances|mesh-ancestor
138830118|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830119|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
138830120|NCT00754819|Colchicine|colchicine|mesh-list
138830121|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
138830122|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138830123|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
138830124|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
138830125|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
138830126|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830127|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830128|NCT02589652|Interferons|interferons|mesh-list
138830129|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
138830130|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
138830131|NCT02589652|Entecavir|entecavir|mesh-list
138830132|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138830133|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830134|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
138830135|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830136|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
138830137|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830138|NCT00679627|Galantamine|galantamine|mesh-list
138830139|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138830140|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830141|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830142|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
138830143|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138830144|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830145|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138830146|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
138830147|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830148|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
138830149|NCT00714688|Methylphenidate|methylphenidate|mesh-list
138830150|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138678555|NCT05713630|Hemostatics|hemostatics|mesh-ancestor
138678556|NCT05713630|Coagulants|coagulants|mesh-ancestor
138678557|NCT05646459|Cannabidiol|cannabidiol|mesh-list
138830151|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830152|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138830153|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138830154|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138830155|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830156|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
138830157|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138830158|NCT05165212|Amoxicillin|amoxicillin|mesh-list
138830159|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138830160|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830161|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
138830162|NCT04051099|Bupivacaine|bupivacaine|mesh-list
138830163|NCT04051099|Propofol|propofol|mesh-list
138830164|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
138830165|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
138830166|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138830167|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830168|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
138830169|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830170|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138830171|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138830172|NCT04051099|Analgesics|analgesics|mesh-ancestor
138830173|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138830174|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138830175|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138830176|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
138830177|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138678589|NCT05555732|Carboplatin|carboplatin|mesh-list
138830178|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678590|NCT05555732|Pembrolizumab|pembrolizumab|mesh-list
138678591|NCT05555732|Pemetrexed|pemetrexed|mesh-list
138830179|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138830180|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
138830181|NCT01031069|Vaccines|vaccines|mesh-list
138830182|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
138830183|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830184|NCT04084912|Dexamethasone|dexamethasone|mesh-list
138830185|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
138830186|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138830187|NCT04084912|BB 1101|bb 1101|mesh-list
138442238|NCT01804127|Rituximab|rituximab|mesh-list
138830188|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138830189|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
138830190|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
138830191|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830192|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830193|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138830194|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
138830195|NCT04084912|Hormones|hormones|mesh-ancestor
138830196|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830197|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138830198|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830199|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
138830200|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830201|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830202|NCT00755053|Clotrimazole|clotrimazole|mesh-list
138830203|NCT00755053|Miconazole|miconazole|mesh-list
138830204|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138830205|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830206|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
138830207|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138830208|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138830209|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830210|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678630|NCT05401565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678631|NCT05401565|Natriuretic Agents|natriuretic agents|mesh-ancestor
138211694|NCT05292066|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138830211|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138830212|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
138830213|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830214|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830215|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138830216|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138830217|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
138830218|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138830219|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138830220|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830221|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
138830222|NCT00755209|Coagulants|coagulants|mesh-ancestor
138830223|NCT02589340|Buspirone|buspirone|mesh-list
138830224|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138830225|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138830226|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138830227|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830228|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138830229|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138830230|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
138830231|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138830232|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830233|NCT00682435|Hydromorphone|hydromorphone|mesh-list
138830234|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138830235|NCT00682435|Narcotics|narcotics|mesh-ancestor
138830236|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138830237|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830238|NCT00682435|Analgesics|analgesics|mesh-ancestor
138830239|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
138471484|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138830240|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830242|NCT05340205|Tranexamic Acid|tranexamic acid|mesh-list
138830243|NCT05340205|Oxytocin|oxytocin|mesh-list
138830245|NCT05340205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138830246|NCT05340205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830247|NCT05340205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138830248|NCT05340205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138830249|NCT05340205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830250|NCT05340205|Hemostatics|hemostatics|mesh-ancestor
138830251|NCT05340205|Coagulants|coagulants|mesh-ancestor
138830252|NCT05340205|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138678668|NCT05146739|Fludarabine|fludarabine|mesh-list
138678671|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
138830253|NCT05340205|Abortifacient Agents|abortifacient agents|mesh-ancestor
138830254|NCT05340205|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138830255|NCT05340205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138830256|NCT00713830|Metformin|metformin|mesh-list
138830257|NCT00713830|Lixisenatide|lixisenatide|mesh-list
138830258|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138830259|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830260|NCT00755521|Etoricoxib|etoricoxib|mesh-list
138830261|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138830262|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138830263|NCT00755521|Analgesics|analgesics|mesh-ancestor
138830264|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
138830265|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830266|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830267|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138830268|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138830269|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138830270|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138830271|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830272|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830273|NCT00681187|Lanreotide|lanreotide|mesh-list
138830274|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830275|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138830276|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
138830277|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138830278|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138830279|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138830280|NCT02588950|Insulin|insulin|mesh-list
138651793|NCT00336414|Prednisone|prednisone|mesh-list
138830281|NCT02588950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138830282|NCT02588950|Insulin, Isophane|insulin, isophane|mesh-list
138830283|NCT02588950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138830284|NCT02588950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830286|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
138830287|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830288|NCT00680407|Protective Agents|protective agents|mesh-ancestor
138830289|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830290|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138830291|NCT04007809|Glucagon|glucagon|mesh-list
138830292|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138830293|NCT04007809|Hormones|hormones|mesh-ancestor
138830294|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830295|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830296|NCT04083664|Hepcidins|hepcidins|mesh-list
138830297|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138678704|NCT05037812|Morphine|morphine|mesh-list
138830298|NCT05202730|Anesthetics|anesthetics|mesh-list
138830299|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
138830300|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138830301|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830302|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
138830303|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830304|NCT00677365|Levofloxacin|levofloxacin|mesh-list
138830305|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138471495|NCT01996306|Irinotecan|irinotecan|mesh-list
138830306|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830307|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138830308|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138830309|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138830310|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830311|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830313|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138830314|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138830317|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138830318|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830319|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830320|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830321|NCT05038462|Lactoferrin|lactoferrin|mesh-list
138830322|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830323|NCT03719131|Rituximab|rituximab|mesh-list
138830324|NCT03719131|Nivolumab|nivolumab|mesh-list
138830325|NCT03719131|Ipilimumab|ipilimumab|mesh-list
138830326|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138830327|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830328|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
138830329|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651807|NCT00336414|Hormones|hormones|mesh-ancestor
138830330|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138830331|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138830332|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830333|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138678734|NCT05019638|Ketorolac|ketorolac|mesh-list
138678735|NCT05019638|Epinephrine|epinephrine|mesh-list
138678736|NCT05019638|Racepinephrine|racepinephrine|mesh-list
138678737|NCT05019638|Morphine|morphine|mesh-list
138678738|NCT05019638|Bupivacaine|bupivacaine|mesh-list
138830334|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
138830335|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138830336|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138830337|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
138830338|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830339|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138830340|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138830341|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830342|NCT00676663|Exemestane|exemestane|mesh-list
138830343|NCT00676663|Entinostat|entinostat|mesh-list
138830344|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830345|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138830346|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138830347|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830348|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830349|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138830350|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
138830351|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830352|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830353|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138830355|NCT02560207|Cefoxitin|cefoxitin|mesh-list
138830356|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138830357|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830358|NCT00678691|Modafinil|modafinil|mesh-list
138830359|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138830360|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830361|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138830362|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138830363|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138471504|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
138830364|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830365|NCT05003752|Goserelin|goserelin|mesh-list
138830366|NCT05003752|Androgens|androgens|mesh-list
138830367|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138830368|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830369|NCT05003752|Hormones|hormones|mesh-ancestor
138830370|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830371|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830372|NCT04997980|Amiodarone|amiodarone|mesh-list
138830373|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138678781|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
138830374|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
138830375|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138830376|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138830377|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830378|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138830379|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138830380|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138830381|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830382|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138830383|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138830384|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138830385|NCT05683912|Aflibercept|aflibercept|mesh-list
138830386|NCT05683912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138830387|NCT05683912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138830388|NCT05683912|Growth Substances|growth substances|mesh-ancestor
138830389|NCT05683912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830390|NCT05683912|Growth Inhibitors|growth inhibitors|mesh-ancestor
138830391|NCT05683912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830392|NCT00679939|Metformin|metformin|mesh-list
138830393|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
138830394|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138830395|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830396|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
138830397|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138830398|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830399|NCT02587390|Simvastatin|simvastatin|mesh-list
138678803|NCT04916002|Cemiplimab|cemiplimab|mesh-list
138678804|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138830400|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138830401|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138830402|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
138830403|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830404|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138830405|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138830406|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830407|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
138830408|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830409|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138830410|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830411|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830412|NCT02588716|Terlipressin|terlipressin|mesh-list
138830413|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138830414|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138830415|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138830416|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138830417|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138830418|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
138830419|NCT00761449|Lenalidomide|lenalidomide|mesh-list
138678850|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138678867|NCT04692285|Zolpidem|zolpidem|mesh-list
138830420|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
138830421|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830422|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138830423|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138830424|NCT00761449|Growth Substances|growth substances|mesh-ancestor
138830425|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
138830426|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830427|NCT04968106|Doxorubicin|doxorubicin|mesh-list
138830428|NCT04968106|Ifosfamide|ifosfamide|mesh-list
138830429|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138830430|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830431|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138830432|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138830433|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830434|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830435|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138830436|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
138830437|NCT00919438|Diuretics|diuretics|mesh-list
138830438|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
138830439|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830440|NCT04082182|Immunomodulating Agents|immunomodulating agents|mesh-list
138830441|NCT04082182|Immunologic Factors|immunologic factors|mesh-ancestor
138830442|NCT04082182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830443|NCT00571519|Metformin|metformin|mesh-list
138830444|NCT00571519|Pioglitazone|pioglitazone|mesh-list
138830445|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138830446|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830447|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138830448|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138830449|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830450|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
138830451|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138830452|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
138830453|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138830454|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830455|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138830456|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138830457|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830458|NCT00921973|Vaccines|vaccines|mesh-list
138830459|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
138830460|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830462|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138830463|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
138830464|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138678903|NCT04538742|Paclitaxel|paclitaxel|mesh-list
138678905|NCT04538742|Durvalumab|durvalumab|mesh-list
138830465|NCT00676195|Expectorants|expectorants|mesh-ancestor
138830466|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
138830467|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138830468|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
138830469|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830470|NCT00676195|Protective Agents|protective agents|mesh-ancestor
138830471|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830472|NCT00676195|Antidotes|antidotes|mesh-ancestor
138830473|NCT02558959|Capecitabine|capecitabine|mesh-list
138830474|NCT02558959|Irinotecan|irinotecan|mesh-list
138830475|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138830476|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
138830477|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830478|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830479|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138830480|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138830481|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830482|NCT04082962|Dexamethasone|dexamethasone|mesh-list
138830483|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138830484|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
138830485|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
138830486|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830487|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471536|NCT01996423|Vitamin D|vitamin d|mesh-list
138830488|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138830489|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
138830490|NCT04082962|Hormones|hormones|mesh-ancestor
138830491|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830492|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138830493|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830494|NCT02471833|Telmisartan|telmisartan|mesh-list
138830495|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138830496|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138830497|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138830498|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830499|NCT04895410|Dexamethasone|dexamethasone|mesh-list
138830500|NCT04895410|Daratumumab|daratumumab|mesh-list
138830501|NCT04895410|Pomalidomide|pomalidomide|mesh-list
138830502|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138830503|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
138678937|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138678938|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830504|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
138678939|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830505|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830506|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830507|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138830508|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
138830509|NCT04895410|Hormones|hormones|mesh-ancestor
138830510|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830511|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138830512|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830513|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
138830514|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138830515|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138830516|NCT04895410|Growth Substances|growth substances|mesh-ancestor
138830517|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
138830518|NCT00675025|Donepezil|donepezil|mesh-list
138830519|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138830520|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830521|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830522|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
138830523|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138830524|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830525|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
138830526|NCT00758407|Methylphenidate|methylphenidate|mesh-list
138830527|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138830528|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830529|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138830530|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138830531|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138830532|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830533|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
138830534|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138830535|NCT00759421|Olanzapine|olanzapine|mesh-list
138678972|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
138830536|NCT00759421|Sertindole|sertindole|mesh-list
138830537|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
138830538|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
138830539|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830540|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830541|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138442460|NCT01808014|Nefopam|nefopam|mesh-list
138830542|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138830543|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138830544|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138830545|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138830546|NCT00759421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138830547|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138830548|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138830549|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830550|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138830551|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
138830553|NCT00762775|Calcium|calcium|mesh-list
138830554|NCT00762775|Vitamins|vitamins|mesh-ancestor
138830555|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
138830556|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830557|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138830558|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138830559|NCT00763165|Triclosan|triclosan|mesh-list
138830560|NCT00763165|Fluorides|fluorides|mesh-list
138830561|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
138679015|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138830562|NCT00763165|Protective Agents|protective agents|mesh-ancestor
138830563|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830564|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138830565|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679016|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138830566|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138830567|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138830568|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
138830569|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830570|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138830572|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830573|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138830574|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138830575|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830576|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830577|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138830578|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
138830579|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830580|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830581|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138830582|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
138830583|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830584|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138830585|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
138830586|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138830587|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138830588|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
138830589|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830590|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
138830591|NCT00760045|Protective Agents|protective agents|mesh-ancestor
138830592|NCT00678379|Lidocaine|lidocaine|mesh-list
138830593|NCT00678379|Clonidine|clonidine|mesh-list
138830594|NCT00678379|Bupivacaine|bupivacaine|mesh-list
138830595|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
138830596|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
138830597|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138830598|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830599|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
138442586|NCT01809301|Niacin|niacin|mesh-list
138830600|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830601|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138830602|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138830603|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138830604|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138173198|NCT00673439|PENTA|penta|mesh-list
138679057|NCT04158050|Omalizumab|omalizumab|mesh-list
138679058|NCT04158050|Antibodies|antibodies|mesh-list
138830605|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830607|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138830609|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
138830610|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138830611|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138830612|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138830613|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
138830614|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138830615|NCT00760279|Azithromycin|azithromycin|mesh-list
138830616|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138830617|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830618|NCT00674323|Ranibizumab|ranibizumab|mesh-list
138830619|NCT00674323|Verteporfin|verteporfin|mesh-list
138830620|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138830621|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138830622|NCT00674323|Growth Substances|growth substances|mesh-ancestor
138830623|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830624|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
138830625|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830626|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138830627|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
138830628|NCT00763633|Vitamins|vitamins|mesh-list
138830629|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
138830630|NCT00763633|Pyridoxal|pyridoxal|mesh-list
138830631|NCT00763633|Pyridoxine|pyridoxine|mesh-list
138830632|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
138830633|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
138830634|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830635|NCT00763789|Remifentanil|remifentanil|mesh-list
138830636|NCT00763789|Anesthetics|anesthetics|mesh-list
138830637|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138442594|NCT01809301|Vitamins|vitamins|mesh-ancestor
138830638|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679093|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830639|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138830640|NCT00763789|Narcotics|narcotics|mesh-ancestor
138830641|NCT00763789|Analgesics|analgesics|mesh-ancestor
138830642|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
138830643|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830644|NCT04115956|Dexamethasone|dexamethasone|mesh-list
138830645|NCT04115956|Melphalan|melphalan|mesh-list
138830646|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138830647|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
138830648|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
138830649|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830650|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830651|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138830652|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
138830653|NCT04115956|Hormones|hormones|mesh-ancestor
138830654|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830655|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138830656|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830657|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138830658|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
138830659|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830660|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138830661|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138830662|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
138830663|NCT04081480|Valacyclovir|valacyclovir|mesh-list
138830664|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
138830665|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830666|NCT00678301|Vaccines|vaccines|mesh-list
138830667|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
138830668|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830669|NCT02586454|Morphine|morphine|mesh-list
138830670|NCT02586454|Ropivacaine|ropivacaine|mesh-list
138830671|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138830672|NCT02586454|Narcotics|narcotics|mesh-ancestor
138830673|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138830674|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830675|NCT02586454|Analgesics|analgesics|mesh-ancestor
138830676|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
138830677|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830678|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
138830679|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
138830680|NCT00939770|Crizotinib|crizotinib|mesh-list
138830681|NCT00939770|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138830682|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830683|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138830684|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442631|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
138830685|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830686|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
138679136|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830687|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
138830688|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
138830689|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138830690|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830691|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
138830692|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830693|NCT00939692|Topiramate|topiramate|mesh-list
138830694|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
138830695|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138830696|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830697|NCT00920608|Methotrexate|methotrexate|mesh-list
138830698|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138830699|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
138830700|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138830701|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830702|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138830703|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
138830704|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830705|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830706|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
138830707|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830708|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138830709|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138830710|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
138830711|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138830712|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138830713|NCT04674514|Dexamethasone|dexamethasone|mesh-list
138830714|NCT04674514|Lenalidomide|lenalidomide|mesh-list
138830715|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138830716|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
138830717|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
138830718|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830719|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830720|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138679163|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
138679164|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138830721|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
138830722|NCT04674514|Hormones|hormones|mesh-ancestor
138471601|NCT01996501|Olanzapine|olanzapine|mesh-list
138830723|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138679180|NCT03933202|Cladribine|cladribine|mesh-list
138830724|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138830725|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830727|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138830728|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138830729|NCT04674514|Growth Substances|growth substances|mesh-ancestor
138830730|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
138830731|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
138830732|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138830733|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
138830734|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830735|NCT04081012|Expectorants|expectorants|mesh-ancestor
138830736|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
138830737|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138830738|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
138830739|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830740|NCT04081012|Protective Agents|protective agents|mesh-ancestor
138830741|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830742|NCT04081012|Antidotes|antidotes|mesh-ancestor
138830743|NCT00942968|Dalteparin|dalteparin|mesh-list
138830744|NCT00942968|Tinzaparin|tinzaparin|mesh-list
138830745|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138830746|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
138679198|NCT03795701|Hormones|hormones|mesh-ancestor
138679199|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830747|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138830748|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138679200|NCT03733067|Abatacept|abatacept|mesh-list
138830749|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830750|NCT00942734|Everolimus|everolimus|mesh-list
138830751|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138830752|NCT00942734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138830753|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138830754|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442699|NCT01810315|Estrogens|estrogens|mesh-ancestor
138830755|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830756|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138830757|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
138830758|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830759|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830760|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
138830761|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138830762|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138830763|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138830764|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138830765|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830766|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
138830767|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138830768|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830769|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138830770|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830773|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138830774|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830775|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
138830776|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
138830777|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
138830778|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830779|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138830780|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
138830781|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830782|NCT00942422|Protective Agents|protective agents|mesh-ancestor
138830783|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830784|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138830785|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138830786|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830787|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138830789|NCT00603824|Lepirudin|lepirudin|mesh-list
138679248|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679249|NCT03241732|Expectorants|expectorants|mesh-ancestor
138679250|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
138679251|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138830790|NCT00603824|Fondaparinux|fondaparinux|mesh-list
138830791|NCT00603824|Argatroban|argatroban|mesh-list
138830792|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138830793|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
138830794|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138830795|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
138830796|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830797|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830798|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
138830799|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138830800|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138442743|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
138830801|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138830802|NCT00677833|Azithromycin|azithromycin|mesh-list
138830803|NCT00677833|Chloroquine|chloroquine|mesh-list
138830804|NCT00677833|Lumefantrine|lumefantrine|mesh-list
138830805|NCT00677833|Artemether|artemether|mesh-list
138830806|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138830807|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138651936|NCT00336960|Celecoxib|celecoxib|mesh-list
138830808|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830809|NCT00677833|Amebicides|amebicides|mesh-ancestor
138830810|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138830811|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138830812|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
138830813|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138830814|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
138830815|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138830816|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138830817|NCT05086874|Protective Agents|protective agents|mesh-ancestor
138830818|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830819|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
138830820|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138830821|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830822|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
138830823|NCT00942266|Leucovorin|leucovorin|mesh-list
138830824|NCT00942266|Fluorouracil|fluorouracil|mesh-list
138830825|NCT00942266|Vorinostat|vorinostat|mesh-list
138830826|NCT00942266|Calcium|calcium|mesh-list
138830827|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
138830828|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138830829|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830830|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138830831|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
138830832|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830833|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138830834|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830835|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138830836|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
138830837|NCT00942266|Antidotes|antidotes|mesh-ancestor
138830838|NCT00942266|Protective Agents|protective agents|mesh-ancestor
138442772|NCT01810731|Vaccines|vaccines|mesh-list
138830839|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
138830841|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
138830842|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138830844|NCT05382182|Androgens|androgens|mesh-list
138830845|NCT05382182|Hormones|hormones|mesh-ancestor
138830846|NCT05382182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830847|NCT05382182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830848|NCT04079374|Etanercept|etanercept|mesh-list
138679280|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138830849|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138830850|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138830851|NCT04079374|Analgesics|analgesics|mesh-ancestor
138830852|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
138679289|NCT03177460|Daratumumab|daratumumab|mesh-list
138830853|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830854|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830855|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138651956|NCT00306410|Vitamin D|vitamin d|mesh-list
138830856|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138830857|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138830858|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138830859|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
138830860|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
138830861|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138830862|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830863|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138830864|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830865|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138830866|NCT02583958|Laxatives|laxatives|mesh-ancestor
138830867|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138830868|NCT00604058|Vaccines|vaccines|mesh-list
138830869|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
138830870|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830871|NCT02852798|Docetaxel|docetaxel|mesh-list
138830872|NCT02852798|Apatinib|apatinib|mesh-list
138830874|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
138830875|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
138830876|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
138830877|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830878|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138830879|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830880|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
138679294|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
138679295|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
138830881|NCT02586610|Capecitabine|capecitabine|mesh-list
138830882|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138830883|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138679296|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138830884|NCT02586610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138830885|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830886|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138830887|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
138830888|NCT00604682|Apremilast|apremilast|mesh-list
138830889|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138830890|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138830891|NCT00604682|Analgesics|analgesics|mesh-ancestor
138830892|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
138830893|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830894|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830895|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138830896|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138830897|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138830898|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138830899|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830900|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830901|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
138830902|NCT00672841|Clotrimazole|clotrimazole|mesh-list
138830903|NCT00672841|Miconazole|miconazole|mesh-list
138830904|NCT00672841|Anidulafungin|anidulafungin|mesh-list
138830905|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830906|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138830907|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138830908|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138830909|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830910|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679338|NCT02872116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679339|NCT02872116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830911|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138830912|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
138830913|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830914|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830915|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138830916|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138830917|NCT00920296|Cabotegravir|cabotegravir|mesh-list
138830919|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138442855|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
138830920|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138830921|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830922|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830923|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138830924|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138830925|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
138830926|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830927|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138830928|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138830930|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
138830931|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830932|NCT00765115|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
138830933|NCT00765115|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138830934|NCT00765115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830935|NCT00765115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830936|NCT04080622|Selenium|selenium|mesh-list
138830937|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
138830938|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830939|NCT04080622|Protective Agents|protective agents|mesh-ancestor
138830940|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830941|NCT04080622|Trace Elements|trace elements|mesh-ancestor
138830942|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
138830943|NCT04079140|Dinoprostone|dinoprostone|mesh-list
138830944|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
138830945|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138830946|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830947|NCT00673465|Metformin|metformin|mesh-list
138830948|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138830949|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830950|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
138830951|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138830952|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138830953|NCT00764413|Prednisolone|prednisolone|mesh-list
138830954|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
138830955|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138830956|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
138830957|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138830958|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
138830959|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
138830960|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138830961|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830962|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138830963|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
138830964|NCT00764413|Hormones|hormones|mesh-ancestor
138830965|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138830966|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138830967|NCT00764413|Protective Agents|protective agents|mesh-ancestor
138830968|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138830969|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830970|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
138830971|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138830972|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
138830974|NCT00583102|Cytarabine|cytarabine|mesh-list
138830975|NCT00583102|Lovastatin|lovastatin|mesh-list
138830976|NCT00583102|L 647318|l 647318|mesh-list
138830977|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
138830978|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138830979|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
138830980|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138830981|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138830982|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
138679417|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830983|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830984|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138830985|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
138830986|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138830987|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138482948|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830988|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138830989|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138830990|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138830991|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138830992|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
138830994|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138830995|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138442916|NCT01811615|Ethanol|ethanol|mesh-list
138830996|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138830997|NCT00605930|Niacinamide|niacinamide|mesh-list
138830999|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
138831000|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
138831001|NCT00605930|Vitamins|vitamins|mesh-ancestor
138831002|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
138831003|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831004|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138831005|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
138831006|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831007|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138831008|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
138831009|NCT00602186|Prazosin|prazosin|mesh-list
138831010|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138831011|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138831012|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138831013|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138831014|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
138831015|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831016|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831017|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831018|NCT04204304|Isotretinoin|isotretinoin|mesh-list
138831019|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
138831020|NCT05380778|Anesthetics|anesthetics|mesh-list
138831021|NCT05380778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831022|NCT05380778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442959|NCT01812096|Bortezomib|bortezomib|mesh-list
138831023|NCT02852720|Anesthetics|anesthetics|mesh-list
138831024|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
138831025|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831026|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831027|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
138831028|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
138831029|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679467|NCT02363374|Vitamins|vitamins|mesh-ancestor
138831030|NCT05857306|Olvanil|olvanil|mesh-list
138679468|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
138679469|NCT02363374|Hematinics|hematinics|mesh-ancestor
138831031|NCT05857306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138831032|NCT05857306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138831033|NCT05857306|Analgesics|analgesics|mesh-ancestor
138831034|NCT05857306|Sensory System Agents|sensory system agents|mesh-ancestor
138831035|NCT05857306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831036|NCT05857306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831037|NCT05857306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138831038|NCT05857306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138831039|NCT05857267|Timolol|timolol|mesh-list
138831040|NCT05857267|Dorzolamide|dorzolamide|mesh-list
138831041|NCT05857267|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138831042|NCT05857267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138831043|NCT05857267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138831044|NCT05857267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138831045|NCT05857267|Adrenergic Agents|adrenergic agents|mesh-ancestor
138831047|NCT05857267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831048|NCT05857267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831049|NCT05857267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138831050|NCT05857267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138831051|NCT05857267|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138831052|NCT05857267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831053|NCT05857202|Analgesics, Opioid|analgesics, opioid|mesh-list
138831054|NCT05857202|Analgesics|analgesics|mesh-list
138831055|NCT05857202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
138679493|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831056|NCT05857202|Narcotics|narcotics|mesh-ancestor
138831057|NCT05857202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831058|NCT05857202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831059|NCT05857202|Sensory System Agents|sensory system agents|mesh-ancestor
138831060|NCT05857202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831061|NCT05857085|Empagliflozin|empagliflozin|mesh-list
138483023|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
138831062|NCT05857085|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138831063|NCT05857085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831064|NCT05857085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138831065|NCT05857085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831066|NCT05857046|Melatonin|melatonin|mesh-list
138831067|NCT05857046|Antioxidants|antioxidants|mesh-ancestor
138831068|NCT05857046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831069|NCT05857046|Protective Agents|protective agents|mesh-ancestor
138679546|NCT01859858|Curcumin|curcumin|mesh-list
138831070|NCT05857046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831071|NCT05857046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831072|NCT05856630|Goserelin|goserelin|mesh-list
138831073|NCT05856630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138831074|NCT05856630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831075|NCT05856578|Canagliflozin|canagliflozin|mesh-list
138831076|NCT05856578|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138831077|NCT05856578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138443000|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138831078|NCT05856578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831079|NCT05856578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831080|NCT05856396|Vaccines|vaccines|mesh-list
138679603|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138679604|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
138831081|NCT05856396|Immunologic Factors|immunologic factors|mesh-ancestor
138831082|NCT05856396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831083|NCT05856383|Vinorelbine|vinorelbine|mesh-list
138831084|NCT05856383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138831085|NCT05856383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831086|NCT05856383|Tubulin Modulators|tubulin modulators|mesh-ancestor
138831087|NCT05856383|Antimitotic Agents|antimitotic agents|mesh-ancestor
138831088|NCT05856383|Mitosis Modulators|mitosis modulators|mesh-ancestor
138652020|NCT00337506|Dexamethasone|dexamethasone|mesh-list
138831089|NCT05856383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831090|NCT05852132|Temazepam|temazepam|mesh-list
138831091|NCT05852132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138831092|NCT05852132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831093|NCT05852132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831094|NCT05852132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138831095|NCT05852132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138831096|NCT05852132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138831097|NCT05852132|GABA Modulators|gaba modulators|mesh-ancestor
138831098|NCT05852132|GABA Agents|gaba agents|mesh-ancestor
138831099|NCT05852132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831100|NCT05852132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831101|NCT05851313|Vitamin D|vitamin d|mesh-list
138831102|NCT05851313|Vitamins|vitamins|mesh-ancestor
138831103|NCT05851313|Micronutrients|micronutrients|mesh-ancestor
138831104|NCT05851313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831105|NCT05851313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138831106|NCT05844813|Doxorubicin|doxorubicin|mesh-list
138831107|NCT05844813|Ifosfamide|ifosfamide|mesh-list
138831108|NCT05844813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138831109|NCT05844813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831110|NCT05844813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138679663|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
138831111|NCT05844813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138831112|NCT05844813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679664|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831113|NCT05844813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831114|NCT05844813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138831115|NCT05844813|Alkylating Agents|alkylating agents|mesh-ancestor
138831116|NCT05812417|DA-8010|da-8010|mesh-list
138831117|NCT05812417|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138831118|NCT05812417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138831119|NCT05812417|Cholinergic Agents|cholinergic agents|mesh-ancestor
138831120|NCT05812417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831121|NCT05812417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831122|NCT05812417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831123|NCT05766540|Metformin|metformin|mesh-list
138831124|NCT05766540|Aripiprazole|aripiprazole|mesh-list
138831125|NCT05766540|Clozapine|clozapine|mesh-list
138831126|NCT05766540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138831127|NCT05766540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831128|NCT05766540|Antidepressive Agents|antidepressive agents|mesh-ancestor
138831129|NCT05766540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138831130|NCT05766540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138831131|NCT05766540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138831132|NCT05766540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831133|NCT05766540|Dopamine Agonists|dopamine agonists|mesh-ancestor
138831134|NCT05766540|Dopamine Agents|dopamine agents|mesh-ancestor
138831135|NCT05766540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483101|NCT05546320|Purinergic Agents|purinergic agents|mesh-ancestor
138679707|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679708|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138679709|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
138443051|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138831136|NCT05766540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138679710|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
138831137|NCT05766540|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138831138|NCT05766540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138831140|NCT05766540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138831141|NCT05766540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138831142|NCT05766540|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138831143|NCT05766540|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138831144|NCT05766540|GABA Antagonists|gaba antagonists|mesh-ancestor
138831145|NCT05766540|GABA Agents|gaba agents|mesh-ancestor
138831146|NCT05746806|Androgens|androgens|mesh-list
138831147|NCT05746806|Hormones|hormones|mesh-ancestor
138831148|NCT05746806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138831149|NCT05746806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831150|NCT05741229|Nitroglycerin|nitroglycerin|mesh-list
138831151|NCT05741229|Vasodilator Agents|vasodilator agents|mesh-ancestor
138831152|NCT05733715|Pembrolizumab|pembrolizumab|mesh-list
138831153|NCT05733715|Lenvatinib|lenvatinib|mesh-list
138831154|NCT05733715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138831155|NCT05733715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831156|NCT05733715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138831157|NCT05733715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831158|NCT05733715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138831159|NCT05733715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831160|NCT05678647|Iron|iron|mesh-list
138831161|NCT05678647|Trace Elements|trace elements|mesh-ancestor
138831162|NCT05678647|Micronutrients|micronutrients|mesh-ancestor
138831163|NCT05678647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831164|NCT05639907|Ethanol|ethanol|mesh-list
138831165|NCT05639907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138831166|NCT05639907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138831167|NCT05639907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831168|NCT05639907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831169|NCT05625334|Aspirin|aspirin|mesh-list
138831170|NCT05625334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138831171|NCT05625334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138831172|NCT05625334|Analgesics|analgesics|mesh-ancestor
138831173|NCT05625334|Sensory System Agents|sensory system agents|mesh-ancestor
138831174|NCT05625334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831175|NCT05625334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831176|NCT05625334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138831177|NCT05625334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138831178|NCT05625334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138679751|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138831179|NCT05625334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138831180|NCT05625334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831181|NCT05625334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138831182|NCT05625334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138831183|NCT05625334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831184|NCT05625334|Antipyretics|antipyretics|mesh-ancestor
138831185|NCT05614115|Empagliflozin|empagliflozin|mesh-list
138831186|NCT05614115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138831187|NCT05614115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831188|NCT05614115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138831189|NCT05614115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831190|NCT05604794|Ketamine|ketamine|mesh-list
138831191|NCT05604794|Analgesics|analgesics|mesh-ancestor
138831192|NCT05604794|Sensory System Agents|sensory system agents|mesh-ancestor
138831193|NCT05604794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831194|NCT05604794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831195|NCT05604794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138831196|NCT05604794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138831197|NCT05604794|Anesthetics, General|anesthetics, general|mesh-ancestor
138831198|NCT05604794|Anesthetics|anesthetics|mesh-ancestor
138831199|NCT05604794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831200|NCT05604794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138831201|NCT05604794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138679785|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
138831202|NCT05604794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831203|NCT05604794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831204|NCT05542134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138831205|NCT05419089|Cisplatin|cisplatin|mesh-list
138831206|NCT05419089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831207|NCT05366829|Tislelizumab|tislelizumab|mesh-list
138831208|NCT05366829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138831209|NCT05366829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471697|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
138831211|NCT05305248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138831212|NCT05305248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831213|NCT05305248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831214|NCT05305248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138831215|NCT05305248|Analgesics|analgesics|mesh-ancestor
138831216|NCT05305248|Sensory System Agents|sensory system agents|mesh-ancestor
138831217|NCT05305248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831218|NCT05305248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138831219|NCT05305248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138831220|NCT05305248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138831221|NCT05305248|Adrenergic Agents|adrenergic agents|mesh-ancestor
138831222|NCT05305248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831223|NCT05305248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831225|NCT05286996|Anesthetics, Local|anesthetics, local|mesh-list
138831226|NCT05286996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831227|NCT05286996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831228|NCT05286996|Sensory System Agents|sensory system agents|mesh-ancestor
138831229|NCT05286996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831230|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
138831231|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
138831232|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831233|NCT05210166|Protective Agents|protective agents|mesh-ancestor
138831234|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831235|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138831236|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831237|NCT05169593|Adalimumab|adalimumab|mesh-list
138831238|NCT05169593|Infliximab|infliximab|mesh-list
138831239|NCT05169593|Ustekinumab|ustekinumab|mesh-list
138679827|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138831240|NCT05169593|Vedolizumab|vedolizumab|mesh-list
138831241|NCT05169593|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138831242|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138831243|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138679829|NCT00507858|Hormones|hormones|mesh-ancestor
138831244|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
138831245|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138831246|NCT05158153|Furosemide|furosemide|mesh-list
138831247|NCT05158153|Diuretics|diuretics|mesh-ancestor
138831248|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
138831249|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831250|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138831251|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138831252|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831253|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
138831254|NCT05147558|Lenvatinib|lenvatinib|mesh-list
138831255|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138831256|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831257|NCT05147558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138831258|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831259|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138831260|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831261|NCT05098366|Furosemide|furosemide|mesh-list
138831262|NCT05098366|Diuretics|diuretics|mesh-ancestor
138831263|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
138831264|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831265|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138831266|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138831267|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831268|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
138831269|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138831270|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
138831271|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831272|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
138831273|NCT05082480|Protective Agents|protective agents|mesh-ancestor
138831274|NCT05073250|Rituximab|rituximab|mesh-list
138831275|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138831276|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831277|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
138831278|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831279|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138831280|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
138831281|NCT05041270|Nalbuphine|nalbuphine|mesh-list
138831282|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138831283|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831284|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831285|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138831286|NCT05041270|Analgesics|analgesics|mesh-ancestor
138831287|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
138831288|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831289|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138831290|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138831291|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138831292|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
138831293|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831294|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831295|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138831298|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138831299|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831300|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138831301|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831302|NCT05010590|Denosumab|denosumab|mesh-list
138679866|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
138831303|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138679867|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138679868|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138679871|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
138831304|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831305|NCT04940637|Niraparib|niraparib|mesh-list
138831306|NCT04940637|Dostarlimab|dostarlimab|mesh-list
138831307|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138831308|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831309|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831310|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831311|NCT04911660|Empagliflozin|empagliflozin|mesh-list
138831312|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138831313|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831314|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138831315|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831316|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
138831317|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138831318|NCT04881682|Antibodies|antibodies|mesh-list
138831319|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
138831320|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831321|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138831322|NCT04839185|Hematinics|hematinics|mesh-ancestor
138652156|NCT00338091|Losartan|losartan|mesh-list
138831323|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138831324|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138831325|NCT04806906|Azacitidine|azacitidine|mesh-list
138831327|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138831328|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
138831329|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831330|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831331|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831332|NCT04752059|Trastuzumab|trastuzumab|mesh-list
138831333|NCT04752059|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138831334|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138831335|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831336|NCT04752059|Immunoconjugates|immunoconjugates|mesh-ancestor
138831337|NCT04752059|Immunologic Factors|immunologic factors|mesh-ancestor
138831338|NCT04752059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831339|NCT04750473|Edetic Acid|edetic acid|mesh-list
138831340|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138831341|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
138831342|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
138831343|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831344|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
138831345|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138831346|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138831347|NCT04745351|Remdesivir|remdesivir|mesh-list
138831348|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
138679877|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138679878|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138679879|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138679880|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
138679881|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831349|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831350|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
138831351|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138831352|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
138679906|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831353|NCT04710277|Narcotics|narcotics|mesh-ancestor
138831354|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831355|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831356|NCT04710277|Analgesics|analgesics|mesh-ancestor
138831357|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
138483324|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
138831358|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831359|NCT04665089|Erythromycin|erythromycin|mesh-list
138831360|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
138831361|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138831362|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
138831363|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138831364|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138831365|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138831366|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138831367|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831368|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831369|NCT04591002|Osimertinib|osimertinib|mesh-list
138831370|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831371|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138831372|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831373|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831374|NCT04498780|Valsartan|valsartan|mesh-list
138831375|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138831376|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138831377|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138831378|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138831379|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831380|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
138831381|NCT04493333|Psyllium|psyllium|mesh-list
138652193|NCT00338247|Capecitabine|capecitabine|mesh-list
138831382|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138831383|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138831384|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
138831385|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831386|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
138831387|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138831388|NCT04493333|Cathartics|cathartics|mesh-ancestor
138831389|NCT04427501|Bamlanivimab|bamlanivimab|mesh-list
138831390|NCT04427501|Antiviral Agents|antiviral agents|mesh-ancestor
138831391|NCT04427501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138831392|NCT04403165|Norepinephrine|norepinephrine|mesh-list
138831393|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138831394|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138831395|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
138831396|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831397|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831398|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831399|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
138831400|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
138831401|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138679907|NCT02954484|Analgesics|analgesics|mesh-ancestor
138831402|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138831403|NCT04289779|Atezolizumab|atezolizumab|mesh-list
138831404|NCT04289779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138831405|NCT04289779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831406|NCT04289779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138831407|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831408|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
138831409|NCT04130516|Antibodies|antibodies|mesh-list
138831410|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
138831411|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831412|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138831413|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831414|NCT04130516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138831415|NCT04130516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831416|NCT03989778|Vitamin D|vitamin d|mesh-list
138831417|NCT03989778|Vitamins|vitamins|mesh-ancestor
138831418|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
138831419|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831420|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138831421|NCT03976063|Nifedipine|nifedipine|mesh-list
138831422|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138831423|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138831424|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831425|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138831426|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831427|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
138831428|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
138831429|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138831430|NCT03959527|Azithromycin|azithromycin|mesh-list
138831431|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
138831432|NCT03959527|Zoliflodacin|zoliflodacin|mesh-list
138652207|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
138831433|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138831434|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138831435|NCT03959527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138831436|NCT03959527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138831437|NCT03959527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831438|NCT03959527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831439|NCT03959527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831441|NCT03955172|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138831442|NCT03955172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138831443|NCT03955172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831444|NCT03955172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831445|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138831446|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
138831447|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831448|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831449|NCT03947216|Pimavanserin|pimavanserin|mesh-list
138831450|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138831451|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138831452|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138831453|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138831454|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831455|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831456|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138831457|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138831458|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138831459|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
138831460|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138679971|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
138679972|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
138679973|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138679974|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138831461|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831462|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138831463|NCT03889249|Tenecteplase|tenecteplase|mesh-list
138831464|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138831465|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138831466|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831467|NCT03841201|Nivolumab|nivolumab|mesh-list
138831468|NCT03841201|Lenvatinib|lenvatinib|mesh-list
138831469|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138831470|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831471|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138831472|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831473|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138831474|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831475|NCT03733535|Benralizumab|benralizumab|mesh-list
138831476|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138831477|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
138831478|NCT03719092|Vitamins|vitamins|mesh-list
138831479|NCT03719092|Vitamin A|vitamin a|mesh-list
138831480|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
138831481|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
138831482|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831483|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
138831484|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831485|NCT03719092|Protective Agents|protective agents|mesh-ancestor
138831486|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138680014|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680015|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
138680017|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138831487|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831488|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
138831489|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138831490|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
138831491|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831492|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831493|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138831494|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
138831495|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138831496|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
138831497|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831498|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831499|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138831500|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
138831501|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
138831502|NCT03661385|Protective Agents|protective agents|mesh-ancestor
138831503|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
138831504|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138831505|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
138831506|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138831507|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
138831508|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831509|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831510|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
138831511|NCT03617731|Dexamethasone|dexamethasone|mesh-list
138831512|NCT03617731|Lenalidomide|lenalidomide|mesh-list
138831513|NCT03617731|Bortezomib|bortezomib|mesh-list
138831514|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138831515|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
138831522|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138831523|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138831524|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831525|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
138831526|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138831527|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138831528|NCT03617731|Growth Substances|growth substances|mesh-ancestor
138831529|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
138831530|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
138831531|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138831532|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138831533|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831534|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
138831535|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
138680063|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138831536|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138831537|NCT03439124|Cephalosporins|cephalosporins|mesh-list
138831538|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
138831539|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
138831540|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138831541|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138831542|NCT03393741|Paclitaxel|paclitaxel|mesh-list
138831543|NCT03393741|Vinorelbine|vinorelbine|mesh-list
138831544|NCT03393741|Docetaxel|docetaxel|mesh-list
138831545|NCT03393741|Epothilones|epothilones|mesh-list
138831546|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
138831547|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138831549|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138680095|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138831550|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831551|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
138831552|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
138831553|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
138831554|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831555|NCT03304093|Nivolumab|nivolumab|mesh-list
138831556|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138831557|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831558|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138680096|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831559|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831565|NCT03263117|Anesthetics|anesthetics|mesh-list
138831566|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138443397|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138831567|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831568|NCT03232918|Oxytocin|oxytocin|mesh-list
138831569|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
138831570|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138831571|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831572|NCT03212989|Vorinostat|vorinostat|mesh-list
138831573|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831574|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138831575|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471788|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
138831576|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831577|NCT03158688|Dexamethasone|dexamethasone|mesh-list
138831578|NCT03158688|Daratumumab|daratumumab|mesh-list
138831579|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138831580|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
138831581|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
138831582|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831583|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831584|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138831585|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
138831587|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138831588|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138831589|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831590|NCT03137173|Vancomycin|vancomycin|mesh-list
138680146|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138680147|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138831591|NCT03137173|Aztreonam|aztreonam|mesh-list
138831592|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
138680148|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138831593|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
138831594|NCT03137173|Cephalosporins|cephalosporins|mesh-list
138831595|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138831596|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138831597|NCT03072147|Teriparatide|teriparatide|mesh-list
138831598|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138831599|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831600|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138831601|NCT02723513|Xenon|xenon|mesh-list
138831602|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138831603|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
138831604|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
138831605|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831606|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831607|NCT02706054|Meloxicam|meloxicam|mesh-list
138443423|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138831608|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138831609|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138831610|NCT02706054|Analgesics|analgesics|mesh-ancestor
138831611|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
138831612|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831613|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831614|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138831615|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138831616|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138680187|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138831617|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138831618|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831619|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831620|NCT02630641|Hormones|hormones|mesh-list
138831621|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138831622|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831623|NCT02600117|Tenofovir|tenofovir|mesh-list
138831624|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
138831625|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471812|NCT01998113|Insulin|insulin|mesh-list
138831626|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138831627|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138831628|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831629|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831630|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138831631|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138831632|NCT02599714|Fulvestrant|fulvestrant|mesh-list
138831633|NCT02599714|Palbociclib|palbociclib|mesh-list
138831634|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138831635|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831636|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138831637|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138831638|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
138831639|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138831640|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831641|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138831642|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831643|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831644|NCT02337634|Silymarin|silymarin|mesh-list
138831645|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
138831646|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680236|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138831647|NCT02337634|Protective Agents|protective agents|mesh-ancestor
138831648|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831649|NCT02288195|Capecitabine|capecitabine|mesh-list
138831650|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
138831651|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138443464|NCT01814501|Vitamins|vitamins|mesh-ancestor
138831652|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
138831653|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831654|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831655|NCT02265874|Nicotine|nicotine|mesh-list
138831656|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138831657|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
138831659|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831660|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138831661|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138831662|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
138831663|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831664|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831665|NCT01996436|Verapamil|verapamil|mesh-list
138831666|NCT01996436|Nicardipine|nicardipine|mesh-list
138831667|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
138831668|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
138831669|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138831670|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138831671|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138831672|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831673|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138831674|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831675|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138831677|NCT01845337|Tegafur|tegafur|mesh-list
138831678|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138831679|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
138831680|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831681|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831682|NCT00836537|Benazepril|benazepril|mesh-list
138831683|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138831684|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
138831685|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831686|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831687|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138831688|NCT00572169|Thalidomide|thalidomide|mesh-list
138831689|NCT00572169|Dexamethasone|dexamethasone|mesh-list
138831690|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
138831691|NCT00572169|Cisplatin|cisplatin|mesh-list
138831692|NCT00572169|Doxorubicin|doxorubicin|mesh-list
138680277|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138680280|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
138831693|NCT00572169|Etoposide|etoposide|mesh-list
138831694|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138831695|NCT00572169|Bortezomib|bortezomib|mesh-list
138831696|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138831697|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
138831698|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831699|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138831700|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138831701|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
138831702|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831703|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831704|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138831705|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138831706|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
138831707|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
138831708|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831709|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138831710|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
138831712|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138831713|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138831714|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138831715|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138831716|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138831717|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831718|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138831719|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
138831720|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138831721|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138831722|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138831723|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138831724|NCT00572169|Growth Substances|growth substances|mesh-ancestor
138831725|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
138831726|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
138831727|NCT00941720|Busulfan|busulfan|mesh-list
138831728|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138831729|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
138831730|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831731|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138483736|NCT00006103|Leucovorin|leucovorin|mesh-list
138831732|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138831733|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
138831734|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831735|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831736|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138831737|NCT02583568|Bevacizumab|bevacizumab|mesh-list
138831738|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138831739|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138680309|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138680310|NCT00510705|Metformin|metformin|mesh-list
138831740|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138831741|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138831742|NCT02583568|Growth Substances|growth substances|mesh-ancestor
138831743|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831744|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
138831745|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
138831746|NCT02852564|Diuretics|diuretics|mesh-ancestor
138831747|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
138831748|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831749|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831750|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831751|NCT05593042|Vaccines|vaccines|mesh-list
138831752|NCT05593042|Immunologic Factors|immunologic factors|mesh-ancestor
138831753|NCT05593042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831754|NCT05509816|Midazolam|midazolam|mesh-list
138831755|NCT05509816|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138831756|NCT05509816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138831757|NCT05509816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831758|NCT05509816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831759|NCT05509816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138831760|NCT05509816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138652348|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
138831761|NCT05509816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138831762|NCT05509816|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138831763|NCT05509816|Anesthetics, General|anesthetics, general|mesh-ancestor
138831764|NCT05509816|Anesthetics|anesthetics|mesh-ancestor
138831765|NCT05509816|GABA Modulators|gaba modulators|mesh-ancestor
138831766|NCT05509816|GABA Agents|gaba agents|mesh-ancestor
138831767|NCT05509816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831768|NCT05509816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443540|NCT01814891|Vitamin A|vitamin a|mesh-list
138831770|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138831771|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138831772|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138831773|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
138831774|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831775|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138831776|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831778|NCT04078048|Vitamin E|vitamin e|mesh-list
138831779|NCT04078048|Antioxidants|antioxidants|mesh-list
138831780|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
138831781|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831782|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831783|NCT04078048|Protective Agents|protective agents|mesh-ancestor
138680337|NCT01248923|Hormones|hormones|mesh-ancestor
138831784|NCT00673387|Pramlintide|pramlintide|mesh-list
138831785|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
138831786|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138831787|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831788|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
138831789|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138831790|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
138831791|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831792|NCT00933608|Memantine|memantine|mesh-list
138831793|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138831794|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138831795|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
138831796|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831797|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831798|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831799|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138831800|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138831801|NCT05380310|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138831802|NCT02558023|Nicardipine|nicardipine|mesh-list
138831803|NCT02558023|Urapidil|urapidil|mesh-list
138831804|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138831805|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138831806|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138831807|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831808|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138831809|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831810|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
138831811|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138831812|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
138831813|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831814|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138831815|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138652353|NCT00309530|Interferons|interferons|mesh-list
138680367|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138680369|NCT00502190|Trace Elements|trace elements|mesh-ancestor
138680370|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
138831816|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138831817|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
138831818|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138831819|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138831820|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138831821|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138831822|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831823|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
138831824|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831825|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831826|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
138831827|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138831828|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
138471900|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
138831829|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831831|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
138831832|NCT00574951|Imetelstat|imetelstat|mesh-list
138831833|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138831834|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831835|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831836|NCT02584816|Vaccines|vaccines|mesh-list
138831837|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
138831838|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831839|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
138831840|NCT02584738|Prednisolone|prednisolone|mesh-list
138831841|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
138831842|NCT02584738|Bromides|bromides|mesh-list
138831843|NCT02584738|Albuterol|albuterol|mesh-list
138831844|NCT02584738|Ipratropium|ipratropium|mesh-list
138831845|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138831846|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
138831847|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
138831848|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831849|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831850|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138831851|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
138831852|NCT02584738|Hormones|hormones|mesh-ancestor
138831853|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138831854|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138831855|NCT02584738|Protective Agents|protective agents|mesh-ancestor
138831856|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138831857|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831858|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
138831859|NCT02584738|Analgesics|analgesics|mesh-ancestor
138831860|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
138831861|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
138831862|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138831863|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138831864|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138680407|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138680408|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831865|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138831866|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680409|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
138831867|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138831868|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
138831869|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138652373|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
138831870|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138831871|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138831872|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
138831873|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138831874|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138831875|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138831876|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
138831877|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138831878|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138831879|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
138831880|NCT00765271|Ritonavir|ritonavir|mesh-list
138831881|NCT00765271|Darunavir|darunavir|mesh-list
138831882|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
138831883|NCT00765271|Abacavir|abacavir|mesh-list
138831884|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138831885|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138831886|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
138831887|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831888|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831889|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138831890|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138831891|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
138831892|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138831893|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138831894|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138831895|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138831896|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138831897|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138831898|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138831899|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
138831900|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138831901|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138831902|NCT02583022|Analgesics|analgesics|mesh-ancestor
138831903|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
138831904|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831905|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831906|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138831907|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138831908|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
138831909|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138831910|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
138831911|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138831912|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831913|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831914|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
138831915|NCT00764725|Infliximab|infliximab|mesh-list
138831916|NCT00764725|Methotrexate|methotrexate|mesh-list
138831917|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138831918|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
138831919|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138831920|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831921|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138831922|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
138831923|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831924|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831925|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
138831926|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831927|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138831928|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138831929|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
138831930|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138831931|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138831932|NCT00764725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138831933|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138831934|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138831935|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138831936|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138831937|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138831939|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
138831940|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831941|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
138831942|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138831943|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831944|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
138831945|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831946|NCT04077892|Budesonide|budesonide|mesh-list
138831947|NCT04077892|Montelukast|montelukast|mesh-list
138831948|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138831949|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138831950|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
138831951|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831952|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831953|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138831954|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
138831955|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
138831956|NCT04077892|Hormones|hormones|mesh-ancestor
138831957|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138831958|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138831959|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
138680455|NCT01249430|Etoposide|etoposide|mesh-list
138680456|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
138680457|NCT01249430|Azacitidine|azacitidine|mesh-list
138680458|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
138831960|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138831961|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138680463|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831962|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831963|NCT00606242|Fluticasone|fluticasone|mesh-list
138831964|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138831965|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138831966|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
138831967|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138831968|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831969|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138831970|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
138831971|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
138831972|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138831973|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138831974|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138831975|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
138831976|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831977|NCT00770263|Sirolimus|sirolimus|mesh-list
138831978|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138831979|NCT00770263|Temsirolimus|temsirolimus|mesh-list
138831980|NCT00770263|MTOR Inhibitors|mtor inhibitors|mesh-list
138831981|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831982|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138831983|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138831984|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831985|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138831986|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
138831987|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138831988|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138831989|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138831990|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138831991|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
138831992|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
138831993|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138831994|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138831995|NCT02691026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138831996|NCT02691026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138831997|NCT05400148|Bupivacaine|bupivacaine|mesh-list
138831998|NCT05400148|Anesthetics, Local|anesthetics, local|mesh-ancestor
138831999|NCT05400148|Anesthetics|anesthetics|mesh-ancestor
138832000|NCT05400148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138832001|NCT05400148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832002|NCT05400148|Sensory System Agents|sensory system agents|mesh-ancestor
138832003|NCT05400148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832004|NCT00765427|Retinol acetate|retinol acetate|mesh-list
138832005|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138832006|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
138832007|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832008|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138443743|NCT01816620|Dexamethasone|dexamethasone|mesh-list
138832009|NCT00765427|Protective Agents|protective agents|mesh-ancestor
138832010|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832011|NCT02584582|Liraglutide|liraglutide|mesh-list
138832012|NCT02584582|Exenatide|exenatide|mesh-list
138832013|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138832014|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832015|NCT02584582|Incretins|incretins|mesh-ancestor
138832016|NCT02584582|Hormones|hormones|mesh-ancestor
138832017|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138832018|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138832019|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138832020|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
138832021|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832022|NCT00765973|Topotecan|topotecan|mesh-list
138832023|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138832024|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138832025|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832026|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832027|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832028|NCT00775177|Doxycycline|doxycycline|mesh-list
138832029|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138832030|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832031|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
138832032|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138832033|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138832035|NCT00770497|Ramipril|ramipril|mesh-list
138832036|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138832037|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832038|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138832039|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
138832040|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443792|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138832041|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832042|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138832043|NCT02581696|Irsogladine|irsogladine|mesh-list
138832045|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832046|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138832047|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138832048|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138680526|NCT00511017|Vitamins|vitamins|mesh-ancestor
138832049|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
138832050|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
138832051|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138832052|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832053|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832054|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138832055|NCT02581696|Protective Agents|protective agents|mesh-ancestor
138832056|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138832057|NCT00607958|Ritonavir|ritonavir|mesh-list
138832058|NCT00607958|Tipranavir|tipranavir|mesh-list
138832059|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138832060|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138832061|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
138832062|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832063|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832064|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138832065|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138832066|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
138832067|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832068|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138832069|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138832070|NCT00770575|Pioglitazone|pioglitazone|mesh-list
138832071|NCT00770575|Atorvastatin|atorvastatin|mesh-list
138832072|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138832073|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138832074|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
138832075|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832076|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138832077|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138832078|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832079|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138832080|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680546|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
138832081|NCT00770731|Sirolimus|sirolimus|mesh-list
138832082|NCT00770731|Bortezomib|bortezomib|mesh-list
138680547|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
138832083|NCT00770731|Topotecan|topotecan|mesh-list
138832084|NCT00770731|Temsirolimus|temsirolimus|mesh-list
138832085|NCT00770731|MTOR Inhibitors|mtor inhibitors|mesh-list
138832086|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832087|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138832088|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138832089|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832090|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385194|NCT01068327|Leucovorin|leucovorin|mesh-list
138832091|NCT00770731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138832092|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138832093|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
138832094|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832095|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138832096|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832097|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138832098|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
138832099|NCT00775255|Clarithromycin|clarithromycin|mesh-list
138832100|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138832101|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832102|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138832103|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832104|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484087|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832105|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138832106|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138832107|NCT00766285|Vaccines|vaccines|mesh-list
138832108|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
138832109|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832110|NCT04265456|Acetaminophen|acetaminophen|mesh-list
138832111|NCT04265456|Pregabalin|pregabalin|mesh-list
138832112|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138832113|NCT04265456|Analgesics|analgesics|mesh-ancestor
138832114|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
138832115|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832116|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832117|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
138832118|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
138832119|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138832120|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138832121|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832122|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138832123|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138832124|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138832125|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138832126|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138832127|NCT04379518|Interferons|interferons|mesh-list
138832128|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
138832129|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
138832130|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138832131|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832132|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
138832133|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832134|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
138680589|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
138680590|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832135|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832136|NCT04378426|Midazolam|midazolam|mesh-list
138832137|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
138832138|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138832139|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138471962|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
138832140|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138832141|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832142|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138832143|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138832144|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138832145|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138832146|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
138832147|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
138832148|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
138832149|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
138832150|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138832151|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832152|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138832153|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138832154|NCT04378426|Analgesics|analgesics|mesh-ancestor
138832155|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
138832156|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832157|NCT02581462|Trastuzumab|trastuzumab|mesh-list
138832158|NCT02581462|Pertuzumab|pertuzumab|mesh-list
138832159|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138832160|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832161|NCT00668863|Leucovorin|leucovorin|mesh-list
138832162|NCT00668863|Fluorouracil|fluorouracil|mesh-list
138832163|NCT00668863|Irinotecan|irinotecan|mesh-list
138832164|NCT00668863|Sunitinib|sunitinib|mesh-list
138832165|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
138832166|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
138832167|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832168|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138832169|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832170|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138832171|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
138832172|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832173|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138832174|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138832175|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832176|NCT00668863|Antidotes|antidotes|mesh-ancestor
138680609|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
138832177|NCT00668863|Protective Agents|protective agents|mesh-ancestor
138832178|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
138484159|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832180|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
138832181|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138832182|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138832183|NCT00668863|Growth Substances|growth substances|mesh-ancestor
138832184|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
138832185|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138832186|NCT04077736|Aldesleukin|aldesleukin|mesh-list
138832187|NCT04077736|Interleukin-2|interleukin-2|mesh-list
138832188|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832189|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138832190|NCT04077736|Analgesics|analgesics|mesh-ancestor
138832191|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
138832192|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832193|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832194|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138832195|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138832196|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
138832197|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832198|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138832199|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138832200|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832201|NCT00766441|Incretins|incretins|mesh-ancestor
138832203|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138832204|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138832205|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
138832206|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832207|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832208|NCT00771043|Natalizumab|natalizumab|mesh-list
138832209|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
138832210|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832211|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
138832212|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138832213|NCT04267250|Estradiol|estradiol|mesh-list
138832214|NCT04267250|PF-06700841|pf-06700841|mesh-list
138832215|NCT04267250|Estrogens|estrogens|mesh-ancestor
138832216|NCT04267250|Hormones|hormones|mesh-ancestor
138832217|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138832218|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832219|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138832220|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
138832221|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138680640|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138832222|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138832223|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138832224|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138832225|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138832226|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138832227|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832228|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832229|NCT00775489|Beclomethasone|beclomethasone|mesh-list
138832230|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138832231|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
138832232|NCT00775489|Hormones|hormones|mesh-ancestor
138832233|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138832234|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832235|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138832236|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
138832237|NCT00771199|Fentanyl|fentanyl|mesh-list
138832238|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138832239|NCT00771199|Narcotics|narcotics|mesh-ancestor
138832240|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138832241|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832242|NCT00771199|Analgesics|analgesics|mesh-ancestor
138832243|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
138832244|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832245|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138832246|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138832247|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
138832248|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
138832249|NCT04264130|Artesunate|artesunate|mesh-list
138832250|NCT04264130|Lumefantrine|lumefantrine|mesh-list
138832251|NCT04264130|Artemether|artemether|mesh-list
138832252|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138832253|NCT04264130|Pyronaridine|pyronaridine|mesh-list
138832254|NCT04264130|Artefenomel|artefenomel|mesh-list
138832255|NCT04264130|Ferroquine|ferroquine|mesh-list
138832256|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
138832257|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138832258|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138832259|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443960|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
138832260|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832261|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
138832262|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
138832263|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138832264|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
138832265|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
138832266|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138832267|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138832268|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832269|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138832270|NCT02557867|Analgesics|analgesics|mesh-ancestor
138680669|NCT00504413|Narcotics|narcotics|mesh-ancestor
138832271|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
138832272|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832273|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138832274|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138832275|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138832276|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
138832277|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138832278|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832279|NCT00605774|Epinephrine|epinephrine|mesh-list
138832280|NCT00605774|Racepinephrine|racepinephrine|mesh-list
138832281|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
138832282|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138832283|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138832284|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
138832285|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138832286|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832287|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832288|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138832289|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138832290|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
138832291|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832292|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138832293|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
138832294|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
138832295|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
138832296|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138832298|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138832299|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138832300|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138832301|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
138832302|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138832303|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832304|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832305|NCT02582476|Bumetanide|bumetanide|mesh-list
138832306|NCT02582476|Diuretics|diuretics|mesh-ancestor
138832307|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
138832308|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832309|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138832310|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138832311|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832312|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
138832313|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138472007|NCT01999413|Cytarabine|cytarabine|mesh-list
138832314|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138832315|NCT04078204|Protective Agents|protective agents|mesh-ancestor
138832316|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832318|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
138832319|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832320|NCT00668707|Protective Agents|protective agents|mesh-ancestor
138832321|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832322|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138832323|NCT00766909|Cyclosporine|cyclosporine|mesh-list
138832324|NCT00766909|Tacrolimus|tacrolimus|mesh-list
138832325|NCT00766909|Cyclosporins|cyclosporins|mesh-list
138832326|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138832327|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
138680694|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138680695|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138357521|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
138832328|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832329|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138832330|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832331|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832332|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
138484310|NCT00007878|Vitamins|vitamins|mesh-ancestor
138832333|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832334|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
138832335|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138832336|NCT00771433|Lenograstim|lenograstim|mesh-list
138832337|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138832338|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
138832339|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832341|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138832342|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138832343|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832344|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832345|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
138832346|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832347|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138832348|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138832349|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138832350|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138832351|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138680712|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
138680713|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832352|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138832353|NCT00668317|Omeprazole|omeprazole|mesh-list
138832354|NCT00668317|Ranitidine|ranitidine|mesh-list
138680722|NCT00513396|Isoniazid|isoniazid|mesh-list
138832355|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138832356|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138832357|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138832358|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138832359|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832360|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832361|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138832362|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
138832363|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
138832364|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138832365|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832366|NCT00775879|Sevoflurane|sevoflurane|mesh-list
138832367|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138832368|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138832369|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
138832371|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138832372|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832373|NCT00767221|Budesonide|budesonide|mesh-list
138832374|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138832375|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138832376|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
138832377|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832378|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832379|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138832380|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
138680758|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832381|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
138832382|NCT00767221|Hormones|hormones|mesh-ancestor
138680759|NCT00505037|Sevelamer|sevelamer|mesh-list
138832383|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138832384|NCT04024072|Brinzolamide|brinzolamide|mesh-list
138832385|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138832386|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832387|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832388|NCT00771511|Capsaicin|capsaicin|mesh-list
138832389|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
138832390|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
138832391|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
138832392|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832393|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832394|NCT00776113|Carvedilol|carvedilol|mesh-list
138832395|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138832396|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138832397|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
138832398|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472065|NCT01999907|Vitamins|vitamins|mesh-list
138832399|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832400|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832401|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138832403|NCT00776113|Protective Agents|protective agents|mesh-ancestor
138832404|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138832405|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138484395|NCT00006376|Tipifarnib|tipifarnib|mesh-list
138832406|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138832407|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
138832408|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138832409|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138832410|NCT02580448|Seviteronel|seviteronel|mesh-list
138832411|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832412|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138832413|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832414|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832415|NCT04008238|Trabectedin|trabectedin|mesh-list
138680805|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680806|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
138832416|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138832417|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
138832418|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832419|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832420|NCT00672139|Bromides|bromides|mesh-list
138832421|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
138832422|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
138832423|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138832432|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138832433|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832435|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138832436|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
138832437|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832438|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138832448|NCT03955042|Pemetrexed|pemetrexed|mesh-list
138832449|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832450|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832451|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832452|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138832453|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138832454|NCT00570739|Metformin|metformin|mesh-list
138832455|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138832456|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138832457|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832458|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138832459|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138832461|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832462|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138832463|NCT04076098|Minocycline|minocycline|mesh-list
138832464|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138832465|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832466|NCT00771979|Saracatinib|saracatinib|mesh-list
138832467|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832468|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832469|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680844|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
138680845|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138357671|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138832470|NCT00767689|Pyridoxine|pyridoxine|mesh-list
138832471|NCT00767689|Pyridoxal|pyridoxal|mesh-list
138832472|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
138832473|NCT00767689|Vitamins|vitamins|mesh-ancestor
138832474|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
138832475|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832476|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
138832477|NCT00772057|Propranolol|propranolol|mesh-list
138832478|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138832479|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138832480|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
138832481|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138832482|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832483|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832484|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138832485|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138832486|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
138832487|NCT00776347|Donepezil|donepezil|mesh-list
138832488|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138832489|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832490|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832491|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
138832492|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444149|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
138832493|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832494|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
138832495|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
138832496|NCT00776425|Hematinics|hematinics|mesh-ancestor
138832497|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
138832498|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138832499|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138832500|NCT03913702|Prednisolone|prednisolone|mesh-list
138832501|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
138832502|NCT03913702|Ketorolac|ketorolac|mesh-list
138832503|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138832504|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138832505|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
138832506|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138832507|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
138832508|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
138832509|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832510|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832511|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138832512|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
138832513|NCT03913702|Hormones|hormones|mesh-ancestor
138832514|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138832515|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138832516|NCT03913702|Protective Agents|protective agents|mesh-ancestor
138832517|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138832518|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832519|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138832520|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138680881|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
138832521|NCT03913702|Analgesics|analgesics|mesh-ancestor
138832522|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
138832523|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138832524|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138832525|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832526|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832527|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
138472123|NCT02000388|Ketorolac|ketorolac|mesh-list
138832528|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832529|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
138444196|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
138832530|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138832531|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138832532|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832533|NCT00772135|Urological Agents|urological agents|mesh-ancestor
138832535|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832536|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138832537|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832538|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832539|NCT04075006|Ketamine|ketamine|mesh-list
138832540|NCT04075006|Analgesics|analgesics|mesh-ancestor
138832541|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
138832542|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832543|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832544|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138832545|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138832546|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
138832547|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
138832548|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138832549|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138832550|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138832551|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138832552|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832553|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
138832554|NCT04188106|Varenicline|varenicline|mesh-list
138680904|NCT00513981|Protective Agents|protective agents|mesh-ancestor
138680905|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
138680906|NCT00513981|Vitamins|vitamins|mesh-ancestor
138680907|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
138444234|NCT01820299|Vitamins|vitamins|mesh-ancestor
138832555|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138832556|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138832557|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
138832558|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138832559|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832560|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832562|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
138832563|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138832564|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
138832565|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
138832566|NCT00669955|Amoxicillin|amoxicillin|mesh-list
138832567|NCT00669955|Metronidazole|metronidazole|mesh-list
138832568|NCT00669955|Clarithromycin|clarithromycin|mesh-list
138832569|NCT00669955|Tetracycline|tetracycline|mesh-list
138832570|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138832571|NCT00669955|Omeprazole|omeprazole|mesh-list
138832572|NCT00669955|Bismuth|bismuth|mesh-list
138832573|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138832574|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832575|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138832576|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138832577|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138832578|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138832579|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138832580|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832581|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832582|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138832583|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138832584|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138832586|NCT00772291|Pregabalin|pregabalin|mesh-list
138832587|NCT00772291|Analgesics|analgesics|mesh-ancestor
138832588|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
138832589|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832590|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832591|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
138832592|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138832593|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138680944|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138680945|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138832594|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680946|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
138832595|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138832596|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138832597|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138680947|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832598|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138832599|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138832600|NCT03595150|Diclofenac|diclofenac|mesh-list
138832601|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138832602|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138832603|NCT03595150|Analgesics|analgesics|mesh-ancestor
138832604|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
138832605|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832606|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832607|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138832608|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138832609|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138832610|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832611|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832612|NCT00768157|Lamivudine|lamivudine|mesh-list
138832613|NCT00768157|Entecavir|entecavir|mesh-list
138832614|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
138832615|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138832616|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138832617|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832618|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832619|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832620|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138832621|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138832622|NCT00671749|Clindamycin|clindamycin|mesh-list
138832623|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
138832624|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
138832626|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138832627|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138832628|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832629|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138832630|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484624|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
138832631|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832633|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138832634|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138832635|NCT00671749|Analgesics|analgesics|mesh-ancestor
138832636|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
138680976|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680977|NCT00514293|Carboplatin|carboplatin|mesh-list
138832637|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832638|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832639|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138832640|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138832641|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
138832642|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
138832643|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138832644|NCT04149106|Amodiaquine|amodiaquine|mesh-list
138832645|NCT04149106|Artenimol|artenimol|mesh-list
138832646|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
138832647|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138832648|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138832649|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832650|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138832651|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652574|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138832652|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832653|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138832654|NCT00768391|Olaratumab|olaratumab|mesh-list
138832655|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832656|NCT00669877|Cytarabine|cytarabine|mesh-list
138832657|NCT00669877|Dexamethasone|dexamethasone|mesh-list
138832658|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
138832659|NCT00669877|Rituximab|rituximab|mesh-list
138832660|NCT00669877|Doxorubicin|doxorubicin|mesh-list
138681012|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138681016|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
138832661|NCT00669877|Methotrexate|methotrexate|mesh-list
138832662|NCT00669877|Vincristine|vincristine|mesh-list
138832663|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138832664|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
138832665|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832666|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138832667|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138832668|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
138832669|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832670|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832671|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138832672|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138832673|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
138832674|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
138832675|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832676|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138832677|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
138832678|NCT00669877|Hormones|hormones|mesh-ancestor
138832679|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138832680|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138832681|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138832682|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138832683|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138832684|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138832685|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832686|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138832687|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
138832688|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138832689|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138832690|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
138832691|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
138832692|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138832693|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138832694|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
138832695|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832696|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138832697|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
138832698|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
138832699|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
138832700|NCT00772681|Docetaxel|docetaxel|mesh-list
138832701|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832702|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
138681060|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681061|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138681062|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681063|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681067|NCT01241240|Timolol|timolol|mesh-list
138832703|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
138832704|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
138832705|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832706|NCT00772759|AZD-3199|azd-3199|mesh-list
138484683|NCT00008307|Cyclosporine|cyclosporine|mesh-list
138832707|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138832708|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138832709|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138832710|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
138832711|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652587|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472159|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138832712|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832713|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832715|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138832716|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138832717|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138832718|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832719|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832720|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138832721|NCT00772837|Amoxicillin|amoxicillin|mesh-list
138681093|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
138681094|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681095|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681096|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138681097|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
138681098|NCT00516009|Hormones|hormones|mesh-ancestor
138681099|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138681100|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138681101|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681102|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
138681103|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
138681104|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138681105|NCT02950584|Protective Agents|protective agents|mesh-ancestor
138681106|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681107|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
138681108|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138681109|NCT01240811|Copper|copper|mesh-list
138681110|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
138681111|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138681112|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
138832722|NCT00772837|Clarithromycin|clarithromycin|mesh-list
138832723|NCT00772837|Omeprazole|omeprazole|mesh-list
138832724|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832725|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138832726|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138832727|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138832728|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832729|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832730|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138832731|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138832732|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138832733|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
138832734|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138832735|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832736|NCT00768859|Paclitaxel|paclitaxel|mesh-list
138832737|NCT00768859|Carboplatin|carboplatin|mesh-list
138832738|NCT00768859|Trastuzumab|trastuzumab|mesh-list
138832739|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138832740|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832741|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
138832742|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
138832743|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
138832744|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213210|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
138681128|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138681129|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
138681130|NCT03459105|Bupivacaine|bupivacaine|mesh-list
138681131|NCT03459105|Anesthetics|anesthetics|mesh-list
138681132|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
138681133|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138681134|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681135|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
138681136|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138681137|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138681138|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138681139|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
138174638|NCT00328523|Ezetimibe|ezetimibe|mesh-list
138681140|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138681141|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
138681142|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681143|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
138832745|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138832747|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832748|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138832749|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832750|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832751|NCT04047745|Bupivacaine|bupivacaine|mesh-list
138832752|NCT04047745|Ropivacaine|ropivacaine|mesh-list
138832753|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
138832754|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
138832755|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138832756|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832757|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
138832758|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832759|NCT00777439|Domperidone|domperidone|mesh-list
138832760|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832761|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
138832762|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
138832763|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832764|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832765|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138832766|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138832767|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
138832768|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138832769|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138832770|NCT00769093|Hematinics|hematinics|mesh-ancestor
138832771|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138681161|NCT01249443|Vorinostat|vorinostat|mesh-list
138681162|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138681163|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681164|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
138681165|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
138681166|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
138681167|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681168|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138681169|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681170|NCT01243073|Imetelstat|imetelstat|mesh-list
138681171|NCT01243073|Motesanib diphosphate|motesanib diphosphate|mesh-list
138681172|NCT01243073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681173|NCT01243073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138213242|NCT01488409|Acipimox|acipimox|mesh-list
138832772|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138832773|NCT00671437|Cetuximab|cetuximab|mesh-list
138832774|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138472166|NCT02000726|Citalopram|citalopram|mesh-list
138832775|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832776|NCT00777517|Atorvastatin|atorvastatin|mesh-list
138832777|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138832778|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138832779|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
138832780|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832781|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138832782|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138832783|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832784|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
138832785|NCT00769171|Metronidazole|metronidazole|mesh-list
138832786|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
138832787|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138832788|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138832789|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832790|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138832791|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138832792|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832793|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832794|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832795|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138832796|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
138832797|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138832798|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652643|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
138832799|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138832800|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138832801|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138832802|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138832803|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138832804|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
138832805|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138832806|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832807|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138832808|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138832809|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832810|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681195|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138681196|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
138681197|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681198|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681199|NCT01249521|Bevacizumab|bevacizumab|mesh-list
138681201|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138681202|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681219|NCT04519463|Lidocaine|lidocaine|mesh-list
138832811|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832812|NCT00769405|Leucovorin|leucovorin|mesh-list
138832814|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
138832815|NCT00769405|Calcium|calcium|mesh-list
138832816|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
138832817|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138832818|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832819|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
138832820|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832821|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138832822|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832823|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138832824|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
138832825|NCT00769405|Antidotes|antidotes|mesh-ancestor
138832826|NCT00769405|Protective Agents|protective agents|mesh-ancestor
138832827|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
138832828|NCT00769405|Vitamins|vitamins|mesh-ancestor
138832829|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
138832830|NCT02829502|Exenatide|exenatide|mesh-list
138832831|NCT02829502|Glucagon|glucagon|mesh-list
138832832|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138444498|NCT01821703|Spironolactone|spironolactone|mesh-list
138832833|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138832834|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832835|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138832837|NCT02829502|Hormones|hormones|mesh-ancestor
138832838|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138832839|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138832840|NCT02635191|Amoxicillin|amoxicillin|mesh-list
138832841|NCT02635191|Metronidazole|metronidazole|mesh-list
138832842|NCT02635191|Clarithromycin|clarithromycin|mesh-list
138832843|NCT02635191|Esomeprazole|esomeprazole|mesh-list
138832844|NCT02635191|Omeprazole|omeprazole|mesh-list
138832845|NCT02635191|Rabeprazole|rabeprazole|mesh-list
138832846|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138832847|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138832848|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138832849|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138832850|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138832851|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138832852|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138832853|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832854|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832855|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138484832|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
138832856|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138832857|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138832858|NCT00777673|Paclitaxel|paclitaxel|mesh-list
138681224|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
138832859|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
138832860|NCT00777673|Bevacizumab|bevacizumab|mesh-list
138832861|NCT00777673|Carboplatin|carboplatin|mesh-list
138832862|NCT00777673|Doxorubicin|doxorubicin|mesh-list
138832863|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138832864|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138832865|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832866|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
138832867|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
138832868|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
138832869|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832870|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138832871|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
138444526|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138832872|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832873|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138832874|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138832875|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
138832876|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138832877|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138832878|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138832879|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138832880|NCT00777673|Growth Substances|growth substances|mesh-ancestor
138832881|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
138832882|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138832883|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138832884|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138832885|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832887|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
138832888|NCT02579902|Vitamins|vitamins|mesh-ancestor
138832889|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
138832890|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832891|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138832892|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138832893|NCT02557087|Meperidine|meperidine|mesh-list
138832894|NCT02557087|Scopolamine|scopolamine|mesh-list
138832895|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138832896|NCT02557087|Narcotics|narcotics|mesh-ancestor
138832897|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138832898|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832899|NCT02557087|Analgesics|analgesics|mesh-ancestor
138832900|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
138832901|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832902|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138832903|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
138832904|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
138832905|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138832906|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
138832907|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138832908|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
138681250|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138832909|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138832910|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681251|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
138832911|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138832912|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138832913|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
138832914|NCT02579590|Desogestrel|desogestrel|mesh-list
138832915|NCT02579590|Etonogestrel|etonogestrel|mesh-list
138387606|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
138832916|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138832918|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138832919|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
138832920|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138832921|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832922|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138832923|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138832924|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138832925|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138832926|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832927|NCT02579590|Progestins|progestins|mesh-ancestor
138832929|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138832930|NCT02634723|Factor VIII|factor viii|mesh-list
138832931|NCT02634723|Coagulants|coagulants|mesh-ancestor
138832932|NCT02634489|Tamsulosin|tamsulosin|mesh-list
138832933|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
138832934|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138832935|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138832936|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138832937|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
138832938|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138832939|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832940|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832941|NCT02634489|Urological Agents|urological agents|mesh-ancestor
138832942|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138832943|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138832944|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
138832945|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
138832946|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
138681270|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138832947|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138832948|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138832949|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832950|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
138832951|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138832952|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138832953|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832954|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138832955|NCT03920566|Dalteparin|dalteparin|mesh-list
138832956|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
138832957|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138832958|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138832959|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832960|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
138832961|NCT00582790|Interleukin-2|interleukin-2|mesh-list
138832962|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138832963|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138832964|NCT00582790|Analgesics|analgesics|mesh-ancestor
138832965|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
138832966|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832967|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832968|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138832969|NCT00774007|Mesalamine|mesalamine|mesh-list
138832970|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138832971|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138832972|NCT00774007|Analgesics|analgesics|mesh-ancestor
138832973|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
138832974|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138832975|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832976|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138832977|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138832978|NCT00769873|Heparin|heparin|mesh-list
138832979|NCT00769873|Enoxaparin|enoxaparin|mesh-list
138832980|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138832981|NCT00769873|Tinzaparin|tinzaparin|mesh-list
138832982|NCT00769873|Dalteparin|dalteparin|mesh-list
138832983|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
138832984|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138832985|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138832986|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832987|NCT00777985|Bosentan|bosentan|mesh-list
138832988|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138681307|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
138832989|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138832990|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138832991|NCT00770107|Thiamine|thiamine|mesh-list
138832992|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
138832993|NCT00770107|Vitamins|vitamins|mesh-ancestor
138832994|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
138832995|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138832996|NCT00774241|Bevacizumab|bevacizumab|mesh-list
138832997|NCT00774241|Docetaxel|docetaxel|mesh-list
138832998|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138832999|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833000|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138833001|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138833002|NCT00774241|Growth Substances|growth substances|mesh-ancestor
138833003|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833004|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
138833005|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
138833006|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
138833007|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
138833008|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833009|NCT00774319|Cisplatin|cisplatin|mesh-list
138833010|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833011|NCT00881751|Bevacizumab|bevacizumab|mesh-list
138833012|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138833013|NCT00881751|Sorafenib|sorafenib|mesh-list
138833014|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138833015|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833016|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138833017|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138833018|NCT00881751|Growth Substances|growth substances|mesh-ancestor
138833019|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833020|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
138833021|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138833022|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833023|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833024|NCT02634255|Fentanyl|fentanyl|mesh-list
138833025|NCT02634255|Propofol|propofol|mesh-list
138681335|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681336|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833026|NCT02634255|Rocuronium|rocuronium|mesh-list
138833027|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138681337|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138833028|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833029|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833030|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138833031|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
138833033|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138833034|NCT02634255|Narcotics|narcotics|mesh-ancestor
138833035|NCT02634255|Analgesics|analgesics|mesh-ancestor
138833036|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
138833037|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833038|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138833039|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138833040|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138833041|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138833042|NCT02634021|Midazolam|midazolam|mesh-list
138833043|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
138833044|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138833045|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833046|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833047|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138833048|NCT02634021|Analgesics|analgesics|mesh-ancestor
138833049|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
138833050|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833051|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138833052|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138833053|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138833054|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
138833055|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833056|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833057|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138833058|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138833059|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138833060|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138833061|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138833062|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
138833063|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
138833064|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
138833065|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
138833066|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
138833067|NCT04161729|Analgesics|analgesics|mesh-ancestor
138833068|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
138833069|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833070|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833071|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
138833072|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833073|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138833074|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
138833075|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138833076|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138681380|NCT01248468|Caffeine|caffeine|mesh-list
138833077|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833078|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138833079|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
138833080|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138833081|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
138833082|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
138833083|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138833084|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138444685|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
138833085|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138833086|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833087|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833088|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138833089|NCT00934856|Docetaxel|docetaxel|mesh-list
138833090|NCT00934856|Trastuzumab|trastuzumab|mesh-list
138833091|NCT00934856|Pertuzumab|pertuzumab|mesh-list
138833092|NCT00934856|Maytansine|maytansine|mesh-list
138833093|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138833094|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833095|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
138833096|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
138833097|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
138833098|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833099|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138833100|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138833101|NCT00934856|Immunotoxins|immunotoxins|mesh-ancestor
138833102|NCT00934856|Immunoconjugates|immunoconjugates|mesh-ancestor
138833103|NCT00934856|Immunologic Factors|immunologic factors|mesh-ancestor
138833104|NCT00934856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833106|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138833107|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
138833108|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
138833109|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833110|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833111|NCT00669409|Tanezumab|tanezumab|mesh-list
138833112|NCT00669409|Analgesics|analgesics|mesh-ancestor
138833113|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
138833114|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833115|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833116|NCT00778141|Metformin|metformin|mesh-list
138833117|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138833118|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833119|NCT00774475|Clopidogrel|clopidogrel|mesh-list
138833120|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138833121|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138833122|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138833123|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138833124|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
138444726|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
138833125|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833126|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833127|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833128|NCT00669331|Mannitol|mannitol|mesh-list
138833129|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138833130|NCT00669331|Diuretics|diuretics|mesh-ancestor
138833131|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
138833132|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833133|NCT00778297|Vaccines|vaccines|mesh-list
138833134|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
138213374|NCT00512876|Bevacizumab|bevacizumab|mesh-list
138833135|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833136|NCT00779233|Zidovudine|zidovudine|mesh-list
138833137|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
138833138|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833139|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138833140|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138833141|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833142|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
138833143|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138833144|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138833145|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138833146|NCT00607178|Vaccines|vaccines|mesh-list
138833147|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
138833148|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833149|NCT02556463|Durvalumab|durvalumab|mesh-list
138833150|NCT02556463|MEDI9197|medi9197|mesh-list
138833151|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138833152|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833153|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138833154|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
138833155|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833156|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138833158|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833159|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138681417|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681428|NCT01246206|Tacrolimus|tacrolimus|mesh-list
138833160|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833161|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833162|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138833163|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138833164|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138833166|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138833167|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833168|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138833169|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138833170|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138833171|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138833172|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138833173|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138833174|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138833175|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138833176|NCT00778765|Gabapentin|gabapentin|mesh-list
138833177|NCT00778765|Analgesics|analgesics|mesh-ancestor
138833178|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
138833179|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833180|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833181|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
138833182|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138833183|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138833184|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833185|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138833186|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138833187|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138833188|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833189|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833190|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
138833191|NCT00779935|Infliximab|infliximab|mesh-list
138681465|NCT01243944|Pomalidomide|pomalidomide|mesh-list
138681466|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
138681467|NCT01243944|Pipobroman|pipobroman|mesh-list
138681468|NCT01243944|Anagrelide|anagrelide|mesh-list
138833192|NCT00779935|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138833193|NCT00779935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833194|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
138833195|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138833196|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138833197|NCT00780013|Metformin|metformin|mesh-list
138833198|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138833199|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833200|NCT00667225|Cantharidin|cantharidin|mesh-list
138833201|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833202|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833203|NCT00780169|Sorafenib|sorafenib|mesh-list
138833204|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833205|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138833206|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833207|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833208|NCT00780325|Celecoxib|celecoxib|mesh-list
138833209|NCT00780325|Naproxen|naproxen|mesh-list
138833210|NCT00780325|Acetazolamide|acetazolamide|mesh-list
138833211|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138833212|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138833213|NCT00780325|Analgesics|analgesics|mesh-ancestor
138833214|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
138833215|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833216|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833217|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833218|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138833219|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138681505|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138833220|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138833221|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444788|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
138833222|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833223|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
138833224|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
138833225|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138833226|NCT00780325|Diuretics|diuretics|mesh-ancestor
138833227|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
138833228|NCT02556229|Aflibercept|aflibercept|mesh-list
138833229|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138833230|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138833231|NCT02556229|Growth Substances|growth substances|mesh-ancestor
138833232|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833233|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
138833234|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833235|NCT00929864|Adalimumab|adalimumab|mesh-list
138833236|NCT00929864|Abatacept|abatacept|mesh-list
138833237|NCT00929864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138833238|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833239|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138833240|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138833241|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833242|NCT00929864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138833243|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833244|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138833245|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
138833246|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833247|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
138833248|NCT00597753|Hematinics|hematinics|mesh-ancestor
138833249|NCT04262804|Gemcitabine|gemcitabine|mesh-list
138833250|NCT04262804|Capecitabine|capecitabine|mesh-list
138833251|NCT04262804|Trastuzumab|trastuzumab|mesh-list
138833252|NCT04262804|Vinorelbine|vinorelbine|mesh-list
138833253|NCT04262804|Margetuximab|margetuximab|mesh-list
138833254|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138833255|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
138833256|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681551|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138681552|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138681553|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
138833257|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833258|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138833259|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138833260|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
138833261|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
138833262|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
138833263|NCT00665431|Celecoxib|celecoxib|mesh-list
138833264|NCT00665431|Antacids|antacids|mesh-list
138833265|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138833266|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138833267|NCT00665431|Analgesics|analgesics|mesh-ancestor
138833268|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
138833269|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833270|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833271|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833272|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138833273|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138833274|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138833275|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833276|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833277|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138833278|NCT02633709|Itraconazole|itraconazole|mesh-list
138833279|NCT02633709|Risdiplam|risdiplam|mesh-list
138833280|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
138833281|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138833282|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138652779|NCT00311870|Lisinopril|lisinopril|mesh-list
138833283|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138833285|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833286|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138833287|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
138833288|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138833289|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833290|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138833291|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138681586|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138681587|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
138833292|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833293|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
138833294|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
138833295|NCT04264988|Protective Agents|protective agents|mesh-ancestor
138833296|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681588|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833297|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138833298|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
138833299|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138833300|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138833301|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833302|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833303|NCT00657033|Urological Agents|urological agents|mesh-ancestor
138833304|NCT02633007|Levodopa|levodopa|mesh-list
138472320|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
138833305|NCT02633007|Carbidopa|carbidopa|mesh-list
138833306|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138833307|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138833308|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
138833309|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833310|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833311|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833312|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138833313|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833314|NCT01000727|Darapladib|darapladib|mesh-list
138833315|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138833316|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833317|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833318|NCT00881205|Rivastigmine|rivastigmine|mesh-list
138833319|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138833320|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833321|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833322|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
138833323|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833324|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833325|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138833326|NCT00881205|Protective Agents|protective agents|mesh-ancestor
138833327|NCT00879879|Losartan|losartan|mesh-list
138833328|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138833329|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138833330|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138833331|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138833332|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833333|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
138833334|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
138833335|NCT00661999|Hematinics|hematinics|mesh-ancestor
138833336|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138833337|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833338|NCT04156815|Isotretinoin|isotretinoin|mesh-list
138833339|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
138833340|NCT04156425|Golimumab|golimumab|mesh-list
138833341|NCT04156425|Dexetimide|dexetimide|mesh-list
138833342|NCT04156425|Citalopram|citalopram|mesh-list
138833343|NCT04156425|Calcium|calcium|mesh-list
138681622|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
138833344|NCT04156425|Escitalopram|escitalopram|mesh-list
138833345|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138833346|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833347|NCT04156425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138833348|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138833349|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138833350|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833351|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833352|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
138833353|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138833354|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138833355|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
138833356|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
138833357|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833358|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138833359|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138833360|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
138833361|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138833362|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
138833363|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138833364|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138833365|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833366|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138833367|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
138833368|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
138833369|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138833370|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138833371|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138833372|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138833373|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833374|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833375|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681649|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138833376|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138833377|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138833378|NCT00790075|Risperidone|risperidone|mesh-list
138833379|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138833380|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
138833381|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833382|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833383|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833384|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138833385|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138833386|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833387|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138833388|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138833389|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
138833390|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138833391|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138833392|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833393|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138833394|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
138833395|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833397|NCT00780637|Kininogens|kininogens|mesh-list
138833398|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
138833399|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138833400|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
138833401|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833402|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833403|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
138652797|NCT00342849|Succimer|succimer|mesh-list
138833405|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833406|NCT00790153|Insulin|insulin|mesh-list
138833407|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138833408|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833409|NCT02631603|Prednisolone|prednisolone|mesh-list
138833410|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833411|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
138833412|NCT02631603|Hormones|hormones|mesh-ancestor
138681692|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
138833413|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138833414|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833415|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138833416|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833417|NCT00790387|Heparin|heparin|mesh-list
138833418|NCT00790387|Enoxaparin|enoxaparin|mesh-list
138833419|NCT00790387|Calcium heparin|calcium heparin|mesh-list
138833420|NCT00790387|Tirofiban|tirofiban|mesh-list
138833421|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
138833422|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138833423|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138472337|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138833424|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833425|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138833426|NCT04156035|Lamotrigine|lamotrigine|mesh-list
138833427|NCT04156035|Ketamine|ketamine|mesh-list
138833428|NCT04156035|Analgesics|analgesics|mesh-ancestor
138833429|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
138833430|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833431|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833432|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138833433|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138833434|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
138833435|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
138833436|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138681728|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681729|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
138833437|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138833438|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138681730|NCT02949843|Nivolumab|nivolumab|mesh-list
138833439|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833440|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833441|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
138833442|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138833443|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138833444|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138833445|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138833446|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138833447|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138833448|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138833449|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
138833450|NCT00662337|Promethazine|promethazine|mesh-list
138833451|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138833452|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138833453|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833454|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833455|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
138833456|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
138833457|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
138833458|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833459|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
138833460|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
138833461|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138833462|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138833463|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
138833464|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
138833465|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833466|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833467|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138833468|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
138833470|NCT00665353|Pioglitazone|pioglitazone|mesh-list
138833471|NCT00665353|Ribavirin|ribavirin|mesh-list
138833472|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
138833473|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833474|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
138472356|NCT02001883|Simvastatin|simvastatin|mesh-list
138833475|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138833476|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138833477|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833479|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
138681773|NCT01242930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138681774|NCT01242930|Vitamin B Complex|vitamin b complex|mesh-ancestor
138833480|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138833481|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833482|NCT00662571|Acamprosate|acamprosate|mesh-list
138833483|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138833484|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
138833485|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833486|NCT00661635|Valdecoxib|valdecoxib|mesh-list
138833487|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138833488|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138833489|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833490|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833491|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138833492|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138833493|NCT00661635|Analgesics|analgesics|mesh-ancestor
138833494|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
138833495|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833496|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833497|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833498|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138833499|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138833500|NCT02555761|Alcaftadine|alcaftadine|mesh-list
138833501|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138833502|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138833503|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
138833504|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
138833505|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833506|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681804|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138833507|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833508|NCT04155879|Colchicine|colchicine|mesh-list
138833509|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
138833510|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138833511|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
138445021|NCT01825616|Vitamin D|vitamin d|mesh-list
138833512|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
138833513|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
138833514|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833515|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833516|NCT00662805|Fluticasone|fluticasone|mesh-list
138833517|NCT00662805|Xhance|xhance|mesh-list
138833518|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138833519|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833520|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138833521|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
138833522|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833523|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833524|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138833525|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
138833526|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
138833527|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138833528|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138833529|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138833530|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138833531|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
138833532|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138652820|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138681857|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138681858|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138681861|NCT00519753|Travoprost|travoprost|mesh-list
138833533|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833534|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
138833535|NCT00662883|Ketamine|ketamine|mesh-list
138833536|NCT00662883|Analgesics|analgesics|mesh-ancestor
138833537|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
138833538|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833539|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833540|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138833541|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138833542|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
138833543|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
138833544|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833545|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138833546|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138833547|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833548|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833549|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833550|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
138833551|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138833552|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
138833553|NCT00785473|Vitamin D|vitamin d|mesh-list
138833554|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
138833555|NCT00785473|Calcium|calcium|mesh-list
138833556|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138833557|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833558|NCT00785473|Vitamins|vitamins|mesh-ancestor
138833559|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
138833560|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138833561|NCT00785473|Antacids|antacids|mesh-ancestor
138833562|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833563|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138833564|NCT00785551|Quinine|quinine|mesh-list
138833565|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
138833566|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138833567|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138833568|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138833569|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138833570|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833571|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138681903|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138681904|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
138833572|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833573|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138833574|NCT00785551|Analgesics|analgesics|mesh-ancestor
138833575|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
138833576|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138833577|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138833578|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138833579|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833580|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833581|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138833582|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138833583|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138833584|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
138833585|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833586|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833587|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138833588|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138833589|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
138833590|NCT00663195|Furosemide|furosemide|mesh-list
138833591|NCT00663195|Spironolactone|spironolactone|mesh-list
138833592|NCT00663195|Diuretics|diuretics|mesh-ancestor
138833593|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
138833594|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833595|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138833596|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138213669|NCT01550341|Naloxone|naloxone|mesh-list
138681937|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
138681940|NCT00520104|Ketamine|ketamine|mesh-list
138833597|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833598|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138833599|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
138833600|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138833601|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138833602|NCT00791011|Bortezomib|bortezomib|mesh-list
138833603|NCT00791011|Vorinostat|vorinostat|mesh-list
138833604|NCT00791011|Conatumumab|conatumumab|mesh-list
138833605|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833606|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138833607|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833608|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833609|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138833611|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
138833612|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138833613|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138833614|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833615|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833616|NCT00785863|Ketorolac|ketorolac|mesh-list
138833617|NCT00785863|Parecoxib|parecoxib|mesh-list
138833618|NCT00785863|Remifentanil|remifentanil|mesh-list
138833619|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138833620|NCT00785863|Narcotics|narcotics|mesh-ancestor
138833621|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833622|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833623|NCT00785863|Analgesics|analgesics|mesh-ancestor
138833624|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
138833625|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833626|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138681984|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138833627|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138681985|NCT00520338|Analgesics|analgesics|mesh-ancestor
138681986|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
138681987|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833628|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833629|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138652855|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138833630|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138833631|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833632|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833633|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138833635|NCT00664105|Docetaxel|docetaxel|mesh-list
138833636|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833637|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
138833638|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
138833639|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
138833640|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833641|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138833642|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
138833643|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833644|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
138833645|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138833646|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833647|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833648|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138833649|NCT02555605|Analgesics|analgesics|mesh-ancestor
138833650|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
138833651|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833652|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138833653|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138833654|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138682023|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682024|NCT02590094|Bevacizumab|bevacizumab|mesh-list
138833655|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
138833656|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833657|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833658|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138833659|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138833660|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138833661|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833662|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833663|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138833664|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138833665|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138833666|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
138833667|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833668|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833669|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138833670|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138833671|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
138833672|NCT00663741|Sorafenib|sorafenib|mesh-list
138833673|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833674|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138833675|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833676|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833677|NCT00663897|Lansoprazole|lansoprazole|mesh-list
138833678|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
138833679|NCT00663897|Mosapride|mosapride|mesh-list
138833680|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138833681|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138833682|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138833683|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833684|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833686|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
138833687|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833688|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833689|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138833690|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138682068|NCT00519987|Ketamine|ketamine|mesh-list
138833691|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
138833692|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833693|NCT04031859|Aspirin|aspirin|mesh-list
138833694|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138833695|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138833696|NCT04031859|Analgesics|analgesics|mesh-ancestor
138833697|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
138833698|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833699|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833700|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833701|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138833702|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138833703|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138833704|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833705|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138682106|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138833706|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138682107|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138682108|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138682109|NCT00519363|Atorvastatin|atorvastatin|mesh-list
138682110|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138682111|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138682112|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
138682113|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682114|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138682120|NCT02955056|Teriparatide|teriparatide|mesh-list
138833707|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833708|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
138833710|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138833711|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
138833712|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833713|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138833714|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
138833715|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
138833716|NCT00664287|Vitamins|vitamins|mesh-ancestor
138833717|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
138833718|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833719|NCT00664599|Rituximab|rituximab|mesh-list
138833720|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138833721|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833722|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
138833723|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445173|NCT01827124|Oxytocin|oxytocin|mesh-list
138833724|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138833725|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
138833726|NCT02631135|Remifentanil|remifentanil|mesh-list
138833727|NCT02631135|Propofol|propofol|mesh-list
138833728|NCT02631135|Rocuronium|rocuronium|mesh-list
138833729|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138833730|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833731|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833732|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138833733|NCT02631135|Analgesics|analgesics|mesh-ancestor
138833734|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
138833735|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833736|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138833737|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138833738|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138833739|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
138833740|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833741|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833742|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138833743|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
138833744|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
138833745|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138833746|NCT02631135|Narcotics|narcotics|mesh-ancestor
138682156|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
138833747|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138833748|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138833749|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138833750|NCT00664677|Masoprocol|masoprocol|mesh-list
138833751|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
138833752|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833753|NCT00664677|Protective Agents|protective agents|mesh-ancestor
138652891|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138833754|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833755|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138833756|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833757|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138833758|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138833759|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138833761|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
138833762|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833763|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833764|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138833765|NCT00596817|Vortioxetine|vortioxetine|mesh-list
138833766|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
138833767|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138833768|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138833769|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138833770|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833771|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833772|NCT00596817|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138833773|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138833774|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138833775|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833776|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833777|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
138682188|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682189|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138833778|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138833779|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138833780|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138833781|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138833782|NCT01000649|Vasopressins|vasopressins|mesh-list
138833783|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
138833784|NCT01000649|Coagulants|coagulants|mesh-ancestor
138833785|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138833786|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138833787|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
138833788|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833789|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138833790|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
138833791|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138833792|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138833793|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833794|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833795|NCT00664833|Urological Agents|urological agents|mesh-ancestor
138833796|NCT00879411|Telmisartan|telmisartan|mesh-list
138833797|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138445260|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138833798|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138833799|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138833800|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833802|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138682227|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
138682228|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833803|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
138682229|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138682230|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138833804|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833805|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833806|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138833807|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
138833808|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138833809|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833810|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833811|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
138833812|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138833813|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138833814|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
138833815|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833816|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138833817|NCT00666757|Sertraline|sertraline|mesh-list
138833818|NCT00666757|Fluoxetine|fluoxetine|mesh-list
138833819|NCT00666757|Paroxetine|paroxetine|mesh-list
138833820|NCT00666757|Citalopram|citalopram|mesh-list
138833821|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138833822|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138833823|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138833824|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833825|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833826|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833827|NCT00666757|Analgesics|analgesics|mesh-ancestor
138833828|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
138833829|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138833830|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
138833831|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138472526|NCT02002403|Danazol|danazol|mesh-list
138833832|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
138833833|NCT00666757|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138833834|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
138833835|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138833836|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138833837|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138445285|NCT01827722|Hormones|hormones|mesh-ancestor
138833838|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833840|NCT01000337|Sevoflurane|sevoflurane|mesh-list
138682273|NCT05146778|Analgesics|analgesics|mesh-ancestor
138833841|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138833842|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833843|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833844|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138833845|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
138833846|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
138833847|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138833848|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138833849|NCT02869763|Ethanol|ethanol|mesh-list
138833850|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138833851|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138833852|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833853|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833854|NCT00671697|Decitabine|decitabine|mesh-list
138833855|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
138833856|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138833857|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
138833858|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833859|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833860|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833861|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
138833862|NCT00666679|Montelukast|montelukast|mesh-list
138833863|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138833864|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
138682308|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138833865|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138682309|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138682310|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
138833866|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
138833867|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138833868|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833869|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138833870|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138833871|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833872|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138445319|NCT01827878|Diuretics|diuretics|mesh-ancestor
138833873|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
138833874|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138833875|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138833876|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138833877|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138833878|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833879|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833880|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138833881|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138833882|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138833883|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
138833884|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833885|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833886|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138833887|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138833888|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
138833889|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138833890|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
138833891|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138833892|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138833893|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833894|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833895|NCT00786253|Urological Agents|urological agents|mesh-ancestor
138833896|NCT00595413|Adalimumab|adalimumab|mesh-list
138682356|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682357|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138682362|NCT00521742|Pioglitazone|pioglitazone|mesh-list
138833897|NCT00595413|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138833898|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138833899|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138833900|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
138833901|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138833902|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833903|NCT00786331|Carboplatin|carboplatin|mesh-list
138833904|NCT00786331|Pemetrexed|pemetrexed|mesh-list
138833905|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833906|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833907|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833908|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138833909|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138833910|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138833911|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138833912|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138833913|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138833914|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833915|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138833916|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138833917|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138833918|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
138833919|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138833920|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833921|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138682395|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138682396|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
138682397|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833923|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
138833924|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
138833925|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138833926|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138682398|NCT02954822|Glimepiride|glimepiride|mesh-list
138682399|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138682400|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138682401|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682402|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138682403|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
138682404|NCT00522015|Rivastigmine|rivastigmine|mesh-list
138833927|NCT00595335|Prednisolone|prednisolone|mesh-list
138833928|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
138833929|NCT00595335|Rituximab|rituximab|mesh-list
138833930|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138833931|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
138833932|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138833933|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833934|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
138833935|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833936|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138472574|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
138833944|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138833945|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138833946|NCT00595335|Protective Agents|protective agents|mesh-ancestor
138833947|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138833948|NCT00781417|Vitamin D|vitamin d|mesh-list
138833949|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
138833950|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
138833951|NCT00781417|Vitamins|vitamins|mesh-list
138833952|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
138833953|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833954|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138833955|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138833956|NCT00672165|Antibodies|antibodies|mesh-list
138833957|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138833958|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
138445386|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
138833959|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833967|NCT00672399|Exenatide|exenatide|mesh-list
138833968|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
138833969|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138833970|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682432|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138833971|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138833972|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138833973|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833974|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833975|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833976|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485987|NCT00000826|Dapsone|dapsone|mesh-list
138652965|NCT00347724|Tramadol|tramadol|mesh-list
138833977|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138833978|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138833979|NCT00672399|Incretins|incretins|mesh-ancestor
138833980|NCT00672399|Hormones|hormones|mesh-ancestor
138833981|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138833982|NCT00661531|Anastrozole|anastrozole|mesh-list
138833983|NCT00661531|Estradiol|estradiol|mesh-list
138833984|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138833985|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138833986|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138833987|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138833988|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138833989|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138833990|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138833991|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
138833992|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138472590|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
138833993|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138833994|NCT00661531|Estrogens|estrogens|mesh-ancestor
138833995|NCT00661531|Hormones|hormones|mesh-ancestor
138833996|NCT00998309|Azithromycin|azithromycin|mesh-list
138833997|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138833998|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138833999|NCT02629575|Sirolimus|sirolimus|mesh-list
138834000|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138834001|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834002|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138834003|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834004|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
138682472|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834005|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138834006|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
138834007|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834008|NCT00781573|Clopidogrel|clopidogrel|mesh-list
138682473|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
138682474|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138682475|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138682476|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682477|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359339|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
138834009|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138834010|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138834011|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138834012|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138834013|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
138834014|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834015|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834016|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834017|NCT00671541|Gentamicins|gentamicins|mesh-list
138834018|NCT00671541|Bacitracin|bacitracin|mesh-list
138834019|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138834020|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834021|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138834022|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834023|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834024|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138834025|NCT04152681|Apatinib|apatinib|mesh-list
138834026|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834027|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138834028|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834029|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834030|NCT00999713|Calfactant|calfactant|mesh-list
138834031|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138834032|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834033|NCT00672867|Adefovir|adefovir|mesh-list
138834034|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138834035|NCT00672867|Clevudine|clevudine|mesh-list
138834036|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
138652989|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
138834037|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834038|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138682506|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682507|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
138834039|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138682508|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682509|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138682510|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138682511|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
138682512|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138682513|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138682514|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138682515|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138682516|NCT00523692|Analgesics|analgesics|mesh-ancestor
138682517|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
138682518|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682519|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138682520|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138682521|NCT00523692|Antiemetics|antiemetics|mesh-ancestor
138682522|NCT00523692|Autonomic Agents|autonomic agents|mesh-ancestor
138682523|NCT00523692|Glucocorticoids|glucocorticoids|mesh-ancestor
138682524|NCT00523692|Hormones|hormones|mesh-ancestor
138682526|NCT00523692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138834040|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834041|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834042|NCT00997373|Letrozole|letrozole|mesh-list
138834043|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834044|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138834045|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138834046|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834047|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834048|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138834049|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
138834050|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138834051|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834052|NCT04152759|Golimumab|golimumab|mesh-list
138834053|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138834054|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138834055|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138834056|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
138834057|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834058|NCT00792025|Sunitinib|sunitinib|mesh-list
138834059|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834060|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138834061|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138834062|NCT00792025|Growth Substances|growth substances|mesh-ancestor
138834063|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834064|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
138834065|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138834066|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834067|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682529|NCT05148689|Phenylephrine|phenylephrine|mesh-list
138682530|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
138682531|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138834068|NCT02870231|Liraglutide|liraglutide|mesh-list
138834069|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138834070|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834071|NCT02870231|Incretins|incretins|mesh-ancestor
138834072|NCT02870231|Hormones|hormones|mesh-ancestor
138834073|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138834074|NCT00782041|Leucovorin|leucovorin|mesh-list
138834075|NCT00782041|Folic Acid|folic acid|mesh-list
138834076|NCT00782041|Fluorouracil|fluorouracil|mesh-list
138834077|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
138834078|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
138834079|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
138834080|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834081|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138834082|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834083|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138834084|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
138834085|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834086|NCT00782041|Antidotes|antidotes|mesh-ancestor
138834087|NCT00782041|Protective Agents|protective agents|mesh-ancestor
138834088|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
138834089|NCT00782041|Vitamins|vitamins|mesh-ancestor
138834090|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
138834091|NCT00782041|Hematinics|hematinics|mesh-ancestor
138834092|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138834093|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834094|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138682573|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682574|NCT00523887|Analgesics|analgesics|mesh-ancestor
138682575|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
138682579|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
138834095|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652997|NCT00347763|Permethrin|permethrin|mesh-list
138834096|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834097|NCT00792181|Midazolam|midazolam|mesh-list
138834098|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138834099|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138834100|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138834101|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834102|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138834103|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138834104|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138834105|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138834106|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
138834107|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
138834108|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
138834109|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
138834110|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834111|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834112|NCT00792337|Simvastatin|simvastatin|mesh-list
138834113|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138834114|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138834115|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
138834116|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834117|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138834118|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138834119|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834120|NCT00787111|Fluoxetine|fluoxetine|mesh-list
138834121|NCT00787111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138834122|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138834123|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138834124|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834125|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834126|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
138834127|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834128|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138834129|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
138834130|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138682623|NCT00523965|Paromomycin|paromomycin|mesh-list
138834131|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138834132|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138834133|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834135|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138834136|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
138834137|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834138|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
138834139|NCT00782197|Protective Agents|protective agents|mesh-ancestor
138834140|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138834141|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138834142|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138834144|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
138834145|NCT00996593|Antibodies|antibodies|mesh-list
138834146|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
138834147|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
138834148|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834149|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138834150|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834151|NCT00996593|Trace Elements|trace elements|mesh-ancestor
138834152|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
138834153|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682659|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138834154|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
138682660|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834155|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138834156|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834157|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834159|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834160|NCT00787501|Fluoxetine|fluoxetine|mesh-list
138834161|NCT00787501|Sertraline|sertraline|mesh-list
138834162|NCT00787501|Escitalopram|escitalopram|mesh-list
138834163|NCT00787501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138682661|NCT00524160|Analgesics|analgesics|mesh-ancestor
138834164|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138834165|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138834166|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834167|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834168|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
138834169|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834170|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138834171|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
138834172|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138834173|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138834174|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138834175|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834176|NCT00787657|Interferons|interferons|mesh-list
138834177|NCT00787657|Interferon-beta|interferon-beta|mesh-list
138834178|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
138834179|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834180|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
138834181|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834182|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
138834183|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834184|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138834185|NCT04264676|Metronidazole|metronidazole|mesh-list
138472631|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
138834186|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834187|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138834188|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138834189|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138834190|NCT00637637|Ritonavir|ritonavir|mesh-list
138834191|NCT00637637|Indinavir|indinavir|mesh-list
138834192|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138834193|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138834194|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
138834195|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834196|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682704|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138682705|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138682706|NCT02947932|Analgesics|analgesics|mesh-ancestor
138834197|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138834198|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138834199|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
138834200|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834201|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138834202|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138834203|NCT00927758|Fluticasone|fluticasone|mesh-list
138834205|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138834206|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138834207|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138834208|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138834209|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
138653026|NCT00347841|Latanoprost|latanoprost|mesh-list
138834210|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834211|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834212|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138834213|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834214|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
138834215|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138834216|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138834217|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138834218|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138834219|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
138834220|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834221|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834222|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
138682742|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834223|NCT00927758|Hormones|hormones|mesh-ancestor
138834224|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138834225|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
138682743|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
138682744|NCT00524706|Vitamins|vitamins|mesh-ancestor
138682745|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
138682746|NCT00507143|Irinotecan|irinotecan|mesh-list
138682747|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138682748|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138682749|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834226|NCT00783523|Doxycycline|doxycycline|mesh-list
138834227|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138834228|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834229|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
138834230|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138834231|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138834232|NCT00783601|Montelukast|montelukast|mesh-list
138834233|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138834234|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834235|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138834236|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
138834237|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138834238|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834239|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138834240|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138834241|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834242|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
138834243|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138834244|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
138834245|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834246|NCT00787813|Expectorants|expectorants|mesh-ancestor
138834247|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834248|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138834249|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
138834250|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834251|NCT00787813|Protective Agents|protective agents|mesh-ancestor
138834252|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834253|NCT00787813|Antidotes|antidotes|mesh-ancestor
138834255|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
138682780|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138359641|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682781|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682782|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138682783|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682785|NCT00507221|Praziquantel|praziquantel|mesh-list
138682786|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
138214182|NCT02129426|Midazolam|midazolam|mesh-list
138834256|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834257|NCT00787969|Sirolimus|sirolimus|mesh-list
138834258|NCT00787969|Rituximab|rituximab|mesh-list
138834259|NCT00787969|Temsirolimus|temsirolimus|mesh-list
138834260|NCT00787969|Cladribine|cladribine|mesh-list
138834261|NCT00787969|MTOR Inhibitors|mtor inhibitors|mesh-list
138834262|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138834263|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834264|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
138834265|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834266|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138834267|NCT00787969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138834268|NCT00787969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653045|NCT00343668|Irinotecan|irinotecan|mesh-list
138834269|NCT00787969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834270|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138834271|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138834272|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834273|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138834274|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
138834275|NCT00609596|Dutasteride|dutasteride|mesh-list
138834276|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138834277|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138834278|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834279|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834280|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
138834281|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138834282|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834283|NCT00608816|Epinephrine|epinephrine|mesh-list
138834284|NCT00608816|Racepinephrine|racepinephrine|mesh-list
138834285|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
138682820|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138682821|NCT02954549|Vitamin D|vitamin d|mesh-list
138834286|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138682822|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
138834287|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138834288|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
138834289|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834290|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834291|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834292|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138834293|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138834294|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
138834295|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834296|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138834297|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834298|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
138834299|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
138834300|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138834301|NCT02535273|Lidocaine|lidocaine|mesh-list
138834302|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
138834303|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
138834304|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
138445649|NCT01833221|Lidocaine|lidocaine|mesh-list
138834305|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138472654|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
138834306|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834307|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
138834308|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834309|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138834310|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138834311|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138834312|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138682859|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
138682860|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
138682861|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
138682862|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138834313|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834314|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138834315|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138834316|NCT02535273|Analgesics|analgesics|mesh-ancestor
138834317|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138834318|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138834319|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138834320|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
138834321|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834322|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
138834323|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
138834324|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834325|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138834326|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138834327|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834328|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834329|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834330|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
138834331|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138834332|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
138834333|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138834334|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
138682904|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138682905|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138682906|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138682907|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
138682908|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
138682909|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138682910|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682911|NCT02947113|Etoposide|etoposide|mesh-list
138682912|NCT02947113|Pemetrexed|pemetrexed|mesh-list
138176516|NCT00743717|Cobalt|cobalt|mesh-list
138682913|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682914|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138834335|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834336|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834337|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138834338|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834339|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138834340|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
138834341|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834342|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834343|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138834344|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
138834345|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
138834346|NCT04259684|Protective Agents|protective agents|mesh-ancestor
138834347|NCT00788515|Lormetazepam|lormetazepam|mesh-list
138834348|NCT00788515|Volinanserin|volinanserin|mesh-list
138834349|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138834350|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138834351|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834352|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138834353|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
138834354|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834355|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834356|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
138834358|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834359|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138834360|NCT00788749|Fluticasone|fluticasone|mesh-list
138834361|NCT00788749|Xhance|xhance|mesh-list
138834362|NCT00788749|Prednisolone|prednisolone|mesh-list
138834363|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138834364|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138834365|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
138834366|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834367|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834368|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138834369|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834370|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
138834371|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138834372|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
138834374|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138834375|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138834376|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834377|NCT00609752|Prednisolone|prednisolone|mesh-list
138834378|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138834379|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
138834380|NCT00609752|Hormones|hormones|mesh-ancestor
138834381|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138834382|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834383|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138834384|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834385|NCT00662857|Insulin|insulin|mesh-list
138834386|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138834387|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138834388|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834389|NCT00878553|Zaleplon|zaleplon|mesh-list
138834390|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
138834391|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138834392|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138653079|NCT00348153|Adalimumab|adalimumab|mesh-list
138834393|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834394|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
138834395|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
138834396|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834397|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834398|NCT05220020|Lenvatinib|lenvatinib|mesh-list
138834399|NCT05220020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834400|NCT05220020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138834401|NCT05220020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834402|NCT05220020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682995|NCT00525447|Lenalidomide|lenalidomide|mesh-list
138682996|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
138834403|NCT00789061|Lansoprazole|lansoprazole|mesh-list
138834404|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138834405|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138834406|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138834407|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834408|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834409|NCT00996437|Ranibizumab|ranibizumab|mesh-list
138834410|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138834411|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138834412|NCT00996437|Growth Substances|growth substances|mesh-ancestor
138834413|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834414|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
138834415|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834416|NCT02628951|Paclitaxel|paclitaxel|mesh-list
138834417|NCT02628951|Ramucirumab|ramucirumab|mesh-list
138834418|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138834419|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834420|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
138834421|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
138834422|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
138472677|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138834423|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683029|NCT02946060|Protective Agents|protective agents|mesh-ancestor
138683030|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683031|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138834424|NCT00662311|Paclitaxel|paclitaxel|mesh-list
138834425|NCT00662311|Vorinostat|vorinostat|mesh-list
138834426|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138486424|NCT00001075|Ritonavir|ritonavir|mesh-list
138834427|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834428|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
138834429|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
138834430|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
138834431|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834432|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138834433|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834434|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
138834436|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138834437|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
138834438|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834439|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834440|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138834441|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834442|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138834443|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138834444|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138834445|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
138834446|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834447|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834448|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138834449|NCT00996281|Olmesartan|olmesartan|mesh-list
138834450|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138834451|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
138834452|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138834453|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138834454|NCT00996281|Diuretics|diuretics|mesh-ancestor
138834455|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
138834456|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834457|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138683081|NCT02945982|Carvedilol|carvedilol|mesh-list
138834458|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138445769|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
138683082|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
138683117|NCT00526617|Veliparib|veliparib|mesh-list
138834459|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834460|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138834461|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138834463|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138834464|NCT04046653|Protective Agents|protective agents|mesh-ancestor
138834465|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834466|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834467|NCT04293887|Interferons|interferons|mesh-list
138834468|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834469|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
138834470|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834471|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138834472|NCT00675207|Dorzolamide|dorzolamide|mesh-list
138834473|NCT00675207|Brinzolamide|brinzolamide|mesh-list
138834474|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138834475|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138834476|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138834477|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138834478|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
138834479|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138683118|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138683119|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
138683120|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683121|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138683122|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138683123|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683124|NCT00507845|Felodipine|felodipine|mesh-list
138683125|NCT00507845|Ramipril|ramipril|mesh-list
138683126|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138834480|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834481|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834482|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138834483|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834484|NCT00795223|Morphine|morphine|mesh-list
138834485|NCT00795223|Bupivacaine|bupivacaine|mesh-list
138834486|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
138834487|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
138834488|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138683164|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
138834489|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834490|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
138834491|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834492|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138834493|NCT00795223|Narcotics|narcotics|mesh-ancestor
138834494|NCT00795223|Analgesics|analgesics|mesh-ancestor
138834495|NCT00795301|Capecitabine|capecitabine|mesh-list
138834496|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
138834497|NCT00795301|Cetuximab|cetuximab|mesh-list
138653093|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
138834498|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138834500|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486501|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138834501|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834502|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138834503|NCT00675285|Montelukast|montelukast|mesh-list
138683188|NCT02946801|Listerine|listerine|mesh-list
138834504|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138834505|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834506|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138834507|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
138834508|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138834509|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834510|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138834511|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138834512|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834513|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
138834514|NCT00789763|Gemcitabine|gemcitabine|mesh-list
138834515|NCT00789763|Sorafenib|sorafenib|mesh-list
138834516|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138834517|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
138834518|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834519|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834520|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138834521|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834522|NCT02554357|Bupivacaine|bupivacaine|mesh-list
138834523|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
138834524|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
138834525|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138834526|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472720|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138445856|NCT01840449|Lanreotide|lanreotide|mesh-list
138683211|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138683212|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138834528|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834529|NCT00877929|Amlodipine|amlodipine|mesh-list
138834530|NCT00877929|Telmisartan|telmisartan|mesh-list
138834531|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138834532|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138834533|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138834534|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834535|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138834536|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834537|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
138834538|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138834539|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138834540|NCT00795457|Poly I-C|poly i-c|mesh-list
138834541|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138834542|NCT00795457|Vaccines|vaccines|mesh-list
138834543|NCT00795457|Poly ICLC|poly iclc|mesh-list
138834544|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
138834545|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834546|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
138834547|NCT00795457|Laxatives|laxatives|mesh-ancestor
138834548|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138834549|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
138834550|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834551|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138834552|NCT00793195|SMOFlipid|smoflipid|mesh-list
138834553|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138683259|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683260|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
138683261|NCT04692558|Protective Agents|protective agents|mesh-ancestor
138683262|NCT02952599|Edoxaban|edoxaban|mesh-list
138683270|NCT00510419|Sumatriptan|sumatriptan|mesh-list
138834554|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138834555|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138834556|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
138834557|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138834558|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834559|NCT00795613|Doxorubicin|doxorubicin|mesh-list
138834560|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138834561|NCT00795613|Vincristine|vincristine|mesh-list
138834562|NCT00795613|Procarbazine|procarbazine|mesh-list
138834563|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138834564|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834565|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138834566|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138834567|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834568|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445892|NCT01840813|Misoprostol|misoprostol|mesh-list
138834569|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138834570|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
138834571|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
138834572|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
138834574|NCT00800761|Deferoxamine|deferoxamine|mesh-list
138834575|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138834577|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
138834578|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834579|NCT00800761|Siderophores|siderophores|mesh-ancestor
138834580|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
138834581|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138834582|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834583|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138834584|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
138834585|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138834586|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683305|NCT00508976|Lidocaine|lidocaine|mesh-list
138834587|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834588|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834589|NCT00800917|Sirolimus|sirolimus|mesh-list
138834590|NCT00800917|Bevacizumab|bevacizumab|mesh-list
138834591|NCT00800917|Temsirolimus|temsirolimus|mesh-list
138834592|NCT00800917|MTOR Inhibitors|mtor inhibitors|mesh-list
138834593|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138834594|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834595|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138834596|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138834597|NCT00800917|Growth Substances|growth substances|mesh-ancestor
138834598|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834599|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
138834600|NCT00800917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138834601|NCT00800917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834602|NCT00800917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834603|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138834604|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
138834605|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138834606|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834607|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138834608|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
138834609|NCT05003102|Fentanyl|fentanyl|mesh-list
138834610|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
138834611|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138834612|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138834613|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834614|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138834615|NCT05003102|Analgesics|analgesics|mesh-ancestor
138834616|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
138834617|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834618|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138834619|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138834620|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138834621|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
138834622|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834623|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834624|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138683350|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138683353|NCT00527085|Cinacalcet|cinacalcet|mesh-list
138834625|NCT05003102|Narcotics|narcotics|mesh-ancestor
138834626|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138834627|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138834628|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
138834629|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
138834630|NCT00676377|Neostigmine|neostigmine|mesh-list
138834631|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138834632|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834633|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834634|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
138834635|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834636|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834637|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138834638|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
138834639|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834640|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
138834641|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138834642|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834643|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138834644|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138834645|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834646|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834647|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834648|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138834649|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138834650|NCT00676845|Olmesartan|olmesartan|mesh-list
138834651|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138834652|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138834653|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138834654|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138834655|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834656|NCT04152057|Paclitaxel|paclitaxel|mesh-list
138834657|NCT04152057|Trastuzumab|trastuzumab|mesh-list
138683388|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
138683389|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683390|NCT00509678|Rituximab|rituximab|mesh-list
138834658|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138834659|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834660|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
138834661|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
138834662|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
138834663|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834664|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138834665|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
138834666|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
138834667|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138445948|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
138834668|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138683426|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
138683427|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
138834669|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138834670|NCT00610142|Analgesics|analgesics|mesh-ancestor
138834671|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
138834672|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834673|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834674|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138834675|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
138834676|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138834677|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
138834678|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138834679|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834680|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834681|NCT04151823|Vitamin D|vitamin d|mesh-list
138834682|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
138834683|NCT04151823|Vitamins|vitamins|mesh-ancestor
138834684|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
138834685|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834686|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138834687|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138834688|NCT05199038|Octreotide|octreotide|mesh-list
138834689|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138683486|NCT03459911|Losartan|losartan|mesh-list
138683498|NCT05648487|Antibodies|antibodies|mesh-list
138834690|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138834691|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834692|NCT00660907|Metformin|metformin|mesh-list
138834693|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
138834694|NCT00660907|Glipizide|glipizide|mesh-list
138834695|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138834696|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834697|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138834698|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834699|NCT04992572|Lidocaine|lidocaine|mesh-list
138834700|NCT04992572|Propofol|propofol|mesh-list
138834701|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
138834702|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
138834703|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138834704|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834705|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
138834706|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834707|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138834708|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138834709|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138834710|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138834711|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834712|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138834713|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138834714|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
138834715|NCT05083052|Propolis|propolis|mesh-list
138683540|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138683541|NCT01580514|Incretins|incretins|mesh-ancestor
138683542|NCT01580514|Hormones|hormones|mesh-ancestor
138683543|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138683544|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
138214555|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138683545|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138683546|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834716|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834717|NCT04031703|Paclitaxel|paclitaxel|mesh-list
138834719|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
138834720|NCT04031703|Carboplatin|carboplatin|mesh-list
138834721|NCT04031703|Fluorouracil|fluorouracil|mesh-list
138834722|NCT04031703|Epirubicin|epirubicin|mesh-list
138486726|NCT00000147|Prednisolone|prednisolone|mesh-list
138834723|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138834724|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834725|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
138834726|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
138834727|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
138834728|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834729|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138834730|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
138834731|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834732|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138834733|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138834734|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
138834735|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138834736|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
138834737|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138683582|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138834738|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138683583|NCT02953184|Protective Agents|protective agents|mesh-ancestor
138683584|NCT00515229|Amitriptyline|amitriptyline|mesh-list
138683585|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138834739|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138834740|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138834741|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834742|NCT00795847|Losartan|losartan|mesh-list
138834743|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138834744|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138834745|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138834746|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138834747|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138834748|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834749|NCT00795847|Diuretics|diuretics|mesh-ancestor
138834750|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
138834751|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834752|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138683627|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
138683628|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683629|NCT02944734|Amlodipine|amlodipine|mesh-list
138683630|NCT02944734|Candesartan|candesartan|mesh-list
138683631|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
138834753|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138834754|NCT00877773|Sirolimus|sirolimus|mesh-list
138834755|NCT00877773|Temsirolimus|temsirolimus|mesh-list
138834756|NCT00877773|MTOR Inhibitors|mtor inhibitors|mesh-list
138834757|NCT00877773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138834758|NCT00877773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834759|NCT00877773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834760|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138834761|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
138834762|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834763|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834764|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138834765|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834766|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138834767|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
138834768|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138834769|NCT00994643|Aldesleukin|aldesleukin|mesh-list
138834770|NCT00994643|Rituximab|rituximab|mesh-list
138683686|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138683688|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
138834771|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138834772|NCT00994643|Interleukin-2|interleukin-2|mesh-list
138834773|NCT00994643|Antibodies|antibodies|mesh-list
138834774|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
138834775|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138834776|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
138834777|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834778|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834779|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138834780|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138834781|NCT00994643|Analgesics|analgesics|mesh-ancestor
138834782|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
138834783|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834784|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138834785|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138834786|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
138834787|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834788|NCT00912171|Budesonide|budesonide|mesh-list
138834789|NCT00912171|Montelukast|montelukast|mesh-list
138834790|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138834791|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138834792|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
138834793|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834794|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446042|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
138834795|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138834796|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834797|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
138834798|NCT00912171|Hormones|hormones|mesh-ancestor
138834799|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138834800|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138834801|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
138834802|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138834803|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138683742|NCT00515736|Vitamin E|vitamin e|mesh-list
138834804|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834805|NCT00677391|Sibutramine|sibutramine|mesh-list
138834806|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
138683743|NCT00515736|Thiamine|thiamine|mesh-list
138683744|NCT00515736|Zinc|zinc|mesh-list
138683745|NCT00515736|Selenium|selenium|mesh-list
138834807|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138834808|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
138834809|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138834810|NCT00629057|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138834811|NCT00629057|Antiviral Agents|antiviral agents|mesh-ancestor
138834812|NCT00629057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834813|NCT00660829|Azelastine|azelastine|mesh-list
138834814|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138834815|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
138834816|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834817|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834818|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138834819|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834820|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138834821|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834822|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834823|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138834824|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138834825|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138834826|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
138834827|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
138834828|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834829|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
138834830|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138834831|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138834832|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
138834833|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834834|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138834835|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
138834836|NCT00629135|Metronidazole|metronidazole|mesh-list
138834837|NCT00629135|Tazobactam|tazobactam|mesh-list
138834838|NCT00629135|Piperacillin|piperacillin|mesh-list
138834839|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138472851|NCT02005120|Bevacizumab|bevacizumab|mesh-list
138834840|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138834841|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834842|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138834843|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138834844|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834845|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834846|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834847|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138834848|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138834849|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138834850|NCT00795925|Propiverine|propiverine|mesh-list
138834851|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
138834852|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
138834853|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138683782|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
138683783|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834854|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834855|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138834856|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138834857|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
138834858|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834859|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834860|NCT00795925|Urological Agents|urological agents|mesh-ancestor
138834861|NCT04293419|Durvalumab|durvalumab|mesh-list
138834862|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138834863|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834864|NCT00793429|Prucalopride|prucalopride|mesh-list
138834865|NCT00793429|Laxatives|laxatives|mesh-ancestor
138834866|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138834867|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138834868|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138834869|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
138834870|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834871|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834872|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834873|NCT00801151|Vinorelbine|vinorelbine|mesh-list
138834875|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138834876|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834877|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
138834878|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
138834879|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
138834880|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834881|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138834882|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834883|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138834884|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138834885|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138834886|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138834887|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834888|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138834889|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138834890|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138834891|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
138834892|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834893|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834894|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138834895|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138834896|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
138834897|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
138683860|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138683864|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
138834898|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138834899|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
138834900|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834901|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834902|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138834903|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834904|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
138834905|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138834906|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
138834907|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834908|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834909|NCT00796159|Olmesartan|olmesartan|mesh-list
138834910|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138834911|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138834912|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138834913|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138834914|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834915|NCT00993473|Insulin|insulin|mesh-list
138834916|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138834917|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
138834918|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
138834919|NCT00993473|Protamines|protamines|mesh-list
138834920|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138834921|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834922|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
138834923|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834924|NCT00993473|Coagulants|coagulants|mesh-ancestor
138834925|NCT00660595|Risperidone|risperidone|mesh-list
138834926|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138834927|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138834928|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
138834929|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834930|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834931|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683919|NCT00513968|Adefovir|adefovir|mesh-list
138683920|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
138683921|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138834932|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138834933|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138834934|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138834935|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138834936|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138472897|NCT02005575|Bupivacaine|bupivacaine|mesh-list
138834937|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
138834938|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
138834939|NCT00929240|Bevacizumab|bevacizumab|mesh-list
138834940|NCT00929240|Capecitabine|capecitabine|mesh-list
138834941|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138834942|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446129|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
138834943|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138834944|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138834945|NCT00929240|Growth Substances|growth substances|mesh-ancestor
138834946|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834947|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
138834948|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138834950|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834952|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
138834953|NCT00793663|Ondansetron|ondansetron|mesh-list
138834954|NCT00793663|Sevoflurane|sevoflurane|mesh-list
138834955|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138834956|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
138834957|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
138834958|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138834959|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683956|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
138834960|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138834961|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
138834962|NCT00793663|Hormones|hormones|mesh-ancestor
138834963|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138834964|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138834965|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834967|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138834968|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
138834969|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
138834970|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138834971|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
138834972|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
138834973|NCT00793663|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138834974|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138834975|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
138834976|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138834977|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834978|NCT02554045|Tadalafil|tadalafil|mesh-list
138834979|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
138834980|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138834981|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138834982|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138834983|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834984|NCT02554045|Urological Agents|urological agents|mesh-ancestor
138834985|NCT05330390|Levetiracetam|levetiracetam|mesh-list
138834986|NCT05330390|Anticonvulsants|anticonvulsants|mesh-ancestor
138834987|NCT05330390|Nootropic Agents|nootropic agents|mesh-ancestor
138834988|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
138834989|NCT00993317|Methotrexate|methotrexate|mesh-list
138834990|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138834991|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
138834992|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138446148|NCT01842373|Tetracaine|tetracaine|mesh-list
138834993|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138834994|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138684005|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
138834995|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
138834996|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138834997|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138834998|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
138834999|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835000|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138835001|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138835002|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
138835003|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138835004|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138835005|NCT00993317|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138835006|NCT00993317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138835007|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138835008|NCT00801385|Sorafenib|sorafenib|mesh-list
138835009|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835010|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138835011|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835012|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835013|NCT00677001|R 306465|r 306465|mesh-list
138835014|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138835015|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835016|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835017|NCT00877071|Doxorubicin|doxorubicin|mesh-list
138835018|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138835019|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835020|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138835021|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138835022|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835023|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835024|NCT02868827|Vitamin D|vitamin d|mesh-list
138835025|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
138835026|NCT02868827|Vitamins|vitamins|mesh-ancestor
138835027|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
138653260|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138835028|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472970|NCT02005770|Sevoflurane|sevoflurane|mesh-list
138472976|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
138835029|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138835030|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138835031|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
138835032|NCT00987389|Hormones|hormones|mesh-ancestor
138835033|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138684044|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138684046|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
138835034|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835035|NCT00929162|Paclitaxel|paclitaxel|mesh-list
138835036|NCT00929162|Carboplatin|carboplatin|mesh-list
138835037|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138835038|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835039|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
138835040|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
138835041|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
138835042|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835043|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
138835044|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138835045|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
138835046|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835047|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835048|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138835049|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
138835050|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
138835051|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138835052|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
138835053|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835054|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835055|NCT00678483|Rimonabant|rimonabant|mesh-list
138446211|NCT01843075|Liraglutide|liraglutide|mesh-list
138835056|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138835057|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138835058|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138835059|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835060|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835061|NCT00678483|Hormones|hormones|mesh-ancestor
138835062|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138835063|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835064|NCT00610454|Levetiracetam|levetiracetam|mesh-list
138835065|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
138835066|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
138835067|NCT04151355|Atorvastatin|atorvastatin|mesh-list
138835068|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138835069|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138835070|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
138835071|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835072|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138684075|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138835073|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138835074|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835075|NCT00609284|Carboplatin|carboplatin|mesh-list
138835076|NCT00609284|Cetuximab|cetuximab|mesh-list
138835077|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835078|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138835079|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138835080|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835081|NCT00930722|Quinapril|quinapril|mesh-list
138835082|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138835083|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
138835084|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835085|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835086|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138835087|NCT00610610|Paroxetine|paroxetine|mesh-list
138835088|NCT00610610|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138835089|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138835090|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138835091|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835092|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835094|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835095|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138835096|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
138835097|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138835098|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138835099|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138835100|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835102|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138835103|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835104|NCT04257812|Tazobactam|tazobactam|mesh-list
138835105|NCT04257812|Ceftolozane|ceftolozane|mesh-list
138835106|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
138835107|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138835108|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835109|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138684109|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138684110|NCT00531024|Growth Substances|growth substances|mesh-ancestor
138835110|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835111|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835112|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138835113|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
138835114|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138835115|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
138835116|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835117|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
138835118|NCT02868749|Protective Agents|protective agents|mesh-ancestor
138835119|NCT00659581|Telmisartan|telmisartan|mesh-list
138835120|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138835121|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138835122|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138835123|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835124|NCT00793741|Somatostatin|somatostatin|mesh-list
138835125|NCT00793741|Hormones|hormones|mesh-ancestor
138835126|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138835127|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835128|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138835129|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138835130|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138835131|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835132|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835133|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138835134|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138835135|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138684153|NCT00514748|Analgesics|analgesics|mesh-ancestor
138835136|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
138835137|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835138|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835139|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138835140|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138835141|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
138835142|NCT00991289|Interferons|interferons|mesh-list
138835144|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
138835145|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
138835146|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138835147|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
138835148|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835149|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
138835150|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835151|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
138835152|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835153|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
138835154|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835155|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138835156|NCT04046029|Heparin|heparin|mesh-list
138835157|NCT04046029|Bivalirudin|bivalirudin|mesh-list
138835158|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
138835159|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138835160|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138835161|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835162|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
138835163|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138835164|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
138835165|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835166|NCT00679653|Sibutramine|sibutramine|mesh-list
138835167|NCT00679653|Metoprolol|metoprolol|mesh-list
138835168|NCT00679653|Verapamil|verapamil|mesh-list
138835169|NCT00679653|Felodipine|felodipine|mesh-list
138835170|NCT00679653|Ramipril|ramipril|mesh-list
138835171|NCT00679653|Trandolapril|trandolapril|mesh-list
138835172|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138835173|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138835174|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
138835175|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
138684192|NCT02951234|Analgesics|analgesics|mesh-ancestor
138835176|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835177|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835178|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138835179|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138684204|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
138835180|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138835181|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
138835182|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835183|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835184|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138835185|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
138835186|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835187|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138835188|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138835189|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138835190|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
138835191|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
138835192|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138835193|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
138835194|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138835195|NCT00793897|Paclitaxel|paclitaxel|mesh-list
138835196|NCT00793897|Carboplatin|carboplatin|mesh-list
138835197|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138835198|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835199|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
138835200|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
138835201|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
138835202|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835203|NCT00793975|Ramucirumab|ramucirumab|mesh-list
138835204|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835205|NCT00679965|Tavaborole|tavaborole|mesh-list
138835206|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
138835207|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138684226|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138835208|NCT00930644|Teduglutide|teduglutide|mesh-list
138835209|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138835210|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138835211|NCT00930644|Protective Agents|protective agents|mesh-ancestor
138835212|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835213|NCT02627469|Listerine|listerine|mesh-list
138835214|NCT02627469|Fluorides|fluorides|mesh-list
138835215|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
138835216|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
138835217|NCT02627469|Protective Agents|protective agents|mesh-ancestor
138835218|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835219|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138835220|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835221|NCT00680277|Carotenoids|carotenoids|mesh-list
138835222|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
138446354|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
138835223|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835224|NCT00680277|Protective Agents|protective agents|mesh-ancestor
138835225|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835226|NCT00680355|Carotenoids|carotenoids|mesh-list
138835227|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
138835228|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835229|NCT00680355|Protective Agents|protective agents|mesh-ancestor
138684276|NCT05319912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684277|NCT05319912|Trace Elements|trace elements|mesh-ancestor
138835230|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835231|NCT00801697|Vaccines|vaccines|mesh-list
138835232|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
138835233|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835234|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
138835235|NCT00684489|Coal Tar|coal tar|mesh-list
138835236|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
138835237|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
138835238|NCT00990821|Midazolam|midazolam|mesh-list
138835239|NCT00990821|Aprepitant|aprepitant|mesh-list
138835240|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
138835241|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138835242|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138835243|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835244|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835245|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138835246|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138835247|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138835248|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138835249|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
138835251|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
138835252|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
138835253|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835254|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835255|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
138835256|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
138835257|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835258|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138835259|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138835260|NCT00801853|Interleukin-4|interleukin-4|mesh-list
138835261|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138835262|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
138835263|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835264|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835265|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138835266|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138835267|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138835268|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
138835269|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138835270|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835271|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138835272|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138835273|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138835274|NCT00658567|Pimavanserin|pimavanserin|mesh-list
138835275|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138835276|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138835277|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138835278|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138835279|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835280|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835281|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138835282|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138835283|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138835284|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
138835285|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835286|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835288|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835289|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138835290|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215076|NCT01588561|Nicotine|nicotine|mesh-list
138684386|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
138835291|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835292|NCT00684957|Hormones|hormones|mesh-list
138835293|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138835294|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835295|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
138835296|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138835297|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138835298|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
138835299|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835300|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138835301|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138835302|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835303|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835304|NCT00685269|Eszopiclone|eszopiclone|mesh-list
138835305|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138835306|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835307|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835308|NCT00794209|Fentanyl|fentanyl|mesh-list
138835309|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138835310|NCT00794209|Narcotics|narcotics|mesh-ancestor
138835311|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835312|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835313|NCT00794209|Analgesics|analgesics|mesh-ancestor
138446431|NCT01844024|Misoprostol|misoprostol|mesh-list
138835314|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
138835315|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835316|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138835317|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138835318|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
138835319|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
138684420|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835320|NCT00985985|Nicotine|nicotine|mesh-list
138835321|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138487317|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
138835322|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
138835323|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835324|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835325|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138835326|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138835327|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
138835328|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835329|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835331|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138835332|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
138835333|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835334|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835335|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138835336|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
138835337|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
138835338|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138835339|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138835340|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138835341|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138835342|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
138835343|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835344|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835345|NCT00685425|Albuterol|albuterol|mesh-list
138835346|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138835347|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
138835348|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835349|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835350|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138835351|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
138835352|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
138835353|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138835354|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138684465|NCT05317572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138684466|NCT05317572|Narcotics|narcotics|mesh-ancestor
138684467|NCT05317572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138684468|NCT05317572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684469|NCT05317572|Analgesics|analgesics|mesh-ancestor
138835355|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138835356|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138835357|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
138835358|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835359|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835360|NCT04290455|Castor Oil|castor oil|mesh-list
138835361|NCT04290455|Cathartics|cathartics|mesh-ancestor
138835362|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138835363|NCT00685503|Ranibizumab|ranibizumab|mesh-list
138835364|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138835365|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138835366|NCT00685503|Growth Substances|growth substances|mesh-ancestor
138835367|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835368|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
138835369|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835371|NCT00802009|Mepivacaine|mepivacaine|mesh-list
138835372|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138835373|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
138835374|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
138653342|NCT00314990|Pyridoxine|pyridoxine|mesh-list
138835375|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835376|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835377|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138835378|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
138835380|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138835381|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138835382|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835383|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
138835384|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
138835385|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138684500|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835386|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
138835387|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
138835388|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138835389|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
138835390|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835391|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
138835392|NCT02868437|Protective Agents|protective agents|mesh-ancestor
138835393|NCT00802087|Acetaminophen|acetaminophen|mesh-list
138835394|NCT00802087|Hydrocodone|hydrocodone|mesh-list
138835395|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138835396|NCT00802087|Analgesics|analgesics|mesh-ancestor
138835397|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
138835398|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835399|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835400|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
138835401|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138835402|NCT00802087|Narcotics|narcotics|mesh-ancestor
138835403|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835404|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
138835405|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
138835406|NCT00923936|Bevacizumab|bevacizumab|mesh-list
138835407|NCT00923936|Doxorubicin|doxorubicin|mesh-list
138835408|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138446475|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
138835409|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138835410|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835411|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138835412|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138835413|NCT00923936|Growth Substances|growth substances|mesh-ancestor
138835414|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835415|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
138835416|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138835417|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138835418|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138835419|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835420|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835422|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138684554|NCT00516854|Clidinium|clidinium|mesh-list
138835423|NCT00797017|Narcotics|narcotics|mesh-ancestor
138835424|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835425|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835426|NCT00797017|Analgesics|analgesics|mesh-ancestor
138835427|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
138835428|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835429|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138835430|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138835431|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
138835432|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
138835433|NCT05330000|Voriconazole|voriconazole|mesh-list
138653375|NCT00344760|Tenofovir|tenofovir|mesh-list
138835434|NCT05330000|Antifungal Agents|antifungal agents|mesh-ancestor
138835435|NCT05330000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835436|NCT05330000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138835437|NCT05330000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138684587|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835438|NCT05330000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138684588|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138835439|NCT05330000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835440|NCT05330000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138835441|NCT05330000|Hormone Antagonists|hormone antagonists|mesh-ancestor
138835442|NCT05330000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138835443|NCT05330000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835444|NCT05330000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138835445|NCT00794443|Diphosphonates|diphosphonates|mesh-list
138473153|NCT05969457|Ropivacaine|ropivacaine|mesh-list
138835446|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138835447|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835448|NCT00924950|Calcitriol|calcitriol|mesh-list
138835449|NCT00924950|Betamethasone|betamethasone|mesh-list
138835450|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138835451|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
138835452|NCT00924950|Hormones|hormones|mesh-ancestor
138835453|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138835454|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835455|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138835456|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
138835457|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138835458|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138835459|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138835460|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835461|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138835462|NCT00924950|Vitamins|vitamins|mesh-ancestor
138835463|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
138835464|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138835465|NCT02626065|Nivolumab|nivolumab|mesh-list
138835466|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138835467|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835468|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138835469|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835470|NCT00794755|Vitamin K|vitamin k|mesh-list
138835471|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
138835472|NCT00794755|Vitamins|vitamins|mesh-ancestor
138835473|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
138835474|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835475|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138835476|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138835477|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835478|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
138835479|NCT00794755|Coagulants|coagulants|mesh-ancestor
138835480|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
138835481|NCT00685971|Vitamin D|vitamin d|mesh-list
138835482|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138835483|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835484|NCT00685971|Vitamins|vitamins|mesh-ancestor
138684696|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
138835485|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
138835486|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138684697|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138684698|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
138835487|NCT00802243|Leflunomide|leflunomide|mesh-list
138835488|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835489|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835490|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138835491|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
138835492|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835493|NCT00988637|Calcitriol|calcitriol|mesh-list
138835494|NCT00988637|Clobetasol|clobetasol|mesh-list
138835495|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138835496|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835497|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138835498|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138835499|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835500|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138835501|NCT00988637|Vitamins|vitamins|mesh-ancestor
138835502|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
138835503|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138835504|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138684742|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835505|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
138835507|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138835508|NCT00802321|Dutasteride|dutasteride|mesh-list
138835509|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138684743|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138835510|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138835511|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835512|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835513|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
138835514|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138835515|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835516|NCT00686361|Choline|choline|mesh-list
138835517|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
138835518|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138835519|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
138835520|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835521|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138835522|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138835523|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
138684792|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
138684793|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835524|NCT00686439|Adalimumab|adalimumab|mesh-list
138835525|NCT00686439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138835526|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138684795|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
138835527|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138835528|NCT00797485|Leucovorin|leucovorin|mesh-list
138835529|NCT00797485|Bevacizumab|bevacizumab|mesh-list
138835530|NCT00797485|Capecitabine|capecitabine|mesh-list
138835531|NCT00797485|Fluorouracil|fluorouracil|mesh-list
138835532|NCT00797485|Irinotecan|irinotecan|mesh-list
138835533|NCT00797485|Calcium|calcium|mesh-list
138835534|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
138835535|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138835536|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835537|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138835538|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138835539|NCT00797485|Growth Substances|growth substances|mesh-ancestor
138835540|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835541|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
138835542|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138835543|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138835545|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835546|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138835547|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
138684850|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
138835548|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138835549|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138835550|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835551|NCT00797485|Antidotes|antidotes|mesh-ancestor
138835552|NCT00797485|Protective Agents|protective agents|mesh-ancestor
138835553|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
138835554|NCT00797485|Vitamins|vitamins|mesh-ancestor
138835555|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
138473197|NCT05968885|Mirabegron|mirabegron|mesh-list
138835557|NCT00686985|Docetaxel|docetaxel|mesh-list
138835558|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835559|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
138835560|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
138835561|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
138835562|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835563|NCT02866955|Tamoxifen|tamoxifen|mesh-list
138835564|NCT02866955|Estramustine|estramustine|mesh-list
138835565|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138835566|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
138835567|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138835568|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835569|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138835570|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835571|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138835572|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138835573|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138835574|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138835575|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
138835576|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835578|NCT02625753|Codeine|codeine|mesh-list
138835579|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138835580|NCT02625753|Analgesics|analgesics|mesh-ancestor
138835581|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
138684902|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138684903|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835582|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835583|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835584|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
138835585|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138835586|NCT02625753|Narcotics|narcotics|mesh-ancestor
138835587|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835588|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
138835589|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
138835590|NCT04257656|Remdesivir|remdesivir|mesh-list
138835591|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
138835592|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653442|NCT00315848|Buprenorphine|buprenorphine|mesh-list
138835593|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
138835594|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835595|NCT05329844|Vildagliptin|vildagliptin|mesh-list
138835596|NCT05329844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138835597|NCT05329844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473210|NCT05968885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138835598|NCT05329844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138835599|NCT05329844|Protease Inhibitors|protease inhibitors|mesh-ancestor
138835600|NCT05329844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835601|NCT05329844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835602|NCT00687999|Interferons|interferons|mesh-list
138835604|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
138835605|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835606|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
138684949|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
138215674|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
138835607|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835608|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
138835609|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835610|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
138835611|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835612|NCT00688077|Calcitonin|calcitonin|mesh-list
138835613|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
138835614|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138835615|NCT00688077|Katacalcin|katacalcin|mesh-list
138835616|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138835617|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835618|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138835619|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
138684997|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
138215779|NCT00594230|Panobinostat|panobinostat|mesh-list
138835620|NCT00923156|Ramipril|ramipril|mesh-list
138835621|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138684998|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
138835622|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
138835623|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835624|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835625|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138685000|NCT00520325|Coagulants|coagulants|mesh-ancestor
138835626|NCT00688857|Diazoxide|diazoxide|mesh-list
138835627|NCT00688857|Choline|choline|mesh-list
138835628|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
138835629|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138835630|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
138835631|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835632|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138835633|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138835634|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
138835635|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138835636|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
138835637|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
138835638|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138835639|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835640|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
138835641|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
138835642|NCT00687843|Tegafur|tegafur|mesh-list
138835643|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138835644|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
138835645|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835646|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835647|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138835648|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
138835649|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835650|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138685046|NCT02277132|Urological Agents|urological agents|mesh-ancestor
138685048|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138685050|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138685051|NCT00520949|Esomeprazole|esomeprazole|mesh-list
138835651|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
138685053|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138685054|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835652|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835653|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
138835654|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138835655|NCT00687843|Protective Agents|protective agents|mesh-ancestor
138835657|NCT00689169|Rituximab|rituximab|mesh-list
138685055|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138685056|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138685057|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138835658|NCT00689169|Etoposide|etoposide|mesh-list
138835659|NCT00689169|Melphalan|melphalan|mesh-list
138685058|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835660|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138835661|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835662|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
138835663|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835664|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138446744|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138835665|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138835666|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138835667|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138835668|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835669|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835670|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138835671|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
138835672|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138835673|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138835674|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138835675|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
138835676|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
138835677|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835678|NCT04203914|Empagliflozin|empagliflozin|mesh-list
138835679|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138835680|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835681|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138835682|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835683|NCT00874731|Sirolimus|sirolimus|mesh-list
138835684|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138685086|NCT02938182|Clopidogrel|clopidogrel|mesh-list
138835685|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835686|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138835687|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835688|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
138835689|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138835690|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
138835691|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835692|NCT02625519|Hormones|hormones|mesh-list
138835693|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138446788|NCT01846325|Vitamin E|vitamin e|mesh-list
138835694|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138835695|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835696|NCT00912483|Heparin|heparin|mesh-list
138835697|NCT00912483|Calcium heparin|calcium heparin|mesh-list
138835698|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
138835699|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138835701|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835702|NCT04257032|Dabigatran|dabigatran|mesh-list
138835703|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138835704|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138835705|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138835706|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
138835707|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685129|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685130|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
138685132|NCT02931474|Tesamorelin|tesamorelin|mesh-list
138835708|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138835709|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138835710|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835711|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
138835712|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138685181|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685182|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138835713|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
138835714|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
138835715|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138835716|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138685183|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138835717|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
138835718|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138835719|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
138835720|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
138835721|NCT00924560|Estradiol|estradiol|mesh-list
138835722|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138835723|NCT00924560|Estrogens|estrogens|mesh-ancestor
138835724|NCT00924560|Hormones|hormones|mesh-ancestor
138835725|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138835727|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138835728|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138835729|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138835730|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138835732|NCT00689559|Aripiprazole|aripiprazole|mesh-list
138835733|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
138835734|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138835735|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138835736|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138835737|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835738|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835739|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
138835740|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
138835741|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835742|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835743|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138835744|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138835745|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
138835746|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138835747|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138835748|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138835749|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138685243|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835750|NCT00689637|Warfarin|warfarin|mesh-list
138835751|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
138835752|NCT00689715|Ethanol|ethanol|mesh-list
138835753|NCT00689715|Paclitaxel|paclitaxel|mesh-list
138685244|NCT00522743|Hormones|hormones|mesh-list
138835754|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138835755|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138835756|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835757|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
138835758|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
138835759|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
138835760|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835761|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138835762|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835763|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835764|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835765|NCT00689949|Folic Acid|folic acid|mesh-list
138835766|NCT00689949|Hematinics|hematinics|mesh-ancestor
138835767|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
138835768|NCT00689949|Vitamins|vitamins|mesh-ancestor
138835769|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
138835770|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835771|NCT04256642|Morphine|morphine|mesh-list
138835772|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138835773|NCT04256642|Narcotics|narcotics|mesh-ancestor
138835774|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835775|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835777|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
138685286|NCT02936895|Vitamins|vitamins|mesh-ancestor
138685287|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
138685292|NCT00522938|Tosedostat|tosedostat|mesh-list
138835778|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835779|NCT00611000|Folic Acid|folic acid|mesh-list
138835780|NCT00611000|Hematinics|hematinics|mesh-ancestor
138835781|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
138835782|NCT00611000|Vitamins|vitamins|mesh-ancestor
138835783|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
138835784|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835785|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
138835786|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138835787|NCT00690105|Fluticasone|fluticasone|mesh-list
138835788|NCT00690105|Tacrolimus|tacrolimus|mesh-list
138835789|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138835790|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
138835791|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835792|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138835793|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835794|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835795|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138835796|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138835797|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
138835798|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835799|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138835800|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
138835801|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
138835802|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138835803|NCT00694317|Zaleplon|zaleplon|mesh-list
138835804|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
138835805|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138685331|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685332|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685333|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
138835806|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835807|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835808|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
138835809|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
138835810|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835811|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835812|NCT04136613|Copper|copper|mesh-list
138835813|NCT04136613|Trace Elements|trace elements|mesh-ancestor
138835814|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
138835815|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835816|NCT00978731|Dasatinib|dasatinib|mesh-list
138835817|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835818|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138835819|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835820|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835821|NCT04136535|Carboplatin|carboplatin|mesh-list
138835822|NCT04136535|Pemetrexed|pemetrexed|mesh-list
138835823|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835824|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835825|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835826|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138653516|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835827|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138835828|NCT00694629|Rifampin|rifampin|mesh-list
138835829|NCT00694629|Rifapentine|rifapentine|mesh-list
138835830|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138835831|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
138835832|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138835833|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138835834|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
138835835|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138835836|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835837|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835838|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138835839|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138835840|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138835841|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138835842|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138835843|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138835844|NCT00912639|Paclitaxel|paclitaxel|mesh-list
138835845|NCT00912639|genexol-PM|genexol-pm|mesh-list
138835846|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138835847|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835848|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
138835849|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
138487849|NCT00000789|Zidovudine|zidovudine|mesh-list
138835851|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835852|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
138835853|NCT02866409|Bupivacaine|bupivacaine|mesh-list
138835854|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
138835855|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
138835856|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835857|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835858|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
138835859|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835860|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138835861|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138835862|NCT02866409|Analgesics|analgesics|mesh-ancestor
138835863|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138835864|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138835865|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138835866|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
138835867|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835868|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835869|NCT05833984|Tislelizumab|tislelizumab|mesh-list
138835870|NCT05833984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138835871|NCT05833984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835872|NCT05833919|Capecitabine|capecitabine|mesh-list
138835873|NCT05833919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138835874|NCT05833919|Antimetabolites|antimetabolites|mesh-ancestor
138835875|NCT05833919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835876|NCT05833919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835878|NCT05833815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138835879|NCT05833815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138835880|NCT05833815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835881|NCT05833815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835882|NCT05833815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138835883|NCT05833815|Immunologic Factors|immunologic factors|mesh-ancestor
138835884|NCT05833815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835885|NCT05833815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835886|NCT05833802|Antineoplastic Agents|antineoplastic agents|mesh-list
138685415|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138685442|NCT02936427|BB 1101|bb 1101|mesh-list
138835887|NCT05833477|Epoetin Alfa|epoetin alfa|mesh-list
138835888|NCT05833477|Hematinics|hematinics|mesh-ancestor
138835889|NCT05833399|Carbamazepine|carbamazepine|mesh-list
138835890|NCT05833399|Amitriptyline|amitriptyline|mesh-list
138835891|NCT05833399|Olanzapine|olanzapine|mesh-list
138835892|NCT05833399|Chlorpromazine|chlorpromazine|mesh-list
138835893|NCT05833399|Risperidone|risperidone|mesh-list
138835894|NCT05833399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138835895|NCT05833399|Mirtazapine|mirtazapine|mesh-list
138835896|NCT05833399|Sertraline|sertraline|mesh-list
138835897|NCT05833399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138835898|NCT05833399|Serotonin Agents|serotonin agents|mesh-ancestor
138835899|NCT05833399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835900|NCT05833399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835901|NCT05833399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835902|NCT05833399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138835903|NCT05833399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138835904|NCT05833399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138835905|NCT05833399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138835906|NCT05833399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138835907|NCT05833399|Dopamine Agents|dopamine agents|mesh-ancestor
138835908|NCT05833399|Antiemetics|antiemetics|mesh-ancestor
138835909|NCT05833399|Autonomic Agents|autonomic agents|mesh-ancestor
138835910|NCT05833399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138835911|NCT05833399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138835912|NCT05833399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138835913|NCT05833399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138835914|NCT05833399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138685449|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
138835915|NCT05833399|Antidepressive Agents|antidepressive agents|mesh-ancestor
138835916|NCT05833399|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138835917|NCT05833399|Histamine Antagonists|histamine antagonists|mesh-ancestor
138685450|NCT02936427|Hormones|hormones|mesh-ancestor
138835918|NCT05833399|Histamine Agents|histamine agents|mesh-ancestor
138835919|NCT05833399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138835920|NCT05833399|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138835921|NCT05833399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138835922|NCT05833399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138835923|NCT05833399|Adrenergic Agents|adrenergic agents|mesh-ancestor
138835924|NCT05833399|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138835925|NCT05833399|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138835926|NCT05833399|Anticonvulsants|anticonvulsants|mesh-ancestor
138835927|NCT05833399|Antimanic Agents|antimanic agents|mesh-ancestor
138835928|NCT05833399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138835929|NCT05833399|Analgesics|analgesics|mesh-ancestor
138835930|NCT05833399|Sensory System Agents|sensory system agents|mesh-ancestor
138835931|NCT05833399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138835932|NCT05833399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138835933|NCT05833399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138835934|NCT05833399|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138835935|NCT05833399|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138835936|NCT05832996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138835937|NCT05832996|Lubricant Eye Drops|lubricant eye drops|mesh-list
138835938|NCT05832996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138835939|NCT05832749|Hyaluronic Acid|hyaluronic acid|mesh-list
138835940|NCT05832749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138835941|NCT05832749|Immunologic Factors|immunologic factors|mesh-ancestor
138835942|NCT05832749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835943|NCT05832749|Viscosupplements|viscosupplements|mesh-ancestor
138835944|NCT05832749|Protective Agents|protective agents|mesh-ancestor
138835945|NCT05832697|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138835946|NCT05832697|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138835947|NCT05832697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138835949|NCT05832619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138835950|NCT05832619|Serotonin Agents|serotonin agents|mesh-ancestor
138835951|NCT05832619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835952|NCT05832619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835953|NCT05832619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835954|NCT05832580|Etidronic Acid|etidronic acid|mesh-list
138835955|NCT05832580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138835956|NCT05832580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835957|NCT05832515|Fludarabine|fludarabine|mesh-list
138835958|NCT05832515|Fludarabine phosphate|fludarabine phosphate|mesh-list
138835959|NCT05832515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835960|NCT05832515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138835961|NCT05832515|Antimetabolites|antimetabolites|mesh-ancestor
138685492|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
138835962|NCT05832515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835963|NCT05832515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138835964|NCT05832515|Immunologic Factors|immunologic factors|mesh-ancestor
138835965|NCT05832515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835966|NCT05832489|Methylphenidate|methylphenidate|mesh-list
138835967|NCT05832489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138835968|NCT05832489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835969|NCT05832489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138835970|NCT05832489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138835971|NCT05832489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138835972|NCT05832489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835973|NCT05832489|Dopamine Agents|dopamine agents|mesh-ancestor
138835974|NCT05832489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138835975|NCT05832333|Vaccines|vaccines|mesh-list
138835976|NCT05832333|Immunologic Factors|immunologic factors|mesh-ancestor
138835977|NCT05832333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835978|NCT05832320|Etoposide|etoposide|mesh-list
138835979|NCT05832320|Daunorubicin|daunorubicin|mesh-list
138835980|NCT05832320|Tretinoin|tretinoin|mesh-list
138835981|NCT05832320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138685525|NCT02935725|Analgesics|analgesics|mesh-ancestor
138685526|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
138685527|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685528|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685529|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138835982|NCT05832320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835983|NCT05832320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138835984|NCT05832320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138835985|NCT05832320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138835986|NCT05832320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138835987|NCT05832320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138835988|NCT05832320|Keratolytic Agents|keratolytic agents|mesh-ancestor
138835989|NCT05832320|Dermatologic Agents|dermatologic agents|mesh-ancestor
138835990|NCT05832216|Daratumumab|daratumumab|mesh-list
138835991|NCT05832216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138835992|NCT05832073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138835993|NCT05832073|Antibodies|antibodies|mesh-list
138835994|NCT05832073|Immunoglobulins|immunoglobulins|mesh-list
138835995|NCT05832073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138835996|NCT05832073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138835997|NCT05832073|Immunologic Factors|immunologic factors|mesh-ancestor
138835998|NCT05832073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138835999|NCT05832073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836000|NCT05832034|Immunoglobulins|immunoglobulins|mesh-list
138836001|NCT05832034|Antibodies|antibodies|mesh-list
138836002|NCT05832034|gamma-Globulins|gamma-globulins|mesh-list
138836003|NCT05832034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138685575|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138685576|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
138836004|NCT05832034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138836005|NCT05832034|Immunologic Factors|immunologic factors|mesh-ancestor
138836006|NCT05832034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836007|NCT05830539|Doxorubicin|doxorubicin|mesh-list
138836008|NCT05830539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138836009|NCT05830539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138836010|NCT05830539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836011|NCT05830539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138836012|NCT05830539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138836013|NCT05830539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836014|NCT05830539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836015|NCT05828940|Losartan|losartan|mesh-list
138836016|NCT05828940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138836017|NCT05828940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138836018|NCT05828940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138836019|NCT05828940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138836020|NCT05828940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836021|NCT05818423|Benzocaine|benzocaine|mesh-list
138836022|NCT05818423|Anesthetics, Local|anesthetics, local|mesh-ancestor
138836023|NCT05818423|Anesthetics|anesthetics|mesh-ancestor
138836024|NCT05818423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836025|NCT05818423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836026|NCT05818423|Sensory System Agents|sensory system agents|mesh-ancestor
138836027|NCT05818423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836028|NCT05816785|Cetuximab|cetuximab|mesh-list
138836029|NCT05816785|Imatinib Mesylate|imatinib mesylate|mesh-list
138836030|NCT05816785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138836031|NCT05816785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836032|NCT05816785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138836033|NCT05816785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836034|NCT05816785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836035|NCT05796401|Leucovorin|leucovorin|mesh-list
138836036|NCT05796401|Folic Acid|folic acid|mesh-list
138836037|NCT05796401|Vitamin B 12|vitamin b 12|mesh-list
138836038|NCT05796401|Levoleucovorin|levoleucovorin|mesh-list
138836039|NCT05796401|Vitamins|vitamins|mesh-ancestor
138836040|NCT05796401|Micronutrients|micronutrients|mesh-ancestor
138836041|NCT05796401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836042|NCT05796401|Antidotes|antidotes|mesh-ancestor
138836043|NCT05796401|Protective Agents|protective agents|mesh-ancestor
138836044|NCT05796401|Vitamin B Complex|vitamin b complex|mesh-ancestor
138836045|NCT05796401|Hematinics|hematinics|mesh-ancestor
138836046|NCT05771402|Antibodies|antibodies|mesh-list
138836047|NCT05771402|Immunologic Factors|immunologic factors|mesh-ancestor
138836048|NCT05771402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685632|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
138836049|NCT05769816|Antibodies|antibodies|mesh-list
138685633|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
138685634|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685635|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685636|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
138685637|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685638|NCT02929797|Gemcitabine|gemcitabine|mesh-list
138685639|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138685640|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
138362472|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138685641|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685642|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685643|NCT00525239|Ritonavir|ritonavir|mesh-list
138685645|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138836050|NCT05769816|Immunologic Factors|immunologic factors|mesh-ancestor
138836051|NCT05769816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836052|NCT05745142|Sunitinib|sunitinib|mesh-list
138836053|NCT05745142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836054|NCT05745142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138473448|NCT05699824|Carvedilol|carvedilol|mesh-list
138836055|NCT05745142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138836056|NCT05745142|Growth Substances|growth substances|mesh-ancestor
138836057|NCT05745142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836058|NCT05745142|Growth Inhibitors|growth inhibitors|mesh-ancestor
138836059|NCT05745142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138836060|NCT05745142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836061|NCT05745142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836063|NCT05737069|Ibuprofen arginine|ibuprofen arginine|mesh-list
138836064|NCT05737069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138836065|NCT05737069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138836066|NCT05737069|Analgesics|analgesics|mesh-ancestor
138836067|NCT05737069|Sensory System Agents|sensory system agents|mesh-ancestor
138836068|NCT05737069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836069|NCT05737069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836070|NCT05737069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138836071|NCT05737069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138836072|NCT05737069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138836073|NCT05737069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836074|NCT05737069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836075|NCT05709483|Aspirin|aspirin|mesh-list
138488085|NCT00000888|Ritonavir|ritonavir|mesh-list
138836076|NCT05709483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138836077|NCT05709483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138836078|NCT05709483|Analgesics|analgesics|mesh-ancestor
138836079|NCT05709483|Sensory System Agents|sensory system agents|mesh-ancestor
138836080|NCT05709483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836081|NCT05709483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836082|NCT05709483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138685646|NCT00525239|Efavirenz|efavirenz|mesh-list
138836083|NCT05709483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138836084|NCT05709483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138685647|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138685648|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138685649|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
138685650|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836085|NCT05709483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138836086|NCT05709483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836087|NCT05709483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138836088|NCT05709483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138836089|NCT05709483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836090|NCT05709483|Antipyretics|antipyretics|mesh-ancestor
138836091|NCT05672134|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
138836092|NCT05672134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138836093|NCT05672134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138836094|NCT05672134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836095|NCT05594615|Midazolam|midazolam|mesh-list
138836096|NCT05594615|Caffeine|caffeine|mesh-list
138836097|NCT05594615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138836098|NCT05594615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138836099|NCT05594615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138836100|NCT05594615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836101|NCT05594615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836102|NCT05594615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138836103|NCT05594615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138836104|NCT05594615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138836105|NCT05594615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138836106|NCT05594615|Anesthetics, General|anesthetics, general|mesh-ancestor
138836107|NCT05594615|Anesthetics|anesthetics|mesh-ancestor
138836108|NCT05594615|GABA Modulators|gaba modulators|mesh-ancestor
138836109|NCT05594615|GABA Agents|gaba agents|mesh-ancestor
138836110|NCT05594615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836111|NCT05594615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836112|NCT05594615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138836113|NCT05594615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138836115|NCT05594615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138421058|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
138653601|NCT06164379|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138836116|NCT05594615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138836117|NCT05594615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836118|NCT05594615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138836119|NCT05594615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138836120|NCT05594615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138836121|NCT05594615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138836122|NCT05594615|Purinergic Agents|purinergic agents|mesh-ancestor
138836124|NCT05594602|Quinidine|quinidine|mesh-list
138836125|NCT05594602|Carbamazepine|carbamazepine|mesh-list
138836126|NCT05594602|Antifungal Agents|antifungal agents|mesh-ancestor
138836127|NCT05594602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138836128|NCT05594602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138836129|NCT05594602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138836130|NCT05594602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836131|NCT05594602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836132|NCT05594602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138836133|NCT05594602|Hormone Antagonists|hormone antagonists|mesh-ancestor
138836134|NCT05594602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138836135|NCT05594602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836136|NCT05594602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138836137|NCT05594602|Anticonvulsants|anticonvulsants|mesh-ancestor
138836138|NCT05594602|Antimanic Agents|antimanic agents|mesh-ancestor
138836139|NCT05594602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138836140|NCT05594602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836141|NCT05594602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138447319|NCT01850628|Paclitaxel|paclitaxel|mesh-list
138836142|NCT05594602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138836143|NCT05594602|Analgesics|analgesics|mesh-ancestor
138836144|NCT05594602|Sensory System Agents|sensory system agents|mesh-ancestor
138836145|NCT05594602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836146|NCT05594602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138836147|NCT05594602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138836148|NCT05594602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138836149|NCT05594602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138836150|NCT05594602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138421132|NCT03811015|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138421133|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421134|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138421135|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138836151|NCT05594602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138836153|NCT05594602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836154|NCT05594602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138836155|NCT05594602|Antimalarials|antimalarials|mesh-ancestor
138836156|NCT05594602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138836157|NCT05594602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138836158|NCT05594602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138836159|NCT05594602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138836160|NCT05594602|Cholinergic Agents|cholinergic agents|mesh-ancestor
138836161|NCT05594602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138836162|NCT05594602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138836163|NCT05589844|Vaccines|vaccines|mesh-list
138836164|NCT05589844|Immunologic Factors|immunologic factors|mesh-ancestor
138836165|NCT05589844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836166|NCT05485519|Midazolam|midazolam|mesh-list
138836167|NCT05485519|Dexmedetomidine|dexmedetomidine|mesh-list
138836168|NCT05485519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138836169|NCT05485519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836170|NCT05485519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836171|NCT05485519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138836172|NCT05485519|Analgesics|analgesics|mesh-ancestor
138836173|NCT05485519|Sensory System Agents|sensory system agents|mesh-ancestor
138836174|NCT05485519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836175|NCT05485519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138836176|NCT05485519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138836177|NCT05485519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138836178|NCT05485519|Adrenergic Agents|adrenergic agents|mesh-ancestor
138836179|NCT05485519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836180|NCT05485519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836181|NCT05485519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138836182|NCT05485519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138421193|NCT03742895|Olaparib|olaparib|mesh-list
138836183|NCT05485519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138836184|NCT05485519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138836185|NCT05485519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138836186|NCT05485519|Anesthetics, General|anesthetics, general|mesh-ancestor
138836187|NCT05485519|Anesthetics|anesthetics|mesh-ancestor
138836188|NCT05485519|GABA Modulators|gaba modulators|mesh-ancestor
138836189|NCT05485519|GABA Agents|gaba agents|mesh-ancestor
138836190|NCT05411744|Vitamin B 6|vitamin b 6|mesh-list
138836191|NCT05411744|Pyridoxal|pyridoxal|mesh-list
138836192|NCT05411744|Pyridoxine|pyridoxine|mesh-list
138836193|NCT05411744|Isoniazid|isoniazid|mesh-list
138836194|NCT05411744|Rifapentine|rifapentine|mesh-list
138836195|NCT05411744|Vitamins|vitamins|mesh-ancestor
138836196|NCT05411744|Micronutrients|micronutrients|mesh-ancestor
138836197|NCT05411744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836198|NCT05411744|Vitamin B Complex|vitamin b complex|mesh-ancestor
138836199|NCT05411744|Antitubercular Agents|antitubercular agents|mesh-ancestor
138836200|NCT05411744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138421228|NCT03648905|Dopamine Agents|dopamine agents|mesh-ancestor
138836201|NCT05411744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138836202|NCT05411744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138836203|NCT05411744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138836204|NCT05411744|Antimetabolites|antimetabolites|mesh-ancestor
138421230|NCT03648905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421231|NCT03648905|Protective Agents|protective agents|mesh-ancestor
138421233|NCT03616587|Palbociclib|palbociclib|mesh-list
138421234|NCT03616587|Anastrozole|anastrozole|mesh-list
138421235|NCT03616587|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138421236|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138421237|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421238|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421239|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138421240|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
138421241|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421242|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421243|NCT03616587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138421244|NCT03616587|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138421245|NCT03616587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138421246|NCT03616587|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138421247|NCT03616587|Hormone Antagonists|hormone antagonists|mesh-ancestor
138421248|NCT03616587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138421250|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
138421251|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138421252|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421273|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138421274|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138421275|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138836205|NCT05411744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836206|NCT05411744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138836207|NCT05411744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138836208|NCT05411744|Leprostatic Agents|leprostatic agents|mesh-ancestor
138836209|NCT05359627|Polymyxins|polymyxins|mesh-list
138836210|NCT05359627|Polymyxin B|polymyxin b|mesh-list
138836211|NCT05359627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138836212|NCT05359627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138836214|NCT05246293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138836215|NCT05246293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138836216|NCT05246293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836217|NCT05246293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836218|NCT05243147|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
138836219|NCT05243147|Hemostatics|hemostatics|mesh-ancestor
138836220|NCT05243147|Coagulants|coagulants|mesh-ancestor
138836221|NCT05212610|Vaccines|vaccines|mesh-list
138836222|NCT05212610|Immunologic Factors|immunologic factors|mesh-ancestor
138836223|NCT05212610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836224|NCT05207280|Terlipressin|terlipressin|mesh-list
138421280|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
138488241|NCT00000978|Zidovudine|zidovudine|mesh-list
138836225|NCT05207280|Norepinephrine|norepinephrine|mesh-list
138836226|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138836227|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138836228|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138836229|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138836230|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
138836231|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836232|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836234|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
138836235|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
138836236|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836237|NCT05149378|Azacitidine|azacitidine|mesh-list
138836238|NCT05149378|Venetoclax|venetoclax|mesh-list
138836239|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138836240|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
138836241|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473492|NCT05637970|Hemostatics|hemostatics|mesh-list
138836242|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836243|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836244|NCT05134857|Zonisamide|zonisamide|mesh-list
138836245|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
138836246|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138836247|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138447433|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138836248|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836249|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138836250|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836251|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
138836253|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138836254|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836255|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138836256|NCT05108935|Buprenorphine|buprenorphine|mesh-list
138421341|NCT03511118|Coagulants|coagulants|mesh-ancestor
138836257|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138836258|NCT05108935|Naloxone|naloxone|mesh-list
138836259|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138836260|NCT05108935|Narcotics|narcotics|mesh-ancestor
138836261|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836262|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836263|NCT05108935|Analgesics|analgesics|mesh-ancestor
138836264|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
138836265|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836266|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138836267|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138836268|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138836269|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653653|NCT06164067|Misoprostol|misoprostol|mesh-list
138836270|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836271|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
138836272|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138836273|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138836274|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138836275|NCT05051527|Silymarin|silymarin|mesh-list
138836276|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
138836277|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836278|NCT05051527|Protective Agents|protective agents|mesh-ancestor
138836279|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836280|NCT04939753|Sevoflurane|sevoflurane|mesh-list
138836281|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138421380|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138836282|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138836283|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
138836284|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
138836285|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836286|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836287|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
138836288|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138836289|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138836290|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138836291|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
138836292|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836293|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473516|NCT05539729|Vancomycin|vancomycin|mesh-list
138836294|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836296|NCT04902885|Etoposide|etoposide|mesh-list
138836297|NCT04902885|Topotecan|topotecan|mesh-list
138836298|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836299|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138836300|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138421381|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138836301|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138836302|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836303|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836304|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138836305|NCT04868058|Ropivacaine|ropivacaine|mesh-list
138836306|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
138836307|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
138836308|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836309|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836310|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
138836311|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836312|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138836313|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138836314|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836315|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
138836317|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138836318|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836319|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836320|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138836321|NCT04525274|Analgesics|analgesics|mesh-ancestor
138836322|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
138836323|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138653688|NCT06163755|Antiemetics|antiemetics|mesh-ancestor
138836324|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138836325|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138836326|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138836327|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
138836328|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836329|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836330|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138836331|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138836332|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
138836334|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138836335|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138836336|NCT04472611|Colchicine|colchicine|mesh-list
138836337|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138836338|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138836339|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138836340|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
138836341|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836342|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138836343|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138836344|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836345|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
138836346|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138421410|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
138421411|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138421412|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138421413|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138421414|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138421415|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138421416|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
138421417|NCT03445858|Decitabine|decitabine|mesh-list
138421419|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836347|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
138836348|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
138836349|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
138836350|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836351|NCT04472598|Navitoclax|navitoclax|mesh-list
138836352|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836353|NCT04125563|Capsaicin|capsaicin|mesh-list
138836354|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
138836355|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
138836356|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
138836357|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836358|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836359|NCT04078295|Nivolumab|nivolumab|mesh-list
138836360|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138836361|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836362|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138836363|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836364|NCT03974828|Anesthetics|anesthetics|mesh-list
138836365|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836366|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836367|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
138836368|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138836369|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138421430|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
138421431|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
138421432|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421433|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138421434|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421435|NCT03377023|Nivolumab|nivolumab|mesh-list
138421436|NCT03377023|Ipilimumab|ipilimumab|mesh-list
138421443|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421445|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138421446|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138421447|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421448|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421449|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421450|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138421451|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
138421452|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138421453|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
138421454|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421455|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421456|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138421458|NCT03295240|Venetoclax|venetoclax|mesh-list
138421459|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138421460|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138836370|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836371|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836372|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138836373|NCT03953677|Analgesics|analgesics|mesh-ancestor
138836374|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
138836375|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836376|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138836377|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138836378|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138836379|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
138836380|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836381|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836382|NCT03934216|Deucravacitinib|deucravacitinib|mesh-list
138836383|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
138836384|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138836385|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836386|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836387|NCT03925480|Azithromycin|azithromycin|mesh-list
138836388|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138836389|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138836390|NCT03878069|Elapegademase|elapegademase|mesh-list
138836391|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138836392|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836393|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836394|NCT03876873|Anesthetics|anesthetics|mesh-list
138836395|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836396|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836397|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
138473557|NCT05474560|Antioxidants|antioxidants|mesh-ancestor
138421465|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138421466|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
138421467|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421468|NCT03223883|Curcumin|curcumin|mesh-list
138421469|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138421470|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138421471|NCT03223883|Analgesics|analgesics|mesh-ancestor
138836398|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
138836400|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138836401|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
138421472|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
138421473|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138421474|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836402|NCT03013998|Cytarabine|cytarabine|mesh-list
138836403|NCT03013998|Azacitidine|azacitidine|mesh-list
138421475|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138421476|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138421477|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421478|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421479|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421489|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836404|NCT03013998|Decitabine|decitabine|mesh-list
138836405|NCT03013998|Daunorubicin|daunorubicin|mesh-list
138836406|NCT03013998|Venetoclax|venetoclax|mesh-list
138836407|NCT03013998|AZD5991|azd5991|mesh-list
138836408|NCT03013998|Pevonedistat|pevonedistat|mesh-list
138836409|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138836410|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
138836411|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836412|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836413|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
138836414|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138836415|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138836416|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
138836417|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836418|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836419|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138836420|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138836421|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138836422|NCT02901067|Aspirin|aspirin|mesh-list
138836423|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138836424|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138836425|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138836426|NCT02901067|Analgesics|analgesics|mesh-ancestor
138836427|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
138836428|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836429|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836430|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138836431|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138836432|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138836433|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138836434|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836435|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138836436|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138836437|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836438|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
138836439|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138836440|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138836441|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
138421490|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138421491|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421492|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421493|NCT03188510|Mirikizumab|mirikizumab|mesh-list
138421494|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138421495|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138421496|NCT03188510|Analgesics|analgesics|mesh-ancestor
138421497|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
138421498|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138421499|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421500|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138421501|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138421502|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138421503|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138421505|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138421506|NCT03120780|Narcotics|narcotics|mesh-ancestor
138836442|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138421507|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138421508|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836443|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138836444|NCT02859896|Calcitriol|calcitriol|mesh-list
138473567|NCT05469893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138836445|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138836446|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138836447|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836448|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138836449|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138447747|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138836450|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836451|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138836453|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
138836454|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138836455|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138836456|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
138836457|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138836458|NCT02711670|Diuretics|diuretics|mesh-ancestor
138836459|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
138836460|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836461|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138836462|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138836463|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836464|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
138836465|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138836466|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836467|NCT02658097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138836468|NCT02658097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836469|NCT02581527|Rifampin|rifampin|mesh-list
138836470|NCT02581527|Isoniazid|isoniazid|mesh-list
138836471|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
138836472|NCT02581527|Ethambutol|ethambutol|mesh-list
138836473|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138836474|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
138836475|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138421509|NCT03120780|Analgesics|analgesics|mesh-ancestor
138836476|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138836477|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
138447794|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421514|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
138836478|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138836480|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836481|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138836482|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138836483|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138836484|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138836485|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138836486|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138836487|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138836488|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138836489|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
138836490|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138836491|NCT02466074|Acetazolamide|acetazolamide|mesh-list
138836492|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
138836493|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138836494|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836495|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836496|NCT02466074|Diuretics|diuretics|mesh-ancestor
138836497|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
138836498|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836499|NCT02393794|Nivolumab|nivolumab|mesh-list
138836500|NCT02393794|Romidepsin|romidepsin|mesh-list
138836501|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138836502|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836503|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138836504|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138836505|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836506|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138836507|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836508|NCT02159950|Vaccines|vaccines|mesh-list
138836509|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
138836510|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421546|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138421547|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138836511|NCT02152137|Paclitaxel|paclitaxel|mesh-list
138836512|NCT02152137|Efatutazone|efatutazone|mesh-list
138836513|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138836515|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
138836516|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
138836517|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
138836518|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836519|NCT02007512|Exemestane|exemestane|mesh-list
138836520|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836521|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138836522|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138836523|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836524|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836525|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138836526|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
138836527|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138836528|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836529|NCT01971489|Cisplatin|cisplatin|mesh-list
138836530|NCT01971489|Gemcitabine|gemcitabine|mesh-list
138836531|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836532|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138836533|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
138836534|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836535|NCT01942135|Fulvestrant|fulvestrant|mesh-list
138836536|NCT01942135|Palbociclib|palbociclib|mesh-list
138836537|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138836538|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836539|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138836540|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138836541|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
138836542|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138836543|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836544|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138836545|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836546|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836547|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
138421590|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836548|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138836549|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138836550|NCT01838174|Prednisolone|prednisolone|mesh-list
138836551|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
138836552|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138836553|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
138836554|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138836555|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
138836556|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
138836557|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836558|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836559|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138836560|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
138836561|NCT01838174|Hormones|hormones|mesh-ancestor
138421627|NCT02734004|Bevacizumab|bevacizumab|mesh-list
138836562|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138836563|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138836564|NCT01838174|Protective Agents|protective agents|mesh-ancestor
138836565|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138836566|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836567|NCT01743131|Abatacept|abatacept|mesh-list
138836568|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138836569|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836570|NCT01743131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138836571|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836572|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138836573|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
138836574|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836575|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138836576|NCT01685814|Lenalidomide|lenalidomide|mesh-list
138836577|NCT01685814|Bortezomib|bortezomib|mesh-list
138836578|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
138836579|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836580|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138447941|NCT01855009|Vitamin D|vitamin d|mesh-list
138836581|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138836582|NCT01685814|Growth Substances|growth substances|mesh-ancestor
138836583|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
138836584|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421688|NCT02567799|Paclitaxel|paclitaxel|mesh-list
138421689|NCT02567799|Carboplatin|carboplatin|mesh-list
138421690|NCT02567799|Genistein|genistein|mesh-list
138421691|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138421697|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138836585|NCT01147016|Paclitaxel|paclitaxel|mesh-list
138836586|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
138836587|NCT01147016|Doxorubicin|doxorubicin|mesh-list
138836588|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138836589|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138836590|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836591|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
138836592|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
138836593|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
138836594|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836595|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138836596|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
138836597|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836598|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138836599|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138836600|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
138836601|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138836602|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138836603|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138836604|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138836605|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836607|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138836608|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836609|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138836610|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138836611|NCT00200200|Growth Substances|growth substances|mesh-ancestor
138836612|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836613|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
138836615|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138836616|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836617|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
138836618|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
138836619|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
138836620|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836621|NCT00694863|Cosyntropin|cosyntropin|mesh-list
138836622|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
138836623|NCT00694863|Hormones|hormones|mesh-ancestor
138836624|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138836625|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836626|NCT00629213|Acarbose|acarbose|mesh-list
138836627|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138836628|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836629|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836630|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138836631|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836632|NCT00978341|Pregabalin|pregabalin|mesh-list
138836633|NCT00978341|Analgesics|analgesics|mesh-ancestor
138836634|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
138836635|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836636|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836637|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
138836638|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138473619|NCT05419505|Hemostatics|hemostatics|mesh-ancestor
138836639|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138836640|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836641|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138395744|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
138836642|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138836643|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138836644|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836645|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138836646|NCT00695331|Misoprostol|misoprostol|mesh-list
138836647|NCT00695331|Oxytocin|oxytocin|mesh-list
138836648|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
138836649|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138836650|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836651|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138836652|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
138836653|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138836654|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138836655|NCT00695643|Mesalamine|mesalamine|mesh-list
138836656|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138836657|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138836658|NCT00695643|Analgesics|analgesics|mesh-ancestor
138836659|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
138836660|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836661|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836662|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138836663|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138836664|NCT02623881|Progesterone|progesterone|mesh-list
138836665|NCT02623881|Progestins|progestins|mesh-ancestor
138836666|NCT02623881|Hormones|hormones|mesh-ancestor
138836667|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138836668|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836669|NCT04135833|Itraconazole|itraconazole|mesh-list
138488698|NCT00005867|Hormones|hormones|mesh-ancestor
138836670|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
138836671|NCT04135833|Rifampin|rifampin|mesh-list
138836672|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
138836673|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138836674|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138836675|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138836676|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836677|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836678|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138836679|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
138836680|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138836681|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836682|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138836683|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138836684|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
138836685|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138836686|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
138836687|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138836688|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138836689|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138836690|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138836691|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138836692|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138836693|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138836694|NCT00696033|Diazepam|diazepam|mesh-list
138836695|NCT00696033|Lorazepam|lorazepam|mesh-list
138836696|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
138836697|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
138836698|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
138836699|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473624|NCT05413343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138836700|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836701|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138836702|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138836703|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836704|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138396108|NCT03186638|Ibuprofen|ibuprofen|mesh-list
138836705|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138836706|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138836707|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
138836708|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
138836709|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836710|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836711|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138836712|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138836713|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138836714|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138836715|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
138836716|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
138836717|NCT02623569|Atenolol|atenolol|mesh-list
138836718|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138836719|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138836720|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
138836721|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
138836722|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836723|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836724|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138836725|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138836726|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138836727|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
138836728|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836729|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836730|NCT00977561|Cisplatin|cisplatin|mesh-list
138836731|NCT00977561|Carboplatin|carboplatin|mesh-list
138836732|NCT00977561|Etoposide|etoposide|mesh-list
138836733|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
138836734|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836735|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138836736|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138448102|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
138836737|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138836738|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836739|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836740|NCT04291313|Vitamin D|vitamin d|mesh-list
138836741|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
138836742|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
138836743|NCT04291313|Vitamins|vitamins|mesh-list
138836744|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
138836745|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836746|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138836747|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138836748|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138836749|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138836750|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
138836751|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836752|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138836753|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138836754|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138836755|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138836757|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
138836758|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
138836759|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836760|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836761|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836763|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138836764|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138836765|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
138836766|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836767|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836768|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836769|NCT00928070|Urological Agents|urological agents|mesh-ancestor
138836770|NCT04001621|Capecitabine|capecitabine|mesh-list
138836771|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138836772|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
138836773|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836774|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836776|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138836777|NCT00976937|Lixisenatide|lixisenatide|mesh-list
138836778|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138836779|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836780|NCT00976937|Incretins|incretins|mesh-ancestor
138836781|NCT00976937|Hormones|hormones|mesh-ancestor
138836782|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138836783|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138836784|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
138836785|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836786|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836787|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
138836788|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138836789|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138836790|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
138836791|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836792|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836793|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836794|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138836795|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138836796|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138836797|NCT04256252|Rituximab|rituximab|mesh-list
138836798|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138836799|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836800|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
138836801|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836802|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138836803|NCT02622555|Mirabegron|mirabegron|mesh-list
138836804|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138836805|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138836806|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138836807|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
138836808|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836809|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836810|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836811|NCT02622555|Urological Agents|urological agents|mesh-ancestor
138836812|NCT05329454|Ibuprofen|ibuprofen|mesh-list
138836813|NCT05329454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138836814|NCT05329454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138836815|NCT05329454|Analgesics|analgesics|mesh-ancestor
138836816|NCT05329454|Sensory System Agents|sensory system agents|mesh-ancestor
138836817|NCT05329454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836818|NCT05329454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836819|NCT05329454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138836820|NCT05329454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138836821|NCT05329454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138836822|NCT05329454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836823|NCT05329454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836824|NCT00629447|Tinzaparin|tinzaparin|mesh-list
138836825|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
138836826|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138836827|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138836828|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836829|NCT02622477|Pirfenidone|pirfenidone|mesh-list
138836830|NCT02622477|Analgesics|analgesics|mesh-ancestor
138836831|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
138836832|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836833|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836834|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138836835|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138836836|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138836837|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138836838|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836839|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
138836840|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
138836841|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138836842|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
138836843|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836844|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448224|NCT01856621|Charcoal|charcoal|mesh-list
138836845|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138836846|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
138836847|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
138836848|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138836849|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
138836850|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836851|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836852|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138836853|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138836854|NCT04289675|Interferons|interferons|mesh-list
138836855|NCT04289675|Interferon-beta|interferon-beta|mesh-list
138836856|NCT04289675|Teriflunomide|teriflunomide|mesh-list
138836857|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138836858|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836859|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
138836860|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138836861|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
138836862|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836863|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
138836864|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138836865|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138836866|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138836867|NCT04289675|Analgesics|analgesics|mesh-ancestor
138448264|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
138836868|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
138836869|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836870|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138836871|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138836872|NCT00696579|Gemcitabine|gemcitabine|mesh-list
138836873|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138836874|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
138836875|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836876|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836877|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
138836878|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138836879|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
138836880|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138836881|NCT02865629|Expectorants|expectorants|mesh-ancestor
138836882|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
138836883|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138836885|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836886|NCT02865629|Protective Agents|protective agents|mesh-ancestor
138836887|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836888|NCT02865629|Antidotes|antidotes|mesh-ancestor
138836889|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
138836890|NCT02867345|Interleukin-2|interleukin-2|mesh-list
138836891|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138836892|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
138836893|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836894|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138836895|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138836896|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
138836897|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836898|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836899|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138836900|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138836901|NCT02867345|Analgesics|analgesics|mesh-ancestor
138836902|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
138836903|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138836905|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138836906|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
138836907|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138836908|NCT00975689|Expectorants|expectorants|mesh-ancestor
138836909|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
138836910|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138836911|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
138836912|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836913|NCT00975689|Protective Agents|protective agents|mesh-ancestor
138836914|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836915|NCT00975689|Antidotes|antidotes|mesh-ancestor
138836916|NCT02621385|Midazolam|midazolam|mesh-list
138836917|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138836918|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138836919|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138836920|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836921|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138836922|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138836923|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138836924|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138836925|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
138836926|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
138836927|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
138836928|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
138836929|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836930|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836931|NCT00922766|Dalteparin|dalteparin|mesh-list
138836932|NCT00922766|Tinzaparin|tinzaparin|mesh-list
138836933|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138836934|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
138836935|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138836936|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138836937|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836938|NCT04134897|Capecitabine|capecitabine|mesh-list
138836939|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
138836940|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138836941|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
138836942|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836943|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836944|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
138836945|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836946|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
138836947|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138836948|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138836949|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138836950|NCT02620995|Urological Agents|urological agents|mesh-ancestor
138836951|NCT02620839|Cisplatin|cisplatin|mesh-list
138836952|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836953|NCT02620605|Cabergoline|cabergoline|mesh-list
138836954|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138836955|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138836956|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
138836957|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
138836958|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138836959|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836960|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836961|NCT00976391|Insulin|insulin|mesh-list
138836962|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138836963|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
138836964|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
138836965|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
138836966|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138836967|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138836968|NCT00976391|Incretins|incretins|mesh-ancestor
138836969|NCT00976391|Hormones|hormones|mesh-ancestor
138836970|NCT00976391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138836971|NCT04252664|Remdesivir|remdesivir|mesh-list
138836972|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
138836973|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138836974|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
138836975|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138836976|NCT00696969|Amphotericin B|amphotericin b|mesh-list
138836977|NCT00696969|Paromomycin|paromomycin|mesh-list
138836978|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138836979|NCT00696969|Miltefosine|miltefosine|mesh-list
138836980|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
138836981|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
138836982|NCT00696969|Amebicides|amebicides|mesh-ancestor
138836983|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138836984|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138836985|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138836986|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138836987|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
138836988|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138836989|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138836990|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138330640|NCT05766085|Hormones|hormones|mesh-ancestor
138836991|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
138836992|NCT04203680|Tryptophan|tryptophan|mesh-list
138836993|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138836994|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138836995|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
138836996|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138836997|NCT02620215|Dinoprostone|dinoprostone|mesh-list
138836998|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
138836999|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138837000|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837001|NCT02620293|Emollients|emollients|mesh-list
138837002|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
138837003|NCT02619981|Lidocaine|lidocaine|mesh-list
138837004|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
138837005|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
138837006|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138837007|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837008|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
138837009|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837010|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138837011|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138837012|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138837013|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138837014|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837016|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837017|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138473684|NCT05291221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138837018|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138837019|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837020|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837021|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138837022|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
138837023|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138837024|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837025|NCT03965117|Norepinephrine|norepinephrine|mesh-list
138837026|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138837027|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138837028|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
138837029|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837030|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837031|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837032|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
138837033|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
138837034|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837035|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138837037|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837038|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138837039|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837040|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837041|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
138837042|NCT02619513|Ropivacaine|ropivacaine|mesh-list
138837043|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138489056|NCT00010270|Immunotoxins|immunotoxins|mesh-list
138837044|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138837045|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837046|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138837048|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
138448477|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
138837049|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837050|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138837051|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138837052|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138837053|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
138837054|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837055|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837056|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
138837057|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
138837058|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
138837059|NCT02619747|Antacids|antacids|mesh-ancestor
138837060|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837061|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138837062|NCT00697125|Vaccines|vaccines|mesh-list
138837063|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
138837064|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837065|NCT04134273|Clindamycin|clindamycin|mesh-list
138837066|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
138837067|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
138837068|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138837069|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138837070|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138653978|NCT05704647|Nivolumab|nivolumab|mesh-list
138837071|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138837072|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837073|NCT04134117|Tisagenlecleucel|tisagenlecleucel|mesh-list
138837074|NCT04134117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138837075|NCT04134117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837077|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138837078|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138837079|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138837080|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
138837081|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837082|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
138837083|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
138837084|NCT00697281|Growth Substances|growth substances|mesh-ancestor
138837085|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837087|NCT00979901|Montelukast|montelukast|mesh-list
138837088|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138837089|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
138837090|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138837091|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
138837092|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138837093|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837094|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138837095|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138837096|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138837097|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
138837098|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
138837099|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138837100|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138837101|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138837102|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
138837103|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
138837104|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138837105|NCT02619201|Ondansetron|ondansetron|mesh-list
138837106|NCT02619201|Metoclopramide|metoclopramide|mesh-list
138837107|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
138837108|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
138837109|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138837110|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138837111|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138837112|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
138837113|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
138837114|NCT02619201|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138837115|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138837116|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
138566950|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138566951|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138566952|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
138566953|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566954|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566956|NCT03464942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138654004|NCT05676294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566957|NCT03464942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566958|NCT03464942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138566960|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
138566961|NCT03431831|Naltrexone|naltrexone|mesh-list
138566962|NCT03431831|Bupropion|bupropion|mesh-list
138566963|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138566964|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138566965|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138566966|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566967|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
138566968|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566969|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138194845|NCT03992482|Antibodies|antibodies|mesh-list
138566971|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138566972|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138566973|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138566974|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138566976|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
138566977|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566978|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138566979|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138566980|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566981|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
138566982|NCT03426891|Temozolomide|temozolomide|mesh-list
138566984|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138566985|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138566986|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566987|NCT03426891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138566988|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566989|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138566990|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
138566991|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566992|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138566993|NCT03422536|Cetuximab|cetuximab|mesh-list
138566994|NCT03422536|Antibodies|antibodies|mesh-list
138566995|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
138566996|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138566997|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
138566998|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566999|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567000|NCT03382977|Carmustine|carmustine|mesh-list
138567001|NCT03382977|Lomustine|lomustine|mesh-list
138567002|NCT03382977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138567003|NCT03382977|Alkylating Agents|alkylating agents|mesh-ancestor
138567004|NCT03382977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567005|NCT03382977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567006|NCT03358693|Infliximab|infliximab|mesh-list
138567007|NCT03358693|Upadacitinib|upadacitinib|mesh-list
138567008|NCT03358693|Ustekinumab|ustekinumab|mesh-list
138567009|NCT03358693|Ixekizumab|ixekizumab|mesh-list
138567010|NCT03358693|Brodalumab|brodalumab|mesh-list
138567011|NCT03358693|Abrocitinib|abrocitinib|mesh-list
138567012|NCT03358693|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138567013|NCT03358693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138567014|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
138567015|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567016|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567017|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138567018|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138567019|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567020|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567021|NCT03228394|Ganaxolone|ganaxolone|mesh-list
138567022|NCT03228394|Neurosteroids|neurosteroids|mesh-ancestor
138567023|NCT03228394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567024|NCT03228394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567025|NCT03228394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567027|NCT03228394|GABA Agents|gaba agents|mesh-ancestor
138567028|NCT03213977|Prednisone|prednisone|mesh-list
138567029|NCT03213977|Cyclophosphamide|cyclophosphamide|mesh-list
138567030|NCT03213977|Doxorubicin|doxorubicin|mesh-list
138567031|NCT03213977|Etoposide|etoposide|mesh-list
138567032|NCT03213977|Vincristine|vincristine|mesh-list
138567033|NCT03213977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567034|NCT03213977|Immunologic Factors|immunologic factors|mesh-ancestor
138567035|NCT03213977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567036|NCT03213977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567037|NCT03213977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138567038|NCT03213977|Alkylating Agents|alkylating agents|mesh-ancestor
138567039|NCT03213977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567040|NCT03213977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567041|NCT03213977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138567042|NCT03213977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138567043|NCT03213977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138567044|NCT03213977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138567045|NCT03213977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567046|NCT03213977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138567047|NCT03213977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138567048|NCT03213977|Glucocorticoids|glucocorticoids|mesh-ancestor
138243372|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138567049|NCT03213977|Hormones|hormones|mesh-ancestor
138567050|NCT03213977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567051|NCT03213977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138567052|NCT03213977|Tubulin Modulators|tubulin modulators|mesh-ancestor
138567053|NCT03213977|Antimitotic Agents|antimitotic agents|mesh-ancestor
138567054|NCT03213977|Mitosis Modulators|mitosis modulators|mesh-ancestor
138567055|NCT02953834|Insulin|insulin|mesh-list
138567056|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138567057|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567058|NCT02849639|Scopolamine|scopolamine|mesh-list
138567059|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138567060|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138567061|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
138567062|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
138567063|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567064|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567065|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567066|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
138567067|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138567068|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
138567069|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567070|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567071|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138567072|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
138567073|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138567074|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138567075|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
138567077|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
138567078|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567079|NCT02594384|Rituximab|rituximab|mesh-list
138567080|NCT02594384|Atezolizumab|atezolizumab|mesh-list
138567081|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138567082|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567083|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
138567084|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567085|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567086|NCT02594384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138448711|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138567087|NCT02594384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567088|NCT02592707|Dexamethasone|dexamethasone|mesh-list
138567089|NCT02592707|Ondansetron|ondansetron|mesh-list
138567090|NCT02592707|Antiemetics|antiemetics|mesh-list
138567091|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138567092|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138567093|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
138567094|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567095|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567096|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567097|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
138567098|NCT02592707|Hormones|hormones|mesh-ancestor
138318005|NCT01439568|Carboplatin|carboplatin|mesh-list
138567099|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567100|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138567101|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567102|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567103|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
138567104|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
138567105|NCT02592707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138567106|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138567107|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
138567108|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567109|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
138567110|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
138567111|NCT02326805|Metronidazole|metronidazole|mesh-list
138567112|NCT02326805|Vaccines|vaccines|mesh-list
138567113|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
138567114|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567115|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567116|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138567117|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138567118|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138567119|NCT01952782|Naloxone|naloxone|mesh-list
138567120|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567121|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138567122|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
138567123|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567124|NCT01423812|Ritonavir|ritonavir|mesh-list
138567125|NCT01423812|Darunavir|darunavir|mesh-list
138567126|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138567127|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138567128|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
138567129|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567130|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567131|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138567132|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138567133|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
138567134|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567135|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138567136|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138567138|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138567139|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567141|NCT01176474|Ipilimumab|ipilimumab|mesh-list
138567142|NCT01176474|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138567143|NCT01176474|Immunologic Factors|immunologic factors|mesh-ancestor
138567144|NCT01176474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567145|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138567146|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567147|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138567148|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567149|NCT01176474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138567150|NCT01141309|Everolimus|everolimus|mesh-list
138567151|NCT01141309|Sorafenib|sorafenib|mesh-list
138567152|NCT01141309|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138567153|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138567154|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567155|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567156|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567157|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
138567158|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567159|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567160|NCT00914823|Hormones|hormones|mesh-list
138567161|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567162|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567163|NCT00859781|Ketoconazole|ketoconazole|mesh-list
138567164|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
138567165|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138567166|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
138567167|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567168|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138567169|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138567170|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567171|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567172|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138567173|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
138448847|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
138567174|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473732|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
138567176|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138567177|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
138567178|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138567179|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567180|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567182|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138318490|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138318491|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138318492|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
138567183|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138567184|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567185|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567186|NCT00099086|Docetaxel|docetaxel|mesh-list
138567187|NCT00099086|Leuprolide|leuprolide|mesh-list
138567188|NCT00099086|Goserelin|goserelin|mesh-list
138567189|NCT00099086|Bicalutamide|bicalutamide|mesh-list
138567190|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567191|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
138567192|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
138567193|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
138567194|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567195|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138567196|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
138567197|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138567198|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567199|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138567200|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
138567201|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
138567202|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567203|NCT00856947|Vitamin D|vitamin d|mesh-list
138567204|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
138567205|NCT00856947|Vitamins|vitamins|mesh-ancestor
138567206|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
138567207|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567208|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138567209|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138567210|NCT00655993|Simvastatin|simvastatin|mesh-list
138567211|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138567212|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138567213|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
138567214|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567215|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138448887|NCT01860014|Beractant|beractant|mesh-list
138567216|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138567217|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567219|NCT00567580|Goserelin|goserelin|mesh-list
138567220|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138567221|NCT00567580|Flutamide|flutamide|mesh-list
138567222|NCT00567580|Bicalutamide|bicalutamide|mesh-list
138567223|NCT00567580|Buserelin|buserelin|mesh-list
138567224|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138567225|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
138318494|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318495|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138318496|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138318497|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
138318498|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138318499|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138318500|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138318501|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318502|NCT01387932|Doxorubicin|doxorubicin|mesh-list
138318503|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
138318504|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138318505|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567226|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138567227|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567228|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138567229|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567230|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
138567231|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
138567232|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567233|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
138567234|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138567235|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
138567236|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138567237|NCT00125151|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138567238|NCT00125151|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138567239|NCT00125151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567240|NCT00125151|Immunologic Factors|immunologic factors|mesh-ancestor
138567241|NCT00125151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567242|NCT00087815|Dexamethasone|dexamethasone|mesh-list
138567243|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138567244|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
138567245|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
138567246|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567247|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567248|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567249|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
138567251|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567252|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138318506|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138318507|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138318508|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318509|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318510|NCT04413786|Oxytocin|oxytocin|mesh-list
138318511|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
138318512|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138318513|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318514|NCT01422408|Fluocinonide|fluocinonide|mesh-list
138318515|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138318516|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
138567253|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567254|NCT00087854|Amonafide|amonafide|mesh-list
138567255|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567256|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
138567257|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567258|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567259|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567260|NCT04715620|Niraparib|niraparib|mesh-list
138567261|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138567262|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567263|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567264|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567265|NCT00125229|Mannitol|mannitol|mesh-list
138567266|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138567267|NCT00125229|Diuretics|diuretics|mesh-ancestor
138567268|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
138567269|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567270|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
138567271|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
138567272|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
138567273|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138567274|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138567275|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567276|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138567277|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567278|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567279|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138567281|NCT00088049|Aripiprazole|aripiprazole|mesh-list
138567282|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
138567283|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
138567284|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567285|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567286|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567287|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138567288|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138567289|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138567290|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138567291|NCT00088049|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138567292|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138567293|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138567294|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567295|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567296|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
138567297|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
138567298|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
138567299|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
138567300|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138567301|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138318518|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567302|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138567303|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138318519|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318520|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138567304|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138567305|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138567306|NCT00088088|Paclitaxel|paclitaxel|mesh-list
138567307|NCT00088088|Carboplatin|carboplatin|mesh-list
138567308|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138567309|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567310|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
138567311|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
138567312|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
138567313|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567315|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567316|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
138567317|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567318|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138567319|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567320|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567322|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
138567323|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567324|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
138567325|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138567326|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138473805|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567327|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
138567328|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567329|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138567330|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138567331|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138567332|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138567333|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138567334|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567335|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138567337|NCT00332995|Dapivirine|dapivirine|mesh-list
138318521|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138318522|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138318523|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138318524|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138318526|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138318527|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138318528|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138318530|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318531|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318532|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138318533|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138318534|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
138318535|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
138318547|NCT01386606|Enclomiphene|enclomiphene|mesh-list
138567338|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138567339|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138567340|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
138567341|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567342|NCT00333034|Etanercept|etanercept|mesh-list
138567343|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138567344|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138567345|NCT00333034|Analgesics|analgesics|mesh-ancestor
138567346|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
138188355|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567347|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567348|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567349|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138567350|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567351|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567352|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567353|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
138567354|NCT00088478|Olanzapine|olanzapine|mesh-list
138567355|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
138567356|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
138318551|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
138567357|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138704125|NCT06136624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704126|NCT06136624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138704127|NCT06136624|Glucocorticoids|glucocorticoids|mesh-ancestor
138704129|NCT06136624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138704130|NCT06136624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138704131|NCT06136624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704132|NCT06136624|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138704133|NCT06136624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704134|NCT06136624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704135|NCT06136624|Hormone Antagonists|hormone antagonists|mesh-ancestor
138704136|NCT06136624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138704137|NCT06136598|Dexamethasone|dexamethasone|mesh-list
138704138|NCT06136598|Dexamethasone acetate|dexamethasone acetate|mesh-list
138704139|NCT06136598|Hydrocortisone|hydrocortisone|mesh-list
138704140|NCT06136598|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138567358|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567359|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567360|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138567361|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138567362|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138567363|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138567364|NCT00088478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138449097|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138567365|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138567366|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138567367|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567368|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567369|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
138567370|NCT00125346|Tobramycin|tobramycin|mesh-list
138567371|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138567372|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567373|NCT00333112|Tamsulosin|tamsulosin|mesh-list
138567374|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
138567375|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138318557|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318558|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138704239|NCT06055608|Sirolimus|sirolimus|mesh-list
138704240|NCT06055608|Abatacept|abatacept|mesh-list
138704241|NCT06055608|Tacrolimus|tacrolimus|mesh-list
138704242|NCT06055608|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138704243|NCT06055608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138704244|NCT06055608|Immunologic Factors|immunologic factors|mesh-ancestor
138704245|NCT06055608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704246|NCT06055608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138704247|NCT06055608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567376|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138567377|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138567378|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
138567379|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473822|NCT04914676|Cytarabine|cytarabine|mesh-list
138567380|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567381|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567382|NCT00333112|Urological Agents|urological agents|mesh-ancestor
138567383|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138567384|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138567385|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
138567386|NCT00333151|Metformin|metformin|mesh-list
138567387|NCT00333151|Liraglutide|liraglutide|mesh-list
138567388|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
138567389|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138567390|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567391|NCT00333151|Incretins|incretins|mesh-ancestor
138567392|NCT00333151|Hormones|hormones|mesh-ancestor
138567393|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567394|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138704262|NCT06048718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567395|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
138567396|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567397|NCT00088556|Paclitaxel|paclitaxel|mesh-list
138567398|NCT00088556|Carboplatin|carboplatin|mesh-list
138567399|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138704263|NCT06048718|Immunoconjugates|immunoconjugates|mesh-ancestor
138704264|NCT06048718|Immunologic Factors|immunologic factors|mesh-ancestor
138704265|NCT06048718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704266|NCT06045806|Cyclophosphamide|cyclophosphamide|mesh-list
138704267|NCT06045806|Fludarabine|fludarabine|mesh-list
138704268|NCT06045806|Lenalidomide|lenalidomide|mesh-list
138704269|NCT06045806|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
138704270|NCT06045806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138704271|NCT06045806|Immunologic Factors|immunologic factors|mesh-ancestor
138704272|NCT06045806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567400|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567401|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
138567402|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
138567403|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
138567404|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567405|NCT00127140|Vorinostat|vorinostat|mesh-list
138567406|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567407|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138567408|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567409|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567410|NCT00333307|Methocarbamol|methocarbamol|mesh-list
138567411|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138567412|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567413|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138567414|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567415|NCT00125424|Midazolam|midazolam|mesh-list
138567416|NCT00125424|Fospropofol|fospropofol|mesh-list
138567417|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138567418|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138567419|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138704320|NCT06039826|Hormone Antagonists|hormone antagonists|mesh-ancestor
138704325|NCT06036836|Lenvatinib|lenvatinib|mesh-list
138567420|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243771|NCT01694966|Methylene Blue|methylene blue|mesh-list
138567421|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138567422|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138567423|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138567424|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138567425|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
138567426|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
138567427|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
138567428|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
138567429|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567430|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567431|NCT00333346|Tramadol|tramadol|mesh-list
138567432|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138567433|NCT00333346|Narcotics|narcotics|mesh-ancestor
138567434|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138567435|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567436|NCT00333346|Analgesics|analgesics|mesh-ancestor
138567437|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
138567438|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567439|NCT00333385|Ceftazidime|ceftazidime|mesh-list
138567440|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138567441|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567442|NCT00127257|Diazepam|diazepam|mesh-list
138567443|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138567444|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
138567445|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
138567446|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
138567447|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567448|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567449|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567450|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138704410|NCT05918094|Fluorouracil|fluorouracil|mesh-list
138704411|NCT05918094|Antimetabolites|antimetabolites|mesh-ancestor
138704412|NCT05918094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567451|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138567452|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138567453|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138567454|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138318018|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
138567455|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138567456|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138567457|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138567458|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
138567459|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
138567460|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
138567461|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
138567462|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567463|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567464|NCT00333424|Vaccines|vaccines|mesh-list
138704482|NCT05889182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138704507|NCT05845645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138704508|NCT05845645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138704509|NCT05845645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704510|NCT05845645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704512|NCT05837091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704513|NCT05837091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138704514|NCT05837091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138704515|NCT05837091|Anesthetics, General|anesthetics, general|mesh-ancestor
138704516|NCT05837091|Anesthetics|anesthetics|mesh-ancestor
138704517|NCT05837091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138704518|NCT05836584|Calcium, Dietary|calcium, dietary|mesh-list
138704519|NCT05836584|Leucovorin|leucovorin|mesh-list
138704520|NCT05836584|Folic Acid|folic acid|mesh-list
138704521|NCT05836584|Docetaxel|docetaxel|mesh-list
138704522|NCT05836584|Capecitabine|capecitabine|mesh-list
138704523|NCT05836584|Fluorouracil|fluorouracil|mesh-list
138704524|NCT05836584|Oxaliplatin|oxaliplatin|mesh-list
138704525|NCT05836584|Atezolizumab|atezolizumab|mesh-list
138704526|NCT05836584|Calcium|calcium|mesh-list
138704527|NCT05836584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138704528|NCT05836584|Levoleucovorin|levoleucovorin|mesh-list
138704529|NCT05836584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704530|NCT05836584|Tubulin Modulators|tubulin modulators|mesh-ancestor
138704531|NCT05836584|Antimitotic Agents|antimitotic agents|mesh-ancestor
138704544|NCT05836584|Vitamins|vitamins|mesh-ancestor
138567465|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
138567466|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567467|NCT00125463|Candesartan|candesartan|mesh-list
138567468|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
138567469|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138567470|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138567471|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138567472|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567473|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138567474|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567475|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138567476|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567477|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567478|NCT00421018|Montelukast|montelukast|mesh-list
138567479|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138567480|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
138567481|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138567482|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
138473864|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138567483|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567484|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567485|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138704547|NCT05836584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138567486|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138704548|NCT05836584|Hematinics|hematinics|mesh-ancestor
138704549|NCT05815160|Carboplatin|carboplatin|mesh-list
138704598|NCT05773989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704599|NCT05773989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704600|NCT05773989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138704601|NCT05773989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138704602|NCT05773989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138704603|NCT05773989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138704605|NCT05773989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138704606|NCT05767346|Metoprolol|metoprolol|mesh-list
138704607|NCT05767346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138704608|NCT05767346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138704609|NCT05767346|Sympatholytics|sympatholytics|mesh-ancestor
138704610|NCT05767346|Autonomic Agents|autonomic agents|mesh-ancestor
138567487|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567489|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567490|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138567491|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
138567492|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567493|NCT00089063|Sargramostim|sargramostim|mesh-list
138567494|NCT00089063|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138567495|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
138567496|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
138567497|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567498|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138567500|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
138567501|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138567503|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138567504|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567505|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138567506|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138567507|NCT00334048|Ropinirole|ropinirole|mesh-list
138567508|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138567509|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138567510|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
138567511|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
138704647|NCT05741060|Equol|equol|mesh-list
138704648|NCT05741060|Phytoestrogens|phytoestrogens|mesh-ancestor
138704649|NCT05741060|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138704651|NCT05741060|Hormones|hormones|mesh-ancestor
138704652|NCT05741060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138704653|NCT05741060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318581|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704654|NCT05740982|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138567512|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567513|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567514|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567515|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138567516|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138567517|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
138567518|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138567519|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138567520|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138567521|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138567522|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567523|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138567524|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138567525|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
138567526|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567527|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567528|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138567529|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138567530|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
138567531|NCT00089219|Sargramostim|sargramostim|mesh-list
138567532|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
138704749|NCT05634057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138704750|NCT05634057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138704751|NCT05634057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138704752|NCT05634057|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138704753|NCT05634057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138704754|NCT05634057|Parasympatholytics|parasympatholytics|mesh-ancestor
138704755|NCT05634057|Autonomic Agents|autonomic agents|mesh-ancestor
138704756|NCT05634057|Vasodilator Agents|vasodilator agents|mesh-ancestor
138704757|NCT05634057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138704764|NCT05609968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138704765|NCT05609968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704766|NCT05609968|Immunoconjugates|immunoconjugates|mesh-ancestor
138567533|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
138567534|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567535|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138567536|NCT00334321|Paclitaxel|paclitaxel|mesh-list
138567537|NCT00334321|Carboplatin|carboplatin|mesh-list
138567538|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138567539|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567540|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
138567541|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
138567542|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
138567543|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567544|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
138567546|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138567547|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138567548|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567549|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138567550|NCT00334360|Analgesics|analgesics|mesh-ancestor
138567551|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
138567552|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567553|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138567554|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138567555|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138704908|NCT05502315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704910|NCT05489926|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138567556|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
138567557|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567558|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567559|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138567560|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138567561|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138567562|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138567563|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
138567564|NCT00334399|Miglitol|miglitol|mesh-list
138567565|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567566|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567567|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138567568|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243906|NCT01938989|Hormones|hormones|mesh-ancestor
138567569|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138567570|NCT00334438|Rituximab|rituximab|mesh-list
138567571|NCT00334438|Bortezomib|bortezomib|mesh-list
138567572|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138567573|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138567574|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567576|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567577|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567578|NCT00334477|Tadalafil|tadalafil|mesh-list
138567579|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
138567580|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138567581|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138567582|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567583|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567584|NCT00334477|Urological Agents|urological agents|mesh-ancestor
138567585|NCT04715269|Alprazolam|alprazolam|mesh-list
138567586|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138567587|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138704988|NCT05406401|Alkylating Agents|alkylating agents|mesh-ancestor
138567588|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567589|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138567590|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138567591|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138567592|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
138567593|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
138567594|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567595|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567596|NCT00125541|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138567597|NCT00125541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138567598|NCT00125541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567599|NCT00125541|Immunologic Factors|immunologic factors|mesh-ancestor
138567600|NCT00125541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567601|NCT00089258|Isotretinoin|isotretinoin|mesh-list
138567602|NCT00089258|Antibodies|antibodies|mesh-list
138567604|NCT00089258|Sargramostim|sargramostim|mesh-list
138567605|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
138567606|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567607|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
138567609|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138567610|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567611|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
138705039|NCT05367245|Histamine Agents|histamine agents|mesh-ancestor
138567612|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449377|NCT01863355|Fentanyl|fentanyl|mesh-list
138567613|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567614|NCT00334594|Pemetrexed|pemetrexed|mesh-list
138567615|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567616|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567617|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567618|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138567619|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138567620|NCT00334672|Cyclosporine|cyclosporine|mesh-list
138567621|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
138567622|NCT00334672|Dexamethasone|dexamethasone|mesh-list
138567623|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
138567624|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138567625|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138567626|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138567627|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
138567628|NCT00334672|Busulfan|busulfan|mesh-list
138567629|NCT00334672|Methotrexate|methotrexate|mesh-list
138567630|NCT00334672|Etoposide|etoposide|mesh-list
138567631|NCT00334672|Cyclosporins|cyclosporins|mesh-list
138567632|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138567633|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567634|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
138567635|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567636|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567637|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138567638|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
138567639|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567640|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567641|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138567642|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138567643|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
138567644|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
138705088|NCT05319730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138705089|NCT05319730|Antiemetics|antiemetics|mesh-ancestor
138705090|NCT05319730|Autonomic Agents|autonomic agents|mesh-ancestor
138705091|NCT05319730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318584|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138318585|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138318586|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318587|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318589|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138318590|NCT01384734|Tenofovir|tenofovir|mesh-list
138318591|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
138567645|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318592|NCT01384734|Fostemsavir|fostemsavir|mesh-list
138318593|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138567646|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567647|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
138567648|NCT00334672|Hormones|hormones|mesh-ancestor
138567649|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567650|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138567652|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
138567653|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138567654|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138567655|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
138567656|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
138567657|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567658|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138567659|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138567660|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138567661|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138567662|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138567663|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
138567664|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567665|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138567666|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138567667|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138567668|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
138567669|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138567670|NCT00089453|Dexamethasone|dexamethasone|mesh-list
138567671|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
138567672|NCT00089453|Melphalan|melphalan|mesh-list
138567673|NCT00089453|Fludarabine|fludarabine|mesh-list
138567674|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567675|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
138567676|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567677|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567678|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138705098|NCT05319730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705099|NCT05319730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138567679|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
138705100|NCT05319730|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138705101|NCT05319730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138705102|NCT05319730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705103|NCT05319730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138705104|NCT05319730|Analgesics|analgesics|mesh-ancestor
138705105|NCT05319730|Sensory System Agents|sensory system agents|mesh-ancestor
138705106|NCT05319730|Antipyretics|antipyretics|mesh-ancestor
138705107|NCT05319730|Immunologic Factors|immunologic factors|mesh-ancestor
138318610|NCT01396512|Vaccines|vaccines|mesh-list
138318611|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
138567680|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567681|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567682|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138567683|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138567684|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
138567685|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
138567686|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567687|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567688|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
138567689|NCT00089453|Hormones|hormones|mesh-ancestor
138567690|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567691|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138567692|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
138567693|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138567694|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138567695|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567696|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138567697|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138567698|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
138567699|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567700|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
138567701|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
138567702|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
138567703|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138567704|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138567705|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567706|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705127|NCT05282121|Empagliflozin|empagliflozin|mesh-list
138567707|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567708|NCT00334789|Vitamin A|vitamin a|mesh-list
138705128|NCT05282121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138567709|NCT00334789|Tretinoin|tretinoin|mesh-list
138567710|NCT00334789|Belinostat|belinostat|mesh-list
138567711|NCT00334789|Isotretinoin|isotretinoin|mesh-list
138705129|NCT05282121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705130|NCT05282121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138705131|NCT05282121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705132|NCT05269355|Dacarbazine|dacarbazine|mesh-list
138705134|NCT05269355|Alkylating Agents|alkylating agents|mesh-ancestor
138705135|NCT05269355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705136|NCT05269355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705137|NCT05230758|Metformin|metformin|mesh-list
138705138|NCT05230758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138705139|NCT05230758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705140|NCT05222828|Mepivacaine|mepivacaine|mesh-list
138705141|NCT05222828|Anesthetics, Local|anesthetics, local|mesh-ancestor
138705142|NCT05222828|Anesthetics|anesthetics|mesh-ancestor
138705147|NCT05212246|Imiquimod|imiquimod|mesh-list
138567712|NCT00334789|Vitamins|vitamins|mesh-ancestor
138567713|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
138567714|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567715|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567716|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
138567717|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
138567718|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567719|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138567720|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567721|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
138567722|NCT00334867|Ifosfamide|ifosfamide|mesh-list
138567723|NCT00334867|Doxorubicin|doxorubicin|mesh-list
138567724|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138567725|NCT00334867|Etoposide|etoposide|mesh-list
138567726|NCT00334867|Vincristine|vincristine|mesh-list
138567727|NCT00334867|Topotecan|topotecan|mesh-list
138567728|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
138567729|NCT00334867|Razoxane|razoxane|mesh-list
138567730|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567731|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
138567732|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567733|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567734|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138567735|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
138567736|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567737|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567738|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138654206|NCT05285813|Analgesics|analgesics|mesh-ancestor
138567739|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138567740|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138567741|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138567742|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705155|NCT05206500|Metronidazole|metronidazole|mesh-list
138567743|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138705156|NCT05206500|Clindamycin|clindamycin|mesh-list
138705157|NCT05206500|Linezolid|linezolid|mesh-list
138705158|NCT05206500|Tetracycline|tetracycline|mesh-list
138567744|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
138567745|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
138567746|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
138567747|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138567748|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138567749|NCT00334867|Protective Agents|protective agents|mesh-ancestor
138567751|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
138567752|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
138567753|NCT04715152|BB 1101|bb 1101|mesh-list
138567754|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138567756|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
138567757|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567758|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567759|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567760|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
138567761|NCT04715152|Hormones|hormones|mesh-ancestor
138567762|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567763|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138567764|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567765|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
138705210|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567766|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567767|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567768|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
138567769|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
138567770|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138567771|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
138705225|NCT05017545|Abatacept|abatacept|mesh-list
138567772|NCT00334906|Memantine|memantine|mesh-list
138567773|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138567774|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138567775|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
138567776|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473954|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
138567777|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567778|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567779|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138567780|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138567782|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138567783|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138567784|NCT00342862|Alefacept|alefacept|mesh-list
138567785|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
138567786|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
138567787|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567788|NCT00089687|Vanoxerine|vanoxerine|mesh-list
138567789|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138567790|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138567791|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138567792|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567793|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
138188356|NCT02975583|Vorapaxar|vorapaxar|mesh-list
138705308|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138705309|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705312|NCT04895358|Paclitaxel|paclitaxel|mesh-list
138567794|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567795|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567796|NCT00127764|Dexamethasone|dexamethasone|mesh-list
138567797|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138567798|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
138567799|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
138567800|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567801|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567802|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567803|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
138567805|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567806|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138567807|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567808|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
138567809|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567810|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
138567811|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567812|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567813|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138567814|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
138567815|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567816|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567817|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138705339|NCT04892017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705354|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567818|NCT00343096|Lorazepam|lorazepam|mesh-list
138567819|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
138567820|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
138567821|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
138567822|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567823|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567824|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567825|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138567826|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138567828|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138567829|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138567830|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
138567831|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
138567832|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567833|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567834|NCT00335179|Imiquimod|imiquimod|mesh-list
138567835|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138567836|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
138567837|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567838|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567839|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
138567840|NCT00089765|Ranibizumab|ranibizumab|mesh-list
138567841|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138567842|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138705404|NCT04821375|Estrogens|estrogens|mesh-list
138567843|NCT00089765|Growth Substances|growth substances|mesh-ancestor
138567844|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567845|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
138567846|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567848|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
138567849|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
138567850|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138567851|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138567852|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567853|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138567854|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567855|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567857|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
138567858|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138567859|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138567860|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567861|NCT00343369|Cytarabine|cytarabine|mesh-list
138567862|NCT00343369|Dexamethasone|dexamethasone|mesh-list
138567863|NCT00343369|Prednisolone|prednisolone|mesh-list
138567864|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
138567865|NCT00343369|Doxorubicin|doxorubicin|mesh-list
138567866|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138567867|NCT00343369|Methotrexate|methotrexate|mesh-list
138567868|NCT00343369|Vincristine|vincristine|mesh-list
138567869|NCT00343369|Daunorubicin|daunorubicin|mesh-list
138567870|NCT00343369|Asparaginase|asparaginase|mesh-list
138567871|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
138567872|NCT00343369|Pegaspargase|pegaspargase|mesh-list
138567873|NCT00343369|Thioguanine|thioguanine|mesh-list
138567874|NCT00343369|Teniposide|teniposide|mesh-list
138567875|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567876|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
138567877|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567878|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567879|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138567880|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
138705454|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138705455|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705456|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138567881|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567882|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567883|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138567884|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138567885|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
138567886|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
138567887|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567888|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138567889|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
138567890|NCT00343369|Hormones|hormones|mesh-ancestor
138567891|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138567892|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138198376|NCT00001498|Vitamins|vitamins|mesh-ancestor
138567894|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138567895|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138567896|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567897|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138567898|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
138567899|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138567900|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138567901|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
138567902|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
138567903|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138567904|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138567905|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
138705498|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705499|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
138705501|NCT04626518|Belzutifan|belzutifan|mesh-list
138705502|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705503|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705504|NCT04626518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705505|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567906|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567907|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138567908|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
138567909|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
138567910|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
138567911|NCT02958111|Capecitabine|capecitabine|mesh-list
138567912|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138567913|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
138473973|NCT04734730|Hormones|hormones|mesh-ancestor
138567914|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567915|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567916|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
138567917|NCT00343447|Rituximab|rituximab|mesh-list
138567918|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567919|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
138567920|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449734|NCT01865721|Entonox|entonox|mesh-list
138567921|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567922|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138567923|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
138567924|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567925|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567926|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138567927|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138567928|NCT00343486|Solabegron|solabegron|mesh-list
138567929|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138567930|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138567931|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138567932|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
138567933|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138567934|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567935|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567936|NCT00089804|Abetimus|abetimus|mesh-list
138567937|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138705564|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138705565|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567938|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
138705566|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705567|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567939|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567940|NCT00343525|Bavituximab|bavituximab|mesh-list
138567941|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138567942|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567943|NCT00127881|Zanolimumab|zanolimumab|mesh-list
138567944|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138567945|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567946|NCT00343720|Bortezomib|bortezomib|mesh-list
138567947|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567948|NCT00343759|Lapatinib|lapatinib|mesh-list
138567949|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567950|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138567951|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567952|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567953|NCT00127920|Bevacizumab|bevacizumab|mesh-list
138567954|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138567955|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567956|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138567957|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138567958|NCT00127920|Growth Substances|growth substances|mesh-ancestor
138567959|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567960|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
138567961|NCT00343798|Cyclosporine|cyclosporine|mesh-list
138567962|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
138567963|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
138567964|NCT00343798|Fludarabine|fludarabine|mesh-list
138567965|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
138567966|NCT00343798|Cyclosporins|cyclosporins|mesh-list
138567967|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138567968|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
138567969|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567970|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567971|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138567972|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
138567973|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138567974|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138567975|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138567976|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138567977|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
138567978|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138567979|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
138567980|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138567981|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
138567982|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138567983|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138567984|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138567985|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
138567986|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138567988|NCT00343876|Clopidogrel|clopidogrel|mesh-list
138567989|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138567990|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138567991|NCT00343876|Analgesics|analgesics|mesh-ancestor
138567992|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
138567993|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138567994|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138567995|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138567996|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138567997|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138567998|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138567999|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568000|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138568001|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138568002|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568003|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
138568004|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138568005|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138568006|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138568007|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
138568008|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568009|NCT00402636|Sirolimus|sirolimus|mesh-list
138568010|NCT00402636|Temsirolimus|temsirolimus|mesh-list
138568011|NCT00402636|MTOR Inhibitors|mtor inhibitors|mesh-list
138705728|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568012|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138568013|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568014|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138568015|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568016|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
138568017|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138568018|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
138705734|NCT04210115|Antidotes|antidotes|mesh-ancestor
138568019|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568020|NCT00402636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138568021|NCT00402636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568022|NCT00402636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244355|NCT05405907|Hemostatics|hemostatics|mesh-list
138568024|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568025|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568026|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
138568027|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568028|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568029|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
138568030|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138473996|NCT04675788|Hormones|hormones|mesh-ancestor
138568031|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568032|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568035|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138568036|NCT00344227|Growth Substances|growth substances|mesh-ancestor
138568037|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568038|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
138568039|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568040|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138568041|NCT00344383|Norgestimate|norgestimate|mesh-list
138568042|NCT00344383|Estradiol|estradiol|mesh-list
138568043|NCT00344383|Estrogens|estrogens|mesh-ancestor
138568044|NCT00344383|Hormones|hormones|mesh-ancestor
138568045|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138568046|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568047|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138568048|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
138568049|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138568050|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138568051|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138568052|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138568053|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138568054|NCT00344422|Dexamethasone|dexamethasone|mesh-list
138568055|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
138568056|NCT00344422|Doxorubicin|doxorubicin|mesh-list
138568057|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138568058|NCT00344422|Vincristine|vincristine|mesh-list
138568059|NCT00344422|BB 1101|bb 1101|mesh-list
138568060|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138568061|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
138568062|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
138568063|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138568064|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568065|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138568066|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
138568067|NCT00344422|Hormones|hormones|mesh-ancestor
138568068|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138568069|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138568070|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568071|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
138568072|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568073|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568074|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138568075|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138568076|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138568077|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138568078|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
138568079|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
138568080|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
138568081|NCT00090038|Rituximab|rituximab|mesh-list
138568082|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568083|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568084|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
138705824|NCT03965468|Carboplatin|carboplatin|mesh-list
138705825|NCT03965468|Durvalumab|durvalumab|mesh-list
138705826|NCT03965468|Tremelimumab|tremelimumab|mesh-list
138705829|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
138568085|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568086|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568087|NCT00402792|Acetaminophen|acetaminophen|mesh-list
138568088|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138568089|NCT00402792|Hydrocodone|hydrocodone|mesh-list
138568090|NCT00402792|Oxycodone|oxycodone|mesh-list
138568091|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138568092|NCT00402792|Analgesics|analgesics|mesh-ancestor
138568093|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
138568094|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138474015|NCT04642547|Gefitinib|gefitinib|mesh-list
138568095|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568096|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
138568097|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138568098|NCT00402792|Narcotics|narcotics|mesh-ancestor
138568099|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138568101|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
138568102|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138568103|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138568104|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568105|NCT00127959|Tenofovir|tenofovir|mesh-list
138568106|NCT00127959|Emtricitabine|emtricitabine|mesh-list
138568107|NCT00127959|Zidovudine|zidovudine|mesh-list
138568108|NCT00127959|Efavirenz|efavirenz|mesh-list
138568109|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
138568110|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568111|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138568112|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138568113|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568114|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568115|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138568116|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138568117|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
138568118|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138705860|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
138568119|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138705867|NCT03929666|Vitamins|vitamins|mesh-ancestor
138568120|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138568121|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138568122|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138568123|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138568124|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138568125|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138568126|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
138568127|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568128|NCT00344539|Antacids|antacids|mesh-ancestor
138568129|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474030|NCT04539314|Analgesics|analgesics|mesh-ancestor
138568130|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138568131|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138568132|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138568133|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568134|NCT00344617|Bevacizumab|bevacizumab|mesh-list
138568135|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568136|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568137|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138568138|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138568139|NCT00344617|Growth Substances|growth substances|mesh-ancestor
138568140|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568141|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
138568142|NCT00127998|Artesunate|artesunate|mesh-list
138568143|NCT00127998|Chloroquine|chloroquine|mesh-list
138568144|NCT00127998|Lumefantrine|lumefantrine|mesh-list
138568145|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
138568146|NCT00127998|Artemether|artemether|mesh-list
138318654|NCT01396278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138568147|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
138705916|NCT03793166|Nivolumab|nivolumab|mesh-list
138568148|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138568149|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138568150|NCT00127998|Amodiaquine|amodiaquine|mesh-list
138568151|NCT00127998|Mefloquine|mefloquine|mesh-list
138568152|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
138568153|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138568154|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138568155|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568156|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568157|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
138568158|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
138568159|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138568160|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
138568161|NCT00127998|Amebicides|amebicides|mesh-ancestor
138568162|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568163|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138568164|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568165|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568166|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138568167|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
138568168|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138568169|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138568170|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450096|NCT01868945|Vitamin D|vitamin d|mesh-list
138568171|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568173|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138568174|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568176|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138568177|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
138568178|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138568179|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138568180|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138568181|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138568182|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568183|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
138705964|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705965|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138705972|NCT03605927|Sirolimus|sirolimus|mesh-list
138568184|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568185|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568186|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138568187|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138568188|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568189|NCT00128037|Mitomycins|mitomycins|mesh-list
138568190|NCT00128037|Mitomycin|mitomycin|mesh-list
138568191|NCT00128037|Vindesine|vindesine|mesh-list
138568192|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474067|NCT04506125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138568194|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
138568195|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568196|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138568197|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568198|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138568199|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
138568200|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
138568201|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
138568202|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138568203|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568204|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568205|NCT00344812|Buprenorphine|buprenorphine|mesh-list
138568206|NCT00344812|Methadone|methadone|mesh-list
138568207|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138568208|NCT00344812|Narcotics|narcotics|mesh-ancestor
138705999|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
138568209|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138568210|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568211|NCT00344812|Analgesics|analgesics|mesh-ancestor
138568212|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
138568213|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138568214|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138568215|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
138568216|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
138568217|NCT00344851|Metformin|metformin|mesh-list
138568218|NCT00344851|Exenatide|exenatide|mesh-list
138568219|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138568220|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654321|NCT05071053|Ramucirumab|ramucirumab|mesh-list
138568221|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138568222|NCT00344851|Incretins|incretins|mesh-ancestor
138568223|NCT00344851|Hormones|hormones|mesh-ancestor
138568224|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138706048|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706049|NCT03204786|Vasopressins|vasopressins|mesh-list
138568225|NCT00090155|Ondansetron|ondansetron|mesh-list
138568226|NCT00090155|Aprepitant|aprepitant|mesh-list
138568227|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
138568228|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
138568229|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138568230|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568231|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138568232|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
138568233|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
138568234|NCT00090155|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138568235|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138568236|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
138568237|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568238|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568239|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138568240|NCT00335413|Spironolactone|spironolactone|mesh-list
138568241|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138568242|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
138568243|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138568244|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568245|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138244575|NCT05316935|Cyproterone|cyproterone|mesh-list
138568246|NCT00335413|Diuretics|diuretics|mesh-ancestor
138568247|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
138568248|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
138568249|NCT00090194|Antibodies|antibodies|mesh-list
138568250|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
138568251|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138568252|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138568253|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
138568254|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706106|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
138568255|NCT00345163|Bevacizumab|bevacizumab|mesh-list
138568256|NCT00345163|Irinotecan|irinotecan|mesh-list
138568257|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568258|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568259|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138568260|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138568261|NCT00345163|Growth Substances|growth substances|mesh-ancestor
138568262|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568263|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
138568264|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138568265|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138450218|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
138568266|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568267|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568269|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138568270|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138568271|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
138568272|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568273|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138654334|NCT04959331|Fosfomycin|fosfomycin|mesh-list
138568274|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138568275|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568276|NCT00335647|Fluphenazine|fluphenazine|mesh-list
138568277|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
138568278|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
138568279|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138568280|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138568281|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138706148|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
138568282|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568283|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138568284|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138568285|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
138568286|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568287|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568288|NCT00128154|Chromium|chromium|mesh-list
138568289|NCT00128154|Picolinic acid|picolinic acid|mesh-list
138568290|NCT00128154|Trace Elements|trace elements|mesh-ancestor
138568291|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
138568292|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568293|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138568294|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
138568295|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
138568296|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568297|NCT00335686|Lopinavir|lopinavir|mesh-list
138568298|NCT00335686|Nevirapine|nevirapine|mesh-list
138568299|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138568300|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138568301|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
138568302|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568303|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706251|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
138706252|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706310|NCT01081951|Paclitaxel|paclitaxel|mesh-list
138568304|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138568305|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138568306|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
138568307|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568308|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138568309|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138568310|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138568311|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138568312|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138568313|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138568314|NCT00128232|Octreotide|octreotide|mesh-list
138568315|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138568316|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138568317|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568318|NCT04708249|Inositol|inositol|mesh-list
138568319|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
138568320|NCT04708249|Vitamins|vitamins|mesh-ancestor
138450313|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
138568322|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568323|NCT00090272|Ertapenem|ertapenem|mesh-list
138568324|NCT00090272|Cefotetan|cefotetan|mesh-list
138568326|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568327|NCT00345787|Buprenorphine|buprenorphine|mesh-list
138568328|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138568329|NCT00345787|Narcotics|narcotics|mesh-ancestor
138568330|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138568331|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706350|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138568332|NCT00345787|Analgesics|analgesics|mesh-ancestor
138706351|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
138706353|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
138568333|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
138568334|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138568335|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138568336|NCT00128271|Bavituximab|bavituximab|mesh-list
138654361|NCT04865289|Paclitaxel|paclitaxel|mesh-list
138568337|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568338|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568339|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138568340|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
138568341|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138568342|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138568343|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138568344|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138568345|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706399|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568346|NCT02959762|Vitamins|vitamins|mesh-list
138568347|NCT02959762|Vitamin K|vitamin k|mesh-list
138568348|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
138568349|NCT02959762|Menaquinone 7|menaquinone 7|mesh-list
138706400|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138568350|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
138568351|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568352|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138568353|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138706401|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138706417|NCT00018044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138706418|NCT00018044|Leprostatic Agents|leprostatic agents|mesh-ancestor
138706419|NCT00018044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138706420|NCT00018044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318663|NCT05365074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138318664|NCT05365074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318665|NCT05365074|Sensory System Agents|sensory system agents|mesh-ancestor
138318666|NCT05365074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318667|NCT01383096|Artefenomel|artefenomel|mesh-list
138318668|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138318671|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138318672|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318674|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
138318675|NCT01382940|Rituximab|rituximab|mesh-list
138318676|NCT01382940|Methotrexate|methotrexate|mesh-list
138318677|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
138318678|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138318679|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138318680|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318681|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
138318682|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318683|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568354|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568355|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
138568356|NCT02959762|Coagulants|coagulants|mesh-ancestor
138568358|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568359|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138568360|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568361|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568362|NCT00345982|Sertindole|sertindole|mesh-list
138568363|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138568364|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138568365|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138568366|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568367|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138568368|NCT00346099|Capecitabine|capecitabine|mesh-list
138568369|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
138568370|NCT00346099|Panitumumab|panitumumab|mesh-list
138568371|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138568372|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
138568373|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568374|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568375|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568376|NCT00125736|Rabeprazole|rabeprazole|mesh-list
138568377|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138568378|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138568379|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138568380|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568381|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318687|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138568382|NCT00090428|Caseins|caseins|mesh-list
138318688|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
138318689|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318690|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
138318691|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318692|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138318693|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138318694|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138318695|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138318696|NCT01382940|Analgesics|analgesics|mesh-ancestor
138318697|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
138318698|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318700|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138318702|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
138318703|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138318704|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
138318706|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138318707|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138318708|NCT01382940|Protective Agents|protective agents|mesh-ancestor
138568383|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
138568384|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
138568385|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568386|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
138568387|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568388|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568390|NCT00346255|Immunoconjugates|immunoconjugates|mesh-ancestor
138568391|NCT00346255|Immunologic Factors|immunologic factors|mesh-ancestor
138568392|NCT00346255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568393|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138568395|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138568396|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138568397|NCT00346294|Analgesics|analgesics|mesh-ancestor
138568398|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
138568399|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138568400|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568401|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138568402|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568403|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138568404|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138568405|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
138568407|NCT00346489|Mitomycins|mitomycins|mesh-list
138568408|NCT00346489|Mitomycin|mitomycin|mesh-list
138568409|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
138568410|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318717|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138318718|NCT01395888|Fluticasone|fluticasone|mesh-list
138318720|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
138318721|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138318722|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138318723|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
138318724|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318726|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138318728|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
138318729|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138318730|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
138318731|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138318733|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318734|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568411|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138568412|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568413|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138568414|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
138568415|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568416|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138568417|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
138568418|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138568419|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568421|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
138568422|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
138568423|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568424|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
138568425|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318736|NCT01381692|Dexamethasone|dexamethasone|mesh-list
138318737|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
138318739|NCT01381692|Bortezomib|bortezomib|mesh-list
138318740|NCT01381692|Temsirolimus|temsirolimus|mesh-list
138318741|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138318742|NCT01381692|MTOR Inhibitors|mtor inhibitors|mesh-list
138318744|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
138318745|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138318746|NCT01381692|BB 1101|bb 1101|mesh-list
138318747|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
138318748|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318749|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138318750|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
138318751|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
138318754|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
138318756|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138318757|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138318758|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318759|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
138318760|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318761|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318762|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138318764|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318765|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138318767|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138318768|NCT01381692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138318769|NCT01395030|Choline|choline|mesh-list
138318770|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
138568426|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
138568427|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568428|NCT00346567|Tenofovir|tenofovir|mesh-list
138568429|NCT00346567|Lamivudine|lamivudine|mesh-list
138568430|NCT00346567|Emtricitabine|emtricitabine|mesh-list
138568431|NCT00346567|Zidovudine|zidovudine|mesh-list
138568432|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138568433|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138568435|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568436|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138568437|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138568438|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450489|NCT01870986|Adalimumab|adalimumab|mesh-list
138568439|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568440|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138568441|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138568442|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
138568443|NCT00090623|Ranibizumab|ranibizumab|mesh-list
138568444|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138568445|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138568446|NCT00090623|Growth Substances|growth substances|mesh-ancestor
138318771|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138568447|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568448|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
138318772|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
138318787|NCT01394250|Lidocaine|lidocaine|mesh-list
138568449|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568450|NCT02957994|Tenofovir|tenofovir|mesh-list
138568451|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
138568452|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568453|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138568454|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138568455|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568456|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568457|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138568458|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138568459|NCT00346645|Bortezomib|bortezomib|mesh-list
138568460|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568461|NCT00346684|Rituximab|rituximab|mesh-list
138568462|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568463|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568464|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
138568465|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318820|NCT05361330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138318821|NCT05361330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568466|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568467|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138568468|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138568469|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138568470|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138568471|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188357|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138568472|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568473|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568474|NCT00125892|Analgesics|analgesics|mesh-ancestor
138568475|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
138568476|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138568477|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
138568478|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138568480|NCT00346801|Celecoxib|celecoxib|mesh-list
138568481|NCT00346801|Cisplatin|cisplatin|mesh-list
138568482|NCT00346801|Irinotecan|irinotecan|mesh-list
138568483|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568484|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138568485|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138568486|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568487|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568488|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138568489|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138568490|NCT00346801|Analgesics|analgesics|mesh-ancestor
138474140|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568491|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
138568492|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318878|NCT04407312|Cilostazol|cilostazol|mesh-list
138318879|NCT04407312|Clopidogrel|clopidogrel|mesh-list
138318880|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138318881|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138568493|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568494|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138568495|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568496|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138568497|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138568498|NCT00346840|Misoprostol|misoprostol|mesh-list
138568499|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138568500|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
138568501|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138568502|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568503|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138568504|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138568505|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
138568506|NCT00346879|PENTA|penta|mesh-list
138568507|NCT00346879|Fondaparinux|fondaparinux|mesh-list
138568508|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138568509|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
138568510|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138568511|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
138568512|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568513|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568514|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
138568515|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138568516|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138568517|NCT00126009|Amisulpride|amisulpride|mesh-list
138568518|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138568519|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138568520|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138568521|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568522|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138568523|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138568524|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
138568525|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568526|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568527|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138568528|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
138568529|NCT00346918|Sirolimus|sirolimus|mesh-list
138568530|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138568531|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568532|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138568533|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568534|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
138568535|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138568536|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
138568537|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568538|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
138568539|NCT00346957|Anecortave|anecortave|mesh-list
138568540|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138568541|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138568542|NCT00346957|Growth Substances|growth substances|mesh-ancestor
138568543|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568544|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
138568545|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568546|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138568547|NCT00346996|Insulin|insulin|mesh-list
138568548|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138568549|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
138568550|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
138568551|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
138568552|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
138568553|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138318970|NCT05631678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568554|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318971|NCT05631678|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138318973|NCT05631678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450626|NCT01871740|Folic Acid|folic acid|mesh-list
138568555|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
138568556|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568557|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
138568558|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568559|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568560|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138568561|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138568562|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138568563|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138568564|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138568565|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138568566|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
138568567|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568568|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568569|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568570|NCT00347113|Albendazole|albendazole|mesh-list
138568571|NCT00347113|Praziquantel|praziquantel|mesh-list
138568572|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
138568573|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138568574|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568575|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
138568576|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138568577|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138568578|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
138568579|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
138654421|NCT04659603|Gemcitabine|gemcitabine|mesh-list
138568580|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
138568581|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568582|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568583|NCT00347152|Valproic Acid|valproic acid|mesh-list
138568584|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
138568585|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568586|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568587|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
138568588|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568589|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568590|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
138568591|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138568592|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319008|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568593|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138319009|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138568594|NCT00090896|Ipilimumab|ipilimumab|mesh-list
138319010|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
138319011|NCT03595254|Nicotine|nicotine|mesh-list
138568595|NCT00090896|Antibodies|antibodies|mesh-list
138568596|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138568597|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
138568598|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568599|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568600|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568601|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138568602|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568603|NCT00402558|Aldesleukin|aldesleukin|mesh-list
138568604|NCT00402558|Methotrexate|methotrexate|mesh-list
138568605|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
138568606|NCT00402558|Fludarabine|fludarabine|mesh-list
138568607|NCT00402558|Busulfan|busulfan|mesh-list
138568608|NCT00402558|Interleukin-2|interleukin-2|mesh-list
138568609|NCT00402558|Tacrolimus|tacrolimus|mesh-list
138568610|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
138568611|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138568612|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138568613|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
138568614|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138568615|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568616|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138568617|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
138474174|NCT04254081|Lidocaine|lidocaine|mesh-list
138568618|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568620|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
138568621|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568622|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138319043|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568623|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138244955|NCT02992028|Vitamins|vitamins|mesh-list
138568624|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
138568626|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138568627|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
138568628|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568629|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138568630|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
138568631|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138568632|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138568633|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138568634|NCT00402558|Analgesics|analgesics|mesh-ancestor
138568635|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
138568636|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138568637|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138568638|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138568639|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
138568640|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568641|NCT00347386|Astringents|astringents|mesh-ancestor
138568642|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
138568643|NCT00347425|Olanzapine|olanzapine|mesh-list
138568644|NCT00347425|Risperidone|risperidone|mesh-list
138568645|NCT00347425|Aripiprazole|aripiprazole|mesh-list
138568646|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138568647|NCT00347425|Ziprasidone|ziprasidone|mesh-list
138568648|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138568649|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
138568650|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568651|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568652|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568653|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138568654|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138568655|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138568656|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138474188|NCT04254081|Narcotics|narcotics|mesh-ancestor
138568657|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138568658|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
138319093|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138568659|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
138568660|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
138202367|NCT04775732|Infliximab|infliximab|mesh-list
138568661|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138568662|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138568663|NCT00347425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138568664|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138568665|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138568666|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
138568667|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
138568668|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138568669|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138568670|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138568671|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138568672|NCT00126048|Atorvastatin|atorvastatin|mesh-list
138568673|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138568674|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138568675|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
138568676|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568677|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138568678|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138568679|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568680|NCT00126087|Dopamine|dopamine|mesh-list
138568681|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138568682|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
138568683|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
138568684|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654457|NCT04523207|Relugolix|relugolix|mesh-list
138568686|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
138568687|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138319134|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568688|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568689|NCT00126087|Protective Agents|protective agents|mesh-ancestor
138568690|NCT00347503|Ketorolac|ketorolac|mesh-list
138568692|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138568693|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138568694|NCT00347503|Analgesics|analgesics|mesh-ancestor
138568695|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
138568696|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138568697|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568698|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138568699|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568700|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138568701|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568702|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568703|NCT00347542|Vitamin D|vitamin d|mesh-list
138568704|NCT00347542|Vitamins|vitamins|mesh-ancestor
138568705|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
138568706|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474233|NCT04209296|Ketamine|ketamine|mesh-list
138568707|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138568708|NCT00091052|Sargramostim|sargramostim|mesh-list
138568709|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
138568710|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568711|NCT00347581|Methamphetamine|methamphetamine|mesh-list
138568712|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138568713|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568714|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
138319180|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138319182|NCT03591744|Bortezomib|bortezomib|mesh-list
138568715|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
138568716|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138568717|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
138568718|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568719|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568720|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
138568721|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138568722|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138568723|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138568724|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138568725|NCT00421252|Clopidogrel|clopidogrel|mesh-list
138568726|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138568727|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138450813|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138568728|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138568729|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138568730|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
138568731|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568732|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568733|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568735|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138568736|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568737|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
138319233|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138319235|NCT03023436|Capecitabine|capecitabine|mesh-list
138568738|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138568739|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138568741|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138568742|NCT04705402|Diuretics|diuretics|mesh-ancestor
138568743|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
138568744|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568745|NCT00091130|Vaccines|vaccines|mesh-list
138568746|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
138568747|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568748|NCT00126243|Rituximab|rituximab|mesh-list
138568749|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568750|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568751|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
138568752|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568753|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568754|NCT00426439|Chloroquine|chloroquine|mesh-list
138568755|NCT00426439|Lumefantrine|lumefantrine|mesh-list
138568756|NCT00426439|Artemether|artemether|mesh-list
138568757|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138568758|NCT00426439|Amebicides|amebicides|mesh-ancestor
138568759|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138568760|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138568761|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568762|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
138568763|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568764|NCT00426478|Amlodipine|amlodipine|mesh-list
138568765|NCT00426478|Valsartan|valsartan|mesh-list
138568766|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138568767|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138568768|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138568769|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138474241|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
138319285|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568770|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568771|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138568772|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568773|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
138245093|NCT03282669|Hydromorphone|hydromorphone|mesh-list
138568774|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138319286|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138568775|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138568776|NCT00426478|Diuretics|diuretics|mesh-ancestor
138568777|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
138568778|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138568779|NCT04705519|Paclitaxel|paclitaxel|mesh-list
138568780|NCT04705519|Bevacizumab|bevacizumab|mesh-list
138568781|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138568782|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568783|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
138568784|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
138568785|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
138568786|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568787|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568788|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138568789|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138568790|NCT04705519|Growth Substances|growth substances|mesh-ancestor
138568791|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568792|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
138568794|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138568795|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568796|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138568797|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
138568798|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138568799|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
138568800|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568802|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
138568803|NCT04705129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568804|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568805|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138568806|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568807|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568808|NCT00126321|Cladribine|cladribine|mesh-list
138568809|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568810|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138568811|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
138568812|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568813|NCT00426595|Omeprazole|omeprazole|mesh-list
138568814|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138568815|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138568816|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138568817|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450935|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
138568818|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568819|NCT00426673|Brivaracetam|brivaracetam|mesh-list
138568820|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
138568821|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
138568822|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138568823|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
138319375|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138568824|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568825|NCT00091247|Tetracycline|tetracycline|mesh-list
138568826|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138568827|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568828|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138568829|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568830|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568831|NCT00126360|Anastrozole|anastrozole|mesh-list
138568832|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138568833|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568834|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138568835|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138568836|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568837|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568838|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138568839|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
138568840|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138568841|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568842|NCT01058863|Albuterol|albuterol|mesh-list
138568843|NCT01058863|Procaterol|procaterol|mesh-list
138568844|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138568845|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
138568846|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138568847|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568848|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138568849|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
138568851|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138568852|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138568853|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138319428|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
138568854|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138319429|NCT04025736|Coagulants|coagulants|mesh-ancestor
138319430|NCT04190160|Xultophy|xultophy|mesh-list
138319433|NCT04190160|Incretins|incretins|mesh-ancestor
138568855|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
138568856|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568857|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568858|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
138568859|NCT00091286|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138568860|NCT00091286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138568861|NCT00091286|Immunologic Factors|immunologic factors|mesh-ancestor
138474296|NCT04042558|Bevacizumab|bevacizumab|mesh-list
138568862|NCT00091286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568863|NCT00126399|Doxycycline|doxycycline|mesh-list
138568864|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138568865|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568866|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
138568867|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138568868|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138568869|NCT01058395|Minocycline|minocycline|mesh-list
138568870|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138568871|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568872|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138568873|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
138318025|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
138568874|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568875|NCT00091325|Protective Agents|protective agents|mesh-ancestor
138568876|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568877|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138568878|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138568879|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568880|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138568882|NCT00126516|Giapreza|giapreza|mesh-list
138568883|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138319473|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138568884|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
138568885|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138568886|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138568887|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568888|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138568889|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138568890|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
138568891|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138568892|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
138568893|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568894|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138568895|NCT01058005|Interferons|interferons|mesh-list
138568896|NCT01058005|Interferon-beta|interferon-beta|mesh-list
138568897|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
138568898|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
138568899|NCT01058005|Natalizumab|natalizumab|mesh-list
138568900|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
138568901|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568902|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
138568903|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568904|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
138568905|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568906|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138568907|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138568908|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568909|NCT00091559|Vorinostat|vorinostat|mesh-list
138568910|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568911|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138568912|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568913|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568914|NCT00426829|Bevacizumab|bevacizumab|mesh-list
138568915|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138568916|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319516|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138568917|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138451077|NCT05854082|Anesthetics|anesthetics|mesh-ancestor
138568918|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138568919|NCT00426829|Growth Substances|growth substances|mesh-ancestor
138568920|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568921|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
138568922|NCT00426946|Reboxetine|reboxetine|mesh-list
138568923|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
138474314|NCT04040946|Choline|choline|mesh-list
138568924|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138568926|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138568927|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138568928|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568929|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
138568930|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568931|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568932|NCT00091598|Ambrisentan|ambrisentan|mesh-list
138568933|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138568934|NCT00426985|Ketoprofen|ketoprofen|mesh-list
138568935|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138568936|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138568937|NCT00426985|Analgesics|analgesics|mesh-ancestor
138568938|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
138568939|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138568940|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568941|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138568942|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138568943|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138568945|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319565|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138568946|NCT00427102|Cisplatin|cisplatin|mesh-list
138568947|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568948|NCT00427414|Daunorubicin|daunorubicin|mesh-list
138319566|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568949|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568950|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138568951|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138568952|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138568953|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138568954|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138568955|NCT00091715|Bosentan|bosentan|mesh-list
138568956|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138568957|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138568958|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568959|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
138568960|NCT00427492|Antacids|antacids|mesh-ancestor
138568961|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568962|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138568963|NCT00427570|Fluorouracil|fluorouracil|mesh-list
138568964|NCT00427570|Vincristine|vincristine|mesh-list
138568965|NCT00427570|Semustine|semustine|mesh-list
138568966|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
138568967|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
138568968|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568969|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138568970|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474322|NCT04038099|Lidocaine|lidocaine|mesh-list
138568971|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138568972|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
138568973|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568974|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138568975|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
138568976|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
138568977|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
138568978|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138568979|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138568980|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
138568981|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138568982|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138568983|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138568984|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
138568985|NCT00091910|Hematinics|hematinics|mesh-ancestor
138568986|NCT00427882|Alfuzosin|alfuzosin|mesh-list
138568987|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138319609|NCT04143906|Vinorelbine|vinorelbine|mesh-list
138319610|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319611|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138568988|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138568989|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138568990|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
138568991|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138568992|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138568993|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138568994|NCT00427882|Urological Agents|urological agents|mesh-ancestor
138568996|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
138568997|NCT04704622|Ketamine|ketamine|mesh-list
138568998|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138568999|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138569000|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569002|NCT04704622|Analgesics|analgesics|mesh-ancestor
138569003|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
138569004|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569005|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138569006|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138569007|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138569008|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
138569009|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569010|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569011|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138569012|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138569013|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
138569014|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
138569015|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138569016|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138569017|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138569018|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138319644|NCT04149678|Cyclosporine|cyclosporine|mesh-list
138319645|NCT04149678|Cyclosporins|cyclosporins|mesh-list
138319646|NCT04149678|Ozanimod|ozanimod|mesh-list
138319647|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319648|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569019|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138569020|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138569021|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
138569022|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
138569023|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138569024|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569025|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138569026|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569027|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569029|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138474351|NCT03994172|Cinacalcet|cinacalcet|mesh-list
138569030|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569031|NCT03769467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138569032|NCT03769467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569033|NCT00092183|Ondansetron|ondansetron|mesh-list
138569034|NCT00092183|Aprepitant|aprepitant|mesh-list
138569035|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
138569036|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
138569037|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569038|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569039|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138569040|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
138569041|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
138569042|NCT00092183|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138569043|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138569044|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
138569045|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569046|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569047|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138569048|NCT00428272|Interferons|interferons|mesh-list
138569049|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
138569050|NCT00428272|Lexatumumab|lexatumumab|mesh-list
138569051|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138569052|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569053|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
138569054|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569055|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
138569056|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569058|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138569059|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138569060|NCT00428311|Metformin|metformin|mesh-list
138319687|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569061|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
138569062|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138569063|NCT00428311|Estradiol|estradiol|mesh-list
138569064|NCT00428311|Cyproterone|cyproterone|mesh-list
138569065|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138569066|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569067|NCT00428311|Estrogens|estrogens|mesh-ancestor
138569068|NCT00428311|Hormones|hormones|mesh-ancestor
138569069|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138569070|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138569071|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
138569072|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138569073|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138569074|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138569075|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138569076|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
138569077|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
138569078|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569079|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138569081|NCT00092300|Rofecoxib|rofecoxib|mesh-list
138569082|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138569083|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138569084|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569085|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451341|NCT05302999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138569086|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138569087|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138569089|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
138569090|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319724|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138319725|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
138319726|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319727|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319754|NCT04146324|Nivolumab|nivolumab|mesh-list
138569091|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569092|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138569093|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138569094|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138569095|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
138569096|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138569097|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138569098|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138569099|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138569100|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569102|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138569103|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138569104|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
138569105|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569106|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569107|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569108|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138569109|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
138569110|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569111|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138569112|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
138319766|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138319767|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319768|NCT04148898|Bevacizumab|bevacizumab|mesh-list
138319780|NCT04148820|Aspirin|aspirin|mesh-list
138569113|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138569114|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
138569115|NCT00428428|Protective Agents|protective agents|mesh-ancestor
138569117|NCT00092339|Rofecoxib|rofecoxib|mesh-list
138569118|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138569119|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138569120|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569121|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569122|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138569123|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138569124|NCT00092339|Analgesics|analgesics|mesh-ancestor
138569125|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
138569126|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569127|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569128|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138569129|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138569130|NCT00428545|Bevacizumab|bevacizumab|mesh-list
138569131|NCT00428545|Bortezomib|bortezomib|mesh-list
138569132|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138569133|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569134|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138569135|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138569136|NCT00428545|Growth Substances|growth substances|mesh-ancestor
138319817|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
138319818|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319823|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
138569137|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569138|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
138569139|NCT00092378|Diclofenac|diclofenac|mesh-list
138569140|NCT00092378|Rofecoxib|rofecoxib|mesh-list
138569141|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138569142|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138569143|NCT00092378|Analgesics|analgesics|mesh-ancestor
138569144|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
138569145|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569146|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569147|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138569148|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138569149|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138569150|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569151|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569152|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138569153|NCT00092846|Lovastatin|lovastatin|mesh-list
138569154|NCT00092846|L 647318|l 647318|mesh-list
138569155|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
138569156|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138569157|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138569158|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
138569159|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569160|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138569161|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138569162|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569163|NCT00092924|Mapatumumab|mapatumumab|mesh-list
138569164|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569165|NCT00093002|Fulvestrant|fulvestrant|mesh-list
138569166|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138569167|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569168|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138569169|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138569170|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
138569171|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138569172|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569173|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138569174|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569175|NCT00093158|Anticoagulants|anticoagulants|mesh-list
138569176|NCT00093158|Bivalirudin|bivalirudin|mesh-list
138569177|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
138569178|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138569179|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
138569180|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569181|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569182|NCT03501498|Loperamide|loperamide|mesh-list
138569183|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
138569184|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138569185|NCT05561049|Thalidomide|thalidomide|mesh-list
138569186|NCT05561049|Dexamethasone|dexamethasone|mesh-list
138569187|NCT05561049|Bortezomib|bortezomib|mesh-list
138569188|NCT05561049|Daratumumab|daratumumab|mesh-list
138569189|NCT05561049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138569190|NCT05561049|Antiemetics|antiemetics|mesh-ancestor
138569191|NCT05561049|Autonomic Agents|autonomic agents|mesh-ancestor
138569192|NCT05561049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569193|NCT05561049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569194|NCT05561049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138569195|NCT05561049|Glucocorticoids|glucocorticoids|mesh-ancestor
138569197|NCT05561049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138569198|NCT05561049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138569199|NCT05561049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569200|NCT05561049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138569201|NCT05561049|Immunologic Factors|immunologic factors|mesh-ancestor
138569202|NCT05561049|Leprostatic Agents|leprostatic agents|mesh-ancestor
138569203|NCT05561049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138569204|NCT05561049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569205|NCT05561049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138569206|NCT05561049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138569207|NCT05561049|Growth Substances|growth substances|mesh-ancestor
138569208|NCT05561049|Growth Inhibitors|growth inhibitors|mesh-ancestor
138569209|NCT00424034|Ambrisentan|ambrisentan|mesh-list
138569210|NCT00424034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138569211|NCT05561010|Bupivacaine|bupivacaine|mesh-list
138569212|NCT05561010|Anesthetics, Local|anesthetics, local|mesh-ancestor
138569213|NCT05561010|Anesthetics|anesthetics|mesh-ancestor
138569214|NCT05561010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138569215|NCT05561010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569216|NCT05561010|Sensory System Agents|sensory system agents|mesh-ancestor
138569217|NCT05561010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569218|NCT03448107|Fluorides|fluorides|mesh-list
138474389|NCT03956966|Hormones|hormones|mesh-ancestor
138569219|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
138569220|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
138569221|NCT03448107|Protective Agents|protective agents|mesh-ancestor
138569222|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569223|NCT00093314|Ofatumumab|ofatumumab|mesh-list
138569224|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569225|NCT00093353|Cefixime|cefixime|mesh-list
138569226|NCT00093353|Irinotecan|irinotecan|mesh-list
138569227|NCT00093353|Temozolomide|temozolomide|mesh-list
138569228|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138569229|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138569230|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319884|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319885|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138569231|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569232|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319886|NCT03586674|Fenofibrate|fenofibrate|mesh-list
138319887|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138319888|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
138569233|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138569234|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
138569235|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138569236|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569237|NCT00093509|Doxorubicin|doxorubicin|mesh-list
138569238|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138569239|NCT00093509|Ifosfamide|ifosfamide|mesh-list
138569240|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
138569242|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138569243|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569244|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138569245|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138569246|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569247|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569248|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138569249|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
138569251|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569252|NCT00093548|Vaccines|vaccines|mesh-list
138569253|NCT00093548|Sargramostim|sargramostim|mesh-list
138569254|NCT00093548|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
138569255|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
138319924|NCT03589326|Ponatinib|ponatinib|mesh-list
138319925|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138319927|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
138319928|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319929|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569256|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569257|NCT00093548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138569258|NCT05549895|Dexamethasone|dexamethasone|mesh-list
138569259|NCT05549895|Bupivacaine|bupivacaine|mesh-list
138569260|NCT05549895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138569261|NCT05549895|Antiemetics|antiemetics|mesh-ancestor
138569262|NCT05549895|Autonomic Agents|autonomic agents|mesh-ancestor
138569263|NCT05549895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569264|NCT05549895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569265|NCT05549895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138569266|NCT05549895|Glucocorticoids|glucocorticoids|mesh-ancestor
138569267|NCT05549895|Hormones|hormones|mesh-ancestor
138569268|NCT05549895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138569269|NCT05549895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138569270|NCT05549895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569271|NCT05549895|Anesthetics, Local|anesthetics, local|mesh-ancestor
138569272|NCT05549895|Anesthetics|anesthetics|mesh-ancestor
138569273|NCT05549895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138569274|NCT05549895|Sensory System Agents|sensory system agents|mesh-ancestor
138569275|NCT00093587|Cyclosporine|cyclosporine|mesh-list
138569276|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
138569277|NCT00093587|Busulfan|busulfan|mesh-list
138569278|NCT00093587|Cyclosporins|cyclosporins|mesh-list
138569279|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138569280|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138569281|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
138569282|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569283|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138569284|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138319974|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138319975|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138319976|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138569285|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
138569286|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569287|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569288|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138569289|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569290|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
138569291|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569292|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
138569293|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138569295|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569296|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138569297|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569298|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569299|NCT05543109|Fentanyl|fentanyl|mesh-list
138569300|NCT05543109|Narcotics|narcotics|mesh-list
138569301|NCT05543109|Propofol|propofol|mesh-list
138569302|NCT05543109|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
138569303|NCT05543109|Ropivacaine|ropivacaine|mesh-list
138569304|NCT05543109|Anesthetics|anesthetics|mesh-list
138569306|NCT05543109|Anesthetics, Local|anesthetics, local|mesh-list
138569307|NCT05543109|Rocuronium|rocuronium|mesh-list
138569308|NCT05543109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138569309|NCT05543109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138569310|NCT05543109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569311|NCT05543109|Anesthetics, General|anesthetics, general|mesh-ancestor
138569312|NCT05543109|Sensory System Agents|sensory system agents|mesh-ancestor
138569313|NCT05543109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569314|NCT05543109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138569315|NCT05543109|Analgesics|analgesics|mesh-ancestor
138569316|NCT05543109|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138569317|NCT05543109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138569318|NCT05543109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138569319|NCT05543109|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138320024|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569320|NCT05543109|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138569321|NCT05543109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138569322|NCT00093665|Fluorouracil|fluorouracil|mesh-list
138320025|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
138569323|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569324|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
138320026|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
138320027|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
138569325|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569326|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138569328|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
138569329|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569330|NCT00093704|Ganciclovir|ganciclovir|mesh-list
138569331|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138569332|NCT00093704|Bortezomib|bortezomib|mesh-list
138569333|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569334|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
138569335|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569336|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138569337|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569338|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569339|NCT01055314|Dactinomycin|dactinomycin|mesh-list
138569340|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
138569341|NCT01055314|Temozolomide|temozolomide|mesh-list
138569342|NCT01055314|Ifosfamide|ifosfamide|mesh-list
138569343|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
138569344|NCT01055314|Doxorubicin|doxorubicin|mesh-list
138569345|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138569346|NCT01055314|Irinotecan|irinotecan|mesh-list
138569347|NCT01055314|Etoposide|etoposide|mesh-list
138569348|NCT01055314|Vincristine|vincristine|mesh-list
138569349|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
138569350|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
138569351|NCT01055314|Camptothecin|camptothecin|mesh-list
138569352|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138569353|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138569354|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
138569355|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569356|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138569357|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138569358|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
138569359|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569360|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569361|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138569362|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138569363|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138569364|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138569365|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569366|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138569367|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138569368|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
138569369|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
138569370|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
138569371|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
138569372|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
138569373|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138569374|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569375|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138569376|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138569378|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
138569379|NCT00093743|Fludarabine|fludarabine|mesh-list
138569380|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
138569382|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569383|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138569384|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
138569385|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569386|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138569387|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
138569388|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569389|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569390|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
138569391|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569392|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
138569393|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138569394|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138569395|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138569396|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138569397|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
138569398|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138569399|NCT00400322|Valganciclovir|valganciclovir|mesh-list
138569400|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
138569401|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569402|NCT00093860|Propranolol|propranolol|mesh-list
138569403|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138569404|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138569405|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
138569406|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569407|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569408|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569409|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138320072|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569410|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138320073|NCT03159234|Epinephrine|epinephrine|mesh-list
138320074|NCT03159234|Racepinephrine|racepinephrine|mesh-list
138320075|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
138569411|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
138569413|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138569414|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569415|NCT02823366|Fenofibrate|fenofibrate|mesh-list
138569416|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138569417|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
138569418|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569419|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138569420|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
138569421|NCT00093977|Hematinics|hematinics|mesh-ancestor
138569423|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138569424|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138569425|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569426|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569427|NCT00094367|Lamivudine|lamivudine|mesh-list
138569428|NCT00094367|Abacavir|abacavir|mesh-list
138569429|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138569430|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138569432|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569433|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
138569434|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569435|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138569436|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138569437|NCT00094406|Dimercaprol|dimercaprol|mesh-list
138569438|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
138569439|NCT00094406|Chelating Agents|chelating agents|mesh-ancestor
138569440|NCT00094406|Sequestering Agents|sequestering agents|mesh-ancestor
138320127|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138569441|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569442|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
138569443|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
138569444|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569445|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569446|NCT00094484|Cinacalcet|cinacalcet|mesh-list
138569447|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138569448|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569449|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138569450|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
138654672|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138451805|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138569451|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138569452|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
138569453|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138569454|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138569455|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
138569456|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569457|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569458|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138569459|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138569460|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
138569461|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569462|NCT00428701|Esomeprazole|esomeprazole|mesh-list
138569463|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138569464|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138569465|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138569466|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569467|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569468|NCT00428818|Doxycycline|doxycycline|mesh-list
138569469|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138320174|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138569470|NCT00428818|Trimethoprim|trimethoprim|mesh-list
138569471|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
138569472|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138569473|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138320175|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138320177|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138569474|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
138569475|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138569476|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138474445|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
138569477|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138569478|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138569479|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569480|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569481|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138569482|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138569483|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138451884|NCT01939275|Copper|copper|mesh-list
138569485|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
138569486|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
138569487|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569488|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569489|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138569490|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138569491|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138569492|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138569493|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138569494|NCT00094640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138569495|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138569496|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138654698|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138451897|NCT01342367|Bicalutamide|bicalutamide|mesh-list
138569497|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569498|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569499|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
138569500|NCT02415309|Melatonin|melatonin|mesh-list
138569501|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
138569502|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569503|NCT02415309|Protective Agents|protective agents|mesh-ancestor
138569504|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569505|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138569506|NCT00403338|Sirolimus|sirolimus|mesh-list
138569507|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138320213|NCT01673724|Protective Agents|protective agents|mesh-ancestor
138569508|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569509|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138320215|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138569510|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569511|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
138569512|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138569513|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
138569514|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569516|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569517|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569518|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569519|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569520|NCT00095069|Analgesics|analgesics|mesh-ancestor
138569521|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
138569522|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
138569523|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
138569524|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
138569525|NCT00403533|Atorvastatin|atorvastatin|mesh-list
138569526|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138569527|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138569528|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
138569529|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569530|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138569531|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138569532|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569533|NCT00095225|Bevacizumab|bevacizumab|mesh-list
138569534|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138569535|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138569536|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569537|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138569538|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138569539|NCT00095225|Growth Substances|growth substances|mesh-ancestor
138569540|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569541|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
138569542|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138569543|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569544|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569545|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
138569546|NCT00095264|Hematinics|hematinics|mesh-ancestor
138569547|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
138569548|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
138569549|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138320248|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138320249|NCT04747392|Teriparatide|teriparatide|mesh-list
138320250|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138569550|NCT00403611|Praziquantel|praziquantel|mesh-list
138569551|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
138569552|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138569553|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569554|NCT00428896|Gefitinib|gefitinib|mesh-list
138569555|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569556|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138569557|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654723|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
138569558|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569560|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
138569561|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569562|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138569563|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138569564|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138569565|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138569566|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569567|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
138569568|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569569|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569570|NCT00095459|Bevacizumab|bevacizumab|mesh-list
138569571|NCT00095459|Sorafenib|sorafenib|mesh-list
138320280|NCT05353062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138320281|NCT05353062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138320282|NCT05353062|Adrenergic Agents|adrenergic agents|mesh-ancestor
138320283|NCT05353062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569572|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138569573|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569574|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138569575|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138569576|NCT00095459|Growth Substances|growth substances|mesh-ancestor
138569577|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569578|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
138569579|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138569580|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569581|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569583|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138569584|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
138569585|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569586|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569587|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138569588|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138569589|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
138569590|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569591|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569592|NCT00429247|Trastuzumab|trastuzumab|mesh-list
138569593|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138569594|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569595|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
138569596|NCT00095654|Ramipril|ramipril|mesh-list
138569597|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138569598|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569599|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138569600|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
138569601|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569602|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569603|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138569604|NCT00095693|Sorafenib|sorafenib|mesh-list
138569605|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138569606|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569607|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138569608|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569609|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569610|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138569611|NCT01054573|Interferons|interferons|mesh-list
138569612|NCT01054573|Ribavirin|ribavirin|mesh-list
138569613|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569614|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
138569615|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569616|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
138569617|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569618|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
138569619|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138654738|NCT03206671|Prednisolone|prednisolone|mesh-list
138569621|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138569622|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138569623|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
138569624|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569625|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138569626|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138569627|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320333|NCT01675206|Vitamins|vitamins|mesh-ancestor
138320334|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
138569628|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
138569629|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138569630|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
138569631|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569632|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
138569633|NCT00429520|Protective Agents|protective agents|mesh-ancestor
138569635|NCT00429559|Topotecan|topotecan|mesh-list
138569636|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138569637|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
138569638|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569639|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569640|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138474482|NCT03859024|Hormones|hormones|mesh-ancestor
138569641|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138569642|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452158|NCT01874470|Diuretics|diuretics|mesh-list
138569644|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
138569645|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138569646|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138569647|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138569648|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138569649|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569650|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
138569652|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569653|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569654|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138569655|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138569656|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
138569657|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138569658|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138569659|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138320352|NCT04747080|Dexamethasone|dexamethasone|mesh-list
138320353|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
138569660|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138569661|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
138569662|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138569663|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569664|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138569665|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569666|NCT00095888|Gemcitabine|gemcitabine|mesh-list
138569667|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138569668|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
138569669|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569670|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569671|NCT00429676|Haloperidol|haloperidol|mesh-list
138569672|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
138569673|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
138569674|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
138569675|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569676|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569677|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138569678|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138569679|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138569680|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138569681|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138569682|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138569683|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
138569684|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569685|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654758|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
138569686|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138569687|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
138569688|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138569689|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
138569690|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569691|NCT00095927|Paclitaxel|paclitaxel|mesh-list
138569692|NCT00095927|Carboplatin|carboplatin|mesh-list
138569693|NCT00095927|Amifostine|amifostine|mesh-list
138569694|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138569695|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569696|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
138569697|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
138569698|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
138569699|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569700|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138569701|NCT00095927|Protective Agents|protective agents|mesh-ancestor
138569702|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569703|NCT00429754|Aprepitant|aprepitant|mesh-list
138569704|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
138569705|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
138569706|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569707|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569708|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138569709|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138569710|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569711|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569712|NCT00429832|Promethazine|promethazine|mesh-list
138569713|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
138569714|NCT00429832|Ondansetron|ondansetron|mesh-list
138569715|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
138569716|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
138569717|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569718|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569719|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138569720|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
138569721|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
138569722|NCT00429832|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138569723|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138569724|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
138569725|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320399|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
138569726|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569727|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138569728|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
138569729|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
138569730|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138569731|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138569732|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138569733|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138569734|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
138569735|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
138569736|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
138569737|NCT00429871|Docetaxel|docetaxel|mesh-list
138209973|NCT00357032|Belinostat|belinostat|mesh-list
138569739|NCT00429871|Epirubicin|epirubicin|mesh-list
138569740|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569741|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
138569742|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
138569743|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
138569744|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569745|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138569746|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
138474542|NCT03630666|Hormones|hormones|mesh-list
138569747|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138569748|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138320407|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569749|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138569750|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569752|NCT00095966|Sorafenib|sorafenib|mesh-list
138569753|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138320408|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138246071|NCT02058251|Oxytocin|oxytocin|mesh-list
138569754|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
138569755|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569756|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569757|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138569758|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569759|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
138569761|NCT01803594|Niacinamide|niacinamide|mesh-list
138569762|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
138569763|NCT01803594|Vitamins|vitamins|mesh-ancestor
138569764|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
138569765|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569766|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138569767|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
138569768|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569769|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138569770|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
138569771|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
138569772|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569773|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138569774|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569775|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569776|NCT00096005|Bortezomib|bortezomib|mesh-list
138569777|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569778|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
138569779|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138569780|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
138569781|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569782|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138569783|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138569784|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
138569785|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569786|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569787|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138569789|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138569790|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138569791|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569792|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569793|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569794|NCT00430261|Sunitinib|sunitinib|mesh-list
138569795|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569796|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138452359|NCT01876108|Amoxicillin|amoxicillin|mesh-list
138569797|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138569798|NCT00430261|Growth Substances|growth substances|mesh-ancestor
138569799|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569800|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
138569801|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138569802|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569803|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569804|NCT00096083|Melphalan|melphalan|mesh-list
138569805|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138569806|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
138569807|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569808|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569809|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138569810|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138569811|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
138654772|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
138569812|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569813|NCT01726452|Leucovorin|leucovorin|mesh-list
138569814|NCT01726452|Paclitaxel|paclitaxel|mesh-list
138569815|NCT01726452|Docetaxel|docetaxel|mesh-list
138569816|NCT01726452|Carboplatin|carboplatin|mesh-list
138569817|NCT01726452|Capecitabine|capecitabine|mesh-list
138569818|NCT01726452|Fluorouracil|fluorouracil|mesh-list
138569819|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
138569820|NCT01726452|Epirubicin|epirubicin|mesh-list
138569821|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138569822|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569823|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
138569824|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
138569825|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
138569826|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569827|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138569828|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
138246146|NCT02061683|Bimatoprost|bimatoprost|mesh-list
138569829|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138320503|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320504|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
138569830|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
138569831|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569832|NCT01726452|Antidotes|antidotes|mesh-ancestor
138569833|NCT01726452|Protective Agents|protective agents|mesh-ancestor
138569834|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
138569835|NCT01726452|Vitamins|vitamins|mesh-ancestor
138569836|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
138569837|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138569838|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138569839|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138569840|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569841|NCT00096317|Ketoconazole|ketoconazole|mesh-list
138569842|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
138569843|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569844|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138569845|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138569846|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569847|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569848|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138569849|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
138569850|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138569851|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569852|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138569854|NCT00096395|Sorafenib|sorafenib|mesh-list
138569855|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138569856|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
138569857|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569858|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569859|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138569860|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569861|NCT00096434|Sorafenib|sorafenib|mesh-list
138569862|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569863|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138569864|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569865|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569866|NCT00096473|Donepezil|donepezil|mesh-list
138569867|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138320529|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
138569868|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569869|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569870|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
138569871|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569872|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569873|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
138569874|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
138569875|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138569876|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569877|NCT00096512|Sorafenib|sorafenib|mesh-list
138569878|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569879|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138569880|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569881|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569882|NCT00096551|Metronidazole|metronidazole|mesh-list
138569883|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569884|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138569885|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138569886|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138569887|NCT00095186|Lactoferrin|lactoferrin|mesh-list
138569888|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569889|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
138569890|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138569891|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138569892|NCT00130572|Analgesics|analgesics|mesh-ancestor
138569893|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
138569894|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569895|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569896|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138569897|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138569898|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
138569899|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138569900|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
138569901|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138569902|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569903|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569904|NCT00096629|Vaccines|vaccines|mesh-list
138569906|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569907|NCT00430651|Carboplatin|carboplatin|mesh-list
138569908|NCT00430651|Docetaxel|docetaxel|mesh-list
138569909|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569910|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
138569911|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
138569912|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
138569913|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320570|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138320585|NCT03618654|Metformin|metformin|mesh-list
138569914|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
138569915|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
138569916|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138569917|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138569918|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569919|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569920|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569921|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138569922|NCT00096668|Paclitaxel|paclitaxel|mesh-list
138569923|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138569924|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138474593|NCT03414658|Avelumab|avelumab|mesh-list
138569925|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
138569926|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
138654805|NCT03006705|Tegafur|tegafur|mesh-list
138569927|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
138569928|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569929|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138569930|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138569931|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569932|NCT00430846|Immunotoxins|immunotoxins|mesh-ancestor
138569933|NCT00430846|Immunoconjugates|immunoconjugates|mesh-ancestor
138569934|NCT00430846|Immunologic Factors|immunologic factors|mesh-ancestor
138569935|NCT00430846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569936|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
138569937|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138569938|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
138569939|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138569940|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
138569941|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569942|NCT00430924|Eplerenone|eplerenone|mesh-list
138569943|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138569944|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
138569945|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138569946|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569947|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138320600|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569949|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
138320602|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138569950|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138569951|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
138569952|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
138569953|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569954|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
138569955|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138569956|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138569957|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138569958|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569959|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569960|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138569961|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138569962|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569963|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
138569964|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569965|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138569966|NCT05102409|Lifitegrast|lifitegrast|mesh-list
138569967|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138569968|NCT01053247|Tacrolimus|tacrolimus|mesh-list
138569969|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138569970|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
138569971|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569972|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138569973|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569974|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569975|NCT00096863|Haloperidol|haloperidol|mesh-list
138569976|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
138569977|NCT00096863|Ziprasidone|ziprasidone|mesh-list
138569978|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
138569979|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
138569980|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138569981|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138569982|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138569983|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138452580|NCT01877954|Xhance|xhance|mesh-list
138569984|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138569985|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138320640|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138569986|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138569987|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138569988|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
138569989|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138569990|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569991|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138569992|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138569993|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
138569994|NCT00130767|Finasteride|finasteride|mesh-list
138569995|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138569996|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138569997|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138569998|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138569999|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
138570000|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138570001|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570002|NCT00130767|Urological Agents|urological agents|mesh-ancestor
138570003|NCT00431080|Paclitaxel|paclitaxel|mesh-list
138570004|NCT00431080|Docetaxel|docetaxel|mesh-list
138570005|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
138570006|NCT00431080|Epirubicin|epirubicin|mesh-list
138570007|NCT00431080|Fluorouracil|fluorouracil|mesh-list
138570008|NCT00431080|Lenograstim|lenograstim|mesh-list
138570009|NCT00431080|Mitogens|mitogens|mesh-list
138570010|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138570011|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570012|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
138570013|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
138570014|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
138570015|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320682|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138570016|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570017|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
138452587|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138570018|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570019|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570020|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138570021|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
138570022|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138570023|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138570024|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138570025|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138570026|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570027|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
138570028|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138570029|NCT00431080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138570030|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
138570031|NCT00431119|Azathioprine|azathioprine|mesh-list
138570032|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138570034|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138570035|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
138570036|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138570037|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570038|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570039|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570040|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
138570041|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138570042|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570043|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
138570044|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570045|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570046|NCT00097019|Bevacizumab|bevacizumab|mesh-list
138570047|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138570048|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570049|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138570050|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138570051|NCT00097019|Growth Substances|growth substances|mesh-ancestor
138570052|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570053|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
138570054|NCT00431197|Ketoconazole|ketoconazole|mesh-list
138570055|NCT00431197|Testosterone|testosterone|mesh-list
138320729|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138320730|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570056|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
138320731|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138320732|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138570057|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570058|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138570059|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138570060|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570061|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570062|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138570063|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
138570064|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138570065|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570066|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138570067|NCT00431197|Androgens|androgens|mesh-ancestor
138570068|NCT00431197|Hormones|hormones|mesh-ancestor
138570069|NCT00431236|Dexamethasone|dexamethasone|mesh-list
138570070|NCT00431236|Ondansetron|ondansetron|mesh-list
138570071|NCT00431236|Casopitant|casopitant|mesh-list
138570072|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138570073|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
138570074|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
138570075|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570076|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570077|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138570078|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
138570079|NCT00431236|Hormones|hormones|mesh-ancestor
138570080|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138570081|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138570082|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570083|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
138570084|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
138570085|NCT00431236|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138570086|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138570087|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
138570088|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320763|NCT06125873|Metformin|metformin|mesh-list
138570089|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570090|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138570091|NCT00431275|Tremelimumab|tremelimumab|mesh-list
138654866|NCT02580994|Carboplatin|carboplatin|mesh-list
138570093|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570094|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138570095|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138570096|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570097|NCT00431353|Valganciclovir|valganciclovir|mesh-list
138570098|NCT00431353|Ganciclovir|ganciclovir|mesh-list
138570099|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138570100|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
138570101|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570102|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138570103|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570104|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570105|NCT00130845|Octreotide|octreotide|mesh-list
138570106|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138570107|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138570109|NCT00431392|Atropine|atropine|mesh-list
138570110|NCT00431392|Propranolol|propranolol|mesh-list
138570111|NCT00431392|Phenylephrine|phenylephrine|mesh-list
138570112|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
138570113|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138570114|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138570115|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
138570116|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
138570117|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570118|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570119|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
138452718|NCT01878734|Micronutrients|micronutrients|mesh-list
138570120|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138570121|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
138570122|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
138570123|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138570124|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138570125|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138570126|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
138570127|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138570128|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570129|NCT00431392|Protective Agents|protective agents|mesh-ancestor
138570130|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138570131|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138570132|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138570133|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138320820|NCT06125353|Melatonin|melatonin|mesh-list
138570134|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
138570135|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138570136|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138570137|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
138570138|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138570139|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138570140|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138570141|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
138570142|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570144|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138570145|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
138570146|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138570147|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138570148|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570149|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570150|NCT00130884|Protective Agents|protective agents|mesh-ancestor
138570151|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570152|NCT01052662|Memantine|memantine|mesh-list
138570153|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138570154|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138654877|NCT02546661|Durvalumab|durvalumab|mesh-list
138570155|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
138570156|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138570157|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570158|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570159|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138570160|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138570161|NCT00097214|Carboplatin|carboplatin|mesh-list
138570162|NCT00097214|Cetuximab|cetuximab|mesh-list
138570163|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452752|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138320835|NCT06125171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570164|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138570166|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138570167|NCT00431665|Somatostatin|somatostatin|mesh-list
138570168|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138570169|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570170|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
138570171|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138570172|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138570173|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570174|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138570175|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138570176|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138570177|NCT00431665|Hormones|hormones|mesh-ancestor
138570178|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138570179|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570180|NCT04703608|Ivermectin|ivermectin|mesh-list
138570181|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138570182|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570183|NCT04727073|Spironolactone|spironolactone|mesh-list
138570184|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138570185|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
138570186|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138570187|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570188|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138570189|NCT04727073|Diuretics|diuretics|mesh-ancestor
138570190|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
138570191|NCT00432016|Zidovudine|zidovudine|mesh-list
138570192|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
138570193|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570194|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138452782|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138570195|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138570197|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
138570198|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570199|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138570200|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138570201|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
138320880|NCT06124573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138320881|NCT06124573|Protease Inhibitors|protease inhibitors|mesh-ancestor
138570202|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138570203|NCT00131040|Aprotinin|aprotinin|mesh-list
138246527|NCT02355821|Bisoprolol|bisoprolol|mesh-list
138570204|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
138570205|NCT00131040|Coagulants|coagulants|mesh-ancestor
138570206|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138570207|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138570208|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
138570209|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570210|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570211|NCT00400478|Rituximab|rituximab|mesh-list
138570212|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138570213|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570214|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
138570215|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570216|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570217|NCT01052038|Dexamethasone|dexamethasone|mesh-list
138570218|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
138570219|NCT01052038|BB 1101|bb 1101|mesh-list
138654888|NCT02530489|Paclitaxel|paclitaxel|mesh-list
138570220|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138570222|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
138570223|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570224|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570226|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
138570227|NCT01052038|Hormones|hormones|mesh-ancestor
138570228|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138570229|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138570230|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320914|NCT06124495|Protease Inhibitors|protease inhibitors|mesh-ancestor
138320915|NCT06124495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570231|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
138289152|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
138570232|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570233|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570234|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
138570235|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138570236|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138570237|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138570238|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138570239|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570240|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
138570241|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138570242|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570243|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138570244|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570246|NCT04711044|Histamine|histamine|mesh-list
138570247|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
138570248|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
138570249|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
138570250|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
138570251|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138570252|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570253|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570254|NCT01051960|Ambrisentan|ambrisentan|mesh-list
138570255|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138570256|NCT00432367|Artesunate|artesunate|mesh-list
138570257|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
138570258|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
138570259|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138570260|NCT00432367|Amodiaquine|amodiaquine|mesh-list
138570261|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
138570262|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138320964|NCT06124157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138570263|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138570264|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570265|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570266|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
138570267|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
138410429|NCT01620476|Hormones|hormones|mesh-ancestor
138570268|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138570270|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138570271|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570272|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570273|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138570274|NCT00097760|Natalizumab|natalizumab|mesh-list
138570275|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
138570276|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570277|NCT00432406|Infliximab|infliximab|mesh-list
138570278|NCT00432406|Etanercept|etanercept|mesh-list
138570279|NCT00432406|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138570280|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138654902|NCT02223377|Morphine|morphine|mesh-list
138570282|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138570283|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570284|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138570285|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138321011|NCT06123962|Chelating Agents|chelating agents|mesh-ancestor
138570286|NCT00432406|Analgesics|analgesics|mesh-ancestor
138570287|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
138570288|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321012|NCT06123962|Sequestering Agents|sequestering agents|mesh-ancestor
138321014|NCT06123884|Paclitaxel|paclitaxel|mesh-list
138570289|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570290|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570291|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
138570292|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
138570293|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138570294|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570295|NCT02957656|Vaccines|vaccines|mesh-list
138474678|NCT02916771|Dexamethasone|dexamethasone|mesh-list
138570296|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
138452909|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570297|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570299|NCT00097799|Tipranavir|tipranavir|mesh-list
138570300|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138570301|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138570302|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
138570303|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570304|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570305|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138570306|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138570307|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
138570308|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570309|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138570310|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138570311|NCT01051921|Interferons|interferons|mesh-list
138570312|NCT01051921|Ribavirin|ribavirin|mesh-list
138570313|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570314|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
138570315|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570316|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
138570317|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570318|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138570319|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138570320|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138570321|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138570322|NCT00432757|Ketotifen|ketotifen|mesh-list
138570323|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
138570324|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
138570325|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138570326|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
138321062|NCT06122948|Midazolam|midazolam|mesh-list
138321063|NCT06122948|Ketamine|ketamine|mesh-list
138570327|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
138570328|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138570329|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570330|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570331|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138570332|NCT00432796|Dalteparin|dalteparin|mesh-list
138570333|NCT00432796|Tinzaparin|tinzaparin|mesh-list
138570334|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138570335|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
138570336|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138570337|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138570338|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570339|NCT00097877|Insulin|insulin|mesh-list
138570340|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138570341|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
138570342|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
138570343|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
138570344|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138570345|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570346|NCT00097916|Memantine|memantine|mesh-list
138570347|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138570348|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138570349|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
138570350|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138570351|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570352|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570353|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138570354|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138570355|NCT00433069|Pioglitazone|pioglitazone|mesh-list
138570356|NCT00433069|Interferons|interferons|mesh-list
138570358|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
138570359|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
138570360|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570361|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
138570362|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570363|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
138570364|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570365|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
138321098|NCT06119893|Antiemetics|antiemetics|mesh-ancestor
138321099|NCT06119893|Autonomic Agents|autonomic agents|mesh-ancestor
138321100|NCT06119893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570366|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570367|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138570368|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138570369|NCT01580371|CKD-581|ckd-581|mesh-list
138570370|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570371|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570372|NCT00403026|Bevacizumab|bevacizumab|mesh-list
138570373|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138570374|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570375|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138570376|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138570377|NCT00403026|Growth Substances|growth substances|mesh-ancestor
138570378|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570379|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
138570380|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
138570381|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570382|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138570383|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570384|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570385|NCT00098033|Clofarabine|clofarabine|mesh-list
138570386|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138570387|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
138570388|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570389|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570390|NCT00403065|Dexamethasone|dexamethasone|mesh-list
138570391|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138570392|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
138570393|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
138654943|NCT01653678|Vitamin D|vitamin d|mesh-list
138570394|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570395|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570396|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138570397|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
138321135|NCT06104280|Melatonin|melatonin|mesh-list
138321136|NCT06104280|Antioxidants|antioxidants|mesh-ancestor
138321141|NCT06086340|Letrozole|letrozole|mesh-list
138570399|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138570400|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138570401|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570402|NCT00098111|Azathioprine|azathioprine|mesh-list
138570403|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
138570404|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570405|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138570406|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570407|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570408|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
138474718|NCT02890082|Tamoxifen|tamoxifen|mesh-list
138570409|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570410|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570411|NCT04702906|Trimetazidine|trimetazidine|mesh-list
138570412|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
138570413|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
138570414|NCT00131313|Rituximab|rituximab|mesh-list
138570415|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570416|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
138570417|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570418|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570419|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138570420|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
138570421|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570422|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570423|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138570424|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138570425|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
138570426|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138570427|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570428|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138570429|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
138570430|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138453092|NCT01882322|Tacrolimus|tacrolimus|mesh-list
138570431|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570432|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570433|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570434|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
138570435|NCT00433225|Prednisolone|prednisolone|mesh-list
138570436|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138570437|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
138570438|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138570439|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
138570440|NCT00433225|Ketorolac|ketorolac|mesh-list
138570441|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138570442|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
138570443|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138570444|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
138570445|NCT00433225|Hormones|hormones|mesh-ancestor
138570446|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138570447|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570448|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138570449|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570450|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
138570451|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
138570452|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570453|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138570454|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138570455|NCT00433225|Protective Agents|protective agents|mesh-ancestor
138654951|NCT01632007|Alogliptin|alogliptin|mesh-list
138570456|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138570457|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138570459|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
138570460|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570461|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138570462|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570463|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570464|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138570465|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570466|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138570467|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138570468|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138570469|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138570470|NCT00433342|Floxacillin|floxacillin|mesh-list
138570471|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138570472|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570473|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
138570474|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138570475|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138570476|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138570477|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570478|NCT00131391|Hormones|hormones|mesh-ancestor
138570479|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321207|NCT06001112|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138321208|NCT06001112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138570480|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570481|NCT00433459|Prednisone|prednisone|mesh-list
138570482|NCT00433459|Prednisolone|prednisolone|mesh-list
138570483|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
138570484|NCT00433459|Dacarbazine|dacarbazine|mesh-list
138570485|NCT00433459|Vincristine|vincristine|mesh-list
138570486|NCT00433459|Procarbazine|procarbazine|mesh-list
138570487|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138570488|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570489|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
138570490|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570491|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570492|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138570493|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
138570494|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570495|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570496|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138570497|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138570498|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
138570499|NCT00433459|Hormones|hormones|mesh-ancestor
138570500|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138570501|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138570502|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138570503|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
138570504|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
138570505|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
138570506|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138321239|NCT05917522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138570507|NCT00433498|Carboplatin|carboplatin|mesh-list
138570508|NCT00433498|Etoposide|etoposide|mesh-list
138570509|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
138570510|NCT00433498|Pravastatin|pravastatin|mesh-list
138570511|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570512|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138570513|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138570514|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138654966|NCT01402271|Paclitaxel|paclitaxel|mesh-list
138570515|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570516|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570517|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138570518|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138570519|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
138570520|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138570521|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138570522|NCT00433576|Resveratrol|resveratrol|mesh-list
138570523|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
138570524|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570525|NCT00433576|Protective Agents|protective agents|mesh-ancestor
138570526|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570527|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570528|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138570529|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
138570530|NCT00433615|Hematinics|hematinics|mesh-ancestor
138570531|NCT00098384|Rifaximin|rifaximin|mesh-list
138321288|NCT05745350|Etoposide|etoposide|mesh-list
138570532|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138570533|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570534|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138570535|NCT00433732|Naproxen|naproxen|mesh-list
138570536|NCT00433732|Sumatriptan|sumatriptan|mesh-list
138321298|NCT05734508|Antiviral Agents|antiviral agents|mesh-ancestor
138570537|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138570538|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138570539|NCT00433732|Analgesics|analgesics|mesh-ancestor
138570540|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
138570541|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570542|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570543|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138570544|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570545|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
138570546|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138570547|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570548|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570549|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138570550|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138570551|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138570552|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
138570553|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138570555|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138570556|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
138570557|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570558|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570559|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
138570560|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570561|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570562|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
138570563|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570564|NCT01050790|Lenalidomide|lenalidomide|mesh-list
138570565|NCT01050790|Azacitidine|azacitidine|mesh-list
138570566|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
138570567|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570568|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138570569|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138570570|NCT01050790|Growth Substances|growth substances|mesh-ancestor
138570571|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
138570572|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570573|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138321332|NCT05566054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570574|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
138321333|NCT05552001|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138321334|NCT05552001|Immunoconjugates|immunoconjugates|mesh-ancestor
138570575|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570576|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570577|NCT00433927|Leucovorin|leucovorin|mesh-list
138570578|NCT00433927|Folic Acid|folic acid|mesh-list
138570579|NCT00433927|Bevacizumab|bevacizumab|mesh-list
138570580|NCT00433927|Cetuximab|cetuximab|mesh-list
138570581|NCT00433927|Irinotecan|irinotecan|mesh-list
138570582|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
138570583|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138570584|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570585|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138570586|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138570587|NCT00433927|Growth Substances|growth substances|mesh-ancestor
138570588|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570589|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
138570590|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138453302|NCT01884298|Narcotics|narcotics|mesh-ancestor
138570591|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138570592|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570593|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570594|NCT00433927|Antidotes|antidotes|mesh-ancestor
138570595|NCT00433927|Protective Agents|protective agents|mesh-ancestor
138570596|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
138570597|NCT00433927|Vitamins|vitamins|mesh-ancestor
138570598|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
138570599|NCT00433927|Hematinics|hematinics|mesh-ancestor
138570600|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
138570601|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138570602|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138570603|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138570604|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570606|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321372|NCT05432778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570607|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570608|NCT00098462|Sirolimus|sirolimus|mesh-list
138570609|NCT00098462|Gefitinib|gefitinib|mesh-list
138570610|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138570611|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570612|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138570613|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570614|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
138570615|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570616|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
138570617|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570618|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138570619|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570620|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570621|NCT00098501|Sirolimus|sirolimus|mesh-list
138570622|NCT00098501|Temsirolimus|temsirolimus|mesh-list
138570623|NCT00098501|MTOR Inhibitors|mtor inhibitors|mesh-list
138570624|NCT00098501|EKB 569|ekb 569|mesh-list
138570625|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138570626|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570627|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570628|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570629|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
138570630|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570631|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570632|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138453356|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
138570633|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570634|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138570635|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
138570636|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
138570637|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138570638|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
138321413|NCT05344209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321414|NCT05335148|Colchicine|colchicine|mesh-list
138570639|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570640|NCT00434005|Expectorants|expectorants|mesh-ancestor
138321415|NCT05335148|Gout Suppressants|gout suppressants|mesh-ancestor
138321416|NCT05335148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138321417|NCT05335148|Tubulin Modulators|tubulin modulators|mesh-ancestor
138321418|NCT05335148|Antimitotic Agents|antimitotic agents|mesh-ancestor
138570641|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
138570642|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138570643|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
138570644|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570645|NCT00434005|Protective Agents|protective agents|mesh-ancestor
138570646|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570647|NCT00434005|Antidotes|antidotes|mesh-ancestor
138570648|NCT00434044|Etanercept|etanercept|mesh-list
138570649|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138570650|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138570651|NCT00434044|Analgesics|analgesics|mesh-ancestor
138570652|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
138570653|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570654|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570655|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138570656|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570657|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138570658|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570659|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
138570660|NCT00434083|Naproxen|naproxen|mesh-list
138570661|NCT00434083|Sumatriptan|sumatriptan|mesh-list
138570662|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138570663|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138570664|NCT00434083|Analgesics|analgesics|mesh-ancestor
138570665|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
138453371|NCT01884623|Methotrexate|methotrexate|mesh-list
138570666|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570667|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570668|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138570669|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570670|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
138570671|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138570672|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570673|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570674|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138570675|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138570676|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138570677|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
138570678|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138570679|NCT00098540|Sorafenib|sorafenib|mesh-list
138570680|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570681|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138570682|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570683|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570684|NCT00098579|Doxorubicin|doxorubicin|mesh-list
138570685|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138570686|NCT00098579|Alvocidib|alvocidib|mesh-list
138570687|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138570688|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570689|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138570690|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138570691|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570692|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570693|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
138570694|NCT00098579|Growth Substances|growth substances|mesh-ancestor
138570695|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321454|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570696|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138570697|NCT00098618|Interferons|interferons|mesh-list
138570698|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
138570699|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
138570700|NCT00098618|Sorafenib|sorafenib|mesh-list
138570701|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570702|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
138570703|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138213577|NCT00526058|Clotrimazole|clotrimazole|mesh-list
138570704|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138570705|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570706|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570707|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
138570708|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570709|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138570710|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138570711|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570712|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570713|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
138570714|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570715|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
138570716|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138570717|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570718|NCT01059448|Brodalumab|brodalumab|mesh-list
138570719|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
138570720|NCT00098891|Entinostat|entinostat|mesh-list
138570721|NCT00098891|Isotretinoin|isotretinoin|mesh-list
138570722|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138570723|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
138570724|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570725|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321475|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
138321476|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321477|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138321483|NCT05161754|Coagulants|coagulants|mesh-ancestor
138570726|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570727|NCT00098969|Resveratrol|resveratrol|mesh-list
138570728|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
138570729|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570730|NCT00098969|Protective Agents|protective agents|mesh-ancestor
138570731|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570732|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570733|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138570735|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138570736|NCT00099008|Protective Agents|protective agents|mesh-ancestor
138570737|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570738|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570739|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138570740|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570741|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570742|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
138570743|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138570744|NCT00099008|Estrogens|estrogens|mesh-ancestor
138570745|NCT00099008|Hormones|hormones|mesh-ancestor
138570746|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138570747|NCT00434239|Lenalidomide|lenalidomide|mesh-list
138570749|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570750|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138570751|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138655025|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
138570752|NCT00434239|Growth Substances|growth substances|mesh-ancestor
138570753|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
138570754|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570755|NCT01057147|Rebamipide|rebamipide|mesh-list
138570756|NCT01057147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138321520|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321521|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321522|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138321523|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
138570757|NCT01057147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138570758|NCT01057147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138570759|NCT01057147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138570760|NCT01057147|Antioxidants|antioxidants|mesh-ancestor
138570761|NCT01057147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570762|NCT01057147|Protective Agents|protective agents|mesh-ancestor
138570763|NCT01057147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570764|NCT01057147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570765|NCT00099125|Irinotecan|irinotecan|mesh-list
138570766|NCT00099125|Temozolomide|temozolomide|mesh-list
138570767|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138570768|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138570769|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570770|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570771|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570772|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138570773|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
138570774|NCT00131703|Chloroquine|chloroquine|mesh-list
138570775|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
138570776|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
138570777|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138570778|NCT00131703|Amodiaquine|amodiaquine|mesh-list
138570779|NCT00131703|Amebicides|amebicides|mesh-ancestor
138570780|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138570781|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138570782|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570783|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
138570784|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570785|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138570786|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570787|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570788|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138570790|NCT01051414|Protease Inhibitors|protease inhibitors|mesh-ancestor
138570791|NCT01051414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570792|NCT01051414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570793|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
138570794|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138570795|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570796|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138570797|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138570798|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138570799|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
138570800|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138570801|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570802|NCT00099164|Progestins|progestins|mesh-ancestor
138570803|NCT00099164|Hormones|hormones|mesh-ancestor
138570804|NCT00131742|Lamivudine|lamivudine|mesh-list
138570805|NCT00131742|Telbivudine|telbivudine|mesh-list
138570806|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138570807|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138570808|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570809|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570810|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
138570811|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570812|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138570813|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138570814|NCT04621149|Lactoferrin|lactoferrin|mesh-list
138570815|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
138570816|NCT04621149|Famotidine|famotidine|mesh-list
138570817|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138570818|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138570819|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138570820|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
138570821|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
138570822|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318030|NCT01442376|Palonosetron|palonosetron|mesh-list
138570823|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570824|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570825|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570826|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
138321609|NCT04597190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138321611|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138570828|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
138570829|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
138570830|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138570831|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570832|NCT00099242|Rivastigmine|rivastigmine|mesh-list
138570833|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138570834|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570835|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570836|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
138570837|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138570838|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570839|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138570840|NCT00099242|Protective Agents|protective agents|mesh-ancestor
138570841|NCT00099320|Exenatide|exenatide|mesh-list
138570842|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138570843|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570844|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138570845|NCT00099320|Incretins|incretins|mesh-ancestor
138570846|NCT00099320|Hormones|hormones|mesh-ancestor
138570847|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138570848|NCT00403650|Iloprost|iloprost|mesh-list
138570849|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138570850|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
138570851|NCT00403728|Cyclosporine|cyclosporine|mesh-list
138570852|NCT00403728|Cyclosporins|cyclosporins|mesh-list
138570853|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321649|NCT04535271|Dacarbazine|dacarbazine|mesh-list
138570854|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321650|NCT04535271|Trabectedin|trabectedin|mesh-list
138570855|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570856|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
138570857|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570858|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
138570859|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570860|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
138570861|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138474790|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
138570862|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138570863|NCT00403806|Dexamethasone|dexamethasone|mesh-list
138570864|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
138570865|NCT00403806|BB 1101|bb 1101|mesh-list
138570866|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138570867|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
138570868|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
138570869|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570870|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655053|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
138570871|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138570872|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
138570874|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138453554|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138570875|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138570877|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
138570878|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247194|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
138570879|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570880|NCT00400556|Lenograstim|lenograstim|mesh-list
138570881|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138570882|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
138321701|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
138570883|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570884|NCT00400595|Mupirocin|mupirocin|mesh-list
138570885|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138570886|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570887|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138570888|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570889|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570890|NCT00099554|Etanercept|etanercept|mesh-list
138570891|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138570892|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138570893|NCT00099554|Analgesics|analgesics|mesh-ancestor
138570894|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
138570895|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570896|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570897|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138570898|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570899|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138570900|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570901|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
138570902|NCT00132054|Irinotecan|irinotecan|mesh-list
138570903|NCT00132054|Amrubicin|amrubicin|mesh-list
138570904|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138570905|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138570906|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570907|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570908|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570909|NCT00099710|Curcumin|curcumin|mesh-list
138570910|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138570911|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138570912|NCT00099710|Analgesics|analgesics|mesh-ancestor
138570913|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
138570914|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570915|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570916|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138570917|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138570918|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570919|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321744|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
138321745|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321746|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570920|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570921|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138570922|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138570923|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570924|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570925|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
138570926|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570927|NCT00132093|Eplerenone|eplerenone|mesh-list
138570928|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138570929|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
138570930|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138655071|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138570931|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570932|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138570934|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
138570935|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138570936|NCT00099788|Ranolazine|ranolazine|mesh-list
138570937|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138570938|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138570939|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570940|NCT00099866|Metformin|metformin|mesh-list
138570941|NCT00099866|Vildagliptin|vildagliptin|mesh-list
138570942|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138570943|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570944|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138570945|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
138570946|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570947|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570948|NCT00099905|Vildagliptin|vildagliptin|mesh-list
138570949|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138570950|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321780|NCT04068597|Dexamethasone|dexamethasone|mesh-list
138570951|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138570952|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
138570953|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570954|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570955|NCT00132210|Interferons|interferons|mesh-list
138570956|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570957|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
138570958|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570959|NCT00099944|Glimepiride|glimepiride|mesh-list
138570960|NCT00099944|Vildagliptin|vildagliptin|mesh-list
138570961|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138570962|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138570963|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570964|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138570965|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
138570966|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138570967|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
138570968|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138570969|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570970|NCT04333914|Avdoralimab|avdoralimab|mesh-list
138570971|NCT04333914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138570972|NCT04333914|Antiviral Agents|antiviral agents|mesh-ancestor
138321826|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321827|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
138570973|NCT04333914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138570974|NCT00100100|Modafinil|modafinil|mesh-list
138570975|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138570976|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570977|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138570978|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138570979|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138570980|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570981|NCT00100139|Paclitaxel|paclitaxel|mesh-list
138570982|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138570983|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138570984|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138570985|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
138570986|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
138570987|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
138570988|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138570989|NCT00100412|Phenylephrine|phenylephrine|mesh-list
138570990|NCT00100412|Dobutamine|dobutamine|mesh-list
138570991|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
138570992|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138570993|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
138570994|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
138570995|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138570996|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138570997|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
138570998|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138570999|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
138571000|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
138571001|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138571002|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138571003|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138571004|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
138571005|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571006|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571007|NCT00100412|Protective Agents|protective agents|mesh-ancestor
138571008|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138571009|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138571011|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138571012|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138571013|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
138571014|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571015|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
138571016|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138321885|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
138321886|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
138321887|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321888|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138571017|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571018|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571019|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138571020|NCT04244058|Analgesics|analgesics|mesh-ancestor
138571021|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
138571022|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571024|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138571025|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
138571026|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571027|NCT00100568|Lamivudine|lamivudine|mesh-list
138321916|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571028|NCT00100568|Zidovudine|zidovudine|mesh-list
138571029|NCT00100568|Efavirenz|efavirenz|mesh-list
138321918|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138571030|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138321919|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571031|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138571032|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138571033|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571034|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571035|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
138571036|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571037|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138571038|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138638106|NCT00252785|Budesonide|budesonide|mesh-list
138571039|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
138571040|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138571041|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138571042|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138571043|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138571044|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138571045|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138571046|NCT00132561|Artesunate|artesunate|mesh-list
138571047|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
138571048|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
138571049|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
138571050|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138571051|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138571052|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571053|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571054|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
138321979|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
138571055|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
138571056|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138571057|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
138571058|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138571059|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571060|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571061|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138571062|NCT04728659|Desogestrel|desogestrel|mesh-list
138571063|NCT04728659|Ganirelix|ganirelix|mesh-list
138571064|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138571065|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138571066|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138571067|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
138571068|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138571069|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571070|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138571071|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138571072|NCT04728659|Progestins|progestins|mesh-ancestor
138571073|NCT04728659|Hormones|hormones|mesh-ancestor
138571074|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138571075|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
138571076|NCT00132600|Bacitracin|bacitracin|mesh-list
138571077|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138571078|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571079|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138571080|NCT00132639|Docetaxel|docetaxel|mesh-list
138571081|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638150|NCT00252824|Budesonide|budesonide|mesh-list
138571082|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
138571083|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
138571084|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322030|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322031|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138322032|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138571085|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571086|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138571087|NCT04728386|Eusol|eusol|mesh-list
138571088|NCT04728386|Curcumin|curcumin|mesh-list
138571089|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138571090|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138571091|NCT04728386|Analgesics|analgesics|mesh-ancestor
138571092|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
138571093|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571094|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474848|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
138571095|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138571096|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138571097|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571098|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571099|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571100|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
138571101|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571103|NCT00100646|Lopinavir|lopinavir|mesh-list
138571104|NCT00100646|Lamivudine|lamivudine|mesh-list
138571105|NCT00100646|Stavudine|stavudine|mesh-list
138571106|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138571107|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138571108|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
138571109|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138655111|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138571110|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571112|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138571113|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
138571114|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571115|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138571116|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138571117|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138571118|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138571121|NCT00100685|Antibodies|antibodies|mesh-list
138571122|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138571123|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
138571124|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571125|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138571126|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138571127|NCT00100685|Growth Substances|growth substances|mesh-ancestor
138571128|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
138571129|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571130|NCT00132756|Estramustine|estramustine|mesh-list
138571131|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138322072|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138571132|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
138322073|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571133|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571134|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571135|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138571136|NCT00100880|Lenalidomide|lenalidomide|mesh-list
138571137|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
138571138|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571139|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138571140|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138571141|NCT00100880|Growth Substances|growth substances|mesh-ancestor
138571142|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
138571143|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571144|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
138571145|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138571146|NCT00100958|Protective Agents|protective agents|mesh-ancestor
138571147|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571148|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571149|NCT00101075|Capecitabine|capecitabine|mesh-list
138571150|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
138571151|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138571152|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
138571153|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571154|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571155|NCT00132912|Vorapaxar|vorapaxar|mesh-list
138571156|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138322102|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322103|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
138322104|NCT03136445|Coagulants|coagulants|mesh-ancestor
138322105|NCT03083665|Brivaracetam|brivaracetam|mesh-list
138571157|NCT00403182|Letrozole|letrozole|mesh-list
138571158|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571159|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138571160|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138571161|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571162|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571163|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138571164|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
138571165|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138571166|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571167|NCT00101114|Interferons|interferons|mesh-list
138571168|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
138571169|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
138571170|NCT00101114|Sorafenib|sorafenib|mesh-list
138571171|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571172|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
138571173|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571174|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138571175|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571176|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571177|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
138571178|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571181|NCT00101153|Tipifarnib|tipifarnib|mesh-list
138571182|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138571183|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
138571184|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571185|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571186|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
138571187|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571188|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138571189|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
138571190|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571191|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138571192|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138571193|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138571194|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571195|NCT00132951|Azithromycin|azithromycin|mesh-list
138571196|NCT00132951|Telithromycin|telithromycin|mesh-list
138571197|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138571198|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571199|NCT00400790|Propofol|propofol|mesh-list
138571200|NCT00400790|Desflurane|desflurane|mesh-list
138571201|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138571202|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138571203|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571204|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138322151|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138571205|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
138571206|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
138571207|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138571208|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138571209|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571210|NCT00135408|Budesonide|budesonide|mesh-list
138571211|NCT00135408|Ipilimumab|ipilimumab|mesh-list
138571212|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138571213|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571214|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138571215|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571216|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138571217|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138571218|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
138571219|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571220|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571221|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138571222|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
138571223|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
138571224|NCT00135408|Hormones|hormones|mesh-ancestor
138571225|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138571226|NCT00101231|Alvocidib|alvocidib|mesh-list
138571227|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571228|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
138571229|NCT00101231|Growth Substances|growth substances|mesh-ancestor
138571230|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571231|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138571232|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571233|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571234|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
138571235|NCT00101270|Irinotecan|irinotecan|mesh-list
138571236|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322181|NCT02505750|Capecitabine|capecitabine|mesh-list
138571237|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138571238|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138571239|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571240|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571242|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571243|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138571244|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138571245|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
138571246|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571247|NCT00101348|Bevacizumab|bevacizumab|mesh-list
138571248|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138571249|NCT00101348|Cetuximab|cetuximab|mesh-list
138322224|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
138322225|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322226|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138571250|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138571251|NCT00101348|Antibodies|antibodies|mesh-list
138571252|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
138571253|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138571254|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571255|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138571256|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138571257|NCT00101348|Growth Substances|growth substances|mesh-ancestor
138571258|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571259|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
138571260|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
138571261|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138571262|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571263|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571264|NCT00101426|Ranirestat|ranirestat|mesh-list
138571265|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571266|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571267|NCT00133185|Losartan|losartan|mesh-list
138571268|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138571270|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138571271|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138638263|NCT02279914|Misoprostol|misoprostol|mesh-list
138571272|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138571273|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138571274|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571276|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
138571277|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571278|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138571279|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138571280|NCT00135603|Amoxicillin|amoxicillin|mesh-list
138571281|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
138571282|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
138571283|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138571284|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138571285|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571286|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138571287|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571288|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571289|NCT00133224|Prednisone|prednisone|mesh-list
138571290|NCT00133224|Docetaxel|docetaxel|mesh-list
138571291|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571292|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
138571293|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
138571294|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322346|NCT03575052|Pimavanserin|pimavanserin|mesh-list
138655152|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571295|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571296|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138571297|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
138322347|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138571298|NCT00133224|Hormones|hormones|mesh-ancestor
138571299|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138571300|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571301|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138571302|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
138571303|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138571304|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571305|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138571306|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
138571307|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138571308|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571310|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571311|NCT00135681|Nedocromil|nedocromil|mesh-list
138571312|NCT00135681|Budesonide|budesonide|mesh-list
138571313|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138571314|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138571315|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
138571316|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571317|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571318|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138571319|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
138571320|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
138571321|NCT00135681|Hormones|hormones|mesh-ancestor
138571322|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138571323|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
138571324|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
138571325|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138571326|NCT00135720|Etanercept|etanercept|mesh-list
138571327|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138571328|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138571329|NCT00135720|Analgesics|analgesics|mesh-ancestor
138571330|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
138571331|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571332|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571333|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138571334|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138322394|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138322396|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
138571335|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138571336|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138571337|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
138571339|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
138571340|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138571341|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571342|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138571344|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571345|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
138571346|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571347|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571349|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138571350|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138571351|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571352|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
138571353|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571354|NCT00133341|Parthenolide|parthenolide|mesh-list
138571355|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138571356|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138571357|NCT00133341|Analgesics|analgesics|mesh-ancestor
138571358|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
138571359|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571360|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571361|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138571362|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138571363|NCT00135837|Verteporfin|verteporfin|mesh-list
138571364|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138571365|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
138571366|NCT00133380|Atorvastatin|atorvastatin|mesh-list
138571367|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138571368|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138571369|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
138322433|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322436|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
138571370|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571371|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138571372|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138571373|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571374|NCT00102167|Gaboxadol|gaboxadol|mesh-list
138571375|NCT00102167|Analgesics|analgesics|mesh-ancestor
138571376|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
138571377|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571378|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571379|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
138571380|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
138571381|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
138571382|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571383|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571384|NCT00135876|Dalteparin|dalteparin|mesh-list
138571385|NCT00135876|Tinzaparin|tinzaparin|mesh-list
138571386|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138571387|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
138571388|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138571389|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138571390|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571391|NCT00102206|Ritonavir|ritonavir|mesh-list
138571392|NCT00102206|Lopinavir|lopinavir|mesh-list
138571393|NCT00102206|Saquinavir|saquinavir|mesh-list
138571394|NCT00102206|Tenofovir|tenofovir|mesh-list
138571395|NCT00102206|Lamivudine|lamivudine|mesh-list
138571396|NCT00102206|Emtricitabine|emtricitabine|mesh-list
138571397|NCT00102206|Zidovudine|zidovudine|mesh-list
138571398|NCT00102206|Abacavir|abacavir|mesh-list
138571399|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138571400|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138571401|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
138571402|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571403|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571404|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138571405|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138571406|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
138571407|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188358|NCT03095638|Dolutegravir|dolutegravir|mesh-list
138571408|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138571409|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138571410|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138571411|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138571412|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
138571413|NCT00102284|Levodopa|levodopa|mesh-list
138571414|NCT00102284|Modafinil|modafinil|mesh-list
138571415|NCT00102284|Rivastigmine|rivastigmine|mesh-list
138571416|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138571417|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138571418|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
138571419|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571420|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322481|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
138571421|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571422|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138571423|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138571424|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138655181|NCT00349557|Growth Substances|growth substances|mesh-ancestor
138571425|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138571426|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138571428|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
138571429|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138571430|NCT00102284|Protective Agents|protective agents|mesh-ancestor
138571432|NCT00135525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138571433|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138571434|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138571435|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571436|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571437|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
138571438|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571439|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138571440|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
138571441|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138571442|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138571443|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138571444|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571445|NCT00403962|Paroxetine|paroxetine|mesh-list
138571446|NCT00403962|Vestipitant|vestipitant|mesh-list
138571447|NCT00403962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138571448|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138571449|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138571450|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571451|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571452|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
138322506|NCT00089544|Lenograstim|lenograstim|mesh-list
138322527|NCT00089076|Ipilimumab|ipilimumab|mesh-list
138571453|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571454|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138474921|NCT02006589|Candesartan|candesartan|mesh-list
138571455|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
138571456|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138571457|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138571458|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138571459|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571460|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138571461|NCT00102479|Aripiprazole|aripiprazole|mesh-list
138571462|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
138571463|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138571464|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138571465|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138571466|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138571467|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571468|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
138571469|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
138571470|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571471|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571472|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138571473|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138571475|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138571476|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138571477|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138571478|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138571479|NCT00135954|Prednisolone|prednisolone|mesh-list
138571480|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
138571481|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138571482|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
138571483|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571484|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138571485|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138571486|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
138571487|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571488|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322548|NCT03770286|Protective Agents|protective agents|mesh-ancestor
138571489|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138571490|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138571493|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138571494|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138571495|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
138571496|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
138571497|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138571498|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138571499|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571500|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138474969|NCT02007148|Docetaxel|docetaxel|mesh-list
138571501|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571502|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138571503|NCT00102635|Fenretinide|fenretinide|mesh-list
138571504|NCT00102635|Lonafarnib|lonafarnib|mesh-list
138571505|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571506|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138571507|NCT00102635|Protective Agents|protective agents|mesh-ancestor
138571508|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571509|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571510|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571511|NCT00133419|Vitamins|vitamins|mesh-list
138571512|NCT00133419|Vitamin A|vitamin a|mesh-list
138571514|NCT00133419|Trace Elements|trace elements|mesh-list
138571515|NCT00133419|Micronutrients|micronutrients|mesh-list
138571516|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
138571517|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571518|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
138571519|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571520|NCT00133419|Protective Agents|protective agents|mesh-ancestor
138571521|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138571522|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571523|NCT00102674|Cangrelor|cangrelor|mesh-list
138571524|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138571525|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138571526|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138571527|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138571528|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
138571529|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571530|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571531|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571532|NCT00135993|Rotigotine|rotigotine|mesh-list
138571533|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
138571534|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
138571535|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571536|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571537|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571538|NCT00102713|Valproic Acid|valproic acid|mesh-list
138571539|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
138571540|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571541|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571542|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
138571543|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571544|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571545|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
138571546|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138655205|NCT00316745|Irinotecan|irinotecan|mesh-list
138571547|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138571548|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138571549|NCT00133458|Albendazole|albendazole|mesh-list
138571550|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
138571551|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138571552|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571553|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
138571554|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138571555|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138571556|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
138571557|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
138571558|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
138571559|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571560|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571561|NCT00102752|Gemcitabine|gemcitabine|mesh-list
138571562|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138571563|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
138571564|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571565|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571566|NCT00102830|Trebananib|trebananib|mesh-list
138571567|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138571568|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138322626|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138322627|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571569|NCT00102830|Growth Substances|growth substances|mesh-ancestor
138571570|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571571|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
138571572|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571573|NCT00136110|Valproic Acid|valproic acid|mesh-list
138571574|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
138571575|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571576|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571577|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
138571578|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571579|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571580|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
138571581|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138571582|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138571583|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138571584|NCT00136188|Folic Acid|folic acid|mesh-list
138571585|NCT00136188|Hematinics|hematinics|mesh-ancestor
138571586|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
138571587|NCT00136188|Vitamins|vitamins|mesh-ancestor
138571588|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
138571589|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571590|NCT00102869|Levodopa|levodopa|mesh-list
138571591|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138571592|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138571593|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
138571594|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571595|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571596|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571597|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
138571598|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138571599|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571600|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
138571601|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571602|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138571603|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322659|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138322660|NCT00083226|Bortezomib|bortezomib|mesh-list
138322661|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138322662|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322684|NCT01678092|Omalizumab|omalizumab|mesh-list
138571604|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571605|NCT00136266|Vitamin D|vitamin d|mesh-list
138571606|NCT00136266|Vitamins|vitamins|mesh-list
138571607|NCT00136266|Vitamin A|vitamin a|mesh-list
138571608|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
138571609|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
138571610|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571611|NCT00136266|Trace Elements|trace elements|mesh-ancestor
138571612|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138571613|NCT00102947|Daptomycin|daptomycin|mesh-list
138571614|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138571615|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138474998|NCT02007330|Lidocaine|lidocaine|mesh-list
138571617|NCT00136344|Cefuroxime|cefuroxime|mesh-list
138571618|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
138571619|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138571620|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571621|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138571622|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138571623|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138571624|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571625|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638492|NCT02272348|Insulin|insulin|mesh-list
138571626|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571627|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138571628|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138571629|NCT00102986|Ritonavir|ritonavir|mesh-list
138571630|NCT00102986|Lopinavir|lopinavir|mesh-list
138571631|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138571632|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138571633|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
138571634|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571635|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571636|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138571637|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138571638|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
138571639|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322697|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
138322698|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
138322700|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
138571640|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138571641|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138571642|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138571644|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138571645|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138571646|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138571647|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571648|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571649|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571650|NCT00136383|Analgesics|analgesics|mesh-ancestor
138571651|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
138571652|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571653|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
138571654|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138571655|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
138571656|NCT00136383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138571657|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
138571658|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138571659|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138571660|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138571661|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571663|NCT00103103|Fluorouracil|fluorouracil|mesh-list
138571664|NCT00103103|Bortezomib|bortezomib|mesh-list
138571665|NCT00103103|Calcium|calcium|mesh-list
138571666|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
138571667|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138655235|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
138571668|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571669|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
138322735|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322736|NCT00081510|Anastrozole|anastrozole|mesh-list
138322737|NCT00081510|Lonafarnib|lonafarnib|mesh-list
138322738|NCT00081510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138571670|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571671|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138571672|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571673|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138571674|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
138571675|NCT00103103|Antidotes|antidotes|mesh-ancestor
138571676|NCT00103103|Protective Agents|protective agents|mesh-ancestor
138571677|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
138571678|NCT00103103|Vitamins|vitamins|mesh-ancestor
138571679|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
138571680|NCT00133692|Atenolol|atenolol|mesh-list
138571681|NCT00133692|Verapamil|verapamil|mesh-list
138571682|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138571683|NCT00133692|Trandolapril|trandolapril|mesh-list
138571684|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138571685|NCT00133692|Diuretics|diuretics|mesh-ancestor
138571686|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
138638577|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
138571687|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571688|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138571689|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138571690|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571691|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138571692|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
138571693|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
138571694|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571695|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138571696|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138571697|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138571698|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
138571699|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138322777|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
138322778|NCT04403100|Ritonavir|ritonavir|mesh-list
138322779|NCT04403100|Lopinavir|lopinavir|mesh-list
138571700|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138571701|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138571702|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
138571703|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138248032|NCT03383523|Emodepside|emodepside|mesh-list
138571705|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571706|NCT00133731|Heparin|heparin|mesh-list
138571707|NCT00133731|Calcium heparin|calcium heparin|mesh-list
138571708|NCT00133731|Otamixaban|otamixaban|mesh-list
138571709|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
138571710|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138571711|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138571712|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322823|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571713|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138571714|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
138571715|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138475030|NCT02007603|Sulbactam|sulbactam|mesh-list
138475031|NCT02007603|Sultamicillin|sultamicillin|mesh-list
138571717|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571718|NCT00103298|Leucovorin|leucovorin|mesh-list
138571719|NCT00103298|Fluorouracil|fluorouracil|mesh-list
138571720|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
138571721|NCT00103298|Melphalan|melphalan|mesh-list
138571722|NCT00103298|Calcium|calcium|mesh-list
138571723|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
138571724|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138571725|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571726|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
138571727|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571728|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138571729|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571730|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138571731|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
138322848|NCT03089658|Avelumab|avelumab|mesh-list
138571732|NCT00103298|Antidotes|antidotes|mesh-ancestor
138571733|NCT00103298|Protective Agents|protective agents|mesh-ancestor
138571734|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
138571735|NCT00103298|Vitamins|vitamins|mesh-ancestor
138571736|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
138571737|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138571739|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138571741|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
138571742|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571743|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
138571744|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
138571745|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138571746|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
138571747|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571748|NCT00133770|Pantoprazole|pantoprazole|mesh-list
138571749|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138571750|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138571751|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138571752|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571753|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704014|NCT06220422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704015|NCT06219226|Chlorhexidine|chlorhexidine|mesh-list
138704016|NCT06219226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138704017|NCT06219226|Chlorine dioxide|chlorine dioxide|mesh-list
138704018|NCT06219226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138704019|NCT06219226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138704020|NCT06219226|Disinfectants|disinfectants|mesh-ancestor
138704021|NCT06219226|Dermatologic Agents|dermatologic agents|mesh-ancestor
138704022|NCT06219226|Dental Disinfectants|dental disinfectants|mesh-ancestor
138704023|NCT06208592|Sevoflurane|sevoflurane|mesh-list
138704024|NCT06208592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138704025|NCT06208592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138704026|NCT06208592|Anesthetics, General|anesthetics, general|mesh-ancestor
138704027|NCT06208592|Anesthetics|anesthetics|mesh-ancestor
138704028|NCT06208592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138704029|NCT06208592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704030|NCT06205628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138704031|NCT06205628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704032|NCT06205407|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138704034|NCT06205407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138704035|NCT06205407|Diuretics|diuretics|mesh-ancestor
138704036|NCT06205407|Natriuretic Agents|natriuretic agents|mesh-ancestor
138704037|NCT06205407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704038|NCT06205407|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138248102|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
138704039|NCT06205407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138571755|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138571756|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571757|NCT00133887|Sirolimus|sirolimus|mesh-list
138571758|NCT00133887|Cyclosporine|cyclosporine|mesh-list
138571759|NCT00133887|Tacrolimus|tacrolimus|mesh-list
138571760|NCT00133887|Cyclosporins|cyclosporins|mesh-list
138571761|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138322866|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
138322867|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571762|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
138571763|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571764|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138571765|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571766|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571768|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571769|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138571770|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571771|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
138571772|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
138571773|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138571774|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
138571775|NCT00136539|Doxorubicin|doxorubicin|mesh-list
138571776|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138571777|NCT00136539|Trastuzumab|trastuzumab|mesh-list
138571778|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138571779|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
138571780|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571781|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138571782|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138571783|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
138571784|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571785|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571786|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138571787|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138571788|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138571789|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138571791|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138571792|NCT00103571|Olanzapine|olanzapine|mesh-list
138571793|NCT00103571|Aripiprazole|aripiprazole|mesh-list
138571794|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
138571795|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
138571796|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571797|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571798|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138571799|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138571800|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138571801|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138571802|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138571803|NCT00103571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138571804|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138571805|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138571806|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571807|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571809|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
138571810|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
138571811|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
138571812|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138571813|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138571814|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138571815|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138571816|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138571817|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138571818|NCT00136578|Carboplatin|carboplatin|mesh-list
138571819|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571820|NCT00103649|Xaliproden|xaliproden|mesh-list
138655275|NCT00317096|Rituximab|rituximab|mesh-list
138571821|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138571823|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
138571824|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571825|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571826|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571827|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
138248181|NCT01648140|Ribavirin|ribavirin|mesh-list
138571828|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138571829|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138571830|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138571831|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571832|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138571833|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138571834|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138571835|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
138571836|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
138571837|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571838|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571839|NCT00103727|Risperidone|risperidone|mesh-list
138571840|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138571841|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
138571842|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571843|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571844|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571845|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138571846|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138571847|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138571848|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138571849|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138571850|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
138571851|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138571852|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138655315|NCT00317408|Leucovorin|leucovorin|mesh-list
138571853|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138571854|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571856|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138571857|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138571858|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
138571859|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138322902|NCT05684484|Analgesics|analgesics|mesh-ancestor
138322903|NCT05684484|Sensory System Agents|sensory system agents|mesh-ancestor
138322904|NCT05684484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138322905|NCT05684484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571860|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475104|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
138571861|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571863|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138571864|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138571865|NCT00404040|Laxatives|laxatives|mesh-ancestor
138571866|NCT00103922|Cilomilast|cilomilast|mesh-list
138571867|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138571868|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138571869|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571870|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571871|NCT00134160|Amlodipine|amlodipine|mesh-list
138571872|NCT00134160|Olmesartan|olmesartan|mesh-list
138571873|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138571874|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
138571875|NCT00134160|Calcium|calcium|mesh-list
138571876|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138571877|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571878|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138571879|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138571880|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571881|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
138571882|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138571883|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138571884|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138571885|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138571886|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571887|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
138571888|NCT00134199|Sibutramine|sibutramine|mesh-list
138571889|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
138571890|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138571891|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
138571892|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138571893|NCT04729088|Isosorbide|isosorbide|mesh-list
138571894|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138571895|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138322937|NCT03086070|Omeprazole|omeprazole|mesh-list
138322939|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138571896|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138571897|NCT04729088|Diuretics|diuretics|mesh-ancestor
138638791|NCT01687894|Vasopressins|vasopressins|mesh-list
138571898|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
138571899|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248249|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138322940|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138571900|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
138571901|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138571902|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571904|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138571905|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571906|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138571907|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138571908|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138655346|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138571909|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571910|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
138571911|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138571914|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138571915|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138571916|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138571917|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571918|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138571919|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571920|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
138571921|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138571922|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
138571923|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571925|NCT00136851|Benazepril|benazepril|mesh-list
138571926|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138571927|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138571928|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138571929|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571930|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138571931|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571932|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
138571933|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138322969|NCT05345808|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138322970|NCT05345808|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138571934|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
138571935|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571936|NCT00104273|Rasagiline|rasagiline|mesh-list
138571937|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138571938|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638846|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571939|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571940|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138571941|NCT00104273|Protective Agents|protective agents|mesh-ancestor
138571942|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571943|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
138571944|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138571945|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571947|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138571948|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571949|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571950|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138571951|NCT00104429|Aplaviroc|aplaviroc|mesh-list
138571952|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138571953|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138571954|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571955|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571956|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
138571957|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571958|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138571959|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138571960|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138323010|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
138323012|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
138571961|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138571962|NCT00136968|Voriconazole|voriconazole|mesh-list
138571963|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
138571964|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571965|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138571966|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138571967|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571968|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571969|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138655366|NCT00317408|Antidotes|antidotes|mesh-ancestor
138571970|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
138248324|NCT05314725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138571971|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138571972|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571973|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138571974|NCT00104468|Troxacitabine|troxacitabine|mesh-list
138571975|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138571976|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138571977|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138571978|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
138571979|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571980|NCT00137007|Azithromycin|azithromycin|mesh-list
138571981|NCT00137007|Ampicillin|ampicillin|mesh-list
138571982|NCT00137007|Sulbactam|sulbactam|mesh-list
138571983|NCT00137007|Sultamicillin|sultamicillin|mesh-list
138571984|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138571985|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138571986|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138323058|NCT04279938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138323059|NCT04279938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571987|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323060|NCT05686434|Osimertinib|osimertinib|mesh-list
138323063|NCT05686434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138571988|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138571989|NCT00137085|Ketamine|ketamine|mesh-list
138571990|NCT00137085|Analgesics|analgesics|mesh-ancestor
138571991|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
138571992|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138571993|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138571994|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138571995|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138571996|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
138571997|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
138571998|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138571999|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138572000|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138572001|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572002|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572003|NCT00104546|Vitamin K|vitamin k|mesh-list
138572004|NCT00104546|Vitamins|vitamins|mesh-ancestor
138572005|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
138572006|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572007|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138572008|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138572009|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572010|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
138572011|NCT00104546|Coagulants|coagulants|mesh-ancestor
138572012|NCT00134394|Etanercept|etanercept|mesh-list
138572014|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138572015|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
138572016|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572017|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138572018|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572019|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572020|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138572021|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138572022|NCT00134394|Analgesics|analgesics|mesh-ancestor
138572023|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
138572024|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138655376|NCT00317408|Analgesics|analgesics|mesh-ancestor
138323104|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138323105|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
138323108|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138572025|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138572026|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138572027|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138572028|NCT00104624|Docetaxel|docetaxel|mesh-list
138572029|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572030|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
138572031|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
138572032|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
138572033|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572034|NCT00104663|Quinacrine|quinacrine|mesh-list
138572035|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
138572036|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138572037|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
138572038|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138572039|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138572040|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
138572041|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138572042|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
138572043|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572044|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572045|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572046|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138572047|NCT00104741|Flutamide|flutamide|mesh-list
138572048|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
138572049|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138572050|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
138572051|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138572052|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572053|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138572054|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138572055|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572056|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
138572057|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
138572058|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138572059|NCT00134511|Atorvastatin|atorvastatin|mesh-list
138323140|NCT03237390|Gemcitabine|gemcitabine|mesh-list
138572060|NCT00134511|Torcetrapib|torcetrapib|mesh-list
138323141|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138639010|NCT00288561|Ranibizumab|ranibizumab|mesh-list
138572061|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138572062|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138572063|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
138572064|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572065|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138572066|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138572067|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572068|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
138572069|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138572070|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
138572071|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572072|NCT00134550|Atorvastatin|atorvastatin|mesh-list
138572073|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138572074|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138572075|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
138475191|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572076|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572077|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138572078|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138572080|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
138572081|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138572082|NCT00104819|Antibodies|antibodies|mesh-list
138572083|NCT00104819|Sargramostim|sargramostim|mesh-list
138572084|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138572085|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
138572086|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572087|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
138572088|NCT00137202|Promethazine|promethazine|mesh-list
138572089|NCT00137202|Ondansetron|ondansetron|mesh-list
138572090|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
138323179|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138572091|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
138572092|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572093|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572094|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138572095|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
138572096|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
138572097|NCT00137202|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138572098|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138572099|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
138572100|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572101|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572102|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138572103|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138572104|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138572105|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
138572106|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
138572107|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
138572108|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138572109|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
138572110|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
138572111|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138572112|NCT00104975|Fludarabine|fludarabine|mesh-list
138572113|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
138572114|NCT00104975|Melphalan|melphalan|mesh-list
138572115|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
138572116|NCT00104975|Thiotepa|thiotepa|mesh-list
138572117|NCT00104975|Tacrolimus|tacrolimus|mesh-list
138572118|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572119|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138572120|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
138572121|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572122|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138572123|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
138323226|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323236|NCT02084706|Hormones|hormones|mesh-ancestor
138572124|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572125|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138572126|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572127|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138572128|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
138572129|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138572130|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138572132|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138572133|NCT00137358|Protective Agents|protective agents|mesh-ancestor
138572134|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572135|NCT00134667|Verteporfin|verteporfin|mesh-list
138572136|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138572137|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
138572138|NCT00134706|Carboplatin|carboplatin|mesh-list
138572139|NCT00134706|Docetaxel|docetaxel|mesh-list
138572140|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572141|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
138572142|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
138572143|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
138639085|NCT02482753|Exemestane|exemestane|mesh-list
138572144|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572145|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138572146|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138572147|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138323271|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323318|NCT03818802|Niacin|niacin|mesh-list
138572148|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
138572149|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572150|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572151|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572152|NCT00137397|Urological Agents|urological agents|mesh-ancestor
138572153|NCT00134745|Estradiol|estradiol|mesh-list
138572154|NCT00134745|Estrogens|estrogens|mesh-ancestor
138572155|NCT00134745|Hormones|hormones|mesh-ancestor
138572156|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138572157|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572159|NCT00105209|Clopidogrel|clopidogrel|mesh-list
138572160|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138572161|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138572162|NCT00105209|Analgesics|analgesics|mesh-ancestor
138572163|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
138572164|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572165|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572166|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138572167|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138572168|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138572169|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138572170|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572171|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138572172|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138572173|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572174|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
138572175|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138572176|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138572177|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138572178|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
138572179|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475217|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
138572181|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138572182|NCT00105287|Narcotics|narcotics|mesh-ancestor
138572183|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138572184|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572185|NCT00105287|Analgesics|analgesics|mesh-ancestor
138572186|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
138572187|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572188|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138572189|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138572190|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
138572191|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
138572192|NCT00137514|Chloroquine|chloroquine|mesh-list
138323323|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572193|NCT00137514|Amodiaquine|amodiaquine|mesh-list
138572194|NCT00137514|Amebicides|amebicides|mesh-ancestor
138572195|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138572196|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138323324|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138323325|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
138572197|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323326|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323328|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
138572198|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
138572199|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138572200|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138572201|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138572202|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138572203|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138572204|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572205|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138572206|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138572207|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138572208|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
138572209|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572210|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572211|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138572212|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138572213|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
138572214|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
138572215|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
138572216|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138572217|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
138572218|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138572219|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138572220|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138572221|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138572222|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572223|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572224|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138572225|NCT00105404|Triamcinolone|triamcinolone|mesh-list
138572226|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138572227|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138572228|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138572229|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138572230|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
138572231|NCT00105404|Hormones|hormones|mesh-ancestor
138572232|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138572233|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572234|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138572235|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
138572236|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572237|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572238|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
138323347|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
138323348|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
138323349|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
138323352|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138572239|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138572240|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
138572241|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572242|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572243|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138572244|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
138572245|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138572246|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138572247|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138572248|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
138572249|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572250|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572251|NCT00135018|Celecoxib|celecoxib|mesh-list
138572252|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138572253|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138572254|NCT00135018|Analgesics|analgesics|mesh-ancestor
138572255|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
138572256|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323379|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
138323380|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323381|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138323386|NCT04195776|Tenofovir|tenofovir|mesh-list
138572257|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572258|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138572259|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138572260|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138572261|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138572262|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572263|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572264|NCT00137709|Lamotrigine|lamotrigine|mesh-list
138572265|NCT00137709|Valproic Acid|valproic acid|mesh-list
138572266|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
138572267|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138572268|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138572269|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572270|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138572271|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572272|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138572273|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138572274|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138572275|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138572276|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138572277|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572278|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
138572279|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572280|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
138572281|NCT01054144|Dexamethasone|dexamethasone|mesh-list
138572282|NCT01054144|Prednisone|prednisone|mesh-list
138572283|NCT01054144|Lenalidomide|lenalidomide|mesh-list
138572284|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138572285|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
138572286|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
138323434|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
138323435|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138323436|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138323437|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323438|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639260|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
138572287|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572288|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572290|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
138572291|NCT01054144|Hormones|hormones|mesh-ancestor
138572292|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138572293|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138572294|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572295|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
138572296|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138572297|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138572298|NCT01054144|Growth Substances|growth substances|mesh-ancestor
138572299|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
138572300|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
138572301|NCT00137787|Cefepime|cefepime|mesh-list
138572302|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138572303|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138572304|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138572305|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138572306|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572307|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475259|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
138572308|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572309|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138572310|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138572311|NCT04702048|Aflibercept|aflibercept|mesh-list
138572312|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138572313|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138572314|NCT04702048|Growth Substances|growth substances|mesh-ancestor
138572315|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572316|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
138572317|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572318|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
138572319|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572320|NCT00135057|Insulin|insulin|mesh-list
138572321|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138572322|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
138323478|NCT05244252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323479|NCT05244252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572323|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
138572324|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138572325|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572327|NCT00434668|Docetaxel|docetaxel|mesh-list
138572328|NCT00434668|Vinorelbine|vinorelbine|mesh-list
138572329|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572330|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
138572331|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
138572332|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
138572333|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572334|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138572335|NCT00434746|Fezakinumab|fezakinumab|mesh-list
138572336|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
138572337|NCT00137826|Bevacizumab|bevacizumab|mesh-list
138572338|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138572339|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138572340|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572341|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138572342|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138572343|NCT00137826|Growth Substances|growth substances|mesh-ancestor
138572344|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572345|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
138572346|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138572347|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572348|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323516|NCT05248932|Adrenergic Agents|adrenergic agents|mesh-ancestor
138323517|NCT05248932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323518|NCT05248932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572349|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
138572350|NCT00434824|Testosterone|testosterone|mesh-list
138572351|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
138572352|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
138572353|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138572354|NCT00434824|Androgens|androgens|mesh-ancestor
138572356|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138572357|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572358|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138572359|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572361|NCT00105950|Lapatinib|lapatinib|mesh-list
138572362|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639318|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
138572363|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138572365|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572366|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
138572367|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138572368|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138572369|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138572370|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138572371|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572372|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
138572373|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572374|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572375|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138572376|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572377|NCT00434941|Capecitabine|capecitabine|mesh-list
138572378|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138572379|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
138572380|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572381|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572382|NCT00135096|Insulin|insulin|mesh-list
138572383|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138572384|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
138323564|NCT02914158|Fertility Agents|fertility agents|mesh-ancestor
138323565|NCT02914158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138323570|NCT05241132|Cisplatin|cisplatin|mesh-list
138572385|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
138572386|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138572387|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572388|NCT00435058|Timolol|timolol|mesh-list
138572389|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138572390|NCT00435058|Travoprost|travoprost|mesh-list
138572391|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655464|NCT00345657|L 647318|l 647318|mesh-list
138572392|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138572393|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138572394|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
138639356|NCT00270270|Hematinics|hematinics|mesh-ancestor
138572395|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572396|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572397|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138572398|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138572399|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138572400|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138572401|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138572402|NCT00435175|Estradiol|estradiol|mesh-list
138572403|NCT00435175|Estrogens|estrogens|mesh-ancestor
138572404|NCT00435175|Hormones|hormones|mesh-ancestor
138572405|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138572406|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572407|NCT00135135|Carboplatin|carboplatin|mesh-list
138572408|NCT00135135|Doxorubicin|doxorubicin|mesh-list
138572409|NCT00135135|Irinotecan|irinotecan|mesh-list
138572410|NCT00135135|Etoposide|etoposide|mesh-list
138572411|NCT00135135|Melphalan|melphalan|mesh-list
138572412|NCT00135135|Topotecan|topotecan|mesh-list
138572413|NCT00135135|Gefitinib|gefitinib|mesh-list
138572414|NCT00135135|Tretinoin|tretinoin|mesh-list
138572415|NCT00135135|Isotretinoin|isotretinoin|mesh-list
138572416|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572417|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138572418|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138572419|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138572420|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572421|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572422|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138572423|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138572424|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138572425|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
138572426|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138572427|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138572428|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
138572429|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323606|NCT05241054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138572430|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138572431|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
138572432|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
138572433|NCT00435292|Naproxen|naproxen|mesh-list
138572434|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138572435|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138572436|NCT00435292|Analgesics|analgesics|mesh-ancestor
138572437|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
138572438|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572439|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572440|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138572441|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138572442|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
138572443|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138572444|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572445|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572446|NCT00435331|Verapamil|verapamil|mesh-list
138572447|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138572448|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138572449|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138639396|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138572450|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572451|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138572453|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
138572454|NCT00435448|Lonidamine|lonidamine|mesh-list
138572455|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572456|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138572457|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572458|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138572459|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
138572460|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138572461|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138572462|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138572463|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138572464|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138572465|NCT00435760|Bromides|bromides|mesh-list
138572466|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
138572467|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138572468|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
138572469|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572470|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572471|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138572472|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
138572473|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
138572474|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138323634|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
138572475|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
138572476|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572477|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572478|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
138572479|NCT00435799|Riboflavin|riboflavin|mesh-list
138572480|NCT00435799|Dextrans|dextrans|mesh-list
138572481|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138572482|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
138572483|NCT00435799|Vitamins|vitamins|mesh-ancestor
138572484|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
138572485|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572486|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138572487|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
138572488|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138572489|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
138572490|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
138572491|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
138572492|NCT00142467|Bevacizumab|bevacizumab|mesh-list
138572493|NCT00142467|Gemcitabine|gemcitabine|mesh-list
138572494|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
138572495|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138572496|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572497|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138572498|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138572499|NCT00142467|Growth Substances|growth substances|mesh-ancestor
138572500|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572501|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
138572502|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138572503|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
138572504|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572506|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138572507|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572508|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
138572509|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572510|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138572512|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
138572513|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138572514|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138572515|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138572516|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572517|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572518|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572519|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138572520|NCT00436033|Analgesics|analgesics|mesh-ancestor
138639458|NCT00270543|Leucovorin|leucovorin|mesh-list
138572521|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
138572522|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572523|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
138572524|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138572525|NCT00436072|Irinotecan|irinotecan|mesh-list
138572526|NCT00436072|Cetuximab|cetuximab|mesh-list
138572527|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138572528|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138572529|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572530|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572531|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572532|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138572533|NCT03276052|Bromides|bromides|mesh-list
138572534|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
138572535|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
138572536|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138572537|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
138572538|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138572539|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
138572540|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572541|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572542|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
138572544|NCT04702360|Elexacaftor|elexacaftor|mesh-list
138572545|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138572546|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138572547|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572548|NCT04702204|Denosumab|denosumab|mesh-list
138572549|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138323700|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
138572550|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572551|NCT00138060|Fluorouracil|fluorouracil|mesh-list
138572552|NCT00138060|Irinotecan|irinotecan|mesh-list
138572553|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
138572554|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323701|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572555|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138572556|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572557|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138572558|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
138572559|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572560|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138572561|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138572562|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572563|NCT04702009|Antibodies|antibodies|mesh-list
138572564|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138572565|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
138572566|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572567|NCT00106145|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
138572568|NCT00106145|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138572569|NCT00106145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572570|NCT00106145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572571|NCT00142545|Apomorphine|apomorphine|mesh-list
138572572|NCT00142545|Emetics|emetics|mesh-ancestor
138572573|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572574|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
138572575|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572576|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138572577|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
138639557|NCT00270777|Promethazine|promethazine|mesh-list
138572578|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
138572579|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572580|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572581|NCT00106262|Irinotecan|irinotecan|mesh-list
138572582|NCT00106262|Bortezomib|bortezomib|mesh-list
138572583|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138323740|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572584|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138323741|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323742|NCT00634920|Cyclosporine|cyclosporine|mesh-list
138572585|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572586|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572587|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572588|NCT00106301|Romidepsin|romidepsin|mesh-list
138572589|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138572590|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572591|NCT00106301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138572592|NCT00106301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572593|NCT00106301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572594|NCT00436267|Fluorouracil|fluorouracil|mesh-list
138572595|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
138572596|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572597|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138572598|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572599|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138572600|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
138572601|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572602|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
138572603|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138572604|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572605|NCT00138099|Dalteparin|dalteparin|mesh-list
138572606|NCT00138099|Tinzaparin|tinzaparin|mesh-list
138572607|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138572608|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
138572609|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138572610|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138572611|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572612|NCT00106379|Tenofovir|tenofovir|mesh-list
138572613|NCT00106379|Emtricitabine|emtricitabine|mesh-list
138572614|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138572615|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
138572616|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138572617|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138572618|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138572619|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572620|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572621|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138572622|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138323783|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138323784|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323798|NCT00634842|Insulin|insulin|mesh-list
138572623|NCT00436423|Gemcitabine|gemcitabine|mesh-list
138572624|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138572625|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
138572626|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572627|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572628|NCT00436579|Sorafenib|sorafenib|mesh-list
138572629|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572630|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138572631|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572632|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572633|NCT00436657|Cisplatin|cisplatin|mesh-list
138572634|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572635|NCT00106418|Romidepsin|romidepsin|mesh-list
138572636|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138572637|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572638|NCT00106418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138572639|NCT00106418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572640|NCT00106418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572641|NCT00436930|Sargramostim|sargramostim|mesh-list
138572642|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
138572643|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572644|NCT00437008|Benphothiamine|benphothiamine|mesh-list
138572645|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138572646|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
138572647|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572648|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
138572649|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
138572650|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572652|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572653|NCT00437164|Insulin|insulin|mesh-list
138572654|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138572655|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138572656|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572657|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138572658|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138572659|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
138572660|NCT00106496|Tacrolimus|tacrolimus|mesh-list
138655572|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
138572661|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138323815|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572662|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
138572663|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323816|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572664|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138572665|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572666|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572667|NCT00437359|Toremifene|toremifene|mesh-list
138572668|NCT00437359|Anastrozole|anastrozole|mesh-list
138572669|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572670|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138572671|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572672|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138572673|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138572674|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572675|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138572676|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
138572677|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138572678|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572679|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138572680|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138572681|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138572682|NCT00437476|Ribavirin|ribavirin|mesh-list
138572683|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138572684|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138572685|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
138572686|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572688|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138572689|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138572690|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572691|NCT00437554|Glimepiride|glimepiride|mesh-list
138572692|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138572693|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138572694|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572695|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138572696|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
138572697|NCT00437632|Caffeine|caffeine|mesh-list
138572698|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138572699|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572700|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138572701|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572702|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572703|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138323850|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138323851|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323852|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138572704|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138572705|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
138572706|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572707|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
138572708|NCT00437671|Antibodies|antibodies|mesh-list
138572709|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
138572710|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138572711|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138572712|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
138572713|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572714|NCT00106613|Romidepsin|romidepsin|mesh-list
138572715|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138572716|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572717|NCT00106613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138572718|NCT00106613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639710|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
138572719|NCT00106613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572720|NCT00401180|Docetaxel|docetaxel|mesh-list
138572721|NCT00401180|Temozolomide|temozolomide|mesh-list
138572722|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572723|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
138572724|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
138572725|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
138572726|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572727|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138572728|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
138572729|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
138572730|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138572731|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572732|NCT03278665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138572733|NCT03278665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572734|NCT00401219|Estrogens|estrogens|mesh-list
138572735|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138572736|NCT00401219|Progestins|progestins|mesh-list
138572737|NCT00401219|Hormones|hormones|mesh-ancestor
138572738|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138572739|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572740|NCT04701463|Calcium|calcium|mesh-list
138323879|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138572741|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138572742|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572743|NCT00438139|Dronabinol|dronabinol|mesh-list
138572744|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
138572745|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572746|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138572747|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138572748|NCT00438139|Analgesics|analgesics|mesh-ancestor
138572749|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
138572750|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572751|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138572752|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138572753|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572754|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572755|NCT00438139|Hormones|hormones|mesh-ancestor
138572756|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138572758|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572759|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572760|NCT00438217|Leuprolide|leuprolide|mesh-list
138572761|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138572762|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138572763|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138572764|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
138572765|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138572766|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572767|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138572768|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572769|NCT00438217|Hormones|hormones|mesh-ancestor
138572770|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138572771|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
138572772|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138323916|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138323918|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
138572773|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
138572774|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138572775|NCT03279757|Lidocaine|lidocaine|mesh-list
138572776|NCT03279757|Epinephrine|epinephrine|mesh-list
138572777|NCT03279757|Racepinephrine|racepinephrine|mesh-list
138572778|NCT03279757|Tetracaine|tetracaine|mesh-list
138572779|NCT03279757|Carticaine|carticaine|mesh-list
138572780|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
138572781|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
138572782|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
138572783|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138572784|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572785|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
138572786|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572787|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138572788|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138572789|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138572790|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138572791|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572792|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138572793|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138572794|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
138572795|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572796|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138572797|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138572798|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
138572799|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138572800|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
138572801|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
138572802|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
138572803|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138572804|NCT00438568|Insulin|insulin|mesh-list
138572805|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138572806|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138572807|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572808|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
138572809|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138323958|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
138323959|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138323960|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572810|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138572811|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138572812|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
138572813|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572814|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572815|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572816|NCT00106847|Infliximab|infliximab|mesh-list
138572817|NCT00106847|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138572818|NCT00106847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138572819|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
138572820|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138572821|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138572823|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
138572824|NCT00106886|Pyridoxal|pyridoxal|mesh-list
138323995|NCT01920204|Midostaurin|midostaurin|mesh-list
138572825|NCT00106886|Pyridoxine|pyridoxine|mesh-list
138572826|NCT00106886|Vitamins|vitamins|mesh-ancestor
138572827|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
138572828|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572829|NCT00106886|Hematinics|hematinics|mesh-ancestor
138572830|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
138323996|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323997|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138323998|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324000|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
138572831|NCT00438841|Thalidomide|thalidomide|mesh-list
138572832|NCT00438841|Dexamethasone|dexamethasone|mesh-list
138572833|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
138572834|NCT00438841|Bortezomib|bortezomib|mesh-list
138572835|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138572836|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
138572837|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572838|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138572839|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138572840|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
138572841|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572842|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572843|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138572844|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138572845|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
138572846|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
138572847|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572848|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138572849|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
138572850|NCT00438841|Hormones|hormones|mesh-ancestor
138572851|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138572852|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138572853|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
138572854|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138572855|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138572856|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138572857|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138572858|NCT00438841|Growth Substances|growth substances|mesh-ancestor
138572859|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
138572860|NCT00438958|Lenograstim|lenograstim|mesh-list
138572861|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138572862|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
138572863|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572864|NCT00107003|Lapatinib|lapatinib|mesh-list
138572865|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572866|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138572867|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572868|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324047|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138324048|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324050|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639840|NCT02272270|Minocycline|minocycline|mesh-list
138572870|NCT00107081|Amoxicillin|amoxicillin|mesh-list
138572871|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
138572872|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138572873|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138572874|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138572875|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572876|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572877|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572878|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138572879|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138572880|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138572881|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138572882|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138572883|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
138475355|NCT05777707|Nedaplatin|nedaplatin|mesh-list
138572884|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572885|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572886|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572887|NCT00439192|Urological Agents|urological agents|mesh-ancestor
138572889|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
138572890|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138572892|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572893|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572894|NCT00138138|Methylphenidate|methylphenidate|mesh-list
138572895|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138572896|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324083|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138324084|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324086|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
138572897|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138572898|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138572899|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138572900|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572901|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
138572902|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572903|NCT00439504|Lobeline|lobeline|mesh-list
138572904|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138572905|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
138572906|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572907|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572908|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138572909|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138572910|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
138572911|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138572912|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572913|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
138572914|NCT00439543|Iloprost|iloprost|mesh-list
138572915|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138572916|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
138572917|NCT00107237|Everolimus|everolimus|mesh-list
138572918|NCT00107237|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138572919|NCT00107237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138572920|NCT00107237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572921|NCT00107237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572922|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138572923|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
138572924|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572925|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572926|NCT00439699|Memantine|memantine|mesh-list
138324132|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
138324133|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
138324134|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324135|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138324136|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
138572927|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138572928|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138572929|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
138572930|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639952|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138639956|NCT00257426|Octreotide|octreotide|mesh-list
138572931|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572932|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572933|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138324172|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
138572934|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138572936|NCT00439855|Enoxaparin|enoxaparin|mesh-list
138324173|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
138572937|NCT00439855|Calcium heparin|calcium heparin|mesh-list
138572938|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
138572939|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138572940|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138572941|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572942|NCT00107354|Cytarabine|cytarabine|mesh-list
138572943|NCT00107354|Aldesleukin|aldesleukin|mesh-list
138572944|NCT00107354|Etoposide|etoposide|mesh-list
138572945|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
138572946|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138572947|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572948|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138572949|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138572950|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572951|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572952|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138572953|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
138475367|NCT05777369|Rituximab|rituximab|mesh-list
138324239|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572954|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
138572955|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324240|NCT01928628|Valsartan|valsartan|mesh-list
138324241|NCT01928628|Lercanidipine|lercanidipine|mesh-list
138324257|NCT03059004|TEMPO|tempo|mesh-list
138572956|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138572957|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
138572958|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572959|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138572960|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138572961|NCT00107354|Analgesics|analgesics|mesh-ancestor
138572962|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
138572963|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138572964|NCT00138177|Leucovorin|leucovorin|mesh-list
138572965|NCT00138177|Fluorouracil|fluorouracil|mesh-list
138572966|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
138572967|NCT00138177|Vorinostat|vorinostat|mesh-list
138572968|NCT00138177|Calcium|calcium|mesh-list
138572969|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
138572970|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138572971|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138572972|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
138572973|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572974|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138572975|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572976|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138572977|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
138572978|NCT00138177|Antidotes|antidotes|mesh-ancestor
138572979|NCT00138177|Protective Agents|protective agents|mesh-ancestor
138572980|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
138572981|NCT00138177|Vitamins|vitamins|mesh-ancestor
138572982|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
138572983|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138572984|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138572985|NCT03279601|Capecitabine|capecitabine|mesh-list
138572986|NCT03279601|Temozolomide|temozolomide|mesh-list
138572987|NCT03279601|Dacarbazine|dacarbazine|mesh-list
138572988|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138572990|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572991|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138572992|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138572993|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
138572994|NCT00107393|Capecitabine|capecitabine|mesh-list
138572995|NCT00107393|Trastuzumab|trastuzumab|mesh-list
138572996|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138572997|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
138572998|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138572999|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573000|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138573001|NCT00105586|Escitalopram|escitalopram|mesh-list
138573002|NCT00105586|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138573003|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138475382|NCT05777369|Glucocorticoids|glucocorticoids|mesh-ancestor
138573004|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573005|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573006|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573007|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
138573008|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573009|NCT00107432|Sorafenib|sorafenib|mesh-list
138573010|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573011|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138573012|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573013|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573015|NCT00439972|Ortho Evra|ortho evra|mesh-list
138573016|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138573017|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138573018|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
138573019|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138573020|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573021|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138573022|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138573023|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138573024|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138573026|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573027|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573028|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138573029|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138573030|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138573031|NCT00440128|Docetaxel|docetaxel|mesh-list
138573032|NCT00440128|Casopitant|casopitant|mesh-list
138573033|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138222925|NCT01512797|Hormones|hormones|mesh-ancestor
138573034|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
138573035|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
138573036|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
138573037|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573038|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
138573039|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
138573040|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573041|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573042|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138573043|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138573044|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573045|NCT00440167|Gemcitabine|gemcitabine|mesh-list
138573046|NCT00440167|Capecitabine|capecitabine|mesh-list
138573047|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138573048|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138573049|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
138573050|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573051|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573052|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138573053|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573054|NCT00107471|Topotecan|topotecan|mesh-list
138573055|NCT00107471|Lenograstim|lenograstim|mesh-list
138573056|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138573057|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
138573058|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573059|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138573060|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138573061|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573062|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573063|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573064|NCT00404157|Rituximab|rituximab|mesh-list
138573065|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138475396|NCT05777122|Lidocaine|lidocaine|mesh-list
138573066|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573067|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
138573068|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573069|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138573071|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573072|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138573073|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
138573074|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573075|NCT03279562|Nalmefene|nalmefene|mesh-list
138573076|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138573077|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655681|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
138573078|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
138573079|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573080|NCT00404196|Calcipotriene|calcipotriene|mesh-list
138573081|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
138573082|NCT00107510|Carboplatin|carboplatin|mesh-list
138573083|NCT00107510|Docetaxel|docetaxel|mesh-list
138573084|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324363|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138324365|NCT05607810|Aflibercept|aflibercept|mesh-list
138573085|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
138573087|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
138573088|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573089|NCT00440245|Albuterol|albuterol|mesh-list
138573090|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138573091|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
138573092|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573093|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573094|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138573095|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
138573096|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
138573097|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138573098|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138573099|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138573100|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138573101|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
138573102|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573103|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573105|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138573106|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573107|NCT00142779|Fluoxetine|fluoxetine|mesh-list
138573108|NCT00142779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138573109|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138573110|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573111|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573112|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573113|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
138573114|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640355|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
138573115|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138573116|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
138573117|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138573118|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138573119|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138573120|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573121|NCT00440323|Zolpidem|zolpidem|mesh-list
138573122|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138573123|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138655696|NCT00319202|Candesartan|candesartan|mesh-list
138573124|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138573125|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573127|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
138573128|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
138573129|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573130|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573131|NCT00440440|Testosterone|testosterone|mesh-list
138573132|NCT00440440|Androgens|androgens|mesh-ancestor
138573133|NCT00440440|Hormones|hormones|mesh-ancestor
138573134|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138573135|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573137|NCT00142896|Tramadol|tramadol|mesh-list
138573138|NCT00142896|Naloxone|naloxone|mesh-list
138573139|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138573140|NCT00142896|Narcotics|narcotics|mesh-ancestor
138573141|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138573142|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573143|NCT00142896|Analgesics|analgesics|mesh-ancestor
138573144|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
138573145|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573146|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138573147|NCT00440479|Bortezomib|bortezomib|mesh-list
138573148|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573149|NCT00440635|Bortezomib|bortezomib|mesh-list
138573150|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573151|NCT00440674|Paclitaxel|paclitaxel|mesh-list
138573152|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138573153|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573154|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
138573155|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
138573156|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
138573157|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573158|NCT00440713|Aripiprazole|aripiprazole|mesh-list
138573159|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
138573160|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138573161|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138573162|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138573163|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138324445|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138324446|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138573164|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573165|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
138573166|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
138573167|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573168|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573169|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138573170|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138573171|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
138573172|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138573173|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138573174|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138573175|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138573176|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
138573177|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138655728|NCT00346359|Busulfan|busulfan|mesh-list
138573178|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
138573179|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138573181|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
138573182|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138573183|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
138573184|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573185|NCT00440869|Protective Agents|protective agents|mesh-ancestor
138573186|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573187|NCT00440869|Antidotes|antidotes|mesh-ancestor
138573188|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
138324479|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
138324480|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324481|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138573189|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138573190|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573191|NCT00441181|Travoprost|travoprost|mesh-list
138573192|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138573193|NCT00441298|Tenofovir|tenofovir|mesh-list
138573194|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
138573195|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138573196|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138573197|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138573198|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573199|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573200|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138573201|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138573203|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138573204|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138573205|NCT00441415|Analgesics|analgesics|mesh-ancestor
138573206|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
138573207|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573208|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573209|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573210|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138573211|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
138573212|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
138573213|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138573214|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138573215|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138573216|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573217|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573218|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
138324528|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138324529|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138324530|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138324531|NCT04120974|Insulin|insulin|mesh-list
138573219|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573220|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573221|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138573222|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573223|NCT00441532|Lidocaine|lidocaine|mesh-list
138573224|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
138573226|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138573227|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573228|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
138573229|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573230|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138573231|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138573232|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138573233|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573234|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573235|NCT00441649|Methylphenidate|methylphenidate|mesh-list
138573236|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138573237|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573238|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138573239|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138573240|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573241|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573242|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
138573243|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573244|NCT00107822|Lidocaine|lidocaine|mesh-list
138249625|NCT00378027|PENTA|penta|mesh-list
138573245|NCT00107822|Tetracaine|tetracaine|mesh-list
138573246|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
138573247|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
138573248|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138573249|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573250|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
138573251|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573252|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138573253|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138573254|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138573255|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573256|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573257|NCT03279328|Petrolatum|petrolatum|mesh-list
138573258|NCT03279328|Emollients|emollients|mesh-ancestor
138573259|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
138324570|NCT04125888|Immunologic Factors|immunologic factors|mesh-ancestor
138573260|NCT00142974|Tegaserod|tegaserod|mesh-list
138573261|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138573262|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
138573263|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573264|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573265|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573266|NCT00441844|Simvastatin|simvastatin|mesh-list
138573267|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138573268|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138573269|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
138573270|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573271|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138573272|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138573273|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573274|NCT03279133|Ledipasvir|ledipasvir|mesh-list
138573275|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
138573276|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138573277|NCT00108017|Timolol|timolol|mesh-list
138573278|NCT00108017|Dorzolamide|dorzolamide|mesh-list
138573279|NCT00108017|Maleic acid|maleic acid|mesh-list
138573280|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573281|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573282|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138573283|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138573284|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
138573285|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573286|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324603|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
138324604|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324605|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138573287|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138573288|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138573289|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138573290|NCT00441922|Docetaxel|docetaxel|mesh-list
138573291|NCT00441922|Vinorelbine|vinorelbine|mesh-list
138573292|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573293|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
138573294|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
138573295|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
138573296|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573297|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138573299|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138573300|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
138573301|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138573302|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573303|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138573304|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
138573305|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573306|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573307|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
138573308|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573309|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138573310|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138573311|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
138573312|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138573313|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138573315|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138573316|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138324650|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138324651|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324652|NCT04393584|Antidotes|antidotes|mesh-ancestor
138573317|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138573318|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138573319|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573320|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573321|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573322|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138640856|NCT00259766|Budesonide|budesonide|mesh-list
138573323|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138573324|NCT00442234|Monteplase|monteplase|mesh-list
138573325|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138573326|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138573327|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573328|NCT00108095|Ondansetron|ondansetron|mesh-list
138573329|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
138573330|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
138573331|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573332|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573333|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138573334|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
138573335|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
138573336|NCT00108095|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138573337|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138573338|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
138573339|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573340|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573342|NCT03278938|Citalopram|citalopram|mesh-list
138573343|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138573344|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
138573345|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138573346|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138573347|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138640909|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138573348|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573349|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573350|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
138324696|NCT03820518|Vitamins|vitamins|mesh-ancestor
138573351|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573352|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655773|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573353|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138573354|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138573355|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573356|NCT03278938|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138573357|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
138573358|NCT03278860|Oxytocin|oxytocin|mesh-list
138573359|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
138573360|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138573361|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573362|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138573363|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138573364|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
138573365|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138573366|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138573367|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
138573368|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573369|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573370|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573371|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138573372|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138573373|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138573374|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
138573375|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573376|NCT00442585|Ibuprofen|ibuprofen|mesh-list
138573377|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138573378|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138573379|NCT00442585|Analgesics|analgesics|mesh-ancestor
138573380|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
138573381|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573382|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324737|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
138573383|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138475443|NCT05279690|Colchicine|colchicine|mesh-list
138573385|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138573386|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573387|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573388|NCT00442741|Epothilone B|epothilone b|mesh-list
138573389|NCT00442741|Epothilones|epothilones|mesh-list
138573391|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138249752|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
138573393|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138573394|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573395|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573396|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573397|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
138573398|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
138573399|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
138573400|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
138573401|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138573402|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138573403|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138573404|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
138573405|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573406|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573407|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573410|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573411|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138573412|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
138573413|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573414|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573415|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138573416|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
138573417|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
138573418|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138573419|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138573420|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
138573421|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138573422|NCT00442819|Protective Agents|protective agents|mesh-ancestor
138324780|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138573423|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573424|NCT00108251|Eplerenone|eplerenone|mesh-list
138573425|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138573426|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
138573427|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138573428|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573429|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138573430|NCT00108251|Diuretics|diuretics|mesh-ancestor
138573431|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
138573432|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138573433|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
138573434|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
138573435|NCT00443170|Midazolam|midazolam|mesh-list
138573436|NCT00443170|Caffeine|caffeine|mesh-list
138573437|NCT00443170|Omeprazole|omeprazole|mesh-list
138573438|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138573439|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138573440|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138573441|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573442|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138573443|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138573444|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138573445|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138573446|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
138573447|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
138573448|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
138573449|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
138573450|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324816|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
138573451|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324817|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324818|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
138573452|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138573453|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138573454|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573455|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138573456|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138573457|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
138573458|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138573459|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138573460|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138573461|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138573462|NCT00443170|Analgesics|analgesics|mesh-ancestor
138573463|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
138573464|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249827|NCT00989937|Oxytocin|oxytocin|mesh-list
138573465|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138573466|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138573467|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573468|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138573469|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138573470|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138573471|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
138573473|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138573475|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138573476|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
138573477|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573478|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573479|NCT00108368|Olanzapine|olanzapine|mesh-list
138573480|NCT00108368|Risperidone|risperidone|mesh-list
138573481|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138573482|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
138573483|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573484|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573485|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573486|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138573487|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138573488|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138573489|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138573490|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138573491|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
138573492|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
138573493|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
138573494|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573495|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138573496|NCT00108368|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138573497|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138324862|NCT01450410|Niacin|niacin|mesh-list
138324863|NCT01450410|Niacinamide|niacinamide|mesh-list
138324864|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
138324865|NCT01450410|Vitamins|vitamins|mesh-ancestor
138324866|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
138573498|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573499|NCT00108446|Lidocaine|lidocaine|mesh-list
138573500|NCT00108446|Fentanyl|fentanyl|mesh-list
138573501|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
138573502|NCT00108446|Naloxone|naloxone|mesh-list
138573503|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
138573504|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
138573505|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138573506|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573507|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
138573508|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573509|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138573510|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138573511|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138573512|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573513|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573514|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138573515|NCT00108446|Narcotics|narcotics|mesh-ancestor
138573516|NCT00108446|Analgesics|analgesics|mesh-ancestor
138641115|NCT01331005|Nepafenac|nepafenac|mesh-list
138573517|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138573518|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138573519|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
138573520|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138573521|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
138573522|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
138573523|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138573524|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138573525|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573526|NCT00138606|Vildagliptin|vildagliptin|mesh-list
138573527|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138573528|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573529|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138573530|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
138324894|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138324895|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138573531|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573532|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573533|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
138573534|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138573535|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
138573536|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573537|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573538|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138573539|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
138573540|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138573541|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138573542|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138573543|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
138573544|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573545|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573546|NCT00443521|Triamcinolone|triamcinolone|mesh-list
138573547|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138573548|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138573549|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138573550|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573551|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
138573552|NCT00443521|Hormones|hormones|mesh-ancestor
138573553|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138573554|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573555|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138573556|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
138573557|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573558|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573559|NCT03278431|Albendazole|albendazole|mesh-list
138573560|NCT03278431|Mebendazole|mebendazole|mesh-list
138573561|NCT03278431|Piperazine|piperazine|mesh-list
138573562|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
138573563|NCT03278431|Pyrantel|pyrantel|mesh-list
138573564|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
138573565|NCT03278431|Oxantel|oxantel|mesh-list
138573566|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
138324935|NCT01451268|Panobinostat|panobinostat|mesh-list
138573567|NCT03278431|DMP 777|dmp 777|mesh-list
138324945|NCT02884908|Pregabalin|pregabalin|mesh-list
138573568|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
138573569|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138573570|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138573571|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
138573572|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138573573|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138573574|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
138573575|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
138573576|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
138573577|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573578|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573579|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
138573580|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573581|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138573582|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138573583|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138573584|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573585|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573586|NCT00108563|Citalopram|citalopram|mesh-list
138573587|NCT00108563|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138573588|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138573589|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573590|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573591|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573592|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
138573593|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573594|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138573595|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
138573596|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138573597|NCT00443716|Estrogens|estrogens|mesh-list
138573598|NCT00443716|Hormones|hormones|mesh-ancestor
138573599|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138573600|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573601|NCT00443794|Aspirin|aspirin|mesh-list
138573602|NCT00443794|Atenolol|atenolol|mesh-list
138324975|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324976|NCT02935374|Amoxicillin|amoxicillin|mesh-list
138573603|NCT00443794|Ramipril|ramipril|mesh-list
138573604|NCT00443794|Simvastatin|simvastatin|mesh-list
138573605|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
138573606|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138573607|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138573608|NCT00443794|Analgesics|analgesics|mesh-ancestor
138573609|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
138573610|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641341|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
138573611|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573612|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573613|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138573614|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138573615|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138573616|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573617|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138573618|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138573619|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573621|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138573622|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138573623|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
138573624|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138573625|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138573626|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138573627|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
138573628|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138573629|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138573630|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
138573631|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
138573632|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138573633|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138573634|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138573635|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
138573636|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573637|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573638|NCT00443794|Diuretics|diuretics|mesh-ancestor
138573639|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
138573640|NCT00108602|Acetazolamide|acetazolamide|mesh-list
138573641|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
138573642|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138325016|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138573643|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573644|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573645|NCT00108602|Diuretics|diuretics|mesh-ancestor
138573646|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
138573647|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573648|NCT03278314|Ivacaftor|ivacaftor|mesh-list
138573649|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138573650|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138475530|NCT04461587|Analgesics|analgesics|mesh-ancestor
138573651|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573653|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138573654|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138573655|NCT00443950|Analgesics|analgesics|mesh-ancestor
138573656|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
138573657|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573658|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573659|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573660|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138573661|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138573662|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138573663|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
138573664|NCT00444184|Timolol|timolol|mesh-list
138573665|NCT00444184|Travoprost|travoprost|mesh-list
138573666|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138573667|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138573668|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
138573669|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573670|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573671|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325049|NCT01455870|Protease Inhibitors|protease inhibitors|mesh-ancestor
138325050|NCT01455870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573672|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138573673|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138573674|NCT00444223|Fluorides|fluorides|mesh-list
138573675|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
138573676|NCT00444223|Protective Agents|protective agents|mesh-ancestor
138573677|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573678|NCT03275701|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
138573679|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138573680|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138573681|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
138573682|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138573683|NCT00451360|Diacerein|diacerein|mesh-list
138573684|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573685|NCT00451399|Metformin|metformin|mesh-list
138250055|NCT01901679|Celecoxib|celecoxib|mesh-list
138573686|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138573687|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573688|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
138573690|NCT04698772|Ketamine|ketamine|mesh-list
138573691|NCT04698772|Morphine|morphine|mesh-list
138573692|NCT04698772|Analgesics|analgesics|mesh-ancestor
138573693|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
138641418|NCT00299013|Prednisolone|prednisolone|mesh-list
138573694|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573695|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573697|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138573698|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
138573699|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
138573700|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138573701|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138573702|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138573703|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573704|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573705|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138573706|NCT04698772|Narcotics|narcotics|mesh-ancestor
138325092|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
138573707|NCT00451594|Dexamethasone|dexamethasone|mesh-list
138325093|NCT01891500|Protective Agents|protective agents|mesh-ancestor
138573708|NCT00451594|Prednisolone|prednisolone|mesh-list
138573709|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573710|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
138573711|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
138573712|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573713|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573714|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138573715|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
138573717|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138573718|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138573719|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573720|NCT00139035|Cyclosporine|cyclosporine|mesh-list
138573721|NCT00139035|Cyclosporins|cyclosporins|mesh-list
138573722|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573723|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573724|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138573725|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
138573726|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573727|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
138573728|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138573729|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
138573730|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138573731|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138573732|NCT00451672|Bromocriptine|bromocriptine|mesh-list
138573733|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138573734|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138573735|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
138573736|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138573737|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325133|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138325135|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138573738|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
138573739|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
138573740|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573741|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573742|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
138573743|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138573744|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
138573745|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573746|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573747|NCT00451711|Amphotericin B|amphotericin b|mesh-list
138573748|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138573749|NCT00451711|Amebicides|amebicides|mesh-ancestor
138573750|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138573751|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138573752|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138573753|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138573754|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
138573755|NCT00139074|Valproic Acid|valproic acid|mesh-list
138573756|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138573757|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
138573758|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138573759|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138573760|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138573761|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138573762|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573763|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
138573764|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641468|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227898|NCT03032978|Calcium|calcium|mesh-list
138641469|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138641470|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641471|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138641472|NCT00299208|Analgesics|analgesics|mesh-ancestor
138421002|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
138641473|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
138641474|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
138641475|NCT00418119|Hematinics|hematinics|mesh-ancestor
138641476|NCT00293592|Dexamethasone|dexamethasone|mesh-list
138641477|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138641478|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
138573765|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573766|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
138573767|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573768|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
138573769|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
138573770|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573771|NCT00451828|Simvastatin|simvastatin|mesh-list
138325180|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138573772|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138573773|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138325181|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138573774|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
138573775|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573776|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138573777|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138573778|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573779|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
138573780|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138573781|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573782|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138573783|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
138573784|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138573785|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138573786|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573787|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573788|NCT00143091|Sertraline|sertraline|mesh-list
138573789|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
138573790|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138573791|NCT00143091|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138573792|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138573793|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573794|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573795|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573796|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
138573797|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573798|NCT00451984|Interleukin-2|interleukin-2|mesh-list
138573799|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573800|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138573801|NCT00451984|Analgesics|analgesics|mesh-ancestor
138573802|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
138573803|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325209|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325210|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325212|NCT01458600|Diclofenac|diclofenac|mesh-list
138573804|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573805|NCT00452062|Dexamethasone|dexamethasone|mesh-list
138573806|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573807|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
138573808|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
138421109|NCT03919071|Trametinib|trametinib|mesh-list
138573809|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573810|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573811|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138573812|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
138573814|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138573815|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138573816|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573817|NCT00108992|Diclofenac|diclofenac|mesh-list
138573818|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138573819|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138573820|NCT00108992|Analgesics|analgesics|mesh-ancestor
138573821|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
138573822|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573823|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573824|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573825|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138573826|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138573827|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573828|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573829|NCT00143130|Pregabalin|pregabalin|mesh-list
138573830|NCT00143130|Analgesics|analgesics|mesh-ancestor
138573831|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
138573832|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573833|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573834|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
138325253|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325254|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573835|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138573836|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573837|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573838|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138573839|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138573840|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138573841|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138573842|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138573843|NCT00109070|Bevacizumab|bevacizumab|mesh-list
138573844|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138573845|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573846|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138573847|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138573848|NCT00109070|Growth Substances|growth substances|mesh-ancestor
138573849|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573850|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
138573851|NCT00452218|Sorafenib|sorafenib|mesh-list
138573852|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573853|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138573854|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573855|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573856|NCT00143169|Parecoxib|parecoxib|mesh-list
138573857|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138573858|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138573859|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573860|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573861|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138573862|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138325299|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325300|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138325301|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
138573863|NCT00143169|Analgesics|analgesics|mesh-ancestor
138573864|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
138573865|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573866|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573867|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573868|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138573869|NCT00109109|Vorinostat|vorinostat|mesh-list
138573870|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573871|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138573872|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573873|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573875|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
138573876|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
138573877|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138573878|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
138573879|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573880|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573881|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138573882|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
138573883|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138573884|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138573885|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138573886|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
138573887|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573888|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573889|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
138325341|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325342|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138325343|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138573890|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138573891|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
138573892|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
138573893|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
138573894|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138573895|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138573896|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573897|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573898|NCT00109148|Hormones|hormones|mesh-ancestor
138573899|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325389|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138573900|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573901|NCT00452296|Insulin|insulin|mesh-list
138573902|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138573903|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573905|NCT00452569|Dexamethasone|dexamethasone|mesh-list
138573906|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138573907|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
138573908|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
138573909|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573910|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573911|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138573912|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
138573913|NCT00452569|Hormones|hormones|mesh-ancestor
138573914|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138573915|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138573916|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573917|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138573918|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
138573919|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
138573920|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138573921|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138573922|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138573923|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138573924|NCT00452569|Growth Substances|growth substances|mesh-ancestor
138573925|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
138573926|NCT00143286|Varenicline|varenicline|mesh-list
138573927|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138573928|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138573929|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
138655940|NCT00347100|Metformin|metformin|mesh-list
138573930|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573931|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573932|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573933|NCT00109187|Omalizumab|omalizumab|mesh-list
138573934|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138325452|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138573935|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138573936|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
138325453|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325455|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138325456|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138325457|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
138325466|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
138573937|NCT00452608|Atorvastatin|atorvastatin|mesh-list
138573938|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138573939|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138573940|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
138573941|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573942|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138573943|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138573944|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573945|NCT00109226|Bevacizumab|bevacizumab|mesh-list
138573946|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138573947|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573948|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138573949|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138573950|NCT00109226|Growth Substances|growth substances|mesh-ancestor
138325486|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325487|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138325488|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
138325489|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325490|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138325491|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138573951|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573952|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
138573953|NCT00452725|Hormones|hormones|mesh-list
138573954|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138573955|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573956|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138573957|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573958|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138573959|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138573960|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573961|NCT00143364|Varenicline|varenicline|mesh-list
138573962|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138573963|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138573964|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
138573965|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138573966|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475616|NCT04050280|Immunotoxins|immunotoxins|mesh-ancestor
138573967|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573968|NCT00452881|Gemcitabine|gemcitabine|mesh-list
138573969|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
138573970|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573971|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138325544|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
138573972|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
138325545|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
138325546|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325549|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138573973|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573974|NCT00452920|Docetaxel|docetaxel|mesh-list
138573975|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138573976|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
138573977|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
138573978|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
138573979|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250345|NCT05722301|Testosterone undecanoate|testosterone undecanoate|mesh-list
138573980|NCT00143442|Reboxetine|reboxetine|mesh-list
138573981|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
138573982|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138573983|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138573984|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138573985|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138573986|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138573987|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
138573988|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138655960|NCT00321074|Tacrolimus|tacrolimus|mesh-list
138573989|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573990|NCT00109382|Aspirin|aspirin|mesh-list
138573991|NCT00109382|Clopidogrel|clopidogrel|mesh-list
138573992|NCT00109382|Simvastatin|simvastatin|mesh-list
138573993|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138573994|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138573995|NCT00109382|Analgesics|analgesics|mesh-ancestor
138573996|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
138573997|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138573998|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138573999|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138574000|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138574001|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138574002|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138574003|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574004|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138574005|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138574006|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574007|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
138574008|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138325594|NCT02283996|Prednisolone|prednisolone|mesh-list
138325595|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
138574009|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138574010|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138574011|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
138574012|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574013|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138574014|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138574015|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
138574016|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138574017|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138574018|NCT00453076|Paclitaxel|paclitaxel|mesh-list
138574019|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138574020|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574021|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
138574022|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
138574023|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
138574024|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574025|NCT00453115|Gemcitabine|gemcitabine|mesh-list
138574026|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
138574027|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138574028|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
138574029|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574030|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574031|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138574032|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138574033|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138574034|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
138574035|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574036|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574037|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574038|NCT00143481|Urological Agents|urological agents|mesh-ancestor
138574039|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138574040|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138574041|NCT00453232|Etoposide|etoposide|mesh-list
138574042|NCT00453232|Bleomycin|bleomycin|mesh-list
138574043|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574044|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138655962|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
138574045|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138574046|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138574047|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574048|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574049|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138574050|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
138574051|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138574052|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574053|NCT00143520|Pioglitazone|pioglitazone|mesh-list
138574054|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138574055|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574057|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
138574058|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574059|NCT00453778|Fluticasone|fluticasone|mesh-list
138574061|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138574062|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138574063|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
138574064|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574065|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574066|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138641795|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574067|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
138574068|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
138574069|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138574070|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
138574071|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138574072|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138574073|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138574074|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574075|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
138574076|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
138574077|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
138574078|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
138574079|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138574080|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
138574081|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138574082|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138574083|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574084|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138574085|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475642|NCT03994731|Antipyretics|antipyretics|mesh-ancestor
138574086|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574088|NCT00454168|Sargramostim|sargramostim|mesh-list
138574089|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
138574090|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574091|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
138574092|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138574093|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
138574094|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574095|NCT03274765|Estradiol|estradiol|mesh-list
138574096|NCT03274765|Estrogens|estrogens|mesh-ancestor
138574097|NCT03274765|Hormones|hormones|mesh-ancestor
138574098|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138574099|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574100|NCT00454402|Alfuzosin|alfuzosin|mesh-list
138574101|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138574102|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138574103|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138574104|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
138574105|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574106|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574107|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574109|NCT00143676|Atorvastatin|atorvastatin|mesh-list
138574110|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138574111|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138574112|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
138574113|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574114|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138574115|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138656021|NCT00321347|Lidocaine|lidocaine|mesh-list
138574116|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574117|NCT00454480|Cytarabine|cytarabine|mesh-list
138574118|NCT00454480|Fludarabine|fludarabine|mesh-list
138574119|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
138574120|NCT00454480|Azacitidine|azacitidine|mesh-list
138574121|NCT00454480|Melphalan|melphalan|mesh-list
138574122|NCT00454480|Busulfan|busulfan|mesh-list
138574123|NCT00454480|Daunorubicin|daunorubicin|mesh-list
138574124|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
138574125|NCT00454480|Clofarabine|clofarabine|mesh-list
138574126|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
138574127|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
138574128|NCT00454480|Tipifarnib|tipifarnib|mesh-list
138574129|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574130|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138574131|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
138574132|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574134|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
138574135|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574136|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
138574137|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574138|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641913|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
138574139|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138574140|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
138574141|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138574142|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138574143|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138574144|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138574145|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138574146|NCT00454480|Immunotoxins|immunotoxins|mesh-ancestor
138574147|NCT00454480|Immunoconjugates|immunoconjugates|mesh-ancestor
138574148|NCT00110006|Prednisone|prednisone|mesh-list
138325640|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138574149|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
138574150|NCT00110006|Rituximab|rituximab|mesh-list
138574151|NCT00110006|Doxorubicin|doxorubicin|mesh-list
138574152|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138574153|NCT00110006|Vincristine|vincristine|mesh-list
138574154|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138574155|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138574156|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
138574157|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574158|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138574159|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138574160|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
138574161|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574162|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574163|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138574164|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138574165|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138574166|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138574167|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138574168|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574169|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138574170|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
138574172|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138574174|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138574175|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
138574176|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
138574177|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
138574178|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138574179|NCT00454519|Mitomycins|mitomycins|mesh-list
138574180|NCT00454519|Mitomycin|mitomycin|mesh-list
138574181|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574182|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138574183|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
138574184|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574185|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138574186|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574187|NCT00112749|Infliximab|infliximab|mesh-list
138574188|NCT00112749|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138574189|NCT00112749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138574190|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
138574191|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138574192|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138574193|NCT00110045|Caspofungin|caspofungin|mesh-list
138574194|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
138574195|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574196|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642086|NCT00265304|Ketoprofen|ketoprofen|mesh-list
138574197|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574198|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
138574199|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
138574200|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138574201|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138574202|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574203|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574204|NCT00454714|Urological Agents|urological agents|mesh-ancestor
138250570|NCT05720273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138574205|NCT00143715|Vitamin K|vitamin k|mesh-list
138574206|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
138475671|NCT03824522|BAX 855|bax 855|mesh-list
138574208|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
138574209|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574210|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138574211|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138574212|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574213|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
138574214|NCT00143715|Coagulants|coagulants|mesh-ancestor
138574215|NCT00454831|Chitosan|chitosan|mesh-list
138574216|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138574217|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138574218|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
138574219|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574220|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138574221|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
138574222|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
138574223|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
138574224|NCT00454831|Coagulants|coagulants|mesh-ancestor
138574225|NCT00110123|Fotemustine|fotemustine|mesh-list
138656085|NCT00322166|Calcium|calcium|mesh-list
138574226|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574227|NCT00455026|Remifentanil|remifentanil|mesh-list
138574228|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138574229|NCT00455026|Narcotics|narcotics|mesh-ancestor
138574231|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656114|NCT00322400|Paclitaxel|paclitaxel|mesh-list
138574232|NCT00455026|Analgesics|analgesics|mesh-ancestor
138574233|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
138574234|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574235|NCT00143325|Varenicline|varenicline|mesh-list
138574236|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138574237|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138574238|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
138574239|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574240|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574241|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574242|NCT00112983|Eculizumab|eculizumab|mesh-list
138574243|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138574244|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138574245|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
138574246|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574247|NCT00110162|Hormones|hormones|mesh-list
138574248|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
138574249|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138475688|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
138574250|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574251|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
138574252|NCT02273713|Paclitaxel|paclitaxel|mesh-list
138574253|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138574254|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574255|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
138574256|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
138574257|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
138574258|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574259|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138574260|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
138642240|NCT00295464|Betamethasone|betamethasone|mesh-list
138574261|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574262|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138574263|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138574264|NCT02273791|Clomiphene|clomiphene|mesh-list
138574265|NCT02273791|Enclomiphene|enclomiphene|mesh-list
138574266|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
138574267|NCT02273791|Estradiol|estradiol|mesh-list
138574268|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138574269|NCT02273791|Estrogens|estrogens|mesh-ancestor
138574270|NCT02273791|Hormones|hormones|mesh-ancestor
138574271|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138574272|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574273|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138574274|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
138574275|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138574276|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138574277|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138574278|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
138574279|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138574280|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
138574281|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138574282|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138574283|NCT00110240|Vildagliptin|vildagliptin|mesh-list
138574284|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138574285|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574286|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138574287|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
138574288|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574289|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574291|NCT00455416|Allicin|allicin|mesh-list
138325646|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138574292|NCT00455416|Resveratrol|resveratrol|mesh-list
138574293|NCT00455416|Quercetin|quercetin|mesh-list
138325648|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
138574294|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
138656271|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138574295|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574296|NCT00455416|Protective Agents|protective agents|mesh-ancestor
138574297|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574298|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574299|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138574300|NCT00455416|Trace Elements|trace elements|mesh-ancestor
138574301|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
138574302|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574303|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138574304|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
138574305|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138574306|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138574307|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138574308|NCT00143871|Rituximab|rituximab|mesh-list
138574309|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138574310|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574311|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
138574312|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574313|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138574314|NCT00455572|Vinorelbine|vinorelbine|mesh-list
138574315|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574316|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138475718|NCT03461120|Anesthetics|anesthetics|mesh-list
138574317|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
138574318|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
138574319|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
138574320|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574321|NCT00401492|Gemcitabine|gemcitabine|mesh-list
138574322|NCT00401492|Vinorelbine|vinorelbine|mesh-list
138574323|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574324|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138574325|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
138574326|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574327|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138574328|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
138574329|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
138574330|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
138574332|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
138574333|NCT00455806|Esomeprazole|esomeprazole|mesh-list
138574334|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138574335|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574336|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138574337|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138574338|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574339|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574340|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574341|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138574342|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138574343|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138574344|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
138574345|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138574346|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
138574347|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138574348|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574349|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138574350|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138574351|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138574352|NCT00110474|Acetaminophen|acetaminophen|mesh-list
138574353|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138574354|NCT00110474|Analgesics|analgesics|mesh-ancestor
138574355|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
138574356|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574357|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574358|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
138574360|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138574361|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138574362|NCT00113100|Estradiol|estradiol|mesh-list
138574363|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138574364|NCT00113100|Estrogens|estrogens|mesh-ancestor
138574365|NCT00113100|Hormones|hormones|mesh-ancestor
138414695|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138574366|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138574367|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574368|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138574369|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
138574370|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138574371|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138574372|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138574373|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574374|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138574375|NCT00143949|Losartan|losartan|mesh-list
138574376|NCT00143949|Enalapril|enalapril|mesh-list
138574377|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138475725|NCT03396588|Morphine|morphine|mesh-list
138574378|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138574379|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138574380|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138574381|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574382|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138574383|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
138574385|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
138574386|NCT00456235|Cyclosporine|cyclosporine|mesh-list
138574387|NCT00456235|Tacrolimus|tacrolimus|mesh-list
138574388|NCT00456235|Cyclosporins|cyclosporins|mesh-list
138574389|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138574390|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
138574391|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574392|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138574393|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574394|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574395|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138574396|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574397|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138574398|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
138574399|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138574400|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574401|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
138574402|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
138574403|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138574404|NCT00456313|Fluticasone|fluticasone|mesh-list
138574405|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138574406|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138574407|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
138574408|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574409|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574410|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138574411|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
138574412|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
138574413|NCT00456313|Hormones|hormones|mesh-ancestor
138574414|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138574415|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
138574416|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138574417|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
138574418|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138574419|NCT00110630|Nicotine|nicotine|mesh-list
138574420|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138574421|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
138574422|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574423|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232025|NCT03192345|Cemiplimab|cemiplimab|mesh-list
138574424|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138574425|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138574426|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
138574427|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574428|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574429|NCT00456430|Escitalopram|escitalopram|mesh-list
138574430|NCT00456430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138574431|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138574432|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138250793|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138574433|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574434|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574435|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
138574436|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574438|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138574439|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138574440|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138574441|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
138574442|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574443|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574444|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574445|NCT00110669|Prednisone|prednisone|mesh-list
138475742|NCT03350451|Lumasiran|lumasiran|mesh-list
138574447|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
138574448|NCT00110669|Hormones|hormones|mesh-ancestor
138574449|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138574450|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574451|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138574452|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574454|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
138574455|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574456|NCT00113256|Rubitecan|rubitecan|mesh-list
138574457|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574458|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138574459|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138574460|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574461|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642556|NCT04718649|Celecoxib|celecoxib|mesh-list
138574462|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
138574463|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138574464|NCT00110708|Antibodies|antibodies|mesh-list
138574465|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
138574466|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574467|NCT00456820|Bupropion|bupropion|mesh-list
138574468|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138574469|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
138574470|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138574471|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138574472|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138574473|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138574474|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574475|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
138574476|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574477|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574478|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138574479|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138574480|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574481|NCT00456898|Codeine|codeine|mesh-list
138574482|NCT00456898|Paroxetine|paroxetine|mesh-list
138656496|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
138574483|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138574484|NCT00456898|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138574485|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138642624|NCT00267722|Visilizumab|visilizumab|mesh-list
138574486|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138574487|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574488|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574489|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
138574490|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574491|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138574492|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
138574493|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138574494|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138574495|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138574496|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574497|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138574498|NCT00456898|Narcotics|narcotics|mesh-ancestor
138574499|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138574500|NCT00456898|Analgesics|analgesics|mesh-ancestor
138574501|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
138325653|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574504|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
138574505|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138574507|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
138574508|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574509|NCT00110747|Lidocaine|lidocaine|mesh-list
138574510|NCT00110747|Tetracaine|tetracaine|mesh-list
138574511|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
138574512|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
138574513|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138574514|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574515|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
138574516|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574517|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138574518|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138574519|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138574520|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138574521|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574522|NCT00456937|Escitalopram|escitalopram|mesh-list
138574523|NCT00456937|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138574524|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138574525|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138574526|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574527|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574528|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
138574529|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574530|NCT00456976|Selegiline|selegiline|mesh-list
138574531|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
138574532|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138574533|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138574534|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138574535|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138574536|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574537|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574538|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138574539|NCT00456976|Protective Agents|protective agents|mesh-ancestor
138574540|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574541|NCT00144066|Gefitinib|gefitinib|mesh-list
138574542|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574543|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138574544|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656523|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
138574545|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574546|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
138574547|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
138574548|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138574549|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574550|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574551|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
138574552|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138574553|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138574554|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574555|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
138574556|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138574557|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574558|NCT00457405|Dipyridamole|dipyridamole|mesh-list
138574559|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138574560|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574561|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574562|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138574563|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
138574565|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138574566|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138325656|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138325657|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
138574567|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138574568|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138574569|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574570|NCT00457483|Diuretics|diuretics|mesh-ancestor
138574571|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
138574572|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574573|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138574574|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138574576|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138574577|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574579|NCT00457678|Ranibizumab|ranibizumab|mesh-list
138574580|NCT00457678|Verteporfin|verteporfin|mesh-list
138574581|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138574582|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
138574583|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
138574584|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574585|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574586|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138574587|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
138574588|NCT00457678|Hormones|hormones|mesh-ancestor
138574589|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138574590|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138574591|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574592|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138574593|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138574594|NCT00457678|Growth Substances|growth substances|mesh-ancestor
138574595|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
138574596|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138574597|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
138574598|NCT00457717|Atropine|atropine|mesh-list
138574599|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138574600|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138574601|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138574602|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
138574603|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574604|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574605|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138574606|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
138574608|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
138574609|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138574610|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138574611|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
138574612|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574613|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574614|NCT00110903|Etanercept|etanercept|mesh-list
138574615|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138574616|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138574617|NCT00110903|Analgesics|analgesics|mesh-ancestor
138574618|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
138574619|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574620|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574621|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138574622|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138574623|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138574624|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138574625|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
138574626|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
138574627|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
138574628|NCT00144144|Giapreza|giapreza|mesh-list
138574629|NCT00144144|Calcium|calcium|mesh-list
138574630|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
138574631|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138574632|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138574633|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574634|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138574635|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138574636|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
138574637|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574638|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325664|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325665|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138574639|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138574640|NCT00465673|Doxorubicin|doxorubicin|mesh-list
138574641|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138574642|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138574643|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574644|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138574645|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138574646|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574647|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574648|NCT00144183|Zidovudine|zidovudine|mesh-list
138574649|NCT00144183|Nevirapine|nevirapine|mesh-list
138574650|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
138642904|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642905|NCT00297141|Capecitabine|capecitabine|mesh-list
138574651|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574652|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138574653|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138574654|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574655|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
138574656|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574657|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138574658|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138574659|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138574660|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138574661|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
138574662|NCT00465751|Cathartics|cathartics|mesh-ancestor
138574663|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138574664|NCT00110981|Etanercept|etanercept|mesh-list
138574665|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138574666|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138574667|NCT00110981|Analgesics|analgesics|mesh-ancestor
138574668|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
138319591|NCT04026282|Hormones|hormones|mesh-ancestor
138574669|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574670|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574671|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138574672|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138574673|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138574674|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138574675|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
138574676|NCT00465907|Paclitaxel|paclitaxel|mesh-list
138574677|NCT00465907|Carboplatin|carboplatin|mesh-list
138574678|NCT00465907|Irinotecan|irinotecan|mesh-list
138574679|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138574680|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574681|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
138574682|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
138574683|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
138574684|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574685|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138574686|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138574687|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574688|NCT00113685|Dextrans|dextrans|mesh-list
138574689|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138574690|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
138574691|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
138574692|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
138574693|NCT00111020|Sorafenib|sorafenib|mesh-list
138574694|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475772|NCT03153319|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138574695|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138574696|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574697|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574698|NCT00466063|Deferasirox|deferasirox|mesh-list
138574699|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138574700|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
138574701|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
138574702|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574703|NCT00466102|Everolimus|everolimus|mesh-list
138574704|NCT00466102|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138574705|NCT00466102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138574706|NCT00466102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574707|NCT00466102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574708|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138574709|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
138574710|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574711|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574712|NCT00144222|Telmisartan|telmisartan|mesh-list
138574713|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138574714|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138574715|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138574716|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574717|NCT00466180|Nevirapine|nevirapine|mesh-list
138574718|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138574719|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138574720|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574721|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574722|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
138574723|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574724|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138574725|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138574726|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138574727|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138574728|NCT00466219|Interferons|interferons|mesh-list
138574729|NCT00466219|Ribavirin|ribavirin|mesh-list
138574730|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
138574731|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
138574732|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138574733|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574734|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
138574735|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574736|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
138574737|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574738|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
138574739|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574740|NCT00144261|Nevirapine|nevirapine|mesh-list
138574741|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138574742|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138574743|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574744|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643039|NCT00269867|Infliximab|infliximab|mesh-list
138574745|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
138574746|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574747|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138574748|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138574749|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138574750|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138574751|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138574752|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
138574753|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574754|NCT00144378|Irinotecan|irinotecan|mesh-list
138574755|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138574756|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138574757|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574758|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574759|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574760|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
138574761|NCT00111098|Hematinics|hematinics|mesh-ancestor
138574762|NCT00347698|Bevacizumab|bevacizumab|mesh-list
138574763|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138574764|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574765|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138574766|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138574767|NCT00347698|Growth Substances|growth substances|mesh-ancestor
138574768|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574769|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
138574770|NCT00347737|Teriparatide|teriparatide|mesh-list
138574771|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138574772|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574773|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138574774|NCT00347815|Buprenorphine|buprenorphine|mesh-list
138574775|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138475832|NCT02358538|GABA Modulators|gaba modulators|mesh-ancestor
138574776|NCT00347815|Narcotics|narcotics|mesh-ancestor
138325667|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
138325670|NCT05578950|Itraconazole|itraconazole|mesh-list
138574777|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138574778|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656588|NCT00324779|Rituximab|rituximab|mesh-list
138574779|NCT00347815|Analgesics|analgesics|mesh-ancestor
138574780|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
138574781|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574782|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138574783|NCT00113802|Epratuzumab|epratuzumab|mesh-list
138574784|NCT00113802|Antibodies|antibodies|mesh-list
138574785|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
138574786|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574787|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138574788|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574789|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
138574791|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138574792|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138574793|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
138574794|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138574795|NCT00347854|Laxatives|laxatives|mesh-ancestor
138574796|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138574797|NCT00347971|Rituximab|rituximab|mesh-list
138574798|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138574799|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574800|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
138574801|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574802|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138574803|NCT00113958|Cinacalcet|cinacalcet|mesh-list
138574804|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138574805|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574806|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138574807|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
138574808|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138574809|NCT00348010|Tramadol|tramadol|mesh-list
138574810|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138574811|NCT00348010|Narcotics|narcotics|mesh-ancestor
138574812|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138574813|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574814|NCT00348010|Analgesics|analgesics|mesh-ancestor
138574815|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
138574816|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574817|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
138574818|NCT00144417|Rifampin|rifampin|mesh-list
138574819|NCT00144417|Isoniazid|isoniazid|mesh-list
138643130|NCT00270569|Cisplatin|cisplatin|mesh-list
138574820|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
138574821|NCT00144417|Ethambutol|ethambutol|mesh-list
138574822|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138574823|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138574824|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138574825|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138574826|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574827|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574828|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574829|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138574830|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
138574831|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
138574832|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138574833|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138574834|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138574835|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138574836|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138574837|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138574838|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138574839|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138656600|NCT00324974|Lansoprazole|lansoprazole|mesh-list
138574840|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138574841|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
138574842|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138574843|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138574844|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
138574845|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138574846|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138574847|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574848|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
138574849|NCT00111215|Coagulants|coagulants|mesh-ancestor
138574850|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138574851|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
138574852|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574853|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
138574854|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
138574855|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
138574856|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574857|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574858|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
138574859|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138574860|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138574861|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
138475895|NCT01476839|Etoposide|etoposide|mesh-list
138475897|NCT01476839|Melphalan|melphalan|mesh-list
138574862|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574863|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574864|NCT00348244|Prednisolone|prednisolone|mesh-list
138574865|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138574866|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
138574867|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138574868|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
138574870|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138574871|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
138574872|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138574873|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
138574874|NCT00348244|Hormones|hormones|mesh-ancestor
138574875|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138574876|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574877|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138251245|NCT00359879|Exenatide|exenatide|mesh-list
138574878|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574880|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
138574881|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574882|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138574883|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138574884|NCT00348244|Protective Agents|protective agents|mesh-ancestor
138574885|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138574886|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138574887|NCT00348244|Analgesics|analgesics|mesh-ancestor
138643195|NCT00418548|Analgesics|analgesics|mesh-ancestor
138574889|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138574890|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138574891|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574892|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574893|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138574894|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
138574895|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138574896|NCT00348361|Fluticasone|fluticasone|mesh-list
138574898|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138574899|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138574900|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
138574901|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138574902|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574903|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138574904|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
138574905|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
138574906|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138574907|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138574908|NCT00348400|Dorzolamide|dorzolamide|mesh-list
138574909|NCT00348400|Latanoprost|latanoprost|mesh-list
138574910|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138574911|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138574912|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138475927|NCT01163357|Bortezomib|bortezomib|mesh-list
138574913|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138325679|NCT05578950|Hormone Antagonists|hormone antagonists|mesh-ancestor
138574914|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138574915|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138574916|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
138574917|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574918|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574919|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574920|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138574921|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574922|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
138574923|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138574924|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
138574925|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138574926|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574928|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
138574929|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
138574930|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138574931|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138574932|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574933|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138574934|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138574935|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
138574936|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138574937|NCT00348517|Laxatives|laxatives|mesh-ancestor
138574938|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138574939|NCT00348634|Tegaserod|tegaserod|mesh-list
138574940|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138574941|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
138574942|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574943|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574944|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574945|NCT00348712|Insulin|insulin|mesh-list
138574946|NCT00348712|Metformin|metformin|mesh-list
138574947|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
138574948|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138574949|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138574950|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574951|NCT02964689|Pemetrexed|pemetrexed|mesh-list
138251332|NCT00000897|Zidovudine|zidovudine|mesh-list
138574952|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574953|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138475953|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
138574954|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574955|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138574956|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138574958|NCT00348985|Belinostat|belinostat|mesh-list
138574959|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138574960|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138574961|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574962|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574963|NCT00349024|Povidone|povidone|mesh-list
138574964|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
138574965|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138574966|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
138574967|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574968|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
138574969|NCT00349024|Protective Agents|protective agents|mesh-ancestor
138574970|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
138574971|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
138574972|NCT00111371|Levodopa|levodopa|mesh-list
138574973|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138574974|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138574975|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
138574976|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574977|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574978|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574979|NCT00349180|Enoxaparin|enoxaparin|mesh-list
138574980|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
138574981|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
138574982|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138574983|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138574984|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574986|NCT00421369|Reboxetine|reboxetine|mesh-list
138574987|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
138574988|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138574989|NCT00421369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138574990|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138574991|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138475988|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138574992|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138574993|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138574994|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
138574995|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138574996|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138574997|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
138574998|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138574999|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575000|NCT00421447|Anastrozole|anastrozole|mesh-list
138575001|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138575002|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575003|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138575004|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138575005|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575006|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575008|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
138575009|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138575010|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575011|NCT04729140|Doxycycline|doxycycline|mesh-list
138575013|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138575014|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138575015|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
138575016|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138575017|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138575018|NCT00349219|Cisplatin|cisplatin|mesh-list
138575019|NCT00349219|Gemcitabine|gemcitabine|mesh-list
138575020|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138575021|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575022|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138575023|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
138575024|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575025|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138575026|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575027|NCT00111449|Etanercept|etanercept|mesh-list
138575028|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138575029|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138575030|NCT00111449|Analgesics|analgesics|mesh-ancestor
138575031|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
138575032|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575033|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575034|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138575035|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575036|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138575037|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138575038|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
138575039|NCT00349258|Leuprolide|leuprolide|mesh-list
138575040|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138575041|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
138575042|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138575043|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575044|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138575045|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575046|NCT00349375|Simvastatin|simvastatin|mesh-list
138575047|NCT00349375|Fenofibrate|fenofibrate|mesh-list
138575048|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138575049|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138575050|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
138575051|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575052|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138575053|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138575054|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325690|NCT01893996|Adalimumab|adalimumab|mesh-list
138575055|NCT00349453|Deferiprone|deferiprone|mesh-list
138575056|NCT00349453|Deferoxamine|deferoxamine|mesh-list
138575057|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138575058|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
138575059|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
138575060|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575061|NCT00349453|Siderophores|siderophores|mesh-ancestor
138575062|NCT00349492|Cisplatin|cisplatin|mesh-list
138575063|NCT00349492|Irinotecan|irinotecan|mesh-list
138575064|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575065|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138575066|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138575067|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575068|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575069|NCT00349531|Pramipexole|pramipexole|mesh-list
138575070|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
138575071|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575072|NCT00349531|Protective Agents|protective agents|mesh-ancestor
138575073|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575074|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138575075|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138575076|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
138575077|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
138575078|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575079|NCT00111566|Eptifibatide|eptifibatide|mesh-list
138575080|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138575081|NCT00404703|Bevacizumab|bevacizumab|mesh-list
138476056|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
138575082|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138575083|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575084|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138575085|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138575086|NCT00404703|Growth Substances|growth substances|mesh-ancestor
138575087|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575088|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
138575090|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
138575091|NCT00349726|Vitamins|vitamins|mesh-ancestor
138575092|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
138575093|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575094|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
138575095|NCT00111644|Lactams|lactams|mesh-list
138575096|NCT00111644|beta-Lactams|beta-lactams|mesh-list
138575097|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138575098|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138575099|NCT00350038|Irbesartan|irbesartan|mesh-list
138575100|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
138575101|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138251477|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
138575102|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138575103|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138575104|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575105|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138575106|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
138575107|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138575108|NCT00350077|Vitamins|vitamins|mesh-list
138575109|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
138575110|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
138575111|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575112|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
138575113|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575114|NCT00350077|Protective Agents|protective agents|mesh-ancestor
138575115|NCT00114153|Carboplatin|carboplatin|mesh-list
138575116|NCT00114153|Capecitabine|capecitabine|mesh-list
138575117|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476088|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
138643561|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138575118|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138575120|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575121|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
138575122|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
138575123|NCT00350116|Vitamins|vitamins|mesh-ancestor
138575124|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
138575125|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575126|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
138325693|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575127|NCT00350116|Hematinics|hematinics|mesh-ancestor
138575128|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
138575129|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138575130|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138575131|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575132|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575133|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138575134|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138575135|NCT00350155|Analgesics|analgesics|mesh-ancestor
138575136|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
138575137|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575138|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575139|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138575140|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575141|NCT00404781|Aspirin|aspirin|mesh-list
138575142|NCT00404781|Cilostazol|cilostazol|mesh-list
138575143|NCT00404781|Clopidogrel|clopidogrel|mesh-list
138575144|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138575145|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138575146|NCT00404781|Analgesics|analgesics|mesh-ancestor
138575147|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
138575148|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575149|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575150|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138575151|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575152|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138575153|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138575154|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575155|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138575156|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138575157|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575158|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
138575159|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138575160|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138575161|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138575162|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
138575163|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575164|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138575165|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
138575166|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138575167|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
138575168|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
138575169|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138575170|NCT00404781|Protective Agents|protective agents|mesh-ancestor
138575171|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138575172|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138575174|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138575175|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
138575176|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656728|NCT00325793|Nicardipine|nicardipine|mesh-list
138575177|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575178|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138575179|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138251547|NCT00001965|Cyclosporine|cyclosporine|mesh-list
138575180|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
138575181|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575182|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575184|NCT00114192|Docetaxel|docetaxel|mesh-list
138575185|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575186|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
138575187|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
138575188|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
138575189|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575190|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138575191|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
138575192|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575193|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
138575194|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138575195|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138575196|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138575197|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138325698|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
138575198|NCT00114192|Growth Substances|growth substances|mesh-ancestor
138575199|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
138575200|NCT00350467|Olanzapine|olanzapine|mesh-list
138575201|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138575202|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
138575203|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
138575204|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575205|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575206|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138575207|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138575208|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138575209|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575210|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138575211|NCT00350467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138575212|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138575213|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575214|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575215|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575216|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
138575217|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138575218|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138575219|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138575220|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138575221|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
138575222|NCT00350662|Deferiprone|deferiprone|mesh-list
138575223|NCT00350662|Deferoxamine|deferoxamine|mesh-list
138575224|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138575225|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
138575226|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
138575227|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575228|NCT00350662|Siderophores|siderophores|mesh-ancestor
138575229|NCT00350818|Azacitidine|azacitidine|mesh-list
138575230|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138575231|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
138575232|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575233|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575234|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575236|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
138575237|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
138575238|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138575239|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575240|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575241|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138575242|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138575243|NCT00350857|Analgesics|analgesics|mesh-ancestor
138656736|NCT00426621|Diclofenac|diclofenac|mesh-list
138575244|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
138575245|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138476201|NCT02011126|Imetelstat|imetelstat|mesh-list
138575246|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138575247|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575248|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575249|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138575250|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138575252|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138575253|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138575255|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
138575256|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575257|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575258|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138575259|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575260|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138575261|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138575262|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
138575263|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
138575265|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575266|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138575267|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138575268|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575269|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325701|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
138575270|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138575271|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
138575272|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138575273|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575274|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138575275|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
138575276|NCT00111995|Hematinics|hematinics|mesh-ancestor
138575277|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
138643920|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
138575278|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138575279|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138575280|NCT00351052|Analgesics|analgesics|mesh-ancestor
138575281|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
138575282|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575283|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575284|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138575285|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575286|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
138575287|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138575288|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
138575289|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138575290|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575291|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575292|NCT00401609|Carboplatin|carboplatin|mesh-list
138575293|NCT00401609|Gemcitabine|gemcitabine|mesh-list
138575294|NCT00401609|Etoposide|etoposide|mesh-list
138575296|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575297|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138575298|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
138575299|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575300|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138575301|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138575302|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138575303|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138656739|NCT00426621|Analgesics|analgesics|mesh-ancestor
138575304|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
138575305|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
138575306|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
138575307|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
138575308|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138575309|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575310|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575311|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138575312|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575313|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138575315|NCT00351130|Valsartan|valsartan|mesh-list
138575316|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138575318|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575319|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575320|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138575321|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575322|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
138575323|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138575324|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138575325|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138575326|NCT00351169|Escitalopram|escitalopram|mesh-list
138575327|NCT00351169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138575328|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138575329|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575330|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575331|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575333|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575334|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
138575335|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138575336|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138575337|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138575338|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138325704|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138575339|NCT00401648|Brivaracetam|brivaracetam|mesh-list
138575340|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
138575341|NCT00351286|Simvastatin|simvastatin|mesh-list
138575342|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138575344|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
138575345|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575346|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138575347|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138575348|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575349|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
138575350|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138575351|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138575352|NCT00112034|Prednisolone|prednisolone|mesh-list
138575353|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
138575354|NCT00112034|Methotrexate|methotrexate|mesh-list
138575355|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138575356|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
138575357|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138575358|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
138575359|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138575360|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575361|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138575363|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575364|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575365|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
138575366|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575367|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138575368|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138575369|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
138575370|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575371|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138575372|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138575373|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
138575374|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
138575375|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575376|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138575377|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
138575378|NCT00112034|Hormones|hormones|mesh-ancestor
138575379|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138575380|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138575381|NCT00112034|Protective Agents|protective agents|mesh-ancestor
138575382|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138575383|NCT00114387|Tocopherols|tocopherols|mesh-list
138575384|NCT00114387|Vitamin E|vitamin e|mesh-list
138575385|NCT00114387|Tocotrienols|tocotrienols|mesh-list
138575386|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
138575387|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
138575388|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575389|NCT00114387|Protective Agents|protective agents|mesh-ancestor
138476271|NCT02011750|Valproic Acid|valproic acid|mesh-list
138575390|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575391|NCT00114387|Vitamins|vitamins|mesh-ancestor
138575392|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
138575393|NCT00351364|Montelukast|montelukast|mesh-list
138575394|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138575395|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
138575396|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138575397|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
138575398|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138575399|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575400|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138575401|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138575402|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575403|NCT00351403|Ribavirin|ribavirin|mesh-list
138575404|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138575405|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
138575406|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575407|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
138575408|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138575409|NCT05595096|Anesthetics|anesthetics|mesh-list
138575410|NCT05595096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138325708|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138575411|NCT05595096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575412|NCT00351637|Methadone|methadone|mesh-list
138575413|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138575414|NCT00351637|Narcotics|narcotics|mesh-ancestor
138656777|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
138575415|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575416|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575417|NCT00351637|Analgesics|analgesics|mesh-ancestor
138476339|NCT02012075|Metoprolol|metoprolol|mesh-list
138575418|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
138575419|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575420|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
138575421|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
138575423|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138575424|NCT00351715|Narcotics|narcotics|mesh-ancestor
138575425|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575426|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575427|NCT00351715|Analgesics|analgesics|mesh-ancestor
138575428|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
138575429|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575430|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
138575431|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
138575432|NCT00351832|Vildagliptin|vildagliptin|mesh-list
138575433|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138575434|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575435|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138575436|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
138575437|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644211|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575438|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575440|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138575441|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
138575442|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575443|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
138575444|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138575445|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138575446|NCT00351910|Amitriptyline|amitriptyline|mesh-list
138575447|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138575448|NCT00351910|Citalopram|citalopram|mesh-list
138575449|NCT00351910|Bupropion|bupropion|mesh-list
138575450|NCT00351910|Fluoxetine|fluoxetine|mesh-list
138575451|NCT00351910|Paroxetine|paroxetine|mesh-list
138575452|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138575453|NCT00351910|Sertraline|sertraline|mesh-list
138575454|NCT00351910|Escitalopram|escitalopram|mesh-list
138575455|NCT00351910|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138575456|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138575457|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575458|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575459|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138476353|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
138575460|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
138575461|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575462|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575463|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138575464|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
138575465|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138575466|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138575467|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
138575468|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138575469|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138575470|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575471|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138575472|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138575473|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575474|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138575476|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
138575477|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138575478|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138575479|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138575480|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
138575481|NCT00112346|Gemcitabine|gemcitabine|mesh-list
138575482|NCT00112346|Cetuximab|cetuximab|mesh-list
138575483|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138575484|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
138575485|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575486|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575487|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138575488|NCT00352144|Eszopiclone|eszopiclone|mesh-list
138575489|NCT00352144|Zopiclone|zopiclone|mesh-list
138575490|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138575491|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575492|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575493|NCT00352183|Simvastatin|simvastatin|mesh-list
138575494|NCT00352183|Fenofibrate|fenofibrate|mesh-list
138575495|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138575496|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138575497|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
138575498|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575499|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138575500|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138575501|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575502|NCT00112619|Topotecan|topotecan|mesh-list
138575503|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138575504|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138575505|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575506|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575507|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575508|NCT00352261|Esomeprazole|esomeprazole|mesh-list
138575509|NCT00352261|Lansoprazole|lansoprazole|mesh-list
138575510|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
138575511|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138575512|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138575513|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138575514|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575515|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575517|NCT00352300|Carboplatin|carboplatin|mesh-list
138575518|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138575519|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575520|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
138575521|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
138575522|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
138575523|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575524|NCT00112658|Leucovorin|leucovorin|mesh-list
138575525|NCT00112658|Gemcitabine|gemcitabine|mesh-list
138575526|NCT00112658|Fluorouracil|fluorouracil|mesh-list
138575527|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
138575528|NCT00112658|Irinotecan|irinotecan|mesh-list
138575529|NCT00112658|Calcium|calcium|mesh-list
138575530|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
138575531|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138575532|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
138575533|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575534|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575535|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138575536|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575537|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138575538|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
138575539|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138575540|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138575541|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575542|NCT00112658|Antidotes|antidotes|mesh-ancestor
138575543|NCT00112658|Protective Agents|protective agents|mesh-ancestor
138575544|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
138575545|NCT00112658|Vitamins|vitamins|mesh-ancestor
138575546|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
138575547|NCT00352339|Aripiprazole|aripiprazole|mesh-list
138575548|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
138575549|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138575550|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138575551|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138575552|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575553|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325718|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138575554|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
138575555|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
138575556|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575557|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575558|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138575559|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138575560|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
138575561|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138575562|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138575563|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138575564|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138575565|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
138575566|NCT00352378|Docetaxel|docetaxel|mesh-list
138575567|NCT00352378|Doxorubicin|doxorubicin|mesh-list
138575568|NCT00352378|Capecitabine|capecitabine|mesh-list
138575569|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138575570|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
138575571|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575572|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575573|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138575574|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
138575575|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318095|NCT01437540|Bromides|bromides|mesh-list
138575576|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575577|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138575578|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
138575579|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
138575580|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
138575581|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138575582|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138575583|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138575584|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575585|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138575586|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
138575587|NCT00352495|Carboplatin|carboplatin|mesh-list
138575588|NCT00352495|Vinblastine|vinblastine|mesh-list
138575589|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575590|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138575592|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
138575593|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
138575594|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575595|NCT00112697|Docetaxel|docetaxel|mesh-list
138575596|NCT00112697|Fluorouracil|fluorouracil|mesh-list
138575597|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575598|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
138575599|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
138575600|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
138476438|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
138644422|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575601|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575602|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
138575603|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138575604|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138575605|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
138575606|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575608|NCT02959606|Clopidogrel|clopidogrel|mesh-list
138575609|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138575610|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138575611|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138575612|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138575613|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
138575614|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575615|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575616|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575617|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138575618|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138575619|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138575620|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
138325720|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575621|NCT00352651|Pregabalin|pregabalin|mesh-list
138575622|NCT00352651|Analgesics|analgesics|mesh-ancestor
138575623|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
138575624|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575625|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575626|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
138575627|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138575628|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575629|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575630|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138575631|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138575632|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138575633|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575634|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138575635|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
138575637|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575638|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138575639|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575640|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575642|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575643|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575644|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138575645|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138575646|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575647|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575648|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138575649|NCT00352768|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138575650|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138575651|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575652|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575653|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
138575654|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138575655|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
138575656|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138575657|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138575658|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138575659|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138575660|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138575661|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138575662|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138575663|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138575664|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
138575665|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575666|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575667|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575668|NCT00112853|Etoposide|etoposide|mesh-list
138575669|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
138575670|NCT00112853|Tipifarnib|tipifarnib|mesh-list
138575671|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138575672|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575673|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138575674|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138575675|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575676|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575677|NCT00353002|Lidocaine|lidocaine|mesh-list
138575678|NCT00353002|Tetracaine|tetracaine|mesh-list
138575679|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
138575680|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
138575681|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575682|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575683|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
138575684|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575685|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138575686|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138575687|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138575688|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575689|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575690|NCT00353041|Lidocaine|lidocaine|mesh-list
138575691|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
138575692|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
138575693|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575694|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575695|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
138575696|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575697|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138575698|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138575699|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138575700|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575701|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575702|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
138575703|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138575704|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575705|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575706|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138575707|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575708|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138575711|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138575712|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138575713|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575714|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575715|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575716|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
138575717|NCT00112892|Protective Agents|protective agents|mesh-ancestor
138575718|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575719|NCT00112892|Trace Elements|trace elements|mesh-ancestor
138575720|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
138575721|NCT00353665|Riluzole|riluzole|mesh-list
138575722|NCT00353665|Memantine|memantine|mesh-list
138575723|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138575724|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138575725|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
138575726|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644594|NCT00279617|Levetiracetam|levetiracetam|mesh-list
138575727|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575728|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575729|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138575730|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138575731|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
138575732|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138575733|NCT00353665|Protective Agents|protective agents|mesh-ancestor
138575734|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
138575735|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138575736|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575737|NCT00353743|Metronidazole|metronidazole|mesh-list
138575738|NCT00353743|Doxycycline|doxycycline|mesh-list
138575739|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138575740|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138575741|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138575742|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138575743|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
138575744|NCT00113165|Lamotrigine|lamotrigine|mesh-list
138575745|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
138575746|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138575747|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575748|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575749|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138575750|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575751|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138575752|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138575753|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575754|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138575755|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138575756|NCT00354094|Reboxetine|reboxetine|mesh-list
138575757|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
138325736|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138575758|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138575759|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138575760|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138575761|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575762|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575763|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
138575764|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575765|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575766|NCT00114816|Docetaxel|docetaxel|mesh-list
138575767|NCT00114816|Capecitabine|capecitabine|mesh-list
138575768|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575769|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
138575770|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
138575771|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
138575772|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575773|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138575774|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
138575775|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
138575776|NCT00354367|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138575777|NCT00354367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138575778|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138575779|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
138575780|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575781|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575782|NCT00354406|Abciximab|abciximab|mesh-list
138575783|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
138575784|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138575785|NCT00354523|Capecitabine|capecitabine|mesh-list
138575786|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
138575787|NCT00354523|Dacarbazine|dacarbazine|mesh-list
138575788|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138575789|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
138575790|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575791|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575792|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138575793|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575794|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138575795|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
138575796|NCT00114933|Ritonavir|ritonavir|mesh-list
138575798|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138575799|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138575800|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
138575801|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575802|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575803|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138575804|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138575805|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
138575806|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138575807|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138575808|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138575809|NCT00113282|Interleukin-2|interleukin-2|mesh-list
138575810|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575811|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138575812|NCT00113282|Analgesics|analgesics|mesh-ancestor
138575813|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
138575814|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575815|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575816|NCT00425932|Rituximab|rituximab|mesh-list
138476590|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575817|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138575818|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575819|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
138575820|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575821|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575823|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138575824|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575825|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138575826|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575827|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325738|NCT04757532|Anastrozole|anastrozole|mesh-list
138575828|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138575829|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138575830|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
138575831|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575832|NCT00115011|Escitalopram|escitalopram|mesh-list
138575833|NCT00115011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138575834|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138575835|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575836|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656871|NCT00419549|Valdecoxib|valdecoxib|mesh-list
138575837|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575838|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
138575839|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575840|NCT00113594|Olanzapine|olanzapine|mesh-list
138575841|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
138575842|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
138575843|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575844|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575845|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138575846|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138575847|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138575848|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575849|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138575850|NCT00113594|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138575851|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138575852|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575853|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575854|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575855|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
138575857|NCT00426049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138575858|NCT00426049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138575859|NCT00426049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575860|NCT00426049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575861|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138575862|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
138575863|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575864|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138575865|NCT00115089|Beclomethasone|beclomethasone|mesh-list
138575866|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138575867|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
138575868|NCT00115089|Hormones|hormones|mesh-ancestor
138575869|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138575870|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575871|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138575872|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
138575873|NCT00115128|Lenograstim|lenograstim|mesh-list
138575874|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138575875|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
138575876|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575877|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
138575878|NCT00115167|Hematinics|hematinics|mesh-ancestor
138575879|NCT00115245|Adefovir|adefovir|mesh-list
138575880|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138575881|NCT00115245|Telbivudine|telbivudine|mesh-list
138575882|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
138575883|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138575884|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138575885|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138575886|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575887|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575888|NCT01059526|Ecallantide|ecallantide|mesh-list
138575889|NCT01059526|Analgesics|analgesics|mesh-ancestor
138575890|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
138575891|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575892|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575893|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138575894|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138575895|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138575896|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575897|NCT00444340|Etanercept|etanercept|mesh-list
138575898|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138575899|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138575900|NCT00444340|Analgesics|analgesics|mesh-ancestor
138575901|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
138575902|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575903|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575904|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138575905|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575906|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138575907|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138575908|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
138575910|NCT00444379|Lopinavir|lopinavir|mesh-list
138575911|NCT00444379|Tenofovir|tenofovir|mesh-list
138575912|NCT00444379|Emtricitabine|emtricitabine|mesh-list
138575913|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138575914|NCT00444379|Efavirenz|efavirenz|mesh-list
138575915|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138575916|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138575917|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
138575918|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138575919|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575920|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138575921|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138575922|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
138575923|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138575924|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138575925|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138575926|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138575927|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138575928|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138575929|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138575930|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138575931|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138575932|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138575934|NCT00444418|Naloxone|naloxone|mesh-list
138575935|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138575936|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138575937|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575938|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
138575939|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575940|NCT00444574|Methylphenidate|methylphenidate|mesh-list
138575941|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138476692|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
138575942|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575943|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138575944|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138575945|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575946|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575948|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575949|NCT00444652|Enoxaparin|enoxaparin|mesh-list
138575950|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
138575951|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138575952|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138575953|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575954|NCT04699903|Antibodies|antibodies|mesh-list
138575955|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
138575956|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
138575957|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575958|NCT00444808|Calcitonin|calcitonin|mesh-list
138575959|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
138575960|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138575961|NCT00444808|Katacalcin|katacalcin|mesh-list
138575962|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138656896|NCT00326768|Diuretics|diuretics|mesh-ancestor
138575963|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575964|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138575965|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
138575966|NCT00113828|Cyclosporine|cyclosporine|mesh-list
138575967|NCT00113828|Cyclosporins|cyclosporins|mesh-list
138575968|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644958|NCT00416897|Dexamethasone|dexamethasone|mesh-list
138575969|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575970|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138575971|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
138575972|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575973|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
138575974|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138575975|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
138656908|NCT00354549|Carboplatin|carboplatin|mesh-list
138575976|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138575977|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138575978|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
138575979|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138575980|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138476725|NCT02014506|Fludarabine|fludarabine|mesh-list
138575981|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138575982|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138575983|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138575984|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
138575985|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138575986|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575987|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138575988|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575990|NCT05594121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138575992|NCT05594121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138575993|NCT05594121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138575994|NCT05594121|Analgesics|analgesics|mesh-ancestor
138575995|NCT05594121|Sensory System Agents|sensory system agents|mesh-ancestor
138252382|NCT00002355|Fomivirsen|fomivirsen|mesh-list
138644996|NCT00417053|Melphalan|melphalan|mesh-list
138575996|NCT05594121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138575997|NCT05594121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138575998|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138575999|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138576000|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138576001|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138576002|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576003|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576004|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645043|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138576005|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138576006|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
138576007|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138576008|NCT00445042|Sorafenib|sorafenib|mesh-list
138576009|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576010|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138576011|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576012|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576013|NCT00445081|Cyclosporine|cyclosporine|mesh-list
138576014|NCT00445081|Prednisolone|prednisolone|mesh-list
138576015|NCT00445081|Cyclosporins|cyclosporins|mesh-list
138576016|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576017|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
138576019|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576020|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576021|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138576023|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576024|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576025|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138576026|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
138656969|NCT00426933|Vancomycin|vancomycin|mesh-list
138576027|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
138576028|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576029|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
138576030|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138576031|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138576032|NCT00113906|Melatonin|melatonin|mesh-list
138576033|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
138576034|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576035|NCT00113906|Protective Agents|protective agents|mesh-ancestor
138576036|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325752|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
138576037|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138576038|NCT00113945|Cinacalcet|cinacalcet|mesh-list
138576039|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138576040|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576041|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138576042|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
138576043|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576044|NCT00445159|Treprostinil|treprostinil|mesh-list
138576045|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138576046|NCT00445276|Diacerein|diacerein|mesh-list
138576047|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576048|NCT00113984|Metronidazole|metronidazole|mesh-list
138576049|NCT00113984|Ipilimumab|ipilimumab|mesh-list
138576050|NCT00113984|Sargramostim|sargramostim|mesh-list
138576051|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
138576052|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576053|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576054|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138576055|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138576056|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576057|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576058|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138576059|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138576060|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138576061|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
138576062|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138576063|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138576065|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252465|NCT00002193|Amprenavir|amprenavir|mesh-list
138576066|NCT00114023|Imiquimod|imiquimod|mesh-list
138576067|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138576068|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
138576069|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576070|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576071|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
138576072|NCT00445861|Docetaxel|docetaxel|mesh-list
138576073|NCT00445861|Cetuximab|cetuximab|mesh-list
138576074|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576075|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
138576076|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
138576077|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
138645202|NCT00317967|Atorvastatin|atorvastatin|mesh-list
138576078|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576079|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138576080|NCT00445900|Thalidomide|thalidomide|mesh-list
138576081|NCT00445900|Prednisone|prednisone|mesh-list
138576082|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
138576083|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138576084|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
138576085|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576086|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138576087|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138576088|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
138576089|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576091|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138576092|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576093|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
138576094|NCT00445900|Hormones|hormones|mesh-ancestor
138576095|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576096|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138576097|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
138576098|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138576099|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576100|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138576101|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138576102|NCT00445900|Growth Substances|growth substances|mesh-ancestor
138576103|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
138576104|NCT00115479|Insulin|insulin|mesh-list
138576105|NCT00115479|Benzocaine|benzocaine|mesh-list
138576106|NCT00115479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138576107|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576108|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
138576109|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
138576110|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138576111|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
138576112|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576113|NCT00446017|Milrinone|milrinone|mesh-list
138576114|NCT00446017|Epinephrine|epinephrine|mesh-list
138576115|NCT00446017|Racepinephrine|racepinephrine|mesh-list
138576116|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
138576117|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138576118|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138576119|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
138576120|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576121|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576122|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576123|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138576124|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138576125|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
138576126|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576127|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138576128|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
138576129|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
138576130|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
138576131|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138576132|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138576133|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138576134|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
138576135|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138576136|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138576137|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576138|NCT00446017|Protective Agents|protective agents|mesh-ancestor
138645358|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
138576139|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
138576140|NCT00446173|Busulfan|busulfan|mesh-list
138576141|NCT00446173|Sargramostim|sargramostim|mesh-list
138576142|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138576143|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
138576144|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576145|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138576146|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138576147|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
138576148|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188467|NCT00989989|Ranibizumab|ranibizumab|mesh-list
138576149|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576150|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138576152|NCT00446212|Desflurane|desflurane|mesh-list
138576153|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138576154|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138576155|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576156|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138576157|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
138576158|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
138576159|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138576160|NCT00446329|Cinacalcet|cinacalcet|mesh-list
138576161|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138576162|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576163|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138576164|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
138576165|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576167|NCT00446368|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138576168|NCT00446368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138576169|NCT00446368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325757|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138576170|NCT00446368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325758|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138576171|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138576172|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
138576173|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576174|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576175|NCT00401765|Docetaxel|docetaxel|mesh-list
138576176|NCT00401765|Siltuximab|siltuximab|mesh-list
138576177|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576178|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
138576179|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
138576180|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
138576181|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576182|NCT00115518|Cetuximab|cetuximab|mesh-list
138576183|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138576184|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576185|NCT00446524|Amlodipine|amlodipine|mesh-list
138576186|NCT00446524|Valsartan|valsartan|mesh-list
138576187|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138576188|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138576189|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138576190|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576191|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138576192|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576193|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
138576194|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138576195|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138576196|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
138576197|NCT00446602|Hematinics|hematinics|mesh-ancestor
138576198|NCT05589753|Acetazolamide|acetazolamide|mesh-list
138576199|NCT05589753|Anticonvulsants|anticonvulsants|mesh-ancestor
138657027|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
138576200|NCT05589753|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138576201|NCT05589753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576202|NCT05589753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576203|NCT05589753|Diuretics|diuretics|mesh-ancestor
138576204|NCT05589753|Natriuretic Agents|natriuretic agents|mesh-ancestor
138576205|NCT05589753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576206|NCT00114179|Bevacizumab|bevacizumab|mesh-list
138576207|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138576208|NCT00114179|Gemcitabine|gemcitabine|mesh-list
138576209|NCT00114179|Capecitabine|capecitabine|mesh-list
138576210|NCT00114179|Antibodies|antibodies|mesh-list
138576211|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
138576212|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138576213|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576214|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138576215|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138576216|NCT00114179|Growth Substances|growth substances|mesh-ancestor
138576217|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576218|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
138576219|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
138576220|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138576221|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
138576222|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576224|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138576225|NCT00446680|Diuretics|diuretics|mesh-ancestor
138576226|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
138576227|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576228|NCT00114257|Decitabine|decitabine|mesh-list
138576229|NCT00114257|Romidepsin|romidepsin|mesh-list
138576230|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138576231|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
138576232|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576233|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576234|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576235|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138576236|NCT00114257|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138576237|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138576238|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
138318098|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
138576240|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576241|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
138576242|NCT00404937|Hormones|hormones|mesh-ancestor
138576243|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576244|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576245|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138576246|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138576247|NCT00446836|Paclitaxel|paclitaxel|mesh-list
138576248|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138576249|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138576250|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576251|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
138476927|NCT02015650|Cetuximab|cetuximab|mesh-list
138576252|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
138576253|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
138576254|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576255|NCT00114374|Escitalopram|escitalopram|mesh-list
138576256|NCT00114374|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138576257|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138576258|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138576259|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576260|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576261|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
138576262|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576263|NCT00446953|Betamethasone|betamethasone|mesh-list
138576264|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576265|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
138576266|NCT00446953|Hormones|hormones|mesh-ancestor
138576267|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576268|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576269|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138576270|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
138576271|NCT00447031|Triamcinolone|triamcinolone|mesh-list
138576272|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138576273|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138576274|NCT00447031|Bevacizumab|bevacizumab|mesh-list
138576275|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138576276|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138576277|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576278|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138576279|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138576280|NCT00447031|Growth Substances|growth substances|mesh-ancestor
138576281|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576282|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
138576283|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576284|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
138576286|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576287|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138576288|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
138576289|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576290|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576291|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138576292|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138576293|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138576294|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
138576295|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476942|NCT02015728|Etoposide|etoposide|mesh-list
138576296|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576298|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138576299|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
138576300|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576301|NCT00115635|Gemcitabine|gemcitabine|mesh-list
138576302|NCT00115635|Docetaxel|docetaxel|mesh-list
138576303|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138576304|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
138576305|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576306|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576307|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
138576308|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
138576309|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
138576310|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
138576311|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138576312|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576313|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138576314|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138576315|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576316|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576317|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576318|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138576319|NCT00447577|Tobramycin|tobramycin|mesh-list
138576320|NCT00447577|Dexamethasone|dexamethasone|mesh-list
138576322|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
138576323|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
138576324|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576325|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576326|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138576327|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
138576328|NCT00447577|Hormones|hormones|mesh-ancestor
138576329|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576330|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138576331|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576332|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138576333|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576334|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138576335|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138576336|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138576337|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138576338|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
138576339|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476984|NCT02016001|Fluorides|fluorides|mesh-list
138576340|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138645991|NCT00313599|Paclitaxel|paclitaxel|mesh-list
138576341|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138576342|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576343|NCT00114569|Lorazepam|lorazepam|mesh-list
138576344|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
138576345|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
138576346|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
138576347|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576348|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576349|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138576350|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138576351|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138576352|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138576353|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138576354|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138576356|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
138576357|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576358|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576359|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
138576360|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
138576361|NCT00447967|Leucovorin|leucovorin|mesh-list
138576362|NCT00447967|Fluorouracil|fluorouracil|mesh-list
138576363|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
138576364|NCT00447967|Irinotecan|irinotecan|mesh-list
138576365|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
138646109|NCT00322296|Bexarotene|bexarotene|mesh-list
138576366|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576367|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138576368|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576369|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138576370|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
138576371|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576372|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138576373|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138576374|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646176|NCT00287963|Topotecan|topotecan|mesh-list
138325775|NCT02063022|Melphalan|melphalan|mesh-list
138325776|NCT02063022|Busulfan|busulfan|mesh-list
138576375|NCT00447967|Antidotes|antidotes|mesh-ancestor
138576376|NCT00447967|Protective Agents|protective agents|mesh-ancestor
138576377|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
138576378|NCT00447967|Vitamins|vitamins|mesh-ancestor
138576379|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
138576380|NCT00401856|Eplerenone|eplerenone|mesh-list
138477000|NCT02016209|Paclitaxel|paclitaxel|mesh-list
138576381|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138576382|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
138576383|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576384|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576385|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138576387|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
138576388|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138576389|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138576390|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576391|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138576392|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576393|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576394|NCT00448396|Epothilone B|epothilone b|mesh-list
138576395|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576396|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
138576397|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
138576398|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
138576399|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576400|NCT00114686|Valproic Acid|valproic acid|mesh-list
138576401|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138576402|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
138576403|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138576404|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138576405|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138576406|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138576407|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576408|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576409|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576410|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
138576411|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
138576412|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
138576413|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576414|NCT05553678|Midazolam|midazolam|mesh-list
138576415|NCT05553678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138576416|NCT05553678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138576417|NCT05553678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138576418|NCT05553678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576419|NCT05553678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138576420|NCT05553678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138576421|NCT05553678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138576422|NCT05553678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138576423|NCT05553678|Anesthetics, General|anesthetics, general|mesh-ancestor
138576424|NCT05553678|Anesthetics|anesthetics|mesh-ancestor
138576425|NCT05553678|GABA Modulators|gaba modulators|mesh-ancestor
138576426|NCT05553678|GABA Agents|gaba agents|mesh-ancestor
138576427|NCT05553678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576428|NCT05553678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576429|NCT00448552|Capecitabine|capecitabine|mesh-list
138576430|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
138576431|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138576432|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
138576433|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576434|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576436|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138576437|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576438|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138576439|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576440|NCT00114764|Lenograstim|lenograstim|mesh-list
138576441|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138252835|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
138576442|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
138576443|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576444|NCT00448786|Niacinamide|niacinamide|mesh-list
138576445|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
138576446|NCT00448786|Imetelstat|imetelstat|mesh-list
138576447|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138576448|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646357|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576449|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576450|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
138576451|NCT00448786|Vitamins|vitamins|mesh-ancestor
138576452|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
138576453|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576454|NCT00114803|Calcitonin|calcitonin|mesh-list
138576455|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
138576456|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138576457|NCT00114803|Katacalcin|katacalcin|mesh-list
138646418|NCT00321477|Casopitant|casopitant|mesh-list
138576458|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138576459|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576460|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138576461|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
138576463|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
138576464|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138576465|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576466|NCT00448903|Bemiparin|bemiparin|mesh-list
138576467|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
138576468|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
138576469|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138576470|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576471|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
138576472|NCT00402012|Pioglitazone|pioglitazone|mesh-list
138576473|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138576474|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576475|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
138576476|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138576477|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138477078|NCT02016443|Tizanidine|tizanidine|mesh-list
138576478|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
138576479|NCT03276325|Dexamethasone|dexamethasone|mesh-list
138576480|NCT03276325|Nalbuphine|nalbuphine|mesh-list
138576481|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576482|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
138576483|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
138576484|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576485|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576486|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138576487|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
138576488|NCT03276325|Hormones|hormones|mesh-ancestor
138576489|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576490|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138576491|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576492|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138576493|NCT03276325|Narcotics|narcotics|mesh-ancestor
138576494|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138576495|NCT03276325|Analgesics|analgesics|mesh-ancestor
138576496|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
138576497|NCT00449020|Carboplatin|carboplatin|mesh-list
138576498|NCT00449020|Docetaxel|docetaxel|mesh-list
138576499|NCT00449020|Irinotecan|irinotecan|mesh-list
138576500|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576501|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
138576502|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
138576503|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
138576504|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576505|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138576506|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138576507|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576508|NCT00115752|Valdecoxib|valdecoxib|mesh-list
138576509|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
138576510|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138576511|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576512|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576513|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138576514|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138291410|NCT00002378|Ritonavir|ritonavir|mesh-list
138576515|NCT00115752|Analgesics|analgesics|mesh-ancestor
138576516|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
138576517|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138477089|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138576518|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646589|NCT06138834|Vasodilator Agents|vasodilator agents|mesh-ancestor
138252924|NCT00002505|Vaccines|vaccines|mesh-list
138576520|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138576521|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
138576522|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
138576523|NCT00449137|Leucovorin|leucovorin|mesh-list
138576524|NCT00449137|Fluorouracil|fluorouracil|mesh-list
138576525|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
138576526|NCT00449137|Calcium|calcium|mesh-list
138576527|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
138576528|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138576529|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576530|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
138576531|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576532|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138576533|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576534|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138576535|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
138576537|NCT00449137|Protective Agents|protective agents|mesh-ancestor
138576538|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
138576540|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
138576541|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
138576542|NCT00449254|Estrone|estrone|mesh-list
138576543|NCT00449254|Estrogens|estrogens|mesh-ancestor
138576544|NCT00449254|Hormones|hormones|mesh-ancestor
138576545|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576546|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576547|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138576548|NCT00449410|Atorvastatin|atorvastatin|mesh-list
138576550|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138576551|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138576552|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
138576553|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576554|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138657125|NCT05457530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138576555|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138576556|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576558|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
138576559|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
138576560|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138576561|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576562|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
138576563|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576564|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138576565|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138477123|NCT02016703|Erythritol|erythritol|mesh-list
138576566|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138576567|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138576568|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576569|NCT00115115|Dopamine|dopamine|mesh-list
138576570|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138576571|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
138576572|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
138576573|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576574|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576575|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
138576576|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576577|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576578|NCT00115115|Protective Agents|protective agents|mesh-ancestor
138576579|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
138576580|NCT00449488|Hematinics|hematinics|mesh-ancestor
138576581|NCT00115830|Atorvastatin|atorvastatin|mesh-list
138576582|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138576583|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138576584|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138576585|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
138576586|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576587|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138576588|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138576589|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576590|NCT00115154|Imiquimod|imiquimod|mesh-list
138576591|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138576592|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
138576593|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576594|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252994|NCT00002523|Leucovorin|leucovorin|mesh-list
138323569|NCT05241132|Paclitaxel|paclitaxel|mesh-list
138576595|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
138576596|NCT00449527|Budesonide|budesonide|mesh-list
138576597|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
138576598|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576599|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138576600|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
138576601|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576602|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576603|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138576604|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
138576605|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
138576606|NCT00449527|Hormones|hormones|mesh-ancestor
138576607|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576608|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138576610|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138576611|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
138576612|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576613|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576614|NCT00449683|Terazosin|terazosin|mesh-list
138576615|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138576616|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138576617|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138576618|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
138576619|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576620|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576621|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576622|NCT00449683|Urological Agents|urological agents|mesh-ancestor
138576623|NCT00449722|Mesalamine|mesalamine|mesh-list
138576624|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138576625|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138576626|NCT00449722|Analgesics|analgesics|mesh-ancestor
138576627|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
138576628|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576629|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576630|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576631|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138576632|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
138576633|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138576634|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576635|NCT00449839|Insulin|insulin|mesh-list
138576636|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138576637|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
138576638|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
138576639|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138576640|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138576641|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576642|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
138576643|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138576644|NCT00450229|Protective Agents|protective agents|mesh-ancestor
138576645|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576646|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576647|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138576648|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138576649|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138576650|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
138576651|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325806|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
138576652|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138576653|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138576654|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576656|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138576657|NCT00450307|Sargramostim|sargramostim|mesh-list
138576658|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
138576659|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576660|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
138576661|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138576662|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576663|NCT03276013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138477185|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576664|NCT03276013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576666|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138576667|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138253061|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576669|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
138576670|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576671|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576672|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576673|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138576674|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138576675|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138576676|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576677|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576678|NCT05536362|Clonidine|clonidine|mesh-list
138576679|NCT05536362|Ketamine|ketamine|mesh-list
138576680|NCT05536362|Propofol|propofol|mesh-list
138576681|NCT05536362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138576682|NCT05536362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138576683|NCT05536362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576684|NCT05536362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138576685|NCT05536362|Anesthetics, General|anesthetics, general|mesh-ancestor
138576686|NCT05536362|Anesthetics|anesthetics|mesh-ancestor
138576687|NCT05536362|Analgesics|analgesics|mesh-ancestor
138576688|NCT05536362|Sensory System Agents|sensory system agents|mesh-ancestor
138576689|NCT05536362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576690|NCT05536362|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138576691|NCT05536362|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138576692|NCT05536362|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138576693|NCT05536362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576694|NCT05536362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576695|NCT05536362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138576696|NCT05536362|Sympatholytics|sympatholytics|mesh-ancestor
138576697|NCT05536362|Autonomic Agents|autonomic agents|mesh-ancestor
138477201|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576698|NCT05536362|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138576699|NCT05536362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138576700|NCT05536362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138576701|NCT05536362|Adrenergic Agents|adrenergic agents|mesh-ancestor
138576702|NCT00450853|Granisetron|granisetron|mesh-list
138576703|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
138576704|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
138576705|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576706|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576707|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138576708|NCT00450853|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138576709|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138647245|NCT04684212|Warfarin|warfarin|mesh-list
138576710|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
138576711|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576712|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576713|NCT00450892|Docetaxel|docetaxel|mesh-list
138576714|NCT00450892|Trastuzumab|trastuzumab|mesh-list
138576715|NCT00450892|Lapatinib|lapatinib|mesh-list
138576716|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576717|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
138576718|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
138576719|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
138576720|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576721|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138576722|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138576723|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576724|NCT00115310|Capsaicin|capsaicin|mesh-list
138576725|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
138576726|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
138576727|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
138576728|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576729|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576730|NCT00115908|Ribavirin|ribavirin|mesh-list
138576731|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138576732|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
138576733|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576734|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
138576735|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576736|NCT00458185|Etanercept|etanercept|mesh-list
138576737|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138576738|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138576739|NCT00458185|Analgesics|analgesics|mesh-ancestor
138477239|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138576740|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
138576741|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576742|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576743|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576744|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138576745|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138576746|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138576747|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
138576748|NCT00458263|Hormones|hormones|mesh-list
138647399|NCT04405167|Dexamethasone|dexamethasone|mesh-list
138576749|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576750|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576752|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138576753|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576754|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
138576755|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576756|NCT00458458|Leuprolide|leuprolide|mesh-list
138576757|NCT00458458|Norethindrone|norethindrone|mesh-list
138576758|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
138576759|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138576760|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
138576761|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138576762|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576763|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138647457|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138576765|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138576766|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138576767|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138576768|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
138576769|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138576770|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138576771|NCT00458614|Lansoprazole|lansoprazole|mesh-list
138576772|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
138576773|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138576774|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138576775|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138576776|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576777|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576778|NCT00458731|Bevacizumab|bevacizumab|mesh-list
138576779|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138576781|NCT00458731|Antibodies|antibodies|mesh-list
138576782|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
138576783|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138576784|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576785|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138576786|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138576787|NCT00458731|Growth Substances|growth substances|mesh-ancestor
138576788|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576789|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
138576790|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
138325817|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138576791|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477272|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
138576792|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576794|NCT03274024|Mitomycins|mitomycins|mesh-list
138576796|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138576798|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
138576799|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576800|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138576801|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576802|NCT00115947|Terlipressin|terlipressin|mesh-list
138576803|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138576804|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138576805|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
138576806|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576807|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
138576808|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576809|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576810|NCT00459004|Rimonabant|rimonabant|mesh-list
138576811|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138576812|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138576813|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138576814|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576815|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576816|NCT00459004|Hormones|hormones|mesh-ancestor
138576817|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576818|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576819|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
138576820|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
138576821|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138576822|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138576823|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576824|NCT00115622|Fluticasone|fluticasone|mesh-list
138576825|NCT00115622|Xhance|xhance|mesh-list
138576826|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576827|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138576828|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
138576829|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576830|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576831|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138576832|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
138576833|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
138576834|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138576835|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
138576836|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576837|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
138576838|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138576839|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576840|NCT04728321|Lenvatinib|lenvatinib|mesh-list
138576841|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576842|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138576843|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576844|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576845|NCT00459901|Capecitabine|capecitabine|mesh-list
138576846|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138576847|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138576848|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
138576849|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576850|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576851|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138576852|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576853|NCT00401804|Dexamethasone|dexamethasone|mesh-list
138576854|NCT00401804|Doxorubicin|doxorubicin|mesh-list
138576856|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138576857|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
138576858|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
138576859|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138576860|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576861|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138576862|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
138325820|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325822|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
138576863|NCT00401804|Hormones|hormones|mesh-ancestor
138576864|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185867|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
138576865|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138576867|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138576868|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138576869|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138576870|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576871|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576872|NCT00459940|Pioglitazone|pioglitazone|mesh-list
138576873|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138576874|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576875|NCT00460057|Alendronate|alendronate|mesh-list
138576876|NCT00460057|Diphosphonates|diphosphonates|mesh-list
138576877|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138576878|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576879|NCT00401921|Minocycline|minocycline|mesh-list
138576880|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138576881|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576882|NCT00460174|Bevacizumab|bevacizumab|mesh-list
138576883|NCT00460174|Gemcitabine|gemcitabine|mesh-list
138576884|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138576885|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576886|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138576887|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138576888|NCT00460174|Growth Substances|growth substances|mesh-ancestor
138576889|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576890|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
138576891|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138576892|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
138576893|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576894|NCT00460213|Valsartan|valsartan|mesh-list
138576895|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138576896|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138576897|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138576898|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576900|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138576901|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576902|NCT00115817|Atorvastatin|atorvastatin|mesh-list
138576903|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138576904|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138576905|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
138576906|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576907|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138576908|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138576909|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576910|NCT00460369|Artesunate|artesunate|mesh-list
138576911|NCT00460369|Lumefantrine|lumefantrine|mesh-list
138576912|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
138576913|NCT00460369|Artemether|artemether|mesh-list
138576914|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
138576915|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138576916|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138576917|NCT00460369|Amodiaquine|amodiaquine|mesh-list
138576918|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
138576919|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138576920|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138576921|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576922|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576923|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
138576924|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
138576925|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138576926|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
138576927|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138576928|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576929|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576930|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138576931|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
138576932|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138576933|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576934|NCT00460447|Immunotoxins|immunotoxins|mesh-ancestor
138325826|NCT02087748|Diclofenac|diclofenac|mesh-list
138576935|NCT00460447|Immunoconjugates|immunoconjugates|mesh-ancestor
138576936|NCT00460447|Immunologic Factors|immunologic factors|mesh-ancestor
138576937|NCT00460447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576938|NCT00460642|Cetrorelix|cetrorelix|mesh-list
138576939|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138576940|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
138576941|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138576942|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576943|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
138576944|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138576945|NCT00460681|Thymopentin|thymopentin|mesh-list
138576946|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138576947|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
138576948|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576949|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
138576950|NCT00460759|Rifapentine|rifapentine|mesh-list
138576951|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138576952|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138576953|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138576954|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138576955|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576956|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576957|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576958|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138576959|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
138576960|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
138576961|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
138576962|NCT00460837|Cathartics|cathartics|mesh-ancestor
138576963|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138576964|NCT00460876|Topotecan|topotecan|mesh-list
138576965|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138576966|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138576967|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576968|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576969|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253366|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
138576971|NCT00460915|Lacidipine|lacidipine|mesh-list
138576972|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138576973|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138576974|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477390|NCT02018874|Gemcitabine|gemcitabine|mesh-list
138576975|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576976|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138576977|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576979|NCT00460954|Levodopa|levodopa|mesh-list
138576980|NCT00460954|Carbidopa|carbidopa|mesh-list
138576981|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138576982|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138576983|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138576984|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
138576985|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138576986|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138576987|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138576988|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138576989|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138576990|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138576991|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
138576992|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
138576993|NCT00461149|Octreotide|octreotide|mesh-list
138576994|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138576995|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138576996|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138576997|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
138576998|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138576999|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577000|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138577001|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
138577002|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
138577003|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138577004|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138577005|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138325829|NCT02087748|Analgesics|analgesics|mesh-ancestor
138577006|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577007|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138577008|NCT00461344|Docetaxel|docetaxel|mesh-list
138577009|NCT00461344|Doxorubicin|doxorubicin|mesh-list
138577010|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577011|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
138577012|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
138577013|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
138577014|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577015|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138577016|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138577017|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138577018|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577019|NCT03273634|Lansoprazole|lansoprazole|mesh-list
138577020|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
138577021|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138577022|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577023|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138577024|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477427|NCT02019056|Pyridoxine|pyridoxine|mesh-list
138577025|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577027|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
138577028|NCT03273595|Trastuzumab|trastuzumab|mesh-list
138577029|NCT03273595|Epirubicin|epirubicin|mesh-list
138577030|NCT03273595|Lapatinib|lapatinib|mesh-list
138577031|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138577032|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577033|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
138577034|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
138577035|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
138577036|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577037|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138577038|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
138577039|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577040|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138577041|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138577042|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
138577043|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138577044|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138577045|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138577046|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138577047|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138577048|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577049|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138577050|NCT03273556|Lidocaine|lidocaine|mesh-list
138577051|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
138577052|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
138577053|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138577054|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577055|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
138577056|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577057|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138577058|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138577059|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138577060|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138577061|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577062|NCT04728308|Bupivacaine|bupivacaine|mesh-list
138577063|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
138577064|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
138577065|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138477447|NCT02019186|Vitamins|vitamins|mesh-list
138577066|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577067|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
138577068|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577070|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
138577071|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325838|NCT01490502|Vitamin D|vitamin d|mesh-list
138577072|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577073|NCT04697992|Vitamins|vitamins|mesh-list
138577074|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
138577075|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
138577076|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
138577077|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577078|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138577079|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138577080|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577081|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
138577082|NCT04697992|Coagulants|coagulants|mesh-ancestor
138577083|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
138577084|NCT04697992|Protective Agents|protective agents|mesh-ancestor
138577086|NCT05483634|Hormones|hormones|mesh-ancestor
138577087|NCT05483634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138577088|NCT05483634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577089|NCT00461578|Artesunate|artesunate|mesh-list
138577090|NCT00461578|Dapsone|dapsone|mesh-list
138577091|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
138577092|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
138577093|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138577094|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138577095|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138577096|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577097|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
138577098|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
138577099|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138577100|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
138577101|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138577102|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186548|NCT05717361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138577103|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577104|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
138577105|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138577106|NCT00461617|Mitiglinide|mitiglinide|mesh-list
138577107|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138577108|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577109|NCT00116064|Lorazepam|lorazepam|mesh-list
138577110|NCT00116064|Paraldehyde|paraldehyde|mesh-list
138577111|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
138577112|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
138577113|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
138577114|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577115|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577116|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577117|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138577118|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138577119|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138577120|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138253521|NCT05805553|Nandrolone|nandrolone|mesh-list
138577121|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138577122|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
138577123|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
138577124|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577125|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577126|NCT04728035|Irinotecan|irinotecan|mesh-list
138577127|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138577128|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138577129|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577130|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577131|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577132|NCT00461890|Naltrexone|naltrexone|mesh-list
138577133|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138577134|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138577135|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577136|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
138577137|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577138|NCT00461968|Simvastatin|simvastatin|mesh-list
138577139|NCT00461968|Ezetimibe|ezetimibe|mesh-list
138577140|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138577141|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138577142|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
138577143|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186664|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138325840|NCT01490502|Vitamins|vitamins|mesh-ancestor
138577144|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138577145|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138577146|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577148|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138577149|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
138577150|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577151|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138577152|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577153|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577154|NCT02956252|Anesthetics|anesthetics|mesh-list
138577155|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138577156|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577157|NCT00462358|Filanesib|filanesib|mesh-list
138577158|NCT00462358|Lenograstim|lenograstim|mesh-list
138577159|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138577160|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
138577161|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186739|NCT02240927|Enoxaparin|enoxaparin|mesh-list
138577162|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
138577163|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
138577164|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577165|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577166|NCT00116181|Etanercept|etanercept|mesh-list
138577167|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138577168|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138577169|NCT00116181|Analgesics|analgesics|mesh-ancestor
138577170|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
138577171|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577172|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577173|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577174|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138577175|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577176|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138577177|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
138577178|NCT00462397|Paclitaxel|paclitaxel|mesh-list
138577179|NCT00462397|Carboplatin|carboplatin|mesh-list
138577180|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138577181|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577182|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
138577183|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
138577184|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
138577185|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577186|NCT00462475|Hormones|hormones|mesh-list
138577187|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138577188|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577189|NCT00462553|Gemcitabine|gemcitabine|mesh-list
138577190|NCT00462553|Sunitinib|sunitinib|mesh-list
138577191|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138577192|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
138577193|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577194|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577195|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138577196|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138577198|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577199|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
138186827|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138577200|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138577201|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577202|NCT00462592|Budesonide|budesonide|mesh-list
138577203|NCT00462592|Montelukast|montelukast|mesh-list
138577204|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577205|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138577206|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
138577207|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577208|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577209|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138577210|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
138577211|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
138577212|NCT00462592|Hormones|hormones|mesh-ancestor
138577213|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138577214|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138577215|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
138577216|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138577217|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138577218|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577219|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
138577220|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138577221|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577223|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138186957|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
138577224|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138577225|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138477536|NCT02019524|Folic Acid|folic acid|mesh-list
138577226|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
138577227|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
138577228|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
138577229|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577230|NCT00462787|Dexamethasone|dexamethasone|mesh-list
138577231|NCT00462787|Topotecan|topotecan|mesh-list
138577232|NCT00462787|Vinorelbine|vinorelbine|mesh-list
138577233|NCT00462787|Thiotepa|thiotepa|mesh-list
138577234|NCT00462787|Clofarabine|clofarabine|mesh-list
138577235|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577236|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
138577237|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
138577238|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577239|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577240|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577241|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
138577242|NCT00462787|Hormones|hormones|mesh-ancestor
138577243|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138577244|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138577245|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577246|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
138577247|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138577248|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138577249|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577250|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577251|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138577252|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
138577253|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
138577254|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
138577255|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138577256|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
138577257|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138577258|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138577259|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138577261|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138577262|NCT00463021|Vitamins|vitamins|mesh-ancestor
138577263|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
138577264|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577265|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138577266|NCT00116259|Aripiprazole|aripiprazole|mesh-list
138577267|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
138577268|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138577269|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138577270|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138577271|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138577272|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577273|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
138577274|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
138577275|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577276|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577277|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138325848|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577278|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138325849|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
138577279|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
138577280|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138577281|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138577282|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138577283|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138577284|NCT00116324|Montelukast|montelukast|mesh-list
138577285|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138577286|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
138577287|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138577288|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
138577289|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138577290|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577291|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138577292|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138577293|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577294|NCT00116402|Fluticasone|fluticasone|mesh-list
138577295|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138577296|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577297|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138577298|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
138577299|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577300|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577301|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138577302|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
138577303|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
138577304|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138577305|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138577306|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138577307|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138577308|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
138577309|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577310|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577311|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138577312|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138577315|NCT00463762|Sulperazone|sulperazone|mesh-list
138577316|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138577317|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138577318|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138577320|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577321|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138577322|NCT00116480|Misoprostol|misoprostol|mesh-list
138577323|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138577324|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
138577325|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138577326|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577327|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138577328|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577329|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
138577330|NCT00463879|Galantamine|galantamine|mesh-list
138577331|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138577332|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577333|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577334|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
138577335|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577336|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577337|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138577338|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
138577339|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577340|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
138577341|NCT00463918|Varenicline|varenicline|mesh-list
138577342|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138577343|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138577344|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
138577345|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577346|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577347|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577350|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
138577351|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138577352|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138577353|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577354|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577355|NCT00463957|Urological Agents|urological agents|mesh-ancestor
138577356|NCT00464035|Calcium|calcium|mesh-list
138577357|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138577358|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577359|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
138577360|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577361|NCT00464191|Escitalopram|escitalopram|mesh-list
138577362|NCT00464191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138577363|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138577364|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138577365|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577366|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577367|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
138577368|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577369|NCT00464347|Triamcinolone|triamcinolone|mesh-list
138577370|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138577371|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138577372|NCT00464347|Bevacizumab|bevacizumab|mesh-list
138577373|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138577374|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138577375|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577376|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138657353|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138577377|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138577379|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577380|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
138577381|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577382|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
138577383|NCT00464347|Hormones|hormones|mesh-ancestor
138577384|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138577385|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138577386|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
138577387|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577388|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577390|NCT00116493|Mebendazole|mebendazole|mesh-list
138577391|NCT00116493|Piperazine|piperazine|mesh-list
138577392|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
138577393|NCT00116493|DMP 777|dmp 777|mesh-list
138577394|NCT00116493|Hematinics|hematinics|mesh-ancestor
138577395|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
138577396|NCT00116493|Vitamins|vitamins|mesh-ancestor
138577397|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
138577398|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577399|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
138577400|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
138577401|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138577402|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138577403|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
138577404|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
138577405|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
138577406|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577407|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577408|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577409|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138577410|NCT00464503|Pravastatin|pravastatin|mesh-list
138577411|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138577412|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138577413|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
138577414|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577415|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138577416|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138577417|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577418|NCT00116532|Escitalopram|escitalopram|mesh-list
138577419|NCT00116532|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138577420|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138577421|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138577422|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577423|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577424|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
138187251|NCT04361513|Triamcinolone|triamcinolone|mesh-list
138577425|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577426|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
138577427|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138577428|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577429|NCT00464893|Catumaxomab|catumaxomab|mesh-list
138577430|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138577431|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577432|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
138577433|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577434|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
138577435|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577436|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
138577437|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138577438|NCT00464932|Protective Agents|protective agents|mesh-ancestor
138577439|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577441|NCT00464971|Estrogens|estrogens|mesh-ancestor
138577442|NCT00464971|Hormones|hormones|mesh-ancestor
138577443|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138657365|NCT01051791|Everolimus|everolimus|mesh-list
138577444|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577445|NCT00116870|Lovastatin|lovastatin|mesh-list
138577446|NCT00116870|L 647318|l 647318|mesh-list
138577447|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
138577448|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138577449|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138577450|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
138577451|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577452|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138577453|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138577454|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577455|NCT00465205|Valacyclovir|valacyclovir|mesh-list
138577456|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
138577457|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138577458|NCT00465244|Levetiracetam|levetiracetam|mesh-list
138577459|NCT00465244|Lorazepam|lorazepam|mesh-list
138577460|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
138577461|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
138577462|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
138577463|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
138577464|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577465|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477637|NCT02020213|Posaconazole|posaconazole|mesh-list
138577466|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577467|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138577468|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138577469|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138577470|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138577471|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138577472|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
138577473|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
138577474|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577475|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577476|NCT00465283|Donepezil|donepezil|mesh-list
138577477|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138577478|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577479|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577480|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
138577481|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577482|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577483|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
138577484|NCT03272425|Allopurinol|allopurinol|mesh-list
138577485|NCT03272425|Lesinurad|lesinurad|mesh-list
138577486|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
138577487|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577488|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577489|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
138577490|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138577491|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138577492|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
138325866|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
138577493|NCT03272425|Protective Agents|protective agents|mesh-ancestor
138577494|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577495|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
138577496|NCT00116948|Cimetidine|cimetidine|mesh-list
138577497|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138577498|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577499|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138577500|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
138577501|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
138577502|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577503|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577504|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577505|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138577506|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138577507|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577508|NCT03272503|Pimozide|pimozide|mesh-list
138577509|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138577510|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138577511|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138577512|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577513|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138577514|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138577515|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
138577516|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577517|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577518|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138577520|NCT00465439|Epinephrine|epinephrine|mesh-list
138577521|NCT00465439|Racepinephrine|racepinephrine|mesh-list
138577522|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
138577523|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
138577524|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
138577525|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138577526|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577527|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
138577528|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577529|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138577530|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138577531|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138577532|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138577533|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577534|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138577535|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138577536|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
138577537|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577538|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138577539|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138577540|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
138577541|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138577542|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
138577544|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
138477722|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
138577545|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138577547|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138577548|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138577549|NCT00116727|Analgesics|analgesics|mesh-ancestor
138577550|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
138577551|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577552|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577553|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577554|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138577555|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577556|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138577557|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
138577558|NCT00473551|Sirolimus|sirolimus|mesh-list
138577559|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
138577560|NCT00473551|Rituximab|rituximab|mesh-list
138577561|NCT00473551|Fludarabine|fludarabine|mesh-list
138577562|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
138577563|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138577564|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
138577565|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577566|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138577567|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138577568|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
138577569|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577570|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577571|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138577572|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138577573|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138577574|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
138577575|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138577576|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138577577|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138577578|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
138577580|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138577581|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
138577582|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577583|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
138577584|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
138577585|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577586|NCT00473980|Celecoxib|celecoxib|mesh-list
138577587|NCT00473980|Indomethacin|indomethacin|mesh-list
138577588|NCT00473980|Esomeprazole|esomeprazole|mesh-list
138577589|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138577590|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138577591|NCT00473980|Analgesics|analgesics|mesh-ancestor
138577592|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
138577593|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577594|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577595|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577596|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138577597|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138577598|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138577599|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577600|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577601|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138577602|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577603|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138577604|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
138577605|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
138577606|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138577608|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138577609|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577610|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138577611|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577612|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577613|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
138577614|NCT00117065|Hematinics|hematinics|mesh-ancestor
138577615|NCT00474136|Diclofenac|diclofenac|mesh-list
138577616|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138577617|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138577618|NCT00474136|Analgesics|analgesics|mesh-ancestor
138577619|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
138577620|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577621|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577622|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577623|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138577624|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138577625|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138657404|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
138577626|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577627|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
138577629|NCT03270709|Vitamin D|vitamin d|mesh-list
138577630|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
138577631|NCT03270709|Vitamins|vitamins|mesh-ancestor
138577632|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
138577633|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577634|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138477782|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
138577635|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138577637|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138577638|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577639|NCT00117182|Budesonide|budesonide|mesh-list
138577640|NCT00117182|Mannitol|mannitol|mesh-list
138577641|NCT00117182|Bromides|bromides|mesh-list
138577642|NCT00117182|Albuterol|albuterol|mesh-list
138577643|NCT00117182|Ipratropium|ipratropium|mesh-list
138577644|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577645|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138577646|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
138577647|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577648|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577649|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138577650|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
138577651|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
138577652|NCT00117182|Hormones|hormones|mesh-ancestor
138577653|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138577654|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
138577655|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
138577656|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138577657|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138577658|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138577659|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138577660|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
138577661|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577662|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577663|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138577664|NCT00117182|Diuretics|diuretics|mesh-ancestor
138577665|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
138577666|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138577667|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
138577668|NCT00116922|Metformin|metformin|mesh-list
138577669|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
138577670|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138577671|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577672|NCT00116961|Dexamethasone|dexamethasone|mesh-list
138577673|NCT00116961|Bortezomib|bortezomib|mesh-list
138577674|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577676|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
138577677|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577678|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577679|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577680|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
138577681|NCT00116961|Hormones|hormones|mesh-ancestor
138577682|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138577683|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138577684|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577685|NCT00474721|Acetaminophen|acetaminophen|mesh-list
138577686|NCT00474721|Ibuprofen|ibuprofen|mesh-list
138577687|NCT00474721|Codeine|codeine|mesh-list
138577688|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138577689|NCT00474721|Analgesics|analgesics|mesh-ancestor
138577690|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
138577691|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577692|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577693|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
138577694|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138577695|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577696|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138577697|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138577698|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577699|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577700|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138577701|NCT00474721|Narcotics|narcotics|mesh-ancestor
138577702|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138577703|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
138577704|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
138577705|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
138577706|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138577707|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138577708|NCT00117260|Estradiol|estradiol|mesh-list
138577709|NCT00117260|Estrogens|estrogens|mesh-ancestor
138325882|NCT01253070|Daunorubicin|daunorubicin|mesh-list
138577710|NCT00117260|Hormones|hormones|mesh-ancestor
138577711|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138577712|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577713|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138577714|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
138577715|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138577716|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138577717|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138577718|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138577719|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138577720|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138577721|NCT00474838|Metformin|metformin|mesh-list
138577722|NCT00474838|Glimepiride|glimepiride|mesh-list
138577723|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138577724|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577725|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138577726|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138577727|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
138577728|NCT00474916|KRN 5500|krn 5500|mesh-list
138577729|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577730|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138577731|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138477844|NCT02021851|Hormones|hormones|mesh-ancestor
138577732|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577734|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138577735|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
138577736|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577737|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
138577738|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138577739|NCT00117299|Vatalanib|vatalanib|mesh-list
138577740|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138577741|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577742|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577743|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
138577744|NCT00117000|Testosterone|testosterone|mesh-list
138577745|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
138577746|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
138577747|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138577748|NCT00117000|Androgens|androgens|mesh-ancestor
138577749|NCT00117000|Hormones|hormones|mesh-ancestor
138577750|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138577751|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657432|NCT00433173|Testosterone|testosterone|mesh-list
138577752|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138577753|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577754|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
138577755|NCT02956408|Vitamin D|vitamin d|mesh-list
138577756|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
138577757|NCT02956408|Vitamins|vitamins|mesh-ancestor
138577758|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
138577759|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577760|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138577761|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138577762|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
138577763|NCT00475189|Norinyl|norinyl|mesh-list
138477865|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138577764|NCT00475189|Mestranol|mestranol|mesh-list
138577765|NCT00475189|Norethindrone|norethindrone|mesh-list
138577766|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138577767|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138577768|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138577769|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
138577770|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138577771|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187660|NCT02976987|Cidofovir|cidofovir|mesh-list
138577772|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138577773|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138577774|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
138577775|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138325890|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
138577777|NCT00475189|Hormones|hormones|mesh-ancestor
138577778|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138577779|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
138577780|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138577781|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138577782|NCT00117377|Analgesics|analgesics|mesh-ancestor
138577783|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
138577784|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577785|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577786|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577787|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138577788|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
138577789|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138657446|NCT01055028|Bevacizumab|bevacizumab|mesh-list
138577790|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
138577791|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138577792|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577793|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577795|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138577796|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188359|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138577797|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138577798|NCT00475462|Metoprolol|metoprolol|mesh-list
138577799|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138577800|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138577801|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
138577802|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
138577803|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577804|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577805|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138577806|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138577808|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
138577809|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577810|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577811|NCT00475618|Fluorides|fluorides|mesh-list
138577812|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
138577813|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
138577814|NCT00475618|Protective Agents|protective agents|mesh-ancestor
138577815|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577816|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
138577817|NCT00117039|Hematinics|hematinics|mesh-ancestor
138577818|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138577819|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138577820|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138577821|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138577822|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577823|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577824|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577825|NCT00475696|Analgesics|analgesics|mesh-ancestor
138577826|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
138577827|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577828|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
138577829|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138577830|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
138577831|NCT00117455|Lenograstim|lenograstim|mesh-list
138577832|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138577833|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
138577834|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577835|NCT03270007|Vinorelbine|vinorelbine|mesh-list
138577836|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138577837|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577838|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
138577839|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
138577840|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
138577841|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577842|NCT00475813|Fluticasone|fluticasone|mesh-list
138577843|NCT00475813|Xhance|xhance|mesh-list
138577844|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
138577845|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577846|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138577847|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
138577848|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577849|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577850|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138577851|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
138657480|NCT00428766|Farletuzumab|farletuzumab|mesh-list
138577852|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
138577853|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138577854|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138577855|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138577856|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138577857|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
138577858|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577859|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577860|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
138577861|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138577862|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577863|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
138577864|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577865|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
138577866|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138577867|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138577868|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138577869|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
138577870|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
138577871|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138577872|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138577873|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138577874|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138577875|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577876|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187774|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
138577877|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577878|NCT00475969|Analgesics|analgesics|mesh-ancestor
138577879|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
138577880|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577881|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
138577882|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138577883|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
138577884|NCT00476164|Rituximab|rituximab|mesh-list
138577885|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138577886|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577887|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
138577888|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577889|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138577890|NCT00402077|Pramlintide|pramlintide|mesh-list
138577891|NCT00402077|Phentermine|phentermine|mesh-list
138577892|NCT00402077|Sibutramine|sibutramine|mesh-list
138577893|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138577894|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577895|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138577896|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
138577897|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138577898|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
138577899|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
138577900|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577901|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
138577902|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138577903|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577904|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
138577905|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138325896|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138577906|NCT00476359|Lopinavir|lopinavir|mesh-list
138577907|NCT00476359|Saquinavir|saquinavir|mesh-list
138577908|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138477953|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138577909|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138577910|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
138577911|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577912|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577913|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138577914|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138577915|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
138577916|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138325912|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
138577917|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138325913|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
138325915|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138577918|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138577919|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
138577920|NCT00117117|Hematinics|hematinics|mesh-ancestor
138577921|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138577922|NCT00117494|Pravastatin|pravastatin|mesh-list
138577923|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138577924|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138577925|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
138577926|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577927|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138577928|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138577929|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577930|NCT00117533|Ribavirin|ribavirin|mesh-list
138577931|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
138577932|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
138577933|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577934|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
138577935|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138577936|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577937|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
138577938|NCT00117234|Hematinics|hematinics|mesh-ancestor
138577939|NCT00117611|Omalizumab|omalizumab|mesh-list
138577940|NCT00117611|Antibodies|antibodies|mesh-list
138577941|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
138577942|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577943|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138577944|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138577945|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
138325972|NCT00875004|Hematinics|hematinics|mesh-ancestor
138325974|NCT05320692|Chlorotrianisene|chlorotrianisene|mesh-list
138325975|NCT05320692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138325976|NCT05320692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138577946|NCT03277261|Teriflunomide|teriflunomide|mesh-list
138577947|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138577948|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138577950|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
138577951|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138577952|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577953|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138577954|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138577955|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138577956|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
138577957|NCT02273947|BMS-955176|bms-955176|mesh-list
138577958|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138577959|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138577960|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
138577961|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326018|NCT04780152|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138577962|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
138577964|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
138577965|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138577966|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138577967|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
138577968|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577969|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138577970|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138577971|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577972|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138577973|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138577974|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138577975|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
138577976|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138577977|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138577978|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
138577979|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138577980|NCT00117273|Estradiol|estradiol|mesh-list
138577981|NCT00117273|Estrogens|estrogens|mesh-ancestor
138577982|NCT00117273|Hormones|hormones|mesh-ancestor
138577983|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138577984|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138577985|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138577986|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
138326080|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
138326081|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138326082|NCT01895400|Cilostazol|cilostazol|mesh-list
138326083|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138326084|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
138577987|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138187895|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138577988|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138577989|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138577990|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138577991|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138577992|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138577993|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138577994|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138577995|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
138577996|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138577997|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138577998|NCT00117728|Nevirapine|nevirapine|mesh-list
138577999|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138578000|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138326139|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
138578001|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578002|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578003|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
138578004|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326140|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138326141|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138578005|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138578006|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138578007|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138578008|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138578010|NCT00117767|Griseofulvin|griseofulvin|mesh-list
138578011|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
138578012|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578013|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578014|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578015|NCT03277066|Diclofenac|diclofenac|mesh-list
138578016|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138578017|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138578018|NCT03277066|Analgesics|analgesics|mesh-ancestor
138578019|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
138578020|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578021|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578022|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138578023|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138578024|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138326195|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578025|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578026|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578027|NCT00117351|Bortezomib|bortezomib|mesh-list
138578028|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578029|NCT00118196|Azacitidine|azacitidine|mesh-list
138578030|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
138578031|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138578032|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
138578033|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326253|NCT00060528|Molgramostim|molgramostim|mesh-list
138578034|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326323|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
138578035|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578036|NCT00118235|Bevacizumab|bevacizumab|mesh-list
138578037|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138578038|NCT00118235|Irinotecan|irinotecan|mesh-list
138578039|NCT00118235|Antibodies|antibodies|mesh-list
138578040|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
138578041|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138578042|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578043|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138578044|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138578045|NCT00118235|Growth Substances|growth substances|mesh-ancestor
138578046|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578047|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
138578048|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
138578049|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138578050|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138326324|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578051|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138478118|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138578052|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578053|NCT00118313|Imiquimod|imiquimod|mesh-list
138578054|NCT00118313|Sargramostim|sargramostim|mesh-list
138578055|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
138578056|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138578057|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
138578058|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578059|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578060|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138578061|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
138578062|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138578063|NCT00118313|Protective Agents|protective agents|mesh-ancestor
138578064|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138578065|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
138578066|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578067|NCT03271021|Minocycline|minocycline|mesh-list
138578068|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138578069|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578070|NCT02273986|Digoxin|digoxin|mesh-list
138578071|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138578072|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138578073|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578074|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138657569|NCT00327665|Vaccines|vaccines|mesh-list
138578075|NCT02273986|Protective Agents|protective agents|mesh-ancestor
138578076|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578077|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
138578078|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138578079|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138578080|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578081|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138578082|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578083|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138578084|NCT00476983|Ritonavir|ritonavir|mesh-list
138578085|NCT00476983|Saquinavir|saquinavir|mesh-list
138578086|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138578087|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138578088|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138578089|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
138578090|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578091|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578092|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138578093|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138578094|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
138578095|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188024|NCT05026905|Antidotes|antidotes|mesh-ancestor
138578096|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138254501|NCT00002751|Antibodies|antibodies|mesh-list
138326379|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578097|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138578098|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138578099|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138578100|NCT00477061|Morphine|morphine|mesh-list
138578101|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138578102|NCT00477061|Narcotics|narcotics|mesh-ancestor
138578103|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138578104|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578105|NCT00477061|Analgesics|analgesics|mesh-ancestor
138578106|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
138578107|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578108|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
138578109|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138578110|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578111|NCT00477373|Valproic Acid|valproic acid|mesh-list
138578112|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
138578113|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578114|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578115|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
138578116|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578117|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578118|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
138578119|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138578120|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138578121|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138578122|NCT00477763|Cyclosporine|cyclosporine|mesh-list
138578123|NCT00477763|Cyclosporins|cyclosporins|mesh-list
138578124|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578125|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578126|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138578127|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
138578128|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578129|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
138578130|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578131|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
138578132|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138578133|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138578134|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
138578135|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138578136|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138578137|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138188068|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
138578138|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138578139|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578140|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
138578141|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578142|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578143|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138578144|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578146|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138578147|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578148|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138578149|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578150|NCT00477997|Hormones|hormones|mesh-list
138578151|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578152|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578153|NCT00478075|Bortezomib|bortezomib|mesh-list
138578154|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
138578155|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578156|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138578157|NCT00478075|Analgesics|analgesics|mesh-ancestor
138578158|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
138578159|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578160|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578161|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
138578162|NCT00117078|Hematinics|hematinics|mesh-ancestor
138578163|NCT00478114|Sorafenib|sorafenib|mesh-list
138578164|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578165|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138578166|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326406|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
138578167|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578168|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
138578169|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138578170|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578171|NCT00478504|Letrozole|letrozole|mesh-list
138578173|NCT00478504|Enclomiphene|enclomiphene|mesh-list
138578174|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
138578175|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578176|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578177|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138578178|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138578179|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578181|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
138578182|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578183|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578184|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138578185|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
138578186|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138578187|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138578188|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138578189|NCT00117468|Progesterone|progesterone|mesh-list
138578190|NCT00117468|Progestins|progestins|mesh-ancestor
138578191|NCT00117468|Hormones|hormones|mesh-ancestor
138578192|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578193|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578194|NCT03271879|Empagliflozin|empagliflozin|mesh-list
138578195|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138578196|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578197|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138578198|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578200|NCT00478543|Diuretics|diuretics|mesh-ancestor
138578201|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
138578202|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657580|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138578203|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138578204|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138578205|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578206|NCT00118937|Metformin|metformin|mesh-list
138578207|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138578208|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578209|NCT00478621|Vaccines|vaccines|mesh-list
138578210|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
138578211|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578212|NCT00478660|Adalimumab|adalimumab|mesh-list
138578213|NCT00478660|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138578214|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138578215|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138578216|NCT00478699|Cisplatin|cisplatin|mesh-list
138578217|NCT00478699|Gemcitabine|gemcitabine|mesh-list
138578218|NCT00478699|Docetaxel|docetaxel|mesh-list
138578219|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578220|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138578221|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
138578222|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578223|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
138578224|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
138578225|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
138578226|NCT00118976|Lisinopril|lisinopril|mesh-list
138578227|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138578228|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
138578229|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578230|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578231|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138578232|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138578233|NCT00118976|Protective Agents|protective agents|mesh-ancestor
138578234|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578235|NCT00478816|Vaccines|vaccines|mesh-list
138578236|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
138578237|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578238|NCT00478855|Piperacillin|piperacillin|mesh-list
138326411|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
138578239|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138578240|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138578241|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578242|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138578243|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578244|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578245|NCT00117546|Methyldopa|methyldopa|mesh-list
138578246|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138578247|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
138578248|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
138578249|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578250|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578251|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138578252|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138578254|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
138578255|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578256|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578258|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
138578259|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138578260|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138578261|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578262|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578263|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
138578264|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
138578265|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138578266|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
138578269|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
138578270|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138578271|NCT00119132|Amodiaquine|amodiaquine|mesh-list
138578272|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
138578273|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138578274|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138578275|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578276|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578277|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
138578278|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
138578279|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138578280|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
138578281|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138578282|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578283|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578284|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138578285|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138578286|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
138578287|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578288|NCT00479362|Aspirin|aspirin|mesh-list
138578289|NCT00479362|Warfarin|warfarin|mesh-list
138578290|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138578291|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138578292|NCT00479362|Analgesics|analgesics|mesh-ancestor
138578293|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
138578294|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578295|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578296|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138578297|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138578298|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138188208|NCT03086356|Dabigatran|dabigatran|mesh-list
138578299|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138578300|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578301|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138578302|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138578303|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578304|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
138578305|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
138578306|NCT00119171|Capecitabine|capecitabine|mesh-list
138578307|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138578308|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
138326414|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
138578309|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578310|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578311|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
138578312|NCT00117624|Hematinics|hematinics|mesh-ancestor
138578313|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
138578314|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
138578315|NCT00479479|Vitamins|vitamins|mesh-ancestor
138578316|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
138578317|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578318|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
138578319|NCT00479479|Hematinics|hematinics|mesh-ancestor
138578320|NCT00119210|Bupropion|bupropion|mesh-list
138578321|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138578322|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
138578323|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138578324|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138578325|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138578326|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138578327|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578328|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
138478290|NCT02024373|Atorvastatin|atorvastatin|mesh-list
138578330|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578331|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138578332|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138578333|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578334|NCT00117663|Hormones|hormones|mesh-list
138578335|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578336|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578337|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
138578338|NCT00479752|Cetuximab|cetuximab|mesh-list
138578339|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578340|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138578341|NCT00119249|Sorafenib|sorafenib|mesh-list
138578342|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578343|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138578344|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578345|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578346|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
138578347|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
138578348|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578349|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
138578350|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138578351|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138578352|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578353|NCT00479908|Urological Agents|urological agents|mesh-ancestor
138578354|NCT00479986|Pioglitazone|pioglitazone|mesh-list
138578355|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138578356|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578357|NCT00480064|Cytarabine|cytarabine|mesh-list
138578358|NCT00480064|Lomustine|lomustine|mesh-list
138578359|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138578360|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
138578361|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578362|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578363|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
138578364|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578365|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138578366|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
138578367|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578368|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138578369|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
138578370|NCT00480103|Mineral Oil|mineral oil|mesh-list
138578371|NCT00480103|Emollients|emollients|mesh-ancestor
138578372|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
138578374|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138578375|NCT00480142|Narcotics|narcotics|mesh-ancestor
138578376|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138578377|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578378|NCT00480142|Analgesics|analgesics|mesh-ancestor
138578379|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
138578380|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578381|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
138578382|NCT00119483|Testosterone|testosterone|mesh-list
138578383|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
138578384|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
138578385|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138578386|NCT00119483|Androgens|androgens|mesh-ancestor
138578387|NCT00119483|Hormones|hormones|mesh-ancestor
138578388|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578389|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462856|NCT04605614|Copper|copper|mesh-list
138578390|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138578391|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578393|NCT00480181|Nabilone|nabilone|mesh-list
138578394|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
138578395|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
138578396|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578397|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578398|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138578399|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138578400|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138578401|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138578402|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138578403|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
138578404|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138578405|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138578406|NCT00480298|Prednisolone|prednisolone|mesh-list
138578407|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
138578408|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138578409|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
138578410|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138578411|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
138578412|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
138578413|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578414|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578415|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138578416|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
138578417|NCT00480298|Hormones|hormones|mesh-ancestor
138578418|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578419|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138578420|NCT00480298|Protective Agents|protective agents|mesh-ancestor
138578421|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138578422|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578423|NCT00480376|Gentamicins|gentamicins|mesh-list
138578424|NCT00480376|Ofloxacin|ofloxacin|mesh-list
138578425|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138578426|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578427|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138578428|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578429|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578430|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138578431|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138578432|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138578433|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578434|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138578435|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138578436|NCT00117702|Everolimus|everolimus|mesh-list
138578437|NCT00117702|Tacrolimus|tacrolimus|mesh-list
138578438|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138578439|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
138578440|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578441|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138578442|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578443|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478395|NCT02024984|Clomiphene|clomiphene|mesh-list
138578444|NCT00117702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138578445|NCT00117702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138578446|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578447|NCT00480454|Vaccines|vaccines|mesh-list
138578448|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
138578449|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578450|NCT00480571|Perphenazine|perphenazine|mesh-list
138578451|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
138578452|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
138578453|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578454|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578455|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578456|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138578457|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138578458|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138578459|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138578460|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138578462|NCT00480610|Tacrolimus|tacrolimus|mesh-list
138578463|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138578464|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
138578465|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578466|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138578467|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578468|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578469|NCT00480649|Fluticasone|fluticasone|mesh-list
138578471|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138578472|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138578473|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138578474|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
138578475|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578476|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578477|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138578478|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
138578479|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
138578480|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138578481|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138578482|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138578483|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138578484|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
138578485|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478425|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138578486|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578487|NCT00119639|Sorafenib|sorafenib|mesh-list
138578488|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578489|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138578490|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578491|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578492|NCT00480844|Risperidone|risperidone|mesh-list
138578493|NCT00480844|Sertindole|sertindole|mesh-list
138578494|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138578496|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578497|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578498|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578499|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138578500|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138578501|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138578502|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138578503|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138578504|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
138578505|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138578506|NCT00480883|Allopurinol|allopurinol|mesh-list
138578507|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
138578508|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578509|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578510|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
138578511|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138578512|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138326433|NCT00038610|Vincristine|vincristine|mesh-list
138578513|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
138578514|NCT00480883|Protective Agents|protective agents|mesh-ancestor
138578515|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578516|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138326434|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
138578517|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138578518|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578519|NCT05236998|Dapagliflozin|dapagliflozin|mesh-list
138578520|NCT05236998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138578521|NCT05236998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138578522|NCT05236998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578523|NCT05236998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138578524|NCT05236998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578525|NCT05236998|Incretins|incretins|mesh-ancestor
138578526|NCT05236998|Hormones|hormones|mesh-ancestor
138578527|NCT05236998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578528|NCT05236998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138578529|NCT05236998|Protease Inhibitors|protease inhibitors|mesh-ancestor
138578530|NCT05236998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578531|NCT01240096|Mirtazapine|mirtazapine|mesh-list
138578532|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
138578533|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138578534|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138578535|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
138578536|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
138326442|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578537|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578538|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326443|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138326444|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138578539|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578540|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138578541|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138578542|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138578543|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138578544|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138578545|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138578546|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
138578547|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138578548|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138578549|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
138578550|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138578551|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138578552|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138578553|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138578554|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138578555|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578556|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138578557|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138578558|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138578559|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
138578560|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578561|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578562|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138326490|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326491|NCT02187354|Blinatumomab|blinatumomab|mesh-list
138326493|NCT01898052|Anesthetics|anesthetics|mesh-list
138578563|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138578564|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
138578565|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138578566|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578568|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138578569|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138578570|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578571|NCT00117780|Insulin|insulin|mesh-list
138578572|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138578573|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
138578574|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
138578575|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138578576|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578577|NCT01240408|Lenvatinib|lenvatinib|mesh-list
138578578|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578579|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138578580|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578581|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578583|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138578584|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
138578585|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578586|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578587|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578588|NCT00481312|Midazolam|midazolam|mesh-list
138578589|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
138578590|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138578591|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138578592|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578593|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138578594|NCT00481312|Analgesics|analgesics|mesh-ancestor
138578595|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
138326541|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138578596|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578597|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138578598|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138326546|NCT02091882|Aripiprazole|aripiprazole|mesh-list
138578599|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138578600|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
138578601|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578602|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578603|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138578604|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138578605|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138578606|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138578607|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138578608|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
138578609|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
138578610|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
138578611|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
138578612|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
138578613|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138578614|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578615|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
138578616|NCT00119990|Icodextrin|icodextrin|mesh-list
138578617|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138578618|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
138578619|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
138578620|NCT00481624|Hematinics|hematinics|mesh-ancestor
138578621|NCT00117897|Lenograstim|lenograstim|mesh-list
138578622|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138578623|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
138578624|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578625|NCT00481663|Metformin|metformin|mesh-list
138326583|NCT00254592|Paclitaxel|paclitaxel|mesh-list
138578626|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138578627|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138578628|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578630|NCT00481663|Hormones|hormones|mesh-ancestor
138578631|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578632|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138578633|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
138578634|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578635|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578636|NCT00481702|Metronidazole|metronidazole|mesh-list
138578637|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
138578638|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578639|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138578640|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138578641|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138578642|NCT00481741|Hemostatics|hemostatics|mesh-list
138578643|NCT00481741|Coagulants|coagulants|mesh-ancestor
138578644|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
138578645|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
138578646|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138578647|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138578648|NCT00481819|Prednisolone|prednisolone|mesh-list
138578649|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
138578651|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138578652|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
138578653|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138578654|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
138578655|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578656|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138578657|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578658|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578659|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138326639|NCT00256776|Thalidomide|thalidomide|mesh-list
138578660|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578661|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138578662|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
138578663|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138578664|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578665|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138578666|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
138578667|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
138578668|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578669|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138578670|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
138578671|NCT00481819|Hormones|hormones|mesh-ancestor
138578672|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578673|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138578674|NCT00481819|Protective Agents|protective agents|mesh-ancestor
138578675|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138578676|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138578677|NCT02958059|Cefoxitin|cefoxitin|mesh-list
138578678|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578679|NCT00481975|Rimonabant|rimonabant|mesh-list
138578680|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138578681|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138578682|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138578683|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578684|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578686|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578687|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578688|NCT00482209|Misoprostol|misoprostol|mesh-list
138578689|NCT00482209|Mifepristone|mifepristone|mesh-list
138578690|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138578691|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
138578692|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138326681|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138578693|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578694|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138578695|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138578696|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
138578697|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138578698|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138578699|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138578700|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138578701|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
138578702|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138578703|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138578704|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
138578705|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578706|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
138578707|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138578708|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138578710|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
138578711|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578712|NCT00482248|Omalizumab|omalizumab|mesh-list
138578713|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138578714|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138578715|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
138657743|NCT02957643|Iron|iron|mesh-list
138326725|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578716|NCT00120185|Interleukin-2|interleukin-2|mesh-list
138326727|NCT00182754|Octreotide|octreotide|mesh-list
138578717|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578718|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138578719|NCT00120185|Analgesics|analgesics|mesh-ancestor
138578720|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
138578721|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578722|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578723|NCT01240642|Vadimezan|vadimezan|mesh-list
138578724|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578725|NCT00117975|Galiximab|galiximab|mesh-list
138578726|NCT00117975|Rituximab|rituximab|mesh-list
138578727|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138578728|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578729|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
138463169|NCT05352178|Antioxidants|antioxidants|mesh-ancestor
138578730|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578731|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138578732|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138578733|NCT00482521|Pomalidomide|pomalidomide|mesh-list
138578734|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
138578735|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578736|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138578737|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138578738|NCT00482521|Growth Substances|growth substances|mesh-ancestor
138578739|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
138578740|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578741|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
138478564|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
138578742|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138578743|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138578744|NCT00120302|Analgesics|analgesics|mesh-ancestor
138578745|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
138578746|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578747|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326776|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578748|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138578749|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326778|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
138578750|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
138578751|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138578752|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
138578753|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138578754|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578755|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578757|NCT00482716|Dextrans|dextrans|mesh-list
138578758|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
138578759|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138578760|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
138578761|NCT00482716|Trace Elements|trace elements|mesh-ancestor
138578762|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
138578763|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578764|NCT00482716|Hematinics|hematinics|mesh-ancestor
138578765|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
138578766|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
138578767|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
138578768|NCT00120341|Analgesics|analgesics|mesh-list
138578769|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
138578770|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578771|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255170|NCT01940276|Prednisone|prednisone|mesh-list
138578772|NCT00482989|Sifalimumab|sifalimumab|mesh-list
138578773|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
138578774|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578775|NCT00120380|Iloprost|iloprost|mesh-list
138578776|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138578777|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
138578779|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138578780|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578781|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578782|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
138578783|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326818|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
138578784|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578785|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
138578786|NCT00118014|Sertraline|sertraline|mesh-list
138578787|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
138578788|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138578789|NCT00118014|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138478582|NCT02025998|Ibudilast|ibudilast|mesh-list
138578790|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138578791|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138578792|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578793|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578794|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
138578795|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578796|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
138578797|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138578798|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578799|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138578800|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
138578801|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138578802|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578803|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578804|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578805|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
138578806|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
138578807|NCT05176470|Fludarabine|fludarabine|mesh-list
138578808|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138578809|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
138578810|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578811|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138578812|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138326861|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578813|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
138578814|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578815|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578816|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138578817|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138578818|NCT05176470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138578819|NCT01241032|Udenafil|udenafil|mesh-list
138578820|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138578821|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138578822|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578823|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578824|NCT00483067|Cytarabine|cytarabine|mesh-list
138578825|NCT00483067|Cladribine|cladribine|mesh-list
138578826|NCT00483067|Lenograstim|lenograstim|mesh-list
138578827|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138578828|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
138578829|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578831|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
138578832|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578833|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138578834|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
138578835|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578836|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138578837|NCT00483106|Methylphenidate|methylphenidate|mesh-list
138578838|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138578839|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578840|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138578841|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138578842|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138578843|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578844|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
138578845|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578846|NCT00118170|Sorafenib|sorafenib|mesh-list
138578847|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578848|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138578849|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318110|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
138578850|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578851|NCT00120497|Hormones|hormones|mesh-list
138578852|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138578853|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578854|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138578855|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138578856|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138578857|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
138578858|NCT00483301|Sorafenib|sorafenib|mesh-list
138578859|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138578860|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578861|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138578862|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578863|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578864|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138578865|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578866|NCT00120536|Vildagliptin|vildagliptin|mesh-list
138326967|NCT00208026|Analgesics|analgesics|mesh-ancestor
138326968|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
138326999|NCT01899690|Cephalexin|cephalexin|mesh-list
138578867|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138578868|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463389|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138578869|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138578870|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
138578871|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578872|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578874|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138578875|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578876|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138578877|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138578878|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
138578879|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578880|NCT00483730|Protective Agents|protective agents|mesh-ancestor
138578881|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138578882|NCT00118326|Lenograstim|lenograstim|mesh-list
138578883|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138578884|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
138578885|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578886|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
138578887|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138578888|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578889|NCT00405171|Nevirapine|nevirapine|mesh-list
138578890|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138578891|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138578892|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578893|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578894|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
138578895|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578896|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138327024|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138327029|NCT00282282|Sirolimus|sirolimus|mesh-list
138578897|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138578898|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138578899|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138578900|NCT00483886|Prucalopride|prucalopride|mesh-list
138578901|NCT00483886|Laxatives|laxatives|mesh-ancestor
138578902|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138578903|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138578904|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138578905|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
138578906|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578907|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578908|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578909|NCT00483964|Olanzapine|olanzapine|mesh-list
138578910|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
138478668|NCT02026583|Simvastatin|simvastatin|mesh-list
138578911|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
138463444|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138578912|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578913|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578914|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138578915|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138578916|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138578917|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138578918|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138578919|NCT00483964|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138578920|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138578921|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138327083|NCT00223704|Coagulants|coagulants|mesh-ancestor
138327086|NCT00223704|Analgesics|analgesics|mesh-ancestor
138188360|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138578922|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578923|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578924|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
138578926|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138578927|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138578928|NCT00484003|Analgesics|analgesics|mesh-ancestor
138578929|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
138578930|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578931|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578932|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138578933|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138578934|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
138578935|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138578936|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
138578937|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138578938|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578939|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578941|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138478708|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578942|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138578943|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138578944|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138578945|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138327129|NCT00225498|Olanzapine|olanzapine|mesh-list
138327130|NCT00225498|Risperidone|risperidone|mesh-list
138327131|NCT00225498|Ziprasidone|ziprasidone|mesh-list
138293313|NCT00314353|Bevacizumab|bevacizumab|mesh-list
138327132|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138578946|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578947|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578948|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578949|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138578950|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138578952|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
138578953|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
138578954|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578955|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578956|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138578957|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138578958|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138578959|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
138578960|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138578961|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578962|NCT00484120|Diclofenac|diclofenac|mesh-list
138578963|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138578964|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138578965|NCT00484120|Analgesics|analgesics|mesh-ancestor
138327185|NCT00114114|Goserelin|goserelin|mesh-list
138578966|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
138578967|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578968|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578969|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138578970|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138578971|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138578972|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578973|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578974|NCT00484237|Etanercept|etanercept|mesh-list
138578975|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138578976|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138578977|NCT00484237|Analgesics|analgesics|mesh-ancestor
138578978|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
138578979|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138578980|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138578981|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138578982|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138578983|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138578984|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138578985|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
138578986|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
138578987|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
138578988|NCT00120692|Hematinics|hematinics|mesh-ancestor
138578989|NCT00484432|Doxorubicin|doxorubicin|mesh-list
138578990|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138578991|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138578992|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138578993|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138578994|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138578995|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138578996|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
138578998|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
138578999|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579000|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
138657828|NCT01050543|Neostigmine|neostigmine|mesh-list
138579001|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579002|NCT00484510|Protective Agents|protective agents|mesh-ancestor
138579004|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
138579005|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579006|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
138579007|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138579008|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579009|NCT00120731|Diuretics|diuretics|mesh-ancestor
138579010|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
138579011|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579012|NCT00120731|Expectorants|expectorants|mesh-ancestor
138579013|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
138579014|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
138579015|NCT00484744|Acetaminophen|acetaminophen|mesh-list
138579016|NCT00484744|Ibuprofen|ibuprofen|mesh-list
138579017|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138579018|NCT00484744|Analgesics|analgesics|mesh-ancestor
138579019|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
138579020|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579021|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579022|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
138327283|NCT01899144|Albuterol|albuterol|mesh-list
138327285|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138579023|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138579024|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138579025|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138579026|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138579027|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579028|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579029|NCT00484822|Heparin|heparin|mesh-list
138579030|NCT00484822|Calcium heparin|calcium heparin|mesh-list
138579031|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
138478805|NCT02027337|Hormones|hormones|mesh-ancestor
138579032|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138579033|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138579034|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579035|NCT00405210|Docetaxel|docetaxel|mesh-list
138579036|NCT00405210|Sorafenib|sorafenib|mesh-list
138579037|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579038|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
138579039|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
138579040|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
138579041|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579042|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138579043|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579044|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
138579045|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
138463612|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138579046|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138579047|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
138327328|NCT00121836|Growth Substances|growth substances|mesh-ancestor
138579048|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138579049|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138579050|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327329|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327330|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
138579051|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138579052|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327331|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138327369|NCT00123630|Omalizumab|omalizumab|mesh-list
138579053|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579054|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138579055|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138579056|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
138579057|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138579058|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138579059|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579061|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138579062|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138579063|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579064|NCT00485056|Pioglitazone|pioglitazone|mesh-list
138579065|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138327371|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138327372|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
138327373|NCT00124176|Albuterol|albuterol|mesh-list
138327374|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138579066|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579067|NCT00120887|Atorvastatin|atorvastatin|mesh-list
138579068|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138579069|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138579070|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
138579071|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579072|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138579073|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138579074|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579075|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
138579076|NCT00118638|Hematinics|hematinics|mesh-ancestor
138579077|NCT00485368|Perindopril|perindopril|mesh-list
138579078|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138579079|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
138579080|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579081|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579082|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138579083|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138579084|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138327431|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138327432|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138327435|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
138579085|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138579086|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138657875|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
138463639|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138579087|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579088|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
138579089|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579090|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579091|NCT01241500|ON 01910|on 01910|mesh-list
138579092|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579093|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138579094|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579095|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579096|NCT02274181|Enclomiphene|enclomiphene|mesh-list
138579097|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138579098|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
138579099|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138579100|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579101|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138579102|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
138579103|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138579104|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138579105|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138579106|NCT01241422|Montelukast|montelukast|mesh-list
138579107|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138579108|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
138579109|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138579110|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
138579111|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138579112|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579113|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138579114|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138579115|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327487|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138327488|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138327499|NCT00127218|Niacin|niacin|mesh-list
138579116|NCT02274337|Abivertinib|abivertinib|mesh-list
138579117|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138478846|NCT02027532|Vancomycin|vancomycin|mesh-list
138579118|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579119|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579120|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138579121|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138579122|NCT00485680|Olanzapine|olanzapine|mesh-list
138579124|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
138579125|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
138579126|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579127|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579128|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138579129|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138579130|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138579131|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138579132|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138579133|NCT00485680|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138579134|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138579135|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138579136|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579137|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579138|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
138327526|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
138327527|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
138579139|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
138579140|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579141|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
138188361|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579143|NCT00118794|Artemether|artemether|mesh-list
138579144|NCT00118794|Dapsone|dapsone|mesh-list
138579145|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
138579146|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138579147|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
138579148|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138579149|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138579150|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579151|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138478873|NCT02027870|Sirolimus|sirolimus|mesh-list
138579152|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579153|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579154|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
138579155|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138579156|NCT01241773|Efavirenz|efavirenz|mesh-list
138579157|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
138579158|NCT01241773|Simeprevir|simeprevir|mesh-list
138579159|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138579160|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138579161|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579162|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579163|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
138579164|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579165|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138579166|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138327580|NCT02103114|Thrombin|thrombin|mesh-list
138327581|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
138327582|NCT02103114|Coagulants|coagulants|mesh-ancestor
138579167|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138579168|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138579169|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138579170|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138579171|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138579172|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138579173|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138579174|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138579175|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
138579177|NCT00121277|Vorinostat|vorinostat|mesh-list
138579178|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138579179|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
138478919|NCT02028078|Insulin|insulin|mesh-list
138579180|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579181|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579182|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138579183|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579184|NCT00485797|Methylphenidate|methylphenidate|mesh-list
138579185|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138579186|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579187|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138579188|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138579189|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138579190|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579191|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
138579192|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579193|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138579194|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138327629|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138579195|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138579196|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138579197|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579198|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
138579199|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579200|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579202|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138579203|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138579204|NCT00121316|Analgesics|analgesics|mesh-ancestor
138579205|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
138579206|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579207|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579208|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138579209|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138579210|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
138579211|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138579213|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138579214|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579215|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579216|NCT00118950|Metformin|metformin|mesh-list
138579217|NCT00118950|Repaglinide|repaglinide|mesh-list
138579218|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138579219|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579220|NCT00486187|Metformin|metformin|mesh-list
138579221|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
138579222|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138579223|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327732|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138579224|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
138327733|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
138327734|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138579225|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138579226|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579227|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
138579228|NCT00486343|Zileuton|zileuton|mesh-list
138579229|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138579230|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138579231|NCT00486343|Analgesics|analgesics|mesh-ancestor
138579232|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
138579233|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579234|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579235|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463781|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
138579236|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138327797|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
138327798|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
138579237|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138327799|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
138579238|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579239|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579240|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138579241|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
138657953|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
138579242|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138579243|NCT00486421|Prednisone|prednisone|mesh-list
138579244|NCT00486421|Rituximab|rituximab|mesh-list
138579245|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138579246|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579247|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
138579248|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579249|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138579250|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138579251|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
138579252|NCT00486421|Hormones|hormones|mesh-ancestor
138579253|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138579254|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138579255|NCT00486460|Curcumin|curcumin|mesh-list
138579256|NCT00486460|Celecoxib|celecoxib|mesh-list
138579257|NCT00486460|Gemcitabine|gemcitabine|mesh-list
138579258|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138579259|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
138478997|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138579260|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579261|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579262|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138579263|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138579264|NCT00486460|Analgesics|analgesics|mesh-ancestor
138579265|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
138579266|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579267|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579268|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138579269|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138579270|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579271|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138579272|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138579273|NCT00121511|Fluorouracil|fluorouracil|mesh-list
138579274|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
138579275|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579276|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138579277|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579278|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138579279|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
138579280|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579281|NCT00486694|Artesunate|artesunate|mesh-list
138579282|NCT00486694|Chloroquine|chloroquine|mesh-list
138579283|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
138327854|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138327855|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
138327856|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579284|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
138579285|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138579286|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
138579287|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138579288|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138579289|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579290|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579291|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
138579292|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
138579293|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138579294|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
138579295|NCT00486694|Amebicides|amebicides|mesh-ancestor
138579296|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138579297|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138579298|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579299|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579300|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138579301|NCT00486772|Calcium|calcium|mesh-list
138579302|NCT00486772|Sevelamer|sevelamer|mesh-list
138579303|NCT00486772|Calcium acetate|calcium acetate|mesh-list
138579304|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138579305|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579306|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
138579307|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
138579308|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579309|NCT00121550|Clarithromycin|clarithromycin|mesh-list
138579310|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138579311|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579312|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138579313|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579314|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579315|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138579316|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138579317|NCT01242046|Caffeine|caffeine|mesh-list
138579318|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138579319|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579320|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138579322|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327878|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579323|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138579324|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138579325|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
138579326|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579327|NCT01242202|Acarbose|acarbose|mesh-list
138579328|NCT01242202|Voglibose|voglibose|mesh-list
138579329|NCT01242202|Miglitol|miglitol|mesh-list
138579330|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
138579331|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
138579332|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579333|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579334|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138579335|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579336|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138579337|NCT00119145|Artesunate|artesunate|mesh-list
138579338|NCT00119145|Amodiaquine|amodiaquine|mesh-list
138579339|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138579340|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
138579341|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138579342|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138579343|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579344|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579345|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
138579346|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
138579347|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138579348|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
138579349|NCT00119184|Anesthetics|anesthetics|mesh-list
138579350|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138579351|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579352|NCT00487123|Valsartan|valsartan|mesh-list
138579353|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138579354|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138464116|NCT01949935|Mupirocin|mupirocin|mesh-list
138579355|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138579356|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138579357|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579358|NCT00487123|Diuretics|diuretics|mesh-ancestor
138579359|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
138579360|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327913|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
138327914|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579361|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138327915|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579362|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138579363|NCT00487591|Simvastatin|simvastatin|mesh-list
138579364|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138255759|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
138479118|NCT02029378|Eculizumab|eculizumab|mesh-list
138579366|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
138579367|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579368|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138579369|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138579370|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579371|NCT00487786|Docetaxel|docetaxel|mesh-list
138579372|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579373|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
138579374|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
138579375|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
138579376|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579377|NCT00488137|Prucalopride|prucalopride|mesh-list
138579378|NCT00488137|Laxatives|laxatives|mesh-ancestor
138579379|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138579380|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138579381|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138579382|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
138579383|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579384|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579385|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579386|NCT00488176|Cetirizine|cetirizine|mesh-list
138579387|NCT00488176|Montelukast|montelukast|mesh-list
138327947|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138327948|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579388|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138579389|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
138579390|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138579391|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
138579392|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138579393|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579394|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138579395|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138579396|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579397|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138579398|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138579399|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138579400|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
138579401|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
138579402|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579403|NCT00488215|Prucalopride|prucalopride|mesh-list
138579404|NCT00488215|Laxatives|laxatives|mesh-ancestor
138579405|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138579406|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138579407|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138579408|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
138479142|NCT02029573|Atorvastatin|atorvastatin|mesh-list
138579409|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579410|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579411|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579412|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
138327996|NCT00354978|Irinotecan|irinotecan|mesh-list
138579413|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138579414|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579415|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579416|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138579417|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
138579418|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579419|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
138579420|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138579421|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579422|NCT00488566|Lamotrigine|lamotrigine|mesh-list
138579423|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
138579424|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138579425|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138464315|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
138579426|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579427|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138579428|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579429|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138579430|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138579431|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138579432|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138579433|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138579434|NCT00488722|Goserelin|goserelin|mesh-list
138328046|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
138579435|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138579436|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579437|NCT00488761|Tigecycline|tigecycline|mesh-list
138579438|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138579439|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579440|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138579441|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579442|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579443|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
138579445|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579446|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138479182|NCT02029612|Nicotine|nicotine|mesh-list
138579447|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
138579448|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138579449|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579450|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579451|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579452|NCT00145236|Nebivolol|nebivolol|mesh-list
138579453|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138579454|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
138579455|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138579456|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138579457|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138579458|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
138579459|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579460|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579461|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579462|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
138579463|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138579464|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579465|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138579466|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
138579467|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579468|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
138579469|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138579470|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579471|NCT00488995|Tremelimumab|tremelimumab|mesh-list
138579472|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328094|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138328095|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
138328096|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138328097|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138579473|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138579474|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138579475|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138464487|NCT01952652|Naproxen|naproxen|mesh-list
138579476|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138579477|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579478|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579479|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579480|NCT00489073|Analgesics|analgesics|mesh-ancestor
138579481|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
138579482|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579483|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
138579484|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138579485|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
138579486|NCT00489151|Lamivudine|lamivudine|mesh-list
138579487|NCT00489151|Adefovir|adefovir|mesh-list
138579488|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138579489|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138579490|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138579491|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579492|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579493|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
138579494|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579495|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138579496|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138579497|NCT00145314|Leucovorin|leucovorin|mesh-list
138579498|NCT00145314|Folic Acid|folic acid|mesh-list
138579499|NCT00145314|Fluorouracil|fluorouracil|mesh-list
138579500|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
138579501|NCT00145314|Cetuximab|cetuximab|mesh-list
138579502|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
138579503|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
138579504|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579505|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138579506|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579507|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138579508|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
138579509|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579510|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138579512|NCT00145314|Protective Agents|protective agents|mesh-ancestor
138579513|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
138579514|NCT00145314|Vitamins|vitamins|mesh-ancestor
138579515|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
138328129|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138579516|NCT00145314|Hematinics|hematinics|mesh-ancestor
138579517|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
138579518|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138328130|NCT00360672|Growth Substances|growth substances|mesh-ancestor
138328131|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
138294487|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
138579519|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579520|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
138579521|NCT00489229|Ramipril|ramipril|mesh-list
138579522|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138579523|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579524|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138579525|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
138579526|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579527|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579528|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138579529|NCT00489385|Ribavirin|ribavirin|mesh-list
138579530|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
138579531|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579532|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
138579533|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579535|NCT01242631|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138328155|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138328156|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328157|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328158|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
138579536|NCT01242631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138579537|NCT01242631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579538|NCT01242631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579539|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138579540|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
138579541|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579542|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579543|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
138579544|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
138579545|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138579546|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579547|NCT01242904|Icodextrin|icodextrin|mesh-list
138579548|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
138328210|NCT00363168|Growth Substances|growth substances|mesh-ancestor
138328211|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328212|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
138579549|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138328213|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328214|NCT00365274|Prednisone|prednisone|mesh-list
138328215|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
138579550|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
138579551|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138579552|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579553|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138579554|NCT00121979|Racivir|racivir|mesh-list
138579555|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138579556|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579557|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579558|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
138579559|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579560|NCT00489658|Eflornithine|eflornithine|mesh-list
138579562|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579563|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138579564|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138579565|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138579566|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579567|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138579568|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579569|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579570|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
138579571|NCT00122018|Fenoldopam|fenoldopam|mesh-list
138579572|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138579573|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
138479272|NCT02031692|Vitamin D|vitamin d|mesh-list
138579574|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579576|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
138579577|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138579578|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
138579579|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579580|NCT00122018|Protective Agents|protective agents|mesh-ancestor
138579581|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579582|NCT00122018|Antidotes|antidotes|mesh-ancestor
138658050|NCT00434382|Narcotics|narcotics|mesh-ancestor
138579583|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138579584|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
138579585|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
138579586|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
138579587|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579588|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138579589|NCT00489775|Paroxetine|paroxetine|mesh-list
138579590|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138579591|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138579592|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138579593|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579594|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579595|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579597|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
138579598|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579599|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
138579600|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138579601|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
138328265|NCT00314106|Aldesleukin|aldesleukin|mesh-list
138328266|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
138579602|NCT00489775|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138579603|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
138579604|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138579605|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138579606|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138579607|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579608|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138579609|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579611|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138579612|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579613|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138579614|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138579615|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138579616|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579617|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
138579618|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138579619|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
138579620|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138579621|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579622|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138579623|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138579624|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138579625|NCT01243060|Zolpidem|zolpidem|mesh-list
138579626|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138579627|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138579628|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138328289|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
138328290|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328291|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328310|NCT02405676|Cytarabine|cytarabine|mesh-list
138579629|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579630|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138579631|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
138579632|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
138579633|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579634|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579635|NCT00490204|Cetirizine|cetirizine|mesh-list
138579636|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138464992|NCT04853446|Dexamethasone|dexamethasone|mesh-list
138579637|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138579638|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138579639|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
138579640|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
138579641|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579642|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658073|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
138579643|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579645|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138579646|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138579647|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579648|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579649|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138579650|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138579651|NCT00122096|Analgesics|analgesics|mesh-ancestor
138579652|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
138579653|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579654|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579655|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138579656|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138579658|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
138579659|NCT00490243|Montelukast|montelukast|mesh-list
138256062|NCT02975219|Bevacizumab|bevacizumab|mesh-list
138579661|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138579662|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
138579663|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579664|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579665|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138579666|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
138579667|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
138579668|NCT00490243|Hormones|hormones|mesh-ancestor
138579669|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138579670|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138579671|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138328333|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138328357|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
138579672|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138579673|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
138579674|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579675|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579676|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138465112|NCT04179890|Afatinib|afatinib|mesh-list
138579677|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
138579678|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138579679|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138579680|NCT00490360|Gemcitabine|gemcitabine|mesh-list
138579681|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579682|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138579683|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
138579684|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579685|NCT00490399|Gemcitabine|gemcitabine|mesh-list
138579686|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579687|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138579688|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
138479379|NCT02036255|Taurolidine|taurolidine|mesh-list
138579689|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579690|NCT04844385|Paclitaxel|paclitaxel|mesh-list
138579691|NCT04844385|Capecitabine|capecitabine|mesh-list
138579692|NCT04844385|Nedaplatin|nedaplatin|mesh-list
138579693|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138579694|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579695|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
138579696|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
138579697|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
138579698|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579699|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138579700|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
138579701|NCT00490633|Ethanol|ethanol|mesh-list
138579702|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
138579703|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138579704|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579705|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138579706|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328363|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
138328364|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138328370|NCT00391716|Gabapentin|gabapentin|mesh-list
138579707|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
138579708|NCT00490711|Paclitaxel|paclitaxel|mesh-list
138579709|NCT00490711|Carboplatin|carboplatin|mesh-list
138579710|NCT00490711|Gemcitabine|gemcitabine|mesh-list
138579711|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138579712|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579713|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
138579714|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
138579715|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
138579716|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579717|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138579718|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
138579720|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138579721|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
138579722|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579723|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579724|NCT00490789|Sirolimus|sirolimus|mesh-list
138579725|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138579726|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579727|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138579728|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579729|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
138579730|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138479418|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138579731|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
138579732|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579733|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
138579734|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138579736|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138579737|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138579738|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
138579739|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
138579740|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579741|NCT00490867|Protective Agents|protective agents|mesh-ancestor
138328399|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328400|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138328408|NCT00638898|Melphalan|melphalan|mesh-list
138579742|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579743|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
138579744|NCT00490867|Vitamins|vitamins|mesh-ancestor
138579745|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
138579746|NCT00122330|Eculizumab|eculizumab|mesh-list
138579747|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138579748|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138579749|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
138465262|NCT02766335|Durvalumab|durvalumab|mesh-list
138579750|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579751|NCT00490906|Interferons|interferons|mesh-list
138579752|NCT00490906|Interferon-beta|interferon-beta|mesh-list
138579753|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
138579754|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
138579755|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
138579756|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
138579757|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579758|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
138579759|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579760|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
138579761|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579762|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138579763|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138579764|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138579765|NCT00122486|Tenofovir|tenofovir|mesh-list
138579766|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
138579767|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138328438|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138579768|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138579769|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138579770|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328439|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138579771|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579772|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138579773|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138579774|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
138579775|NCT00491413|Hematinics|hematinics|mesh-ancestor
138579776|NCT00145665|Telbivudine|telbivudine|mesh-list
138579777|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
138579778|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579779|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138579780|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579781|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579782|NCT00491725|Metformin|metformin|mesh-list
138579783|NCT00491725|Repaglinide|repaglinide|mesh-list
138579784|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138579785|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579786|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
138579787|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
138579788|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138579789|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138579790|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579791|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579792|NCT00491803|Urological Agents|urological agents|mesh-ancestor
138579793|NCT00122603|Saquinavir|saquinavir|mesh-list
138579794|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
138579795|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138579796|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138579797|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
138579798|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579799|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579800|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138579801|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138579802|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
138465370|NCT02177695|Doxorubicin|doxorubicin|mesh-list
138465371|NCT02177695|Methotrexate|methotrexate|mesh-list
138579803|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579804|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138579805|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138579806|NCT00491920|Vitamin D|vitamin d|mesh-list
138579807|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
138579808|NCT00491920|Vitamins|vitamins|mesh-ancestor
138328487|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138579810|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328488|NCT00377832|Analgesics|analgesics|mesh-ancestor
138328492|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
138579811|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138579812|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138579814|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138579815|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138579816|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138579817|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579818|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579819|NCT00492037|Conivaptan|conivaptan|mesh-list
138579820|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138579821|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579822|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
138579823|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579824|NCT00402272|Everolimus|everolimus|mesh-list
138579825|NCT00402272|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138579826|NCT00402272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138579827|NCT00402272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579828|NCT00402272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579829|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138579830|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
138579831|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579832|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579834|NCT00492388|Analgesics|analgesics|mesh-ancestor
138579835|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
138579836|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579837|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579838|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138328522|NCT00381810|Acetaminophen|acetaminophen|mesh-list
138328523|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
138579839|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138579840|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
138579841|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
138579842|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138579843|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138579844|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138579845|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579846|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579847|NCT01243528|Vitamin D|vitamin d|mesh-list
138579848|NCT01243528|Vitamins|vitamins|mesh-ancestor
138579849|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
138579850|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579851|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138579852|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
138579853|NCT00492427|Hematinics|hematinics|mesh-ancestor
138579854|NCT00492466|Interferons|interferons|mesh-list
138579855|NCT00492466|Interferon-beta|interferon-beta|mesh-list
138579856|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
138579857|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
138579858|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579859|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
138579860|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579861|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138579862|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
138579863|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
138579864|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579865|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579866|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138579867|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
138579868|NCT00492466|Hormones|hormones|mesh-ancestor
138579869|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138579870|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138579871|NCT00492466|Protective Agents|protective agents|mesh-ancestor
138579872|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
138579874|NCT00492505|Tamoxifen|tamoxifen|mesh-list
138579875|NCT00492505|Sorafenib|sorafenib|mesh-list
138579876|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579877|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579878|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138328574|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138579879|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579880|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138579881|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
138328575|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579882|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138318116|NCT01467492|Ribavirin|ribavirin|mesh-list
138579883|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579884|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138579885|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138579887|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138579889|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138579890|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
138579891|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579892|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138579893|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579894|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579896|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138579897|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579898|NCT00402350|Fentanyl|fentanyl|mesh-list
138579899|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138579900|NCT00402350|Narcotics|narcotics|mesh-ancestor
138579901|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138579902|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579903|NCT00402350|Analgesics|analgesics|mesh-ancestor
138579904|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
138465605|NCT01953757|Vitamins|vitamins|mesh-list
138579905|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579906|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138579907|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138579908|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
138328607|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138328608|NCT00382590|Cytarabine|cytarabine|mesh-list
138328609|NCT00382590|Azacitidine|azacitidine|mesh-list
138328632|NCT00382824|Vitamins|vitamins|mesh-ancestor
138579909|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
138579910|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
138579911|NCT00122720|Hematinics|hematinics|mesh-ancestor
138579912|NCT00492934|Menotropins|menotropins|mesh-list
138579913|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138579914|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
138579915|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138579916|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579917|NCT02274454|Oxytocin|oxytocin|mesh-list
138579918|NCT02274454|Calcium|calcium|mesh-list
138579919|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138579920|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579921|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
138579922|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138579923|NCT04760730|Vaccines|vaccines|mesh-list
138579924|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
138579925|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579926|NCT00122759|Ketamine|ketamine|mesh-list
138579927|NCT00122759|Analgesics|analgesics|mesh-ancestor
138579928|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
138579929|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579930|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579931|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138579932|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138579933|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
138579934|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
138579935|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138579936|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138579937|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138579939|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579940|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
138579941|NCT00493129|Interleukin-2|interleukin-2|mesh-list
138579942|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579943|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138579944|NCT00493129|Analgesics|analgesics|mesh-ancestor
138579945|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
138579946|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579947|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579949|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138579950|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138579951|NCT00126542|Antibodies|antibodies|mesh-list
138328655|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328656|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138328657|NCT00383448|Cyclosporine|cyclosporine|mesh-list
138579952|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
138465662|NCT01953848|Tamsulosin|tamsulosin|mesh-list
138579953|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138579954|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579955|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138579956|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138579957|NCT00126542|Growth Substances|growth substances|mesh-ancestor
138579958|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579960|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
138579961|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138579962|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579963|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579964|NCT00493324|Alefacept|alefacept|mesh-list
138579965|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138579966|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
138579967|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579968|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
138579969|NCT01243801|Ketamine|ketamine|mesh-list
138579970|NCT01243801|Analgesics|analgesics|mesh-ancestor
138579971|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
138579972|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138579973|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138579974|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138579975|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138579976|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
138579977|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
138579978|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138579979|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138579980|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138579981|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138579982|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579983|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138579984|NCT00126620|Sorafenib|sorafenib|mesh-list
138579985|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579986|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138579987|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138579988|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138579989|NCT00493363|Artesunate|artesunate|mesh-list
138579990|NCT00493363|Mefloquine|mefloquine|mesh-list
138579991|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
138579992|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138579993|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138579994|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138579995|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579996|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
138579997|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
138579998|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138465730|NCT01954043|Rifampin|rifampin|mesh-list
138328689|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138579999|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
138580000|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
138479614|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138580001|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138580003|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
138580004|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138580005|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580006|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138580007|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138580008|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580009|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580010|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580011|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138580012|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138580013|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138580014|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
138580015|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138580016|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138580017|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138580018|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138580019|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138580020|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
138580021|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138580022|NCT00493402|Estrogens|estrogens|mesh-ancestor
138580023|NCT00493402|Hormones|hormones|mesh-ancestor
138580024|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138580025|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328715|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138328716|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138328719|NCT00385008|Naproxen|naproxen|mesh-list
138580026|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138580027|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580028|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
138580029|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
138580030|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138580031|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138580032|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580033|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580034|NCT00145938|Urological Agents|urological agents|mesh-ancestor
138580035|NCT00493480|Propranolol|propranolol|mesh-list
138580036|NCT00493480|Carvedilol|carvedilol|mesh-list
138580037|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138580038|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138580039|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
138580040|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138580041|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580042|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580043|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138580044|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138580045|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
138580047|NCT00493480|Protective Agents|protective agents|mesh-ancestor
138580048|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138580049|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138580050|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138580051|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138580052|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138580053|NCT01243996|Ibuprofen|ibuprofen|mesh-list
138580054|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138580055|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138580056|NCT01243996|Analgesics|analgesics|mesh-ancestor
138580057|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
138580058|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580059|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580060|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138580061|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138580062|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138580063|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580064|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328762|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328763|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
138580065|NCT01244113|Propofol|propofol|mesh-list
138580066|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138580067|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138580068|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580069|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138580070|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
138580071|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
138580072|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
138580073|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138580074|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138580075|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580076|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580077|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
138580078|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138328795|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328796|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
138328797|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138328798|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138328799|NCT00466752|Sorafenib|sorafenib|mesh-list
138580079|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138580080|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138580081|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
138580082|NCT00493987|Testosterone|testosterone|mesh-list
138580083|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
138580084|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
138580085|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138580086|NCT00493987|Dutasteride|dutasteride|mesh-list
138580087|NCT00493987|Androgens|androgens|mesh-ancestor
138580089|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138580090|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580091|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138580092|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580093|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
138580094|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138580095|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138580096|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580097|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580098|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
138580099|NCT00494104|Vitamin D|vitamin d|mesh-list
138580100|NCT00494104|Vitamins|vitamins|mesh-ancestor
138580101|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
138580102|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580103|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138580104|NCT00405366|Sorafenib|sorafenib|mesh-list
138580105|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580106|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138256520|NCT04330677|Oxytocin|oxytocin|mesh-list
138580107|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580108|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580110|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580111|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
138580112|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
138580113|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
138580114|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580115|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138580116|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138580117|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138580118|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138580119|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328851|NCT00413634|Anagrelide|anagrelide|mesh-list
138328852|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138328856|NCT00387036|Fluticasone|fluticasone|mesh-list
138580120|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138580121|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580122|NCT00494377|Analgesics|analgesics|mesh-ancestor
138580123|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
138580124|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580125|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
138580126|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138580127|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
138580128|NCT00146016|Amantadine|amantadine|mesh-list
138580129|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138580130|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138580131|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
138580132|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580133|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
138580134|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138580135|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580136|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580137|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138580138|NCT00146016|Analgesics|analgesics|mesh-ancestor
138580139|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
138580140|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580141|NCT00126971|Dapsone|dapsone|mesh-list
138580142|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
138580143|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580144|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
138580145|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138580146|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138580147|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138580148|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580149|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580150|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
138580151|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138580152|NCT01244230|Fexofenadine|fexofenadine|mesh-list
138580153|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138580154|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138580155|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138580156|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
138580157|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
138328885|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138580158|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138580159|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580160|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328886|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138328887|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138328888|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328889|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580161|NCT01244269|Methylphenidate|methylphenidate|mesh-list
138328891|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
138580162|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138580163|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580164|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138391885|NCT01507064|Sorafenib|sorafenib|mesh-list
138580165|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138580166|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138580167|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580168|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
138580169|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138580171|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
138580172|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580173|NCT00494533|Treprostinil|treprostinil|mesh-list
138580174|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138580175|NCT00494572|Montelukast|montelukast|mesh-list
138580176|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138580177|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
138580178|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138580179|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
138256583|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
138580180|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138580181|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580182|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138580183|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138580184|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580185|NCT00494611|Cetuximab|cetuximab|mesh-list
138580186|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138580187|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580188|NCT00127049|Gemcitabine|gemcitabine|mesh-list
138580189|NCT00127049|Ifosfamide|ifosfamide|mesh-list
138580190|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580191|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138580192|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
138580193|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580194|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138580195|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
138580196|NCT00494884|Vildagliptin|vildagliptin|mesh-list
138580197|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138580198|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580199|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138580200|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
138580201|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580202|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580203|NCT00127088|Docetaxel|docetaxel|mesh-list
138580204|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580205|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
138580206|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
138580207|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
138328912|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138580208|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580209|NCT02957877|Heparin|heparin|mesh-list
138580210|NCT02957877|Calcium heparin|calcium heparin|mesh-list
138580211|NCT02957877|Nadroparin|nadroparin|mesh-list
138580213|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138580214|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138580215|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580216|NCT01244581|Amoxicillin|amoxicillin|mesh-list
138580217|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
138580218|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
138658229|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
138580219|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138580220|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138580221|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580222|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138580223|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580224|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580226|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138580227|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
138580228|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580229|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138580230|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580231|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580232|NCT01244698|Clindamycin|clindamycin|mesh-list
138580233|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
138580234|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
138580235|NCT01244698|Cefazolin|cefazolin|mesh-list
138580236|NCT01244698|Cefadroxil|cefadroxil|mesh-list
138580237|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138580238|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580239|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138580240|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580241|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580242|NCT00495118|Risperidone|risperidone|mesh-list
138580243|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138580244|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
138580245|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328939|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
138465910|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138328940|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
138328941|NCT00478218|Dexamethasone|dexamethasone|mesh-list
138328942|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
138328943|NCT00478218|Lenalidomide|lenalidomide|mesh-list
138328959|NCT00478218|Hormones|hormones|mesh-ancestor
138580246|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580247|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580248|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138580249|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138580250|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138580251|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138580252|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138580253|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
138580254|NCT00495313|Metronidazole|metronidazole|mesh-list
138580255|NCT00495313|Doxycycline|doxycycline|mesh-list
138580256|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580257|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138580258|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138580259|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138580260|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
138580261|NCT00495352|Bupropion|bupropion|mesh-list
138580262|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138580263|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
138580264|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138580265|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138580266|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138580267|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138580268|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580269|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
138580271|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580272|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138580273|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138580274|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580275|NCT00495547|Azacitidine|azacitidine|mesh-list
138580276|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
138580277|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138658274|NCT00431340|Belinostat|belinostat|mesh-list
138580278|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
138328971|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138328972|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
138580279|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580280|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580281|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580282|NCT00495547|Hematinics|hematinics|mesh-ancestor
138580284|NCT00495781|Trace Elements|trace elements|mesh-ancestor
138580285|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
138580286|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580287|NCT00405405|Bevacizumab|bevacizumab|mesh-list
138580288|NCT00405405|Cisplatin|cisplatin|mesh-list
138580289|NCT00405405|Docetaxel|docetaxel|mesh-list
138580290|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138580291|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138580292|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580293|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138580294|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138580296|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580297|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
138580298|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
138580299|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
138580300|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
138580301|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580302|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138329012|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
138580303|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329013|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138580304|NCT00495898|Sirolimus|sirolimus|mesh-list
138580305|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138329014|NCT00530634|Gemcitabine|gemcitabine|mesh-list
138329015|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580306|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580307|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138580308|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580309|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
138580310|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138580311|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
138580312|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580313|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138580314|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
138580315|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580316|NCT00127478|Atrasentan|atrasentan|mesh-list
138580317|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580318|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138580319|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138580320|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329058|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329059|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580321|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138329060|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138329061|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138580322|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138329070|NCT00533442|Sirolimus|sirolimus|mesh-list
138479827|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
138580324|NCT00496405|Bevacizumab|bevacizumab|mesh-list
138580325|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138580326|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580327|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138580328|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138580329|NCT00496405|Growth Substances|growth substances|mesh-ancestor
138580330|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580331|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
138580332|NCT00496444|Azacitidine|azacitidine|mesh-list
138580333|NCT00496444|Valproic Acid|valproic acid|mesh-list
138580334|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138580335|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
138580336|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580337|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580338|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138329111|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
138329112|NCT00429702|Promethazine|promethazine|mesh-list
138329114|NCT00429702|Lorazepam|lorazepam|mesh-list
138580339|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
138580340|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
138580341|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138658279|NCT00431379|Tenecteplase|tenecteplase|mesh-list
138580342|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580343|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
138580344|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138580345|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138580346|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138580347|NCT00496561|Immunomodulating Agents|immunomodulating agents|mesh-list
138580348|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
138580349|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580350|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
138580351|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138580352|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
138580353|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
138580354|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138580355|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580356|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138580357|NCT00146250|Analgesics|analgesics|mesh-ancestor
138580358|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
138580359|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580361|NCT00496600|Epothilone B|epothilone b|mesh-list
138580362|NCT00496600|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138580363|NCT00496600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138580364|NCT00496600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580365|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580366|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138580367|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
138580368|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580369|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580370|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
138580371|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
138580372|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
138580373|NCT00127595|Gemcitabine|gemcitabine|mesh-list
138580374|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
138580375|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138580376|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
138329171|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
138580377|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580378|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580379|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
138580380|NCT00497107|Leucovorin|leucovorin|mesh-list
138580381|NCT00497107|Calcium|calcium|mesh-list
138580382|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
138580383|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138479839|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
138580384|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580385|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138580386|NCT00497107|Antidotes|antidotes|mesh-ancestor
138580387|NCT00497107|Protective Agents|protective agents|mesh-ancestor
138580388|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
138580389|NCT00497107|Vitamins|vitamins|mesh-ancestor
138580390|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
138580391|NCT00146289|Telmisartan|telmisartan|mesh-list
138580392|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138580393|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138580394|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138580395|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580396|NCT01244932|Bupivacaine|bupivacaine|mesh-list
138580397|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
138580398|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
138580399|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138580400|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256817|NCT01726621|Insulin|insulin|mesh-list
138329208|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580402|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580403|NCT01244971|Acarbose|acarbose|mesh-list
138580404|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138329209|NCT01796028|Metformin|metformin|mesh-list
138580405|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580406|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580407|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138580408|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580409|NCT04599894|Pregabalin|pregabalin|mesh-list
138580410|NCT04599894|Analgesics|analgesics|mesh-ancestor
138580411|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
138580412|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580413|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580415|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138580416|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138580417|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580418|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138580419|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138580420|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138580421|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138580422|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138580423|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138580424|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580425|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138580426|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580427|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580428|NCT04726982|Acetazolamide|acetazolamide|mesh-list
138580429|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
138580430|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138580431|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580432|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580433|NCT04726982|Diuretics|diuretics|mesh-ancestor
138580434|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
138580435|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580436|NCT00497341|Cefuroxime|cefuroxime|mesh-list
138580437|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
138580438|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138580439|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580440|NCT00127829|Gefitinib|gefitinib|mesh-list
138580441|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580442|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138580443|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580444|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580445|NCT00497458|Testosterone|testosterone|mesh-list
138580446|NCT00497458|Androgens|androgens|mesh-ancestor
138580447|NCT00497458|Hormones|hormones|mesh-ancestor
138282902|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
138295953|NCT00002798|Idarubicin|idarubicin|mesh-list
138580448|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138580449|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580450|NCT00497497|Bevacizumab|bevacizumab|mesh-list
138580452|NCT00497497|Irinotecan|irinotecan|mesh-list
138580453|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138580454|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580455|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138580456|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138580457|NCT00497497|Growth Substances|growth substances|mesh-ancestor
138580458|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580459|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
138580460|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138580461|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138580462|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580463|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580464|NCT00127868|Selenium|selenium|mesh-list
138580465|NCT00127868|Ketoconazole|ketoconazole|mesh-list
138580466|NCT00127868|Ciclopirox|ciclopirox|mesh-list
138580467|NCT00127868|Griseofulvin|griseofulvin|mesh-list
138580468|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
138580469|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
138580470|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580471|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138580472|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138580473|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580474|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580475|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138580476|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
138580477|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138580478|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580479|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138580480|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
138580481|NCT00127868|Protective Agents|protective agents|mesh-ancestor
138580482|NCT00127868|Trace Elements|trace elements|mesh-ancestor
138580483|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
138580484|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
138580485|NCT00497536|Insulin|insulin|mesh-list
138580486|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138580487|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
138580488|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
138580489|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138282935|NCT03001843|Analgesics|analgesics|mesh-ancestor
138282936|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
138282937|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580490|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138580491|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580492|NCT00497614|Adalimumab|adalimumab|mesh-list
138580493|NCT00497614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138580494|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138580495|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138580496|NCT00127907|Vasopressins|vasopressins|mesh-list
138580497|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
138580498|NCT00127907|Epinephrine|epinephrine|mesh-list
138580499|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138580500|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138580501|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
138580502|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138580503|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580504|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580505|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138580506|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138580507|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
138580508|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580509|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138580510|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
138580511|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
138282967|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138282968|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138282978|NCT03003949|Hormones|hormones|mesh-ancestor
138580512|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
138580513|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138580514|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
138580515|NCT00127907|Coagulants|coagulants|mesh-ancestor
138580516|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138580517|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
138580518|NCT00497809|Lenograstim|lenograstim|mesh-list
138580519|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138580520|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
138580521|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580522|NCT00146484|Insulin|insulin|mesh-list
138580523|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138658308|NCT00331994|Metronidazole|metronidazole|mesh-list
138580524|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580526|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
138580527|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138580528|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
138580529|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138580530|NCT00498004|Risperidone|risperidone|mesh-list
138580531|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138580532|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138580533|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
138580534|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138580535|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580536|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580537|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138580538|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138580539|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138580540|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138580541|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138580542|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
138580543|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
138580544|NCT00146523|Mifepristone|mifepristone|mesh-list
138580545|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138580546|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
138580547|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138580548|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580549|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138580550|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138580551|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138580552|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
138580553|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138580554|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138580555|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
138580556|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138580557|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
138580558|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138580559|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138580560|NCT00402623|Quercetin|quercetin|mesh-list
138580561|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
138466192|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138580562|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580563|NCT00402623|Protective Agents|protective agents|mesh-ancestor
138283020|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138580564|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580565|NCT00402662|Everolimus|everolimus|mesh-list
138580566|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
138580567|NCT00402662|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138580568|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138580569|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580570|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580571|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138580572|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
138580573|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580574|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580575|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
138580576|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
138580577|NCT00498316|Melphalan|melphalan|mesh-list
138580578|NCT00498316|Busulfan|busulfan|mesh-list
138580579|NCT00498316|Rituximab|rituximab|mesh-list
138580580|NCT00498316|Fludarabine|fludarabine|mesh-list
138580581|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
138580582|NCT00498316|Clofarabine|clofarabine|mesh-list
138580583|NCT00498316|Tacrolimus|tacrolimus|mesh-list
138580584|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
138580585|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138580586|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138580587|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
138580588|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580589|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138580590|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138580591|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
138580592|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580593|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580594|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138580595|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138580596|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138580597|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
138580598|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580599|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138580600|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580601|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138283040|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138283048|NCT02902237|Thromboplastin|thromboplastin|mesh-list
138580602|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138580603|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
138580604|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138580607|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138580608|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580609|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138580610|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580611|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580612|NCT00146601|Fulvestrant|fulvestrant|mesh-list
138580613|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138580614|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580615|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138580616|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138580617|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
138580618|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138580619|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580620|NCT00498589|Methotrexate|methotrexate|mesh-list
138580621|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138580622|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
138580623|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138580624|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580625|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138580626|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
138283081|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
138283082|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580627|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580628|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580629|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
138580631|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138580632|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138580633|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
138580634|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138580635|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138580636|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
138580637|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138580638|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
138580639|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138580640|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580641|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138580642|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138580643|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138580646|NCT00498901|Goserelin|goserelin|mesh-list
138580647|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580648|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138580649|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138580650|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580651|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580652|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138580653|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
138580654|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138580655|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580656|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138580657|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
138580658|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138580659|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138580660|NCT00498979|Interferons|interferons|mesh-list
138580661|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
138580662|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
138580663|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138580664|NCT00498979|Dacarbazine|dacarbazine|mesh-list
138580665|NCT00498979|Vinblastine|vinblastine|mesh-list
138580666|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283134|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580667|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
138580668|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580669|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
138580670|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580671|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138580672|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
138580673|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580674|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138580675|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
138580676|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
138580677|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
138580678|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138580679|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138580680|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
138580681|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138580682|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
138580683|NCT01245205|Lapatinib|lapatinib|mesh-list
138580684|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580685|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138580686|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580687|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580688|NCT01245244|Morphine|morphine|mesh-list
138580689|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138580690|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138580691|NCT01245244|Narcotics|narcotics|mesh-ancestor
138580692|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138580693|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580694|NCT01245244|Analgesics|analgesics|mesh-ancestor
138580695|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
138580696|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580697|NCT00405717|Atorvastatin|atorvastatin|mesh-list
138580698|NCT00405717|Pravastatin|pravastatin|mesh-list
138580699|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138580700|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138580701|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
138580702|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580703|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138257106|NCT00002943|Carboplatin|carboplatin|mesh-list
138580704|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138283172|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580705|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580706|NCT00499018|Cytarabine|cytarabine|mesh-list
138580707|NCT00499018|Prednisone|prednisone|mesh-list
138580708|NCT00499018|Rituximab|rituximab|mesh-list
138580709|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
138580710|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
138580711|NCT00499018|Vincristine|vincristine|mesh-list
138580712|NCT00499018|Doxorubicin|doxorubicin|mesh-list
138580713|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138580715|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138580716|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580717|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
138580718|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580719|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138580720|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138580721|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
138580722|NCT00499018|Hormones|hormones|mesh-ancestor
138580723|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138580724|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138580725|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138580726|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
138580727|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580728|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
138580729|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580730|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138580731|NCT00499018|Analgesics|analgesics|mesh-ancestor
138580732|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
138580733|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580734|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138580735|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138580736|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580737|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138580738|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
138580739|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138580740|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138580741|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138580742|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
138580743|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
138580744|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
138580745|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138580746|NCT00127985|Prednisolone|prednisolone|mesh-list
138580747|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138580748|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
138580749|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138580750|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
138580751|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138580752|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
138580753|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138580754|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
138580756|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138580757|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580758|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138580759|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580761|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
138580762|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580763|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138580764|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138580765|NCT00127985|Protective Agents|protective agents|mesh-ancestor
138580766|NCT00424164|Tamoxifen|tamoxifen|mesh-list
138580767|NCT00424164|Lapatinib|lapatinib|mesh-list
138580768|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580769|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138580770|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
138580771|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138580772|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580773|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138580774|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580775|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138580776|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138580777|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138580778|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138580779|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580780|NCT00499135|Alovudine|alovudine|mesh-list
138580781|NCT00499135|Sunitinib|sunitinib|mesh-list
138580782|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580783|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138580784|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138580785|NCT00499135|Growth Substances|growth substances|mesh-ancestor
138580786|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580787|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
138580788|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138580789|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580790|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580791|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
138580792|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580793|NCT01245361|Infliximab|infliximab|mesh-list
138580794|NCT01245361|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138580795|NCT01245361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138580796|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
138466421|NCT01959074|Naftopidil|naftopidil|mesh-list
138580797|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138580798|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138580799|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
138580800|NCT00424203|Doxorubicin|doxorubicin|mesh-list
138580801|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138580802|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138580803|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
138580804|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580805|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138580806|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138580807|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
138580808|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580809|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580810|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138580811|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138580812|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138580813|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138580814|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580815|NCT01245556|Ipilimumab|ipilimumab|mesh-list
138580816|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138580817|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580818|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138580819|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580820|NCT00499525|Paclitaxel|paclitaxel|mesh-list
138580821|NCT00499525|Sorafenib|sorafenib|mesh-list
138580822|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138580823|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580824|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
138580825|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
138580826|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
138580827|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580828|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138580829|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580831|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138580832|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580833|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138580834|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138580835|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580836|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580837|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580838|NCT00499720|Aztreonam|aztreonam|mesh-list
138580839|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138580840|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580841|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138580842|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
138580843|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138580844|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138283256|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580845|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
138580846|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580847|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580848|NCT00499876|Mefloquine|mefloquine|mesh-list
138580849|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
138580850|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138580851|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138580852|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580853|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
138580854|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
138580855|NCT00146718|Amodiaquine|amodiaquine|mesh-list
138580856|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
138580857|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138580858|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138580859|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580860|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138580861|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580862|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580863|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138580864|NCT00499993|Lanreotide|lanreotide|mesh-list
138580865|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580866|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
138580867|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138658474|NCT00332930|Interferons|interferons|mesh-list
138580868|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138580870|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580871|NCT04710914|Midazolam|midazolam|mesh-list
138580872|NCT04710914|Isoflurane|isoflurane|mesh-list
138580873|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138466501|NCT01959477|Busulfan|busulfan|mesh-list
138580874|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138580875|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138580876|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580877|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138580878|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138283299|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580879|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138580880|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138580881|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
138580882|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
138580883|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
138580884|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
138580885|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138580886|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580887|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138580888|NCT00500344|Ranibizumab|ranibizumab|mesh-list
138580889|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138580890|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138580891|NCT00500344|Growth Substances|growth substances|mesh-ancestor
138580892|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580893|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
138580894|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580895|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138580896|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
138580897|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580898|NCT01245868|Lidocaine|lidocaine|mesh-list
138580899|NCT01245868|Bupivacaine|bupivacaine|mesh-list
138580900|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
138580901|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
138580902|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138580903|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580904|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
138580905|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580906|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138580907|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138580908|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138580909|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138580910|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580912|NCT00500422|Doxorubicin|doxorubicin|mesh-list
138580913|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138580914|NCT00500422|Bortezomib|bortezomib|mesh-list
138580915|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138580916|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
138580917|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580918|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580919|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138580920|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138580921|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138580922|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138283336|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
138580924|NCT01245946|Adapalene|adapalene|mesh-list
138580925|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138580926|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580927|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
138580928|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138580929|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138580930|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138580931|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138580932|NCT01245946|Analgesics|analgesics|mesh-ancestor
138580933|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
138479973|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
138580934|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580935|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580936|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138580937|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138580938|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
138580939|NCT00146913|Interferons|interferons|mesh-list
138580940|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
138580941|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580942|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
138580943|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580944|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138580945|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580946|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580947|NCT00501124|Clevudine|clevudine|mesh-list
138580948|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
138580949|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138580950|NCT00501241|ATI 7505|ati 7505|mesh-list
138580951|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138580952|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138580953|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
138580954|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466565|NCT01960205|Metformin|metformin|mesh-list
138580955|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580956|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580958|NCT01246180|Amiloride|amiloride|mesh-list
138580959|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138580960|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138580961|NCT01246180|Analgesics|analgesics|mesh-ancestor
138283370|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580962|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
138580963|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138580964|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283371|NCT03035929|Dexamethasone|dexamethasone|mesh-list
138283372|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
138580965|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138580966|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138580967|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138580968|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580969|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580970|NCT01246180|Diuretics|diuretics|mesh-ancestor
138580971|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
138580972|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138580973|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138580974|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138580975|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138580976|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138580977|NCT05561972|Hyaluronic Acid|hyaluronic acid|mesh-list
138580978|NCT05561972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138580979|NCT05561972|Immunologic Factors|immunologic factors|mesh-ancestor
138580980|NCT05561972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138580981|NCT05561972|Viscosupplements|viscosupplements|mesh-ancestor
138580982|NCT05561972|Protective Agents|protective agents|mesh-ancestor
138580983|NCT02274610|Docetaxel|docetaxel|mesh-list
138580984|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138580985|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
138580986|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
138580987|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
138580988|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580989|NCT00501397|Ketoconazole|ketoconazole|mesh-list
138580990|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
138580991|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138658523|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479992|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
138283404|NCT02953886|Fluorides|fluorides|mesh-list
138580992|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138283405|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
138283408|NCT03035708|Varenicline|varenicline|mesh-list
138580993|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138580994|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138580995|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138580996|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138580997|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
138580998|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138580999|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581000|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138581002|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138581003|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581004|NCT00147186|Hylan|hylan|mesh-list
138581005|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
138581006|NCT00147186|Protective Agents|protective agents|mesh-ancestor
138581007|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581008|NCT00501748|Rituximab|rituximab|mesh-list
138581009|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138581010|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581011|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
138581012|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581013|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138581014|NCT00501787|Metformin|metformin|mesh-list
138581015|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138581016|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581017|NCT00147264|Telmisartan|telmisartan|mesh-list
138581018|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138581019|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138581020|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138581021|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581022|NCT00501904|Metformin|metformin|mesh-list
138581023|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138581024|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581025|NCT00501982|Poractant alfa|poractant alfa|mesh-list
138581026|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138581027|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
138581028|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
138581029|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138581030|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138283450|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138296508|NCT00002864|Tamoxifen|tamoxifen|mesh-list
138283454|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
138581031|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581032|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138581033|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138581034|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
138581035|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138581036|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581038|NCT00502060|Gefitinib|gefitinib|mesh-list
138581039|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581040|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138581041|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581042|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581043|NCT00502099|Interferons|interferons|mesh-list
138581044|NCT00502099|Ribavirin|ribavirin|mesh-list
138581045|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
138581046|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
138581047|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138581048|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138581049|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581050|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
138581051|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138581052|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
138581053|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581054|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
138581055|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581056|NCT00502138|Pramlintide|pramlintide|mesh-list
138581057|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
138581058|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138581059|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581060|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
138581061|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138581062|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
138581063|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581064|NCT00502294|Visilizumab|visilizumab|mesh-list
138581065|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
138581066|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581067|NCT00502411|Doxorubicin|doxorubicin|mesh-list
138581068|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138581069|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138581070|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581071|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138581072|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138581073|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581074|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581075|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
138581076|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138581077|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138581078|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138283484|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138283485|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138283489|NCT02958956|Pioglitazone|pioglitazone|mesh-list
138581079|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
138581080|NCT00147381|Tacrolimus|tacrolimus|mesh-list
138581081|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138581082|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
138581083|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581084|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138581085|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581086|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581087|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138581088|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581089|NCT00502567|Leucovorin|leucovorin|mesh-list
138581090|NCT00502567|Docetaxel|docetaxel|mesh-list
138581091|NCT00502567|Fluorouracil|fluorouracil|mesh-list
138581092|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
138581093|NCT00502567|Irinotecan|irinotecan|mesh-list
138581094|NCT00502567|Pemetrexed|pemetrexed|mesh-list
138581095|NCT00502567|Cetuximab|cetuximab|mesh-list
138581096|NCT00502567|Cediranib|cediranib|mesh-list
138581097|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581098|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
138581099|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
138581100|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
138658562|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138581101|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581102|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
138581103|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138581104|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138581105|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
138581106|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581107|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138581108|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138581109|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581111|NCT00502567|Protective Agents|protective agents|mesh-ancestor
138581112|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
138581113|NCT00502567|Vitamins|vitamins|mesh-ancestor
138581114|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
138581115|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138581116|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138581117|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138581118|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138581119|NCT05561231|Pyrithione zinc|pyrithione zinc|mesh-list
138581120|NCT05561231|Keratolytic Agents|keratolytic agents|mesh-ancestor
138581121|NCT05561231|Dermatologic Agents|dermatologic agents|mesh-ancestor
138581122|NCT00502684|Etodolac|etodolac|mesh-list
138581123|NCT00502684|Propranolol|propranolol|mesh-list
138581124|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138581125|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138581126|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
138581127|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138581128|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581129|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466673|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
138581130|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138581131|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138283511|NCT05829148|Analgesics|analgesics|mesh-ancestor
138581132|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
138581133|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138581134|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138581135|NCT00502684|Analgesics|analgesics|mesh-ancestor
138581136|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
138581137|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581138|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138581139|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138581140|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138581141|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138581142|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581143|NCT00502762|Topotecan|topotecan|mesh-list
138581144|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138581145|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138581146|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581147|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581149|NCT00502879|Etanercept|etanercept|mesh-list
138581150|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138581151|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138581152|NCT00502879|Analgesics|analgesics|mesh-ancestor
138581153|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
138283532|NCT05829057|Immunologic Factors|immunologic factors|mesh-ancestor
138581154|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581155|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581156|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138581157|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138581158|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138581159|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138581160|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
138581161|NCT00503152|Valsartan|valsartan|mesh-list
138581162|NCT00503152|Benazepril|benazepril|mesh-list
138581163|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138581164|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138581165|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138581166|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466719|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581167|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138581168|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
138283583|NCT05827497|Methotrexate|methotrexate|mesh-list
138283586|NCT05827497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138581169|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581170|NCT00503347|Bavituximab|bavituximab|mesh-list
138581171|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138581172|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581173|NCT00503386|Palonosetron|palonosetron|mesh-list
138581174|NCT00503386|Granisetron|granisetron|mesh-list
138581175|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
138581176|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
138581177|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581178|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581179|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138581180|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138581181|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138581182|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
138581183|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138581184|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581185|NCT00503503|Etanercept|etanercept|mesh-list
138581186|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138581187|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138581188|NCT00503503|Analgesics|analgesics|mesh-ancestor
138581189|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
138581190|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581191|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581192|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138581193|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138581194|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138581195|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138581196|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
138581197|NCT00503542|Metronidazole|metronidazole|mesh-list
138581198|NCT00503542|Clindamycin|clindamycin|mesh-list
138581199|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
138581200|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
138581201|NCT00503542|Fluconazole|fluconazole|mesh-list
138581202|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138581203|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138658605|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138581204|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138581205|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138581206|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138581207|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581208|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581209|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
138581210|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138581211|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138581212|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138283643|NCT05821972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138581214|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138581215|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581216|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138581217|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138581218|NCT00147615|Eplerenone|eplerenone|mesh-list
138581219|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138581220|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
138581221|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138581222|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581223|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138581224|NCT00147615|Diuretics|diuretics|mesh-ancestor
138581225|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
138581226|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138581227|NCT05561036|Doxorubicin|doxorubicin|mesh-list
138581228|NCT05561036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138581229|NCT05561036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581230|NCT05561036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138581231|NCT05561036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138581232|NCT05561036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581233|NCT05561036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581234|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
138581235|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138581236|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138581237|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
138581238|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138581239|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138466796|NCT01962285|Propofol|propofol|mesh-list
138581240|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138581241|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581242|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581244|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138581245|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138581246|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138581247|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138581248|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
138581249|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138283674|NCT05683535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138581250|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581251|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581252|NCT00147654|Urological Agents|urological agents|mesh-ancestor
138581253|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138581254|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138581255|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
138581256|NCT01246921|Fluticasone|fluticasone|mesh-list
138581257|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138581258|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138581259|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
138581260|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581261|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581262|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138581263|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
138581264|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
138581265|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138581266|NCT04696939|Carboplatin|carboplatin|mesh-list
138581267|NCT04696939|Etoposide|etoposide|mesh-list
138581268|NCT04696939|Atezolizumab|atezolizumab|mesh-list
138581269|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581270|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138581271|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138581272|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138581273|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581274|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581275|NCT04696939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138581276|NCT04696939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138581277|NCT05560919|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138581278|NCT05560919|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138581279|NCT05560919|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138581280|NCT05560919|Protective Agents|protective agents|mesh-ancestor
138581281|NCT05560919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581282|NCT05560919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138581283|NCT05560919|Antioxidants|antioxidants|mesh-ancestor
138283713|NCT05675319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138581284|NCT05560919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581285|NCT05560919|Vitamins|vitamins|mesh-ancestor
138581286|NCT05560919|Micronutrients|micronutrients|mesh-ancestor
138581287|NCT05560919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138581288|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
138581289|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138581290|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138581291|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138581292|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138283714|NCT05675319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138283715|NCT05675319|Protease Inhibitors|protease inhibitors|mesh-ancestor
138581293|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581295|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138581296|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581297|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138581298|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581299|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
138581300|NCT00503659|Miotics|miotics|mesh-ancestor
138581301|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
138581302|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581303|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466941|NCT01963741|Histamine|histamine|mesh-list
138581304|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138581305|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138581306|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
138581307|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138581308|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138581309|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
138581310|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138581311|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581312|NCT04063163|Carboplatin|carboplatin|mesh-list
138581313|NCT04063163|Etoposide|etoposide|mesh-list
138581314|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581315|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138581316|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138581317|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138581318|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581319|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581320|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138581321|NCT00503815|Laxatives|laxatives|mesh-ancestor
138581322|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138581323|NCT01247077|Selenium|selenium|mesh-list
138581324|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
138581325|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581326|NCT01247077|Protective Agents|protective agents|mesh-ancestor
138581327|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581328|NCT01247077|Trace Elements|trace elements|mesh-ancestor
138581329|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
138581330|NCT03990467|Tazobactam|tazobactam|mesh-list
138581331|NCT03990467|Piperacillin|piperacillin|mesh-list
138283742|NCT05615311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138283745|NCT05607615|Betadex|betadex|mesh-list
138581332|NCT03990467|Amikacin|amikacin|mesh-list
138581333|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138581334|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138581335|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138581336|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581337|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581338|NCT01247311|Vitamin D|vitamin d|mesh-list
138581339|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
138581341|NCT01247311|Vitamins|vitamins|mesh-list
138581342|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
138581343|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581344|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138581345|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138581346|NCT00147771|Imiquimod|imiquimod|mesh-list
138581347|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138581348|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
138581349|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581350|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581351|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
138581352|NCT00503932|Capecitabine|capecitabine|mesh-list
138581353|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138581354|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
138283779|NCT05527912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581355|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581356|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581357|NCT03981146|Nivolumab|nivolumab|mesh-list
138581358|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138581359|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581360|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138581361|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581362|NCT01247857|Ropivacaine|ropivacaine|mesh-list
138581363|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
138581364|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
138581365|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138581366|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581367|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
138581368|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581369|NCT04331730|Aflibercept|aflibercept|mesh-list
138581370|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138581371|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138658674|NCT00432198|Zolpidem|zolpidem|mesh-list
138581372|NCT04331730|Growth Substances|growth substances|mesh-ancestor
138581373|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581374|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
138581375|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581376|NCT01248091|Nitroprusside|nitroprusside|mesh-list
138581377|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138581378|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
138581379|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138581380|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581381|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138581382|NCT00503971|Vorinostat|vorinostat|mesh-list
138581383|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581384|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138581385|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581386|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581387|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138467164|NCT01964586|Lidocaine|lidocaine|mesh-list
138581388|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138581389|NCT02274961|Pantoprazole|pantoprazole|mesh-list
138581390|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138581391|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138581392|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138581393|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581394|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581395|NCT02275039|Gemcitabine|gemcitabine|mesh-list
138581396|NCT02275039|Vaccines|vaccines|mesh-list
138581397|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
138581398|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581399|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138581400|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
138581401|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581402|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581403|NCT01248403|Paclitaxel|paclitaxel|mesh-list
138581404|NCT01248403|Everolimus|everolimus|mesh-list
138581405|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138581406|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581407|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
138581408|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
138581409|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
138581410|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581411|NCT01248403|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138581412|NCT01248403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138581413|NCT01248403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581414|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138581415|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
138581416|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581417|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
138581418|NCT01248442|Vitamin D|vitamin d|mesh-list
138581419|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138581420|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581421|NCT01248442|Vitamins|vitamins|mesh-ancestor
138581422|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
138581423|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138581424|NCT01248481|Acarbose|acarbose|mesh-list
138581425|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138581426|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581427|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581428|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138581429|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581430|NCT01249339|Lobeline|lobeline|mesh-list
138581431|NCT01249339|Nicotine|nicotine|mesh-list
138581432|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138581433|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
138581434|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581435|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581436|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138581437|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138581438|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
138581439|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138581440|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581441|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
138581442|NCT03809429|Cetrorelix|cetrorelix|mesh-list
138581443|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138581444|NCT03809429|Hormones|hormones|mesh-ancestor
138581445|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138581446|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581447|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138581448|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
138581449|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138581450|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
138581451|NCT00504127|Naproxen|naproxen|mesh-list
138581452|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
138581453|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138581454|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138257802|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
138581455|NCT00504127|Analgesics|analgesics|mesh-ancestor
138581456|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
138581457|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581458|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581459|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138480110|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581460|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138581461|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
138581462|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138581463|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581464|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581465|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138581466|NCT00504205|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138581467|NCT00504205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138581468|NCT00504205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581469|NCT00504205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581470|NCT01249690|Thalidomide|thalidomide|mesh-list
138283904|NCT05157581|Methoxsalen|methoxsalen|mesh-list
138581471|NCT01249690|Dexamethasone|dexamethasone|mesh-list
138581472|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
138581474|NCT01249690|Pirarubicin|pirarubicin|mesh-list
138581475|NCT01249690|Doxorubicin|doxorubicin|mesh-list
138581476|NCT01249690|BB 1101|bb 1101|mesh-list
138581477|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138581478|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
138581479|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
138581480|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581481|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581482|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138581483|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
138581484|NCT01249690|Hormones|hormones|mesh-ancestor
138581485|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138581486|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138581487|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581488|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
138581489|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581490|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581491|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138581492|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
138581493|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
138581494|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138581495|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138581496|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138581497|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138581498|NCT01249690|Growth Substances|growth substances|mesh-ancestor
138581499|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
138581500|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138581501|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138581502|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138581504|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
138581505|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
138581506|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138581507|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138581508|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138581509|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
138581510|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
138581511|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
138581512|NCT00504244|Azathioprine|azathioprine|mesh-list
138581513|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
138581514|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581515|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138283941|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138581516|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581517|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138581518|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
138581519|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581520|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138480125|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138581521|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138581522|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138581524|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138581525|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138581526|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581528|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138581529|NCT00405444|Narcotics|narcotics|mesh-ancestor
138581530|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138581531|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581532|NCT00405444|Analgesics|analgesics|mesh-ancestor
138581533|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
138581534|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581535|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138581536|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138581537|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
138581538|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
138581539|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138581540|NCT00504283|Morphine|morphine|mesh-list
138581541|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138581542|NCT00504283|Narcotics|narcotics|mesh-ancestor
138581543|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138581544|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581545|NCT00504283|Analgesics|analgesics|mesh-ancestor
138581546|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
138581547|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581548|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138581549|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138581550|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138581551|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138581552|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138581553|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581554|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581555|NCT00504400|Ranibizumab|ranibizumab|mesh-list
138581556|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138283967|NCT04987892|Urological Agents|urological agents|mesh-ancestor
138283968|NCT05019222|Anesthetics|anesthetics|mesh-list
138283969|NCT05019222|Sevoflurane|sevoflurane|mesh-list
138283973|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138581557|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138581558|NCT00504400|Growth Substances|growth substances|mesh-ancestor
138581559|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581560|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
138581561|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581562|NCT00504439|Simvastatin|simvastatin|mesh-list
138581563|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138581564|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138581565|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
138581566|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581567|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138581568|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138581569|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581570|NCT04054830|Diclofenac|diclofenac|mesh-list
138581571|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138581572|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138581573|NCT04054830|Analgesics|analgesics|mesh-ancestor
138581574|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
138480138|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581575|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581576|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581577|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138581578|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138581579|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138581580|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581581|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581582|NCT01249651|Esomeprazole|esomeprazole|mesh-list
138581583|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138581584|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138581585|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138581586|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581587|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581588|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
138581589|NCT03999723|Vitamins|vitamins|mesh-ancestor
138581590|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
138581591|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581592|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
138581593|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581594|NCT03999723|Protective Agents|protective agents|mesh-ancestor
138581595|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
138581596|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138581597|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138581598|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138284004|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138581599|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138581600|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581601|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
138284006|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
138581602|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138581603|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257954|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581604|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138581605|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581606|NCT00403325|Ranibizumab|ranibizumab|mesh-list
138581607|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138581608|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138581609|NCT00403325|Growth Substances|growth substances|mesh-ancestor
138581610|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581611|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
138581612|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581613|NCT04725747|Midazolam|midazolam|mesh-list
138581614|NCT04725747|Ketamine|ketamine|mesh-list
138581615|NCT04725747|Analgesics|analgesics|mesh-ancestor
138581616|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
138581617|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581618|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581619|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138581620|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138581621|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
138581622|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
138581623|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138581624|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138581625|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138581626|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138581627|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581628|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138581629|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138581630|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138581631|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138581632|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138581633|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
138581634|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
138581635|NCT04725942|Posaconazole|posaconazole|mesh-list
138581636|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
138581637|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138581638|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138581639|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138581640|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138581641|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138581642|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138581643|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581644|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581645|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138581646|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
138581647|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138581648|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581650|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
138284031|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
138581651|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138581652|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138581653|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581654|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138581655|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581656|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138581657|NCT03890952|Bevacizumab|bevacizumab|mesh-list
138581658|NCT03890952|Nivolumab|nivolumab|mesh-list
138581659|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
138581660|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138581661|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581662|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138581663|NCT03890952|Growth Substances|growth substances|mesh-ancestor
138581664|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581665|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
138581666|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138581667|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581668|NCT03868722|Venetoclax|venetoclax|mesh-list
138581669|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
138467615|NCT01967498|Montelukast|montelukast|mesh-list
138581670|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581671|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
138581672|NCT02952092|Hematinics|hematinics|mesh-ancestor
138581673|NCT00139152|Omalizumab|omalizumab|mesh-list
138581674|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138581675|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138581676|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
138581677|NCT02824523|Aspirin|aspirin|mesh-list
138581678|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138581679|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138581680|NCT02824523|Analgesics|analgesics|mesh-ancestor
138581681|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
138581682|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581683|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581684|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138581685|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138581686|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138581687|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138581688|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581689|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138581690|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138284055|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284056|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
138284058|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581691|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581692|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
138581694|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138581695|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
138581696|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
138581697|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138581698|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581699|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
138581700|NCT03682029|Vitamins|vitamins|mesh-ancestor
138581701|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
138581702|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581703|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
138581704|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581705|NCT03682029|Protective Agents|protective agents|mesh-ancestor
138581706|NCT00139230|Leucovorin|leucovorin|mesh-list
138581707|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
138581708|NCT00139230|Fluorouracil|fluorouracil|mesh-list
138581709|NCT00139230|Docetaxel|docetaxel|mesh-list
138581710|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581711|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
138581712|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581713|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138581714|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138581715|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
138581716|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581717|NCT00139230|Antidotes|antidotes|mesh-ancestor
138581718|NCT00139230|Protective Agents|protective agents|mesh-ancestor
138581719|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
138581720|NCT00139230|Vitamins|vitamins|mesh-ancestor
138581721|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
138581722|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
138467703|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
138581723|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
138581724|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
138581725|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138581726|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138581727|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138581728|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138581729|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581730|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138581731|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138581733|NCT00139269|Fluorouracil|fluorouracil|mesh-list
138581734|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581735|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
138581736|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
138581737|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
138581738|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581740|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138284087|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284093|NCT04414748|Cetrorelix|cetrorelix|mesh-list
138581741|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138581742|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
138581743|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581744|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
138581745|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138581746|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
138581747|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581748|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138581749|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138581750|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
138258108|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
138581751|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581752|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581753|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138581754|NCT00403364|Amoxicillin|amoxicillin|mesh-list
138581755|NCT00403364|Clarithromycin|clarithromycin|mesh-list
138581756|NCT00403364|Tinidazole|tinidazole|mesh-list
138581757|NCT00403364|Pantoprazole|pantoprazole|mesh-list
138581758|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138581759|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138581760|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138581761|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581762|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581763|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138581764|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138581765|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138581766|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138581767|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138581768|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
138581769|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138581770|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138581771|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138581772|NCT00403442|Bevacizumab|bevacizumab|mesh-list
138581773|NCT00403442|Verteporfin|verteporfin|mesh-list
138581774|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138581775|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284117|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138581776|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138581777|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138581778|NCT00403442|Growth Substances|growth substances|mesh-ancestor
138658780|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581779|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467870|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
138581781|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138581782|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
138581783|NCT00139386|Candesartan|candesartan|mesh-list
138581784|NCT00139386|Candesartan cilexetil|candesartan cilexetil|mesh-list
138581785|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138581786|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138581787|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138581788|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581789|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
138581791|NCT00402974|Menaquinone 7|menaquinone 7|mesh-list
138581792|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138581793|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138581794|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581795|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
138581796|NCT00402974|Coagulants|coagulants|mesh-ancestor
138581797|NCT00402974|Vitamins|vitamins|mesh-ancestor
138581798|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
138581799|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581800|NCT03510078|Insulin|insulin|mesh-list
138581801|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138581802|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581803|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
138581804|NCT00139581|Tacrolimus|tacrolimus|mesh-list
138581805|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138581806|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138581807|NCT00139581|Analgesics|analgesics|mesh-ancestor
138581808|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
138581809|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581810|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581811|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138581813|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
138581814|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138581815|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
138581816|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138581817|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581818|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581819|NCT03500913|Hormones|hormones|mesh-list
138284152|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284153|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581820|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138581821|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581822|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138581823|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581824|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138581825|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581826|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581827|NCT00130481|Atorvastatin|atorvastatin|mesh-list
138581828|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138581829|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138581830|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
138581831|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581832|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138581833|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138581834|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581835|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138581836|NCT00139698|Olmesartan|olmesartan|mesh-list
138581837|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138581838|NCT00139698|Diuretics|diuretics|mesh-ancestor
138581839|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
138581840|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581841|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138581842|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138581843|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468037|NCT01970046|Metformin|metformin|mesh-list
138581844|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138581845|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138581847|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138581848|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
138581849|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138581850|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581851|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138581852|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138581853|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138581854|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
138581855|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138581856|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138284187|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284188|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
138581857|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
138581858|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138581859|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
138581860|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138581861|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138581862|NCT00404274|Casopitant|casopitant|mesh-list
138581863|NCT00404274|Warfarin|warfarin|mesh-list
138581864|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
138581865|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
138581866|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
138581867|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581868|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581869|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138581870|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138581871|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138581872|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581873|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
138581874|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
138581875|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581876|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138581877|NCT00130871|Simendan|simendan|mesh-list
138581878|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138581879|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
138581880|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138581881|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138581882|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318125|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
138581883|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581884|NCT00130871|Protective Agents|protective agents|mesh-ancestor
138581885|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581886|NCT00130910|Albendazole|albendazole|mesh-list
138581887|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
138581889|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138581890|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
138581891|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138581892|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138581893|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
138581894|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
138581895|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
138284221|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
138284222|NCT03141671|Hormones|hormones|mesh-ancestor
138284224|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581896|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581897|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581898|NCT03226821|Tesamorelin|tesamorelin|mesh-list
138581899|NCT03226821|Growth Substances|growth substances|mesh-ancestor
138581900|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581903|NCT00139815|Fondaparinux|fondaparinux|mesh-list
138581904|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
138581905|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138581906|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138581907|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581908|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138581909|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
138581910|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138581911|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
138581912|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581913|NCT00131027|Cytarabine|cytarabine|mesh-list
138581914|NCT00131027|Dexamethasone|dexamethasone|mesh-list
138581915|NCT00131027|Prednisolone|prednisolone|mesh-list
138581916|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
138581917|NCT00131027|Doxorubicin|doxorubicin|mesh-list
138581918|NCT00131027|Methotrexate|methotrexate|mesh-list
138581919|NCT00131027|Etoposide|etoposide|mesh-list
138581920|NCT00131027|Vincristine|vincristine|mesh-list
138581921|NCT00131027|Daunorubicin|daunorubicin|mesh-list
138581922|NCT00131027|Asparaginase|asparaginase|mesh-list
138581923|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
138581924|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138581925|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
138581926|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581927|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138581928|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138581929|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
138581930|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581931|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581932|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138581933|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138581934|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
138581935|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
138581936|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581937|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138581938|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
138581939|NCT00131027|Hormones|hormones|mesh-ancestor
138581940|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138581941|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138581942|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138581943|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138581944|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138581945|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138581946|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138581947|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
138581948|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138581949|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138284255|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138581950|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
138581951|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
138284257|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
138284258|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480213|NCT02045992|Caffeine|caffeine|mesh-list
138581952|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138581953|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138581954|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138581955|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
138581956|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138581957|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
138581958|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
138581959|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
138581961|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138581962|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138581963|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581964|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138581965|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138581966|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138581967|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
138581968|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
138581969|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138581970|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581972|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138581973|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138581974|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138581975|NCT00139893|Metoclopramide|metoclopramide|mesh-list
138581976|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
138581977|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
138581978|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581979|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581981|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138658860|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
138581982|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138581983|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
138581984|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138581985|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138581986|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
138581987|NCT00131183|Androgens|androgens|mesh-ancestor
138581988|NCT00131183|Hormones|hormones|mesh-ancestor
138581989|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138581990|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581991|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
138581992|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138581993|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
138581994|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138581995|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138581996|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138581997|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
138581998|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138581999|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138582000|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138582001|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
138582002|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582003|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582004|NCT00131261|Dexamethasone|dexamethasone|mesh-list
138582005|NCT00131261|Belinostat|belinostat|mesh-list
138582006|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138582007|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
138582009|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582010|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582011|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138582012|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
138582013|NCT00131261|Hormones|hormones|mesh-ancestor
138582014|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138658896|NCT00334763|Paclitaxel|paclitaxel|mesh-list
138582015|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138582016|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582017|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138582018|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582019|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582021|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
138582022|NCT00131300|Protective Agents|protective agents|mesh-ancestor
138582023|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582024|NCT00131339|Cycloserine|cycloserine|mesh-list
138582025|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138582026|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582027|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138582028|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
138582029|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138582030|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
138582031|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582032|NCT00139971|Gemcitabine|gemcitabine|mesh-list
138582033|NCT00139971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138582035|NCT00139971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582036|NCT00139971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582037|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
138582038|NCT00140010|Hematinics|hematinics|mesh-ancestor
138582039|NCT00131495|Testosterone|testosterone|mesh-list
138582040|NCT00131495|Androgens|androgens|mesh-ancestor
138582041|NCT00131495|Hormones|hormones|mesh-ancestor
138582042|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138582043|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582044|NCT04726631|Insulin|insulin|mesh-list
138582045|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138582046|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
138284311|NCT02194829|Gemcitabine|gemcitabine|mesh-list
138582047|NCT04726631|Protamines|protamines|mesh-list
138468289|NCT01971814|Infliximab|infliximab|mesh-list
138582048|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138582049|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582050|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
138582051|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582052|NCT04726631|Coagulants|coagulants|mesh-ancestor
138582053|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
138582054|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582055|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
138582056|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582057|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582058|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138582061|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138582062|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582063|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138582064|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582065|NCT00140166|Pyridoxine|pyridoxine|mesh-list
138582066|NCT00140166|Niacinamide|niacinamide|mesh-list
138582067|NCT00140166|Niacin|niacin|mesh-list
138582068|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
138582069|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
138582070|NCT00140166|Vitamins|vitamins|mesh-ancestor
138582071|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
138582072|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582073|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138582074|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
138582075|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582076|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138582077|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
138582078|NCT03095274|Durvalumab|durvalumab|mesh-list
138582079|NCT03095274|Tremelimumab|tremelimumab|mesh-list
138582080|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138582081|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582082|NCT00131768|Hylan|hylan|mesh-list
138582083|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
138582085|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582086|NCT01248949|Paclitaxel|paclitaxel|mesh-list
138582087|NCT01248949|Bevacizumab|bevacizumab|mesh-list
138582088|NCT01248949|Carboplatin|carboplatin|mesh-list
138582089|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138582090|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582091|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
138582092|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
138582093|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
138468392|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
138582094|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284337|NCT02834624|Calfactant|calfactant|mesh-list
138582095|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138582096|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138582097|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138284338|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138582098|NCT01248949|Growth Substances|growth substances|mesh-ancestor
138582099|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582100|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
138582101|NCT00403637|Maleic acid|maleic acid|mesh-list
138582102|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582103|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582104|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
138582105|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138582106|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
138582107|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582108|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
138582109|NCT04696666|Protective Agents|protective agents|mesh-ancestor
138582110|NCT01248793|Golimumab|golimumab|mesh-list
138582111|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138582112|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138582113|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399717|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582114|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138582115|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
138582116|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582117|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138582118|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138582119|NCT01248364|Empagliflozin|empagliflozin|mesh-list
138582120|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138582121|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582122|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138582123|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582124|NCT00140361|Artesunate|artesunate|mesh-list
138582125|NCT00140361|Lumefantrine|lumefantrine|mesh-list
138582126|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
138582127|NCT00140361|Artemether|artemether|mesh-list
138582128|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
138582129|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138582130|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
138582131|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138582132|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138582133|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582134|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582135|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
138582136|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
138582137|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138582138|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
138582139|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138468505|NCT01973751|Budesonide|budesonide|mesh-list
138582140|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582141|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582142|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138582144|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
138582145|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
138582146|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582147|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138582148|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582149|NCT00131963|Paclitaxel|paclitaxel|mesh-list
138582150|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
138582151|NCT00131963|Doxorubicin|doxorubicin|mesh-list
138582152|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138284368|NCT03043105|Hormones|hormones|mesh-ancestor
138582153|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582154|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
138582155|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
138582156|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
138582157|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582158|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138582159|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
138582160|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582161|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138582162|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138582163|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
138582164|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138582165|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138582166|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138582167|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138468554|NCT01973855|Ribavirin|ribavirin|mesh-list
138582168|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582169|NCT00140400|Immunomodulating Agents|immunomodulating agents|mesh-list
138582170|NCT00140400|Immunologic Factors|immunologic factors|mesh-ancestor
138582171|NCT00140400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582172|NCT00132119|Nalmefene|nalmefene|mesh-list
138582173|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138582174|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582175|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
138582176|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582177|NCT00132158|Irinotecan|irinotecan|mesh-list
138582178|NCT00132158|Gefitinib|gefitinib|mesh-list
138582179|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138582180|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138582181|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582182|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582183|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582184|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138582186|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138582187|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
138582188|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138582189|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582190|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138582191|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138582192|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138582193|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
138582194|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138582195|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138582196|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
138582197|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138582198|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
138582199|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138582200|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138582201|NCT00140517|Chloroquine|chloroquine|mesh-list
138582202|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
138582203|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
138582204|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138284382|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138284383|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
138582205|NCT00140517|Amebicides|amebicides|mesh-ancestor
138582206|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138258555|NCT05318521|Ibuprofen|ibuprofen|mesh-list
138582207|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138582208|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582209|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
138582210|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138582211|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138582212|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582213|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582214|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138582215|NCT00132236|Nicotine|nicotine|mesh-list
138582216|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138659090|NCT00335348|Bortezomib|bortezomib|mesh-list
138582218|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582219|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582220|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138582221|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138582222|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
138582223|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582224|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582225|NCT00132275|Amoxicillin|amoxicillin|mesh-list
138582226|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
138582227|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
138582228|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138582229|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582230|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138582231|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138284401|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
138284402|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582232|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582233|NCT01246999|Vaccines|vaccines|mesh-list
138582234|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
138284403|NCT02969876|Vortioxetine|vortioxetine|mesh-list
138284415|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
138582235|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582236|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
138582237|NCT00140595|Rituximab|rituximab|mesh-list
138582238|NCT00140595|Doxorubicin|doxorubicin|mesh-list
138582239|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138582240|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
138582241|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582242|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138582243|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138582244|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
138582245|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582246|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582247|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138582248|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138582249|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138582250|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138582251|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138582252|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582253|NCT04696783|Esomeprazole|esomeprazole|mesh-list
138582254|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138582255|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138582256|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138582257|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582258|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582259|NCT00132431|Cinacalcet|cinacalcet|mesh-list
138582260|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138582261|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582262|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138582263|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
138582264|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138582266|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138582267|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138582268|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
138582269|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
138582270|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284442|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138582271|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582272|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582273|NCT00132548|Artesunate|artesunate|mesh-list
138582274|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
138582275|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
138582276|NCT00132548|Amodiaquine|amodiaquine|mesh-list
138582277|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138582278|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
138258636|NCT02537873|Cocaine|cocaine|mesh-list
138284444|NCT02846792|Nivolumab|nivolumab|mesh-list
138582279|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138582280|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138582281|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582282|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582283|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
138582284|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
138582286|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
138582287|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138582288|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582289|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582290|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138582291|NCT00140751|Ritonavir|ritonavir|mesh-list
138582292|NCT00140751|Lopinavir|lopinavir|mesh-list
138582293|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138582294|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138582295|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
138582296|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582297|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582298|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138582299|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138582300|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
138582301|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582302|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138468715|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
138582303|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138582304|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138582305|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
138582306|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138582307|NCT00132587|Protective Agents|protective agents|mesh-ancestor
138582308|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582309|NCT00140790|Valsartan|valsartan|mesh-list
138582310|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138582311|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138582312|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138582313|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582314|NCT01245673|Lenalidomide|lenalidomide|mesh-list
138582315|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138582316|NCT01245673|Poly ICLC|poly iclc|mesh-list
138582317|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
138582318|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582319|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138480307|NCT02046538|Vitamins|vitamins|mesh-ancestor
138582320|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138582321|NCT01245673|Growth Substances|growth substances|mesh-ancestor
138582322|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
138582323|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582324|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
138582325|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
138284471|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138284472|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138284473|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138284474|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138284476|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
138582326|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138582327|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138582328|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582329|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
138582330|NCT02261415|Coagulants|coagulants|mesh-ancestor
138582331|NCT00132743|Cilostazol|cilostazol|mesh-list
138582332|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138582333|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
138582334|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582335|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582336|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138582337|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
138582338|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138582339|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138582340|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582341|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138582342|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
138582343|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138582344|NCT00132743|Protective Agents|protective agents|mesh-ancestor
138582345|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138582346|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138582347|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582349|NCT00132821|Nicotine|nicotine|mesh-list
138582350|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138582351|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
138582352|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582353|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582354|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138582355|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138582356|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
138582357|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582358|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582359|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138582360|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
138582361|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138582363|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138582364|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138582365|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
138582366|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138480315|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582367|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138582368|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582369|NCT00132860|Azithromycin|azithromycin|mesh-list
138284497|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
138659244|NCT00336245|Copper|copper|mesh-list
138582370|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138582371|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582373|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138582374|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138582375|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138582376|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582377|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138582378|NCT00132899|Methotrexate|methotrexate|mesh-list
138582379|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138582380|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
138582381|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138284523|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582382|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582383|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138284524|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582384|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
138284525|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138284526|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138284530|NCT03065179|Ipilimumab|ipilimumab|mesh-list
138582385|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582386|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582387|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
138582388|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582389|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138582390|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138582391|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
138582392|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138582393|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138582394|NCT00140868|Phenobarbital|phenobarbital|mesh-list
138582395|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
138582396|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138582397|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138582398|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582399|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138582400|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138582401|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582402|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582403|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
138582404|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
138582405|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138582406|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138582407|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138582408|NCT00132938|Telithromycin|telithromycin|mesh-list
138582409|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138582410|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582411|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
138582412|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
138582413|NCT02955706|Vitamins|vitamins|mesh-ancestor
138582414|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
138582415|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582416|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
138582417|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138582418|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
138582419|NCT01244425|Coagulants|coagulants|mesh-ancestor
138582420|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
138582421|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138582422|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582423|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138582424|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138582425|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138582426|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582428|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582429|NCT01154439|Cytarabine|cytarabine|mesh-list
138582430|NCT01154439|Etoposide|etoposide|mesh-list
138582432|NCT01154439|Idarubicin|idarubicin|mesh-list
138582433|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
138582434|NCT01154439|Everolimus|everolimus|mesh-list
138582435|NCT01154439|Ifosfamide|ifosfamide|mesh-list
138582436|NCT01154439|Carboplatin|carboplatin|mesh-list
138582437|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138582438|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582439|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138582440|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138582441|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582442|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582443|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138582444|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
138582445|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
138582446|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582447|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138582448|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
138582449|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582450|NCT01154439|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138582451|NCT01154439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138582452|NCT01154439|Analgesics|analgesics|mesh-ancestor
138582453|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
138582454|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582455|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138582456|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138582457|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
138284613|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
138480366|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138582458|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
138582460|NCT00133172|Tacrolimus|tacrolimus|mesh-list
138582461|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138582462|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
138582463|NCT00133172|Hormones|hormones|mesh-ancestor
138284614|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
138582464|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138582465|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582466|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138582467|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582468|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138582469|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
138582470|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138582471|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582472|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582473|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138582474|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138582475|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
138582476|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138582477|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582478|NCT00141141|Atorvastatin|atorvastatin|mesh-list
138582479|NCT00141141|Simvastatin|simvastatin|mesh-list
138582480|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138582481|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138582482|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
138582483|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582484|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138582485|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138582486|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582487|NCT00133250|Heparin|heparin|mesh-list
138582488|NCT00133250|Calcium heparin|calcium heparin|mesh-list
138582489|NCT00133250|Abciximab|abciximab|mesh-list
138582490|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
138582491|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138582492|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138582493|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582494|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138582495|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
138582496|NCT00144495|Hematinics|hematinics|mesh-ancestor
138582497|NCT00133328|Valsartan|valsartan|mesh-list
138582498|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138582499|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138582500|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138469038|NCT01977989|Vancomycin|vancomycin|mesh-list
138582501|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582502|NCT00133367|Sirolimus|sirolimus|mesh-list
138582503|NCT00133367|Fludarabine|fludarabine|mesh-list
138582504|NCT00133367|Melphalan|melphalan|mesh-list
138258857|NCT02434523|Amitriptyline|amitriptyline|mesh-list
138582505|NCT00133367|Tacrolimus|tacrolimus|mesh-list
138582506|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
138582507|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138284656|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284657|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582508|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582509|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582510|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138582511|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
138582512|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582513|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138582514|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582515|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138582516|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582517|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138582518|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
138582519|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138582520|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
138582521|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138582523|NCT00141258|Analgesics|analgesics|mesh-ancestor
138582524|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
138582525|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582526|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582527|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
138582528|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138582529|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138582530|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469081|NCT01978405|Protective Agents|protective agents|mesh-ancestor
138582531|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138582532|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138582533|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138582534|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138582535|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138582536|NCT00403910|Canrenone|canrenone|mesh-list
138582537|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138582538|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
138582539|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138582540|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284685|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138284686|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582541|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138582542|NCT00403910|Diuretics|diuretics|mesh-ancestor
138582543|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
138582544|NCT00141336|Pregabalin|pregabalin|mesh-list
138582545|NCT00141336|Analgesics|analgesics|mesh-ancestor
138582546|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
138582547|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582548|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582549|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
138582550|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138582551|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138582552|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582553|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138582554|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138582555|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138582556|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138582557|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138582558|NCT00133406|Vitamin A|vitamin a|mesh-list
138582559|NCT00133406|Glycine|glycine|mesh-list
138582560|NCT00133406|Vitamins|vitamins|mesh-ancestor
138582561|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
138582562|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582563|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582564|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
138582565|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582566|NCT00133445|Vaccines|vaccines|mesh-list
138582567|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
138582568|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582569|NCT00141375|Pregabalin|pregabalin|mesh-list
138582570|NCT00141375|Analgesics|analgesics|mesh-ancestor
138582571|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
138582572|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582573|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582574|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
138582575|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138582576|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138582577|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582578|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138258931|NCT02439281|Clonidine|clonidine|mesh-list
138582580|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138659317|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
138582581|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138582582|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138582583|NCT00133523|Vaccines|vaccines|mesh-list
138582584|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
138582585|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582586|NCT00133562|Glycine|glycine|mesh-list
138284725|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582587|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
138582588|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582589|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582590|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582591|NCT00404391|Acetaminophen|acetaminophen|mesh-list
138582592|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138582593|NCT00404391|Hydrocodone|hydrocodone|mesh-list
138582594|NCT00404391|Oxycodone|oxycodone|mesh-list
138582595|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138582596|NCT00404391|Analgesics|analgesics|mesh-ancestor
138582597|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
138582598|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582599|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582600|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
138582601|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138582602|NCT00404391|Narcotics|narcotics|mesh-ancestor
138582603|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138582604|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
138582605|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
138582606|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138582607|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138582608|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138582610|NCT00144807|Rituximab|rituximab|mesh-list
138582611|NCT00144807|Doxorubicin|doxorubicin|mesh-list
138582612|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138582613|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
138582614|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582615|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138582616|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138582617|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
138582618|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582619|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582620|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138582621|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138582622|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138582623|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138582624|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138582625|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582626|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
138582627|NCT00133640|Vitamin D|vitamin d|mesh-list
138582628|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138582629|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582630|NCT00133640|Vitamins|vitamins|mesh-ancestor
138582631|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
138582632|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138582633|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138582634|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582635|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138582636|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582637|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582639|NCT00404508|Valproic Acid|valproic acid|mesh-list
138582640|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
138582641|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582642|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284749|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582643|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
138582644|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284750|NCT03057704|Lidocaine|lidocaine|mesh-list
138582645|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582646|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
138582647|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138582648|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138582649|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138582650|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138582651|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
138582652|NCT00133757|Bupropion|bupropion|mesh-list
138582653|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138582654|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
138582655|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138582656|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138582657|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138582658|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138469328|NCT01980407|Antidotes|antidotes|mesh-ancestor
138582659|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582660|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
138582661|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582662|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582663|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138582664|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138582665|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582666|NCT00144846|Albuterol|albuterol|mesh-list
138582667|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138582668|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
138582669|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582670|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582671|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138582672|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
138582673|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
138582674|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138582675|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138582676|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138582677|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138582678|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
138582679|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582680|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582681|NCT00133796|Trastuzumab|trastuzumab|mesh-list
138582682|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138582683|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582684|NCT00133874|Retapamulin|retapamulin|mesh-list
138582685|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138582686|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582687|NCT00141414|Pregabalin|pregabalin|mesh-list
138582688|NCT00141414|Analgesics|analgesics|mesh-ancestor
138582689|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
138582690|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582691|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284770|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582692|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
138582693|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138582694|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138480444|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138582695|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582696|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138582697|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138582698|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138582699|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138582700|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138582701|NCT00145002|Lenograstim|lenograstim|mesh-list
138582702|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138582703|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
138582704|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582705|NCT00141492|Testosterone|testosterone|mesh-list
138582706|NCT00141492|Androgens|androgens|mesh-ancestor
138582707|NCT00141492|Hormones|hormones|mesh-ancestor
138659390|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
138284798|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
138582708|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138582709|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582710|NCT00141531|Apaziquone|apaziquone|mesh-list
138582711|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582712|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138582713|NCT00134069|Cetuximab|cetuximab|mesh-list
138582714|NCT00134069|Irinotecan|irinotecan|mesh-list
138582715|NCT00134069|Sorafenib|sorafenib|mesh-list
138582716|NCT00134069|Antibodies|antibodies|mesh-list
138582717|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
138582718|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138582719|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
138582720|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582721|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582722|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138582723|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138582724|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582725|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582726|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138582727|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
138582728|NCT00141570|Estrogens|estrogens|mesh-list
138582729|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
138582730|NCT00141570|Testosterone|testosterone|mesh-list
138582731|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
138582732|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
138582733|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138582734|NCT00141570|Hormones|hormones|mesh-ancestor
138582735|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138582736|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582737|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138582738|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582739|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
138582740|NCT00141570|Androgens|androgens|mesh-ancestor
138582741|NCT00134147|Insulin|insulin|mesh-list
138582742|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138582743|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582744|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
138582745|NCT00403988|Vinorelbine|vinorelbine|mesh-list
138582746|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582747|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138582748|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
138582749|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
138582750|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
138582751|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582752|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
138582753|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582754|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138582756|NCT00141648|Prednisolone|prednisolone|mesh-list
138582757|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
138582758|NCT00141648|Doxorubicin|doxorubicin|mesh-list
138469523|NCT01981889|Prednisone|prednisone|mesh-list
138582759|NCT00141648|Vincristine|vincristine|mesh-list
138582760|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138582761|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
138480459|NCT02047175|Amlodipine|amlodipine|mesh-list
138582762|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582763|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138582764|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138582765|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
138582766|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582767|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582768|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138582769|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138582770|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138582771|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138582772|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582773|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138582774|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
138582775|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
138582776|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
138582777|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138582779|NCT00141648|Hormones|hormones|mesh-ancestor
138582780|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138582781|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138582782|NCT00134420|Clonidine|clonidine|mesh-list
138582783|NCT00134420|Mitogens|mitogens|mesh-list
138582784|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582785|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
138582786|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582787|NCT00134420|Analgesics|analgesics|mesh-ancestor
138582788|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
138582789|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582790|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138582791|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
138582792|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
138284880|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
138582793|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138582794|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138582795|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138582796|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
138582797|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582798|NCT00141804|Sirolimus|sirolimus|mesh-list
138582800|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138582801|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138582802|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582803|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
138582804|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138582805|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
138582806|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582808|NCT00134498|Torcetrapib|torcetrapib|mesh-list
138582809|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138582810|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138582811|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
138582812|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582813|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138582815|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582816|NCT00141843|Factor VIII|factor viii|mesh-list
138582817|NCT00141843|Coagulants|coagulants|mesh-ancestor
138582818|NCT00141882|Memantine|memantine|mesh-list
138582819|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138582820|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138582821|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
138582823|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582824|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582825|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138582826|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138582827|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138582828|NCT00152295|Estrogens|estrogens|mesh-ancestor
138582829|NCT00152295|Hormones|hormones|mesh-ancestor
138582830|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138582831|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582832|NCT00152373|Levetiracetam|levetiracetam|mesh-list
138582833|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
138582834|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
138582835|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138582836|NCT00134654|Estrogens|estrogens|mesh-ancestor
138582837|NCT00134654|Hormones|hormones|mesh-ancestor
138582838|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138582839|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582840|NCT00141960|Famotidine|famotidine|mesh-list
138582841|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138582842|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138582843|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138582844|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
138405783|NCT01590537|Copper|copper|mesh-list
138284921|NCT03071744|Analgesics|analgesics|mesh-ancestor
138582845|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
138582846|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582847|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582848|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582849|NCT00134693|Prednisolone|prednisolone|mesh-list
138582850|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138582851|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
138582852|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138582853|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
138582854|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138582855|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
138582856|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138582857|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
138582859|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138582860|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582861|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138582862|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582863|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
138582864|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
138582865|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582866|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138582867|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138582868|NCT00134693|Protective Agents|protective agents|mesh-ancestor
138582869|NCT00152412|Levocetirizine|levocetirizine|mesh-list
138469797|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
138582870|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138582871|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138582872|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
138582873|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
138582874|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582875|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582876|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582877|NCT00142038|Docetaxel|docetaxel|mesh-list
138582878|NCT00142038|Capecitabine|capecitabine|mesh-list
138582879|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582880|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
138582881|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
138582882|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
138582883|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582884|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138582885|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
138582886|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
138582887|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138582888|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138582889|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138582890|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138284943|NCT05404334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582891|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582892|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
138582893|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582894|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582895|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138582896|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582898|NCT02964455|Nedaplatin|nedaplatin|mesh-list
138582899|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582900|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
138582901|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
138582902|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
138582903|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582904|NCT00142155|Rituximab|rituximab|mesh-list
138582905|NCT00142155|Antibodies|antibodies|mesh-list
138582906|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138582907|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
138582908|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582909|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138582910|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582911|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138582912|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
138582913|NCT00152490|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138582914|NCT00152490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138582915|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138582916|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
138582917|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582918|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138582920|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138582921|NCT00134888|Naloxone|naloxone|mesh-list
138582922|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138582923|NCT00134888|Narcotics|narcotics|mesh-ancestor
138582924|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138582925|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582926|NCT00134888|Analgesics|analgesics|mesh-ancestor
138582927|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
138582928|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582930|NCT00134966|Levodopa|levodopa|mesh-list
138582931|NCT00134966|Carbidopa|carbidopa|mesh-list
138582932|NCT00134966|Entacapone|entacapone|mesh-list
138582933|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138582934|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138582935|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
138582936|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582937|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582938|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582939|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138582941|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138582942|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
138582943|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582944|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138284971|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
138284975|NCT02858713|Betamethasone|betamethasone|mesh-list
138582945|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138582946|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582947|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
138582948|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138582949|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138582950|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138582951|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582952|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582953|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
138582954|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138582955|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582957|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138582958|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138284995|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284997|NCT00375050|Protective Agents|protective agents|mesh-ancestor
138582960|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
138582961|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582962|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582963|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138582964|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138582965|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138582966|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138582967|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470010|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138582968|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582970|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138582971|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
138582972|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138582973|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
138582974|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138659712|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
138582975|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
138582976|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138582977|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
138582978|NCT00135122|Hormones|hormones|mesh-ancestor
138582979|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138582980|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582981|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138582982|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582983|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
138582984|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
138582985|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138582986|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138582987|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138582988|NCT00135122|Protective Agents|protective agents|mesh-ancestor
138582989|NCT00142350|Fluorouracil|fluorouracil|mesh-list
138582990|NCT00142350|Irinotecan|irinotecan|mesh-list
138480532|NCT00005826|Rubitecan|rubitecan|mesh-list
138582991|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138582992|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
138470058|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
138582993|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138582994|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138582996|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
138582997|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138582998|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138582999|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138583000|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583001|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
138583002|NCT00135317|Hematinics|hematinics|mesh-ancestor
138583003|NCT00152646|Clopidogrel|clopidogrel|mesh-list
138583004|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138583005|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138583006|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138583007|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138583008|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
138583009|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285056|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583010|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583011|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583012|NCT00135434|Ritonavir|ritonavir|mesh-list
138583013|NCT00135434|Lopinavir|lopinavir|mesh-list
138583014|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138583015|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138583016|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138583017|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
138583018|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583019|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583020|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138583021|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138583022|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
138583023|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583024|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138659763|NCT00340574|Antacids|antacids|mesh-ancestor
138583025|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138583026|NCT00135473|Insulin|insulin|mesh-list
138583027|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138583028|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138583029|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138583030|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583031|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
138583032|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
138583034|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138583035|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583036|NCT00135551|Benidipine|benidipine|mesh-list
138583037|NCT00135551|Diuretics|diuretics|mesh-list
138583038|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138470109|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
138583039|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
138583040|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138583041|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
138583042|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583043|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583044|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138583045|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138480543|NCT00005832|Tipifarnib|tipifarnib|mesh-list
138583046|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
138583047|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583048|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138583049|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138583050|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
138583051|NCT00152724|Aspirin|aspirin|mesh-list
138583052|NCT00152724|Celecoxib|celecoxib|mesh-list
138583053|NCT00152724|Indomethacin|indomethacin|mesh-list
138285077|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583054|NCT00152724|Nitroprusside|nitroprusside|mesh-list
138583055|NCT00152724|Acetylcholine|acetylcholine|mesh-list
138583056|NCT00152724|Capsaicin|capsaicin|mesh-list
138583057|NCT00152724|Clopidogrel|clopidogrel|mesh-list
138583058|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138583059|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138583060|NCT00152724|Analgesics|analgesics|mesh-ancestor
138583061|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
138583062|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583063|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583064|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583065|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583066|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138583067|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138583068|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583069|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138583070|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138583071|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583072|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
138583073|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138583074|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138583075|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138583076|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
138583077|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583078|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138583079|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
138583080|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
138583081|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
138583082|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
138583083|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138583084|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138583085|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
138583086|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138583087|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138583088|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
138583089|NCT00152802|Vaccines|vaccines|mesh-list
138583090|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
138583091|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583092|NCT00135746|Nicotine|nicotine|mesh-list
138583093|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138583094|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
138583095|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583096|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583097|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138583098|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138583099|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
138583100|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583101|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583102|NCT00135785|Bupropion|bupropion|mesh-list
138583103|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138583104|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
138583105|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138583106|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138470187|NCT01986283|Oxycodone|oxycodone|mesh-list
138583107|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138583108|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138583109|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583110|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
138583111|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583112|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583113|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138583114|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138583115|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583116|NCT00159081|Haloperidol|haloperidol|mesh-list
138583117|NCT00159081|Risperidone|risperidone|mesh-list
138583118|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
138583119|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138583120|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
138583121|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583122|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583123|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583124|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138583125|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138583126|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138583127|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138583128|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138583129|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
138583130|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
138583131|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
138583132|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583133|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138583134|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138583135|NCT00152841|Vitamin E|vitamin e|mesh-list
138583137|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
138659875|NCT00452829|Vitamins|vitamins|mesh-ancestor
138583138|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583140|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583141|NCT00152841|Protective Agents|protective agents|mesh-ancestor
138583142|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
138583143|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138583144|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138583145|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583146|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138583147|NCT00159159|Cyclosporine|cyclosporine|mesh-list
138583148|NCT00159159|Cyclosporins|cyclosporins|mesh-list
138583149|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583150|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583151|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138583152|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
138583153|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583154|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
138583155|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583156|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
138583157|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583158|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138583159|NCT00135824|Povidone|povidone|mesh-list
138583160|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138583161|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138583162|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
138583163|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
138583164|NCT00135863|Tinzaparin|tinzaparin|mesh-list
138583165|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138583166|NCT00135863|Dalteparin|dalteparin|mesh-list
138583167|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
138285167|NCT03104725|Protective Agents|protective agents|mesh-ancestor
138285169|NCT03104725|Antidotes|antidotes|mesh-ancestor
138583168|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138583169|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138583170|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583171|NCT00135902|Progesterone|progesterone|mesh-list
138470323|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
138583172|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138583174|NCT00135902|Progestins|progestins|mesh-ancestor
138583175|NCT00135902|Hormones|hormones|mesh-ancestor
138583176|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138583177|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583178|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138583179|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
138583180|NCT00135941|Insulin|insulin|mesh-list
138259531|NCT02604173|Hormones|hormones|mesh-ancestor
138583181|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138583182|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
138583183|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
138583184|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138583185|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583186|NCT00152919|Meloxicam|meloxicam|mesh-list
138583187|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138583188|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138583189|NCT00152919|Analgesics|analgesics|mesh-ancestor
138583190|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
138583191|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583192|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583193|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583194|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583195|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138583196|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138583197|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583198|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583200|NCT00406146|Lumefantrine|lumefantrine|mesh-list
138583201|NCT00406146|Artemether|artemether|mesh-list
138583202|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138583203|NCT00406146|Amodiaquine|amodiaquine|mesh-list
138583204|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
138583205|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138583206|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138583207|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583208|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583209|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
138583210|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
138583211|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138583212|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
138583213|NCT00136058|Alendronate|alendronate|mesh-list
138583214|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
138583215|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138583216|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285220|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
138583217|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138583218|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138583219|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583220|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138583221|NCT00152958|Pramipexole|pramipexole|mesh-list
138583222|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
138583223|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583224|NCT00152958|Protective Agents|protective agents|mesh-ancestor
138583225|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583226|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138583227|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138583228|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
138583231|NCT00136175|Paclitaxel|paclitaxel|mesh-list
138583232|NCT00136175|Carboplatin|carboplatin|mesh-list
138583233|NCT00136175|Gemcitabine|gemcitabine|mesh-list
138583234|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138583235|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583236|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
138583237|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
138583238|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
138583239|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583240|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138583241|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
138583242|NCT00152997|Pramipexole|pramipexole|mesh-list
138583243|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
138583244|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470494|NCT01988649|Oxytocin|oxytocin|mesh-list
138583245|NCT00152997|Protective Agents|protective agents|mesh-ancestor
138583246|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285245|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583247|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138583248|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138583249|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
138583250|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
138583251|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583252|NCT00136292|Daptomycin|daptomycin|mesh-list
138583253|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138583254|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583255|NCT00159471|Gemcitabine|gemcitabine|mesh-list
138583256|NCT00159471|Capecitabine|capecitabine|mesh-list
138583257|NCT00159471|Docetaxel|docetaxel|mesh-list
138583258|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138583259|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
138659960|NCT00446862|Losartan|losartan|mesh-list
138583260|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583261|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583262|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
138583263|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
138583264|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
138583265|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
138583266|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138583267|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583268|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
138583269|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
138583270|NCT00159510|Methylene Blue|methylene blue|mesh-list
138583271|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138583272|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
138583273|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583274|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583275|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138583276|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
138583277|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138583278|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
138583279|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583280|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583281|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138583282|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
138583283|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
138583284|NCT00159510|Protective Agents|protective agents|mesh-ancestor
138583285|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583286|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
138583287|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583288|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138583289|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583290|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583291|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138583292|NCT00153114|Laxatives|laxatives|mesh-ancestor
138583293|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138583295|NCT00136448|Interleukin-2|interleukin-2|mesh-list
138583296|NCT00136448|Daunorubicin|daunorubicin|mesh-list
138285289|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138480612|NCT00005868|Docetaxel|docetaxel|mesh-list
138583297|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138583298|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
138583299|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583300|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583301|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
138583302|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583303|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138583304|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
138583305|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583306|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138583307|NCT00136448|Analgesics|analgesics|mesh-ancestor
138583308|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
138583309|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583310|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138583311|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138583312|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138583313|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583314|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138583315|NCT00153153|Laxatives|laxatives|mesh-ancestor
138583316|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138583317|NCT00136487|Celecoxib|celecoxib|mesh-list
138583318|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138583319|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138583320|NCT00136487|Analgesics|analgesics|mesh-ancestor
138583321|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
138583322|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583323|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583324|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583325|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583326|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138583327|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138583328|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583329|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583330|NCT00153192|Dronabinol|dronabinol|mesh-list
138583331|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
138583332|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285316|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583333|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138583334|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138583335|NCT00153192|Analgesics|analgesics|mesh-ancestor
138583336|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
138583337|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583338|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138583339|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138470757|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
138583340|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583341|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583343|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138583344|NCT00136526|Docetaxel|docetaxel|mesh-list
138583345|NCT00136526|Fosfestrol|fosfestrol|mesh-list
138583346|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
138583347|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583348|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
138583349|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
138583350|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
138583351|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583352|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138583354|NCT00136526|Hormones|hormones|mesh-ancestor
138583355|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138583356|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583357|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138583359|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
138583360|NCT00136565|Doxorubicin|doxorubicin|mesh-list
138583361|NCT00136565|Bortezomib|bortezomib|mesh-list
138583362|NCT00136565|Bleomycin|bleomycin|mesh-list
138583363|NCT00136565|Vindesine|vindesine|mesh-list
138583364|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138583365|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
138583366|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583367|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583368|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138583369|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
138583370|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583371|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583372|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138583373|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138583374|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138583375|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138583376|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583377|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583378|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
138583379|NCT00136565|Hormones|hormones|mesh-ancestor
138583380|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470864|NCT01991275|Analgesics|analgesics|mesh-ancestor
138583381|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138583382|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138583383|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
138583384|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
138583385|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
138583386|NCT00159627|Rolofylline|rolofylline|mesh-list
138583387|NCT00159627|Diuretics|diuretics|mesh-ancestor
138583388|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
138583389|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583391|NCT00159666|Analgesics|analgesics|mesh-ancestor
138583392|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
138583393|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583394|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583395|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
138583396|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138583397|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138583398|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583399|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138583400|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138583401|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138660070|NCT04715360|Favipiravir|favipiravir|mesh-list
138583402|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138583403|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138583404|NCT00153270|Valproic Acid|valproic acid|mesh-list
138583405|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
138583406|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583407|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583408|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
138583409|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583410|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583412|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138583413|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138583414|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138583415|NCT00159705|Pregabalin|pregabalin|mesh-list
138583416|NCT00159705|Analgesics|analgesics|mesh-ancestor
138480624|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138583417|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
138583418|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583419|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583421|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138583422|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138583423|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583424|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138583425|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138583426|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138583427|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138583428|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138285379|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583429|NCT00136994|Ziprasidone|ziprasidone|mesh-list
138583430|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138583431|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
138583432|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583433|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583434|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583435|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138583436|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138583437|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138583438|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138583439|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138583440|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
138583441|NCT00137033|Celecoxib|celecoxib|mesh-list
138583442|NCT00137033|Naproxen|naproxen|mesh-list
138583443|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138583444|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138583445|NCT00137033|Analgesics|analgesics|mesh-ancestor
138583446|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
138583447|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583448|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583449|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583450|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583451|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138583452|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138583453|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583454|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583455|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
138583456|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
138583457|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583458|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
138583459|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138583460|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138583461|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583462|NCT00137072|Urological Agents|urological agents|mesh-ancestor
138583463|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
138583464|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138583465|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583466|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
138583467|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583468|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
138583469|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138583470|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138583471|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583472|NCT00159900|Urological Agents|urological agents|mesh-ancestor
138583473|NCT00159978|Alovudine|alovudine|mesh-list
138583474|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
138583475|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583476|NCT00137345|Sirolimus|sirolimus|mesh-list
138583477|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138583478|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138480651|NCT00005880|Hormones|hormones|mesh-ancestor
138285402|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138583479|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138583480|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583481|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
138583482|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138583483|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
138259825|NCT00550771|Paclitaxel|paclitaxel|mesh-list
138583484|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583485|NCT00137462|Atorvastatin|atorvastatin|mesh-list
138583486|NCT00137462|Torcetrapib|torcetrapib|mesh-list
138583487|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138471060|NCT01992900|Artenimol|artenimol|mesh-list
138583488|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138583489|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
138583490|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583491|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138583492|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138583493|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583494|NCT00153543|Vaccines|vaccines|mesh-list
138583495|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138583496|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
138583497|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583498|NCT00137501|Nifedipine|nifedipine|mesh-list
138583499|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138660129|NCT00453804|Naltrexone|naltrexone|mesh-list
138583500|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138583501|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583502|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138583503|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471111|NCT01993459|Midazolam|midazolam|mesh-list
138583504|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
138583506|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138583507|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138583508|NCT00153660|Celecoxib|celecoxib|mesh-list
138583509|NCT00153660|Naproxen|naproxen|mesh-list
138583510|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138583511|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138583512|NCT00153660|Analgesics|analgesics|mesh-ancestor
138583513|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
138583514|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583515|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583516|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583517|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583518|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138583519|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138583520|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583521|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583522|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
138583523|NCT00137657|Trimethoprim|trimethoprim|mesh-list
138471169|NCT01993771|Anesthetics|anesthetics|mesh-list
138583524|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138583525|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
138583526|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138583527|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583529|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138583530|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138583531|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138583532|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583533|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583534|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138583535|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138480657|NCT00005883|Protective Agents|protective agents|mesh-ancestor
138583536|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138583538|NCT00153699|Topiramate|topiramate|mesh-list
138583539|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
138583540|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138583541|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583542|NCT00160290|Lactulose|lactulose|mesh-list
138583543|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138583544|NCT00137735|Gabapentin|gabapentin|mesh-list
138583545|NCT00137735|Analgesics|analgesics|mesh-ancestor
138583546|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
138583547|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583548|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583549|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
138583550|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138583551|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138583552|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138583553|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138583554|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138583555|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138583556|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583557|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583560|NCT00137774|Temozolomide|temozolomide|mesh-list
138583561|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138583562|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583563|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138285456|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
138583564|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138583565|NCT00137774|Growth Substances|growth substances|mesh-ancestor
138583566|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583567|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
138583568|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138471272|NCT01994733|Antacids|antacids|mesh-ancestor
138583569|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
138583570|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583571|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138583572|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138583573|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138583574|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
138583575|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583576|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583577|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138583578|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138583579|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
138583580|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583582|NCT00137813|Docetaxel|docetaxel|mesh-list
138583583|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138583584|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583585|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138583586|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138583587|NCT00137813|Growth Substances|growth substances|mesh-ancestor
138583588|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583589|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
138583590|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
138583591|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
138583592|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
138583593|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583594|NCT00137852|Celecoxib|celecoxib|mesh-list
138583595|NCT00137852|Irinotecan|irinotecan|mesh-list
138480672|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583596|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583597|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138583598|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138583600|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583601|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138583602|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138583603|NCT00137852|Analgesics|analgesics|mesh-ancestor
138583604|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
138583605|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583606|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583607|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583608|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583609|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138583610|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138583611|NCT00160407|Orlistat|orlistat|mesh-list
138285493|NCT02979301|Tamoxifen|tamoxifen|mesh-list
138583612|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583613|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583614|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138583615|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138583616|NCT00153933|Lenalidomide|lenalidomide|mesh-list
138583617|NCT00153933|Bortezomib|bortezomib|mesh-list
138583618|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
138583619|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583620|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138583621|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138583622|NCT00153933|Growth Substances|growth substances|mesh-ancestor
138583623|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
138583624|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583625|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
138583626|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583627|NCT00153972|Levodopa|levodopa|mesh-list
138583628|NCT00153972|Cabergoline|cabergoline|mesh-list
138583629|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138583630|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138583631|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
138583632|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583633|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583634|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583635|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
138583636|NCT00160485|Glyburide|glyburide|mesh-list
138583637|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138583638|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583639|NCT00404183|Acetaminophen|acetaminophen|mesh-list
138583640|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138583641|NCT00404183|Hydrocodone|hydrocodone|mesh-list
138583642|NCT00404183|Oxycodone|oxycodone|mesh-list
138583643|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138583644|NCT00404183|Analgesics|analgesics|mesh-ancestor
138583645|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
138583646|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583647|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583649|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138583650|NCT00404183|Narcotics|narcotics|mesh-ancestor
138583651|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138583652|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
138583653|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
138583654|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138583655|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583656|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583657|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
138480688|NCT00005898|Cyclosporine|cyclosporine|mesh-list
138583658|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138583659|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583660|NCT00404222|Acetaminophen|acetaminophen|mesh-list
138583661|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138583662|NCT00404222|Hydrocodone|hydrocodone|mesh-list
138583663|NCT00404222|Oxycodone|oxycodone|mesh-list
138583664|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138583665|NCT00404222|Analgesics|analgesics|mesh-ancestor
138583666|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
138583667|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583668|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583669|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
138583670|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138583671|NCT00404222|Narcotics|narcotics|mesh-ancestor
138583672|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138583673|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
138583674|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
138583675|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138583676|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583677|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583678|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
138583679|NCT00160602|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138583680|NCT00160602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583681|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138583682|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
138583683|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583684|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583686|NCT00138242|Docetaxel|docetaxel|mesh-list
138583687|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583688|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
138583689|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
138583690|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
138583691|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583692|NCT00154050|Candesartan|candesartan|mesh-list
138583693|NCT00154050|Candesartan cilexetil|candesartan cilexetil|mesh-list
138583694|NCT00154050|Quinapril|quinapril|mesh-list
138583695|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138583696|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138583697|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138583698|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583699|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138583700|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
138583701|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583702|NCT00154089|Masoprocol|masoprocol|mesh-list
138583703|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
138583704|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583705|NCT00154089|Protective Agents|protective agents|mesh-ancestor
138583706|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583707|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138583708|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583709|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138583710|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138583711|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138583712|NCT00154089|Analgesics|analgesics|mesh-ancestor
138583713|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
138583714|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583715|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583716|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583717|NCT00138359|Niclosamide|niclosamide|mesh-list
138583718|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
138583719|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138583720|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
138583721|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138583722|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583723|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
138583724|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
138583725|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583726|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
138583727|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
138583728|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
138583729|NCT00154167|Phentolamine|phentolamine|mesh-list
138583730|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138583731|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138583732|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
138583733|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583734|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583735|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583736|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138583737|NCT00138515|Vildagliptin|vildagliptin|mesh-list
138583738|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138583739|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583740|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138583741|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
138583742|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583743|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583744|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
138583745|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138583746|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583747|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138583748|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
138583749|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138583750|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318136|NCT01418352|Aripiprazole|aripiprazole|mesh-list
138583752|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583753|NCT00138554|Pioglitazone|pioglitazone|mesh-list
138583754|NCT00138554|Vildagliptin|vildagliptin|mesh-list
138583755|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138583756|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583757|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138583758|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
138583759|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583760|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583761|NCT00138593|Vildagliptin|vildagliptin|mesh-list
138583762|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138583763|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583764|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138583765|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
138583766|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583767|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285558|NCT02988349|Listerine|listerine|mesh-list
138583769|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138583770|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583771|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138583772|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
138583773|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138583774|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583775|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583776|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583777|NCT00138632|Vatalanib|vatalanib|mesh-list
138583778|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138583779|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583780|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583781|NCT00160875|Irinotecan|irinotecan|mesh-list
138583782|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583783|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138583784|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138583785|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583786|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583787|NCT00138710|Letrozole|letrozole|mesh-list
138583788|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583789|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138583790|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138583791|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583792|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583793|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138583794|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
138583795|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138583796|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583797|NCT01243762|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
138583798|NCT01243762|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138583799|NCT01243762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583800|NCT01243762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583801|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
138583802|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138583803|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138583804|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583805|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138583806|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583807|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138583808|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
138583809|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
138285584|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
138583810|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138583811|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138583812|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138583813|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583814|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138583815|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138583816|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138583817|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138583818|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138583819|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138583820|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583821|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
138583822|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583823|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583824|NCT00154401|Liraglutide|liraglutide|mesh-list
138583825|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138583826|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583827|NCT00154401|Incretins|incretins|mesh-ancestor
138583829|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138583830|NCT00138944|Eplerenone|eplerenone|mesh-list
138583831|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138583832|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
138583833|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138583834|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583835|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138583836|NCT00138944|Diuretics|diuretics|mesh-ancestor
138583837|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
138583838|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138583840|NCT00161070|Dipyridamole|dipyridamole|mesh-list
138583841|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138583842|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138583843|NCT00161070|Analgesics|analgesics|mesh-ancestor
138583844|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
138583845|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583846|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583847|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583848|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583849|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138583850|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138260202|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138583851|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583852|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138583853|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138583854|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583855|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
138299339|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
138583856|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138583857|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
138583858|NCT00138983|Vitamin D|vitamin d|mesh-list
138583860|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
138583861|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138583862|NCT00138983|Vitamins|vitamins|mesh-ancestor
138583863|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
138583864|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583865|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138583867|NCT01243177|Carbamazepine|carbamazepine|mesh-list
138583868|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
138583869|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138583870|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138583871|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138583872|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583873|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
138583874|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138583875|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138583876|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583877|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138583878|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138583879|NCT01243177|Analgesics|analgesics|mesh-ancestor
138583880|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
138583881|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583882|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138583883|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138583884|NCT00154440|Amoxicillin|amoxicillin|mesh-list
138583885|NCT00154440|Metronidazole|metronidazole|mesh-list
138583886|NCT00154440|Clarithromycin|clarithromycin|mesh-list
138583887|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138583888|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138583889|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583890|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138583891|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138318137|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
138480752|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
138583893|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583894|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472070|NCT01999933|Cisplatin|cisplatin|mesh-list
138583895|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138583896|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138583897|NCT00139061|Atorvastatin|atorvastatin|mesh-list
138583898|NCT00139061|Torcetrapib|torcetrapib|mesh-list
138583899|NCT00139061|Fenofibrate|fenofibrate|mesh-list
138583900|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138583901|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138583902|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
138583903|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583904|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138583905|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138583906|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583907|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
138285638|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
138299370|NCT00004778|Dexamethasone|dexamethasone|mesh-list
138583908|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138583909|NCT04705584|Cyclosporine|cyclosporine|mesh-list
138583910|NCT04705584|Prednisolone|prednisolone|mesh-list
138583911|NCT04705584|Cyclosporins|cyclosporins|mesh-list
138583912|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583913|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583914|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138583915|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
138583916|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583917|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
138583918|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138583919|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
138583920|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138583921|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138583922|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583924|NCT04705584|Hormones|hormones|mesh-ancestor
138583925|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138260282|NCT02303405|Pioglitazone|pioglitazone|mesh-list
138583926|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138583927|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583928|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
138583929|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138583930|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
138583931|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138583932|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583933|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138583934|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
138583935|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138583936|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
138583937|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583938|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583939|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138583940|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
138583941|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
138583942|NCT00139217|Protective Agents|protective agents|mesh-ancestor
138583943|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
138583944|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138583945|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
138583946|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138660469|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
138583948|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138480759|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
138583950|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138299420|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138285660|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138583951|NCT00139256|Betamethasone|betamethasone|mesh-list
138583952|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138583953|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
138583954|NCT00139256|Hormones|hormones|mesh-ancestor
138583955|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138583956|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583957|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138583958|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
138583959|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
138583960|NCT00161304|Testosterone|testosterone|mesh-list
138583961|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
138583962|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
138583963|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138583965|NCT00161304|Hormones|hormones|mesh-ancestor
138583966|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138583967|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583968|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138583969|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583970|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
138583971|NCT01242748|Goserelin|goserelin|mesh-list
138583972|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138583973|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583974|NCT00139373|Donepezil|donepezil|mesh-list
138583975|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138583976|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583977|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583978|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
138583979|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138583980|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583981|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
138583982|NCT00161421|Leuprolide|leuprolide|mesh-list
138583983|NCT00161421|Testosterone|testosterone|mesh-list
138583984|NCT00161421|Dutasteride|dutasteride|mesh-list
138583985|NCT00161421|Androgens|androgens|mesh-ancestor
138583986|NCT00161421|Hormones|hormones|mesh-ancestor
138583987|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138583988|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138583989|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138583990|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583991|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138583992|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
138285691|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138583993|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138583994|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138583995|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138583996|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138583997|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138583998|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
138583999|NCT00139568|Tegaserod|tegaserod|mesh-list
138584000|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138584001|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
138584002|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584003|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584004|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584005|NCT00139646|Diclofenac|diclofenac|mesh-list
138584006|NCT00139646|Parecoxib|parecoxib|mesh-list
138584007|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138584008|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138584009|NCT00139646|Analgesics|analgesics|mesh-ancestor
138584010|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
138584011|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584012|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584013|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138584014|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138584015|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138584016|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584017|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584018|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138584019|NCT00406302|Docetaxel|docetaxel|mesh-list
138584020|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
138584021|NCT00406302|Cetuximab|cetuximab|mesh-list
138584022|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584023|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
138584024|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
138584025|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
138584026|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584027|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138584028|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138584029|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
138584030|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
138584031|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138584032|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584033|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138584034|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138584035|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138584036|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138584037|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584038|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138584039|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138584040|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138584042|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
138584044|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138584045|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584046|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138584047|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138285724|NCT02221674|Tapentadol|tapentadol|mesh-list
138584048|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138584049|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
138584050|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584051|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584052|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584053|NCT00139724|Urological Agents|urological agents|mesh-ancestor
138584054|NCT00161577|Ketorolac|ketorolac|mesh-list
138584055|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138584056|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138584057|NCT00161577|Analgesics|analgesics|mesh-ancestor
138584058|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
138584059|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584060|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584061|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138584062|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138584063|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138584064|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584065|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584066|NCT00404261|Fluticasone|fluticasone|mesh-list
138584067|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138584068|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138584069|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138584070|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138472484|NCT02002260|Hormones|hormones|mesh-ancestor
138584071|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
138584072|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584073|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584074|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138584075|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
138584076|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
138584077|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138584078|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138584079|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138584080|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138584081|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
138584082|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584083|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584084|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
138584085|NCT00404261|Hormones|hormones|mesh-ancestor
138584086|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138584087|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
138584088|NCT00406380|Bevacizumab|bevacizumab|mesh-list
138584089|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138584090|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584091|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138584092|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138584093|NCT00406380|Growth Substances|growth substances|mesh-ancestor
138584094|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584095|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
138584096|NCT00406497|Difluprednate|difluprednate|mesh-list
138584097|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
138584098|NCT00406497|Hormones|hormones|mesh-ancestor
138584099|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138584100|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584101|NCT00161655|Etanercept|etanercept|mesh-list
138285743|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138584102|NCT00161655|Methotrexate|methotrexate|mesh-list
138584103|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138584104|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
138584105|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138584106|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584107|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138584108|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
138584109|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584111|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
138584112|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584113|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138584114|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138584115|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
138584116|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138285761|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
138285762|NCT04736108|Hormones|hormones|mesh-ancestor
138584117|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138584118|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138480820|NCT00005946|Etoposide|etoposide|mesh-list
138584119|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138584120|NCT00161655|Analgesics|analgesics|mesh-ancestor
138584121|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
138584122|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584123|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138584124|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138584125|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138584126|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
138584127|NCT00161733|Coagulants|coagulants|mesh-ancestor
138584128|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138584129|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138584130|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
138584131|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584132|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584133|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138584134|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138584135|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
138584136|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584137|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138584138|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138584139|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
138584140|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
138584141|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584142|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584143|NCT04724187|Misoprostol|misoprostol|mesh-list
138584144|NCT04724187|Oxytocin|oxytocin|mesh-list
138584145|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
138584146|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138584147|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584148|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138584150|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138584151|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138584152|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
138584153|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138584154|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
138584155|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138584156|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
138584157|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584158|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584159|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
138584160|NCT04724226|Apatinib|apatinib|mesh-list
138584161|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480857|NCT00005958|Docetaxel|docetaxel|mesh-list
138584162|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138584163|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584164|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584165|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
138584166|NCT00140075|Epirubicin|epirubicin|mesh-list
138584167|NCT00140075|Taxane|taxane|mesh-list
138584168|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138584169|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
138584170|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584171|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138584172|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138584173|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
138584174|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584175|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584176|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138584177|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138584178|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138584179|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138584180|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584181|NCT00140114|Misoprostol|misoprostol|mesh-list
138584182|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138417160|NCT01670149|Rifaximin|rifaximin|mesh-list
138584183|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
138584184|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138584185|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584186|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138584187|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138584188|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
138584189|NCT00140153|Testosterone|testosterone|mesh-list
138584190|NCT00140153|Androgens|androgens|mesh-ancestor
138584191|NCT00140153|Hormones|hormones|mesh-ancestor
138285851|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138285852|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584192|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138584193|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584194|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
138584195|NCT00140309|Rifampin|rifampin|mesh-list
138584196|NCT00140309|Isoniazid|isoniazid|mesh-list
138584197|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
138584198|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138584199|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138584200|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138584201|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138584202|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584203|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584204|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584205|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138584206|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
138584207|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
138472739|NCT02004197|Bismuth|bismuth|mesh-list
138584208|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138584209|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138584210|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138584211|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138584212|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138584213|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138584214|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138584215|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138584216|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138584217|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
138584218|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138584219|NCT00161811|Vaccines|vaccines|mesh-list
138584221|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260575|NCT02283762|Riociguat|riociguat|mesh-list
138584222|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138480865|NCT00005961|Carmustine|carmustine|mesh-list
138584223|NCT00140348|Immunomodulating Agents|immunomodulating agents|mesh-list
138285889|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138584224|NCT00140348|Immunologic Factors|immunologic factors|mesh-ancestor
138584225|NCT00140348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584226|NCT01240759|Metformin|metformin|mesh-list
138584227|NCT01240759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138584228|NCT01240759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584229|NCT00140387|Immunomodulating Agents|immunomodulating agents|mesh-list
138584230|NCT00140387|Immunologic Factors|immunologic factors|mesh-ancestor
138584231|NCT00140387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584232|NCT00504634|Bortezomib|bortezomib|mesh-list
138584233|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584234|NCT00140465|Clopidogrel|clopidogrel|mesh-list
138584235|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138584236|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138584237|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138584238|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138584239|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
138584240|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584241|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584242|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584243|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
138584244|NCT01247701|Busulfan|busulfan|mesh-list
138584245|NCT01247701|Fludarabine|fludarabine|mesh-list
138584246|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138584247|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
138584248|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584249|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138584250|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138584251|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
138584252|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584253|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584254|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138584255|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
138584256|NCT00140543|Sirolimus|sirolimus|mesh-list
138584257|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138584258|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584259|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138584260|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
138584261|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138584262|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138584264|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584265|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
138584266|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138584267|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
138285930|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584268|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584270|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
138584271|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138584272|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
138584273|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584274|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584275|NCT00140582|Rituximab|rituximab|mesh-list
138584276|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138584277|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584278|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
138584279|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584280|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138584281|NCT00154869|Ribavirin|ribavirin|mesh-list
138584282|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138584283|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
138584284|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584285|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
138584286|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138584287|NCT00140660|Rituximab|rituximab|mesh-list
138584288|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138584289|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584290|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
138285961|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138285962|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138584291|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584292|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138584293|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
138584294|NCT00162006|Antibodies|antibodies|mesh-list
138584295|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
138584296|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138584297|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138584298|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
138584299|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584300|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138584301|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138584302|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584303|NCT02964572|Empagliflozin|empagliflozin|mesh-list
138584304|NCT02964572|Glimepiride|glimepiride|mesh-list
138584305|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138584306|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584307|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138584308|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584309|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138584310|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138584311|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
138584312|NCT00162201|Abatacept|abatacept|mesh-list
138584313|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138584314|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584315|NCT00162201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138584316|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138480900|NCT00005967|Tipifarnib|tipifarnib|mesh-list
138584317|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138584318|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
138584319|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584320|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138584321|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138584322|NCT01248247|Sorafenib|sorafenib|mesh-list
138584323|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584324|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138584325|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584326|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584327|NCT00140894|Rofecoxib|rofecoxib|mesh-list
138584328|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584329|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584330|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584331|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138584332|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138584333|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584334|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138584335|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138584336|NCT00140894|Analgesics|analgesics|mesh-ancestor
138584337|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
138584338|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138584339|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138584340|NCT00155064|Losartan|losartan|mesh-list
138584341|NCT00155064|Captopril|captopril|mesh-list
138584342|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138584343|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138584344|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138584345|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138584346|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584347|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138584348|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
138584349|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584350|NCT02483260|Ribavirin|ribavirin|mesh-list
138584351|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
138584352|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584353|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
138584354|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138584355|NCT00140933|Diclofenac|diclofenac|mesh-list
138584356|NCT00140933|Rofecoxib|rofecoxib|mesh-list
138584357|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138584358|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138584359|NCT00140933|Analgesics|analgesics|mesh-ancestor
138584360|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
138584361|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584362|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584363|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138584364|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138584365|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138584366|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584367|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584368|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138584369|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138584370|NCT04515628|Branebrutinib|branebrutinib|mesh-list
138584371|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138584372|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138584373|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
138584374|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584375|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138584376|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138584377|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584378|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138584379|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138584380|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138584382|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
138584383|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138584384|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138286032|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
138584385|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584386|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
138584387|NCT00504946|Vitamin D|vitamin d|mesh-list
138584388|NCT00504946|Prednisone|prednisone|mesh-list
138584389|NCT00504946|Budesonide|budesonide|mesh-list
138584390|NCT00504946|Montelukast|montelukast|mesh-list
138584391|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138584392|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
138584393|NCT00504946|Hormones|hormones|mesh-ancestor
138584394|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138584395|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584396|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138584397|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584398|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138584399|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
138584400|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138584401|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
138584402|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138584403|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138473068|NCT05970679|Ezetimibe|ezetimibe|mesh-list
138584404|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584405|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138584406|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
138584407|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584408|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138584410|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
138584411|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138584412|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
138584413|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138584414|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584415|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138584416|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138584417|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584418|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584419|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
138584420|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584422|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138584423|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584424|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138584425|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138584426|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
138584427|NCT00407082|Hormones|hormones|mesh-ancestor
138584428|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138286065|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584429|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584430|NCT00141089|Tegaserod|tegaserod|mesh-list
138660692|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
138584431|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138584432|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
138584433|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584434|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584435|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584436|NCT00407121|Bevacizumab|bevacizumab|mesh-list
138584437|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138584438|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584439|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138584440|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138584441|NCT00407121|Growth Substances|growth substances|mesh-ancestor
138584442|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584443|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
138584444|NCT00141167|Varenicline|varenicline|mesh-list
138584445|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138584446|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138584447|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
138584448|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584449|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584450|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584451|NCT00141206|Varenicline|varenicline|mesh-list
138584452|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138584453|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138584454|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
138584455|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584456|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584457|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584458|NCT00141245|Pregabalin|pregabalin|mesh-list
138584459|NCT00141245|Analgesics|analgesics|mesh-ancestor
138584460|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
138584461|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584462|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584463|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
138584464|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138584465|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584466|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584467|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138584468|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138584469|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138584470|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584471|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138584472|NCT00141362|Pregabalin|pregabalin|mesh-list
138584473|NCT00141362|Analgesics|analgesics|mesh-ancestor
138584474|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
138584475|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584476|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584477|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
138584478|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138584479|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584480|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584481|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138584482|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138584483|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138584484|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584485|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138584487|NCT00155259|Capecitabine|capecitabine|mesh-list
138480965|NCT00005985|Dexamethasone|dexamethasone|mesh-list
138584489|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
138584490|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
138584491|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
138660703|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
138584492|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584493|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138584494|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
138584496|NCT00141401|Analgesics|analgesics|mesh-ancestor
138584497|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
138584498|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584499|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584500|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
138584501|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138584502|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584503|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584504|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138584505|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138584506|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138584507|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584508|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138584509|NCT00505102|Everolimus|everolimus|mesh-list
138584510|NCT00505102|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138584511|NCT00505102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138584512|NCT00505102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584513|NCT00505102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584514|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138584515|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
138260880|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
138584516|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584517|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584518|NCT00404378|Ketoconazole|ketoconazole|mesh-list
138584519|NCT00404378|Casopitant|casopitant|mesh-list
138584520|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
138584521|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138584522|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138584523|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138584524|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584525|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584526|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138584527|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
138584528|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138584529|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584530|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138584531|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
138584532|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
138584533|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584534|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138584535|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138584536|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584537|NCT04511728|Propofol|propofol|mesh-list
138584538|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138584539|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584540|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584541|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138584542|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
138584543|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
138584544|NCT00162318|Cetuximab|cetuximab|mesh-list
138584545|NCT00162318|Gefitinib|gefitinib|mesh-list
138584546|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138584547|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584548|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138584549|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584550|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473207|NCT05968885|Cholinergic Agents|cholinergic agents|mesh-ancestor
138584552|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138584553|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138584554|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138584555|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584556|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584557|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
138286154|NCT03424681|Modafinil|modafinil|mesh-list
138584558|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584559|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584560|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138584561|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584562|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138584563|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138584564|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138584565|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138584566|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584567|NCT00404456|Melatonin|melatonin|mesh-list
138584568|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
138584569|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584570|NCT00404456|Protective Agents|protective agents|mesh-ancestor
138584571|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584572|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584573|NCT00404534|Amoxicillin|amoxicillin|mesh-list
138584574|NCT00404534|Clarithromycin|clarithromycin|mesh-list
138584575|NCT00404534|Omeprazole|omeprazole|mesh-list
138584576|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138584577|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138584578|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138584579|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138584580|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138584581|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584582|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584583|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138584584|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138584585|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138584586|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
138584587|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
138584588|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138584589|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138584590|NCT00162396|Albuterol|albuterol|mesh-list
138584591|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138584592|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
138584593|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473251|NCT05967650|Vaccines|vaccines|mesh-list
138286183|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286185|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138584594|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584595|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138584596|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
138584597|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
138584598|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138584599|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138584600|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138584601|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138584602|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
138584603|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584604|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584605|NCT00162435|Warfarin|warfarin|mesh-list
138584607|NCT04518982|Lenalidomide|lenalidomide|mesh-list
138584608|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
138584609|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584610|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138584611|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138584612|NCT04518982|Growth Substances|growth substances|mesh-ancestor
138584613|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
138584614|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584615|NCT00155376|Morphine|morphine|mesh-list
138584616|NCT00155376|Glucagon|glucagon|mesh-list
138584617|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138584618|NCT00155376|Narcotics|narcotics|mesh-ancestor
138584619|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584620|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584622|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
138584623|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584624|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138584626|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138584627|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
138584628|NCT00141557|Estrogens|estrogens|mesh-list
138584629|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
138584630|NCT00141557|Estrone|estrone|mesh-list
138584631|NCT00141557|Testosterone|testosterone|mesh-list
138584632|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
138584633|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
138584634|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138584635|NCT00141557|Hormones|hormones|mesh-ancestor
138584636|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138584637|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584638|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138286217|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
138584639|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584640|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
138584641|NCT00141557|Androgens|androgens|mesh-ancestor
138584642|NCT00162474|Phenytoin|phenytoin|mesh-list
138584643|NCT00162474|Warfarin|warfarin|mesh-list
138584644|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
138584645|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
138584646|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138584647|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138584648|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584649|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584650|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138584651|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138584652|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
138584653|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138584654|NCT00505336|Eplerenone|eplerenone|mesh-list
138584655|NCT00505336|Atorvastatin|atorvastatin|mesh-list
138584656|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138584657|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138584658|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
138584659|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584660|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138584661|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138584662|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584663|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138584664|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
138584665|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138584666|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584667|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138584668|NCT00505336|Diuretics|diuretics|mesh-ancestor
138584669|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
138584670|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138584671|NCT04518202|Lidocaine|lidocaine|mesh-list
138584672|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
138584673|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
138584674|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584675|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584676|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
138584677|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584678|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138584679|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138584680|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138584681|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584682|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584683|NCT04517890|Lidocaine|lidocaine|mesh-list
138584684|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
138584685|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
138584686|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584687|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286252|NCT03236168|Ivermectin|ivermectin|mesh-list
138584688|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
138584689|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584690|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138584691|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138584692|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138584693|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584694|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584695|NCT00141596|Amiloride|amiloride|mesh-list
138584696|NCT00141596|Furosemide|furosemide|mesh-list
138584698|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
138584699|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584700|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138584701|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584702|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584703|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138584704|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138584705|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138584706|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138584707|NCT02275663|Cytarabine|cytarabine|mesh-list
138584708|NCT02275663|Fludarabine|fludarabine|mesh-list
138473427|NCT05725031|Ephedrine|ephedrine|mesh-list
138584710|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584711|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138584712|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
138584713|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584714|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138584715|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
138584716|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584717|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
138584718|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138584719|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584720|NCT02275702|Dexamethasone|dexamethasone|mesh-list
138584721|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138584722|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
138584723|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
138584724|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481033|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
138584725|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584726|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138584727|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
138584728|NCT02275702|Hormones|hormones|mesh-ancestor
138584729|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138286279|NCT03315559|Nemiralisib|nemiralisib|mesh-list
138584730|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138584731|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584732|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
138584733|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138584734|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138584735|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584736|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
138584737|NCT04518163|Coagulants|coagulants|mesh-ancestor
138473532|NCT05493371|Empagliflozin|empagliflozin|mesh-list
138584739|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138584740|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584742|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138584743|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138584744|NCT00141713|Analgesics|analgesics|mesh-ancestor
138584745|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
138584746|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584747|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584748|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138584749|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138584750|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138584751|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138584752|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
138584754|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
138584755|NCT04517188|Povidone|povidone|mesh-list
138584756|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138584757|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138584758|NCT04517188|Trace Elements|trace elements|mesh-ancestor
138473587|NCT05422066|Prednisone|prednisone|mesh-list
138584759|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
138584760|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584761|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
138584762|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
138584763|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
138584764|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138584765|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584766|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286305|NCT03211117|Docetaxel|docetaxel|mesh-list
138286306|NCT03211117|Doxorubicin|doxorubicin|mesh-list
138286307|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138584767|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138584768|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138584769|NCT00162552|Protective Agents|protective agents|mesh-ancestor
138584770|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584771|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
138584772|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138584773|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
138584774|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
138584775|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584776|NCT04516681|Vitamins|vitamins|mesh-ancestor
138584777|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
138584778|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
138584779|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584780|NCT04516681|Protective Agents|protective agents|mesh-ancestor
138584782|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138584783|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138584784|NCT00141791|Analgesics|analgesics|mesh-ancestor
138584785|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
138473645|NCT05319899|Nootropic Agents|nootropic agents|mesh-ancestor
138584786|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584787|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584788|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138584789|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138584790|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138584791|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138584792|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
138584793|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
138584794|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138584795|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584796|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584798|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138420438|NCT05098210|Poly ICLC|poly iclc|mesh-list
138473694|NCT05280132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473695|NCT05280132|Antitubercular Agents|antitubercular agents|mesh-ancestor
138473696|NCT05274269|Ivacaftor|ivacaftor|mesh-list
138473697|NCT05274269|Elexacaftor|elexacaftor|mesh-list
138473701|NCT05268614|Cisplatin|cisplatin|mesh-list
138584799|NCT00162591|Narcotics|narcotics|mesh-ancestor
138584800|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584801|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584802|NCT00162591|Analgesics|analgesics|mesh-ancestor
138584803|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
138584804|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584805|NCT00505492|Paclitaxel|paclitaxel|mesh-list
138584806|NCT00505492|Cisplatin|cisplatin|mesh-list
138584807|NCT00505492|Carboplatin|carboplatin|mesh-list
138584808|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138584809|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584810|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
138584811|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
138261174|NCT05431673|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138584812|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
138584813|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584814|NCT00141830|Methotrexate|methotrexate|mesh-list
138584815|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138584816|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
138584817|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138584818|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584819|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138584820|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
138473756|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
138584821|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584822|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584823|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
138584824|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584825|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138584826|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138584827|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
138584828|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138584829|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138584830|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
138584831|NCT04516174|Ropivacaine|ropivacaine|mesh-list
138584832|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138584833|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584834|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584835|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138584836|NCT04516174|Analgesics|analgesics|mesh-ancestor
138584837|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
138584838|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286374|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584839|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138584840|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138584841|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138584842|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
138584843|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584844|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584845|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
138584846|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
138584847|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
138584848|NCT04515979|Vactosertib|vactosertib|mesh-list
138584849|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138584850|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584851|NCT04515979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138584852|NCT04515979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584853|NCT04515979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138584854|NCT04515979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138584855|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
138584856|NCT00505531|Tramadol|tramadol|mesh-list
138584857|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138584858|NCT00505531|Narcotics|narcotics|mesh-ancestor
138584859|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584860|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584861|NCT00505531|Analgesics|analgesics|mesh-ancestor
138584862|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
138584863|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584864|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138584865|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138584866|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
138584867|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
138584868|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
138584869|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
138584870|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138584871|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138584872|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
138584873|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
138584874|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584875|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584876|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138161793|NCT03855371|Decitabine|decitabine|mesh-list
138584877|NCT00141908|Castor Oil|castor oil|mesh-list
138584878|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138584879|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138584880|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138584881|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
138584882|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138584883|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584884|NCT00141908|Progestins|progestins|mesh-ancestor
138584886|NCT00141908|Cathartics|cathartics|mesh-ancestor
138584887|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138584889|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138584890|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584891|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138584892|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138584893|NCT00162669|Growth Substances|growth substances|mesh-ancestor
138584894|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584895|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
138584896|NCT00141947|Bexarotene|bexarotene|mesh-list
138584897|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584898|NCT04514770|Misoprostol|misoprostol|mesh-list
138584899|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138584900|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
138584901|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138584902|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584903|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138584904|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138584905|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
138584906|NCT00141986|Vitamin D|vitamin d|mesh-list
138584907|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
138584908|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
138584909|NCT00141986|Vitamins|vitamins|mesh-list
138584910|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
138584911|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584912|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138584913|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138584914|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
138584915|NCT04514731|Analgesics|analgesics|mesh-ancestor
138584916|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
138584917|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584918|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584919|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
138584920|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584921|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138584922|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
138584923|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138584924|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584925|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584927|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
138584928|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138584930|NCT04514419|Trastuzumab|trastuzumab|mesh-list
138584931|NCT04514419|Pertuzumab|pertuzumab|mesh-list
138584932|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584933|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
138584934|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
138584935|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
138584936|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584937|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138584938|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
138584939|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
138584940|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138584941|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138584942|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584943|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584944|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138584945|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138584946|NCT02275897|Methamphetamine|methamphetamine|mesh-list
138584947|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138584948|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584949|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
138584950|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
138584951|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584952|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
138584953|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584954|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584955|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
138584956|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138584957|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138584958|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138584959|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138584960|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
138286495|NCT02213094|Niacin|niacin|mesh-list
138584961|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
138584962|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
138584963|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138584964|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
138584965|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
138584966|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584967|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584968|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584969|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
138584970|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138584971|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138584972|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
138584973|NCT00505804|Haloperidol|haloperidol|mesh-list
138584974|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
138584975|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138584976|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138584977|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138584978|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138584979|NCT00505804|Analgesics|analgesics|mesh-ancestor
138584980|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
138584981|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138584982|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138584983|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138584984|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138584985|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
138584986|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138584987|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138584988|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
138584989|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
138584990|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138584991|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138584992|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138584993|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138584994|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138584995|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
138584996|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138584997|NCT00505843|Levodopa|levodopa|mesh-list
138584999|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138585000|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138585001|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
138585002|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138585003|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585004|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585005|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138585006|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585007|NCT00505882|Pramlintide|pramlintide|mesh-list
138585008|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138585009|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585010|NCT00142337|Zidovudine|zidovudine|mesh-list
138585011|NCT00142337|Didanosine|didanosine|mesh-list
138286519|NCT02177838|Antibodies|antibodies|mesh-list
138585012|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
138585013|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585014|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138585015|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138585016|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585017|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
138585018|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585019|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138585020|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138585021|NCT00162864|Montelukast|montelukast|mesh-list
138585022|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138585023|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
138585024|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138585025|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
138585026|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138585027|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585028|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138474234|NCT04209296|Analgesics|analgesics|mesh-ancestor
138585029|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138585030|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585031|NCT04512313|Rocuronium|rocuronium|mesh-list
138585032|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138585033|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138585034|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138585035|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585036|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585037|NCT00142493|Midazolam|midazolam|mesh-list
138585038|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
138585039|NCT00142493|Thiopental|thiopental|mesh-list
138585040|NCT00142493|Propofol|propofol|mesh-list
138481098|NCT00006012|Paclitaxel|paclitaxel|mesh-list
138585041|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138585042|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138585043|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585044|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138585045|NCT00142493|Analgesics|analgesics|mesh-ancestor
138585046|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
138585047|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585048|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138585049|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138585050|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138585051|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
138585052|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138585053|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585054|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138585055|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
138585056|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
138585057|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138585058|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138585059|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138585060|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138585061|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
138585062|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
138585063|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
138585065|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
138585066|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138585067|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138585068|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585069|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
138585070|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138585071|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
138585072|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138585073|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
138585074|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585075|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585076|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
138585077|NCT04511299|SMOFlipid|smoflipid|mesh-list
138585078|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138585079|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138585080|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138585081|NCT00142571|Gemcitabine|gemcitabine|mesh-list
138585082|NCT00142571|Docetaxel|docetaxel|mesh-list
138585083|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138474344|NCT03994172|Vitamin D|vitamin d|mesh-list
138585084|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
138585085|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585086|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585087|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
138585088|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
138585089|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
138585090|NCT00142610|Vitamins|vitamins|mesh-list
138585091|NCT00142610|Vitamin E|vitamin e|mesh-list
138585092|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
138585093|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585094|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
138585095|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585096|NCT00142610|Protective Agents|protective agents|mesh-ancestor
138585097|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
138585098|NCT04510870|Hematinics|hematinics|mesh-ancestor
138585099|NCT00406575|Methocarbamol|methocarbamol|mesh-list
138286567|NCT03383588|Narcotics|narcotics|mesh-ancestor
138585100|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138585101|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585102|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138585103|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585104|NCT02275975|Fluconazole|fluconazole|mesh-list
138585105|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
138585107|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138585108|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138585109|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585110|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585111|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138585112|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
138585113|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138585114|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585115|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138585116|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138585117|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
138585118|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138585119|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
138585121|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
138585122|NCT00142727|Narcotics|narcotics|mesh-ancestor
138585123|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138585124|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585125|NCT00142727|Analgesics|analgesics|mesh-ancestor
138585126|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
138585127|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585128|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
138585129|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
138585130|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
138585131|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138585132|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585133|NCT00506194|Gliclazide|gliclazide|mesh-list
138585134|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138585135|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585136|NCT00404573|Cariprazine|cariprazine|mesh-list
138585137|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138585138|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138286599|NCT03588806|Oxycodone|oxycodone|mesh-list
138286600|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138585139|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138585140|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585141|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138585142|NCT00506272|Insulin|insulin|mesh-list
138585143|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138585144|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585145|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138585146|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
138585147|NCT00506311|Coagulants|coagulants|mesh-ancestor
138585148|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138585149|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585150|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585151|NCT00142844|Naltrexone|naltrexone|mesh-list
138585152|NCT00142844|Disulfiram|disulfiram|mesh-list
138585153|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138585155|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585156|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
138585157|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585158|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138585159|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585160|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585161|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138585162|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138585163|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
138481123|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
138585164|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138585165|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585166|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138585167|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138585168|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138585169|NCT00142883|Pregabalin|pregabalin|mesh-list
138585170|NCT00142883|Analgesics|analgesics|mesh-ancestor
138585171|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
138585172|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585173|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585174|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
138585175|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138585176|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138585177|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585178|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138585179|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138585180|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138585181|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138585182|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138585183|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138585184|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138585185|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138585186|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138585187|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585189|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138585190|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585191|NCT00163254|Abciximab|abciximab|mesh-list
138585192|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
138585193|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138585194|NCT00143000|Ribavirin|ribavirin|mesh-list
138585195|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138585196|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
138585197|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585199|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585200|NCT02590393|Nicotine|nicotine|mesh-list
138585201|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138585202|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
138585203|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585204|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585205|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138585206|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138585207|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
138585208|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138585209|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585210|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
138585211|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138585212|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
138585213|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585214|NCT00506506|Expectorants|expectorants|mesh-ancestor
138585215|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
138585216|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138585217|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
138585218|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585219|NCT00506506|Protective Agents|protective agents|mesh-ancestor
138585220|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585221|NCT00506506|Antidotes|antidotes|mesh-ancestor
138585222|NCT02594254|Anti-Infective Agents|anti-infective agents|mesh-list
138585223|NCT02594254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138585224|NCT00163332|Ciclesonide|ciclesonide|mesh-list
138585225|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
138585226|NCT00163332|Hormones|hormones|mesh-ancestor
138585227|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138585228|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585229|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138585230|NCT00163371|Ciclesonide|ciclesonide|mesh-list
138286661|NCT03398330|Narcotics|narcotics|mesh-ancestor
138286664|NCT03398330|Analgesics|analgesics|mesh-ancestor
138585231|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
138585232|NCT00163371|Hormones|hormones|mesh-ancestor
138585233|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138585234|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585235|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138585236|NCT00143156|Pregabalin|pregabalin|mesh-list
138585237|NCT00143156|Analgesics|analgesics|mesh-ancestor
138585238|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
138585239|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585240|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585241|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
138585242|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138585243|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138585244|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585245|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138585246|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138585247|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138585248|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138585249|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138585250|NCT00163410|Ciclesonide|ciclesonide|mesh-list
138585251|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
138585252|NCT00163410|Hormones|hormones|mesh-ancestor
138474681|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138585253|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138585254|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585255|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138585256|NCT00143195|Amlodipine|amlodipine|mesh-list
138585257|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138585258|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138585259|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138261649|NCT01911169|Vitamin D|vitamin d|mesh-list
138585260|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585261|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138585262|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585263|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
138585264|NCT00163449|Ciclesonide|ciclesonide|mesh-list
138585265|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
138585266|NCT00163449|Hormones|hormones|mesh-ancestor
138585267|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138585268|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585269|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138585270|NCT00143234|Amlodipine|amlodipine|mesh-list
138585271|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
138585272|NCT00143234|Atorvastatin|atorvastatin|mesh-list
138585273|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138585274|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138585275|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
138585276|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286695|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
138585277|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138474734|NCT02842749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585278|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138585279|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585280|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138585281|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138585282|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138585283|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138585284|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585285|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
138585287|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
138585288|NCT00163488|Hormones|hormones|mesh-ancestor
138585289|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138585290|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585291|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138585292|NCT00143351|Ziprasidone|ziprasidone|mesh-list
138585293|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138585294|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
138585295|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138585296|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585297|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585298|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138585299|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138585300|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138585301|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138585302|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138585303|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
138585304|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138585305|NCT00163605|Thrombin|thrombin|mesh-list
138585306|NCT00163605|Calcium|calcium|mesh-list
138286718|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
138286720|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138585307|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138585308|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585309|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
138585310|NCT00163605|Coagulants|coagulants|mesh-ancestor
138585311|NCT02598583|Ravulizumab|ravulizumab|mesh-list
138585312|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138585313|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138585314|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
138585315|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585316|NCT00143429|Latanoprost|latanoprost|mesh-list
138585317|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138585318|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138585319|NCT02598895|Carboplatin|carboplatin|mesh-list
138585320|NCT02598895|Docetaxel|docetaxel|mesh-list
138585321|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585322|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
138585323|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
138585324|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
138585325|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585326|NCT00143546|Defibrotide|defibrotide|mesh-list
138474833|NCT02274779|Leuprolide|leuprolide|mesh-list
138585327|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138585328|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138585329|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585330|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138585331|NCT00155883|Leucovorin|leucovorin|mesh-list
138585332|NCT00155883|Fluorouracil|fluorouracil|mesh-list
138585333|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
138585334|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585335|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138585336|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585337|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138585338|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
138585339|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585340|NCT00155883|Antidotes|antidotes|mesh-ancestor
138585341|NCT00155883|Protective Agents|protective agents|mesh-ancestor
138585342|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
138585343|NCT00155883|Vitamins|vitamins|mesh-ancestor
138585344|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
138585345|NCT00506545|Rolapitant|rolapitant|mesh-list
138585346|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138585347|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138481165|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138585348|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474882|NCT02059265|Dasatinib|dasatinib|mesh-list
138286764|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585349|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585350|NCT04696393|Mitapivat|mitapivat|mesh-list
138585351|NCT04696393|Enzyme Activators|enzyme activators|mesh-ancestor
138585352|NCT04696393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585353|NCT05143723|Hormones|hormones|mesh-list
138585354|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138585355|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585356|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
138585357|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138585358|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585359|NCT05142865|Carboplatin|carboplatin|mesh-list
138585360|NCT05142865|Etoposide|etoposide|mesh-list
138585361|NCT05142865|Apatinib|apatinib|mesh-list
138585362|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585363|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138585364|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138585365|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138585366|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585367|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585368|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138585369|NCT00143702|Riboflavin|riboflavin|mesh-list
138585370|NCT00143702|Thiamine|thiamine|mesh-list
138585372|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138585373|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138585374|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585375|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585376|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
138585377|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585378|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138585379|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138585380|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
138585381|NCT00143702|Vitamins|vitamins|mesh-ancestor
138660942|NCT00348452|Celecoxib|celecoxib|mesh-list
138585382|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
138585383|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585384|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138585385|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
138585386|NCT00156078|Pregabalin|pregabalin|mesh-list
138585387|NCT00156078|Analgesics|analgesics|mesh-ancestor
138585388|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
138585389|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585390|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585391|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
138585392|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138286792|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
138286793|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585393|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138585394|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585395|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138585396|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138585397|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138585398|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138585399|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138585400|NCT00506623|Capecitabine|capecitabine|mesh-list
138585402|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138585403|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
138585404|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585405|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585406|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138585407|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138585408|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585409|NCT00143741|Atorvastatin|atorvastatin|mesh-list
138585410|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138585411|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138585412|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
138585413|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585414|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138585415|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138585416|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585418|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
138585419|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585420|NCT02276365|Pioglitazone|pioglitazone|mesh-list
138475029|NCT02007603|Ampicillin|ampicillin|mesh-list
138585421|NCT02276365|Empagliflozin|empagliflozin|mesh-list
138585422|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138585423|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585424|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138585425|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585426|NCT05145634|Anticoagulants|anticoagulants|mesh-list
138585427|NCT00143975|Cytarabine|cytarabine|mesh-list
138585428|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
138585429|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
138585430|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138585431|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
138585432|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585433|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585434|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
138585435|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585436|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138585437|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
138585438|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585440|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
138585441|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585442|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138585443|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138585444|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585445|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138585446|NCT00143975|Immunotoxins|immunotoxins|mesh-ancestor
138585447|NCT00143975|Immunoconjugates|immunoconjugates|mesh-ancestor
138585448|NCT00156312|Docetaxel|docetaxel|mesh-list
138585449|NCT00156312|Capecitabine|capecitabine|mesh-list
138585450|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585451|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
138585452|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
138585453|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
138585454|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286849|NCT04495712|Diuretics|diuretics|mesh-ancestor
138286850|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
138585455|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138585456|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
138585457|NCT00506701|Tadalafil|tadalafil|mesh-list
138585458|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
138585459|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138585460|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138585461|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585462|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585463|NCT00506701|Urological Agents|urological agents|mesh-ancestor
138585464|NCT05147857|Misoprostol|misoprostol|mesh-list
138585465|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138585466|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
138585467|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138585468|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585469|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138585470|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138585471|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
138585472|NCT00144053|Paclitaxel|paclitaxel|mesh-list
138585473|NCT00144053|Vindesine|vindesine|mesh-list
138585474|NCT00144053|Carboplatin|carboplatin|mesh-list
138585475|NCT00144053|Irinotecan|irinotecan|mesh-list
138585476|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138585477|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585478|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
138585479|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
138585480|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
138585481|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585482|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138585483|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138585484|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585485|NCT05147194|Trimetazidine|trimetazidine|mesh-list
138585486|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
138585487|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
138585488|NCT00144131|Hematinics|hematinics|mesh-ancestor
138585490|NCT00144209|Pramipexole|pramipexole|mesh-list
138585491|NCT00144209|Benserazide|benserazide|mesh-list
138585492|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138585493|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138585494|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
138585495|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138286919|NCT03570476|Olaparib|olaparib|mesh-list
138475178|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
138585496|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585497|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585498|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
138585499|NCT00144209|Protective Agents|protective agents|mesh-ancestor
138585500|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
138585501|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585502|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
138585503|NCT05149339|Vitamin D|vitamin d|mesh-list
138585504|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138585505|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585506|NCT05149339|Vitamins|vitamins|mesh-ancestor
138585507|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
138585508|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138585509|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138585510|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
138585511|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475238|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
138585512|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585513|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585514|NCT00144287|Ritonavir|ritonavir|mesh-list
138585515|NCT00144287|Tipranavir|tipranavir|mesh-list
138585516|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138585517|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138585518|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
138585519|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585520|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585521|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138585522|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138585523|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
138585524|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585525|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138585526|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138585527|NCT00144326|Bromides|bromides|mesh-list
138585528|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
138585529|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138585530|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
138585531|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585532|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585533|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138585534|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
138585535|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
138585536|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138585537|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
138585538|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138475295|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138286955|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585539|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585540|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
138585541|NCT02954692|Metformin|metformin|mesh-list
138585542|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
138585543|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
138585544|NCT02954692|Meglitinide|meglitinide|mesh-list
138585545|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
138585546|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138585547|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585548|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585549|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585550|NCT00506935|Vigabatrin|vigabatrin|mesh-list
138585551|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
138585552|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585553|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585554|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
138585555|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138585556|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585557|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138585558|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
138585559|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138286984|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585560|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
138585561|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138585562|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138261925|NCT02741687|Insulin|insulin|mesh-list
138585563|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
138585564|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
138585565|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138585566|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585567|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138585568|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585569|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
138585570|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138585571|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
138585572|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585573|NCT00507052|Expectorants|expectorants|mesh-ancestor
138585574|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
138585575|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138585576|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
138585577|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585578|NCT00507052|Protective Agents|protective agents|mesh-ancestor
138585579|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585580|NCT00507052|Antidotes|antidotes|mesh-ancestor
138585582|NCT00507091|Fluorouracil|fluorouracil|mesh-list
138585583|NCT00507091|Irinotecan|irinotecan|mesh-list
138585584|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
138585585|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585586|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138585587|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585588|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138585589|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
138585590|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585591|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138585592|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138585593|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585595|NCT00507091|Protective Agents|protective agents|mesh-ancestor
138585596|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
138585598|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
138585599|NCT05148910|Copper|copper|mesh-list
138585600|NCT05148910|Trace Elements|trace elements|mesh-ancestor
138585601|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
138585602|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585603|NCT00148083|Risperidone|risperidone|mesh-list
138585604|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138585605|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
138585606|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138585607|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585608|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585609|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138585610|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138585611|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138585612|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138585613|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138585614|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
138585615|NCT05148403|Glyburide|glyburide|mesh-list
138585616|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138585617|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585618|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
138585619|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138585620|NCT05148169|Sulforaphane|sulforaphane|mesh-list
138585621|NCT05148169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138585622|NCT05148169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138585623|NCT05148169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138585624|NCT05148169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585625|NCT05148169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138585626|NCT05148169|Serotonin Agents|serotonin agents|mesh-ancestor
138585627|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585628|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138585629|NCT05148169|Protective Agents|protective agents|mesh-ancestor
138585630|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585631|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
138585632|NCT00144482|Hematinics|hematinics|mesh-ancestor
138585634|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138585635|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138585636|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
138585637|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585638|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138585639|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
138585640|NCT05146687|Bevacizumab|bevacizumab|mesh-list
138585641|NCT05146687|Ranibizumab|ranibizumab|mesh-list
138585642|NCT05146687|Aflibercept|aflibercept|mesh-list
138585643|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138585644|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585645|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138585646|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138585647|NCT05146687|Growth Substances|growth substances|mesh-ancestor
138585648|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585649|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
138585650|NCT05141422|Efavirenz|efavirenz|mesh-list
138585651|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138585652|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138585653|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585654|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585655|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
138585656|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585657|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138585658|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138162566|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
138585659|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138585660|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138585661|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138585662|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138585663|NCT05148637|Lidocaine|lidocaine|mesh-list
138585664|NCT05148637|Fentanyl|fentanyl|mesh-list
138585665|NCT05148637|Anesthetics|anesthetics|mesh-list
138585666|NCT05148637|Sevoflurane|sevoflurane|mesh-list
138585667|NCT05148637|Desflurane|desflurane|mesh-list
138585668|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
138585669|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138585670|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585671|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
138287074|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
138287075|NCT03670160|Clonidine|clonidine|mesh-list
138287076|NCT03670160|Phenobarbital|phenobarbital|mesh-list
138585672|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585674|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138585676|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138585677|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585678|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138585679|NCT05148637|Narcotics|narcotics|mesh-ancestor
138585680|NCT05148637|Analgesics|analgesics|mesh-ancestor
138585681|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138585682|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138585683|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
138585684|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138585685|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138585686|NCT00148278|Dobutamine|dobutamine|mesh-list
138585687|NCT00148278|Epinephrine|epinephrine|mesh-list
138585688|NCT00148278|Norepinephrine|norepinephrine|mesh-list
138585689|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138585690|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138661056|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
138585691|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
138585692|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138585693|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585694|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585695|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138585696|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138585697|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
138585698|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585699|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138585700|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
138585701|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
138585702|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
138585703|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138585704|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138585705|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138585706|NCT00148278|Protective Agents|protective agents|mesh-ancestor
138585707|NCT05594849|Budesonide|budesonide|mesh-list
138585708|NCT05594849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138585709|NCT05594849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138585710|NCT05594849|Autonomic Agents|autonomic agents|mesh-ancestor
138585711|NCT05594849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585712|NCT05594849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585713|NCT05594849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138585714|NCT05594849|Respiratory System Agents|respiratory system agents|mesh-ancestor
138585715|NCT05594849|Glucocorticoids|glucocorticoids|mesh-ancestor
138585716|NCT05594849|Hormones|hormones|mesh-ancestor
138585717|NCT05594849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138585718|NCT00507247|Daptomycin|daptomycin|mesh-list
138585719|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138585720|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585721|NCT00507286|Alprostadil|alprostadil|mesh-list
138585722|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138585723|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
138585724|NCT00507286|Urological Agents|urological agents|mesh-ancestor
138585726|NCT05143762|Dexamethasone|dexamethasone|mesh-list
138585727|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138585728|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
138585729|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
138585730|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585731|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585732|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138585733|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
138585734|NCT05143762|Hormones|hormones|mesh-ancestor
138585735|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138585736|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138585737|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585738|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138585739|NCT05143762|Analgesics|analgesics|mesh-ancestor
138585740|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
138585741|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
138585742|NCT00148356|Paclitaxel|paclitaxel|mesh-list
138585743|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138585744|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585745|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
138585746|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
138585747|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
138318149|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
138585748|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585749|NCT00424281|PENTA|penta|mesh-list
138585750|NCT00424281|Fondaparinux|fondaparinux|mesh-list
138585751|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138585752|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
138585753|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138585754|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
138585755|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585756|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585757|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
138585758|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138585759|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138585760|NCT00148395|Carboplatin|carboplatin|mesh-list
138585761|NCT00148395|Gemcitabine|gemcitabine|mesh-list
138585763|NCT00148395|Mitomycins|mitomycins|mesh-list
138585765|NCT00148395|Vinorelbine|vinorelbine|mesh-list
138585766|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585767|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138585768|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
138585769|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585770|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138585771|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
138287157|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
138585772|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138585773|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138585774|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585775|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138585776|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
138585777|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
138585778|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
138585779|NCT02276677|Oxytocin|oxytocin|mesh-list
138585780|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
138585781|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138475658|NCT03994731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138585782|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585783|NCT05141344|Melatonin|melatonin|mesh-list
138585784|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
138585785|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585786|NCT05141344|Protective Agents|protective agents|mesh-ancestor
138585787|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585788|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138585789|NCT00156858|Busulfan|busulfan|mesh-list
138585790|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
138585791|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585792|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138585793|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
138585794|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585795|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138585796|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585797|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138585799|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138585800|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138585801|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138475724|NCT03396588|Clonidine|clonidine|mesh-list
138585802|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
138585803|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585804|NCT00156897|Orlistat|orlistat|mesh-list
138585805|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661128|NCT00421460|Hormones|hormones|mesh-ancestor
138585806|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585807|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138585808|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138585810|NCT03459859|Pevonedistat|pevonedistat|mesh-list
138585811|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138585812|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
138585813|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585814|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585815|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
138585816|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585817|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138585818|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
138585819|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585820|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585821|NCT05594459|Analgesics|analgesics|mesh-list
138481309|NCT05679336|Rituximab|rituximab|mesh-list
138585822|NCT05594459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585823|NCT05594459|Sensory System Agents|sensory system agents|mesh-ancestor
138585824|NCT05594459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585826|NCT00507403|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138585827|NCT00507403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138585828|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
138585829|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138585830|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138585831|NCT00156975|Capecitabine|capecitabine|mesh-list
138585832|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
138585833|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138585834|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
138585835|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585836|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585837|NCT05594381|Oxaliplatin|oxaliplatin|mesh-list
138585838|NCT05594381|Tegafur|tegafur|mesh-list
138585839|NCT05594381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585840|NCT05594381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138585841|NCT05594381|Antimetabolites|antimetabolites|mesh-ancestor
138585842|NCT05594381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585843|NCT00148473|Misoprostol|misoprostol|mesh-list
138585844|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138585845|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
138585846|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138585847|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585848|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138585849|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138585850|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
138585851|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
138585852|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138585853|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138475827|NCT02358538|Ganaxolone|ganaxolone|mesh-list
138585855|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138585856|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138585857|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585858|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
138585859|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138585860|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585861|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138585862|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585863|NCT05594342|Dobutamine|dobutamine|mesh-list
138585864|NCT05594342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138585865|NCT05594342|Sympathomimetics|sympathomimetics|mesh-ancestor
138585866|NCT05594342|Autonomic Agents|autonomic agents|mesh-ancestor
138585867|NCT05594342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585868|NCT05594342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585869|NCT05594342|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138661133|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
138585870|NCT05594342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138585871|NCT05594342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138585872|NCT05594342|Adrenergic Agents|adrenergic agents|mesh-ancestor
138585873|NCT05594342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138287216|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287217|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
138585874|NCT05594342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585875|NCT05594342|Protective Agents|protective agents|mesh-ancestor
138585876|NCT00157053|Factor VIII|factor viii|mesh-list
138585877|NCT00157053|Coagulants|coagulants|mesh-ancestor
138585878|NCT00507793|Cyclosporine|cyclosporine|mesh-list
138585879|NCT00507793|Sirolimus|sirolimus|mesh-list
138585880|NCT00507793|Cyclosporins|cyclosporins|mesh-list
138585881|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481320|NCT05677152|Zoledronic Acid|zoledronic acid|mesh-list
138585882|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585883|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138585884|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
138585885|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585886|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
138585887|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138475881|NCT02038452|Hormones|hormones|mesh-ancestor
138585888|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
138585889|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138585890|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138585891|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138585892|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138585893|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585894|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
138585895|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138585896|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138585897|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138585898|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
138585899|NCT00507832|Tacrolimus|tacrolimus|mesh-list
138585900|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138585901|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138585902|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138585904|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
138585905|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585906|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585907|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138585908|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
138585909|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138585910|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
138585911|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138585912|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585913|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585914|NCT00507949|Megestrol|megestrol|mesh-list
138585915|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
138585916|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138585917|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138585918|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138585919|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
138585920|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138585921|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585922|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138585923|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138585924|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138585925|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585926|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
138287233|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
138287237|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
138585927|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138585928|NCT00148551|Triamcinolone|triamcinolone|mesh-list
138585929|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138585930|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138585931|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138585932|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138585933|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
138585934|NCT00148551|Hormones|hormones|mesh-ancestor
138585935|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138585936|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585937|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138475958|NCT00863369|Rituximab|rituximab|mesh-list
138585938|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
138585939|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585940|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585941|NCT05594186|Tranexamic Acid|tranexamic acid|mesh-list
138585942|NCT05594186|Contraceptive Agents|contraceptive agents|mesh-list
138585943|NCT05594186|Levonorgestrel|levonorgestrel|mesh-list
138585944|NCT05594186|Contraceptives, Oral|contraceptives, oral|mesh-list
138585945|NCT05594186|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138585946|NCT05594186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138585947|NCT05594186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138585948|NCT05594186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585950|NCT05594186|Coagulants|coagulants|mesh-ancestor
138585951|NCT05594186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138585952|NCT05594186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585953|NCT05594186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138585954|NCT05594186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138585955|NCT05594186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138585956|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138585957|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
138585958|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138585959|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138585960|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
138585961|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138585962|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585963|NCT00148590|Memantine|memantine|mesh-list
138585964|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138585965|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138585966|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
138585967|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138585968|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287254|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
138585969|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585970|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138585971|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138585972|NCT02954068|Oxytocin|oxytocin|mesh-list
138585973|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
138585974|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138585975|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585977|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
138585978|NCT00157131|Coagulants|coagulants|mesh-ancestor
138585979|NCT02954029|Hemostatics|hemostatics|mesh-list
138585980|NCT02954029|Coagulants|coagulants|mesh-ancestor
138585982|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138481364|NCT03940131|Panitumumab|panitumumab|mesh-list
138585983|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
138585984|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138585985|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138585986|NCT00508495|Acetaminophen|acetaminophen|mesh-list
138585987|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138585988|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138585989|NCT00508495|Analgesics|analgesics|mesh-ancestor
138585990|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
138585991|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138585992|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138585993|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
138585994|NCT00508690|Metronidazole|metronidazole|mesh-list
138585995|NCT00508690|Kanamycin|kanamycin|mesh-list
138585996|NCT00508690|Cefmetazole|cefmetazole|mesh-list
138585997|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138585998|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138585999|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138586000|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138586001|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138586002|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586003|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586004|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138586005|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586006|NCT02953522|Folic Acid|folic acid|mesh-list
138586007|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
138586008|NCT02953522|Hematinics|hematinics|mesh-ancestor
138586009|NCT02953522|Vitamins|vitamins|mesh-ancestor
138586010|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
138586011|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586012|NCT00148746|Cyclosporine|cyclosporine|mesh-list
138586013|NCT00148746|Prednisolone|prednisolone|mesh-list
138586014|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
138586015|NCT00148746|Prednicarbate|prednicarbate|mesh-list
138586016|NCT00148746|Tacrolimus|tacrolimus|mesh-list
138586017|NCT00148746|Cyclosporins|cyclosporins|mesh-list
138586018|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138586019|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
138262381|NCT01996657|Warfarin|warfarin|mesh-list
138586020|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586021|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138586022|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586023|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586024|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
138586025|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586026|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
138586027|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138586028|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138586029|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
138586031|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138586032|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138586033|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138287313|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138287314|NCT04114058|Bupivacaine|bupivacaine|mesh-list
138586034|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586035|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138586036|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138586037|NCT00148746|Analgesics|analgesics|mesh-ancestor
138586038|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
138586039|NCT00148785|Ritonavir|ritonavir|mesh-list
138586040|NCT00148785|Indinavir|indinavir|mesh-list
138586041|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
138586042|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138586043|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138586044|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
138586045|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586046|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586047|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138586048|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138586049|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
138586050|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586051|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138586052|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138586054|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138586056|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586057|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
138586058|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
138586059|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138586060|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586061|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138586062|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138586063|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586064|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586065|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586066|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138586067|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138586068|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138586069|NCT00466609|Fluoxetine|fluoxetine|mesh-list
138586070|NCT00466609|Clomipramine|clomipramine|mesh-list
138586071|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
138586072|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138586073|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138586074|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138586075|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586076|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586077|NCT00466609|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138586078|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138586079|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138586080|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586081|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586082|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
138586083|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138586084|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138586085|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138586086|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586087|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138586088|NCT00157326|Tadalafil|tadalafil|mesh-list
138586089|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
138586090|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138586091|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138586092|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586093|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586094|NCT00157326|Urological Agents|urological agents|mesh-ancestor
138586095|NCT00466843|Prednisone|prednisone|mesh-list
138586096|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138586097|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138586098|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
138586099|NCT00466843|Hormones|hormones|mesh-ancestor
138586100|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138586101|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586102|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138586103|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586104|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
138586105|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138586106|NCT00148863|Interferons|interferons|mesh-list
138586107|NCT00148863|Ribavirin|ribavirin|mesh-list
138586108|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
138586109|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
138586111|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138481401|NCT03834909|Tenofovir|tenofovir|mesh-list
138586112|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586114|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586115|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
138287408|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
138586116|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586117|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
138586118|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586119|NCT00466999|Misoprostol|misoprostol|mesh-list
138586120|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138586121|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
138586122|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138586123|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586124|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138586125|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138586126|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
138586127|NCT00467116|Gemcitabine|gemcitabine|mesh-list
138586129|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138586130|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
138586131|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586132|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476310|NCT02011906|Protective Agents|protective agents|mesh-ancestor
138586133|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138586134|NCT00157482|Simvastatin|simvastatin|mesh-list
138586135|NCT00157482|Ezetimibe|ezetimibe|mesh-list
138586136|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138586137|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138586138|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
138586139|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586140|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138586141|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138586142|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586143|NCT00467194|Sirolimus|sirolimus|mesh-list
138586144|NCT00467194|Bevacizumab|bevacizumab|mesh-list
138586145|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138586146|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586147|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138476361|NCT02012088|Prednisone|prednisone|mesh-list
138586148|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138586149|NCT00467194|Growth Substances|growth substances|mesh-ancestor
138586150|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586151|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
138586152|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138586153|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586154|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138586155|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
138586156|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138586157|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
138586158|NCT00148902|Docetaxel|docetaxel|mesh-list
138586159|NCT00148902|Lapatinib|lapatinib|mesh-list
138586160|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586161|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
138287439|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
138586162|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
138586163|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
138586164|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586165|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138586166|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586167|NCT05507645|Saruplase|saruplase|mesh-list
138586168|NCT05507645|Anticoagulants|anticoagulants|mesh-list
138586169|NCT05507645|Clopidogrel|clopidogrel|mesh-list
138586170|NCT05507645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586171|NCT05507645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138586172|NCT05507645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138476419|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138586173|NCT05507645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586174|NCT05507645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138586175|NCT05507645|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138586176|NCT05507645|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138586177|NCT05507645|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138586178|NCT05507645|Purinergic Agents|purinergic agents|mesh-ancestor
138586179|NCT05507645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586181|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138586182|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138586183|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
138586184|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
138586185|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586186|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586187|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138661240|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138287464|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
138287465|NCT03820388|Propofol|propofol|mesh-list
138586189|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138586190|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138586191|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138586192|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
138586193|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586194|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586195|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586196|NCT00467467|Urological Agents|urological agents|mesh-ancestor
138586197|NCT00406887|Difluprednate|difluprednate|mesh-list
138586198|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
138586199|NCT00406887|Hormones|hormones|mesh-ancestor
138586200|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138586201|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586202|NCT00467506|Antibodies|antibodies|mesh-list
138586203|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138586204|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
138586205|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586206|NCT00467545|Telbivudine|telbivudine|mesh-list
138586207|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
138586208|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586209|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138586210|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586211|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586213|NCT00467662|Docosanol|docosanol|mesh-list
138586214|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
138586215|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586216|NCT05497310|Tretinoin|tretinoin|mesh-list
138586217|NCT05497310|Arsenic Trioxide|arsenic trioxide|mesh-list
138586218|NCT05497310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586219|NCT05497310|Keratolytic Agents|keratolytic agents|mesh-ancestor
138586220|NCT05497310|Dermatologic Agents|dermatologic agents|mesh-ancestor
138586221|NCT00467935|Ranibizumab|ranibizumab|mesh-list
138586222|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138586223|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138586224|NCT00467935|Growth Substances|growth substances|mesh-ancestor
138586225|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586226|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
138586227|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586228|NCT00149019|Antibodies|antibodies|mesh-list
138586229|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138586230|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
138586231|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586232|NCT00468091|Atropine|atropine|mesh-list
138586233|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138586234|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138586235|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138586236|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
138586237|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586238|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586239|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138586240|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
138586242|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
138586243|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138586244|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138586245|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
138586246|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586247|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586249|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138586250|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
138586251|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
138586252|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
138586253|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
138586254|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138586255|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586256|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
138586257|NCT00149058|Hematinics|hematinics|mesh-ancestor
138586258|NCT00468520|Oxytocin|oxytocin|mesh-list
138586259|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
138586260|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138586261|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586262|NCT03271450|Warfarin|warfarin|mesh-list
138586263|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
138586264|NCT03271450|Dabigatran|dabigatran|mesh-list
138586265|NCT03271450|Apixaban|apixaban|mesh-list
138586266|NCT03271450|Edoxaban|edoxaban|mesh-list
138586267|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
138586268|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138586269|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
138586270|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138586271|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
138586272|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586273|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586274|NCT00468754|Insulin|insulin|mesh-list
138586275|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138586276|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586277|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138586278|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138586279|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138586280|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
138586281|NCT00468871|Hormones|hormones|mesh-ancestor
138586282|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138586283|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586284|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
138586285|NCT00468988|Travoprost|travoprost|mesh-list
138586286|NCT00468988|Latanoprost|latanoprost|mesh-list
138661301|NCT00421538|Nadroparin|nadroparin|mesh-list
138586287|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138586288|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138586289|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138586291|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586292|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138586293|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586294|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586295|NCT00469261|Doxycycline|doxycycline|mesh-list
138586296|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138586297|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586298|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
138586299|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138586300|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138586301|NCT00469300|Acyclovir|acyclovir|mesh-list
138586302|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
138586303|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586304|NCT04697641|Amoxicillin|amoxicillin|mesh-list
138586305|NCT04697641|Clarithromycin|clarithromycin|mesh-list
138586306|NCT04697641|Pantoprazole|pantoprazole|mesh-list
138586307|NCT04697641|Z 338|z 338|mesh-list
138586308|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138586309|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586310|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138586311|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586312|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586313|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138586314|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138586315|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138586316|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138586317|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138586318|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138586319|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
138586320|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586321|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586322|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138586323|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138586324|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138586325|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
138586326|NCT00469495|Anthelmintics|anthelmintics|mesh-list
138586327|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138586328|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586329|NCT00469651|Vaccines|vaccines|mesh-list
138586330|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
138586331|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287552|NCT00377546|Nepafenac|nepafenac|mesh-list
138586332|NCT00149253|Etoricoxib|etoricoxib|mesh-list
138586333|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586334|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138586335|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138586336|NCT00149253|Analgesics|analgesics|mesh-ancestor
138476712|NCT02014454|Propranolol|propranolol|mesh-list
138586338|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586339|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138661349|NCT00457470|Rucaparib|rucaparib|mesh-list
138586340|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138586341|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138586342|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138586343|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586344|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586345|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138586346|NCT00469690|Bromfenac|bromfenac|mesh-list
138586347|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138586348|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138586349|NCT00469690|Analgesics|analgesics|mesh-ancestor
138586350|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
138586351|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586352|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586353|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138586354|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138586355|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138586356|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586357|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586358|NCT00469768|Dapivirine|dapivirine|mesh-list
138586359|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138586360|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138586361|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
138586362|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586363|NCT06183567|Anesthetics|anesthetics|mesh-list
138586364|NCT06183567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586365|NCT06183567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586366|NCT06183242|Niacinamide|niacinamide|mesh-list
138586367|NCT06183242|Niacin|niacin|mesh-list
138586368|NCT06183242|Nicotinic Acids|nicotinic acids|mesh-list
138287590|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586369|NCT06183242|Vitamin B Complex|vitamin b complex|mesh-ancestor
138586370|NCT06183242|Vitamins|vitamins|mesh-ancestor
138586371|NCT06183242|Micronutrients|micronutrients|mesh-ancestor
138586372|NCT06183242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586373|NCT06183242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138586374|NCT06183242|Antimetabolites|antimetabolites|mesh-ancestor
138586375|NCT06183242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586376|NCT06183242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138586377|NCT06183242|Vasodilator Agents|vasodilator agents|mesh-ancestor
138586378|NCT06183229|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
138586379|NCT06183229|Interferon Inducers|interferon inducers|mesh-ancestor
138586380|NCT06183229|Immunologic Factors|immunologic factors|mesh-ancestor
138586381|NCT06183229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586382|NCT06183216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138586383|NCT06183216|Immunologic Factors|immunologic factors|mesh-ancestor
138586384|NCT06183216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586385|NCT06183073|Dexmedetomidine|dexmedetomidine|mesh-list
138586386|NCT06183073|Bupivacaine|bupivacaine|mesh-list
138586387|NCT06183073|Anesthetics, Local|anesthetics, local|mesh-ancestor
138586388|NCT06183073|Anesthetics|anesthetics|mesh-ancestor
138586389|NCT06183073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586390|NCT06183073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586391|NCT06183073|Sensory System Agents|sensory system agents|mesh-ancestor
138586392|NCT06183073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586393|NCT06183073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138586394|NCT06183073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138586395|NCT06183073|Analgesics|analgesics|mesh-ancestor
138586396|NCT06183073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138586397|NCT06183073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138586398|NCT06183073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138586399|NCT06183073|Adrenergic Agents|adrenergic agents|mesh-ancestor
138586400|NCT06183073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586401|NCT06183073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586403|NCT06183008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138586405|NCT06183008|gamma-Globulins|gamma-globulins|mesh-list
138586406|NCT06183008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138586407|NCT06183008|Immunologic Factors|immunologic factors|mesh-ancestor
138586408|NCT06183008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586409|NCT06182891|Dulaglutide|dulaglutide|mesh-list
138586410|NCT06182891|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138586411|NCT06182891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586412|NCT06182800|Bevacizumab|bevacizumab|mesh-list
138586413|NCT06182800|Docetaxel|docetaxel|mesh-list
138476863|NCT02015299|Linagliptin|linagliptin|mesh-list
138586414|NCT06182800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138586415|NCT06182800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586416|NCT06182800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138586417|NCT06182800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138586419|NCT06182800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586420|NCT06182800|Growth Inhibitors|growth inhibitors|mesh-ancestor
138586421|NCT06182800|Tubulin Modulators|tubulin modulators|mesh-ancestor
138586422|NCT06182800|Antimitotic Agents|antimitotic agents|mesh-ancestor
138586423|NCT06182800|Mitosis Modulators|mitosis modulators|mesh-ancestor
138586424|NCT06182800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586425|NCT06182774|Dexamethasone|dexamethasone|mesh-list
138586426|NCT06182774|Lenalidomide|lenalidomide|mesh-list
138586427|NCT06182774|Daratumumab|daratumumab|mesh-list
138586428|NCT06182774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138586429|NCT06182774|Antiemetics|antiemetics|mesh-ancestor
138586430|NCT06182774|Autonomic Agents|autonomic agents|mesh-ancestor
138481454|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
138586431|NCT06182774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586432|NCT06182774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586433|NCT06182774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138586434|NCT06182774|Glucocorticoids|glucocorticoids|mesh-ancestor
138586436|NCT06182774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138586437|NCT06182774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138586438|NCT06182774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586439|NCT06182774|Immunologic Factors|immunologic factors|mesh-ancestor
138586440|NCT06182774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138586441|NCT06182774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138586442|NCT06182774|Growth Substances|growth substances|mesh-ancestor
138586443|NCT06182774|Growth Inhibitors|growth inhibitors|mesh-ancestor
138586444|NCT06182735|Cyclophosphamide|cyclophosphamide|mesh-list
138586446|NCT06182735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138586447|NCT06182735|Immunologic Factors|immunologic factors|mesh-ancestor
138476928|NCT02015650|Mitomycins|mitomycins|mesh-list
138586448|NCT06182735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586449|NCT06182735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138586450|NCT06182735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138586452|NCT06182735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586453|NCT06182735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586454|NCT06182735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138586456|NCT06182618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138586457|NCT06182618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586458|NCT06182410|Defibrotide|defibrotide|mesh-list
138586459|NCT06182410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138586460|NCT06182410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138586461|NCT06182410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586462|NCT06182410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138586463|NCT06182397|Sirolimus|sirolimus|mesh-list
138586464|NCT06182397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138586465|NCT06182397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586466|NCT06182397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138586467|NCT06182397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586468|NCT06182397|Antifungal Agents|antifungal agents|mesh-ancestor
138586469|NCT06182397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138586470|NCT06182397|Immunologic Factors|immunologic factors|mesh-ancestor
138586471|NCT06182397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586472|NCT06182358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138481496|NCT02936505|Tacrolimus|tacrolimus|mesh-list
138586473|NCT06182358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138586475|NCT06182176|Sulfadoxine|sulfadoxine|mesh-list
138262850|NCT01960387|Cytarabine|cytarabine|mesh-list
138586476|NCT06182176|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138586477|NCT06182176|Amodiaquine|amodiaquine|mesh-list
138586478|NCT06182176|Antimalarials|antimalarials|mesh-ancestor
138586479|NCT06182176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138586480|NCT06182176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138586481|NCT06182176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586482|NCT06182176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138586483|NCT06182176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586484|NCT06182176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586485|NCT06182176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138586486|NCT06182111|Morphine|morphine|mesh-list
138586487|NCT06182111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138586488|NCT06182111|Narcotics|narcotics|mesh-ancestor
138586489|NCT06182111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586490|NCT06182111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586491|NCT06182111|Analgesics|analgesics|mesh-ancestor
138586492|NCT06182111|Sensory System Agents|sensory system agents|mesh-ancestor
138586493|NCT06182111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586494|NCT06182098|Diphenhydramine|diphenhydramine|mesh-list
138586495|NCT06182098|Promethazine|promethazine|mesh-list
138586496|NCT06182098|Ketorolac|ketorolac|mesh-list
138586497|NCT06182098|Prochlorperazine|prochlorperazine|mesh-list
138586498|NCT06182098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138586499|NCT06182098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138586500|NCT06182098|Analgesics|analgesics|mesh-ancestor
138586501|NCT06182098|Sensory System Agents|sensory system agents|mesh-ancestor
138586502|NCT06182098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586503|NCT06182098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586504|NCT06182098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138586505|NCT06182098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138318154|NCT01436370|Vaccines|vaccines|mesh-list
138586506|NCT06182098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138586507|NCT06182098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586508|NCT06182098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586509|NCT06182098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138586510|NCT06182098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138586511|NCT06182098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586512|NCT06182098|Anesthetics, Local|anesthetics, local|mesh-ancestor
138586514|NCT06182098|Antiemetics|antiemetics|mesh-ancestor
138586515|NCT06182098|Autonomic Agents|autonomic agents|mesh-ancestor
138586516|NCT06182098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138586517|NCT06182098|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138586518|NCT06182098|Histamine Antagonists|histamine antagonists|mesh-ancestor
138586519|NCT06182098|Histamine Agents|histamine agents|mesh-ancestor
138586520|NCT06182098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586521|NCT06182098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138586522|NCT06182098|Antipruritics|antipruritics|mesh-ancestor
138586523|NCT06182098|Dermatologic Agents|dermatologic agents|mesh-ancestor
138586524|NCT06182098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138586525|NCT06182098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138477055|NCT02016391|Analgesics|analgesics|mesh-ancestor
138586526|NCT06182098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138586527|NCT06182098|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138586528|NCT06182098|Dopamine Agents|dopamine agents|mesh-ancestor
138586529|NCT06182072|Paclitaxel|paclitaxel|mesh-list
138586530|NCT06182072|Gemcitabine|gemcitabine|mesh-list
138586531|NCT06182072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138586532|NCT06182072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586533|NCT06182072|Tubulin Modulators|tubulin modulators|mesh-ancestor
138586534|NCT06182072|Antimitotic Agents|antimitotic agents|mesh-ancestor
138586535|NCT06182072|Mitosis Modulators|mitosis modulators|mesh-ancestor
138586536|NCT06182072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586537|NCT06182072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138586538|NCT06182072|Antimetabolites|antimetabolites|mesh-ancestor
138586539|NCT06182020|Calcium|calcium|mesh-list
138586540|NCT06182020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138481506|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
138586541|NCT06182020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586542|NCT06181760|Fenretinide|fenretinide|mesh-list
138586543|NCT06181760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586544|NCT06181760|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138586545|NCT06181760|Protective Agents|protective agents|mesh-ancestor
138586546|NCT06181760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586547|NCT06181695|Sufentanil|sufentanil|mesh-list
138586548|NCT06181695|Morphine|morphine|mesh-list
138586550|NCT06181695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138262920|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
138586551|NCT06181695|Narcotics|narcotics|mesh-ancestor
138586552|NCT06181695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586553|NCT06181695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586554|NCT06181695|Analgesics|analgesics|mesh-ancestor
138586555|NCT06181695|Sensory System Agents|sensory system agents|mesh-ancestor
138586556|NCT06181695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586557|NCT06181695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138586558|NCT06181695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138586559|NCT06181695|Anesthetics, General|anesthetics, general|mesh-ancestor
138586560|NCT06181695|Anesthetics|anesthetics|mesh-ancestor
138586561|NCT06181682|Midazolam|midazolam|mesh-list
138586562|NCT06181682|Dexmedetomidine|dexmedetomidine|mesh-list
138586563|NCT06181682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138586564|NCT06181682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586565|NCT06181682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586566|NCT06181682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138586567|NCT06181682|Analgesics|analgesics|mesh-ancestor
138586568|NCT06181682|Sensory System Agents|sensory system agents|mesh-ancestor
138586569|NCT06181682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586570|NCT06181682|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138477100|NCT02016495|Vitamins|vitamins|mesh-ancestor
138586571|NCT06181682|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138586572|NCT06181682|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138586573|NCT06181682|Adrenergic Agents|adrenergic agents|mesh-ancestor
138586574|NCT06181682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586575|NCT06181682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586576|NCT06181682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138586577|NCT06181682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138586578|NCT06181682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138586579|NCT06181682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138287749|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
138586580|NCT06181682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138586581|NCT06181682|Anesthetics, General|anesthetics, general|mesh-ancestor
138586582|NCT06181682|Anesthetics|anesthetics|mesh-ancestor
138586583|NCT06181682|GABA Modulators|gaba modulators|mesh-ancestor
138586584|NCT06181682|GABA Agents|gaba agents|mesh-ancestor
138586585|NCT06181591|Mirabegron|mirabegron|mesh-list
138586586|NCT06181591|Oxybutynin|oxybutynin|mesh-list
138586587|NCT06181591|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138586588|NCT06181591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138586589|NCT06181591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138586590|NCT06181591|Adrenergic Agents|adrenergic agents|mesh-ancestor
138586591|NCT06181591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586592|NCT06181591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586593|NCT06181591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586594|NCT06181591|Urological Agents|urological agents|mesh-ancestor
138287785|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138586595|NCT06181591|Parasympatholytics|parasympatholytics|mesh-ancestor
138586596|NCT06181591|Autonomic Agents|autonomic agents|mesh-ancestor
138586597|NCT06181591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586598|NCT06181591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138586599|NCT06181591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138586600|NCT06181591|Cholinergic Agents|cholinergic agents|mesh-ancestor
138586601|NCT06181422|Metformin|metformin|mesh-list
138586602|NCT06181422|Lactoferrin|lactoferrin|mesh-list
138586603|NCT06181422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138586604|NCT06181422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586605|NCT06181422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586606|NCT06181396|Oxytocin|oxytocin|mesh-list
138586607|NCT06181396|Oxytocics|oxytocics|mesh-ancestor
138586608|NCT06181396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138586609|NCT06181396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586610|NCT06181305|Letrozole|letrozole|mesh-list
138586611|NCT06181305|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138586612|NCT06181305|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138586613|NCT06181305|Estradiol|estradiol|mesh-list
138586614|NCT06181305|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138586615|NCT06181305|Estrogens|estrogens|mesh-ancestor
138586616|NCT06181305|Hormones|hormones|mesh-ancestor
138586617|NCT06181305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138586618|NCT06181305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586619|NCT06181305|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138586620|NCT06181305|Contraceptive Agents|contraceptive agents|mesh-ancestor
138586621|NCT06181305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138586622|NCT06181305|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138586623|NCT06181305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586624|NCT06181305|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138262990|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586625|NCT06181305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138586626|NCT06181305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586627|NCT06181305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586628|NCT06181305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138586629|NCT06181305|Hormone Antagonists|hormone antagonists|mesh-ancestor
138586630|NCT06181188|Midazolam|midazolam|mesh-list
138586631|NCT06181188|Fentanyl|fentanyl|mesh-list
138586632|NCT06181188|Ketamine|ketamine|mesh-list
138586634|NCT06181188|Sensory System Agents|sensory system agents|mesh-ancestor
138586635|NCT06181188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586636|NCT06181188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586637|NCT06181188|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138586638|NCT06181188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138586639|NCT06181188|Anesthetics, General|anesthetics, general|mesh-ancestor
138586640|NCT06181188|Anesthetics|anesthetics|mesh-ancestor
138287842|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138586641|NCT06181188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586642|NCT06181188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138586643|NCT06181188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138586644|NCT06181188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586645|NCT06181188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586646|NCT06181188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138586647|NCT06181188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138586648|NCT06181188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138586649|NCT06181188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138586650|NCT06181188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138586651|NCT06181188|GABA Modulators|gaba modulators|mesh-ancestor
138586652|NCT06181188|GABA Agents|gaba agents|mesh-ancestor
138586653|NCT06181188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138586654|NCT06181188|Narcotics|narcotics|mesh-ancestor
138586655|NCT06181175|Tamsulosin|tamsulosin|mesh-list
138586656|NCT06181175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138287881|NCT03723980|Propolis|propolis|mesh-list
138586657|NCT06181175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138586658|NCT06181175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138586659|NCT06181175|Adrenergic Agents|adrenergic agents|mesh-ancestor
138586660|NCT06181175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586661|NCT06181175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586662|NCT06181175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586663|NCT06181175|Urological Agents|urological agents|mesh-ancestor
138586664|NCT06181084|Esomeprazole|esomeprazole|mesh-list
138586665|NCT06181084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138586666|NCT06181084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138586667|NCT06181084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138586668|NCT06181084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586669|NCT06181084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586671|NCT06181032|Gemcitabine|gemcitabine|mesh-list
138586673|NCT06181032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586674|NCT06181032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138586675|NCT06181032|Antimetabolites|antimetabolites|mesh-ancestor
138586676|NCT06181032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586677|NCT06181032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138586678|NCT06181032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586679|NCT06181019|Mirabegron|mirabegron|mesh-list
138586680|NCT06181019|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138586681|NCT06181019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138586682|NCT06181019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138586683|NCT06181019|Adrenergic Agents|adrenergic agents|mesh-ancestor
138586684|NCT06181019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586685|NCT06181019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586686|NCT06181019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586687|NCT06181019|Urological Agents|urological agents|mesh-ancestor
138586688|NCT06181006|Pirtobrutinib|pirtobrutinib|mesh-list
138586689|NCT06181006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138586690|NCT06181006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586691|NCT06181006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586692|NCT06180980|Pirtobrutinib|pirtobrutinib|mesh-list
138586693|NCT06180980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138586694|NCT06180980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586695|NCT06180980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586696|NCT06180967|Midazolam|midazolam|mesh-list
138586697|NCT06180967|Pirtobrutinib|pirtobrutinib|mesh-list
138586698|NCT06180967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138586699|NCT06180967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138586700|NCT06180967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586701|NCT06180967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586702|NCT06180967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138586703|NCT06180967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138586704|NCT06180967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138586705|NCT06180967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138287932|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586706|NCT06180967|Anesthetics, General|anesthetics, general|mesh-ancestor
138586707|NCT06180967|Anesthetics|anesthetics|mesh-ancestor
138586708|NCT06180967|GABA Modulators|gaba modulators|mesh-ancestor
138586709|NCT06180967|GABA Agents|gaba agents|mesh-ancestor
138586710|NCT06180967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586711|NCT06180967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586712|NCT06180967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138586713|NCT06180967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586714|NCT06180954|Pirtobrutinib|pirtobrutinib|mesh-list
138586715|NCT06180954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138586716|NCT06180954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586717|NCT06180954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586718|NCT06180941|Magnesium Sulfate|magnesium sulfate|mesh-list
138586719|NCT06180941|Clonidine|clonidine|mesh-list
138586720|NCT06180941|Analgesics|analgesics|mesh-ancestor
138586721|NCT06180941|Sensory System Agents|sensory system agents|mesh-ancestor
138586722|NCT06180941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586723|NCT06180941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586724|NCT06180941|Anesthetics|anesthetics|mesh-ancestor
138586725|NCT06180941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586726|NCT06180941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138586727|NCT06180941|Anticonvulsants|anticonvulsants|mesh-ancestor
138586728|NCT06180941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138586729|NCT06180941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138481546|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138586730|NCT06180941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586731|NCT06180941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138586733|NCT06180941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138586734|NCT06180941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138586735|NCT06180941|Sympatholytics|sympatholytics|mesh-ancestor
138586736|NCT06180941|Autonomic Agents|autonomic agents|mesh-ancestor
138586737|NCT06180941|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138586738|NCT06180941|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138586739|NCT06180941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138586740|NCT06180941|Adrenergic Agents|adrenergic agents|mesh-ancestor
138586741|NCT06180941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586742|NCT06180876|Propofol|propofol|mesh-list
138586743|NCT06180876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138586744|NCT06180876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586745|NCT06180876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586746|NCT06180876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138586747|NCT06180876|Anesthetics, General|anesthetics, general|mesh-ancestor
138287962|NCT01194908|Tamoxifen|tamoxifen|mesh-list
138586748|NCT06180876|Anesthetics|anesthetics|mesh-ancestor
138586749|NCT06180863|Azacitidine|azacitidine|mesh-list
138586750|NCT06180863|Cc-486|cc-486|mesh-list
138586751|NCT06180863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138586752|NCT06180863|Antimetabolites|antimetabolites|mesh-ancestor
138586753|NCT06180863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586754|NCT06180863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586755|NCT06180863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586756|NCT06176963|Ranibizumab|ranibizumab|mesh-list
138586757|NCT06176963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138586758|NCT06176963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138586759|NCT06176963|Growth Substances|growth substances|mesh-ancestor
138586760|NCT06176963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586761|NCT06176963|Growth Inhibitors|growth inhibitors|mesh-ancestor
138586762|NCT06176963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586763|NCT06176235|Dexamethasone|dexamethasone|mesh-list
138586764|NCT06176235|Teriflunomide|teriflunomide|mesh-list
138586765|NCT06176235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138586766|NCT06176235|Antiemetics|antiemetics|mesh-ancestor
138586767|NCT06176235|Autonomic Agents|autonomic agents|mesh-ancestor
138586768|NCT06176235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586769|NCT06176235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586770|NCT06176235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138586771|NCT06176235|Glucocorticoids|glucocorticoids|mesh-ancestor
138586772|NCT06176235|Hormones|hormones|mesh-ancestor
138586773|NCT06176235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138586774|NCT06176235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138586775|NCT06176235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586776|NCT06176235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138586777|NCT06176235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138586778|NCT06176235|Analgesics|analgesics|mesh-ancestor
138586779|NCT06176235|Sensory System Agents|sensory system agents|mesh-ancestor
138586780|NCT06176235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138586781|NCT06176235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138586782|NCT06176235|Immunologic Factors|immunologic factors|mesh-ancestor
138586784|NCT06175390|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138477394|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586785|NCT06175390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586786|NCT06174155|Botulinum Toxins|botulinum toxins|mesh-list
138586787|NCT06174155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138586788|NCT06174155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138586789|NCT06174155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138586790|NCT06174155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138586791|NCT06174155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586792|NCT06174155|Cholinergic Agents|cholinergic agents|mesh-ancestor
138586793|NCT06174155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586794|NCT06174155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586795|NCT06174155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138586796|NCT06174155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586798|NCT06172764|Ergocalciferols|ergocalciferols|mesh-list
138586799|NCT06172764|Cholecalciferol|cholecalciferol|mesh-list
138586800|NCT06172764|Vitamins|vitamins|mesh-list
138287987|NCT01155518|Clomiphene|clomiphene|mesh-list
138586801|NCT06172764|Fluorides|fluorides|mesh-list
138586802|NCT06172764|Fluorides, Topical|fluorides, topical|mesh-list
138586803|NCT06172764|Micronutrients|micronutrients|mesh-ancestor
138586804|NCT06172764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586805|NCT06172764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138586806|NCT06172764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138586807|NCT06172764|Cariostatic Agents|cariostatic agents|mesh-ancestor
138586808|NCT06172764|Protective Agents|protective agents|mesh-ancestor
138586809|NCT06172400|Mepivacaine|mepivacaine|mesh-list
138586810|NCT06172400|Anesthetics, Local|anesthetics, local|mesh-ancestor
138586811|NCT06172400|Anesthetics|anesthetics|mesh-ancestor
138586812|NCT06172400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586814|NCT06172400|Sensory System Agents|sensory system agents|mesh-ancestor
138586815|NCT06172400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586816|NCT06171152|Liraglutide|liraglutide|mesh-list
138586817|NCT06171152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138586818|NCT06171152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586819|NCT06171152|Incretins|incretins|mesh-ancestor
138586820|NCT06171152|Hormones|hormones|mesh-ancestor
138586821|NCT06171152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138586822|NCT06163820|Bevacizumab|bevacizumab|mesh-list
138586823|NCT06163820|Nivolumab|nivolumab|mesh-list
138586824|NCT06163820|Ipilimumab|ipilimumab|mesh-list
138586825|NCT06163820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138586826|NCT06163820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586827|NCT06163820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138586828|NCT06163820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138586829|NCT06163820|Growth Substances|growth substances|mesh-ancestor
138586830|NCT06163820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586831|NCT06163820|Growth Inhibitors|growth inhibitors|mesh-ancestor
138586832|NCT06163820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138586833|NCT06163820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586834|NCT06161454|Baloxavir|baloxavir|mesh-list
138586836|NCT06161454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586837|NCT06161454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586838|NCT06161454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586839|NCT06157242|Ceftibuten|ceftibuten|mesh-list
138586840|NCT06157242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138586841|NCT06157242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586842|NCT06145191|Epinephrine|epinephrine|mesh-list
138586843|NCT06145191|Racepinephrine|racepinephrine|mesh-list
138586844|NCT06145191|Tranexamic Acid|tranexamic acid|mesh-list
138586845|NCT06145191|Epinephryl borate|epinephryl borate|mesh-list
138586846|NCT06145191|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138586847|NCT06145191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138586848|NCT06145191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586849|NCT06145191|Hemostatics|hemostatics|mesh-ancestor
138586850|NCT06145191|Coagulants|coagulants|mesh-ancestor
138586851|NCT06145191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138586852|NCT06145191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138586853|NCT06145191|Adrenergic Agents|adrenergic agents|mesh-ancestor
138586854|NCT06145191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586855|NCT06145191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586856|NCT06145191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138586857|NCT06145191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138586858|NCT06145191|Autonomic Agents|autonomic agents|mesh-ancestor
138586859|NCT06145191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586860|NCT06145191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138586861|NCT06145191|Respiratory System Agents|respiratory system agents|mesh-ancestor
138586862|NCT06145191|Mydriatics|mydriatics|mesh-ancestor
138586863|NCT06145191|Sympathomimetics|sympathomimetics|mesh-ancestor
138586864|NCT06145191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138586865|NCT06143306|Bupivacaine|bupivacaine|mesh-list
138481563|NCT01959204|Analgesics|analgesics|mesh-ancestor
138586866|NCT06143306|Anesthetics, Local|anesthetics, local|mesh-ancestor
138586868|NCT06143306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586869|NCT06143306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586870|NCT06143306|Sensory System Agents|sensory system agents|mesh-ancestor
138586871|NCT06143306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586872|NCT06131437|Tirzepatide|tirzepatide|mesh-list
138586873|NCT06131437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138586874|NCT06131437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586875|NCT06131437|Incretins|incretins|mesh-ancestor
138586876|NCT06131437|Hormones|hormones|mesh-ancestor
138477531|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138586877|NCT06131437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138586878|NCT06113237|Cannabidiol|cannabidiol|mesh-list
138586879|NCT06113237|Anticonvulsants|anticonvulsants|mesh-ancestor
138586880|NCT06111313|Androgens|androgens|mesh-list
138586881|NCT06111313|Relugolix|relugolix|mesh-list
138586882|NCT06111313|Hormones|hormones|mesh-ancestor
138586883|NCT06111313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138586884|NCT06111313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586885|NCT06111313|Androgen Antagonists|androgen antagonists|mesh-ancestor
138586886|NCT06111313|Hormone Antagonists|hormone antagonists|mesh-ancestor
138586887|NCT06106412|Calcimycin|calcimycin|mesh-list
138288029|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138586888|NCT06106412|Ionomycin|ionomycin|mesh-list
138586889|NCT06106412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138586890|NCT06106412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138586891|NCT06106412|Calcium Ionophores|calcium ionophores|mesh-ancestor
138586892|NCT06106412|Ionophores|ionophores|mesh-ancestor
138586893|NCT06106412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138586894|NCT06106412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586895|NCT06104618|Immunoconjugates|immunoconjugates|mesh-list
138586896|NCT06104618|Immunologic Factors|immunologic factors|mesh-ancestor
138586897|NCT06104618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586898|NCT06099886|N-Methylaspartate|n-methylaspartate|mesh-list
138586899|NCT06099886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586900|NCT06099886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586901|NCT06099886|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138586902|NCT06099886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138586903|NCT06099886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586904|NCT06077669|Methylphenidate|methylphenidate|mesh-list
138586905|NCT06077669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138586906|NCT06077669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586907|NCT06077669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138586908|NCT06077669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138586909|NCT06077669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138586910|NCT06077669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586911|NCT06077669|Dopamine Agents|dopamine agents|mesh-ancestor
138586912|NCT06077669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586913|NCT06077487|Ketamine|ketamine|mesh-list
138586914|NCT06077487|Analgesics|analgesics|mesh-ancestor
138586915|NCT06077487|Sensory System Agents|sensory system agents|mesh-ancestor
138586916|NCT06077487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138586917|NCT06077487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586918|NCT06077487|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138586919|NCT06077487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138586920|NCT06077487|Anesthetics, General|anesthetics, general|mesh-ancestor
138586921|NCT06077487|Anesthetics|anesthetics|mesh-ancestor
138586922|NCT06077487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138586923|NCT06077487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138586924|NCT06077487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138477652|NCT02020330|Artemether|artemether|mesh-list
138288071|NCT02369744|Tamsulosin|tamsulosin|mesh-list
138586925|NCT06077487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138586926|NCT06077487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586928|NCT06072781|Doxorubicin|doxorubicin|mesh-list
138586929|NCT06072781|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138586930|NCT06072781|Letrozole|letrozole|mesh-list
138586931|NCT06072781|Topotecan|topotecan|mesh-list
138586932|NCT06072781|Anastrozole|anastrozole|mesh-list
138586933|NCT06072781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138586934|NCT06072781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586935|NCT06072781|Tubulin Modulators|tubulin modulators|mesh-ancestor
138586936|NCT06072781|Antimitotic Agents|antimitotic agents|mesh-ancestor
138586937|NCT06072781|Mitosis Modulators|mitosis modulators|mesh-ancestor
138586938|NCT06072781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586939|NCT06072781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138586940|NCT06072781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138586941|NCT06072781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138586942|NCT06072781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586943|NCT06072781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138586944|NCT06072781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138586945|NCT06072781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138586946|NCT06072781|Hormone Antagonists|hormone antagonists|mesh-ancestor
138586947|NCT06072781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138586948|NCT06072781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586949|NCT06072781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138586950|NCT06072781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138477682|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138586951|NCT06062966|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138586952|NCT06062966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138586953|NCT06061146|Tislelizumab|tislelizumab|mesh-list
138586954|NCT06061146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138586955|NCT06061146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586956|NCT06059456|Vaccines|vaccines|mesh-list
138586957|NCT06059456|Immunologic Factors|immunologic factors|mesh-ancestor
138586958|NCT06059456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586959|NCT06055179|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138586960|NCT06055179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138586961|NCT06055179|Hormone Antagonists|hormone antagonists|mesh-ancestor
138288108|NCT00376051|Citalopram|citalopram|mesh-list
138586962|NCT06055179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138586963|NCT06055179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586964|NCT06055179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138586965|NCT06055179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138586966|NCT06055179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138586967|NCT06054815|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138586968|NCT06054815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138586969|NCT06054815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586970|NCT06054815|Incretins|incretins|mesh-ancestor
138586971|NCT06054815|Hormones|hormones|mesh-ancestor
138586972|NCT06054815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138586973|NCT06054815|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138586974|NCT06054815|Protease Inhibitors|protease inhibitors|mesh-ancestor
138586975|NCT06054815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138586976|NCT06054815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586977|NCT06015880|Lenalidomide|lenalidomide|mesh-list
138586978|NCT06015880|Antibodies|antibodies|mesh-list
138586979|NCT06015880|Immunoglobulins|immunoglobulins|mesh-list
138586980|NCT06015880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138586981|NCT06015880|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138586982|NCT06015880|Immunoconjugates|immunoconjugates|mesh-list
138586983|NCT06015880|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138586984|NCT06015880|Immunologic Factors|immunologic factors|mesh-ancestor
138586985|NCT06015880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586986|NCT06015880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138586987|NCT06015880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138586988|NCT06015880|Growth Substances|growth substances|mesh-ancestor
138586990|NCT06015880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138586991|NCT06012279|Dapagliflozin|dapagliflozin|mesh-list
138586992|NCT06012279|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138586993|NCT06012279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138586994|NCT06012279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138586995|NCT06012279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138586996|NCT06010719|Amoxicillin|amoxicillin|mesh-list
138586997|NCT06010719|Azithromycin|azithromycin|mesh-list
138586998|NCT06010719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138586999|NCT06010719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587000|NCT06002477|Mecamylamine|mecamylamine|mesh-list
138587001|NCT06002477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138661583|NCT00466518|Hormones|hormones|mesh-ancestor
138587002|NCT06002477|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138587003|NCT06002477|Autonomic Agents|autonomic agents|mesh-ancestor
138587004|NCT06002477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587005|NCT06002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477778|NCT02021240|Analgesics|analgesics|mesh-ancestor
138587006|NCT06002477|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138263366|NCT01977781|Hormones|hormones|mesh-ancestor
138587007|NCT06002477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138587008|NCT06002477|Cholinergic Agents|cholinergic agents|mesh-ancestor
138587009|NCT06002477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587010|NCT06002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587011|NCT05979311|Tenofovir|tenofovir|mesh-list
138587012|NCT05979311|Lamivudine|lamivudine|mesh-list
138587013|NCT05979311|Emtricitabine|emtricitabine|mesh-list
138587014|NCT05979311|Dolutegravir|dolutegravir|mesh-list
138587015|NCT05979311|Antiviral Agents|antiviral agents|mesh-ancestor
138587016|NCT05979311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587017|NCT05979311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138587018|NCT05979311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138587019|NCT05979311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587020|NCT05979311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587021|NCT05979311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138587022|NCT05979311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138587023|NCT05979311|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138587024|NCT05979311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138587025|NCT05976347|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138587026|NCT05976347|Fluoxetine|fluoxetine|mesh-list
138587027|NCT05976347|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138587028|NCT05976347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138587029|NCT05976347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138477822|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
138288178|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138288179|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587030|NCT05976347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587031|NCT05976347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587032|NCT05976347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587034|NCT05976347|Sensory System Agents|sensory system agents|mesh-ancestor
138587035|NCT05976347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481604|NCT00006054|Prednisone|prednisone|mesh-list
138587036|NCT05976347|Antidepressive Agents|antidepressive agents|mesh-ancestor
138587037|NCT05976347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138587038|NCT05976347|Dopamine Agents|dopamine agents|mesh-ancestor
138587039|NCT05976347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138587040|NCT05976347|Serotonin Agents|serotonin agents|mesh-ancestor
138587041|NCT05976347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138587042|NCT05976347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138587043|NCT05976347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138587044|NCT05976347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587045|NCT05969431|Hydrocortisone|hydrocortisone|mesh-list
138587046|NCT05969431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138587047|NCT05968612|Ivacaftor|ivacaftor|mesh-list
138587048|NCT05968612|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138587049|NCT05968612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138587050|NCT05968612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587051|NCT05938530|Sirolimus|sirolimus|mesh-list
138587052|NCT05938530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138288216|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138288217|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
138587053|NCT05938530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587054|NCT05938530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138587055|NCT05938530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587056|NCT05938530|Antifungal Agents|antifungal agents|mesh-ancestor
138587057|NCT05938530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138587058|NCT05938530|Immunologic Factors|immunologic factors|mesh-ancestor
138587059|NCT05938530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587060|NCT05935202|Mitapivat|mitapivat|mesh-list
138587061|NCT05935202|Enzyme Activators|enzyme activators|mesh-ancestor
138587062|NCT05935202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587063|NCT05931393|Nivolumab|nivolumab|mesh-list
138477872|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138587064|NCT05931393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587065|NCT05931393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587066|NCT05931393|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138587067|NCT05931393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587068|NCT05923996|Botulinum Toxins|botulinum toxins|mesh-list
138587069|NCT05923996|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138587070|NCT05923996|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138587071|NCT05923996|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138587072|NCT05923996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138288265|NCT00843986|Conivaptan|conivaptan|mesh-list
138587073|NCT05923996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587074|NCT05923996|Cholinergic Agents|cholinergic agents|mesh-ancestor
138587075|NCT05923996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587076|NCT05923996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587077|NCT05923996|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138587078|NCT05923996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587079|NCT05919823|Xanomeline|xanomeline|mesh-list
138587080|NCT05919823|Trospium chloride|trospium chloride|mesh-list
138587081|NCT05919823|Parasympatholytics|parasympatholytics|mesh-ancestor
138587082|NCT05919823|Autonomic Agents|autonomic agents|mesh-ancestor
138587083|NCT05919823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587084|NCT05919823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587085|NCT05919823|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138587086|NCT05919823|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138587087|NCT05919823|Cholinergic Agents|cholinergic agents|mesh-ancestor
138587088|NCT05919823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587089|NCT05919823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587090|NCT05919823|Urological Agents|urological agents|mesh-ancestor
138587091|NCT05919823|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138587092|NCT05919823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138587093|NCT05919823|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138587094|NCT05919823|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138587095|NCT05911906|Remdesivir|remdesivir|mesh-list
138587096|NCT05911906|Antimetabolites|antimetabolites|mesh-ancestor
138587097|NCT05911906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587099|NCT05911906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587100|NCT05907304|Trametinib|trametinib|mesh-list
138587101|NCT05907304|Naporafenib|naporafenib|mesh-list
138587102|NCT05907304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661623|NCT00458250|Busulfan|busulfan|mesh-list
138587103|NCT05907304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138587104|NCT05907304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587105|NCT05907304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587106|NCT05896228|Acetaminophen|acetaminophen|mesh-list
138288321|NCT03545893|Ibuprofen|ibuprofen|mesh-list
138587107|NCT05896228|Diphenhydramine|diphenhydramine|mesh-list
138587108|NCT05896228|Promethazine|promethazine|mesh-list
138587109|NCT05896228|Dexamethasone|dexamethasone|mesh-list
138587110|NCT05896228|Daratumumab|daratumumab|mesh-list
138587111|NCT05896228|Montelukast|montelukast|mesh-list
138587112|NCT05896228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138587113|NCT05896228|Antiemetics|antiemetics|mesh-ancestor
138587114|NCT05896228|Autonomic Agents|autonomic agents|mesh-ancestor
138587115|NCT05896228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587116|NCT05896228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587117|NCT05896228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138587118|NCT05896228|Glucocorticoids|glucocorticoids|mesh-ancestor
138587119|NCT05896228|Hormones|hormones|mesh-ancestor
138587120|NCT05896228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138587121|NCT05896228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138587122|NCT05896228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587123|NCT05896228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138587125|NCT05896228|Sensory System Agents|sensory system agents|mesh-ancestor
138587126|NCT05896228|Antipyretics|antipyretics|mesh-ancestor
138587127|NCT05896228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138587128|NCT05896228|Respiratory System Agents|respiratory system agents|mesh-ancestor
138587129|NCT05896228|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138587130|NCT05896228|Hormone Antagonists|hormone antagonists|mesh-ancestor
138587131|NCT05896228|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138587132|NCT05896228|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138587133|NCT05896228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587134|NCT05896228|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138587135|NCT05896228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138587136|NCT05896228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138587137|NCT05896228|Anesthetics, Local|anesthetics, local|mesh-ancestor
138587138|NCT05896228|Anesthetics|anesthetics|mesh-ancestor
138587139|NCT05896228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138288355|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288356|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138587140|NCT05896228|Histamine Antagonists|histamine antagonists|mesh-ancestor
138587141|NCT05896228|Histamine Agents|histamine agents|mesh-ancestor
138587142|NCT05896228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587143|NCT05896228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138587144|NCT05896228|Antipruritics|antipruritics|mesh-ancestor
138587145|NCT05896228|Dermatologic Agents|dermatologic agents|mesh-ancestor
138587163|NCT05875701|Vaccines|vaccines|mesh-list
138481641|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
138587164|NCT05875701|Immunologic Factors|immunologic factors|mesh-ancestor
138587165|NCT05875701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587166|NCT05851898|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138587167|NCT05851898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138587168|NCT05851898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138587169|NCT05851898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138587170|NCT05851898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587171|NCT05851898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587174|NCT05851898|Sensory System Agents|sensory system agents|mesh-ancestor
138587175|NCT05851898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587176|NCT05851898|Antidepressive Agents|antidepressive agents|mesh-ancestor
138587177|NCT05851898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138587178|NCT05851898|Dopamine Agents|dopamine agents|mesh-ancestor
138587179|NCT05839314|Cyclosporine|cyclosporine|mesh-list
138587180|NCT05839314|Cyclosporins|cyclosporins|mesh-list
138587181|NCT05839314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587182|NCT05839314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587183|NCT05839314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138587184|NCT05839314|Immunologic Factors|immunologic factors|mesh-ancestor
138587185|NCT05839314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587186|NCT05839314|Antifungal Agents|antifungal agents|mesh-ancestor
138587187|NCT05839314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587188|NCT05839314|Dermatologic Agents|dermatologic agents|mesh-ancestor
138587189|NCT05839314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138587190|NCT05839314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138587191|NCT05823532|Infliximab|infliximab|mesh-list
138587192|NCT05823532|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138587193|NCT05823532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138587194|NCT05823532|Dermatologic Agents|dermatologic agents|mesh-ancestor
138288394|NCT05286554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587195|NCT05823532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138587196|NCT05823532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138587197|NCT05822765|Epinephrine|epinephrine|mesh-list
138587198|NCT05822765|Racepinephrine|racepinephrine|mesh-list
138587199|NCT05822765|Epinephryl borate|epinephryl borate|mesh-list
138587200|NCT05822765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138478043|NCT02023021|Paclitaxel|paclitaxel|mesh-list
138587201|NCT05822765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138587202|NCT05822765|Adrenergic Agents|adrenergic agents|mesh-ancestor
138587203|NCT05822765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587204|NCT05822765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661670|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587205|NCT05822765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587206|NCT05822765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138587207|NCT05822765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138587208|NCT05822765|Autonomic Agents|autonomic agents|mesh-ancestor
138587209|NCT05822765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587210|NCT05822765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138587211|NCT05822765|Respiratory System Agents|respiratory system agents|mesh-ancestor
138587212|NCT05822765|Mydriatics|mydriatics|mesh-ancestor
138288430|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138288432|NCT00795236|Melatonin|melatonin|mesh-list
138587213|NCT05822765|Sympathomimetics|sympathomimetics|mesh-ancestor
138587214|NCT05822765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138587215|NCT05822752|Sorafenib|sorafenib|mesh-list
138587216|NCT05822752|Lenvatinib|lenvatinib|mesh-list
138587217|NCT05822752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587218|NCT05822752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138587219|NCT05822752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587220|NCT05822752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587221|NCT05805436|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138587222|NCT05805436|Laxatives|laxatives|mesh-ancestor
138587223|NCT05805436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138587224|NCT05780281|Remdesivir|remdesivir|mesh-list
138587225|NCT05780281|Sotrovimab|sotrovimab|mesh-list
138587226|NCT05780281|Antimetabolites|antimetabolites|mesh-ancestor
138587227|NCT05780281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587228|NCT05780281|Antiviral Agents|antiviral agents|mesh-ancestor
138587229|NCT05780281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587230|NCT05780268|Remdesivir|remdesivir|mesh-list
138587231|NCT05780268|Bamlanivimab|bamlanivimab|mesh-list
138587232|NCT05780268|Antimetabolites|antimetabolites|mesh-ancestor
138263583|NCT01982539|Analgesics|analgesics|mesh-ancestor
138587233|NCT05780268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587234|NCT05780268|Antiviral Agents|antiviral agents|mesh-ancestor
138587235|NCT05780268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587236|NCT05776953|Ketorolac|ketorolac|mesh-list
138587237|NCT05776953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138661708|NCT00354146|Tipifarnib|tipifarnib|mesh-list
138587238|NCT05776953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138587239|NCT05776953|Analgesics|analgesics|mesh-ancestor
138587240|NCT05776953|Sensory System Agents|sensory system agents|mesh-ancestor
138587241|NCT05776953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587242|NCT05776953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587243|NCT05776953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138587244|NCT05776953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138587245|NCT05776953|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138587246|NCT05776953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587247|NCT05776953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587248|NCT05753735|Amoxicillin|amoxicillin|mesh-list
138587249|NCT05753735|Tazobactam|tazobactam|mesh-list
138587250|NCT05753735|Piperacillin|piperacillin|mesh-list
138587251|NCT05753735|Clavulanic Acids|clavulanic acids|mesh-list
138587252|NCT05753735|Clavulanic Acid|clavulanic acid|mesh-list
138587253|NCT05753735|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138587254|NCT05753735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138587255|NCT05753735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587256|NCT05753735|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138587257|NCT05753735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587258|NCT05753735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587259|NCT05746572|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138587260|NCT05746572|Hallucinogens|hallucinogens|mesh-ancestor
138288484|NCT05080556|Carboplatin|carboplatin|mesh-list
138587261|NCT05746572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587262|NCT05746572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138587263|NCT05746572|Serotonin Agents|serotonin agents|mesh-ancestor
138288486|NCT01797380|Escitalopram|escitalopram|mesh-list
138587264|NCT05746572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587265|NCT05746572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587266|NCT05746572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138587267|NCT05746572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138587268|NCT05746572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138587269|NCT05746572|Adrenergic Agents|adrenergic agents|mesh-ancestor
138587270|NCT05744375|Trastuzumab|trastuzumab|mesh-list
138587271|NCT05744375|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138587272|NCT05744375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587273|NCT05744375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587274|NCT05744375|Immunoconjugates|immunoconjugates|mesh-ancestor
138587275|NCT05744375|Immunologic Factors|immunologic factors|mesh-ancestor
138587276|NCT05744375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587277|NCT05726344|Lactulose|lactulose|mesh-list
138587278|NCT05726344|Bisacodyl|bisacodyl|mesh-list
138587279|NCT05726344|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138587280|NCT05726344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138587281|NCT05726344|Cathartics|cathartics|mesh-ancestor
138587282|NCT05726344|Laxatives|laxatives|mesh-ancestor
138587283|NCT05722704|Salicylic Acid|salicylic acid|mesh-list
138587284|NCT05722704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587285|NCT05722704|Antifungal Agents|antifungal agents|mesh-ancestor
138587286|NCT05722704|Keratolytic Agents|keratolytic agents|mesh-ancestor
138587287|NCT05722704|Dermatologic Agents|dermatologic agents|mesh-ancestor
138587288|NCT05721170|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138587289|NCT05721170|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138587290|NCT05721170|Adrenergic Agents|adrenergic agents|mesh-ancestor
138587292|NCT05721170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587293|NCT05721170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587294|NCT05717153|Eflornithine|eflornithine|mesh-list
138587295|NCT05717153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587296|NCT05717153|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138587297|NCT05717153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138587298|NCT05717153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138288504|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587299|NCT05717153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587300|NCT05717153|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138587301|NCT05717153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587302|NCT05717153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587303|NCT05701917|Heparin|heparin|mesh-list
138587304|NCT05701917|Calcium heparin|calcium heparin|mesh-list
138587305|NCT05701917|Rivaroxaban|rivaroxaban|mesh-list
138587306|NCT05701917|Apixaban|apixaban|mesh-list
138587307|NCT05701917|Warfarin|warfarin|mesh-list
138587308|NCT05701917|Anticoagulants|anticoagulants|mesh-ancestor
138587309|NCT05701917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138587310|NCT05701917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138587311|NCT05701917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587312|NCT05701917|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138587313|NCT05701917|Antithrombins|antithrombins|mesh-ancestor
138587314|NCT05701917|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138587315|NCT05701917|Protease Inhibitors|protease inhibitors|mesh-ancestor
138587316|NCT05701917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587317|NCT05699408|Insulin Glargine|insulin glargine|mesh-list
138587318|NCT05699408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138587319|NCT05699408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587321|NCT05673811|Gemcitabine|gemcitabine|mesh-list
138587322|NCT05673811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138587323|NCT05673811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587324|NCT05673811|Tubulin Modulators|tubulin modulators|mesh-ancestor
138587325|NCT05673811|Antimitotic Agents|antimitotic agents|mesh-ancestor
138587326|NCT05673811|Mitosis Modulators|mitosis modulators|mesh-ancestor
138587327|NCT05673811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587328|NCT05673811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138587329|NCT05673811|Antimetabolites|antimetabolites|mesh-ancestor
138587330|NCT05663905|Ambroxol|ambroxol|mesh-list
138587331|NCT05663905|Expectorants|expectorants|mesh-ancestor
138587332|NCT05663905|Respiratory System Agents|respiratory system agents|mesh-ancestor
138587333|NCT05661357|Disitamab vedotin|disitamab vedotin|mesh-list
138587334|NCT05661357|Immunoconjugates|immunoconjugates|mesh-ancestor
138587335|NCT05661357|Immunologic Factors|immunologic factors|mesh-ancestor
138288546|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
138288549|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
138587336|NCT05661357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587337|NCT05581706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138587338|NCT05581706|Calcium|calcium|mesh-list
138587339|NCT05581706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138587340|NCT05581706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587341|NCT05581706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587343|NCT05553938|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138587344|NCT05553938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587345|NCT05553938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138481668|NCT00006078|Lycopene|lycopene|mesh-list
138587347|NCT05549037|Immunomodulating Agents|immunomodulating agents|mesh-list
138587348|NCT05549037|Immunologic Factors|immunologic factors|mesh-ancestor
138587349|NCT05549037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587351|NCT05548582|Ibuprofen|ibuprofen|mesh-list
138587352|NCT05548582|Oxycodone|oxycodone|mesh-list
138587353|NCT05548582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138587354|NCT05548582|Analgesics|analgesics|mesh-ancestor
138587355|NCT05548582|Sensory System Agents|sensory system agents|mesh-ancestor
138587356|NCT05548582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587357|NCT05548582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587358|NCT05548582|Antipyretics|antipyretics|mesh-ancestor
138587359|NCT05548582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138587360|NCT05548582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138587361|NCT05548582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138587362|NCT05548582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138587363|NCT05548582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587364|NCT05548582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587365|NCT05548582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138587366|NCT05548582|Narcotics|narcotics|mesh-ancestor
138587367|NCT05548582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138587368|NCT05532241|Chlorhexidine|chlorhexidine|mesh-list
138587369|NCT05532241|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138587370|NCT05532241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587371|NCT05532241|Disinfectants|disinfectants|mesh-ancestor
138587373|NCT05514912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138587374|NCT05514912|Cisplatin|cisplatin|mesh-list
138587375|NCT05514912|Gemcitabine|gemcitabine|mesh-list
138587376|NCT05514912|Infigratinib|infigratinib|mesh-list
138587377|NCT05514912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138587378|NCT05514912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587379|NCT05514912|Tubulin Modulators|tubulin modulators|mesh-ancestor
138587380|NCT05514912|Antimitotic Agents|antimitotic agents|mesh-ancestor
138587381|NCT05514912|Mitosis Modulators|mitosis modulators|mesh-ancestor
138587382|NCT05514912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263732|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587383|NCT05514912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138587384|NCT05514912|Antimetabolites|antimetabolites|mesh-ancestor
138587385|NCT05514535|Insulin Glargine|insulin glargine|mesh-list
138587386|NCT05514535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138587387|NCT05514535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587388|NCT05514509|Cabotegravir|cabotegravir|mesh-list
138587389|NCT05514509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138587390|NCT05514509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138587391|NCT05514509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587392|NCT05514509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587393|NCT05514509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138587394|NCT05514509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138587395|NCT05514509|Antiviral Agents|antiviral agents|mesh-ancestor
138587396|NCT05514509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587398|NCT05512819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138587399|NCT05512819|Immunologic Factors|immunologic factors|mesh-ancestor
138587400|NCT05512819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587401|NCT05511337|Citric Acid|citric acid|mesh-list
138587402|NCT05511337|Sodium Citrate|sodium citrate|mesh-list
138587403|NCT05511337|Anticoagulants|anticoagulants|mesh-ancestor
138587404|NCT05511337|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138587405|NCT05511337|Chelating Agents|chelating agents|mesh-ancestor
138587406|NCT05511337|Sequestering Agents|sequestering agents|mesh-ancestor
138587407|NCT05511337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587409|NCT05511025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138587410|NCT05511025|Analgesics|analgesics|mesh-ancestor
138587411|NCT05511025|Sensory System Agents|sensory system agents|mesh-ancestor
138481690|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481695|NCT00006105|Gemcitabine|gemcitabine|mesh-list
138587412|NCT05511025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288630|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
138587413|NCT05511025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587414|NCT05511025|Antipyretics|antipyretics|mesh-ancestor
138587415|NCT05485103|Glycerol|glycerol|mesh-list
138587416|NCT05485103|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138587417|NCT05485103|Protective Agents|protective agents|mesh-ancestor
138587418|NCT05485103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587419|NCT05483933|Doxorubicin|doxorubicin|mesh-list
138587420|NCT05483933|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138587421|NCT05483933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138587422|NCT05483933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587423|NCT05483933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138587424|NCT05483933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138587425|NCT05483933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587426|NCT05483933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587427|NCT05439616|Cariprazine|cariprazine|mesh-list
138587428|NCT05439616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138478428|NCT02025166|Lornoxicam|lornoxicam|mesh-list
138587429|NCT05439616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138587430|NCT05439616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138587431|NCT05439616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587432|NCT05439616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138587433|NCT05375305|Morphine|morphine|mesh-list
138587434|NCT05375305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138587435|NCT05375305|Narcotics|narcotics|mesh-ancestor
138587436|NCT05375305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138587437|NCT05375305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587438|NCT05375305|Analgesics|analgesics|mesh-ancestor
138587439|NCT05375305|Sensory System Agents|sensory system agents|mesh-ancestor
138587440|NCT05375305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587441|NCT05374525|Cabotegravir|cabotegravir|mesh-list
138587442|NCT05374525|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138587443|NCT05374525|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138587444|NCT05374525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587445|NCT05374525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587446|NCT05374525|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138587447|NCT05374525|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138587448|NCT05374525|Antiviral Agents|antiviral agents|mesh-ancestor
138587449|NCT05374525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587450|NCT05371093|Prednisone|prednisone|mesh-list
138587451|NCT05371093|Cyclophosphamide|cyclophosphamide|mesh-list
138587452|NCT05371093|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138587453|NCT05371093|Rituximab|rituximab|mesh-list
138587454|NCT05371093|Doxorubicin|doxorubicin|mesh-list
138587455|NCT05371093|Fludarabine|fludarabine|mesh-list
138587456|NCT05371093|Vincristine|vincristine|mesh-list
138587457|NCT05371093|Lenalidomide|lenalidomide|mesh-list
138587458|NCT05371093|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138587459|NCT05371093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138263813|NCT02059213|Palbociclib|palbociclib|mesh-list
138288659|NCT01705106|Capecitabine|capecitabine|mesh-list
138587460|NCT05371093|Immunologic Factors|immunologic factors|mesh-ancestor
138481702|NCT00006105|Protective Agents|protective agents|mesh-ancestor
138587461|NCT05371093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587462|NCT05371093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138587463|NCT05371093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138587464|NCT05371093|Alkylating Agents|alkylating agents|mesh-ancestor
138587465|NCT05371093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587466|NCT05371093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587467|NCT05371093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138587468|NCT05371093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587469|NCT05371093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138587470|NCT05371093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138587471|NCT05371093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138587472|NCT05371093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587473|NCT05371093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138587474|NCT05371093|Glucocorticoids|glucocorticoids|mesh-ancestor
138587475|NCT05371093|Hormones|hormones|mesh-ancestor
138587476|NCT05371093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138587477|NCT05371093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138587478|NCT05371093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138587479|NCT05371093|Tubulin Modulators|tubulin modulators|mesh-ancestor
138587480|NCT05371093|Antimitotic Agents|antimitotic agents|mesh-ancestor
138587481|NCT05371093|Mitosis Modulators|mitosis modulators|mesh-ancestor
138587482|NCT05371093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138587483|NCT05371093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138587484|NCT05371093|Growth Substances|growth substances|mesh-ancestor
138587485|NCT05371093|Growth Inhibitors|growth inhibitors|mesh-ancestor
138587487|NCT05339529|Thymalfasin|thymalfasin|mesh-list
138587488|NCT05339529|Glycine Agents|glycine agents|mesh-ancestor
138587489|NCT05339529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587490|NCT05339529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587491|NCT05339529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587492|NCT05339529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138587493|NCT05339529|Immunologic Factors|immunologic factors|mesh-ancestor
138587494|NCT05332457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138587495|NCT05332457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138587496|NCT05332457|Adrenergic Agents|adrenergic agents|mesh-ancestor
138587497|NCT05332457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587498|NCT05332457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587499|NCT05332457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587500|NCT05329740|Methylprednisolone|methylprednisolone|mesh-list
138587501|NCT05329740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138288688|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
138587502|NCT05329740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138587503|NCT05329740|Prednisolone|prednisolone|mesh-list
138587504|NCT05329740|Prednisolone acetate|prednisolone acetate|mesh-list
138587505|NCT05329740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138587506|NCT05329740|Prednisolone phosphate|prednisolone phosphate|mesh-list
138587507|NCT05329740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138587508|NCT05329740|Antiemetics|antiemetics|mesh-ancestor
138587509|NCT05329740|Autonomic Agents|autonomic agents|mesh-ancestor
138587510|NCT05329740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587511|NCT05329740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587512|NCT05329740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138587513|NCT05329740|Glucocorticoids|glucocorticoids|mesh-ancestor
138587514|NCT05329740|Hormones|hormones|mesh-ancestor
138587515|NCT05329740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138587516|NCT05329740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138587517|NCT05329740|Protective Agents|protective agents|mesh-ancestor
138587518|NCT05329740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138587519|NCT05329740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587520|NCT05324748|Methylprednisolone|methylprednisolone|mesh-list
138587521|NCT05324748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138587522|NCT05324748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138587523|NCT05324748|Prednisolone|prednisolone|mesh-list
138587524|NCT05324748|Prednisolone acetate|prednisolone acetate|mesh-list
138587525|NCT05324748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138587526|NCT05324748|Prednisolone phosphate|prednisolone phosphate|mesh-list
138587527|NCT05324748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138587528|NCT05324748|Antiemetics|antiemetics|mesh-ancestor
138587529|NCT05324748|Autonomic Agents|autonomic agents|mesh-ancestor
138587530|NCT05324748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587531|NCT05324748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587532|NCT05324748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138587533|NCT05324748|Glucocorticoids|glucocorticoids|mesh-ancestor
138587534|NCT05324748|Hormones|hormones|mesh-ancestor
138587535|NCT05324748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138587536|NCT05324748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138587537|NCT05324748|Protective Agents|protective agents|mesh-ancestor
138587538|NCT05324748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138587539|NCT05324748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587540|NCT05318443|Paclitaxel|paclitaxel|mesh-list
138587541|NCT05318443|Carboplatin|carboplatin|mesh-list
138587542|NCT05318443|Bevacizumab|bevacizumab|mesh-list
138587543|NCT05318443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138587544|NCT05318443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587545|NCT05318443|Tubulin Modulators|tubulin modulators|mesh-ancestor
138587546|NCT05318443|Antimitotic Agents|antimitotic agents|mesh-ancestor
138587547|NCT05318443|Mitosis Modulators|mitosis modulators|mesh-ancestor
138587548|NCT05318443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587549|NCT05318443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587550|NCT05318443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138587551|NCT05318443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138587552|NCT05318443|Growth Substances|growth substances|mesh-ancestor
138587553|NCT05318443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587554|NCT05318443|Growth Inhibitors|growth inhibitors|mesh-ancestor
138587555|NCT05302388|Diphenhydramine|diphenhydramine|mesh-list
138587556|NCT05302388|Promethazine|promethazine|mesh-list
138587557|NCT05302388|Dexamethasone|dexamethasone|mesh-list
138661863|NCT00426101|Cyclosporine|cyclosporine|mesh-list
138587559|NCT05302388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138587561|NCT05302388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138587562|NCT05302388|Prednisolone acetate|prednisolone acetate|mesh-list
138587563|NCT05302388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138587564|NCT05302388|Prednisolone phosphate|prednisolone phosphate|mesh-list
138587565|NCT05302388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138587566|NCT05302388|Antiemetics|antiemetics|mesh-ancestor
138587567|NCT05302388|Autonomic Agents|autonomic agents|mesh-ancestor
138587568|NCT05302388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478612|NCT02026219|Ticagrelor|ticagrelor|mesh-list
138587569|NCT05302388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587570|NCT05302388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138587571|NCT05302388|Glucocorticoids|glucocorticoids|mesh-ancestor
138587573|NCT05302388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138587574|NCT05302388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138587575|NCT05302388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587576|NCT05302388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138587577|NCT05302388|Protective Agents|protective agents|mesh-ancestor
138481734|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587578|NCT05302388|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138587579|NCT05302388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138587580|NCT05302388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138587581|NCT05302388|Anesthetics, Local|anesthetics, local|mesh-ancestor
138587582|NCT05302388|Anesthetics|anesthetics|mesh-ancestor
138587583|NCT05302388|Sensory System Agents|sensory system agents|mesh-ancestor
138587584|NCT05302388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138587585|NCT05302388|Histamine Antagonists|histamine antagonists|mesh-ancestor
138587586|NCT05302388|Histamine Agents|histamine agents|mesh-ancestor
138587587|NCT05302388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587588|NCT05302388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587589|NCT05302388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138587590|NCT05302388|Antipruritics|antipruritics|mesh-ancestor
138587591|NCT05302388|Dermatologic Agents|dermatologic agents|mesh-ancestor
138587592|NCT05300594|Vitamins|vitamins|mesh-list
138587593|NCT05300594|Micronutrients|micronutrients|mesh-ancestor
138587594|NCT05300594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587595|NCT05266846|Bevacizumab|bevacizumab|mesh-list
138587596|NCT05266846|Pembrolizumab|pembrolizumab|mesh-list
138587597|NCT05266846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587598|NCT05266846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288749|NCT00378716|Tegafur|tegafur|mesh-list
138288750|NCT00378716|Calcium|calcium|mesh-list
138587599|NCT05266846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138587600|NCT05266846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138587601|NCT05266846|Growth Substances|growth substances|mesh-ancestor
138587602|NCT05266846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587634|NCT05254002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138587635|NCT05254002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587636|NCT05254002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138587637|NCT05254002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587638|NCT05236647|Morphine|morphine|mesh-list
138587639|NCT05236647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138587640|NCT05236647|Narcotics|narcotics|mesh-ancestor
138288774|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587641|NCT05236647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138587642|NCT05236647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587643|NCT05236647|Analgesics|analgesics|mesh-ancestor
138587644|NCT05236647|Sensory System Agents|sensory system agents|mesh-ancestor
138587645|NCT05236647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587646|NCT05220722|Pembrolizumab|pembrolizumab|mesh-list
138587647|NCT05220722|Nivolumab|nivolumab|mesh-list
138587648|NCT05220722|Ipilimumab|ipilimumab|mesh-list
138587649|NCT05220722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587650|NCT05220722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587651|NCT05220722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138587652|NCT05220722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587653|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
138587654|NCT05201638|Calcium|calcium|mesh-list
138587655|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138587656|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587657|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138587658|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
138587659|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138587660|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138587661|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587662|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
138587663|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
138587664|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587665|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138587666|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138587667|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
138587668|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138478704|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
138587669|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587670|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138587671|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138587672|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138587673|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
138587674|NCT05134441|Calcium|calcium|mesh-list
138587675|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138587676|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587677|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138587678|NCT05131828|Metformin|metformin|mesh-list
138587679|NCT05131828|Clemastine|clemastine|mesh-list
138587680|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138587681|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587682|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
138587683|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
138587684|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138587685|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
138587686|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
138288833|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587687|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587688|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587689|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138587690|NCT05127980|Antibodies|antibodies|mesh-list
138587691|NCT05127980|Autoantibodies|autoantibodies|mesh-list
138587692|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
138587693|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587694|NCT05114837|Cyclophosphamide|cyclophosphamide|mesh-list
138587695|NCT05114837|Fludarabine|fludarabine|mesh-list
138587696|NCT05114837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138587697|NCT05114837|Immunologic Factors|immunologic factors|mesh-ancestor
138587698|NCT05114837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587699|NCT05114837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138587700|NCT05114837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138587701|NCT05114837|Alkylating Agents|alkylating agents|mesh-ancestor
138587702|NCT05114837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587703|NCT05114837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587704|NCT05114837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138587706|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
138587707|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138587708|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
138587709|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587710|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138587711|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138587712|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
138587713|NCT05089916|Osimertinib|osimertinib|mesh-list
138587714|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587715|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138587716|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138288859|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
138288860|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138587717|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587718|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
138587719|NCT05060432|Dostarlimab|dostarlimab|mesh-list
138587720|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587721|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587722|NCT05060432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138587723|NCT05060432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587724|NCT05041907|Ritonavir|ritonavir|mesh-list
138587725|NCT05041907|Hydroxychloroquine|hydroxychloroquine|mesh-list
138587726|NCT05041907|Ivermectin|ivermectin|mesh-list
138587727|NCT05041907|Nitazoxanide|nitazoxanide|mesh-list
138587728|NCT05041907|Remdesivir|remdesivir|mesh-list
138587729|NCT05041907|Favipiravir|favipiravir|mesh-list
138587730|NCT05041907|Nirmatrelvir|nirmatrelvir|mesh-list
138587731|NCT05041907|Sotrovimab|sotrovimab|mesh-list
138587732|NCT05041907|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
138587733|NCT05041907|Molnupiravir|molnupiravir|mesh-list
138587734|NCT05041907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138587735|NCT05041907|Fluoxetine|fluoxetine|mesh-list
138587736|NCT05041907|Antibodies|antibodies|mesh-list
138587737|NCT05041907|Immunoglobulins|immunoglobulins|mesh-list
138587738|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138587739|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
138587740|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587741|NCT05041907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587742|NCT05041907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138587743|NCT05041907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138587744|NCT05041907|Protease Inhibitors|protease inhibitors|mesh-ancestor
138587745|NCT05041907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587746|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587747|NCT05041907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138587748|NCT05041907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138587749|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
138587750|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587751|NCT05041907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138587752|NCT05041907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138587753|NCT05041907|Antimalarials|antimalarials|mesh-ancestor
138587754|NCT05041907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138587755|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138288900|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138587756|NCT05041907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138587757|NCT05041907|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138587758|NCT05041907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138587759|NCT05041907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138587760|NCT05041907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587761|NCT05041907|Serotonin Agents|serotonin agents|mesh-ancestor
138587762|NCT05041907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138478831|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138587763|NCT05041907|Antidepressive Agents|antidepressive agents|mesh-ancestor
138587764|NCT05041907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138587765|NCT05041907|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138587766|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
138661937|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587768|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138587769|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587770|NCT04965506|Dulaglutide|dulaglutide|mesh-list
138587771|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138587772|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587773|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138587774|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138587775|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138587776|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587777|NCT04963283|Nivolumab|nivolumab|mesh-list
138587778|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587779|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318161|NCT01465386|Bortezomib|bortezomib|mesh-list
138587780|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138587781|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587782|NCT04951947|Lenvatinib|lenvatinib|mesh-list
138587783|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587784|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138587785|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587786|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587787|NCT04935229|Nivolumab|nivolumab|mesh-list
138587788|NCT04935229|Ipilimumab|ipilimumab|mesh-list
138587789|NCT04935229|Relatlimab|relatlimab|mesh-list
138587790|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587791|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587792|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138587793|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587794|NCT04924062|Cisplatin|cisplatin|mesh-list
138587795|NCT04924062|Gemcitabine|gemcitabine|mesh-list
138587796|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
138587797|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587798|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138587799|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
138587800|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587801|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138288935|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138587802|NCT04924062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138587803|NCT04912856|Ezogabine|ezogabine|mesh-list
138587804|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
138587805|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138587806|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587807|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
138587808|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
138587809|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587810|NCT04898023|Protective Agents|protective agents|mesh-ancestor
138587811|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587812|NCT04898023|Vitamins|vitamins|mesh-ancestor
138587813|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
138587814|NCT04886323|Itraconazole|itraconazole|mesh-list
138587815|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
138587816|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587817|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138587818|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138587819|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587820|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587821|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138587822|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
138587823|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138587824|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587825|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138587826|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
138587827|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138587828|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
138587829|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587830|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
138587831|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
138587832|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587833|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
138587834|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138587835|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587836|NCT04859465|Doxorubicin|doxorubicin|mesh-list
138587837|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138587838|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138587839|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138478912|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
138587840|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587841|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138587842|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138288959|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138587843|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587844|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587845|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
138587846|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587847|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587848|NCT04857164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138587849|NCT04857164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587850|NCT04826484|Bupivacaine|bupivacaine|mesh-list
138587851|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
138587852|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
138587853|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138587854|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587855|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
138587856|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138587857|NCT04818216|Niacinamide|niacinamide|mesh-list
138587859|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
138587860|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
138587861|NCT04818216|Vitamins|vitamins|mesh-ancestor
138587862|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
138587863|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587864|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138587865|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
138587866|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587867|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138587868|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
138587869|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
138587870|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587871|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587872|NCT04768686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138587873|NCT04768686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587874|NCT04756505|Interleukin-12|interleukin-12|mesh-list
138587875|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
138661989|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138587876|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138587877|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
138587878|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587879|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138587880|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138587881|NCT04756505|Growth Substances|growth substances|mesh-ancestor
138478968|NCT02028507|Exemestane|exemestane|mesh-list
138587882|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
138587883|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138288990|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288991|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
138587884|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138587885|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138587886|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587887|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587888|NCT04742023|Insulin|insulin|mesh-list
138587889|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138587890|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587891|NCT04739761|Trastuzumab|trastuzumab|mesh-list
138587892|NCT04739761|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138587893|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587894|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587895|NCT04739761|Immunoconjugates|immunoconjugates|mesh-ancestor
138587896|NCT04739761|Immunologic Factors|immunologic factors|mesh-ancestor
138587897|NCT04739761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587898|NCT04737187|Trifluridine|trifluridine|mesh-list
138587899|NCT04737187|Bevacizumab|bevacizumab|mesh-list
138587900|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587901|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587902|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138587903|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138587904|NCT04737187|Growth Substances|growth substances|mesh-ancestor
138587905|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587906|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
138587907|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
138587908|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587909|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
138587910|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138587911|NCT04708054|Fludarabine|fludarabine|mesh-list
138587912|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
138587913|NCT04708054|Busulfan|busulfan|mesh-list
138587914|NCT04708054|Venetoclax|venetoclax|mesh-list
138587915|NCT04708054|Thiotepa|thiotepa|mesh-list
138587916|NCT04708054|Cladribine|cladribine|mesh-list
138587917|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
138587918|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587919|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138587920|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
138478983|NCT02028533|Oxytocin|oxytocin|mesh-list
138587921|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587922|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138587923|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
138587924|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587925|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
138587926|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138587927|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138587928|NCT04635423|Vaccines|vaccines|mesh-list
138587929|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
138587930|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587931|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138587932|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587933|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587934|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587935|NCT04565483|Benralizumab|benralizumab|mesh-list
138587936|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138587937|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
138587938|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138587939|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138587940|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138587941|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138587942|NCT04542278|Prednisone|prednisone|mesh-list
138587943|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138587944|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
138587945|NCT04542278|Hormones|hormones|mesh-ancestor
138587946|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138587947|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587948|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138587949|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587950|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
138587951|NCT04535401|Leucovorin|leucovorin|mesh-list
138587952|NCT04535401|Folic Acid|folic acid|mesh-list
138587953|NCT04535401|Fluorouracil|fluorouracil|mesh-list
138587954|NCT04535401|Irinotecan|irinotecan|mesh-list
138587955|NCT04535401|Camptothecin|camptothecin|mesh-list
138587956|NCT04535401|Calcium|calcium|mesh-list
138587957|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
138587958|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138587959|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587960|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138587961|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
138587962|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138587963|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138587964|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587965|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138587967|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138587968|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138587969|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138587970|NCT04535401|Antidotes|antidotes|mesh-ancestor
138587971|NCT04535401|Protective Agents|protective agents|mesh-ancestor
138587972|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
138587973|NCT04535401|Vitamins|vitamins|mesh-ancestor
138587974|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
138587975|NCT04535401|Hematinics|hematinics|mesh-ancestor
138587976|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138587977|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
138587978|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138587979|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289043|NCT03663283|Bupivacaine|bupivacaine|mesh-list
138289044|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
138289065|NCT00484718|Celecoxib|celecoxib|mesh-list
138587980|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138587981|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587982|NCT04486352|Bevacizumab|bevacizumab|mesh-list
138587983|NCT04486352|Trastuzumab|trastuzumab|mesh-list
138587984|NCT04486352|Atezolizumab|atezolizumab|mesh-list
138587985|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138587986|NCT04486352|Letrozole|letrozole|mesh-list
138587987|NCT04486352|Maytansine|maytansine|mesh-list
138587988|NCT04486352|Talazoparib|talazoparib|mesh-list
138587990|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138587991|NCT04486352|Inavolisib|inavolisib|mesh-list
138587992|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138587993|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138587994|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138587995|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138587996|NCT04486352|Growth Substances|growth substances|mesh-ancestor
138587997|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138587998|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
138587999|NCT04486352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588000|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588001|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
138588002|NCT04486352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138588003|NCT04486352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138588004|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588005|NCT04486352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138588006|NCT04486352|Hormone Antagonists|hormone antagonists|mesh-ancestor
138588007|NCT04486352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138588008|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138588009|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588010|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
138588011|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588012|NCT04486352|Immunotoxins|immunotoxins|mesh-ancestor
138588014|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138588015|NCT04486352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588016|NCT04486352|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138588017|NCT04468360|Pregnanolone|pregnanolone|mesh-list
138588018|NCT04468360|Brexanolone|brexanolone|mesh-list
138588019|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
138588020|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138588021|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588022|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
138588023|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138588024|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588025|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
138588026|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
138588028|NCT04466618|Calcium heparin|calcium heparin|mesh-list
138588029|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138588030|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
138588031|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138588032|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138588033|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588034|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138588035|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138588036|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138588037|NCT04460326|Insulin|insulin|mesh-list
138588038|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138588039|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
138588040|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
138588041|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138479075|NCT02029118|Ramipril|ramipril|mesh-list
138588042|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588043|NCT04458610|Rituximab|rituximab|mesh-list
138588044|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138588045|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
138588046|NCT04458610|Antibodies|antibodies|mesh-list
138588047|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
138588048|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138588049|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
138588050|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588051|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588052|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138588053|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588054|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588055|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588057|NCT04401059|Osimertinib|osimertinib|mesh-list
138588058|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588059|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588060|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588061|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588062|NCT04382664|Nivolumab|nivolumab|mesh-list
138588063|NCT04382664|Ipilimumab|ipilimumab|mesh-list
138588064|NCT04382664|Sargramostim|sargramostim|mesh-list
138588065|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588066|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138289099|NCT00448682|Vitamins|vitamins|mesh-ancestor
138588067|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588068|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588069|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
138588070|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588071|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
138588072|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138588073|NCT04382404|Velpatasvir|velpatasvir|mesh-list
138588074|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
138588075|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138588076|NCT04375605|Leucovorin|leucovorin|mesh-list
138588077|NCT04375605|Docetaxel|docetaxel|mesh-list
138588078|NCT04375605|Fluorouracil|fluorouracil|mesh-list
138588079|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
138588080|NCT04375605|Calcium|calcium|mesh-list
138588081|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
138588083|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588084|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
138453645|NCT01886443|Tocopherols|tocopherols|mesh-list
138453646|NCT01886443|Vitamin E|vitamin e|mesh-list
138453649|NCT01886443|Epoprostenol|epoprostenol|mesh-list
138588085|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588086|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481903|NCT00006216|Ganciclovir|ganciclovir|mesh-list
138588087|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138588088|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588089|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
138588090|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138588091|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588092|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
138588094|NCT04375605|Protective Agents|protective agents|mesh-ancestor
138588095|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
138588096|NCT04375605|Vitamins|vitamins|mesh-ancestor
138588097|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
138588098|NCT04363359|Vaccines|vaccines|mesh-list
138588099|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
138588100|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588101|NCT04361279|Rituximab|rituximab|mesh-list
138588102|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588103|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588104|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
138588105|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588106|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138588107|NCT04338191|Leucovorin|leucovorin|mesh-list
138588108|NCT04338191|Fluorouracil|fluorouracil|mesh-list
138588109|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
138588110|NCT04338191|Irinotecan|irinotecan|mesh-list
138588111|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
138588112|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
138588113|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588114|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138588115|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138479163|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
138588116|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588117|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
138588118|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588119|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138588120|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138588121|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588122|NCT04338191|Antidotes|antidotes|mesh-ancestor
138588123|NCT04338191|Protective Agents|protective agents|mesh-ancestor
138588124|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
138588125|NCT04338191|Vitamins|vitamins|mesh-ancestor
138588126|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
138588127|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
138588128|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138588129|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138588130|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453705|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
138588131|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
138588132|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
138588133|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138588134|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
138588135|NCT04305041|Lenvatinib|lenvatinib|mesh-list
138588136|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588137|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588138|NCT04305041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588139|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588140|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588141|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588142|NCT04271735|Niacinamide|niacinamide|mesh-list
138588143|NCT04271735|Niacin|niacin|mesh-list
138588144|NCT04271735|Nicotinic Acids|nicotinic acids|mesh-list
138588145|NCT04271735|Vitamin B Complex|vitamin b complex|mesh-ancestor
138588146|NCT04271735|Vitamins|vitamins|mesh-ancestor
138588147|NCT04271735|Micronutrients|micronutrients|mesh-ancestor
138588148|NCT04271735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588149|NCT04271735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138588150|NCT04271735|Antimetabolites|antimetabolites|mesh-ancestor
138588151|NCT04271735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588152|NCT04271735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138588153|NCT04271735|Vasodilator Agents|vasodilator agents|mesh-ancestor
138588154|NCT04271384|Nivolumab|nivolumab|mesh-list
138588155|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588156|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588157|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588158|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588159|NCT04234048|Fenretinide|fenretinide|mesh-list
138588160|NCT04234048|Retinamide|retinamide|mesh-list
138588161|NCT04234048|Tretinoin|tretinoin|mesh-list
138588162|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662087|NCT00468351|Growth Substances|growth substances|mesh-ancestor
138588163|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138588165|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588166|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
138588167|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
138588168|NCT04193215|Vaccines|vaccines|mesh-list
138588169|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
138588170|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588171|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
138588172|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588173|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588174|NCT04187872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138479252|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
138453731|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138588175|NCT04187872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588176|NCT04170348|Vitamin D|vitamin d|mesh-list
138588177|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
138588178|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
138588179|NCT04170348|Vitamins|vitamins|mesh-list
138588180|NCT04170348|Trientine|trientine|mesh-list
138588181|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
138588182|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588183|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138588184|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138588185|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
138588186|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
138588187|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588188|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
138588189|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588191|NCT04165083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588192|NCT04165083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588193|NCT04161066|Psilocybin|psilocybin|mesh-list
138588194|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
138588195|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588196|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138588197|NCT04110028|Niacinamide|niacinamide|mesh-list
138588198|NCT04110028|Niacin|niacin|mesh-list
138588199|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
138588200|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
138588201|NCT04110028|Vitamins|vitamins|mesh-ancestor
138588202|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
138588203|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588204|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138588205|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
138588206|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588207|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138588208|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
138588209|NCT04099836|Bevacizumab|bevacizumab|mesh-list
138588210|NCT04099836|Atezolizumab|atezolizumab|mesh-list
138588211|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588212|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588213|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138588214|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138588215|NCT04099836|Growth Substances|growth substances|mesh-ancestor
138588216|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588217|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
138588218|NCT04099836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588219|NCT04099836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588220|NCT04094012|Isoniazid|isoniazid|mesh-list
138588221|NCT04094012|Rifapentine|rifapentine|mesh-list
138453759|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138588222|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
138588223|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138588224|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138588225|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138588226|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138588227|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
138588228|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588229|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138588230|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138588231|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
138588232|NCT04082364|Trastuzumab|trastuzumab|mesh-list
138588233|NCT04082364|Margetuximab|margetuximab|mesh-list
138588234|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588235|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588237|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
138588238|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588239|NCT04068207|Minocycline|minocycline|mesh-list
138588240|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138453788|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138588241|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138588242|NCT04065841|Licogliflozin|licogliflozin|mesh-list
138588243|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138481991|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
138588244|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588245|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138588246|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588248|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138588249|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138588250|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138588251|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138588257|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588258|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
138588259|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588260|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588261|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588262|NCT03976375|Docetaxel|docetaxel|mesh-list
138588263|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
138588264|NCT03976375|Lenvatinib|lenvatinib|mesh-list
138588265|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588266|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588267|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
138588268|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588269|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588270|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138453849|NCT01887626|Ticagrelor|ticagrelor|mesh-list
138588271|NCT03976375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138662136|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
138588272|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588273|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588274|NCT03968653|Carboplatin|carboplatin|mesh-list
138588275|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588280|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
138588281|NCT03939923|Rocuronium|rocuronium|mesh-list
138588282|NCT03939923|Neostigmine|neostigmine|mesh-list
138588283|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138588284|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138588285|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138588286|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138588287|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588288|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138588289|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479368|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588290|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588291|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
138588292|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138588293|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138588294|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
138588295|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138264628|NCT03177395|Antidotes|antidotes|mesh-ancestor
138588296|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138588297|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138588298|NCT03918252|Nivolumab|nivolumab|mesh-list
138482006|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
138588300|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588301|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588302|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588303|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588304|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
138588305|NCT03912831|Fludarabine|fludarabine|mesh-list
138588306|NCT03912831|Interleukin-2|interleukin-2|mesh-list
138588307|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588308|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
138588309|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588310|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138588311|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138588312|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
138588313|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588314|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588315|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138588316|NCT03912831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138588317|NCT03912831|Analgesics|analgesics|mesh-ancestor
138588318|NCT03912831|Sensory System Agents|sensory system agents|mesh-ancestor
138588319|NCT03912831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138588320|NCT03873883|Paclitaxel|paclitaxel|mesh-list
138588321|NCT03873883|Carboplatin|carboplatin|mesh-list
138588322|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
138588323|NCT03873883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138588324|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588325|NCT03873883|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588326|NCT03873883|Antimitotic Agents|antimitotic agents|mesh-ancestor
138588327|NCT03873883|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588328|NCT03873883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588329|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588330|NCT03873883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588331|NCT03816345|Nivolumab|nivolumab|mesh-list
138588332|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138479407|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
138588333|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588334|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138482025|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
138588335|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588336|NCT03790800|Urapidil|urapidil|mesh-list
138588337|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138588338|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
138588339|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138588340|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
138588341|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138588342|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588343|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588344|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138588345|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138588346|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138588347|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
138588348|NCT03787628|Cannabidiol|cannabidiol|mesh-list
138588349|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
138588350|NCT03739931|Durvalumab|durvalumab|mesh-list
138588351|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588352|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588353|NCT03718559|Edoxaban|edoxaban|mesh-list
138588354|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138588355|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138588356|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
138588357|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138588358|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
138588359|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588360|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453915|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138588361|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
138588362|NCT03649880|Misonidazole|misonidazole|mesh-list
138588363|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588364|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138588365|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138588366|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138588367|NCT03647592|Bevacizumab|bevacizumab|mesh-list
138588368|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138588369|NCT03647592|Gefitinib|gefitinib|mesh-list
138264701|NCT02065687|Metformin|metformin|mesh-list
138588370|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588371|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588372|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138588373|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138453965|NCT01888120|Ziconotide|ziconotide|mesh-list
138588374|NCT03647592|Growth Substances|growth substances|mesh-ancestor
138588375|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588376|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
138588377|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588378|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588379|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588381|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588382|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588383|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588384|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588386|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588387|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588388|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588389|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588390|NCT03646968|Docetaxel|docetaxel|mesh-list
138588391|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588392|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588393|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
138588394|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588395|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588396|NCT03637660|Penicillins|penicillins|mesh-list
138588397|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138588399|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
138588400|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138588401|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138588402|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
138588403|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138588404|NCT03604315|Fluorides|fluorides|mesh-list
138588405|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138588406|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588407|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
138588408|NCT03604315|Protective Agents|protective agents|mesh-ancestor
138588409|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588410|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
138588411|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
138588412|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138588413|NCT03601806|Thalidomide|thalidomide|mesh-list
138588414|NCT03601806|Pomalidomide|pomalidomide|mesh-list
138588415|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588416|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
138588417|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588418|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
138588419|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138588420|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454002|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138588421|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138588422|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138588423|NCT03601806|Growth Substances|growth substances|mesh-ancestor
138588424|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
138588425|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588426|NCT03508570|Nivolumab|nivolumab|mesh-list
138588427|NCT03508570|Ipilimumab|ipilimumab|mesh-list
138588428|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588429|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588430|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588431|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588432|NCT03505320|Leucovorin|leucovorin|mesh-list
138588433|NCT03505320|Folic Acid|folic acid|mesh-list
138588434|NCT03505320|Docetaxel|docetaxel|mesh-list
138588435|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
138588436|NCT03505320|Fluorouracil|fluorouracil|mesh-list
138588437|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
138588438|NCT03505320|Nivolumab|nivolumab|mesh-list
138588439|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
138588440|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588441|NCT03505320|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588442|NCT03505320|Antimitotic Agents|antimitotic agents|mesh-ancestor
138588443|NCT03505320|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588444|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588445|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588446|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588447|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
138588448|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138588449|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588450|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
138588451|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588452|NCT03505320|Antidotes|antidotes|mesh-ancestor
138588453|NCT03505320|Protective Agents|protective agents|mesh-ancestor
138588454|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
138588455|NCT03505320|Vitamins|vitamins|mesh-ancestor
138588456|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
138588457|NCT03505320|Hematinics|hematinics|mesh-ancestor
138588458|NCT03473743|Carboplatin|carboplatin|mesh-list
138588459|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588460|NCT03433183|Sirolimus|sirolimus|mesh-list
138588461|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138588463|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138588464|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588465|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
138454032|NCT01888445|Hematinics|hematinics|mesh-ancestor
138588466|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588467|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
138588468|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588469|NCT03331341|Doxorubicin|doxorubicin|mesh-list
138588470|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138588471|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
138588472|NCT03331341|Dacarbazine|dacarbazine|mesh-list
138588473|NCT03331341|Vinblastine|vinblastine|mesh-list
138588475|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138588476|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588477|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138588478|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138588479|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588480|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588481|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588482|NCT03331341|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588483|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138588484|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
138588485|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138588486|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588487|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
138588488|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588489|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
138588490|NCT03310957|SGN-LIV1A|sgn-liv1a|mesh-list
138588491|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588492|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588493|NCT03310957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588494|NCT03310957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588495|NCT03310957|Immunoconjugates|immunoconjugates|mesh-ancestor
138588496|NCT03310957|Immunologic Factors|immunologic factors|mesh-ancestor
138588497|NCT03310957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588498|NCT03300557|Exemestane|exemestane|mesh-list
138588499|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588500|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138588501|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138588502|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588503|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588504|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138588505|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
138454068|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138588506|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138588507|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588508|NCT03256981|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138588509|NCT03256981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588510|NCT03256981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588511|NCT03256981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588512|NCT03203850|Deferasirox|deferasirox|mesh-list
138588513|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138588514|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
138588515|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
138479532|NCT02040636|Vaccines|vaccines|mesh-list
138479535|NCT02040649|Midazolam|midazolam|mesh-list
138588516|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588518|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588519|NCT03179904|Paclitaxel|paclitaxel|mesh-list
138588520|NCT03179904|Trastuzumab|trastuzumab|mesh-list
138588521|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138588523|NCT03179904|Fulvestrant|fulvestrant|mesh-list
138264856|NCT05717582|Androgens|androgens|mesh-list
138588524|NCT03179904|Anastrozole|anastrozole|mesh-list
138588525|NCT03179904|Exemestane|exemestane|mesh-list
138588526|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
138588527|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
138588528|NCT03179904|Immunoglobulin G|immunoglobulin g|mesh-list
138588529|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138588530|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588531|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588532|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
138588533|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588534|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588535|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588536|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138588537|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138588538|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588539|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138588540|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
138588541|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138588542|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588543|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
138588544|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138588545|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138588547|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
138588548|NCT03132454|Sorafenib|sorafenib|mesh-list
138588549|NCT03132454|Decitabine|decitabine|mesh-list
138588550|NCT03132454|Palbociclib|palbociclib|mesh-list
138588551|NCT03132454|Ichthammol|ichthammol|mesh-list
138588552|NCT03132454|BB 1101|bb 1101|mesh-list
138588553|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138588554|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
138588555|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
138588556|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138588557|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588558|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138588559|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
138588560|NCT03132454|Hormones|hormones|mesh-ancestor
138588561|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138588562|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138588563|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588564|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
138588565|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588566|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588567|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588568|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138588569|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
138588570|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
138588571|NCT03123783|Nivolumab|nivolumab|mesh-list
138588572|NCT03123783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588573|NCT03123783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588574|NCT03123783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588575|NCT03123783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588576|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
138588577|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138588578|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
138588579|NCT03118232|Povidone|povidone|mesh-list
138588580|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138588581|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138588582|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
138588583|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
138588584|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
138588585|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
138588586|NCT03099174|Letrozole|letrozole|mesh-list
138588587|NCT03099174|Fulvestrant|fulvestrant|mesh-list
138588588|NCT03099174|Anastrozole|anastrozole|mesh-list
138588589|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138454136|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454137|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138588590|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138588591|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138588592|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588593|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588594|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138588595|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
138588596|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138588597|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588598|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138264935|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
138588599|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138588600|NCT03003962|Paclitaxel|paclitaxel|mesh-list
138588601|NCT03003962|Cisplatin|cisplatin|mesh-list
138588602|NCT03003962|Carboplatin|carboplatin|mesh-list
138588603|NCT03003962|Gemcitabine|gemcitabine|mesh-list
138588604|NCT03003962|Pemetrexed|pemetrexed|mesh-list
138588605|NCT03003962|Durvalumab|durvalumab|mesh-list
138588606|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138588608|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588609|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
138588610|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
138318169|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
138588611|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588612|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138588613|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
138588614|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588615|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138588616|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138588617|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588618|NCT02968810|Simvastatin|simvastatin|mesh-list
138588619|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138588620|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138588621|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
138588622|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588623|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138454167|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588624|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138588625|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588626|NCT02913274|Paclitaxel|paclitaxel|mesh-list
138588627|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138588628|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588629|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588630|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
138588631|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588632|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588633|NCT02899052|Dexamethasone|dexamethasone|mesh-list
138588634|NCT02899052|Venetoclax|venetoclax|mesh-list
138588635|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138588636|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
138588637|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
138588638|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138588639|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588640|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138588641|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
138588642|NCT02899052|Hormones|hormones|mesh-ancestor
138588643|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138588644|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138588645|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588646|NCT02847624|Tolvaptan|tolvaptan|mesh-list
138662290|NCT00469131|Tacrolimus|tacrolimus|mesh-list
138588647|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138588648|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588650|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588654|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
138588655|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138588656|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138588657|NCT02784210|Prednisolone|prednisolone|mesh-list
138588658|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
138588659|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138588660|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
138588661|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138588662|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
138588663|NCT02784210|Hormones|hormones|mesh-ancestor
138588664|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138454207|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138454208|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138588665|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588666|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138588667|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588668|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
138588669|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
138588670|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138588671|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138588672|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138588673|NCT02784210|Protective Agents|protective agents|mesh-ancestor
138265002|NCT03286829|Metoprolol|metoprolol|mesh-list
138588674|NCT02774421|Trastuzumab|trastuzumab|mesh-list
138588675|NCT02774421|Molgramostim|molgramostim|mesh-list
138588676|NCT02774421|Sargramostim|sargramostim|mesh-list
138588677|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588678|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588679|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
138588680|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588681|NCT02728102|Lenalidomide|lenalidomide|mesh-list
138588682|NCT02728102|Melphalan|melphalan|mesh-list
138588683|NCT02728102|Molgramostim|molgramostim|mesh-list
138588685|NCT02728102|Sargramostim|sargramostim|mesh-list
138588686|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
138588687|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588688|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138588689|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138588690|NCT02728102|Growth Substances|growth substances|mesh-ancestor
138588691|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
138588692|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588693|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138454240|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138588694|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
138588695|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588696|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138588697|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588698|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
138588699|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588700|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588701|NCT02706353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138588702|NCT02706353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588704|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588705|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588706|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588707|NCT02660580|Adalimumab|adalimumab|mesh-list
138588708|NCT02660580|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138588709|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138588710|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138588711|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
138588712|NCT02629809|Fludarabine|fludarabine|mesh-list
138588713|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
138588714|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
138588715|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588716|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
138588717|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588718|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138588719|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138588720|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
138588721|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588722|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588723|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138588724|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138588725|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
138588726|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588727|NCT02600897|Rituximab|rituximab|mesh-list
138588728|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
138588729|NCT02600897|Lenalidomide|lenalidomide|mesh-list
138588730|NCT02600897|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138588731|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588732|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588733|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
138588734|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588735|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138588736|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138588737|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138588738|NCT02600897|Growth Substances|growth substances|mesh-ancestor
138588739|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
138588740|NCT02600897|Immunoconjugates|immunoconjugates|mesh-ancestor
138588741|NCT02399215|Nintedanib|nintedanib|mesh-list
138588742|NCT02399215|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138588743|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588744|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588745|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588746|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588747|NCT02365649|Upadacitinib|upadacitinib|mesh-list
138588748|NCT02365649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138454286|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
138454288|NCT01889680|Antidotes|antidotes|mesh-ancestor
138588749|NCT02365649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588750|NCT02365649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588751|NCT02365649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588752|NCT02365649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138588753|NCT02271919|Nicotine|nicotine|mesh-list
138588754|NCT02271919|Varenicline|varenicline|mesh-list
138588755|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138588756|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
138588757|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138588758|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588760|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138588761|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
138588762|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138588763|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588765|NCT02225405|Docetaxel|docetaxel|mesh-list
138588766|NCT02225405|Nintedanib|nintedanib|mesh-list
138588767|NCT02225405|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138588768|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588769|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588770|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
138588771|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588772|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588773|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588774|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588775|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138588776|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138588777|NCT02110225|Mitogens|mitogens|mesh-list
138588778|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588779|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588780|NCT02098954|Gemcitabine|gemcitabine|mesh-list
138588781|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138588782|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138588783|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
138588784|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588785|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588786|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588787|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588788|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
138588789|NCT02065362|Fludarabine|fludarabine|mesh-list
138588790|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588791|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
138588792|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588793|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138588794|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138588795|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
138588796|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588797|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588798|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138588799|NCT02016820|Omeprazole|omeprazole|mesh-list
138588800|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138588801|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138588802|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138588803|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588804|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588805|NCT01955460|Aldesleukin|aldesleukin|mesh-list
138588806|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
138482177|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588808|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
138588809|NCT01955460|Interleukin-2|interleukin-2|mesh-list
138588810|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138454306|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
138588811|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
138588812|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588813|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138588814|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138588815|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
138588816|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588817|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588818|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138588819|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138588820|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
138588821|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138588822|NCT01955460|Analgesics|analgesics|mesh-ancestor
138588823|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
138479906|NCT02043886|Acarbose|acarbose|mesh-list
138588824|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138588825|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138588826|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138588827|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
138588828|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138588830|NCT01902173|Dabrafenib|dabrafenib|mesh-list
138588831|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138588832|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588833|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588834|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588835|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588836|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138588837|NCT01902173|Protective Agents|protective agents|mesh-ancestor
138588838|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588839|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138588840|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
138588841|NCT01805297|Aflibercept|aflibercept|mesh-list
138588842|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138588843|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138588844|NCT01805297|Growth Substances|growth substances|mesh-ancestor
138588845|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588846|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
138588847|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588848|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138588850|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588851|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588852|NCT01744704|Mitogens|mitogens|mesh-list
138588853|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588854|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588855|NCT01734512|Everolimus|everolimus|mesh-list
138588856|NCT01734512|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138588857|NCT01734512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588858|NCT01734512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588859|NCT01734512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588860|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588861|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
138588862|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588863|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588864|NCT01477333|Treprostinil|treprostinil|mesh-list
138588865|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138588866|NCT01371630|Cytarabine|cytarabine|mesh-list
138588867|NCT01371630|Dexamethasone|dexamethasone|mesh-list
138588868|NCT01371630|Prednisone|prednisone|mesh-list
138454313|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588869|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
138588870|NCT01371630|Rituximab|rituximab|mesh-list
138588871|NCT01371630|Methotrexate|methotrexate|mesh-list
138588872|NCT01371630|Vincristine|vincristine|mesh-list
138588873|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
138588874|NCT01371630|Blinatumomab|blinatumomab|mesh-list
138588875|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138588876|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588877|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
138588878|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588879|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138588880|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138588881|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
138588882|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588883|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588885|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138588886|NCT01371630|Antiemetics|antiemetics|mesh-ancestor
138588887|NCT01371630|Autonomic Agents|autonomic agents|mesh-ancestor
138588888|NCT01371630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138588889|NCT01371630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138588890|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
138588891|NCT01371630|Hormones|hormones|mesh-ancestor
138588892|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138588893|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138588894|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588895|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138588896|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
138588897|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138588898|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138588899|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
138588900|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
138588901|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588902|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138588903|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138588904|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
138588905|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138588906|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138588907|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588908|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
138588910|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138588911|NCT01371630|Immunotoxins|immunotoxins|mesh-ancestor
138588912|NCT01371630|Immunoconjugates|immunoconjugates|mesh-ancestor
138588913|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138588914|NCT01336803|Hematinics|hematinics|mesh-ancestor
138479976|NCT02044250|Aspirin|aspirin|mesh-list
138588915|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138588916|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138588917|NCT01206465|Fluorouracil|fluorouracil|mesh-list
138588918|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
138588919|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588920|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138588921|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588922|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588923|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
138588924|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588925|NCT01116648|Olaparib|olaparib|mesh-list
138588926|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138588927|NCT01116648|Cediranib|cediranib|mesh-list
138588928|NCT01116648|Maleic acid|maleic acid|mesh-list
138588929|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588930|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588931|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588932|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588933|NCT00979693|Psilocybin|psilocybin|mesh-list
138588934|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
138588935|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588936|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138588937|NCT00801489|Cytarabine|cytarabine|mesh-list
138588938|NCT00801489|Fludarabine|fludarabine|mesh-list
138588939|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
138588940|NCT00801489|Decitabine|decitabine|mesh-list
138588941|NCT00801489|Idarubicin|idarubicin|mesh-list
138588942|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
138588943|NCT00801489|Calicheamicins|calicheamicins|mesh-list
138588944|NCT00801489|Lenograstim|lenograstim|mesh-list
138588945|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588946|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138588947|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
138588948|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588949|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138588950|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
138588951|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588953|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138588954|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138588955|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138588956|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138588957|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138588958|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138588959|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138588960|NCT00801489|Immunotoxins|immunotoxins|mesh-ancestor
138588961|NCT00801489|Immunoconjugates|immunoconjugates|mesh-ancestor
138588962|NCT00694655|Vaccines|vaccines|mesh-list
138588963|NCT00694655|Immunologic Factors|immunologic factors|mesh-ancestor
138588964|NCT00694655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588965|NCT00642434|Metoprolol|metoprolol|mesh-list
138588966|NCT00642434|Carvedilol|carvedilol|mesh-list
138588967|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138588968|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138588970|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
138588971|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138588972|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138588973|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138588974|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138588975|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138588976|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
138588977|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138588978|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265301|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
138588979|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
138588980|NCT00642434|Protective Agents|protective agents|mesh-ancestor
138588981|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138588982|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138588983|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138588984|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
138588985|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138588986|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138588988|NCT00600496|Docetaxel|docetaxel|mesh-list
138588989|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138588990|NCT00600496|Temsirolimus|temsirolimus|mesh-list
138588991|NCT00600496|Dacarbazine|dacarbazine|mesh-list
138588992|NCT00600496|MTOR Inhibitors|mtor inhibitors|mesh-list
138588993|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138588994|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
138588995|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
138588996|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
138588997|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138588998|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138588999|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589000|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138589001|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
138482296|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
138589005|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138589006|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
138589007|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138662380|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
138589008|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
138589009|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138589010|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138589011|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138589012|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589013|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
138589014|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138589015|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
138589019|NCT00318981|Methylphenidate|methylphenidate|mesh-list
138589020|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138589021|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589022|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138589023|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138589024|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138589025|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589026|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
138589027|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589029|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
138589030|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138589031|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589032|NCT00089245|Trace Elements|trace elements|mesh-ancestor
138589033|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
138589034|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589035|NCT00004198|Sargramostim|sargramostim|mesh-list
138589036|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138589037|NCT00004198|Vaccines|vaccines|mesh-list
138589038|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
138589039|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589040|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138589041|NCT00004192|Cytarabine|cytarabine|mesh-list
138589042|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
138589043|NCT00004192|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138589044|NCT00004192|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138589045|NCT00004192|Prednisolone|prednisolone|mesh-list
138480069|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
138589046|NCT00004192|Prednisolone acetate|prednisolone acetate|mesh-list
138589047|NCT00004192|Etoposide|etoposide|mesh-list
138454360|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
138589048|NCT00004192|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138589049|NCT00004192|Prednisolone phosphate|prednisolone phosphate|mesh-list
138589050|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589051|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138589052|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138589053|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138265379|NCT03203681|Testosterone|testosterone|mesh-list
138589054|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589055|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589056|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138589057|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
138589058|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
138589059|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589060|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138589061|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
138589062|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589063|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138589064|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
138589065|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
138589066|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589067|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138589068|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
138589069|NCT00004192|Hormones|hormones|mesh-ancestor
138589070|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662396|NCT04704713|Afamelanotide|afamelanotide|mesh-list
138589071|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138589072|NCT00004192|Protective Agents|protective agents|mesh-ancestor
138589073|NCT00004192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138589075|NCT00004112|Prednisolone|prednisolone|mesh-list
138589076|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
138589077|NCT00004112|Rituximab|rituximab|mesh-list
138589078|NCT00004112|Doxorubicin|doxorubicin|mesh-list
138589079|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138589080|NCT00004112|Vincristine|vincristine|mesh-list
138589081|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138589082|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
138589083|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589084|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138589085|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138589086|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
138589087|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589088|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589089|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138589090|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138589091|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138589092|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138589093|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138589094|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589095|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138589096|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
138589097|NCT00004112|Hormones|hormones|mesh-ancestor
138589098|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138589099|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138589100|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138589101|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
138589102|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
138589103|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
138589104|NCT00469885|Nicotine|nicotine|mesh-list
138589105|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138589106|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
138454389|NCT01893229|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138454394|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
138589107|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589108|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589109|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138589110|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138589111|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
138589112|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589113|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589114|NCT00469924|Caffeine|caffeine|mesh-list
138589115|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138589116|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589117|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138589118|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589119|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589120|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138589121|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138589122|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
138589123|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589124|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
138589125|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138589126|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138589127|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265453|NCT05992883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138589128|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
138589129|NCT00157677|Coagulants|coagulants|mesh-ancestor
138589130|NCT00470041|Lamivudine|lamivudine|mesh-list
138589131|NCT00470041|Zidovudine|zidovudine|mesh-list
138589132|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
138589133|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138589134|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138589136|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589137|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589138|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138589139|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138589141|NCT00157716|Pyridoxal|pyridoxal|mesh-list
138589142|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
138589143|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
138589144|NCT00157716|Vitamins|vitamins|mesh-ancestor
138589145|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
138589146|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589147|NCT00470197|Cytarabine|cytarabine|mesh-list
138589148|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
138589149|NCT00470197|Alvocidib|alvocidib|mesh-list
138589150|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138589151|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
138589152|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589153|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589154|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
138589155|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589156|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138589157|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
138589158|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589159|NCT00470197|Analgesics|analgesics|mesh-ancestor
138589160|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
138589161|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589162|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138589163|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138589164|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589165|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
138589166|NCT00470197|Growth Substances|growth substances|mesh-ancestor
138589167|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138589168|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
138589169|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138589170|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138589171|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454407|NCT01894269|Lamivudine|lamivudine|mesh-list
138589172|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589173|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589174|NCT00149292|Olanzapine|olanzapine|mesh-list
138589175|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
138589176|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
138589177|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589178|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589179|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138589180|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138589181|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138589182|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138589183|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138589184|NCT00149292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138480223|NCT02046044|Digoxin|digoxin|mesh-list
138589185|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138589186|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138482332|NCT00005872|Rubitecan|rubitecan|mesh-list
138589187|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589188|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589189|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
138589190|NCT00470509|Adalimumab|adalimumab|mesh-list
138589191|NCT00470509|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138589192|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138589193|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138589194|NCT05378906|Darunavir|darunavir|mesh-list
138589195|NCT05378906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138589196|NCT05378906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138589197|NCT05378906|Protease Inhibitors|protease inhibitors|mesh-ancestor
138589198|NCT05378906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589199|NCT05378906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589200|NCT05378906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138589201|NCT05378906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138589202|NCT05378906|Antiviral Agents|antiviral agents|mesh-ancestor
138589203|NCT05378906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589204|NCT00470665|Sirolimus|sirolimus|mesh-list
138589205|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138589206|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589208|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589209|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
138589210|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138589211|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
138589212|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589213|NCT00470743|Ibuprofen|ibuprofen|mesh-list
138589214|NCT00470743|Indomethacin|indomethacin|mesh-list
138589215|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138589216|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138589217|NCT00470743|Analgesics|analgesics|mesh-ancestor
138589218|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
138589220|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589221|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138589222|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138589223|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138589224|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589225|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589226|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
138589227|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
138589228|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138589229|NCT00470821|Melatonin|melatonin|mesh-list
138589230|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
138589231|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589232|NCT00470821|Protective Agents|protective agents|mesh-ancestor
138589233|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589234|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138589235|NCT00335920|Dexamethasone|dexamethasone|mesh-list
138589236|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138589237|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
138589238|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
138589239|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589240|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589241|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138589242|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
138589243|NCT00335920|Hormones|hormones|mesh-ancestor
138589244|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138589245|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138589246|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589247|NCT00335998|Cisplatin|cisplatin|mesh-list
138589248|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589249|NCT00470977|Ranibizumab|ranibizumab|mesh-list
138589250|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138589251|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138589252|NCT00470977|Growth Substances|growth substances|mesh-ancestor
138589253|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589254|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
138482355|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589256|NCT05350592|Dobutamine|dobutamine|mesh-list
138589257|NCT05350592|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138589258|NCT05350592|Sympathomimetics|sympathomimetics|mesh-ancestor
138589259|NCT05350592|Autonomic Agents|autonomic agents|mesh-ancestor
138589260|NCT05350592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589261|NCT05350592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589262|NCT05350592|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138589263|NCT05350592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138589264|NCT05350592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138589265|NCT05350592|Adrenergic Agents|adrenergic agents|mesh-ancestor
138589266|NCT05350592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589267|NCT05350592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589268|NCT05350592|Protective Agents|protective agents|mesh-ancestor
138589269|NCT00471055|Capsaicin|capsaicin|mesh-list
138589270|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
138589271|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
138589272|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
138589273|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589274|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589275|NCT00471094|Lansoprazole|lansoprazole|mesh-list
138589276|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
138589277|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138589278|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138589279|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138480335|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
138589280|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589281|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589284|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138589285|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138589286|NCT00157872|Analgesics|analgesics|mesh-ancestor
138589287|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
138589288|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589289|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589290|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138589291|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138589292|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
138589293|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138589294|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589295|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589296|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138589297|NCT03271255|Bevacizumab|bevacizumab|mesh-list
138589299|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138589300|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589301|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138589302|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138589303|NCT03271255|Growth Substances|growth substances|mesh-ancestor
138454422|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138589304|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589305|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
138589306|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138589307|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589308|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589309|NCT00471289|Paclitaxel|paclitaxel|mesh-list
138589310|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138589311|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589312|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
138589313|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
138482366|NCT00005887|Efaproxiral|efaproxiral|mesh-list
138589314|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
138589315|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589316|NCT00336154|Tetracycline|tetracycline|mesh-list
138589317|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138589318|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589319|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138589320|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589321|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589322|NCT00158028|Risperidone|risperidone|mesh-list
138589323|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138589324|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
138589325|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589326|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589327|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589328|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138589329|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138589330|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138589331|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138589332|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138589333|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
138589334|NCT00471406|Verteporfin|verteporfin|mesh-list
138589335|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138589336|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
138589337|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
138589338|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589339|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
138589340|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589341|NCT00471484|Interferons|interferons|mesh-list
138589342|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
138589343|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
138589344|NCT00471484|Doxorubicin|doxorubicin|mesh-list
138589345|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138589346|NCT00471484|Fluorouracil|fluorouracil|mesh-list
138589347|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
138589348|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138589349|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589350|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138589351|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138589352|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454432|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138454435|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
138589353|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589354|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
138589356|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138589357|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
138589358|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589359|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
138589360|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589361|NCT00471523|Metformin|metformin|mesh-list
138589362|NCT00471523|Clomiphene|clomiphene|mesh-list
138589363|NCT00471523|Enclomiphene|enclomiphene|mesh-list
138589364|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
138589365|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138589366|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589367|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138589368|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
138589369|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138589370|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138589372|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138589373|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138589374|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138589375|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138589376|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138589377|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
138589379|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138589380|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
138589381|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
138589382|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589383|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589384|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138589385|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
138589386|NCT00471640|Hormones|hormones|mesh-ancestor
138589387|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138589388|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138589389|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589390|NCT00471679|Ethanol|ethanol|mesh-list
138589391|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138589392|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589393|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138589394|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589395|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138589396|NCT00149604|Estrogens|estrogens|mesh-list
138589397|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138589398|NCT00149604|Hormones|hormones|mesh-ancestor
138589399|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138589400|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589401|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138589402|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
138589403|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138589404|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138589405|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138589406|NCT00471952|Caffeine|caffeine|mesh-list
138589407|NCT00471952|Rizatriptan|rizatriptan|mesh-list
138589408|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138589409|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589410|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138589411|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454458|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589412|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589413|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138589414|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138589415|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
138589416|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589417|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138589418|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
138589419|NCT00471991|Dienogest|dienogest|mesh-list
138589420|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138589421|NCT00471991|Estradiol|estradiol|mesh-list
138589422|NCT00471991|Estrogens|estrogens|mesh-ancestor
138589423|NCT00471991|Hormones|hormones|mesh-ancestor
138589424|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138589425|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589426|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138589427|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
138589428|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138589429|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138589430|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138589431|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138589432|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138589433|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
138589434|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138662486|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
138589435|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589436|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138589437|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138589438|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
138589439|NCT00336310|Repaglinide|repaglinide|mesh-list
138589440|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138589441|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589442|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
138589443|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138589444|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138589445|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138589446|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138589447|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589448|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
138589449|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589450|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589451|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138589452|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589453|NCT00472225|Rituximab|rituximab|mesh-list
138589454|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138589455|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589456|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
138589457|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589458|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138589459|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
138589460|NCT00336466|Hematinics|hematinics|mesh-ancestor
138589461|NCT00472381|Insulin|insulin|mesh-list
138589462|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138589463|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589464|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138589465|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138589466|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
138589467|NCT00336739|Cinacalcet|cinacalcet|mesh-list
138589468|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138589469|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589470|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138589471|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
138589472|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138589473|NCT00424151|Rituximab|rituximab|mesh-list
138454475|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138454476|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138454477|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
138454478|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454480|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138589474|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138589475|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589476|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
138589477|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589478|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138589479|NCT00472810|Mitomycins|mitomycins|mesh-list
138589480|NCT00472810|Mitomycin|mitomycin|mesh-list
138589481|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138589482|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589483|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
138589484|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589485|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138589486|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589487|NCT00337051|Propofol|propofol|mesh-list
138589488|NCT00337051|Sevoflurane|sevoflurane|mesh-list
138589489|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138589490|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138589491|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589492|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138589493|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
138589495|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138589496|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138589497|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138589498|NCT00472927|Estrogens|estrogens|mesh-ancestor
138589499|NCT00472927|Hormones|hormones|mesh-ancestor
138589500|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138589501|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589502|NCT00337090|Mirabegron|mirabegron|mesh-list
138589503|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138589504|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138589505|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138589506|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
138589507|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138480560|NCT00005850|Gemcitabine|gemcitabine|mesh-list
138589508|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589509|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589510|NCT00337090|Urological Agents|urological agents|mesh-ancestor
138589512|NCT05262452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589513|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
138589515|NCT00337246|Fludarabine|fludarabine|mesh-list
138589516|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
138589517|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
138589518|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138589519|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
138589520|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589521|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138589522|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138589523|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
138589524|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589525|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589526|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138589527|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138589528|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138589529|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
138589530|NCT00337246|Analgesics|analgesics|mesh-ancestor
138589531|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
138589532|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589533|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138589534|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138589535|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454482|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
138454483|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454484|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138454485|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138454487|NCT01897051|Propranolol|propranolol|mesh-list
138454488|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138589536|NCT00158301|Fluoxetine|fluoxetine|mesh-list
138589537|NCT00158301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138589538|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138589539|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138589540|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589541|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589542|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
138589543|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589544|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138589545|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
138589547|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138589548|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138589549|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589551|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138589552|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
138589553|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589554|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589555|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589556|NCT00473239|Vitamin D|vitamin d|mesh-list
138589557|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
138589558|NCT00473239|Vitamins|vitamins|mesh-ancestor
138589559|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
138589560|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589561|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138589562|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138589563|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
138589564|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138589565|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589566|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138589567|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
138589568|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138589569|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589570|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589571|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589572|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
138589573|NCT00337441|Hematinics|hematinics|mesh-ancestor
138589574|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
138589575|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138589576|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589577|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
138589578|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138589579|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138589580|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
138589581|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589582|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589583|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589584|NCT00337558|Urological Agents|urological agents|mesh-ancestor
138589585|NCT02964104|Insulin|insulin|mesh-list
138589586|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138589587|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138589588|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589589|NCT00158457|Tenofovir|tenofovir|mesh-list
138589590|NCT00158457|Emtricitabine|emtricitabine|mesh-list
138589591|NCT00158457|Efavirenz|efavirenz|mesh-list
138589592|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
138589593|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589594|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138589595|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138589596|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589597|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589598|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138589599|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138589600|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138589601|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138589602|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138454491|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589603|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138589604|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138589605|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138589606|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138589607|NCT00509158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138482447|NCT00005926|Trastuzumab|trastuzumab|mesh-list
138482449|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
138589608|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138589609|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
138589610|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589611|NCT00509158|Antacids|antacids|mesh-ancestor
138589612|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589613|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138589614|NCT00405080|Rifampin|rifampin|mesh-list
138589615|NCT00405080|Casopitant|casopitant|mesh-list
138589616|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138589617|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
138589618|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138589619|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589620|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
138589621|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138589622|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589623|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589624|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138589625|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138589626|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138589627|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138589628|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138589629|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138589630|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
138589631|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
138589632|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589633|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589634|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138589635|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138589636|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589637|NCT00158496|Interferons|interferons|mesh-list
138589639|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
138589640|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
138589641|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138589642|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589643|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
138589644|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589645|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
138589646|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589647|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
138589648|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589650|NCT00337792|Fentanyl|fentanyl|mesh-list
138589651|NCT00337792|Oxycodone|oxycodone|mesh-list
138589654|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138589655|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138589656|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589657|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138589658|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138454507|NCT01897753|Hormones|hormones|mesh-list
138589659|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138589660|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138589661|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
138589662|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
138589663|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
138589664|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
138589665|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589666|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589667|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138589668|NCT00337792|Narcotics|narcotics|mesh-ancestor
138589669|NCT00337792|Analgesics|analgesics|mesh-ancestor
138589670|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
138589671|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589672|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
138589673|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
138589674|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
138662553|NCT06188767|Anabolic Agents|anabolic agents|mesh-ancestor
138589675|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138589676|NCT00405119|Esomeprazole|esomeprazole|mesh-list
138589677|NCT00405119|Ranitidine|ranitidine|mesh-list
138589678|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138589679|NCT00405119|Loxtidine|loxtidine|mesh-list
138589680|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138589681|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138589682|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138589683|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589684|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589685|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138589686|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
138589687|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
138589688|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589689|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589690|NCT04715737|Vasopressins|vasopressins|mesh-list
138589691|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
138589692|NCT04715737|Oxytocin|oxytocin|mesh-list
138589693|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
138589694|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138589695|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589696|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
138589697|NCT04715737|Coagulants|coagulants|mesh-ancestor
138589698|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138589699|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138589700|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
138589701|NCT00509431|Sirolimus|sirolimus|mesh-list
138589702|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138589703|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589704|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138589705|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589706|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589707|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138589708|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589709|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138589710|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
138589711|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138589712|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
138589713|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589714|NCT00509470|Amlodipine|amlodipine|mesh-list
138589715|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138589716|NCT00509470|Telmisartan|telmisartan|mesh-list
138589717|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138589718|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138589719|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138589720|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589721|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138589722|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589723|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
138589724|NCT00509470|Diuretics|diuretics|mesh-ancestor
138589725|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
138589726|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138589727|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138589728|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138589729|NCT00405158|Acetaminophen|acetaminophen|mesh-list
138589730|NCT00405158|Antipyretics|antipyretics|mesh-list
138589731|NCT00405158|Penicillins|penicillins|mesh-list
138589732|NCT00405158|Floxacillin|floxacillin|mesh-list
138589733|NCT00405158|Cefadroxil|cefadroxil|mesh-list
138589734|NCT00405158|Oxytocin|oxytocin|mesh-list
138589736|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138589737|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589738|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138589739|NCT00405158|Analgesics|analgesics|mesh-ancestor
138589740|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
138482471|NCT00006348|Ondansetron|ondansetron|mesh-list
138589741|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589742|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138589743|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589744|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
138589745|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589746|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138589747|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589748|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589749|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
138589750|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138589751|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
138589752|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138589753|NCT00150111|Rituximab|rituximab|mesh-list
138589754|NCT00150111|Methimazole|methimazole|mesh-list
138589755|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138589756|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589757|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
138589758|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589759|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138589760|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
138589761|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
138589762|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138589763|NCT02953210|Dexamethasone|dexamethasone|mesh-list
138589764|NCT02953210|Ketorolac|ketorolac|mesh-list
138589765|NCT02953210|Lidocaine|lidocaine|mesh-list
138589766|NCT02953210|Clonidine|clonidine|mesh-list
138589767|NCT02953210|Midazolam|midazolam|mesh-list
138589768|NCT02953210|Fentanyl|fentanyl|mesh-list
138589769|NCT02953210|Ketamine|ketamine|mesh-list
138589770|NCT02953210|Ondansetron|ondansetron|mesh-list
138589771|NCT02953210|Bupivacaine|bupivacaine|mesh-list
138589772|NCT02953210|Propofol|propofol|mesh-list
138589773|NCT02953210|Isoflurane|isoflurane|mesh-list
138589774|NCT02953210|Ranitidine|ranitidine|mesh-list
138589775|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138589776|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138589777|NCT02953210|Rocuronium|rocuronium|mesh-list
138589778|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138589780|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
138589781|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589782|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589783|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138589784|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
138589785|NCT02953210|Hormones|hormones|mesh-ancestor
138589786|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138589787|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138589788|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589789|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
138589790|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
138589791|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138589792|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
138589793|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138589794|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138589795|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138589796|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138589797|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589798|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138589799|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138589800|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
138589801|NCT02953210|Analgesics|analgesics|mesh-ancestor
138589802|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138589803|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138589804|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138589805|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589806|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138589807|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138589808|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138589809|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138589810|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
138589811|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
138589812|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138589813|NCT02953210|Narcotics|narcotics|mesh-ancestor
138589814|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
138589815|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
138589816|NCT02953210|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138589817|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138589818|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
138589819|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138589820|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138589821|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138589822|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138589823|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589824|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138589825|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138589826|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138589827|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138589828|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
138589829|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138589830|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138589831|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138589832|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
138589833|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138589834|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138589835|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138589836|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
138589837|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
138589839|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138589840|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138589842|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
138589843|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589844|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589845|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138589846|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138589847|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138589848|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589849|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454543|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138589850|NCT00509860|Irinotecan|irinotecan|mesh-list
138454544|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138589851|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138589852|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138589853|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589854|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589855|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589856|NCT00509938|Lactoferrin|lactoferrin|mesh-list
138589857|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589858|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
138589859|NCT00337948|Hematinics|hematinics|mesh-ancestor
138589860|NCT02958215|Phenylephrine|phenylephrine|mesh-list
138589861|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
138589862|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138589863|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
138589864|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
138589865|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589866|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589867|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
138589868|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138589869|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
138589870|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
138589871|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138589872|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138589873|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138589874|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
138589875|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589876|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589877|NCT02958215|Protective Agents|protective agents|mesh-ancestor
138589878|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
138482536|NCT00387699|Etoposide|etoposide|mesh-list
138589879|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
138589880|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138589881|NCT00158574|Dapsone|dapsone|mesh-list
138589882|NCT00158574|Mefloquine|mefloquine|mesh-list
138589885|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
138589886|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138589887|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138589888|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138589889|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138589890|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589891|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589892|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138589893|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
138589894|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138589895|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
138589897|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
138589898|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589899|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589900|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589901|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
138589902|NCT00338299|Hematinics|hematinics|mesh-ancestor
138589903|NCT00510016|Clonidine|clonidine|mesh-list
138589904|NCT00510016|Analgesics|analgesics|mesh-ancestor
138589905|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
138589906|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589907|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589908|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138589909|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
138589910|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
138589911|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138589912|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138589913|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138589914|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
138589915|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589916|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589917|NCT00150228|Varenicline|varenicline|mesh-list
138589918|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138589919|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138589920|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
138589921|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589922|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480926|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
138589924|NCT00338338|Amlodipine|amlodipine|mesh-list
138589925|NCT00338338|Lacidipine|lacidipine|mesh-list
138589926|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138589927|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138589928|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138589929|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589930|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138589931|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589932|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
138589933|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
138589934|NCT00338416|Hematinics|hematinics|mesh-ancestor
138589935|NCT00338494|Clofarabine|clofarabine|mesh-list
138589936|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138589937|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
138589938|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589939|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589940|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138589941|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138589942|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138589943|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138589944|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589945|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138589946|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138589947|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589948|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
138589949|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589950|NCT00473005|Capecitabine|capecitabine|mesh-list
138589951|NCT00473005|Everolimus|everolimus|mesh-list
138589952|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138589953|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
138589954|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589956|NCT00473005|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138589958|NCT00473005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589959|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138589960|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
138589961|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589962|NCT00158652|Carboplatin|carboplatin|mesh-list
138266270|NCT05319756|Oxycodone|oxycodone|mesh-list
138589963|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138589964|NCT00338650|Adalimumab|adalimumab|mesh-list
138589965|NCT00338650|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138589966|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138589967|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138589968|NCT00158691|Amifostine|amifostine|mesh-list
138589969|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138589970|NCT00158691|Protective Agents|protective agents|mesh-ancestor
138589971|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589972|NCT00338767|Fluoxetine|fluoxetine|mesh-list
138589973|NCT00338767|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138589974|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138589975|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138589976|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589977|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454574|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138589978|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
138589979|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589980|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138589981|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
138589982|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138589983|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138589984|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138589985|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138589986|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
138589987|NCT00339001|Hematinics|hematinics|mesh-ancestor
138589988|NCT00150306|Sertraline|sertraline|mesh-list
138589989|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
138589990|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138589991|NCT00150306|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138589992|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138589993|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138589994|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138589995|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138589996|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
138589997|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138589998|NCT00510172|Epoprostenol|epoprostenol|mesh-list
138589999|NCT00510172|Tezosentan|tezosentan|mesh-list
138590000|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138590001|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138590002|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
138590003|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
138590004|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
138590005|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138662662|NCT06188143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138590006|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138590007|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590008|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590009|NCT00420901|Urological Agents|urological agents|mesh-ancestor
138590011|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
138590012|NCT00150384|Atorvastatin|atorvastatin|mesh-list
138590013|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138590014|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138590015|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
138590016|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590017|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138590018|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138590019|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590020|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138590021|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138590022|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138590023|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138590024|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590025|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
138590026|NCT00425191|Gemcitabine|gemcitabine|mesh-list
138590027|NCT00425191|Docetaxel|docetaxel|mesh-list
138590028|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590029|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590030|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
138590031|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590032|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
138590033|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
138590034|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
138590035|NCT00339118|Doxorubicin|doxorubicin|mesh-list
138590036|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
138590038|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590039|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138590040|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138590041|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590042|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590043|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138590044|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
138590045|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590046|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138590047|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138590048|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
138590049|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138590050|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138590051|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138590052|NCT00339196|Azacitidine|azacitidine|mesh-list
138590053|NCT00339196|Tretinoin|tretinoin|mesh-list
138590054|NCT00339196|Valproic Acid|valproic acid|mesh-list
138590055|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590056|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
138590057|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590058|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590059|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590060|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
138590061|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
138590062|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
138590063|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
138590064|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590065|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590066|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
138590067|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138590068|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138590069|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138590070|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138590071|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
138590072|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590073|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138590074|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138590075|NCT00510211|Olanzapine|olanzapine|mesh-list
138590076|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
138590077|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
138590078|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590079|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590080|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138590081|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138590082|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138590083|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138590084|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138590085|NCT00510211|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138590086|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138480996|NCT00005985|Analgesics|analgesics|mesh-ancestor
138590087|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138590088|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590089|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590090|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
138590092|NCT00150423|Analgesics|analgesics|mesh-ancestor
138590093|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
138590094|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590095|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454602|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
138454606|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
138590096|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
138590097|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138590098|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138590099|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590100|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138590101|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138590102|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138590103|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138590104|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138590106|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590107|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138482646|NCT00005977|Hormones|hormones|mesh-ancestor
138590108|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590109|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590110|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
138590112|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138590113|NCT00510367|Fluorouracil|fluorouracil|mesh-list
138590114|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138590115|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
138590116|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590117|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138590118|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138590119|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
138590120|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590121|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590122|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138590123|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138590124|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138590125|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138590126|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590127|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
138590128|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590129|NCT00158847|Fluticasone|fluticasone|mesh-list
138590131|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138590132|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138590133|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138590134|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
138590135|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590136|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590137|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138590138|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
138590139|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
138590140|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138590141|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138590142|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138590143|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138590144|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
138590145|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590146|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590147|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138590148|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590149|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138590150|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590151|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454614|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590152|NCT00158886|Topotecan|topotecan|mesh-list
138590153|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138590154|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138590155|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590156|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590157|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590158|NCT00510406|Tamsulosin|tamsulosin|mesh-list
138590159|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
138590160|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138590161|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138590162|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138590163|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
138590164|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590165|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590166|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590167|NCT00510406|Urological Agents|urological agents|mesh-ancestor
138590168|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138590169|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138590170|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
138590171|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
138590172|NCT00165555|Antidotes|antidotes|mesh-ancestor
138590173|NCT00165555|Protective Agents|protective agents|mesh-ancestor
138590174|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590176|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590177|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
138590178|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138590179|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590180|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
138590181|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
138590182|NCT00150579|Amphetamine|amphetamine|mesh-list
138590183|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
138590184|NCT00150579|Adderall|adderall|mesh-list
138266488|NCT05074589|Leucovorin|leucovorin|mesh-list
138590185|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138590186|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590187|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
138590188|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
138590189|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590190|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
138590191|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590192|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590193|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
138590194|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138590195|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138590196|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138590197|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138590198|NCT00511732|Insulin|insulin|mesh-list
138590199|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138590200|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590201|NCT00510445|Imetelstat|imetelstat|mesh-list
138590202|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
138590203|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590204|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590205|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138590206|NCT00150657|Bevacizumab|bevacizumab|mesh-list
138590207|NCT00150657|Carboplatin|carboplatin|mesh-list
138590208|NCT00150657|Gemcitabine|gemcitabine|mesh-list
138590209|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138590210|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590211|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138590212|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138590213|NCT00150657|Growth Substances|growth substances|mesh-ancestor
138590214|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590215|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
138590216|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590217|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
138454633|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138590218|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590219|NCT00511771|Tegaserod|tegaserod|mesh-list
138590220|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138590221|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
138482656|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590222|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590223|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590224|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590225|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
138590226|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590227|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138590228|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590229|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590230|NCT00511849|Paclitaxel|paclitaxel|mesh-list
138590231|NCT00511849|Carboplatin|carboplatin|mesh-list
138590232|NCT00511849|Sunitinib|sunitinib|mesh-list
138590233|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138590234|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590235|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
138590236|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
138590237|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
138590238|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590239|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138590240|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138590241|NCT00511849|Growth Substances|growth substances|mesh-ancestor
138590242|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590243|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
138590244|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138590245|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590246|NCT00510640|Sunitinib|sunitinib|mesh-list
138590247|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590248|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138590249|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138590250|NCT00510640|Growth Substances|growth substances|mesh-ancestor
138590251|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662724|NCT06187584|Narcotics|narcotics|mesh-ancestor
138590252|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
138590253|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138590254|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590255|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590256|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
138481100|NCT00006012|Topotecan|topotecan|mesh-list
138590257|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138590258|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138590259|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590260|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138590261|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590262|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138590263|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
138590264|NCT00165633|Menatetrenone|menatetrenone|mesh-list
138590265|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
138590266|NCT00165633|Coagulants|coagulants|mesh-ancestor
138590267|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138590268|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138590269|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590270|NCT00165633|Vitamins|vitamins|mesh-ancestor
138590271|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
138590272|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590273|NCT02952469|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138590274|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590275|NCT02952469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138590276|NCT00510913|Tacrolimus|tacrolimus|mesh-list
138590277|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138590278|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
138590279|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590280|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138590281|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482680|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590282|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590283|NCT00150735|Levetiracetam|levetiracetam|mesh-list
138590284|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
138590285|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
138590286|NCT04695925|Carboplatin|carboplatin|mesh-list
138590287|NCT04695925|Pemetrexed|pemetrexed|mesh-list
138590288|NCT04695925|Osimertinib|osimertinib|mesh-list
138590289|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590290|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590291|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590292|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138590293|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138590294|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138590295|NCT00511069|Bortezomib|bortezomib|mesh-list
138590296|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590297|NCT00165750|Donepezil|donepezil|mesh-list
138590298|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138590299|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590300|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590301|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
138590302|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590303|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590304|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
138590305|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
138590306|NCT00511225|Vitamin D|vitamin d|mesh-list
138590307|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138590308|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590310|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
138590311|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138590312|NCT00150774|Levetiracetam|levetiracetam|mesh-list
138590313|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
138590314|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
138590315|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
138590316|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590317|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138590318|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590319|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590320|NCT00165828|Zonisamide|zonisamide|mesh-list
138590321|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
138590322|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138590323|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138590324|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590325|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138454664|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590326|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590327|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
138590328|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
138590329|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138590330|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138590331|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590332|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481168|NCT00386685|Trastuzumab|trastuzumab|mesh-list
138590333|NCT00511498|Urological Agents|urological agents|mesh-ancestor
138590334|NCT00511576|Docetaxel|docetaxel|mesh-list
138590335|NCT00511576|Mocetinostat|mocetinostat|mesh-list
138590336|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590337|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
138590338|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
138590339|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
138590340|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590341|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138590342|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590343|NCT00511654|Midazolam|midazolam|mesh-list
138590344|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138590345|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138590346|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138590347|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590348|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138590349|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138590350|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138590351|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138590352|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
138590353|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
138590354|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
138590355|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
138590356|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590357|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590358|NCT00150852|Vancomycin|vancomycin|mesh-list
138590359|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138590360|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590361|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
138590362|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138590363|NCT02952235|Protective Agents|protective agents|mesh-ancestor
138590364|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590365|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
138590366|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
138590367|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138662763|NCT06187441|Hormones|hormones|mesh-ancestor
138590368|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138590369|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590370|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590371|NCT02951806|Fentanyl|fentanyl|mesh-list
138590372|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138590373|NCT02951806|Narcotics|narcotics|mesh-ancestor
138590374|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138590375|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590376|NCT02951806|Analgesics|analgesics|mesh-ancestor
138590377|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
138590378|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590379|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138590380|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138590381|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
138590382|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
138590383|NCT00512980|Prednisone|prednisone|mesh-list
138590384|NCT00512980|Gemcitabine|gemcitabine|mesh-list
138590385|NCT00512980|Doxorubicin|doxorubicin|mesh-list
138590386|NCT00512980|Vinblastine|vinblastine|mesh-list
138590387|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138454678|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
138590388|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
138590389|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590390|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590391|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138590393|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138590394|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590395|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138590396|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
138482714|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
138590397|NCT00512980|Hormones|hormones|mesh-ancestor
138590398|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138590399|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590400|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138590401|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138590402|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
138590403|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
138590404|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
138590405|NCT00150891|Cyclosporine|cyclosporine|mesh-list
138590406|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
138590407|NCT00150891|Azathioprine|azathioprine|mesh-list
138590408|NCT00150891|Tacrolimus|tacrolimus|mesh-list
138590409|NCT00150891|Cyclosporins|cyclosporins|mesh-list
138590410|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138590411|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
138590412|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590413|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138590414|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590415|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590416|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
138590417|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590418|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
138590419|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138590420|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138590421|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590422|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138590423|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
138590424|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138590425|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
138590426|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590427|NCT00513058|Vinorelbine|vinorelbine|mesh-list
138590428|NCT00513058|Lapatinib|lapatinib|mesh-list
138590429|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138590430|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590431|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
138590432|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
138590433|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
138590434|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662771|NCT06187441|Growth Inhibitors|growth inhibitors|mesh-ancestor
138590435|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138590436|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590437|NCT02951962|Amlodipine|amlodipine|mesh-list
138590438|NCT02951962|Telmisartan|telmisartan|mesh-list
138590439|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138590440|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138590441|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138590442|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138590443|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138590444|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590445|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138590446|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590447|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
138590448|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138590449|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138590450|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
138454687|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138590451|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138590452|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138590453|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590454|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138590455|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138590456|NCT00513253|Lapatinib|lapatinib|mesh-list
138482730|NCT00005998|Analgesics|analgesics|mesh-ancestor
138590457|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590458|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138590459|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590460|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590461|NCT00513487|Fluticasone|fluticasone|mesh-list
138590462|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
138590463|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138590464|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138590465|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
138590466|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590467|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590468|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138590469|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
138590470|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
138590471|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138590473|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138590474|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138590475|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138590476|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138590477|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
138590478|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590479|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590480|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
138590481|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138590482|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
138590483|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590484|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590485|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138590486|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
138590487|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
138590488|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138590489|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
138590490|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590491|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590493|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590494|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
138590495|NCT00513643|Insulin|insulin|mesh-list
138590496|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138590497|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
138590498|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138590499|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590500|NCT00151008|Bexarotene|bexarotene|mesh-list
138590501|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590502|NCT00513877|Bortezomib|bortezomib|mesh-list
138590503|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590504|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
138590505|NCT04695613|Analgesics|analgesics|mesh-ancestor
138590506|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
138590507|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590508|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590509|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
138481354|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138590510|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138590511|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138590512|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
138590513|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138590514|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138590515|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590516|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138590517|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
138590518|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138590519|NCT00151047|Docetaxel|docetaxel|mesh-list
138590520|NCT00151047|Capecitabine|capecitabine|mesh-list
138590521|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590522|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
138590523|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
138590524|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
138590525|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590526|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590527|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
138590528|NCT00513955|Prednisolone|prednisolone|mesh-list
138590529|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
138590530|NCT00513955|Doxorubicin|doxorubicin|mesh-list
138590531|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138590532|NCT00513955|Vincristine|vincristine|mesh-list
138590533|NCT00513955|Bortezomib|bortezomib|mesh-list
138590534|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138590535|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
138590536|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590537|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138590538|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138590539|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
138590540|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590541|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590542|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138590543|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138590544|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138590545|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138590546|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590547|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138590548|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
138590549|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
138590550|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
138590551|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138590552|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
138590553|NCT00513955|Hormones|hormones|mesh-ancestor
138590554|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138590555|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138590556|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
138266861|NCT04669197|Paclitaxel|paclitaxel|mesh-list
138590557|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
138590558|NCT00514072|Vaccines|vaccines|mesh-list
138590559|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
138590560|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
138454727|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454729|NCT01900860|Vitamin D|vitamin d|mesh-list
138590561|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590562|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138590563|NCT00514111|Interferons|interferons|mesh-list
138590564|NCT00514111|Ribavirin|ribavirin|mesh-list
138481413|NCT04360473|Ketamine|ketamine|mesh-list
138590566|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
138590567|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590568|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
138590569|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590570|NCT00151086|Vinorelbine|vinorelbine|mesh-list
138590571|NCT00151086|Estramustine|estramustine|mesh-list
138590572|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138590573|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590574|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
138590575|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
138590576|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
138590577|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590578|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138590579|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
138590580|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138590581|NCT00514228|Sunitinib|sunitinib|mesh-list
138590582|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590583|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138590584|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138590585|NCT00514228|Growth Substances|growth substances|mesh-ancestor
138590586|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590587|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
138590588|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138590589|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590590|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590591|NCT00151125|Oprelvekin|oprelvekin|mesh-list
138590592|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590593|NCT00514657|Mitogens|mitogens|mesh-list
138590594|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
138590595|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590596|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138590597|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138590598|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138590599|NCT02951260|Metformin|metformin|mesh-list
138590600|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138590601|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590602|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
138590603|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138590604|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590605|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590606|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138590607|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138590608|NCT02951299|Protective Agents|protective agents|mesh-ancestor
138481422|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
138590609|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590610|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
138590611|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138590612|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
138590614|NCT00514891|Vitamins|vitamins|mesh-ancestor
138590615|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
138590616|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590618|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590619|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138590620|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590621|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138454737|NCT01900886|Ribavirin|ribavirin|mesh-list
138454738|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138590622|NCT02950948|Progesterone|progesterone|mesh-list
138590623|NCT02950948|Progestins|progestins|mesh-ancestor
138590624|NCT02950948|Hormones|hormones|mesh-ancestor
138590625|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138590626|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590627|NCT00515320|Fluoxetine|fluoxetine|mesh-list
138590628|NCT00515320|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138590629|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138590630|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138590631|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590632|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590633|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
138266993|NCT04458545|Heroin|heroin|mesh-list
138590634|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590635|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138590636|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
138590637|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138590638|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138590639|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138590640|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590641|NCT00515554|Rituximab|rituximab|mesh-list
138590642|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138590643|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590644|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
138590645|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590646|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138590647|NCT00151203|Clarithromycin|clarithromycin|mesh-list
138482827|NCT00386659|Ritonavir|ritonavir|mesh-list
138590648|NCT00151203|Dexamethasone|dexamethasone|mesh-list
138590649|NCT00151203|Lenalidomide|lenalidomide|mesh-list
138590650|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138590651|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
138590652|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
138590653|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590654|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590655|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138590656|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
138590657|NCT00151203|Hormones|hormones|mesh-ancestor
138590658|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138590659|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138590660|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590661|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
138590662|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138590663|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138590664|NCT00151203|Growth Substances|growth substances|mesh-ancestor
138590665|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
138590666|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138590667|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590668|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138590669|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590670|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590671|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138590672|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138590674|NCT04620200|Ipilimumab|ipilimumab|mesh-list
138590675|NCT04620200|Immunomodulating Agents|immunomodulating agents|mesh-list
138590676|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
138590677|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138590678|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590679|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138454751|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138454752|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138590680|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590681|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590682|NCT00515593|Hormones|hormones|mesh-list
138590683|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
138590684|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138590685|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590686|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138590688|NCT00515788|Temozolomide|temozolomide|mesh-list
138590689|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590690|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
138590691|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590692|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590693|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
138590694|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590695|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138590696|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
138590697|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590698|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138590699|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
138482852|NCT00006028|Gemcitabine|gemcitabine|mesh-list
138590700|NCT02950870|Ritonavir|ritonavir|mesh-list
138590701|NCT02950870|Ribavirin|ribavirin|mesh-list
138590702|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138590703|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138590704|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
138590705|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590706|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267011|NCT04414475|Hormones|hormones|mesh-ancestor
138590707|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138590708|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138590709|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
138590710|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590711|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138590712|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138590713|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
138590714|NCT00515866|Gemcitabine|gemcitabine|mesh-list
138590715|NCT00515866|Olaparib|olaparib|mesh-list
138590716|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138590717|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590718|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
138590719|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590720|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590721|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590722|NCT00515905|Propofol|propofol|mesh-list
138590723|NCT00515905|Sevoflurane|sevoflurane|mesh-list
138590724|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138590725|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138590726|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590727|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138590728|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
138590729|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
138662849|NCT06186895|Narcotics|narcotics|mesh-ancestor
138590730|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138590731|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138590732|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
138590733|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138590734|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138590735|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138590736|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138590737|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590738|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
138590739|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590740|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590741|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138590742|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590743|NCT00151242|Cytarabine|cytarabine|mesh-list
138590744|NCT00151242|Etoposide|etoposide|mesh-list
138590745|NCT00151242|Idarubicin|idarubicin|mesh-list
138590746|NCT00151242|Tretinoin|tretinoin|mesh-list
138590747|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138590748|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590749|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138590750|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138590751|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482879|NCT00006037|Irinotecan|irinotecan|mesh-list
138590752|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590753|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590754|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
138590755|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
138590756|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590757|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138590758|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
138590759|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590760|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138590762|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
138590763|NCT00516100|Pemetrexed|pemetrexed|mesh-list
138590764|NCT00516100|Bortezomib|bortezomib|mesh-list
138590765|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590766|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590767|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590768|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138590769|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138590770|NCT00166413|Thalidomide|thalidomide|mesh-list
138590771|NCT00166413|Lenalidomide|lenalidomide|mesh-list
138590772|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138590773|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
138590774|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590775|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
138590776|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138590777|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590778|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138590779|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138590780|NCT00166413|Growth Substances|growth substances|mesh-ancestor
138481553|NCT02373813|Analgesics|analgesics|mesh-ancestor
138590781|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
138267110|NCT04256707|Docetaxel|docetaxel|mesh-list
138590782|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590783|NCT02950441|Niacinamide|niacinamide|mesh-list
138590785|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
138590786|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
138590787|NCT02950441|Vitamins|vitamins|mesh-ancestor
138590788|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
138590789|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590790|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138590791|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
138590792|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590793|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138590794|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
138590795|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
138590796|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138590797|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590798|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
138590799|NCT02950168|Edoxaban|edoxaban|mesh-list
138590800|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138590801|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
138590802|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138590803|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
138590804|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590805|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590806|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
138590807|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
138590808|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590809|NCT00166491|Insulin|insulin|mesh-list
138454774|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138590810|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138590811|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590812|NCT00508885|Niacinamide|niacinamide|mesh-list
138590813|NCT00508885|Niacin|niacin|mesh-list
138590814|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
138590815|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
138590816|NCT00508885|Vitamins|vitamins|mesh-ancestor
138590817|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
138590818|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590819|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138590820|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
138590821|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138482896|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590823|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
138590824|NCT02953405|Clopidogrel|clopidogrel|mesh-list
138590825|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138590826|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138590827|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138590828|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138590829|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
138590830|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590831|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590832|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590833|NCT00516802|Olaparib|olaparib|mesh-list
138590834|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138590835|NCT00516802|Dacarbazine|dacarbazine|mesh-list
138481583|NCT00006045|Analgesics|analgesics|mesh-ancestor
138590836|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590837|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590838|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590839|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138590840|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
138590842|NCT05861466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138590843|NCT05861466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138590844|NCT05861466|Growth Substances|growth substances|mesh-ancestor
138590845|NCT05861466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590846|NCT05861466|Growth Inhibitors|growth inhibitors|mesh-ancestor
138590847|NCT05861466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590848|NCT05861310|Metronidazole|metronidazole|mesh-list
138590849|NCT05861310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590850|NCT05861310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138590851|NCT05861310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138590852|NCT05861310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138590853|NCT05861297|Dexamethasone|dexamethasone|mesh-list
138590854|NCT05861297|Prednisolone|prednisolone|mesh-list
138590855|NCT05861297|Rituximab|rituximab|mesh-list
138590856|NCT05861297|Azathioprine|azathioprine|mesh-list
138590857|NCT05861297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138590858|NCT05861297|Antiemetics|antiemetics|mesh-ancestor
138590859|NCT05861297|Autonomic Agents|autonomic agents|mesh-ancestor
138590860|NCT05861297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590862|NCT05861297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138590863|NCT05861297|Glucocorticoids|glucocorticoids|mesh-ancestor
138590864|NCT05861297|Hormones|hormones|mesh-ancestor
138590865|NCT05861297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138590866|NCT05861297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138590867|NCT05861297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590868|NCT05861297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138590869|NCT05861297|Immunologic Factors|immunologic factors|mesh-ancestor
138590870|NCT05861297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138590871|NCT05861297|Antimetabolites|antimetabolites|mesh-ancestor
138590872|NCT05861297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590873|NCT05861297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590874|NCT05861297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138590875|NCT05861271|Capecitabine|capecitabine|mesh-list
138590876|NCT05861271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138590877|NCT05861271|Antimetabolites|antimetabolites|mesh-ancestor
138454785|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454788|NCT01901120|Urological Agents|urological agents|mesh-ancestor
138590878|NCT05861271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590879|NCT05861271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590880|NCT05861206|Listerine|listerine|mesh-list
138590881|NCT05861206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138590882|NCT05861206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590883|NCT05861154|Benzocaine|benzocaine|mesh-list
138590884|NCT05861154|Anesthetics, Local|anesthetics, local|mesh-ancestor
138590885|NCT05861154|Anesthetics|anesthetics|mesh-ancestor
138590886|NCT05861154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138482906|NCT00006363|Busulfan|busulfan|mesh-list
138590887|NCT05861154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590888|NCT05861154|Sensory System Agents|sensory system agents|mesh-ancestor
138590889|NCT05861154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590891|NCT05861063|Dezocine|dezocine|mesh-list
138590892|NCT05861063|Anesthetics, Local|anesthetics, local|mesh-ancestor
138590893|NCT05861063|Anesthetics|anesthetics|mesh-ancestor
138481601|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
138590894|NCT05861063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138590895|NCT05861063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590896|NCT05861063|Sensory System Agents|sensory system agents|mesh-ancestor
138590897|NCT05861063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590898|NCT05861063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138590899|NCT05861063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138590900|NCT05861063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138590901|NCT05861063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138590902|NCT05861063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590903|NCT05861063|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138590904|NCT05861063|Narcotics|narcotics|mesh-ancestor
138590905|NCT05861063|Analgesics|analgesics|mesh-ancestor
138590906|NCT05860699|Ethanol|ethanol|mesh-list
138590907|NCT05860699|Cannabidiol|cannabidiol|mesh-list
138590908|NCT05860699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138590909|NCT05860699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138590910|NCT05860699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138590911|NCT05860699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590912|NCT05860699|Anticonvulsants|anticonvulsants|mesh-ancestor
138590913|NCT05860335|Paclitaxel|paclitaxel|mesh-list
138590914|NCT05860335|Nedaplatin|nedaplatin|mesh-list
138590915|NCT05860335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138590916|NCT05860335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590917|NCT05860335|Tubulin Modulators|tubulin modulators|mesh-ancestor
138590918|NCT05860335|Antimitotic Agents|antimitotic agents|mesh-ancestor
138590919|NCT05860335|Mitosis Modulators|mitosis modulators|mesh-ancestor
138590920|NCT05860335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590921|NCT05860244|Albuterol|albuterol|mesh-list
138590922|NCT05860244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138590923|NCT05860244|Autonomic Agents|autonomic agents|mesh-ancestor
138590924|NCT05860244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590925|NCT05860244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590926|NCT05860244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138590927|NCT05860244|Respiratory System Agents|respiratory system agents|mesh-ancestor
138590928|NCT05860244|Tocolytic Agents|tocolytic agents|mesh-ancestor
138590929|NCT05860244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138481621|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138590930|NCT05860244|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138590931|NCT05860244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138590932|NCT05860244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138590933|NCT05860244|Adrenergic Agents|adrenergic agents|mesh-ancestor
138590934|NCT05860244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590935|NCT05860244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590936|NCT05860153|Diazepam|diazepam|mesh-list
138590937|NCT05860153|Levetiracetam|levetiracetam|mesh-list
138590938|NCT05860153|Anticonvulsants|anticonvulsants|mesh-ancestor
138590939|NCT05860153|Nootropic Agents|nootropic agents|mesh-ancestor
138590940|NCT05860153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138590941|NCT05860153|Antiemetics|antiemetics|mesh-ancestor
138590942|NCT05860153|Autonomic Agents|autonomic agents|mesh-ancestor
138590943|NCT05860153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138590944|NCT05860153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590945|NCT05860153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138590946|NCT05860153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138590947|NCT05860153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138590948|NCT05860153|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138590949|NCT05860153|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138590950|NCT05860153|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138590951|NCT05860153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138482915|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
138590953|NCT05860153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138590954|NCT05860153|Anesthetics, General|anesthetics, general|mesh-ancestor
138590955|NCT05860153|Anesthetics|anesthetics|mesh-ancestor
138590956|NCT05860153|GABA Modulators|gaba modulators|mesh-ancestor
138590957|NCT05860153|GABA Agents|gaba agents|mesh-ancestor
138590958|NCT05860153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590959|NCT05860153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590960|NCT05860114|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
138590961|NCT05860114|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138590962|NCT05860114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138590963|NCT05860114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590964|NCT05860062|Vitamin D|vitamin d|mesh-list
138590965|NCT05860062|Calcium|calcium|mesh-list
138590966|NCT05860062|Vitamins|vitamins|mesh-ancestor
138590967|NCT05860062|Micronutrients|micronutrients|mesh-ancestor
138590968|NCT05860062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590969|NCT05860062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138590970|NCT05860062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138590971|NCT05860010|Epinephrine|epinephrine|mesh-list
138590972|NCT05860010|Dexmedetomidine|dexmedetomidine|mesh-list
138590973|NCT05860010|Bupivacaine|bupivacaine|mesh-list
138590974|NCT05860010|Anesthetics, Local|anesthetics, local|mesh-ancestor
138590975|NCT05860010|Anesthetics|anesthetics|mesh-ancestor
138590976|NCT05860010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138590977|NCT05860010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138590978|NCT05860010|Sensory System Agents|sensory system agents|mesh-ancestor
138590979|NCT05860010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138481659|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
138590980|NCT05860010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138590981|NCT05860010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138590982|NCT05860010|Analgesics|analgesics|mesh-ancestor
138590983|NCT05860010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138590984|NCT05860010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138590985|NCT05860010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138590986|NCT05860010|Adrenergic Agents|adrenergic agents|mesh-ancestor
138590987|NCT05860010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138590988|NCT05860010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138590989|NCT05860010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138590990|NCT05860010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138590991|NCT05860010|Autonomic Agents|autonomic agents|mesh-ancestor
138590992|NCT05860010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138590993|NCT05860010|Respiratory System Agents|respiratory system agents|mesh-ancestor
138590994|NCT05860010|Mydriatics|mydriatics|mesh-ancestor
138590995|NCT05860010|Sympathomimetics|sympathomimetics|mesh-ancestor
138590996|NCT05860010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138590997|NCT05859984|Interferons|interferons|mesh-list
138590998|NCT05859984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138590999|NCT05859984|Antiviral Agents|antiviral agents|mesh-ancestor
138591000|NCT05859984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591001|NCT05859802|4-Aminopyridine|4-aminopyridine|mesh-list
138591002|NCT05859802|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138454801|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591003|NCT05859802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138591004|NCT05859802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591005|NCT05859750|Paclitaxel|paclitaxel|mesh-list
138591006|NCT05859750|Gemcitabine|gemcitabine|mesh-list
138591007|NCT05859750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138591008|NCT05859750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482931|NCT05680870|Omeprazole|omeprazole|mesh-list
138591009|NCT05859750|Tubulin Modulators|tubulin modulators|mesh-ancestor
138591010|NCT05859750|Antimitotic Agents|antimitotic agents|mesh-ancestor
138591011|NCT05859750|Mitosis Modulators|mitosis modulators|mesh-ancestor
138591012|NCT05859750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591013|NCT05859750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138591014|NCT05859750|Antimetabolites|antimetabolites|mesh-ancestor
138591016|NCT05858918|Ticagrelor|ticagrelor|mesh-list
138591017|NCT05858918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138591018|NCT05858918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138591019|NCT05858918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138591020|NCT05858918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138591021|NCT05858918|Purinergic Agents|purinergic agents|mesh-ancestor
138591022|NCT05858918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138591023|NCT05858918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591024|NCT05858918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591025|NCT05856877|Insulin|insulin|mesh-list
138591026|NCT05856877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138591027|NCT05856877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591028|NCT05856864|Ramucirumab|ramucirumab|mesh-list
138591029|NCT05856864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591030|NCT05829187|Piperaquine|piperaquine|mesh-list
138591031|NCT05829187|Primaquine|primaquine|mesh-list
138591032|NCT05829187|Artenimol|artenimol|mesh-list
138591033|NCT05829187|Antimalarials|antimalarials|mesh-ancestor
138591034|NCT05829187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138591035|NCT05829187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138591036|NCT05829187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591037|NCT05779644|Metformin|metformin|mesh-list
138591038|NCT05779644|Liraglutide|liraglutide|mesh-list
138591039|NCT05779644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138591040|NCT05779644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591041|NCT05779644|Incretins|incretins|mesh-ancestor
138591042|NCT05779644|Hormones|hormones|mesh-ancestor
138591043|NCT05779644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591044|NCT05749211|Niraparib|niraparib|mesh-list
138591045|NCT05749211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138591046|NCT05749211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591047|NCT05749211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591048|NCT05749211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591049|NCT05748093|Cobicistat|cobicistat|mesh-list
138591050|NCT05748093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138591051|NCT05748093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138591052|NCT05748093|Antiviral Agents|antiviral agents|mesh-ancestor
138591053|NCT05748093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591054|NCT05748093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138591055|NCT05748093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138591056|NCT05748093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591057|NCT05748093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591058|NCT05731596|Ubiquinone|ubiquinone|mesh-list
138591059|NCT05731596|Coenzyme Q10|coenzyme q10|mesh-list
138591060|NCT05731596|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138591061|NCT05731596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138591062|NCT05731596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138591063|NCT05731596|Antimetabolites|antimetabolites|mesh-ancestor
138591064|NCT05731596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591065|NCT05731596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138591066|NCT05731596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138591068|NCT05731596|Micronutrients|micronutrients|mesh-ancestor
138591069|NCT05731596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591070|NCT05731596|Vitamins|vitamins|mesh-ancestor
138591071|NCT05710328|Deoxyglucose|deoxyglucose|mesh-list
138591072|NCT05710328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138591073|NCT05710328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138591074|NCT05710328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591075|NCT05710328|Antimetabolites|antimetabolites|mesh-ancestor
138591076|NCT05710328|Antiviral Agents|antiviral agents|mesh-ancestor
138591077|NCT05710328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591078|NCT05709990|Vitamin D|vitamin d|mesh-list
138591079|NCT05709990|Cholecalciferol|cholecalciferol|mesh-list
138591080|NCT05709990|Solifenacin Succinate|solifenacin succinate|mesh-list
138591081|NCT05709990|Vitamins|vitamins|mesh-ancestor
138591082|NCT05709990|Micronutrients|micronutrients|mesh-ancestor
138591083|NCT05709990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591084|NCT05709990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138591085|NCT05709990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138591086|NCT05709990|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138591087|NCT05709990|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138591089|NCT05709990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138591090|NCT05709990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591091|NCT05709990|Urological Agents|urological agents|mesh-ancestor
138591092|NCT05684744|Methotrexate|methotrexate|mesh-list
138591093|NCT05684744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138591094|NCT05684744|Abortifacient Agents|abortifacient agents|mesh-ancestor
138591095|NCT05684744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138591096|NCT05684744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591097|NCT05684744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138591098|NCT05684744|Antimetabolites|antimetabolites|mesh-ancestor
138591099|NCT05684744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591100|NCT05684744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591101|NCT05684744|Dermatologic Agents|dermatologic agents|mesh-ancestor
138591102|NCT05684744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591103|NCT05684744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138591104|NCT05684744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138591105|NCT05684744|Immunologic Factors|immunologic factors|mesh-ancestor
138591106|NCT05684744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138591107|NCT05684744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138591108|NCT05678114|Inositol|inositol|mesh-list
138591109|NCT05678114|Vitamin B Complex|vitamin b complex|mesh-ancestor
138591110|NCT05678114|Vitamins|vitamins|mesh-ancestor
138591111|NCT05678114|Micronutrients|micronutrients|mesh-ancestor
138591112|NCT05678114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591113|NCT05675787|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138591114|NCT05675787|Atorvastatin|atorvastatin|mesh-list
138591115|NCT05675787|Medroxyprogesterone|medroxyprogesterone|mesh-list
138482964|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
138591116|NCT05675787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138591117|NCT05675787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138591118|NCT05675787|Antimetabolites|antimetabolites|mesh-ancestor
138591119|NCT05675787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591120|NCT05675787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138591121|NCT05675787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138591122|NCT05675787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591123|NCT05675787|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138591124|NCT05675787|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138591125|NCT05675787|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138591126|NCT05675787|Contraceptive Agents|contraceptive agents|mesh-ancestor
138591127|NCT05675787|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138591128|NCT05675787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591129|NCT05675787|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138591130|NCT05675787|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138591131|NCT05675787|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138591132|NCT05675787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138454823|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454824|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591133|NCT05675787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591134|NCT05662527|Pembrolizumab|pembrolizumab|mesh-list
138591135|NCT05662527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138591136|NCT05662527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591137|NCT05662527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138591138|NCT05662527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591139|NCT05576792|Ranibizumab|ranibizumab|mesh-list
138591140|NCT05576792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138591141|NCT05576792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138591143|NCT05576792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591144|NCT05576792|Growth Inhibitors|growth inhibitors|mesh-ancestor
138591145|NCT05576792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591146|NCT05491278|Remifentanil|remifentanil|mesh-list
138591148|NCT05491278|Fospropofol|fospropofol|mesh-list
138591149|NCT05491278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138591150|NCT05491278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591151|NCT05491278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591152|NCT05491278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138591153|NCT05491278|Anesthetics, General|anesthetics, general|mesh-ancestor
138591154|NCT05491278|Anesthetics|anesthetics|mesh-ancestor
138591155|NCT05491278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138591156|NCT05491278|Narcotics|narcotics|mesh-ancestor
138591157|NCT05491278|Analgesics|analgesics|mesh-ancestor
138591158|NCT05491278|Sensory System Agents|sensory system agents|mesh-ancestor
138591159|NCT05491278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591160|NCT05457582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138591161|NCT05457582|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
138591163|NCT05457582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138591164|NCT05457582|Antimetabolites|antimetabolites|mesh-ancestor
138591165|NCT05457582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591166|NCT05457582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591167|NCT05457582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138591168|NCT05457582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138591169|NCT05457582|Protease Inhibitors|protease inhibitors|mesh-ancestor
138591170|NCT05375916|Hydromorphone|hydromorphone|mesh-list
138591171|NCT05375916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138591172|NCT05375916|Narcotics|narcotics|mesh-ancestor
138591173|NCT05375916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591174|NCT05375916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591175|NCT05375916|Analgesics|analgesics|mesh-ancestor
138591176|NCT05375916|Sensory System Agents|sensory system agents|mesh-ancestor
138591177|NCT05375916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591178|NCT05359354|Vaccines|vaccines|mesh-list
138591179|NCT05359354|Immunologic Factors|immunologic factors|mesh-ancestor
138591180|NCT05359354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591182|NCT05346562|Anticonvulsants|anticonvulsants|mesh-ancestor
138591183|NCT05313529|Metformin|metformin|mesh-list
138591184|NCT05313529|Liraglutide|liraglutide|mesh-list
138591185|NCT05313529|Empagliflozin|empagliflozin|mesh-list
138591186|NCT05313529|Linagliptin|linagliptin|mesh-list
138591187|NCT05313529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138591188|NCT05313529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591189|NCT05313529|Incretins|incretins|mesh-ancestor
138591190|NCT05313529|Hormones|hormones|mesh-ancestor
138591191|NCT05313529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591192|NCT05313529|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138591193|NCT05313529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591194|NCT05313529|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138591195|NCT05313529|Protease Inhibitors|protease inhibitors|mesh-ancestor
138591196|NCT05313529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591197|NCT05287633|Esomeprazole|esomeprazole|mesh-list
138591198|NCT05287633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138591199|NCT05287633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138591200|NCT05287633|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138591201|NCT05287633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591202|NCT05287633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591203|NCT05285449|Cannabidiol|cannabidiol|mesh-list
138591204|NCT05285449|Anticonvulsants|anticonvulsants|mesh-ancestor
138591205|NCT05238597|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138591206|NCT05238597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138591207|NCT05221320|Hydroxychloroquine|hydroxychloroquine|mesh-list
138591208|NCT05221320|Antimalarials|antimalarials|mesh-ancestor
138591209|NCT05221320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138591210|NCT05221320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138591211|NCT05221320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591212|NCT05221320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591213|NCT05221320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591214|NCT05221320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138591215|NCT05190705|Dexamethasone|dexamethasone|mesh-list
138483019|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138591216|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
138591217|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
138591219|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138591220|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
138591221|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
138591222|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591223|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591224|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138591225|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
138591226|NCT05190705|Hormones|hormones|mesh-ancestor
138591227|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591228|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138591229|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591230|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
138591231|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481792|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591232|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591233|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138591234|NCT05188118|Nivolumab|nivolumab|mesh-list
138591235|NCT05188118|Ipilimumab|ipilimumab|mesh-list
138267542|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
138591236|NCT05188118|Everolimus|everolimus|mesh-list
138591237|NCT05188118|Lenvatinib|lenvatinib|mesh-list
138591238|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138591240|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138591241|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591242|NCT05188118|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138591243|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138591244|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591245|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138591246|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
138591247|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591248|NCT05172908|Dexamethasone|dexamethasone|mesh-list
138591249|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138591250|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
138591251|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
138591252|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591253|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591254|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138591255|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
138591256|NCT05172908|Hormones|hormones|mesh-ancestor
138591257|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591258|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138591259|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591260|NCT05140512|Goserelin|goserelin|mesh-list
138591261|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138591262|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591263|NCT05110170|Goserelin|goserelin|mesh-list
138454851|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138591264|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138591265|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591266|NCT04971499|Dapansutrile|dapansutrile|mesh-list
138591267|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
138591268|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138591269|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591270|NCT04971499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138591271|NCT04971499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591272|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138591273|NCT04918017|Esomeprazole|esomeprazole|mesh-list
138591274|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138591275|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138591276|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138591277|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591278|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591279|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
138591280|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138591281|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138591282|NCT04898231|Prednisolone|prednisolone|mesh-list
138591283|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
138591285|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138591286|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138591287|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
138591288|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138591289|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
138591290|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
138591291|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591292|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591293|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138591294|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
138591296|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591297|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138591298|NCT04898231|Protective Agents|protective agents|mesh-ancestor
138591299|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138591300|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591301|NCT04898231|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138591302|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
138591303|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138591304|NCT04849026|Clozapine|clozapine|mesh-list
138591305|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138591306|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
138591307|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138591308|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138481856|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138591309|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591311|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138591312|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591313|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138591314|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
138591315|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
138591316|NCT04841980|Rifaximin|rifaximin|mesh-list
138591317|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138591318|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591319|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138591320|NCT04831736|Ketamine|ketamine|mesh-list
138591321|NCT04831736|Analgesics|analgesics|mesh-ancestor
138591322|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
138591323|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663010|NCT06148337|Psyllium|psyllium|mesh-list
138454858|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138591324|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591325|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138591326|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138591327|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
138591328|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
138591329|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591330|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138591331|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138591332|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138591333|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591334|NCT04830462|Rifampin|rifampin|mesh-list
138591335|NCT04830462|Isoniazid|isoniazid|mesh-list
138591336|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138591337|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
138591338|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138591339|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591340|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
138591341|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138591342|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591367|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138591370|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
138591371|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138591372|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591373|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138591374|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
138591375|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138591376|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
138591377|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
138591378|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591379|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
138591380|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138591381|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591382|NCT04721015|Docetaxel|docetaxel|mesh-list
138591383|NCT04721015|Osimertinib|osimertinib|mesh-list
138591384|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591385|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
138267688|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591386|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
138591387|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
138591388|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591389|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138591390|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591399|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
138591400|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138591401|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591402|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138591403|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
138591404|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138591405|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591406|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591407|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591408|NCT04634162|Cangrelor|cangrelor|mesh-list
138591409|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138591410|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138591411|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138591412|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138591413|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
138591414|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138454873|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138591415|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591416|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591417|NCT04616196|Cetuximab|cetuximab|mesh-list
138591418|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138591419|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591420|NCT04583956|Remdesivir|remdesivir|mesh-list
138591421|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
138591422|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591423|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
138591424|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591425|NCT04541407|Temozolomide|temozolomide|mesh-list
138591426|NCT04541407|Osimertinib|osimertinib|mesh-list
138591427|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138591428|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
138591429|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591430|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591431|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138591432|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591433|NCT04552795|Lamivudine|lamivudine|mesh-list
138591434|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138591435|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138591436|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591437|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591438|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
138591439|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591440|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138591441|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138591442|NCT04463680|Rifampin|rifampin|mesh-list
138591443|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138591444|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
138591445|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138591446|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591447|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
138591448|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138591449|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591450|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591451|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138591452|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138591453|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138591454|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138591455|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138591456|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138591457|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138591458|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591459|NCT04304014|Sulfalene|sulfalene|mesh-list
138591460|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591461|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138591462|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
138591463|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138591464|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138591465|NCT04300231|Hydromorphone|hydromorphone|mesh-list
138591466|NCT04300231|Bupivacaine|bupivacaine|mesh-list
138591467|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
138591468|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
138591469|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591470|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591471|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
138591472|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591473|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138591474|NCT04300231|Narcotics|narcotics|mesh-ancestor
138591475|NCT04300231|Analgesics|analgesics|mesh-ancestor
138591476|NCT04171050|Anesthetics|anesthetics|mesh-list
138591477|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
138591478|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591479|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591480|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
138591481|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591482|NCT04098081|Gemcitabine|gemcitabine|mesh-list
138591483|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
138591484|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138591485|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
138591486|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591487|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591488|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591489|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
138591490|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138663139|NCT06097676|Antimanic Agents|antimanic agents|mesh-ancestor
138591492|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138591493|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591494|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138591495|NCT03914612|Paclitaxel|paclitaxel|mesh-list
138591496|NCT03914612|Carboplatin|carboplatin|mesh-list
138591497|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
138591498|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138591499|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138483106|NCT05546320|Protease Inhibitors|protease inhibitors|mesh-ancestor
138591500|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591501|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
138591502|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
138591503|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
138591504|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591505|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138591506|NCT03914612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138591507|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138591508|NCT03896880|Clotrimazole|clotrimazole|mesh-list
138591509|NCT03896880|Miconazole|miconazole|mesh-list
138591510|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
138591511|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591512|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138591513|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138591514|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138591515|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591516|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591517|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138591518|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
138591519|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591520|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591521|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138591522|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138591523|NCT03815019|Megestrol|megestrol|mesh-list
138591524|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
138591525|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138591526|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138591527|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138591528|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
138591529|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138591530|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591531|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138591532|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138591533|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138591534|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591535|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
138591536|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138591537|NCT03767218|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138454904|NCT01902121|Insulin|insulin|mesh-list
138591538|NCT03767218|Hormones|hormones|mesh-ancestor
138591539|NCT03767218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591540|NCT03767218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591541|NCT03739645|Metronidazole|metronidazole|mesh-list
138591542|NCT03739645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591543|NCT03739645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138591544|NCT03739645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138591546|NCT03603509|Vaccines|vaccines|mesh-list
138591547|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
138591548|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591549|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
138591550|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138663154|NCT06057038|Carboplatin|carboplatin|mesh-list
138591551|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138591552|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591553|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
138591554|NCT03361345|Coagulants|coagulants|mesh-ancestor
138591555|NCT03216187|Pregabalin|pregabalin|mesh-list
138591556|NCT03216187|Analgesics|analgesics|mesh-ancestor
138591557|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
138591558|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591559|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591560|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
138591561|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138591562|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138591563|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591564|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138591565|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138591566|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138591567|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591568|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138591569|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138591570|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138591571|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591572|NCT03172754|Nivolumab|nivolumab|mesh-list
138591573|NCT03172754|Axitinib|axitinib|mesh-list
138591574|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138591575|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591576|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138591577|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591578|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138591579|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591580|NCT03137888|Temozolomide|temozolomide|mesh-list
138591581|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138591582|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
138591583|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591584|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591585|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
138591586|NCT03123913|Testosterone|testosterone|mesh-list
138591587|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
138591588|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
138591589|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138591590|NCT03123913|Androgens|androgens|mesh-ancestor
138591592|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591593|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591594|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138591595|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591596|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
138591597|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
138591598|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
138591599|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138591600|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591601|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591602|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
138591603|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138591604|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138454909|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138454910|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138267914|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
138591605|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591608|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591609|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138591610|NCT03007238|Analgesics|analgesics|mesh-ancestor
138591611|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
138591612|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591613|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591614|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138591615|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138591616|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
138591617|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591618|NCT02902198|Quinine|quinine|mesh-list
138591619|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
138591620|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138591621|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138591622|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591623|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138591624|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591626|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591627|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138159900|NCT01228240|Metformin|metformin|mesh-list
138591628|NCT02902198|Analgesics|analgesics|mesh-ancestor
138591629|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
138591630|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
138591631|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138591632|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591633|NCT02858869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138591634|NCT02858869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591635|NCT02811523|Doxorubicin|doxorubicin|mesh-list
138591636|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138591637|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591638|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138591639|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138591640|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591641|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591642|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
138591643|NCT02750319|Amiodarone|amiodarone|mesh-list
138591644|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138591645|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
138591646|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591647|NCT02750319|Expectorants|expectorants|mesh-ancestor
138591648|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
138591649|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138591650|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
138591651|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591652|NCT02750319|Protective Agents|protective agents|mesh-ancestor
138591653|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591654|NCT02750319|Antidotes|antidotes|mesh-ancestor
138591655|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138591656|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
138591657|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138591658|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138591660|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138591661|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138591662|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591663|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138591664|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138591665|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138591666|NCT02611258|Tadalafil|tadalafil|mesh-list
138591667|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
138591668|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138482120|NCT00005818|Irinotecan|irinotecan|mesh-list
138591669|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138591670|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591671|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591672|NCT02611258|Urological Agents|urological agents|mesh-ancestor
138454914|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
138454915|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138454916|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
138454917|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
138591673|NCT02172651|Vitamin D|vitamin d|mesh-list
138591674|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
138591675|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
138591676|NCT02172651|Vitamins|vitamins|mesh-list
138591677|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
138591678|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591679|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138483160|NCT05285683|Dopamine Agents|dopamine agents|mesh-ancestor
138591680|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138591681|NCT02144857|Cyclosporine|cyclosporine|mesh-list
138591682|NCT02144857|Etanercept|etanercept|mesh-list
138591683|NCT02144857|Apremilast|apremilast|mesh-list
138591684|NCT02144857|Ustekinumab|ustekinumab|mesh-list
138591685|NCT02144857|Cyclosporins|cyclosporins|mesh-list
138591686|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591687|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591688|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138591689|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
138591690|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591691|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
138591692|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591693|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
138591694|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138591695|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138591696|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138591697|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138591698|NCT02144857|Analgesics|analgesics|mesh-ancestor
138591699|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
138591700|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591701|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138591702|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138591703|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138591704|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138591705|NCT02095184|Letrozole|letrozole|mesh-list
138591706|NCT02095184|Anastrozole|anastrozole|mesh-list
138591707|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482169|NCT00005827|Hormones|hormones|mesh-ancestor
138591709|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138591710|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591711|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591712|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138591713|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
138591714|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591715|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591716|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138591717|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
138591718|NCT01252953|Anacetrapib|anacetrapib|mesh-list
138591719|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138591720|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138591721|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
138591722|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591723|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138591724|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591725|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138591726|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289601|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138591727|NCT00937131|Rituximab|rituximab|mesh-list
138591728|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138591729|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591730|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
138591731|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591732|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138591733|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138591734|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138591735|NCT00837616|Estradiol|estradiol|mesh-list
138591736|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138591737|NCT00837616|Estrogens|estrogens|mesh-ancestor
138591738|NCT00837616|Hormones|hormones|mesh-ancestor
138591739|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591740|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591741|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138591742|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
138591743|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138591744|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138591745|NCT00610051|Alprostadil|alprostadil|mesh-list
138591746|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138591748|NCT00610051|Urological Agents|urological agents|mesh-ancestor
138591749|NCT00176254|Paclitaxel|paclitaxel|mesh-list
138591750|NCT00176254|Carboplatin|carboplatin|mesh-list
138591751|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138591752|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591753|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
138591754|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
138591755|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
138591756|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591757|NCT02949895|Etoposide|etoposide|mesh-list
138482190|NCT00005839|Capecitabine|capecitabine|mesh-list
138591758|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591759|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138591760|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138591761|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138591762|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591763|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591764|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
138591765|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138591766|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591767|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
138591768|NCT00516841|Volociximab|volociximab|mesh-list
138591769|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138591770|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138591771|NCT00516841|Growth Substances|growth substances|mesh-ancestor
138591772|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591773|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
138591774|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591775|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
138591776|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138591777|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591778|NCT04694677|Misoprostol|misoprostol|mesh-list
138591779|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
138591780|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138591781|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138591782|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591784|NCT04694677|Coagulants|coagulants|mesh-ancestor
138454939|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138454941|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
138591785|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138591786|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
138591787|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138591788|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591789|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138591790|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138591791|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
138591792|NCT00516958|Levofloxacin|levofloxacin|mesh-list
138591793|NCT00516958|Ofloxacin|ofloxacin|mesh-list
138591794|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138591795|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138591796|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591797|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138591798|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138483187|NCT00006441|Aldesleukin|aldesleukin|mesh-list
138591799|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138591800|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591801|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591802|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591803|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138591804|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138591805|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
138591806|NCT00517114|Rabeprazole|rabeprazole|mesh-list
138591807|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138591809|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138591810|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591811|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591813|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138591814|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138591815|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138591816|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591817|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591818|NCT00517309|Vaccines|vaccines|mesh-list
138591819|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
138591820|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591821|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138591822|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
138591823|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138591824|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138591825|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138591826|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591827|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591828|NCT00517426|Acetazolamide|acetazolamide|mesh-list
138591829|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
138591830|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138591831|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591832|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591833|NCT00517426|Diuretics|diuretics|mesh-ancestor
138591834|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
138591835|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591836|NCT00517504|Methylphenidate|methylphenidate|mesh-list
138591837|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138591838|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591839|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138591840|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138591841|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138591842|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591843|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
138591844|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138591845|NCT00517582|Icatibant|icatibant|mesh-list
138591846|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138591847|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138591848|NCT00517582|Analgesics|analgesics|mesh-ancestor
138591849|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
138591850|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591851|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591852|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138591853|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138591854|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138591855|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138591856|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591857|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138483211|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138483212|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138483213|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483214|NCT03926845|Thiamidol|thiamidol|mesh-list
138483215|NCT03926845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591858|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138591859|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
138591860|NCT00517621|Paclitaxel|paclitaxel|mesh-list
138591861|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138591862|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591863|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
138591864|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
138591865|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
138591866|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591867|NCT00151515|Minoxidil|minoxidil|mesh-list
138591868|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138591869|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
138591870|NCT00166686|Clonidine|clonidine|mesh-list
138591871|NCT00166686|Analgesics|analgesics|mesh-ancestor
138591872|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
138591873|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591874|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591875|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138591876|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
138591877|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
138591878|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138591879|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138591880|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138591882|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138591883|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591884|NCT02949778|Ropivacaine|ropivacaine|mesh-list
138591885|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
138591886|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
138591887|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591888|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591889|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
138663249|NCT06003218|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138591890|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591892|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
138591893|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138591894|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138482262|NCT00005860|Calcium|calcium|mesh-list
138591895|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591896|NCT02957903|Ropivacaine|ropivacaine|mesh-list
138591897|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
138591898|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
138591899|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591900|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591901|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
138591902|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138591903|NCT00518479|Amlodipine|amlodipine|mesh-list
138454971|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138591904|NCT00518479|Valsartan|valsartan|mesh-list
138591905|NCT00518479|Moxonidine|moxonidine|mesh-list
138591906|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
138591907|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138591908|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138591909|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138591910|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483216|NCT03926845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483218|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483219|NCT00006453|Carboplatin|carboplatin|mesh-list
138483220|NCT00006453|Gemcitabine|gemcitabine|mesh-list
138483221|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591911|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138591912|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591913|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
138591914|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138591915|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138591916|NCT00518479|Diuretics|diuretics|mesh-ancestor
138591917|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
138591918|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138591919|NCT00166725|Octreotide|octreotide|mesh-list
138591920|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138591921|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138591922|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591923|NCT00518635|Insulin|insulin|mesh-list
138591924|NCT00518635|Hormones|hormones|mesh-list
138591925|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138591926|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591927|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591928|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
138591929|NCT00151632|Tacrolimus|tacrolimus|mesh-list
138591930|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138591931|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
138591932|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591933|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138591934|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591935|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591936|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138591937|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663299|NCT05896839|Sirolimus|sirolimus|mesh-list
138591938|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138591939|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
138591940|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138591941|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138591942|NCT02949232|Prednisolone|prednisolone|mesh-list
138591943|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138591944|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
138591945|NCT02949232|Hormones|hormones|mesh-ancestor
138591946|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591947|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591948|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138591949|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138591950|NCT00518908|Sevoflurane|sevoflurane|mesh-list
138591951|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138591952|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138591953|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
138591954|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
138591955|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591956|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591957|NCT00518947|Verapamil|verapamil|mesh-list
138591958|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
138591959|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
138591960|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138591961|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138454978|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138454979|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591962|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591963|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
138591964|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138591965|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591966|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591967|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138591968|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138591969|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138591970|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138591972|NCT02949466|Triamcinolone|triamcinolone|mesh-list
138591973|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
138591974|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138483234|NCT00006459|Gemcitabine|gemcitabine|mesh-list
138591975|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
138591976|NCT02949466|Hormones|hormones|mesh-ancestor
138591977|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138591978|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591979|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
138591980|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138591981|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
138591982|NCT02949466|Protective Agents|protective agents|mesh-ancestor
138591983|NCT00151710|Pioglitazone|pioglitazone|mesh-list
138591984|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138591985|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591986|NCT00519181|Valproic Acid|valproic acid|mesh-list
138591987|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
138591988|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138591989|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138591990|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
138591991|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138591992|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138591993|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
138591994|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138591995|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138591996|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138591997|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
138591998|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138591999|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592000|NCT02949310|Nefopam|nefopam|mesh-list
138592001|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138592002|NCT02949310|Analgesics|analgesics|mesh-ancestor
138592003|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
138592004|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592005|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592006|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
138592007|NCT02949349|Prednisolone|prednisolone|mesh-list
138592008|NCT02949349|Azathioprine|azathioprine|mesh-list
138592009|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138592010|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592011|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138592012|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
138592013|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138592014|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592015|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592016|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592017|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138592018|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
138592019|NCT02949349|Hormones|hormones|mesh-ancestor
138592020|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138592021|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592022|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138592023|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
138483242|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
138454989|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592024|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138592025|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592026|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
138592027|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592029|NCT00166842|Sirolimus|sirolimus|mesh-list
138592030|NCT00166842|Tacrolimus|tacrolimus|mesh-list
138592031|NCT00166842|Cyclosporins|cyclosporins|mesh-list
138592032|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592033|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
138592034|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592035|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138592036|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592037|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592038|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
138592039|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592041|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592042|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138592043|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138592044|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592045|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138592046|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138592047|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592048|NCT02949193|Incretins|incretins|mesh-ancestor
138592049|NCT02949193|Hormones|hormones|mesh-ancestor
138592050|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138592051|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138592052|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
138592053|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592054|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592056|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138592057|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
138592058|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592059|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592060|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138592061|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138592062|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
138592063|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592064|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592065|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
138592066|NCT00519298|Donepezil|donepezil|mesh-list
138592067|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138592068|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592069|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592070|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
138592071|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592072|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592073|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
138592074|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
138592075|NCT00519337|Vitamins|vitamins|mesh-ancestor
138592076|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
138592077|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592078|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
138592079|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592080|NCT00519337|Protective Agents|protective agents|mesh-ancestor
138592081|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138592082|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138592083|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138592084|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
138592085|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592086|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138592087|NCT00166881|Docetaxel|docetaxel|mesh-list
138592088|NCT00166881|Irinotecan|irinotecan|mesh-list
138592089|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592090|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
138592091|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
138592092|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
138482446|NCT00005926|Gemcitabine|gemcitabine|mesh-list
138455000|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138592093|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592094|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138592095|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138592096|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592098|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138592099|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
138592100|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138592101|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592102|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138592103|NCT02948998|Diuretics|diuretics|mesh-ancestor
138592104|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
138592105|NCT00519688|Thalidomide|thalidomide|mesh-list
138592106|NCT00519688|Tegafur|tegafur|mesh-list
138592107|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592108|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
138592109|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592110|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
138592111|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138592112|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592113|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138592114|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138592115|NCT00519688|Growth Substances|growth substances|mesh-ancestor
138482484|NCT00005938|Exatecan|exatecan|mesh-list
138592117|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592118|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138592119|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
138592120|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592121|NCT02948920|Ephedrine|ephedrine|mesh-list
138592122|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138592123|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592124|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
138592125|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
138592126|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592127|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138592128|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
138268457|NCT03331835|Brodalumab|brodalumab|mesh-list
138592129|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592130|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592131|NCT00151827|Losartan|losartan|mesh-list
138592132|NCT00151827|Olmesartan|olmesartan|mesh-list
138592133|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138592134|NCT00151827|Furosemide|furosemide|mesh-list
138592135|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138592136|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138592137|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138592138|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138592139|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592140|NCT00151827|Diuretics|diuretics|mesh-ancestor
138592141|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
138592142|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592143|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138592144|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138592145|NCT00519805|Dalteparin|dalteparin|mesh-list
138592146|NCT00519805|Tinzaparin|tinzaparin|mesh-list
138592147|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138592149|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138592150|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138592151|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592152|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
138592153|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138592154|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592156|NCT04457180|Apatinib|apatinib|mesh-list
138592157|NCT04457180|Bupropion|bupropion|mesh-list
138592158|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592159|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138455008|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138592160|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592161|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592162|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138592163|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
138592164|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138592165|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138592166|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138592167|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138592168|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
138592169|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592170|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592171|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138592172|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138592173|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138592174|NCT00520000|Carboplatin|carboplatin|mesh-list
138592175|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138592176|NCT00520000|Paclitaxel|paclitaxel|mesh-list
138592177|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592178|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138592179|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
138592180|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
138592181|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
138592182|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592183|NCT00151944|Mesalamine|mesalamine|mesh-list
138592184|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138592185|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138592186|NCT00151944|Analgesics|analgesics|mesh-ancestor
138592187|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
138592188|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592189|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592190|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138592191|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592192|NCT00520507|Olanzapine|olanzapine|mesh-list
138592193|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
138592194|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
138592195|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592196|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592197|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138592198|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138592199|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138592200|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138592201|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138592202|NCT00520507|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138592203|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138592204|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138592205|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592206|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592207|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
138592209|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592210|NCT04694365|Fluzoparib|fluzoparib|mesh-list
138592211|NCT04694365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138592212|NCT04694365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592213|NCT04694365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592214|NCT04694365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592215|NCT00151983|Methylphenidate|methylphenidate|mesh-list
138592216|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138592217|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592218|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138592219|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138592220|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138592221|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592222|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
138592223|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592224|NCT00520585|Atorvastatin|atorvastatin|mesh-list
138455024|NCT01902537|Prucalopride|prucalopride|mesh-list
138592225|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138592226|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138592227|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
138592228|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592229|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138592230|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138592231|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483330|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138592233|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
138592234|NCT00152022|Adderall|adderall|mesh-list
138592235|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138592236|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592237|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
138592238|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
138592239|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592240|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
138592241|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592242|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592243|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
138592244|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138592245|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138592246|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138592247|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138592248|NCT00520819|Antioxidants|antioxidants|mesh-list
138592249|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592250|NCT00520819|Protective Agents|protective agents|mesh-ancestor
138592251|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592252|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
138592253|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138592254|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138592255|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
138592256|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592257|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138592258|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138592259|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592260|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592262|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592263|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138592264|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138592265|NCT00521092|Growth Substances|growth substances|mesh-ancestor
138592266|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592267|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
138592268|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138592269|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592270|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592271|NCT00521131|Levocetirizine|levocetirizine|mesh-list
138592272|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138592273|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138592274|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
138592275|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
138592276|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592277|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592278|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592280|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138592281|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138592282|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
138592283|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455029|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
138592284|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592285|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592286|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138592287|NCT00521170|Levocetirizine|levocetirizine|mesh-list
138592288|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138592289|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138592290|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
138592291|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
138592292|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592293|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592294|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592295|NCT00521248|Morphine|morphine|mesh-list
138592296|NCT00521248|Buprenorphine|buprenorphine|mesh-list
138592297|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138592298|NCT00521248|Narcotics|narcotics|mesh-ancestor
138592299|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138592300|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592301|NCT00521248|Analgesics|analgesics|mesh-ancestor
138592303|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592304|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138592305|NCT00167154|Risperidone|risperidone|mesh-list
138592306|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138592307|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
138592308|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592309|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592310|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592311|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138592312|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138592313|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138592314|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138592315|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138592316|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
138592317|NCT00521482|Thalidomide|thalidomide|mesh-list
138592318|NCT00521482|Temozolomide|temozolomide|mesh-list
138592319|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138592320|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
138592321|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592322|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592323|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592324|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
138592325|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592326|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
138592327|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138592328|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592329|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138592330|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138592331|NCT00521482|Growth Substances|growth substances|mesh-ancestor
138592332|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
138592333|NCT00521521|Docetaxel|docetaxel|mesh-list
138592334|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592335|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
138592336|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
138592337|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
138592338|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592339|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
138592340|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138592341|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592342|NCT00522184|Etanercept|etanercept|mesh-list
138592343|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138592344|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138592345|NCT00522184|Analgesics|analgesics|mesh-ancestor
138592346|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
138592347|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592348|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592349|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138592350|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592351|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138592352|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592353|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
138592355|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138592356|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138592357|NCT03458923|Ranibizumab|ranibizumab|mesh-list
138592358|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
138592359|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138592360|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138592361|NCT03458923|Growth Substances|growth substances|mesh-ancestor
138592362|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592363|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
138592364|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138483362|NCT03265405|Hormones|hormones|mesh-ancestor
138592365|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592366|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138592368|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
138592369|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592370|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592371|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138592372|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592374|NCT04186013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138592375|NCT04186013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592376|NCT04186013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138592377|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592378|NCT00152139|Antibodies|antibodies|mesh-list
138592379|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
138592380|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592381|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138592382|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138592383|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592384|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
138592385|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138592386|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138592387|NCT00167232|Naltrexone|naltrexone|mesh-list
138592388|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138592389|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138592390|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592391|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
138592392|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592393|NCT00522886|Cetuximab|cetuximab|mesh-list
138592394|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138592395|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592396|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
138592397|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
138592398|NCT04083560|Hematinics|hematinics|mesh-ancestor
138592399|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
138592400|NCT04083560|Vitamins|vitamins|mesh-ancestor
138592401|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
138592402|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592403|NCT00511966|Rabeprazole|rabeprazole|mesh-list
138592404|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138592405|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138592406|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138592407|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138663476|NCT05806346|Coagulants|coagulants|mesh-ancestor
138455051|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455052|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138305786|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455053|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138455054|NCT01902771|Imiquimod|imiquimod|mesh-list
138455055|NCT01902771|Vaccines|vaccines|mesh-list
138455056|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
138592408|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483378|NCT02966548|Nivolumab|nivolumab|mesh-list
138592410|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
138592411|NCT00152178|Fluorouracil|fluorouracil|mesh-list
138592412|NCT00152178|Methotrexate|methotrexate|mesh-list
138592413|NCT00152178|Tegafur|tegafur|mesh-list
138592414|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592415|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
138592416|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592417|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592418|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138592419|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
138592420|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592421|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592422|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138592423|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
138592424|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138592425|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138592426|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
138592427|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138592428|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
138592429|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592430|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138592431|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138592432|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138592433|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
138592434|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138592435|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138592436|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138592437|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138592438|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138592439|NCT00523120|Diclofenac|diclofenac|mesh-list
138592440|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138592441|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138592442|NCT00523120|Analgesics|analgesics|mesh-ancestor
138592443|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
138592444|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592445|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592446|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138592447|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592448|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138592449|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592450|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592451|NCT00523159|Sargramostim|sargramostim|mesh-list
138592452|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
138592453|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592454|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
138592455|NCT04693897|Mirabegron|mirabegron|mesh-list
138592456|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138592457|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138592458|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
138592459|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592460|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592461|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592463|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138592464|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138592465|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138592466|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
138592467|NCT00424242|Pemetrexed|pemetrexed|mesh-list
138592468|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592469|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592470|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592471|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138592472|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138592473|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
138592474|NCT04726553|Antimalarials|antimalarials|mesh-list
138592475|NCT04726553|Methotrexate|methotrexate|mesh-list
138592476|NCT04726553|Azathioprine|azathioprine|mesh-list
138592477|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138592478|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
138592479|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138592480|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592481|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138592482|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
138592483|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592484|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592485|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
138592486|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592487|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138592488|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592489|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
138592490|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592491|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138592492|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138592493|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138592494|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
138592495|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138592496|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592497|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138592498|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138592499|NCT02947945|Reslizumab|reslizumab|mesh-list
138592500|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138592501|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
138592502|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
138592503|NCT02948101|Antibodies|antibodies|mesh-list
138592504|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138592505|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592506|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
138592507|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592508|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592509|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138592510|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
138592511|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592512|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592513|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138592514|NCT02952157|Lidocaine|lidocaine|mesh-list
138592515|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
138592516|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
138592517|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138592518|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592519|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
138592520|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592521|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138592522|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138455076|NCT01902862|Rituximab|rituximab|mesh-list
138592524|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138592525|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592526|NCT02951728|Prednisone|prednisone|mesh-list
138592527|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
138592528|NCT02951728|Rituximab|rituximab|mesh-list
138592529|NCT02951728|Doxorubicin|doxorubicin|mesh-list
138592530|NCT02951728|Vincristine|vincristine|mesh-list
138592531|NCT02951728|Decitabine|decitabine|mesh-list
138592532|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592533|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
138592534|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592535|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592536|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138592538|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592539|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592540|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138592541|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138592542|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138592543|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138592544|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138592545|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592546|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138592547|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
138592548|NCT02951728|Hormones|hormones|mesh-ancestor
138592549|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138592550|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138592551|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138592552|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
138592553|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
138592554|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
138592555|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138592556|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
138592557|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138592558|NCT04726046|Cefotetan|cefotetan|mesh-list
138592559|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592560|NCT00523354|Infliximab|infliximab|mesh-list
138592561|NCT00523354|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138592562|NCT00523354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138592563|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
138592564|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138592565|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592566|NCT00523393|Insulin|insulin|mesh-list
138592567|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138592568|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138592569|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592570|NCT00523432|Sirolimus|sirolimus|mesh-list
138592571|NCT00523432|Topotecan|topotecan|mesh-list
138592572|NCT00523432|Temsirolimus|temsirolimus|mesh-list
138592573|NCT00523432|MTOR Inhibitors|mtor inhibitors|mesh-list
138592574|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138663553|NCT05756621|GABA Modulators|gaba modulators|mesh-ancestor
138592575|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138592576|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592577|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592578|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592579|NCT00523432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138592580|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592581|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
138592582|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592583|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138592584|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455097|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592585|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138592586|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
138592587|NCT00512044|Anesthetics|anesthetics|mesh-list
138592588|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138592589|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592590|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
138592591|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138592592|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592593|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
138592594|NCT00521950|Azathioprine|azathioprine|mesh-list
138592595|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
138592596|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592597|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138592598|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592599|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592600|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
138592601|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592602|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138592603|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592604|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592606|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138592607|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592608|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592609|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
138592610|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592611|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592612|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138592613|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
138592614|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592615|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
138455114|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138592616|NCT00167583|Interferons|interferons|mesh-list
138592617|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
138592618|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
138592619|NCT00167583|Cyclosporine|cyclosporine|mesh-list
138592620|NCT00167583|Cyclosporins|cyclosporins|mesh-list
138592621|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592622|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
138592623|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592624|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592625|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592626|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592627|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
138592628|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592629|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
138592630|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
138592631|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592632|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138592633|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138592634|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592635|NCT00172809|Interferons|interferons|mesh-list
138592636|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
138592637|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
138592638|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138592639|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592640|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
138592641|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592642|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
138592643|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592644|NCT04696120|Apixaban|apixaban|mesh-list
138482724|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138592645|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138592646|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
138592647|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138592648|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
138592649|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592650|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592651|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
138592653|NCT00512395|Ropivacaine|ropivacaine|mesh-list
138592654|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138592655|NCT00512395|Narcotics|narcotics|mesh-ancestor
138592656|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138592657|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592658|NCT00512395|Analgesics|analgesics|mesh-ancestor
138592659|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
138592660|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592661|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138592662|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138592663|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
138592664|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
138592665|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
138592666|NCT00512473|Hormones|hormones|mesh-list
138592667|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138592668|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592669|NCT00524095|Fluticasone|fluticasone|mesh-list
138592670|NCT00524095|Xhance|xhance|mesh-list
138592671|NCT00524095|Azithromycin|azithromycin|mesh-list
138592672|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138592673|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138592674|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
138592675|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592676|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592677|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138592678|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
138592679|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
138592680|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138592681|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138592682|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592683|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138592684|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138592685|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138592686|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138592687|NCT00512668|Sirolimus|sirolimus|mesh-list
138592688|NCT00512668|Leuprolide|leuprolide|mesh-list
138592689|NCT00512668|Goserelin|goserelin|mesh-list
138592690|NCT00512668|Flutamide|flutamide|mesh-list
138592692|NCT00512668|Bicalutamide|bicalutamide|mesh-list
138592693|NCT00512668|Nilutamide|nilutamide|mesh-list
138592694|NCT00512668|MTOR Inhibitors|mtor inhibitors|mesh-list
138592695|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138592696|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
138592697|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138592698|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592699|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138592700|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592701|NCT00512668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138592702|NCT00512668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592703|NCT00512668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592704|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592705|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
138592706|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138592707|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592708|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138592709|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
138592710|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
138592711|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
138592712|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138592713|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
138592714|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
138592715|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138592716|NCT00167739|Quinine|quinine|mesh-list
138592717|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
138663631|NCT05676112|Nintedanib|nintedanib|mesh-list
138592718|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138592719|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138592720|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592721|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138592722|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592723|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592724|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138592725|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138592726|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592727|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138592728|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592729|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138592730|NCT00167739|Analgesics|analgesics|mesh-ancestor
138592731|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
138592732|NCT00524251|Esomeprazole|esomeprazole|mesh-list
138592733|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138592734|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138592735|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138592736|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592737|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592738|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
138592739|NCT00512824|Calcium|calcium|mesh-list
138592740|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138592741|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592742|NCT00512824|Antacids|antacids|mesh-ancestor
138592743|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592744|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138592745|NCT00512863|Adalimumab|adalimumab|mesh-list
138592746|NCT00512863|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138592747|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138592748|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592749|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
138592750|NCT00524407|Hematinics|hematinics|mesh-ancestor
138592751|NCT00525889|Sirolimus|sirolimus|mesh-list
138592752|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138592753|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592754|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138592755|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592756|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
138592757|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592758|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
138592759|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592760|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
138592761|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592762|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138592763|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138592764|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138482761|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
138592765|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592766|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
138592767|NCT03879122|Docetaxel|docetaxel|mesh-list
138592768|NCT03879122|Nivolumab|nivolumab|mesh-list
138592769|NCT03879122|Ipilimumab|ipilimumab|mesh-list
138592770|NCT03879122|Androgens|androgens|mesh-list
138592771|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592772|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
138592773|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
138592774|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
138592775|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592776|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138592777|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138592778|NCT03879122|Hormones|hormones|mesh-ancestor
138592779|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138592780|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592781|NCT00525928|Varenicline|varenicline|mesh-list
138592782|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138592783|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138592784|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
138592785|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592786|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592787|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592788|NCT00167817|Aripiprazole|aripiprazole|mesh-list
138592789|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
138592790|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138592791|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138592792|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138592793|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138592794|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592795|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
138592796|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
138159987|NCT00334633|Tinidazole|tinidazole|mesh-list
138592797|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592798|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592799|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138592800|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138592802|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138592803|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138592804|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138592805|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138592807|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138592808|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138592809|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138592810|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592811|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138592812|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592813|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
138592814|NCT03845348|Ketoconazole|ketoconazole|mesh-list
138592815|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
138592816|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592817|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138592818|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138592819|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592820|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592821|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138592822|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
138592823|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138592824|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592825|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138592826|NCT04723563|Heparin|heparin|mesh-list
138592827|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
138592828|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138592829|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138592830|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592831|NCT00525967|Acetaminophen|acetaminophen|mesh-list
138592832|NCT00525967|Methadone|methadone|mesh-list
138592833|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138592834|NCT00525967|Analgesics|analgesics|mesh-ancestor
138592835|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
138592836|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592837|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592838|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
138455145|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592839|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138592840|NCT00525967|Narcotics|narcotics|mesh-ancestor
138592841|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138592842|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
138592843|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
138592844|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138592845|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138592846|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138592847|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138592848|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592849|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592850|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592851|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138592852|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
138592853|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138592854|NCT00526006|Esomeprazole|esomeprazole|mesh-list
138592855|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138592856|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138592857|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138592858|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592859|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592861|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
138592862|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138592863|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592864|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
138592865|NCT02946814|Protective Agents|protective agents|mesh-ancestor
138592866|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592867|NCT00524836|Levocetirizine|levocetirizine|mesh-list
138592868|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138592869|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138592870|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
138592871|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
138592872|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592873|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269202|NCT01445067|Calcitonin|calcitonin|mesh-list
138592874|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592876|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138592877|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138592878|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138592879|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138592880|NCT00524875|Growth Substances|growth substances|mesh-ancestor
138592881|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592882|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
138592883|NCT00524914|Apomorphine|apomorphine|mesh-list
138592884|NCT00524914|Emetics|emetics|mesh-ancestor
138592885|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592886|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
138592887|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592888|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138592889|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
138592890|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
138592891|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138592892|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592893|NCT02957864|Tenofovir|tenofovir|mesh-list
138592894|NCT02957864|Abacavir|abacavir|mesh-list
138592895|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
138592896|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138592897|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138592898|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138592899|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592900|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592901|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138592902|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138592903|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
138592904|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138592906|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
138592907|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592908|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
138592909|NCT03585452|Propofol|propofol|mesh-list
138592910|NCT03585452|Anesthetics|anesthetics|mesh-ancestor
138592911|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138592912|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592913|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138592914|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138592915|NCT03585452|Analgesics|analgesics|mesh-ancestor
138592916|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
138592917|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592918|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138592919|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138592920|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138592921|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
138592922|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483492|NCT00006708|Rituximab|rituximab|mesh-list
138592923|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592924|NCT03585452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138592925|NCT03585452|Anesthetics, General|anesthetics, general|mesh-ancestor
138592926|NCT02947672|Dexamethasone|dexamethasone|mesh-list
138592927|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138592928|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
138592929|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
138592930|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592931|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592932|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138592933|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
138592934|NCT02947672|Hormones|hormones|mesh-ancestor
138592935|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138592936|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138592937|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455174|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455175|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138592938|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138592939|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138592940|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138592941|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592942|NCT02946268|Ropivacaine|ropivacaine|mesh-list
138592943|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
138592944|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
138592945|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138592946|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592947|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
138592948|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592949|NCT00168051|Factor VIII|factor viii|mesh-list
138592950|NCT00168051|Coagulants|coagulants|mesh-ancestor
138592951|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
138592952|NCT00526318|Melphalan|melphalan|mesh-list
138592953|NCT00526318|Ifosfamide|ifosfamide|mesh-list
138592954|NCT00526318|Dacarbazine|dacarbazine|mesh-list
138592955|NCT00526318|Carboplatin|carboplatin|mesh-list
138592956|NCT00526318|Doxorubicin|doxorubicin|mesh-list
138592957|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138592958|NCT00526318|Etoposide|etoposide|mesh-list
138592959|NCT00526318|Vincristine|vincristine|mesh-list
138592960|NCT00526318|Topotecan|topotecan|mesh-list
138592961|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
138592962|NCT00526318|Vindesine|vindesine|mesh-list
138592963|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138592964|NCT00526318|Isotretinoin|isotretinoin|mesh-list
138592965|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138592966|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
138592967|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592968|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138592969|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138592970|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
138663688|NCT05663866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138592971|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138592972|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482838|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138592973|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138592974|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138592975|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138592976|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138592978|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138592979|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
138592980|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
138592981|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
138592982|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138592983|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
138592984|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138592985|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
138592986|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138592987|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138592988|NCT04693312|Prednisolone|prednisolone|mesh-list
138592990|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138592991|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
138592992|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138592993|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
138592994|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
138592995|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138592996|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138592997|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138592998|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
138592999|NCT04693312|Hormones|hormones|mesh-ancestor
138593000|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138593001|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138593002|NCT04693312|Protective Agents|protective agents|mesh-ancestor
138593003|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138593004|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593005|NCT00168090|Factor VIII|factor viii|mesh-list
138593006|NCT00168090|Coagulants|coagulants|mesh-ancestor
138593007|NCT00525382|Levocetirizine|levocetirizine|mesh-list
138593008|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138593009|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138593010|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
138593011|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
138593012|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593013|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593014|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593015|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
138663702|NCT05660967|Lenalidomide|lenalidomide|mesh-list
138593016|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138593017|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593018|NCT00168168|Lenograstim|lenograstim|mesh-list
138593019|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138593020|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
138593021|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593022|NCT03225755|Hormones|hormones|mesh-list
138593023|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138593024|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593025|NCT00525577|Probucol|probucol|mesh-list
138593027|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138593028|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
138593029|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593030|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138593032|NCT00525577|Protective Agents|protective agents|mesh-ancestor
138593033|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593034|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138593035|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138593037|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138593038|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138593039|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
138593040|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593041|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
138593042|NCT03186755|Protective Agents|protective agents|mesh-ancestor
138593043|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138593044|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138593045|NCT03186755|Analgesics|analgesics|mesh-ancestor
138593046|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
138593047|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593048|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138593049|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138593050|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138593051|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138593052|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138593053|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
138593054|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
138593055|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593056|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593057|NCT00525616|Rituximab|rituximab|mesh-list
138593058|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138593059|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593060|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
138593061|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593062|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138593064|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
138593065|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
138455218|NCT01904097|Pregabalin|pregabalin|mesh-list
138593066|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593067|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593068|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
138593069|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593070|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138593071|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138593072|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138593073|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593074|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593075|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
138593076|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593078|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138593079|NCT02947243|Narcotics|narcotics|mesh-ancestor
138593080|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593081|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593082|NCT02947243|Analgesics|analgesics|mesh-ancestor
138593083|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
138593084|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593085|NCT02946970|Quinine|quinine|mesh-list
138593086|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
138593087|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138593088|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138593089|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593090|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138593091|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593092|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138593093|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593094|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138593096|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
138593097|NCT00527020|Nicotine|nicotine|mesh-list
138593098|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138593099|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
138269436|NCT04735445|Liver Extracts|liver extracts|mesh-list
138593100|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593101|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593103|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138593104|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
138593106|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593107|NCT00407277|Nicotine|nicotine|mesh-list
138593108|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138593109|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
138593110|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593111|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593112|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138593113|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138593114|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
138593115|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593116|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593117|NCT00527059|Simendan|simendan|mesh-list
138593118|NCT00527059|Spironolactone|spironolactone|mesh-list
138593119|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138593120|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138593121|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
138593122|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138593123|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593124|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138593125|NCT00527059|Diuretics|diuretics|mesh-ancestor
138593126|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
138593127|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138593128|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
138593129|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593130|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593131|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138593132|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
138593133|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138593134|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138593135|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593136|NCT00527059|Protective Agents|protective agents|mesh-ancestor
138593137|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
138593139|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138593140|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593141|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138593142|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
138593143|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138593144|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593145|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593146|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593147|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138593148|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
138593149|NCT03156452|Hormones|hormones|mesh-ancestor
138593150|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138593151|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593152|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138593153|NCT00525772|Ciclesonide|ciclesonide|mesh-list
138593154|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
138593155|NCT00525772|Hormones|hormones|mesh-ancestor
138593156|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138593157|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593159|NCT02945956|Entecavir|entecavir|mesh-list
138593160|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
138593161|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593162|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
138593163|NCT00527137|Hematinics|hematinics|mesh-ancestor
138593164|NCT02945839|Topiramate|topiramate|mesh-list
138593165|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
138593166|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138593167|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593168|NCT02957786|Varenicline|varenicline|mesh-list
138593169|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138593170|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138593171|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
138593172|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593173|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593174|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593175|NCT00407394|Amoxicillin|amoxicillin|mesh-list
138593176|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138593177|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593178|NCT03109964|Hemostatics|hemostatics|mesh-list
138593179|NCT03109964|Surgiflo|surgiflo|mesh-list
138593180|NCT03109964|Coagulants|coagulants|mesh-ancestor
138593181|NCT00407433|Gemcitabine|gemcitabine|mesh-list
138593182|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
138593183|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138593184|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
138663780|NCT05596747|Insulin Glargine|insulin glargine|mesh-list
138593185|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593186|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455242|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593187|NCT00516412|Everolimus|everolimus|mesh-list
138593188|NCT00516412|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138593189|NCT00516412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138593190|NCT00516412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593191|NCT00516412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593192|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138593193|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
138593194|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593195|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593196|NCT03058835|Tenofovir|tenofovir|mesh-list
138593197|NCT03058835|Emtricitabine|emtricitabine|mesh-list
138593198|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
138593199|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593200|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138593201|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138593202|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593203|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593204|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138593205|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138593206|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138593207|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
138593208|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138593209|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
138593210|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138593211|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593212|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138593214|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593216|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138593217|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
138593218|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593219|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593220|NCT00173667|Nifedipine|nifedipine|mesh-list
138593221|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138593222|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593223|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593224|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138593225|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593226|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
138593227|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
138593228|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138593229|NCT00516685|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138593230|NCT00516685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138593231|NCT00516685|Immunologic Factors|immunologic factors|mesh-ancestor
138593232|NCT00516685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593233|NCT03458689|Analgesics|analgesics|mesh-list
138593234|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
138593235|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455261|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138455262|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138455263|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593236|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593237|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
138593238|NCT00527215|Hematinics|hematinics|mesh-ancestor
138593239|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
138593240|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138593241|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138593242|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138593243|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593244|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593245|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
138593246|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593247|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593248|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138593249|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593250|NCT02945644|Trazodone|trazodone|mesh-list
138593251|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138593252|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138593253|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593254|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593255|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138593256|NCT02945644|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138593257|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138593258|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593259|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593260|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593261|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
138593262|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138593263|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
138593264|NCT02945527|Dexamethasone|dexamethasone|mesh-list
138593265|NCT02945527|Acetazolamide|acetazolamide|mesh-list
138593266|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138593267|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
138593268|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
138593269|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593270|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593271|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138593272|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
138593273|NCT02945527|Hormones|hormones|mesh-ancestor
138483008|NCT05675293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138593274|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138593275|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138593276|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593277|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
138593278|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138593279|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593280|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593281|NCT02945527|Diuretics|diuretics|mesh-ancestor
138593283|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138593284|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138593286|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138593287|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138593288|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
138593289|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593290|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593291|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593292|NCT02448095|Ponatinib|ponatinib|mesh-list
138593293|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593294|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138593295|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593296|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593297|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
138593298|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138593299|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138593300|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138593301|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138455286|NCT01904539|Cathartics|cathartics|mesh-ancestor
138593302|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593303|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
138593304|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593305|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593306|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138593307|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593308|NCT00529594|Etoricoxib|etoricoxib|mesh-list
138593309|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138593310|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138593311|NCT00529594|Analgesics|analgesics|mesh-ancestor
138593312|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
138593313|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138483024|NCT03996148|Remifentanil|remifentanil|mesh-list
138593314|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593315|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138593316|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138593317|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138593318|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138593319|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593320|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593322|NCT00173862|Ifosfamide|ifosfamide|mesh-list
138593323|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138593324|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
138593325|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593326|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593327|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138593328|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
138593329|NCT00529750|Atenolol|atenolol|mesh-list
138593330|NCT00529750|Irbesartan|irbesartan|mesh-list
138593331|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138593332|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138593333|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138593334|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593335|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138593336|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
138593337|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
138593338|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593339|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593341|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138593342|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138593343|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
138593344|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593345|NCT00529867|Lumefantrine|lumefantrine|mesh-list
138593346|NCT00529867|Artemether|artemether|mesh-list
138593347|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138593348|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
138593349|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138593350|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138593351|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593352|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
138593353|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138593354|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138593355|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138593356|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593357|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593359|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455296|NCT01904591|Trace Elements|trace elements|mesh-ancestor
138593360|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593361|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138663815|NCT05575063|Viscosupplements|viscosupplements|mesh-ancestor
138593362|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593363|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
138593364|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138593365|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138593366|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138593367|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593368|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593369|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
138593370|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593371|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593372|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138593373|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593374|NCT00527449|Carboplatin|carboplatin|mesh-list
138593375|NCT00527449|Docetaxel|docetaxel|mesh-list
138593376|NCT00527449|Epirubicin|epirubicin|mesh-list
138593377|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593378|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
138593379|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
138593380|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
138593381|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593382|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138593383|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138593384|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138593385|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593386|NCT00168519|Nitroprusside|nitroprusside|mesh-list
138593387|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138593388|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
138593389|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138593390|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593391|NCT04692376|Cyclosporine|cyclosporine|mesh-list
138593392|NCT04692376|Cyclosporins|cyclosporins|mesh-list
138593393|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
138593394|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593395|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593396|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138593397|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
138593398|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593399|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
138593400|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593401|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
138593402|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138593403|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138593405|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138593406|NCT00527683|Vigabatrin|vigabatrin|mesh-list
138593407|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
138593408|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483084|NCT05546320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138593409|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593411|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593412|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593413|NCT00173901|Ceftazidime|ceftazidime|mesh-list
138593414|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138593415|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138455314|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455315|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138593416|NCT00527761|Cisplatin|cisplatin|mesh-list
138593417|NCT00527761|Docetaxel|docetaxel|mesh-list
138593418|NCT00527761|Temozolomide|temozolomide|mesh-list
138593419|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593420|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
138593421|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
138593422|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
138593423|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593424|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138593425|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
138593427|NCT00527800|Artemether|artemether|mesh-list
138593428|NCT00527800|Piperaquine|piperaquine|mesh-list
138593429|NCT00527800|Trimethoprim|trimethoprim|mesh-list
138593430|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138593431|NCT00527800|Artenimol|artenimol|mesh-list
138593432|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138593433|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
138593434|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
138593435|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138593436|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138593437|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593438|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138593439|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138593440|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593441|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593442|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138593443|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138593444|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138593445|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138593446|NCT02945293|Oxycodone|oxycodone|mesh-list
138483620|NCT00388167|Caspofungin|caspofungin|mesh-list
138593448|NCT02945293|Narcotics|narcotics|mesh-ancestor
138593449|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593450|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593451|NCT02945293|Analgesics|analgesics|mesh-ancestor
138593452|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
138593453|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593454|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
138593455|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138593456|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593457|NCT02945215|Rituximab|rituximab|mesh-list
138593458|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138593459|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593460|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
138593461|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593462|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138593463|NCT00144677|Sirolimus|sirolimus|mesh-list
138593464|NCT00144677|Tacrolimus|tacrolimus|mesh-list
138593466|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
138593467|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593468|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138593469|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593470|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593472|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593473|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138593474|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593475|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
138593476|NCT00531076|Bevacizumab|bevacizumab|mesh-list
138593477|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138593478|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593479|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138593480|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138455337|NCT01904734|Clomiphene|clomiphene|mesh-list
138593481|NCT00531076|Growth Substances|growth substances|mesh-ancestor
138593482|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593483|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
138593484|NCT00531115|Cetuximab|cetuximab|mesh-list
138593485|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138593486|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593487|NCT00144716|Insect Repellents|insect repellents|mesh-list
138593488|NCT00144716|Protective Agents|protective agents|mesh-ancestor
138593489|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593490|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
138593491|NCT00531193|SCH 442416|sch 442416|mesh-list
138593492|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138593493|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138593494|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138593495|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
138593496|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593497|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593498|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593499|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
138593500|NCT00144755|Hematinics|hematinics|mesh-ancestor
138593501|NCT00531271|Docetaxel|docetaxel|mesh-list
138593502|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593503|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
138593504|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
138593505|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
138593506|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593507|NCT00531310|Fludarabine|fludarabine|mesh-list
138593508|NCT00531310|Busulfan|busulfan|mesh-list
138593509|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593510|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593511|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138593512|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
138593513|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593514|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
138593515|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138593516|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138593517|NCT00407862|Losartan|losartan|mesh-list
138593518|NCT00407862|Telmisartan|telmisartan|mesh-list
138593519|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138593520|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138593521|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138593522|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138593523|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593524|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
138593525|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
138593526|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138593527|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138593528|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593529|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593530|NCT00527995|Urological Agents|urological agents|mesh-ancestor
138593531|NCT00144833|Ritonavir|ritonavir|mesh-list
138593532|NCT00144833|Lopinavir|lopinavir|mesh-list
138593533|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
138593534|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138593535|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138593536|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
138593537|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593538|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593539|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138455345|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
138455346|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138593540|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138593541|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
138593542|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593543|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138593544|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138593545|NCT02944942|Anesthetics|anesthetics|mesh-list
138593546|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593547|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593548|NCT00144872|Lamotrigine|lamotrigine|mesh-list
138593549|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
138593550|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138593551|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593552|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593553|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138593554|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593555|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138593556|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138593557|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593558|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138593559|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138593560|NCT02945020|Simeprevir|simeprevir|mesh-list
138593561|NCT02945020|Odalasvir|odalasvir|mesh-list
138593562|NCT02945020|Dabigatran|dabigatran|mesh-list
138593563|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
138593564|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138593565|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
138593566|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593567|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593568|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
138593569|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
138593570|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593571|NCT00528073|Rifaximin|rifaximin|mesh-list
138593572|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138593573|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593574|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138593575|NCT00528151|Curcumin|curcumin|mesh-list
138593576|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138593577|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138593578|NCT00528151|Analgesics|analgesics|mesh-ancestor
138593579|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
138593580|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593581|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593582|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138593583|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138593584|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593585|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593586|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593587|NCT00144911|Fluticasone|fluticasone|mesh-list
138593588|NCT00144911|Xhance|xhance|mesh-list
138593589|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138593590|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138593591|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138593592|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
138593593|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593594|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593595|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138593596|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
138593597|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
138593598|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138593599|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138593600|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138593601|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138593602|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
138593603|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593604|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593605|NCT00168597|Vitamin A|vitamin a|mesh-list
138593606|NCT00168597|Vitamins|vitamins|mesh-ancestor
138593607|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
138593608|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593609|NCT00528385|Spironolactone|spironolactone|mesh-list
138593610|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138593611|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
138593612|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138593613|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593614|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138593615|NCT00528385|Diuretics|diuretics|mesh-ancestor
138593616|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
138593617|NCT02944981|Gabapentin|gabapentin|mesh-list
138269959|NCT05923021|Sertraline|sertraline|mesh-list
138593618|NCT02944981|Analgesics|analgesics|mesh-ancestor
138593619|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
138593620|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593621|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593622|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
138593623|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138593624|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138593625|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593626|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138663924|NCT05521087|Cytarabine|cytarabine|mesh-list
138593627|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138593628|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138593629|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593630|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593631|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
138593632|NCT00168636|Vitamin A|vitamin a|mesh-list
138593633|NCT00168636|Vitamins|vitamins|mesh-ancestor
138593634|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
138593635|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593636|NCT00144989|Cisplatin|cisplatin|mesh-list
138593637|NCT00144989|Irinotecan|irinotecan|mesh-list
138593638|NCT00144989|Etoposide|etoposide|mesh-list
138593639|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593640|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138593641|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138593642|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593643|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593644|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138593645|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138593646|NCT00528502|Lidocaine|lidocaine|mesh-list
138593647|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
138593648|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
138593649|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593650|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593651|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
138593652|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593653|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138593654|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138593655|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138593656|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593657|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593658|NCT00528619|Carboplatin|carboplatin|mesh-list
138593659|NCT00528619|Pemetrexed|pemetrexed|mesh-list
138593660|NCT00528619|Sunitinib|sunitinib|mesh-list
138593661|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593662|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593663|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593664|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138483225|NCT00387322|Pemetrexed|pemetrexed|mesh-list
138455366|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455373|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
138593665|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138593666|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138593667|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138593668|NCT00528619|Growth Substances|growth substances|mesh-ancestor
138593669|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593670|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
138593671|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138593672|NCT00168714|Interferons|interferons|mesh-list
138593673|NCT00168714|Interferon-beta|interferon-beta|mesh-list
138593674|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
138593675|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593676|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
138593677|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593678|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
138593679|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593680|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138593681|NCT00528658|Acetaminophen|acetaminophen|mesh-list
138593682|NCT00528658|Ibuprofen|ibuprofen|mesh-list
138663945|NCT05521087|Antiviral Agents|antiviral agents|mesh-ancestor
138593683|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138593684|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138593685|NCT00528658|Analgesics|analgesics|mesh-ancestor
138593686|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
138593687|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593688|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483698|NCT00006082|Rubitecan|rubitecan|mesh-list
138593689|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138593690|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138593691|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138593692|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593693|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593695|NCT00145028|Carboplatin|carboplatin|mesh-list
138593696|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593697|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
138593698|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138593699|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593700|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
138593701|NCT00168753|Alefacept|alefacept|mesh-list
138593702|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
138593703|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
138593704|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593705|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
138593706|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138483243|NCT03876106|LUT014|lut014|mesh-list
138593707|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138593708|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
138593709|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593710|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138593711|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138593712|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593713|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593714|NCT00531349|Propofol|propofol|mesh-list
138593715|NCT00531349|Sevoflurane|sevoflurane|mesh-list
138593716|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
138593717|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593718|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593719|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138593720|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138593721|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
138593722|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138593723|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138593724|NCT00531466|Tolperisone|tolperisone|mesh-list
138593725|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138593726|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593727|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138593728|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593729|NCT00168792|Tenecteplase|tenecteplase|mesh-list
138455380|NCT01905059|Lopinavir|lopinavir|mesh-list
138455381|NCT01905059|Darunavir|darunavir|mesh-list
138593730|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138593731|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138593732|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593734|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593735|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138593736|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138593737|NCT00531544|Growth Substances|growth substances|mesh-ancestor
138593738|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593739|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
138593740|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138593742|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593743|NCT00145106|Minocycline|minocycline|mesh-list
138593744|NCT00145106|Tazarotene|tazarotene|mesh-list
138593745|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138593746|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593747|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
138593748|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
138593749|NCT00145184|Vitamins|vitamins|mesh-list
138593750|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
138593751|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
138593752|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593753|NCT02944357|Cisplatin|cisplatin|mesh-list
138593754|NCT02944357|Gemcitabine|gemcitabine|mesh-list
138593755|NCT02944357|Vaccines|vaccines|mesh-list
138593756|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593757|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138593758|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
138593759|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593760|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
138593761|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593762|NCT02944396|Paclitaxel|paclitaxel|mesh-list
138593763|NCT02944396|Carboplatin|carboplatin|mesh-list
138593764|NCT02944396|Nivolumab|nivolumab|mesh-list
138593765|NCT02944396|Pemetrexed|pemetrexed|mesh-list
138593766|NCT02944396|Veliparib|veliparib|mesh-list
138593767|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138593768|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593769|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
138593770|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
138593771|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
138593772|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593773|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138593774|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138593775|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593776|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138593777|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138593778|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138593780|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138593781|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593782|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138593783|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138593784|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138593785|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593786|NCT00530101|Doxorubicin|doxorubicin|mesh-list
138593787|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138593788|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593789|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138593790|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138593791|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593792|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593793|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138593794|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
138306368|NCT00000263|Analgesics|analgesics|mesh-ancestor
138593795|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593796|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
138593797|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138593798|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
138593799|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593800|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138593801|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
138593802|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138593803|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138593804|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593805|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593806|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138593807|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138593808|NCT00145301|Analgesics|analgesics|mesh-ancestor
138593809|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
138593810|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593811|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593812|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138593813|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138593814|NCT00168870|Gemcitabine|gemcitabine|mesh-list
138593816|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138593817|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
138593818|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593819|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593820|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138593821|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
138593823|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138593824|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138593825|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
138593826|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593827|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593828|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593829|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138593830|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
138593831|NCT02944201|Protective Agents|protective agents|mesh-ancestor
138593832|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138593833|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593834|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138593835|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
138593836|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138593837|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138593838|NCT00145340|Pioglitazone|pioglitazone|mesh-list
138593839|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138593840|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593841|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
138593842|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138593843|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138483755|NCT00006103|Vitamins|vitamins|mesh-ancestor
138593844|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593847|NCT00145379|Metformin|metformin|mesh-list
138593848|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138593849|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593850|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
138593851|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
138593852|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138593853|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138593854|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138593855|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138593856|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593857|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593858|NCT00530413|Phenobarbital|phenobarbital|mesh-list
138455399|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138455406|NCT01905150|Leucovorin|leucovorin|mesh-list
138593859|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
138593860|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138593861|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593862|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593863|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138593864|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138593865|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593866|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593867|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
138593868|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
138593869|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138593870|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138593871|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138593872|NCT00174330|Amlodipine|amlodipine|mesh-list
138593873|NCT00174330|Atorvastatin|atorvastatin|mesh-list
138593874|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138593875|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138593876|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
138593877|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593878|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138593879|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138593880|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593881|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138593882|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138593883|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593884|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138593885|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593886|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
138593887|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
138593888|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
138593889|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593890|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
138593891|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593892|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593893|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138593894|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138593895|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138593896|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593897|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593898|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593899|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593901|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
138593902|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593904|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138593905|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
138593906|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
138593907|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138593908|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593909|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
138593910|NCT00169026|Clozapine|clozapine|mesh-list
138593911|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138593912|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593913|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593914|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138593915|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138593917|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593918|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593919|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
138593920|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
138593921|NCT00145613|Antibodies|antibodies|mesh-list
138593922|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
138593923|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593924|NCT00531973|Doxorubicin|doxorubicin|mesh-list
138593925|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138593926|NCT00531973|Epirubicin|epirubicin|mesh-list
138593927|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138664013|NCT05455684|Aticaprant|aticaprant|mesh-list
138593928|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593929|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138593930|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138593932|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593933|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138593934|NCT00145652|Hematinics|hematinics|mesh-ancestor
138593935|NCT00174486|Tadalafil|tadalafil|mesh-list
138593936|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
138593937|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138593938|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138593939|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593940|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593941|NCT00174486|Urological Agents|urological agents|mesh-ancestor
138593943|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
138593944|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138593945|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138593946|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593947|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593948|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138593949|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138593950|NCT05319340|Anticoagulants|anticoagulants|mesh-list
138593951|NCT05319301|Melatonin|melatonin|mesh-list
138593952|NCT05319301|Antioxidants|antioxidants|mesh-ancestor
138593953|NCT05319301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593954|NCT05319301|Protective Agents|protective agents|mesh-ancestor
138593955|NCT05319301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593956|NCT05319301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593957|NCT00169065|Olanzapine|olanzapine|mesh-list
138593958|NCT00169065|Clozapine|clozapine|mesh-list
138593959|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
138593960|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
138593961|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593962|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593963|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138593964|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138593965|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138593966|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138593967|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138593968|NCT00169065|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138593969|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138593970|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138593971|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593972|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138593973|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
138593974|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138593975|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
138593976|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
138593977|NCT00145730|Ibuprofen|ibuprofen|mesh-list
138593978|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138593979|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138593980|NCT00145730|Analgesics|analgesics|mesh-ancestor
138593981|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
138593982|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138593983|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593984|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138593985|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138593986|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138593987|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138593988|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138593989|NCT00169143|Rituximab|rituximab|mesh-list
138593990|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138593991|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138593992|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
138593993|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138593994|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138593995|NCT02942680|Aspirin|aspirin|mesh-list
138593996|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138593997|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138593998|NCT02942680|Analgesics|analgesics|mesh-ancestor
138593999|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
138594000|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594001|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594002|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138594003|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138594004|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138594005|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138594006|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594007|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138594008|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138594009|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594010|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
138594011|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
138594012|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594013|NCT02276911|Ibuprofen|ibuprofen|mesh-list
138594014|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138594015|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138594016|NCT02276911|Analgesics|analgesics|mesh-ancestor
138594017|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
138594018|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594019|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594020|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138594021|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138594022|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138594023|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594024|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594025|NCT00145847|Naltrexone|naltrexone|mesh-list
138594026|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138594027|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138594028|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594029|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
138594030|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594031|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
138594033|NCT00169182|Docetaxel|docetaxel|mesh-list
138594034|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594035|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
138594036|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
138594037|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
138594038|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594039|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
138594040|NCT00169182|Vitamins|vitamins|mesh-ancestor
138594041|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
138594042|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594043|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138594044|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
138594045|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138594046|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
138594047|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
138594048|NCT02944825|Trimethoprim|trimethoprim|mesh-list
138594049|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
138594050|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138594051|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594052|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138594053|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138594054|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594055|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594056|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594057|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138594058|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138594059|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138594060|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
138270401|NCT05601700|Carboplatin|carboplatin|mesh-list
138594061|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138594062|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138594063|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138594064|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138594065|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138594066|NCT02942758|Pioglitazone|pioglitazone|mesh-list
138594067|NCT02942758|Azacitidine|azacitidine|mesh-list
138594069|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138594070|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
138594071|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594072|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594073|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594074|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138594075|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594076|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
138594077|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
138594078|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
138594079|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594080|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138594081|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138594082|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
138594083|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138594084|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138594085|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138594086|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138594087|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594088|NCT02942563|Capecitabine|capecitabine|mesh-list
138594089|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
138594090|NCT02942563|Irinotecan|irinotecan|mesh-list
138594091|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138594092|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
138594093|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594094|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594095|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138594096|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138594097|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594098|NCT00145925|Gliclazide|gliclazide|mesh-list
138594099|NCT00145925|Perindopril|perindopril|mesh-list
138594100|NCT00145925|Indapamide|indapamide|mesh-list
138594101|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
138594102|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138594104|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594105|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594106|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138594107|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138455456|NCT01905501|Anesthetics|anesthetics|mesh-list
138594108|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594109|NCT00145925|Diuretics|diuretics|mesh-ancestor
138594110|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
138594111|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138594112|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138594113|NCT00529321|Immunomodulating Agents|immunomodulating agents|mesh-list
138594114|NCT00529321|Immunologic Factors|immunologic factors|mesh-ancestor
138594115|NCT00529321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594116|NCT00169221|Gefitinib|gefitinib|mesh-list
138594117|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594118|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138594119|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594120|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594121|NCT00529360|Clofarabine|clofarabine|mesh-list
138594122|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138594123|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
138594124|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594125|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594126|NCT00174642|Insulin|insulin|mesh-list
138594127|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138594128|NCT00174642|Metformin|metformin|mesh-list
138594129|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
138594130|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
138594131|NCT00174642|Secretagogues|secretagogues|mesh-list
138594132|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138594133|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594134|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
138594135|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138594136|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594138|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
138594139|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138594140|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
138594142|NCT00146042|Trastuzumab|trastuzumab|mesh-list
138594143|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594144|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
138594145|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
138594146|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
138594147|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594148|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138594149|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138594150|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594151|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138594152|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138594153|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594154|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138594155|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
138594156|NCT00169299|Estrogens|estrogens|mesh-list
138594157|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138594158|NCT00169299|Hormones|hormones|mesh-ancestor
138594159|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594160|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594161|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138594162|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138594163|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138594164|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
138594165|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138594166|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138594167|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138594168|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138594169|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138594170|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455464|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138594171|NCT02942602|Atorvastatin|atorvastatin|mesh-list
138594172|NCT02942602|Ezetimibe|ezetimibe|mesh-list
138594173|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
138594174|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138594175|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138594176|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
138594177|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594178|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138594179|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138594180|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594181|NCT02942329|Apatinib|apatinib|mesh-list
138594182|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594183|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138594184|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594185|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594186|NCT00174720|Ciclesonide|ciclesonide|mesh-list
138594187|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
138594188|NCT00174720|Hormones|hormones|mesh-ancestor
138594189|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594190|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594191|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138594192|NCT02942212|Nicotine|nicotine|mesh-list
138594193|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138594194|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
138594195|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594196|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594197|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138483867|NCT00006145|Valganciclovir|valganciclovir|mesh-list
138483868|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
138594198|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138594199|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
138594200|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594201|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594203|NCT00146120|Idarubicin|idarubicin|mesh-list
138594204|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138594205|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594206|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138594207|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138594208|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594209|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594210|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138594212|NCT00146159|Analgesics|analgesics|mesh-ancestor
138594213|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
138594214|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594215|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594216|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594217|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138594218|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138594219|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594220|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594221|NCT02276989|Riboflavin|riboflavin|mesh-list
138594222|NCT02276989|Quinine|quinine|mesh-list
138594223|NCT02276989|Acetazolamide|acetazolamide|mesh-list
138594224|NCT02276989|Vitamins|vitamins|mesh-ancestor
138594225|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
138594226|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594227|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
138594228|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138594229|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
138594230|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
138594231|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138594232|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594233|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594234|NCT02276989|Diuretics|diuretics|mesh-ancestor
138594235|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
138594236|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
138594237|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138594238|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138594239|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594240|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138594241|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138594242|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594243|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138594244|NCT02276989|Analgesics|analgesics|mesh-ancestor
138594245|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
138594247|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138594248|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138594249|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138594250|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138594251|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
138594252|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594253|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594254|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594255|NCT00146237|Phenytoin|phenytoin|mesh-list
138594256|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
138594257|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138594258|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138594259|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138594260|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483880|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138483881|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138483882|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138483883|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138483884|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
138594261|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138594262|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138594263|NCT02277067|Misoprostol|misoprostol|mesh-list
138594265|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138594266|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
138594267|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138594268|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594269|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138594270|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138594271|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
138594272|NCT00146276|Gemcitabine|gemcitabine|mesh-list
138594273|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138594274|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
138594275|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594276|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594277|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138594278|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138594279|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138594280|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
138594281|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594282|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594283|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594284|NCT00174798|Urological Agents|urological agents|mesh-ancestor
138594285|NCT02940808|Caffeine|caffeine|mesh-list
138483630|NCT00006049|Paclitaxel|paclitaxel|mesh-list
138594286|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138594287|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594288|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138455490|NCT01905696|Antidotes|antidotes|mesh-ancestor
138455491|NCT01905774|Deferasirox|deferasirox|mesh-list
138594289|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594290|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594291|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138594292|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138594293|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
138594294|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594295|NCT00169416|Valacyclovir|valacyclovir|mesh-list
138594296|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
138594297|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594298|NCT00174876|Aripiprazole|aripiprazole|mesh-list
138594299|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
138594300|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138594301|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138594302|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138594303|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138594304|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594305|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
138594306|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
138594307|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594308|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594309|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138594310|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138594311|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
138594312|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138594313|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138594314|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138594315|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138594316|NCT00146471|Levetiracetam|levetiracetam|mesh-list
138594317|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
138594318|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
138594319|NCT00174993|Pioglitazone|pioglitazone|mesh-list
138594320|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138594321|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594322|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138594323|NCT02940379|Metoprolol|metoprolol|mesh-list
138594325|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138594326|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138594327|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138594328|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594329|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138594330|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138594331|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138594332|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138594333|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
138594334|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
138594335|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
138594336|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
138594337|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594338|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594339|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138594340|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138594341|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
138594342|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
138594343|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594344|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138594345|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138594346|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138594347|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
138594348|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138594349|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138594350|NCT00146549|Paclitaxel|paclitaxel|mesh-list
138594351|NCT00146549|Vinorelbine|vinorelbine|mesh-list
138594352|NCT00146549|Docetaxel|docetaxel|mesh-list
138594353|NCT00146549|Trastuzumab|trastuzumab|mesh-list
138455501|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138594354|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138594355|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594356|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
138594357|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
138594358|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
138594359|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594360|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138594361|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138594362|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138594363|NCT02940535|Menotropins|menotropins|mesh-list
138594364|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
138594365|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138594366|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
138594367|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138594368|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594369|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138594370|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138594371|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594372|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138594373|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
138594374|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
138594375|NCT00146588|Capecitabine|capecitabine|mesh-list
138594376|NCT00146588|Epirubicin|epirubicin|mesh-list
138594377|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138594378|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
138594379|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594380|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138594381|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138594382|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
138594383|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594384|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594385|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138594386|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138594387|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
138594388|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138594389|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138594390|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138594391|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594392|NCT00175032|Aspirin|aspirin|mesh-list
138594393|NCT00175032|Celecoxib|celecoxib|mesh-list
138594394|NCT00175032|Naproxen|naproxen|mesh-list
138594395|NCT00175032|Lansoprazole|lansoprazole|mesh-list
138594396|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
138594397|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138594398|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138594399|NCT00175032|Analgesics|analgesics|mesh-ancestor
138594400|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
138594401|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594402|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594403|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138594404|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138594405|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138594406|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138594407|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594408|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138594409|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138594410|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594412|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138594413|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
138594414|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138594415|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138594416|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138594417|NCT00146627|Eflornithine|eflornithine|mesh-list
138594418|NCT00146627|Nifurtimox|nifurtimox|mesh-list
138594419|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138455511|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594420|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138594421|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138594422|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138594423|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594424|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138594425|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594426|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594427|NCT00169533|Lapatinib|lapatinib|mesh-list
138594428|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594429|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138594430|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594431|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594432|NCT00424229|Lenalidomide|lenalidomide|mesh-list
138594433|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
138594434|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483904|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138594435|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138594436|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138594437|NCT00424229|Growth Substances|growth substances|mesh-ancestor
138270773|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
138594438|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
138594439|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594440|NCT02944123|Clopidogrel|clopidogrel|mesh-list
138594441|NCT02944123|Ticagrelor|ticagrelor|mesh-list
138594442|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138594443|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138594444|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138594445|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138594446|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138594447|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
138594448|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594449|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594450|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594451|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
138594452|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138594453|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138594454|NCT02944045|Prednisolone|prednisolone|mesh-list
138594455|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
138594456|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138594457|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
138594458|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138594459|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
138594460|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
138594461|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594462|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594463|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138594465|NCT02944045|Hormones|hormones|mesh-ancestor
138594466|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594467|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138594468|NCT02944045|Protective Agents|protective agents|mesh-ancestor
138594469|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138594470|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594471|NCT00169572|Dexamethasone|dexamethasone|mesh-list
138594472|NCT00169572|Ondansetron|ondansetron|mesh-list
138594473|NCT00169572|Aprepitant|aprepitant|mesh-list
138594474|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
138594475|NCT00169572|Casopitant|casopitant|mesh-list
138594476|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138594477|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
138594478|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
138594479|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594480|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594481|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138594482|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
138594483|NCT00169572|Hormones|hormones|mesh-ancestor
138594484|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594485|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138594486|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594487|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
138594488|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
138594489|NCT00169572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138594490|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138594491|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
138594492|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594493|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594495|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
138594496|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
138594497|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138594498|NCT00146783|Amodiaquine|amodiaquine|mesh-list
138594499|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
138594500|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138594501|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138594502|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594503|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138594504|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594505|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594506|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138594507|NCT00169611|Methylphenidate|methylphenidate|mesh-list
138594508|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138594509|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594510|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138594511|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138270850|NCT04487392|Estrogens|estrogens|mesh-list
138594512|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138594513|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594515|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594516|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
138594517|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138594518|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
138594519|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
138594520|NCT02943655|Progesterone|progesterone|mesh-list
138594521|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138594522|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594523|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138594524|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138594525|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138594526|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138594527|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138594528|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138594529|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138594530|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594531|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138594532|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138594533|NCT02943655|Analgesics|analgesics|mesh-ancestor
138594534|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
138594535|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594536|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138594537|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138594538|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138594539|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594540|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594541|NCT02943655|Progestins|progestins|mesh-ancestor
138594542|NCT02943655|Hormones|hormones|mesh-ancestor
138594543|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594544|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
138594545|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138594546|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
138594547|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594548|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
138594549|NCT05085067|Protective Agents|protective agents|mesh-ancestor
138594551|NCT00175227|Mannitol|mannitol|mesh-list
138594552|NCT00175227|Diuretics|diuretics|mesh-ancestor
138664217|NCT05192200|Interferons|interferons|mesh-list
138594554|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594555|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138594556|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138594557|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594558|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138594559|NCT02940262|Edetic Acid|edetic acid|mesh-list
138594560|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138594561|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
138594562|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
138594563|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594564|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
138594565|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138594566|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138594567|NCT00146900|Escitalopram|escitalopram|mesh-list
138594568|NCT00146900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138594569|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138594570|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138594571|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594572|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594573|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
138594574|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594575|NCT02939482|Triamcinolone|triamcinolone|mesh-list
138594576|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138594577|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138594578|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138594579|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138594580|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
138594581|NCT02939482|Hormones|hormones|mesh-ancestor
138594582|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594583|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594584|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138594585|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
138594586|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594587|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594588|NCT00175266|Infliximab|infliximab|mesh-list
138594589|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
138594590|NCT00175266|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138594591|NCT00175266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138594592|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
138594593|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138594594|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138594595|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138594596|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594597|NCT05013892|Memantine|memantine|mesh-list
138594598|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138594599|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138594600|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
138594601|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138455545|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455547|NCT01906450|Azithromycin|azithromycin|mesh-list
138594602|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594603|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594604|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138594605|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138594606|NCT02939248|Morphine|morphine|mesh-list
138594607|NCT02939248|Naloxone|naloxone|mesh-list
138594608|NCT02939248|Ticagrelor|ticagrelor|mesh-list
138594609|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138594610|NCT02939248|Narcotics|narcotics|mesh-ancestor
138594611|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138594612|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594613|NCT02939248|Analgesics|analgesics|mesh-ancestor
138594614|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
138594615|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594616|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138594617|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138594618|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138594619|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138594620|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
138594621|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594622|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594623|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138594624|NCT02938975|Permethrin|permethrin|mesh-list
138594625|NCT02938975|Insect Repellents|insect repellents|mesh-list
138594626|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594627|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594628|NCT02938975|Protective Agents|protective agents|mesh-ancestor
138594629|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594631|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138594632|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594633|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
138594634|NCT00175305|Octreotide|octreotide|mesh-list
138594635|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138594636|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138594637|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594638|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
138594639|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
138594640|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594641|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138594643|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138594644|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594645|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138594646|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138594647|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594648|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594649|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594650|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138594651|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138594652|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594653|NCT00175383|Hormones|hormones|mesh-list
138594654|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138594655|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594656|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594657|NCT02938468|Dexamethasone|dexamethasone|mesh-list
138594658|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138594659|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
138271004|NCT04268121|Cisplatin|cisplatin|mesh-list
138594661|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594662|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594663|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138594664|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
138594665|NCT02938468|Hormones|hormones|mesh-ancestor
138594666|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594667|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138594668|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594670|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138594671|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138594672|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138594673|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
138594674|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594675|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594676|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594677|NCT00169728|Vaccines|vaccines|mesh-list
138594678|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138594679|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
138594680|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594681|NCT00147524|Quinapril|quinapril|mesh-list
138594682|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138594683|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
138594684|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594685|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594686|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138594687|NCT00147563|Eplerenone|eplerenone|mesh-list
138594688|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138594689|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
138594690|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594691|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594692|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138594693|NCT00147563|Diuretics|diuretics|mesh-ancestor
138594694|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
138594695|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138594696|NCT02938273|Cetuximab|cetuximab|mesh-list
138594697|NCT02938273|Avelumab|avelumab|mesh-list
138594698|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138594699|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594700|NCT00147602|Atorvastatin|atorvastatin|mesh-list
138594701|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138594702|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138594703|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
138594704|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594705|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138594706|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138594707|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594708|NCT02941744|Nivolumab|nivolumab|mesh-list
138594709|NCT02941744|Ipilimumab|ipilimumab|mesh-list
138594710|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138594711|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594712|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138594713|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594714|NCT02941822|Ambroxol|ambroxol|mesh-list
138594715|NCT02941822|Expectorants|expectorants|mesh-ancestor
138594716|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
138594717|NCT02941510|Budesonide|budesonide|mesh-list
138594718|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138594720|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
138594721|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455581|NCT01906762|Acetaminophen|acetaminophen|mesh-list
138594722|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484001|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
138594723|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138594724|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
138594725|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
138594727|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594728|NCT00147680|Paclitaxel|paclitaxel|mesh-list
138594729|NCT00147680|Carboplatin|carboplatin|mesh-list
138594730|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138594731|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594732|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
138271080|NCT03974217|Decitabine|decitabine|mesh-list
138594733|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
138594734|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
138594735|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594736|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138594737|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138594738|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594740|NCT02940184|Hormones|hormones|mesh-ancestor
138594741|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594742|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138594743|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
138594744|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594745|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594746|NCT03458143|Ketamine|ketamine|mesh-list
138594747|NCT03458143|Remifentanil|remifentanil|mesh-list
138594748|NCT03458143|Analgesics|analgesics|mesh-ancestor
138594749|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
138594750|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594751|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594752|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138594753|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138594754|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
138594755|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
138594756|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138594757|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138594758|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138594759|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594760|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594761|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138483977|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
138594762|NCT03458143|Narcotics|narcotics|mesh-ancestor
138594763|NCT02941198|Copper|copper|mesh-list
138594764|NCT02941198|Trace Elements|trace elements|mesh-ancestor
138594765|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
138594766|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594767|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138594768|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138484028|NCT00006232|Idarubicin|idarubicin|mesh-list
138594769|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138594770|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
138594771|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594772|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138594773|NCT05273671|Dexmedetomidine|dexmedetomidine|mesh-list
138594774|NCT05273671|Nalbuphine|nalbuphine|mesh-list
138594775|NCT05273671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138594776|NCT05273671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138455591|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
138594777|NCT05273671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594778|NCT05273671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138594780|NCT05273671|Sensory System Agents|sensory system agents|mesh-ancestor
138594781|NCT05273671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594782|NCT05273671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138594783|NCT05273671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138594784|NCT05273671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138594785|NCT05273671|Adrenergic Agents|adrenergic agents|mesh-ancestor
138594786|NCT05273671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594787|NCT05273671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594788|NCT05273671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138594789|NCT05273671|Narcotics|narcotics|mesh-ancestor
138594790|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138594791|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138594792|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138594793|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
138484004|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138484005|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
138484008|NCT00006223|Protective Agents|protective agents|mesh-ancestor
138594794|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594795|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138594796|NCT02931526|Tigecycline|tigecycline|mesh-list
138594797|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138594798|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594799|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138594800|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594801|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594802|NCT00169845|Tocopherols|tocopherols|mesh-list
138594803|NCT00169845|Vitamin E|vitamin e|mesh-list
138594804|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
138594805|NCT00169845|Beta Carotene|beta carotene|mesh-list
138594806|NCT00169845|Carotenoids|carotenoids|mesh-list
138594807|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
138594808|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594810|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594811|NCT00169845|Vitamins|vitamins|mesh-ancestor
138594812|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
138594813|NCT00169845|Provitamins|provitamins|mesh-ancestor
138594814|NCT00147836|Insulin|insulin|mesh-list
138594815|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138594816|NCT00147836|Metformin|metformin|mesh-list
138594817|NCT00147836|Gliclazide|gliclazide|mesh-list
138594818|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
138594819|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
138594820|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
138594821|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138594822|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594823|NCT02931136|Huperzine A|huperzine a|mesh-list
138594824|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138594825|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594826|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594828|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138594829|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594830|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138484049|NCT00006235|Carboplatin|carboplatin|mesh-list
138594831|NCT02931136|Protective Agents|protective agents|mesh-ancestor
138594832|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138594833|NCT02931175|Hormones|hormones|mesh-ancestor
138594834|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594835|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594836|NCT00147875|Prednisone|prednisone|mesh-list
138594837|NCT00147875|Gemcitabine|gemcitabine|mesh-list
138594839|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138594840|NCT00147875|Vinblastine|vinblastine|mesh-list
138594841|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138594842|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
138594843|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594844|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594845|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138455611|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138594846|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138594847|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138594848|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594849|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138594850|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
138594851|NCT00147875|Hormones|hormones|mesh-ancestor
138594852|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594853|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594854|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138594855|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138594856|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
138594857|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
138594858|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
138594859|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
138594860|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138484081|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484084|NCT00006250|Hormones|hormones|mesh-ancestor
138594861|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594863|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
138594864|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
138594865|NCT00147914|Cefdinir|cefdinir|mesh-list
138594866|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138594867|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138594868|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594869|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138594870|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594871|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594872|NCT00147953|Rituximab|rituximab|mesh-list
138594873|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138594874|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594875|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
138594876|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594877|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138594878|NCT02930551|Lidocaine|lidocaine|mesh-list
138594879|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
138594880|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
138271234|NCT03631784|Paclitaxel|paclitaxel|mesh-list
138594881|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138594882|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594883|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
138484133|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
138484141|NCT00007605|Amiodarone|amiodarone|mesh-list
138594884|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594885|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138594886|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138594887|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138594888|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138594889|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594891|NCT00175617|Spironolactone|spironolactone|mesh-list
138594892|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138594893|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
138594894|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138484183|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138594895|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594896|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138594897|NCT00175617|Diuretics|diuretics|mesh-ancestor
138594898|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
138594899|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138594900|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
138594901|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
138594902|NCT02930707|Bupivacaine|bupivacaine|mesh-list
138594903|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
138594904|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
138594905|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138594906|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594907|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
138594908|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594909|NCT02930707|Analgesics|analgesics|mesh-ancestor
138594910|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138484248|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
138594911|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
138594912|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138594913|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138594914|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594915|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138594916|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
138594917|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138594918|NCT00148031|Interferons|interferons|mesh-list
138594920|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594921|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
138594922|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594923|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
138594924|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594925|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
138594926|NCT02930434|Vitamin D|vitamin d|mesh-list
138594927|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
138594928|NCT02930434|Vitamins|vitamins|mesh-ancestor
138594929|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
138594930|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594931|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138594932|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138594933|NCT00148070|Erythromycin|erythromycin|mesh-list
138594934|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
138594935|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138594936|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
138594938|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594939|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
138594940|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
138594941|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
138594942|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594943|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138594944|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594945|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138594946|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138594947|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594948|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138594949|NCT00175695|Protein C|protein c|mesh-list
138594950|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
138594951|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138594952|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138594953|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594954|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594955|NCT02930317|Factor VIII|factor viii|mesh-list
138594956|NCT02930317|Coagulants|coagulants|mesh-ancestor
138594957|NCT00148148|Amphotericin B|amphotericin b|mesh-list
138594958|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138594959|NCT00148148|Caspofungin|caspofungin|mesh-list
138594960|NCT00148148|Amebicides|amebicides|mesh-ancestor
138594961|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138594962|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138594963|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138594964|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138594965|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
138594966|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594967|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594968|NCT00170001|Esomeprazole|esomeprazole|mesh-list
138594969|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138594970|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138594971|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138594972|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138594973|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594974|NCT00148265|Triamcinolone|triamcinolone|mesh-list
138594975|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138594976|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
138594978|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138594979|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594980|NCT02929693|Gefitinib|gefitinib|mesh-list
138594981|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594982|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138594983|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484100|NCT00006265|Cytarabine|cytarabine|mesh-list
138594984|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594986|NCT00175734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138594987|NCT00175734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138594988|NCT00175734|Analgesics|analgesics|mesh-ancestor
138594989|NCT00175734|Sensory System Agents|sensory system agents|mesh-ancestor
138594990|NCT00175734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138594991|NCT00175734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138594992|NCT00175734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138594993|NCT00175734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138594994|NCT00148382|Cetilistat|cetilistat|mesh-list
138594995|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484341|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138484342|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138594996|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138594997|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138594998|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138594999|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
138595000|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
138595001|NCT00148421|Hematinics|hematinics|mesh-ancestor
138595002|NCT02929888|Aspirin|aspirin|mesh-list
138595003|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138595004|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138595005|NCT02929888|Analgesics|analgesics|mesh-ancestor
138595006|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
138595007|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595008|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595009|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138595010|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138595011|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138595012|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138595013|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595014|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138595015|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138595016|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595017|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
138595018|NCT04689412|Resveratrol|resveratrol|mesh-list
138595019|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
138595020|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595021|NCT04689412|Protective Agents|protective agents|mesh-ancestor
138595022|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595023|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595024|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138595025|NCT00148460|Tenecteplase|tenecteplase|mesh-list
138595026|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138595027|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138595028|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595029|NCT00170196|Prednisone|prednisone|mesh-list
138595030|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138455635|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138455636|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
138455638|NCT01907061|Protective Agents|protective agents|mesh-ancestor
138595031|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
138595032|NCT00170196|Hormones|hormones|mesh-ancestor
138484377|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138595033|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138595034|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595035|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138595036|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595039|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
138595040|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
138595041|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595042|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138595043|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
138595044|NCT02929576|Paclitaxel|paclitaxel|mesh-list
138595045|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138595046|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595047|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
138595048|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
138595049|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
138595050|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595051|NCT00175812|Tretinoin|tretinoin|mesh-list
138595052|NCT00175812|Theophylline|theophylline|mesh-list
138595053|NCT00175812|Valproic Acid|valproic acid|mesh-list
138595054|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595055|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
138595056|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
138595057|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
138595058|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595059|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595060|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
138595061|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595062|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595063|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
138595064|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138595065|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138595066|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138595067|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138595068|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
138595069|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595070|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138595071|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
138664366|NCT05069545|Insulin|insulin|mesh-list
138484414|NCT00006385|Sargramostim|sargramostim|mesh-list
138595072|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138595073|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
138595074|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138595075|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138595076|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
138595077|NCT00148499|Benzocaine|benzocaine|mesh-list
138595078|NCT00148499|Ambroxol|ambroxol|mesh-list
138595079|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
138595080|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
138595081|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138595082|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595083|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
138595084|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595085|NCT00148499|Expectorants|expectorants|mesh-ancestor
138595086|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
138595087|NCT03457597|Pioglitazone|pioglitazone|mesh-list
138595088|NCT03457597|Tolbutamide|tolbutamide|mesh-list
138595089|NCT03457597|Metoprolol|metoprolol|mesh-list
138595090|NCT03457597|Midazolam|midazolam|mesh-list
138595091|NCT03457597|Omeprazole|omeprazole|mesh-list
138595092|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138595093|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138595094|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138455656|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
138455659|NCT01907204|Prednisolone|prednisolone|mesh-list
138595095|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595096|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138595097|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138595098|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138595099|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138595100|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
138595101|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
138595102|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
138595103|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
138595104|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595105|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595106|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138595107|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138595108|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138595109|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138595110|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595111|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138595112|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138595114|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
138484451|NCT00008034|Epirubicin|epirubicin|mesh-list
138595115|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595116|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138595117|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138595118|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138595119|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
138484195|NCT00007683|Analgesics|analgesics|mesh-ancestor
138595120|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138595121|NCT02929147|Morphine|morphine|mesh-list
138595122|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138595123|NCT02929147|Narcotics|narcotics|mesh-ancestor
138595124|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138595125|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595126|NCT02929147|Analgesics|analgesics|mesh-ancestor
138595127|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
138595128|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595129|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138595130|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138595131|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138595132|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138595133|NCT00175890|Levetiracetam|levetiracetam|mesh-list
138595134|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
138595135|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
138595136|NCT00148616|Memantine|memantine|mesh-list
138595137|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138595138|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138595139|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
138595140|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595141|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595142|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595143|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138595144|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138595145|NCT00175929|Brivaracetam|brivaracetam|mesh-list
138595146|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
138595147|NCT02928679|Liraglutide|liraglutide|mesh-list
138595148|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138595149|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595150|NCT02928679|Incretins|incretins|mesh-ancestor
138595151|NCT02928679|Hormones|hormones|mesh-ancestor
138595152|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138595153|NCT02928601|Ondansetron|ondansetron|mesh-list
138595154|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
138595155|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
138595156|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138455671|NCT01907204|Hormones|hormones|mesh-ancestor
138595157|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595158|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138595159|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
138595160|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
138595161|NCT02928601|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138595162|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138484227|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138595163|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
138595164|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595165|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595166|NCT02928328|Lidocaine|lidocaine|mesh-list
138595167|NCT02928328|Lorazepam|lorazepam|mesh-list
138595168|NCT02928328|Capsaicin|capsaicin|mesh-list
138595169|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
138595170|NCT02928328|Butyric Acid|butyric acid|mesh-list
138595171|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
138595172|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
138595173|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138595174|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595175|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
138595176|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595177|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138595178|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138595179|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138595180|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138595181|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595182|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
138595183|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
138595184|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
138595185|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
138484516|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595186|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
138595187|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138595189|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138595190|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138595191|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138595192|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
138595193|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
138595194|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595195|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
138595196|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
138595197|NCT00148694|Cisplatin|cisplatin|mesh-list
138595198|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595199|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138595200|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595201|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138595202|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595203|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595204|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
138595205|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595206|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138595207|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138595208|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
138595209|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595210|NCT02927587|Propofol|propofol|mesh-list
138595211|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138595212|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138595213|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595214|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138595215|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
138595216|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
138595217|NCT00148850|Pioglitazone|pioglitazone|mesh-list
138595218|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138595219|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595220|NCT02927353|Adalimumab|adalimumab|mesh-list
138595221|NCT02927353|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138595222|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138595223|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138595224|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
138484261|NCT00387868|Etoposide|etoposide|mesh-list
138595225|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138595226|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
138595227|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595228|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595229|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595230|NCT02926885|Liver Extracts|liver extracts|mesh-list
138595231|NCT02926885|Hematinics|hematinics|mesh-ancestor
138595232|NCT02926846|Vancomycin|vancomycin|mesh-list
138595233|NCT02926846|Gentamicins|gentamicins|mesh-list
138595234|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138595235|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595236|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138595237|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595238|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595239|NCT02926183|Paclitaxel|paclitaxel|mesh-list
138595240|NCT02926183|Gemcitabine|gemcitabine|mesh-list
138595241|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138595242|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595243|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
138595244|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
138595245|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
138595246|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595247|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138595248|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
138595249|NCT02925832|Bupivacaine|bupivacaine|mesh-list
138595250|NCT02925832|Ropivacaine|ropivacaine|mesh-list
138595251|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
138595252|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
138595253|NCT02925832|Anesthetics|anesthetics|mesh-list
138595254|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138595255|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595256|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
138595257|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595258|NCT00170430|Fluconazole|fluconazole|mesh-list
138595259|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
138595260|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138271600|NCT02101021|Paclitaxel|paclitaxel|mesh-list
138161112|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
138595261|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138595262|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138595263|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595264|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595265|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138595266|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
138595267|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138595268|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595269|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138595270|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138595271|NCT00149084|Amoxicillin|amoxicillin|mesh-list
138595272|NCT00149084|Clarithromycin|clarithromycin|mesh-list
138595273|NCT00149084|Lansoprazole|lansoprazole|mesh-list
138595274|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
138595275|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138595276|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595277|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138595278|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595279|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595280|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138595281|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138595282|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138595283|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138595284|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138595285|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138595286|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138595287|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
138595288|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595290|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595291|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138595292|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
138595293|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138595294|NCT00149162|Aldesleukin|aldesleukin|mesh-list
138595295|NCT00149162|Interleukin-2|interleukin-2|mesh-list
138595296|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595297|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138595298|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138595299|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
138595300|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595301|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138484638|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
138595302|NCT00149162|Analgesics|analgesics|mesh-ancestor
138595303|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
138595304|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595305|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595306|NCT00170547|Vaccines|vaccines|mesh-list
138595307|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
138595308|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595309|NCT00149201|Fluorouracil|fluorouracil|mesh-list
138595310|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
138595311|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595312|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138595313|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595314|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138595316|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595317|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
138595318|NCT02925559|Gliclazide|gliclazide|mesh-list
138595319|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138595320|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595321|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138595322|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595323|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
138484670|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
138595324|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138595325|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138595326|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138595327|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138595328|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595329|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
138595330|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595331|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595332|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138455729|NCT01907594|Cycloserine|cycloserine|mesh-list
138595333|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595334|NCT02925247|Anticoagulants|anticoagulants|mesh-list
138595335|NCT00170664|Paclitaxel|paclitaxel|mesh-list
138595336|NCT00170664|Carboplatin|carboplatin|mesh-list
138271671|NCT01566240|Paclitaxel|paclitaxel|mesh-list
138595337|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138595338|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595340|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
138595341|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
138595342|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595343|NCT00170742|Octreotide|octreotide|mesh-list
138595344|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138595345|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138484294|NCT00007878|Leucovorin|leucovorin|mesh-list
138595346|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595348|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
138595349|NCT02917525|Vitamins|vitamins|mesh-ancestor
138595350|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
138595351|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595352|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138595353|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138595354|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595355|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
138595356|NCT02917525|Coagulants|coagulants|mesh-ancestor
138595357|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
138595358|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138595359|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138595360|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595361|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595362|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138595363|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138595365|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
138595366|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595367|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595368|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138595369|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138595370|NCT00170820|Everolimus|everolimus|mesh-list
138595371|NCT00170820|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138595372|NCT00170820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138595373|NCT00170820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595374|NCT00170820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595375|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138595376|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
138595377|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595378|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595379|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
138595380|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138595381|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138595382|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595383|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138595384|NCT02917018|Analgesics|analgesics|mesh-ancestor
138595385|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
138595386|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595387|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138595388|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138595389|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138595390|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
138595392|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455732|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
138595393|NCT00170859|Everolimus|everolimus|mesh-list
138595394|NCT00170859|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138595395|NCT00170859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138595396|NCT00170859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595397|NCT00170859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595398|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138595399|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
138595400|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595401|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595402|NCT02917057|Exenatide|exenatide|mesh-list
138595403|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138595404|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595405|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138595406|NCT02917057|Incretins|incretins|mesh-ancestor
138595407|NCT02917057|Hormones|hormones|mesh-ancestor
138595408|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138595409|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
138595410|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138595412|NCT02916940|Hormones|hormones|mesh-ancestor
138595413|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138595414|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595415|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
138595416|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138595417|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138595418|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595419|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595420|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138595421|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138595422|NCT00170898|Analgesics|analgesics|mesh-ancestor
138595423|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
138595424|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595425|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595426|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138595427|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138595428|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138595429|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138595430|NCT00170937|Valsartan|valsartan|mesh-list
138595431|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138595432|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138595433|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138484797|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
138595434|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138595435|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595436|NCT00170937|Diuretics|diuretics|mesh-ancestor
138595437|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
138595438|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595439|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138595440|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138595442|NCT02916238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138595443|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138595444|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138595445|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595446|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595447|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
138455747|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
138455756|NCT01907685|Docetaxel|docetaxel|mesh-list
138595448|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595449|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138595450|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
138595451|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138595452|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138595453|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138595454|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595455|NCT00149708|Hormones|hormones|mesh-list
138595456|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138595457|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595458|NCT00163761|Gemcitabine|gemcitabine|mesh-list
138595459|NCT00163761|Vinorelbine|vinorelbine|mesh-list
138595460|NCT00163761|Ifosfamide|ifosfamide|mesh-list
138595461|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138484838|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595462|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
138595463|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595464|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595465|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138595466|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
138595467|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
138595468|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
138595469|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138595470|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
138595472|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138595473|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138595474|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138595475|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138595476|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595478|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
138595479|NCT02916121|Vitamins|vitamins|mesh-ancestor
138595480|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
138595482|NCT02916121|Hematinics|hematinics|mesh-ancestor
138595483|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
138595484|NCT00170976|Amlodipine|amlodipine|mesh-list
138595485|NCT00170976|Valsartan|valsartan|mesh-list
138595486|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138595487|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138595488|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138595489|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595490|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138595491|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595492|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
138595493|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138595494|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138595495|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
138595496|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138595497|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595498|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138595499|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
138595500|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138595501|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595502|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595503|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595504|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
138595505|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138595506|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595507|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138595508|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
138595509|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138595510|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595511|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595512|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595513|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
138595514|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138595515|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138595516|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595517|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138595518|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138595519|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595520|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595521|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595522|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138595523|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
138595524|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138595525|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595526|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138595527|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138595528|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138595529|NCT05786677|Serotonin|serotonin|mesh-list
138595530|NCT05786677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138595531|NCT05786677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138595532|NCT05786677|Serotonin Agents|serotonin agents|mesh-ancestor
138595533|NCT05786677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138484322|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595534|NCT05786677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595535|NCT05786677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595536|NCT05786677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138595537|NCT05786677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138595538|NCT05786495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138664493|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
138595539|NCT05786495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595540|NCT05786430|Carboplatin|carboplatin|mesh-list
138595541|NCT05786430|Pemetrexed|pemetrexed|mesh-list
138595542|NCT05786430|Lazertinib|lazertinib|mesh-list
138595543|NCT05786430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595544|NCT05786430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595545|NCT05786430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595546|NCT05786430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138595547|NCT05786430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138595548|NCT05786430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138595549|NCT05786339|Irbesartan|irbesartan|mesh-list
138595550|NCT05786339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138188362|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595551|NCT05786339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138595552|NCT05786339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138595553|NCT05786339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595554|NCT05785429|Colchicine|colchicine|mesh-list
138595555|NCT05785429|Gout Suppressants|gout suppressants|mesh-ancestor
138595556|NCT05785429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138595558|NCT05785429|Antimitotic Agents|antimitotic agents|mesh-ancestor
138595559|NCT05785429|Mitosis Modulators|mitosis modulators|mesh-ancestor
138595560|NCT05785429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595561|NCT05785429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595562|NCT05785377|Bupivacaine|bupivacaine|mesh-list
138595563|NCT05785377|Neostigmine|neostigmine|mesh-list
138595564|NCT05785377|Anesthetics, Local|anesthetics, local|mesh-ancestor
138595565|NCT05785377|Anesthetics|anesthetics|mesh-ancestor
138595566|NCT05785377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138595567|NCT05785377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595568|NCT05785377|Sensory System Agents|sensory system agents|mesh-ancestor
138595569|NCT05785377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595570|NCT05785377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138455772|NCT01907802|Dabrafenib|dabrafenib|mesh-list
138595571|NCT05785377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595572|NCT05785377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595573|NCT05785377|Cholinergic Agents|cholinergic agents|mesh-ancestor
138595574|NCT05785377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595575|NCT05785377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138595576|NCT05785377|Autonomic Agents|autonomic agents|mesh-ancestor
138595577|NCT05785234|Sufentanil|sufentanil|mesh-list
138595578|NCT05785234|Remifentanil|remifentanil|mesh-list
138595579|NCT05785234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138595580|NCT05785234|Narcotics|narcotics|mesh-ancestor
138595581|NCT05785234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138595582|NCT05785234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595583|NCT05785234|Analgesics|analgesics|mesh-ancestor
138595584|NCT05785234|Sensory System Agents|sensory system agents|mesh-ancestor
138595585|NCT05785234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595586|NCT05785234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138595587|NCT05785234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138595588|NCT05785234|Anesthetics, General|anesthetics, general|mesh-ancestor
138595589|NCT05785234|Anesthetics|anesthetics|mesh-ancestor
138595590|NCT05785208|Osimertinib|osimertinib|mesh-list
138595591|NCT05785208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595592|NCT05785208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138595593|NCT05785208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595594|NCT05785208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595595|NCT05785026|Menthol|menthol|mesh-list
138595596|NCT05785026|Antipruritics|antipruritics|mesh-ancestor
138595597|NCT05785026|Dermatologic Agents|dermatologic agents|mesh-ancestor
138595598|NCT05784987|Rituximab|rituximab|mesh-list
138595599|NCT05784987|Etoposide|etoposide|mesh-list
138595600|NCT05784987|Lenalidomide|lenalidomide|mesh-list
138595601|NCT05784987|Mitoxantrone|mitoxantrone|mesh-list
138595602|NCT05784987|Ifosfamide|ifosfamide|mesh-list
138595603|NCT05784987|Isophosphamide mustard|isophosphamide mustard|mesh-list
138595604|NCT05784987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138595605|NCT05784987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595606|NCT05784987|Immunologic Factors|immunologic factors|mesh-ancestor
138595607|NCT05784987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595608|NCT05784987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138595609|NCT05784987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138485079|NCT00008281|Leucovorin|leucovorin|mesh-list
138595610|NCT05784987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138595611|NCT05784987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138595612|NCT05784987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595613|NCT05784987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595614|NCT05784987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138595615|NCT05784987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138595616|NCT05784987|Growth Substances|growth substances|mesh-ancestor
138595617|NCT05784987|Growth Inhibitors|growth inhibitors|mesh-ancestor
138595618|NCT05784987|Analgesics|analgesics|mesh-ancestor
138595619|NCT05784987|Sensory System Agents|sensory system agents|mesh-ancestor
138595620|NCT05784987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595621|NCT05784987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138595622|NCT05784987|Alkylating Agents|alkylating agents|mesh-ancestor
138595623|NCT05784519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138595624|NCT05784519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138595625|NCT05784467|Methamphetamine|methamphetamine|mesh-list
138595626|NCT05784467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138595627|NCT05784467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595628|NCT05784467|Sympathomimetics|sympathomimetics|mesh-ancestor
138595629|NCT05784467|Autonomic Agents|autonomic agents|mesh-ancestor
138595630|NCT05784467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595631|NCT05784467|Dopamine Agents|dopamine agents|mesh-ancestor
138485119|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
138595632|NCT05784467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595633|NCT05784467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595634|NCT05784467|Adrenergic Agents|adrenergic agents|mesh-ancestor
138595635|NCT05784467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138595636|NCT05784467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138595637|NCT05784467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138595638|NCT05784467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138595639|NCT05782712|Adenosine|adenosine|mesh-list
138595640|NCT05782712|Analgesics|analgesics|mesh-ancestor
138595641|NCT05782712|Sensory System Agents|sensory system agents|mesh-ancestor
138595642|NCT05782712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595643|NCT05782712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595644|NCT05782712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138595645|NCT05782712|Vasodilator Agents|vasodilator agents|mesh-ancestor
138595646|NCT05782712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138595647|NCT05782712|Purinergic Agonists|purinergic agonists|mesh-ancestor
138595648|NCT05782712|Purinergic Agents|purinergic agents|mesh-ancestor
138595649|NCT05782712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595650|NCT05782712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595651|NCT05781516|Prednisolone|prednisolone|mesh-list
138595652|NCT05781516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138595653|NCT05781516|Glucocorticoids|glucocorticoids|mesh-ancestor
138595654|NCT05781516|Hormones|hormones|mesh-ancestor
138595655|NCT05781516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138595656|NCT05781516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595657|NCT05781516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138595658|NCT05781516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595660|NCT05780437|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
138595661|NCT05780437|Antimetabolites|antimetabolites|mesh-ancestor
138595662|NCT05780437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595663|NCT05780437|Antiviral Agents|antiviral agents|mesh-ancestor
138595664|NCT05780437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595666|NCT05780424|Antimetabolites|antimetabolites|mesh-ancestor
138595667|NCT05780424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595668|NCT05780424|Antiviral Agents|antiviral agents|mesh-ancestor
138595669|NCT05780424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595670|NCT05778266|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138595672|NCT05778266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138595673|NCT05774405|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138595674|NCT05774405|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138595675|NCT05774405|Estradiol|estradiol|mesh-list
138595676|NCT05774405|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138595677|NCT05774405|Estrogens|estrogens|mesh-ancestor
138595678|NCT05774405|Hormones|hormones|mesh-ancestor
138595679|NCT05774405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138595680|NCT05774405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595681|NCT05774405|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138595683|NCT05774405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138455804|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595684|NCT05774405|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138595685|NCT05764941|Vinorelbine|vinorelbine|mesh-list
138595686|NCT05764941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138595687|NCT05764941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595688|NCT05764941|Tubulin Modulators|tubulin modulators|mesh-ancestor
138595689|NCT05764941|Antimitotic Agents|antimitotic agents|mesh-ancestor
138595690|NCT05764941|Mitosis Modulators|mitosis modulators|mesh-ancestor
138595691|NCT05764941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595692|NCT05750017|Vaccines|vaccines|mesh-list
138595693|NCT05750017|Immunologic Factors|immunologic factors|mesh-ancestor
138595694|NCT05750017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595695|NCT05723705|Liver Extracts|liver extracts|mesh-list
138595696|NCT05723705|Hematinics|hematinics|mesh-ancestor
138595697|NCT05634577|Pembrolizumab|pembrolizumab|mesh-list
138595698|NCT05634577|Mitotane|mitotane|mesh-list
138595699|NCT05634577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138595700|NCT05634577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595701|NCT05634577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138595702|NCT05634577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595703|NCT05634577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138595704|NCT05616260|Acetazolamide|acetazolamide|mesh-list
138595705|NCT05616260|Anticonvulsants|anticonvulsants|mesh-ancestor
138595706|NCT05616260|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138595707|NCT05616260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595708|NCT05616260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595709|NCT05616260|Diuretics|diuretics|mesh-ancestor
138595710|NCT05616260|Natriuretic Agents|natriuretic agents|mesh-ancestor
138485269|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595711|NCT05616260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595712|NCT05611034|Oxaliplatin|oxaliplatin|mesh-list
138595713|NCT05611034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595714|NCT05592509|Vitamins|vitamins|mesh-list
138595715|NCT05592509|Micronutrients|micronutrients|mesh-ancestor
138595716|NCT05592509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595717|NCT05582213|Anesthetics|anesthetics|mesh-list
138595718|NCT05582213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138595719|NCT05582213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595720|NCT05550597|Fentanyl|fentanyl|mesh-list
138595721|NCT05550597|Bupivacaine|bupivacaine|mesh-list
138595722|NCT05550597|Anesthetics, Local|anesthetics, local|mesh-ancestor
138595723|NCT05550597|Anesthetics|anesthetics|mesh-ancestor
138595724|NCT05550597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138595725|NCT05550597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595726|NCT05550597|Sensory System Agents|sensory system agents|mesh-ancestor
138595727|NCT05550597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595728|NCT05550597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138595729|NCT05550597|Narcotics|narcotics|mesh-ancestor
138595730|NCT05550597|Analgesics|analgesics|mesh-ancestor
138595731|NCT05550597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138484357|NCT00006367|Cytarabine|cytarabine|mesh-list
138595732|NCT05550597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138595733|NCT05550597|Anesthetics, General|anesthetics, general|mesh-ancestor
138595734|NCT05495269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138595735|NCT05495269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138595737|NCT05355935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138595738|NCT05355935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595739|NCT05355935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138595740|NCT05355935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138595741|NCT05355935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595742|NCT05355935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595743|NCT05355935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595744|NCT05334017|Cocaine|cocaine|mesh-list
138595745|NCT05334017|Xylometazoline|xylometazoline|mesh-list
138595746|NCT05334017|Anesthetics, Local|anesthetics, local|mesh-ancestor
138485313|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138485315|NCT00000214|Analgesics|analgesics|mesh-ancestor
138595747|NCT05334017|Anesthetics|anesthetics|mesh-ancestor
138595748|NCT05334017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138595749|NCT05334017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595750|NCT05334017|Sensory System Agents|sensory system agents|mesh-ancestor
138595751|NCT05334017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595752|NCT05334017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138595753|NCT05334017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138595754|NCT05334017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138595755|NCT05334017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138595756|NCT05334017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595757|NCT05334017|Dopamine Agents|dopamine agents|mesh-ancestor
138595758|NCT05334017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595759|NCT05334017|Nasal Decongestants|nasal decongestants|mesh-ancestor
138595760|NCT05334017|Respiratory System Agents|respiratory system agents|mesh-ancestor
138595762|NCT05292339|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138595763|NCT05292339|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138595764|NCT05292339|Ketorolac|ketorolac|mesh-list
138595765|NCT05292339|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138595766|NCT05292339|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138595767|NCT05292339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138595768|NCT05292339|Glucocorticoids|glucocorticoids|mesh-ancestor
138595769|NCT05292339|Hormones|hormones|mesh-ancestor
138595770|NCT05292339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138595771|NCT05292339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595772|NCT05292339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138595773|NCT05292339|Immunologic Factors|immunologic factors|mesh-ancestor
138595774|NCT05292339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595775|NCT05292339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595776|NCT05292339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138595777|NCT05292339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138595779|NCT05292339|Sensory System Agents|sensory system agents|mesh-ancestor
138595780|NCT05292339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595781|NCT05292339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138595782|NCT05292339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138595783|NCT05291650|Hyaluronic Acid|hyaluronic acid|mesh-list
138595784|NCT05291650|Glucocorticoids|glucocorticoids|mesh-list
138595785|NCT05291650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138595786|NCT05291650|Immunologic Factors|immunologic factors|mesh-ancestor
138595787|NCT05291650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595788|NCT05291650|Viscosupplements|viscosupplements|mesh-ancestor
138595789|NCT05291650|Protective Agents|protective agents|mesh-ancestor
138595790|NCT05291650|Hormones|hormones|mesh-ancestor
138595791|NCT05291650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138595792|NCT05266027|Nalbuphine|nalbuphine|mesh-list
138595793|NCT05266027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138595794|NCT05266027|Narcotics|narcotics|mesh-ancestor
138595795|NCT05266027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138595796|NCT05266027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595797|NCT05266027|Analgesics|analgesics|mesh-ancestor
138595798|NCT05266027|Sensory System Agents|sensory system agents|mesh-ancestor
138595799|NCT05266027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595800|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
138485399|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138485405|NCT00000472|Heparin|heparin|mesh-list
138595801|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138595802|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
138595803|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595804|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595805|NCT05131386|Trabectedin|trabectedin|mesh-list
138595806|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138595807|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
138595808|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595809|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595810|NCT05129332|Vitamin E|vitamin e|mesh-list
138595811|NCT05129332|Vitamins|vitamins|mesh-ancestor
138595812|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
138455834|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
138595813|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595814|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
138595815|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595816|NCT05129332|Protective Agents|protective agents|mesh-ancestor
138595817|NCT05111262|Budesonide|budesonide|mesh-list
138595818|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
138595819|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138595820|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138595821|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
138595822|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595823|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595824|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138595825|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
138595826|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
138595827|NCT05111262|Hormones|hormones|mesh-ancestor
138595828|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138595829|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138595830|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138595831|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138595832|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
138595833|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595834|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595836|NCT05091242|Analgesics|analgesics|mesh-ancestor
138595837|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
138595838|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595839|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595840|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138595841|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
138595842|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
138595843|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138595844|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138595845|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138595846|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
138595847|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595848|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595849|NCT05028140|Pioglitazone|pioglitazone|mesh-list
138595850|NCT05028140|Empagliflozin|empagliflozin|mesh-list
138595851|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138595852|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595853|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138595854|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595855|NCT05027516|Azithromycin|azithromycin|mesh-list
138595856|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
138595857|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138485501|NCT00000514|Diuretics|diuretics|mesh-ancestor
138595858|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595859|NCT04992013|Niraparib|niraparib|mesh-list
138595860|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138595862|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595863|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595864|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138595865|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138595866|NCT04933630|Norepinephrine|norepinephrine|mesh-list
138595867|NCT04933630|Serotonin|serotonin|mesh-list
138455838|NCT01908114|Vaccines|vaccines|mesh-list
138455841|NCT01908257|Lesinurad|lesinurad|mesh-list
138595868|NCT04933630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138595869|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138595870|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138595871|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
138595872|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595873|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595874|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595875|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
138595876|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
138595877|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595878|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138595879|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138595880|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
138595881|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138595882|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138595883|NCT04923841|Atropine|atropine|mesh-list
138595884|NCT04923841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138595885|NCT04923841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138595886|NCT04923841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138485547|NCT00000529|Tamoxifen|tamoxifen|mesh-list
138595887|NCT04923841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138664592|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
138595888|NCT04923841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138595889|NCT04923841|Autonomic Agents|autonomic agents|mesh-ancestor
138595890|NCT04923841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595891|NCT04923841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595892|NCT04923841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138595893|NCT04923841|Respiratory System Agents|respiratory system agents|mesh-ancestor
138595894|NCT04923841|Mydriatics|mydriatics|mesh-ancestor
138595895|NCT04923841|Parasympatholytics|parasympatholytics|mesh-ancestor
138595896|NCT04923841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138595897|NCT04923841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138595898|NCT04923841|Cholinergic Agents|cholinergic agents|mesh-ancestor
138595899|NCT04923841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595900|NCT04923841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595901|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
138595902|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138595903|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
138595904|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138595905|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
138595906|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595907|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595908|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
138595910|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
138595911|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595912|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138595913|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138595914|NCT04792502|Growth Substances|growth substances|mesh-ancestor
138595915|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
138595916|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595917|NCT04761198|Nivolumab|nivolumab|mesh-list
138595918|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138485592|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
138485606|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
138595919|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595920|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138595921|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595922|NCT04748276|Norepinephrine|norepinephrine|mesh-list
138595923|NCT04748276|Serotonin|serotonin|mesh-list
138595924|NCT04748276|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138595925|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138595926|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138595927|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
138595928|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138595929|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595930|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595931|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
138595932|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
138595933|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138595934|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138595935|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138595936|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
138595937|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138595938|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138595939|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
138595940|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138595941|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595942|NCT04659811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138485633|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138485635|NCT00000568|Ipratropium|ipratropium|mesh-list
138595943|NCT04659811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595944|NCT04610658|Nivolumab|nivolumab|mesh-list
138595945|NCT04610658|Ipilimumab|ipilimumab|mesh-list
138595946|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138595947|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595948|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138595949|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595950|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
138595951|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138595952|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
138595953|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595954|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595955|NCT04532918|Cyclosporine|cyclosporine|mesh-list
138595956|NCT04532918|Rifampin|rifampin|mesh-list
138595957|NCT04532918|Allopurinol|allopurinol|mesh-list
138595958|NCT04532918|Verinurad|verinurad|mesh-list
138595959|NCT04532918|Cyclosporins|cyclosporins|mesh-list
138595960|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138595961|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138595962|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138595963|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
138595964|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595965|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
138595966|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595967|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
138595968|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138595969|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138595970|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138595971|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
138595972|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138595973|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
138595974|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138595975|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138595976|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138595977|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138595978|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138595979|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138595980|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138595981|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
138595982|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
138595983|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138595984|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
138595985|NCT04532918|Protective Agents|protective agents|mesh-ancestor
138595987|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138595988|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138595989|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138595990|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138595991|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
138595992|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138595993|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
138595994|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138595995|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
138595996|NCT04387084|Nivolumab|nivolumab|mesh-list
138595997|NCT04387084|Atezolizumab|atezolizumab|mesh-list
138595998|NCT04387084|Durvalumab|durvalumab|mesh-list
138595999|NCT04387084|Avelumab|avelumab|mesh-list
138596000|NCT04387084|Cemiplimab|cemiplimab|mesh-list
138596001|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
138485729|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138272363|NCT03472469|Ketorolac|ketorolac|mesh-list
138596002|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138596003|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
138596004|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138596005|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596006|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138596007|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596008|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
138596009|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596010|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
138596011|NCT04347798|Chloroquine|chloroquine|mesh-list
138596012|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
138596013|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138596014|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138596015|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596016|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596017|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596018|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138596019|NCT04347798|Amebicides|amebicides|mesh-ancestor
138596020|NCT04335669|Paclitaxel|paclitaxel|mesh-list
138596021|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138596022|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
138596023|NCT04335669|Carboplatin|carboplatin|mesh-list
138596024|NCT04335669|Pembrolizumab|pembrolizumab|mesh-list
138596025|NCT04335669|Capecitabine|capecitabine|mesh-list
138596026|NCT04335669|Epirubicin|epirubicin|mesh-list
138596027|NCT04335669|Taxane|taxane|mesh-list
138596028|NCT04335669|Antimetabolites|antimetabolites|mesh-list
138596029|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138596030|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596031|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
138596032|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
138596033|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
138596034|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596035|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138596036|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
138596037|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596038|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138596039|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138596040|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
138596041|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138596042|NCT04335669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138596043|NCT04335669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138596044|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138596045|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138596046|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138596047|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138596048|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596050|NCT04298983|Hormones|hormones|mesh-ancestor
138596051|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596052|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596054|NCT04236609|Everolimus|everolimus|mesh-list
138596055|NCT04236609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138455880|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138596056|NCT04236609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138596057|NCT04236609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596058|NCT04236609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596059|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138596061|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596062|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596063|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138485822|NCT00000718|Zalcitabine|zalcitabine|mesh-list
138596065|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138596066|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
138596067|NCT04232657|Denosumab|denosumab|mesh-list
138596068|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138596069|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596070|NCT04173585|Bortezomib|bortezomib|mesh-list
138596071|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
138596072|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596073|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138596074|NCT04173585|Immunotoxins|immunotoxins|mesh-ancestor
138596075|NCT04173585|Immunoconjugates|immunoconjugates|mesh-ancestor
138596076|NCT04173585|Immunologic Factors|immunologic factors|mesh-ancestor
138596077|NCT04173585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596078|NCT04172987|Tirzepatide|tirzepatide|mesh-list
138596079|NCT04172987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138596080|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596081|NCT04172987|Incretins|incretins|mesh-ancestor
138596082|NCT04172987|Hormones|hormones|mesh-ancestor
138596083|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596084|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
138596085|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596086|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138596087|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138484423|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
138596088|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596090|NCT04127786|Immunologic Factors|immunologic factors|mesh-ancestor
138596091|NCT04127786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596092|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
138596093|NCT04049331|Testosterone|testosterone|mesh-list
138596094|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
138596095|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
138596096|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138596097|NCT04049331|Androgens|androgens|mesh-ancestor
138596098|NCT04049331|Hormones|hormones|mesh-ancestor
138596099|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596100|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138485867|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596101|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138596102|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596103|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
138596104|NCT04033055|Ropivacaine|ropivacaine|mesh-list
138596105|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
138596106|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
138596107|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596108|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596109|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
138596110|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596111|NCT04015596|Naproxen|naproxen|mesh-list
138596112|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138596113|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138596114|NCT04015596|Analgesics|analgesics|mesh-ancestor
138596115|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
138596116|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596117|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596118|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138596119|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138596120|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
138596121|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138596122|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138293753|NCT04295486|Aspirin|aspirin|mesh-list
138596123|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596124|NCT03985722|Trabectedin|trabectedin|mesh-list
138596125|NCT03985722|Olaratumab|olaratumab|mesh-list
138596126|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138596127|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
138596128|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596129|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596130|NCT03954327|Tenofovir|tenofovir|mesh-list
138596131|NCT03954327|Emtricitabine|emtricitabine|mesh-list
138596132|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
138596133|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
138596134|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596135|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138596136|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138485910|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596137|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596138|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596139|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138596140|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138596141|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138596142|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138596144|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
138596145|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596146|NCT03762096|Protective Agents|protective agents|mesh-ancestor
138596147|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596148|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596149|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138596150|NCT03460379|Citalopram|citalopram|mesh-list
138596151|NCT03460379|Escitalopram|escitalopram|mesh-list
138596152|NCT03460379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138596153|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138596154|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138596155|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596156|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596158|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596159|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138596160|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
138596161|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138596162|NCT03460366|Enalapril|enalapril|mesh-list
138596163|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138596164|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
138596165|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596166|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596167|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138596168|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
138596169|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138596170|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596171|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138596172|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138596173|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138596174|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596175|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
138596176|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596177|NCT03460327|Candesartan|candesartan|mesh-list
138596178|NCT03460327|Candesartan cilexetil|candesartan cilexetil|mesh-list
138596179|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138596180|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138596181|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138596182|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596183|NCT03460314|Buprenorphine|buprenorphine|mesh-list
138596184|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138596185|NCT03460314|Narcotics|narcotics|mesh-ancestor
138596186|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596187|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596188|NCT03460314|Analgesics|analgesics|mesh-ancestor
138596189|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
138596190|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596191|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138596192|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138596193|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138596194|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138596195|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138596196|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596197|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
138596198|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596199|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596200|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138596201|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
138596202|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138596203|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138596204|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138596205|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596206|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596207|NCT03440879|Goserelin|goserelin|mesh-list
138596208|NCT03440879|Androgens|androgens|mesh-list
138596209|NCT03440879|Hormones|hormones|mesh-ancestor
138596210|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596211|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596212|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138596213|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596214|NCT03433755|Evolocumab|evolocumab|mesh-list
138596215|NCT03433755|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138596216|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138596217|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138596218|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
138596219|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596220|NCT03433755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138596221|NCT03433755|Protease Inhibitors|protease inhibitors|mesh-ancestor
138486042|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596222|NCT03433755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596223|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138596224|NCT03406507|Ravulizumab|ravulizumab|mesh-list
138272582|NCT02973659|Oxybutynin|oxybutynin|mesh-list
138596225|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138596226|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138596227|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
138596228|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596229|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
138596231|NCT03283150|Propofol|propofol|mesh-list
138596232|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138596233|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596234|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596235|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138596236|NCT03283150|Analgesics|analgesics|mesh-ancestor
138596237|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
138596238|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596239|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138596240|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138596241|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138596242|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
138596243|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138486087|NCT00000898|Saquinavir|saquinavir|mesh-list
138486105|NCT00389233|Vitamins|vitamins|mesh-ancestor
138596244|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596245|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138596246|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
138596247|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
138596248|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138596249|NCT03283150|Narcotics|narcotics|mesh-ancestor
138596250|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
138484509|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
138596251|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138596252|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596253|NCT03249792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138596254|NCT03249792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596255|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
138596256|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138596257|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596258|NCT03132675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138596259|NCT03132675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596260|NCT03110744|Palbociclib|palbociclib|mesh-list
138596261|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596262|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138596263|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596264|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596265|NCT03056040|Eculizumab|eculizumab|mesh-list
138596266|NCT03056040|Ravulizumab|ravulizumab|mesh-list
138596267|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138596268|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138596269|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
138596270|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596271|NCT02924038|Poly ICLC|poly iclc|mesh-list
138596272|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
138596273|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
138596274|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596275|NCT02726581|Dexamethasone|dexamethasone|mesh-list
138596276|NCT02726581|Nivolumab|nivolumab|mesh-list
138596277|NCT02726581|Pomalidomide|pomalidomide|mesh-list
138596278|NCT02726581|Elotuzumab|elotuzumab|mesh-list
138596279|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138596280|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
138455929|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
138455935|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
138596281|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
138596282|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596283|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596284|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138596285|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
138596286|NCT02726581|Hormones|hormones|mesh-ancestor
138596287|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596288|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138596289|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596290|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138596291|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138596292|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596293|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
138596294|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138596295|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138596296|NCT02726581|Growth Substances|growth substances|mesh-ancestor
138596297|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
138596298|NCT02700048|Naloxone|naloxone|mesh-list
138596299|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138596300|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596301|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
138486200|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
138596302|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596304|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138596305|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596307|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138596308|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
138596309|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596311|NCT02406209|Prednisolone|prednisolone|mesh-list
138596312|NCT02406209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138596313|NCT02406209|Methylprednisolone|methylprednisolone|mesh-list
138596314|NCT02406209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138596315|NCT02406209|Prednisolone acetate|prednisolone acetate|mesh-list
138596316|NCT02406209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138596317|NCT02406209|Prednisolone phosphate|prednisolone phosphate|mesh-list
138596318|NCT02406209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138596319|NCT02406209|Glucocorticoids|glucocorticoids|mesh-ancestor
138596320|NCT02406209|Hormones|hormones|mesh-ancestor
138596321|NCT02406209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596322|NCT02406209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596323|NCT02406209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138596324|NCT02406209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596325|NCT02406209|Antiemetics|antiemetics|mesh-ancestor
138596326|NCT02406209|Autonomic Agents|autonomic agents|mesh-ancestor
138596327|NCT02406209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596328|NCT02406209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138596329|NCT02406209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138596330|NCT02406209|Protective Agents|protective agents|mesh-ancestor
138596331|NCT02295722|Gemcitabine|gemcitabine|mesh-list
138596332|NCT02295722|Melphalan|melphalan|mesh-list
138596333|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138596334|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
138596335|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596336|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596337|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138596338|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
138596339|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138596340|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138596341|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
138596342|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596343|NCT02282059|Sunitinib|sunitinib|mesh-list
138596344|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596345|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138596346|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138596347|NCT02282059|Growth Substances|growth substances|mesh-ancestor
138486242|NCT00000970|Ganciclovir|ganciclovir|mesh-list
138596348|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596349|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
138596350|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138596351|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596352|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596354|NCT01964989|Immunologic Factors|immunologic factors|mesh-ancestor
138596355|NCT01964989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596356|NCT01575860|Lenalidomide|lenalidomide|mesh-list
138596357|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
138596358|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596359|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138596360|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138596361|NCT01575860|Growth Substances|growth substances|mesh-ancestor
138596362|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
138596363|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596364|NCT01416831|Interleukin-2|interleukin-2|mesh-list
138596365|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596366|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138596367|NCT01416831|Analgesics|analgesics|mesh-ancestor
138596368|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
138596369|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596370|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596371|NCT00635700|Ziprasidone|ziprasidone|mesh-list
138596372|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138596373|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
138484539|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138596374|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596375|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486274|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138486275|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138596376|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596378|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138596379|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596380|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138596381|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138596383|NCT00582075|Temozolomide|temozolomide|mesh-list
138596384|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138596385|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
138596386|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596387|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596388|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
138596389|NCT00558961|Chlorambucil|chlorambucil|mesh-list
138596390|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596391|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138596392|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596393|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596394|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138596395|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
138596397|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596398|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138596399|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138596400|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596401|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596402|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138596403|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
138596404|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596405|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486321|NCT05639127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596406|NCT00326456|Paclitaxel|paclitaxel|mesh-list
138596407|NCT00326456|Carboplatin|carboplatin|mesh-list
138596408|NCT00326456|Doxorubicin|doxorubicin|mesh-list
138596409|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138596410|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138596411|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596412|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
138596413|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
138596414|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
138596415|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596416|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138596417|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138596418|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138596419|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596420|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
138596421|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138596422|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596423|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138596424|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
138596425|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138596426|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596427|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596428|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596429|NCT00149981|Everolimus|everolimus|mesh-list
138596430|NCT00149981|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138596431|NCT00149981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138596432|NCT00149981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596433|NCT00149981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596434|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138596435|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
138596436|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596437|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596439|NCT02915731|Vitamins|vitamins|mesh-ancestor
138596440|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
138484548|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596441|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596442|NCT02915809|Vaccines|vaccines|mesh-list
138596443|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
138486365|NCT00001036|Analgesics|analgesics|mesh-ancestor
138486369|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
138596444|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596446|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138596447|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272804|NCT03663101|Lidocaine|lidocaine|mesh-list
138596449|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
138596450|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138596451|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596452|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596453|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596454|NCT02914678|Fentanyl|fentanyl|mesh-list
138596455|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138596456|NCT02914678|Narcotics|narcotics|mesh-ancestor
138596457|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596458|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596459|NCT02914678|Analgesics|analgesics|mesh-ancestor
138596460|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
138596461|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596462|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138596463|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138596464|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
138596465|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
138596466|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
138596467|NCT00405977|Analgesics|analgesics|mesh-ancestor
138596468|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
138596469|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596470|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596471|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
138596472|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596473|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138596474|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
138596475|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138596476|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138596477|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596478|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138596479|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
138596480|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138596481|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
138596482|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138596483|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596484|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138664819|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
138596485|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
138596486|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138596487|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596488|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596489|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596490|NCT02914015|Morphine|morphine|mesh-list
138596491|NCT02914015|Ropivacaine|ropivacaine|mesh-list
138596492|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
138596493|NCT02914015|Anesthetics|anesthetics|mesh-list
138596494|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138596495|NCT02914015|Narcotics|narcotics|mesh-ancestor
138596496|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596497|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596498|NCT02914015|Analgesics|analgesics|mesh-ancestor
138596499|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
138596500|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596501|NCT00171093|Valsartan|valsartan|mesh-list
138596502|NCT00171093|Simvastatin|simvastatin|mesh-list
138596503|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138596504|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138596505|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
138596506|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596507|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138596508|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138596509|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596510|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138596511|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138596512|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138596513|NCT02914054|Dexamethasone|dexamethasone|mesh-list
138596514|NCT02914054|Prednisone|prednisone|mesh-list
138596515|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138596516|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
138596517|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
138596518|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596519|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596520|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138596521|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
138596522|NCT02914054|Hormones|hormones|mesh-ancestor
138596523|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596524|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138596525|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596526|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
138596527|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138596528|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138596529|NCT00150059|Analgesics|analgesics|mesh-ancestor
138596530|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
138596531|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138486429|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
138486441|NCT00001084|Lamivudine|lamivudine|mesh-list
138455960|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
138596532|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596533|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138596534|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138596535|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
138596536|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138596537|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
138596538|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138596539|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596540|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596541|NCT00171132|Atenolol|atenolol|mesh-list
138596542|NCT00171132|Valsartan|valsartan|mesh-list
138596543|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138596544|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138596545|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138596546|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138596547|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596548|NCT00171132|Diuretics|diuretics|mesh-ancestor
138596549|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
138596550|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596551|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138596552|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138596553|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138596554|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
138596555|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
138484574|NCT00008190|Aldesleukin|aldesleukin|mesh-list
138596556|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596557|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138596558|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138596559|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138596561|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596562|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
138596563|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
138596564|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596565|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596566|NCT00150137|Methimazole|methimazole|mesh-list
138596567|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
138596568|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
138596569|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596570|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596571|NCT00150215|Olanzapine|olanzapine|mesh-list
138596572|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
138596573|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
138596574|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596575|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596576|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138596577|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138596578|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138486487|NCT00001105|Antibodies|antibodies|mesh-list
138596579|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596580|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138596581|NCT00150215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138596582|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138596583|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138596584|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596585|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596586|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
138596587|NCT00171171|Deferasirox|deferasirox|mesh-list
138596588|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138596589|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
138596590|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
138596591|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596593|NCT02913430|Fulvestrant|fulvestrant|mesh-list
138596594|NCT02913430|Palbociclib|palbociclib|mesh-list
138596595|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138596596|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
138596597|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596598|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596599|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138596600|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596601|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138596602|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138596603|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138664863|NCT04630028|Ustekinumab|ustekinumab|mesh-list
138596604|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138596605|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138596606|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596607|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596608|NCT02913469|Morphine|morphine|mesh-list
138596609|NCT02913469|Metoclopramide|metoclopramide|mesh-list
138596610|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138596611|NCT02913469|Narcotics|narcotics|mesh-ancestor
138596612|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596613|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138486507|NCT00001114|Didanosine|didanosine|mesh-list
138596614|NCT02913469|Analgesics|analgesics|mesh-ancestor
138596615|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
138596616|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596617|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
138596618|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
138596619|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138596620|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138596621|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138596622|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
138596623|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596624|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596625|NCT00150254|Varenicline|varenicline|mesh-list
138596626|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138596627|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138596628|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
138596629|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596630|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596631|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596632|NCT02913508|Vedolizumab|vedolizumab|mesh-list
138596633|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138596634|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
138596635|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
138596636|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138596637|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138596638|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596639|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596640|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596641|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138596642|NCT00150293|Pregabalin|pregabalin|mesh-list
138596643|NCT00150293|Analgesics|analgesics|mesh-ancestor
138596644|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
138596645|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596646|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596647|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
138596648|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138596649|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138596650|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596651|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138596652|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138596653|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138596654|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596655|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138596656|NCT02913118|Amoxicillin|amoxicillin|mesh-list
138596657|NCT02913118|Azithromycin|azithromycin|mesh-list
138596658|NCT02913118|Doxycycline|doxycycline|mesh-list
138596659|NCT02913118|Minocycline|minocycline|mesh-list
138596660|NCT02913118|Cephalosporins|cephalosporins|mesh-list
138596661|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
138596662|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138664871|NCT04623541|Venetoclax|venetoclax|mesh-list
138596663|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596664|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
138596665|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138455989|NCT01909661|Caseins|caseins|mesh-list
138596666|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138596667|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138596668|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596669|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596670|NCT00150332|Linezolid|linezolid|mesh-list
138596671|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138596672|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596673|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138596674|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596675|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596676|NCT00150371|Atorvastatin|atorvastatin|mesh-list
138596677|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138596678|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138596679|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
138596680|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596681|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138596682|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138596683|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596684|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
138596685|NCT02912494|Hematinics|hematinics|mesh-ancestor
138596686|NCT00150410|Insulin|insulin|mesh-list
138596687|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138596688|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596689|NCT00171288|Ezetimibe|ezetimibe|mesh-list
138596690|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138596691|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138596692|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
138596693|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596694|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138596695|NCT00150449|Pregabalin|pregabalin|mesh-list
138596696|NCT00150449|Analgesics|analgesics|mesh-ancestor
138596697|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
138596698|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596699|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596700|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
138596701|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138596702|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138596703|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596704|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138596705|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138596706|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138486563|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486564|NCT00000114|Vitamins|vitamins|mesh-list
138486565|NCT00000114|Vitamin E|vitamin e|mesh-list
138596708|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138596709|NCT02912182|Prednisolone|prednisolone|mesh-list
138596710|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138596711|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
138596712|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138596713|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
138596714|NCT02912182|Betamethasone|betamethasone|mesh-list
138596715|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138596716|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
138596717|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138596718|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
138596719|NCT02912182|Hormones|hormones|mesh-ancestor
138596720|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596721|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318266|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
138596722|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138596723|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596724|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
138596725|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
138596726|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596727|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138596728|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138596729|NCT02912182|Protective Agents|protective agents|mesh-ancestor
138596730|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138414945|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
138596731|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
138596732|NCT02912026|Olorofim|olorofim|mesh-list
138596733|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
138596734|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596735|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
138596736|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138596737|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596738|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138596739|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138596740|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596741|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596742|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596743|NCT02843230|Bevacizumab|bevacizumab|mesh-list
138273096|NCT03743246|Fludarabine|fludarabine|mesh-list
138596744|NCT02843230|Temozolomide|temozolomide|mesh-list
138596745|NCT02843230|Lomustine|lomustine|mesh-list
138596746|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138596747|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596748|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138486587|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138486588|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
138486589|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138596749|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138596751|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596752|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
138596753|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138596754|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
138596755|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596757|NCT02712814|Hormones|hormones|mesh-ancestor
138596758|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596759|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596760|NCT00150527|Dexamethasone|dexamethasone|mesh-list
138596761|NCT00150527|Citalopram|citalopram|mesh-list
138664921|NCT04585789|Tenofovir|tenofovir|mesh-list
138596762|NCT00150527|Escitalopram|escitalopram|mesh-list
138596763|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138596764|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
138596765|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
138596766|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596767|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596768|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138596769|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
138596770|NCT00150527|Hormones|hormones|mesh-ancestor
138596771|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138596772|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138596773|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596774|NCT00150527|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138596775|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138596776|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138596777|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596778|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596779|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
138596780|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138596781|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
138596782|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138596783|NCT00171327|Valsartan|valsartan|mesh-list
138596784|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138596785|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138596786|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138596787|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596788|NCT02911597|Naltrexone|naltrexone|mesh-list
138484684|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
138484686|NCT00008307|Fludarabine|fludarabine|mesh-list
138596789|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138596790|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138596791|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138456002|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596792|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
138596793|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596796|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138596797|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596798|NCT00171366|Amlodipine|amlodipine|mesh-list
138596799|NCT00171366|Benazepril|benazepril|mesh-list
138596800|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138596801|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138596802|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138486620|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596803|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596804|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138596805|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596806|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
138596807|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138596808|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
138596809|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596810|NCT00150605|Carbamazepine|carbamazepine|mesh-list
138596811|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
138596812|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
138596813|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138596814|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596815|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596816|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138596817|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138596818|NCT00150605|Analgesics|analgesics|mesh-ancestor
138596819|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
138664936|NCT04581473|Antibodies|antibodies|mesh-list
138596820|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138596821|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138596822|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138596823|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596824|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138596825|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138596826|NCT02910778|Ticagrelor|ticagrelor|mesh-list
138596827|NCT02910778|Atorvastatin|atorvastatin|mesh-list
138596828|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138596829|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138596830|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
138596831|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596832|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138596833|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138596834|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596835|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138596836|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138596837|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138596838|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138596839|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
138596840|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596841|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596842|NCT00164112|Azithromycin|azithromycin|mesh-list
138596843|NCT00164112|Levofloxacin|levofloxacin|mesh-list
138596844|NCT00164112|Telithromycin|telithromycin|mesh-list
138596845|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138596846|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596847|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138596848|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138596849|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138596850|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486640|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138596851|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596852|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596853|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138596854|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138596855|NCT02910817|Metformin|metformin|mesh-list
138596856|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138596857|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596858|NCT00150722|Atorvastatin|atorvastatin|mesh-list
138596859|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138596860|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138596861|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
138596862|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596863|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138596864|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138596865|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596867|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138596868|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138596869|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
138596871|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596872|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596873|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596874|NCT00171483|Tegaserod|tegaserod|mesh-list
138596875|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138596876|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
138596877|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596878|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596879|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596881|NCT03777904|Trace Elements|trace elements|mesh-ancestor
138596882|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
138596883|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596884|NCT00150839|Mirtazapine|mirtazapine|mesh-list
138596885|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138596886|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138596887|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138596888|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138596889|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273246|NCT02974712|Fentanyl|fentanyl|mesh-list
138596890|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138596891|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596892|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138596893|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
138596894|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138596895|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138596896|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
138596897|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
138596898|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138596899|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138596900|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596901|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138596902|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138596903|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138596904|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
138596905|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138596906|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138596907|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
138596908|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138596909|NCT03782740|Melatonin|melatonin|mesh-list
138596910|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
138596911|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596912|NCT03782740|Protective Agents|protective agents|mesh-ancestor
138596913|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596914|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138596915|NCT00532168|Ritonavir|ritonavir|mesh-list
138596916|NCT00532168|Lopinavir|lopinavir|mesh-list
138596917|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138596918|NCT00532168|Tenofovir|tenofovir|mesh-list
138596919|NCT00532168|Emtricitabine|emtricitabine|mesh-list
138596920|NCT00532168|Efavirenz|efavirenz|mesh-list
138596921|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138456019|NCT01909856|Dexamethasone|dexamethasone|mesh-list
138596922|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138596923|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
138596924|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596925|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596926|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138596927|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138596928|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
138596929|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138596930|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138596931|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138596932|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138596933|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138596934|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138596935|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138596936|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138486704|NCT00001576|Leucovorin|leucovorin|mesh-list
138596937|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138596938|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138596940|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138596941|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596942|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138596944|NCT04723836|Vitamins|vitamins|mesh-ancestor
138596945|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
138596946|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596947|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
138596948|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138596949|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
138596950|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138596951|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
138596952|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
138596953|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596954|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138596955|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138596956|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138596957|NCT00150995|Growth Substances|growth substances|mesh-ancestor
138596958|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596959|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
138596960|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596961|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138596962|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138596963|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
138596964|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138486728|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138486729|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
138596965|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596966|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138596967|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138596968|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138596970|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138596971|NCT00532285|Gemcitabine|gemcitabine|mesh-list
138596972|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138596973|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596974|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
138596975|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
138596976|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
138596977|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596978|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138596979|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
138596980|NCT00151034|Paclitaxel|paclitaxel|mesh-list
138596981|NCT00151034|Carboplatin|carboplatin|mesh-list
138596982|NCT00151034|Gemcitabine|gemcitabine|mesh-list
138596983|NCT00151034|Trastuzumab|trastuzumab|mesh-list
138596984|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138596985|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138596987|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
138596988|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
138596989|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138596990|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138596992|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138596993|NCT02817451|Vaccines|vaccines|mesh-list
138596994|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
138596995|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138596996|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138596997|NCT00171522|Tegaserod|tegaserod|mesh-list
138596998|NCT00171522|Laxatives|laxatives|mesh-ancestor
138596999|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138597000|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138597001|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
138597002|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597003|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597004|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597005|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
138597006|NCT00151073|Docetaxel|docetaxel|mesh-list
138597007|NCT00151073|Estramustine|estramustine|mesh-list
138597008|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486775|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486776|NCT00001696|Genistein|genistein|mesh-list
138486777|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138597009|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
138597010|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
138597011|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
138597012|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597013|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138597014|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597015|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138597016|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
138597017|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138597018|NCT00171561|Valsartan|valsartan|mesh-list
138597019|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138597020|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138597021|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138597022|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138597023|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597024|NCT00171561|Diuretics|diuretics|mesh-ancestor
138597025|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
138597026|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597027|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138597028|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138597029|NCT00151112|Anesthetics|anesthetics|mesh-list
138597030|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138597031|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597032|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
138597033|NCT00532324|Mupirocin|mupirocin|mesh-list
138597034|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138597035|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597036|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
138597037|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138597038|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138597039|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597040|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597041|NCT00171600|Valsartan|valsartan|mesh-list
138597042|NCT00171600|Lisinopril|lisinopril|mesh-list
138597043|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138597044|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138597045|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138597046|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597047|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138597048|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
138597049|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597050|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138597051|NCT00171600|Protective Agents|protective agents|mesh-ancestor
138597052|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597054|NCT05467384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138597055|NCT05467384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138597056|NCT05467384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138486812|NCT00001729|Ribavirin|ribavirin|mesh-list
138597057|NCT05467384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597058|NCT05467384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138597059|NCT05467384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597061|NCT05467189|Paclitaxel|paclitaxel|mesh-list
138597062|NCT05467189|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138597063|NCT05467189|Busulfan|busulfan|mesh-list
138597064|NCT05467189|Lapatinib|lapatinib|mesh-list
138597065|NCT05467189|Afatinib|afatinib|mesh-list
138597066|NCT05467189|Crizotinib|crizotinib|mesh-list
138597067|NCT05467189|Ceritinib|ceritinib|mesh-list
138597068|NCT05467189|Antineoplastic Agents|antineoplastic agents|mesh-list
138597069|NCT05467189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138597070|NCT05467189|Tubulin Modulators|tubulin modulators|mesh-ancestor
138597071|NCT05467189|Antimitotic Agents|antimitotic agents|mesh-ancestor
138597072|NCT05467189|Mitosis Modulators|mitosis modulators|mesh-ancestor
138597073|NCT05467189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486830|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597074|NCT05467189|Alkylating Agents|alkylating agents|mesh-ancestor
138597075|NCT05467189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138597076|NCT05467189|Immunologic Factors|immunologic factors|mesh-ancestor
138597077|NCT05467189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597078|NCT05467189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138597079|NCT05467189|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138597080|NCT05467189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138597081|NCT05467189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597082|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
138597083|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138597084|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597085|NCT05466604|Dexamethasone|dexamethasone|mesh-list
138597086|NCT05466604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138597087|NCT05466604|Antiemetics|antiemetics|mesh-ancestor
138597088|NCT05466604|Autonomic Agents|autonomic agents|mesh-ancestor
138597089|NCT05466604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138665043|NCT04540692|Paclitaxel|paclitaxel|mesh-list
138597090|NCT05466604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597091|NCT05466604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138597092|NCT05466604|Glucocorticoids|glucocorticoids|mesh-ancestor
138597093|NCT05466604|Hormones|hormones|mesh-ancestor
138597094|NCT05466604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138597095|NCT05466604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138486831|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
138486832|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597096|NCT05466604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597098|NCT04723875|Docetaxel|docetaxel|mesh-list
138597099|NCT04723875|Carboplatin|carboplatin|mesh-list
138597100|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138597101|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597102|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
138597103|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
138597104|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
138597105|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597106|NCT05466019|Leucovorin|leucovorin|mesh-list
138597107|NCT05466019|Docetaxel|docetaxel|mesh-list
138597108|NCT05466019|Oxaliplatin|oxaliplatin|mesh-list
138597109|NCT05466019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597110|NCT05466019|Tubulin Modulators|tubulin modulators|mesh-ancestor
138597111|NCT05466019|Antimitotic Agents|antimitotic agents|mesh-ancestor
138597112|NCT05466019|Mitosis Modulators|mitosis modulators|mesh-ancestor
138597113|NCT05466019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597115|NCT05466019|Protective Agents|protective agents|mesh-ancestor
138597116|NCT05466019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597117|NCT05466019|Vitamin B Complex|vitamin b complex|mesh-ancestor
138597118|NCT05466019|Vitamins|vitamins|mesh-ancestor
138597119|NCT05466019|Micronutrients|micronutrients|mesh-ancestor
138597120|NCT05465902|Vaccines|vaccines|mesh-list
138597121|NCT05465902|Immunologic Factors|immunologic factors|mesh-ancestor
138597122|NCT05465902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597123|NCT00151346|Fentanyl|fentanyl|mesh-list
138597124|NCT00151346|Bupivacaine|bupivacaine|mesh-list
138597125|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
138597126|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
138597127|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138597128|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597129|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
138597130|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597131|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138597132|NCT00151346|Narcotics|narcotics|mesh-ancestor
138597133|NCT00151346|Analgesics|analgesics|mesh-ancestor
138597134|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138597135|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138597136|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
138597137|NCT00164424|Acyclovir|acyclovir|mesh-list
138597138|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
138597139|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597140|NCT00532519|Citalopram|citalopram|mesh-list
138597141|NCT00532519|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138486863|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
138486864|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138597142|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138597143|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138597144|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597145|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597146|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
138597147|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597148|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138597149|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
138597150|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138597151|NCT00171678|Diclofenac|diclofenac|mesh-list
138597152|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138597153|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138597154|NCT00171678|Analgesics|analgesics|mesh-ancestor
138597155|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
138597156|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597157|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597158|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138597159|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138597160|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138597162|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597163|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
138597164|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597165|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
138597166|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138597168|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597169|NCT00151463|Urological Agents|urological agents|mesh-ancestor
138597170|NCT00171717|Cyclosporine|cyclosporine|mesh-list
138597171|NCT00171717|Cyclosporins|cyclosporins|mesh-list
138597172|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597173|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597174|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138597175|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
138597176|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597177|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
138597178|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138486895|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138486896|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597179|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
138597180|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138597181|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138597182|NCT00151502|Atorvastatin|atorvastatin|mesh-list
138597183|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138597184|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138597185|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
138597186|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597187|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138597188|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138597189|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597190|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
138597191|NCT00164463|Isoniazid|isoniazid|mesh-list
138597192|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138597193|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597194|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138597195|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138597196|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597197|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597198|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597199|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
138597200|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138597201|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138597202|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
138597203|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138597204|NCT00171756|Atenolol|atenolol|mesh-list
138597205|NCT00171756|Valsartan|valsartan|mesh-list
138597206|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138597207|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138597208|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138597209|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597210|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138597211|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
138597212|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
138597213|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597214|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597215|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138597216|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138597217|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138597218|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
138597219|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597220|NCT00171795|Rivastigmine|rivastigmine|mesh-list
138597221|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138597222|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138486931|NCT05640427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138597223|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597224|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
138597225|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597227|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138597228|NCT00171795|Protective Agents|protective agents|mesh-ancestor
138597230|NCT00151541|Adapalene|adapalene|mesh-list
138597231|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138597232|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
138597233|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138597234|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138597235|NCT00151541|Analgesics|analgesics|mesh-ancestor
138597236|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
138597237|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597238|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597239|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138597240|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138597241|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597242|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
138597243|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138597244|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138597245|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138597246|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597247|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597248|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
138597249|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138597250|NCT00151580|Ribavirin|ribavirin|mesh-list
138597251|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
138597252|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597253|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
138597254|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597255|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
138597256|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597257|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138597258|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597259|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597260|NCT00151619|Amlodipine|amlodipine|mesh-list
138597261|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138597262|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138597263|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138597264|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138484882|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
138597265|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138486960|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597266|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597267|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
138597269|NCT00532675|Panobinostat|panobinostat|mesh-list
138597270|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
138597271|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597272|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138597273|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138597274|NCT00532675|Growth Substances|growth substances|mesh-ancestor
138597275|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
138597276|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597277|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138597278|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597279|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597280|NCT05308030|Aspirin|aspirin|mesh-list
138597281|NCT05308030|Rivaroxaban|rivaroxaban|mesh-list
138597282|NCT05308030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138597283|NCT05308030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138597284|NCT05308030|Analgesics|analgesics|mesh-ancestor
138597285|NCT05308030|Sensory System Agents|sensory system agents|mesh-ancestor
138597286|NCT05308030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597287|NCT05308030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597288|NCT05308030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138597289|NCT05308030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138597290|NCT05308030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138597291|NCT05308030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138597292|NCT05308030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597293|NCT05308030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138597294|NCT05308030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138597295|NCT05308030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597296|NCT05308030|Antipyretics|antipyretics|mesh-ancestor
138597297|NCT05308030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138597298|NCT05308030|Antithrombins|antithrombins|mesh-ancestor
138597299|NCT05308030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138597301|NCT05308030|Anticoagulants|anticoagulants|mesh-ancestor
138597302|NCT05293600|Acetazolamide|acetazolamide|mesh-list
138597303|NCT05293600|Eszopiclone|eszopiclone|mesh-list
138597304|NCT05293600|Trazodone|trazodone|mesh-list
138597305|NCT05293600|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138597306|NCT05293600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138597307|NCT05293600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138597308|NCT05293600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138597309|NCT05293600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597310|NCT05293600|Adrenergic Agents|adrenergic agents|mesh-ancestor
138597311|NCT05293600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138487002|NCT00000378|Sertraline|sertraline|mesh-list
138597312|NCT05293600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597313|NCT05293600|Anticonvulsants|anticonvulsants|mesh-ancestor
138597314|NCT05293600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138597315|NCT05293600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597316|NCT05293600|Diuretics|diuretics|mesh-ancestor
138597317|NCT05293600|Natriuretic Agents|natriuretic agents|mesh-ancestor
138597318|NCT05293600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138597319|NCT05293600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138597320|NCT05293600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138597321|NCT05293600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138597322|NCT05293600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138597323|NCT05293600|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138597324|NCT05293600|Serotonin Agents|serotonin agents|mesh-ancestor
138597325|NCT05293600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138597326|NCT05293600|Antidepressive Agents|antidepressive agents|mesh-ancestor
138597327|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
138597328|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138597329|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138597330|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597331|NCT00532714|Capecitabine|capecitabine|mesh-list
138597332|NCT00532714|Irinotecan|irinotecan|mesh-list
138597333|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138597334|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
138597335|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597336|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273704|NCT01152541|Riboflavin|riboflavin|mesh-list
138597337|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138597338|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138597339|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597340|NCT00151736|Etodolac|etodolac|mesh-list
138597341|NCT00151736|Chlorambucil|chlorambucil|mesh-list
138597342|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138597343|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
138597344|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597345|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597346|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138597347|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138597348|NCT00151736|Analgesics|analgesics|mesh-ancestor
138597349|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
138597350|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597351|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597352|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138597353|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138597354|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138597355|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138597356|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597357|NCT00171990|Famciclovir|famciclovir|mesh-list
138597358|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
138487024|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138487025|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
138597359|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597360|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138597361|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597362|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597363|NCT00406094|Montelukast|montelukast|mesh-list
138597364|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138597365|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
138597366|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138597367|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
138597368|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138597369|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484939|NCT00007852|Etoposide|etoposide|mesh-list
138597370|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138318274|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
138597371|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138597372|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597374|NCT00164736|Lopinavir|lopinavir|mesh-list
138597375|NCT00164736|Lamivudine|lamivudine|mesh-list
138597376|NCT00164736|Zidovudine|zidovudine|mesh-list
138597377|NCT00164736|Nevirapine|nevirapine|mesh-list
138597378|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138597379|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138597380|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
138597381|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597382|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597383|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138597384|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138597385|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
138597386|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597387|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138597388|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138597389|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138597390|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138597391|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
138597392|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138597393|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138597394|NCT00532909|Bevacizumab|bevacizumab|mesh-list
138597395|NCT00532909|Capecitabine|capecitabine|mesh-list
138597396|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
138597397|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138597398|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597399|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138597400|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138597401|NCT00532909|Growth Substances|growth substances|mesh-ancestor
138487049|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138487050|NCT00000420|Norinyl|norinyl|mesh-list
138487052|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138597402|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597403|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
138597404|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138597405|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
138597406|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597407|NCT00172068|Vitamin D|vitamin d|mesh-list
138597408|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
138597409|NCT00172068|Calcium|calcium|mesh-list
138597410|NCT00172068|Vitamins|vitamins|mesh-ancestor
138273775|NCT02451488|Sargramostim|sargramostim|mesh-list
138597411|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
138597412|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597413|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138484967|NCT00007969|Verteporfin|verteporfin|mesh-list
138597414|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138597415|NCT00151970|Methylphenidate|methylphenidate|mesh-list
138597416|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138597417|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597418|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138597419|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138597420|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138597421|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597422|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
138597423|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597424|NCT00152048|Eflornithine|eflornithine|mesh-list
138597425|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597426|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138597427|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138597428|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138597429|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597430|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138597431|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597432|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665138|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138597434|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138597435|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138597436|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138597437|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138597438|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597439|NCT00164775|Imipramine|imipramine|mesh-list
138487077|NCT05519683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487107|NCT02972476|Xhance|xhance|mesh-list
138597440|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138597441|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
138597443|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138597444|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138597445|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138597446|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597447|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
138597448|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597449|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597450|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138597452|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
138597453|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138597454|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138597455|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138597456|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597457|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597458|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597459|NCT00533026|Analgesics|analgesics|mesh-ancestor
138597460|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
138597461|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597462|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
138597463|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138597464|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
138597465|NCT00152126|Melphalan|melphalan|mesh-list
138597466|NCT00152126|Busulfan|busulfan|mesh-list
138597467|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138597468|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
138597469|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597470|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597471|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138597472|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138597473|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
138597474|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597475|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
138597476|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138487110|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
138487111|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138597477|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597478|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
138597479|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
138597480|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138597481|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
138273848|NCT02453672|Bevacizumab|bevacizumab|mesh-list
138597482|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138597483|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597484|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
138597485|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
138597486|NCT00425451|Analgesics|analgesics|mesh-ancestor
138597487|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
138597488|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597489|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597490|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138597491|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138597492|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138597493|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138597494|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138597495|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597496|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597497|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
138597498|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
138597499|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138597500|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
138597501|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138597502|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138597503|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597504|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138597505|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597506|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597507|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138597509|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138597510|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597511|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597512|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
138597513|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597514|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597515|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
138597516|NCT00152243|Tegafur|tegafur|mesh-list
138597517|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138597518|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
138456077|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138456078|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
138597519|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597520|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597521|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
138597522|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138597523|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597524|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138597525|NCT00152282|Estrogens|estrogens|mesh-ancestor
138597526|NCT00152282|Hormones|hormones|mesh-ancestor
138487146|NCT05349838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138597527|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138597528|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597530|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597531|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597532|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138597533|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138597534|NCT00164892|Rofecoxib|rofecoxib|mesh-list
138597535|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138597536|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138597537|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597538|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665187|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597539|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138597540|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138597542|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
138597543|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597544|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597545|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138597546|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138597547|NCT00152399|Somatostatin|somatostatin|mesh-list
138597548|NCT00152399|Hormones|hormones|mesh-ancestor
138597549|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138597550|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597551|NCT00164931|Omeprazole|omeprazole|mesh-list
138597552|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138597553|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138597554|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138597555|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487170|NCT05233696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487173|NCT00000492|Propranolol|propranolol|mesh-list
138597556|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597558|NCT00152438|Progestins|progestins|mesh-ancestor
138597559|NCT00152438|Hormones|hormones|mesh-ancestor
138597560|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138597561|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597562|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
138597563|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
138597564|NCT00164970|Vitamins|vitamins|mesh-ancestor
138597565|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
138597566|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597567|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
138597568|NCT00164970|Hematinics|hematinics|mesh-ancestor
138597569|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
138597570|NCT02937844|Fludarabine|fludarabine|mesh-list
138597571|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138597572|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
138597573|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597574|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138597575|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138597576|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
138597577|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597578|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597579|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138597580|NCT02937415|Antioxidants|antioxidants|mesh-list
138597581|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
138597582|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597583|NCT02937415|Protective Agents|protective agents|mesh-ancestor
138597584|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597585|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
138597586|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
138597587|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597588|NCT00152594|Voriconazole|voriconazole|mesh-list
138597589|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
138597590|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597591|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138597592|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138597593|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597594|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597645|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138597646|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138597647|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138597648|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597649|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
138597650|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
138597651|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597652|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597653|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138597654|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138597655|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138597656|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
138597657|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597658|NCT02937181|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138597659|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138597660|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597661|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138597662|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138597663|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597665|NCT00425490|Hormones|hormones|mesh-ancestor
138597666|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138597667|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138597668|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
138597669|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597670|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597671|NCT03457753|Riluzole|riluzole|mesh-list
138597672|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
138597673|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138597674|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138597675|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597676|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597677|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597678|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138597679|NCT03457753|Protective Agents|protective agents|mesh-ancestor
138597680|NCT02936830|Listerine|listerine|mesh-list
138597681|NCT02936830|Fluorides|fluorides|mesh-list
138597682|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
138597683|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
138597684|NCT02936830|Glycerol|glycerol|mesh-list
138597685|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
138597686|NCT02936830|Protective Agents|protective agents|mesh-ancestor
138597687|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487298|NCT00000531|Amiodarone|amiodarone|mesh-list
138597688|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138597689|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597690|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138597691|NCT00165048|Rofecoxib|rofecoxib|mesh-list
138597692|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138485162|NCT05637073|Dienogest|dienogest|mesh-list
138597693|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138597694|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597695|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597696|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138597697|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138597698|NCT00165048|Analgesics|analgesics|mesh-ancestor
138597699|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
138597700|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597701|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597702|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138597703|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138597704|NCT04690270|Sumatriptan|sumatriptan|mesh-list
138597705|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138597706|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138597707|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138597708|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
138597709|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597710|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597711|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597712|NCT00165087|Doxorubicin|doxorubicin|mesh-list
138597713|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
138597714|NCT00165087|Asparaginase|asparaginase|mesh-list
138597715|NCT00165087|Razoxane|razoxane|mesh-list
138597716|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138597717|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597718|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138597719|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138597720|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597721|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597722|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138487305|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138597723|NCT00165087|Protective Agents|protective agents|mesh-ancestor
138597724|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597725|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
138597726|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
138597728|NCT00152750|Analgesics|analgesics|mesh-ancestor
138597729|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
138597730|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597731|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597732|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138597733|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
138597734|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
138597735|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138597736|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138597737|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138597738|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
138597739|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597740|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597741|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
138597742|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138597743|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138597744|NCT00152828|Celecoxib|celecoxib|mesh-list
138597745|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138597746|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138597747|NCT00152828|Analgesics|analgesics|mesh-ancestor
138597748|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
138597749|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597750|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597751|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138597752|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138597753|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138597754|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138597755|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597756|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597757|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
138597758|NCT02935933|Morphine|morphine|mesh-list
138597759|NCT02935933|Bupivacaine|bupivacaine|mesh-list
138597760|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
138597761|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
138597762|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138597763|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597764|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
138597765|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487343|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138487344|NCT00000555|Progestins|progestins|mesh-ancestor
138597766|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138597767|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138487345|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
138597769|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138597770|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138597771|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138597772|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
138597773|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597774|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597775|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138597776|NCT02935933|Narcotics|narcotics|mesh-ancestor
138597777|NCT00152867|Dexamethasone|dexamethasone|mesh-list
138597778|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138597779|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
138597780|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
138597781|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597782|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597783|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138597785|NCT00152867|Hormones|hormones|mesh-ancestor
138597786|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138597787|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138597788|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597789|NCT02935972|Lidocaine|lidocaine|mesh-list
138597790|NCT02935972|Diazepam|diazepam|mesh-list
138597791|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
138597792|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
138597793|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138597794|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597795|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
138597796|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597797|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138597798|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138597799|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138597800|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138597801|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597802|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138597803|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
138597804|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
138597805|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
138597806|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138597807|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138597808|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138597809|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138597810|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138597811|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138597812|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138597814|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
138597815|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
138597816|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
138597817|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597818|NCT02935855|Warfarin|warfarin|mesh-list
138597819|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
138597820|NCT02935855|Dabigatran|dabigatran|mesh-list
138597821|NCT02935855|Apixaban|apixaban|mesh-list
138597822|NCT02935855|Edoxaban|edoxaban|mesh-list
138487373|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138597823|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
138597824|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138597825|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
138597826|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138485234|NCT00000145|Trace Elements|trace elements|mesh-ancestor
138597827|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
138597828|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138330783|NCT05715931|Antidotes|antidotes|mesh-ancestor
138597829|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597830|NCT02935582|Betamethasone|betamethasone|mesh-list
138597831|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
138597832|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138597833|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
138597834|NCT02935582|Calcipotriene|calcipotriene|mesh-list
138597835|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138597836|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138597837|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
138597838|NCT02935582|Hormones|hormones|mesh-ancestor
138597839|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138597840|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597841|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138597842|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
138597843|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
138597844|NCT00406172|Bevacizumab|bevacizumab|mesh-list
138597845|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138597846|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597847|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138597848|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138597849|NCT00406172|Growth Substances|growth substances|mesh-ancestor
138597850|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597851|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
138597852|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138597853|NCT00152945|Glycerol|glycerol|mesh-list
138597854|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138597855|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138597856|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138597857|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138597858|NCT00152945|Protective Agents|protective agents|mesh-ancestor
138597859|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597860|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138597861|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
138597862|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138597863|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597864|NCT02935231|Nicotine|nicotine|mesh-list
138597865|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138597866|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
138597867|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138487396|NCT00000588|Chelating Agents|chelating agents|mesh-ancestor
138597869|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138597870|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138597871|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
138597872|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597873|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597874|NCT00172380|Docetaxel|docetaxel|mesh-list
138597875|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597876|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
138597877|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
138597879|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597880|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
138597881|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138597882|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
138597883|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597884|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597885|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138597886|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
138597887|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
138597888|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138597890|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597891|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597892|NCT02935075|Tenofovir|tenofovir|mesh-list
138597893|NCT02935075|Lamivudine|lamivudine|mesh-list
138597894|NCT02935075|Efavirenz|efavirenz|mesh-list
138597895|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
138597896|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597897|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138456113|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
138597898|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138597899|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597900|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597901|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138597902|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138597903|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138487425|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138597905|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138597906|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138597907|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138597908|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138597909|NCT02934919|Nalmefene|nalmefene|mesh-list
138597910|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138597911|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597912|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
138597913|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597914|NCT00172419|Atorvastatin|atorvastatin|mesh-list
138597915|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138597916|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138597917|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
138597918|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597919|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138597920|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138597921|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138597922|NCT00153023|Valsartan|valsartan|mesh-list
138597923|NCT00153023|Telmisartan|telmisartan|mesh-list
138597924|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138597925|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138597926|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138597927|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597928|NCT00165204|Tibolone|tibolone|mesh-list
138597929|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
138188363|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138597930|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
138597931|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138597932|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597933|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138597934|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138597935|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138597936|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138597937|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
138597938|NCT00165204|Hormones|hormones|mesh-ancestor
138597939|NCT02934763|Propranolol|propranolol|mesh-list
138597940|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138597941|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138597942|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
138597943|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138597944|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597945|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597946|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138597947|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138597948|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
138597949|NCT04689958|Vitamin D|vitamin d|mesh-list
138597950|NCT04689958|Vitamins|vitamins|mesh-ancestor
138597951|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
138597952|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597953|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138597954|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138597956|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138597957|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138597958|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138597959|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
138597960|NCT00153296|Carbamazepine|carbamazepine|mesh-list
138597961|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
138597962|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
138597963|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138597964|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138597965|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597966|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138330923|NCT04920032|Irinotecan|irinotecan|mesh-list
138597967|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138597968|NCT00153296|Analgesics|analgesics|mesh-ancestor
138597969|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
138597970|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597971|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138597972|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138597973|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597974|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138597975|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138597976|NCT02934295|Antibodies|antibodies|mesh-list
138597977|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
138597978|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597979|NCT02934022|Maraviroc|maraviroc|mesh-list
138597980|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138597981|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138597982|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138597984|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138597985|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
138597986|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138597987|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138597988|NCT02934061|Tizanidine|tizanidine|mesh-list
138597989|NCT02934061|Analgesics|analgesics|mesh-ancestor
138597990|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
138487490|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138487491|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
138487492|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597991|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138597992|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138597993|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
138597994|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138597995|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138597996|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
138597997|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
138597998|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138597999|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138598000|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138598001|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
138598002|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598003|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598004|NCT02934217|Cyclosporine|cyclosporine|mesh-list
138598005|NCT02934217|Cyclosporins|cyclosporins|mesh-list
138598006|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598007|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598008|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138598009|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
138598010|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598011|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
138598012|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598013|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
138598014|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598015|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138598016|NCT00165360|Temozolomide|temozolomide|mesh-list
138598017|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138598018|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
138598019|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598020|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598021|NCT02933905|Ranibizumab|ranibizumab|mesh-list
138598022|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138598023|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138598024|NCT02933905|Growth Substances|growth substances|mesh-ancestor
138598025|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598026|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
138598027|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598029|NCT02933788|Cilostazol|cilostazol|mesh-list
138598030|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138598031|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138598032|NCT02933788|Analgesics|analgesics|mesh-ancestor
138598033|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
138598034|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598035|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598037|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138294499|NCT00002984|Paclitaxel|paclitaxel|mesh-list
138598038|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138598039|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138598040|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598041|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138598042|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138598043|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598045|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138598046|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
138598047|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138598048|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
138598049|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
138598050|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138598051|NCT02933788|Protective Agents|protective agents|mesh-ancestor
138598052|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138598053|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138598054|NCT00165399|Docetaxel|docetaxel|mesh-list
138598055|NCT00165399|Goserelin|goserelin|mesh-list
138598056|NCT00165399|Bicalutamide|bicalutamide|mesh-list
138598057|NCT00165399|Estramustine|estramustine|mesh-list
138598058|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598059|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
138598060|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
138598061|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
138598062|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598063|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138598064|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
138598065|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
138598066|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138598067|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598068|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138598069|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
138598070|NCT02933593|Labetalol|labetalol|mesh-list
138598071|NCT02933593|Hydralazine|hydralazine|mesh-list
138598072|NCT02933593|Nifedipine|nifedipine|mesh-list
138487565|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487567|NCT00000672|Didanosine|didanosine|mesh-list
138598073|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138598074|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138598075|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598076|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138598077|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598078|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
138598079|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
138598080|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138598081|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138598082|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138598083|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
138598084|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598085|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138598086|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
138598087|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
138598088|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598089|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138598090|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138598091|NCT00153491|Lumefantrine|lumefantrine|mesh-list
138598093|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138598094|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
138598095|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138598096|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138665380|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
138598097|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598098|NCT02933437|Ajmaline|ajmaline|mesh-list
138598099|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138598100|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138598101|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138598102|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138598103|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598104|NCT00153530|Methotrexate|methotrexate|mesh-list
138598105|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138487595|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138487596|NCT00390403|Acetic Acid|acetic acid|mesh-list
138598106|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
138598107|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138598108|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598109|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138598110|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
138598111|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598112|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598113|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
138598114|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598115|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138598116|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138598117|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
138598118|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598119|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138598120|NCT00165477|Lenalidomide|lenalidomide|mesh-list
138598121|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
138598122|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598123|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138598124|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138598125|NCT00165477|Growth Substances|growth substances|mesh-ancestor
138598126|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
138598127|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598128|NCT02932930|Ropivacaine|ropivacaine|mesh-list
138598129|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
138598130|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
138598131|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598132|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598133|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
138598134|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598135|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
138598136|NCT00165516|Antidotes|antidotes|mesh-ancestor
138598137|NCT00165516|Protective Agents|protective agents|mesh-ancestor
138598138|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598139|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
138598140|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598141|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
138598142|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138598143|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138487635|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
138487638|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
138598144|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
138598145|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
138598146|NCT04642378|Insulin|insulin|mesh-list
138598147|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138598148|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138598149|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598150|NCT00407784|Eplerenone|eplerenone|mesh-list
138598151|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138598152|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
138274520|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138598153|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138598154|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598155|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138598156|NCT00407784|Diuretics|diuretics|mesh-ancestor
138598157|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
138598158|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138598159|NCT02932774|Cetirizine|cetirizine|mesh-list
138598160|NCT02932774|Loratadine|loratadine|mesh-list
138598161|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138598162|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138598163|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138598164|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
138598165|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
138598166|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598167|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598168|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598169|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
138598170|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
138598171|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138456133|NCT01910285|Narcotics|narcotics|mesh-ancestor
138598172|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598173|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598174|NCT00153725|Aspirin|aspirin|mesh-list
138598175|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138598176|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138598177|NCT00153725|Analgesics|analgesics|mesh-ancestor
138598178|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
138598179|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598180|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598181|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138598182|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598183|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138598184|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138598185|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598186|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138598187|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138598188|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598189|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
138598191|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
138487673|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
138487674|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598193|NCT00180102|Cytarabine|cytarabine|mesh-list
138598194|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
138598195|NCT00180102|Amsacrine|amsacrine|mesh-list
138598196|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138598197|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
138598198|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598199|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598200|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
138598201|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598202|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138598203|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
138598204|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598205|NCT00180102|Analgesics|analgesics|mesh-ancestor
138598206|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
138598207|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598208|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138598209|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138598210|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598211|NCT04690309|Insulin|insulin|mesh-list
138598212|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138485365|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
138598213|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138598214|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598216|NCT00153881|Docetaxel|docetaxel|mesh-list
138598217|NCT00153881|Capecitabine|capecitabine|mesh-list
138598218|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598219|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
138598220|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
138598221|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
138598222|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598223|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138598224|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
138598225|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
138598226|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138487699|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598228|NCT00180141|Analgesics|analgesics|mesh-ancestor
138598229|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
138665401|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
138598230|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598231|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598232|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138598233|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598234|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
138598235|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138598236|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
138598237|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138598238|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598239|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598240|NCT02931877|Propofol|propofol|mesh-list
138598241|NCT02931877|Sevoflurane|sevoflurane|mesh-list
138598242|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138598243|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598244|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598245|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138598246|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
138598247|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
138598248|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138598249|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138598250|NCT00153998|Leucovorin|leucovorin|mesh-list
138598251|NCT00153998|Folic Acid|folic acid|mesh-list
138598252|NCT00153998|Fluorouracil|fluorouracil|mesh-list
138598253|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
138598254|NCT00153998|Irinotecan|irinotecan|mesh-list
138598255|NCT00153998|Cetuximab|cetuximab|mesh-list
138598256|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
138598257|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
138598258|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598259|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138598260|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598261|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138598262|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
138598263|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598264|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138598265|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138598266|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598267|NCT00153998|Antidotes|antidotes|mesh-ancestor
138598268|NCT00153998|Protective Agents|protective agents|mesh-ancestor
138598269|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
138598270|NCT00153998|Vitamins|vitamins|mesh-ancestor
138598271|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
138598272|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138598273|NCT00153998|Hematinics|hematinics|mesh-ancestor
138598274|NCT02925130|Albuterol|albuterol|mesh-list
138598275|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138598276|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
138598277|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485402|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138598278|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598279|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138598280|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
138598281|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
138598282|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138598283|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138487739|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138487740|NCT00000720|Zidovudine|zidovudine|mesh-list
138598284|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138598285|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138598286|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
138598287|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598288|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598289|NCT02924974|Lidocaine|lidocaine|mesh-list
138598290|NCT02924974|Morphine|morphine|mesh-list
138598291|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
138598292|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
138598293|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598294|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598295|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
138598296|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598297|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138598298|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138598299|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138598300|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138598301|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598302|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138598303|NCT02924974|Narcotics|narcotics|mesh-ancestor
138598304|NCT02924974|Analgesics|analgesics|mesh-ancestor
138274671|NCT00003273|Leucovorin|leucovorin|mesh-list
138598305|NCT00154037|Pioglitazone|pioglitazone|mesh-list
138598306|NCT00154037|Candesartan|candesartan|mesh-list
138598307|NCT00154037|Candesartan cilexetil|candesartan cilexetil|mesh-list
138598308|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138598309|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598310|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138598311|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138598312|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138598313|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598314|NCT00154076|Topiramate|topiramate|mesh-list
138598315|NCT00154076|Zonisamide|zonisamide|mesh-list
138598316|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
138598317|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138598318|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598319|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138598320|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138598321|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598322|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138598323|NCT00154115|Simendan|simendan|mesh-list
138598324|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138598325|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
138598326|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138598327|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138598328|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598329|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598330|NCT00154115|Protective Agents|protective agents|mesh-ancestor
138598331|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487758|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138487759|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
138487760|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598332|NCT02924506|Meloxicam|meloxicam|mesh-list
138598333|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138598334|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138598335|NCT02924506|Analgesics|analgesics|mesh-ancestor
138598336|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
138598337|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598338|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598339|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138598340|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598341|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138598342|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138598343|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598344|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598345|NCT02924233|Nivolumab|nivolumab|mesh-list
138598346|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138598347|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598348|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138598349|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598350|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138598351|NCT02923999|Antibodies|antibodies|mesh-list
138598352|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
138598353|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138598354|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
138598355|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598356|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598357|NCT00154193|Cyclosporine|cyclosporine|mesh-list
138598358|NCT00154193|Cyclosporins|cyclosporins|mesh-list
138598359|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598360|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598361|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138598362|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
138598363|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598364|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
138598365|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598366|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
138598367|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598368|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138598369|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
138598370|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138598371|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598372|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138598373|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
138598374|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138598375|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598376|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598377|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598378|NCT00154271|Valsartan|valsartan|mesh-list
138598379|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138598380|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138598381|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138487798|NCT04020172|Dobutamine|dobutamine|mesh-list
138598382|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598383|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
138598384|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485436|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138598385|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138598386|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598387|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598388|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
138598389|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138598390|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598391|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138598392|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
138598393|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138598394|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598395|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598396|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598397|NCT02923687|Ketorolac|ketorolac|mesh-list
138598398|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138598399|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138598400|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138598401|NCT02923687|Analgesics|analgesics|mesh-ancestor
138598402|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
138598403|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598404|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598406|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598407|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138598408|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598409|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598410|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
138598411|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598412|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138598413|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598414|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598415|NCT02923258|Docetaxel|docetaxel|mesh-list
138598416|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598417|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
138487805|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138598418|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
138598419|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
138598420|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598421|NCT02923336|Propranolol|propranolol|mesh-list
138598422|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138598423|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138598424|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
138598425|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598426|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598427|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598428|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138598429|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138598430|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
138598431|NCT02922946|Entinostat|entinostat|mesh-list
138598432|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598433|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138598434|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598435|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598436|NCT02922712|Nimesulide|nimesulide|mesh-list
138598437|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138598438|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138598439|NCT02922712|Analgesics|analgesics|mesh-ancestor
138598440|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
138598441|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598442|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598443|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138598444|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598445|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138598446|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598447|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598448|NCT02922673|Aspirin|aspirin|mesh-list
138598449|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138598450|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138598451|NCT02922673|Analgesics|analgesics|mesh-ancestor
138598452|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
138598453|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598454|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598455|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138598456|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598457|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138598458|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138487844|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
138487845|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598459|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598460|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138598461|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138598462|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598463|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
138598465|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598466|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138598467|NCT02922283|Analgesics|analgesics|mesh-ancestor
138598468|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
138598469|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598470|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598471|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
138598472|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138598473|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598474|NCT02922166|SRX246|srx246|mesh-list
138598475|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138598476|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598477|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
138598478|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598479|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
138598480|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
138598481|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
138598482|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138598483|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138598484|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598485|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138598486|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138598488|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
138598489|NCT02921659|Vitamins|vitamins|mesh-ancestor
138485475|NCT00000499|Diuretics|diuretics|mesh-ancestor
138598490|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
138598491|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598492|NCT04689100|Leucovorin|leucovorin|mesh-list
138598493|NCT04689100|Fluorouracil|fluorouracil|mesh-list
138598494|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
138598495|NCT04689100|Irinotecan|irinotecan|mesh-list
138598496|NCT04689100|Calcium|calcium|mesh-list
138487876|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598497|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
138598498|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138598499|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487877|NCT00390520|Vildagliptin|vildagliptin|mesh-list
138487895|NCT00390598|Sennosides|sennosides|mesh-list
138598500|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
138598501|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598502|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138598503|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598504|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138598505|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
138598506|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138598507|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138598508|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598509|NCT04689100|Antidotes|antidotes|mesh-ancestor
138598510|NCT04689100|Protective Agents|protective agents|mesh-ancestor
138598511|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
138598512|NCT04689100|Vitamins|vitamins|mesh-ancestor
138598513|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
138598514|NCT00188136|Fludarabine|fludarabine|mesh-list
138598515|NCT00188136|Melphalan|melphalan|mesh-list
138598516|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598517|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598518|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138598519|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
138598520|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598521|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138598522|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
138598523|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138598524|NCT00406250|Bevacizumab|bevacizumab|mesh-list
138598525|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138598526|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598527|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138598528|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138598529|NCT00406250|Growth Substances|growth substances|mesh-ancestor
138598530|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598531|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
138598532|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138598533|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138598534|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598535|NCT02921269|Bevacizumab|bevacizumab|mesh-list
138598536|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138487911|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138598537|NCT02921269|Atezolizumab|atezolizumab|mesh-list
138598538|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
138598539|NCT02921269|Antibodies|antibodies|mesh-list
138598540|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
138598541|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138598542|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
138485496|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138598543|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598544|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138598545|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138598546|NCT02921269|Growth Substances|growth substances|mesh-ancestor
138598547|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598548|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
138665508|NCT04034927|Ipilimumab|ipilimumab|mesh-list
138598549|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
138598550|NCT02921269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138598551|NCT02921269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598553|NCT02920801|Saxagliptin|saxagliptin|mesh-list
138598554|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138598555|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598556|NCT02920801|Incretins|incretins|mesh-ancestor
138598557|NCT02920801|Hormones|hormones|mesh-ancestor
138598558|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138598559|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138598560|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
138598561|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598562|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598563|NCT00180843|Bromides|bromides|mesh-list
138598564|NCT00180843|Albuterol|albuterol|mesh-list
138598565|NCT00180843|Ipratropium|ipratropium|mesh-list
138598566|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
138598567|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138598568|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
138598569|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598570|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598571|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138598572|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
138598573|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
138598574|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138598575|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138598576|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138598577|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138487951|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598578|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
138598579|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598580|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598581|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138598582|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
138598584|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138598585|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138598586|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598587|NCT00180882|Rituximab|rituximab|mesh-list
138598588|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138598589|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598590|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
138598591|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598592|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598593|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
138598594|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598595|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138598596|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598597|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598598|NCT02920489|Sufentanil|sufentanil|mesh-list
138598599|NCT02920489|Dsuvia|dsuvia|mesh-list
138598600|NCT02920489|Ropivacaine|ropivacaine|mesh-list
138598601|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
138274976|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598602|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
138598603|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598604|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598605|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
138598606|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598607|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138598608|NCT02920489|Narcotics|narcotics|mesh-ancestor
138598609|NCT02920489|Analgesics|analgesics|mesh-ancestor
138598610|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138598611|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138598612|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
138598613|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
138598614|NCT02920372|Hematinics|hematinics|mesh-ancestor
138598615|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
138598616|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138598617|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598618|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598619|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138598620|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138598621|NCT00154661|Protective Agents|protective agents|mesh-ancestor
138598622|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598623|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
138598624|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138598625|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
138598626|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
138598627|NCT00180960|Irinotecan|irinotecan|mesh-list
138598628|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598629|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138598631|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598632|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598633|NCT00154700|Folic Acid|folic acid|mesh-list
138598634|NCT00154700|Paclitaxel|paclitaxel|mesh-list
138598635|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138598636|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598637|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
138598638|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
138598639|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
138598640|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598641|NCT00154700|Hematinics|hematinics|mesh-ancestor
138598642|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
138598643|NCT00154700|Vitamins|vitamins|mesh-ancestor
138598644|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
138598645|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598646|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
138598647|NCT04688983|Blinatumomab|blinatumomab|mesh-list
138598648|NCT04688983|Ponatinib|ponatinib|mesh-list
138598649|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598650|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138598651|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598652|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598653|NCT02920060|Levetiracetam|levetiracetam|mesh-list
138598654|NCT02920060|Valproic Acid|valproic acid|mesh-list
138598655|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
138598656|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
138598657|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138485536|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598658|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488020|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
138488021|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
138598659|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
138488026|NCT00000870|Zidovudine|zidovudine|mesh-list
138598660|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598661|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598662|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
138598663|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138598664|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598665|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138598666|NCT00154739|Gemcitabine|gemcitabine|mesh-list
138598667|NCT00154739|Epirubicin|epirubicin|mesh-list
138598668|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598669|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138598670|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
138598671|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598672|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138598673|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138598674|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138598675|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598676|NCT00154778|Leucovorin|leucovorin|mesh-list
138598677|NCT00154778|Antidotes|antidotes|mesh-ancestor
138598678|NCT00154778|Protective Agents|protective agents|mesh-ancestor
138275055|NCT00002865|Leucovorin|leucovorin|mesh-list
138598679|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598680|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
138598681|NCT00154778|Vitamins|vitamins|mesh-ancestor
138598682|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
138598683|NCT02919202|Listerine|listerine|mesh-list
138598684|NCT02919202|Fluorides|fluorides|mesh-list
138598685|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
138598686|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
138598687|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
138598688|NCT02919202|Protective Agents|protective agents|mesh-ancestor
138598689|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598690|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138598691|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598692|NCT00154895|Minocycline|minocycline|mesh-list
138598693|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138598694|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598695|NCT00181116|Levetiracetam|levetiracetam|mesh-list
138598696|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
138598697|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
138598698|NCT02918812|Diclofenac|diclofenac|mesh-list
138598700|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
138598701|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
138598702|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598703|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598704|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
138488061|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488068|NCT00000882|Lamivudine|lamivudine|mesh-list
138598705|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598706|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138318279|NCT01408914|Rifampin|rifampin|mesh-list
138456181|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598707|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138598708|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138598709|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138598710|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598711|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138598712|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138598713|NCT02918812|Analgesics|analgesics|mesh-ancestor
138598714|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138485557|NCT00000553|Niacin|niacin|mesh-list
138598715|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598716|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138598717|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598719|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138598720|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
138598721|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138598722|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598723|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138598724|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138598725|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
138598726|NCT00181272|Azithromycin|azithromycin|mesh-list
138598727|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138598728|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598729|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
138598730|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
138598731|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138598732|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138598733|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598734|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598735|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598736|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598737|NCT02910115|Oxytocin|oxytocin|mesh-list
138598738|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
138598739|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138598740|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598741|NCT00188565|Celecoxib|celecoxib|mesh-list
138598742|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138488095|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
138488096|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598743|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138598744|NCT00188565|Analgesics|analgesics|mesh-ancestor
138598745|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
138598746|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598747|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598748|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138598749|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598750|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138598751|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138598752|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598753|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598754|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
138598755|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138598756|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598757|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598758|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138598759|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138598760|NCT00155246|Protective Agents|protective agents|mesh-ancestor
138598761|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598762|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
138598763|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138598764|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
138598765|NCT02909413|Sevoflurane|sevoflurane|mesh-list
138598766|NCT02909413|Desflurane|desflurane|mesh-list
138598767|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138598768|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138598769|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
138598770|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
138598771|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598772|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598773|NCT02909257|Bupivacaine|bupivacaine|mesh-list
138598774|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
138598775|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
138456186|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598776|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598777|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598778|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
138598779|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598780|NCT02908945|Ketamine|ketamine|mesh-list
138598781|NCT02908945|Analgesics|analgesics|mesh-ancestor
138598782|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
138598783|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598784|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488132|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598786|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138598787|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
138598788|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
138598789|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598790|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138598791|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138598792|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598793|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598794|NCT02939833|Ropivacaine|ropivacaine|mesh-list
138598795|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
138598796|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
138598797|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598798|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598799|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
138598800|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598801|NCT00188604|Selenious Acid|selenious acid|mesh-list
138598802|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
138598803|NCT00188604|Trace Elements|trace elements|mesh-ancestor
138598804|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
138598805|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598806|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138598807|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
138598808|NCT00155402|Coagulants|coagulants|mesh-ancestor
138598809|NCT00188643|Lamotrigine|lamotrigine|mesh-list
138598810|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138598811|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138598812|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138598813|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138598814|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598815|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598816|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598817|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138598818|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
138598819|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138598820|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
138598821|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138598822|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138598823|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138488162|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488164|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138598825|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598826|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138598827|NCT00533299|Hydralazine|hydralazine|mesh-list
138598828|NCT00533299|Valproic Acid|valproic acid|mesh-list
138598829|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
138598830|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598831|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598832|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
138598833|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598834|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598835|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
138598836|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138598837|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598838|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138598839|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138598840|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
138598841|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
138598842|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138598843|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598844|NCT00181662|Curcumin|curcumin|mesh-list
138598845|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138598846|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138598847|NCT00181662|Analgesics|analgesics|mesh-ancestor
138598848|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
138598849|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598850|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598851|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138598852|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598853|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598854|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598855|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598857|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598858|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138598859|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598860|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598861|NCT00155558|Leucovorin|leucovorin|mesh-list
138598862|NCT00155558|Fluorouracil|fluorouracil|mesh-list
138598863|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
138598864|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598865|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138598866|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598867|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138598868|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
138665659|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
138598869|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598870|NCT00155558|Antidotes|antidotes|mesh-ancestor
138598871|NCT00155558|Protective Agents|protective agents|mesh-ancestor
138598872|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
138598873|NCT00155558|Vitamins|vitamins|mesh-ancestor
138598874|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
138598875|NCT00533455|Gabapentin|gabapentin|mesh-list
138598876|NCT00533455|Analgesics|analgesics|mesh-ancestor
138598877|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
138598878|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138598879|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598880|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
138598881|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138598882|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138598883|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598884|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138598885|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138598886|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138598887|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598888|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598889|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
138598890|NCT00533533|Docetaxel|docetaxel|mesh-list
138598891|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
138598892|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598893|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
138598894|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
138598895|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
138598896|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598897|NCT00533611|Niacin|niacin|mesh-list
138598898|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598899|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598900|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138598901|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
138598902|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138598903|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
138598904|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
138598905|NCT00533611|Vitamins|vitamins|mesh-ancestor
138598906|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
138598908|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138598909|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598910|NCT04575844|Incretins|incretins|mesh-ancestor
138598911|NCT04575844|Hormones|hormones|mesh-ancestor
138456194|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598912|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138598913|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
138598914|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
138598915|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
138598916|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138598917|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598918|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598919|NCT00155714|Urological Agents|urological agents|mesh-ancestor
138598920|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138598921|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138598922|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138598923|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138598924|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598926|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598927|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598928|NCT00181779|Aripiprazole|aripiprazole|mesh-list
138598929|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
138598930|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138598931|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138598932|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138598933|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598934|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598935|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
138598936|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
138598937|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598938|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598939|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138598940|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138598941|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
138598942|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138598943|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138598944|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138598945|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138488268|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138488269|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488274|NCT00005819|Paclitaxel|paclitaxel|mesh-list
138598946|NCT00533923|Cyclosporine|cyclosporine|mesh-list
138598947|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
138598948|NCT00533923|Fludarabine|fludarabine|mesh-list
138598949|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
138598950|NCT00533923|Cyclosporins|cyclosporins|mesh-list
138598951|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138598952|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
138598953|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598954|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138598955|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138598956|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
138598957|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598958|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598959|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138598960|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598961|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
138598962|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138598963|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
138598964|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138598965|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138598966|NCT00409227|Alfuzosin|alfuzosin|mesh-list
138598967|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
138598968|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138598969|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138598970|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
138598971|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598972|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598973|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598974|NCT00409227|Urological Agents|urological agents|mesh-ancestor
138598975|NCT00533962|Anecortave|anecortave|mesh-list
138598976|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138598977|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138598978|NCT00533962|Growth Substances|growth substances|mesh-ancestor
138598979|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598980|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
138598981|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138598982|NCT00181818|Bupropion|bupropion|mesh-list
138598983|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138598984|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
138598985|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138488300|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138598986|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138598987|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138598988|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138598989|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138598990|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
138598991|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138598992|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598993|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138665695|NCT03809793|Acipimox|acipimox|mesh-list
138598994|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138598995|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138598996|NCT04462627|Antibodies|antibodies|mesh-list
138598997|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
138598998|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138598999|NCT00406601|Sorafenib|sorafenib|mesh-list
138599000|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599001|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138599002|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599003|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599004|NCT00409305|Betahistine|betahistine|mesh-list
138599005|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
138599006|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
138599007|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
138599008|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599009|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599010|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599011|NCT00406679|Acetaminophen|acetaminophen|mesh-list
138599012|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138599013|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138599014|NCT00406679|Analgesics|analgesics|mesh-ancestor
138599015|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
138599016|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599017|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599018|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
138599019|NCT00181896|Bupropion|bupropion|mesh-list
138599020|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138599021|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
138599022|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138488333|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138488335|NCT00391261|Metformin|metformin|mesh-list
138599023|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138599024|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138599025|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138599026|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599027|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
138599028|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599029|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599030|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138599031|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138599032|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599033|NCT04686448|Fentanyl|fentanyl|mesh-list
138599034|NCT04686448|Ketamine|ketamine|mesh-list
138599035|NCT04686448|Propofol|propofol|mesh-list
138599036|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138599037|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138599038|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599039|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138599040|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
138599041|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
138599042|NCT04686448|Analgesics|analgesics|mesh-ancestor
138599043|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
138599044|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599045|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138599046|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138599047|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138599048|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599049|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599050|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138599051|NCT04686448|Narcotics|narcotics|mesh-ancestor
138599052|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138599053|NCT00181935|Olanzapine|olanzapine|mesh-list
138599054|NCT00181935|Risperidone|risperidone|mesh-list
138665712|NCT03748641|Prednisone|prednisone|mesh-list
138599055|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138599056|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
138599057|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599058|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599059|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599060|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138599061|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138599062|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138599063|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138599064|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138599065|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
138599066|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
138488406|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138599067|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
138599068|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599069|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138599070|NCT00181935|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138599071|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138599072|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138599073|NCT00409383|Paclitaxel|paclitaxel|mesh-list
138599074|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138599075|NCT00409383|Temozolomide|temozolomide|mesh-list
138599076|NCT00409383|Oblimersen|oblimersen|mesh-list
138599077|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138599078|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599079|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
138599080|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
138599081|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
138599082|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599083|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138599084|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
138599085|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
138599086|NCT04893148|Dulaglutide|dulaglutide|mesh-list
138599087|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138599088|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599089|NCT04883632|Lidocaine|lidocaine|mesh-list
138599090|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
138599091|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
138599092|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138599093|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599094|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
138599095|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599096|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138599097|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138599098|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138599099|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138599100|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599101|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138599102|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
138599103|NCT00181974|Coagulants|coagulants|mesh-ancestor
138599104|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138599105|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138599106|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138599107|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
138599108|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599109|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138599110|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138599111|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599113|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138599114|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599115|NCT00182013|Olanzapine|olanzapine|mesh-list
138599116|NCT00182013|Risperidone|risperidone|mesh-list
138599117|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138599118|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138599120|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599121|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599122|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599123|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138599124|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138599125|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138599126|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138599127|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138599128|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
138599130|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
138599131|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599132|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138599133|NCT00182013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138599134|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138599135|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138599136|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
138488460|NCT00001029|Zidovudine|zidovudine|mesh-list
138599176|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
138488487|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
138599177|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599178|NCT00182169|Hormones|hormones|mesh-list
138599179|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138599180|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599181|NCT05471050|Danazol|danazol|mesh-list
138599182|NCT05471050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138599183|NCT05471050|Hormone Antagonists|hormone antagonists|mesh-ancestor
138599184|NCT05471050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138599185|NCT05471050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599186|NCT05470972|Ethanol|ethanol|mesh-list
138599187|NCT05470972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138599188|NCT05470972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599189|NCT05470972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138599190|NCT05470972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599191|NCT04686058|Midazolam|midazolam|mesh-list
138599192|NCT04686058|Meperidine|meperidine|mesh-list
138599193|NCT04686058|Propofol|propofol|mesh-list
138599194|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138599195|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138599196|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599197|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138599198|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
138599199|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
138599200|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138599201|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138599202|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138599203|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138275577|NCT00004017|Antibodies|antibodies|mesh-list
138599205|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
138599206|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599207|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599208|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138599209|NCT04686058|Narcotics|narcotics|mesh-ancestor
138599210|NCT04686058|Analgesics|analgesics|mesh-ancestor
138599211|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
138599212|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599213|NCT00156299|Dexamethasone|dexamethasone|mesh-list
138599214|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
138599215|NCT00156299|Choline|choline|mesh-list
138599216|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138599217|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
138599218|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
138488521|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
138599219|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599220|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599221|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138599222|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
138599223|NCT00156299|Hormones|hormones|mesh-ancestor
138599224|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138599225|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138485720|NCT00389038|Amitriptyline|amitriptyline|mesh-list
138599226|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599227|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
138599228|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138599229|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
138599230|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599231|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138599232|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
138599233|NCT00156299|Analgesics|analgesics|mesh-ancestor
138599234|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
138599235|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138599236|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138599237|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138599238|NCT00535951|Panobinostat|panobinostat|mesh-list
138599239|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599240|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138599241|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599242|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599243|NCT00188955|Sirolimus|sirolimus|mesh-list
138599244|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138599245|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599246|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138599247|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599248|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
138599249|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138599250|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
138599251|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599252|NCT00536068|Acetaminophen|acetaminophen|mesh-list
138599253|NCT00536068|Aspirin|aspirin|mesh-list
138599254|NCT00536068|Diclofenac|diclofenac|mesh-list
138599255|NCT00536068|Naproxen|naproxen|mesh-list
138599256|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138599257|NCT00536068|Analgesics|analgesics|mesh-ancestor
138599258|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
138599259|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599260|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599261|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
138599262|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138599263|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138599264|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138599265|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138599266|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599267|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599268|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
138599269|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138599270|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138599271|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138488555|NCT00001071|Lenograstim|lenograstim|mesh-list
138599272|NCT05470582|Vaccines|vaccines|mesh-list
138599273|NCT05470582|Immunologic Factors|immunologic factors|mesh-ancestor
138599274|NCT05470582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599275|NCT00156377|Mupirocin|mupirocin|mesh-list
138599276|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138599277|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599278|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138599279|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599280|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599281|NCT00188994|Insulin|insulin|mesh-list
138599282|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138599283|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599285|NCT05469880|Dermatologic Agents|dermatologic agents|mesh-ancestor
138599286|NCT00408525|Donepezil|donepezil|mesh-list
138599287|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138599288|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599289|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599290|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
138599291|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599292|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599293|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
138599294|NCT05469529|Dexmedetomidine|dexmedetomidine|mesh-list
138599295|NCT05469529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138599296|NCT05469529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138599297|NCT05469529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599298|NCT05469529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138599300|NCT05469529|Sensory System Agents|sensory system agents|mesh-ancestor
138599301|NCT05469529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599302|NCT05469529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138599303|NCT05469529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138599304|NCT05469529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138599305|NCT05469529|Adrenergic Agents|adrenergic agents|mesh-ancestor
138599306|NCT05469529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599307|NCT05469529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599309|NCT00189033|Cathartics|cathartics|mesh-ancestor
138599310|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138599311|NCT05469061|Cisplatin|cisplatin|mesh-list
138599312|NCT05469061|Tislelizumab|tislelizumab|mesh-list
138599313|NCT05469061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599314|NCT05469061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138599315|NCT05469022|Lazertinib|lazertinib|mesh-list
138599316|NCT05469022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138599317|NCT05469022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599318|NCT05469022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599319|NCT00189072|Gabapentin|gabapentin|mesh-list
138599320|NCT00189072|Analgesics|analgesics|mesh-ancestor
138599321|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
138599322|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599323|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599324|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
138599325|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138599326|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138599327|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138599328|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138599329|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138488576|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488577|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138488579|NCT00005858|Immunotoxins|immunotoxins|mesh-list
138599331|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599332|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599333|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
138599334|NCT00156611|Abciximab|abciximab|mesh-list
138599335|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
138599336|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138599337|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138599338|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
138599339|NCT00156650|Testosterone|testosterone|mesh-list
138599340|NCT00156650|Acyline|acyline|mesh-list
138599341|NCT00156650|Androgens|androgens|mesh-ancestor
138599342|NCT00156650|Hormones|hormones|mesh-ancestor
138599343|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138599344|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599345|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138599346|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599347|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138599348|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138599349|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138599350|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
138599351|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138599352|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138599353|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138275720|NCT00004071|Prednisone|prednisone|mesh-list
138599354|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138599355|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
138599356|NCT00536419|Methylphenidate|methylphenidate|mesh-list
138599357|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138599358|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599359|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138599360|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138599361|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138599362|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599363|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
138599364|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599365|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
138599366|NCT00189150|Valganciclovir|valganciclovir|mesh-list
138599367|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138599368|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599369|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138599370|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
138599371|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138599372|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599373|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599374|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599377|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
138599378|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
138599379|NCT00536614|Cetuximab|cetuximab|mesh-list
138599380|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138599381|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599382|NCT05468164|Omeprazole|omeprazole|mesh-list
138488595|NCT00001083|Nevirapine|nevirapine|mesh-list
138488596|NCT00001083|Stavudine|stavudine|mesh-list
138599383|NCT05468164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138599384|NCT05468164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138599385|NCT05468164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138599386|NCT05468164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599387|NCT05468164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599388|NCT05468047|Ketamine|ketamine|mesh-list
138599389|NCT05468047|Analgesics|analgesics|mesh-ancestor
138599390|NCT05468047|Sensory System Agents|sensory system agents|mesh-ancestor
138599391|NCT05468047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599392|NCT05468047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599393|NCT05468047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138599394|NCT05468047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138599395|NCT05468047|Anesthetics, General|anesthetics, general|mesh-ancestor
138599396|NCT05468047|Anesthetics|anesthetics|mesh-ancestor
138599397|NCT05468047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138485784|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138599398|NCT05468047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138599399|NCT05468047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138599400|NCT05468047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599401|NCT05468047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599402|NCT00182364|Heparin|heparin|mesh-list
138599403|NCT00182364|Calcium heparin|calcium heparin|mesh-list
138599404|NCT00182364|Dalteparin|dalteparin|mesh-list
138599405|NCT00182364|Tinzaparin|tinzaparin|mesh-list
138599406|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138599407|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
138599408|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138599409|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138599410|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599411|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
138599412|NCT00536653|Vitamin D|vitamin d|mesh-list
138599413|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
138599414|NCT00536653|Cholecalciferol|cholecalciferol|mesh-list
138599415|NCT00536653|Vitamins|vitamins|mesh-list
138599416|NCT00536653|Goserelin|goserelin|mesh-list
138599417|NCT00536653|Bicalutamide|bicalutamide|mesh-list
138599418|NCT00536653|Calcium|calcium|mesh-list
138599419|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138599420|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
138488617|NCT00001086|Indinavir|indinavir|mesh-list
138488620|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599421|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599422|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138599423|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138599424|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138599425|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599426|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
138599427|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
138599428|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138599429|NCT00536653|Hormones|hormones|mesh-ancestor
138599430|NCT05467852|Dydrogesterone|dydrogesterone|mesh-list
138599431|NCT05467852|Progestins|progestins|mesh-ancestor
138599432|NCT05467852|Hormones|hormones|mesh-ancestor
138599433|NCT05467852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138599434|NCT05467852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599435|NCT00536692|Mecamylamine|mecamylamine|mesh-list
138599436|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138599437|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138599438|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
138599439|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599440|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599441|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138599442|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138599443|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
138599444|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599445|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599446|NCT00189345|Catumaxomab|catumaxomab|mesh-list
138599447|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
138599448|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
138599449|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599450|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138599451|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138599452|NCT00156884|Cisplatin|cisplatin|mesh-list
138599453|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599454|NCT05464693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138599455|NCT05464693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599456|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
138488654|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
138599457|NCT00156962|Hematinics|hematinics|mesh-ancestor
138599458|NCT00182442|Olanzapine|olanzapine|mesh-list
138488655|NCT00001113|Interferons|interferons|mesh-list
138488658|NCT00001113|Zidovudine|zidovudine|mesh-list
138599459|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138599460|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
138599461|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
138599462|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599463|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599464|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138599465|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138599466|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138599467|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138599468|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138599469|NCT00182442|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138599470|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138599471|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138599472|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599473|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599474|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
138599475|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
138599476|NCT00536770|Calcitriol|calcitriol|mesh-list
138599477|NCT00536770|Gemcitabine|gemcitabine|mesh-list
138599478|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138599479|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138599480|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
138599481|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599482|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599483|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138599484|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599485|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138599486|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599487|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138599488|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138599489|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138599490|NCT00536770|Vitamins|vitamins|mesh-ancestor
138488692|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138488693|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
138599492|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138599493|NCT04685512|Tenofovir|tenofovir|mesh-list
138599494|NCT04685512|Emtricitabine|emtricitabine|mesh-list
138599495|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
138599496|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599497|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138599498|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138599499|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599500|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599501|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138599502|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138599503|NCT00157040|Factor VIII|factor viii|mesh-list
138599504|NCT00157040|Coagulants|coagulants|mesh-ancestor
138599506|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
138599507|NCT00189384|Penicillins|penicillins|mesh-list
138318288|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138599508|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138599509|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
138599511|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138599512|NCT00189384|Procaine|procaine|mesh-list
138599513|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138599514|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599515|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138599516|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599517|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599518|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138599519|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
138599520|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138599521|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138599522|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
138599523|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
138599524|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138488739|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
138599525|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599526|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
138599527|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599528|NCT00536848|Metronidazole|metronidazole|mesh-list
138599529|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599530|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138599531|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138599532|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138599533|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
138599535|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
138599536|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138599537|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138599538|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
138599539|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599540|NCT00189501|Cinacalcet|cinacalcet|mesh-list
138599541|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138599542|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599543|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138599544|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
138599545|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138599546|NCT00157118|Protein C|protein c|mesh-list
138599547|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
138599548|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138599549|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138599550|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599551|NCT00189579|Trastuzumab|trastuzumab|mesh-list
138599552|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138599553|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599554|NCT00157235|Bromides|bromides|mesh-list
138599555|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
138599556|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138599558|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599559|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599560|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138599561|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
138599562|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
138599563|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138599564|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
138599565|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599566|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599567|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
138599568|NCT00182520|Topiramate|topiramate|mesh-list
138599569|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
138599570|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138599571|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599572|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
138599573|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138599574|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599575|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
138599576|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
138275931|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138275932|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
138599577|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138599578|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
138599579|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138485821|NCT00000718|Zidovudine|zidovudine|mesh-list
138599580|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138599581|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138599582|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138599583|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138599584|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599585|NCT00182559|Cyclosporine|cyclosporine|mesh-list
138599586|NCT00182559|Tacrolimus|tacrolimus|mesh-list
138599587|NCT00182559|Cyclosporins|cyclosporins|mesh-list
138599588|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138599589|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
138599590|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599591|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138599592|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599593|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599594|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
138599595|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599596|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
138488824|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138599597|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138599598|NCT00425568|Testosterone|testosterone|mesh-list
138488826|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
138599599|NCT00425568|Androgens|androgens|mesh-ancestor
138599600|NCT00425568|Hormones|hormones|mesh-ancestor
138599601|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138599602|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599603|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
138599604|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138599605|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138599606|NCT00157508|Analgesics|analgesics|mesh-ancestor
138599607|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
138599608|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599609|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599610|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138599611|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138599612|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138599613|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138599614|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599615|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138599616|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138599617|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
138599618|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599619|NCT00189618|Aspirin|aspirin|mesh-list
138599620|NCT00189618|Clopidogrel|clopidogrel|mesh-list
138599621|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138599622|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138599623|NCT00189618|Analgesics|analgesics|mesh-ancestor
138599624|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
138599625|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599626|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599627|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138599628|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138599629|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138599630|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138599631|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599632|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138599633|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138599634|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599635|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
138599636|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138599637|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138599638|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138599640|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599641|NCT00406796|Ranibizumab|ranibizumab|mesh-list
138488852|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599642|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138599643|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138599645|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599646|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
138599647|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599648|NCT00534391|Polymyxins|polymyxins|mesh-list
138599649|NCT00534391|Neomycin|neomycin|mesh-list
138599650|NCT00534391|Polymyxin B|polymyxin b|mesh-list
138599651|NCT00534391|Gramicidin|gramicidin|mesh-list
138599652|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
138599653|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138599654|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138599655|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138599656|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599657|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138599658|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599659|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599660|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138599661|NCT00534508|Tacrolimus|tacrolimus|mesh-list
138599662|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138599663|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
138599664|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599665|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138599666|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599667|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599668|NCT00182715|Leucovorin|leucovorin|mesh-list
138599669|NCT00182715|Capecitabine|capecitabine|mesh-list
138599670|NCT00182715|Fluorouracil|fluorouracil|mesh-list
138599671|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
138599672|NCT00182715|Cetuximab|cetuximab|mesh-list
138599673|NCT00182715|Calcium|calcium|mesh-list
138599674|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
138599675|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138599676|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599677|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138599678|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
138599679|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599680|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599681|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138488884|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138599682|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
138599683|NCT00182715|Antidotes|antidotes|mesh-ancestor
138599684|NCT00182715|Protective Agents|protective agents|mesh-ancestor
138599685|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
138599686|NCT00182715|Vitamins|vitamins|mesh-ancestor
138599687|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
138599688|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138599689|NCT00534586|Ketamine|ketamine|mesh-list
138599690|NCT00534586|Remifentanil|remifentanil|mesh-list
138599691|NCT00534586|Propofol|propofol|mesh-list
138599692|NCT00534586|Sevoflurane|sevoflurane|mesh-list
138599693|NCT00534586|Esketamine|esketamine|mesh-list
138599694|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138599695|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138599696|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599697|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138599698|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
138599699|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
138485851|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599700|NCT00534586|Analgesics|analgesics|mesh-ancestor
138599701|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
138599702|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599703|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138599704|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138599705|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138599706|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599707|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599708|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138599709|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138599710|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138599711|NCT00534586|Narcotics|narcotics|mesh-ancestor
138599712|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
138599713|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138599714|NCT00534625|Zileuton|zileuton|mesh-list
138599715|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
138599716|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138599717|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138599718|NCT00534625|Analgesics|analgesics|mesh-ancestor
138599719|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
138599720|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599721|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599722|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138599723|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138599724|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138599725|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488917|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599726|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599727|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138599728|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
138599729|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138276080|NCT00004233|Protective Agents|protective agents|mesh-ancestor
138599730|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599731|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
138599732|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138599734|NCT00406874|Hematinics|hematinics|mesh-ancestor
138599735|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
138599736|NCT00406874|Vitamins|vitamins|mesh-ancestor
138599737|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
138599738|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599739|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
138599740|NCT04106830|Azathioprine|azathioprine|mesh-list
138599741|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599742|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
138599743|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599744|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138599745|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138599746|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138599747|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
138599748|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138599749|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599750|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599751|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599752|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
138599753|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138599754|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138599756|NCT00189657|Fluorouracil|fluorouracil|mesh-list
138488953|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138488969|NCT00010036|Irinotecan|irinotecan|mesh-list
138599757|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138599758|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138599759|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599760|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599761|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599762|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
138599763|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138599764|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138599765|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
138599766|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599767|NCT00406913|Mupirocin|mupirocin|mesh-list
138294970|NCT00001357|Analgesics|analgesics|mesh-ancestor
138599768|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138599769|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599770|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138599771|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599772|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599773|NCT00406952|Sertraline|sertraline|mesh-list
138599774|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
138599775|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138599776|NCT00406952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138599777|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138599778|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138599779|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599780|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599781|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
138599782|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599783|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
138599784|NCT00157547|Citalopram|citalopram|mesh-list
138599785|NCT00157547|Fluoxetine|fluoxetine|mesh-list
138599786|NCT00157547|Paroxetine|paroxetine|mesh-list
138599787|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138599788|NCT00157547|Sertraline|sertraline|mesh-list
138599789|NCT00157547|Escitalopram|escitalopram|mesh-list
138599790|NCT00157547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138599791|NCT00157547|Serotonin|serotonin|mesh-list
138599792|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138599793|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138599794|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599795|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599796|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
138599797|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599798|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138599799|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
138485895|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
138485904|NCT00000760|Zidovudine|zidovudine|mesh-list
138599800|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138599801|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138599802|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138599803|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488997|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138599804|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138599807|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138599808|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138599809|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138599810|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138599811|NCT04061161|Bromides|bromides|mesh-list
138599812|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
138599813|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138599814|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
138599815|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599816|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599817|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138599818|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
138599819|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
138599820|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138599821|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
138599822|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599823|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599824|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
138599825|NCT00157586|Manidipine|manidipine|mesh-list
138599826|NCT00157586|Delapril|delapril|mesh-list
138599827|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138599828|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138599829|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138599830|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599831|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138599832|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599833|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138599834|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
138599835|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599836|NCT00182871|Testosterone|testosterone|mesh-list
138599837|NCT00182871|Androgens|androgens|mesh-ancestor
138599838|NCT00182871|Hormones|hormones|mesh-ancestor
138599839|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138599840|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599841|NCT00189774|Nateglinide|nateglinide|mesh-list
138599842|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138599843|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599845|NCT04686643|Amlodipine|amlodipine|mesh-list
138599846|NCT04686643|Valsartan|valsartan|mesh-list
138599847|NCT04686643|Indapamide|indapamide|mesh-list
138599848|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138599849|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138599850|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138599851|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599852|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138599853|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599854|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
138599855|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138599856|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138599857|NCT04686643|Diuretics|diuretics|mesh-ancestor
138599858|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
138599859|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138599860|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138599861|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
138599862|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138599864|NCT04686643|Vitamins|vitamins|mesh-ancestor
138599865|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
138599866|NCT00534898|Fenretinide|fenretinide|mesh-list
138599867|NCT00534898|Bexarotene|bexarotene|mesh-list
138599868|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599869|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138599870|NCT00534898|Protective Agents|protective agents|mesh-ancestor
138599871|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489060|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
138489061|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138599872|NCT03748810|Metformin|metformin|mesh-list
138599873|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
138599874|NCT03748810|Empagliflozin|empagliflozin|mesh-list
138599875|NCT03748810|Glimepiride|glimepiride|mesh-list
138599876|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138599877|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138599878|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599879|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138599880|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599881|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138599882|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138599883|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
138599884|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
138599885|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599886|NCT00157859|Chloroquine|chloroquine|mesh-list
138599887|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
138599888|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
138599889|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138599890|NCT00157859|Amebicides|amebicides|mesh-ancestor
138599891|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138599892|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138599893|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599894|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
138599895|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138599896|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138599897|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599898|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599899|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138599900|NCT00157898|Metronidazole|metronidazole|mesh-list
138599901|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
138599902|NCT00157898|Ertapenem|ertapenem|mesh-list
138599903|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599904|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138599905|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138599906|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138599907|NCT03669523|Denosumab|denosumab|mesh-list
138599908|NCT03669523|Nivolumab|nivolumab|mesh-list
138599909|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138599910|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599911|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138599912|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599913|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138489107|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599914|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599915|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
138599916|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138599917|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
138599918|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
138599919|NCT00158093|Atenolol|atenolol|mesh-list
138599920|NCT00158093|Nebivolol|nebivolol|mesh-list
138599921|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138599922|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599923|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138599924|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138599925|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599926|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599927|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138599928|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599929|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138599930|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138599931|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
138599932|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
138599933|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599934|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138599935|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138599936|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138599937|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
138599938|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599939|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
138599940|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138599941|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138599942|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138599943|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138599944|NCT03429946|Spironolactone|spironolactone|mesh-list
138599945|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138599946|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
138599947|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138599948|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599949|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138599950|NCT03429946|Diuretics|diuretics|mesh-ancestor
138599951|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
138599952|NCT00189930|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138599953|NCT00189930|Antiviral Agents|antiviral agents|mesh-ancestor
138489139|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
138489140|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489141|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489143|NCT00001212|Prednisone|prednisone|mesh-list
138599954|NCT00189930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599956|NCT00158132|Propranolol|propranolol|mesh-list
138599957|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138599958|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138599959|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
138599960|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599961|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599962|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599963|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138599964|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138599965|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
138599966|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138599967|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138599968|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
138599969|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599970|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
138456271|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599971|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138599972|NCT00158132|Analgesics|analgesics|mesh-ancestor
138599973|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
138599974|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599975|NCT00158171|Folic Acid|folic acid|mesh-list
138599976|NCT00158171|Nicotine|nicotine|mesh-list
138599977|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138599978|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
138599979|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138599980|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599981|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138599982|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138599983|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
138599984|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138599985|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599986|NCT00158171|Hematinics|hematinics|mesh-ancestor
138599987|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
138599988|NCT00158171|Vitamins|vitamins|mesh-ancestor
138599989|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
138599990|NCT03370783|Ethanol|ethanol|mesh-list
138599991|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138599992|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138599993|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138599994|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138599995|NCT00158210|Rivastigmine|rivastigmine|mesh-list
138599996|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138599997|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138599998|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138599999|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
138600000|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600001|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600002|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138489171|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600004|NCT00190008|Piracetam|piracetam|mesh-list
138600005|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138600006|NCT00190008|Protective Agents|protective agents|mesh-ancestor
138600007|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600008|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
138600009|NCT00183222|Naltrexone|naltrexone|mesh-list
138600010|NCT00183222|Ondansetron|ondansetron|mesh-list
138600011|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138600012|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138600013|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600014|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
138600015|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600016|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
138600017|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
138600018|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138600019|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
138600020|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
138600021|NCT00183222|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138600022|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138600023|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
138600024|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600025|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600026|NCT00158405|Ritonavir|ritonavir|mesh-list
138600027|NCT00158405|Indinavir|indinavir|mesh-list
138600028|NCT00158405|Lamivudine|lamivudine|mesh-list
138600029|NCT00158405|Zidovudine|zidovudine|mesh-list
138600031|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138600032|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138600033|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
138600034|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600035|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600036|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138600037|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138600038|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
138600039|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600040|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138600041|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138600042|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138600043|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138600044|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
138600045|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138600046|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138600047|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138600048|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138600049|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138600050|NCT00158483|Acyclovir|acyclovir|mesh-list
138600051|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
138485961|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
138600053|NCT00158522|Interferons|interferons|mesh-list
138600054|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
138600055|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
138600056|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138600057|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600058|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
138489197|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489198|NCT00005942|Daunorubicin|daunorubicin|mesh-list
138600059|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600060|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
138600061|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600062|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
138600063|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
138600064|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138600065|NCT00158561|Dapsone|dapsone|mesh-list
138600066|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
138600067|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
138600068|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138600069|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138600070|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600071|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138600072|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600073|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600074|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138600075|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
138600076|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138600077|NCT05169229|Vancomycin|vancomycin|mesh-list
138600078|NCT05169229|Tobramycin|tobramycin|mesh-list
138600079|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138600080|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600081|NCT00538018|Telithromycin|telithromycin|mesh-list
138600082|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138600083|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600084|NCT00538096|Blinatumomab|blinatumomab|mesh-list
138600085|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600086|NCT00158678|Cisplatin|cisplatin|mesh-list
138600087|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600088|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
138600089|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138600090|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600091|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138600092|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600093|NCT00538330|Tamoxifen|tamoxifen|mesh-list
138600094|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138600095|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
138600096|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138600097|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600098|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138600099|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600100|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138600101|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138600102|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138318020|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138318021|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
138318022|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318023|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138318024|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138318026|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318027|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318028|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138318029|NCT01442376|Ondansetron|ondansetron|mesh-list
138318031|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
138318032|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
138318033|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318034|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318035|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138600103|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138600104|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
138600105|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600106|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138600107|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138600108|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600109|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600112|NCT00538486|Telmisartan|telmisartan|mesh-list
138600113|NCT00538486|Candesartan|candesartan|mesh-list
138600115|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138600116|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600117|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138600118|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138600119|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138600120|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600121|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138600122|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
138600123|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138600124|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138600125|NCT00538525|Docetaxel|docetaxel|mesh-list
138600126|NCT00538525|Doxorubicin|doxorubicin|mesh-list
138600127|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600128|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
138600129|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
138600130|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
138600131|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600132|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138600133|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138600134|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138600135|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600136|NCT00538564|Tadalafil|tadalafil|mesh-list
138600137|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
138666166|NCT03178149|Ionophores|ionophores|mesh-ancestor
138600138|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138600139|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138600140|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600141|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600142|NCT00538564|Urological Agents|urological agents|mesh-ancestor
138600143|NCT00538603|Paclitaxel|paclitaxel|mesh-list
138600144|NCT00538603|Carboplatin|carboplatin|mesh-list
138600145|NCT00538603|Doxorubicin|doxorubicin|mesh-list
138600146|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138600147|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138318037|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
138318038|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138318039|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138318040|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
138318041|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318042|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318044|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138318045|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138318046|NCT01442064|Growth Substances|growth substances|mesh-ancestor
138318047|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318051|NCT01441596|Afatinib|afatinib|mesh-list
138600148|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600149|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
138600150|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
138600151|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
138600152|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600153|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138600154|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138600155|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138600156|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600157|NCT00158834|Fluticasone|fluticasone|mesh-list
138600159|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138600160|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138600161|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138600162|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
138600163|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600164|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600165|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138600166|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
138600167|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
138600168|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138600169|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138600170|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138600171|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138600172|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
138600173|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600174|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600175|NCT00538720|Vitamin D|vitamin d|mesh-list
138600176|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
138600177|NCT00538720|Vitamins|vitamins|mesh-ancestor
138600178|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
138600179|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600180|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138600181|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138600182|NCT00536887|Atorvastatin|atorvastatin|mesh-list
138600183|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138600184|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138600185|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
138600186|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600187|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138600188|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138600189|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600190|NCT00158873|Midazolam|midazolam|mesh-list
138600191|NCT00158873|Fentanyl|fentanyl|mesh-list
138600192|NCT00158873|Morphine|morphine|mesh-list
138318058|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138318070|NCT03026478|Betamethasone|betamethasone|mesh-list
138600193|NCT00158873|Remifentanil|remifentanil|mesh-list
138600194|NCT00158873|Lorazepam|lorazepam|mesh-list
138600195|NCT00158873|Propofol|propofol|mesh-list
138600196|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138600197|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138600198|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600199|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138600200|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
138600201|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
138600202|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138600203|NCT00158873|Narcotics|narcotics|mesh-ancestor
138600204|NCT00158873|Analgesics|analgesics|mesh-ancestor
138600205|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
138600206|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600207|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138600208|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138600209|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138600210|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138600211|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
138600212|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
138600213|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600214|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600215|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
138600216|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
138600217|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
138600218|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138600220|NCT00537121|Fluorouracil|fluorouracil|mesh-list
138600221|NCT00537121|Irinotecan|irinotecan|mesh-list
138600222|NCT00537121|Vorinostat|vorinostat|mesh-list
138600223|NCT00537121|Calcium|calcium|mesh-list
138600224|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
138600225|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138600226|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600227|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
138600228|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600229|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138600230|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600231|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138600232|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
138600233|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138600234|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138456288|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
138600235|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600236|NCT00537121|Antidotes|antidotes|mesh-ancestor
138600237|NCT00537121|Protective Agents|protective agents|mesh-ancestor
138600238|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
138318089|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138318090|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
138318091|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318092|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318093|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138318094|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138318096|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
138318097|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138318099|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318100|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318101|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138318102|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
138318103|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138318104|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138600239|NCT00537121|Vitamins|vitamins|mesh-ancestor
138600240|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
138600241|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138600242|NCT00406991|Aspirin|aspirin|mesh-list
138600243|NCT00406991|Clopidogrel|clopidogrel|mesh-list
138600244|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138600245|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138600246|NCT00406991|Analgesics|analgesics|mesh-ancestor
138600247|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
138600248|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600249|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600250|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138600251|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138600252|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138600253|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138600254|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600255|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138318303|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600256|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138600257|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600258|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
138600259|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138600260|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138600261|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138600262|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
138600263|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600264|NCT05432947|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138600265|NCT05432947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138600266|NCT05432947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600267|NCT00158990|Sertraline|sertraline|mesh-list
138600268|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
138600269|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138600270|NCT00158990|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138600271|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138600272|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138600273|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600274|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600275|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
138318108|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318109|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
138318111|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318112|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
138318113|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
138318114|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
138318115|NCT01467492|Interferons|interferons|mesh-list
138318117|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
138318118|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
138318119|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138318120|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318121|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
138456292|NCT01911247|Metformin|metformin|mesh-list
138318122|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600276|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600277|NCT00537355|Histamine|histamine|mesh-list
138600278|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
138600279|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
138600280|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600281|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600282|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600283|NCT00183612|Olanzapine|olanzapine|mesh-list
138600284|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
138600285|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
138600286|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600287|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600288|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138600289|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138600290|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138600291|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138600292|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138600293|NCT00183612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138600294|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138600295|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138600296|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600297|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600298|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
138600299|NCT00537472|Bupivacaine|bupivacaine|mesh-list
138600300|NCT00537472|Anesthetics|anesthetics|mesh-list
138600301|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
138600302|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138600303|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600304|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
138600305|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600306|NCT00159107|Acamprosate|acamprosate|mesh-list
138600307|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138600308|NCT00537550|Methotrexate|methotrexate|mesh-list
138600309|NCT00537550|Vincristine|vincristine|mesh-list
138318138|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138318139|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138318140|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138318141|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138318142|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318143|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
138318144|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
138318145|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318146|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318147|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138600311|NCT00537550|Daunorubicin|daunorubicin|mesh-list
138600312|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138600313|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
138600314|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138600315|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600316|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138600317|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
138600318|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600319|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600320|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
138600321|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600322|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138600323|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138600324|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
138600325|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138600326|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138600327|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138600328|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
138600329|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
138600330|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
138600331|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138600332|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138600333|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138600334|NCT00159146|Pindolol|pindolol|mesh-list
138600335|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138600336|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138600337|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
138600338|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318172|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318173|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138318174|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318175|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318176|NCT01393626|Tofacitinib|tofacitinib|mesh-list
138318177|NCT01393626|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138318178|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138318180|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318181|NCT01393158|Apremilast|apremilast|mesh-list
138318182|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138318183|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138318184|NCT01393158|Analgesics|analgesics|mesh-ancestor
138318185|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
138318186|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318187|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318188|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138318189|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138318190|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138318195|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
138600339|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600340|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600341|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138600342|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138600343|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
138600344|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
138600345|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138600346|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138600347|NCT00538876|Decitabine|decitabine|mesh-list
138600348|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138600349|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
138600350|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600351|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600352|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600353|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
138600354|NCT00538954|Antacids|antacids|mesh-ancestor
138600355|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600356|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138600357|NCT00539071|Risperidone|risperidone|mesh-list
138600358|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138600359|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
138600360|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600361|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600362|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600363|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138600364|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138600365|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138600366|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138318199|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318200|NCT01413360|Protective Agents|protective agents|mesh-ancestor
138318201|NCT03815448|Methotrexate|methotrexate|mesh-list
138318202|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138318203|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
138318204|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138318205|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318206|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138318207|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
138318208|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318217|NCT01392378|Acetaminophen|acetaminophen|mesh-list
138600367|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138600368|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
138600369|NCT00539149|Amoxicillin|amoxicillin|mesh-list
138600370|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138600371|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600372|NCT00183807|Celecoxib|celecoxib|mesh-list
138600373|NCT00183807|Irinotecan|irinotecan|mesh-list
138600374|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600375|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138600376|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138600377|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600378|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600379|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138600380|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138600381|NCT00183807|Analgesics|analgesics|mesh-ancestor
138600382|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
138600383|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600384|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600385|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138600386|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138600387|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138600388|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138600389|NCT00539773|Interferons|interferons|mesh-list
138600390|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600391|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
138600392|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600393|NCT00409461|Sirolimus|sirolimus|mesh-list
138600394|NCT00409461|Tacrolimus|tacrolimus|mesh-list
138600395|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138600396|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
138600397|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600398|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138600399|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318232|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318233|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
138318234|NCT01412424|Octreotide|octreotide|mesh-list
138318235|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138318236|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138318237|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318238|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138318239|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
138318240|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318241|NCT01432938|Dulaglutide|dulaglutide|mesh-list
138600400|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600401|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138600402|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600403|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138600404|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600405|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
138600406|NCT00539890|Insulin|insulin|mesh-list
138600407|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138600408|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600409|NCT00539968|Docetaxel|docetaxel|mesh-list
138600410|NCT00539968|Lonafarnib|lonafarnib|mesh-list
138600411|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600412|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
138600413|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
138600414|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
138600415|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600416|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600417|NCT00183846|Irinotecan|irinotecan|mesh-list
138600418|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138600419|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138600420|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600421|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600422|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600423|NCT00540085|Rocuronium|rocuronium|mesh-list
138600424|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138600425|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138318265|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318267|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138318268|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318269|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318270|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
138318271|NCT04046094|Vitamins|vitamins|mesh-ancestor
138318272|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
138318273|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318275|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318276|NCT04046094|Protective Agents|protective agents|mesh-ancestor
138318277|NCT01410240|Hemostatics|hemostatics|mesh-list
138318278|NCT01410240|Coagulants|coagulants|mesh-ancestor
138318280|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138318281|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
138318282|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138318283|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318284|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
138318285|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138318286|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318287|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600426|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138600427|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600428|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600430|NCT00540202|Artemether|artemether|mesh-list
138600431|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138600432|NCT00540202|Quinine|quinine|mesh-list
138600433|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
138600434|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138600435|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138600436|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600437|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138600438|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600439|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138600440|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600441|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138600442|NCT00540202|Analgesics|analgesics|mesh-ancestor
138600443|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
138600444|NCT00540241|Pemetrexed|pemetrexed|mesh-list
138600445|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600446|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600447|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318297|NCT04044222|Ifosfamide|ifosfamide|mesh-list
138600448|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138318298|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
138318299|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318300|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138318301|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138318302|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138318304|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318305|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138318306|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
138318308|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
138318309|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318311|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
138318312|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
138318313|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138318314|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318318|NCT01405950|Tizanidine|tizanidine|mesh-list
138600449|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138600451|NCT00159224|Lopinavir|lopinavir|mesh-list
138600452|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138600453|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138600454|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
138600455|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600456|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600457|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138600459|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
138600460|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600461|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138600462|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138600463|NCT00540280|Gemcitabine|gemcitabine|mesh-list
138600464|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600465|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138600466|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
138600467|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600468|NCT00183924|Carboplatin|carboplatin|mesh-list
138600469|NCT00183924|Docetaxel|docetaxel|mesh-list
138600470|NCT00183924|Estramustine|estramustine|mesh-list
138600471|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600472|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
138600473|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
138600474|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
138600475|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600476|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138600477|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
138600478|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138318335|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
138318337|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
138318338|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318339|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
138318340|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318341|NCT01428882|Midazolam|midazolam|mesh-list
138318342|NCT01428882|Propofol|propofol|mesh-list
138600480|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138600481|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
138600482|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600483|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600484|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138600485|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
138600486|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138600488|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600489|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600490|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138600491|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
138600492|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
138600493|NCT00159302|Protective Agents|protective agents|mesh-ancestor
138600494|NCT00540631|Immunomodulating Agents|immunomodulating agents|mesh-list
138600495|NCT00540631|Immunologic Factors|immunologic factors|mesh-ancestor
138600496|NCT00540631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600497|NCT00183885|Mitomycins|mitomycins|mesh-list
138600498|NCT00183885|Mitomycin|mitomycin|mesh-list
138600499|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600500|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138600501|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
138600502|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600503|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138600504|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600505|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
138600506|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138600507|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600508|NCT00540748|Oxytocin|oxytocin|mesh-list
138600509|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
138600510|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138600511|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318380|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600512|NCT00540787|Quinidine|quinidine|mesh-list
138318382|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138318383|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138318384|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138600515|NCT00540787|Flecainide|flecainide|mesh-list
138600516|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138600517|NCT00540787|Propafenone|propafenone|mesh-list
138600518|NCT00540787|Dofetilide|dofetilide|mesh-list
138600519|NCT00540787|Cifenline|cifenline|mesh-list
138600520|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
138600521|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138600522|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600523|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
138600524|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138600525|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138600526|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600527|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138600528|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138600529|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138600530|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456320|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
138600531|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138600532|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138600533|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138600534|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138600535|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138600536|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
138600537|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600538|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
138600539|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
138600540|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600541|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138600542|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138600543|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
138600544|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138600545|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138600546|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600547|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138600548|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138600549|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
138600551|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318414|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138600552|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600553|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138600554|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138600555|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138600556|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138276887|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138276888|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138276889|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276891|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138600557|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600558|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
138600559|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600560|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600562|NCT00540943|Cetuximab|cetuximab|mesh-list
138600563|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138600564|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138600565|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600566|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600567|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600568|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138600569|NCT00159458|Gemcitabine|gemcitabine|mesh-list
138600570|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
138600571|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138600572|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
138600573|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600574|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600575|NCT00541021|Gemcitabine|gemcitabine|mesh-list
138600576|NCT00541021|Sorafenib|sorafenib|mesh-list
138600577|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138600578|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
138600579|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600580|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600581|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138600582|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600583|NCT00541138|Tamoxifen|tamoxifen|mesh-list
138600585|NCT00541138|Topotecan|topotecan|mesh-list
138600586|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600587|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600588|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138600589|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138600590|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600591|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138600592|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
138600593|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138600594|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600595|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138456325|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
138600596|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138600597|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138600598|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138600599|NCT00541177|Atropine|atropine|mesh-list
138600600|NCT00541177|Tropicamide|tropicamide|mesh-list
138600601|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138600602|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138600603|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138600604|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
138600605|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600606|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600607|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138600608|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
138600610|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
138600611|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138600612|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138600613|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
138600614|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600615|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600617|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138600618|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600619|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
138600620|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
138600621|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600622|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138600623|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
138600624|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600625|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600626|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
138600627|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138600628|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
138600629|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600630|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138600631|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138600632|NCT00541372|Insulin|insulin|mesh-list
138600633|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138600634|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600636|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138600637|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600638|NCT00541411|Dactinomycin|dactinomycin|mesh-list
138600639|NCT00541411|Vincristine|vincristine|mesh-list
138600640|NCT00541411|Ifosfamide|ifosfamide|mesh-list
138600641|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138600642|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600643|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
138600644|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
138600645|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
138600646|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600647|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138600648|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
138600649|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138600650|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600651|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138600652|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138600653|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600654|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138600655|NCT00541489|Naproxen|naproxen|mesh-list
138600656|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
138600657|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138600658|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138600659|NCT00541489|Analgesics|analgesics|mesh-ancestor
138600660|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
138600661|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600662|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600663|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138600664|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138600665|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
138600666|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138600667|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456329|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138456331|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
138600668|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600669|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138600670|NCT00190437|Amoxicillin|amoxicillin|mesh-list
138600671|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138600672|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600673|NCT00159575|Metformin|metformin|mesh-list
138600674|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138600675|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600676|NCT00541567|Ibipinabant|ibipinabant|mesh-list
138600677|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138600678|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138600679|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600680|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600681|NCT00541567|Hormones|hormones|mesh-ancestor
138600682|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138600683|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600684|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
138600685|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138600686|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138600687|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138600689|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600690|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
138600691|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138486142|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138486151|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600692|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600693|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138600694|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600695|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138600696|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138600697|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600698|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600699|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138600700|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138600701|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600702|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
138600703|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600705|NCT00159614|Diuretics|diuretics|mesh-ancestor
138600706|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
138600707|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600708|NCT00541840|Sorafenib|sorafenib|mesh-list
138600709|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600710|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138600711|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600712|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600713|NCT00190476|Docetaxel|docetaxel|mesh-list
138600714|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600715|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
138600716|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
138600717|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
138600718|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600719|NCT00159653|Timolol|timolol|mesh-list
138600720|NCT00159653|Latanoprost|latanoprost|mesh-list
138600721|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138600722|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138600723|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
138600724|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600725|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600726|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600727|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138600728|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138600729|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138600730|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138600731|NCT00541918|Propofol|propofol|mesh-list
138600732|NCT00541918|Sevoflurane|sevoflurane|mesh-list
138600733|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138600734|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138600735|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600736|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138600737|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
138600738|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
138600739|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138600740|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138600741|NCT00190515|Leucovorin|leucovorin|mesh-list
138600742|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
138600743|NCT00190515|Antidotes|antidotes|mesh-ancestor
138600744|NCT00190515|Protective Agents|protective agents|mesh-ancestor
138600745|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600746|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
138486157|NCT00000922|Efavirenz|efavirenz|mesh-list
138486158|NCT00000922|Nevirapine|nevirapine|mesh-list
138600747|NCT00190515|Vitamins|vitamins|mesh-ancestor
138600748|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
138600749|NCT00159692|Amlodipine|amlodipine|mesh-list
138600750|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138600751|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138600752|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138600753|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600754|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138600755|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600756|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
138600757|NCT00542074|Ethanol|ethanol|mesh-list
138600758|NCT00542074|Emollients|emollients|mesh-list
138600759|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
138600760|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138600761|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600762|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138600763|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600764|NCT00542152|Cyclosporine|cyclosporine|mesh-list
138600765|NCT00542152|Infliximab|infliximab|mesh-list
138600766|NCT00542152|Cyclosporins|cyclosporins|mesh-list
138600767|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600768|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600769|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138600770|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
138600771|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600772|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
138600773|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600774|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
138600775|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138600776|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138600777|NCT00542152|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138600778|NCT00542152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138600779|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138600780|NCT00159731|Pregabalin|pregabalin|mesh-list
138600781|NCT00159731|Analgesics|analgesics|mesh-ancestor
138600783|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138649758|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600785|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
138600786|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138600787|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138600788|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600789|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138600790|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138600791|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138600792|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138600793|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138600794|NCT00408915|Lisuride|lisuride|mesh-list
138600795|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138600796|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138600797|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138600798|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
138600799|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600800|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600801|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600802|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
138600803|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
138600804|NCT00542347|Esomeprazole|esomeprazole|mesh-list
138600805|NCT00542347|Omeprazole|omeprazole|mesh-list
138600806|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138600807|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138600808|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138600809|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600810|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600811|NCT00190554|Cisplatin|cisplatin|mesh-list
138600812|NCT00190554|Fluorouracil|fluorouracil|mesh-list
138600813|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600814|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
138666431|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
138600815|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600817|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138600818|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
138600819|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600820|NCT00159770|Olanzapine|olanzapine|mesh-list
138600821|NCT00159770|Risperidone|risperidone|mesh-list
138600822|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138600823|NCT00159770|Ziprasidone|ziprasidone|mesh-list
138600824|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138600825|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
138600826|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600827|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600828|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600829|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138600830|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138600831|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138600832|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138600834|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
138600835|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
138600836|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
138600837|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600838|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138600839|NCT00159770|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138600840|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138600841|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138600842|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
138600843|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138600844|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138600845|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
138600846|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138600847|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600848|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138600849|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138600850|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138600851|NCT00542893|Dacarbazine|dacarbazine|mesh-list
138600853|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138600854|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
138486197|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138600855|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600857|NCT00184041|Cytarabine|cytarabine|mesh-list
138600858|NCT00184041|Prednisone|prednisone|mesh-list
138600859|NCT00184041|Methotrexate|methotrexate|mesh-list
138600860|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
138600861|NCT00184041|Vincristine|vincristine|mesh-list
138600862|NCT00184041|Daunorubicin|daunorubicin|mesh-list
138600863|NCT00184041|Asparaginase|asparaginase|mesh-list
138600864|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
138600865|NCT00184041|Thioguanine|thioguanine|mesh-list
138600866|NCT00184041|Pegaspargase|pegaspargase|mesh-list
138600867|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138600868|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
138600869|NCT00184041|Hormones|hormones|mesh-ancestor
138600870|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138649814|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138600871|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600872|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138600873|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600874|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138600875|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
138600876|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138456341|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138600877|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138600878|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
138600879|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600880|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
138600881|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600882|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138600883|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138600884|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
138600885|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138600886|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138600887|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138600888|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
138600889|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138600890|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138600891|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
138600892|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
138600893|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
138600894|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
138600895|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600896|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138600897|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138600898|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138600900|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600901|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138600902|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138600903|NCT00543049|Growth Substances|growth substances|mesh-ancestor
138600904|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138649848|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
138600905|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
138600906|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138600907|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600908|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600909|NCT04685005|Caffeine|caffeine|mesh-list
138600910|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138600911|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600912|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138600913|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600914|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600915|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138600916|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138600917|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
138318307|NCT01390428|Grazoprevir|grazoprevir|mesh-list
138600918|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600919|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138600920|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138600921|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138600922|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138600923|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600924|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600925|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600927|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
138600928|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600929|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
138600930|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138600931|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
138600932|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138600933|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138600934|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
138600935|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600936|NCT00543205|Oblimersen|oblimersen|mesh-list
138600937|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600938|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
138600939|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600940|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
138600941|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138600942|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138600943|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600944|NCT00159809|Urological Agents|urological agents|mesh-ancestor
138649892|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
138600945|NCT00543244|Interferons|interferons|mesh-list
138600946|NCT00543244|Ribavirin|ribavirin|mesh-list
138600947|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
138600948|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138600949|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138600950|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
138600951|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600952|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
138600953|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600954|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
138600955|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600956|NCT00190710|Carboplatin|carboplatin|mesh-list
138600957|NCT00190710|Gemcitabine|gemcitabine|mesh-list
138600958|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138486250|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600959|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138600960|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
138600961|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600962|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
138600963|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
138600964|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138600965|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138600966|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600967|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138600968|NCT03456661|Analgesics|analgesics|mesh-ancestor
138600969|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
138600970|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138600971|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138600972|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138600973|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138600974|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
138600975|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138600976|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600977|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
138600978|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
138600979|NCT03456544|Vancomycin|vancomycin|mesh-list
138600980|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138649925|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
138600981|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600982|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
138600983|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138600984|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
138600985|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138600986|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138600987|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138600988|NCT00159887|Urological Agents|urological agents|mesh-ancestor
138600989|NCT00543361|Metformin|metformin|mesh-list
138600990|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138600991|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138600992|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138600993|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138600994|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138600995|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138600996|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138600997|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
138600998|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138600999|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601000|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138601001|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138601002|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138601003|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601005|NCT00543634|Hormones|hormones|mesh-ancestor
138601006|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138601007|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
138601008|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138601009|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138601010|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601011|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
138601012|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601013|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601014|NCT00543829|Tamoxifen|tamoxifen|mesh-list
138601015|NCT00543829|Docetaxel|docetaxel|mesh-list
138601016|NCT00543829|Doxorubicin|doxorubicin|mesh-list
138601017|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138601018|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601019|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
138601020|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
138601021|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
138601022|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601023|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138601024|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138601025|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138601026|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601027|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138601028|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
138649959|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138649960|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138601029|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138601030|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601031|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138601032|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138601033|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138601034|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138601035|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138601036|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138601037|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138601038|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138601039|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601040|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601041|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601042|NCT00190827|Analgesics|analgesics|mesh-ancestor
138601043|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
138601044|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601045|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
138601046|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138601047|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
138601048|NCT00160043|Vatalanib|vatalanib|mesh-list
138601049|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138601050|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601051|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601052|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
138601053|NCT00544063|Irinotecan|irinotecan|mesh-list
138601054|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601055|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138601056|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138601057|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601058|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601059|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
138601060|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138601061|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138601062|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486289|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
138486291|NCT00001003|Zidovudine|zidovudine|mesh-list
138601063|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138601064|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601065|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138601067|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
138601068|NCT00544219|Rituximab|rituximab|mesh-list
138649986|NCT00299819|Sifalimumab|sifalimumab|mesh-list
138649987|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138601069|NCT00544219|Doxorubicin|doxorubicin|mesh-list
138601070|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138601071|NCT00544219|Vincristine|vincristine|mesh-list
138601072|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138601073|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
138601074|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601075|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138601076|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138601077|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
138601078|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601079|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601080|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138601081|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138601082|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138601083|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138601084|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138601085|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601086|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138601087|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
138601089|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138601090|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138601091|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138601092|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
138601093|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
138601094|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
138601095|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138601096|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138601097|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138601098|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138601099|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601100|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601101|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601102|NCT00190866|Analgesics|analgesics|mesh-ancestor
138601103|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
138601104|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601105|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
138601106|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138601107|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
138650015|NCT05455944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138601108|NCT00160160|Eprosartan|eprosartan|mesh-list
138601109|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138601110|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
138601111|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138601112|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601113|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
138601115|NCT00544570|Carmustine|carmustine|mesh-list
138601116|NCT00544570|Etoposide|etoposide|mesh-list
138601117|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138601118|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
138601120|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138601121|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138601122|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
138601123|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601124|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601125|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138601126|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138601127|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138601128|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138601129|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601130|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138601131|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138601132|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138601133|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138601134|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601136|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601137|NCT00190905|Analgesics|analgesics|mesh-ancestor
138601138|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
138601139|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601140|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
138601141|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138601142|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
138601143|NCT00544609|Sorafenib|sorafenib|mesh-list
138601144|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601145|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138601146|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601147|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601148|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
138601149|NCT00544687|Nortriptyline|nortriptyline|mesh-list
138601150|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138601151|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
138601152|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138601153|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138601154|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
138601155|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138601156|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138601157|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138650050|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138601159|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601160|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
138601161|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601162|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601163|NCT00160238|Betahistine|betahistine|mesh-list
138601164|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
138601165|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
138601166|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
138601167|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601168|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601169|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601170|NCT00544804|Lapatinib|lapatinib|mesh-list
138601171|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601172|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138601173|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138666598|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601174|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601176|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138601177|NCT02963181|Melatonin|melatonin|mesh-list
138601178|NCT02963181|Yohimbine|yohimbine|mesh-list
138601179|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
138601180|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601181|NCT02963181|Protective Agents|protective agents|mesh-ancestor
138601182|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601183|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138601184|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
138601185|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
138601186|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601187|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138601188|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138601189|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138601190|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
138601191|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601192|NCT02963181|Urological Agents|urological agents|mesh-ancestor
138601193|NCT00544999|Cytarabine|cytarabine|mesh-list
138601194|NCT00544999|Everolimus|everolimus|mesh-list
138601195|NCT00544999|Daunorubicin|daunorubicin|mesh-list
138601196|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138601197|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
138601198|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601199|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601200|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
138601201|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138601202|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138650074|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
138601204|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601205|NCT00544999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138601206|NCT00544999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138601207|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601209|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138601210|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138601211|NCT00160316|Estradiol|estradiol|mesh-list
138601212|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
138601213|NCT00160316|Estrogens|estrogens|mesh-ancestor
138601214|NCT00160316|Hormones|hormones|mesh-ancestor
138601215|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138601216|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601217|NCT00160316|Progestins|progestins|mesh-ancestor
138601218|NCT00545194|Dinoprostone|dinoprostone|mesh-list
138601219|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
138601220|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138601221|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601222|NCT00190944|Teriparatide|teriparatide|mesh-list
138601223|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138601224|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601225|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138601227|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138601228|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601229|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
138486353|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138601230|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601231|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138601233|NCT00160355|Melphalan|melphalan|mesh-list
138601234|NCT00160355|Thiotepa|thiotepa|mesh-list
138601235|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601236|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601237|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138601238|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
138601239|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601240|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138601241|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
138601242|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138650106|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601243|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
138601244|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138601245|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138601246|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138601247|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
138601248|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601249|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601250|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601251|NCT00160394|Adapalene|adapalene|mesh-list
138601252|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138601253|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138601254|NCT00160394|Analgesics|analgesics|mesh-ancestor
138601255|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
138601256|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601257|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601258|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138601259|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138601260|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
138601261|NCT00191022|Paroxetine|paroxetine|mesh-list
138601262|NCT00191022|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138601263|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138601264|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138601265|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601266|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601267|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
138601268|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601269|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138601270|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
138601271|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138601272|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138601273|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138601274|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601275|NCT00545389|Mesalamine|mesalamine|mesh-list
138601276|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138601277|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138601278|NCT00545389|Analgesics|analgesics|mesh-ancestor
138601279|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
138601280|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601281|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601283|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138601284|NCT00545467|Aripiprazole|aripiprazole|mesh-list
138601285|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
138601286|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138601287|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138601288|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138601289|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138601290|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601291|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
138601292|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
138601293|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601294|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601295|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138601296|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138601297|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
138601298|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138601299|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138601300|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138601301|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138601302|NCT00545857|Pioglitazone|pioglitazone|mesh-list
138601303|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138601304|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601306|NCT00545935|Amodiaquine|amodiaquine|mesh-list
138601307|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
138601308|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138601309|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138601310|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138601311|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601312|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
138601313|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
138601314|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138601315|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
138601316|NCT00160511|Levetiracetam|levetiracetam|mesh-list
138601317|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
138601318|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
138601319|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138601320|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138601321|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138601322|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138601323|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601324|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138650177|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601325|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601326|NCT00191061|Analgesics|analgesics|mesh-ancestor
138601327|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
138601328|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601329|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
138601330|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138601331|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
138601332|NCT00160550|Levetiracetam|levetiracetam|mesh-list
138601333|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
138601334|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
138601335|NCT00160589|Levocetirizine|levocetirizine|mesh-list
138601336|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138601337|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138601338|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
138601339|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
138601340|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601341|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601342|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601343|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
138601345|NCT00546130|Irinotecan|irinotecan|mesh-list
138601346|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601347|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138601348|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138601349|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601350|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601351|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138601352|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
138601353|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601354|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138601356|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138601358|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138601359|NCT00546130|Protective Agents|protective agents|mesh-ancestor
138601360|NCT00191178|Insulin|insulin|mesh-list
138601361|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138601362|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
138601363|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
138601364|NCT00191178|Protamines|protamines|mesh-list
138601365|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138650208|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
138601366|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601367|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
138601368|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601369|NCT00191178|Coagulants|coagulants|mesh-ancestor
138601370|NCT00546169|Thrombin|thrombin|mesh-list
138601371|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
138601372|NCT00546169|Coagulants|coagulants|mesh-ancestor
138601373|NCT00160628|Levetiracetam|levetiracetam|mesh-list
138601374|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
138601375|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
138601376|NCT00546286|Timolol|timolol|mesh-list
138601377|NCT00546286|Dorzolamide|dorzolamide|mesh-list
138601378|NCT00546286|Maleic acid|maleic acid|mesh-list
138601379|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601380|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601381|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138601382|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138601383|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
138601384|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601385|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601386|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138666679|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
138601387|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138601388|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138601390|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138601391|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138601392|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138601393|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601394|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601395|NCT00546325|Hormones|hormones|mesh-ancestor
138601396|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138601397|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601398|NCT00546403|Modafinil|modafinil|mesh-list
138601399|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138601400|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601401|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138650244|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
138601402|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138601403|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138601404|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601406|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138601407|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601408|NCT00191256|Paclitaxel|paclitaxel|mesh-list
138601409|NCT00191256|Carboplatin|carboplatin|mesh-list
138601410|NCT00191256|Gemcitabine|gemcitabine|mesh-list
138456396|NCT01911624|Coagulants|coagulants|mesh-ancestor
138601411|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138601412|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601413|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
138601415|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
138601416|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601417|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138601418|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
138601419|NCT00546520|Ciclesonide|ciclesonide|mesh-list
138601420|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
138601421|NCT00546520|Hormones|hormones|mesh-ancestor
138601422|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138601423|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601424|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138601425|NCT00546559|Simvastatin|simvastatin|mesh-list
138601426|NCT00546559|Pravastatin|pravastatin|mesh-list
138601427|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138601428|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138601429|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
138601430|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601431|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138318310|NCT01429584|Bupivacaine|bupivacaine|mesh-list
138601432|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138601434|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138601435|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138601436|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138601437|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
138666699|NCT01922076|Adavosertib|adavosertib|mesh-list
138601438|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601439|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138601440|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138601441|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601442|NCT00546676|Telithromycin|telithromycin|mesh-list
138601443|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138601444|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138601445|NCT00546832|Celecoxib|celecoxib|mesh-list
138601446|NCT00546832|Diclofenac|diclofenac|mesh-list
138601447|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138601448|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138601449|NCT00546832|Analgesics|analgesics|mesh-ancestor
138601451|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650279|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138601452|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601453|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138601454|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138601455|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138601456|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138601457|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601458|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601459|NCT00184587|Candesartan|candesartan|mesh-list
138601460|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
138601461|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
138601462|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138601463|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138601464|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138601465|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601466|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138601468|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138601469|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
138601470|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601471|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601472|NCT00547183|Tadalafil|tadalafil|mesh-list
138601473|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
138601474|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138601475|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138601476|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601477|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601478|NCT00547183|Urological Agents|urological agents|mesh-ancestor
138601479|NCT00184626|Insulin|insulin|mesh-list
138601480|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138601481|NCT00184626|Metformin|metformin|mesh-list
138601482|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
138601483|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
138601484|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
138601485|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138601486|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601487|NCT00547417|Tadalafil|tadalafil|mesh-list
138601488|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
138601489|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138601490|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138601491|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650311|NCT00328029|Busulfan|busulfan|mesh-list
138601492|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601494|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138601495|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138601496|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138601497|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138601498|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601499|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
138601500|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601501|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601502|NCT00547495|Tadalafil|tadalafil|mesh-list
138601503|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
138601504|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138601505|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138601507|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601508|NCT00547495|Urological Agents|urological agents|mesh-ancestor
138601509|NCT02277223|Curcumin|curcumin|mesh-list
138601510|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138601511|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138601512|NCT02277223|Analgesics|analgesics|mesh-ancestor
138601513|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
138601514|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601515|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601516|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138601517|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138601518|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601519|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601520|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601521|NCT00547573|Tadalafil|tadalafil|mesh-list
138601522|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
138601523|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138601524|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138601525|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601526|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601527|NCT00547573|Urological Agents|urological agents|mesh-ancestor
138601528|NCT00191373|Gemcitabine|gemcitabine|mesh-list
138601529|NCT00191373|Trastuzumab|trastuzumab|mesh-list
138601530|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138601531|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
138601532|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601533|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601534|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138650342|NCT00328107|Coagulants|coagulants|mesh-ancestor
138601535|NCT00547612|Substance P|substance p|mesh-list
138601536|NCT00547612|Neurokinin A|neurokinin a|mesh-list
138601537|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601538|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601539|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601540|NCT00547768|Fexofenadine|fexofenadine|mesh-list
138601541|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138601542|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138601543|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138601544|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
138601545|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
138601546|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601547|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601548|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601549|NCT00184665|Insulin|insulin|mesh-list
138601550|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138601551|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
138601552|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
138601553|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
138601554|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
138601555|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
138601556|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138601557|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601558|NCT04974385|Bupivacaine|bupivacaine|mesh-list
138601559|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
138601560|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
138601561|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138601562|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601563|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
138601564|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601565|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
138601566|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138601567|NCT00547885|Narcotics|narcotics|mesh-ancestor
138601568|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138601569|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601570|NCT00547885|Analgesics|analgesics|mesh-ancestor
138601571|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
138601572|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601573|NCT00161018|Risperidone|risperidone|mesh-list
138601574|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138601575|NCT00161018|Fluphenazine|fluphenazine|mesh-list
138601576|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
138601577|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
138601578|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138601579|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
138601580|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601581|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601583|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138601584|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138601585|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138601586|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138601587|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138601588|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
138601589|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
138601590|NCT00191412|Pemetrexed|pemetrexed|mesh-list
138601591|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601592|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601593|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601594|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138601595|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138601596|NCT00548002|Levofloxacin|levofloxacin|mesh-list
138601597|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
138277937|NCT02513498|Ixazomib|ixazomib|mesh-list
138601598|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138601599|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138601600|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138601601|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138601602|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138601603|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601604|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601605|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601606|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138601607|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138601608|NCT00191490|Gemcitabine|gemcitabine|mesh-list
138601610|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601611|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138601612|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
138601613|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601614|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
138601615|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
138601616|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
138601617|NCT00548080|Caspofungin|caspofungin|mesh-list
138601618|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
138601619|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138601620|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601621|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601622|NCT00161096|Pantoprazole|pantoprazole|mesh-list
138601623|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138601624|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138601625|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138601626|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601627|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601628|NCT00184821|Glyburide|glyburide|mesh-list
138601629|NCT00184821|Adenosine|adenosine|mesh-list
138601630|NCT00184821|Diazoxide|diazoxide|mesh-list
138650391|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601631|NCT00184821|Annexin A5|annexin a5|mesh-list
138601632|NCT00184821|Analgesics|analgesics|mesh-ancestor
138601633|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
138601634|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601635|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601636|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138601637|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
138601638|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138601639|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
138601640|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
138601641|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601642|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601643|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138601644|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138601645|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601647|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
138601648|NCT00548509|Menatetrenone|menatetrenone|mesh-list
138601649|NCT00548509|Vitamins|vitamins|mesh-ancestor
138601650|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
138601651|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601652|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138601653|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138601654|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601655|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
138601657|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
138601658|NCT00548704|Razoxane|razoxane|mesh-list
138601659|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601660|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138601661|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138601662|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138601664|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601665|NCT00548704|Protective Agents|protective agents|mesh-ancestor
138601666|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601667|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
138601668|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
138601669|NCT00184899|Heparin|heparin|mesh-list
138601670|NCT00184899|Calcium heparin|calcium heparin|mesh-list
138601671|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138601672|NCT00184899|Glycerol|glycerol|mesh-list
138601673|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
138601674|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138601675|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138601676|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601677|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138601678|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138601679|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138601680|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138601681|NCT00184899|Protective Agents|protective agents|mesh-ancestor
138601682|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601683|NCT00548821|Cisplatin|cisplatin|mesh-list
138601684|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601685|NCT00161291|Bevacizumab|bevacizumab|mesh-list
138601686|NCT00161291|Letrozole|letrozole|mesh-list
138601687|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138601688|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601689|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138601690|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138601691|NCT00161291|Growth Substances|growth substances|mesh-ancestor
138601692|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601693|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
138601694|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138601695|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138601697|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601698|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138601699|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
138601700|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138601701|NCT00548899|Sorafenib|sorafenib|mesh-list
138601702|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601703|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138601704|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601705|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601706|NCT00191568|Gemcitabine|gemcitabine|mesh-list
138601707|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
138601708|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138601709|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
138486562|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138601710|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601712|NCT00548938|Temozolomide|temozolomide|mesh-list
138601713|NCT00548938|Carmustine|carmustine|mesh-list
138601714|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138601715|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
138601716|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601717|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601718|NCT00161330|Amoxicillin|amoxicillin|mesh-list
138601719|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
138601720|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
138601721|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
138601722|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138601723|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138601724|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601725|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601726|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138601727|NCT00184938|Morphine|morphine|mesh-list
138601728|NCT00184938|Naloxone|naloxone|mesh-list
138601729|NCT00184938|Annexin A5|annexin a5|mesh-list
138601730|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138601731|NCT00184938|Narcotics|narcotics|mesh-ancestor
138601733|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601734|NCT00184938|Analgesics|analgesics|mesh-ancestor
138601735|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
138601736|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601737|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138650511|NCT00328692|Rolofylline|rolofylline|mesh-list
138601738|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601739|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601740|NCT00549133|Irbesartan|irbesartan|mesh-list
138601741|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138601742|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138601743|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138601744|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601745|NCT00191607|Gemcitabine|gemcitabine|mesh-list
138601746|NCT00191607|Doxorubicin|doxorubicin|mesh-list
138601747|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138601748|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138601749|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
138601750|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601751|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601752|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138601753|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138601754|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138666908|NCT00325403|Treprostinil|treprostinil|mesh-list
138601755|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601756|NCT00549289|Cyclosporine|cyclosporine|mesh-list
138601757|NCT00549289|Cyclosporins|cyclosporins|mesh-list
138601758|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601759|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601760|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138601761|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
138601762|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601763|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
138601764|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138601765|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
138601766|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138601767|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138601768|NCT00184977|Fluticasone|fluticasone|mesh-list
138601770|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
138601771|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138601772|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138601773|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138601774|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
138601775|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601776|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601777|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138601778|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
138601779|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
138601780|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138601781|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
138601782|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138601783|NCT00184977|Expectorants|expectorants|mesh-ancestor
138601784|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138601785|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
138650545|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138601786|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601787|NCT00184977|Protective Agents|protective agents|mesh-ancestor
138601788|NCT00184977|Antidotes|antidotes|mesh-ancestor
138601789|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
138601790|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138601791|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
138601792|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
138601793|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
138601794|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138601795|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
138601796|NCT00161447|Testosterone|testosterone|mesh-list
138601797|NCT00161447|Acyline|acyline|mesh-list
138601798|NCT00161447|Androgens|androgens|mesh-ancestor
138601799|NCT00161447|Hormones|hormones|mesh-ancestor
138601800|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138601801|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601802|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138601803|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601804|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138601805|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138601806|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138601807|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
138601808|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138601809|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138601810|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138601811|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138601812|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
138601813|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138601814|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138601815|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138601816|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138601817|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601818|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601819|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601820|NCT00191685|Analgesics|analgesics|mesh-ancestor
138601821|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
138601822|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601823|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
138601824|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138601826|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
138601827|NCT00161486|Testosterone|testosterone|mesh-list
138601828|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
138601829|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
138601830|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138650571|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601832|NCT00161486|Androgens|androgens|mesh-ancestor
138601833|NCT00161486|Hormones|hormones|mesh-ancestor
138601834|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138486593|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138601835|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601836|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138601838|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
138601839|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
138601840|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
138601841|NCT00549874|Glyburide|glyburide|mesh-list
138601842|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138601843|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601844|NCT00191763|Gemcitabine|gemcitabine|mesh-list
138601845|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601846|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138601847|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
138601848|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601850|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138601851|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601852|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
138601853|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601854|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138601855|NCT00185055|Valsartan|valsartan|mesh-list
138601856|NCT00185055|Olmesartan|olmesartan|mesh-list
138601857|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138601858|NCT00185055|Irbesartan|irbesartan|mesh-list
138601859|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138601860|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138601861|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138601862|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601863|NCT00550108|Ethanol|ethanol|mesh-list
138601864|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138601865|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138601866|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138601867|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601868|NCT00185094|Losartan|losartan|mesh-list
138601869|NCT00185094|Atenolol|atenolol|mesh-list
138601870|NCT00185094|Olmesartan|olmesartan|mesh-list
138601871|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138601872|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138601873|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138601874|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138601875|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138601876|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601877|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
138601878|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
138601879|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601880|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601881|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138601882|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138601883|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138601884|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
138601885|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601886|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
138601887|NCT00550303|Estrogens|estrogens|mesh-list
138650602|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138601888|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138601889|NCT00550303|Hormones|hormones|mesh-ancestor
138601890|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138601891|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601892|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138601893|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138601894|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
138601895|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138601896|NCT00550342|Rituximab|rituximab|mesh-list
138486602|NCT00001303|Protective Agents|protective agents|mesh-ancestor
138601897|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138601898|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601899|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
138601900|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601901|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138601902|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
138601903|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138601905|NCT00161681|Estrogens|estrogens|mesh-ancestor
138601906|NCT00161681|Hormones|hormones|mesh-ancestor
138601907|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138601908|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601909|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138601910|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
138601911|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138601912|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138601913|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138601914|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138601915|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138601916|NCT02963454|Simendan|simendan|mesh-list
138601917|NCT02963454|Dobutamine|dobutamine|mesh-list
138601918|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138601919|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
138601920|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138601921|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138601922|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601923|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601924|NCT02963454|Protective Agents|protective agents|mesh-ancestor
138601925|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601926|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
138601927|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
138601928|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601929|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138601930|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138601931|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138601932|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
138256243|NCT04350086|Analgesics|analgesics|mesh-ancestor
138601933|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138601934|NCT00191802|Teriparatide|teriparatide|mesh-list
138601935|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138601936|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601937|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138601938|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
138601939|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138601940|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138601941|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
138601942|NCT00550810|Sunitinib|sunitinib|mesh-list
138601943|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601944|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138601945|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138601946|NCT00550810|Growth Substances|growth substances|mesh-ancestor
138486615|NCT00001333|Topotecan|topotecan|mesh-list
138601947|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601948|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
138601949|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138601950|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601951|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601952|NCT00191841|Gemcitabine|gemcitabine|mesh-list
138601953|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601954|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138601955|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
138601956|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601957|NCT00550927|Bevacizumab|bevacizumab|mesh-list
138601958|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138601959|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601960|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138601961|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138601962|NCT00550927|Growth Substances|growth substances|mesh-ancestor
138601963|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601964|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
138601966|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
138601967|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138601968|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138601969|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601970|NCT00185133|Amlodipine|amlodipine|mesh-list
138601971|NCT00185133|Olmesartan|olmesartan|mesh-list
138601972|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138601973|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138601974|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138601975|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138601976|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601977|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138601978|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650651|NCT00332397|Temsirolimus|temsirolimus|mesh-list
138601979|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
138601980|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138601981|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138601983|NCT00551005|Etoposide|etoposide|mesh-list
138601984|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138601985|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138601986|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138601987|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138601988|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138601989|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138601990|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138601991|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138601992|NCT00551005|Analgesics|analgesics|mesh-ancestor
138601993|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
138601994|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138601995|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138601996|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138601997|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138601998|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138601999|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138602000|NCT00551044|Bicalutamide|bicalutamide|mesh-list
138602001|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
138602002|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
138602003|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138602004|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602005|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602006|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138602007|NCT00161759|Thrombin|thrombin|mesh-list
138602008|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
138602009|NCT00161759|Coagulants|coagulants|mesh-ancestor
138602011|NCT00551122|Gemcitabine|gemcitabine|mesh-list
138602012|NCT00551122|Ifosfamide|ifosfamide|mesh-list
138602013|NCT00551122|Lenograstim|lenograstim|mesh-list
138602014|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138602015|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602016|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
138602017|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
138602018|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
138602019|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602020|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138602021|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
138602022|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138602023|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
138602024|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602025|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138602026|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
138602027|NCT00551239|Rituximab|rituximab|mesh-list
138602028|NCT00551239|Fludarabine|fludarabine|mesh-list
138650681|NCT00304538|Glucagon|glucagon|mesh-list
138602029|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
138602030|NCT00551239|Pixantrone|pixantrone|mesh-list
138602031|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138602032|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602033|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
138602034|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602035|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138602036|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138602037|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
138602038|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602039|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138602040|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138602041|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138602042|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602043|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138602044|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138602045|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138602046|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602047|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602048|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
138602049|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602050|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602051|NCT00551317|Darapladib|darapladib|mesh-list
138602052|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138602053|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602054|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602055|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
138667061|NCT00430118|Etoposide|etoposide|mesh-list
138602056|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138602057|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602058|NCT02963337|Remifentanil|remifentanil|mesh-list
138602059|NCT02963337|Bupivacaine|bupivacaine|mesh-list
138602060|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
138602061|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
138602062|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138602063|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602064|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
138602065|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602066|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138602067|NCT02963337|Narcotics|narcotics|mesh-ancestor
138602068|NCT02963337|Analgesics|analgesics|mesh-ancestor
138602069|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138602070|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138602071|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138602072|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602073|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602074|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602075|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602076|NCT00191919|Analgesics|analgesics|mesh-ancestor
138650704|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138650705|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138602077|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
138602078|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602079|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
138602080|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138602081|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
138602082|NCT00161837|Vaccines|vaccines|mesh-list
138602083|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
138602084|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602085|NCT00551512|Cisplatin|cisplatin|mesh-list
138602086|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602087|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138602088|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138602089|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602090|NCT00551590|Incretins|incretins|mesh-ancestor
138602091|NCT00551590|Hormones|hormones|mesh-ancestor
138602092|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138602093|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138602094|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
138602095|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602096|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602097|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138602098|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
138602099|NCT00161915|Coagulants|coagulants|mesh-ancestor
138602100|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138602101|NCT00185172|Olmesartan|olmesartan|mesh-list
138602103|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138602104|NCT00185172|Diuretics|diuretics|mesh-ancestor
138602105|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
138602106|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602107|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138602108|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602109|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602110|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138602111|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138602112|NCT00191997|Olanzapine|olanzapine|mesh-list
138602113|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
138602115|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602116|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602117|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138602118|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138602119|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138602120|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138602121|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138602122|NCT00191997|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138602123|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138602124|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602125|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602126|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602127|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
138650725|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138602129|NCT00551824|Mitomycin|mitomycin|mesh-list
138602130|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138602131|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602132|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
138602133|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602134|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138602135|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602136|NCT00185250|Interferons|interferons|mesh-list
138602137|NCT00185250|Interferon-beta|interferon-beta|mesh-list
138602138|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
138602139|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602140|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
138602141|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602142|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
138602143|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602144|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138602145|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
138602146|NCT00161993|Antibodies|antibodies|mesh-list
138602147|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
138602148|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138602149|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138602150|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
138602151|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602152|NCT00185328|Estradiol|estradiol|mesh-list
138602153|NCT00185328|Estrogens|estrogens|mesh-ancestor
138602154|NCT00185328|Hormones|hormones|mesh-ancestor
138602155|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138602156|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602157|NCT00162110|Cetuximab|cetuximab|mesh-list
138602158|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138602159|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602160|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
138602161|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138602162|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602163|NCT00162149|Ritonavir|ritonavir|mesh-list
138602164|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138602166|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138602167|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138602168|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
138602169|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602170|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602171|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138602172|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138650750|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
138650751|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602173|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
138602174|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602175|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138602176|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138602177|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138602178|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138602179|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138602180|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138602181|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
138602183|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138602184|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138602185|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602186|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602187|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
138602188|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602189|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138602190|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138602191|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138602192|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138602193|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138602194|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138602196|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138602197|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138602198|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602199|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602201|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602202|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138602203|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138602204|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138602205|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138602206|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138602207|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138602208|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138602209|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138602210|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602211|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138602212|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138602213|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138602214|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602215|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602216|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602217|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602218|NCT00552682|Analgesics|analgesics|mesh-ancestor
138650780|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602219|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
138602220|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602221|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
138602222|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138602223|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
138602224|NCT04652089|Simvastatin|simvastatin|mesh-list
138602225|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138602226|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138602227|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
138602228|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602229|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138602230|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138602231|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602232|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138602233|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138602234|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602235|NCT04684498|Oseltamivir|oseltamivir|mesh-list
138602236|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
138602237|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602238|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602239|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602240|NCT00552799|Penicillins|penicillins|mesh-list
138602241|NCT00552799|Penicillin V|penicillin v|mesh-list
138602242|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138602243|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602244|NCT00409071|Sinomenine|sinomenine|mesh-list
138602245|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138602246|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
138602247|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138602248|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602249|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138602250|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602251|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138486687|NCT00001495|Irinotecan|irinotecan|mesh-list
138602253|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602254|NCT00162383|Dapsone|dapsone|mesh-list
138602255|NCT00162383|Debrisoquin|debrisoquin|mesh-list
138602256|NCT00162383|Mephenytoin|mephenytoin|mesh-list
138602257|NCT00162383|Caffeine|caffeine|mesh-list
138602258|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138602259|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602260|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138602261|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602262|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602263|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138602264|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138650804|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602266|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602267|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278608|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138602268|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
138602269|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138602270|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138602271|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138602272|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
138602273|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138602274|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138602275|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
138602276|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
138602277|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602278|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
138602279|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
138602280|NCT00162422|Albuterol|albuterol|mesh-list
138602281|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138602282|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
138602283|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602284|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602285|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138602286|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
138602287|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
138602288|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138602289|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138602290|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138602291|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138602292|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
138602293|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602294|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602295|NCT04355143|Colchicine|colchicine|mesh-list
138602296|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
138602297|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138602298|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
138602299|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
138602300|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
138602301|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602302|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602304|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
138602305|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602306|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138602307|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
138602308|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602309|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138602310|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
138486706|NCT00001576|Floxuridine|floxuridine|mesh-list
138602311|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602312|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
138602313|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138602314|NCT04233034|Verapamil|verapamil|mesh-list
138602315|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138650829|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138602316|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138602317|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602318|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138650830|NCT00332787|Fluoxetine|fluoxetine|mesh-list
138602319|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138602320|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602321|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
138602323|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
138602324|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138602325|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138602326|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602327|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602328|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138602329|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138602330|NCT00185562|Adalimumab|adalimumab|mesh-list
138602331|NCT00185562|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138602332|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138602333|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138602334|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
138602335|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138602336|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
138602337|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602338|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138602339|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138602340|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
138602341|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602342|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602343|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138602344|NCT00162695|Etoposide|etoposide|mesh-list
138602345|NCT00162695|Vincristine|vincristine|mesh-list
138602346|NCT00162695|Epirubicin|epirubicin|mesh-list
138602347|NCT00162695|Ifosfamide|ifosfamide|mesh-list
138602348|NCT00162695|Carboplatin|carboplatin|mesh-list
138602349|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138602350|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602351|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138667221|NCT00461916|Buserelin|buserelin|mesh-list
138602352|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138602353|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602354|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602355|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138602356|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
138602357|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
138602358|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
138602359|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
138602360|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138602361|NCT00162734|Interferons|interferons|mesh-list
138602362|NCT00162734|Ribavirin|ribavirin|mesh-list
138602363|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
138602364|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602365|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
138602366|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602367|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
138602368|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602369|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138256601|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
138602370|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
138602371|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602372|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138486722|NCT00000147|Prednisone|prednisone|mesh-list
138602374|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138602375|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602376|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138602377|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138602378|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138456477|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
138602379|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602380|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
138602381|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138602382|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602383|NCT04015414|Varenicline|varenicline|mesh-list
138602384|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138602385|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138602386|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
138602387|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602388|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602389|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602390|NCT00185835|Gefitinib|gefitinib|mesh-list
138602391|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602392|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138602393|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602394|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602395|NCT00162968|Escitalopram|escitalopram|mesh-list
138602396|NCT00162968|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138602397|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138602398|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602399|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602400|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602401|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
138602402|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602404|NCT03970330|Norethindrone|norethindrone|mesh-list
138602405|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
138602406|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138602407|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138602408|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602409|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
138602410|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602411|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138602412|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138602413|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138602414|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
138602415|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138188364|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138602417|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138602418|NCT00185874|Immunomodulating Agents|immunomodulating agents|mesh-list
138602419|NCT00185874|Immunologic Factors|immunologic factors|mesh-ancestor
138602420|NCT00185874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138650871|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138602422|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
138602423|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138602424|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
138602425|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602426|NCT03757585|Expectorants|expectorants|mesh-ancestor
138602427|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
138602428|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138602429|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
138602430|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602431|NCT03757585|Protective Agents|protective agents|mesh-ancestor
138602432|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602433|NCT03757585|Antidotes|antidotes|mesh-ancestor
138602434|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
138602435|NCT03757585|Vitamins|vitamins|mesh-ancestor
138602436|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
138602437|NCT00163046|Gabapentin|gabapentin|mesh-list
138602438|NCT00163046|Analgesics|analgesics|mesh-ancestor
138602439|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
138602440|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602441|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602442|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
138602443|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138602444|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138602445|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138602446|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138456479|NCT01912118|Narcotics|narcotics|mesh-ancestor
138602447|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138602448|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138602449|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602450|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602451|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
138602452|NCT00185952|Nifedipine|nifedipine|mesh-list
138602453|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138602454|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602455|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602456|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138602458|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
138602459|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
138602460|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138602461|NCT03541447|Octreotide|octreotide|mesh-list
138602462|NCT03541447|Tolvaptan|tolvaptan|mesh-list
138602463|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138602464|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138602465|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318317|NCT01405950|Clonidine|clonidine|mesh-list
138602466|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138602467|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602468|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
138602469|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602470|NCT00192621|Lamivudine|lamivudine|mesh-list
138602471|NCT00192621|Zidovudine|zidovudine|mesh-list
138650890|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138650891|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
138650892|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602472|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138602473|NCT00192621|Lopinavir|lopinavir|mesh-list
138602474|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138602475|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138602476|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667282|NCT00470886|Telmisartan|telmisartan|mesh-list
138602477|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602478|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
138602479|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602480|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138602481|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138602482|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
138602483|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138602484|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138602485|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
138602486|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138602487|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138602488|NCT03516604|Citalopram|citalopram|mesh-list
138602489|NCT03516604|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138602490|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138602491|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602492|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602493|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138486750|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
138602496|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138602497|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
138602498|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138602499|NCT00185991|Gentamicins|gentamicins|mesh-list
138602500|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138602501|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602502|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138602503|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138650913|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650914|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602504|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602505|NCT03434158|Olaparib|olaparib|mesh-list
138456487|NCT01912378|Oxytocin|oxytocin|mesh-list
138602506|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138602507|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602508|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602509|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602510|NCT00163202|Atorvastatin|atorvastatin|mesh-list
138602511|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138602512|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138602513|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
138602514|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602515|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138602516|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138602517|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602518|NCT03318952|Lidocaine|lidocaine|mesh-list
138602519|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-list
138602520|NCT03318952|Carticaine|carticaine|mesh-list
138602521|NCT03318952|Anesthetics|anesthetics|mesh-list
138602522|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138602523|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602524|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
138602525|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602526|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138602527|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138602528|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138602529|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602530|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602531|NCT00192660|Ritonavir|ritonavir|mesh-list
138602532|NCT00192660|Nelfinavir|nelfinavir|mesh-list
138602533|NCT00192660|Indinavir|indinavir|mesh-list
138602534|NCT00192660|Saquinavir|saquinavir|mesh-list
138602535|NCT00192660|Amprenavir|amprenavir|mesh-list
138602536|NCT00192660|Tenofovir|tenofovir|mesh-list
138602537|NCT00192660|Lamivudine|lamivudine|mesh-list
138602538|NCT00192660|Zidovudine|zidovudine|mesh-list
138602539|NCT00192660|Nevirapine|nevirapine|mesh-list
138602540|NCT00192660|Abacavir|abacavir|mesh-list
138602542|NCT00192660|Stavudine|stavudine|mesh-list
138602543|NCT00192660|Tipranavir|tipranavir|mesh-list
138602544|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
138650954|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138650957|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
138602545|NCT00192660|Efavirenz|efavirenz|mesh-list
138602546|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138602547|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138602548|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
138602549|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602550|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602551|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138602552|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138602553|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
138602554|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602555|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138602556|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138602557|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138602558|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138602559|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
138602560|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138602561|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138602562|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138486760|NCT00001669|Mecasermin|mecasermin|mesh-list
138602563|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138602564|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138602566|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138602567|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138602568|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
138602569|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138602570|NCT00163241|Celecoxib|celecoxib|mesh-list
138602571|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138602572|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138602573|NCT00163241|Analgesics|analgesics|mesh-ancestor
138602574|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
138602575|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602576|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602577|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138602578|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138602579|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138602580|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138602581|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602582|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602583|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
138602584|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138602585|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138602586|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138602587|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138602588|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602589|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602590|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667418|NCT00431990|Bortezomib|bortezomib|mesh-list
138602591|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651008|NCT00305630|Triamcinolone|triamcinolone|mesh-list
138602592|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138602593|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
138602594|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138602596|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
138602598|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138602599|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602600|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138602601|NCT02812420|Durvalumab|durvalumab|mesh-list
138602602|NCT02812420|Ipilimumab|ipilimumab|mesh-list
138602603|NCT02812420|Tremelimumab|tremelimumab|mesh-list
138602604|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
138602605|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138602606|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
138602607|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138602608|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602609|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
138602610|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602611|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138602612|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602613|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
138602614|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
138602616|NCT02556931|Tacrolimus|tacrolimus|mesh-list
138602617|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138602618|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
138602619|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602620|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138602621|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138602622|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
138667439|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
138602623|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602624|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602625|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138602626|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138602627|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602628|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138602629|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138602630|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
138602631|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138602632|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602633|NCT00163358|Ciclesonide|ciclesonide|mesh-list
138602634|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
138602636|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138456510|NCT01912534|Valsartan|valsartan|mesh-list
138188365|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
138602637|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602638|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138602639|NCT00163397|Ciclesonide|ciclesonide|mesh-list
138602640|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
138602642|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138602643|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602644|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138602645|NCT00163436|Ciclesonide|ciclesonide|mesh-list
138602646|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
138602647|NCT00163436|Hormones|hormones|mesh-ancestor
138602648|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138602649|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602650|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138602651|NCT00186420|Docetaxel|docetaxel|mesh-list
138602652|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602653|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
138602654|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
138602655|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
138602656|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602657|NCT00163514|Ciclesonide|ciclesonide|mesh-list
138602658|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
138602659|NCT00163514|Hormones|hormones|mesh-ancestor
138667483|NCT00471393|Protective Agents|protective agents|mesh-ancestor
138602660|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138602661|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602662|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138602663|NCT00717652|Triamcinolone|triamcinolone|mesh-list
138602664|NCT00717652|Tretinoin|tretinoin|mesh-list
138602665|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138602666|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
138602667|NCT00717652|Hormones|hormones|mesh-ancestor
138602668|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138602669|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602670|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602671|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
138602672|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
138602673|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
138602674|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
138602675|NCT00066040|Fluorides|fluorides|mesh-list
138602676|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
138602677|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
138602678|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
138602679|NCT00066040|Protective Agents|protective agents|mesh-ancestor
138602680|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602681|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138602682|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602683|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
138602684|NCT00163553|Meperidine|meperidine|mesh-list
138602685|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138602686|NCT00163553|Narcotics|narcotics|mesh-ancestor
138651045|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651046|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
138651049|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
138602687|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138602689|NCT00163553|Analgesics|analgesics|mesh-ancestor
138602690|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
138602691|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602692|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138602693|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138602694|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
138602695|NCT00163592|Coagulants|coagulants|mesh-ancestor
138602696|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
138602697|NCT04683445|Trastuzumab|trastuzumab|mesh-list
138602698|NCT04683445|Pertuzumab|pertuzumab|mesh-list
138602699|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138602700|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602701|NCT04683445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138602702|NCT04683445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602703|NCT00192777|Capecitabine|capecitabine|mesh-list
138602704|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138602705|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
138602706|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602707|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602708|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
138602709|NCT00553072|Analgesics|analgesics|mesh-ancestor
138602710|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
138602711|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667525|NCT00463086|Isoniazid|isoniazid|mesh-list
138602712|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602713|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
138602714|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138602715|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138602716|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
138602717|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138602718|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602719|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602720|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138602721|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
138602722|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138602723|NCT05808387|Resveratrol|resveratrol|mesh-list
138602724|NCT05808387|Antioxidants|antioxidants|mesh-ancestor
138602725|NCT05808387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602726|NCT05808387|Protective Agents|protective agents|mesh-ancestor
138651072|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602731|NCT05808231|Antimalarials|antimalarials|mesh-ancestor
138602732|NCT05808231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138602733|NCT05808231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138602734|NCT05808231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602735|NCT05808231|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138602736|NCT05808231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602737|NCT05808231|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138602738|NCT05808231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602739|NCT05808231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138602740|NCT05808231|Analgesics|analgesics|mesh-ancestor
138602741|NCT05808231|Sensory System Agents|sensory system agents|mesh-ancestor
138602742|NCT05808192|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138602743|NCT05808192|Immunologic Factors|immunologic factors|mesh-ancestor
138602744|NCT05808192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602745|NCT05808049|Antioxidants|antioxidants|mesh-list
138602746|NCT05808049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602747|NCT05808049|Protective Agents|protective agents|mesh-ancestor
138602748|NCT05808049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602750|NCT05807945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138602751|NCT05807945|Anesthetics, Local|anesthetics, local|mesh-ancestor
138602752|NCT05807945|Anesthetics|anesthetics|mesh-ancestor
138602753|NCT05807945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138602754|NCT05807945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602755|NCT05807945|Sensory System Agents|sensory system agents|mesh-ancestor
138602756|NCT05807945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602757|NCT05807893|Bevacizumab|bevacizumab|mesh-list
138602758|NCT05807893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138602759|NCT05807893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602760|NCT05807893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138602761|NCT05807893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138667554|NCT00463203|Bevacizumab|bevacizumab|mesh-list
138602762|NCT05807893|Growth Substances|growth substances|mesh-ancestor
138602763|NCT05807893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602764|NCT05807893|Growth Inhibitors|growth inhibitors|mesh-ancestor
138602765|NCT05807880|Capecitabine|capecitabine|mesh-list
138602766|NCT05807880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138602767|NCT05807880|Antimetabolites|antimetabolites|mesh-ancestor
138602768|NCT05807880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602769|NCT05807880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602771|NCT05807776|Tislelizumab|tislelizumab|mesh-list
138602772|NCT05807776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602773|NCT05807776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138602774|NCT05807776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602775|NCT05807776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602776|NCT05807776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138651104|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138602782|NCT05807659|Busulfan|busulfan|mesh-list
138602783|NCT05807659|Alkylating Agents|alkylating agents|mesh-ancestor
138335980|NCT00939120|Dutasteride|dutasteride|mesh-list
138602784|NCT05807659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602785|NCT05807659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138602786|NCT05807659|Immunologic Factors|immunologic factors|mesh-ancestor
138602787|NCT05807659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602788|NCT05807659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138602789|NCT05807659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602790|NCT05807659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138602792|NCT05807542|Carboplatin|carboplatin|mesh-list
138602793|NCT05807542|Tislelizumab|tislelizumab|mesh-list
138602794|NCT05807542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138602795|NCT05807542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602796|NCT05807542|Tubulin Modulators|tubulin modulators|mesh-ancestor
138602797|NCT05807542|Antimitotic Agents|antimitotic agents|mesh-ancestor
138602798|NCT05807542|Mitosis Modulators|mitosis modulators|mesh-ancestor
138602799|NCT05807542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602800|NCT05807542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138602801|NCT05807503|Cerebrolysin|cerebrolysin|mesh-list
138602802|NCT05807503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138602803|NCT05807503|Protective Agents|protective agents|mesh-ancestor
138602804|NCT05807503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602805|NCT05807503|Nootropic Agents|nootropic agents|mesh-ancestor
138602806|NCT05807425|Polidocanol|polidocanol|mesh-list
138602807|NCT05807425|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138602808|NCT05807425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138602809|NCT05807347|Cytarabine|cytarabine|mesh-list
138602810|NCT05807347|Azacitidine|azacitidine|mesh-list
138602811|NCT05807347|Venetoclax|venetoclax|mesh-list
138602812|NCT05807347|Aclacinomycins|aclacinomycins|mesh-list
138602813|NCT05807347|Lenograstim|lenograstim|mesh-list
138486807|NCT00001723|Orlistat|orlistat|mesh-list
138602814|NCT05807347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138602816|NCT05807347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602817|NCT05807347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602818|NCT05807347|Antiviral Agents|antiviral agents|mesh-ancestor
138602819|NCT05807347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602820|NCT05807347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138602821|NCT05807347|Immunologic Factors|immunologic factors|mesh-ancestor
138602822|NCT05807347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602823|NCT05807347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602824|NCT05807347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138602825|NCT05807347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138602826|NCT05807165|Memantine|memantine|mesh-list
138602827|NCT05807165|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138602828|NCT05807165|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138602829|NCT05807165|Dopamine Agents|dopamine agents|mesh-ancestor
138602830|NCT05807165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602831|NCT05807165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602832|NCT05807165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602833|NCT05807165|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138602834|NCT05807165|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138602835|NCT05807100|Salicylic Acid|salicylic acid|mesh-list
138602836|NCT05807100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602837|NCT05807100|Antifungal Agents|antifungal agents|mesh-ancestor
138602838|NCT05807100|Keratolytic Agents|keratolytic agents|mesh-ancestor
138651123|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138602839|NCT05807100|Dermatologic Agents|dermatologic agents|mesh-ancestor
138602842|NCT05807035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602844|NCT05781698|Fenofibrate|fenofibrate|mesh-list
138602845|NCT05781698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138602846|NCT05781698|Antimetabolites|antimetabolites|mesh-ancestor
138602847|NCT05781698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602848|NCT05781698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138602849|NCT05781698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138602850|NCT05781698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138602851|NCT05781698|Analgesics|analgesics|mesh-ancestor
138602852|NCT05781698|Sensory System Agents|sensory system agents|mesh-ancestor
138602853|NCT05781698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602854|NCT05781698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602855|NCT05781698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138602856|NCT05781698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138602857|NCT05709509|Aspirin|aspirin|mesh-list
138602858|NCT05709509|Colchicine|colchicine|mesh-list
138602859|NCT05709509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138602860|NCT05709509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138602861|NCT05709509|Analgesics|analgesics|mesh-ancestor
138602862|NCT05709509|Sensory System Agents|sensory system agents|mesh-ancestor
138279211|NCT03019640|Antibodies|antibodies|mesh-list
138602863|NCT05709509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602864|NCT05709509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602865|NCT05709509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138602866|NCT05709509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138602867|NCT05709509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138602868|NCT05709509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138602869|NCT05709509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602870|NCT05709509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138602871|NCT05709509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138602872|NCT05709509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602873|NCT05709509|Antipyretics|antipyretics|mesh-ancestor
138602875|NCT05709509|Tubulin Modulators|tubulin modulators|mesh-ancestor
138602876|NCT05709509|Antimitotic Agents|antimitotic agents|mesh-ancestor
138602877|NCT05709509|Mitosis Modulators|mitosis modulators|mesh-ancestor
138602878|NCT05709509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602879|NCT05693844|Paclitaxel|paclitaxel|mesh-list
138602880|NCT05693844|Cyclophosphamide|cyclophosphamide|mesh-list
138602881|NCT05693844|Fludarabine|fludarabine|mesh-list
138602882|NCT05693844|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138602883|NCT05693844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138602884|NCT05693844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602885|NCT05693844|Tubulin Modulators|tubulin modulators|mesh-ancestor
138602886|NCT05693844|Antimitotic Agents|antimitotic agents|mesh-ancestor
138602887|NCT05693844|Mitosis Modulators|mitosis modulators|mesh-ancestor
138602888|NCT05693844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602889|NCT05693844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138602891|NCT05693844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602892|NCT05693844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138602893|NCT05693844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138602894|NCT05693844|Alkylating Agents|alkylating agents|mesh-ancestor
138602895|NCT05693844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138602896|NCT05674513|Ulipristal acetate|ulipristal acetate|mesh-list
138602897|NCT05674513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138602898|NCT05674513|Contraceptive Agents|contraceptive agents|mesh-ancestor
138602899|NCT05674513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138602900|NCT05674513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602901|NCT05674513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138602902|NCT05644340|Methamphetamine|methamphetamine|mesh-list
138602903|NCT05644340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138602904|NCT05644340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602905|NCT05644340|Sympathomimetics|sympathomimetics|mesh-ancestor
138602906|NCT05644340|Autonomic Agents|autonomic agents|mesh-ancestor
138602907|NCT05644340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602908|NCT05644340|Dopamine Agents|dopamine agents|mesh-ancestor
138602909|NCT05644340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602910|NCT05644340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602911|NCT05644340|Adrenergic Agents|adrenergic agents|mesh-ancestor
138602912|NCT05644340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138602913|NCT05644340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138602914|NCT05644340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602915|NCT05644340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138602916|NCT05627947|Cyclosporine|cyclosporine|mesh-list
138602917|NCT05627947|Mitomycins|mitomycins|mesh-list
138602918|NCT05627947|Mitomycin|mitomycin|mesh-list
138602919|NCT05627947|Cyclosporins|cyclosporins|mesh-list
138602920|NCT05627947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602921|NCT05627947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602922|NCT05627947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138602923|NCT05627947|Immunologic Factors|immunologic factors|mesh-ancestor
138602924|NCT05627947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651169|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138651170|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138602925|NCT05627947|Antifungal Agents|antifungal agents|mesh-ancestor
138602926|NCT05627947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138602927|NCT05627947|Dermatologic Agents|dermatologic agents|mesh-ancestor
138602928|NCT05627947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138602929|NCT05627947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138602930|NCT05627947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138602931|NCT05627947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602932|NCT05627947|Alkylating Agents|alkylating agents|mesh-ancestor
138602933|NCT05627947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138602934|NCT05617118|Baclofen|baclofen|mesh-list
138602935|NCT05617118|Botulinum Toxins|botulinum toxins|mesh-list
138602936|NCT05617118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138602937|NCT05617118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138602938|NCT05617118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138602939|NCT05617118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602940|NCT05617118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602941|NCT05617118|Cholinergic Agents|cholinergic agents|mesh-ancestor
138602942|NCT05617118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602943|NCT05617118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602944|NCT05617118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138602945|NCT05617118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602946|NCT05617118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138602947|NCT05617118|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138602948|NCT05617118|GABA Agonists|gaba agonists|mesh-ancestor
138602950|NCT05606341|1018 oligonucleotide|1018 oligonucleotide|mesh-list
138602951|NCT05606341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138602952|NCT05606341|Immunologic Factors|immunologic factors|mesh-ancestor
138602953|NCT05606341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602954|NCT05546658|Psilocybin|psilocybin|mesh-list
138602955|NCT05546658|Hallucinogens|hallucinogens|mesh-ancestor
138602956|NCT05546658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602957|NCT05546658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138602958|NCT05494580|Pamiparib|pamiparib|mesh-list
138602959|NCT05494580|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138602960|NCT05494580|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138602961|NCT05494580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138602962|NCT05494580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138602963|NCT05494580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602964|NCT05494580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602965|NCT05464654|Estrogens|estrogens|mesh-list
138602966|NCT05464654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138602967|NCT05464654|Hormones|hormones|mesh-ancestor
138602968|NCT05464654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138602969|NCT05464654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602970|NCT05267873|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138602971|NCT05267873|Vortioxetine|vortioxetine|mesh-list
138602972|NCT05267873|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138602973|NCT05267873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138602974|NCT05267873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138602975|NCT05267873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138602976|NCT05267873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138602977|NCT05267873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138602978|NCT05267873|Analgesics|analgesics|mesh-ancestor
138602979|NCT05267873|Sensory System Agents|sensory system agents|mesh-ancestor
138602980|NCT05267873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138602981|NCT05267873|Antidepressive Agents|antidepressive agents|mesh-ancestor
138602982|NCT05267873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138602983|NCT05267873|Dopamine Agents|dopamine agents|mesh-ancestor
138602984|NCT05267873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138602985|NCT05267873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138602986|NCT05267873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138602987|NCT05267873|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138602988|NCT05267873|Serotonin Agents|serotonin agents|mesh-ancestor
138602989|NCT05267873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138602990|NCT05267873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138602991|NCT05267873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138602992|NCT05267873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138602993|NCT05075603|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138602994|NCT05075603|Tisagenlecleucel|tisagenlecleucel|mesh-list
138602995|NCT05075603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138602996|NCT05075603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138602997|NCT05024214|Sunitinib|sunitinib|mesh-list
138602998|NCT05024214|Lenvatinib|lenvatinib|mesh-list
138602999|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603000|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138603001|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138603002|NCT05024214|Growth Substances|growth substances|mesh-ancestor
138486842|NCT00000177|Estrogens|estrogens|mesh-list
138603003|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603005|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138603006|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603007|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603008|NCT04999644|Nicotine|nicotine|mesh-list
138603009|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138603010|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
138279367|NCT02511535|Vaccines|vaccines|mesh-list
138603011|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603012|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603013|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138603014|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138603015|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
138603016|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138603017|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603018|NCT04962503|Afamelanotide|afamelanotide|mesh-list
138603019|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
138603020|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
138603021|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138603022|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
138603023|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603024|NCT04916080|Expectorants|expectorants|mesh-ancestor
138603025|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
138603026|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138603027|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
138603028|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603029|NCT04916080|Protective Agents|protective agents|mesh-ancestor
138603030|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603031|NCT04916080|Antidotes|antidotes|mesh-ancestor
138603032|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138603033|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138603034|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603035|NCT04833140|Estradiol|estradiol|mesh-list
138603036|NCT04833140|Estrogens|estrogens|mesh-ancestor
138603037|NCT04833140|Hormones|hormones|mesh-ancestor
138603038|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138603039|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603040|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138603041|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
138603042|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603043|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138603044|NCT04767841|Metformin|metformin|mesh-list
138603045|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138603046|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603047|NCT04761861|Vildagliptin|vildagliptin|mesh-list
138603048|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138603049|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603050|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138603051|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
138603052|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603053|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603054|NCT04716699|Lidocaine|lidocaine|mesh-list
138603055|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
138603056|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
138603057|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138603058|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603059|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
138603060|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603061|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138603062|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138603064|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138603065|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603067|NCT04685980|Anesthetics|anesthetics|mesh-list
138603068|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
138603069|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138603070|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603071|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138603072|NCT04685980|Narcotics|narcotics|mesh-ancestor
138603073|NCT04685980|Analgesics|analgesics|mesh-ancestor
138603074|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
138603075|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603076|NCT04657692|Anesthetics|anesthetics|mesh-list
138603077|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138603078|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603079|NCT04577690|Epinephrine|epinephrine|mesh-list
138603080|NCT04577690|Racepinephrine|racepinephrine|mesh-list
138603081|NCT04577690|Bupivacaine|bupivacaine|mesh-list
138603082|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
138603083|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
138603084|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
138603085|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138603086|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603087|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
138603088|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603089|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138603090|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138603091|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
138603092|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138603093|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603094|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138603095|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138603096|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
138603097|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138603098|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
138603099|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
138603100|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
138603101|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138603102|NCT04531176|Liraglutide|liraglutide|mesh-list
138603103|NCT04531176|Topiramate|topiramate|mesh-list
138603104|NCT04531176|Orlistat|orlistat|mesh-list
138603105|NCT04531176|Phentermine|phentermine|mesh-list
138603106|NCT04531176|Naltrexone|naltrexone|mesh-list
138603107|NCT04531176|Bupropion|bupropion|mesh-list
138603108|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138603109|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138603110|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603111|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
138603112|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603113|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138603114|NCT04531176|Incretins|incretins|mesh-ancestor
138603115|NCT04531176|Hormones|hormones|mesh-ancestor
138603116|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138603117|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138603118|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
138603119|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138603120|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138603121|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138603122|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138603123|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603124|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
138603125|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138603126|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138603127|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138603128|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603129|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
138603130|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138603131|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138603132|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138603133|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
138603134|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
138603135|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
138603136|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
138603138|NCT04472767|Ipilimumab|ipilimumab|mesh-list
138603140|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603141|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138603142|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603143|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
138603144|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603145|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
138603146|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
138603147|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
138603148|NCT04409860|Paclitaxel|paclitaxel|mesh-list
138603149|NCT04409860|Cisplatin|cisplatin|mesh-list
138603150|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138603151|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603152|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603153|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603154|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603155|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603156|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138603157|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
138603158|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603159|NCT04303390|Cefazolin|cefazolin|mesh-list
138603160|NCT04303390|Cefuroxime|cefuroxime|mesh-list
138603161|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
138279514|NCT00365287|Cyclosporine|cyclosporine|mesh-list
138603162|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138603163|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603164|NCT04075110|Montelukast|montelukast|mesh-list
138603165|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138603166|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
138603167|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138603168|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
138603169|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138667720|NCT01051349|Daclizumab|daclizumab|mesh-list
138603170|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603171|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138603172|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138603173|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651334|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603175|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138603176|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
138603177|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138603178|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603179|NCT03978689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138603180|NCT03978689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603181|NCT03816553|Apatinib|apatinib|mesh-list
138603182|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603183|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138603184|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603185|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603186|NCT03729245|Nivolumab|nivolumab|mesh-list
138603187|NCT03729245|Sunitinib|sunitinib|mesh-list
138603188|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138603189|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603190|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138603191|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603192|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138603193|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138603194|NCT03729245|Growth Substances|growth substances|mesh-ancestor
138603195|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603196|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
138603197|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138603198|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603199|NCT03712397|Irinotecan|irinotecan|mesh-list
138603200|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138603201|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138603202|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603203|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603204|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603205|NCT03557918|Tremelimumab|tremelimumab|mesh-list
138603206|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603207|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
138603208|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138603209|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603210|NCT03544099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138603211|NCT03544099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603213|NCT03528408|Ipilimumab|ipilimumab|mesh-list
138603214|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138603215|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603216|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138603217|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603218|NCT03501381|Aldesleukin|aldesleukin|mesh-list
138603219|NCT03501381|Interleukin-2|interleukin-2|mesh-list
138603220|NCT03501381|Entinostat|entinostat|mesh-list
138603221|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603222|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138603223|NCT03501381|Analgesics|analgesics|mesh-ancestor
138603224|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
138603225|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603226|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603227|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138603228|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138603229|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
138651335|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138603230|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603231|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138603232|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603233|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603234|NCT03478488|Gemcitabine|gemcitabine|mesh-list
138603235|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
138279591|NCT02616523|Analgesics|analgesics|mesh-ancestor
138603236|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138603237|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
138603238|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603239|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603240|NCT03406299|Leucovorin|leucovorin|mesh-list
138603241|NCT03406299|Gemcitabine|gemcitabine|mesh-list
138603242|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
138603243|NCT03406299|Tegafur|tegafur|mesh-list
138603244|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603245|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138603246|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
138603247|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603248|NCT03406299|Antidotes|antidotes|mesh-ancestor
138603249|NCT03406299|Protective Agents|protective agents|mesh-ancestor
138603250|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603251|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
138603252|NCT03406299|Vitamins|vitamins|mesh-ancestor
138603253|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
138603254|NCT03396445|Paclitaxel|paclitaxel|mesh-list
138603255|NCT03396445|Carboplatin|carboplatin|mesh-list
138603256|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
138603257|NCT03396445|Pemetrexed|pemetrexed|mesh-list
138603258|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138603259|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603260|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603261|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603262|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603263|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603264|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138603265|NCT03396445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138603266|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603267|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138603268|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138603269|NCT03355469|Metformin|metformin|mesh-list
138603270|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138603271|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603272|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
138603273|NCT03330028|Promethazine|promethazine|mesh-list
138603274|NCT03330028|Dexamethasone|dexamethasone|mesh-list
138603275|NCT03330028|Paclitaxel|paclitaxel|mesh-list
138603276|NCT03330028|Cisplatin|cisplatin|mesh-list
138603277|NCT03330028|Mitomycins|mitomycins|mesh-list
138603278|NCT03330028|Mitomycin|mitomycin|mesh-list
138603279|NCT03330028|Famotidine|famotidine|mesh-list
138603280|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138603281|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603282|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603283|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603284|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603285|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603286|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138603287|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
138651351|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
138603288|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
138603289|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667770|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
138603290|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603291|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138603292|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
138603293|NCT03330028|Hormones|hormones|mesh-ancestor
138603294|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138603295|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138603296|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138603297|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
138603298|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138603299|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603300|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138603301|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138603302|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138603303|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
138603304|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
138603305|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
138603306|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138603307|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
138603308|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
138603309|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138603310|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138603311|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
138603312|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
138603313|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138603314|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138603315|NCT03311555|Docetaxel|docetaxel|mesh-list
138603317|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603318|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603319|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603320|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603321|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603322|NCT03311555|Hormones|hormones|mesh-ancestor
138603323|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138603324|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603325|NCT03271866|Metformin|metformin|mesh-list
138603326|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138603327|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603328|NCT03217565|Tedizolid|tedizolid|mesh-list
138603329|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
138603330|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
138603331|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138603332|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603333|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138603334|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603335|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603336|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
138603337|NCT02992743|Fludarabine|fludarabine|mesh-list
138336535|NCT05395962|Carboplatin|carboplatin|mesh-list
138603338|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138603339|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
138603340|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603341|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138603342|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138603343|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
138651369|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
138651370|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
138603344|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603345|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603346|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138603347|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
138603348|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138603349|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603350|NCT02853344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138603351|NCT02853344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603352|NCT02738229|Valacyclovir|valacyclovir|mesh-list
138603353|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
138603354|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603355|NCT02675426|Upadacitinib|upadacitinib|mesh-list
138603356|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138603357|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138603358|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603359|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603360|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138603361|NCT02579473|Rotigotine|rotigotine|mesh-list
138603362|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
138603363|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
138603364|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138603365|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603366|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603367|NCT02401035|Pantoprazole|pantoprazole|mesh-list
138603368|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138603369|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138603370|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138603371|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603372|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603373|NCT02153944|Propranolol|propranolol|mesh-list
138603374|NCT02153944|Methylphenidate|methylphenidate|mesh-list
138603375|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138603376|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603377|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138603378|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138603379|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138603380|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603381|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
138603382|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138603383|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138603384|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138603385|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
138603386|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138603387|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138603388|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
138603389|NCT02060721|Macitentan|macitentan|mesh-list
138603390|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138603391|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138667807|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
138603392|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603393|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138603394|NCT01527149|Cytarabine|cytarabine|mesh-list
138603395|NCT01527149|Dexamethasone|dexamethasone|mesh-list
138603396|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
138603397|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
138603398|NCT01527149|Doxorubicin|doxorubicin|mesh-list
138603399|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138603400|NCT01527149|Methotrexate|methotrexate|mesh-list
138651388|NCT00330993|Mifepristone|mifepristone|mesh-list
138456571|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138603402|NCT01527149|Ofatumumab|ofatumumab|mesh-list
138603403|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138603404|NCT01527149|BB 1101|bb 1101|mesh-list
138603405|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138603406|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
138603407|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603408|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138603409|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138603410|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
138603411|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603412|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603413|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138603414|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138603415|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
138603416|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
138603417|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603418|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138603419|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
138603420|NCT01527149|Hormones|hormones|mesh-ancestor
138603421|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138603422|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138603423|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138603424|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138603425|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138603426|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603427|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138603428|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
138603429|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138651402|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138486936|NCT05640427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138603430|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138603431|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
138603432|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
138603433|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138603434|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138603435|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
138603436|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603437|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138603438|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603439|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603440|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603441|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
138603442|NCT01359956|Interferons|interferons|mesh-list
138603443|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
138603444|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
138603445|NCT01359956|Dacarbazine|dacarbazine|mesh-list
138603446|NCT01359956|Fotemustine|fotemustine|mesh-list
138603447|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603448|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
138603449|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603450|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
138603451|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603452|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138603453|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
138603454|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603455|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138603456|NCT01306045|Sunitinib|sunitinib|mesh-list
138603457|NCT01306045|Lapatinib|lapatinib|mesh-list
138603458|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603459|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138603460|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603461|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603462|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138603463|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138603464|NCT01306045|Growth Substances|growth substances|mesh-ancestor
138603465|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603466|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
138603467|NCT01196936|Tamoxifen|tamoxifen|mesh-list
138603468|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138603469|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
138603470|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138603471|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603472|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138603473|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603474|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138603475|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138603476|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138603477|NCT01075971|Buprenorphine|buprenorphine|mesh-list
138603478|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138603479|NCT01075971|Narcotics|narcotics|mesh-ancestor
138603480|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138603481|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603482|NCT01075971|Analgesics|analgesics|mesh-ancestor
138603483|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
138603484|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603485|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138603486|NCT00775749|Nicotine|nicotine|mesh-list
138603487|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138603488|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
138603489|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603490|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603491|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138603492|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138603493|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
138603494|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138603495|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603496|NCT00324922|Vancomycin|vancomycin|mesh-list
138603497|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138603498|NCT00324922|Trimethoprim|trimethoprim|mesh-list
138603499|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
138603500|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138603501|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603502|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138603503|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
138603504|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138651431|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603505|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138603506|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138651432|NCT00452192|Telmisartan|telmisartan|mesh-list
138603507|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667853|NCT00464256|Hormones|hormones|mesh-ancestor
138603508|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603510|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138603511|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138603512|NCT00192855|Entacapone|entacapone|mesh-list
138603513|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138603514|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138603515|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138603516|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603517|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603518|NCT00407186|Cisplatin|cisplatin|mesh-list
138603519|NCT00407186|Capecitabine|capecitabine|mesh-list
138603520|NCT00407186|Epirubicin|epirubicin|mesh-list
138603521|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603522|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138603523|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
138603524|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603525|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138603526|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138603527|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138603528|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603529|NCT00163748|Gemcitabine|gemcitabine|mesh-list
138603530|NCT00163748|Vinorelbine|vinorelbine|mesh-list
138603531|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138603532|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
138603533|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603534|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603535|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138603536|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603537|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603539|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
138603540|NCT00193011|Docetaxel|docetaxel|mesh-list
138603541|NCT00193011|Fluorouracil|fluorouracil|mesh-list
138603542|NCT00193011|Methotrexate|methotrexate|mesh-list
138603543|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138603544|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
138603545|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603546|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138603547|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138603548|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
138651444|NCT00334152|Casopitant|casopitant|mesh-list
138603549|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603550|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603551|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138603552|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603553|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603554|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603555|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
138603556|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138603557|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138603558|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
138603559|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138603560|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
138603561|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603562|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138667872|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
138486953|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138603563|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138603564|NCT00193089|Docetaxel|docetaxel|mesh-list
138603565|NCT00193089|Trastuzumab|trastuzumab|mesh-list
138603566|NCT00193089|Vinorelbine|vinorelbine|mesh-list
138603567|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603568|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603569|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603570|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603571|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603572|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138603573|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138603574|NCT00193167|Topotecan|topotecan|mesh-list
138603575|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138603576|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138603577|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603578|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603579|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603580|NCT00193245|Docetaxel|docetaxel|mesh-list
138603581|NCT00193245|Topotecan|topotecan|mesh-list
138603582|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603583|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603584|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603585|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603586|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603587|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138603588|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138603589|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603591|NCT00193284|Docetaxel|docetaxel|mesh-list
138603592|NCT00193284|Fluorouracil|fluorouracil|mesh-list
138603593|NCT00193284|Gefitinib|gefitinib|mesh-list
138603594|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603595|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603596|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
138160580|NCT00320749|Docetaxel|docetaxel|mesh-list
138603597|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603598|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603599|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
138603600|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138603601|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138603602|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
138603603|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603604|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138603605|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603606|NCT00163982|Norfloxacin|norfloxacin|mesh-list
138603607|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138603608|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603609|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138603610|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138603611|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279973|NCT02206152|Expectorants|expectorants|mesh-ancestor
138456582|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
138603612|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603613|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603614|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138486963|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138603615|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138603617|NCT00193323|Docetaxel|docetaxel|mesh-list
138603618|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138603619|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
138603620|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603621|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603622|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603623|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603624|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603625|NCT00193362|Paclitaxel|paclitaxel|mesh-list
138603626|NCT00193362|Vinorelbine|vinorelbine|mesh-list
138603627|NCT00193362|Carboplatin|carboplatin|mesh-list
138603628|NCT00193362|Gemcitabine|gemcitabine|mesh-list
138603629|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138603630|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603631|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603632|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603633|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603634|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603635|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138603636|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
138603637|NCT00193401|Topotecan|topotecan|mesh-list
138603638|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138603639|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138603640|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603641|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603642|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603643|NCT00553189|Topotecan|topotecan|mesh-list
138603644|NCT00553189|Veliparib|veliparib|mesh-list
138603645|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138603646|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138603647|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603648|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667924|NCT00433940|Prednisolone|prednisolone|mesh-list
138603649|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603650|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138603651|NCT00193440|Rituximab|rituximab|mesh-list
138603652|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138603653|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603654|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
138603655|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603656|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138603657|NCT05077969|Celecoxib|celecoxib|mesh-list
138603658|NCT05077969|Famotidine|famotidine|mesh-list
138603659|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138603660|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138603661|NCT05077969|Analgesics|analgesics|mesh-ancestor
138603662|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
138603663|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603664|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603665|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138603666|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138603667|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138603668|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138603669|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603670|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603671|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138603672|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138603673|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138603674|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
138603675|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
138603676|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138603677|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
138603678|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603680|NCT00164216|Mefloquine|mefloquine|mesh-list
138486991|NCT03295552|Decitabine|decitabine|mesh-list
138603681|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
138603682|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138603683|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138603684|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603685|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603686|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
138603687|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
138280051|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
138603688|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138603689|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
138603690|NCT00193557|Bortezomib|bortezomib|mesh-list
138603691|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603692|NCT00164255|Artesunate|artesunate|mesh-list
138603693|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
138603694|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
138603695|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
138603696|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138603697|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138603698|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603699|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603700|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
138603701|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
138603702|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138603703|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
138603704|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138603705|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603706|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603707|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138603708|NCT00409656|Basiliximab|basiliximab|mesh-list
138603709|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138603710|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
138603711|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603712|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
138603713|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138603714|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
138603715|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603716|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138603717|NCT04977232|Escitalopram|escitalopram|mesh-list
138603718|NCT04977232|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138603719|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138603720|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138603721|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603722|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138668006|NCT01050530|Tolvaptan|tolvaptan|mesh-list
138603723|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
138603724|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603725|NCT04974814|Atorvastatin|atorvastatin|mesh-list
138603726|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138603727|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138603728|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138603729|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
138603730|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603731|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138603732|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138603733|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603734|NCT00164411|Vaccines|vaccines|mesh-list
138603735|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138603736|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
138603737|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603738|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
138603739|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138603740|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603741|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138603742|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
138603743|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138603744|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603745|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603746|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603747|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
138603748|NCT00193674|Progestins|progestins|mesh-ancestor
138603749|NCT00193674|Hormones|hormones|mesh-ancestor
138603750|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138603751|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603752|NCT00164450|Isoniazid|isoniazid|mesh-list
138603753|NCT00164450|Rifapentine|rifapentine|mesh-list
138651538|NCT00334581|Irbesartan|irbesartan|mesh-list
138603754|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
138603755|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138603756|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603757|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138603758|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138603759|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
138603760|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603761|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138603762|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138603763|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
138603764|NCT00193869|Dexamethasone|dexamethasone|mesh-list
138603765|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138603767|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
138603768|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603769|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603770|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138603771|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
138603772|NCT00193869|Hormones|hormones|mesh-ancestor
138603773|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138603774|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138603775|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603776|NCT00176241|Paclitaxel|paclitaxel|mesh-list
138603777|NCT00176241|Gemcitabine|gemcitabine|mesh-list
138603778|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138603779|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603780|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603781|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603782|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603783|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603784|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138603785|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
138603786|NCT00164801|Diltiazem|diltiazem|mesh-list
138603787|NCT00164801|Baclofen|baclofen|mesh-list
138603788|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138603789|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603790|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138603791|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603792|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138603793|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
138603794|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
138603795|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138603796|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603797|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138603798|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138603800|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138603801|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
138603802|NCT00176280|Dexamethasone|dexamethasone|mesh-list
138603803|NCT00176280|Sargramostim|sargramostim|mesh-list
138603804|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138603805|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
138603806|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
138603807|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603808|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603809|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138603810|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
138603812|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138603813|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138603814|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603815|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
138603816|NCT04723940|Doxycycline|doxycycline|mesh-list
138603817|NCT04723940|Clindamycin|clindamycin|mesh-list
138603818|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
138603819|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
138603820|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138603821|NCT04723940|Cefadroxil|cefadroxil|mesh-list
138603822|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138603823|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603824|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
138603825|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138603826|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138487030|NCT05631925|Propofol|propofol|mesh-list
138603827|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138603828|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603829|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603830|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138603832|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138603833|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138603834|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138603835|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603836|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603837|NCT04641247|Niraparib|niraparib|mesh-list
138603838|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138280194|NCT00367874|Analgesics|analgesics|mesh-ancestor
138603839|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603840|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603841|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603842|NCT04635007|Misoprostol|misoprostol|mesh-list
138603843|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
138603844|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138603845|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138603846|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603847|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
138603848|NCT04635007|Coagulants|coagulants|mesh-ancestor
138603849|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138603850|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
138603851|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138603852|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603853|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138603854|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138603855|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
138603856|NCT00194064|Olanzapine|olanzapine|mesh-list
138603857|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
138603858|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
138603859|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138603860|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603861|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138603862|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138651587|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138651589|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138603863|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138603864|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138603865|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138603866|NCT00194064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138603867|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138603868|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138603869|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603870|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138603871|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
138603872|NCT00164996|Anesthetics|anesthetics|mesh-list
138603873|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138603874|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603875|NCT04418557|Antibodies|antibodies|mesh-list
138603876|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
138487076|NCT05519683|Serotonin Agents|serotonin agents|mesh-ancestor
138603877|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603879|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
138603880|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138603881|NCT00165035|Paclitaxel|paclitaxel|mesh-list
138603882|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138603883|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138603884|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603885|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603886|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603887|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603888|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603889|NCT00165074|Calfactant|calfactant|mesh-list
138603890|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138603891|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
138603892|NCT04307953|Saracatinib|saracatinib|mesh-list
138603893|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603894|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603895|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603896|NCT04297267|Gemcitabine|gemcitabine|mesh-list
138603897|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603898|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138603899|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
138603900|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603901|NCT00176475|Rituximab|rituximab|mesh-list
138603902|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138603903|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603904|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
138603905|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603906|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138603907|NCT00165191|Doxorubicin|doxorubicin|mesh-list
138603908|NCT00165191|Fluorouracil|fluorouracil|mesh-list
138603909|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603910|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138603911|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138603912|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138603913|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603914|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603916|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138603917|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138603918|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
138603919|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651622|NCT00335088|Iodine|iodine|mesh-list
138603920|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
138603921|NCT00165230|Thalidomide|thalidomide|mesh-list
138603922|NCT00165230|Temozolomide|temozolomide|mesh-list
138603923|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138603924|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
138603925|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603926|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
138603927|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138603928|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603929|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138603930|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138603931|NCT00165230|Growth Substances|growth substances|mesh-ancestor
138603932|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
138603933|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603934|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138603935|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
138603936|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603937|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
138603938|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
138603939|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
138487098|NCT05448820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138603940|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138603941|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138603942|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138603943|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603944|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603945|NCT00165308|Tamoxifen|tamoxifen|mesh-list
138603946|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138603947|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
138603948|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138603949|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603950|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138603951|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603952|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138603953|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138603954|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138603956|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138603957|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603958|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603959|NCT00176670|Midazolam|midazolam|mesh-list
138651627|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138603960|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138603961|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138603962|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138603963|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603964|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138603965|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138603966|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138603967|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138603968|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
138603970|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
138603971|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
138603972|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138603973|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603974|NCT00165464|Irinotecan|irinotecan|mesh-list
138603975|NCT00165464|Docetaxel|docetaxel|mesh-list
138603976|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603977|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138603978|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138603979|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138603980|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603981|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
138603982|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
138603983|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
138603984|NCT04082650|Vitamin D|vitamin d|mesh-list
138603985|NCT04082650|Vitamins|vitamins|mesh-ancestor
138603986|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
138280357|NCT05441761|Dexamethasone|dexamethasone|mesh-list
138487123|NCT02972476|Hormones|hormones|mesh-ancestor
138603987|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603988|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138603989|NCT00176787|Capecitabine|capecitabine|mesh-list
138603990|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138603991|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
138603992|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138603993|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603994|NCT00176943|Imiquimod|imiquimod|mesh-list
138603996|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
138603997|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138603998|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138603999|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
138604000|NCT03978208|Naproxen|naproxen|mesh-list
138604001|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138604002|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138604003|NCT03978208|Analgesics|analgesics|mesh-ancestor
138604004|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
138604005|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138651660|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138604006|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604007|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604008|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138604009|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
138604010|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138604011|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604012|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604013|NCT00165659|Donepezil|donepezil|mesh-list
138604014|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138604015|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604016|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604017|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
138604018|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604019|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604020|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
138604021|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
138604022|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
138604023|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138604024|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138604025|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604026|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604027|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604028|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138604029|NCT00165737|Donepezil|donepezil|mesh-list
138668367|NCT00436709|Paclitaxel|paclitaxel|mesh-list
138604030|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138604031|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604032|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604033|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
138604034|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604035|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604036|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
138604037|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138604038|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138604039|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604040|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
138604041|NCT03789916|Aspirin|aspirin|mesh-list
138604042|NCT03789916|Ticagrelor|ticagrelor|mesh-list
138604043|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138604044|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138604045|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138604046|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138604047|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
138604048|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604049|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604050|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604051|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138604052|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138604053|NCT03789916|Analgesics|analgesics|mesh-ancestor
138604054|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
138604055|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604056|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604057|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138604058|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138604059|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138604060|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138604061|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604063|NCT00165815|Donepezil|donepezil|mesh-list
138651684|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604064|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138604065|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604066|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604067|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
138604068|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604069|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604070|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
138604072|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138604073|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
138604074|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604075|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604076|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
138604077|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
138604078|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
138604079|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604080|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604081|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604082|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
138604083|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
138604084|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
138604085|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604086|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138604087|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604088|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604089|NCT00177060|Hydromorphone|hydromorphone|mesh-list
138604090|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138604091|NCT00177060|Narcotics|narcotics|mesh-ancestor
138604092|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138604093|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604094|NCT00177060|Analgesics|analgesics|mesh-ancestor
138604095|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
138604096|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604097|NCT03421639|Leuprolide|leuprolide|mesh-list
138604098|NCT03421639|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138604099|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138604100|NCT03421639|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138604101|NCT03421639|Fertility Agents|fertility agents|mesh-ancestor
138604102|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138604103|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604104|NCT03421639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138604105|NCT03421639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604106|NCT03421639|Hormones|hormones|mesh-ancestor
138604107|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604108|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138604109|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604110|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604111|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138604112|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
138604113|NCT00177099|Tacrolimus|tacrolimus|mesh-list
138604114|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138604115|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
138604116|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604117|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138604118|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604119|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138651707|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604121|NCT03413800|Lenalidomide|lenalidomide|mesh-list
138604122|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604123|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
138604124|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
138604125|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604126|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604127|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138604128|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
138604129|NCT03413800|Hormones|hormones|mesh-ancestor
138604130|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604131|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138604132|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604133|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
138604134|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138604135|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138604136|NCT03413800|Growth Substances|growth substances|mesh-ancestor
138604137|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
138604138|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138604139|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
138668476|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
138604140|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604141|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
138604142|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138604143|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604144|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138604145|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
138604146|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604147|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604148|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604149|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604150|NCT00537901|Bevacizumab|bevacizumab|mesh-list
138604151|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138604152|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604153|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138604154|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138604155|NCT00537901|Growth Substances|growth substances|mesh-ancestor
138604156|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604157|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
138604159|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138604160|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
138604161|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138604162|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138604164|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604165|NCT00166127|Protective Agents|protective agents|mesh-ancestor
138604166|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604167|NCT00194649|Miglustat|miglustat|mesh-list
138604168|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604169|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604170|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138604171|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138604172|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
138604173|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604174|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138604175|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138604176|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604177|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
138604178|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138604179|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651724|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604180|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138604181|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
138604182|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604183|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604184|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604185|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604187|NCT00177138|Tacrolimus|tacrolimus|mesh-list
138604188|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138604189|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
138604190|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604191|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138604192|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604193|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604194|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138604195|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604196|NCT05311774|Tramadol|tramadol|mesh-list
138604197|NCT05311774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138604198|NCT05311774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138604199|NCT05311774|Narcotics|narcotics|mesh-ancestor
138604200|NCT05311774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138604201|NCT05311774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604202|NCT05311774|Analgesics|analgesics|mesh-ancestor
138604203|NCT05311774|Sensory System Agents|sensory system agents|mesh-ancestor
138604204|NCT05311774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604205|NCT05311774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138604206|NCT05311774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138604207|NCT05311774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138280558|NCT02697188|Hormones|hormones|mesh-ancestor
138604208|NCT05311774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604209|NCT05311774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604210|NCT05311774|Antidepressive Agents|antidepressive agents|mesh-ancestor
138604211|NCT05311774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138604212|NCT05311774|Dopamine Agents|dopamine agents|mesh-ancestor
138604214|NCT00194727|Vinorelbine|vinorelbine|mesh-list
138604215|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138604216|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
138604217|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604218|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604219|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138604220|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
138604221|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
138604223|NCT00166400|Metoprolol|metoprolol|mesh-list
138604224|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138604225|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138604226|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
138604227|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
138604228|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604229|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604230|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138604231|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138604232|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138604233|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
138604234|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604235|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604236|NCT02042287|Metronidazole|metronidazole|mesh-list
138651736|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138604237|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138651737|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138604238|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604239|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138604240|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138604242|NCT05296213|Fluorides|fluorides|mesh-list
138604243|NCT05296213|Caseins|caseins|mesh-list
138604244|NCT05296213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138604245|NCT05296213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604246|NCT05296213|Cariostatic Agents|cariostatic agents|mesh-ancestor
138604247|NCT05296213|Protective Agents|protective agents|mesh-ancestor
138604248|NCT05296213|Chelating Agents|chelating agents|mesh-ancestor
138604249|NCT05296213|Sequestering Agents|sequestering agents|mesh-ancestor
138604250|NCT05296213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604251|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
138604252|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604253|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138604254|NCT00166478|Protective Agents|protective agents|mesh-ancestor
138604255|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604256|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138604257|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604258|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604259|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138604260|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138604261|NCT00166478|Analgesics|analgesics|mesh-ancestor
138604262|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
138604263|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604264|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604265|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138604266|NCT05282875|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138604267|NCT05282875|Immunologic Factors|immunologic factors|mesh-ancestor
138604268|NCT05282875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604269|NCT00194766|Temozolomide|temozolomide|mesh-list
138604270|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138604271|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
138604272|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604273|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604274|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
138604275|NCT00166556|Tacrolimus|tacrolimus|mesh-list
138604276|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138604277|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
138604278|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668633|NCT00438113|Atenolol|atenolol|mesh-list
138604279|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138604280|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604281|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604282|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138604283|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604285|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138604286|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
138651749|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138651750|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138604287|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604288|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604289|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604290|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138604291|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138604292|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138604293|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138604294|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138604295|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
138604296|NCT05259631|Propofol|propofol|mesh-list
138604297|NCT05259631|Sevoflurane|sevoflurane|mesh-list
138604298|NCT05259631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138604299|NCT05259631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138456623|NCT01913054|Fentanyl|fentanyl|mesh-list
138604300|NCT05259631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604301|NCT05259631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138604302|NCT05259631|Anesthetics, General|anesthetics, general|mesh-ancestor
138604303|NCT05259631|Anesthetics|anesthetics|mesh-ancestor
138604304|NCT05259631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138604305|NCT05259631|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138604306|NCT00408135|Telithromycin|telithromycin|mesh-list
138604307|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604308|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604309|NCT00407225|Difluprednate|difluprednate|mesh-list
138604310|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
138604311|NCT00407225|Hormones|hormones|mesh-ancestor
138604312|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604313|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604314|NCT05124067|Dexamethasone|dexamethasone|mesh-list
138604315|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
138604316|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
138604317|NCT05124067|Ondansetron|ondansetron|mesh-list
138604318|NCT05124067|BB 1101|bb 1101|mesh-list
138604319|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604320|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
138604321|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
138604322|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604323|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604324|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138604325|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
138604326|NCT05124067|Hormones|hormones|mesh-ancestor
138604327|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604328|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138604329|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604330|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
138604331|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604332|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604333|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138604334|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138604335|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138604336|NCT05124067|Analgesics|analgesics|mesh-ancestor
138604337|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
138604338|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138604339|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138604340|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138604341|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
138604342|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604343|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
138651773|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
138604344|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
138604345|NCT05124067|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138604346|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138604348|NCT00194883|Hormones|hormones|mesh-list
138604349|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604350|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604351|NCT02277184|Cisplatin|cisplatin|mesh-list
138604352|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604353|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
138604354|NCT00166829|Sirolimus|sirolimus|mesh-list
138604355|NCT00166829|Tacrolimus|tacrolimus|mesh-list
138604356|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138604357|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
138604358|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604359|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138604360|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604361|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604362|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138604363|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604364|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138604365|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
138604366|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604367|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604368|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
138604369|NCT00177333|Doxycycline|doxycycline|mesh-list
138604370|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604371|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604372|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
138604373|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138604374|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138604375|NCT00166868|Neomycin|neomycin|mesh-list
138604376|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604377|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604378|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138487257|NCT00000522|Diuretics|diuretics|mesh-ancestor
138604379|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604380|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604381|NCT00194961|Hormones|hormones|mesh-list
138604382|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604383|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604384|NCT00177372|Misoprostol|misoprostol|mesh-list
138604385|NCT00177372|Mifepristone|mifepristone|mesh-list
138604386|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138604387|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
138604388|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138604389|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604390|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138604391|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138604392|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
138604393|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138604394|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138604395|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138604396|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138604397|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
138604398|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138604399|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138604400|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
138604401|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604402|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
138604403|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138604404|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138604405|NCT04819399|Catumaxomab|catumaxomab|mesh-list
138604406|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138604407|NCT00177411|Hormones|hormones|mesh-list
138604408|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
138604409|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
138604410|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604411|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604412|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138604414|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604415|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138604416|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604417|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604418|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
138604419|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
138604420|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138604421|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604422|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
138604423|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604424|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138318370|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604425|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138604426|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138604427|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138604428|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604429|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604430|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604431|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138604432|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
138604433|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138604434|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
138604435|NCT04566250|Analgesics|analgesics|mesh-ancestor
138604436|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
138604437|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604438|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604439|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
138604440|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604441|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
138604442|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604443|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138604444|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138604445|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138604446|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138604447|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604448|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
138604449|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604450|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604452|NCT00177567|Valproic Acid|valproic acid|mesh-list
138604453|NCT00177567|Olanzapine|olanzapine|mesh-list
138604454|NCT00177567|Risperidone|risperidone|mesh-list
138604455|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
138604456|NCT00177567|Mirtazapine|mirtazapine|mesh-list
138668841|NCT00439166|Doxycycline|doxycycline|mesh-list
138604457|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
138604458|NCT00177567|Bupropion|bupropion|mesh-list
138604459|NCT00177567|Paroxetine|paroxetine|mesh-list
138604460|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138604461|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138604462|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
138604463|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604464|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604465|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138651806|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
138604467|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138604468|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138604469|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138604470|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138604471|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
138604472|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
138604473|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
138604474|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604475|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138604476|NCT00177567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138604477|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138604478|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138604479|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138604480|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
138604481|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138604482|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138604483|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138604485|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
138604486|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138604487|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
138604488|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138604489|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138604490|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138604491|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138604492|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
138604493|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
138604494|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138604495|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138604496|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138604498|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
138604499|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138604500|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138604501|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
138604502|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138604503|NCT00195156|Valproic Acid|valproic acid|mesh-list
138604504|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
138604505|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604506|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604507|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
138604508|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604509|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604510|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
138604511|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138604512|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138604513|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138604515|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138604516|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138604517|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604518|NCT00195000|Cytarabine|cytarabine|mesh-list
138604519|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
138604520|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138604521|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
138604522|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604523|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138651817|NCT00336531|Itraconazole|itraconazole|mesh-list
138651818|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
138604524|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
138604525|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604526|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138604527|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
138604528|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604529|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138604530|NCT00195000|Immunotoxins|immunotoxins|mesh-ancestor
138604531|NCT00195000|Immunoconjugates|immunoconjugates|mesh-ancestor
138604532|NCT00195195|Sirolimus|sirolimus|mesh-list
138604533|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604534|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604535|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138604536|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604537|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
138604538|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138604539|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
138604540|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604541|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
138604542|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138604543|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604544|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138604545|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
138604546|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604547|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604548|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604549|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604550|NCT00177684|Amphotericin B|amphotericin b|mesh-list
138604551|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138604552|NCT00177684|Amebicides|amebicides|mesh-ancestor
138604553|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138604554|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138604555|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604556|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604557|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
138604558|NCT00532090|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
138604559|NCT00532090|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138604560|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604561|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604562|NCT00195312|Bupivacaine|bupivacaine|mesh-list
138604563|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
138604564|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
138604565|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138604566|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604567|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
138604568|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604569|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138604570|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138604571|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
138604572|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604573|NCT03888079|Anesthetics|anesthetics|mesh-list
138604574|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
138604575|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
138604576|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138604577|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604578|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
138604579|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604581|NCT00167648|Goserelin|goserelin|mesh-list
138604582|NCT00167648|Estradiol|estradiol|mesh-list
138604583|NCT00167648|Estrogens|estrogens|mesh-ancestor
138604584|NCT00167648|Hormones|hormones|mesh-ancestor
138604585|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604586|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604587|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138651831|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
138651837|NCT00322062|Laxatives|laxatives|mesh-ancestor
138604588|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138604589|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
138604590|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138604591|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604592|NCT02906722|Colistin|colistin|mesh-list
138604593|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604594|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604595|NCT00167687|Prazosin|prazosin|mesh-list
138604596|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138604597|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138604598|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138604600|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
138604601|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604602|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604603|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604604|NCT02906995|Nicotine|nicotine|mesh-list
138604605|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138604606|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
138604607|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604608|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604609|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138604610|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138604611|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
138604612|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604613|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604614|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138604615|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
138604616|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604617|NCT02906800|Digoxin|digoxin|mesh-list
138604618|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138604619|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138604620|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604621|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604622|NCT02906800|Protective Agents|protective agents|mesh-ancestor
138604623|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604624|NCT00195468|Cyclosporine|cyclosporine|mesh-list
138604625|NCT00195468|Cyclosporins|cyclosporins|mesh-list
138604626|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604627|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604628|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138604630|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604631|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
138604632|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604633|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
138604634|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138604635|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138604637|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
138604638|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138604639|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138604640|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604641|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
138604642|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
138604643|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138604644|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
138604645|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138651842|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456649|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
138604646|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138651843|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138604647|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604648|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138604650|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604651|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138604652|NCT02906059|Irinotecan|irinotecan|mesh-list
138604653|NCT02906059|Adavosertib|adavosertib|mesh-list
138604654|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138604655|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138604656|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604657|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604658|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604660|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
138604661|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604662|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138604663|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138604664|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604665|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604666|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138604667|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
138604668|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604669|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604670|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138604671|NCT02905864|Liraglutide|liraglutide|mesh-list
138604672|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138604673|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604674|NCT02905864|Incretins|incretins|mesh-ancestor
138604675|NCT02905864|Hormones|hormones|mesh-ancestor
138604676|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604677|NCT00167882|Mesalamine|mesalamine|mesh-list
138604678|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138604679|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138604680|NCT00167882|Analgesics|analgesics|mesh-ancestor
138604681|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
138604682|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604683|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604684|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604685|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138604686|NCT02905708|Charcoal|charcoal|mesh-list
138604687|NCT02905708|Antidotes|antidotes|mesh-ancestor
138604688|NCT02905708|Protective Agents|protective agents|mesh-ancestor
138604689|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604690|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138604691|NCT00167921|Estrogens|estrogens|mesh-ancestor
138604692|NCT00167921|Hormones|hormones|mesh-ancestor
138604693|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604694|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604696|NCT00167960|Piperacillin|piperacillin|mesh-list
138604697|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138604698|NCT00167960|Lactams|lactams|mesh-list
138604699|NCT00167960|beta-Lactams|beta-lactams|mesh-list
138604700|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604701|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604702|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138604703|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604704|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604705|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
138604706|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138604707|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604709|NCT00167999|Piperacillin|piperacillin|mesh-list
138604710|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138604711|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604712|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604713|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138604714|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337987|NCT01110876|Vorinostat|vorinostat|mesh-list
138604715|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604716|NCT00177996|Sertraline|sertraline|mesh-list
138604717|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
138604718|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138604719|NCT00177996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138604720|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138604721|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138651931|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
138604722|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604723|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604724|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
138604725|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604726|NCT00168077|Thrombin|thrombin|mesh-list
138604727|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
138604728|NCT00168077|Coagulants|coagulants|mesh-ancestor
138604729|NCT00195585|Leucovorin|leucovorin|mesh-list
138604730|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
138604731|NCT00195585|Antidotes|antidotes|mesh-ancestor
138604732|NCT00195585|Protective Agents|protective agents|mesh-ancestor
138604733|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604734|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
138604735|NCT00195585|Vitamins|vitamins|mesh-ancestor
138604736|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
138604737|NCT02905045|Ketoprofen|ketoprofen|mesh-list
138604738|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138604739|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138604740|NCT02905045|Analgesics|analgesics|mesh-ancestor
138604741|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
138604742|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604743|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604744|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604745|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138604746|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138604747|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604748|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604749|NCT02904772|Cyclosporine|cyclosporine|mesh-list
138604750|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
138604751|NCT02904772|Prednisolone|prednisolone|mesh-list
138604752|NCT02904772|Cyclosporins|cyclosporins|mesh-list
138604753|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604754|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604755|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138604756|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
138604757|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604758|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
138604759|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138604760|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
138604761|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138604762|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138604763|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138604764|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604765|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138604766|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
138604767|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138604768|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138669333|NCT00441662|Triamcinolone|triamcinolone|mesh-list
138604769|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
138604770|NCT02904772|Hormones|hormones|mesh-ancestor
138604771|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604772|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138604773|NCT00195741|Valproic Acid|valproic acid|mesh-list
138604774|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
138604775|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604776|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604777|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
138604778|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604779|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604780|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
138604781|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138456660|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138604782|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138604784|NCT00178035|Paroxetine|paroxetine|mesh-list
138604785|NCT00178035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138604786|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138604787|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138604788|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604789|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604790|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
138604791|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604792|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138604793|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
138604794|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138604795|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138604796|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138604797|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604798|NCT02904538|Dexamethasone|dexamethasone|mesh-list
138604799|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604800|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
138604801|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
138604802|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604803|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604804|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138604805|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
138604806|NCT02904538|Hormones|hormones|mesh-ancestor
138604807|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138604808|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138604809|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604810|NCT02963103|Tacrolimus|tacrolimus|mesh-list
138604811|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138604812|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
138604813|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604814|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138604815|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604816|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604817|NCT00407264|Fluticasone|fluticasone|mesh-list
138604818|NCT00407264|Xhance|xhance|mesh-list
138604819|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604820|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138604821|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
138604822|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604823|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604824|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138604825|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
138604826|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
138604827|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138604828|NCT02904499|Dabigatran|dabigatran|mesh-list
138604829|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
138604830|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138604831|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
138604832|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604833|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669415|NCT00442052|Aspirin|aspirin|mesh-list
138604834|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
138604835|NCT00195780|Valproic Acid|valproic acid|mesh-list
138604836|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
138604837|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604838|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604839|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
138604840|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604841|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604843|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138604844|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138604845|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138604846|NCT00407342|Alefacept|alefacept|mesh-list
138604847|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
138604848|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
138604849|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604850|NCT00553423|Lactulose|lactulose|mesh-list
138604851|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138604852|NCT02904304|Ibuprofen|ibuprofen|mesh-list
138604853|NCT02904304|Phenylephrine|phenylephrine|mesh-list
138604854|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
138604855|NCT02904304|Desloratadine|desloratadine|mesh-list
138604856|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138604857|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138604859|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
138604860|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604861|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604862|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604863|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138604864|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138604865|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604866|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604867|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138604868|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
138604869|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
138604870|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
138604871|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138604872|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
138604873|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
138487351|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
138604874|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138604875|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138604876|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138604877|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
138604878|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604879|NCT02904304|Protective Agents|protective agents|mesh-ancestor
138604880|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138604881|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
138604882|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138604883|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138604884|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
138604886|NCT00407459|Bevacizumab|bevacizumab|mesh-list
138604887|NCT00407459|Carboplatin|carboplatin|mesh-list
138604888|NCT00407459|Pemetrexed|pemetrexed|mesh-list
138604889|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138604890|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604891|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138604892|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138258348|NCT01804075|Analgesics|analgesics|mesh-ancestor
138604893|NCT00407459|Growth Substances|growth substances|mesh-ancestor
138604894|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604895|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
138604896|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604897|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604898|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138604899|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138604900|NCT02904031|Leucovorin|leucovorin|mesh-list
138604901|NCT02904031|Fluorouracil|fluorouracil|mesh-list
138604902|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
138604903|NCT02904031|Panitumumab|panitumumab|mesh-list
138604904|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
138604905|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
138604906|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604907|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138604908|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604909|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138604910|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
138604911|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604912|NCT02904031|Antidotes|antidotes|mesh-ancestor
138604913|NCT02904031|Protective Agents|protective agents|mesh-ancestor
138604914|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
138604915|NCT02904031|Vitamins|vitamins|mesh-ancestor
138604916|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
138604917|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138604918|NCT02904109|Mannitol|mannitol|mesh-list
138604919|NCT02904109|Triflusal|triflusal|mesh-list
138604920|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138604921|NCT02904109|Diuretics|diuretics|mesh-ancestor
138604922|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
138604923|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604924|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138604925|NCT00178113|Lycopene|lycopene|mesh-list
138604926|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604927|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
138604928|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604929|NCT00178113|Protective Agents|protective agents|mesh-ancestor
138604930|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604931|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138604932|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138604933|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604935|NCT02903524|Doxorubicin|doxorubicin|mesh-list
138487375|NCT00000579|Hormones|hormones|mesh-ancestor
138604936|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138604937|NCT02903524|Pirarubicin|pirarubicin|mesh-list
138604938|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138604939|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
138604940|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604941|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138604942|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138604943|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
138604944|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604945|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604946|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138604947|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138669603|NCT00440349|Tamoxifen|tamoxifen|mesh-list
138604948|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138604950|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604951|NCT00168350|Memantine|memantine|mesh-list
138604952|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138604953|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138604954|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
138604955|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138604956|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604957|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604958|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138604959|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138604961|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138604962|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604963|NCT05995912|Naproxen|naproxen|mesh-list
138604964|NCT05995912|Etoricoxib|etoricoxib|mesh-list
138604965|NCT05995912|Tramadol|tramadol|mesh-list
138604966|NCT05995912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138604967|NCT05995912|Narcotics|narcotics|mesh-ancestor
138604968|NCT05995912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138604969|NCT05995912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604970|NCT05995912|Analgesics|analgesics|mesh-ancestor
138604971|NCT05995912|Sensory System Agents|sensory system agents|mesh-ancestor
138604972|NCT05995912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138604973|NCT05995912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138604974|NCT05995912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138604975|NCT05995912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604976|NCT05995912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138604977|NCT05995912|Gout Suppressants|gout suppressants|mesh-ancestor
138604978|NCT05995912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138669645|NCT03278522|Ramosetron|ramosetron|mesh-list
138604979|NCT05995912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138604980|NCT05995912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604981|NCT05995912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138604982|NCT05995691|Adalimumab|adalimumab|mesh-list
138604983|NCT05995691|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138604984|NCT05995691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138604985|NCT05995691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138604986|NCT05995522|Vitamin K|vitamin k|mesh-list
138604987|NCT05995522|Vitamin K 2|vitamin k 2|mesh-list
138604988|NCT05995522|Vitamins|vitamins|mesh-ancestor
138604989|NCT05995522|Micronutrients|micronutrients|mesh-ancestor
138604990|NCT05995522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138604991|NCT05995522|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138604992|NCT05995522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138456679|NCT01913808|Iron|iron|mesh-list
138604993|NCT05995522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138604994|NCT05995522|Hemostatics|hemostatics|mesh-ancestor
138604995|NCT05995522|Coagulants|coagulants|mesh-ancestor
138604996|NCT05995054|Obinutuzumab|obinutuzumab|mesh-list
138604997|NCT05995054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138604998|NCT05995054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138604999|NCT05994742|Pyridoxine|pyridoxine|mesh-list
138605000|NCT05994742|Vitamin B 6|vitamin b 6|mesh-list
138605001|NCT05994742|Azithromycin|azithromycin|mesh-list
138605002|NCT05994742|Rifampin|rifampin|mesh-list
138605003|NCT05994742|Isoniazid|isoniazid|mesh-list
138605004|NCT05994742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138605005|NCT05994742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138605006|NCT05994742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138605007|NCT05994742|Antitubercular Agents|antitubercular agents|mesh-ancestor
138605008|NCT05994742|Leprostatic Agents|leprostatic agents|mesh-ancestor
138605009|NCT05994742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138605010|NCT05994742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605011|NCT05994742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605013|NCT05994742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138605014|NCT05994742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138605015|NCT05994742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138605016|NCT05994742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138605017|NCT05994742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138605018|NCT05994742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138605019|NCT05994742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138605021|NCT05994742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138605022|NCT05994742|Vitamin B Complex|vitamin b complex|mesh-ancestor
138605023|NCT05994742|Vitamins|vitamins|mesh-ancestor
138605024|NCT05994742|Micronutrients|micronutrients|mesh-ancestor
138605025|NCT05994742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605026|NCT05994599|NuvaRing|nuvaring|mesh-list
138605027|NCT05994599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138605028|NCT05994599|Contraceptive Agents|contraceptive agents|mesh-ancestor
138281383|NCT05450497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138605029|NCT05994599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138605030|NCT05994599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605031|NCT05994547|Midazolam|midazolam|mesh-list
138605032|NCT05994547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138605033|NCT05994547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138605034|NCT05994547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605035|NCT05994547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605036|NCT05994547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138605037|NCT05994547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138605038|NCT05994547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138605039|NCT05994547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138605040|NCT05994547|Anesthetics, General|anesthetics, general|mesh-ancestor
138605041|NCT05994547|Anesthetics|anesthetics|mesh-ancestor
138605042|NCT05994547|GABA Modulators|gaba modulators|mesh-ancestor
138605043|NCT05994547|GABA Agents|gaba agents|mesh-ancestor
138605044|NCT05994547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138605045|NCT05994547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605046|NCT05994456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138605047|NCT05994456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605048|NCT05994456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605049|NCT05994456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605050|NCT05994131|Aflutinib|aflutinib|mesh-list
138605051|NCT05994131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138605052|NCT05994131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605053|NCT05994131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605054|NCT05994001|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138605055|NCT05994001|Immunologic Factors|immunologic factors|mesh-ancestor
138605056|NCT05994001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605057|NCT05983224|Quercetin|quercetin|mesh-list
138605058|NCT05983224|Antioxidants|antioxidants|mesh-ancestor
138605059|NCT05983224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605060|NCT05983224|Protective Agents|protective agents|mesh-ancestor
138605061|NCT05983224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605062|NCT05880459|Magnesium Sulfate|magnesium sulfate|mesh-list
138605063|NCT05880459|Nalbuphine|nalbuphine|mesh-list
138652033|NCT00307307|Niacin|niacin|mesh-list
138605066|NCT05880459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605067|NCT05880459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605069|NCT05880459|Anesthetics, General|anesthetics, general|mesh-ancestor
138605070|NCT05880459|Anesthetics|anesthetics|mesh-ancestor
138605071|NCT05880459|Analgesics|analgesics|mesh-ancestor
138605072|NCT05880459|Sensory System Agents|sensory system agents|mesh-ancestor
138605073|NCT05880459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605074|NCT05880459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138605075|NCT05880459|Anticonvulsants|anticonvulsants|mesh-ancestor
138605076|NCT05880459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138605077|NCT05880459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138605078|NCT05880459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605079|NCT05880459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138605081|NCT05880459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138605082|NCT05880459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138605084|NCT05864417|Sunscreening Agents|sunscreening agents|mesh-list
138605085|NCT05864417|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138605086|NCT05864417|Protective Agents|protective agents|mesh-ancestor
138605087|NCT05864417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605088|NCT05864417|Dermatologic Agents|dermatologic agents|mesh-ancestor
138605089|NCT05856136|Fentanyl|fentanyl|mesh-list
138605090|NCT05856136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138605091|NCT05856136|Narcotics|narcotics|mesh-ancestor
138605092|NCT05856136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605093|NCT05856136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605094|NCT05856136|Analgesics|analgesics|mesh-ancestor
138605095|NCT05856136|Sensory System Agents|sensory system agents|mesh-ancestor
138605096|NCT05856136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605097|NCT05856136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138605098|NCT05856136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138605099|NCT05856136|Anesthetics, General|anesthetics, general|mesh-ancestor
138605100|NCT05856136|Anesthetics|anesthetics|mesh-ancestor
138605101|NCT05812300|Hyaluronic Acid|hyaluronic acid|mesh-list
138605102|NCT05812300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138605103|NCT05812300|Immunologic Factors|immunologic factors|mesh-ancestor
138605104|NCT05812300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605105|NCT05812300|Viscosupplements|viscosupplements|mesh-ancestor
138605106|NCT05812300|Protective Agents|protective agents|mesh-ancestor
138605107|NCT05788016|Analgesics, Opioid|analgesics, opioid|mesh-list
138605108|NCT05788016|Narcotics|narcotics|mesh-ancestor
138605109|NCT05788016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605110|NCT05788016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605111|NCT05788016|Analgesics|analgesics|mesh-ancestor
138605112|NCT05788016|Sensory System Agents|sensory system agents|mesh-ancestor
138605113|NCT05788016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605114|NCT05755048|Trastuzumab|trastuzumab|mesh-list
138605115|NCT05755048|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138605116|NCT05755048|Maytansine|maytansine|mesh-list
138605117|NCT05755048|Antibodies|antibodies|mesh-list
138605118|NCT05755048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138605119|NCT05755048|Immunologic Factors|immunologic factors|mesh-ancestor
138605120|NCT05755048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605121|NCT05755048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605122|NCT05755048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605123|NCT05755048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138162575|NCT00382265|Tamsulosin|tamsulosin|mesh-list
138605124|NCT05755048|Tubulin Modulators|tubulin modulators|mesh-ancestor
138605125|NCT05755048|Antimitotic Agents|antimitotic agents|mesh-ancestor
138605126|NCT05755048|Mitosis Modulators|mitosis modulators|mesh-ancestor
138605127|NCT05755048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605129|NCT05755048|Immunoconjugates|immunoconjugates|mesh-ancestor
138605130|NCT05750199|Immunomodulating Agents|immunomodulating agents|mesh-list
138605131|NCT05750199|Immunologic Factors|immunologic factors|mesh-ancestor
138605132|NCT05750199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605133|NCT05706779|Cetuximab|cetuximab|mesh-list
138605134|NCT05706779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605135|NCT05706779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605136|NCT05622201|Rituximab|rituximab|mesh-list
138456691|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
138605137|NCT05622201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605138|NCT05622201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605139|NCT05622201|Immunologic Factors|immunologic factors|mesh-ancestor
138605140|NCT05622201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605141|NCT05622201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138605142|NCT05583708|Pembrolizumab|pembrolizumab|mesh-list
138605143|NCT05583708|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138605144|NCT05583708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605145|NCT05583708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605146|NCT05583708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138605147|NCT05583708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605148|NCT05583708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138605149|NCT05470699|Fluorides|fluorides|mesh-list
138605150|NCT05470699|Cariostatic Agents|cariostatic agents|mesh-ancestor
138605151|NCT05470699|Protective Agents|protective agents|mesh-ancestor
138605152|NCT05470699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605153|NCT05458453|Esketamine|esketamine|mesh-list
138605154|NCT05458453|Antidepressive Agents|antidepressive agents|mesh-ancestor
138605155|NCT05458453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138605156|NCT05438979|Calcium|calcium|mesh-list
138605157|NCT05438979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138605158|NCT05438979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605159|NCT05379803|Aflutinib|aflutinib|mesh-list
138605160|NCT05379803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138605161|NCT05379803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605162|NCT05379803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605163|NCT05365451|Metformin|metformin|mesh-list
138605164|NCT05365451|Probenecid|probenecid|mesh-list
138605165|NCT05365451|Furosemide|furosemide|mesh-list
138605166|NCT05365451|Cimetidine|cimetidine|mesh-list
138605167|NCT05365451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138605168|NCT05365451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605169|NCT05365451|Diuretics|diuretics|mesh-ancestor
138605170|NCT05365451|Natriuretic Agents|natriuretic agents|mesh-ancestor
138605171|NCT05365451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138605172|NCT05365451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138605173|NCT05365451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605174|NCT05365451|Uricosuric Agents|uricosuric agents|mesh-ancestor
138605175|NCT05365451|Gout Suppressants|gout suppressants|mesh-ancestor
138605176|NCT05365451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138605177|NCT05365451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138605178|NCT05365451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138605179|NCT05365451|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138605180|NCT05365451|Histamine Antagonists|histamine antagonists|mesh-ancestor
138281565|NCT00370591|Xhance|xhance|mesh-list
138605182|NCT05365451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138605183|NCT05365451|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138605184|NCT05365451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138605185|NCT05365451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605186|NCT05296070|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
138605187|NCT05296070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605188|NCT05296070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605189|NCT05294146|Clofazimine|clofazimine|mesh-list
138605190|NCT05294146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138605191|NCT05294146|Leprostatic Agents|leprostatic agents|mesh-ancestor
138605192|NCT05294146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138669879|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605193|NCT05294146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138605194|NCT05284591|Daratumumab|daratumumab|mesh-list
138605195|NCT05284591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605196|NCT05154747|Rilpivirine|rilpivirine|mesh-list
138605197|NCT05154747|Cabotegravir|cabotegravir|mesh-list
138605198|NCT05154747|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
138605199|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138605200|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138605201|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605202|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605203|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
138605204|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138605205|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138605206|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138605207|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138605208|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138605209|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
138605210|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138605211|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605212|NCT05131204|Eculizumab|eculizumab|mesh-list
138605213|NCT05131204|Ravulizumab|ravulizumab|mesh-list
138605214|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138605215|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138605216|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
138605217|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605218|NCT05106335|Docetaxel|docetaxel|mesh-list
138605219|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605220|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
138605221|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
138605222|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
138605223|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605224|NCT05090085|Z 350|z 350|mesh-list
138605225|NCT05090085|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138669957|NCT00441909|UC-781|uc-781|mesh-list
138605226|NCT05090085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138605228|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605229|NCT05090085|Hormone Antagonists|hormone antagonists|mesh-ancestor
138605230|NCT05090085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138605231|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605233|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138605234|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138605235|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605236|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
138605237|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605238|NCT04956094|Uric Acid|uric acid|mesh-list
138605239|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
138605240|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605241|NCT04956094|Protective Agents|protective agents|mesh-ancestor
138605242|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605243|NCT04929392|Paclitaxel|paclitaxel|mesh-list
138605244|NCT04929392|Carboplatin|carboplatin|mesh-list
138605245|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
138605246|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138605247|NCT04929392|Lenvatinib|lenvatinib|mesh-list
138605248|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138605249|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605250|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
138605251|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
138605252|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
138605253|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669967|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
138605254|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605255|NCT04929392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138605256|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138605257|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605258|NCT04831294|Cannabidiol|cannabidiol|mesh-list
138605259|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
138605260|NCT04828694|Naltrexone|naltrexone|mesh-list
138605261|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138605262|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138605263|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605264|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
138605265|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605266|NCT04820309|Xanomeline|xanomeline|mesh-list
138605267|NCT04820309|Trospium chloride|trospium chloride|mesh-list
138605268|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
138605269|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
138605270|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605271|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605272|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138605273|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138605274|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
138605275|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138605276|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605277|NCT04820309|Urological Agents|urological agents|mesh-ancestor
138605278|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138605279|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138605280|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138605281|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138605283|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
138605284|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138605285|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605286|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605287|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138605288|NCT04801589|Analgesics|analgesics|mesh-ancestor
138605289|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
138605290|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605291|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138605292|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138605293|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138605294|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
138487465|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605295|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138605296|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605297|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138605298|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138605299|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138605300|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138605301|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138605302|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
138605303|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
138605304|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
138605305|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
138605306|NCT04796948|Leucovorin|leucovorin|mesh-list
138605307|NCT04796948|Fluorouracil|fluorouracil|mesh-list
138605308|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
138605310|NCT04796948|Calcium|calcium|mesh-list
138605311|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
138605312|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138605313|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605314|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
138605315|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605316|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138605317|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605318|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138605319|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
138605320|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138605321|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138605322|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605323|NCT04796948|Antidotes|antidotes|mesh-ancestor
138605324|NCT04796948|Protective Agents|protective agents|mesh-ancestor
138605325|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
138605326|NCT04796948|Vitamins|vitamins|mesh-ancestor
138605327|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
138605328|NCT04692467|Amlodipine|amlodipine|mesh-list
138605329|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138605330|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138605331|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138605332|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605333|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138605334|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605335|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
138605338|NCT04692077|Cabotegravir|cabotegravir|mesh-list
138605339|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
138605340|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138605341|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138605342|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138605343|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605344|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605345|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138605346|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138605347|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138605348|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138605349|NCT04531982|Pimavanserin|pimavanserin|mesh-list
138605350|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138605351|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138605352|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138605353|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138605354|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605355|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605356|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138605357|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138605358|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138605359|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
138605360|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138605361|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605363|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605365|NCT04497961|Daratumumab|daratumumab|mesh-list
138605366|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
138605367|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605368|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138605369|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138605370|NCT04497961|Growth Substances|growth substances|mesh-ancestor
138605371|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
138605372|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605373|NCT04464629|Prednisolone|prednisolone|mesh-list
138605374|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138605375|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
138605376|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138605377|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
138605378|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138605379|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
138605380|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138605381|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
138605382|NCT04464629|Hormones|hormones|mesh-ancestor
138605383|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138605384|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605386|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605387|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
138605388|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
138605389|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605390|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138605391|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138605392|NCT04464629|Protective Agents|protective agents|mesh-ancestor
138605393|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
138605394|NCT04459416|Narcotics|narcotics|mesh-ancestor
138605395|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605396|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605397|NCT04459416|Analgesics|analgesics|mesh-ancestor
138605398|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
138605399|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605400|NCT04432935|Lactoferrin|lactoferrin|mesh-list
138605401|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138605402|NCT04414722|Amoxicillin|amoxicillin|mesh-list
138605403|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
138605404|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
138605405|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138605406|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138605407|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138605408|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138605409|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605410|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605411|NCT04392037|Dexamethasone|dexamethasone|mesh-list
138605412|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
138605413|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138605414|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
138605415|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605416|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138605417|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138605418|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
138605419|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605420|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605421|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138605422|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138605423|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
138605424|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
138605425|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605426|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138605427|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
138605428|NCT04392037|Hormones|hormones|mesh-ancestor
138605429|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138670175|NCT00480207|Vitamins|vitamins|mesh-ancestor
138605430|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138605433|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138605434|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605435|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605436|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138605437|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138605438|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605439|NCT04229368|Vitamin D|vitamin d|mesh-list
138605440|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
138605441|NCT04229368|Vitamins|vitamins|mesh-ancestor
138605442|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
138605443|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605444|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138605445|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138605446|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
138605447|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138605448|NCT03989271|Quercetin|quercetin|mesh-list
138605449|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
138605450|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605451|NCT03989271|Protective Agents|protective agents|mesh-ancestor
138605452|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605453|NCT03961334|Aspirin|aspirin|mesh-list
138605454|NCT03961334|Dabigatran|dabigatran|mesh-list
138605455|NCT03961334|Apixaban|apixaban|mesh-list
138605456|NCT03961334|Edoxaban|edoxaban|mesh-list
138605457|NCT03961334|Clopidogrel|clopidogrel|mesh-list
138605458|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138605459|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138605460|NCT03961334|Analgesics|analgesics|mesh-ancestor
138605461|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
138605462|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605463|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605464|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138605465|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138605466|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138605467|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138605468|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670241|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
138605469|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138605470|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138605471|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605472|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
138605473|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138605474|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138605475|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138605476|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
138605477|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138605478|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
138605479|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138605480|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
138605481|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
138605482|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138605483|NCT03933163|Resveratrol|resveratrol|mesh-list
138605484|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
138605485|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605486|NCT03933163|Protective Agents|protective agents|mesh-ancestor
138605487|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605488|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605489|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138605490|NCT03913104|Mifepristone|mifepristone|mesh-list
138605491|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138605492|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
138605493|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138605494|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605495|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138605496|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138605497|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138605498|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
138605499|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138605500|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138605501|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
138605502|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138605503|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
138605504|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138605505|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138605506|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
138605507|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
138605508|NCT03854370|Povidone|povidone|mesh-list
138605509|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138605510|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138605511|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
138605512|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
138605513|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
138605514|NCT03729349|Golimumab|golimumab|mesh-list
138605515|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138605516|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138605517|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138605518|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
138605519|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605520|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
138605521|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
138605522|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605523|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605524|NCT03598998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138605525|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605526|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138605527|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605528|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
138605529|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138605530|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138605531|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605533|NCT03553186|Coagulants|coagulants|mesh-ancestor
138605534|NCT03535298|Interferons|interferons|mesh-list
138605535|NCT03535298|Interferon-beta|interferon-beta|mesh-list
138605536|NCT03535298|Teriflunomide|teriflunomide|mesh-list
138605537|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
138605538|NCT03535298|Ofatumumab|ofatumumab|mesh-list
138605539|NCT03535298|Cladribine|cladribine|mesh-list
138605540|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
138605541|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138605542|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
138605543|NCT03535298|Natalizumab|natalizumab|mesh-list
138605544|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138605545|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
138605546|NCT03535298|Ozanimod|ozanimod|mesh-list
138605547|NCT03535298|Ponesimod|ponesimod|mesh-list
138605548|NCT03535298|Siponimod|siponimod|mesh-list
138605549|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605550|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605551|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
138605552|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605553|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138605554|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
138605555|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138652302|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
138605556|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138281912|NCT05277727|Fucoidan|fucoidan|mesh-list
138605557|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138605558|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605559|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
138605560|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138605561|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138605562|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138605564|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
138605565|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605566|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138605568|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138605569|NCT03493178|Glycine|glycine|mesh-list
138605570|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
138605571|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138605572|NCT03493178|Expectorants|expectorants|mesh-ancestor
138605573|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
138605574|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138605575|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
138605576|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605577|NCT03493178|Protective Agents|protective agents|mesh-ancestor
138605578|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605579|NCT03493178|Antidotes|antidotes|mesh-ancestor
138605580|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
138605581|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138605582|NCT03406650|Durvalumab|durvalumab|mesh-list
138605583|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605584|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605585|NCT03377725|Decitabine|decitabine|mesh-list
138605586|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
138605587|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138605588|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
138605589|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605590|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605591|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605592|NCT03346135|Melphalan|melphalan|mesh-list
138605593|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
138605594|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138605595|NCT03346135|Daratumumab|daratumumab|mesh-list
138605596|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138605597|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
138605598|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605599|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605600|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138605601|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138605602|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
138605603|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605604|NCT03282916|Valacyclovir|valacyclovir|mesh-list
138605605|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
138605606|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138605607|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
138605608|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605609|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605610|NCT03215693|Ensartinib|ensartinib|mesh-list
138605611|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605612|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138605613|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138652323|NCT00309374|Simvastatin|simvastatin|mesh-list
138605614|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605615|NCT03187106|Metronidazole|metronidazole|mesh-list
138605616|NCT03187106|Cephalexin|cephalexin|mesh-list
138605617|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138605618|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138605619|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138605620|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138605621|NCT03159702|Fludarabine|fludarabine|mesh-list
138605622|NCT03159702|Melphalan|melphalan|mesh-list
138605623|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605624|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605625|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138605626|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
138605627|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605628|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138605629|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
138670430|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
138605630|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138605631|NCT03044977|Octreotide|octreotide|mesh-list
138605632|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138605633|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138605634|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605635|NCT03009201|Doxorubicin|doxorubicin|mesh-list
138605636|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138605637|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138605638|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605639|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138605640|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138605641|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605642|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605643|NCT02985749|Oxytocin|oxytocin|mesh-list
138605644|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
138605645|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138605646|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605647|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
138605648|NCT02905591|Paclitaxel|paclitaxel|mesh-list
138605649|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138605650|NCT02905591|Carboplatin|carboplatin|mesh-list
138605651|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138605652|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605653|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
138605654|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
138605655|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
138605656|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605657|NCT02905591|Vitamins|vitamins|mesh-ancestor
138605658|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
138605659|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605660|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
138605661|NCT02905591|Protective Agents|protective agents|mesh-ancestor
138605662|NCT02635672|Pembrolizumab|pembrolizumab|mesh-list
138605663|NCT02635672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605664|NCT02635672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605665|NCT02635672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138605666|NCT02635672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605668|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
138605669|NCT02589600|Calcium|calcium|mesh-list
138605670|NCT02589600|Vitamins|vitamins|mesh-ancestor
138605671|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
138605672|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605673|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138605674|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138605675|NCT02222155|Cyclophosphamide|cyclophosphamide|mesh-list
138605676|NCT02222155|Rituximab|rituximab|mesh-list
138605677|NCT02222155|Glucocorticoids|glucocorticoids|mesh-list
138605678|NCT02222155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138605679|NCT02222155|Immunologic Factors|immunologic factors|mesh-ancestor
138605680|NCT02222155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605681|NCT02222155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138605682|NCT02222155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138605683|NCT02222155|Alkylating Agents|alkylating agents|mesh-ancestor
138605684|NCT02222155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605685|NCT02222155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605686|NCT02222155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138605687|NCT02222155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605688|NCT02222155|Hormones|hormones|mesh-ancestor
138605689|NCT02222155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138605690|NCT02020070|Ipilimumab|ipilimumab|mesh-list
138605691|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605692|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138670510|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138605693|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138605694|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605695|NCT01465100|Liver Extracts|liver extracts|mesh-list
138605696|NCT01465100|Hematinics|hematinics|mesh-ancestor
138605697|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
138605698|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
138605699|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
138605700|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605701|NCT01029002|Vitamin D|vitamin d|mesh-list
138605702|NCT01029002|Vitamins|vitamins|mesh-ancestor
138605703|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
138605704|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605705|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138605706|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138605707|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138605708|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138605709|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
138605710|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605711|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138605712|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138605713|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605714|NCT00799864|Tenofovir|tenofovir|mesh-list
138605715|NCT00799864|Lamivudine|lamivudine|mesh-list
138605717|NCT00799864|Zidovudine|zidovudine|mesh-list
138605718|NCT00799864|Abacavir|abacavir|mesh-list
138605719|NCT00799864|Rilpivirine|rilpivirine|mesh-list
138605720|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
138605721|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138605722|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138605723|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138605724|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605725|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605726|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138605727|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138605728|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
138605729|NCT00695279|Vaccines|vaccines|mesh-list
138605730|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
138605731|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605732|NCT00272714|Afimoxifene|afimoxifene|mesh-list
138605733|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605734|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138605735|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
138605736|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138487546|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
138605737|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605738|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138605739|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138605741|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
138605742|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
138605743|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605744|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605745|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
138652401|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138605746|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605747|NCT00178269|Docetaxel|docetaxel|mesh-list
138605748|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605749|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
138605750|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
138605751|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
138605752|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605753|NCT02903251|Oxytocin|oxytocin|mesh-list
138605754|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
138605755|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138605756|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605757|NCT00168467|Ramipril|ramipril|mesh-list
138605758|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138605760|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605761|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605762|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138605763|NCT00195936|Cinacalcet|cinacalcet|mesh-list
138605764|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138605765|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605766|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138605767|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
138605768|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138605769|NCT00168506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138605770|NCT00168506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138605771|NCT00168506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138605772|NCT00168506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605773|NCT00168506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138605774|NCT00168506|Serotonin Agents|serotonin agents|mesh-ancestor
138605775|NCT00168506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605776|NCT02902861|Methotrexate|methotrexate|mesh-list
138605777|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138605778|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
138605779|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138605780|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605781|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138605782|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
138605783|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605784|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605785|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
138605786|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605787|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138605788|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138605790|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138605791|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138605792|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
138605793|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138605794|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138605795|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605796|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
138605797|NCT02903017|Coagulants|coagulants|mesh-ancestor
138605798|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138605799|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138605800|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
138605801|NCT02902744|Hormones|hormones|mesh-ancestor
138605802|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138670623|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138605803|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605804|NCT00168584|Vitamin A|vitamin a|mesh-list
138605805|NCT00168584|Vitamins|vitamins|mesh-ancestor
138605806|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
138605807|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605808|NCT02902666|Acetaminophen|acetaminophen|mesh-list
138605809|NCT02902666|Codeine|codeine|mesh-list
138605810|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138605811|NCT02902666|Analgesics|analgesics|mesh-ancestor
138605812|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
138605813|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605814|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605815|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
138605816|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138605817|NCT02902666|Narcotics|narcotics|mesh-ancestor
138605818|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605819|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
138605820|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
138605821|NCT02902354|Nifedipine|nifedipine|mesh-list
138605822|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138605823|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138605824|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605825|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138605826|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605827|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
138605828|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
138605829|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138605830|NCT00168623|Vitamin A|vitamin a|mesh-list
138605831|NCT00168623|Vitamins|vitamins|mesh-ancestor
138605833|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605834|NCT02902315|Vitamins|vitamins|mesh-list
138605835|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
138605836|NCT02902315|Tocopherols|tocopherols|mesh-list
138605837|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
138605838|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
138605839|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605840|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
138605841|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605842|NCT02902315|Protective Agents|protective agents|mesh-ancestor
138605843|NCT02902432|Endostar protein|endostar protein|mesh-list
138605844|NCT02902432|Endostatins|endostatins|mesh-list
138670671|NCT00444015|Dasatinib|dasatinib|mesh-list
138605845|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138605846|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138605847|NCT02902432|Growth Substances|growth substances|mesh-ancestor
138605848|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605849|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
138605850|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605851|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
138605852|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605853|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605854|NCT02902042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138605855|NCT02902042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605856|NCT00168740|Rituximab|rituximab|mesh-list
138605857|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605858|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605859|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
138605860|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605861|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138605862|NCT00168779|Valsartan|valsartan|mesh-list
138605863|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138605864|NCT00168779|Telmisartan|telmisartan|mesh-list
138605865|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138605866|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138605867|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138605868|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605869|NCT00168779|Diuretics|diuretics|mesh-ancestor
138605870|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
138605871|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605872|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138652445|NCT00309881|Vincristine|vincristine|mesh-list
138605873|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138605874|NCT00196131|Morphine|morphine|mesh-list
138605875|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138605876|NCT00196131|Narcotics|narcotics|mesh-ancestor
138605877|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605878|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605879|NCT00196131|Analgesics|analgesics|mesh-ancestor
138605880|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
138605881|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605882|NCT00168896|Carboplatin|carboplatin|mesh-list
138605883|NCT00168896|Irinotecan|irinotecan|mesh-list
138605884|NCT00168896|Etoposide|etoposide|mesh-list
138605885|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605886|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138605887|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138605888|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605889|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605890|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138605891|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138605892|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
138605893|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
138605894|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605895|NCT02901379|Atorvastatin|atorvastatin|mesh-list
138605896|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138605897|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138605898|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
138605899|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605900|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138605901|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138605902|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605903|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138605904|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
138605905|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138605906|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
138605907|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605908|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
138605910|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138605911|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
138605912|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605913|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138605914|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138670881|NCT00460382|Ritonavir|ritonavir|mesh-list
138605915|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
138605916|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605917|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138652462|NCT00309881|Hormones|hormones|mesh-ancestor
138605918|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138605919|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605920|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138605921|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
138605922|NCT02901301|Capecitabine|capecitabine|mesh-list
138605923|NCT02901301|Trastuzumab|trastuzumab|mesh-list
138605924|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605925|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605926|NCT02901301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138605927|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605928|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138605929|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
138605931|NCT00169013|Analgesics|analgesics|mesh-ancestor
138605932|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
138605933|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605934|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605935|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
138605936|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138605937|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138605938|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605939|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138605940|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138605941|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138605942|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138605943|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605944|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
138605945|NCT00169091|Haloperidol|haloperidol|mesh-list
138605946|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
138605947|NCT00169091|Clozapine|clozapine|mesh-list
138605948|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
138605949|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
138605950|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138605951|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605952|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138605953|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138605954|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138605955|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138605956|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138605957|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138605958|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
138605959|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138605960|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605961|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138605962|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138605963|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
138605964|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
138605965|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
138605966|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
138605967|NCT00169130|Doxorubicin|doxorubicin|mesh-list
138605968|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138605969|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
138605970|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605971|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138605972|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138605973|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
138605974|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605975|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605976|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138605977|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138605978|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138605979|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138605980|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138605981|NCT00178620|Reteplase|reteplase|mesh-list
138605982|NCT00178620|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138605983|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138605984|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138605985|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138605987|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605988|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605989|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
138605990|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605991|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138605992|NCT00169208|Rituximab|rituximab|mesh-list
138605993|NCT00169208|Fludarabine|fludarabine|mesh-list
138605994|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
138605995|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138605996|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138605997|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
138605998|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138605999|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138606000|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606001|NCT00169208|Analgesics|analgesics|mesh-ancestor
138606002|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
138606003|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606004|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138606005|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138606006|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606007|NCT00178698|Interferons|interferons|mesh-list
138606008|NCT00178698|Gemcitabine|gemcitabine|mesh-list
138606009|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606010|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138606011|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
138606012|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606013|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
138606014|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606015|NCT00169247|Cetuximab|cetuximab|mesh-list
138606016|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606017|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138606018|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138606019|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
138606020|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606021|NCT02899507|Amoxicillin|amoxicillin|mesh-list
138606022|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138606023|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
138606024|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
138606025|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138606026|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606027|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138606028|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606029|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606030|NCT00178854|Risperidone|risperidone|mesh-list
138606031|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138606032|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
138606033|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606034|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606035|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606036|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138606037|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138606038|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138606039|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138606040|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138606041|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
138606042|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
138606043|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138606044|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
138606045|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138606046|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606047|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138606048|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138671219|NCT00222872|Hormones|hormones|mesh-list
138606049|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138606050|NCT02898961|Gentamicins|gentamicins|mesh-list
138606052|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138606053|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606054|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138606055|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606056|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606058|NCT00553618|Interleukin-2|interleukin-2|mesh-list
138606059|NCT00553618|Dacarbazine|dacarbazine|mesh-list
138606060|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606061|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138606062|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138606063|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
138606064|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606065|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138606066|NCT00553618|Analgesics|analgesics|mesh-ancestor
138606067|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
138606068|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606069|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606070|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138606071|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
138606072|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606073|NCT02898376|Tocopherols|tocopherols|mesh-list
138606074|NCT02898376|Vitamin E|vitamin e|mesh-list
138606075|NCT02898376|Tocotrienols|tocotrienols|mesh-list
138606076|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
138606077|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
138606078|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138606079|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606080|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606081|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138606082|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138606083|NCT02898376|Protective Agents|protective agents|mesh-ancestor
138606084|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606085|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
138606086|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138606087|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
138606088|NCT02898376|Vitamins|vitamins|mesh-ancestor
138606089|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
138606090|NCT00408174|Balsalazide|balsalazide|mesh-list
138282428|NCT04737967|Memantine|memantine|mesh-list
138606091|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138606092|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138606094|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
138606095|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606096|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606097|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138606098|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138606099|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138606100|NCT00169520|Docetaxel|docetaxel|mesh-list
138606101|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606102|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
138606103|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
138606104|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
138606105|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606106|NCT02897986|Vinorelbine|vinorelbine|mesh-list
138606107|NCT02897986|Propranolol|propranolol|mesh-list
138606108|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138606109|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606110|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
138606111|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
138606112|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
138606113|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606114|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138606115|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138606116|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
138606117|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606118|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606119|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138606120|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138606121|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
138606122|NCT00169559|Fenofibrate|fenofibrate|mesh-list
138606123|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138606124|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
138606125|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606126|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138606127|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
138606128|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138652543|NCT00310505|Amphotericin B|amphotericin b|mesh-list
138606129|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606130|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138606131|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
138606132|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138606133|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606134|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606135|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606136|NCT00408252|Sunitinib|sunitinib|mesh-list
138606137|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606138|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138606139|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138606140|NCT00408252|Growth Substances|growth substances|mesh-ancestor
138606141|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606142|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
138606143|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138606144|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606145|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606146|NCT02897869|Amikacin|amikacin|mesh-list
138606147|NCT02897869|Murepavadin|murepavadin|mesh-list
138606148|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138606149|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606150|NCT02897830|Dexamethasone|dexamethasone|mesh-list
138606151|NCT02897830|Lenalidomide|lenalidomide|mesh-list
138606152|NCT02897830|Ixazomib|ixazomib|mesh-list
138606153|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138606154|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
138606155|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
138606156|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138309230|NCT01545557|Lidocaine|lidocaine|mesh-list
138606157|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606158|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138606159|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
138606160|NCT02897830|Hormones|hormones|mesh-ancestor
138606161|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138606162|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138606163|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606164|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
138606165|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138606166|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138606167|NCT02897830|Growth Substances|growth substances|mesh-ancestor
138606168|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
138606169|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
138606170|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606171|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606172|NCT02897557|Pancrelipase|pancrelipase|mesh-list
138606173|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138606174|NCT02897596|Grazoprevir|grazoprevir|mesh-list
138606175|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
138606176|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606177|NCT04681027|Oxymorphone|oxymorphone|mesh-list
138606178|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138606179|NCT04681027|Narcotics|narcotics|mesh-ancestor
138606180|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138606181|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606182|NCT04681027|Analgesics|analgesics|mesh-ancestor
138606183|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
138606184|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606185|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138606186|NCT00408330|Azelaic acid|azelaic acid|mesh-list
138606187|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606188|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
138606189|NCT00408369|Pafuramidine|pafuramidine|mesh-list
138606190|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138606191|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138606192|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138606193|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606194|NCT02897206|Imipenem|imipenem|mesh-list
138606195|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
138606196|NCT02897206|Cilastatin|cilastatin|mesh-list
138606197|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138606198|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606199|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
138606200|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606201|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606202|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
138606203|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
138606204|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606205|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
138606206|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606207|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606208|NCT02897011|Methotrexate|methotrexate|mesh-list
138606209|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138606211|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138606212|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606213|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138606214|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
138606215|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606216|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606217|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
138606218|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606219|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138606220|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138606221|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
138606222|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138606223|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138606224|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
138606225|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138456815|NCT01914627|Analgesics|analgesics|mesh-ancestor
138606226|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606227|NCT00196599|Emtricitabine|emtricitabine|mesh-list
138606229|NCT00196599|Didanosine|didanosine|mesh-list
138606230|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
138606231|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606232|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138606233|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138259960|NCT05688215|Vitamins|vitamins|mesh-ancestor
138606235|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606236|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138606237|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138606238|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138606239|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138606240|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138606241|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138606242|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138606243|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138606245|NCT00178971|Buspirone|buspirone|mesh-list
138606246|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138606247|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138606248|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138606249|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606250|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138606251|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138606252|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
138606253|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606254|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606255|NCT02896621|Amlodipine|amlodipine|mesh-list
138606256|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
138606257|NCT02896621|Amiloride|amiloride|mesh-list
138606258|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138606259|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138606260|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138606261|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606262|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138606263|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606264|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
138606265|NCT02896621|Diuretics|diuretics|mesh-ancestor
138606266|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
138606267|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138606268|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138606269|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138606270|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138606271|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138606273|NCT02896582|Dexamethasone|dexamethasone|mesh-list
138606274|NCT02896582|Etoposide|etoposide|mesh-list
138606275|NCT02896582|Melphalan|melphalan|mesh-list
138606276|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
138606277|NCT02896582|Cisplatin|cisplatin|mesh-list
138606278|NCT02896582|Carmustine|carmustine|mesh-list
138606279|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138606280|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
138606281|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
138606282|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606283|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606284|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138606285|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
138606286|NCT02896582|Hormones|hormones|mesh-ancestor
138606287|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138606288|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138606289|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606290|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138606291|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138606292|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138606293|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606294|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606295|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138606296|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
138606297|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
138606298|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606299|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138606300|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
138606301|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138606302|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
138606303|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138606304|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138606306|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
138606307|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138606308|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606309|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
138606310|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606311|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
138606312|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606313|NCT02896270|Valproic Acid|valproic acid|mesh-list
138606314|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
138671782|NCT00491478|Sertraline|sertraline|mesh-list
138606315|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606316|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606317|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
138606318|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606319|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606320|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
138606321|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138606322|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138606323|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138606324|NCT00196677|Vitamins|vitamins|mesh-list
138606325|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
138606326|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606327|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138606328|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
138606329|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606330|NCT00169949|Aripiprazole|aripiprazole|mesh-list
138606331|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
138606332|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138487728|NCT00000717|Clindamycin|clindamycin|mesh-list
138606333|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138606334|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138606335|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138606336|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606337|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
138606338|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
138606339|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606340|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606341|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138606342|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138606343|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
138606344|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138606345|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138606346|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138606347|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138606348|NCT00196755|Calcium|calcium|mesh-list
138606349|NCT00196755|Sevelamer|sevelamer|mesh-list
138606350|NCT00196755|Calcium acetate|calcium acetate|mesh-list
138606351|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138606352|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606353|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
138606354|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
138318401|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606355|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606356|NCT00169988|Risperidone|risperidone|mesh-list
138606357|NCT00169988|Sertraline|sertraline|mesh-list
138606358|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138606359|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
138606360|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606361|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606362|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606363|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138606364|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138606365|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138606366|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138606367|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138606368|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
138606369|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
138606370|NCT00169988|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138606371|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138606372|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138606373|NCT02895529|Itraconazole|itraconazole|mesh-list
138606374|NCT02895529|Caspofungin|caspofungin|mesh-list
138606375|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
138606376|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606377|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138606378|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138606379|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606380|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606381|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138606382|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
138606383|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138606384|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606385|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138606386|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
138606387|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138606388|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138606389|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606390|NCT02895061|Vitamins|vitamins|mesh-ancestor
138606391|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
138606392|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138606394|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606395|NCT00170222|Doxycycline|doxycycline|mesh-list
138606396|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138606397|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606398|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
138606399|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138606400|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138606401|NCT02894983|Calpastatin|calpastatin|mesh-list
138606402|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138606403|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
138606404|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606405|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606406|NCT02895022|Lidocaine|lidocaine|mesh-list
138606407|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
138606408|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
138606409|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138606410|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606411|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
138606412|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606413|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138606414|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138606415|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138606416|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138606417|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606419|NCT00409851|Valsartan|valsartan|mesh-list
138606420|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138606421|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138606422|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138606423|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606424|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138606425|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606426|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
138606427|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138606428|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138606430|NCT00409890|Bromides|bromides|mesh-list
138606431|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138606432|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
138671888|NCT00592111|Bleomycin|bleomycin|mesh-list
138606433|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138606434|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
138606435|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
138606436|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606437|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606438|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138606439|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
138606440|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138606441|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
138606442|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606443|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606444|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138606445|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
138606446|NCT05423821|Anesthetics|anesthetics|mesh-list
138606447|NCT05423821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138606448|NCT05423821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606449|NCT00170378|Enoxaparin|enoxaparin|mesh-list
138606450|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
138606451|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138606452|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138606453|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606454|NCT00179244|Bupropion|bupropion|mesh-list
138606455|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138606456|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
138606457|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138487748|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
138606458|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138606459|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138606460|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138606461|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606462|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
138606463|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606464|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606465|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138652734|NCT00311636|Paclitaxel|paclitaxel|mesh-list
138606466|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138606468|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
138606470|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138606471|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
138606472|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606473|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138606474|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138606475|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
138606476|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606477|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606478|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138606479|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138606480|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138606481|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138606482|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606483|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138606484|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138606485|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
138606486|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606487|NCT00170456|Antacids|antacids|mesh-ancestor
138606488|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606489|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138606490|NCT00179283|Sertraline|sertraline|mesh-list
138606491|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138606492|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
138606493|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138606494|NCT00179283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138606495|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138606496|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138606497|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606498|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606499|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
138606500|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138652754|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
138606501|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138456830|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138456834|NCT01914744|Lamivudine|lamivudine|mesh-list
138606502|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138606503|NCT05420350|Lamotrigine|lamotrigine|mesh-list
138606504|NCT05420350|Bupropion|bupropion|mesh-list
138606505|NCT05420350|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138606506|NCT05420350|Antidepressive Agents|antidepressive agents|mesh-ancestor
138606507|NCT05420350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138606508|NCT05420350|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138606509|NCT05420350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138606510|NCT05420350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138606511|NCT05420350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606512|NCT05420350|Dopamine Agents|dopamine agents|mesh-ancestor
138606513|NCT05420350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606514|NCT05420350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606515|NCT05420350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138606516|NCT05420350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138606517|NCT05420350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606518|NCT05420350|Anticonvulsants|anticonvulsants|mesh-ancestor
138606519|NCT05420350|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138606520|NCT05420350|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138606521|NCT05420350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138606522|NCT05420350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138606523|NCT05420350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138606524|NCT05420350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138606525|NCT03014635|Botulinum Toxins|botulinum toxins|mesh-list
138606526|NCT03014635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138606527|NCT03014635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138606528|NCT03014635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138606529|NCT03014635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138606530|NCT03014635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606531|NCT03014635|Cholinergic Agents|cholinergic agents|mesh-ancestor
138606532|NCT03014635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606533|NCT03014635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606534|NCT03014635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138606536|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138606537|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138606538|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606539|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
138606540|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138606541|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138606542|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606544|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
138606545|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606546|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138606547|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138606548|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
138606549|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606550|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606551|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138606552|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
138606553|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606555|NCT00170690|Busulfan|busulfan|mesh-list
138606556|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138606557|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
138606558|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606559|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606560|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138606561|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
138606562|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606563|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138606564|NCT00196989|Pioglitazone|pioglitazone|mesh-list
138606565|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138606566|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606567|NCT00170729|Prednisolone|prednisolone|mesh-list
138296956|NCT00003992|Trastuzumab|trastuzumab|mesh-list
138606568|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138606569|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
138606570|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138606571|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
138606572|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138606573|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
138487764|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606574|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138606577|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138606578|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606579|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138606580|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606581|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
138606582|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
138606583|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606584|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138606585|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138606586|NCT00170729|Protective Agents|protective agents|mesh-ancestor
138606588|NCT00170768|Darifenacin|darifenacin|mesh-list
138606589|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
138606590|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
138606591|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606592|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606593|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138606594|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138606595|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
138606596|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606597|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606598|NCT00170768|Urological Agents|urological agents|mesh-ancestor
138606599|NCT02655562|Montelukast|montelukast|mesh-list
138606600|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138606601|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
138606602|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138606603|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
138606604|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138606605|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606606|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138606607|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138606608|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606610|NCT00170885|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138606611|NCT00170885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138606612|NCT00170885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606613|NCT00170885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606614|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138606615|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
138606616|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606617|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606618|NCT02607748|Listerine|listerine|mesh-list
138606619|NCT02607748|Fluorides|fluorides|mesh-list
138606620|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
138672068|NCT00492219|Cimetidine|cimetidine|mesh-list
138606621|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
138606622|NCT02607748|Protective Agents|protective agents|mesh-ancestor
138606623|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606624|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138487785|NCT00000744|Fluconazole|fluconazole|mesh-list
138606625|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606627|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
138606628|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606629|NCT02502253|Protective Agents|protective agents|mesh-ancestor
138606630|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606631|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606632|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138606633|NCT00170924|Valsartan|valsartan|mesh-list
138606634|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138606635|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138606636|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138606637|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606639|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138456845|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138606640|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138606641|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606642|NCT00170963|Amlodipine|amlodipine|mesh-list
138606643|NCT00170963|Valsartan|valsartan|mesh-list
138606644|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138606645|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138606646|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138672109|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138606647|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606648|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138606649|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606650|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
138606651|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138606652|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138606653|NCT02492776|Omeprazole|omeprazole|mesh-list
138606654|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138606655|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138606656|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138606657|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606658|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606659|NCT00171041|Valsartan|valsartan|mesh-list
138606660|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138606661|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138606662|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138606663|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606664|NCT05392699|Interleukin-12|interleukin-12|mesh-list
138606665|NCT05392699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138606666|NCT05392699|Immunologic Factors|immunologic factors|mesh-ancestor
138606667|NCT05392699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606668|NCT05392699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138606669|NCT05392699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138606670|NCT05392699|Growth Substances|growth substances|mesh-ancestor
138606671|NCT05392699|Growth Inhibitors|growth inhibitors|mesh-ancestor
138606672|NCT05392699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606673|NCT00171080|Valsartan|valsartan|mesh-list
138606674|NCT00171080|Irbesartan|irbesartan|mesh-list
138606675|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138672157|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606676|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138606677|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138606678|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606679|NCT02229877|Omeprazole|omeprazole|mesh-list
138283019|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606681|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138606682|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138606683|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138487811|NCT00000747|Nevirapine|nevirapine|mesh-list
138606684|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606685|NCT00171119|Valsartan|valsartan|mesh-list
138606686|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138606687|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138606688|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138606689|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606690|NCT05349448|Triamcinolone|triamcinolone|mesh-list
138606691|NCT05349448|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138606692|NCT05349448|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138606693|NCT05349448|Dexmedetomidine|dexmedetomidine|mesh-list
138652874|NCT00339768|Amoxicillin|amoxicillin|mesh-list
138606694|NCT05349448|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138606695|NCT05349448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138606696|NCT05349448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138606697|NCT05349448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606698|NCT05349448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138606700|NCT05349448|Sensory System Agents|sensory system agents|mesh-ancestor
138606701|NCT05349448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606702|NCT05349448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138606703|NCT05349448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138606704|NCT05349448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138606705|NCT05349448|Adrenergic Agents|adrenergic agents|mesh-ancestor
138606706|NCT05349448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606707|NCT05349448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606708|NCT05349448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138606709|NCT05349448|Glucocorticoids|glucocorticoids|mesh-ancestor
138606711|NCT05349448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138606712|NCT05349448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138606713|NCT05349448|Immunologic Factors|immunologic factors|mesh-ancestor
138606714|NCT05349448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606715|NCT00171353|Valsartan|valsartan|mesh-list
138606716|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138606717|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138606718|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138606719|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606720|NCT01656343|Abatacept|abatacept|mesh-list
138606721|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138606722|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138606723|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606724|NCT01656343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138606725|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606726|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138606727|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
138606728|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606729|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138606730|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606731|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138606732|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138606733|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606734|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
138606735|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
138606736|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138487816|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
138606738|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138606739|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
138606740|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138606741|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606742|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606743|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606745|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138606746|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
138606747|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606748|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606749|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606750|NCT01330030|Selegiline|selegiline|mesh-list
138283098|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
138606752|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138606753|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138606754|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138606755|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138606756|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606757|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606758|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138606759|NCT01330030|Protective Agents|protective agents|mesh-ancestor
138606760|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606761|NCT00171470|Tegaserod|tegaserod|mesh-list
138606762|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138606763|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
138606764|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606765|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672292|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
138606766|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606767|NCT00171509|Cyclosporine|cyclosporine|mesh-list
138606768|NCT00171509|Cyclosporins|cyclosporins|mesh-list
138606769|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606770|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606771|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138606772|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
138606773|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606774|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
138606775|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606776|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
138606778|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138606779|NCT00179712|Topotecan|topotecan|mesh-list
138606780|NCT00179712|Lenalidomide|lenalidomide|mesh-list
138606781|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138606782|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138606783|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606784|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606785|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606786|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
138606787|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606788|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138606789|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138606790|NCT00179712|Growth Substances|growth substances|mesh-ancestor
138606791|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
138606793|NCT00611572|Antidotes|antidotes|mesh-ancestor
138606794|NCT00611572|Protective Agents|protective agents|mesh-ancestor
138606795|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606796|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
138606797|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
138606798|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606799|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606800|NCT00197340|Ropivacaine|ropivacaine|mesh-list
138606801|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
138606803|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138606804|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606805|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
138606806|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606808|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138606809|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606810|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606811|NCT00171626|Diclofenac|diclofenac|mesh-list
138606812|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138606813|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138606814|NCT00171626|Analgesics|analgesics|mesh-ancestor
138606815|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
138606816|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606817|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606818|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138606819|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138606820|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138606821|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606822|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606823|NCT00171665|Diclofenac|diclofenac|mesh-list
138283173|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606824|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138606825|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138606827|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
138606828|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606829|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606830|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138606831|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138606832|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138606833|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606834|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606835|NCT00179751|Gemcitabine|gemcitabine|mesh-list
138652944|NCT00313001|Exenatide|exenatide|mesh-list
138606836|NCT00179751|Lenalidomide|lenalidomide|mesh-list
138606837|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138606838|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
138606839|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606840|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606841|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
138606842|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606843|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138606844|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138606845|NCT00179751|Growth Substances|growth substances|mesh-ancestor
138606846|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
138606847|NCT00171743|Cyclosporine|cyclosporine|mesh-list
138606848|NCT00171743|Cyclosporins|cyclosporins|mesh-list
138606849|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606850|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606851|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138606852|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
138606853|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606854|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
138606855|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606856|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
138606857|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138606858|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138606859|NCT00171782|Valsartan|valsartan|mesh-list
138672506|NCT00473915|Xhance|xhance|mesh-list
138606861|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138606862|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138606863|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138606864|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606865|NCT00171782|Diuretics|diuretics|mesh-ancestor
138606866|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
138606867|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606868|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138606869|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138606870|NCT00197379|Roxithromycin|roxithromycin|mesh-list
138606871|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138606872|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606873|NCT00197418|Amoxicillin|amoxicillin|mesh-list
138606874|NCT00197418|Metronidazole|metronidazole|mesh-list
138606875|NCT00197418|Clarithromycin|clarithromycin|mesh-list
138606876|NCT00197418|Rabeprazole|rabeprazole|mesh-list
138606877|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138606878|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606879|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138606880|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138606881|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138606882|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606883|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606884|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138606885|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138606886|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138606887|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138606888|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138606889|NCT00171821|Deferasirox|deferasirox|mesh-list
138606890|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138606891|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
138606892|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
138606893|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606894|NCT05054023|Piroxicam|piroxicam|mesh-list
138606895|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138606896|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138606897|NCT05054023|Analgesics|analgesics|mesh-ancestor
138606898|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
138606899|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606900|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606901|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138606902|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138606903|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138606904|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606905|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606906|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
138606907|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606908|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138606909|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606910|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606911|NCT00553930|Interferons|interferons|mesh-list
138606913|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
138606914|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
138606915|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138606916|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606917|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
138606918|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606919|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
138606920|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606921|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
138606922|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606924|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606925|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138606926|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606927|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606928|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
138606929|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606930|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138606931|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606932|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606933|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
138606934|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606935|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138606936|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606937|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606938|NCT02240407|Acetaminophen|acetaminophen|mesh-list
138606939|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
138606940|NCT02240407|Promethazine|promethazine|mesh-list
138606941|NCT02240407|Sirolimus|sirolimus|mesh-list
138606942|NCT02240407|Rituximab|rituximab|mesh-list
138606943|NCT02240407|Lidocaine|lidocaine|mesh-list
138606944|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138606945|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138606946|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
138606947|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606948|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138606949|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
138606950|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
138606951|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138606952|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
138606953|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138606954|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138606955|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138606956|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138606957|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138606958|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606959|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138606960|NCT02240407|Analgesics|analgesics|mesh-ancestor
138606961|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
138606962|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138606963|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606964|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138606966|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138606967|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138606968|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138606969|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
138606970|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
138606971|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138672621|NCT01605721|Everolimus|everolimus|mesh-list
138606972|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138606973|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
138606974|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
138606975|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138606976|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138606977|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
138606978|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
138606979|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
138606980|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138606981|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138606983|NCT00197613|Zidovudine|zidovudine|mesh-list
138606984|NCT00197613|Efavirenz|efavirenz|mesh-list
138606985|NCT00197613|Nevirapine|nevirapine|mesh-list
138606986|NCT00197613|Didanosine|didanosine|mesh-list
138606987|NCT00197613|Stavudine|stavudine|mesh-list
138606988|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138606989|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138606990|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138606991|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138606992|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
138606993|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138606994|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138606995|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138606996|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
138606997|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138606998|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138606999|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138607000|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138607001|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138672658|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138607002|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138607004|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138607005|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138607006|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138607007|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607008|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
138607009|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138607010|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607011|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
138607012|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607013|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
138607014|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
138607015|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
138607016|NCT03455179|Methamphetamine|methamphetamine|mesh-list
138607017|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138607018|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607019|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
138607020|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
138653057|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607021|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607022|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
138607023|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607024|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607025|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
138487909|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607026|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138607027|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138607028|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138607029|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138607031|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
138607032|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
138607033|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
138607034|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607035|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607036|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138607037|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138607038|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138607039|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138607040|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138607041|NCT00202293|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138607042|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138607043|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138607044|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607045|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607046|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
138283400|NCT03036163|Macozinone|macozinone|mesh-list
138607047|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138607048|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
138607049|NCT00197730|Folic Acid|folic acid|mesh-list
138607050|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
138607051|NCT00197730|Vitamins|vitamins|mesh-ancestor
138607052|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
138607053|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607054|NCT00197730|Hematinics|hematinics|mesh-ancestor
138607055|NCT00172172|Calcium|calcium|mesh-list
138607056|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
138607057|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138607058|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607059|NCT02908711|Ropivacaine|ropivacaine|mesh-list
138607060|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
138607061|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
138607063|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607064|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
138607065|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607066|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138607067|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607068|NCT02908438|Hormones|hormones|mesh-list
138607069|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138607070|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607072|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138607073|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
138607074|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607075|NCT00172367|Protective Agents|protective agents|mesh-ancestor
138607076|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607077|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138607078|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138607079|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607080|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
138607081|NCT04632316|Fludarabine|fludarabine|mesh-list
138607082|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138607083|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
138607084|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607085|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138487926|NCT00000822|Ritonavir|ritonavir|mesh-list
138607086|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138607087|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
138607088|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607089|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607090|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138607091|NCT00197886|Norepinephrine|norepinephrine|mesh-list
138607092|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138607093|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138607094|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
138607095|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607096|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653138|NCT00343980|Insulin|insulin|mesh-list
138607097|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607099|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
138607100|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607101|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138607102|NCT02908165|Sorafenib|sorafenib|mesh-list
138607103|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
138607104|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607105|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138607106|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607107|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607108|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138607109|NCT02908165|Estrogens|estrogens|mesh-ancestor
138607110|NCT02908165|Hormones|hormones|mesh-ancestor
138607111|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138607112|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607113|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138607114|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
138607115|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138607116|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607117|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138607118|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607119|NCT02908282|Povidone|povidone|mesh-list
138607120|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
138607121|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
138607123|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
138607124|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138607125|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607126|NCT00202605|Amphetamine|amphetamine|mesh-list
138607127|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
138607128|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138607129|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607130|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
138607131|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
138607132|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607133|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
138607134|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607135|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607136|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
138607137|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138607138|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138607139|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138607140|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138607141|NCT00198120|Cycloserine|cycloserine|mesh-list
138607142|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138607143|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138672880|NCT00469703|Growth Substances|growth substances|mesh-ancestor
138487936|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
138607144|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138607145|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
138607146|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138607147|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
138607148|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607150|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607151|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138607152|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607153|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607154|NCT02907307|Clotrimazole|clotrimazole|mesh-list
138607155|NCT02907307|Miconazole|miconazole|mesh-list
138607156|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138607157|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607158|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
138607159|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138607160|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138607161|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607162|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607163|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138607164|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
138607165|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138607166|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607167|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138607168|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138607169|NCT00553345|Vitamin E|vitamin e|mesh-list
138607170|NCT00553345|Selenium|selenium|mesh-list
138607171|NCT00553345|Vitamins|vitamins|mesh-ancestor
138653203|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138607172|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
138607173|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607174|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
138607175|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607176|NCT00553345|Protective Agents|protective agents|mesh-ancestor
138607177|NCT00553345|Trace Elements|trace elements|mesh-ancestor
138607178|NCT00407771|Tirofiban|tirofiban|mesh-list
138607179|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138607180|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138456889|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138607181|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607182|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138607183|NCT00198198|Aripiprazole|aripiprazole|mesh-list
138607184|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
138607185|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138607186|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138607187|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138607188|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138607189|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607190|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
138607191|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
138607192|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607193|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607194|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138607195|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138607196|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
138607197|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138607198|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138607199|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138607200|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138607201|NCT02206087|Heparin|heparin|mesh-list
138607202|NCT02206087|Calcium heparin|calcium heparin|mesh-list
138607203|NCT02206087|Anticoagulants|anticoagulants|mesh-ancestor
138607204|NCT02206087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138607205|NCT02206087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138487949|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138487950|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138607206|NCT02206087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607208|NCT00198237|Capecitabine|capecitabine|mesh-list
138607209|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607210|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
138607211|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
138607212|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
138653235|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138653236|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
138653238|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
138607213|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607214|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138607215|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
138607216|NCT00198354|Paclitaxel|paclitaxel|mesh-list
138607217|NCT00198354|Gemcitabine|gemcitabine|mesh-list
138607219|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138607220|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607221|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
138607222|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
138607223|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
138607224|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607225|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138607226|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
138607227|NCT02158585|Lamotrigine|lamotrigine|mesh-list
138607228|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
138607229|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138607230|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138607231|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607232|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138607233|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607234|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138607235|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138607236|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138607237|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138607238|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138607239|NCT00202917|Fludarabine|fludarabine|mesh-list
138607240|NCT00202917|Melphalan|melphalan|mesh-list
138607241|NCT00202917|Thiotepa|thiotepa|mesh-list
138607242|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607243|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607244|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138607245|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
138607246|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607247|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138607248|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
138607249|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138607250|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
138653269|NCT00344409|Hematinics|hematinics|mesh-ancestor
138607252|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
138607253|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138607254|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
138607255|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607256|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138607257|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138607258|NCT04677868|Methotrexate|methotrexate|mesh-list
138607259|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138607260|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
138607261|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138607262|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607263|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138607264|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
138607265|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607266|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607267|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
138607268|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607269|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138283649|NCT05748587|Iron|iron|mesh-list
138607271|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
138607272|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138607273|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138607275|NCT00198393|Docetaxel|docetaxel|mesh-list
138607276|NCT00198393|Gefitinib|gefitinib|mesh-list
138607277|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138607278|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
138607279|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607280|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607281|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
138607282|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
138607283|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
138607284|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138607285|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607286|NCT02103322|Imatinib Mesylate|imatinib mesylate|mesh-list
138607287|NCT02103322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607288|NCT02103322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138653303|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138607289|NCT02103322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607290|NCT02103322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607291|NCT00554827|Vitamins|vitamins|mesh-list
138607292|NCT00554827|Folic Acid|folic acid|mesh-list
138607293|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
138607294|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
138607295|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
138607296|NCT00554827|Aminopterin|aminopterin|mesh-list
138607297|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
138607298|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138673125|NCT00599950|Mitomycins|mitomycins|mesh-list
138607300|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138607301|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607302|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607303|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607304|NCT00203034|Rasagiline|rasagiline|mesh-list
138607305|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138607306|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607307|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607308|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138607309|NCT00203034|Protective Agents|protective agents|mesh-ancestor
138607310|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607311|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
138607312|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
138607313|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
138607314|NCT00203073|Analgesics|analgesics|mesh-ancestor
138607315|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
138415839|NCT01660750|Dexamethasone|dexamethasone|mesh-list
138607316|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607317|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607318|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607319|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138607320|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138607321|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607322|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607323|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138607324|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
138607325|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138607326|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138607327|NCT00198432|Paclitaxel|paclitaxel|mesh-list
138607328|NCT00198432|Vinorelbine|vinorelbine|mesh-list
138607329|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138607330|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607331|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
138607332|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
138607333|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
138607334|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607336|NCT02072863|Melphalan|melphalan|mesh-list
138607337|NCT02072863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138607338|NCT02072863|Glucocorticoids|glucocorticoids|mesh-ancestor
138607339|NCT02072863|Hormones|hormones|mesh-ancestor
138607340|NCT02072863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138607341|NCT02072863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607342|NCT02072863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138607343|NCT02072863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607344|NCT02072863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138607345|NCT02072863|Alkylating Agents|alkylating agents|mesh-ancestor
138607346|NCT02072863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607347|NCT02072863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138607348|NCT02072863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138607349|NCT02072863|Immunologic Factors|immunologic factors|mesh-ancestor
138607350|NCT02072161|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138607351|NCT02072161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138607352|NCT02072161|Antimetabolites|antimetabolites|mesh-ancestor
138607353|NCT02072161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607354|NCT02072161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138607355|NCT02072161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607356|NCT02072161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138673195|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
138607357|NCT02072161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607358|NCT00203112|Minocycline|minocycline|mesh-list
138607359|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
138607361|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138607362|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607363|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138607364|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
138607365|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607366|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138607367|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138607368|NCT02057380|Dexamethasone|dexamethasone|mesh-list
138607369|NCT02057380|Paclitaxel|paclitaxel|mesh-list
138607370|NCT02057380|Bortezomib|bortezomib|mesh-list
138607371|NCT02057380|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138607372|NCT02057380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138607373|NCT02057380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607374|NCT02057380|Tubulin Modulators|tubulin modulators|mesh-ancestor
138607375|NCT02057380|Antimitotic Agents|antimitotic agents|mesh-ancestor
138607376|NCT02057380|Mitosis Modulators|mitosis modulators|mesh-ancestor
138607377|NCT02057380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607378|NCT02057380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138607379|NCT02057380|Antiemetics|antiemetics|mesh-ancestor
138607380|NCT02057380|Autonomic Agents|autonomic agents|mesh-ancestor
138607381|NCT02057380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607382|NCT02057380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138653366|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
138653367|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138607383|NCT02057380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138607384|NCT02057380|Glucocorticoids|glucocorticoids|mesh-ancestor
138607385|NCT02057380|Hormones|hormones|mesh-ancestor
138607386|NCT02057380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138487997|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
138607387|NCT02057380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138607388|NCT02057380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138607390|NCT02052778|Futibatinib|futibatinib|mesh-list
138607391|NCT02052778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607392|NCT02050828|Ranibizumab|ranibizumab|mesh-list
138607393|NCT02050828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138607394|NCT02050828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138607395|NCT02050828|Growth Substances|growth substances|mesh-ancestor
138607396|NCT02050828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607397|NCT02050828|Growth Inhibitors|growth inhibitors|mesh-ancestor
138607398|NCT02050828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607399|NCT02046694|Allopurinol|allopurinol|mesh-list
138607400|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
138607401|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607402|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607403|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
138607404|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138607405|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138607406|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
138607407|NCT02046694|Protective Agents|protective agents|mesh-ancestor
138607408|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607409|NCT00203190|Topiramate|topiramate|mesh-list
138607410|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
138607411|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138607412|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607413|NCT02019589|Progesterone|progesterone|mesh-list
138607414|NCT02019589|Progestins|progestins|mesh-ancestor
138607415|NCT02019589|Hormones|hormones|mesh-ancestor
138653405|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
138607416|NCT02019589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138607417|NCT02019589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607418|NCT02018926|Azacitidine|azacitidine|mesh-list
138607419|NCT02018926|Mocetinostat|mocetinostat|mesh-list
138607420|NCT02018926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138607421|NCT02018926|Antimetabolites|antimetabolites|mesh-ancestor
138607422|NCT02018926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607423|NCT02018926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607425|NCT02018926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138607426|NCT01989325|Dexamethasone|dexamethasone|mesh-list
138607427|NCT01989325|Filanesib|filanesib|mesh-list
138607428|NCT01989325|Lenograstim|lenograstim|mesh-list
138607429|NCT01989325|Proteasome Inhibitors|proteasome inhibitors|mesh-list
138607430|NCT01989325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138607431|NCT01989325|Antiemetics|antiemetics|mesh-ancestor
138607432|NCT01989325|Autonomic Agents|autonomic agents|mesh-ancestor
138607433|NCT01989325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607434|NCT01989325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607436|NCT01989325|Glucocorticoids|glucocorticoids|mesh-ancestor
138607437|NCT01989325|Hormones|hormones|mesh-ancestor
138607438|NCT01989325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138607439|NCT01989325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138607440|NCT01989325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607441|NCT01989325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138607442|NCT01989325|Immunologic Factors|immunologic factors|mesh-ancestor
138607443|NCT01989325|Protease Inhibitors|protease inhibitors|mesh-ancestor
138607444|NCT01989325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607445|NCT01989325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607446|NCT01989325|Antimitotic Agents|antimitotic agents|mesh-ancestor
138607447|NCT01989325|Mitosis Modulators|mitosis modulators|mesh-ancestor
138607449|NCT01978366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607450|NCT01978366|Coccidiostats|coccidiostats|mesh-ancestor
138607451|NCT01978366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138607452|NCT01978366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138607453|NCT01978366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607454|NCT01978366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138607455|NCT01978366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607456|NCT01978366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607457|NCT01978366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138607458|NCT01978366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138607459|NCT01978366|Growth Substances|growth substances|mesh-ancestor
138607460|NCT01978366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607461|NCT01978366|Growth Inhibitors|growth inhibitors|mesh-ancestor
138607462|NCT02962986|Phenylephrine|phenylephrine|mesh-list
138607463|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
138607464|NCT02962986|Norepinephrine|norepinephrine|mesh-list
138607465|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138607467|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
138607468|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607469|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607470|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
138607471|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138607472|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
138607473|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
138607474|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138607475|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138607476|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138607477|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
138607478|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607479|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607480|NCT02962986|Protective Agents|protective agents|mesh-ancestor
138607481|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
138607482|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138607483|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607484|NCT04677361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138607485|NCT04677361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607486|NCT01968733|Moxifloxacin|moxifloxacin|mesh-list
138607487|NCT01968733|Solithromycin|solithromycin|mesh-list
138607488|NCT01968733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138607489|NCT01968733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607490|NCT01968733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138607491|NCT01968733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138607492|NCT01968733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607493|NCT01968733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607494|NCT01968733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607495|NCT00410553|Gemcitabine|gemcitabine|mesh-list
138607496|NCT00410553|Halichondrin B|halichondrin b|mesh-list
138607497|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138607498|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
138607499|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607500|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607501|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
138607502|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
138607503|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
138607504|NCT00410592|Esomeprazole|esomeprazole|mesh-list
138607505|NCT00410592|Pantoprazole|pantoprazole|mesh-list
138607506|NCT00410592|Lansoprazole|lansoprazole|mesh-list
138607507|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
138607508|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138607509|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138607510|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138607511|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607512|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607513|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
138607515|NCT00410631|Ifosfamide|ifosfamide|mesh-list
138607516|NCT00410631|Dacarbazine|dacarbazine|mesh-list
138607517|NCT00410631|Carboplatin|carboplatin|mesh-list
138607518|NCT00410631|Doxorubicin|doxorubicin|mesh-list
138607519|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138607520|NCT00410631|Etoposide|etoposide|mesh-list
138607521|NCT00410631|Vincristine|vincristine|mesh-list
138607522|NCT00410631|Topotecan|topotecan|mesh-list
138488025|NCT00000870|Lamivudine|lamivudine|mesh-list
138607523|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
138607525|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138607526|NCT00410631|Isotretinoin|isotretinoin|mesh-list
138456923|NCT01915277|Analgesics|analgesics|mesh-ancestor
138607527|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138607528|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
138607529|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607530|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138607531|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138607532|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
138607533|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607534|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607535|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138607536|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138607537|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138607538|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138607539|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607540|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138607541|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
138607542|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
138607543|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
138607544|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138607545|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
138607546|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138607547|NCT01930357|Vaccines|vaccines|mesh-list
138607548|NCT01930357|Immunologic Factors|immunologic factors|mesh-ancestor
138607549|NCT01930357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607550|NCT01913158|Hydrocortisone|hydrocortisone|mesh-list
138607551|NCT01913158|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138607552|NCT01913158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138607553|NCT01903954|Ribavirin|ribavirin|mesh-list
138607554|NCT01903954|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138607555|NCT01903954|Antimetabolites|antimetabolites|mesh-ancestor
138607556|NCT01903954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607557|NCT01903954|Antiviral Agents|antiviral agents|mesh-ancestor
138607558|NCT01903954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607559|NCT01893190|Nimodipine|nimodipine|mesh-list
138607560|NCT01893190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138607561|NCT01893190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138607562|NCT01893190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138607563|NCT01893190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607564|NCT01893190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138607565|NCT01893190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607566|NCT01893190|Vasodilator Agents|vasodilator agents|mesh-ancestor
138607567|NCT00198588|Argatroban|argatroban|mesh-list
138607568|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
138607569|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138607570|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
138607571|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607572|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607573|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
138607574|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138607575|NCT01887886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138607576|NCT01887886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607577|NCT01887886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138607578|NCT01887886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488033|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138488044|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
138607579|NCT01887886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607581|NCT01877395|Immunologic Factors|immunologic factors|mesh-ancestor
138607582|NCT01877395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607583|NCT01874626|Ibuprofen|ibuprofen|mesh-list
138607584|NCT01874626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138607585|NCT01874626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138607586|NCT01874626|Analgesics|analgesics|mesh-ancestor
138607587|NCT01874626|Sensory System Agents|sensory system agents|mesh-ancestor
138673499|NCT00470483|Paroxetine|paroxetine|mesh-list
138607588|NCT01874626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607589|NCT01874626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607591|NCT01874626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138607592|NCT01874626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138607593|NCT01874626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607594|NCT01874626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607595|NCT00410748|Hydromorphone|hydromorphone|mesh-list
138607596|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138607597|NCT00410748|Narcotics|narcotics|mesh-ancestor
138607598|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138607599|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607601|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
138607602|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607603|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138607604|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138607605|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607606|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138607607|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
138607608|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138607609|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138607610|NCT01862224|Methotrexate|methotrexate|mesh-list
138673547|NCT00502164|Cediranib|cediranib|mesh-list
138607611|NCT01862224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138607612|NCT01862224|Abortifacient Agents|abortifacient agents|mesh-ancestor
138607613|NCT01862224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138607614|NCT01862224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607615|NCT01862224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138607616|NCT01862224|Antimetabolites|antimetabolites|mesh-ancestor
138607617|NCT01862224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607618|NCT01862224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607619|NCT01862224|Dermatologic Agents|dermatologic agents|mesh-ancestor
138607620|NCT01862224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607621|NCT01862224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138607622|NCT01862224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138607623|NCT01862224|Immunologic Factors|immunologic factors|mesh-ancestor
138607624|NCT01862224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138607625|NCT01862224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138607627|NCT01859962|Antimetabolites|antimetabolites|mesh-ancestor
138607628|NCT01859962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607629|NCT01859962|Antiviral Agents|antiviral agents|mesh-ancestor
138607630|NCT01859962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607631|NCT00173888|Cisplatin|cisplatin|mesh-list
138607632|NCT00173888|Gemcitabine|gemcitabine|mesh-list
138607633|NCT00173888|Docetaxel|docetaxel|mesh-list
138607634|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607635|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138607636|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
138607637|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607638|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
138607639|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
138607640|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
138607641|NCT00555022|Bromides|bromides|mesh-list
138607642|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
138607643|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138607644|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
138607645|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607646|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607647|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138607648|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
138653572|NCT06164834|Esomeprazole|esomeprazole|mesh-list
138607649|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
138607650|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138607651|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
138607652|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607653|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607654|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
138607655|NCT00203385|Valproic Acid|valproic acid|mesh-list
138607656|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
138607657|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607658|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607659|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
138607660|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607661|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607663|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138607664|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138607665|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138607666|NCT00555100|Dexamethasone|dexamethasone|mesh-list
138607667|NCT00555100|Lenalidomide|lenalidomide|mesh-list
138607668|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138607669|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
138607670|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
138607671|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607672|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607673|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138607674|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
138607675|NCT00555100|Hormones|hormones|mesh-ancestor
138607676|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138607677|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138607678|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607679|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
138607680|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138607681|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138607682|NCT00555100|Growth Substances|growth substances|mesh-ancestor
138607683|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
138607684|NCT00555139|Alprazolam|alprazolam|mesh-list
138607685|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138607686|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138607687|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607688|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138653588|NCT06164665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607689|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138607690|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138607691|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
138607692|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
138607693|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607694|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607695|NCT00203463|Topiramate|topiramate|mesh-list
138607696|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
138607697|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138607698|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607699|NCT00407849|Triamcinolone|triamcinolone|mesh-list
138607700|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138607701|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138607702|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138607703|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138607704|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
138607705|NCT00407849|Hormones|hormones|mesh-ancestor
138607706|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138607707|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607708|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138607709|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
138607710|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607711|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607712|NCT00407927|Epinastine|epinastine|mesh-list
138607713|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138607714|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
138607715|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
138607716|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607717|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607718|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607719|NCT01818076|Botulinum Toxins|botulinum toxins|mesh-list
138607720|NCT01818076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138607721|NCT01818076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138607722|NCT01818076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138607723|NCT01818076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138607724|NCT01818076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607725|NCT01818076|Cholinergic Agents|cholinergic agents|mesh-ancestor
138673810|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
138607726|NCT01818076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607727|NCT01818076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607728|NCT01818076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138607729|NCT01818076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607731|NCT01807546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607732|NCT01807546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138607733|NCT01807546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607734|NCT01807546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607735|NCT03454984|Guadecitabine|guadecitabine|mesh-list
138607736|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607737|NCT01785433|Tiotropium Bromide|tiotropium bromide|mesh-list
138607738|NCT01785433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138607739|NCT01785433|Autonomic Agents|autonomic agents|mesh-ancestor
138607740|NCT01785433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607741|NCT01785433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607742|NCT01785433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138607743|NCT01785433|Respiratory System Agents|respiratory system agents|mesh-ancestor
138607744|NCT01785433|Parasympatholytics|parasympatholytics|mesh-ancestor
138607745|NCT01785433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138607746|NCT01785433|Cholinergic Agents|cholinergic agents|mesh-ancestor
138607747|NCT01785433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607748|NCT01785433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607749|NCT00203580|Tinzaparin|tinzaparin|mesh-list
138607750|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138607751|NCT00203580|Dalteparin|dalteparin|mesh-list
138607752|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
138607753|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138607754|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138607755|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607756|NCT01777555|Levodopa|levodopa|mesh-list
138607757|NCT01777555|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138607758|NCT01777555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138607760|NCT01777555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607761|NCT01777555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607762|NCT01777555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607763|NCT01773928|Vaccines|vaccines|mesh-list
138607764|NCT01773928|Immunologic Factors|immunologic factors|mesh-ancestor
138607765|NCT01773928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607766|NCT01768975|Dapansutrile|dapansutrile|mesh-list
138607767|NCT01768975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138607768|NCT01756924|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138607770|NCT01756924|Ciprofloxacin|ciprofloxacin|mesh-list
138607771|NCT01756924|Levofloxacin|levofloxacin|mesh-list
138607772|NCT01756924|Rifampin|rifampin|mesh-list
138607773|NCT01756924|Cefazolin|cefazolin|mesh-list
138607774|NCT01756924|Ceftriaxone|ceftriaxone|mesh-list
138607775|NCT01756924|Linezolid|linezolid|mesh-list
138607776|NCT01756924|Daptomycin|daptomycin|mesh-list
138607777|NCT01756924|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138607778|NCT01756924|Oxacillin|oxacillin|mesh-list
138607779|NCT01756924|Fusidic Acid|fusidic acid|mesh-list
138607780|NCT01756924|Nafcillin|nafcillin|mesh-list
138607781|NCT01756924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607782|NCT01756924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138607783|NCT01756924|Antitubercular Agents|antitubercular agents|mesh-ancestor
138607784|NCT01756924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138607785|NCT01756924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138607786|NCT01756924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607787|NCT01756924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607788|NCT01756924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607789|NCT01756924|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138607790|NCT01756924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138607791|NCT01756924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138607792|NCT01756924|Leprostatic Agents|leprostatic agents|mesh-ancestor
138607793|NCT01756924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138607794|NCT01756924|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138607795|NCT01756924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138607796|NCT01756924|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138607797|NCT01756924|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138607798|NCT01756924|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138607799|NCT01756924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138607800|NCT01756924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138607801|NCT01756924|Antimalarials|antimalarials|mesh-ancestor
138607802|NCT01756924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138607803|NCT01756924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138607804|NCT01756339|Moxifloxacin|moxifloxacin|mesh-list
138607805|NCT01756339|Solithromycin|solithromycin|mesh-list
138607806|NCT01756339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138607807|NCT01756339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607808|NCT01756339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138607809|NCT01756339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138607810|NCT01756339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607811|NCT01756339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607812|NCT01756339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607813|NCT00174200|Risperidone|risperidone|mesh-list
138607814|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138607815|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
138607816|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607817|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138653694|NCT06163755|Hormones|hormones|mesh-ancestor
138607818|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607819|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138607820|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138607821|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138607822|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138607823|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138607824|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
138607825|NCT00203658|Tinzaparin|tinzaparin|mesh-list
138607826|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138607827|NCT00203658|Dalteparin|dalteparin|mesh-list
138607828|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
138607829|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138607830|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138607831|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607832|NCT00174239|Levodopa|levodopa|mesh-list
138607833|NCT00174239|Carbidopa|carbidopa|mesh-list
138607834|NCT00174239|Cabergoline|cabergoline|mesh-list
138607835|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138673932|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
138607836|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138607837|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
138607838|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607839|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607840|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607841|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138607842|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607843|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
138607844|NCT00203697|Minocycline|minocycline|mesh-list
138607845|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138607846|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607847|NCT00174317|Celecoxib|celecoxib|mesh-list
138607848|NCT00174317|Diclofenac|diclofenac|mesh-list
138607849|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138607850|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138607851|NCT00174317|Analgesics|analgesics|mesh-ancestor
138607852|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
138607853|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607854|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607855|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138607856|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138607857|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138607858|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138607859|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607860|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607861|NCT01737892|Epinephrine|epinephrine|mesh-list
138607862|NCT01737892|Racepinephrine|racepinephrine|mesh-list
138607863|NCT01737892|Epinephryl borate|epinephryl borate|mesh-list
138607864|NCT01737892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138607865|NCT01737892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138607866|NCT01737892|Adrenergic Agents|adrenergic agents|mesh-ancestor
138607867|NCT01737892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673963|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
138607868|NCT01737892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607869|NCT01737892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607870|NCT01737892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138607871|NCT01737892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138607872|NCT01737892|Autonomic Agents|autonomic agents|mesh-ancestor
138607873|NCT01737892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607874|NCT01737892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138607875|NCT01737892|Respiratory System Agents|respiratory system agents|mesh-ancestor
138607876|NCT01737892|Mydriatics|mydriatics|mesh-ancestor
138607877|NCT01737892|Sympathomimetics|sympathomimetics|mesh-ancestor
138341074|NCT04054752|Vaccines|vaccines|mesh-list
138607878|NCT01737892|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138607879|NCT00203736|Artesunate|artesunate|mesh-list
138607880|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
138607881|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
138607882|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138607883|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
138607884|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138607885|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138607886|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607887|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607888|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
138607889|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
138607890|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138607891|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
138607892|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138607893|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607894|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607895|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138607896|NCT01719016|Adenosine|adenosine|mesh-list
138607898|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
138607899|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138607900|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607901|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138607903|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138607904|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
138607905|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
138607906|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607907|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607909|NCT00174356|Carboplatin|carboplatin|mesh-list
138607910|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138607911|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607912|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
138607913|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
138607914|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
138607915|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607916|NCT01718158|Ribavirin|ribavirin|mesh-list
138607917|NCT01718158|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138607918|NCT01718158|Antimetabolites|antimetabolites|mesh-ancestor
138607919|NCT01718158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607920|NCT01718158|Antiviral Agents|antiviral agents|mesh-ancestor
138607921|NCT01718158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607922|NCT00174395|Eletriptan|eletriptan|mesh-list
138607923|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138607924|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
138607925|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607926|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138674063|NCT05645302|Lidocaine|lidocaine|mesh-list
138607927|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607928|NCT00203775|Risperidone|risperidone|mesh-list
138607929|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138607930|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
138607931|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138607932|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607933|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607934|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138607935|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138607936|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138607937|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138607938|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138607939|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
138607940|NCT00555256|Sirolimus|sirolimus|mesh-list
138607941|NCT00555256|Sunitinib|sunitinib|mesh-list
138607942|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607943|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138607944|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138607945|NCT00555256|Growth Substances|growth substances|mesh-ancestor
138607946|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607947|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
138607948|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138607949|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138653795|NCT06050252|Cisplatin|cisplatin|mesh-list
138607950|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607951|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138607952|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607953|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138607954|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
138607955|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138607956|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
138607957|NCT00174434|Paclitaxel|paclitaxel|mesh-list
138607958|NCT00174434|Sunitinib|sunitinib|mesh-list
138607959|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138607960|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607961|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
138607962|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
138607963|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
138607964|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607965|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138607966|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138607967|NCT00174434|Growth Substances|growth substances|mesh-ancestor
138607968|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138607969|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
138607970|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138607971|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607974|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
138607975|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138607976|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
138607977|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138607978|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138607979|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607980|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138607981|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
138607982|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
138607983|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138607984|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
138607985|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138607986|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607987|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607988|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138607989|NCT00174473|Voriconazole|voriconazole|mesh-list
138607990|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
138607991|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138607992|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138607993|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138607994|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138607995|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138607996|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138607997|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
138607998|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138607999|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608000|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138608001|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
138608002|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138608003|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608004|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138608005|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138608006|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608007|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608008|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608009|NCT00199017|Cytarabine|cytarabine|mesh-list
138608010|NCT00199017|Dexamethasone|dexamethasone|mesh-list
138608011|NCT00199017|Prednisolone|prednisolone|mesh-list
138608012|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
138608013|NCT00199017|Methotrexate|methotrexate|mesh-list
138608014|NCT00199017|Vincristine|vincristine|mesh-list
138608015|NCT00199017|Doxorubicin|doxorubicin|mesh-list
138608016|NCT00199017|Daunorubicin|daunorubicin|mesh-list
138608017|NCT00199017|Asparaginase|asparaginase|mesh-list
138608018|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
138608019|NCT00199017|Thioguanine|thioguanine|mesh-list
138608020|NCT00199017|Cladribine|cladribine|mesh-list
138608021|NCT00199017|Vindesine|vindesine|mesh-list
138608022|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608023|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
138608024|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608025|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608026|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138608027|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
138608028|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608029|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608030|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138608031|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138608033|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
138608034|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608035|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138608036|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
138608037|NCT00199017|Hormones|hormones|mesh-ancestor
138608038|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138608039|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138608040|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138608041|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
138608042|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138608043|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138608044|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
138608045|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
138608046|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608047|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138608048|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138608049|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
138608050|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608051|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138608052|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
138608054|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
138608055|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138608056|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138608057|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138608058|NCT01665391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138608059|NCT01665391|Immunologic Factors|immunologic factors|mesh-ancestor
138608060|NCT01665391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608062|NCT01660633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138608063|NCT01660633|Alkylating Agents|alkylating agents|mesh-ancestor
138608064|NCT01660633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608065|NCT01660633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608066|NCT01660633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138608067|NCT01660633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608068|NCT01660633|Immunologic Factors|immunologic factors|mesh-ancestor
138608069|NCT01660633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608071|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138608072|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138608073|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138608074|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138608075|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
138608076|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608077|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608078|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608079|NCT04676659|Tenecteplase|tenecteplase|mesh-list
138608080|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138608081|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138608082|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608083|NCT00174590|Risperidone|risperidone|mesh-list
138608084|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138608085|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
138608086|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608087|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608088|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608089|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138608090|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138608091|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138608092|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138608093|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138608094|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
138608095|NCT01652482|Leucovorin|leucovorin|mesh-list
138608096|NCT01652482|Fluorouracil|fluorouracil|mesh-list
138608097|NCT01652482|Irinotecan|irinotecan|mesh-list
138608099|NCT01652482|Antimetabolites|antimetabolites|mesh-ancestor
138608100|NCT01652482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608101|NCT01652482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138653865|NCT05980806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608102|NCT01652482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608103|NCT01652482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608104|NCT01652482|Immunologic Factors|immunologic factors|mesh-ancestor
138608105|NCT01652482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608106|NCT01652482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138608107|NCT01652482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138608108|NCT01652482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608109|NCT01652482|Antidotes|antidotes|mesh-ancestor
138608110|NCT01652482|Protective Agents|protective agents|mesh-ancestor
138608111|NCT01652482|Vitamin B Complex|vitamin b complex|mesh-ancestor
138608112|NCT01652482|Vitamins|vitamins|mesh-ancestor
138608113|NCT01652482|Micronutrients|micronutrients|mesh-ancestor
138608114|NCT01652482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138608115|NCT00174629|Gemcitabine|gemcitabine|mesh-list
138608116|NCT00174629|Docetaxel|docetaxel|mesh-list
138608117|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138608118|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
138608119|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608120|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608121|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
138608122|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
138608123|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
138608124|NCT02962947|Propranolol|propranolol|mesh-list
138608125|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138608126|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138608127|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
138608128|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608129|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608130|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608131|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138608132|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138608133|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
138608135|NCT00555334|Entecavir|entecavir|mesh-list
138608136|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138608137|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138608138|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608139|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608141|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608142|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138608143|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138608144|NCT01640080|Esketamine|esketamine|mesh-list
138608145|NCT01640080|Antidepressive Agents|antidepressive agents|mesh-ancestor
138608146|NCT01640080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138608147|NCT00174668|Insulin|insulin|mesh-list
138608148|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138608149|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
138608150|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
138608151|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138608152|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608153|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
138608155|NCT00174707|Methotrexate|methotrexate|mesh-list
138608156|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608157|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
138608158|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608159|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608160|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138608161|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
138608162|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608163|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608165|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
138608166|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
138608167|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
138608168|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138608169|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
138608170|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138608171|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138456966|NCT01915602|Sorafenib|sorafenib|mesh-list
138608172|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
138608173|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
138608174|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608175|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138608176|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138608177|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
138608178|NCT01235923|Hematinics|hematinics|mesh-ancestor
138608179|NCT00199134|Letrozole|letrozole|mesh-list
138608180|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608181|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138608183|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608184|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608185|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138608186|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
138608187|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138608188|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608189|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
138608190|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138608191|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608192|NCT00174863|SR 31747|sr 31747|mesh-list
138608193|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608194|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608195|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608196|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
138608197|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608198|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
138608199|NCT00712582|Ifosfamide|ifosfamide|mesh-list
138608201|NCT00712582|Carmustine|carmustine|mesh-list
138608202|NCT00712582|Rituximab|rituximab|mesh-list
138608203|NCT00712582|Carboplatin|carboplatin|mesh-list
138608204|NCT00712582|Etoposide|etoposide|mesh-list
138608205|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
138608206|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
138608207|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138674461|NCT00473213|Interferons|interferons|mesh-list
138608208|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
138608209|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608210|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608211|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138608212|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
138608213|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608214|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608215|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138608216|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138608217|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138608218|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138608219|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138608220|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608221|NCT00712582|Analgesics|analgesics|mesh-ancestor
138608222|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
138608223|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608224|NCT00174902|Aspirin|aspirin|mesh-list
138608225|NCT00174902|Propranolol|propranolol|mesh-list
138608226|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138608227|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138608228|NCT00174902|Analgesics|analgesics|mesh-ancestor
138608229|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
138608230|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608231|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608232|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138608233|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608234|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138608235|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138608236|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608237|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138608238|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138608239|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608240|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
138608241|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138608242|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138608243|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
138608244|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608245|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138608246|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138608247|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
138608248|NCT00373711|Iodine|iodine|mesh-list
138608249|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
138608250|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138608251|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138608252|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608253|NCT00373711|Trace Elements|trace elements|mesh-ancestor
138608254|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
138608255|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608256|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138608257|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608258|NCT00199212|Trastuzumab|trastuzumab|mesh-list
138608259|NCT00199212|Bortezomib|bortezomib|mesh-list
138608260|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138608261|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608262|NCT00555373|Sirolimus|sirolimus|mesh-list
138608263|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138608264|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608265|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138608266|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608267|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
138608268|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608269|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
138608270|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608271|NCT00555412|Loxapine|loxapine|mesh-list
138608272|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138608273|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138608274|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138608275|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608276|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138608277|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138608278|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
138608279|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608280|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608281|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
138608282|NCT04676776|Mifepristone|mifepristone|mesh-list
138608283|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138608284|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
138608285|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138608286|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608287|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138608288|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138608289|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138608290|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138608291|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
138608292|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138608293|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138608294|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
138608295|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138608296|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
138608297|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138608298|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
138608299|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138608300|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608301|NCT00199329|Ondansetron|ondansetron|mesh-list
138608303|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
138608304|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608305|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608306|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138608307|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
138608308|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
138608309|NCT00199329|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138456971|NCT01915758|Clindamycin|clindamycin|mesh-list
138608310|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138608311|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
138608312|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608313|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608314|NCT00555607|Prednisolone|prednisolone|mesh-list
138608315|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138608316|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
138608317|NCT00555607|Hormones|hormones|mesh-ancestor
138608318|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138608319|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608320|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138608321|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608322|NCT00199368|Istradefylline|istradefylline|mesh-list
138608323|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138608324|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138608325|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138608326|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
138608327|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608328|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608329|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608331|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138608332|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608334|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
138608335|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
138608336|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608338|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138608339|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138608340|NCT00175370|Vancomycin|vancomycin|mesh-list
138608341|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138608342|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608343|NCT00204243|Naltrexone|naltrexone|mesh-list
138608344|NCT00204243|Methadone|methadone|mesh-list
138608345|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138608346|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138608347|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608348|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
138608349|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608350|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138608351|NCT00204243|Narcotics|narcotics|mesh-ancestor
138608352|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138608353|NCT00204243|Analgesics|analgesics|mesh-ancestor
138608354|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
138608355|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
138608356|NCT04675372|Midazolam|midazolam|mesh-list
138608357|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
138608358|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138608359|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138608360|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608361|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138608362|NCT04675372|Analgesics|analgesics|mesh-ancestor
138608363|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
138608364|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608365|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138608366|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138608368|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
138608369|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608370|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608371|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138608372|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138608373|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138608374|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138608375|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138608376|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
138608377|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
138456984|NCT01915901|Bismuth|bismuth|mesh-list
138608378|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
138608379|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
138608380|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
138608381|NCT04424602|Dimethoate|dimethoate|mesh-list
138608382|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608383|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608384|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608385|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138608386|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
138608387|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608388|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608389|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608390|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
138608391|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608392|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138608393|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
138608394|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138608395|NCT00199407|Istradefylline|istradefylline|mesh-list
138608396|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138608397|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138608398|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138608399|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
138608400|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608401|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608402|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608403|NCT00199446|Istradefylline|istradefylline|mesh-list
138608404|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138608405|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138608406|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138608407|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
138608408|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608409|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608410|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608411|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
138608412|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138608413|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
138608414|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608415|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608416|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138608417|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
138608418|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138608419|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
138608420|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608421|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608422|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138608423|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
138608424|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
138608425|NCT04306393|Protective Agents|protective agents|mesh-ancestor
138608426|NCT00204321|Sirolimus|sirolimus|mesh-list
138608427|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138608428|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608429|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138608430|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608431|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
138608432|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608433|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
138608434|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608435|NCT00175565|Fluticasone|fluticasone|mesh-list
138608436|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138608437|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138608438|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
138608439|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608440|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608441|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138608442|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
138608443|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
138608444|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138608446|NCT04230187|Bevacizumab|bevacizumab|mesh-list
138608447|NCT04230187|Fluorouracil|fluorouracil|mesh-list
138608448|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
138608449|NCT04230187|Irinotecan|irinotecan|mesh-list
138608450|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
138608451|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138608452|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608453|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138608454|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138608455|NCT04230187|Growth Substances|growth substances|mesh-ancestor
138608456|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608457|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
138608458|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
138608459|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608460|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138608461|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608462|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
138608463|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138608464|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138608465|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608466|NCT04230187|Antidotes|antidotes|mesh-ancestor
138608467|NCT04230187|Protective Agents|protective agents|mesh-ancestor
138608468|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
138608469|NCT04230187|Vitamins|vitamins|mesh-ancestor
138608470|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
138608471|NCT00175643|Imiquimod|imiquimod|mesh-list
138608472|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138608473|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
138608474|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608475|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608476|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
138608477|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138608478|NCT00204438|Desogestrel|desogestrel|mesh-list
138608479|NCT00204438|Estradiol|estradiol|mesh-list
138608480|NCT00204438|Estrogens|estrogens|mesh-ancestor
138284834|NCT03118466|Analgesics|analgesics|mesh-ancestor
138608481|NCT00204438|Hormones|hormones|mesh-ancestor
138704040|NCT06205407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608482|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138608483|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608484|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138608485|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
138608486|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138608487|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138608488|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138608489|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138608490|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138608493|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138608494|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138608495|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138608496|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138608497|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
138608498|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138654009|NCT05676294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138654015|NCT05676294|Serotonin Agents|serotonin agents|mesh-ancestor
138608499|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608500|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608502|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
138608503|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
138608504|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138608505|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608506|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608507|NCT04173364|Ropivacaine|ropivacaine|mesh-list
138608508|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138608509|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
138608510|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
138608511|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138608512|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608513|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
138608514|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608515|NCT04171453|Pregabalin|pregabalin|mesh-list
138608516|NCT04171453|Analgesics|analgesics|mesh-ancestor
138608517|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
138608518|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608519|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608520|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
138608521|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138608522|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138608523|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608524|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138608525|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138608526|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138608527|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138608528|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138608529|NCT04111315|Dipyrone|dipyrone|mesh-list
138608530|NCT04111315|Ibuprofen|ibuprofen|mesh-list
138608531|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138608532|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138608533|NCT04111315|Analgesics|analgesics|mesh-ancestor
138608534|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
138608535|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608536|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608537|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138608538|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608539|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138608540|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608541|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608542|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
138608543|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
138608544|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
138608545|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138608546|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138608547|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138674865|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138608548|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608549|NCT00199563|Urological Agents|urological agents|mesh-ancestor
138608551|NCT04679506|Etoposide|etoposide|mesh-list
138608552|NCT04679506|Cladribine|cladribine|mesh-list
138608553|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138284907|NCT02946073|Buprenorphine|buprenorphine|mesh-list
138608555|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138608556|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138608557|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608558|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608559|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138608560|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
138608561|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
138608562|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608563|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608564|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
138608565|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608566|NCT02962830|Sufentanil|sufentanil|mesh-list
138608567|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138608568|NCT02962830|Narcotics|narcotics|mesh-ancestor
138608569|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138608570|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608571|NCT02962830|Analgesics|analgesics|mesh-ancestor
138608573|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608574|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138608575|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138608576|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
138608577|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
138608579|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
138608580|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138608581|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138608582|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608583|NCT00554125|Sirolimus|sirolimus|mesh-list
138608584|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138608585|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608586|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138608587|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608588|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
138608589|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608590|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
138608591|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608592|NCT00175838|Aspirin|aspirin|mesh-list
138608593|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
138674959|NCT04518618|Fentanyl|fentanyl|mesh-list
138608594|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138608595|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138608596|NCT00175838|Analgesics|analgesics|mesh-ancestor
138608597|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
138608598|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608599|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608600|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138608601|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608602|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138608603|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138608604|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608605|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138608606|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138608607|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608608|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
138608609|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608610|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
138608611|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138608612|NCT00204555|Imiquimod|imiquimod|mesh-list
138608613|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138608614|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
138608615|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608616|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608617|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
138608618|NCT00175955|Levetiracetam|levetiracetam|mesh-list
138608619|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
138608620|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
138608622|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608623|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138608624|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608625|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608626|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
138608627|NCT00204633|Hematinics|hematinics|mesh-ancestor
138608629|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
138608630|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608631|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
138608632|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608633|NCT03430882|Paclitaxel|paclitaxel|mesh-list
138608634|NCT03430882|Carboplatin|carboplatin|mesh-list
138675012|NCT01310803|Valrubicin|valrubicin|mesh-list
138608635|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138608636|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138608637|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608638|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
138608639|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
138608640|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
138608641|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608642|NCT00199758|Gemcitabine|gemcitabine|mesh-list
138608643|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608644|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138608645|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
138608646|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608647|NCT03291886|Exemestane|exemestane|mesh-list
138608648|NCT03291886|Entinostat|entinostat|mesh-list
138608649|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608650|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138608651|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138608652|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608653|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608654|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138608655|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
138608656|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138608657|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675047|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
138608659|NCT00199953|Rabeprazole|rabeprazole|mesh-list
138608660|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138608661|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138608662|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138608663|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608664|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608665|NCT03184090|Palbociclib|palbociclib|mesh-list
138608666|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608667|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138608668|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138654057|NCT05621616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608669|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608670|NCT03160846|Milrinone|milrinone|mesh-list
138608671|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138608672|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138608673|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
138608674|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138608675|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138608676|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608677|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608678|NCT03160846|Protective Agents|protective agents|mesh-ancestor
138608679|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608680|NCT00204789|Eflornithine|eflornithine|mesh-list
138608681|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608682|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138608683|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138608684|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138608686|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138608687|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608688|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488219|NCT00000969|Zalcitabine|zalcitabine|mesh-list
138608689|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
138608690|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
138608691|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
138608692|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138608693|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138457022|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138608694|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608695|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608696|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608697|NCT00176618|Curcumin|curcumin|mesh-list
138608698|NCT00176618|Sulindac|sulindac|mesh-list
138608699|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138608700|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138608701|NCT00176618|Analgesics|analgesics|mesh-ancestor
138608702|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
138608703|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608704|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608705|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138608706|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608707|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608708|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608709|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608710|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138608711|NCT00410787|Hydromorphone|hydromorphone|mesh-list
138608712|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138608713|NCT00410787|Narcotics|narcotics|mesh-ancestor
138608714|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138608715|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608716|NCT00410787|Analgesics|analgesics|mesh-ancestor
138608717|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
138608718|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608719|NCT00554164|Prednisone|prednisone|mesh-list
138654080|NCT05541484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138608720|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
138608721|NCT00554164|Doxorubicin|doxorubicin|mesh-list
138608722|NCT00554164|Vincristine|vincristine|mesh-list
138608723|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608724|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
138608725|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608726|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608727|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138608728|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
138608729|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608730|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608731|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138608732|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138608733|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138608734|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138608735|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608736|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138608737|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
138608738|NCT00554164|Hormones|hormones|mesh-ancestor
138608739|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138608740|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138608741|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138488242|NCT00000978|Zalcitabine|zalcitabine|mesh-list
138608742|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
138608743|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
138608744|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
138608745|NCT02572141|Leucovorin|leucovorin|mesh-list
138608746|NCT02572141|Capecitabine|capecitabine|mesh-list
138608747|NCT02572141|Fluorouracil|fluorouracil|mesh-list
138608748|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
138608749|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
138608750|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138608751|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
138608752|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608753|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608754|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608755|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
138608756|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608757|NCT02572141|Antidotes|antidotes|mesh-ancestor
138608758|NCT02572141|Protective Agents|protective agents|mesh-ancestor
138608759|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
138608760|NCT02572141|Vitamins|vitamins|mesh-ancestor
138608761|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
138608762|NCT02470039|Insulin|insulin|mesh-list
138608763|NCT02470039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138608764|NCT02470039|Insulin Glargine|insulin glargine|mesh-list
138608765|NCT02470039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138608766|NCT02470039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608767|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
138608768|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608769|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138608770|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138608771|NCT00554203|Analgesics|analgesics|mesh-ancestor
138608772|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
138608773|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608774|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608775|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138608776|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608777|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138608778|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
138285133|NCT03100123|Dalteparin|dalteparin|mesh-list
138608779|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
138608780|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
138654102|NCT05479123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608781|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608782|NCT00554242|Protective Agents|protective agents|mesh-ancestor
138608783|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608784|NCT00554242|Vitamins|vitamins|mesh-ancestor
138608785|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
138608786|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138608787|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608788|NCT00176735|Capecitabine|capecitabine|mesh-list
138608789|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138608790|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
138608791|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608792|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608793|NCT00410943|Hydromorphone|hydromorphone|mesh-list
138608794|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138608795|NCT00410943|Narcotics|narcotics|mesh-ancestor
138488251|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138608796|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138608797|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608798|NCT00410943|Analgesics|analgesics|mesh-ancestor
138608799|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
138608800|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608801|NCT00176774|Leucovorin|leucovorin|mesh-list
138608803|NCT00176774|Irinotecan|irinotecan|mesh-list
138608804|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138608805|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
138608806|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608807|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138608808|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608809|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608810|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
138608811|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608812|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138608813|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138608814|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608815|NCT00176774|Antidotes|antidotes|mesh-ancestor
138608816|NCT00176774|Protective Agents|protective agents|mesh-ancestor
138608817|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
138608818|NCT00176774|Vitamins|vitamins|mesh-ancestor
138608819|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
138608820|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
138608821|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
138608822|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138608823|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138608824|NCT00176774|Growth Substances|growth substances|mesh-ancestor
138608825|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
138608826|NCT02421679|Cyclobenzaprine|cyclobenzaprine|mesh-list
138457050|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138457051|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
138608827|NCT02421679|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138608828|NCT02421679|Antidepressive Agents|antidepressive agents|mesh-ancestor
138608829|NCT02421679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138608830|NCT02421679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138608831|NCT02421679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608832|NCT02421679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138608833|NCT02421679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608834|NCT02421679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138608835|NCT02421679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138608836|NCT00410982|Rituximab|rituximab|mesh-list
138608837|NCT00410982|Gemcitabine|gemcitabine|mesh-list
138608838|NCT00410982|Melphalan|melphalan|mesh-list
138608839|NCT00410982|Busulfan|busulfan|mesh-list
138608840|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138608841|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608842|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
138608843|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608844|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608845|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138608846|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
138608847|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608848|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138608849|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
138608850|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138608851|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608853|NCT02372578|Analgesics|analgesics|mesh-ancestor
138608854|NCT02372578|Sensory System Agents|sensory system agents|mesh-ancestor
138608855|NCT02372578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608856|NCT02372578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608857|NCT02372578|Anticonvulsants|anticonvulsants|mesh-ancestor
138608858|NCT02372578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138608859|NCT02372578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138608860|NCT02372578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608861|NCT02372578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138608862|NCT02372578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138608863|NCT02372578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138608864|NCT02372578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138608865|NCT02372578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138608866|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
138608867|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138608868|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138608870|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608871|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138608872|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138608873|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608874|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608876|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138608877|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138608878|NCT00554476|Indomethacin|indomethacin|mesh-list
138608879|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138608880|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138608881|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
138608882|NCT00554476|Hormones|hormones|mesh-ancestor
138608883|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138608884|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608885|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138608886|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
138608887|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608888|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654132|NCT05425862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608889|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138608890|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138608891|NCT00554476|Analgesics|analgesics|mesh-ancestor
138608892|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
138608893|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608894|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608895|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
138608896|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
138608897|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138608898|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138608899|NCT02336698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138608900|NCT02336698|Immunologic Factors|immunologic factors|mesh-ancestor
138608901|NCT02336698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608903|NCT00204906|Vitamins|vitamins|mesh-ancestor
138608904|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
138608905|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608906|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138608907|NCT02335918|Nivolumab|nivolumab|mesh-list
138608908|NCT02335918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138608909|NCT02335918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608910|NCT02335918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138608911|NCT02335918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608912|NCT00176813|Celecoxib|celecoxib|mesh-list
138608913|NCT00176813|Gemcitabine|gemcitabine|mesh-list
138608914|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138608915|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138608916|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
138608917|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608918|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138608919|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138608920|NCT00176813|Analgesics|analgesics|mesh-ancestor
138608921|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
138608922|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608923|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608924|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138608925|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608926|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138608927|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138608928|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608929|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
138608930|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138608931|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608932|NCT02320708|Acetaminophen|acetaminophen|mesh-list
138608933|NCT02320708|Ibuprofen|ibuprofen|mesh-list
138608934|NCT02320708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138608935|NCT02320708|Analgesics|analgesics|mesh-ancestor
138608936|NCT02320708|Sensory System Agents|sensory system agents|mesh-ancestor
138608937|NCT02320708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608938|NCT02320708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608939|NCT02320708|Antipyretics|antipyretics|mesh-ancestor
138608940|NCT02320708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138608941|NCT02320708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138608942|NCT02320708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138608943|NCT02320708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138608944|NCT02320708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138608945|NCT02320708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608946|NCT02309671|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138608947|NCT02309671|Hormones|hormones|mesh-ancestor
138608948|NCT02309671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138608949|NCT02309671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608951|NCT02296645|Chlorhexidine|chlorhexidine|mesh-list
138608952|NCT02296645|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138608953|NCT02296645|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138608954|NCT02296645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138608955|NCT02296645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138608956|NCT02296645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608958|NCT02296645|Dermatologic Agents|dermatologic agents|mesh-ancestor
138608959|NCT02295865|Toreforant|toreforant|mesh-list
138608960|NCT02295865|Histamine Antagonists|histamine antagonists|mesh-ancestor
138608961|NCT02295865|Histamine Agents|histamine agents|mesh-ancestor
138608962|NCT02295865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608963|NCT02295865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608964|NCT02295865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608965|NCT02282215|Lenograstim|lenograstim|mesh-list
138608966|NCT02282215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138608967|NCT02282215|Immunologic Factors|immunologic factors|mesh-ancestor
138608968|NCT02282215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608970|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
138608971|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
138608972|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
138608973|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138608974|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608975|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138608976|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
138608977|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138675413|NCT00483470|Vaccines|vaccines|mesh-list
138608978|NCT00177008|Aripiprazole|aripiprazole|mesh-list
138608979|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
138608980|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138608981|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138608982|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138608983|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138608984|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138608985|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
138608986|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
138608987|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138608988|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138608989|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138608990|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138608991|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
138608992|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138608993|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138608994|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138608995|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138608996|NCT04677985|Analgesics|analgesics|mesh-list
138608997|NCT04677985|Menthol|menthol|mesh-list
138608998|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
138608999|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609000|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609001|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
138609002|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
138609003|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138609004|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138609005|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138609006|NCT00554632|Norgestimate|norgestimate|mesh-list
138609007|NCT00554632|Norelgestromin|norelgestromin|mesh-list
138609008|NCT00554632|Ortho Evra|ortho evra|mesh-list
138609010|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138609011|NCT00554632|Estrogens|estrogens|mesh-ancestor
138609012|NCT00554632|Hormones|hormones|mesh-ancestor
138609013|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138609014|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609015|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138609016|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
138609018|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138609019|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138609020|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138609021|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138609022|NCT00204984|Hydralazine|hydralazine|mesh-list
138609023|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138609024|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
138609025|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609026|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138609027|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
138609028|NCT02236195|Mocetinostat|mocetinostat|mesh-list
138609029|NCT02236195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138609030|NCT02236195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609031|NCT02236195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609032|NCT02236156|Metronidazole|metronidazole|mesh-list
138609033|NCT02236156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609034|NCT02236156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138609035|NCT02236156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138609036|NCT02236156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138609037|NCT00177086|Alfuzosin|alfuzosin|mesh-list
138609038|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138609039|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138609040|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138609041|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
138609042|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138457069|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138609043|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609044|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609045|NCT00177086|Urological Agents|urological agents|mesh-ancestor
138609046|NCT02207257|Edoxaban|edoxaban|mesh-list
138609047|NCT02207257|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138609048|NCT02207257|Antithrombins|antithrombins|mesh-ancestor
138609049|NCT02207257|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138609050|NCT02207257|Protease Inhibitors|protease inhibitors|mesh-ancestor
138609051|NCT02207257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609052|NCT02207257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609053|NCT02207257|Anticoagulants|anticoagulants|mesh-ancestor
138609054|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
138609055|NCT00554710|Budesonide|budesonide|mesh-list
138609056|NCT00554710|Infliximab|infliximab|mesh-list
138609057|NCT00554710|Azathioprine|azathioprine|mesh-list
138609058|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138609059|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
138609060|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
138609061|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609062|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609063|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138609064|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
138609065|NCT00554710|Hormones|hormones|mesh-ancestor
138609066|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138654176|NCT05372887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138609067|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138609068|NCT00554710|Protective Agents|protective agents|mesh-ancestor
138609069|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609070|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138609071|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138609072|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
138609073|NCT00554710|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138609074|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
138609075|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138609076|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
138285435|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138609077|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609078|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138609079|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609080|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
138609082|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138609083|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609084|NCT04659109|Glenzocimab|glenzocimab|mesh-list
138609085|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
138609086|NCT00177242|Gefitinib|gefitinib|mesh-list
138609087|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609088|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138609089|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609090|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609091|NCT04659070|Telmisartan|telmisartan|mesh-list
138609092|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138609093|NCT04659070|Ezetimibe|ezetimibe|mesh-list
138609094|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138609095|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138609096|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
138609097|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609098|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138609099|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138609101|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138609102|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138609103|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138609104|NCT00177281|Belotecan|belotecan|mesh-list
138609105|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138609106|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138609107|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609108|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609109|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609110|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
138609111|NCT00200226|Pyridoxal|pyridoxal|mesh-list
138609112|NCT00200226|Pyridoxine|pyridoxine|mesh-list
138609113|NCT00200226|Misoprostol|misoprostol|mesh-list
138609114|NCT00200226|Vitamins|vitamins|mesh-ancestor
138609115|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
138609116|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609117|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138609118|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
138609119|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138609120|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138609121|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138609122|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
138609123|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
138609124|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138609125|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
138609126|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609127|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
138609128|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609129|NCT04658134|Glycine|glycine|mesh-list
138609130|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
138609131|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609132|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609133|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609134|NCT00200382|Bortezomib|bortezomib|mesh-list
138609135|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609136|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138609137|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138609138|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609139|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609140|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
138609141|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609142|NCT00177398|Insulin|insulin|mesh-list
138609143|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138609144|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
138609145|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138609146|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609147|NCT00200421|Atenolol|atenolol|mesh-list
138609148|NCT00200421|Nebivolol|nebivolol|mesh-list
138609149|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138609150|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138609151|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
138609152|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
138609153|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609154|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609155|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138285507|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
138609157|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138609158|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
138609159|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609160|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609161|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
138609162|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138609163|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138609164|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138609165|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138609166|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138675589|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609167|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609169|NCT04656262|Doxorubicin|doxorubicin|mesh-list
138609170|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609171|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
138609172|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609173|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138609174|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138488414|NCT00005831|Paclitaxel|paclitaxel|mesh-list
138609175|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
138609176|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609177|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609178|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138609179|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138609180|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138609181|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138609182|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609183|NCT00200460|Nebivolol|nebivolol|mesh-list
138609184|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138609185|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
138609186|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138609187|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138609188|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138609189|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
138609190|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609191|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609192|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609193|NCT00200499|Nebivolol|nebivolol|mesh-list
138609194|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138609195|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
138609196|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138609197|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138609198|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138609199|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
138609200|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609201|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609202|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609203|NCT00200538|Memantine|memantine|mesh-list
138609204|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138609205|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138609206|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
138609207|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138675633|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
138609208|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609209|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609210|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138609211|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138609212|NCT00177710|Amphotericin B|amphotericin b|mesh-list
138609213|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138654248|NCT05211895|Durvalumab|durvalumab|mesh-list
138609214|NCT00177710|Amebicides|amebicides|mesh-ancestor
138609215|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138609216|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138609217|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609218|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138609219|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
138609220|NCT00177749|Posaconazole|posaconazole|mesh-list
138609221|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
138609222|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609223|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138609224|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138609225|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138609226|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138609227|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138609228|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609229|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609230|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138609231|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
138609232|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138609233|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609234|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138488427|NCT00005834|Thalidomide|thalidomide|mesh-list
138609235|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138609236|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138609237|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138609238|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609239|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609240|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609241|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138609242|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
138609243|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138609245|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138609246|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609247|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138609248|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
138609249|NCT04654741|Ganirelix|ganirelix|mesh-list
138609250|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138609251|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138609252|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138609253|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
138609254|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138609255|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609256|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138609257|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138609258|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138609259|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138609260|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609261|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
138609262|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138609263|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
138654275|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654276|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138609264|NCT04654195|Doxorubicin|doxorubicin|mesh-list
138609265|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609266|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
138609267|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609268|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138609269|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138609270|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
138609271|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609272|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609273|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138609274|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138609275|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138609276|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138609277|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609278|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
138609279|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138609280|NCT03454789|Lidocaine|lidocaine|mesh-list
138609281|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
138609282|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
138609283|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138609284|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609285|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
138609286|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609287|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138609288|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138609289|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138609290|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138488446|NCT00005834|Hormones|hormones|mesh-ancestor
138609291|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609293|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138609294|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138609295|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
138609296|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609297|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138609298|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138609299|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609300|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
138609301|NCT04653493|Fludarabine|fludarabine|mesh-list
138609302|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609303|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
138609304|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609305|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138609306|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138609307|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
138675694|NCT00484055|Gentamicins|gentamicins|mesh-list
138654295|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
138609308|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609309|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609310|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138609312|NCT00200694|Ramipril|ramipril|mesh-list
138609313|NCT00200694|Furosemide|furosemide|mesh-list
138609314|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138609315|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138609316|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138609317|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609319|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
138609320|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609321|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138609322|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138609323|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138609324|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
138609325|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609326|NCT00557713|Bevacizumab|bevacizumab|mesh-list
138609327|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138609328|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609329|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138609330|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138609331|NCT00557713|Growth Substances|growth substances|mesh-ancestor
138609332|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609333|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
138609334|NCT00178100|Paroxetine|paroxetine|mesh-list
138609335|NCT00178100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138609336|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138609337|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138609338|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609339|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609340|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
138609341|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609342|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138609343|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
138609344|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138609345|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138609346|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138609347|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609348|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
138609349|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138654325|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
138609350|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138609351|NCT04653415|Prednisolone|prednisolone|mesh-list
138609352|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
138609353|NCT04653415|Gabapentin|gabapentin|mesh-list
138609354|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138609355|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
138609356|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138609357|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
138609358|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
138609359|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609360|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609361|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138609362|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
138609363|NCT04653415|Hormones|hormones|mesh-ancestor
138675708|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609364|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138457101|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609365|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138609366|NCT04653415|Protective Agents|protective agents|mesh-ancestor
138609367|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138609368|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609369|NCT04653415|Analgesics|analgesics|mesh-ancestor
138609370|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
138609371|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
138609372|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138609373|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138609374|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138609375|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138609376|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138609377|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138609378|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609379|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609380|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
138609381|NCT00557791|Ranibizumab|ranibizumab|mesh-list
138609382|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138609383|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138609384|NCT00557791|Growth Substances|growth substances|mesh-ancestor
138609385|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609386|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
138609388|NCT04652284|Amoxicillin|amoxicillin|mesh-list
138609389|NCT04652284|Clarithromycin|clarithromycin|mesh-list
138609390|NCT04652284|Rifabutin|rifabutin|mesh-list
138609391|NCT04652284|Tinidazole|tinidazole|mesh-list
138609392|NCT04652284|Esomeprazole|esomeprazole|mesh-list
138609393|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138609394|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609395|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138609396|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138609397|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138609398|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609399|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609400|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138654364|NCT04865289|Lenvatinib|lenvatinib|mesh-list
138609401|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138609402|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138609403|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138609406|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138609407|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138609408|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138609409|NCT04652323|Calcium|calcium|mesh-list
138609410|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138609411|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609412|NCT04652011|Analgesics|analgesics|mesh-list
138609413|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
138609414|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609415|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609416|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
138609417|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138609418|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609419|NCT00205725|Olanzapine|olanzapine|mesh-list
138609420|NCT00205725|Ziprasidone|ziprasidone|mesh-list
138609421|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
138609422|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
138609423|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609424|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609425|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138609426|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138609427|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138609428|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138609429|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138609430|NCT00205725|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138457108|NCT01916577|Plerixafor|plerixafor|mesh-list
138609431|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138609432|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138609433|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609434|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609435|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
138609436|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138609437|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138609438|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
138609439|NCT00178373|Modafinil|modafinil|mesh-list
138609440|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138609441|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609442|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138609443|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138609444|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138609445|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609446|NCT00205764|Melphalan|melphalan|mesh-list
138609447|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138609448|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
138609449|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609450|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609451|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138609452|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609453|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
138609454|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488497|NCT00005843|Tipifarnib|tipifarnib|mesh-list
138609455|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
138609456|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138609457|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
138609458|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609459|NCT00558142|Expectorants|expectorants|mesh-ancestor
138609460|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
138609462|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
138609463|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609464|NCT00558142|Protective Agents|protective agents|mesh-ancestor
138609465|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609466|NCT00558142|Antidotes|antidotes|mesh-ancestor
138609467|NCT00205842|Alvimopan|alvimopan|mesh-list
138609468|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138609469|NCT00178451|Abciximab|abciximab|mesh-list
138609470|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
138609471|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138609472|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138609473|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
138609474|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138609475|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138609476|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138609477|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138609478|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609480|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
138609481|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138609482|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138609483|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
138609484|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609485|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609486|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138609487|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
138609488|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
138609489|NCT00206154|Hormones|hormones|mesh-ancestor
138609490|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138609491|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138609492|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138609493|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138609494|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
138609495|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609496|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609497|NCT00559702|Natalizumab|natalizumab|mesh-list
138609498|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
138609499|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609500|NCT00559741|Leucovorin|leucovorin|mesh-list
138609501|NCT00559741|Fluorouracil|fluorouracil|mesh-list
138654412|NCT04666636|Mirabegron|mirabegron|mesh-list
138609502|NCT00559741|Irinotecan|irinotecan|mesh-list
138609503|NCT00559741|Cetuximab|cetuximab|mesh-list
138609504|NCT00559741|Calcium|calcium|mesh-list
138609505|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
138609506|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138609507|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609508|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
138609509|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609510|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138609511|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609512|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609513|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
138609514|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138609515|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138609516|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609517|NCT00559741|Antidotes|antidotes|mesh-ancestor
138609518|NCT00559741|Protective Agents|protective agents|mesh-ancestor
138609519|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
138609520|NCT00559741|Vitamins|vitamins|mesh-ancestor
138609521|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
138609522|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138609523|NCT00178763|Interferons|interferons|mesh-list
138609524|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
138609525|NCT00178763|Cisplatin|cisplatin|mesh-list
138609526|NCT00178763|Gemcitabine|gemcitabine|mesh-list
138609527|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609528|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138609529|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
138609530|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609531|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
138609532|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609533|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
138609534|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609536|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
138609537|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
138609538|NCT00559858|Vitamins|vitamins|mesh-ancestor
138609539|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
138609540|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609541|NCT00559975|Vaccines|vaccines|mesh-list
138609542|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
138609543|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609544|NCT00206193|Misoprostol|misoprostol|mesh-list
138609545|NCT00206193|Sulprostone|sulprostone|mesh-list
138609546|NCT00206193|Mifepristone|mifepristone|mesh-list
138609547|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138609548|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
138609549|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138609550|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609551|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138609552|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138609553|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
138609554|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138609555|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138609556|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138609557|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138609558|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
138609559|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138609560|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138609561|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
138675864|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
138609562|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138609563|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
138609564|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138609565|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138609567|NCT04638439|Nivolumab|nivolumab|mesh-list
138457129|NCT01916707|Enoxaparin|enoxaparin|mesh-list
138609568|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138609569|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609570|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138609571|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609572|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
138609573|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609574|NCT00178802|Interferons|interferons|mesh-list
138609575|NCT00178802|Doxorubicin|doxorubicin|mesh-list
138609576|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138609577|NCT00178802|Fluorouracil|fluorouracil|mesh-list
138609578|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138609579|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609580|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138609581|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138609582|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609583|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609584|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
138609585|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138609586|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609587|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
138675907|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138609588|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609589|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
138164979|NCT01013779|Etoposide|etoposide|mesh-list
138609590|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609592|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
138609593|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138609594|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138609595|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609596|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138609597|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609598|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
138609599|NCT00408278|Analgesics|analgesics|mesh-ancestor
138609600|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
138609601|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609602|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609603|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609604|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138609605|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138609606|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609607|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609608|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
138609609|NCT00560092|Analgesics|analgesics|mesh-ancestor
138609610|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
138654456|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138609611|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609612|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609614|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138609615|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138609616|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
138609617|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138609618|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138609619|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138675956|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138609620|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138609621|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
138609622|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138609623|NCT00560170|Simvastatin|simvastatin|mesh-list
138609624|NCT00560170|Ezetimibe|ezetimibe|mesh-list
138609625|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138609626|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138609627|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138609628|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
138609629|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609630|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138609631|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138609632|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609633|NCT04637152|Valsartan|valsartan|mesh-list
138609634|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138609635|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138609636|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138609637|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138609638|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609639|NCT04636918|Cyclosporine|cyclosporine|mesh-list
138609640|NCT04636918|Cyclosporins|cyclosporins|mesh-list
138609641|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609642|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609643|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609644|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
138609645|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609646|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
138609647|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609648|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
138609649|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138609650|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138609652|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138609653|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138609654|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
138609655|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609656|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609657|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609658|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138609659|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
138609660|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138609661|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138609662|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138609663|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609664|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138609665|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138609666|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609667|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609668|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609669|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138609670|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138609671|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138609672|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
138609673|NCT04636957|Hormones|hormones|mesh-ancestor
138609674|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138609675|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609676|NCT00560326|Tacrolimus|tacrolimus|mesh-list
138609677|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609678|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
138609679|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609680|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138609681|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609682|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609683|NCT00560443|Ketorolac|ketorolac|mesh-list
138609684|NCT00560443|Tramadol|tramadol|mesh-list
138609685|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138609686|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138609687|NCT00560443|Analgesics|analgesics|mesh-ancestor
138609688|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
138609689|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609690|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609691|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138609692|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138609693|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138609694|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609695|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609696|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138609697|NCT00560443|Narcotics|narcotics|mesh-ancestor
138609698|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138609699|NCT00179114|Baclofen|baclofen|mesh-list
138609700|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
138609701|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138609702|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138609703|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138609704|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138609705|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609706|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
138609707|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609708|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609709|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138676032|NCT00485108|Prednisolone|prednisolone|mesh-list
138488546|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
138609710|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609711|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138609712|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138609713|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
138609715|NCT00201318|Lamivudine|lamivudine|mesh-list
138609716|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
138609717|NCT00201318|Doxorubicin|doxorubicin|mesh-list
138609718|NCT00201318|Vincristine|vincristine|mesh-list
138609719|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609720|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
138609721|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609722|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138609723|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138609724|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
138609725|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609726|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609727|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138609728|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138609729|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138609730|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138609731|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609732|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138609733|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
138609734|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
138609735|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
138609736|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138609737|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138609738|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
138609739|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609740|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138609741|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138609742|NCT00201357|Thalidomide|thalidomide|mesh-list
138609743|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609744|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
138609745|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286111|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609746|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
138609747|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138609748|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609749|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138609750|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138609752|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
138609753|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609754|NCT00201396|Leucovorin|leucovorin|mesh-list
138609755|NCT00201396|Fluorouracil|fluorouracil|mesh-list
138609756|NCT00201396|Epirubicin|epirubicin|mesh-list
138609757|NCT00201396|Mitomycins|mitomycins|mesh-list
138609758|NCT00201396|Mitomycin|mitomycin|mesh-list
138609759|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609760|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
138609761|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609762|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138609763|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609764|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
138609765|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609766|NCT00201396|Antidotes|antidotes|mesh-ancestor
138609767|NCT00201396|Protective Agents|protective agents|mesh-ancestor
138609768|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
138609769|NCT00201396|Vitamins|vitamins|mesh-ancestor
138609770|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
138609771|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138609772|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138609773|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138609774|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609775|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
138609776|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138609777|NCT00201435|Paclitaxel|paclitaxel|mesh-list
138609778|NCT00201435|Docetaxel|docetaxel|mesh-list
138609779|NCT00201435|Capecitabine|capecitabine|mesh-list
138609780|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138609781|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609782|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
138609783|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
138609784|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
138609785|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609786|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138609787|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
138609788|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
138609789|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138609790|NCT00560599|Mupirocin|mupirocin|mesh-list
138609791|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138609792|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609793|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
138609794|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
138609795|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138609796|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138609797|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609798|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609799|NCT04635553|Praziquantel|praziquantel|mesh-list
138609800|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
138609801|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138609802|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138609803|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138609804|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138609805|NCT04634656|Lidocaine|lidocaine|mesh-list
138609806|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
138609807|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
138609808|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138609809|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609810|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
138609811|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609812|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138609813|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138609814|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138609815|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138609816|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609817|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
138609818|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138609819|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609820|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138609822|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138609823|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138609824|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138609825|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138609826|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138609827|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
138609828|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609829|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609830|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654607|NCT03793478|Cytarabine|cytarabine|mesh-list
138609832|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138609833|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138609834|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138609835|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
138609836|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609837|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609838|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609839|NCT00201630|Urological Agents|urological agents|mesh-ancestor
138609840|NCT00179231|Olanzapine|olanzapine|mesh-list
138609841|NCT00179231|Clozapine|clozapine|mesh-list
138609842|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
138609843|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
138609844|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609845|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609846|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138609847|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138609848|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138609849|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138609850|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138609851|NCT00179231|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138609852|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138609853|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138609854|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609855|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609856|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
138609857|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138609858|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
138609859|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
138609860|NCT00201669|Clofarabine|clofarabine|mesh-list
138676165|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
138609861|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138609863|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609864|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609865|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
138609866|NCT00201708|Docetaxel|docetaxel|mesh-list
138609867|NCT00201708|Doxorubicin|doxorubicin|mesh-list
138609868|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138654626|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
138609869|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
138609870|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609871|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138609872|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138609873|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
138609874|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609875|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609876|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138609877|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
138609878|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
138609879|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
138609880|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138609881|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138609882|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138609883|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609884|NCT04632121|Nicorandil|nicorandil|mesh-list
138609885|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138609886|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138609887|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
138609888|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
138609889|NCT04632121|Vitamins|vitamins|mesh-ancestor
138609890|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
138609891|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609892|NCT00179699|Pemetrexed|pemetrexed|mesh-list
138609893|NCT00179699|Lenalidomide|lenalidomide|mesh-list
138609894|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609895|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609896|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609897|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138609898|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138609899|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
138609900|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609901|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138609902|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138609903|NCT00179699|Growth Substances|growth substances|mesh-ancestor
138676219|NCT00485576|Eculizumab|eculizumab|mesh-list
138609904|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
138609905|NCT00201747|Mitomycins|mitomycins|mesh-list
138609906|NCT00201747|Mitomycin|mitomycin|mesh-list
138609907|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138609908|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609909|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
138609910|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609911|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138609912|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609913|NCT00179738|Lenalidomide|lenalidomide|mesh-list
138609914|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
138609915|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609916|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138609917|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138609918|NCT00179738|Growth Substances|growth substances|mesh-ancestor
138609919|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
138609920|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609921|NCT04631341|Melatonin|melatonin|mesh-list
138609922|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
138609923|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609924|NCT04631341|Protective Agents|protective agents|mesh-ancestor
138609925|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609926|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138609927|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138609928|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138609929|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138609930|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138609931|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609932|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609933|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609934|NCT04723238|Analgesics|analgesics|mesh-ancestor
138609935|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
138609936|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138609937|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
138609938|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138609939|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
138609940|NCT00201786|Pentostatin|pentostatin|mesh-list
138609941|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609942|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138609943|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138609944|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609945|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
138609946|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609947|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
138609948|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609949|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138676235|NCT00489944|Tamoxifen|tamoxifen|mesh-list
138609950|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138609951|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
138609952|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609953|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609954|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138609955|NCT04630444|Riluzole|riluzole|mesh-list
138609956|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
138609957|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138609958|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138609959|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609960|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609961|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138654692|NCT03383692|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138268228|NCT01687127|Calcium|calcium|mesh-list
138609963|NCT04630444|Protective Agents|protective agents|mesh-ancestor
138609964|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
138609965|NCT00186810|Busulfan|busulfan|mesh-list
138609966|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138609967|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
138609968|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609969|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138609970|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138609971|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
138609972|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609973|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138609974|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138609976|NCT04630288|Ticagrelor|ticagrelor|mesh-list
138609977|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138609978|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138609979|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138609980|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138609981|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
138609982|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138609983|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138609984|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609986|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
138609987|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138609988|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
138609989|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138609990|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138609991|NCT00561067|Prednisolone|prednisolone|mesh-list
138488631|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138609992|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
138609993|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
138609994|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138609995|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
138609996|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138609997|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
138609998|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
138609999|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610000|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610001|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138610002|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
138610003|NCT00561067|Hormones|hormones|mesh-ancestor
138610004|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610005|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138610006|NCT00561067|Protective Agents|protective agents|mesh-ancestor
138610007|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138610008|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610009|NCT00561067|Hematinics|hematinics|mesh-ancestor
138610010|NCT00561106|Valacyclovir|valacyclovir|mesh-list
138610011|NCT00561106|Prednisone|prednisone|mesh-list
138610012|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138610013|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
138654724|NCT03330132|Vaccines|vaccines|mesh-list
138610015|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610016|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610017|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138610019|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
138610020|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610021|NCT00561184|Vaccines|vaccines|mesh-list
138610022|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
138610023|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610024|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
138610025|NCT00186849|Ifosfamide|ifosfamide|mesh-list
138610026|NCT00186849|Carboplatin|carboplatin|mesh-list
138610027|NCT00186849|Doxorubicin|doxorubicin|mesh-list
138610028|NCT00186849|Etoposide|etoposide|mesh-list
138610029|NCT00186849|Topotecan|topotecan|mesh-list
138610030|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610031|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
138610032|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610033|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138610034|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138610035|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
138610036|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610037|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610038|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138610039|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138610040|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138610041|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138610042|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676340|NCT00485823|Olanzapine|olanzapine|mesh-list
138610043|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138610044|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138610045|NCT00201981|Rebamipide|rebamipide|mesh-list
138610046|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138610047|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138610048|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
138610049|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610050|NCT00201981|Protective Agents|protective agents|mesh-ancestor
138610051|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610052|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610054|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138610055|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
138610056|NCT00180011|Omalizumab|omalizumab|mesh-list
138610057|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138610058|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138610059|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
138610060|NCT00186966|Cytarabine|cytarabine|mesh-list
138610061|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
138610062|NCT00186966|Melphalan|melphalan|mesh-list
138610063|NCT00186966|Busulfan|busulfan|mesh-list
138610064|NCT00186966|Fludarabine|fludarabine|mesh-list
138610065|NCT00186966|Etoposide|etoposide|mesh-list
138610066|NCT00186966|Daunorubicin|daunorubicin|mesh-list
138610067|NCT00186966|Thioguanine|thioguanine|mesh-list
138610068|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610069|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
138610070|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610071|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138610072|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138610073|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
138610074|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610075|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610076|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138610077|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138610078|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
138610079|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138610080|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138610081|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138610082|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610083|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
138610084|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610085|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138610086|NCT00180050|Budesonide|budesonide|mesh-list
138610087|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138610088|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138610089|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
138610090|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610091|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610092|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138610093|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
138610094|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
138610096|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610097|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138610098|NCT00575302|Hormones|hormones|mesh-ancestor
138610099|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610100|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610101|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138610102|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138610103|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
138610104|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610105|NCT00180089|Budesonide|budesonide|mesh-list
138610106|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138610107|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138610108|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
138610109|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138654775|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
138610110|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610111|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138610112|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
138610113|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
138610115|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610116|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
138488675|NCT00005867|Etoposide|etoposide|mesh-list
138610117|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138610118|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
138610119|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610120|NCT00575419|Expectorants|expectorants|mesh-ancestor
138610121|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
138610122|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138610123|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
138610124|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610125|NCT00575419|Protective Agents|protective agents|mesh-ancestor
138610126|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610128|NCT00180128|Cytarabine|cytarabine|mesh-list
138610129|NCT00180128|Daunorubicin|daunorubicin|mesh-list
138610130|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
138610131|NCT00180128|Idarubicin|idarubicin|mesh-list
138610132|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138610133|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
138610134|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610135|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610136|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
138610137|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610138|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610139|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
138610140|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610141|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138610142|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138610143|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138610144|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610145|NCT00180128|Analgesics|analgesics|mesh-ancestor
138610146|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
138610147|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610148|NCT00575614|Prucalopride|prucalopride|mesh-list
138610149|NCT00575614|Laxatives|laxatives|mesh-ancestor
138610150|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138610151|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138610152|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138610153|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
138676411|NCT00485940|Prucalopride|prucalopride|mesh-list
138610154|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610155|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610156|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610158|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
138654804|NCT03006705|Capecitabine|capecitabine|mesh-list
138610159|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610160|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610161|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610162|NCT00576238|Betamethasone|betamethasone|mesh-list
138610163|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
138610164|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138610165|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
138610166|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138610167|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138610168|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
138610169|NCT00576238|Hormones|hormones|mesh-ancestor
138488680|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
138610170|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610171|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610172|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138610173|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
138610174|NCT00576394|Insulin|insulin|mesh-list
138610175|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138610176|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138610177|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610178|NCT00576433|Rituximab|rituximab|mesh-list
138610179|NCT00576433|Methotrexate|methotrexate|mesh-list
138610180|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138610181|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610182|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
138610183|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610184|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138610185|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138610186|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
138610187|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138610188|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138610189|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
138610190|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610191|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
138610192|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610193|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138610194|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610195|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138610196|NCT00576511|Prucalopride|prucalopride|mesh-list
138610197|NCT00576511|Laxatives|laxatives|mesh-ancestor
138286585|NCT03388268|Vancomycin|vancomycin|mesh-list
138610198|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138610199|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138610200|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138610202|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610203|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610204|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610205|NCT00576550|Betamethasone|betamethasone|mesh-list
138610206|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
138610207|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138610208|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
138654828|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
138610209|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138610210|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138610211|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
138610212|NCT00576550|Hormones|hormones|mesh-ancestor
138676421|NCT00486005|Nizatidine|nizatidine|mesh-list
138610213|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610214|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610215|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138610216|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
138610217|NCT00576706|Misoprostol|misoprostol|mesh-list
138610218|NCT00576706|Rebamipide|rebamipide|mesh-list
138610219|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138610220|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
138610221|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138610222|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610223|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138610224|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138610225|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
138610226|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
138610227|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610228|NCT00576706|Protective Agents|protective agents|mesh-ancestor
138610229|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610230|NCT00576784|Pioglitazone|pioglitazone|mesh-list
138610231|NCT00576784|Glimepiride|glimepiride|mesh-list
138610232|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138610233|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610234|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138610235|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610236|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
138610237|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
138610238|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138610239|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610240|NCT00202020|Aspirin|aspirin|mesh-list
138610241|NCT00202020|Cilostazol|cilostazol|mesh-list
138610242|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138610243|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138610244|NCT00202020|Analgesics|analgesics|mesh-ancestor
138610245|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
138610246|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610247|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610248|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138610249|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138610250|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138610251|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138610252|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654848|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138654854|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
138610253|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138610254|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138610255|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610256|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
138610257|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138610258|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
138610259|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138610261|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
138610262|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138610263|NCT00202020|Protective Agents|protective agents|mesh-ancestor
138610264|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138610265|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138610266|NCT00577018|Prucalopride|prucalopride|mesh-list
138610267|NCT00577018|Laxatives|laxatives|mesh-ancestor
138610268|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138610269|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138610270|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138610271|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
138610272|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610273|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610274|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610275|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
138610276|NCT04578847|Dasatinib|dasatinib|mesh-list
138610277|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610278|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138610279|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610280|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610281|NCT00577057|Capecitabine|capecitabine|mesh-list
138610282|NCT00577057|Fluorouracil|fluorouracil|mesh-list
138610283|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610284|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138610286|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610287|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610288|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
138610289|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610290|NCT00187005|Cytarabine|cytarabine|mesh-list
138610291|NCT00187005|Dexamethasone|dexamethasone|mesh-list
138610292|NCT00187005|Prednisone|prednisone|mesh-list
138610293|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
138610294|NCT00187005|Methotrexate|methotrexate|mesh-list
138610295|NCT00187005|Etoposide|etoposide|mesh-list
138610296|NCT00187005|Vincristine|vincristine|mesh-list
138610297|NCT00187005|Daunorubicin|daunorubicin|mesh-list
138610298|NCT00187005|Asparaginase|asparaginase|mesh-list
138610299|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
138610300|NCT00187005|Idarubicin|idarubicin|mesh-list
138610301|NCT00187005|Pegaspargase|pegaspargase|mesh-list
138654878|NCT02546661|Olaparib|olaparib|mesh-list
138610302|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610303|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
138610304|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610305|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138610306|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138610307|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
138610308|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610309|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610310|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138610311|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138610313|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
138457187|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610314|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610315|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138610316|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
138610318|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610319|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138610320|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138610321|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
138610322|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138610323|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138610324|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
138610325|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
138610326|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610327|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138610328|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138610329|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138610330|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138610331|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138610332|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
138610333|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610334|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
138610335|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
138610336|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138610337|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138610338|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
138610339|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138610340|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610341|NCT00577369|Desflurane|desflurane|mesh-list
138610342|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138610343|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
138610344|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
138610345|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138610346|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610347|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138610348|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
138610349|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610351|NCT00187083|Methotrexate|methotrexate|mesh-list
138610352|NCT00187083|Fludarabine|fludarabine|mesh-list
138610353|NCT00187083|Etoposide|etoposide|mesh-list
138610354|NCT00187083|Vincristine|vincristine|mesh-list
138654907|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610355|NCT00187083|Asparaginase|asparaginase|mesh-list
138610356|NCT00187083|Topotecan|topotecan|mesh-list
138610357|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
138610358|NCT00187083|Idarubicin|idarubicin|mesh-list
138610359|NCT00187083|Pegaspargase|pegaspargase|mesh-list
138610360|NCT00187083|Teniposide|teniposide|mesh-list
138610361|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138610362|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
138610363|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
138610364|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610365|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610366|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138610367|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
138610368|NCT00187083|Hormones|hormones|mesh-ancestor
138610369|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610370|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138610371|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610372|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138610374|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138610375|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138610376|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
138610377|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610378|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
138610379|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610380|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138610381|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610382|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
138610383|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138610384|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138610385|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138610386|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138610387|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138610388|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
138610389|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
138610390|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
138610391|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138610392|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138610393|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
138610394|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
138610395|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138610396|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138610397|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610398|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138610399|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610400|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138610401|NCT00578149|Paclitaxel|paclitaxel|mesh-list
138610402|NCT00578149|Bevacizumab|bevacizumab|mesh-list
138610403|NCT00578149|Carboplatin|carboplatin|mesh-list
138610404|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138610405|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610406|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
138610407|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
138610408|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
138610409|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610410|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138610411|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138610412|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138610413|NCT00578149|Growth Substances|growth substances|mesh-ancestor
138610414|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610415|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
138610416|NCT00187122|Cytarabine|cytarabine|mesh-list
138610417|NCT00187122|Dexamethasone|dexamethasone|mesh-list
138610418|NCT00187122|Prednisone|prednisone|mesh-list
138610419|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
138610420|NCT00187122|Methotrexate|methotrexate|mesh-list
138610421|NCT00187122|Etoposide|etoposide|mesh-list
138610422|NCT00187122|Vincristine|vincristine|mesh-list
138610423|NCT00187122|Asparaginase|asparaginase|mesh-list
138610424|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
138610425|NCT00187122|Daunorubicin|daunorubicin|mesh-list
138610426|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610427|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
138610428|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610429|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138610430|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138610431|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
138610432|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610433|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610434|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138488737|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
138610435|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138610436|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
138610437|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
138610438|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610439|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138610442|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610443|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138610444|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138610445|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
138610446|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138610447|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138610448|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
138610449|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
138610450|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610451|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138610452|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138610453|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138610454|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138610455|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138610456|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
138610457|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610458|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
138610459|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
138610460|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
138610461|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138610462|NCT00180635|Pimagedine|pimagedine|mesh-list
138610463|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610464|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610465|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
138610466|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
138610467|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610468|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
138610469|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610470|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138610471|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138610472|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
138654952|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138610473|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610474|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610475|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138610476|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138610477|NCT04578496|Afamelanotide|afamelanotide|mesh-list
138610478|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
138610479|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
138610480|NCT00579046|Hematinics|hematinics|mesh-ancestor
138610481|NCT00579085|Ketamine|ketamine|mesh-list
138610482|NCT00579085|Analgesics|analgesics|mesh-ancestor
138610483|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
138610484|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610485|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610486|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138610487|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138610488|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
138610489|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
138610490|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138610491|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138610492|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138610493|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610494|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610495|NCT00187161|Cytarabine|cytarabine|mesh-list
138610496|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
138610497|NCT00187161|Doxorubicin|doxorubicin|mesh-list
138488747|NCT00001119|Zidovudine|zidovudine|mesh-list
138610498|NCT00187161|Methotrexate|methotrexate|mesh-list
138610499|NCT00187161|Etoposide|etoposide|mesh-list
138610500|NCT00187161|Vincristine|vincristine|mesh-list
138610501|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610502|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
138610503|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610504|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138610505|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138610506|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
138610507|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610508|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610509|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138610510|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138610511|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138610512|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138610513|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610514|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138610515|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
138610516|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138654969|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610517|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138610518|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
138610519|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
138610520|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138610521|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138610522|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138610523|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
138610524|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610525|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
138610526|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
138610527|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
138610529|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138610530|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
138610531|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138610532|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610533|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138610534|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138610535|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138610536|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
138610537|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138610538|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138610539|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
138610540|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610541|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
138610542|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138610543|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138610544|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
138610545|NCT00579592|Rituximab|rituximab|mesh-list
138610546|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
138610547|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138610548|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138676607|NCT01301833|Biguanides|biguanides|mesh-list
138610550|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610551|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138610552|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138610553|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138488761|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
138610555|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138610556|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610557|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610558|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457242|NCT01917149|Valsartan|valsartan|mesh-list
138655001|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138610559|NCT00180791|Carboplatin|carboplatin|mesh-list
138610560|NCT00180791|Etoposide|etoposide|mesh-list
138610561|NCT00180791|Melphalan|melphalan|mesh-list
138610562|NCT00180791|Thiotepa|thiotepa|mesh-list
138610563|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610564|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138610565|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138610566|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138610567|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610568|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610569|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138610570|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
138610571|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138610572|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610573|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
138610574|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610575|NCT01054248|Artesunate|artesunate|mesh-list
138286948|NCT04352660|Mitomycins|mitomycins|mesh-list
138610576|NCT01054248|Piperaquine|piperaquine|mesh-list
138610577|NCT01054248|Artenimol|artenimol|mesh-list
138610578|NCT01054248|Mefloquine|mefloquine|mesh-list
138610579|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
138610580|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138610581|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138610582|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610583|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610584|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
138610585|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
138610586|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138610587|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
138610588|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
138610589|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610590|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138610591|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610592|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610593|NCT00202176|Bromides|bromides|mesh-list
138610594|NCT00202176|Ipratropium|ipratropium|mesh-list
138610595|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
138610596|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138610597|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
138610598|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610599|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610600|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138610601|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
138610602|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138610603|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
138610604|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610605|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610606|NCT00580060|Molgramostim|molgramostim|mesh-list
138610607|NCT00580060|Sargramostim|sargramostim|mesh-list
138610608|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
138610609|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610610|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610611|NCT00180908|Doxorubicin|doxorubicin|mesh-list
138610612|NCT00180908|Etoposide|etoposide|mesh-list
138610613|NCT00180908|Methotrexate|methotrexate|mesh-list
138610614|NCT00180908|Ifosfamide|ifosfamide|mesh-list
138610615|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138610616|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610617|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138610618|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138610619|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610620|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610621|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138610623|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138610624|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610625|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138610626|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
138610627|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
138610628|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138610629|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610630|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
138610631|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138610632|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138610633|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138610634|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138610635|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
138610636|NCT00580450|Thymalfasin|thymalfasin|mesh-list
138610637|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138610638|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
138610639|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610640|NCT00180947|Vinorelbine|vinorelbine|mesh-list
138610641|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138610642|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610643|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
138610644|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
138610645|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
138610646|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610647|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138610648|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
138610649|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610650|NCT00581425|Interferons|interferons|mesh-list
138610651|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
138287038|NCT03336853|Hybenx|hybenx|mesh-list
138610652|NCT00581425|Imiquimod|imiquimod|mesh-list
138610653|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610654|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
138610655|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610656|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
138610657|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610658|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138610659|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
138610661|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
138610662|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610664|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
138610665|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
138610666|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610667|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138610668|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610669|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
138610670|NCT04576975|Ketamine|ketamine|mesh-list
138610671|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138610672|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138610673|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610674|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138610676|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
138676707|NCT00486980|Peramivir|peramivir|mesh-list
138610677|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610678|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138610679|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138610680|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138610681|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
138610682|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610683|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610684|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138610685|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138610686|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
138610687|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
138610688|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138610689|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138610690|NCT00209118|Paroxetine|paroxetine|mesh-list
138610691|NCT00209118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138610692|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138610693|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138610694|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610695|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610696|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
138610697|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610698|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138610699|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
138610700|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138610701|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138610702|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138610703|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610704|NCT00181025|Melphalan|melphalan|mesh-list
138610705|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138610706|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
138610707|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610708|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610709|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138610710|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610711|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
138610712|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610713|NCT00209313|Acyclovir|acyclovir|mesh-list
138610714|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
138610715|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610716|NCT00582634|Docetaxel|docetaxel|mesh-list
138676731|NCT00487032|Xhance|xhance|mesh-list
138610717|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610718|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
138610719|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
138610720|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
138610721|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610722|NCT00209352|Acyclovir|acyclovir|mesh-list
138610723|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
138610724|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610725|NCT00181142|Daclizumab|daclizumab|mesh-list
138610726|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610727|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
138610728|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610729|NCT00582985|Antibodies|antibodies|mesh-list
138610730|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
138610731|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610732|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
138610733|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138610734|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138610735|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610736|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138610737|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138610738|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
138610739|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610741|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138610742|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138610743|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
138610744|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610745|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138610746|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138610747|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610748|NCT00181220|Valproic Acid|valproic acid|mesh-list
138610749|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
138610750|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610751|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610752|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
138610753|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138655122|NCT00349401|Ketorolac|ketorolac|mesh-list
138610754|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610755|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
138610756|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138610757|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138610758|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138610759|NCT00583063|Sirolimus|sirolimus|mesh-list
138610760|NCT00583063|Sunitinib|sunitinib|mesh-list
138610761|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610762|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138610763|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138610764|NCT00583063|Growth Substances|growth substances|mesh-ancestor
138610765|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610766|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
138457259|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
138610767|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138610768|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610769|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610770|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138610771|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610772|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138610773|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
138610774|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138610775|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
138610776|NCT00181298|Memantine|memantine|mesh-list
138610777|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138610778|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138610779|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
138610780|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610781|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610782|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610783|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138610784|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138610785|NCT00583180|Capsaicin|capsaicin|mesh-list
138610786|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
138610787|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
138610788|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
138610789|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610790|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610791|NCT00583258|Alfuzosin|alfuzosin|mesh-list
138610792|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138610793|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138610794|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138610795|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
138610796|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610797|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610798|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610799|NCT00583258|Urological Agents|urological agents|mesh-ancestor
138610800|NCT00181532|Celecoxib|celecoxib|mesh-list
138287176|NCT03473665|Celecoxib|celecoxib|mesh-list
138610801|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138610802|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138610803|NCT00181532|Analgesics|analgesics|mesh-ancestor
138610804|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
138610805|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610806|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610807|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138318425|NCT01402284|Dexamethasone|dexamethasone|mesh-list
138610808|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138610809|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138610810|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138610811|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610812|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610814|NCT04576390|Palonosetron|palonosetron|mesh-list
138610815|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
138610816|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
138610817|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610818|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610819|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138610820|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
138610821|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
138610822|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138610823|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138610824|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
138610825|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610826|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610827|NCT00181571|Methylphenidate|methylphenidate|mesh-list
138610828|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138610829|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655176|NCT00349557|Bicalutamide|bicalutamide|mesh-list
138610831|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138610832|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138610833|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610834|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
138610835|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610836|NCT00187707|Gabapentin|gabapentin|mesh-list
138610837|NCT00187707|Analgesics|analgesics|mesh-ancestor
138610838|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
138610839|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610840|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610841|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
138610842|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138610843|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138610844|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138610845|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138610846|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138610847|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138610848|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610849|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610850|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
138610851|NCT00187746|Adefovir|adefovir|mesh-list
138610852|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138610853|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
138610854|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610855|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138610856|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138610857|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610858|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610859|NCT00181688|Anastrozole|anastrozole|mesh-list
138610860|NCT00181688|Gefitinib|gefitinib|mesh-list
138610861|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138610862|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610863|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138610864|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138610865|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610866|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610867|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138610868|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
138610869|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610870|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610871|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138610872|NCT00209469|Alendronate|alendronate|mesh-list
138610873|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138610874|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610875|NCT00181727|Valproic Acid|valproic acid|mesh-list
138610876|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
138610877|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610878|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610879|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
138610880|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610881|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610882|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
138610883|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138610884|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138610885|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138610886|NCT00584155|Ofloxacin|ofloxacin|mesh-list
138610887|NCT00584155|Levofloxacin|levofloxacin|mesh-list
138610888|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138610889|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138610890|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138610891|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138610892|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138610893|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138610894|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610895|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610896|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138610897|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138610898|NCT00411372|Fluticasone|fluticasone|mesh-list
138610900|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138610901|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138610902|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138610903|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138610904|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
138610905|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610906|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610907|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138610908|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
138610909|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
138610910|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138610911|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138610912|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138610913|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138610914|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
138610915|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610916|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610917|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
138610918|NCT00411372|Hormones|hormones|mesh-ancestor
138610919|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610920|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
138610921|NCT00181922|Ziprasidone|ziprasidone|mesh-list
138610922|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138610923|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
138610924|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610925|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610926|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610927|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138655244|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
138610928|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138610929|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138610930|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138610931|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138610932|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
138610933|NCT00182039|Metoprolol|metoprolol|mesh-list
138610934|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138610935|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138610936|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
138610937|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
138610938|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610939|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610940|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138610941|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138610942|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138610943|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
138610944|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610945|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610946|NCT00584389|Rimonabant|rimonabant|mesh-list
138610947|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138287323|NCT00376831|Midazolam|midazolam|mesh-list
138610948|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138610949|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138610950|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318427|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138610951|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610952|NCT00584389|Hormones|hormones|mesh-ancestor
138610953|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138610954|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610955|NCT00216372|Lanreotide|lanreotide|mesh-list
138610956|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138610957|NCT00584662|Phenylephrine|phenylephrine|mesh-list
138610958|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
138610959|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138610960|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138610961|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
138610962|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610963|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610964|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610966|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
138610967|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610968|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
138610969|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138610970|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
138610971|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138610972|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
138610973|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138610974|NCT00584662|Protective Agents|protective agents|mesh-ancestor
138610975|NCT00584779|Gabapentin|gabapentin|mesh-list
138610976|NCT00584779|Analgesics|analgesics|mesh-ancestor
138610977|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
138610978|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138610979|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610980|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
138610981|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138610982|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138610983|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138610984|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138610985|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138610986|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138610987|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610988|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610989|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
138610990|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
138610991|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138610992|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138610993|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138610994|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138676912|NCT04697355|Vitamins|vitamins|mesh-ancestor
138610995|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138610997|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138610998|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138610999|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138611000|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611001|NCT00585091|Phenylephrine|phenylephrine|mesh-list
138611002|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
138611003|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138611004|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
138611005|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
138611006|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611007|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655295|NCT00317330|Isoniazid|isoniazid|mesh-list
138611008|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
138611009|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138611010|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
138611011|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
138611012|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138611013|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138611014|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138611015|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
138611016|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611017|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611018|NCT00585091|Protective Agents|protective agents|mesh-ancestor
138611019|NCT00216450|Rabeprazole|rabeprazole|mesh-list
138611020|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138611021|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138611022|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138318428|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
138611024|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611025|NCT00585442|Vitamin D|vitamin d|mesh-list
138611026|NCT00585442|Calcitriol|calcitriol|mesh-list
138611027|NCT00585442|Vitamins|vitamins|mesh-ancestor
138611028|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
138611029|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611030|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138611031|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138611032|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138611033|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138611034|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611035|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138611036|NCT00585520|Progesterone|progesterone|mesh-list
138611037|NCT00585520|Progestins|progestins|mesh-ancestor
138611038|NCT00585520|Hormones|hormones|mesh-ancestor
138611039|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138611040|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611041|NCT00216489|Rabeprazole|rabeprazole|mesh-list
138611042|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138611043|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138611044|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138611045|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611046|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611047|NCT00585754|Guanfacine|guanfacine|mesh-list
138611048|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138611049|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138611050|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138611051|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138611052|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
138611053|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611054|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611055|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611056|NCT00209547|Fospropofol|fospropofol|mesh-list
138611057|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138611058|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611059|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611060|NCT00585871|Metoprolol|metoprolol|mesh-list
138611061|NCT00585871|Clonidine|clonidine|mesh-list
138611062|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138655335|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138611063|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138611064|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
138611065|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
138611066|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611067|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611068|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138611069|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138611070|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138611071|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
138611072|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611073|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611074|NCT00585871|Analgesics|analgesics|mesh-ancestor
138611075|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
138611076|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138611077|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138611078|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138611079|NCT03452722|Plasminogen|plasminogen|mesh-list
138611080|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138611081|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138488905|NCT00009880|Paclitaxel|paclitaxel|mesh-list
138611082|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138611083|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611084|NCT00408551|Leucovorin|leucovorin|mesh-list
138611085|NCT00408551|Fluorouracil|fluorouracil|mesh-list
138611086|NCT00408551|Floxuridine|floxuridine|mesh-list
138611087|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
138611088|NCT00408551|Irinotecan|irinotecan|mesh-list
138611089|NCT00408551|Calcium|calcium|mesh-list
138611090|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
138611091|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138611092|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611093|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
138611094|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611095|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138318429|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
138611096|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611097|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138611098|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
138611099|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138611100|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138611101|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611102|NCT00408551|Antidotes|antidotes|mesh-ancestor
138611103|NCT00408551|Protective Agents|protective agents|mesh-ancestor
138611104|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
138611105|NCT00408551|Vitamins|vitamins|mesh-ancestor
138611106|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
138611107|NCT04575415|Bevacizumab|bevacizumab|mesh-list
138611108|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138611109|NCT04575415|Gefitinib|gefitinib|mesh-list
138611110|NCT04575415|Osimertinib|osimertinib|mesh-list
138611111|NCT04575415|Afatinib|afatinib|mesh-list
138611112|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138611113|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611114|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138611115|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138611116|NCT04575415|Growth Substances|growth substances|mesh-ancestor
138611117|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611118|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
138611119|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138611120|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611121|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611122|NCT00209625|Leucovorin|leucovorin|mesh-list
138611123|NCT00209625|Fluorouracil|fluorouracil|mesh-list
138611124|NCT00209625|Irinotecan|irinotecan|mesh-list
138611125|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
138611126|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611127|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138611128|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611129|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138611130|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
138611131|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611132|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138611133|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138611134|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611135|NCT00209625|Antidotes|antidotes|mesh-ancestor
138611136|NCT00209625|Protective Agents|protective agents|mesh-ancestor
138611137|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
138611138|NCT00209625|Vitamins|vitamins|mesh-ancestor
138611139|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
138611140|NCT00216528|Risperidone|risperidone|mesh-list
138655385|NCT00317447|Hormones|hormones|mesh-ancestor
138611141|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138611142|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
138611143|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611144|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611145|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611146|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138611147|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138611148|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611149|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138611150|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138611151|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
138611153|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
138611154|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611155|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138611156|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611157|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138611158|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611159|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138611160|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138611161|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
138611162|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611163|NCT00209664|Irinotecan|irinotecan|mesh-list
138611164|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138611165|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138611166|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611167|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611168|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611169|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
138611170|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138611171|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287549|NCT03799484|Emollients|emollients|mesh-ancestor
138611172|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138611173|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138611174|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611175|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611176|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611177|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138611178|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138611180|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138611181|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138611182|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
138611183|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611184|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138655439|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
138611185|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138611186|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
138611187|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
138611188|NCT00587119|Hormones|hormones|mesh-ancestor
138611189|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138611190|NCT00216567|Topiramate|topiramate|mesh-list
138611191|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
138611192|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138611193|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611194|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
138611195|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138611196|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138611197|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611198|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
138611199|NCT00182351|Coagulants|coagulants|mesh-ancestor
138611200|NCT00587470|Candesartan|candesartan|mesh-list
138611201|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
138611202|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138611203|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138611204|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138611205|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611206|NCT00209703|Leucovorin|leucovorin|mesh-list
138611207|NCT00209703|Fluorouracil|fluorouracil|mesh-list
138611208|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
138611209|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
138611210|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
138611211|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611212|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138611213|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488928|NCT00009958|Metronidazole|metronidazole|mesh-list
138611214|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138611215|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
138611216|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611217|NCT00209703|Antidotes|antidotes|mesh-ancestor
138611218|NCT00209703|Protective Agents|protective agents|mesh-ancestor
138611219|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
138611220|NCT00209703|Vitamins|vitamins|mesh-ancestor
138611221|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
138611222|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
138611223|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138611224|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611225|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611226|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138611227|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
138611228|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138611229|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611230|NCT00216606|Topiramate|topiramate|mesh-list
138611231|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
138611232|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138611233|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611234|NCT00587665|Ketamine|ketamine|mesh-list
138611235|NCT00587665|Analgesics|analgesics|mesh-ancestor
138611236|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
138611237|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611238|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611239|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138611240|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138611241|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
138611242|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
138611243|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611244|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138611245|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138611246|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611247|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611248|NCT00182429|Metronidazole|metronidazole|mesh-list
138611249|NCT00182429|Rifampin|rifampin|mesh-list
138611250|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138611251|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138611252|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138611253|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138611254|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138611255|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
138611256|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
138611257|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138611258|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611259|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611260|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138611261|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138611262|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138611263|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138611264|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138611265|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138611266|NCT00216645|Doxorubicin|doxorubicin|mesh-list
138611267|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138611268|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138611269|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611270|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138611271|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138611272|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611273|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611274|NCT00588016|Itraconazole|itraconazole|mesh-list
138611275|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
138611276|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138611277|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138611278|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138677066|NCT00487773|Budesonide|budesonide|mesh-list
138611279|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611280|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611281|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138611282|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
138611283|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138611284|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611285|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138611287|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138611288|NCT00216684|Narcotics|narcotics|mesh-ancestor
138611289|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611290|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611291|NCT00216684|Analgesics|analgesics|mesh-ancestor
138611292|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
138611293|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611294|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138611295|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138611296|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
138611297|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
138611298|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
138611299|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138611300|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138611301|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611302|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
138611303|NCT00588133|Coagulants|coagulants|mesh-ancestor
138611304|NCT00588172|Metformin|metformin|mesh-list
138611305|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138611306|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611307|NCT00182507|Olanzapine|olanzapine|mesh-list
138611308|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
138611309|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
138611310|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611311|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611312|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138611313|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138611314|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138611315|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611316|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138611317|NCT00182507|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138611318|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138611319|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138611320|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611321|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611322|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
138611323|NCT00209742|Leucovorin|leucovorin|mesh-list
138611324|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
138611325|NCT00209742|Tegafur|tegafur|mesh-list
138611326|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
138611327|NCT00209742|Antidotes|antidotes|mesh-ancestor
138611328|NCT00209742|Protective Agents|protective agents|mesh-ancestor
138611329|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611330|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
138611331|NCT00209742|Vitamins|vitamins|mesh-ancestor
138611332|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
138655503|NCT00317915|Irbesartan|irbesartan|mesh-list
138611333|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138677086|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
138611335|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611336|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611337|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138611338|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
138611339|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138611340|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
138611341|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138611342|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
138611343|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138611344|NCT00216723|Aripiprazole|aripiprazole|mesh-list
138611345|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
138611346|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138611347|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138611348|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138611349|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611350|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611351|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
138611352|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
138611353|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611354|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611355|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138611356|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138611357|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
138611358|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138611359|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138611360|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138611361|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138611362|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
138611363|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
138655529|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
138611364|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138611366|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138611367|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138611368|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138611369|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138611370|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611371|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611372|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138611373|NCT00182663|Clarithromycin|clarithromycin|mesh-list
138611374|NCT00182663|Thalidomide|thalidomide|mesh-list
138611375|NCT00182663|Dexamethasone|dexamethasone|mesh-list
138611376|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138611377|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
138611378|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
138611379|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611380|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611381|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138611382|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
138611383|NCT00182663|Hormones|hormones|mesh-ancestor
138611384|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138611385|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138611386|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611387|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138611388|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138611389|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138611390|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611391|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138457294|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
138611392|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138611393|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138611394|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138611395|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
138611396|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
138611397|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138611398|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138488958|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138611399|NCT00182663|Growth Substances|growth substances|mesh-ancestor
138611400|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
138611402|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138611403|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611404|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
138611405|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611406|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138655573|NCT02959749|Bevacizumab|bevacizumab|mesh-list
138655574|NCT02959749|Docetaxel|docetaxel|mesh-list
138655575|NCT02959749|Osimertinib|osimertinib|mesh-list
138611409|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
138611410|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
138611411|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
138611412|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611413|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611414|NCT00588835|Dexamethasone|dexamethasone|mesh-list
138611415|NCT00588835|Ondansetron|ondansetron|mesh-list
138611416|NCT00588835|Aprepitant|aprepitant|mesh-list
138611417|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138611418|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
138611419|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
138611420|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611421|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611422|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138611423|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
138611424|NCT00588835|Hormones|hormones|mesh-ancestor
138611425|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138611426|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138611427|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611428|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
138611429|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
138611430|NCT00588835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138611431|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138611432|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
138611433|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611434|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655602|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
138611435|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138611436|NCT00209859|Cyclosporine|cyclosporine|mesh-list
138611437|NCT00209859|Betamethasone|betamethasone|mesh-list
138611438|NCT00209859|Methotrexate|methotrexate|mesh-list
138611439|NCT00209859|Cyclosporins|cyclosporins|mesh-list
138611440|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138611441|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
138611442|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138677189|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138611443|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611444|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138611445|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
138611446|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611447|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611448|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
138611449|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611450|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138611451|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138611452|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
138611453|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138611454|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138611455|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
138611456|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138611457|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138457301|NCT01917448|Narcotics|narcotics|mesh-ancestor
138611458|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138611459|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
138611460|NCT00209859|Hormones|hormones|mesh-ancestor
138611461|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138611462|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138611463|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
138611464|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
138611465|NCT00588913|Aldesleukin|aldesleukin|mesh-list
138611466|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611467|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138611468|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138611469|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
138611470|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138611471|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138611472|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611475|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
138611476|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138611477|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
138611478|NCT00182741|Hormones|hormones|mesh-ancestor
138611479|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138611480|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611481|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138611482|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611483|NCT00182741|Analgesics|analgesics|mesh-ancestor
138611484|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
138611485|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611486|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138611487|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138611488|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611489|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611490|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138611491|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138611492|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138611493|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138611494|NCT00182741|Vitamins|vitamins|mesh-ancestor
138611495|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
138611496|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138611497|NCT00589186|Celecoxib|celecoxib|mesh-list
138611498|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138611499|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138611500|NCT00589186|Analgesics|analgesics|mesh-ancestor
138611501|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
138611502|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271569|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
138611503|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611504|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138611506|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138611507|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138611508|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611509|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611510|NCT00589264|Copper|copper|mesh-list
138611511|NCT00589264|Trace Elements|trace elements|mesh-ancestor
138611512|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
138611513|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611514|NCT00589381|Fenretinide|fenretinide|mesh-list
138611515|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611516|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138611518|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611519|NCT00182819|Temozolomide|temozolomide|mesh-list
138611520|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138611521|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
138611522|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611523|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611524|NCT00216840|Betamethasone|betamethasone|mesh-list
138611525|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
138611526|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138611527|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
138611528|NCT00216840|Calcipotriene|calcipotriene|mesh-list
138611529|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138611530|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138611531|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
138611532|NCT00216840|Hormones|hormones|mesh-ancestor
138611533|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138611534|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611535|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138611536|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
138611537|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
138611539|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138611540|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138611541|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138611542|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611543|NCT00216879|Betamethasone|betamethasone|mesh-list
138287925|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
138611544|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
138611545|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138611546|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
138611548|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138611549|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138611550|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
138611552|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138611553|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271763|NCT01160107|Prednisone|prednisone|mesh-list
138611554|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138611555|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
138611556|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
138611557|NCT00589927|Cilostazol|cilostazol|mesh-list
138611558|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138611559|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
138611560|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611561|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611562|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138611563|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
138611564|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138611565|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138611566|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611567|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138611568|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
138611569|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138611570|NCT00589927|Protective Agents|protective agents|mesh-ancestor
138611571|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138611572|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138611573|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611574|NCT00209937|Gaboxadol|gaboxadol|mesh-list
138611575|NCT00209937|Analgesics|analgesics|mesh-ancestor
138611576|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
138611577|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611578|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611579|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
138611580|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
138611581|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
138611582|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611583|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611584|NCT00590278|Raltitrexed|raltitrexed|mesh-list
138611585|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138611586|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
138611587|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611588|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611589|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138611590|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611591|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138611592|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138677276|NCT00507000|Vitamin D|vitamin d|mesh-list
138611593|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138611594|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138611595|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611596|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
138611597|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611598|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611600|NCT04574791|Analgesics|analgesics|mesh-ancestor
138457313|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138611601|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
138611602|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611603|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611604|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
138611605|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138611606|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138611607|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
138611608|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
138611609|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138611610|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138611611|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138611612|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
138611613|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611614|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611615|NCT00590629|Niacin|niacin|mesh-list
138611616|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
138611617|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138611618|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
138611619|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611620|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138611621|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
138611622|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
138611623|NCT00590629|Vitamins|vitamins|mesh-ancestor
138611624|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
138611625|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611626|NCT00590785|Tamoxifen|tamoxifen|mesh-list
138611627|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
138611628|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
138611629|NCT00590785|Doxorubicin|doxorubicin|mesh-list
138611630|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138611631|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
138611632|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611633|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138611634|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138611635|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
138611636|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138655785|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138611637|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611638|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138611639|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138611640|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138611641|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138611642|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611643|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138611644|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
138611645|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138611646|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138611647|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138611648|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138611649|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138611650|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138611651|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138611652|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138611653|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138611655|NCT00477295|Zonisamide|zonisamide|mesh-list
138611656|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
138611657|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
138611658|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138611659|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611660|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611661|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138611662|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138611663|NCT00477295|Analgesics|analgesics|mesh-ancestor
138611664|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
138611665|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611666|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138611667|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138611668|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611670|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138611671|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138611672|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138611673|NCT00476593|Dexamethasone|dexamethasone|mesh-list
138611674|NCT00476593|Diclofenac|diclofenac|mesh-list
138611675|NCT00476593|Lactitol|lactitol|mesh-list
138655820|NCT00320021|Vitamins|vitamins|mesh-ancestor
138655821|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
138611676|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138611677|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138611678|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
138611679|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
138611680|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611681|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611682|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138611683|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
138611684|NCT00476593|Hormones|hormones|mesh-ancestor
138611685|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138611686|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138611687|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611688|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138611689|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138611690|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138611691|NCT00476593|Analgesics|analgesics|mesh-ancestor
138611694|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138611695|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611696|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611697|NCT00476593|Cathartics|cathartics|mesh-ancestor
138611698|NCT00210132|Ropivacaine|ropivacaine|mesh-list
138611699|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
138611700|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
138611701|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611702|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611703|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
138611704|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611705|NCT00183404|Olanzapine|olanzapine|mesh-list
138611707|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
138611708|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611709|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611710|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138611711|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138611712|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138611713|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611714|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138611715|NCT00183404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138611716|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138611717|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138611718|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611719|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611720|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
138611721|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138611722|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611723|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138611724|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611725|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611726|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
138611727|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138611728|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
138611729|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138611730|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611731|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138611732|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
138611733|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138611734|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138611735|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611736|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611737|NCT00210210|Ketamine|ketamine|mesh-list
138611738|NCT00210210|Analgesics|analgesics|mesh-ancestor
138611739|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
138611740|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611741|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611742|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138611743|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138655891|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611745|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
138611746|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611747|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138611748|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138611749|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611750|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611751|NCT00476086|Gemcitabine|gemcitabine|mesh-list
138611752|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
138611753|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138611754|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
138611755|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611756|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611757|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
138611758|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611759|NCT00217191|Ibuprofen|ibuprofen|mesh-list
138611760|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138611761|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138611762|NCT00217191|Analgesics|analgesics|mesh-ancestor
138611763|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
138611764|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611765|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611766|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138611767|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138611768|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138611769|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611770|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611771|NCT00476008|Memantine|memantine|mesh-list
138611772|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138611773|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138611774|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
138611775|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611776|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611777|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611778|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138611779|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138611780|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
138611781|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138611782|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138611783|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138611784|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138611785|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611786|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
138611787|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611788|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611789|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138611790|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611791|NCT00183833|Capecitabine|capecitabine|mesh-list
138611792|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
138611793|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138611794|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
138611795|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611796|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611797|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138611798|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611799|NCT00183911|Leucovorin|leucovorin|mesh-list
138611800|NCT00183911|Fluorouracil|fluorouracil|mesh-list
138611801|NCT00183911|Floxuridine|floxuridine|mesh-list
138611802|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
138611803|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611804|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138611805|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611806|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138611807|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
138611808|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611809|NCT00183911|Antidotes|antidotes|mesh-ancestor
138611810|NCT00183911|Protective Agents|protective agents|mesh-ancestor
138611811|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
138611813|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
138611814|NCT00412152|Oxycodone|oxycodone|mesh-list
138611815|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138611816|NCT00412152|Narcotics|narcotics|mesh-ancestor
138611817|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611818|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611819|NCT00412152|Analgesics|analgesics|mesh-ancestor
138611820|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
138611821|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611822|NCT02963402|Adalimumab|adalimumab|mesh-list
138611823|NCT02963402|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138611824|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138611825|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138611826|NCT00210327|Bortezomib|bortezomib|mesh-list
138611827|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611828|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
138611829|NCT00425516|Docetaxel|docetaxel|mesh-list
138611830|NCT00425516|Fluorouracil|fluorouracil|mesh-list
138611831|NCT00425516|Epirubicin|epirubicin|mesh-list
138489053|NCT00010231|Vitamins|vitamins|mesh-ancestor
138611832|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138611833|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
138611834|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611835|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138611836|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138611837|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
138611838|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611839|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611840|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138611841|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
138611842|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
138611843|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
138611844|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
138611845|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138611846|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138611847|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138611848|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138611850|NCT00412191|Lamotrigine|lamotrigine|mesh-list
138611851|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
138611852|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138611853|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138611854|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611855|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138611856|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611857|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138611858|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138611859|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611860|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138611861|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138611862|NCT00183950|Noscapine|noscapine|mesh-list
138611863|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
138611864|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
138611865|NCT00210366|Idarubicin|idarubicin|mesh-list
138611866|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138611867|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611868|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138611869|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138611870|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611871|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611872|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
138611873|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138611874|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138611875|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138611876|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138611877|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611878|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
138611879|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611880|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611881|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138611882|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611883|NCT00475735|Methylphenidate|methylphenidate|mesh-list
138611884|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138611885|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611886|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138611887|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138611888|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138611889|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611890|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
138611891|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611892|NCT00475657|Pemetrexed|pemetrexed|mesh-list
138611893|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611894|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611895|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611896|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138611897|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138611898|NCT00210405|Micronutrients|micronutrients|mesh-list
138489070|NCT00010426|Cysteamine|cysteamine|mesh-list
138611899|NCT00210405|Trace Elements|trace elements|mesh-list
138611900|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611902|NCT00408941|Prilocaine|prilocaine|mesh-list
138611903|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138611904|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611905|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611906|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138611907|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
138611908|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
138611909|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
138611910|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
138611911|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611912|NCT00475423|Rituximab|rituximab|mesh-list
138611913|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138611914|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611915|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
138611916|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611917|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138611919|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138611920|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138611921|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138611922|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138611923|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611924|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
138611925|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611926|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611927|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138611928|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611929|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
138611930|NCT00475306|Promethazine|promethazine|mesh-list
138611931|NCT00475306|Metoclopramide|metoclopramide|mesh-list
138611932|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138611933|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138611934|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138611935|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611936|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
138611937|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
138611938|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
138611939|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611940|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
138611941|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
138611942|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138611943|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138611944|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
138611945|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
138611946|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611947|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611948|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138611949|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
138611950|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
138611951|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138611952|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138611953|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
138611954|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
138611955|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138611956|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
138611957|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138611958|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611959|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138611960|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138611961|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138611963|NCT00183989|Fludarabine|fludarabine|mesh-list
138611964|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
138611965|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138611966|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138611967|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
138611968|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611969|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138611970|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138611971|NCT00183989|Analgesics|analgesics|mesh-ancestor
138611972|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
138611973|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138611974|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138611975|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138611976|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611977|NCT00184067|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138611978|NCT00184067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138611979|NCT00184067|Immunologic Factors|immunologic factors|mesh-ancestor
138611980|NCT00184067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611982|NCT00184106|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138611983|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138611984|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138611985|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318433|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
138611986|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611987|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
138611988|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138611989|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138611990|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
138611991|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138611992|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138611993|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138611994|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138611995|NCT00210483|Almotriptan|almotriptan|mesh-list
138611996|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138611997|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
138611998|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138611999|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612000|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612001|NCT00210561|Acetaminophen|acetaminophen|mesh-list
138612003|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138612004|NCT00210561|Analgesics|analgesics|mesh-ancestor
138612005|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
138612006|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138656174|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
138612007|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612008|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
138612009|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138612010|NCT00210561|Narcotics|narcotics|mesh-ancestor
138612011|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138612012|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
138612013|NCT00210600|Hematinics|hematinics|mesh-ancestor
138612015|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138612016|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138612017|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138612018|NCT00217386|Analgesics|analgesics|mesh-ancestor
138612019|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
138612020|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612021|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612022|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138612023|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138612024|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138612025|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138612026|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
138612027|NCT00217503|Zidovudine|zidovudine|mesh-list
138612028|NCT00217503|Valganciclovir|valganciclovir|mesh-list
138612029|NCT00217503|Ganciclovir|ganciclovir|mesh-list
138612030|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
138612031|NCT00217503|Bevacizumab|bevacizumab|mesh-list
138612032|NCT00217503|Doxorubicin|doxorubicin|mesh-list
138612033|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138612034|NCT00217503|Etoposide|etoposide|mesh-list
138612035|NCT00217503|Bortezomib|bortezomib|mesh-list
138489081|NCT00010699|Vitamin E|vitamin e|mesh-list
138612036|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138612037|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
138612038|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612039|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138612040|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138612041|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
138612042|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612043|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612044|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138612045|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138612046|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138612047|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138612048|NCT00217503|Growth Substances|growth substances|mesh-ancestor
138612049|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
138612050|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138656196|NCT00322751|Topotecan|topotecan|mesh-list
138612051|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138612052|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138612053|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612054|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138612055|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
138612056|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138612057|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138612058|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
138612059|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612060|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138612061|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138612062|NCT00217542|Interferons|interferons|mesh-list
138612064|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
138288450|NCT00791336|Nelfinavir|nelfinavir|mesh-list
138612065|NCT00217542|Azacitidine|azacitidine|mesh-list
138612066|NCT00217542|Amifostine|amifostine|mesh-list
138612067|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612068|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
138612069|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612070|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138612071|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
138612072|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612073|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612074|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
138612075|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612076|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138612077|NCT00217542|Protective Agents|protective agents|mesh-ancestor
138612078|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138612079|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138612080|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138612081|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138612082|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612083|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138489087|NCT00010699|Protective Agents|protective agents|mesh-ancestor
138612084|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138612085|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138612087|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612088|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612089|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138612090|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138612091|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
138612092|NCT00184496|Methadone|methadone|mesh-list
138612093|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138612094|NCT00184496|Narcotics|narcotics|mesh-ancestor
138612095|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138612096|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612097|NCT00184496|Analgesics|analgesics|mesh-ancestor
138612098|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
138612099|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612100|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
138612101|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
138612102|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
138612103|NCT00210756|Hematinics|hematinics|mesh-ancestor
138612104|NCT00217659|Anastrozole|anastrozole|mesh-list
138612105|NCT00217659|Goserelin|goserelin|mesh-list
138612106|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138612107|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612108|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138612109|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138612110|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612111|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612112|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138612113|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
138612114|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138612115|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612116|NCT00184574|Metformin|metformin|mesh-list
138612117|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
138612118|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
138612119|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138612120|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612121|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
138612122|NCT00210795|Hematinics|hematinics|mesh-ancestor
138612123|NCT00217698|Gemcitabine|gemcitabine|mesh-list
138612124|NCT00217698|Gefitinib|gefitinib|mesh-list
138612125|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612126|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138612127|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
138612128|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612129|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138612130|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612131|NCT00184613|Insulin|insulin|mesh-list
138612132|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138612133|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
138612134|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
138612135|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138612136|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612137|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
138612138|NCT00210834|Hematinics|hematinics|mesh-ancestor
138612139|NCT00217815|Efungumab|efungumab|mesh-list
138612140|NCT00217815|Docetaxel|docetaxel|mesh-list
138288527|NCT00691574|Melatonin|melatonin|mesh-list
138612141|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612142|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
138612143|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
138612144|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
138612145|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612146|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
138612147|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612149|NCT04722471|Progestins|progestins|mesh-ancestor
138612150|NCT04722471|Hormones|hormones|mesh-ancestor
138612151|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138612152|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612153|NCT00210873|Topiramate|topiramate|mesh-list
138612154|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
138612155|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138612156|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612157|NCT00210912|Topiramate|topiramate|mesh-list
138612158|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
138612159|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138612160|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612161|NCT00184847|Adenosine|adenosine|mesh-list
138612162|NCT00184847|Acetylcholine|acetylcholine|mesh-list
138612163|NCT00184847|Caffeine|caffeine|mesh-list
138612164|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138612165|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612166|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138612167|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612168|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612169|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138612170|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138612171|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
138612172|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612173|NCT00184847|Analgesics|analgesics|mesh-ancestor
138612174|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
138612175|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612176|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138612177|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
138612178|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138612179|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
138612180|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138612181|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
138612182|NCT00184886|Methotrexate|methotrexate|mesh-list
138612183|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138612184|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
138612185|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138612186|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612187|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138612188|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
138612189|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612190|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612191|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
138612192|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612193|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138612194|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138612195|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
138612196|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138612197|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138612198|NCT00217932|Valproic Acid|valproic acid|mesh-list
138612199|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
138612200|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612201|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612202|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
138612203|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612204|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612205|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
138612206|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138612207|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138612208|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138612209|NCT00210990|Doripenem|doripenem|mesh-list
138612210|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138612211|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612212|NCT00185003|Tolbutamide|tolbutamide|mesh-list
138612213|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
138612214|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612215|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138612216|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612217|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138612218|NCT00185120|Amlodipine|amlodipine|mesh-list
138612219|NCT00185120|Olmesartan|olmesartan|mesh-list
138612220|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138612221|NCT00185120|Benazepril|benazepril|mesh-list
138612222|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138612223|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138612224|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138656328|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612225|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612226|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138612227|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612228|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
138612229|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138612230|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138612231|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138612232|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
138612233|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612234|NCT00218049|Vanoxerine|vanoxerine|mesh-list
138612235|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138612236|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138612237|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138457350|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
138612238|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612239|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
138612240|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612241|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612242|NCT00185159|Olmesartan|olmesartan|mesh-list
138612243|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138612244|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138612245|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138612246|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138612247|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612248|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
138612249|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138612250|NCT00218127|Narcotics|narcotics|mesh-ancestor
138612251|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138612252|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612253|NCT00218127|Analgesics|analgesics|mesh-ancestor
138612255|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612256|NCT00185198|Testosterone|testosterone|mesh-list
138612257|NCT00185198|Androgens|androgens|mesh-ancestor
138612258|NCT00185198|Hormones|hormones|mesh-ancestor
138612259|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138612260|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612261|NCT00185237|Estradiol|estradiol|mesh-list
138612262|NCT00185237|Estrogens|estrogens|mesh-ancestor
138612263|NCT00185237|Hormones|hormones|mesh-ancestor
138612264|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138612265|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612267|NCT00218166|Tiagabine|tiagabine|mesh-list
138612268|NCT00218166|Baclofen|baclofen|mesh-list
138612269|NCT00218166|GABA Agonists|gaba agonists|mesh-list
138612270|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138612271|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612272|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138612273|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612274|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138612275|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
138612276|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612277|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612278|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138612279|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138612280|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138612281|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138612282|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138612283|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
138612284|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
138612285|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
138612286|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138612287|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138612288|NCT00185315|Iloprost|iloprost|mesh-list
138612289|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138612290|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
138612291|NCT00409019|Tenofovir|tenofovir|mesh-list
138612292|NCT00409019|Adefovir|adefovir|mesh-list
138612293|NCT00409019|Telbivudine|telbivudine|mesh-list
138612294|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
138612295|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612296|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138612297|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138612298|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612299|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612300|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138612301|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138612303|NCT00211146|Hematinics|hematinics|mesh-ancestor
138612304|NCT00211224|Riluzole|riluzole|mesh-list
138612305|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
138612306|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138612307|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138612308|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612309|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612310|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612311|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138612312|NCT00211224|Protective Agents|protective agents|mesh-ancestor
138612313|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
138612314|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138612315|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612316|NCT00218205|Celecoxib|celecoxib|mesh-list
138612317|NCT00218205|Epirubicin|epirubicin|mesh-list
138612318|NCT00218205|Estramustine|estramustine|mesh-list
138612319|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138612320|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138612321|NCT00218205|Analgesics|analgesics|mesh-ancestor
138612322|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
138612323|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612324|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612325|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138612326|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138612327|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138612328|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138612329|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612330|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612331|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138612332|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612334|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138612335|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138612336|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
138612337|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138612338|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
138612339|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138612340|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138612341|NCT00185510|Prednisolone|prednisolone|mesh-list
138612342|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
138612343|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
138612344|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138612345|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
138677943|NCT00498134|Analgesics|analgesics|mesh-ancestor
138612346|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138612347|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
138612348|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
138612349|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612350|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612351|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138612352|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
138612354|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138612355|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138612356|NCT00185510|Protective Agents|protective agents|mesh-ancestor
138612357|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138612358|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612359|NCT00218244|Lobeline|lobeline|mesh-list
138612360|NCT00218244|Nicotine|nicotine|mesh-list
138612361|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138612363|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612364|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612365|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138612366|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138612367|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
138612368|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612369|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612370|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
138612371|NCT00211302|Aripiprazole|aripiprazole|mesh-list
138612372|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
138612373|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138612374|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138612375|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138612376|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138612377|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612378|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
138612379|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
138612380|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612381|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612382|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138612383|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138612384|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
138612385|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138612386|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138612387|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138612388|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138612389|NCT00218283|Nicotine|nicotine|mesh-list
138612390|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138612391|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
138612392|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612393|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612394|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138612395|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138612396|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
138612397|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612398|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612400|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138612401|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138612402|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138612403|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612404|NCT00211341|Vitamin A|vitamin a|mesh-list
138612405|NCT00211341|Vitamins|vitamins|mesh-ancestor
138612406|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
138612407|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612408|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
138612409|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138612410|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
138612411|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612412|NCT00211380|Aripiprazole|aripiprazole|mesh-list
138612413|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
138612414|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138612415|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138612416|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138612417|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138612418|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612419|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
138612420|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
138612421|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612422|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612423|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138612424|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138612425|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
138612426|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138612427|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138612428|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138612429|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138656499|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
138612430|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138612431|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138612432|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612433|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138612434|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612435|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612436|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138612437|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138612438|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138612439|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138612440|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612441|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
138612442|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612443|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612445|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138612446|NCT00218361|Narcotics|narcotics|mesh-ancestor
138612447|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138612448|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612449|NCT00218361|Analgesics|analgesics|mesh-ancestor
138612450|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
138457369|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138612451|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612452|NCT00218517|Selegiline|selegiline|mesh-list
138612453|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
138612454|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138612455|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138612456|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138612457|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138612458|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612459|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612460|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138612461|NCT00218517|Protective Agents|protective agents|mesh-ancestor
138612462|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612464|NCT00211419|Anecortave|anecortave|mesh-list
138612465|NCT00211419|Verteporfin|verteporfin|mesh-list
138612466|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138612467|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
138612468|NCT00211419|Hormones|hormones|mesh-ancestor
138612469|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138612470|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612471|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138612472|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
138612473|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138656522|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138656527|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
138612474|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138678055|NCT00503204|Cediranib|cediranib|mesh-list
138612477|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612478|NCT00211458|Anecortave|anecortave|mesh-list
138612479|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138612480|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138612481|NCT00211458|Growth Substances|growth substances|mesh-ancestor
138612482|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612483|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
138612484|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612485|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
138612486|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612487|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138612488|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
138612489|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612490|NCT00211614|Lansoprazole|lansoprazole|mesh-list
138612491|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
138612492|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138612493|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138612494|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138612495|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612496|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612497|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
138612498|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138612499|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
138612500|NCT00186797|Fludarabine|fludarabine|mesh-list
138612501|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138612502|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
138612503|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612504|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138612505|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138612506|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
138612507|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612508|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612509|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138612511|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138612512|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
138612513|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612514|NCT00211653|Expectorants|expectorants|mesh-ancestor
138612515|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
138656551|NCT00426348|Valsartan|valsartan|mesh-list
138612516|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138612517|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
138612518|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612519|NCT00211653|Protective Agents|protective agents|mesh-ancestor
138612520|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612521|NCT00211653|Antidotes|antidotes|mesh-ancestor
138612522|NCT00187031|Topotecan|topotecan|mesh-list
138612523|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138612524|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138612525|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612526|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612527|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612528|NCT00187070|Cytarabine|cytarabine|mesh-list
138612529|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138612530|NCT00187070|Dexamethasone|dexamethasone|mesh-list
138612531|NCT00187070|Prednisone|prednisone|mesh-list
138612532|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
138612533|NCT00187070|Ifosfamide|ifosfamide|mesh-list
138612534|NCT00187070|Carboplatin|carboplatin|mesh-list
138612535|NCT00187070|Doxorubicin|doxorubicin|mesh-list
138612536|NCT00187070|Methotrexate|methotrexate|mesh-list
138612537|NCT00187070|Etoposide|etoposide|mesh-list
138612538|NCT00187070|Vincristine|vincristine|mesh-list
138612539|NCT00187070|Vinblastine|vinblastine|mesh-list
138612540|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138612542|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612543|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138612544|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138612545|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
138612546|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612547|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612548|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138612549|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138612550|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
138612551|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
138612552|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612553|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138612554|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
138612555|NCT00187070|Hormones|hormones|mesh-ancestor
138612556|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138612557|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138612558|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138612559|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138612560|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138612561|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612562|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138612563|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
138612564|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138612565|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138612566|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
138612567|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
138612568|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138656594|NCT00324818|Azithromycin|azithromycin|mesh-list
138612569|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138612570|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138612571|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
138612572|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612573|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
138612574|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
138612575|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
138612576|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138612577|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138612578|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
138612579|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138612580|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138612581|NCT00211848|Interferons|interferons|mesh-list
138612583|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612584|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
138612585|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612586|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
138612587|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612588|NCT00412347|Insulin|insulin|mesh-list
138612589|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138612590|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288977|NCT00521924|Amebicides|amebicides|mesh-ancestor
138612591|NCT00187499|Fluticasone|fluticasone|mesh-list
138612592|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138612593|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138612595|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612596|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612597|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138612598|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
138612599|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
138612600|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138612601|NCT00212004|Pioglitazone|pioglitazone|mesh-list
138612602|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138612603|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612604|NCT00187577|Bimatoprost|bimatoprost|mesh-list
138612605|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138612606|NCT00187577|Latanoprost|latanoprost|mesh-list
138612607|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138612608|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138612609|NCT00212043|Carboplatin|carboplatin|mesh-list
138612610|NCT00212043|Gemcitabine|gemcitabine|mesh-list
138612611|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612612|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138612613|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
138612614|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612615|NCT00212082|Docetaxel|docetaxel|mesh-list
138612616|NCT00212082|Doxorubicin|doxorubicin|mesh-list
138612617|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612618|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
138612619|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
138612620|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
138612621|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612622|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138612623|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138612624|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138612625|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612626|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
138612627|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138612628|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612630|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
138612631|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138612632|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612633|NCT00212199|Orlistat|orlistat|mesh-list
138612634|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612635|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612636|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138612637|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138612638|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
138612639|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138612640|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612641|NCT00188006|Heparin|heparin|mesh-list
138612642|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
138612643|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138612644|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138612645|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612646|NCT00188045|Propranolol|propranolol|mesh-list
138612647|NCT00188045|Spironolactone|spironolactone|mesh-list
138612648|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138612649|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138612650|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
138612651|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612652|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612653|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612654|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138612655|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138612656|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
138612657|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138612658|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
138612659|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138612660|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138612662|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
138612663|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138612664|NCT00212277|Norethindrone|norethindrone|mesh-list
138612665|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
138612666|NCT00212277|Estradiol|estradiol|mesh-list
138612667|NCT00212277|Estrogens|estrogens|mesh-ancestor
138612668|NCT00212277|Hormones|hormones|mesh-ancestor
138289050|NCT00000764|Interferons|interferons|mesh-list
138612669|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138612670|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457376|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
138612671|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138612673|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138612674|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138612675|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138612676|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138612677|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138612678|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138612679|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612680|NCT00219375|Sivelestat|sivelestat|mesh-list
138612681|NCT00219375|Glycine|glycine|mesh-list
138612682|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138612683|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
138612684|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612685|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612686|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
138612687|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612688|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612689|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138612690|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
138612691|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612692|NCT00188396|Citalopram|citalopram|mesh-list
138612693|NCT00188396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138612694|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138612695|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138612696|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612697|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612698|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
138612699|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612700|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138612701|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
138612702|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138612703|NCT00219570|Clindamycin|clindamycin|mesh-list
138612704|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
138612705|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
138612706|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
138612707|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138612708|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612709|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138612710|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612711|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612712|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138612713|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138612714|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612716|NCT00212472|Coagulants|coagulants|mesh-ancestor
138612717|NCT00188552|Tocopherols|tocopherols|mesh-list
138612718|NCT00188552|Vitamin E|vitamin e|mesh-list
138612719|NCT00188552|Tocotrienols|tocotrienols|mesh-list
138678120|NCT00503321|Tegafur|tegafur|mesh-list
138612720|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
138612721|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
138612722|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138612723|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612724|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612725|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138612726|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138612727|NCT00188552|Protective Agents|protective agents|mesh-ancestor
138612728|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612729|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
138612730|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138612731|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
138612732|NCT00188552|Vitamins|vitamins|mesh-ancestor
138612733|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
138612735|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138612736|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
138612737|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612738|NCT00188630|Expectorants|expectorants|mesh-ancestor
138612739|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
138612740|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138656647|NCT00325325|Tacrolimus|tacrolimus|mesh-list
138612741|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
138612742|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612743|NCT00188630|Protective Agents|protective agents|mesh-ancestor
138309900|NCT00003215|Vincristine|vincristine|mesh-list
138612744|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612746|NCT00188669|Tocopherols|tocopherols|mesh-list
138612747|NCT00188669|Vitamin E|vitamin e|mesh-list
138612748|NCT00188669|Tocotrienols|tocotrienols|mesh-list
138612749|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
138612750|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
138612751|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138612752|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612753|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612754|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138612755|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138612756|NCT00188669|Protective Agents|protective agents|mesh-ancestor
138612757|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612758|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
138612759|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138612760|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
138612761|NCT00188669|Vitamins|vitamins|mesh-ancestor
138612762|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
138612763|NCT00409214|Talaporfin|talaporfin|mesh-list
138612764|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612765|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138612766|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
138612768|NCT02963051|Disulfiram|disulfiram|mesh-list
138612769|NCT02963051|Trace Elements|trace elements|mesh-ancestor
138612770|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
138612771|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612772|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138612773|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138612774|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612775|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612777|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612778|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138612779|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612780|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612781|NCT00409253|Nicardipine|nicardipine|mesh-list
138612782|NCT00409253|Urapidil|urapidil|mesh-list
138612783|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138612784|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138612785|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138612786|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612787|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138612788|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612789|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
138612790|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138612791|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
138612792|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612793|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138612794|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138612795|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138612796|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
138612797|NCT00219765|Cytarabine|cytarabine|mesh-list
138612798|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
138612799|NCT00219765|Daunorubicin|daunorubicin|mesh-list
138612800|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138612801|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
138612802|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612803|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612804|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
138612805|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612806|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138612807|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
138612808|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612809|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138612810|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612811|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138612812|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138612813|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138612814|NCT00212589|Leucovorin|leucovorin|mesh-list
138612815|NCT00212589|Folic Acid|folic acid|mesh-list
138612816|NCT00212589|Capecitabine|capecitabine|mesh-list
138612817|NCT00212589|Fluorouracil|fluorouracil|mesh-list
138612818|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
138612819|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138612820|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
138612821|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612822|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612823|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138612824|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
138612825|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612826|NCT00212589|Antidotes|antidotes|mesh-ancestor
138612827|NCT00212589|Protective Agents|protective agents|mesh-ancestor
138612828|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
138612829|NCT00212589|Vitamins|vitamins|mesh-ancestor
138612830|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
138612831|NCT00212589|Hematinics|hematinics|mesh-ancestor
138612832|NCT00188825|Basiliximab|basiliximab|mesh-list
138612833|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138318043|NCT01442064|Ranibizumab|ranibizumab|mesh-list
138612834|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
138612835|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612837|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138612838|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138612839|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138612840|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612841|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
138612842|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612843|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612844|NCT00188864|Dexamethasone|dexamethasone|mesh-list
138612845|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138612846|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
138612847|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
138612848|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612849|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612850|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138612851|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
138612852|NCT00188864|Hormones|hormones|mesh-ancestor
138612853|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138612854|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138612855|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612856|NCT00188942|Olanzapine|olanzapine|mesh-list
138612857|NCT00188942|Fluoxetine|fluoxetine|mesh-list
138612858|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
138612859|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
138275480|NCT00003597|Etoposide|etoposide|mesh-list
138612860|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612861|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612862|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138612863|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138612864|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138612865|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138612866|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138612867|NCT00188942|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138612868|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138612869|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138612870|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612871|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612872|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
138612873|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138612874|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
138612875|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138612876|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138612877|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612878|NCT00219882|Turmeric extract|turmeric extract|mesh-list
138612879|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
138612880|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612881|NCT00219882|Protective Agents|protective agents|mesh-ancestor
138612882|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612883|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138612884|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
138612885|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612886|NCT00219921|Morphine|morphine|mesh-list
138457391|NCT01918098|Naloxone|naloxone|mesh-list
138612887|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138612888|NCT00219921|Narcotics|narcotics|mesh-ancestor
138612889|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138612890|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612891|NCT00219921|Analgesics|analgesics|mesh-ancestor
138612892|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
138612893|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612894|NCT00212823|Almotriptan|almotriptan|mesh-list
138678149|NCT01245452|Methotrexate|methotrexate|mesh-list
138318054|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
138612895|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138612896|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
138612897|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612898|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612899|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612900|NCT00189059|Amitriptyline|amitriptyline|mesh-list
138612901|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138612902|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
138612903|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138612904|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138612905|NCT00189059|Analgesics|analgesics|mesh-ancestor
138612906|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
138612907|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138612908|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612909|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138612910|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138612911|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138612912|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612913|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
138612914|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138612915|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138612916|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
138612917|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
138612918|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612919|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612920|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138612921|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138612922|NCT00189176|Growth Substances|growth substances|mesh-ancestor
138612923|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612924|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
138612925|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612927|NCT00189371|Carboplatin|carboplatin|mesh-list
138612928|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
138612929|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138612930|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612931|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
138612932|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
138612933|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
138612934|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612935|NCT00189371|Hematinics|hematinics|mesh-ancestor
138612936|NCT00189410|Carboplatin|carboplatin|mesh-list
138612937|NCT00189410|Doxorubicin|doxorubicin|mesh-list
138612938|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138678177|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
138612939|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612940|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138612941|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138612942|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138612943|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318064|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612944|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612945|NCT00189566|Paclitaxel|paclitaxel|mesh-list
138612946|NCT00189566|Carboplatin|carboplatin|mesh-list
138612947|NCT00189566|Topotecan|topotecan|mesh-list
138612948|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138612949|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612950|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
138612951|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
138612952|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
138612953|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612954|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138612955|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138612956|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612957|NCT00220116|Capecitabine|capecitabine|mesh-list
138612958|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
138612959|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138656716|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138612961|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612962|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612963|NCT02963129|Mupirocin|mupirocin|mesh-list
138612964|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138612965|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138612966|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138612967|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612968|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289349|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
138612970|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138612971|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
138612972|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612973|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612974|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
138612975|NCT00189644|Fluorouracil|fluorouracil|mesh-list
138612976|NCT00189644|Epirubicin|epirubicin|mesh-list
138612977|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138612978|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
138612979|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138612980|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138612981|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138612982|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
138612983|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138612984|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612985|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138612986|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
138612987|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138612988|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138612989|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138612990|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138612991|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138612992|NCT00189683|Capecitabine|capecitabine|mesh-list
138612993|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138612994|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
138612995|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138656755|NCT00354276|Cytarabine|cytarabine|mesh-list
138612996|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138612997|NCT00189722|Tacrolimus|tacrolimus|mesh-list
138612998|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138613000|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613001|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138613002|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613003|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613004|NCT00220194|Leuprolide|leuprolide|mesh-list
138613005|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138613006|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
138613007|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138613008|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613009|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138613010|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613011|NCT00189761|Tacrolimus|tacrolimus|mesh-list
138613012|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138613013|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
138613014|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613015|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138613016|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613017|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613018|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138613019|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138613021|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138613022|NCT00213096|ST 1435|st 1435|mesh-list
138613023|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
138613024|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
138613025|NCT00213096|Estradiol|estradiol|mesh-list
138613026|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138613027|NCT00213096|Estrogens|estrogens|mesh-ancestor
138613028|NCT00213096|Hormones|hormones|mesh-ancestor
138613029|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138613030|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613031|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138613032|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138613033|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138613034|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138613035|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138613036|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
138613037|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138613038|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138656786|NCT00326027|Pantoprazole|pantoprazole|mesh-list
138613039|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
138613040|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613041|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613042|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613043|NCT00189800|Urological Agents|urological agents|mesh-ancestor
138613044|NCT00220233|Amlodipine|amlodipine|mesh-list
138613045|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138613046|NCT00220233|Olmesartan|olmesartan|mesh-list
138613047|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138613048|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138613049|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138613050|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613051|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613052|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138613053|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613054|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
138613055|NCT00220233|Diuretics|diuretics|mesh-ancestor
138613056|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
138613057|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138613058|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138613059|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138613060|NCT00189839|Tacrolimus|tacrolimus|mesh-list
138613061|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138613062|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
138613063|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613064|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138613065|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613066|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613067|NCT00189878|Methotrexate|methotrexate|mesh-list
138613068|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138613069|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
138613070|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138613071|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613072|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138613073|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
138613074|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613076|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
138613077|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613078|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138613079|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138613080|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
138613081|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138613082|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138613083|NCT00220311|Fludarabine|fludarabine|mesh-list
138613084|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
138613085|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613086|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138613087|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
138613088|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613089|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138613090|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
138613091|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613092|NCT00189917|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138613093|NCT00189917|Antiviral Agents|antiviral agents|mesh-ancestor
138613094|NCT00189917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138613095|NCT00189956|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138613096|NCT00189956|Antiviral Agents|antiviral agents|mesh-ancestor
138613097|NCT00189956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138613098|NCT00213252|Prednisolone|prednisolone|mesh-list
138613099|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138613101|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138613102|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
138613103|NCT00213252|Montelukast|montelukast|mesh-list
138613104|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138613105|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
138613106|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138613107|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
138613108|NCT00213252|Hormones|hormones|mesh-ancestor
138613109|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138613110|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613111|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138613112|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613113|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
138613114|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
138613116|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138613117|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138613118|NCT00213252|Protective Agents|protective agents|mesh-ancestor
138613119|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138613120|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
138613121|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138613122|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
138678283|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613123|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138613124|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138613125|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613127|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
138613128|NCT00189995|Clozapine|clozapine|mesh-list
138613129|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
138613130|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
138613131|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613132|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613133|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138613134|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138613135|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138613136|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138613137|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613138|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138613139|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
138613140|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613141|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613142|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138656827|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138613143|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138613144|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
138613145|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
138613146|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
138613147|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
138613148|NCT00213291|Hematinics|hematinics|mesh-ancestor
138613149|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
138613150|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138613151|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
138613152|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138613153|NCT00190034|Expectorants|expectorants|mesh-ancestor
138613154|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
138613155|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138613156|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
138613157|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613158|NCT00190034|Protective Agents|protective agents|mesh-ancestor
138613159|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613160|NCT00190034|Antidotes|antidotes|mesh-ancestor
138613161|NCT00412503|Temozolomide|temozolomide|mesh-list
138613162|NCT00412503|Topotecan|topotecan|mesh-list
138613163|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138613164|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
138613165|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613166|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613167|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138613168|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138613169|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613170|NCT00412581|Lenalidomide|lenalidomide|mesh-list
138613171|NCT00412581|Dacarbazine|dacarbazine|mesh-list
138613172|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
138613173|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613174|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138613175|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138613176|NCT00412581|Growth Substances|growth substances|mesh-ancestor
138613177|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
138613178|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613179|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138613180|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
138613181|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613182|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
138613183|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138613184|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138613185|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138613186|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138613187|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613188|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613189|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613190|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138613191|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138613193|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138613194|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
138613195|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613196|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138613197|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138613198|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
138613199|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613200|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613201|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138613202|NCT00190268|Amifampridine|amifampridine|mesh-list
138613203|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138613204|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613205|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613206|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138613207|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613208|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613210|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138613211|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
138613212|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138613213|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613214|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138613215|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613216|NCT00190307|Aspirin|aspirin|mesh-list
138613217|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138613218|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138613219|NCT00190307|Analgesics|analgesics|mesh-ancestor
138678344|NCT06154304|Albuterol|albuterol|mesh-list
138613220|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
138613221|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613222|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613223|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138613224|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138613225|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138613226|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138613227|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613228|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138613229|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138613230|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613231|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
138613232|NCT02963168|Docetaxel|docetaxel|mesh-list
138613233|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613234|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
138613235|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
138613236|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
138613237|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613238|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
138613239|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138613240|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
138613241|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613242|NCT00190463|Amphotericin B|amphotericin b|mesh-list
138613243|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138613244|NCT00190463|Amebicides|amebicides|mesh-ancestor
138613245|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138613246|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138613247|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138613248|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138613249|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
138613250|NCT00213486|Irinotecan|irinotecan|mesh-list
138613251|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138613252|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138613253|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613254|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613255|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613257|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
138613258|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613259|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138613260|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138613261|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138613262|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138613263|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613264|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613265|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613266|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613267|NCT00122837|Analgesics|analgesics|mesh-ancestor
138613268|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
138613269|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613270|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
138613271|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613272|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
138613273|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138613274|NCT00190580|Valsartan|valsartan|mesh-list
138613275|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
138613276|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138613277|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138613278|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613279|NCT00220506|Modafinil|modafinil|mesh-list
138613280|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138613281|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613282|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138613283|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138613284|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138613285|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613286|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138613287|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138613288|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138613289|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613290|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613291|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613292|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613293|NCT00190619|Analgesics|analgesics|mesh-ancestor
138613294|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
138613295|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613296|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
138613297|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613298|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
138613299|NCT00213564|Infliximab|infliximab|mesh-list
138613300|NCT00213564|Methotrexate|methotrexate|mesh-list
138613301|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138613302|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
138613303|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138613304|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613305|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138613306|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
138613307|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613308|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613309|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
138656885|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613311|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138613312|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138613313|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
138613314|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138613315|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138613316|NCT00213564|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138613317|NCT00213564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138613318|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138613319|NCT00122876|Talaporfin|talaporfin|mesh-list
138613320|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613321|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138613322|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
138613323|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138613324|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138613325|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138613326|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613327|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613328|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
138613329|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613330|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613332|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138613333|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613334|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613335|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
138613336|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613337|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613338|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
138613339|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138613340|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138613341|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138613342|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613343|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613344|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613345|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613346|NCT00190814|Analgesics|analgesics|mesh-ancestor
138613347|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
138613348|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613349|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
138613350|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613351|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
138613352|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
138613353|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613354|NCT00220818|Lansoprazole|lansoprazole|mesh-list
138678426|NCT06018727|Hydrocortisone|hydrocortisone|mesh-list
138613355|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
138656923|NCT01057251|Nebivolol|nebivolol|mesh-list
138613356|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138613357|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138613358|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138613359|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613360|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613361|NCT00213759|Lenograstim|lenograstim|mesh-list
138613362|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138613363|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
138613364|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613365|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138613366|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138613367|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138613368|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613369|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613370|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613371|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613372|NCT00190853|Analgesics|analgesics|mesh-ancestor
138613373|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
138613374|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613375|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
138613376|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613377|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
138613378|NCT00190892|Carbamazepine|carbamazepine|mesh-list
138613379|NCT00190892|Olanzapine|olanzapine|mesh-list
138613380|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
138613381|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
138613382|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613383|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138656935|NCT04708353|Analgesics|analgesics|mesh-ancestor
138613384|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138613385|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138613386|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138613387|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138613388|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613389|NCT00190892|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138613390|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138613391|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613392|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613393|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613394|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
138613395|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
138613396|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
138613397|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138613398|NCT00190892|Analgesics|analgesics|mesh-ancestor
138613399|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
138613400|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138613401|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138613402|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138613403|NCT00220857|Rabeprazole|rabeprazole|mesh-list
138613404|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138613405|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138289808|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613406|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138613407|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613408|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613409|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138613410|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138188366|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188367|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
138188368|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
138188369|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188370|NCT04450108|Nitric Oxide|nitric oxide|mesh-list
138188371|NCT04450108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138188372|NCT04450108|Autonomic Agents|autonomic agents|mesh-ancestor
138188373|NCT04450108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188374|NCT04450108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188375|NCT04450108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138188376|NCT04450108|Respiratory System Agents|respiratory system agents|mesh-ancestor
138188377|NCT04450108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138188378|NCT04450108|Antioxidants|antioxidants|mesh-ancestor
138188379|NCT04450108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188380|NCT04450108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188381|NCT04450108|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138188382|NCT04450108|Vasodilator Agents|vasodilator agents|mesh-ancestor
138188383|NCT04450108|Gasotransmitters|gasotransmitters|mesh-ancestor
138188384|NCT04450108|Protective Agents|protective agents|mesh-ancestor
138188385|NCT03891849|Octreotide|octreotide|mesh-list
138188386|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138188387|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138188388|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188389|NCT04341831|Teicoplanin|teicoplanin|mesh-list
138188390|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138188391|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188392|NCT00361959|Fluticasone|fluticasone|mesh-list
138188394|NCT00361959|Bromides|bromides|mesh-list
138188395|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
138188396|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138188397|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138188398|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138188399|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
138188400|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188401|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188402|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138188403|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
138188404|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
138188405|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138188406|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
138188407|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138188408|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
138188409|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188410|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188411|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138188412|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138188413|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138188414|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
138188415|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
138188416|NCT03158116|Aztreonam|aztreonam|mesh-list
138188417|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138188418|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188419|NCT03096730|Sufentanil|sufentanil|mesh-list
138188420|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
138188421|NCT03096730|Remifentanil|remifentanil|mesh-list
138188423|NCT03096730|Nalmefene|nalmefene|mesh-list
138188424|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138188425|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188426|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188427|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138188428|NCT03096730|Analgesics|analgesics|mesh-ancestor
138188429|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
138188430|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188431|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138188432|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138188433|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138188434|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
138188435|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188436|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188437|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138613411|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138613412|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613413|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613414|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
138613415|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613416|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613417|NCT00220896|Donepezil|donepezil|mesh-list
138613418|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138613419|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613420|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613421|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
138613422|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613423|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613424|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
138613425|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
138613426|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613427|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613428|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138613429|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138613430|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138656992|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613431|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613432|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613433|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
138613434|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613435|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613436|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138613437|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138613438|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138613439|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613440|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613441|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
138613442|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613443|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613445|NCT00123149|Hematinics|hematinics|mesh-ancestor
138613446|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138613447|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138613448|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138613450|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613451|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613452|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613453|NCT00191087|Analgesics|analgesics|mesh-ancestor
138613454|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
138613455|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613456|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
138613457|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613458|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
138613459|NCT00191126|Gemcitabine|gemcitabine|mesh-list
138613460|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613461|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138613462|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
138613463|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613464|NCT00221052|Diclofenac|diclofenac|mesh-list
138613465|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138613466|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138613467|NCT00221052|Analgesics|analgesics|mesh-ancestor
138613468|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
138613469|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613470|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613471|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138613472|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138613473|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138613474|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193360|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
138613475|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613476|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138613477|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138613478|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138613479|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138289889|NCT00001940|Voriconazole|voriconazole|mesh-list
138613480|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613481|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613482|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613483|NCT00191204|Analgesics|analgesics|mesh-ancestor
138613484|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
138613485|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613486|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
138613487|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613488|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
138657008|NCT00426972|Estrogens|estrogens|mesh-ancestor
138657009|NCT00426972|Hormones|hormones|mesh-ancestor
138613490|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138613491|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613492|NCT00191243|Gemcitabine|gemcitabine|mesh-list
138613494|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138613495|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
138613496|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613497|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613498|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
138613499|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
138613500|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
138613501|NCT00214032|Pycnogenols|pycnogenols|mesh-list
138613502|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138613503|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
138613504|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613505|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
138613506|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613507|NCT00214032|Protective Agents|protective agents|mesh-ancestor
138613508|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138613509|NCT00123266|Plasminogen|plasminogen|mesh-list
138318157|NCT01465464|Orantinib|orantinib|mesh-list
138613511|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138613512|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613513|NCT06117137|Dapagliflozin|dapagliflozin|mesh-list
138613514|NCT06117137|Empagliflozin|empagliflozin|mesh-list
138613515|NCT06117137|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138613516|NCT06117137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613517|NCT06117137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138613518|NCT06117137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613519|NCT06116994|Anesthetics|anesthetics|mesh-list
138613520|NCT06116994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138613521|NCT06116994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613522|NCT06116916|Aflibercept|aflibercept|mesh-list
138613523|NCT06116916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138613524|NCT06116916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138613525|NCT06116916|Growth Substances|growth substances|mesh-ancestor
138613526|NCT06116916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613527|NCT06116916|Growth Inhibitors|growth inhibitors|mesh-ancestor
138613528|NCT06116916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613530|NCT06116890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138613531|NCT06116890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138613532|NCT06116890|Growth Substances|growth substances|mesh-ancestor
138613533|NCT06116890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613534|NCT06116890|Growth Inhibitors|growth inhibitors|mesh-ancestor
138613535|NCT06116890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613536|NCT06116825|Fluorides|fluorides|mesh-list
138613537|NCT06116825|Cariostatic Agents|cariostatic agents|mesh-ancestor
138613538|NCT06116825|Protective Agents|protective agents|mesh-ancestor
138613539|NCT06116825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613540|NCT06116682|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138613541|NCT06116682|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138613542|NCT06116682|Immunologic Factors|immunologic factors|mesh-ancestor
138613543|NCT06116682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613544|NCT06116682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138613545|NCT06116682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613546|NCT06116461|Nivolumab|nivolumab|mesh-list
138613547|NCT06116461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138613548|NCT06116461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613549|NCT06116461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138613550|NCT06116461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613551|NCT06116253|Pentetic Acid|pentetic acid|mesh-list
138613552|NCT06116253|Antidotes|antidotes|mesh-ancestor
138613553|NCT06116253|Protective Agents|protective agents|mesh-ancestor
138188438|NCT03096730|Narcotics|narcotics|mesh-ancestor
138613554|NCT06116253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613555|NCT06116253|Chelating Agents|chelating agents|mesh-ancestor
138613556|NCT06116253|Sequestering Agents|sequestering agents|mesh-ancestor
138613557|NCT06116253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613558|NCT06116253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138613559|NCT06116240|Pemetrexed|pemetrexed|mesh-list
138613560|NCT06116240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613561|NCT06116240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613562|NCT06116240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613563|NCT06116240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138613564|NCT06116240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138613565|NCT06116214|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138613566|NCT06116214|Eusol|eusol|mesh-list
138613567|NCT06116214|Disinfectants|disinfectants|mesh-ancestor
138613568|NCT06116214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138613569|NCT06115733|Capecitabine|capecitabine|mesh-list
138613570|NCT06115733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138613571|NCT06115733|Antimetabolites|antimetabolites|mesh-ancestor
138457474|NCT01918384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138613572|NCT06115733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613573|NCT06115733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613574|NCT06115499|Paclitaxel|paclitaxel|mesh-list
138613575|NCT06115499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138657035|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613576|NCT06115499|Gemcitabine|gemcitabine|mesh-list
138613577|NCT06115499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138613578|NCT06115499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613579|NCT06115499|Tubulin Modulators|tubulin modulators|mesh-ancestor
138613580|NCT06115499|Antimitotic Agents|antimitotic agents|mesh-ancestor
138613581|NCT06115499|Mitosis Modulators|mitosis modulators|mesh-ancestor
138613582|NCT06115499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613583|NCT06115499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138613584|NCT06115499|Antimetabolites|antimetabolites|mesh-ancestor
138613585|NCT06115421|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138613586|NCT06115421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613587|NCT06115408|Acetylcysteine|acetylcysteine|mesh-list
138613588|NCT06115408|Dienogest|dienogest|mesh-list
138613589|NCT06115408|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138613590|NCT06115408|Antiviral Agents|antiviral agents|mesh-ancestor
138613591|NCT06115408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138613592|NCT06115408|Expectorants|expectorants|mesh-ancestor
138613593|NCT06115408|Respiratory System Agents|respiratory system agents|mesh-ancestor
138613594|NCT06115408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138613595|NCT06115408|Antioxidants|antioxidants|mesh-ancestor
138613596|NCT06115408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613597|NCT06115408|Protective Agents|protective agents|mesh-ancestor
138613598|NCT06115408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613599|NCT06115408|Antidotes|antidotes|mesh-ancestor
138613600|NCT06115408|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138613601|NCT06115408|Contraceptive Agents|contraceptive agents|mesh-ancestor
138613602|NCT06115408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138613603|NCT06115408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138613604|NCT06115408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138613605|NCT06115408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138613606|NCT06115408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138613607|NCT06115408|Hormone Antagonists|hormone antagonists|mesh-ancestor
138613608|NCT06115408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138613609|NCT06115408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138613610|NCT06115408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613611|NCT06112808|Nivolumab|nivolumab|mesh-list
138613612|NCT06112808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138613613|NCT06112808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657082|NCT00425997|Diuretics|diuretics|mesh-ancestor
138613614|NCT06112808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138613615|NCT06112808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613618|NCT06111573|Vitamins|vitamins|mesh-ancestor
138613619|NCT06111573|Micronutrients|micronutrients|mesh-ancestor
138613620|NCT06111573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613621|NCT06111573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138613622|NCT06111573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138613623|NCT06111573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138613624|NCT06111573|Analgesics|analgesics|mesh-ancestor
138613625|NCT06111573|Sensory System Agents|sensory system agents|mesh-ancestor
138613626|NCT06111573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613627|NCT06111573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138613628|NCT06111573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138613629|NCT06111573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138613630|NCT06111573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613631|NCT06111573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613632|NCT06108193|Minoxidil|minoxidil|mesh-list
138613633|NCT06108193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138613634|NCT06108193|Vasodilator Agents|vasodilator agents|mesh-ancestor
138613635|NCT06097611|Tranexamic Acid|tranexamic acid|mesh-list
138613636|NCT06097611|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138613637|NCT06097611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138613638|NCT06097611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613639|NCT06097611|Hemostatics|hemostatics|mesh-ancestor
138613640|NCT06097611|Coagulants|coagulants|mesh-ancestor
138613641|NCT06085638|Azacitidine|azacitidine|mesh-list
138613642|NCT06085638|Venetoclax|venetoclax|mesh-list
138613643|NCT06085638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138613644|NCT06085638|Antimetabolites|antimetabolites|mesh-ancestor
138613645|NCT06085638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613646|NCT06085638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657117|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613647|NCT06085638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613649|NCT05981365|Repaglinide|repaglinide|mesh-list
138613650|NCT05981365|Flurbiprofen|flurbiprofen|mesh-list
138613651|NCT05981365|Furosemide|furosemide|mesh-list
138613652|NCT05981365|Midazolam|midazolam|mesh-list
138613653|NCT05981365|Bupropion|bupropion|mesh-list
138613654|NCT05981365|Omeprazole|omeprazole|mesh-list
138613655|NCT05981365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138613656|NCT05981365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138613657|NCT05981365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613658|NCT05981365|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138613659|NCT05981365|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138613660|NCT05981365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138613661|NCT05981365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138613662|NCT05981365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138613663|NCT05981365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613664|NCT05981365|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138613665|NCT05981365|Anesthetics, General|anesthetics, general|mesh-ancestor
138613667|NCT05981365|GABA Modulators|gaba modulators|mesh-ancestor
138613668|NCT05981365|GABA Agents|gaba agents|mesh-ancestor
138613669|NCT05981365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613670|NCT05981365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613671|NCT05981365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138613672|NCT05981365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138613673|NCT05981365|Antimetabolites|antimetabolites|mesh-ancestor
138613674|NCT05981365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138657159|NCT02957448|Rifampin|rifampin|mesh-list
138613675|NCT05981365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138613676|NCT05981365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613677|NCT05981365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138613678|NCT05981365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138613679|NCT05981365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138613680|NCT05981365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138613681|NCT05981365|Antidepressive Agents|antidepressive agents|mesh-ancestor
138613682|NCT05981365|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138613683|NCT05981365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138613684|NCT05981365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613685|NCT05981365|Dopamine Agents|dopamine agents|mesh-ancestor
138613686|NCT05981365|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138613687|NCT05981365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138613688|NCT05981365|Diuretics|diuretics|mesh-ancestor
138613689|NCT05981365|Natriuretic Agents|natriuretic agents|mesh-ancestor
138613690|NCT05981365|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138613691|NCT05981365|Analgesics|analgesics|mesh-ancestor
138613692|NCT05981365|Sensory System Agents|sensory system agents|mesh-ancestor
138613693|NCT05981365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613694|NCT05981365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138613695|NCT05981365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138613696|NCT05981365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138613697|NCT05981365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138613698|NCT05981365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138290114|NCT00380276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613699|NCT05965583|Itraconazole|itraconazole|mesh-list
138613700|NCT05965583|Antifungal Agents|antifungal agents|mesh-ancestor
138613701|NCT05965583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138613702|NCT05965583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138613703|NCT05965583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138613704|NCT05965583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613705|NCT05965583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613706|NCT05965583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138613707|NCT05965583|Hormone Antagonists|hormone antagonists|mesh-ancestor
138613708|NCT05965583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138613709|NCT05965583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613710|NCT05965583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138613711|NCT05953428|Analgesics, Opioid|analgesics, opioid|mesh-list
138613712|NCT05953428|Anesthetics|anesthetics|mesh-list
138613713|NCT05953428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138613714|NCT05953428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613715|NCT05953428|Narcotics|narcotics|mesh-ancestor
138613716|NCT05953428|Analgesics|analgesics|mesh-ancestor
138613717|NCT05953428|Sensory System Agents|sensory system agents|mesh-ancestor
138613718|NCT05953428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613719|NCT05943496|Obinutuzumab|obinutuzumab|mesh-list
138613720|NCT05943496|Acalabrutinib|acalabrutinib|mesh-list
138613721|NCT05943496|Immunoglobulins|immunoglobulins|mesh-list
138613722|NCT05943496|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138613723|NCT05943496|Immunologic Factors|immunologic factors|mesh-ancestor
138613724|NCT05943496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613725|NCT05943496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138613726|NCT05943496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138457685|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613727|NCT05943496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138613728|NCT05943496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613729|NCT05943496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613731|NCT05925686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138613732|NCT05925686|Narcotics|narcotics|mesh-ancestor
138613733|NCT05925686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138613734|NCT05925686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613735|NCT05925686|Analgesics|analgesics|mesh-ancestor
138613736|NCT05925686|Sensory System Agents|sensory system agents|mesh-ancestor
138613737|NCT05925686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613738|NCT05913232|Timolol|timolol|mesh-list
138613739|NCT05913232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138613740|NCT05913232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138613741|NCT05913232|Adrenergic Agents|adrenergic agents|mesh-ancestor
138613742|NCT05913232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613743|NCT05913232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613744|NCT05913232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613745|NCT05913232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138613746|NCT05913232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138613747|NCT05895513|Pimavanserin|pimavanserin|mesh-list
138613748|NCT05895513|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138613749|NCT05895513|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138613750|NCT05895513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138613751|NCT05895513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138613752|NCT05895513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138613753|NCT05895513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613754|NCT05895513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613755|NCT05895513|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138613756|NCT05895513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138613757|NCT05895513|Serotonin Agents|serotonin agents|mesh-ancestor
138613758|NCT05895513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613759|NCT05895513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613760|NCT05894538|Ivermectin|ivermectin|mesh-list
138613761|NCT05894538|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138613762|NCT05894538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138613763|NCT05855798|Magnesium Sulfate|magnesium sulfate|mesh-list
138613764|NCT05855798|Ketamine|ketamine|mesh-list
138613765|NCT05855798|Bupivacaine|bupivacaine|mesh-list
138613766|NCT05855798|Anesthetics, Local|anesthetics, local|mesh-ancestor
138613767|NCT05855798|Anesthetics|anesthetics|mesh-ancestor
138613768|NCT05855798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138613769|NCT05855798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613770|NCT05855798|Sensory System Agents|sensory system agents|mesh-ancestor
138613771|NCT05855798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613772|NCT05855798|Analgesics|analgesics|mesh-ancestor
138613773|NCT05855798|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138613774|NCT05855798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138613775|NCT05855798|Anesthetics, General|anesthetics, general|mesh-ancestor
138613776|NCT05855798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138290185|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
138613777|NCT05855798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138613778|NCT05855798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613779|NCT05855798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613780|NCT05855798|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138613781|NCT05855798|Anticonvulsants|anticonvulsants|mesh-ancestor
138613782|NCT05855798|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138613783|NCT05855798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613784|NCT05855798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138613785|NCT05855798|Tocolytic Agents|tocolytic agents|mesh-ancestor
138613786|NCT05855798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138613787|NCT05840952|Itraconazole|itraconazole|mesh-list
138613788|NCT05840952|Carbamazepine|carbamazepine|mesh-list
138613790|NCT05840952|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138657346|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
138657347|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
138613791|NCT05840952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138613792|NCT05840952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138613793|NCT05840952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613794|NCT05840952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138613795|NCT05840952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138613796|NCT05840952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613797|NCT05840952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138613798|NCT05840952|Anesthetics, General|anesthetics, general|mesh-ancestor
138613799|NCT05840952|Anesthetics|anesthetics|mesh-ancestor
138613800|NCT05840952|GABA Modulators|gaba modulators|mesh-ancestor
138613801|NCT05840952|GABA Agents|gaba agents|mesh-ancestor
138613802|NCT05840952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613803|NCT05840952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613804|NCT05840952|Antifungal Agents|antifungal agents|mesh-ancestor
138613805|NCT05840952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138613806|NCT05840952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138613807|NCT05840952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138613808|NCT05840952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613809|NCT05840952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138613810|NCT05840952|Hormone Antagonists|hormone antagonists|mesh-ancestor
138613811|NCT05840952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138613812|NCT05840952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138613813|NCT05840952|Anticonvulsants|anticonvulsants|mesh-ancestor
138613814|NCT05840952|Antimanic Agents|antimanic agents|mesh-ancestor
138613815|NCT05840952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138613816|NCT05840952|Analgesics|analgesics|mesh-ancestor
138613817|NCT05840952|Sensory System Agents|sensory system agents|mesh-ancestor
138613818|NCT05840952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138613819|NCT05840952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138657385|NCT01056276|Dexamethasone|dexamethasone|mesh-list
138613820|NCT05840952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138613821|NCT05840952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138457807|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
138613822|NCT05840952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138613824|NCT05823948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138613825|NCT05823948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613826|NCT05712941|Letrozole|letrozole|mesh-list
138613827|NCT05712941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613828|NCT05712941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138613829|NCT05712941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138613830|NCT05712941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613831|NCT05712941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613832|NCT05712941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138613833|NCT05712941|Hormone Antagonists|hormone antagonists|mesh-ancestor
138613834|NCT05712941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138318447|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
138318179|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613835|NCT05712941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613837|NCT05701007|Goserelin|goserelin|mesh-list
138613838|NCT05701007|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138613839|NCT05701007|Leuprolide|leuprolide|mesh-list
138613840|NCT05701007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613841|NCT05701007|Tubulin Modulators|tubulin modulators|mesh-ancestor
138613842|NCT05701007|Antimitotic Agents|antimitotic agents|mesh-ancestor
138613843|NCT05701007|Mitosis Modulators|mitosis modulators|mesh-ancestor
138613844|NCT05701007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613845|NCT05701007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138613846|NCT05701007|Luteolytic Agents|luteolytic agents|mesh-ancestor
138613847|NCT05701007|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138613848|NCT05701007|Contraceptive Agents|contraceptive agents|mesh-ancestor
138613849|NCT05701007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138613850|NCT05701007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613851|NCT05701007|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138613852|NCT05701007|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138613853|NCT05701007|Fertility Agents|fertility agents|mesh-ancestor
138613855|NCT05694936|Panitumumab|panitumumab|mesh-list
138613856|NCT05694936|Valproic Acid|valproic acid|mesh-list
138613857|NCT05694936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138613858|NCT05694936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613859|NCT05694936|Anticonvulsants|anticonvulsants|mesh-ancestor
138613860|NCT05694936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613861|NCT05694936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613862|NCT05694936|GABA Agents|gaba agents|mesh-ancestor
138613863|NCT05694936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138613864|NCT05694936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613865|NCT05694936|Antimanic Agents|antimanic agents|mesh-ancestor
138613866|NCT05694936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138613867|NCT05694936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138613868|NCT05694936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613869|NCT05687721|Avelumab|avelumab|mesh-list
138613870|NCT05687721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138613871|NCT05687721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613872|NCT05673928|Trastuzumab|trastuzumab|mesh-list
138613873|NCT05673928|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138613874|NCT05673928|Maytansine|maytansine|mesh-list
138613875|NCT05673928|Tucatinib|tucatinib|mesh-list
138613876|NCT05673928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138613877|NCT05673928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613878|NCT05673928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138613879|NCT05673928|Tubulin Modulators|tubulin modulators|mesh-ancestor
138613880|NCT05673928|Antimitotic Agents|antimitotic agents|mesh-ancestor
138613881|NCT05673928|Mitosis Modulators|mitosis modulators|mesh-ancestor
138613882|NCT05673928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613883|NCT05673928|Immunotoxins|immunotoxins|mesh-ancestor
138613884|NCT05673928|Immunoconjugates|immunoconjugates|mesh-ancestor
138613885|NCT05673928|Immunologic Factors|immunologic factors|mesh-ancestor
138613886|NCT05673928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138657473|NCT00428727|Protective Agents|protective agents|mesh-ancestor
138613887|NCT05673928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138613888|NCT05673928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613889|NCT05646303|Psilocybin|psilocybin|mesh-list
138613890|NCT05646303|Hallucinogens|hallucinogens|mesh-ancestor
138613891|NCT05646303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613892|NCT05646303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138613893|NCT05630209|Doxorubicin|doxorubicin|mesh-list
138613894|NCT05630209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138613895|NCT05630209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613896|NCT05630209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138613897|NCT05630209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138613898|NCT05630209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613899|NCT05630209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613900|NCT05615623|Doxorubicin|doxorubicin|mesh-list
138613901|NCT05615623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138613902|NCT05615623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613903|NCT05615623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138613904|NCT05615623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138613905|NCT05615623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457938|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138613906|NCT05615623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613907|NCT05572684|Pembrolizumab|pembrolizumab|mesh-list
138613908|NCT05572684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138613909|NCT05572684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613910|NCT05572684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138613911|NCT05572684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678844|NCT04761822|Vaccines|vaccines|mesh-list
138613913|NCT05501821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138613914|NCT05501821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613915|NCT05501821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138613916|NCT05501821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613918|NCT05500443|Vitamin K 2|vitamin k 2|mesh-list
138613919|NCT05500443|Menaquinone 7|menaquinone 7|mesh-list
138613920|NCT05500443|Vitamins|vitamins|mesh-ancestor
138613921|NCT05500443|Micronutrients|micronutrients|mesh-ancestor
138613922|NCT05500443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613923|NCT05500443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138290337|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
138613924|NCT05500443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138613925|NCT05500443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613926|NCT05500443|Hemostatics|hemostatics|mesh-ancestor
138613927|NCT05500443|Coagulants|coagulants|mesh-ancestor
138613928|NCT05487586|Ceftazidime|ceftazidime|mesh-list
138613930|NCT05487586|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
138613931|NCT05487586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138613932|NCT05487586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138613933|NCT05487586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138613934|NCT05487586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613935|NCT05487586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613936|NCT05408429|Vaccines|vaccines|mesh-list
138613937|NCT05408429|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138613938|NCT05408429|Immunologic Factors|immunologic factors|mesh-ancestor
138457984|NCT01930552|Growth Substances|growth substances|mesh-ancestor
138457985|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
138613939|NCT05408429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613940|NCT05405439|Prednisone|prednisone|mesh-list
138613941|NCT05405439|Abiraterone Acetate|abiraterone acetate|mesh-list
138657556|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138657557|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138613942|NCT05405439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138613943|NCT05405439|Glucocorticoids|glucocorticoids|mesh-ancestor
138613945|NCT05405439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138613946|NCT05405439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613947|NCT05405439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138613948|NCT05405439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613949|NCT05405439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138613950|NCT05405439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613951|NCT05405439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613952|NCT05405439|Hormone Antagonists|hormone antagonists|mesh-ancestor
138613953|NCT05405439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138613954|NCT05386472|Ritonavir|ritonavir|mesh-list
138613955|NCT05386472|Nirmatrelvir|nirmatrelvir|mesh-list
138613956|NCT05386472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138613957|NCT05386472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138613958|NCT05386472|Protease Inhibitors|protease inhibitors|mesh-ancestor
138613959|NCT05386472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138613960|NCT05386472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613961|NCT05386472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138613962|NCT05386472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138613963|NCT05386472|Antiviral Agents|antiviral agents|mesh-ancestor
138613964|NCT05386472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138613965|NCT05386472|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138613966|NCT05386472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138613967|NCT05376553|Docetaxel|docetaxel|mesh-list
138613968|NCT05376553|Cemiplimab|cemiplimab|mesh-list
138613969|NCT05376553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613970|NCT05376553|Tubulin Modulators|tubulin modulators|mesh-ancestor
138613971|NCT05376553|Antimitotic Agents|antimitotic agents|mesh-ancestor
138613972|NCT05376553|Mitosis Modulators|mitosis modulators|mesh-ancestor
138613973|NCT05376553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678856|NCT04729543|Analgesics|analgesics|mesh-ancestor
138613974|NCT05376553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138613975|NCT05332483|Megestrol|megestrol|mesh-list
138613976|NCT05332483|Megestrol Acetate|megestrol acetate|mesh-list
138613977|NCT05332483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138613978|NCT05332483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138613979|NCT05332483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138613980|NCT05332483|Contraceptive Agents|contraceptive agents|mesh-ancestor
138613981|NCT05332483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138613982|NCT05332483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138613983|NCT05332483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138613984|NCT05332483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138613985|NCT05332483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138613986|NCT05332483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613987|NCT05332483|Appetite Stimulants|appetite stimulants|mesh-ancestor
138613988|NCT05332483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138613989|NCT05301192|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138613990|NCT05301192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138613991|NCT05301192|Vasodilator Agents|vasodilator agents|mesh-ancestor
138613992|NCT05296512|Pembrolizumab|pembrolizumab|mesh-list
138613994|NCT05296512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138613995|NCT05296512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138613996|NCT05296512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138613997|NCT05296512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138613998|NCT05296512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138613999|NCT05296512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614000|NCT05290857|Hemostatics|hemostatics|mesh-list
138614001|NCT05290857|Coagulants|coagulants|mesh-ancestor
138657642|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138614002|NCT05251909|Benralizumab|benralizumab|mesh-list
138614003|NCT05251909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138614004|NCT05251909|Respiratory System Agents|respiratory system agents|mesh-ancestor
138614005|NCT05244525|Epinephrine|epinephrine|mesh-list
138614006|NCT05244525|Bupivacaine|bupivacaine|mesh-list
138614007|NCT05244525|Anesthetics, Local|anesthetics, local|mesh-ancestor
138614008|NCT05244525|Anesthetics|anesthetics|mesh-ancestor
138614009|NCT05244525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138614010|NCT05244525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614011|NCT05244525|Sensory System Agents|sensory system agents|mesh-ancestor
138614012|NCT05244525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614013|NCT05244525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138614014|NCT05244525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138614015|NCT05244525|Adrenergic Agents|adrenergic agents|mesh-ancestor
138614016|NCT05244525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138614017|NCT05244525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614018|NCT05244525|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138614019|NCT05244525|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138614020|NCT05244525|Autonomic Agents|autonomic agents|mesh-ancestor
138614021|NCT05244525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138614022|NCT05244525|Respiratory System Agents|respiratory system agents|mesh-ancestor
138614024|NCT05244525|Sympathomimetics|sympathomimetics|mesh-ancestor
138614025|NCT05244525|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138614026|NCT05220358|Fostemsavir|fostemsavir|mesh-list
138614027|NCT05220358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138614028|NCT05220358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138614029|NCT05220358|Antiviral Agents|antiviral agents|mesh-ancestor
138614030|NCT05220358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614031|NCT05220358|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138614032|NCT05220358|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138614033|NCT05220358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614035|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
138614036|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138614037|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138614038|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614039|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614040|NCT05206955|Urological Agents|urological agents|mesh-ancestor
138614041|NCT05182112|Gemcitabine|gemcitabine|mesh-list
138614042|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614043|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138614044|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
138614045|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614046|NCT05162053|Clopidogrel|clopidogrel|mesh-list
138614047|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138614048|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138614049|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138614050|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138614051|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
138614052|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138614053|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614054|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614055|NCT05149898|Cannabidiol|cannabidiol|mesh-list
138614057|NCT05125380|Acetic Acid|acetic acid|mesh-list
138614058|NCT05125380|Retinol acetate|retinol acetate|mesh-list
138614059|NCT05125380|Lugol's solution|lugol's solution|mesh-list
138614060|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138614061|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614062|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138614063|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
138614064|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614065|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138614066|NCT05125380|Protective Agents|protective agents|mesh-ancestor
138614067|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614068|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
138614069|NCT05125380|Coagulants|coagulants|mesh-ancestor
138614070|NCT04979052|Interferons|interferons|mesh-list
138614071|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
138614072|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138657747|NCT02957604|Evolocumab|evolocumab|mesh-list
138614073|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
138614074|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614075|NCT04934683|Propofol|propofol|mesh-list
138614076|NCT04934683|Etomidate|etomidate|mesh-list
138614077|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138614078|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138614079|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138459595|NCT05464836|Venetoclax|venetoclax|mesh-list
138614080|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138614081|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
138614082|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
138614083|NCT04920344|Cisplatin|cisplatin|mesh-list
138614084|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614085|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
138614086|NCT04862221|Promethazine|promethazine|mesh-list
138614087|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
138614088|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138614089|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138614090|NCT04862221|Prednisolone|prednisolone|mesh-list
138614091|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
138614092|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138614093|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
138614094|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138614095|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138614096|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
138614097|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
138614098|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614099|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614100|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138614101|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
138614102|NCT04862221|Hormones|hormones|mesh-ancestor
138459851|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138614103|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138614104|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138614105|NCT04862221|Protective Agents|protective agents|mesh-ancestor
138614106|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138614107|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614108|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
138614109|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138657771|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
138614110|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138614111|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138614112|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138614114|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
138614115|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
138614116|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138614117|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
138614118|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
138614119|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138614120|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614121|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138614122|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
138614123|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
138614124|NCT04854434|Trifluridine|trifluridine|mesh-list
138614125|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
138614126|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614127|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614128|NCT04854434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138614129|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614130|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
138614131|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
138614132|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614133|NCT04739826|Flumatinib|flumatinib|mesh-list
138614134|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138614135|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614136|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614137|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
138459988|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138614138|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138614139|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138614140|NCT04692831|Pertuzumab|pertuzumab|mesh-list
138657807|NCT00434031|Trastuzumab|trastuzumab|mesh-list
138657809|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
138614141|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614142|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614143|NCT04677387|Naloxone|naloxone|mesh-list
138460050|NCT04460352|Antidotes|antidotes|mesh-ancestor
138614144|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138614145|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614146|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
138614147|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614148|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138614149|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138614150|NCT04677114|Buprenorphine|buprenorphine|mesh-list
138614151|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138614152|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614153|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
138614154|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138614155|NCT04677114|Narcotics|narcotics|mesh-ancestor
138614156|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138460268|NCT04066114|Prednisone|prednisone|mesh-list
138614157|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614158|NCT04677114|Analgesics|analgesics|mesh-ancestor
138614159|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
138614160|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614161|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138614162|NCT04585737|Tenofovir|tenofovir|mesh-list
138614163|NCT04585737|Lamivudine|lamivudine|mesh-list
138614164|NCT04585737|Emtricitabine|emtricitabine|mesh-list
138614165|NCT04585737|Dolutegravir|dolutegravir|mesh-list
138614166|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138614167|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
138614168|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614169|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138614170|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138614171|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614172|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614173|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138614174|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138614175|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138614176|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138614177|NCT04397458|Dexamethasone|dexamethasone|mesh-list
138614178|NCT04397458|Bupivacaine|bupivacaine|mesh-list
138678940|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138460473|NCT03324932|Denosumab|denosumab|mesh-list
138614179|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138614180|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
138614181|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
138657856|NCT00329459|Naproxen|naproxen|mesh-list
138614182|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614183|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614185|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
138614186|NCT04397458|Hormones|hormones|mesh-ancestor
138614187|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138614188|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138614189|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614190|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
138614191|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
138460607|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
138614192|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138614193|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
138614194|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138614195|NCT04390646|Hormones|hormones|mesh-ancestor
138614196|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138614197|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614198|NCT04383743|Cisplatin|cisplatin|mesh-list
138614199|NCT04383743|Doxorubicin|doxorubicin|mesh-list
138614200|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138614201|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
138614202|NCT04383743|Methotrexate|methotrexate|mesh-list
138614203|NCT04383743|Daunorubicin|daunorubicin|mesh-list
138614204|NCT04383743|Vinblastine|vinblastine|mesh-list
138614205|NCT04383743|Lenograstim|lenograstim|mesh-list
138678967|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
138657885|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
138614207|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138460737|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614208|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138614209|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138614210|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614211|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614212|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138460808|NCT01234025|Docetaxel|docetaxel|mesh-list
138614213|NCT04383743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138614214|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138614216|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138614217|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614218|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138614219|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
138614220|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
138614221|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138614222|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138614223|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
138614224|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138614225|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138614226|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138460944|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138614227|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138614228|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
138614229|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
138614230|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
138614232|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
138614233|NCT04332874|Melphalan|melphalan|mesh-list
138614234|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614235|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614236|NCT04332874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138614237|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614238|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138614239|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
138461080|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138614240|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138657934|NCT01055106|Metronidazole|metronidazole|mesh-list
138614241|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138614242|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
138614243|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614244|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138614245|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614246|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138614247|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138614248|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614249|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138614250|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
138614251|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
138614252|NCT04232085|Melphalan|melphalan|mesh-list
138614253|NCT04232085|Fludarabine|fludarabine|mesh-list
138614254|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
138614255|NCT04232085|Tacrolimus|tacrolimus|mesh-list
138614256|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138614257|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
138614258|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614259|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138614260|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138614261|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
138614262|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614263|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614264|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138614265|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138614266|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614267|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138614268|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138614269|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
138614270|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138614271|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614272|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614273|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
138614274|NCT04195568|Antacids|antacids|mesh-ancestor
138614275|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614276|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138614277|NCT04057300|Aspirin|aspirin|mesh-list
138614278|NCT04057300|Clopidogrel|clopidogrel|mesh-list
138614279|NCT04057300|Ticagrelor|ticagrelor|mesh-list
138614280|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138614281|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138614282|NCT04057300|Analgesics|analgesics|mesh-ancestor
138614283|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
138614284|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614285|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614286|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138657971|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138614287|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138614288|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138614289|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138614290|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614291|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138614292|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138614293|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614294|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
138614295|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138614296|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138614297|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138614298|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
138420818|NCT04562129|Nivolumab|nivolumab|mesh-list
138614299|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138614300|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138614301|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614302|NCT03905941|Metformin|metformin|mesh-list
138614303|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
138614304|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138614305|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614306|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138614308|NCT03905603|Hormones|hormones|mesh-ancestor
138614309|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138461995|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614310|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614311|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
138614312|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138614313|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138614314|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614315|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
138614316|NCT03822793|Coagulants|coagulants|mesh-ancestor
138614317|NCT03797014|Tenofovir|tenofovir|mesh-list
138462061|NCT01943240|Ropivacaine|ropivacaine|mesh-list
138614318|NCT03797014|Emtricitabine|emtricitabine|mesh-list
138614319|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138614320|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
138462125|NCT01943760|Tramadol|tramadol|mesh-list
138679033|NCT04177095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614321|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614322|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138614323|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138614324|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614325|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614326|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138614327|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138614328|NCT03796273|Ketoconazole|ketoconazole|mesh-list
138614329|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
138614330|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462264|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
138614331|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138614332|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138614333|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614334|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614335|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138614336|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
138462332|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462334|NCT01945476|Midazolam|midazolam|mesh-list
138614337|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138614338|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614339|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138614341|NCT03782207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138462397|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614342|NCT03782207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614343|NCT03782207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614344|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614345|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138614346|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138614347|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
138614348|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138614349|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614350|NCT03713294|Dexamethasone|dexamethasone|mesh-list
138614351|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
138614352|NCT03713294|Pomalidomide|pomalidomide|mesh-list
138614354|NCT03713294|Ichthammol|ichthammol|mesh-list
138614355|NCT03713294|BB 1101|bb 1101|mesh-list
138614356|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138614357|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
138614358|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
138614359|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614360|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614361|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138614362|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
138614363|NCT03713294|Hormones|hormones|mesh-ancestor
138614364|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138614365|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138614366|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614367|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
138614368|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614369|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614370|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
138614371|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138614372|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138614373|NCT03713294|Growth Substances|growth substances|mesh-ancestor
138614375|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
138614376|NCT03605342|Buprenorphine|buprenorphine|mesh-list
138614377|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138614378|NCT03605342|Narcotics|narcotics|mesh-ancestor
138614379|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138614380|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614382|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
138614383|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614384|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138614385|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138614386|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138614387|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
138614388|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
138614390|NCT03579875|Busulfan|busulfan|mesh-list
138614391|NCT03579875|Rituximab|rituximab|mesh-list
138614392|NCT03579875|Fludarabine|fludarabine|mesh-list
138614393|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138614394|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
138614395|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614396|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138614397|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138614398|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
138614399|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614400|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614401|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138614402|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614403|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138165826|NCT05129475|Ritonavir|ritonavir|mesh-list
138614404|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
138614405|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
138614406|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614407|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138614408|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
138614409|NCT03579875|Hormones|hormones|mesh-ancestor
138614410|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138614411|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138614412|NCT03579875|Protective Agents|protective agents|mesh-ancestor
138614413|NCT03451799|Temozolomide|temozolomide|mesh-list
138614414|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138614415|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
138614416|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614417|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614418|NCT03401320|Letrozole|letrozole|mesh-list
138614419|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614420|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138614421|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138614422|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138165896|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
138165897|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614423|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614424|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138614425|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
138614426|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138614427|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614428|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138614429|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138165941|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138165947|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
138614430|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614431|NCT03389620|Dexamethasone|dexamethasone|mesh-list
138614434|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
138614435|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614436|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614437|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138614438|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
138614439|NCT03389620|Hormones|hormones|mesh-ancestor
138166008|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138166010|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
138614440|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138614441|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138614442|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614443|NCT03300817|Poly ICLC|poly iclc|mesh-list
138614444|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
138614445|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
138614446|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614447|NCT03260712|Gemcitabine|gemcitabine|mesh-list
138614448|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
138614449|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614450|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138614451|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
138166146|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138166147|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138614452|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614453|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614454|NCT03260712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138614456|NCT03255915|Emtricitabine|emtricitabine|mesh-list
138614457|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
138614458|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614459|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138166209|NCT03597581|Bevacizumab|bevacizumab|mesh-list
138166210|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614460|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138614461|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614462|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614463|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138614464|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138614465|NCT03235245|Nivolumab|nivolumab|mesh-list
138614466|NCT03235245|Ipilimumab|ipilimumab|mesh-list
138614467|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138658083|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138658084|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138614468|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614469|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138614470|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614471|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138614472|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138614473|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614474|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138166423|NCT01393795|Capsaicin|capsaicin|mesh-list
138614476|NCT03222492|Immunoconjugates|immunoconjugates|mesh-ancestor
138614477|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
138614478|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614479|NCT03156790|Asparaginase|asparaginase|mesh-list
138614480|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614481|NCT03097783|Lidocaine|lidocaine|mesh-list
138614482|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
138614483|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
138614484|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138614485|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614486|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
138614487|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614488|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138166556|NCT00548197|Growth Substances|growth substances|mesh-ancestor
138614489|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138614490|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138614491|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138614492|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614493|NCT03088059|Durvalumab|durvalumab|mesh-list
138614494|NCT03088059|Palbociclib|palbociclib|mesh-list
138614495|NCT03088059|Niraparib|niraparib|mesh-list
138614496|NCT03088059|Afatinib|afatinib|mesh-list
138614497|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614498|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614499|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138658121|NCT00330902|Artesunate|artesunate|mesh-list
138614500|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166695|NCT00475085|Palonosetron|palonosetron|mesh-list
138614501|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614502|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138614503|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
138614504|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138614505|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
138614506|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614507|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
138614508|NCT03003130|Protective Agents|protective agents|mesh-ancestor
138614510|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318295|NCT04044222|Etoposide|etoposide|mesh-list
138166841|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614511|NCT02782468|Azacitidine|azacitidine|mesh-list
138614512|NCT02782468|Pevonedistat|pevonedistat|mesh-list
138614513|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138614514|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
138614515|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614516|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614517|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614518|NCT02681549|Bevacizumab|bevacizumab|mesh-list
138614519|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
138614520|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614521|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614522|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138614523|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138314694|NCT01720602|Letrozole|letrozole|mesh-list
138614524|NCT02681549|Growth Substances|growth substances|mesh-ancestor
138614525|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614526|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
138290940|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
138614527|NCT02681549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138658162|NCT00331058|Prednisolone|prednisolone|mesh-list
138614528|NCT02681549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614530|NCT02664181|Decitabine|decitabine|mesh-list
138614531|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
138614532|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614533|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614534|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138614535|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167122|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614536|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138614537|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
138614538|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614539|NCT02595866|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138614540|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
138614541|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138679107|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614543|NCT02595866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138614544|NCT02595866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167182|NCT03842839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138614545|NCT02595866|Antiviral Agents|antiviral agents|mesh-ancestor
138614546|NCT02595866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614547|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
138614548|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
138614549|NCT02563769|Cocaine|cocaine|mesh-list
138614550|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138614551|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614552|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167251|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167252|NCT02123017|Lactulose|lactulose|mesh-list
138614553|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614554|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138614555|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
138614556|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
138614557|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138614558|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614559|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
138167319|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
138167320|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
138614560|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614561|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138614562|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138614563|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138614564|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138614565|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
138614566|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138614567|NCT02420717|Leucovorin|leucovorin|mesh-list
138614568|NCT02420717|Cytarabine|cytarabine|mesh-list
138614570|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
138614571|NCT02420717|Prednisone|prednisone|mesh-list
138614572|NCT02420717|Cortisone|cortisone|mesh-list
138614573|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
138167384|NCT04148846|Gabapentin|gabapentin|mesh-list
138614575|NCT02420717|Doxorubicin|doxorubicin|mesh-list
138614576|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138614577|NCT02420717|Methotrexate|methotrexate|mesh-list
138614578|NCT02420717|Vincristine|vincristine|mesh-list
138614579|NCT02420717|Daunorubicin|daunorubicin|mesh-list
138614580|NCT02420717|Dasatinib|dasatinib|mesh-list
138614581|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
138614582|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138614583|NCT02420717|Antibodies|antibodies|mesh-list
138614584|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
138614586|NCT02420717|BB 1101|bb 1101|mesh-list
138614587|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138614588|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
138614589|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614590|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138614591|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138614592|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
138167510|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167511|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
138614593|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614594|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614595|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138614596|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138614597|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
138614598|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
138614599|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138167593|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
138167594|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614600|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138614601|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
138614602|NCT02420717|Hormones|hormones|mesh-ancestor
138614603|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138614604|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138614605|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
138614606|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614607|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138614608|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138614609|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138614610|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138614611|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
138614612|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138167736|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658241|NCT00431145|Vitamins|vitamins|mesh-ancestor
138658242|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
138614613|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138614614|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
138614615|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
138614616|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138614617|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138614618|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
138167800|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138167802|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138614619|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614620|NCT02420717|Antidotes|antidotes|mesh-ancestor
138614621|NCT02420717|Protective Agents|protective agents|mesh-ancestor
138614622|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
138614623|NCT02420717|Vitamins|vitamins|mesh-ancestor
138614624|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
138614625|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138614626|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
138614627|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
138614628|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
138614629|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138614630|NCT02259621|Paclitaxel|paclitaxel|mesh-list
138614631|NCT02259621|Carboplatin|carboplatin|mesh-list
138614632|NCT02259621|Nivolumab|nivolumab|mesh-list
138614633|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138614634|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614635|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
138614636|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
138614637|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
138614638|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614639|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614640|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138614641|NCT02257138|Decitabine|decitabine|mesh-list
138614642|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138168002|NCT00609739|Cyclosporine|cyclosporine|mesh-list
138168003|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
138614643|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
138614644|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614645|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614646|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614647|NCT02188368|Clarithromycin|clarithromycin|mesh-list
138614648|NCT02188368|Dexamethasone|dexamethasone|mesh-list
138614649|NCT02188368|Prednisone|prednisone|mesh-list
138614650|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
138614651|NCT02188368|Bortezomib|bortezomib|mesh-list
138614652|NCT02188368|Pomalidomide|pomalidomide|mesh-list
138614653|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138614654|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
138614655|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614656|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138658275|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614657|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138614658|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
138614659|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318456|NCT01400958|Modafinil|modafinil|mesh-list
138614660|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614661|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138614662|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138614663|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
138614664|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
138614665|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614666|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138614667|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
138614668|NCT02188368|Hormones|hormones|mesh-ancestor
138614669|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138614670|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138614671|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614672|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138614673|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614674|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138614675|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138614676|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138291085|NCT00002312|Delavirdine|delavirdine|mesh-list
138614677|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138168271|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138168272|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138614678|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138614679|NCT02188368|Growth Substances|growth substances|mesh-ancestor
138614680|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
138614681|NCT02126579|Poly ICLC|poly iclc|mesh-list
138614682|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
138614683|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
138168334|NCT00502853|Rituximab|rituximab|mesh-list
138614684|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614685|NCT02074839|Ivosidenib|ivosidenib|mesh-list
138614686|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614687|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614688|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614689|NCT01962636|Cyclosporine|cyclosporine|mesh-list
138614690|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
138614691|NCT01962636|Fludarabine|fludarabine|mesh-list
138614692|NCT01962636|Cyclosporins|cyclosporins|mesh-list
138614693|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138614694|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
138614695|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614696|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138614697|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138614698|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
138614699|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614700|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614701|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138614702|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614703|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
138614704|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168574|NCT00578617|Amiodarone|amiodarone|mesh-list
138614705|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
138614706|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138614707|NCT01795313|Imiquimod|imiquimod|mesh-list
138614708|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138614709|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
138614710|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614711|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614712|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
138614713|NCT01709292|Vemurafenib|vemurafenib|mesh-list
138614714|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168609|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138168610|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168611|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138168612|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168613|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
138168614|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
138168617|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614715|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138614716|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614717|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614718|NCT01574274|Pegaspargase|pegaspargase|mesh-list
138614719|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614720|NCT01479842|Rituximab|rituximab|mesh-list
138614721|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138614722|NCT01479842|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138614723|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614724|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614725|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
138614726|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614727|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168666|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138168667|NCT00556049|Growth Substances|growth substances|mesh-ancestor
138614728|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138614729|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
138614730|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614731|NCT01479842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138614732|NCT01479842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614733|NCT01396408|Sirolimus|sirolimus|mesh-list
138614734|NCT01396408|Sunitinib|sunitinib|mesh-list
138614735|NCT01396408|Temsirolimus|temsirolimus|mesh-list
138168723|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138168724|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
138614736|NCT01396408|MTOR Inhibitors|mtor inhibitors|mesh-list
138614737|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614738|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138614739|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138614740|NCT01396408|Growth Substances|growth substances|mesh-ancestor
138614741|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614742|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
138614743|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138614744|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614745|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614746|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138614747|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
138614748|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138614749|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168854|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614750|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138614751|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
138614752|NCT01375140|Prednisone|prednisone|mesh-list
138614753|NCT01375140|Lenalidomide|lenalidomide|mesh-list
138614754|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138614755|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
138614757|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138168929|NCT00581971|Celecoxib|celecoxib|mesh-list
138614758|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614759|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138614760|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614761|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
138614762|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138614763|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138614764|NCT01375140|Growth Substances|growth substances|mesh-ancestor
138168990|NCT00626431|Leuprolide|leuprolide|mesh-list
138168991|NCT00626431|Hormones|hormones|mesh-list
138614765|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
138614766|NCT01130077|Poly ICLC|poly iclc|mesh-list
138614767|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
138614768|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
138614769|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614770|NCT01063647|Treosulfan|treosulfan|mesh-list
138614771|NCT01063647|Busulfan|busulfan|mesh-list
138614772|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138614773|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
138614774|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614775|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614776|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138614777|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
138614778|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614779|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138614780|NCT00625586|Gemcitabine|gemcitabine|mesh-list
138614781|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138614782|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
138614783|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614784|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614785|NCT00400946|Leucovorin|leucovorin|mesh-list
138614786|NCT00400946|Cytarabine|cytarabine|mesh-list
138614787|NCT00400946|Dexamethasone|dexamethasone|mesh-list
138614788|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
138614789|NCT00400946|Prednisolone|prednisolone|mesh-list
138614790|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
138614791|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138614792|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138614793|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138614794|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
138614795|NCT00400946|Doxorubicin|doxorubicin|mesh-list
138614796|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138614797|NCT00400946|Methotrexate|methotrexate|mesh-list
138614798|NCT00400946|Etoposide|etoposide|mesh-list
138614799|NCT00400946|Vincristine|vincristine|mesh-list
138614800|NCT00400946|Asparaginase|asparaginase|mesh-list
138614801|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
138169332|NCT00586729|Mafenide|mafenide|mesh-list
138614802|NCT00400946|Pegaspargase|pegaspargase|mesh-list
138614803|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
138614804|NCT00400946|Razoxane|razoxane|mesh-list
138614805|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
138614806|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138614807|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
138318361|NCT01442688|Mesalamine|mesalamine|mesh-list
138614808|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614809|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138614810|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138614811|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
138614812|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614813|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614814|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138169464|NCT01676246|Analgesics|analgesics|mesh-ancestor
138614815|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138614817|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
138658413|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614818|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614819|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138614820|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
138614821|NCT00400946|Hormones|hormones|mesh-ancestor
138169535|NCT00641563|Midazolam|midazolam|mesh-list
138614822|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138614823|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138614824|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138614825|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138614826|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138614827|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169598|NCT03152474|Protective Agents|protective agents|mesh-ancestor
138169599|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138614828|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138614829|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
138614830|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138614831|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138614832|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
138614833|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
138614834|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138614835|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138614836|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138614837|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
138614838|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614839|NCT00400946|Antidotes|antidotes|mesh-ancestor
138614840|NCT00400946|Protective Agents|protective agents|mesh-ancestor
138614841|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
138614842|NCT00400946|Vitamins|vitamins|mesh-ancestor
138614843|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
138614844|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
138614845|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
138614846|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
138614847|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138614848|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138169807|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138614849|NCT00191321|Teriparatide|teriparatide|mesh-list
138614850|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138614851|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614852|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138614853|NCT00123305|Plasminogen|plasminogen|mesh-list
138614854|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
138614855|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138614856|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138614857|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614859|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138614860|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
138614861|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138614862|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614863|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138614864|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614865|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138169868|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169869|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
138169870|NCT01674686|Atorvastatin|atorvastatin|mesh-list
138614866|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138614867|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138614868|NCT00191399|Olanzapine|olanzapine|mesh-list
138614869|NCT00191399|Fluoxetine|fluoxetine|mesh-list
138614870|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
138614871|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
138614872|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318374|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
138169914|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138169917|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
138614873|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614874|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138614875|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138614876|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138614877|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138614878|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138614879|NCT00191399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138614880|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138614881|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138614882|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614883|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138614884|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
138614885|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138170056|NCT01931163|Everolimus|everolimus|mesh-list
138614886|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
138614887|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138614888|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138614889|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138614890|NCT00191438|Gemcitabine|gemcitabine|mesh-list
138614891|NCT00191438|Capecitabine|capecitabine|mesh-list
138614892|NCT00191438|Docetaxel|docetaxel|mesh-list
138614893|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138170117|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138170118|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
138614894|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
138614895|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614896|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614897|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
138614898|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
138614899|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
138170188|NCT02142049|Lenalidomide|lenalidomide|mesh-list
138658478|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614900|NCT00221286|Interferons|interferons|mesh-list
138614901|NCT00221286|Tenofovir|tenofovir|mesh-list
138614902|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
138614903|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
138614904|NCT00221286|Emtricitabine|emtricitabine|mesh-list
138614905|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138614906|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614907|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
138170254|NCT03704714|Antibodies|antibodies|mesh-list
138614908|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614909|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138614910|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138614911|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138679413|NCT02828358|Hormones|hormones|mesh-ancestor
138170319|NCT03547622|Galantamine|galantamine|mesh-list
138614912|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614914|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138614915|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
138614916|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614917|NCT00123383|Modafinil|modafinil|mesh-list
138614918|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138614919|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614920|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138170460|NCT00667615|Hormones|hormones|mesh-ancestor
138614921|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138614922|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138614923|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614924|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
138614925|NCT00214266|Rituximab|rituximab|mesh-list
138614926|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
138614927|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138170537|NCT00393211|Etoricoxib|etoricoxib|mesh-list
138614928|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614929|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
138614930|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614931|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138614932|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138170636|NCT00692185|Olanzapine|olanzapine|mesh-list
138614933|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138614934|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
138614935|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138318381|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138614936|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614937|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170672|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
138614938|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614940|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138614941|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138614943|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614944|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138614945|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138614946|NCT00123461|Vitamins|vitamins|mesh-ancestor
138614947|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
138614948|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614949|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138614950|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138614951|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138614952|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138614953|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138679452|NCT02363374|Leucovorin|leucovorin|mesh-list
138614954|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614955|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
138614956|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138614957|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614958|NCT00191555|Haloperidol|haloperidol|mesh-list
138614960|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
138614961|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
138614962|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
138614963|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614964|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614965|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138614966|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138614967|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138614968|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138614969|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138614970|NCT00191555|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138614971|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138614972|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138614973|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614974|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138614975|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
138171012|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138614976|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138614977|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
138614978|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138614979|NCT00221364|Azithromycin|azithromycin|mesh-list
138614980|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138291392|NCT00002372|Nelfinavir|nelfinavir|mesh-list
138614981|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138614982|NCT00123539|Estrogens|estrogens|mesh-list
138614983|NCT00123539|Hormones|hormones|mesh-ancestor
138171069|NCT00596167|Levofloxacin|levofloxacin|mesh-list
138171070|NCT00596167|Gentamicins|gentamicins|mesh-list
138614984|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138614985|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614986|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138614987|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138614988|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138614989|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138318389|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138614990|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138614991|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138614992|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138614993|NCT00191594|Analgesics|analgesics|mesh-ancestor
138171135|NCT01678664|Doxorubicin|doxorubicin|mesh-list
138614994|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
138614995|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138614996|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
138614997|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138614998|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
138614999|NCT00221442|Zonisamide|zonisamide|mesh-list
138615000|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
138615001|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138615002|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138615003|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615004|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138171271|NCT00598663|Insulin|insulin|mesh-list
138615005|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615006|NCT00123578|Pentobarbital|pentobarbital|mesh-list
138615007|NCT00123578|Lorazepam|lorazepam|mesh-list
138658573|NCT01052493|Hormones|hormones|mesh-ancestor
138615008|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
138615009|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
138615010|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
138615011|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615012|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615013|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138615014|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138615015|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138615016|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138615017|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138615018|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138615019|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
138615020|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
138615021|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615022|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615023|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138615024|NCT00221481|Valproic Acid|valproic acid|mesh-list
138171471|NCT05220917|Simvastatin|simvastatin|mesh-list
138615025|NCT00221481|Olanzapine|olanzapine|mesh-list
138615026|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
138615027|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
138615028|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615029|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615030|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138615031|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138615032|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138615033|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138171535|NCT03654105|Aspirin|aspirin|mesh-list
138615034|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138658618|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615035|NCT00221481|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138615036|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138615037|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138615038|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615039|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615040|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
138615041|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
138615042|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615043|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
138615044|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
138615045|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138171670|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615046|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138615047|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138615048|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138615049|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615050|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
138171736|NCT02990455|Nicotine|nicotine|mesh-list
138615051|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615052|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615053|NCT00221520|Midazolam|midazolam|mesh-list
138615054|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138615056|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138615057|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615058|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138615059|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138615060|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138615061|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138615063|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
138615064|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
138615065|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
138615066|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615067|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615069|NCT00191672|Docetaxel|docetaxel|mesh-list
138615070|NCT00191672|Gemcitabine|gemcitabine|mesh-list
138615071|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138171942|NCT01276717|Vorinostat|vorinostat|mesh-list
138615072|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615073|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615074|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
138615075|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
138615076|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172013|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138615077|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138615078|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
138615079|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138615080|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
138615081|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138615082|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138615083|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138615084|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138615085|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615086|NCT00191711|Gemcitabine|gemcitabine|mesh-list
138615087|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138172084|NCT01277731|Protective Agents|protective agents|mesh-ancestor
138172085|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138615088|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
138615089|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615090|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615091|NCT00221637|Valproic Acid|valproic acid|mesh-list
138615092|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
138615093|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615094|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615095|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
138615096|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615097|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615098|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
138615099|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138172219|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
138615100|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138615101|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138615102|NCT00123656|Fluticasone|fluticasone|mesh-list
138615103|NCT00123656|Esomeprazole|esomeprazole|mesh-list
138615104|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138615105|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138615106|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
138615107|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615108|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615109|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138658714|NCT00432354|Atorvastatin|atorvastatin|mesh-list
138615110|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
138615112|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138615113|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138615114|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138615115|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138172358|NCT00580229|Prednisone|prednisone|mesh-list
138172359|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138172360|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
138172361|NCT00580229|Hormones|hormones|mesh-ancestor
138172362|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138172363|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172364|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138172367|NCT00580853|Varenicline|varenicline|mesh-list
138615116|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615117|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615118|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138615119|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138615120|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138615121|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
138615122|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615123|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138615124|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138615125|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138172417|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
138172418|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138172419|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
138172420|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172421|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
138172422|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138172423|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
138172424|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172425|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138615126|NCT00191750|Pemetrexed|pemetrexed|mesh-list
138615127|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138291538|NCT05709626|Aspirin|aspirin|mesh-list
138615128|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615129|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615130|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138615131|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138615132|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
138615133|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138615134|NCT00221754|Pravastatin|pravastatin|mesh-list
138615135|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138615136|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138615137|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
138615138|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615139|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138172537|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
138615140|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138615141|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615142|NCT00191828|Olanzapine|olanzapine|mesh-list
138615143|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
138615144|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
138615145|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172604|NCT02780609|Hormones|hormones|mesh-ancestor
138615146|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615147|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138615148|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138615149|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138615150|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138615151|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138615152|NCT00191828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138615153|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138615154|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138615155|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615156|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615157|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
138615158|NCT00191867|Teriparatide|teriparatide|mesh-list
138172743|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
138172744|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172746|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
138172747|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172748|NCT03434678|Fentanyl|fentanyl|mesh-list
138172749|NCT03434678|Bupivacaine|bupivacaine|mesh-list
138172750|NCT03434678|Propofol|propofol|mesh-list
138172751|NCT03434678|Rocuronium|rocuronium|mesh-list
138172752|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
138172753|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
138172754|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138172755|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138172756|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
138172757|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172758|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138172759|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138615159|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138615160|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615161|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138615162|NCT00123851|Capecitabine|capecitabine|mesh-list
138615163|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
138615164|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138615165|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138615166|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
138615167|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615168|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615169|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138615170|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615172|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138679699|NCT00506727|Adderall|adderall|mesh-list
138615173|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138615174|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615175|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138615176|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138615177|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
138615178|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138615180|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138615181|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138173018|NCT00618917|Manganese|manganese|mesh-list
138615182|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138615183|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615184|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615185|NCT00412698|Hormones|hormones|mesh-ancestor
138615186|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138615187|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615188|NCT00123929|Docetaxel|docetaxel|mesh-list
138615189|NCT00123929|Doxorubicin|doxorubicin|mesh-list
138615190|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615191|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615192|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
138615193|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
138615194|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615195|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138615196|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138615197|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138173145|NCT00622895|Fludarabine|fludarabine|mesh-list
138615198|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615199|NCT00475033|Vaccines|vaccines|mesh-list
138615200|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138291612|NCT05701436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615201|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
138615202|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615203|NCT00192062|Gemcitabine|gemcitabine|mesh-list
138615204|NCT00192062|Vinorelbine|vinorelbine|mesh-list
138173212|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
138173217|NCT03029013|Apatinib|apatinib|mesh-list
138615205|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138615206|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
138615207|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615209|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138615210|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615211|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
138615212|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
138615213|NCT00192101|Gemcitabine|gemcitabine|mesh-list
138615214|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615215|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138615216|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
138173359|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138615217|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615218|NCT00215007|Levofloxacin|levofloxacin|mesh-list
138615219|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138615220|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138615221|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138615222|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138658810|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138615224|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615225|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615226|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615227|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138173513|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
138615228|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138615229|NCT00474994|Sunitinib|sunitinib|mesh-list
138615230|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615231|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138615232|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138615233|NCT00474994|Growth Substances|growth substances|mesh-ancestor
138615234|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615235|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
138615236|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138615237|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615238|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615239|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138615240|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
138615241|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173652|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138173653|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
138173674|NCT03286634|Hormones|hormones|mesh-ancestor
138615242|NCT00215046|Methotrexate|methotrexate|mesh-list
138615243|NCT00215046|Vinblastine|vinblastine|mesh-list
138615244|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138615245|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
138615246|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138615247|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615248|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138615249|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
138615250|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615251|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615252|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
138615253|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615254|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138615255|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138615256|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
138615257|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138615258|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138173788|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
138173789|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
138615259|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138615262|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
138615264|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
138615265|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615266|NCT00124124|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138615267|NCT00124124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138615268|NCT00124124|Immunologic Factors|immunologic factors|mesh-ancestor
138615269|NCT00124124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615270|NCT00474253|Rocuronium|rocuronium|mesh-list
138615271|NCT00474253|Succinylcholine|succinylcholine|mesh-list
138615272|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138615273|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138615274|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138173920|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
138615275|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615276|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615277|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138615278|NCT00221871|Ketamine|ketamine|mesh-list
138615279|NCT00221871|Analgesics|analgesics|mesh-ancestor
138615280|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
138615281|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615282|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615283|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138615284|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138615285|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
138615286|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
138174056|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
138615287|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138615288|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138615289|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138615290|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615291|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615292|NCT00474058|Rotigotine|rotigotine|mesh-list
138615293|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
138615294|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
138615295|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615296|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615297|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615298|NCT02277730|Phenylephrine|phenylephrine|mesh-list
138615299|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
138615300|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138615301|NCT02277730|Ephedrine|ephedrine|mesh-list
138615302|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138615303|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
138615304|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
138174337|NCT00652847|Ezetimibe|ezetimibe|mesh-list
138615305|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615306|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615307|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
138615308|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
138615309|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
138615310|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138174409|NCT00699491|MTOR Inhibitors|mtor inhibitors|mesh-list
138615311|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138615312|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138615313|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
138615314|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615315|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615316|NCT02277730|Protective Agents|protective agents|mesh-ancestor
138615317|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138615318|NCT04571437|Capecitabine|capecitabine|mesh-list
138174481|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
138174508|NCT00551447|Ezetimibe|ezetimibe|mesh-list
138615319|NCT04571437|Letrozole|letrozole|mesh-list
138615320|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138615321|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
138615322|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615323|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615324|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138615325|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138174549|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
138174550|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138615326|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615327|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138615328|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
138615329|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138615330|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615331|NCT00215124|Lenograstim|lenograstim|mesh-list
138615332|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138615333|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
138615334|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615335|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
138615336|NCT00473824|Antibodies|antibodies|mesh-list
138615337|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
138615338|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138615339|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138615340|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
138615341|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174684|NCT00242489|Diclofenac|diclofenac|mesh-list
138174685|NCT00242489|Etoricoxib|etoricoxib|mesh-list
138174686|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138174687|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138174688|NCT00242489|Analgesics|analgesics|mesh-ancestor
138174689|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
138174692|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138615342|NCT00215163|Paroxetine|paroxetine|mesh-list
138615343|NCT00215163|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138615344|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138615345|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138615346|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615347|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615348|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
138615349|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615350|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138615351|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
138615352|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138615353|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138615354|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138615355|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615357|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174890|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
138174891|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615358|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138615359|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615360|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615361|NCT00215241|Risperidone|risperidone|mesh-list
138615362|NCT00215241|Sertraline|sertraline|mesh-list
138615363|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138615364|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
138615365|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615366|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174960|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
138615368|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138615369|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138615370|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138615371|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138615372|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138615373|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
138615374|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
138615375|NCT00215241|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138615376|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138615377|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138615378|NCT00124241|Lamivudine|lamivudine|mesh-list
138615379|NCT00124241|Telbivudine|telbivudine|mesh-list
138615380|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138615381|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138615382|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615383|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615384|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
138615385|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138615386|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138615387|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138615388|NCT00124280|Everolimus|everolimus|mesh-list
138175168|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138615389|NCT00124280|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138615390|NCT00124280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138615391|NCT00124280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615392|NCT00124280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615393|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138615394|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
138615395|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615396|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615397|NCT00215280|Ivermectin|ivermectin|mesh-list
138615398|NCT00215280|Albendazole|albendazole|mesh-list
138615399|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138615400|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138615401|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
138615402|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
138615403|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138615404|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138615405|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615406|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
138615407|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
138615408|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615409|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615410|NCT00192413|Vaccines|vaccines|mesh-list
138615411|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
138615412|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615413|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
138615414|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138615415|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
138615416|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615417|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138658923|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
138175472|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138175473|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138615419|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
138615420|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138615421|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138615422|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138615423|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
138615424|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615425|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615426|NCT00192569|Interferons|interferons|mesh-list
138615427|NCT00192569|Ribavirin|ribavirin|mesh-list
138615428|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
138615429|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
138615430|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138615431|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615432|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
138175610|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
138175616|NCT02999633|Hormones|hormones|mesh-ancestor
138615433|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138615434|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
138615435|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615436|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
138615437|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615438|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
138615439|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138615440|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
138615441|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615442|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615443|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138615444|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
138615445|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138615446|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138615448|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
138615449|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615450|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615451|NCT00192608|Saquinavir|saquinavir|mesh-list
138615452|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138615453|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138615454|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
138615455|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615456|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615457|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138615458|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138615459|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
138615460|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138615461|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138615462|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138615463|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
138615464|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138615465|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
138615466|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615467|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615468|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138615470|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138615471|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138658947|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
138615472|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138615473|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
138615474|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615475|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615477|NCT00215514|Epirubicin|epirubicin|mesh-list
138615478|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615479|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
138615480|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615481|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138615482|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138615483|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
138615484|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615485|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138615486|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138615487|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138615488|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615489|NCT00192725|Tryptophan|tryptophan|mesh-list
138615490|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138615491|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
138615492|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138615494|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
138615495|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138615496|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138615497|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615498|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138615499|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615500|NCT00222144|Docetaxel|docetaxel|mesh-list
138615501|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
138176074|NCT00638456|Lansoprazole|lansoprazole|mesh-list
138615502|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615503|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615504|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
138615505|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
138615506|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615507|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138615508|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615509|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
138615510|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138615511|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138615512|NCT00222183|Analgesics|analgesics|mesh-ancestor
138615513|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
138615514|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615515|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615516|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138615517|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138176210|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
138176211|NCT01273727|BB 1101|bb 1101|mesh-list
138615518|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
138615519|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138615520|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
138615521|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138615522|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615523|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138658972|NCT00436839|Hormones|hormones|mesh-ancestor
138615529|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138615530|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
138615531|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176276|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138615532|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615533|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138615534|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138615535|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138615536|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138615537|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
138615538|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615539|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176460|NCT00742469|Rifaximin|rifaximin|mesh-list
138615540|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138615541|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138615542|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
138615543|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138615545|NCT00192803|Candesartan cilexetil|candesartan cilexetil|mesh-list
138615546|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138176497|NCT03805945|Analgesics|analgesics|mesh-ancestor
138615547|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138615548|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138615549|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615550|NCT00192842|Curcumin|curcumin|mesh-list
138615551|NCT00192842|Gemcitabine|gemcitabine|mesh-list
138615552|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138615553|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
138615554|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615555|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615556|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138615557|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138615558|NCT00192842|Analgesics|analgesics|mesh-ancestor
138176650|NCT01270841|Clomiphene|clomiphene|mesh-list
138615559|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
138615560|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615561|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615562|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138615563|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138615564|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615565|NCT00411996|Ritonavir|ritonavir|mesh-list
138615566|NCT00411996|Indinavir|indinavir|mesh-list
138615567|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138615568|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138615569|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
138615570|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615571|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615573|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138615574|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
138615575|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138615576|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138615577|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138615578|NCT00222261|Aspirin|aspirin|mesh-list
138615579|NCT00222261|Clopidogrel|clopidogrel|mesh-list
138615580|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138615581|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138615582|NCT00222261|Analgesics|analgesics|mesh-ancestor
138615583|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
138615584|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615585|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615586|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138615587|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138615588|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138615589|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138615590|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615591|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138615592|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138615593|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615594|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
138615595|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138615596|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138615597|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138615598|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
138177072|NCT00791323|Ketorolac|ketorolac|mesh-list
138615599|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615600|NCT00192959|Propofol|propofol|mesh-list
138615601|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138615602|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138615603|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615604|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138615605|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
138615606|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
138615607|NCT00215631|Tadalafil|tadalafil|mesh-list
138615608|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
138177142|NCT00775411|Growth Substances|growth substances|mesh-ancestor
138659022|NCT00335192|Lamivudine|lamivudine|mesh-list
138615609|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138615610|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138177209|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615612|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615613|NCT00215631|Urological Agents|urological agents|mesh-ancestor
138615614|NCT00193076|Carboplatin|carboplatin|mesh-list
138615615|NCT00193076|Gemcitabine|gemcitabine|mesh-list
138615616|NCT00193076|Trastuzumab|trastuzumab|mesh-list
138177290|NCT00248651|Analgesics|analgesics|mesh-ancestor
138615618|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138615619|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
138615620|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615621|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138615622|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
138615624|NCT00193115|Doxorubicin|doxorubicin|mesh-list
138615625|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138615626|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
138615627|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615628|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138615629|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138177428|NCT02305329|Opicapone|opicapone|mesh-list
138615630|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
138615631|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615632|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615633|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138615634|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615635|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
138615636|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
138615637|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138615638|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138615639|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138615640|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615641|NCT00193154|Bevacizumab|bevacizumab|mesh-list
138615642|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138615643|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138615644|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615646|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138615647|NCT00193154|Growth Substances|growth substances|mesh-ancestor
138615648|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615649|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
138615650|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138615651|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615652|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615653|NCT00193193|Paclitaxel|paclitaxel|mesh-list
138615654|NCT00193193|Carboplatin|carboplatin|mesh-list
138615655|NCT00193193|Estramustine|estramustine|mesh-list
138615656|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138177794|NCT01985763|Hormones|hormones|mesh-ancestor
138615657|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615658|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615659|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
138615660|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
138659051|NCT00335270|Lamivudine|lamivudine|mesh-list
138615661|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615662|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138615663|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
138615664|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138615665|NCT00193232|Docetaxel|docetaxel|mesh-list
138615666|NCT00193232|Bortezomib|bortezomib|mesh-list
138615667|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615668|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615669|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
138615670|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
138615671|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615672|NCT00222495|Olanzapine|olanzapine|mesh-list
138615673|NCT00222495|Risperidone|risperidone|mesh-list
138615674|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138615675|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138615676|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
138615677|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177999|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
138178000|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138178003|NCT05236621|Dexamethasone|dexamethasone|mesh-list
138615678|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615679|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615680|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138615681|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138615682|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138615683|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138615684|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138615685|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
138615686|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
138615687|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
138615688|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615689|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138615690|NCT00222495|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138615691|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138615692|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138615693|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
138615694|NCT00193271|Docetaxel|docetaxel|mesh-list
138615695|NCT00193271|Estramustine|estramustine|mesh-list
138615696|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615697|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615698|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
138615699|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
138679982|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615700|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615701|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138615702|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
138178281|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
138615703|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138615704|NCT00222534|Acetazolamide|acetazolamide|mesh-list
138615705|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
138615706|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138615707|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615708|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615709|NCT00222534|Diuretics|diuretics|mesh-ancestor
138178385|NCT00241631|Xhance|xhance|mesh-list
138615710|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
138615711|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615713|NCT00193310|Carboplatin|carboplatin|mesh-list
138178418|NCT00240071|Growth Substances|growth substances|mesh-ancestor
138615714|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138615715|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615716|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615718|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
138292190|NCT00002618|Cobalt|cobalt|mesh-list
138615719|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615720|NCT00193349|Carboplatin|carboplatin|mesh-list
138615721|NCT00193349|Irinotecan|irinotecan|mesh-list
138615722|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
138615723|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615724|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138615725|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138615726|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615727|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615728|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138615729|NCT00193388|Topotecan|topotecan|mesh-list
138615730|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138615731|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138615732|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615733|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615734|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615736|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615737|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615738|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
138615739|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
138615740|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615741|NCT00193466|Rituximab|rituximab|mesh-list
138615742|NCT00193466|Fludarabine|fludarabine|mesh-list
138615743|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138615744|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615745|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
138615746|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615747|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138615748|NCT00215748|Dexamethasone|dexamethasone|mesh-list
138615749|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138615750|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
138615751|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
138615752|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178793|NCT00770861|Nebivolol|nebivolol|mesh-list
138615753|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615754|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138615755|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
138615756|NCT00215748|Hormones|hormones|mesh-ancestor
138615757|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138615758|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138615759|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615760|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
138615761|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
138615762|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138615763|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
138615764|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615767|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138615768|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
138615769|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615770|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
138615771|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138615772|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138615773|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138615774|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138615775|NCT00193544|Growth Substances|growth substances|mesh-ancestor
138615776|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
138615777|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615779|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138615780|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
138615781|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615782|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
138615783|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138615784|NCT00124358|Buprenorphine|buprenorphine|mesh-list
138615785|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138615786|NCT00124358|Narcotics|narcotics|mesh-ancestor
138615787|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138615788|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615789|NCT00124358|Analgesics|analgesics|mesh-ancestor
138615790|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
138615791|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615792|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138615793|NCT00193583|Carboplatin|carboplatin|mesh-list
138179126|NCT04345445|Hormones|hormones|mesh-ancestor
138179135|NCT05713877|Melatonin|melatonin|mesh-list
138615794|NCT00193583|Topotecan|topotecan|mesh-list
138615795|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615796|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138615797|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138615798|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615799|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615800|NCT00215982|Capecitabine|capecitabine|mesh-list
138615801|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
138615802|NCT00215982|Irinotecan|irinotecan|mesh-list
138615803|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138615804|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
138615805|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615806|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615807|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138615808|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138615810|NCT00124397|Atorvastatin|atorvastatin|mesh-list
138615811|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138615812|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138680040|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
138615814|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615815|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138615816|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138615817|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615819|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
138615820|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138615821|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
138615822|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615823|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179271|NCT05590299|Immunomodulating Agents|immunomodulating agents|mesh-list
138615824|NCT00409526|Iloprost|iloprost|mesh-list
138615825|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138615826|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
138615827|NCT00216138|Docetaxel|docetaxel|mesh-list
138615828|NCT00216138|Capecitabine|capecitabine|mesh-list
138615829|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615830|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615831|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
138615832|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
138615833|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615834|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138615835|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
138615836|NCT00216177|Adalimumab|adalimumab|mesh-list
138615837|NCT00216177|Infliximab|infliximab|mesh-list
138615838|NCT00216177|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138615839|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138615840|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138615841|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
138615842|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138615843|NCT00216216|Pemetrexed|pemetrexed|mesh-list
138615844|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615845|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615846|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615847|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138615848|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138615849|NCT00473746|Dexamethasone|dexamethasone|mesh-list
138615850|NCT00473746|Prednisone|prednisone|mesh-list
138615851|NCT00473746|Prednisolone|prednisolone|mesh-list
138615852|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
138615853|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138615854|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
138615855|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
138615856|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615857|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615858|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138615859|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
138615860|NCT00473746|Hormones|hormones|mesh-ancestor
138615861|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138615862|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138615863|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615864|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138615865|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615866|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615867|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
138615868|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138615869|NCT00409643|Amlodipine|amlodipine|mesh-list
138615870|NCT00409643|Valsartan|valsartan|mesh-list
138615871|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138615872|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138615873|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138615874|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615875|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138615876|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615877|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
138615878|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138615879|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138615883|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138615884|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615885|NCT00409721|Memantine|memantine|mesh-list
138615886|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138615887|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138615888|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
138615889|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615890|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615891|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615892|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138615893|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138615894|NCT00193622|Bevacizumab|bevacizumab|mesh-list
138615895|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138615896|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138615897|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615898|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138615899|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138615900|NCT00193622|Growth Substances|growth substances|mesh-ancestor
138615901|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615902|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
138615903|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138615904|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615905|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615906|NCT00473590|Bevacizumab|bevacizumab|mesh-list
138615907|NCT00473590|Bortezomib|bortezomib|mesh-list
138615908|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138615909|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615910|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138615911|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138615912|NCT00473590|Growth Substances|growth substances|mesh-ancestor
138615913|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615914|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
138615915|NCT00223275|Naltrexone|naltrexone|mesh-list
138615916|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138615917|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138615918|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615919|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
138615920|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138615921|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
138615922|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
138615923|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
138615924|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138659178|NCT00437853|Anastrozole|anastrozole|mesh-list
138615925|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615926|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138615927|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138615928|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
138615929|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
138615930|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138615931|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615932|NCT00193661|Testosterone|testosterone|mesh-list
138615933|NCT00193661|Androgens|androgens|mesh-ancestor
138615934|NCT00193661|Hormones|hormones|mesh-ancestor
138615935|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138615936|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615937|NCT00206232|Spironolactone|spironolactone|mesh-list
138615938|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138615939|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
138615940|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138615941|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615942|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138615943|NCT00206232|Diuretics|diuretics|mesh-ancestor
138615944|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
138615945|NCT00193700|Testosterone|testosterone|mesh-list
138615946|NCT00193700|Androgens|androgens|mesh-ancestor
138615948|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138615949|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615952|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615954|NCT00193739|Carboplatin|carboplatin|mesh-list
138615955|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138615956|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615957|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
138615958|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
138615959|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
138615960|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615961|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138615962|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138615963|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138615964|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
138615965|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615966|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138680114|NCT02955719|Sertraline|sertraline|mesh-list
138615967|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138615968|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615969|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
138615970|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138615971|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
138659185|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138615972|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615974|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138615975|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
138615976|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615977|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615978|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138615979|NCT00125021|Capecitabine|capecitabine|mesh-list
138615980|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138615981|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138615982|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
138615983|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138615984|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615985|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138615986|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138615987|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
138615988|NCT00193856|Leuprolide|leuprolide|mesh-list
138615989|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138615990|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138615991|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138615992|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
138615993|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138615994|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138615995|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138615996|NCT00223509|Lamotrigine|lamotrigine|mesh-list
138615997|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
138615998|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138615999|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138616000|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659213|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138616001|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138616002|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616003|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138616004|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138616005|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616006|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138616007|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138616008|NCT00193895|Carboplatin|carboplatin|mesh-list
138616009|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616011|NCT00223548|Protective Agents|protective agents|mesh-ancestor
138616012|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616013|NCT00125060|Simvastatin|simvastatin|mesh-list
138616014|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138616015|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138616016|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
138616017|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616018|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138616019|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138616020|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616021|NCT00223626|Topiramate|topiramate|mesh-list
138616022|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
138616023|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138616024|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616025|NCT00223743|Zonisamide|zonisamide|mesh-list
138616026|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
138616027|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138616028|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138616029|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616030|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138616031|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616032|NCT00193973|Methotrexate|methotrexate|mesh-list
138616033|NCT00193973|Idarubicin|idarubicin|mesh-list
138616034|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138616035|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
138616036|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138616037|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616038|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138616039|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
138616040|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616041|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616042|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
138616043|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616044|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138616045|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138616046|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
138616047|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138616048|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138616049|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138680196|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
138616050|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138659259|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616051|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138616052|NCT00411879|Vasopressins|vasopressins|mesh-list
138616053|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
138616054|NCT00411879|Epinephrine|epinephrine|mesh-list
138616055|NCT00411879|Racepinephrine|racepinephrine|mesh-list
138616056|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
138616057|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138616058|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138616059|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
138616060|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616061|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616062|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616063|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138616064|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138616065|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
138616066|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616067|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138616068|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
138616069|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
138616070|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
138616071|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138616072|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
138616073|NCT00411879|Coagulants|coagulants|mesh-ancestor
138616074|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138616075|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
138616076|NCT00193505|Rituximab|rituximab|mesh-list
138616077|NCT00193505|Carboplatin|carboplatin|mesh-list
138616078|NCT00193505|Etoposide|etoposide|mesh-list
138616079|NCT00193505|Ifosfamide|ifosfamide|mesh-list
138616080|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138616081|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616082|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
138616083|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616084|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138616085|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138616086|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138616087|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138616088|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616089|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616090|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138616091|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
138616092|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138616093|NCT00223860|Hormones|hormones|mesh-list
138616094|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138179424|NCT04591925|Insulin|insulin|mesh-list
138616095|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138616096|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616097|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138616098|NCT00125255|Lidocaine|lidocaine|mesh-list
138616099|NCT00125255|Tetracaine|tetracaine|mesh-list
138616100|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
138616101|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
138659283|NCT00444522|Alprazolam|alprazolam|mesh-list
138616102|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616103|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616104|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
138616105|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616106|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138318568|NCT01385748|Clonidine|clonidine|mesh-list
138616107|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138616108|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138616109|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138616110|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616111|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
138616112|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
138616113|NCT00223938|Hematinics|hematinics|mesh-ancestor
138616115|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138616116|NCT00125294|Narcotics|narcotics|mesh-ancestor
138616117|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616118|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616119|NCT00125294|Analgesics|analgesics|mesh-ancestor
138616120|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
138616121|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616122|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
138616123|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
138616124|NCT00206466|Docetaxel|docetaxel|mesh-list
138616125|NCT00206466|Doxorubicin|doxorubicin|mesh-list
138616126|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
138616127|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138616128|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616129|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
138616130|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
138616131|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
138616132|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616133|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138616134|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138616135|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138616136|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616137|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138616138|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
138616139|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616140|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138616141|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138616142|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
138616143|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138616144|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138616145|NCT00224094|Estrogens|estrogens|mesh-ancestor
138616146|NCT00224094|Hormones|hormones|mesh-ancestor
138616147|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138704284|NCT06044311|Carboplatin|carboplatin|mesh-list
138616148|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616149|NCT00125411|Docetaxel|docetaxel|mesh-list
138616150|NCT00125411|Satraplatin|satraplatin|mesh-list
138616151|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659319|NCT00444561|Pramlintide|pramlintide|mesh-list
138616152|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
138179431|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
138616153|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
138616154|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
138616155|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616156|NCT00206505|Docetaxel|docetaxel|mesh-list
138616157|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616158|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
138616159|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
138616160|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
138616161|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616162|NCT00206544|Tamoxifen|tamoxifen|mesh-list
138616163|NCT00206544|Progesterone|progesterone|mesh-list
138616164|NCT00206544|Progestins|progestins|mesh-ancestor
138616165|NCT00206544|Hormones|hormones|mesh-ancestor
138616166|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138616167|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616168|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138616169|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
138616170|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138616171|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616172|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138616173|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138616174|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138616175|NCT00194324|Miconazole|miconazole|mesh-list
138616176|NCT00194324|Clotrimazole|clotrimazole|mesh-list
138616177|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
138616178|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616179|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138616180|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138616181|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616182|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616183|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138616184|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
138616185|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138616186|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704314|NCT06039826|Contraceptive Agents|contraceptive agents|mesh-ancestor
138616187|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138616188|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138616189|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138616190|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138616191|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138616193|NCT00206622|Estradiol|estradiol|mesh-list
138616194|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138616195|NCT00206622|Estrogens|estrogens|mesh-ancestor
138616196|NCT00206622|Hormones|hormones|mesh-ancestor
138616197|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138616198|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616199|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138616200|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
138616201|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138659331|NCT00336947|Tegafur|tegafur|mesh-list
138616202|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138616203|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138616204|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138616206|NCT00194402|Niacinamide|niacinamide|mesh-list
138616207|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
138616208|NCT00194402|Atorvastatin|atorvastatin|mesh-list
138616209|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138179446|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616210|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138616211|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
138616212|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616213|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138616214|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138616215|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616216|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
138616217|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
138616218|NCT00194402|Vitamins|vitamins|mesh-ancestor
138616219|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
138616220|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616221|NCT00473512|Dexamethasone|dexamethasone|mesh-list
138616222|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
138616223|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138616224|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
138616225|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
138616226|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616227|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616228|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138616229|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
138616230|NCT00473512|Hormones|hormones|mesh-ancestor
138616231|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138616232|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138616233|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616234|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138616235|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616236|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616237|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
138616238|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138616239|NCT00125489|Chloroquine|chloroquine|mesh-list
138616240|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138616241|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
138616242|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
138616243|NCT00125489|Amebicides|amebicides|mesh-ancestor
138616244|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138616245|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138616246|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616247|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
138616248|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138616249|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138616250|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138616251|NCT00125489|Analgesics|analgesics|mesh-ancestor
138616252|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
138616253|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616254|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138659351|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616256|NCT00125489|Filaricides|filaricides|mesh-ancestor
138616257|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
138616258|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
138616259|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138616260|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179461|NCT00802919|Varenicline|varenicline|mesh-list
138616261|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616262|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138616263|NCT00206661|Molgramostim|molgramostim|mesh-list
138616264|NCT00206661|Sargramostim|sargramostim|mesh-list
138616265|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
138616266|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616267|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616268|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138616269|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138616270|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138616271|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616272|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616273|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138616274|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138616275|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138616276|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
138616277|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616278|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616279|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138616280|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138616281|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
138616282|NCT00125567|Levodopa|levodopa|mesh-list
138616283|NCT00125567|Carbidopa|carbidopa|mesh-list
138616284|NCT00125567|Entacapone|entacapone|mesh-list
138616285|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138616286|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138616287|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
138616288|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616289|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616290|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616291|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138616292|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616293|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138616294|NCT00473083|Minocycline|minocycline|mesh-list
138616295|NCT00473083|Clindamycin|clindamycin|mesh-list
138616296|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
138616297|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
138616298|NCT00473083|Triamcinolone|triamcinolone|mesh-list
138616299|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138616300|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138616301|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
138616302|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138616303|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616304|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616305|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138616306|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
138616307|NCT00473083|Hormones|hormones|mesh-ancestor
138616308|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138616309|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616310|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138616311|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
138616312|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138616313|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616314|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138616315|NCT00194480|Interferons|interferons|mesh-list
138616316|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616317|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
138616320|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138616321|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616322|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
138616323|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616324|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138616325|NCT00194519|Acyclovir|acyclovir|mesh-list
138616326|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
138616327|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616328|NCT00206700|Sargramostim|sargramostim|mesh-list
138616329|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
138616330|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616331|NCT00125645|Irbesartan|irbesartan|mesh-list
138616332|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138616333|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138616334|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138616335|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616337|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138616338|NCT00125684|Narcotics|narcotics|mesh-ancestor
138616339|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616340|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616341|NCT00125684|Analgesics|analgesics|mesh-ancestor
138616342|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
138616343|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616344|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
138616345|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616346|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
138616347|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138616348|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138616350|NCT00194597|Urological Agents|urological agents|mesh-ancestor
138616351|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
138616352|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
138616353|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
138616354|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138616355|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138616356|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616357|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138616358|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616359|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616360|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138616361|NCT00206778|Lamotrigine|lamotrigine|mesh-list
138616362|NCT00206778|Valproic Acid|valproic acid|mesh-list
138179518|NCT03236649|Sorafenib|sorafenib|mesh-list
138616363|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
138616364|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138616365|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138616366|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616367|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138616368|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616369|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138616370|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138616371|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616372|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138616373|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138616374|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616376|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616377|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
138616378|NCT00125801|Hydromorphone|hydromorphone|mesh-list
138616379|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138616380|NCT00125801|Narcotics|narcotics|mesh-ancestor
138616381|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616382|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616383|NCT00125801|Analgesics|analgesics|mesh-ancestor
138616384|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
138616385|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616386|NCT00125840|Clofarabine|clofarabine|mesh-list
138616387|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138616388|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
138616389|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616390|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616391|NCT00224445|Ritonavir|ritonavir|mesh-list
138616392|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138638004|NCT00287352|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138616393|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138616394|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138616395|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138616396|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
138616397|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616398|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616399|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138616400|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138616401|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
138616402|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616403|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138616404|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138616405|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138616406|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138616408|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
138616409|NCT00194753|Doxorubicin|doxorubicin|mesh-list
138616410|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138616411|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616412|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
138704472|NCT05891171|Vitamins|vitamins|mesh-ancestor
138616414|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
138179541|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138616415|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616416|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138616417|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
138616418|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616419|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138616420|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138616421|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
138616422|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138616423|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138616424|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138616425|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138616426|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616427|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138616428|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
138616429|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616430|NCT00125918|Tadalafil|tadalafil|mesh-list
138680451|NCT00502541|Hormones|hormones|mesh-ancestor
138616431|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
138616432|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138616433|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138616434|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616435|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616436|NCT00125918|Urological Agents|urological agents|mesh-ancestor
138616437|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
138616438|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138616439|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
138616440|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138616441|NCT00472303|Morphine|morphine|mesh-list
138616442|NCT00472303|Tapentadol|tapentadol|mesh-list
138616443|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138616444|NCT00472303|Narcotics|narcotics|mesh-ancestor
138616445|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616446|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616447|NCT00472303|Analgesics|analgesics|mesh-ancestor
138616448|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
138616449|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616450|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138616451|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138616452|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138616453|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616454|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
138616455|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616456|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138616457|NCT00125996|Hematinics|hematinics|mesh-ancestor
138616458|NCT00206934|Dexetimide|dexetimide|mesh-list
138616459|NCT00206934|Citalopram|citalopram|mesh-list
138616460|NCT00206934|Escitalopram|escitalopram|mesh-list
138616461|NCT00206934|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138616462|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138616463|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138659441|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138282030|NCT02958800|Olanzapine|olanzapine|mesh-list
138616464|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179564|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138616465|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616467|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616468|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138616469|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138616470|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
138616471|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
138616472|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616473|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138616474|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138616475|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
138616476|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138616477|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
138616478|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138616479|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
138616480|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
138616481|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138616482|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138616483|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616484|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616485|NCT00194909|Urological Agents|urological agents|mesh-ancestor
138616486|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
138616487|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
138616488|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
138616489|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616490|NCT00194948|Escitalopram|escitalopram|mesh-list
138616491|NCT00194948|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138616492|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138616493|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138616494|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616495|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616496|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
138616497|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616499|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138616500|NCT00206973|Diuretics|diuretics|mesh-ancestor
138616501|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
138616502|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616503|NCT00471445|Ketamine|ketamine|mesh-list
138616504|NCT00471445|Amitriptyline|amitriptyline|mesh-list
138616506|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
138616507|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616508|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616509|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138616510|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138616511|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
138616512|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
138616513|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616514|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138616515|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138616516|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616517|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616518|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138616519|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
138616520|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138616521|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138659467|NCT00451113|Incretins|incretins|mesh-ancestor
138616522|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138616523|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138616524|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138616525|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
138616526|NCT00207051|Cetuximab|cetuximab|mesh-list
138616527|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138616528|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616529|NCT00402467|Enoxaparin|enoxaparin|mesh-list
138616530|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
138616531|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
138616532|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138616533|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
138616534|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138616535|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
138616536|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616537|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616538|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
138616539|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138616540|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138616541|NCT00224679|Aspirin|aspirin|mesh-list
138616542|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138616544|NCT00224679|Analgesics|analgesics|mesh-ancestor
138704551|NCT05815160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616545|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
138616546|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616547|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616548|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138616549|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138616550|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138616551|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138616552|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616553|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138616554|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138616555|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616557|NCT00402506|Pyridoxal|pyridoxal|mesh-list
138616558|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
138616559|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
138616560|NCT00402506|Vitamins|vitamins|mesh-ancestor
138616561|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
138616562|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616563|NCT00207129|Capecitabine|capecitabine|mesh-list
138616564|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138616565|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
138616566|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616567|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616568|NCT00402545|Docetaxel|docetaxel|mesh-list
138616569|NCT00402545|Fluorouracil|fluorouracil|mesh-list
138616570|NCT00402545|Cetuximab|cetuximab|mesh-list
138616571|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616572|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
138616573|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
138616574|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
138616575|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616576|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
138616578|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138616579|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
138616580|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616581|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138616582|NCT00126074|Tedisamil|tedisamil|mesh-list
138616583|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138616584|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138616585|NCT00126074|Protective Agents|protective agents|mesh-ancestor
138616586|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616587|NCT00195104|Cytarabine|cytarabine|mesh-list
138616588|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
138616589|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138616590|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
138616591|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616592|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616593|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
138680521|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
138616594|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616595|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138616596|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
138616597|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616599|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
138616600|NCT00409760|Amlodipine|amlodipine|mesh-list
138616601|NCT00409760|Valsartan|valsartan|mesh-list
138616602|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138616603|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138616604|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138616605|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616606|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138616607|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616608|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
138616609|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138616610|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138616611|NCT00413127|Lidocaine|lidocaine|mesh-list
138616612|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
138616614|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616615|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616616|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
138616617|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616618|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138616619|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138616620|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138616621|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138616622|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616624|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616625|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
138616626|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
138616627|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
138616628|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616629|NCT00207363|Interferons|interferons|mesh-list
138616630|NCT00207363|Ribavirin|ribavirin|mesh-list
138616631|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
138616632|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
138616633|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138616634|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616635|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
138616636|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616637|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
138616638|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616639|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
138616640|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616641|NCT00126269|Gemcitabine|gemcitabine|mesh-list
138616642|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616643|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138616644|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
138616645|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616646|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
138616647|NCT00207402|Interferons|interferons|mesh-list
138616648|NCT00207402|Ribavirin|ribavirin|mesh-list
138616649|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
138616650|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616651|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
138616652|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616653|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
138616654|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616655|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138616656|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616657|NCT00195299|Sirolimus|sirolimus|mesh-list
138616658|NCT00195299|Temsirolimus|temsirolimus|mesh-list
138616659|NCT00195299|MTOR Inhibitors|mtor inhibitors|mesh-list
138616660|NCT00195299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138616661|NCT00195299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616662|NCT00195299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616663|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138616664|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
138616665|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616666|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616667|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138616668|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616669|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138616670|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
138616671|NCT00471328|Sunitinib|sunitinib|mesh-list
138616672|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
138616673|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616674|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138616675|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138616676|NCT00471328|Growth Substances|growth substances|mesh-ancestor
138616677|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704650|NCT05741060|Estrogens|estrogens|mesh-ancestor
138616678|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
138616679|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138616680|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616681|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616682|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
138179647|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138616683|NCT00126308|Mannitol|mannitol|mesh-list
138616684|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138616685|NCT00126308|Diuretics|diuretics|mesh-ancestor
138616686|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
138616687|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616688|NCT00195377|Etanercept|etanercept|mesh-list
138616689|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138616690|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138616691|NCT00195377|Analgesics|analgesics|mesh-ancestor
138293132|NCT00954187|Pregabalin|pregabalin|mesh-list
138616692|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
138616693|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616694|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616695|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138616696|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138616697|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138616698|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138616699|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
138616700|NCT00225108|Tinzaparin|tinzaparin|mesh-list
138616701|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138616702|NCT00225108|Dalteparin|dalteparin|mesh-list
138616703|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
138616704|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138616705|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138616706|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616707|NCT00195416|Etanercept|etanercept|mesh-list
138616708|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138616709|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138616710|NCT00195416|Analgesics|analgesics|mesh-ancestor
138616711|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
138616712|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616713|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616714|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138616715|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138616716|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138616717|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138616718|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
138616719|NCT00195455|Estradiol|estradiol|mesh-list
138616720|NCT00195455|Estrogens|estrogens|mesh-ancestor
138616721|NCT00195455|Hormones|hormones|mesh-ancestor
138659557|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
138616722|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138616723|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616724|NCT00126347|Folic Acid|folic acid|mesh-list
138616725|NCT00126347|Betaine|betaine|mesh-list
138616726|NCT00126347|Hematinics|hematinics|mesh-ancestor
138616727|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
138616728|NCT00126347|Vitamins|vitamins|mesh-ancestor
138616729|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
138616730|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616731|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138616732|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
138616733|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138616734|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
138616735|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616736|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138616737|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
138616738|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138179669|NCT00845507|Hormones|hormones|mesh-ancestor
138616739|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616740|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
138616741|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138616742|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616743|NCT00225264|Pioglitazone|pioglitazone|mesh-list
138616744|NCT00225264|Glimepiride|glimepiride|mesh-list
138616745|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138616746|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616747|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138616748|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138616749|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
138616750|NCT00126464|Tamoxifen|tamoxifen|mesh-list
138616751|NCT00126464|Fulvestrant|fulvestrant|mesh-list
138616752|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138616753|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
138616754|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138616755|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616756|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138616757|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616758|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138616759|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138616760|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138616761|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138616763|NCT00195533|Piperacillin|piperacillin|mesh-list
138616764|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138616765|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138616766|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616767|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138616769|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616770|NCT00207558|Folic Acid|folic acid|mesh-list
138616771|NCT00207558|Hematinics|hematinics|mesh-ancestor
138616772|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
138616773|NCT00207558|Vitamins|vitamins|mesh-ancestor
138616774|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
138616775|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616776|NCT00195572|Leucovorin|leucovorin|mesh-list
138616777|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
138616778|NCT00195572|Antidotes|antidotes|mesh-ancestor
138616779|NCT00195572|Protective Agents|protective agents|mesh-ancestor
138616780|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616781|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
138616782|NCT00195572|Vitamins|vitamins|mesh-ancestor
138616783|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
138616784|NCT00202280|Folic Acid|folic acid|mesh-list
138616785|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
138616786|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
138616787|NCT00202280|Vitamins|vitamins|mesh-ancestor
138616788|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
138616789|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616790|NCT00202280|Hematinics|hematinics|mesh-ancestor
138616791|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
138616792|NCT00225303|Etravirine|etravirine|mesh-list
138616793|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138616794|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138616795|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616796|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616797|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
138616798|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616799|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
138616800|NCT00225342|Gliclazide|gliclazide|mesh-list
138616801|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138616802|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616803|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138616804|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
138616805|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616806|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
138616807|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616808|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138616809|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616810|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616811|NCT00195689|Adalimumab|adalimumab|mesh-list
138616812|NCT00195689|Antibodies|antibodies|mesh-list
138616813|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138616814|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
138616815|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616816|NCT00195689|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138616817|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138616818|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138616819|NCT00470275|Cytarabine|cytarabine|mesh-list
138616820|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138616821|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
138616822|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616823|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138659603|NCT00338780|Lamivudine|lamivudine|mesh-list
138616825|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616826|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138616827|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
138616828|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616829|NCT00225381|Anesthetics|anesthetics|mesh-list
138616830|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616831|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616832|NCT00195728|Acetaminophen|acetaminophen|mesh-list
138616833|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138616835|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138616836|NCT00195728|Analgesics|analgesics|mesh-ancestor
138616837|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
138616838|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616839|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616840|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
138293280|NCT00879619|Prednisone|prednisone|mesh-list
138616841|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138616842|NCT00195728|Narcotics|narcotics|mesh-ancestor
138616843|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616844|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
138616845|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
138616846|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138616847|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138616848|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138616849|NCT00470158|Iron|iron|mesh-list
138616850|NCT00470158|Zinc|zinc|mesh-list
138616851|NCT00470158|Trace Elements|trace elements|mesh-ancestor
138616852|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
138616853|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616854|NCT00472186|Lansoprazole|lansoprazole|mesh-list
138616855|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
138616856|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138616857|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138616858|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138616859|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616860|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616861|NCT00195767|Valproic Acid|valproic acid|mesh-list
138616862|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
138616863|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616864|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616865|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
138616866|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616867|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616868|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
138616869|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138616870|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616871|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138616872|NCT00207675|Infliximab|infliximab|mesh-list
138616873|NCT00207675|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138616874|NCT00207675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138616875|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
138616876|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138616877|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138616878|NCT00202358|Atenolol|atenolol|mesh-list
138616879|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138616880|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138616881|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
138616882|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
138616883|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616884|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616885|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138659631|NCT00451776|Etomidate|etomidate|mesh-list
138616886|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138616887|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138616888|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
138616889|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616890|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616891|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138616892|NCT00479713|Simvastatin|simvastatin|mesh-list
138179745|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
138616893|NCT00479713|Ezetimibe|ezetimibe|mesh-list
138616894|NCT00479713|Calcium|calcium|mesh-list
138616895|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138616896|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616897|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138616898|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138616899|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
138616900|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616901|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138616902|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138616903|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616904|NCT00207753|Ivermectin|ivermectin|mesh-list
138616905|NCT00207753|Albendazole|albendazole|mesh-list
138616906|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138616907|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138616908|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
138616909|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
138616910|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138616911|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138616912|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
138616913|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
138616914|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
138616915|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616916|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616917|NCT00202397|Riluzole|riluzole|mesh-list
138616918|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
138616919|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138293351|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
138616920|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138616921|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138704781|NCT05590728|Apramycin|apramycin|mesh-list
138616922|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616923|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616924|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138616926|NCT00478972|Rimonabant|rimonabant|mesh-list
138616927|NCT00478972|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138616928|NCT00478972|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138616929|NCT00478972|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138616930|NCT00478972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616931|NCT00478972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616932|NCT00478972|Hormones|hormones|mesh-ancestor
138616933|NCT00478972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138616934|NCT00478972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616935|NCT00207792|Lenograstim|lenograstim|mesh-list
138616936|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138616937|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
138616938|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616939|NCT00195806|Valproic Acid|valproic acid|mesh-list
138616940|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
138616941|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179778|NCT00851357|Nicotine|nicotine|mesh-list
138616942|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616943|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
138616944|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616945|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616946|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
138616947|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138616948|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616949|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138616950|NCT00477529|Docetaxel|docetaxel|mesh-list
138616951|NCT00477529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616952|NCT00477529|Tubulin Modulators|tubulin modulators|mesh-ancestor
138616954|NCT00477529|Mitosis Modulators|mitosis modulators|mesh-ancestor
138616955|NCT00477529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616956|NCT00472693|Bevacizumab|bevacizumab|mesh-list
138616957|NCT00472693|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138616958|NCT00472693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138616959|NCT00472693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616960|NCT00472693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138616961|NCT00472693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138616962|NCT00472693|Growth Substances|growth substances|mesh-ancestor
138616963|NCT00472693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616964|NCT00472693|Growth Inhibitors|growth inhibitors|mesh-ancestor
138616966|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138616967|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616968|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616969|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
138616970|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616971|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616972|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138616973|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
138616974|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138616975|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
138616976|NCT00202514|Valproic Acid|valproic acid|mesh-list
138616977|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
138616978|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138616979|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616980|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
138616981|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138616982|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138616983|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
138616984|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138616985|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138616986|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138616987|NCT00207831|Tegafur|tegafur|mesh-list
138616988|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138616989|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
138616990|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138616991|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138616992|NCT00195923|Clindamycin|clindamycin|mesh-list
138616993|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
138616994|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
138616995|NCT00195923|Gentamicins|gentamicins|mesh-list
138616996|NCT00195923|Ceftazidime|ceftazidime|mesh-list
138616997|NCT00195923|Ampicillin|ampicillin|mesh-list
138616998|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138616999|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617000|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138617001|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617002|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617004|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138617005|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138617006|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138617007|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617008|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138617009|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617010|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
138617011|NCT00202553|Perindopril|perindopril|mesh-list
138617012|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138617013|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
138617014|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617015|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617016|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138617017|NCT00202592|Perindopril|perindopril|mesh-list
138617018|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138617019|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
138617020|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617021|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617022|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138617023|NCT00411333|Triamcinolone|triamcinolone|mesh-list
138617024|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138617025|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138617026|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138617027|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138617028|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
138617029|NCT00411333|Hormones|hormones|mesh-ancestor
138617030|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138617031|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617032|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138617033|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
138617034|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617035|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617036|NCT00225849|Aspirin|aspirin|mesh-list
138617037|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138617038|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138617039|NCT00225849|Analgesics|analgesics|mesh-ancestor
138617040|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
138617041|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617042|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617043|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138617044|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617045|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138617046|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138617047|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617048|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138617049|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138617050|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617051|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
138617052|NCT00202787|Leucovorin|leucovorin|mesh-list
138617053|NCT00202787|Cetuximab|cetuximab|mesh-list
138617054|NCT00202787|Fluorouracil|fluorouracil|mesh-list
138617055|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
138680752|NCT00504959|Growth Substances|growth substances|mesh-ancestor
138617056|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138617057|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617058|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
138617059|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617060|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138617061|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138617062|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
138617063|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617065|NCT00202787|Protective Agents|protective agents|mesh-ancestor
138179805|NCT00852761|Clobetasol|clobetasol|mesh-list
138617066|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
138617068|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
138617069|NCT00424437|Insulin|insulin|mesh-list
138617070|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138617071|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138617072|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617073|NCT00202865|Infliximab|infliximab|mesh-list
138617074|NCT00202865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138617075|NCT00202865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138617076|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
138617077|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138617078|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617079|NCT00226005|Vatalanib|vatalanib|mesh-list
138617080|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138617081|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617082|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617083|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
138617084|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138617085|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
138617086|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138617087|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617088|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138617089|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138617090|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138617091|NCT00226044|Omeprazole|omeprazole|mesh-list
138617092|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138617093|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138617094|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138617095|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617096|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617097|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
138617098|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
138617099|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138617100|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
138617101|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617102|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138617103|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617104|NCT00207948|Ritonavir|ritonavir|mesh-list
138617105|NCT00207948|Lopinavir|lopinavir|mesh-list
138617106|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138617107|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138617108|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
138617109|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617110|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617111|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138617112|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138617113|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
138617114|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617115|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138617116|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138617117|NCT00196391|Progesterone|progesterone|mesh-list
138617118|NCT00196391|Progestins|progestins|mesh-ancestor
138617120|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138617121|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617123|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138617124|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617125|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617126|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138617127|NCT00203060|Protective Agents|protective agents|mesh-ancestor
138617128|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617129|NCT00226122|Indomethacin|indomethacin|mesh-list
138617130|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138617131|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138617132|NCT00226122|Analgesics|analgesics|mesh-ancestor
138617133|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
138617134|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617135|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617136|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138617137|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617138|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
138617139|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
138617140|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138617141|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138617142|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617143|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138293578|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617145|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
138617146|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138617147|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138617148|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617149|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
138617150|NCT00208065|Ephedrine|ephedrine|mesh-list
138617151|NCT00208065|Almotriptan|almotriptan|mesh-list
138617152|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138617153|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
138617154|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617155|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617156|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138617157|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
138617158|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
138617159|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138617160|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138680781|NCT02275247|Ropivacaine|ropivacaine|mesh-list
138617162|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
138659706|NCT00451971|Leflunomide|leflunomide|mesh-list
138617163|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617164|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617165|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138617166|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
138617167|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
138617168|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
138617169|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138617170|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
138617171|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
138617172|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617173|NCT00203099|Expectorants|expectorants|mesh-ancestor
138188464|NCT03321045|Trastuzumab|trastuzumab|mesh-list
138617174|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
138617175|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138617176|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
138617177|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617178|NCT00203099|Protective Agents|protective agents|mesh-ancestor
138617179|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617180|NCT00203099|Antidotes|antidotes|mesh-ancestor
138617181|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138617182|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
138617183|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138617184|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617186|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138617187|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138617188|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
138617189|NCT00203138|Rasagiline|rasagiline|mesh-list
138617190|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138617191|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617192|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617193|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138617194|NCT00203138|Protective Agents|protective agents|mesh-ancestor
138617195|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617196|NCT00196547|Montelukast|montelukast|mesh-list
138617197|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138617198|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
138617199|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138617200|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
138617201|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138617202|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617203|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138617204|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138617205|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617206|NCT00203177|Rasagiline|rasagiline|mesh-list
138617207|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138617208|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617209|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138318465|NCT01400412|Tenofovir|tenofovir|mesh-list
138617210|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138617211|NCT00203177|Protective Agents|protective agents|mesh-ancestor
138617212|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617213|NCT00208143|Risperidone|risperidone|mesh-list
138617214|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138680813|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617215|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138617217|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617218|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617219|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179853|NCT01733693|Buprenorphine|buprenorphine|mesh-list
138617220|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138617221|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138617222|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138617223|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138617224|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138617225|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
138617226|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
138617227|NCT00196586|Interferons|interferons|mesh-list
138617229|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
138617230|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
138617231|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138617232|NCT00196586|Interleukin-2|interleukin-2|mesh-list
138617233|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617234|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
138617235|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617236|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
138617237|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617238|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
138617239|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617240|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138617241|NCT00196586|Analgesics|analgesics|mesh-ancestor
138617242|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
138617243|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617244|NCT00226317|Aripiprazole|aripiprazole|mesh-list
138617245|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
138617246|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138617247|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138617248|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138617249|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138617250|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617251|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
138617252|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
138617253|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617254|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617255|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138617256|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138617257|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
138617258|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138617259|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138617260|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138617261|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138617263|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138617264|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
138617265|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138617266|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
138617267|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617268|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138617269|NCT00208182|Risperidone|risperidone|mesh-list
138617270|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138617271|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
138617272|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617273|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617274|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617275|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138617276|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138617277|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138617278|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138617279|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138617280|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
138617281|NCT00208221|Telmisartan|telmisartan|mesh-list
138617282|NCT00208221|Ramipril|ramipril|mesh-list
138179883|NCT00366262|Naproxen|naproxen|mesh-list
138617283|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138617284|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138617285|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138617286|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617287|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138617288|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
138617289|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617290|NCT00196625|Ritonavir|ritonavir|mesh-list
138617291|NCT00196625|Amprenavir|amprenavir|mesh-list
138617292|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138617293|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138617294|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
138293747|NCT00584935|Rituximab|rituximab|mesh-list
138617296|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617297|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138617298|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138617299|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
138617300|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617301|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138617302|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138617303|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138617304|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
138617305|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138617306|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138617307|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
138617308|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617309|NCT00208260|Leucovorin|leucovorin|mesh-list
138617310|NCT00208260|Fluorouracil|fluorouracil|mesh-list
138617311|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
138617312|NCT00208260|Folfirinox|folfirinox|mesh-list
138617313|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
138617314|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617315|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138617316|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617317|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138617318|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
138617319|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617320|NCT00208260|Antidotes|antidotes|mesh-ancestor
138617321|NCT00208260|Protective Agents|protective agents|mesh-ancestor
138617322|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
138617323|NCT00208260|Vitamins|vitamins|mesh-ancestor
138617324|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
138617325|NCT00226473|Dacarbazine|dacarbazine|mesh-list
138617326|NCT00226473|Vindesine|vindesine|mesh-list
138617327|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617328|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138617329|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
138659776|NCT00452244|Simvastatin|simvastatin|mesh-list
138617330|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617331|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138617332|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
138617333|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
138617334|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
138617335|NCT00208299|Adenosine|adenosine|mesh-list
138617336|NCT00208299|Regadenoson|regadenoson|mesh-list
138617337|NCT00208299|Analgesics|analgesics|mesh-ancestor
138617338|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
138617339|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617340|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617341|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138617342|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
138617343|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138617344|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
138617345|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
138617346|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617347|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617348|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138617349|NCT00196664|Paroxetine|paroxetine|mesh-list
138617350|NCT00196664|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138617351|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138617352|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138617353|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617354|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617355|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
138617356|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617357|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138617358|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
138617359|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138617360|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138617361|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138617362|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617363|NCT00196703|Memantine|memantine|mesh-list
138617364|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138617365|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138680879|NCT00514605|Antibodies|antibodies|mesh-list
138617366|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
138617367|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617368|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617370|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138617371|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138617372|NCT00413322|Fluorouracil|fluorouracil|mesh-list
138617373|NCT00413322|Belinostat|belinostat|mesh-list
138617374|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
138617375|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617376|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138617377|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617378|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138617379|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
138705076|NCT05327010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617380|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617381|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138617382|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617383|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
138617384|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
138617385|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138617386|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138617387|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617388|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617389|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617390|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617391|NCT00410657|Prednisone|prednisone|mesh-list
138617392|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
138617393|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138617394|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138617395|NCT00410657|Prednisolone|prednisolone|mesh-list
138617396|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
138617397|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
138617398|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138617399|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
138617400|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138617401|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
138617402|NCT00410657|Hormones|hormones|mesh-ancestor
138617403|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138617404|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617405|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138617406|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617407|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
138617408|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
138617409|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617410|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138617411|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138617412|NCT00410657|Protective Agents|protective agents|mesh-ancestor
138617413|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138617414|NCT00196820|Capecitabine|capecitabine|mesh-list
138617415|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138617416|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
138617417|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617418|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617419|NCT00410696|Lenograstim|lenograstim|mesh-list
138617420|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138617421|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
138617422|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617423|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
138617424|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138617425|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617426|NCT00410735|Pranlukast|pranlukast|mesh-list
138617427|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138617428|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
138617429|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138617430|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
138617431|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138617432|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617433|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
138617434|NCT00203372|Bevacizumab|bevacizumab|mesh-list
138617436|NCT00203372|Doxorubicin|doxorubicin|mesh-list
138617437|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138617438|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
138617439|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617440|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617441|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138617442|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
138293885|NCT00000769|Interleukin-4|interleukin-4|mesh-list
138617443|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617444|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617445|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138617446|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138617447|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138617448|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138617449|NCT00203372|Growth Substances|growth substances|mesh-ancestor
138617450|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
138617451|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
138617452|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
138617453|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
138617454|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138617455|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138617456|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138617457|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617459|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138617460|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138617461|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
138617462|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617463|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617464|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617465|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138617466|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
138617467|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617468|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138617469|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
138617470|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138617471|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
138617472|NCT00226551|Protective Agents|protective agents|mesh-ancestor
138617473|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
138617474|NCT00196859|Capecitabine|capecitabine|mesh-list
138617475|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138617476|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
138617477|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617478|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617479|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138179982|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
138617480|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617481|NCT00208533|Aripiprazole|aripiprazole|mesh-list
138617482|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
138617483|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138617484|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138617485|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138617486|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138617487|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617488|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
138617489|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
138617490|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617491|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617492|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138617493|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138617494|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
138617495|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138617496|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138617497|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138617498|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138617499|NCT00203450|Zonisamide|zonisamide|mesh-list
138617500|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
138617501|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138617502|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138617503|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138680956|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617504|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138617505|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617506|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
138617508|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138617509|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617511|NCT00208572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138617512|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138617513|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138293952|NCT00000355|Analgesics|analgesics|mesh-ancestor
138617514|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659874|NCT00452829|Hematinics|hematinics|mesh-ancestor
138617515|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617517|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617518|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138617519|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
138617520|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138617521|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
138617522|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138617523|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138617524|NCT00226707|Analgesics|analgesics|mesh-ancestor
138617525|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
138617526|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617527|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617528|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138617529|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617530|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
138617531|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138617532|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
138180001|NCT05236907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138617533|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138617534|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617535|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617536|NCT00203528|Valproic Acid|valproic acid|mesh-list
138617537|NCT00203528|Risperidone|risperidone|mesh-list
138617538|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138617539|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
138617540|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617541|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617542|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617543|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138617544|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138617545|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138617546|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138617547|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138617548|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
138617549|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
138617550|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617551|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
138617552|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
138617554|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
138617555|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
138617556|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
138617557|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
138617558|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617559|NCT00208611|Hematinics|hematinics|mesh-ancestor
138617560|NCT00203567|Carbamazepine|carbamazepine|mesh-list
138617561|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
138617562|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
138617563|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138617564|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138617565|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617566|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138617567|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138617568|NCT00203567|Analgesics|analgesics|mesh-ancestor
138617569|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
138617570|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617571|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138617572|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138617573|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617574|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138617575|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138617576|NCT00226746|Paclitaxel|paclitaxel|mesh-list
138617577|NCT00226746|Gemcitabine|gemcitabine|mesh-list
138617578|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138617579|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617580|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
138617581|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
138617582|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
138638005|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138617583|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617584|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138617585|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
138617586|NCT00203606|Interferons|interferons|mesh-list
138617587|NCT00203606|Ribavirin|ribavirin|mesh-list
138617588|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
138617589|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
138617590|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138617591|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617592|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
138617593|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617594|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
138617595|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617596|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
138617597|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617598|NCT00203684|Flunisolide|flunisolide|mesh-list
138617599|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138617600|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138617601|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
138617602|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
138705176|NCT05147805|Treprostinil|treprostinil|mesh-list
138617604|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138617605|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617606|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138617607|NCT00226785|Analgesics|analgesics|mesh-ancestor
138617608|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
138617609|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617610|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138617611|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138617612|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138617613|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
138617614|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617615|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617616|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
138617617|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138617618|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617619|NCT00226824|Galantamine|galantamine|mesh-list
138617620|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138617621|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138659920|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138617622|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617623|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
138617624|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617625|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617626|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138617627|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
138617628|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617629|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
138617630|NCT00197249|Vaccines|vaccines|mesh-list
138617631|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
138617632|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617633|NCT00203723|Risperidone|risperidone|mesh-list
138617634|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138617635|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
138617636|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617637|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617638|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617639|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138617640|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138617641|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138617642|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138617643|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138617644|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
138617645|NCT00226902|Chrysarobin|chrysarobin|mesh-list
138617646|NCT00226902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138705203|NCT05065411|Everolimus|everolimus|mesh-list
138617647|NCT00226902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138617648|NCT00226902|Analgesics|analgesics|mesh-ancestor
138617649|NCT00226902|Sensory System Agents|sensory system agents|mesh-ancestor
138617650|NCT00226902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617651|NCT00226902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617652|NCT00226902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138617653|NCT00226902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617654|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138617655|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
138617656|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617658|NCT00226980|Capecitabine|capecitabine|mesh-list
138617659|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138617660|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
138617661|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617662|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617663|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138617664|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
138617665|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617666|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
138617667|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138617668|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617669|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138617670|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138617671|NCT00226980|Growth Substances|growth substances|mesh-ancestor
138617672|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
138617674|NCT00203801|Lumefantrine|lumefantrine|mesh-list
138617675|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
138617676|NCT00203801|Artemether|artemether|mesh-list
138617677|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
138617678|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138617679|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138617680|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
138617681|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138617682|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138617683|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617684|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617685|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
138617686|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
138617687|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138617688|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
138617689|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138617690|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617691|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617692|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138617693|NCT00197327|Bupivacaine|bupivacaine|mesh-list
138617694|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
138617695|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
138705229|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617696|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138617697|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617698|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
138180055|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617699|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617700|NCT00227097|Anticoagulants|anticoagulants|mesh-list
138617701|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
138617702|NCT00208923|Busulfan|busulfan|mesh-list
138617703|NCT00208923|Fludarabine|fludarabine|mesh-list
138617704|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138617705|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
138617706|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617707|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617708|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138617709|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
138659972|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138659975|NCT00446901|Trace Elements|trace elements|mesh-ancestor
138617710|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617711|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617712|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138617713|NCT00227136|Serotonin|serotonin|mesh-list
138617714|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138617715|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
138617716|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617717|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617718|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617719|NCT00203957|Istradefylline|istradefylline|mesh-list
138617720|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138617721|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138617722|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138617723|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
138617724|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617725|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617726|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617727|NCT00197444|Nedaplatin|nedaplatin|mesh-list
138617728|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617729|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138617731|NCT00204074|Estradiol|estradiol|mesh-list
138617732|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138617735|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138617736|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617737|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138617738|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
138294174|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
138617739|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138617740|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138617741|NCT00227292|Escitalopram|escitalopram|mesh-list
138617742|NCT00227292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138617743|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138617744|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138617745|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617746|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180078|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617747|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
138617748|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617749|NCT00197483|Pergolide|pergolide|mesh-list
138617750|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
138617751|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
138617752|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617753|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617754|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617755|NCT00230529|Infliximab|infliximab|mesh-list
138617756|NCT00230529|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138617757|NCT00230529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138617758|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
138660021|NCT00343187|Dapsone|dapsone|mesh-list
138617759|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138617760|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617761|NCT00230568|Donepezil|donepezil|mesh-list
138617762|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138617763|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617764|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617765|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
138617766|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617767|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617768|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
138617769|NCT00227331|Amoxicillin|amoxicillin|mesh-list
138617770|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138617771|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617772|NCT00197561|Selenium|selenium|mesh-list
138617773|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
138617774|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617775|NCT00197561|Protective Agents|protective agents|mesh-ancestor
138617776|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617777|NCT00197561|Trace Elements|trace elements|mesh-ancestor
138617778|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
138617780|NCT00227409|Calcium|calcium|mesh-list
138617781|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
138617782|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138617783|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617784|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
138617785|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138617787|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
138617788|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617789|NCT00227409|Antidotes|antidotes|mesh-ancestor
138617790|NCT00227409|Protective Agents|protective agents|mesh-ancestor
138617791|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138617792|NCT00197639|Ritonavir|ritonavir|mesh-list
138617793|NCT00197639|Indinavir|indinavir|mesh-list
138617794|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138617795|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138617796|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
138617797|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617798|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617799|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138617800|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138617801|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
138617802|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617803|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138617804|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138617805|NCT00227448|Phenylephrine|phenylephrine|mesh-list
138617806|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
138617808|NCT00227448|Norepinephrine|norepinephrine|mesh-list
138617809|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138617810|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
138617811|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
138617812|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617813|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617814|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
138617815|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138617816|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
138617817|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
138617818|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138617819|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138617820|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138617821|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
138617822|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617823|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617824|NCT00227448|Protective Agents|protective agents|mesh-ancestor
138617825|NCT00204191|Tacrolimus|tacrolimus|mesh-list
138617826|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138617827|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
138617828|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617829|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138617830|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705324|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138617831|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617832|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
138617833|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138617834|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617835|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138617836|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
138617837|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138617838|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617839|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617840|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617841|NCT00204269|Testosterone|testosterone|mesh-list
138617842|NCT00204269|Androgens|androgens|mesh-ancestor
138617844|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138617845|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617846|NCT00197756|Vitamins|vitamins|mesh-list
138617847|NCT00197756|Vitamin A|vitamin a|mesh-list
138617848|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
138617849|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
138617850|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617851|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
138617852|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617853|NCT00197756|Protective Agents|protective agents|mesh-ancestor
138617854|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138180142|NCT04952194|Carbidopa|carbidopa|mesh-list
138617855|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617856|NCT00227565|Carboplatin|carboplatin|mesh-list
138617857|NCT00227565|Pemetrexed|pemetrexed|mesh-list
138617858|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617859|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617860|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617861|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138617862|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138617863|NCT00204308|Tenofovir|tenofovir|mesh-list
138617864|NCT00204308|Emtricitabine|emtricitabine|mesh-list
138617865|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
138617866|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617867|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138617868|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138617869|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138660060|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
138617870|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617871|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138617872|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138617873|NCT00204347|Risperidone|risperidone|mesh-list
138617874|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138617875|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
138617876|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617877|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617878|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617879|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138617880|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138617881|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138617882|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138617883|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138617884|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
138617885|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
138617886|NCT00227682|Thalidomide|thalidomide|mesh-list
138617887|NCT00227682|Dexamethasone|dexamethasone|mesh-list
138617888|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
138617889|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138617890|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
138617891|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
138617892|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617893|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617894|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138617895|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
138617896|NCT00227682|Hormones|hormones|mesh-ancestor
138617897|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138617898|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138617899|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617900|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138617901|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
138617902|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
138617903|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138617904|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138617905|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138617906|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138617907|NCT00227682|Growth Substances|growth substances|mesh-ancestor
138617908|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
138617909|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
138617910|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617911|NCT00227682|Protective Agents|protective agents|mesh-ancestor
138617912|NCT00227682|Vitamins|vitamins|mesh-ancestor
138617913|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
138617914|NCT00230763|Timolol|timolol|mesh-list
138617916|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138617917|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138617918|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
138617919|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617920|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617921|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617922|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138617923|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138617924|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138617925|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138617927|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
138617928|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138617929|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617930|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
138617931|NCT04721964|Trace Elements|trace elements|mesh-ancestor
138617932|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
138617933|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617934|NCT00197834|Valproic Acid|valproic acid|mesh-list
138617935|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
138617936|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617937|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617938|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
138617939|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617940|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617941|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
138617942|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138617943|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138617944|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138617945|NCT00197912|Celecoxib|celecoxib|mesh-list
138617946|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
138617947|NCT00197912|Interleukin-2|interleukin-2|mesh-list
138617948|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
138617949|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617950|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138617951|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617952|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138617953|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
138617954|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617955|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138617956|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138617957|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138617958|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138617959|NCT00197912|Analgesics|analgesics|mesh-ancestor
138617960|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
138617961|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617962|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138617963|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138617964|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138617965|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617966|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138617967|NCT02962323|Calcium|calcium|mesh-list
138681200|NCT01249521|Trebananib|trebananib|mesh-list
138617968|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138180172|NCT00827099|Melphalan|melphalan|mesh-list
138617969|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617971|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138617972|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
138617973|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617974|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138617975|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138617976|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617977|NCT00204503|Valproic Acid|valproic acid|mesh-list
138617978|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
138617979|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617980|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138617981|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
138617982|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138617983|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617984|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
138617985|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138617986|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138617987|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138617988|NCT00204542|Diclofenac|diclofenac|mesh-list
138617989|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138617990|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138617991|NCT00204542|Analgesics|analgesics|mesh-ancestor
138617992|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
138617993|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138617994|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138617995|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138617996|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138617997|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138617998|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138617999|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618000|NCT00230958|Interferons|interferons|mesh-list
138618001|NCT00230958|Ribavirin|ribavirin|mesh-list
138618002|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
138618003|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
138618004|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138618005|NCT00230958|Taribavirin|taribavirin|mesh-list
138618006|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681217|NCT04511897|Expectorants|expectorants|mesh-list
138618007|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
138618008|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618009|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
138618010|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618011|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
138618012|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618013|NCT00227955|Imipramine|imipramine|mesh-list
138180183|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618014|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138618015|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
138618016|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138618017|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138618018|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138618019|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138660127|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138660135|NCT00343850|Mesalamine|mesalamine|mesh-list
138618020|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618022|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618023|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618024|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
138618025|NCT00228033|Calcium|calcium|mesh-list
138618026|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138618027|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618028|NCT00228033|Antacids|antacids|mesh-ancestor
138618029|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618030|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618031|NCT00230997|Galantamine|galantamine|mesh-list
138618032|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138618033|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618034|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618035|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
138618036|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618037|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618038|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138618039|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
138618040|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618041|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
138618042|NCT00204581|Aldesleukin|aldesleukin|mesh-list
138618043|NCT00204581|Interleukin-2|interleukin-2|mesh-list
138618044|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618045|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138618046|NCT00204581|Analgesics|analgesics|mesh-ancestor
138618047|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
138618048|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618049|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618050|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138180214|NCT02617888|Bismuth|bismuth|mesh-list
138618051|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138618052|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
138618053|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618054|NCT00231075|Paclitaxel|paclitaxel|mesh-list
138618055|NCT00231075|Carboplatin|carboplatin|mesh-list
138618056|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138618057|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618058|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
138618059|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
138618060|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
138618061|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618062|NCT00198146|Daclizumab|daclizumab|mesh-list
138618063|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138618064|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
138618065|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618066|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138618067|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138618068|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
138618069|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618070|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618071|NCT02962518|Triamcinolone|triamcinolone|mesh-list
138618072|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138618073|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
138618075|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618076|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618077|NCT00204659|Rituximab|rituximab|mesh-list
138618078|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138618079|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618080|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
138618081|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618082|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138618083|NCT00231192|Repaglinide|repaglinide|mesh-list
138618084|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138618085|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618086|NCT00204698|Rabeprazole|rabeprazole|mesh-list
138618087|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138618088|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618089|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138618090|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618091|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618092|NCT00204737|Prednisone|prednisone|mesh-list
138618093|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138618094|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
138618095|NCT00204737|Hormones|hormones|mesh-ancestor
138618096|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618097|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618098|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138618099|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618100|NCT00198380|Gefitinib|gefitinib|mesh-list
138618101|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618102|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138618103|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618104|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618105|NCT00228267|Propofol|propofol|mesh-list
138618106|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138618108|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618109|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138618110|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
138618111|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
138618112|NCT00231348|Nefazodone|nefazodone|mesh-list
138618113|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138618114|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138618115|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138618116|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618117|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180294|NCT00836407|Vaccines|vaccines|mesh-list
138660183|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138660195|NCT00344201|Coagulants|coagulants|mesh-ancestor
138618118|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618119|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138618120|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
138618121|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138618122|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138618123|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138618124|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
138618125|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
138618126|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138618127|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618128|NCT00198536|Ecabet|ecabet|mesh-list
138618129|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618130|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138618131|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618132|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
138618133|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618134|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618135|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138618136|NCT00198536|Protective Agents|protective agents|mesh-ancestor
138681258|NCT01249833|Oseltamivir|oseltamivir|mesh-list
138618137|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618138|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618140|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138618141|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618142|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138618143|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618144|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
138618145|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138618146|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
138618147|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618148|NCT00410033|Insulin|insulin|mesh-list
138618149|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138618150|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
138618151|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
138618152|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
138618153|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
138618154|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138180337|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138180338|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138180352|NCT00859651|Vitamin D|vitamin d|mesh-list
138618155|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618156|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138618157|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
138618158|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138618159|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138618160|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138618161|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138618162|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618163|NCT00198614|Metoprolol|metoprolol|mesh-list
138618164|NCT00198614|Carvedilol|carvedilol|mesh-list
138618165|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138618166|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138618167|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
138618168|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
138618169|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618171|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138618172|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138618173|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138618174|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
138618175|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618176|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618177|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
138618178|NCT00198614|Protective Agents|protective agents|mesh-ancestor
138618179|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138618180|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138618181|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138618182|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
138618183|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138618184|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138618186|NCT00231582|Etoposide|etoposide|mesh-list
138618187|NCT00231582|Carboplatin|carboplatin|mesh-list
138618188|NCT00231582|Epirubicin|epirubicin|mesh-list
138618189|NCT00231582|Ifosfamide|ifosfamide|mesh-list
138618190|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138618191|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138294645|NCT00001039|Clarithromycin|clarithromycin|mesh-list
138618193|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
138618194|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
138618195|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618196|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138618197|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138618198|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618199|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138618200|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138618201|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
138618203|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138180373|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
138618204|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618205|NCT00228540|Modafinil|modafinil|mesh-list
138618206|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138618207|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618208|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138618209|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138618210|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138618211|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618212|NCT00231621|Topiramate|topiramate|mesh-list
138618213|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
138618214|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138618215|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618216|NCT00474526|Vaccines|vaccines|mesh-list
138618217|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138618218|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
138618219|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618220|NCT00231660|Topiramate|topiramate|mesh-list
138618221|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
138618222|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138618223|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618224|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138618225|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138618226|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138618227|NCT00198848|Folic Acid|folic acid|mesh-list
138618228|NCT00198848|Hematinics|hematinics|mesh-ancestor
138618229|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
138618230|NCT00198848|Vitamins|vitamins|mesh-ancestor
138618231|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
138618232|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618233|NCT00478426|Sunitinib|sunitinib|mesh-list
138618234|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618235|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138618236|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138618237|NCT00478426|Growth Substances|growth substances|mesh-ancestor
138618238|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618239|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
138618240|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138180402|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
138618241|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618242|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618243|NCT00231855|Docetaxel|docetaxel|mesh-list
138618244|NCT00231855|Topotecan|topotecan|mesh-list
138618245|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618246|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
138618247|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
138618248|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
138705553|NCT04463368|Ipilimumab|ipilimumab|mesh-list
138618249|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618250|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138618251|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138618252|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618253|NCT00199004|Cytarabine|cytarabine|mesh-list
138618254|NCT00199004|Dexamethasone|dexamethasone|mesh-list
138618255|NCT00199004|Prednisolone|prednisolone|mesh-list
138618256|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
138618257|NCT00199004|Rituximab|rituximab|mesh-list
138618259|NCT00199004|Vincristine|vincristine|mesh-list
138618260|NCT00199004|Doxorubicin|doxorubicin|mesh-list
138618261|NCT00199004|Daunorubicin|daunorubicin|mesh-list
138618262|NCT00199004|Asparaginase|asparaginase|mesh-list
138618263|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
138618264|NCT00199004|Thioguanine|thioguanine|mesh-list
138618265|NCT00199004|Vindesine|vindesine|mesh-list
138618266|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138618267|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
138618268|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618269|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138618270|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138618271|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
138681333|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
138618272|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618273|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618274|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138618275|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138618276|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
138618277|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
138618278|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618279|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618280|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
138618281|NCT00199004|Hormones|hormones|mesh-ancestor
138618282|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618283|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138660245|NCT00344552|Paclitaxel|paclitaxel|mesh-list
138618284|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138618285|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138618286|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
138618287|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138618288|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138618289|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
138618290|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
138618291|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618292|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138618293|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138618294|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
138618295|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618296|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138618297|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
138618298|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
138618299|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
138618300|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138618301|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138618302|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138618303|NCT00228852|Fludarabine|fludarabine|mesh-list
138618304|NCT00228852|Busulfan|busulfan|mesh-list
138618305|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618306|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618307|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138618308|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
138618309|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618311|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138618312|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138618313|NCT00204776|Capecitabine|capecitabine|mesh-list
138618314|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
138618315|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138618316|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
138618317|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618318|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618320|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138681377|NCT01248468|Aspirin|aspirin|mesh-list
138618322|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618323|NCT00477412|Cytarabine|cytarabine|mesh-list
138618324|NCT00477412|Dexamethasone|dexamethasone|mesh-list
138618325|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
138618326|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
138618327|NCT00477412|Rituximab|rituximab|mesh-list
138618328|NCT00477412|Doxorubicin|doxorubicin|mesh-list
138618329|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138618330|NCT00477412|Methotrexate|methotrexate|mesh-list
138618331|NCT00477412|Vincristine|vincristine|mesh-list
138618332|NCT00477412|Bortezomib|bortezomib|mesh-list
138618333|NCT00477412|Daunorubicin|daunorubicin|mesh-list
138618334|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138618335|NCT00477412|Antibodies|antibodies|mesh-list
138618337|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138618338|NCT00477412|BB 1101|bb 1101|mesh-list
138618339|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138618340|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
138618341|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618342|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138618343|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138618344|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
138618345|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618346|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618347|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138618348|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138618349|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
138618350|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
138618351|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618352|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618353|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
138618354|NCT00477412|Hormones|hormones|mesh-ancestor
138618355|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618356|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138618357|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138180461|NCT02641522|Siltuximab|siltuximab|mesh-list
138618358|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138618359|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138618360|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618361|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138618362|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
138618363|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138618364|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138618365|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
138618366|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
138618367|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138618368|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138618369|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
138618370|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618371|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138618372|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
138618373|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
138618374|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
138618375|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
138618376|NCT00410774|Bevacizumab|bevacizumab|mesh-list
138618377|NCT00410774|Gemcitabine|gemcitabine|mesh-list
138618378|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138618380|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138618381|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138618382|NCT00410774|Growth Substances|growth substances|mesh-ancestor
138618383|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618384|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
138618385|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138618386|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
138618387|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618388|NCT00228930|Tamoxifen|tamoxifen|mesh-list
138618389|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138618390|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
138618391|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618392|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618393|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138618394|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618395|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138618396|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138618397|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138618398|NCT00410852|Insulin|insulin|mesh-list
138618399|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138660276|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
138618400|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138618401|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618402|NCT01086982|Octreotide|octreotide|mesh-list
138618403|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618404|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138618405|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618406|NCT00410930|Immunomodulating Agents|immunomodulating agents|mesh-list
138618407|NCT00410930|Immunologic Factors|immunologic factors|mesh-ancestor
138618408|NCT00410930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618410|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138618411|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618412|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
138618413|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138618414|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138618415|NCT00232011|Analgesics|analgesics|mesh-ancestor
138180494|NCT02620774|Tazobactam|tazobactam|mesh-list
138618416|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
138618417|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618418|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618419|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138618420|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138618421|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
138618422|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138618423|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
138681413|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
138618424|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138618425|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618426|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618427|NCT00232050|Omalizumab|omalizumab|mesh-list
138618428|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138618429|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138618430|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
138618431|NCT00232089|Tegaserod|tegaserod|mesh-list
138618432|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138618433|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
138618434|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618435|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618436|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618437|NCT00205166|Caffeine|caffeine|mesh-list
138618438|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138618439|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618440|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138618441|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618442|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618443|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138618444|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138618445|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
138618446|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618447|NCT00229125|Gabapentin|gabapentin|mesh-list
138618448|NCT00229125|Lorazepam|lorazepam|mesh-list
138618449|NCT00229125|Analgesics|analgesics|mesh-ancestor
138618450|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
138618451|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618452|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618453|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
138618454|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138618455|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138618456|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138618457|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138618458|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138618459|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138618460|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618461|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618462|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
138618463|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
138180498|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618464|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
138618465|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618466|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138618467|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
138618468|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
138618470|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138618471|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138618472|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
138618473|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618474|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618475|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138618476|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138618477|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
138618478|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618479|NCT00232167|Indiplon|indiplon|mesh-list
138618480|NCT00232167|Sertraline|sertraline|mesh-list
138618481|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
138618482|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138638006|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138618483|NCT00232167|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138618484|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138618485|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138618486|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618488|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
138618489|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618490|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138618491|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138618492|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
138618493|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
138618494|NCT00205322|Leucovorin|leucovorin|mesh-list
138618495|NCT00205322|Capecitabine|capecitabine|mesh-list
138618496|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
138618497|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138618498|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
138618499|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618500|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618501|NCT00205322|Antidotes|antidotes|mesh-ancestor
138618502|NCT00205322|Protective Agents|protective agents|mesh-ancestor
138618503|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618504|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
138618505|NCT00205322|Vitamins|vitamins|mesh-ancestor
138618506|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
138618507|NCT00232206|Docetaxel|docetaxel|mesh-list
138618508|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618509|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
138618510|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
138618511|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
138618512|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618513|NCT00229242|Diuretics|diuretics|mesh-list
138618514|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
138618515|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180519|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618516|NCT00232284|Sertraline|sertraline|mesh-list
138618517|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
138618518|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138618519|NCT00232284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138660321|NCT00448149|Everolimus|everolimus|mesh-list
138618520|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138618521|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138618522|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618524|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
138618525|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618526|NCT00205634|Clarithromycin|clarithromycin|mesh-list
138618527|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138618528|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618529|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138618530|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618531|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618532|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138618533|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138618534|NCT00232362|Pioglitazone|pioglitazone|mesh-list
138618535|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
138618536|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138618537|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618538|NCT00205751|Thalidomide|thalidomide|mesh-list
138618539|NCT00205751|Dexamethasone|dexamethasone|mesh-list
138618540|NCT00205751|Prednisone|prednisone|mesh-list
138618541|NCT00205751|Melphalan|melphalan|mesh-list
138618542|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138618543|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
138618544|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
138618545|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618546|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618547|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618550|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618551|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138618552|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618553|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138618554|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
138618555|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618556|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138618557|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138618558|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
138618559|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
138618560|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138618561|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618562|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138618563|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138618564|NCT00205751|Growth Substances|growth substances|mesh-ancestor
138618565|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
138618566|NCT00229476|Sertraline|sertraline|mesh-list
138618567|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
138618568|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138618569|NCT00229476|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138705669|NCT04238819|Irinotecan|irinotecan|mesh-list
138660329|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618570|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138618571|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138618572|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618573|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618574|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
138618575|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618576|NCT00205946|Bupropion|bupropion|mesh-list
138618577|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138618578|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
138618579|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138618580|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138618581|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138618582|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138618583|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618584|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
138618585|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618586|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618587|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138681532|NCT00516750|Methotrexate|methotrexate|mesh-list
138618588|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138618589|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618590|NCT00229515|Sirolimus|sirolimus|mesh-list
138618591|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
138618592|NCT00229515|Temsirolimus|temsirolimus|mesh-list
138618593|NCT00229515|MTOR Inhibitors|mtor inhibitors|mesh-list
138618594|NCT00229515|Tirofiban|tirofiban|mesh-list
138618595|NCT00229515|Abciximab|abciximab|mesh-list
138618596|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138618597|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618598|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138618599|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618600|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
138618601|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138618602|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
138618603|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618604|NCT00229515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138180599|NCT05587426|Iproplatin|iproplatin|mesh-list
138618605|NCT00229515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618606|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618607|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
138618608|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138618609|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138618610|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138618611|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138618612|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
138618613|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
138618614|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138618615|NCT00229515|Protective Agents|protective agents|mesh-ancestor
138618616|NCT00206024|Esomeprazole|esomeprazole|mesh-list
138618617|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138618618|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618619|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138618620|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618621|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618622|NCT00206063|Ximelagatran|ximelagatran|mesh-list
138618623|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
138618624|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138618625|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
138660356|NCT00344981|Tenofovir|tenofovir|mesh-list
138618626|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618627|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618628|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
138618629|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138618630|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
138618631|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138618632|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138618633|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138618634|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138618635|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618637|NCT00229593|Testosterone|testosterone|mesh-list
138618638|NCT00229593|Androgens|androgens|mesh-ancestor
138618639|NCT00229593|Hormones|hormones|mesh-ancestor
138618640|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618641|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618642|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138618643|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
138618644|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138618645|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138618646|NCT00229632|Idebenone|idebenone|mesh-list
138618647|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
138681565|NCT00506168|Irinotecan|irinotecan|mesh-list
138618648|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618649|NCT00229632|Protective Agents|protective agents|mesh-ancestor
138618650|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618651|NCT00206180|Esomeprazole|esomeprazole|mesh-list
138618652|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138618653|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618654|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138618655|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138180607|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138180610|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
138618656|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618657|NCT00206219|Methotrexate|methotrexate|mesh-list
138618658|NCT00206219|Gefitinib|gefitinib|mesh-list
138618659|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138618660|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
138618661|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138618662|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618663|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138618664|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
138618665|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618666|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618667|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
138618668|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618669|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138618670|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138618671|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
138618672|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138618673|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138618674|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138618675|NCT00206258|Pramlintide|pramlintide|mesh-list
138618676|NCT00206258|Glucagon|glucagon|mesh-list
138618677|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618678|NCT00206258|Hormones|hormones|mesh-ancestor
138618679|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618680|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618682|NCT00206297|Pramlintide|pramlintide|mesh-list
138618683|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138618684|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618685|NCT00411047|Gefitinib|gefitinib|mesh-list
138618686|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618687|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138618688|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618689|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618690|NCT00411125|Calcitonin|calcitonin|mesh-list
138618691|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
138618692|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138618693|NCT00411125|Katacalcin|katacalcin|mesh-list
138618694|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138618695|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618696|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138618697|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
138618698|NCT00411164|Hydromorphone|hydromorphone|mesh-list
138618699|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138618700|NCT00411164|Narcotics|narcotics|mesh-ancestor
138618701|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138618702|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618703|NCT00411164|Analgesics|analgesics|mesh-ancestor
138618704|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
138618705|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618706|NCT00411203|Tamoxifen|tamoxifen|mesh-list
138618707|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138618708|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
138618709|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618710|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618711|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138618712|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618713|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138618714|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138618715|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138618716|NCT00411281|Cytarabine|cytarabine|mesh-list
138618717|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138618718|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
138618719|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618720|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618721|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
138618722|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618723|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138618724|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
138618725|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618726|NCT00206414|Gefitinib|gefitinib|mesh-list
138618727|NCT00206414|Fulvestrant|fulvestrant|mesh-list
138618728|NCT00206414|Anastrozole|anastrozole|mesh-list
138618729|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618730|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138618731|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618732|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705748|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
138618733|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138618734|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138618735|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138618736|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
138618737|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618738|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618739|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138618740|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138618741|NCT00232674|Budesonide|budesonide|mesh-list
138618742|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138618743|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138618744|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
138681610|NCT02949765|Trace Elements|trace elements|mesh-ancestor
138618745|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618746|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618747|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138618748|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
138618749|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
138618750|NCT00232674|Hormones|hormones|mesh-ancestor
138618751|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618752|NCT00206453|Docetaxel|docetaxel|mesh-list
138618753|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618754|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
138618755|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
138618756|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
138618757|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618758|NCT00206492|Tamoxifen|tamoxifen|mesh-list
138618759|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138618760|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
138618761|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138705771|NCT04086485|Olaparib|olaparib|mesh-list
138618762|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618763|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138618764|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618765|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138618766|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138618767|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138618768|NCT00206570|Estradiol|estradiol|mesh-list
138618769|NCT00206570|Estrogens|estrogens|mesh-ancestor
138618770|NCT00206570|Hormones|hormones|mesh-ancestor
138180647|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
138618771|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618772|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618774|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138681633|NCT00517062|Hormones|hormones|mesh-list
138618775|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
138618776|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618777|NCT01056159|Albuterol|albuterol|mesh-list
138618778|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138618780|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618781|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618782|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138618783|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
138618784|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
138618785|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138618786|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138618787|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138618788|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138618789|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
138618790|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618791|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618792|NCT00206765|Risperidone|risperidone|mesh-list
138618793|NCT00206765|Paroxetine|paroxetine|mesh-list
138618794|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138618795|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
138618796|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618797|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618798|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618799|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138618800|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138618801|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138618802|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138618803|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138618804|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
138618805|NCT00206765|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138618806|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138618807|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138618808|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138618809|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
138618810|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138618811|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138618812|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618813|NCT00424710|Ranibizumab|ranibizumab|mesh-list
138618814|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138618815|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138618816|NCT00424710|Growth Substances|growth substances|mesh-ancestor
138180668|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
138618817|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618818|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
138618819|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618820|NCT00206960|Risperidone|risperidone|mesh-list
138618821|NCT00206960|Clopenthixol|clopenthixol|mesh-list
138618822|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138618824|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618825|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618826|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618827|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138618828|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138618829|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138618830|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138618831|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138618832|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
138618834|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138618835|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
138618836|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138618837|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138618838|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138618839|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138618840|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618841|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
138618842|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618843|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618844|NCT00229944|Azithromycin|azithromycin|mesh-list
138618845|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138705837|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618846|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618848|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138618849|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138618850|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618851|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138618852|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618853|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618854|NCT00207116|Cetuximab|cetuximab|mesh-list
138618855|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138618856|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618857|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
138618858|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138618859|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138618860|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618861|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138618862|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138618863|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
138618864|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618865|NCT00207155|Cetuximab|cetuximab|mesh-list
138618866|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138618867|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618868|NCT00232947|Vaccines|vaccines|mesh-list
138618869|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
138660463|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138618870|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618871|NCT00413712|Adenosine|adenosine|mesh-list
138618872|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
138618873|NCT00413712|Calcium|calcium|mesh-list
138618874|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138618875|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618876|NCT00413712|Analgesics|analgesics|mesh-ancestor
138618877|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
138618878|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618879|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138618880|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
138618881|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138618882|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
138618883|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
138618884|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618885|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618886|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138618888|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
138618889|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138618890|NCT00207311|Interferons|interferons|mesh-list
138618891|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
138618892|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
138618893|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138618894|NCT00207311|Orlistat|orlistat|mesh-list
138618895|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618896|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
138618897|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618898|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
138705868|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
138618899|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618900|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618901|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618902|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138618903|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138618904|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138618905|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138618906|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138618907|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138618908|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618909|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138618910|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618912|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
138618913|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618914|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
138618915|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138618916|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
138618917|NCT00207428|Carbamazepine|carbamazepine|mesh-list
138618918|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
138618919|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
138618920|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138180714|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618921|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138618922|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618923|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138618924|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138618925|NCT00207428|Analgesics|analgesics|mesh-ancestor
138618926|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
138618927|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618928|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138618929|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138618930|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618931|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138618932|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138618934|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618935|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138618936|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618937|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618938|NCT00207584|Doxycycline|doxycycline|mesh-list
138618939|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138618940|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618941|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
138295391|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138618942|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138618943|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138618945|NCT00207662|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138618946|NCT00207662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138618947|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
138618948|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618949|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138618950|NCT00207701|Infliximab|infliximab|mesh-list
138618951|NCT00207701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138618952|NCT00207701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138618953|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
138618954|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618955|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138618956|NCT00207779|Heparin|heparin|mesh-list
138618957|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
138618958|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138618959|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138618960|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618961|NCT00230373|Imiquimod|imiquimod|mesh-list
138618962|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138618963|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
138618964|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618965|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618966|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
138618967|NCT00230451|Paclitaxel|paclitaxel|mesh-list
138618968|NCT00230451|Fluorouracil|fluorouracil|mesh-list
138618969|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138618970|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618971|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
138618972|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
138618973|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
138618974|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138618975|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
138618976|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138618977|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138618978|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
138618979|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618980|NCT00411320|Dexamethasone|dexamethasone|mesh-list
138618981|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138618982|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
138618983|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
138618984|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138618985|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138618986|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138618987|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
138618988|NCT00411320|Hormones|hormones|mesh-ancestor
138618989|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138618990|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138618991|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138618992|NCT00233337|Artemether|artemether|mesh-list
138618993|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138618994|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
138618995|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138618996|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138618997|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138618998|NCT00230490|Adefovir|adefovir|mesh-list
138618999|NCT00230490|Pradefovir|pradefovir|mesh-list
138619000|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
138619001|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138619002|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138619003|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138619004|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619005|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619006|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138619008|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138619009|NCT01089556|Analgesics|analgesics|mesh-ancestor
138619010|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
138619011|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619012|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619013|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
138619014|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138619015|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619016|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619017|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138619018|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138619019|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138619020|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619021|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619022|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138619023|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138619024|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619025|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
138619026|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
138619027|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138619028|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138619029|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138619030|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
138619031|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
138619032|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138619033|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619034|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138619035|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138619036|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
138619037|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619038|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619039|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138619040|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
138619041|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138619042|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138619043|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138619044|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
138619045|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619046|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619047|NCT00424580|Montelukast|montelukast|mesh-list
138619048|NCT00424580|Desloratadine|desloratadine|mesh-list
138619049|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138619050|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
138619051|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138619052|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
138705931|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
138705932|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138619053|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138619054|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619055|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138619056|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138619057|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619058|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138619059|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
138180794|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138619060|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619061|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138619062|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138619063|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
138619064|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
138619065|NCT00233532|Verapamil|verapamil|mesh-list
138619066|NCT00233532|Trandolapril|trandolapril|mesh-list
138619067|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138681745|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
138619068|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138619069|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619070|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619071|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138619072|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619073|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
138619074|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138619075|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
138619076|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619077|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138619078|NCT00233571|Adalimumab|adalimumab|mesh-list
138619079|NCT00233571|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138619080|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138619081|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138619082|NCT00237198|Letrozole|letrozole|mesh-list
138619083|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619084|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138619085|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138619086|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619087|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619088|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138619089|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
138295549|NCT00002197|Abacavir|abacavir|mesh-list
138619090|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138619091|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619092|NCT00233610|Tamoxifen|tamoxifen|mesh-list
138619093|NCT00233610|Bicalutamide|bicalutamide|mesh-list
138619094|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138619095|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
138619096|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138619097|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619098|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138619099|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619100|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138705956|NCT03613532|Fludarabine|fludarabine|mesh-list
138619101|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138619102|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138619103|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
138619105|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
138619106|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138619107|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619108|NCT00237237|Vildagliptin|vildagliptin|mesh-list
138619109|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138619110|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619111|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138619112|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
138619113|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619114|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619115|NCT00208169|Aripiprazole|aripiprazole|mesh-list
138619116|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
138619117|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619118|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138619119|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138619120|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619121|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619122|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
138619123|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
138619124|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619125|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619126|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138619127|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138619128|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
138619129|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138619130|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138619131|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138619132|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138619133|NCT01087723|Heparin|heparin|mesh-list
138619134|NCT01087723|Bivalirudin|bivalirudin|mesh-list
138619135|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
138619136|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138619137|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138619138|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619139|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
138619140|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138619141|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
138619142|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619143|NCT00208208|Ziprasidone|ziprasidone|mesh-list
138619144|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138619145|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
138619146|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619147|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619148|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619149|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138619150|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138619151|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619152|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619153|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138619154|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
138619156|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
138660547|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619157|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138619158|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138619159|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619160|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619161|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138295615|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
138619162|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619163|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
138619164|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619165|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138619166|NCT01085812|Analgesics|analgesics|mesh-ancestor
138619167|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
138180833|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
138619168|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619169|NCT01085734|Bevacizumab|bevacizumab|mesh-list
138619170|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138619171|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619172|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138619173|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138619174|NCT01085734|Growth Substances|growth substances|mesh-ancestor
138619175|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619176|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
138619177|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138619178|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
138706002|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619179|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138619180|NCT00208403|Protective Agents|protective agents|mesh-ancestor
138619181|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619183|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138619184|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
138619185|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619186|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619187|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138619188|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138619189|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
138619190|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619191|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619192|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
138619194|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
138619195|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619196|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138619197|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619198|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619199|NCT00233766|Sirolimus|sirolimus|mesh-list
138619200|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138619201|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138619202|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138619203|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619204|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
138660563|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138619205|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138619206|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
138619207|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619208|NCT00208520|Lamotrigine|lamotrigine|mesh-list
138619209|NCT00208520|Carbamazepine|carbamazepine|mesh-list
138619210|NCT00208520|Levetiracetam|levetiracetam|mesh-list
138619211|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
138619213|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138619214|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619215|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681814|NCT00518271|Sirolimus|sirolimus|mesh-list
138619216|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138619217|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619218|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138619219|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138619220|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619221|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619222|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138619223|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
138619224|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138619225|NCT00208520|Analgesics|analgesics|mesh-ancestor
138619226|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
138619227|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619228|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138619229|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138619230|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138619231|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
138619232|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619233|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138619234|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138619235|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138295699|NCT00002515|Topotecan|topotecan|mesh-list
138619236|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619237|NCT00208559|Ziprasidone|ziprasidone|mesh-list
138619238|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138619239|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
138619240|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619241|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619242|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619243|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138619244|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138619245|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619246|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619247|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138619248|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
138619249|NCT00233805|Sirolimus|sirolimus|mesh-list
138619250|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138619251|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138619252|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138619253|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619254|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
138619255|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138619256|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
138619257|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619258|NCT01084135|Rivastigmine|rivastigmine|mesh-list
138619259|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138619260|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619261|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619262|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
138619263|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619264|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619265|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138619266|NCT01084135|Protective Agents|protective agents|mesh-ancestor
138619267|NCT01083316|Dexamethasone|dexamethasone|mesh-list
138619268|NCT01083316|Bortezomib|bortezomib|mesh-list
138619269|NCT01083316|Melphalan|melphalan|mesh-list
138619270|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138619271|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
138619272|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
138619273|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619274|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619275|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138619276|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
138619277|NCT01083316|Hormones|hormones|mesh-ancestor
138619278|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138180880|NCT03215407|Betamethasone|betamethasone|mesh-list
138619279|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138681827|NCT00518193|Cetuximab|cetuximab|mesh-list
138619280|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619281|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138619282|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
138619283|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619284|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138619285|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138619286|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
138619288|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138619289|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619290|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138619291|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138619292|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138619293|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619294|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
138619295|NCT00208793|Vitamin D|vitamin d|mesh-list
138619296|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
138619297|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
138619298|NCT00208793|Vitamins|vitamins|mesh-list
138619299|NCT00208793|Calcium|calcium|mesh-list
138619300|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
138619301|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619302|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138619303|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138619304|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
138619305|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138619306|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138619307|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619308|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138619309|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138619310|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
138619311|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138619313|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138619314|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
138619315|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138619316|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619317|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138619318|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619319|NCT00237471|Insulin|insulin|mesh-list
138619320|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138619321|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619322|NCT00237510|Terazosin|terazosin|mesh-list
138619323|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138619324|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138619325|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138619326|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
138619327|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619328|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180896|NCT05310331|Immunologic Factors|immunologic factors|mesh-ancestor
138619329|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619330|NCT00237510|Urological Agents|urological agents|mesh-ancestor
138619331|NCT01081795|Topiramate|topiramate|mesh-list
138619332|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
138681841|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
138619333|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138619334|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619335|NCT00233961|Lenograstim|lenograstim|mesh-list
138619336|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138619337|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
138619338|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619339|NCT00234000|Azacitidine|azacitidine|mesh-list
138619340|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
138619341|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138619342|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
138619343|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619344|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619345|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619346|NCT00234117|Rabeprazole|rabeprazole|mesh-list
138619347|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138619348|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138619349|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138619350|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619351|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619352|NCT00209144|Insulin|insulin|mesh-list
138619353|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138619354|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619355|NCT00209222|Cytarabine|cytarabine|mesh-list
138619356|NCT00209222|Dexamethasone|dexamethasone|mesh-list
138619357|NCT00209222|Prednisone|prednisone|mesh-list
138619358|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
138619359|NCT00209222|Melphalan|melphalan|mesh-list
138619360|NCT00209222|Rituximab|rituximab|mesh-list
138619361|NCT00209222|Doxorubicin|doxorubicin|mesh-list
138619363|NCT00209222|Vincristine|vincristine|mesh-list
138619364|NCT00209222|Cisplatin|cisplatin|mesh-list
138619365|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138619366|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
138619367|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619368|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138619369|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138619370|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
138619371|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619372|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619373|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138619374|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138619375|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
138619376|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
138619377|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619378|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138619379|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
138619380|NCT00209222|Hormones|hormones|mesh-ancestor
138619381|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138619382|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138619383|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138619384|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138660613|NCT00346853|Protective Agents|protective agents|mesh-ancestor
138619386|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138619387|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138681859|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619388|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138619390|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
138619391|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
138619392|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138619393|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
138619394|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
138619395|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138619397|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138619398|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
138619399|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619400|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138619401|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138619402|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619403|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619404|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
138619405|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619406|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619407|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138619408|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138619409|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619410|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138619411|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
138619412|NCT00209261|Coagulants|coagulants|mesh-ancestor
138619413|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138619414|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
138619415|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619416|NCT00209300|Mesalamine|mesalamine|mesh-list
138619417|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138619418|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138619419|NCT00209300|Analgesics|analgesics|mesh-ancestor
138619420|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
138619421|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619422|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619423|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138619424|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138619425|NCT00234234|Adalimumab|adalimumab|mesh-list
138619426|NCT00234234|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138619427|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138619428|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138619429|NCT00237588|Losartan|losartan|mesh-list
138619430|NCT00237588|Amlodipine|amlodipine|mesh-list
138619431|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138619432|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138619433|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619434|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180953|NCT02726620|Propofol|propofol|mesh-list
138619435|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138619436|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619437|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
138619438|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138660634|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
138619439|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138619440|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138619441|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138619442|NCT00411437|Oxybutynin|oxybutynin|mesh-list
138619443|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138619444|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138619445|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
138619446|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619447|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619448|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619449|NCT00411437|Urological Agents|urological agents|mesh-ancestor
138619450|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
138619451|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
138619452|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619454|NCT00234312|Escitalopram|escitalopram|mesh-list
138619455|NCT00234312|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138619456|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138619457|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619458|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619459|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619460|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
138619461|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619462|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
138619463|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619464|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
138619465|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138619466|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619467|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138619468|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
138619469|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138619470|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138619471|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619472|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619473|NCT00237627|Doxorubicin|doxorubicin|mesh-list
138619474|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138619476|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138619477|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619478|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138619479|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138619480|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619481|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619482|NCT00209495|Dexamethasone|dexamethasone|mesh-list
138619483|NCT00209495|Pregabalin|pregabalin|mesh-list
138619484|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138619485|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
138619486|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
138619487|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619488|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619489|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138619490|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
138619491|NCT00209495|Hormones|hormones|mesh-ancestor
138619492|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138619493|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138619494|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619495|NCT00209495|Analgesics|analgesics|mesh-ancestor
138706242|NCT01652092|Vidarabine|vidarabine|mesh-list
138619496|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
138619497|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
138619498|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138660652|NCT00347204|Ketorolac|ketorolac|mesh-list
138619499|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619500|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619501|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138619502|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138619503|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138619504|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619505|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619506|NCT00234390|Budesonide|budesonide|mesh-list
138619507|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138619508|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138619509|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
138619510|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619511|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619512|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138619513|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
138619514|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
138619515|NCT00234390|Hormones|hormones|mesh-ancestor
138619516|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138619517|NCT00209534|Fospropofol|fospropofol|mesh-list
138619518|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138619519|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619520|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619521|NCT00209573|Fospropofol|fospropofol|mesh-list
138619522|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138619523|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619524|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619525|NCT00209612|Paclitaxel|paclitaxel|mesh-list
138619526|NCT00209612|Irinotecan|irinotecan|mesh-list
138619527|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138619528|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619529|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
138619530|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
138619531|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
138619532|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619533|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138619534|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138619535|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619536|NCT01081249|Oxytocin|oxytocin|mesh-list
138706257|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619538|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138619539|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619540|NCT00234429|Gefitinib|gefitinib|mesh-list
138619541|NCT00234429|Raltitrexed|raltitrexed|mesh-list
138619542|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619543|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138619544|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619545|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619546|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138619547|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
138619548|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138619549|NCT00209651|Irinotecan|irinotecan|mesh-list
138619550|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138619551|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138619552|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619553|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619554|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619555|NCT02961855|Diclofenac|diclofenac|mesh-list
138619556|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138619557|NCT02961855|Lidocaine|lidocaine|mesh-list
138619558|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
138619559|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
138619560|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138181061|NCT03214627|Iron|iron|mesh-list
138619561|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619562|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
138619563|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619564|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138619565|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138619566|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138619567|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619568|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619569|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138619570|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138619571|NCT02961855|Analgesics|analgesics|mesh-ancestor
138619572|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138619573|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138619574|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619575|NCT00209690|Cisplatin|cisplatin|mesh-list
138619576|NCT00209690|Docetaxel|docetaxel|mesh-list
138619577|NCT00209690|Fluorouracil|fluorouracil|mesh-list
138619578|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619579|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
138619580|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
138619581|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
138619582|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619583|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
138619584|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138619585|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138619586|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
138619587|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619589|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138619590|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138619591|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138619592|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138619593|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
138619594|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619595|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619596|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619597|NCT00234468|Gefitinib|gefitinib|mesh-list
138619598|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138681929|NCT02955251|Nivolumab|nivolumab|mesh-list
138619599|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138619600|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619601|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619602|NCT01080625|Phenylephrine|phenylephrine|mesh-list
138619603|NCT01080625|Epinephrine|epinephrine|mesh-list
138619604|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
138619605|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138619606|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138619607|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
138619608|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619609|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619610|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619611|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138619612|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138619613|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
138619614|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619615|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138619616|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
138619617|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
138619618|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
138619619|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138619620|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138619621|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
138619622|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138619623|NCT01080625|Protective Agents|protective agents|mesh-ancestor
138619624|NCT00209729|Docetaxel|docetaxel|mesh-list
138619625|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619626|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
138619627|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
138619628|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
138619629|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619630|NCT00414180|Bupropion|bupropion|mesh-list
138619631|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138619632|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
138619633|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619634|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138619635|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138619636|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619637|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619638|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
138619639|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619640|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619641|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138619642|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138619643|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619644|NCT01089790|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138619645|NCT01089790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138619646|NCT01089790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619647|NCT01089790|Incretins|incretins|mesh-ancestor
138619648|NCT01089790|Hormones|hormones|mesh-ancestor
138619649|NCT01089790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138619650|NCT01089790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138619651|NCT01089790|Protease Inhibitors|protease inhibitors|mesh-ancestor
138619652|NCT01089790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619653|NCT01089790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619654|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
138619655|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138619656|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138619657|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138619658|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619659|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619660|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
138619661|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619662|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619663|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138619664|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619666|NCT01084330|Irinotecan|irinotecan|mesh-list
138619667|NCT01084330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619668|NCT01084330|Tubulin Modulators|tubulin modulators|mesh-ancestor
138619669|NCT01084330|Antimitotic Agents|antimitotic agents|mesh-ancestor
138619670|NCT01084330|Mitosis Modulators|mitosis modulators|mesh-ancestor
138619671|NCT01084330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619672|NCT01084330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138619673|NCT01084330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138660696|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
138619674|NCT01084330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619675|NCT00209807|Reboxetine|reboxetine|mesh-list
138619676|NCT00209807|Escitalopram|escitalopram|mesh-list
138181139|NCT05446090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619677|NCT00209807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138619678|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138619679|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619680|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619681|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138296148|NCT00002816|Etoposide|etoposide|mesh-list
138619683|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619684|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
138619685|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619686|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138619687|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
138619688|NCT00209846|Gaboxadol|gaboxadol|mesh-list
138619689|NCT00209846|Analgesics|analgesics|mesh-ancestor
138619690|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
138619691|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619692|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619693|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
138619694|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
138619695|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
138619696|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619697|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619698|NCT01082068|Letrozole|letrozole|mesh-list
138619699|NCT01082068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619700|NCT01082068|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138619701|NCT01082068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138619702|NCT01082068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619703|NCT01082068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619704|NCT01082068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138619705|NCT01082068|Hormone Antagonists|hormone antagonists|mesh-ancestor
138619706|NCT01082068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138619707|NCT01082068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619708|NCT01086748|Risperidone|risperidone|mesh-list
138619709|NCT01086748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138619710|NCT01086748|Serotonin Agents|serotonin agents|mesh-ancestor
138619711|NCT01086748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619712|NCT01086748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619713|NCT01086748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619714|NCT01086748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138619715|NCT01086748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138619716|NCT01086748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619717|NCT01086748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619718|NCT01086748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138619719|NCT01086748|Dopamine Agents|dopamine agents|mesh-ancestor
138619721|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
138619722|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
138619723|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619724|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619725|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138619726|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138619727|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138619728|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
138318473|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138619729|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619730|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619731|NCT00209885|Lidocaine|lidocaine|mesh-list
138619732|NCT00209885|Droperidol|droperidol|mesh-list
138619733|NCT00209885|Ketamine|ketamine|mesh-list
138619734|NCT00209885|Gabapentin|gabapentin|mesh-list
138619735|NCT00209885|Esketamine|esketamine|mesh-list
138619736|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
138619737|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
138619738|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619739|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619740|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
138619741|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619742|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138619743|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138619744|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138619745|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619746|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619747|NCT00209885|Analgesics|analgesics|mesh-ancestor
138619748|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138619749|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138619750|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
138619751|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138619752|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138619753|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619754|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
138619755|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138619756|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138619757|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619758|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
138619759|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
138619760|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138619761|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
138619762|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
138619763|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138619764|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138619765|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138619766|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138619767|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
138619768|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
138619769|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138619770|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138619771|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138619772|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138619773|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619774|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
138619775|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138681990|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138619776|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619777|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138619778|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619779|NCT00209924|Gaboxadol|gaboxadol|mesh-list
138619780|NCT00209924|Analgesics|analgesics|mesh-ancestor
138660736|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
138619781|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
138619782|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619783|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619784|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
138181204|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138619785|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
138619786|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
138619787|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619788|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619789|NCT00209963|Gaboxadol|gaboxadol|mesh-list
138619790|NCT00209963|Analgesics|analgesics|mesh-ancestor
138619791|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
138619792|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619793|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619794|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
138619795|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
138619796|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
138619797|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619798|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619799|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
138619800|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138619801|NCT00210002|Hematinics|hematinics|mesh-ancestor
138619802|NCT02277886|Esomeprazole|esomeprazole|mesh-list
138619803|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138619804|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138619805|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138619806|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619807|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619808|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138619809|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138619810|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138619811|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138619812|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138619813|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138619814|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138619815|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
138619816|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619817|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619818|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619819|NCT00210041|Gemcitabine|gemcitabine|mesh-list
138619820|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619821|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138619822|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
138619823|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619824|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
138619825|NCT04990804|Analgesics|analgesics|mesh-list
138619826|NCT04990804|Narcotics|narcotics|mesh-ancestor
138619827|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619828|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619829|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
138619830|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619831|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
138296301|NCT00002828|Fluorouracil|fluorouracil|mesh-list
138619832|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138619833|NCT04991662|Phenylephrine|phenylephrine|mesh-list
138619834|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
138181220|NCT05443282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138181223|NCT00904345|Cetuximab|cetuximab|mesh-list
138619835|NCT04991662|Norepinephrine|norepinephrine|mesh-list
138619836|NCT04991662|Metaraminol|metaraminol|mesh-list
138619837|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138619838|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
138619839|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
138619840|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619841|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619842|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
138619843|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138619844|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
138619845|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
138619846|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138619847|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138619848|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138619849|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
138619850|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619851|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619852|NCT04991662|Protective Agents|protective agents|mesh-ancestor
138619853|NCT04997941|Tamoxifen|tamoxifen|mesh-list
138619854|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138619855|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
138619856|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138619857|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619858|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138619859|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619860|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138619861|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138619862|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138619863|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
138619864|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138619865|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
138619866|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
138619867|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619868|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619869|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138619870|NCT00210158|Analgesics|analgesics|mesh-ancestor
138619871|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
138619872|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619873|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138619874|NCT00413790|Darifenacin|darifenacin|mesh-list
138619875|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138619876|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138619877|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
138619878|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619879|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619880|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619881|NCT00413790|Urological Agents|urological agents|mesh-ancestor
138619883|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
138619884|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
138619885|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619886|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619887|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619889|NCT04996771|Etoposide|etoposide|mesh-list
138619891|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619892|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138619893|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138619894|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138619896|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619897|NCT00210314|Cytarabine|cytarabine|mesh-list
138619898|NCT00210314|Methotrexate|methotrexate|mesh-list
138619899|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138619900|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
138619901|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138619902|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619903|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138619904|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
138619905|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619906|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619907|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
138619908|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619909|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138619910|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138619911|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
138619912|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138619913|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138619914|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
138619915|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138619916|NCT00210392|Bortezomib|bortezomib|mesh-list
138619917|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619918|NCT00413829|Ranibizumab|ranibizumab|mesh-list
138619919|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138619920|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138619921|NCT00413829|Growth Substances|growth substances|mesh-ancestor
138619922|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619923|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
138619924|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619925|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
138619926|NCT02210104|Ipilimumab|ipilimumab|mesh-list
138619927|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138619928|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
138619929|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619930|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138619931|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138619932|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
138619933|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619934|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619935|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138619936|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138619937|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138619938|NCT02210182|Pentamidine|pentamidine|mesh-list
138619939|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
138619940|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138619941|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138619942|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138619943|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138619944|NCT00210509|Almotriptan|almotriptan|mesh-list
138619945|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138181275|NCT03211897|Midazolam|midazolam|mesh-list
138619946|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
138619947|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619948|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619949|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619950|NCT02210260|Heroin|heroin|mesh-list
138619951|NCT02210260|Bupivacaine|bupivacaine|mesh-list
138619952|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
138619953|NCT02210260|Anesthetics|anesthetics|mesh-list
138619954|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619955|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660789|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
138619957|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619958|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138619959|NCT02210260|Narcotics|narcotics|mesh-ancestor
138619960|NCT02210260|Analgesics|analgesics|mesh-ancestor
138619961|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138619962|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138619963|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138619964|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138619965|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619966|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138619967|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138619968|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138619969|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
138619970|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138619971|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619972|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138619973|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138619974|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
138619975|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
138619976|NCT00210587|Hematinics|hematinics|mesh-ancestor
138619977|NCT00210665|Trabectedin|trabectedin|mesh-list
138619978|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138619979|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
138619980|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619981|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138619982|NCT04570345|Aspirin|aspirin|mesh-list
138619983|NCT04570345|Ticagrelor|ticagrelor|mesh-list
138619984|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138619985|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138619986|NCT04570345|Analgesics|analgesics|mesh-ancestor
138619987|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
138619988|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138619989|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138619990|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138619991|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138619992|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138619993|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138619994|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138619995|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138619996|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138619997|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138619998|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
138619999|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138181287|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138620000|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138620001|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138620002|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
138620003|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620004|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
138620006|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138620007|NCT00234819|Hormones|hormones|mesh-ancestor
138620008|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138620009|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620010|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138620011|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138620012|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
138620013|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138620014|NCT04570306|Belimumab|belimumab|mesh-list
138620015|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138620016|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
138682055|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620017|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620018|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
138620019|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138620020|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620021|NCT00234858|Losartan|losartan|mesh-list
138620022|NCT00234858|Verapamil|verapamil|mesh-list
138620023|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138620024|NCT00234858|Trandolapril|trandolapril|mesh-list
138620025|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138620026|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138620027|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138620028|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138620029|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620031|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
138620032|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620033|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138620034|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138620035|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138620036|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138620037|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
138620038|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138620039|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
138620040|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620041|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138620042|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138620043|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
138620044|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620045|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620046|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
138620047|NCT00210743|Hematinics|hematinics|mesh-ancestor
138620048|NCT04569916|Irinotecan|irinotecan|mesh-list
138620049|NCT04569916|Apatinib|apatinib|mesh-list
138620050|NCT04569916|Antibodies|antibodies|mesh-list
138620051|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
138620052|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620053|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138620054|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138620055|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620056|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181307|NCT01831687|Etodolac|etodolac|mesh-list
138620057|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620058|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138620059|NCT00210782|Topiramate|topiramate|mesh-list
138620060|NCT00210782|Phenytoin|phenytoin|mesh-list
138620061|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
138620062|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138620063|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620064|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138620065|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138620066|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138660813|NCT00348023|Bimatoprost|bimatoprost|mesh-list
138620067|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620068|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138620069|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138620071|NCT00237861|Risperidone|risperidone|mesh-list
138620072|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138620073|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138620074|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
138620075|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620076|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620077|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620078|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138620079|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138620080|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138620081|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138620082|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138620084|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
138620085|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
138620086|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620087|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138620088|NCT00237861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138620089|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138620090|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138620091|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
138620092|NCT00237900|Leucovorin|leucovorin|mesh-list
138620093|NCT00237900|Fluorouracil|fluorouracil|mesh-list
138620094|NCT00237900|Gefitinib|gefitinib|mesh-list
138620095|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
138620096|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620097|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138620098|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620099|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138620100|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
138620101|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620103|NCT00237900|Protective Agents|protective agents|mesh-ancestor
138620104|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
138620105|NCT00237900|Vitamins|vitamins|mesh-ancestor
138620106|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
138620107|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138620108|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620109|NCT00210821|Topiramate|topiramate|mesh-list
138620110|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
138620111|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138620112|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620113|NCT00237939|Aripiprazole|aripiprazole|mesh-list
138620114|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
138620115|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138620116|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138620117|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138660833|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620118|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138620119|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620120|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
138620121|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
138620122|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620123|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620124|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138620125|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138620126|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
138620127|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138620128|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138620129|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138620130|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138620131|NCT04569214|PAZ320|paz320|mesh-list
138620132|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138620133|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620134|NCT00210860|Topiramate|topiramate|mesh-list
138620135|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
138620136|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138620137|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620138|NCT00210899|Vancomycin|vancomycin|mesh-list
138318673|NCT01382940|Acetaminophen|acetaminophen|mesh-list
138620139|NCT00210899|Ceftazidime|ceftazidime|mesh-list
138620140|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
138620141|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
138620142|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138620143|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620144|NCT04568863|Melatonin|melatonin|mesh-list
138620145|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
138620146|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620147|NCT04568863|Protective Agents|protective agents|mesh-ancestor
138620148|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620149|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138620150|NCT00210938|Doripenem|doripenem|mesh-list
138620151|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138620152|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620153|NCT02278081|Lansoprazole|lansoprazole|mesh-list
138620154|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
138620155|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138620156|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138620157|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138620158|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620159|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620160|NCT00211016|Doripenem|doripenem|mesh-list
138620161|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138620162|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620163|NCT00238017|Artesunate|artesunate|mesh-list
138620164|NCT00238017|Amodiaquine|amodiaquine|mesh-list
138620165|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
138620166|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138620167|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138620168|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620169|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620170|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
138620171|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
138620172|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138620173|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
138620174|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
138181348|NCT02470390|Fentanyl|fentanyl|mesh-list
138620175|NCT00238056|Domperidone|domperidone|mesh-list
138620176|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
138620177|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
138620179|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620180|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138620181|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138620182|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
138620183|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620184|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620185|NCT04566952|Olaparib|olaparib|mesh-list
138620186|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138620187|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620188|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620189|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620190|NCT04567069|Vaccines|vaccines|mesh-list
138620191|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
138620192|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620193|NCT04566796|Neostigmine|neostigmine|mesh-list
138620194|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138620195|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620196|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620197|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
138620198|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620199|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620200|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138620201|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
138620202|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620203|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
138620204|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
138620205|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
138620206|NCT00238173|Carboplatin|carboplatin|mesh-list
138620207|NCT00238173|Etoposide|etoposide|mesh-list
138620208|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
138620209|NCT00238173|Mannitol|mannitol|mesh-list
138620210|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138620211|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138620212|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
138620213|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620214|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138620215|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138620216|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
138620217|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620218|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620219|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138620220|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138620221|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138620222|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138620223|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620224|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
138620225|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620226|NCT00238173|Expectorants|expectorants|mesh-ancestor
138620227|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
138620228|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138620229|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
138620230|NCT00238173|Protective Agents|protective agents|mesh-ancestor
138620231|NCT00238173|Antidotes|antidotes|mesh-ancestor
138620232|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138620233|NCT00238173|Diuretics|diuretics|mesh-ancestor
138620234|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
138620235|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
138620236|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138620237|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
138620238|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
138620239|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
138620240|NCT00211133|Hematinics|hematinics|mesh-ancestor
138620241|NCT00238212|Sorafenib|sorafenib|mesh-list
138620243|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138620244|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620245|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620246|NCT00211250|Valproic Acid|valproic acid|mesh-list
138620247|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
138620248|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620249|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620250|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
138620251|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620252|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620253|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
138620254|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138620255|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138620256|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138620257|NCT00238251|Temozolomide|temozolomide|mesh-list
138620258|NCT00238251|Gefitinib|gefitinib|mesh-list
138620259|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138620260|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
138620261|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620262|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620263|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138620264|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620265|NCT04566718|Metformin|metformin|mesh-list
138620266|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138620267|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620268|NCT02210884|Vitamin D|vitamin d|mesh-list
138620269|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
138620270|NCT02210884|Cholecalciferol|cholecalciferol|mesh-list
138620271|NCT02210884|Vitamins|vitamins|mesh-list
138620272|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
138620273|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620274|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138620275|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138620276|NCT00238290|Trastuzumab|trastuzumab|mesh-list
138620277|NCT00238290|Letrozole|letrozole|mesh-list
138620278|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138620279|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620280|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138620281|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138620282|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181388|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620283|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620284|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138620285|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
138620286|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138620287|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620289|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138620290|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138620291|NCT00211328|Growth Substances|growth substances|mesh-ancestor
138620292|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660888|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620294|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620295|NCT00238329|Interferons|interferons|mesh-list
138620296|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
138620297|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
138620298|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138620299|NCT00238329|Thalidomide|thalidomide|mesh-list
138620300|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620301|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
138620302|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620303|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
138620304|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620305|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138620306|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
138620307|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138620308|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138620309|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138620311|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
138620312|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
138620313|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
138620314|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620315|NCT00211367|Anecortave|anecortave|mesh-list
138620316|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138620317|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138620318|NCT00211367|Growth Substances|growth substances|mesh-ancestor
138620319|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620320|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
138620321|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620322|NCT00238368|Cytarabine|cytarabine|mesh-list
138620323|NCT00238368|Prednisone|prednisone|mesh-list
138620324|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
138620325|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
138620326|NCT00238368|Busulfan|busulfan|mesh-list
138620327|NCT00238368|Rituximab|rituximab|mesh-list
138620328|NCT00238368|Doxorubicin|doxorubicin|mesh-list
138620329|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138620330|NCT00238368|Etoposide|etoposide|mesh-list
138660910|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138660911|NCT00348413|Prednisolone|prednisolone|mesh-list
138620331|NCT00238368|Vincristine|vincristine|mesh-list
138620332|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138620333|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138181410|NCT05394142|Metformin|metformin|mesh-list
138620334|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
138620335|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620336|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138620337|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138620338|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
138620339|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620340|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620341|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138620342|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138620343|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138620344|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138620345|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138620346|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620347|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138620348|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
138620349|NCT00238368|Hormones|hormones|mesh-ancestor
138620350|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138620351|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138620352|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138620353|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138620354|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
138620355|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
138620356|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620357|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
138620358|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
138620359|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
138620360|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
138620361|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
138620362|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620363|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138620364|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138620365|NCT00238368|Protective Agents|protective agents|mesh-ancestor
138620366|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138620367|NCT02894593|Ethanol|ethanol|mesh-list
138620368|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
138620369|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138620370|NCT02894593|Listerine|listerine|mesh-list
138620371|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
138620372|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138620373|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620374|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138620375|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620376|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
138620377|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
138620378|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
138620379|NCT02894593|Protective Agents|protective agents|mesh-ancestor
138620380|NCT00211406|Anecortave|anecortave|mesh-list
138620381|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138660957|NCT00348452|Narcotics|narcotics|mesh-ancestor
138620382|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138620383|NCT00211406|Growth Substances|growth substances|mesh-ancestor
138620384|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620385|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
138620386|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620387|NCT02894554|Lamivudine|lamivudine|mesh-list
138620388|NCT02894554|Telbivudine|telbivudine|mesh-list
138620389|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138620390|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138620391|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620392|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620393|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
138620394|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620395|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138620396|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138620397|NCT00238407|Docetaxel|docetaxel|mesh-list
138620398|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620399|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
138620400|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
138620401|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
138620402|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620403|NCT02894515|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
138620404|NCT02894515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138620405|NCT02894515|Serotonin Agents|serotonin agents|mesh-ancestor
138620406|NCT02894515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620407|NCT02894515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620408|NCT02894515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620410|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138620411|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
138620412|NCT02894710|Lidocaine|lidocaine|mesh-list
138620413|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
138620414|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
138620415|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138620416|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138660973|NCT00348491|Analgesics|analgesics|mesh-ancestor
138620417|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
138682154|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
138620418|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620419|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138620420|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138620421|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138620422|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138620423|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620425|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138620426|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138620427|NCT00211484|Growth Substances|growth substances|mesh-ancestor
138620428|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620429|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
138620430|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620431|NCT05428072|Aspirin|aspirin|mesh-list
138620432|NCT05428072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138620433|NCT05428072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138620434|NCT05428072|Analgesics|analgesics|mesh-ancestor
138620435|NCT05428072|Sensory System Agents|sensory system agents|mesh-ancestor
138620436|NCT05428072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620437|NCT05428072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620438|NCT05428072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138181461|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
138620439|NCT05428072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138296906|NCT05664061|Xhance|xhance|mesh-list
138620440|NCT05428072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138620441|NCT05428072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138620442|NCT05428072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620443|NCT05428072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138620444|NCT05428072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138620445|NCT05428072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620447|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
138620448|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620449|NCT00211562|Vitamin E|vitamin e|mesh-list
138620450|NCT00211562|Olanzapine|olanzapine|mesh-list
138620451|NCT00211562|Vitamins|vitamins|mesh-ancestor
138620452|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
138620453|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620454|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
138620455|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
138620456|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620457|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138620458|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138620459|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138661010|NCT00448734|Docetaxel|docetaxel|mesh-list
138620461|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138620462|NCT00211562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138620463|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138620464|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138620465|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620466|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620467|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
138620468|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
138620469|NCT00211562|Protective Agents|protective agents|mesh-ancestor
138620470|NCT05427721|Thymol|thymol|mesh-list
138620471|NCT05427721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620472|NCT05427721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138620473|NCT05427721|Antifungal Agents|antifungal agents|mesh-ancestor
138620474|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
138620475|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
138620476|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138620477|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138620478|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138620479|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138620480|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620482|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620483|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620484|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138620485|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620486|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138620487|NCT05427175|Methotrexate|methotrexate|mesh-list
138620488|NCT05427175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138620489|NCT05427175|Abortifacient Agents|abortifacient agents|mesh-ancestor
138620490|NCT05427175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138620491|NCT05427175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620492|NCT05427175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138620493|NCT05427175|Antimetabolites|antimetabolites|mesh-ancestor
138620494|NCT05427175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620495|NCT05427175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620496|NCT05427175|Dermatologic Agents|dermatologic agents|mesh-ancestor
138620497|NCT05427175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620498|NCT05427175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138620499|NCT05427175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138620500|NCT05427175|Immunologic Factors|immunologic factors|mesh-ancestor
138181480|NCT01834183|Gemcitabine|gemcitabine|mesh-list
138620501|NCT05427175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138620502|NCT05427175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138620503|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
138620504|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138620505|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138620506|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138620507|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138682232|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138620508|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620509|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
138620510|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620511|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620512|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138620513|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620514|NCT04680091|Efavirenz|efavirenz|mesh-list
138620515|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620516|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620517|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138620518|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138620519|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
138620520|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620521|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138620522|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138620523|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138620524|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138620525|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138620526|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138620527|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
138620528|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138620529|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138620530|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138620531|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138620532|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620533|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
138620534|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620535|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620536|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138620537|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620538|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138620539|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138620540|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138620541|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138620542|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138661072|NCT00449553|Metformin|metformin|mesh-list
138620543|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620544|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620545|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138620546|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
138620547|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138620548|NCT04680208|Anesthetics|anesthetics|mesh-list
138620549|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138620550|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620551|NCT00211796|Valproic Acid|valproic acid|mesh-list
138620552|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
138620553|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181495|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138620554|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620555|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
138620556|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620557|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620558|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
138620559|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138620560|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138620561|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138620562|NCT05426824|Pegaspargase|pegaspargase|mesh-list
138620563|NCT05426824|Asparaginase|asparaginase|mesh-list
138620564|NCT05426824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620565|NCT00238797|Gefitinib|gefitinib|mesh-list
138620566|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620567|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138620568|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620569|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620570|NCT05426044|Metformin|metformin|mesh-list
138620571|NCT05426044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138620572|NCT05426044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620573|NCT05425654|Cyclophosphamide|cyclophosphamide|mesh-list
138620574|NCT05425654|Busulfan|busulfan|mesh-list
138620575|NCT05425654|Carmustine|carmustine|mesh-list
138620576|NCT05425654|Rituximab|rituximab|mesh-list
138620577|NCT05425654|Methotrexate|methotrexate|mesh-list
138620578|NCT05425654|Vincristine|vincristine|mesh-list
138620579|NCT05425654|Lenalidomide|lenalidomide|mesh-list
138620580|NCT05425654|Procarbazine|procarbazine|mesh-list
138620581|NCT05425654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138620582|NCT05425654|Immunologic Factors|immunologic factors|mesh-ancestor
138620583|NCT05425654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620584|NCT05425654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138620585|NCT05425654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138620586|NCT05425654|Alkylating Agents|alkylating agents|mesh-ancestor
138661101|NCT00456339|Prednisolone|prednisolone|mesh-list
138661102|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138620587|NCT05425654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620588|NCT05425654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620589|NCT05425654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138620590|NCT05425654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138620591|NCT05425654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138620592|NCT05425654|Abortifacient Agents|abortifacient agents|mesh-ancestor
138620593|NCT05425654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138620594|NCT05425654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138620595|NCT05425654|Antimetabolites|antimetabolites|mesh-ancestor
138620596|NCT05425654|Dermatologic Agents|dermatologic agents|mesh-ancestor
138620597|NCT05425654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620598|NCT05425654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138620599|NCT05425654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138620600|NCT05425654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138620601|NCT05425654|Tubulin Modulators|tubulin modulators|mesh-ancestor
138620602|NCT05425654|Antimitotic Agents|antimitotic agents|mesh-ancestor
138620603|NCT05425654|Mitosis Modulators|mitosis modulators|mesh-ancestor
138620604|NCT05425654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138620605|NCT05425654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138620606|NCT05425654|Growth Substances|growth substances|mesh-ancestor
138620607|NCT05425654|Growth Inhibitors|growth inhibitors|mesh-ancestor
138620608|NCT05425576|Pembrolizumab|pembrolizumab|mesh-list
138620609|NCT05425576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138620610|NCT05425576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620611|NCT05425576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138620612|NCT05425576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620614|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138620615|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138620616|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620617|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
138620618|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620619|NCT04668976|Gemcitabine|gemcitabine|mesh-list
138620620|NCT04668976|Fluorouracil|fluorouracil|mesh-list
138620621|NCT04668976|Floxuridine|floxuridine|mesh-list
138620622|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
138620623|NCT04668976|Irinotecan|irinotecan|mesh-list
138620624|NCT04668976|Cetuximab|cetuximab|mesh-list
138620625|NCT04668976|Panitumumab|panitumumab|mesh-list
138620626|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138620627|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
138620628|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620630|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138620631|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
138620632|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620633|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138620634|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138620635|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620636|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138620637|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
138620638|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138620639|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620640|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138661132|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620641|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
138620642|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138620643|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620644|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620645|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620646|NCT04669366|Sunitinib|sunitinib|mesh-list
138620647|NCT04669366|Axitinib|axitinib|mesh-list
138620648|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620649|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138620650|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138620651|NCT04669366|Growth Substances|growth substances|mesh-ancestor
138620652|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620653|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
138620654|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138620655|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620656|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620657|NCT04721301|Maraviroc|maraviroc|mesh-list
138620658|NCT04721301|Nivolumab|nivolumab|mesh-list
138620659|NCT04721301|Ipilimumab|ipilimumab|mesh-list
138620660|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138620661|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620662|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138620663|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620664|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138620665|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138620666|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138620667|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138620668|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
138620669|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620670|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138620671|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
138620672|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138620673|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620674|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138620675|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
138620676|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138620677|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620678|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620679|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620680|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
138620681|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138620682|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
138620683|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620684|NCT00556465|Expectorants|expectorants|mesh-ancestor
138620685|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
138620686|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138620687|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
138318775|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138620688|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620689|NCT00556465|Protective Agents|protective agents|mesh-ancestor
138620690|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620691|NCT00556465|Antidotes|antidotes|mesh-ancestor
138620692|NCT04668469|Acetaminophen|acetaminophen|mesh-list
138620694|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
138620695|NCT04668469|Zinc|zinc|mesh-list
138620696|NCT04668469|Azithromycin|azithromycin|mesh-list
138620697|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
138620698|NCT04668469|Ivermectin|ivermectin|mesh-list
138620699|NCT04668469|Lactoferrin|lactoferrin|mesh-list
138620700|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
138620701|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
138620702|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620703|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138620704|NCT04668469|Analgesics|analgesics|mesh-ancestor
138337915|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
138620705|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
138620706|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620707|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
138620708|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138620709|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620710|NCT04668469|Trace Elements|trace elements|mesh-ancestor
138620711|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
138620712|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138620713|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138620714|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620715|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620716|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138620717|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
138620718|NCT04668469|Protective Agents|protective agents|mesh-ancestor
138620719|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138620720|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138620721|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
138620722|NCT04668469|Coagulants|coagulants|mesh-ancestor
138620723|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
138620724|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138620725|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620726|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138620727|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
138620728|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138620729|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620730|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620731|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620732|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
138620733|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138620734|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620735|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138620736|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
138620737|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138620738|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138620739|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620740|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620742|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138620743|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138620744|NCT00211952|Analgesics|analgesics|mesh-ancestor
138620745|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
138620746|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620747|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620748|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138620749|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138620750|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138620751|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138620752|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620753|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620754|NCT00239109|Olanzapine|olanzapine|mesh-list
138620755|NCT00239109|Ziprasidone|ziprasidone|mesh-list
138620756|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
138620757|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
138620758|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620759|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620760|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138682347|NCT04693962|Mitogens|mitogens|mesh-list
138620761|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138620762|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138620763|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138620764|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138620765|NCT00239109|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138620766|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138620767|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138620768|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620769|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620770|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
138620771|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138620772|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138620773|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
138620774|NCT00212030|Nicorandil|nicorandil|mesh-list
138620775|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138620776|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138620777|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
138620778|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
138620779|NCT00212030|Vitamins|vitamins|mesh-ancestor
138620780|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
138620781|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620782|NCT00212069|Carboplatin|carboplatin|mesh-list
138620783|NCT00212069|Gemcitabine|gemcitabine|mesh-list
138620784|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620785|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138620786|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
138318839|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138620787|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620788|NCT00212108|Celecoxib|celecoxib|mesh-list
138620789|NCT00212108|Gefitinib|gefitinib|mesh-list
138620790|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138620791|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138620792|NCT00212108|Analgesics|analgesics|mesh-ancestor
138620793|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
138620794|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620795|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620796|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138620797|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138620798|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138620799|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138620800|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620801|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620802|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620803|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138620804|NCT00212186|Selenium|selenium|mesh-list
138620805|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
138620806|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620807|NCT00212186|Protective Agents|protective agents|mesh-ancestor
138620808|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620809|NCT00212186|Trace Elements|trace elements|mesh-ancestor
138620810|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
138620811|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138620812|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138620813|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
138297297|NCT00002689|Hormones|hormones|mesh-ancestor
138661186|NCT00350051|Sagopilone|sagopilone|mesh-list
138620814|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620815|NCT00414336|Antacids|antacids|mesh-ancestor
138620816|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620817|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138620818|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138620819|NCT00212342|Norethindrone|norethindrone|mesh-list
138620820|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
138620821|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138620822|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138620823|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138620824|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
138620825|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138620826|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620827|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138620828|NCT00212342|Estrogens|estrogens|mesh-ancestor
138620829|NCT00212342|Hormones|hormones|mesh-ancestor
138620830|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138620831|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138620832|NCT00414414|Prednisone|prednisone|mesh-list
138620833|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138620834|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
138620835|NCT00414414|Hormones|hormones|mesh-ancestor
138620836|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138181575|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
138181576|NCT01834963|Cisplatin|cisplatin|mesh-list
138620837|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620838|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138620839|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620840|NCT00239304|Gefitinib|gefitinib|mesh-list
138620841|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620842|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138620843|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620844|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620845|NCT00239343|Gefitinib|gefitinib|mesh-list
138620846|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620847|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138620848|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620849|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620850|NCT00411593|Bevacizumab|bevacizumab|mesh-list
138620852|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138620853|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138661216|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
138620854|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138620855|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138620856|NCT00411593|Growth Substances|growth substances|mesh-ancestor
138620857|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620858|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
138620860|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138620861|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138620862|NCT00239382|Analgesics|analgesics|mesh-ancestor
138620863|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
138620864|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620865|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620866|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138620867|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138620868|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138620869|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138620870|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620871|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620872|NCT00239421|Fluticasone|fluticasone|mesh-list
138620874|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
138620875|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
138620876|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138620877|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138620878|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138620879|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
138620880|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620881|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620882|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138620883|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
138620884|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
138620885|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138620886|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138297360|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138620887|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138620888|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138620889|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
138620890|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620891|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620892|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
138620893|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138620894|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
138620895|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
138620896|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138620897|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
138620898|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620899|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620900|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138620901|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
138620902|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
138620903|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138620904|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
138620905|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620906|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620907|NCT00239499|Fluticasone|fluticasone|mesh-list
138620908|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
138620909|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138620910|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138620911|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138620912|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
138620913|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620914|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620915|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138620916|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
138620917|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
138620918|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138620919|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
138620920|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138620921|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
138620922|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620923|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620924|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138620925|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138620927|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
138620928|NCT00212615|Capecitabine|capecitabine|mesh-list
138620929|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
138620930|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138620931|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
138620932|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620933|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138620934|NCT00222573|Metoprolol|metoprolol|mesh-list
138620935|NCT00222573|Clopidogrel|clopidogrel|mesh-list
138620936|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138620937|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138620938|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138620939|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138620940|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
138620941|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620942|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620943|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620944|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138620945|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138620946|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
138620947|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
138620948|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620949|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138620950|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138620951|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138620952|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
138620953|NCT00212654|Landiolol|landiolol|mesh-list
138620954|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138620955|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138620956|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
138620957|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138620958|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620959|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620960|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138620962|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138620964|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138620965|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138620966|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138620967|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620968|NCT00239538|Diuretics|diuretics|mesh-ancestor
138620969|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
138620970|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620971|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138620972|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138620974|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
138620975|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138620976|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620977|NCT00222651|Tenecteplase|tenecteplase|mesh-list
138620978|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138620979|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138620980|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620981|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138620982|NCT00239616|Hematinics|hematinics|mesh-ancestor
138620983|NCT00213122|Miglitol|miglitol|mesh-list
138620984|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138620985|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138620986|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138620987|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620988|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138620989|NCT00213200|Morphine|morphine|mesh-list
138620990|NCT00213200|Tetracaine|tetracaine|mesh-list
138620991|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138620992|NCT00213200|Narcotics|narcotics|mesh-ancestor
138620993|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138620994|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138620995|NCT00213200|Analgesics|analgesics|mesh-ancestor
138181648|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
138620996|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
138620997|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138620998|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
138620999|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
138621000|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138621001|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138621002|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621003|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138621005|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621006|NCT00213278|Vinblastine|vinblastine|mesh-list
138682416|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621007|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138621008|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621009|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
138621010|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
138621011|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
138621012|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621013|NCT00239889|Calcitonin|calcitonin|mesh-list
138621014|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
138621015|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138621016|NCT00239889|Katacalcin|katacalcin|mesh-list
138621017|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138621018|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621019|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138621020|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
138621021|NCT00239967|Rimonabant|rimonabant|mesh-list
138621022|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138621023|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138621024|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138621025|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621026|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621027|NCT00239967|Hormones|hormones|mesh-ancestor
138621028|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138621029|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621030|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
138621031|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138621032|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621033|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
138621034|NCT00213512|Rituximab|rituximab|mesh-list
138621035|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138621036|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621037|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
138621038|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621039|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621040|NCT00213551|Antioxidants|antioxidants|mesh-list
138621041|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621042|NCT00213551|Protective Agents|protective agents|mesh-ancestor
138621043|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621044|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138621045|NCT00213590|Cyclosporine|cyclosporine|mesh-list
138621046|NCT00213590|Cyclosporins|cyclosporins|mesh-list
138621047|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621048|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621049|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138621050|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
138621051|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621052|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
138621053|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138181673|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
138621054|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
138621055|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621056|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138621057|NCT00240045|Octreotide|octreotide|mesh-list
138621058|NCT00240045|Midodrine|midodrine|mesh-list
138621059|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138621060|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138621061|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621062|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
138621063|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
138621064|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621065|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621066|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138621067|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138621068|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138621069|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138621070|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
138621071|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621072|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621075|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138621076|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138621077|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
138621078|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621079|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138621080|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138621081|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621082|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138621083|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138621084|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138621085|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
138621086|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621087|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138621088|NCT00243711|Glycerol|glycerol|mesh-list
138621089|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138621090|NCT00243711|Protective Agents|protective agents|mesh-ancestor
138621091|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621092|NCT00243711|Laxatives|laxatives|mesh-ancestor
138621093|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138621094|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
138621095|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138621096|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138621097|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138621098|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138284420|NCT02970032|Heparin|heparin|mesh-list
138621099|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
138621100|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
138621101|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
138621102|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621103|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
138621104|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
138621105|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138621106|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138621107|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
138621108|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
138297591|NCT00003620|Alvocidib|alvocidib|mesh-list
138621109|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621110|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621111|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138621112|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138621113|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138682452|NCT00522132|Artesunate|artesunate|mesh-list
138621114|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138621116|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621117|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138181683|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138621118|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138621119|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621120|NCT00243750|Methotrexate|methotrexate|mesh-list
138621121|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138621122|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
138621123|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138621124|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621125|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138621126|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
138621127|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621128|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621129|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
138621130|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621131|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138621132|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138621133|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
138621134|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621135|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138621136|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
138621137|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138621138|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621139|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621140|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138621141|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138621142|NCT00243789|Protective Agents|protective agents|mesh-ancestor
138621143|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621144|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
138621145|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138621147|NCT00214058|Carboplatin|carboplatin|mesh-list
138621149|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621150|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
138621151|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
138621152|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
138621153|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621154|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138621155|NCT00240318|Calcium|calcium|mesh-list
138621156|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138621157|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621158|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138621159|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138621160|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
138621161|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621162|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138621163|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138621165|NCT00243945|Rotigotine|rotigotine|mesh-list
138621166|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
138621167|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
138621168|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138661291|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138621169|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621170|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621171|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
138621172|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138621173|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621174|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
138621175|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138621176|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621177|NCT00240396|Narcotics|narcotics|mesh-list
138621178|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138621179|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621180|NCT00240396|Analgesics|analgesics|mesh-ancestor
138621181|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
138621182|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621184|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
138621185|NCT00214331|Gentamicins|gentamicins|mesh-list
138621186|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138621187|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621188|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138621189|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138621190|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621191|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621192|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181729|NCT02489734|Sevoflurane|sevoflurane|mesh-list
138181731|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138621193|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138621194|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138621195|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138621196|NCT00243984|Topiramate|topiramate|mesh-list
138621197|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
138621198|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138621199|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621200|NCT00214370|Fentanyl|fentanyl|mesh-list
138621201|NCT00214370|Propofol|propofol|mesh-list
138621202|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138621203|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138621204|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621205|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138621206|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
138621207|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
138682490|NCT00523692|Etanercept|etanercept|mesh-list
138621208|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138621209|NCT00214370|Narcotics|narcotics|mesh-ancestor
138621210|NCT00214370|Analgesics|analgesics|mesh-ancestor
138621211|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
138621212|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621213|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138621214|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138621215|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
138621216|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138621217|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
138621218|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621219|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621220|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138621221|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
138621222|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
138621223|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138621224|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
138621225|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621226|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621227|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
138621228|NCT00244023|Testosterone|testosterone|mesh-list
138621229|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
138621230|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
138621231|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138621232|NCT00244023|Androgens|androgens|mesh-ancestor
138621234|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138621235|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621236|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138621237|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621238|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
138621239|NCT00240474|Amlodipine|amlodipine|mesh-list
138621240|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138621241|NCT00240474|Telmisartan|telmisartan|mesh-list
138621242|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138621243|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138621244|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138621245|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621246|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138621247|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621249|NCT00240474|Diuretics|diuretics|mesh-ancestor
138621250|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
138621251|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138621252|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138621253|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138621254|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138621255|NCT00214604|Pravastatin|pravastatin|mesh-list
138621256|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138621257|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138621258|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
138621259|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621260|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138621261|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138621262|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621263|NCT00214643|Clindamycin|clindamycin|mesh-list
138621264|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
138621265|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
138621267|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138621268|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621269|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138621270|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621271|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621272|NCT00414531|Atorvastatin|atorvastatin|mesh-list
138621273|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138621274|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138621275|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
138621276|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621277|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138621278|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138621279|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319092|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621280|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
138621281|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
138621282|NCT00214682|Vitamins|vitamins|mesh-ancestor
138621283|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
138621284|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621285|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
138621286|NCT00214682|Hematinics|hematinics|mesh-ancestor
138621287|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
138621288|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138621289|NCT00240513|Minocycline|minocycline|mesh-list
138621290|NCT00240513|Tretinoin|tretinoin|mesh-list
138621291|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138621292|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621293|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621294|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
138621295|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
138621296|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
138621297|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138621298|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138621299|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
138621300|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138661299|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138621301|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621303|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138621305|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621306|NCT00214877|Methylene Blue|methylene blue|mesh-list
138621307|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181794|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621308|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621309|NCT00214955|Fentanyl|fentanyl|mesh-list
138621310|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138621311|NCT00214955|Narcotics|narcotics|mesh-ancestor
138621312|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138621313|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621314|NCT00214955|Analgesics|analgesics|mesh-ancestor
138621315|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
138621316|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621317|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138621318|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138621319|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
138621320|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
138621321|NCT00244179|Interferons|interferons|mesh-list
138621322|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
138621323|NCT00244179|Infliximab|infliximab|mesh-list
138621324|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621325|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
138621326|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621327|NCT00244179|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138621328|NCT00244179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138621329|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
138621330|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138621331|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621332|NCT00214994|Tiagabine|tiagabine|mesh-list
138621333|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
138621334|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
138621335|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138621336|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138621337|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621338|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
138621339|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621340|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621341|NCT00240630|Naproxen|naproxen|mesh-list
138621342|NCT00240630|Sumatriptan|sumatriptan|mesh-list
138621343|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138621344|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138621345|NCT00240630|Analgesics|analgesics|mesh-ancestor
138621346|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
138621347|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621348|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621349|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138621350|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621351|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
138621352|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138621353|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621354|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621355|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138621356|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138621357|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138621358|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
138621359|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621360|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138621361|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138621362|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138621363|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138621364|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621365|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621366|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621367|NCT00244296|Analgesics|analgesics|mesh-ancestor
138621368|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
138621369|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621370|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
138621371|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138621372|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
138621373|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138621374|NCT00215228|Escitalopram|escitalopram|mesh-list
138621375|NCT00215228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138621376|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138621377|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138621378|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621379|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621380|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
138621381|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621382|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621383|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
138621384|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138621385|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138621386|NCT00215228|Analgesics|analgesics|mesh-ancestor
138621387|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
138621388|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
138621389|NCT00215267|Praziquantel|praziquantel|mesh-list
138621390|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
138621391|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138621392|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621393|NCT00240708|Risperidone|risperidone|mesh-list
138621394|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138621395|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
138621396|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621397|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621398|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621399|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138621400|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138621401|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138621402|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138621403|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138621404|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
138621405|NCT00215345|Celecoxib|celecoxib|mesh-list
138621406|NCT00215345|Docetaxel|docetaxel|mesh-list
138661332|NCT00351143|Xhance|xhance|mesh-list
138621407|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181827|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
138181828|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181831|NCT02494180|Narcotics|narcotics|mesh-ancestor
138621408|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
138621409|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
138621410|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
138621411|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621412|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138621413|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138621414|NCT00215345|Analgesics|analgesics|mesh-ancestor
138621415|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
138621416|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621417|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621418|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138621419|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621420|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138621421|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138621422|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621423|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
138621424|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138621425|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621426|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138621427|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621428|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621429|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
138319151|NCT03596502|Warfarin|warfarin|mesh-list
138621430|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138621431|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
138621432|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621433|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621434|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138621435|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
138621436|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138621437|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138621439|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
138621440|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621441|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621442|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
138621443|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138621445|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621446|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621447|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138621448|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
138621449|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138621450|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138621451|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138621452|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
138621453|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621454|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621455|NCT04668352|Dactolisib|dactolisib|mesh-list
138621456|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621457|NCT00215462|Vinorelbine|vinorelbine|mesh-list
138621458|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138621459|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621460|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
138621461|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
138621462|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
138621463|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621464|NCT00215501|Capecitabine|capecitabine|mesh-list
138621465|NCT00215501|Fluorouracil|fluorouracil|mesh-list
138621466|NCT00215501|Irinotecan|irinotecan|mesh-list
138621467|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621468|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138621469|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
138621470|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621471|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138621472|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
138621473|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621474|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138621475|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138621476|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621477|NCT00240786|Acetaminophen|acetaminophen|mesh-list
138621478|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138621479|NCT00240786|Analgesics|analgesics|mesh-ancestor
138297983|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
138319181|NCT03591744|Lenalidomide|lenalidomide|mesh-list
138621481|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621482|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621483|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
138621484|NCT00215579|Risperidone|risperidone|mesh-list
138621485|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138621486|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
138621487|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621488|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621489|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621490|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138621491|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138621492|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138621493|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138621494|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138621495|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
138621496|NCT00556621|Gemcitabine|gemcitabine|mesh-list
138621497|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621498|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138621499|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
138621500|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621501|NCT00244452|Cetrorelix|cetrorelix|mesh-list
138621502|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138621503|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
138621504|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138621505|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621506|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
138621507|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138621508|NCT00556699|Rituximab|rituximab|mesh-list
138621509|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138621510|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621511|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
138621512|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367437|NCT03281369|Vitamins|vitamins|mesh-ancestor
138621513|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621515|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
138621516|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621517|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138621518|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138621519|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621520|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621521|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138621522|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
138621523|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138621524|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621525|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138621526|NCT04667299|Amoxicillin|amoxicillin|mesh-list
138621527|NCT04667299|Metronidazole|metronidazole|mesh-list
138621528|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
138621529|NCT04667299|Rabeprazole|rabeprazole|mesh-list
138621530|NCT04667299|Bismuth|bismuth|mesh-list
138621531|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621532|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138621533|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621534|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138621535|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138621536|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138621537|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138621538|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138621539|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621540|NCT04667299|Antacids|antacids|mesh-ancestor
138621541|NCT04667299|Diuretics|diuretics|mesh-ancestor
138621542|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
138621543|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621544|NCT04667299|Expectorants|expectorants|mesh-ancestor
138621545|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
138621547|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138621548|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621549|NCT00240825|Acetaminophen|acetaminophen|mesh-list
138621550|NCT00240825|Ibuprofen|ibuprofen|mesh-list
138621551|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138621552|NCT00240825|Analgesics|analgesics|mesh-ancestor
138621553|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
138621554|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621555|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621556|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
138621557|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138621558|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138621559|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621560|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138621561|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621562|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621563|NCT04666675|Upadacitinib|upadacitinib|mesh-list
138621564|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138621565|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138621566|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621567|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621568|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621569|NCT00244530|Nifedipine|nifedipine|mesh-list
138621570|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138621571|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138621572|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621573|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138621574|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621575|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
138621576|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
138621577|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138621578|NCT00411905|Bortezomib|bortezomib|mesh-list
138621579|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621580|NCT00240864|Acetaminophen|acetaminophen|mesh-list
138621581|NCT00240864|Ibuprofen|ibuprofen|mesh-list
138621582|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138621583|NCT00240864|Analgesics|analgesics|mesh-ancestor
138621584|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
138621585|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621586|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621587|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
138621588|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138621589|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138621590|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621591|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138621592|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621593|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621595|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138621596|NCT00557011|Adderall|adderall|mesh-list
138621597|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138621598|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621599|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
138621600|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
138621601|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621602|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
138621603|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621604|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621605|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
138319215|NCT04196946|Analgesics|analgesics|mesh-ancestor
138621606|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138621607|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138621608|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138621609|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138621610|NCT04666324|Simethicone|simethicone|mesh-list
138621611|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
138621612|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621613|NCT04666324|Emollients|emollients|mesh-ancestor
138621614|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
138621615|NCT04720833|Vitamin D|vitamin d|mesh-list
138661492|NCT00352742|Bortezomib|bortezomib|mesh-list
138621616|NCT04720833|Calcium|calcium|mesh-list
138181929|NCT04937452|Rotigotine|rotigotine|mesh-list
138621617|NCT04720833|Vitamins|vitamins|mesh-ancestor
138621618|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
138621619|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621620|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138621621|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138621622|NCT00244608|Budesonide|budesonide|mesh-list
138621623|NCT00244608|Terbutaline|terbutaline|mesh-list
138621624|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
138621625|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138621626|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138621627|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
138621628|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621629|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621630|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138298129|NCT05495035|Dexamethasone|dexamethasone|mesh-list
138621631|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
138621633|NCT00244608|Hormones|hormones|mesh-ancestor
138621634|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138621635|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138621636|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138621637|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138621638|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
138621639|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621640|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621641|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
138621642|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
138621643|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138621644|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
138621645|NCT04666168|Fludarabine|fludarabine|mesh-list
138621646|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138621647|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
138621648|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621649|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621650|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138621651|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
138621652|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621653|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621654|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138621655|NCT00215774|Flecainide|flecainide|mesh-list
138621656|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138621657|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138621658|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138621659|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138621660|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621662|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621663|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138661522|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
138621664|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138621665|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621666|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621667|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138621668|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
138621669|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138621670|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621671|NCT00215891|Interferons|interferons|mesh-list
138621672|NCT00215891|Ribavirin|ribavirin|mesh-list
138621673|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621674|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
138621675|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621676|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
138621677|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621678|NCT02961816|Pyridoxine|pyridoxine|mesh-list
138621679|NCT02961816|Dexamethasone|dexamethasone|mesh-list
138621680|NCT02961816|Rituximab|rituximab|mesh-list
138621681|NCT02961816|Gemcitabine|gemcitabine|mesh-list
138621682|NCT02961816|Melphalan|melphalan|mesh-list
138621683|NCT02961816|Busulfan|busulfan|mesh-list
138621684|NCT02961816|Panobinostat|panobinostat|mesh-list
138621685|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138621686|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
138621687|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
138621688|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621689|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621690|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138621691|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
138621692|NCT02961816|Hormones|hormones|mesh-ancestor
138621693|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138621694|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138621695|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621696|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138621697|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
138621698|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621699|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138621700|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
138621701|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621702|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138621703|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
138621704|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138621706|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138621707|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621708|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
138621709|NCT02961816|Vitamins|vitamins|mesh-ancestor
138621710|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
138621711|NCT04665232|Progesterone|progesterone|mesh-list
138621712|NCT04665232|Progestins|progestins|mesh-ancestor
138621713|NCT04665232|Hormones|hormones|mesh-ancestor
138661547|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621714|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138621715|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621717|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621718|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
138621719|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
138621720|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
138621721|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621722|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
138621723|NCT04665076|Fludarabine|fludarabine|mesh-list
138621724|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138621725|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
138621726|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621727|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621728|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138621729|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
138621730|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181966|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138181973|NCT02506660|Hormones|hormones|mesh-ancestor
138621731|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621732|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138621733|NCT00241020|Octreotide|octreotide|mesh-list
138621734|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138621735|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138621736|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621737|NCT00216047|Trastuzumab|trastuzumab|mesh-list
138621738|NCT00216047|Vatalanib|vatalanib|mesh-list
138621739|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138621740|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621741|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138621742|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621743|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621744|NCT04665310|Tacrolimus|tacrolimus|mesh-list
138621745|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138621746|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
138621747|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621748|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138621749|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138682615|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138621750|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621752|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138621753|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621754|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138621755|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
138621756|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138621757|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621758|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621759|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621760|NCT00216164|Rituximab|rituximab|mesh-list
138621761|NCT00216164|Gemcitabine|gemcitabine|mesh-list
138621762|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138621763|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621764|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
138621765|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621766|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621767|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138661574|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138621769|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621770|NCT04664803|Cefdinir|cefdinir|mesh-list
138621771|NCT04664803|Cefetamet|cefetamet|mesh-list
138621772|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138621773|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621774|NCT04664725|Repaglinide|repaglinide|mesh-list
138621775|NCT04664725|Bupropion|bupropion|mesh-list
138621776|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138621777|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
138621778|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138621779|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138621780|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138181982|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138621781|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138621782|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621783|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
138621784|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621785|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621786|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138621787|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138621788|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621789|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138621790|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
138621791|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
138621792|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
138621793|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138621794|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621795|NCT00216281|Clozapine|clozapine|mesh-list
138621796|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138621797|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138621798|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138682641|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
138621799|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138621800|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621801|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
138621802|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621803|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621804|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138621805|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
138621806|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138621807|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138621808|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138621809|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138621810|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
138621811|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
138621812|NCT00241137|Valsartan|valsartan|mesh-list
138621813|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138621814|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138661590|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
138621815|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138621816|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621817|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138621819|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
138621820|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621821|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138621822|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138621823|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319284|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
138621824|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138621825|NCT04664530|Esketamine|esketamine|mesh-list
138621826|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
138621827|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138621828|NCT00216398|Lanreotide|lanreotide|mesh-list
138621829|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621830|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
138621831|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138621832|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138621833|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621834|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
138621835|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621836|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621837|NCT00216437|Capecitabine|capecitabine|mesh-list
138621838|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138621839|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
138621840|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621841|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621842|NCT00244920|Squalamine|squalamine|mesh-list
138621843|NCT00244920|Leuprolide|leuprolide|mesh-list
138621844|NCT00244920|Bicalutamide|bicalutamide|mesh-list
138621845|NCT00244920|Hormones|hormones|mesh-list
138621846|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
138621847|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138621848|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621849|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138621850|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
138621851|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138621852|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138298362|NCT05477875|Hormones|hormones|mesh-ancestor
138621853|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621854|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
138621855|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138621856|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621857|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138621858|NCT00244920|Protective Agents|protective agents|mesh-ancestor
138621859|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138621860|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138621861|NCT00244920|Growth Substances|growth substances|mesh-ancestor
138621862|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
138621863|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
138621864|NCT00216515|Galantamine|galantamine|mesh-list
138621865|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138621866|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621867|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621868|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
138621869|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621870|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621871|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138621872|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
138621873|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621874|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
138621875|NCT00244959|Anastrozole|anastrozole|mesh-list
138621876|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138621877|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621878|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138621879|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138621880|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621881|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621882|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138621883|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
138621884|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138621885|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621886|NCT00244998|Fulvestrant|fulvestrant|mesh-list
138621887|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138621888|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621889|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138621890|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138621891|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
138621892|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138621893|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621894|NCT00216554|Risperidone|risperidone|mesh-list
138621895|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138621896|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
138621897|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621898|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621899|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621900|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138621901|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138621902|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138621903|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138621904|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138621905|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
138621906|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
138682694|NCT00524433|Tezosentan|tezosentan|mesh-list
138621908|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138621909|NCT00241254|Prednisolone|prednisolone|mesh-list
138621910|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
138621911|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
138621912|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138621913|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
138621914|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138621915|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
138621916|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621917|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621918|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138621919|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
138621920|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621921|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621922|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138621923|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138621924|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
138661649|NCT00353717|Paclitaxel|paclitaxel|mesh-list
138621926|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138621927|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138621929|NCT00241254|Hormones|hormones|mesh-ancestor
138182043|NCT01726465|Expectorants|expectorants|mesh-ancestor
138621930|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138621931|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138621932|NCT00241254|Protective Agents|protective agents|mesh-ancestor
138621933|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138621934|NCT00216632|Risperidone|risperidone|mesh-list
138621935|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138621936|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
138621937|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138621938|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621939|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621940|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138621941|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138621942|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138621943|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138621944|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138621945|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
138621946|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138621947|NCT04662736|Tedizolid|tedizolid|mesh-list
138621948|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621949|NCT04662658|Xenon|xenon|mesh-list
138621950|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138621951|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
138621952|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
138621953|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138621954|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621955|NCT00216788|Esomeprazole|esomeprazole|mesh-list
138621956|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138621957|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138621958|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138621959|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138621960|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621961|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
138621962|NCT00245115|Busulfan|busulfan|mesh-list
138621963|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138621964|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
138621965|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621966|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138621967|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138621968|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
138621969|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138621970|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138621971|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138621973|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
138621974|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
138621975|NCT04662385|Protective Agents|protective agents|mesh-ancestor
138621976|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621977|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138621978|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138621979|NCT00216827|Betamethasone|betamethasone|mesh-list
138621980|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
138621981|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138621982|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
138621983|NCT00216827|Calcipotriene|calcipotriene|mesh-list
138621984|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138621985|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138621986|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
138621987|NCT00216827|Hormones|hormones|mesh-ancestor
138621988|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138621989|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621990|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138621991|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
138621992|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
138621993|NCT00241332|Fentanyl|fentanyl|mesh-list
138621994|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138621995|NCT00241332|Narcotics|narcotics|mesh-ancestor
138621996|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138621997|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138621998|NCT00241332|Analgesics|analgesics|mesh-ancestor
138621999|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
138622000|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622001|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138298514|NCT00003776|Leucovorin|leucovorin|mesh-list
138622002|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138622003|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
138622004|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
138622005|NCT00216866|Dalteparin|dalteparin|mesh-list
138622006|NCT00216866|Tinzaparin|tinzaparin|mesh-list
138622007|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138622008|NCT00216866|Warfarin|warfarin|mesh-list
138622009|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
138622010|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138622011|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138622012|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622013|NCT00557206|Docetaxel|docetaxel|mesh-list
138622014|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
138622015|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622016|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
138622017|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
138622018|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
138622019|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622020|NCT00241371|Clofarabine|clofarabine|mesh-list
138682720|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
138622021|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138622023|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622024|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622025|NCT04660786|Vitamin D|vitamin d|mesh-list
138622026|NCT04660786|Triamcinolone|triamcinolone|mesh-list
138622027|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138182115|NCT01727401|PENTA|penta|mesh-list
138622028|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138622029|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138622030|NCT04660786|Vitamins|vitamins|mesh-ancestor
138622031|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
138622032|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622033|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138622034|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138622035|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
138622036|NCT04660786|Hormones|hormones|mesh-ancestor
138622037|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138622039|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
138622040|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622041|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622042|NCT00217178|Folic Acid|folic acid|mesh-list
138622043|NCT00217178|Vitamins|vitamins|mesh-ancestor
138622044|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
138622045|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622046|NCT00217178|Hematinics|hematinics|mesh-ancestor
138622047|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
138622048|NCT00241449|Tamoxifen|tamoxifen|mesh-list
138622049|NCT00241449|Fulvestrant|fulvestrant|mesh-list
138622050|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138622051|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
138622052|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138622053|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622054|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138622055|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622056|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138622057|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138622058|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138622059|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138622060|NCT00412100|Oxycodone|oxycodone|mesh-list
138622061|NCT00412100|Naloxone|naloxone|mesh-list
138622062|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138622063|NCT00412100|Narcotics|narcotics|mesh-ancestor
138622064|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622065|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622066|NCT00412100|Analgesics|analgesics|mesh-ancestor
138622067|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
138622068|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622069|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138622070|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138622071|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138182138|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138622072|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138622073|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
138622074|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622075|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138622076|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138622077|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622078|NCT04659499|Paclitaxel|paclitaxel|mesh-list
138622079|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138622080|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622081|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
138622082|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
138622083|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
138622084|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622086|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138622087|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138622088|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138622089|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622090|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622092|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
138622093|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138622094|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
138622095|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622096|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622097|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138622098|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
138622099|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
138622100|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138622101|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
138622102|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622103|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622104|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
138622105|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
138622106|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138622107|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138622108|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
138622109|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
138622110|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622111|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622112|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
138622113|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138622114|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138622116|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
138622117|NCT00558181|Rituximab|rituximab|mesh-list
138622118|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138622119|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
138682766|NCT02947854|Poly ICLC|poly iclc|mesh-list
138622120|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138622121|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622122|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
138622123|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622124|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138622125|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138622127|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
138182170|NCT00864383|Ethambutol|ethambutol|mesh-list
138622128|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622129|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138622130|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
138622131|NCT00558181|Hormones|hormones|mesh-ancestor
138508080|NCT06196580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622132|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138622133|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138622134|NCT00558181|Protective Agents|protective agents|mesh-ancestor
138622135|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138622136|NCT00558220|Immunomodulating Agents|immunomodulating agents|mesh-list
138622137|NCT00558220|Immunologic Factors|immunologic factors|mesh-ancestor
138622138|NCT00558220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622140|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
138622141|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138622142|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622143|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138622144|NCT00245427|Lactams|lactams|mesh-list
138622145|NCT00245427|beta-Lactams|beta-lactams|mesh-list
138622146|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138622147|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138622148|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
138622149|NCT00558298|Risperidone|risperidone|mesh-list
138622150|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138622151|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
138622152|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622153|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298667|NCT00004376|Guanfacine|guanfacine|mesh-list
138622154|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622155|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138622156|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138622157|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622158|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138622159|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138622160|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
138622161|NCT00245505|Mesalamine|mesalamine|mesh-list
138622162|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138622163|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138622164|NCT00245505|Analgesics|analgesics|mesh-ancestor
138622165|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
138622166|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622167|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622168|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138622169|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138622170|NCT04647838|Tepotinib|tepotinib|mesh-list
138622171|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622172|NCT00217373|Interferons|interferons|mesh-list
138622173|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
138622174|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
138622175|NCT00217373|Metronidazole|metronidazole|mesh-list
138622176|NCT00217373|Vaccines|vaccines|mesh-list
138622177|NCT00217373|Sargramostim|sargramostim|mesh-list
138622178|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
138622179|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622180|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622181|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
138622182|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138319388|NCT04191954|Fasudil|fasudil|mesh-list
138622184|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138622185|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138622186|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
138622187|NCT00241605|Metformin|metformin|mesh-list
138622188|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
138622189|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138622190|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622191|NCT00217412|Vorinostat|vorinostat|mesh-list
138622192|NCT00217412|Isotretinoin|isotretinoin|mesh-list
138622194|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138622195|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622196|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622197|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
138622198|NCT04646824|Pemetrexed|pemetrexed|mesh-list
138622199|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622200|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622201|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622202|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138622203|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138622204|NCT00217451|Clindamycin|clindamycin|mesh-list
138622205|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
138622206|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
138622207|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
138622208|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138622209|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138622210|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138622211|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622212|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622213|NCT00217529|Carboplatin|carboplatin|mesh-list
138622214|NCT00217529|Docetaxel|docetaxel|mesh-list
138622215|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138622216|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622217|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
138622218|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
138622219|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
138622220|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622221|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138622222|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622223|NCT00245661|Temazepam|temazepam|mesh-list
138622224|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138622225|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622226|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622227|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138622228|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138622229|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138182211|NCT05532072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622230|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
138622231|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
138622232|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622233|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622234|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
138622235|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138622236|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622237|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622238|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138622239|NCT04646317|Analgesics|analgesics|mesh-ancestor
138622240|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
138622241|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622242|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138622243|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138622244|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138622245|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
138622246|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622247|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622248|NCT00217568|Carboplatin|carboplatin|mesh-list
138622250|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622251|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
138622252|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
138622253|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
138622254|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622255|NCT04646161|Misoprostol|misoprostol|mesh-list
138661759|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
138622256|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138622257|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
138622258|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138622259|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622260|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138622261|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138622262|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
138622263|NCT00241722|Alvimopan|alvimopan|mesh-list
138622264|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138622265|NCT00558337|Levodopa|levodopa|mesh-list
138622266|NCT00558337|Carbidopa|carbidopa|mesh-list
138622267|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138319444|NCT04406376|Prednisone|prednisone|mesh-list
138622270|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
138622271|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622272|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622273|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622274|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138622275|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622276|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138622277|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
138622278|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
138622279|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138622280|NCT00558376|Laxatives|laxatives|mesh-ancestor
138622281|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138622282|NCT00217646|Sorafenib|sorafenib|mesh-list
138622283|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622284|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138622285|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622286|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622287|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
138622288|NCT00558454|Hematinics|hematinics|mesh-ancestor
138622289|NCT00558493|Clevudine|clevudine|mesh-list
138622290|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
138622291|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138622292|NCT04645303|Triamcinolone|triamcinolone|mesh-list
138622293|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138622294|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138622295|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
138622296|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138622297|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138622298|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
138622299|NCT04645303|Hormones|hormones|mesh-ancestor
138622300|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138622301|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622302|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138622303|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
138622304|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622305|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319472|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
138622306|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138622307|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
138622308|NCT04645303|Protective Agents|protective agents|mesh-ancestor
138622309|NCT00217607|Paclitaxel|paclitaxel|mesh-list
138622310|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138622311|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622312|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
138622313|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
138622314|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
138622315|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622317|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
138622318|NCT04644484|Antibodies|antibodies|mesh-list
138622319|NCT04644484|gamma-Globulins|gamma-globulins|mesh-list
138622320|NCT04644484|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138622321|NCT04644484|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138622322|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
138622323|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622324|NCT04644250|Paclitaxel|paclitaxel|mesh-list
138622325|NCT04644250|Carboplatin|carboplatin|mesh-list
138622326|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138622327|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622328|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
138622329|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
138622330|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
138622331|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622332|NCT00245739|Darunavir|darunavir|mesh-list
138622333|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138682857|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
138622334|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138622335|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
138622336|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622337|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622338|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138622339|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138622340|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
138622341|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138622342|NCT00558883|Acarbose|acarbose|mesh-list
138622343|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138622344|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622345|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622346|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138622347|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622348|NCT04644094|Dexamethasone|dexamethasone|mesh-list
138622349|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138622350|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
138622351|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
138622352|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138319512|NCT04020588|Analgesics|analgesics|mesh-ancestor
138622353|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622354|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138622355|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
138622356|NCT04644094|Hormones|hormones|mesh-ancestor
138622357|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138622358|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138622359|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622360|NCT04644406|Trastuzumab|trastuzumab|mesh-list
138622361|NCT04644406|Pertuzumab|pertuzumab|mesh-list
138622362|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138622363|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622364|NCT04643821|Calcitriol|calcitriol|mesh-list
138622365|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
138622366|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138622367|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
138622368|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138622369|NCT04643821|Expectorants|expectorants|mesh-ancestor
138622370|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
138622371|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138622372|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
138622373|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622374|NCT04643821|Protective Agents|protective agents|mesh-ancestor
138622375|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622376|NCT04643821|Antidotes|antidotes|mesh-ancestor
138622377|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138622378|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138622379|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138622380|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138622381|NCT04643821|Vitamins|vitamins|mesh-ancestor
138622382|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
138622383|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138622385|NCT00218075|Carbidopa|carbidopa|mesh-list
138622386|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138622387|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138622388|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
138622389|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622390|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138682886|NCT04693026|Remdesivir|remdesivir|mesh-list
138622391|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622392|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138622393|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622394|NCT00218114|Valproic Acid|valproic acid|mesh-list
138622395|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
138622396|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622397|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622398|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
138622399|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622400|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622401|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
138622402|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138622403|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622404|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138182349|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
138622405|NCT00424788|Natalizumab|natalizumab|mesh-list
138622406|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
138622407|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622408|NCT00218153|Naltrexone|naltrexone|mesh-list
138622409|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138622410|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138622411|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622412|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
138319538|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622413|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622414|NCT04642846|Fluorides|fluorides|mesh-list
138622415|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
138622416|NCT04642846|Protective Agents|protective agents|mesh-ancestor
138622417|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622418|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
138622419|NCT00245895|Hematinics|hematinics|mesh-ancestor
138622420|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
138622421|NCT00559195|Hematinics|hematinics|mesh-ancestor
138622423|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138622424|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138622425|NCT00245934|Analgesics|analgesics|mesh-ancestor
138622426|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
138622427|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622428|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622429|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138622430|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138622431|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138622432|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138622433|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
138622434|NCT00218231|Bupropion|bupropion|mesh-list
138622435|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138622436|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
138622437|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138622438|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138622439|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138622440|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138622441|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622442|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
138622443|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622444|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622445|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138622446|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138622447|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622448|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
138622449|NCT00218309|Hydromorphone|hydromorphone|mesh-list
138622450|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138622451|NCT00218309|Narcotics|narcotics|mesh-ancestor
138182373|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138622452|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622453|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622454|NCT00218309|Analgesics|analgesics|mesh-ancestor
138622455|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
138622456|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622457|NCT00218348|Amphetamine|amphetamine|mesh-list
138622458|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
138298966|NCT00003908|Docetaxel|docetaxel|mesh-list
138622459|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138622460|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622462|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
138622463|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622464|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
138622465|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622466|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622467|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
138622468|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138661861|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
138622469|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138622470|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138622471|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138622473|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138622474|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138622475|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138622476|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138622477|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
138622478|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622479|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622480|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138622481|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
138622482|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
138622483|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138622484|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138622485|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138622486|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138622487|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
138622488|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622489|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622490|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
138622491|NCT00559312|Hormones|hormones|mesh-ancestor
138182402|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
138182403|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
138622492|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138622493|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
138622494|NCT00559351|Fluorouracil|fluorouracil|mesh-list
138622496|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
138622497|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622498|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138622499|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138622500|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
138622501|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622502|NCT00218504|Dronabinol|dronabinol|mesh-list
138622503|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
138622504|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622505|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138622506|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138622507|NCT00218504|Analgesics|analgesics|mesh-ancestor
138622508|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
138622509|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622510|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138622511|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138622512|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622513|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622514|NCT00218504|Hormones|hormones|mesh-ancestor
138622515|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138622516|NCT00559429|Docetaxel|docetaxel|mesh-list
138622517|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
138622518|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622519|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
138622520|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
138622521|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
138622522|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622523|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138622524|NCT00559429|Analgesics|analgesics|mesh-ancestor
138622525|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
138622526|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622527|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622528|NCT00218621|Buprenorphine|buprenorphine|mesh-list
138622529|NCT00218621|Methadone|methadone|mesh-list
138622530|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138622531|NCT00218621|Narcotics|narcotics|mesh-ancestor
138622532|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138182435|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622533|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622535|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
138622536|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622537|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138622538|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
138622539|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
138622540|NCT00246168|Acetaminophen|acetaminophen|mesh-list
138622541|NCT00246168|Tramadol|tramadol|mesh-list
138622542|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138622543|NCT00246168|Analgesics|analgesics|mesh-ancestor
138622544|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
138622545|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622546|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622547|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
138622548|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138622549|NCT00246168|Narcotics|narcotics|mesh-ancestor
138622550|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622551|NCT00218660|Naltrexone|naltrexone|mesh-list
138622552|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138622553|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138622554|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622555|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
138622556|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622557|NCT00559546|Montelukast|montelukast|mesh-list
138622558|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138622559|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
138622560|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138622561|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
138622562|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138622563|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622564|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138622565|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138622566|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622568|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138622569|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622570|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138622571|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138622572|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138682921|NCT05149274|Fexuprazan|fexuprazan|mesh-list
138622573|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622575|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622576|NCT04639804|Celecoxib|celecoxib|mesh-list
138622577|NCT04639804|Naproxen|naproxen|mesh-list
138622578|NCT04639804|Aceclofenac|aceclofenac|mesh-list
138622579|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138622580|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138622581|NCT04639804|Analgesics|analgesics|mesh-ancestor
138622582|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
138622583|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622584|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622585|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138622586|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138319594|NCT04144218|Lacosamide|lacosamide|mesh-list
138622587|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138622588|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138622589|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622590|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622591|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
138622592|NCT00218855|Thalidomide|thalidomide|mesh-list
138622593|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138622594|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
138622595|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622596|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
138622597|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138622598|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138622599|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138622600|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138622601|NCT00218855|Growth Substances|growth substances|mesh-ancestor
138622602|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
138622603|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622604|NCT00246246|Risperidone|risperidone|mesh-list
138299119|NCT00004652|Pimozide|pimozide|mesh-list
138622605|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138622606|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
138622607|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622608|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622609|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622610|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138622611|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138622612|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622613|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138622614|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138622615|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
138622616|NCT00242190|Gemcitabine|gemcitabine|mesh-list
138622617|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
138622618|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138622619|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
138622620|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622621|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622622|NCT04628884|Heparin|heparin|mesh-list
138622623|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
138622624|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138622625|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138622626|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622627|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138622628|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
138622629|NCT00412334|Ribavirin|ribavirin|mesh-list
138622630|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
138622631|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138622632|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
138622633|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622634|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
138622635|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622636|NCT00561379|Rituximab|rituximab|mesh-list
138622637|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138622638|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622639|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
138622640|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622641|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138622642|NCT04629118|Sirolimus|sirolimus|mesh-list
138622643|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138622644|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138622645|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138622646|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622647|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
138622648|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138622649|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
138622650|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622651|NCT00561496|Tenofovir|tenofovir|mesh-list
138622652|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
138622653|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138622654|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138508081|NCT06196580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138622655|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138622657|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622658|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138622659|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138622660|NCT00246285|Risperidone|risperidone|mesh-list
138622661|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138622662|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
138622663|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622664|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622665|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622666|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138622667|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138622668|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622669|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138622670|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138622671|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
138622672|NCT00242268|Simvastatin|simvastatin|mesh-list
138622673|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138622674|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138622675|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
138622676|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622677|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138682955|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
138622678|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138299191|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
138622679|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622680|NCT00246363|Silymarin|silymarin|mesh-list
138622681|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
138622682|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622683|NCT00246363|Protective Agents|protective agents|mesh-ancestor
138622684|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622685|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
138622686|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138622687|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138622688|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
138319624|NCT05587608|Anesthetics|anesthetics|mesh-list
138622689|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622690|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622691|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622692|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
138622693|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
138622694|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622695|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
138622696|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138622697|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
138622698|NCT00246402|Acipimox|acipimox|mesh-list
138622699|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138622700|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
138182502|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138622701|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622702|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138622703|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
138622704|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138622705|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622706|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138622707|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
138508082|NCT06196554|Paclitaxel|paclitaxel|mesh-list
138622708|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138622709|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
138622710|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138622711|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622712|NCT04628143|Nafamostat|nafamostat|mesh-list
138622713|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138622714|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138622715|NCT04628143|Analgesics|analgesics|mesh-ancestor
138622716|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
138622717|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622718|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622719|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138622720|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138622722|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
138622723|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622724|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622725|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138622726|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138622727|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138622728|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138622729|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
138622730|NCT00242346|Candesartan|candesartan|mesh-list
138622731|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
138622732|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138622733|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138622734|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138622735|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622736|NCT00219245|Rivastigmine|rivastigmine|mesh-list
138622737|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138622738|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622739|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622740|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
138622741|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622742|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622743|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138622744|NCT00219245|Protective Agents|protective agents|mesh-ancestor
138622745|NCT04627363|Bevacizumab|bevacizumab|mesh-list
138622746|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138622747|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622748|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138622749|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138622750|NCT04627363|Growth Substances|growth substances|mesh-ancestor
138622751|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622752|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
138622754|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138622755|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138622756|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
138622757|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
138622758|NCT00246597|Hematinics|hematinics|mesh-ancestor
138622759|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
138622760|NCT04626739|Fludarabine|fludarabine|mesh-list
138622761|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138622762|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
138622763|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622764|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138622765|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138622766|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
138622767|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622768|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622769|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138622770|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138622771|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
138622772|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622773|NCT04627129|Itraconazole|itraconazole|mesh-list
138622774|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
138622775|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138683014|NCT00525486|Nifedipine|nifedipine|mesh-list
138622776|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138622777|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138622778|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622779|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622780|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138622781|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
138622782|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138622783|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622784|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138622785|NCT00246636|Fenofibrate|fenofibrate|mesh-list
138622786|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138622787|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
138622788|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622789|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138622791|NCT00219440|Pioglitazone|pioglitazone|mesh-list
138622792|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138622793|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622794|NCT00246675|Furosemide|furosemide|mesh-list
138622795|NCT00246675|Diuretics|diuretics|mesh-ancestor
138622796|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
138622797|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622798|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138622799|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138622800|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622801|NCT00219479|Phenytoin|phenytoin|mesh-list
138622802|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
138622803|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138622804|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138622805|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138622806|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622807|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138622808|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138622809|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138622810|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138622811|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138662024|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138622812|NCT04626973|Ezetimibe|ezetimibe|mesh-list
138622813|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138622814|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138622815|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138622816|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
138622817|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622818|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138622819|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622820|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
138622821|NCT00242463|Nandrolone|nandrolone|mesh-list
138622822|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
138622823|NCT00242463|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
138622824|NCT00242463|Androgens|androgens|mesh-ancestor
138622825|NCT00242463|Hormones|hormones|mesh-ancestor
138622826|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138622827|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622828|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
138622829|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138622830|NCT00242463|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
138622831|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
138622832|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138622833|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
138622834|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622835|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622836|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138622837|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
138622838|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138622839|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138622840|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138622841|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
138622842|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622843|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622844|NCT00561964|Irbesartan|irbesartan|mesh-list
138622845|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138622846|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138622847|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138622848|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622849|NCT00219596|Timolol|timolol|mesh-list
138622850|NCT00219596|Latanoprost|latanoprost|mesh-list
138622851|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138622852|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138622853|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
138622854|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622855|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622856|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622857|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138622858|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138622859|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138622860|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138622861|NCT04626193|Amoxicillin|amoxicillin|mesh-list
138622862|NCT04626193|Doxycycline|doxycycline|mesh-list
138622864|NCT04626193|Esomeprazole|esomeprazole|mesh-list
138622865|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138622866|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138622867|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138622868|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138622869|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138622870|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622871|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622872|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
138622873|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138622874|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138622875|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138622876|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138622877|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138182621|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
138622878|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622879|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138622880|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138622881|NCT00242541|Octreotide|octreotide|mesh-list
138622882|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138622883|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138622884|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622886|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138622887|NCT04625608|Analgesics|analgesics|mesh-ancestor
138622888|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
138622889|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622890|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622891|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
138622892|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
138622893|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138622894|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
138622895|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
138622896|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622897|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622898|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138622899|NCT00219713|Analgesics|analgesics|mesh-ancestor
138622900|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
138622901|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622902|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
138622903|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622904|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138622905|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622906|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622907|NCT00242697|Anesthetics|anesthetics|mesh-list
138622908|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622909|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622910|NCT04625179|Melatonin|melatonin|mesh-list
138622911|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
138622912|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
138622913|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622914|NCT04625179|Protective Agents|protective agents|mesh-ancestor
138622915|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622916|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138622917|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138622918|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
138622919|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
138622920|NCT02962232|Paclitaxel|paclitaxel|mesh-list
138622921|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138622922|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622923|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
138622924|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
138622925|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
138622926|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182652|NCT00913627|Ibuprofen|ibuprofen|mesh-list
138622927|NCT00246909|Pantoprazole|pantoprazole|mesh-list
138622928|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138622929|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138622930|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138622931|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622932|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622934|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138622935|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622936|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622938|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622939|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622940|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138622941|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
138622942|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622943|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
138622944|NCT04624360|Dexamethasone|dexamethasone|mesh-list
138622945|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138622947|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
138622948|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622949|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622950|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138622951|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
138622952|NCT04624360|Hormones|hormones|mesh-ancestor
138622953|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138622954|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138622955|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622956|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
138622957|NCT00219908|Analgesics|analgesics|mesh-ancestor
138182674|NCT05523102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622958|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
138622959|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622960|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622961|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138622962|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138622963|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138622964|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622965|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622966|NCT00242736|Esomeprazole|esomeprazole|mesh-list
138622967|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138622968|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138622969|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138622970|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138622971|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138662090|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138622972|NCT00242775|Fluticasone|fluticasone|mesh-list
138622973|NCT00242775|Budesonide|budesonide|mesh-list
138299493|NCT00385658|Ezetimibe|ezetimibe|mesh-list
138622974|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
138622975|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138622976|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138622977|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138622978|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
138622979|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138622980|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622981|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138622982|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
138622983|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
138622984|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138622985|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
138622986|NCT00242775|Hormones|hormones|mesh-ancestor
138622987|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138622988|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138622989|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138622990|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138622991|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
138622992|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138622993|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138622994|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
138622995|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
138622996|NCT04623619|Vitamins|vitamins|mesh-ancestor
138622997|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
138622998|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138622999|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
138623000|NCT00562198|Carbidopa|carbidopa|mesh-list
138623001|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138623002|NCT00562198|Entacapone|entacapone|mesh-list
138623003|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138623004|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138623005|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
138182721|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138623006|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623007|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623008|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623009|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138623010|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623011|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138623012|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
138623013|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
138623014|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138623016|NCT00220064|Fluorouracil|fluorouracil|mesh-list
138623017|NCT00220064|Irinotecan|irinotecan|mesh-list
138623018|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
138508083|NCT06196554|Pembrolizumab|pembrolizumab|mesh-list
138623019|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623020|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138623021|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623022|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138623023|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
138623024|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623025|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138623026|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138623027|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623029|NCT00220064|Protective Agents|protective agents|mesh-ancestor
138623030|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
138623031|NCT00220064|Vitamins|vitamins|mesh-ancestor
138623032|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
138623033|NCT00220103|Capecitabine|capecitabine|mesh-list
138623034|NCT00220103|Epirubicin|epirubicin|mesh-list
138623035|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623036|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138623037|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
138623038|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623039|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138623040|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138623041|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138623042|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623043|NCT00247026|Ubiquinone|ubiquinone|mesh-list
138623044|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
138623045|NCT00247026|Curcumin|curcumin|mesh-list
138623046|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138182745|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
138623047|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138623048|NCT00247026|Analgesics|analgesics|mesh-ancestor
138623049|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
138299566|NCT00005810|Carboplatin|carboplatin|mesh-list
138623050|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138623051|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623052|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138623053|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138623054|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623055|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623056|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623057|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
138623059|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
138623060|NCT01580683|Vitamins|vitamins|mesh-ancestor
138623061|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
138623062|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623063|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
138623064|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623065|NCT01580683|Protective Agents|protective agents|mesh-ancestor
138623066|NCT04623385|Tretinoin|tretinoin|mesh-list
138623067|NCT04623385|Isotretinoin|isotretinoin|mesh-list
138623068|NCT04623385|Testosterone|testosterone|mesh-list
138623069|NCT04623385|Androgens|androgens|mesh-ancestor
138662138|NCT01058642|Pregabalin|pregabalin|mesh-list
138662152|NCT00426920|Insulin|insulin|mesh-list
138623071|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138623072|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623073|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623074|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
138623075|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
138623076|NCT00220220|Amlodipine|amlodipine|mesh-list
138623077|NCT00220220|Olmesartan|olmesartan|mesh-list
138623078|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138623079|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138623080|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138623081|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138623082|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623083|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138623084|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623085|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
138623086|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138623087|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138623088|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
138623089|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138623090|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
138623091|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138623092|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623093|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138623094|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
138623095|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138623096|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
138623097|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683137|NCT00507962|Cisplatin|cisplatin|mesh-list
138623098|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623099|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138623100|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
138623101|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
138623102|NCT00242853|Protective Agents|protective agents|mesh-ancestor
138623103|NCT00220259|Fluticasone|fluticasone|mesh-list
138623104|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138623105|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138623107|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138623108|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623109|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138623110|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
138623111|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
138623112|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138623113|NCT04622956|Methotrexate|methotrexate|mesh-list
138623114|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138623115|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
138623116|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138623117|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623118|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138662166|NCT00427076|Vancomycin|vancomycin|mesh-list
138623120|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623121|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623122|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
138623123|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299646|NCT04568876|Palmidrol|palmidrol|mesh-list
138623124|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138623125|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138623126|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
138623127|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138623128|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138623129|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
138623130|NCT04622566|Lenvatinib|lenvatinib|mesh-list
138623131|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138623132|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623133|NCT04622566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138182809|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623134|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623135|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138623136|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623137|NCT04622488|Diclofenac|diclofenac|mesh-list
138623138|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138623139|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138623140|NCT04622488|Analgesics|analgesics|mesh-ancestor
138623141|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
138623142|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138623143|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623144|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138623145|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138623146|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138623147|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623148|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623149|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
138623151|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
138623152|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
138623153|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138623154|NCT00220298|Androgens|androgens|mesh-ancestor
138623155|NCT00220298|Hormones|hormones|mesh-ancestor
138623156|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662187|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138623157|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623158|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138623159|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319759|NCT03588936|Nivolumab|nivolumab|mesh-list
138623160|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
138623161|NCT00412412|Trastuzumab|trastuzumab|mesh-list
138623162|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138623163|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623164|NCT04621669|Metformin|metformin|mesh-list
138623165|NCT04621669|Digoxin|digoxin|mesh-list
138623166|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138623167|NCT04621669|Calcium|calcium|mesh-list
138623168|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138623169|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623170|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138623171|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138623172|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138623173|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
138623174|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623175|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138182842|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
138623176|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138623177|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623178|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138623179|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138623180|NCT04621669|Protective Agents|protective agents|mesh-ancestor
138623181|NCT00412646|Etravirine|etravirine|mesh-list
138623182|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138623183|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138623184|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623185|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623186|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
138623187|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623188|NCT00243009|Cyclosporine|cyclosporine|mesh-list
138623189|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
138623190|NCT00243009|Fludarabine|fludarabine|mesh-list
138623191|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
138623192|NCT00243009|Cyclosporins|cyclosporins|mesh-list
138623193|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623194|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138623195|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
138623196|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623197|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138188439|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138623199|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623200|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623201|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
138623202|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623203|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
138623204|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138623205|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138623206|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138623207|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138623208|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
138623209|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138623210|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
138683160|NCT00508664|Docetaxel|docetaxel|mesh-list
138623212|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138623213|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
138623214|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623215|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138623216|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138623217|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623218|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623219|NCT04621513|Montelukast|montelukast|mesh-list
138623220|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138623221|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
138623222|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138623223|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
138623224|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138623225|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623226|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138623227|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138623228|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623229|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
138623230|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138623231|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138623233|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138623234|NCT00562705|Hormones|hormones|mesh-list
138623235|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138623236|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623237|NCT04620967|Insulin|insulin|mesh-list
138623238|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138623239|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
138623240|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
138182921|NCT02740114|Oxycodone|oxycodone|mesh-list
138623241|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138623242|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138623243|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623244|NCT00220493|Methylphenidate|methylphenidate|mesh-list
138623245|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138623246|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623247|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138623248|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138623249|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138623250|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623251|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
138623252|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623253|NCT04620616|Menthol|menthol|mesh-list
138623254|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
138623255|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
138623256|NCT00220532|Folic Acid|folic acid|mesh-list
138623257|NCT00220532|Riboflavin|riboflavin|mesh-list
138623258|NCT00220532|Hematinics|hematinics|mesh-ancestor
138623259|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
138623260|NCT00220532|Vitamins|vitamins|mesh-ancestor
138623261|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
138623262|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623263|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138623264|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
138623265|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
138623266|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138623267|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
138623268|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138683174|NCT02946684|Letrozole|letrozole|mesh-list
138623269|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138623270|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138623271|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
138623272|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623273|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623274|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138623275|NCT00243204|Docetaxel|docetaxel|mesh-list
138623276|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623277|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
138623278|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
138623279|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
138623280|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623281|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138623282|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623283|NCT04620031|Propofol|propofol|mesh-list
138623284|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138623285|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138623286|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623287|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138623288|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
138623289|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
138182960|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
138623290|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138623291|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138623292|NCT00220649|Leucovorin|leucovorin|mesh-list
138623293|NCT00220649|Gemcitabine|gemcitabine|mesh-list
138623294|NCT00220649|Fluorouracil|fluorouracil|mesh-list
138623295|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
138623296|NCT00220649|Irinotecan|irinotecan|mesh-list
138623297|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138623298|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
138623299|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623300|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623301|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138623302|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
138623303|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623304|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138623305|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138623306|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623308|NCT00220649|Protective Agents|protective agents|mesh-ancestor
138623309|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
138623310|NCT00220649|Vitamins|vitamins|mesh-ancestor
138623311|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
138623312|NCT04619758|Emollients|emollients|mesh-list
138623313|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
138623314|NCT04619914|Letrozole|letrozole|mesh-list
138623315|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623316|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138623317|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138623318|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623319|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623320|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138623321|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
138623322|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138623323|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623324|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
138623325|NCT00220766|Antibodies|antibodies|mesh-list
138623326|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
138623327|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138623328|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138623329|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
138623330|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
138623331|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623332|NCT04619875|Lactulose|lactulose|mesh-list
138623333|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138623334|NCT04619290|Methylene Blue|methylene blue|mesh-list
138623335|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623336|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623337|NCT04619563|Docetaxel|docetaxel|mesh-list
138623338|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623339|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
138623340|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
138623341|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
138623342|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623343|NCT00220844|Amitriptyline|amitriptyline|mesh-list
138623344|NCT00220844|Desipramine|desipramine|mesh-list
138623345|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138623347|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138623348|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138623349|NCT00220844|Analgesics|analgesics|mesh-ancestor
138623350|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
138623351|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138623352|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623353|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138623354|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138623355|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138623356|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623357|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
138623358|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623359|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623360|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
138623361|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138623362|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623363|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138623364|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
138623365|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138623366|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623367|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623368|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623369|NCT04619251|Itraconazole|itraconazole|mesh-list
138623370|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
138623371|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623372|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138623373|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138623374|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623375|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623376|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138623378|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138623379|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623380|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138623382|NCT00243399|Androgens|androgens|mesh-ancestor
138623383|NCT00243399|Hormones|hormones|mesh-ancestor
138623384|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138623385|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623386|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
138623387|NCT00220922|Ethanol|ethanol|mesh-list
138623388|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138623389|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623390|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138623391|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623392|NCT00221000|Methoxsalen|methoxsalen|mesh-list
138623393|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138623394|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
138623395|NCT00243477|Escitalopram|escitalopram|mesh-list
138623396|NCT00243477|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138623397|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138319814|NCT03580980|Morphine|morphine|mesh-list
138623398|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138623399|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623400|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623401|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
138623402|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623403|NCT00221039|Methoxsalen|methoxsalen|mesh-list
138623404|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138623405|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
138623407|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138623408|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
138623409|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623410|NCT00221156|Acarbose|acarbose|mesh-list
138623411|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138623412|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623413|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623414|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138623415|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623416|NCT04617613|Amoxicillin|amoxicillin|mesh-list
138623417|NCT04617613|Metronidazole|metronidazole|mesh-list
138623418|NCT04617613|Clarithromycin|clarithromycin|mesh-list
138623419|NCT04617613|Omeprazole|omeprazole|mesh-list
138623420|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138623421|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138299945|NCT00383695|Capecitabine|capecitabine|mesh-list
138623422|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138623423|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138623424|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138623425|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138623426|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138623427|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623428|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623429|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138623430|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138623431|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138623432|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
138623433|NCT04617652|Analgesics|analgesics|mesh-ancestor
138623434|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
138623435|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138623436|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623437|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
138623438|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138623439|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138623440|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
138623441|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138623442|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138623443|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623444|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138623445|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
138623446|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138623447|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138623448|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138623449|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623450|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138623451|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138623452|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138623453|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623455|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623456|NCT00221312|Alendronate|alendronate|mesh-list
138623457|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138623458|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623459|NCT04616872|Methotrexate|methotrexate|mesh-list
138623460|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138623461|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
138623462|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138623463|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623464|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138623465|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
138623466|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623467|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623468|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
138623469|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183068|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138623470|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138623471|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138623472|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
138623473|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138623474|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138623476|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138623477|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138623478|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
138623479|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
138623480|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623481|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623482|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623483|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
138623484|NCT00247650|Letrozole|letrozole|mesh-list
138623485|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623486|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138623487|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138623488|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623489|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623490|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138623491|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
138623492|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300025|NCT03693781|Colchicine|colchicine|mesh-list
138623493|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623494|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138623495|NCT00221429|Valproic Acid|valproic acid|mesh-list
138623496|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138623497|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623498|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623499|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
138623500|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138623501|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138623502|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623503|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
138623504|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
138623505|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623506|NCT00563017|Risperidone|risperidone|mesh-list
138183100|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138183104|NCT05311709|Sotorasib|sotorasib|mesh-list
138623507|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138623508|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
138623509|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623510|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623511|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623512|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138623513|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138623514|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138623515|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138623516|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138623518|NCT00563056|Fluticasone|fluticasone|mesh-list
138623519|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
138623520|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138623521|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
138623522|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138623523|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623524|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138318489|NCT01422876|Hormones|hormones|mesh-ancestor
138623526|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138623527|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138623528|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138623529|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
138623530|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623531|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623532|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138623533|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
138623534|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138623535|NCT00563095|Interferons|interferons|mesh-list
138623536|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623537|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
138623538|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623539|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138623540|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
138623541|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138623542|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138623543|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138623544|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138623545|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623546|NCT00563212|Interferons|interferons|mesh-list
138623547|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
138623548|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138183136|NCT05519514|Hormones|hormones|mesh-ancestor
138183139|NCT02756572|Cyclosporine|cyclosporine|mesh-list
138623549|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
138623550|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623551|NCT00563251|Azithromycin|azithromycin|mesh-list
138623552|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138623553|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623554|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138623555|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138623556|NCT00251082|Estradiol|estradiol|mesh-list
138623557|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138623558|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
138623559|NCT00251082|Estrogens|estrogens|mesh-ancestor
138623560|NCT00251082|Hormones|hormones|mesh-ancestor
138623561|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138623562|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623563|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138623564|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
138623565|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138623566|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138623567|NCT00251082|Progestins|progestins|mesh-ancestor
138300089|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138623568|NCT00221624|Ribavirin|ribavirin|mesh-list
138623569|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138623570|NCT00221624|Amantadine|amantadine|mesh-list
138623571|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
138623572|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319880|NCT03891576|Niraparib|niraparib|mesh-list
138623573|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
138623574|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623575|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138623576|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138623577|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
138623578|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623579|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623580|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138623582|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
138623583|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138623584|NCT06178211|Paclitaxel|paclitaxel|mesh-list
138623585|NCT06178211|Carboplatin|carboplatin|mesh-list
138623586|NCT06178211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138183173|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138623587|NCT06178211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623588|NCT06178211|Tubulin Modulators|tubulin modulators|mesh-ancestor
138623589|NCT06178211|Antimitotic Agents|antimitotic agents|mesh-ancestor
138623590|NCT06178211|Mitosis Modulators|mitosis modulators|mesh-ancestor
138623591|NCT06178211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623592|NCT06178159|Pertuzumab|pertuzumab|mesh-list
138623593|NCT06178159|Disitamab vedotin|disitamab vedotin|mesh-list
138623594|NCT06178159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138623595|NCT06178159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623596|NCT06178159|Immunoconjugates|immunoconjugates|mesh-ancestor
138623597|NCT06178159|Immunologic Factors|immunologic factors|mesh-ancestor
138623598|NCT06178159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623599|NCT06178146|Mycophenolic Acid|mycophenolic acid|mesh-list
138623602|NCT06178146|Tacrolimus|tacrolimus|mesh-list
138623603|NCT06178146|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138623604|NCT06178146|Thymalfasin|thymalfasin|mesh-list
138662352|NCT00428558|Cytarabine|cytarabine|mesh-list
138623605|NCT06178146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138623606|NCT06178146|Glucocorticoids|glucocorticoids|mesh-ancestor
138623607|NCT06178146|Hormones|hormones|mesh-ancestor
138623608|NCT06178146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138623609|NCT06178146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623610|NCT06178146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138623611|NCT06178146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623612|NCT06178146|Immunologic Factors|immunologic factors|mesh-ancestor
138623613|NCT06178146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138623614|NCT06178146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623615|NCT06178146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623616|NCT06178146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138623617|NCT06178146|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138623618|NCT06178146|Antitubercular Agents|antitubercular agents|mesh-ancestor
138623619|NCT06178146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138623620|NCT06178146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623621|NCT06178146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138183210|NCT02973958|Ketorolac|ketorolac|mesh-list
138623622|NCT06178068|Bronchodilator Agents|bronchodilator agents|mesh-list
138623623|NCT06178068|Autonomic Agents|autonomic agents|mesh-ancestor
138623624|NCT06178068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138623625|NCT06178068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623626|NCT06178068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138623627|NCT06178068|Respiratory System Agents|respiratory system agents|mesh-ancestor
138623628|NCT06177964|Lomustine|lomustine|mesh-list
138623629|NCT06177964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138623630|NCT06177964|Alkylating Agents|alkylating agents|mesh-ancestor
138623631|NCT06177964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623633|NCT06177938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138623634|NCT06177925|Carboplatin|carboplatin|mesh-list
138623635|NCT06177925|Etoposide|etoposide|mesh-list
138623636|NCT06177925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623637|NCT06177925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138623638|NCT06177925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138623639|NCT06177925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138623640|NCT06177925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623641|NCT06177925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623642|NCT06177678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138623643|NCT06177678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138623644|NCT06177522|Paclitaxel|paclitaxel|mesh-list
138623645|NCT06177522|Gemcitabine|gemcitabine|mesh-list
138623646|NCT06177522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138623647|NCT06177522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138623648|NCT06177522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623649|NCT06177522|Tubulin Modulators|tubulin modulators|mesh-ancestor
138623650|NCT06177522|Antimitotic Agents|antimitotic agents|mesh-ancestor
138623651|NCT06177522|Mitosis Modulators|mitosis modulators|mesh-ancestor
138623652|NCT06177522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623653|NCT06177522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138623654|NCT06177522|Antimetabolites|antimetabolites|mesh-ancestor
138623655|NCT06177496|Sorafenib|sorafenib|mesh-list
138623656|NCT06177496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623657|NCT06177496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138623658|NCT06177496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623659|NCT06177496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623660|NCT06177444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138623661|NCT06177444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623662|NCT06177405|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
138623663|NCT06177405|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
138623664|NCT06177405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138183254|NCT05348434|Ether|ether|mesh-list
138623665|NCT06177405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623666|NCT06177405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623667|NCT06177405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138623668|NCT06177288|Bevacizumab|bevacizumab|mesh-list
138623669|NCT06177288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138623670|NCT06177288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623671|NCT06177288|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138623672|NCT06177288|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138623673|NCT06177288|Growth Substances|growth substances|mesh-ancestor
138623674|NCT06177288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623675|NCT06177288|Growth Inhibitors|growth inhibitors|mesh-ancestor
138623676|NCT06177249|Vaccines|vaccines|mesh-list
138623677|NCT06177249|Immunologic Factors|immunologic factors|mesh-ancestor
138623678|NCT06177249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623679|NCT06177197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138623680|NCT06177171|Olaparib|olaparib|mesh-list
138623681|NCT06177171|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138623682|NCT06177171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138623683|NCT06177171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623684|NCT06177171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623685|NCT06177171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623686|NCT06177171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138623687|NCT06177171|Antimetabolites|antimetabolites|mesh-ancestor
138623688|NCT06177119|Amoxicillin|amoxicillin|mesh-list
138623689|NCT06177119|Metronidazole|metronidazole|mesh-list
138623690|NCT06177119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138623691|NCT06177119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623692|NCT06177119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138623693|NCT06177119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138623694|NCT06177067|Cytarabine|cytarabine|mesh-list
138623695|NCT06177067|Hydrocortisone|hydrocortisone|mesh-list
138623696|NCT06177067|Methotrexate|methotrexate|mesh-list
138623697|NCT06177067|Azacitidine|azacitidine|mesh-list
138623698|NCT06177067|Venetoclax|venetoclax|mesh-list
138623699|NCT06177067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138623700|NCT06177067|Abortifacient Agents|abortifacient agents|mesh-ancestor
138623701|NCT06177067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138623702|NCT06177067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623703|NCT06177067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138623704|NCT06177067|Antimetabolites|antimetabolites|mesh-ancestor
138623705|NCT06177067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623706|NCT06177067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623707|NCT06177067|Dermatologic Agents|dermatologic agents|mesh-ancestor
138623708|NCT06177067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623709|NCT06177067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138623710|NCT06177067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138623711|NCT06177067|Immunologic Factors|immunologic factors|mesh-ancestor
138623712|NCT06177067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138623713|NCT06177067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138623714|NCT06177067|Antiviral Agents|antiviral agents|mesh-ancestor
138623715|NCT06177067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623716|NCT06177067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138300242|NCT01478035|Phenytoin|phenytoin|mesh-list
138623717|NCT06177041|Capecitabine|capecitabine|mesh-list
138623718|NCT06177041|Oxaliplatin|oxaliplatin|mesh-list
138623719|NCT06177041|Antibodies|antibodies|mesh-list
138623720|NCT06177041|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138623721|NCT06177041|Immunologic Factors|immunologic factors|mesh-ancestor
138623722|NCT06177041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623723|NCT06177041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138623725|NCT06177041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623726|NCT06177041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623727|NCT06177028|Lenalidomide|lenalidomide|mesh-list
138623728|NCT06177028|Immunologic Factors|immunologic factors|mesh-ancestor
138623729|NCT06177028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623730|NCT06177028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138623731|NCT06177028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138623732|NCT06177028|Growth Substances|growth substances|mesh-ancestor
138623733|NCT06177028|Growth Inhibitors|growth inhibitors|mesh-ancestor
138623734|NCT06177028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623735|NCT06176976|Lugol's solution|lugol's solution|mesh-list
138623736|NCT06176976|Hemostatics|hemostatics|mesh-ancestor
138623737|NCT06176976|Coagulants|coagulants|mesh-ancestor
138623738|NCT06176937|Hyaluronic Acid|hyaluronic acid|mesh-list
138623739|NCT06176937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138623740|NCT06176937|Immunologic Factors|immunologic factors|mesh-ancestor
138623741|NCT06176937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623742|NCT06176937|Viscosupplements|viscosupplements|mesh-ancestor
138623743|NCT06176937|Protective Agents|protective agents|mesh-ancestor
138623744|NCT06176911|Teriflunomide|teriflunomide|mesh-list
138623745|NCT06176911|Danazol|danazol|mesh-list
138623746|NCT06176911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138623747|NCT06176911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138623748|NCT06176911|Analgesics|analgesics|mesh-ancestor
138623749|NCT06176911|Sensory System Agents|sensory system agents|mesh-ancestor
138623750|NCT06176911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138623751|NCT06176911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623752|NCT06176911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138623753|NCT06176911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138623754|NCT06176911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138623755|NCT06176911|Immunologic Factors|immunologic factors|mesh-ancestor
138623756|NCT06176911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138623758|NCT06176911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138623759|NCT06176794|Torsemide|torsemide|mesh-list
138623760|NCT06176794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138623761|NCT06176794|Diuretics|diuretics|mesh-ancestor
138623762|NCT06176794|Natriuretic Agents|natriuretic agents|mesh-ancestor
138623763|NCT06176794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623764|NCT06176794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138623765|NCT06176794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138623766|NCT06176794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623767|NCT06176781|Edaravone|edaravone|mesh-list
138623768|NCT06176781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138623769|NCT06176781|Antioxidants|antioxidants|mesh-ancestor
138623770|NCT06176781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623771|NCT06176781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138623772|NCT06176781|Protective Agents|protective agents|mesh-ancestor
138623773|NCT06176781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623776|NCT06176729|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138623777|NCT06176729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138623778|NCT06176729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623779|NCT06176729|Immunologic Factors|immunologic factors|mesh-ancestor
138623780|NCT06176729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623781|NCT06176729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138623782|NCT06176729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138623783|NCT06176729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138623784|NCT06176729|Growth Substances|growth substances|mesh-ancestor
138623785|NCT06176729|Growth Inhibitors|growth inhibitors|mesh-ancestor
138623786|NCT06176729|Immunoconjugates|immunoconjugates|mesh-ancestor
138623787|NCT06171802|Empagliflozin|empagliflozin|mesh-list
138623788|NCT06171802|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138623789|NCT06171802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623790|NCT06171802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138623791|NCT06171802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623792|NCT06171269|Androgens|androgens|mesh-list
138300317|NCT00003019|Methotrexate|methotrexate|mesh-list
138623793|NCT06171269|Hormones|hormones|mesh-ancestor
138623794|NCT06171269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138623796|NCT06170697|Carboplatin|carboplatin|mesh-list
138623797|NCT06170697|Nedaplatin|nedaplatin|mesh-list
138623798|NCT06170697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623799|NCT06170463|Metformin|metformin|mesh-list
138623800|NCT06170463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138623801|NCT06170463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623802|NCT06170372|Nitric Oxide|nitric oxide|mesh-list
138623803|NCT06170372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138623804|NCT06170372|Autonomic Agents|autonomic agents|mesh-ancestor
138623805|NCT06170372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138623806|NCT06170372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623807|NCT06170372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138623808|NCT06170372|Respiratory System Agents|respiratory system agents|mesh-ancestor
138623809|NCT06170372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138623810|NCT06170372|Antioxidants|antioxidants|mesh-ancestor
138623811|NCT06170372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623812|NCT06170372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623813|NCT06170372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138623814|NCT06170372|Vasodilator Agents|vasodilator agents|mesh-ancestor
138623815|NCT06170372|Gasotransmitters|gasotransmitters|mesh-ancestor
138623816|NCT06170372|Protective Agents|protective agents|mesh-ancestor
138623818|NCT06167057|Mitomycins|mitomycins|mesh-list
138623819|NCT06167057|Mitomycin|mitomycin|mesh-list
138623820|NCT06167057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138623821|NCT06167057|Antimetabolites|antimetabolites|mesh-ancestor
138623822|NCT06167057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623823|NCT06167057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623824|NCT06167057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138623825|NCT06167057|Alkylating Agents|alkylating agents|mesh-ancestor
138623826|NCT06167057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138623827|NCT06167057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623828|NCT06166394|Bupivacaine|bupivacaine|mesh-list
138319985|NCT03155646|Clonidine|clonidine|mesh-list
138623829|NCT06166394|Anesthetics, Local|anesthetics, local|mesh-list
138623830|NCT06166394|Mepivacaine|mepivacaine|mesh-list
138623832|NCT06166394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138623833|NCT06166394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623834|NCT06166394|Sensory System Agents|sensory system agents|mesh-ancestor
138623835|NCT06166394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183454|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138623836|NCT06160713|Itraconazole|itraconazole|mesh-list
138623837|NCT06160713|Antifungal Agents|antifungal agents|mesh-ancestor
138623838|NCT06160713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623839|NCT06160713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138623840|NCT06160713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138623841|NCT06160713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623842|NCT06160713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623843|NCT06160713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138623844|NCT06160713|Hormone Antagonists|hormone antagonists|mesh-ancestor
138623845|NCT06160713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138623846|NCT06160713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623847|NCT06160713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138623848|NCT06155318|Edotreotide|edotreotide|mesh-list
138623849|NCT06155318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138623850|NCT06155318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623851|NCT06154174|Amoxicillin|amoxicillin|mesh-list
138623852|NCT06154174|Choline|choline|mesh-list
138623853|NCT06154174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138623854|NCT06154174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138623855|NCT06154174|Lipotropic Agents|lipotropic agents|mesh-ancestor
138623856|NCT06154174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138623857|NCT06154174|Antimetabolites|antimetabolites|mesh-ancestor
138623858|NCT06154174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623859|NCT06154174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138623860|NCT06154174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138623861|NCT06154174|Nootropic Agents|nootropic agents|mesh-ancestor
138623862|NCT06151236|Nivolumab|nivolumab|mesh-list
138623863|NCT06151236|Relatlimab|relatlimab|mesh-list
138623864|NCT06151236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138623865|NCT06151236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623866|NCT06151236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138300392|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
138623867|NCT06151236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623868|NCT06140186|Betamethasone|betamethasone|mesh-list
138623869|NCT06140186|Betamethasone Valerate|betamethasone valerate|mesh-list
138623870|NCT06140186|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138623871|NCT06140186|Betamethasone benzoate|betamethasone benzoate|mesh-list
138623872|NCT06140186|Timolol|timolol|mesh-list
138623873|NCT06140186|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138623874|NCT06140186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138623875|NCT06140186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138623876|NCT06140186|Adrenergic Agents|adrenergic agents|mesh-ancestor
138623877|NCT06140186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138662444|NCT00469443|Leucovorin|leucovorin|mesh-list
138623887|NCT06140186|Respiratory System Agents|respiratory system agents|mesh-ancestor
138320008|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138623897|NCT06100146|Folic Acid|folic acid|mesh-list
138623898|NCT06100146|Vitamin B 12|vitamin b 12|mesh-list
138623899|NCT06100146|Hydroxocobalamin|hydroxocobalamin|mesh-list
138623900|NCT06100146|Vitamins|vitamins|mesh-ancestor
138623901|NCT06100146|Micronutrients|micronutrients|mesh-ancestor
138623902|NCT06100146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623903|NCT06100146|Hematinics|hematinics|mesh-ancestor
138623904|NCT06100146|Vitamin B Complex|vitamin b complex|mesh-ancestor
138623905|NCT06097273|Vaccines|vaccines|mesh-list
138623906|NCT06097273|Immunologic Factors|immunologic factors|mesh-ancestor
138623907|NCT06097273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623908|NCT06083948|Phenylephrine|phenylephrine|mesh-list
138623909|NCT06083948|Oxymetazoline|oxymetazoline|mesh-list
138623910|NCT06083948|Norepinephrine|norepinephrine|mesh-list
138623911|NCT06083948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138623912|NCT06083948|Mydriatics|mydriatics|mesh-ancestor
138623913|NCT06083948|Autonomic Agents|autonomic agents|mesh-ancestor
138623914|NCT06083948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138623915|NCT06083948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623916|NCT06083948|Sympathomimetics|sympathomimetics|mesh-ancestor
138623917|NCT06083948|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138623918|NCT06083948|Nasal Decongestants|nasal decongestants|mesh-ancestor
138623919|NCT06083948|Respiratory System Agents|respiratory system agents|mesh-ancestor
138183543|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138183544|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
138623920|NCT06083948|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138662467|NCT00469443|Vitamins|vitamins|mesh-ancestor
138623921|NCT06083948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138623922|NCT06083948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138623923|NCT06083948|Adrenergic Agents|adrenergic agents|mesh-ancestor
138623924|NCT06083948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623925|NCT06083948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623926|NCT06083948|Protective Agents|protective agents|mesh-ancestor
138623927|NCT06082492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138623928|NCT06082492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138623929|NCT06082492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623930|NCT06081998|Histamine|histamine|mesh-list
138623931|NCT06081998|Histamine Agonists|histamine agonists|mesh-ancestor
138623932|NCT06081998|Histamine Agents|histamine agents|mesh-ancestor
138623933|NCT06081998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138623934|NCT06081998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623935|NCT06081998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623936|NCT06062810|Crizotinib|crizotinib|mesh-list
138623937|NCT06062810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623938|NCT06062810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138623939|NCT06062810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623940|NCT06062810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623941|NCT06056050|Vaccines|vaccines|mesh-list
138623942|NCT06056050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138623943|NCT06056050|Immunologic Factors|immunologic factors|mesh-ancestor
138623944|NCT06056050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320023|NCT03101046|Docetaxel|docetaxel|mesh-list
138623945|NCT06044857|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138623946|NCT06044857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138623947|NCT06044857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623948|NCT06035744|Pembrolizumab|pembrolizumab|mesh-list
138623949|NCT06035744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138183576|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138183580|NCT05337436|Calcium|calcium|mesh-list
138623950|NCT06035744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623951|NCT06035744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138623952|NCT06035744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623953|NCT06035536|Calcium|calcium|mesh-list
138623954|NCT06035536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138623955|NCT06035536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623956|NCT06017817|Anti-Infective Agents|anti-infective agents|mesh-list
138623957|NCT06015750|Folic Acid|folic acid|mesh-list
138623958|NCT06015750|Rituximab|rituximab|mesh-list
138623959|NCT06015750|Methotrexate|methotrexate|mesh-list
138623960|NCT06015750|Bortezomib|bortezomib|mesh-list
138623961|NCT06015750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138623962|NCT06015750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623963|NCT06015750|Immunologic Factors|immunologic factors|mesh-ancestor
138623964|NCT06015750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138623965|NCT06015750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138623966|NCT06015750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138623967|NCT06015750|Abortifacient Agents|abortifacient agents|mesh-ancestor
138662500|NCT06189521|Antiemetics|antiemetics|mesh-ancestor
138623968|NCT06015750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138623969|NCT06015750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138623971|NCT06015750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623972|NCT06015750|Dermatologic Agents|dermatologic agents|mesh-ancestor
138623973|NCT06015750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623974|NCT06015750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138623975|NCT06015750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138623976|NCT06015750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138623977|NCT06015750|Hematinics|hematinics|mesh-ancestor
138623978|NCT06015750|Vitamin B Complex|vitamin b complex|mesh-ancestor
138623979|NCT06015750|Vitamins|vitamins|mesh-ancestor
138623980|NCT06015750|Micronutrients|micronutrients|mesh-ancestor
138623981|NCT06015659|Gemcitabine|gemcitabine|mesh-list
138683359|NCT00509327|Bisacodyl|bisacodyl|mesh-list
138623982|NCT06015659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138623984|NCT06015659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623985|NCT06015659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623986|NCT06008093|Carboplatin|carboplatin|mesh-list
138183625|NCT05455918|Paclitaxel|paclitaxel|mesh-list
138623987|NCT06008093|Pembrolizumab|pembrolizumab|mesh-list
138623988|NCT06008093|Pemetrexed|pemetrexed|mesh-list
138623989|NCT06008093|Durvalumab|durvalumab|mesh-list
138623990|NCT06008093|Tremelimumab|tremelimumab|mesh-list
138623991|NCT06008093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138623992|NCT06008093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138623993|NCT06008093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138623994|NCT06008093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138623995|NCT06008093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138623996|NCT06008093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138623997|NCT06008093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138623998|NCT06007352|Gentamicins|gentamicins|mesh-list
138320042|NCT03583476|Amoxicillin|amoxicillin|mesh-list
138623999|NCT06007352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138624000|NCT06007352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138624001|NCT06007352|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138624002|NCT06007352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624003|NCT06007352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624004|NCT06004479|Carotenoids|carotenoids|mesh-list
138624005|NCT06004479|Antioxidants|antioxidants|mesh-ancestor
138624006|NCT06004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624007|NCT06004479|Protective Agents|protective agents|mesh-ancestor
138624008|NCT06004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624009|NCT05996185|Prednisone|prednisone|mesh-list
138624010|NCT05996185|Cyclophosphamide|cyclophosphamide|mesh-list
138624011|NCT05996185|Doxorubicin|doxorubicin|mesh-list
138624012|NCT05996185|Etoposide|etoposide|mesh-list
138624013|NCT05996185|Vincristine|vincristine|mesh-list
138624014|NCT05996185|Mogamulizumab|mogamulizumab|mesh-list
138624015|NCT05996185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138624016|NCT05996185|Immunologic Factors|immunologic factors|mesh-ancestor
138624017|NCT05996185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624019|NCT05996185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138624020|NCT05996185|Alkylating Agents|alkylating agents|mesh-ancestor
138624021|NCT05996185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624022|NCT05996185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624023|NCT05996185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138624024|NCT05996185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138624025|NCT05996185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138624026|NCT05996185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138624027|NCT05996185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624028|NCT05996185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138624029|NCT05996185|Glucocorticoids|glucocorticoids|mesh-ancestor
138624030|NCT05996185|Hormones|hormones|mesh-ancestor
138624031|NCT05996185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138662529|NCT06189144|Emollients|emollients|mesh-list
138624032|NCT05996185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138624033|NCT05996185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138624034|NCT05996185|Tubulin Modulators|tubulin modulators|mesh-ancestor
138624035|NCT05996185|Antimitotic Agents|antimitotic agents|mesh-ancestor
138624036|NCT05996185|Mitosis Modulators|mitosis modulators|mesh-ancestor
138624037|NCT05988671|Dexamethasone|dexamethasone|mesh-list
138624038|NCT05988671|Dexamethasone acetate|dexamethasone acetate|mesh-list
138624039|NCT05988671|Dexmedetomidine|dexmedetomidine|mesh-list
138624040|NCT05988671|BB 1101|bb 1101|mesh-list
138624041|NCT05988671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138624042|NCT05988671|Antiemetics|antiemetics|mesh-ancestor
138624043|NCT05988671|Autonomic Agents|autonomic agents|mesh-ancestor
138624044|NCT05988671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624045|NCT05988671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624046|NCT05988671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138624049|NCT05988671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624050|NCT05988671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138624051|NCT05988671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624052|NCT05988671|Protease Inhibitors|protease inhibitors|mesh-ancestor
138624053|NCT05988671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624054|NCT05988671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624055|NCT05988671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138183692|NCT00895817|Fluticasone|fluticasone|mesh-list
138183693|NCT00895817|Esomeprazole|esomeprazole|mesh-list
138624056|NCT05988671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138624057|NCT05988671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138624058|NCT05988671|Analgesics|analgesics|mesh-ancestor
138624059|NCT05988671|Sensory System Agents|sensory system agents|mesh-ancestor
138624060|NCT05988671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138624061|NCT05988671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138624062|NCT05988671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138624063|NCT05988671|Adrenergic Agents|adrenergic agents|mesh-ancestor
138624064|NCT05988671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138320069|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
138624066|NCT05950841|Antidiarrheals|antidiarrheals|mesh-ancestor
138624067|NCT05950841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138624068|NCT05941897|Durvalumab|durvalumab|mesh-list
138624069|NCT05941897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624070|NCT05941897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624071|NCT05922904|Doxorubicin|doxorubicin|mesh-list
138624072|NCT05922904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138624073|NCT05922904|Pembrolizumab|pembrolizumab|mesh-list
138624074|NCT05922904|Dacarbazine|dacarbazine|mesh-list
138624075|NCT05922904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138624076|NCT05922904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138624077|NCT05922904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624078|NCT05922904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138624079|NCT05922904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138624080|NCT05922904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624081|NCT05922904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624082|NCT05922904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624083|NCT05922904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624084|NCT05922904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138183741|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138183742|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138624085|NCT05922904|Alkylating Agents|alkylating agents|mesh-ancestor
138624086|NCT05922904|Immunotoxins|immunotoxins|mesh-ancestor
138624087|NCT05922904|Immunoconjugates|immunoconjugates|mesh-ancestor
138624088|NCT05922904|Immunologic Factors|immunologic factors|mesh-ancestor
138624089|NCT05922904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624090|NCT05887609|Olaparib|olaparib|mesh-list
138624091|NCT05887609|Maytansine|maytansine|mesh-list
138624092|NCT05887609|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
138624093|NCT05887609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138624094|NCT05887609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624095|NCT05887609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624096|NCT05887609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624097|NCT05887609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138624098|NCT05887609|Tubulin Modulators|tubulin modulators|mesh-ancestor
138624099|NCT05887609|Antimitotic Agents|antimitotic agents|mesh-ancestor
138624100|NCT05887609|Mitosis Modulators|mitosis modulators|mesh-ancestor
138624101|NCT05887609|Immunoconjugates|immunoconjugates|mesh-ancestor
138624102|NCT05887609|Immunologic Factors|immunologic factors|mesh-ancestor
138624103|NCT05887609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624104|NCT05867251|Carboplatin|carboplatin|mesh-list
138624105|NCT05867251|Letrozole|letrozole|mesh-list
138624106|NCT05867251|Fulvestrant|fulvestrant|mesh-list
138624107|NCT05867251|Palbociclib|palbociclib|mesh-list
138624108|NCT05867251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624109|NCT05867251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138624110|NCT05867251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138624111|NCT05867251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624112|NCT05867251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624113|NCT05867251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138624114|NCT05867251|Hormone Antagonists|hormone antagonists|mesh-ancestor
138624115|NCT05867251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624116|NCT05867251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624117|NCT05867251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138624118|NCT05867251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138624119|NCT05867251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138624120|NCT05837845|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138624121|NCT05837845|Hallucinogens|hallucinogens|mesh-ancestor
138624122|NCT05837845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624123|NCT05837845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138624124|NCT05837845|Serotonin Agents|serotonin agents|mesh-ancestor
138624125|NCT05837845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624126|NCT05837845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624127|NCT05837845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138624143|NCT05750992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138624144|NCT05750992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624145|NCT05750992|Sensory System Agents|sensory system agents|mesh-ancestor
138624146|NCT05750992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624147|NCT05750992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138624148|NCT05750992|Narcotics|narcotics|mesh-ancestor
138624149|NCT05750992|Analgesics|analgesics|mesh-ancestor
138624150|NCT05750992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138624151|NCT05750992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138624152|NCT05750992|Anesthetics, General|anesthetics, general|mesh-ancestor
138624153|NCT05739292|Vaccines|vaccines|mesh-list
138624154|NCT05739292|Immunologic Factors|immunologic factors|mesh-ancestor
138624155|NCT05739292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624156|NCT05711615|Doxorubicin|doxorubicin|mesh-list
138624157|NCT05711615|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138624158|NCT05711615|Peposertib|peposertib|mesh-list
138624159|NCT05711615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138624160|NCT05711615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624161|NCT05711615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138624162|NCT05711615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138624163|NCT05711615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624164|NCT05711615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624165|NCT05711615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138624166|NCT05698524|Temozolomide|temozolomide|mesh-list
138624167|NCT05698524|Abexinostat|abexinostat|mesh-list
138624168|NCT05698524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138624169|NCT05698524|Alkylating Agents|alkylating agents|mesh-ancestor
138624170|NCT05698524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624171|NCT05698524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624172|NCT05698524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138624173|NCT05698524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624175|NCT05685602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138624176|NCT05685602|Gemcitabine|gemcitabine|mesh-list
138624177|NCT05685602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138624178|NCT05685602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624179|NCT05685602|Tubulin Modulators|tubulin modulators|mesh-ancestor
138624180|NCT05685602|Antimitotic Agents|antimitotic agents|mesh-ancestor
138624181|NCT05685602|Mitosis Modulators|mitosis modulators|mesh-ancestor
138624182|NCT05685602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624183|NCT05685602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138624184|NCT05685602|Antimetabolites|antimetabolites|mesh-ancestor
138624185|NCT05679024|Apixaban|apixaban|mesh-list
138624186|NCT05679024|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138624187|NCT05679024|Antithrombins|antithrombins|mesh-ancestor
138624188|NCT05679024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138624189|NCT05679024|Protease Inhibitors|protease inhibitors|mesh-ancestor
138624190|NCT05679024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624191|NCT05679024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624192|NCT05679024|Anticoagulants|anticoagulants|mesh-ancestor
138624193|NCT05677282|Azithromycin|azithromycin|mesh-list
138624194|NCT05677282|Rifaximin|rifaximin|mesh-list
138624196|NCT05677282|Antidiarrheals|antidiarrheals|mesh-list
138624197|NCT05677282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138624198|NCT05677282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138624199|NCT05677282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138624200|NCT05654662|Listerine|listerine|mesh-list
138624201|NCT05654662|Chlorhexidine|chlorhexidine|mesh-list
138624202|NCT05654662|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138624203|NCT05654662|Sodium Fluoride|sodium fluoride|mesh-list
138624204|NCT05654662|Cariostatic Agents|cariostatic agents|mesh-ancestor
138624205|NCT05654662|Protective Agents|protective agents|mesh-ancestor
138624206|NCT05654662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624207|NCT05654662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138624208|NCT05654662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138624209|NCT05654662|Disinfectants|disinfectants|mesh-ancestor
138624210|NCT05654662|Dermatologic Agents|dermatologic agents|mesh-ancestor
138624211|NCT05625412|Docetaxel|docetaxel|mesh-list
138624212|NCT05625412|Capecitabine|capecitabine|mesh-list
138624213|NCT05625412|Nivolumab|nivolumab|mesh-list
138624214|NCT05625412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624215|NCT05625412|Tubulin Modulators|tubulin modulators|mesh-ancestor
138624216|NCT05625412|Antimitotic Agents|antimitotic agents|mesh-ancestor
138624217|NCT05625412|Mitosis Modulators|mitosis modulators|mesh-ancestor
138624218|NCT05625412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624219|NCT05625412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138624220|NCT05625412|Antimetabolites|antimetabolites|mesh-ancestor
138624221|NCT05625412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624222|NCT05625412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624223|NCT05602636|Midazolam|midazolam|mesh-list
138624224|NCT05602636|Bupivacaine|bupivacaine|mesh-list
138624225|NCT05602636|Anesthetics, Local|anesthetics, local|mesh-ancestor
138624226|NCT05602636|Anesthetics|anesthetics|mesh-ancestor
138183858|NCT00891995|Insulin|insulin|mesh-list
138624227|NCT05602636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138624228|NCT05602636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624229|NCT05602636|Sensory System Agents|sensory system agents|mesh-ancestor
138624234|NCT05602636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138624235|NCT05602636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138624236|NCT05602636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138624237|NCT05602636|Anesthetics, General|anesthetics, general|mesh-ancestor
138624238|NCT05602636|GABA Modulators|gaba modulators|mesh-ancestor
138624239|NCT05602636|GABA Agents|gaba agents|mesh-ancestor
138624240|NCT05602636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624241|NCT05602636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624247|NCT05557110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624258|NCT05536856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138624259|NCT05536856|Immunologic Factors|immunologic factors|mesh-ancestor
138624260|NCT05536856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624261|NCT05497453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138624262|NCT05497453|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138624263|NCT05497453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138624264|NCT05497453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624265|NCT05497453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624266|NCT05497453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624267|NCT05497453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624268|NCT05452772|Niacin|niacin|mesh-list
138624269|NCT05452772|Psilocybin|psilocybin|mesh-list
138624270|NCT05452772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138624271|NCT05452772|Antimetabolites|antimetabolites|mesh-ancestor
138624272|NCT05452772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624274|NCT05452772|Vasodilator Agents|vasodilator agents|mesh-ancestor
138624275|NCT05452772|Vitamin B Complex|vitamin b complex|mesh-ancestor
138624276|NCT05452772|Vitamins|vitamins|mesh-ancestor
138624277|NCT05452772|Micronutrients|micronutrients|mesh-ancestor
138624278|NCT05452772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624279|NCT05452772|Hallucinogens|hallucinogens|mesh-ancestor
138624280|NCT05452772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138624281|NCT05439772|Ondansetron|ondansetron|mesh-list
138624282|NCT05439772|Antiemetics|antiemetics|mesh-ancestor
138624283|NCT05439772|Autonomic Agents|autonomic agents|mesh-ancestor
138624284|NCT05439772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624285|NCT05439772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624286|NCT05439772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138624287|NCT05439772|Antipruritics|antipruritics|mesh-ancestor
138624288|NCT05439772|Dermatologic Agents|dermatologic agents|mesh-ancestor
138624289|NCT05439772|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138624290|NCT05439772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138624291|NCT05439772|Serotonin Agents|serotonin agents|mesh-ancestor
138624292|NCT05439772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624293|NCT05439772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624294|NCT05402111|Olanzapine|olanzapine|mesh-list
138624295|NCT05402111|Risperidone|risperidone|mesh-list
138662587|NCT06188637|Ozanimod|ozanimod|mesh-list
138624300|NCT05402111|Serotonin Agents|serotonin agents|mesh-ancestor
138624301|NCT05402111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624302|NCT05402111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624303|NCT05402111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624304|NCT05402111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138624305|NCT05402111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138624306|NCT05402111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138624307|NCT05402111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138624308|NCT05402111|Dopamine Agents|dopamine agents|mesh-ancestor
138624309|NCT05402111|Antiemetics|antiemetics|mesh-ancestor
138624310|NCT05402111|Autonomic Agents|autonomic agents|mesh-ancestor
138624311|NCT05402111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624312|NCT05402111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138624313|NCT05402111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138320117|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624314|NCT05402111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138624315|NCT05402111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138624316|NCT05402111|Antidepressive Agents|antidepressive agents|mesh-ancestor
138624317|NCT05402111|Dopamine Agonists|dopamine agonists|mesh-ancestor
138624318|NCT05402111|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138624319|NCT05402111|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138183928|NCT03400267|Acetaminophen|acetaminophen|mesh-list
138183929|NCT03400267|Fentanyl|fentanyl|mesh-list
138624320|NCT05402111|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138624321|NCT05402111|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138624322|NCT05362292|Mirabegron|mirabegron|mesh-list
138624323|NCT05362292|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138624324|NCT05362292|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138624325|NCT05362292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138624326|NCT05362292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138624327|NCT05362292|Adrenergic Agents|adrenergic agents|mesh-ancestor
138624328|NCT05362292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624329|NCT05362292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624330|NCT05362292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624331|NCT05362292|Urological Agents|urological agents|mesh-ancestor
138624332|NCT05362292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138624333|NCT05362292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138624334|NCT05362292|Cholinergic Agents|cholinergic agents|mesh-ancestor
138624336|NCT05351554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138624337|NCT05351554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138624338|NCT05351554|Glucocorticoids|glucocorticoids|mesh-ancestor
138624339|NCT05351554|Hormones|hormones|mesh-ancestor
138624340|NCT05351554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624342|NCT05351554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138624343|NCT05351554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624344|NCT05351554|Immunologic Factors|immunologic factors|mesh-ancestor
138508084|NCT06196554|Fluorouracil|fluorouracil|mesh-list
138624392|NCT05221645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624393|NCT05221645|Immunologic Factors|immunologic factors|mesh-ancestor
138624394|NCT05221645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624396|NCT05221645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624397|NCT05221645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624398|NCT05221645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138624399|NCT05221645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138624400|NCT05221645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138624401|NCT05221645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624402|NCT05221645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138624403|NCT05221645|Alkylating Agents|alkylating agents|mesh-ancestor
138624404|NCT05174312|Diuretics|diuretics|mesh-list
138624405|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
138624406|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624407|NCT05170724|Remibrutinib|remibrutinib|mesh-list
138624408|NCT05170724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138624409|NCT05170724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624410|NCT05170724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624411|NCT05149131|Leuprolide|leuprolide|mesh-list
138624412|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138624414|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138624415|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624416|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138624417|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624419|NCT05136846|Carboplatin|carboplatin|mesh-list
138624420|NCT05136846|Pemetrexed|pemetrexed|mesh-list
138624421|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138624422|NCT05136846|Durvalumab|durvalumab|mesh-list
138624424|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
138624425|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138624426|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
138624427|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138624428|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624429|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
138624430|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
138624431|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
138624432|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624433|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624434|NCT05136846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138624435|NCT05136846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138683514|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
138624436|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624438|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624439|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138624440|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
138624441|NCT05136846|Urological Agents|urological agents|mesh-ancestor
138624442|NCT05130463|Empagliflozin|empagliflozin|mesh-list
138624443|NCT05130463|Linagliptin|linagliptin|mesh-list
138624444|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138624445|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624446|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138624447|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624448|NCT05130463|Incretins|incretins|mesh-ancestor
138624449|NCT05130463|Hormones|hormones|mesh-ancestor
138624450|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624451|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138624452|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
138624453|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624454|NCT05129358|Furosemide|furosemide|mesh-list
138624455|NCT05129358|Diuretics|diuretics|mesh-ancestor
138184010|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
138624456|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
138624457|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624458|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138624459|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138624460|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624461|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
138624462|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138624463|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138624464|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624465|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
138624466|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624467|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624469|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
138624470|NCT05096169|Clomiphene|clomiphene|mesh-list
138624471|NCT05096169|Enclomiphene|enclomiphene|mesh-list
138624472|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
138624473|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
138624474|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138624475|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
138624476|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
138624477|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624478|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138624479|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
138624480|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624481|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624482|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138624483|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
138624484|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138508085|NCT06196554|Oxaliplatin|oxaliplatin|mesh-list
138624485|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138184034|NCT00013897|Efavirenz|efavirenz|mesh-list
138462782|NCT05411757|Bevacizumab|bevacizumab|mesh-list
138624486|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138624490|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
138624491|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
138624492|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138624493|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624494|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
138624495|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624496|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138624497|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138624498|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138624499|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138624500|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624501|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
138624502|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624503|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624504|NCT05071014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624505|NCT05071014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624506|NCT05067634|Cenobamate|cenobamate|mesh-list
138624507|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
138624508|NCT05063565|Durvalumab|durvalumab|mesh-list
138624509|NCT05063565|Tremelimumab|tremelimumab|mesh-list
138624510|NCT05063565|Immunomodulating Agents|immunomodulating agents|mesh-list
138624511|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
138624512|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624513|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624514|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624515|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
138624516|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138624517|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
138624518|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624519|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
138624520|NCT05061017|Nivolumab|nivolumab|mesh-list
138624521|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138624522|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
138624523|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624524|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138624525|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138624526|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
138624527|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624528|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624529|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138624530|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624531|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624532|NCT05023369|Dexamethasone|dexamethasone|mesh-list
138624533|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138624534|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
138683556|NCT02953184|Vitamins|vitamins|mesh-list
138624535|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
138624536|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624537|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624538|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138624539|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
138624540|NCT05023369|Hormones|hormones|mesh-ancestor
138301082|NCT00003679|Tamoxifen|tamoxifen|mesh-list
138624541|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624542|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138624543|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624545|NCT05001776|Fondaparinux|fondaparinux|mesh-list
138662639|NCT06188208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624546|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138624547|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
138624548|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138624549|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
138624550|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624551|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624553|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138624554|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138624555|NCT04981678|Buprenorphine|buprenorphine|mesh-list
138624556|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138624557|NCT04981678|Narcotics|narcotics|mesh-ancestor
138624558|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138624559|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624560|NCT04981678|Analgesics|analgesics|mesh-ancestor
138624561|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
138624562|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624563|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138624564|NCT04970901|Obinutuzumab|obinutuzumab|mesh-list
138624565|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
138624566|NCT04970901|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138624567|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624568|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624569|NCT04970901|Immunoconjugates|immunoconjugates|mesh-ancestor
138624570|NCT04970901|Immunologic Factors|immunologic factors|mesh-ancestor
138624571|NCT04970901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624572|NCT04962126|Atezolizumab|atezolizumab|mesh-list
138624573|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
138624574|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138624575|NCT04962126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624576|NCT04962126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624577|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624578|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624579|NCT04940013|Misoprostol|misoprostol|mesh-list
138624580|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138624581|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
138624582|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138624583|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624584|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138624585|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138624586|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
138624587|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
138624588|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138624589|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138624590|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184160|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138184162|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624591|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138624592|NCT04916197|Analgesics|analgesics|mesh-ancestor
138624593|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
138624594|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624595|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138624596|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138624597|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138624598|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
138624599|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624600|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624601|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
138624602|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138624603|NCT04910269|Antibodies|antibodies|mesh-list
138624604|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
138624605|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624606|NCT04857034|Deucravacitinib|deucravacitinib|mesh-list
138624607|NCT04857034|Dermatologic Agents|dermatologic agents|mesh-ancestor
138624608|NCT04857034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138624609|NCT04857034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624610|NCT04857034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624611|NCT04848584|Vaccines|vaccines|mesh-list
138624612|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
138624613|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624620|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624622|NCT04681105|Acetaminophen|acetaminophen|mesh-list
138624623|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
138624624|NCT04681105|Promethazine|promethazine|mesh-list
138624625|NCT04681105|Dexamethasone|dexamethasone|mesh-list
138662655|NCT06188143|Ibuprofen|ibuprofen|mesh-list
138624626|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
138624628|NCT04681105|Ranitidine|ranitidine|mesh-list
138624629|NCT04681105|Antibodies|antibodies|mesh-list
138624630|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
138624631|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138624632|NCT04681105|BB 1101|bb 1101|mesh-list
138624633|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
138624634|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624635|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138624636|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
138624637|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
138624638|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624639|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138624640|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
138624641|NCT04681105|Hormones|hormones|mesh-ancestor
138624642|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624643|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138624644|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624645|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
138624646|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624647|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624648|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138624649|NCT04681105|Analgesics|analgesics|mesh-ancestor
138624650|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
138624651|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
138624652|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138624653|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138624654|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138624655|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138624656|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138624657|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138624658|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
138624659|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
138624660|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138624661|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
138624662|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
138624663|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624664|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138624665|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
138624666|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
138624667|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138624668|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138624669|NCT04614974|Famotidine|famotidine|mesh-list
138624670|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138624671|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138624672|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138184233|NCT03213041|Carboplatin|carboplatin|mesh-list
138624673|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
138624674|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
138662656|NCT06188143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138624675|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624676|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320209|NCT01673724|Pramipexole|pramipexole|mesh-list
138624677|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624679|NCT04609020|Anesthetics, Local|anesthetics, local|mesh-ancestor
138624680|NCT04609020|Anesthetics|anesthetics|mesh-ancestor
138624681|NCT04609020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138624682|NCT04609020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624683|NCT04609020|Sensory System Agents|sensory system agents|mesh-ancestor
138624684|NCT04609020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624685|NCT04609020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138624686|NCT04609020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138624687|NCT04609020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138624688|NCT04609020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138624689|NCT04609020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624690|NCT04520607|Lorecivivint|lorecivivint|mesh-list
138624692|NCT04517435|Prednisone|prednisone|mesh-list
138624693|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
138624694|NCT04517435|Rituximab|rituximab|mesh-list
138624695|NCT04517435|Doxorubicin|doxorubicin|mesh-list
138624696|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138624697|NCT04517435|Vincristine|vincristine|mesh-list
138624698|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138624699|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
138624700|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624701|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138624702|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138624703|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
138624704|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624705|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624706|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138624707|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624708|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138624709|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138624710|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138624711|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624712|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138624713|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
138624714|NCT04517435|Hormones|hormones|mesh-ancestor
138624715|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624716|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138624717|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138624718|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
138184273|NCT01833767|Analgesics|analgesics|mesh-ancestor
138624719|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
138624720|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
138624721|NCT04411758|Propolis|propolis|mesh-list
138624722|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138624723|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138624724|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138624725|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
138320218|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
138624727|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624728|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624729|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624730|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624732|NCT04392011|Midazolam|midazolam|mesh-list
138624733|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
138624734|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138624735|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138624736|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138624737|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624738|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138624739|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138624740|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138624741|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138624742|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
138624743|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
138624744|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
138624745|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
138624746|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624747|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624748|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
138624749|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
138624750|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138624751|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138624752|NCT04334070|Clofazimine|clofazimine|mesh-list
138624753|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138624754|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
138624755|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138624756|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138624757|NCT04329429|Trastuzumab|trastuzumab|mesh-list
138624758|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624759|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624760|NCT04324294|Pancrelipase|pancrelipase|mesh-list
138624761|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138624762|NCT04323046|Nivolumab|nivolumab|mesh-list
138624763|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138184302|NCT03213353|Expectorants|expectorants|mesh-ancestor
138624764|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624765|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624766|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624768|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138624769|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624770|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138624771|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138624772|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138624773|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624774|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
138624775|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624777|NCT04151667|Lenalidomide|lenalidomide|mesh-list
138624778|NCT04151667|Bortezomib|bortezomib|mesh-list
138624779|NCT04151667|Daratumumab|daratumumab|mesh-list
138624780|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138624781|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
138624782|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
138624783|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624784|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624785|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138624786|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
138624787|NCT04151667|Hormones|hormones|mesh-ancestor
138624788|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624789|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138624790|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624791|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
138624792|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138624793|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138624794|NCT04151667|Growth Substances|growth substances|mesh-ancestor
138624795|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
138624796|NCT04148911|Paclitaxel|paclitaxel|mesh-list
138624797|NCT04148911|Atezolizumab|atezolizumab|mesh-list
138624798|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138624799|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624800|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
138624801|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
138624802|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
138624803|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624804|NCT04148911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624805|NCT04148911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624806|NCT04144933|Acetaminophen|acetaminophen|mesh-list
138184338|NCT03217409|Ezetimibe|ezetimibe|mesh-list
138624807|NCT04144933|Dexamethasone|dexamethasone|mesh-list
138624808|NCT04144933|Lidocaine|lidocaine|mesh-list
138624809|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
138624810|NCT04144933|Sufentanil|sufentanil|mesh-list
138624811|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
138624812|NCT04144933|Ketamine|ketamine|mesh-list
138624813|NCT04144933|Gabapentin|gabapentin|mesh-list
138624814|NCT04144933|Dsuvia|dsuvia|mesh-list
138624815|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
138624816|NCT04144933|Ondansetron|ondansetron|mesh-list
138624817|NCT04144933|Sevoflurane|sevoflurane|mesh-list
138624818|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138624819|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138624820|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
138624821|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
138624822|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624823|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624824|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138624825|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
138624826|NCT04144933|Hormones|hormones|mesh-ancestor
138624827|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624828|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138624829|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624830|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
138624831|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
138624832|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138683651|NCT00510263|Hormones|hormones|mesh-ancestor
138624833|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
138508086|NCT06196554|Nivolumab|nivolumab|mesh-list
138624834|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138624835|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138624836|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138624837|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138624838|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624839|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138624840|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138624841|NCT04144933|Analgesics|analgesics|mesh-ancestor
138624842|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138624843|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138624845|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
138624846|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624847|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138624848|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138624849|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
138624850|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138624851|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138624852|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
138624853|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138624854|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138624855|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
138624856|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138624857|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138624858|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138624859|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
138624860|NCT04144933|Narcotics|narcotics|mesh-ancestor
138624861|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
138624862|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
138624863|NCT04144933|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138624864|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138624865|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
138624866|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138624867|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138624869|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138624870|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138624871|NCT04092673|Trastuzumab|trastuzumab|mesh-list
138624872|NCT04092673|Sotorasib|sotorasib|mesh-list
138624873|NCT04092673|Fulvestrant|fulvestrant|mesh-list
138624874|NCT04092673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624875|NCT04092673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624876|NCT04092673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138624877|NCT04092673|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138624878|NCT04092673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138624879|NCT04092673|Hormone Antagonists|hormone antagonists|mesh-ancestor
138624880|NCT04092673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624881|NCT04092673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624882|NCT04092673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624883|NCT04092673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624884|NCT04090398|Paclitaxel|paclitaxel|mesh-list
138624885|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138508087|NCT06196554|Irinotecan|irinotecan|mesh-list
138662755|NCT06187441|Daratumumab|daratumumab|mesh-list
138662756|NCT06187441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138662757|NCT06187441|Antiemetics|antiemetics|mesh-ancestor
138662758|NCT06187441|Autonomic Agents|autonomic agents|mesh-ancestor
138662759|NCT06187441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662760|NCT06187441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138662761|NCT06187441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138662762|NCT06187441|Glucocorticoids|glucocorticoids|mesh-ancestor
138184401|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138624886|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138624887|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138624888|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624889|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
138624890|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
138624891|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
138624892|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624893|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
138624894|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624895|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624896|NCT04082572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624897|NCT04082572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624898|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
138624899|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
138624900|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624901|NCT04008797|Lenvatinib|lenvatinib|mesh-list
138624902|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624903|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138624904|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624905|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624906|NCT03994601|Nivolumab|nivolumab|mesh-list
138624907|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624908|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624909|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624910|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624911|NCT03978598|Etonogestrel|etonogestrel|mesh-list
138624912|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138624913|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
138624914|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138624915|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624916|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138624918|NCT03951649|Caffeine|caffeine|mesh-list
138624919|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138624920|NCT03951649|Analgesics|analgesics|mesh-ancestor
138624921|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
138624922|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624923|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624924|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
138624925|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138624926|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138624927|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624928|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624929|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138624930|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138624931|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
138624932|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624933|NCT03949855|Rituximab|rituximab|mesh-list
138624934|NCT03949855|Belimumab|belimumab|mesh-list
138624935|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624936|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624937|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
138624938|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624939|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138662784|NCT06187090|Palmidrol|palmidrol|mesh-list
138662785|NCT06187090|Analgesics|analgesics|mesh-ancestor
138662786|NCT06187090|Sensory System Agents|sensory system agents|mesh-ancestor
138662787|NCT06187090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138662790|NCT06187090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138624940|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138624941|NCT03920267|Deucravacitinib|deucravacitinib|mesh-list
138624942|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
138624943|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138624944|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138683677|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
138624945|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624946|NCT03918915|Atropine|atropine|mesh-list
138624947|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138624948|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138624949|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138624950|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
138624951|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138624952|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624953|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138624954|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
138624955|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
138624956|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
138624957|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138624958|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138624959|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
138624960|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624961|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624962|NCT03913455|Carboplatin|carboplatin|mesh-list
138624963|NCT03913455|Guadecitabine|guadecitabine|mesh-list
138624964|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624965|NCT03894891|Docetaxel|docetaxel|mesh-list
138624966|NCT03894891|Nivolumab|nivolumab|mesh-list
138624967|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624968|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
138624969|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
138624970|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
138624971|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624972|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624973|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624974|NCT03883412|Liraglutide|liraglutide|mesh-list
138624975|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138624976|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624977|NCT03883412|Incretins|incretins|mesh-ancestor
138624978|NCT03883412|Hormones|hormones|mesh-ancestor
138624979|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138624980|NCT03840837|Rivastigmine|rivastigmine|mesh-list
138624981|NCT03840837|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138624982|NCT03840837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138624983|NCT03840837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624984|NCT03840837|Cholinergic Agents|cholinergic agents|mesh-ancestor
138624985|NCT03840837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138624986|NCT03840837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138624987|NCT03840837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138624988|NCT03840837|Protective Agents|protective agents|mesh-ancestor
138624989|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
138624990|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624991|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138624992|NCT03834493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138624993|NCT03834493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138624994|NCT03833154|Durvalumab|durvalumab|mesh-list
138624995|NCT03833154|Osimertinib|osimertinib|mesh-list
138683693|NCT00529620|Artenimol|artenimol|mesh-list
138624996|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138624998|NCT03833154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138624999|NCT03833154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625000|NCT03833154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625001|NCT03770416|Nivolumab|nivolumab|mesh-list
138625002|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138625003|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625004|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138625005|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625006|NCT03631043|Lenalidomide|lenalidomide|mesh-list
138625007|NCT03631043|Vaccines|vaccines|mesh-list
138625008|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
138625009|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625010|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138625011|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138625012|NCT03631043|Growth Substances|growth substances|mesh-ancestor
138625013|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
138625014|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625016|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138625017|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138625018|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138625019|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
138625020|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625021|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625022|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625023|NCT03609580|Urological Agents|urological agents|mesh-ancestor
138625024|NCT03583710|Cisplatin|cisplatin|mesh-list
138625025|NCT03583710|Etoposide|etoposide|mesh-list
138625026|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
138625027|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
138625028|NCT03583710|Mitotane|mitotane|mesh-list
138625029|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625030|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138625031|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138625032|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138625033|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625034|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625035|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
138625036|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
138625037|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
138625038|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
138625039|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
138625040|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138625041|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
138625042|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138625043|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138625044|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625045|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138625046|NCT03564093|Analgesics|analgesics|mesh-ancestor
138625047|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
138625048|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625049|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138625050|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138625051|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138625052|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
138625053|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625054|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625055|NCT03482479|Naltrexone|naltrexone|mesh-list
138625056|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138625057|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138625058|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320272|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
138625072|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625073|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
138625074|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625075|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625076|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138625077|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
138625078|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625079|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625080|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138625081|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138625082|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138625083|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138625084|NCT03449108|Analgesics|analgesics|mesh-ancestor
138625085|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
138625086|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625087|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138625088|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138625089|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
138625090|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138625091|NCT03412747|Adalimumab|adalimumab|mesh-list
138625092|NCT03412747|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138625093|NCT03412747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138625094|NCT03412747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625095|NCT03342404|Luspatercept|luspatercept|mesh-list
138625096|NCT03342404|Hematinics|hematinics|mesh-ancestor
138625097|NCT03277196|Ivacaftor|ivacaftor|mesh-list
138625098|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138625099|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138625100|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625101|NCT03272698|Ketamine|ketamine|mesh-list
138625102|NCT03272698|Analgesics|analgesics|mesh-ancestor
138625103|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
138625104|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625105|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625106|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138625107|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138625108|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
138625109|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
138625110|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138625111|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138625112|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138625113|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625114|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625115|NCT03213457|Norethindrone|norethindrone|mesh-list
138625116|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
138625117|NCT03213457|Estradiol|estradiol|mesh-list
138625118|NCT03213457|Estrogens|estrogens|mesh-ancestor
138625119|NCT03213457|Hormones|hormones|mesh-ancestor
138625120|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138625121|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320288|NCT05353062|Autonomic Agents|autonomic agents|mesh-ancestor
138625122|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138625123|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
138625124|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138625125|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138625126|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138625127|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138625128|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138625130|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
138625131|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
138625132|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138625133|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138625134|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138625135|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138625136|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625137|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
138625138|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
138625139|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625140|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625141|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138625142|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138625143|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
138625144|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138625145|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138625146|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138625147|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138625148|NCT03165994|Paclitaxel|paclitaxel|mesh-list
138625149|NCT03165994|Carboplatin|carboplatin|mesh-list
138662808|NCT06186921|Dexamethasone|dexamethasone|mesh-list
138625150|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138625151|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625152|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
138625153|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
138625154|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
138625155|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625156|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
138625157|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138625158|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138625159|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625160|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138625161|NCT03069638|Analgesics|analgesics|mesh-ancestor
138625162|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
138625163|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625164|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138625165|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138625166|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138625167|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
138625168|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625169|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625170|NCT03036098|Carboplatin|carboplatin|mesh-list
138625171|NCT03036098|Gemcitabine|gemcitabine|mesh-list
138625172|NCT03036098|Nivolumab|nivolumab|mesh-list
138625173|NCT03036098|Ipilimumab|ipilimumab|mesh-list
138625174|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625175|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138625176|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
138625177|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625178|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138625179|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138625180|NCT02938442|Paclitaxel|paclitaxel|mesh-list
138625181|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138625182|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
138625183|NCT02938442|Doxorubicin|doxorubicin|mesh-list
138625184|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138625185|NCT02938442|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138625186|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
138625187|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138625188|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625189|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
138625190|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
138625191|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
138625192|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625193|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625194|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
138625195|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625196|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625197|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138625198|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
138625199|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138625200|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138625201|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138625202|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138625203|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625204|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138625205|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
138625206|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
138625207|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625208|NCT02910531|Protective Agents|protective agents|mesh-ancestor
138625209|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625210|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
138625211|NCT02910531|Vitamins|vitamins|mesh-ancestor
138625212|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
138625213|NCT02883062|Paclitaxel|paclitaxel|mesh-list
138625214|NCT02883062|Carboplatin|carboplatin|mesh-list
138625215|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138625217|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138625218|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138625219|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625220|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
138625221|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
138625222|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
138625223|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683780|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
138625224|NCT02883062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138625225|NCT02883062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138625226|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
138625227|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625228|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
138625229|NCT02875314|Thiotepa|thiotepa|mesh-list
138625230|NCT02875314|Cisplatin|cisplatin|mesh-list
138625231|NCT02875314|Carboplatin|carboplatin|mesh-list
138625232|NCT02875314|Methotrexate|methotrexate|mesh-list
138625233|NCT02875314|Etoposide|etoposide|mesh-list
138625234|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
138625235|NCT02875314|Vincristine|vincristine|mesh-list
138625236|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625237|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
138625238|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625239|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625240|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138625241|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
138625242|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625243|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625244|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138625245|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138625246|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
138372123|NCT01416337|Trametinib|trametinib|mesh-list
138625247|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138662846|NCT06186895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625248|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138625249|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
138625250|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
138625251|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625252|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138625253|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138625254|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138625255|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138625256|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138625257|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
138625258|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
138625259|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
138625260|NCT02808650|Prexasertib|prexasertib|mesh-list
138625261|NCT02808650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138625262|NCT02808650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625263|NCT02808650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625264|NCT02797548|Aspirin|aspirin|mesh-list
138625265|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138625266|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138625267|NCT02797548|Analgesics|analgesics|mesh-ancestor
138625268|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
138625269|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625270|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625271|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138625272|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625273|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138625274|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138625275|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625276|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138625277|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138625278|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625279|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
138625280|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
138625281|NCT02727803|Melphalan|melphalan|mesh-list
138625282|NCT02727803|Busulfan|busulfan|mesh-list
138625283|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
138625284|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138625285|NCT02727803|Rituximab|rituximab|mesh-list
138625287|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
138188440|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138625288|NCT02727803|Clofarabine|clofarabine|mesh-list
138625289|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138625290|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138625292|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
138625293|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138625294|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625295|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
138625296|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625297|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625298|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138625299|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
138625300|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625301|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625302|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138625303|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138625304|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
138625305|NCT02630693|Tamoxifen|tamoxifen|mesh-list
138625306|NCT02630693|Fulvestrant|fulvestrant|mesh-list
138625307|NCT02630693|Palbociclib|palbociclib|mesh-list
138625308|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138625309|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138625310|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
138625311|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138625312|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625313|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138625314|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625315|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138625316|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138625317|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138625318|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138625319|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138625320|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625321|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625322|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138625323|NCT02626338|Cytarabine|cytarabine|mesh-list
138625324|NCT02626338|Fludarabine|fludarabine|mesh-list
138625325|NCT02626338|Fludarabine phosphate|fludarabine phosphate|mesh-list
138625326|NCT02626338|Etoposide|etoposide|mesh-list
138625327|NCT02626338|Etoposide phosphate|etoposide phosphate|mesh-list
138625328|NCT02626338|Mitoxantrone|mitoxantrone|mesh-list
138625329|NCT02626338|Idarubicin|idarubicin|mesh-list
138625330|NCT02626338|Crenolanib|crenolanib|mesh-list
138625331|NCT02626338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625332|NCT02626338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138625333|NCT02626338|Antimetabolites|antimetabolites|mesh-ancestor
138625334|NCT02626338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625335|NCT02626338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625336|NCT02626338|Immunologic Factors|immunologic factors|mesh-ancestor
138625337|NCT02626338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625338|NCT02626338|Antiviral Agents|antiviral agents|mesh-ancestor
138625339|NCT02626338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138625340|NCT02626338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138625341|NCT02626338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138625342|NCT02626338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138625343|NCT02626338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625345|NCT02626338|Sensory System Agents|sensory system agents|mesh-ancestor
138184836|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
138625346|NCT02626338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625347|NCT02626338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138625348|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
138625349|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
138625350|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138625351|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138625352|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138625353|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625354|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625355|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625356|NCT02484859|Metoprolol|metoprolol|mesh-list
138625357|NCT02484859|Remifentanil|remifentanil|mesh-list
138625358|NCT02484859|Tramadol|tramadol|mesh-list
138625359|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138625360|NCT02484859|Narcotics|narcotics|mesh-ancestor
138625361|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138625362|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625363|NCT02484859|Analgesics|analgesics|mesh-ancestor
138625364|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
138625365|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625366|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138625367|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138625368|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
138662886|NCT06186596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138625369|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
138625370|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138625371|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138625372|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138625373|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
138625374|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625375|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625378|NCT02452918|Anticoagulants|anticoagulants|mesh-ancestor
138625379|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138625380|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138625381|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
138625383|NCT02379520|Fludarabine|fludarabine|mesh-list
138625384|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625385|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
138625386|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625387|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625388|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138625389|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
138625390|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625391|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625392|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138625393|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138625394|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138625395|NCT02332902|Everolimus|everolimus|mesh-list
138625396|NCT02332902|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138625397|NCT02332902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138625398|NCT02332902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625399|NCT02332902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625400|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625401|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
138625402|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625403|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625404|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138625405|NCT02324608|Cetuximab|cetuximab|mesh-list
138625406|NCT02324608|Antibodies|antibodies|mesh-list
138625407|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
138625408|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138625409|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
138625410|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625411|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625412|NCT02305654|Paclitaxel|paclitaxel|mesh-list
138625413|NCT02305654|Ifosfamide|ifosfamide|mesh-list
138625414|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138625415|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625416|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
138625417|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
138625418|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
138625419|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625420|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138625421|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
138625422|NCT02229084|Paclitaxel|paclitaxel|mesh-list
138625423|NCT02229084|Docetaxel|docetaxel|mesh-list
138625424|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
138625425|NCT02229084|Doxorubicin|doxorubicin|mesh-list
138625426|NCT02229084|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138625427|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
138625428|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138625429|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625430|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
138625431|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
138625432|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
138683869|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
138625433|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320356|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138625434|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625435|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
138625436|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625437|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625438|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138625439|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
138625440|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138625441|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138625442|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138625443|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138625444|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625445|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138625447|NCT02213497|Carboplatin|carboplatin|mesh-list
138625448|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138625449|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138625450|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625451|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
138625452|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
138625453|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
138625454|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625455|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138625456|NCT01792583|Modafinil|modafinil|mesh-list
138625457|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138625458|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625459|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138625460|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138625461|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138625462|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625463|NCT01750073|Paclitaxel|paclitaxel|mesh-list
138625464|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
138625465|NCT01750073|Doxorubicin|doxorubicin|mesh-list
138625466|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138625467|NCT01750073|Trastuzumab|trastuzumab|mesh-list
138625468|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138625469|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138625470|NCT01750073|Antibodies|antibodies|mesh-list
138625471|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
138625472|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138625473|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138625474|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625475|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
138625476|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
138625477|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
138625478|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372619|NCT01419366|Donepezil|donepezil|mesh-list
138625480|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
138625481|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625482|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625483|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138625484|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
138625485|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138625486|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138625487|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138625488|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138625489|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625490|NCT01723774|Anastrozole|anastrozole|mesh-list
138625491|NCT01723774|Goserelin|goserelin|mesh-list
138625492|NCT01723774|Palbociclib|palbociclib|mesh-list
138625493|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138625494|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625495|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138625496|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138625497|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625498|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625499|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138625500|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
138625501|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138625502|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625503|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138625504|NCT01674140|Tamoxifen|tamoxifen|mesh-list
138625505|NCT01674140|Everolimus|everolimus|mesh-list
138625506|NCT01674140|Letrozole|letrozole|mesh-list
138625507|NCT01674140|Anastrozole|anastrozole|mesh-list
138625508|NCT01674140|Leuprolide|leuprolide|mesh-list
138625509|NCT01674140|Exemestane|exemestane|mesh-list
138625510|NCT01674140|Goserelin|goserelin|mesh-list
138625511|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625512|NCT01674140|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138625513|NCT01674140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138625514|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625515|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625516|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
138625517|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625518|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625519|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138625520|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138625521|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138625522|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
138625523|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138625524|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138625525|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138625526|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138625527|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138625528|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138625529|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
138625530|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138625531|NCT01356628|Palbociclib|palbociclib|mesh-list
138625532|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625533|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138625534|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625535|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625537|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138625538|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138625539|NCT01294072|Analgesics|analgesics|mesh-ancestor
138625540|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
138625541|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625542|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625543|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138625544|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625545|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625546|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625547|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625548|NCT01087554|Sirolimus|sirolimus|mesh-list
138625549|NCT01087554|Everolimus|everolimus|mesh-list
138625550|NCT01087554|MTOR Inhibitors|mtor inhibitors|mesh-list
138625551|NCT01087554|Temsirolimus|temsirolimus|mesh-list
138625552|NCT01087554|Vorinostat|vorinostat|mesh-list
138625553|NCT01087554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138625554|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625555|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372720|NCT01420302|Insulin|insulin|mesh-list
138625556|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625557|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
138625558|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625559|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625560|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138625561|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138625562|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138625563|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
138625564|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138625566|NCT01012817|Veliparib|veliparib|mesh-list
138625567|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138625568|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138625569|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625570|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625571|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625572|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138625573|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138625574|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
138625575|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138625576|NCT00439049|Naltrexone|naltrexone|mesh-list
138625577|NCT00439049|Modafinil|modafinil|mesh-list
138625578|NCT00439049|Amphetamine|amphetamine|mesh-list
138625579|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
138625580|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138625581|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138625582|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625583|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
138625584|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625585|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138625586|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138625587|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138625588|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138625589|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625590|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
138625591|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
138625592|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
138625593|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625594|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
138625595|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138625596|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138625597|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138625598|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138625599|NCT00254423|Dasatinib|dasatinib|mesh-list
138625600|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625601|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138625602|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185087|NCT01721915|Vitamin D|vitamin d|mesh-list
138625603|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625604|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
138625605|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138625606|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
138625607|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138625608|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
138625609|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625610|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625611|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
138625612|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138625613|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
138625614|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138625615|NCT04615702|Acetaminophen|acetaminophen|mesh-list
138625616|NCT04615702|Metronidazole|metronidazole|mesh-list
138625617|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
138625618|NCT04615702|Imipenem|imipenem|mesh-list
138625619|NCT04615702|Diclofenac|diclofenac|mesh-list
138625620|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138625621|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
138625622|NCT04615702|Secretin|secretin|mesh-list
138662942|NCT06182267|Listerine|listerine|mesh-list
138625623|NCT04615702|Bilirubin|bilirubin|mesh-list
138320396|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
138625624|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625625|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138625626|NCT04615702|Analgesics|analgesics|mesh-ancestor
138625627|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
138625628|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625629|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
138625630|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138625631|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138625632|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138625633|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138625634|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138625635|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625636|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138625637|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625638|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625639|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138625640|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138625641|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625642|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138625643|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138625644|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138625645|NCT04615702|Narcotics|narcotics|mesh-ancestor
138625646|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138625647|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138625649|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138625650|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
138625651|NCT04615702|Protective Agents|protective agents|mesh-ancestor
138625652|NCT04615351|Metformin|metformin|mesh-list
138625653|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138625654|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625655|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
138625656|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138625657|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
138625658|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625659|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
138625660|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138625661|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138625662|NCT04614727|Calcium|calcium|mesh-list
138625663|NCT04614727|Fluorides|fluorides|mesh-list
138625664|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138625665|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625666|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
138625667|NCT04614727|Protective Agents|protective agents|mesh-ancestor
138625668|NCT04614298|Brodalumab|brodalumab|mesh-list
138625669|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
138625670|NCT04614259|Bupivacaine|bupivacaine|mesh-list
138625671|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
138625672|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
138625673|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138625674|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625675|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
138662959|NCT06179030|Hormones|hormones|mesh-ancestor
138625676|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625677|NCT00412763|Silymarin|silymarin|mesh-list
138625678|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
138683999|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
138185184|NCT01722539|Piperaquine|piperaquine|mesh-list
138625679|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625680|NCT00412763|Protective Agents|protective agents|mesh-ancestor
138625681|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625682|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
138625684|NCT00563485|Doxazosin|doxazosin|mesh-list
138625685|NCT00563485|Terazosin|terazosin|mesh-list
138625686|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138625687|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138625688|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138625689|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138625690|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
138625691|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625692|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625693|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625694|NCT00563485|Urological Agents|urological agents|mesh-ancestor
138625695|NCT00251277|Rituximab|rituximab|mesh-list
138625696|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138625697|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625698|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
138625699|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625700|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625701|NCT00412802|Enoxaparin|enoxaparin|mesh-list
138625702|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
138625703|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
138625704|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138625705|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138625706|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625707|NCT00563524|Fezakinumab|fezakinumab|mesh-list
138625708|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
138625709|NCT04613869|Hydromorphone|hydromorphone|mesh-list
138625710|NCT04613869|Esketamine|esketamine|mesh-list
138625711|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138625712|NCT04613869|Narcotics|narcotics|mesh-ancestor
138625713|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138625714|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625715|NCT04613869|Analgesics|analgesics|mesh-ancestor
138625716|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
138625717|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625718|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
138625719|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138625720|NCT00251355|Gemcitabine|gemcitabine|mesh-list
138625721|NCT00251355|Fluorouracil|fluorouracil|mesh-list
138625722|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138625723|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
138625724|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625725|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625726|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625727|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
138625728|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625729|NCT02962388|Anagrelide|anagrelide|mesh-list
138625730|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138625731|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138625732|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625733|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138625734|NCT04613167|Evolocumab|evolocumab|mesh-list
138625735|NCT04613167|Alirocumab|alirocumab|mesh-list
138625736|NCT04613167|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138625737|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138625738|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138625739|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
138625740|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625741|NCT04613167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138625742|NCT04613167|Protease Inhibitors|protease inhibitors|mesh-ancestor
138625743|NCT04613167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625744|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138625745|NCT04613284|Durvalumab|durvalumab|mesh-list
138625746|NCT04613284|Endostar protein|endostar protein|mesh-list
138625748|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138625749|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625750|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138625751|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138625752|NCT04613284|Growth Substances|growth substances|mesh-ancestor
138625753|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625754|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
138625755|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138625756|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
138625757|NCT00248118|Bupropion|bupropion|mesh-list
138625758|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138625759|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
138625760|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138625761|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138625762|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138625763|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138625764|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663004|NCT06150144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663005|NCT06150144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138663006|NCT06150144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138663007|NCT06150144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138663008|NCT06150144|Immunologic Factors|immunologic factors|mesh-ancestor
138663009|NCT06150144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663011|NCT06148337|Cathartics|cathartics|mesh-ancestor
138663012|NCT06148337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138625766|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625767|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625768|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138625769|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138625770|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625771|NCT04612894|Apatinib|apatinib|mesh-list
138625772|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625773|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138625774|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625775|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625776|NCT00251394|Rituximab|rituximab|mesh-list
138625777|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138625778|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625779|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
138625780|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625781|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625782|NCT00221975|Lamotrigine|lamotrigine|mesh-list
138625783|NCT00221975|Valproic Acid|valproic acid|mesh-list
138625784|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138625785|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625786|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625787|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
138625788|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138625789|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138625790|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625791|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
138625792|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138625793|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138625794|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138625795|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138625796|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138625797|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
138625798|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625799|NCT04612582|Thalidomide|thalidomide|mesh-list
138185299|NCT04347031|Azithromycin|azithromycin|mesh-list
138625800|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
138625801|NCT04612582|Bortezomib|bortezomib|mesh-list
138625802|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625803|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
138625804|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625805|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625806|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138625807|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
138625808|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625809|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625810|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138625811|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
138625812|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138625813|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138625814|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138625815|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138625816|NCT04612582|Growth Substances|growth substances|mesh-ancestor
138625817|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
138625819|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138625820|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138625821|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625822|NCT00251472|Paclitaxel|paclitaxel|mesh-list
138625823|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138625824|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625825|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
138625826|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
138625827|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
138625829|NCT00222053|Diphosphonates|diphosphonates|mesh-list
138625830|NCT00222053|Thalidomide|thalidomide|mesh-list
138625831|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625832|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
138625833|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625834|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
138625835|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138625836|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138625837|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138625838|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138625839|NCT00222053|Growth Substances|growth substances|mesh-ancestor
138684065|NCT00512681|Irinotecan|irinotecan|mesh-list
138625840|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
138625841|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625842|NCT00222053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138625843|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
138625844|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625845|NCT04611958|Bupivacaine|bupivacaine|mesh-list
138625846|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
138625847|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
138625848|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138625849|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625850|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
138625851|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625852|NCT00412919|Azacitidine|azacitidine|mesh-list
138185329|NCT04378283|Lidocaine|lidocaine|mesh-list
138625853|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138625854|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
138625855|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625856|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625857|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625858|NCT00222170|Rabeprazole|rabeprazole|mesh-list
138625859|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138625860|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138625861|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138625862|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625863|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625864|NCT04611724|Folfirinox|folfirinox|mesh-list
138625865|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625867|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138625868|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
138625869|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625870|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625871|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625872|NCT00563836|Catumaxomab|catumaxomab|mesh-list
138625873|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138625874|NCT00563875|Aspirin|aspirin|mesh-list
138625875|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138625876|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138625877|NCT00563875|Analgesics|analgesics|mesh-ancestor
138625878|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
138663054|NCT06140966|Growth Substances|growth substances|mesh-ancestor
138625879|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625880|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625881|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138625882|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625883|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138625884|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138625885|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625886|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138625887|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138625888|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625889|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
138625890|NCT04611685|Parecoxib|parecoxib|mesh-list
138625891|NCT04611685|Loxoprofen|loxoprofen|mesh-list
138625892|NCT04611685|Tramadol|tramadol|mesh-list
138625893|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138625894|NCT04611685|Narcotics|narcotics|mesh-ancestor
138625895|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138625896|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625897|NCT04611685|Analgesics|analgesics|mesh-ancestor
138625898|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
138625899|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138625900|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138625901|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138625902|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185345|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
138625903|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625904|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138625905|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138625906|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138625907|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625908|NCT00563914|Amodiaquine|amodiaquine|mesh-list
138625910|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
138625911|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138625912|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138625913|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138625914|NCT00563953|Doxorubicin|doxorubicin|mesh-list
138625915|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138625916|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625917|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138625918|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138625919|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625920|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625921|NCT00563992|Valproic Acid|valproic acid|mesh-list
138625922|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138625923|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625924|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625925|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
138625926|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138625927|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138320462|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
138625928|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625929|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
138625930|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
138684128|NCT02943798|Paclitaxel|paclitaxel|mesh-list
138625931|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625932|NCT00251550|Pemetrexed|pemetrexed|mesh-list
138625933|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625934|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625935|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625937|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138625938|NCT04611373|Levamisole|levamisole|mesh-list
138625939|NCT04611373|Acetazolamide|acetazolamide|mesh-list
138625940|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
138625941|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138625942|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625943|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625944|NCT04611373|Diuretics|diuretics|mesh-ancestor
138625945|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
138625946|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625947|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138625948|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
138625949|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
138625950|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
138625951|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138625952|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138625953|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625954|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138625955|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
138625956|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138625957|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
138625958|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138625959|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625960|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138625961|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138625962|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138625963|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625964|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138625965|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138625966|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138625967|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
138625968|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
138625969|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138302535|NCT00386191|Clopidogrel|clopidogrel|mesh-list
138625970|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
138625971|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138185425|NCT02909140|Phenylephrine|phenylephrine|mesh-list
138625972|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138625973|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625974|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
138625975|NCT04610164|Coagulants|coagulants|mesh-ancestor
138625976|NCT00222443|Irinotecan|irinotecan|mesh-list
138625977|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138625978|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138625979|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625980|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625981|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138625983|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
138625984|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138625985|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138625986|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
138625987|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138625989|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
138625990|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138625991|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138625992|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138625993|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
138625994|NCT04610125|Fludarabine|fludarabine|mesh-list
138625995|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138625996|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
138625997|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138625998|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138625999|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138626000|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
138626001|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626002|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626003|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138626004|NCT00564148|Bevacizumab|bevacizumab|mesh-list
138626005|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138626006|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185460|NCT01724879|Dasatinib|dasatinib|mesh-list
138626007|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138626008|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138626009|NCT00564148|Growth Substances|growth substances|mesh-ancestor
138626010|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626011|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
138626012|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
138626013|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138626014|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626015|NCT04609540|Trastuzumab|trastuzumab|mesh-list
138626016|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138626017|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626018|NCT00564187|Irbesartan|irbesartan|mesh-list
138626019|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138626020|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138626021|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138626022|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626023|NCT00222677|Aspirin|aspirin|mesh-list
138626024|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138626025|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138626026|NCT00222677|Analgesics|analgesics|mesh-ancestor
138626027|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
138626028|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626029|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626030|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138626031|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138626032|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138626033|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138663123|NCT06101173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626034|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626035|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138626036|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138626037|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626038|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
138626039|NCT00564460|Finasteride|finasteride|mesh-list
138626040|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138626041|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138626042|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188441|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
138626043|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626044|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
138626045|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138626046|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626047|NCT00564460|Urological Agents|urological agents|mesh-ancestor
138626049|NCT04609033|Morphine|morphine|mesh-list
138626050|NCT04609033|Bupivacaine|bupivacaine|mesh-list
138626051|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
138626052|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
138626053|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138626054|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626055|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
138626056|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626057|NCT04609033|Analgesics|analgesics|mesh-ancestor
138626058|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138626059|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138626060|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
138626061|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138626062|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138626063|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626064|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626065|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138626066|NCT04609033|Narcotics|narcotics|mesh-ancestor
138626068|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138626069|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626070|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138626071|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626072|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
138626073|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138626074|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
138626075|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626076|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138626077|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138626078|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138626079|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138626080|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626081|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
138626082|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626083|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626084|NCT04608253|Choline|choline|mesh-list
138626085|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
138626086|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138626087|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
138626088|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626089|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138626090|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138626091|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
138626092|NCT00222833|Aripiprazole|aripiprazole|mesh-list
138626093|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
138626094|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138320497|NCT03652974|Amisulpride|amisulpride|mesh-list
138626095|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138626096|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138626097|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138626098|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626099|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
138626100|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
138626101|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185522|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
138626102|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626103|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138626104|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138626105|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
138626106|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138626107|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138626108|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138626109|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138626110|NCT00564538|Tacrolimus|tacrolimus|mesh-list
138626111|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
138626112|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138626113|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138626114|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
138626115|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626116|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138626117|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626118|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626119|NCT00251706|Amiodarone|amiodarone|mesh-list
138626120|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138626121|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
138626122|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138626123|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138626124|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626125|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138626126|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138626127|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138626128|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626129|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138663164|NCT06057038|Immunologic Factors|immunologic factors|mesh-ancestor
138626130|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138626131|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138626133|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
138626134|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626135|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138626136|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138626137|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626138|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
138626139|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626140|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138626141|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138626142|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
138626143|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138626144|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138626145|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626146|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
138626147|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
138626148|NCT00199160|Sorafenib|sorafenib|mesh-list
138626149|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626150|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138626151|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626152|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626153|NCT04607629|Omalizumab|omalizumab|mesh-list
138626154|NCT04607629|Budesonide|budesonide|mesh-list
138626155|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
138626156|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138626157|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138626158|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138626159|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138663195|NCT06046274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626161|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626162|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626163|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138626164|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
138626165|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
138626166|NCT04607629|Hormones|hormones|mesh-ancestor
138626167|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138626168|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138626169|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138626170|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138626171|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
138626172|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626173|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626174|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138626175|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
138626176|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
138626177|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
138626178|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138626179|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138626180|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626181|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626182|NCT00251784|Urological Agents|urological agents|mesh-ancestor
138626183|NCT00248430|Aldesleukin|aldesleukin|mesh-list
138626184|NCT00248430|Melphalan|melphalan|mesh-list
138626185|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138626186|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
138626187|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185586|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
138626188|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626189|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138626190|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138626191|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
138684232|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626192|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626193|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138626194|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138626195|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
138626196|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626197|NCT00564655|Epinephrine|epinephrine|mesh-list
138626198|NCT00564655|Racepinephrine|racepinephrine|mesh-list
138626199|NCT00564655|Bupivacaine|bupivacaine|mesh-list
138626200|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
138626201|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
138626202|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
138626203|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138626204|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626205|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
138626206|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626207|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138626208|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138626209|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
138626210|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626211|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626212|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138626213|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138626214|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
138626215|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138626216|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
138626217|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
138626218|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
138626219|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138626220|NCT04606537|Itraconazole|itraconazole|mesh-list
138626222|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
138626223|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626224|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138626225|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138626226|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626227|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185610|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138626228|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138626229|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
138626230|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138626231|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626232|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138626233|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138626234|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
138626235|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138626236|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
138626237|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138626238|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138626239|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138626240|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138626241|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138626242|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138626243|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138626244|NCT00251823|Eptifibatide|eptifibatide|mesh-list
138626245|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138626246|NCT04606225|Losartan|losartan|mesh-list
138626247|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138684255|NCT05319912|Molybdenum|molybdenum|mesh-list
138626248|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138626249|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138626250|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138626251|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626252|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138626253|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185645|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626254|NCT04606108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138626255|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626256|NCT04719507|Meperidine|meperidine|mesh-list
138626257|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138626258|NCT04719507|Narcotics|narcotics|mesh-ancestor
138626259|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138626260|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626261|NCT04719507|Analgesics|analgesics|mesh-ancestor
138302835|NCT00004759|Tirilazad|tirilazad|mesh-list
138626262|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
138626263|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626264|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138626266|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
138626267|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
138626268|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626269|NCT04605562|Palbociclib|palbociclib|mesh-list
138626270|NCT04605562|Antibodies|antibodies|mesh-list
138626271|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
138626272|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
138626273|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626274|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626275|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138626276|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626277|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626278|NCT00251901|Esomeprazole|esomeprazole|mesh-list
138626279|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138626280|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138626281|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138626282|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626283|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626284|NCT00564772|Ritonavir|ritonavir|mesh-list
138626285|NCT00564772|Lopinavir|lopinavir|mesh-list
138626286|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
138626287|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138626288|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138626289|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
138626290|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626291|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626292|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138626293|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138626294|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
138626295|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626296|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138626297|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138626298|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138626299|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138626300|NCT00251940|Glyburide|glyburide|mesh-list
138626301|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138626302|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626303|NCT04604938|Losartan|losartan|mesh-list
138626304|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138626305|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138626306|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138626307|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138626308|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626309|NCT00565006|Anacetrapib|anacetrapib|mesh-list
138626310|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138626311|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138626312|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
138626313|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626314|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138626315|NCT00565123|Levofloxacin|levofloxacin|mesh-list
138626316|NCT00565123|Ofloxacin|ofloxacin|mesh-list
138626318|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138626319|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138626320|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626321|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138626322|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138626323|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138626324|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626325|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626326|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626327|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138626328|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138626329|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
138626330|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138626331|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626332|NCT04603729|Dexamethasone|dexamethasone|mesh-list
138626333|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
138626334|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138626335|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138626336|NCT04603729|Prednisolone|prednisolone|mesh-list
138626337|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
138626338|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138626339|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
138626340|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138626341|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
138626342|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
138626343|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320565|NCT00003816|Carboplatin|carboplatin|mesh-list
138626344|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626345|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138626346|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
138626347|NCT04603729|Hormones|hormones|mesh-ancestor
138626348|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138626349|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138626350|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626351|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138626352|NCT04603729|Protective Agents|protective agents|mesh-ancestor
138626353|NCT04603573|Listerine|listerine|mesh-list
138626354|NCT04603573|Fluorides|fluorides|mesh-list
138626355|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
138626356|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
138626357|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
138626358|NCT04603573|Protective Agents|protective agents|mesh-ancestor
138626359|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626360|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138626361|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626362|NCT05361824|Acetaminophen|acetaminophen|mesh-list
138626363|NCT05361824|Ketorolac|ketorolac|mesh-list
138626364|NCT05361824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138626365|NCT05361824|Analgesics|analgesics|mesh-ancestor
138626366|NCT05361824|Sensory System Agents|sensory system agents|mesh-ancestor
138626367|NCT05361824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626368|NCT05361824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626369|NCT05361824|Antipyretics|antipyretics|mesh-ancestor
138626370|NCT05361824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138626371|NCT05361824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138626372|NCT05361824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138626373|NCT05361824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138626374|NCT05361824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626375|NCT05361824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626376|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
138626377|NCT04603456|Antacids|antacids|mesh-ancestor
138626378|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626379|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138626380|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
138626381|NCT00252291|Miotics|miotics|mesh-ancestor
138626382|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
138626383|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626384|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626385|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138626386|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138626387|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
138626388|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138626389|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138626390|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
138626391|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626392|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626393|NCT00565240|Letrozole|letrozole|mesh-list
138626394|NCT00565240|NuvaRing|nuvaring|mesh-list
138626395|NCT00565240|Desogestrel|desogestrel|mesh-list
138626396|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626397|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138684328|NCT00516152|Methotrexate|methotrexate|mesh-list
138626399|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626400|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626401|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138626402|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
138320575|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
138626403|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138626404|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626405|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138626406|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
138626407|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138626408|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138626409|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138626410|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138626411|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138626413|NCT00565240|Hormones|hormones|mesh-ancestor
138626414|NCT04602247|Fesoterodine|fesoterodine|mesh-list
138626415|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138626416|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138626417|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
138626418|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626419|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626420|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626421|NCT04602247|Urological Agents|urological agents|mesh-ancestor
138626422|NCT00252330|Amibegron|amibegron|mesh-list
138626423|NCT00252330|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138626424|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138626425|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138626426|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
138626427|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626428|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626429|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626430|NCT00252330|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138626431|NCT04602013|Paclitaxel|paclitaxel|mesh-list
138626432|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138626433|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138626434|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626435|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
138626436|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
138626437|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
138626438|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626439|NCT04601701|Dexamethasone|dexamethasone|mesh-list
138626440|NCT04601701|Bevacizumab|bevacizumab|mesh-list
138626441|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138626442|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626443|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138626444|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138626445|NCT04601701|Growth Substances|growth substances|mesh-ancestor
138626446|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626447|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
138626448|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138626449|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
138626450|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
138626451|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626452|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138626453|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
138626454|NCT04601701|Hormones|hormones|mesh-ancestor
138626455|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138626456|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138626457|NCT00252369|Infliximab|infliximab|mesh-list
138626458|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138626459|NCT00252369|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138626460|NCT00252369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138626461|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
138663368|NCT05878691|Pembrolizumab|pembrolizumab|mesh-list
138626462|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138626463|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138216554|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
138626465|NCT00252369|Coagulants|coagulants|mesh-ancestor
138626466|NCT00565318|Benphothiamine|benphothiamine|mesh-list
138626467|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138626468|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
138626469|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626470|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
138626471|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
138626472|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626473|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
138626474|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
138626475|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138626476|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138626477|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626478|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626479|NCT05201144|Urological Agents|urological agents|mesh-ancestor
138626481|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138626482|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626483|NCT04601389|Omalizumab|omalizumab|mesh-list
138626484|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138626485|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138626486|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138626487|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
138626488|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
138626489|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626490|NCT00565396|Losartan|losartan|mesh-list
138626491|NCT00565396|Fosinopril|fosinopril|mesh-list
138626492|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138626493|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138626494|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138626495|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138626496|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684375|NCT00515489|Risperidone|risperidone|mesh-list
138626497|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138626498|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
138626499|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626501|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138626502|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138626503|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
138626504|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626505|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138216593|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216594|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
138626506|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138626507|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626508|NCT00249132|Risperidone|risperidone|mesh-list
138626509|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138626510|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
138626511|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626512|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138663382|NCT05868122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138663383|NCT05868122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138626513|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626514|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138626516|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138626517|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138626518|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138626519|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
138626520|NCT04600492|Riociguat|riociguat|mesh-list
138626521|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
138626522|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626523|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
138626524|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138626525|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626526|NCT00414687|Iloprost|iloprost|mesh-list
138626527|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138626528|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
138626529|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
138626530|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138626531|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138626532|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626533|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
138626534|NCT04599205|Coagulants|coagulants|mesh-ancestor
138626535|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
138626536|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
138626537|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138626538|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626539|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626540|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
138216624|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
138626541|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138626542|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138626543|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626544|NCT00565591|Albuterol|albuterol|mesh-list
138626545|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138626546|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
138626547|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626548|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626549|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138626550|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
138626551|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
138626552|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138626553|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138626554|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138626555|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138626556|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
138626557|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626558|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626559|NCT00252603|Galantamine|galantamine|mesh-list
138626560|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138188442|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
138626561|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626562|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626563|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
138626564|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626565|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626566|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138626567|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
138320627|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
138663406|NCT05850546|Prednisolone|prednisolone|mesh-list
138626568|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138216661|NCT02990312|Maraviroc|maraviroc|mesh-list
138626570|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
138626571|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138626572|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138626573|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626574|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138626575|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138626576|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626577|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626578|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626579|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138626580|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
138626581|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138626582|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626583|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138626584|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138626585|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138626586|NCT00565708|Aspirin|aspirin|mesh-list
138626587|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138626588|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138626589|NCT00565708|Analgesics|analgesics|mesh-ancestor
138626590|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
138626591|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626592|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626593|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138626594|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138626595|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138626596|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138626597|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626598|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138626599|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138626600|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626601|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
138626602|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138626603|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
138626604|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626605|NCT04598542|Triamcinolone|triamcinolone|mesh-list
138626606|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138626608|NCT04598542|Lorecivivint|lorecivivint|mesh-list
138626609|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138663423|NCT05845008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626610|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138626611|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
138626612|NCT04598542|Hormones|hormones|mesh-ancestor
138626613|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138626614|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626615|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138626616|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
138684414|NCT02951117|Dexamethasone|dexamethasone|mesh-list
138626617|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626618|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626619|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138626620|NCT04995263|Caffeine|caffeine|mesh-list
138626621|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138626622|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626623|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138626624|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626625|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626626|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138626627|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138626628|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
138626629|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626630|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138626632|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138303212|NCT02141490|Hematinics|hematinics|mesh-ancestor
138626634|NCT00249171|Risperidone|risperidone|mesh-list
138626635|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138626636|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
138626637|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626638|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626639|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626640|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138626641|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138626642|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138626643|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138626644|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138626645|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
138626646|NCT00565981|Fludarabine|fludarabine|mesh-list
138626647|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
138626648|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
138626649|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626650|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138626651|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
138626652|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626653|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138626654|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
138626655|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626656|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138626657|NCT04952519|Amantadine|amantadine|mesh-list
138626658|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138626659|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138626660|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
138626661|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626662|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
138626663|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626664|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626665|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216725|NCT01245647|Naltrexone|naltrexone|mesh-list
138626666|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138626667|NCT04952519|Analgesics|analgesics|mesh-ancestor
138626668|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
138684427|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
138626669|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626670|NCT00414921|Clonidine|clonidine|mesh-list
138626671|NCT00414921|Methylphenidate|methylphenidate|mesh-list
138626672|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138626673|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626674|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138626675|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138626676|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138626677|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626678|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
138626679|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626680|NCT00414921|Analgesics|analgesics|mesh-ancestor
138626681|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
138626682|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626683|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138626684|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
138626685|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
138626686|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138626687|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138626688|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138626689|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
138626690|NCT04597762|Cyclosporine|cyclosporine|mesh-list
138626691|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
138626692|NCT04597762|Cyclosporins|cyclosporins|mesh-list
138626693|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626694|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626695|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138626696|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
138626697|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626698|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
138626699|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626700|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
138626701|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138626702|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138626703|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138626704|NCT00249210|Levofloxacin|levofloxacin|mesh-list
138626705|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138626706|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138303285|NCT02119026|Irinotecan|irinotecan|mesh-list
138626707|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138626708|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138626709|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138626710|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626711|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626712|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626713|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138626714|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138626715|NCT00252798|Paclitaxel|paclitaxel|mesh-list
138626716|NCT00252798|Carboplatin|carboplatin|mesh-list
138626717|NCT00252798|Gefitinib|gefitinib|mesh-list
138626718|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138626719|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626720|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
138626721|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
138626722|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
138626723|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626724|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138626725|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626726|NCT02961660|Odalasvir|odalasvir|mesh-list
138626727|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
138626728|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626729|NCT00403013|Anesthetics|anesthetics|mesh-list
138626730|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138626731|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626732|NCT00566332|Fludarabine|fludarabine|mesh-list
138626733|NCT00566332|Chlorambucil|chlorambucil|mesh-list
138626734|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626735|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626736|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138626737|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
138626738|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
138626739|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138626740|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
138626741|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626742|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138626743|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138626744|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138626745|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138626746|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626747|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
138626748|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626749|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626750|NCT04595929|Leucovorin|leucovorin|mesh-list
138626751|NCT04595929|Docetaxel|docetaxel|mesh-list
138626752|NCT04595929|Fluorouracil|fluorouracil|mesh-list
138626753|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
138626754|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626755|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
138626756|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
138626757|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
138626758|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626760|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138626761|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138626762|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
138626763|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626764|NCT04595929|Antidotes|antidotes|mesh-ancestor
138626765|NCT04595929|Protective Agents|protective agents|mesh-ancestor
138626766|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
138626767|NCT04595929|Vitamins|vitamins|mesh-ancestor
138626768|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
138626769|NCT00252954|Levetiracetam|levetiracetam|mesh-list
138626770|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
138626771|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
138626772|NCT04595812|Misoprostol|misoprostol|mesh-list
138626773|NCT04595812|Hemostatics|hemostatics|mesh-list
138626774|NCT04595812|Oxytocin|oxytocin|mesh-list
138626775|NCT04595812|Carbetocin|carbetocin|mesh-list
138626776|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
138626777|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138626778|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626779|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138626780|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
138626781|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138626782|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138303357|NCT02091414|Cyclosporine|cyclosporine|mesh-list
138626783|NCT04595812|Coagulants|coagulants|mesh-ancestor
138626784|NCT00249366|Lorazepam|lorazepam|mesh-list
138626785|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
138626786|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
138626787|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
138626788|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626789|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626790|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138626791|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138626792|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138626793|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138626794|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138626795|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138626796|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
138626797|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
138626798|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626799|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626800|NCT04635683|Lenalidomide|lenalidomide|mesh-list
138216815|NCT02322242|Hormones|hormones|mesh-ancestor
138626801|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
138626802|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626803|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138626804|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138626805|NCT04635683|Growth Substances|growth substances|mesh-ancestor
138626806|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
138626807|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626808|NCT00249405|Citalopram|citalopram|mesh-list
138626809|NCT00249405|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138626810|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138626811|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138626812|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626813|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626814|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
138626815|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626816|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138663501|NCT05765851|Immunologic Factors|immunologic factors|mesh-ancestor
138626817|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
138626818|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138626819|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
138626820|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138626821|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
138626822|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138626823|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626824|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138626825|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138626826|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138626827|NCT00253110|Haloperidol|haloperidol|mesh-list
138626828|NCT00253110|Risperidone|risperidone|mesh-list
138626829|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
138626831|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
138626832|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626833|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626834|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626835|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138626836|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138626837|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138626838|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138626839|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138626840|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
138626841|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
138626842|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
138626843|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626844|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138626845|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138626846|NCT00566683|Meperidine|meperidine|mesh-list
138626847|NCT00566683|Diazepam|diazepam|mesh-list
138626848|NCT00566683|Alfentanil|alfentanil|mesh-list
138626849|NCT00566683|Propofol|propofol|mesh-list
138626850|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138626851|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138626852|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626853|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138626854|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
138626855|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
138626856|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138626857|NCT00566683|Narcotics|narcotics|mesh-ancestor
138626858|NCT00566683|Analgesics|analgesics|mesh-ancestor
138626859|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
138626860|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626861|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138626863|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
138626864|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
138626865|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138626866|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138626867|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138626868|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138626869|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138626870|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138626871|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
138626872|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
138626873|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626874|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626876|NCT00566761|Bevacizumab|bevacizumab|mesh-list
138626877|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138626878|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626879|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138626880|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138626881|NCT00566761|Growth Substances|growth substances|mesh-ancestor
138626882|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626883|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
138626884|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138626885|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
138626886|NCT00566761|Hormones|hormones|mesh-ancestor
138626887|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138626888|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138626889|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626890|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138626891|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216881|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138216882|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
138626892|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626893|NCT04593706|Dexamethasone|dexamethasone|mesh-list
138626894|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
138626895|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138626896|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138626897|NCT04593706|Prednisolone|prednisolone|mesh-list
138626898|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
138626899|NCT04593706|Triamcinolone|triamcinolone|mesh-list
138626900|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138626901|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138626902|NCT04593706|Betamethasone|betamethasone|mesh-list
138626903|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
138626904|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138626905|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
138626906|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
138626907|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
138626909|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
138663568|NCT05730712|Pertuzumab|pertuzumab|mesh-list
138626910|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138626911|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138626912|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138626914|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138626915|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
138626916|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
138626917|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626918|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626919|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138626920|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
138626921|NCT04593706|Hormones|hormones|mesh-ancestor
138626922|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138626923|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138626924|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626925|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138626926|NCT04593706|Protective Agents|protective agents|mesh-ancestor
138626927|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138626928|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
138626929|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626930|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138216910|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626931|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138626932|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
138626933|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
138626934|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138626935|NCT04593238|Calcium|calcium|mesh-list
138626936|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138626937|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684544|NCT02941224|Sirolimus|sirolimus|mesh-list
138626938|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138626939|NCT04593160|Acetaminophen|acetaminophen|mesh-list
138626941|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138626942|NCT04593160|Analgesics|analgesics|mesh-ancestor
138626943|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
138626944|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626945|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626946|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
138626947|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138626948|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138626949|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138626950|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138626951|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626952|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626953|NCT00253149|Risperidone|risperidone|mesh-list
138626954|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138626955|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
138626956|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626957|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626958|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626959|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138626960|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138626961|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138626962|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138626963|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138626964|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
138626965|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138626966|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138626967|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138626968|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138626969|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626970|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138626971|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626972|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138663598|NCT05698407|Sensory System Agents|sensory system agents|mesh-ancestor
138626973|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
138626974|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138626975|NCT00567034|Naltrexone|naltrexone|mesh-list
138626976|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138626977|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138626978|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626979|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
138318493|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626980|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138626982|NCT04484363|Pevonedistat|pevonedistat|mesh-list
138626983|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138626984|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
138626985|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626986|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138626987|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138626988|NCT04592380|Clevidipine|clevidipine|mesh-list
138626989|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138626990|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138626991|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138626992|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138626993|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138626994|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138626995|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138626996|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138626997|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138626998|NCT00253188|Galantamine|galantamine|mesh-list
138626999|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138627000|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627001|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684563|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
138627002|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
138627003|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627004|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627005|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138627006|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
138188443|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138627007|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627008|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
138627009|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
138627010|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
138627011|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
138627012|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627013|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627014|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
138627015|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627016|NCT04591795|Diclofenac|diclofenac|mesh-list
138627017|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138627018|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138627019|NCT04591795|Analgesics|analgesics|mesh-ancestor
138663607|NCT05698407|Anesthetics|anesthetics|mesh-ancestor
138663618|NCT05690087|Lidocaine|lidocaine|mesh-list
138627020|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
138627021|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627022|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627023|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138627024|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138627025|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138627026|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627027|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627028|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
138627029|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138627030|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627031|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138627032|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627033|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138627034|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627035|NCT04719585|Analgesics|analgesics|mesh-ancestor
138627036|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
138627037|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627038|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138627039|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138627040|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138627041|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627042|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627043|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
138627044|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138627045|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
138627046|NCT04592029|Bevacizumab|bevacizumab|mesh-list
138627047|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138217016|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138627048|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627049|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138627050|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138627051|NCT04592029|Growth Substances|growth substances|mesh-ancestor
138627052|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627053|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
138627055|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138627056|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627057|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627058|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
138627059|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627060|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627061|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138627062|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
138627063|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627064|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
138627066|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
138627067|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
138627068|NCT04591444|Protective Agents|protective agents|mesh-ancestor
138627069|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627070|NCT04591327|Anesthetics|anesthetics|mesh-list
138627071|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627072|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627073|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138627075|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
138627076|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138627077|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138627078|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138627079|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627080|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627081|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138627082|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138627083|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138627084|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627085|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627086|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138627087|NCT00253305|Terbinafine|terbinafine|mesh-list
138627088|NCT00253305|Naftifine|naftifine|mesh-list
138627089|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
138627090|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138627091|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627092|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627093|NCT04591600|Ivermectin|ivermectin|mesh-list
138627094|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138627095|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138627096|NCT04590742|Melatonin|melatonin|mesh-list
138627097|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
138627098|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627099|NCT04590742|Protective Agents|protective agents|mesh-ancestor
138627100|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627101|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627102|NCT00253344|Docetaxel|docetaxel|mesh-list
138627103|NCT00253344|Lenalidomide|lenalidomide|mesh-list
138627104|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627105|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
138627106|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
138627107|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
138627108|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627109|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
138627110|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627111|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138627112|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138627113|NCT00253344|Growth Substances|growth substances|mesh-ancestor
138627114|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
138627115|NCT00567463|Fluticasone|fluticasone|mesh-list
138627116|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138627117|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138627118|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
138627119|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627120|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627121|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138627122|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
138627123|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
138627124|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138627125|NCT00253422|Fulvestrant|fulvestrant|mesh-list
138627126|NCT00253422|Anastrozole|anastrozole|mesh-list
138627127|NCT00253422|Exemestane|exemestane|mesh-list
138663652|NCT05672342|Sensory System Agents|sensory system agents|mesh-ancestor
138627128|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138627129|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627130|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138627131|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138627132|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
138627133|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138627134|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627135|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138627136|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138627137|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627138|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217078|NCT00737204|Modafinil|modafinil|mesh-list
138627139|NCT04590625|Carboplatin|carboplatin|mesh-list
138627140|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138627141|NCT04590625|Apatinib|apatinib|mesh-list
138627142|NCT04590625|Cisplatin|cisplatin|mesh-list
138627143|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138684611|NCT00516971|Esomeprazole|esomeprazole|mesh-list
138627144|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627145|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138627146|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627147|NCT00253461|Topotecan|topotecan|mesh-list
138627148|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138627149|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138627150|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138627151|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627152|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627153|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627154|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138627155|NCT00567658|Esomeprazole|esomeprazole|mesh-list
138627156|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138627157|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138627158|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138627159|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627160|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627161|NCT00567697|Ranibizumab|ranibizumab|mesh-list
138627162|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138627163|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138627164|NCT00567697|Growth Substances|growth substances|mesh-ancestor
138627165|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627166|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
138627167|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627168|NCT04589494|Morphine|morphine|mesh-list
138627169|NCT04589494|Tramadol|tramadol|mesh-list
138627170|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138627171|NCT04589494|Narcotics|narcotics|mesh-ancestor
138627172|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627173|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627174|NCT04589494|Analgesics|analgesics|mesh-ancestor
138663670|NCT05663866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138663677|NCT05663866|Hormones|hormones|mesh-ancestor
138627180|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
138627181|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627182|NCT00253500|Epirubicin|epirubicin|mesh-list
138627183|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138627184|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627185|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138627186|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138627187|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627188|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627193|NCT04588987|Apatinib|apatinib|mesh-list
138627194|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627195|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138627196|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627197|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627198|NCT00253539|Tamoxifen|tamoxifen|mesh-list
138627199|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138627200|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
138627201|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138627202|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627203|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138627204|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627205|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138627206|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138627207|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138627208|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
138627209|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138627210|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
138627211|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
138627212|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
138627213|NCT00567775|Insulin|insulin|mesh-list
138627214|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138627215|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138627216|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627217|NCT00567814|Oxazepam|oxazepam|mesh-list
138627218|NCT00567814|Metyrapone|metyrapone|mesh-list
138627219|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
138627220|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627221|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627222|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138627223|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627224|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627225|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138627226|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138627227|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138188444|NCT00362037|Irbesartan|irbesartan|mesh-list
138627228|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
138627229|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
138627230|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627231|NCT04588090|Cisplatin|cisplatin|mesh-list
138627232|NCT04588090|Paclitaxel|paclitaxel|mesh-list
138627233|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627234|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138627235|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
138627236|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
138627237|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
138217146|NCT01272908|Rituximab|rituximab|mesh-list
138627238|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627239|NCT00253578|Sorafenib|sorafenib|mesh-list
138627240|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627241|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138627242|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627243|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627244|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
138627245|NCT04153565|Pemetrexed|pemetrexed|mesh-list
138627246|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627247|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138627248|NCT04153565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138627249|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627250|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627251|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138684674|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
138627252|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138627253|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
138627254|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138627256|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627257|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
138627258|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138627259|NCT04587778|Ketamine|ketamine|mesh-list
138627260|NCT04587778|Esketamine|esketamine|mesh-list
138627261|NCT04587778|Analgesics|analgesics|mesh-ancestor
138627262|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
138627263|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627264|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627265|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138627266|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138627267|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
138627268|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
138627269|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627270|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138627271|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138627272|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627273|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627274|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
138627275|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138627276|NCT04587505|Morphine|morphine|mesh-list
138627277|NCT04587505|Tramadol|tramadol|mesh-list
138627278|NCT04587505|Anesthetics|anesthetics|mesh-list
138627279|NCT04587505|Ropivacaine|ropivacaine|mesh-list
138627280|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627281|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627282|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138627283|NCT04587505|Narcotics|narcotics|mesh-ancestor
138627284|NCT04587505|Analgesics|analgesics|mesh-ancestor
138627285|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
138627286|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138663710|NCT05656599|Letermovir|letermovir|mesh-list
138627287|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
138627288|NCT04587115|Oxycodone|oxycodone|mesh-list
138627289|NCT04587115|Risperidone|risperidone|mesh-list
138627290|NCT04587115|Ziprasidone|ziprasidone|mesh-list
138627291|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138627292|NCT04587115|Narcotics|narcotics|mesh-ancestor
138627293|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627294|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627295|NCT04587115|Analgesics|analgesics|mesh-ancestor
138627296|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
138627297|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627298|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138627299|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
138627300|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627301|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627302|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138627303|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138627304|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138627305|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138627306|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
138627307|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
138627308|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
138627309|NCT00403247|Pyridoxine|pyridoxine|mesh-list
138627310|NCT00403247|Vitamins|vitamins|mesh-ancestor
138627311|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
138627312|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627313|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
138627314|NCT00403247|Hematinics|hematinics|mesh-ancestor
138627315|NCT00253773|Acetaminophen|acetaminophen|mesh-list
138627316|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138627318|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
138627319|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627320|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627321|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
138627322|NCT00403286|Fluticasone|fluticasone|mesh-list
138663730|NCT05641246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627323|NCT00403286|Xhance|xhance|mesh-list
138627324|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
138627325|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138627326|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138627327|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138627328|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
138627329|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627330|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627331|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138627332|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
138627333|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
138627334|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138627335|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138627336|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138627337|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138627338|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
138627339|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627340|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627341|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138627342|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138627343|NCT04585867|Bupivacaine|bupivacaine|mesh-list
138627344|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
138627345|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
138217235|NCT01279694|Melphalan|melphalan|mesh-list
138627346|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627347|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627348|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
138627349|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627350|NCT00253851|Heparin|heparin|mesh-list
138627351|NCT00253851|Calcium heparin|calcium heparin|mesh-list
138627352|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
138627353|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138627354|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138627355|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627356|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138627357|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138627358|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138627359|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
138627360|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627361|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138627362|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138627363|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627364|NCT04585438|Diclofenac|diclofenac|mesh-list
138627365|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138627366|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138627367|NCT04585438|Analgesics|analgesics|mesh-ancestor
138627368|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
138627369|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627370|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627371|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138286434|NCT03355820|Antibodies|antibodies|mesh-list
138627372|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138627373|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138627374|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627375|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627376|NCT00223223|Levetiracetam|levetiracetam|mesh-list
138627377|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
138627379|NCT00567931|Tryptophan|tryptophan|mesh-list
138627380|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138627381|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
138627382|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138627383|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
138217286|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
138627384|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138627385|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627386|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138627387|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
138627388|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138627389|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138627390|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627391|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627392|NCT04585321|Diclofenac|diclofenac|mesh-list
138627393|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
138627394|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138627395|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138627396|NCT04585321|Analgesics|analgesics|mesh-ancestor
138627397|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
138627398|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627399|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627400|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138627401|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138627402|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138627403|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627404|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627405|NCT00412997|Panobinostat|panobinostat|mesh-list
138627406|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627407|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138627408|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627409|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627410|NCT00253929|Adenosine|adenosine|mesh-list
138627411|NCT00253929|Nitroprusside|nitroprusside|mesh-list
138627412|NCT00253929|Acetylcholine|acetylcholine|mesh-list
138627413|NCT00253929|Caffeine|caffeine|mesh-list
138627414|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138627415|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627416|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138627417|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627418|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627419|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138627420|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138627421|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
138627422|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627423|NCT00253929|Analgesics|analgesics|mesh-ancestor
138627424|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
138663797|NCT05582434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138627425|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627426|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138627427|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
138627428|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138627429|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
138627430|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138627431|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138627432|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138627433|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
138627434|NCT00568048|Bevacizumab|bevacizumab|mesh-list
138627435|NCT00568048|Temozolomide|temozolomide|mesh-list
138627436|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138627437|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627438|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138627439|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138627441|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627442|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
138627443|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138627444|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
138627445|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627447|NCT04584580|Enoxaparin|enoxaparin|mesh-list
138627448|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138627449|NCT04584580|Tinzaparin|tinzaparin|mesh-list
138627450|NCT04584580|Dalteparin|dalteparin|mesh-list
138627451|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
138627452|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138627453|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138627454|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627455|NCT00250029|Capecitabine|capecitabine|mesh-list
138627456|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
138627457|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138627458|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
138627459|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627460|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627461|NCT00223418|Aripiprazole|aripiprazole|mesh-list
138627462|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
138627463|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138627464|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138627465|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138627466|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627467|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627468|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
138627469|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
138627470|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627471|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627472|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138627473|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138627474|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
138627475|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138627476|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138627477|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138627478|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138627480|NCT04584736|Pitavastatin|pitavastatin|mesh-list
138627481|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138627482|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138627483|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
138627484|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627485|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138627486|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138627487|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627488|NCT00250068|Rubitecan|rubitecan|mesh-list
138627489|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627490|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138627491|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138627492|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627493|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627494|NCT04584307|Pomalidomide|pomalidomide|mesh-list
138627495|NCT04584307|Elotuzumab|elotuzumab|mesh-list
138627496|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
138627497|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138663818|NCT05572515|Bortezomib|bortezomib|mesh-list
138627498|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138627499|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138627501|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
138627502|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627503|NCT04584034|Albuterol|albuterol|mesh-list
138627504|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
138627505|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
138684726|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
138627506|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627507|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627508|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138627509|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
138627510|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
138627511|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138627512|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138627513|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138627514|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138627515|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
138627516|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627517|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627518|NCT04583410|Nicotine|nicotine|mesh-list
138217454|NCT00724568|Bortezomib|bortezomib|mesh-list
138627519|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138627520|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
138627521|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627522|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627523|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138627524|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138663823|NCT05572515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627525|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
138627526|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627527|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627528|NCT00254007|Citalopram|citalopram|mesh-list
138627529|NCT00254007|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138627530|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138627531|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138627532|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627533|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627534|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
138627535|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627536|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138627537|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
138627538|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138627539|NCT00223613|Insulin|insulin|mesh-list
138627540|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138627541|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627542|NCT04583137|Lidocaine|lidocaine|mesh-list
138627543|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
138627544|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
138627545|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627546|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627547|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
138627548|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627549|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138627550|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138627551|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138627552|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138627553|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627554|NCT00223691|Acarbose|acarbose|mesh-list
138627555|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
138627556|NCT00223691|Promethazine|promethazine|mesh-list
138627557|NCT00223691|Ibuprofen|ibuprofen|mesh-list
138627558|NCT00223691|Celecoxib|celecoxib|mesh-list
138627559|NCT00223691|Indomethacin|indomethacin|mesh-list
138627560|NCT00223691|Octreotide|octreotide|mesh-list
138627561|NCT00223691|Phenylephrine|phenylephrine|mesh-list
138627562|NCT00223691|Acetazolamide|acetazolamide|mesh-list
138627563|NCT00223691|Midodrine|midodrine|mesh-list
138627564|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
138627565|NCT00223691|Ephedrine|ephedrine|mesh-list
138627566|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
138663872|NCT05563961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627567|NCT00223691|Ergotamine|ergotamine|mesh-list
138627568|NCT00223691|Bromides|bromides|mesh-list
138627569|NCT00223691|Levodopa|levodopa|mesh-list
138627570|NCT00223691|Carbidopa|carbidopa|mesh-list
138627571|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138627572|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
138627573|NCT00223691|Caffeine|caffeine|mesh-list
138627574|NCT00223691|Methylphenidate|methylphenidate|mesh-list
138627575|NCT00223691|Modafinil|modafinil|mesh-list
138627576|NCT00223691|Rivastigmine|rivastigmine|mesh-list
138627577|NCT00223691|Ranitidine|ranitidine|mesh-list
138627578|NCT00223691|Yohimbine|yohimbine|mesh-list
138627579|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138627580|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138627581|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138627582|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138627583|NCT00223691|Analgesics|analgesics|mesh-ancestor
138627584|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
138627585|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627586|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627587|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138627588|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138627589|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138627590|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627591|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627592|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138627593|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138627594|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138627595|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138627596|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138627597|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
138627598|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627599|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138627600|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138627601|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138627602|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
138627603|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
138627604|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138627605|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138627606|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138627607|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138627608|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627609|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138627610|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138627611|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
138627612|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138627613|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138627614|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627615|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
138627616|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
138627617|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
138627618|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
138627619|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138627620|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
138627621|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
138627622|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138627623|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
138627624|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
138627625|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138627626|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138627627|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138627628|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
138627629|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
138627630|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138627631|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138627633|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
138627634|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138627635|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138627636|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138627637|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
138627638|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138627639|NCT00223691|Protective Agents|protective agents|mesh-ancestor
138627640|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
138627641|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138627642|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138627643|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138627644|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138627645|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138627646|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
138627647|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
138627648|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138627649|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138627650|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
138627652|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138627654|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138627655|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138627656|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138627657|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138627658|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138627659|NCT00223691|Urological Agents|urological agents|mesh-ancestor
138627660|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
138627661|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138627662|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138627663|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138627664|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138627665|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
138627666|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138627667|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
138627668|NCT04583020|Temozolomide|temozolomide|mesh-list
138627669|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138627670|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
138627671|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627672|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627673|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138627674|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627675|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627676|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627677|NCT04582786|Morphine|morphine|mesh-list
138627678|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138627679|NCT04582786|Narcotics|narcotics|mesh-ancestor
138627680|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138304254|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
138627681|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627682|NCT04582786|Analgesics|analgesics|mesh-ancestor
138627683|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
138627684|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627685|NCT00223769|Oxandrolone|oxandrolone|mesh-list
138627686|NCT00223769|Androgens|androgens|mesh-ancestor
138627687|NCT00223769|Hormones|hormones|mesh-ancestor
138627688|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138627689|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627690|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
138627691|NCT04582084|Etanercept|etanercept|mesh-list
138627692|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138627693|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138627694|NCT04582084|Analgesics|analgesics|mesh-ancestor
138627695|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
138627696|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627697|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138684760|NCT00517985|Analgesics|analgesics|mesh-ancestor
138627698|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138627699|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138627700|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138627701|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138627702|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
138627704|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138627705|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138627706|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627707|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627708|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
138627709|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138627710|NCT00223925|Maribavir|maribavir|mesh-list
138627711|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
138627712|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138627713|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
138627714|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138320862|NCT06124729|Bevacizumab|bevacizumab|mesh-list
138627715|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627716|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
138627717|NCT04581967|Doxorubicin|doxorubicin|mesh-list
138663966|NCT05498428|Tinzaparin|tinzaparin|mesh-list
138627718|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138627719|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
138217603|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627720|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627721|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138627722|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138627723|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
138627724|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627726|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138627727|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138627728|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138627729|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138627730|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627731|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
138627732|NCT00223964|Hematinics|hematinics|mesh-ancestor
138627733|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
138627734|NCT00224081|Hematinics|hematinics|mesh-ancestor
138627735|NCT04581265|Paclitaxel|paclitaxel|mesh-list
138627736|NCT04581265|Ifosfamide|ifosfamide|mesh-list
138627737|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138627738|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138627739|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627740|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
138627741|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
138627742|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
138627743|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627744|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138627745|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
138627746|NCT04580797|PF-06700841|pf-06700841|mesh-list
138627747|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138627748|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627749|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627750|NCT00568477|Rituximab|rituximab|mesh-list
138627751|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138627752|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627753|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
138627754|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627755|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138627756|NCT00568711|Doxycycline|doxycycline|mesh-list
138627757|NCT00568711|Rifampin|rifampin|mesh-list
138627758|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138304339|NCT01989156|Menthol|menthol|mesh-list
138627759|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138627760|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
138627761|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138627762|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138627763|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138627764|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
138627765|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
138627766|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138627767|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627768|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217650|NCT00243386|Factor VIII|factor viii|mesh-list
138627769|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138627770|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138627771|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138627772|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138627773|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138627774|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138627776|NCT00415116|Docetaxel|docetaxel|mesh-list
138627777|NCT00415116|Lenalidomide|lenalidomide|mesh-list
138627778|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627779|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
138627780|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
138627781|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
138627782|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627783|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
138627784|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627785|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138627786|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138627787|NCT00415116|Growth Substances|growth substances|mesh-ancestor
138627788|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
138627789|NCT00568750|Dasatinib|dasatinib|mesh-list
138627790|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627791|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138627792|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627793|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627794|NCT00568789|Zolpidem|zolpidem|mesh-list
138627795|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138627796|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138627797|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627798|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627800|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
138627801|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
138627802|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627803|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627804|NCT00254202|Iloperidone|iloperidone|mesh-list
138627805|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138627806|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138217677|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217679|NCT00241358|Plerixafor|plerixafor|mesh-list
138627807|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627808|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627809|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138627810|NCT00568984|Metformin|metformin|mesh-list
138627811|NCT00568984|Repaglinide|repaglinide|mesh-list
138627812|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138627813|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627814|NCT00254241|Risperidone|risperidone|mesh-list
138627815|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138627816|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138627817|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
138627818|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627819|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627820|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627821|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138627822|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138627823|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627824|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138627825|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138627826|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
138627827|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
138627828|NCT00224315|Risperidone|risperidone|mesh-list
138627829|NCT00224315|Ziprasidone|ziprasidone|mesh-list
138627830|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138627831|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
138627832|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627833|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627834|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627835|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138627836|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138627837|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627838|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138627839|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138627840|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
138627841|NCT00569101|Tacrolimus|tacrolimus|mesh-list
138627842|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138627843|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
138627844|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627845|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138627846|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627847|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627848|NCT00224354|Interleukin-2|interleukin-2|mesh-list
138627849|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
138627850|NCT00224354|Immunotoxins|immunotoxins|mesh-list
138627851|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627852|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138627853|NCT00224354|Analgesics|analgesics|mesh-ancestor
138627854|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
138627855|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627856|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627857|NCT00224354|Immunoconjugates|immunoconjugates|mesh-ancestor
138627858|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
138627859|NCT00569296|Aldesleukin|aldesleukin|mesh-list
138627860|NCT00569296|Sargramostim|sargramostim|mesh-list
138627861|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
138627862|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627863|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627864|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138627865|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138627866|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
138627867|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138627868|NCT00569335|Bevacizumab|bevacizumab|mesh-list
138627870|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138627871|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138664047|NCT05453903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138627873|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138627874|NCT00569335|Growth Substances|growth substances|mesh-ancestor
138627875|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627876|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
138627877|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138627878|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138627879|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627880|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627881|NCT00254319|Bevacizumab|bevacizumab|mesh-list
138627882|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138627883|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627884|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138627885|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138627886|NCT00254319|Growth Substances|growth substances|mesh-ancestor
138627887|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627888|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
138627889|NCT00569452|Insulin|insulin|mesh-list
138627890|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138627891|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138627892|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627893|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
138627894|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
138627895|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138627896|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138627897|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138627898|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138627899|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627900|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627901|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627902|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138627903|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138627904|NCT00224471|Vaccines|vaccines|mesh-list
138627905|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
138627906|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627907|NCT00569920|Dexamethasone|dexamethasone|mesh-list
138627908|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
138627909|NCT00569920|BB 1101|bb 1101|mesh-list
138627910|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138627911|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
138627912|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
138627913|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627914|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627915|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138627917|NCT00569920|Hormones|hormones|mesh-ancestor
138627918|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138627919|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138627920|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627921|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
138627922|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138627923|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627924|NCT00224510|Lamotrigine|lamotrigine|mesh-list
138627925|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
138627926|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138627927|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138627928|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627929|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138627930|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627931|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138217780|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627932|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138627933|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138684835|NCT04691076|Fentanyl|fentanyl|mesh-list
138627934|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138627935|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138627936|NCT00570193|Ranibizumab|ranibizumab|mesh-list
138627937|NCT00570193|Verteporfin|verteporfin|mesh-list
138627938|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138627939|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138627940|NCT00570193|Growth Substances|growth substances|mesh-ancestor
138627941|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627942|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
138627943|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138627944|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138627945|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
138627946|NCT00224549|Amlodipine|amlodipine|mesh-list
138627947|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138627948|NCT00224549|Irbesartan|irbesartan|mesh-list
138627949|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138627950|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138627951|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138627952|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627953|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138627954|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627956|NCT00224549|Diuretics|diuretics|mesh-ancestor
138627957|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
138627958|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138627959|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138627960|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138627961|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
138627962|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138627963|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
138627964|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627965|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627966|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138627967|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
138627968|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
138627969|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138627970|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
138627971|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627972|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627973|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
138627974|NCT00254436|Hematinics|hematinics|mesh-ancestor
138627975|NCT00224588|Ketamine|ketamine|mesh-list
138627976|NCT00224588|Analgesics|analgesics|mesh-ancestor
138627977|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
138627978|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138627979|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627980|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138627981|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138627982|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
138627983|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
138627984|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138627985|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138304549|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
138627986|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138627987|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138627988|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627990|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138627991|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138627992|NCT00254475|Valsartan|valsartan|mesh-list
138627993|NCT00254475|Simvastatin|simvastatin|mesh-list
138627994|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138627995|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138627996|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
138627997|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138627998|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138627999|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138628000|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628001|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138628002|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138628003|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138628005|NCT00570856|Hematinics|hematinics|mesh-ancestor
138628006|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
138628008|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
138628009|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628010|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
138628011|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
138628012|NCT00570934|Vitamin D|vitamin d|mesh-list
138628013|NCT00570934|Calcium|calcium|mesh-list
138628014|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138628015|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628016|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138628017|NCT00570934|Vitamins|vitamins|mesh-ancestor
138628018|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
138628019|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
138628020|NCT00254553|Testosterone|testosterone|mesh-list
138628021|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
138628022|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
138628023|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138628024|NCT00254553|Androgens|androgens|mesh-ancestor
138628025|NCT00254553|Hormones|hormones|mesh-ancestor
138628026|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138628027|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628028|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138628029|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628030|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
138628031|NCT00571129|Mitomycins|mitomycins|mesh-list
138628032|NCT00571129|Mitomycin|mitomycin|mesh-list
138628033|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138628034|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628035|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
138628036|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628037|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138628038|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628039|NCT00571246|Topiramate|topiramate|mesh-list
138628040|NCT00571246|Lamotrigine|lamotrigine|mesh-list
138628041|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
138628042|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138628043|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628044|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138628045|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138628046|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628047|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138628048|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138664087|NCT05427162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138628049|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138628050|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628051|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628052|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138628053|NCT00254631|Oxycodone|oxycodone|mesh-list
138628054|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138628055|NCT00254631|Narcotics|narcotics|mesh-ancestor
138628056|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628057|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628058|NCT00254631|Analgesics|analgesics|mesh-ancestor
138628059|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
138628060|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138628061|NCT00571285|Vitamin D|vitamin d|mesh-list
138628062|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
138628063|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
138628064|NCT00571285|Vitamins|vitamins|mesh-list
138628065|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
138628066|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628067|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138628068|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138628069|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138217872|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138628070|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138628071|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
138628072|NCT00571636|Fentanyl|fentanyl|mesh-list
138628073|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138628074|NCT00571636|Narcotics|narcotics|mesh-ancestor
138628075|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628076|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628077|NCT00571636|Analgesics|analgesics|mesh-ancestor
138628078|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
138628079|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138628080|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138628081|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138628082|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
138628083|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
138628084|NCT00571675|Prednisone|prednisone|mesh-list
138628085|NCT00571675|Docetaxel|docetaxel|mesh-list
138628086|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628087|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
138628088|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
138628089|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
138628090|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628091|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138628092|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
138628093|NCT00571675|Hormones|hormones|mesh-ancestor
138628094|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138628095|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628096|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138628097|NCT00571753|Isoniazid|isoniazid|mesh-list
138628098|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
138664108|NCT05388669|Lazertinib|lazertinib|mesh-list
138628099|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138628100|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628101|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138628102|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138628104|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684883|NCT02940405|Ketorolac|ketorolac|mesh-list
138628105|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138628106|NCT00254709|Sirolimus|sirolimus|mesh-list
138628107|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138628108|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628109|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138628110|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628111|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
138628112|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138628113|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
138628114|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628115|NCT00224822|Aripiprazole|aripiprazole|mesh-list
138628116|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
138628117|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138320917|NCT06124417|Sertraline|sertraline|mesh-list
138628118|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138628119|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138628120|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628121|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628122|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
138628123|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
138628124|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628125|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628126|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138628127|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138628128|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
138628129|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138628130|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138628131|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138628132|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138628133|NCT00571870|Cetrorelix|cetrorelix|mesh-list
138628134|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138304694|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
138628135|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
138628136|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138628138|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
138628139|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138628140|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138628141|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
138628142|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628143|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138628144|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138628145|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628146|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628147|NCT00572026|Methylphenidate|methylphenidate|mesh-list
138628148|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138628149|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628150|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138628151|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138628152|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138628153|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628154|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
138628155|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628157|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
138628158|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138628159|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
138346929|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
138628160|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628161|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628162|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
138628163|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628164|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138628165|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
138628166|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628167|NCT00234897|Adalimumab|adalimumab|mesh-list
138628168|NCT00234897|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138628169|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138628170|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138628171|NCT00572182|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
138664171|NCT05253053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138628172|NCT00572182|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138628173|NCT00572182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628175|NCT00572299|Alendronate|alendronate|mesh-list
138628176|NCT00572299|Prednisone|prednisone|mesh-list
138628177|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138628178|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
138628179|NCT00572299|Hormones|hormones|mesh-ancestor
138628180|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138628181|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628182|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138628183|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628184|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138628185|NCT00234936|Adalimumab|adalimumab|mesh-list
138628186|NCT00234936|Methotrexate|methotrexate|mesh-list
138628187|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138628188|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
138628189|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138628190|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628191|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138628192|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
138628193|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628194|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628195|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
138628196|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628197|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138628198|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138628199|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
138628200|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138628201|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138628202|NCT00234936|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138628203|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138628204|NCT00413075|Belinostat|belinostat|mesh-list
138217965|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628205|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628206|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138628207|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628208|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628209|NCT00572650|Vildagliptin|vildagliptin|mesh-list
138628210|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138628211|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628212|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138628213|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
138628214|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628215|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628216|NCT00572689|Exenatide|exenatide|mesh-list
138628217|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138628218|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628219|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138628220|NCT00572689|Incretins|incretins|mesh-ancestor
138628221|NCT00572689|Hormones|hormones|mesh-ancestor
138628222|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138628223|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
138628224|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138628225|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628226|NCT00224978|Chloroquine|chloroquine|mesh-list
138628227|NCT00224978|Amebicides|amebicides|mesh-ancestor
138628228|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138664205|NCT05242471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138628229|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138628230|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628231|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
138628232|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138628233|NCT00572884|Permethrin|permethrin|mesh-list
138628234|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628235|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628236|NCT00573001|Ritonavir|ritonavir|mesh-list
138628237|NCT00573001|Lopinavir|lopinavir|mesh-list
138628238|NCT00573001|Tenofovir|tenofovir|mesh-list
138628239|NCT00573001|Emtricitabine|emtricitabine|mesh-list
138628240|NCT00573001|Zidovudine|zidovudine|mesh-list
138628241|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138628242|NCT00573001|Nevirapine|nevirapine|mesh-list
138628243|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138628244|NCT00573001|Efavirenz|efavirenz|mesh-list
138628245|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138628246|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138628247|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
138628249|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628250|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138628251|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138628252|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
138628253|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628254|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138628255|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138628256|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138628257|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138628258|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
138628259|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138628260|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138628261|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138218000|NCT03804866|Doxorubicin|doxorubicin|mesh-list
138628262|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138628263|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138628264|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138628265|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
138628266|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628267|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138628268|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138628269|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628270|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628271|NCT00225056|Docetaxel|docetaxel|mesh-list
138628272|NCT00225056|Capecitabine|capecitabine|mesh-list
138628273|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628274|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
138628275|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
138628276|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
138684936|NCT02940483|Azacitidine|azacitidine|mesh-list
138628277|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628278|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138628279|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
138628280|NCT00225173|Prednisone|prednisone|mesh-list
138628281|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
138304876|NCT00378833|Niacin|niacin|mesh-list
138628282|NCT00225173|Gemcitabine|gemcitabine|mesh-list
138628283|NCT00225173|Doxorubicin|doxorubicin|mesh-list
138628284|NCT00225173|Etoposide|etoposide|mesh-list
138628285|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
138628286|NCT00225173|Vincristine|vincristine|mesh-list
138628287|NCT00225173|Vinorelbine|vinorelbine|mesh-list
138628288|NCT00225173|Bleomycin|bleomycin|mesh-list
138628289|NCT00225173|Vinblastine|vinblastine|mesh-list
138628290|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138628291|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
138628292|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628293|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138628294|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138628295|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
138628296|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628297|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628298|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138628299|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138628300|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
138628301|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138628302|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138628303|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138628304|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628305|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138628306|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
138628308|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138628309|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138628310|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138628311|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
138628312|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
138628313|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
138628314|NCT00234975|Ritonavir|ritonavir|mesh-list
138628315|NCT00234975|Lopinavir|lopinavir|mesh-list
138628316|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138628317|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138628318|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
138628319|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628320|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628321|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138628323|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
138218068|NCT01216241|Daptomycin|daptomycin|mesh-list
138628324|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628325|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138628326|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138628327|NCT00235014|Verapamil|verapamil|mesh-list
138628328|NCT00235014|Trandolapril|trandolapril|mesh-list
138628329|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138628330|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138628331|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138628332|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628333|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138628334|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628335|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
138628336|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138628337|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
138664238|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138628338|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628339|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138628341|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138628342|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
138628343|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628344|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
138628345|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138628346|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628347|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138628348|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138628349|NCT00225290|Growth Substances|growth substances|mesh-ancestor
138628350|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
138628351|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628352|NCT00573547|Fluoxetine|fluoxetine|mesh-list
138218097|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138628353|NCT00573547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138628354|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138628355|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138628356|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628357|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628359|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628360|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138628361|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
138628362|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628363|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138628364|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138628365|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628366|NCT00573664|Gabapentin|gabapentin|mesh-list
138628367|NCT00573664|Analgesics|analgesics|mesh-ancestor
138628368|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
138628369|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138628370|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628371|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
138628372|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138628373|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138628374|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628375|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628376|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138628377|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138628378|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628379|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628380|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
138628381|NCT00573742|Candesartan|candesartan|mesh-list
138628382|NCT00573742|Candesartan cilexetil|candesartan cilexetil|mesh-list
138628383|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138628384|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138628385|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138628386|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628387|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138628388|NCT00254865|Norelgestromin|norelgestromin|mesh-list
138628389|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
138628390|NCT00254865|Estradiol|estradiol|mesh-list
138628391|NCT00254865|Estrogens|estrogens|mesh-ancestor
138628392|NCT00254865|Hormones|hormones|mesh-ancestor
138218143|NCT04278872|SJX-653|sjx-653|mesh-list
138218144|NCT04278872|Hormone Antagonists|hormone antagonists|mesh-ancestor
138218146|NCT04278872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628393|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138628394|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628395|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138628438|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
138628439|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138628440|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138628441|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138628442|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138628443|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138628444|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138628445|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138628446|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628447|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628448|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628449|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138628450|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
138628451|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628452|NCT00574093|Ranibizumab|ranibizumab|mesh-list
138628453|NCT00574093|Verteporfin|verteporfin|mesh-list
138628454|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138628455|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138628456|NCT00574093|Growth Substances|growth substances|mesh-ancestor
138628457|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628458|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
138628459|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628460|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138628461|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
138628462|NCT00574366|Everolimus|everolimus|mesh-list
138628463|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138685049|NCT00520949|Furazolidone|furazolidone|mesh-list
138628464|NCT00574366|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138628465|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138628466|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628467|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628468|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138628470|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628471|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628472|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138628473|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138628474|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138628475|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138628476|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628477|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628478|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628479|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138218174|NCT05310968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138628480|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
138628481|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628483|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
138628484|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138628485|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
138628486|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138628487|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628488|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
138628489|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138628490|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
138628491|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628492|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628493|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628494|NCT00235092|Sirolimus|sirolimus|mesh-list
138628495|NCT00235092|Paclitaxel|paclitaxel|mesh-list
138628496|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138628497|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628498|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
138628499|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
138628500|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
138628501|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628502|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138305079|NCT01216631|Infliximab|infliximab|mesh-list
138628503|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628504|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138628505|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
138628506|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138628507|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
138628508|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628510|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
138628511|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628512|NCT00574639|Alprazolam|alprazolam|mesh-list
138628513|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138628514|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628515|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628516|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138628517|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138628518|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628519|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
138628520|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
138628521|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628522|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628523|NCT00255255|Budesonide|budesonide|mesh-list
138628524|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
138628525|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138628526|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138628527|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
138628528|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138628529|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628530|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138628531|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
138628532|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
138628533|NCT00255255|Hormones|hormones|mesh-ancestor
138628534|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138628535|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138628536|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138628537|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138628538|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
138628539|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628540|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628541|NCT00574756|Ranolazine|ranolazine|mesh-list
138628543|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138628544|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628546|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
138628547|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
138628548|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628549|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
138628550|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628553|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628554|NCT00575224|Interferons|interferons|mesh-list
138628555|NCT00575224|Ribavirin|ribavirin|mesh-list
138628556|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628557|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
138628558|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628559|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
138628560|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628561|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
138628562|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138628563|NCT00591487|Lidocaine|lidocaine|mesh-list
138628564|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
138628565|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
138628566|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628567|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628568|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
138628569|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138628570|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138628571|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138628572|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138628573|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138628574|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628575|NCT00225875|Rituximab|rituximab|mesh-list
138628576|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138305143|NCT02634827|Decitabine|decitabine|mesh-list
138628577|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628578|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
138628579|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628580|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138628582|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138628583|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628584|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
138628586|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138628587|NCT00225914|Paroxetine|paroxetine|mesh-list
138628588|NCT00225914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138628589|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138628590|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138628591|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628592|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628593|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
138628594|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286952|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
138628595|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138628596|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
138628597|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628598|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138628599|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138628600|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628601|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138628602|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138628603|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138628604|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628605|NCT00235248|Aspirin|aspirin|mesh-list
138628606|NCT00235248|Warfarin|warfarin|mesh-list
138628607|NCT00235248|Clopidogrel|clopidogrel|mesh-list
138628608|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138628609|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138628610|NCT00235248|Analgesics|analgesics|mesh-ancestor
138628611|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
138628612|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138628613|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628614|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138628616|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138628617|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138628618|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628619|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138628620|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138628621|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218257|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138628622|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
138628623|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138628624|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138628625|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138628626|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
138628627|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628628|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
138628629|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
138628630|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628631|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
138628632|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138628633|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
138628634|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628635|NCT03451435|Expectorants|expectorants|mesh-ancestor
138628636|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
138628637|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138628638|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
138628639|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138664371|NCT05068960|Bupivacaine|bupivacaine|mesh-list
138664372|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
138628641|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628642|NCT03451435|Antidotes|antidotes|mesh-ancestor
138628643|NCT04575064|Remdesivir|remdesivir|mesh-list
138628644|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
138628645|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628646|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
138628647|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628648|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
138628649|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138305224|NCT02504099|Ritonavir|ritonavir|mesh-list
138628650|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
138628651|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138628652|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138628653|NCT00255450|Hematinics|hematinics|mesh-ancestor
138628654|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138628655|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138628656|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
138628657|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138628659|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
138628660|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628661|NCT00226109|Spironolactone|spironolactone|mesh-list
138628662|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138628663|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
138628664|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138628665|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628666|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138628667|NCT00226109|Diuretics|diuretics|mesh-ancestor
138628668|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
138628669|NCT04573426|Acetaminophen|acetaminophen|mesh-list
138628670|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138628671|NCT04573426|Analgesics|analgesics|mesh-ancestor
138628672|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
138628673|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138321032|NCT06123715|Ascorbic Acid|ascorbic acid|mesh-list
138628675|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
138628676|NCT00235287|Candesartan|candesartan|mesh-list
138628677|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
138664405|NCT05040126|Linezolid|linezolid|mesh-list
138628679|NCT00235287|Enalaprilat|enalaprilat|mesh-list
138628680|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138628681|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138628682|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138628683|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628684|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138628685|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
138628686|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628688|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628689|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138628690|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628691|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628692|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
138628693|NCT04573153|Sorbitol|sorbitol|mesh-list
138628694|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
138628695|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138628696|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138628697|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628698|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628699|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628700|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138628701|NCT04573153|Cathartics|cathartics|mesh-ancestor
138628702|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138628703|NCT00255528|Metoprolol|metoprolol|mesh-list
138628704|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138628705|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138628706|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
138628707|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
138628708|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138628709|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628710|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138628711|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138628712|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138628713|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
138628714|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628715|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628716|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138628717|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138628718|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138628719|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628720|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628721|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628722|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138628723|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138628724|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
138305287|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
138628726|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628727|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138628728|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138628729|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
138628730|NCT04572724|Valsartan|valsartan|mesh-list
138628731|NCT04572724|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138218373|NCT01339091|Linezolid|linezolid|mesh-list
138218374|NCT01339091|Dalbavancin|dalbavancin|mesh-list
138628732|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138628733|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138628734|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138685155|NCT02937519|Cisplatin|cisplatin|mesh-list
138628735|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628736|NCT00255567|Paromomycin|paromomycin|mesh-list
138628737|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138628738|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138628739|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628740|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138628741|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138628742|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
138628743|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138628744|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
138628745|NCT03450967|Durvalumab|durvalumab|mesh-list
138628746|NCT03450967|Tremelimumab|tremelimumab|mesh-list
138628747|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138628748|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628749|NCT00255606|Prednisone|prednisone|mesh-list
138628750|NCT00255606|Docetaxel|docetaxel|mesh-list
138628751|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628752|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
138628753|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
138628754|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
138628755|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628756|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138628757|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
138628758|NCT00255606|Hormones|hormones|mesh-ancestor
138628759|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138628760|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628761|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138628762|NCT00226343|Valproic Acid|valproic acid|mesh-list
138628763|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
138628764|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628765|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628766|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
138628767|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628768|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628769|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
138218399|NCT00772772|Vitamin D|vitamin d|mesh-list
138218400|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
138628770|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138628771|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628772|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628773|NCT03450499|Ketamine|ketamine|mesh-list
138628774|NCT03450499|Analgesics|analgesics|mesh-ancestor
138628775|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
138628776|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138628777|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628778|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138628779|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138628780|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
138628781|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
138628782|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628783|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138628784|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138628785|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628786|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628787|NCT00226382|Interferons|interferons|mesh-list
138628788|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
138628789|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
138628790|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138628791|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628792|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
138628793|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628794|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
138628795|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628796|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138628797|NCT01580839|Plasminogen|plasminogen|mesh-list
138628798|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138628799|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138628800|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628801|NCT03450226|Bupivacaine|bupivacaine|mesh-list
138628802|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
138628803|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
138628804|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628805|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628806|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
138628807|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138664502|NCT04967417|Paclitaxel|paclitaxel|mesh-list
138628809|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138628810|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138628811|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138628813|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138628814|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628815|NCT00413387|Budesonide|budesonide|mesh-list
138628816|NCT00413387|Beclomethasone|beclomethasone|mesh-list
138628817|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
138628818|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138628819|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138628820|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
138628821|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138628822|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628823|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138628824|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
138628825|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
138628826|NCT00413387|Hormones|hormones|mesh-ancestor
138628827|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138628828|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138628829|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138628830|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138628831|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
138628832|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628833|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628834|NCT00413426|Darifenacin|darifenacin|mesh-list
138628835|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138628836|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138628837|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
138628838|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628839|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628840|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628841|NCT00413426|Urological Agents|urological agents|mesh-ancestor
138628843|NCT00255762|Bevacizumab|bevacizumab|mesh-list
138628844|NCT00255762|Carboplatin|carboplatin|mesh-list
138628845|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138628846|NCT00255762|Antibodies|antibodies|mesh-list
138628847|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
138628848|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138628849|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138628850|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628851|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
138628853|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
138628854|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628855|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138628856|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138628857|NCT00255762|Growth Substances|growth substances|mesh-ancestor
138628858|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628859|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
138628860|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
138628861|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138628862|NCT02277457|Crizotinib|crizotinib|mesh-list
138628863|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628864|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138628865|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628866|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628867|NCT00255879|Olanzapine|olanzapine|mesh-list
138628868|NCT00255879|Risperidone|risperidone|mesh-list
138628869|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138628870|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138628871|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
138628872|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628873|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628874|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628875|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138628876|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138628877|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628878|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628879|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138628880|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
138628881|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
138628882|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
138628883|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138628884|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138628885|NCT00255879|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138628886|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138628887|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138628890|NCT00413504|Fondaparinux|fondaparinux|mesh-list
138628891|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138628892|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
138628893|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138628894|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
138628895|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628896|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628897|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
138628898|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138628899|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138628900|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138628901|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628902|NCT04721223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138628903|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628904|NCT00226538|Rifampin|rifampin|mesh-list
138628905|NCT00226538|Fluconazole|fluconazole|mesh-list
138628906|NCT00226538|Diclofenac|diclofenac|mesh-list
138628907|NCT00226538|Phenytoin|phenytoin|mesh-list
138218553|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138628908|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138628909|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138628910|NCT00226538|Analgesics|analgesics|mesh-ancestor
138628911|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
138628912|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138628913|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628914|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138628915|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138628916|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138628917|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628918|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628919|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138628920|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
138628921|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138628922|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628923|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
138628924|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138628925|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138628926|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138664606|NCT04886531|Trastuzumab|trastuzumab|mesh-list
138628927|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138628928|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138628929|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138628930|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138628931|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
138628932|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138628933|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138628934|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138628935|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
138321131|NCT06113640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628936|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138628937|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138628938|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138628939|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
138628940|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138628941|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138628942|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138628943|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138628944|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
138628945|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138628946|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138628947|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
138628948|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628949|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628950|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628952|NCT00226694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138628953|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138628954|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138628955|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628956|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628957|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
138628958|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628959|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138628960|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
138628961|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628962|NCT00255996|Linezolid|linezolid|mesh-list
138628963|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138628964|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138628965|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138628966|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138628967|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628968|NCT00226889|Bosentan|bosentan|mesh-list
138628970|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138628971|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628972|NCT00226967|Octreotide|octreotide|mesh-list
138628973|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138628974|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138628975|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138628976|NCT00199381|Istradefylline|istradefylline|mesh-list
138628977|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138628978|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138628979|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138628980|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
138628981|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628982|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628983|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628984|NCT00227084|Hemostatics|hemostatics|mesh-list
138628985|NCT00227084|Coagulants|coagulants|mesh-ancestor
138628986|NCT00227123|Risperidone|risperidone|mesh-list
138628987|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138628988|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138628989|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
138628990|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138628991|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138628992|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138628993|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138628994|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138628995|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138628996|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138628997|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138628998|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
138628999|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
138629000|NCT00235521|Iloprost|iloprost|mesh-list
138629001|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138629002|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
138629003|NCT00235560|Sirolimus|sirolimus|mesh-list
138629004|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138629005|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138218630|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629006|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138629007|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629008|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
138629009|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138629010|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
138629011|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629012|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
138629013|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138664663|NCT04799054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138629014|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138629015|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138629016|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629018|NCT00227357|Methadone|methadone|mesh-list
138629019|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138629021|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138629022|NCT00227357|Narcotics|narcotics|mesh-ancestor
138629023|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629024|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629025|NCT00227357|Analgesics|analgesics|mesh-ancestor
138629026|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
138629027|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629028|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138629029|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
138685226|NCT00522587|Narcotics|narcotics|mesh-ancestor
138629030|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
138629031|NCT00198133|Pemetrexed|pemetrexed|mesh-list
138629032|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629033|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629034|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629035|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138629036|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138629037|NCT00227474|Vaccines|vaccines|mesh-list
138629038|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
138629039|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629040|NCT00227513|Bortezomib|bortezomib|mesh-list
138629041|NCT00227513|Vorinostat|vorinostat|mesh-list
138629042|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629043|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138629044|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629045|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629046|NCT00227630|Pemetrexed|pemetrexed|mesh-list
138629047|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629048|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138664688|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138664694|NCT04742673|Guanfacine|guanfacine|mesh-list
138629049|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629050|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138629051|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138629052|NCT00256230|Disulfiram|disulfiram|mesh-list
138629053|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138629054|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138629055|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629056|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629057|NCT00227669|Gemcitabine|gemcitabine|mesh-list
138629058|NCT00227669|Docetaxel|docetaxel|mesh-list
138629059|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138629060|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
138629061|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629062|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629063|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
138629065|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
138629066|NCT00235794|Sirolimus|sirolimus|mesh-list
138629067|NCT00235794|Temsirolimus|temsirolimus|mesh-list
138629068|NCT00235794|MTOR Inhibitors|mtor inhibitors|mesh-list
138629069|NCT00235794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138629070|NCT00235794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629071|NCT00235794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629072|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138629073|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
138629074|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629075|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629076|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138629077|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138629078|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138629079|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
138629080|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
138629081|NCT00256269|Irinotecan|irinotecan|mesh-list
138629082|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629083|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138629084|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138629085|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629086|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629087|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138629088|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
138629089|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629091|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629092|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
138629093|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
138629094|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
138629095|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629096|NCT00235911|Budesonide|budesonide|mesh-list
138629097|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
138629098|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138629099|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138629100|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
138629101|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629102|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629103|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138218679|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
138629104|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
138629105|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
138629106|NCT00235911|Hormones|hormones|mesh-ancestor
138629107|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138629108|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138629109|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138629110|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138629111|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
138629112|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629113|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629114|NCT00256347|Morphine|morphine|mesh-list
138629115|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138629116|NCT00256347|Narcotics|narcotics|mesh-ancestor
138629117|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629118|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629119|NCT00256347|Analgesics|analgesics|mesh-ancestor
138629120|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
138629121|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629123|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
138629124|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138629125|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
138629126|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629127|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629128|NCT00235950|Clopidogrel|clopidogrel|mesh-list
138629129|NCT00235950|Atorvastatin|atorvastatin|mesh-list
138629130|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138629131|NCT00235950|Simvastatin|simvastatin|mesh-list
138629132|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138629133|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138629134|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
138629135|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629136|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138629137|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138629138|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629139|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138629140|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138629141|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138629142|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138629143|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
138629144|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629145|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629147|NCT00227942|Estrogens|estrogens|mesh-list
138629148|NCT00227942|Hormones|hormones|mesh-ancestor
138629149|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138629150|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629151|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138629152|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138629153|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629154|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138629155|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
138629156|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
138629157|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629158|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629159|NCT00227981|Fluoxetine|fluoxetine|mesh-list
138629160|NCT00227981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138629161|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138629162|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138629163|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629164|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629165|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
138629166|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629167|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138629168|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
138629169|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138629170|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138629171|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138629172|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629174|NCT00236028|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138629175|NCT00236028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138629176|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
138321188|NCT06027723|Nicotine|nicotine|mesh-list
138629177|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138629178|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138629179|NCT00256542|Lidocaine|lidocaine|mesh-list
138629180|NCT00256542|Heparin|heparin|mesh-list
138629181|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
138629182|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
138629183|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138218742|NCT06214533|Ropivacaine|ropivacaine|mesh-list
138629184|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629186|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629187|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138629188|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138629189|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138629190|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138629191|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629192|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
138629193|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138629194|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138629195|NCT00228020|Cyclosporine|cyclosporine|mesh-list
138629196|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
138629197|NCT00228020|Prednisone|prednisone|mesh-list
138629198|NCT00228020|Cyclosporins|cyclosporins|mesh-list
138629199|NCT00228020|Basiliximab|basiliximab|mesh-list
138629200|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138629201|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
138629202|NCT00228020|Hormones|hormones|mesh-ancestor
138629203|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138629204|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629205|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138629206|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629207|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629208|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629209|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138629210|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
138629211|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
138629212|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138629213|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
138629214|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138629215|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138629216|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138629217|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138629218|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
138629219|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138629221|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
138629222|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
138629223|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138629224|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138629225|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629226|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
138629227|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629228|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629229|NCT00195715|Adalimumab|adalimumab|mesh-list
138629230|NCT00195715|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138629231|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138629232|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138629233|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
138629234|NCT00236106|Tacrolimus|tacrolimus|mesh-list
138629235|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138629236|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
138629237|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629238|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138629239|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629240|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629241|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138629242|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
138629243|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138629245|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138629246|NCT00236145|Narcotics|narcotics|mesh-ancestor
138629247|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629248|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629249|NCT00236145|Analgesics|analgesics|mesh-ancestor
138629250|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
138629251|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629252|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138629253|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138629254|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
138629255|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
138629256|NCT00228254|Vitamin A|vitamin a|mesh-list
138629257|NCT00228254|Vitamins|vitamins|mesh-ancestor
138629258|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
138629259|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629260|NCT00195676|Adalimumab|adalimumab|mesh-list
138629261|NCT00195676|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138629262|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138629263|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138629264|NCT00194077|Aripiprazole|aripiprazole|mesh-list
138629265|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
138629266|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138629267|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138629268|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138629269|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629270|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629271|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
138629273|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629274|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629275|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138629276|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138629277|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
138629278|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138629279|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138629280|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138664845|NCT04630145|Bedaquiline|bedaquiline|mesh-list
138629281|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138629283|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
138629284|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138629285|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
138629286|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629287|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629288|NCT00228410|Vancomycin|vancomycin|mesh-list
138629289|NCT00228410|Tigecycline|tigecycline|mesh-list
138218812|NCT06213987|Tretinoin|tretinoin|mesh-list
138629290|NCT00228410|Aztreonam|aztreonam|mesh-list
138629291|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138629292|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138629293|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138629294|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629295|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629296|NCT00193180|Docetaxel|docetaxel|mesh-list
138629297|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
138629298|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629299|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
138629300|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
138629301|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
138629302|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321214|NCT05991232|Ketamine|ketamine|mesh-list
138629303|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138629304|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629305|NCT00193063|Gemcitabine|gemcitabine|mesh-list
138629306|NCT00193063|Trastuzumab|trastuzumab|mesh-list
138629307|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138629308|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
138629309|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629310|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629311|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138629312|NCT00228488|Gefitinib|gefitinib|mesh-list
138629313|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629314|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138629315|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629316|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629317|NCT00228527|Esomeprazole|esomeprazole|mesh-list
138629318|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138629319|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138629320|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138629321|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629322|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629324|NCT00191854|Carboplatin|carboplatin|mesh-list
138629325|NCT00191854|Gemcitabine|gemcitabine|mesh-list
138629326|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138629327|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629328|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
138629329|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
138629330|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
138629331|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629332|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138629333|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
138629334|NCT00228605|Fentanyl|fentanyl|mesh-list
138629335|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138629336|NCT00228605|Narcotics|narcotics|mesh-ancestor
138629337|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629338|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629340|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
138629341|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629342|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138629343|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138629344|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
138629345|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
138629346|NCT00191815|Gemcitabine|gemcitabine|mesh-list
138629347|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629348|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138629349|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
138629350|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629351|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138629352|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138629353|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138629354|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138629355|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629356|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
138629357|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629358|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629359|NCT00191308|Pemetrexed|pemetrexed|mesh-list
138629360|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629361|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629362|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629363|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138629364|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138629365|NCT00228839|Infliximab|infliximab|mesh-list
138629366|NCT00228839|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138629367|NCT00228839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138629368|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
138629369|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138629370|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138629371|NCT00191269|Gemcitabine|gemcitabine|mesh-list
138629372|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138629373|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
138629374|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629375|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629376|NCT00228878|Insulin|insulin|mesh-list
138629377|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
138629378|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138629379|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629380|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
138629381|NCT00228995|Hematinics|hematinics|mesh-ancestor
138629382|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
138629383|NCT00413946|Hematinics|hematinics|mesh-ancestor
138629384|NCT00229112|Tazobactam|tazobactam|mesh-list
138629385|NCT00229112|Piperacillin|piperacillin|mesh-list
138629386|NCT00229112|Ertapenem|ertapenem|mesh-list
138629387|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138629388|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629389|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138629390|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138629391|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138629392|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629394|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138305975|NCT01351415|Docetaxel|docetaxel|mesh-list
138629395|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138629396|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138629397|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629398|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629401|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629402|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629403|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138629404|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138629405|NCT00414024|Tegaserod|tegaserod|mesh-list
138629406|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138629407|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
138629408|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629409|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629410|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629411|NCT00256893|Ropinirole|ropinirole|mesh-list
138629412|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138629413|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138629414|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
138629415|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
138629416|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629417|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629418|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629419|NCT00229385|Ziprasidone|ziprasidone|mesh-list
138629420|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138629421|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
138629422|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629423|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629424|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629425|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138218882|NCT06213506|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138218883|NCT06213506|Immunologic Factors|immunologic factors|mesh-ancestor
138218884|NCT06213506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218892|NCT06213324|Ketamine|ketamine|mesh-list
138218893|NCT06213324|Analgesics|analgesics|mesh-ancestor
138218894|NCT06213324|Sensory System Agents|sensory system agents|mesh-ancestor
138218895|NCT06213324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629426|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138629427|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629428|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138629429|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138629430|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
138629431|NCT00236223|Dexamethasone|dexamethasone|mesh-list
138664976|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138629432|NCT00236223|Ketamine|ketamine|mesh-list
138629433|NCT00236223|Gabapentin|gabapentin|mesh-list
138629434|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138629435|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
138629436|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
138629437|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629438|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629439|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138629440|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
138629441|NCT00236223|Hormones|hormones|mesh-ancestor
138685340|NCT00523289|Bupivacaine|bupivacaine|mesh-list
138629442|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138629444|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629445|NCT00236223|Analgesics|analgesics|mesh-ancestor
138629446|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
138629447|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138629448|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138629449|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
138629450|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
138629451|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629452|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138629453|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138629454|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629455|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629456|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
138629457|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138629458|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138629459|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138629460|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
138629461|NCT00229424|Famotidine|famotidine|mesh-list
138629462|NCT00229424|Lafutidine|lafutidine|mesh-list
138629463|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138629464|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138629465|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138629466|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
138629467|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
138629468|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629469|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629470|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629472|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138629473|NCT00191152|Gemcitabine|gemcitabine|mesh-list
138629474|NCT00191152|Capecitabine|capecitabine|mesh-list
138629475|NCT00191152|Docetaxel|docetaxel|mesh-list
138629476|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138629477|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
138629478|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665027|NCT04542824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138629479|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629480|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
138629481|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
138629482|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
138629483|NCT00257049|Levofloxacin|levofloxacin|mesh-list
138629484|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138629485|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138629486|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138629487|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138629488|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138629489|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629490|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629491|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629492|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138629493|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138629494|NCT01059188|Docetaxel|docetaxel|mesh-list
138629495|NCT01059188|Cetuximab|cetuximab|mesh-list
138629496|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629497|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
138629498|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
138629499|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
138629500|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629501|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138629502|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138629503|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138629505|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138629506|NCT00236301|Estrogens|estrogens|mesh-ancestor
138629507|NCT00236301|Hormones|hormones|mesh-ancestor
138629508|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138629509|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629510|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138629511|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
138629512|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138629513|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138629514|NCT00229697|Tamoxifen|tamoxifen|mesh-list
138629515|NCT00229697|Gefitinib|gefitinib|mesh-list
138629516|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138629517|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
138629518|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138629519|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629520|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138629521|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629522|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138629523|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138629524|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138665059|NCT04538664|Carboplatin|carboplatin|mesh-list
138629525|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138629526|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629527|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629528|NCT00236379|Olanzapine|olanzapine|mesh-list
138629529|NCT00236379|Risperidone|risperidone|mesh-list
138629530|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138629531|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
138629532|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629533|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629534|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629535|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138629536|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138629537|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629538|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138629539|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138629540|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
138629541|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
138629542|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
138629543|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629544|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138629545|NCT00236379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138629546|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138218931|NCT06213077|Antioxidants|antioxidants|mesh-ancestor
138629547|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138629549|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
138629550|NCT00229775|Artemether|artemether|mesh-list
138629551|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
138629552|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138629553|NCT00229775|Amebicides|amebicides|mesh-ancestor
138629554|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138629555|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138629556|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138629557|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
138629558|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138629559|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138629560|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629561|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629562|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138629563|NCT00257127|Vaccines|vaccines|mesh-list
138629564|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138629565|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
138629566|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629567|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138629568|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138629569|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138629570|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138629571|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629572|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
138629573|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629574|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629576|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
138629577|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138629578|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629579|NCT00236457|Risperidone|risperidone|mesh-list
138629580|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138629581|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
138629582|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629583|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629584|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629585|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138629586|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138629587|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629588|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138629589|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138629590|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
138629591|NCT00236496|Topiramate|topiramate|mesh-list
138629592|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
138629593|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138629594|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629595|NCT00199277|Iron|iron|mesh-list
138629596|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138685411|NCT02947880|Bumetanide|bumetanide|mesh-list
138629597|NCT00199277|Trace Elements|trace elements|mesh-ancestor
138629598|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
138629599|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629600|NCT00199277|Hematinics|hematinics|mesh-ancestor
138629601|NCT00236535|Acetaminophen|acetaminophen|mesh-list
138629602|NCT00236535|Tramadol|tramadol|mesh-list
138629603|NCT00236535|Hydrocodone|hydrocodone|mesh-list
138629604|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138629605|NCT00236535|Analgesics|analgesics|mesh-ancestor
138629606|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
138629607|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629608|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629609|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
138629610|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138629611|NCT00236535|Narcotics|narcotics|mesh-ancestor
138629612|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629613|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
138629614|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
138629615|NCT00193219|Leucovorin|leucovorin|mesh-list
138629616|NCT00193219|Bevacizumab|bevacizumab|mesh-list
138629617|NCT00193219|Cetuximab|cetuximab|mesh-list
138629618|NCT00193219|Fluorouracil|fluorouracil|mesh-list
138629619|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
138665110|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
138665111|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138665112|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
138629620|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138629621|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629622|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138629623|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138629625|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629626|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
138629627|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
138629628|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629629|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138629630|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138629631|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
138629632|NCT00193219|Antidotes|antidotes|mesh-ancestor
138629633|NCT00193219|Protective Agents|protective agents|mesh-ancestor
138629634|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
138629635|NCT00193219|Vitamins|vitamins|mesh-ancestor
138629636|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
138629637|NCT00199316|Morphine|morphine|mesh-list
138629638|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138629639|NCT00199316|Narcotics|narcotics|mesh-ancestor
138629640|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629641|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629642|NCT00199316|Analgesics|analgesics|mesh-ancestor
138629643|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
138629644|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629645|NCT00196339|Cyproterone Acetate|cyproterone acetate|mesh-list
138629646|NCT00196339|Cyproterone|cyproterone|mesh-list
138629647|NCT00196339|Androgen Antagonists|androgen antagonists|mesh-ancestor
138629648|NCT00196339|Hormone Antagonists|hormone antagonists|mesh-ancestor
138218970|NCT06212830|Acetaminophen|acetaminophen|mesh-list
138629649|NCT00196339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138629650|NCT00196339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629651|NCT00196339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629652|NCT00196339|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138629653|NCT00196339|Contraceptive Agents|contraceptive agents|mesh-ancestor
138629654|NCT00196339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138629655|NCT00257361|Cycloserine|cycloserine|mesh-list
138629656|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138629657|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685429|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138629658|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138629659|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
138629660|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138629661|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
138629662|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629663|NCT00199355|Istradefylline|istradefylline|mesh-list
138629664|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138629665|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138629666|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138629667|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
138629668|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629669|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629670|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629671|NCT00179959|Mupirocin|mupirocin|mesh-list
138629672|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138629674|NCT00179959|Petrolatum|petrolatum|mesh-list
138629675|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138629676|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138629677|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138629678|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629679|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629680|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
138629681|NCT00179959|Emollients|emollients|mesh-ancestor
138629682|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
138629683|NCT00199394|Istradefylline|istradefylline|mesh-list
138629684|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138629685|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138629687|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
138629688|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629689|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629690|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629691|NCT00236574|Galantamine|galantamine|mesh-list
138629692|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138629693|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218994|NCT06212752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219005|NCT06212661|Botulinum Toxins|botulinum toxins|mesh-list
138629694|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629695|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
138629696|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629697|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629698|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138629700|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629701|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
138629702|NCT00199433|Istradefylline|istradefylline|mesh-list
138629703|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138629704|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138629705|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138629706|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
138629707|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629708|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665169|NCT04388163|Gentian Violet|gentian violet|mesh-list
138665170|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138629711|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
138629712|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629713|NCT00199511|Mannitol|mannitol|mesh-list
138629714|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138629715|NCT00199511|Diuretics|diuretics|mesh-ancestor
138629716|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
138629717|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629718|NCT00236613|Topiramate|topiramate|mesh-list
138629719|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
138629721|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629722|NCT00236652|Levofloxacin|levofloxacin|mesh-list
138629723|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138629724|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138629725|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138629726|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138629727|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138629728|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629729|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629730|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629731|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138629732|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138629733|NCT00257595|Cetirizine|cetirizine|mesh-list
138629734|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138629735|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138629736|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138629737|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
138629738|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
138629739|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629740|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629741|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629742|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
138629743|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138629744|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629745|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138629746|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
138629747|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138629748|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138629749|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629750|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629751|NCT00236691|Topiramate|topiramate|mesh-list
138629752|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
138629753|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138629754|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629755|NCT00236730|Topiramate|topiramate|mesh-list
138629756|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
138629757|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138629758|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629759|NCT00199745|Atorvastatin|atorvastatin|mesh-list
138629760|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138629761|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138629762|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
138629763|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629764|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138629765|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138629766|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629767|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
138629768|NCT04709172|Cefditoren|cefditoren|mesh-list
138629769|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138306358|NCT00000263|Ethanol|ethanol|mesh-list
138629771|NCT00199784|Phenylephrine|phenylephrine|mesh-list
138629772|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
138629773|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138629774|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
138629775|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
138629776|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629777|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629778|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
138629779|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138629780|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
138629781|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
138629782|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138629783|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138629784|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138629785|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
138629786|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629787|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629788|NCT00199784|Protective Agents|protective agents|mesh-ancestor
138629789|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138629790|NCT00236769|Norelgestromin|norelgestromin|mesh-list
138629791|NCT00236769|Estradiol|estradiol|mesh-list
138629792|NCT00236769|Estrogens|estrogens|mesh-ancestor
138629793|NCT00236769|Hormones|hormones|mesh-ancestor
138665237|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138665239|NCT04224740|Cisplatin|cisplatin|mesh-list
138629794|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138629795|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629796|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138629798|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138629799|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138629800|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138629801|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138629802|NCT00415311|Lectins|lectins|mesh-list
138629803|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
138629804|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
138629805|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629806|NCT00415311|Coagulants|coagulants|mesh-ancestor
138629807|NCT00199940|Ziprasidone|ziprasidone|mesh-list
138629808|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138629809|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
138629810|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629811|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629812|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629814|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138629815|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138629816|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138629817|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138629818|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
138629819|NCT00236808|Levofloxacin|levofloxacin|mesh-list
138629820|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138629821|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138629822|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138629823|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138629824|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138629825|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629826|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629827|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629828|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138629829|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138629830|NCT00199979|Nevirapine|nevirapine|mesh-list
138629831|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138629832|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138629833|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629834|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629835|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
138629837|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138629838|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138629839|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138629840|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138629841|NCT00257634|Dexamethasone|dexamethasone|mesh-list
138629842|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138629843|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
138629844|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
138629845|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629846|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629847|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138629848|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
138629850|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138629851|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138629852|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629853|NCT00236847|Topiramate|topiramate|mesh-list
138629854|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
138629855|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138629856|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629857|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
138219063|NCT06212583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629858|NCT00410306|Testosterone|testosterone|mesh-list
138629859|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
138629860|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
138629861|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138629862|NCT00410306|Androgens|androgens|mesh-ancestor
138629863|NCT00410306|Hormones|hormones|mesh-ancestor
138629864|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138629865|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629866|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138629867|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629868|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
138629869|NCT00257712|Hormones|hormones|mesh-list
138629870|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
138629871|NCT00257712|Tesamorelin|tesamorelin|mesh-list
138321326|NCT05566054|Azacitidine|azacitidine|mesh-list
138629872|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138629873|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629874|NCT00257712|Growth Substances|growth substances|mesh-ancestor
138629875|NCT00179647|Dexamethasone|dexamethasone|mesh-list
138629876|NCT00179647|Lenalidomide|lenalidomide|mesh-list
138629877|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138629878|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
138629879|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
138629880|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629881|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629882|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138629883|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
138629884|NCT00179647|Hormones|hormones|mesh-ancestor
138629885|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138629886|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138629887|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629888|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
138629889|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138629890|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138629891|NCT00179647|Growth Substances|growth substances|mesh-ancestor
138629892|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
138629893|NCT00257751|Aprotinin|aprotinin|mesh-list
138629894|NCT00257751|Hemostatics|hemostatics|mesh-ancestor
138629895|NCT00257751|Coagulants|coagulants|mesh-ancestor
138629896|NCT00257751|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138629897|NCT00257751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138629898|NCT00257751|Protease Inhibitors|protease inhibitors|mesh-ancestor
138629899|NCT00257751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629900|NCT00257751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629901|NCT00179413|Interferons|interferons|mesh-list
138629902|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
138629903|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
138629904|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138629905|NCT00179413|Colchicine|colchicine|mesh-list
138629906|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665284|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
138629907|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
138629908|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138629909|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
138629910|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629911|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
138629912|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138629913|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
138629914|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
138629915|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
138629916|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629917|NCT00236886|Topiramate|topiramate|mesh-list
138306499|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629918|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
138629919|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138629920|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629921|NCT00257790|Tobramycin|tobramycin|mesh-list
138629922|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138629923|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138629924|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
138629926|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
138629927|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138629928|NCT00236964|Hematinics|hematinics|mesh-ancestor
138629929|NCT00200252|Oxytocin|oxytocin|mesh-list
138629930|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
138629931|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138629932|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629933|NCT00177307|Bevacizumab|bevacizumab|mesh-list
138629934|NCT00177307|Capecitabine|capecitabine|mesh-list
138629935|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
138629936|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138629938|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138629939|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138629940|NCT00177307|Growth Substances|growth substances|mesh-ancestor
138629941|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629942|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
138629943|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138629944|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
138629945|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629946|NCT00257829|Methazolamide|methazolamide|mesh-list
138629947|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138629948|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629949|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629950|NCT00257829|Diuretics|diuretics|mesh-ancestor
138629951|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
138629952|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629954|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138629955|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138629956|NCT02484664|Analgesics|analgesics|mesh-ancestor
138629957|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
138629958|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138629959|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219115|NCT06200194|Atropine|atropine|mesh-list
138629960|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138629961|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138629962|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138629963|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138629964|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685506|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
138629965|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629967|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138629968|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629969|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629970|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
138629971|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138629972|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629973|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138629974|NCT00257868|Protective Agents|protective agents|mesh-ancestor
138629975|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
138629976|NCT00176605|Etoposide|etoposide|mesh-list
138629977|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138629978|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
138629979|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138629980|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138629981|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138629982|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
138629983|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629984|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629985|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138629986|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138629987|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138629988|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138629989|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138629990|NCT00176488|Vinorelbine|vinorelbine|mesh-list
138629991|NCT00176488|Epirubicin|epirubicin|mesh-list
138629992|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138629993|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138629994|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
138306581|NCT00000311|Buprenorphine|buprenorphine|mesh-list
138629995|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
138629996|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
138629997|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138629999|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138630000|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138630001|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630002|NCT00200447|Carbidopa|carbidopa|mesh-list
138630003|NCT00200447|Levodopa|levodopa|mesh-list
138630004|NCT00200447|Entacapone|entacapone|mesh-list
138630005|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
138630006|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138630007|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138630008|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
138630009|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630010|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630011|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630012|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138630013|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630014|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138630015|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
138630016|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630017|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138630018|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630019|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630020|NCT00175825|Brivaracetam|brivaracetam|mesh-list
138630021|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
138630022|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
138630023|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
138630024|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630025|NCT04710329|Protective Agents|protective agents|mesh-ancestor
138630026|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630027|NCT04710329|Vitamins|vitamins|mesh-ancestor
138630028|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
138630029|NCT00200525|Apomorphine|apomorphine|mesh-list
138630030|NCT00200525|Emetics|emetics|mesh-ancestor
138630031|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630032|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
138630033|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630034|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630035|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
138630036|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
138630037|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630038|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630039|NCT00174967|Febuxostat|febuxostat|mesh-list
138630040|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
138630041|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138630042|NCT00200564|Ketamine|ketamine|mesh-list
138630043|NCT00200564|Analgesics|analgesics|mesh-ancestor
138630044|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
138630045|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219163|NCT06190249|Analgesics|analgesics|mesh-ancestor
138630046|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138665360|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
138630047|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138630048|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138630049|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
138630050|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
138630051|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138630052|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138630053|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138630054|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630055|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630056|NCT00174265|Olanzapine|olanzapine|mesh-list
138630057|NCT00174265|Asenapine|asenapine|mesh-list
138630058|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
138630059|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
138630060|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630061|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630062|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630063|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138630064|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138630065|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138630066|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138321363|NCT05482542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630067|NCT00174265|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138685538|NCT02935764|Leucovorin|leucovorin|mesh-list
138630068|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138630069|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138630070|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630071|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630072|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
138630073|NCT00200603|Calcium|calcium|mesh-list
138630074|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138630075|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630077|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630078|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138630079|NCT00258063|Norelgestromin|norelgestromin|mesh-list
138630080|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
138630081|NCT00258063|Estradiol|estradiol|mesh-list
138630082|NCT00258063|Estrogens|estrogens|mesh-ancestor
138630083|NCT00258063|Hormones|hormones|mesh-ancestor
138532538|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219204|NCT06132958|Mitosis Modulators|mitosis modulators|mesh-ancestor
138219215|NCT06108830|Propofol|propofol|mesh-list
138630084|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630085|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630086|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138630087|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138630088|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138630089|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138630090|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138630091|NCT00258102|Levofloxacin|levofloxacin|mesh-list
138630092|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138630093|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630094|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138665395|NCT04087317|Ibuprofen|ibuprofen|mesh-list
138630095|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138630096|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138630097|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630098|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630099|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630100|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138630101|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138630103|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138630104|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630105|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138630106|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138630107|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138630108|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630109|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
138630110|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138630111|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630112|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
138630113|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138630114|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630115|NCT00258297|Gefitinib|gefitinib|mesh-list
138630116|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138630117|NCT00258297|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138630118|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630119|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138630120|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630121|NCT00258336|Rituximab|rituximab|mesh-list
138630122|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
138630123|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138630124|NCT00258336|Antibodies|antibodies|mesh-list
138630125|NCT00258336|Sargramostim|sargramostim|mesh-list
138630126|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138630127|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138630129|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
138630130|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630131|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138630132|NCT00171925|Vitamin D|vitamin d|mesh-list
138630133|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
138630134|NCT00171925|Calcium|calcium|mesh-list
138630135|NCT00171925|Vitamins|vitamins|mesh-ancestor
138630136|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
138630137|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630138|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138630139|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138630140|NCT00201305|Leucovorin|leucovorin|mesh-list
138630141|NCT00201305|Gemcitabine|gemcitabine|mesh-list
138630142|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138630143|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
138630144|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630145|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630146|NCT00201305|Antidotes|antidotes|mesh-ancestor
138630147|NCT00201305|Protective Agents|protective agents|mesh-ancestor
138630149|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
138630150|NCT00201305|Vitamins|vitamins|mesh-ancestor
138630151|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
138630152|NCT00265551|Olanzapine|olanzapine|mesh-list
138630153|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
138630154|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
138630155|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630156|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630157|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630158|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138630159|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138630160|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138630161|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138630162|NCT00265551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138630163|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138630164|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138630165|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630166|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630167|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
138630168|NCT00201344|Leucovorin|leucovorin|mesh-list
138630169|NCT00201344|Antidotes|antidotes|mesh-ancestor
138630170|NCT00201344|Protective Agents|protective agents|mesh-ancestor
138630171|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630172|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
138630173|NCT00201344|Vitamins|vitamins|mesh-ancestor
138630174|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
138630175|NCT00201383|Cisplatin|cisplatin|mesh-list
138630176|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630177|NCT00201422|Amoxicillin|amoxicillin|mesh-list
138630178|NCT00201422|Clarithromycin|clarithromycin|mesh-list
138630179|NCT00201422|Omeprazole|omeprazole|mesh-list
138630180|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138630181|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630182|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138630183|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630184|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138630185|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630186|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630187|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138630188|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138630189|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138630190|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
138630191|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138630192|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138630193|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138630194|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138630195|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630196|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
138630197|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630198|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630199|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138630200|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630201|NCT00265746|Metformin|metformin|mesh-list
138630202|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138630203|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630204|NCT00201539|Morphine|morphine|mesh-list
138630205|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138630206|NCT00201539|Narcotics|narcotics|mesh-ancestor
138630207|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138630208|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630209|NCT00201539|Analgesics|analgesics|mesh-ancestor
138630210|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
138630211|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630212|NCT00265824|Bevacizumab|bevacizumab|mesh-list
138630213|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138630214|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138630215|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630216|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138630217|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138630218|NCT00265824|Growth Substances|growth substances|mesh-ancestor
138630219|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630220|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
138630221|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138630222|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630223|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630225|NCT00201695|Doxorubicin|doxorubicin|mesh-list
138630226|NCT00201695|Vincristine|vincristine|mesh-list
138630227|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
138630228|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138630229|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
138630230|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
138630231|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630232|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630233|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630234|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
138630235|NCT00201695|Hormones|hormones|mesh-ancestor
138630236|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630237|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138630238|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138665482|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
138630239|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138630240|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138630241|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138630242|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630243|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630244|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138630245|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
138630246|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
138685598|NCT00524186|Vitamins|vitamins|mesh-ancestor
138630247|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
138630248|NCT00410345|Mifepristone|mifepristone|mesh-list
138630249|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138630250|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
138630251|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138630252|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630253|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138630254|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138630255|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138630256|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
138630257|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138630258|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138630259|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
138630260|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630261|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
138630262|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138630263|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138630264|NCT00265863|Mitomycins|mitomycins|mesh-list
138630265|NCT00265863|Mitomycin|mitomycin|mesh-list
138630266|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138630267|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630268|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
138630269|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138665501|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
138630270|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138630271|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630272|NCT00410462|Doxorubicin|doxorubicin|mesh-list
138630273|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138630274|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138630275|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630276|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138630277|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138630278|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630279|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630280|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
138630281|NCT00258765|Docetaxel|docetaxel|mesh-list
138630282|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630283|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
138630284|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
138630285|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
138630286|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630287|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138630288|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630289|NCT00410540|Morphine|morphine|mesh-list
138630290|NCT00410540|Hydromorphone|hydromorphone|mesh-list
138630291|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138630292|NCT00410540|Narcotics|narcotics|mesh-ancestor
138630293|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138630294|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630295|NCT00410540|Analgesics|analgesics|mesh-ancestor
138630296|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
138630297|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630298|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
138630299|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138630300|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630301|NCT00201812|Dexamethasone|dexamethasone|mesh-list
138630302|NCT00201812|Etanercept|etanercept|mesh-list
138630303|NCT00201812|Docetaxel|docetaxel|mesh-list
138630304|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
138630305|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138630306|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
138630307|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
138665547|NCT03993327|Trace Elements|trace elements|mesh-ancestor
138630308|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630309|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630310|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630311|NCT00201812|Hormones|hormones|mesh-ancestor
138219472|NCT05761171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630312|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630313|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138630314|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630315|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
138630316|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
138630317|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
138630318|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630319|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138630320|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138630321|NCT00201812|Analgesics|analgesics|mesh-ancestor
138630322|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
138630323|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138630324|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138630325|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
138630326|NCT00258843|Vaccines|vaccines|mesh-list
138630327|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
138630328|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630329|NCT04709094|Bupropion|bupropion|mesh-list
138630330|NCT04709094|Warfarin|warfarin|mesh-list
138630331|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138630332|NCT04709094|Norethindrone|norethindrone|mesh-list
138630333|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
138630334|NCT04709094|Norinyl|norinyl|mesh-list
138630335|NCT04709094|Estradiol|estradiol|mesh-list
138630336|NCT04709094|Estrogens|estrogens|mesh-ancestor
138630337|NCT04709094|Hormones|hormones|mesh-ancestor
138630338|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630339|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630340|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138630341|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
138685623|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
138630342|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138630343|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138630344|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
138630345|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138219496|NCT05761171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219497|NCT05761171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138219498|NCT05761171|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138219499|NCT05761171|Protective Agents|protective agents|mesh-ancestor
138219500|NCT05747794|Paclitaxel|paclitaxel|mesh-list
138219503|NCT05747794|Tubulin Modulators|tubulin modulators|mesh-ancestor
138630346|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
138630347|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138630348|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138630349|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138630350|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138630351|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630352|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
138630353|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630354|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138630355|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138630356|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630357|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138630358|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138630359|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138630360|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138630361|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
138630362|NCT00171340|Letrozole|letrozole|mesh-list
138630363|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630364|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138630365|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138630366|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630367|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630368|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138630369|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
138630370|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630371|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630372|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138630374|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138630375|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
138630376|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
138630377|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630378|NCT00266058|Ritonavir|ritonavir|mesh-list
138630379|NCT00266058|Lopinavir|lopinavir|mesh-list
138630380|NCT00266058|Efavirenz|efavirenz|mesh-list
138630381|NCT00266058|Lumefantrine|lumefantrine|mesh-list
138630382|NCT00266058|Artemether|artemether|mesh-list
138630383|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138665622|NCT03876769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630384|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138630385|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138630386|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
138630387|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630388|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630389|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138630390|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138630391|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
138630392|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138219546|NCT05723601|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138219547|NCT05723601|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138219548|NCT05723601|Estradiol|estradiol|mesh-list
138219554|NCT05723601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138219556|NCT05723601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138219557|NCT05723601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138219558|NCT05691712|Tirzepatide|tirzepatide|mesh-list
138219559|NCT05691712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138219560|NCT05691712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219561|NCT05691712|Incretins|incretins|mesh-ancestor
138630393|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138630394|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138630395|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138630396|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138630397|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138630398|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138630399|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138630400|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138630401|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138630402|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
138630403|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138630404|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138630405|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
138630406|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630407|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138630408|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630409|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630411|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138630412|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
138630413|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138630415|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
138630416|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138630417|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138630418|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
138630419|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630420|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630421|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138630422|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630423|NCT00202163|Testosterone|testosterone|mesh-list
138630425|NCT00202163|Hormones|hormones|mesh-ancestor
138630426|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630427|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630428|NCT00476554|Sapacitabine|sapacitabine|mesh-list
138630429|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630430|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138630431|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138630432|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
138630433|NCT00202241|Testosterone|testosterone|mesh-list
138630434|NCT00202241|Androgens|androgens|mesh-ancestor
138219567|NCT05681715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630436|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630437|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630438|NCT00266136|Cytarabine|cytarabine|mesh-list
138630439|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
138630440|NCT00266136|Daunorubicin|daunorubicin|mesh-list
138630441|NCT00266136|Thioguanine|thioguanine|mesh-list
138630442|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138630443|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
138630444|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188445|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138630445|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138630446|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138630447|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
138685665|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
138630448|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630449|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630450|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138630451|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138630452|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
138630453|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
138630454|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630455|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138630456|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138630457|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138630458|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630459|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138630460|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
138630461|NCT00230594|Coagulants|coagulants|mesh-ancestor
138630462|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138630463|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
138630464|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630465|NCT00259077|Omeprazole|omeprazole|mesh-list
138630466|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138630467|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138219637|NCT05623319|Olaparib|olaparib|mesh-list
138630468|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138630469|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630470|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630471|NCT00479674|Paclitaxel|paclitaxel|mesh-list
138630472|NCT00479674|Bevacizumab|bevacizumab|mesh-list
138630473|NCT00479674|Carboplatin|carboplatin|mesh-list
138665683|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630474|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138630475|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138630476|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630477|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
138630478|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
138630479|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
138630480|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630481|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138630482|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138630483|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138630484|NCT00479674|Growth Substances|growth substances|mesh-ancestor
138321462|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630485|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630486|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
138630487|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138630488|NCT02962310|Calcium|calcium|mesh-list
138630489|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138630490|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630491|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138219648|NCT05615220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219649|NCT05615220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138219650|NCT05615220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138219651|NCT05615220|Dopamine Agents|dopamine agents|mesh-ancestor
138219652|NCT05615220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138219653|NCT05615220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219664|NCT05604131|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138630492|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138630493|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
138630494|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630495|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138630496|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138630497|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630498|NCT00259116|Methocarbamol|methocarbamol|mesh-list
138630499|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138630500|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630501|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138630502|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630503|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
138630504|NCT00415779|Docetaxel|docetaxel|mesh-list
138630505|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630506|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
138630507|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
138630508|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
138630509|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630510|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138685684|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138630511|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630513|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138630514|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630515|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630516|NCT00479401|Pramipexole|pramipexole|mesh-list
138630517|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
138630518|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630519|NCT00479401|Protective Agents|protective agents|mesh-ancestor
138630520|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630521|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138630522|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138630523|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
138630524|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
138630525|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630526|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138630527|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138219710|NCT05534243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630528|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138630529|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
138630530|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630531|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630532|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630533|NCT00230789|Urological Agents|urological agents|mesh-ancestor
138630534|NCT00478777|Dexamethasone|dexamethasone|mesh-list
138630535|NCT00478777|Lenalidomide|lenalidomide|mesh-list
138630536|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138630537|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
138630538|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
138630539|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630540|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630541|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630542|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
138630543|NCT00478777|Hormones|hormones|mesh-ancestor
138630544|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630545|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138630546|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630547|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
138321482|NCT05161754|Hemostatics|hemostatics|mesh-list
138630548|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138630549|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138630550|NCT00478777|Growth Substances|growth substances|mesh-ancestor
138665773|NCT03644485|Tacrolimus|tacrolimus|mesh-list
138630551|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
138630552|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
138630553|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
138630554|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630555|NCT00477607|Protective Agents|protective agents|mesh-ancestor
138630556|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630557|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
138630559|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
138630560|NCT00230867|Acyclovir|acyclovir|mesh-list
138630561|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
138630562|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630563|NCT00266214|Lidocaine|lidocaine|mesh-list
138630564|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
138630565|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
138630566|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138630567|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630568|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
138630569|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630570|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138630571|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138630572|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138219757|NCT05464966|Insulin|insulin|mesh-list
138630573|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138630574|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630575|NCT00266253|Metformin|metformin|mesh-list
138630577|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630578|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
138630579|NCT00230984|Testosterone|testosterone|mesh-list
138630580|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
138630581|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
138630582|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138630583|NCT00230984|Androgens|androgens|mesh-ancestor
138630584|NCT00230984|Hormones|hormones|mesh-ancestor
138630585|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630586|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630587|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138630588|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630589|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
138630590|NCT00415350|Azithromycin|azithromycin|mesh-list
138630591|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138630592|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630593|NCT00231023|Triamcinolone|triamcinolone|mesh-list
138630594|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138630595|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138630596|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138630597|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138630598|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
138630599|NCT00231023|Hormones|hormones|mesh-ancestor
138630600|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630601|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630602|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138630603|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
138630604|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630605|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630606|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138630607|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
138630608|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138630609|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138630610|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138630611|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138630612|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630613|NCT00231140|Thalidomide|thalidomide|mesh-list
138630614|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138630615|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
138630616|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630617|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
138630618|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138630619|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630620|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138630621|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138630622|NCT00231140|Growth Substances|growth substances|mesh-ancestor
138630623|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
138630624|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630625|NCT00231218|Propolis|propolis|mesh-list
138630626|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630627|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
138630628|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138630629|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685714|NCT00526175|Cytarabine|cytarabine|mesh-list
138630630|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
138630632|NCT00231335|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138630633|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138630634|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138630635|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630636|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630637|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
138630638|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630639|NCT00266487|Vitamins|vitamins|mesh-list
138630640|NCT00266487|Folic Acid|folic acid|mesh-list
138630641|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
138630642|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
138630643|NCT00266487|Pyridoxal|pyridoxal|mesh-list
138630644|NCT00266487|Pyridoxine|pyridoxine|mesh-list
138665821|NCT03596645|Infliximab|infliximab|mesh-list
138630645|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
138630646|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
138630647|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630648|NCT00266487|Hematinics|hematinics|mesh-ancestor
138630649|NCT00231452|Artesunate|artesunate|mesh-list
138630650|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
138630651|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
138630652|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138630653|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
138630654|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138630655|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138630656|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630657|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630658|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
138630659|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
138630660|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138630661|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
138532539|NCT00218218|Nicotine|nicotine|mesh-list
138630662|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138630663|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630664|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630665|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138630666|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
138630667|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138630668|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138630669|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138630670|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138630671|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630673|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630674|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630675|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138630676|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630677|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138630678|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
138630679|NCT00477490|Coagulants|coagulants|mesh-ancestor
138630680|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138665843|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
138630681|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
138630682|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630683|NCT00231530|Topiramate|topiramate|mesh-list
138630684|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
138630685|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138630686|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630687|NCT00231569|Mipomersen|mipomersen|mesh-list
138630688|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138630689|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138630690|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
138630691|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630692|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138630693|NCT00477334|Famciclovir|famciclovir|mesh-list
138630694|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
138630695|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630696|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138630697|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630698|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630699|NCT00231608|Topiramate|topiramate|mesh-list
138630700|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
138630702|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630703|NCT00266604|Topiramate|topiramate|mesh-list
138630704|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
138630705|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138630706|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630707|NCT04561336|Cetuximab|cetuximab|mesh-list
138630708|NCT04561336|Avelumab|avelumab|mesh-list
138630709|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138630710|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630711|NCT00259428|Dronedarone|dronedarone|mesh-list
138630712|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138630713|NCT00231647|Topiramate|topiramate|mesh-list
138630714|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
138630715|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138630716|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630717|NCT04560751|Lenvatinib|lenvatinib|mesh-list
138630718|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630719|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138630720|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630721|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630722|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138665874|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
138665875|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
138665885|NCT03517969|Docetaxel|docetaxel|mesh-list
138630723|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138630724|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138630725|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138630726|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630727|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630728|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630729|NCT00266643|Analgesics|analgesics|mesh-ancestor
138630730|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
138630731|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630732|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
138630733|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138630734|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
138630735|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
138630736|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138630737|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630738|NCT04560049|Phenol|phenol|mesh-list
138630739|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
138630740|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138630741|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630742|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
138630743|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138630744|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138630745|NCT04559425|Dexamethasone|dexamethasone|mesh-list
138630747|NCT04559425|BB 1101|bb 1101|mesh-list
138307324|NCT00002111|Saquinavir|saquinavir|mesh-list
138630748|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138630749|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
138630750|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
138685737|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
138665907|NCT03466411|Ustekinumab|ustekinumab|mesh-list
138630751|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630752|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630753|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630754|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
138630755|NCT04559425|Hormones|hormones|mesh-ancestor
138630756|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630757|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138630758|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630759|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
138630760|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630761|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630762|NCT00231764|Daclizumab|daclizumab|mesh-list
138630763|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138630764|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
138630765|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630766|NCT04559308|Metformin|metformin|mesh-list
138630767|NCT04559308|Paclitaxel|paclitaxel|mesh-list
138630768|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
138630769|NCT04559308|Doxorubicin|doxorubicin|mesh-list
138630770|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138630771|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630772|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
138630773|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
138630774|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
138630775|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630776|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138630777|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
138630778|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630779|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138630780|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138630781|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
138630782|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138630783|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138630784|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138630785|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138630786|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138630787|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630788|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
138630789|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138630790|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138630791|NCT04559113|Prednisolone|prednisolone|mesh-list
138630792|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
138630793|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138630795|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138630796|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
138630797|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
138630798|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630799|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630800|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630801|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
138630802|NCT04559113|Hormones|hormones|mesh-ancestor
138630803|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630804|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138630805|NCT04559113|Protective Agents|protective agents|mesh-ancestor
138630806|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138630807|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630808|NCT00266721|Pancrelipase|pancrelipase|mesh-list
138630809|NCT00266721|Pancreatin|pancreatin|mesh-list
138630810|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630812|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138630813|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138630814|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138630815|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630816|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138630817|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630818|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
138630819|NCT02211976|Bisacodyl|bisacodyl|mesh-list
138630820|NCT02211976|Cathartics|cathartics|mesh-ancestor
138630821|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630823|NCT04558684|Immunomodulating Agents|immunomodulating agents|mesh-list
138630824|NCT04558684|Immunologic Factors|immunologic factors|mesh-ancestor
138630825|NCT04558684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630826|NCT00231959|Pramipexole|pramipexole|mesh-list
138630827|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
138630828|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630829|NCT00231959|Protective Agents|protective agents|mesh-ancestor
138630830|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630831|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138630832|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138630833|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
138630834|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
138630835|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630836|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
138630837|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138630838|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138630839|NCT00231998|Analgesics|analgesics|mesh-ancestor
138630840|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
138630841|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630842|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630843|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138630844|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138630845|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
138630846|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138630847|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
138630848|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138630849|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630850|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630851|NCT00266838|Dexamethasone|dexamethasone|mesh-list
138630852|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138630853|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
138630854|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
138630855|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630856|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630857|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630858|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
138630860|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630861|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138630862|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630864|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138630865|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
138630866|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630867|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630868|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666041|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
138630869|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
138630870|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138630871|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138630872|NCT02212210|Prednisolone|prednisolone|mesh-list
138630873|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
138630874|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138630875|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
138630876|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138630877|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
138630878|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
138630879|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630880|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630881|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138630882|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
138630883|NCT02212210|Hormones|hormones|mesh-ancestor
138630884|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630885|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138630886|NCT02212210|Protective Agents|protective agents|mesh-ancestor
138630887|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138630888|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138630889|NCT00232076|Cyclosporine|cyclosporine|mesh-list
138630890|NCT00232076|Cyclosporins|cyclosporins|mesh-list
138630891|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630892|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630893|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138630894|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
138630895|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220224|NCT04858009|Paclitaxel|paclitaxel|mesh-list
138630897|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630898|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
138630899|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138630900|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138630901|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
138666089|NCT03234972|Bortezomib|bortezomib|mesh-list
138630902|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138630903|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138630904|NCT00232115|Analgesics|analgesics|mesh-ancestor
138630905|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
138630906|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630907|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630908|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138630909|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138630910|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
138630911|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138630912|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
138630913|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138630914|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630915|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630916|NCT04558021|Niclosamide|niclosamide|mesh-list
138630917|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
138630918|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138630919|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
138630920|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138630921|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630922|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
138630923|NCT00232154|Azithromycin|azithromycin|mesh-list
138630924|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138630925|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630926|NCT00259662|Atorvastatin|atorvastatin|mesh-list
138630927|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138630928|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138630929|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
138630930|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630931|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138630932|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138630933|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630934|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
138630935|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138630936|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
138630937|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630938|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
138630939|NCT04557943|Protective Agents|protective agents|mesh-ancestor
138220373|NCT04569032|Prednisone|prednisone|mesh-list
138630941|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138630942|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138630943|NCT04557475|Analgesics|analgesics|mesh-ancestor
138630944|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
138630945|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138630946|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630947|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138630948|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138630949|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138630950|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138630951|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630952|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138630953|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138630954|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630955|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
138630956|NCT00232271|Enoxaparin|enoxaparin|mesh-list
138630957|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
138630958|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138630959|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138630960|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630961|NCT04557397|Itraconazole|itraconazole|mesh-list
138630962|NCT04557397|Rifampin|rifampin|mesh-list
138630963|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
138630964|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138630965|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138666110|NCT03217812|Hormones|hormones|mesh-ancestor
138630966|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138630967|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630968|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630969|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138630970|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
138630971|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138630972|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630973|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138630974|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138630976|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138630977|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
138630978|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138630979|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138220404|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
138630980|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138630981|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138630982|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138630983|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138630984|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138630985|NCT04557202|Tamsulosin|tamsulosin|mesh-list
138630986|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138630987|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138630988|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138630989|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
138630990|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138630991|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630992|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138630993|NCT04557202|Urological Agents|urological agents|mesh-ancestor
138630994|NCT00232349|Galantamine|galantamine|mesh-list
138630995|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138630996|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138630997|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138630998|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
138630999|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631000|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631001|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138631002|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
138631003|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631004|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
138631005|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
138631006|NCT00259701|Acetylcholine|acetylcholine|mesh-list
138631007|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
138631008|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138631009|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
138631010|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631011|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631012|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631013|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138631014|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138631015|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
138631016|NCT04566211|Amoxicillin|amoxicillin|mesh-list
138631017|NCT04566211|Metronidazole|metronidazole|mesh-list
138631018|NCT04566211|Clarithromycin|clarithromycin|mesh-list
138631019|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138631020|NCT04566211|Pantoprazole|pantoprazole|mesh-list
138631021|NCT04566211|Bismuth|bismuth|mesh-list
138631022|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138631023|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631024|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138631025|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138631026|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138631027|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631029|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138631030|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138220460|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138220461|NCT04412096|Latanoprost|latanoprost|mesh-list
138220462|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138220463|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138220464|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138220465|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
138631031|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138631032|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138631033|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138631034|NCT04566211|Antacids|antacids|mesh-ancestor
138631035|NCT00259779|Prednisolone|prednisolone|mesh-list
138631036|NCT00259779|Budesonide|budesonide|mesh-list
138631037|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
138631038|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138631039|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
138631040|NCT00259779|Hormones|hormones|mesh-ancestor
138631041|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138631042|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631043|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138631044|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631045|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
138631046|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631047|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138631048|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138321658|NCT04533997|Diuretics|diuretics|mesh-ancestor
138631049|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
138631050|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138631052|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138631053|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
138631054|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631055|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631056|NCT02211079|Tolbutamide|tolbutamide|mesh-list
138631057|NCT02211079|Midazolam|midazolam|mesh-list
138631058|NCT02211079|Caffeine|caffeine|mesh-list
138631059|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138631060|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138631061|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138631062|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631063|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138631064|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138631065|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138631066|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138631067|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
138631068|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
138631070|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
138631071|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631072|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631073|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138631074|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138631075|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631076|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138631077|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138631078|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
138631079|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138631080|NCT00232622|Streptokinase|streptokinase|mesh-list
138631081|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138631082|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138631083|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631085|NCT00232661|Anastrozole|anastrozole|mesh-list
138631086|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138631087|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
138631088|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138631089|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631090|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138631091|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631092|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138631093|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138631094|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138631095|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138631096|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138631097|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631098|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631099|NCT00267267|Atorvastatin|atorvastatin|mesh-list
138631100|NCT00267267|Simvastatin|simvastatin|mesh-list
138631101|NCT00267267|Ezetimibe|ezetimibe|mesh-list
138631102|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138631103|NCT00267267|Torcetrapib|torcetrapib|mesh-list
138631104|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138631105|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138631106|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
138631107|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631108|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138631109|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138631110|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631111|NCT04564690|Vitamin E|vitamin e|mesh-list
138631112|NCT04564690|Selenium|selenium|mesh-list
138631113|NCT04564690|Vitamins|vitamins|mesh-ancestor
138631114|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
138631115|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631116|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
138631117|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631118|NCT04564690|Protective Agents|protective agents|mesh-ancestor
138631119|NCT04564690|Trace Elements|trace elements|mesh-ancestor
138631121|NCT00232700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138631122|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138631123|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138631124|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631125|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631126|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
138631127|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631128|NCT04564456|Fluticasone|fluticasone|mesh-list
138631129|NCT04564456|Xhance|xhance|mesh-list
138631130|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138631131|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138631132|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138631133|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138631134|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
138631135|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631136|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631137|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138631138|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
138631139|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
138631140|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138631141|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138631142|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138631143|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138631144|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
138631145|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631146|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631147|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
138631149|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138631150|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
138631151|NCT04564144|Meclizine|meclizine|mesh-list
138631152|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
138631153|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
138631154|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631155|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631156|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138631157|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138631158|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
138631159|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
138631160|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631161|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631162|NCT04564144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138631163|NCT04564144|Cholinergic Agents|cholinergic agents|mesh-ancestor
138631164|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138631165|NCT00267306|Visilizumab|visilizumab|mesh-list
138631166|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
138631167|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631169|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138631170|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631171|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138631172|NCT00259896|Incretins|incretins|mesh-ancestor
138631173|NCT00259896|Hormones|hormones|mesh-ancestor
138184513|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138631174|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138631176|NCT04564222|Micronutrients|micronutrients|mesh-list
138631177|NCT04564222|Trace Elements|trace elements|mesh-list
138631178|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631179|NCT00232817|Nicotine|nicotine|mesh-list
138631180|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138631181|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
138631182|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631183|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631184|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138631185|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138631186|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
138631187|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631188|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631189|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
138220526|NCT04254107|Immunologic Factors|immunologic factors|mesh-ancestor
138631190|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138631191|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
138631192|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631193|NCT00267384|Expectorants|expectorants|mesh-ancestor
138631194|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
138631195|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138631196|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
138631197|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631198|NCT00267384|Protective Agents|protective agents|mesh-ancestor
138631199|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631201|NCT00259935|Topotecan|topotecan|mesh-list
138631202|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138631203|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138631204|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631205|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631206|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631207|NCT00232856|Sirolimus|sirolimus|mesh-list
138631208|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138631209|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631210|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138631211|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631212|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
138631213|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138631214|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
138631215|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631216|NCT00259974|Rituximab|rituximab|mesh-list
138631217|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138631218|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631219|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
138631220|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631221|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138631222|NCT00232895|Propofol|propofol|mesh-list
138631223|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138631224|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138631225|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631226|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138631227|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
138631228|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
138631229|NCT00232934|Thalidomide|thalidomide|mesh-list
138631230|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138631231|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
138631232|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631233|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
138631234|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138631235|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631236|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138631237|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138631238|NCT00232934|Growth Substances|growth substances|mesh-ancestor
138631239|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
138631240|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631241|NCT04673812|Fentanyl|fentanyl|mesh-list
138631242|NCT04673812|Bupivacaine|bupivacaine|mesh-list
138631243|NCT04673812|Naloxone|naloxone|mesh-list
138631244|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
138631245|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
138631246|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138631247|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631248|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
138631249|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631250|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138631251|NCT04673812|Narcotics|narcotics|mesh-ancestor
138631252|NCT04673812|Analgesics|analgesics|mesh-ancestor
138631253|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138631254|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138631255|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
138631256|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138631257|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
138631258|NCT00260052|Hematinics|hematinics|mesh-ancestor
138631259|NCT04673500|Lidocaine|lidocaine|mesh-list
138631260|NCT04673500|Propofol|propofol|mesh-list
138631261|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
138631262|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
138631263|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138631264|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631265|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
138631266|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631267|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138631268|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138631269|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138631270|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138631271|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631272|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138631273|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138631274|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
138631275|NCT00233012|Topiramate|topiramate|mesh-list
138631276|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
138631277|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138631278|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631279|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
138220583|NCT04008030|Leucovorin|leucovorin|mesh-list
138631280|NCT00267540|Vitamin D|vitamin d|mesh-list
138631282|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
138631283|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631284|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138631285|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138631286|NCT00233051|Fluticasone|fluticasone|mesh-list
138631287|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138631288|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138631289|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138631290|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
138631291|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631292|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631293|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138631294|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
138631295|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
138631296|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138631297|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138631298|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138631299|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138631300|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
138631301|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631302|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631303|NCT04672759|Durvalumab|durvalumab|mesh-list
138631304|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138631305|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138631306|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631307|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
138631308|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631309|NCT00260247|Carbamazepine|carbamazepine|mesh-list
138631310|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
138631311|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
138631312|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
138631313|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138631314|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138631315|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631316|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138631317|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138631318|NCT00260247|Analgesics|analgesics|mesh-ancestor
138631319|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
138631320|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631321|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138631322|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138631323|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631324|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138631325|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138631326|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138631327|NCT04671589|Meropenem|meropenem|mesh-list
138631328|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138631329|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631330|NCT00260325|Valdecoxib|valdecoxib|mesh-list
138631331|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138631332|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138631333|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631334|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631335|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138631336|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138631337|NCT00260325|Analgesics|analgesics|mesh-ancestor
138631338|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
138631339|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631340|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631341|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138631343|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138631344|NCT04671160|Dalteparin|dalteparin|mesh-list
138631345|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
138631346|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138631347|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138631348|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631349|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
138631350|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
138631351|NCT00233558|Adalimumab|adalimumab|mesh-list
138631353|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138631354|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
138666298|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138631355|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138631356|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631357|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138631358|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
138631359|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631360|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631361|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
138631362|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631363|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138631364|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138631365|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
138631366|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138631367|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138631368|NCT00233558|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138631369|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138631370|NCT00233636|Gefitinib|gefitinib|mesh-list
138631371|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631372|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138631373|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631374|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631375|NCT00267657|Reserpine|reserpine|mesh-list
138631376|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138631377|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138631378|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138631379|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138631380|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631381|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138631382|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138631383|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138631384|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138321770|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
138631385|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631386|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
138631387|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631388|NCT04670809|Clevidipine|clevidipine|mesh-list
138631389|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138631390|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138631391|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631392|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138631393|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631394|NCT00233714|Sirolimus|sirolimus|mesh-list
138631395|NCT00233714|Temsirolimus|temsirolimus|mesh-list
138631396|NCT00233714|MTOR Inhibitors|mtor inhibitors|mesh-list
138631397|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138631398|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631399|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138631400|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631401|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
138631402|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138631403|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
138631404|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631405|NCT00233714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138631406|NCT00233714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631407|NCT00233714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631408|NCT04670497|Epinephrine|epinephrine|mesh-list
138631409|NCT04670497|Racepinephrine|racepinephrine|mesh-list
138631410|NCT04670497|Bupivacaine|bupivacaine|mesh-list
138631411|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
138631412|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
138631413|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
138631414|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138631415|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631416|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
138631417|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631418|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138631419|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138631420|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
138631421|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631422|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631423|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138308005|NCT00002267|Rifabutin|rifabutin|mesh-list
138631424|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138631425|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
138631426|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138631427|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
138631428|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
138631429|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
138631430|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138220852|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220853|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220854|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220863|NCT03396601|Ketamine|ketamine|mesh-list
138220864|NCT03396601|Analgesics|analgesics|mesh-ancestor
138220865|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
138220866|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138220867|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220868|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138631431|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138631432|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631433|NCT04670107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138631434|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631435|NCT00260364|Bevacizumab|bevacizumab|mesh-list
138631436|NCT00260364|Gemcitabine|gemcitabine|mesh-list
138631437|NCT00260364|Capecitabine|capecitabine|mesh-list
138631438|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138631439|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138631440|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631441|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138321790|NCT04068597|Glucocorticoids|glucocorticoids|mesh-ancestor
138631442|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138631443|NCT00260364|Growth Substances|growth substances|mesh-ancestor
138631444|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631445|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
138631446|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138631447|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
138631448|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631449|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138631450|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631451|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
138631452|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138631453|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631454|NCT04557007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138631455|NCT04557007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631456|NCT00233792|Sirolimus|sirolimus|mesh-list
138631457|NCT00233792|Temsirolimus|temsirolimus|mesh-list
138631458|NCT00233792|MTOR Inhibitors|mtor inhibitors|mesh-list
138631459|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138631460|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631461|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138631462|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631463|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
138631464|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138631465|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
138631466|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631467|NCT00233792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138631468|NCT00233792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631469|NCT00233792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631470|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138220893|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138631471|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631472|NCT00556192|Rituximab|rituximab|mesh-list
138631473|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138631474|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631475|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
138631476|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686131|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
138631477|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138631479|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138631480|NCT00556270|Narcotics|narcotics|mesh-ancestor
138631481|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138631482|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631483|NCT00556270|Analgesics|analgesics|mesh-ancestor
138631484|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
138321806|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631485|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631486|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138631487|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138631488|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
138631489|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
138631490|NCT00260520|Dalteparin|dalteparin|mesh-list
138631491|NCT00260520|Tinzaparin|tinzaparin|mesh-list
138631492|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138631493|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
138631494|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138631495|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138631496|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631497|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
138631498|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138631499|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631500|NCT00233909|Immunotoxins|immunotoxins|mesh-ancestor
138631501|NCT00233909|Immunoconjugates|immunoconjugates|mesh-ancestor
138631502|NCT00233909|Immunologic Factors|immunologic factors|mesh-ancestor
138631503|NCT00233909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631504|NCT00267813|Bupropion|bupropion|mesh-list
138631505|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138631506|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
138631507|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138631508|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138631509|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138631510|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138631511|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631512|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
138631513|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631514|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631515|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138631516|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138631517|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631518|NCT00234026|Gemcitabine|gemcitabine|mesh-list
138631519|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138631520|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
138631521|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631522|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631523|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
138631524|NCT00234143|Hematinics|hematinics|mesh-ancestor
138631525|NCT00234182|Interferons|interferons|mesh-list
138631527|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
138321837|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138321838|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
138321839|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321840|NCT03914443|Cisplatin|cisplatin|mesh-list
138321841|NCT03914443|Docetaxel|docetaxel|mesh-list
138321842|NCT03914443|Fluorouracil|fluorouracil|mesh-list
138321843|NCT03914443|Nivolumab|nivolumab|mesh-list
138631528|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631529|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
138631530|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631531|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
138631532|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631533|NCT04669990|Remdesivir|remdesivir|mesh-list
138631534|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
138631535|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631536|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
138631537|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631538|NCT00556348|Bevacizumab|bevacizumab|mesh-list
138631539|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138631540|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631541|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138631542|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138631543|NCT00556348|Growth Substances|growth substances|mesh-ancestor
138631544|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631545|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
138631546|NCT00556387|Ketamine|ketamine|mesh-list
138631547|NCT00556387|Analgesics|analgesics|mesh-ancestor
138631548|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
138631549|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631550|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631551|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138631552|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138631553|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
138631554|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
138631555|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138631556|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138631557|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138631558|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138321864|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631559|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631560|NCT04552093|Floxuridine|floxuridine|mesh-list
138631561|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138631562|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
138631563|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631564|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631565|NCT04556110|Perindopril|perindopril|mesh-list
138631566|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138631567|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
138631568|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631569|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631570|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138631571|NCT00234299|Aspirin|aspirin|mesh-list
138631572|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138631573|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138631574|NCT00234299|Analgesics|analgesics|mesh-ancestor
138631575|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
138631576|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631577|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631578|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138631579|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138631580|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138631581|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138631582|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631583|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138631584|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138631585|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631586|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
138631587|NCT04556032|Ergothioneine|ergothioneine|mesh-list
138631588|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
138220984|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138631589|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631590|NCT04556032|Protective Agents|protective agents|mesh-ancestor
138631591|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631592|NCT04556071|Bevacizumab|bevacizumab|mesh-list
138631593|NCT04556071|Niraparib|niraparib|mesh-list
138631594|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138631595|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631596|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138631597|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138631598|NCT04556071|Growth Substances|growth substances|mesh-ancestor
138631599|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666498|NCT02270814|Paclitaxel|paclitaxel|mesh-list
138631600|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
138631601|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138631602|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631603|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631604|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138631605|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
138631606|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138631607|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138631608|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138631609|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138631610|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631611|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
138631612|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138631613|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138631614|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631615|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138631616|NCT02211118|Analgesics|analgesics|mesh-ancestor
138631617|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
138631618|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631619|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138631620|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138631621|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138631622|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
138631623|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631624|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631625|NCT00234416|Gemcitabine|gemcitabine|mesh-list
138631626|NCT00234416|Gefitinib|gefitinib|mesh-list
138631627|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138631628|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
138631629|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631630|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631631|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138631632|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631633|NCT00234455|Sirolimus|sirolimus|mesh-list
138631634|NCT00234455|Temsirolimus|temsirolimus|mesh-list
138631635|NCT00234455|MTOR Inhibitors|mtor inhibitors|mesh-list
138631636|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138631637|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631638|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138631639|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631640|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
138631641|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138631642|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
138631643|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631644|NCT00234455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138631645|NCT00234455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631646|NCT00234455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631648|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631649|NCT00260793|Ropinirole|ropinirole|mesh-list
138631650|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138631651|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138631652|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
138631653|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
138631654|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631655|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631656|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631657|NCT00415935|Methotrexate|methotrexate|mesh-list
138631658|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138321932|NCT03677141|Prednisone|prednisone|mesh-list
138631659|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
138631660|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138631661|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631662|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138343318|NCT05997134|Sensory System Agents|sensory system agents|mesh-ancestor
138631663|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
138631664|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631665|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631666|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
138631667|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631668|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138631669|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138631670|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
138631671|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138631672|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138631673|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138631674|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631675|NCT02211391|Caseins|caseins|mesh-list
138631676|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
138631677|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
138686298|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631678|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631679|NCT04562311|Tislelizumab|tislelizumab|mesh-list
138631680|NCT04562311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138631681|NCT04562311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631682|NCT00234689|Naltrexone|naltrexone|mesh-list
138631683|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138631684|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138631685|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631686|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
138631687|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631688|NCT04561960|Fluorides|fluorides|mesh-list
138631689|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
138631690|NCT04561960|Protective Agents|protective agents|mesh-ancestor
138631691|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631692|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
138631693|NCT04561921|Nordefrin|nordefrin|mesh-list
138631695|NCT04561921|Analgesics|analgesics|mesh-ancestor
138631696|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
138631697|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631698|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631699|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
138631700|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138631701|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138631702|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
138631703|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138631704|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138631705|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631706|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138631707|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
138631708|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138631709|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
138631710|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138631712|NCT04561687|Budesonide|budesonide|mesh-list
138631713|NCT04561687|Montelukast|montelukast|mesh-list
138631714|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138631715|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138631716|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
138631717|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631718|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631719|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138631720|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
138631721|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
138631722|NCT04561687|Hormones|hormones|mesh-ancestor
138631723|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138631724|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138631725|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
138631726|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138631727|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138686327|NCT02923869|Bupivacaine|bupivacaine|mesh-list
138631728|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631729|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138631731|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138631732|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138631733|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138631734|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
138631735|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
138631736|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631737|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
138631738|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138631739|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631740|NCT00234845|Adalimumab|adalimumab|mesh-list
138631741|NCT00234845|Methotrexate|methotrexate|mesh-list
138221155|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631742|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138666647|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138631743|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
138631744|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138631745|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631746|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138631747|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
138631748|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631749|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631750|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
138631751|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631752|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138631753|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138631754|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
138631755|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138631756|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138631757|NCT00234845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138631758|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138631759|NCT02211625|Oxycodone|oxycodone|mesh-list
138631760|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138631761|NCT02211625|Narcotics|narcotics|mesh-ancestor
138631762|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138631763|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631764|NCT02211625|Analgesics|analgesics|mesh-ancestor
138631765|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
138631766|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631767|NCT00234923|Ritonavir|ritonavir|mesh-list
138631768|NCT00234923|Lopinavir|lopinavir|mesh-list
138631769|NCT00234923|Lamivudine|lamivudine|mesh-list
138631770|NCT00234923|Zidovudine|zidovudine|mesh-list
138631771|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138631772|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138631773|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138631774|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
138631775|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631776|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631777|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138631778|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138631780|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631781|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138631782|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138631783|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138631784|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138631785|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
138631786|NCT02213887|Pantoprazole|pantoprazole|mesh-list
138631787|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138631788|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138631789|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138631790|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631791|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631792|NCT00234962|Ritonavir|ritonavir|mesh-list
138631793|NCT00234962|Lopinavir|lopinavir|mesh-list
138631794|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138631795|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138631796|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
138631797|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631798|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631799|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138631800|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138631801|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
138631802|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631803|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138631804|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138631805|NCT04551703|Epinephrine|epinephrine|mesh-list
138631806|NCT04551703|Racepinephrine|racepinephrine|mesh-list
138631807|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
138631808|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138631809|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138631810|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
138631811|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631812|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631813|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631814|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138631815|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138631816|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
138631817|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631818|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138631819|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
138631820|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
138631821|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
138631822|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138631823|NCT00235001|Verapamil|verapamil|mesh-list
138631824|NCT00235001|Trandolapril|trandolapril|mesh-list
138631825|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138631826|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138631827|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138631828|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631829|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138631830|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631831|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
138631832|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138631833|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
138631834|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631835|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138631836|NCT04551781|Prednisone|prednisone|mesh-list
138631837|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138631838|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
138631839|NCT04551781|Hormones|hormones|mesh-ancestor
138631840|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138631841|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631842|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138631843|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631844|NCT00424944|Vaccines|vaccines|mesh-list
138631845|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
138631846|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631847|NCT02214004|Trastuzumab|trastuzumab|mesh-list
138631848|NCT02214004|Letrozole|letrozole|mesh-list
138631849|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138631850|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631851|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138631852|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138631853|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631854|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631855|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138631856|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
138631857|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138631858|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631859|NCT00235079|Colchicine|colchicine|mesh-list
138631860|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
138631861|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138631862|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
138221265|NCT01271855|Glycerol|glycerol|mesh-list
138631863|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
138631864|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
138631865|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631866|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631867|NCT00260988|Dalteparin|dalteparin|mesh-list
138631868|NCT00260988|Tinzaparin|tinzaparin|mesh-list
138631869|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138631870|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
138631871|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138631872|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138631873|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631875|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138631876|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631877|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138631878|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631880|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138631881|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
138631882|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631883|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
138631884|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138631885|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138631886|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631887|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
138631888|NCT04550338|Coagulants|coagulants|mesh-ancestor
138631889|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
138631890|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138631891|NCT04550611|Antibodies|antibodies|mesh-list
138686400|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
138631892|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
138631893|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138631894|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
138631895|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631896|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
138631897|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138631898|NCT00261027|Exemestane|exemestane|mesh-list
138631899|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631900|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138631901|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138631902|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631903|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631904|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138631905|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
138631906|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138631907|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631908|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
138631909|NCT00235235|Gemcitabine|gemcitabine|mesh-list
138631910|NCT00235235|Doxorubicin|doxorubicin|mesh-list
138631911|NCT00235235|Capecitabine|capecitabine|mesh-list
138631912|NCT00235235|Vinorelbine|vinorelbine|mesh-list
138631913|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138631914|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
138631915|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631916|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138631917|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138631918|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
138666769|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138631919|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631920|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631921|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138631922|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138631923|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
138631924|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138631925|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138631926|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138631927|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631928|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138631929|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
138631930|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
138631931|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
138631932|NCT00268359|Bevacizumab|bevacizumab|mesh-list
138631934|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138631935|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631936|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138631937|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138631938|NCT00268359|Growth Substances|growth substances|mesh-ancestor
138631939|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631940|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
138631941|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138631942|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138631943|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631944|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631946|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138631947|NCT00235274|Hormones|hormones|mesh-ancestor
138631948|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138631949|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631951|NCT00268398|Folic Acid|folic acid|mesh-list
138631952|NCT00268398|Fluorouracil|fluorouracil|mesh-list
138631953|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
138631954|NCT00268398|Irinotecan|irinotecan|mesh-list
138631955|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
138631956|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
138631957|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631958|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138631959|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138631960|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138631961|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
138631962|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631963|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138631964|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138631965|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138631966|NCT00268398|Antidotes|antidotes|mesh-ancestor
138631967|NCT00268398|Protective Agents|protective agents|mesh-ancestor
138631968|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
138631969|NCT00268398|Vitamins|vitamins|mesh-ancestor
138631970|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
138631971|NCT00268398|Hematinics|hematinics|mesh-ancestor
138631972|NCT00235313|Nicotine|nicotine|mesh-list
138631973|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138631974|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
138631975|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138631976|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138666841|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138631978|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138631979|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
138631980|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138631981|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631982|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
138631983|NCT04549012|Oxytocin|oxytocin|mesh-list
138631984|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
138631985|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138631986|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631987|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138631988|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138631989|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631990|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
138631991|NCT04549012|Coagulants|coagulants|mesh-ancestor
138631992|NCT00261105|Telithromycin|telithromycin|mesh-list
138631993|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138221420|NCT03839888|Atropine|atropine|mesh-list
138631994|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138631995|NCT00235508|Eszopiclone|eszopiclone|mesh-list
138631996|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138631997|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138666890|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138631998|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138631999|NCT00268515|Cyclosporine|cyclosporine|mesh-list
138632000|NCT00268515|Prednisone|prednisone|mesh-list
138632001|NCT00268515|Azathioprine|azathioprine|mesh-list
138632002|NCT00268515|Tacrolimus|tacrolimus|mesh-list
138632004|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138632005|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
138632006|NCT00268515|Hormones|hormones|mesh-ancestor
138632007|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138632008|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632009|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138632010|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632011|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138632012|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
138632013|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138322093|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
138632014|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632015|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632016|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
138632017|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632018|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
138632019|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138632020|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
138632021|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138632022|NCT04548700|Prednisone|prednisone|mesh-list
138632023|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
138632024|NCT04548700|Vincristine|vincristine|mesh-list
138632025|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
138632026|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138666950|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632027|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
138632028|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632029|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138632030|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138632031|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
138632032|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632033|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632034|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138632035|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138632036|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
138632037|NCT04548700|Hormones|hormones|mesh-ancestor
138632038|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138632039|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138632040|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138632041|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
138632042|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
138632043|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
138632044|NCT04548700|Analgesics|analgesics|mesh-ancestor
138632045|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
138666993|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
138632047|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138632048|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138632049|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632050|NCT02214433|Pantoprazole|pantoprazole|mesh-list
138632051|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138632052|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138632053|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138632054|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138632055|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632056|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632057|NCT02212561|Cytarabine|cytarabine|mesh-list
138632058|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
138632059|NCT02212561|Methotrexate|methotrexate|mesh-list
138632060|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
138632061|NCT02212561|Fludarabine|fludarabine|mesh-list
138632062|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138632063|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
138632064|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138632065|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632066|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138632067|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
138632068|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632069|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632070|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
138632071|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632072|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138322129|NCT02957968|Doxorubicin|doxorubicin|mesh-list
138667050|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632073|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138632074|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
138632075|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138632076|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138632077|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
138632078|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632079|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138632080|NCT00268554|Dipyridamole|dipyridamole|mesh-list
138632081|NCT00268554|Caffeine|caffeine|mesh-list
138632082|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138632083|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632084|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138632085|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632086|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632087|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138632088|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138632089|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
138632090|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632091|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138221564|NCT01275365|Hormones|hormones|mesh-ancestor
138632092|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
138632093|NCT00268593|Prednisone|prednisone|mesh-list
138632094|NCT00268593|Docetaxel|docetaxel|mesh-list
138632095|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632096|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
138632097|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
138632098|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
138632099|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632100|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138632101|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
138632103|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138632104|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632105|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138632106|NCT04555525|Sarecycline|sarecycline|mesh-list
138632107|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138632108|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632109|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
138632110|NCT00261183|Melatonin|melatonin|mesh-list
138632111|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
138632112|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632113|NCT00261183|Protective Agents|protective agents|mesh-ancestor
138632114|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632115|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632116|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
138632117|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138632118|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138221589|NCT03678506|Apixaban|apixaban|mesh-list
138632119|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632120|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138632121|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632122|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138632123|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138632124|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
138632125|NCT04554979|Anticoagulants|anticoagulants|mesh-list
138632126|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632127|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
138632128|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138632129|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138632130|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632131|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632132|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138632133|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
138632134|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138632135|NCT00261222|Amodiaquine|amodiaquine|mesh-list
138322153|NCT02889653|Anticoagulants|anticoagulants|mesh-list
138632136|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
138632137|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138632138|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138632139|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632140|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
138632141|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
138632142|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632143|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138632144|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
138632145|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138632146|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138632147|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138632148|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
138632149|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221638|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138632150|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632151|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632152|NCT00268671|Docetaxel|docetaxel|mesh-list
138632153|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632154|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
138632155|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
138632156|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
138632157|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632158|NCT04554433|Ethanol|ethanol|mesh-list
138632159|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138632160|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632161|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632162|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632163|NCT04721054|Lidocaine|lidocaine|mesh-list
138632164|NCT04721054|Bupivacaine|bupivacaine|mesh-list
138632165|NCT04721054|Anesthetics|anesthetics|mesh-list
138632166|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
138632167|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632168|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632169|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
138632170|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632171|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138632172|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138632173|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138632174|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138632175|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632176|NCT02212639|Digoxin|digoxin|mesh-list
138686481|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
138632177|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138632178|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138632179|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632180|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632181|NCT02212639|Protective Agents|protective agents|mesh-ancestor
138632182|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632183|NCT02212756|Metformin|metformin|mesh-list
138632184|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138632185|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632186|NCT02212795|Levofloxacin|levofloxacin|mesh-list
138632187|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
138632188|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138632189|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322156|NCT02819518|Carboplatin|carboplatin|mesh-list
138632190|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138632191|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138632192|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138632193|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632194|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632195|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632196|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138632197|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138632198|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138632200|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138632201|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138632202|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632203|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632204|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138632205|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138632206|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138632207|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138221751|NCT01332461|Xhance|xhance|mesh-list
138632208|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
138632209|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
138632210|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
138632211|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
138632212|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632213|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632214|NCT00235820|Adalimumab|adalimumab|mesh-list
138632215|NCT00235820|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138632216|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138632217|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138632218|NCT00268710|Docetaxel|docetaxel|mesh-list
138632219|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632220|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
138632221|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
138632222|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
138632223|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632224|NCT00261300|Pantoprazole|pantoprazole|mesh-list
138632225|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138632226|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138632227|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138632228|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632229|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667184|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667185|NCT01053962|Plecanatide|plecanatide|mesh-list
138632230|NCT02212990|Acetaminophen|acetaminophen|mesh-list
138632231|NCT02212990|Ibuprofen|ibuprofen|mesh-list
138632232|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138632233|NCT02212990|Analgesics|analgesics|mesh-ancestor
138632234|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
138632235|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632236|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632238|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138632239|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138632240|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138632241|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138632242|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632243|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632244|NCT00235859|Adalimumab|adalimumab|mesh-list
138632245|NCT00235859|Methotrexate|methotrexate|mesh-list
138632246|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138632247|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
138221769|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138632248|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138308843|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
138632250|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138632251|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
138632252|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632253|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632254|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
138632255|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632256|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138632257|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138632258|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
138632259|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138632260|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138632261|NCT00235859|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138632262|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138632263|NCT02213029|Oxytocin|oxytocin|mesh-list
138632264|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
138632265|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138632266|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632267|NCT02213146|Insulin|insulin|mesh-list
138632268|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
138632269|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138632270|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138632271|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632272|NCT00268749|Glycine|glycine|mesh-list
138632273|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
138632274|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632275|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632276|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632277|NCT00235898|Leucovorin|leucovorin|mesh-list
138632278|NCT00235898|Fluorouracil|fluorouracil|mesh-list
138221803|NCT01334957|Analgesics|analgesics|mesh-ancestor
138322205|NCT02407119|Omeprazole|omeprazole|mesh-list
138632279|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
138632280|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667220|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138667231|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
138632281|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138632282|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632283|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138632284|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
138632285|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632287|NCT00235898|Protective Agents|protective agents|mesh-ancestor
138632288|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
138632289|NCT00235898|Vitamins|vitamins|mesh-ancestor
138632290|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
138632291|NCT02213224|Amlodipine|amlodipine|mesh-list
138632292|NCT02213224|Telmisartan|telmisartan|mesh-list
138632293|NCT02213224|Perindopril|perindopril|mesh-list
138632294|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138632295|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138632296|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138632297|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632298|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138632299|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632300|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
138632301|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138632302|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138632303|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138632305|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632306|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
138632307|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138632308|NCT00268788|Antibodies|antibodies|mesh-list
138632309|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
138632310|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138632311|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
138632312|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632313|NCT00235937|Anastrozole|anastrozole|mesh-list
138632314|NCT00235937|Goserelin|goserelin|mesh-list
138632315|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138632316|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632317|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138632318|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138632319|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632320|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632321|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138632322|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
138308920|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138632323|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138632324|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632325|NCT00261339|Pantoprazole|pantoprazole|mesh-list
138632326|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138632327|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138632328|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138632329|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632330|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667294|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
138632331|NCT04553380|Insulin|insulin|mesh-list
138632332|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
138632333|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138322239|NCT02074267|Gabapentin|gabapentin|mesh-list
138632334|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632335|NCT00236015|Tiagabine|tiagabine|mesh-list
138632336|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
138632337|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
138632338|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138632339|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138632340|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632341|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
138632342|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632343|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632344|NCT00261378|Doxorubicin|doxorubicin|mesh-list
138632345|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138632346|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138632347|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632348|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138632349|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138632350|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632351|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632352|NCT04553458|Ethanol|ethanol|mesh-list
138632353|NCT04553458|Sorafenib|sorafenib|mesh-list
138632354|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632355|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138632356|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632357|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632358|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138632359|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632360|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632361|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632362|NCT00236054|Tiagabine|tiagabine|mesh-list
138221873|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138632363|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
138632364|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
138632365|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138632366|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138632367|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632368|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
138632369|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632370|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632371|NCT04552951|Vitamin D|vitamin d|mesh-list
138632372|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
138632373|NCT04552951|Vitamins|vitamins|mesh-ancestor
138632374|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
138632375|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632376|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138632377|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138632378|NCT02213419|Ethanol|ethanol|mesh-list
138632379|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138632380|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632381|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632382|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632383|NCT00236093|Fentanyl|fentanyl|mesh-list
138632384|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138632385|NCT00236093|Narcotics|narcotics|mesh-ancestor
138632386|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632387|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632388|NCT00236093|Analgesics|analgesics|mesh-ancestor
138632389|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
138632390|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632391|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138632392|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138632393|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
138632394|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
138632395|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
138632396|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138308999|NCT00002987|Etoposide|etoposide|mesh-list
138221905|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138632397|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632398|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
138632399|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
138632400|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138667389|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138632401|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632402|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632403|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
138632404|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138632405|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632406|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632407|NCT02213653|Iron|iron|mesh-list
138632408|NCT02213653|Trace Elements|trace elements|mesh-ancestor
138632409|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
138632410|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632411|NCT04552444|Biapenem|biapenem|mesh-list
138632412|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632413|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
138632414|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138632415|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138632416|NCT02213848|Calcium|calcium|mesh-list
138632417|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138632418|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632419|NCT00261573|Galantamine|galantamine|mesh-list
138686600|NCT02922348|Hormones|hormones|mesh-list
138632420|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138632421|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632422|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632423|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
138632424|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138667417|NCT00431990|Dexamethasone|dexamethasone|mesh-list
138632425|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632426|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138632427|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
138632428|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632429|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
138632431|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632432|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138632433|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632434|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632435|NCT04541719|Remifentanil|remifentanil|mesh-list
138632436|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138632437|NCT04541719|Narcotics|narcotics|mesh-ancestor
138632438|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632439|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632440|NCT04541719|Analgesics|analgesics|mesh-ancestor
138632441|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
138221951|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
138632442|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632443|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138632444|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
138632445|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632446|NCT00261612|Dexamethasone|dexamethasone|mesh-list
138632447|NCT00261612|Rituximab|rituximab|mesh-list
138632448|NCT00261612|Bortezomib|bortezomib|mesh-list
138632449|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138632450|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
138632451|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
138632452|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632453|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632454|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138632455|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
138632456|NCT00261612|Hormones|hormones|mesh-ancestor
138632457|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138632458|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138632459|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632460|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138632461|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
138632462|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138632463|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138632464|NCT04547764|Calcium|calcium|mesh-list
138632465|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138632466|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632467|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632468|NCT04547608|Propofol|propofol|mesh-list
138632469|NCT04547608|Rocuronium|rocuronium|mesh-list
138632470|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138632471|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632472|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632473|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138632474|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
138632475|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
138632476|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138632477|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138632478|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138632479|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221976|NCT01476449|Ranibizumab|ranibizumab|mesh-list
138632480|NCT00236249|Lidocaine|lidocaine|mesh-list
138632481|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
138632482|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
138632483|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632484|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632485|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
138632486|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632487|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138322295|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138632488|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138632489|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138632490|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138632491|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632493|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138632494|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632495|NCT04547452|Antibodies|antibodies|mesh-list
138632496|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
138632497|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632498|NCT04547335|Voriconazole|voriconazole|mesh-list
138632499|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
138632500|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632501|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138632502|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138632503|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632504|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632505|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138632506|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
138632507|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138632508|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632509|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138632510|NCT00236288|Bupropion|bupropion|mesh-list
138632511|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138632512|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
138632513|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138632514|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138632515|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138632516|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138632517|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632518|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
138632519|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632520|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632521|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138632522|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138632523|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632524|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138632525|NCT00236327|Fentanyl|fentanyl|mesh-list
138632526|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138632527|NCT00236327|Narcotics|narcotics|mesh-ancestor
138632528|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632529|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632530|NCT00236327|Analgesics|analgesics|mesh-ancestor
138632531|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
138632532|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632533|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138632534|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138686647|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
138632535|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
138632536|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
138632537|NCT00236366|Fentanyl|fentanyl|mesh-list
138632538|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138632539|NCT00236366|Narcotics|narcotics|mesh-ancestor
138222058|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632540|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632541|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632542|NCT00236366|Analgesics|analgesics|mesh-ancestor
138632543|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
138632544|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632545|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138632546|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138632548|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
138632549|NCT04547179|Erenumab|erenumab|mesh-list
138632550|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138632551|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632552|NCT04547179|Analgesics|analgesics|mesh-ancestor
138632553|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
138632554|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632555|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632556|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
138222172|NCT00818324|Rebamipide|rebamipide|mesh-list
138632557|NCT00236405|Hematinics|hematinics|mesh-ancestor
138632558|NCT00236444|Risperidone|risperidone|mesh-list
138632559|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138632560|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
138632561|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632562|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632563|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632564|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138632565|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138632566|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632567|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138632568|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138632569|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
138632571|NCT00269217|Niacinamide|niacinamide|mesh-list
138632572|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
138632573|NCT00269217|Simvastatin|simvastatin|mesh-list
138632574|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138632575|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138632576|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
138532540|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138632577|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322356|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
138632578|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138632579|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138632580|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632581|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
138632582|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
138222447|NCT00825500|Loxapine|loxapine|mesh-list
138632584|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
138632585|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632586|NCT04546282|Osimertinib|osimertinib|mesh-list
138632587|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632588|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138632589|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632590|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632591|NCT00236483|Acetaminophen|acetaminophen|mesh-list
138632592|NCT00236483|Tramadol|tramadol|mesh-list
138632593|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138632594|NCT00236483|Analgesics|analgesics|mesh-ancestor
138632595|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
138632596|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632597|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632598|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
138632599|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138632600|NCT00236483|Narcotics|narcotics|mesh-ancestor
138632601|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632602|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
138632603|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138632604|NCT04545970|Protective Agents|protective agents|mesh-ancestor
138632605|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632606|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
138532541|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
138222585|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138632607|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138632608|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
138632609|NCT04545931|Coagulants|coagulants|mesh-ancestor
138632610|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138632611|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
138632612|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632613|NCT00236522|Levofloxacin|levofloxacin|mesh-list
138632614|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138632615|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632616|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138632617|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138222647|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632618|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138632619|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632620|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632621|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138322387|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632622|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138632623|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138632625|NCT00261729|Paroxetine|paroxetine|mesh-list
138632626|NCT00261729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138632627|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138632628|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138532542|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632629|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632630|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632631|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
138632632|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632633|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138632634|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
138632635|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138632636|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138222848|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
138222849|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138222850|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138222851|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138222852|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138632637|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138632638|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632639|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138632640|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138632641|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138632642|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138632643|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
138632644|NCT00236561|Topiramate|topiramate|mesh-list
138632645|NCT00236561|Propranolol|propranolol|mesh-list
138632646|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138632647|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138632648|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
138632649|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686678|NCT00530387|Homosalate|homosalate|mesh-list
138632650|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632651|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138222992|NCT01397591|Bortezomib|bortezomib|mesh-list
138632652|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138632653|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138632654|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
138632655|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
138632656|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138632657|NCT02215330|Eplerenone|eplerenone|mesh-list
138322419|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138632658|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138632659|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
138632660|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138632661|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223045|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
138632662|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138632663|NCT02215330|Diuretics|diuretics|mesh-ancestor
138632664|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
138632665|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138632666|NCT02278510|Topotecan|topotecan|mesh-list
138632667|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138632668|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138632669|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632670|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632671|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632672|NCT04545892|Capsaicin|capsaicin|mesh-list
138632673|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
138632674|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
138632675|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
138632676|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632677|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632678|NCT02214706|Sirolimus|sirolimus|mesh-list
138223176|NCT05945173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632679|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138632680|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632681|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138632682|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632683|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
138632684|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138632685|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
138632686|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632687|NCT00236600|Topiramate|topiramate|mesh-list
138632688|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
138632689|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138632690|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632691|NCT00236639|Topiramate|topiramate|mesh-list
138632692|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
138632693|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138632694|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632695|NCT04545463|Psyllium|psyllium|mesh-list
138632696|NCT04545463|Cathartics|cathartics|mesh-ancestor
138632697|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138632698|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
138632699|NCT00236678|Hematinics|hematinics|mesh-ancestor
138632700|NCT00269334|Paroxetine|paroxetine|mesh-list
138632701|NCT00269334|Citalopram|citalopram|mesh-list
138632702|NCT00269334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138632703|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138632704|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138632705|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632706|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632707|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
138632708|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632709|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138322456|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
138686699|NCT00530582|Progesterone|progesterone|mesh-list
138632710|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
138632711|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138632712|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138632713|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138632714|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632715|NCT04541251|Paclitaxel|paclitaxel|mesh-list
138632716|NCT04541251|Carboplatin|carboplatin|mesh-list
138632717|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138632718|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632719|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
138632720|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
138632721|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
138632722|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632723|NCT00236717|Topiramate|topiramate|mesh-list
138632724|NCT00236717|Carbamazepine|carbamazepine|mesh-list
138632725|NCT00236717|Valproic Acid|valproic acid|mesh-list
138632726|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
138223398|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138632727|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138632728|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632729|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632730|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632731|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
138632732|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632733|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
138632734|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138667671|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138632735|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632736|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138632737|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138632738|NCT00236717|Analgesics|analgesics|mesh-ancestor
138632739|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
138632740|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632741|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138632742|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138632743|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138632744|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138632746|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
138632747|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138632748|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632749|NCT00269412|Rifaximin|rifaximin|mesh-list
138632750|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138632751|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632752|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138632753|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138632754|NCT00236795|Norelgestromin|norelgestromin|mesh-list
138632755|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138632756|NCT00236795|Estradiol|estradiol|mesh-list
138632757|NCT00236795|Estrogens|estrogens|mesh-ancestor
138632758|NCT00236795|Hormones|hormones|mesh-ancestor
138632759|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138632760|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632761|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138632762|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
138632763|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138322480|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138632765|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138632766|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138632767|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138632768|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138632769|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138632770|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138632771|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138223718|NCT00788125|Etoposide|etoposide|mesh-list
138632772|NCT04540627|Palivizumab|palivizumab|mesh-list
138632773|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
138632774|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632775|NCT00236834|Levofloxacin|levofloxacin|mesh-list
138632776|NCT00236834|Imipenem|imipenem|mesh-list
138632777|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138632778|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632779|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138632780|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138632781|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138632782|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138667677|NCT03273075|Ticagrelor|ticagrelor|mesh-list
138632783|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632784|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223784|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138223785|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138223786|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
138223787|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138223788|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138223789|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
138223790|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138223791|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138223792|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355155|NCT00002220|Efavirenz|efavirenz|mesh-list
138632785|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138632786|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138632787|NCT00236873|Topiramate|topiramate|mesh-list
138632788|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
138632789|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138632790|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632791|NCT00236912|Metronidazole|metronidazole|mesh-list
138632792|NCT00236912|Levofloxacin|levofloxacin|mesh-list
138632793|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632794|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138632795|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138632796|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138632797|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138632798|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138632799|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138632800|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632801|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632802|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632803|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138632804|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138632805|NCT02215447|Paclitaxel|paclitaxel|mesh-list
138632806|NCT02215447|Carboplatin|carboplatin|mesh-list
138223842|NCT00836888|Nivolumab|nivolumab|mesh-list
138632807|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138632808|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632809|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
138632810|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
138632811|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
138632812|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632813|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
138632814|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
138632815|NCT00237068|Lansoprazole|lansoprazole|mesh-list
138632816|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
138632817|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138632818|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138632819|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138632820|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632821|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632822|NCT00269568|Misoprostol|misoprostol|mesh-list
138632823|NCT00269568|Mifepristone|mifepristone|mesh-list
138223895|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223896|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
138223897|NCT02966912|Antacids|antacids|mesh-ancestor
138632824|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138632826|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138632827|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632828|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138632829|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138632830|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
138632831|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138632832|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138632833|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138632834|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138632835|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
138632836|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138223953|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138632837|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138632838|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
138632839|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138632840|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
138632841|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138632842|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138632843|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
138632844|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138632845|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632846|NCT04544059|Lenalidomide|lenalidomide|mesh-list
138632847|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
138632848|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632849|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138632850|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138632851|NCT04544059|Growth Substances|growth substances|mesh-ancestor
138632852|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
138632853|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632854|NCT00269607|Naltrexone|naltrexone|mesh-list
138632855|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138632856|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138632857|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632858|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
138632859|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632861|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632862|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138632863|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138632864|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224014|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
138224016|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632865|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138667729|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
138632866|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138632867|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
138632868|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138632869|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632870|NCT00237302|Topiramate|topiramate|mesh-list
138632871|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
138686875|NCT02920515|Leuprolide|leuprolide|mesh-list
138632872|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138632873|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632874|NCT00262275|Aspirin|aspirin|mesh-list
138632875|NCT00262275|Clopidogrel|clopidogrel|mesh-list
138632876|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138632877|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138632878|NCT00262275|Analgesics|analgesics|mesh-ancestor
138632879|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
138632880|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138224058|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
138224074|NCT01549223|Oxytocin|oxytocin|mesh-list
138632881|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632882|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138632883|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138632884|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138632885|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138632886|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632887|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138632888|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138632889|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632890|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
138632891|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138632892|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138632893|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138632894|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
138632895|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632896|NCT02214979|Telmisartan|telmisartan|mesh-list
138632897|NCT02214979|Ramipril|ramipril|mesh-list
138224180|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
138224181|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138632898|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138632899|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138632900|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138632901|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632902|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138632903|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
138632905|NCT00237341|Fentanyl|fentanyl|mesh-list
138632906|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138632907|NCT00237341|Narcotics|narcotics|mesh-ancestor
138632908|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632909|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632910|NCT00237341|Analgesics|analgesics|mesh-ancestor
138632911|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
138632912|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632913|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138632914|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138632915|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
138632916|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
138632917|NCT04539301|Anticoagulants|anticoagulants|mesh-list
138632918|NCT00237419|Infliximab|infliximab|mesh-list
138632919|NCT00237419|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138632920|NCT00237419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138632921|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
138632922|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138632923|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224247|NCT00904826|Eculizumab|eculizumab|mesh-list
138632924|NCT04539106|Ranibizumab|ranibizumab|mesh-list
138632925|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138632926|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138632927|NCT04539106|Growth Substances|growth substances|mesh-ancestor
138632928|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632929|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
138632930|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632931|NCT00237497|Zopiclone|zopiclone|mesh-list
138632932|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138632933|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632934|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632935|NCT00416130|Vorinostat|vorinostat|mesh-list
138632936|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632937|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138322577|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632938|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632939|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632940|NCT00416169|Galantamine|galantamine|mesh-list
138632941|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138224301|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224302|NCT02475564|Resveratrol|resveratrol|mesh-list
138632942|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632943|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632944|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
138632945|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632946|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632947|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138632948|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
138632949|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138667816|NCT00463983|Octreotide|octreotide|mesh-list
138224355|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
138632950|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
138632951|NCT00237536|Lonidamine|lonidamine|mesh-list
138632952|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632953|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138632954|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632955|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138632956|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
138632957|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138632958|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138632959|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138224425|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138632960|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138632961|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632962|NCT02215720|Sirolimus|sirolimus|mesh-list
138632963|NCT02215720|Cetuximab|cetuximab|mesh-list
138632964|NCT02215720|Temsirolimus|temsirolimus|mesh-list
138632965|NCT02215720|MTOR Inhibitors|mtor inhibitors|mesh-list
138632966|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138632967|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632968|NCT02215720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138632969|NCT02215720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138632970|NCT02215720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632971|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138632972|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
138632973|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632974|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138632975|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138632976|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138632977|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
138632979|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138632980|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138632981|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138632982|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138632983|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138632984|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138632985|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138632986|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632987|NCT02215798|Analgesics|analgesics|mesh-ancestor
138632988|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
138632989|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138632990|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
138632991|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138632992|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
138632993|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138632994|NCT02215057|Lidocaine|lidocaine|mesh-list
138309608|NCT00003461|Antibodies|antibodies|mesh-list
138632995|NCT02215057|Anesthetics|anesthetics|mesh-list
138632996|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
138632997|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138632998|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138632999|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
138633000|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633001|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138633002|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138633003|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138633004|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138633005|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633006|NCT00269685|Vasopressins|vasopressins|mesh-list
138633007|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
138633008|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
138633009|NCT00269685|Coagulants|coagulants|mesh-ancestor
138633010|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138633011|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138633012|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
138633013|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633014|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
138633015|NCT04543123|Escitalopram|escitalopram|mesh-list
138633016|NCT04543123|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138633017|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138633018|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138633019|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633020|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224552|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633021|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
138686974|NCT02942888|Niacin|niacin|mesh-list
138633022|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633023|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138633025|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
138633026|NCT04539418|Vitamins|vitamins|mesh-ancestor
138633027|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
138667865|NCT00464295|Capecitabine|capecitabine|mesh-list
138633028|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633029|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138633030|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138633031|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633032|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
138633033|NCT04539418|Coagulants|coagulants|mesh-ancestor
138633034|NCT00269724|Oxybutynin|oxybutynin|mesh-list
138633036|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
138633037|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633038|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633040|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138633041|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
138633042|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138224574|NCT03217838|Pyrazole|pyrazole|mesh-list
138633043|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633044|NCT00269724|Urological Agents|urological agents|mesh-ancestor
138633045|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138633046|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
138633047|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
138633048|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138633049|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138633050|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633051|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
138633052|NCT04710017|Coagulants|coagulants|mesh-ancestor
138633053|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138633054|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138633055|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138633056|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
138633057|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138633058|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633059|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138633060|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138224630|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138633061|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138633062|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138633063|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633065|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
138633066|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138633067|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
138633068|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633069|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138633071|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
138633072|NCT04538521|Vitamins|vitamins|mesh-ancestor
138633073|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
138633074|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633075|NCT00269763|Fentanyl|fentanyl|mesh-list
138633076|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138224689|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
138633077|NCT00269763|Narcotics|narcotics|mesh-ancestor
138633078|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138633079|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633080|NCT00269763|Analgesics|analgesics|mesh-ancestor
138633081|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
138633082|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633083|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138633084|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138633085|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
138633086|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
138633087|NCT00237575|Gemcitabine|gemcitabine|mesh-list
138633088|NCT00237575|Sargramostim|sargramostim|mesh-list
138633089|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633090|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138633091|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
138633092|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633094|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633095|NCT00269802|Methylphenidate|methylphenidate|mesh-list
138633096|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138633097|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633098|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138633099|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138633100|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138508088|NCT06196554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138633101|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633102|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
138633103|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633104|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138633105|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138633106|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138633107|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
138633108|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633109|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138633110|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138633111|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633112|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
138633113|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138633114|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
138633115|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633116|NCT00237614|Expectorants|expectorants|mesh-ancestor
138633117|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
138633118|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138633119|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
138633120|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224699|NCT01460225|Lubiprostone|lubiprostone|mesh-list
138633121|NCT00237614|Protective Agents|protective agents|mesh-ancestor
138633122|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633123|NCT00237614|Antidotes|antidotes|mesh-ancestor
138633124|NCT00269841|Infliximab|infliximab|mesh-list
138633125|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138633126|NCT00269841|Antibodies|antibodies|mesh-list
138633127|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
138633128|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138633130|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633131|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633132|NCT00269841|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138633133|NCT00269841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633134|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
138633135|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138633136|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138633137|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
138633138|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
138633139|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138633140|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
138633141|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633142|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138633143|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138633144|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
138633145|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633146|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633147|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138633148|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138633149|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138633150|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
138633151|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138633152|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633153|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322699|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
138633156|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138633157|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138633158|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633159|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138633160|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138633161|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
138633162|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633163|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138633164|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138633165|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138633166|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
138633167|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633168|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633169|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138633170|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138633171|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
138633173|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138633174|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633175|NCT00269880|Heparin|heparin|mesh-list
138633176|NCT00269880|Abciximab|abciximab|mesh-list
138633177|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
138633178|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138633179|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138633180|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633181|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138633182|NCT00237653|Valganciclovir|valganciclovir|mesh-list
138633183|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
138633184|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633185|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
138633186|NCT00269958|Hematinics|hematinics|mesh-ancestor
138633187|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
138633188|NCT02215876|Doxorubicin|doxorubicin|mesh-list
138633189|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138633190|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
138633191|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633193|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138633194|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
138633195|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633196|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633197|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138633198|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138633199|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138633200|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138224749|NCT01837394|Morphine|morphine|mesh-list
138633201|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633202|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
138633203|NCT00269997|Hematinics|hematinics|mesh-ancestor
138633204|NCT00237731|Morphine|morphine|mesh-list
138633205|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138633206|NCT00237731|Narcotics|narcotics|mesh-ancestor
138633207|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138633208|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633209|NCT00237731|Analgesics|analgesics|mesh-ancestor
138633210|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
138633211|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633212|NCT04542226|Bromides|bromides|mesh-list
138633213|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
138633214|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
138633215|NCT00270036|Hematinics|hematinics|mesh-ancestor
138633216|NCT00262392|Pamidronate|pamidronate|mesh-list
138633217|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138633218|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633219|NCT04537780|Montelukast|montelukast|mesh-list
138633220|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138633221|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
138633222|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138633223|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
138667978|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
138633224|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138633225|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633226|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138633227|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138224776|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138224779|NCT01837628|Lidocaine|lidocaine|mesh-list
138633228|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633229|NCT00237887|Adalimumab|adalimumab|mesh-list
138633230|NCT00237887|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138633231|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633232|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138633233|NCT02215993|Ticagrelor|ticagrelor|mesh-list
138633234|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138633235|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138633236|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138633237|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138633238|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138633239|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
138224823|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633240|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633241|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633242|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633244|NCT02216149|Tegafur|tegafur|mesh-list
138633245|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
138633246|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138633247|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
138633248|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633249|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633250|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
138633251|NCT00238004|Niacin|niacin|mesh-list
138633252|NCT00238004|Niacinamide|niacinamide|mesh-list
138633253|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
138633254|NCT00238004|Vitamins|vitamins|mesh-ancestor
138633255|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
138633256|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633257|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138633258|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
138633259|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633260|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138633261|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
138633262|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138633263|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138633264|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138633265|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
138633266|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633267|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138633268|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138633270|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
138633271|NCT00238043|Hematinics|hematinics|mesh-ancestor
138633272|NCT00415584|Cinacalcet|cinacalcet|mesh-list
138633273|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138633274|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633275|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138633276|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
138633277|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138633278|NCT04536922|Aldesleukin|aldesleukin|mesh-list
138633279|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
138633280|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
138633281|NCT04536922|Fludarabine|fludarabine|mesh-list
138633283|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
138633284|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633285|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138633286|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138633287|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
138633288|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633289|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633290|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138633291|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138633292|NCT04536922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138633293|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138633294|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138633295|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
138633296|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633297|NCT04536961|Deucravacitinib|deucravacitinib|mesh-list
138633298|NCT04536961|Famotidine|famotidine|mesh-list
138633299|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138633300|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138224886|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
138633301|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138633302|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
138633303|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
138633304|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633305|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633306|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633307|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
138633308|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138633309|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633310|NCT00238160|Fluorouracil|fluorouracil|mesh-list
138633311|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633312|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
138224903|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
138633313|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633314|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138633315|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138633316|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
138633317|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633318|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
138633319|NCT00415701|Propofol|propofol|mesh-list
138633320|NCT00415701|Etomidate|etomidate|mesh-list
138633321|NCT00415701|Cosyntropin|cosyntropin|mesh-list
138633322|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138633323|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138633324|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633325|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138633326|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
138633327|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
138633328|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633329|NCT00415701|Hormones|hormones|mesh-ancestor
138633330|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138633331|NCT02961998|Celecoxib|celecoxib|mesh-list
138633332|NCT02961998|Sorafenib|sorafenib|mesh-list
138633333|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633334|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138633335|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532543|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224967|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138633336|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633337|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138633338|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138633339|NCT02961998|Analgesics|analgesics|mesh-ancestor
138633340|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
138633341|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633342|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633343|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633344|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138633345|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138633346|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138633347|NCT04536415|Oseltamivir|oseltamivir|mesh-list
138633348|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
138633349|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633350|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633351|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633352|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138633353|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138633354|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
138633355|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687116|NCT03153150|Warfarin|warfarin|mesh-list
138633356|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633357|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138633358|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
138633359|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
138633360|NCT00262587|Hormones|hormones|mesh-ancestor
138633361|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138633362|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
138633363|NCT00238199|Calcitriol|calcitriol|mesh-list
138633364|NCT00238199|Docetaxel|docetaxel|mesh-list
138633365|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633366|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
138633367|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
138633368|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
138532545|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138225072|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
138225073|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225074|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225075|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225076|NCT03409874|Diclofenac|diclofenac|mesh-list
138633369|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633370|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138633371|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633372|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138633373|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138633374|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138633375|NCT00238199|Vitamins|vitamins|mesh-ancestor
138633376|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
138633377|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138633378|NCT04536493|Lidocaine|lidocaine|mesh-list
138633379|NCT04536493|Epinephrine|epinephrine|mesh-list
138633380|NCT04536493|Racepinephrine|racepinephrine|mesh-list
138633381|NCT04536493|Tetracaine|tetracaine|mesh-list
138633382|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
138633383|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
138633385|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225135|NCT01469585|Doxycycline|doxycycline|mesh-list
138633386|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633387|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
138633388|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633389|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138633390|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138633391|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138633392|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138633393|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633394|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138633395|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138633396|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
138633397|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138225193|NCT01722110|Analgesics|analgesics|mesh-ancestor
138633398|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138633399|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138633401|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138633402|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
138633403|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
138633404|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
138633405|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138633406|NCT04536181|Prednisone|prednisone|mesh-list
138633407|NCT04536181|Prednisolone|prednisolone|mesh-list
138633408|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633409|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
138633410|NCT04536181|Hormones|hormones|mesh-ancestor
138633411|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138633412|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633413|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138633414|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633415|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
138225317|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138633416|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
138633417|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633419|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
138633420|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138633421|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
138633422|NCT02216227|Vancomycin|vancomycin|mesh-list
138633423|NCT02216227|Cefazolin|cefazolin|mesh-list
138633424|NCT02216227|Mupirocin|mupirocin|mesh-list
138633425|NCT02216227|Povidone|povidone|mesh-list
138633426|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138633427|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633428|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
138633429|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
138633430|NCT02216227|Trace Elements|trace elements|mesh-ancestor
138633431|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
138633432|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633433|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138633434|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
138633435|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
138633436|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138633437|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633438|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633439|NCT00238277|Temozolomide|temozolomide|mesh-list
138633440|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138633441|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
138633442|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633443|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633444|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138633445|NCT02216266|Physostigmine|physostigmine|mesh-list
138668056|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138633446|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138322772|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
138633447|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633448|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633449|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
138633450|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633451|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633452|NCT02216266|Miotics|miotics|mesh-ancestor
138633453|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
138633454|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633455|NCT00238316|Letrozole|letrozole|mesh-list
138225318|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
138633456|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633457|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138633458|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138633459|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633460|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633461|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138633462|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
138633463|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138318517|NCT01422408|Hormones|hormones|mesh-ancestor
138633464|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633466|NCT04535518|Infliximab|infliximab|mesh-list
138633467|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
138532546|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
138225327|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
138225328|NCT03001661|Dinoprostone|dinoprostone|mesh-list
138633468|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138633469|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
138633470|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138633471|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138633472|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138633473|NCT04535518|Analgesics|analgesics|mesh-ancestor
138633474|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
138633475|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633476|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633477|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633478|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138633479|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138633480|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138633481|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633482|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138633483|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138633484|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633485|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
138633486|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
138633487|NCT04535518|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138633488|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
138687186|NCT06025825|Mydriatics|mydriatics|mesh-ancestor
138633490|NCT02216383|Oxytocin|oxytocin|mesh-list
138633491|NCT02216383|Carbetocin|carbetocin|mesh-list
138633492|NCT02216383|Syntometrine|syntometrine|mesh-list
138633493|NCT02216383|Ergonovine|ergonovine|mesh-list
138633494|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
138633495|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138633496|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633497|NCT00262782|Fludarabine|fludarabine|mesh-list
138633498|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633499|NCT00238394|Cediranib|cediranib|mesh-list
138633500|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633501|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633502|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633503|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138633504|NCT00238472|Nateglinide|nateglinide|mesh-list
138633505|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138322804|NCT03473730|Daratumumab|daratumumab|mesh-list
138668072|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
138633506|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633508|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633509|NCT02216617|Docetaxel|docetaxel|mesh-list
138633510|NCT02216617|Afatinib|afatinib|mesh-list
138633511|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633512|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
138633513|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
138633514|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
138225512|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633515|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633516|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138633517|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633518|NCT00262977|Aspirin|aspirin|mesh-list
138633519|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138633520|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138633521|NCT00262977|Analgesics|analgesics|mesh-ancestor
138633522|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
138633523|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633524|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633525|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633526|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138633527|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138633528|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138633529|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633530|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138633531|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138633532|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633533|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
138633534|NCT00238667|Aspirin|aspirin|mesh-list
138633535|NCT00238667|Heparin|heparin|mesh-list
138633536|NCT00238667|Calcium heparin|calcium heparin|mesh-list
138225572|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138633537|NCT00238667|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138633538|NCT00238667|Dalteparin|dalteparin|mesh-list
138633539|NCT00238667|Dipyridamole|dipyridamole|mesh-list
138633540|NCT00238667|Warfarin|warfarin|mesh-list
138633541|NCT00238667|Anticoagulants|anticoagulants|mesh-list
138633542|NCT00238667|Clopidogrel|clopidogrel|mesh-list
138633543|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138633544|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138633545|NCT00238667|Analgesics|analgesics|mesh-ancestor
138633546|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
138687239|NCT06025409|Leuprolide|leuprolide|mesh-list
138322817|NCT01679574|Clomiphene|clomiphene|mesh-list
138633547|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633548|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633549|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633550|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138633551|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138633552|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138633553|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633554|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138633555|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138633556|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633557|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
138225626|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633558|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138633559|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138633560|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138633561|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
138633562|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633563|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138633564|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
138633565|NCT00263016|Docetaxel|docetaxel|mesh-list
138633566|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633567|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
138633568|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
138633569|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
138633570|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633572|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138633573|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138633574|NCT04534465|Diuretics|diuretics|mesh-ancestor
138633575|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
138633576|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633577|NCT04534465|Laxatives|laxatives|mesh-ancestor
138633578|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138633579|NCT02216656|Cinacalcet|cinacalcet|mesh-list
138633580|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138633581|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633582|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138633583|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
138633584|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138633585|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
138633586|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633587|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
138633588|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138633589|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138633590|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
138633591|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138633592|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633593|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138633594|NCT04534231|Nicotine|nicotine|mesh-list
138633595|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138633596|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
138633597|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633598|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633599|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138633600|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138633601|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
138633602|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633603|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138225816|NCT03005483|Gabapentin|gabapentin|mesh-list
138633605|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138633606|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138633607|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633608|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633609|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138633610|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138633611|NCT00263094|Analgesics|analgesics|mesh-ancestor
138633612|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
138225857|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633613|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633614|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633615|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633616|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138633617|NCT00238784|Budesonide|budesonide|mesh-list
138633618|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
138633619|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633620|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138633621|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
138633622|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633623|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633625|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
138633626|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
138633627|NCT00238784|Hormones|hormones|mesh-ancestor
138633628|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138633629|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138322879|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138633630|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138633631|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138633632|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
138225924|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138225926|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
138633633|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633634|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633635|NCT00263133|Sertraline|sertraline|mesh-list
138633636|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
138633637|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138633638|NCT00263133|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138633639|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138633640|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138633641|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633642|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633643|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
138633644|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633645|NCT04533724|Amisulpride|amisulpride|mesh-list
138633646|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138633647|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138633648|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138225974|NCT00919802|Oxytocin|oxytocin|mesh-list
138633649|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633650|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138633651|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138633652|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
138633653|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633654|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633655|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138633656|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
138633657|NCT00238901|Basiliximab|basiliximab|mesh-list
138633658|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138633659|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
138633660|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633661|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
138633662|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138633663|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633664|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138633665|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
138633666|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138633667|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633668|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633669|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633671|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138633672|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226042|NCT04526951|Aspirin|aspirin|mesh-list
138633673|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138633674|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
138633675|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138633676|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633677|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633678|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633679|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
138633680|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138633681|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633682|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138633683|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
138633684|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138633685|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138226093|NCT03002675|Incretins|incretins|mesh-ancestor
138633686|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633687|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633689|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138633690|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
138633691|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
138633692|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687297|NCT06025071|Tubulin Modulators|tubulin modulators|mesh-ancestor
138633693|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633694|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
138633695|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138633696|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138226141|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633697|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138633698|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
138633699|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138633700|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633701|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633702|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633703|NCT00238082|Beclomethasone|beclomethasone|mesh-list
138633705|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633706|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
138633707|NCT00238082|Hormones|hormones|mesh-ancestor
138633708|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138633709|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633710|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138633711|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
138633712|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
138633713|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138633714|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
138633715|NCT02217007|Acamprosate|acamprosate|mesh-list
138226204|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138226209|NCT04716335|Harmine|harmine|mesh-list
138633716|NCT02217007|Calcium|calcium|mesh-list
138633717|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138633718|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633719|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138633720|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138633721|NCT05897372|Pentoxifylline|pentoxifylline|mesh-list
138633722|NCT05897372|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138633723|NCT05897372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633724|NCT05897372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633725|NCT05897372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138633726|NCT05897372|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138633727|NCT05897372|Protective Agents|protective agents|mesh-ancestor
138633728|NCT05897372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633729|NCT05897372|Vasodilator Agents|vasodilator agents|mesh-ancestor
138633730|NCT05897372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138633731|NCT05897372|Antioxidants|antioxidants|mesh-ancestor
138633732|NCT05897294|Voriconazole|voriconazole|mesh-list
138633733|NCT05897294|Antifungal Agents|antifungal agents|mesh-ancestor
138633734|NCT05897294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633735|NCT05897294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138633736|NCT05897294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138633737|NCT05897294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226260|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138226261|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138226262|NCT04373018|Eusol|eusol|mesh-list
138633738|NCT05897294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633739|NCT05897294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138633740|NCT05897294|Hormone Antagonists|hormone antagonists|mesh-ancestor
138633741|NCT05897294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138633742|NCT05897294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633743|NCT05897294|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138633744|NCT05896943|Ustekinumab|ustekinumab|mesh-list
138633745|NCT05896943|Dermatologic Agents|dermatologic agents|mesh-ancestor
138633746|NCT05896930|Amoxicillin|amoxicillin|mesh-list
138633748|NCT05896930|Meropenem|meropenem|mesh-list
138633749|NCT05896930|Ertapenem|ertapenem|mesh-list
138633750|NCT05896930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138633751|NCT05896930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633752|NCT05896930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138633753|NCT05896930|Antitubercular Agents|antitubercular agents|mesh-ancestor
138633754|NCT05896930|Leprostatic Agents|leprostatic agents|mesh-ancestor
138633755|NCT05896930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138633756|NCT05896930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633757|NCT05896930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633758|NCT05896930|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138633759|NCT05896930|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138633760|NCT05896930|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138633761|NCT05896930|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138633762|NCT05896930|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138633763|NCT05896930|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138633764|NCT05896787|Paclitaxel|paclitaxel|mesh-list
138633765|NCT05896787|Carboplatin|carboplatin|mesh-list
138633766|NCT05896787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138633767|NCT05896787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633768|NCT05896787|Tubulin Modulators|tubulin modulators|mesh-ancestor
138633769|NCT05896787|Antimitotic Agents|antimitotic agents|mesh-ancestor
138633770|NCT05896787|Mitosis Modulators|mitosis modulators|mesh-ancestor
138633771|NCT05896787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633772|NCT05896631|Bupivacaine|bupivacaine|mesh-list
138633773|NCT05896631|Anesthetics, Local|anesthetics, local|mesh-ancestor
138633774|NCT05896631|Anesthetics|anesthetics|mesh-ancestor
138633775|NCT05896631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138633776|NCT05896631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633777|NCT05896631|Sensory System Agents|sensory system agents|mesh-ancestor
138633778|NCT05896631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633779|NCT05896605|Azathioprine|azathioprine|mesh-list
138633780|NCT05896605|Antimetabolites|antimetabolites|mesh-ancestor
138633781|NCT05896605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633782|NCT05896605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138633783|NCT05896605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633784|NCT05896605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138226434|NCT05208983|Vaccines|vaccines|mesh-list
138633785|NCT05896605|Immunologic Factors|immunologic factors|mesh-ancestor
138633786|NCT05896605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633787|NCT05896605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138633788|NCT05896553|Oxytocin|oxytocin|mesh-list
138633789|NCT05896553|Oxytocics|oxytocics|mesh-ancestor
138633790|NCT05896553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138633791|NCT05896553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633792|NCT05896462|Povidone-Iodine|povidone-iodine|mesh-list
138633793|NCT05896462|Povidone|povidone|mesh-list
138633794|NCT05896462|Plasma Substitutes|plasma substitutes|mesh-ancestor
138633795|NCT05896462|Blood Substitutes|blood substitutes|mesh-ancestor
138633796|NCT05896462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138633797|NCT05896462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633799|NCT05896449|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138633800|NCT05896449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633801|NCT05896319|Hyaluronic Acid|hyaluronic acid|mesh-list
138226492|NCT02242838|Telmisartan|telmisartan|mesh-list
138226493|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138633802|NCT05896319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138633803|NCT05896319|Immunologic Factors|immunologic factors|mesh-ancestor
138633804|NCT05896319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633805|NCT05896319|Viscosupplements|viscosupplements|mesh-ancestor
138633806|NCT05896319|Protective Agents|protective agents|mesh-ancestor
138633807|NCT05896059|Tislelizumab|tislelizumab|mesh-list
138633808|NCT05896059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138633809|NCT05896059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633810|NCT05895942|Imatinib Mesylate|imatinib mesylate|mesh-list
138633811|NCT05895942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633812|NCT05895942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138633813|NCT05895942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226568|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
138633814|NCT05895942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633815|NCT05876715|Nivolumab|nivolumab|mesh-list
138633816|NCT05876715|Ipilimumab|ipilimumab|mesh-list
138322936|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
138633817|NCT05876715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138633818|NCT05876715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633819|NCT05876715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138633820|NCT05876715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633821|NCT05853120|Doxycycline|doxycycline|mesh-list
138633822|NCT05853120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138633823|NCT05853120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633824|NCT05853120|Antimalarials|antimalarials|mesh-ancestor
138633825|NCT05853120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138633826|NCT05853120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138633827|NCT05841160|Moxifloxacin|moxifloxacin|mesh-list
138633828|NCT05841160|Ecopipam|ecopipam|mesh-list
138633829|NCT05841160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138633830|NCT05841160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633831|NCT05841160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138633832|NCT05841160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138633833|NCT05841160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633834|NCT05841160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226632|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
138226633|NCT02244632|Irinotecan|irinotecan|mesh-list
138633835|NCT05841160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633836|NCT05841160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633837|NCT05841160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138633839|NCT05841160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138633840|NCT05841160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138633841|NCT05841160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138633842|NCT05841160|Dopamine Agents|dopamine agents|mesh-ancestor
138633843|NCT05841160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633845|NCT05815758|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138633846|NCT05815758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138633847|NCT05815758|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138633848|NCT05815758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138633849|NCT05815758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138633850|NCT05815758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138633851|NCT05815758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138633852|NCT05815758|Adrenergic Agents|adrenergic agents|mesh-ancestor
138633853|NCT05815758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633854|NCT05815758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633855|NCT05815758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633856|NCT05815758|Antipruritics|antipruritics|mesh-ancestor
138633857|NCT05815758|Dermatologic Agents|dermatologic agents|mesh-ancestor
138633858|NCT05815758|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138633859|NCT05815758|Histamine Antagonists|histamine antagonists|mesh-ancestor
138633860|NCT05815758|Histamine Agents|histamine agents|mesh-ancestor
138633861|NCT05815758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138633862|NCT05694533|Midazolam|midazolam|mesh-list
138633863|NCT05694533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138633864|NCT05694533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138633865|NCT05694533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138633866|NCT05694533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633867|NCT05694533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138633868|NCT05694533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138633869|NCT05694533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138633870|NCT05694533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138633871|NCT05694533|Anesthetics, General|anesthetics, general|mesh-ancestor
138633872|NCT05694533|Anesthetics|anesthetics|mesh-ancestor
138633873|NCT05694533|GABA Modulators|gaba modulators|mesh-ancestor
138633874|NCT05694533|GABA Agents|gaba agents|mesh-ancestor
138633875|NCT05694533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633876|NCT05694533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633877|NCT05681390|Tislelizumab|tislelizumab|mesh-list
138633878|NCT05681390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138633879|NCT05681390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633880|NCT05669547|Hormones|hormones|mesh-list
138633881|NCT05669547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138633882|NCT05669547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633884|NCT05669079|Epoetin Alfa|epoetin alfa|mesh-list
138633885|NCT05669079|Lenograstim|lenograstim|mesh-list
138226734|NCT02224313|Progestins|progestins|mesh-ancestor
138633886|NCT05669079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138633887|NCT05669079|Antimetabolites|antimetabolites|mesh-ancestor
138633888|NCT05669079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633889|NCT05669079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633890|NCT05669079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633891|NCT05669079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138633892|NCT05669079|Immunologic Factors|immunologic factors|mesh-ancestor
138633893|NCT05669079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633894|NCT05669079|Hematinics|hematinics|mesh-ancestor
138633895|NCT05611905|Probenecid|probenecid|mesh-list
138633896|NCT05611905|Uricosuric Agents|uricosuric agents|mesh-ancestor
138633897|NCT05611905|Gout Suppressants|gout suppressants|mesh-ancestor
138633898|NCT05611905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138633899|NCT05586373|Dipyrone|dipyrone|mesh-list
138226790|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
138633900|NCT05586373|Ibuprofen|ibuprofen|mesh-list
138633901|NCT05586373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138633902|NCT05586373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138633903|NCT05586373|Analgesics|analgesics|mesh-ancestor
138633904|NCT05586373|Sensory System Agents|sensory system agents|mesh-ancestor
138633905|NCT05586373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633906|NCT05586373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633907|NCT05586373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633908|NCT05586373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138633909|NCT05586373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138633910|NCT05586373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633911|NCT05586373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633912|NCT05586373|Antipyretics|antipyretics|mesh-ancestor
138226851|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
138226865|NCT02451930|Necitumumab|necitumumab|mesh-list
138633913|NCT05434546|Pregnanolone|pregnanolone|mesh-list
138633914|NCT05434546|Anesthetics|anesthetics|mesh-ancestor
138633915|NCT05434546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138633916|NCT05434546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633917|NCT05359939|Choline|choline|mesh-list
138633918|NCT05359939|Lipotropic Agents|lipotropic agents|mesh-ancestor
138633919|NCT05359939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138633920|NCT05359939|Antimetabolites|antimetabolites|mesh-ancestor
138633921|NCT05359939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633922|NCT05359939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138633924|NCT05359939|Nootropic Agents|nootropic agents|mesh-ancestor
138633925|NCT05250791|Lidocaine|lidocaine|mesh-list
138633926|NCT05250791|Anesthetics, Local|anesthetics, local|mesh-ancestor
138633927|NCT05250791|Anesthetics|anesthetics|mesh-ancestor
138226913|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
138226914|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
138226931|NCT04925076|Ethanol|ethanol|mesh-list
138633928|NCT05250791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138633929|NCT05250791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633930|NCT05250791|Sensory System Agents|sensory system agents|mesh-ancestor
138633931|NCT05250791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633932|NCT05250791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138633933|NCT05250791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138633934|NCT05250791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138633935|NCT05250791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138633936|NCT05250791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633937|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
138633938|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138633939|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633940|NCT05197322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138633941|NCT05197322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633942|NCT05145764|Suvorexant|suvorexant|mesh-list
138633943|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138633944|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138633945|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138633946|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633947|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138633948|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138633949|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633950|NCT05085496|Atezolizumab|atezolizumab|mesh-list
138633951|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138633952|NCT05085496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138633953|NCT05085496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633954|NCT05085496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138633955|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633956|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
138633957|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633958|NCT04983836|Anesthetics|anesthetics|mesh-list
138633959|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138633960|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633961|NCT04933383|Budesonide|budesonide|mesh-list
138633962|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633963|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138227100|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
138633964|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
138668342|NCT04697745|Hormones|hormones|mesh-ancestor
138633965|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633966|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633967|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138633968|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
138633969|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
138633971|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138633973|NCT04923776|Etoposide|etoposide|mesh-list
138633974|NCT04923776|Atezolizumab|atezolizumab|mesh-list
138633975|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138633976|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138633977|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138633978|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138633979|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138633980|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633981|NCT04923776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138227165|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633982|NCT04923776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138633983|NCT04716881|Naltrexone|naltrexone|mesh-list
138633984|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138633985|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138633986|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138633987|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
138322972|NCT05345808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138633988|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138633989|NCT04582266|Remdesivir|remdesivir|mesh-list
138633990|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
138633991|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138633992|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
138633993|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138633994|NCT04528134|Listerine|listerine|mesh-list
138633995|NCT04528134|Fluorides|fluorides|mesh-list
138227221|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138633996|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
138633997|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
138633998|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
138633999|NCT04528134|Protective Agents|protective agents|mesh-ancestor
138634000|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634001|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138634002|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138634003|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138634004|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138634005|NCT04521920|Narcotics|narcotics|mesh-ancestor
138634006|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138634007|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634008|NCT04521920|Analgesics|analgesics|mesh-ancestor
138634009|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
138634010|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634011|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138634013|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138634014|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138227283|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634016|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
138634017|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634018|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634019|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138634020|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138634021|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138634022|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138634023|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634024|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138634025|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138227339|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138360071|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
138634026|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634027|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
138634028|NCT04370093|Pioglitazone|pioglitazone|mesh-list
138634029|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138634030|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634031|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
138634032|NCT04298229|Diuretics|diuretics|mesh-list
138634033|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138634034|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634035|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138634036|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634037|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
138634038|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
138634039|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138634040|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138634041|NCT04177433|Prednisolone|prednisolone|mesh-list
138634042|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
138634043|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138634044|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
138634045|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138634046|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
138634047|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
138634048|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634049|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634050|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634051|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
138634053|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634054|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138634055|NCT04177433|Protective Agents|protective agents|mesh-ancestor
138634056|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138687447|NCT06022614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138634057|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634058|NCT04108897|Doxycycline|doxycycline|mesh-list
138634059|NCT04108897|Ivermectin|ivermectin|mesh-list
138634060|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138634061|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138634062|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
138634063|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138227466|NCT01617083|Azithromycin|azithromycin|mesh-list
138634064|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138634065|NCT04101877|Bevacizumab|bevacizumab|mesh-list
138634066|NCT04101877|Aflibercept|aflibercept|mesh-list
138634067|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138634068|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634069|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138634070|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138634071|NCT04101877|Growth Substances|growth substances|mesh-ancestor
138634072|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634073|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
138634074|NCT04101838|Vaccines|vaccines|mesh-list
138634075|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
138227519|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227520|NCT01620047|Fentanyl|fentanyl|mesh-list
138634076|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634077|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
138634078|NCT04026958|Clarithromycin|clarithromycin|mesh-list
138634079|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138634080|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138634081|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138634082|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634083|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634084|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138634085|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138634086|NCT04024254|Folic Acid|folic acid|mesh-list
138634087|NCT04024254|Hematinics|hematinics|mesh-ancestor
138634088|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
138634089|NCT04024254|Vitamins|vitamins|mesh-ancestor
138634090|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
138634091|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634093|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138634094|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634095|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634096|NCT03887702|Tenofovir|tenofovir|mesh-list
138634097|NCT03887702|Entecavir|entecavir|mesh-list
138634098|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
138634099|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138634100|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138634101|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138634102|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634103|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634104|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138634105|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138634106|NCT03878589|Oxytocin|oxytocin|mesh-list
138634107|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
138634108|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138634109|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634110|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
138634111|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138634112|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634113|NCT03813836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138634114|NCT03813836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634115|NCT03730649|Sulforaphane|sulforaphane|mesh-list
138634116|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138634117|NCT03730649|Protective Agents|protective agents|mesh-ancestor
138634118|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634119|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634120|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138634121|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138634122|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634123|NCT03598426|Dexamethasone|dexamethasone|mesh-list
138634124|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138634125|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
138634126|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
138227586|NCT03516968|Vitamin D|vitamin d|mesh-list
138634127|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634128|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634129|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634130|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
138634131|NCT03598426|Hormones|hormones|mesh-ancestor
138634132|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634133|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138634134|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634135|NCT03521037|Rucaparib|rucaparib|mesh-list
138634136|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138634137|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634138|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634139|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634140|NCT03499444|Rucaparib|rucaparib|mesh-list
138687516|NCT06012734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138634141|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138634142|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634143|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634144|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634145|NCT03494322|Cetuximab|cetuximab|mesh-list
138634146|NCT03494322|Avelumab|avelumab|mesh-list
138634147|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138634148|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227616|NCT02777372|Sertraline|sertraline|mesh-list
138634149|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
138634150|NCT03441633|Apixaban|apixaban|mesh-list
138634151|NCT03441633|Dabigatran|dabigatran|mesh-list
138634152|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138634153|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
138634154|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138634155|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
138634156|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634157|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634158|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
138227659|NCT03031808|Lidocaine|lidocaine|mesh-list
138634159|NCT03397394|Rucaparib|rucaparib|mesh-list
138634160|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138634161|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634162|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323030|NCT05345574|Narcotics|narcotics|mesh-ancestor
138634163|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634165|NCT03373760|Ipilimumab|ipilimumab|mesh-list
138634166|NCT03373760|Tremelimumab|tremelimumab|mesh-list
138634167|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
138634168|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138634169|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
138634170|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138634171|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634172|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
138634173|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634174|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138634175|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634176|NCT03290794|Aflibercept|aflibercept|mesh-list
138634177|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138634178|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138634179|NCT03290794|Growth Substances|growth substances|mesh-ancestor
138634180|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227726|NCT02238977|Bupropion|bupropion|mesh-list
138634181|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
138634182|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634183|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
138634184|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138668596|NCT04701242|Ezetimibe|ezetimibe|mesh-list
138634185|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138634187|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634188|NCT02986100|Rucaparib|rucaparib|mesh-list
138634189|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138634190|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634191|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634192|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634193|NCT02965027|Prazosin|prazosin|mesh-list
138634194|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138634195|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138634196|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138227781|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
138227789|NCT03030950|Analgesics|analgesics|mesh-ancestor
138634197|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138634199|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634200|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634202|NCT02952534|Rucaparib|rucaparib|mesh-list
138634203|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138634204|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634205|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634206|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634207|NCT02949934|Tolcapone|tolcapone|mesh-list
138634208|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138634209|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138634210|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138634211|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634212|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634214|NCT02935634|Ipilimumab|ipilimumab|mesh-list
138634215|NCT02935634|Relatlimab|relatlimab|mesh-list
138634216|NCT02935634|Rucaparib|rucaparib|mesh-list
138634217|NCT02935634|Linrodostat|linrodostat|mesh-list
138634218|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138634219|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634220|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138634221|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634222|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138634223|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634224|NCT02864992|Tepotinib|tepotinib|mesh-list
138634225|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634226|NCT02740712|Vitamin K|vitamin k|mesh-list
138634227|NCT02740712|Rucaparib|rucaparib|mesh-list
138634228|NCT02740712|Digoxin|digoxin|mesh-list
138634229|NCT02740712|Midazolam|midazolam|mesh-list
138634230|NCT02740712|Caffeine|caffeine|mesh-list
138634231|NCT02740712|Omeprazole|omeprazole|mesh-list
138634232|NCT02740712|Warfarin|warfarin|mesh-list
138634233|NCT02740712|Vitamins|vitamins|mesh-ancestor
138634234|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
138634235|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634236|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138634237|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138634238|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138634239|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138634240|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138634241|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138634242|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138227962|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138634243|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
138634244|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
138634245|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
138634246|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
138634247|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634248|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634249|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
138634250|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138634251|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138634252|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634253|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138634254|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138634255|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
138634256|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138687561|NCT05986136|Analgesics|analgesics|mesh-ancestor
138634257|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634258|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138634259|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138634260|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138634261|NCT02740712|Protective Agents|protective agents|mesh-ancestor
138634262|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138634263|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138634265|NCT02740712|Coagulants|coagulants|mesh-ancestor
138634266|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138634267|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634269|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138634270|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634271|NCT02580305|Memantine|memantine|mesh-list
138634272|NCT02580305|Donepezil|donepezil|mesh-list
138228086|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
138228087|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634273|NCT02580305|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
138634274|NCT02580305|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138634275|NCT02580305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634276|NCT02580305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634277|NCT02580305|Cholinergic Agents|cholinergic agents|mesh-ancestor
138634278|NCT02580305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634279|NCT02580305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634280|NCT02580305|Nootropic Agents|nootropic agents|mesh-ancestor
138634281|NCT02580305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138228147|NCT00964496|Growth Substances|growth substances|mesh-ancestor
138634282|NCT02580305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138634283|NCT02580305|Dopamine Agents|dopamine agents|mesh-ancestor
138634284|NCT02580305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138634285|NCT02580305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138634286|NCT02580305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138634287|NCT02580305|Serotonin Agents|serotonin agents|mesh-ancestor
138634288|NCT02279394|Dexamethasone|dexamethasone|mesh-list
138634289|NCT02279394|Lenalidomide|lenalidomide|mesh-list
138634290|NCT02279394|Elotuzumab|elotuzumab|mesh-list
138634291|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138634292|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
138634293|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
138634294|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634295|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634296|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634297|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
138634298|NCT02279394|Hormones|hormones|mesh-ancestor
138634299|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634300|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138634301|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634302|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
138634303|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138634304|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138634305|NCT02279394|Growth Substances|growth substances|mesh-ancestor
138634306|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
138634308|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
138634309|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
138634310|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138634311|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634312|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
138228215|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
138634313|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634314|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138634315|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138634316|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138634317|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138634318|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634319|NCT01821781|Fludarabine|fludarabine|mesh-list
138634320|NCT01821781|Melphalan|melphalan|mesh-list
138634321|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
138634322|NCT01821781|Thiotepa|thiotepa|mesh-list
138634323|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634324|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634325|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138634326|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
138634327|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634328|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138634329|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
138228268|NCT02455518|Ibuprofen|ibuprofen|mesh-list
138634330|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138634331|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138634332|NCT01555463|Azelaic acid|azelaic acid|mesh-list
138634333|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634334|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
138323087|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634335|NCT01482715|Rucaparib|rucaparib|mesh-list
138668776|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
138634336|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138634337|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634338|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634339|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634340|NCT01257919|Azelaic acid|azelaic acid|mesh-list
138634341|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634342|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
138634343|NCT00915837|Triamcinolone|triamcinolone|mesh-list
138634344|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138634345|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138634346|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138634347|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138634348|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
138634349|NCT00915837|Hormones|hormones|mesh-ancestor
138634350|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634351|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634352|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138634353|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
138634354|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634355|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634356|NCT00239096|Losartan|losartan|mesh-list
138634357|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138634358|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138634359|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138228382|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138668802|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634360|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138634361|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634363|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634364|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634365|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
138634366|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138634367|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138228444|NCT02161484|Bupivacaine|bupivacaine|mesh-list
138634368|NCT02217163|Dexamethasone|dexamethasone|mesh-list
138634369|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
138634370|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138634371|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
138634372|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634373|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138634374|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138634375|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
138508089|NCT06196554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634376|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634377|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634378|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138634379|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138634380|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
138634381|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
138634382|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634383|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634384|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
138634385|NCT02217163|Hormones|hormones|mesh-ancestor
138228508|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634386|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634387|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138634388|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138634389|NCT02217202|Laxatives|laxatives|mesh-ancestor
138634390|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634391|NCT00239174|Surinabant|surinabant|mesh-list
138634392|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138634393|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138634394|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634395|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634396|NCT00239174|Hormones|hormones|mesh-ancestor
138508090|NCT06196554|Tubulin Modulators|tubulin modulators|mesh-ancestor
138634397|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138228579|NCT00994760|Fentanyl|fentanyl|mesh-list
138634398|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634399|NCT04531423|Golimumab|golimumab|mesh-list
138634400|NCT04531423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138634401|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138634402|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138634403|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138634404|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
138228623|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634405|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634406|NCT04531423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138687610|NCT05926427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634407|NCT04531423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138634408|NCT04531423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634409|NCT04531423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634410|NCT04531423|Serotonin Agents|serotonin agents|mesh-ancestor
138634411|NCT00239252|Interferons|interferons|mesh-list
138634412|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
138634413|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634414|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
138634415|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138634416|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138228760|NCT01051778|Aspirin|aspirin|mesh-list
138634417|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
138634418|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634419|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634421|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138634422|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634423|NCT04531228|Lenvatinib|lenvatinib|mesh-list
138634424|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634425|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138634426|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634427|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634428|NCT04531072|Ritonavir|ritonavir|mesh-list
138634429|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138634430|NCT04531072|Lumefantrine|lumefantrine|mesh-list
138634431|NCT04531072|Artemether|artemether|mesh-list
138634432|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138634433|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138634434|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138634435|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
138634436|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634437|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634438|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138634439|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138634440|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
138228891|NCT01062230|Bortezomib|bortezomib|mesh-list
138228892|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634441|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138634442|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138634443|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138634444|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
138634445|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138634446|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138634447|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138634448|NCT00414323|Escitalopram|escitalopram|mesh-list
138634449|NCT00414323|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138634450|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138634451|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138228958|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
138228959|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228967|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
138634452|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634453|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634454|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
138634455|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229022|NCT01076504|Carboplatin|carboplatin|mesh-list
138634456|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634457|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
138634458|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138634459|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138634461|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
138634462|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
138634463|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
138634464|NCT00263484|Thalidomide|thalidomide|mesh-list
138229094|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
138634465|NCT00263484|Dexamethasone|dexamethasone|mesh-list
138634466|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
138634467|NCT00263484|BB 1101|bb 1101|mesh-list
138634468|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138634469|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
138634470|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
138634471|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634472|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229184|NCT02440854|Afatinib|afatinib|mesh-list
138634473|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634474|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
138634475|NCT00263484|Hormones|hormones|mesh-ancestor
138634476|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634477|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138634478|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634479|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
138634480|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229231|NCT01036802|Warfarin|warfarin|mesh-list
138229232|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
138229233|NCT01037192|Vancomycin|vancomycin|mesh-list
138229234|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138634481|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138669057|NCT00440024|Tazarotene|tazarotene|mesh-list
138634482|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138634483|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
138634484|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
138634485|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138634486|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138634487|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138634488|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138634489|NCT00263484|Growth Substances|growth substances|mesh-ancestor
138634490|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
138634491|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138634492|NCT02217319|Sevoflurane|sevoflurane|mesh-list
138323132|NCT04399434|Insulin|insulin|mesh-list
138634493|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138634494|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138634495|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
138634496|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
138229369|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138229370|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138634497|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138634498|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634499|NCT00263601|Immunomodulating Agents|immunomodulating agents|mesh-list
138634500|NCT00263601|Immunologic Factors|immunologic factors|mesh-ancestor
138634501|NCT00263601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634502|NCT02217514|Midazolam|midazolam|mesh-list
138634503|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138634504|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138634505|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138229434|NCT01113632|Ofatumumab|ofatumumab|mesh-list
138634506|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634507|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138634508|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138634509|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138634510|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138634511|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
138634512|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
138634513|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
138634514|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
138634515|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634516|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634517|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
138634518|NCT02217553|Vitamin D|vitamin d|mesh-list
138229508|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
138634519|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138634520|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634521|NCT02217553|Vitamins|vitamins|mesh-ancestor
138634522|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
138634523|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138634524|NCT02217631|Prednisolone|prednisolone|mesh-list
138634525|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138634526|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
138634527|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138634528|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
138634529|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138634530|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
138634531|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138634533|NCT02217631|Hormones|hormones|mesh-ancestor
138634534|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634535|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634536|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138634537|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634538|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
138634539|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
138229564|NCT02435901|Fludarabine|fludarabine|mesh-list
138634540|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634541|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634542|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138634543|NCT02217631|Protective Agents|protective agents|mesh-ancestor
138634544|NCT02217670|Metformin|metformin|mesh-list
138634545|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138634546|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634547|NCT00239291|Gefitinib|gefitinib|mesh-list
138634548|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634549|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138634550|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229624|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229625|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634551|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634552|NCT00263640|Immunomodulating Agents|immunomodulating agents|mesh-list
138634553|NCT00263640|Immunologic Factors|immunologic factors|mesh-ancestor
138634554|NCT00263640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634555|NCT02217826|Octreotide|octreotide|mesh-list
138634556|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634557|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138634558|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634559|NCT00239330|Atorvastatin|atorvastatin|mesh-list
138229697|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138229698|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138229699|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
138634560|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138634561|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138634562|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138634563|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
138634564|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634565|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138634566|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138634567|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634568|NCT02218021|Oxycodone|oxycodone|mesh-list
138634569|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138229763|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229765|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
138634571|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138634572|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634573|NCT02218021|Analgesics|analgesics|mesh-ancestor
138634574|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
138634575|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634576|NCT00239369|Telmisartan|telmisartan|mesh-list
138634577|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138634578|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138634579|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138634580|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138634581|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634582|NCT00239369|Diuretics|diuretics|mesh-ancestor
138634583|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
138634584|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634585|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138634586|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138634587|NCT04529668|Vitamin D|vitamin d|mesh-list
138634588|NCT04529668|Vitamins|vitamins|mesh-ancestor
138634589|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
138634590|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634591|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138634592|NCT00239408|Bromides|bromides|mesh-list
138634593|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
138634594|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138634595|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
138323181|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
138634596|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634597|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634598|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138634599|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
138634600|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
138634601|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138634602|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
138634603|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634604|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634605|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
138634606|NCT02218177|Ranibizumab|ranibizumab|mesh-list
138634607|NCT02218177|Aflibercept|aflibercept|mesh-list
138634608|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138634609|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138634610|NCT02218177|Growth Substances|growth substances|mesh-ancestor
138634611|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634612|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
138634613|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634614|NCT00263718|Betamethasone|betamethasone|mesh-list
138634615|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
138634616|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138634617|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
138634618|NCT00263718|Calcipotriene|calcipotriene|mesh-list
138634619|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138634620|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138634621|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
138634623|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634624|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634625|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138634626|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
138634627|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
138634628|NCT02218645|Brotizolam|brotizolam|mesh-list
138634629|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138634630|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138634631|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634632|NCT02218684|Telmisartan|telmisartan|mesh-list
138634633|NCT02218684|Lacidipine|lacidipine|mesh-list
138634634|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138634635|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138229825|NCT05307614|Contraceptive Agents|contraceptive agents|mesh-ancestor
138367429|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
138634636|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138634637|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634639|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138634640|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138634641|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634642|NCT02278861|Tretinoin|tretinoin|mesh-list
138634643|NCT02278861|Isotretinoin|isotretinoin|mesh-list
138634644|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
138634645|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
138634646|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634647|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
138634650|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229834|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
138634651|NCT01642030|Buprenorphine|buprenorphine|mesh-list
138634652|NCT01642030|Hydromorphone|hydromorphone|mesh-list
138634653|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138634654|NCT01642030|Narcotics|narcotics|mesh-ancestor
138634655|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138634656|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634657|NCT01642030|Analgesics|analgesics|mesh-ancestor
138687687|NCT05891132|Lidocaine|lidocaine|mesh-list
138634659|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634660|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138634661|NCT00263796|Oxytocin|oxytocin|mesh-list
138634662|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
138634663|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138634664|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229906|NCT01166126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138634665|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138634666|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138634667|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634669|NCT01642108|Hormones|hormones|mesh-ancestor
138634670|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634671|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138634672|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
138634673|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634674|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634675|NCT00250185|Acetylcholine|acetylcholine|mesh-list
138229974|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
138229999|NCT02384850|Folic Acid|folic acid|mesh-list
138634676|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
138634677|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138634678|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
138634679|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634680|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634681|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634682|NCT00239486|Pramipexole|pramipexole|mesh-list
138634683|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
138508091|NCT06196554|Antimitotic Agents|antimitotic agents|mesh-ancestor
138634684|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634685|NCT00239486|Protective Agents|protective agents|mesh-ancestor
138634686|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634687|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138634688|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138634689|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
138634690|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
138634691|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634692|NCT01642966|Ticagrelor|ticagrelor|mesh-list
138634693|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138634694|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138634695|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138230058|NCT01171118|Physostigmine|physostigmine|mesh-list
138634696|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138634697|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138634698|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
138634699|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634700|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634701|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634702|NCT01643083|Rifaximin|rifaximin|mesh-list
138634703|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138634704|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138323251|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
138634705|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634707|NCT01643278|Dasatinib|dasatinib|mesh-list
138634708|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138634709|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230120|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
138634710|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138634711|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634712|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138634713|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634714|NCT01643629|Minoxidil|minoxidil|mesh-list
138634715|NCT01643629|Finasteride|finasteride|mesh-list
138634716|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138634717|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
138634718|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138634719|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138634720|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634721|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634722|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
138634723|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634724|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634725|NCT01643629|Urological Agents|urological agents|mesh-ancestor
138634726|NCT01644253|Rituximab|rituximab|mesh-list
138634727|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
138230185|NCT01174082|Vaccines|vaccines|mesh-list
138634728|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138634729|NCT01644253|Idelalisib|idelalisib|mesh-list
138634730|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
138323258|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
138323259|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634731|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138634732|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634733|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
138634734|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634735|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138634736|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138634737|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
138634738|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634739|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634740|NCT01644799|Lenalidomide|lenalidomide|mesh-list
138634741|NCT01644799|Idelalisib|idelalisib|mesh-list
138230247|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634742|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
138634743|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634744|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138634745|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138634746|NCT01644799|Growth Substances|growth substances|mesh-ancestor
138634747|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
138634748|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634749|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634750|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634751|NCT01644838|Promethazine|promethazine|mesh-list
138230309|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
138230310|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371504|NCT01411670|Protein C|protein c|mesh-list
138634752|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
138634753|NCT01644838|Scopolamine|scopolamine|mesh-list
138634754|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138634755|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
138634756|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
138634757|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634758|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634759|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634760|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
138634761|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138634762|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
138634763|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634764|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634765|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138230372|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138230373|NCT01143818|Androgens|androgens|mesh-ancestor
138634766|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
138634767|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
138634768|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138634769|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
138634770|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
138634771|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138634772|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138634773|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138634774|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138634775|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
138230434|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230435|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
138230436|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230437|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230439|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138230440|NCT02501265|Nicotine|nicotine|mesh-list
138230441|NCT02501265|Varenicline|varenicline|mesh-list
138634776|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
138634777|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
138634778|NCT01644955|Carboplatin|carboplatin|mesh-list
138634779|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634780|NCT01644994|Cisplatin|cisplatin|mesh-list
138634781|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634782|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
138634783|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138634784|NCT04528888|Heparin|heparin|mesh-list
138634785|NCT04528888|Enoxaparin|enoxaparin|mesh-list
138634786|NCT04528888|Calcium heparin|calcium heparin|mesh-list
138634787|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138230495|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138230496|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
138230497|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230500|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138230501|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138230503|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230505|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230506|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138230507|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
138634788|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
138634789|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
138634790|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634791|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634792|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634793|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
138634794|NCT04528888|Hormones|hormones|mesh-ancestor
138634795|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634796|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138634797|NCT04528888|Protective Agents|protective agents|mesh-ancestor
138669671|NCT00440739|Analgesics|analgesics|mesh-ancestor
138634798|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138634799|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230555|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138230556|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138230557|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230558|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
138230559|NCT02584725|Coagulants|coagulants|mesh-ancestor
138230561|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138230562|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230563|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138634801|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138634802|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138634803|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634804|NCT01645384|Atorvastatin|atorvastatin|mesh-list
138634805|NCT01645384|Calcium|calcium|mesh-list
138634806|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138634807|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634808|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138634809|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138634810|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
138634811|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230612|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230613|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230614|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138230615|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
138634812|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138634813|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138634814|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634815|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138634816|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138634817|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634818|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138634819|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
138634820|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634821|NCT01645423|Atorvastatin|atorvastatin|mesh-list
138634822|NCT01645423|Calcium|calcium|mesh-list
138634823|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138634824|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634825|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138634826|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138230683|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230684|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230685|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138230694|NCT01191476|Propofol|propofol|mesh-list
138634827|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
138634828|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634829|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138323327|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138508092|NCT06196554|Mitosis Modulators|mitosis modulators|mesh-ancestor
138634830|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138634832|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
138634833|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138634834|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138634835|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
138634836|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634837|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634838|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634839|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
138634840|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
138634841|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634842|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
138634843|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138634844|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
138634845|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138634846|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138634847|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634848|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138634849|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
138634850|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634851|NCT02961075|Anesthetics|anesthetics|mesh-list
138634852|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138634853|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634854|NCT01646281|Flecainide|flecainide|mesh-list
138634855|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138634856|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138634857|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138634858|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138634859|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634860|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
138634861|NCT01646554|Aflibercept|aflibercept|mesh-list
138634862|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634863|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138634864|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138634865|NCT01646554|Growth Substances|growth substances|mesh-ancestor
138634866|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634867|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
138634868|NCT00250263|Immunomodulating Agents|immunomodulating agents|mesh-list
138634869|NCT00250263|Immunologic Factors|immunologic factors|mesh-ancestor
138634870|NCT00250263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634871|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
138634873|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138634874|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138634875|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138634876|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634877|NCT01646788|Paclitaxel|paclitaxel|mesh-list
138669830|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138634878|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138634879|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634880|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
138634881|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
138634882|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
138634883|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634884|NCT01647256|Nikkomycin|nikkomycin|mesh-list
138634885|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
138634886|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138634887|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634888|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634889|NCT00239954|Escitalopram|escitalopram|mesh-list
138634890|NCT00239954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138634891|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138634892|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138634893|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634894|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138669871|NCT00444314|Sunitinib|sunitinib|mesh-list
138634895|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
138634896|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230754|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138634897|NCT04528927|Azithromycin|azithromycin|mesh-list
138634898|NCT04528927|Doxycycline|doxycycline|mesh-list
138634899|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138634900|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138634901|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
138634902|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138634903|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138634904|NCT04720287|Bupivacaine|bupivacaine|mesh-list
138634905|NCT04720287|Neostigmine|neostigmine|mesh-list
138634906|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
138634907|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
138634908|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230823|NCT01159262|Narcotics|narcotics|mesh-ancestor
138634909|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634910|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
138634911|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634912|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138634913|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634914|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634915|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
138634916|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634917|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138634918|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
138634919|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
138634920|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
138634921|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138634922|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
138634923|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230891|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
138230892|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230893|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634924|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138634925|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138634926|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
138669995|NCT00479739|Hormones|hormones|mesh-ancestor
138634928|NCT00264108|Hematinics|hematinics|mesh-ancestor
138634929|NCT01647412|Curcumin|curcumin|mesh-list
138634930|NCT01647412|Hormones|hormones|mesh-list
138634931|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634932|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634933|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138634934|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138634936|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
138634937|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634938|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138634939|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138634940|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138634941|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634942|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634943|NCT01647529|Ganciclovir|ganciclovir|mesh-list
138230948|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138230949|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138230950|NCT02515305|Clindamycin|clindamycin|mesh-list
138230960|NCT01206452|Prednisone|prednisone|mesh-list
138634944|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138634945|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
138634946|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138634947|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138323382|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634948|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138634949|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634950|NCT00240032|Cetirizine|cetirizine|mesh-list
138634951|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
138634952|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
138634953|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138634954|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138231003|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231004|NCT05859217|Atezolizumab|atezolizumab|mesh-list
138231005|NCT05859217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138231006|NCT05859217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231007|NCT05859217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138231008|NCT05859217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231009|NCT05859126|Choline|choline|mesh-list
138231010|NCT05859126|Lipotropic Agents|lipotropic agents|mesh-ancestor
138231011|NCT05859126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138634955|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138634956|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
138634957|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
138634958|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138634959|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138634960|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634961|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138634962|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
138634963|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138634964|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138634965|NCT00240149|Insulin|insulin|mesh-list
138634966|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138634967|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138634968|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231067|NCT05844618|Glucocorticoids|glucocorticoids|mesh-ancestor
138231068|NCT05844618|Hormones|hormones|mesh-ancestor
138687748|NCT05881915|Protective Agents|protective agents|mesh-ancestor
138634969|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138634970|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138634971|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
138634972|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138634973|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
138634974|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138634975|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634976|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
138634977|NCT01647646|Hormones|hormones|mesh-ancestor
138670091|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138634978|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634980|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
138634981|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138634982|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138634983|NCT01647685|Prednisolone|prednisolone|mesh-list
138634984|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
138634985|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138634986|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
138634987|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138634988|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
138634989|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
138634990|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231131|NCT05624151|Magnesium Sulfate|magnesium sulfate|mesh-list
138634991|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138634992|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138634993|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
138634994|NCT01647685|Hormones|hormones|mesh-ancestor
138634995|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138634996|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138634997|NCT01647685|Protective Agents|protective agents|mesh-ancestor
138634998|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138634999|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635000|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138635001|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138231184|NCT05554939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138231185|NCT05554939|Alkylating Agents|alkylating agents|mesh-ancestor
138231186|NCT05554939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635002|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138635003|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
138635004|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635005|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138635006|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138635007|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635009|NCT01648036|Calcium heparin|calcium heparin|mesh-list
138635011|NCT01648036|Tinzaparin|tinzaparin|mesh-list
138635012|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138635013|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
138635014|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138670204|NCT00455117|Analgesics|analgesics|mesh-ancestor
138323391|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635015|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138635016|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231260|NCT05229055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138231261|NCT05229055|Anesthetics, General|anesthetics, general|mesh-ancestor
138231262|NCT05229055|Anesthetics|anesthetics|mesh-ancestor
138635017|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138635018|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138687778|NCT05838560|Dasatinib|dasatinib|mesh-list
138635019|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138635020|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
138311646|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635021|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635022|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138635023|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138635024|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635025|NCT01648231|Losartan|losartan|mesh-list
138635026|NCT01648231|Amlodipine|amlodipine|mesh-list
138635027|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138635028|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138635029|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138231341|NCT04616313|Xenon|xenon|mesh-list
138635030|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635031|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138635032|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635033|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
138635034|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138670280|NCT00480402|Hormones|hormones|mesh-ancestor
138635035|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138635036|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138635037|NCT00264186|Norepinephrine|norepinephrine|mesh-list
138635038|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
138635039|NCT00264186|Acetylcholine|acetylcholine|mesh-list
138635040|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138635041|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138635042|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
138635043|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635044|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231387|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138635045|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635046|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
138635047|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
138635048|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635049|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138635050|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
138635051|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138635052|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
138635053|NCT00240422|Telmisartan|telmisartan|mesh-list
138635054|NCT00240422|Ramipril|ramipril|mesh-list
138635055|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138231447|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138635056|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138670312|NCT00443235|Thalidomide|thalidomide|mesh-list
138635057|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138635058|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635059|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138635062|NCT00264225|Codeine|codeine|mesh-list
138635063|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138635064|NCT00264225|Narcotics|narcotics|mesh-ancestor
138635065|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138635066|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635067|NCT00264225|Analgesics|analgesics|mesh-ancestor
138635068|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
138635069|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635070|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
138635071|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
138635072|NCT02279563|Fluticasone|fluticasone|mesh-list
138635073|NCT02279563|Xhance|xhance|mesh-list
138635074|NCT02279563|Azelastine|azelastine|mesh-list
138635075|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635076|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138635077|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
138635078|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635079|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635080|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138635081|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
138635082|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
138635083|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138635084|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138635085|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635086|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138670365|NCT04700475|Citric Acid|citric acid|mesh-list
138635087|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138635088|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138635089|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
138635090|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
138635091|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635093|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138635094|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311752|NCT04723134|Leucovorin|leucovorin|mesh-list
138635095|NCT01649245|Interferons|interferons|mesh-list
138635096|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635097|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
138635098|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138635099|NCT01649284|Afatinib|afatinib|mesh-list
138635100|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635101|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138635102|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635103|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635104|NCT00415740|Levodopa|levodopa|mesh-list
138635105|NCT00415740|Carbidopa|carbidopa|mesh-list
138635106|NCT00415740|Entacapone|entacapone|mesh-list
138635107|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138635108|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138635109|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138635110|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
138635111|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635112|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635113|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635114|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138635116|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138635117|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138635118|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
138635119|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
138635120|NCT01649479|Antibodies|antibodies|mesh-list
138635121|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
138635122|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
138635123|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635124|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
138635125|NCT01649635|Prednisone|prednisone|mesh-list
138635126|NCT01649635|Lenograstim|lenograstim|mesh-list
138635127|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635128|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
138635129|NCT01649635|Hormones|hormones|mesh-ancestor
138687802|NCT05834569|Antipyretics|antipyretics|mesh-ancestor
138635130|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138635131|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635132|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138635133|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635134|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138635135|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
138670413|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
138231530|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231531|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231535|NCT03096041|Analgesics|analgesics|mesh-list
138635136|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138635137|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138635138|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138635139|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138635140|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635141|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635142|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138231582|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231583|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138231584|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
138231593|NCT02723500|Xenon|xenon|mesh-list
138635143|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138635144|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
138635145|NCT00250536|Nandrolone|nandrolone|mesh-list
138635146|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
138635147|NCT00250536|Androgens|androgens|mesh-ancestor
138635148|NCT00250536|Hormones|hormones|mesh-ancestor
138635149|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138635150|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635151|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
138635152|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138635153|NCT00240617|Naproxen|naproxen|mesh-list
138635154|NCT00240617|Sumatriptan|sumatriptan|mesh-list
138635155|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138635156|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138635158|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
138635159|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231653|NCT02620865|Hematinics|hematinics|mesh-ancestor
138231654|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138231656|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
138635160|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635161|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635162|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138635163|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
138635164|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138635165|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635166|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635167|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138635168|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138311803|NCT04602767|Phenylephrine|phenylephrine|mesh-list
138635170|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
138635171|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635172|NCT01649830|Temozolomide|temozolomide|mesh-list
138323447|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138231712|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138635173|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138635174|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
138635175|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635176|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635178|NCT00240656|Captopril|captopril|mesh-list
138635179|NCT00240656|Spironolactone|spironolactone|mesh-list
138635180|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138635181|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
138635182|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138635183|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635184|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138635185|NCT00240656|Diuretics|diuretics|mesh-ancestor
138635186|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
138635187|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138635188|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138635189|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
138231774|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231783|NCT02431806|Fluoxetine|fluoxetine|mesh-list
138635190|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635191|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635192|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138635193|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
138635194|NCT00240656|Protective Agents|protective agents|mesh-ancestor
138635196|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138635197|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138635198|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
138635199|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138635200|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138231831|NCT05220813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231833|NCT05220813|Sensory System Agents|sensory system agents|mesh-ancestor
138231834|NCT05220813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138231844|NCT01212302|Clopidogrel|clopidogrel|mesh-list
138635201|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138635202|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
138635203|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635204|NCT00250575|Clozapine|clozapine|mesh-list
138635205|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138635206|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
138635207|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635208|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635209|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635210|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138635211|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138635212|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138635213|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138635214|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
138231892|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138231898|NCT04899492|Nicotine|nicotine|mesh-list
138635215|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
138635216|NCT00240695|Galantamine|galantamine|mesh-list
138635217|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138635218|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635219|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635220|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
138635221|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635222|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635223|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138635224|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
138635225|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635226|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
138635227|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
138635228|NCT00240734|Hematinics|hematinics|mesh-ancestor
138635230|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138635232|NCT04720248|Analgesics|analgesics|mesh-ancestor
138635233|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
138231950|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138231951|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138231952|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138635234|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635235|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635236|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635237|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138635238|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
138635239|NCT01646515|Udenafil|udenafil|mesh-list
138635240|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138635241|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138635242|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635243|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635244|NCT00240773|Acetaminophen|acetaminophen|mesh-list
138635245|NCT00240773|Naproxen|naproxen|mesh-list
138635246|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138635247|NCT00240773|Analgesics|analgesics|mesh-ancestor
138232005|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
138232006|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232007|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138232017|NCT01289912|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138635248|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
138635250|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635251|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
138635252|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138635253|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635254|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138635255|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
138635256|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138635257|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635258|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635259|NCT01688401|Melphalan|melphalan|mesh-list
138635260|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138635261|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
138635262|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635263|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635264|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138635265|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138635266|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
138635267|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635268|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138635269|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138635270|NCT04708821|Dexamethasone|dexamethasone|mesh-list
138635271|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138635272|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635273|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
138635274|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
138635275|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635276|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635277|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138635278|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
138635279|NCT04708821|Hormones|hormones|mesh-ancestor
138635280|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138635281|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138635282|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635283|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138635284|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138635285|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138635286|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138635287|NCT04708821|Analgesics|analgesics|mesh-ancestor
138635288|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
138635289|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138635290|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138635291|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138635292|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
138635293|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
138635294|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635295|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635296|NCT00240812|Ibuprofen|ibuprofen|mesh-list
138635297|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
138635298|NCT00240812|Ephedrine|ephedrine|mesh-list
138635299|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138635300|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138635301|NCT00240812|Analgesics|analgesics|mesh-ancestor
138635302|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
138635303|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635304|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635305|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635306|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138635307|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138635308|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232066|NCT05457647|Riboflavin|riboflavin|mesh-list
138635309|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635310|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138232077|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138635311|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
138635312|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138635313|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
138635314|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
138635315|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138635316|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138635318|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
138635319|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635320|NCT01688518|Lidocaine|lidocaine|mesh-list
138635321|NCT01688518|Tetracaine|tetracaine|mesh-list
138635322|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
138635323|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
138635324|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138635325|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635326|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
138635327|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635328|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138635329|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138635330|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138635331|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138635332|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635333|NCT00240851|Acetaminophen|acetaminophen|mesh-list
138635334|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138635335|NCT00240851|Analgesics|analgesics|mesh-ancestor
138635336|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
138635337|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635338|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635339|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
138635340|NCT00240929|Palivizumab|palivizumab|mesh-list
138635341|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
138635342|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138635343|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
138635344|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138635345|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
138635346|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
138635347|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138635348|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138670501|NCT00457106|Paroxetine|paroxetine|mesh-list
138635349|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138635350|NCT00250692|Analgesics|analgesics|mesh-ancestor
138635351|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
138635352|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635353|NCT01688791|Paclitaxel|paclitaxel|mesh-list
138635354|NCT01688791|Carboplatin|carboplatin|mesh-list
138323486|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635355|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138635356|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635357|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
138635358|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
138635359|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
138232143|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138635360|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635362|NCT01688947|Analgesics|analgesics|mesh-ancestor
138635363|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
138635364|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635365|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635366|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
138635367|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138635368|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138635369|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635370|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138635371|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138232175|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138635372|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138635373|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138635374|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138635375|NCT00241007|Valsartan|valsartan|mesh-list
138635376|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138635377|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138635378|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138635379|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138635380|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635381|NCT00241007|Diuretics|diuretics|mesh-ancestor
138635382|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
138635383|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635384|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138635385|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138635386|NCT01689142|Insulin|insulin|mesh-list
138635387|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138635388|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
138635389|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138635390|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635391|NCT00241046|Letrozole|letrozole|mesh-list
138635392|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635393|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138635394|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138635395|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635396|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635397|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138635398|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
138232241|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
138635399|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138635400|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635401|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
138635402|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138635403|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
138635404|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138635405|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138635406|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635407|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138635408|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635409|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138635410|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138635412|NCT01689298|Carbetocin|carbetocin|mesh-list
138635413|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
138635414|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138635415|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635416|NCT00241085|Valsartan|valsartan|mesh-list
138635417|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138635418|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138323510|NCT04276428|Insulin|insulin|mesh-list
138635419|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138232285|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
138232286|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635420|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635421|NCT00241124|Valsartan|valsartan|mesh-list
138635422|NCT00241124|Lisinopril|lisinopril|mesh-list
138635423|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138635424|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138635425|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138635426|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635427|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138635428|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
138635429|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635430|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138635431|NCT00241124|Protective Agents|protective agents|mesh-ancestor
138635432|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635433|NCT00241163|Thrombin|thrombin|mesh-list
138635434|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
138635435|NCT00241163|Coagulants|coagulants|mesh-ancestor
138635436|NCT02277106|Brexanolone|brexanolone|mesh-list
138635437|NCT02277106|Neurosteroids|neurosteroids|mesh-ancestor
138635438|NCT02277106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635439|NCT02277106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635440|NCT02277106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635441|NCT02277106|GABA Modulators|gaba modulators|mesh-ancestor
138635442|NCT02277106|GABA Agents|gaba agents|mesh-ancestor
138635443|NCT00241241|Interferons|interferons|mesh-list
138635444|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
138232409|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
138232410|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635445|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
138635446|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138687941|NCT05497843|Chiauranib|chiauranib|mesh-list
138635447|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635448|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
138635449|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138635450|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
138635451|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635452|NCT02279602|Fosbretabulin|fosbretabulin|mesh-list
138232469|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138232470|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138232476|NCT01303406|Idebenone|idebenone|mesh-list
138635453|NCT02279602|Combretastatin|combretastatin|mesh-list
138635454|NCT02279602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138635455|NCT02279602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635457|NCT02279602|Antimitotic Agents|antimitotic agents|mesh-ancestor
138635458|NCT02279602|Mitosis Modulators|mitosis modulators|mesh-ancestor
138635459|NCT02279602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635460|NCT00241436|Anastrozole|anastrozole|mesh-list
138635461|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138635462|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635463|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138635464|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138635465|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635466|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232535|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232536|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138232538|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635467|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138323520|NCT05248932|Sympathomimetics|sympathomimetics|mesh-ancestor
138635468|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
138635469|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138635470|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635471|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
138635472|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138635473|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635474|NCT00241475|Gefitinib|gefitinib|mesh-list
138635475|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635476|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138635477|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232604|NCT04154787|Rituximab|rituximab|mesh-list
138635478|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635479|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
138635480|NCT01685359|Hematinics|hematinics|mesh-ancestor
138635481|NCT02278978|Nintedanib|nintedanib|mesh-list
138635482|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635483|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138635484|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635485|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635486|NCT02218762|Fluticasone|fluticasone|mesh-list
138635487|NCT02218762|Xhance|xhance|mesh-list
138635488|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138232659|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
138232660|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635489|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138635490|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635491|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138635492|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
138635493|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635494|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635495|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138635496|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
138635497|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
138635498|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138635499|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138635500|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138635501|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138635502|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
138635503|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635504|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635505|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
138635506|NCT02218762|Hormones|hormones|mesh-ancestor
138687953|NCT05474846|Protective Agents|protective agents|mesh-ancestor
138635507|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138635509|NCT00264459|Immunomodulating Agents|immunomodulating agents|mesh-list
138635510|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
138635511|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635512|NCT00241514|Esomeprazole|esomeprazole|mesh-list
138635513|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138635514|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138635515|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138635516|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635517|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635518|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138635519|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
138635520|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138635522|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635523|NCT00241553|Esomeprazole|esomeprazole|mesh-list
138635524|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138635525|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138635526|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138635527|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635528|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635529|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
138635530|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138635531|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138232726|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
138635532|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635534|NCT02219152|Coagulants|coagulants|mesh-ancestor
138635535|NCT00264615|Lamotrigine|lamotrigine|mesh-list
138635536|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
138635537|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138635538|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138635539|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635540|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138635541|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635542|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138232758|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635543|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138635544|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138635545|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138635546|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138635547|NCT02219191|Puerarin|puerarin|mesh-list
138635548|NCT02219191|Atorvastatin|atorvastatin|mesh-list
138635549|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138635550|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138635551|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
138635552|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635553|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138635554|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138635555|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635556|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
138635565|NCT04529512|Hormones|hormones|mesh-ancestor
138635566|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138635567|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138635568|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232823|NCT04425239|Protective Agents|protective agents|mesh-ancestor
138232824|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
138232825|NCT04425239|Vitamins|vitamins|mesh-ancestor
138635577|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138635578|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138635579|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
138635580|NCT02219737|Rituximab|rituximab|mesh-list
138635581|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138635582|NCT02219737|Carboplatin|carboplatin|mesh-list
138635584|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
138635585|NCT02219737|Ifosfamide|ifosfamide|mesh-list
138635586|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
138635587|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
138635588|NCT02219737|Antibodies|antibodies|mesh-list
138635589|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
138635590|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138635591|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
138635592|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635593|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635594|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138635595|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138635596|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138635597|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138232880|NCT05730621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232890|NCT05730621|Antipyretics|antipyretics|mesh-ancestor
138635598|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635599|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635600|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138635601|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
138635602|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
138635603|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
138635604|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
138635605|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
138635606|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
138635607|NCT02219893|Immunotoxins|immunotoxins|mesh-list
138635608|NCT02219893|MOC31PE immunotoxin|moc31pe immunotoxin|mesh-list
138635609|NCT02219893|Immunoconjugates|immunoconjugates|mesh-ancestor
138635610|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
138635611|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232936|NCT05343429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232937|NCT05343429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138232938|NCT05343429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138232944|NCT01310582|Sevoflurane|sevoflurane|mesh-list
138635612|NCT02212951|Insulin Lispro|insulin lispro|mesh-list
138635613|NCT02212951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138635614|NCT02212951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635615|NCT02210806|Albuterol|albuterol|mesh-list
138635616|NCT02210806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138635617|NCT02210806|Autonomic Agents|autonomic agents|mesh-ancestor
138635618|NCT02210806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635619|NCT02210806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635620|NCT02210806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138635621|NCT02210806|Respiratory System Agents|respiratory system agents|mesh-ancestor
138635623|NCT02210806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138635624|NCT02210806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138635625|NCT02210806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138635626|NCT02210806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138635627|NCT02210806|Adrenergic Agents|adrenergic agents|mesh-ancestor
138635628|NCT02210806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635629|NCT02210806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635631|NCT00264654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138635632|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138635633|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138635634|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635635|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635636|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
138635637|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635638|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138635639|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
138635640|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138635641|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138635642|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138635643|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635645|NCT02219659|Fentanyl|fentanyl|mesh-list
138635646|NCT02219659|Propofol|propofol|mesh-list
138635647|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138635648|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138232998|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138233000|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233005|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
138635649|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635650|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138635651|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
138635652|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
138635653|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138635654|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138635655|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138635656|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138635657|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
138635659|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635660|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635661|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138670976|NCT00460928|Antibodies|antibodies|mesh-list
138635662|NCT02219659|Narcotics|narcotics|mesh-ancestor
138635663|NCT02219659|Analgesics|analgesics|mesh-ancestor
138635664|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
138635665|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635666|NCT00241982|Prednisolone|prednisolone|mesh-list
138635667|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635668|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
138635669|NCT00241982|Hormones|hormones|mesh-ancestor
138635670|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138635671|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635672|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138233042|NCT01749293|Busulfan|busulfan|mesh-list
138635673|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635674|NCT02212015|Paclitaxel|paclitaxel|mesh-list
138635675|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138635676|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635677|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
138635678|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
138635679|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
138687995|NCT05385432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138635680|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635681|NCT04720859|Canagliflozin|canagliflozin|mesh-list
138635682|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138635683|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635684|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138635685|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635686|NCT02961842|Ephedrine|ephedrine|mesh-list
138635687|NCT02961842|Fentanyl|fentanyl|mesh-list
138635688|NCT02961842|Bupivacaine|bupivacaine|mesh-list
138635689|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
138635690|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
138312320|NCT00003815|Vincristine|vincristine|mesh-list
138635691|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138635692|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635693|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
138635694|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635695|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138635696|NCT02961842|Narcotics|narcotics|mesh-ancestor
138635697|NCT02961842|Analgesics|analgesics|mesh-ancestor
138635698|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138635699|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138635700|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
138635701|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138635702|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
138635703|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
138635704|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138635705|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
138635706|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635707|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635708|NCT00272805|Carvedilol|carvedilol|mesh-list
138635709|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138635710|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138635711|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
138635712|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635713|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635714|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635715|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138635716|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
138635717|NCT00272805|Protective Agents|protective agents|mesh-ancestor
138635718|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138635719|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138635720|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138635721|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
138323581|NCT05241054|Fentanyl|fentanyl|mesh-list
138635722|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138635724|NCT00242177|Pioglitazone|pioglitazone|mesh-list
138635725|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138635726|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635728|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138635729|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635730|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
138635731|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635732|NCT00242372|Insulin|insulin|mesh-list
138635733|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138635734|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688055|NCT05302921|Nivolumab|nivolumab|mesh-list
138635735|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138635736|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138635737|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138635738|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635740|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
138635741|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635742|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138635743|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
138635744|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635745|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635746|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138318529|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
138635747|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
138635748|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
138635749|NCT00242411|Hormones|hormones|mesh-ancestor
138635750|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138635751|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138635752|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138635753|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138635754|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
138635755|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635756|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635758|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
138635759|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635760|NCT02962037|Protective Agents|protective agents|mesh-ancestor
138635761|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635762|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233203|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233204|NCT01315574|Travoprost|travoprost|mesh-list
138233218|NCT01316042|Metformin|metformin|mesh-list
138635763|NCT00282399|Decitabine|decitabine|mesh-list
138635764|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138635765|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
138635766|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635767|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635768|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635769|NCT00242450|Metoclopramide|metoclopramide|mesh-list
138635770|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
138635772|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635773|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635774|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138635775|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138635776|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138635777|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
138635778|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233220|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233221|NCT01754909|Enalapril|enalapril|mesh-list
138635779|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635780|NCT00273039|Paroxetine|paroxetine|mesh-list
138635781|NCT00273039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138635782|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138635783|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138635784|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635785|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635786|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
138635787|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635788|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138233279|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138671151|NCT00496392|Analgesics|analgesics|mesh-ancestor
138635789|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
138635790|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138635791|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138635792|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138635793|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635794|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
138635795|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138635796|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635797|NCT00242606|Lamotrigine|lamotrigine|mesh-list
138635798|NCT00242606|Levetiracetam|levetiracetam|mesh-list
138635799|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
138635800|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
138635801|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138635802|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138233341|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
138233343|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138635803|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635804|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138635805|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635806|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138635807|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138635808|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138635809|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138635810|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138635811|NCT00242762|Docetaxel|docetaxel|mesh-list
138635812|NCT00242762|Gefitinib|gefitinib|mesh-list
138635813|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138233399|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138233400|NCT02621619|Analgesics|analgesics|mesh-ancestor
138233401|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
138233404|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
138635814|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
138635815|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
138635816|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
138635817|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688135|NCT05177510|Mifepristone|mifepristone|mesh-list
138635818|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138635819|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635821|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635822|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138635823|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635824|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635826|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138635827|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138635829|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635830|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635831|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138635832|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138635833|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
138635834|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138635835|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138312472|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
138635836|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138635837|NCT00282594|Insulin|insulin|mesh-list
138635838|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138635839|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635840|NCT00242918|Docetaxel|docetaxel|mesh-list
138635841|NCT00242918|Gefitinib|gefitinib|mesh-list
138635842|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635843|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
138635844|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
138635845|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
138635846|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635847|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138635848|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635849|NCT00273312|Epothilone B|epothilone b|mesh-list
138635850|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635851|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
138635852|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
138635853|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
138635854|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635855|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
138635856|NCT00242996|Carmustine|carmustine|mesh-list
138635857|NCT00242996|Rituximab|rituximab|mesh-list
138635858|NCT00242996|Etoposide|etoposide|mesh-list
138635859|NCT00242996|Sargramostim|sargramostim|mesh-list
138635860|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138635861|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
138635862|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635863|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138635864|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138635865|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
138635866|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635867|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635868|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138635869|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138635870|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138635871|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138635872|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138635873|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635875|NCT00273390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138635876|NCT00273390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635877|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
138635878|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138635879|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138635880|NCT00243035|Bortezomib|bortezomib|mesh-list
138635881|NCT00243035|Tipifarnib|tipifarnib|mesh-list
138635882|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635883|NCT00243113|Docetaxel|docetaxel|mesh-list
138233465|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138635884|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635885|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
138635886|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
138635887|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
138635888|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635890|NCT00273429|Dorzolamide|dorzolamide|mesh-list
138635891|NCT00273429|Latanoprost|latanoprost|mesh-list
138635892|NCT00273429|Maleic acid|maleic acid|mesh-list
138635893|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635894|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233469|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138635895|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138635896|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138635897|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
138635898|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635899|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635900|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138635901|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138635902|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138635903|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138635904|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138233535|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
138635905|NCT00273468|Granisetron|granisetron|mesh-list
138635906|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
138635907|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
138635908|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635909|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635910|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138635911|NCT00273468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138635912|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138635914|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138635915|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635916|NCT00243464|Betamethasone|betamethasone|mesh-list
138635917|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
138635918|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138671320|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
138233607|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635919|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
138635920|NCT00243464|Calcipotriene|calcipotriene|mesh-list
138635921|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138635922|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635923|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
138635924|NCT00243464|Hormones|hormones|mesh-ancestor
138635925|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138635926|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233668|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233669|NCT02626611|Omalizumab|omalizumab|mesh-list
138635927|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138635928|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
138635930|NCT00273507|Paclitaxel|paclitaxel|mesh-list
138635931|NCT00273507|Carboplatin|carboplatin|mesh-list
138688184|NCT05144854|Capecitabine|capecitabine|mesh-list
138635932|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138635933|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635934|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
138635935|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
138635936|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
138635937|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635939|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
138233736|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635940|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138635941|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635942|NCT00273546|Docetaxel|docetaxel|mesh-list
138635943|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635944|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
138635945|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
138635946|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
138635947|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635948|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
138635949|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138635950|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635951|NCT00243737|Artesunate|artesunate|mesh-list
138635952|NCT00243737|Mefloquine|mefloquine|mesh-list
138635953|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
138635954|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138635955|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138635956|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138635957|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138635958|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
138635959|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
138635960|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138635961|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
138635962|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
138635963|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138635964|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
138635965|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138635966|NCT00273702|Expectorants|expectorants|mesh-ancestor
138233803|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
138233804|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233805|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233806|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
138233815|NCT01366976|Acetaminophen|acetaminophen|mesh-list
138635967|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
138635968|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138635969|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
138635970|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635971|NCT00273702|Protective Agents|protective agents|mesh-ancestor
138635972|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635974|NCT00243815|Ibuprofen|ibuprofen|mesh-list
138635975|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138635976|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138635977|NCT00243815|Analgesics|analgesics|mesh-ancestor
138233850|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138233851|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138635978|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
138635979|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138635980|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635981|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138635982|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138635983|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138635984|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138635985|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635986|NCT00283179|Risperidone|risperidone|mesh-list
138635987|NCT00283179|Aripiprazole|aripiprazole|mesh-list
138635988|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138635989|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
138635990|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138323681|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
138233914|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233915|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233950|NCT01783847|Hormones|hormones|mesh-ancestor
138635991|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138635992|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138635993|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138635994|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138635995|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138635996|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138635997|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138635998|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
138635999|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
138636000|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
138636001|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138636002|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138636003|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138636004|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138636005|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138636006|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636007|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138636008|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636009|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636010|NCT00273741|Methylphenidate|methylphenidate|mesh-list
138636011|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138636012|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636013|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138636014|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138636015|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138671522|NCT00466466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636016|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636018|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636019|NCT02279134|Paclitaxel|paclitaxel|mesh-list
138636020|NCT02279134|Nedaplatin|nedaplatin|mesh-list
138636021|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138636022|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636023|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636024|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
138636025|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
138234033|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138234034|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
138636026|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636027|NCT00243893|Doxycycline|doxycycline|mesh-list
138636028|NCT00243893|Minocycline|minocycline|mesh-list
138636029|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138636030|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636031|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
138636032|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138636033|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138636034|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
138636035|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138636036|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138234099|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138234100|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
138234101|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
138636037|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636038|NCT00244127|Prednisone|prednisone|mesh-list
138636039|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
138636040|NCT00244127|Rituximab|rituximab|mesh-list
138671566|NCT00464165|Hormones|hormones|mesh-ancestor
138636042|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138636043|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
138636044|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636045|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138323698|NCT00636636|Gabapentin|gabapentin|mesh-list
138636046|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138636048|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636049|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636050|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138636051|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138636052|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138636053|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
138636054|NCT00244127|Hormones|hormones|mesh-ancestor
138636055|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138636056|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138636057|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138636058|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636059|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
138636060|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
138636061|NCT00244166|Prednisolone|prednisolone|mesh-list
138636062|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138234160|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138234161|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
138636063|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
138636064|NCT00244166|Hormones|hormones|mesh-ancestor
138636065|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138636066|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636067|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138636068|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636069|NCT00273975|Lamivudine|lamivudine|mesh-list
138636070|NCT00273975|Zidovudine|zidovudine|mesh-list
138636071|NCT00273975|Nevirapine|nevirapine|mesh-list
138636072|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138636073|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138636074|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234209|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636075|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636076|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
138636077|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636078|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138636079|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138636080|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
138323713|NCT05244954|Chloroquine|chloroquine|mesh-list
138636081|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138636082|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138636083|NCT00244283|Sevoflurane|sevoflurane|mesh-list
138636084|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138636085|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138636086|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
138636087|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
138636088|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138671722|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138636089|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636090|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
138636091|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138636092|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
138636093|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636094|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138636095|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138636096|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138688230|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
138636097|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636098|NCT00244322|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
138636099|NCT00244322|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138636100|NCT00244322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636101|NCT00244322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636102|NCT00244361|Rituximab|rituximab|mesh-list
138636103|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138636104|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636105|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
138636106|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636107|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138636108|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
138636109|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138636110|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
138636111|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636112|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636113|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138636114|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
138636115|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
138636116|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138636117|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
138636118|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636119|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636120|NCT00244439|Permethrin|permethrin|mesh-list
138636121|NCT00244439|Malathion|malathion|mesh-list
138636122|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636123|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636124|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138636125|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
138636126|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636127|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636128|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138636129|NCT00417144|Ganirelix|ganirelix|mesh-list
138636130|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
138636131|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138636132|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
138636133|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138636134|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636135|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138234272|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138636136|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138636137|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636138|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
138636139|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138636140|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
138636141|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138636142|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
138636143|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636144|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636145|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138636146|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
138636147|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
138636148|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138636149|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
138636150|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234280|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
138636151|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636152|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138636153|NCT00417183|Ganirelix|ganirelix|mesh-list
138636154|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
138636155|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138636156|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
138636157|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138636158|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636159|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138636160|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138636161|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636162|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
138636163|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138636164|NCT00244517|Remifentanil|remifentanil|mesh-list
138636165|NCT00244517|Sevoflurane|sevoflurane|mesh-list
138636166|NCT00244517|Desflurane|desflurane|mesh-list
138636167|NCT00244517|Isoflurane|isoflurane|mesh-list
138636168|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
138636169|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138636170|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636171|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138636172|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138636173|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
138636174|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138636175|NCT00244517|Narcotics|narcotics|mesh-ancestor
138636176|NCT00244517|Analgesics|analgesics|mesh-ancestor
138636177|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
138636178|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636179|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
138636180|NCT00274092|Ipratropium|ipratropium|mesh-list
138636181|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138636182|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
138636183|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636184|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636185|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138636186|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
138636187|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
138636188|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138636189|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
138636190|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636191|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636193|NCT00244556|Methotrexate|methotrexate|mesh-list
138636194|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138636195|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
138636196|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138636197|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636198|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138636199|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
138636200|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636201|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636202|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
138636203|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636204|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138636205|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138636206|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
138636207|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138636208|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138636209|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138636210|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138234338|NCT01797575|Protective Agents|protective agents|mesh-ancestor
138636212|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
138636213|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636214|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138636215|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138636216|NCT00274131|Pramipexole|pramipexole|mesh-list
138636217|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
138636218|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636219|NCT00274131|Protective Agents|protective agents|mesh-ancestor
138636220|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636221|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138636222|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138636223|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
138636224|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
138636225|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636226|NCT00274170|Octreotide|octreotide|mesh-list
138636227|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138636228|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138636229|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636230|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
138636231|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636232|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138636233|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636234|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234353|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636235|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
138636236|NCT00244907|Genistein|genistein|mesh-list
138636237|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138636238|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138636239|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636240|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138636241|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636242|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138636243|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138636244|NCT00244907|Protective Agents|protective agents|mesh-ancestor
138636245|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636246|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138636247|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636248|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
138636249|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138636250|NCT00244907|Estrogens|estrogens|mesh-ancestor
138636251|NCT00244907|Hormones|hormones|mesh-ancestor
138636252|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234403|NCT01335932|Ganciclovir|ganciclovir|mesh-list
138234405|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
138636253|NCT00244946|Cytarabine|cytarabine|mesh-list
138636254|NCT00244946|Etoposide|etoposide|mesh-list
138636255|NCT00244946|Melphalan|melphalan|mesh-list
138636256|NCT00244946|Carmustine|carmustine|mesh-list
138636257|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138636258|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636259|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138636260|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138636261|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636262|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234461|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138234462|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138234463|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138234464|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
138234465|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234466|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234467|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138234468|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138636263|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138636264|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
138636265|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
138636266|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636267|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138636268|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
138636269|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636270|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138636271|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
138636272|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138636273|NCT00245024|Sulindac|sulindac|mesh-list
138234520|NCT05588037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234521|NCT05588037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138234522|NCT05588037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234523|NCT05588037|Protease Inhibitors|protease inhibitors|mesh-ancestor
138234526|NCT02194088|Diclofenac|diclofenac|mesh-list
138636274|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138636275|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138636276|NCT00245024|Analgesics|analgesics|mesh-ancestor
138636277|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
138636278|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636279|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138672073|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
138636280|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138636281|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138636282|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312924|NCT01903356|Linagliptin|linagliptin|mesh-list
138636283|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138636284|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234580|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
138636285|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636286|NCT00274326|Satavaptan|satavaptan|mesh-list
138636287|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138636288|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636289|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
138636290|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636291|NCT00245141|Dactinomycin|dactinomycin|mesh-list
138636292|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
138636293|NCT00245141|Vincristine|vincristine|mesh-list
138636294|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138636295|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
138636296|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636297|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138636298|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138636299|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
138636300|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636301|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636302|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138636303|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138636304|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636305|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
138636306|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
138636307|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138636308|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636309|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138672175|NCT01243710|Heparin|heparin|mesh-list
138636310|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138636311|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636312|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138636313|NCT00416637|Bevacizumab|bevacizumab|mesh-list
138636314|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138636315|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636316|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138636317|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138636318|NCT00416637|Growth Substances|growth substances|mesh-ancestor
138636319|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234695|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138234696|NCT01794143|Liraglutide|liraglutide|mesh-list
138234697|NCT01794143|Glimepiride|glimepiride|mesh-list
138636320|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
138636321|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
138636322|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636323|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
138636324|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138636325|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138636326|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636327|NCT00245258|Urological Agents|urological agents|mesh-ancestor
138636328|NCT02961803|Biotin|biotin|mesh-list
138636329|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
138636330|NCT02961803|Vitamins|vitamins|mesh-ancestor
138636331|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
138636332|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636333|NCT00245297|Factor VIII|factor viii|mesh-list
138636334|NCT00245297|Coagulants|coagulants|mesh-ancestor
138636335|NCT00274404|Valacyclovir|valacyclovir|mesh-list
138636336|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
138636337|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636338|NCT00283764|Latanoprost|latanoprost|mesh-list
138636339|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138636340|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138636341|NCT00245336|Thrombin|thrombin|mesh-list
138636342|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
138636343|NCT00245336|Coagulants|coagulants|mesh-ancestor
138636344|NCT00274443|Carboplatin|carboplatin|mesh-list
138234759|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636345|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138636346|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636347|NCT00245375|Acetaminophen|acetaminophen|mesh-list
138636348|NCT00245375|Ibuprofen|ibuprofen|mesh-list
138636349|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138636350|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138636351|NCT00245375|Analgesics|analgesics|mesh-ancestor
138636352|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
138672301|NCT00465452|Dopamine|dopamine|mesh-list
138636353|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636354|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313003|NCT01898442|Ticagrelor|ticagrelor|mesh-list
138636355|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138636356|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138636357|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138636358|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636359|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636360|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
138636361|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138636362|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
138636363|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
138636364|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636365|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
138636366|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636367|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
138636368|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138636369|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
138636370|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636371|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234812|NCT02249663|Fluticasone|fluticasone|mesh-list
138636372|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138636373|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
138636374|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
138636375|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138636376|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
138636377|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636378|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636379|NCT00245453|Azithromycin|azithromycin|mesh-list
138636380|NCT00245453|Clarithromycin|clarithromycin|mesh-list
138636381|NCT00245453|Telithromycin|telithromycin|mesh-list
138636382|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138636383|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636384|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138636385|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636386|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636387|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138636388|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138234856|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
138636390|NCT00245609|Alprazolam|alprazolam|mesh-list
138636391|NCT00245609|Analgesics|analgesics|mesh-ancestor
138636392|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
138636393|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636394|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636395|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
138636396|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138636397|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138636398|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636399|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138636400|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138636401|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138636402|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138234917|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636403|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138636404|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138636405|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
138636406|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
138636407|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636408|NCT00274638|Losartan|losartan|mesh-list
138636409|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138636410|NCT00274638|Telmisartan|telmisartan|mesh-list
138636411|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138636412|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138636413|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138636414|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138234980|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138234981|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138636415|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636416|NCT00274638|Diuretics|diuretics|mesh-ancestor
138636417|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
138636418|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636419|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138636420|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138636421|NCT00274677|Lamotrigine|lamotrigine|mesh-list
138636422|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
138636423|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138235042|NCT01836185|Evacetrapib|evacetrapib|mesh-list
138235043|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138235044|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138235045|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
138235046|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235047|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138636424|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138636425|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636426|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138636427|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636428|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138636429|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138636430|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138636431|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138313069|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138636433|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
138636434|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138636435|NCT00245921|Estradiol|estradiol|mesh-list
138636436|NCT00245921|Estrogens|estrogens|mesh-ancestor
138636437|NCT00245921|Hormones|hormones|mesh-ancestor
138688347|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323832|NCT01923558|Donepezil|donepezil|mesh-list
138636438|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138636439|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636440|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138636441|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
138235103|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138235104|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
138235105|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
138235106|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138235107|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138235108|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
138636442|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138636443|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138636444|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138636445|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138636446|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138636448|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138636449|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636450|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
138636451|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636452|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138636453|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
138636454|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138636455|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138636456|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138235156|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
138235160|NCT04795583|Prednisone|prednisone|mesh-list
138636457|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138672481|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138636458|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636459|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
138636460|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636461|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636462|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138636463|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636465|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
138636466|NCT00284193|Factor VIII|factor viii|mesh-list
138235216|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636467|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
138636468|NCT00284193|Coagulants|coagulants|mesh-ancestor
138636469|NCT00246194|Risperidone|risperidone|mesh-list
138636470|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138636472|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636473|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636474|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636475|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138636476|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138636477|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138636478|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138636479|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138636480|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
138636481|NCT00284232|Insulin|insulin|mesh-list
138636482|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138636483|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636484|NCT00246233|Methylphenidate|methylphenidate|mesh-list
138636485|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138636486|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636487|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138636488|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138636489|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138636490|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323842|NCT01921218|Prednisone|prednisone|mesh-list
138636492|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636493|NCT00274833|Temozolomide|temozolomide|mesh-list
138636494|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138636495|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138636496|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
138532547|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235286|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
138235287|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235288|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235290|NCT02731833|Fluorides|fluorides|mesh-list
138636497|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636498|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636499|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138636500|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636501|NCT00274872|Leucovorin|leucovorin|mesh-list
138636502|NCT00274872|Fluorouracil|fluorouracil|mesh-list
138636503|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
138313142|NCT01894152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636504|NCT00274872|Calcium|calcium|mesh-list
138636505|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
138636506|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138636507|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636509|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636510|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138636511|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636512|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138636513|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
138636514|NCT00274872|Antidotes|antidotes|mesh-ancestor
138636515|NCT00274872|Protective Agents|protective agents|mesh-ancestor
138636516|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
138636517|NCT00274872|Vitamins|vitamins|mesh-ancestor
138636518|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
138636519|NCT00246272|Risperidone|risperidone|mesh-list
138235327|NCT01852955|Acetaminophen|acetaminophen|mesh-list
138636520|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138636521|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
138636522|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636523|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636524|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636525|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138636526|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138688400|NCT04768023|Vitamin D|vitamin d|mesh-list
138636527|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138636528|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138636529|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138636531|NCT00284271|Prednisone|prednisone|mesh-list
138636532|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
138636533|NCT00284271|Vincristine|vincristine|mesh-list
138636534|NCT00284271|Bleomycin|bleomycin|mesh-list
138636535|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
138636536|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138636537|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
138636538|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636539|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138636540|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138636541|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
138636542|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636543|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636544|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138636545|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138636546|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
138636547|NCT00284271|Hormones|hormones|mesh-ancestor
138636548|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138636549|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138636550|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138636551|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636552|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
138636553|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
138636554|NCT00284271|Hematinics|hematinics|mesh-ancestor
138636555|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138636557|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138636558|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
138636559|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138636560|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138636561|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636562|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138636563|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636564|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138636565|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138636566|NCT00274911|Vincristine|vincristine|mesh-list
138636567|NCT00274911|Lomustine|lomustine|mesh-list
138636568|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636569|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138636570|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636571|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
138636572|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
138235380|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138235381|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
138636573|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636574|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138636575|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
138636576|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138636577|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138636578|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
138636579|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636580|NCT00246467|Antacids|antacids|mesh-ancestor
138688420|NCT04753879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138636581|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636582|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138636583|NCT00277251|Alendronate|alendronate|mesh-list
138235402|NCT02428296|Sirolimus|sirolimus|mesh-list
138672647|NCT00493233|Olanzapine|olanzapine|mesh-list
138636584|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138636585|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636586|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
138636587|NCT00416676|Carboplatin|carboplatin|mesh-list
138636588|NCT00416676|Etoposide|etoposide|mesh-list
138636589|NCT00416676|Vincristine|vincristine|mesh-list
138636590|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138636591|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
138636592|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636593|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138235482|NCT01400906|Xhance|xhance|mesh-list
138636594|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138636595|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
138636596|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636597|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636598|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138636599|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138672713|NCT01243827|Carvedilol|carvedilol|mesh-list
138636600|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138636601|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138636602|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235538|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138235539|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
138235541|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138235542|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138235543|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138235544|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138235545|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
138235546|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636603|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636604|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
138636605|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
138636606|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138636607|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636608|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
138636609|NCT00284427|Vitamins|vitamins|mesh-ancestor
138636610|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
138636611|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636612|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
138636613|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636614|NCT00284427|Protective Agents|protective agents|mesh-ancestor
138636615|NCT00246701|Simvastatin|simvastatin|mesh-list
138235598|NCT02651259|Isoniazid|isoniazid|mesh-list
138235599|NCT02651259|Rifapentine|rifapentine|mesh-list
138235600|NCT02651259|Rifamycins|rifamycins|mesh-list
138235601|NCT02651259|Hydrazine|hydrazine|mesh-list
138636616|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138636617|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138636618|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
138636619|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636620|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138636621|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138636622|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636623|NCT00284505|Thalidomide|thalidomide|mesh-list
138636624|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138636625|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
138235659|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138636626|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636627|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
138636628|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138636629|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636630|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138636631|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138636632|NCT00284505|Growth Substances|growth substances|mesh-ancestor
138636633|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
138636634|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636635|NCT00246974|Gemcitabine|gemcitabine|mesh-list
138636636|NCT00246974|Gefitinib|gefitinib|mesh-list
138636637|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138235726|NCT05439993|Mitosis Modulators|mitosis modulators|mesh-ancestor
138235729|NCT00554099|Mesalamine|mesalamine|mesh-list
138636638|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138636639|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
138672822|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138636640|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636641|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138636642|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636643|NCT00284583|Lidocaine|lidocaine|mesh-list
138636644|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
138636645|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
138636646|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138636647|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636648|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
138235787|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235788|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
138235790|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
138636649|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636650|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138636651|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138636652|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138636653|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138636654|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636655|NCT00247052|Diclofenac|diclofenac|mesh-list
138636656|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138636657|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138636658|NCT00247052|Analgesics|analgesics|mesh-ancestor
138636659|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
138636660|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636661|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636662|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138636663|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138636664|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138636665|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636666|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636668|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
138636669|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138636670|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138636671|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636672|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636673|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636674|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138636675|NCT00277602|Protective Agents|protective agents|mesh-ancestor
138636676|NCT00277641|Lamotrigine|lamotrigine|mesh-list
138636677|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
138636678|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138636679|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138636680|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138672934|NCT03271502|Anesthetics|anesthetics|mesh-list
138636681|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138636682|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636683|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138636684|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138636685|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138636686|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138636687|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138636689|NCT00247130|Ranitidine|ranitidine|mesh-list
138636690|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138636691|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138636692|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138235898|NCT01543568|Growth Substances|growth substances|mesh-ancestor
138636693|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138636694|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636695|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636696|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138636697|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
138636698|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
138636699|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636700|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636701|NCT00247169|Progesterone|progesterone|mesh-list
138636702|NCT00247169|Progestins|progestins|mesh-ancestor
138636703|NCT00247169|Hormones|hormones|mesh-ancestor
138636704|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138636705|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636706|NCT00247208|Paclitaxel|paclitaxel|mesh-list
138636707|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138636708|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636709|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636710|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
138636711|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
138636712|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636713|NCT00284778|Docetaxel|docetaxel|mesh-list
138636714|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636715|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636716|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
138636717|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
138636718|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323900|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
138636720|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138636721|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138636722|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138636723|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636724|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636725|NCT00277758|Interferons|interferons|mesh-list
138636726|NCT00277758|Ribavirin|ribavirin|mesh-list
138636727|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
138636728|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138636729|NCT00277758|Interleukin-2|interleukin-2|mesh-list
138636730|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636731|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
138636732|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636733|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
138636734|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636735|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
138636736|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636737|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138636738|NCT00277758|Analgesics|analgesics|mesh-ancestor
138636739|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
138636740|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636741|NCT00247364|Levetiracetam|levetiracetam|mesh-list
138636742|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
138636743|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
138636744|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
138636745|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
138636746|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636747|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
138636748|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636749|NCT00424814|Ritonavir|ritonavir|mesh-list
138636750|NCT00424814|Lopinavir|lopinavir|mesh-list
138636751|NCT00424814|Lamivudine|lamivudine|mesh-list
138636752|NCT00424814|Zidovudine|zidovudine|mesh-list
138636753|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138636754|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138636755|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138636756|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
138636757|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636758|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636759|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138636760|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138636761|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
138636762|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636763|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138636764|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138636765|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138636766|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138636767|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
138636768|NCT00284973|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138636769|NCT00284973|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138636770|NCT00284973|Immunologic Factors|immunologic factors|mesh-ancestor
138636771|NCT00284973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636772|NCT00247481|Docetaxel|docetaxel|mesh-list
138235969|NCT04976595|Androgens|androgens|mesh-ancestor
138235971|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138235972|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235973|NCT00367965|Eszopiclone|eszopiclone|mesh-list
138235974|NCT00367965|Zopiclone|zopiclone|mesh-list
138235975|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138235976|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138235977|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636773|NCT00247481|Gefitinib|gefitinib|mesh-list
138636774|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636775|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636776|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
138636777|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
138636778|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636779|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138636780|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236021|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138236022|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236023|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236024|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
138636781|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
138636782|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138636784|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138636785|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138636786|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636787|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
138636788|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636789|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636790|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138236086|NCT05449899|Lenograstim|lenograstim|mesh-list
138236087|NCT05449899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138236088|NCT05449899|Immunologic Factors|immunologic factors|mesh-ancestor
138236089|NCT05449899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636791|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636792|NCT00285051|Ondansetron|ondansetron|mesh-list
138636793|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
138636794|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
138673071|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
138636795|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138636796|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636797|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138636798|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
138636799|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
138236147|NCT05448885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236148|NCT05448885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138236150|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138236151|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138236152|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138236153|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138236154|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
138236155|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236156|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636800|NCT00285051|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138636801|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138313449|NCT01799226|Triclosan|triclosan|mesh-list
138636802|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
138636803|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636804|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636806|NCT00247715|Ranitidine|ranitidine|mesh-list
138636807|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138636808|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
138636809|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138236203|NCT01431014|Hormones|hormones|mesh-ancestor
138236204|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138236205|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138236210|NCT01431170|Trimethoprim|trimethoprim|mesh-list
138636810|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138636811|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138636812|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138636813|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636814|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636815|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138636816|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
138636817|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
138636818|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636819|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636821|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138636822|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
138636823|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
138636824|NCT00285090|Vitamin D|vitamin d|mesh-list
138636825|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
138636826|NCT00285090|Cholecalciferol|cholecalciferol|mesh-list
138636827|NCT00285090|Vitamins|vitamins|mesh-list
138636828|NCT00285090|Calcium|calcium|mesh-list
138636829|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
138636830|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636831|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138636832|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138636833|NCT00417222|Olmesartan|olmesartan|mesh-list
138636834|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138636835|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138636836|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138636837|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138236324|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
138236355|NCT01551056|Cetirizine|cetirizine|mesh-list
138636838|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636839|NCT00278070|Vinorelbine|vinorelbine|mesh-list
138636840|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138636841|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636842|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636843|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
138636844|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
138636845|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636846|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
138636847|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138636848|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636849|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138636850|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138636852|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
138636853|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636854|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138636855|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138636856|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636857|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138636858|NCT00278187|Volociximab|volociximab|mesh-list
138636859|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236386|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138236387|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636860|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138636861|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636862|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636863|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138636864|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138636865|NCT00278187|Growth Substances|growth substances|mesh-ancestor
138636866|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636867|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
138636868|NCT00247988|Carboplatin|carboplatin|mesh-list
138636869|NCT00247988|Docetaxel|docetaxel|mesh-list
138636870|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636871|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636872|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
138636873|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
138236435|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138636874|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636875|NCT00248144|Famciclovir|famciclovir|mesh-list
138636876|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
138636877|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636878|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138636880|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636882|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
138636883|NCT00278265|Fludarabine|fludarabine|mesh-list
138636884|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138236493|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138636885|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
138636886|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138636887|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636888|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138636889|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
138636890|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636891|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636892|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
138636893|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636894|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138636895|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138636897|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138636898|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138636899|NCT00248183|Naluzotan|naluzotan|mesh-list
138636900|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138636901|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138636902|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
138236558|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236559|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138236560|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138236566|NCT00370539|Hormones|hormones|mesh-ancestor
138673236|NCT00600535|Hormones|hormones|mesh-ancestor
138636903|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636904|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636905|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636906|NCT00278343|Cediranib|cediranib|mesh-list
138636907|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636908|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636909|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636910|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138636911|NCT00248261|Ziprasidone|ziprasidone|mesh-list
138636912|NCT00248261|Sertraline|sertraline|mesh-list
138636913|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
138636914|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138688672|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
138636915|NCT00248261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138636916|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138636917|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138636918|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636919|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138636920|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
138636921|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636922|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138636923|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138636924|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138636925|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138636926|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138636927|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
138636928|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
138636929|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138636930|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636931|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
138636932|NCT00278382|Sorafenib|sorafenib|mesh-list
138636933|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236669|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138236671|NCT00370617|Metformin|metformin|mesh-list
138636934|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138636935|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636936|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636937|NCT00248339|Ribavirin|ribavirin|mesh-list
138636938|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138636939|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
138636940|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
138636941|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636942|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
138636943|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138636944|NCT00248339|Hematinics|hematinics|mesh-ancestor
138636945|NCT00278421|Prednisone|prednisone|mesh-list
138236732|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138236733|NCT03325959|Analgesics|analgesics|mesh-ancestor
138636946|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
138636947|NCT00278421|Rituximab|rituximab|mesh-list
138636948|NCT00278421|Doxorubicin|doxorubicin|mesh-list
138636949|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138636950|NCT00278421|Vincristine|vincristine|mesh-list
138636951|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138636952|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
138636953|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636954|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138636955|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138636956|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
138636957|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636958|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138636959|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138636960|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138636961|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138636962|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138688764|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636963|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138236794|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636964|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138636965|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138636966|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
138636967|NCT00278421|Hormones|hormones|mesh-ancestor
138636968|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138636969|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138636970|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138636971|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636972|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
138236851|NCT05283837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138636973|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
138636974|NCT00248456|Betamethasone|betamethasone|mesh-list
138636975|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
138636976|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138636977|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
138636978|NCT00248456|Calcipotriene|calcipotriene|mesh-list
138636979|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138636980|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138636981|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
138636982|NCT00248456|Hormones|hormones|mesh-ancestor
138236918|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
138236919|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
138236920|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138636983|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138636984|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138636985|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138636986|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
138636987|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
138636988|NCT00278460|Gemcitabine|gemcitabine|mesh-list
138636989|NCT00278460|Docetaxel|docetaxel|mesh-list
138636990|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138636991|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
138636992|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138636993|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236982|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236983|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
138636994|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
138636995|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
138636996|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
138636997|NCT00248729|Midazolam|midazolam|mesh-list
138636998|NCT00248729|Etomidate|etomidate|mesh-list
138636999|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138637000|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138637001|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138637002|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637003|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138637004|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138637005|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138637006|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138637007|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
138637008|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
138637009|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
138637010|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
138637011|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637012|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637013|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
138237044|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138237047|NCT02772783|Insulin|insulin|mesh-list
138637014|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637015|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
138637016|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138637019|NCT00248963|Hormones|hormones|mesh-ancestor
138637020|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138637021|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637022|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138637023|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
138637024|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138637025|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138637026|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138237101|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138237103|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138313670|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
138637027|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138637028|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138637029|NCT00249041|Etanercept|etanercept|mesh-list
138637030|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138637031|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138637032|NCT00249041|Analgesics|analgesics|mesh-ancestor
138637033|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
138637034|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637035|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637036|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138237163|NCT05437965|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138237164|NCT05437965|Hormones|hormones|mesh-ancestor
138637037|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138637038|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138637039|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138637040|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
138637042|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138637043|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138637044|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138637045|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138637046|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
138637047|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637048|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688826|NCT04078152|Durvalumab|durvalumab|mesh-list
138237226|NCT05456763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237227|NCT05456763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237231|NCT02369874|Durvalumab|durvalumab|mesh-list
138637049|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637051|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
138637052|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637053|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637054|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
138637055|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637056|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637057|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
138637058|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138637059|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138637060|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138637061|NCT00249119|Risperidone|risperidone|mesh-list
138637062|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138237288|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237297|NCT01515176|Ofatumumab|ofatumumab|mesh-list
138637063|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
138637064|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138673440|NCT00601666|Zolpidem|zolpidem|mesh-list
138637065|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637066|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637067|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138637068|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138237350|NCT01516424|Risperidone|risperidone|mesh-list
138237351|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138637069|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138637070|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138637071|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138637072|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
138637073|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138637074|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138637075|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138637076|NCT00249158|Risperidone|risperidone|mesh-list
138237419|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237420|NCT06196021|Hyaluronic Acid|hyaluronic acid|mesh-list
138237421|NCT06196021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138237422|NCT06196021|Immunologic Factors|immunologic factors|mesh-ancestor
138237423|NCT06196021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637077|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138637078|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
138637079|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637080|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637081|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637082|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138637083|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138237524|NCT06194734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237525|NCT06194734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138237527|NCT06194721|Anesthetics|anesthetics|mesh-list
138637084|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138637085|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138637086|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138637087|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
138637088|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138637089|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138637090|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138637091|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138637092|NCT00249197|Levofloxacin|levofloxacin|mesh-list
138637093|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138637094|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138237593|NCT06191640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138237594|NCT06191640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237595|NCT06191497|Chlorhexidine|chlorhexidine|mesh-list
138237596|NCT06191497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138637095|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138637096|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138637097|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138637098|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637099|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637100|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637101|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138313743|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138637102|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138237654|NCT06190600|Paclitaxel|paclitaxel|mesh-list
138237655|NCT06190600|Cyclophosphamide|cyclophosphamide|mesh-list
138237656|NCT06190600|Doxorubicin|doxorubicin|mesh-list
138237657|NCT06190600|Trastuzumab|trastuzumab|mesh-list
138637103|NCT00278967|Bisacodyl|bisacodyl|mesh-list
138637104|NCT00278967|Cathartics|cathartics|mesh-ancestor
138637105|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138637106|NCT00278967|Laxatives|laxatives|mesh-ancestor
138637107|NCT00249236|Risperidone|risperidone|mesh-list
138637108|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138637109|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
138637110|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637111|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637112|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237722|NCT06190314|Vitamin B 12|vitamin b 12|mesh-list
138237723|NCT06190314|Hydroxocobalamin|hydroxocobalamin|mesh-list
138237724|NCT06190314|Vitamins|vitamins|mesh-ancestor
138237725|NCT06190314|Micronutrients|micronutrients|mesh-ancestor
138237726|NCT06190314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237727|NCT06190314|Vitamin B Complex|vitamin b complex|mesh-ancestor
138237728|NCT06190314|Hematinics|hematinics|mesh-ancestor
138237729|NCT06190301|Rituximab|rituximab|mesh-list
138237730|NCT06190301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138237731|NCT06190301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237732|NCT06190301|Immunologic Factors|immunologic factors|mesh-ancestor
138237733|NCT06190301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637113|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138637114|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138637115|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138637116|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138637117|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138637118|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
138637119|NCT00285675|Calcitriol|calcitriol|mesh-list
138637120|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138637121|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637122|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138637123|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138637124|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637125|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138637126|NCT00285675|Vitamins|vitamins|mesh-ancestor
138637127|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
138637128|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138637129|NCT02215096|GSK2636771|gsk2636771|mesh-list
138637130|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237875|NCT06186622|Anesthetics, General|anesthetics, general|mesh-ancestor
138237876|NCT06186622|Anesthetics|anesthetics|mesh-ancestor
138237877|NCT06186622|GABA Modulators|gaba modulators|mesh-ancestor
138237895|NCT06185985|Viloxazine|viloxazine|mesh-list
138637131|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138637132|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637133|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637134|NCT00279045|Metformin|metformin|mesh-list
138637135|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
138637136|NCT00279045|Glyburide|glyburide|mesh-list
138637137|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138637138|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637139|NCT00249353|Methylphenidate|methylphenidate|mesh-list
138637140|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138237936|NCT06173531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237937|NCT06171178|Pembrolizumab|pembrolizumab|mesh-list
138237938|NCT06171178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138237939|NCT06171178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138237940|NCT06171178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138237946|NCT06157827|Carboplatin|carboplatin|mesh-list
138637141|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637142|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138637143|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138637144|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138637145|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637146|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
138637147|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637148|NCT00249431|Sertraline|sertraline|mesh-list
138637149|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
138637150|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138637151|NCT00249431|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138637152|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138637153|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138238001|NCT06136650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238002|NCT06136650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238003|NCT06136650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138238004|NCT06136650|Glucocorticoids|glucocorticoids|mesh-ancestor
138238005|NCT06136650|Hormones|hormones|mesh-ancestor
138238006|NCT06136650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138238007|NCT06136650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138238008|NCT06136650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238009|NCT06136650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138238010|NCT06136650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238012|NCT06136650|Hormone Antagonists|hormone antagonists|mesh-ancestor
138637154|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637155|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637157|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637158|NCT00249509|Bupropion|bupropion|mesh-list
138637159|NCT00249509|Nefazodone|nefazodone|mesh-list
138637160|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138637161|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
138637162|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138238082|NCT06104449|Hydrocortisone|hydrocortisone|mesh-list
138238083|NCT06104449|Fludrocortisone|fludrocortisone|mesh-list
138238084|NCT06104449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238085|NCT06104449|Antiemetics|antiemetics|mesh-ancestor
138238086|NCT06104449|Autonomic Agents|autonomic agents|mesh-ancestor
138238087|NCT06104449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238088|NCT06104449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238089|NCT06104449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138238092|NCT06104449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138238093|NCT06104449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138238094|NCT06104449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138238095|NCT06101134|Nivolumab|nivolumab|mesh-list
138238096|NCT06101134|Relatlimab|relatlimab|mesh-list
138637163|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138637164|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138637165|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138637166|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637167|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
138637168|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637169|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637170|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138637171|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138238150|NCT06082986|Ustekinumab|ustekinumab|mesh-list
138238151|NCT06082986|Dermatologic Agents|dermatologic agents|mesh-ancestor
138238181|NCT06059495|Dostarlimab|dostarlimab|mesh-list
138238188|NCT06047171|Cyclophosphamide|cyclophosphamide|mesh-list
138637172|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637173|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138313829|NCT01813422|Evolocumab|evolocumab|mesh-list
138637174|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138688949|NCT03770260|Ixazomib|ixazomib|mesh-list
138637175|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138637176|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
138637177|NCT00279084|Chrysarobin|chrysarobin|mesh-list
138637178|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
138637179|NCT00279084|Hematinics|hematinics|mesh-ancestor
138637180|NCT00279084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138637181|NCT00279084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138637182|NCT00279084|Analgesics|analgesics|mesh-ancestor
138637183|NCT00279084|Sensory System Agents|sensory system agents|mesh-ancestor
138637184|NCT00279084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637185|NCT00279084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238324|NCT05979415|Apomorphine|apomorphine|mesh-list
138637186|NCT00279084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138637187|NCT00279084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138637188|NCT00249587|Methadone|methadone|mesh-list
138637189|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138637190|NCT00249587|Narcotics|narcotics|mesh-ancestor
138637191|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138637192|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637193|NCT00249587|Analgesics|analgesics|mesh-ancestor
138637194|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
138637195|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637196|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
138637197|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
138637198|NCT00279123|Pantoprazole|pantoprazole|mesh-list
138637199|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138637200|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138637201|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138637202|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637203|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637204|NCT00279162|Betamethasone|betamethasone|mesh-list
138637205|NCT00279162|Calcipotriene|calcipotriene|mesh-list
138637206|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238453|NCT05896384|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138238455|NCT05894239|Inavolisib|inavolisib|mesh-list
138238456|NCT05894239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637207|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
138637208|NCT00279162|Hormones|hormones|mesh-ancestor
138637209|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138637210|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637211|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138688964|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637212|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
138238510|NCT05861336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238511|NCT05861336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138238512|NCT05861336|Antimetabolites|antimetabolites|mesh-ancestor
138238513|NCT05861336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138637213|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
138637214|NCT00249704|Vitamin D|vitamin d|mesh-list
138637215|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
138637216|NCT00249704|Cholecalciferol|cholecalciferol|mesh-list
138637217|NCT00249704|Vitamins|vitamins|mesh-list
138637218|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
138637219|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637220|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138637221|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138637222|NCT00249782|Metronidazole|metronidazole|mesh-list
138637224|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637225|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138637226|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138637227|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138637228|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
138238576|NCT05833763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637229|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138637230|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637231|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637232|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
138637233|NCT00279240|Metformin|metformin|mesh-list
138637234|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138637235|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238640|NCT05766267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637236|NCT00249860|Interferons|interferons|mesh-list
138637237|NCT00249860|Ribavirin|ribavirin|mesh-list
138637238|NCT00249860|Interferon-beta|interferon-beta|mesh-list
138637239|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
138637240|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637241|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
138637242|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637243|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
138637244|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637245|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
138238706|NCT05730920|Methadone|methadone|mesh-list
138637246|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637247|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138637248|NCT00249899|Atorvastatin|atorvastatin|mesh-list
138637249|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138637250|NCT00249899|Simvastatin|simvastatin|mesh-list
138637251|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138637252|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138637253|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138637254|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
138637255|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637256|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138637257|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637258|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138637259|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138637261|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
138637262|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637263|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138637264|NCT00249977|Capecitabine|capecitabine|mesh-list
138637265|NCT00249977|Irinotecan|irinotecan|mesh-list
138637266|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637267|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138637268|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
138637269|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637270|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138637271|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138238912|NCT05623020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138637272|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637273|NCT00250094|Topotecan|topotecan|mesh-list
138637274|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138637275|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138637276|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637277|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637278|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637279|NCT00279435|Visilizumab|visilizumab|mesh-list
138637280|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
138637281|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637282|NCT00286026|Azithromycin|azithromycin|mesh-list
138637283|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138238975|NCT05586802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138238976|NCT05586802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238981|NCT05583474|Carteolol|carteolol|mesh-list
138637284|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637285|NCT00250172|Rolipram|rolipram|mesh-list
138637286|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
138637287|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138637288|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138673606|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138637290|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637291|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637292|NCT02961608|Tacrolimus|tacrolimus|mesh-list
138637293|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138637294|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
138637295|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637296|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138637297|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637298|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637299|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138637300|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138239106|NCT05511038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138239107|NCT05511038|Growth Substances|growth substances|mesh-ancestor
138239108|NCT05511038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239109|NCT05511038|Growth Inhibitors|growth inhibitors|mesh-ancestor
138239110|NCT05511038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239112|NCT05498272|Leuprolide|leuprolide|mesh-list
138239113|NCT05498272|Goserelin|goserelin|mesh-list
138239114|NCT05498272|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138239115|NCT05498272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138239116|NCT05498272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239117|NCT05498272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239118|NCT05498272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239119|NCT05498272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138239120|NCT05498272|Fertility Agents|fertility agents|mesh-ancestor
138239121|NCT05498272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138239122|NCT05498272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239123|NCT05498272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138239124|NCT05498272|Luteolytic Agents|luteolytic agents|mesh-ancestor
138239125|NCT05498272|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138239126|NCT05498272|Contraceptive Agents|contraceptive agents|mesh-ancestor
138239127|NCT05498272|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138637301|NCT00286143|Fentanyl|fentanyl|mesh-list
138637302|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138637303|NCT00286143|Narcotics|narcotics|mesh-ancestor
138637304|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138637305|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637306|NCT00286143|Analgesics|analgesics|mesh-ancestor
138637307|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
138637308|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637309|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138637310|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138239173|NCT05455697|Prednisone|prednisone|mesh-list
138239174|NCT05455697|Cyclophosphamide|cyclophosphamide|mesh-list
138239175|NCT05455697|Rituximab|rituximab|mesh-list
138239176|NCT05455697|Doxorubicin|doxorubicin|mesh-list
138637311|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
138637312|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
138637313|NCT00286260|Levetiracetam|levetiracetam|mesh-list
138324066|NCT00982488|Dasatinib|dasatinib|mesh-list
138637314|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
138637315|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
138637316|NCT00250367|Risperidone|risperidone|mesh-list
138637317|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138637318|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
138637319|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138239240|NCT05417594|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138689015|NCT03756961|Desflurane|desflurane|mesh-list
138689016|NCT03756961|Esketamine|esketamine|mesh-list
138637320|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637321|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637322|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138637323|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138637324|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138637325|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138239317|NCT05359211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138239318|NCT05351541|Zolpidem|zolpidem|mesh-list
138239319|NCT05351541|Modafinil|modafinil|mesh-list
138239321|NCT05351541|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138239322|NCT05351541|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138637326|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138637327|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
138637328|NCT00250562|Valsartan|valsartan|mesh-list
138637329|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138637330|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138637331|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138637332|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138637333|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239388|NCT05257824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138239389|NCT05257824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138637334|NCT00250562|Diuretics|diuretics|mesh-ancestor
138637335|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
138637336|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637337|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138637338|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138637339|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
138637340|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
138637341|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138239456|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239457|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239462|NCT05171686|Torsemide|torsemide|mesh-list
138637342|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
138637343|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138637344|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
138637345|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637346|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637347|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
138637348|NCT00279747|Naproxen|naproxen|mesh-list
138637349|NCT00279747|Meloxicam|meloxicam|mesh-list
138239528|NCT05112965|Tubulin Modulators|tubulin modulators|mesh-ancestor
138637350|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138637351|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138637352|NCT00279747|Analgesics|analgesics|mesh-ancestor
138637353|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
138637354|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637355|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637356|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138637357|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138637358|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
138637359|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138637360|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239598|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239599|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138239601|NCT05053334|Omalizumab|omalizumab|mesh-list
138637361|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637362|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138637363|NCT00250640|Iloprost|iloprost|mesh-list
138637364|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138637365|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
138673676|NCT00470990|Acyline|acyline|mesh-list
138637366|NCT00250796|Interferons|interferons|mesh-list
138637367|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
138637368|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138637369|NCT00250796|Thalidomide|thalidomide|mesh-list
138637370|NCT00250796|Octreotide|octreotide|mesh-list
138239665|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138239666|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637371|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637372|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
138637373|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637374|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138324087|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
138637375|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
138637376|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637377|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
138239732|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239733|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138637378|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138637379|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138637380|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138637381|NCT00250796|Growth Substances|growth substances|mesh-ancestor
138637382|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
138637383|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138637384|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138239807|NCT04831320|Nivolumab|nivolumab|mesh-list
138239816|NCT04793958|Cetuximab|cetuximab|mesh-list
138637386|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138637387|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138637388|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
138637389|NCT00250874|Docetaxel|docetaxel|mesh-list
138637390|NCT00250874|Doxorubicin|doxorubicin|mesh-list
138637391|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138637392|NCT00250874|Trastuzumab|trastuzumab|mesh-list
138637393|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637394|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
138239878|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138239879|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
138239881|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637395|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
138637396|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
138637397|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637398|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138637399|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138637400|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138637401|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637402|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138637403|NCT00279825|Levodopa|levodopa|mesh-list
138637404|NCT00279825|Carbidopa|carbidopa|mesh-list
138637405|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138239948|NCT04624230|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138239949|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138239950|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239952|NCT04620603|Immunomodulating Agents|immunomodulating agents|mesh-list
138637406|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138637407|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138637408|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
138637409|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637410|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637411|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637412|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138240015|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637413|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637414|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138637415|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
138637416|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
138637417|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138637418|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138637419|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138637420|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637421|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637422|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138637423|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138637424|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637425|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
138637426|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637427|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138637428|NCT00250991|Eptifibatide|eptifibatide|mesh-list
138240087|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
138240088|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
138240089|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
138240090|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
138637429|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138637430|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138637431|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637432|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138637433|NCT00286611|Amifostine|amifostine|mesh-list
138637434|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138324094|NCT01926210|Letrozole|letrozole|mesh-list
138637435|NCT00286611|Protective Agents|protective agents|mesh-ancestor
138637436|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637438|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
138637439|NCT00416832|Dacarbazine|dacarbazine|mesh-list
138637440|NCT00416832|Doxorubicin|doxorubicin|mesh-list
138637441|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138637442|NCT00416832|Etoposide|etoposide|mesh-list
138637443|NCT00416832|Vincristine|vincristine|mesh-list
138637444|NCT00416832|Procarbazine|procarbazine|mesh-list
138637445|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138637446|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
138240142|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138240143|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138240145|NCT04413799|Analgesics|analgesics|mesh-ancestor
138637447|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637448|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138637449|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138637450|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
138637451|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637452|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637453|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138240200|NCT04372433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240201|NCT04372108|Ustekinumab|ustekinumab|mesh-list
138240202|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
138637454|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138637455|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138637456|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138637457|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637458|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138637459|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
138637461|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138637462|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138673784|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637463|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138637464|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
138637465|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
138637466|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
138240268|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138240269|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138240270|NCT04249362|Durvalumab|durvalumab|mesh-list
138240271|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138637468|NCT00251030|Omeprazole|omeprazole|mesh-list
138637469|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138637470|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138637471|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138637472|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637473|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637474|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138637475|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138637476|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
138637477|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138637478|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138637479|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
138637480|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637481|NCT00286689|Hormones|hormones|mesh-list
138637482|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138637483|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637484|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138637485|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637486|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637487|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637488|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138637489|NCT01640002|Bromides|bromides|mesh-list
138637490|NCT01640002|Propantheline|propantheline|mesh-list
138637491|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
138637492|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138637493|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138637494|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138637495|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138240394|NCT04046887|Paclitaxel|paclitaxel|mesh-list
138240419|NCT04021043|Nivolumab|nivolumab|mesh-list
138637496|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
138637497|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637498|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324106|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324110|NCT00981084|Modafinil|modafinil|mesh-list
138637499|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637500|NCT00279903|Cortisone|cortisone|mesh-list
138637501|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
138637502|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138637503|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138637504|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138637505|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138637506|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637507|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
138637508|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637509|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637510|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138637511|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637512|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138637513|NCT01640275|Propofol|propofol|mesh-list
138637514|NCT01640275|Isoflurane|isoflurane|mesh-list
138637515|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138637516|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138637517|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637518|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138637519|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
138637520|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
138637521|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138637522|NCT04529356|Acetaminophen|acetaminophen|mesh-list
138637523|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138637524|NCT04529356|Analgesics|analgesics|mesh-ancestor
138637525|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
138637526|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138240527|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138240528|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138637527|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637529|NCT01640665|Capecitabine|capecitabine|mesh-list
138637530|NCT01640665|Sorafenib|sorafenib|mesh-list
138637531|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138637532|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
138637533|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637534|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637535|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138637536|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637537|NCT01640782|Leucovorin|leucovorin|mesh-list
138637538|NCT01640782|Docetaxel|docetaxel|mesh-list
138637539|NCT01640782|Fluorouracil|fluorouracil|mesh-list
138637540|NCT01640782|Irinotecan|irinotecan|mesh-list
138637541|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
138637542|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637543|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
138637544|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
138637545|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
138637546|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240646|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138240647|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
138637547|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
138637548|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138637549|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138637550|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
138637551|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637552|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138637553|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138637554|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637555|NCT01640782|Antidotes|antidotes|mesh-ancestor
138637556|NCT01640782|Protective Agents|protective agents|mesh-ancestor
138637557|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
138637558|NCT01640782|Vitamins|vitamins|mesh-ancestor
138637559|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
138637560|NCT00251186|Capecitabine|capecitabine|mesh-list
138637561|NCT00251186|Cetuximab|cetuximab|mesh-list
138637562|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138637563|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
138637564|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240782|NCT03471663|Palbociclib|palbociclib|mesh-list
138637565|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637566|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138637567|NCT01641250|Cytarabine|cytarabine|mesh-list
138637568|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138637569|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
138637570|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637571|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240850|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138240851|NCT03337698|Incretins|incretins|mesh-ancestor
138240852|NCT03337698|Hormones|hormones|mesh-ancestor
138240853|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138240854|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138240855|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
138637572|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
138637573|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637574|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138637575|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
138637576|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637577|NCT01641289|Acetaminophen|acetaminophen|mesh-list
138637578|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138637579|NCT01641289|Analgesics|analgesics|mesh-ancestor
138637580|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
138637581|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637582|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240911|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
138240912|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637583|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
138637584|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
138637585|NCT01641406|Bevacizumab|bevacizumab|mesh-list
138637586|NCT01641406|Docetaxel|docetaxel|mesh-list
138637587|NCT01641406|Capecitabine|capecitabine|mesh-list
138637588|NCT01641406|Trastuzumab|trastuzumab|mesh-list
138637589|NCT01641406|Epirubicin|epirubicin|mesh-list
138637590|NCT01641406|Vinorelbine|vinorelbine|mesh-list
138637591|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138637592|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
138637593|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637594|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138240976|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637595|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138637596|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
138637597|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637598|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637599|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138637600|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138637602|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138637604|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
138241044|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138637605|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
138637606|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
138637607|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
138637608|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138637609|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
138637610|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138637611|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138637612|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138241110|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138241111|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241112|NCT02632409|Nivolumab|nivolumab|mesh-list
138241113|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138241115|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138241116|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241150|NCT02625480|Fludarabine|fludarabine|mesh-list
138241151|NCT02625480|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
138241152|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138241153|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
138241154|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241155|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138241156|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138241157|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
138241158|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241159|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241160|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138241161|NCT02625480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138241162|NCT02620046|Vedolizumab|vedolizumab|mesh-list
138241163|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138241164|NCT02500849|Busulfan|busulfan|mesh-list
138241165|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
138241166|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241167|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138241168|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
138241169|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241170|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138241171|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241172|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138241173|NCT02489318|Androgens|androgens|mesh-list
138637613|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637614|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138637615|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138637616|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
138637617|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138637618|NCT01641523|Protective Agents|protective agents|mesh-ancestor
138637619|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637620|NCT01641796|Paromomycin|paromomycin|mesh-list
138637621|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138637622|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637623|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138241179|NCT02477826|Gemcitabine|gemcitabine|mesh-list
138241180|NCT02477826|Nivolumab|nivolumab|mesh-list
138637624|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138637625|NCT00280098|Docetaxel|docetaxel|mesh-list
138637626|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637627|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
138637628|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
138637629|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
138637630|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637631|NCT00251381|Cetuximab|cetuximab|mesh-list
138241242|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138241243|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
138637632|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138637633|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637634|NCT01685827|Eflornithine|eflornithine|mesh-list
138637635|NCT01685827|Nifurtimox|nifurtimox|mesh-list
138637636|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637637|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138637638|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138637639|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138637640|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637641|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138637642|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241310|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
138637643|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637644|NCT05140096|Fluconazole|fluconazole|mesh-list
138637645|NCT05140096|Isavuconazole|isavuconazole|mesh-list
138637647|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
138637648|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637649|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138637650|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138637651|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637652|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637653|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138637654|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
138637655|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138637656|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637657|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138637658|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138637659|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637660|NCT00251459|Ranibizumab|ranibizumab|mesh-list
138637661|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138637662|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138637663|NCT00251459|Growth Substances|growth substances|mesh-ancestor
138637664|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637665|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
138637666|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637668|NCT04823065|Loperamide|loperamide|mesh-list
138637669|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
138637670|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138637671|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138637672|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138637673|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
138637674|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
138637675|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637676|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637678|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138637679|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
138689140|NCT03586999|Hormones|hormones|mesh-ancestor
138241591|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
138241592|NCT00295893|Paclitaxel|paclitaxel|mesh-list
138241593|NCT00295893|Docetaxel|docetaxel|mesh-list
138637681|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637682|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138637683|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
138637684|NCT00280176|Fluorouracil|fluorouracil|mesh-list
138637685|NCT00280176|Bortezomib|bortezomib|mesh-list
138637686|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
138637687|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637688|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138637689|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637690|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138637692|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637693|NCT00280215|Losartan|losartan|mesh-list
138637694|NCT00280215|Lisinopril|lisinopril|mesh-list
138637695|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138637696|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138637697|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138637698|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138637699|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138637700|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138241724|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138241725|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138241726|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138637701|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637702|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
138637703|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138637704|NCT00280215|Protective Agents|protective agents|mesh-ancestor
138637705|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637706|NCT00251498|Cetuximab|cetuximab|mesh-list
138637707|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138314352|NCT01730118|Mitogens|mitogens|mesh-list
138241789|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241790|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637708|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637709|NCT02271334|Albuterol|albuterol|mesh-list
138637710|NCT02271334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138637711|NCT02271334|Autonomic Agents|autonomic agents|mesh-ancestor
138637712|NCT02271334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637713|NCT02271334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637714|NCT02271334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138637715|NCT02271334|Respiratory System Agents|respiratory system agents|mesh-ancestor
138241857|NCT01578980|Pancrelipase|pancrelipase|mesh-list
138637716|NCT02271334|Tocolytic Agents|tocolytic agents|mesh-ancestor
138637717|NCT02271334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138637718|NCT02271334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138637719|NCT02271334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138637720|NCT02271334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138637721|NCT02271334|Adrenergic Agents|adrenergic agents|mesh-ancestor
138637722|NCT02271334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637723|NCT02271334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637724|NCT02276755|Vitamin D|vitamin d|mesh-list
138637725|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
138637726|NCT02276755|Vitamins|vitamins|mesh-ancestor
138637727|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
138637728|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637729|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138637730|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138637731|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
138637732|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138637733|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
138637734|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637735|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637736|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138637737|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
138637738|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138637739|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138637740|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138637741|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
138637742|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637743|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637744|NCT00251654|Anesthetics|anesthetics|mesh-list
138637745|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138637746|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637747|NCT00286923|Topiramate|topiramate|mesh-list
138637748|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
138637749|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138637750|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637751|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
138637752|NCT00251732|Nortriptyline|nortriptyline|mesh-list
138637753|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
138637754|NCT00251732|Rabeprazole|rabeprazole|mesh-list
138637755|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138637756|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138637757|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138637758|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637759|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637760|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138637761|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138637762|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138242203|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637763|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138637764|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
138637765|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637766|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637767|NCT00286962|Insulin|insulin|mesh-list
138637768|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138637769|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138637770|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637771|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
138637772|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138637773|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637774|NCT00251849|KRM 1648|krm 1648|mesh-list
138637775|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138637776|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
138637777|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138637778|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637779|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
138637780|NCT00251888|Irinotecan|irinotecan|mesh-list
138637781|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637782|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138637783|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138637784|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637785|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637786|NCT00251966|Esomeprazole|esomeprazole|mesh-list
138637787|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138637788|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138637789|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138637790|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637791|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637792|NCT00252044|Pergolide|pergolide|mesh-list
138637793|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
138637795|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637796|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637797|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637798|NCT01805284|Linezolid|linezolid|mesh-list
138637799|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138637800|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637801|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138637802|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637803|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637804|NCT00280605|Alfuzosin|alfuzosin|mesh-list
138637805|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138637806|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138637807|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138637808|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
138637809|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637810|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637811|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637812|NCT00280605|Urological Agents|urological agents|mesh-ancestor
138637813|NCT01134601|Capecitabine|capecitabine|mesh-list
138637814|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138637815|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
138637816|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637817|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637818|NCT00252122|Ketamine|ketamine|mesh-list
138637819|NCT00252122|Analgesics|analgesics|mesh-ancestor
138637820|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
138637821|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637822|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138242372|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138637823|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138637824|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138637825|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
138637826|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
138637827|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138637828|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138637829|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138637830|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242439|NCT02981030|Mifepristone|mifepristone|mesh-list
138242440|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138242446|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
138637831|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637833|NCT00287157|Analgesics|analgesics|mesh-ancestor
138637834|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
138637835|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637836|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637837|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
138637838|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138242505|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138242506|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
138242508|NCT03000218|Metformin|metformin|mesh-list
138637839|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138637840|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
138637841|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
138637842|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138637843|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138637844|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138637845|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
138637846|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637847|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637848|NCT00280644|Leflunomide|leflunomide|mesh-list
138242573|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138637849|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637850|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637851|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138637852|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
138637853|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637854|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138314497|NCT01725126|Metformin|metformin|mesh-list
138242641|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138242642|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138242643|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
138637856|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637857|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138637858|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138637859|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138637860|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138637861|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637862|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
138637863|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637864|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637865|NCT00252317|Captopril|captopril|mesh-list
138637866|NCT00252317|Trandolapril|trandolapril|mesh-list
138637867|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138637868|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
138637869|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637870|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637871|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138637872|NCT00252356|Amibegron|amibegron|mesh-list
138637873|NCT00252356|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138637874|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138637875|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138637876|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
138637877|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637878|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242778|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138242779|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637879|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637880|NCT00252356|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138637881|NCT02753998|Paclitaxel|paclitaxel|mesh-list
138689220|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637882|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138637883|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637884|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
138637885|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
138637886|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
138242843|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
138637887|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637888|NCT02754154|Warfarin|warfarin|mesh-list
138637889|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
138637890|NCT02754154|Dabigatran|dabigatran|mesh-list
138637891|NCT02754154|Apixaban|apixaban|mesh-list
138637892|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
138637893|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138637894|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
138637895|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138637896|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
138637898|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637899|NCT00252434|Methamphetamine|methamphetamine|mesh-list
138637900|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138637901|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637902|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
138242979|NCT00555035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138637903|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
138637904|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138637905|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
138637906|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138637907|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637908|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
138243045|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
138637909|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138637910|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138637911|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138637912|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138637913|NCT00280839|Topiramate|topiramate|mesh-list
138637914|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
138637915|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138637916|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637917|NCT00280878|Rituximab|rituximab|mesh-list
138637918|NCT00280878|Gemcitabine|gemcitabine|mesh-list
138637919|NCT00280878|Vinorelbine|vinorelbine|mesh-list
138243111|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
138637920|NCT00280878|Ifosfamide|ifosfamide|mesh-list
138637921|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138637922|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138637923|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
138637924|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637925|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138637926|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138637927|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
138637928|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243175|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138637929|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138637931|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
138637932|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
138637933|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138637934|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
138637935|NCT00287313|Vitamin K|vitamin k|mesh-list
138637936|NCT00287313|Vitamins|vitamins|mesh-ancestor
138637937|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
138637938|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637939|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138637940|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138637941|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637942|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
138637943|NCT00287313|Coagulants|coagulants|mesh-ancestor
138637944|NCT01680250|Sirolimus|sirolimus|mesh-list
138637945|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138637946|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637947|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138689245|NCT03306264|Decitabine|decitabine|mesh-list
138637949|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
138637950|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138637951|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
138243312|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138243313|NCT03686657|Metformin|metformin|mesh-list
138243358|NCT02071394|Xenon|xenon|mesh-list
138637952|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637953|NCT00280956|Natalizumab|natalizumab|mesh-list
138637954|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
138637955|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138637956|NCT02279875|Rifampin|rifampin|mesh-list
138637957|NCT02279875|Isoniazid|isoniazid|mesh-list
138637958|NCT02279875|Linezolid|linezolid|mesh-list
138637959|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
138637960|NCT02279875|Ethambutol|ethambutol|mesh-list
138637961|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138637962|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
138637963|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138637964|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138637965|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
138637966|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138637967|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637968|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637969|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138637970|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138637971|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138637972|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138243381|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138637973|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138637974|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138704655|NCT05740982|Antiviral Agents|antiviral agents|mesh-ancestor
138637975|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138637976|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138318619|NCT01383954|Analgesics|analgesics|mesh-ancestor
138705470|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
138318660|NCT05365074|Chloroprocaine|chloroprocaine|mesh-list
138637978|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138637979|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138637980|NCT00280995|Mipomersen|mipomersen|mesh-list
138637981|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138637982|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138637983|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
138637984|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637985|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138637986|NCT05139667|Tacrolimus|tacrolimus|mesh-list
138637987|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706357|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
138489204|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489205|NCT00012103|Dimercaprol|dimercaprol|mesh-list
138489206|NCT00012103|Chelating Agents|chelating agents|mesh-ancestor
138489207|NCT00012103|Sequestering Agents|sequestering agents|mesh-ancestor
138243442|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
138489208|NCT00012103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324210|NCT03423342|Vitamins|vitamins|mesh-ancestor
138489209|NCT00001251|Mafosfamide|mafosfamide|mesh-list
138489210|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138489211|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
138489212|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489213|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489214|NCT00012142|Sirolimus|sirolimus|mesh-list
138489215|NCT00012142|Temsirolimus|temsirolimus|mesh-list
138489216|NCT00012142|MTOR Inhibitors|mtor inhibitors|mesh-list
138489217|NCT00012142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138489218|NCT00012142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489219|NCT00012142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489220|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489221|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
138489222|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489223|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489224|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138489225|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489226|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138489227|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
138489228|NCT00012181|Alvocidib|alvocidib|mesh-list
138489229|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489230|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
138243488|NCT05376722|Hormones|hormones|mesh-ancestor
138243489|NCT05376722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489231|NCT00012181|Growth Substances|growth substances|mesh-ancestor
138489232|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489233|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138489234|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489235|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489236|NCT00005945|Cytarabine|cytarabine|mesh-list
138489237|NCT00005945|Dexamethasone|dexamethasone|mesh-list
138489238|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
138489239|NCT00005945|Doxorubicin|doxorubicin|mesh-list
138489240|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138489241|NCT00005945|Methotrexate|methotrexate|mesh-list
138489242|NCT00005945|Vincristine|vincristine|mesh-list
138489243|NCT00005945|Daunorubicin|daunorubicin|mesh-list
138243539|NCT02950467|Psilocybin|psilocybin|mesh-list
138243540|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138243541|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
138243542|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138243543|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138243544|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138243578|NCT01915823|Xhance|xhance|mesh-list
138489244|NCT00005945|Asparaginase|asparaginase|mesh-list
138489245|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
138489246|NCT00005945|Pegaspargase|pegaspargase|mesh-list
138489247|NCT00005945|Thioguanine|thioguanine|mesh-list
138489248|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489249|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
138489250|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489251|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138489252|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138489253|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
138489254|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489255|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489256|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138489257|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138489258|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
138489259|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
138489260|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138489261|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138489262|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
138489263|NCT00005945|Hormones|hormones|mesh-ancestor
138489264|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489265|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138489266|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138489267|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138489268|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138489269|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489270|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138489271|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
138489272|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138489273|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138489275|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
138489276|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138489277|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138324224|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138489278|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
138489279|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243603|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
138243607|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
138489280|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138489281|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
138489282|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
138489283|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
138489286|NCT01929811|Epirubicin|epirubicin|mesh-list
138489287|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138489288|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489289|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489290|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
138489291|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
138489292|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
138489293|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489294|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138489295|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138489296|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138489297|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489298|NCT00012220|Gemcitabine|gemcitabine|mesh-list
138243642|NCT02955147|Ustekinumab|ustekinumab|mesh-list
138489299|NCT00012220|Docetaxel|docetaxel|mesh-list
138489300|NCT00012220|Irinotecan|irinotecan|mesh-list
138489301|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489302|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138489303|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
138489304|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489305|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
138489306|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
138489307|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
138489308|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138489309|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138489310|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489311|NCT00012259|Troxacitabine|troxacitabine|mesh-list
138489312|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243704|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243708|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
138489313|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138489314|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138489315|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
138489316|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489317|NCT00012337|Gefitinib|gefitinib|mesh-list
138489318|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489319|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138489320|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489321|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489322|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
138489323|NCT00012376|Sargramostim|sargramostim|mesh-list
138243767|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138489324|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
138489325|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489326|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489327|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138489328|NCT00001266|Suramin|suramin|mesh-list
138489329|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
138489330|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
138489331|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138489332|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489333|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243835|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138489334|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138674516|NCT02891161|Durvalumab|durvalumab|mesh-list
138489335|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138489336|NCT00005948|Interferons|interferons|mesh-list
138489337|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
138489338|NCT00005948|Aldesleukin|aldesleukin|mesh-list
138489340|NCT00005948|Sargramostim|sargramostim|mesh-list
138489341|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489342|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
138489343|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489344|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
138489345|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489346|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
138489347|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489348|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489349|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138489350|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138489351|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138489352|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138489353|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
138165796|NCT05137262|Durvalumab|durvalumab|mesh-list
138489354|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138489355|NCT00012688|Doxycycline|doxycycline|mesh-list
138489356|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138489357|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489358|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
138489359|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
138489360|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138489361|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
138489362|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138489363|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138489364|NCT00005951|Irinotecan|irinotecan|mesh-list
138489365|NCT00005951|Temozolomide|temozolomide|mesh-list
138489366|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138489367|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138489368|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489369|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489371|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138489372|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
138489373|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
138489374|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138489375|NCT00001287|Antibodies|antibodies|mesh-list
138489376|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
138489377|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138489378|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
138489379|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489380|NCT00005954|Temozolomide|temozolomide|mesh-list
138489381|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138489382|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
138489383|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489384|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489385|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
138489386|NCT00005960|Docetaxel|docetaxel|mesh-list
138489387|NCT00005960|Doxorubicin|doxorubicin|mesh-list
138489388|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138489389|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489390|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
138489391|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489392|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138489393|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138243930|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138243931|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
138243932|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138489394|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
138489395|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489396|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489397|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138489399|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
138489400|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
138489401|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138489402|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138489403|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138324250|NCT01929096|Edaravone|edaravone|mesh-list
138489405|NCT00005963|Carboplatin|carboplatin|mesh-list
138489406|NCT00005963|Docetaxel|docetaxel|mesh-list
138489407|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489408|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
138489409|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
138489410|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
138489411|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489412|NCT00013585|Selegiline|selegiline|mesh-list
138489413|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
138489414|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138489415|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138489416|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138489417|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138489418|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489419|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489420|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138489421|NCT00013585|Protective Agents|protective agents|mesh-ancestor
138489422|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489423|NCT00013624|Levodopa|levodopa|mesh-list
138489424|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138489425|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138489426|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
138489427|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138489428|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489429|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489430|NCT00013663|Aldesleukin|aldesleukin|mesh-list
138489431|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489433|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138489434|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
138489435|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489436|NCT00013702|Adefovir|adefovir|mesh-list
138489437|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
138489438|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489439|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138489440|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138489441|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489442|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489443|NCT00005966|Interferons|interferons|mesh-list
138489444|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
138244049|NCT03076112|Hormones|hormones|mesh-ancestor
138244050|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489445|NCT00005966|Thalidomide|thalidomide|mesh-list
138489446|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489447|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
138489448|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489449|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
138489450|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489451|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138244100|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
138489452|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
138489453|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138489454|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138489455|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138489456|NCT00005966|Growth Substances|growth substances|mesh-ancestor
138489457|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
138489458|NCT00005969|Tretinoin|tretinoin|mesh-list
138489459|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489460|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
138489461|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
138489462|NCT00014014|Lamivudine|lamivudine|mesh-list
138489463|NCT00014014|Zidovudine|zidovudine|mesh-list
138489464|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138324258|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
138489465|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138489466|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138489467|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489468|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489469|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
138489470|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489471|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138489472|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138244160|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138489473|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
138489474|NCT00014092|Interferons|interferons|mesh-list
138489475|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
138489476|NCT00014092|Aldesleukin|aldesleukin|mesh-list
138489477|NCT00014092|Temozolomide|temozolomide|mesh-list
138489478|NCT00014092|Sargramostim|sargramostim|mesh-list
138489479|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489480|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
138489481|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489482|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138489483|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
138244215|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
138489484|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489485|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
138489486|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489487|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138489488|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138489489|NCT00005972|Gemcitabine|gemcitabine|mesh-list
138489490|NCT00005972|Irinotecan|irinotecan|mesh-list
138244282|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138244283|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
138489491|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138489492|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
138489493|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489494|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489495|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138489496|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138489497|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489498|NCT00014170|Gefitinib|gefitinib|mesh-list
138489499|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489500|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138489501|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489502|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489503|NCT00014209|Dexamethasone|dexamethasone|mesh-list
138489504|NCT00014209|Gemcitabine|gemcitabine|mesh-list
138489505|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138489506|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
138489507|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
138489508|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138489509|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489510|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138489511|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
138489512|NCT00014209|Hormones|hormones|mesh-ancestor
138489513|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138461233|NCT01938456|Docetaxel|docetaxel|mesh-list
138489514|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138489515|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489516|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138489518|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489519|NCT00014248|Adenosine|adenosine|mesh-list
138244409|NCT01605032|Busulfan|busulfan|mesh-list
138489520|NCT00014248|Analgesics|analgesics|mesh-ancestor
138489521|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
138489522|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138489523|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489524|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138489525|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
138489526|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138489527|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
138489528|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
138489529|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138489530|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244473|NCT05400993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489531|NCT00005975|Megestrol|megestrol|mesh-list
138489532|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
138489533|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138489534|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138489535|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138489536|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
138489537|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138489538|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489539|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138489540|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138489541|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138489542|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489543|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
138244534|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244535|NCT02992886|Raltitrexed|raltitrexed|mesh-list
138489544|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138489545|NCT00014287|Gemcitabine|gemcitabine|mesh-list
138489546|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138489547|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
138489548|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489549|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489550|NCT02971930|Factor VIII|factor viii|mesh-list
138489551|NCT02971930|Coagulants|coagulants|mesh-ancestor
138489552|NCT00005978|Carboplatin|carboplatin|mesh-list
138489553|NCT00005978|Etoposide|etoposide|mesh-list
138489554|NCT00005978|Melphalan|melphalan|mesh-list
138489555|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138489556|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489557|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138489558|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138244595|NCT05738759|Anesthetics|anesthetics|mesh-list
138244597|NCT05738759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489559|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138489560|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489561|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489562|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
138489563|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489564|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138489565|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
138489566|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138489567|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489568|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138244656|NCT05259995|Autonomic Agents|autonomic agents|mesh-ancestor
138244661|NCT03028883|Buprenorphine|buprenorphine|mesh-list
138489569|NCT00014404|Celecoxib|celecoxib|mesh-list
138489570|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138489571|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138489572|NCT00014404|Analgesics|analgesics|mesh-ancestor
138489573|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
138489574|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138489575|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489576|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138244721|NCT04997525|Hormones|hormones|mesh-ancestor
138489577|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138489578|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138489579|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138489580|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637988|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
138489581|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489583|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489584|NCT00014599|Paclitaxel|paclitaxel|mesh-list
138489585|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138244787|NCT05421416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244788|NCT04868045|Hormones|hormones|mesh-list
138489586|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324283|NCT05605002|Serotonin Agents|serotonin agents|mesh-ancestor
138324284|NCT05605002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324285|NCT05605002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324286|NCT05605002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324287|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
138324288|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138489587|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
138489589|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
138489590|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489591|NCT00005981|Carmustine|carmustine|mesh-list
138489592|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138489593|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138489594|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
138489595|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489596|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489597|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489598|NCT00014638|Letrozole|letrozole|mesh-list
138489599|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489600|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138489601|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138489602|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489603|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244914|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138244915|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244916|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
138489604|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138489605|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
138489606|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489607|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489608|NCT00001341|Raltitrexed|raltitrexed|mesh-list
138489609|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138489610|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
138244976|NCT01662908|Calcium heparin|calcium heparin|mesh-list
138489611|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489612|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489613|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138489614|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489615|NCT00014677|Interleukin-4|interleukin-4|mesh-list
138489616|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138489617|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
138489618|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489619|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489620|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138245045|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245046|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
138245047|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138245048|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245049|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
138245051|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
138489621|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
138489622|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
138489623|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138489624|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138674792|NCT01313182|Povidone|povidone|mesh-list
138489625|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138489626|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489627|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138489628|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138245103|NCT00375843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138245104|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138489629|NCT00005984|Interferons|interferons|mesh-list
138489630|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
138489631|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
138489632|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489633|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
138489634|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489635|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138689364|NCT02980510|Leucovorin|leucovorin|mesh-list
138324296|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138489636|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138489637|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
138245168|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245170|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489638|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489639|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489640|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138489641|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
138489642|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489643|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
138489644|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138489645|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245234|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245235|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245237|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245238|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
138245239|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138245240|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245241|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138245242|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
138245243|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
138245244|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138245245|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138245251|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138489646|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138489647|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
138489648|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138489649|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489650|NCT00005987|Interferons|interferons|mesh-list
138489651|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
138489652|NCT00005987|Dexamethasone|dexamethasone|mesh-list
138489653|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
138489654|NCT00005987|Carmustine|carmustine|mesh-list
138245288|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245289|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138245290|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245291|NCT03194373|Carboplatin|carboplatin|mesh-list
138245292|NCT03194373|Palbociclib|palbociclib|mesh-list
138245293|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489656|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
138489657|NCT00005987|Sargramostim|sargramostim|mesh-list
138489658|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489659|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
138489660|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489661|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138166108|NCT04052776|Levodopa|levodopa|mesh-list
138489662|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138489663|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
138489664|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489665|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489666|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138489667|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138489668|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
138489669|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
138489670|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138489671|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138489672|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
138489673|NCT00005987|Hormones|hormones|mesh-ancestor
138489674|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138245351|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245352|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
138245353|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138245354|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138489675|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138489676|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138489677|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138489678|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138489679|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489680|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
138489681|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489682|NCT00005987|Analgesics|analgesics|mesh-ancestor
138489683|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
138489684|NCT00014755|Prednisone|prednisone|mesh-list
138489685|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
138489686|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138324320|NCT03033576|Nivolumab|nivolumab|mesh-list
138489687|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489688|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
138489689|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489690|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138489691|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138489692|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
138489693|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489694|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489695|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138489696|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138689376|NCT02980510|Antidotes|antidotes|mesh-ancestor
138245444|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489697|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
138489698|NCT00014755|Hormones|hormones|mesh-ancestor
138489699|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489700|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138489701|NCT00005990|Topotecan|topotecan|mesh-list
138489702|NCT00005990|Tipifarnib|tipifarnib|mesh-list
138489703|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138489704|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138489705|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245512|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489706|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489707|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489708|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
138489709|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
138489710|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
138489711|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138489712|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138245583|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
138245584|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
138489713|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138489714|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489715|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489716|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
138489717|NCT00014989|Analgesics|analgesics|mesh-ancestor
138489718|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
138489719|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138245655|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489720|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489721|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
138489722|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138489723|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138489724|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
138489725|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138489726|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138637989|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489728|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138489729|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
138489730|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138489731|NCT00005993|Aldesleukin|aldesleukin|mesh-list
138489732|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489733|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138489734|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138489735|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
138489736|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489737|NCT00015028|Buprenorphine|buprenorphine|mesh-list
138489738|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138245788|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138489739|NCT00015028|Naloxone|naloxone|mesh-list
138489740|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138489741|NCT00015028|Narcotics|narcotics|mesh-ancestor
138489742|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138489743|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489745|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
138489746|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138489747|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138489748|NCT00015067|Methylphenidate|methylphenidate|mesh-list
138245856|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138245857|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
138245858|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138245859|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245860|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138245861|NCT01971593|Diuretics|diuretics|mesh-ancestor
138245862|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
138489749|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138489750|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489751|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138489752|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138489753|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138689393|NCT02967289|Irinotecan|irinotecan|mesh-list
138674895|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489754|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245919|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245927|NCT02007863|Melphalan|melphalan|mesh-list
138489755|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
138489756|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138489757|NCT00015106|Lamotrigine|lamotrigine|mesh-list
138489758|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
138489759|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138489760|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138489761|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489762|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138245985|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138245986|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138245987|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
138489763|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489764|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138489765|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138489766|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138489767|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138489768|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138489769|NCT00005996|Gemcitabine|gemcitabine|mesh-list
138489770|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246048|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138246049|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138246050|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246052|NCT02057939|Leuprolide|leuprolide|mesh-list
138489771|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138489772|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
138489773|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489774|NCT00001359|Penicillins|penicillins|mesh-list
138489775|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138489776|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489777|NCT00015223|Methylphenidate|methylphenidate|mesh-list
138246113|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138246114|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138489778|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138489779|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489780|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138489781|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138489782|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138489783|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489784|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
138489785|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138489786|NCT00015301|Methylphenidate|methylphenidate|mesh-list
138489787|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138489788|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489789|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138489790|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138489791|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138246247|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246248|NCT01741454|Urological Agents|urological agents|mesh-ancestor
138246249|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138489792|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489793|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
138489794|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138489795|NCT00015340|Buprenorphine|buprenorphine|mesh-list
138489796|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138489797|NCT00015340|Naloxone|naloxone|mesh-list
138489798|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138489799|NCT00015340|Narcotics|narcotics|mesh-ancestor
138489800|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246311|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324374|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
138674927|NCT04518735|Anticoagulants|anticoagulants|mesh-list
138489801|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489803|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
138489804|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138489805|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138489806|NCT00015652|Ribavirin|ribavirin|mesh-list
138166245|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
138489807|NCT00015652|Aldesleukin|aldesleukin|mesh-list
138246378|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
138246379|NCT01744574|Progesterone|progesterone|mesh-list
138246380|NCT01744574|Progestins|progestins|mesh-ancestor
138489808|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138489809|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
138489810|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489811|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
138489812|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489813|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489814|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138489815|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138246443|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
138246444|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138246446|NCT02044367|Dabigatran|dabigatran|mesh-list
138489816|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
138689407|NCT02902484|Nintedanib|nintedanib|mesh-list
138489817|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489818|NCT00015691|Metformin|metformin|mesh-list
138489819|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
138489820|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138489821|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489822|NCT00015769|Levetiracetam|levetiracetam|mesh-list
138489823|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
138246509|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
138246510|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138489824|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
138489825|NCT00015808|Idebenone|idebenone|mesh-list
138489826|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
138489827|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489828|NCT00015808|Protective Agents|protective agents|mesh-ancestor
138489829|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489830|NCT00015886|Docetaxel|docetaxel|mesh-list
138489831|NCT00015886|Fluorouracil|fluorouracil|mesh-list
138489832|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489833|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
138489834|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
138489835|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
138489836|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489837|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
138489838|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138489839|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138246577|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
138489840|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
138489841|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489842|NCT00006002|Dexamethasone|dexamethasone|mesh-list
138489843|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138489844|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
138489845|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
138489846|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138489847|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489848|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138489849|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
138489851|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489852|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138489853|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489854|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
138489855|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
138489856|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
138489857|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138489858|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138489859|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138489860|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489861|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489862|NCT00015925|Entinostat|entinostat|mesh-list
138489863|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489864|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138489865|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489866|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489867|NCT00006005|Thalidomide|thalidomide|mesh-list
138324377|NCT04121910|Itraconazole|itraconazole|mesh-list
138489869|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
138489870|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489871|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
138489872|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138489873|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489874|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138489875|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138489876|NCT00006005|Growth Substances|growth substances|mesh-ancestor
138489877|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
138489878|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489879|NCT00015964|Gefitinib|gefitinib|mesh-list
138246755|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
138489880|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489881|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138489882|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489883|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489885|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
138674982|NCT01311505|Rifampin|rifampin|mesh-list
138489886|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
138489887|NCT01630213|Vitamins|vitamins|mesh-list
138246824|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138489888|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
138489889|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489890|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138489891|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138489892|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
138489893|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489894|NCT00016042|Interferons|interferons|mesh-list
138489895|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
138246890|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
138246903|NCT01763606|Aspirin|aspirin|mesh-list
138489896|NCT00016042|Fluorouracil|fluorouracil|mesh-list
138489897|NCT00016042|Sargramostim|sargramostim|mesh-list
138489898|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
138462515|NCT04487990|Heparin|heparin|mesh-list
138489899|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489900|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138489901|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489902|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489903|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
138489904|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246955|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138246958|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
138489905|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
138489906|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489907|NCT00016081|Ribavirin|ribavirin|mesh-list
138489908|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
138489909|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489910|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
138489911|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138489912|NCT00016159|Idarubicin|idarubicin|mesh-list
138489913|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
138247019|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
138489914|NCT00016159|Tretinoin|tretinoin|mesh-list
138489915|NCT00016159|Lintuzumab|lintuzumab|mesh-list
138489916|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138489917|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489918|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138489919|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138489920|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489921|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489922|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
138489923|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
138489924|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138489926|NCT00016198|Fluorouracil|fluorouracil|mesh-list
138247083|NCT04873349|Oleuropein|oleuropein|mesh-list
138247084|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247085|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138489927|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
138489928|NCT00016198|Calcium|calcium|mesh-list
138489929|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
138489930|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138489931|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489932|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
138489933|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489934|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138247144|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247145|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
138247146|NCT01783574|Testosterone|testosterone|mesh-list
138247148|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
138489935|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489936|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489937|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
138489938|NCT00016198|Antidotes|antidotes|mesh-ancestor
138489939|NCT00016198|Protective Agents|protective agents|mesh-ancestor
138489940|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
138489941|NCT00016198|Vitamins|vitamins|mesh-ancestor
138489942|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
138489943|NCT00016276|Tamoxifen|tamoxifen|mesh-list
138489944|NCT00016276|Paclitaxel|paclitaxel|mesh-list
138489945|NCT00016276|Razoxane|razoxane|mesh-list
138489946|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
138489947|NCT00016276|Doxorubicin|doxorubicin|mesh-list
138489948|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138247206|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
138489949|NCT00016276|Trastuzumab|trastuzumab|mesh-list
138489950|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
138675142|NCT01240109|Remifentanil|remifentanil|mesh-list
138489951|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138489952|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489953|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
138489954|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
138489955|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
138247269|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247270|NCT04903652|Vinorelbine|vinorelbine|mesh-list
138247271|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138489956|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489957|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489958|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
138489959|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489960|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138489961|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138489962|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
138489963|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138247338|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247339|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247340|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138247341|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138247342|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247343|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138247344|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138247345|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138247346|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
138247347|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
138247348|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247356|NCT01878656|Sevoflurane|sevoflurane|mesh-list
138489964|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138489965|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138489966|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138489967|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489968|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138489969|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138489970|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
138247392|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138489971|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138489972|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138489973|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138489974|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138489975|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138489976|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138489977|NCT00016276|Protective Agents|protective agents|mesh-ancestor
138247462|NCT00357305|Cytarabine|cytarabine|mesh-list
138247463|NCT00357305|Etoposide|etoposide|mesh-list
138247464|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
138247465|NCT00357305|Vorinostat|vorinostat|mesh-list
138247466|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138247467|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247468|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138324403|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138324405|NCT04073784|Gemcitabine|gemcitabine|mesh-list
138489978|NCT00016315|Paclitaxel|paclitaxel|mesh-list
138489979|NCT00016315|Carboplatin|carboplatin|mesh-list
138489980|NCT00016315|Gemcitabine|gemcitabine|mesh-list
138489981|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138489982|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489983|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
138247523|NCT00357461|Ipilimumab|ipilimumab|mesh-list
138247524|NCT00357461|Vaccines|vaccines|mesh-list
138247525|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
138247526|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
138247533|NCT00357539|Azithromycin|azithromycin|mesh-list
138489984|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
138489985|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
138689451|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138489986|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489987|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138489989|NCT00006014|Semaxinib|semaxinib|mesh-list
138489991|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138489992|NCT00006014|Growth Substances|growth substances|mesh-ancestor
138247589|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138247590|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247591|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138247592|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138489993|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489994|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
138489995|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138489996|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138489997|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138489998|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138489999|NCT00016432|Exemestane|exemestane|mesh-list
138490000|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490001|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138247656|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138247657|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138247658|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
138247660|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247661|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138247662|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
138247663|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
138247664|NCT03522441|Clindamycin|clindamycin|mesh-list
138247665|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
138247666|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
138247667|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138247668|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247669|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138247670|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247671|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247673|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138247674|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247675|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138247676|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
138247677|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
138247678|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
138247679|NCT03351933|Antibodies|antibodies|mesh-list
138247680|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
138247681|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138490002|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138490003|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490004|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490005|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138490006|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
138490007|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138247699|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247700|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138247701|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138247702|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138247703|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138247704|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247705|NCT03597009|Nivolumab|nivolumab|mesh-list
138247706|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138247707|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138247708|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247710|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247712|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
138247713|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138247714|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138247726|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
138490008|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490009|NCT00389376|Silymarin|silymarin|mesh-list
138490010|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
138490011|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490012|NCT00389376|Protective Agents|protective agents|mesh-ancestor
138490013|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490014|NCT00016549|Bevacizumab|bevacizumab|mesh-list
138490015|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138490016|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138247753|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
138247754|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
138247755|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247756|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247757|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138247758|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138247759|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
138247760|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
138247761|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
138247763|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
138247764|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
138490017|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138490018|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138490019|NCT00016549|Growth Substances|growth substances|mesh-ancestor
138324427|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324428|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
138324429|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138324430|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138247810|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138247811|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247812|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247813|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138247815|NCT02310672|Macitentan|macitentan|mesh-list
138247816|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138247817|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138247818|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247820|NCT03626415|Abrocitinib|abrocitinib|mesh-list
138324431|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138490020|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490021|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
138490022|NCT00006023|Capecitabine|capecitabine|mesh-list
138490023|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138490024|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
138490025|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490026|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490027|NCT00016588|Tenofovir|tenofovir|mesh-list
138490028|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
138247869|NCT02338362|Fluticasone|fluticasone|mesh-list
138247871|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138247872|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138247873|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
138247874|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247875|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247876|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138247877|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
138247878|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
138247879|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138247881|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138490029|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490030|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138490031|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138490032|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490033|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490034|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138490035|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138490036|NCT00006026|Rubitecan|rubitecan|mesh-list
138490037|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490038|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138247928|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138247929|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138247934|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490039|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138490040|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490041|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490042|NCT00016666|Propranolol|propranolol|mesh-list
138490043|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138490044|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138490045|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
138490046|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138490047|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689476|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138490048|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490049|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138490050|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138490051|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
138490052|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138490054|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490055|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138490056|NCT00016744|Protective Agents|protective agents|mesh-ancestor
138490057|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490058|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138490059|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490060|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490061|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
138490062|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138490063|NCT00016744|Estrogens|estrogens|mesh-ancestor
138248140|NCT04392141|Colchicine|colchicine|mesh-list
138490064|NCT00016744|Hormones|hormones|mesh-ancestor
138490065|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138490066|NCT00016861|Irinotecan|irinotecan|mesh-list
138490067|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138675436|NCT05644210|Aspirin|aspirin|mesh-list
138490068|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138490069|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248208|NCT02305758|Growth Substances|growth substances|mesh-ancestor
138248209|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248210|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
138248211|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
138248213|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138490070|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490071|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490072|NCT00016900|Paclitaxel|paclitaxel|mesh-list
138324454|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138248271|NCT00558896|Pomalidomide|pomalidomide|mesh-list
138490073|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138490074|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490075|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
138490076|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
138248272|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138490077|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
138248273|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
138248274|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
138490078|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490079|NCT00016939|Alvocidib|alvocidib|mesh-list
138490080|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490081|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
138490082|NCT00016939|Growth Substances|growth substances|mesh-ancestor
138490083|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490084|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138490085|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490086|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490087|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
138490088|NCT00386672|Vitamin D|vitamin d|mesh-list
138248335|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138490089|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
138490090|NCT00386672|Cholecalciferol|cholecalciferol|mesh-list
138490091|NCT00386672|Vitamins|vitamins|mesh-list
138490092|NCT00386672|Calcium|calcium|mesh-list
138490093|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
138490094|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248407|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138490095|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138490096|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138490097|NCT00016978|Leucovorin|leucovorin|mesh-list
138490098|NCT00016978|Fluorouracil|fluorouracil|mesh-list
138490099|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
138248464|NCT03705273|BB 1101|bb 1101|mesh-list
138248465|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248466|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
138490100|NCT00016978|Calcium|calcium|mesh-list
138490101|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
138490102|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138490103|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490104|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
138490105|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490106|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138490107|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490108|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166544|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138490109|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
138490111|NCT00016978|Protective Agents|protective agents|mesh-ancestor
138490112|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
138490113|NCT00016978|Vitamins|vitamins|mesh-ancestor
138490114|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
138490115|NCT00017017|Paclitaxel|paclitaxel|mesh-list
138490116|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138490117|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138490118|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490119|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
138490120|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
138490121|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
138490122|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490123|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
138490124|NCT00017095|Docetaxel|docetaxel|mesh-list
138490125|NCT00017095|Fluorouracil|fluorouracil|mesh-list
138490127|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138490128|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
138490129|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490130|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138248592|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138248594|NCT04076787|Growth Substances|growth substances|mesh-ancestor
138490131|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138490132|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
138689522|NCT02585388|Letrozole|letrozole|mesh-list
138490133|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490134|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490135|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138490136|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
138490137|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
138490138|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
138248658|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490139|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
138490140|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138490141|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138490142|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138490143|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138490144|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490145|NCT00006029|Gemcitabine|gemcitabine|mesh-list
138248725|NCT00552578|Analgesics|analgesics|mesh-ancestor
138490146|NCT00006029|Doxorubicin|doxorubicin|mesh-list
138248726|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
138490147|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138248727|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490148|NCT00006029|Vinorelbine|vinorelbine|mesh-list
138490149|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138490150|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
138490151|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490152|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490153|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138490154|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138490155|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138490156|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490157|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138490158|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
138248861|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
138490159|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
138490160|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
138490161|NCT00371059|Memantine|memantine|mesh-list
138490162|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138490163|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138490164|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
138490165|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138490166|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490167|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490168|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138490169|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138490170|NCT00001482|Lamotrigine|lamotrigine|mesh-list
138490171|NCT00001482|Gabapentin|gabapentin|mesh-list
138490172|NCT00001482|Analgesics|analgesics|mesh-ancestor
138490173|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
138490174|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248864|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
138490175|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689553|NCT02579161|Ampicillin|ampicillin|mesh-list
138490176|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
138490177|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138490178|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138490179|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138490180|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138490181|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138248917|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
138248924|NCT03847389|Clobetasol|clobetasol|mesh-list
138490182|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138490183|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138490184|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490185|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
138490186|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138490187|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138490188|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138490189|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138248986|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
138249053|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138490190|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138490191|NCT00017134|Fenretinide|fenretinide|mesh-list
138490192|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490194|NCT00017134|Protective Agents|protective agents|mesh-ancestor
138490195|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490196|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
138490197|NCT04734418|Remifentanil|remifentanil|mesh-list
138490198|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138490199|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138490200|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490201|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138490202|NCT04734418|Analgesics|analgesics|mesh-ancestor
138490203|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
138490204|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490205|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138689596|NCT02431897|Estrogens|estrogens|mesh-list
138490207|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138490208|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
138490209|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138490210|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490211|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138490212|NCT04734418|Narcotics|narcotics|mesh-ancestor
138490213|NCT00006032|Etoposide|etoposide|mesh-list
138490214|NCT00006032|Topotecan|topotecan|mesh-list
138490215|NCT00006032|Ifosfamide|ifosfamide|mesh-list
138490216|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138249123|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249127|NCT02971839|Ivacaftor|ivacaftor|mesh-list
138490217|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490218|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138490219|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138490220|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490221|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490222|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138490223|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138490224|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
138490225|NCT00017173|Cisplatin|cisplatin|mesh-list
138490226|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490227|NCT00001509|Tretinoin|tretinoin|mesh-list
138490228|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490229|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
138490230|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
138490231|NCT00006035|Bleomycin|bleomycin|mesh-list
138490232|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138490233|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490234|NCT00017212|Exatecan|exatecan|mesh-list
138249249|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138249250|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
138249253|NCT02717949|Ribavirin|ribavirin|mesh-list
138490235|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138490236|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138689631|NCT02386735|Prednisone|prednisone|mesh-list
138490237|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490238|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490239|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490240|NCT00017251|Carboplatin|carboplatin|mesh-list
138490241|NCT00017251|Etoposide|etoposide|mesh-list
138249316|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490242|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
138490243|NCT00017251|Oblimersen|oblimersen|mesh-list
138490244|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490245|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138490246|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138490247|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138490248|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490249|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324506|NCT05602428|Antidepressive Agents|antidepressive agents|mesh-ancestor
138490250|NCT00006038|Leucovorin|leucovorin|mesh-list
138490251|NCT00006038|Docetaxel|docetaxel|mesh-list
138490252|NCT00006038|Fluorouracil|fluorouracil|mesh-list
138490253|NCT00006038|Floxuridine|floxuridine|mesh-list
138490254|NCT00006038|Calcium|calcium|mesh-list
138490255|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
138490256|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490257|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
138490258|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
138490259|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
138675766|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490260|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490261|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138490262|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490263|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
138490264|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138490265|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138490266|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
138490267|NCT00006038|Antidotes|antidotes|mesh-ancestor
138490268|NCT00006038|Protective Agents|protective agents|mesh-ancestor
138490269|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
138490270|NCT00006038|Vitamins|vitamins|mesh-ancestor
138490271|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
138490272|NCT00017290|Prednisone|prednisone|mesh-list
138490273|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
138490274|NCT00017290|Vincristine|vincristine|mesh-list
138490275|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
138490276|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138490277|NCT00017290|Antibodies|antibodies|mesh-list
138490278|NCT00017290|Sargramostim|sargramostim|mesh-list
138490279|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138490280|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138490281|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138490283|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249460|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490284|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138490285|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138490286|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
138490287|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249512|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138249513|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138490288|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490289|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138490290|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138490291|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
138490292|NCT00017290|Hormones|hormones|mesh-ancestor
138490293|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138490294|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138675823|NCT04514796|Adalimumab|adalimumab|mesh-list
138490295|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138490296|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
138490297|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
138490298|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
138249575|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
138490299|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138490300|NCT00017329|Bortezomib|bortezomib|mesh-list
138249645|NCT02413047|Azathioprine|azathioprine|mesh-list
138490301|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490302|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
138490303|NCT00017368|Melphalan|melphalan|mesh-list
138490304|NCT00017368|Ifosfamide|ifosfamide|mesh-list
138490305|NCT00017368|Thiotepa|thiotepa|mesh-list
138490307|NCT00017368|Doxorubicin|doxorubicin|mesh-list
138490308|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138490309|NCT00017368|Etoposide|etoposide|mesh-list
138490310|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
138490311|NCT00017368|Vincristine|vincristine|mesh-list
138490312|NCT00017368|Isotretinoin|isotretinoin|mesh-list
138490313|NCT00017368|Sargramostim|sargramostim|mesh-list
138249712|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138490314|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138490315|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
138490316|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490317|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138490318|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138249713|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490319|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
138490320|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490321|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490322|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138490323|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138675871|NCT00484601|Ifosfamide|ifosfamide|mesh-list
138249779|NCT01902758|Ambrisentan|ambrisentan|mesh-list
138490324|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138490325|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138490326|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249780|NCT01902758|Theophylline|theophylline|mesh-list
138249781|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138249796|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
138490327|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138490328|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
138490329|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
138490330|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
138490331|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
138490333|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138490334|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
138490335|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249859|NCT02266797|Hormones|hormones|mesh-ancestor
138490336|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
138490337|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138490338|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490339|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138166769|NCT04193852|Dienogest|dienogest|mesh-list
138490340|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138490341|NCT00001524|Growth Substances|growth substances|mesh-ancestor
138490342|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
138249926|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490343|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490344|NCT00006041|Vaccines|vaccines|mesh-list
138490345|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
138490346|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
138490347|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490348|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138490349|NCT00017602|Dexamethasone|dexamethasone|mesh-list
138490350|NCT00017602|Oblimersen|oblimersen|mesh-list
138490351|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138490352|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
138249996|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138249997|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
138249999|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
138490353|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
138675973|NCT00484991|Verapamil|verapamil|mesh-list
138490354|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490355|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490356|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138490357|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
138490358|NCT00017602|Hormones|hormones|mesh-ancestor
138324543|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138490359|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138490360|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138490361|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250060|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250062|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138490362|NCT00001533|Cyclosporine|cyclosporine|mesh-list
138490363|NCT00001533|Cyclosporins|cyclosporins|mesh-list
138490364|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490365|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490366|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138490367|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
138490368|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250122|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490369|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
138490370|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490371|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
138490372|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138490373|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138490374|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
138490375|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138490376|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138490377|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
138490378|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490379|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138490380|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138490381|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
138250193|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250194|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138250195|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
138250198|NCT01691079|Ipratropium|ipratropium|mesh-list
138490382|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490383|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250256|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490384|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138490385|NCT00017680|Melphalan|melphalan|mesh-list
138676035|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138490386|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138490387|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
138250257|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138250260|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
138490388|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490389|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490390|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138490391|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138490392|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
138490393|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490395|NCT00017719|Zidovudine|zidovudine|mesh-list
138490396|NCT00017719|Nevirapine|nevirapine|mesh-list
138250324|NCT01533753|Analgesics|analgesics|mesh-ancestor
138250325|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
138250326|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490397|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138490398|NCT00017719|Nelfinavir|nelfinavir|mesh-list
138490399|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138490400|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138490401|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138676077|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490402|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490403|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
138490404|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490405|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138490406|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138490407|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
138490408|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138490409|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138490410|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138490411|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138490412|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
138490413|NCT00001542|Fluconazole|fluconazole|mesh-list
138490414|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
138490415|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490416|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138490417|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138490418|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490419|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250459|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138490420|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138490421|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
138490422|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138324569|NCT04125888|Immunomodulating Agents|immunomodulating agents|mesh-list
138490423|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490424|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138490425|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138490426|NCT00017758|Efavirenz|efavirenz|mesh-list
138490427|NCT00017758|Nelfinavir|nelfinavir|mesh-list
138490428|NCT00017758|Atorvastatin|atorvastatin|mesh-list
138490429|NCT00017758|Simvastatin|simvastatin|mesh-list
138490430|NCT00017758|Pravastatin|pravastatin|mesh-list
138490431|NCT00017758|Calcium|calcium|mesh-list
138490432|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138490433|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250519|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
138250520|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250533|NCT03004105|Durvalumab|durvalumab|mesh-list
138490434|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138490435|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138490436|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
138490437|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490438|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138490439|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138250579|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138490440|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250583|NCT05719961|Insulin|insulin|mesh-list
138490441|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138490442|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138490443|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
138490444|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490445|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138490446|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138490447|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138490448|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138490449|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138490450|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138490451|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138490452|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138490453|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
138490454|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138490455|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138490456|NCT00017992|Ritonavir|ritonavir|mesh-list
138250649|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138490457|NCT00017992|Lopinavir|lopinavir|mesh-list
138490458|NCT00017992|Emtricitabine|emtricitabine|mesh-list
138490459|NCT00017992|Stavudine|stavudine|mesh-list
138169948|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
138490460|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138490461|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138490462|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
138490463|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138250711|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138250712|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138250713|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250718|NCT00000195|Naltrexone|naltrexone|mesh-list
138490464|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138676216|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
138490465|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138490466|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138490467|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
138490468|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490469|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138490470|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138490471|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138490472|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138490473|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
138490474|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138490475|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490476|NCT04734067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138490477|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490479|NCT00018148|Nicotine|nicotine|mesh-list
138490480|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138490481|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
138324576|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
138490482|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490483|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490484|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138490485|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138490486|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
138490487|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138490488|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490489|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138490490|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
138490491|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138250920|NCT02322216|Analgesics|analgesics|mesh-ancestor
138490492|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138490493|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138490494|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138490495|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
138490496|NCT00001563|Rituximab|rituximab|mesh-list
138490497|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138490498|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490499|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
138490500|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490501|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138490502|NCT00018187|Mecamylamine|mecamylamine|mesh-list
138490503|NCT00018187|Bupropion|bupropion|mesh-list
138490504|NCT00018187|Nicotine|nicotine|mesh-list
138490505|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138490506|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
138490507|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490508|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490509|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138490510|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138490511|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
138490512|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324592|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
138324602|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
138250983|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138250984|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138490513|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689974|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138490514|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138490515|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
138490516|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138490517|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138490518|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138490519|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138490520|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
138490521|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138676262|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138490522|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138490523|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490524|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138490525|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138490526|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138490527|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138490528|NCT00018343|Estrogens|estrogens|mesh-list
138490529|NCT00018343|Hormones|hormones|mesh-ancestor
138490530|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138490531|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490532|NCT00001566|Indinavir|indinavir|mesh-list
138490533|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138490534|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138490535|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
138490536|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490537|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490538|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138490539|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138490540|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
138490541|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490542|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
138490543|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138251184|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
138251185|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138490544|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490545|NCT00018460|Vitamins|vitamins|mesh-list
138490546|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
138490547|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
138490548|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490550|NCT00386750|Artemether|artemether|mesh-list
138490551|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138490552|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
138490553|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138490554|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138490555|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490556|NCT00001575|Edetic Acid|edetic acid|mesh-list
138490557|NCT00001575|Calcium|calcium|mesh-list
138251239|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138490558|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
138251307|NCT00000885|Adefovir|adefovir|mesh-list
138251308|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138490559|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138490560|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490561|NCT00001575|Antidotes|antidotes|mesh-ancestor
138490562|NCT00001575|Protective Agents|protective agents|mesh-ancestor
138490563|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
138490564|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
138676341|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
138490565|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490567|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
138490568|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138490569|NCT00001596|Pirfenidone|pirfenidone|mesh-list
138490570|NCT00001596|Analgesics|analgesics|mesh-ancestor
138490571|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
138490572|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490573|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490574|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138490575|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138490578|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490579|NCT00391885|Anesthetics|anesthetics|mesh-list
138490580|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138490581|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490582|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138490583|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138490584|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
138490585|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490586|NCT00392002|Esomeprazole|esomeprazole|mesh-list
138490587|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138490588|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138490589|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138490590|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490591|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490592|NCT00392080|Naproxen|naproxen|mesh-list
138490593|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138490594|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138490595|NCT00392080|Analgesics|analgesics|mesh-ancestor
138490596|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
138490597|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490598|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490599|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138490600|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138490601|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
138490602|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138490603|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490604|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490605|NCT00001644|Lamivudine|lamivudine|mesh-list
138490606|NCT00001644|Zidovudine|zidovudine|mesh-list
138490607|NCT00001644|Nevirapine|nevirapine|mesh-list
138490608|NCT00001644|Indinavir|indinavir|mesh-list
138490609|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138490610|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138490611|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490612|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490613|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
138490614|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490615|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138490616|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138490617|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
138490618|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138490619|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138490620|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138490621|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138490622|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
138490623|NCT05573386|Lenograstim|lenograstim|mesh-list
138251327|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138251328|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
138490624|NCT05573386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138490625|NCT05573386|Immunologic Factors|immunologic factors|mesh-ancestor
138490626|NCT05573386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490627|NCT00001656|Olanzapine|olanzapine|mesh-list
138490628|NCT00001656|Clozapine|clozapine|mesh-list
138490629|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
138490630|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
138676442|NCT00485979|Trastuzumab|trastuzumab|mesh-list
138490631|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490632|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490633|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138251394|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138251396|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138490634|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138490635|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138490636|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138490637|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138490638|NCT00001656|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138167070|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138690014|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490639|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138490640|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138251474|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
138490641|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490642|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138490643|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
138490644|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138490645|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
138490648|NCT05573191|Anesthetics, Local|anesthetics, local|mesh-ancestor
138490649|NCT05573191|Anesthetics|anesthetics|mesh-ancestor
138490650|NCT05573191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138251539|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138490651|NCT05573191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490652|NCT05573191|Sensory System Agents|sensory system agents|mesh-ancestor
138490653|NCT05573191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490654|NCT05573191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138490655|NCT05573191|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138490656|NCT05573191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138490657|NCT05573191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138251610|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490658|NCT05573191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490659|NCT05679830|Cannabidiol|cannabidiol|mesh-list
138490660|NCT05679830|Anticonvulsants|anticonvulsants|mesh-ancestor
138490661|NCT05572996|Treprostinil|treprostinil|mesh-list
138490662|NCT05572996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138490663|NCT05572723|Dexmedetomidine|dexmedetomidine|mesh-list
138490664|NCT05572723|Remifentanil|remifentanil|mesh-list
138490665|NCT05572723|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138490666|NCT05572723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138490667|NCT05572723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490668|NCT05572723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138490669|NCT05572723|Analgesics|analgesics|mesh-ancestor
138251679|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490670|NCT05572723|Sensory System Agents|sensory system agents|mesh-ancestor
138490671|NCT05572723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490672|NCT05572723|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138490673|NCT05572723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138490674|NCT05572723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138490675|NCT05572723|Adrenergic Agents|adrenergic agents|mesh-ancestor
138490676|NCT05572723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138490677|NCT05572723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251746|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138251747|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138490678|NCT05572723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138490679|NCT05572723|Narcotics|narcotics|mesh-ancestor
138490680|NCT05563753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138490681|NCT05563753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490682|NCT00389415|Vildagliptin|vildagliptin|mesh-list
138490683|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138490684|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490685|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138251814|NCT05270057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490686|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
138490687|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490688|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490690|NCT05419921|Anesthetics, Local|anesthetics, local|mesh-ancestor
138490692|NCT05419921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138490693|NCT05419921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490694|NCT05419921|Sensory System Agents|sensory system agents|mesh-ancestor
138490695|NCT05419921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490696|NCT05419921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138251881|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138490697|NCT05419921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138490698|NCT05419921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138490699|NCT05419921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138490700|NCT05419921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490701|NCT00386828|Bevacizumab|bevacizumab|mesh-list
138490702|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138490703|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490704|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138251949|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138490705|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138490706|NCT00386828|Growth Substances|growth substances|mesh-ancestor
138490707|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490709|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
138490710|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
138490711|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
138490712|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138490713|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138490714|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138490715|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490716|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490717|NCT05311618|Pembrolizumab|pembrolizumab|mesh-list
138490718|NCT05311618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138490719|NCT05311618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490720|NCT05311618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138490721|NCT05311618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490722|NCT00001728|Alendronate|alendronate|mesh-list
138490723|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138252018|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490724|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490725|NCT00001731|Cyclosporine|cyclosporine|mesh-list
138490726|NCT00001731|Cyclosporins|cyclosporins|mesh-list
138252074|NCT00001449|Leucovorin|leucovorin|mesh-list
138490727|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490728|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490729|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138490730|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
138490731|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252075|NCT00001449|Gemcitabine|gemcitabine|mesh-list
138252076|NCT00001449|Floxuridine|floxuridine|mesh-list
138252077|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138490732|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
138490733|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490734|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
138490735|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138490736|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138490737|NCT00392158|Anesthetics|anesthetics|mesh-list
138490738|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138490739|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490740|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
138490741|NCT00392275|Levofloxacin|levofloxacin|mesh-list
138490742|NCT00392275|Ofloxacin|ofloxacin|mesh-list
138490743|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138490744|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490745|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138490746|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138490747|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490748|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490749|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490750|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138490751|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138490752|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138490753|NCT00001749|Cyclosporine|cyclosporine|mesh-list
138490754|NCT00001749|Cyclosporins|cyclosporins|mesh-list
138490755|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138490756|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490757|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490758|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138324665|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252201|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252202|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138490759|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
138490760|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490761|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
138490763|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
138490764|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138490765|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138490767|NCT00001752|Hormones|hormones|mesh-ancestor
138490768|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138676661|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138252266|NCT00002313|Ionophores|ionophores|mesh-ancestor
138676662|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
138490769|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490771|NCT00001758|Abacavir|abacavir|mesh-list
138490772|NCT00001758|Amprenavir|amprenavir|mesh-list
138490773|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138490774|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138490775|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490776|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490777|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
138490778|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490779|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138490780|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138490781|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138490782|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138490783|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138490784|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138252331|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138252335|NCT00002169|Nelfinavir|nelfinavir|mesh-list
138167219|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
138490786|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138490787|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138490788|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
138490789|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138490790|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138490791|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138490792|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
138490793|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
138490794|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138490795|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490796|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138490797|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
138490798|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138490799|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490800|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490801|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490802|NCT04971343|Antibodies|antibodies|mesh-list
138490803|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
138490804|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
138690077|NCT03458078|Analgesics|analgesics|mesh-ancestor
138490805|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490806|NCT05620628|Durvalumab|durvalumab|mesh-list
138490807|NCT05620628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138490808|NCT05620628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490809|NCT04905121|Psilocybin|psilocybin|mesh-list
138252392|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138252397|NCT00002361|Ritonavir|ritonavir|mesh-list
138490810|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
138490811|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490812|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138490813|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
138490814|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490815|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
138490816|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490817|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490818|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138490819|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
138252444|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138490820|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
138490821|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490823|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490824|NCT00000102|Nifedipine|nifedipine|mesh-list
138252512|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138490825|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138490826|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138490827|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490828|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138490829|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490830|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
138490831|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
138490832|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138490833|NCT05641506|Niraparib|niraparib|mesh-list
138490834|NCT05641506|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138490835|NCT05641506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252515|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
138490836|NCT05641506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490837|NCT05641506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490838|NCT00386867|Misoprostol|misoprostol|mesh-list
138490839|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138490840|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
138490841|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138490842|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490843|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138490844|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138490845|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
138490846|NCT04526119|Z 338|z 338|mesh-list
138490847|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138490848|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490849|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490850|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
138490851|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138490852|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490853|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138490854|NCT00392431|Amiodarone|amiodarone|mesh-list
138490855|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138252572|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138490856|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
138252573|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252574|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490857|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138490858|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138490859|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490860|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138490861|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138490862|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138490863|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490864|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138490865|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138490866|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138490869|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138490870|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138490871|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490872|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490873|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252625|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252631|NCT00002223|Indinavir|indinavir|mesh-list
138490874|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138490875|NCT03960151|Dexamethasone|dexamethasone|mesh-list
138490876|NCT03960151|Olanzapine|olanzapine|mesh-list
138490877|NCT03960151|Palonosetron|palonosetron|mesh-list
138490878|NCT03960151|Rolapitant|rolapitant|mesh-list
138490879|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138490880|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
138490881|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
138490882|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324695|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138490883|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490884|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138490885|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
138676914|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138490886|NCT03960151|Hormones|hormones|mesh-ancestor
138490887|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138490888|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138490889|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490890|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138490891|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138490892|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138490893|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138490894|NCT03960151|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138490895|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138490896|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138490897|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490898|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138490899|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
138490900|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138490901|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138490902|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138252747|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490903|NCT04733326|Ketorolac|ketorolac|mesh-list
138490904|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138490905|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138490906|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138490907|NCT04733326|Analgesics|analgesics|mesh-ancestor
138490908|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
138490909|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490910|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490911|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138490912|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138490913|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138490915|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490917|NCT00386984|Somatostatin|somatostatin|mesh-list
138490918|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138252809|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138252822|NCT04862585|Hormones|hormones|mesh-ancestor
138324710|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374442|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138374443|NCT01427491|Laxatives|laxatives|mesh-ancestor
138324725|NCT04392648|Bortezomib|bortezomib|mesh-list
138490919|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138490920|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490921|NCT00386984|Hormones|hormones|mesh-ancestor
138490922|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138490923|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490924|NCT03959761|Nivolumab|nivolumab|mesh-list
138490925|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138490926|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374444|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138374445|NCT01427582|Trabectedin|trabectedin|mesh-list
138490927|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138490928|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490929|NCT00387179|Melatonin|melatonin|mesh-list
138490930|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
138167370|NCT00567229|Rituximab|rituximab|mesh-list
138490931|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490932|NCT00387179|Protective Agents|protective agents|mesh-ancestor
138490933|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490934|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138374509|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138490936|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
138490937|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138490938|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138490939|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490940|NCT04733521|Cisplatin|cisplatin|mesh-list
138490941|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490942|NCT05640726|Leucovorin|leucovorin|mesh-list
138490943|NCT05640726|Bevacizumab|bevacizumab|mesh-list
138490944|NCT05640726|Fluorouracil|fluorouracil|mesh-list
138490945|NCT05640726|Oxaliplatin|oxaliplatin|mesh-list
138490946|NCT05640726|Calcium|calcium|mesh-list
138490947|NCT05640726|Levoleucovorin|levoleucovorin|mesh-list
138677011|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374574|NCT01428414|Paclitaxel|paclitaxel|mesh-list
138374577|NCT01428414|Epirubicin|epirubicin|mesh-list
138490948|NCT05640726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138490949|NCT05640726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138490950|NCT05640726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138490951|NCT05640726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138490952|NCT05640726|Growth Substances|growth substances|mesh-ancestor
138490953|NCT05640726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490954|NCT05640726|Growth Inhibitors|growth inhibitors|mesh-ancestor
138490955|NCT05640726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138490956|NCT05640726|Antimetabolites|antimetabolites|mesh-ancestor
138490957|NCT05640726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374639|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138374646|NCT01428622|Olodaterol|olodaterol|mesh-list
138490958|NCT05640726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138490959|NCT05640726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138490960|NCT05640726|Immunologic Factors|immunologic factors|mesh-ancestor
138490961|NCT05640726|Antidotes|antidotes|mesh-ancestor
138490962|NCT05640726|Protective Agents|protective agents|mesh-ancestor
138490964|NCT05640726|Vitamins|vitamins|mesh-ancestor
138490965|NCT05640726|Micronutrients|micronutrients|mesh-ancestor
138490966|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138490967|NCT03959176|Phenylephrine|phenylephrine|mesh-list
138490968|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
138374706|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374707|NCT01429181|Analgesics|analgesics|mesh-ancestor
138374708|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
138490969|NCT03959176|Tropicamide|tropicamide|mesh-list
138490970|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138490971|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
138490972|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
138490973|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138490974|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490975|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
138490976|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138490977|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
138490978|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
138490979|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138374771|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
138490980|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138490981|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138490982|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
138490983|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138490984|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138490985|NCT03959176|Protective Agents|protective agents|mesh-ancestor
138324747|NCT04392648|Growth Substances|growth substances|mesh-ancestor
138490986|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138490987|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138374836|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138490988|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138490989|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138490990|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
138490991|NCT03958981|Castor Oil|castor oil|mesh-list
138490992|NCT03958981|Cathartics|cathartics|mesh-ancestor
138490993|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138374901|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
138490994|NCT03958942|Bupivacaine|bupivacaine|mesh-list
138490995|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
138490996|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
138490997|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138490998|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138490999|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
138491000|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491001|NCT03958708|Rifaximin|rifaximin|mesh-list
138491002|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138491003|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138491004|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138491005|NCT05640609|Bevacizumab|bevacizumab|mesh-list
138491006|NCT05640609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138491007|NCT05640609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491009|NCT05640609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138491010|NCT05640609|Growth Substances|growth substances|mesh-ancestor
138374902|NCT01430195|Afamelanotide|afamelanotide|mesh-list
138374903|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
138491011|NCT05640609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491012|NCT05640609|Growth Inhibitors|growth inhibitors|mesh-ancestor
138491013|NCT05411861|Analgesics|analgesics|mesh-list
138491014|NCT05411861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
138491015|NCT05411861|Sensory System Agents|sensory system agents|mesh-ancestor
138491016|NCT05411861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491017|NCT05411861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491018|NCT03958513|Bupivacaine|bupivacaine|mesh-list
138491019|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
138491020|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
138374959|NCT01431053|Aspirin|aspirin|mesh-list
138374960|NCT01431053|Exemestane|exemestane|mesh-list
138374961|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138374982|NCT01431092|Melatonin|melatonin|mesh-list
138491021|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138491022|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491023|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
138491024|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491025|NCT03958396|Remifentanil|remifentanil|mesh-list
138491026|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138491027|NCT03958396|Narcotics|narcotics|mesh-ancestor
138491028|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138491029|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491030|NCT03958396|Analgesics|analgesics|mesh-ancestor
138491031|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
138491032|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491033|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
138491034|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138491035|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138375023|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375024|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138375025|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138491036|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138491037|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138491038|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138491039|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491040|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491041|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491042|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138491043|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
138491044|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138491045|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491046|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138491047|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138491048|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138491049|NCT03933865|Ketamine|ketamine|mesh-list
138491050|NCT03933865|Hydromorphone|hydromorphone|mesh-list
138677209|NCT00492479|Kinetin|kinetin|mesh-list
138491051|NCT03933865|Analgesics|analgesics|mesh-ancestor
138491052|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
138491053|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375083|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
138375084|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375085|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138324756|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491054|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491055|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138491056|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138491057|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
138491058|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
138491059|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138491060|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138491061|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138491062|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138375139|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138375141|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138375150|NCT01432080|Prednisone|prednisone|mesh-list
138690166|NCT04817033|Midazolam|midazolam|mesh-list
138491063|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491064|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138491065|NCT03933865|Narcotics|narcotics|mesh-ancestor
138491066|NCT05206175|Methamphetamine|methamphetamine|mesh-list
138491067|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138491068|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491069|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
138491070|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
138375204|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375205|NCT01432249|Etanercept|etanercept|mesh-list
138491071|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491072|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
138491073|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491074|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491075|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
138491076|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138491077|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138375268|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375269|NCT01432665|Urological Agents|urological agents|mesh-ancestor
138375270|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
138491078|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138491079|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138491081|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138491082|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
138491083|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491084|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491085|NCT05638893|Metformin|metformin|mesh-list
138491086|NCT05638893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138677311|NCT00492830|Antibodies|antibodies|mesh-list
138491087|NCT05638893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491088|NCT00392938|Docetaxel|docetaxel|mesh-list
138491089|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
138491090|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491091|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
138491092|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
138491093|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
138491094|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491095|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
138491096|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138491097|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491098|NCT03432091|Melatonin|melatonin|mesh-list
138491099|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
138491100|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491101|NCT03432091|Protective Agents|protective agents|mesh-ancestor
138491102|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491103|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138491104|NCT05634564|Paclitaxel|paclitaxel|mesh-list
138491105|NCT05634564|Gemcitabine|gemcitabine|mesh-list
138491106|NCT05634564|Tislelizumab|tislelizumab|mesh-list
138491107|NCT05634564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138491108|NCT05634564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375475|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138375476|NCT01434147|Growth Substances|growth substances|mesh-ancestor
138375477|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491109|NCT05634564|Tubulin Modulators|tubulin modulators|mesh-ancestor
138491110|NCT05634564|Antimitotic Agents|antimitotic agents|mesh-ancestor
138491111|NCT05634564|Mitosis Modulators|mitosis modulators|mesh-ancestor
138690199|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138677358|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
138491112|NCT05634564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491113|NCT05634564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138375538|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138491114|NCT05634564|Antimetabolites|antimetabolites|mesh-ancestor
138491115|NCT05634564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138491117|NCT03152149|Xhance|xhance|mesh-list
138491118|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
138491119|NCT03152149|Olodaterol|olodaterol|mesh-list
138375607|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138491120|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138491121|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138491122|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
138491123|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491124|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491125|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138491126|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
138491127|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
138491128|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138491129|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
138491130|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138491131|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
138491132|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491133|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491134|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138491135|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138491136|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138491137|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375670|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375672|NCT01435343|Cytarabine|cytarabine|mesh-list
138491138|NCT05633472|Vitamin D|vitamin d|mesh-list
138491139|NCT05633472|Vitamins|vitamins|mesh-ancestor
138491140|NCT05633472|Micronutrients|micronutrients|mesh-ancestor
138491141|NCT05633472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491142|NCT05633472|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138491143|NCT03151876|Gemcitabine|gemcitabine|mesh-list
138491144|NCT03151876|Busulfan|busulfan|mesh-list
138491145|NCT03151876|Cladribine|cladribine|mesh-list
138491146|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138491147|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
138491148|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375738|NCT01435837|Caffeine|caffeine|mesh-list
138491149|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491150|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
138491151|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138491152|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
138491153|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491154|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138491155|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138491156|NCT03151720|Loratadine|loratadine|mesh-list
138491157|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
138491158|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
138491159|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138491160|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138491161|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138324775|NCT02952222|Analgesics|analgesics|mesh-ancestor
138375806|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375808|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138491162|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
138491163|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
138491164|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491165|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491166|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491168|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138491169|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375867|NCT01436838|Interferons|interferons|mesh-list
138375868|NCT01436838|Interferon-beta|interferon-beta|mesh-list
138375869|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
138375870|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375871|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
138375872|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375873|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
138375874|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375875|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138375876|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
138375877|NCT01436916|Vitamin D|vitamin d|mesh-list
138375878|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138375880|NCT01436916|Vitamins|vitamins|mesh-ancestor
138491170|NCT03151525|Infliximab|infliximab|mesh-list
138491171|NCT03151525|Azathioprine|azathioprine|mesh-list
138491172|NCT03151525|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138491173|NCT03151525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138491174|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
138491175|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138491176|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138491177|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
138491178|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491179|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138491180|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491181|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138375937|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491182|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
138491183|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491184|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
138491185|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
138491186|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138491187|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138491188|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
138491189|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491190|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491191|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491192|NCT00387374|Paclitaxel|paclitaxel|mesh-list
138491193|NCT00387374|Bevacizumab|bevacizumab|mesh-list
138491194|NCT00387374|Carboplatin|carboplatin|mesh-list
138491195|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138491196|NCT00387374|Antibodies|antibodies|mesh-list
138491197|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
138491198|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138376001|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
138376002|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
138376003|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138376006|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
138491199|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138491200|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491201|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
138491202|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
138491203|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
138491204|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491205|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138491206|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138491207|NCT00387374|Growth Substances|growth substances|mesh-ancestor
138376059|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
138376060|NCT01437839|Apixaban|apixaban|mesh-list
138376061|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138491208|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491209|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
138376127|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376128|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376129|NCT01438320|Quercetin|quercetin|mesh-list
138491210|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
138491211|NCT03151369|Morphine|morphine|mesh-list
138491212|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-list
138491213|NCT03151369|Analgesics|analgesics|mesh-list
138491214|NCT03151369|Narcotics|narcotics|mesh-ancestor
138491215|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138491216|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491217|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
138491218|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491219|NCT04712266|Insulin|insulin|mesh-list
138491220|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138491221|NCT04712266|Glucagon|glucagon|mesh-list
138491222|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376130|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
138491223|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491224|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138491225|NCT04712266|Hormones|hormones|mesh-ancestor
138491226|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138491227|NCT03151213|Pregabalin|pregabalin|mesh-list
138491228|NCT03151213|Analgesics|analgesics|mesh-ancestor
138491229|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
138491230|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491231|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491233|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138491234|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138491235|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690242|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138491236|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138491237|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138376256|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138376257|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138376258|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138376259|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138491238|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138491239|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138491240|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138491241|NCT03151174|Vitamin D|vitamin d|mesh-list
138491242|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
138491243|NCT03151174|Cholecalciferol|cholecalciferol|mesh-list
138491244|NCT03151174|Vitamins|vitamins|mesh-list
138491245|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
138491246|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491247|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138491248|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138491249|NCT03151096|Riboflavin|riboflavin|mesh-list
138491250|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
138491251|NCT03151096|Vitamins|vitamins|mesh-ancestor
138376324|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138376325|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
138376326|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138491252|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
138491253|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491254|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138491255|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
138491256|NCT03906539|Atorvastatin|atorvastatin|mesh-list
138491257|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138491258|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138491259|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
138376388|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376389|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138491260|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491261|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138324827|NCT03829332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138491262|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138491263|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491264|NCT00389688|Pemetrexed|pemetrexed|mesh-list
138491265|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491266|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376459|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
138376461|NCT02436733|Pemetrexed|pemetrexed|mesh-list
138491267|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491268|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138491269|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138491270|NCT05605665|Sirolimus|sirolimus|mesh-list
138491271|NCT05605665|Aldesleukin|aldesleukin|mesh-list
138491272|NCT05605665|Interleukin-2|interleukin-2|mesh-list
138491273|NCT05605665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138491274|NCT05605665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138491275|NCT05605665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138491276|NCT05605665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376527|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138491277|NCT05605665|Antifungal Agents|antifungal agents|mesh-ancestor
138491278|NCT05605665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138491279|NCT05605665|Immunologic Factors|immunologic factors|mesh-ancestor
138491280|NCT05605665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491281|NCT05605665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138491283|NCT05605665|Sensory System Agents|sensory system agents|mesh-ancestor
138491284|NCT05605665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491285|NCT05605665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138491286|NCT05605665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138491287|NCT05605665|Antiviral Agents|antiviral agents|mesh-ancestor
138491288|NCT03150706|Avelumab|avelumab|mesh-list
138491289|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138376593|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
138376594|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
138376612|NCT01438554|Trametinib|trametinib|mesh-list
138491290|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491291|NCT03150667|Clopidogrel|clopidogrel|mesh-list
138491292|NCT03150667|Ticagrelor|ticagrelor|mesh-list
138491293|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138491294|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138491295|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138491296|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138491297|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
138491298|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491299|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491300|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491301|NCT03150316|Dexamethasone|dexamethasone|mesh-list
138491302|NCT03150316|Lenalidomide|lenalidomide|mesh-list
138491303|NCT03150316|CKD-581|ckd-581|mesh-list
138491304|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138491305|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
138491306|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
138491307|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376662|NCT01438736|Hormones|hormones|mesh-ancestor
138491308|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324851|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
138491309|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138376719|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
138491310|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
138491311|NCT03150316|Hormones|hormones|mesh-ancestor
138491312|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138491313|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138491314|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138376720|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
138376721|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
138376722|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376730|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
138491315|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677746|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138491316|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491317|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
138491318|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138491319|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138491320|NCT03150316|Growth Substances|growth substances|mesh-ancestor
138491321|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
138491322|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138491323|NCT02972125|Lacosamide|lacosamide|mesh-list
138491324|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
138491325|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138376782|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138376784|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491326|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138491327|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138491328|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491329|NCT05597553|Pemetrexed|pemetrexed|mesh-list
138491330|NCT05597553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491331|NCT05597553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491332|NCT05597553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491333|NCT05597553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138491334|NCT05597553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138491336|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138491337|NCT03086044|Velpatasvir|velpatasvir|mesh-list
138491338|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
138491339|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138491340|NCT02866006|Topotecan|topotecan|mesh-list
138491341|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138491342|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138491343|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138677856|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138491344|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491345|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491346|NCT02633098|Artesunate|artesunate|mesh-list
138491347|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
138491348|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138491349|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138491350|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138491351|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491352|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
138491353|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
138491354|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138491355|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
138491356|NCT00393289|Calcium|calcium|mesh-list
138491357|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138491358|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491359|NCT02285179|Tamoxifen|tamoxifen|mesh-list
138491360|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138491361|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
138376845|NCT01440335|Fenoterol|fenoterol|mesh-list
138376846|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138376847|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
138491362|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138491363|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491364|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138491365|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491366|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138324880|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138324881|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138324882|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138324883|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138324884|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491367|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138491368|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138491370|NCT02122081|Methotrexate|methotrexate|mesh-list
138491371|NCT02122081|Tacrolimus|tacrolimus|mesh-list
138491372|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
138491373|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138491374|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
138491375|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138491376|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
138491377|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491378|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138491379|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138491380|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
138491381|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491382|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491383|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138491384|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138491385|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
138491386|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138491387|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138491388|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
138491389|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
138491390|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491391|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138491392|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138491393|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138491394|NCT00393328|Ritonavir|ritonavir|mesh-list
138491395|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138491396|NCT00393328|Aripiprazole|aripiprazole|mesh-list
138491397|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138491398|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138491399|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
138376884|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
138491400|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491401|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491402|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138491403|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138491404|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
138491405|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138491406|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138491407|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138491408|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
138491409|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138491410|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138491411|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138491412|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138491413|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491414|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
138491415|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
138491416|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491417|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138491418|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138491419|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
138491420|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138491421|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138491422|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138491423|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138491424|NCT05530551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138491425|NCT05530551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138491427|NCT01807429|Ketamine|ketamine|mesh-list
138491429|NCT01807429|Analgesics|analgesics|mesh-ancestor
138491430|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
138491431|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491432|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491433|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138491434|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138491435|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
138491436|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
138491437|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138491438|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138491439|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138491440|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690320|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
138491441|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491442|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138491443|NCT01807429|Narcotics|narcotics|mesh-ancestor
138491444|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138376917|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
138491445|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138491446|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138491447|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138491448|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138491449|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
138491450|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
138491451|NCT01807078|Ezetimibe|ezetimibe|mesh-list
138491452|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138491453|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138167892|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
138491454|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
138491455|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491456|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138491457|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
138491458|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138491459|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
138491460|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491461|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491462|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138491463|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
138491464|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138491465|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138491466|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138491467|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
138491468|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491469|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491470|NCT01807000|Prucalopride|prucalopride|mesh-list
138491471|NCT01807000|Laxatives|laxatives|mesh-ancestor
138491472|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138491473|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138491474|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138491475|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
138491476|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491477|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491478|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491479|NCT01806805|Zonisamide|zonisamide|mesh-list
138491480|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
138376946|NCT01440790|Protective Agents|protective agents|mesh-ancestor
138491481|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138491482|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138491483|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678165|NCT00503516|Megestrol|megestrol|mesh-list
138376947|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
138376948|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138376949|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138376950|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491484|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138491485|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491487|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138491488|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138491489|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138491490|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138491491|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491492|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491493|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491494|NCT00387413|Analgesics|analgesics|mesh-ancestor
138491495|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
138491496|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491497|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
138491498|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138491499|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
138491500|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
138491501|NCT00387413|Vitamins|vitamins|mesh-ancestor
138491502|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
138491503|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138491504|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
138491505|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491506|NCT05517291|Paclitaxel|paclitaxel|mesh-list
138491507|NCT05517291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138491508|NCT05517291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491509|NCT05517291|Tubulin Modulators|tubulin modulators|mesh-ancestor
138491510|NCT05517291|Antimitotic Agents|antimitotic agents|mesh-ancestor
138491511|NCT05517291|Mitosis Modulators|mitosis modulators|mesh-ancestor
138491512|NCT05517291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491513|NCT01806454|Calcium|calcium|mesh-list
138491514|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138491515|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491516|NCT01806415|Imidazole|imidazole|mesh-list
138491517|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491518|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491519|NCT01806376|Maleic acid|maleic acid|mesh-list
138491520|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491521|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491522|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
138491523|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138491524|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491525|NCT01806259|Ketorolac|ketorolac|mesh-list
138376977|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138376978|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138491526|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138491527|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138491528|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138491529|NCT01806259|Analgesics|analgesics|mesh-ancestor
138491530|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
138491531|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491532|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491533|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138491534|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138491535|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138491536|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491537|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491538|NCT04579757|Tislelizumab|tislelizumab|mesh-list
138491539|NCT04579757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138491540|NCT04579757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491541|NCT00393445|Glucagon|glucagon|mesh-list
138491542|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138491543|NCT00393445|Incretins|incretins|mesh-ancestor
138491544|NCT00393445|Hormones|hormones|mesh-ancestor
138491545|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138491546|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491547|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138491548|NCT00393562|Methylphenidate|methylphenidate|mesh-list
138491549|NCT00393562|Modafinil|modafinil|mesh-list
138491550|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138491551|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377009|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138678332|NCT06154590|Immunologic Factors|immunologic factors|mesh-ancestor
138491552|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138491553|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138491554|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138491555|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491556|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
138491557|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491558|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138491559|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138491560|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138491561|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
138491562|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138491563|NCT01805908|Pertuzumab|pertuzumab|mesh-list
138377010|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678370|NCT06145360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138678373|NCT06126419|Insulin|insulin|mesh-list
138491564|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138491565|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491566|NCT05437887|Fucoidan|fucoidan|mesh-list
138491567|NCT05437887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138491568|NCT05437887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138491569|NCT05437887|Anticoagulants|anticoagulants|mesh-ancestor
138491570|NCT05437887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491571|NCT01805596|Clopidogrel|clopidogrel|mesh-list
138491572|NCT01805596|Ticagrelor|ticagrelor|mesh-list
138491573|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138491574|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138491575|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138491576|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138491577|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
138491578|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491579|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491580|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491581|NCT04474223|Dexamethasone|dexamethasone|mesh-list
138491582|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138491584|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
138491585|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491586|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491587|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138491588|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
138491589|NCT04474223|Hormones|hormones|mesh-ancestor
138491590|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138324962|NCT01451658|Propranolol|propranolol|mesh-list
138491591|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138491592|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491593|NCT01466530|Misoprostol|misoprostol|mesh-list
138678481|NCT05851508|Prednisolone acetate|prednisolone acetate|mesh-list
138491594|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138491595|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
138491596|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138491597|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491598|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138377038|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377040|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491599|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138491600|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
138377041|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138377042|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491601|NCT01466452|Aspirin|aspirin|mesh-list
138491602|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138168043|NCT00610987|Cefazolin|cefazolin|mesh-list
138491603|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138491604|NCT01466452|Analgesics|analgesics|mesh-ancestor
138491605|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
138491606|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491607|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491608|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690421|NCT02978391|Coagulants|coagulants|mesh-ancestor
138491609|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138491610|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138491611|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138491612|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491613|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138491614|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138491615|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491617|NCT01466374|Antibodies|antibodies|mesh-list
138491618|NCT01466374|Immunoglobulins|immunoglobulins|mesh-list
138491619|NCT01466374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138491620|NCT01466374|Immunologic Factors|immunologic factors|mesh-ancestor
138491621|NCT01466374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491622|NCT01466257|Cetuximab|cetuximab|mesh-list
138491623|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491624|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138491625|NCT01466101|Pregabalin|pregabalin|mesh-list
138491626|NCT01466101|Analgesics|analgesics|mesh-ancestor
138491627|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
138491628|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491629|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491630|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
138491631|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138491632|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138491633|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491634|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138491635|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138491636|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138491637|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138491638|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138491639|NCT01465984|Acetaminophen|acetaminophen|mesh-list
138324963|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138491640|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138491641|NCT01465984|Analgesics|analgesics|mesh-ancestor
138491642|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
138377073|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377074|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138491643|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491644|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491645|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
138491646|NCT01465906|Bromides|bromides|mesh-list
138491647|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
138491648|NCT01465906|Tulobuterol|tulobuterol|mesh-list
138491649|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138491650|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
138491651|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491652|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491653|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138491654|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
138491655|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
138491656|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138491657|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
138491658|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491659|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491660|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
138491661|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138491662|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138491663|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
138491664|NCT01465867|Selenium|selenium|mesh-list
138491665|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
138491666|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491667|NCT01465867|Protective Agents|protective agents|mesh-ancestor
138491668|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491669|NCT01465867|Trace Elements|trace elements|mesh-ancestor
138491670|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
138491671|NCT01465828|Clopidogrel|clopidogrel|mesh-list
138491672|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138491673|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138491674|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138491675|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138491676|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138377099|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
138491677|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
138491678|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491679|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491680|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491681|NCT01465438|Adalimumab|adalimumab|mesh-list
138491682|NCT01465438|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138491683|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138491684|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138491685|NCT01465399|Mitogens|mitogens|mesh-list
138491686|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
138491687|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491688|NCT05393505|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138491689|NCT05393505|Amoxicillin|amoxicillin|mesh-list
138491690|NCT05393505|Levofloxacin|levofloxacin|mesh-list
138491691|NCT05393505|Meropenem|meropenem|mesh-list
138491692|NCT05393505|Clavulanic Acid|clavulanic acid|mesh-list
138491693|NCT05393505|Clavulanic Acids|clavulanic acids|mesh-list
138491694|NCT05393505|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138491695|NCT05393505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138491696|NCT05393505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138491697|NCT05393505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138491698|NCT05393505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138491699|NCT05393505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491700|NCT05393505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491701|NCT05393505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491702|NCT05393505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138491703|NCT05393505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138491704|NCT05393505|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138491706|NCT01465009|Acetaminophen|acetaminophen|mesh-list
138491707|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138491708|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138491709|NCT01465009|Analgesics|analgesics|mesh-ancestor
138491710|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
138491711|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491712|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491713|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138491714|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138491715|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138690481|NCT02936492|Clobetasol|clobetasol|mesh-list
138491716|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138377142|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138377145|NCT01441986|Amantadine|amantadine|mesh-list
138491717|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491718|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138491719|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138491720|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491721|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
138491722|NCT00389766|Topotecan|topotecan|mesh-list
138491723|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138491724|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138491725|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138491726|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491727|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491728|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491729|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138491730|NCT01464697|Progesterone|progesterone|mesh-list
138491731|NCT01464697|Progestins|progestins|mesh-ancestor
138491733|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138491734|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491735|NCT00393679|Artesunate|artesunate|mesh-list
138491736|NCT00393679|Lumefantrine|lumefantrine|mesh-list
138491737|NCT00393679|Artemether|artemether|mesh-list
138491738|NCT00393679|Piperaquine|piperaquine|mesh-list
138491739|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138491740|NCT00393679|Amodiaquine|amodiaquine|mesh-list
138491741|NCT00393679|Artenimol|artenimol|mesh-list
138491742|NCT00393679|Dapsone|dapsone|mesh-list
138491743|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
138491744|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
138491745|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138491746|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138491747|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138491748|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377178|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
138377179|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377180|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138491749|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
138491750|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
138491751|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138491752|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
138491753|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138491754|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703943|NCT06225466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491755|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491756|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
138491757|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138491758|NCT00393835|Azithromycin|azithromycin|mesh-list
138491759|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138491760|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138491762|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138491763|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
138491764|NCT01057069|Carboplatin|carboplatin|mesh-list
138491765|NCT01057069|Doxorubicin|doxorubicin|mesh-list
138491766|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138491767|NCT01057069|Thiotepa|thiotepa|mesh-list
138491768|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138491769|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491770|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
138491771|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
138491772|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
138491773|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491774|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138491776|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491777|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138491778|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138491779|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
138491780|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138491781|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138491782|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138491783|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138491784|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491785|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138491786|NCT00847834|Irbesartan|irbesartan|mesh-list
138491787|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138491788|NCT00847834|Diuretics|diuretics|mesh-ancestor
138491789|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
138491790|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491791|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138491792|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138491793|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491794|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138491795|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138491796|NCT00847678|Amphotericin B|amphotericin b|mesh-list
138491797|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138678813|NCT04790903|Prednisone|prednisone|mesh-list
138491799|NCT00847678|Efungumab|efungumab|mesh-list
138491800|NCT00847678|Amebicides|amebicides|mesh-ancestor
138491801|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138491802|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138491803|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138491804|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138491805|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
138491806|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
138491807|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491808|NCT00847639|Lenalidomide|lenalidomide|mesh-list
138491809|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
138377223|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
138377233|NCT01442532|Midazolam|midazolam|mesh-list
138491810|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491811|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138491812|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138491813|NCT00847639|Growth Substances|growth substances|mesh-ancestor
138491814|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
138491815|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491816|NCT00847483|Bimatoprost|bimatoprost|mesh-list
138491817|NCT00847483|Travoprost|travoprost|mesh-list
138491818|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138491819|NCT00847483|Latanoprost|latanoprost|mesh-list
138491820|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138491821|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138491823|NCT00847366|Trastuzumab|trastuzumab|mesh-list
138491824|NCT00847366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138491825|NCT00847366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491826|NCT00847366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138491827|NCT00847366|Hormone Antagonists|hormone antagonists|mesh-ancestor
138491828|NCT00847366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138491829|NCT00847366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491830|NCT00847366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138491831|NCT00847366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138491832|NCT00847366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138491833|NCT00847366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138491835|NCT05321160|Sevoflurane|sevoflurane|mesh-list
138491836|NCT05321160|Esketamine|esketamine|mesh-list
138491837|NCT05321160|Analgesics|analgesics|mesh-ancestor
138491838|NCT05321160|Sensory System Agents|sensory system agents|mesh-ancestor
138491839|NCT05321160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491840|NCT05321160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491841|NCT05321160|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138491842|NCT05321160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138491843|NCT05321160|Anesthetics, General|anesthetics, general|mesh-ancestor
138491844|NCT05321160|Anesthetics|anesthetics|mesh-ancestor
138491845|NCT05321160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377237|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377238|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138377239|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138377240|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138377241|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138491846|NCT05321160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138491847|NCT05321160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138491848|NCT05321160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491849|NCT05321160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491850|NCT05321160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138491851|NCT05321160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138491852|NCT05321160|Antidepressive Agents|antidepressive agents|mesh-ancestor
138491853|NCT05321160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138491854|NCT03969641|Vaccines|vaccines|mesh-list
138491855|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
138491856|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491857|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
138491858|NCT00847210|Lansoprazole|lansoprazole|mesh-list
138491859|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138491860|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138491861|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138491862|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491863|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491864|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
138491865|NCT00847171|Trastuzumab|trastuzumab|mesh-list
138491866|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138491867|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
138491868|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491869|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138491870|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138491871|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
138491872|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491873|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491874|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138491875|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138491876|NCT00847093|Lidocaine|lidocaine|mesh-list
138491877|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
138491878|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
138491879|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138491880|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491881|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
138690530|NCT01289119|Pioglitazone|pioglitazone|mesh-list
138491882|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491883|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138491884|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138491885|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138377273|NCT01442701|Triclosan|triclosan|mesh-list
138491886|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138377281|NCT01442727|Selenium|selenium|mesh-list
138491887|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491888|NCT00847054|Antibodies|antibodies|mesh-list
138491889|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138491890|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
138491891|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138678968|NCT04455750|Leuprolide|leuprolide|mesh-list
138491892|NCT00846976|Bicalutamide|bicalutamide|mesh-list
138491893|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
138491894|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
138491895|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138491896|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491897|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491898|NCT00846859|Varenicline|varenicline|mesh-list
138491899|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138491900|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138491901|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
138491902|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138491903|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491904|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491905|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
138491906|NCT03885830|Dasatinib|dasatinib|mesh-list
138491907|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491908|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138491909|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491910|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491911|NCT00846703|Dexamethasone|dexamethasone|mesh-list
138491912|NCT00846703|Methotrexate|methotrexate|mesh-list
138491913|NCT00846703|Vincristine|vincristine|mesh-list
138491914|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
138491915|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138491916|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
138491917|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
138491918|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491919|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377307|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138377308|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491920|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138491921|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
138491922|NCT00846703|Hormones|hormones|mesh-ancestor
138491923|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138491924|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138491925|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491926|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138491927|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
138491928|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138491929|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138377351|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491930|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
138491931|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491932|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
138491933|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491934|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138491935|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138491936|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
138491937|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138491938|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138491939|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138491940|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
138491941|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
138491942|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
138491943|NCT03772964|Metformin|metformin|mesh-list
138491944|NCT03772964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138491945|NCT03772964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491946|NCT00846625|Triamcinolone|triamcinolone|mesh-list
138491947|NCT00846625|Ranibizumab|ranibizumab|mesh-list
138377352|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
138377353|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
138377354|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
138377355|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377356|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138377357|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
138377358|NCT01442987|Irbesartan|irbesartan|mesh-list
138491948|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138491949|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138491951|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491952|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
138491953|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491954|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138491955|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
138491956|NCT00846625|Hormones|hormones|mesh-ancestor
138491957|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138491958|NCT00846508|Cisplatin|cisplatin|mesh-list
138491959|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138491960|NCT03721172|Apremilast|apremilast|mesh-list
138491961|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138491962|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138491963|NCT03721172|Analgesics|analgesics|mesh-ancestor
138491964|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
138491965|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138491966|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491967|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138491968|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138491969|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138491970|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138491971|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491972|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491973|NCT00846274|Antithrombins|antithrombins|mesh-list
138491974|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
138491975|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138491976|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
138491977|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491978|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491979|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
138491980|NCT00846235|Glycerol|glycerol|mesh-list
138491981|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138491982|NCT00846235|Protective Agents|protective agents|mesh-ancestor
138491983|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491984|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
138491985|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
138491986|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138491987|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138491988|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491989|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138491990|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138491991|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138491992|NCT00846118|Pitavastatin|pitavastatin|mesh-list
138377397|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138679068|NCT04150731|Estrogens|estrogens|mesh-ancestor
138377398|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
138377404|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
138491993|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138491994|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138491995|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138491996|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
138325134|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
138491997|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138491998|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138491999|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138492000|NCT00846079|Regadenoson|regadenoson|mesh-list
138492001|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138492002|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138492003|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
138492004|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
138492005|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138492006|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492007|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492008|NCT00845962|Bupivacaine|bupivacaine|mesh-list
138492009|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
138492010|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
138492011|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
138492012|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138492013|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492014|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
138492015|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138492016|NCT03620942|Phenylephrine|phenylephrine|mesh-list
138492017|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
138492018|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138492019|NCT03620942|Ephedrine|ephedrine|mesh-list
138492020|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138492022|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
138492023|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138492024|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492025|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
138492026|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
138492027|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
138492028|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138492029|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138492030|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138492031|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
138377425|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492032|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138492033|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138325167|NCT01458054|Ritonavir|ritonavir|mesh-list
138492034|NCT03620942|Protective Agents|protective agents|mesh-ancestor
138492035|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138492037|NCT00277108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138492038|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138492039|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138492040|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492041|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138492042|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
138492043|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492044|NCT00277069|Carboplatin|carboplatin|mesh-list
138492045|NCT00277069|Capecitabine|capecitabine|mesh-list
138492046|NCT00277069|Vinorelbine|vinorelbine|mesh-list
138492047|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492048|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138492049|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
138492050|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492051|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492052|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
138492053|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
138492054|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
138492055|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138492056|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
138492057|NCT00276991|Immunomodulating Agents|immunomodulating agents|mesh-list
138492058|NCT00276991|Immunologic Factors|immunologic factors|mesh-ancestor
138492059|NCT00276991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492060|NCT00276874|Aripiprazole|aripiprazole|mesh-list
138492061|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
138492062|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138492063|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138492064|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138492065|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138492066|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492067|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
138492068|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
138492069|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138492070|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492071|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138492073|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
138492074|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138492075|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138492076|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138492077|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138492078|NCT00276835|Aldesleukin|aldesleukin|mesh-list
138492079|NCT00276835|Interleukin-2|interleukin-2|mesh-list
138492080|NCT00276835|Genistein|genistein|mesh-list
138492081|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492082|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138492083|NCT00276835|Analgesics|analgesics|mesh-ancestor
138492084|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
138492085|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138492086|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492087|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138492088|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138492089|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
138325200|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
138492090|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492091|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138492092|NCT00276835|Protective Agents|protective agents|mesh-ancestor
138492093|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138492094|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492095|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492096|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
138492097|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138492098|NCT00276835|Estrogens|estrogens|mesh-ancestor
138492099|NCT00276835|Hormones|hormones|mesh-ancestor
138679341|NCT02872116|Immunologic Factors|immunologic factors|mesh-ancestor
138492100|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138492101|NCT00276796|Paclitaxel|paclitaxel|mesh-list
138492102|NCT00276796|Topotecan|topotecan|mesh-list
138492103|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492104|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492105|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
138492106|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
138492107|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
138492108|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492109|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138492110|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138492111|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492112|NCT00276757|Leucovorin|leucovorin|mesh-list
138492113|NCT00276757|Prednisolone|prednisolone|mesh-list
138492114|NCT00276757|Methotrexate|methotrexate|mesh-list
138492115|NCT00276757|Vinblastine|vinblastine|mesh-list
138377479|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138492116|NCT00276757|Calcium|calcium|mesh-list
138492117|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
138492118|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138492119|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492120|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138492121|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
138492122|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138492123|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138492124|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
138492125|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492126|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492127|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
138492128|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492129|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138492130|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492131|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
138492132|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138492133|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138492134|NCT00276757|Antidotes|antidotes|mesh-ancestor
138492135|NCT00276757|Protective Agents|protective agents|mesh-ancestor
138492136|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
138492137|NCT00276757|Vitamins|vitamins|mesh-ancestor
138492138|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
138492139|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138492140|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
138492141|NCT00276757|Hormones|hormones|mesh-ancestor
138492142|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138492143|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138492144|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492145|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
138377529|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
138377530|NCT01443897|Cholecalciferol|cholecalciferol|mesh-list
138377531|NCT01443897|Vitamins|vitamins|mesh-list
138492146|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
138492147|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
138492148|NCT00276718|Carboplatin|carboplatin|mesh-list
138492149|NCT00276718|Etoposide|etoposide|mesh-list
138492150|NCT00276718|Bleomycin|bleomycin|mesh-list
138492151|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492152|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138325218|NCT01458600|Analgesics|analgesics|mesh-ancestor
138492153|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138492154|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138492155|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492156|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492157|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138492158|NCT00276679|Temozolomide|temozolomide|mesh-list
138492159|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138492160|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
138492161|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492162|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492163|NCT00276601|Cytarabine|cytarabine|mesh-list
138492164|NCT00276601|Methotrexate|methotrexate|mesh-list
138492165|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
138492166|NCT00276601|Daunorubicin|daunorubicin|mesh-list
138492167|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
138492168|NCT00276601|Tretinoin|tretinoin|mesh-list
138492169|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138679508|NCT02174666|Vitamin D|vitamin d|mesh-list
138492170|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
138492171|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138492172|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492173|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138492174|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
138492175|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492176|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492177|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
138492178|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492179|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138492180|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492181|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
138492182|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138492183|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138492184|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
138492185|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492186|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138492187|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138492188|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138377576|NCT01444248|Metformin|metformin|mesh-list
138492189|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
138492190|NCT00276523|Interferons|interferons|mesh-list
138492191|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
138492192|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
138492193|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138492194|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492195|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
138492196|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492197|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
138492198|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492199|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
138492200|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138492201|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
138492202|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492203|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138492204|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138492205|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492206|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492207|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
138492208|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138492209|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492210|NCT00389883|Anesthetics|anesthetics|mesh-list
138492211|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138492212|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492213|NCT00389922|Vinorelbine|vinorelbine|mesh-list
138492214|NCT00389922|Lapatinib|lapatinib|mesh-list
138492215|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492216|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492217|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
138492218|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
138492219|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
138492220|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492221|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138492222|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492223|NCT00276289|Spironolactone|spironolactone|mesh-list
138492224|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138492225|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
138492226|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138377604|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492227|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492228|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138492229|NCT00276289|Diuretics|diuretics|mesh-ancestor
138492230|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
138492231|NCT00276250|Abatacept|abatacept|mesh-list
138492232|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138492233|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492234|NCT00276250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138492235|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492236|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492237|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
138492238|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492239|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138492240|NCT00394186|Solabegron|solabegron|mesh-list
138679677|NCT05146713|Eusol|eusol|mesh-list
138492241|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138492242|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138492244|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
138492245|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138492246|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492247|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492249|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
138492250|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492251|NCT00276133|Atorvastatin|atorvastatin|mesh-list
138492252|NCT00276133|Probucol|probucol|mesh-list
138492253|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138492254|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138492255|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
138492256|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492257|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138492258|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138492259|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492260|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
138492261|NCT00276133|Protective Agents|protective agents|mesh-ancestor
138492262|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492263|NCT00276055|Bevacizumab|bevacizumab|mesh-list
138492264|NCT00276055|Gemcitabine|gemcitabine|mesh-list
138492265|NCT00276055|Docetaxel|docetaxel|mesh-list
138492266|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138492267|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492268|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138492269|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138492270|NCT00276055|Growth Substances|growth substances|mesh-ancestor
138377639|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492271|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492272|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
138492273|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138492274|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
138492275|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492276|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
138492277|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
138492278|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
138492279|NCT00275938|Interferons|interferons|mesh-list
138492281|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
138492282|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
138492283|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492284|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
138492285|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492286|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
138492287|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492288|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
138492289|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492290|NCT00275665|Valganciclovir|valganciclovir|mesh-list
138492291|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
138492292|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492293|NCT00276640|Carboplatin|carboplatin|mesh-list
138492294|NCT00276640|Etoposide|etoposide|mesh-list
138492295|NCT00276640|Vincristine|vincristine|mesh-list
138492296|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492297|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492298|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138492299|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138492300|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492301|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492302|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
138492303|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
138492304|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
138492305|NCT00275548|Ribavirin|ribavirin|mesh-list
138492306|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138492307|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
138492308|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492309|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
138492310|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138377672|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138377673|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138377674|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
138492311|NCT00275431|Gossypol acetic acid|gossypol acetic acid|mesh-list
138492312|NCT00275431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492313|NCT00275431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492314|NCT00275431|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138492315|NCT00275431|Contraceptive Agents|contraceptive agents|mesh-ancestor
138325274|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138492316|NCT00275431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138492317|NCT00275431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492318|NCT00275431|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138492320|NCT00275431|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138492321|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138492322|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138492323|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492325|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
138492326|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138492327|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138492328|NCT02921555|Prednisolone|prednisolone|mesh-list
138492329|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
138492330|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138492331|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
138492332|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138492333|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
138492334|NCT02921555|Hormones|hormones|mesh-ancestor
138492335|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138492336|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492337|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138492338|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492340|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
138492341|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138492342|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138492343|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138492344|NCT02921555|Protective Agents|protective agents|mesh-ancestor
138492345|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
138492346|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492347|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492348|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138492349|NCT05070585|Protective Agents|protective agents|mesh-ancestor
138492350|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492351|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492352|NCT00387530|Valganciclovir|valganciclovir|mesh-list
138492353|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138492354|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
138492355|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138679919|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138377708|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138492356|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492358|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138492359|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492360|NCT02680184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138492361|NCT02680184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492362|NCT00390000|Pemetrexed|pemetrexed|mesh-list
138492363|NCT00390000|Vatalanib|vatalanib|mesh-list
138492364|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492365|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325294|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
138492366|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492367|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138492368|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138492369|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138492370|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138492372|NCT04574245|Immunomodulating Agents|immunomodulating agents|mesh-list
138492373|NCT04574245|Immunologic Factors|immunologic factors|mesh-ancestor
138492374|NCT04574245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492375|NCT04556617|Prednisone|prednisone|mesh-list
138492376|NCT04556617|Olaparib|olaparib|mesh-list
138492377|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
138492378|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138492379|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
138492380|NCT04556617|Hormones|hormones|mesh-ancestor
138492381|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138492382|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492383|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138492384|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492385|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138492386|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492387|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492388|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138492389|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
138492390|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138492391|NCT04554862|Ketorolac|ketorolac|mesh-list
138492392|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138377739|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377740|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
138492394|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138492395|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138492396|NCT04554862|Analgesics|analgesics|mesh-ancestor
138492397|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
138492398|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138492399|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492400|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138492401|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138492402|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138492403|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492404|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492405|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
138492406|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138492407|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138492408|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
138492409|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138492410|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138492411|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138492412|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
138492413|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138492414|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
138492415|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138690667|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
138492417|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138492418|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492419|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138492420|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492421|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
138492422|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492423|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
138492424|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492425|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
138492426|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138492427|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
138492428|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492429|NCT04712435|Expectorants|expectorants|mesh-ancestor
138492430|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
138492431|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138492433|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492434|NCT04712435|Protective Agents|protective agents|mesh-ancestor
138377773|NCT01445405|Bortezomib|bortezomib|mesh-list
138377774|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377775|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138492435|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492436|NCT04712435|Antidotes|antidotes|mesh-ancestor
138492438|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138492439|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138492440|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492441|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138492442|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
138492443|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
138492444|NCT04712357|Tenofovir|tenofovir|mesh-list
138492445|NCT04712357|Emtricitabine|emtricitabine|mesh-list
138492446|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
138492447|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492448|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138492449|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138492450|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492451|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492452|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138492453|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138492454|NCT00390039|Morphine|morphine|mesh-list
138492455|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138492456|NCT00390039|Narcotics|narcotics|mesh-ancestor
138377808|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138492457|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138492458|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492459|NCT00390039|Analgesics|analgesics|mesh-ancestor
138492460|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
138492461|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138492462|NCT02832544|Vitamin K|vitamin k|mesh-list
138492463|NCT02832544|Warfarin|warfarin|mesh-list
138492464|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
138492465|NCT02832544|Vitamins|vitamins|mesh-ancestor
138492466|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
138492467|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492468|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
138492469|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138492470|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
138492471|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138492472|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
138492473|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492474|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492475|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138492476|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138492477|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
138492478|NCT02832544|Coagulants|coagulants|mesh-ancestor
138492479|NCT00006044|Testosterone|testosterone|mesh-list
138492480|NCT00006044|Androgens|androgens|mesh-ancestor
138492482|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138492483|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492484|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
138492485|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
138492486|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138492487|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492488|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492489|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
138492490|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138492491|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138492492|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492493|NCT02395705|Paclitaxel|paclitaxel|mesh-list
138492494|NCT02395705|Cisplatin|cisplatin|mesh-list
138492495|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492496|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492497|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
138492498|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
138492499|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
138492500|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492501|NCT00006047|Etoposide|etoposide|mesh-list
138492502|NCT00006047|Rubitecan|rubitecan|mesh-list
138492503|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
138492504|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492505|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492506|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138492507|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138492508|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492509|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492510|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138492511|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
138492513|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138492514|NCT00083824|Hormones|hormones|mesh-ancestor
138492515|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138492516|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492517|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138492518|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138492519|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138492520|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
138492521|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138492522|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138377838|NCT01445860|Simvastatin|simvastatin|mesh-list
138377839|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138377840|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138377841|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
138377842|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377843|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138492523|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138492524|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138492525|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138492526|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492527|NCT00083902|Thalidomide|thalidomide|mesh-list
138492528|NCT00083902|Dexamethasone|dexamethasone|mesh-list
138492529|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138492530|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
138492531|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
138492532|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138492533|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492534|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138492535|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
138492536|NCT00083902|Hormones|hormones|mesh-ancestor
138325344|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
138492537|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138492538|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138492540|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492541|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
138492542|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
138492543|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138492544|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492545|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138492546|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138492547|NCT00083902|Growth Substances|growth substances|mesh-ancestor
138377866|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138377867|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
138377868|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
138377869|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377872|NCT01446107|Fluorides|fluorides|mesh-list
138492548|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
138492549|NCT00006050|Leucovorin|leucovorin|mesh-list
138492550|NCT00006050|Fluorouracil|fluorouracil|mesh-list
138492552|NCT00006050|Calcium|calcium|mesh-list
138492553|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
138492554|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138492555|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492556|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
138492557|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492558|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138492559|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492560|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492561|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
138492562|NCT00006050|Antidotes|antidotes|mesh-ancestor
138492563|NCT00006050|Protective Agents|protective agents|mesh-ancestor
138492564|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
138492565|NCT00006050|Vitamins|vitamins|mesh-ancestor
138492566|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
138492567|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138492568|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138492569|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138492570|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138492571|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492572|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138492573|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492574|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138492575|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
138492576|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138492578|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138492579|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138492580|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138377914|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
138377915|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492581|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
138492582|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377916|NCT01446276|Protective Agents|protective agents|mesh-ancestor
138492583|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492584|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138492585|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138492586|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
138492587|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492588|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138492589|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138492591|NCT00084058|Lopinavir|lopinavir|mesh-list
138492592|NCT00084058|Saquinavir|saquinavir|mesh-list
138492593|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138492594|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138492595|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
138492596|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492597|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492598|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138492599|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138492600|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
138492601|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492602|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138492603|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138492605|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492606|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138492607|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492608|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492609|NCT00084097|Omalizumab|omalizumab|mesh-list
138492610|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138492611|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138492612|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
138492613|NCT00084214|Paclitaxel|paclitaxel|mesh-list
138492614|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492615|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492616|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
138492617|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
138377954|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492619|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492620|NCT00006056|Cyclosporine|cyclosporine|mesh-list
138492621|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
138492622|NCT00006056|Busulfan|busulfan|mesh-list
138492623|NCT00006056|Methotrexate|methotrexate|mesh-list
138492624|NCT00006056|Etoposide|etoposide|mesh-list
138492625|NCT00006056|Cyclosporins|cyclosporins|mesh-list
138492626|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138492627|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492628|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
138492629|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492630|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138492631|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138492632|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
138492633|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492634|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492635|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138690777|NCT02911662|Cephalexin|cephalexin|mesh-list
138492636|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138492637|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
138492638|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138492639|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138492640|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
138492641|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
138492642|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492643|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138492644|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138492645|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492646|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138492647|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138492648|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
138492649|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492650|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138492651|NCT00084370|Celecoxib|celecoxib|mesh-list
138492652|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138492653|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138492654|NCT00084370|Analgesics|analgesics|mesh-ancestor
138492655|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
138492656|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377997|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138377998|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138377999|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
138378001|NCT01446679|Atorvastatin|atorvastatin|mesh-list
138492657|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492658|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138492659|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138492660|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138492661|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138492662|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492663|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492664|NCT00084448|Celecoxib|celecoxib|mesh-list
138492665|NCT00084448|Paclitaxel|paclitaxel|mesh-list
138492666|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492667|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492668|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
138492669|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
138492670|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
138492671|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492672|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138492673|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138492674|NCT00084448|Analgesics|analgesics|mesh-ancestor
138680279|NCT00502034|Interferons|interferons|mesh-list
138492675|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
138492676|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138492677|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492678|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138492679|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138492680|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138492681|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138492682|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492683|NCT00084565|Paclitaxel|paclitaxel|mesh-list
138492684|NCT00084565|Topotecan|topotecan|mesh-list
138492685|NCT00084565|Estramustine|estramustine|mesh-list
138492686|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492687|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492688|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
138492689|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
138492690|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
138492691|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492692|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138492693|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138492694|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492695|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138492696|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
138492697|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138492698|NCT00084604|Bevacizumab|bevacizumab|mesh-list
138492699|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138492700|NCT00084604|Irinotecan|irinotecan|mesh-list
138378032|NCT01446952|Tocotrienols|tocotrienols|mesh-list
138492701|NCT00084604|Antibodies|antibodies|mesh-list
138492702|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
138492703|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138378033|NCT01446952|Vitamins|vitamins|mesh-ancestor
138492704|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492705|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138492706|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138492707|NCT00084604|Growth Substances|growth substances|mesh-ancestor
138492708|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492709|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
138492710|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
138492711|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138492712|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138492713|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492714|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492715|NCT00084643|Capecitabine|capecitabine|mesh-list
138492716|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
138492717|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138492718|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
138325403|NCT02684292|Immunotoxins|immunotoxins|mesh-ancestor
138492719|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492720|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492721|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
138492722|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492723|NCT00084721|Celecoxib|celecoxib|mesh-list
138492724|NCT00084721|Irinotecan|irinotecan|mesh-list
138492725|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138492726|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138492727|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492728|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492729|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492730|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138169175|NCT01672112|Oxycodone|oxycodone|mesh-list
138492731|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138492732|NCT00084721|Analgesics|analgesics|mesh-ancestor
138492733|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
138492734|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138492735|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492736|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138492737|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138492738|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138492739|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138492740|NCT00084877|Irinotecan|irinotecan|mesh-list
138492741|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138492742|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138492743|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492744|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492745|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378059|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138492746|NCT00084916|Sirolimus|sirolimus|mesh-list
138492747|NCT00084916|Temsirolimus|temsirolimus|mesh-list
138492748|NCT00084916|MTOR Inhibitors|mtor inhibitors|mesh-list
138492749|NCT00084916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138492750|NCT00084916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492751|NCT00084916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492752|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492753|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
138492754|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492755|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492756|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138492757|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492758|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138492759|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
138492760|NCT00085111|Bevacizumab|bevacizumab|mesh-list
138492761|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138492762|NCT00085111|Antibodies|antibodies|mesh-list
138492763|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
138492764|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138492765|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492766|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138492767|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138492768|NCT00085111|Growth Substances|growth substances|mesh-ancestor
138492769|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680499|NCT00504062|Hormones|hormones|mesh-ancestor
138492770|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
138378092|NCT01447368|Cinacalcet|cinacalcet|mesh-list
138378093|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138378094|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378095|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138492771|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
138492772|NCT00085150|Immunotoxins|immunotoxins|mesh-list
138492773|NCT00085150|Immunoconjugates|immunoconjugates|mesh-ancestor
138492774|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
138492775|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492776|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
138492777|NCT00400075|Azathioprine|azathioprine|mesh-list
138492778|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492779|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
138492780|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492781|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138492782|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138492783|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
138492784|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492785|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492786|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138492787|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
138492788|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138492789|NCT00400114|Irinotecan|irinotecan|mesh-list
138492790|NCT00400114|Sunitinib|sunitinib|mesh-list
138492791|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492792|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138492793|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138492794|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492795|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492796|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138492797|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138492798|NCT00400114|Growth Substances|growth substances|mesh-ancestor
138492799|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492800|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
138492801|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138492802|NCT00085189|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138492803|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
138492804|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138492805|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
138492806|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492807|NCT00085228|Docetaxel|docetaxel|mesh-list
138492808|NCT00085228|Oblimersen|oblimersen|mesh-list
138492809|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492810|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
138492811|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
138492812|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
138492813|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492814|NCT00085306|Interferons|interferons|mesh-list
138492815|NCT00085306|Interferon-beta|interferon-beta|mesh-list
138492816|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492817|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
138378141|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138492818|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492819|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
138378142|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138378144|NCT01447797|Irbesartan|irbesartan|mesh-list
138492820|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492821|NCT00006077|Levodopa|levodopa|mesh-list
138492822|NCT00006077|Domperidone|domperidone|mesh-list
138492823|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138492824|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138492825|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
138492826|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325436|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
138492827|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492828|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492829|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
138492830|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
138492831|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138492832|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138492833|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138492834|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
138492835|NCT04729348|Lenvatinib|lenvatinib|mesh-list
138492836|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138492837|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492838|NCT04729348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138492839|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492840|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138492841|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492842|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
138492843|NCT00085345|Melphalan|melphalan|mesh-list
138492844|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
138492845|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138492846|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
138492847|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492848|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492849|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138492850|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492851|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
138492852|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492853|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
138492854|NCT00085345|Protective Agents|protective agents|mesh-ancestor
138492855|NCT00085345|Vitamins|vitamins|mesh-ancestor
138492856|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
138492857|NCT00085384|Interferons|interferons|mesh-list
138492858|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
138492859|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
138492860|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138492861|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492862|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
138492863|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492864|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
138378180|NCT01448070|Insulin|insulin|mesh-list
138492865|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492866|NCT00006080|Fenretinide|fenretinide|mesh-list
138492867|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492868|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138492869|NCT00006080|Protective Agents|protective agents|mesh-ancestor
138492870|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492871|NCT00085462|Aldesleukin|aldesleukin|mesh-list
138492872|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
138492873|NCT00085462|Fludarabine|fludarabine|mesh-list
138492874|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
138492875|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492876|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
138492877|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492878|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138492879|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138492880|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
138169312|NCT03152942|Aminophylline|aminophylline|mesh-list
138325476|NCT02300922|Antibodies|antibodies|mesh-list
138492882|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492883|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138492884|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138492885|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
138492886|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138492887|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138492888|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
138492889|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492890|NCT00085501|Paclitaxel|paclitaxel|mesh-list
138492891|NCT00085501|Carboplatin|carboplatin|mesh-list
138492892|NCT00085501|Cetuximab|cetuximab|mesh-list
138492893|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492894|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492895|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
138492896|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
138492897|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
138492898|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492899|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138492900|NCT00006083|Dalteparin|dalteparin|mesh-list
138492901|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
138378199|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138492902|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138492903|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138492904|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492905|NCT00085579|Aldesleukin|aldesleukin|mesh-list
138492906|NCT00085579|Sargramostim|sargramostim|mesh-list
138492907|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
138492908|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680731|NCT01249274|Progesterone|progesterone|mesh-list
138492909|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492910|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138492911|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138492912|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
138492913|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492915|NCT00085696|Bortezomib|bortezomib|mesh-list
138492916|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138492917|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492918|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
138492919|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492920|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138492921|NCT00006086|Carboplatin|carboplatin|mesh-list
138492923|NCT04798638|Osimertinib|osimertinib|mesh-list
138492924|NCT04798638|Complement Factor H|complement factor h|mesh-list
138492925|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492926|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138492927|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492928|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492929|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138492930|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492931|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
138492932|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492933|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138492934|NCT00006089|Trastuzumab|trastuzumab|mesh-list
138492935|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
138492936|NCT00006089|Antibodies|antibodies|mesh-list
138378235|NCT01448304|Protease Inhibitors|protease inhibitors|mesh-ancestor
138378238|NCT01448317|Alirocumab|alirocumab|mesh-list
138492937|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
138492938|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138492939|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
138492940|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492941|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492942|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138492943|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
138492944|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138492945|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138492946|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138492947|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138492948|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492949|NCT00085969|Exenatide|exenatide|mesh-list
138492950|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138492951|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492952|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138492953|NCT00085969|Incretins|incretins|mesh-ancestor
138492954|NCT00085969|Hormones|hormones|mesh-ancestor
138492955|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138492956|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
138492957|NCT00086086|Hematinics|hematinics|mesh-ancestor
138492958|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
138492959|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492960|NCT00086125|Sirolimus|sirolimus|mesh-list
138492961|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138492962|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138492963|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138492964|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492965|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
138492966|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138492967|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
138492968|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492969|NCT00086203|Rituximab|rituximab|mesh-list
138492970|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138492971|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492972|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
138492973|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492974|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138492975|NCT00006095|Irinotecan|irinotecan|mesh-list
138492976|NCT00006095|Vincristine|vincristine|mesh-list
138492977|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138378281|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138492978|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138492979|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138492980|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492981|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138492982|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138492983|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
138492984|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
138492985|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
138492986|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138492987|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138492988|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138492989|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138492990|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138492991|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138492992|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138492993|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138492994|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
138325493|NCT02983422|Aminophylline|aminophylline|mesh-list
138492996|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138492997|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138492998|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138378317|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378318|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378321|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
138492999|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
138493000|NCT00086359|Ritonavir|ritonavir|mesh-list
138493001|NCT00086359|Lopinavir|lopinavir|mesh-list
138493002|NCT00086359|Lamivudine|lamivudine|mesh-list
138493003|NCT00086359|Zidovudine|zidovudine|mesh-list
138493004|NCT00086359|Abacavir|abacavir|mesh-list
138493005|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138493006|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138493007|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138493008|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
138493009|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493010|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493011|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138493012|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138493013|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
138493014|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493015|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138493016|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138493017|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138493018|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138493019|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
138493020|NCT00006098|Bortezomib|bortezomib|mesh-list
138493021|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493022|NCT00086593|Lamotrigine|lamotrigine|mesh-list
138493023|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
138493024|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138493025|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138493026|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493027|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138493028|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493029|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138493030|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138493031|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138493032|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138493033|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138493034|NCT00387569|Vaccines|vaccines|mesh-list
138493035|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
138169455|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138493036|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493037|NCT04784637|Insulin|insulin|mesh-list
138493038|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138493039|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493040|NCT00086632|Oregovomab|oregovomab|mesh-list
138378371|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138493041|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138493042|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378372|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138493043|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
138493044|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138493045|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138325513|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138493046|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493047|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138493048|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138493049|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
138493050|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493052|NCT00006104|Trastuzumab|trastuzumab|mesh-list
138493053|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493054|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
138493055|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
138493056|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
138493057|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493058|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138493059|NCT00086827|Romidepsin|romidepsin|mesh-list
138493060|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138493061|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493062|NCT00086827|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138493063|NCT00086827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493064|NCT00086827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493065|NCT00086944|Rituximab|rituximab|mesh-list
138493066|NCT00086944|Carboplatin|carboplatin|mesh-list
138493067|NCT00086944|Etoposide|etoposide|mesh-list
138493068|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
138493069|NCT00086944|Ifosfamide|ifosfamide|mesh-list
138493070|NCT00086944|Oblimersen|oblimersen|mesh-list
138493071|NCT00086944|Lenograstim|lenograstim|mesh-list
138493072|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138493073|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493074|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
138493075|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138680954|NCT04695483|Hormones|hormones|mesh-ancestor
138493076|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138493077|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138493078|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138493079|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138493080|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493081|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493082|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138493083|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138493084|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
138493086|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378405|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138493087|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
138493088|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
138493089|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
138493090|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493091|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
138493092|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493093|NCT00087100|Pemetrexed|pemetrexed|mesh-list
138493094|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493095|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493096|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493097|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138493098|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138493099|NCT00006113|Interferons|interferons|mesh-list
138493100|NCT00006113|Aldesleukin|aldesleukin|mesh-list
138493101|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
138493102|NCT00006113|Interleukin-4|interleukin-4|mesh-list
138493103|NCT00006113|Sargramostim|sargramostim|mesh-list
138493104|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493105|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
138493106|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493107|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
138493108|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493109|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138493110|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138493111|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138169532|NCT01673204|Vitamins|vitamins|mesh-ancestor
138493112|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138493113|NCT00087217|Paclitaxel|paclitaxel|mesh-list
138493114|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138493115|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493116|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
138493117|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
138690901|NCT02932397|Propofol|propofol|mesh-list
138493118|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
138493119|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493120|NCT00087256|Celecoxib|celecoxib|mesh-list
138493121|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138493122|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138378437|NCT01449344|Bortezomib|bortezomib|mesh-list
138378438|NCT01449344|BB 1101|bb 1101|mesh-list
138493123|NCT00087256|Analgesics|analgesics|mesh-ancestor
138493124|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
138493125|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493126|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493127|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138493128|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138493129|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138493130|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138378474|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
138493131|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493132|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493133|NCT00006116|Gemcitabine|gemcitabine|mesh-list
138493134|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493135|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138493136|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
138493137|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493138|NCT00087295|Romidepsin|romidepsin|mesh-list
138493139|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138493140|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493141|NCT00087295|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138493142|NCT00087295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493143|NCT00087295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493144|NCT00087334|Capecitabine|capecitabine|mesh-list
138493146|NCT00087334|Gefitinib|gefitinib|mesh-list
138493147|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138493148|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
138681026|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138493149|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493150|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493151|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138493152|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493153|NCT00087373|Metronidazole|metronidazole|mesh-list
138493154|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493155|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138493156|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138493157|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138493158|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
138493159|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493160|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
138493161|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493162|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493163|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138493164|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138493165|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493166|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138493167|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325547|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138493168|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138681074|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
138493169|NCT00390078|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138493170|NCT00390078|Antiviral Agents|antiviral agents|mesh-ancestor
138378475|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378476|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378478|NCT01449448|Ketorolac|ketorolac|mesh-list
138493171|NCT00390078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493172|NCT00006122|Cytarabine|cytarabine|mesh-list
138493173|NCT00006122|Etoposide|etoposide|mesh-list
138493174|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
138493175|NCT00006122|Idarubicin|idarubicin|mesh-list
138493176|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
138493177|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138493178|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493179|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138493180|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138493181|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493182|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493183|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138493184|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
138493185|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
138493186|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493187|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493188|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
138493189|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493190|NCT00006122|Analgesics|analgesics|mesh-ancestor
138493191|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
138493192|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493193|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138681127|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493194|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138493195|NCT00006122|Immunotoxins|immunotoxins|mesh-ancestor
138493196|NCT00006122|Immunoconjugates|immunoconjugates|mesh-ancestor
138493198|NCT00087802|Carboplatin|carboplatin|mesh-list
138493199|NCT00087802|Gemcitabine|gemcitabine|mesh-list
138493200|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
138493201|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138493202|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493203|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
138493204|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
138493205|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
138493206|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493207|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138493208|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
138493209|NCT00006125|Doxorubicin|doxorubicin|mesh-list
138493210|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138493211|NCT00006125|Topotecan|topotecan|mesh-list
138493212|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138493213|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378499|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
138493214|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138493215|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138493216|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493217|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493218|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138493219|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138318699|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
138493220|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138493221|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493222|NCT00087880|Bupropion|bupropion|mesh-list
138493223|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138493224|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
138493226|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138493227|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138493228|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138493229|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493230|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
138493231|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138493232|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690923|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
138493233|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138493234|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138493235|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493236|NCT00088036|Olanzapine|olanzapine|mesh-list
138493237|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
138493238|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
138493239|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493240|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493241|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138493242|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138493243|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138493244|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138493245|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138493246|NCT00088036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138493247|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138378535|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138378536|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138378538|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378539|NCT01449799|Fluticasone|fluticasone|mesh-list
138378541|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138493248|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138493249|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493250|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138493251|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
138493252|NCT00088075|Risperidone|risperidone|mesh-list
138493253|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138493254|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
138493255|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138493256|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493257|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169684|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493258|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138493259|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138493260|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138493261|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138493262|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138493263|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
138493264|NCT00088114|Paclitaxel|paclitaxel|mesh-list
138493265|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138493266|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493267|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
138493268|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
138493269|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
138493270|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493271|NCT00006131|Valacyclovir|valacyclovir|mesh-list
138493272|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
138493273|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493274|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
138493275|NCT00088231|Vatalanib|vatalanib|mesh-list
138493276|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493277|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138493278|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493279|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493280|NCT00088270|Leucovorin|leucovorin|mesh-list
138493281|NCT00088270|Fluorouracil|fluorouracil|mesh-list
138493282|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
138493283|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378571|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138493284|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138493285|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493286|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493287|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
138493288|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493289|NCT00088270|Antidotes|antidotes|mesh-ancestor
138493290|NCT00088270|Protective Agents|protective agents|mesh-ancestor
138493291|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
138493292|NCT00088270|Vitamins|vitamins|mesh-ancestor
138493293|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
138493294|NCT00088387|Valproic Acid|valproic acid|mesh-list
138493295|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138493296|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493297|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493298|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
138493299|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138493300|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138493301|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493302|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
138493303|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
138493304|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138174876|NCT01990677|Eplerenone|eplerenone|mesh-list
138493305|NCT00088504|Interferons|interferons|mesh-list
138493306|NCT00088504|Ribavirin|ribavirin|mesh-list
138493307|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
138493308|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
138493309|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138493310|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493311|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
138493312|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493313|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
138493314|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493315|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
138493316|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493317|NCT00006137|Enalapril|enalapril|mesh-list
138493318|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138493319|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
138493320|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493321|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493322|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138493323|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
138493324|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138493325|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
138493326|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493327|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493328|NCT00088582|Octreotide|octreotide|mesh-list
138493329|NCT00088582|Pasireotide|pasireotide|mesh-list
138493330|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138378608|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493331|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138493332|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138169771|NCT01670084|Vitamins|vitamins|mesh-ancestor
138493333|NCT00088582|Hormones|hormones|mesh-ancestor
138493334|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138493335|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493337|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493338|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138493339|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
138493340|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493341|NCT00088855|Doxorubicin|doxorubicin|mesh-list
138493342|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138493343|NCT00088855|Bortezomib|bortezomib|mesh-list
138493344|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138493345|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493346|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138493347|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138493348|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493349|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493350|NCT00088894|Bevacizumab|bevacizumab|mesh-list
138493351|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138493352|NCT00088894|Gemcitabine|gemcitabine|mesh-list
138493353|NCT00088894|Antibodies|antibodies|mesh-list
138493354|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
138493355|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138493356|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493357|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138493358|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138493360|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493361|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
138493362|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
138493363|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138493364|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
138493365|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493366|NCT00006152|Ritonavir|ritonavir|mesh-list
138493367|NCT00006152|Amprenavir|amprenavir|mesh-list
138493368|NCT00006152|Abacavir|abacavir|mesh-list
138690987|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138493369|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138378635|NCT01451853|Protective Agents|protective agents|mesh-ancestor
138378636|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138378637|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493370|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138493371|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
138493372|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493373|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493374|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138493375|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138493376|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
138493377|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493378|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138493379|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138493380|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138493381|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138493382|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138493383|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
138493384|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138493386|NCT00088933|Docetaxel|docetaxel|mesh-list
138493387|NCT00088933|Vaccines|vaccines|mesh-list
138493388|NCT00088933|Sargramostim|sargramostim|mesh-list
138493389|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
138493390|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493391|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493392|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
138493393|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
138493394|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
138493395|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493396|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493397|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138493398|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138493399|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138493400|NCT00089050|Cyclosporine|cyclosporine|mesh-list
138493401|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
138493402|NCT00089050|Cyclosporins|cyclosporins|mesh-list
138493403|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493404|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378670|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
138378671|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493405|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138378676|NCT01453062|Ofatumumab|ofatumumab|mesh-list
138493406|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
138493407|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493408|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
138493409|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493410|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
138493411|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138493412|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138493413|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138493414|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493415|NCT00089050|Immunotoxins|immunotoxins|mesh-ancestor
138493416|NCT00089050|Immunoconjugates|immunoconjugates|mesh-ancestor
138493417|NCT00006155|Carboplatin|carboplatin|mesh-list
138493419|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493420|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138493421|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138493422|NCT00006155|Growth Substances|growth substances|mesh-ancestor
138493423|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493424|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
138493425|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138493426|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493427|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493428|NCT00089089|Decitabine|decitabine|mesh-list
138493429|NCT00089089|Azacitidine|azacitidine|mesh-list
138493430|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138493431|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
138493432|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493433|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493434|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493435|NCT00089167|Thalidomide|thalidomide|mesh-list
138493436|NCT00089167|Dexamethasone|dexamethasone|mesh-list
138493437|NCT00089167|Melphalan|melphalan|mesh-list
138493438|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138493439|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
138493440|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
138493441|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493442|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493443|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138493444|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
138493445|NCT00089167|Hormones|hormones|mesh-ancestor
138637990|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138493446|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138493447|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138493448|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493449|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
138493450|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138493451|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
138378708|NCT05964387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138493452|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493453|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138493454|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493455|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
138378709|NCT05964387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138378710|NCT05964387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138493456|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138493457|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493458|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138493459|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138493460|NCT00089167|Growth Substances|growth substances|mesh-ancestor
138493461|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
138493463|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
138493464|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
138493465|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493466|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138493467|NCT00400231|Metformin|metformin|mesh-list
138493468|NCT00400231|Fenofibrate|fenofibrate|mesh-list
138493469|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138493470|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138681596|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
138493472|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
138493473|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493474|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138493475|NCT00006158|Testosterone|testosterone|mesh-list
138493476|NCT00006158|Androgens|androgens|mesh-ancestor
138493477|NCT00006158|Hormones|hormones|mesh-ancestor
138493478|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138493479|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493480|NCT00423826|Cytarabine|cytarabine|mesh-list
138493481|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
138493482|NCT00423826|Fludarabine|fludarabine|mesh-list
138493483|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
138493484|NCT00423826|Busulfan|busulfan|mesh-list
138493485|NCT00423826|Tacrolimus|tacrolimus|mesh-list
138493486|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493487|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138493488|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
138493489|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493490|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493491|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
138681646|NCT00506207|Irinotecan|irinotecan|mesh-list
138493492|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493493|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
138493494|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493495|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138493496|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493497|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138493498|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138493499|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
138493500|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138493501|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
138378730|NCT05964114|Vancomycin|vancomycin|mesh-list
138378731|NCT05964114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138493502|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138493503|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138493505|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493506|NCT00423865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138493507|NCT00423865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138493508|NCT00423865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493509|NCT00423865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493510|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493511|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
138493512|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493514|NCT00423982|Rifampin|rifampin|mesh-list
138493515|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138493516|NCT00423982|Cloxacillin|cloxacillin|mesh-list
138493517|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
138325647|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138493518|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138493519|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
138493520|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
138493521|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138493522|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493523|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493524|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138493525|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138493526|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138493527|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138493528|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138493529|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138493531|NCT02965261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138493532|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138493533|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138493534|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493535|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138493537|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493538|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138493539|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
138493540|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138493541|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138493542|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138493543|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378760|NCT05963334|Antimitotic Agents|antimitotic agents|mesh-ancestor
138378761|NCT05963334|Mitosis Modulators|mitosis modulators|mesh-ancestor
138378762|NCT05963334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493544|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
138493545|NCT00390156|Bevacizumab|bevacizumab|mesh-list
138493546|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
138493547|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493548|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
138493549|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493550|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138493551|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138493552|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
138493553|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493554|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493555|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138493556|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138493557|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138493558|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138169993|NCT00680797|Testosterone|testosterone|mesh-list
138493560|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
138493561|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138493562|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493563|NCT00089401|Melphalan|melphalan|mesh-list
138681810|NCT00505505|Insulin|insulin|mesh-list
138493564|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138493566|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493567|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493568|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138493569|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493570|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
138493571|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493572|NCT00089440|Aripiprazole|aripiprazole|mesh-list
138493573|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
138493574|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138493575|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138493576|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138493577|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138493578|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493579|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
138493580|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
138493581|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138493582|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493583|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138493584|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138378791|NCT05962775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378792|NCT05962671|Analgesics, Opioid|analgesics, opioid|mesh-list
138493586|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138493587|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138493588|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138493589|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138493591|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138493592|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138493593|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138493594|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493596|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
138493597|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
138493598|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
138493599|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493600|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493601|NCT00087451|Sirolimus|sirolimus|mesh-list
138493602|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138493603|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493604|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138493605|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493606|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
138493607|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138681860|NCT00519753|Timolol|timolol|mesh-list
138493608|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
138493609|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493610|NCT00089830|Squalamine|squalamine|mesh-list
138493611|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138493612|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493613|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138493614|NCT00089830|Protective Agents|protective agents|mesh-ancestor
138493615|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493616|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493617|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138493618|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138493619|NCT00089830|Growth Substances|growth substances|mesh-ancestor
138493620|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
138493622|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138493623|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
138493624|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
138493625|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493626|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493627|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138493628|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138493629|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138493630|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138493631|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138493632|NCT00089869|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138493633|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138493634|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138493635|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493636|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138493637|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
138493638|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138493639|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
138493640|NCT00006167|Oxandrolone|oxandrolone|mesh-list
138493641|NCT00006167|Androgens|androgens|mesh-ancestor
138493643|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138493644|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493645|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
138493646|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
138493647|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138493648|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
138493649|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493650|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493651|NCT00090025|Leucovorin|leucovorin|mesh-list
138493652|NCT00090025|Fluorouracil|fluorouracil|mesh-list
138493653|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
138493654|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493655|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138493656|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493657|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493658|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
138493659|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493660|NCT00090025|Antidotes|antidotes|mesh-ancestor
138493661|NCT00090025|Protective Agents|protective agents|mesh-ancestor
138493662|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
138493663|NCT00090025|Vitamins|vitamins|mesh-ancestor
138493664|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
138493665|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
138493666|NCT04633902|Olaparib|olaparib|mesh-list
138493667|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138318701|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
138493668|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493669|NCT04633902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138493670|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493671|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138493672|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325713|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138493674|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493675|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
138378857|NCT05961202|Hydroxychloroquine|hydroxychloroquine|mesh-list
138378858|NCT05961202|Prednisolone|prednisolone|mesh-list
138378859|NCT05961202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138378860|NCT05961202|Glucocorticoids|glucocorticoids|mesh-ancestor
138378861|NCT05961202|Hormones|hormones|mesh-ancestor
138378866|NCT05961202|Antimalarials|antimalarials|mesh-ancestor
138493676|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138493677|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493678|NCT00091039|Metronidazole|metronidazole|mesh-list
138493679|NCT00091039|Paclitaxel|paclitaxel|mesh-list
138493680|NCT00091039|Carboplatin|carboplatin|mesh-list
138493681|NCT00091039|Vaccines|vaccines|mesh-list
138493682|NCT00091039|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
138493683|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
138493684|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493685|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138493686|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493687|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
138493688|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
138493689|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
138493690|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493691|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493692|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138493693|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138493694|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138493695|NCT00091039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138493696|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
138493698|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493699|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138493700|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493701|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493702|NCT00091117|Bortezomib|bortezomib|mesh-list
138493703|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493704|NCT00091156|Gefitinib|gefitinib|mesh-list
138493705|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493706|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138493707|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378886|NCT05960721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138378887|NCT05960721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138493708|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493709|NCT00091195|Romidepsin|romidepsin|mesh-list
138493710|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138493711|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493712|NCT00091195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138493713|NCT00091195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493714|NCT00091195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493716|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138493717|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493718|NCT00091234|Immunotoxins|immunotoxins|mesh-ancestor
138493719|NCT00091234|Immunoconjugates|immunoconjugates|mesh-ancestor
138493720|NCT00091234|Immunologic Factors|immunologic factors|mesh-ancestor
138493721|NCT00091234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493722|NCT00091312|Leucovorin|leucovorin|mesh-list
138493723|NCT00091312|Fluorouracil|fluorouracil|mesh-list
138493724|NCT00091312|Irinotecan|irinotecan|mesh-list
138493725|NCT00091312|Calcium|calcium|mesh-list
138493726|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
138493727|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138493728|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493729|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
138493730|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493731|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138493732|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493733|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138325737|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
138493734|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
138493735|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138493736|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138493737|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493738|NCT00091312|Antidotes|antidotes|mesh-ancestor
138493739|NCT00091312|Protective Agents|protective agents|mesh-ancestor
138493740|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
138493741|NCT00091312|Vitamins|vitamins|mesh-ancestor
138493742|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
138493743|NCT04619706|Palmidrol|palmidrol|mesh-list
138493744|NCT04619706|Analgesics|analgesics|mesh-ancestor
138378931|NCT05928611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378932|NCT05928611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378933|NCT05917912|Amitriptyline|amitriptyline|mesh-list
138691154|NCT02923388|Pyridoxine|pyridoxine|mesh-list
138378934|NCT05917912|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138378935|NCT05917912|Antidepressive Agents|antidepressive agents|mesh-ancestor
138378936|NCT05917912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138378938|NCT05917912|Analgesics|analgesics|mesh-ancestor
138493745|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
138493746|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493747|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493748|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138493749|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138493750|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138493751|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138493752|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
138493753|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493754|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138493755|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138493756|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138493757|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493758|NCT04619706|Hormones|hormones|mesh-ancestor
138493759|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138493760|NCT00091429|Ranolazine|ranolazine|mesh-list
138493761|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138493762|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138493763|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493764|NCT00091468|Nicotine|nicotine|mesh-list
138493765|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138493766|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
138493767|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493768|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493769|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138378964|NCT05887726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378965|NCT05887726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138378966|NCT05887726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138493770|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138493771|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
138493772|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138493773|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493774|NCT00006200|Thalidomide|thalidomide|mesh-list
138493775|NCT00006200|Dacarbazine|dacarbazine|mesh-list
138493776|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493777|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
138493778|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493779|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
138493780|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138493781|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493782|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138493783|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138170208|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138493784|NCT00006200|Growth Substances|growth substances|mesh-ancestor
138493785|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
138493786|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493787|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138493788|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
138493789|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493791|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138493792|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138493793|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493794|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
138493795|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493796|NCT00091624|Lenalidomide|lenalidomide|mesh-list
138493797|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
138493798|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493799|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138493800|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138379010|NCT05854251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138493801|NCT00091624|Growth Substances|growth substances|mesh-ancestor
138379011|NCT05854251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138493802|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
138379014|NCT05848947|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
138379015|NCT05848947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138379016|NCT05848947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379018|NCT05841420|Gemcitabine|gemcitabine|mesh-list
138379019|NCT05841420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138379020|NCT05841420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379021|NCT05841420|Tubulin Modulators|tubulin modulators|mesh-ancestor
138379026|NCT05841420|Antimetabolites|antimetabolites|mesh-ancestor
138493803|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493804|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138493805|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493806|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138493807|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493808|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493809|NCT00006206|Naltrexone|naltrexone|mesh-list
138493810|NCT00006206|Acamprosate|acamprosate|mesh-list
138493811|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138493812|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138493813|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493814|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
138493815|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493816|NCT00091702|Vaccines|vaccines|mesh-list
138493817|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
138493818|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493820|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138493821|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138493822|NCT00091741|Analgesics|analgesics|mesh-ancestor
138493823|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
138493824|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493825|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493826|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138379042|NCT05818852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138379044|NCT05814146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138379046|NCT05801315|Glycine Agents|glycine agents|mesh-ancestor
138379047|NCT05801315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379048|NCT05801315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379049|NCT05801315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379050|NCT05798403|Solifenacin Succinate|solifenacin succinate|mesh-list
138379051|NCT05798403|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138379052|NCT05798403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138379082|NCT05734625|Hormones|hormones|mesh-ancestor
138493827|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138493828|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138493829|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493830|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
138493831|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
138493832|NCT00091858|Hematinics|hematinics|mesh-ancestor
138493833|NCT00390195|Everolimus|everolimus|mesh-list
138493834|NCT00390195|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138493835|NCT00390195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138493836|NCT00390195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493837|NCT00390195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493838|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138493839|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
138493840|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493841|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493842|NCT00091897|Rituximab|rituximab|mesh-list
138493843|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138493844|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493845|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
138493846|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493847|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138493848|NCT00006212|Vinblastine|vinblastine|mesh-list
138493849|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138682283|NCT00505700|Cytarabine|cytarabine|mesh-list
138493850|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138493851|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
138493852|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
138493853|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
138493854|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493855|NCT00091936|Lamivudine|lamivudine|mesh-list
138493856|NCT00091936|Efavirenz|efavirenz|mesh-list
138493857|NCT00091936|Didanosine|didanosine|mesh-list
138379086|NCT05734625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138493858|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138493859|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138691207|NCT02922803|Vitamin D|vitamin d|mesh-list
138493860|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379087|NCT05734625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379088|NCT05712096|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
138379089|NCT05712096|Antiviral Agents|antiviral agents|mesh-ancestor
138379090|NCT05712096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379091|NCT05671172|Bupivacaine|bupivacaine|mesh-list
138379092|NCT05671172|Anesthetics, Local|anesthetics, local|mesh-ancestor
138493861|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493863|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493865|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138493866|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138493867|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138493868|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138493869|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138493870|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138493871|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138493872|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
138493873|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138493874|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138493875|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
138493876|NCT02972346|Hormones|hormones|mesh-ancestor
138493877|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138493878|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493879|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138493880|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493881|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
138493882|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
138493883|NCT00092170|Ertapenem|ertapenem|mesh-list
138493884|NCT00092170|Ticarcillin|ticarcillin|mesh-list
138493885|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138493886|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493887|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493888|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138493889|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493890|NCT00006215|Docetaxel|docetaxel|mesh-list
138493891|NCT00006215|Vinorelbine|vinorelbine|mesh-list
138493892|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493893|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
138493894|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
138493895|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
138493896|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493897|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138493899|NCT00092287|Lanreotide|lanreotide|mesh-list
138493900|NCT00092287|Somatostatin|somatostatin|mesh-list
138493901|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138493902|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138493903|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493904|NCT00092287|Hormones|hormones|mesh-ancestor
138379120|NCT05618314|Uricosuric Agents|uricosuric agents|mesh-ancestor
138493905|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138379121|NCT05618314|Gout Suppressants|gout suppressants|mesh-ancestor
138379122|NCT05618314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138379123|NCT05603104|Lamotrigine|lamotrigine|mesh-list
138493906|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493907|NCT00092326|Acetaminophen|acetaminophen|mesh-list
138493908|NCT00092326|Rofecoxib|rofecoxib|mesh-list
138493909|NCT00092326|Oxycodone|oxycodone|mesh-list
138493910|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138493911|NCT00092326|Analgesics|analgesics|mesh-ancestor
138493912|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
138325781|NCT02063022|Etoposide|etoposide|mesh-list
138493913|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493914|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493915|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
138493916|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138493917|NCT00092326|Narcotics|narcotics|mesh-ancestor
138493918|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138682422|NCT00523458|Nevirapine|nevirapine|mesh-list
138493919|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138493920|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138493921|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493922|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493923|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138493924|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138493925|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138493926|NCT00092365|Celecoxib|celecoxib|mesh-list
138493927|NCT00092365|Rofecoxib|rofecoxib|mesh-list
138493928|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138493929|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138379149|NCT05603104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138379150|NCT05603104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138379152|NCT05603104|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138379153|NCT05603104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138379154|NCT05603104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138379155|NCT05603104|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138379157|NCT05603104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379158|NCT05603104|Antimanic Agents|antimanic agents|mesh-ancestor
138379159|NCT05603104|Anticonvulsants|anticonvulsants|mesh-ancestor
138493930|NCT00092365|Analgesics|analgesics|mesh-ancestor
138493931|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
138493932|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493933|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493934|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138493935|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138493936|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138493937|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138493938|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493939|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493941|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
138493942|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493943|NCT04728880|Remdesivir|remdesivir|mesh-list
138493944|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
138493945|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493946|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
138493947|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493948|NCT00093028|Bortezomib|bortezomib|mesh-list
138493949|NCT00093028|Lenalidomide|lenalidomide|mesh-list
138493950|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493951|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
138493952|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493953|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138493954|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138493955|NCT00093028|Growth Substances|growth substances|mesh-ancestor
138493956|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
138493957|NCT00093067|Daptomycin|daptomycin|mesh-list
138493958|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138493959|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138493960|NCT00093184|Anticoagulants|anticoagulants|mesh-list
138493961|NCT00093184|Bivalirudin|bivalirudin|mesh-list
138325798|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
138493962|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
138493963|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138493964|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
138493965|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493966|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493967|NCT00006224|Gemcitabine|gemcitabine|mesh-list
138493968|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138493969|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
138493970|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493971|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493972|NCT00093223|Paclitaxel|paclitaxel|mesh-list
138493973|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138379190|NCT05558956|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138493974|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138379191|NCT05558956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379192|NCT05542849|Acarbose|acarbose|mesh-list
138493975|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138493976|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
138493977|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
138493978|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
138493979|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493981|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138493982|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138493983|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493984|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138493985|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493986|NCT00093301|Simendan|simendan|mesh-list
138493987|NCT00093301|Dobutamine|dobutamine|mesh-list
138493988|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138493989|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
138493990|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138493991|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138493992|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138493993|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138493994|NCT00093301|Protective Agents|protective agents|mesh-ancestor
138493995|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138493996|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
138493997|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
138493998|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138493999|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138494000|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138494001|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138494002|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
138494003|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138494004|NCT00093418|Tipifarnib|tipifarnib|mesh-list
138494005|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494006|NCT00387608|Veliparib|veliparib|mesh-list
138494007|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138494008|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494009|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494010|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494011|NCT00093613|Sorafenib|sorafenib|mesh-list
138494012|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494013|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138494014|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494015|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379219|NCT05498233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138494016|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
138494017|NCT00093652|Gefitinib|gefitinib|mesh-list
138494018|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494020|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494021|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494022|NCT00006230|Rubitecan|rubitecan|mesh-list
138494023|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494024|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138494025|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138494026|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494027|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494028|NCT00093769|Rituximab|rituximab|mesh-list
138494029|NCT00093769|Bortezomib|bortezomib|mesh-list
138494030|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138494031|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494032|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
138494033|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494034|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138494035|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
138494036|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494037|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
138494038|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
138494039|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
138494040|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494042|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
138494043|NCT00006233|Fludarabine|fludarabine|mesh-list
138494045|NCT00006233|Cyclosporins|cyclosporins|mesh-list
138494046|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494047|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138494048|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
138494049|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494050|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138494051|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
138494052|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494053|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494054|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
138494055|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494056|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
138494057|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138494058|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138494059|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138494060|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138494061|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
138379248|NCT05428215|Contraceptive Agents|contraceptive agents|mesh-ancestor
138379249|NCT05428215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138379251|NCT05417646|Empagliflozin|empagliflozin|mesh-list
138494062|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138494063|NCT02964715|Empagliflozin|empagliflozin|mesh-list
138494064|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138494065|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494066|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138682618|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138494067|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494068|NCT00093886|Clevidipine|clevidipine|mesh-list
138494069|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
138494070|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
138494071|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138494072|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138494073|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494074|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138494075|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494076|NCT00093925|Nicardipine|nicardipine|mesh-list
138494077|NCT00093925|Clevidipine|clevidipine|mesh-list
138494078|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138494079|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138494080|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494081|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138494082|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494083|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138494084|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
138494086|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138494087|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494088|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
138494089|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
138494091|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
138494092|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494093|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
138494094|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
138494095|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379281|NCT05289323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138494096|NCT00094081|Tirapazamine|tirapazamine|mesh-list
138494097|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494098|NCT00094120|Squalamine|squalamine|mesh-list
138494099|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138494100|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494101|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138494102|NCT00094120|Protective Agents|protective agents|mesh-ancestor
138494103|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494104|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494105|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138494106|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138494107|NCT00094120|Growth Substances|growth substances|mesh-ancestor
138494108|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
138494109|NCT00006245|Paclitaxel|paclitaxel|mesh-list
138494110|NCT00006245|Alvocidib|alvocidib|mesh-list
138494111|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138494112|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494113|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
138494114|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
138494115|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
138494116|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494117|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
138494118|NCT00006245|Growth Substances|growth substances|mesh-ancestor
138494119|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494120|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138494121|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494123|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
138494124|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
138494125|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138494126|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494127|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
138494128|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138494129|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138494130|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138494131|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138494132|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138325853|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
138494133|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494134|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
138494135|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138494136|NCT00094432|Aripiprazole|aripiprazole|mesh-list
138494137|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
138494138|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138494139|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138494140|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138494141|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138494142|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494143|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
138494144|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
138379324|NCT05213650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138494145|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138494146|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494147|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138494148|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138494149|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
138494150|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138494151|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138494152|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138494153|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138494154|NCT00006248|Paclitaxel|paclitaxel|mesh-list
138494155|NCT00006248|Fluorouracil|fluorouracil|mesh-list
138494156|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138170590|NCT01799083|Decitabine|decitabine|mesh-list
138494157|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494158|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
138494159|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
138494160|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
138494161|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494162|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
138494163|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138494164|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138494165|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
138494166|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379349|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138379350|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
138379351|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138379352|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
138379353|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379354|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379355|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138379356|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138379357|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138379358|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
138379359|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
138379362|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
138494167|NCT00094549|Valproic Acid|valproic acid|mesh-list
138494168|NCT00094549|Olanzapine|olanzapine|mesh-list
138494169|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
138494170|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
138494171|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138494172|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494173|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138494174|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138494175|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138494176|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138494177|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138494178|NCT00094549|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138494179|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138494180|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138494181|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494182|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138494184|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
138494185|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325880|NCT01253070|Cytarabine|cytarabine|mesh-list
138494187|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
138494188|NCT00094627|Gaboxadol|gaboxadol|mesh-list
138494189|NCT00094627|Analgesics|analgesics|mesh-ancestor
138494190|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
138494191|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138494192|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494193|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
138494194|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
138494195|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
138494196|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138494197|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494199|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138494200|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494201|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379392|NCT05099198|Incretins|incretins|mesh-ancestor
138494202|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138494203|NCT00094666|Analgesics|analgesics|mesh-ancestor
138494204|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
138494205|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
138494206|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
138494207|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
138494208|NCT00006251|Cyclosporine|cyclosporine|mesh-list
138494209|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
138494210|NCT00006251|Fludarabine|fludarabine|mesh-list
138494211|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
138494212|NCT00006251|Cyclosporins|cyclosporins|mesh-list
138494213|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494214|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138494215|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
138494216|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494217|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138494218|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
138494219|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494220|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494221|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
138494222|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494223|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
138494224|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138494225|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138494226|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138494227|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138494228|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
138379432|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138494229|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138379433|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138379434|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
138494231|NCT00094978|Romidepsin|romidepsin|mesh-list
138494232|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494233|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
138494234|NCT00094978|Growth Substances|growth substances|mesh-ancestor
138494235|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494236|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138494237|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494238|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494239|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138494240|NCT00094978|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138494242|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138494243|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
138494244|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138494245|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494246|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494247|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138494248|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138494249|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138494250|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138494251|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138494252|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
138494254|NCT00006257|Semaxinib|semaxinib|mesh-list
138494255|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138494256|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494257|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
138494258|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
138494259|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
138494260|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494261|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138494262|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138494263|NCT00006257|Growth Substances|growth substances|mesh-ancestor
138683026|NCT02946060|TEMPO|tempo|mesh-list
138494264|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494265|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
138318705|NCT01382940|Hormones|hormones|mesh-ancestor
138494266|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138494267|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494268|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
138379479|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
138494269|NCT00095251|Lorazepam|lorazepam|mesh-list
138494270|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138494271|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138494272|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494273|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138494274|NCT00095251|Analgesics|analgesics|mesh-ancestor
138494275|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
138494276|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138494277|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138494278|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138494279|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138494280|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
138494281|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138494282|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494283|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
138494284|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
138494285|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
138494286|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138494287|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138494288|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138494289|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138494290|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
138494291|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
138494292|NCT00006260|Etoposide|etoposide|mesh-list
138494293|NCT00006260|Ifosfamide|ifosfamide|mesh-list
138494294|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494295|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138494296|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138494297|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138494298|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494299|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494300|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138494301|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
138494302|NCT00095329|Sirolimus|sirolimus|mesh-list
138494303|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138494304|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494305|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138494306|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494307|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
138494308|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138170737|NCT00590863|Dexetimide|dexetimide|mesh-list
138494309|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
138494310|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494311|NCT00095368|Amoxicillin|amoxicillin|mesh-list
138494312|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138494313|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494314|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
138494315|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138494316|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494317|NCT00006263|Carboplatin|carboplatin|mesh-list
138494318|NCT00006263|Temozolomide|temozolomide|mesh-list
138494319|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494320|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138494321|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
138494322|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494323|NCT00095524|Aripiprazole|aripiprazole|mesh-list
138494324|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
138494325|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138494326|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138494327|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138494328|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138494329|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494330|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
138494331|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
138494332|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138494333|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494334|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138379554|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138379555|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379557|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379558|NCT04910711|Dolutegravir|dolutegravir|mesh-list
138379560|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
138494335|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138494336|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
138494337|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138494338|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138494339|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138494340|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138494341|NCT00095641|Capecitabine|capecitabine|mesh-list
138494342|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138494343|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
138494344|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494345|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494346|NCT00006269|Irinotecan|irinotecan|mesh-list
138494347|NCT00006269|Octreotide|octreotide|mesh-list
138494348|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138494349|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138494350|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494351|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494352|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494353|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138494354|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138494355|NCT00095680|Bortezomib|bortezomib|mesh-list
138494356|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494357|NCT00095719|Aripiprazole|aripiprazole|mesh-list
138494358|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
138494359|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138494360|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138494361|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138494362|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138494363|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494364|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
138494365|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
138494366|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138494367|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494368|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138494369|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138379598|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138379599|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
138379600|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379601|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379602|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138494370|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
138494371|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138494372|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138494373|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138494374|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138494376|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
138494377|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138494378|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138494379|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138494380|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138494381|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494382|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
138494383|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
138494384|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138494385|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494386|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138494387|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138691401|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
138494389|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138494390|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138494391|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138494392|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138494393|NCT00095914|Paclitaxel|paclitaxel|mesh-list
138494394|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138494395|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138494396|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494397|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
138494398|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
138494399|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
138494400|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379634|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494401|NCT04432428|Sufentanil|sufentanil|mesh-list
138379635|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138379636|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138379637|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138494402|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138494403|NCT04432428|Narcotics|narcotics|mesh-ancestor
138494404|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138494405|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494406|NCT04432428|Analgesics|analgesics|mesh-ancestor
138494407|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
138494408|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138494409|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138494410|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138494411|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
138494412|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
138494413|NCT00096070|Gemcitabine|gemcitabine|mesh-list
138494414|NCT00096070|Fluorouracil|fluorouracil|mesh-list
138494415|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
138494416|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138494417|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
138683367|NCT00509405|Expectorants|expectorants|mesh-ancestor
138494418|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494419|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494420|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138494421|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
138494422|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494423|NCT00006275|Calcitriol|calcitriol|mesh-list
138494424|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138494425|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494426|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138494427|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138494428|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494429|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138494430|NCT00006275|Vitamins|vitamins|mesh-ancestor
138494431|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
138494432|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138494433|NCT00096148|Cytarabine|cytarabine|mesh-list
138494434|NCT00096148|Bevacizumab|bevacizumab|mesh-list
138494435|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138494436|NCT00096148|Idarubicin|idarubicin|mesh-list
138494437|NCT00096148|Antibodies|antibodies|mesh-list
138494438|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
138494439|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138494440|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494441|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138494442|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138494443|NCT00096148|Growth Substances|growth substances|mesh-ancestor
138494444|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494445|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
138494446|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
138494447|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138494448|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
138494449|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494451|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494452|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138494453|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138494454|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138494455|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138494456|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494457|NCT00096187|Pemetrexed|pemetrexed|mesh-list
138494458|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494459|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138325991|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494460|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494462|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138494464|NCT00096304|Epirubicin|epirubicin|mesh-list
138494465|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494466|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
138494467|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
138494468|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
138494469|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494470|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138494471|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138494472|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138494473|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494474|NCT00096343|Paclitaxel|paclitaxel|mesh-list
138494475|NCT00096343|Carboplatin|carboplatin|mesh-list
138494476|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138494477|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494478|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
138494479|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
138494480|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
138494481|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494482|NCT00096616|Albuterol|albuterol|mesh-list
138494483|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138379698|NCT06040489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379699|NCT06040346|Meplazumab|meplazumab|mesh-list
138494484|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
138494485|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138494486|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494487|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138494488|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
138494489|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
138494490|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138494491|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138494492|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138683444|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138494493|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138494494|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
138494495|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138494496|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494497|NCT00096655|Infliximab|infliximab|mesh-list
138494498|NCT00096655|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138494499|NCT00096655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138494500|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
138494501|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138494502|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138494503|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
138494504|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138494505|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
138494506|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138494507|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494508|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138494509|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138494510|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138494511|NCT00006299|Celecoxib|celecoxib|mesh-list
138494512|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138494513|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138494514|NCT00006299|Analgesics|analgesics|mesh-ancestor
138494515|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
138494516|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138494517|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494518|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138494519|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138326006|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
138494520|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138379749|NCT06040112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138379757|NCT06039592|Metoprolol|metoprolol|mesh-list
138494521|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138494522|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494523|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494524|NCT00096811|Entecavir|entecavir|mesh-list
138494525|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
138494526|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494527|NCT00096850|Ritonavir|ritonavir|mesh-list
138494528|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138494529|NCT00096850|Rifampin|rifampin|mesh-list
138494530|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138494531|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138494532|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
138494533|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494534|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494535|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138494537|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
138494538|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494539|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138494540|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138494541|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138494542|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
138494543|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138494544|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
138494545|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138494546|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138494547|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138494548|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138494549|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138494550|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138494551|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138379782|NCT06039592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138379783|NCT06039592|Protease Inhibitors|protease inhibitors|mesh-ancestor
138379784|NCT06039592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379785|NCT06039592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138379786|NCT06039592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138379787|NCT06039540|Metoprolol|metoprolol|mesh-list
138379788|NCT06039540|Captopril|captopril|mesh-list
138379789|NCT06039540|Torsemide|torsemide|mesh-list
138379790|NCT06039540|Spironolactone|spironolactone|mesh-list
138379791|NCT06039540|Potassium Citrate|potassium citrate|mesh-list
138494552|NCT00096967|Bevacizumab|bevacizumab|mesh-list
138494553|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138494554|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494555|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138494556|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138494557|NCT00096967|Growth Substances|growth substances|mesh-ancestor
138494558|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494559|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
138494560|NCT00097045|Interferons|interferons|mesh-list
138494561|NCT00097045|Ribavirin|ribavirin|mesh-list
138494562|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
138494563|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494565|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494566|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
138494567|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494568|NCT00097084|Insulin|insulin|mesh-list
138494569|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138494570|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
138494571|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
138494572|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
138494573|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138494574|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494575|NCT04310709|Nivolumab|nivolumab|mesh-list
138494576|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138494577|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494578|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138494579|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494580|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
138494581|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138494582|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
138494583|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494584|NCT00097123|Misoprostol|misoprostol|mesh-list
138494585|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138494586|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
138379817|NCT06039423|Ketorolac|ketorolac|mesh-list
138494587|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138494588|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494589|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138494590|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138494591|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
138494592|NCT00097279|Metformin|metformin|mesh-list
138494593|NCT00097279|Pioglitazone|pioglitazone|mesh-list
138494594|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
138494595|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
138494596|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138494597|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494598|NCT00390273|Metformin|metformin|mesh-list
138494599|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138494600|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494601|NCT00097318|Interferons|interferons|mesh-list
138494602|NCT00097318|Interferon-beta|interferon-beta|mesh-list
138494603|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
138494604|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494605|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
138494606|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494607|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
138494608|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138171036|NCT02995057|Nickel|nickel|mesh-list
138494609|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138494610|NCT00097435|Ribavirin|ribavirin|mesh-list
138379859|NCT06039202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494611|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
138379860|NCT06039202|Growth Inhibitors|growth inhibitors|mesh-ancestor
138379861|NCT06039202|Antimetabolites|antimetabolites|mesh-ancestor
138494612|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494613|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
138494614|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494615|NCT00006326|Ritonavir|ritonavir|mesh-list
138494616|NCT00006326|Indinavir|indinavir|mesh-list
138494617|NCT00006326|Delavirdine|delavirdine|mesh-list
138494618|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138494619|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138494620|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
138494621|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494622|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494623|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138494624|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138494625|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
138494626|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691488|NCT05466708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138494627|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138494628|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138494630|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138494632|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138494633|NCT00390312|Narcotics|narcotics|mesh-ancestor
138494634|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138494635|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494636|NCT00390312|Analgesics|analgesics|mesh-ancestor
138494637|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
138494638|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138494639|NCT00400387|Riboflavin|riboflavin|mesh-list
138494640|NCT00400387|Thiamine|thiamine|mesh-list
138494642|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
138379908|NCT06038552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379909|NCT06038552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138379910|NCT06038552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494643|NCT00400387|Folic Acid|folic acid|mesh-list
138494644|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
138494645|NCT00400387|Tocopherols|tocopherols|mesh-list
138494646|NCT00400387|Vitamin E|vitamin e|mesh-list
138494647|NCT00400387|Tocotrienols|tocotrienols|mesh-list
138494648|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
138494649|NCT00400387|Heparin|heparin|mesh-list
138494650|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138494651|NCT00400387|Tinzaparin|tinzaparin|mesh-list
138494652|NCT00400387|Dalteparin|dalteparin|mesh-list
138494653|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494654|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
138494655|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138494656|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138494657|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494658|NCT00400387|Vitamins|vitamins|mesh-ancestor
138494659|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
138494660|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138494661|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
138494662|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
138494663|NCT00400387|Protective Agents|protective agents|mesh-ancestor
138379950|NCT06037434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379951|NCT06037434|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138494664|NCT00400387|Hematinics|hematinics|mesh-ancestor
138494665|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138494666|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
138494667|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
138494668|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494669|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494670|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138494671|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138494672|NCT00006332|Growth Substances|growth substances|mesh-ancestor
138494673|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494675|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494676|NCT00390390|Lansoprazole|lansoprazole|mesh-list
138494677|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
138494678|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138494679|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138494680|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138494681|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494682|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494683|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
138171116|NCT04200833|Golimumab|golimumab|mesh-list
138494684|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138494685|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494686|NCT00097903|Camptothecin|camptothecin|mesh-list
138494687|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138494688|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494689|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138494690|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138494692|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494693|NCT00097942|Memantine|memantine|mesh-list
138494694|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138494695|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138494696|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
138380013|NCT05806931|Growth Substances|growth substances|mesh-ancestor
138494697|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138380015|NCT05806931|Growth Inhibitors|growth inhibitors|mesh-ancestor
138494698|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494699|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494701|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138494702|NCT04294836|Curcumin|curcumin|mesh-list
138494703|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138494704|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138494705|NCT04294836|Analgesics|analgesics|mesh-ancestor
138494706|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
138494707|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138494708|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494709|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138494710|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138494711|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494712|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494713|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494714|NCT00098137|Olmesartan|olmesartan|mesh-list
138494715|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138494716|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138494717|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138494718|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494719|NCT00098488|Rituximab|rituximab|mesh-list
138494720|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138494721|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494722|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
138494723|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494724|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138494725|NCT00098527|Romidepsin|romidepsin|mesh-list
138494726|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138494727|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494728|NCT00098527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138494729|NCT00098527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494730|NCT00098527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380057|NCT05548985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683731|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
138494731|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138380061|NCT05548985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138494733|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
138494734|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138494735|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
138494736|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494737|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494738|NCT00098605|Lapatinib|lapatinib|mesh-list
138494739|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494740|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138494741|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494742|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494744|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138494745|NCT00098683|Protective Agents|protective agents|mesh-ancestor
138494746|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494747|NCT00098800|Fenretinide|fenretinide|mesh-list
138494748|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494749|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138494750|NCT00098800|Protective Agents|protective agents|mesh-ancestor
138494751|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494752|NCT00098878|Carboplatin|carboplatin|mesh-list
138494753|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494754|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138494755|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138494756|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494757|NCT00098917|Vaccines|vaccines|mesh-list
138494758|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
138380097|NCT05433116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380098|NCT05433116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138380099|NCT05433116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494759|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494760|NCT00098995|Tirapazamine|tirapazamine|mesh-list
138683771|NCT00513188|Leucovorin|leucovorin|mesh-list
138494761|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494762|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
138494763|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494764|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138494765|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138494766|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494767|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494768|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
138494769|NCT00099502|Interferons|interferons|mesh-list
138494770|NCT00099502|Interferon-beta|interferon-beta|mesh-list
138326067|NCT04779060|Dexamethasone|dexamethasone|mesh-list
138494771|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
138494772|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
138494773|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494774|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
138494775|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494776|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
138494777|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494778|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138494779|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138494780|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138494782|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494783|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138494784|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138494785|NCT00387920|Growth Substances|growth substances|mesh-ancestor
138494786|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494787|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
138494788|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138494789|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494790|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380147|NCT05221580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138494791|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
138494792|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138494793|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494795|NCT00006350|Tacrolimus|tacrolimus|mesh-list
138494796|NCT00006350|Daclizumab|daclizumab|mesh-list
138494797|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138494798|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
138494799|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494800|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138494801|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494802|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494803|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138494804|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494805|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138683882|NCT00513578|Sargramostim|sargramostim|mesh-list
138494806|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
138494807|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138494808|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494810|NCT00400582|Candesartan cilexetil|candesartan cilexetil|mesh-list
138494811|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138494812|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138494813|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138494814|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494815|NCT00400621|Acetaminophen|acetaminophen|mesh-list
138494816|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138494817|NCT00400621|Analgesics|analgesics|mesh-ancestor
138494818|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
138494819|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138494820|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494821|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
138494822|NCT00006353|Temozolomide|temozolomide|mesh-list
138380191|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138494823|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138380192|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138380193|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138380194|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138380195|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
138380196|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138380197|NCT05192889|Antidotes|antidotes|mesh-ancestor
138380198|NCT05192889|Protective Agents|protective agents|mesh-ancestor
138380199|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
138380200|NCT05192889|Vitamins|vitamins|mesh-ancestor
138380201|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
138380202|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
138380203|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
138380204|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
138380205|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138380206|NCT05168163|Atezolizumab|atezolizumab|mesh-list
138380208|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138380209|NCT05168163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138380210|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494824|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
138494825|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138683930|NCT00512291|Fluoxetine|fluoxetine|mesh-list
138494827|NCT00400738|Ritonavir|ritonavir|mesh-list
138494828|NCT00400738|Lopinavir|lopinavir|mesh-list
138494829|NCT00400738|Saquinavir|saquinavir|mesh-list
138494830|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138494831|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138494832|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
138494842|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494844|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138494845|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
138494846|NCT00099619|Exenatide|exenatide|mesh-list
138494847|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138494848|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494849|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138494850|NCT00099619|Incretins|incretins|mesh-ancestor
138494851|NCT00099619|Hormones|hormones|mesh-ancestor
138494852|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138380239|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
138380240|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138494853|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
138380241|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138494854|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
138494855|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138494856|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494857|NCT00099736|Cyclosporine|cyclosporine|mesh-list
138494858|NCT00099736|Cyclosporins|cyclosporins|mesh-list
138494859|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138494860|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
138494861|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494862|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
138494863|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494864|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494865|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138691618|NCT02932137|Analgesics|analgesics|mesh-ancestor
138494866|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
138683982|NCT00531336|Growth Substances|growth substances|mesh-ancestor
138494867|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494868|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138494869|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138494870|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138494881|NCT00099775|Caspofungin|caspofungin|mesh-list
138494882|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
138494883|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494884|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494885|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494886|NCT00006362|Bortezomib|bortezomib|mesh-list
138494887|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380294|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138380295|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
138494888|NCT00099892|Vildagliptin|vildagliptin|mesh-list
138494889|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138494890|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494891|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138494892|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
138494893|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494894|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494895|NCT00099931|Vildagliptin|vildagliptin|mesh-list
138494896|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138494897|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494898|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138494899|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
138494900|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494901|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494902|NCT00099970|Dacarbazine|dacarbazine|mesh-list
138494903|NCT00099970|Volociximab|volociximab|mesh-list
138494904|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138494905|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
138380344|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138494906|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380345|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494907|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494908|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138494909|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138171341|NCT02987985|Analgesics|analgesics|mesh-ancestor
138494910|NCT00099970|Growth Substances|growth substances|mesh-ancestor
138494911|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494912|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
138494913|NCT00100009|Triamcinolone|triamcinolone|mesh-list
138494914|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138494915|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138494916|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138494917|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138494918|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
138494919|NCT00100009|Hormones|hormones|mesh-ancestor
138494920|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138684087|NCT00530907|Bevacizumab|bevacizumab|mesh-list
138494921|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494922|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138494923|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
138494924|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494925|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494926|NCT00100126|Amoxicillin|amoxicillin|mesh-list
138494927|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138494928|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494929|NCT00100243|Abarelix|abarelix|mesh-list
138494930|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
138494931|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138494932|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494933|NCT00006368|Edotreotide|edotreotide|mesh-list
138494934|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138494935|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494936|NCT00100477|Etoposide|etoposide|mesh-list
138494937|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
138494938|NCT00100477|Topotecan|topotecan|mesh-list
138380402|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138494939|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138494940|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494941|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138494942|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138494943|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494944|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494945|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138494946|NCT00100477|Analgesics|analgesics|mesh-ancestor
138494947|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
138494948|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138494949|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494950|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
138494951|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138494952|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494953|NCT00006371|Ketoconazole|ketoconazole|mesh-list
138494954|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
138494955|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138494956|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138494957|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138494958|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
138494959|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138326094|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138326095|NCT01895400|Protective Agents|protective agents|mesh-ancestor
138326098|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494961|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494962|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138494963|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138494964|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380443|NCT03887650|Epinephrine|epinephrine|mesh-list
138494965|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494966|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138494967|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
138494968|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138494969|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138494970|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138691662|NCT02919878|Gemcitabine|gemcitabine|mesh-list
138494971|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138494972|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494973|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138494974|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138494975|NCT00100594|Lamivudine|lamivudine|mesh-list
138494976|NCT00100594|Zidovudine|zidovudine|mesh-list
138494977|NCT00100594|Efavirenz|efavirenz|mesh-list
138494978|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138494979|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138494980|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138494981|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171408|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138494982|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138494983|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
138494984|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138494985|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138494986|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138494987|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
138494988|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138494989|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138494990|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138494991|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138494992|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138494993|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138494994|NCT00006374|Paclitaxel|paclitaxel|mesh-list
138494995|NCT00006374|Etoposide|etoposide|mesh-list
138494996|NCT00006374|Topotecan|topotecan|mesh-list
138494997|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138494998|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138494999|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
138495000|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
138495001|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
138495002|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326101|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326102|NCT05605314|Cyclosporine|cyclosporine|mesh-list
138326103|NCT05605314|Cyclosporins|cyclosporins|mesh-list
138326104|NCT05605314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326105|NCT05605314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326106|NCT05605314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326107|NCT05605314|Immunologic Factors|immunologic factors|mesh-ancestor
138380541|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138326108|NCT05605314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495003|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138380554|NCT03404180|Analgesics|analgesics|mesh-ancestor
138495004|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138495005|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495006|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138495008|NCT00100750|Tipifarnib|tipifarnib|mesh-list
138495009|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138495010|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
138495011|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138684266|NCT05319912|Antimetabolites|antimetabolites|mesh-ancestor
138495012|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495014|NCT00006377|Carboplatin|carboplatin|mesh-list
138495015|NCT00006377|Doxorubicin|doxorubicin|mesh-list
138495016|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138495017|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138495018|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495019|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
138495020|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
138495021|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
138495022|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495023|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138495024|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138495025|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138495026|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495027|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
138380595|NCT03264131|Immunoconjugates|immunoconjugates|mesh-ancestor
138495028|NCT01350102|Bacitracin|bacitracin|mesh-list
138495029|NCT01350102|Vitamins|vitamins|mesh-ancestor
138495030|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
138495031|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495033|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495034|NCT01350102|Protective Agents|protective agents|mesh-ancestor
138380596|NCT03264131|Immunologic Factors|immunologic factors|mesh-ancestor
138495035|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138495036|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495037|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138495038|NCT00424060|Sagopilone|sagopilone|mesh-list
138495039|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380597|NCT03264131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495040|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138495041|NCT00006380|Antibodies|antibodies|mesh-list
138495042|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
138495043|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138495044|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
138495045|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495046|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495047|NCT00100906|Aldesleukin|aldesleukin|mesh-list
138495048|NCT00100906|Interleukin-2|interleukin-2|mesh-list
138495049|NCT00100906|Tretinoin|tretinoin|mesh-list
138495050|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495051|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138495052|NCT00100906|Analgesics|analgesics|mesh-ancestor
138495053|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
138495054|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495055|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495056|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138495057|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138495058|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
138495059|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495060|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
138495061|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
138495062|NCT00100945|Gefitinib|gefitinib|mesh-list
138380635|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495063|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495064|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138495065|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495066|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495067|NCT00006383|Vincristine|vincristine|mesh-list
138326122|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
138495068|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138495069|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380636|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
138495070|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
138495071|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
138495072|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
138495073|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495074|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
138495075|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138495076|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138495077|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495078|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138495079|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138495080|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
138495081|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495082|NCT00101062|Celecoxib|celecoxib|mesh-list
138495083|NCT00101062|Letrozole|letrozole|mesh-list
138495084|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495085|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138495086|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138495087|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495088|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495089|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138495090|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
138495091|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138495092|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495093|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138495094|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138495095|NCT00101062|Analgesics|analgesics|mesh-ancestor
138495096|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
138495097|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495098|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138380682|NCT02807207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138380683|NCT02807207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138380685|NCT02807116|Rifampin|rifampin|mesh-list
138495099|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138495100|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138495101|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138495103|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138495104|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
138495105|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495106|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495108|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
138495109|NCT00101140|Thiotepa|thiotepa|mesh-list
138495110|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138495111|NCT00101140|Immunomodulating Agents|immunomodulating agents|mesh-list
138495112|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495113|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138495114|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
138495115|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495116|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138495117|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
138495118|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495119|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138495120|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
138495121|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138495122|NCT00101179|Azacitidine|azacitidine|mesh-list
138495123|NCT00101179|Entinostat|entinostat|mesh-list
138495124|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138495125|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138495126|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
138495127|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495128|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495129|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495130|NCT00400777|Amlodipine|amlodipine|mesh-list
138495131|NCT00400777|Valsartan|valsartan|mesh-list
138380724|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138495132|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138495133|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138495134|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138495135|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138495136|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495137|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138495138|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495139|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
138495140|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138495141|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138495142|NCT00400777|Diuretics|diuretics|mesh-ancestor
138495143|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
138495144|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138495145|NCT00400816|Temozolomide|temozolomide|mesh-list
138495146|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138495147|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
138495148|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495149|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495150|NCT00400855|Fluticasone|fluticasone|mesh-list
138495152|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138495153|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138495154|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
138495155|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495156|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495157|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138495158|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
138326171|NCT01896960|Narcotics|narcotics|mesh-ancestor
138495159|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
138495160|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138495161|NCT00101296|Tipifarnib|tipifarnib|mesh-list
138495162|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495163|NCT00006398|Timolol|timolol|mesh-list
138495164|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495165|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138495166|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138495167|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
138495168|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495169|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495170|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138495171|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138380769|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380771|NCT01990196|Dasatinib|dasatinib|mesh-list
138495172|NCT00101335|Celecoxib|celecoxib|mesh-list
138495173|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138495174|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138495175|NCT00101335|Analgesics|analgesics|mesh-ancestor
138495176|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
138495177|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495178|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495179|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138495180|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138495181|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138684509|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
138495182|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138495183|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495184|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495185|NCT00101374|Leflunomide|leflunomide|mesh-list
138495186|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495187|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495188|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138495189|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
138691738|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
138495190|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495191|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
138495192|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138495193|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
138495194|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495195|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495196|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138495197|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
138495198|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138495199|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
138495200|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495201|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495202|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138495203|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
138495204|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
138380806|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495205|NCT00006401|Protective Agents|protective agents|mesh-ancestor
138495206|NCT00101569|Aripiprazole|aripiprazole|mesh-list
138495207|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
138495208|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138495209|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138495210|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138495211|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138495212|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495213|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
138495214|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
138495215|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495216|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495217|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138495218|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138495219|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
138495220|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138495221|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138684533|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
138495222|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138495223|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138495224|NCT00101764|Triamcinolone|triamcinolone|mesh-list
138495225|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138495226|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138495227|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138495228|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138495229|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
138495230|NCT00101764|Hormones|hormones|mesh-ancestor
138380842|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
138380844|NCT00716066|Prednisone|prednisone|mesh-list
138380845|NCT00716066|Cortisone|cortisone|mesh-list
138380846|NCT00716066|Etoposide|etoposide|mesh-list
138495231|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138495232|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495233|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138495234|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
138495235|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495236|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495237|NCT00101803|Vildagliptin|vildagliptin|mesh-list
138495238|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138495239|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495240|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138495241|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
138495242|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495243|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495244|NCT00101842|Gemcitabine|gemcitabine|mesh-list
138495246|NCT00101842|Cisplatin|cisplatin|mesh-list
138495247|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138495248|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
138495249|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495250|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495251|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495252|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138326234|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138495253|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138495254|NCT00102115|Talaporfin|talaporfin|mesh-list
138495255|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495256|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138495257|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
138495258|NCT00102154|Gaboxadol|gaboxadol|mesh-list
138495259|NCT00102154|Analgesics|analgesics|mesh-ancestor
138495260|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
138495261|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495262|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495263|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
138380896|NCT04787289|Growth Substances|growth substances|mesh-ancestor
138380898|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
138495264|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
138495265|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
138495266|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495267|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495268|NCT00102271|Oxypurinol|oxypurinol|mesh-list
138495269|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495270|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495271|NCT00102310|Z 338|z 338|mesh-list
138495272|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138495273|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495274|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495275|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
138495276|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495277|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495278|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138495279|NCT00102388|Vildagliptin|vildagliptin|mesh-list
138495280|NCT00102388|Gliclazide|gliclazide|mesh-list
138495281|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138495282|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495283|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138380937|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138495284|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
138495285|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380938|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138380939|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138380940|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
138380941|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138380942|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138380943|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138380944|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
138495286|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495287|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
138495288|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495289|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138495290|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
138495292|NCT00102583|Cyclosporins|cyclosporins|mesh-list
138495293|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495294|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495295|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326252|NCT00060528|Metronidazole|metronidazole|mesh-list
138495296|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
138495297|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495298|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
138495299|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495300|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
138495301|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138495302|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138495304|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138495305|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495306|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
138495307|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
138495308|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
138495309|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495310|NCT00006428|Amitriptyline|amitriptyline|mesh-list
138495311|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138495312|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
138495313|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138495314|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138495315|NCT00006428|Analgesics|analgesics|mesh-ancestor
138495316|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
138380990|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
138380991|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
138495317|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495318|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495319|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138495320|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138495321|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138495322|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495323|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
138495324|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495325|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
138691807|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138495326|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138495327|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495328|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
138495329|NCT00102700|Gemcitabine|gemcitabine|mesh-list
138495330|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138495332|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495333|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495334|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495335|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138495336|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138495337|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495338|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
138495340|NCT00102778|Lopinavir|lopinavir|mesh-list
138495341|NCT00102778|Aplaviroc|aplaviroc|mesh-list
138495342|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138495343|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138495344|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
138495345|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495346|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381037|NCT04518410|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
138381038|NCT04518410|Gabexate|gabexate|mesh-list
138495347|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138495348|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138495349|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
138495350|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495351|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138495352|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138495353|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138495354|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138495355|NCT00101998|Alvimopan|alvimopan|mesh-list
138495356|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138495357|NCT00102856|Pramipexole|pramipexole|mesh-list
138326287|NCT01897038|Sorafenib|sorafenib|mesh-list
138495358|NCT00102856|Rivastigmine|rivastigmine|mesh-list
138495359|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
138495360|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495361|NCT00102856|Protective Agents|protective agents|mesh-ancestor
138495362|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495363|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138495364|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138495365|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
138381080|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
138495366|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
138495367|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495368|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138495369|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495370|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
138495371|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138495372|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
138495373|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138495374|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138495375|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495376|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138495377|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138495378|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
138495379|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495380|NCT00006443|Lamivudine|lamivudine|mesh-list
138495381|NCT00006443|Stavudine|stavudine|mesh-list
138495382|NCT00006443|Nelfinavir|nelfinavir|mesh-list
138495383|NCT00006443|Indinavir|indinavir|mesh-list
138495384|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138495385|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138495386|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495387|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495388|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
138495389|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495390|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138495391|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138495392|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138495393|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138495394|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
138381139|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495395|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
138495396|NCT00102973|Carboplatin|carboplatin|mesh-list
138495397|NCT00102973|Doxorubicin|doxorubicin|mesh-list
138495398|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138495399|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495400|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138495401|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138381140|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
138495402|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138495403|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495404|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495405|NCT00103051|Gemcitabine|gemcitabine|mesh-list
138495406|NCT00103051|Gefitinib|gefitinib|mesh-list
138495407|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495408|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138495409|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
138495410|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495411|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138495412|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495413|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
138495414|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495415|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138495416|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495417|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495418|NCT02697474|Vaccines|vaccines|mesh-list
138495419|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
138495420|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495421|NCT00103246|Silicon|silicon|mesh-list
138495422|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
138381188|NCT04126070|Docetaxel|docetaxel|mesh-list
138495423|NCT00103246|Trace Elements|trace elements|mesh-ancestor
138495424|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
138495425|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495426|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
138495427|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138495428|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138495429|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495430|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
138495431|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138495432|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
138495433|NCT00103324|Lapatinib|lapatinib|mesh-list
138495434|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495435|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138495436|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495437|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495438|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
138495439|NCT00103519|Hormones|hormones|mesh-ancestor
138495440|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138495441|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495442|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
138495443|NCT00103597|Domperidone|domperidone|mesh-list
138495444|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
138495445|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
138495446|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495447|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495448|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138495449|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138495450|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
138381253|NCT03919448|Bevacizumab|bevacizumab|mesh-list
138495451|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495452|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495453|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138495455|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138495456|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138495457|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495458|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
138495459|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495460|NCT00103753|Deferiprone|deferiprone|mesh-list
138495461|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138495462|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
138495463|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
138495464|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495465|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
138495466|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495467|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138495468|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
138495469|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
138495470|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
138495471|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138495472|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
138495473|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495474|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138495475|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138495476|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
138495477|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495478|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495479|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138495480|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138495481|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138495482|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
138495483|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138495484|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495485|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495486|NCT00103948|Donepezil|donepezil|mesh-list
138495487|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138495488|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495489|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495490|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
138495491|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495492|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495493|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
138495494|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138495495|NCT00006458|Antibodies|antibodies|mesh-list
138495496|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
138495497|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138495498|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
138381340|NCT03613792|Fentanyl|fentanyl|mesh-list
138381341|NCT03613792|Ketamine|ketamine|mesh-list
138495499|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495500|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381342|NCT03613792|Remifentanil|remifentanil|mesh-list
138495501|NCT03879408|Acetaminophen|acetaminophen|mesh-list
138495502|NCT03879408|Naproxen|naproxen|mesh-list
138495503|NCT03879408|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138495504|NCT03879408|Hydrocodone|hydrocodone|mesh-list
138381392|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
138495505|NCT03879408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138495506|NCT03879408|Analgesics|analgesics|mesh-ancestor
138495507|NCT03879408|Sensory System Agents|sensory system agents|mesh-ancestor
138171932|NCT00572897|Fludarabine|fludarabine|mesh-list
138495508|NCT03879408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495509|NCT03879408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495510|NCT03879408|Antipyretics|antipyretics|mesh-ancestor
138495511|NCT03879408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138381393|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381394|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495512|NCT03879408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138495513|NCT03879408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138495514|NCT03879408|Gout Suppressants|gout suppressants|mesh-ancestor
138495515|NCT03879408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138495516|NCT03879408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495517|NCT03879408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495518|NCT03879408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138495519|NCT03879408|Narcotics|narcotics|mesh-ancestor
138495520|NCT03879408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138495521|NCT03879408|Antitussive Agents|antitussive agents|mesh-ancestor
138495522|NCT03879408|Respiratory System Agents|respiratory system agents|mesh-ancestor
138495523|NCT00104182|Insulin|insulin|mesh-list
138495524|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138495525|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
138495526|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
138495527|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
138495528|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
138684836|NCT04691076|Propofol|propofol|mesh-list
138495529|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138495530|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495532|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138495533|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138495534|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138495535|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138637991|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495536|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138495537|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495538|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
138495539|NCT00388076|Paclitaxel|paclitaxel|mesh-list
138495540|NCT00388076|Carboplatin|carboplatin|mesh-list
138495541|NCT00388076|Lapatinib|lapatinib|mesh-list
138495542|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138495543|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495544|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
138495545|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
138495546|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
138495547|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326318|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138495548|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138495549|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495550|NCT00104689|Capecitabine|capecitabine|mesh-list
138495551|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
138495552|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138495553|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
138495554|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495555|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495556|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
138495557|NCT00006461|Etoposide|etoposide|mesh-list
138495558|NCT00006461|Vincristine|vincristine|mesh-list
138381456|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495559|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
138495560|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138495561|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
138495562|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495563|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138495564|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138495565|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
138495566|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495567|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495568|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138495569|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138495570|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138495571|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138495572|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495573|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
138495574|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
138495575|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
138495576|NCT00104767|Celecoxib|celecoxib|mesh-list
138495577|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138495578|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138495579|NCT00104767|Analgesics|analgesics|mesh-ancestor
138495580|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
138381481|NCT03182907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138381482|NCT03170960|Atezolizumab|atezolizumab|mesh-list
138381483|NCT03170960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138381493|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
138381494|NCT02921191|Lenograstim|lenograstim|mesh-list
138381495|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138381496|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
138381497|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495581|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172007|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495582|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495583|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138495584|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138495585|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138495586|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138495587|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495588|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495589|NCT02972268|Tamsulosin|tamsulosin|mesh-list
138495590|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
138495591|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138326330|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138495592|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138495593|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138495594|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
138495595|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138381558|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
138495596|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495597|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495598|NCT02972268|Urological Agents|urological agents|mesh-ancestor
138495599|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138495600|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138495601|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
138495602|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
138495604|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
138495605|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138495606|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495607|NCT00104806|Vitamins|vitamins|mesh-ancestor
138495608|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
138495609|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138495610|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495611|NCT00401128|Gemcitabine|gemcitabine|mesh-list
138495612|NCT00401128|Irinotecan|irinotecan|mesh-list
138495613|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138495614|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
138495615|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495616|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495617|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138495618|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138495619|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495620|NCT00401167|Memantine|memantine|mesh-list
138684904|NCT04690647|Dexamethasone|dexamethasone|mesh-list
138495621|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138495622|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138495623|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
138495624|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495625|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495626|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495627|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138495628|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138495629|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138495630|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495631|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138381600|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
138495632|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495633|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495635|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
138495636|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495637|NCT00104923|Fenretinide|fenretinide|mesh-list
138495638|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495639|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138495640|NCT00104923|Protective Agents|protective agents|mesh-ancestor
138495641|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495642|NCT00104962|Lenalidomide|lenalidomide|mesh-list
138495643|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
138495644|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495645|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138495646|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138495647|NCT00104962|Growth Substances|growth substances|mesh-ancestor
138326362|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
138495648|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
138495649|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495650|NCT00006467|Gemcitabine|gemcitabine|mesh-list
138495651|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138495652|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
138495653|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495654|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495655|NCT00105040|Levetiracetam|levetiracetam|mesh-list
138495656|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
138381640|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138381652|NCT01910402|Ritonavir|ritonavir|mesh-list
138495657|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
138495658|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138495661|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
138495662|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138691949|NCT05467319|Hematinics|hematinics|mesh-ancestor
138495663|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138495664|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
138495665|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495667|NCT00105352|Glucagon|glucagon|mesh-list
138495668|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138495669|NCT00105352|Hormones|hormones|mesh-ancestor
138495670|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138495671|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495672|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
138495673|NCT00105547|Tarenflurbil|tarenflurbil|mesh-list
138495674|NCT00105547|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138495675|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495676|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495677|NCT00105547|Analgesics|analgesics|mesh-ancestor
138495678|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
138495679|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495680|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495681|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138495682|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138495683|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138495685|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138495686|NCT00390624|Mannitol|mannitol|mesh-list
138495687|NCT00390624|Ularitide|ularitide|mesh-list
138495688|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138495689|NCT00390624|Diuretics|diuretics|mesh-ancestor
138495690|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
138495691|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495692|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138495693|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
138495694|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495695|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138381690|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
138381691|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
138495696|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
138495697|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
138495698|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495699|NCT00006476|Suramin|suramin|mesh-list
138495700|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
138495701|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
138495702|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138495703|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495704|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495705|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138495706|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138495707|NCT00105937|Fentanyl|fentanyl|mesh-list
138495708|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138495709|NCT00105937|Narcotics|narcotics|mesh-ancestor
138495710|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138495711|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495712|NCT00105937|Analgesics|analgesics|mesh-ancestor
138495713|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
138495714|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495715|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138495716|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138381727|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495717|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
138495718|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
138495719|NCT00006479|Leucovorin|leucovorin|mesh-list
138495720|NCT00006479|Fluorouracil|fluorouracil|mesh-list
138495722|NCT00006479|Calcium|calcium|mesh-list
138495723|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
138495724|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138381733|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
138495725|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495726|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
138495727|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495728|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138495729|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138172159|NCT05734911|Niraparib|niraparib|mesh-list
138495730|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138495731|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
138495732|NCT00006479|Antidotes|antidotes|mesh-ancestor
138495733|NCT00006479|Protective Agents|protective agents|mesh-ancestor
138495734|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
138495735|NCT00006479|Vitamins|vitamins|mesh-ancestor
138495736|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
138495737|NCT00106054|Leucovorin|leucovorin|mesh-list
138495738|NCT00106054|Bevacizumab|bevacizumab|mesh-list
138495739|NCT00106054|Irinotecan|irinotecan|mesh-list
138495740|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138495741|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138326404|NCT00036738|Fludarabine|fludarabine|mesh-list
138495743|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138495744|NCT00106054|Growth Substances|growth substances|mesh-ancestor
138495745|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495746|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
138495747|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138495748|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138495749|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495750|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495751|NCT00106054|Antidotes|antidotes|mesh-ancestor
138495752|NCT00106054|Protective Agents|protective agents|mesh-ancestor
138495753|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
138495754|NCT00106054|Vitamins|vitamins|mesh-ancestor
138495755|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
138495756|NCT00106132|Triamcinolone|triamcinolone|mesh-list
138495757|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138495758|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138495759|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138495760|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138495761|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
138495762|NCT00106132|Hormones|hormones|mesh-ancestor
138495763|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138495764|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495765|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138495766|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
138495767|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495768|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495769|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
138495770|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381835|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
138495771|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495772|NCT03815682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138381838|NCT00544115|Sirolimus|sirolimus|mesh-list
138495773|NCT03815682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495774|NCT00106288|Amphotericin B|amphotericin b|mesh-list
138495775|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138495777|NCT00106288|Amebicides|amebicides|mesh-ancestor
138495778|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138495779|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138495780|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495781|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138495782|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
138495783|NCT00006482|Gemcitabine|gemcitabine|mesh-list
138495784|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495785|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138495786|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
138495787|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495788|NCT00106366|Insulin|insulin|mesh-list
138495789|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138495790|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
138495791|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
138381887|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138381888|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495792|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
138495793|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138691980|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
138495794|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495795|NCT00106405|Memantine|memantine|mesh-list
138495796|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138495797|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138495798|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
138495799|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495800|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495801|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495802|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138495803|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138495804|NCT00006485|Irinotecan|irinotecan|mesh-list
138495805|NCT00006485|Alvocidib|alvocidib|mesh-list
138495806|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138495807|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138495808|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495809|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495810|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495811|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
138495812|NCT00006485|Growth Substances|growth substances|mesh-ancestor
138495813|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495814|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138495815|NCT00106522|Methotrexate|methotrexate|mesh-list
138495816|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138381945|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138381946|NCT01459445|Metformin|metformin|mesh-list
138495817|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
138495818|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138495819|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495820|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138495821|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
138495822|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495823|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495824|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
138495825|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495826|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138495827|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138495828|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
138495829|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138495830|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138495831|NCT00106561|Irbesartan|irbesartan|mesh-list
138495832|NCT00106561|Spironolactone|spironolactone|mesh-list
138495833|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138495834|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
138326461|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
138381999|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138382015|NCT01460420|Lenalidomide|lenalidomide|mesh-list
138495835|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138495836|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495837|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138495838|NCT00106561|Diuretics|diuretics|mesh-ancestor
138495839|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
138495840|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138495841|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138495842|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138495843|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495844|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
138495845|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138495846|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138495847|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495848|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138495850|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
138495851|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495852|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138495853|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138495854|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138495855|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
138495856|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495857|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495858|NCT00401323|Docetaxel|docetaxel|mesh-list
138495859|NCT00401323|Fluorouracil|fluorouracil|mesh-list
138382056|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382057|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
138382070|NCT01460693|Dasatinib|dasatinib|mesh-list
138495860|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495861|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
138495862|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
138495863|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
138326497|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
138495864|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495865|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
138495866|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138495867|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138495868|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
138495869|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495870|NCT00401362|Naltrexone|naltrexone|mesh-list
138382107|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138495871|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
138495872|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138495873|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495874|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
138495875|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138495876|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138495878|NCT00106834|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138495879|NCT00106834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138495880|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
138495881|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138495882|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138495883|NCT00107107|Pramlintide|pramlintide|mesh-list
138495884|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138495885|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495886|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
138495887|NCT00107263|Letrozole|letrozole|mesh-list
138495888|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495889|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138495890|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138495891|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495892|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495893|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138495894|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
138382176|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138495895|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138382177|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
138382179|NCT01462058|Vitamin D|vitamin d|mesh-list
138495896|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495897|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138495898|NCT02964949|Edoxaban|edoxaban|mesh-list
138495899|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138495900|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
138495901|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138495902|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
138495903|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495904|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495905|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
138495906|NCT00107341|Paclitaxel|paclitaxel|mesh-list
138495907|NCT00107341|Carboplatin|carboplatin|mesh-list
138495908|NCT00107341|Bortezomib|bortezomib|mesh-list
138495909|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138495910|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495912|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
138495913|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
138382233|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495914|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495915|NCT00107419|Pemetrexed|pemetrexed|mesh-list
138495916|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138495917|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495918|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685047|NCT00520949|Amoxicillin|amoxicillin|mesh-list
138495919|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138495920|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138495921|NCT03683667|Azithromycin|azithromycin|mesh-list
138495922|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138495923|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495924|NCT00006578|Ritonavir|ritonavir|mesh-list
138495925|NCT00006578|Amprenavir|amprenavir|mesh-list
138495926|NCT00006578|Lamivudine|lamivudine|mesh-list
138495927|NCT00006578|Abacavir|abacavir|mesh-list
138382302|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138495928|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138495929|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138495930|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
138495931|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495932|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495933|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138495934|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138495935|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
138495936|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495937|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138495938|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138495939|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138495940|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138495941|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138495942|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
138495943|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138495944|NCT00107458|Valproic Acid|valproic acid|mesh-list
138495945|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
138495946|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495947|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495948|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
138382355|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
138382356|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138382360|NCT01463956|Interferons|interferons|mesh-list
138495949|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495950|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495951|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
138495952|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138495953|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138495954|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138495955|NCT00006617|Lamivudine|lamivudine|mesh-list
138495956|NCT00006617|Zidovudine|zidovudine|mesh-list
138495957|NCT00006617|Abacavir|abacavir|mesh-list
138495958|NCT00006617|Amprenavir|amprenavir|mesh-list
138495959|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138495960|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138495961|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326573|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685073|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
138495962|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495964|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495965|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138495966|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138495967|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
138495968|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138495969|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
138495970|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382412|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
138495971|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138495972|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138495973|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
138495974|NCT00107731|Valproic Acid|valproic acid|mesh-list
138495975|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138495976|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
138495977|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138495978|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138495980|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138495981|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495982|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495983|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495984|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
138495985|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
138495986|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
138495987|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138495989|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
138495990|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138495991|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138495992|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138495993|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138495994|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138495995|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138495996|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
138495997|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138495998|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138495999|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138496000|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138496001|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496002|NCT00107809|Modafinil|modafinil|mesh-list
138496003|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138496004|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496005|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138382470|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
138496006|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138496007|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138496008|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496009|NCT00006656|Ethanol|ethanol|mesh-list
138496010|NCT00006656|Carmustine|carmustine|mesh-list
138496011|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138496012|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496013|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138496014|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496015|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138496016|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
138685103|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
138496017|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496018|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496020|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138496021|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496022|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138496023|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138382510|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138382511|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496024|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138496025|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496026|NCT00006695|Iodine|iodine|mesh-list
138496027|NCT00006695|Cytarabine|cytarabine|mesh-list
138496028|NCT00006695|Etoposide|etoposide|mesh-list
138496029|NCT00006695|Melphalan|melphalan|mesh-list
138496030|NCT00006695|Carmustine|carmustine|mesh-list
138496031|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
138496032|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138496033|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496034|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138496035|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138496036|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496037|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496038|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138496039|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
138496041|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496042|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138382568|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
138382569|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
138382570|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138496043|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
138496044|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496045|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138496046|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
138496047|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138496048|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138496049|NCT00006695|Trace Elements|trace elements|mesh-ancestor
138496050|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
138496051|NCT00108004|Pramlintide|pramlintide|mesh-list
138496052|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138496053|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496054|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138496055|NCT00108238|Estradiol|estradiol|mesh-list
138382631|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138496056|NCT00108238|Progesterone|progesterone|mesh-list
138496057|NCT00108238|Estrogens|estrogens|mesh-ancestor
138496058|NCT00108238|Hormones|hormones|mesh-ancestor
138382632|NCT01467518|Narcotics|narcotics|mesh-ancestor
138382633|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138382634|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382635|NCT01467518|Analgesics|analgesics|mesh-ancestor
138382636|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
138382637|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382638|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
138382639|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
138496059|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138496061|NCT00108238|Progestins|progestins|mesh-ancestor
138496062|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138496063|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
138496064|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138496065|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138496066|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138496067|NCT00108316|Fluoxetine|fluoxetine|mesh-list
138496068|NCT00108316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138496069|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138496070|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138496071|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496072|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138496073|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
138326613|NCT00255684|Cyclosporine|cyclosporine|mesh-list
138496074|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496075|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138496076|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
138496077|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138496078|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138496079|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138496080|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496081|NCT00108394|Pamidronate|pamidronate|mesh-list
138496082|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138496083|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496084|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
138496085|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138496086|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
138496087|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496088|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138496089|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138496090|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138496091|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496092|NCT00401440|Misoprostol|misoprostol|mesh-list
138496093|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138496094|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
138496095|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138496096|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496097|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138496098|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138496099|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
138496100|NCT00108667|Levodopa|levodopa|mesh-list
138496101|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138496102|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138496103|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
138496104|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138496105|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496106|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496107|NCT00006773|Bortezomib|bortezomib|mesh-list
138496108|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496109|NCT00108706|Candesartan|candesartan|mesh-list
138496110|NCT00108706|Candesartan cilexetil|candesartan cilexetil|mesh-list
138496111|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138496112|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138496113|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138496114|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496115|NCT00006812|Capecitabine|capecitabine|mesh-list
138496116|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138496117|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
138496118|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382735|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382736|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138496119|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496120|NCT00006890|Thalidomide|thalidomide|mesh-list
138496121|NCT00006890|Prednisone|prednisone|mesh-list
138496122|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138496123|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
138496124|NCT00006890|Hormones|hormones|mesh-ancestor
138685209|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
138496125|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138496126|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496127|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138496129|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496130|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
138496131|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
138496132|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138496133|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496134|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138496135|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138692057|NCT04322565|Colchicine|colchicine|mesh-list
138496136|NCT00006890|Growth Substances|growth substances|mesh-ancestor
138496137|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
138496139|NCT00108979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138496140|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138496141|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138496142|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496143|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138496144|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
138496145|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496146|NCT03608397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138382775|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138496147|NCT03608397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138496148|NCT03608397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138496149|NCT03608397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496150|NCT03608397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496151|NCT03608397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138685242|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
138496152|NCT03608397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138496153|NCT03608397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496154|NCT03608397|Cholinergic Agents|cholinergic agents|mesh-ancestor
138496155|NCT03608397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138496156|NCT00109057|Bevacizumab|bevacizumab|mesh-list
138496157|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138496158|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496159|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138496160|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138496161|NCT00109057|Growth Substances|growth substances|mesh-ancestor
138496162|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496163|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
138496165|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496166|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382824|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382825|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138382826|NCT01468571|Diuretics|diuretics|mesh-ancestor
138496167|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496168|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138496169|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138496170|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
138496171|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138496172|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138496173|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326655|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
138496174|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496176|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138496177|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496178|NCT00006929|Suramin|suramin|mesh-list
138496179|NCT00006929|Paclitaxel|paclitaxel|mesh-list
138496180|NCT00006929|Carboplatin|carboplatin|mesh-list
138496181|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138496183|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
138496184|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
138496185|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
138496186|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496187|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
138382880|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138496188|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
138496189|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138496190|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496191|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138496192|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138496193|NCT00006968|Cyclosporine|cyclosporine|mesh-list
138496194|NCT00006968|Pentostatin|pentostatin|mesh-list
138496195|NCT00006968|Cyclosporins|cyclosporins|mesh-list
138496197|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496198|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496199|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496200|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496201|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
138496202|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496203|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
138496204|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138496205|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138496206|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496207|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138496209|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138496210|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
138496211|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138496212|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496213|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138496214|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
138382934|NCT06077539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496215|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496216|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496217|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
138496218|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496219|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138496220|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496221|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
138496222|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138496223|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138496224|NCT00109564|Acetylcholine|acetylcholine|mesh-list
138496225|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
138685321|NCT02930733|Bupivacaine|bupivacaine|mesh-list
138496226|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
138496227|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138496228|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
138326674|NCT00176202|Risperidone|risperidone|mesh-list
138496229|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138496230|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496231|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496232|NCT00109603|Tenofovir|tenofovir|mesh-list
138496233|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
138496234|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496235|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138496236|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138382988|NCT06076837|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138496237|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496238|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496239|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138496240|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138496241|NCT00109798|Temozolomide|temozolomide|mesh-list
138496242|NCT00109798|Topotecan|topotecan|mesh-list
138496243|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138496244|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
138496245|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685359|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
138496246|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496247|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138496248|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138496249|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496250|NCT00109954|Cisplatin|cisplatin|mesh-list
138496251|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383042|NCT06076759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496252|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
138496253|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138496254|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138496255|NCT00109993|Prednisolone|prednisolone|mesh-list
138496256|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
138496257|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
138496258|NCT00109993|Tacrolimus|tacrolimus|mesh-list
138496259|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138496260|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
138496261|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496262|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
138496263|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496264|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138496265|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496266|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496267|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138496268|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
138496269|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
138496270|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496271|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138496272|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
138496273|NCT00109993|Hormones|hormones|mesh-ancestor
138496274|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138496275|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138496276|NCT00109993|Protective Agents|protective agents|mesh-ancestor
138496277|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138496278|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496279|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138496281|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496282|NCT00110071|Iodine|iodine|mesh-list
138496283|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
138496284|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138496285|NCT00110071|Fludarabine|fludarabine|mesh-list
138496286|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
138496287|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
138496288|NCT00110071|Antibodies|antibodies|mesh-list
138496289|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
138496290|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138685412|NCT02947880|Diuretics|diuretics|mesh-ancestor
138496291|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
138496292|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496293|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496294|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138496295|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
138496296|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496297|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496298|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138496299|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496300|NCT00110071|Trace Elements|trace elements|mesh-ancestor
138496301|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
138496303|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138496304|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496305|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138496306|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496307|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
138496308|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496309|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
138496310|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383163|NCT06072716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138383164|NCT06072716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138383165|NCT06072716|Antimetabolites|antimetabolites|mesh-ancestor
138383166|NCT06072716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383167|NCT06072716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138383168|NCT06072716|Chelating Agents|chelating agents|mesh-ancestor
138383169|NCT06072716|Sequestering Agents|sequestering agents|mesh-ancestor
138383170|NCT06072716|Hemostatics|hemostatics|mesh-ancestor
138496311|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138496312|NCT00007202|Didanosine|didanosine|mesh-list
138496313|NCT00007202|Stavudine|stavudine|mesh-list
138496314|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138496315|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138496316|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
138496317|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496318|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496320|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138496321|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
138496322|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496323|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
138496324|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138496325|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138496326|NCT00110344|Sorafenib|sorafenib|mesh-list
138496327|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496328|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138496329|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496330|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496332|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138496333|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138496334|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138496335|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
138496336|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138496337|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383208|NCT06072118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138496338|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496339|NCT00110578|Aldesleukin|aldesleukin|mesh-list
138496340|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496341|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138496342|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138496343|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
138496344|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138496345|NCT00388193|Rituximab|rituximab|mesh-list
138496346|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138496347|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496348|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
138383262|NCT06060704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496349|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496350|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138496351|NCT00110695|Paclitaxel|paclitaxel|mesh-list
138496352|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138496353|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138496354|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138496355|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
138496356|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
138496357|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
138496358|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496359|NCT00110734|Lidocaine|lidocaine|mesh-list
138496360|NCT00110734|Tetracaine|tetracaine|mesh-list
138496361|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
138326766|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138496363|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138496364|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496365|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
138496366|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496367|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138496368|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138496369|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138496370|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138496371|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496372|NCT00110773|Lidocaine|lidocaine|mesh-list
138496373|NCT00110773|Tetracaine|tetracaine|mesh-list
138496374|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
138496375|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
138496376|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138496377|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496378|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
138383324|NCT05998317|Dexamethasone acetate|dexamethasone acetate|mesh-list
138383325|NCT05998317|BB 1101|bb 1101|mesh-list
138496379|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496380|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138496381|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138496382|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138496383|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138496384|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496386|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
138496387|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138496388|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496389|NCT00110929|Cinacalcet|cinacalcet|mesh-list
138496390|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138496391|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496392|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138496393|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
138496394|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138496395|NCT00111046|Ibuprofen|ibuprofen|mesh-list
138496396|NCT00111046|Tramadol|tramadol|mesh-list
138496397|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138496398|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138496399|NCT00111046|Analgesics|analgesics|mesh-ancestor
138496400|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
138496401|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383379|NCT05935306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138496402|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496403|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138496404|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138496406|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138496407|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496408|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138496409|NCT00111046|Narcotics|narcotics|mesh-ancestor
138496410|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138496411|NCT00388271|Alfuzosin|alfuzosin|mesh-list
138496412|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138496413|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138496414|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138496415|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
138496416|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138496417|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138496418|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383436|NCT05789303|Immunologic Factors|immunologic factors|mesh-ancestor
138383437|NCT05789303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138496419|NCT00388271|Urological Agents|urological agents|mesh-ancestor
138496420|NCT00111124|Etanercept|etanercept|mesh-list
138496421|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138496422|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138496423|NCT00111124|Analgesics|analgesics|mesh-ancestor
138496424|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
138496425|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138496426|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138496427|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138496428|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138383497|NCT05767086|Progestins|progestins|mesh-ancestor
138383537|NCT05728372|Copper|copper|mesh-list
138496429|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138496430|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138496431|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
138496432|NCT00111163|Artesunate|artesunate|mesh-list
138496433|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
138496434|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
138496435|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138496436|NCT00111163|Amodiaquine|amodiaquine|mesh-list
138496437|NCT00111163|Dapsone|dapsone|mesh-list
138496438|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
138383567|NCT05684692|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138496439|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
138496440|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138383569|NCT05684692|Analgesics|analgesics|mesh-ancestor
138496441|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138685620|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
138525208|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138525209|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525210|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525211|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525212|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525213|NCT00022646|Gemcitabine|gemcitabine|mesh-list
138525214|NCT00022646|Pemetrexed|pemetrexed|mesh-list
138525215|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525216|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
138525217|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525218|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525219|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525220|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138525221|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138383635|NCT05641649|GABA Agents|gaba agents|mesh-ancestor
138525222|NCT00022685|Epratuzumab|epratuzumab|mesh-list
138525223|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138525224|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525225|NCT00022724|Sirolimus|sirolimus|mesh-list
138525226|NCT00022724|Temsirolimus|temsirolimus|mesh-list
138525227|NCT00022724|MTOR Inhibitors|mtor inhibitors|mesh-list
138525228|NCT00022724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138525229|NCT00022724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525230|NCT00022724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525231|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138460783|NCT01349881|Eflornithine|eflornithine|mesh-list
138525233|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383696|NCT05487196|Fentanyl|fentanyl|mesh-list
138525234|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525235|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138201614|NCT03187834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525236|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383697|NCT05487196|Dexmedetomidine|dexmedetomidine|mesh-list
138525237|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138525238|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
138525239|NCT00050154|Tipifarnib|tipifarnib|mesh-list
138525240|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525241|NCT00022841|Pamidronate|pamidronate|mesh-list
138525242|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138525243|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525244|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
138525245|NCT00022880|Antibodies|antibodies|mesh-list
138525246|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
138525247|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525248|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525249|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
138525250|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
138525251|NCT00050271|Vitamins|vitamins|mesh-ancestor
138525252|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
138525253|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525254|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
138525255|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
138525256|NCT00022958|Antibodies|antibodies|mesh-list
138525257|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
138383761|NCT05431595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138525258|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525259|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525260|NCT00050349|Epothilones|epothilones|mesh-list
138525261|NCT00050349|Epothilone B|epothilone b|mesh-list
138383762|NCT05431595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138525262|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
138383763|NCT05431595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138383764|NCT05431595|Dopamine Agents|dopamine agents|mesh-ancestor
138383769|NCT05431595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525265|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525266|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525267|NCT00050427|Trabectedin|trabectedin|mesh-list
138525268|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138525269|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
138525270|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525271|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525272|NCT00023153|Adefovir|adefovir|mesh-list
138525273|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138525275|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525276|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138525277|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138525278|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525279|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525280|NCT00050505|Vaccines|vaccines|mesh-list
138383815|NCT05265728|Natalizumab|natalizumab|mesh-list
138525281|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
138525282|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525283|NCT00050661|Daclizumab|daclizumab|mesh-list
138525284|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525285|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
138525286|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525287|NCT00050817|Clopidogrel|clopidogrel|mesh-list
138525288|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138525289|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138525290|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138525291|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138525292|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
138525293|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138525294|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525295|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525296|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
138525297|NCT00023231|Sirolimus|sirolimus|mesh-list
138525298|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138525299|NCT00023231|Ganciclovir|ganciclovir|mesh-list
138420985|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
138420986|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420987|NCT04330729|Aspirin|aspirin|mesh-list
138420988|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138420989|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138420990|NCT04330729|Analgesics|analgesics|mesh-ancestor
138420991|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
138383876|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420992|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138420993|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420994|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138420995|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138420997|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138420998|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420999|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138421000|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138421001|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525300|NCT00023231|Prednisone|prednisone|mesh-list
138525301|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
138525302|NCT00023231|Atorvastatin|atorvastatin|mesh-list
138525303|NCT00023231|Daclizumab|daclizumab|mesh-list
138525304|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138525305|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
138525306|NCT00023231|Hormones|hormones|mesh-ancestor
138525307|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138525308|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525309|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138525310|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525311|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138201689|NCT00002890|Lintuzumab|lintuzumab|mesh-list
138525312|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138525313|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
138525314|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138383924|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383925|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138525315|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525316|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525317|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702403|NCT00450203|Epirubicin|epirubicin|mesh-list
138525319|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525320|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
138525321|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
138525322|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
138525323|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138525324|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138525325|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138525326|NCT00023231|Protective Agents|protective agents|mesh-ancestor
138525327|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138525328|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138525329|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
138525330|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138525331|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138525332|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
138525333|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138525334|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
138525335|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138525336|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138525337|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
138525338|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138421023|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
138421024|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
138421025|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138421026|NCT04205786|Vitamins|vitamins|mesh-ancestor
138525339|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138525340|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525341|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138525342|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138525343|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
138525344|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525345|NCT00023348|Isoniazid|isoniazid|mesh-list
138525346|NCT00023348|Rifabutin|rifabutin|mesh-list
138525347|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
138525348|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138525349|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525350|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138525351|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138525352|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
138525353|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525354|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138525355|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138525356|NCT00050895|Ritonavir|ritonavir|mesh-list
138525357|NCT00050895|Lopinavir|lopinavir|mesh-list
138525358|NCT00050895|Tenofovir|tenofovir|mesh-list
138525359|NCT00050895|Lamivudine|lamivudine|mesh-list
138525360|NCT00050895|Zidovudine|zidovudine|mesh-list
138525361|NCT00050895|Stavudine|stavudine|mesh-list
138525362|NCT00050895|Efavirenz|efavirenz|mesh-list
138525363|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138525364|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138525365|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
138525366|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384032|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138525367|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525368|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138525369|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138525370|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
138525371|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525372|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138525373|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138525374|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138525375|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138525376|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
138525377|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138525378|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138525379|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138525381|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138525382|NCT00023387|Isoniazid|isoniazid|mesh-list
138525383|NCT00023387|Rifapentine|rifapentine|mesh-list
138525384|NCT00023387|Rifampin|rifampin|mesh-list
138525385|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
138525386|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138525387|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201765|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138525389|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138525390|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
138525391|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525392|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138525393|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138525394|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
138525395|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138525396|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525397|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138525398|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138525399|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138525400|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138525401|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138525402|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138525403|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
138525404|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
138525405|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138525406|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138525407|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138525408|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525409|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138525410|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138525411|NCT00023426|Rifapentine|rifapentine|mesh-list
138525412|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138525413|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
138525414|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138525415|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525416|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
138525417|NCT00050973|Bexarotene|bexarotene|mesh-list
138525418|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525419|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138525420|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
138525421|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525422|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
138525423|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
138525424|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
138525425|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138525426|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384132|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138384133|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
138525427|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
138525428|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138525429|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525430|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138525431|NCT00051051|Protective Agents|protective agents|mesh-ancestor
138525433|NCT00051090|Efavirenz|efavirenz|mesh-list
138525434|NCT00051090|Abacavir|abacavir|mesh-list
138525435|NCT00051090|Didanosine|didanosine|mesh-list
138525436|NCT00051090|Telbivudine|telbivudine|mesh-list
138525437|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138525438|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138525439|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525440|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525441|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
138525442|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525443|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138525444|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138525445|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138525446|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138525447|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138525448|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138525449|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138525450|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138525451|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
138525452|NCT00023621|Celecoxib|celecoxib|mesh-list
138525453|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138525454|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138525455|NCT00023621|Analgesics|analgesics|mesh-ancestor
138525456|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
138525457|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138525458|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525459|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138525460|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138525461|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138525462|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138525463|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384172|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138384173|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138384192|NCT04664829|Bexarotene|bexarotene|mesh-list
138525464|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525465|NCT00023660|Celecoxib|celecoxib|mesh-list
138525466|NCT00023660|Fluorouracil|fluorouracil|mesh-list
138525467|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525468|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
138525469|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525470|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525471|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525472|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
138525473|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525474|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138525475|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138525476|NCT00023660|Analgesics|analgesics|mesh-ancestor
138702476|NCT02931383|Liraglutide|liraglutide|mesh-list
138384208|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138384209|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384210|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384211|NCT04649502|Metformin|metformin|mesh-list
138384212|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138525477|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
138525478|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138525479|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138525480|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138525481|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138525482|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138525483|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525485|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138525486|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
138525487|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138525488|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138525489|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525490|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525491|NCT00051285|Protective Agents|protective agents|mesh-ancestor
138525492|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525493|NCT00023699|Gefitinib|gefitinib|mesh-list
138525494|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525495|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138525496|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525497|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525498|NCT00051441|Benzydamine|benzydamine|mesh-list
138525499|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138525500|NCT00023738|Doxorubicin|doxorubicin|mesh-list
138525501|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138525502|NCT00023738|Ifosfamide|ifosfamide|mesh-list
138525503|NCT00023738|Dacarbazine|dacarbazine|mesh-list
138525504|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138525505|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525506|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138525507|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525508|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421229|NCT03648905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138384270|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
138525509|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525510|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138525511|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
138525512|NCT00397917|Folic Acid|folic acid|mesh-list
138525513|NCT00397917|Hematinics|hematinics|mesh-ancestor
138525514|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
138525515|NCT00397917|Vitamins|vitamins|mesh-ancestor
138525516|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
138525517|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525518|NCT00397956|Ertapenem|ertapenem|mesh-list
138525519|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138525520|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525521|NCT00023777|Cytarabine|cytarabine|mesh-list
138525522|NCT00023777|Daunorubicin|daunorubicin|mesh-list
138525523|NCT00023777|Sargramostim|sargramostim|mesh-list
138525524|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525525|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
138525526|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525527|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525528|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
138525529|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525530|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525531|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
138384338|NCT04332341|Niacin|niacin|mesh-list
138229632|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
138525532|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525533|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138525534|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138525535|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525536|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525537|NCT00023816|Carbendazim|carbendazim|mesh-list
138525538|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
138525539|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
138525540|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138702490|NCT01187953|Tacrolimus|tacrolimus|mesh-list
138525541|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525542|NCT00023855|Doxorubicin|doxorubicin|mesh-list
138525543|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138525544|NCT00023855|Bortezomib|bortezomib|mesh-list
138525545|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138525546|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525547|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138525548|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525549|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384381|NCT04303403|Trametinib|trametinib|mesh-list
138525550|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525551|NCT00023894|Alvocidib|alvocidib|mesh-list
138525552|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525553|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
138525554|NCT00023894|Growth Substances|growth substances|mesh-ancestor
138525555|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525556|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138525557|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525558|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525559|NCT00023933|Antibodies|antibodies|mesh-list
138525560|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138525561|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
138525562|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525563|NCT00051597|Antibodies|antibodies|mesh-list
138525564|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138525565|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
138525566|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525567|NCT00023972|Gemcitabine|gemcitabine|mesh-list
138525568|NCT00023972|Exatecan|exatecan|mesh-list
138525569|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525570|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
138525571|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525572|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525573|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138525574|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525575|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525576|NCT00024011|Bortezomib|bortezomib|mesh-list
138525577|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525578|NCT00051753|Amoxicillin|amoxicillin|mesh-list
138525579|NCT00051753|Levofloxacin|levofloxacin|mesh-list
138525580|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
138525581|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
138525582|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138525583|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138525584|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525585|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138384461|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138384462|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525586|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138525587|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525588|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525589|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525590|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525591|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138525592|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138525593|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138525594|NCT00024050|Cyclosporine|cyclosporine|mesh-list
138525595|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
138525596|NCT00024050|Busulfan|busulfan|mesh-list
138525597|NCT00024050|Methotrexate|methotrexate|mesh-list
138525598|NCT00024050|Cyclosporins|cyclosporins|mesh-list
138525599|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525600|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
138525601|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525602|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138525603|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138525604|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
138525605|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525606|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525607|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138525608|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138384499|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525610|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138525611|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525612|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
138384500|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525613|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
138525614|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525615|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138525616|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138525617|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
138525618|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525619|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138525621|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525622|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138525623|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525624|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525625|NCT00051831|Ritonavir|ritonavir|mesh-list
138525626|NCT00051831|Saquinavir|saquinavir|mesh-list
138525627|NCT00051831|Tenofovir|tenofovir|mesh-list
138525628|NCT00051831|Emtricitabine|emtricitabine|mesh-list
138525629|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
138525630|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138525632|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
138525633|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525634|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525635|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138525636|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138525637|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
138525638|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525639|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138525640|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138525641|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138525642|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138525643|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138525644|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138525645|NCT00024128|Cyclosporine|cyclosporine|mesh-list
138525646|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
138525647|NCT00024128|Cyclosporins|cyclosporins|mesh-list
138525648|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138525649|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525650|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
138702512|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138384550|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384551|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138525651|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525652|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138525653|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138525654|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
138525655|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525656|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525657|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138525658|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525659|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
138525660|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525661|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
138525662|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138525663|NCT00024206|Orantinib|orantinib|mesh-list
138525664|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138525665|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525666|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525667|NCT00024245|Probenecid|probenecid|mesh-list
138525668|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
138525669|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
138525670|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138525671|NCT00051987|Bortezomib|bortezomib|mesh-list
138525672|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525673|NCT00024284|Carboplatin|carboplatin|mesh-list
138525674|NCT00024284|Irinotecan|irinotecan|mesh-list
138525675|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525676|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138525677|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525678|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525679|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525680|NCT00052026|Carvedilol|carvedilol|mesh-list
138525681|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138384590|NCT03567473|Protease Inhibitors|protease inhibitors|mesh-ancestor
138384591|NCT03567473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525682|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138525683|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
138525684|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138384592|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525685|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525686|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525687|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138525688|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
138525689|NCT00052026|Protective Agents|protective agents|mesh-ancestor
138525690|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138525691|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138525692|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138525693|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
138525694|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138525695|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138525697|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525698|NCT00024362|BBR 3464|bbr 3464|mesh-list
138525699|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525700|NCT00024401|Paclitaxel|paclitaxel|mesh-list
138525701|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138525702|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525703|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
138525704|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
138525705|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
138525706|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525707|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
138525708|NCT00024440|Fludarabine|fludarabine|mesh-list
138525709|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
138525710|NCT00024440|Oblimersen|oblimersen|mesh-list
138525711|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525712|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
138525713|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525714|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138525715|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138384633|NCT03500328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525716|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
138460878|NCT00993044|Temozolomide|temozolomide|mesh-list
138525717|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525718|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525719|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138525720|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525721|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
138525723|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
138525724|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525725|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
138525726|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525727|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
138525728|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525729|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
138525730|NCT00052221|Hematinics|hematinics|mesh-ancestor
138525731|NCT00024557|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
138525732|NCT00024557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525733|NCT00052299|Cytarabine|cytarabine|mesh-list
138525734|NCT00052299|Etoposide|etoposide|mesh-list
138525735|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
138525736|NCT00052299|Idarubicin|idarubicin|mesh-list
138525737|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
138525738|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138525739|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525740|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138525741|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525742|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525743|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525744|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525745|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
138384677|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138384678|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525746|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
138525747|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525748|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525749|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
138525750|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525751|NCT00052299|Analgesics|analgesics|mesh-ancestor
138525752|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
138525753|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138525754|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138229638|NCT01100606|Pancrelipase|pancrelipase|mesh-list
138525755|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138525756|NCT00052299|Immunotoxins|immunotoxins|mesh-ancestor
138525757|NCT00052299|Immunoconjugates|immunoconjugates|mesh-ancestor
138525758|NCT00052338|Carboplatin|carboplatin|mesh-list
138525759|NCT00052338|Gemcitabine|gemcitabine|mesh-list
138525760|NCT00052338|Bortezomib|bortezomib|mesh-list
138525761|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525762|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525763|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
138525764|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525766|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138525767|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138525768|NCT04733066|Protective Agents|protective agents|mesh-ancestor
138525769|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525770|NCT00052377|Aldesleukin|aldesleukin|mesh-list
138525771|NCT00052377|Interleukin-2|interleukin-2|mesh-list
138525772|NCT00052377|Interleukin-12|interleukin-12|mesh-list
138460923|NCT00116272|Etanercept|etanercept|mesh-list
138525773|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384723|NCT03184571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525774|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138525775|NCT00052377|Analgesics|analgesics|mesh-ancestor
138525776|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
138525777|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138525778|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525779|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138525780|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138525781|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
138525782|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525783|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138525784|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
138525785|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138525786|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138525787|NCT00052377|Growth Substances|growth substances|mesh-ancestor
138525788|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
138525789|NCT00052416|Thalidomide|thalidomide|mesh-list
138525790|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525791|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
138702599|NCT02929901|Caffeine|caffeine|mesh-list
138525792|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525793|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
138525794|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138525795|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525796|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138525797|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138525798|NCT00052416|Growth Substances|growth substances|mesh-ancestor
138525799|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
138525800|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525801|NCT00052455|Vincristine|vincristine|mesh-list
138525802|NCT00052455|Temozolomide|temozolomide|mesh-list
138525803|NCT00052455|Lomustine|lomustine|mesh-list
138525804|NCT00052455|Procarbazine|procarbazine|mesh-list
138525805|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138525806|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525807|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
138384769|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384770|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384771|NCT03033446|Nivolumab|nivolumab|mesh-list
138525808|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
138525809|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
138525810|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525811|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138525812|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
138525813|NCT00052494|Irinotecan|irinotecan|mesh-list
138525814|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
138525815|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525816|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138525817|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525818|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525819|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525820|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138525821|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
138525822|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
138525823|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
138525824|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384826|NCT02945241|Cystatins|cystatins|mesh-list
138525825|NCT00395174|Coagulants|coagulants|mesh-ancestor
138525826|NCT00395213|Norepinephrine|norepinephrine|mesh-list
138525827|NCT00395213|Serotonin|serotonin|mesh-list
138525828|NCT00395213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138525829|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138229641|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
138525830|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138525831|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
138525832|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138525833|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460925|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138525834|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525836|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
138525837|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138525838|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138525839|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138525840|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
138202204|NCT00003436|Cytarabine|cytarabine|mesh-list
138525841|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138525842|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138525844|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138525845|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138525846|NCT00052611|Analgesics|analgesics|mesh-ancestor
138525847|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
138525848|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138525849|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525850|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138525851|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138525852|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138525853|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138525854|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525855|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525856|NCT00395252|Gemcitabine|gemcitabine|mesh-list
138525858|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138384882|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138384883|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384885|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138525859|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
138525860|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525861|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525862|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138525863|NCT00052689|Gemcitabine|gemcitabine|mesh-list
138525864|NCT00052689|Bortezomib|bortezomib|mesh-list
138525865|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138525866|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
138525867|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525868|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525869|NCT00052728|Tamoxifen|tamoxifen|mesh-list
138525870|NCT00052728|Tipifarnib|tipifarnib|mesh-list
138525871|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138525872|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
138384923|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138384924|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
138384925|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384926|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138384927|NCT02632708|Analgesics|analgesics|mesh-ancestor
138384928|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
138384929|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384930|NCT02617277|Durvalumab|durvalumab|mesh-list
138384931|NCT02617277|Adavosertib|adavosertib|mesh-list
138384932|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384933|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384934|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384935|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384937|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138384940|NCT02471144|Analgesics|analgesics|mesh-ancestor
138525873|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138525874|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525875|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138525876|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525877|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138525878|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138525879|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138525880|NCT00395369|Aprotinin|aprotinin|mesh-list
138421535|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138525881|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
138525882|NCT00395369|Coagulants|coagulants|mesh-ancestor
138525883|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138525884|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138525885|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
138525886|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525887|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525889|NCT00052845|Docetaxel|docetaxel|mesh-list
138525890|NCT00052845|Estramustine|estramustine|mesh-list
138525891|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525892|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
138525893|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
138525894|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
138525895|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525896|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138525897|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
138525898|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138525899|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138384974|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384975|NCT02403674|Tenofovir|tenofovir|mesh-list
138384976|NCT02403674|Lamivudine|lamivudine|mesh-list
138384978|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
138229645|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
138525900|NCT00052845|Protective Agents|protective agents|mesh-ancestor
138525901|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525902|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138525903|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525904|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138525905|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138525906|NCT00052845|Analgesics|analgesics|mesh-ancestor
138460981|NCT01937013|Oxytocin|oxytocin|mesh-list
138525907|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
138525908|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138525909|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138525911|NCT00024986|Tenofovir|tenofovir|mesh-list
138525912|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
138421579|NCT02960022|Prednisone|prednisone|mesh-list
138525913|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525914|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138525915|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138525916|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525917|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525918|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138525919|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138525920|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
138525921|NCT00052923|Carmustine|carmustine|mesh-list
138525922|NCT00052923|Rituximab|rituximab|mesh-list
138525923|NCT00052923|Etoposide|etoposide|mesh-list
138525924|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525925|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
138525926|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385019|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
138385020|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525927|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138525928|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138525929|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
138525930|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525931|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525932|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138525933|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138525934|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138525935|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138525936|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138525937|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525938|NCT00025064|Prednisolone|prednisolone|mesh-list
138525939|NCT00025064|Doxorubicin|doxorubicin|mesh-list
138525940|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138525941|NCT00025064|Etoposide|etoposide|mesh-list
138525942|NCT00025064|Vincristine|vincristine|mesh-list
138525943|NCT00025064|Melphalan|melphalan|mesh-list
138525944|NCT00025064|Ifosfamide|ifosfamide|mesh-list
138525945|NCT00025064|Dacarbazine|dacarbazine|mesh-list
138525946|NCT00025064|Bleomycin|bleomycin|mesh-list
138525947|NCT00025064|Vinblastine|vinblastine|mesh-list
138525948|NCT00025064|Procarbazine|procarbazine|mesh-list
138525949|NCT00025064|Chlorambucil|chlorambucil|mesh-list
138525950|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525951|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138525952|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138525953|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138385069|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138385070|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
138525954|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138525955|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138525956|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138525957|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
138525958|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
138525959|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
138525960|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138525961|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
138525962|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138525963|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525964|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
138525965|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525966|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138525968|NCT00025064|Hormones|hormones|mesh-ancestor
138525969|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138525970|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138525971|NCT00053001|Thalidomide|thalidomide|mesh-list
138385121|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
138525972|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
138525973|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525974|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
138525975|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461015|NCT01937182|Serotonin|serotonin|mesh-list
138525976|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
138525977|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138525978|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138525979|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138525980|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138525981|NCT00053001|Growth Substances|growth substances|mesh-ancestor
138525982|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
138525983|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138525984|NCT00053001|Hematinics|hematinics|mesh-ancestor
138525985|NCT00025103|Dactinomycin|dactinomycin|mesh-list
138525986|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
138525987|NCT00025103|Melphalan|melphalan|mesh-list
138525988|NCT00025103|Carboplatin|carboplatin|mesh-list
138525989|NCT00025103|Doxorubicin|doxorubicin|mesh-list
138525990|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138525991|NCT00025103|Etoposide|etoposide|mesh-list
138525992|NCT00025103|Vincristine|vincristine|mesh-list
138525993|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138525994|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
138702705|NCT02928614|Hormones|hormones|mesh-ancestor
138525995|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138525997|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138525998|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
138525999|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385179|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526000|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385180|NCT01279850|Pregabalin|pregabalin|mesh-list
138526001|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138526002|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138526003|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138526004|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138526005|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526006|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138526007|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
138526008|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526009|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
138526010|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138526011|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526012|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138526013|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138526014|NCT00053040|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
138526015|NCT00053040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526017|NCT00025142|Fluorouracil|fluorouracil|mesh-list
138526018|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
138526019|NCT00025142|Gefitinib|gefitinib|mesh-list
138526020|NCT00025142|Calcium|calcium|mesh-list
138526021|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
138526022|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138526023|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526024|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
138526025|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526026|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526027|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526028|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526029|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
138526030|NCT00025142|Antidotes|antidotes|mesh-ancestor
138526031|NCT00025142|Protective Agents|protective agents|mesh-ancestor
138526032|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
138526033|NCT00025142|Vitamins|vitamins|mesh-ancestor
138526034|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
138421692|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421693|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
138421694|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
138421695|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
138385230|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
138385231|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138385232|NCT01035463|Antibodies|antibodies|mesh-list
138421696|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421698|NCT02567799|Protective Agents|protective agents|mesh-ancestor
138385233|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
138385234|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138385235|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
138385236|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385237|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385238|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138526035|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138526036|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526037|NCT00053118|Carboplatin|carboplatin|mesh-list
138526039|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526040|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138526041|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138526042|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138526043|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702724|NCT02928575|Sunitinib|sunitinib|mesh-list
138526044|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526046|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
138526047|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138526048|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526049|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138526050|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526051|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138526052|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
138526053|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526054|NCT00025220|Thalidomide|thalidomide|mesh-list
138526055|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526056|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
138526057|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526058|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
138526059|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138526060|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526061|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138526062|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138526063|NCT00025220|Growth Substances|growth substances|mesh-ancestor
138526064|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
138526065|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526066|NCT00053157|Sargramostim|sargramostim|mesh-list
138385259|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526067|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
138526068|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526069|NCT00025298|Paclitaxel|paclitaxel|mesh-list
138526070|NCT00025298|Carboplatin|carboplatin|mesh-list
138526071|NCT00025298|Amifostine|amifostine|mesh-list
138526072|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138526074|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
138526075|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526076|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
138526077|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526078|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138526079|NCT00025298|Protective Agents|protective agents|mesh-ancestor
138526080|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526081|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
138526082|NCT00053196|Methotrexate|methotrexate|mesh-list
138526083|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
138526084|NCT00053196|Fludarabine|fludarabine|mesh-list
138526085|NCT00053196|Busulfan|busulfan|mesh-list
138385307|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526086|NCT00053196|Allopurinol|allopurinol|mesh-list
138526087|NCT00053196|Tacrolimus|tacrolimus|mesh-list
138526088|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138526089|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138526090|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
138385308|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
138385309|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385310|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
138385311|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385312|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
138385313|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138385314|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138385315|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138385316|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138526091|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138526092|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526093|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526094|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
138526095|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526096|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526097|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
138526098|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526099|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138526100|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526101|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
138526102|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138526103|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138526105|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138526106|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138526107|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
138526108|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138526109|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526110|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
138526111|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138526112|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138526113|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
138526114|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138526116|NCT00053196|Protective Agents|protective agents|mesh-ancestor
138526117|NCT00025337|Leucovorin|leucovorin|mesh-list
138526118|NCT00025337|Bevacizumab|bevacizumab|mesh-list
138526119|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138526120|NCT00025337|Fluorouracil|fluorouracil|mesh-list
138526121|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
138526122|NCT00025337|Antibodies|antibodies|mesh-list
138526123|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
138526124|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138526125|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
138526126|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526127|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138526128|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138526129|NCT00025337|Growth Substances|growth substances|mesh-ancestor
138526130|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526131|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
138526132|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
138526133|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
138526134|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526135|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526136|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526138|NCT00025337|Protective Agents|protective agents|mesh-ancestor
138526139|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
138526140|NCT00025337|Vitamins|vitamins|mesh-ancestor
138526141|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
138526142|NCT00025376|Bortezomib|bortezomib|mesh-list
138526143|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526144|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
138526145|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385402|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202500|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526146|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138526147|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526148|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526149|NCT00025454|Tipifarnib|tipifarnib|mesh-list
138526150|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526151|NCT00025493|Docetaxel|docetaxel|mesh-list
138526152|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526153|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
138526154|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526155|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
138526156|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526157|NCT00025532|Antibodies|antibodies|mesh-list
138526158|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138526159|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
138526160|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526161|NCT00053430|Thalidomide|thalidomide|mesh-list
138526162|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526163|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
138526164|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526165|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
138526166|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138526167|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526168|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138526169|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138526170|NCT00053430|Growth Substances|growth substances|mesh-ancestor
138526172|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526173|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
138526174|NCT00025610|Carboplatin|carboplatin|mesh-list
138526175|NCT00025610|Doxorubicin|doxorubicin|mesh-list
138526176|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138526177|NCT00025610|Etoposide|etoposide|mesh-list
138526178|NCT00025610|Vincristine|vincristine|mesh-list
138526179|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526180|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
138526181|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526182|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138385460|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
138526183|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138526184|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
138526185|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526186|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526187|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138526188|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138526189|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138526190|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138526191|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702813|NCT04680195|Growth Substances|growth substances|mesh-ancestor
138526192|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138526193|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
138526194|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526195|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
138526198|NCT00025649|Busulfan|busulfan|mesh-list
138526199|NCT00025649|Carboplatin|carboplatin|mesh-list
138526200|NCT00025649|Doxorubicin|doxorubicin|mesh-list
138526201|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138526202|NCT00025649|Etoposide|etoposide|mesh-list
138526203|NCT00025649|Vincristine|vincristine|mesh-list
138526204|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526205|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
138385496|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385497|NCT01470040|Aspirin|aspirin|mesh-list
138526206|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526207|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138526208|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138526209|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
138526210|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526211|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526212|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138526213|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138526214|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138526215|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138526216|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526217|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138526218|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
138526219|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526220|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
138526222|NCT00025688|Carboplatin|carboplatin|mesh-list
138526223|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138526224|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526225|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
138526226|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526227|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
138526228|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526231|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
138385610|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526232|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138526233|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138385612|NCT01470690|Omeprazole|omeprazole|mesh-list
138526234|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
138526235|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526236|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526237|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138526238|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138526239|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
138526240|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526241|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138526242|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138526243|NCT00053820|Interferons|interferons|mesh-list
138526244|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
138526245|NCT00053820|Aldesleukin|aldesleukin|mesh-list
138526246|NCT00053820|Fluorouracil|fluorouracil|mesh-list
138526247|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
138526248|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526249|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526250|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526251|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526252|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
138702832|NCT04798287|Adalimumab|adalimumab|mesh-list
138526253|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385679|NCT01471158|Timolol|timolol|mesh-list
138385680|NCT01471158|Dorzolamide|dorzolamide|mesh-list
138526255|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526256|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138526257|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138526258|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138526259|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
138526260|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138526261|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526262|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
138526263|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138526264|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526265|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526266|NCT00053937|Pirfenidone|pirfenidone|mesh-list
138526267|NCT00053937|Analgesics|analgesics|mesh-ancestor
138526268|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
138526269|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138526270|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526277|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138526278|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138526280|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
138526281|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138526282|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
138526283|NCT00053976|Daclizumab|daclizumab|mesh-list
138385737|NCT01471678|Tamsulosin|tamsulosin|mesh-list
138526284|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138385738|NCT01471678|Dutasteride|dutasteride|mesh-list
138385739|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138385740|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138526285|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
138526286|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
138526287|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138526288|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526289|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138526290|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
138526291|NCT00053976|Hormones|hormones|mesh-ancestor
138526292|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138526293|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138385787|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138385788|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385789|NCT01471886|Ketorolac|ketorolac|mesh-list
138385790|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138385791|NCT01471886|Naproxen|naproxen|mesh-list
138385792|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138385806|NCT01471899|Naproxen|naproxen|mesh-list
138526294|NCT00053976|Protective Agents|protective agents|mesh-ancestor
138526295|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138526296|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526297|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526298|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
138526299|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
138526300|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202648|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
138526302|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
138526303|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
138526304|NCT00054054|Docetaxel|docetaxel|mesh-list
138526305|NCT00054054|Fluorouracil|fluorouracil|mesh-list
138526306|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526307|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
138526308|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526309|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
138526310|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526311|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
138526313|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526314|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
138526315|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526317|NCT00026078|Ifosfamide|ifosfamide|mesh-list
138526318|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526319|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
138352010|NCT03060486|Hybenx|hybenx|mesh-list
138526320|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526321|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
138526322|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526323|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138526324|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
138526325|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138526326|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138526327|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526329|NCT00026156|Vinorelbine|vinorelbine|mesh-list
138526330|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385849|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138385850|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526331|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
138526332|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526333|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
138526334|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526335|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138526336|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138526337|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138526338|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
138526340|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138526341|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138526342|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526343|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526344|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526346|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138526347|NCT00054210|Carboplatin|carboplatin|mesh-list
138526348|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138526349|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138526350|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526351|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
138526352|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526353|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
138526354|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526355|NCT00026234|Dexamethasone|dexamethasone|mesh-list
138526356|NCT00026234|Capecitabine|capecitabine|mesh-list
138526357|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
138526358|NCT00026234|Floxuridine|floxuridine|mesh-list
138526359|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138526360|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
138526361|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
138526362|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138526363|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526364|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138526365|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
138526366|NCT00026234|Hormones|hormones|mesh-ancestor
138526367|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138526368|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138526369|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526370|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526371|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
138526372|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526373|NCT00054288|Gemcitabine|gemcitabine|mesh-list
138526374|NCT00054288|Irinotecan|irinotecan|mesh-list
138526375|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526376|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
138526377|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526378|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526379|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138526380|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138526381|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526382|NCT00026273|Leucovorin|leucovorin|mesh-list
138526383|NCT00026273|Fluorouracil|fluorouracil|mesh-list
138526384|NCT00026273|Irinotecan|irinotecan|mesh-list
138526385|NCT00026273|Calcium|calcium|mesh-list
138526386|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
138526387|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138526388|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526389|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
138526390|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526391|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526392|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526393|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526394|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
138526395|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138526396|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138526397|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526398|NCT00026273|Antidotes|antidotes|mesh-ancestor
138526399|NCT00026273|Protective Agents|protective agents|mesh-ancestor
138526400|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
138526401|NCT00026273|Vitamins|vitamins|mesh-ancestor
138526402|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
138526403|NCT00054405|Aldesleukin|aldesleukin|mesh-list
138526404|NCT00054405|Interleukin-2|interleukin-2|mesh-list
138526405|NCT00054405|Interleukin-12|interleukin-12|mesh-list
138526406|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526407|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138526408|NCT00054405|Analgesics|analgesics|mesh-ancestor
138526409|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
138526410|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138385998|NCT01473251|Growth Substances|growth substances|mesh-ancestor
138386001|NCT01473277|Triamcinolone|triamcinolone|mesh-list
138526411|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526412|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138526413|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138526414|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
138526415|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526416|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138526417|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
138526418|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138526419|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138526420|NCT00054405|Growth Substances|growth substances|mesh-ancestor
138526421|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
138526424|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138526425|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526426|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
138386049|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
138386051|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526427|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526428|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138526429|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138526430|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526431|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526432|NCT00054444|Topotecan|topotecan|mesh-list
138526433|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526434|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138526435|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138526436|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526437|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526438|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
138526439|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526440|NCT00054483|Bortezomib|bortezomib|mesh-list
138386112|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386113|NCT01474304|Acetaminophen|acetaminophen|mesh-list
138386114|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138386115|NCT01474304|Analgesics|analgesics|mesh-ancestor
138386116|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
138386119|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
138526441|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526444|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138526445|NCT00026468|Protective Agents|protective agents|mesh-ancestor
138526446|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526447|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138526448|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526449|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526450|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138526451|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138526452|NCT00026468|Analgesics|analgesics|mesh-ancestor
138526453|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
138526454|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138526455|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138526456|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138526457|NCT00054522|Calcitriol|calcitriol|mesh-list
138526458|NCT00054522|Dexamethasone|dexamethasone|mesh-list
138526459|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138526460|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
138526461|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
138526462|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138526463|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526464|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138526465|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
138526466|NCT00054522|Hormones|hormones|mesh-ancestor
138526467|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138526468|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138526469|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526470|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138526471|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138526472|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138526473|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526474|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138526475|NCT00054522|Vitamins|vitamins|mesh-ancestor
138526476|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
138526477|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138526478|NCT00026585|Tamoxifen|tamoxifen|mesh-list
138526479|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138526480|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
138386173|NCT01475006|AMG 595|amg 595|mesh-list
138526481|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138526482|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526483|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138526484|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526485|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138526486|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138526487|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138526489|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138526490|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
138526491|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526492|NCT00054600|Methoxsalen|methoxsalen|mesh-list
138526493|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138526494|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
138526495|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
138526496|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526497|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138526498|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
138526499|NCT00026819|Rofecoxib|rofecoxib|mesh-list
138526500|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138526501|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138229658|NCT02180828|Miconazole|miconazole|mesh-list
138526503|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526504|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138526505|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138526506|NCT00026819|Analgesics|analgesics|mesh-ancestor
138526507|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
138526508|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138526509|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526510|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138526511|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138526512|NCT00054834|Epratuzumab|epratuzumab|mesh-list
138526513|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138526515|NCT00054873|Fluorouracil|fluorouracil|mesh-list
138526516|NCT00054873|Tezacitabine|tezacitabine|mesh-list
138526517|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
138526518|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526519|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526520|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526521|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526522|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
138526523|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386211|NCT01475266|Apaziquone|apaziquone|mesh-list
138386212|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386213|NCT01475279|Warfarin|warfarin|mesh-list
138526524|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526525|NCT00398385|Gemcitabine|gemcitabine|mesh-list
138526526|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526527|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526528|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
138526529|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526530|NCT00027014|Fentanyl|fentanyl|mesh-list
138526531|NCT00027014|Oxycodone|oxycodone|mesh-list
138526532|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138526533|NCT00027014|Narcotics|narcotics|mesh-ancestor
138526534|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138526535|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526536|NCT00027014|Analgesics|analgesics|mesh-ancestor
138526537|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
138526538|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138526539|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138526540|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138526541|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
138526542|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
138526543|NCT00398424|Cisplatin|cisplatin|mesh-list
138526544|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526545|NCT00027053|Trazodone|trazodone|mesh-list
138526546|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138526547|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138526548|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138526549|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526550|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138526551|NCT00027053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138526552|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138526553|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138526554|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526555|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138526556|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
138526557|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138526558|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
138526559|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
138526560|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138386241|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138526561|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526562|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
138526563|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
138526564|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526565|NCT00055302|Anastrozole|anastrozole|mesh-list
138461181|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
138526566|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138526567|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526568|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138526569|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138526570|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526571|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526572|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138526573|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
138229659|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
138526574|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138526575|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526576|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
138526577|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526579|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138526580|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
138526581|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526582|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
138386285|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138386289|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
138526583|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526584|NCT00027287|Vitamin E|vitamin e|mesh-list
138526585|NCT00027287|Vitamins|vitamins|mesh-ancestor
138526586|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
138526587|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526588|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
138526589|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526590|NCT00027287|Protective Agents|protective agents|mesh-ancestor
138526591|NCT00055419|Cetuximab|cetuximab|mesh-list
138526592|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138526593|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526594|NCT00055536|Natalizumab|natalizumab|mesh-list
138526595|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
138526596|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526597|NCT00027443|Cyclosporine|cyclosporine|mesh-list
138526598|NCT00027443|Cyclosporins|cyclosporins|mesh-list
138526599|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
138526600|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202954|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
138526601|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526602|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526603|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
138526604|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526605|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
138386341|NCT01476189|Analgesics|analgesics|mesh-ancestor
138526606|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526607|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
138526608|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138526609|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138526611|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138526612|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138526613|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526614|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526615|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526616|NCT00027521|Bleomycin|bleomycin|mesh-list
138526617|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138526618|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526619|NCT00027599|Bevacizumab|bevacizumab|mesh-list
138526620|NCT00027599|Sargramostim|sargramostim|mesh-list
138526621|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138526622|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526623|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138526624|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138526625|NCT00027599|Growth Substances|growth substances|mesh-ancestor
138526626|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526627|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
138526628|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
138526629|NCT00055653|Cyclosporine|cyclosporine|mesh-list
138526630|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
138526631|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
138526632|NCT00055653|Melphalan|melphalan|mesh-list
138526633|NCT00055653|Busulfan|busulfan|mesh-list
138526634|NCT00055653|Fludarabine|fludarabine|mesh-list
138526635|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
138526636|NCT00055653|Cyclosporins|cyclosporins|mesh-list
138526637|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138526638|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526639|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
138526640|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526641|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138386396|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138386397|NCT01476410|Immunotoxins|immunotoxins|mesh-ancestor
138526642|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138526643|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
138526644|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526645|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526646|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138526647|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526648|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
138526649|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526650|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
138526651|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526652|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
138526653|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138526654|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138526655|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
138526656|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
138526657|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386437|NCT01476800|Ketoconazole|ketoconazole|mesh-list
138386438|NCT01476800|Mirabegron|mirabegron|mesh-list
138386439|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
138526658|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138526659|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
138526660|NCT00055653|Hormones|hormones|mesh-ancestor
138526661|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138526662|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138526663|NCT00055653|Protective Agents|protective agents|mesh-ancestor
138526664|NCT00055770|Docetaxel|docetaxel|mesh-list
138526665|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138526666|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526667|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
138526668|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526669|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
138526670|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526671|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138526672|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526673|NCT00027638|Thalidomide|thalidomide|mesh-list
138526674|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526675|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
138526676|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526677|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
138526678|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138526679|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526680|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138526681|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138526682|NCT00027638|Growth Substances|growth substances|mesh-ancestor
138526683|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
138526684|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526685|NCT00055809|Interferons|interferons|mesh-list
138526686|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
138526687|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
138526688|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138386497|NCT01477112|Vitamins|vitamins|mesh-ancestor
138526689|NCT00055809|Bevacizumab|bevacizumab|mesh-list
138526690|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138526692|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
138526693|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138526694|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526695|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138526696|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138526697|NCT00055809|Growth Substances|growth substances|mesh-ancestor
138526698|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526699|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
138526700|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
138526701|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
138526702|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526703|NCT00027677|Halofuginone|halofuginone|mesh-list
138526704|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526705|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
138526706|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138526707|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138526708|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138386539|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
138386540|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386541|NCT01477294|Caffeine|caffeine|mesh-list
138386544|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138526709|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138526710|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526711|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526713|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138526714|NCT00027677|Growth Substances|growth substances|mesh-ancestor
138526715|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526716|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
138526718|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526719|NCT00055887|Paclitaxel|paclitaxel|mesh-list
138526720|NCT00055887|Vinorelbine|vinorelbine|mesh-list
138526721|NCT00055887|Carboplatin|carboplatin|mesh-list
138526722|NCT00055887|Gemcitabine|gemcitabine|mesh-list
138526723|NCT00055887|Efaproxiral|efaproxiral|mesh-list
138526724|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138526725|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526726|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
138526727|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526728|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
138526729|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526730|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526731|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
138526732|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
138526733|NCT00026039|Estrogens|estrogens|mesh-list
138526734|NCT00026039|Hormones|hormones|mesh-ancestor
138526735|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138526736|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526737|NCT00027404|Fluoxetine|fluoxetine|mesh-list
138386594|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138386595|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138386596|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138386597|NCT01477632|Norethindrone|norethindrone|mesh-list
138386598|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
138386599|NCT01477632|Estradiol|estradiol|mesh-list
138526738|NCT00027404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138526739|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138526740|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138526741|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526742|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138526743|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
138526744|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526745|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138526746|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
138526747|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138526748|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138526749|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138526750|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526751|NCT00055965|Carboplatin|carboplatin|mesh-list
138526752|NCT00055965|Gemcitabine|gemcitabine|mesh-list
138526753|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386637|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138386638|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
138386639|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138526754|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526755|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
138526756|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526757|NCT00027833|Leucovorin|leucovorin|mesh-list
138526758|NCT00027833|Fluorouracil|fluorouracil|mesh-list
138526759|NCT00027833|Irinotecan|irinotecan|mesh-list
138526760|NCT00027833|Calcium|calcium|mesh-list
138526761|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
138526762|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138526763|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526764|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
138526765|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526766|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526767|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526768|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526769|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
138526770|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138526772|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526773|NCT00027833|Antidotes|antidotes|mesh-ancestor
138526774|NCT00027833|Protective Agents|protective agents|mesh-ancestor
138526775|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
138526776|NCT00027833|Vitamins|vitamins|mesh-ancestor
138526777|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
138526778|NCT00027872|Tipifarnib|tipifarnib|mesh-list
138526779|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526780|NCT00027911|Sargramostim|sargramostim|mesh-list
138386693|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
138526781|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
138386694|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526782|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526783|NCT00027989|Gemcitabine|gemcitabine|mesh-list
138526784|NCT00027989|Doxorubicin|doxorubicin|mesh-list
138526785|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138526786|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526787|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
138526788|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526789|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526790|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138526791|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138526792|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138526793|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526794|NCT00056004|Zileuton|zileuton|mesh-list
138526795|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138526796|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138526797|NCT00056004|Analgesics|analgesics|mesh-ancestor
138526798|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
138526799|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138526800|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526801|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138386747|NCT01478386|Protective Agents|protective agents|mesh-ancestor
138526802|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138386748|NCT01478490|Metoprolol|metoprolol|mesh-list
138386749|NCT01478490|Mirabegron|mirabegron|mesh-list
138526803|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138526804|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526805|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526806|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138526807|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
138526808|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138526809|NCT00028028|Sirolimus|sirolimus|mesh-list
138526810|NCT00028028|Temsirolimus|temsirolimus|mesh-list
138526811|NCT00028028|MTOR Inhibitors|mtor inhibitors|mesh-list
138526812|NCT00028028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138526813|NCT00028028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526814|NCT00028028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526815|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526816|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
138526817|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526818|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526819|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138526820|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526821|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138526822|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
138526823|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138526824|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526825|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526826|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526827|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138526828|NCT00056082|Celecoxib|celecoxib|mesh-list
138526829|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138526830|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138526831|NCT00056082|Analgesics|analgesics|mesh-ancestor
138526832|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
138526833|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386799|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138386800|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138386801|NCT01478607|Capsaicin|capsaicin|mesh-list
138386802|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
138386803|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
138386804|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
138386805|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386806|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386822|NCT01478685|Cc-486|cc-486|mesh-list
138526834|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526835|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138526836|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138526837|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138526838|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138526839|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526840|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526842|NCT04730973|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138526843|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138526844|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138526845|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
138526846|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526847|NCT04730973|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138526848|NCT04730973|Protease Inhibitors|protease inhibitors|mesh-ancestor
138526849|NCT04730973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526850|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138526851|NCT00028418|Clofarabine|clofarabine|mesh-list
138526852|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526853|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
138526854|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526855|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526856|NCT00028496|Metronidazole|metronidazole|mesh-list
138526857|NCT00028496|Molgramostim|molgramostim|mesh-list
138526858|NCT00028496|Vaccines|vaccines|mesh-list
138526859|NCT00028496|Sargramostim|sargramostim|mesh-list
138526860|NCT00028496|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
138526861|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
138526862|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386853|NCT01478997|Acetaminophen|acetaminophen|mesh-list
138386854|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138386855|NCT01478997|Analgesics|analgesics|mesh-ancestor
138386856|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
138386857|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138386858|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386859|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
138386860|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138386861|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
138386862|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386863|NCT01479036|Docetaxel|docetaxel|mesh-list
138386864|NCT01479036|Epirubicin|epirubicin|mesh-list
138526863|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526864|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526865|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138526866|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138526867|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138526868|NCT00028496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138526869|NCT00028535|Paclitaxel|paclitaxel|mesh-list
138526870|NCT00028535|Trastuzumab|trastuzumab|mesh-list
138526871|NCT00028535|Interleukin-12|interleukin-12|mesh-list
138526872|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138526873|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386890|NCT01479179|Trastuzumab|trastuzumab|mesh-list
138526874|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
138386893|NCT01479192|Fenretinide|fenretinide|mesh-list
138526875|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
138526876|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
138526877|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526878|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138526879|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138526880|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
138526881|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526882|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138526883|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138526884|NCT00028535|Growth Substances|growth substances|mesh-ancestor
138526885|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
138526886|NCT00056277|Lamotrigine|lamotrigine|mesh-list
138526887|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
138526888|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138526889|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138526890|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526891|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138526892|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526893|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138526894|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138526895|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138526896|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138526897|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138526899|NCT00028574|Analgesics|analgesics|mesh-ancestor
138526900|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
138526901|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138526902|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526903|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
138526904|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138526905|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138526906|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138526907|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138526908|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138386955|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138526909|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138526910|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138526911|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526912|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
138526913|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
138526914|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
138461293|NCT01938911|Oxytocin|oxytocin|mesh-list
138526916|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138526917|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138526918|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526919|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526920|NCT00056433|Urological Agents|urological agents|mesh-ancestor
138526921|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526922|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
138526923|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138526924|NCT00028613|Antibodies|antibodies|mesh-list
138526925|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138526926|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
138526927|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526928|NCT00028652|Interleukin-12|interleukin-12|mesh-list
138526929|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138526930|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
138526931|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526932|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138386995|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386996|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
138526933|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138526934|NCT00028652|Growth Substances|growth substances|mesh-ancestor
138526935|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
138526936|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526938|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138526939|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
138526940|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526941|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526942|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
138526943|NCT00028730|Thiotepa|thiotepa|mesh-list
138526944|NCT00028730|Fludarabine|fludarabine|mesh-list
138526945|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
138526946|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138526947|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526948|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
138526949|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526950|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138526951|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138526952|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
138526953|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526954|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526955|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138526956|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526957|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
138526959|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
138526960|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138526961|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
138526962|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526963|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526964|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
138387044|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526965|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138526966|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526967|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
138526968|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526969|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138526970|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138526971|NCT00028886|Interferons|interferons|mesh-list
138526972|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
138526973|NCT00028886|Thalidomide|thalidomide|mesh-list
138526974|NCT00028886|Dexamethasone|dexamethasone|mesh-list
138526975|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
138526976|NCT00028886|Melphalan|melphalan|mesh-list
138526977|NCT00028886|Doxorubicin|doxorubicin|mesh-list
138387087|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526978|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138526979|NCT00028886|Vincristine|vincristine|mesh-list
138526980|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138526981|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
138387088|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138387091|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
138526982|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138526983|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138526984|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138526986|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138526987|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138526988|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138526989|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138526990|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
138526991|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
138526992|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138526993|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138526994|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
138526995|NCT00028886|Hormones|hormones|mesh-ancestor
138526996|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138387147|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138387148|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138526997|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138526998|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138526999|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138527000|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138527001|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527002|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
138527003|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527004|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138527005|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
138527006|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
138527007|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527008|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
138527009|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138527011|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138527012|NCT00028886|Growth Substances|growth substances|mesh-ancestor
138527013|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
138527014|NCT00028925|Carboplatin|carboplatin|mesh-list
138527015|NCT00028925|Topotecan|topotecan|mesh-list
138527016|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527017|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138527018|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138527019|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527020|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527021|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
138527022|NCT00398463|Tirofiban|tirofiban|mesh-list
138527023|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138527024|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138527025|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527026|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138527027|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138527028|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
138527029|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527030|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138527031|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527032|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
138527033|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138461317|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
138527035|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138527036|NCT00398463|Protective Agents|protective agents|mesh-ancestor
138527037|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
138527038|NCT00028964|Doxorubicin|doxorubicin|mesh-list
138527039|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138527040|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138527041|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
138527042|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527043|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138387263|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138703236|NCT01643226|Riboflavin|riboflavin|mesh-list
138527044|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138527045|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
138527046|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527048|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138527049|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138527050|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138527051|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138527052|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527053|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138527054|NCT00423501|Incretins|incretins|mesh-ancestor
138527055|NCT00423501|Hormones|hormones|mesh-ancestor
138527056|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138203410|NCT00003700|Hormones|hormones|mesh-ancestor
138527057|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527059|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527060|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138527061|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527062|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527063|NCT00029042|Infliximab|infliximab|mesh-list
138527064|NCT00029042|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138527065|NCT00029042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138527066|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
138527067|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138527068|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138527069|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
138527070|NCT00423540|Analgesics|analgesics|mesh-ancestor
138527071|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
138527072|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138527073|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527074|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
138527075|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138387313|NCT01481844|Amoxicillin|amoxicillin|mesh-list
138527076|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138527077|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
138527078|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138527079|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138527080|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703266|NCT02077881|Paclitaxel|paclitaxel|mesh-list
138527081|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138527082|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
138527083|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138527085|NCT00029159|Androgens|androgens|mesh-list
138527086|NCT00029159|Hormones|hormones|mesh-ancestor
138527087|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138387360|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138387361|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138527088|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527089|NCT00423696|Leucovorin|leucovorin|mesh-list
138527090|NCT00423696|Bevacizumab|bevacizumab|mesh-list
138527092|NCT00423696|Fluorouracil|fluorouracil|mesh-list
138527093|NCT00423696|Irinotecan|irinotecan|mesh-list
138527094|NCT00423696|Calcium|calcium|mesh-list
138527096|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138527097|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527098|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138527099|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138527100|NCT00423696|Growth Substances|growth substances|mesh-ancestor
138527101|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527102|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
138527103|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138527104|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138527105|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
138527106|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527107|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138527108|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
138527109|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138527110|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138527111|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527112|NCT00423696|Antidotes|antidotes|mesh-ancestor
138527113|NCT00423696|Protective Agents|protective agents|mesh-ancestor
138527114|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
138527115|NCT00423696|Vitamins|vitamins|mesh-ancestor
138527116|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
138527117|NCT00029315|Plasminogen|plasminogen|mesh-list
138387421|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387425|NCT01482416|Hormones|hormones|mesh-ancestor
138527118|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138527119|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138527120|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138527121|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527122|NCT00056823|Ranibizumab|ranibizumab|mesh-list
138527123|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138527124|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138527125|NCT00056823|Growth Substances|growth substances|mesh-ancestor
138527126|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527127|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
138527128|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527129|NCT00029627|Yohimbine|yohimbine|mesh-list
138527130|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
138527131|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
138527132|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138527133|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527134|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138527135|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138527136|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138527138|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138527139|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527140|NCT00029627|Urological Agents|urological agents|mesh-ancestor
138527142|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
138387469|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387470|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138527143|NCT02970084|Vitamins|vitamins|mesh-ancestor
138527144|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
138527145|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527146|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138527147|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138527148|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527149|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
138527150|NCT02970084|Coagulants|coagulants|mesh-ancestor
138527151|NCT00056979|Fludarabine|fludarabine|mesh-list
138527152|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
138527153|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387520|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138527154|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138387521|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387522|NCT01483274|Vaccines|vaccines|mesh-list
138387523|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
138387524|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387525|NCT01483300|Cisplatin|cisplatin|mesh-list
138387526|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387527|NCT01483365|Progesterone|progesterone|mesh-list
138387528|NCT01483365|Progestins|progestins|mesh-ancestor
138527155|NCT00029822|Alfuzosin|alfuzosin|mesh-list
138527156|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138527157|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138527158|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138527159|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
138527160|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138527161|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527162|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527163|NCT00029822|Urological Agents|urological agents|mesh-ancestor
138527164|NCT00395681|Propofol|propofol|mesh-list
138527165|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138527166|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138527167|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527168|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138387578|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
138527169|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
138387579|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527171|NCT00395720|Vaccines|vaccines|mesh-list
138527172|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
138527173|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527174|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
138527175|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138527176|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138527177|NCT00395915|Aripiprazole|aripiprazole|mesh-list
138527178|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
138527179|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138527180|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138527181|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138527182|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138527183|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387638|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527184|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
138527185|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
138527186|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138527187|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527188|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138527190|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
138527191|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138527192|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138527193|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138527194|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138527196|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138527197|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138527198|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138527199|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138527200|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527202|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138527203|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527204|NCT00057369|Dalbavancin|dalbavancin|mesh-list
138527205|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138527206|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527207|NCT00057408|Olanzapine|olanzapine|mesh-list
138527208|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
138527209|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
138527210|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
138527211|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138527212|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527213|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138527214|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138527215|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138387697|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138527216|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138527217|NCT00057408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138527218|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138527219|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138527220|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527221|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138527222|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
138527224|NCT00030056|Sargramostim|sargramostim|mesh-list
138527226|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527228|NCT00057447|Interferons|interferons|mesh-list
138527229|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
138527230|NCT00057447|Rituximab|rituximab|mesh-list
138527231|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138527232|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527233|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
138527234|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527235|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138527236|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
138527237|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527238|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
138387747|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387748|NCT01485445|Fluticasone|fluticasone|mesh-list
138387749|NCT01485445|Xhance|xhance|mesh-list
138387750|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138527239|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527240|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
138527241|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
138527242|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527243|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527244|NCT00030173|Epothilones|epothilones|mesh-list
138527245|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
138527246|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
138527247|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
138527248|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527249|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527250|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527251|NCT00057564|Thalidomide|thalidomide|mesh-list
138527252|NCT00057564|Dexamethasone|dexamethasone|mesh-list
138527253|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
138527254|NCT00057564|BB 1101|bb 1101|mesh-list
138527255|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138527256|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
138527257|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
138527258|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138527259|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387802|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138527260|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138387803|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138527262|NCT00057564|Hormones|hormones|mesh-ancestor
138527263|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138703383|NCT02057172|Liraglutide|liraglutide|mesh-list
138527264|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138527265|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527266|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
138527267|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527268|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527269|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138527270|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
138527271|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
138387858|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138387859|NCT01485835|Dexamethasone|dexamethasone|mesh-list
138387860|NCT01485835|Bortezomib|bortezomib|mesh-list
138387861|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138527272|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138527273|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527274|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138527275|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138527276|NCT00057564|Growth Substances|growth substances|mesh-ancestor
138527277|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
138527279|NCT00030368|Bortezomib|bortezomib|mesh-list
138527280|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138527281|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527282|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
138527283|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203638|NCT00003994|Amifostine|amifostine|mesh-list
138527284|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527285|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527286|NCT00030407|Celecoxib|celecoxib|mesh-list
138527287|NCT00030407|Docetaxel|docetaxel|mesh-list
138527288|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527289|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
138527290|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
138527291|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527292|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387921|NCT01486082|Amoxicillin|amoxicillin|mesh-list
138527293|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138527294|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138527295|NCT00030407|Analgesics|analgesics|mesh-ancestor
138527296|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
138387922|NCT01486082|Clarithromycin|clarithromycin|mesh-list
138387923|NCT01486082|Omeprazole|omeprazole|mesh-list
138387924|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138387925|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138387926|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138527297|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138527298|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527299|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138527300|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138527301|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138527302|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138527303|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527304|NCT00057642|Sertraline|sertraline|mesh-list
138527305|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138527306|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
138527307|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138527308|NCT00057642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138527309|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138527310|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138387965|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138387966|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
138387967|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
138387968|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138387969|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387970|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138387971|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
138387975|NCT01486485|Nafamostat|nafamostat|mesh-list
138527311|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527312|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138527313|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
138229673|NCT02525523|Alicaforsen|alicaforsen|mesh-list
138527314|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527315|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138527316|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138527317|NCT00030446|Carboplatin|carboplatin|mesh-list
138527318|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138527319|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527320|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138527321|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527322|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527323|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138527324|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527325|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138527326|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461400|NCT01939483|Irinotecan|irinotecan|mesh-list
138461408|NCT01939509|Atenolol|atenolol|mesh-list
138527327|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388020|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138388021|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388022|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138388024|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138527329|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138527330|NCT00057720|Topotecan|topotecan|mesh-list
138527331|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138527332|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527333|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138527334|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138527335|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527336|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527337|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138527338|NCT00030524|Gefitinib|gefitinib|mesh-list
138527339|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527340|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138527341|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527342|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527343|NCT00030563|Irinotecan|irinotecan|mesh-list
138527344|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138527345|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138527346|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527347|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527357|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138388074|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138388075|NCT01486979|Estrogens|estrogens|mesh-ancestor
138388076|NCT01486979|Hormones|hormones|mesh-ancestor
138388077|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138388078|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388079|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138388080|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
138388081|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138527358|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527359|NCT00057759|Urological Agents|urological agents|mesh-ancestor
138527361|NCT00030641|Oblimersen|oblimersen|mesh-list
138527362|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527363|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
138527364|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
138527365|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527366|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527367|NCT00057798|Gemcitabine|gemcitabine|mesh-list
138527368|NCT00057798|Vinorelbine|vinorelbine|mesh-list
138527369|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138527370|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
138527371|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527372|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388120|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
138388121|NCT01487304|Hormones|hormones|mesh-list
138388124|NCT01487317|Rivastigmine|rivastigmine|mesh-list
138527373|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138527374|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
138527375|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
138527376|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527378|NCT02969733|Ketamine|ketamine|mesh-list
138527379|NCT02969733|Analgesics|analgesics|mesh-ancestor
138527380|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
138527381|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138527382|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527383|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138527384|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138461425|NCT01939561|Lamotrigine|lamotrigine|mesh-list
138527385|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
138527387|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138527388|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138527389|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138388184|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388185|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388186|NCT01487798|Insulin|insulin|mesh-list
138527391|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527392|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
138527394|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138527395|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138527396|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138527397|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
138527398|NCT00030719|Melphalan|melphalan|mesh-list
138527399|NCT00030719|Busulfan|busulfan|mesh-list
138527400|NCT00030719|Carboplatin|carboplatin|mesh-list
138527401|NCT00030719|Etoposide|etoposide|mesh-list
138527402|NCT00030719|Vincristine|vincristine|mesh-list
138527403|NCT00030719|Dinutuximab|dinutuximab|mesh-list
138527404|NCT00030719|Isotretinoin|isotretinoin|mesh-list
138527405|NCT00030719|Antibodies|antibodies|mesh-list
138527406|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138527407|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138527408|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
138388244|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527409|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388245|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388246|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
138527410|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138527411|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138527412|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
138527413|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527414|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527415|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138527416|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138527417|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138527418|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138527419|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527420|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
138527421|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
138527422|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
138388297|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
138388298|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138388299|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138527423|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
138388300|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138388301|NCT01488526|Tenofovir|tenofovir|mesh-list
138527424|NCT00030758|Lenograstim|lenograstim|mesh-list
138527425|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138527426|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
138527427|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527428|NCT04730895|Tretinoin|tretinoin|mesh-list
138527429|NCT04730895|Isotretinoin|isotretinoin|mesh-list
138527430|NCT04730895|Vaccines|vaccines|mesh-list
138203772|NCT00093782|Sirolimus|sirolimus|mesh-list
138527431|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
138527432|NCT04730895|Paraproteins|paraproteins|mesh-list
138527433|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
138527434|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527435|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388358|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
138388359|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138527436|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
138388360|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388361|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138388362|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
138388363|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138527437|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
138527439|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138527440|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138527441|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527442|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527443|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527444|NCT00058071|Amifostine|amifostine|mesh-list
138527445|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138527446|NCT00058071|Protective Agents|protective agents|mesh-ancestor
138527447|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527448|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138527449|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138527450|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
138527451|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138527452|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138527453|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138527454|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527455|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388413|NCT01489202|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138388414|NCT01489202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138388415|NCT01489202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388416|NCT01489202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388421|NCT01489202|Trace Elements|trace elements|mesh-ancestor
138527456|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527457|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138527458|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
138527459|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138527460|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138527461|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138527462|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138527463|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
138527464|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138527465|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138527466|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138527467|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138527468|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138527469|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527470|NCT00058149|Gemcitabine|gemcitabine|mesh-list
138527471|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
138527472|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138527473|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
138527474|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527475|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527476|NCT00058227|Rituximab|rituximab|mesh-list
138388467|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138527477|NCT00058227|Fludarabine|fludarabine|mesh-list
138388468|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388469|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388470|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138388471|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388472|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388473|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527478|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
138527479|NCT00058227|Alvocidib|alvocidib|mesh-list
138527480|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138527481|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527482|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
138527483|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527484|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138527485|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138527486|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
138527487|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527488|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138527489|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
138527490|NCT00058227|Growth Substances|growth substances|mesh-ancestor
138527491|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138527492|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527493|NCT00031070|Cyclosporine|cyclosporine|mesh-list
138527494|NCT00031070|Lamivudine|lamivudine|mesh-list
138527495|NCT00031070|Zidovudine|zidovudine|mesh-list
138527496|NCT00031070|Efavirenz|efavirenz|mesh-list
138527497|NCT00031070|Abacavir|abacavir|mesh-list
138527498|NCT00031070|Vaccines|vaccines|mesh-list
138527500|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138527501|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
138388514|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388515|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
138388516|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138527502|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527503|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527504|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527505|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138527506|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
138527507|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527508|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
138527509|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138527510|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138527511|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138527512|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138527514|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138527515|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138527516|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
138527517|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138527518|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138527519|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138527520|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138527521|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138318525|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527523|NCT00058305|Vincristine|vincristine|mesh-list
138527524|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
138527525|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138527526|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527527|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
138527528|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
138527529|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527530|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527531|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138527532|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
138527533|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527534|NCT00058461|Cytarabine|cytarabine|mesh-list
138388565|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388566|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138388567|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
138388568|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138388570|NCT01489865|Fluorouracil|fluorouracil|mesh-list
138527535|NCT00058461|Rituximab|rituximab|mesh-list
138527536|NCT00058461|Carboplatin|carboplatin|mesh-list
138527537|NCT00058461|Methotrexate|methotrexate|mesh-list
138527538|NCT00058461|Etoposide|etoposide|mesh-list
138527539|NCT00058461|Ifosfamide|ifosfamide|mesh-list
138527540|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138527541|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527542|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
138527543|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527544|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138527545|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138527546|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
138703642|NCT01972854|Riboflavin|riboflavin|mesh-list
138527547|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138527548|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138527549|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
138527550|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527551|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
138388604|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138388605|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388606|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388607|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138388608|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138527552|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527553|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138527554|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138318552|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
138318553|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138318554|NCT01386606|Androgens|androgens|mesh-ancestor
138318555|NCT01386606|Hormones|hormones|mesh-ancestor
138704110|NCT06154824|Histamine|histamine|mesh-list
138704111|NCT06154824|Histamine Agonists|histamine agonists|mesh-ancestor
138704112|NCT06154824|Histamine Agents|histamine agents|mesh-ancestor
138704113|NCT06154824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138704114|NCT06154824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704115|NCT06154824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388658|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388659|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704116|NCT06136624|Dexamethasone|dexamethasone|mesh-list
138388660|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138388661|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138388662|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138388691|NCT01490229|Ezetimibe|ezetimibe|mesh-list
138704117|NCT06136624|Prednisone|prednisone|mesh-list
138704118|NCT06136624|Hydrocortisone|hydrocortisone|mesh-list
138704119|NCT06136624|Fludrocortisone|fludrocortisone|mesh-list
138704120|NCT06136624|Abiraterone Acetate|abiraterone acetate|mesh-list
138704121|NCT06136624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138704122|NCT06136624|Antiemetics|antiemetics|mesh-ancestor
138704123|NCT06136624|Autonomic Agents|autonomic agents|mesh-ancestor
138527555|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138527556|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138527557|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138527558|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138527559|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
138527560|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527561|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138461486|NCT01939743|Diclofenac|diclofenac|mesh-list
138527562|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
138527564|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138527565|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
138527566|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527567|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138527568|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138527569|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
138527570|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527571|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388717|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138388718|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138388719|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
138388720|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
138388721|NCT01490333|Vitamin D|vitamin d|mesh-list
138388722|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
138388723|NCT01490333|Vitamins|vitamins|mesh-ancestor
138527572|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138527573|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138527574|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138527575|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
138527576|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527578|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527579|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138527580|NCT00031148|Mitogens|mitogens|mesh-list
138527581|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527582|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527584|NCT00031187|Doxorubicin|doxorubicin|mesh-list
138388763|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388764|NCT01490476|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138388765|NCT01490476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138388766|NCT01490476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527585|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
138527586|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527587|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
138527588|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
138527589|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527590|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527591|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138527592|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138527593|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138704124|NCT06136624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138527595|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
138527596|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527597|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138527598|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
138527599|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527600|NCT00058890|Gabapentin|gabapentin|mesh-list
138527601|NCT00058890|Analgesics|analgesics|mesh-ancestor
138527602|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
138527603|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138527604|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527605|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
138527606|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138527607|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138527608|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138527609|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138527610|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138527611|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138527612|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388825|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
138388826|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388827|NCT01490944|Hematinics|hematinics|mesh-ancestor
138388828|NCT01490944|Vitamins|vitamins|mesh-ancestor
138527613|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527614|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
138527615|NCT00058929|Treprostinil|treprostinil|mesh-list
138527616|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138527617|NCT00396071|Vildagliptin|vildagliptin|mesh-list
138527618|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138527619|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527620|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138527621|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
138527622|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527623|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527624|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138527625|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138527626|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138527627|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138527628|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527629|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138527630|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704150|NCT06136598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138388872|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138388873|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
138388874|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388876|NCT01491061|Ranolazine|ranolazine|mesh-list
138388877|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138388878|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138388879|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388880|NCT01491100|Interferons|interferons|mesh-list
138704151|NCT06136598|Glucocorticoids|glucocorticoids|mesh-ancestor
138704152|NCT06136598|Hormones|hormones|mesh-ancestor
138704153|NCT06136598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138704154|NCT06136598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138704155|NCT06136598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704156|NCT06136598|Protease Inhibitors|protease inhibitors|mesh-ancestor
138704157|NCT06136598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704158|NCT06136598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704178|NCT06109662|Cystatins|cystatins|mesh-list
138704179|NCT06109662|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138704180|NCT06109662|Protease Inhibitors|protease inhibitors|mesh-ancestor
138704181|NCT06109662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704182|NCT06109662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704183|NCT06107413|Leucovorin|leucovorin|mesh-list
138527631|NCT00058968|Analgesics|analgesics|mesh-ancestor
138527632|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
138527633|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138527634|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
138527635|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138527636|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
138527637|NCT00396227|Pioglitazone|pioglitazone|mesh-list
138527638|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
138527639|NCT00396227|Vildagliptin|vildagliptin|mesh-list
138527640|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
138527641|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138703705|NCT02910596|Bethanechol|bethanechol|mesh-list
138388919|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138388920|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138388921|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
138388922|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
138527642|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527643|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138527644|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
138527645|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527646|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527648|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138527649|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138527650|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138527651|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138527652|NCT00031499|Azithromycin|azithromycin|mesh-list
138527653|NCT00031499|Doxycycline|doxycycline|mesh-list
138527654|NCT00031499|Penicillins|penicillins|mesh-list
138527655|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138527656|NCT00031499|Penicillin G|penicillin g|mesh-list
138527657|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
138527658|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138527659|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388966|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138388967|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138388968|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388969|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138388970|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138388971|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
138388972|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
138388973|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388974|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138388975|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138388976|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138388977|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138388978|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
138527660|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
138527661|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138527662|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138527663|NCT00059358|Interferons|interferons|mesh-list
138527664|NCT00059358|Ribavirin|ribavirin|mesh-list
138527665|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
138527666|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
138527667|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138527668|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704188|NCT06107413|Levoleucovorin|levoleucovorin|mesh-list
138704189|NCT06107413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704190|NCT06107413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704191|NCT06107413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138704192|NCT06107413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138704193|NCT06107413|Growth Substances|growth substances|mesh-ancestor
138389011|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138389012|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389013|NCT01492205|Insulin|insulin|mesh-list
138389014|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138389015|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138389016|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389017|NCT01492218|Insulin|insulin|mesh-list
138389018|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138704194|NCT06107413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704195|NCT06107413|Growth Inhibitors|growth inhibitors|mesh-ancestor
138704196|NCT06107413|Antimetabolites|antimetabolites|mesh-ancestor
138704197|NCT06107413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704198|NCT06107413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138704204|NCT06107413|Antidotes|antidotes|mesh-ancestor
138527672|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527674|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527675|NCT00031577|Paclitaxel|paclitaxel|mesh-list
138461509|NCT01939886|Artesunate|artesunate|mesh-list
138527676|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138527677|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527678|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
138527679|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
138527680|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527681|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527682|NCT00031616|Brivudine|brivudine|mesh-list
138527683|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
138389062|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138527684|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
138527685|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527686|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389064|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138389065|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138389066|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389067|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138389068|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
138389069|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
138527687|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703734|NCT06227429|Nitisinone|nitisinone|mesh-list
138527688|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138527689|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
138527690|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138527691|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
138527692|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527693|NCT00031655|Cyclosporine|cyclosporine|mesh-list
138527694|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
138527695|NCT00031655|Fludarabine|fludarabine|mesh-list
138527696|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
138527697|NCT00031655|Cyclosporins|cyclosporins|mesh-list
138527698|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527699|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138527700|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
138527701|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527702|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138527703|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
138527704|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527705|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527706|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
138527707|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527708|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
138527709|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138527710|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138527711|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138527712|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138527713|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
138527714|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138527715|NCT00059592|Valacyclovir|valacyclovir|mesh-list
138527716|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
138318556|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138704238|NCT06055608|Mycophenolic Acid|mycophenolic acid|mesh-list
138527717|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527719|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138527720|NCT00031733|Sargramostim|sargramostim|mesh-list
138527721|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
138527722|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
138527723|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
138389113|NCT01492985|Vaccines|vaccines|mesh-list
138389114|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
138389115|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389116|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
138389117|NCT01493050|Calcium|calcium|mesh-list
138389118|NCT01493050|Sevelamer|sevelamer|mesh-list
138389119|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138389121|NCT01493050|Antacids|antacids|mesh-ancestor
138527724|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527725|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527726|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138527727|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138527728|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138527729|NCT00031733|Growth Substances|growth substances|mesh-ancestor
138527730|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
138527732|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527733|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138527734|NCT02969265|Amlodipine|amlodipine|mesh-list
138527735|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
138527736|NCT02969265|Candesartan|candesartan|mesh-list
138527737|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138527738|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138389146|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138527739|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138527740|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527741|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138389147|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389148|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
138389149|NCT01493154|Vaccines|vaccines|mesh-list
138389150|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
138389151|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527742|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527743|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
138389152|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138527744|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138527745|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138527746|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138527747|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138527748|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
138527749|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138527750|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527751|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138527752|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138527753|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138527754|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138527756|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138527757|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527758|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138527759|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
138527760|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138527761|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527762|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138527763|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138527764|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138527765|NCT00059631|Bortezomib|bortezomib|mesh-list
138527766|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
138527767|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527768|NCT00059631|Analgesics|analgesics|mesh-ancestor
138527769|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
138389193|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138389194|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389195|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
138389196|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138389197|NCT01493479|Rituximab|rituximab|mesh-list
138389198|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138389199|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389200|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
138389201|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389202|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389203|NCT01493570|BI 409306|bi 409306|mesh-list
138389204|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138389205|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389206|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389207|NCT01493622|Minocycline|minocycline|mesh-list
138389208|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138389209|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138389211|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
138527770|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138527771|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527772|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138527773|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138527774|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527775|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527776|NCT00031889|Exemestane|exemestane|mesh-list
138527777|NCT00031889|Bicalutamide|bicalutamide|mesh-list
138527778|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527779|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138527780|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138527781|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389223|NCT01493674|Hematinics|hematinics|mesh-ancestor
138389224|NCT01493674|Vitamins|vitamins|mesh-ancestor
138389225|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
138389226|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389227|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
138389228|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138389229|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
138389230|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138389231|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389233|NCT01493843|Paclitaxel|paclitaxel|mesh-list
138527782|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527783|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138527784|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
138527785|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138527786|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527787|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
138527788|NCT00031928|Mafosfamide|mafosfamide|mesh-list
138527789|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138527790|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
138527791|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527792|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527793|NCT00031967|Melatonin|melatonin|mesh-list
138527794|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
138527795|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527796|NCT00031967|Protective Agents|protective agents|mesh-ancestor
138527797|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138461550|NCT01940172|Conatumumab|conatumumab|mesh-list
138527798|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138527799|NCT00059826|Interferons|interferons|mesh-list
138527800|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
138527801|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
138527802|NCT00059826|Fluorouracil|fluorouracil|mesh-list
138527803|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527804|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
138527805|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527806|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138389276|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138389277|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138389278|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
138389279|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527807|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138527808|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
138527809|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527810|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
138527811|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527812|NCT00032045|Ipilimumab|ipilimumab|mesh-list
138527813|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
138527814|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138527815|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527816|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138527817|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527818|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138527819|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
138527820|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527821|NCT00059865|Gemcitabine|gemcitabine|mesh-list
138527822|NCT00059865|Pemetrexed|pemetrexed|mesh-list
138527823|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138527824|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
138527825|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527826|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389323|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389324|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138389325|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138389326|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138389327|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138527827|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527828|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138527829|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138527830|NCT00032084|Bupropion|bupropion|mesh-list
138527831|NCT00032084|Nicotine|nicotine|mesh-list
138527832|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138527833|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
138527834|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138527835|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527836|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138527837|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138527838|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
138527839|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138527840|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527841|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138527842|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
138527843|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138527844|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138527845|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138527846|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138527848|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138527849|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138527850|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527851|NCT00059904|Aldesleukin|aldesleukin|mesh-list
138527852|NCT00059904|Rituximab|rituximab|mesh-list
138704286|NCT06044311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704287|NCT06044311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138389374|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
138389375|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389376|NCT01494597|Cyclosporine|cyclosporine|mesh-list
138389377|NCT01494597|Isavuconazole|isavuconazole|mesh-list
138389378|NCT01494597|Cyclosporins|cyclosporins|mesh-list
138389379|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704288|NCT06044311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704289|NCT06044311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704290|NCT06042478|Omalizumab|omalizumab|mesh-list
138527853|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138527854|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527855|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
138527856|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527857|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138527858|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138527859|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138527860|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
138527861|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527862|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138527863|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527864|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138389417|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138389418|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389419|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138527865|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389420|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389421|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
138389422|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138527866|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527868|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527869|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
138527870|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
138527871|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
138527872|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527873|NCT00032162|Carboplatin|carboplatin|mesh-list
138527874|NCT00032162|Doxorubicin|doxorubicin|mesh-list
138527875|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138527876|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527877|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138527878|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138527879|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138527880|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204217|NCT00003862|Vitamins|vitamins|mesh-ancestor
138527881|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527882|NCT00032279|Visilizumab|visilizumab|mesh-list
138527883|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
138389469|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138527884|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389470|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138389472|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
138389473|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138389474|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
138389475|NCT01495117|Povidone|povidone|mesh-list
138389497|NCT01495195|Selegiline|selegiline|mesh-list
138527885|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
138527886|NCT00060138|Antibodies|antibodies|mesh-list
138527887|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138527888|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
138527889|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527890|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138527891|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138527892|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138527893|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
138527894|NCT00032396|Hormones|hormones|mesh-ancestor
138461592|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
138527895|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138527896|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704308|NCT06039826|Estradiol|estradiol|mesh-list
138704309|NCT06039826|Estrogens|estrogens|mesh-ancestor
138704310|NCT06039826|Hormones|hormones|mesh-ancestor
138704311|NCT06039826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138389523|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138389524|NCT01495260|Vitamins|vitamins|mesh-ancestor
138389525|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
138389526|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389527|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
138389528|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138704312|NCT06039826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704313|NCT06039826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138527897|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
138527899|NCT00060255|Busulfan|busulfan|mesh-list
138527900|NCT00060255|Thiotepa|thiotepa|mesh-list
138527901|NCT00060255|Carmustine|carmustine|mesh-list
138527902|NCT00060255|Carboplatin|carboplatin|mesh-list
138527903|NCT00060255|Etoposide|etoposide|mesh-list
138527904|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138527905|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
138527906|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527907|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138527908|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138527909|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
138527910|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527911|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527912|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138527913|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138527914|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138527915|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138527916|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138527917|NCT00060294|Rituximab|rituximab|mesh-list
138527918|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138527919|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527920|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
138527921|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527922|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138527923|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138389578|NCT01495624|Anesthetics|anesthetics|mesh-list
138527924|NCT00060372|Ipilimumab|ipilimumab|mesh-list
138389579|NCT01495624|BB 1101|bb 1101|mesh-list
138527925|NCT00060372|Antibodies|antibodies|mesh-list
138389580|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138389581|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
138389582|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
138389587|NCT01495624|Hormones|hormones|mesh-ancestor
138527926|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
138527927|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138527928|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
138527929|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527930|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527931|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138527932|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389620|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389621|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138527934|NCT00060411|Bevacizumab|bevacizumab|mesh-list
138527935|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138389622|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389623|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389624|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
138389626|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527936|NCT00060411|Fluorouracil|fluorouracil|mesh-list
138527937|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
138527938|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138527939|NCT00060411|Antibodies|antibodies|mesh-list
138527940|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
138704344|NCT06029270|Cisplatin|cisplatin|mesh-list
138704345|NCT06029270|Carboplatin|carboplatin|mesh-list
138704346|NCT06029270|Gemcitabine|gemcitabine|mesh-list
138704347|NCT06029270|Nivolumab|nivolumab|mesh-list
138389679|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389680|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138704348|NCT06029270|Relatlimab|relatlimab|mesh-list
138704349|NCT06029270|Immunoglobulins|immunoglobulins|mesh-list
138704350|NCT06029270|Immunoglobulin G|immunoglobulin g|mesh-list
138527941|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138527942|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
138389681|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138389682|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527943|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138527944|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138527945|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138527946|NCT00060411|Growth Substances|growth substances|mesh-ancestor
138527947|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527948|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
138527949|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
138527950|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
138527951|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527952|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138527953|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138527954|NCT00060411|Antidotes|antidotes|mesh-ancestor
138527955|NCT00060411|Protective Agents|protective agents|mesh-ancestor
138527956|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
138527957|NCT00060411|Vitamins|vitamins|mesh-ancestor
138527958|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
138527959|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138389738|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138527960|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389739|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138527962|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138389740|NCT01496690|Pregabalin|pregabalin|mesh-list
138389741|NCT01496690|Analgesics|analgesics|mesh-ancestor
138389742|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
138527963|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
138527964|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138527965|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527966|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138527967|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
138527968|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138527969|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
138527970|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527971|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138527972|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138703884|NCT06225752|Probucol|probucol|mesh-list
138527973|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
138527974|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
138527975|NCT00060450|Protective Agents|protective agents|mesh-ancestor
138527976|NCT00032747|Vasopressins|vasopressins|mesh-list
138527977|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
138527978|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
138527979|NCT00032747|Coagulants|coagulants|mesh-ancestor
138527980|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138527981|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138527982|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
138527983|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527984|NCT00032786|Natalizumab|natalizumab|mesh-list
138527985|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
138527986|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527987|NCT02968719|Donepezil|donepezil|mesh-list
138704373|NCT06001788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138704374|NCT06001788|Immunologic Factors|immunologic factors|mesh-ancestor
138704375|NCT06001788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704376|NCT06001788|Antiviral Agents|antiviral agents|mesh-ancestor
138704377|NCT06001788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138704378|NCT06001788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138704379|NCT06001788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138527988|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138527989|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389791|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
138389792|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389793|NCT01497002|Cytarabine|cytarabine|mesh-list
138389794|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138389795|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
138389796|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389797|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389798|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
138527990|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138527991|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
138527992|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138527993|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138527994|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
138527995|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138527996|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
138527997|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138527998|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138527999|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138528000|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138528001|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528002|NCT00032825|Ketoconazole|ketoconazole|mesh-list
138528003|NCT00032825|Docetaxel|docetaxel|mesh-list
138528004|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528005|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528006|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
138528007|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
138528008|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528009|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
138528010|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528011|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138389826|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138389827|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138389828|NCT01497093|Growth Substances|growth substances|mesh-ancestor
138389829|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
138389830|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138389831|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
138389832|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138389833|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138389834|NCT01497132|Vitamin D|vitamin d|mesh-list
138528012|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138528013|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528014|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138528015|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
138528016|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138528017|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528018|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138528020|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138528022|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138528023|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528024|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
138528025|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138389874|NCT01497470|Carboplatin|carboplatin|mesh-list
138389875|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138389876|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389877|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528026|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
138528027|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528029|NCT00060684|Rituximab|rituximab|mesh-list
138528030|NCT00060684|Fludarabine|fludarabine|mesh-list
138528031|NCT00060684|Pixantrone|pixantrone|mesh-list
138528032|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138704401|NCT05947071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704402|NCT05943535|Treprostinil|treprostinil|mesh-list
138704403|NCT05943535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138704404|NCT05919472|Iron|iron|mesh-list
138528033|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
138528034|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
138528035|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528036|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528037|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138528038|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
138528040|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138389935|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
138389936|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138389937|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389938|NCT01497600|Insulin|insulin|mesh-list
138389939|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138389940|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
138389941|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
138389942|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
138389943|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
138389944|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138528041|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138528042|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528043|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138528044|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
138528045|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389986|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138389987|NCT01498003|Tirofiban|tirofiban|mesh-list
138389988|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138389989|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138389990|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389991|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138389992|NCT01498016|Busulfan|busulfan|mesh-list
138389993|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
138389995|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138528046|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528047|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138528048|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138528049|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528050|NCT02971475|Analgesics|analgesics|mesh-list
138528051|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
138528052|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528053|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528054|NCT00032942|Lofexidine|lofexidine|mesh-list
138528055|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138528056|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138528057|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528058|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
138528059|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528060|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138528061|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138528062|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138528063|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
138528064|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138421828|NCT01684982|Sirolimus|sirolimus|mesh-list
138528065|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528066|NCT00033059|Tolcapone|tolcapone|mesh-list
138528067|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138528068|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138528069|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138528070|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528071|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390037|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
138528073|NCT00060918|Carvedilol|carvedilol|mesh-list
138528074|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138390038|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390039|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138390040|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390042|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138528075|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138528076|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
138528077|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
138528078|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528079|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528080|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138704432|NCT05900245|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138704433|NCT05900245|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138704434|NCT05900245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138704447|NCT05892744|Sertraline|sertraline|mesh-list
138704448|NCT05892744|Antidepressive Agents|antidepressive agents|mesh-ancestor
138704449|NCT05892744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138704450|NCT05892744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138704451|NCT05892744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138704452|NCT05892744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138390088|NCT01498861|Dolutegravir|dolutegravir|mesh-list
138390089|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
138390090|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138390091|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138390092|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138704453|NCT05892744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704454|NCT05892744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528081|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138229731|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528082|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138528083|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
138528084|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528085|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528086|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
138528087|NCT00060918|Protective Agents|protective agents|mesh-ancestor
138528088|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138528089|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138528090|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138528091|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
138528092|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138528093|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138528094|NCT00033098|Metyrapone|metyrapone|mesh-list
138528095|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
138528096|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528097|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528098|NCT02968641|Ritonavir|ritonavir|mesh-list
138528099|NCT02968641|Lonafarnib|lonafarnib|mesh-list
138528100|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138528101|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138528102|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
138528103|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390144|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390145|NCT01499108|Incretins|incretins|mesh-ancestor
138390147|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390149|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390150|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138390151|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138390152|NCT01499121|Growth Substances|growth substances|mesh-ancestor
138390154|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
138528104|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528105|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138528106|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138528107|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
138528109|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138528110|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138528112|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
138528113|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528114|NCT00033176|Protective Agents|protective agents|mesh-ancestor
138528115|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528116|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
138528117|NCT00033176|Vitamins|vitamins|mesh-ancestor
138528118|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
138528119|NCT00033215|S 3304|s 3304|mesh-list
138528120|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
138390186|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138390187|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528121|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
138528122|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528123|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528124|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
138528125|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138528126|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138704456|NCT05892744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390188|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138390189|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
138390190|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
138390191|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138390192|NCT01499485|Acetazolamide|acetazolamide|mesh-list
138390193|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
138390194|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138390195|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704457|NCT05891171|Leucovorin|leucovorin|mesh-list
138704458|NCT05891171|Carboplatin|carboplatin|mesh-list
138704459|NCT05891171|Fluorouracil|fluorouracil|mesh-list
138704460|NCT05891171|Oxaliplatin|oxaliplatin|mesh-list
138461667|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
138528129|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528131|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528132|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528133|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138528134|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528135|NCT00060996|Treprostinil|treprostinil|mesh-list
138528136|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138528137|NCT00033254|Thalidomide|thalidomide|mesh-list
138528138|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138528139|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
138421865|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
138528140|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528141|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
138528142|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138528143|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528144|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138528145|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138390229|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138390230|NCT01499641|Protective Agents|protective agents|mesh-ancestor
138390231|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138528146|NCT00033254|Growth Substances|growth substances|mesh-ancestor
138528147|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
138390232|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528148|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390233|NCT01499693|Pantoprazole|pantoprazole|mesh-list
138390234|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138528149|NCT00061074|Nicotine|nicotine|mesh-list
138390235|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138390236|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138390239|NCT01499758|Atorvastatin|atorvastatin|mesh-list
138528150|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138704488|NCT05864118|Antibodies|antibodies|mesh-list
138704489|NCT05864118|Immunologic Factors|immunologic factors|mesh-ancestor
138704490|NCT05864118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704500|NCT05845814|Pembrolizumab|pembrolizumab|mesh-list
138704501|NCT05845814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704502|NCT05845814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704503|NCT05845814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138704504|NCT05845814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704505|NCT05845645|Esomeprazole|esomeprazole|mesh-list
138704506|NCT05845645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138528152|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528153|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528154|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138528155|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138528156|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
138528157|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390274|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138390275|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138390276|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390277|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390278|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138390279|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
138528158|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528159|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
138528160|NCT00033332|Pamidronate|pamidronate|mesh-list
138528161|NCT00033332|Thalidomide|thalidomide|mesh-list
138528162|NCT00033332|Dexamethasone|dexamethasone|mesh-list
138528163|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138528164|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
138528165|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
138528166|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528167|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528168|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138528169|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
138528170|NCT00033332|Hormones|hormones|mesh-ancestor
138528171|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138528172|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138528173|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528174|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138528175|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
138528176|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
138528177|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138528178|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528179|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138528180|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138528181|NCT00033332|Growth Substances|growth substances|mesh-ancestor
138528182|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
138528183|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138528185|NCT00033410|Carboplatin|carboplatin|mesh-list
138528186|NCT00033410|Tirapazamine|tirapazamine|mesh-list
138528187|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138528188|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528189|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528190|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
138528191|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
138704511|NCT05837091|Sodium Oxybate|sodium oxybate|mesh-list
138528196|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138528197|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528198|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528199|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
138528200|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528201|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138528202|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
138528203|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138229737|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
138528204|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138528205|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138528207|NCT00033449|Gefitinib|gefitinib|mesh-list
138528208|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528209|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138528210|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528211|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528212|NCT00061152|Capsaicin|capsaicin|mesh-list
138528213|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
138390372|NCT01500824|Crizotinib|crizotinib|mesh-list
138390373|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528214|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
138390374|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138390375|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390376|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528215|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
138528216|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528217|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528219|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
138528220|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
138528221|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528222|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528223|NCT00033605|Octreotide|octreotide|mesh-list
138528224|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138528225|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138421967|NCT01690221|Diltiazem|diltiazem|mesh-list
138528226|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528227|NCT00033644|Doxorubicin|doxorubicin|mesh-list
138528228|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138528229|NCT00033644|Mitomycins|mitomycins|mesh-list
138528230|NCT00033644|Mitomycin|mitomycin|mesh-list
138528231|NCT00033644|Dacarbazine|dacarbazine|mesh-list
138528232|NCT00033644|Sargramostim|sargramostim|mesh-list
138528233|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704550|NCT05815160|Etoposide|etoposide|mesh-list
138390421|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390422|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390423|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138390424|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
138390425|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138390426|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138390427|NCT01500863|Progestins|progestins|mesh-ancestor
138390428|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
138390431|NCT01500915|Ranibizumab|ranibizumab|mesh-list
138704552|NCT05815160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138704553|NCT05815160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138704554|NCT05815160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138704555|NCT05815160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704556|NCT05815160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528239|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
138528240|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528241|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
138528242|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138528243|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138528244|NCT00033683|Tamoxifen|tamoxifen|mesh-list
138528245|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
138528246|NCT00033683|Docetaxel|docetaxel|mesh-list
138528247|NCT00033683|Fluorouracil|fluorouracil|mesh-list
138528248|NCT00033683|Methotrexate|methotrexate|mesh-list
138528249|NCT00033683|Epirubicin|epirubicin|mesh-list
138528250|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138528251|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
138528252|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528253|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138528254|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138528255|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
138528256|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390470|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138390471|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138390472|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138390473|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390474|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138390475|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138390476|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138528257|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528258|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138528259|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528260|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
138528261|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
138528262|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
138528263|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138528264|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138528265|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
138528266|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138528267|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
138528268|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528269|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138528270|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138528271|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138528272|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138528273|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138528274|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138528275|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
138528276|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138528277|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138528278|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138528279|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138390520|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138390521|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138390523|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138390524|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
138528280|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138528281|NCT00061308|Gemcitabine|gemcitabine|mesh-list
138528282|NCT00061308|Topotecan|topotecan|mesh-list
138528283|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138528284|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
138528285|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528286|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528287|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138704578|NCT05794555|Lactulose|lactulose|mesh-list
138704579|NCT05794555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138704595|NCT05773989|Clopidogrel|clopidogrel|mesh-list
138704596|NCT05773989|Ticagrelor|ticagrelor|mesh-list
138704597|NCT05773989|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138528288|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138390568|NCT01501370|Vorinostat|vorinostat|mesh-list
138390569|NCT01501370|BB 1101|bb 1101|mesh-list
138390570|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138390571|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
138528289|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390572|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
138390577|NCT01501370|Hormones|hormones|mesh-ancestor
138528290|NCT00033722|Folic Acid|folic acid|mesh-list
138528291|NCT00033722|Lometrexol|lometrexol|mesh-list
138528292|NCT00033722|Hematinics|hematinics|mesh-ancestor
138528293|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
138528294|NCT00033722|Vitamins|vitamins|mesh-ancestor
138528295|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
138528296|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528297|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138528298|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
138528299|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528300|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528301|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138528302|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528303|NCT00061425|Epratuzumab|epratuzumab|mesh-list
138528304|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138528305|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528306|NCT00061464|Gemcitabine|gemcitabine|mesh-list
138528307|NCT00061464|Pemetrexed|pemetrexed|mesh-list
138528308|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138528309|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
138528310|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528311|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528312|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528313|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138528314|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138528315|NCT00061503|Travoprost|travoprost|mesh-list
138528316|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138528317|NCT00061542|Timolol|timolol|mesh-list
138528318|NCT00061542|Betaxolol|betaxolol|mesh-list
138461711|NCT01941173|Leucovorin|leucovorin|mesh-list
138528319|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138528320|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138390625|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390626|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528321|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
138528322|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528323|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528324|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528325|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138528326|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138528327|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
138528328|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
138528329|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528330|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138528331|NCT00061620|Tezacitabine|tezacitabine|mesh-list
138528332|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528333|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528334|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390669|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138390670|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390671|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
138390672|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390673|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
138390682|NCT01501669|Capecitabine|capecitabine|mesh-list
138528335|NCT00034151|Paclitaxel|paclitaxel|mesh-list
138528336|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138528337|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528338|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528339|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
138528340|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
138528341|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528342|NCT00034190|Paclitaxel|paclitaxel|mesh-list
138528343|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138528344|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528345|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528346|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
138528347|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
138528348|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528350|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
138704604|NCT05773989|Purinergic Agents|purinergic agents|mesh-ancestor
138528351|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138528352|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138528353|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528354|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528355|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528356|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
138528357|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138528358|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528359|NCT00061776|Capsaicin|capsaicin|mesh-list
138528360|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
138528361|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
138528362|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
138528363|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528364|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528365|NCT00034346|Paclitaxel|paclitaxel|mesh-list
138528366|NCT00034346|Carboplatin|carboplatin|mesh-list
138528367|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138390730|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138528368|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528369|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528370|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
138528371|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
138528372|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528373|NCT00034385|Valganciclovir|valganciclovir|mesh-list
138528374|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
138528375|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528376|NCT00034463|Folic Acid|folic acid|mesh-list
138528377|NCT00034463|Vitamins|vitamins|mesh-ancestor
138528378|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
138528379|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528380|NCT00034463|Hematinics|hematinics|mesh-ancestor
138528381|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
138528382|NCT02971397|Cytarabine|cytarabine|mesh-list
138528383|NCT02971397|Daunorubicin|daunorubicin|mesh-list
138528384|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138528385|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
138528386|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528387|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528388|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
138528389|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528390|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138390769|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
138390770|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138528391|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
138528392|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390771|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138390772|NCT01501799|Analgesics|analgesics|mesh-ancestor
138528393|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138528394|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138528395|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138528396|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528397|NCT00396500|Vitamin A|vitamin a|mesh-list
138528398|NCT00396500|Albendazole|albendazole|mesh-list
138704619|NCT05763004|Pembrolizumab|pembrolizumab|mesh-list
138528406|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528407|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
138528408|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138528409|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138528410|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528411|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
138528412|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
138528414|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138528415|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138528416|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528417|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528418|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528419|NCT00034541|Paclitaxel|paclitaxel|mesh-list
138528420|NCT00034541|Carboplatin|carboplatin|mesh-list
138528421|NCT00034541|Cetuximab|cetuximab|mesh-list
138528422|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138528423|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528424|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528425|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
138528426|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
138528427|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528428|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138528429|NCT00034580|Olanzapine|olanzapine|mesh-list
138528430|NCT00034580|Risperidone|risperidone|mesh-list
138528431|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138528432|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
138528433|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528434|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528435|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528436|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138528437|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138528438|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138528439|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138528440|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138528441|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
138528442|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
138528443|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
138528444|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528445|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138528446|NCT00034580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138528447|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138528448|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138528449|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
138528450|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528451|NCT00061815|Leucovorin|leucovorin|mesh-list
138528452|NCT00061815|Fluorouracil|fluorouracil|mesh-list
138528453|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
138528454|NCT00061815|Cetuximab|cetuximab|mesh-list
138528455|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
138528456|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528457|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138528458|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528459|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138528460|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
138528461|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528462|NCT00061815|Antidotes|antidotes|mesh-ancestor
138528463|NCT00061815|Protective Agents|protective agents|mesh-ancestor
138528464|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
138528465|NCT00061815|Vitamins|vitamins|mesh-ancestor
138528466|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
138528467|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138528468|NCT00061854|Soblidotin|soblidotin|mesh-list
138528469|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390933|NCT01503060|Lidocaine|lidocaine|mesh-list
138528470|NCT00034658|Posaconazole|posaconazole|mesh-list
138528471|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
138528472|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528473|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138528474|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138528475|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138528476|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138528477|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138528478|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528479|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528480|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138528481|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
138528482|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138204803|NCT03808077|Rocuronium|rocuronium|mesh-list
138528483|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528485|NCT00398580|Testosterone|testosterone|mesh-list
138528486|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
138528487|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
138528488|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138528489|NCT00398580|Dutasteride|dutasteride|mesh-list
138528490|NCT00398580|Androgens|androgens|mesh-ancestor
138528491|NCT00398580|Hormones|hormones|mesh-ancestor
138704687|NCT05708859|Tirzepatide|tirzepatide|mesh-list
138704688|NCT05708859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138704689|NCT05708859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390980|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704690|NCT05708859|Incretins|incretins|mesh-ancestor
138704691|NCT05708859|Hormones|hormones|mesh-ancestor
138704692|NCT05708859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138390981|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528492|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138528493|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528494|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138528495|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528496|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
138528497|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138528498|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138528499|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528500|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528501|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
138528502|NCT00034697|Temozolomide|temozolomide|mesh-list
138528503|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138528504|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
138528505|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528506|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528507|NCT00034736|Levofloxacin|levofloxacin|mesh-list
138528508|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138528509|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528510|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138528511|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138528512|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138528513|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391025|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138391026|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138391035|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
138528514|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528515|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528516|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138528517|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138528518|NCT02967939|Tenofovir|tenofovir|mesh-list
138528519|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
138528520|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528521|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138528522|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138528523|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528524|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528525|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138528526|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138528527|NCT00034775|Risperidone|risperidone|mesh-list
138528528|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138528529|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
138528530|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528531|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528532|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528533|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138528534|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138528535|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138528536|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138528537|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138528538|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
138528539|NCT00062127|Thalidomide|thalidomide|mesh-list
138528540|NCT00062127|Irinotecan|irinotecan|mesh-list
138704700|NCT05687032|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138704701|NCT05687032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704702|NCT05687032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704703|NCT05687032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138704704|NCT05687032|Immunotoxins|immunotoxins|mesh-ancestor
138704705|NCT05687032|Immunoconjugates|immunoconjugates|mesh-ancestor
138704706|NCT05687032|Immunologic Factors|immunologic factors|mesh-ancestor
138704707|NCT05687032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704708|NCT05677451|Remibrutinib|remibrutinib|mesh-list
138704709|NCT05677451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138391075|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138704710|NCT05677451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528541|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138528542|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138528543|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528544|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528545|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528546|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138528547|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
138461771|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
138528548|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528550|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138528551|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528552|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138528553|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138528554|NCT00062127|Growth Substances|growth substances|mesh-ancestor
138528555|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
138528556|NCT00034853|Naproxen|naproxen|mesh-list
138528557|NCT00034853|Meloxicam|meloxicam|mesh-list
138528558|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138528559|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138528561|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
138528562|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528563|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528564|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138528565|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138528566|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
138528567|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138528568|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138391111|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
138391112|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391113|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138528569|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528570|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138528571|NCT00034892|Olanzapine|olanzapine|mesh-list
138528572|NCT00034892|Risperidone|risperidone|mesh-list
138528573|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138528574|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
138528575|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528576|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528577|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528578|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138528579|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138528580|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138528581|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138528582|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138528583|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
138528584|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
138528585|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
138528586|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528587|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138528588|NCT00034892|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138528589|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138528590|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138528591|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
138528592|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528593|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138528594|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528595|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528596|NCT00062244|Oblimersen|oblimersen|mesh-list
138528597|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528598|NCT00035009|Aprepitant|aprepitant|mesh-list
138528599|NCT00035009|Paroxetine|paroxetine|mesh-list
138704728|NCT05640102|Zanubrutinib|zanubrutinib|mesh-list
138704729|NCT05640102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704730|NCT05640102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138704731|NCT05640102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704732|NCT05640102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528600|NCT00035009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138528601|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138528602|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138528603|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528604|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528605|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
138528606|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391215|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
138528607|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138528608|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
138528609|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138528610|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138528611|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138461788|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528612|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528613|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
138528614|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
138528615|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528616|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138528617|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138528619|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138528620|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528621|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
138528622|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
138528623|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528624|NCT00035048|Aprepitant|aprepitant|mesh-list
138528625|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
138528626|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
138528627|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528628|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391268|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528629|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138528630|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138528631|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528632|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528634|NCT00035087|Epothilone B|epothilone b|mesh-list
138528635|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528636|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
138528637|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
138461804|NCT01941810|Lactoferrin|lactoferrin|mesh-list
138528638|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528639|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528640|NCT00062322|Irinotecan|irinotecan|mesh-list
138528641|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528642|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138528643|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138528644|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528645|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528646|NCT00035126|Epothilones|epothilones|mesh-list
138528647|NCT00035126|Epothilone B|epothilone b|mesh-list
138528648|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528649|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
138528650|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
138422267|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
138528651|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528652|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528653|NCT00035165|Epothilones|epothilones|mesh-list
138528654|NCT00035165|Epothilone B|epothilone b|mesh-list
138528655|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528656|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
138528657|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
138528658|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528659|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391326|NCT01504516|Donepezil|donepezil|mesh-list
138528660|NCT00035204|Galantamine|galantamine|mesh-list
138528661|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138528662|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528663|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528664|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
138528665|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528666|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528667|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138528668|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
138528669|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528670|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
138528671|NCT00062478|Camptothecin|camptothecin|mesh-list
138528672|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138528673|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528674|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138528675|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138528676|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528677|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528678|NCT00035243|Epothilones|epothilones|mesh-list
138528679|NCT00035243|Epothilone B|epothilone b|mesh-list
138528680|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528681|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
138528682|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
138528683|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528684|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528686|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
138528688|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528689|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391367|NCT01504724|Growth Substances|growth substances|mesh-ancestor
138391368|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391369|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
138391370|NCT01504776|Bortezomib|bortezomib|mesh-list
138391371|NCT01504776|Panobinostat|panobinostat|mesh-list
138528690|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138528691|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138528692|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528693|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528696|NCT00062556|L 647318|l 647318|mesh-list
138528697|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
138528698|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138528699|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
138528700|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528701|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138528702|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
138528703|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
138528704|NCT00062556|Vitamins|vitamins|mesh-ancestor
138528705|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
138205028|NCT00199056|Vindesine|vindesine|mesh-list
138528706|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528707|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138528708|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138528709|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704759|NCT05634057|Protective Agents|protective agents|mesh-ancestor
138704760|NCT05609968|Pembrolizumab|pembrolizumab|mesh-list
138704761|NCT05609968|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138704762|NCT05609968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138391410|NCT01505088|Dexamethasone|dexamethasone|mesh-list
138704763|NCT05609968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528732|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
138391411|NCT01505088|Prednisolone|prednisolone|mesh-list
138528733|NCT00062595|Vitamin K|vitamin k|mesh-list
138704782|NCT05590728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138704783|NCT05590728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138318582|NCT01397448|Rabeprazole|rabeprazole|mesh-list
138528734|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138528735|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138528736|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422346|NCT01692457|Golimumab|golimumab|mesh-list
138528738|NCT00062595|Coagulants|coagulants|mesh-ancestor
138528739|NCT00062595|Vitamins|vitamins|mesh-ancestor
138528740|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
138528741|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528742|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138528743|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
138528744|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528745|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138461878|NCT01942109|Torsemide|torsemide|mesh-list
138528746|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138528747|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138528748|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138528749|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528750|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528751|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528752|NCT00062673|Analgesics|analgesics|mesh-ancestor
138528753|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
138528754|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528755|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
138528756|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138528757|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
138528758|NCT00035477|Azimilide|azimilide|mesh-list
138528759|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138528760|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138528761|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138528762|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528763|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138528764|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528765|NCT00062712|Sirolimus|sirolimus|mesh-list
138528766|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138528767|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138391460|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391461|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138528768|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528769|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138528770|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528771|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
138528772|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138528773|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
138528774|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528775|NCT00062790|Dutasteride|dutasteride|mesh-list
138528776|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138528777|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138528778|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528779|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528781|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138528782|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528783|NCT00035516|Epothilones|epothilones|mesh-list
138528784|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528785|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
138528786|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
138528787|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528788|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528789|NCT00062946|Fallypride|fallypride|mesh-list
138528790|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138461904|NCT01942187|Aripiprazole|aripiprazole|mesh-list
138528791|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138528792|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
138704812|NCT05568888|Thrombin|thrombin|mesh-list
138704813|NCT05568888|Hemostatics|hemostatics|mesh-ancestor
138704814|NCT05568888|Coagulants|coagulants|mesh-ancestor
138528794|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528795|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391496|NCT01505283|Analgesics|analgesics|mesh-ancestor
138391497|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138528796|NCT00063024|Calcium|calcium|mesh-list
138528797|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138528798|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528799|NCT00035984|Exenatide|exenatide|mesh-list
138528800|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138528801|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528802|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138528803|NCT00035984|Incretins|incretins|mesh-ancestor
138528804|NCT00035984|Hormones|hormones|mesh-ancestor
138528805|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138528806|NCT00063141|Irinotecan|irinotecan|mesh-list
138528807|NCT00063141|Cetuximab|cetuximab|mesh-list
138528808|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138528809|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138528810|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528811|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528812|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528813|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138528814|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
138528815|NCT00036023|Hematinics|hematinics|mesh-ancestor
138528816|NCT00036062|Sivelestat|sivelestat|mesh-list
138391539|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
138391540|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138391541|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138391542|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
138528817|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138528818|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
138528819|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528820|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528821|NCT00036101|Aripiprazole|aripiprazole|mesh-list
138528822|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
138528823|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138528824|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138528825|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138528826|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138528827|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528828|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
138528829|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
138528830|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528831|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528832|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138528833|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138528834|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
138229802|NCT05308160|Dapagliflozin|dapagliflozin|mesh-list
138528835|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138528836|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138528837|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138528838|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138528841|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528842|NCT00036218|Ropinirole|ropinirole|mesh-list
138528843|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138528844|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138528845|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
138528846|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
138528847|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528848|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528849|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528850|NCT00063453|Vitamins|vitamins|mesh-list
138528851|NCT00063453|Vitamin E|vitamin e|mesh-list
138528852|NCT00063453|Tocopherols|tocopherols|mesh-list
138528853|NCT00063453|Tocotrienols|tocotrienols|mesh-list
138528854|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
138528856|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
138528857|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528858|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
138391590|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138391591|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
138528859|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528860|NCT00063453|Protective Agents|protective agents|mesh-ancestor
138528861|NCT00063453|Trace Elements|trace elements|mesh-ancestor
138528862|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138528863|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138528864|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138528865|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138528866|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528867|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138528868|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528869|NCT00036335|Analgesics|analgesics|mesh-ancestor
138528870|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
138528871|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138528872|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
138528873|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138528875|NCT00036374|Infliximab|infliximab|mesh-list
138528876|NCT00036374|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138528877|NCT00036374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138528878|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
138528879|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138528880|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138528881|NCT00036452|Ritonavir|ritonavir|mesh-list
138528882|NCT00036452|Lopinavir|lopinavir|mesh-list
138528883|NCT00036452|Tenofovir|tenofovir|mesh-list
138528884|NCT00036452|Emtricitabine|emtricitabine|mesh-list
138528885|NCT00036452|Stavudine|stavudine|mesh-list
138528886|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138528887|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138528888|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
138528889|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528890|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528891|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138528892|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138528893|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
138528894|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138391624|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138391628|NCT01506050|Desloratadine|desloratadine|mesh-list
138229808|NCT01127438|Propofol|propofol|mesh-list
138528895|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138528896|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138528897|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138528898|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138528899|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
138528900|NCT02967276|Metformin|metformin|mesh-list
138528901|NCT02967276|Dexamethasone|dexamethasone|mesh-list
138528902|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138528903|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
138528908|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
138528910|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138528911|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138528912|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528913|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138528914|NCT00036491|Rituximab|rituximab|mesh-list
138422454|NCT01693302|Insulin|insulin|mesh-list
138528915|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138528916|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528917|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
138528918|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528919|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138528920|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
138528921|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138528922|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528923|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
138528924|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138528925|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528926|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138528927|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528928|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138528929|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528930|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528932|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528933|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528934|NCT00036764|Epothilones|epothilones|mesh-list
138528935|NCT00036764|Epothilone B|epothilone b|mesh-list
138528936|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
138528937|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
138391663|NCT01506167|Capecitabine|capecitabine|mesh-list
138391664|NCT01506167|Fluorouracil|fluorouracil|mesh-list
138391666|NCT01506167|Irinotecan|irinotecan|mesh-list
138528938|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
138528939|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528940|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528941|NCT00063726|Bortezomib|bortezomib|mesh-list
138528942|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528943|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
138528944|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528945|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
138528946|NCT00036881|Astringents|astringents|mesh-ancestor
138528947|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528948|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
138528950|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138528951|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138528952|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
138528953|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528954|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528955|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138528956|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138528957|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
138528958|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528959|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138528960|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138528961|NCT02967432|Mupirocin|mupirocin|mesh-list
138528963|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138528964|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138528965|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138528966|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528967|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528968|NCT02967432|Emollients|emollients|mesh-ancestor
138528969|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
138528970|NCT00063960|Irinotecan|irinotecan|mesh-list
138528971|NCT00063960|Floxuridine|floxuridine|mesh-list
138528972|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138528973|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138528974|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138528975|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528976|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528977|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138528979|NCT00064116|Rituximab|rituximab|mesh-list
138528980|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138528981|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528982|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
138528983|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528984|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138528986|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
138528987|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528988|NCT00064194|Vitamin E|vitamin e|mesh-list
138528989|NCT00064194|Selenium|selenium|mesh-list
138528990|NCT00064194|Vitamins|vitamins|mesh-ancestor
138528991|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
138528992|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138528993|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
138528994|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138528995|NCT00064194|Protective Agents|protective agents|mesh-ancestor
138528996|NCT00064194|Trace Elements|trace elements|mesh-ancestor
138528997|NCT00064233|Dasatinib|dasatinib|mesh-list
138528998|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138528999|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138529000|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529001|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529002|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
138529003|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138529004|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529005|NCT00037115|Interferons|interferons|mesh-list
138529006|NCT00037115|Interferon-beta|interferon-beta|mesh-list
138529007|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
138529008|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
138529009|NCT00037115|Methotrexate|methotrexate|mesh-list
138529010|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138529011|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
138529012|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138529013|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529014|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529015|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
138529016|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529017|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318583|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138704878|NCT05514054|Tamoxifen|tamoxifen|mesh-list
138704879|NCT05514054|Letrozole|letrozole|mesh-list
138391732|NCT01506505|Analgesics|analgesics|mesh-ancestor
138704880|NCT05514054|Anastrozole|anastrozole|mesh-list
138704881|NCT05514054|Exemestane|exemestane|mesh-list
138704882|NCT05514054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529018|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
138529019|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529020|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138529021|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529022|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
138529023|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138529024|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138529025|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
138529026|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529027|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138529029|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
138529030|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529031|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138529032|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
138529033|NCT00037115|Hormones|hormones|mesh-ancestor
138529034|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529035|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138529036|NCT00037115|Protective Agents|protective agents|mesh-ancestor
138529037|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138529038|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
138529039|NCT00037154|Urological Agents|urological agents|mesh-ancestor
138529040|NCT00064389|Albuterol|albuterol|mesh-list
138529041|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138529042|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
138529043|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529044|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529045|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138529046|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
138529047|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
138529048|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138529049|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138529050|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138529051|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138529052|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
138529053|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138391775|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138391776|NCT01506635|Timolol|timolol|mesh-list
138529054|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138391779|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
138529056|NCT00064428|Fondaparinux|fondaparinux|mesh-list
138529057|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138529058|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
138529059|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138529060|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
138529061|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529062|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529063|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
138529064|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138529065|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138529066|NCT00064467|Bupropion|bupropion|mesh-list
138529067|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138529068|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
138529069|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138529070|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138529071|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138529072|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138529073|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529074|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
138529075|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138529076|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529077|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138529078|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138529079|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704898|NCT05507580|Upadacitinib|upadacitinib|mesh-list
138529081|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
138529082|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
138529083|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
138391811|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138391812|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
138391813|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529084|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529085|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529086|NCT00064779|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
138529087|NCT00064779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529088|NCT00037544|Factor VIII|factor viii|mesh-list
138529089|NCT00037544|Coagulants|coagulants|mesh-ancestor
138529090|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
138529091|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138529092|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529093|NCT00037583|Immunotoxins|immunotoxins|mesh-ancestor
138529094|NCT00037583|Immunoconjugates|immunoconjugates|mesh-ancestor
138529095|NCT00037583|Immunologic Factors|immunologic factors|mesh-ancestor
138529096|NCT00037583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529097|NCT00064857|Pycnogenols|pycnogenols|mesh-list
138529098|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138529099|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
138529100|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529101|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
138529102|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529103|NCT00064857|Protective Agents|protective agents|mesh-ancestor
138529104|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138529105|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
138529106|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138529107|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138529108|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529109|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529110|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
138529111|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529112|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138529113|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138529114|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138529115|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138529116|NCT04730622|Mitogens|mitogens|mesh-list
138391860|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138529117|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
138529118|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529119|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138529120|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138529121|NCT00064974|Lenalidomide|lenalidomide|mesh-list
138529122|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
138529123|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529124|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138529125|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138529126|NCT00064974|Growth Substances|growth substances|mesh-ancestor
138529127|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
138529128|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529129|NCT00037817|Celecoxib|celecoxib|mesh-list
138529130|NCT00037817|Decitabine|decitabine|mesh-list
138529131|NCT00037817|Romidepsin|romidepsin|mesh-list
138529132|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138529133|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138529134|NCT00037817|Analgesics|analgesics|mesh-ancestor
138529135|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
138529136|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529137|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529138|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138529139|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138529140|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138704909|NCT05489926|Pamiparib|pamiparib|mesh-list
138529141|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138529142|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529143|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529144|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529146|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529147|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138422655|NCT05291104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138529148|NCT00037817|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138529150|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138529151|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
138529152|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
138391902|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529153|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
138391903|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138529154|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
138529155|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138529156|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529157|NCT00065169|Celecoxib|celecoxib|mesh-list
138529158|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138529159|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138529160|NCT00065169|Analgesics|analgesics|mesh-ancestor
138529161|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
138529162|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529163|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529164|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138529165|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138529166|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138529167|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138529168|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529169|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529170|NCT00038012|Carboplatin|carboplatin|mesh-list
138529171|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529172|NCT00038051|Lintuzumab|lintuzumab|mesh-list
138529173|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138529174|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529176|NCT00038090|Dexamethasone|dexamethasone|mesh-list
138529177|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138529178|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
138529179|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
138529180|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529181|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529182|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138529183|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
138529184|NCT00038090|Hormones|hormones|mesh-ancestor
138529185|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529186|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138391939|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138529187|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529188|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529189|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
138529190|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
138529191|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138529192|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138704918|NCT05470491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704919|NCT05470491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138529193|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138529194|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138529195|NCT00038090|Growth Substances|growth substances|mesh-ancestor
138529196|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
138529197|NCT00065325|Fulvestrant|fulvestrant|mesh-list
138529198|NCT00065325|Exemestane|exemestane|mesh-list
138529199|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138529200|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529201|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138529202|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138529203|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
138529204|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529205|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529206|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138529207|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138529208|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529209|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529210|NCT00038168|Paclitaxel|paclitaxel|mesh-list
138529211|NCT00038168|Estramustine|estramustine|mesh-list
138529212|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138529213|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529214|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
138529215|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
138391980|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138391981|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529216|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
138529217|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529218|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138529219|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
138529220|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138529221|NCT00398658|Clindamycin|clindamycin|mesh-list
138529222|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
138529223|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
138529224|NCT00398658|Gentamicins|gentamicins|mesh-list
138529225|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138529226|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529227|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138529228|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529229|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529230|NCT00038207|Vincristine|vincristine|mesh-list
138529231|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138529232|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529233|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
138529234|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
138529235|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
138529236|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392026|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392027|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529237|NCT00398697|Gemcitabine|gemcitabine|mesh-list
138529238|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529239|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
138461985|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138704942|NCT05446870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704943|NCT05446870|Growth Inhibitors|growth inhibitors|mesh-ancestor
138529240|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529241|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529242|NCT00038246|Thalidomide|thalidomide|mesh-list
138529244|NCT00038246|Estramustine|estramustine|mesh-list
138529245|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138529246|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529247|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
138529248|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
138529249|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
138529250|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529251|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529252|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
138422775|NCT05294926|Rocuronium|rocuronium|mesh-list
138529253|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529254|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
138529255|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138529256|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529257|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138529258|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138529259|NCT00038246|Growth Substances|growth substances|mesh-ancestor
138529260|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
138529261|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138529262|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
138529263|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138529264|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138529265|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529267|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529268|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138529269|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392077|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
138529270|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529271|NCT00065559|Celecoxib|celecoxib|mesh-list
138529272|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138529273|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138529274|NCT00065559|Analgesics|analgesics|mesh-ancestor
138529275|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
138529276|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529277|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529278|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138529279|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138529280|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138529281|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138529282|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529283|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529284|NCT00065637|Teriparatide|teriparatide|mesh-list
138704966|NCT05422794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138704978|NCT05406401|Prednisone|prednisone|mesh-list
138704979|NCT05406401|Prednisolone|prednisolone|mesh-list
138704980|NCT05406401|Cyclophosphamide|cyclophosphamide|mesh-list
138704981|NCT05406401|Rituximab|rituximab|mesh-list
138704982|NCT05406401|Doxorubicin|doxorubicin|mesh-list
138704983|NCT05406401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138704984|NCT05406401|Immunologic Factors|immunologic factors|mesh-ancestor
138392118|NCT01508104|Everolimus|everolimus|mesh-list
138392119|NCT01508104|Dactolisib|dactolisib|mesh-list
138392120|NCT01508104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138392121|NCT01508104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138704985|NCT05406401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704986|NCT05406401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138704987|NCT05406401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138529285|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138529286|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529287|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138529289|NCT00396578|Gentamicins|gentamicins|mesh-list
138529290|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138529291|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529292|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138529293|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529294|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529295|NCT00398853|Chromium|chromium|mesh-list
138529296|NCT00398853|Picolinic acid|picolinic acid|mesh-list
138529297|NCT00398853|Trace Elements|trace elements|mesh-ancestor
138529298|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
138529299|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529300|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138529301|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
138529302|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
138529303|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392166|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
138529304|NCT05433896|Dasatinib|dasatinib|mesh-list
138529305|NCT05433896|Omeprazole|omeprazole|mesh-list
138529306|NCT05433896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138529307|NCT05433896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138529308|NCT05433896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138529309|NCT05433896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392167|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529310|NCT05433896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529311|NCT05433896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529312|NCT05433896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138529314|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529315|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
138529316|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
138529317|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
138529318|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529319|NCT05433428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138529320|NCT05433428|Lubricant Eye Drops|lubricant eye drops|mesh-list
138529321|NCT05433428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138529322|NCT00069927|Methylphenidate|methylphenidate|mesh-list
138529323|NCT00069927|Amphetamine|amphetamine|mesh-list
138529324|NCT00069927|Adderall|adderall|mesh-list
138529325|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
138529326|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138529327|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529328|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138529329|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138529330|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138529331|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529332|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
138529333|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138529334|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
138529335|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
138392214|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138392215|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
138392216|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392217|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
138392230|NCT01508637|Terazosin|terazosin|mesh-list
138529336|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529337|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
138529338|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138529340|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
138529341|NCT00069966|Rituximab|rituximab|mesh-list
138529342|NCT00069966|Pixantrone|pixantrone|mesh-list
138529343|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138529344|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704997|NCT05406401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138529345|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
138529346|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529347|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138529348|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529349|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
138529350|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529351|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
138529352|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529353|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529354|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138529355|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
138529356|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
138529357|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529358|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138529359|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
138529360|NCT00069966|Hormones|hormones|mesh-ancestor
138529361|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529362|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138529363|NCT00069966|Protective Agents|protective agents|mesh-ancestor
138529364|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138529365|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138529366|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529367|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
138529368|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138529369|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529370|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
138529371|NCT00065949|Analgesics|analgesics|mesh-ancestor
138529372|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
138529373|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392263|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
138392264|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529374|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529375|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
138529376|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138529377|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138529378|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
138529379|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138529380|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138205676|NCT00004288|Olsalazine|olsalazine|mesh-list
138529381|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529382|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138529383|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
138529384|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138529385|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138529386|NCT00066027|Doxycycline|doxycycline|mesh-list
138529387|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529388|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
138529389|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138529390|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138529391|NCT00396734|Topiramate|topiramate|mesh-list
138529392|NCT00396734|Modafinil|modafinil|mesh-list
138529393|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
138529394|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138529395|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529396|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138529397|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138529398|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138529399|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138529400|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529402|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
138529403|NCT00070083|Rituximab|rituximab|mesh-list
138529404|NCT00070083|Doxorubicin|doxorubicin|mesh-list
138392302|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
138392303|NCT01509131|Bisacodyl|bisacodyl|mesh-list
138529405|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138392305|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138529406|NCT00070083|Vincristine|vincristine|mesh-list
138529407|NCT00070083|Oblimersen|oblimersen|mesh-list
138529408|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529409|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
138529410|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529411|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138529412|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138529413|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
138529414|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529415|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529416|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138529417|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138529418|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138529419|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138529420|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138529421|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529422|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138529423|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
138529424|NCT00070083|Hormones|hormones|mesh-ancestor
138529425|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529426|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138529427|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138529428|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
138529429|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
138529430|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
138392347|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138529431|NCT00070122|Leucovorin|leucovorin|mesh-list
138529432|NCT00070122|Bevacizumab|bevacizumab|mesh-list
138529433|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138529434|NCT00070122|Capecitabine|capecitabine|mesh-list
138529435|NCT00070122|Fluorouracil|fluorouracil|mesh-list
138529436|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
138529437|NCT00070122|Antibodies|antibodies|mesh-list
138422920|NCT05296863|Minoxidil|minoxidil|mesh-list
138529438|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
138392348|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
138392373|NCT01509469|Caseins|caseins|mesh-list
138529439|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138529440|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
138229861|NCT02481375|Trace Elements|trace elements|mesh-list
138529441|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529442|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138529443|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138529444|NCT00070122|Growth Substances|growth substances|mesh-ancestor
138529445|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529446|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
138529447|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
138529448|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529449|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
138529450|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529451|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529452|NCT00070122|Antidotes|antidotes|mesh-ancestor
138529453|NCT00070122|Protective Agents|protective agents|mesh-ancestor
138205755|NCT00005638|Irinotecan|irinotecan|mesh-list
138529454|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
138529455|NCT00070122|Vitamins|vitamins|mesh-ancestor
138529456|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
138529457|NCT00070161|Donepezil|donepezil|mesh-list
138529458|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138529459|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529460|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705031|NCT05382286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705036|NCT05367245|Butyric Acid|butyric acid|mesh-list
138705037|NCT05367245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529461|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
138392387|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138529462|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138392400|NCT01509560|Everolimus|everolimus|mesh-list
138529463|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529464|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
138529465|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
138529467|NCT00070200|Doxorubicin|doxorubicin|mesh-list
138529468|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138529470|NCT00070200|Vincristine|vincristine|mesh-list
138529471|NCT00070200|Topotecan|topotecan|mesh-list
138529472|NCT00070200|Isotretinoin|isotretinoin|mesh-list
138529473|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529474|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
138529475|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529476|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138529477|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138529478|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
138529479|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529480|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529481|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138529482|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138529483|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138529484|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138529485|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529486|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138529487|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
138529488|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
138529489|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
138529490|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138529491|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
138529492|NCT00066339|Gefitinib|gefitinib|mesh-list
138392434|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138529493|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529494|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138529495|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392456|NCT01510132|Timolol|timolol|mesh-list
138529496|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529497|NCT00070239|Alvocidib|alvocidib|mesh-list
138529498|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138529499|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138529500|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529501|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529502|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529503|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
138529504|NCT00070239|Growth Substances|growth substances|mesh-ancestor
138529505|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138529506|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529507|NCT00070278|Paclitaxel|paclitaxel|mesh-list
138529508|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
138529510|NCT00070278|Epirubicin|epirubicin|mesh-list
138529511|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138529512|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529513|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
138529514|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
138529515|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
138529516|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529517|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529518|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
138529519|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529520|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138392478|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392479|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138392480|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392481|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
138392483|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
138392485|NCT01510509|Everolimus|everolimus|mesh-list
138529521|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138529522|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
138529523|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138529524|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529525|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
138529526|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138705053|NCT05342636|Paclitaxel|paclitaxel|mesh-list
138529527|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138529528|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138529529|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529530|NCT00066378|Gefitinib|gefitinib|mesh-list
138529531|NCT00066378|Anastrozole|anastrozole|mesh-list
138529532|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529533|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138529534|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529535|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529536|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138529537|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138529538|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138529539|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138529540|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
138529541|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529542|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529544|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
138529545|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
138529546|NCT00066417|Thiotepa|thiotepa|mesh-list
138529547|NCT00066417|Fludarabine|fludarabine|mesh-list
138529548|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
138529549|NCT00066417|Cyclosporins|cyclosporins|mesh-list
138529550|NCT00066417|Immunomodulating Agents|immunomodulating agents|mesh-list
138423034|NCT05266248|Caffeine|caffeine|mesh-list
138529551|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529552|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
138529553|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529554|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138529555|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138529556|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
138529557|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529558|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529559|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138529560|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529561|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
138392525|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392526|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392527|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138529562|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392528|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
138529563|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
138529564|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529565|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
138529566|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138529567|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138529568|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
138529569|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
138529570|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529571|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138529572|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
138529573|NCT00066417|Hormones|hormones|mesh-ancestor
138529574|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529575|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138529576|NCT00066417|Protective Agents|protective agents|mesh-ancestor
138529577|NCT00066456|Docetaxel|docetaxel|mesh-list
138529578|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529579|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
138529580|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
138529581|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
138529582|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529583|NCT00070434|Leucovorin|leucovorin|mesh-list
138529584|NCT00070434|Pyridoxine|pyridoxine|mesh-list
138529585|NCT00070434|Capecitabine|capecitabine|mesh-list
138529587|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
138529588|NCT00070434|Irinotecan|irinotecan|mesh-list
138529589|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
138392552|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
138392553|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
138529590|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529591|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529592|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
138392554|NCT01510847|Androgens|androgens|mesh-ancestor
138392555|NCT01510847|Hormones|hormones|mesh-ancestor
138392556|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529593|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529594|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529595|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529596|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
138529597|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138529598|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138529599|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529600|NCT00070434|Antidotes|antidotes|mesh-ancestor
138529601|NCT00070434|Protective Agents|protective agents|mesh-ancestor
138529602|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
138529603|NCT00070434|Vitamins|vitamins|mesh-ancestor
138529604|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
138529605|NCT05402891|Lithium Carbonate|lithium carbonate|mesh-list
138529606|NCT05402891|Antidepressive Agents|antidepressive agents|mesh-ancestor
138529607|NCT05402891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138529608|NCT05402891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529609|NCT05402891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529610|NCT05402891|Antimanic Agents|antimanic agents|mesh-ancestor
138529611|NCT05402891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138529612|NCT05402891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138529613|NCT05402891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529614|NCT00070473|Pemetrexed|pemetrexed|mesh-list
138529615|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529616|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529617|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392600|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529618|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138529619|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138529620|NCT00066612|Irinotecan|irinotecan|mesh-list
138392606|NCT01511159|Insulin|insulin|mesh-list
138529621|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138529622|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138529623|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529624|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462106|NCT01943526|Natalizumab|natalizumab|mesh-list
138529625|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529626|NCT00070551|Cytarabine|cytarabine|mesh-list
138529627|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529628|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
138529629|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529630|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529631|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
138529632|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529633|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529634|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
138529635|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529636|NCT00070629|Paclitaxel|paclitaxel|mesh-list
138529637|NCT00070629|Docetaxel|docetaxel|mesh-list
138529638|NCT00070629|Cisplatin|cisplatin|mesh-list
138529639|NCT00070629|Carboplatin|carboplatin|mesh-list
138529640|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138392648|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392649|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138529641|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529642|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
138529643|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
138529644|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
138529645|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529646|NCT01349595|Bortezomib|bortezomib|mesh-list
138392655|NCT01511237|Lamivudine|lamivudine|mesh-list
138529647|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529648|NCT05184920|Nicotine|nicotine|mesh-list
138529649|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138529650|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
138529651|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529652|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529653|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138529654|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138529655|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
138529656|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138529657|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529658|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
138529659|NCT02958501|Vitamin D|vitamin d|mesh-list
138529660|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138529661|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529662|NCT02958501|Vitamins|vitamins|mesh-ancestor
138529664|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138529665|NCT00066651|Immunotoxins|immunotoxins|mesh-list
138529666|NCT00066651|Immunoconjugates|immunoconjugates|mesh-ancestor
138529667|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
138529668|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529669|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
138529670|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
138529671|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529672|NCT00398892|Protective Agents|protective agents|mesh-ancestor
138529673|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392695|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392696|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392697|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138392700|NCT01511302|Hormones|hormones|mesh-ancestor
138529675|NCT00398892|Vitamins|vitamins|mesh-ancestor
138529676|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
138529677|NCT05019794|Infigratinib|infigratinib|mesh-list
138529678|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529679|NCT00066768|Suramin|suramin|mesh-list
138529680|NCT00066768|Gemcitabine|gemcitabine|mesh-list
138529681|NCT00066768|Docetaxel|docetaxel|mesh-list
138529682|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529683|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
138205964|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529684|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529685|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529686|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
138529687|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
138529688|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
138529689|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
138529690|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
138529691|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138529692|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529693|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138529694|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138529695|NCT00066846|Leucovorin|leucovorin|mesh-list
138529696|NCT00066846|Bevacizumab|bevacizumab|mesh-list
138529697|NCT00066846|Fluorouracil|fluorouracil|mesh-list
138529698|NCT00066846|Calcium|calcium|mesh-list
138529699|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
138529700|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138392741|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529701|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529702|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138529703|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138529704|NCT00066846|Growth Substances|growth substances|mesh-ancestor
138392742|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529705|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318588|NCT01384734|Ritonavir|ritonavir|mesh-list
138529706|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
138529707|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138529708|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
138529709|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529710|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529711|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529712|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
138529713|NCT00066846|Antidotes|antidotes|mesh-ancestor
138529714|NCT00066846|Protective Agents|protective agents|mesh-ancestor
138529715|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
138529716|NCT00066846|Vitamins|vitamins|mesh-ancestor
138529717|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
138529718|NCT00066885|Calcitriol|calcitriol|mesh-list
138529719|NCT00066885|Docetaxel|docetaxel|mesh-list
138529720|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529721|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
138529722|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
138529723|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
138529724|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529725|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138529726|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529727|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138529728|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138529729|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138392788|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
138392789|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138529730|NCT00066885|Vitamins|vitamins|mesh-ancestor
138529731|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
138529732|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138529733|NCT04941521|Exenatide|exenatide|mesh-list
138529734|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138529735|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392790|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392800|NCT01511757|Fluconazole|fluconazole|mesh-list
138529736|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138529737|NCT04941521|Incretins|incretins|mesh-ancestor
138529738|NCT04941521|Hormones|hormones|mesh-ancestor
138529739|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529740|NCT02966457|Colistin|colistin|mesh-list
138529741|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138529742|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529743|NCT00067041|Treprostinil|treprostinil|mesh-list
138529744|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138529745|NCT04732364|Bupivacaine|bupivacaine|mesh-list
138529746|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
138529747|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
138529748|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138529749|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529750|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
138529751|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529752|NCT00067080|Deferasirox|deferasirox|mesh-list
138529753|NCT00067080|Deferoxamine|deferoxamine|mesh-list
138529754|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138529755|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
138529756|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
138529757|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529758|NCT00067080|Siderophores|siderophores|mesh-ancestor
138529759|NCT00396851|Metformin|metformin|mesh-list
138529760|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138529761|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529762|NCT00067119|Dipyridamole|dipyridamole|mesh-list
138529763|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138318606|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138392826|NCT01511822|Inositol|inositol|mesh-list
138705095|NCT05319730|Hormones|hormones|mesh-ancestor
138392827|NCT01511822|Drospirenone|drospirenone|mesh-list
138392828|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138392829|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138529764|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529765|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138529766|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529767|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138529768|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
138529770|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138529771|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529772|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
138423195|NCT05083572|Rifaximin|rifaximin|mesh-list
138529773|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
138462210|NCT01944215|Caffeine|caffeine|mesh-list
138529774|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
138529775|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529776|NCT04750772|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138529777|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138529778|NCT04750772|Chelating Agents|chelating agents|mesh-ancestor
138529779|NCT04750772|Sequestering Agents|sequestering agents|mesh-ancestor
138529780|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529781|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138529782|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
138529783|NCT00399165|Testosterone|testosterone|mesh-list
138529784|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
138529785|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
138529786|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138529787|NCT00399165|Dutasteride|dutasteride|mesh-list
138529788|NCT00399165|Androgens|androgens|mesh-ancestor
138529789|NCT00399165|Hormones|hormones|mesh-ancestor
138529790|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529791|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529792|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138529793|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529794|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
138529795|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138529796|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138529797|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529798|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529799|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
138529800|NCT00067158|Nicotine|nicotine|mesh-list
138529801|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138529802|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
138392871|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529803|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392874|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138529804|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529805|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138529806|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138529807|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
138529808|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138529809|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529811|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138529812|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138529813|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
138529814|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529815|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529816|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138529817|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138529818|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
138529819|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529820|NCT00067353|Fluorides|fluorides|mesh-list
138529821|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
138529822|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
138529823|NCT00067353|Protective Agents|protective agents|mesh-ancestor
138529824|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529825|NCT00071136|Gemcitabine|gemcitabine|mesh-list
138529826|NCT00071136|Pemetrexed|pemetrexed|mesh-list
138529827|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529828|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
138529829|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529830|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529831|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529832|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138529833|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138529834|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
138529835|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138529836|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
138529837|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138529838|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
138392905|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
138529839|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529840|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529841|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
138529843|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
138529844|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392906|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
138392908|NCT01512147|Isoflurane|isoflurane|mesh-list
138529845|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529846|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
138529847|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138529848|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529849|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
138529850|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138529851|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138529852|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138529853|NCT00067509|Progesterone|progesterone|mesh-list
138529854|NCT00067509|Estrogens|estrogens|mesh-list
138529855|NCT00067509|Progestins|progestins|mesh-ancestor
138529856|NCT00067509|Hormones|hormones|mesh-ancestor
138529857|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529858|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529859|NCT01349673|Budesonide|budesonide|mesh-list
138529860|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138529861|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138529862|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
138423244|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
138529863|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529864|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392943|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
138529866|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
138529867|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
138529868|NCT01349673|Hormones|hormones|mesh-ancestor
138529869|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392954|NCT01512355|Analgesics|analgesics|mesh-ancestor
138529870|NCT00071253|Valproic Acid|valproic acid|mesh-list
138529871|NCT00071253|Olanzapine|olanzapine|mesh-list
138529872|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
138529873|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
138529874|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138529875|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529876|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138529877|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138529878|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138529879|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138529880|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138529881|NCT00071253|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138529882|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138529883|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138229893|NCT02556333|Tenofovir|tenofovir|mesh-list
138529884|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529885|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138529886|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
138529887|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
138529888|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529889|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
138529890|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
138529891|NCT00067548|EKB 569|ekb 569|mesh-list
138529892|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529893|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138529894|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392989|NCT01512511|Analgesics|analgesics|mesh-ancestor
138392990|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
138392991|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138392993|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
138529895|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529896|NCT00071331|Tolvaptan|tolvaptan|mesh-list
138529897|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138529898|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529899|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
138529900|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529901|NCT00067626|Chromium|chromium|mesh-list
138529902|NCT00067626|Trace Elements|trace elements|mesh-ancestor
138529903|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
138529904|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529905|NCT00067743|Lenalidomide|lenalidomide|mesh-list
138529906|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
138529907|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529908|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138529909|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138529910|NCT00067743|Growth Substances|growth substances|mesh-ancestor
138529911|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
138529912|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529913|NCT00396968|Plerixafor|plerixafor|mesh-list
138529914|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138423278|NCT04897802|Incretins|incretins|mesh-ancestor
138529915|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138529916|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
138529917|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529918|NCT00067860|Hormones|hormones|mesh-list
138529919|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529920|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529921|NCT00071448|Insulin|insulin|mesh-list
138529922|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138529923|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
138529924|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
138529925|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138529926|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529927|NCT00067899|Vitamins|vitamins|mesh-list
138529928|NCT00067899|Vitamin E|vitamin e|mesh-list
138529929|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
138529930|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529931|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
138529932|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529933|NCT00067899|Protective Agents|protective agents|mesh-ancestor
138393037|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393038|NCT01512953|Lansoprazole|lansoprazole|mesh-list
138529934|NCT00067938|Lamotrigine|lamotrigine|mesh-list
138529935|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
138529936|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138529937|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138529938|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529939|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138529940|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529941|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138529942|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138529943|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138529944|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138529945|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138529946|NCT02358187|Poly ICLC|poly iclc|mesh-list
138529947|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
138529948|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
138529949|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529950|NCT01809808|Hormones|hormones|mesh-list
138529951|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529952|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529953|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
138529954|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138529955|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138529956|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
138229894|NCT02556333|Emtricitabine|emtricitabine|mesh-list
138529957|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529958|NCT01406197|Progesterone|progesterone|mesh-list
138529959|NCT01406197|Progestins|progestins|mesh-ancestor
138529960|NCT01406197|Hormones|hormones|mesh-ancestor
138529961|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138529962|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529963|NCT00038402|Paclitaxel|paclitaxel|mesh-list
138529964|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
138393072|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138393073|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138393074|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138393088|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
138529965|NCT00038402|Fluorouracil|fluorouracil|mesh-list
138529966|NCT00038402|Trastuzumab|trastuzumab|mesh-list
138529967|NCT00038402|Epirubicin|epirubicin|mesh-list
138529968|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138529969|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138529970|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
138529971|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
138529972|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
138529973|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529974|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529975|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
138529976|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529977|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138529978|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138529979|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
138529980|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138529981|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
138529982|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138529983|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138529984|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138529985|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138529986|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138529987|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529989|NCT00144703|Tacrolimus|tacrolimus|mesh-list
138529990|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138529991|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
138529992|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138529993|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138529994|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138529995|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138529996|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138705133|NCT05269355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138529997|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138529998|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138529999|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530000|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
138393113|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393114|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138530001|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
138530002|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138530003|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
138530004|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530005|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
138530006|NCT00144820|Protective Agents|protective agents|mesh-ancestor
138530007|NCT00071643|Escitalopram|escitalopram|mesh-list
138530008|NCT00071643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138530009|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138530010|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138530011|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530012|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138530013|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
138530014|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530015|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138530016|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530017|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138530018|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530019|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530020|NCT00038480|Ritonavir|ritonavir|mesh-list
138530021|NCT00038480|Lopinavir|lopinavir|mesh-list
138530022|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138530023|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138530024|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
138530025|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393152|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
138393153|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530026|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530027|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138530028|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138530029|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
138530030|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530031|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138530032|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138530033|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
138530034|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
138530035|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138530036|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530037|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530038|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
138530039|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138530040|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138530041|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530043|NCT00038519|Saquinavir|saquinavir|mesh-list
138530044|NCT00038519|Amprenavir|amprenavir|mesh-list
138530045|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138530046|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138530047|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
138530048|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530049|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530050|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138530051|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138530052|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
138530053|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530054|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138530055|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138530056|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138530057|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
138530058|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138530059|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138530060|NCT00202345|Hematinics|hematinics|mesh-ancestor
138530061|NCT00202423|Nabiximols|nabiximols|mesh-list
138530062|NCT00202423|Analgesics|analgesics|mesh-ancestor
138530063|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
138393200|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138393202|NCT01513785|Amoxicillin|amoxicillin|mesh-list
138530064|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530065|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530066|NCT00202462|Testosterone|testosterone|mesh-list
138206347|NCT00103376|Bortezomib|bortezomib|mesh-list
138530068|NCT00202462|Hormones|hormones|mesh-ancestor
138530069|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138530070|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530071|NCT00038558|Doxorubicin|doxorubicin|mesh-list
138530072|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138530073|NCT00038558|Bleomycin|bleomycin|mesh-list
138393238|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138530074|NCT00038558|Dacarbazine|dacarbazine|mesh-list
138530075|NCT00038558|Vinblastine|vinblastine|mesh-list
138530076|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138530077|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530078|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138530079|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138530080|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530081|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530082|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138530083|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
138530084|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138530085|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
138530086|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
138530087|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
138530088|NCT00038597|Lonafarnib|lonafarnib|mesh-list
138530089|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530090|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530091|NCT00202618|Amlodipine|amlodipine|mesh-list
138530092|NCT00202618|Valsartan|valsartan|mesh-list
138530093|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138530094|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138530095|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138530096|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530097|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138530098|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138393296|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530099|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
138229899|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530100|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138530101|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138530103|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138530104|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530105|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
138530106|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530108|NCT00038636|Lopinavir|lopinavir|mesh-list
138530109|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138530110|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138530111|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
138530112|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530113|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530114|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138530115|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138530116|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
138530117|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530118|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138530119|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138530120|NCT00071838|Daclizumab|daclizumab|mesh-list
138530121|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530122|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
138530123|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530124|NCT00202852|Infliximab|infliximab|mesh-list
138530125|NCT00202852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138530126|NCT00202852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138530127|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
138530128|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138530129|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530130|NCT00202891|Sisomicin|sisomicin|mesh-list
138530131|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138393353|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138530132|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530133|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138530134|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530135|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393354|NCT01514812|Digoxin|digoxin|mesh-list
138530136|NCT00202969|Cisplatin|cisplatin|mesh-list
138530137|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530138|NCT00203125|Rasagiline|rasagiline|mesh-list
138530139|NCT00203125|Tyramine|tyramine|mesh-list
138530140|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138530141|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530142|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530143|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138530144|NCT00203125|Protective Agents|protective agents|mesh-ancestor
138530145|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530146|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
138530147|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
138530148|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530149|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138530150|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138530151|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138530152|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
138530153|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138530154|NCT00203164|Rasagiline|rasagiline|mesh-list
138705182|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705183|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705184|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
138393393|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138393394|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138393398|NCT01514942|Folic Acid|folic acid|mesh-list
138705185|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705186|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138705187|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138530155|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138530156|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530157|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530158|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138530159|NCT00203164|Protective Agents|protective agents|mesh-ancestor
138530160|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530161|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
138530163|NCT00203281|Daclizumab|daclizumab|mesh-list
138530164|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
138530165|NCT00203281|Antibodies|antibodies|mesh-list
138530166|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
138530167|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138530168|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138530169|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530170|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
138530171|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530172|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138530173|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229902|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138530174|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530175|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138530176|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530177|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138530178|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
138530179|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138530180|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530182|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138530183|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138393448|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138393449|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
138530184|NCT00203320|Analgesics|analgesics|mesh-ancestor
138530185|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
138530186|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530187|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530188|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138530189|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530190|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138530191|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530192|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
138530193|NCT00038792|Mitogens|mitogens|mesh-list
138530194|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
138530195|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530196|NCT00203359|Etanercept|etanercept|mesh-list
138530197|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138530198|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138530199|NCT00203359|Analgesics|analgesics|mesh-ancestor
138530200|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
138530201|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530202|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530203|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138530204|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530205|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138530206|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530207|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
138393489|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138705215|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138705216|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138393490|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705217|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
138705219|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138530208|NCT00410644|Hydromorphone|hydromorphone|mesh-list
138530209|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138530210|NCT00410644|Narcotics|narcotics|mesh-ancestor
138530211|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138530212|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530213|NCT00410644|Analgesics|analgesics|mesh-ancestor
138530214|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
138530215|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530216|NCT00038831|Fludarabine|fludarabine|mesh-list
138530217|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
138530219|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
138530220|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138530221|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
138530222|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530223|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138530225|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530226|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530227|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
138530228|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530229|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138530230|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
138530231|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138393534|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
138393535|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138393536|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138393537|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138393538|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138393539|NCT01515826|BB 1101|bb 1101|mesh-list
138530232|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138530233|NCT00038831|Immunotoxins|immunotoxins|mesh-ancestor
138530234|NCT00038831|Immunoconjugates|immunoconjugates|mesh-ancestor
138530235|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
138530236|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138530237|NCT00071955|Antibodies|antibodies|mesh-list
138530238|NCT00071955|Sargramostim|sargramostim|mesh-list
138530239|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138530240|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
138530241|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530242|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138530243|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
138530244|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138530245|NCT00203554|Protective Agents|protective agents|mesh-ancestor
138530246|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530247|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
138530248|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138530249|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530250|NCT00071994|Gefitinib|gefitinib|mesh-list
138530251|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530252|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138530253|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530254|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705238|NCT04989816|Immunoconjugates|immunoconjugates|mesh-ancestor
138705239|NCT04989816|Immunologic Factors|immunologic factors|mesh-ancestor
138530255|NCT00203788|Risperidone|risperidone|mesh-list
138530256|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138530257|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
138530258|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138530259|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530260|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530261|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138530262|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138393581|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138530263|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138530264|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138530265|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138393582|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
138530266|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
138530267|NCT00072033|Docetaxel|docetaxel|mesh-list
138530268|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530269|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
138530270|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
138530271|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
138530272|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530273|NCT00203905|Bevacizumab|bevacizumab|mesh-list
138530274|NCT00203905|Fluorouracil|fluorouracil|mesh-list
138530275|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
138530276|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138530277|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530278|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138530279|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138530280|NCT00203905|Growth Substances|growth substances|mesh-ancestor
138530281|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530282|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
138530283|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
138530284|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530285|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138530286|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530287|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
138530288|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
138530289|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530290|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138530291|NCT00072072|Celecoxib|celecoxib|mesh-list
138530292|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138530293|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530294|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138530295|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530296|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393618|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530297|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138393619|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138530298|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138530300|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
138530301|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530302|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530303|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138530304|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530305|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138530306|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138530307|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
138705287|NCT04921358|Docetaxel|docetaxel|mesh-list
138705288|NCT04921358|Tislelizumab|tislelizumab|mesh-list
138705289|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705290|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
138705291|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
138705292|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
138530308|NCT00204022|Azathioprine|azathioprine|mesh-list
138530309|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138393658|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530310|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530311|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138530312|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
138530313|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138530314|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530315|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530316|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530317|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
138530318|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138530319|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530320|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
138530321|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530322|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530324|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138530325|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138530326|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138530327|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530328|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138530329|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138530330|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
138530331|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138393718|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138393719|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138393721|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
138393724|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
138530332|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530333|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138530334|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
138530335|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
138530336|NCT02966652|Testosterone|testosterone|mesh-list
138530337|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
138530338|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
138530339|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138530340|NCT02966652|Androgens|androgens|mesh-ancestor
138530342|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138530343|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530344|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138530345|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530346|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
138530347|NCT00039026|Exenatide|exenatide|mesh-list
138393773|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
138393774|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393775|NCT01516866|Listerine|listerine|mesh-list
138393776|NCT01516866|Fluorides|fluorides|mesh-list
138393777|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
138393778|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
138530348|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138530349|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530350|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138530351|NCT00039026|Incretins|incretins|mesh-ancestor
138530352|NCT00039026|Hormones|hormones|mesh-ancestor
138530353|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138530354|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138530355|NCT00204256|Hematinics|hematinics|mesh-ancestor
138530356|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138530357|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530358|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
138705293|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705294|NCT04921358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705303|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138705304|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138705305|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138705306|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705307|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138530359|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138530360|NCT00204451|Estradiol|estradiol|mesh-list
138530361|NCT00204451|Estrogens|estrogens|mesh-ancestor
138530362|NCT00204451|Hormones|hormones|mesh-ancestor
138530363|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138530364|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530365|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138393833|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138393834|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530366|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
138530367|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138530368|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138530369|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138530370|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138530371|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138530372|NCT00204529|Interferons|interferons|mesh-list
138530373|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
138530374|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
138530375|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138530376|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530377|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
138530378|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530379|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
138530380|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530381|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
138530382|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138530383|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530384|NCT00204568|Doxorubicin|doxorubicin|mesh-list
138530385|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138530386|NCT00204568|Trofosfamide|trofosfamide|mesh-list
138393883|NCT01517399|Protective Agents|protective agents|mesh-ancestor
138393884|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138393885|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138530387|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138530388|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530389|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138530390|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138530391|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530392|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229910|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
138530393|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530394|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
138530395|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530396|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138530397|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
138530399|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530400|NCT00204646|Carboplatin|carboplatin|mesh-list
138530401|NCT00204646|Etoposide|etoposide|mesh-list
138393940|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138530402|NCT00204646|Doxorubicin|doxorubicin|mesh-list
138393941|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138393950|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
138705318|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138530403|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138530404|NCT00204646|Ifosfamide|ifosfamide|mesh-list
138530405|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530406|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138530407|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138530408|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138530409|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530410|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530411|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138530412|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138530413|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
138530414|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138530415|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530416|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138530417|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530418|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530419|NCT00410878|Hydromorphone|hydromorphone|mesh-list
138530420|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138530421|NCT00410878|Narcotics|narcotics|mesh-ancestor
138530422|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138530423|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530424|NCT00410878|Analgesics|analgesics|mesh-ancestor
138530425|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
138393996|NCT01516944|Capecitabine|capecitabine|mesh-list
138530426|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530427|NCT00410995|Naproxen|naproxen|mesh-list
138530428|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138530429|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138530430|NCT00410995|Analgesics|analgesics|mesh-ancestor
138530431|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
138530432|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530433|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530434|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138530435|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530436|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
138530437|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138530438|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530439|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530440|NCT00039338|Cisplatin|cisplatin|mesh-list
138530441|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530443|NCT00072228|Soblidotin|soblidotin|mesh-list
138530444|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138394049|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
138530445|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
138530446|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530447|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530448|NCT00072267|Topotecan|topotecan|mesh-list
138530449|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138530450|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138530451|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138530452|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530453|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530454|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530455|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705333|NCT04892017|Sotorasib|sotorasib|mesh-list
138705334|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705335|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705336|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318636|NCT01383486|Analgesics|analgesics|mesh-ancestor
138318637|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
138318638|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530456|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
138530457|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530458|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138394108|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138530459|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530460|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530461|NCT00072345|Thalidomide|thalidomide|mesh-list
138530462|NCT00072345|Temozolomide|temozolomide|mesh-list
138530463|NCT00072345|Lomustine|lomustine|mesh-list
138229912|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530464|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138530465|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
138530466|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530467|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530468|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530469|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
138530470|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530471|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
138530472|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138530473|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530474|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138394161|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394162|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
138530475|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138530476|NCT00072345|Growth Substances|growth substances|mesh-ancestor
138530477|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
138530478|NCT00039455|Trastuzumab|trastuzumab|mesh-list
138530479|NCT00039455|Alvocidib|alvocidib|mesh-list
138530480|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138530481|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530482|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
138530483|NCT00039455|Growth Substances|growth substances|mesh-ancestor
138530484|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530485|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138530486|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530487|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530488|NCT00205231|Etanercept|etanercept|mesh-list
138530489|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138530490|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138530491|NCT00205231|Analgesics|analgesics|mesh-ancestor
138530492|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
138530493|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394218|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
138394219|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530494|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530495|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138530496|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530497|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138530498|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530499|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
138530500|NCT00072462|Tamoxifen|tamoxifen|mesh-list
138530501|NCT00072462|Anastrozole|anastrozole|mesh-list
138462376|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530502|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530503|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138530504|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
138530505|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138705350|NCT04869943|Exemestane|exemestane|mesh-list
138705351|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705352|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138705353|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138530506|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530507|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138530508|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530509|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138394275|NCT01519401|Diuretics|diuretics|mesh-ancestor
138530510|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138530511|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138530513|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138530514|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530515|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138530516|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
138530517|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530518|NCT00039494|Temozolomide|temozolomide|mesh-list
138530519|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138530520|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138530521|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
138530522|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530523|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530524|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138530525|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530526|NCT00205738|Olanzapine|olanzapine|mesh-list
138530527|NCT00205738|Risperidone|risperidone|mesh-list
138394328|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138394329|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138530528|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138530529|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
138530530|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138530531|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530532|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530533|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138530534|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138530535|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138530536|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138394383|NCT01520298|Analgesics|analgesics|mesh-ancestor
138530537|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138530539|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
138530540|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
138530541|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530542|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138530543|NCT00205738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138394384|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
138394385|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530544|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138530545|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138530546|NCT00205816|Tigecycline|tigecycline|mesh-list
138530547|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138530548|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530549|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138530550|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530551|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530552|NCT00072540|Celecoxib|celecoxib|mesh-list
138530553|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138530554|NCT00072540|Mitogens|mitogens|mesh-list
138530555|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138530556|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138530557|NCT00072540|Analgesics|analgesics|mesh-ancestor
138530558|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
138530559|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138394439|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394440|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138394441|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138530560|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530561|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138530562|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530563|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138530564|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138530565|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530566|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
138530567|NCT00206050|Esomeprazole|esomeprazole|mesh-list
138530568|NCT00206050|Pantoprazole|pantoprazole|mesh-list
138530569|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138530570|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138530571|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138530572|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530573|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530575|NCT00206089|Melagatran|melagatran|mesh-list
138530576|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
138530577|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138394496|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530578|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
138530579|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530580|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530581|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
138394497|NCT01520896|Ketoconazole|ketoconazole|mesh-list
138394498|NCT01520896|Naloxegol|naloxegol|mesh-list
138530582|NCT00072579|Sargramostim|sargramostim|mesh-list
138530583|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
138530584|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530585|NCT04732247|Oxytocin|oxytocin|mesh-list
138530586|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
138530587|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138530588|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530589|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138530590|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
138188479|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138530591|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138530592|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138530593|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138530594|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138530595|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530596|NCT00206167|Budesonide|budesonide|mesh-list
138530597|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
138530598|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138530599|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138530600|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
138530601|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530602|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530603|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138530604|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
138530605|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
138530606|NCT00206167|Hormones|hormones|mesh-ancestor
138530607|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138530608|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138530609|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138530611|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
138530612|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138530613|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705391|NCT04827979|Daratumumab|daratumumab|mesh-list
138530615|NCT00039611|Fluorouracil|fluorouracil|mesh-list
138530616|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
138530617|NCT00039611|Calcium|calcium|mesh-list
138530618|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
138530619|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138462402|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
138530620|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530621|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
138530622|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530623|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138530624|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530625|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530626|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
138530627|NCT00039611|Antidotes|antidotes|mesh-ancestor
138530628|NCT00039611|Protective Agents|protective agents|mesh-ancestor
138530629|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
138530630|NCT00039611|Vitamins|vitamins|mesh-ancestor
138530631|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
138530632|NCT00068289|Bortezomib|bortezomib|mesh-list
138530633|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530634|NCT00039767|Lepirudin|lepirudin|mesh-list
138394588|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138530635|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
138394589|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530636|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138530637|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
138394590|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
138394591|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530638|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530639|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530640|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
138530641|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138530642|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138530643|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
138530644|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530645|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138530646|NCT00072618|Protective Agents|protective agents|mesh-ancestor
138530647|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530648|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138530649|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530650|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530651|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138530652|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138530653|NCT00072618|Analgesics|analgesics|mesh-ancestor
138530654|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
138530655|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530656|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138394637|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138394638|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138394639|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138530657|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530658|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
138530659|NCT00039884|Hematinics|hematinics|mesh-ancestor
138530660|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
138530661|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138530662|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530663|NCT00399204|Metformin|metformin|mesh-list
138530664|NCT00399204|Pioglitazone|pioglitazone|mesh-list
138530665|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138530666|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423787|NCT05800847|Gabapentin|gabapentin|mesh-list
138530667|NCT00411034|Hydromorphone|hydromorphone|mesh-list
138530668|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138530669|NCT00411034|Narcotics|narcotics|mesh-ancestor
138530670|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138530671|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530672|NCT00411034|Analgesics|analgesics|mesh-ancestor
138530673|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
138530674|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530675|NCT00411073|Darapladib|darapladib|mesh-list
138530676|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138530677|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394690|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394691|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394692|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138394693|NCT01522534|Morphine|morphine|mesh-list
138705410|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138530678|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530679|NCT00411190|Acetaminophen|acetaminophen|mesh-list
138530680|NCT00411190|Ibuprofen|ibuprofen|mesh-list
138530681|NCT00411190|Atorvastatin|atorvastatin|mesh-list
138530683|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138530684|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
138462419|NCT05410483|Tubulin Modulators|tubulin modulators|mesh-ancestor
138530685|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530686|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138530687|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138530688|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530689|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138530691|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
138530692|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530693|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530694|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
138530695|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138530696|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138530697|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530698|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138530699|NCT00411229|Capecitabine|capecitabine|mesh-list
138530700|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
138530701|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138530702|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
138530703|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530704|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530705|NCT00411268|Hydromorphone|hydromorphone|mesh-list
138530706|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138530707|NCT00411268|Narcotics|narcotics|mesh-ancestor
138530708|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138530709|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530710|NCT00411268|Analgesics|analgesics|mesh-ancestor
138394743|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138394744|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394745|NCT01522729|Analgesics|analgesics|mesh-ancestor
138394746|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
138530711|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
138530712|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530713|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138530714|NCT00039962|Thymalfasin|thymalfasin|mesh-list
138530715|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
138530716|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530717|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138530718|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
138530719|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530720|NCT00424333|Insulin|insulin|mesh-list
138530721|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138530722|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138530723|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530724|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138530725|NCT00206557|Estradiol|estradiol|mesh-list
138530726|NCT00206557|Estrogens|estrogens|mesh-ancestor
138530727|NCT00206557|Hormones|hormones|mesh-ancestor
138530728|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394785|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530729|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530730|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138530731|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
138530732|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138530733|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138394786|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
138394787|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138530734|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138394788|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138394789|NCT01522872|Growth Substances|growth substances|mesh-ancestor
138530735|NCT00068484|Bortezomib|bortezomib|mesh-list
138530736|NCT00068484|Topotecan|topotecan|mesh-list
138530737|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530738|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138705421|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
138705434|NCT04700124|Cisplatin|cisplatin|mesh-list
138530739|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138530740|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530741|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530742|NCT00206596|Sargramostim|sargramostim|mesh-list
138530743|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
138530744|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530746|NCT00206635|Interferon-beta|interferon-beta|mesh-list
138530747|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
138530748|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530749|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
138530750|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530751|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
138530752|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530753|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138530754|NCT00206674|Sargramostim|sargramostim|mesh-list
138530755|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
138530756|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530757|NCT00206713|Sargramostim|sargramostim|mesh-list
138530758|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
138530759|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530760|NCT00040040|Bupropion|bupropion|mesh-list
138530761|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138530762|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
138530763|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138530764|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138530765|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138394833|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138530766|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138423849|NCT05797597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138530767|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530768|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
138530769|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138530770|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530771|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138530772|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138530773|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530774|NCT00068523|Cyclosporine|cyclosporine|mesh-list
138530775|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
138530776|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
138530777|NCT00068523|Fludarabine|fludarabine|mesh-list
138530778|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
138530779|NCT00068523|Cyclosporins|cyclosporins|mesh-list
138530780|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138530781|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530782|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
138530783|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530784|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530785|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138530786|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
138394877|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138394878|NCT01523314|Dexamethasone|dexamethasone|mesh-list
138394879|NCT01523314|Bevacizumab|bevacizumab|mesh-list
138394880|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138394881|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138394882|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
138394883|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
138394884|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530787|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530788|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530789|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138530790|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138530791|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
138530792|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530793|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
138530794|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530795|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
138530796|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138530797|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138530799|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
138530800|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530801|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138530802|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
138530803|NCT00068523|Hormones|hormones|mesh-ancestor
138530804|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138530805|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138530806|NCT00068523|Protective Agents|protective agents|mesh-ancestor
138530807|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
138394926|NCT01523431|Irinotecan|irinotecan|mesh-list
138530808|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138530809|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138530810|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138394927|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
138394928|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138394930|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530811|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530812|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
138530813|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530814|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138530815|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138530816|NCT00206947|Ziprasidone|ziprasidone|mesh-list
138530817|NCT00206947|Donepezil|donepezil|mesh-list
138423872|NCT05785689|Analgesics|analgesics|mesh-ancestor
138530818|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138207069|NCT01366885|Vitamin D|vitamin d|mesh-list
138530819|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530820|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530821|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
138394977|NCT01523574|Protective Agents|protective agents|mesh-ancestor
138394978|NCT01523639|Metformin|metformin|mesh-list
138530822|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138530823|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530824|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
138530825|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138530826|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
138394979|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138394980|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394982|NCT01523678|Carboplatin|carboplatin|mesh-list
138530827|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138530828|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138530829|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138530830|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138530831|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138530832|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
138530833|NCT00068757|Paclitaxel|paclitaxel|mesh-list
138530834|NCT00068757|Trastuzumab|trastuzumab|mesh-list
138530835|NCT00068757|Lonafarnib|lonafarnib|mesh-list
138530836|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138530837|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530838|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
138530839|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
138530840|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
138530841|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530842|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395034|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395035|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395036|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138395037|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
138530843|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530844|NCT00206986|Clonidine|clonidine|mesh-list
138530845|NCT00206986|Analgesics|analgesics|mesh-ancestor
138530846|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
138530847|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530848|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530849|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138530850|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
138530851|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
138530852|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138530853|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138530854|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138530855|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
138530856|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138530857|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530858|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138395090|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138530859|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
138395091|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138395092|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
138395093|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395094|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530860|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138530861|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138530862|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138530863|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138530864|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530866|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138530867|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138530868|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530869|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530870|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
138530871|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138530872|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138530873|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138530875|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138530876|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138530877|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530878|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530879|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530880|NCT00207532|Folic Acid|folic acid|mesh-list
138530881|NCT00207532|Hematinics|hematinics|mesh-ancestor
138530882|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
138530883|NCT00207532|Vitamins|vitamins|mesh-ancestor
138530884|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
138530885|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530886|NCT00040391|Leucovorin|leucovorin|mesh-list
138530887|NCT00040391|Fluorouracil|fluorouracil|mesh-list
138530888|NCT00040391|Irinotecan|irinotecan|mesh-list
138395141|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138395142|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138395143|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
138395144|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395145|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138395147|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530889|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
138530890|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530891|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138530892|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530893|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530894|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
138423931|NCT05601154|Listerine|listerine|mesh-list
138530896|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138530897|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138530898|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530900|NCT00040391|Protective Agents|protective agents|mesh-ancestor
138530901|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
138530902|NCT00040391|Vitamins|vitamins|mesh-ancestor
138530903|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
138530904|NCT00207688|Infliximab|infliximab|mesh-list
138530905|NCT00207688|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138530906|NCT00207688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138530907|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
138530908|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138530909|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530910|NCT00207766|Infliximab|infliximab|mesh-list
138530911|NCT00207766|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138530912|NCT00207766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138530913|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
138530914|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138530915|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138530916|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
138530917|NCT00040469|Busulfan|busulfan|mesh-list
138530918|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
138530919|NCT00040469|Phenytoin|phenytoin|mesh-list
138395185|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395186|NCT01524809|Insulin|insulin|mesh-list
138395187|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138530920|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530921|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
138530922|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530923|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138462486|NCT04887389|Fluorides|fluorides|mesh-list
138395188|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
138395189|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
138395190|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138530924|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138530925|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
138530926|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530927|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530928|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138530929|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138530930|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
138530931|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138530932|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138395222|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
138395223|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395224|NCT01525004|Vaccines|vaccines|mesh-list
138395225|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
138395226|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395227|NCT06053580|Valsartan|valsartan|mesh-list
138395228|NCT06053580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138395229|NCT06053580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138530933|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138530934|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138530935|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138530936|NCT00207844|Selenium|selenium|mesh-list
138530937|NCT00207844|Selenious Acid|selenious acid|mesh-list
138530938|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
138530939|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
138530940|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530941|NCT00207844|Protective Agents|protective agents|mesh-ancestor
138530942|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530943|NCT00207844|Trace Elements|trace elements|mesh-ancestor
138530944|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
138530945|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
138530946|NCT00072930|Prednisone|prednisone|mesh-list
138530947|NCT00072930|Docetaxel|docetaxel|mesh-list
138530948|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530949|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
138530950|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
138530951|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
138530952|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530953|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138530954|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
138530955|NCT00072930|Hormones|hormones|mesh-ancestor
138530956|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138530958|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138530959|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138530960|NCT00411307|Hydromorphone|hydromorphone|mesh-list
138530961|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138530962|NCT00411307|Narcotics|narcotics|mesh-ancestor
138530963|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395278|NCT06052111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395279|NCT06052111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395286|NCT06052111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138530964|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530965|NCT00411307|Analgesics|analgesics|mesh-ancestor
138530966|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
138530967|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138530968|NCT00040508|Sirolimus|sirolimus|mesh-list
138530969|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138530970|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138207224|NCT00262964|Niacin|niacin|mesh-list
138530971|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138530972|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530973|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
138530974|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530975|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
138530976|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530977|NCT00424411|Insulin|insulin|mesh-list
138530978|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138530979|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138530980|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530981|NCT00072969|Daclizumab|daclizumab|mesh-list
138530982|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138530983|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
138530984|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138530985|NCT00424606|Docetaxel|docetaxel|mesh-list
138530986|NCT00424606|Epirubicin|epirubicin|mesh-list
138530987|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138530988|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
138395323|NCT06051851|Gemcitabine|gemcitabine|mesh-list
138395324|NCT06051851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138705483|NCT04662515|Warfarin|warfarin|mesh-list
138395325|NCT06051851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395326|NCT06051851|Tubulin Modulators|tubulin modulators|mesh-ancestor
138530989|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
138462498|NCT04722835|Dimercaprol|dimercaprol|mesh-list
138395327|NCT06051851|Antimitotic Agents|antimitotic agents|mesh-ancestor
138530990|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
138530991|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138530992|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138530993|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138530994|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138530995|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138530997|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138530998|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
138530999|NCT02962921|Insulin|insulin|mesh-list
138531000|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138531001|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
138531002|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138531003|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531004|NCT00040586|Interleukin-2|interleukin-2|mesh-list
138531005|NCT00040586|Antibodies|antibodies|mesh-list
138531006|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138531007|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
138531008|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531009|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531010|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138531011|NCT00040586|Analgesics|analgesics|mesh-ancestor
138531012|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
138531013|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531014|NCT00208117|Sertraline|sertraline|mesh-list
138531015|NCT00208117|Simvastatin|simvastatin|mesh-list
138531016|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138531017|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138531018|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
138531019|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531020|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138531021|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138531022|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531023|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
138395368|NCT06051370|Anesthetics, Local|anesthetics, local|mesh-ancestor
138395370|NCT06051370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138531024|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138395371|NCT06051370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531025|NCT00208117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138531026|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138531028|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531029|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
138531030|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531031|NCT00208156|Mifepristone|mifepristone|mesh-list
138531032|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138531033|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
138531034|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138531035|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531036|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138531037|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138531038|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138531039|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
138424017|NCT05161468|Lidocaine|lidocaine|mesh-list
138531040|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138531041|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138531042|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
138531043|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138531044|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
138531045|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138207301|NCT01429987|Plecanatide|plecanatide|mesh-list
138531046|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138531048|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531049|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462508|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138705500|NCT04626518|Lenvatinib|lenvatinib|mesh-list
138395409|NCT05973851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395412|NCT05973851|Anesthetics, General|anesthetics, general|mesh-ancestor
138531050|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531052|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138531053|NCT00208195|Valproic Acid|valproic acid|mesh-list
138531054|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
138531055|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531056|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531057|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
138531058|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531059|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531060|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
138531061|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138531062|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138531063|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138531064|NCT00208234|Omalizumab|omalizumab|mesh-list
138531065|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138531066|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138531067|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138531068|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
138531069|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
138531070|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395456|NCT05958875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395467|NCT05891262|Estradiol|estradiol|mesh-list
138531071|NCT00208273|Letrozole|letrozole|mesh-list
138531072|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531073|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138531074|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138531075|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531076|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531077|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138531078|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
138531079|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138531080|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531082|NCT00208312|Regadenoson|regadenoson|mesh-list
138531083|NCT00208312|Analgesics|analgesics|mesh-ancestor
138531084|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
138531085|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531086|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531087|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138531088|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
138531089|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138531090|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
138531091|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
138531092|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531093|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531094|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138531095|NCT00040781|Gefitinib|gefitinib|mesh-list
138531096|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395513|NCT05781321|Alkylating Agents|alkylating agents|mesh-ancestor
138395514|NCT05781321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395515|NCT05781321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531097|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138395516|NCT05781321|Cariostatic Agents|cariostatic agents|mesh-ancestor
138395517|NCT05781321|Protective Agents|protective agents|mesh-ancestor
138395526|NCT05672355|Vaccines|vaccines|mesh-list
138531098|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531099|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531101|NCT00068952|Carmustine|carmustine|mesh-list
138531102|NCT00068952|Lomustine|lomustine|mesh-list
138531103|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138531104|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
138531105|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531106|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531107|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
138531108|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531109|NCT00208546|Bevacizumab|bevacizumab|mesh-list
138531110|NCT00208546|Cetuximab|cetuximab|mesh-list
138531111|NCT00208546|Capecitabine|capecitabine|mesh-list
138531112|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
138531113|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138531114|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395562|NCT05491356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531115|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138531116|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138531117|NCT00208546|Growth Substances|growth substances|mesh-ancestor
138395564|NCT05470400|Immunologic Factors|immunologic factors|mesh-ancestor
138395565|NCT05470400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395566|NCT05415397|Celecoxib|celecoxib|mesh-list
138395568|NCT05415397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138531118|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531119|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
138531120|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138424096|NCT04717908|Linezolid|linezolid|mesh-list
138531121|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
138531122|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531123|NCT00208585|Sertraline|sertraline|mesh-list
138531124|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
138531125|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138531126|NCT00208585|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138531127|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138531128|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138531129|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531130|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531131|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
138531132|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531133|NCT00040859|Capecitabine|capecitabine|mesh-list
138531134|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
138531135|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138531136|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
138531137|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531138|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531139|NCT00208702|Sertraline|sertraline|mesh-list
138531140|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
138395616|NCT05300087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395617|NCT05300087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138395618|NCT05300087|Respiratory System Agents|respiratory system agents|mesh-ancestor
138395619|NCT05300087|Tocolytic Agents|tocolytic agents|mesh-ancestor
138531141|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138531142|NCT00208702|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138531143|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138531144|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138531145|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531146|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531147|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
138531148|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531149|NCT00208741|Tiagabine|tiagabine|mesh-list
138531150|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
138531151|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
138531152|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138531153|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138531154|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531155|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
138531156|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395666|NCT05252429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395667|NCT05252429|Tubulin Modulators|tubulin modulators|mesh-ancestor
138395668|NCT05252429|Antimitotic Agents|antimitotic agents|mesh-ancestor
138395669|NCT05252429|Mitosis Modulators|mitosis modulators|mesh-ancestor
138395670|NCT05252429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395674|NCT05249309|Analgesics|analgesics|mesh-ancestor
138531157|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531158|NCT00399048|Hydromorphone|hydromorphone|mesh-list
138531159|NCT00399048|Oxycodone|oxycodone|mesh-list
138531160|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138531161|NCT00399048|Narcotics|narcotics|mesh-ancestor
138531162|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138531163|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531164|NCT00399048|Analgesics|analgesics|mesh-ancestor
138531165|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
138531166|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531167|NCT00208819|Valproic Acid|valproic acid|mesh-list
138462542|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138531169|NCT00208819|Risperidone|risperidone|mesh-list
138531170|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138531171|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138531172|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
138531173|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531174|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531175|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531176|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138531177|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138531178|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138531179|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138531180|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138531181|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
138395778|NCT04837716|Growth Substances|growth substances|mesh-ancestor
138531182|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
138531183|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
138395779|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395780|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
138531184|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531185|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138531186|NCT00208819|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138531187|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138531188|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138531189|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
138531190|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
138531191|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531192|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
138531193|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
138531194|NCT00208858|Topiramate|topiramate|mesh-list
138531195|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
138531196|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138531197|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531199|NCT00041015|Topotecan|topotecan|mesh-list
138531200|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531201|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138531202|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138531203|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138531204|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531205|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531206|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138531207|NCT00073047|Daclizumab|daclizumab|mesh-list
138531208|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138531209|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
138395824|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138705541|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395825|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705550|NCT04510506|Pancrelipase|pancrelipase|mesh-list
138705551|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138705552|NCT04463368|Nivolumab|nivolumab|mesh-list
138705554|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705555|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705556|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705557|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531210|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531211|NCT00208897|Fluoxetine|fluoxetine|mesh-list
138531212|NCT00208897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138531213|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138531214|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138531215|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531216|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531217|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
138531218|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531219|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138395873|NCT04544111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395874|NCT04522739|Spironolactone|spironolactone|mesh-list
138395875|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138395876|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
138395882|NCT04522336|Docetaxel|docetaxel|mesh-list
138531220|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
138531221|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138531222|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138531223|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138531224|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531225|NCT00208936|Fluorouracil|fluorouracil|mesh-list
138531226|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531227|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
138531228|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531229|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138531230|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138531231|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
138531232|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531233|NCT00209014|Thalidomide|thalidomide|mesh-list
138531234|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138531235|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
138395926|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
138395927|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
138531236|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531237|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
138531238|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138531239|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138531240|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138531241|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138229959|NCT02486211|Amantadine|amantadine|mesh-list
138531242|NCT00209014|Growth Substances|growth substances|mesh-ancestor
138531243|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
138531244|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531245|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
138531246|NCT00041054|Carboplatin|carboplatin|mesh-list
138531247|NCT00041054|Etoposide|etoposide|mesh-list
138531248|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531249|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138395985|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138531250|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138395987|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
138395988|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138395989|NCT03951831|Docetaxel|docetaxel|mesh-list
138395990|NCT03951831|Leuprolide|leuprolide|mesh-list
138531251|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138531252|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531253|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531254|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138531255|NCT00041054|Protective Agents|protective agents|mesh-ancestor
138531256|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531257|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138531258|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138531259|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138531260|NCT00041054|Analgesics|analgesics|mesh-ancestor
138531261|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
138531262|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531263|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138531264|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138531265|NCT00209209|Interferons|interferons|mesh-list
138531266|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
138531267|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
138531268|NCT00209209|Prednisone|prednisone|mesh-list
138207516|NCT05448456|Hemostatics|hemostatics|mesh-ancestor
138531269|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
138531270|NCT00209209|Rituximab|rituximab|mesh-list
138531271|NCT00209209|Doxorubicin|doxorubicin|mesh-list
138531272|NCT00209209|Fludarabine|fludarabine|mesh-list
138531273|NCT00209209|Vincristine|vincristine|mesh-list
138531274|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138531275|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
138396041|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
138396042|NCT03726879|Doxorubicin|doxorubicin|mesh-list
138396043|NCT03726879|Trastuzumab|trastuzumab|mesh-list
138396044|NCT03726879|Atezolizumab|atezolizumab|mesh-list
138531276|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531277|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138531278|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138531279|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
138531280|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396045|NCT03726879|Pertuzumab|pertuzumab|mesh-list
138396046|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138396047|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531281|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531282|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138531283|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138531284|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138531285|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138531286|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138531287|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531288|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138531289|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
138531290|NCT00209209|Hormones|hormones|mesh-ancestor
138531291|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138531292|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138531293|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
138531294|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138531295|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138531296|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
138531297|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
138531298|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
138531299|NCT00041093|Docetaxel|docetaxel|mesh-list
138531300|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531301|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
138531302|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
138531303|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
138531304|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531305|NCT00399087|Prednisone|prednisone|mesh-list
138531306|NCT00399087|Docetaxel|docetaxel|mesh-list
138531307|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531308|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
138531309|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
138531310|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
138531311|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396082|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396083|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396085|NCT03630042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396097|NCT03364868|Insulin|insulin|mesh-list
138531312|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138531313|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
138531314|NCT00399087|Hormones|hormones|mesh-ancestor
138531315|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138229960|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138531316|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531317|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138531318|NCT00209482|Metformin|metformin|mesh-list
138531319|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138531320|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531321|NCT00041171|Docetaxel|docetaxel|mesh-list
138531322|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531323|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
138531324|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
138396130|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138396131|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
138531325|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
138531326|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531327|NCT00209521|Propofol|propofol|mesh-list
138531328|NCT00209521|Fospropofol|fospropofol|mesh-list
138531329|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138531330|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138531331|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531332|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138531333|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
138396203|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705578|NCT04420884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531335|NCT00209638|Irinotecan|irinotecan|mesh-list
138396204|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138531336|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138531337|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138531338|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531339|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531340|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531341|NCT00399126|Paclitaxel|paclitaxel|mesh-list
138531342|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138531343|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138207593|NCT01118741|Disulfiram|disulfiram|mesh-list
138531344|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
138531345|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
138396267|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531346|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
138396268|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138396270|NCT01092702|Varenicline|varenicline|mesh-list
138531347|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531349|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138531350|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
138531351|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531352|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531353|NCT00209716|Cisplatin|cisplatin|mesh-list
138531354|NCT00209716|Docetaxel|docetaxel|mesh-list
138531355|NCT00209716|Fluorouracil|fluorouracil|mesh-list
138396328|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
138396329|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396330|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138396331|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
138396332|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396333|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138396334|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138396335|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
138396342|NCT00336024|Leucovorin|leucovorin|mesh-list
138531356|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531357|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
138531358|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
138531359|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
138531360|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531361|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
138531362|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138531363|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138396391|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138396392|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
138396393|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138396406|NCT01525043|Naproxen|naproxen|mesh-list
138531364|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
138531365|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531366|NCT00209755|Ribavirin|ribavirin|mesh-list
138531367|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
138531368|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531370|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138531371|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
138531372|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
138531373|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138531374|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
138531375|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138531376|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138531377|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138531378|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138531379|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531380|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531381|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138531382|NCT00209833|Cytarabine|cytarabine|mesh-list
138531383|NCT00209833|Fludarabine|fludarabine|mesh-list
138531384|NCT00209833|Etoposide|etoposide|mesh-list
138531385|NCT00209833|Idarubicin|idarubicin|mesh-list
138531386|NCT00209833|Daunorubicin|daunorubicin|mesh-list
138531387|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531388|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138531389|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
138396456|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138531390|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531391|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138531392|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
138531393|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531394|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138531395|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138531396|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138531397|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531398|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
138705598|NCT04330664|Adagrasib|adagrasib|mesh-list
138396506|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396507|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
138705599|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396510|NCT01526083|Warfarin|warfarin|mesh-list
138705600|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138705601|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138705602|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531399|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138531400|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138531401|NCT00041210|Prednisone|prednisone|mesh-list
138531402|NCT00041210|Doxorubicin|doxorubicin|mesh-list
138531403|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138531404|NCT00041210|Bleomycin|bleomycin|mesh-list
138531405|NCT00041210|Etoposide|etoposide|mesh-list
138531406|NCT00041210|Vincristine|vincristine|mesh-list
138531407|NCT00041210|Dacarbazine|dacarbazine|mesh-list
138531408|NCT00041210|Vinblastine|vinblastine|mesh-list
138396568|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396569|NCT01526278|Alendronate|alendronate|mesh-list
138531409|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
138531410|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138396570|NCT01526278|Calcitriol|calcitriol|mesh-list
138531411|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531412|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138531413|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138531414|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531415|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531416|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138531417|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
138531418|NCT00041210|Hormones|hormones|mesh-ancestor
138188480|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
138531419|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138396628|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531420|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531421|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138531422|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138531423|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
138531424|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
138531425|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
138462657|NCT03148366|Levofloxacin|levofloxacin|mesh-list
138531426|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138531427|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
138531428|NCT00209872|Lidocaine|lidocaine|mesh-list
138531429|NCT00209872|Ketamine|ketamine|mesh-list
138531430|NCT00209872|Gabapentin|gabapentin|mesh-list
138531431|NCT00209872|Esketamine|esketamine|mesh-list
138531432|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
138531433|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
138424230|NCT03749187|Pamiparib|pamiparib|mesh-list
138531434|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138531435|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705611|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
138705612|NCT04305054|Lenvatinib|lenvatinib|mesh-list
138705613|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138396693|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
138396725|NCT01526850|Hormones|hormones|mesh-ancestor
138705614|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705615|NCT04305054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138705616|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705617|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138705618|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705619|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
138705620|NCT04303169|Tretinoin|tretinoin|mesh-list
138705621|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138531436|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
138531437|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531438|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138531439|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138531440|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138531441|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138531442|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531444|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138531445|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138531446|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
138531447|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138396749|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138531448|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138531449|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531450|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
138531451|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138531452|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138531453|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138531454|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
138531455|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
138531456|NCT00209950|Gaboxadol|gaboxadol|mesh-list
138531457|NCT00209950|Analgesics|analgesics|mesh-ancestor
138531458|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
138531459|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531460|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531461|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
138531462|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
138531463|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
138531464|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531465|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531466|NCT00209989|Tipifarnib|tipifarnib|mesh-list
138531467|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531468|NCT00210028|Tamoxifen|tamoxifen|mesh-list
138531469|NCT00210028|Tipifarnib|tipifarnib|mesh-list
138531470|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138531471|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
138531472|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138531473|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531474|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138531475|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531476|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138531477|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138531478|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138531479|NCT00041288|Cyclosporine|cyclosporine|mesh-list
138531480|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
138531481|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
138531482|NCT00041288|Methotrexate|methotrexate|mesh-list
138531483|NCT00041288|Fludarabine|fludarabine|mesh-list
138396868|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
138531484|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
138531485|NCT00041288|Tacrolimus|tacrolimus|mesh-list
138531486|NCT00041288|Cyclosporins|cyclosporins|mesh-list
138531487|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138531488|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
138531489|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531490|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138531491|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138705644|NCT04241185|Mitomycins|mitomycins|mesh-list
138531492|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
138531493|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531494|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531495|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138531496|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138531497|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
138531498|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138531499|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138531500|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
138531501|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
138531502|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531503|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138531504|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138531505|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138531506|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
138531507|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138396917|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396918|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396920|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
138531508|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138531509|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138531510|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
138531511|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138531512|NCT00073164|Valproic Acid|valproic acid|mesh-list
138531513|NCT00073164|Olanzapine|olanzapine|mesh-list
138531514|NCT00073164|Risperidone|risperidone|mesh-list
138531515|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138531516|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
138531517|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531518|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531519|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531520|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138531521|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138531522|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138531523|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138531524|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138531525|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
138531526|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
138531527|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
138531528|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531529|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138396972|NCT01527994|Aprepitant|aprepitant|mesh-list
138396973|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
138396974|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
138531530|NCT00073164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138531531|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138531532|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138531533|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
138531534|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531535|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
138531536|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
138531538|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138531539|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531540|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138531541|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138531542|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138531543|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531544|NCT00210340|Rituximab|rituximab|mesh-list
138531545|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138531547|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
138531548|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531549|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138531550|NCT00411541|Dexamethasone|dexamethasone|mesh-list
138531551|NCT00411541|Vincristine|vincristine|mesh-list
138531552|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138531553|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
138531554|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
138531555|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531556|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397025|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
138397034|NCT01528540|Pregabalin|pregabalin|mesh-list
138531557|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138531558|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
138531559|NCT00411541|Hormones|hormones|mesh-ancestor
138531560|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138531561|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138531562|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531563|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138531564|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
138531565|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
138531566|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
138531567|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138207819|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138531568|NCT00210379|Rituximab|rituximab|mesh-list
138531569|NCT00210379|Methotrexate|methotrexate|mesh-list
138531570|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138531571|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531572|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
138531573|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531574|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138531575|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138531576|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
138531577|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138397074|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397075|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
138397076|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397077|NCT01528800|Vitamin K|vitamin k|mesh-list
138397078|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
138397079|NCT01528800|Vitamins|vitamins|mesh-ancestor
138397080|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
138397081|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397085|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
138531578|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138531579|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
138531580|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531581|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
138531582|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531583|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138531584|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138531585|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138531586|NCT00041327|Interferons|interferons|mesh-list
138531587|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
138531588|NCT00041327|Lamivudine|lamivudine|mesh-list
138531589|NCT00041327|Zidovudine|zidovudine|mesh-list
138531590|NCT00041327|Prednisone|prednisone|mesh-list
138531591|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
138531592|NCT00041327|Doxorubicin|doxorubicin|mesh-list
138531593|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138531594|NCT00041327|Etoposide|etoposide|mesh-list
138531595|NCT00041327|Vincristine|vincristine|mesh-list
138531596|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138397126|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
138531597|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
138531598|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531599|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138705683|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138705684|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705685|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138705686|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138318643|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138531600|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138531601|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
138531602|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531603|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531604|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138531605|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138531606|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138397184|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138397190|NCT01529190|Pregabalin|pregabalin|mesh-list
138531607|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138531608|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229969|NCT02486211|Analgesics|analgesics|mesh-ancestor
138531609|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138531612|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138531613|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138531614|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138531615|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
138531616|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138531617|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
138531618|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
138531619|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
138531620|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138531621|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138531622|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138531623|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138531624|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
138531625|NCT00210457|Lanreotide|lanreotide|mesh-list
138531626|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531627|NCT00210496|Topiramate|topiramate|mesh-list
138397239|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
138397240|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138397241|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531628|NCT00210496|Almotriptan|almotriptan|mesh-list
138531629|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
138531630|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138531631|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531632|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138531633|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
138531634|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531635|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531636|NCT00210535|Topiramate|topiramate|mesh-list
138531637|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
138531638|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138531639|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531640|NCT00210574|Topiramate|topiramate|mesh-list
138531641|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
138531642|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138531643|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531644|NCT00210691|Risperidone|risperidone|mesh-list
138531645|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138531646|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
138531647|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531648|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531649|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531650|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138531651|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138531652|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138531653|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138531654|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138531655|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
138531656|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
138397289|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397290|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397291|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397292|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138531657|NCT00210730|Hematinics|hematinics|mesh-ancestor
138705706|NCT04211961|Scopolamine|scopolamine|mesh-list
138705707|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138705708|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138705709|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
138705710|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
138705711|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531658|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138531659|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138531660|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138531661|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138531662|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531663|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138531664|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138531665|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138531666|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
138531667|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531668|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531669|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138531670|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138531671|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
138397333|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397334|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138397335|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138397336|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138531672|NCT00210808|Topiramate|topiramate|mesh-list
138531673|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
138531674|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138531675|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531676|NCT00210847|Acetaminophen|acetaminophen|mesh-list
138531677|NCT00210847|Tramadol|tramadol|mesh-list
138531678|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138531680|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
138531681|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531682|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531683|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
138531684|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138397383|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
138397384|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
138397390|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
138531685|NCT00210847|Narcotics|narcotics|mesh-ancestor
138531686|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138531687|NCT00210886|Levofloxacin|levofloxacin|mesh-list
138531688|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138531689|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138531690|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138531691|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138531692|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138531693|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397446|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138397447|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397448|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138397449|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138397450|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531694|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531695|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531696|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138531697|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138531698|NCT00210925|Topiramate|topiramate|mesh-list
138531699|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
138531700|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138531701|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531702|NCT00211003|Doripenem|doripenem|mesh-list
138531703|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138531704|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138531705|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
138531706|NCT00211120|Hematinics|hematinics|mesh-ancestor
138531707|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
138531708|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531709|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
138531710|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705720|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
138531712|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138531713|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138531714|NCT00211315|Growth Substances|growth substances|mesh-ancestor
138397509|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138397510|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138397511|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138397512|NCT01530620|Propiverine|propiverine|mesh-list
138397513|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
138397514|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
138531715|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531716|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
138531717|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531718|NCT00211354|Anecortave|anecortave|mesh-list
138531719|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138531720|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138531721|NCT00211354|Growth Substances|growth substances|mesh-ancestor
138531722|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531723|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
138531724|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531725|NCT00211393|Ketoconazole|ketoconazole|mesh-list
138531726|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
138531727|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138531728|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138397559|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397560|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
138397561|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397562|NCT01531049|Nicotine|nicotine|mesh-list
138531729|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138531730|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531731|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531732|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138531733|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
138531734|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138531735|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531736|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138531739|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138531740|NCT00211432|Growth Substances|growth substances|mesh-ancestor
138531741|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531742|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
138531743|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531744|NCT00211471|Anecortave|anecortave|mesh-list
138531745|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138531746|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138531747|NCT00211471|Growth Substances|growth substances|mesh-ancestor
138531748|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531749|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
138531750|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531751|NCT00211588|Galantamine|galantamine|mesh-list
138531752|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138531753|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397618|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397619|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138397620|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397621|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138531754|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531756|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531757|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531758|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138531759|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
138531760|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531761|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
138531762|NCT00211705|Pravastatin|pravastatin|mesh-list
138531763|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138531764|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138705743|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705744|NCT04137380|Mirikizumab|mirikizumab|mesh-list
138705745|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138705746|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138397666|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
138397667|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138705747|NCT04137380|Analgesics|analgesics|mesh-ancestor
138705749|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138705750|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138705751|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138397668|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138397669|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138397671|NCT01531647|Ritonavir|ritonavir|mesh-list
138705752|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138705753|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138531765|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
138531766|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531767|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138531768|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138531769|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531770|NCT00211744|Topiramate|topiramate|mesh-list
138424410|NCT02160353|Hormones|hormones|mesh-ancestor
138531771|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
138397719|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138531772|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138531773|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397720|NCT01531790|Growth Substances|growth substances|mesh-ancestor
138531774|NCT00211939|Atorvastatin|atorvastatin|mesh-list
138397721|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397722|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
138397723|NCT01531829|Heparin|heparin|mesh-list
138531775|NCT00211939|Calcium|calcium|mesh-list
138531776|NCT00211939|Sevelamer|sevelamer|mesh-list
138531777|NCT00211939|Calcium acetate|calcium acetate|mesh-list
138531778|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138531779|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531780|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138531781|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138531782|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
138462753|NCT05412576|Anesthetics, Local|anesthetics, local|mesh-ancestor
138531783|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531785|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138531786|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531787|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
138531788|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
138531789|NCT00211978|Calcium|calcium|mesh-list
138531790|NCT00211978|Calcium acetate|calcium acetate|mesh-list
138531791|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138531792|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531793|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
138531794|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
138531795|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531796|NCT00212017|Voglibose|voglibose|mesh-list
138531797|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138397778|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397779|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
138397780|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138397781|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138397783|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138397785|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138531798|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531799|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138531800|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531801|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531802|NCT00212095|Ketoconazole|ketoconazole|mesh-list
138531803|NCT00212095|Docetaxel|docetaxel|mesh-list
138531804|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531805|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
138531806|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
138531807|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
138531808|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531809|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
138531810|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397826|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
138397827|NCT01532856|Prednisone|prednisone|mesh-list
138397828|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
138397829|NCT01532856|Melphalan|melphalan|mesh-list
138397830|NCT01532856|BB 1101|bb 1101|mesh-list
138531811|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138531812|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138531813|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531814|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138531815|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
138531816|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138531817|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531818|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138531820|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
138705772|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138705773|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138705774|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705775|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531821|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138531822|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
138531823|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138531824|NCT00212212|Selenium|selenium|mesh-list
138531825|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
138531826|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397888|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531828|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531829|NCT00212212|Trace Elements|trace elements|mesh-ancestor
138397889|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138397890|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138531830|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
138531831|NCT00212290|Pioglitazone|pioglitazone|mesh-list
138531832|NCT00212290|Nateglinide|nateglinide|mesh-list
138531833|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138531834|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531835|NCT00073203|Paroxetine|paroxetine|mesh-list
138531836|NCT00073203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138531837|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138531838|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138531839|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424493|NCT03870880|Risperidone|risperidone|mesh-list
138531840|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531841|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
138531842|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531843|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138531844|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
138531845|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138531846|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138397938|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138397939|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
138397940|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138397947|NCT01533324|Antidotes|antidotes|mesh-ancestor
138531847|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138531848|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531849|NCT00411736|Azithromycin|azithromycin|mesh-list
138531850|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138531851|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138531852|NCT00212602|Aprepitant|aprepitant|mesh-list
138531853|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
138531854|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
138531855|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
138531856|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397993|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138397994|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397995|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138531857|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397996|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138531858|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138531859|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138531860|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531861|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531862|NCT00212680|Landiolol|landiolol|mesh-list
138531863|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138531864|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138531865|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
138531866|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531867|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138208120|NCT05272397|Dopamine Agents|dopamine agents|mesh-ancestor
138531868|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531869|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138531870|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
138398057|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
138531872|NCT00213070|Miglitol|miglitol|mesh-list
138531873|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398058|NCT01533740|Vitamins|vitamins|mesh-ancestor
138398059|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
138398060|NCT01533740|Hematinics|hematinics|mesh-ancestor
138398061|NCT01533818|Amoxicillin|amoxicillin|mesh-list
138398062|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138398063|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398064|NCT01533870|Rifampin|rifampin|mesh-list
138398065|NCT01533870|Naloxegol|naloxegol|mesh-list
138398066|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138398067|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
138398068|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138398069|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398070|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
138398071|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138398072|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398080|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138531874|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531875|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138531876|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531877|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138531879|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531880|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531881|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138531882|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531883|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138531884|NCT00213226|Dexamethasone|dexamethasone|mesh-list
138531885|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138531886|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
138531887|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
138531888|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531889|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531890|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138531891|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
138531892|NCT00213226|Hormones|hormones|mesh-ancestor
138531893|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138398101|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138531894|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138398103|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
138398104|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398105|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398106|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138398107|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
138398112|NCT01534247|Metronidazole|metronidazole|mesh-list
138531895|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531897|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138531898|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
138531899|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531900|NCT00213538|Methotrexate|methotrexate|mesh-list
138531901|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138531902|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138531903|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
138531904|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138531905|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531906|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138531907|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
138531908|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531909|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138531910|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
138531911|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531912|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138531913|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138531914|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
138531915|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138531916|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138398151|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398152|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398154|NCT01534585|Mitogens|mitogens|mesh-list
138398155|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138398156|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398157|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
138398158|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
138398159|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
138531917|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
138531918|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138531919|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138531920|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531921|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
138531922|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138705823|NCT03965468|Paclitaxel|paclitaxel|mesh-list
138531923|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531924|NCT00213694|Celecoxib|celecoxib|mesh-list
138531925|NCT00213694|Docetaxel|docetaxel|mesh-list
138531926|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138165765|NCT05369468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531927|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
138531928|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
138531929|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
138531930|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531931|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138531932|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138531934|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
138398197|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531935|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531936|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531937|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138531938|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138531939|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138531940|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138531941|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531942|NCT00214084|Allopurinol|allopurinol|mesh-list
138531943|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
138531944|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531946|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
138531947|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138531948|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138531949|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
138531950|NCT00214084|Protective Agents|protective agents|mesh-ancestor
138531951|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531952|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
138531953|NCT00214240|Antibodies|antibodies|mesh-list
138531954|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
138398251|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138398252|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398253|NCT01535157|Ketoconazole|ketoconazole|mesh-list
138398254|NCT01535157|Fenretinide|fenretinide|mesh-list
138531955|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138531956|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138531957|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
138531958|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531959|NCT00214318|Metoprolol|metoprolol|mesh-list
138531960|NCT00214318|Carvedilol|carvedilol|mesh-list
138531961|NCT00214318|Terbutaline|terbutaline|mesh-list
138531962|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138531963|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138531964|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
138531965|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
138705833|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138531966|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138531967|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138531968|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138531969|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138398302|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138398303|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138398304|NCT01535495|Propranolol|propranolol|mesh-list
138398305|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138531970|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138531971|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
138531972|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138531973|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138531975|NCT00214318|Protective Agents|protective agents|mesh-ancestor
138531976|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138531977|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138531978|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138531979|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
138531980|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138531981|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138531982|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138531983|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138165806|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
138531984|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
138531985|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
138531986|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
138398356|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
138531987|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138531988|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138531989|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138531990|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138398359|NCT01535859|Cabergoline|cabergoline|mesh-list
138531991|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138531992|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
138531993|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138531994|NCT00214552|Rabeprazole|rabeprazole|mesh-list
138531995|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138531996|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138531997|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138531998|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138531999|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532000|NCT00069459|Bupropion|bupropion|mesh-list
138532001|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138532002|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
138532003|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138532004|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138398409|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138398410|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398411|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
138398412|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138398413|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
138532005|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138532006|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138532007|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138705864|NCT03929666|Antidotes|antidotes|mesh-ancestor
138532009|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532010|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532011|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138532012|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138532013|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532014|NCT00214630|Atorvastatin|atorvastatin|mesh-list
138532015|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138532017|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138532018|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532019|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138532020|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138532021|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
138398467|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138398468|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
138398469|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
138398470|NCT01536301|Morphine|morphine|mesh-list
138532022|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532023|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138532024|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138532025|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532026|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138532027|NCT00214825|Eplerenone|eplerenone|mesh-list
138532028|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138532029|NCT00214825|Diuretics|diuretics|mesh-ancestor
138532030|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
138532031|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532032|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138532033|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138398521|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
138398522|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138398523|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138398524|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532034|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532035|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138532036|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
138532037|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138532038|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138532039|NCT00214864|Docetaxel|docetaxel|mesh-list
138532041|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532042|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
138532043|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
138532044|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
138532045|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532046|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532048|NCT00214942|Fentanyl|fentanyl|mesh-list
138532049|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138532050|NCT00214942|Narcotics|narcotics|mesh-ancestor
138532051|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532052|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532053|NCT00214942|Analgesics|analgesics|mesh-ancestor
138532054|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
138532055|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138398580|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138705887|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398581|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138398582|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138705888|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
138705889|NCT03832998|Erenumab|erenumab|mesh-list
138705890|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138705891|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138705893|NCT03832998|Analgesics|analgesics|mesh-ancestor
138532056|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138532057|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138532058|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
138532059|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
138532060|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
138532061|NCT00069498|Mesalamine|mesalamine|mesh-list
138532062|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
138532063|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138532064|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138532065|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138398630|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138532066|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138532067|NCT00069498|Analgesics|analgesics|mesh-ancestor
138532068|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
138532069|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532070|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532071|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138532072|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138532073|NCT00214981|Modafinil|modafinil|mesh-list
138532074|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138532075|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532076|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138532077|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138532078|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138424648|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398691|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138398692|NCT01537861|Thalidomide|thalidomide|mesh-list
138398693|NCT01537861|Dexamethasone|dexamethasone|mesh-list
138398694|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
138398695|NCT01537861|Lenalidomide|lenalidomide|mesh-list
138532079|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532080|NCT00397241|Timolol|timolol|mesh-list
138532081|NCT00397241|Dorzolamide|dorzolamide|mesh-list
138532082|NCT00397241|Latanoprost|latanoprost|mesh-list
138532083|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
138532084|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138532085|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138532086|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
138532087|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532088|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532089|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532090|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138532091|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138165839|NCT05062031|Atropine|atropine|mesh-list
138532092|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138398750|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138532093|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138398751|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398752|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138398753|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398754|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
138532094|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138532095|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532096|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138532097|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138532098|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138532099|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532100|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532101|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138532102|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138532103|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138398806|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
138532104|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
138318655|NCT01396278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138318656|NCT01396278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138318657|NCT01396278|Respiratory System Agents|respiratory system agents|mesh-ancestor
138398807|NCT01538459|Hormones|hormones|mesh-ancestor
138398808|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138398809|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138398810|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138398811|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
138318658|NCT01396278|Dermatologic Agents|dermatologic agents|mesh-ancestor
138532105|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532106|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532107|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138532108|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138532110|NCT00215176|Modafinil|modafinil|mesh-list
138532111|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138532112|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532113|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138532114|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138532115|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138398861|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138532116|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398862|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138398863|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138398864|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532117|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138532118|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
138532119|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138532120|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138532121|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138532122|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532123|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532124|NCT00041483|Anecortave|anecortave|mesh-list
138532125|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138532126|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138532127|NCT00041483|Growth Substances|growth substances|mesh-ancestor
138532128|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532129|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
138532130|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532131|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
138532132|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138532133|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
138532134|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532135|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398922|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138398923|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
138398924|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398934|NCT01538901|Imiquimod|imiquimod|mesh-list
138532136|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138532137|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
138532138|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138532139|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138532140|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138532141|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
138532142|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532143|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532144|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
138532145|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138532146|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
138398978|NCT01539174|Prednisone|prednisone|mesh-list
138398979|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
138398980|NCT01539174|Rituximab|rituximab|mesh-list
138532147|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532148|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532149|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138532150|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
138532151|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138532152|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138532153|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138532154|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
138532155|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165861|NCT04988685|Paclitaxel|paclitaxel|mesh-list
138532156|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532157|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
138532158|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138399040|NCT01539473|Tyramine|tyramine|mesh-list
138399041|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138532159|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
138532160|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532161|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532162|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138532163|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
138208407|NCT00210470|Zinc|zinc|mesh-list
138532164|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138532165|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138532166|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138532167|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
138532168|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532169|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532170|NCT00215722|Cetuximab|cetuximab|mesh-list
138532171|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138399102|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138532172|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399103|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
138399104|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399105|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532173|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138532174|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
138532175|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138532176|NCT00215839|Ribavirin|ribavirin|mesh-list
138532177|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
138532178|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532179|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
138532180|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138532182|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138532183|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138532184|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532185|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532186|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532187|NCT00215995|Cisplatin|cisplatin|mesh-list
138532188|NCT00215995|Irinotecan|irinotecan|mesh-list
138532189|NCT00215995|Gefitinib|gefitinib|mesh-list
138532190|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532191|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138532192|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138532193|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532194|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399156|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138399157|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138399158|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138532195|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138532196|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
138532197|NCT00216034|Tegafur|tegafur|mesh-list
138532198|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532199|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
138532200|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532201|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532202|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138532203|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
138532204|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532205|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138532206|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
138399208|NCT01540500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138399209|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138532207|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138532208|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
138532209|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138532210|NCT00216034|Protective Agents|protective agents|mesh-ancestor
138532212|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
138532213|NCT00216073|Trastuzumab|trastuzumab|mesh-list
138532214|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532215|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
138532216|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532217|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532218|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138532219|NCT00216112|Docetaxel|docetaxel|mesh-list
138532220|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
138532221|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532222|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
138532223|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
138532224|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
138399268|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
138399269|NCT01540812|Cytarabine|cytarabine|mesh-list
138532225|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532226|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138532227|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532228|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
138532229|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138532230|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532231|NCT00216190|Midazolam|midazolam|mesh-list
138532232|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
138532233|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138399329|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
138532234|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532235|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532236|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138399330|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138399331|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532237|NCT00216190|Analgesics|analgesics|mesh-ancestor
138532238|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
138532239|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532240|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138532241|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138532242|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138532243|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
138532244|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532245|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532246|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138532247|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138532248|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138532249|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138532250|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138532251|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
138532252|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
138399388|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399389|NCT01541332|Dexamethasone|dexamethasone|mesh-list
138399390|NCT01541332|Doxorubicin|doxorubicin|mesh-list
138399391|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138399392|NCT01541332|Pomalidomide|pomalidomide|mesh-list
138532254|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
138532255|NCT00216268|Ribavirin|ribavirin|mesh-list
138532256|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
138532257|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532258|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
138532259|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138705976|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532260|NCT00216346|Amphotericin B|amphotericin b|mesh-list
138532261|NCT00216346|Paromomycin|paromomycin|mesh-list
138532262|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138532263|NCT00216346|Amebicides|amebicides|mesh-ancestor
138532264|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138532265|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138532266|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138532267|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138532268|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
138532269|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
138532270|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138532271|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138532272|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138399443|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
138532273|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138532274|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138532275|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138532276|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532277|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532278|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532279|NCT00216424|Capecitabine|capecitabine|mesh-list
138532280|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532281|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
138532282|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532283|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399499|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138399500|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
138399501|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399502|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138399503|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138532285|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138532286|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138532287|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
138532288|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399558|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532289|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138532290|NCT00216502|Galantamine|galantamine|mesh-list
138532291|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138532292|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532293|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532294|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
138532295|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532296|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532297|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138532298|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
138532299|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532300|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
138532301|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
138532302|NCT00216541|Hematinics|hematinics|mesh-ancestor
138532303|NCT00216580|Risperidone|risperidone|mesh-list
138532304|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138532305|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
138399622|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399624|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
138532306|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532307|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532308|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532309|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138532310|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138399688|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138532311|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532312|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138532313|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138532314|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
138532315|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
138532316|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138532317|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
138532318|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138399689|NCT01543165|Ketorolac|ketorolac|mesh-list
138399690|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138399691|NCT01543165|Morphine|morphine|mesh-list
138399692|NCT01543165|Analgesics|analgesics|mesh-list
138532319|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532320|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138532321|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
138532322|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138532324|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532325|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532326|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138532327|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
138532328|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
138532329|NCT00041561|Protective Agents|protective agents|mesh-ancestor
138532330|NCT00216619|Topiramate|topiramate|mesh-list
138532331|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
138532332|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138532333|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399749|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
138532334|NCT00216658|Fentanyl|fentanyl|mesh-list
138532335|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138532336|NCT00216658|Narcotics|narcotics|mesh-ancestor
138532337|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532338|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532339|NCT00216658|Analgesics|analgesics|mesh-ancestor
138532340|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
138532341|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532343|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138532344|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
138532345|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
138532346|NCT00216697|Bortezomib|bortezomib|mesh-list
138532347|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532348|NCT00216775|Interferons|interferons|mesh-list
138532349|NCT00216775|Ribavirin|ribavirin|mesh-list
138532350|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
138532351|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
138399810|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
138399811|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
138532352|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532353|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
138532354|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138532355|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
138424734|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138532356|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532357|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
138532358|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532359|NCT00041639|Labetuzumab|labetuzumab|mesh-list
138532360|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138532361|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532362|NCT00216892|Betamethasone|betamethasone|mesh-list
138532363|NCT00216892|Calcipotriene|calcipotriene|mesh-list
138532364|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138532365|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
138399870|NCT01544283|Hormones|hormones|mesh-ancestor
138399871|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138532366|NCT00216892|Hormones|hormones|mesh-ancestor
138532367|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138532368|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532369|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138532370|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
138532371|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
138532373|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138532374|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
138532375|NCT00217009|Furocoumarins|furocoumarins|mesh-list
138532376|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
138532377|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138532378|NCT00217048|Yohimbine|yohimbine|mesh-list
138532379|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
138532380|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
138532381|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532382|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532383|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138532384|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138532385|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138399930|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138532386|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
138399931|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138399932|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138532387|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532388|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532389|NCT00217048|Urological Agents|urological agents|mesh-ancestor
138532390|NCT00217204|Pancrelipase|pancrelipase|mesh-list
138532391|NCT00217204|Pancreatin|pancreatin|mesh-list
138532392|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138532393|NCT00412126|Insulin|insulin|mesh-list
138532394|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138532395|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532396|NCT00412204|Bromides|bromides|mesh-list
138230001|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
138532398|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138532399|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
138532400|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532401|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532402|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138424763|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
138532403|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
138532404|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
138532405|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138532406|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
138399983|NCT01544842|Hormones|hormones|mesh-ancestor
138532407|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532408|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399985|NCT01544881|Insulin|insulin|mesh-list
138399997|NCT01544907|Paclitaxel|paclitaxel|mesh-list
138532409|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
138532410|NCT00041678|Aripiprazole|aripiprazole|mesh-list
138532411|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
138532412|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138532413|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138532414|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138532415|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532416|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532417|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
138532418|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
138532419|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532420|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532421|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138532422|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138532423|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
138532424|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138532425|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138532426|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138532427|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138532428|NCT00217243|Lidocaine|lidocaine|mesh-list
138400035|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532429|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
138532430|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
138532431|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532432|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532433|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
138532434|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532435|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138532436|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138532437|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138532438|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138532439|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532440|NCT00217282|Bevacizumab|bevacizumab|mesh-list
138532441|NCT00217282|Gemcitabine|gemcitabine|mesh-list
138532442|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
138532443|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138532444|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532445|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138532446|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138532447|NCT00217282|Growth Substances|growth substances|mesh-ancestor
138532448|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400090|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138400091|NCT01545778|Narcotics|narcotics|mesh-ancestor
138532449|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
138532450|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532451|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
138532452|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532453|NCT00217477|Gemcitabine|gemcitabine|mesh-list
138532454|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532455|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
138532456|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532457|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532458|NCT00217516|Selenium|selenium|mesh-list
138532459|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
138532460|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138400142|NCT01546090|Alprazolam|alprazolam|mesh-list
138400146|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138532461|NCT00217516|Protective Agents|protective agents|mesh-ancestor
138532462|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532463|NCT00217516|Trace Elements|trace elements|mesh-ancestor
138532464|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
138532465|NCT00217555|Gemcitabine|gemcitabine|mesh-list
138532466|NCT00217555|Topotecan|topotecan|mesh-list
138532467|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532468|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
138532469|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138165926|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
138532470|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532471|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138532472|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138532473|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400207|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400208|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138400209|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138400210|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138400211|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
138532474|NCT00217711|Capecitabine|capecitabine|mesh-list
138532475|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
138532476|NCT00217711|Irinotecan|irinotecan|mesh-list
138532477|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532478|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
138532479|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532480|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532481|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138532482|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138532483|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532484|NCT00217789|Dimercaprol|dimercaprol|mesh-list
138532485|NCT00217789|Chelating Agents|chelating agents|mesh-ancestor
138532486|NCT00217789|Sequestering Agents|sequestering agents|mesh-ancestor
138532487|NCT00217789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532488|NCT00217828|Citalopram|citalopram|mesh-list
138400265|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138400266|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
138400267|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
138532489|NCT00217828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138532490|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138532491|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138532492|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532493|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532494|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
138532495|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532496|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138532497|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
138532498|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138532499|NCT00041990|Decitabine|decitabine|mesh-list
138532500|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532501|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
138532502|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532503|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532504|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532505|NCT00073437|Infliximab|infliximab|mesh-list
138532506|NCT00073437|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138400326|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
138400345|NCT01547494|Vitamins|vitamins|mesh-list
138532507|NCT00073437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138532509|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138532510|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138532511|NCT00218101|Buprenorphine|buprenorphine|mesh-list
138532512|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138532513|NCT00218101|Narcotics|narcotics|mesh-ancestor
138532514|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532515|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532516|NCT00218101|Analgesics|analgesics|mesh-ancestor
138532517|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
138532518|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532519|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138532520|NCT00218140|Nicotine|nicotine|mesh-list
138532521|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138532522|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
138532523|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532524|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532525|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138532526|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138400382|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400384|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
138400385|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711096|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711097|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138711098|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138711099|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
138711100|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
138711101|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138711102|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138711103|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138711104|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138711105|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138711106|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138711107|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
138711108|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
138711109|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138711111|NCT04620720|Gabapentin|gabapentin|mesh-list
138711112|NCT04620720|Analgesics|analgesics|mesh-ancestor
138711113|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
138711114|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711115|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711116|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
138711117|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138400436|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138400437|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138711118|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138711119|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711120|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138711121|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138711122|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138711123|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711124|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711125|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
138711126|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138711127|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138711128|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711129|NCT02900417|Incretins|incretins|mesh-ancestor
138711130|NCT02900417|Hormones|hormones|mesh-ancestor
138711131|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138711132|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138711133|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
138711134|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532527|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
138400489|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138400503|NCT01548560|Dapivirine|dapivirine|mesh-list
138711135|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711136|NCT04620837|Tislelizumab|tislelizumab|mesh-list
138711137|NCT04620837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138711138|NCT04620837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711139|NCT04620018|Amoxicillin|amoxicillin|mesh-list
138711140|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138711141|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711142|NCT02900105|Letrozole|letrozole|mesh-list
138711143|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711144|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138711145|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138508064|NCT06196606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711147|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711148|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138711149|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
138711150|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138711151|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711152|NCT04619862|Gabapentin|gabapentin|mesh-list
138711153|NCT04619862|Analgesics|analgesics|mesh-ancestor
138711154|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
138400545|NCT01548859|Sevoflurane|sevoflurane|mesh-list
138400546|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138400564|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
138711155|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711156|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711157|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
138711158|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138711159|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138711160|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711161|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138711162|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138711163|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138711164|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711165|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711166|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
138711167|NCT01190839|Infliximab|infliximab|mesh-list
138711168|NCT01190839|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138711169|NCT01190839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138711170|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
138711171|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138400598|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138711172|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138711173|NCT00562770|Valacyclovir|valacyclovir|mesh-list
138711174|NCT00562770|Valganciclovir|valganciclovir|mesh-list
138711175|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
138711176|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711177|NCT05424692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
138711178|NCT05424692|Fluorouracil|fluorouracil|mesh-list
138711179|NCT05424692|Oxaliplatin|oxaliplatin|mesh-list
138711180|NCT05424692|Irinotecan|irinotecan|mesh-list
138711181|NCT05424692|Cetuximab|cetuximab|mesh-list
138711182|NCT05424692|Antimetabolites|antimetabolites|mesh-ancestor
138711183|NCT05424692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711184|NCT05424692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138711185|NCT05424692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711186|NCT05424692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138711187|NCT05424692|Immunologic Factors|immunologic factors|mesh-ancestor
138711188|NCT05424692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711189|NCT05424692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138711190|NCT05424692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138400655|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138400656|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711191|NCT05424692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711192|NCT05424692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138711193|NCT05424692|Vitamin B Complex|vitamin b complex|mesh-ancestor
138711194|NCT05424692|Vitamins|vitamins|mesh-ancestor
138711195|NCT05424692|Micronutrients|micronutrients|mesh-ancestor
138711196|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
138711197|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138711198|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711199|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711200|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138711201|NCT04618965|Analgesics|analgesics|mesh-ancestor
138711202|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
138400711|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138711203|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711204|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138711205|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138711206|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138711207|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
138711208|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711209|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711210|NCT01190449|Ofatumumab|ofatumumab|mesh-list
138711211|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711212|NCT00562809|Irbesartan|irbesartan|mesh-list
138711213|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138711214|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138711215|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138711216|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711217|NCT01190098|Lacosamide|lacosamide|mesh-list
138711218|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
138711219|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138711220|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138711221|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138711222|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711223|NCT04314739|Resveratrol|resveratrol|mesh-list
138711224|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
138165933|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
138400777|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400778|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
138711225|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711226|NCT04314739|Protective Agents|protective agents|mesh-ancestor
138711227|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711228|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711229|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138711230|NCT02885740|Adenosine|adenosine|mesh-list
138711231|NCT02885740|Analgesics|analgesics|mesh-ancestor
138711232|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
138711233|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711234|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400829|NCT01550653|Liraglutide|liraglutide|mesh-list
138711235|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138711237|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138400830|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138400831|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711238|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
138711239|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
138711240|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711241|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711242|NCT05309785|Canagliflozin|canagliflozin|mesh-list
138711243|NCT05309785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138711244|NCT05309785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711245|NCT05309785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138711246|NCT05309785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711247|NCT01190020|Lubiprostone|lubiprostone|mesh-list
138711248|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138711249|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138711250|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711251|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138711252|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711253|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138711254|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138400896|NCT01551290|Infliximab|infliximab|mesh-list
138711255|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711256|NCT01165996|Decitabine|decitabine|mesh-list
138711257|NCT01165996|Azacitidine|azacitidine|mesh-list
138711258|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138711259|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
138711260|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711261|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711262|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711263|NCT04619433|Carboplatin|carboplatin|mesh-list
138711264|NCT04619433|Pemetrexed|pemetrexed|mesh-list
138711265|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711266|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711267|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711268|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138711269|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138711270|NCT04619160|Propofol|propofol|mesh-list
138711271|NCT04619160|Sevoflurane|sevoflurane|mesh-list
138711272|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138711273|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138400945|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138711274|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711275|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138711276|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
138711277|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
138711278|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138711279|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138711280|NCT01165684|Insulin|insulin|mesh-list
138667597|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138711281|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138711282|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
138711283|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
138711284|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138711285|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
138711286|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138711287|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711288|NCT01189201|Linagliptin|linagliptin|mesh-list
138711289|NCT01189201|Empagliflozin|empagliflozin|mesh-list
138711290|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138711291|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711292|NCT01189201|Incretins|incretins|mesh-ancestor
138711293|NCT01189201|Hormones|hormones|mesh-ancestor
138401000|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401001|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138401002|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138711294|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138711295|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138711296|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
138711297|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711298|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711299|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138711300|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
138711301|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
138532528|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138401056|NCT01552122|Vitamin D|vitamin d|mesh-list
138401057|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
138401058|NCT01552122|Alendronate|alendronate|mesh-list
138401060|NCT01552122|Calcium|calcium|mesh-list
138711302|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711303|NCT01188811|Protective Agents|protective agents|mesh-ancestor
138711304|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711305|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
138711306|NCT01188811|Vitamins|vitamins|mesh-ancestor
138711307|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
138711308|NCT01183234|Methylphenidate|methylphenidate|mesh-list
138711309|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138711310|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401123|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138401124|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138711311|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138711312|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138711313|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138711314|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711316|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711317|NCT04618497|Ketorolac|ketorolac|mesh-list
138711318|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
138711319|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138711320|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138711321|NCT04618497|Analgesics|analgesics|mesh-ancestor
138545790|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
138711323|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711324|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711325|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138711326|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138711327|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138401190|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
138401191|NCT01553357|Hormones|hormones|mesh-ancestor
138711328|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711329|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711330|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138711331|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
138711332|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
138711333|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711334|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138711335|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138711336|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138711337|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
138711338|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138711339|NCT04618536|Protective Agents|protective agents|mesh-ancestor
138401247|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138711340|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711341|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
138401248|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138711342|NCT04651959|Favipiravir|favipiravir|mesh-list
138711343|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
138711344|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711345|NCT01165216|Paclitaxel|paclitaxel|mesh-list
138711346|NCT01165216|Carboplatin|carboplatin|mesh-list
138711347|NCT01165216|Ipilimumab|ipilimumab|mesh-list
138711348|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138711349|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711350|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
138711351|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
138711352|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
138711353|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711354|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138711355|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138711356|NCT04652115|Defibrotide|defibrotide|mesh-list
138711357|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138711358|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138711359|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401310|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138401322|NCT01554852|Melphalan|melphalan|mesh-list
138711360|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138711361|NCT04618107|Anesthetics|anesthetics|mesh-list
138711362|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711363|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711364|NCT05423015|Levan|levan|mesh-list
138711365|NCT05423015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711366|NCT04618146|Morphine|morphine|mesh-list
138711367|NCT04618146|Bupivacaine|bupivacaine|mesh-list
138711368|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
138265204|NCT04525820|Vitamin D|vitamin d|mesh-list
138711369|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
138711370|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711371|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711372|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
138711373|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711374|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138711375|NCT04618146|Narcotics|narcotics|mesh-ancestor
138711376|NCT04618146|Analgesics|analgesics|mesh-ancestor
138711377|NCT04651842|Insulin|insulin|mesh-list
138711378|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138711379|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711380|NCT05421962|Fentanyl|fentanyl|mesh-list
138711381|NCT05421962|Ketamine|ketamine|mesh-list
138711382|NCT05421962|Analgesics|analgesics|mesh-ancestor
138711383|NCT05421962|Sensory System Agents|sensory system agents|mesh-ancestor
138401373|NCT01554969|Capecitabine|capecitabine|mesh-list
138401375|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
138711384|NCT05421962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711385|NCT05421962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711386|NCT05421962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138711387|NCT05421962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138711388|NCT05421962|Anesthetics, General|anesthetics, general|mesh-ancestor
138711389|NCT05421962|Anesthetics|anesthetics|mesh-ancestor
138711390|NCT05421962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711391|NCT05421962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138711392|NCT05421962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138711393|NCT05421962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711394|NCT05421962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711395|NCT05421962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138711396|NCT05421962|Narcotics|narcotics|mesh-ancestor
138711397|NCT05421962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138711398|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
138711399|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138711400|NCT00557817|Hematinics|hematinics|mesh-ancestor
138401424|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
138401436|NCT01555476|Ibuprofen|ibuprofen|mesh-list
138711402|NCT05419583|Warfarin|warfarin|mesh-list
138711403|NCT05419583|Apixaban|apixaban|mesh-list
138711404|NCT05419583|Anticoagulants|anticoagulants|mesh-list
138711405|NCT05419583|Edoxaban|edoxaban|mesh-list
138711406|NCT05419583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138711407|NCT05419583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138711408|NCT05419583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138711409|NCT05419583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138711410|NCT05419583|Analgesics|analgesics|mesh-ancestor
138711411|NCT05419583|Sensory System Agents|sensory system agents|mesh-ancestor
138711412|NCT05419583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711413|NCT05419583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711414|NCT05419583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138711415|NCT05419583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138711416|NCT05419583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138711417|NCT05419583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138711418|NCT05419583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508066|NCT06196580|Midazolam|midazolam|mesh-list
138711419|NCT05419583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138711420|NCT05419583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711421|NCT05419583|Antipyretics|antipyretics|mesh-ancestor
138711422|NCT05419583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138711423|NCT05419583|Antithrombins|antithrombins|mesh-ancestor
138401484|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
138401485|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138401486|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711424|NCT05419583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138711425|NCT05419583|Protease Inhibitors|protease inhibitors|mesh-ancestor
138711426|NCT05419583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138711427|NCT05419583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138711428|NCT05419583|Antimetabolites|antimetabolites|mesh-ancestor
138711429|NCT05419583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138711430|NCT05387408|Analgesics, Opioid|analgesics, opioid|mesh-list
138711431|NCT05387408|Narcotics|narcotics|mesh-ancestor
138711432|NCT05387408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711433|NCT05387408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711435|NCT05387408|Sensory System Agents|sensory system agents|mesh-ancestor
138401534|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138711436|NCT05387408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711437|NCT05376761|Dexmedetomidine|dexmedetomidine|mesh-list
138711438|NCT05376761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138711439|NCT05376761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711440|NCT05376761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711441|NCT05376761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138711442|NCT05376761|Analgesics|analgesics|mesh-ancestor
138711443|NCT05376761|Sensory System Agents|sensory system agents|mesh-ancestor
138711444|NCT05376761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711445|NCT05376761|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138711446|NCT05376761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138711447|NCT05376761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138711448|NCT05376761|Adrenergic Agents|adrenergic agents|mesh-ancestor
138711449|NCT05376761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647466|NCT04222920|Adalimumab|adalimumab|mesh-list
138324207|NCT03423342|Niacin|niacin|mesh-list
138711450|NCT05376761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711451|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
138711452|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138711453|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138401600|NCT05847413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138401601|NCT05847413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138401605|NCT05847413|Vasodilator Agents|vasodilator agents|mesh-ancestor
138711454|NCT04617561|Prednisolone|prednisolone|mesh-list
138711455|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
138711456|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138711457|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138711458|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
138711459|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
138711460|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138711461|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
138711462|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
138711463|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711464|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711465|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138711467|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138711468|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138401652|NCT05847049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138401653|NCT05847049|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138711469|NCT04617561|Protective Agents|protective agents|mesh-ancestor
138711470|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138711471|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711472|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138711473|NCT04617483|Vaccines|vaccines|mesh-list
138711474|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
138711475|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711476|NCT04617249|Anesthetics|anesthetics|mesh-list
138711477|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711478|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711479|NCT05349383|Antineoplastic Agents|antineoplastic agents|mesh-list
138711480|NCT05349383|Antibodies|antibodies|mesh-list
138711481|NCT05349383|Immunoglobulins|immunoglobulins|mesh-list
138711482|NCT05349383|Immunoconjugates|immunoconjugates|mesh-list
138711483|NCT05349383|Immunomodulating Agents|immunomodulating agents|mesh-list
138711484|NCT05349383|Immunologic Factors|immunologic factors|mesh-ancestor
138711485|NCT05349383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711486|NCT04617171|Benralizumab|benralizumab|mesh-list
138711487|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138711488|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
138711489|NCT00557934|Dobutamine|dobutamine|mesh-list
138711490|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138711491|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
138711492|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
138711493|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711494|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711495|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138401711|NCT05840536|Chlorothiazide|chlorothiazide|mesh-list
138711496|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138711497|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138711498|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
138711499|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711500|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711501|NCT00557934|Protective Agents|protective agents|mesh-ancestor
138711502|NCT00558051|Vaccines|vaccines|mesh-list
138711503|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
138711504|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711505|NCT00558090|Morphine|morphine|mesh-list
138667825|NCT00472173|Calcium|calcium|mesh-list
138711506|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138711507|NCT00558090|Narcotics|narcotics|mesh-ancestor
138265275|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138711508|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711509|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711511|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
138711512|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711513|NCT04650828|Tenofovir|tenofovir|mesh-list
138711514|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
138711515|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711516|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138711517|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138401763|NCT05840328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138711518|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711519|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711520|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138711521|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138711522|NCT04650555|Genistein|genistein|mesh-list
138711523|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138711524|NCT04650555|Protective Agents|protective agents|mesh-ancestor
138711525|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711526|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711527|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138711528|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711529|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711530|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
138711531|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138711532|NCT04650555|Estrogens|estrogens|mesh-ancestor
138711533|NCT04650555|Hormones|hormones|mesh-ancestor
138401816|NCT05839522|Antibodies|antibodies|mesh-list
138401832|NCT05839236|Calcium|calcium|mesh-list
138545804|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138711534|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138711535|NCT05181683|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
138711536|NCT05181683|Antiviral Agents|antiviral agents|mesh-ancestor
138711537|NCT05181683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711538|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
138711539|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
138711540|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711541|NCT05153525|Cisatracurium|cisatracurium|mesh-list
138711542|NCT05153525|Atracurium|atracurium|mesh-list
138711543|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138711544|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138711545|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138401876|NCT05830630|Bupivacaine|bupivacaine|mesh-list
138401877|NCT05830630|Methylene Blue|methylene blue|mesh-list
138711546|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711547|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138711548|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138711549|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138711550|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
138711551|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711552|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711553|NCT04649892|Naltrexone|naltrexone|mesh-list
138711554|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138711555|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138711556|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711557|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
138711558|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711559|NCT05125796|Acetaminophen|acetaminophen|mesh-list
138711560|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138711561|NCT05125796|Ketoprofen|ketoprofen|mesh-list
138711562|NCT05125796|Lidocaine|lidocaine|mesh-list
138711563|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
138711564|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
138401939|NCT05527470|Gemcitabine|gemcitabine|mesh-list
138401940|NCT05527470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711565|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711566|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711567|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
138711568|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711569|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138711570|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138711571|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138711572|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138711573|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711574|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138711575|NCT05125796|Analgesics|analgesics|mesh-ancestor
138711576|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
138711577|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138711578|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138667895|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138711579|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138711580|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138711581|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711582|NCT04616859|Ethanol|ethanol|mesh-list
138711583|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138711584|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711585|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138711586|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138401998|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
138401999|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
138402002|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
138711587|NCT04616586|Siltuximab|siltuximab|mesh-list
138711588|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711589|NCT04616352|Cefuroxime|cefuroxime|mesh-list
138711590|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
138711591|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138711592|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711593|NCT00553943|Cytarabine|cytarabine|mesh-list
138711594|NCT00553943|Rituximab|rituximab|mesh-list
138711595|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138711596|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711597|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
138711598|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711599|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138711600|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138711601|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
138711602|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711603|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
138711604|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711605|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138711606|NCT00563160|Carboplatin|carboplatin|mesh-list
138711607|NCT00563160|Gemcitabine|gemcitabine|mesh-list
138711608|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711609|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138402047|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
138402048|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711610|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
138711611|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711612|NCT00563238|Metoprolol|metoprolol|mesh-list
138711613|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138711614|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138711615|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
138711616|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
138711617|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138647529|NCT04030143|Aripiprazole|aripiprazole|mesh-list
138711618|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711619|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138711620|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138711621|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138711622|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
138711623|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711624|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711625|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
138711626|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138711627|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711628|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
138711629|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138711630|NCT04934228|Clonidine|clonidine|mesh-list
138402101|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
138402102|NCT04835129|Hormones|hormones|mesh-ancestor
138711631|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138711632|NCT04934228|Diuretics|diuretics|mesh-ancestor
138711633|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
138711634|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711635|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138265363|NCT00375869|Hematinics|hematinics|mesh-ancestor
138711636|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138711637|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711638|NCT04934228|Analgesics|analgesics|mesh-ancestor
138711639|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
138711640|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711641|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
138711642|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
138711643|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138711644|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138402155|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
138402156|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711645|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138711646|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
138711647|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711648|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
138711649|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711650|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138711651|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711652|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711653|NCT04616391|Insulin|insulin|mesh-list
138711654|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138711655|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711656|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
138711657|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
138711658|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138711659|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138711660|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138711661|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138711662|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
138711663|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138711664|NCT04881929|Docetaxel|docetaxel|mesh-list
138711665|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711666|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
138711667|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
138711668|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
138711669|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711670|NCT04615767|Inositol|inositol|mesh-list
138711671|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
138711672|NCT04615767|Vitamins|vitamins|mesh-ancestor
138711673|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
138711674|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711675|NCT04615611|Albuterol|albuterol|mesh-list
138711676|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138711677|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
138402213|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138402214|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138402215|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138711678|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711679|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711680|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138711681|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
138711682|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
138711683|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138711684|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138711685|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138711686|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138711687|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
138711688|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711689|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711690|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138711691|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711692|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
138711694|NCT04713371|Ipilimumab|ipilimumab|mesh-list
138402253|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138711695|NCT04713371|Sargramostim|sargramostim|mesh-list
138711696|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138711697|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
138711698|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711699|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138711700|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138711701|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
138711702|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711703|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711704|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138711705|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138711706|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138711707|NCT04683614|Norepinephrine|norepinephrine|mesh-list
138711708|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138711709|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138711710|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
138711711|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138711712|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711713|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711714|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
138711715|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
138711716|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138711717|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138402313|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138402320|NCT03983993|Niraparib|niraparib|mesh-list
138711718|NCT04613895|Fexuprazan|fexuprazan|mesh-list
138711719|NCT04613895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138711720|NCT04613700|Secretin|secretin|mesh-list
138711721|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138711722|NCT04613700|Hormones|hormones|mesh-ancestor
138711723|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138711724|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138711725|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
138711726|NCT00563355|Hematinics|hematinics|mesh-ancestor
138711727|NCT00563394|Ofloxacin|ofloxacin|mesh-list
138265439|NCT05992883|Triamcinolone|triamcinolone|mesh-list
138711728|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138711729|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138402362|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138402363|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711730|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138668040|NCT00464919|Tegafur|tegafur|mesh-list
138402364|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711731|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138402371|NCT03664180|Enoxaparin|enoxaparin|mesh-list
138711732|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138711733|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138711734|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711735|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711736|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138711737|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138711738|NCT00563433|Ofloxacin|ofloxacin|mesh-list
138711739|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138402421|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138711740|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138711741|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138711742|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138711743|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138711744|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138402422|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
138402423|NCT03634852|Hormones|hormones|mesh-ancestor
138402424|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138402425|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138402426|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402427|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138711745|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138711746|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138711747|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138711748|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138711749|NCT00563472|Desogestrel|desogestrel|mesh-list
138791670|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138791671|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
138791672|NCT00655018|Tocopherols|tocopherols|mesh-list
138791673|NCT00655018|Vitamin E|vitamin e|mesh-list
138791674|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
138791675|NCT00655018|Vitamins|vitamins|mesh-ancestor
138791676|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
138791677|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791678|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
138791679|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791680|NCT00655018|Protective Agents|protective agents|mesh-ancestor
138791681|NCT02635750|Donepezil|donepezil|mesh-list
138791682|NCT02635750|BI 409306|bi 409306|mesh-list
138402475|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138791683|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138791684|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791685|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402476|NCT03495388|Oxycodone|oxycodone|mesh-list
138402477|NCT03495388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138402478|NCT03495388|Narcotics|narcotics|mesh-ancestor
138402479|NCT03495388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138791686|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
138791687|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791688|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791689|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
138791690|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138791692|NCT04164238|Carboplatin|carboplatin|mesh-list
138791693|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138791694|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791695|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
138791696|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
138791697|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
138791698|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791699|NCT02645734|Bevacizumab|bevacizumab|mesh-list
138791700|NCT02645734|Aflibercept|aflibercept|mesh-list
138791701|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138791702|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791703|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138791704|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138791705|NCT02645734|Growth Substances|growth substances|mesh-ancestor
138791706|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402526|NCT03321526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138402527|NCT03321526|Antidepressive Agents|antidepressive agents|mesh-ancestor
138791707|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
138791708|NCT01133522|Evolocumab|evolocumab|mesh-list
138791709|NCT01133522|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138791711|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138791712|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
138791713|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791714|NCT01133522|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138791715|NCT01133522|Protease Inhibitors|protease inhibitors|mesh-ancestor
138791716|NCT01133522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791717|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138791718|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
138791719|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138791720|NCT00655252|Everolimus|everolimus|mesh-list
138791721|NCT00655252|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138791722|NCT00655252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138791723|NCT00655252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791724|NCT00655252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791725|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138791726|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
138791727|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791728|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791729|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
138791730|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138402581|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138791731|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138791732|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402582|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138402585|NCT03126435|Gemcitabine|gemcitabine|mesh-list
138791733|NCT02645656|Curcumin|curcumin|mesh-list
138791734|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138791735|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138791736|NCT02645656|Analgesics|analgesics|mesh-ancestor
138791737|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
138791738|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791739|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791740|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138791741|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138791742|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791743|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791744|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791746|NCT01132820|Maleic acid|maleic acid|mesh-list
138791747|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791748|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791749|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791750|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138791751|NCT00655330|Valsartan|valsartan|mesh-list
138791752|NCT00655330|Probucol|probucol|mesh-list
138791753|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138402628|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
138402629|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138402630|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138791754|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138791755|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138791756|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791757|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138791758|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138791759|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
138791760|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138791761|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
138791762|NCT00655330|Protective Agents|protective agents|mesh-ancestor
138791763|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791764|NCT00655408|Iron|iron|mesh-list
138791765|NCT00655408|Trace Elements|trace elements|mesh-ancestor
138791766|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
138791767|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791768|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
138791769|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138791770|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138791771|NCT04163536|Prednisolone|prednisolone|mesh-list
138791772|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
138791773|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138265527|NCT05988177|Spiramycin|spiramycin|mesh-list
138791774|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
138791775|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138791777|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
138791778|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791779|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402679|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138402680|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791780|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138791781|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
138402681|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
138791782|NCT04163536|Hormones|hormones|mesh-ancestor
138791783|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138791784|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138791785|NCT04163536|Protective Agents|protective agents|mesh-ancestor
138791786|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138791787|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791788|NCT00652288|Insulin|insulin|mesh-list
138791789|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138791790|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
138791791|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
138791792|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
138791793|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138791794|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
138791795|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
138791796|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138185776|NCT01047293|Growth Substances|growth substances|mesh-ancestor
138791797|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791798|NCT00911092|Fluorouracil|fluorouracil|mesh-list
138791799|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791800|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
138791801|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791802|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138402725|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138791803|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138791804|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
138402726|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791805|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791806|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
138791807|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791808|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138791809|NCT02635360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138791810|NCT02635360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791811|NCT02635282|Midazolam|midazolam|mesh-list
138791812|NCT02635282|Fentanyl|fentanyl|mesh-list
138791813|NCT02635282|Ketamine|ketamine|mesh-list
138791814|NCT02635282|Analgesics|analgesics|mesh-ancestor
138791815|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
138791816|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791817|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791818|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138791819|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138791820|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
138791821|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
138791822|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138402778|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138402779|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138402780|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791823|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138791824|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138791825|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791826|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791827|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138791828|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138791829|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138791830|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138791831|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138791832|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
138791833|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
138791834|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138791835|NCT02635282|Narcotics|narcotics|mesh-ancestor
138791836|NCT00655798|Antioxidants|antioxidants|mesh-list
138791837|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791838|NCT00655798|Protective Agents|protective agents|mesh-ancestor
138791839|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791840|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
138791841|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138791843|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
138402835|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402836|NCT00674609|Nabiximols|nabiximols|mesh-list
138791844|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138791845|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
138791846|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791847|NCT02637466|Vortioxetine|vortioxetine|mesh-list
138791848|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
138791849|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138791850|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138791851|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138791852|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138791853|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791854|NCT02637466|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138791855|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138791856|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138791857|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791858|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791859|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
138791860|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138791861|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138791862|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138791863|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138791864|NCT02634970|Ranibizumab|ranibizumab|mesh-list
138791865|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138791866|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138402890|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138402891|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791867|NCT02634970|Growth Substances|growth substances|mesh-ancestor
138791868|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791869|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
138791870|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791871|NCT00885352|Metformin|metformin|mesh-list
138791872|NCT00885352|Pioglitazone|pioglitazone|mesh-list
138791873|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138791874|NCT00885352|Glipizide|glipizide|mesh-list
138791875|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138791876|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791877|NCT00885352|Incretins|incretins|mesh-ancestor
138791878|NCT00885352|Hormones|hormones|mesh-ancestor
138791879|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138791880|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138791881|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
138791882|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791883|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791884|NCT00656032|Cinacalcet|cinacalcet|mesh-list
138791885|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138791886|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791887|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138791888|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
138791889|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138791890|NCT00885118|Empagliflozin|empagliflozin|mesh-list
138450937|NCT01872988|Tenofovir|tenofovir|mesh-list
138791891|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138791892|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791893|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138791894|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791895|NCT00656812|Rituximab|rituximab|mesh-list
138791896|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138791897|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791898|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
138791899|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791900|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138791901|NCT00656110|Ethanol|ethanol|mesh-list
138791902|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
138791903|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138791904|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138791905|NCT00656110|Prednisolone|prednisolone|mesh-list
138402936|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402937|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
138402939|NCT01557257|Oxycodone|oxycodone|mesh-list
138402940|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138402941|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138791906|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
138791907|NCT00656110|Lidocaine|lidocaine|mesh-list
138791908|NCT00656110|Bupivacaine|bupivacaine|mesh-list
138791909|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138791910|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
138791911|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
138791912|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
138791913|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138791914|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791915|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
138791916|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791917|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138791918|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138791919|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138791920|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138791921|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791922|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138791923|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
138791924|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
138791925|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138791926|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
138791927|NCT00656110|Hormones|hormones|mesh-ancestor
138791928|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138791929|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138402969|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
138402989|NCT01557374|Abatacept|abatacept|mesh-list
138791930|NCT00656110|Protective Agents|protective agents|mesh-ancestor
138791931|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138791932|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791933|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138791934|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791935|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138791936|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
138791937|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138791938|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138791939|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791940|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791941|NCT00656188|Urological Agents|urological agents|mesh-ancestor
138791942|NCT00880906|Fluticasone|fluticasone|mesh-list
138791943|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138791944|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138791945|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138791946|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
138791947|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791948|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791949|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138791950|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
138403020|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138791951|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
138791952|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138169381|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403041|NCT01557764|Lapatinib|lapatinib|mesh-list
138791953|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791954|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791955|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
138791956|NCT04160026|Piperaquine|piperaquine|mesh-list
138791957|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
138791958|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138791959|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
138791960|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138791961|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138791962|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791963|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138791964|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265657|NCT05985278|Catalase|catalase|mesh-list
138791965|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791966|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138791968|NCT04159870|Norfloxacin|norfloxacin|mesh-list
138791969|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138791970|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791971|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138791972|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138791973|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138791974|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791975|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791976|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791977|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138791978|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138791980|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138791981|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138403067|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403068|NCT01557907|Insulin|insulin|mesh-list
138791982|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791983|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
138791984|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138791985|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791986|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138791987|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
138791988|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138791989|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791990|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791991|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791992|NCT00882310|Gemcitabine|gemcitabine|mesh-list
138791993|NCT00882310|Capecitabine|capecitabine|mesh-list
138791994|NCT00882310|Docetaxel|docetaxel|mesh-list
138791995|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138791996|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
138791997|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791998|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791999|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
138792000|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
138792001|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
138792002|NCT00884650|Analgesics|analgesics|mesh-list
138792003|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
138792004|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450970|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138792005|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792006|NCT02636842|Aripiprazole|aripiprazole|mesh-list
138792007|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
138792008|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
138792009|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138403114|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138792010|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138403115|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138792011|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138792012|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138792013|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792014|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
138792015|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
138792016|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792017|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792018|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138792019|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138792020|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
138792021|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138792022|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138792023|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138792024|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138792026|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138792027|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138169528|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138792028|NCT00656422|Insulin|insulin|mesh-list
138792029|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138792030|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
138792031|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138792032|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792033|NCT02634034|Pitavastatin|pitavastatin|mesh-list
138792034|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138792035|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138792036|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138792037|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
138792038|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792039|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792040|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138792041|NCT00657748|Triacetin|triacetin|mesh-list
138792042|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
138792043|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
138792044|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138403157|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138403158|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138403162|NCT01558648|Analgesics|analgesics|mesh-list
138792045|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792046|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792047|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
138792048|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138792049|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138792050|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792051|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
138792052|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792053|NCT04161586|Prilocaine|prilocaine|mesh-list
138792054|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
138792055|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
138792056|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138792057|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792058|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
138792059|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792060|NCT02636218|Ketamine|ketamine|mesh-list
138792061|NCT02636218|Analgesics|analgesics|mesh-ancestor
138792062|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
138792063|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792064|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792065|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138792066|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138792067|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
138792068|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
138792069|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403200|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
138403201|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138403204|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138792070|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138792071|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138792072|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792073|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792074|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
138792075|NCT04161508|Neostigmine|neostigmine|mesh-list
138792076|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138792077|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792078|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792079|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
138792080|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792081|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792082|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138792083|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
138792084|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792085|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138792086|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138185845|NCT04363255|Cisplatin|cisplatin|mesh-list
138792087|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138792089|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138792090|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138792091|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
138792093|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138792094|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792095|NCT00883558|Insulin|insulin|mesh-list
138792096|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138792097|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
138792098|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
138792099|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138792100|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792101|NCT04162834|Papaverine|papaverine|mesh-list
138792102|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138792103|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792104|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792105|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
138792106|NCT04162834|Urological Agents|urological agents|mesh-ancestor
138792107|NCT00657904|Bicalutamide|bicalutamide|mesh-list
138403246|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138403247|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403249|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138792108|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
138792109|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
138792110|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792111|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792112|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792113|NCT02633878|Progesterone|progesterone|mesh-list
138792115|NCT02633878|Hormones|hormones|mesh-ancestor
138792116|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792117|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792118|NCT00597766|Triamcinolone|triamcinolone|mesh-list
138792119|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138792120|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138792121|NCT00597766|Lidocaine|lidocaine|mesh-list
138792122|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138792123|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
138792124|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
138792125|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138792126|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403282|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138403283|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138403285|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
138792127|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
138792128|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792129|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138792130|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138792131|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138792132|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138792133|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792134|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138792135|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
138792136|NCT00597766|Hormones|hormones|mesh-ancestor
138792137|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792138|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792139|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
138792140|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792141|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
138792142|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138451047|NCT05854537|Lidocaine|lidocaine|mesh-list
138792143|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792145|NCT00657982|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138792146|NCT00657982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138792147|NCT00657982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792148|NCT00657982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792149|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792150|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
138792151|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792152|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792153|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
138792154|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
138792155|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138403338|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
138403340|NCT01559753|Cefoxitin|cefoxitin|mesh-list
138403341|NCT01559753|Netilmicin|netilmicin|mesh-list
138403342|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792156|NCT00979992|Sunitinib|sunitinib|mesh-list
138792157|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792158|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138792159|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138792160|NCT00979992|Growth Substances|growth substances|mesh-ancestor
138792161|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792162|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
138792163|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138792164|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792165|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792166|NCT01079741|Poly I-C|poly i-c|mesh-list
138792167|NCT01079741|Mineral Oil|mineral oil|mesh-list
138792168|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138792169|NCT01079741|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138792170|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
138792171|NCT01079741|Poly ICLC|poly iclc|mesh-list
138792172|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138792173|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
138169606|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
138792174|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792175|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
138792176|NCT01079741|Laxatives|laxatives|mesh-ancestor
138169636|NCT04333459|Vaccines|vaccines|mesh-list
138792178|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
138792179|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138403385|NCT05569668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403386|NCT05569668|Tubulin Modulators|tubulin modulators|mesh-ancestor
138792180|NCT01079741|Emollients|emollients|mesh-ancestor
138792181|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
138792182|NCT02877641|Vitamin D|vitamin d|mesh-list
138792183|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
138792184|NCT02877641|Vitamins|vitamins|mesh-list
138403387|NCT05569668|Antimitotic Agents|antimitotic agents|mesh-ancestor
138792185|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
138185875|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138792186|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792187|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138792188|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138792189|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
138792190|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138792191|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792193|NCT02867046|Dexamethasone|dexamethasone|mesh-list
138792194|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138792195|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
138792196|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
138792197|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792198|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792199|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138792200|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
138792201|NCT02867046|Hormones|hormones|mesh-ancestor
138508067|NCT06196580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138792202|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792203|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138792204|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792205|NCT02865174|Heparin|heparin|mesh-list
138792206|NCT02865174|Enoxaparin|enoxaparin|mesh-list
138792207|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138792208|NCT02865174|Tinzaparin|tinzaparin|mesh-list
138792209|NCT02865174|Dalteparin|dalteparin|mesh-list
138792210|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
138792211|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
138792212|NCT02865174|Thrombin|thrombin|mesh-list
138792213|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
138792214|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138792215|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138792216|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792217|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138792218|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
138792219|NCT02865174|Coagulants|coagulants|mesh-ancestor
138792220|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
138792221|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138792222|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138792223|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792224|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138792225|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138792226|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138792227|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792228|NCT00879814|Vaccines|vaccines|mesh-list
138792229|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
138792230|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792231|NCT02633176|Docetaxel|docetaxel|mesh-list
138792232|NCT02633176|Capecitabine|capecitabine|mesh-list
138792233|NCT02633176|Cetuximab|cetuximab|mesh-list
138185919|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792234|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792235|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
138792236|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
138792237|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
138792238|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792239|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138792240|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
138792241|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138792242|NCT04156984|Golimumab|golimumab|mesh-list
138792243|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138792244|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138792245|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792246|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
138792247|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792248|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138792249|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
138792250|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792251|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138169682|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138792252|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
138403461|NCT05522582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138403462|NCT05522582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138792253|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792254|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792255|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138792256|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138792257|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138792258|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
138792259|NCT01132664|Capecitabine|capecitabine|mesh-list
138792260|NCT01132664|Trastuzumab|trastuzumab|mesh-list
138792261|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138792262|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
138792263|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792264|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792265|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138792266|NCT01078805|Teriparatide|teriparatide|mesh-list
138403508|NCT05219604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138403509|NCT05219604|Antipruritics|antipruritics|mesh-ancestor
138403511|NCT05137080|Dexamethasone|dexamethasone|mesh-list
138792267|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138792268|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792269|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138792271|NCT00820027|Etoricoxib|etoricoxib|mesh-list
138792272|NCT00820027|Morphine|morphine|mesh-list
138792273|NCT00820027|Oxycodone|oxycodone|mesh-list
138792274|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138792275|NCT00820027|Narcotics|narcotics|mesh-ancestor
138792276|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138792277|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792278|NCT00820027|Analgesics|analgesics|mesh-ancestor
138792279|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
138792280|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792281|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138403568|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792282|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138403571|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
138792283|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138792284|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138792285|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138792286|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792287|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792288|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138792289|NCT02876549|Chloroquine|chloroquine|mesh-list
138792291|NCT02876549|Amebicides|amebicides|mesh-ancestor
138792292|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138792293|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138792294|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792295|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
138792296|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138792297|NCT00913549|Clemastine|clemastine|mesh-list
138792298|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
138792299|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
138792300|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138792301|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
138792302|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
138792303|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792304|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792305|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792306|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138792308|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138792309|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792310|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138403628|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
138792311|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792312|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792313|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138792314|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138792316|NCT01076075|Pioglitazone|pioglitazone|mesh-list
138792317|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138792318|NCT01076075|Glimepiride|glimepiride|mesh-list
138792319|NCT01076075|Gliclazide|gliclazide|mesh-list
138792320|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138792321|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792322|NCT01076075|Incretins|incretins|mesh-ancestor
138792323|NCT01076075|Hormones|hormones|mesh-ancestor
138792324|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792325|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138792326|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
138792327|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792328|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792329|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138792330|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792331|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
138403676|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138403677|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138792332|NCT01075763|Interferons|interferons|mesh-list
138403678|NCT02909686|Analgesics|analgesics|mesh-ancestor
138403694|NCT02713373|Cetuximab|cetuximab|mesh-list
138792333|NCT01075763|Interferon-beta|interferon-beta|mesh-list
138792334|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
138792335|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792336|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
138792337|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792338|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
138792339|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792340|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138792341|NCT00881530|Metformin|metformin|mesh-list
138792342|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138792343|NCT00881530|Empagliflozin|empagliflozin|mesh-list
138792344|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138792345|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792347|NCT00881530|Hormones|hormones|mesh-ancestor
138185968|NCT05555251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792348|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138403728|NCT02546492|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138792349|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138792350|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
138792351|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792352|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403729|NCT02546492|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138403730|NCT02546492|beta-Endorphin|beta-endorphin|mesh-list
138792353|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138792354|NCT02632474|Tenofovir|tenofovir|mesh-list
138792355|NCT02632474|Lamivudine|lamivudine|mesh-list
138792356|NCT02632474|Efavirenz|efavirenz|mesh-list
138792357|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
138792358|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792359|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138792360|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138792361|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792362|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792363|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138792364|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138792365|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138792366|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138792367|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138792368|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138792369|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138792370|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138792371|NCT04156750|Metformin|metformin|mesh-list
138792372|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138792373|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792374|NCT02877173|Alprostadil|alprostadil|mesh-list
138792375|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138792376|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
138792377|NCT02877173|Urological Agents|urological agents|mesh-ancestor
138792378|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138792379|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138792380|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138792381|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792382|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792383|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138792384|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138792385|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792386|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
138792387|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792388|NCT00661180|Sorafenib|sorafenib|mesh-list
138792389|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792390|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138792391|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792392|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792393|NCT01078571|Adalimumab|adalimumab|mesh-list
138792394|NCT01078571|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138792395|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138792396|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138792398|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
138792399|NCT04160416|Irinotecan|irinotecan|mesh-list
138792400|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138792401|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
138403824|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138403825|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
138792402|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792403|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792404|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138792405|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138792406|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792407|NCT00661336|Melphalan|melphalan|mesh-list
138792408|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
138451169|NCT05755737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138792409|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138792410|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
138792411|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792412|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792413|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138792414|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792415|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
138792416|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792417|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
138792418|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138792419|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792420|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138792421|NCT00661336|Protective Agents|protective agents|mesh-ancestor
138792422|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
138792423|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138792424|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792425|NCT04158700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138792426|NCT04158700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792427|NCT00657202|Ranibizumab|ranibizumab|mesh-list
138792428|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138792429|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138792430|NCT00657202|Growth Substances|growth substances|mesh-ancestor
138792431|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792432|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
138792433|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792434|NCT00626483|Basiliximab|basiliximab|mesh-list
138792435|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792436|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
138792437|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792438|NCT00626717|Riboflavin|riboflavin|mesh-list
138792439|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
138792440|NCT00626717|Vitamins|vitamins|mesh-ancestor
138792441|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
138792442|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792443|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138792444|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
138792445|NCT04156204|Tacrolimus|tacrolimus|mesh-list
138792446|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792447|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
138792448|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792449|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138792450|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792451|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792452|NCT02631694|Propranolol|propranolol|mesh-list
138792453|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138792454|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138792455|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
138792456|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138403918|NCT01568684|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138403920|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138185998|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186001|NCT03002506|Tazobactam|tazobactam|mesh-list
138792457|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792458|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792459|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138792460|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138792461|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
138792462|NCT04305587|Clopidogrel|clopidogrel|mesh-list
138792463|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138451179|NCT05732506|Edoxaban|edoxaban|mesh-list
138792464|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138792465|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138792467|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
138792468|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792469|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792470|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792471|NCT00658840|Capecitabine|capecitabine|mesh-list
138792472|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138792473|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
138792474|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792475|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792476|NCT00658918|Ciclesonide|ciclesonide|mesh-list
138792477|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
138792478|NCT00658918|Hormones|hormones|mesh-ancestor
138265945|NCT05746481|Pemetrexed|pemetrexed|mesh-list
138792479|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792480|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792481|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138403974|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138792482|NCT02876081|Afatinib|afatinib|mesh-list
138403975|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138403982|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
138792483|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792484|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138792485|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792486|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792487|NCT02631616|Somatostatin|somatostatin|mesh-list
138792488|NCT02631616|Hormones|hormones|mesh-ancestor
138792489|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792490|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792491|NCT00661648|Pancrelipase|pancrelipase|mesh-list
138792492|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138792493|NCT00659074|Ondansetron|ondansetron|mesh-list
138792494|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
138792495|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
138792496|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792497|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792498|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138792499|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
138792500|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
138792501|NCT00659074|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138792502|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138792503|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
138792504|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792505|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792506|NCT01077713|Bevacizumab|bevacizumab|mesh-list
138792507|NCT01077713|Gemcitabine|gemcitabine|mesh-list
138792508|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138792509|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792510|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138792511|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138792512|NCT01077713|Growth Substances|growth substances|mesh-ancestor
138792513|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792514|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
138792515|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138404018|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138792516|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
138695375|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
138792517|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792518|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
138792519|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138792520|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
138404019|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138404020|NCT01570608|Growth Substances|growth substances|mesh-ancestor
138404021|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792521|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792522|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792523|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
138451200|NCT05651633|Lidocaine|lidocaine|mesh-list
138792524|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792525|NCT01077323|Exenatide|exenatide|mesh-list
138792526|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138792527|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792528|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138792529|NCT01077323|Incretins|incretins|mesh-ancestor
138792530|NCT01077323|Hormones|hormones|mesh-ancestor
138792531|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792532|NCT03870438|Lamivudine|lamivudine|mesh-list
138792533|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138792534|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138792535|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792536|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404050|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138404051|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138792537|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
138792538|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792539|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138792540|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138792541|NCT04287894|Pemetrexed|pemetrexed|mesh-list
138792542|NCT04287894|Durvalumab|durvalumab|mesh-list
138792543|NCT04287894|Tremelimumab|tremelimumab|mesh-list
138792544|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792545|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792546|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792547|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138792548|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138792549|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138792550|NCT04287426|Remifentanil|remifentanil|mesh-list
138169984|NCT04763876|Analgesics|analgesics|mesh-ancestor
138792551|NCT04287426|Rocuronium|rocuronium|mesh-list
138404107|NCT01571167|Varenicline|varenicline|mesh-list
138404108|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138404109|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138404110|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
138792552|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138792553|NCT04287426|Narcotics|narcotics|mesh-ancestor
138266003|NCT05634707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792554|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138792555|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792557|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
138792558|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792559|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138792560|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138792561|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138792562|NCT04047576|Sirolimus|sirolimus|mesh-list
138792563|NCT04047576|Prednisone|prednisone|mesh-list
138792564|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138792565|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
138792566|NCT04047576|Hormones|hormones|mesh-ancestor
138792567|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792568|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792569|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138792570|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792571|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138404168|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404170|NCT01571583|Interferons|interferons|mesh-list
138792572|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792573|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138792574|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
138792575|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792576|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
138792577|NCT00976950|Ritonavir|ritonavir|mesh-list
138792578|NCT00976950|Tipranavir|tipranavir|mesh-list
138792579|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138792580|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138792581|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
138792582|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792583|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792584|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138792585|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138792586|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
138792587|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792588|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138792589|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138792590|NCT00629382|Polymyxins|polymyxins|mesh-list
138792591|NCT00629382|Polymyxin B|polymyxin b|mesh-list
138792592|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138792593|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792594|NCT06200220|Venetoclax|venetoclax|mesh-list
138792595|NCT06200220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792596|NCT06200181|Olanzapine|olanzapine|mesh-list
138404225|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138792597|NCT06200181|Antiemetics|antiemetics|mesh-ancestor
138792598|NCT06200181|Autonomic Agents|autonomic agents|mesh-ancestor
138792599|NCT06200181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792600|NCT06200181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792601|NCT06200181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138792602|NCT06200181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138792603|NCT06200181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138792604|NCT06200181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138792605|NCT06200181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138792606|NCT06200181|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138792607|NCT06200181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138792608|NCT06200181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138404276|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792609|NCT06200181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792610|NCT06200181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792611|NCT06200181|Serotonin Agents|serotonin agents|mesh-ancestor
138792612|NCT06200168|Antiemetics|antiemetics|mesh-list
138792613|NCT06200168|Autonomic Agents|autonomic agents|mesh-ancestor
138792614|NCT06200168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792615|NCT06200168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792616|NCT06200168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138792617|NCT06200103|Edetic Acid|edetic acid|mesh-list
138792618|NCT06200103|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138792619|NCT06200103|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138792620|NCT06200103|177Lu-PSMA-617|177lu-psma-617|mesh-list
138792621|NCT06200103|Chelating Agents|chelating agents|mesh-ancestor
138792622|NCT06200103|Sequestering Agents|sequestering agents|mesh-ancestor
138792623|NCT06200103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792624|NCT06200103|Anticoagulants|anticoagulants|mesh-ancestor
138792625|NCT06200103|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138792626|NCT06200103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138792627|NCT06199999|Anesthetics|anesthetics|mesh-list
138404339|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138404340|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
138404341|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
138404346|NCT01572285|Hormones|hormones|mesh-ancestor
138792628|NCT06199999|Anesthetics, Local|anesthetics, local|mesh-list
138792629|NCT06199999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138792630|NCT06199999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792631|NCT06199999|Sensory System Agents|sensory system agents|mesh-ancestor
138792632|NCT06199999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792633|NCT06199921|Atorvastatin|atorvastatin|mesh-list
138792634|NCT06199921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138792635|NCT06199921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138792636|NCT06199921|Antimetabolites|antimetabolites|mesh-ancestor
138792637|NCT06199921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792638|NCT06199921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138792639|NCT06199921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138792640|NCT06199921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186054|NCT03033589|Bupivacaine|bupivacaine|mesh-list
138792642|NCT06199895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138792657|NCT06199843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138792658|NCT06199843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792659|NCT06199843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792660|NCT06199843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792661|NCT06199843|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138792662|NCT06199843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138792663|NCT06199791|Lamotrigine|lamotrigine|mesh-list
138792664|NCT06199791|Anticonvulsants|anticonvulsants|mesh-ancestor
138792665|NCT06199791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138404394|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404395|NCT01572363|Urological Agents|urological agents|mesh-ancestor
138404396|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
138792666|NCT06199791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138792667|NCT06199791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792668|NCT06199791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138792669|NCT06199791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792670|NCT06199791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138792671|NCT06199791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138792672|NCT06199791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138792673|NCT06199791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138792674|NCT06199791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138792708|NCT06199557|Antimetabolites|antimetabolites|mesh-ancestor
138792709|NCT06199557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792710|NCT06199557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138792711|NCT06199557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792712|NCT06199557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792713|NCT06199557|Immunologic Factors|immunologic factors|mesh-ancestor
138792714|NCT06199557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792715|NCT06199557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138792716|NCT06199557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792717|NCT06199557|Antisickling Agents|antisickling agents|mesh-ancestor
138404442|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138792718|NCT06199557|Anticonvulsants|anticonvulsants|mesh-ancestor
138792719|NCT06199557|GABA Agents|gaba agents|mesh-ancestor
138792720|NCT06199557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792721|NCT06199557|Antimanic Agents|antimanic agents|mesh-ancestor
138792722|NCT06199557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138792723|NCT06199557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138792724|NCT06199557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138792725|NCT06199544|Metformin|metformin|mesh-list
138792726|NCT06199544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138792727|NCT06199544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792728|NCT06199505|Insulin|insulin|mesh-list
138792729|NCT06199505|Insulin Aspart|insulin aspart|mesh-list
138792730|NCT06199505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138792731|NCT06199505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792732|NCT06199453|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138792733|NCT06199453|Chelating Agents|chelating agents|mesh-ancestor
138792734|NCT06199453|Sequestering Agents|sequestering agents|mesh-ancestor
138792735|NCT06199453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792736|NCT06199427|Cyclophosphamide|cyclophosphamide|mesh-list
138792737|NCT06199427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792738|NCT06199427|Immunologic Factors|immunologic factors|mesh-ancestor
138792739|NCT06199427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792740|NCT06199427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138792741|NCT06199427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138792742|NCT06199427|Alkylating Agents|alkylating agents|mesh-ancestor
138792743|NCT06199427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792744|NCT06199427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792745|NCT06199427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138792746|NCT06199154|Misoprostol|misoprostol|mesh-list
138792747|NCT06199154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138792748|NCT06199154|Abortifacient Agents|abortifacient agents|mesh-ancestor
138792749|NCT06199154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138792750|NCT06199154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792751|NCT06199154|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138792752|NCT06199154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138792753|NCT06199154|Oxytocics|oxytocics|mesh-ancestor
138792754|NCT06199102|Cholecalciferol|cholecalciferol|mesh-list
138792755|NCT06199102|Vitamin D|vitamin d|mesh-list
138792756|NCT06199102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138404496|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138792757|NCT06199102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792760|NCT06199102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138792761|NCT06199076|Oxytocin|oxytocin|mesh-list
138792762|NCT06199076|Oxytocics|oxytocics|mesh-ancestor
138792763|NCT06199076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138792764|NCT06199076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792765|NCT06199011|Esketamine|esketamine|mesh-list
138792766|NCT06199011|Antidepressive Agents|antidepressive agents|mesh-ancestor
138792767|NCT06199011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138792768|NCT06198842|Treosulfan|treosulfan|mesh-list
138266164|NCT05450965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792769|NCT06198842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138792770|NCT06198842|Alkylating Agents|alkylating agents|mesh-ancestor
138792771|NCT06198842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792772|NCT06198842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792773|NCT06198764|Meropenem|meropenem|mesh-list
138792774|NCT06198764|Colistin|colistin|mesh-list
138404533|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138404534|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138404539|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138792775|NCT06198764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138792776|NCT06198764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792777|NCT06198673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138792778|NCT06198465|Paclitaxel|paclitaxel|mesh-list
138792779|NCT06198465|Fluorouracil|fluorouracil|mesh-list
138792780|NCT06198465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138792781|NCT06198465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792782|NCT06198465|Tubulin Modulators|tubulin modulators|mesh-ancestor
138792783|NCT06198465|Antimitotic Agents|antimitotic agents|mesh-ancestor
138792784|NCT06198465|Mitosis Modulators|mitosis modulators|mesh-ancestor
138792785|NCT06198465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792786|NCT06198465|Antimetabolites|antimetabolites|mesh-ancestor
138792787|NCT06198465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138792788|NCT06198465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792789|NCT06198465|Immunologic Factors|immunologic factors|mesh-ancestor
138792790|NCT06198465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792791|NCT06198387|Hormones|hormones|mesh-list
138792792|NCT06198387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792793|NCT06198387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792794|NCT06196814|Antibodies|antibodies|mesh-list
138792795|NCT06196814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138792796|NCT06196814|Immunologic Factors|immunologic factors|mesh-ancestor
138792797|NCT06196814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792798|NCT06195891|Fludarabine|fludarabine|mesh-list
138792799|NCT06195891|Melphalan|melphalan|mesh-list
138792800|NCT06195891|Mechlorethamine|mechlorethamine|mesh-list
138792801|NCT06195891|Thiotepa|thiotepa|mesh-list
138792802|NCT06195891|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138792803|NCT06195891|Tacrolimus|tacrolimus|mesh-list
138792804|NCT06195891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792805|NCT06195891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404590|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138404593|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138792806|NCT06195891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792807|NCT06195891|Immunologic Factors|immunologic factors|mesh-ancestor
138792808|NCT06195891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792809|NCT06195891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138792810|NCT06195891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792811|NCT06195891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138792812|NCT06195891|Alkylating Agents|alkylating agents|mesh-ancestor
138792813|NCT06195891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138792814|NCT06180616|Tirzepatide|tirzepatide|mesh-list
138792815|NCT06180616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138792816|NCT06180616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792817|NCT06180616|Incretins|incretins|mesh-ancestor
138792818|NCT06180616|Hormones|hormones|mesh-ancestor
138792819|NCT06180616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792821|NCT06174961|Calcium heparin|calcium heparin|mesh-list
138792822|NCT06174961|Anticoagulants|anticoagulants|mesh-ancestor
138792823|NCT06174961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138792824|NCT06174961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138508068|NCT06196580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138792825|NCT06174961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792826|NCT06165614|Artesunate|artesunate|mesh-list
138792827|NCT06165614|Antimalarials|antimalarials|mesh-ancestor
138792828|NCT06165614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138792829|NCT06165614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138792830|NCT06165614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792831|NCT06165614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792832|NCT06165614|Antiviral Agents|antiviral agents|mesh-ancestor
138792833|NCT06165614|Schistosomicides|schistosomicides|mesh-ancestor
138792834|NCT06165614|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138792835|NCT06165614|Anthelmintics|anthelmintics|mesh-ancestor
138792836|NCT06153251|Cyclophosphamide|cyclophosphamide|mesh-list
138792837|NCT06153251|Fludarabine|fludarabine|mesh-list
138792838|NCT06153251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792839|NCT06153251|Immunologic Factors|immunologic factors|mesh-ancestor
138792840|NCT06153251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792841|NCT06153251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138792842|NCT06153251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138404633|NCT01574027|Vitamin D|vitamin d|mesh-list
138404634|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
138404635|NCT01574027|Vitamins|vitamins|mesh-ancestor
138792843|NCT06153251|Alkylating Agents|alkylating agents|mesh-ancestor
138792844|NCT06153251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792845|NCT06153251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792846|NCT06153251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138792847|NCT06119529|Prednisone|prednisone|mesh-list
138792848|NCT06119529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138792849|NCT06119529|Glucocorticoids|glucocorticoids|mesh-ancestor
138792850|NCT06119529|Hormones|hormones|mesh-ancestor
138792851|NCT06119529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792852|NCT06119529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792853|NCT06119529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138792854|NCT06119529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792855|NCT06109558|Osimertinib|osimertinib|mesh-list
138792856|NCT06109558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792857|NCT06109558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138792858|NCT06109558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792859|NCT06109558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792860|NCT06104683|Pirtobrutinib|pirtobrutinib|mesh-list
138792861|NCT06104683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138792862|NCT06104683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792863|NCT06104683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792864|NCT06100874|Trastuzumab|trastuzumab|mesh-list
138792865|NCT06100874|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138792866|NCT06100874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138792867|NCT06100874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792868|NCT06100874|Immunoconjugates|immunoconjugates|mesh-ancestor
138792869|NCT06100874|Immunologic Factors|immunologic factors|mesh-ancestor
138792870|NCT06100874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792871|NCT06098079|Naltrexone|naltrexone|mesh-list
138792872|NCT06098079|Bupropion|bupropion|mesh-list
138404674|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
138792873|NCT06098079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138792874|NCT06098079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138792875|NCT06098079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792876|NCT06098079|Sensory System Agents|sensory system agents|mesh-ancestor
138792877|NCT06098079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792878|NCT06098079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138792879|NCT06098079|Antidepressive Agents|antidepressive agents|mesh-ancestor
138792880|NCT06098079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138792881|NCT06098079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138792882|NCT06098079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138792883|NCT06098079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138792884|NCT06098079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792885|NCT06098079|Dopamine Agents|dopamine agents|mesh-ancestor
138792886|NCT06098079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792887|NCT06098079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138792888|NCT06098079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138792889|NCT06098079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792890|NCT06083675|Metformin|metformin|mesh-list
138792891|NCT06083675|Empagliflozin|empagliflozin|mesh-list
138792892|NCT06083675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138186103|NCT03033199|Dexamethasone|dexamethasone|mesh-list
138792893|NCT06083675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792894|NCT06083675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138792895|NCT06083675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792896|NCT06079164|Cyclophosphamide|cyclophosphamide|mesh-list
138792897|NCT06079164|Fludarabine|fludarabine|mesh-list
138792898|NCT06079164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792899|NCT06079164|Immunologic Factors|immunologic factors|mesh-ancestor
138792900|NCT06079164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792901|NCT06079164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138792902|NCT06079164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138792903|NCT06079164|Alkylating Agents|alkylating agents|mesh-ancestor
138792904|NCT06079164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792905|NCT06079164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792906|NCT06079164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138792908|NCT06075771|Carbidopa|carbidopa|mesh-list
138792909|NCT06075771|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138792910|NCT06075771|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138792911|NCT06075771|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138792912|NCT06075771|Dopamine Agents|dopamine agents|mesh-ancestor
138792913|NCT06075771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792914|NCT06075771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792915|NCT06075771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792916|NCT06075771|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138792917|NCT06075771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404780|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138404781|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
138792918|NCT06075771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138404782|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792919|NCT06075771|Immunologic Factors|immunologic factors|mesh-ancestor
138792920|NCT06075771|Dopamine Agonists|dopamine agonists|mesh-ancestor
138792921|NCT06054776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138792922|NCT06054776|Obinutuzumab|obinutuzumab|mesh-list
138792924|NCT06054776|Antibodies|antibodies|mesh-list
138792925|NCT06054776|Immunoglobulins|immunoglobulins|mesh-list
138792926|NCT06054776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138170437|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
138792927|NCT06054776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138792928|NCT06054776|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138792929|NCT06054776|Immunologic Factors|immunologic factors|mesh-ancestor
138792930|NCT06054776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792931|NCT06054776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792932|NCT06054776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138451312|NCT05357547|Buspirone|buspirone|mesh-list
138792933|NCT06054776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138792934|NCT06054776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792935|NCT06043323|Acetaminophen|acetaminophen|mesh-list
138792936|NCT06043323|Diphenhydramine|diphenhydramine|mesh-list
138792937|NCT06043323|Promethazine|promethazine|mesh-list
138792938|NCT06043323|Prednisone|prednisone|mesh-list
138792939|NCT06043323|Cyclophosphamide|cyclophosphamide|mesh-list
138792940|NCT06043323|Fludarabine|fludarabine|mesh-list
138792941|NCT06043323|Fludarabine phosphate|fludarabine phosphate|mesh-list
138792942|NCT06043323|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138792943|NCT06043323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138792944|NCT06043323|Immunologic Factors|immunologic factors|mesh-ancestor
138792945|NCT06043323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792946|NCT06043323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138792947|NCT06043323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138792948|NCT06043323|Alkylating Agents|alkylating agents|mesh-ancestor
138792949|NCT06043323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792950|NCT06043323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138792951|NCT06043323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138792952|NCT06043323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138792953|NCT06043323|Glucocorticoids|glucocorticoids|mesh-ancestor
138792954|NCT06043323|Hormones|hormones|mesh-ancestor
138404822|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404823|NCT01576094|Simendan|simendan|mesh-list
138792955|NCT06043323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138792956|NCT06043323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138792957|NCT06043323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138792958|NCT06043323|Antimetabolites|antimetabolites|mesh-ancestor
138792959|NCT06043323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138792960|NCT06043323|Analgesics|analgesics|mesh-ancestor
138792961|NCT06043323|Sensory System Agents|sensory system agents|mesh-ancestor
138792962|NCT06043323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792964|NCT06043323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138792965|NCT06043323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138792966|NCT06043323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138792967|NCT06043323|Anesthetics, Local|anesthetics, local|mesh-ancestor
138451333|NCT05302999|Gabapentin|gabapentin|mesh-list
138792968|NCT06043323|Anesthetics|anesthetics|mesh-ancestor
138792969|NCT06043323|Antiemetics|antiemetics|mesh-ancestor
138792970|NCT06043323|Autonomic Agents|autonomic agents|mesh-ancestor
138792971|NCT06043323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138792972|NCT06043323|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138792973|NCT06043323|Histamine Antagonists|histamine antagonists|mesh-ancestor
138792974|NCT06043323|Histamine Agents|histamine agents|mesh-ancestor
138792975|NCT06043323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792976|NCT06043323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138792977|NCT06043323|Antipruritics|antipruritics|mesh-ancestor
138792978|NCT06043323|Dermatologic Agents|dermatologic agents|mesh-ancestor
138792979|NCT06043323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138792980|NCT06040840|Lidocaine|lidocaine|mesh-list
138792981|NCT06040840|Epinephrine|epinephrine|mesh-list
138404859|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138792982|NCT06040840|Anesthetics, Local|anesthetics, local|mesh-ancestor
138792983|NCT06040840|Anesthetics|anesthetics|mesh-ancestor
138792984|NCT06040840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138404860|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138404867|NCT01576627|Zinc|zinc|mesh-list
138792985|NCT06040840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138792986|NCT06040840|Sensory System Agents|sensory system agents|mesh-ancestor
138792987|NCT06040840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138792988|NCT06040840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138792989|NCT06040840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138792990|NCT06040840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138266321|NCT05273567|Guanfacine|guanfacine|mesh-list
138792991|NCT06040840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138792992|NCT06040840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138792993|NCT06040840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138792994|NCT06040840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138792995|NCT06040840|Adrenergic Agents|adrenergic agents|mesh-ancestor
138792996|NCT06040840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138792997|NCT06040840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138792998|NCT06040840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138404904|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138792999|NCT06040840|Autonomic Agents|autonomic agents|mesh-ancestor
138793000|NCT06040840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138793001|NCT06040840|Respiratory System Agents|respiratory system agents|mesh-ancestor
138793002|NCT06040840|Mydriatics|mydriatics|mesh-ancestor
138793003|NCT06040840|Sympathomimetics|sympathomimetics|mesh-ancestor
138793004|NCT06040840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138404906|NCT01576731|Emtricitabine|emtricitabine|mesh-list
138404907|NCT01576731|Lopinavir|lopinavir|mesh-list
138793005|NCT06015022|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138793006|NCT06015022|Antioxidants|antioxidants|mesh-ancestor
138793007|NCT06015022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793008|NCT06015022|Protective Agents|protective agents|mesh-ancestor
138793009|NCT06015022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793010|NCT06015022|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138793011|NCT06015022|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138793012|NCT06015022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793013|NCT06015022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138793014|NCT06013423|Cyclosporine|cyclosporine|mesh-list
138793015|NCT06013423|Mycophenolic Acid|mycophenolic acid|mesh-list
138793016|NCT06013423|Cyclophosphamide|cyclophosphamide|mesh-list
138793017|NCT06013423|Thiotepa|thiotepa|mesh-list
138793018|NCT06013423|Fludarabine|fludarabine|mesh-list
138793019|NCT06013423|Fludarabine phosphate|fludarabine phosphate|mesh-list
138793020|NCT06013423|Cyclosporins|cyclosporins|mesh-list
138793021|NCT06013423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138404958|NCT01577121|Indomethacin|indomethacin|mesh-list
138793022|NCT06013423|Immunologic Factors|immunologic factors|mesh-ancestor
138793023|NCT06013423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793024|NCT06013423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138793025|NCT06013423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138793026|NCT06013423|Alkylating Agents|alkylating agents|mesh-ancestor
138793027|NCT06013423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451366|NCT05225363|Cyclophosphamide|cyclophosphamide|mesh-list
138793028|NCT06013423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793029|NCT06013423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138793030|NCT06013423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793031|NCT06013423|Antimetabolites|antimetabolites|mesh-ancestor
138793032|NCT06013423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793033|NCT06013423|Antifungal Agents|antifungal agents|mesh-ancestor
138793034|NCT06013423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138793035|NCT06013423|Dermatologic Agents|dermatologic agents|mesh-ancestor
138793036|NCT06013423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138793037|NCT06013423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138793038|NCT06013423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138793039|NCT06013423|Antitubercular Agents|antitubercular agents|mesh-ancestor
138793040|NCT06013423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138793041|NCT06011772|Leucovorin|leucovorin|mesh-list
138793042|NCT06011772|Bevacizumab|bevacizumab|mesh-list
138793043|NCT06011772|Cetuximab|cetuximab|mesh-list
138405015|NCT01577524|Povidone|povidone|mesh-list
138793044|NCT06011772|Fluorouracil|fluorouracil|mesh-list
138793046|NCT06011772|Irinotecan|irinotecan|mesh-list
138793047|NCT06011772|Vaccines|vaccines|mesh-list
138793048|NCT06011772|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138793049|NCT06011772|Immunologic Factors|immunologic factors|mesh-ancestor
138793050|NCT06011772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793051|NCT06011772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793052|NCT06011772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793053|NCT06011772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138793054|NCT06011772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138793055|NCT06011772|Growth Substances|growth substances|mesh-ancestor
138793056|NCT06011772|Growth Inhibitors|growth inhibitors|mesh-ancestor
138793057|NCT06011772|Antimetabolites|antimetabolites|mesh-ancestor
138793058|NCT06011772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793059|NCT06011772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793060|NCT06011772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138186152|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138793061|NCT06011772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138793062|NCT06011772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138793063|NCT06011772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793064|NCT06011772|Antidotes|antidotes|mesh-ancestor
138793065|NCT06011772|Protective Agents|protective agents|mesh-ancestor
138793066|NCT06011772|Vitamin B Complex|vitamin b complex|mesh-ancestor
138793068|NCT06011772|Micronutrients|micronutrients|mesh-ancestor
138793069|NCT06011772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138793070|NCT05973487|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
138793071|NCT05973487|Antioxidants|antioxidants|mesh-ancestor
138793072|NCT05973487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793073|NCT05973487|Protective Agents|protective agents|mesh-ancestor
138793074|NCT05973487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405067|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405068|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138405069|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
138793075|NCT05973487|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138170512|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
138793076|NCT05973487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793077|NCT05955157|Tegafur|tegafur|mesh-list
138793078|NCT05955157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793079|NCT05955157|Antimetabolites|antimetabolites|mesh-ancestor
138793080|NCT05955157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793081|NCT05955157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793082|NCT05954871|Cetuximab|cetuximab|mesh-list
138793083|NCT05954871|Osimertinib|osimertinib|mesh-list
138793084|NCT05954871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793085|NCT05954871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793086|NCT05954871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138793087|NCT05954871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793088|NCT05954871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793089|NCT05945875|Panitumumab|panitumumab|mesh-list
138793090|NCT05945875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793091|NCT05945875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793092|NCT05944237|Atezolizumab|atezolizumab|mesh-list
138405109|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793093|NCT05944237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138793094|NCT05944237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405110|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138793095|NCT05944237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793096|NCT05944237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793097|NCT05940324|Naltrexone|naltrexone|mesh-list
138793098|NCT05940324|Ketamine|ketamine|mesh-list
138793099|NCT05940324|Analgesics|analgesics|mesh-ancestor
138793100|NCT05940324|Sensory System Agents|sensory system agents|mesh-ancestor
138793101|NCT05940324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793102|NCT05940324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793103|NCT05940324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138793104|NCT05940324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138793105|NCT05940324|Anesthetics, General|anesthetics, general|mesh-ancestor
138793106|NCT05940324|Anesthetics|anesthetics|mesh-ancestor
138793107|NCT05940324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138793108|NCT05940324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138793109|NCT05940324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138793110|NCT05940324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138793111|NCT05940324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793112|NCT05940324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138793113|NCT05940324|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138793114|NCT05931276|Metoprolol|metoprolol|mesh-list
138793115|NCT05931276|Carvedilol|carvedilol|mesh-list
138793116|NCT05931276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138793117|NCT05931276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138793118|NCT05931276|Sympatholytics|sympatholytics|mesh-ancestor
138793119|NCT05931276|Autonomic Agents|autonomic agents|mesh-ancestor
138793120|NCT05931276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793121|NCT05931276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405159|NCT01578265|Ondansetron|ondansetron|mesh-list
138405160|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
138405161|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
138405162|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793122|NCT05931276|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138793123|NCT05931276|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138793124|NCT05931276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138793125|NCT05931276|Adrenergic Agents|adrenergic agents|mesh-ancestor
138793126|NCT05931276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138793127|NCT05931276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793128|NCT05931276|Antioxidants|antioxidants|mesh-ancestor
138793129|NCT05931276|Protective Agents|protective agents|mesh-ancestor
138793130|NCT05931276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138793131|NCT05931276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138793132|NCT05931276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138793133|NCT05931276|Vasodilator Agents|vasodilator agents|mesh-ancestor
138793134|NCT05931276|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138793135|NCT05931276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138793136|NCT05874414|Trametinib|trametinib|mesh-list
138793137|NCT05874414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793138|NCT05874414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138793139|NCT05874414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793140|NCT05874414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793141|NCT05867849|Cannabidiol|cannabidiol|mesh-list
138793142|NCT05867849|Anticonvulsants|anticonvulsants|mesh-ancestor
138793143|NCT05864677|Cerebrolysin|cerebrolysin|mesh-list
138793144|NCT05864677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138793145|NCT05864677|Protective Agents|protective agents|mesh-ancestor
138405205|NCT01578343|Analgesics|analgesics|mesh-ancestor
138405206|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
138405207|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138793146|NCT05864677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793147|NCT05864677|Nootropic Agents|nootropic agents|mesh-ancestor
138793148|NCT05856227|Ceftobiprole|ceftobiprole|mesh-list
138793149|NCT05856227|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
138793150|NCT05856227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138793151|NCT05856227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138793152|NCT05834478|Fallypride|fallypride|mesh-list
138170596|NCT01799161|Theophylline|theophylline|mesh-list
138793153|NCT05834478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138793154|NCT05834478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138793156|NCT05834478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138793157|NCT05834478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793158|NCT05834478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793159|NCT05832229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138793160|NCT05832229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138793161|NCT05832229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138793162|NCT05832229|Antimetabolites|antimetabolites|mesh-ancestor
138793163|NCT05832229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793164|NCT05832229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138793165|NCT05832229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138793166|NCT05832229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793167|NCT05832190|Biotin|biotin|mesh-list
138793168|NCT05832190|Vitamin B Complex|vitamin b complex|mesh-ancestor
138793169|NCT05832190|Vitamins|vitamins|mesh-ancestor
138793170|NCT05832190|Micronutrients|micronutrients|mesh-ancestor
138793171|NCT05832190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793172|NCT05818553|Pramoxine|pramoxine|mesh-list
138793173|NCT05818553|Anesthetics, Local|anesthetics, local|mesh-ancestor
138793174|NCT05818553|Anesthetics|anesthetics|mesh-ancestor
138793175|NCT05818553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138793176|NCT05818553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793177|NCT05818553|Sensory System Agents|sensory system agents|mesh-ancestor
138793178|NCT05818553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793179|NCT05804032|Dexamethasone|dexamethasone|mesh-list
138793180|NCT05804032|Lenalidomide|lenalidomide|mesh-list
138793181|NCT05804032|Bortezomib|bortezomib|mesh-list
138793182|NCT05804032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138405254|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
138405255|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
138405259|NCT01578564|SOR-C13|sor-c13|mesh-list
138793183|NCT05804032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138793184|NCT05804032|Antiemetics|antiemetics|mesh-ancestor
138793185|NCT05804032|Autonomic Agents|autonomic agents|mesh-ancestor
138793186|NCT05804032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793187|NCT05804032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793188|NCT05804032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138793189|NCT05804032|Glucocorticoids|glucocorticoids|mesh-ancestor
138793190|NCT05804032|Hormones|hormones|mesh-ancestor
138793191|NCT05804032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138793192|NCT05804032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138793193|NCT05804032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793194|NCT05804032|Immunologic Factors|immunologic factors|mesh-ancestor
138793195|NCT05804032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138793196|NCT05804032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138793197|NCT05804032|Growth Substances|growth substances|mesh-ancestor
138793198|NCT05804032|Growth Inhibitors|growth inhibitors|mesh-ancestor
138186213|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186214|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
138793200|NCT05774951|Letrozole|letrozole|mesh-list
138793201|NCT05774951|Anastrozole|anastrozole|mesh-list
138793202|NCT05774951|Exemestane|exemestane|mesh-list
138793203|NCT05774951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793204|NCT05774951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138793205|NCT05774951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138793206|NCT05774951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793207|NCT05774951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793208|NCT05774951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138793209|NCT05774951|Hormone Antagonists|hormone antagonists|mesh-ancestor
138793210|NCT05774951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138793211|NCT05774951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793212|NCT05774951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138793213|NCT05774951|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138793214|NCT05774951|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138793215|NCT05774951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138793216|NCT05764590|Sevelamer|sevelamer|mesh-list
138793217|NCT05764590|Chelating Agents|chelating agents|mesh-ancestor
138793218|NCT05764590|Sequestering Agents|sequestering agents|mesh-ancestor
138793219|NCT05764590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793220|NCT05741294|Tirbanibulin|tirbanibulin|mesh-list
138793221|NCT05741294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793222|NCT05741294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793223|NCT05737784|Pramoxine|pramoxine|mesh-list
138793224|NCT05737784|Anesthetics, Local|anesthetics, local|mesh-ancestor
138170661|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793225|NCT05737784|Anesthetics|anesthetics|mesh-ancestor
138793226|NCT05737784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138405291|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138405292|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793227|NCT05737784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793228|NCT05737784|Sensory System Agents|sensory system agents|mesh-ancestor
138793229|NCT05737784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793230|NCT05709821|Pembrolizumab|pembrolizumab|mesh-list
138793231|NCT05709821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793232|NCT05709821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793233|NCT05709821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138793234|NCT05709821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793235|NCT05704595|Diuretics|diuretics|mesh-list
138793236|NCT05704595|Natriuretic Agents|natriuretic agents|mesh-ancestor
138793237|NCT05704595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793238|NCT05701189|Immunoglobulins|immunoglobulins|mesh-list
138793239|NCT05701189|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138793240|NCT05701189|Antibodies|antibodies|mesh-list
138793241|NCT05701189|gamma-Globulins|gamma-globulins|mesh-list
138793242|NCT05701189|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138793243|NCT05701189|Immunologic Factors|immunologic factors|mesh-ancestor
138266589|NCT05020600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138793244|NCT05701189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793246|NCT05691478|Doxorubicin|doxorubicin|mesh-list
138793247|NCT05691478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138793248|NCT05691478|Methotrexate|methotrexate|mesh-list
138793249|NCT05691478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793250|NCT05691478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138793251|NCT05691478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138793252|NCT05691478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138793253|NCT05691478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793254|NCT05691478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793255|NCT05691478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138793256|NCT05691478|Abortifacient Agents|abortifacient agents|mesh-ancestor
138793257|NCT05691478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138793258|NCT05691478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793259|NCT05691478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793260|NCT05691478|Antimetabolites|antimetabolites|mesh-ancestor
138793261|NCT05691478|Dermatologic Agents|dermatologic agents|mesh-ancestor
138793262|NCT05691478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138793263|NCT05691478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138793264|NCT05691478|Immunologic Factors|immunologic factors|mesh-ancestor
138405318|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
138405319|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138405320|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138405321|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
138793265|NCT05691478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138793266|NCT05691478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138793267|NCT05678348|Pyrimethamine|pyrimethamine|mesh-list
138793268|NCT05678348|Antimalarials|antimalarials|mesh-ancestor
138793269|NCT05678348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138793270|NCT05678348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138793271|NCT05678348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138793272|NCT05678348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138793273|NCT05678348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793274|NCT05678348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793275|NCT05667662|Itraconazole|itraconazole|mesh-list
138793276|NCT05667662|Antifungal Agents|antifungal agents|mesh-ancestor
138793277|NCT05667662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138793278|NCT05667662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138793279|NCT05667662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138793280|NCT05667662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793281|NCT05667662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793282|NCT05667662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138793283|NCT05667662|Hormone Antagonists|hormone antagonists|mesh-ancestor
138793284|NCT05667662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138793285|NCT05667662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793286|NCT05667662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138793287|NCT05664386|Propofol|propofol|mesh-list
138793288|NCT05664386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138793289|NCT05664386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138793290|NCT05664386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138405353|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138793291|NCT05664386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138793292|NCT05664386|Anesthetics, General|anesthetics, general|mesh-ancestor
138793293|NCT05664386|Anesthetics|anesthetics|mesh-ancestor
138793294|NCT05662397|Cemiplimab|cemiplimab|mesh-list
138793295|NCT05662397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793296|NCT05662397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793297|NCT05662319|Antithrombins|antithrombins|mesh-list
138793298|NCT05662319|Antithrombin III|antithrombin iii|mesh-list
138793299|NCT05662319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138793300|NCT05662319|Protease Inhibitors|protease inhibitors|mesh-ancestor
138170738|NCT00590863|Mirtazapine|mirtazapine|mesh-list
138451470|NCT04893525|Analgesics|analgesics|mesh-ancestor
138793301|NCT05662319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793302|NCT05662319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793303|NCT05662319|Anticoagulants|anticoagulants|mesh-ancestor
138793304|NCT05662098|Hydroxyurea|hydroxyurea|mesh-list
138793305|NCT05662098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793306|NCT05662098|Antisickling Agents|antisickling agents|mesh-ancestor
138793307|NCT05662098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793308|NCT05662098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793309|NCT05662098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138405397|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793310|NCT05632627|Cannabidiol|cannabidiol|mesh-list
138793311|NCT05632627|Anticonvulsants|anticonvulsants|mesh-ancestor
138793312|NCT05627466|Magrolimab|magrolimab|mesh-list
138793313|NCT05627466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793314|NCT05627466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793315|NCT05602194|Asparaginase|asparaginase|mesh-list
138793316|NCT05602194|Pegaspargase|pegaspargase|mesh-list
138793317|NCT05602194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793318|NCT05584267|Immunomodulating Agents|immunomodulating agents|mesh-list
138793319|NCT05584267|Immunologic Factors|immunologic factors|mesh-ancestor
138793320|NCT05584267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793321|NCT05513391|Vaccines|vaccines|mesh-list
138793322|NCT05513391|Immunologic Factors|immunologic factors|mesh-ancestor
138405398|NCT01579227|Protective Agents|protective agents|mesh-ancestor
138793323|NCT05513391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793324|NCT05502237|Paclitaxel|paclitaxel|mesh-list
138793325|NCT05502237|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138793326|NCT05502237|Carboplatin|carboplatin|mesh-list
138793327|NCT05502237|Pembrolizumab|pembrolizumab|mesh-list
138793328|NCT05502237|Pemetrexed|pemetrexed|mesh-list
138793329|NCT05502237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138793330|NCT05502237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793331|NCT05502237|Tubulin Modulators|tubulin modulators|mesh-ancestor
138793332|NCT05502237|Antimitotic Agents|antimitotic agents|mesh-ancestor
138793333|NCT05502237|Mitosis Modulators|mitosis modulators|mesh-ancestor
138793334|NCT05502237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793335|NCT05502237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793336|NCT05502237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138793337|NCT05502237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793338|NCT05502237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138793339|NCT05502237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138793340|NCT05485805|Naproxen|naproxen|mesh-list
138793341|NCT05485805|Caffeine|caffeine|mesh-list
138793342|NCT05485805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138793343|NCT05485805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793344|NCT05485805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138793345|NCT05485805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405440|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
138793346|NCT05485805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405441|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138793347|NCT05485805|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138793348|NCT05485805|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138793349|NCT05485805|Purinergic Agents|purinergic agents|mesh-ancestor
138793350|NCT05485805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138793351|NCT05485805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138793352|NCT05485805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138793353|NCT05485805|Analgesics|analgesics|mesh-ancestor
138793354|NCT05485805|Sensory System Agents|sensory system agents|mesh-ancestor
138793355|NCT05485805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793356|NCT05485805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138793357|NCT05485805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138793358|NCT05485805|Gout Suppressants|gout suppressants|mesh-ancestor
138793359|NCT05485805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138793360|NCT05460533|Tisagenlecleucel|tisagenlecleucel|mesh-list
138793361|NCT05460533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793362|NCT05460533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793363|NCT05446571|Valacyclovir|valacyclovir|mesh-list
138793364|NCT05446571|Letermovir|letermovir|mesh-list
138793365|NCT05446571|Antiviral Agents|antiviral agents|mesh-ancestor
138793366|NCT05446571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138793367|NCT05446571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138793368|NCT05446571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793369|NCT05446571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793370|NCT05446571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793371|NCT05446298|Pembrolizumab|pembrolizumab|mesh-list
138793372|NCT05446298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793373|NCT05446298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793374|NCT05446298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138793375|NCT05446298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405490|NCT01579786|Analgesics|analgesics|mesh-ancestor
138405491|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
138793376|NCT05431777|Avelumab|avelumab|mesh-list
138793377|NCT05431777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793378|NCT05431777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793379|NCT05379166|Azacitidine|azacitidine|mesh-list
138793380|NCT05379166|Venetoclax|venetoclax|mesh-list
138793381|NCT05379166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793382|NCT05379166|Antimetabolites|antimetabolites|mesh-ancestor
138793383|NCT05379166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793384|NCT05379166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793385|NCT05379166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793386|NCT05296603|Lenvatinib|lenvatinib|mesh-list
138793387|NCT05296603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793388|NCT05296603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138793389|NCT05296603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793390|NCT05296603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793391|NCT05296278|Bevacizumab|bevacizumab|mesh-list
138793392|NCT05296278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793393|NCT05296278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793394|NCT05296278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138793395|NCT05296278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138793396|NCT05296278|Growth Substances|growth substances|mesh-ancestor
138793397|NCT05296278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793398|NCT05296278|Growth Inhibitors|growth inhibitors|mesh-ancestor
138793399|NCT05287906|Cardiac Glycosides|cardiac glycosides|mesh-list
138793400|NCT05287906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138793401|NCT05287906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138793402|NCT05287906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793403|NCT05287906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793404|NCT05287906|Protective Agents|protective agents|mesh-ancestor
138793405|NCT05287906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793406|NCT05287568|Venetoclax|venetoclax|mesh-list
138793408|NCT05287568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793409|NCT05285228|Fluorides|fluorides|mesh-list
138793410|NCT05285228|Fluorides, Topical|fluorides, topical|mesh-list
138793411|NCT05285228|Cariostatic Agents|cariostatic agents|mesh-ancestor
138793412|NCT05285228|Protective Agents|protective agents|mesh-ancestor
138405533|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405534|NCT01580228|Ofatumumab|ofatumumab|mesh-list
138793413|NCT05285228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793415|NCT05273320|Nabilone|nabilone|mesh-list
138793416|NCT05273320|Antiemetics|antiemetics|mesh-ancestor
138793417|NCT05273320|Autonomic Agents|autonomic agents|mesh-ancestor
138793418|NCT05273320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793419|NCT05273320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793420|NCT05273320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138793421|NCT05273320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138793422|NCT05273320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138793423|NCT05273320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138793424|NCT05273320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138793425|NCT05273320|Hallucinogens|hallucinogens|mesh-ancestor
138793426|NCT05273320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138793427|NCT05273320|Analgesics|analgesics|mesh-ancestor
138793428|NCT05273320|Sensory System Agents|sensory system agents|mesh-ancestor
138793429|NCT05273320|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138793430|NCT05273320|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138793431|NCT05273320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138793432|NCT05273320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793433|NCT05273320|Hormones|hormones|mesh-ancestor
138793434|NCT05273320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138793435|NCT05256225|Paclitaxel|paclitaxel|mesh-list
138793436|NCT05256225|Carboplatin|carboplatin|mesh-list
138793437|NCT05256225|Trastuzumab|trastuzumab|mesh-list
138186301|NCT01042535|Tryptophan|tryptophan|mesh-list
138793438|NCT05256225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138793440|NCT05256225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138793441|NCT05256225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793442|NCT05256225|Tubulin Modulators|tubulin modulators|mesh-ancestor
138793443|NCT05256225|Antimitotic Agents|antimitotic agents|mesh-ancestor
138793444|NCT05256225|Mitosis Modulators|mitosis modulators|mesh-ancestor
138793445|NCT05256225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793446|NCT05256225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793447|NCT05245474|Tislelizumab|tislelizumab|mesh-list
138793448|NCT05245474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138793449|NCT05245474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793450|NCT05245474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793451|NCT05245474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793453|NCT05233605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138793454|NCT05233605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138405570|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
138405571|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138405572|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138793455|NCT05233605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793456|NCT05233605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138793457|NCT05233605|Analgesics|analgesics|mesh-ancestor
138793458|NCT05233605|Sensory System Agents|sensory system agents|mesh-ancestor
138793459|NCT05233605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793460|NCT05233605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138793461|NCT05233605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138793462|NCT05233605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138793463|NCT05233605|Adrenergic Agents|adrenergic agents|mesh-ancestor
138793464|NCT05233605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138793465|NCT05233605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793466|NCT05232032|Nociceptin|nociceptin|mesh-list
138793467|NCT05232032|Vasodilator Agents|vasodilator agents|mesh-ancestor
138793468|NCT05209295|Azacitidine|azacitidine|mesh-list
138793469|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793470|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
138793471|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793472|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793473|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793474|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
138793475|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
138793476|NCT05171166|Leucovorin|leucovorin|mesh-list
138793477|NCT05171166|Fluorouracil|fluorouracil|mesh-list
138793478|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
138793479|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
138793480|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
138405602|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405603|NCT01583972|Vitamin A|vitamin a|mesh-list
138793481|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793482|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793483|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793484|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138793485|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
138793486|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793487|NCT05171166|Antidotes|antidotes|mesh-ancestor
138793488|NCT05171166|Protective Agents|protective agents|mesh-ancestor
138793489|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
138793490|NCT05171166|Vitamins|vitamins|mesh-ancestor
138793491|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
138793492|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138793493|NCT05171166|Estrogens|estrogens|mesh-ancestor
138793494|NCT05171166|Hormones|hormones|mesh-ancestor
138793495|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138793496|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138793497|NCT05144542|Nicotine|nicotine|mesh-list
138793498|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138793499|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
138793500|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793501|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793502|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138793503|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138793504|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
138793505|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138793506|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793507|NCT05113251|Paclitaxel|paclitaxel|mesh-list
138793508|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
138793509|NCT05113251|Doxorubicin|doxorubicin|mesh-list
138793510|NCT05113251|Trastuzumab|trastuzumab|mesh-list
138793511|NCT05113251|Pertuzumab|pertuzumab|mesh-list
138793512|NCT05113251|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138793513|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138793514|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793515|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
138793516|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
138793517|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
138793518|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793519|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138405652|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138793520|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
138793521|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793522|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138793523|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138793524|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
138793525|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138170957|NCT03088046|Progestins|progestins|mesh-ancestor
138793526|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138793527|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138793528|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138793529|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793530|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793531|NCT05113251|Immunoconjugates|immunoconjugates|mesh-ancestor
138793532|NCT05103605|Osimertinib|osimertinib|mesh-list
138793533|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793534|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138793535|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793536|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793537|NCT05090566|Dexamethasone|dexamethasone|mesh-list
138793538|NCT05090566|Lenalidomide|lenalidomide|mesh-list
138793539|NCT05090566|Nirogacestat|nirogacestat|mesh-list
138793540|NCT05090566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138793541|NCT05090566|Antiemetics|antiemetics|mesh-ancestor
138793542|NCT05090566|Autonomic Agents|autonomic agents|mesh-ancestor
138793543|NCT05090566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793544|NCT05090566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793545|NCT05090566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138793546|NCT05090566|Glucocorticoids|glucocorticoids|mesh-ancestor
138793547|NCT05090566|Hormones|hormones|mesh-ancestor
138793548|NCT05090566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138793549|NCT05090566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138793550|NCT05090566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793551|NCT05090566|Immunologic Factors|immunologic factors|mesh-ancestor
138793552|NCT05090566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138793553|NCT05090566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138793554|NCT05090566|Growth Substances|growth substances|mesh-ancestor
138793555|NCT05090566|Growth Inhibitors|growth inhibitors|mesh-ancestor
138793556|NCT05090566|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138793557|NCT05090566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793558|NCT05090566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793559|NCT05076175|Ozanimod|ozanimod|mesh-list
138793560|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138793561|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186333|NCT01041287|Metoprolol|metoprolol|mesh-list
138793562|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138793563|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
138793564|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793565|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
138793566|NCT05024773|Paclitaxel|paclitaxel|mesh-list
138793567|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
138793568|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138793569|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138405689|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138793570|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
138405690|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
138793571|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
138793572|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
138793573|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793574|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138793575|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
138793576|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793577|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
138793578|NCT05024773|Protective Agents|protective agents|mesh-ancestor
138793579|NCT05024513|Fluorouracil|fluorouracil|mesh-list
138793580|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
138793581|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
138793582|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793583|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793584|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793585|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138793586|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
138793587|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793588|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
138793589|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793590|NCT05020665|Cytarabine|cytarabine|mesh-list
138793591|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793592|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
138793593|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793594|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793595|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
138793596|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138793597|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138793598|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
138793599|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793600|NCT04975997|Dexamethasone|dexamethasone|mesh-list
138405709|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138405710|NCT01589432|Lidocaine|lidocaine|mesh-list
138171040|NCT02474173|Paclitaxel|paclitaxel|mesh-list
138793601|NCT04975997|Bortezomib|bortezomib|mesh-list
138793602|NCT04975997|Daratumumab|daratumumab|mesh-list
138793603|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138793604|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
138793605|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
138793606|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793607|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793608|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138793609|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
138793610|NCT04975997|Hormones|hormones|mesh-ancestor
138793611|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138793612|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138793613|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793614|NCT04941287|Atezolizumab|atezolizumab|mesh-list
138793615|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
138793616|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138793617|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
138793618|NCT04941287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138793619|NCT04941287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793620|NCT04941287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793621|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793622|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
138793623|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793624|NCT04903470|Bisacodyl|bisacodyl|mesh-list
138793625|NCT04903470|Cathartics|cathartics|mesh-ancestor
138793626|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138793627|NCT04903470|Laxatives|laxatives|mesh-ancestor
138793628|NCT04876248|Lenalidomide|lenalidomide|mesh-list
138793629|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
138793630|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793631|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138793632|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138793633|NCT04876248|Growth Substances|growth substances|mesh-ancestor
138793634|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
138793635|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793637|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793638|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138793639|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793640|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793641|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
138793642|NCT04789408|Fludarabine|fludarabine|mesh-list
138793643|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138793644|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
138405751|NCT01590199|Pasireotide|pasireotide|mesh-list
138405752|NCT01590199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138405754|NCT01590199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793645|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793646|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138451573|NCT04717362|Androgens|androgens|mesh-ancestor
138793647|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138793648|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
138793649|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793650|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793651|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138793652|NCT04760275|Fluoxetine|fluoxetine|mesh-list
138793653|NCT04760275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138793654|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138793655|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138793656|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793657|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138793658|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
138793659|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793660|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138793661|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
138793662|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138793663|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138793664|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138793665|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793666|NCT04716946|Durvalumab|durvalumab|mesh-list
138793667|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793668|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793669|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
138793670|NCT04714372|Fludarabine|fludarabine|mesh-list
138793671|NCT04714372|Daratumumab|daratumumab|mesh-list
138793672|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138793673|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
138171107|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793674|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793675|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138793676|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138793677|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
138793678|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793679|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793680|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138793681|NCT04710030|Valacyclovir|valacyclovir|mesh-list
138793682|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
138793683|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138793684|NCT04700176|Dexamethasone|dexamethasone|mesh-list
138793685|NCT04700176|Daratumumab|daratumumab|mesh-list
138793686|NCT04700176|Pomalidomide|pomalidomide|mesh-list
138793687|NCT04700176|Tretinoin|tretinoin|mesh-list
138405781|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405784|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
138793688|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138793689|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
138793690|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
138793691|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793692|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793693|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138793694|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
138793695|NCT04700176|Hormones|hormones|mesh-ancestor
138793696|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138793697|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138793698|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793699|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
138793700|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138793701|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138793702|NCT04700176|Growth Substances|growth substances|mesh-ancestor
138793703|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
138793704|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
138793705|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
138793706|NCT04686305|Carboplatin|carboplatin|mesh-list
138793707|NCT04686305|Trastuzumab|trastuzumab|mesh-list
138793708|NCT04686305|Pemetrexed|pemetrexed|mesh-list
138793709|NCT04686305|Durvalumab|durvalumab|mesh-list
138793710|NCT04686305|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138793711|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793712|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793713|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793714|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793715|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138793716|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138793717|NCT04686305|Immunoconjugates|immunoconjugates|mesh-ancestor
138793718|NCT04686305|Immunologic Factors|immunologic factors|mesh-ancestor
138793719|NCT04686305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793720|NCT04661358|Fenofibrate|fenofibrate|mesh-list
138793721|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138793722|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
138793723|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793724|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138793725|NCT04609046|Rituximab|rituximab|mesh-list
138793726|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138793727|NCT04609046|Nivolumab|nivolumab|mesh-list
138793728|NCT04609046|Methotrexate|methotrexate|mesh-list
138793729|NCT04609046|Lenalidomide|lenalidomide|mesh-list
138793730|NCT04609046|Antibodies|antibodies|mesh-list
138793731|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
138793732|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138793733|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
138793734|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793735|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793736|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138793737|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138793738|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793739|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138186366|NCT01042925|Trastuzumab|trastuzumab|mesh-list
138793740|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
138793741|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138793742|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793743|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
138793744|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
138793745|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138405811|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138793746|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138793747|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138171183|NCT03474770|Protective Agents|protective agents|mesh-ancestor
138793748|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138793749|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138793750|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138793751|NCT04609046|Growth Substances|growth substances|mesh-ancestor
138793752|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
138793754|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793755|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793756|NCT04585490|Paclitaxel|paclitaxel|mesh-list
138793757|NCT04585490|Cisplatin|cisplatin|mesh-list
138793758|NCT04585490|Carboplatin|carboplatin|mesh-list
138793759|NCT04585490|Pemetrexed|pemetrexed|mesh-list
138793760|NCT04585490|Durvalumab|durvalumab|mesh-list
138793761|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138793762|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138793763|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793764|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
138793765|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
138451602|NCT04255160|Estradiol|estradiol|mesh-list
138793766|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
138793767|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793768|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793769|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138793770|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138793771|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793772|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
138793773|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793774|NCT04575181|Insulin|insulin|mesh-list
138793775|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138793784|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793785|NCT04533880|Calcium|calcium|mesh-list
138793786|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138793787|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793795|NCT04508725|Mitogens|mitogens|mesh-list
138793796|NCT04508725|Endothelial Growth Factors|endothelial growth factors|mesh-list
138793797|NCT04508725|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138793798|NCT04508725|Mitosis Modulators|mitosis modulators|mesh-ancestor
138793799|NCT04508725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793800|NCT04508725|Growth Substances|growth substances|mesh-ancestor
138186385|NCT03400709|Antidotes|antidotes|mesh-ancestor
138793801|NCT04508725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793802|NCT04508725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138793803|NCT04508725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793804|NCT04500756|Metformin|metformin|mesh-list
138793805|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138793806|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266981|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266994|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138266995|NCT04458545|Narcotics|narcotics|mesh-ancestor
138266996|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138405829|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
138405830|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
138405831|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
138405832|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
138405833|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138266997|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266998|NCT04458545|Analgesics|analgesics|mesh-ancestor
138266999|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
138267000|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267001|NCT04414475|Dexamethasone|dexamethasone|mesh-list
138267002|NCT04414475|Bortezomib|bortezomib|mesh-list
138267020|NCT04392622|Cisplatin|cisplatin|mesh-list
138793807|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
138793808|NCT04469842|Prednisone|prednisone|mesh-list
138793809|NCT04469842|Azathioprine|azathioprine|mesh-list
138793810|NCT04469842|Tacrolimus|tacrolimus|mesh-list
138793811|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138793812|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
138793813|NCT04469842|Hormones|hormones|mesh-ancestor
138405850|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138793814|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138793815|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793816|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138793817|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793818|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138793819|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
138793820|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138793821|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793822|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793823|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138793824|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138793825|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
138793827|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138793829|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793830|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138793831|NCT04447755|Lenvatinib|lenvatinib|mesh-list
138793832|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793833|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138793834|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793835|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793836|NCT04396535|Docetaxel|docetaxel|mesh-list
138793837|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793838|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
138793839|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
138793840|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
138793841|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793842|NCT04341571|Metformin|metformin|mesh-list
138793843|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138793844|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793845|NCT04340843|Decitabine|decitabine|mesh-list
138793846|NCT04340843|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138793847|NCT04340843|Azacitidine|azacitidine|mesh-list
138793850|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793851|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
138793852|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793853|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793854|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793855|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138793858|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
138793859|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138793860|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138793861|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793862|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
138793863|NCT04272606|Coagulants|coagulants|mesh-ancestor
138793864|NCT04216316|Carboplatin|carboplatin|mesh-list
138793865|NCT04216316|Gemcitabine|gemcitabine|mesh-list
138793866|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
138793867|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793868|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793869|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
138793870|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793871|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793872|NCT04216316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138793873|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
138793874|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793875|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793876|NCT04214067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138793877|NCT04214067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793878|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
138793879|NCT04209660|Lenvatinib|lenvatinib|mesh-list
138793880|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793881|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793882|NCT04209660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138793883|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793884|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138793885|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793894|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793896|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
138793897|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138793898|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138793899|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
138171331|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
138793900|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793901|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138793902|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138793903|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138405874|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
138405882|NCT01591070|Tacrolimus|tacrolimus|mesh-list
138793904|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793905|NCT04112160|Ketorolac|ketorolac|mesh-list
138793906|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138793907|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138793908|NCT04112160|Analgesics|analgesics|mesh-ancestor
138793909|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
138793910|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138793911|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793912|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138793913|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138793914|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138793915|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793916|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793917|NCT04109456|Atezolizumab|atezolizumab|mesh-list
138793918|NCT04109456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138793919|NCT04109456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793920|NCT04109456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793921|NCT04109456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793922|NCT04108468|Golimumab|golimumab|mesh-list
138793923|NCT04108468|Methotrexate|methotrexate|mesh-list
138793924|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138793925|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
138793926|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138793927|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793928|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793929|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
138793930|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793931|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793932|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
138793933|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267119|NCT04249427|Erenumab|erenumab|mesh-list
138793934|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138793935|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138793936|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
138793937|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138793938|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138793939|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138405911|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138405922|NCT01591148|Propofol|propofol|mesh-list
138793940|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138793941|NCT04082754|Antibodies|antibodies|mesh-list
138793942|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138793943|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
138793944|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793945|NCT04079712|Nivolumab|nivolumab|mesh-list
138793946|NCT04079712|Ipilimumab|ipilimumab|mesh-list
138793947|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138793948|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793949|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138793950|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793951|NCT04001829|Paclitaxel|paclitaxel|mesh-list
138793952|NCT04001829|Docetaxel|docetaxel|mesh-list
138793953|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138793954|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138793955|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793956|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
138793957|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
138186460|NCT05706987|Lidocaine|lidocaine|mesh-list
138793958|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
138793959|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793960|NCT03989414|Dexamethasone|dexamethasone|mesh-list
138793961|NCT03989414|Bortezomib|bortezomib|mesh-list
138793962|NCT03989414|Daratumumab|daratumumab|mesh-list
138793963|NCT03989414|Elotuzumab|elotuzumab|mesh-list
138793964|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138793965|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
138793966|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
138793967|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138405949|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138405950|NCT01591434|Laxatives|laxatives|mesh-ancestor
138405951|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138793968|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793969|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138405952|NCT01591551|Natalizumab|natalizumab|mesh-list
138793970|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
138793971|NCT03989414|Hormones|hormones|mesh-ancestor
138793972|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138793973|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138793974|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793975|NCT03981614|Trifluridine|trifluridine|mesh-list
138793976|NCT03981614|Palbociclib|palbociclib|mesh-list
138793977|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793978|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138793979|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793980|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793981|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
138793982|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
138405990|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138793983|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138793984|NCT03974854|Gemcitabine|gemcitabine|mesh-list
138405991|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138793985|NCT03974854|Capecitabine|capecitabine|mesh-list
138793986|NCT03974854|Irinotecan|irinotecan|mesh-list
138793987|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138793988|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
138793989|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138793990|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138793991|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138793992|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138793993|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138793994|NCT03965689|Paclitaxel|paclitaxel|mesh-list
138793995|NCT03965689|Carboplatin|carboplatin|mesh-list
138793996|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138793997|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138793998|NCT03965689|Pevonedistat|pevonedistat|mesh-list
138793999|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794000|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794001|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
138794002|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
138794003|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
138794004|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794005|NCT03958877|Interferons|interferons|mesh-list
138794006|NCT03958877|Interferon-beta|interferon-beta|mesh-list
138794007|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794008|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
138794009|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138794010|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
138406051|NCT01592162|Remifentanil|remifentanil|mesh-list
138406052|NCT01592162|Propofol|propofol|mesh-list
138406060|NCT01592162|Narcotics|narcotics|mesh-ancestor
138794011|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794012|NCT03932162|Insulin|insulin|mesh-list
138794013|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138794014|NCT03932162|Mitogens|mitogens|mesh-list
138794015|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138267165|NCT04173780|Atropine|atropine|mesh-list
138794016|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794017|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
138794018|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794019|NCT03914300|Nivolumab|nivolumab|mesh-list
138794020|NCT03914300|Ipilimumab|ipilimumab|mesh-list
138451656|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794021|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794023|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794024|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794025|NCT03896217|Simvastatin|simvastatin|mesh-list
138794026|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138794027|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138794028|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
138794029|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794030|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138794031|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138794032|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794033|NCT03862157|Azacitidine|azacitidine|mesh-list
138794034|NCT03862157|Venetoclax|venetoclax|mesh-list
138794035|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138794036|NCT03862157|Pevonedistat|pevonedistat|mesh-list
138794037|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138794038|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
138794039|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794040|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794041|NCT03858322|Paclitaxel|paclitaxel|mesh-list
138794042|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
138794043|NCT03858322|Carboplatin|carboplatin|mesh-list
138794044|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794045|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406101|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
138794046|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
138406104|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
138794047|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
138794048|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
138794049|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794050|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138794051|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
138171560|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138794052|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794053|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138794054|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138794055|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
138794056|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138794057|NCT03842228|Durvalumab|durvalumab|mesh-list
138794058|NCT03842228|Olaparib|olaparib|mesh-list
138794059|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138794060|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
138794061|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794062|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
138794063|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794064|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794065|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
138794066|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794067|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794068|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794069|NCT03816358|Gemcitabine|gemcitabine|mesh-list
138794070|NCT03816358|Nivolumab|nivolumab|mesh-list
138794071|NCT03816358|Ipilimumab|ipilimumab|mesh-list
138794072|NCT03816358|Maytansine|maytansine|mesh-list
138794073|NCT03816358|Anetumab ravtansine|anetumab ravtansine|mesh-list
138794074|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138186483|NCT02951182|Ivacaftor|ivacaftor|mesh-list
138794075|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
138406139|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138794076|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406143|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138794078|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794079|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794080|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794081|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
138794082|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
138794083|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
138794084|NCT03816358|Immunoconjugates|immunoconjugates|mesh-ancestor
138794085|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
138794086|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794087|NCT03811002|Cisplatin|cisplatin|mesh-list
138794088|NCT03811002|Carboplatin|carboplatin|mesh-list
138794089|NCT03811002|Etoposide|etoposide|mesh-list
138794090|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
138794091|NCT03811002|Atezolizumab|atezolizumab|mesh-list
138794092|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
138794093|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794094|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794095|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794096|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138794097|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138794098|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138406182|NCT01593033|Trace Elements|trace elements|mesh-list
138406183|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406197|NCT01593124|Nonoxynol|nonoxynol|mesh-list
138794099|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794100|NCT03811002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794101|NCT03811002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794102|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
138794103|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794104|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
138794105|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
138794106|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
138794107|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
138794108|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
138794109|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
138794110|NCT03765229|Entinostat|entinostat|mesh-list
138794111|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794112|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794113|NCT03765229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794114|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794115|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138794116|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794117|NCT03727971|Omalizumab|omalizumab|mesh-list
138794118|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138794119|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138406238|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794120|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
138794121|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
138794122|NCT03713593|Lenvatinib|lenvatinib|mesh-list
138794123|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794124|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794125|NCT03713593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794126|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794127|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138794129|NCT03685188|Sufentanil|sufentanil|mesh-list
138794130|NCT03685188|Oxycodone|oxycodone|mesh-list
138794131|NCT03685188|Dsuvia|dsuvia|mesh-list
138794132|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138794133|NCT03685188|Narcotics|narcotics|mesh-ancestor
138794134|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138794135|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794136|NCT03685188|Analgesics|analgesics|mesh-ancestor
138794137|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
138794138|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138794139|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138794140|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138794141|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
138794142|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
138186500|NCT00924209|Etoposide|etoposide|mesh-list
138794143|NCT03668041|Eszopiclone|eszopiclone|mesh-list
138794144|NCT03668041|Trazodone|trazodone|mesh-list
138794145|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138794146|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138794147|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794148|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138794149|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138794150|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138794151|NCT03668041|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138794152|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138794153|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138794154|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794155|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138794156|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
138794157|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138406294|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138794158|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
138794159|NCT03643744|Celecoxib|celecoxib|mesh-list
138794160|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138794161|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138794162|NCT03643744|Analgesics|analgesics|mesh-ancestor
138794163|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
138794164|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138794165|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794166|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138794167|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138794168|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138794169|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138794170|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794171|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794172|NCT03641313|Irinotecan|irinotecan|mesh-list
138794173|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138794174|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138794175|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794176|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794177|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794178|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
138794179|NCT03610490|Fludarabine|fludarabine|mesh-list
138794180|NCT03610490|Interleukin-2|interleukin-2|mesh-list
138794181|NCT03610490|Mitogens|mitogens|mesh-list
138794182|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138794183|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
138794184|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794185|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138186510|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794186|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138794187|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
138406332|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794188|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406333|NCT01593605|Protective Agents|protective agents|mesh-ancestor
138406337|NCT01593644|Adenosine|adenosine|mesh-list
138794189|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794190|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138794191|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138794192|NCT03610490|Analgesics|analgesics|mesh-ancestor
138794193|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
138794194|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138794195|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
138794196|NCT03601455|Durvalumab|durvalumab|mesh-list
138794197|NCT03601455|Ipilimumab|ipilimumab|mesh-list
138794198|NCT03601455|Tremelimumab|tremelimumab|mesh-list
138794199|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
138171636|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
138794200|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794201|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
138794202|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794203|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794204|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
138794205|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794206|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794207|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794209|NCT03590652|Daratumumab|daratumumab|mesh-list
138406372|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138406379|NCT01593826|Antidotes|antidotes|mesh-ancestor
138794210|NCT03590652|Pomalidomide|pomalidomide|mesh-list
138794211|NCT03590652|Ixazomib|ixazomib|mesh-list
138794212|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138794213|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
138794214|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
138794215|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138794216|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794217|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138794218|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
138794219|NCT03590652|Hormones|hormones|mesh-ancestor
138794220|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138794221|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138794222|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794223|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
138794224|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138794225|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138794226|NCT03590652|Growth Substances|growth substances|mesh-ancestor
138794227|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
138406426|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138794228|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
138794229|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794230|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794231|NCT03587662|Gemcitabine|gemcitabine|mesh-list
138794232|NCT03587662|Doxorubicin|doxorubicin|mesh-list
138794233|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138794234|NCT03587662|Daunorubicin|daunorubicin|mesh-list
138794235|NCT03587662|Ixazomib|ixazomib|mesh-list
138794236|NCT03587662|Glycine|glycine|mesh-list
138794237|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138794238|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
138794239|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794240|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794241|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138794242|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138794243|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138794244|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794245|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
138794246|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
138794247|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138794248|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794249|NCT03535259|Sorafenib|sorafenib|mesh-list
138794250|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794252|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794253|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794254|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
138794255|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138794256|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
138794257|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138794258|NCT03499249|Expectorants|expectorants|mesh-ancestor
138794259|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
138794260|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138794261|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
138794262|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406484|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794263|NCT03499249|Protective Agents|protective agents|mesh-ancestor
138794264|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794265|NCT03499249|Antidotes|antidotes|mesh-ancestor
138794266|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
138406485|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794267|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138406486|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138406487|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138794268|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138794269|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794270|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
138794271|NCT03475342|Coagulants|coagulants|mesh-ancestor
138794272|NCT03412773|Sorafenib|sorafenib|mesh-list
138794273|NCT03412773|Tislelizumab|tislelizumab|mesh-list
138794274|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794275|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138794276|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794277|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794278|NCT03412773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794279|NCT03410043|Osimertinib|osimertinib|mesh-list
138794280|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794281|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138794282|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794283|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794284|NCT03392246|Osimertinib|osimertinib|mesh-list
138794285|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794286|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138794287|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794288|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794289|NCT03375307|Olaparib|olaparib|mesh-list
138794290|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138406515|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
138794291|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794292|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794293|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794294|NCT03367741|Nivolumab|nivolumab|mesh-list
138794295|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794296|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794297|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794298|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794299|NCT03273023|Chromium|chromium|mesh-list
138794300|NCT03273023|Everolimus|everolimus|mesh-list
138794301|NCT03273023|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138794302|NCT03273023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138794303|NCT03273023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794304|NCT03273023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794305|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138794306|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
138794307|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794308|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794309|NCT03273023|Trace Elements|trace elements|mesh-ancestor
138794310|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
138406569|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406570|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138794311|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
138794312|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794313|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794314|NCT03244384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794315|NCT03244384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794317|NCT03237780|Halichondrin B|halichondrin b|mesh-list
138794318|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794319|NCT03237780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794320|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794321|NCT03237780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794322|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794323|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
138794324|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794325|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
138794326|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
138794327|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
138794328|NCT03233711|Nivolumab|nivolumab|mesh-list
138794329|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794330|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794331|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794332|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794333|NCT03212274|Olaparib|olaparib|mesh-list
138406620|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
138794334|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138794335|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794336|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794337|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794338|NCT03175432|Bevacizumab|bevacizumab|mesh-list
138794339|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138794340|NCT03175432|Atezolizumab|atezolizumab|mesh-list
138794341|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
138794342|NCT03175432|Antibodies|antibodies|mesh-list
138794343|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
138794344|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794345|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
138267461|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794346|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794347|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138794348|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138794349|NCT03175432|Growth Substances|growth substances|mesh-ancestor
138794350|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794351|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
138794352|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
138794353|NCT03175432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794354|NCT03175432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794355|NCT03158129|Cisplatin|cisplatin|mesh-list
138794356|NCT03158129|Carboplatin|carboplatin|mesh-list
138794357|NCT03158129|Docetaxel|docetaxel|mesh-list
138794358|NCT03158129|Nivolumab|nivolumab|mesh-list
138794359|NCT03158129|Pemetrexed|pemetrexed|mesh-list
138794360|NCT03158129|Ipilimumab|ipilimumab|mesh-list
138794361|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794362|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
138794363|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
138794364|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
138794365|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794366|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794367|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794369|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138794370|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138794371|NCT03141684|Bevacizumab|bevacizumab|mesh-list
138794372|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138794373|NCT03141684|Atezolizumab|atezolizumab|mesh-list
138794374|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
138794375|NCT03141684|Antibodies|antibodies|mesh-list
138794376|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
138794377|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794378|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
138794379|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794380|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138794381|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138406674|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138794382|NCT03141684|Growth Substances|growth substances|mesh-ancestor
138794383|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794384|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
138794385|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
138794386|NCT03141684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794387|NCT03141684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794388|NCT03138499|Nivolumab|nivolumab|mesh-list
138794389|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138794390|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794391|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794392|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794393|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794394|NCT03138499|Immunotoxins|immunotoxins|mesh-ancestor
138794395|NCT03138499|Immunoconjugates|immunoconjugates|mesh-ancestor
138794396|NCT03138499|Immunologic Factors|immunologic factors|mesh-ancestor
138794397|NCT03138499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794398|NCT03125902|Paclitaxel|paclitaxel|mesh-list
138794399|NCT03125902|Atezolizumab|atezolizumab|mesh-list
138794400|NCT03125902|Antibodies|antibodies|mesh-list
138794401|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794402|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138406704|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794403|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794404|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
138794405|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
138794406|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
138794407|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794408|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
138794409|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794410|NCT03125902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794411|NCT03125902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794412|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
138794413|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794414|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794415|NCT03085719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794416|NCT03085719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794417|NCT03083353|Isradipine|isradipine|mesh-list
138794418|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138794419|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138794420|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138794421|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794422|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138794423|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794424|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
138794425|NCT03069131|Rifaximin|rifaximin|mesh-list
138794426|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138794427|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138794428|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138794430|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138794431|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138794432|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
138794433|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138794434|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794435|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406759|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138406760|NCT01596010|Norethindrone|norethindrone|mesh-list
138794436|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138794437|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138794438|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
138794439|NCT02985957|Prednisone|prednisone|mesh-list
138794440|NCT02985957|Nivolumab|nivolumab|mesh-list
138794441|NCT02985957|Ipilimumab|ipilimumab|mesh-list
138794442|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138794443|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
138794444|NCT02985957|Hormones|hormones|mesh-ancestor
138794445|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138794446|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794447|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138794448|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794449|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794450|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794451|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794452|NCT02978625|Nivolumab|nivolumab|mesh-list
138794453|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138794454|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794455|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794456|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794457|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794458|NCT02971501|Bevacizumab|bevacizumab|mesh-list
138794459|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138794460|NCT02971501|Osimertinib|osimertinib|mesh-list
138794461|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
138794462|NCT02971501|Antibodies|antibodies|mesh-list
138794463|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
138794464|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794465|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
138794466|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794467|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138794468|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138794469|NCT02971501|Growth Substances|growth substances|mesh-ancestor
138794470|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794471|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
138794472|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
138794473|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794474|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138794475|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186614|NCT04374071|Hormones|hormones|mesh-ancestor
138794476|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
138794477|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794478|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406801|NCT01596166|Analgesics|analgesics|mesh-ancestor
138406802|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
138794479|NCT02955758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794480|NCT02955758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794482|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794483|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794484|NCT02954874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794485|NCT02954874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794486|NCT02915523|Avelumab|avelumab|mesh-list
138794487|NCT02915523|Entinostat|entinostat|mesh-list
138794488|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794489|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794490|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138794491|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794492|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794493|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
138794494|NCT02912559|Leucovorin|leucovorin|mesh-list
138794495|NCT02912559|Folic Acid|folic acid|mesh-list
138794496|NCT02912559|Fluorouracil|fluorouracil|mesh-list
138794497|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
138794498|NCT02912559|Atezolizumab|atezolizumab|mesh-list
138794499|NCT02912559|Calcium|calcium|mesh-list
138794500|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794501|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
138794502|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138794503|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794504|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138794506|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794507|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138794508|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794509|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138794510|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
138794511|NCT02912559|Antidotes|antidotes|mesh-ancestor
138794512|NCT02912559|Protective Agents|protective agents|mesh-ancestor
138794513|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
138794514|NCT02912559|Vitamins|vitamins|mesh-ancestor
138794515|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
138794516|NCT02912559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794517|NCT02912559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794518|NCT02912559|Hematinics|hematinics|mesh-ancestor
138794519|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
138794520|NCT02890355|Leucovorin|leucovorin|mesh-list
138406833|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
138794521|NCT02890355|Folic Acid|folic acid|mesh-list
138794522|NCT02890355|Fluorouracil|fluorouracil|mesh-list
138794523|NCT02890355|Irinotecan|irinotecan|mesh-list
138794524|NCT02890355|Veliparib|veliparib|mesh-list
138794525|NCT02890355|Camptothecin|camptothecin|mesh-list
138794526|NCT02890355|Calcium|calcium|mesh-list
138794527|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
138794528|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138794529|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794530|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138794531|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
138794532|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794533|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138794534|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794535|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138794536|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
138186633|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
138794537|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138794538|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138794539|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794540|NCT02890355|Antidotes|antidotes|mesh-ancestor
138794541|NCT02890355|Protective Agents|protective agents|mesh-ancestor
138406867|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406869|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138406870|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
138406871|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
138794542|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
138794544|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
138794545|NCT02890355|Hematinics|hematinics|mesh-ancestor
138794546|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138794547|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794548|NCT02888743|Durvalumab|durvalumab|mesh-list
138794549|NCT02888743|Ipilimumab|ipilimumab|mesh-list
138794550|NCT02888743|Tremelimumab|tremelimumab|mesh-list
138794551|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
138794552|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794553|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
138794554|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794555|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794556|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
138794557|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794558|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794559|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794561|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794562|NCT02844816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794563|NCT02844816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794564|NCT02844816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794565|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794566|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
138794567|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794568|NCT02834013|Nivolumab|nivolumab|mesh-list
138794569|NCT02834013|Ipilimumab|ipilimumab|mesh-list
138794570|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138406920|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138794571|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794572|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794573|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794574|NCT02595944|Nivolumab|nivolumab|mesh-list
138794575|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794576|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794577|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267610|NCT03474198|Clofazimine|clofazimine|mesh-list
138794578|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794579|NCT02595931|Irinotecan|irinotecan|mesh-list
138794580|NCT02595931|Camptothecin|camptothecin|mesh-list
138794581|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138794582|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138794583|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794584|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794585|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794586|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794587|NCT02595424|Carboplatin|carboplatin|mesh-list
138794588|NCT02595424|Capecitabine|capecitabine|mesh-list
138794589|NCT02595424|Etoposide|etoposide|mesh-list
138794590|NCT02595424|Temozolomide|temozolomide|mesh-list
138794591|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794592|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138406971|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138794593|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
138186645|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406972|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138406973|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138794594|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794595|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794596|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138794597|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138794598|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794599|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138794600|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
138794601|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138794602|NCT02568553|Lenalidomide|lenalidomide|mesh-list
138794603|NCT02568553|Blinatumomab|blinatumomab|mesh-list
138794604|NCT02568553|Antibodies|antibodies|mesh-list
138794605|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
138794606|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794607|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
138794608|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138794609|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
138794610|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794611|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794612|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138794613|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138794614|NCT02568553|Growth Substances|growth substances|mesh-ancestor
138794615|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
138794616|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138794617|NCT02567409|Cisplatin|cisplatin|mesh-list
138794618|NCT02567409|Gemcitabine|gemcitabine|mesh-list
138794619|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794620|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138794621|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
138794622|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794623|NCT02513563|Paclitaxel|paclitaxel|mesh-list
138794624|NCT02513563|Carboplatin|carboplatin|mesh-list
138794626|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794627|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794628|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
138794629|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
138794630|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
138794631|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794632|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794633|NCT02506153|Interferons|interferons|mesh-list
138794634|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
138794635|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
138794636|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
138794637|NCT02506153|Ipilimumab|ipilimumab|mesh-list
138794638|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794639|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794640|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794641|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794642|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
138794643|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138794644|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
138794645|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794646|NCT02498600|Nivolumab|nivolumab|mesh-list
138794647|NCT02498600|Ipilimumab|ipilimumab|mesh-list
138794648|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794649|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794650|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138186665|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
138407068|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138407069|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794651|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794652|NCT02496585|Prednisone|prednisone|mesh-list
138794653|NCT02496585|Nintedanib|nintedanib|mesh-list
138172083|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138794654|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138794655|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
138794656|NCT02496585|Hormones|hormones|mesh-ancestor
138794657|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138794658|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794659|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138794660|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794661|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138794662|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794663|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794664|NCT02496208|Nivolumab|nivolumab|mesh-list
138794665|NCT02496208|Ipilimumab|ipilimumab|mesh-list
138794666|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794667|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794668|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794669|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794670|NCT02466971|Cisplatin|cisplatin|mesh-list
138794671|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794672|NCT02443545|Deferiprone|deferiprone|mesh-list
138794673|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138794674|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
138794675|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
138794676|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794677|NCT02443077|Cytarabine|cytarabine|mesh-list
138794678|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
138794679|NCT02443077|Melphalan|melphalan|mesh-list
138794680|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
138794681|NCT02443077|Carmustine|carmustine|mesh-list
138794682|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138794683|NCT02443077|Etoposide|etoposide|mesh-list
138794684|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
138794685|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
138794686|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138794687|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
138794688|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794689|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138794690|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138794691|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
138794692|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794693|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794694|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138794695|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794696|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138794697|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138794698|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794699|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138794700|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
138794701|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
138794702|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138794703|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
138794704|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
138794705|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
138794706|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
138794707|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
138794708|NCT02388906|Nivolumab|nivolumab|mesh-list
138794709|NCT02388906|Ipilimumab|ipilimumab|mesh-list
138794710|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794711|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794712|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794713|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794714|NCT02375555|Dexamethasone|dexamethasone|mesh-list
138794715|NCT02375555|Lenalidomide|lenalidomide|mesh-list
138794716|NCT02375555|Bortezomib|bortezomib|mesh-list
138794717|NCT02375555|Elotuzumab|elotuzumab|mesh-list
138794718|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138794719|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
138794720|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
138794721|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138794722|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794723|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138794724|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
138407163|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138794725|NCT02375555|Hormones|hormones|mesh-ancestor
138794726|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138794727|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138794728|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794729|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
138794730|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138794731|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138794732|NCT02375555|Growth Substances|growth substances|mesh-ancestor
138794733|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
138794734|NCT02367040|Rituximab|rituximab|mesh-list
138794735|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794736|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794737|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
138794738|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794739|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138794740|NCT02330952|Prednisone|prednisone|mesh-list
138794741|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138794742|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
138794743|NCT02330952|Hormones|hormones|mesh-ancestor
138794744|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138794745|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794746|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138794747|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794748|NCT02314169|Nivolumab|nivolumab|mesh-list
138794749|NCT02314169|Ipilimumab|ipilimumab|mesh-list
138794750|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794751|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794752|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794753|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794755|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138794756|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
138794757|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138794758|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794759|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138794760|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794761|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138794762|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138794763|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138794765|NCT02306161|Ifosfamide|ifosfamide|mesh-list
138794766|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
138794767|NCT02306161|Doxorubicin|doxorubicin|mesh-list
138794768|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138407200|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
138794769|NCT02306161|Etoposide|etoposide|mesh-list
138794770|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
138794771|NCT02306161|Vincristine|vincristine|mesh-list
138794772|NCT02306161|Daunorubicin|daunorubicin|mesh-list
138794773|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
138794774|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794775|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138794776|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
138794777|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794778|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138794779|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138794780|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
138794781|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794782|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794783|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138794784|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138794785|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138794786|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138794787|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794788|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794789|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
138794790|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
138794791|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
138794792|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
138407233|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138407234|NCT01597934|Adefovir|adefovir|mesh-list
138794793|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
138794794|NCT02299999|Vincristine|vincristine|mesh-list
138794795|NCT02299999|Vinorelbine|vinorelbine|mesh-list
138794796|NCT02299999|Vinblastine|vinblastine|mesh-list
138407235|NCT01597934|Lamivudine|lamivudine|mesh-list
138407236|NCT01597934|Telbivudine|telbivudine|mesh-list
138794798|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
138794799|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
138794800|NCT02299999|Bevacizumab|bevacizumab|mesh-list
138794801|NCT02299999|Cisplatin|cisplatin|mesh-list
138794802|NCT02299999|Carboplatin|carboplatin|mesh-list
138794803|NCT02299999|Gemcitabine|gemcitabine|mesh-list
138794804|NCT02299999|Doxorubicin|doxorubicin|mesh-list
138172239|NCT01913535|Aticaprant|aticaprant|mesh-list
138794805|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138794806|NCT02299999|Capecitabine|capecitabine|mesh-list
138794807|NCT02299999|Methotrexate|methotrexate|mesh-list
138794808|NCT02299999|Durvalumab|durvalumab|mesh-list
138794809|NCT02299999|Epirubicin|epirubicin|mesh-list
138794810|NCT02299999|Olaparib|olaparib|mesh-list
138794811|NCT02299999|Mitomycins|mitomycins|mesh-list
138794812|NCT02299999|Mitomycin|mitomycin|mesh-list
138794813|NCT02299999|Bicalutamide|bicalutamide|mesh-list
138794814|NCT02299999|Taxane|taxane|mesh-list
138794815|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794816|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794817|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
138794818|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
138794819|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
138407279|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
138407280|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138407281|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
138794820|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794821|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138794822|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
138794823|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794824|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138794825|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138794826|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
138794827|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138794828|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794829|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138794830|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138794831|NCT02299999|Growth Substances|growth substances|mesh-ancestor
138794832|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
138794833|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138794834|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
138794835|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138794836|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138794837|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138794838|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794839|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138794840|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
138407333|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
138407342|NCT01598558|Rituximab|rituximab|mesh-list
138794841|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138794842|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
138794843|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138794844|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138794845|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138794846|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
138794847|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
138794848|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138794849|NCT02275533|Nivolumab|nivolumab|mesh-list
138794850|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794851|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794852|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794853|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794854|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
138794855|NCT02251548|Rituximab|rituximab|mesh-list
138794856|NCT02251548|Fludarabine|fludarabine|mesh-list
138794857|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138794858|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
138794859|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794860|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138794861|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138794862|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
138794863|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794864|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794865|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138794866|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794867|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138794868|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794869|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138794870|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794871|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407387|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407388|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
138794872|NCT02152982|Temozolomide|temozolomide|mesh-list
138794873|NCT02152982|Veliparib|veliparib|mesh-list
138794874|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138794875|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
138794876|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186747|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138186748|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138794877|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794878|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138794879|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794880|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
138794881|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
138794882|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138794883|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794884|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794885|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
138794886|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138794887|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138794888|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794889|NCT02117167|Pemetrexed|pemetrexed|mesh-list
138794890|NCT02117167|Durvalumab|durvalumab|mesh-list
138794891|NCT02117167|Olaparib|olaparib|mesh-list
138794892|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407428|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407429|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794893|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794894|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794895|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138794896|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138794897|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794898|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138794899|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
138794900|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794901|NCT02106988|Dexamethasone|dexamethasone|mesh-list
138794902|NCT02106988|Carboplatin|carboplatin|mesh-list
138794903|NCT02106988|Etoposide|etoposide|mesh-list
138794904|NCT02106988|Ifosfamide|ifosfamide|mesh-list
138794905|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
138794906|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138794907|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
138794908|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
138794909|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138794910|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794911|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138794912|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
138794913|NCT02106988|Hormones|hormones|mesh-ancestor
138794914|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138794915|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138794916|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794917|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794918|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138407480|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138407481|NCT01599377|Tofacitinib|tofacitinib|mesh-list
138794919|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138794920|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794921|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794922|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138794923|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
138794925|NCT02101788|Paclitaxel|paclitaxel|mesh-list
138794926|NCT02101788|Doxorubicin|doxorubicin|mesh-list
138794927|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138794928|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138794929|NCT02101788|Letrozole|letrozole|mesh-list
138794930|NCT02101788|Topotecan|topotecan|mesh-list
138794931|NCT02101788|Trametinib|trametinib|mesh-list
138794932|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138794933|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138794934|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794935|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
138794936|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
138794937|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
138794938|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794939|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138794940|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138794941|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138794942|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138794943|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138794944|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138794945|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138794946|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
138794947|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138794948|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794949|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138794950|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138407531|NCT05689983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138794951|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138794952|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138407539|NCT05689983|Hormones|hormones|mesh-ancestor
138794953|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138794954|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138794955|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138794956|NCT02101788|Protective Agents|protective agents|mesh-ancestor
138172381|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138794957|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138794958|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
138794959|NCT01950390|Bevacizumab|bevacizumab|mesh-list
138794960|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138794961|NCT01950390|Ipilimumab|ipilimumab|mesh-list
138794962|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
138794963|NCT01950390|Antibodies|antibodies|mesh-list
138794964|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
138794965|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138794966|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
138794967|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794968|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138794969|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138794970|NCT01950390|Growth Substances|growth substances|mesh-ancestor
138794971|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794972|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
138794973|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
138267824|NCT02908477|Docetaxel|docetaxel|mesh-list
138794974|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794975|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794976|NCT01928394|Nivolumab|nivolumab|mesh-list
138794977|NCT01928394|Ipilimumab|ipilimumab|mesh-list
138794978|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138794979|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794980|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138794981|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794982|NCT01886872|Rituximab|rituximab|mesh-list
138794983|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138794984|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138407572|NCT05689242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138794985|NCT01886872|Antibodies|antibodies|mesh-list
138794986|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
138407573|NCT05689242|Adrenergic Agents|adrenergic agents|mesh-ancestor
138794987|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138407574|NCT05689242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138407576|NCT05689242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138794988|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
138794989|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138794990|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138794991|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138794992|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138794993|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
138794994|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138794995|NCT01864018|Dexamethasone|dexamethasone|mesh-list
138794996|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
138794997|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
138794998|NCT01864018|Ixazomib|ixazomib|mesh-list
138794999|NCT01864018|Ichthammol|ichthammol|mesh-list
138795000|NCT01864018|BB 1101|bb 1101|mesh-list
138795001|NCT01864018|Glycine|glycine|mesh-list
138795002|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795003|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
138795004|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795005|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795006|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138795007|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
138795008|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795009|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795010|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138795011|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138795012|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
138795013|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
138795014|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138795015|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138795016|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
138795017|NCT01864018|Hormones|hormones|mesh-ancestor
138795018|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138795019|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138795020|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
138407607|NCT05540184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407608|NCT05540184|Gout Suppressants|gout suppressants|mesh-ancestor
138795021|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795022|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
138795023|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
138795024|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138795025|NCT01856192|Prednisone|prednisone|mesh-list
138795026|NCT01856192|Cortisone|cortisone|mesh-list
138795027|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
138795028|NCT01856192|Rituximab|rituximab|mesh-list
138795029|NCT01856192|Doxorubicin|doxorubicin|mesh-list
138795030|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138795031|NCT01856192|Vincristine|vincristine|mesh-list
138795032|NCT01856192|Lenalidomide|lenalidomide|mesh-list
138795033|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138795034|NCT01856192|Antibodies|antibodies|mesh-list
138186818|NCT04347005|Protective Agents|protective agents|mesh-ancestor
138795035|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
138795037|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795038|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
138795039|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795040|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795041|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138795042|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
138795043|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795044|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795045|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138795046|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138795047|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138795048|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138795049|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795050|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138795051|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
138795052|NCT01856192|Hormones|hormones|mesh-ancestor
138451960|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138795053|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138795054|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138795055|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795056|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795057|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795058|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795059|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138795060|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795061|NCT01856192|Growth Substances|growth substances|mesh-ancestor
138795062|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
138795063|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
138795064|NCT01850108|Sirolimus|sirolimus|mesh-list
138795065|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
138795066|NCT01850108|Fludarabine|fludarabine|mesh-list
138795067|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
138795068|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795069|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
138795070|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795071|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795072|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138795073|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
138795074|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795075|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795076|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138795077|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138186829|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
138407697|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138407698|NCT04753216|Bevacizumab|bevacizumab|mesh-list
138795078|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138795079|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
138795080|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138407699|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138407701|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
138795081|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795082|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795083|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
138795085|NCT01844505|Ipilimumab|ipilimumab|mesh-list
138795086|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138795087|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795088|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138795089|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795090|NCT01796171|Rituximab|rituximab|mesh-list
138795091|NCT01796171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138795092|NCT01796171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795093|NCT01796171|Immunologic Factors|immunologic factors|mesh-ancestor
138795094|NCT01796171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795095|NCT01796171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795096|NCT01620944|Ritonavir|ritonavir|mesh-list
138795097|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138795098|NCT01620944|Tenofovir|tenofovir|mesh-list
138795099|NCT01620944|Lamivudine|lamivudine|mesh-list
138795100|NCT01620944|Emtricitabine|emtricitabine|mesh-list
138795101|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138795102|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138795103|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
138795104|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795105|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795106|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138795107|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138795108|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
138795109|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795110|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138795111|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138795112|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138795113|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138795114|NCT01522976|Lenalidomide|lenalidomide|mesh-list
138795115|NCT01522976|Azacitidine|azacitidine|mesh-list
138795116|NCT01522976|Vorinostat|vorinostat|mesh-list
138795117|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
138407745|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
138407746|NCT04563494|Hormones|hormones|mesh-ancestor
138407748|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138795118|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795119|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138267901|NCT02568618|Analgesics|analgesics|mesh-list
138795120|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795121|NCT01522976|Growth Substances|growth substances|mesh-ancestor
138795122|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
138795123|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795124|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138795125|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
138795126|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795127|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795128|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138795129|NCT01444469|Azithromycin|azithromycin|mesh-list
138795130|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138795131|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795132|NCT01386385|Paclitaxel|paclitaxel|mesh-list
138795133|NCT01386385|Carboplatin|carboplatin|mesh-list
138795134|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138795135|NCT01386385|Veliparib|veliparib|mesh-list
138795136|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795137|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407784|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138795138|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795139|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
138407785|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795140|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795141|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795142|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138795143|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795145|NCT01371981|Etoposide|etoposide|mesh-list
138795146|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
138795147|NCT01371981|Daunorubicin|daunorubicin|mesh-list
138795148|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
138795149|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
138795150|NCT01371981|Bortezomib|bortezomib|mesh-list
138795151|NCT01371981|Sorafenib|sorafenib|mesh-list
138795152|NCT01371981|Asparaginase|asparaginase|mesh-list
138795153|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795154|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795155|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138795156|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138795157|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795158|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795159|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138795160|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
138795161|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
138795162|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795163|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138267932|NCT02514382|Hormones|hormones|mesh-ancestor
138795165|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795166|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138795167|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138407833|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138407834|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138795168|NCT01371981|Analgesics|analgesics|mesh-ancestor
138795169|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
138795170|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138795171|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
138795172|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
138452002|NCT01873313|Ropivacaine|ropivacaine|mesh-list
138795173|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795174|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795175|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795176|NCT01345851|Paclitaxel|paclitaxel|mesh-list
138795177|NCT01345851|Carboplatin|carboplatin|mesh-list
138795178|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795179|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795180|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795181|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795182|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795183|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795184|NCT01274338|Interferons|interferons|mesh-list
138795185|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
138795186|NCT01274338|Interferon alpha-2|interferon alpha-2|mesh-list
138795187|NCT01274338|Ipilimumab|ipilimumab|mesh-list
138795188|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795189|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
138795190|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795191|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138795192|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138795193|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795194|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
138795195|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795196|NCT01272037|Tamoxifen|tamoxifen|mesh-list
138795197|NCT01272037|Letrozole|letrozole|mesh-list
138795198|NCT01272037|Anastrozole|anastrozole|mesh-list
138795199|NCT01272037|Exemestane|exemestane|mesh-list
138795200|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795201|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795202|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138795203|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138795204|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795205|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138795206|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
138795207|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138795208|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795209|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138795210|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138186871|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
138795211|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138795212|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138407879|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407880|NCT03272334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138407882|NCT03258281|Evolocumab|evolocumab|mesh-list
138795214|NCT01199575|Lenalidomide|lenalidomide|mesh-list
138795215|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138795216|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795217|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
138795218|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795219|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795220|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138795221|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795222|NCT01199575|Growth Substances|growth substances|mesh-ancestor
138795223|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
138795224|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
138795225|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
138795226|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795227|NCT01169922|Ethanol|ethanol|mesh-list
138795228|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138795229|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795230|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452021|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
138795231|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795232|NCT01169337|Lenalidomide|lenalidomide|mesh-list
138795233|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
138795234|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795235|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138795236|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795237|NCT01169337|Growth Substances|growth substances|mesh-ancestor
138795238|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
138795239|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795240|NCT01167712|Paclitaxel|paclitaxel|mesh-list
138795241|NCT01167712|Bevacizumab|bevacizumab|mesh-list
138795242|NCT01167712|Carboplatin|carboplatin|mesh-list
138795243|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138795244|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138795245|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
138795246|NCT01167712|Antibodies|antibodies|mesh-list
138795247|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
138795248|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138795249|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
138795250|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138267998|NCT02409147|Nystatin|nystatin|mesh-list
138795251|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795252|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795253|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795254|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795255|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795256|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138795257|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795258|NCT01167712|Growth Substances|growth substances|mesh-ancestor
138795259|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795260|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
138172678|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
138795261|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
138795263|NCT01081262|Bevacizumab|bevacizumab|mesh-list
138795265|NCT01081262|Capecitabine|capecitabine|mesh-list
138795266|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
138795267|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138795268|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138795269|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
138795270|NCT01081262|Antibodies|antibodies|mesh-list
138407905|NCT05705336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138407906|NCT05705336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795271|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
138795272|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138795273|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
138795274|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795275|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795276|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795277|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795278|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795279|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795280|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138795281|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795295|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138795296|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138795297|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138795311|NCT00980460|Sirolimus|sirolimus|mesh-list
138795312|NCT00980460|Cisplatin|cisplatin|mesh-list
138795313|NCT00980460|Doxorubicin|doxorubicin|mesh-list
138795314|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138795315|NCT00980460|Fluorouracil|fluorouracil|mesh-list
138795316|NCT00980460|Irinotecan|irinotecan|mesh-list
138795317|NCT00980460|Vincristine|vincristine|mesh-list
138795318|NCT00980460|Temsirolimus|temsirolimus|mesh-list
138795319|NCT00980460|Camptothecin|camptothecin|mesh-list
138795320|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
138795321|NCT00980460|Razoxane|razoxane|mesh-list
138186892|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138795322|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
138795324|NCT00980460|Liver Extracts|liver extracts|mesh-list
138795325|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795326|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138795327|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138795328|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138268076|NCT02207712|Ranibizumab|ranibizumab|mesh-list
138795329|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795330|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795331|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
138795332|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138795333|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795334|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
138795335|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795336|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138407922|NCT05704894|Hematinics|hematinics|mesh-ancestor
138795337|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795338|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
138407923|NCT05704816|Anesthetics|anesthetics|mesh-list
138407924|NCT05704816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138407926|NCT05704114|Tazarotene|tazarotene|mesh-list
138795339|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795340|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795341|NCT00980460|Hematinics|hematinics|mesh-ancestor
138795342|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138795343|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795344|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
138795345|NCT00980460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138795346|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138795347|NCT00980460|Protective Agents|protective agents|mesh-ancestor
138795348|NCT00977574|Sirolimus|sirolimus|mesh-list
138795349|NCT00977574|Paclitaxel|paclitaxel|mesh-list
138795350|NCT00977574|Epothilones|epothilones|mesh-list
138795351|NCT00977574|Epothilone B|epothilone b|mesh-list
138795352|NCT00977574|Bevacizumab|bevacizumab|mesh-list
138795353|NCT00977574|Carboplatin|carboplatin|mesh-list
138795354|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138795355|NCT00977574|Temsirolimus|temsirolimus|mesh-list
138795356|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138795357|NCT00977574|MTOR Inhibitors|mtor inhibitors|mesh-list
138795358|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
138795359|NCT00977574|Antibodies|antibodies|mesh-list
138795360|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
138795361|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138795362|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
138795363|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795364|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795365|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795366|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795367|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795368|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795369|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138795370|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795371|NCT00977574|Growth Substances|growth substances|mesh-ancestor
138407953|NCT05702190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138795372|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795373|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
138407954|NCT05702190|Narcotics|narcotics|mesh-ancestor
138407955|NCT05702190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138795374|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
138795375|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138795376|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795377|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138795378|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
138795379|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795380|NCT00977574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138795381|NCT00977574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795382|NCT00972478|Prednisone|prednisone|mesh-list
138795383|NCT00972478|Cortisone|cortisone|mesh-list
138795384|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
138795385|NCT00972478|Rituximab|rituximab|mesh-list
138795386|NCT00972478|Doxorubicin|doxorubicin|mesh-list
138795387|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138795388|NCT00972478|Vincristine|vincristine|mesh-list
138795389|NCT00972478|Vorinostat|vorinostat|mesh-list
138795390|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138795391|NCT00972478|Antibodies|antibodies|mesh-list
138795392|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
138795393|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138795394|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795395|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
138795396|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795397|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795398|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138795399|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
138795400|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795401|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795402|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138795403|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138795404|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138452074|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
138795405|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138795406|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795407|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138407993|NCT05458232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138795408|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
138407994|NCT05458232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138795409|NCT00972478|Hormones|hormones|mesh-ancestor
138795410|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138795411|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138407998|NCT05274243|Phenol|phenol|mesh-list
138795412|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795413|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795414|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795415|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795416|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138795417|NCT00861705|Paclitaxel|paclitaxel|mesh-list
138172836|NCT03432650|Hormones|hormones|mesh-ancestor
138795418|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
138795419|NCT00861705|Bevacizumab|bevacizumab|mesh-list
138795420|NCT00861705|Carboplatin|carboplatin|mesh-list
138795421|NCT00861705|Doxorubicin|doxorubicin|mesh-list
138795422|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138795423|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138795424|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138795425|NCT00861705|Antibodies|antibodies|mesh-list
138795426|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
138795427|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138795428|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
138795429|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
138795430|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795431|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795432|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795433|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795434|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
138408030|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138795435|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795436|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795437|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
138795438|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795439|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795440|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138795441|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
138795442|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138795443|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138795444|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795445|NCT00861705|Growth Substances|growth substances|mesh-ancestor
138408031|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
138795446|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
138795447|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138408032|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795448|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138795449|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138795450|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795451|NCT00843882|Lenalidomide|lenalidomide|mesh-list
138795452|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
138795453|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
138795454|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795455|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138795456|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795457|NCT00843882|Growth Substances|growth substances|mesh-ancestor
138186933|NCT02241941|Daptomycin|daptomycin|mesh-list
138795459|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795460|NCT00843882|Hematinics|hematinics|mesh-ancestor
138795461|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
138795462|NCT00792948|Leucovorin|leucovorin|mesh-list
138795463|NCT00792948|Folic Acid|folic acid|mesh-list
138795464|NCT00792948|Cytarabine|cytarabine|mesh-list
138795465|NCT00792948|Sirolimus|sirolimus|mesh-list
138795466|NCT00792948|Dexamethasone|dexamethasone|mesh-list
138795467|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
138795468|NCT00792948|Prednisone|prednisone|mesh-list
138795469|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
138795470|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138795471|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138795472|NCT00792948|Prednisolone|prednisolone|mesh-list
138408070|NCT04077515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408072|NCT03841110|Aldesleukin|aldesleukin|mesh-list
138795473|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
138795474|NCT00792948|Cortisone|cortisone|mesh-list
138795475|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
138795476|NCT00792948|Doxorubicin|doxorubicin|mesh-list
138795477|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138795478|NCT00792948|Methotrexate|methotrexate|mesh-list
138795479|NCT00792948|Etoposide|etoposide|mesh-list
138795480|NCT00792948|Vincristine|vincristine|mesh-list
138795481|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
138795482|NCT00792948|Dasatinib|dasatinib|mesh-list
138795483|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
138795484|NCT00792948|Tacrolimus|tacrolimus|mesh-list
138795485|NCT00792948|Lenograstim|lenograstim|mesh-list
138795486|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138795487|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
138795489|NCT00792948|Calcium|calcium|mesh-list
138795490|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
138795491|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795492|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
138795493|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795494|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795495|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138795496|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
138795497|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795498|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795499|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138795500|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138795502|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
138795503|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138795504|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138795505|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
138795506|NCT00792948|Hormones|hormones|mesh-ancestor
138795507|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138795508|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138795509|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
138795510|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186940|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
138795511|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138795512|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138795513|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138408122|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138268263|NCT01059786|Pentostatin|pentostatin|mesh-list
138795514|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138795515|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138795516|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138795517|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
138795518|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138795519|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138795520|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
138795521|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
138795522|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138795523|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138795524|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795525|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
138795526|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795527|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138795528|NCT00792948|Antidotes|antidotes|mesh-ancestor
138795529|NCT00792948|Protective Agents|protective agents|mesh-ancestor
138795530|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
138795531|NCT00792948|Vitamins|vitamins|mesh-ancestor
138795532|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
138795533|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138795534|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795535|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795536|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795537|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138795538|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
138795539|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138795540|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138795541|NCT00792948|Hematinics|hematinics|mesh-ancestor
138795542|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
138795543|NCT00769379|Trastuzumab|trastuzumab|mesh-list
138795544|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
138795545|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138795546|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795547|NCT00750841|Cediranib|cediranib|mesh-list
138795548|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795549|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138795550|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795551|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795552|NCT00658814|Azacitidine|azacitidine|mesh-list
138795553|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
138795554|NCT00658814|Calicheamicins|calicheamicins|mesh-list
138795555|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138795556|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
138702095|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795557|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795558|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795559|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795560|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138795561|NCT00658814|Immunotoxins|immunotoxins|mesh-ancestor
138795562|NCT00658814|Immunoconjugates|immunoconjugates|mesh-ancestor
138795563|NCT00658814|Immunologic Factors|immunologic factors|mesh-ancestor
138795564|NCT00658814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795565|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138795566|NCT00644228|Dexamethasone|dexamethasone|mesh-list
138795567|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
138795568|NCT00644228|Lenalidomide|lenalidomide|mesh-list
138795569|NCT00644228|Bortezomib|bortezomib|mesh-list
138795570|NCT00644228|Ichthammol|ichthammol|mesh-list
138795571|NCT00644228|BB 1101|bb 1101|mesh-list
138795572|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138795573|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
138795574|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
138795575|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138795576|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795577|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138795578|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
138795580|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138795581|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138795582|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795583|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
138795584|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408198|NCT02990806|Infliximab|infliximab|mesh-list
138408199|NCT02990806|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138795585|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795586|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
138795587|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138795588|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795589|NCT00644228|Growth Substances|growth substances|mesh-ancestor
138795590|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
138795591|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
138795592|NCT00588770|Bevacizumab|bevacizumab|mesh-list
138795593|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138795594|NCT00588770|Cisplatin|cisplatin|mesh-list
138795595|NCT00588770|Carboplatin|carboplatin|mesh-list
138795596|NCT00588770|Docetaxel|docetaxel|mesh-list
138795597|NCT00588770|Fluorouracil|fluorouracil|mesh-list
138795598|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
138795599|NCT00588770|Antibodies|antibodies|mesh-list
138795600|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
138795601|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138795602|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
138795603|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795604|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138795605|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795606|NCT00588770|Growth Substances|growth substances|mesh-ancestor
138795607|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795608|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
138795609|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
138795610|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795611|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795612|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795613|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795614|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
138795615|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138795616|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795617|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
138795618|NCT00470223|Doxorubicin|doxorubicin|mesh-list
138795619|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138795621|NCT00470223|Etoposide|etoposide|mesh-list
138795622|NCT00470223|Ifosfamide|ifosfamide|mesh-list
138268392|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
138795623|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795624|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138795625|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138795626|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138795628|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795629|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138795630|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
138795631|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138795632|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795633|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138795634|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
138795635|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
138408235|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138408236|NCT02039063|Quetmolimab|quetmolimab|mesh-list
138795636|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138795637|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795638|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
138795639|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795640|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138795641|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795642|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138795643|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
138795644|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138795645|NCT00433511|Paclitaxel|paclitaxel|mesh-list
138795646|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
138795647|NCT00433511|Bevacizumab|bevacizumab|mesh-list
138795649|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138795650|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138795651|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138795652|NCT00433511|Antibodies|antibodies|mesh-list
138795653|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
138795654|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138795656|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
138795657|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795658|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795659|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795660|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795661|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795662|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795663|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795664|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
138795665|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795666|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795667|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138795668|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
138795669|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138795670|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138795671|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795672|NCT00433511|Growth Substances|growth substances|mesh-ancestor
138795673|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
138795674|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138795675|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138795676|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138795677|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795678|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
138795680|NCT00408005|Folic Acid|folic acid|mesh-list
138795681|NCT00408005|Cytarabine|cytarabine|mesh-list
138795682|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
138795683|NCT00408005|Dexamethasone|dexamethasone|mesh-list
138795684|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
138795685|NCT00408005|Prednisone|prednisone|mesh-list
138795686|NCT00408005|Cortisone|cortisone|mesh-list
138795687|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
138795689|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138795690|NCT00408005|Methotrexate|methotrexate|mesh-list
138795691|NCT00408005|Vincristine|vincristine|mesh-list
138795692|NCT00408005|Daunorubicin|daunorubicin|mesh-list
138795693|NCT00408005|Asparaginase|asparaginase|mesh-list
138795694|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
138795695|NCT00408005|Pegaspargase|pegaspargase|mesh-list
138795696|NCT00408005|Thioguanine|thioguanine|mesh-list
138795697|NCT00408005|BB 1101|bb 1101|mesh-list
138795698|NCT00408005|Calcium|calcium|mesh-list
138795699|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
138795700|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
138795701|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795702|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
138795703|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795704|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795705|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138795706|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
138795707|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795708|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795709|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138795710|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138795711|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
138795712|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
138795713|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138795714|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138795715|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
138795716|NCT00408005|Hormones|hormones|mesh-ancestor
138795717|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138795718|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138795719|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
138795720|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795721|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138795722|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138795723|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138795724|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138795725|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138795726|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138795727|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
138173127|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
138795728|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138795729|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138795730|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
138795731|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
138795732|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138795733|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138408303|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
138795734|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
138795735|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795736|NCT00408005|Antidotes|antidotes|mesh-ancestor
138795737|NCT00408005|Protective Agents|protective agents|mesh-ancestor
138795738|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
138795739|NCT00408005|Vitamins|vitamins|mesh-ancestor
138795740|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
138795741|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795742|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795743|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795744|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795745|NCT00408005|Hematinics|hematinics|mesh-ancestor
138795746|NCT00324805|Bevacizumab|bevacizumab|mesh-list
138795747|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138795748|NCT00324805|Cisplatin|cisplatin|mesh-list
138795749|NCT00324805|Gemcitabine|gemcitabine|mesh-list
138795750|NCT00324805|Docetaxel|docetaxel|mesh-list
138795751|NCT00324805|Pemetrexed|pemetrexed|mesh-list
138795752|NCT00324805|Vinorelbine|vinorelbine|mesh-list
138795753|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
138795754|NCT00324805|Antibodies|antibodies|mesh-list
138795755|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
138795756|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138795757|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
138795758|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795759|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138795760|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795761|NCT00324805|Growth Substances|growth substances|mesh-ancestor
138795762|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795763|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
138795764|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
138408317|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
138795765|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138795766|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
138795767|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795768|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795769|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795770|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795771|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795772|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138795773|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138795774|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795775|NCT00310180|Tamoxifen|tamoxifen|mesh-list
138795776|NCT00310180|Letrozole|letrozole|mesh-list
138795777|NCT00310180|Anastrozole|anastrozole|mesh-list
138795778|NCT00310180|Exemestane|exemestane|mesh-list
138268550|NCT00358124|Metformin|metformin|mesh-list
138795779|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795780|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795781|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138795782|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138795783|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795784|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138795785|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
138795786|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138795787|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795788|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138795789|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138795790|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138795791|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138795792|NCT02866032|Ciclopirox|ciclopirox|mesh-list
138795793|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
138795794|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795795|NCT00976716|Celecoxib|celecoxib|mesh-list
138795796|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138795797|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138795798|NCT00976716|Analgesics|analgesics|mesh-ancestor
138795799|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
138795800|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138795801|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795802|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138795803|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795804|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138795805|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138795806|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795807|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795808|NCT00973674|Estrogens|estrogens|mesh-list
138795810|NCT00973674|Hormones|hormones|mesh-ancestor
138795811|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138795812|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795813|NCT00819091|Linagliptin|linagliptin|mesh-list
138795814|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138795815|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795816|NCT00819091|Incretins|incretins|mesh-ancestor
138795817|NCT00819091|Hormones|hormones|mesh-ancestor
138795818|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138795819|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138795820|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
138795821|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795822|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795823|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
138795824|NCT02864784|Calcium|calcium|mesh-list
138795825|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138795826|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795827|NCT02864784|Antacids|antacids|mesh-ancestor
138795828|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795829|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138795830|NCT00819013|Vaccines|vaccines|mesh-list
138795831|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
138795832|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795833|NCT04868461|Caseins|caseins|mesh-list
138795834|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
138795835|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
138795836|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795837|NCT02865642|Escitalopram|escitalopram|mesh-list
138795838|NCT02865642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138795839|NCT02865642|Serotonin|serotonin|mesh-list
138795840|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138795841|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138187088|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795842|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795843|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138795844|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
138408401|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795845|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795846|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138795847|NCT03762564|Paclitaxel|paclitaxel|mesh-list
138795848|NCT03762564|Ramucirumab|ramucirumab|mesh-list
138795849|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795850|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795851|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795852|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795853|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795854|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795855|NCT00629616|Fulvestrant|fulvestrant|mesh-list
138795856|NCT00629616|Anastrozole|anastrozole|mesh-list
138795857|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138795858|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795859|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138795860|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138795861|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
138795862|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138795863|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795864|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138795865|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138795866|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795867|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795868|NCT02864628|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138795869|NCT02864628|Antiviral Agents|antiviral agents|mesh-ancestor
138795870|NCT02864628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795871|NCT01120184|Paclitaxel|paclitaxel|mesh-list
138795872|NCT01120184|Maytansine|maytansine|mesh-list
138795873|NCT01120184|Docetaxel|docetaxel|mesh-list
138795874|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138795875|NCT01120184|Trastuzumab|trastuzumab|mesh-list
138795876|NCT01120184|Pertuzumab|pertuzumab|mesh-list
138795877|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138795878|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795879|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
138795880|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
138795881|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
138795882|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795883|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138795884|NCT01120184|Immunotoxins|immunotoxins|mesh-ancestor
138795885|NCT01120184|Immunoconjugates|immunoconjugates|mesh-ancestor
138795886|NCT01120184|Immunologic Factors|immunologic factors|mesh-ancestor
138795887|NCT01120184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795889|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
138795890|NCT01120028|Tacrolimus|tacrolimus|mesh-list
138795891|NCT01120028|Basiliximab|basiliximab|mesh-list
138795892|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795893|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
138187097|NCT05475639|Diclofenac|diclofenac|mesh-list
138795894|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795895|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138795896|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795897|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795898|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138268659|NCT02362321|Hormones|hormones|mesh-ancestor
138795899|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795900|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138795901|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795902|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
138795903|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138795905|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138795906|NCT00878800|Belinostat|belinostat|mesh-list
138795907|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138795908|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795909|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138795910|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138795911|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795912|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795913|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138795914|NCT00662272|Vaccines|vaccines|mesh-list
138795915|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
138795916|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795917|NCT04158856|Trastuzumab|trastuzumab|mesh-list
138795918|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138795919|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795920|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
138795921|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138795922|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138795923|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138795924|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
138795925|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138795926|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795927|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795928|NCT02882828|Tacrolimus|tacrolimus|mesh-list
138795929|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138795930|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
138795931|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795932|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138795933|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795934|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795935|NCT02882126|Treprostinil|treprostinil|mesh-list
138795936|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138795937|NCT01145222|Midazolam|midazolam|mesh-list
138795938|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138795939|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138795940|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138795941|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795942|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138795943|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138795944|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138795945|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138795946|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
138795947|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
138795948|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
138795949|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
138795950|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138795951|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795952|NCT01145066|Borage oil|borage oil|mesh-list
138795953|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795954|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
138795955|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
138795956|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138795957|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138795958|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138795959|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795960|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795961|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138795962|NCT00637442|Galantamine|galantamine|mesh-list
138795963|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138795964|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138795965|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795966|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
138795967|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138795968|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795969|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138795970|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
138795971|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138795972|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
138795973|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138408488|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138408490|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
138795974|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138795975|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138795976|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138795977|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138795978|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
138795979|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138795980|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795981|NCT02864472|Ranibizumab|ranibizumab|mesh-list
138795982|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138795983|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138795984|NCT02864472|Growth Substances|growth substances|mesh-ancestor
138795985|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795986|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
138795987|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138795988|NCT00975000|Cinacalcet|cinacalcet|mesh-list
138795989|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138795990|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138795991|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138795992|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
138795993|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138795994|NCT02863614|Ibuprofen|ibuprofen|mesh-list
138795995|NCT02863614|Lorazepam|lorazepam|mesh-list
138795996|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138795997|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138795998|NCT02863614|Analgesics|analgesics|mesh-ancestor
138795999|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
138796000|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796001|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796002|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138796003|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138796004|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138796005|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796006|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796007|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
138796008|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
138796009|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
138796010|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138796011|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138408522|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138408523|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
138796012|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796013|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138796014|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138796015|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138796016|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
138796017|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
138796018|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796019|NCT00974922|Vitamin D|vitamin d|mesh-list
138796020|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
138796021|NCT00974922|Vitamins|vitamins|mesh-ancestor
138796022|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
138796023|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796024|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138796025|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138796026|NCT00972504|Cetirizine|cetirizine|mesh-list
138796027|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138796028|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138796029|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138796030|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
138796031|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
138173466|NCT00738049|Darusentan|darusentan|mesh-list
138796032|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796033|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796034|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796035|NCT00969150|Milnacipran|milnacipran|mesh-list
138796036|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
138796037|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138796038|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138796039|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138796040|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796041|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796042|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796043|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
138796044|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138796045|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138796046|NCT00969150|Analgesics|analgesics|mesh-ancestor
138796047|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
138796048|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796049|NCT00974220|Fentanyl|fentanyl|mesh-list
138796050|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138796051|NCT00974220|Narcotics|narcotics|mesh-ancestor
138796052|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796053|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796054|NCT00974220|Analgesics|analgesics|mesh-ancestor
138796055|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
138796056|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796057|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138796058|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138408557|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138796059|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
138796060|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
138796061|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
138796062|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138796063|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796064|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796065|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138796066|NCT00971178|Analgesics|analgesics|mesh-ancestor
138796067|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
138796068|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796069|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138796070|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138796071|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138796072|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
138796073|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796074|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796075|NCT00970944|Amantadine|amantadine|mesh-list
138796076|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138796077|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138796078|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
138796079|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138796080|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
138796081|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796082|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796083|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796084|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138796085|NCT00970944|Analgesics|analgesics|mesh-ancestor
138796086|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
138796087|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796088|NCT05780723|Mesalamine|mesalamine|mesh-list
138796089|NCT05780723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138796090|NCT05780723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138796091|NCT05780723|Analgesics|analgesics|mesh-ancestor
138796092|NCT05780723|Sensory System Agents|sensory system agents|mesh-ancestor
138796093|NCT05780723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796094|NCT05780723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796095|NCT05780723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138796096|NCT05780723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138796097|NCT05780515|Immunoglobulins|immunoglobulins|mesh-list
138796098|NCT05780515|Immunoglobulin G|immunoglobulin g|mesh-list
138796099|NCT05780515|Immunologic Factors|immunologic factors|mesh-ancestor
138796100|NCT05780515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796102|NCT05780489|Progesterone|progesterone|mesh-list
138796103|NCT05780489|Estrogens|estrogens|mesh-ancestor
138796104|NCT05780489|Hormones|hormones|mesh-ancestor
138796105|NCT05780489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138173519|NCT01798979|Midazolam|midazolam|mesh-list
138796106|NCT05780489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796107|NCT05780489|Progestins|progestins|mesh-ancestor
138796108|NCT05780320|Amiodarone|amiodarone|mesh-list
138796109|NCT05780320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138796110|NCT05780320|Vasodilator Agents|vasodilator agents|mesh-ancestor
138796111|NCT05780320|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138796112|NCT05780320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138796113|NCT05780320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796114|NCT05780320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138796115|NCT05780320|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138796116|NCT05780320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138796117|NCT05780320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796118|NCT05780320|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138796119|NCT05780320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138796120|NCT05780320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138796121|NCT05780294|Asparaginase|asparaginase|mesh-list
138796122|NCT05780294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796123|NCT05780229|Analgesics|analgesics|mesh-list
138796124|NCT05780229|Sensory System Agents|sensory system agents|mesh-ancestor
138408643|NCT01604213|Metformin|metformin|mesh-list
138796125|NCT05780229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796126|NCT05780229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796127|NCT05780151|Insulin Glargine|insulin glargine|mesh-list
138796128|NCT05780151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138796129|NCT05780151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796130|NCT05780086|Icodextrin|icodextrin|mesh-list
138796131|NCT05780086|Dialysis Solutions|dialysis solutions|mesh-ancestor
138796132|NCT05780086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138796133|NCT05779514|Mirabegron|mirabegron|mesh-list
138796134|NCT05779514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138796135|NCT05779514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138796136|NCT05779514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138796137|NCT05779514|Adrenergic Agents|adrenergic agents|mesh-ancestor
138796138|NCT05779514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796139|NCT05779514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796140|NCT05779514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796141|NCT05779514|Urological Agents|urological agents|mesh-ancestor
138796142|NCT05779423|Nivolumab|nivolumab|mesh-list
138796143|NCT05779423|Ipilimumab|ipilimumab|mesh-list
138796144|NCT05779423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138796145|NCT05779423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796146|NCT05779423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138796147|NCT05779423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796148|NCT05779410|Vitamin D|vitamin d|mesh-list
138796149|NCT05779410|Ergocalciferols|ergocalciferols|mesh-list
138796150|NCT05779410|Cholecalciferol|cholecalciferol|mesh-list
138796151|NCT05779410|Vitamins|vitamins|mesh-list
138796152|NCT05779410|Micronutrients|micronutrients|mesh-ancestor
138796153|NCT05779410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796154|NCT05779410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138796155|NCT05779410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138796156|NCT05779254|Metronidazole|metronidazole|mesh-list
138796157|NCT05779254|Neomycin|neomycin|mesh-list
138796158|NCT05779254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138796159|NCT05779254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138796160|NCT05779254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138796161|NCT05779254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138796162|NCT05779254|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138796163|NCT05779254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796164|NCT05779254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796165|NCT05779059|Ticagrelor|ticagrelor|mesh-list
138796166|NCT05779059|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138796167|NCT05779059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138796168|NCT05779059|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138796169|NCT05779059|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138796170|NCT05779059|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138408666|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138796171|NCT05779059|Purinergic Agents|purinergic agents|mesh-ancestor
138796172|NCT05779059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796173|NCT05779059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796174|NCT05779059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796175|NCT05778422|Anesthetics|anesthetics|mesh-list
138796176|NCT05778422|Anesthetics, Local|anesthetics, local|mesh-list
138796177|NCT05778422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796178|NCT05778422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796179|NCT05778422|Sensory System Agents|sensory system agents|mesh-ancestor
138268887|NCT03226223|Methamphetamine|methamphetamine|mesh-list
138796180|NCT05778422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796182|NCT05769842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138796183|NCT05769842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187189|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
138187191|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187192|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187194|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138187195|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
138796184|NCT05769842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796185|NCT05769842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138796186|NCT05769842|Anesthetics, General|anesthetics, general|mesh-ancestor
138796187|NCT05769842|Anesthetics|anesthetics|mesh-ancestor
138796188|NCT05739929|Colchicine|colchicine|mesh-list
138796189|NCT05739929|Gout Suppressants|gout suppressants|mesh-ancestor
138796190|NCT05739929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138796191|NCT05739929|Tubulin Modulators|tubulin modulators|mesh-ancestor
138796192|NCT05739929|Antimitotic Agents|antimitotic agents|mesh-ancestor
138796193|NCT05739929|Mitosis Modulators|mitosis modulators|mesh-ancestor
138796194|NCT05739929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796195|NCT05739929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796196|NCT05712265|Fluvoxamine|fluvoxamine|mesh-list
138796197|NCT05712265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138796198|NCT05712265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138796199|NCT05712265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796200|NCT05712265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796201|NCT05712265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138796202|NCT05712265|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138796203|NCT05712265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138268927|NCT03226457|Diuretics|diuretics|mesh-ancestor
138796204|NCT05712265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138796205|NCT05712265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796207|NCT05712265|Serotonin Agents|serotonin agents|mesh-ancestor
138796208|NCT05712265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138408694|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
138796209|NCT05712265|Antidepressive Agents|antidepressive agents|mesh-ancestor
138796210|NCT05712265|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138796211|NCT05712265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138796212|NCT05712265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796213|NCT05712265|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138796214|NCT05659654|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138796215|NCT05659654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138796216|NCT05659654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138796217|NCT05637060|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138796218|NCT05637060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138796219|NCT05637060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138796220|NCT05637060|Antimetabolites|antimetabolites|mesh-ancestor
138796221|NCT05637060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796222|NCT05637060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138796223|NCT05637060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138796224|NCT05637060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796225|NCT05616494|Docetaxel|docetaxel|mesh-list
138796226|NCT05616494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796227|NCT05616494|Tubulin Modulators|tubulin modulators|mesh-ancestor
138796228|NCT05616494|Antimitotic Agents|antimitotic agents|mesh-ancestor
138796229|NCT05616494|Mitosis Modulators|mitosis modulators|mesh-ancestor
138796230|NCT05616494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796231|NCT05614609|Lidocaine|lidocaine|mesh-list
138796232|NCT05614609|Anesthetics, Local|anesthetics, local|mesh-ancestor
138796233|NCT05614609|Anesthetics|anesthetics|mesh-ancestor
138796234|NCT05614609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796235|NCT05614609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796236|NCT05614609|Sensory System Agents|sensory system agents|mesh-ancestor
138796237|NCT05614609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796238|NCT05614609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138796239|NCT05614609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138796240|NCT05614609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138796241|NCT05614609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138796242|NCT05614609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796243|NCT05598957|Vitamin D|vitamin d|mesh-list
138796244|NCT05598957|Vitamins|vitamins|mesh-ancestor
138408724|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796245|NCT05598957|Micronutrients|micronutrients|mesh-ancestor
138796246|NCT05598957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796247|NCT05598957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138796248|NCT05567068|Mesalamine|mesalamine|mesh-list
138796249|NCT05567068|Atorvastatin|atorvastatin|mesh-list
138796250|NCT05567068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138796251|NCT05567068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138796252|NCT05567068|Antimetabolites|antimetabolites|mesh-ancestor
138796253|NCT05567068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796254|NCT05567068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138796255|NCT05567068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138796256|NCT05567068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796257|NCT05567068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138796258|NCT05567068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138796259|NCT05567068|Analgesics|analgesics|mesh-ancestor
138796260|NCT05567068|Sensory System Agents|sensory system agents|mesh-ancestor
138796261|NCT05567068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796262|NCT05567068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796263|NCT05567068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138796264|NCT05567068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138796265|NCT05565001|Cromakalim|cromakalim|mesh-list
138796266|NCT05565001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138796267|NCT05565001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138796268|NCT05565001|Autonomic Agents|autonomic agents|mesh-ancestor
138796269|NCT05565001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796270|NCT05565001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796271|NCT05565001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138796272|NCT05565001|Respiratory System Agents|respiratory system agents|mesh-ancestor
138796273|NCT05565001|Parasympatholytics|parasympatholytics|mesh-ancestor
138796274|NCT05565001|Vasodilator Agents|vasodilator agents|mesh-ancestor
138796275|NCT05561062|Atorvastatin|atorvastatin|mesh-list
138796276|NCT05561062|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138796277|NCT05561062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138796278|NCT05561062|Antimetabolites|antimetabolites|mesh-ancestor
138796279|NCT05561062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796280|NCT05561062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138796281|NCT05561062|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138796282|NCT05561062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796283|NCT05444946|Itraconazole|itraconazole|mesh-list
138796284|NCT05444946|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
138796285|NCT05444946|Prednisone|prednisone|mesh-list
138796286|NCT05444946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138796287|NCT05444946|Glucocorticoids|glucocorticoids|mesh-ancestor
138796288|NCT05444946|Hormones|hormones|mesh-ancestor
138796289|NCT05444946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138796290|NCT05444946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796291|NCT05444946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138452464|NCT01876797|Ticagrelor|ticagrelor|mesh-list
138796292|NCT05444946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796293|NCT05444946|Antifungal Agents|antifungal agents|mesh-ancestor
138796294|NCT05444946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138796295|NCT05444946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138796296|NCT05444946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138796297|NCT05444946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796298|NCT05444946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796299|NCT05444946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138408805|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796300|NCT05444946|Hormone Antagonists|hormone antagonists|mesh-ancestor
138796301|NCT05444946|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138796302|NCT05409157|Bisacodyl|bisacodyl|mesh-list
138796303|NCT05409157|Cathartics|cathartics|mesh-ancestor
138796304|NCT05409157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138796305|NCT05409157|Laxatives|laxatives|mesh-ancestor
138796306|NCT05407519|Tislelizumab|tislelizumab|mesh-list
138796307|NCT05407519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138796308|NCT05407519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796309|NCT05355311|Acetylcarnitine|acetylcarnitine|mesh-list
138269044|NCT02979223|Vitamins|vitamins|mesh-ancestor
138796310|NCT05355311|Vitamin B Complex|vitamin b complex|mesh-ancestor
138796312|NCT05355311|Micronutrients|micronutrients|mesh-ancestor
138796313|NCT05355311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796314|NCT05355311|Nootropic Agents|nootropic agents|mesh-ancestor
138796315|NCT05311033|Tranexamic Acid|tranexamic acid|mesh-list
138796316|NCT05311033|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138796317|NCT05311033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138796318|NCT05311033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796319|NCT05311033|Hemostatics|hemostatics|mesh-ancestor
138796320|NCT05311033|Coagulants|coagulants|mesh-ancestor
138796321|NCT05281562|Ascorbic Acid|ascorbic acid|mesh-list
138796323|NCT05281562|Micronutrients|micronutrients|mesh-ancestor
138796324|NCT05281562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796325|NCT05281562|Antioxidants|antioxidants|mesh-ancestor
138796326|NCT05281562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796327|NCT05281562|Protective Agents|protective agents|mesh-ancestor
138796329|NCT05276596|Ephedrine|ephedrine|mesh-list
138796330|NCT05276596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138796331|NCT05276596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138796332|NCT05276596|Adrenergic Agents|adrenergic agents|mesh-ancestor
138796334|NCT05276596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796335|NCT05276596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796336|NCT05276596|Sympathomimetics|sympathomimetics|mesh-ancestor
138796337|NCT05276596|Autonomic Agents|autonomic agents|mesh-ancestor
138796338|NCT05276596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796339|NCT05276596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138796340|NCT05276596|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138796341|NCT05241262|Acetylcysteine|acetylcysteine|mesh-list
138796342|NCT05241262|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138796343|NCT05241262|Antiviral Agents|antiviral agents|mesh-ancestor
138796344|NCT05241262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138408849|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
138796345|NCT05241262|Expectorants|expectorants|mesh-ancestor
138796346|NCT05241262|Respiratory System Agents|respiratory system agents|mesh-ancestor
138796347|NCT05241262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138796348|NCT05241262|Antioxidants|antioxidants|mesh-ancestor
138796349|NCT05241262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796350|NCT05241262|Protective Agents|protective agents|mesh-ancestor
138796351|NCT05241262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796352|NCT05241262|Antidotes|antidotes|mesh-ancestor
138796353|NCT05161936|Lumasiran|lumasiran|mesh-list
138796354|NCT05161936|Renal Agents|renal agents|mesh-ancestor
138796355|NCT05143424|Morphine|morphine|mesh-list
138796356|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138796357|NCT05143424|Narcotics|narcotics|mesh-ancestor
138796358|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796359|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796360|NCT05143424|Analgesics|analgesics|mesh-ancestor
138796361|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
138796362|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796363|NCT05108649|Nicotine|nicotine|mesh-list
138796364|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138796365|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
138796366|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796367|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796368|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138796369|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138796370|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
138187221|NCT04368377|Aspirin|aspirin|mesh-list
138796371|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796372|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796374|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
138796375|NCT05003713|Prednisone|prednisone|mesh-list
138796377|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138796378|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
138796379|NCT05003713|Hormones|hormones|mesh-ancestor
138796380|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138796381|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796382|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138796383|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796384|NCT04907370|Cisplatin|cisplatin|mesh-list
138796385|NCT04907370|Gemcitabine|gemcitabine|mesh-list
138796386|NCT04907370|Antibodies|antibodies|mesh-list
138796387|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
138796388|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
138796389|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796390|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796391|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138796392|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
138408884|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138796393|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796394|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
138796395|NCT04903054|Prednisone|prednisone|mesh-list
138796396|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
138796397|NCT04903054|Tacrolimus|tacrolimus|mesh-list
138796398|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
138796399|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138796400|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138796401|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
138173817|NCT03335540|Nivolumab|nivolumab|mesh-list
138796402|NCT04903054|Hormones|hormones|mesh-ancestor
138796403|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138796404|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796405|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138796406|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796407|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138796408|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
138796409|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138796410|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796411|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796412|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138796413|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138796414|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
138796415|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138796416|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138796419|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796420|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138796421|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138796422|NCT04903054|Protective Agents|protective agents|mesh-ancestor
138796423|NCT04834557|Digoxin|digoxin|mesh-list
138796424|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138796425|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138796426|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138796427|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796428|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796429|NCT04834557|Protective Agents|protective agents|mesh-ancestor
138796430|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796431|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138796432|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138796433|NCT04825093|Vitamin D|vitamin d|mesh-list
138408910|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138796434|NCT04825093|Vitamins|vitamins|mesh-ancestor
138796435|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
138796437|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138796438|NCT04793152|Vancomycin|vancomycin|mesh-list
138796439|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138796440|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138796441|NCT04770493|Lamotrigine|lamotrigine|mesh-list
138796442|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
138796443|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138796444|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138796445|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796446|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138796447|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796448|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138796449|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138796450|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796451|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138796452|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138796453|NCT04741464|Tinzaparin|tinzaparin|mesh-list
138796454|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138796455|NCT04741464|Dalteparin|dalteparin|mesh-list
138796456|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
138796457|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138796458|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138796459|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796460|NCT04663555|Dexamethasone|dexamethasone|mesh-list
138796461|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138796463|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
138796464|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796465|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796466|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138796467|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
138796468|NCT04663555|Hormones|hormones|mesh-ancestor
138796469|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138796470|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138796471|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796472|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138796473|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138796474|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138796475|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138408946|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408949|NCT01611896|Trace Elements|trace elements|mesh-ancestor
138796476|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796477|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
138796478|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796479|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796480|NCT04496024|Ofloxacin|ofloxacin|mesh-list
138796481|NCT04496024|Levofloxacin|levofloxacin|mesh-list
138796482|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138796483|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138796484|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138796485|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138796486|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138796487|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796488|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796489|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796490|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138796491|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138796492|NCT04425473|Esketamine|esketamine|mesh-list
138796493|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
138796494|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138796495|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138796496|NCT04387071|Antibodies|antibodies|mesh-list
138796497|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
138796498|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138796499|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
138796500|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796501|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796502|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
138796503|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138796504|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
138796505|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138796506|NCT04300920|Expectorants|expectorants|mesh-ancestor
138796507|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
138796508|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138796509|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
138796510|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796511|NCT04300920|Protective Agents|protective agents|mesh-ancestor
138796512|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796513|NCT04300920|Antidotes|antidotes|mesh-ancestor
138796514|NCT04252768|Paclitaxel|paclitaxel|mesh-list
138796515|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138796516|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796517|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
138796518|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
138796519|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
138408979|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138408980|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138796520|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796521|NCT04084171|Insulin|insulin|mesh-list
138796523|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138796524|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796525|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138796526|NCT04047706|Nivolumab|nivolumab|mesh-list
138796527|NCT04047706|Temozolomide|temozolomide|mesh-list
138269237|NCT00003399|Hormones|hormones|mesh-ancestor
138796528|NCT04047706|Linrodostat|linrodostat|mesh-list
138796529|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138796530|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796531|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138796532|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796533|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138796534|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
138796535|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796536|NCT03967249|Octreotide|octreotide|mesh-list
138796537|NCT03967249|Lanreotide|lanreotide|mesh-list
138796538|NCT03967249|Somatostatin|somatostatin|mesh-list
138796539|NCT03967249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138796540|NCT03967249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138796541|NCT03967249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796542|NCT03967249|Hormones|hormones|mesh-ancestor
138796543|NCT03967249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138796544|NCT03967249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796545|NCT03935139|Glycerol|glycerol|mesh-list
138796546|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138796547|NCT03935139|Protective Agents|protective agents|mesh-ancestor
138796548|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796549|NCT03926403|Anesthetics|anesthetics|mesh-list
138796550|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796551|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796552|NCT03871621|Metformin|metformin|mesh-list
138796553|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
138409008|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138796554|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
138796555|NCT03871621|Meglitinide|meglitinide|mesh-list
138796556|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138796557|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796558|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138796559|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796560|NCT03867188|Bupivacaine|bupivacaine|mesh-list
138796561|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
138796562|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
138796563|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796564|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796565|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
138796566|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796567|NCT03745040|Bupivacaine|bupivacaine|mesh-list
138796568|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
138796569|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
138796570|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796571|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187256|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187257|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
138187258|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187259|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138796573|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796574|NCT03671967|Meropenem|meropenem|mesh-list
138796575|NCT03671967|Tazobactam|tazobactam|mesh-list
138796576|NCT03671967|Piperacillin|piperacillin|mesh-list
138796577|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138796578|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138796579|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138796580|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138409047|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138409048|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138796581|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796582|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796584|NCT03657810|Promethazine|promethazine|mesh-list
138796585|NCT03657810|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138796586|NCT03657810|Hydrocodone|hydrocodone|mesh-list
138796587|NCT03657810|Oxycodone|oxycodone|mesh-list
138796588|NCT03657810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138796589|NCT03657810|Analgesics|analgesics|mesh-ancestor
138796590|NCT03657810|Sensory System Agents|sensory system agents|mesh-ancestor
138796591|NCT03657810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796592|NCT03657810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796593|NCT03657810|Antipyretics|antipyretics|mesh-ancestor
138796594|NCT03657810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138796595|NCT03657810|Narcotics|narcotics|mesh-ancestor
138796596|NCT03657810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796597|NCT03657810|Antitussive Agents|antitussive agents|mesh-ancestor
138796598|NCT03657810|Respiratory System Agents|respiratory system agents|mesh-ancestor
138796599|NCT03657810|Antipruritics|antipruritics|mesh-ancestor
138796600|NCT03657810|Dermatologic Agents|dermatologic agents|mesh-ancestor
138796601|NCT03657810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138796602|NCT03657810|Histamine Antagonists|histamine antagonists|mesh-ancestor
138796603|NCT03657810|Histamine Agents|histamine agents|mesh-ancestor
138796604|NCT03657810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796605|NCT03657810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796606|NCT03657810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138269283|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138796607|NCT03657810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138796608|NCT03657810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138409088|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138409090|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138796609|NCT03657810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138796610|NCT03640026|Tacrolimus|tacrolimus|mesh-list
138796611|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138796612|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
138796613|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796614|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138796615|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796616|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796617|NCT03544736|Paclitaxel|paclitaxel|mesh-list
138796618|NCT03544736|Carboplatin|carboplatin|mesh-list
138796619|NCT03544736|Nivolumab|nivolumab|mesh-list
138796620|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138796621|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796622|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
138796623|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
138796624|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
138796625|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796626|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138796627|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138796628|NCT03533010|Vitamin D|vitamin d|mesh-list
138796629|NCT03533010|Vitamins|vitamins|mesh-ancestor
138796630|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
138174059|NCT00649961|Melatonin|melatonin|mesh-list
138796631|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796632|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138796633|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
138796634|NCT03409198|Doxorubicin|doxorubicin|mesh-list
138796635|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138796636|NCT03409198|Nivolumab|nivolumab|mesh-list
138796637|NCT03409198|Ipilimumab|ipilimumab|mesh-list
138796638|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138187260|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
138187261|NCT04361513|Hormones|hormones|mesh-ancestor
138796639|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
138796640|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796641|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138796642|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138796643|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
138796644|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269329|NCT00358358|Hormones|hormones|mesh-ancestor
138796645|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796646|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138796647|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138796648|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138796649|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138409133|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
138796650|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796651|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138796652|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138796654|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138796655|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
138796656|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796657|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138796658|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796659|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796660|NCT03236987|Azithromycin|azithromycin|mesh-list
138796661|NCT03236987|Clarithromycin|clarithromycin|mesh-list
138796663|NCT03236987|Ethambutol|ethambutol|mesh-list
138796664|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138796665|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138796666|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138796667|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796668|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796669|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138796670|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138796671|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138796672|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
138796673|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
138796674|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138796675|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138796676|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138796677|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138796678|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138796679|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138796680|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138796681|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
138796682|NCT03094637|Azacitidine|azacitidine|mesh-list
138796683|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138796684|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796685|NCT03094637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138796686|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796687|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138796688|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
138796689|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796690|NCT03055507|Acetaminophen|acetaminophen|mesh-list
138796691|NCT03055507|Ibuprofen|ibuprofen|mesh-list
138796692|NCT03055507|Oxycodone|oxycodone|mesh-list
138187274|NCT05595993|Vasodilator Agents|vasodilator agents|mesh-ancestor
138796693|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138409161|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796695|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
138796696|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796697|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796698|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
138452669|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
138796699|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138796700|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138796701|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138796702|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138796703|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796704|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796705|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138796706|NCT03055507|Narcotics|narcotics|mesh-ancestor
138796707|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796709|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138796710|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
138796711|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796712|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796713|NCT02870738|Triamcinolone|triamcinolone|mesh-list
138796714|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138796715|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
138796716|NCT02870738|Hormones|hormones|mesh-ancestor
138796717|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138796718|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796719|NCT02789982|Propranolol|propranolol|mesh-list
138796720|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
138796721|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
138796722|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138796723|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796724|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796725|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796726|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138796727|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138796728|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
138796729|NCT02667886|Axitinib|axitinib|mesh-list
138796730|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796731|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138796732|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796733|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796734|NCT02587195|Teriflunomide|teriflunomide|mesh-list
138796735|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138796736|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138796737|NCT02587195|Analgesics|analgesics|mesh-ancestor
138796738|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
138796739|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796740|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796741|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138796742|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138796743|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138796744|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
138796746|NCT02582008|Nicotine|nicotine|mesh-list
138796747|NCT02582008|Varenicline|varenicline|mesh-list
138796748|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138796749|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
138796750|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796751|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796752|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138796753|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138796754|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
138796755|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796756|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796757|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138796758|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
138796759|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138796760|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138796761|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138796762|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138796763|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
138796764|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138796765|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138796766|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796767|NCT02502799|Methylphenidate|methylphenidate|mesh-list
138796768|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138796769|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796770|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138409226|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138409227|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138409228|NCT01613573|Hormones|hormones|mesh-list
138409229|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138796771|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138796772|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138796773|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796774|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
138796775|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796776|NCT01993836|Anesthetics|anesthetics|mesh-list
138174186|NCT00654329|Narcotics|narcotics|mesh-ancestor
138796778|NCT01993836|Isoflurane|isoflurane|mesh-list
138796779|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796780|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796781|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138796782|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138796783|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
138796784|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138796785|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138796786|NCT01717586|Pravastatin|pravastatin|mesh-list
138796787|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138796788|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138796789|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
138796790|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796791|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138796792|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138796793|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796794|NCT00753545|Olaparib|olaparib|mesh-list
138409258|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409259|NCT01613807|Insulin|insulin|mesh-list
138452701|NCT01878708|Asparaginase|asparaginase|mesh-list
138796795|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138796796|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796797|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796798|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796799|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
138796800|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138796801|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
138796802|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138796803|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796804|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138796805|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138796806|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138796807|NCT00408447|Fludarabine|fludarabine|mesh-list
138796808|NCT00408447|Busulfan|busulfan|mesh-list
138796809|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
138796810|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796811|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796812|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138796813|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
138796814|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796815|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
138796816|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138796817|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138796818|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138796819|NCT00278915|Fulvestrant|fulvestrant|mesh-list
138796820|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138796821|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796822|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138796823|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138796824|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
138796825|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138796826|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796827|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138796828|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138796829|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138796830|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
138796831|NCT00970632|Tadalafil|tadalafil|mesh-list
138796832|NCT00970632|Tamsulosin|tamsulosin|mesh-list
138796833|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
138796834|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138796835|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138796836|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796837|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796838|NCT00970632|Urological Agents|urological agents|mesh-ancestor
138796839|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138796840|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138796841|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138796842|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
138796843|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796844|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796845|NCT01144364|Rituximab|rituximab|mesh-list
138796846|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138796847|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796848|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
138796849|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174259|NCT00696293|Analgesics|analgesics|mesh-ancestor
138796850|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138796851|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
138796852|NCT00965094|Everolimus|everolimus|mesh-list
138796853|NCT00965094|Tacrolimus|tacrolimus|mesh-list
138796854|NCT00965094|Basiliximab|basiliximab|mesh-list
138796855|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138796856|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
138796857|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796858|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138796859|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409352|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138409353|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
138796860|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796861|NCT00965094|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138796862|NCT00965094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138796863|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796864|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138796865|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138796866|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
138796867|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138796868|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138796869|NCT01131182|Metformin|metformin|mesh-list
138796870|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138796871|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138796872|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796873|NCT01131182|Incretins|incretins|mesh-ancestor
138796874|NCT01131182|Hormones|hormones|mesh-ancestor
138796875|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138796876|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138796877|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
138796878|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796879|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796880|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
138796882|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138796883|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
138796884|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
138796885|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138796886|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796887|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796888|NCT01131104|Urological Agents|urological agents|mesh-ancestor
138796889|NCT04264884|Daratumumab|daratumumab|mesh-list
138796890|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796891|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138796892|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138796893|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138796894|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138796895|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796896|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138796897|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796898|NCT01118780|Analgesics|analgesics|mesh-ancestor
138796899|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
138796900|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796901|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
138796902|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138796903|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
138796904|NCT00629928|Esomeprazole|esomeprazole|mesh-list
138796905|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138796906|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138796907|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138409392|NCT01614301|Trofosfamide|trofosfamide|mesh-list
138409416|NCT01614366|Amlodipine|amlodipine|mesh-list
138796908|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796909|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796910|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
138796911|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
138796912|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138796913|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138796914|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796915|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796916|NCT00964782|Urological Agents|urological agents|mesh-ancestor
138796917|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138796918|NCT02882984|Gefitinib|gefitinib|mesh-list
138796919|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796920|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138796921|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796922|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796923|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138796924|NCT00966654|Incretins|incretins|mesh-ancestor
138796925|NCT00966654|Hormones|hormones|mesh-ancestor
138796926|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138796927|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796928|NCT00625196|Fluticasone|fluticasone|mesh-list
138796929|NCT00625196|Xhance|xhance|mesh-list
138796930|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138796931|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138796932|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
138796933|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796934|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796935|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138796936|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
138796937|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
138796938|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138796939|NCT03262116|Insulin|insulin|mesh-list
138796940|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138796941|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
138796942|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
138796943|NCT03262116|Pancrelipase|pancrelipase|mesh-list
138796944|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138796945|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796946|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138796947|NCT01130168|Amlodipine|amlodipine|mesh-list
138796948|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138796949|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138796950|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138796951|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796952|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138796953|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796954|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
138796955|NCT04283292|Capsaicin|capsaicin|mesh-list
138796956|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
138796957|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
138796958|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
138796959|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796960|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796961|NCT01144052|Interferons|interferons|mesh-list
138796962|NCT01144052|Interferon-beta|interferon-beta|mesh-list
138796963|NCT01144052|Natalizumab|natalizumab|mesh-list
138796964|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
138796965|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796966|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
138796967|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138796968|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
138796969|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796970|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138796971|NCT04283526|Decitabine|decitabine|mesh-list
138796972|NCT04283526|Spartalizumab|spartalizumab|mesh-list
138796973|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138796974|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
138796975|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796976|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138796977|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138796978|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138796979|NCT04283526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138796980|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
138796981|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138796982|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
138796983|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138796984|NCT01117766|Pregabalin|pregabalin|mesh-list
138796985|NCT01117766|Analgesics|analgesics|mesh-ancestor
138796986|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
138796987|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138796988|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138796989|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
138796990|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138796991|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138796992|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138796993|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138796995|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138796996|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138796997|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138796998|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
138796999|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138797000|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138797001|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797002|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
138797003|NCT04312880|Coagulants|coagulants|mesh-ancestor
138797005|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138797006|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138797007|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
138797008|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797009|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409496|NCT01615042|Growth Substances|growth substances|mesh-ancestor
138409497|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
138409498|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797010|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797011|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138797012|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138797013|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138797014|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138797016|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797017|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138797018|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138797019|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797020|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797021|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138797022|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
138797023|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138797024|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797025|NCT01128842|Capecitabine|capecitabine|mesh-list
138797026|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138797027|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
138797028|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797029|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797030|NCT00625274|Esomeprazole|esomeprazole|mesh-list
138797031|NCT00625274|Pantoprazole|pantoprazole|mesh-list
138797032|NCT00625274|Lansoprazole|lansoprazole|mesh-list
138797033|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
138797034|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138797035|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138797036|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138797037|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797038|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797039|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
138797040|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138409540|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
138797041|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138797042|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138797043|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138797044|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797045|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
138797046|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797047|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797048|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138797049|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797050|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138797052|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138797053|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138797054|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
138797055|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797056|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138797057|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138797058|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797059|NCT05132595|Ketorolac|ketorolac|mesh-list
138797060|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138797061|NCT05132595|Esketamine|esketamine|mesh-list
138797062|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138797063|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138797064|NCT05132595|Analgesics|analgesics|mesh-ancestor
138797065|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
138797066|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797067|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797068|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138797069|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797070|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138797071|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797072|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138174480|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
138797073|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
138797074|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138797075|NCT01074047|Azacitidine|azacitidine|mesh-list
138797076|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138797077|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
138452869|NCT01880307|Infliximab|infliximab|mesh-list
138797078|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797079|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797080|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797081|NCT05226117|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138797082|NCT05226117|Immunoconjugates|immunoconjugates|mesh-ancestor
138797083|NCT05226117|Immunologic Factors|immunologic factors|mesh-ancestor
138797084|NCT05226117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797085|NCT01142726|Methotrexate|methotrexate|mesh-list
138797087|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138797088|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
138797089|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138797090|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797091|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138797092|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
138797093|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797094|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797095|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
138797096|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797097|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138797098|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138797099|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
138797100|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797101|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138797102|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138797103|NCT01142726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138797104|NCT04472637|Atorvastatin|atorvastatin|mesh-list
138797105|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138797106|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138797107|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
138797108|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797109|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138508069|NCT06196580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138409612|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138409613|NCT01615757|Cytarabine|cytarabine|mesh-list
138409614|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138797110|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138797111|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797112|NCT01142336|Simvastatin|simvastatin|mesh-list
138797113|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138797114|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138797115|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
138797116|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187384|NCT02881996|Acetaminophen|acetaminophen|mesh-list
138797117|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138797118|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138797119|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797120|NCT00915681|Silybin|silybin|mesh-list
138797121|NCT00915681|Protective Agents|protective agents|mesh-ancestor
138797122|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797123|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138797124|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797125|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
138797126|NCT01128296|Gemcitabine|gemcitabine|mesh-list
138797127|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138797128|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
138797129|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797130|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797131|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
138797132|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138797133|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138797134|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797135|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797136|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797137|NCT05082909|Probenecid|probenecid|mesh-list
138797138|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
138452905|NCT01880385|Docetaxel|docetaxel|mesh-list
138797139|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
138797140|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797141|NCT04240509|Tenofovir|tenofovir|mesh-list
138797142|NCT04240509|Emtricitabine|emtricitabine|mesh-list
138797143|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
138797144|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797145|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138797146|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138269946|NCT05924100|Luspatercept|luspatercept|mesh-list
138174556|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
138797147|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797148|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797149|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138409656|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138409657|NCT01616069|Simendan|simendan|mesh-list
138797150|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138797151|NCT04450329|Aflibercept|aflibercept|mesh-list
138797152|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138797153|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138797154|NCT04450329|Growth Substances|growth substances|mesh-ancestor
138797155|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797156|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
138797157|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797158|NCT01115738|Clopidogrel|clopidogrel|mesh-list
138797159|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138797160|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138797161|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138797162|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138797163|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138797164|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
138797165|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797166|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797167|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797169|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797170|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797171|NCT01141478|Sorafenib|sorafenib|mesh-list
138797172|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797173|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138797174|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797175|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797176|NCT01114880|Adalimumab|adalimumab|mesh-list
138409686|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797177|NCT01114880|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138797178|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138797179|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797180|NCT00625352|Gemcitabine|gemcitabine|mesh-list
138797181|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138797182|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
138797183|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797184|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797185|NCT04539873|Colchicine|colchicine|mesh-list
138797186|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
138797187|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797188|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
138797189|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
138797190|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
138702096|NCT05424393|Etanercept|etanercept|mesh-list
138797191|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797192|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797193|NCT02861040|Vincristine|vincristine|mesh-list
138797194|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138797195|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797196|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
138270042|NCT05921942|Metformin|metformin|mesh-list
138797197|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
138797198|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
138797199|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797200|NCT04282902|Pirfenidone|pirfenidone|mesh-list
138797201|NCT04282902|Analgesics|analgesics|mesh-ancestor
138797202|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
138797203|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797204|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797205|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138797206|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138797207|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138797208|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797209|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797210|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
138797211|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
138797212|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
138797213|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138797214|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138797215|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797216|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797217|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797218|NCT00878722|Idarubicin|idarubicin|mesh-list
138797219|NCT00878722|Belinostat|belinostat|mesh-list
138797220|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138797221|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797222|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138797223|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138797224|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797225|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797226|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138797227|NCT03432897|Olaparib|olaparib|mesh-list
138797228|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138797229|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797230|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797231|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797232|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
138797233|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138797234|NCT00659386|Antibodies|antibodies|mesh-list
138797235|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
138797236|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138797237|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
138797238|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138489127|NCT00011362|BB 1101|bb 1101|mesh-list
138797240|NCT04155814|Hematinics|hematinics|mesh-ancestor
138797241|NCT04158076|Amlodipine|amlodipine|mesh-list
138409778|NCT01616875|Cisplatin|cisplatin|mesh-list
138409779|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797242|NCT04158076|Telmisartan|telmisartan|mesh-list
138797243|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138187398|NCT04367831|Heparin|heparin|mesh-list
138797244|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138797245|NCT04158076|Ezetimibe|ezetimibe|mesh-list
138797246|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138797247|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138797248|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138797249|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797250|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138797251|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797252|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
138797253|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138797254|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138797255|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
138797256|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138797257|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138797258|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797259|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138797260|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138797261|NCT00961350|Aspirin|aspirin|mesh-list
138797262|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138797263|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138797264|NCT00961350|Analgesics|analgesics|mesh-ancestor
138797265|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
138797266|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797267|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797268|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138797269|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797270|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138797271|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138797272|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138409820|NCT01617135|Carbidopa|carbidopa|mesh-list
138797273|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138797274|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138797275|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797276|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
138797277|NCT03537690|Paclitaxel|paclitaxel|mesh-list
138797278|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138797279|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138797280|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797281|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
138797282|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
138797283|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
138797284|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797285|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
138797286|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138797287|NCT04032184|Fluorides|fluorides|mesh-list
138797288|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
138797289|NCT04032184|Protective Agents|protective agents|mesh-ancestor
138797290|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797291|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138797292|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797293|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
138174701|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
138797294|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
138797295|NCT00662896|Ibuprofen|ibuprofen|mesh-list
138797296|NCT00662896|Naproxen|naproxen|mesh-list
138797297|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
138187406|NCT03051646|Aspirin|aspirin|mesh-list
138187423|NCT04344405|Vitamins|vitamins|mesh-ancestor
138797298|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138797299|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138797300|NCT00662896|Analgesics|analgesics|mesh-ancestor
138797301|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
138797302|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797303|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797304|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138797305|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797306|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138797307|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797308|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797309|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
138797310|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138409859|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138409860|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
138797311|NCT00963924|Cycloserine|cycloserine|mesh-list
138797312|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138797313|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797314|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138270206|NCT05883852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138797315|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
138797316|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138797317|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
138797318|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797319|NCT04155658|Fluorides|fluorides|mesh-list
138797320|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
138797321|NCT04155658|Protective Agents|protective agents|mesh-ancestor
138797322|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797323|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
138453003|NCT01881100|Listerine|listerine|mesh-list
138797324|NCT02861976|Narcotics|narcotics|mesh-ancestor
138797325|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138797326|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797327|NCT02861976|Analgesics|analgesics|mesh-ancestor
138797328|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
138797329|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797330|NCT00666484|Prednisolone|prednisolone|mesh-list
138797331|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
138797332|NCT00666484|Doxorubicin|doxorubicin|mesh-list
138797333|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138797334|NCT00666484|Etoposide|etoposide|mesh-list
138797335|NCT00666484|Vincristine|vincristine|mesh-list
138797336|NCT00666484|Procarbazine|procarbazine|mesh-list
138797337|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138797338|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
138797339|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797340|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797341|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138797342|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
138409891|NCT01617538|Atorvastatin|atorvastatin|mesh-list
138797343|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797344|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797345|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138797346|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138797347|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138797348|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138797349|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797350|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138797351|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
138797352|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
138797353|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
138797354|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138797355|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
138797356|NCT00666484|Hormones|hormones|mesh-ancestor
138797357|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138270266|NCT05832398|Vitamins|vitamins|mesh-ancestor
138797359|NCT00663130|Tadalafil|tadalafil|mesh-list
138187427|NCT05187429|Nivolumab|nivolumab|mesh-list
138797360|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138797361|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
138797362|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138797363|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138797364|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797365|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797366|NCT00663130|Urological Agents|urological agents|mesh-ancestor
138797367|NCT00965562|Fluoxetine|fluoxetine|mesh-list
138797368|NCT00965562|Calcium|calcium|mesh-list
138797369|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138453033|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
138797370|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797371|NCT00965562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138409933|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797372|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138797373|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138797374|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797375|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797376|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
138797377|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138797378|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
138797379|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138797380|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138797381|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138797382|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797383|NCT00659698|Pancrelipase|pancrelipase|mesh-list
138797384|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138797385|NCT00666796|Ethanol|ethanol|mesh-list
138797386|NCT00666796|Gabapentin|gabapentin|mesh-list
138797387|NCT00666796|Analgesics|analgesics|mesh-ancestor
138797388|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
138797389|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797390|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797391|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
138797392|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138797393|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138797394|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138797395|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138797396|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138797397|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138797398|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797399|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797400|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
138797401|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138797402|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797403|NCT00912093|Icatibant|icatibant|mesh-list
138797404|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138797405|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138797406|NCT00912093|Analgesics|analgesics|mesh-ancestor
138797411|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797412|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138797413|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138797414|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453062|NCT01882127|Tretinoin|tretinoin|mesh-list
138797415|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138797416|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138797417|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
138797422|NCT03500484|Liraglutide|liraglutide|mesh-list
138409983|NCT01617811|Anesthetics|anesthetics|mesh-list
138797423|NCT03500484|Glucagon|glucagon|mesh-list
138797424|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138797425|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138797426|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797427|NCT03500484|Incretins|incretins|mesh-ancestor
138797428|NCT03500484|Hormones|hormones|mesh-ancestor
138797429|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138797430|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138270391|NCT05603065|Paclitaxel|paclitaxel|mesh-list
138797431|NCT02631460|Carboplatin|carboplatin|mesh-list
138797432|NCT02631460|Pemetrexed|pemetrexed|mesh-list
138797433|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797434|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797435|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797436|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138797437|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138797438|NCT04282824|Edetic Acid|edetic acid|mesh-list
138797439|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138797440|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
138797441|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
138797442|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797443|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
138797444|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138797445|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138797446|NCT00663286|Clindamycin|clindamycin|mesh-list
138797447|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
138797448|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
138797449|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138797450|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138797451|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797452|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138797453|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797454|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797455|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
138797456|NCT03237702|Carotenoids|carotenoids|mesh-list
138797457|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
138797458|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797459|NCT03237702|Protective Agents|protective agents|mesh-ancestor
138797460|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797461|NCT00667108|Gabapentin|gabapentin|mesh-list
138797462|NCT00667108|Analgesics|analgesics|mesh-ancestor
138410003|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
138797463|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
138797464|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797465|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270447|NCT05438316|Ramipril|ramipril|mesh-list
138797467|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138797468|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138797469|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138797470|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138797471|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138797472|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138797473|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797474|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797475|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
138797476|NCT00961116|Fenofibrate|fenofibrate|mesh-list
138797477|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
138797478|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138797479|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
138797480|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797481|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138797482|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138797483|NCT04158388|Tryptophan|tryptophan|mesh-list
138797484|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138797485|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
138797486|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138797487|NCT04283136|Padsevonil|padsevonil|mesh-list
138797488|NCT04283136|Anticonvulsants|anticonvulsants|mesh-ancestor
138797489|NCT04283058|Ketamine|ketamine|mesh-list
138797490|NCT04283058|Anesthetics|anesthetics|mesh-list
138797491|NCT04283058|Analgesics|analgesics|mesh-ancestor
138410038|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138410039|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138797492|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
138797493|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797494|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797495|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138797496|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138797497|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
138797498|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270477|NCT05353140|Antipyretics|antipyretics|mesh-ancestor
138797499|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138797500|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138797501|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797502|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797503|NCT00631995|Vaccines|vaccines|mesh-list
138797504|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
138797505|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797506|NCT00663442|Methylphenidate|methylphenidate|mesh-list
138797507|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138797508|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797509|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138797510|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138797511|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138797512|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797513|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
138797514|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797515|NCT00912015|Tramadol|tramadol|mesh-list
138797516|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138797517|NCT00912015|Narcotics|narcotics|mesh-ancestor
138797518|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138797519|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797521|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
138797522|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797524|NCT00960804|Analgesics|analgesics|mesh-ancestor
138797525|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
138797526|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187481|NCT05405595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138797527|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797529|NCT01126580|Dulaglutide|dulaglutide|mesh-list
138797530|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138797531|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797532|NCT00911157|Heparin|heparin|mesh-list
138797533|NCT00911157|Calcium heparin|calcium heparin|mesh-list
138797534|NCT00911157|PENTA|penta|mesh-list
138797535|NCT00911157|Fondaparinux|fondaparinux|mesh-list
138797536|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
138797537|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138797538|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138797539|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797540|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138797541|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
138797542|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138410085|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138797543|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
138797544|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797545|NCT00960570|Efavirenz|efavirenz|mesh-list
138797546|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
138797547|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138797548|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138797549|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797550|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797551|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
138797552|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797553|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138797554|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138797555|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138797556|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138797557|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138797558|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138797559|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138797560|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138797561|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
138797562|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138797563|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
138797564|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138797565|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
138797566|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797567|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
138797568|NCT04204278|Protective Agents|protective agents|mesh-ancestor
138797569|NCT00625430|Fludarabine|fludarabine|mesh-list
138797570|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
138797571|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797572|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138797573|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
138797574|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797575|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138797576|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
138797577|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797578|NCT04282746|Ketamine|ketamine|mesh-list
138797579|NCT04282746|Analgesics|analgesics|mesh-ancestor
138797580|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
138797581|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797582|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797583|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138797584|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138797585|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
138797586|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
138797587|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138797588|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138797589|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138797590|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175000|NCT03173612|Cytarabine|cytarabine|mesh-list
138797591|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797592|NCT03773445|Golimumab|golimumab|mesh-list
138797593|NCT03773445|Antibodies|antibodies|mesh-list
138797595|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
138797596|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797597|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138797598|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138797599|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138797600|NCT00630084|Interferons|interferons|mesh-list
138797601|NCT00630084|Ribavirin|ribavirin|mesh-list
138797602|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
138797603|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
138797604|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138797605|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797606|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
138797607|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797608|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
138797609|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797610|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
138797611|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797612|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
138797613|NCT01126424|Oxybutynin|oxybutynin|mesh-list
138797614|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138797615|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138797616|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
138797617|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797618|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797619|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797620|NCT01126424|Urological Agents|urological agents|mesh-ancestor
138270657|NCT04990037|Folfirinox|folfirinox|mesh-list
138797622|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
138797623|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797624|NCT01126268|Retapamulin|retapamulin|mesh-list
138797625|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138797626|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797627|NCT04284150|Midazolam|midazolam|mesh-list
138797628|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
138797629|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138797630|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138797631|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797632|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138797633|NCT04284150|Analgesics|analgesics|mesh-ancestor
138797634|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
138797635|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797636|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138797637|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138797638|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138797639|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
138797640|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797641|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797642|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138797643|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138797644|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138797645|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138797646|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138797647|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
138797648|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
138797649|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
138797650|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
138797651|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
138797652|NCT03311334|Nivolumab|nivolumab|mesh-list
138797653|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138797654|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797655|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138797656|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797657|NCT04313036|Defibrotide|defibrotide|mesh-list
138797658|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138187500|NCT01012297|Gemcitabine|gemcitabine|mesh-list
138797659|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138797660|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797661|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138797662|NCT00879658|Siponimod|siponimod|mesh-list
138797663|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138797664|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797665|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138797666|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
138797667|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797668|NCT00959946|Capecitabine|capecitabine|mesh-list
138797669|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138797670|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
138410155|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138797671|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797672|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797673|NCT00667264|Ropivacaine|ropivacaine|mesh-list
138797674|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
138797675|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
138797676|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138797677|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797678|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
138797679|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797680|NCT00660244|Anastrozole|anastrozole|mesh-list
138797681|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138797682|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797683|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138797684|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138797685|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797686|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797687|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138797688|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
138797689|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138797690|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797691|NCT04282200|Ketorolac|ketorolac|mesh-list
138797692|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138797693|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138797694|NCT04282200|Analgesics|analgesics|mesh-ancestor
138797695|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
138797696|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797697|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797698|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138797699|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797700|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138797701|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187514|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
138797702|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797703|NCT00667498|Metformin|metformin|mesh-list
138797704|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138797705|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410204|NCT01619150|Analgesics|analgesics|mesh-ancestor
138410214|NCT01619163|Prednisolone|prednisolone|mesh-list
138797706|NCT02860650|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138797707|NCT02860650|Antiviral Agents|antiviral agents|mesh-ancestor
138797708|NCT02860650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797709|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138797710|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
138797711|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138797712|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138797713|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797714|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797715|NCT00667966|Urological Agents|urological agents|mesh-ancestor
138797716|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
138797717|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138797718|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138797719|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797720|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
138797721|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797722|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797723|NCT00911937|Fesoterodine|fesoterodine|mesh-list
138797724|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138797725|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138797726|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
138797727|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797728|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797729|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797730|NCT00911937|Urological Agents|urological agents|mesh-ancestor
138797731|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138797732|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
138797733|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138453263|NCT01884272|Lesinurad|lesinurad|mesh-list
138797734|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138797735|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797736|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410241|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138410242|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
138410245|NCT01619527|Cobicistat|cobicistat|mesh-list
138797737|NCT00663598|Urological Agents|urological agents|mesh-ancestor
138797738|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138175149|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138797739|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138797740|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138797742|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797743|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138797744|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138797745|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797746|NCT01076543|Sirolimus|sirolimus|mesh-list
138797747|NCT01076543|Lenalidomide|lenalidomide|mesh-list
138797748|NCT01076543|Temsirolimus|temsirolimus|mesh-list
138797749|NCT01076543|MTOR Inhibitors|mtor inhibitors|mesh-list
138797750|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
138797751|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797752|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138797753|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138797754|NCT01076543|Growth Substances|growth substances|mesh-ancestor
138797755|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
138797756|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797757|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138797758|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797759|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138797760|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
138797761|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138797762|NCT01076543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138797763|NCT01076543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797764|NCT01076543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797765|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
138797766|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138797767|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797768|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138797769|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138797770|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797771|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797772|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797773|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138797774|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138797776|NCT02860494|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138797777|NCT02860494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138410280|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138797778|NCT02860494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797779|NCT02860494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797780|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138797781|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
138797782|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797783|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797784|NCT00663832|Panobinostat|panobinostat|mesh-list
138797785|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797786|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138797787|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797788|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797789|NCT04281576|Capecitabine|capecitabine|mesh-list
138797790|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
138797791|NCT04281576|Trastuzumab|trastuzumab|mesh-list
138797792|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138797793|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
138797794|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797795|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797796|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138797797|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
138797798|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138797799|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797800|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138797801|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138797802|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797803|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270851|NCT04487392|Hormones|hormones|mesh-ancestor
138797804|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797805|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138797806|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138797807|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138797808|NCT04304807|Melatonin|melatonin|mesh-list
138797809|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797810|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
138797811|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797813|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797814|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138797815|NCT04280874|Dinoprostone|dinoprostone|mesh-list
138797816|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
138797817|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138797818|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797819|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138410313|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797820|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138797821|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
138797822|NCT04157998|Metoclopramide|metoclopramide|mesh-list
138797823|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
138797824|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
138797825|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797826|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797827|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138797828|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138797829|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138797830|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
138797831|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797832|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797833|NCT01072877|Polidocanol|polidocanol|mesh-list
138797834|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138797835|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138797836|NCT00630474|Xylometazoline|xylometazoline|mesh-list
138797837|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
138797838|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138797839|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
138797840|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
138797841|NCT00957528|Testosterone|testosterone|mesh-list
138797842|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
138797843|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
138797844|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138797845|NCT00957528|Androgens|androgens|mesh-ancestor
138797846|NCT00957528|Hormones|hormones|mesh-ancestor
138508070|NCT06196580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797847|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138797848|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797849|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138797850|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797851|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
138797852|NCT02857062|Emollients|emollients|mesh-list
138797853|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
138410345|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138797854|NCT00958776|Peramivir|peramivir|mesh-list
138797855|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
138797856|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797857|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797858|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797859|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
138797860|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797861|NCT02858856|Mitogens|mitogens|mesh-ancestor
138797862|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
138797863|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797864|NCT02858622|Fentanyl|fentanyl|mesh-list
138797865|NCT02858622|Meperidine|meperidine|mesh-list
138797866|NCT02858622|Bupivacaine|bupivacaine|mesh-list
138797867|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
138797868|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
138797869|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138797870|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797871|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
138797872|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797873|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138797875|NCT02858622|Analgesics|analgesics|mesh-ancestor
138187580|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
138797876|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138797877|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138797878|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
138797879|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
138797880|NCT02191566|Tegafur|tegafur|mesh-list
138797881|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797882|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138797883|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
138797884|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797885|NCT00596830|Paclitaxel|paclitaxel|mesh-list
138797886|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138797887|NCT00596830|Carboplatin|carboplatin|mesh-list
138797888|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138797889|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138797890|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
138797891|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
138270961|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138797892|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
138797893|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453349|NCT01884467|Gentamicins|gentamicins|mesh-list
138797894|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138797895|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
138797896|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138797897|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138410376|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138410377|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
138797898|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138797899|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797900|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138797901|NCT05143164|Gentamicins|gentamicins|mesh-list
138797902|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138797903|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797904|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138797905|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797906|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797907|NCT00664144|Rasburicase|rasburicase|mesh-list
138797908|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
138797909|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797910|NCT02819856|Ebselen|ebselen|mesh-list
138797911|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138797912|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138797913|NCT02819856|Analgesics|analgesics|mesh-ancestor
138797914|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
138797915|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797916|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797917|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138797918|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138797919|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138797920|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138797921|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
138797922|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797923|NCT02819856|Protective Agents|protective agents|mesh-ancestor
138797924|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138797925|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797926|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138797927|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
138797928|NCT02630290|Ropivacaine|ropivacaine|mesh-list
138797929|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138797930|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138797931|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797932|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138797933|NCT02630290|Analgesics|analgesics|mesh-ancestor
138797934|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
138797935|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138797936|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138797937|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138797938|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138797939|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
138797940|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138797941|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797942|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
138797944|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
138797945|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797946|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
138797947|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
138797948|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
138797949|NCT00668356|Didanosine|didanosine|mesh-list
138797950|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
138271072|NCT04085458|Factor VIII|factor viii|mesh-list
138797951|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797953|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138797954|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138797955|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
138797956|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138797957|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138797958|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138797959|NCT00664222|Furosemide|furosemide|mesh-list
138797960|NCT00664222|Spironolactone|spironolactone|mesh-list
138797961|NCT00664222|Diuretics|diuretics|mesh-ancestor
138797962|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
138797963|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797964|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138797965|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138797966|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797967|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138797969|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138797970|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138797971|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138797972|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138797973|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
138797974|NCT00952614|Hormones|hormones|mesh-ancestor
138797975|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138797976|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138797977|NCT00911859|Prednisone|prednisone|mesh-list
138797978|NCT00911859|Bortezomib|bortezomib|mesh-list
138797979|NCT00911859|Melphalan|melphalan|mesh-list
138797980|NCT00911859|Siltuximab|siltuximab|mesh-list
138797981|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138797982|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138797983|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
138797984|NCT00911859|Hormones|hormones|mesh-ancestor
138797985|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138797986|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187600|NCT02244515|Analgesics|analgesics|mesh-ancestor
138797987|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138797989|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138797990|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
138797991|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797992|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138797993|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138797994|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
138797995|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
138797996|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138797997|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138797998|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138797999|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798000|NCT00911625|Insulin|insulin|mesh-list
138798001|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138798002|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
138798003|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
138798004|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138798005|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798006|NCT00596752|Alprostadil|alprostadil|mesh-list
138798007|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138798008|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
138798009|NCT00596752|Urological Agents|urological agents|mesh-ancestor
138798010|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138798011|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798013|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798014|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138798015|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798016|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798017|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
138798018|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138798019|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138410448|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138798020|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798021|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138798022|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138798023|NCT00660868|Protective Agents|protective agents|mesh-ancestor
138798024|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798025|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
138798026|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138798027|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
138798028|NCT00664690|Celecoxib|celecoxib|mesh-list
138798029|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138798030|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138798031|NCT00664690|Analgesics|analgesics|mesh-ancestor
138798032|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
138798033|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798034|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798035|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138798036|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138175483|NCT00706589|Aripiprazole|aripiprazole|mesh-list
138798038|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138798039|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798040|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798041|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
138798042|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138798043|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
138798044|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138798045|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
138798046|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798047|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798048|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
138798049|NCT04338165|Evolocumab|evolocumab|mesh-list
138798050|NCT04338165|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138798051|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138798052|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138798053|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
138187628|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138798054|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798055|NCT04338165|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138798056|NCT04338165|Protease Inhibitors|protease inhibitors|mesh-ancestor
138798057|NCT04338165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798058|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138798059|NCT00664846|Aspirin|aspirin|mesh-list
138798060|NCT00664846|Clopidogrel|clopidogrel|mesh-list
138798061|NCT00664846|Atorvastatin|atorvastatin|mesh-list
138798062|NCT00664846|Simvastatin|simvastatin|mesh-list
138798063|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138798064|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138798065|NCT00664846|Analgesics|analgesics|mesh-ancestor
138798066|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
138798067|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798068|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798069|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138798070|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138798071|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138798072|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138798073|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798074|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138798075|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138798076|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798077|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
138798078|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138798079|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138798080|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
138798081|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138798082|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138798083|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138798084|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138798085|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138798086|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
138798087|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798088|NCT00913783|Clomipramine|clomipramine|mesh-list
138798089|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138798090|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
138798091|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138798092|NCT00913783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138798093|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138798094|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138798095|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798096|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798097|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
138798098|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798099|NCT00661102|Capecitabine|capecitabine|mesh-list
138798100|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138798101|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
138798102|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798103|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798104|NCT00669370|Docetaxel|docetaxel|mesh-list
138798105|NCT00669370|Capecitabine|capecitabine|mesh-list
138798106|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798107|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
138798108|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
138798109|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
138175576|NCT01279057|Xhance|xhance|mesh-list
138798110|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798111|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138798112|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
138798113|NCT00665314|Plerixafor|plerixafor|mesh-list
138187636|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798115|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138798116|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
138798117|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138798118|NCT04154722|Azithromycin|azithromycin|mesh-list
138798119|NCT04154722|Meropenem|meropenem|mesh-list
138798120|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138798121|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138798122|NCT02631928|Insulin|insulin|mesh-list
138798123|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138798124|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
138798125|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138798126|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798127|NCT00632385|Eletriptan|eletriptan|mesh-list
138798128|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138798129|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
138798130|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798131|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798132|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798133|NCT00910689|Propranolol|propranolol|mesh-list
138798134|NCT00910689|Nadolol|nadolol|mesh-list
138798135|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138508071|NCT06196580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138798136|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138798137|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
138798138|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798139|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453408|NCT01884857|Metoprolol|metoprolol|mesh-list
138798140|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798141|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138798142|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138798143|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
138798144|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
138798145|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
138798146|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798147|NCT04669717|Amoxicillin|amoxicillin|mesh-list
138798148|NCT04669717|Azithromycin|azithromycin|mesh-list
138798149|NCT04669717|Metronidazole|metronidazole|mesh-list
138798150|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138798151|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138798152|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138798153|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138798154|NCT00809341|Prednisone|prednisone|mesh-list
138798155|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
138798156|NCT00809341|Ifosfamide|ifosfamide|mesh-list
138798157|NCT00809341|Rituximab|rituximab|mesh-list
138798158|NCT00809341|Carboplatin|carboplatin|mesh-list
138798159|NCT00809341|Doxorubicin|doxorubicin|mesh-list
138798160|NCT00809341|Etoposide|etoposide|mesh-list
138798161|NCT00809341|Vincristine|vincristine|mesh-list
138798162|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138798163|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
138508072|NCT06196580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138798164|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798165|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138798166|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138798167|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
138798168|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798169|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798170|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138798171|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138798172|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138798173|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138798174|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138798176|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138798177|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
138798178|NCT00809341|Hormones|hormones|mesh-ancestor
138410571|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138410572|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
138798179|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138798180|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138798181|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138798182|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
138798183|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
138798184|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
138798185|NCT02609581|Immunomodulating Agents|immunomodulating agents|mesh-list
138798186|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
138175631|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
138798187|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798189|NCT00811135|Trastuzumab|trastuzumab|mesh-list
138798190|NCT00811135|Capecitabine|capecitabine|mesh-list
138798191|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138798192|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798193|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138508073|NCT06196580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138798194|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138798195|NCT00811135|Growth Substances|growth substances|mesh-ancestor
138453418|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
138798196|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798197|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
138798198|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138798199|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
138798200|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798201|NCT00811057|Indomethacin|indomethacin|mesh-list
138798202|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
138798203|NCT00811057|Nifedipine|nifedipine|mesh-list
138798204|NCT00811057|Analgesics|analgesics|mesh-ancestor
138798205|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
138798206|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798207|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798208|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
138798209|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138798210|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138798211|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
138798212|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138798213|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138798214|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798215|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138798216|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
138798217|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138798218|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
138798219|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138798220|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138798221|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138798222|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138798223|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
138410607|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138798224|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138798225|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798227|NCT00879970|Pioglitazone|pioglitazone|mesh-list
138798228|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
138798229|NCT00879970|Vitamins|vitamins|mesh-ancestor
138798230|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
138798231|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798232|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138798233|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138798235|NCT00808639|Methotrexate|methotrexate|mesh-list
138798236|NCT00808639|Vinblastine|vinblastine|mesh-list
138798237|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798238|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138798239|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138798240|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138798241|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798242|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798243|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138798244|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
138798245|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138798246|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798247|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138798248|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
138798249|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
138798250|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138798251|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138798252|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
138798253|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138798254|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138798255|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138798256|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
138798257|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
138798258|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
138798260|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138798261|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138410624|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
138798262|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138798263|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138798264|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138798265|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
138798266|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798267|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798268|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798269|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
138798271|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138798272|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798273|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138271554|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138798274|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798275|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138798276|NCT03007329|Incretins|incretins|mesh-ancestor
138798277|NCT03007329|Hormones|hormones|mesh-ancestor
138798278|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138798279|NCT04072341|Propolis|propolis|mesh-list
138798280|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138798281|NCT04030039|Interferons|interferons|mesh-list
138798282|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798283|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
138798284|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138798285|NCT02628574|Gemcitabine|gemcitabine|mesh-list
138798286|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
138798287|NCT02628574|Nivolumab|nivolumab|mesh-list
138798288|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138798289|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
138453467|NCT01885091|Kinetin|kinetin|mesh-list
138798290|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798291|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798292|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138410656|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138798293|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138798294|NCT00596362|Bevacizumab|bevacizumab|mesh-list
138798295|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138798296|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798297|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138798298|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138798299|NCT00596362|Growth Substances|growth substances|mesh-ancestor
138187681|NCT03062488|Narcotics|narcotics|mesh-ancestor
138798300|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798301|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
138798303|NCT00907803|Antiviral Agents|antiviral agents|mesh-ancestor
138798304|NCT00907803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138798306|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138798307|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138798308|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138798309|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138798310|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798311|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798312|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798313|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138798314|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138798315|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138798316|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138798317|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
138798318|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
138798319|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798320|NCT00676156|Protective Agents|protective agents|mesh-ancestor
138798321|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798322|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
138798323|NCT00676156|Vitamins|vitamins|mesh-ancestor
138798324|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
138798326|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798327|NCT00914017|Atorvastatin|atorvastatin|mesh-list
138798328|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138798329|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138798330|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
138798331|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798332|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138798333|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138798334|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798335|NCT00671320|Diclofenac|diclofenac|mesh-list
138798336|NCT00671320|Valdecoxib|valdecoxib|mesh-list
138798337|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138798338|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138798339|NCT00671320|Analgesics|analgesics|mesh-ancestor
138798340|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
138798341|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798342|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798343|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138453491|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
138798344|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138798345|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138798346|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798347|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798348|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138798349|NCT00676468|Montelukast|montelukast|mesh-list
138798350|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138410693|NCT01622361|Docetaxel|docetaxel|mesh-list
138798351|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
138798352|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138798353|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
138798354|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138798355|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798356|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138798357|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138798358|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798359|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138798360|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138798361|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138187689|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
138798362|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798364|NCT00676702|Pancrelipase|pancrelipase|mesh-list
138798365|NCT00676702|Pancreatin|pancreatin|mesh-list
138798366|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138798367|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138798368|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138798369|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798370|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
138798371|NCT00676702|Coagulants|coagulants|mesh-ancestor
138798372|NCT00676702|Vitamins|vitamins|mesh-ancestor
138798373|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
138798374|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798375|NCT05753371|Metformin|metformin|mesh-list
138798376|NCT05753371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138798377|NCT05753371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798378|NCT00671476|Doxorubicin|doxorubicin|mesh-list
138798379|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138798380|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138798381|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798382|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138798383|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138798384|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798385|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798386|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
138798387|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138798388|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138798389|NCT00908583|Prednisolone|prednisolone|mesh-list
138798391|NCT00908583|Rituximab|rituximab|mesh-list
138798392|NCT00908583|Bortezomib|bortezomib|mesh-list
138798393|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138798394|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
138798395|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138798396|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798397|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
138798398|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798399|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138798400|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138798401|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
138798402|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
138798403|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798404|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138798405|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
138798406|NCT00908583|Hormones|hormones|mesh-ancestor
138798407|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138798408|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138798409|NCT00908583|Protective Agents|protective agents|mesh-ancestor
138798410|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138798411|NCT00671632|Triazolam|triazolam|mesh-list
138798412|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138798413|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138798414|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138798415|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138798416|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798417|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138798418|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
138798419|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
138798420|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798421|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798422|NCT04153708|Antibodies|antibodies|mesh-list
138798423|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
138798424|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
138798425|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
138798426|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798427|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
138798428|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138798429|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138798430|NCT00676936|Prednisolone|prednisolone|mesh-list
138798431|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
138798432|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138798433|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
138798434|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138798435|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
138798436|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
138798437|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798438|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798439|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138798440|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
138798441|NCT00676936|Hormones|hormones|mesh-ancestor
138798442|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138798443|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138798444|NCT00676936|Protective Agents|protective agents|mesh-ancestor
138798445|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138798446|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798447|NCT02629744|Etrolizumab|etrolizumab|mesh-list
138798448|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138798449|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
138798450|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798451|NCT00677170|Pevonedistat|pevonedistat|mesh-list
138798452|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798453|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798454|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
138798455|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
138798456|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138798457|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138798458|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138798459|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798460|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138798461|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138798462|NCT01125566|Trastuzumab|trastuzumab|mesh-list
138798463|NCT01125566|Vinorelbine|vinorelbine|mesh-list
138798465|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138798466|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798467|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138798468|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
138798469|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
138798470|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
138798471|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798472|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138798473|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798474|NCT04031872|Capecitabine|capecitabine|mesh-list
138798475|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138798476|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
138798477|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798478|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798479|NCT00670696|Tetracaine|tetracaine|mesh-list
138798480|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
138798481|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
138798482|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138798483|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798484|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
138187710|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798485|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798487|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138798488|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138798489|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
138798490|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798491|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138798492|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138798493|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138798494|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
138798495|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
138798496|NCT00911716|Bevacizumab|bevacizumab|mesh-list
138798497|NCT00911716|Docetaxel|docetaxel|mesh-list
138798499|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
138798500|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798501|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138798502|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138798503|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
138798504|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798505|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798506|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138798507|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138798508|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138798509|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138798510|NCT00911716|Growth Substances|growth substances|mesh-ancestor
138798511|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
138798512|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
138798513|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
138798514|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
138798515|NCT00595582|Curcumin|curcumin|mesh-list
138508074|NCT06196580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138292244|NCT00002630|Cobalt|cobalt|mesh-list
138271992|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
138798516|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138798517|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138798518|NCT00595582|Analgesics|analgesics|mesh-ancestor
138798519|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
138798520|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798521|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798522|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138798523|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138798524|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798525|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798526|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798527|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
138798528|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138798529|NCT00680446|Antibodies|antibodies|mesh-list
138798530|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
138798531|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
138798532|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798533|NCT00672022|Miglustat|miglustat|mesh-list
138798534|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798535|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798536|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138798537|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138798538|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
138798539|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138798540|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138798541|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138798542|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798543|NCT00680602|Sertraline|sertraline|mesh-list
138798544|NCT00680602|Fluoxetine|fluoxetine|mesh-list
138798545|NCT00680602|Paroxetine|paroxetine|mesh-list
138798546|NCT00680602|Citalopram|citalopram|mesh-list
138798547|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
138798548|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138798549|NCT00680602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138798550|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138798551|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138798552|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798553|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798554|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
138798555|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798556|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138798557|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138798558|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138798559|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798560|NCT00680680|Dutasteride|dutasteride|mesh-list
138798561|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138410812|NCT01622946|Coagulants|coagulants|mesh-ancestor
138798562|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138798563|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798564|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798565|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
138798566|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138798567|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798568|NCT00808015|Varenicline|varenicline|mesh-list
138798569|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138798570|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138798571|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
138798572|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798573|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798574|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798575|NCT00680758|Paclitaxel|paclitaxel|mesh-list
138798576|NCT00680758|Everolimus|everolimus|mesh-list
138798577|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138798578|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798579|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
138798580|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
138798581|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
138798582|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798583|NCT00680758|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138798584|NCT00680758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138798585|NCT00680758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798586|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138798587|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
138798588|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798590|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138798591|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138798592|NCT00810199|Methotrexate|methotrexate|mesh-list
138798593|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138798594|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
138798595|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138798596|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798597|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138798598|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
138798599|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410835|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
138410836|NCT01623206|Coagulants|coagulants|mesh-ancestor
138798600|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798601|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
138798602|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798603|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138798604|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138798605|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
138798606|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138798607|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138798608|NCT00877006|Prednisone|prednisone|mesh-list
138798609|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
138798610|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138798611|NCT00877006|Rituximab|rituximab|mesh-list
138272221|NCT00003389|Hormones|hormones|mesh-ancestor
138798613|NCT00877006|Vincristine|vincristine|mesh-list
138798614|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138798615|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
138798616|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798617|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138798618|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138798619|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
138798620|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798621|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798622|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138798623|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138798624|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138798625|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138798626|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138798627|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798628|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138798629|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
138798630|NCT00877006|Hormones|hormones|mesh-ancestor
138798631|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138798632|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138798633|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138798634|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
138176152|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798635|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
138798636|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
138798637|NCT00678184|Atorvastatin|atorvastatin|mesh-list
138798638|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138798639|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138798640|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
138272260|NCT02259348|Melphalan|melphalan|mesh-list
138798641|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410864|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
138410865|NCT01623401|Tedizolid|tedizolid|mesh-list
138798643|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138798644|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798646|NCT00876928|Vitamins|vitamins|mesh-ancestor
138798647|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
138798648|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798649|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138798650|NCT02627950|Metoclopramide|metoclopramide|mesh-list
138798651|NCT02627950|Ticagrelor|ticagrelor|mesh-list
138798652|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138798653|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138798654|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138798655|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138798656|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
138798657|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798658|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798659|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798660|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
138798661|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
138798662|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798663|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138798664|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138798665|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138798666|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
138798667|NCT00807937|Lorazepam|lorazepam|mesh-list
138798668|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
138272313|NCT03587207|Vaccines|vaccines|mesh-list
138798669|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
138798670|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
138798671|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798672|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798673|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138798674|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138798675|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138798676|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138798677|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138798678|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138798679|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
138798680|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
138798681|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798682|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798683|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138798684|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138798685|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798686|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798687|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138798688|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138798689|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798690|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
138798691|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138292440|NCT01303003|Hormones|hormones|mesh-ancestor
138798692|NCT00681226|Ramipril|ramipril|mesh-list
138798693|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138798694|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
138798695|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798696|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798697|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138272346|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138798698|NCT00678964|Carboplatin|carboplatin|mesh-list
138798699|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138798700|NCT00678964|Vinorelbine|vinorelbine|mesh-list
138798701|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798702|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138798703|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798704|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798705|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138798706|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
138798707|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
138798708|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
138798709|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
138798710|NCT02627248|Docetaxel|docetaxel|mesh-list
138798711|NCT02627248|Epirubicin|epirubicin|mesh-list
138798712|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138798713|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
138798714|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798715|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138798716|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138798717|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
138798718|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798719|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798720|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138798721|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
138798722|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
138798723|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
138272403|NCT04926233|Bromides|bromides|mesh-list
138798724|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138798725|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138798726|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138798727|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798728|NCT03993535|Serotonin|serotonin|mesh-list
138798729|NCT03993535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138798730|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138798731|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
138798732|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798733|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187760|NCT00976183|Vorinostat|vorinostat|mesh-list
138798734|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798735|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138798736|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138798737|NCT02626936|Insulin|insulin|mesh-list
138798738|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138798739|NCT02626936|Glucagon|glucagon|mesh-list
138798740|NCT02626936|Hormones|hormones|mesh-list
138798741|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138798742|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638054|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798743|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138798744|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138798746|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
138798747|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
138798748|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
138798749|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798750|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798751|NCT00906945|Cytarabine|cytarabine|mesh-list
138798752|NCT00906945|Plerixafor|plerixafor|mesh-list
138798753|NCT00906945|Etoposide|etoposide|mesh-list
138798754|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
138798755|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138272444|NCT05646810|Lidocaine|lidocaine|mesh-list
138798756|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798757|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138798758|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138798759|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798760|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798761|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138798762|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
138798763|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
138798764|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138798765|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138798766|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
138798767|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798768|NCT00906945|Analgesics|analgesics|mesh-ancestor
138798769|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
138798770|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798771|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138798772|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138798773|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138798774|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
138798775|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
138798776|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138798777|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138798778|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798779|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
138798780|NCT02627560|Coagulants|coagulants|mesh-ancestor
138798781|NCT00681460|Metformin|metformin|mesh-list
138798782|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138176226|NCT00708071|Thrombin|thrombin|mesh-list
138798783|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798784|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138798785|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138798786|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
138798787|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138410929|NCT01623921|Celecoxib|celecoxib|mesh-list
138798788|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798789|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138638067|NCT01680406|Artemether|artemether|mesh-list
138798790|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
138798791|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138798792|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138798793|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138798794|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
138798795|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798796|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798798|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
138798799|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
138798800|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
138798801|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798802|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798803|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138798804|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
138798805|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
138798806|NCT00590317|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138798807|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138798808|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
138798809|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798810|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798811|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138798812|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138798813|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138798814|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138798815|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138798816|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
138798817|NCT01139762|Tadalafil|tadalafil|mesh-list
138798818|NCT01139762|Finasteride|finasteride|mesh-list
138798819|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
138798820|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138798821|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138798822|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798823|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798824|NCT01139762|Urological Agents|urological agents|mesh-ancestor
138798825|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138798826|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138798827|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
138798828|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138798829|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798830|NCT00805285|Budesonide|budesonide|mesh-list
138798831|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
138798832|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138798833|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138798834|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
138410953|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
138410959|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
138798835|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798836|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798837|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138798838|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
138798839|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
138798840|NCT00805285|Hormones|hormones|mesh-ancestor
138798841|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138798842|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
138798843|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
138798844|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798845|NCT02606773|Protective Agents|protective agents|mesh-ancestor
138798846|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798847|NCT02606773|Vitamins|vitamins|mesh-ancestor
138798848|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
138798849|NCT04310774|Tegafur|tegafur|mesh-list
138798850|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138798851|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
138798852|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638096|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
138798853|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798854|NCT01139450|Tacrolimus|tacrolimus|mesh-list
138798855|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138798856|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
138187793|NCT01575925|Thalidomide|thalidomide|mesh-list
138272637|NCT04812470|Analgesics|analgesics|mesh-ancestor
138798857|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798858|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138798859|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798860|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798861|NCT00805207|Estradiol|estradiol|mesh-list
138798862|NCT00805207|Estrogens|estrogens|mesh-list
138798863|NCT00805207|Testosterone|testosterone|mesh-list
138410977|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138798864|NCT00805207|Progesterone|progesterone|mesh-list
138798865|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
138798866|NCT00805207|Hormones|hormones|mesh-ancestor
138798867|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138798868|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798869|NCT00805207|Androgens|androgens|mesh-ancestor
138798870|NCT00805207|Progestins|progestins|mesh-ancestor
138798871|NCT00805675|Tenofovir|tenofovir|mesh-list
138798872|NCT00805675|Telbivudine|telbivudine|mesh-list
138798873|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
138798874|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138798875|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138798876|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138798877|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798878|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798879|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138798880|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138798881|NCT03958201|Rocuronium|rocuronium|mesh-list
138798882|NCT03958201|Neostigmine|neostigmine|mesh-list
138272682|NCT04871958|Insulin|insulin|mesh-list
138798883|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138798884|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138798885|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138798886|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798887|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798888|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138798889|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798890|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798891|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
138798892|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798893|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138798894|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
138798895|NCT00589303|Metoprolol|metoprolol|mesh-list
138798896|NCT00589303|Amiodarone|amiodarone|mesh-list
138798897|NCT00589303|Verapamil|verapamil|mesh-list
138798898|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138798899|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138798900|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
138798901|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
138798902|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798903|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798904|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138798905|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138798906|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138798907|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
138798908|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508075|NCT06196580|Anesthetics, General|anesthetics, general|mesh-ancestor
138798909|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798910|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
138798911|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138798912|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138798913|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138798914|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138798915|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138798916|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138798917|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138798918|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138798919|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138798920|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138798921|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138798922|NCT02607943|Insulin|insulin|mesh-list
138798923|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138798924|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
138798925|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138411061|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798926|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798927|NCT02606617|Mosapride|mosapride|mesh-list
138798928|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138798929|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138798930|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
138798931|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798932|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138176374|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
138798933|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798934|NCT00914095|Methylphenidate|methylphenidate|mesh-list
138798935|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138798936|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798937|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138411088|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138411089|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
138798938|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138798939|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138798940|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798941|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
138798942|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798943|NCT05745337|Metoprolol|metoprolol|mesh-list
138798944|NCT05745337|Verapamil|verapamil|mesh-list
138798945|NCT05745337|Diltiazem|diltiazem|mesh-list
138798946|NCT05745337|Calcium Channel Blockers|calcium channel blockers|mesh-list
138798947|NCT05745337|Calcium|calcium|mesh-list
138798948|NCT05745337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138798949|NCT05745337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138798950|NCT05745337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798951|NCT05745337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138798952|NCT05745337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138798953|NCT05745337|Sympatholytics|sympatholytics|mesh-ancestor
138798954|NCT05745337|Autonomic Agents|autonomic agents|mesh-ancestor
138798955|NCT05745337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798956|NCT05745337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138798957|NCT05745337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138798958|NCT05745337|Adrenergic Agents|adrenergic agents|mesh-ancestor
138798959|NCT05745337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798960|NCT05745337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798961|NCT05745337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138798962|NCT05745337|Vasodilator Agents|vasodilator agents|mesh-ancestor
138798963|NCT00952380|Dalteparin|dalteparin|mesh-list
138798964|NCT00952380|Tinzaparin|tinzaparin|mesh-list
138798965|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138798966|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
138798967|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138798968|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138411147|NCT01625520|Everolimus|everolimus|mesh-list
138798969|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798971|NCT02856750|Analgesics|analgesics|mesh-ancestor
138798972|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
138798973|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138798974|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138798975|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
138798976|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138798977|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138798978|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138798979|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138798980|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138798981|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138798982|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138798983|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798984|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
138798985|NCT05751967|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138798987|NCT05751967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138798988|NCT05751967|Antimetabolites|antimetabolites|mesh-ancestor
138798989|NCT05751967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138798990|NCT05751967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138798991|NCT05751967|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138798992|NCT05751967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138798993|NCT02857920|Bevacizumab|bevacizumab|mesh-list
138798994|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138798995|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138798996|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138798997|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138798998|NCT02857920|Growth Substances|growth substances|mesh-ancestor
138798999|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799000|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
138799001|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
138411183|NCT01625793|Interferons|interferons|mesh-list
138799002|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138799003|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799004|NCT02607631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138799005|NCT02607631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799006|NCT02857842|Prednisolone|prednisolone|mesh-list
138799007|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138799008|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
138799010|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799011|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799012|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138799013|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799014|NCT03635437|Alprazolam|alprazolam|mesh-list
138272925|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
138799015|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
138799016|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138799017|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799018|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799019|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138799020|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138799021|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138799023|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
138799024|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799025|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799026|NCT00803179|Hormones|hormones|mesh-list
138799027|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799028|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799029|NCT00804193|Ciclopirox|ciclopirox|mesh-list
138799030|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
138799031|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799032|NCT05697211|Ferric maltol|ferric maltol|mesh-list
138799033|NCT05697211|Hematinics|hematinics|mesh-ancestor
138799034|NCT00957996|Peramivir|peramivir|mesh-list
138799035|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
138799036|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799037|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799038|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799039|NCT02606539|Leucovorin|leucovorin|mesh-list
138799040|NCT02606539|Folic Acid|folic acid|mesh-list
138799042|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
138411217|NCT01625156|Sirolimus|sirolimus|mesh-list
138799043|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138799044|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
138799045|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138272982|NCT04844814|Prednisone|prednisone|mesh-list
138799047|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138799048|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
138187820|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799049|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799050|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799051|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
138799052|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799053|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138799054|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138799055|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
138799056|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138799057|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138799058|NCT02606539|Antidotes|antidotes|mesh-ancestor
138799059|NCT02606539|Protective Agents|protective agents|mesh-ancestor
138799060|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
138799061|NCT02606539|Vitamins|vitamins|mesh-ancestor
138799062|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
138799063|NCT02606539|Hematinics|hematinics|mesh-ancestor
138799064|NCT00589693|Imipenem|imipenem|mesh-list
138799065|NCT00589693|Doripenem|doripenem|mesh-list
138273017|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138273018|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273019|NCT04832100|Pregabalin|pregabalin|mesh-list
138273020|NCT04832100|Imipramine|imipramine|mesh-list
138273021|NCT04832100|Analgesics|analgesics|mesh-ancestor
138273022|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
138799066|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
138799067|NCT00589693|Cilastatin|cilastatin|mesh-list
138799068|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138799069|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799070|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
138799071|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799072|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799073|NCT02606383|Ketoconazole|ketoconazole|mesh-list
138799074|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
138411255|NCT01626443|Folic Acid|folic acid|mesh-list
138799075|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799076|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138799077|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138799078|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799079|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799080|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138799081|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
138799082|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799083|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799084|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138799086|NCT05660473|Dexamethasone|dexamethasone|mesh-list
138799087|NCT05660473|Prednisone|prednisone|mesh-list
138799088|NCT05660473|Cyclophosphamide|cyclophosphamide|mesh-list
138799089|NCT05660473|Methotrexate|methotrexate|mesh-list
138799090|NCT05660473|Vincristine|vincristine|mesh-list
138799091|NCT05660473|Daunorubicin|daunorubicin|mesh-list
138799092|NCT05660473|Venetoclax|venetoclax|mesh-list
138799093|NCT05660473|Mercaptopurine|mercaptopurine|mesh-list
138799094|NCT05660473|Pegaspargase|pegaspargase|mesh-list
138799095|NCT05660473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138799096|NCT05660473|Immunologic Factors|immunologic factors|mesh-ancestor
138799097|NCT05660473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799098|NCT05660473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138799099|NCT05660473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138799100|NCT05660473|Alkylating Agents|alkylating agents|mesh-ancestor
138799101|NCT05660473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799102|NCT05660473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799103|NCT05660473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138187835|NCT04359095|Tenofovir|tenofovir|mesh-list
138799104|NCT05660473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138799105|NCT05660473|Antiemetics|antiemetics|mesh-ancestor
138799106|NCT05660473|Autonomic Agents|autonomic agents|mesh-ancestor
138799107|NCT05660473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799108|NCT05660473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138799109|NCT05660473|Glucocorticoids|glucocorticoids|mesh-ancestor
138799110|NCT05660473|Hormones|hormones|mesh-ancestor
138799111|NCT05660473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799112|NCT05660473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138273118|NCT05346666|GABA Modulators|gaba modulators|mesh-ancestor
138799113|NCT05660473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138799114|NCT05660473|Abortifacient Agents|abortifacient agents|mesh-ancestor
138799115|NCT05660473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138799116|NCT05660473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138799117|NCT05660473|Antimetabolites|antimetabolites|mesh-ancestor
138799118|NCT05660473|Dermatologic Agents|dermatologic agents|mesh-ancestor
138799119|NCT05660473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799120|NCT05660473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138799121|NCT05660473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138799122|NCT05660473|Antiviral Agents|antiviral agents|mesh-ancestor
138799123|NCT05660473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799124|NCT05660473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138799125|NCT05660473|Tubulin Modulators|tubulin modulators|mesh-ancestor
138799126|NCT05660473|Antimitotic Agents|antimitotic agents|mesh-ancestor
138799127|NCT05660473|Mitosis Modulators|mitosis modulators|mesh-ancestor
138799128|NCT05660473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138799129|NCT05660473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138799130|NCT05660473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138799131|NCT00803101|Protein C|protein c|mesh-list
138799132|NCT00803101|Protein S|protein s|mesh-list
138799133|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
138799134|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138799135|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138799136|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799137|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138799138|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138799139|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799140|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138799141|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138411324|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799142|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138799143|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799144|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
138799145|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799146|NCT04269954|Heparin|heparin|mesh-list
138799147|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138799148|NCT04269954|Tinzaparin|tinzaparin|mesh-list
138799149|NCT04269954|Dalteparin|dalteparin|mesh-list
138799150|NCT04269954|Batroxobin|batroxobin|mesh-list
138799151|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
138799152|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138799153|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138799154|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799155|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
138799156|NCT04269954|Coagulants|coagulants|mesh-ancestor
138799157|NCT00630630|Levetiracetam|levetiracetam|mesh-list
138799158|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
138799159|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
138799160|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
138176676|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
138799161|NCT02854722|Vitamin D|vitamin d|mesh-list
138799162|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
138799163|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
138799164|NCT02854722|Vitamins|vitamins|mesh-list
138799165|NCT02854722|Calcium|calcium|mesh-list
138799166|NCT02854722|Deferasirox|deferasirox|mesh-list
138799167|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
138799168|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799169|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138799170|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138799171|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138799172|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
138799173|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
138799174|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799175|NCT00800683|Linagliptin|linagliptin|mesh-list
138799176|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138799177|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799178|NCT00800683|Incretins|incretins|mesh-ancestor
138799179|NCT00800683|Hormones|hormones|mesh-ancestor
138411354|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138799180|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799181|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138799182|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
138799183|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799184|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799185|NCT01113710|Rotigotine|rotigotine|mesh-list
138799186|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
138799187|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
138799188|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799189|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799190|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799191|NCT01124162|Losartan|losartan|mesh-list
138799192|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138799193|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138799194|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138799195|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138799196|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799197|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138799198|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138799199|NCT00923533|Diuretics|diuretics|mesh-ancestor
138799200|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
138799201|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799202|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138799203|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138799204|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273277|NCT04818450|Gabapentin|gabapentin|mesh-list
138799205|NCT00906399|Interferons|interferons|mesh-list
138799206|NCT00906399|Interferon-beta|interferon-beta|mesh-list
138411396|NCT01627236|Hormones|hormones|mesh-ancestor
138799207|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
138799208|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799209|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
138799210|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799211|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
138799212|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799213|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138799214|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138799215|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138799216|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799217|NCT00947856|Immunotoxins|immunotoxins|mesh-ancestor
138799218|NCT00947856|Immunoconjugates|immunoconjugates|mesh-ancestor
138799219|NCT00947856|Immunologic Factors|immunologic factors|mesh-ancestor
138799220|NCT00947856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799221|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138799222|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799223|NCT00907335|Tretinoin|tretinoin|mesh-list
138799224|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138799225|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799226|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
138799227|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
138799228|NCT00947154|Aripiprazole|aripiprazole|mesh-list
138799229|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
138799230|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138799231|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138799232|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138799233|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799234|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799235|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
138799236|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
138799237|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799238|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799239|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138799240|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138799241|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
138799242|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138799243|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138799244|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138799245|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138799246|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
138799247|NCT00952068|Tramadol|tramadol|mesh-list
138799248|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138799249|NCT00952068|Narcotics|narcotics|mesh-ancestor
138799250|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799251|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799252|NCT00952068|Analgesics|analgesics|mesh-ancestor
138799253|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
138799254|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799255|NCT00951912|Genistein|genistein|mesh-list
138799256|NCT00951912|Daidzein|daidzein|mesh-list
138799257|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138799258|NCT00951912|Protective Agents|protective agents|mesh-ancestor
138799259|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799260|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799261|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138799262|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799263|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799264|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
138799265|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138799266|NCT00951912|Estrogens|estrogens|mesh-ancestor
138799267|NCT00951912|Hormones|hormones|mesh-ancestor
138799268|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799269|NCT02882594|Anesthetics|anesthetics|mesh-list
138799270|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799271|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799272|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138799273|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
138799274|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138799275|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
138799276|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138799277|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799278|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138411470|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411477|NCT01627626|Pilocarpine|pilocarpine|mesh-list
138799279|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138799280|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799281|NCT01123070|Rituximab|rituximab|mesh-list
138799282|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138799283|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799284|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
138799285|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799286|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138799288|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799289|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799291|NCT03198741|Clopidogrel|clopidogrel|mesh-list
138799292|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138273407|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
138799293|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138799294|NCT03198741|Analgesics|analgesics|mesh-ancestor
138799295|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
138799296|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799297|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799298|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138799299|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138799300|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138799301|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138799302|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799303|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138799304|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138799305|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799306|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
138799307|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138799308|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138799309|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138799310|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
138799311|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799312|NCT01122680|Bromides|bromides|mesh-list
138799313|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
138799314|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138799315|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
138411494|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411495|NCT01627678|Molgramostim|molgramostim|mesh-list
138799316|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799317|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799318|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138799319|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
138799320|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
138799321|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138799322|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
138799323|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799324|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799325|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
138799327|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
138799328|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138799329|NCT00946998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138799330|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138799331|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138799332|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799333|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799334|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
138799335|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799336|NCT01138826|Amlodipine|amlodipine|mesh-list
138799337|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138799338|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138799339|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138799340|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138508076|NCT06196580|Anesthetics|anesthetics|mesh-ancestor
138799341|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138799342|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799343|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
138799345|NCT00906087|Dorzolamide|dorzolamide|mesh-list
138799346|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138799347|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138799348|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138799349|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
138799350|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799351|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799352|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799353|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138799354|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138799355|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138799356|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138799357|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799358|NCT03525795|Ipilimumab|ipilimumab|mesh-list
138799359|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
138799360|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138799361|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799362|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138799363|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799364|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799365|NCT02420574|Albendazole|albendazole|mesh-list
138799366|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
138799367|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138799368|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799369|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
138799370|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138799371|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138799372|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
138799373|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
138799374|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
138799375|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799376|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799377|NCT02855502|Prednisolone|prednisolone|mesh-list
138799378|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138799379|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
138799380|NCT02855502|Hormones|hormones|mesh-ancestor
138799381|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799382|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799383|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138799384|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799386|NCT02853864|Propofol|propofol|mesh-list
138799387|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138411562|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
138411563|NCT01628055|Antibodies|antibodies|mesh-list
138799388|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799389|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799390|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138799391|NCT02853864|Analgesics|analgesics|mesh-ancestor
138799392|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
138187924|NCT00979615|Analgesics|analgesics|mesh-ancestor
138799393|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799394|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138799395|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138799396|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138799397|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
138799398|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799399|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799400|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138799402|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
138799403|NCT00907257|Tretinoin|tretinoin|mesh-list
138799404|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138799405|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
138799406|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799407|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
138799408|NCT01138046|Paclitaxel|paclitaxel|mesh-list
138799409|NCT01138046|Lapatinib|lapatinib|mesh-list
138799410|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138799411|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799412|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
138799413|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
138799414|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
138799415|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799416|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138799417|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799418|NCT00876460|Docetaxel|docetaxel|mesh-list
138799419|NCT00876460|Nintedanib|nintedanib|mesh-list
138799420|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799421|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
138799422|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
138799423|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
138799424|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799425|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138799426|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799427|NCT01137812|Metformin|metformin|mesh-list
138799428|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138799429|NCT01137812|Canagliflozin|canagliflozin|mesh-list
138799430|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138799431|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799432|NCT01137812|Incretins|incretins|mesh-ancestor
138799433|NCT01137812|Hormones|hormones|mesh-ancestor
138508077|NCT06196580|GABA Modulators|gaba modulators|mesh-ancestor
138799434|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799435|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138799436|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
138799437|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799438|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799439|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138799440|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138799441|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138799442|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138799443|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
138799444|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799445|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138799446|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138799447|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799448|NCT04146220|Prednisolone|prednisolone|mesh-list
138799449|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138799450|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
138799451|NCT04146220|Hormones|hormones|mesh-ancestor
138799452|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799453|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799454|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138799456|NCT00679666|Riboflavin|riboflavin|mesh-list
138799457|NCT00679666|Vitamins|vitamins|mesh-ancestor
138799458|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
138799459|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799460|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
138799461|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138799462|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
138273751|NCT05717335|Thrombin|thrombin|mesh-list
138799463|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
138799464|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
138799465|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138411636|NCT01628783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138411637|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138799466|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138799467|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799468|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138799469|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799470|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799471|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138799472|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
138799473|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138799474|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138799475|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799476|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799477|NCT00681772|Urological Agents|urological agents|mesh-ancestor
138799478|NCT00946920|Goserelin|goserelin|mesh-list
138799479|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138799480|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799481|NCT00679900|SR 46349B|sr 46349b|mesh-list
138799482|NCT00679900|Lormetazepam|lormetazepam|mesh-list
138799483|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138799484|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138799485|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799486|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138799487|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138799488|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
138799489|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799490|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799491|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138799492|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799493|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
138411659|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138799494|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138799495|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138799496|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799497|NCT00681928|Letrozole|letrozole|mesh-list
138799498|NCT00681928|Anastrozole|anastrozole|mesh-list
138799499|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799500|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138799501|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138799502|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799503|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799504|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138799505|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
138799506|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799507|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799508|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138799509|NCT00594646|Tenofovir|tenofovir|mesh-list
138799510|NCT00594646|Emtricitabine|emtricitabine|mesh-list
138799511|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
138799512|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138799513|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
138508078|NCT06196580|GABA Agents|gaba agents|mesh-ancestor
138799514|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799515|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138799516|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138799517|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799518|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799519|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138799520|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138799521|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138799522|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138799524|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
138799525|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799526|NCT00680212|Beta Carotene|beta carotene|mesh-list
138799527|NCT00680212|Carotenoids|carotenoids|mesh-list
138799528|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
138176987|NCT03803449|Midazolam|midazolam|mesh-list
138799529|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799530|NCT00680212|Protective Agents|protective agents|mesh-ancestor
138799531|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799532|NCT00680212|Provitamins|provitamins|mesh-ancestor
138799534|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
138799535|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
138799536|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138799537|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138799538|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799539|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
138799540|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
138799541|NCT02855346|Dapivirine|dapivirine|mesh-list
138799542|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
138799543|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138799544|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
138799545|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138799546|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799547|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138799548|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138799549|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138799550|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138411702|NCT01629368|Carbamazepine|carbamazepine|mesh-list
138799551|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138799552|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
138799553|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799554|NCT01111604|Ramucirumab|ramucirumab|mesh-list
138799555|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799556|NCT00950742|Trastuzumab|trastuzumab|mesh-list
138799557|NCT00950742|Afatinib|afatinib|mesh-list
138799558|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138799559|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799560|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138799561|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799562|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799563|NCT04310228|Favipiravir|favipiravir|mesh-list
138799564|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
138799565|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799566|NCT00955110|Oxymorphone|oxymorphone|mesh-list
138799567|NCT00955110|Oxycodone|oxycodone|mesh-list
138799568|NCT00955110|Hydromorphone|hydromorphone|mesh-list
138799569|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138799570|NCT00955110|Narcotics|narcotics|mesh-ancestor
138799571|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799572|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799573|NCT00955110|Analgesics|analgesics|mesh-ancestor
138273936|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138799575|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799576|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138799577|NCT05056142|Anesthetics|anesthetics|mesh-list
138799578|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799579|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799580|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138799581|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138799582|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138799583|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799584|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411717|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138411718|NCT01629394|Neostigmine|neostigmine|mesh-list
138799585|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138799586|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138799587|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799589|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799590|NCT01111526|Panobinostat|panobinostat|mesh-list
138799591|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799592|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138799593|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799594|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799595|NCT02881346|Betamethasone|betamethasone|mesh-list
138799596|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
138799597|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138799598|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
138799599|NCT02881346|Calcipotriene|calcipotriene|mesh-list
138799600|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138799601|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138799602|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
138799603|NCT02881346|Hormones|hormones|mesh-ancestor
138799604|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799605|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799606|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138799607|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
138799608|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
138799609|NCT00630708|Losartan|losartan|mesh-list
138799610|NCT00630708|Benazepril|benazepril|mesh-list
138799611|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138799612|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138273992|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
138799613|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138799614|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138799615|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799616|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138638297|NCT01683175|Cisplatin|cisplatin|mesh-list
138799617|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
138799618|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799619|NCT01111292|Inositol|inositol|mesh-list
138799620|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
138799621|NCT01111292|Vitamins|vitamins|mesh-ancestor
138799622|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
138799623|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799624|NCT02853630|Metformin|metformin|mesh-list
138799625|NCT02853630|Vildagliptin|vildagliptin|mesh-list
138799626|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138799627|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799628|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138799629|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
138799630|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799631|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799632|NCT04309838|Treprostinil|treprostinil|mesh-list
138274024|NCT02978443|Nivolumab|nivolumab|mesh-list
138799633|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138799634|NCT05367206|Paclitaxel|paclitaxel|mesh-list
138799635|NCT05367206|Carboplatin|carboplatin|mesh-list
138799636|NCT05367206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138799637|NCT05367206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138799638|NCT05367206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799639|NCT05367206|Tubulin Modulators|tubulin modulators|mesh-ancestor
138799640|NCT05367206|Antimitotic Agents|antimitotic agents|mesh-ancestor
138799641|NCT05367206|Mitosis Modulators|mitosis modulators|mesh-ancestor
138799642|NCT05367206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138411802|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138411805|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
138799643|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
138799644|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138799645|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138799646|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
138799647|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799648|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799649|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799650|NCT00944658|Apremilast|apremilast|mesh-list
138799651|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138799652|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138799653|NCT00944658|Analgesics|analgesics|mesh-ancestor
138799654|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
138274077|NCT05458609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138799656|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799657|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138799658|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138799659|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138799660|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138799661|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799662|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799663|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138799664|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138799665|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138799666|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
138799667|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799668|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799669|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138799670|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
138799671|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138799672|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138799673|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138799674|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
138799675|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799676|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799677|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
138177135|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
138799679|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138411838|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799680|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
138799681|NCT01136954|Zonisamide|zonisamide|mesh-list
138799682|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
138799683|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138799684|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138799685|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799686|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138799687|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799688|NCT01108094|Itraconazole|itraconazole|mesh-list
138799689|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
138799690|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799691|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138799692|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138799693|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799694|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799695|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138799696|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
138274185|NCT02976805|Bisacodyl|bisacodyl|mesh-list
138799697|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799698|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799699|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138799701|NCT00954174|Carboplatin|carboplatin|mesh-list
138799702|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138799703|NCT00954174|Ifosfamide|ifosfamide|mesh-list
138799704|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
138799705|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138411868|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411869|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411870|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
138411871|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138411872|NCT01630343|Narcotics|narcotics|mesh-ancestor
138411873|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138411874|NCT01630369|Insulin|insulin|mesh-list
138411875|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138411876|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138411877|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411878|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
138411879|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138411880|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
138411881|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411882|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138799706|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799707|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
138799708|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
138799709|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
138799710|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799711|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138799712|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
138799713|NCT04309058|Vitamin D|vitamin d|mesh-list
138799714|NCT04309058|Vitamins|vitamins|mesh-ancestor
138799715|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
138799716|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799717|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138799718|NCT01136408|Warfarin|warfarin|mesh-list
138799719|NCT01136408|Dabigatran|dabigatran|mesh-list
138799720|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
138799721|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
138799722|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138799724|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799725|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799726|NCT01136174|Nintedanib|nintedanib|mesh-list
138799727|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799728|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138799729|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799730|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799731|NCT01135394|Pioglitazone|pioglitazone|mesh-list
138799732|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138799733|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138411899|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411900|NCT01630642|Clopidogrel|clopidogrel|mesh-list
138411901|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138411904|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138799734|NCT00949884|Losartan|losartan|mesh-list
138799735|NCT00949884|Olmesartan|olmesartan|mesh-list
138799736|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138799737|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138799738|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138799739|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138799740|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138799741|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799742|NCT00949650|Pemetrexed|pemetrexed|mesh-list
138799743|NCT00949650|Afatinib|afatinib|mesh-list
138799744|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799745|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799746|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799747|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138799748|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138799749|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138799750|NCT03082755|Gabapentin|gabapentin|mesh-list
138799751|NCT03082755|Analgesics|analgesics|mesh-ancestor
138799752|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
138799753|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799754|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799755|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
138799756|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138799757|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138799758|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799759|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138799760|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138799761|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138799762|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799763|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799764|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
138799765|NCT05332353|BCG Vaccine|bcg vaccine|mesh-list
138799766|NCT05332353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138799767|NCT05332353|Immunologic Factors|immunologic factors|mesh-ancestor
138799768|NCT05332353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799769|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138799770|NCT00904215|Telmisartan|telmisartan|mesh-list
138799771|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138799772|NCT00904215|Diuretics|diuretics|mesh-ancestor
138799773|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
138799774|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188010|NCT05026905|Leucovorin|leucovorin|mesh-list
138799775|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138799776|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138799777|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799778|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138799779|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138799780|NCT05317689|Psilocybin|psilocybin|mesh-list
138799781|NCT05317689|Psilocin|psilocin|mesh-list
138799782|NCT05317689|Hallucinogens|hallucinogens|mesh-ancestor
138799783|NCT05317689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799784|NCT05317689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138799785|NCT05293665|Vaccines|vaccines|mesh-list
138799786|NCT05293665|Immunologic Factors|immunologic factors|mesh-ancestor
138799787|NCT05293665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799788|NCT00905307|Aripiprazole|aripiprazole|mesh-list
138799789|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
138411983|NCT01631201|KRM 1648|krm 1648|mesh-list
138411984|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138411989|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
138799790|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138799791|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138799792|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138799793|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799794|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799795|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
138799796|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
138799797|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799798|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799799|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138799800|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138799801|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
138799802|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138799803|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138799804|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138799805|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138799806|NCT00904839|Bevacizumab|bevacizumab|mesh-list
138799807|NCT00904839|Nintedanib|nintedanib|mesh-list
138799808|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138799809|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799810|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138799811|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138799812|NCT00904839|Growth Substances|growth substances|mesh-ancestor
138799813|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799814|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
138799815|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138799816|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799817|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799818|NCT04985955|Tofacitinib|tofacitinib|mesh-list
138799819|NCT04985955|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138799820|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138799821|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799822|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799823|NCT02821923|Erythritol|erythritol|mesh-list
138799824|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
138799825|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
138799826|NCT00903357|Montelukast|montelukast|mesh-list
138799827|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138799828|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
138412023|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138799829|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138799830|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
138638378|NCT01684111|Nintedanib|nintedanib|mesh-list
138799831|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799832|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799833|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138799834|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138799835|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799837|NCT00903357|Protective Agents|protective agents|mesh-ancestor
138799839|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
138799840|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
138799841|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138799842|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138799843|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799844|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799845|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138799846|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
138799847|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
138799848|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799849|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799850|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
138799851|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138799852|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138799853|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799854|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138799855|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138799856|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
138799857|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138799858|NCT01730313|Pyridoxine|pyridoxine|mesh-list
138799859|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
138799860|NCT01730313|Phenytoin|phenytoin|mesh-list
138799861|NCT01730313|Valproic Acid|valproic acid|mesh-list
138412051|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412078|NCT01631513|Tapentadol|tapentadol|mesh-list
138799862|NCT01730313|Vitamins|vitamins|mesh-ancestor
138799863|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
138799864|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799865|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
138799866|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
138799867|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138799868|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799869|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
138799870|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799871|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
138799872|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138799873|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799874|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138799875|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138799876|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138799877|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138799878|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138799879|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138799880|NCT02849379|Immunomodulating Agents|immunomodulating agents|mesh-list
138799881|NCT02849379|Immunologic Factors|immunologic factors|mesh-ancestor
138799882|NCT02849379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799883|NCT01104662|Vancomycin|vancomycin|mesh-list
138799884|NCT01104662|Daptomycin|daptomycin|mesh-list
138412086|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138412087|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138412088|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138799885|NCT01104662|Penicillins|penicillins|mesh-list
138799886|NCT01104662|Cloxacillin|cloxacillin|mesh-list
138799887|NCT01104662|Oxacillin|oxacillin|mesh-list
138799888|NCT01104662|Nafcillin|nafcillin|mesh-list
138799889|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138799890|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799891|NCT05062785|Insulin|insulin|mesh-list
138799892|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138799893|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799894|NCT01103960|Amlodipine|amlodipine|mesh-list
138799895|NCT01103960|Telmisartan|telmisartan|mesh-list
138274441|NCT02412306|Blinatumomab|blinatumomab|mesh-list
138274444|NCT05616468|Fludarabine|fludarabine|mesh-list
138799896|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138799897|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138799898|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138799899|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799900|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138799901|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799902|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
138799903|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138799904|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138799905|NCT04413279|Dexamethasone|dexamethasone|mesh-list
138799906|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138799907|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
138799908|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
138799909|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799910|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799911|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138799912|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
138799913|NCT04413279|Hormones|hormones|mesh-ancestor
138799914|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799915|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138799916|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799917|NCT04975256|Adagrasib|adagrasib|mesh-list
138799918|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799919|NCT02880800|Morphine|morphine|mesh-list
138799920|NCT02880800|Hydromorphone|hydromorphone|mesh-list
138799921|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138799922|NCT02880800|Narcotics|narcotics|mesh-ancestor
138799923|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799924|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799925|NCT02880800|Analgesics|analgesics|mesh-ancestor
138412134|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
138412135|NCT01631877|Enoxaparin|enoxaparin|mesh-list
138412136|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
138412137|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
138412142|NCT01631968|Colistin|colistin|mesh-list
138799926|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
138799927|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799928|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
138799929|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138799930|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138799931|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138799932|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138638426|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138799933|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799934|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
138799935|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799936|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799937|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138799938|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799939|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
138799940|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138799941|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
138799942|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799943|NCT01106846|Ketamine|ketamine|mesh-list
138799944|NCT01106846|Analgesics|analgesics|mesh-ancestor
138799945|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
138799946|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799947|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799948|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138799949|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138799950|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
138799951|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
138799952|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799953|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138799954|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138799955|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138799956|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799957|NCT05034783|Exenatide|exenatide|mesh-list
138799958|NCT05034783|Edetic Acid|edetic acid|mesh-list
138799959|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
138799960|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
138799961|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799962|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
138799963|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138799964|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138799965|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799966|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138799967|NCT05034783|Incretins|incretins|mesh-ancestor
138799968|NCT05034783|Hormones|hormones|mesh-ancestor
138799969|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799970|NCT00902577|Misonidazole|misonidazole|mesh-list
138412165|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138799971|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138799972|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138799973|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138799974|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138799976|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
138799977|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
138799978|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138799979|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799980|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
138799981|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799982|NCT02846493|Dexamethasone|dexamethasone|mesh-list
138799983|NCT02846493|Bromocriptine|bromocriptine|mesh-list
138799984|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138799985|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
138799986|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
138799987|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138799988|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138799989|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138799990|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
138799991|NCT02846493|Hormones|hormones|mesh-ancestor
138799992|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138799993|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138799995|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138799996|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138799997|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
138799998|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
138799999|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
138800000|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800001|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800002|NCT01106690|Metformin|metformin|mesh-list
138800003|NCT01106690|Pioglitazone|pioglitazone|mesh-list
138800004|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138800005|NCT01106690|Canagliflozin|canagliflozin|mesh-list
138800006|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138800007|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800008|NCT01106690|Incretins|incretins|mesh-ancestor
138800009|NCT01106690|Hormones|hormones|mesh-ancestor
138800010|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138800011|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138274619|NCT00003417|Carmustine|carmustine|mesh-list
138800012|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
138800013|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800014|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800015|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138800016|NCT04286529|Calcitriol|calcitriol|mesh-list
138412194|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138412195|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138800017|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138800018|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800019|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138800020|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138800021|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800022|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138800023|NCT04286529|Vitamins|vitamins|mesh-ancestor
138800024|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
138800025|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138800026|NCT01103180|Escitalopram|escitalopram|mesh-list
138800027|NCT01103180|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138800028|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138800029|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138800030|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800031|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800032|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
138800033|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800034|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
138800035|NCT00625898|Bevacizumab|bevacizumab|mesh-list
138800036|NCT00625898|Carboplatin|carboplatin|mesh-list
138800037|NCT00625898|Docetaxel|docetaxel|mesh-list
138800038|NCT00625898|Fluorouracil|fluorouracil|mesh-list
138800039|NCT00625898|Trastuzumab|trastuzumab|mesh-list
138800040|NCT00625898|Epirubicin|epirubicin|mesh-list
138800041|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138800042|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
138800043|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800044|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138800045|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138800046|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
138800047|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800048|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800049|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138800050|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138800051|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138800052|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138800053|NCT00625898|Growth Substances|growth substances|mesh-ancestor
138800054|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
138800055|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
138800056|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
138800057|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
138800058|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
138800059|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138800060|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138800061|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138800062|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138412223|NCT01632826|Growth Substances|growth substances|mesh-ancestor
138412224|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
138412225|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800063|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800064|NCT02853552|Misoprostol|misoprostol|mesh-list
138800065|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138800066|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
138800067|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138800068|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800069|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138800070|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138800071|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
138800072|NCT04268472|Darunavir|darunavir|mesh-list
138800073|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138800074|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138800075|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
138800076|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800077|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800078|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138800079|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138800080|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
138638506|NCT00287859|Topotecan|topotecan|mesh-list
138800081|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138800083|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138800084|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138800085|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138800086|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188069|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800087|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800088|NCT00941304|Oxycodone|oxycodone|mesh-list
138800089|NCT00941304|Buprenorphine|buprenorphine|mesh-list
138800090|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138800091|NCT00941304|Narcotics|narcotics|mesh-ancestor
138800092|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138800093|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800094|NCT00941304|Analgesics|analgesics|mesh-ancestor
138800095|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
138800096|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800097|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138800098|NCT02846025|Folic Acid|folic acid|mesh-list
138800099|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
138800100|NCT02846025|Antioxidants|antioxidants|mesh-list
138800101|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800102|NCT02846025|Protective Agents|protective agents|mesh-ancestor
138800103|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800104|NCT02846025|Hematinics|hematinics|mesh-ancestor
138800105|NCT02846025|Vitamins|vitamins|mesh-ancestor
138412257|NCT01633294|Gentamicins|gentamicins|mesh-list
138800106|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
138800107|NCT02880410|Temozolomide|temozolomide|mesh-list
138800108|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138800109|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
138800110|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800111|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800112|NCT02879006|Omalizumab|omalizumab|mesh-list
138800113|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138800114|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138800115|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
138800116|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138800117|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138800118|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800119|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138800120|NCT02857218|Hematinics|hematinics|mesh-ancestor
138800121|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138800122|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138800123|NCT00602316|Chelating Agents|chelating agents|mesh-list
138800124|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
138800125|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800126|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
138800127|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
138800128|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138800129|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800130|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800131|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
138800132|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138800133|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138800134|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800135|NCT04956302|Dexamethasone|dexamethasone|mesh-list
138800136|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
138412282|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412283|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
138412284|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800137|NCT04956302|Bortezomib|bortezomib|mesh-list
138800138|NCT04956302|Daratumumab|daratumumab|mesh-list
138800139|NCT04956302|Panobinostat|panobinostat|mesh-list
138800140|NCT04956302|Ichthammol|ichthammol|mesh-list
138800141|NCT04956302|BB 1101|bb 1101|mesh-list
138800142|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138800143|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138800144|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
138800145|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
138188083|NCT04719819|Anesthetics|anesthetics|mesh-list
138800146|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800147|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800148|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138800149|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
138800150|NCT04956302|Hormones|hormones|mesh-ancestor
138800151|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138800152|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138800153|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800154|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
138800155|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800156|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800157|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
138800158|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
138800159|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138800160|NCT02848443|Trifluridine|trifluridine|mesh-list
138800161|NCT02848443|Bevacizumab|bevacizumab|mesh-list
138800162|NCT02848443|Nivolumab|nivolumab|mesh-list
138800163|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
138800164|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138800165|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800166|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138800167|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138800168|NCT02848443|Growth Substances|growth substances|mesh-ancestor
138800169|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800170|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
138800171|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138800172|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800173|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
138800174|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
138800175|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138800176|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
138800177|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138800178|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800179|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800180|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138800181|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138800182|NCT00632697|Protective Agents|protective agents|mesh-ancestor
138412326|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412327|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138412328|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138800183|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800184|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
138800185|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138800186|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
138800188|NCT02848209|Croton Oil|croton oil|mesh-list
138800189|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138800190|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138800192|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138800193|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138800194|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
138800195|NCT05337969|Metformin|metformin|mesh-list
138800196|NCT05337969|Vildagliptin|vildagliptin|mesh-list
138800197|NCT05337969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138800198|NCT05337969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800199|NCT05337969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138800200|NCT05337969|Protease Inhibitors|protease inhibitors|mesh-ancestor
138800201|NCT05337969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800202|NCT05337969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800203|NCT02844153|Metformin|metformin|mesh-list
138800204|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138800205|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800206|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138800207|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
138800208|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138800209|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800210|NCT02844075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138800211|NCT02844075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800212|NCT02844309|Thalidomide|thalidomide|mesh-list
138800213|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138800214|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
138800215|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800216|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
138800217|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138800218|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138800219|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138800220|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138800221|NCT02844309|Growth Substances|growth substances|mesh-ancestor
138800222|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
138800223|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800224|NCT02845713|Ivermectin|ivermectin|mesh-list
138800225|NCT02845713|Albendazole|albendazole|mesh-list
138800226|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
138800227|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138412351|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
138800228|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138800229|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
138800230|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
138800231|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138800232|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138800233|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
138800234|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
138800235|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
138800236|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800237|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800238|NCT02845713|Filaricides|filaricides|mesh-ancestor
138800239|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
138800240|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138800241|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800242|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138800243|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
138800244|NCT00902265|Coagulants|coagulants|mesh-ancestor
138800245|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138800246|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
138800247|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800248|NCT02848287|Ropivacaine|ropivacaine|mesh-list
138275013|NCT00003351|Irinotecan|irinotecan|mesh-list
138800250|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
138800251|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138800252|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800253|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
138800254|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800255|NCT05337657|Letrozole|letrozole|mesh-list
138800256|NCT05337657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800257|NCT05337657|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138800258|NCT05337657|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138800259|NCT05337657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800260|NCT05337657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800261|NCT05337657|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138800262|NCT05337657|Hormone Antagonists|hormone antagonists|mesh-ancestor
138188119|NCT04672395|Vaccines|vaccines|mesh-list
138800263|NCT05337657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138800264|NCT05337657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800266|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138800267|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800268|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138275056|NCT00002865|Cobalt|cobalt|mesh-list
138800269|NCT02690883|Incretins|incretins|mesh-ancestor
138800270|NCT02690883|Hormones|hormones|mesh-ancestor
138800271|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138800272|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
138800273|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138800274|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138800275|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412380|NCT01634321|Leuprolide|leuprolide|mesh-list
138412381|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138412383|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138800276|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800277|NCT02847429|Crenolanib|crenolanib|mesh-list
138800278|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800279|NCT04750005|Listerine|listerine|mesh-list
138800280|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138800281|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138800282|NCT05336721|Capecitabine|capecitabine|mesh-list
138800283|NCT05336721|Chiauranib|chiauranib|mesh-list
138800284|NCT05336721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138800285|NCT05336721|Antimetabolites|antimetabolites|mesh-ancestor
138800286|NCT05336721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800287|NCT05336721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800288|NCT05336721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138800289|NCT05336721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800290|NCT00653913|Ezetimibe|ezetimibe|mesh-list
138800291|NCT00653913|Pitavastatin|pitavastatin|mesh-list
138800292|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138800293|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138800294|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
138800295|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800296|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138800297|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138800298|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800299|NCT00652431|Niacin|niacin|mesh-list
138800300|NCT00652431|Niacinamide|niacinamide|mesh-list
138800301|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
138800302|NCT00652431|Simvastatin|simvastatin|mesh-list
138800303|NCT00652431|Ezetimibe|ezetimibe|mesh-list
138800304|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138800305|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138800306|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138800307|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
138800308|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800309|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138275123|NCT04154943|Cemiplimab|cemiplimab|mesh-list
138800310|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138800311|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800312|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
138800313|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
138800314|NCT00652431|Vitamins|vitamins|mesh-ancestor
138800315|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
138800316|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800317|NCT00380523|Etoricoxib|etoricoxib|mesh-list
138800318|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138638660|NCT01686607|Micafungin|micafungin|mesh-list
138800319|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138800320|NCT00380523|Analgesics|analgesics|mesh-ancestor
138800321|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
138800322|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800323|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800324|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138800325|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138800326|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138800327|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138800328|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412405|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
138294090|NCT00000415|Calcium|calcium|mesh-list
138800329|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800330|NCT00319995|Loratadine|loratadine|mesh-list
138800331|NCT00319995|Montelukast|montelukast|mesh-list
138800332|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138800333|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
138800334|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138800335|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
138800336|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138800337|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800338|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138800339|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138412425|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138412426|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412428|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138412429|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138800340|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800341|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
138800342|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
138800343|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138800344|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138800345|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138800346|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
138800347|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
138800348|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800349|NCT02842281|Levan|levan|mesh-list
138800350|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800351|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
138800352|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138800353|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138800354|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800355|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138177820|NCT04037683|Misoprostol|misoprostol|mesh-list
138800356|NCT02842437|Analgesics|analgesics|mesh-ancestor
138800357|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
138800358|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800359|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138800360|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138800361|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138800362|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
138800363|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800364|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800365|NCT00157911|Simvastatin|simvastatin|mesh-list
138800366|NCT00157911|Ezetimibe|ezetimibe|mesh-list
138800367|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138800368|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138800369|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
138800370|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800371|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138800372|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138800373|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800374|NCT05336175|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138800375|NCT05336175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138800376|NCT05336175|Vasodilator Agents|vasodilator agents|mesh-ancestor
138800377|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
138800378|NCT02842125|Nivolumab|nivolumab|mesh-list
138800379|NCT02842125|Capecitabine|capecitabine|mesh-list
138800380|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138800381|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412485|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800382|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138800383|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800384|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138800385|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
138800386|NCT03708549|Metformin|metformin|mesh-list
138800387|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138800388|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800389|NCT00156117|Olanzapine|olanzapine|mesh-list
138800390|NCT00156117|Asenapine|asenapine|mesh-list
138800391|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
138800392|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
138800393|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800394|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800395|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138800396|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138800397|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138800398|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138800399|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138800400|NCT00156117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138800401|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138800402|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138800403|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800404|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800405|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
138800406|NCT00140985|Losartan|losartan|mesh-list
138800407|NCT00140985|Amlodipine|amlodipine|mesh-list
138800408|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138638719|NCT02274571|Estrogens|estrogens|mesh-list
138800409|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138800410|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138800411|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800412|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138800413|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800414|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
138800415|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138800416|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138800417|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138800418|NCT00140907|Losartan|losartan|mesh-list
138800419|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138800420|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138800421|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138800422|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138800423|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800424|NCT00132717|Atorvastatin|atorvastatin|mesh-list
138800425|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138800426|NCT00132717|Simvastatin|simvastatin|mesh-list
138800427|NCT00132717|Ezetimibe|ezetimibe|mesh-list
138800428|NCT00132717|Pravastatin|pravastatin|mesh-list
138800429|NCT00132717|Lovastatin|lovastatin|mesh-list
138800430|NCT00132717|L 647318|l 647318|mesh-list
138412515|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138412518|NCT01634906|Atorvastatin|atorvastatin|mesh-list
138800431|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
138800432|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138800433|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138800434|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
138800435|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800436|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138800437|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138800438|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800439|NCT00127179|Finasteride|finasteride|mesh-list
138800440|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800441|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800442|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138800443|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138800444|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800445|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
138800446|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138800447|NCT00127179|Urological Agents|urological agents|mesh-ancestor
138800448|NCT00953706|Ivacaftor|ivacaftor|mesh-list
138800449|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138800450|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138800451|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800452|NCT02852382|Morphine|morphine|mesh-list
138800453|NCT02852382|Bupivacaine|bupivacaine|mesh-list
138800454|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
138800455|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
138800456|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138800457|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800458|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
138800459|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800460|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138800461|NCT02852382|Narcotics|narcotics|mesh-ancestor
138800462|NCT02852382|Analgesics|analgesics|mesh-ancestor
138800463|NCT00630942|Minocycline|minocycline|mesh-list
138800464|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138800465|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138800466|NCT00602550|Zidovudine|zidovudine|mesh-list
138800467|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
138800468|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800469|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138800470|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138800471|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800472|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
138800473|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138412567|NCT01635400|Irinotecan|irinotecan|mesh-list
138800474|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138800475|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138800477|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
138800478|NCT00602706|Sargramostim|sargramostim|mesh-list
138800479|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138800480|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
138800481|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800482|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800483|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138800484|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138800485|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
138800486|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800487|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138800488|NCT00602706|Analgesics|analgesics|mesh-ancestor
138800489|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
138800490|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800491|NCT00604344|Insulin|insulin|mesh-list
138800492|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138800493|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
138800494|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
138800495|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
138800496|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
138800497|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138800498|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800499|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
138800500|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
138800501|NCT02851914|Serotonin|serotonin|mesh-list
138800502|NCT02851914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138800503|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138800504|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138800505|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
138800506|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800507|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412572|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800508|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800509|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138800510|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138800511|NCT00938964|Lidocaine|lidocaine|mesh-list
138800512|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
138800513|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
138800514|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138800515|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800516|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
138800517|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800518|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138800519|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138800520|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138800521|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138800522|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800523|NCT00938886|Naltrexone|naltrexone|mesh-list
138800524|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138800525|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138800526|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800527|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
138800528|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800529|NCT02852070|Dimercaprol|dimercaprol|mesh-list
138800530|NCT02852070|Chelating Agents|chelating agents|mesh-ancestor
138800531|NCT02852070|Sequestering Agents|sequestering agents|mesh-ancestor
138638740|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138800532|NCT02852070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800533|NCT00602862|Bevacizumab|bevacizumab|mesh-list
138800534|NCT00602862|Sorafenib|sorafenib|mesh-list
138800535|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138800536|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800537|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138800538|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138800539|NCT00602862|Growth Substances|growth substances|mesh-ancestor
138800540|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800541|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
138800542|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138800543|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800544|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800545|NCT00942708|Fluoxetine|fluoxetine|mesh-list
138800546|NCT00942708|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138412616|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138412617|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138412619|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138800547|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138275417|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
138800548|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138800549|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800550|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800552|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800553|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138800554|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
138800555|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138800556|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138800557|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138800558|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800559|NCT00942084|Acyclovir|acyclovir|mesh-list
138800560|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
138800561|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138800562|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
138800563|NCT00941928|Fludarabine|fludarabine|mesh-list
138800564|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
138800565|NCT00941928|Interleukin-2|interleukin-2|mesh-list
138800566|NCT00941928|Epratuzumab|epratuzumab|mesh-list
138800567|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138800568|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
138800569|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800570|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138800571|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138800572|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
138800573|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800574|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800575|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138800576|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138800577|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
138800578|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138800579|NCT00941928|Analgesics|analgesics|mesh-ancestor
138800580|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
138800581|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800582|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138800583|NCT02852694|Adalimumab|adalimumab|mesh-list
138800584|NCT02852694|Methotrexate|methotrexate|mesh-list
138800585|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
138800586|NCT02852694|Azathioprine|azathioprine|mesh-list
138800587|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138800588|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
138800589|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138800590|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800591|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138800592|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
138800593|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800594|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800595|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
138800596|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412646|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412647|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
138412648|NCT01635816|Vaccines|vaccines|mesh-list
138412649|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
138412652|NCT01635829|Phenytoin|phenytoin|mesh-list
138800597|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138800598|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138800599|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
138800600|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138800601|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138800602|NCT02852694|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138800603|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138800604|NCT00604578|Pioglitazone|pioglitazone|mesh-list
138800605|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138800606|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800607|NCT00937560|Paclitaxel|paclitaxel|mesh-list
138800608|NCT00937560|Bevacizumab|bevacizumab|mesh-list
138800609|NCT00937560|Carboplatin|carboplatin|mesh-list
138800610|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138800611|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800612|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
138800613|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
138800614|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
138800615|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800616|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138800617|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138800618|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138800619|NCT00937560|Growth Substances|growth substances|mesh-ancestor
138800620|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800621|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
138800622|NCT04268394|Metformin|metformin|mesh-list
138800623|NCT04268394|Itraconazole|itraconazole|mesh-list
138800625|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
138800626|NCT04268394|Methotrexate|methotrexate|mesh-list
138800627|NCT04268394|Digoxin|digoxin|mesh-list
138800628|NCT04268394|Midazolam|midazolam|mesh-list
138800629|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138800630|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138800631|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800632|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138800633|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
138800634|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138800635|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138800636|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
138800637|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800638|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800639|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
138800640|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800641|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138412665|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412666|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138412667|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138412668|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138412682|NCT01635972|Bupropion|bupropion|mesh-list
138800642|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138800643|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
138800644|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138800645|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138800646|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138800647|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138800648|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138275481|NCT00003597|Ifosfamide|ifosfamide|mesh-list
138800649|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138800650|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138800651|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138800652|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138800653|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
138800654|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
138800655|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
138800656|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
138800657|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800658|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138800659|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138800660|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138800661|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138800662|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
138800663|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138800664|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138800665|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138800666|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138800667|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
138800668|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138800669|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138800670|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138800671|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
138800672|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138800673|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
138800674|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138800675|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138800676|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138800677|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138800678|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138800679|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138800680|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138800681|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138800682|NCT04268394|Protective Agents|protective agents|mesh-ancestor
138800683|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138800684|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138800685|NCT04268394|Analgesics|analgesics|mesh-ancestor
138800686|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
138800687|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800688|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138800689|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138800690|NCT02851212|Metformin|metformin|mesh-list
138800691|NCT02851212|Canagliflozin|canagliflozin|mesh-list
138800692|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138800693|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138412690|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
138412691|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412699|NCT01636037|Carbidopa|carbidopa|mesh-list
138800694|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138800695|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800696|NCT00594568|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
138275549|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275550|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275551|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275552|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275569|NCT00004011|Paclitaxel|paclitaxel|mesh-list
138800697|NCT00594568|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138800698|NCT00594568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800699|NCT00594568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800700|NCT04143802|Dulaglutide|dulaglutide|mesh-list
138800701|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138800702|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800704|NCT00682630|Pyronaridine|pyronaridine|mesh-list
138800705|NCT00682630|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
138800706|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
138800707|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138800708|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138800709|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138800710|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800711|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
138800712|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
138800713|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138800714|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
138800715|NCT00875056|Vorinostat|vorinostat|mesh-list
138800716|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800717|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138800718|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800719|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800720|NCT00685594|Vitamin D|vitamin d|mesh-list
138800721|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
138800722|NCT00685594|Vitamins|vitamins|mesh-ancestor
138800723|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
138800724|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800725|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138800726|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138800728|NCT00685672|Racepinephrine|racepinephrine|mesh-list
138800729|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
138800730|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138800731|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138800732|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
138800733|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138508079|NCT06196580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800734|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800735|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800736|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138800737|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138800738|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
138800739|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800740|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138800741|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
138800742|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
138800743|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
138800744|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138800746|NCT00683176|Fenofibrate|fenofibrate|mesh-list
138800747|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138800748|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
138800749|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800750|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138800751|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
138800752|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138800753|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
138800754|NCT02626234|Digoxin|digoxin|mesh-list
138800755|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138800756|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138800757|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138800758|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
138800759|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800760|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138800761|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138800763|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138800764|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138800765|NCT02626234|Protective Agents|protective agents|mesh-ancestor
138800766|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800767|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
138800768|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800769|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138800770|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800771|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800772|NCT00685906|Ticagrelor|ticagrelor|mesh-list
138800773|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
138800774|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138800775|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138800776|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138800777|NCT00685906|Estradiol|estradiol|mesh-list
138800778|NCT00685906|Estrogens|estrogens|mesh-ancestor
138800779|NCT00685906|Hormones|hormones|mesh-ancestor
138800780|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138800781|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800782|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138800783|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
138800784|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138800785|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138275684|NCT00003639|Interferons|interferons|mesh-list
138800786|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138800787|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138412730|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138800788|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138800789|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138800790|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138800791|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138800792|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138800793|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
138800794|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800795|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800796|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138800797|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138800798|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138178264|NCT02347605|Nicotine|nicotine|mesh-list
138800799|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138800800|NCT04139824|Naproxen|naproxen|mesh-list
138800801|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138800802|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138800803|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138800804|NCT04139824|Analgesics|analgesics|mesh-ancestor
138800805|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
138800806|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800807|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383504|NCT05746546|Nicotine|nicotine|mesh-list
138800808|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138800809|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
138800810|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138800811|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800812|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800813|NCT00940602|Deferasirox|deferasirox|mesh-list
138800814|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138800815|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
138638895|NCT00288444|Docetaxel|docetaxel|mesh-list
138800816|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
138800817|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800818|NCT00686140|Celecoxib|celecoxib|mesh-list
138800819|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138800820|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138800821|NCT00686140|Analgesics|analgesics|mesh-ancestor
138800822|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
138800823|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800824|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800825|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138800826|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138800827|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138800828|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138800829|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800830|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800831|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
138800832|NCT00686218|Panobinostat|panobinostat|mesh-list
138800833|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138800834|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800835|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138800836|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800837|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800838|NCT00683956|Propofol|propofol|mesh-list
138800839|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
138275776|NCT00004089|Paclitaxel|paclitaxel|mesh-list
138800840|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138800841|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800842|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138800843|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138800844|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
138800845|NCT02850744|Temozolomide|temozolomide|mesh-list
138800846|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138800847|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
138800848|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800849|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800850|NCT04139668|Naltrexone|naltrexone|mesh-list
138800851|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138800852|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138800853|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800854|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
138800855|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800856|NCT04266756|Selexipag|selexipag|mesh-list
138800857|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138800858|NCT00606060|Factor VIII|factor viii|mesh-list
138800859|NCT00606060|Coagulants|coagulants|mesh-ancestor
138800860|NCT00875524|Vaccines|vaccines|mesh-list
138800861|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
138800862|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800863|NCT01094288|Docetaxel|docetaxel|mesh-list
138800864|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800865|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
138800866|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
138800867|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
138800868|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800869|NCT05380986|Apatinib|apatinib|mesh-list
138800870|NCT05380986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638909|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
138188254|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138800871|NCT05380986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138800872|NCT05380986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412779|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412781|NCT01636336|Hormones|hormones|mesh-ancestor
138800873|NCT05380986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800875|NCT00684112|Analgesics|analgesics|mesh-ancestor
138800876|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
138800877|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800878|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800879|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
138800880|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138800881|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138800882|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138800883|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138800884|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138800885|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138800886|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800887|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800888|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
138800889|NCT00684190|Esomeprazole|esomeprazole|mesh-list
138800890|NCT00684190|Lesogaberan|lesogaberan|mesh-list
138800891|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138800892|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138800893|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138800894|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800895|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800896|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138800897|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
138275875|NCT00384657|Iron|iron|mesh-list
138800898|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
138800899|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800900|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800902|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138800903|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800904|NCT00684268|Protective Agents|protective agents|mesh-ancestor
138800905|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800906|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
138412814|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
138412815|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
138412816|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800907|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138800908|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800909|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138800910|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138800911|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800912|NCT00874120|Phenylephrine|phenylephrine|mesh-list
138800913|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
138800914|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138800915|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
138800916|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
138800917|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800918|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800919|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
138800920|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138800921|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
138800922|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
138800923|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138800924|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138800925|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138800926|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
138800927|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638929|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800928|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800930|NCT00939822|Simvastatin|simvastatin|mesh-list
138800931|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138800932|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138800933|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
138800934|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800935|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138800936|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138800937|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800938|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138800939|NCT00685126|Albuterol|albuterol|mesh-list
138800940|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138800941|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
138800942|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800943|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800944|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138800945|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
138800946|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
138178412|NCT00240071|Letrozole|letrozole|mesh-list
138800947|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138800948|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138800949|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138800950|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138800951|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
138412856|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
138412857|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138412858|NCT01636622|Paclitaxel|paclitaxel|mesh-list
138800952|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800953|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800954|NCT00687388|Celecoxib|celecoxib|mesh-list
138800955|NCT00687388|Doxazosin|doxazosin|mesh-list
138800956|NCT00687388|Prazosin|prazosin|mesh-list
138800957|NCT00687388|Tamsulosin|tamsulosin|mesh-list
138800958|NCT00687388|Alfuzosin|alfuzosin|mesh-list
138800959|NCT00687388|Terazosin|terazosin|mesh-list
138800960|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
138800961|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138800962|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138800963|NCT00687388|Analgesics|analgesics|mesh-ancestor
138800964|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
138800965|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800966|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800967|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138800968|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138800969|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138800970|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138800971|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138800972|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138800973|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138800974|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138800975|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
138800976|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138800977|NCT00687388|Urological Agents|urological agents|mesh-ancestor
138800978|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138800980|NCT00939510|Sargramostim|sargramostim|mesh-list
138800981|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
138800982|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800983|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138800984|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138800985|NCT00939510|Growth Substances|growth substances|mesh-ancestor
138800986|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
138800987|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138800988|NCT00687466|Insulin|insulin|mesh-list
138800989|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138800990|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800991|NCT04266288|Ketamine|ketamine|mesh-list
138800992|NCT04266288|Analgesics|analgesics|mesh-ancestor
138800993|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
138800994|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138800995|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138800996|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138800997|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138188281|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138800998|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
138801000|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138801001|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138801002|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138801003|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801004|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801005|NCT00687622|Trametinib|trametinib|mesh-list
138801006|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801007|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138801008|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801009|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801010|NCT00687700|Propranolol|propranolol|mesh-list
138276107|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
138801011|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138801012|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138801013|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
138801014|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801015|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801016|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801017|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138801018|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138801019|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
138801020|NCT00935532|Insulin|insulin|mesh-list
138801021|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138801022|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
138801023|NCT00935532|Exenatide|exenatide|mesh-list
138801024|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138801025|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801026|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138801027|NCT00935532|Incretins|incretins|mesh-ancestor
138801028|NCT00935532|Hormones|hormones|mesh-ancestor
138801029|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138801030|NCT04138420|Bevacizumab|bevacizumab|mesh-list
138801031|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138801032|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801033|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138801034|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138801035|NCT04138420|Growth Substances|growth substances|mesh-ancestor
138801036|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801037|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
138801038|NCT05378646|Interferons|interferons|mesh-list
138801039|NCT05378646|Interferon-gamma|interferon-gamma|mesh-list
138801040|NCT05378646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801041|NCT05378646|Antiviral Agents|antiviral agents|mesh-ancestor
138801042|NCT05378646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138801043|NCT01093586|Cyclosporine|cyclosporine|mesh-list
138801044|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
138801045|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
138801046|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138276166|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
138801047|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138801048|NCT01093586|Prednisolone|prednisolone|mesh-list
138801049|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
138801050|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
138801051|NCT01093586|Busulfan|busulfan|mesh-list
138801052|NCT01093586|Cyclosporins|cyclosporins|mesh-list
138412907|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138412908|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
138801053|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
138801054|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138801055|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138801056|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
138801057|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138801058|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
138801059|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801060|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138801061|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138801062|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
138801063|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801064|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801065|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138801066|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801067|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
138801068|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138801069|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
138412928|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138412929|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
138412930|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801070|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138801071|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138801072|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138801073|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
138801074|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138801075|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138801076|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
138801077|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
138801078|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801079|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138801080|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
138801081|NCT01093586|Hormones|hormones|mesh-ancestor
138801082|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138801083|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138801084|NCT01093586|Protective Agents|protective agents|mesh-ancestor
138801085|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138801087|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
138801088|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
138801089|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138801090|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801091|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
138801092|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801093|NCT02625454|Acetaminophen|acetaminophen|mesh-list
138801094|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138801095|NCT02625454|Analgesics|analgesics|mesh-ancestor
138801096|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
138801097|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801098|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801099|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
138801100|NCT00606450|Thalidomide|thalidomide|mesh-list
138801101|NCT00606450|Apremilast|apremilast|mesh-list
138801102|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138801103|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138801104|NCT00606450|Analgesics|analgesics|mesh-ancestor
138801105|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
138801106|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801107|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801108|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138801109|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138801110|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138801111|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138801112|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801113|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801114|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138801115|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
138801116|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
138801117|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138801118|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138801119|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138801120|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138412988|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138801121|NCT00606450|Growth Substances|growth substances|mesh-ancestor
138801122|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
138801123|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801124|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138801125|NCT04138888|Olmesartan|olmesartan|mesh-list
138801126|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138801127|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138801128|NCT04138888|Diuretics|diuretics|mesh-ancestor
138801129|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
138639017|NCT01607086|Lamotrigine|lamotrigine|mesh-list
138801130|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801131|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138801132|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138801133|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801134|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138801135|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138801136|NCT01098110|Asenapine|asenapine|mesh-list
138801137|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138801138|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138801139|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138801140|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801141|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138801142|NCT00688402|Lesogaberan|lesogaberan|mesh-list
138801143|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138801144|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138801145|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
138801146|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
138801147|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801148|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276335|NCT00003783|Leucovorin|leucovorin|mesh-list
138801149|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801150|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
138801151|NCT04138264|Narcotics|narcotics|mesh-ancestor
138801152|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138801153|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801154|NCT04138264|Analgesics|analgesics|mesh-ancestor
138801155|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
138801156|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801157|NCT00688480|Allopurinol|allopurinol|mesh-list
138801158|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
138801159|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801160|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801161|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
138801162|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138801163|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138801164|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
138462824|NCT04898478|Narcotics|narcotics|mesh-ancestor
138801165|NCT00688480|Protective Agents|protective agents|mesh-ancestor
138801166|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801167|NCT01092728|Dasatinib|dasatinib|mesh-list
138801168|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801169|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138801170|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801171|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801172|NCT00688558|Simvastatin|simvastatin|mesh-list
138801173|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
138413028|NCT01637376|Temoporfin|temoporfin|mesh-list
138801174|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138801175|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138801176|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
138178714|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801177|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801178|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138801179|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138801180|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801181|NCT02625376|Resveratrol|resveratrol|mesh-list
138801182|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
138639044|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138801183|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801184|NCT02625376|Protective Agents|protective agents|mesh-ancestor
138801185|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801186|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801187|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138801188|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
138801189|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138801191|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138801192|NCT04153084|Laxatives|laxatives|mesh-ancestor
138801193|NCT00688948|Alfuzosin|alfuzosin|mesh-list
138801194|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138801195|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138801196|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138801197|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
138801198|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801199|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801200|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801201|NCT00688948|Urological Agents|urological agents|mesh-ancestor
138801202|NCT04152694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138801203|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138639067|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
138801204|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138801206|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138801207|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138801208|NCT00873730|Analgesics|analgesics|mesh-ancestor
138801209|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
138801210|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801211|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801212|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138801213|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138801214|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138413030|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138801215|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138801216|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
138801217|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138801218|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138801219|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138801220|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
138801221|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801222|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138801223|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138801224|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801225|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
138801226|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138801227|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
138801228|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138801229|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801230|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138801231|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138801232|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138801233|NCT00672568|Capsaicin|capsaicin|mesh-list
138801234|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
138801235|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
138801236|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
138801237|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801238|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801239|NCT00604032|Tretinoin|tretinoin|mesh-list
138801240|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801241|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
138801242|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
138801243|NCT00874432|Lisinopril|lisinopril|mesh-list
138801244|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138801245|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138801246|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
138801247|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801248|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138801249|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138801250|NCT00874432|Protective Agents|protective agents|mesh-ancestor
138801251|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801253|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138801254|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801255|NCT00935220|Incretins|incretins|mesh-ancestor
138801256|NCT00935220|Hormones|hormones|mesh-ancestor
138801257|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138801258|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138801259|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
138801260|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801261|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801262|NCT00691912|Paclitaxel|paclitaxel|mesh-list
138801264|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138639115|NCT00288873|Vitamins|vitamins|mesh-ancestor
138801265|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138801266|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801268|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
138801269|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
138801270|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801271|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138801272|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138801273|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138801274|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801275|NCT05382390|Cytarabine|cytarabine|mesh-list
138801276|NCT05382390|Decitabine|decitabine|mesh-list
138801277|NCT05382390|Aclarubicin|aclarubicin|mesh-list
138801278|NCT05382390|Lenograstim|lenograstim|mesh-list
138801279|NCT05382390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138801280|NCT05382390|Antimetabolites|antimetabolites|mesh-ancestor
138801281|NCT05382390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801282|NCT05382390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801283|NCT05382390|Antiviral Agents|antiviral agents|mesh-ancestor
138801284|NCT05382390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138801285|NCT05382390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138801286|NCT05382390|Immunologic Factors|immunologic factors|mesh-ancestor
138801287|NCT05382390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801288|NCT05382390|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138801289|NCT05382390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801290|NCT05382390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138801291|NCT05382390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138801292|NCT05382390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138801293|NCT00689806|Lovastatin|lovastatin|mesh-list
138801294|NCT00689806|L 647318|l 647318|mesh-list
138801295|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
138801296|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138276662|NCT00004695|Interleukin-2|interleukin-2|mesh-list
138801297|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138801298|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
138801299|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801300|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138801301|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138801302|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801303|NCT00594958|Vaccines|vaccines|mesh-list
138801304|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
138801305|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801306|NCT04204044|Folic Acid|folic acid|mesh-list
138801307|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
138801308|NCT04204044|Inositol|inositol|mesh-list
138801309|NCT04204044|Metformin|metformin|mesh-list
138801310|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138801311|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801312|NCT04204044|Hematinics|hematinics|mesh-ancestor
138801313|NCT04204044|Vitamins|vitamins|mesh-ancestor
138801314|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
138801315|NCT00594880|Interferons|interferons|mesh-list
138801316|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
138801317|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
138801318|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138801319|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801320|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
138801321|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413089|NCT01637571|Lansoprazole|lansoprazole|mesh-list
138801322|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
138801323|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801324|NCT00690118|Pioglitazone|pioglitazone|mesh-list
138801325|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138801326|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801327|NCT00694252|Lapatinib|lapatinib|mesh-list
138801328|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801329|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138801330|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801331|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801332|NCT00871858|Fulvestrant|fulvestrant|mesh-list
138801333|NCT00871858|Anastrozole|anastrozole|mesh-list
138462872|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
138801334|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138801335|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801336|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138801337|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138801338|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
138801339|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138801340|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801341|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138801342|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138801343|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801344|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801345|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
138801346|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138801347|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138801348|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138801349|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
138801350|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138801352|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
138801353|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801354|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
138801355|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138801356|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138801357|NCT00694408|Prednisolone|prednisolone|mesh-list
138801358|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
138801359|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
138801360|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138801361|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138801362|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138801363|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138801364|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
138801365|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138801366|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
138801367|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
138801368|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801369|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801370|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138801371|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
138801372|NCT00694408|Hormones|hormones|mesh-ancestor
138413110|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138801373|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138801374|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138801375|NCT00694408|Protective Agents|protective agents|mesh-ancestor
138801376|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138801377|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801378|NCT04136782|Paclitaxel|paclitaxel|mesh-list
138801379|NCT04136782|Docetaxel|docetaxel|mesh-list
138801380|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138801381|NCT04136782|Carboplatin|carboplatin|mesh-list
138801382|NCT04136782|Epirubicin|epirubicin|mesh-list
138276795|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
138801383|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138801384|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801385|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
138801386|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
138801387|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
138801388|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801389|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138801390|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138801391|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138801392|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801393|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
138801395|NCT04137640|Letrozole|letrozole|mesh-list
138801396|NCT04137640|Epirubicin|epirubicin|mesh-list
138801397|NCT04137640|Palbociclib|palbociclib|mesh-list
138801398|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138801399|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
138801400|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801401|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138801402|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138801403|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
138801404|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801405|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801406|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138801407|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
138801408|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
138801409|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
138801410|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138801411|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138801412|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801413|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138801414|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
138801415|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138801416|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138801417|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138801418|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138801419|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138801420|NCT02624830|Glyburide|glyburide|mesh-list
138801421|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138801422|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801423|NCT02629042|Prednisolone|prednisolone|mesh-list
138801424|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801425|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138801426|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
138801427|NCT02629042|Hormones|hormones|mesh-ancestor
138801428|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138801429|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138801430|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801431|NCT00692614|Triamcinolone|triamcinolone|mesh-list
138276886|NCT00005643|Doxorubicin|doxorubicin|mesh-list
138801432|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138801433|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138801434|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138801435|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138801437|NCT00692614|Hormones|hormones|mesh-ancestor
138462920|NCT03703102|KHK4083|khk4083|mesh-list
138801438|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138801439|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801440|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138801441|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
138801442|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801443|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801444|NCT04136470|Nivolumab|nivolumab|mesh-list
138801445|NCT04136470|Ipilimumab|ipilimumab|mesh-list
138801446|NCT04136470|Atezolizumab|atezolizumab|mesh-list
138801447|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138801448|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801449|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138801450|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801452|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
138801453|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138801454|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138801455|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801456|NCT00673504|Gemcitabine|gemcitabine|mesh-list
138801457|NCT00673504|Sunitinib|sunitinib|mesh-list
138801458|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138801459|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
138801460|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801461|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276934|NCT00005769|Hormones|hormones|mesh-list
138801462|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138801463|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138801464|NCT00673504|Growth Substances|growth substances|mesh-ancestor
138801465|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801466|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
138801467|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138801468|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801469|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138801470|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138801471|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138801472|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
138801473|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801474|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138801475|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138801476|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801477|NCT00912574|Molgramostim|molgramostim|mesh-list
138801478|NCT00912574|Sargramostim|sargramostim|mesh-list
138801479|NCT00912574|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138801480|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
138801481|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
138801482|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801483|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801484|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138801485|NCT00695032|Ifosfamide|ifosfamide|mesh-list
138801486|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801487|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138801488|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
138801489|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801490|NCT04137328|Liraglutide|liraglutide|mesh-list
138801491|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138801492|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801493|NCT04137328|Incretins|incretins|mesh-ancestor
138801494|NCT04137328|Hormones|hormones|mesh-ancestor
138801495|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138801496|NCT00693004|Donepezil|donepezil|mesh-list
138801497|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138801498|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276967|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138801499|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801500|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
138801501|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801502|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801503|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
138801504|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
138801505|NCT00695344|Everolimus|everolimus|mesh-list
138801506|NCT00695344|Azathioprine|azathioprine|mesh-list
138801507|NCT00695344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138801508|NCT00695344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138801509|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801510|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801511|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138801512|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
138801513|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801514|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413180|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138413181|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138413182|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
138801515|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138801516|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138801517|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
138801518|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138801519|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138801520|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
138801521|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138801522|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138801523|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
138801524|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138801525|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138801526|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
138801527|NCT00607542|Baclofen|baclofen|mesh-list
138801528|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138801529|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801530|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138801531|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801532|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138801533|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
138801534|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
138801535|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801536|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801537|NCT00936858|Everolimus|everolimus|mesh-list
138801538|NCT00936858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138801539|NCT00936858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138801540|NCT00936858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277065|NCT02483000|Biotin|biotin|mesh-list
138801541|NCT00936858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801542|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138801543|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
138801544|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801545|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801547|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138801548|NCT02624440|Trimethoprim|trimethoprim|mesh-list
138801549|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
138801550|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138801551|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138801552|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138801553|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413215|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413216|NCT01638234|Protective Agents|protective agents|mesh-ancestor
138413217|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801554|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801555|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138277114|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801556|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138801557|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138801559|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138801560|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138801561|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138801562|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138801563|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138801564|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138801566|NCT00693862|Carbidopa|carbidopa|mesh-list
138801567|NCT00693862|Entacapone|entacapone|mesh-list
138801568|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138801569|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138801570|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
138801571|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801572|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801573|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801574|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138801575|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801576|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138801577|NCT05377788|Lazertinib|lazertinib|mesh-list
138801578|NCT05377788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138801579|NCT05377788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801580|NCT05377788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801581|NCT00674050|Fluticasone|fluticasone|mesh-list
138801582|NCT00674050|Albuterol|albuterol|mesh-list
138801583|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801584|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138801585|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138801586|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
138801587|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801588|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138801589|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
138801590|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
138801591|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138801592|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
138801593|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138801594|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138801595|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138801596|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138801597|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
138801598|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801599|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801600|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
138801601|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
138801602|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138801603|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138801604|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801605|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801606|NCT00872170|Urological Agents|urological agents|mesh-ancestor
138413248|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
138801608|NCT00936702|Carboplatin|carboplatin|mesh-list
138801609|NCT00936702|Everolimus|everolimus|mesh-list
138801610|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138801611|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801612|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
138801613|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
138801614|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
138801615|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801616|NCT00936702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138801617|NCT00936702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138801618|NCT00936702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801619|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138801620|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
138801621|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801622|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138801623|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
138801624|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138801625|NCT00607932|Protective Agents|protective agents|mesh-ancestor
138801626|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801627|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801629|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138801630|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
138801631|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801632|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801633|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138801634|NCT00674674|Topotecan|topotecan|mesh-list
138801635|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138801636|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138463008|NCT02625610|Antidotes|antidotes|mesh-ancestor
138801637|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801638|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801639|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801640|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138801641|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
138801642|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801643|NCT04265508|Hemostatics|hemostatics|mesh-list
138801644|NCT04265508|Coagulants|coagulants|mesh-ancestor
138801645|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138801646|NCT02623738|Latanoprost|latanoprost|mesh-list
138801647|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138801648|NCT00607074|Albendazole|albendazole|mesh-list
138801649|NCT00607074|Anthelmintics|anthelmintics|mesh-list
138801650|NCT00607074|Secnidazole|secnidazole|mesh-list
138801651|NCT00607074|Metronidazole|metronidazole|mesh-list
138801652|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138801653|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138801654|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
138801655|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138801656|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138801657|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
138801658|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
138801659|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
138639246|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
138413268|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138801660|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801661|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801662|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138801663|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
138801664|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138801665|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
138801666|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801667|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138801668|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138801669|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
138801670|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801671|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801672|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138801673|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
138801674|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138801675|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
138413288|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
138413290|NCT01638650|Ritonavir|ritonavir|mesh-list
138413291|NCT01638650|Saquinavir|saquinavir|mesh-list
138801676|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138801677|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801678|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138801679|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138801680|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138801681|NCT00674752|Gabapentin|gabapentin|mesh-list
138801682|NCT00674752|Analgesics|analgesics|mesh-ancestor
138801683|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
138801684|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801685|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801686|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
138801687|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138801688|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138801689|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138801690|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138801691|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138801692|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138801693|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801694|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801695|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
138801696|NCT00607152|Allopurinol|allopurinol|mesh-list
138801697|NCT00607152|Rasburicase|rasburicase|mesh-list
138801698|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
138801699|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801700|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801701|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
138801702|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138801703|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138801705|NCT00607152|Protective Agents|protective agents|mesh-ancestor
138801706|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801707|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
138801708|NCT00696748|Testosterone|testosterone|mesh-list
138801709|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
138801710|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
138801711|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138801712|NCT00696748|Androgens|androgens|mesh-ancestor
138801713|NCT00696748|Hormones|hormones|mesh-ancestor
138801714|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138801715|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801716|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138801717|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801718|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
138801719|NCT02621554|Resveratrol|resveratrol|mesh-list
138801720|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
138801721|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801722|NCT02621554|Protective Agents|protective agents|mesh-ancestor
138801723|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801724|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801725|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138801726|NCT02623036|Enalapril|enalapril|mesh-list
138801727|NCT02623036|Lisinopril|lisinopril|mesh-list
138801728|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138801729|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
138801730|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801731|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413345|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413346|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138413348|NCT01638780|Resveratrol|resveratrol|mesh-list
138801732|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138801733|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138801734|NCT02623036|Protective Agents|protective agents|mesh-ancestor
138801735|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801736|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138801737|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138801738|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801739|NCT00696826|Incretins|incretins|mesh-ancestor
138801740|NCT00696826|Hormones|hormones|mesh-ancestor
138801741|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138801742|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138801743|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
138801744|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801745|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801746|NCT01092182|Prednisone|prednisone|mesh-list
138801747|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
138801748|NCT01092182|Rituximab|rituximab|mesh-list
138801749|NCT01092182|Doxorubicin|doxorubicin|mesh-list
138801750|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138801751|NCT01092182|Etoposide|etoposide|mesh-list
138801752|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
138801753|NCT01092182|Vincristine|vincristine|mesh-list
138801754|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138801755|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
138801756|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801757|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138801758|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138801759|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
138801760|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801761|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801762|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138801763|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138801764|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138801765|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138801766|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138801767|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801768|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138801769|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
138801770|NCT01092182|Hormones|hormones|mesh-ancestor
138801771|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138277664|NCT02535806|Hormones|hormones|mesh-ancestor
138413361|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801772|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138801773|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138801775|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
138801776|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
138801777|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
138801778|NCT04135378|Vitamins|vitamins|mesh-ancestor
138801779|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
138801780|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801781|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
138801782|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801783|NCT04135378|Protective Agents|protective agents|mesh-ancestor
138801784|NCT02878772|Aspirin|aspirin|mesh-list
138801785|NCT02878772|Vinpocetine|vinpocetine|mesh-list
138801786|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138801787|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138801788|NCT02878772|Analgesics|analgesics|mesh-ancestor
138801789|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
138801790|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801791|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801793|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138801794|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138801795|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138801796|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801797|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138801798|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138801799|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801800|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
138801801|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138801802|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
138277719|NCT02432456|Acetaminophen|acetaminophen|mesh-list
138801803|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138801804|NCT02878772|Protective Agents|protective agents|mesh-ancestor
138801805|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
138801806|NCT02623114|Methylphenidate|methylphenidate|mesh-list
138801807|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138801808|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138801809|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801810|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138801811|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138801812|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138801813|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801814|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
138801815|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801816|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138801817|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
138801819|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
138463154|NCT05409365|Antibodies|antibodies|mesh-list
138801820|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138801821|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
138413396|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138413398|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
138801822|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801823|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801824|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138801825|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
138801826|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138801827|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138801828|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138801829|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
138801830|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801831|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801832|NCT00871234|Etravirine|etravirine|mesh-list
138801833|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138277761|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
138801834|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138801835|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801836|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801837|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
138801838|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138801839|NCT04267224|Ticagrelor|ticagrelor|mesh-list
138801840|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138801841|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138801842|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138801843|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138801844|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
138801845|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138801846|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801847|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801848|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
138801849|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138801850|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801851|NCT04267146|Nivolumab|nivolumab|mesh-list
138801852|NCT04267146|Temozolomide|temozolomide|mesh-list
138801853|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138801854|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277822|NCT02436668|Paclitaxel|paclitaxel|mesh-list
138801856|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801857|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138801858|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
138801859|NCT02621320|Vitamin D|vitamin d|mesh-list
138801860|NCT02621320|Vitamins|vitamins|mesh-ancestor
138801861|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
138801862|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801863|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138801864|NCT01097330|Amiodarone|amiodarone|mesh-list
138801865|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138801866|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
138801867|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138801868|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138801869|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801870|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138801871|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138801872|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138801873|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413423|NCT01639066|Entecavir|entecavir|mesh-list
138801874|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138801875|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138801876|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138801877|NCT00934440|Bevacizumab|bevacizumab|mesh-list
138801878|NCT00934440|Azacitidine|azacitidine|mesh-list
138801879|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138801880|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801881|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138801882|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138801883|NCT00934440|Growth Substances|growth substances|mesh-ancestor
138801884|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801886|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138277857|NCT02541422|Antidotes|antidotes|mesh-ancestor
138801887|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
138801888|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801889|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801890|NCT02622802|Acetaminophen|acetaminophen|mesh-list
138801891|NCT02622802|Azithromycin|azithromycin|mesh-list
138801892|NCT02622802|Erythromycin|erythromycin|mesh-list
138801893|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
138801894|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138801895|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
138801896|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138801897|NCT02622802|Analgesics|analgesics|mesh-ancestor
138801898|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
138801899|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801900|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801901|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
138801902|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138801903|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138801904|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138801905|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138801906|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801907|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801908|NCT05158374|Aspirin|aspirin|mesh-list
138801909|NCT05158374|Metformin|metformin|mesh-list
138277901|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
138801910|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138801911|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801912|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138801913|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138801914|NCT05158374|Analgesics|analgesics|mesh-ancestor
138801915|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
138801916|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801917|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138801918|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138413444|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138413445|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
138413446|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138801919|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138801920|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138801921|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801922|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138179390|NCT03761277|Morphine|morphine|mesh-list
138801923|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138801924|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138801925|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
138801926|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138801927|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
138801928|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138801929|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
138801930|NCT00675688|Estrogens|estrogens|mesh-list
138801931|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138801932|NCT00675688|Hormones|hormones|mesh-ancestor
138801933|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138801934|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801935|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138801936|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
138801937|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138801938|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138801939|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138801941|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138801942|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138801943|NCT00696514|Vitamin D|vitamin d|mesh-list
138801944|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
138801945|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
138801946|NCT00696514|Vitamins|vitamins|mesh-list
138801947|NCT00696514|Folic Acid|folic acid|mesh-list
138801948|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
138801949|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
138801950|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801951|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138801952|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138801953|NCT00696514|Hematinics|hematinics|mesh-ancestor
138801954|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
138801955|NCT04263870|Capecitabine|capecitabine|mesh-list
138801956|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
138801957|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138801958|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
138801959|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801960|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801961|NCT05317182|Salicylic Acid|salicylic acid|mesh-list
138801962|NCT05317182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138801963|NCT05317182|Antifungal Agents|antifungal agents|mesh-ancestor
138413471|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138801964|NCT05317182|Keratolytic Agents|keratolytic agents|mesh-ancestor
138801965|NCT05317182|Dermatologic Agents|dermatologic agents|mesh-ancestor
138801966|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
138801967|NCT00871000|Antidotes|antidotes|mesh-ancestor
138801968|NCT00871000|Protective Agents|protective agents|mesh-ancestor
138801969|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801970|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
138277988|NCT04542434|Niclosamide|niclosamide|mesh-list
138801971|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
138801972|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138801973|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138801974|NCT01096784|Mecasermin|mecasermin|mesh-list
138801975|NCT01096784|Growth Substances|growth substances|mesh-ancestor
138801976|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801977|NCT00696592|Bevacizumab|bevacizumab|mesh-list
138801978|NCT00696592|Verteporfin|verteporfin|mesh-list
138801979|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138801980|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138801981|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138801982|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138801983|NCT00696592|Growth Substances|growth substances|mesh-ancestor
138801984|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801985|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
138801986|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138801987|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
138801988|NCT02622022|Morphine|morphine|mesh-list
138801989|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138801990|NCT02622022|Narcotics|narcotics|mesh-ancestor
138801991|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138801992|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138801993|NCT02622022|Analgesics|analgesics|mesh-ancestor
138801994|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
138801995|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138801996|NCT00934050|Inositol|inositol|mesh-list
138801997|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
138801998|NCT00934050|Vitamins|vitamins|mesh-ancestor
138801999|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
138802000|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802001|NCT02620618|Infliximab|infliximab|mesh-list
138802002|NCT02620618|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138802003|NCT02620618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138802004|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
138802005|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138802006|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138802007|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
138413501|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802008|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802009|NCT05321576|Analgesics, Opioid|analgesics, opioid|mesh-list
138802010|NCT05321576|Narcotics|narcotics|mesh-ancestor
138802011|NCT05321576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138802012|NCT05321576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802014|NCT05321576|Sensory System Agents|sensory system agents|mesh-ancestor
138802015|NCT05321576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802016|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138802017|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
138802018|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138802019|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278092|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
138802020|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802021|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138802022|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138802023|NCT00864916|Protective Agents|protective agents|mesh-ancestor
138802024|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802025|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
138802026|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138802027|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
138802028|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
138802029|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802030|NCT00864682|Lidocaine|lidocaine|mesh-list
138802031|NCT00864682|Propofol|propofol|mesh-list
138802032|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
138802033|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
138802034|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138802035|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802036|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
138802037|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802038|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138802039|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138802040|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138802041|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138802042|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802043|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138802044|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138802045|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
138802046|NCT00931944|Pramipexole|pramipexole|mesh-list
138802047|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
138802048|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463224|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
138802049|NCT00931944|Protective Agents|protective agents|mesh-ancestor
138802050|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802051|NCT00931944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138802052|NCT00931944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138802053|NCT00931944|Dopamine Agonists|dopamine agonists|mesh-ancestor
138802055|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802056|NCT02614456|Interferons|interferons|mesh-list
138802057|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
138802058|NCT02614456|Nivolumab|nivolumab|mesh-list
138802059|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138802060|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802061|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138802062|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802063|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
138802064|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802065|NCT04130230|Choline|choline|mesh-list
138802066|NCT04130230|Neostigmine|neostigmine|mesh-list
138802067|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138802068|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802069|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802070|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
138802071|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802072|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802073|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138802074|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
138802075|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802076|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
138802077|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138802078|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
138802079|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463240|NCT04524663|Camostat|camostat|mesh-list
138802080|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138802081|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
138802082|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138802083|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138802084|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802085|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
138802086|NCT02616874|Romidepsin|romidepsin|mesh-list
138802087|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138802088|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802089|NCT02616874|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138802090|NCT02616874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802091|NCT02616874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802092|NCT04133428|Valsartan|valsartan|mesh-list
138802093|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138802094|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138413564|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
138413565|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413566|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138639391|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
138802095|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138802096|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138802097|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802098|NCT00869050|Capecitabine|capecitabine|mesh-list
138802099|NCT00869050|Temozolomide|temozolomide|mesh-list
138802100|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138802101|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
138802102|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802103|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802104|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138802105|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
138802106|NCT04133506|Aspirin|aspirin|mesh-list
138802107|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138802108|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138802109|NCT04133506|Analgesics|analgesics|mesh-ancestor
138802110|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
138802111|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802112|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802113|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138802114|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138802116|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138802117|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802118|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138802119|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138802120|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802121|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
138802122|NCT04872218|Abatacept|abatacept|mesh-list
138802123|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
138802124|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802125|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138802126|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802127|NCT04872218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138802128|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802129|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138802130|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138802131|NCT00698464|Pasireotide|pasireotide|mesh-list
138802132|NCT00698464|Hormones|hormones|mesh-ancestor
138802133|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138802134|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802135|NCT04933682|Rifampin|rifampin|mesh-list
138802136|NCT04933682|Fluconazole|fluconazole|mesh-list
138802137|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138802138|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
138802139|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138802140|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802141|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
138802142|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138802143|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802144|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802145|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138802146|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138413594|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413596|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
138802147|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138802148|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138802149|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138802150|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138802151|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
138802152|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138802153|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138802154|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138802155|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
138802156|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138802157|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802158|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138802159|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138802160|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
138802162|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138802163|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802164|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138802165|NCT00593554|Fludarabine|fludarabine|mesh-list
138802166|NCT00593554|Thiotepa|thiotepa|mesh-list
138802167|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
138802168|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138802169|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802170|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802171|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138802172|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
138278327|NCT02974166|Ibuprofen|ibuprofen|mesh-list
138802173|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802174|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138802175|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
138802176|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138802177|NCT01101308|Oxycodone|oxycodone|mesh-list
138802178|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138802179|NCT01101308|Narcotics|narcotics|mesh-ancestor
138802180|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138802181|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802182|NCT01101308|Analgesics|analgesics|mesh-ancestor
138802183|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
138802184|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802185|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138802186|NCT00926796|Azithromycin|azithromycin|mesh-list
138802187|NCT00926796|Gentamicins|gentamicins|mesh-list
138802188|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
138802189|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138802190|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802191|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138802192|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802193|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802194|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138802195|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138802196|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802197|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138802198|NCT00696982|Glyburide|glyburide|mesh-list
138802199|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138802200|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802201|NCT00696982|Incretins|incretins|mesh-ancestor
138802202|NCT00696982|Hormones|hormones|mesh-ancestor
138802203|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138802204|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138802205|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
138802206|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802207|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802208|NCT01087736|Topiramate|topiramate|mesh-list
138278370|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
138802210|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138802211|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802212|NCT04262388|Durvalumab|durvalumab|mesh-list
138802213|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138802214|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802215|NCT00608712|Esomeprazole|esomeprazole|mesh-list
138463333|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138802216|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138639485|NCT00270582|Gemcitabine|gemcitabine|mesh-list
138802217|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138802218|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138802219|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802220|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802221|NCT01079936|Lenalidomide|lenalidomide|mesh-list
138802222|NCT01079936|Melphalan|melphalan|mesh-list
138802223|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
138802224|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802225|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138802226|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138802227|NCT01079936|Growth Substances|growth substances|mesh-ancestor
138802228|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
138802229|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802230|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138802232|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802233|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138802234|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138802235|NCT00931710|Losartan|losartan|mesh-list
138413644|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138413645|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138413646|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
138413647|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802236|NCT00931710|Amlodipine|amlodipine|mesh-list
138802237|NCT00931710|Valsartan|valsartan|mesh-list
138802238|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138802239|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138802240|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138802241|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138802242|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802243|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138802244|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802245|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
138802246|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138802247|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138802248|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138802249|NCT00931710|Diuretics|diuretics|mesh-ancestor
138802250|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
138802251|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138802252|NCT01100528|Interferons|interferons|mesh-list
138802253|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
138802254|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
138802255|NCT01100528|Dacarbazine|dacarbazine|mesh-list
138802256|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802257|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
138802258|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802259|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
138802260|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278455|NCT00851136|Bevacizumab|bevacizumab|mesh-list
138802261|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138802262|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
138802263|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802264|NCT01079234|Insulin|insulin|mesh-list
138802265|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138802266|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
138802267|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
138802268|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138802269|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802270|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
138802271|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138802272|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
138802273|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802274|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802275|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138802276|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
138802277|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138802278|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
138802279|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802280|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802281|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138802282|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
138802283|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
138802284|NCT00931632|Protective Agents|protective agents|mesh-ancestor
138802285|NCT00608790|Albuterol|albuterol|mesh-list
138802286|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138802287|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
138413664|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138802288|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802289|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802290|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138802291|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
138802292|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
138802293|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138802294|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138278501|NCT02621060|Antacids|antacids|mesh-ancestor
138802295|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138802296|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138802297|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
138802298|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802299|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802301|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802303|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138802304|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802305|NCT00863746|Sorafenib|sorafenib|mesh-list
138802306|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802307|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138802308|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802309|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802310|NCT04992156|Palbociclib|palbociclib|mesh-list
138802311|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802312|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138802313|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802314|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802315|NCT00608946|Copper|copper|mesh-list
138802316|NCT00608946|Trace Elements|trace elements|mesh-ancestor
138802317|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
138802318|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802319|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
138802320|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
138802321|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138802322|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138802323|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802324|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802325|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802326|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138802328|NCT00926328|Fluorides|fluorides|mesh-list
138802329|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
138802330|NCT00926328|Protective Agents|protective agents|mesh-ancestor
138413686|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
138413687|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413688|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138802331|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463392|NCT03052933|Gemcitabine|gemcitabine|mesh-list
138802332|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138802333|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802334|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138802335|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138802336|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
138802337|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802338|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138802339|NCT04203732|Anesthetics|anesthetics|mesh-list
138802340|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138802341|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802342|NCT00863512|Gemcitabine|gemcitabine|mesh-list
138802343|NCT00863512|Docetaxel|docetaxel|mesh-list
138802344|NCT00863512|Pemetrexed|pemetrexed|mesh-list
138802346|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802347|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138802348|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
138802349|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802350|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
138802351|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
138802352|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
138802353|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802354|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138802355|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138802356|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138802357|NCT02619994|Levofloxacin|levofloxacin|mesh-list
138802358|NCT02619994|Linezolid|linezolid|mesh-list
138802359|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
138802360|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138802361|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802362|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138802363|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138802364|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138802365|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802366|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802367|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802368|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138802369|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138802370|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138802371|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
138802372|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
138802373|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138802374|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138802375|NCT04263402|Prednisolone|prednisolone|mesh-list
138802376|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
138802377|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138802378|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
138802379|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138802380|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
138413716|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802381|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
138802382|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463411|NCT02900560|Cc-486|cc-486|mesh-list
138802383|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802384|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138802385|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
138802386|NCT04263402|Hormones|hormones|mesh-ancestor
138278641|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138802387|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138802388|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138802389|NCT04263402|Protective Agents|protective agents|mesh-ancestor
138802390|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138802391|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802393|NCT00868192|Pemetrexed|pemetrexed|mesh-list
138802394|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138802395|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802396|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138802397|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138802398|NCT00868192|Growth Substances|growth substances|mesh-ancestor
138802399|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802400|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
138802401|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802402|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802403|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138802404|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138802405|NCT02615782|Tadalafil|tadalafil|mesh-list
138802406|NCT02615782|Tamsulosin|tamsulosin|mesh-list
138802407|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
138802408|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138802409|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138802410|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802411|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802412|NCT02615782|Urological Agents|urological agents|mesh-ancestor
138802413|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138802414|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138802415|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138802416|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
138802417|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802418|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802419|NCT00930930|Paclitaxel|paclitaxel|mesh-list
138802420|NCT00930930|Everolimus|everolimus|mesh-list
138802421|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138802422|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802423|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
138802424|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
138802425|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
138802426|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802427|NCT00930930|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138802428|NCT00930930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138802429|NCT00930930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413740|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413741|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278720|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
138278721|NCT04068272|Bosentan|bosentan|mesh-list
138802430|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138802431|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
138802432|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802433|NCT00698776|Lenalidomide|lenalidomide|mesh-list
138802434|NCT00698776|KRN 7000|krn 7000|mesh-list
138802435|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
138802436|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802437|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138802438|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138802439|NCT00698776|Growth Substances|growth substances|mesh-ancestor
138802440|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
138802441|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802442|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138802443|NCT04122040|Roxithromycin|roxithromycin|mesh-list
138802444|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138802445|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802446|NCT04258956|Avelumab|avelumab|mesh-list
138802447|NCT04258956|Axitinib|axitinib|mesh-list
138802448|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138802450|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138802451|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802452|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802453|NCT00862654|Ketoconazole|ketoconazole|mesh-list
138802454|NCT00862654|Clobetasol|clobetasol|mesh-list
138802455|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
138802456|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802457|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138802458|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138802459|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802460|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802461|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138802462|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
138802463|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138802464|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802465|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138413762|NCT01650012|Eplerenone|eplerenone|mesh-list
138413763|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138413764|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
138802466|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138802467|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
138802468|NCT00862654|Hormones|hormones|mesh-ancestor
138802469|NCT00609180|Antioxidants|antioxidants|mesh-list
138278796|NCT02474407|Diazepam|diazepam|mesh-list
138802470|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802471|NCT00609180|Protective Agents|protective agents|mesh-ancestor
138802472|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802474|NCT00867490|Candesartan|candesartan|mesh-list
138802475|NCT00867490|Candesartan cilexetil|candesartan cilexetil|mesh-list
138802476|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138802477|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138463452|NCT02034110|Trametinib|trametinib|mesh-list
138802478|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138802479|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138802480|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802481|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138802482|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802483|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
138802484|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138802485|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138802486|NCT00867490|Diuretics|diuretics|mesh-ancestor
138802487|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
138802488|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138802489|NCT00697060|Docetaxel|docetaxel|mesh-list
138802490|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802491|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
138802492|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
138802493|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
138802494|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802495|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
138802496|NCT00867334|Panitumumab|panitumumab|mesh-list
138802497|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802498|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138802499|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802500|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802501|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138802502|NCT00925704|Calcitriol|calcitriol|mesh-list
138802503|NCT00925704|Sevelamer|sevelamer|mesh-list
138802504|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138802505|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802506|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138802507|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138802508|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802509|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138802510|NCT00925704|Vitamins|vitamins|mesh-ancestor
138802511|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
138802512|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138802513|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
138639747|NCT00290121|Olanzapine|olanzapine|mesh-list
138802514|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
138802515|NCT00697138|Amphetamine|amphetamine|mesh-list
138802516|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
138802517|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138802518|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138802519|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138802520|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138802521|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802522|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
138413800|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802523|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802524|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802525|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138278864|NCT02564497|Abatacept|abatacept|mesh-list
138802526|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
138802527|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
138802528|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802529|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
138802530|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138802531|NCT00609960|Midazolam|midazolam|mesh-list
138802532|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138802533|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138802534|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138802535|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802536|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138802537|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138802538|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138802539|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138802540|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
138802541|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
138802542|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
138802543|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
138802544|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802545|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802546|NCT04879134|Apomorphine|apomorphine|mesh-list
138802547|NCT04879134|Emetics|emetics|mesh-ancestor
138802548|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802549|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
138802550|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802551|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138802552|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
138802553|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
138802554|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278902|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
138802555|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802556|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
138802557|NCT04134130|Testosterone|testosterone|mesh-list
138802558|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
138802559|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
138802560|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138802561|NCT04134130|Androgens|androgens|mesh-ancestor
138802562|NCT04134130|Hormones|hormones|mesh-ancestor
138802563|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138802564|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802565|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138802566|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802567|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
138802568|NCT04258644|Paclitaxel|paclitaxel|mesh-list
138413815|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
138802569|NCT04258644|Apatinib|apatinib|mesh-list
138802570|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138802571|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802572|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
138802573|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
138802574|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
138802575|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802576|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138802577|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802578|NCT02619448|Paclitaxel|paclitaxel|mesh-list
138802579|NCT02619448|Carboplatin|carboplatin|mesh-list
138802580|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138802581|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802582|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
138802583|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
138802584|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
138463499|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138802585|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802586|NCT00610038|Glyburide|glyburide|mesh-list
138802587|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138802588|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802589|NCT02619526|Carvedilol|carvedilol|mesh-list
138802590|NCT02619526|Nebivolol|nebivolol|mesh-list
138802591|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138802592|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138802593|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
138802594|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802595|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802596|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802597|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138802598|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
138802599|NCT02619526|Protective Agents|protective agents|mesh-ancestor
138802600|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138802601|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138802602|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138802603|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
138802604|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138802605|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138413843|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
138413844|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413845|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413846|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138802606|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138802607|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138802608|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138802609|NCT04119622|Capecitabine|capecitabine|mesh-list
138802610|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
138802611|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138802612|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
138278992|NCT02577991|Triamcinolone|triamcinolone|mesh-list
138802613|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802614|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802615|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
138802616|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138802617|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
138802618|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802619|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138639797|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
138802620|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138802622|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802623|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802624|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138802625|NCT00866788|Omalizumab|omalizumab|mesh-list
138802626|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
138802627|NCT00866788|Promethazine|promethazine|mesh-list
138802628|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138802629|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
138802630|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138802631|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138802632|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
138802633|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138802634|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138802635|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138802636|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802637|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
138802638|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
138802639|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
138802640|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802641|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
138802642|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
138802643|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138802645|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413896|NCT01650727|Rituximab|rituximab|mesh-list
138802646|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802647|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
138802648|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
138802649|NCT04132570|Budesonide|budesonide|mesh-list
138802650|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138802651|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138802652|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
138802653|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802654|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802655|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138802656|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
138802657|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
138802658|NCT04132570|Hormones|hormones|mesh-ancestor
138802659|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138802660|NCT00699244|Anesthetics|anesthetics|mesh-list
138802661|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138802662|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802663|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138802664|NCT00699322|Glimepiride|glimepiride|mesh-list
138802665|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138802666|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802667|NCT00699322|Incretins|incretins|mesh-ancestor
138802668|NCT00699322|Hormones|hormones|mesh-ancestor
138802669|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138802670|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138802671|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
138639817|NCT00257036|Levofloxacin|levofloxacin|mesh-list
138802673|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802674|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138802675|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138802676|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
138802678|NCT00860470|Trace Elements|trace elements|mesh-list
138802679|NCT00860470|Folic Acid|folic acid|mesh-list
138802680|NCT00860470|Micronutrients|micronutrients|mesh-list
138802681|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802682|NCT00860470|Hematinics|hematinics|mesh-ancestor
138802683|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
138802684|NCT00860470|Vitamins|vitamins|mesh-ancestor
138802685|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
138802686|NCT00923364|Fludarabine|fludarabine|mesh-list
138802687|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
138802688|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138802689|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138802690|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
138802691|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802692|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138802693|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138802694|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
138802695|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413912|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
138802696|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802697|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138802698|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138802699|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
138802700|NCT02613676|Bilirubin|bilirubin|mesh-list
138802701|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
138802702|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802703|NCT02613676|Protective Agents|protective agents|mesh-ancestor
138802704|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802705|NCT00860158|Dasatinib|dasatinib|mesh-list
138802706|NCT00860158|Leuprolide|leuprolide|mesh-list
138802707|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802708|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138802709|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802710|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802711|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138802712|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
138802713|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138802714|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802715|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138802716|NCT02878538|Deferiprone|deferiprone|mesh-list
138802717|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138802718|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
138802719|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
138802720|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802721|NCT04134598|Tamoxifen|tamoxifen|mesh-list
138802722|NCT04134598|Letrozole|letrozole|mesh-list
138802723|NCT04134598|Anastrozole|anastrozole|mesh-list
138802724|NCT04134598|Exemestane|exemestane|mesh-list
138802725|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802726|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138802727|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138802728|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802729|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802730|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138802731|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
138802732|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138802733|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802734|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138802735|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138802736|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138802737|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138802738|NCT04134052|Midazolam|midazolam|mesh-list
138802740|NCT04134052|Analgesics|analgesics|mesh-ancestor
138802741|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
138802742|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802743|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138413937|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
138413940|NCT01651156|Tolvaptan|tolvaptan|mesh-list
138802744|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138802745|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138802746|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
138802747|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
138802748|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138802749|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138802750|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138802751|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802752|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802753|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138802754|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138802755|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138802756|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138802757|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138802758|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
138802759|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
138802760|NCT02615080|Pemirolast|pemirolast|mesh-list
138802761|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
138802762|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
138802763|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279222|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802764|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802765|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802766|NCT00859456|Sunitinib|sunitinib|mesh-list
138802767|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802768|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138802769|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138802770|NCT00859456|Growth Substances|growth substances|mesh-ancestor
138802771|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802772|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
138802773|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138802774|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802775|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802776|NCT01075646|Ropivacaine|ropivacaine|mesh-list
138802777|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138802778|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
138802779|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
138802780|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138802781|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802782|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
138802783|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802784|NCT00799903|Darapladib|darapladib|mesh-list
138802785|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138802786|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413969|NCT01651325|Isavuconazole|isavuconazole|mesh-list
138802787|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802788|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
138802789|NCT01075256|Calcium|calcium|mesh-list
138802790|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138802791|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802792|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138802793|NCT02876432|Diclofenac|diclofenac|mesh-list
138802794|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138802795|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138802796|NCT02876432|Analgesics|analgesics|mesh-ancestor
138802797|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
138802798|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802799|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802800|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138802801|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138802802|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138802803|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463572|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
138802804|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802805|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
138802806|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138802808|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802809|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
138802810|NCT02876276|Protective Agents|protective agents|mesh-ancestor
138802811|NCT00923130|Bevacizumab|bevacizumab|mesh-list
138802812|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138802813|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802814|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138802815|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138802816|NCT00923130|Growth Substances|growth substances|mesh-ancestor
138802817|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802818|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
138802819|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138802820|NCT04258098|Metronidazole|metronidazole|mesh-list
138180284|NCT02630992|Amoxicillin|amoxicillin|mesh-list
138802821|NCT04258098|Streptomycin|streptomycin|mesh-list
138802822|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802823|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138802824|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138802825|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138802826|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802827|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802828|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
138802829|NCT02605915|Carboplatin|carboplatin|mesh-list
138802830|NCT02605915|Docetaxel|docetaxel|mesh-list
138413989|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
138413990|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802831|NCT02605915|Doxorubicin|doxorubicin|mesh-list
138802832|NCT02605915|Trastuzumab|trastuzumab|mesh-list
138802833|NCT02605915|Atezolizumab|atezolizumab|mesh-list
138802834|NCT02605915|Pertuzumab|pertuzumab|mesh-list
138802835|NCT02605915|Maytansine|maytansine|mesh-list
138802836|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138463598|NCT01946555|Narcotics|narcotics|mesh-ancestor
138802837|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138802838|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
138802839|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802840|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138802841|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138802842|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
138279302|NCT02508103|Oxytocin|oxytocin|mesh-list
138802843|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802844|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802845|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138802846|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
138802847|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
138802848|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
138802849|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138802850|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138802851|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138802852|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802853|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138802854|NCT02605915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138802855|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138802856|NCT02605915|Immunotoxins|immunotoxins|mesh-ancestor
138802857|NCT02605915|Immunoconjugates|immunoconjugates|mesh-ancestor
138802858|NCT04028323|Octreotide|octreotide|mesh-list
138802859|NCT04028323|Terlipressin|terlipressin|mesh-list
138802860|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138802861|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138802862|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802863|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138802864|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138802865|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
138802866|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138802867|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138802868|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802869|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138802870|NCT02607163|Analgesics|analgesics|mesh-ancestor
138802871|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
138802872|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414018|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138414019|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138414020|NCT01651416|Amodiaquine|amodiaquine|mesh-list
138802873|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138802874|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138802875|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138463640|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
138802876|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
138802877|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802878|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802879|NCT01075100|Carboplatin|carboplatin|mesh-list
138802880|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802882|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
138802883|NCT02876354|Vitamins|vitamins|mesh-ancestor
138802884|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
138802885|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802886|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138802887|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138802888|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802890|NCT02876354|Coagulants|coagulants|mesh-ancestor
138802891|NCT00626678|Prednisone|prednisone|mesh-list
138802892|NCT00626678|Azathioprine|azathioprine|mesh-list
138802893|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138802894|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
138802895|NCT00626678|Hormones|hormones|mesh-ancestor
138180370|NCT00806221|Emollients|emollients|mesh-list
138802896|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138802897|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802898|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138802899|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802900|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
138279404|NCT02513095|Dantrolene|dantrolene|mesh-list
138802901|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802902|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138802903|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138802904|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
138802905|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138802906|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
138802907|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138802908|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138802909|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
138802910|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
138802911|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138802912|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802913|NCT00859222|Bevacizumab|bevacizumab|mesh-list
138802914|NCT00859222|Panobinostat|panobinostat|mesh-list
138802915|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138802916|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802917|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138802918|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138802919|NCT00859222|Growth Substances|growth substances|mesh-ancestor
138802920|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802921|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
138802922|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138802923|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802924|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802925|NCT00858988|Rifaximin|rifaximin|mesh-list
138802926|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138802927|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138802928|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138802929|NCT00858832|Methylergonovine|methylergonovine|mesh-list
138802930|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
138414044|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
138802931|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138802932|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802933|NCT01071512|Natalizumab|natalizumab|mesh-list
138802934|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
138802935|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802937|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
138802938|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802939|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802940|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
138802941|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802942|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802944|NCT04255992|Vitamin D|vitamin d|mesh-list
138802945|NCT04255992|Calcium|calcium|mesh-list
138802946|NCT04255992|Vitamins|vitamins|mesh-ancestor
138802947|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
138802948|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802949|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138802950|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138802951|NCT02618824|Tryptophan|tryptophan|mesh-list
138802952|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138802953|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
138802954|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138802955|NCT00610350|Simendan|simendan|mesh-list
138802956|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138802957|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
138802959|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138802960|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138802961|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802962|NCT00610350|Protective Agents|protective agents|mesh-ancestor
138802963|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802964|NCT01071200|Hormones|hormones|mesh-list
138802965|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138802966|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138802967|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802968|NCT04255836|Durvalumab|durvalumab|mesh-list
138802969|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138180433|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138802970|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138802971|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
138802972|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
138802974|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
138802975|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802976|NCT01070888|Budesonide|budesonide|mesh-list
138414061|NCT01651585|Valacyclovir|valacyclovir|mesh-list
138802977|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
138802978|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138802979|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138802980|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
138802981|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138802982|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138802983|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138802984|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
138802985|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
138639936|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
138802987|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138802988|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138802989|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138802990|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138802991|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
138802992|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802993|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138802994|NCT00857896|Fesoterodine|fesoterodine|mesh-list
138802995|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138802996|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138802997|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
138802998|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138802999|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803000|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803001|NCT00857896|Urological Agents|urological agents|mesh-ancestor
138803002|NCT00857818|Risperidone|risperidone|mesh-list
138803003|NCT00857818|Aripiprazole|aripiprazole|mesh-list
138803004|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138803005|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138803006|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
138803007|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803008|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803009|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803010|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138803011|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138803012|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803013|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138803014|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138803015|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
138803016|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
138803017|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
138279643|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803018|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138803019|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138803020|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138803021|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138803022|NCT02618668|Ketamine|ketamine|mesh-list
138803023|NCT02618668|Propofol|propofol|mesh-list
138414094|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
138803024|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138803025|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803026|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803027|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138803028|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
138803029|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
138803030|NCT02618668|Analgesics|analgesics|mesh-ancestor
138803031|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
138803032|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803033|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138803034|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138803035|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138803036|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803037|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803038|NCT01074944|Eliglustat|eliglustat|mesh-list
138803039|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803040|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803041|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
138803042|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803043|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138803044|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138803045|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803046|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803047|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138803048|NCT01074554|Azithromycin|azithromycin|mesh-list
138803049|NCT01074554|Levofloxacin|levofloxacin|mesh-list
138803051|NCT01074554|Ethambutol|ethambutol|mesh-list
138803052|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803053|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138803054|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
138803055|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138803056|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138803057|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138803058|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803059|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803060|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803061|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138803062|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138803063|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
138803064|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138803065|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138803066|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138803067|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138803068|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138803069|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138803070|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138803071|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138803072|NCT00857584|Sertraline|sertraline|mesh-list
138803073|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
138803074|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138803075|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138803076|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138803077|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803078|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803079|NCT00857584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138803080|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138803081|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138279818|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138803082|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803084|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
138803085|NCT00798967|Teduglutide|teduglutide|mesh-list
138803086|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138803087|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138803088|NCT00798967|Protective Agents|protective agents|mesh-ancestor
138803089|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803091|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803092|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138803093|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803094|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803095|NCT02618356|Raltitrexed|raltitrexed|mesh-list
138803096|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138803097|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
138803098|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414154|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138414155|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414156|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
138803099|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803100|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138803101|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803102|NCT00697996|Rituximab|rituximab|mesh-list
138803103|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138803104|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803105|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
138803106|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803107|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803108|NCT04118842|Rifampin|rifampin|mesh-list
138803109|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138803110|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
138803111|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138803112|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803113|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
138463717|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
138803114|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138803115|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803116|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803117|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138803118|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138803119|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138803120|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138803121|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138803122|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138803123|NCT00699634|Nabilone|nabilone|mesh-list
138803124|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
138803125|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
138803126|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803127|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803128|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138803129|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138803130|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138803131|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803132|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138803133|NCT00798889|Sunitinib|sunitinib|mesh-list
138803134|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803135|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138414188|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138414189|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
138803136|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138803137|NCT00798889|Growth Substances|growth substances|mesh-ancestor
138640010|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
138803138|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279910|NCT02207244|Adalimumab|adalimumab|mesh-list
138803141|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803142|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803143|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
138803144|NCT04113889|Metformin|metformin|mesh-list
138803145|NCT04113889|Pioglitazone|pioglitazone|mesh-list
138803146|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138803147|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803148|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
138803149|NCT04113889|Vitamins|vitamins|mesh-ancestor
138803150|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
138803151|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
138803152|NCT00796861|Sunitinib|sunitinib|mesh-list
138803153|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803154|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138463737|NCT01947465|Vaccines|vaccines|mesh-list
138803155|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138803156|NCT00796861|Growth Substances|growth substances|mesh-ancestor
138803157|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803158|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
138803159|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138803160|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803161|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803162|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
138279952|NCT02239692|Cathartics|cathartics|mesh-ancestor
138803163|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
138803164|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138803165|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803166|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803167|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
138803168|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138803169|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803170|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803171|NCT00914797|Terbutaline|terbutaline|mesh-list
138803172|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138803173|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
138803174|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803175|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803176|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138803177|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
138803178|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
138803179|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
138803180|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138803181|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138803182|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138803183|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138803184|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
138803185|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803186|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803187|NCT00798655|Cisplatin|cisplatin|mesh-list
138803188|NCT00798655|Panitumumab|panitumumab|mesh-list
138803189|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803190|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138803191|NCT00914641|Apixaban|apixaban|mesh-list
138803192|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138803194|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138803195|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
138803196|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803197|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803198|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
138803199|NCT00796549|Afatinib|afatinib|mesh-list
138803200|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803201|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138803202|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803203|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803204|NCT00856492|Paclitaxel|paclitaxel|mesh-list
138463769|NCT01947790|Metformin|metformin|mesh-list
138803205|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
138803206|NCT00856492|Bevacizumab|bevacizumab|mesh-list
138803207|NCT00856492|Doxorubicin|doxorubicin|mesh-list
138803208|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138803209|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138803210|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138803211|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803212|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
138803213|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
138803214|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
138803215|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803216|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138803217|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
138803218|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803219|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803220|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138803221|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
138803222|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138414258|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138414263|NCT01652534|Amantadine|amantadine|mesh-list
138803223|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138803224|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138803225|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138803226|NCT00856492|Growth Substances|growth substances|mesh-ancestor
138803227|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
138803228|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138803229|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138803230|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138803231|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803233|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138803234|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803235|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803236|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138803237|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
138803238|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
138803239|NCT00697372|Sirolimus|sirolimus|mesh-list
138803240|NCT00697372|Everolimus|everolimus|mesh-list
138803241|NCT00697372|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138803242|NCT00697372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138803243|NCT00697372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803244|NCT00697372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803245|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138803246|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
138803247|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803248|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803249|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138803250|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803251|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138803252|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
138803253|NCT04111003|Anesthetics|anesthetics|mesh-list
138803254|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803255|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803256|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
138803257|NCT00856180|Bevacizumab|bevacizumab|mesh-list
138803258|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138803259|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
138803260|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803261|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803262|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138803263|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
138803264|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803265|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803266|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138414282|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138803267|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138803268|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138803269|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138803270|NCT00856180|Growth Substances|growth substances|mesh-ancestor
138803271|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
138803273|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138803274|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803275|NCT00900627|Paclitaxel|paclitaxel|mesh-list
138803276|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138803277|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803278|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
138803279|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
138803280|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
138803281|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803282|NCT00866320|Sorafenib|sorafenib|mesh-list
138803283|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803284|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138803285|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803286|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803287|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
138803288|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138803289|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803290|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803291|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138803292|NCT04115449|Analgesics|analgesics|mesh-ancestor
138803293|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
138803294|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803295|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138280198|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
138803296|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138803297|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138803298|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
138803299|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803300|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803301|NCT04133974|Methadone|methadone|mesh-list
138803302|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138803303|NCT04133974|Narcotics|narcotics|mesh-ancestor
138803304|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803305|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803306|NCT04133974|Analgesics|analgesics|mesh-ancestor
138803307|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
138803308|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803309|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
138803310|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
138803311|NCT03679611|Neostigmine|neostigmine|mesh-list
138803312|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138803313|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280251|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138803314|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803315|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
138803316|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803317|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803318|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138803319|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
138414314|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138414315|NCT01652586|Narcotics|narcotics|mesh-ancestor
138803320|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803321|NCT00914953|Oxytocin|oxytocin|mesh-list
138803322|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
138803323|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138803324|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803325|NCT00869518|Trimethoprim|trimethoprim|mesh-list
138803326|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138803327|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
138803328|NCT00869518|Rifabutin|rifabutin|mesh-list
138803329|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138803330|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803331|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
138803332|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138803333|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138803334|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138803335|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803336|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803337|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138803338|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138803339|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138803340|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138803341|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138803342|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
138803343|NCT00869440|Midazolam|midazolam|mesh-list
138803344|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138803345|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138803346|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803347|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803348|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138803349|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138803350|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138803351|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138803352|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
138803353|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
138803354|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
138803355|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
138803356|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803357|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803358|NCT00895947|Interferons|interferons|mesh-list
138803359|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
138803360|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803361|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
138803362|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803363|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
138640093|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
138803364|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803365|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138803366|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
138803367|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414335|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138803368|NCT02841579|Osimertinib|osimertinib|mesh-list
138803369|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803370|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138803371|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803372|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803373|NCT00588445|Gefitinib|gefitinib|mesh-list
138803374|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803375|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138803376|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803377|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803378|NCT00092781|Celecoxib|celecoxib|mesh-list
138803379|NCT00092781|Etoricoxib|etoricoxib|mesh-list
138803380|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138463833|NCT01948011|Thiorphan|thiorphan|mesh-list
138803381|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138803382|NCT00092781|Analgesics|analgesics|mesh-ancestor
138803383|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
138803384|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803385|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803386|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138803387|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803388|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138803389|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138803390|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803391|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803392|NCT00092703|Diclofenac|diclofenac|mesh-list
138803393|NCT00092703|Etoricoxib|etoricoxib|mesh-list
138803394|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138803395|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138803396|NCT00092703|Analgesics|analgesics|mesh-ancestor
138803397|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
138803398|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803399|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803400|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138803401|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803402|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138803403|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803404|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803405|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138803406|NCT00699946|Olanzapine|olanzapine|mesh-list
138803407|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
138803408|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
138803409|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803410|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803411|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138803412|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138414360|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138414361|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414364|NCT01652898|Esmolol|esmolol|mesh-list
138803413|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138803414|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803415|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138180882|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
138803416|NCT00699946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138803417|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138803418|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414387|NCT01653067|Cytarabine|cytarabine|mesh-list
138414388|NCT01653067|Sirolimus|sirolimus|mesh-list
138414389|NCT01653067|Dexamethasone|dexamethasone|mesh-list
138414390|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
138414391|NCT01653067|Rituximab|rituximab|mesh-list
138803419|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803420|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803421|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
138803422|NCT00796315|Doxylamine|doxylamine|mesh-list
138803423|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
138803424|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
138803425|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
138803426|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803427|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803428|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138803429|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138803430|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
138803431|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
138803432|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188294|NCT05386459|Antiviral Agents|antiviral agents|mesh-ancestor
138803433|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803434|NCT00855166|Metformin|metformin|mesh-list
138803435|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
138803436|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138803437|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138803438|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803439|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138803440|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803441|NCT00855166|Incretins|incretins|mesh-ancestor
138803442|NCT00855166|Hormones|hormones|mesh-ancestor
138803443|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138803444|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138803446|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803447|NCT00854620|Sorafenib|sorafenib|mesh-list
138803448|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803449|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138803450|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803451|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803452|NCT00793585|Allopurinol|allopurinol|mesh-list
138803453|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
138803454|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803455|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803456|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
138803457|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803458|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138803459|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
138803460|NCT00793585|Protective Agents|protective agents|mesh-ancestor
138803461|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803463|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138803464|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803465|NCT04107103|Nivolumab|nivolumab|mesh-list
138803466|NCT04107103|Pemetrexed|pemetrexed|mesh-list
138803467|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138414450|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803468|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803469|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138803470|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803471|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803472|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138803473|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138803474|NCT02617810|Midazolam|midazolam|mesh-list
138803475|NCT02617810|Warfarin|warfarin|mesh-list
138803476|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138803477|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138803478|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803479|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803480|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138803481|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138803482|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138803483|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138803484|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
138803485|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
138803486|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
138803487|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
138803488|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803489|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181039|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803490|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
138803491|NCT00898443|Anesthetics|anesthetics|mesh-list
138803492|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803493|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803495|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
138803496|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138803497|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138803498|NCT02614612|Prednisolone|prednisolone|mesh-list
138803499|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
138803500|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138803501|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
138803502|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138803503|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
138803504|NCT02614612|Hormones|hormones|mesh-ancestor
138280514|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138803505|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138803506|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803507|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138803508|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803509|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
138803510|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
138803511|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803512|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138803513|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138414477|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138414478|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
138414480|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138803514|NCT02614612|Protective Agents|protective agents|mesh-ancestor
138803515|NCT00900159|Eszopiclone|eszopiclone|mesh-list
138803516|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138803517|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803518|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803519|NCT01689909|Zolpidem|zolpidem|mesh-list
138803520|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138803521|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138803522|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803523|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803524|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138803525|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
138803526|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
138803527|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803528|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803529|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138803530|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803531|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138803532|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803533|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803534|NCT00592852|Fluoxetine|fluoxetine|mesh-list
138803535|NCT00592852|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138803536|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138803537|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138803538|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803539|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803540|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
138803541|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803542|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138803543|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
138803544|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138803545|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138803546|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138803547|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803548|NCT00895245|Dexamethasone|dexamethasone|mesh-list
138803549|NCT00895245|Palonosetron|palonosetron|mesh-list
138803550|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
138803551|NCT00895245|Aprepitant|aprepitant|mesh-list
138803552|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138803553|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
138414506|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
138414507|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138803554|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
138803555|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803556|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803557|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138803559|NCT00895245|Hormones|hormones|mesh-ancestor
138803560|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138803561|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138803562|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803563|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138803564|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138803565|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
138803566|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803567|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803568|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138803570|NCT03172377|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138803571|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138803572|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803573|NCT02617654|Liraglutide|liraglutide|mesh-list
138803574|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138803575|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803576|NCT02617654|Incretins|incretins|mesh-ancestor
138803577|NCT02617654|Hormones|hormones|mesh-ancestor
138803578|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138803579|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
138803580|NCT00700024|Testosterone|testosterone|mesh-list
138803581|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
138803582|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
138803583|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138803584|NCT00700024|Androgens|androgens|mesh-ancestor
138803585|NCT00700024|Hormones|hormones|mesh-ancestor
138803586|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138803587|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803588|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138803589|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803590|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
138803591|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
138803592|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138803593|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803594|NCT00796003|Decitabine|decitabine|mesh-list
138803595|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138803596|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
138803597|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803598|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803599|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803600|NCT04110535|Midazolam|midazolam|mesh-list
138414537|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138803601|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138803602|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138803603|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803604|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803605|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138803606|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138803607|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138803608|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138803609|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
138803610|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
138803611|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
138803612|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
138803613|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803614|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803615|NCT04025203|Ibuprofen|ibuprofen|mesh-list
138803616|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
138803617|NCT04025203|Gabapentin|gabapentin|mesh-list
138803618|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138803619|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138803620|NCT04025203|Analgesics|analgesics|mesh-ancestor
138803621|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
138803622|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803623|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803624|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138803625|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803626|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138803627|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803628|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803629|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
138803630|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138803631|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138803632|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803633|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138803634|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138803635|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138803636|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803638|NCT02843607|Immunomodulating Agents|immunomodulating agents|mesh-list
138803639|NCT02843607|Immunologic Factors|immunologic factors|mesh-ancestor
138803640|NCT02843607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803641|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138803642|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803643|NCT00915577|Interferons|interferons|mesh-list
138414566|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138414567|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803644|NCT00915577|Interferon-beta|interferon-beta|mesh-list
138803645|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
138803646|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803647|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
138803648|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803649|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
138803650|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803651|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138803652|NCT00899847|Acetaminophen|acetaminophen|mesh-list
138803653|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
138803654|NCT00899847|Promethazine|promethazine|mesh-list
138803655|NCT00899847|Cyclosporine|cyclosporine|mesh-list
138803656|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
138803657|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
138803658|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138803659|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
138803660|NCT00899847|Melphalan|melphalan|mesh-list
138803661|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
138803662|NCT00899847|Cyclosporins|cyclosporins|mesh-list
138803663|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
138803664|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138803665|NCT00899847|Lenograstim|lenograstim|mesh-list
138803666|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138803667|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
138803668|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803669|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803670|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138803671|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
138803672|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803673|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803674|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138803675|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138803676|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803677|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
138803678|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803679|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
138803680|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138803681|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138803682|NCT00899847|Analgesics|analgesics|mesh-ancestor
138803683|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
138803684|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803685|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
138803686|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138463898|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
138803687|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138803688|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
138803689|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138803690|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138803691|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138803692|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138803693|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138803694|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
138803695|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
138803696|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
138803697|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
138803698|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138803699|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138803700|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
138803701|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
138803702|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803703|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138803704|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
138803705|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
138803706|NCT00899847|Hormones|hormones|mesh-ancestor
138803707|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138803709|NCT00899847|Protective Agents|protective agents|mesh-ancestor
138181187|NCT05444218|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138803710|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138803711|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138803712|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
138803713|NCT04117750|Vitamin D|vitamin d|mesh-list
138803714|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
138803715|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138803717|NCT04117750|Vitamins|vitamins|mesh-ancestor
138803719|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138803720|NCT04117750|Antacids|antacids|mesh-ancestor
138803721|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803722|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138803723|NCT04131322|Adalimumab|adalimumab|mesh-list
138803724|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138803725|NCT04131322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138803726|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138803727|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803728|NCT02840175|Adalimumab|adalimumab|mesh-list
138803729|NCT02840175|Etanercept|etanercept|mesh-list
138803730|NCT02840175|Abatacept|abatacept|mesh-list
138803731|NCT02840175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138803732|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138803733|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803734|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138803735|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138803736|NCT02840175|Analgesics|analgesics|mesh-ancestor
138803737|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
138803738|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463911|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138803739|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803740|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138803741|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138803742|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
138803743|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138803744|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803745|NCT02840175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138803746|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803747|NCT02603497|Peficitinib|peficitinib|mesh-list
138803748|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803749|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803750|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138803751|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
138803752|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414620|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414621|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414629|NCT01654640|Metformin|metformin|mesh-list
138803753|NCT02840409|Bevacizumab|bevacizumab|mesh-list
138803754|NCT02840409|Vinblastine|vinblastine|mesh-list
138803755|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138803756|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803757|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138803758|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138803759|NCT02840409|Growth Substances|growth substances|mesh-ancestor
138803760|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803761|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
138803762|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138803763|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
138803764|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
138803765|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
138803766|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803767|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
138803768|NCT02839941|Tacrolimus|tacrolimus|mesh-list
138803769|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
138803770|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138803771|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
138803772|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803773|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138803774|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138803775|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803776|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138803777|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803778|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138803779|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
138803780|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138803781|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803782|NCT02839941|Hormones|hormones|mesh-ancestor
138803783|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138803784|NCT02842983|Esmolol|esmolol|mesh-list
138803785|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138803786|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138803787|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
138803788|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181263|NCT03212599|Disulfiram|disulfiram|mesh-list
138640318|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138803789|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803791|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138803793|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138803794|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138803795|NCT02839785|Analgesics|analgesics|mesh-ancestor
138803796|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
138803797|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803798|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803799|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138803800|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803801|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138803802|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414638|NCT01654705|Pantoprazole|pantoprazole|mesh-list
138803803|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803804|NCT02843061|Rituximab|rituximab|mesh-list
138803805|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138803806|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138803807|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
138803808|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803809|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138803810|NCT02839239|Vitamin D|vitamin d|mesh-list
138803811|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
138803812|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
138803813|NCT02839239|Vitamins|vitamins|mesh-list
138803814|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
138803815|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803816|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138803817|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138803818|NCT02837835|Ceftazidime|ceftazidime|mesh-list
138803819|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138803820|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138803821|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138803822|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138803823|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
138803824|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803826|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803827|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138803828|NCT04249713|Brodalumab|brodalumab|mesh-list
138803829|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
138803830|NCT00610506|Dexetimide|dexetimide|mesh-list
138803831|NCT00610506|Citalopram|citalopram|mesh-list
138803832|NCT00610506|Escitalopram|escitalopram|mesh-list
138803833|NCT00610506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138803834|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138803835|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138640358|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138803836|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138803837|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138803838|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
138803839|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138803840|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138803841|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138803842|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
138803843|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
138803844|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138803845|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138803846|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138803847|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
138803848|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138414662|NCT01654939|Rifaximin|rifaximin|mesh-list
138532548|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532549|NCT00218374|Gabapentin|gabapentin|mesh-list
138532550|NCT00218374|Analgesics|analgesics|mesh-ancestor
138532551|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
138532552|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532553|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532554|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
138532555|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138532556|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138532557|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532558|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138532559|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138532560|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138532561|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532562|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532563|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
138532564|NCT00218413|Vaccines|vaccines|mesh-list
138532565|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
138532566|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532567|NCT00042068|Meloxicam|meloxicam|mesh-list
138532568|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138532569|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138424916|NCT04895046|Niraparib|niraparib|mesh-list
138532571|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
138532572|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532573|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532574|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138165952|NCT04688788|Hormones|hormones|mesh-ancestor
138532575|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138532576|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138532577|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138532578|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532579|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532580|NCT00218530|Lofexidine|lofexidine|mesh-list
138532581|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138532582|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138532583|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532584|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
138532585|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532586|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138532587|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138532588|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138532589|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
138532590|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532591|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532592|NCT00218569|Naltrexone|naltrexone|mesh-list
138532593|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138532594|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138532595|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532596|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
138532597|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532598|NCT00218608|Disulfiram|disulfiram|mesh-list
138532599|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138532600|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138532601|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532602|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532603|NCT00042146|Zolpidem|zolpidem|mesh-list
138532604|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138532605|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138532606|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532607|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532608|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138532609|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
138706158|NCT02607202|Paclitaxel|paclitaxel|mesh-list
138532611|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532612|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532614|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414740|NCT01655199|Albuterol|albuterol|mesh-list
138532615|NCT00219232|Rivastigmine|rivastigmine|mesh-list
138532616|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138532617|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532618|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532619|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
138532620|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532621|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532622|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138532623|NCT00219232|Protective Agents|protective agents|mesh-ancestor
138532624|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
138532625|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138532626|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532627|NCT00219310|Famciclovir|famciclovir|mesh-list
138532628|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
138532629|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138532630|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138532631|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532632|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532633|NCT00219388|Simendan|simendan|mesh-list
138532634|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138532635|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
138532636|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138532637|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138532638|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532639|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532640|NCT00219388|Protective Agents|protective agents|mesh-ancestor
138532641|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532642|NCT00219466|Zinc|zinc|mesh-list
138532643|NCT00219466|Tocopherols|tocopherols|mesh-list
138532644|NCT00219466|Vitamin E|vitamin e|mesh-list
138532645|NCT00219466|Tocotrienols|tocotrienols|mesh-list
138532646|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
138532647|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
138532648|NCT00219466|Trace Elements|trace elements|mesh-ancestor
138532649|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
138532650|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706175|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138706176|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138706177|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138706178|NCT02446236|Growth Substances|growth substances|mesh-ancestor
138706179|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
138706180|NCT02402660|Vitamin A|vitamin a|mesh-list
138706181|NCT02402660|Retinol acetate|retinol acetate|mesh-list
138706182|NCT02402660|Vitamins|vitamins|mesh-ancestor
138706183|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
138706184|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706185|NCT02402660|Protective Agents|protective agents|mesh-ancestor
138706186|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138706187|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138706188|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138706189|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
138532651|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
138532652|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532653|NCT00219466|Protective Agents|protective agents|mesh-ancestor
138532654|NCT00219466|Vitamins|vitamins|mesh-ancestor
138532655|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
138532656|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
138532657|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138532658|NCT00042302|Paclitaxel|paclitaxel|mesh-list
138532659|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138532660|NCT00042302|Carboplatin|carboplatin|mesh-list
138532661|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138532662|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532663|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
138532664|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
138532665|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
138532666|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532667|NCT00219700|Ibuprofen|ibuprofen|mesh-list
138532668|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138532669|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138532670|NCT00219700|Analgesics|analgesics|mesh-ancestor
138414743|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
138532671|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
138532672|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532673|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532674|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138532675|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138532676|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138532677|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532678|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532679|NCT00219739|Interferons|interferons|mesh-list
138532680|NCT00219739|Cytarabine|cytarabine|mesh-list
138532681|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
138532682|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532683|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
138532684|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138532685|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532686|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
138532687|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532688|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138424995|NCT03230097|BI 409306|bi 409306|mesh-list
138532689|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
138532690|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532691|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138532692|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138706219|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
138706220|NCT02162420|Fludarabine|fludarabine|mesh-list
138706221|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
138706222|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138706223|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138706224|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
138706225|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706226|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138706227|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138706228|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
138532693|NCT00219778|Mifepristone|mifepristone|mesh-list
138166000|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
138532694|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138532695|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
138532696|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138532697|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532698|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138532699|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138532700|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138532701|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
138532702|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138532703|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138532704|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
138532705|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138532706|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
138532707|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138532708|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138532709|NCT00219856|Propofol|propofol|mesh-list
138532710|NCT00219856|Desflurane|desflurane|mesh-list
138532711|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138532712|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532713|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532714|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138532715|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
138532716|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
138532717|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138532718|NCT00042458|Pramlintide|pramlintide|mesh-list
138532719|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138532720|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532721|NCT00219895|Ibuprofen|ibuprofen|mesh-list
138532722|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138532723|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138532724|NCT00219895|Analgesics|analgesics|mesh-ancestor
138532725|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
138532726|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532727|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532728|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138532729|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138532730|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138532731|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532732|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532733|NCT00077337|Romidepsin|romidepsin|mesh-list
138532734|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138532735|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532736|NCT00077337|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138532737|NCT00077337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532738|NCT00077337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532739|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138532740|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
138532741|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138706243|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
138706244|NCT01652092|Melphalan|melphalan|mesh-list
138706245|NCT01652092|Busulfan|busulfan|mesh-list
138706246|NCT01652092|Fludarabine|fludarabine|mesh-list
138706247|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
138532743|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
138532744|NCT00220051|Capecitabine|capecitabine|mesh-list
138532745|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
138532746|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532747|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
138532748|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532749|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532750|NCT00077415|Gemcitabine|gemcitabine|mesh-list
138532751|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532752|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
138532753|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532754|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532755|NCT00042536|Naltrexone|naltrexone|mesh-list
138532756|NCT00042536|Yohimbine|yohimbine|mesh-list
138532757|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138532758|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138532759|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532760|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
138166009|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
138532761|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532763|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
138532764|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138532765|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138532766|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138209001|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532767|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
138532768|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532769|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532770|NCT00042536|Urological Agents|urological agents|mesh-ancestor
138532771|NCT00220129|Capecitabine|capecitabine|mesh-list
138532772|NCT00220129|Epirubicin|epirubicin|mesh-list
138532773|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532774|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532775|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
138532776|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532777|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138532778|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138532779|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138532780|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532781|NCT00220168|Capecitabine|capecitabine|mesh-list
138532782|NCT00220168|Irinotecan|irinotecan|mesh-list
138532783|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138532784|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
138532785|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532786|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532787|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138532788|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138532789|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414762|NCT01655303|Metoprolol|metoprolol|mesh-list
138532790|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138532791|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138532792|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138532793|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138532794|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706284|NCT01566695|Azacitidine|azacitidine|mesh-list
138706285|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138706286|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
138706287|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138706288|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532795|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532796|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532797|NCT00042575|Analgesics|analgesics|mesh-ancestor
138532798|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
138532799|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532800|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
138532801|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138532802|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
138532803|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138532804|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
138532805|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532806|NCT00077454|Temozolomide|temozolomide|mesh-list
138532807|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138532808|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138532809|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
138532810|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532811|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532812|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138532813|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166016|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138532814|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138532815|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138532816|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138532817|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138532818|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
138532819|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138532820|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532821|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138532822|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138425223|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
138532823|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138532824|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138532825|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138532826|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138532828|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
138532829|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138532830|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532831|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532832|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
138532833|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138532834|NCT00042653|Cinacalcet|cinacalcet|mesh-list
138532835|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138532836|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532837|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138532838|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
138532839|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138532841|NCT00073593|Bivalirudin|bivalirudin|mesh-list
138532842|NCT00073593|Protamines|protamines|mesh-list
138532843|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
138532844|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138532845|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138532846|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532847|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
138532848|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138706289|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532849|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
138532850|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532851|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
138532852|NCT00073593|Coagulants|coagulants|mesh-ancestor
138532853|NCT00220480|Escitalopram|escitalopram|mesh-list
138532854|NCT00220480|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138532855|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138532856|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138532857|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532858|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532859|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
138532860|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532861|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
138532862|NCT00220675|Hematinics|hematinics|mesh-ancestor
138532863|NCT00042731|Lycopene|lycopene|mesh-list
138532864|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138532865|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
138532866|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532867|NCT00042731|Protective Agents|protective agents|mesh-ancestor
138532868|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532869|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138532870|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138532871|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532872|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
138166033|NCT04415008|Cytarabine|cytarabine|mesh-list
138532873|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138532874|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532875|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532876|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138532877|NCT00077493|Antibodies|antibodies|mesh-list
138532878|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
138532879|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138532880|NCT00077493|Immunotoxins|immunotoxins|mesh-list
138532881|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
138532882|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
138532883|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532884|NCT00220831|Vitamin E|vitamin e|mesh-list
138532885|NCT00220831|Vitamins|vitamins|mesh-ancestor
138532886|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
138532887|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532888|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
138532889|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532890|NCT00220831|Protective Agents|protective agents|mesh-ancestor
138532891|NCT00220909|Lansoprazole|lansoprazole|mesh-list
138532892|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
138532893|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138532894|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138532895|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138532896|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532897|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532898|NCT00220987|Insulin|insulin|mesh-list
138532900|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138532901|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532902|NCT02966067|Anesthetics|anesthetics|mesh-list
138532903|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138532904|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532905|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532907|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138532908|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
138532909|NCT00042809|Paclitaxel|paclitaxel|mesh-list
138532910|NCT00042809|Trastuzumab|trastuzumab|mesh-list
138532911|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138532912|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138532913|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532914|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
138532915|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
138414773|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
138414774|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
138532916|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
138532917|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532918|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138532919|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138532920|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532921|NCT00073710|Calcitriol|calcitriol|mesh-list
138532922|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138532923|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532924|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138532925|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138532926|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532927|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138532928|NCT00073710|Vitamins|vitamins|mesh-ancestor
138532929|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
138532930|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138532931|NCT00042848|Modafinil|modafinil|mesh-list
138532932|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138532933|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532934|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138532935|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138532936|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138532937|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532939|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138532940|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532942|NCT00402259|Omeprazole|omeprazole|mesh-list
138532943|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138532944|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138532945|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138532946|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532947|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532948|NCT02965677|Paclitaxel|paclitaxel|mesh-list
138532949|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138532950|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532951|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
138532952|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
138532953|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
138532954|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532955|NCT00402376|Carvedilol|carvedilol|mesh-list
138532956|NCT00402376|Perindopril|perindopril|mesh-list
138532957|NCT00402376|Pravastatin|pravastatin|mesh-list
138532958|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138532959|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138532960|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
138532961|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138532962|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532963|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138532964|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138532965|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
138532966|NCT00402376|Protective Agents|protective agents|mesh-ancestor
138532967|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138532968|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138532969|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138532970|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
138532971|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138532972|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138230022|NCT02487303|Analgesics|analgesics|mesh-ancestor
138532973|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138532974|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138532975|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
138532976|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138532977|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138532978|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532979|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138532980|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
138414780|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138532982|NCT00042887|Mitomycin|mitomycin|mesh-list
138532983|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138532984|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532985|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
138532986|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138532987|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138209229|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
138532988|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138532989|NCT00122746|Cisplatin|cisplatin|mesh-list
138532990|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138532991|NCT00122785|Dexamethasone|dexamethasone|mesh-list
138706383|NCT00352534|Dactinomycin|dactinomycin|mesh-list
138532992|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138532993|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
138532994|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
138532995|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138532996|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138166064|NCT04367051|Diuretics|diuretics|mesh-ancestor
138532997|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138532998|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
138532999|NCT00122785|Hormones|hormones|mesh-ancestor
138425429|NCT02325466|Ticagrelor|ticagrelor|mesh-list
138425451|NCT02323100|Glycerol|glycerol|mesh-list
138533000|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138533001|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138533002|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533003|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138533004|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138533005|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138533006|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138533007|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533008|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533009|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533011|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
138533012|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533013|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
138533014|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138533015|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
138533016|NCT00077532|Ipilimumab|ipilimumab|mesh-list
138533017|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
138533018|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138533019|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533020|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138533021|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533022|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138533023|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
138533024|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533025|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138533026|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138533027|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138533028|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138533029|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533030|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533031|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533032|NCT00122863|Analgesics|analgesics|mesh-ancestor
138533033|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
138533034|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425471|NCT02283281|Hormones|hormones|mesh-ancestor
138533035|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
138533036|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138533038|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
138533039|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138533040|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533041|NCT00122941|Micronutrients|micronutrients|mesh-list
138533042|NCT00122941|Trace Elements|trace elements|mesh-list
138706396|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
138533043|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533044|NCT00077688|Paclitaxel|paclitaxel|mesh-list
138488534|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138414787|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533045|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138533046|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533047|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
138533048|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
138533049|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
138533050|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533051|NCT00397319|Hormones|hormones|mesh-list
138533052|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138533053|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533054|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
138533055|NCT02965443|Saxagliptin|saxagliptin|mesh-list
138533056|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138166073|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
138533057|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533058|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138533059|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533061|NCT02965443|Hormones|hormones|mesh-ancestor
138533062|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138533063|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138533064|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
138533065|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533066|NCT00042965|Gemcitabine|gemcitabine|mesh-list
138533067|NCT00042965|Capecitabine|capecitabine|mesh-list
138533068|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138533069|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
138533070|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533071|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533072|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138533073|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
138533074|NCT00123175|Progestins|progestins|mesh-list
138533075|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138533076|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138533077|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138533078|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
138533079|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138533080|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533081|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138414791|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138533082|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138533083|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138425506|NCT02120079|Lubricant Eye Drops|lubricant eye drops|mesh-list
138533084|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138533085|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533087|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138533088|NCT00077727|Galantamine|galantamine|mesh-list
138533089|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138533090|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533091|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533092|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
138533093|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533094|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138706416|NCT00018044|Clofazimine|clofazimine|mesh-list
138533095|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138533096|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
138533097|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533098|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
138533099|NCT00123292|Plasminogen|plasminogen|mesh-list
138533100|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
138533101|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138533102|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138533103|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533104|NCT00043004|Leucovorin|leucovorin|mesh-list
138533105|NCT00043004|Bevacizumab|bevacizumab|mesh-list
138533106|NCT00043004|Fluorouracil|fluorouracil|mesh-list
138533107|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
138533108|NCT00043004|Calcium|calcium|mesh-list
138533109|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
138533110|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138533111|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533112|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138533113|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138533114|NCT00043004|Growth Substances|growth substances|mesh-ancestor
138533115|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533116|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
138533117|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138533118|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
138533119|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533120|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138533121|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138533122|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
138533123|NCT00043004|Antidotes|antidotes|mesh-ancestor
138533124|NCT00043004|Protective Agents|protective agents|mesh-ancestor
138533125|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
138533126|NCT00043004|Vitamins|vitamins|mesh-ancestor
138533127|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
138533128|NCT00123331|Cyclosporine|cyclosporine|mesh-list
138533129|NCT00123331|Sirolimus|sirolimus|mesh-list
138533130|NCT00123331|Cyclosporins|cyclosporins|mesh-list
138533131|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533132|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533133|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138533134|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
138533135|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533136|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
138533137|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533138|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
138533139|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138533140|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138533141|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138533142|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138533143|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533144|NCT00123370|Modafinil|modafinil|mesh-list
138533145|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138318669|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
138318670|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138533147|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138533148|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138533149|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138533150|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533151|NCT00043043|Celecoxib|celecoxib|mesh-list
138533152|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138533153|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138533154|NCT00043043|Analgesics|analgesics|mesh-ancestor
138533155|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
138533156|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533157|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533158|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138533159|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138533160|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138533161|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138414805|NCT01655524|Protective Agents|protective agents|mesh-ancestor
138414807|NCT01655628|Gemcitabine|gemcitabine|mesh-list
138533162|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533163|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533164|NCT00077805|Enoxaparin|enoxaparin|mesh-list
138533165|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
138533166|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
138533167|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138533168|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138533169|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533170|NCT00043082|Carboplatin|carboplatin|mesh-list
138533171|NCT00043082|Doxorubicin|doxorubicin|mesh-list
138533172|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138533173|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533174|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138533175|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138166094|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533176|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138533177|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533178|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533179|NCT00123877|Esorubicin|esorubicin|mesh-list
138533180|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138533181|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533182|NCT00123916|Benzonidazole|benzonidazole|mesh-list
138533183|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138533184|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
138533185|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533186|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138533187|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138533188|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138533189|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533190|NCT00073827|Albuterol|albuterol|mesh-list
138533191|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138533192|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
138533193|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533194|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533195|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138533197|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
138533198|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138533199|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138533200|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138533201|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138533202|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
138533203|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533204|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533205|NCT02970539|Paclitaxel|paclitaxel|mesh-list
138533206|NCT02970539|Ramucirumab|ramucirumab|mesh-list
138533207|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138533208|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533209|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
138533210|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
138533211|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
138533212|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533213|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
138533214|NCT00124111|Fluorouracil|fluorouracil|mesh-list
138533215|NCT00124111|Methotrexate|methotrexate|mesh-list
138533216|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138533217|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
138533218|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533219|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138533220|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138533221|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
138533222|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533223|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533224|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138533225|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
138533226|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138533227|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138414815|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533228|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
138533229|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138414817|NCT01655641|Coagulants|coagulants|mesh-ancestor
138533230|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
138533231|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533232|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138533233|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138533234|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
138533235|NCT00124150|Analgesics|analgesics|mesh-ancestor
138533236|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
138533237|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533238|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533239|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
138533240|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138533241|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138533242|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
138533243|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138533244|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138533245|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533246|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138533247|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
138533248|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138533249|NCT02958046|Domperidone|domperidone|mesh-list
138533250|NCT02958046|Lansoprazole|lansoprazole|mesh-list
138533251|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
138425574|NCT01863186|Lofexidine|lofexidine|mesh-list
138533253|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138533254|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138533255|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533256|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533257|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
138533258|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
138533259|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533260|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533261|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138533262|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
138533263|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533264|NCT00073905|Gemcitabine|gemcitabine|mesh-list
138533265|NCT00073905|Capecitabine|capecitabine|mesh-list
138533266|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138533267|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
138533268|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533269|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533270|NCT00124267|Quinine|quinine|mesh-list
138533271|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
138533272|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138533273|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138533274|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533275|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138533276|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533277|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138533278|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533279|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138533280|NCT00124267|Analgesics|analgesics|mesh-ancestor
138533281|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
138533282|NCT00077844|Enoxaparin|enoxaparin|mesh-list
138533283|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
138533284|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
138533285|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138533286|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138533287|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533289|NCT00043121|Capecitabine|capecitabine|mesh-list
138533290|NCT00043121|Fluorouracil|fluorouracil|mesh-list
138533291|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
138533292|NCT00043121|Calcium|calcium|mesh-list
138533293|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
138533294|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138533295|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533296|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138533297|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
138414823|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414824|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414825|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
138533298|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533299|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533300|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138533301|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
138533302|NCT00043121|Antidotes|antidotes|mesh-ancestor
138533303|NCT00043121|Protective Agents|protective agents|mesh-ancestor
138533304|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
138533305|NCT00043121|Vitamins|vitamins|mesh-ancestor
138533306|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
138533307|NCT00402415|Sirolimus|sirolimus|mesh-list
138533308|NCT00402415|Sunitinib|sunitinib|mesh-list
138533309|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138533310|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533311|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138533312|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533313|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
138533314|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138533315|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
138533316|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533317|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138533318|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533319|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533320|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138533321|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138533322|NCT00402415|Growth Substances|growth substances|mesh-ancestor
138533323|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
138533324|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138533325|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138533326|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533327|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138533328|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138533329|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138230034|NCT05305508|Calcium|calcium|mesh-list
138533331|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
138533332|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533333|NCT00124306|Amitriptyline|amitriptyline|mesh-list
138533334|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138533335|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
138533336|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138533337|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138533338|NCT00124306|Analgesics|analgesics|mesh-ancestor
138533339|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
138533340|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533341|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533342|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138533343|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138533344|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138533345|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533346|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
138533347|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533348|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
138533349|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533350|NCT00124384|Modafinil|modafinil|mesh-list
138533351|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138533352|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533353|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138533354|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138533355|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138533356|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533357|NCT00077883|Cisplatin|cisplatin|mesh-list
138533358|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533359|NCT00124540|Misoprostol|misoprostol|mesh-list
138533360|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138318727|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
138533361|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
138533362|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138533363|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533364|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138533365|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138533366|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
138533367|NCT00124696|Cocaethylene|cocaethylene|mesh-list
138533368|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138533369|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138533370|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138533371|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533372|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
138533373|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533374|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533375|NCT00043277|Bivalirudin|bivalirudin|mesh-list
138533376|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
138533377|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138533378|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
138533379|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533380|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533381|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
138533382|NCT00074022|Docetaxel|docetaxel|mesh-list
138533383|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533384|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
138533385|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
138533386|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
138533387|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533388|NCT00124813|Thalidomide|thalidomide|mesh-list
138533389|NCT00124813|Idarubicin|idarubicin|mesh-list
138533390|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138533391|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
138533392|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533393|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
138533394|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138533395|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533396|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138533397|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138533398|NCT00124813|Growth Substances|growth substances|mesh-ancestor
138533399|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
138533400|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533401|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138166234|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
138533402|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138533403|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138533404|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533407|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
138533408|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
138533409|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533410|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533411|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138533412|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138533413|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138533414|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138533415|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138425619|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
138533416|NCT00124930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138533417|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138533418|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138533419|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414844|NCT01655758|Bimatoprost|bimatoprost|mesh-list
138414845|NCT01655758|Travoprost|travoprost|mesh-list
138414846|NCT01655758|Dorzolamide|dorzolamide|mesh-list
138533420|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533421|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
138533422|NCT00124969|Amlodipine|amlodipine|mesh-list
138533423|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138533424|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138533425|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138533426|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533427|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138533428|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533429|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
138533430|NCT00043316|Interferons|interferons|mesh-list
138533431|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
138533432|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533433|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
138533434|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533435|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
138533436|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138533437|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533438|NCT00125008|Vaccines|vaccines|mesh-list
138533439|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
138533440|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533441|NCT00125047|Vaccines|vaccines|mesh-list
138533442|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
138533443|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533444|NCT00078000|Sunitinib|sunitinib|mesh-list
138533445|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533446|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138533447|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138533448|NCT00078000|Growth Substances|growth substances|mesh-ancestor
138533449|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533450|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
138533451|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138533452|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533453|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533454|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
138533455|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
138533456|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138533458|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138533459|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138533460|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533461|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
138533462|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533463|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533464|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138533465|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533466|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138533467|NCT00043355|Interferons|interferons|mesh-list
138533468|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
138533469|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533470|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
138533471|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533472|NCT00125398|Fospropofol|fospropofol|mesh-list
138533473|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138533474|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138533475|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533476|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
138533477|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138533478|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
138533479|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138533480|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
138533481|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533482|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533483|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
138533484|NCT00125437|Spironolactone|spironolactone|mesh-list
138533485|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138533486|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
138533487|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138533488|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533489|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138533490|NCT00125437|Diuretics|diuretics|mesh-ancestor
138533491|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
138533492|NCT00125554|Metyrapone|metyrapone|mesh-list
138533493|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
138533494|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533495|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533496|NCT00043394|Trastuzumab|trastuzumab|mesh-list
138533497|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138533498|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533499|NCT00125671|Warfarin|warfarin|mesh-list
138533500|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
138533501|NCT00125827|Clofarabine|clofarabine|mesh-list
138533502|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138533503|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
138533504|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533505|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138209755|NCT00351416|Letrozole|letrozole|mesh-list
138533506|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138318752|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138318753|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138533507|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138533508|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138533509|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138533510|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533511|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138533512|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138533513|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138533514|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
138533515|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533516|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533517|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138533518|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138533519|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
138533521|NCT00125905|Nicotine|nicotine|mesh-list
138533522|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138533523|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
138533524|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533525|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533526|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138533527|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138533528|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
138533529|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533530|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533531|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138533532|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
138533533|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138533534|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138166265|NCT03296033|Enoxaparin|enoxaparin|mesh-list
138533535|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138533536|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138414859|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533537|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
138533538|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138533539|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138533540|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533541|NCT00078117|Buprenorphine|buprenorphine|mesh-list
138533542|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138533543|NCT00078117|Narcotics|narcotics|mesh-ancestor
138533544|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138533545|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533546|NCT00078117|Analgesics|analgesics|mesh-ancestor
138533547|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
138533548|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533549|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138533550|NCT00125983|Ritonavir|ritonavir|mesh-list
138533551|NCT00125983|Lopinavir|lopinavir|mesh-list
138533552|NCT00125983|Norinyl|norinyl|mesh-list
138533553|NCT00125983|Ortho Evra|ortho evra|mesh-list
138533554|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138533555|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138533556|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
138533557|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318766|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
138533558|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533559|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138533560|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138533561|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
138533562|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533563|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138533564|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138533565|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138533566|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138533567|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138533568|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
138533569|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138533570|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533571|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138533572|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138533573|NCT00126022|Tedisamil|tedisamil|mesh-list
138533574|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138533575|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138533576|NCT00126022|Protective Agents|protective agents|mesh-ancestor
138533577|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533578|NCT00402454|Rifampin|rifampin|mesh-list
138533579|NCT00402454|Isoniazid|isoniazid|mesh-list
138533580|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
138533581|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138533582|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
138533583|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138533584|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533585|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
138533586|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138533587|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533588|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533589|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138533590|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138533591|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138533592|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138533593|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138533594|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138533595|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138533596|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138533597|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
138533598|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138533599|NCT00402493|Ibuprofen|ibuprofen|mesh-list
138533600|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138533601|NCT00402493|Latanoprost|latanoprost|mesh-list
138533602|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138533603|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138533604|NCT00402493|Analgesics|analgesics|mesh-ancestor
138533605|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
138533606|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533607|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533608|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138533610|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138533611|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533612|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533613|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138533614|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138533615|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138533616|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138533617|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138533618|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138533619|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
138533620|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533621|NCT00402532|Everolimus|everolimus|mesh-list
138533622|NCT00402532|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138533623|NCT00402532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138533624|NCT00402532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414891|NCT01655914|Antidotes|antidotes|mesh-ancestor
138414892|NCT01655914|Protective Agents|protective agents|mesh-ancestor
138414893|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414895|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
138533625|NCT00402532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533626|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138533627|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
138533628|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533629|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533630|NCT00126061|Tedisamil|tedisamil|mesh-list
138533631|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138533632|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138533633|NCT00126061|Protective Agents|protective agents|mesh-ancestor
138533634|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533636|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138533637|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533638|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533639|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
138415021|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
138533640|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533641|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533642|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
138533643|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
138533644|NCT00399399|Azathioprine|azathioprine|mesh-list
138533645|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138533646|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
138533647|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415085|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138415086|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
138415099|NCT01656980|Carmustine|carmustine|mesh-list
138533648|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138166304|NCT03018418|Mitomycins|mitomycins|mesh-list
138533649|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138533650|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
138415151|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533651|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533652|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533653|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138533654|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
138415152|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415153|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138415154|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
138533655|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138533656|NCT00126100|Lenograstim|lenograstim|mesh-list
138533657|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138533658|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
138533659|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533660|NCT00123253|Tesamorelin|tesamorelin|mesh-list
138533661|NCT00123253|Growth Substances|growth substances|mesh-ancestor
138533662|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533663|NCT00126139|Abciximab|abciximab|mesh-list
138533664|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
138533665|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138533666|NCT00074100|Amonafide|amonafide|mesh-list
138533667|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533668|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
138533669|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533670|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415280|NCT01657838|Ketoconazole|ketoconazole|mesh-list
138533671|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533672|NCT00126256|Leucovorin|leucovorin|mesh-list
138533673|NCT00126256|Fluorouracil|fluorouracil|mesh-list
138533674|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
138533675|NCT00126256|Irinotecan|irinotecan|mesh-list
138533676|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
138488535|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138533677|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533678|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138533679|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533680|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138533681|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
138533682|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533683|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138415493|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
138533684|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138533685|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533686|NCT00126256|Antidotes|antidotes|mesh-ancestor
138533687|NCT00126256|Protective Agents|protective agents|mesh-ancestor
138533688|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
138533689|NCT00126256|Vitamins|vitamins|mesh-ancestor
138533690|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
138533691|NCT00043667|Daclizumab|daclizumab|mesh-list
138533692|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138533693|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
138533694|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415642|NCT01659476|Miotics|miotics|mesh-ancestor
138533695|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
138533696|NCT00074139|Docetaxel|docetaxel|mesh-list
138533697|NCT00074139|Doxorubicin|doxorubicin|mesh-list
138533698|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138533699|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138533700|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
138533701|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533702|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138415705|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138488536|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
138415706|NCT01659918|Montelukast|montelukast|mesh-list
138533703|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138533704|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
138533705|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533706|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533707|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138533708|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
138533709|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
138415769|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415771|NCT01660373|Ticagrelor|ticagrelor|mesh-list
138415772|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138533710|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
138166306|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138533711|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138533712|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138533713|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138533714|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533715|NCT00126373|Bupropion|bupropion|mesh-list
138415835|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138415836|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
138533716|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138533717|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
138533718|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138533719|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138533720|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138533721|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138533722|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138415901|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
138415902|NCT01660997|Hormones|hormones|mesh-ancestor
138533723|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
138533724|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533725|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533726|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138533727|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138533728|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533729|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138533730|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138415970|NCT01661335|Aprepitant|aprepitant|mesh-list
138533731|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425753|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138533732|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533733|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138533734|NCT00043706|Antibodies|antibodies|mesh-list
138533735|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138533736|NCT00043706|Mitogens|mitogens|mesh-list
138533737|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
138416055|NCT01662089|Zinc|zinc|mesh-list
138533738|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533739|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
138533740|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533741|NCT00126451|Vorinostat|vorinostat|mesh-list
138533742|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533743|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138533744|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533745|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533746|NCT00126607|Trastuzumab|trastuzumab|mesh-list
138416105|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
138416114|NCT01662518|Hormones|hormones|mesh-ancestor
138533747|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138533748|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533749|NCT00074178|Cytarabine|cytarabine|mesh-list
138533750|NCT00074178|Dexamethasone|dexamethasone|mesh-list
138533751|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
138533752|NCT00074178|Methotrexate|methotrexate|mesh-list
138533753|NCT00074178|Etoposide|etoposide|mesh-list
138533754|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
138533755|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138416177|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138533756|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
138533757|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533758|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138533759|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138533760|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
138533761|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533762|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416244|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138416245|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
138416246|NCT01663662|Tolvaptan|tolvaptan|mesh-list
138533763|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138533764|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138533765|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
138533766|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
138533767|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533768|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138533769|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
138533770|NCT00074178|Hormones|hormones|mesh-ancestor
138416312|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138416313|NCT01664520|Analgesics|analgesics|mesh-ancestor
138533771|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138533772|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138533773|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138533774|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
138533775|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138533776|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138533777|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
138416380|NCT01664871|Protective Agents|protective agents|mesh-ancestor
138318846|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533778|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
138533779|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533780|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138416460|NCT01665248|Fluorides|fluorides|mesh-list
138533781|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138533782|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138533783|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138533784|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138533785|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
138533786|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533788|NCT00126646|Immunotoxins|immunotoxins|mesh-list
138533789|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
138533790|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
138533791|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533792|NCT00126763|Fentanyl|fentanyl|mesh-list
138533793|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138533794|NCT00126763|Narcotics|narcotics|mesh-ancestor
138533795|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138533796|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416591|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
138533797|NCT00126763|Analgesics|analgesics|mesh-ancestor
138533798|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
138416660|NCT01666587|Analgesics|analgesics|mesh-ancestor
138416661|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
138533799|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533800|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138533801|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138533802|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
138533803|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
138533804|NCT00402571|Acetaminophen|acetaminophen|mesh-list
138533805|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138416662|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416672|NCT01666600|Nintedanib|nintedanib|mesh-list
138533806|NCT00402571|Analgesics|analgesics|mesh-ancestor
138533807|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
138533808|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533809|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533810|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
138533811|NCT00126880|Lamivudine|lamivudine|mesh-list
138533812|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138533813|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138416727|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138416728|NCT01667094|Meropenem|meropenem|mesh-list
138533814|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533815|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533816|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
138533817|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533818|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138533819|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138533820|NCT02965911|Fenofibrate|fenofibrate|mesh-list
138416796|NCT01667575|Clarithromycin|clarithromycin|mesh-list
138416797|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138533821|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138533822|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
138533823|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533824|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138318864|NCT05632692|Antipruritics|antipruritics|mesh-ancestor
138533825|NCT00127075|Estradiol|estradiol|mesh-list
138533826|NCT00127075|Estrogens|estrogens|mesh-ancestor
138533827|NCT00127075|Hormones|hormones|mesh-ancestor
138416865|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138416866|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533828|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138533829|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533831|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138533832|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138533833|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
138533834|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533835|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
138533836|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533837|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533838|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533839|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138533840|NCT00127114|Analgesics|analgesics|mesh-ancestor
138533841|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
138533842|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138417077|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138417078|NCT01669304|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138533844|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
138533845|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138533846|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138533847|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533848|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138533849|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
138417079|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138533850|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533851|NCT00399477|Levodopa|levodopa|mesh-list
138533852|NCT00399477|Pramipexole|pramipexole|mesh-list
138533853|NCT00399477|Rasagiline|rasagiline|mesh-list
138533854|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138533855|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138533856|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
138533857|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533858|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533859|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533860|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138533861|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533862|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138533863|NCT00399477|Protective Agents|protective agents|mesh-ancestor
138533864|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
138533865|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
138533866|NCT00127270|Darifenacin|darifenacin|mesh-list
138533867|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138533868|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138533869|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
138533870|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417286|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
138533871|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417356|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533872|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533873|NCT00127270|Urological Agents|urological agents|mesh-ancestor
138533875|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138533876|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138533877|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533878|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138417357|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138417358|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138417360|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
138533879|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138533880|NCT00043823|Growth Substances|growth substances|mesh-ancestor
138533881|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533882|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
138210134|NCT00392444|Sunitinib|sunitinib|mesh-list
138533883|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138533884|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533885|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533886|NCT00074334|Immunotoxins|immunotoxins|mesh-list
138417420|NCT01680120|Anesthetics|anesthetics|mesh-list
138417423|NCT01680198|Vitamin D|vitamin d|mesh-list
138533887|NCT00074334|Immunoconjugates|immunoconjugates|mesh-ancestor
138533888|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
138533889|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533890|NCT00127387|Etanercept|etanercept|mesh-list
138533891|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138533892|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138533893|NCT00127387|Analgesics|analgesics|mesh-ancestor
138533894|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
138533895|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533896|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533897|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138533898|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138417567|NCT05567822|Esmolol|esmolol|mesh-list
138533899|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138533900|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138533901|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
138533902|NCT00043862|Topotecan|topotecan|mesh-list
138533903|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138533904|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138533905|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533906|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533907|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138533908|NCT00127504|Azithromycin|azithromycin|mesh-list
138417634|NCT05057949|Rifampin|rifampin|mesh-list
138417658|NCT04901312|Narcotics|narcotics|mesh-ancestor
138533909|NCT00127504|Rifampin|rifampin|mesh-list
138533910|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138533911|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533912|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138533913|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
138533914|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
138533915|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138533916|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533917|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533918|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138533919|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138533920|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138417768|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
138417769|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138417770|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417771|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138417772|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138417773|NCT03907800|Paclitaxel|paclitaxel|mesh-list
138533921|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138417774|NCT03907800|Carboplatin|carboplatin|mesh-list
138533922|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138533923|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138533924|NCT00043901|Lamotrigine|lamotrigine|mesh-list
138533925|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
138533926|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138533927|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138533928|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533929|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138533930|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533931|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138533932|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138533933|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138533934|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138533935|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138533936|NCT00127777|Amantadine|amantadine|mesh-list
138533937|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138533938|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138533939|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
138533940|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533941|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
138533942|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138533943|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138417968|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
138533944|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533945|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138533946|NCT00127777|Analgesics|analgesics|mesh-ancestor
138533947|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
138533948|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533949|NCT00399633|Sumatriptan|sumatriptan|mesh-list
138533950|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138533951|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138533952|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138533953|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
138533954|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318957|NCT03024840|Propofol|propofol|mesh-list
138318968|NCT05631678|Rifampin|rifampin|mesh-list
138533955|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533956|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210213|NCT05902169|Carboplatin|carboplatin|mesh-list
138533958|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138533959|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
138533960|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
138533961|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
138533962|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138533963|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418184|NCT05769868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138418197|NCT05650996|Calpastatin|calpastatin|mesh-list
138533964|NCT00402610|Rifampin|rifampin|mesh-list
138533965|NCT00402610|Isoniazid|isoniazid|mesh-list
138533966|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
138533967|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138533968|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
138533969|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138533970|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138533971|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
138418253|NCT05317403|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138533972|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138533973|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138533974|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138533975|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138533976|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138533977|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138533978|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138533979|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138533980|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138533981|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138533982|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138533983|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
138533984|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138533985|NCT00402766|Dexamethasone|dexamethasone|mesh-list
138533986|NCT00402766|Cisplatin|cisplatin|mesh-list
138533987|NCT00402766|Pemetrexed|pemetrexed|mesh-list
138533988|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
138533989|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138533990|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
138533991|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
138533992|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138533993|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533994|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138533995|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
138533996|NCT00402766|Hormones|hormones|mesh-ancestor
138533997|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138418398|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138533999|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418399|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138418400|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138418401|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138534000|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138318987|NCT05631678|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138318988|NCT05631678|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138418455|NCT03268499|Cisplatin|cisplatin|mesh-list
138534001|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534002|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138534003|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138534004|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138534005|NCT00127972|Lamivudine|lamivudine|mesh-list
138534006|NCT00127972|Efavirenz|efavirenz|mesh-list
138534007|NCT00127972|Nevirapine|nevirapine|mesh-list
138534008|NCT00127972|Stavudine|stavudine|mesh-list
138534009|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138418526|NCT02036086|Vemurafenib|vemurafenib|mesh-list
138418527|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418528|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138418529|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418530|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534010|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138418531|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
138418532|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138418534|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138418535|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138418536|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418537|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
138418538|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138418539|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418540|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138418541|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418542|NCT01299480|Vaccines|vaccines|mesh-list
138418543|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
138418544|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418550|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
138534011|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534012|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534013|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
138534014|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534015|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138534016|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138534017|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138534018|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138534019|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138418595|NCT06225310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138418596|NCT06225310|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138418597|NCT06225310|Protective Agents|protective agents|mesh-ancestor
138418598|NCT06225310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138418599|NCT06225310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418615|NCT06225271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418616|NCT06225258|Xanthohumol|xanthohumol|mesh-list
138418617|NCT06225258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418618|NCT06225258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138418619|NCT06225258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138418620|NCT06225258|Growth Substances|growth substances|mesh-ancestor
138418621|NCT06225258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534020|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138534021|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138534022|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138534023|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
138534025|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
138534026|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138534027|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
138418702|NCT06224790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418713|NCT06224673|Immunoconjugates|immunoconjugates|mesh-list
138534028|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534029|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534030|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
138534031|NCT04711434|Antibodies|antibodies|mesh-list
138534032|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
138534033|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534034|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
138534035|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138418796|NCT06223698|Anastrozole|anastrozole|mesh-list
138418797|NCT06223698|Exemestane|exemestane|mesh-list
138418798|NCT06223698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418811|NCT06223685|Rifaximin|rifaximin|mesh-list
138534036|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138534037|NCT00128245|Analgesics|analgesics|mesh-ancestor
138534038|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
138534039|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138534040|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534041|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138534042|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138418874|NCT06223074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138418875|NCT06223074|Protective Agents|protective agents|mesh-ancestor
138534043|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
138534044|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138534045|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
138534046|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138534047|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534048|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534049|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138418944|NCT06220344|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138534050|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138534051|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138319015|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419030|NCT06184399|Ivermectin|ivermectin|mesh-list
138534052|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534054|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
138534055|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534057|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
138534058|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
138534059|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138419353|NCT05994287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138534060|NCT00078195|Immunomodulating Agents|immunomodulating agents|mesh-list
138534061|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534062|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138534063|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138534064|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
138534065|NCT00044291|Toremifene|toremifene|mesh-list
138534066|NCT00044291|Letrozole|letrozole|mesh-list
138534067|NCT00044291|Hormones|hormones|mesh-list
138534068|NCT00044291|Atamestane|atamestane|mesh-list
138419354|NCT05994287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138419355|NCT05994287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138419356|NCT05994287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534069|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
138534070|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
138534071|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
138534072|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138534073|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419476|NCT05913388|Pembrolizumab|pembrolizumab|mesh-list
138534074|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534075|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138534076|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138534077|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534078|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534079|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
138534080|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138419819|NCT05662306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138419820|NCT05662306|Serotonin Agents|serotonin agents|mesh-ancestor
138534081|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138534082|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138534083|NCT00078234|Rituximab|rituximab|mesh-list
138534084|NCT00078234|Fludarabine|fludarabine|mesh-list
138534085|NCT00078234|Oblimersen|oblimersen|mesh-list
138534086|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138534087|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534088|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
138419920|NCT05625932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138419921|NCT05625932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138419922|NCT05625932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419923|NCT05624554|Cyclophosphamide|cyclophosphamide|mesh-list
138419925|NCT05624554|Rituximab|rituximab|mesh-list
138420056|NCT05534620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534089|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534090|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138534091|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
138534092|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534093|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534095|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
138534096|NCT00078351|Protective Agents|protective agents|mesh-ancestor
138534097|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534098|NCT00044447|Glimepiride|glimepiride|mesh-list
138420057|NCT05534620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420058|NCT05534620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138420059|NCT05534620|Alkylating Agents|alkylating agents|mesh-ancestor
138420060|NCT05533697|Pembrolizumab|pembrolizumab|mesh-list
138420061|NCT05533697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420062|NCT05533697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420063|NCT05533697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420064|NCT05533697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420065|NCT05529251|Carboplatin|carboplatin|mesh-list
138420066|NCT05529251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534099|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138534100|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138534101|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210348|NCT05897138|Tislelizumab|tislelizumab|mesh-list
138534102|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138534103|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
138534104|NCT00397358|Icodextrin|icodextrin|mesh-list
138534105|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
138420119|NCT05466279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420120|NCT05457257|Prednisone|prednisone|mesh-list
138420121|NCT05457257|Olaparib|olaparib|mesh-list
138420122|NCT05457257|Abiraterone Acetate|abiraterone acetate|mesh-list
138420123|NCT05457257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138420124|NCT05457257|Glucocorticoids|glucocorticoids|mesh-ancestor
138420125|NCT05457257|Hormones|hormones|mesh-ancestor
138420126|NCT05457257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138420127|NCT05457257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420128|NCT05457257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138534106|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138534107|NCT05519917|Afatinib|afatinib|mesh-list
138534108|NCT05519917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534109|NCT05519917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138534110|NCT05519917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534111|NCT05519917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534113|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
138534114|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
138420215|NCT05364424|Rituximab|rituximab|mesh-list
138420216|NCT05364424|Obinutuzumab|obinutuzumab|mesh-list
138420217|NCT05364424|Carboplatin|carboplatin|mesh-list
138534115|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534116|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534118|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
138534119|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534120|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138534121|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138534122|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138534123|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138420281|NCT05317416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420282|NCT05316129|Hormones|hormones|mesh-list
138420283|NCT05316129|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138420284|NCT05316129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138420285|NCT05316129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420286|NCT05316116|Siltuximab|siltuximab|mesh-list
138420287|NCT05316116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420288|NCT05308654|Dexamethasone|dexamethasone|mesh-list
138420289|NCT05308654|Lenalidomide|lenalidomide|mesh-list
138420290|NCT05308654|Daratumumab|daratumumab|mesh-list
138420291|NCT05308654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138420292|NCT05308654|Antiemetics|antiemetics|mesh-ancestor
138420293|NCT05308654|Autonomic Agents|autonomic agents|mesh-ancestor
138420294|NCT05308654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138420295|NCT05308654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420296|NCT05308654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138420297|NCT05308654|Glucocorticoids|glucocorticoids|mesh-ancestor
138534124|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138534125|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534126|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534127|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138534128|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
138534129|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138420367|NCT05282277|Raclopride|raclopride|mesh-list
138420368|NCT05282277|Estradiol|estradiol|mesh-list
138420369|NCT05282277|Progesterone|progesterone|mesh-list
138420371|NCT05282277|Hormones|hormones|mesh-ancestor
138420372|NCT05282277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138420373|NCT05282277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420374|NCT05282277|Progestins|progestins|mesh-ancestor
138420375|NCT05282277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138420376|NCT05282277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138420377|NCT05282277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138420378|NCT05282277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138420379|NCT05282277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138420380|NCT05282277|Dopamine Agents|dopamine agents|mesh-ancestor
138420381|NCT05282277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138420382|NCT05282277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420384|NCT05270213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420385|NCT05270213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420386|NCT05270213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420387|NCT05270213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420388|NCT05254743|Pirtobrutinib|pirtobrutinib|mesh-list
138420389|NCT05254743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138420390|NCT05254743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420391|NCT05254743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420392|NCT05239728|Pembrolizumab|pembrolizumab|mesh-list
138420393|NCT05239728|Belzutifan|belzutifan|mesh-list
138534130|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534131|NCT05497336|Cetuximab|cetuximab|mesh-list
138534132|NCT05497336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138534133|NCT05497336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534135|NCT00044525|IDN 5109|idn 5109|mesh-list
138534136|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534137|NCT00074607|Gemcitabine|gemcitabine|mesh-list
138534138|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138534139|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
138534140|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534141|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420411|NCT05225558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534142|NCT05305885|Pemetrexed|pemetrexed|mesh-list
138534143|NCT05305885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534144|NCT05305885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534145|NCT05305885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534146|NCT05305885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138534147|NCT05305885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138534148|NCT00044564|IDN 5109|idn 5109|mesh-list
138534149|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420489|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
138420490|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534150|NCT00078546|Antibodies|antibodies|mesh-list
138534151|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138534152|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
138534153|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534154|NCT00044642|Lorazepam|lorazepam|mesh-list
138534155|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
138534156|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
138534157|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
138534158|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138420582|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534159|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534160|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138534161|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138534162|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138534163|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138534164|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138534165|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138534166|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
138534167|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
138534168|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138534169|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534170|NCT00044681|Risperidone|risperidone|mesh-list
138534171|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138534172|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
138534173|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138534174|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534175|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534176|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138534177|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138534178|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138534179|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138534180|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138534181|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
138534183|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138420803|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
138420805|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138420809|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
138534184|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534185|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138534186|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534187|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
138534188|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138534189|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
138534190|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534191|NCT00403000|Dutasteride|dutasteride|mesh-list
138534192|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138420873|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138420874|NCT04548219|Mirikizumab|mirikizumab|mesh-list
138420875|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138420876|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138534193|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138534194|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534195|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420877|NCT04548219|Analgesics|analgesics|mesh-ancestor
138420878|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
138420879|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138420880|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534196|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
138534197|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138534198|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534199|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
138534200|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138534201|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534202|NCT00403039|Ranibizumab|ranibizumab|mesh-list
138297386|NCT00002701|Busulfan|busulfan|mesh-list
138297387|NCT00002701|Methotrexate|methotrexate|mesh-list
138297388|NCT00002701|Etoposide|etoposide|mesh-list
138297389|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
138297390|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
138297391|NCT00002701|Idarubicin|idarubicin|mesh-list
138534203|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138534204|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138534205|NCT00403039|Growth Substances|growth substances|mesh-ancestor
138534206|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534207|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
138534208|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534209|NCT00078858|Cyclosporine|cyclosporine|mesh-list
138534210|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
138297456|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
138297470|NCT00003596|Mitomycin|mitomycin|mesh-list
138534212|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
138534213|NCT00078858|Cyclosporins|cyclosporins|mesh-list
138534214|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534215|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138534216|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
138534217|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534218|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138534219|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
138534220|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534221|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534222|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
138534223|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534224|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
138534225|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138534226|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138297599|NCT00003344|Irinotecan|irinotecan|mesh-list
138297600|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138534227|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138534228|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138297666|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138534229|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
138534230|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138534231|NCT00044759|Tazobactam|tazobactam|mesh-list
138534232|NCT00044759|Piperacillin|piperacillin|mesh-list
138534233|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138534234|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138297667|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
138534235|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534236|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138534237|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534238|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534239|NCT00044798|Citalopram|citalopram|mesh-list
138297668|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297669|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297670|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297671|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
138297673|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534240|NCT00044798|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138534241|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138534242|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138534243|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534244|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138534245|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
138534246|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534247|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138534248|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
138534249|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138297724|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138297725|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297726|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
138297727|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
138534250|NCT00074841|Azithromycin|azithromycin|mesh-list
138297786|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
138534251|NCT00074841|Chloroquine|chloroquine|mesh-list
138534252|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138534253|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
138534254|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
138534255|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138534256|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138534257|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534258|NCT00074841|Amebicides|amebicides|mesh-ancestor
138534260|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138297787|NCT00002761|Busulfan|busulfan|mesh-list
138297788|NCT00002761|Idarubicin|idarubicin|mesh-list
138297789|NCT00002761|Cyclosporins|cyclosporins|mesh-list
138297791|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
138534261|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
138534262|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138534263|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138534264|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138534265|NCT00074841|Analgesics|analgesics|mesh-ancestor
138534266|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
138534267|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138534268|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534269|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138534270|NCT00074841|Filaricides|filaricides|mesh-ancestor
138534271|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
138534272|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
138534273|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138534274|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138297924|NCT00003680|Thiotepa|thiotepa|mesh-list
138297925|NCT00003680|Fluorouracil|fluorouracil|mesh-list
138297926|NCT00003680|Methotrexate|methotrexate|mesh-list
138297927|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138534275|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534276|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138534278|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138534279|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
138534280|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297928|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
138297929|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138297930|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138297931|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297932|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
138297933|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138297934|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138297981|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138534281|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534282|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138534283|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
138534284|NCT00044837|Estradiol|estradiol|mesh-list
138534285|NCT00044837|Estrogens|estrogens|mesh-ancestor
138534286|NCT00044837|Hormones|hormones|mesh-ancestor
138534287|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138534288|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534289|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138534290|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
138534291|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138534292|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138534293|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138534294|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138297982|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138297984|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
138297985|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138297986|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138166526|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138298041|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298042|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138534295|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138534296|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138534297|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138534298|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534300|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
138534301|NCT04457557|Anesthetics|anesthetics|mesh-list
138534302|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138534303|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298043|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138298044|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138298045|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
138298046|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138298047|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138298048|NCT00384566|Metoprolol|metoprolol|mesh-list
138298049|NCT00384566|Carvedilol|carvedilol|mesh-list
138385088|NCT02125461|Durvalumab|durvalumab|mesh-list
138534304|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
138534305|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138534307|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138534308|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
138534309|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138534310|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534311|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138298100|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
138298101|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298102|NCT00004838|Succimer|succimer|mesh-list
138534312|NCT00079014|Doxorubicin|doxorubicin|mesh-list
138534313|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138298103|NCT00004838|Antidotes|antidotes|mesh-ancestor
138298104|NCT00004838|Protective Agents|protective agents|mesh-ancestor
138298105|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298106|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
138298107|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
138298108|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298109|NCT00004202|Paclitaxel|paclitaxel|mesh-list
138298110|NCT00004202|Carboplatin|carboplatin|mesh-list
138298111|NCT00004202|Efaproxiral|efaproxiral|mesh-list
138298112|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298113|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298114|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
138534314|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138534315|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534316|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138534317|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138534318|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534319|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534320|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
138298155|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138298156|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
138298158|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
138534321|NCT00397475|Vitamin D|vitamin d|mesh-list
138534322|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138534323|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534324|NCT00397475|Vitamins|vitamins|mesh-ancestor
138534325|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
138534326|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138534327|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
138534328|NCT04731740|Lenvatinib|lenvatinib|mesh-list
138534329|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138298224|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298225|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298226|NCT00004244|Interferons|interferons|mesh-list
138298227|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
138298228|NCT00004244|Interleukin-12|interleukin-12|mesh-list
138298229|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298230|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
138298231|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298232|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
138534330|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534331|NCT04731740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138534332|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534333|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138534334|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534335|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
138534336|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138298290|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
138298291|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
138298292|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138298293|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138298294|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
138298295|NCT00003728|Hormones|hormones|mesh-ancestor
138298296|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138534337|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138534338|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
138534339|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138534340|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534341|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534342|NCT04263298|Capecitabine|capecitabine|mesh-list
138534343|NCT04263298|Fulvestrant|fulvestrant|mesh-list
138534344|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138534345|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
138298354|NCT05477875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298356|NCT05477875|Hallucinogens|hallucinogens|mesh-ancestor
138534346|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534347|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534348|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138534349|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138534350|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138534351|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
138534352|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138298425|NCT00004904|Hormones|hormones|mesh-ancestor
138534353|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534354|NCT00044954|Cyclosporine|cyclosporine|mesh-list
138534355|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
138534356|NCT00044954|Fludarabine|fludarabine|mesh-list
138534357|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
138534358|NCT00044954|Cyclosporins|cyclosporins|mesh-list
138534359|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534360|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138298490|NCT00004928|Vitamins|vitamins|mesh-ancestor
138298491|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
138298494|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138298495|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
138534361|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
138534362|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298561|NCT00004340|Calcitriol|calcitriol|mesh-list
138298562|NCT00004340|Hormones|hormones|mesh-list
138298563|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138534363|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138534364|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
138534365|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534366|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534367|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
138534368|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534369|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
138534370|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138298564|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298565|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138298570|NCT00004340|Vitamins|vitamins|mesh-ancestor
138534371|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138534372|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138534373|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138534374|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
138534375|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138534376|NCT00079092|Thalidomide|thalidomide|mesh-list
138534377|NCT00079092|Procarbazine|procarbazine|mesh-list
138534378|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138534379|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
138534380|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534381|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
138534382|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138534383|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534384|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138534385|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138534386|NCT00079092|Growth Substances|growth substances|mesh-ancestor
138534387|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
138534388|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298623|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
138534389|NCT00044993|Docetaxel|docetaxel|mesh-list
138534390|NCT00044993|Doxorubicin|doxorubicin|mesh-list
138166607|NCT00525421|Curcumin|curcumin|mesh-list
138534391|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138534392|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534393|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
138534394|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
138534395|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
138298683|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138298684|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
138298685|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298686|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298687|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138298688|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
138298689|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138298690|NCT00004400|Testosterone|testosterone|mesh-list
138298691|NCT00004400|Androgens|androgens|mesh-ancestor
138534396|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534397|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138534398|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138534399|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138534400|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534401|NCT00079131|Oblimersen|oblimersen|mesh-list
138534402|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534403|NCT00045149|Aldesleukin|aldesleukin|mesh-list
138298747|NCT00005024|Carboplatin|carboplatin|mesh-list
138534404|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534405|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138210643|NCT04855266|Hematinics|hematinics|mesh-ancestor
138534406|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138534407|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
138534408|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534409|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
138534410|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534411|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138534412|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298812|NCT00005036|Fluorouracil|fluorouracil|mesh-list
138298813|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
138298814|NCT00005036|Irinotecan|irinotecan|mesh-list
138298815|NCT00005036|Calcium|calcium|mesh-list
138298816|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
138298817|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138534413|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534414|NCT00403156|Ranibizumab|ranibizumab|mesh-list
138534415|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
138534416|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138534417|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138534418|NCT00403156|Growth Substances|growth substances|mesh-ancestor
138534419|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138298877|NCT00003860|Ifosfamide|ifosfamide|mesh-list
138298878|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138298879|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138298880|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138298881|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138298882|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138298883|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138298884|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138534420|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
138319187|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
138534422|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138534423|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534424|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534425|NCT00045227|Docetaxel|docetaxel|mesh-list
138534426|NCT00045227|Vaccines|vaccines|mesh-list
138534427|NCT00045227|Sargramostim|sargramostim|mesh-list
138534428|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
138534429|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534430|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534431|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
138534432|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
138534433|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
138534434|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534435|NCT00075075|Infliximab|infliximab|mesh-list
138534436|NCT00075075|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138534437|NCT00075075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138166617|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534439|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138534440|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138534441|NCT04065451|Epinephrine|epinephrine|mesh-list
138534442|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138534443|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138534444|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
138534445|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138534446|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534447|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534448|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138534449|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138534450|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
138534451|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138534452|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138534453|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
138534454|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
138534455|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
138534456|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138534457|NCT00045266|Aflibercept|aflibercept|mesh-list
138534458|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138534459|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138534460|NCT00045266|Growth Substances|growth substances|mesh-ancestor
138299296|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
138534461|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534462|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
138534463|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534464|NCT03948568|Tamoxifen|tamoxifen|mesh-list
138534465|NCT03948568|Letrozole|letrozole|mesh-list
138534466|NCT03948568|Anastrozole|anastrozole|mesh-list
138534467|NCT03948568|Exemestane|exemestane|mesh-list
138534468|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534469|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138534470|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138319204|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138319205|NCT03591744|Growth Substances|growth substances|mesh-ancestor
138534471|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534472|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534473|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138534474|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
138534475|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138299439|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299440|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
138534476|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210718|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138210719|NCT04644796|Bupivacaine|bupivacaine|mesh-list
138210720|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
138210721|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
138210722|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138534477|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138534478|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138299505|NCT00005762|Saquinavir|saquinavir|mesh-list
138534479|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138534480|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138534481|NCT03928366|Remifentanil|remifentanil|mesh-list
138534482|NCT03928366|Propofol|propofol|mesh-list
138534483|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138534484|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138534485|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534486|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138534487|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
138534489|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138534490|NCT03928366|Narcotics|narcotics|mesh-ancestor
138534491|NCT03928366|Analgesics|analgesics|mesh-ancestor
138534492|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
138534493|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138534494|NCT00045422|Interferons|interferons|mesh-list
138534495|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
138534496|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
138534497|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534498|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
138534499|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534500|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
138534501|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534502|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138534503|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138299648|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
138299649|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138299650|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299651|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138299652|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138534504|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534505|NCT00075192|Leuprolide|leuprolide|mesh-list
138534506|NCT00075192|Bicalutamide|bicalutamide|mesh-list
138534507|NCT00075192|Tremelimumab|tremelimumab|mesh-list
138534508|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138534509|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
138534510|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138534511|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299699|NCT02278172|Vitamins|vitamins|mesh-list
138534512|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138534513|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534514|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
138534515|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
138319230|NCT04196400|Hormones|hormones|mesh-ancestor
138319244|NCT04195074|Tenofovir|tenofovir|mesh-list
138534516|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138534517|NCT00045461|Carboplatin|carboplatin|mesh-list
138299767|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
138299768|NCT04561934|Fluorides|fluorides|mesh-list
138534518|NCT00045461|Ifosfamide|ifosfamide|mesh-list
138534519|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534520|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138534521|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
138534522|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534523|NCT00075231|Ritonavir|ritonavir|mesh-list
138534524|NCT00075231|Lopinavir|lopinavir|mesh-list
138534525|NCT00075231|Lamivudine|lamivudine|mesh-list
138534526|NCT00075231|Zidovudine|zidovudine|mesh-list
138299836|NCT04123717|Ibuprofen|ibuprofen|mesh-list
138299837|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138534527|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138534528|NCT00075231|Efavirenz|efavirenz|mesh-list
138534529|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138534530|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138534531|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
138534532|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534533|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534534|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138534535|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138534536|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
138534537|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534538|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138534539|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138534540|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138299976|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
138299977|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138534541|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138534543|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138534544|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138534545|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138534546|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138534547|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138210798|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
138210799|NCT04436926|Narcotics|narcotics|mesh-ancestor
138210800|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138210802|NCT04436926|Analgesics|analgesics|mesh-ancestor
138534549|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138534550|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
138534551|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138300044|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138300045|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138300046|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300047|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300048|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300049|NCT00002977|Melphalan|melphalan|mesh-list
138300050|NCT00002977|Thiotepa|thiotepa|mesh-list
138300051|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
138300052|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300053|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300054|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
138300055|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300056|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300057|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138534552|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534553|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138534554|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138534555|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
138534556|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230065|NCT01171118|Miotics|miotics|mesh-ancestor
138534557|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534559|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300095|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300096|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
138300097|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138534560|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
138534561|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
138534562|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
138534563|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534564|NCT00045500|Prednisone|prednisone|mesh-list
138534565|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138534566|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138534567|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
138534568|NCT00045500|Hormones|hormones|mesh-ancestor
138300162|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300163|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138534569|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138534570|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300230|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138300231|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138300232|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
138300233|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
138534571|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138534572|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534573|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138534574|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534575|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300234|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138300250|NCT00003013|Tamoxifen|tamoxifen|mesh-list
138534576|NCT00045539|Leucovorin|leucovorin|mesh-list
138534577|NCT00045539|Methotrexate|methotrexate|mesh-list
138534578|NCT00045539|Thiotepa|thiotepa|mesh-list
138534579|NCT00045539|Calcium|calcium|mesh-list
138300294|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300295|NCT00003451|Interferons|interferons|mesh-list
138534580|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
138534581|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138534582|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534583|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138300296|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
138300297|NCT00003451|Interleukin-12|interleukin-12|mesh-list
138300298|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534584|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
138534585|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138534586|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138534587|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
138534588|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300360|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300361|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
138300362|NCT00003031|Voriconazole|voriconazole|mesh-list
138300364|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138534589|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534590|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
138534591|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534592|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138300365|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
138300366|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
138300367|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
138534593|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138534594|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
138166694|NCT00475085|Aprepitant|aprepitant|mesh-list
138534595|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138534596|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138534597|NCT00045539|Antidotes|antidotes|mesh-ancestor
138534598|NCT00045539|Protective Agents|protective agents|mesh-ancestor
138534599|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
138534600|NCT00045539|Vitamins|vitamins|mesh-ancestor
138534601|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
138300422|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138300423|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138534602|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138534603|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
138534604|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138534605|NCT00079248|Progesterone|progesterone|mesh-list
138534606|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138534607|NCT00079248|Estrogens|estrogens|mesh-list
138534608|NCT00079248|Progestins|progestins|mesh-ancestor
138534609|NCT00079248|Hormones|hormones|mesh-ancestor
138534610|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138300488|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138300501|NCT00002827|Cobalt|cobalt|mesh-list
138534611|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534612|NCT00045617|Etoposide|etoposide|mesh-list
138534613|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138534614|NCT00045617|Vaccines|vaccines|mesh-list
138534615|NCT00045617|Antibodies|antibodies|mesh-list
138534616|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
138534617|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138319282|NCT04029090|Edaravone|edaravone|mesh-list
138534618|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138534619|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
138534620|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534621|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534622|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138534623|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138534624|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138534625|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534626|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534628|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
138534629|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138534630|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138534631|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534632|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138534633|NCT03399838|Analgesics|analgesics|mesh-ancestor
138534634|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
138300693|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138534635|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138534636|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138534637|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138534638|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138534639|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
138534640|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138300694|NCT00003595|Vincristine|vincristine|mesh-list
138300695|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300696|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
138300697|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300698|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300710|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
138534641|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534642|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138534643|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138534644|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138534645|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138534646|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138534647|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
138534648|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
138534649|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
138534650|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
138300759|NCT00002875|Vincristine|vincristine|mesh-list
138300760|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300761|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
138300762|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300763|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138300764|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300765|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
138300767|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534651|NCT00079287|Paclitaxel|paclitaxel|mesh-list
138534652|NCT00079287|Vinorelbine|vinorelbine|mesh-list
138534653|NCT00079287|Docetaxel|docetaxel|mesh-list
138534654|NCT00079287|Carboplatin|carboplatin|mesh-list
138534655|NCT00079287|Gemcitabine|gemcitabine|mesh-list
138534656|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138534657|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534658|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
138534659|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
138300824|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138300825|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138300826|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138300827|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
138300828|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300829|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138300830|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
138300832|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138534660|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
138534661|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534662|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138534663|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
138534664|NCT00045695|Bortezomib|bortezomib|mesh-list
138534665|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534666|NCT00079365|Gemcitabine|gemcitabine|mesh-list
138534667|NCT00079365|Fluorouracil|fluorouracil|mesh-list
138300886|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138300887|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300888|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
138300889|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138300890|NCT00003937|Protective Agents|protective agents|mesh-ancestor
138300893|NCT00003625|Cyclosporine|cyclosporine|mesh-list
138534668|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138534669|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
138534670|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138319299|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319301|NCT04028856|Interferons|interferons|mesh-list
138534671|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534672|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138534673|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
138534674|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534675|NCT00045773|Sertraline|sertraline|mesh-list
138300951|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138300952|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
138300953|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138300954|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534676|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
138534677|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138534678|NCT00045773|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138534679|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138534680|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138534681|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534682|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138301016|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138534683|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
138534684|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534685|NCT00045812|Ezetimibe|ezetimibe|mesh-list
138534686|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138534687|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138534689|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534690|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138534691|NCT00079443|Rituximab|rituximab|mesh-list
138534692|NCT00079443|Fludarabine|fludarabine|mesh-list
138534693|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
138534694|NCT00079443|Romidepsin|romidepsin|mesh-list
138301086|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138301087|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138301088|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
138301089|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301090|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138534695|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138534696|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534697|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
138534698|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534699|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138534700|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138534701|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
138534702|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301149|NCT00003127|Amifostine|amifostine|mesh-list
138301150|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138534703|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138534704|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138534705|NCT00079443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138534706|NCT00079443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301243|NCT00004039|Prednisone|prednisone|mesh-list
138534707|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138534708|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138534709|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138534710|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138534711|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534712|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138534713|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138534714|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534715|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
138534716|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138534717|NCT00403429|Capecitabine|capecitabine|mesh-list
138534718|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138534719|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
138426264|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
138534720|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534721|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534722|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
138534723|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534724|NCT00079560|Dronabinol|dronabinol|mesh-list
138534725|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
138534726|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534727|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138534728|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138534729|NCT00079560|Analgesics|analgesics|mesh-ancestor
138534730|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
138534731|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138534732|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138534733|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138534734|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138534735|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534736|NCT00079560|Hormones|hormones|mesh-ancestor
138534737|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138534738|NCT00046163|Midodrine|midodrine|mesh-list
138301585|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301586|NCT02972905|Nemiralisib|nemiralisib|mesh-list
138301587|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138301588|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301589|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301590|NCT00003799|Leucovorin|leucovorin|mesh-list
138301592|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
138301593|NCT00003799|Calcium|calcium|mesh-list
138301594|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
138301595|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138301596|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534739|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
138534740|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
138534741|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138534742|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534743|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138534744|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138534745|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138534746|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138301642|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138301649|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
138534747|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
138534748|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138534749|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534750|NCT00079638|Niacin|niacin|mesh-list
138534751|NCT00079638|Atorvastatin|atorvastatin|mesh-list
138534752|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138534753|NCT00079638|Simvastatin|simvastatin|mesh-list
138534754|NCT00079638|Ezetimibe|ezetimibe|mesh-list
138301710|NCT00003217|Cytarabine|cytarabine|mesh-list
138166747|NCT04193930|Letrozole|letrozole|mesh-list
138301711|NCT00003217|Dexamethasone|dexamethasone|mesh-list
138301712|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
138301713|NCT00003217|Doxorubicin|doxorubicin|mesh-list
138301714|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138301715|NCT00003217|Methotrexate|methotrexate|mesh-list
138534755|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138534756|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138534757|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
138230090|NCT01172522|Fexofenadine|fexofenadine|mesh-list
138534758|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534759|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138534760|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138534761|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138301779|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138301780|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301781|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
138301782|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301783|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138534762|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
138534763|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
138534764|NCT00079638|Vitamins|vitamins|mesh-ancestor
138534765|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
138534766|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138301843|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
138301844|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534767|NCT00046241|Bupropion|bupropion|mesh-list
138534768|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138534769|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
138301845|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301846|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
138301847|NCT00003859|Carboplatin|carboplatin|mesh-list
138301848|NCT00003859|Etoposide|etoposide|mesh-list
138301849|NCT00003859|Vincristine|vincristine|mesh-list
138534770|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138534771|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138534772|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138211020|NCT02462837|Urological Agents|urological agents|mesh-ancestor
138534773|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138534774|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534775|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
138534776|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138534777|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534778|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138534779|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138534780|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534781|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
138534782|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138301906|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138301907|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138301908|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
138301909|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138534783|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534784|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
138534785|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138534786|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
138534787|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534788|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
138534789|NCT00130468|Protective Agents|protective agents|mesh-ancestor
138534790|NCT00130507|Capecitabine|capecitabine|mesh-list
138301963|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
138301964|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138301965|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
138301966|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
138301967|NCT00003913|Busulfan|busulfan|mesh-list
138301968|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138534791|NCT00130507|Trastuzumab|trastuzumab|mesh-list
138534792|NCT00130507|Vinorelbine|vinorelbine|mesh-list
138534793|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138534794|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
138534795|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534796|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534797|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138302032|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138534798|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302034|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138302035|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
138302036|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
138534799|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
138534800|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
138534801|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
138534803|NCT00130546|Paclitaxel|paclitaxel|mesh-list
138534804|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138534805|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534806|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
138534807|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
138302103|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138534808|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302104|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302105|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138302120|NCT00003307|Amifostine|amifostine|mesh-list
138534809|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534810|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138534811|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534812|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138534813|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
138319371|NCT04192656|Prednisolone|prednisolone|mesh-list
138319372|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
138534814|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302169|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138302170|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138534815|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
138534816|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534818|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
138534819|NCT00130585|Hematinics|hematinics|mesh-ancestor
138534820|NCT00130585|Vitamins|vitamins|mesh-ancestor
138534821|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
138534822|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534823|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138534824|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138302239|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302240|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
138534825|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534826|NCT00079755|Immunotoxins|immunotoxins|mesh-ancestor
138534827|NCT00079755|Immunoconjugates|immunoconjugates|mesh-ancestor
138534828|NCT00079755|Immunologic Factors|immunologic factors|mesh-ancestor
138534829|NCT00079755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534830|NCT00130702|Gefitinib|gefitinib|mesh-list
138534831|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534832|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138302307|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302309|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
138302310|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
138302311|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
138302312|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302313|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138302314|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
138302315|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534833|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534834|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534835|NCT00130819|Buprenorphine|buprenorphine|mesh-list
138534836|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138534837|NCT00130819|Narcotics|narcotics|mesh-ancestor
138534838|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138534839|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534840|NCT00130819|Analgesics|analgesics|mesh-ancestor
138302370|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138302371|NCT00003367|Vitamin E|vitamin e|mesh-list
138302372|NCT00003367|Vitamins|vitamins|mesh-ancestor
138302373|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
138302374|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138302375|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
138302377|NCT00003367|Protective Agents|protective agents|mesh-ancestor
138534841|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
138534842|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138534843|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138534844|NCT00130858|Carboplatin|carboplatin|mesh-list
138534845|NCT00130858|Topotecan|topotecan|mesh-list
138534846|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534847|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138534848|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138302433|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138302434|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138302435|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
138302436|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
138302437|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
138302438|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138302440|NCT00005017|Ritonavir|ritonavir|mesh-list
138534849|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534850|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534851|NCT00130897|Sunitinib|sunitinib|mesh-list
138534852|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534853|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138534854|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138534855|NCT00130897|Growth Substances|growth substances|mesh-ancestor
138302498|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302499|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138534856|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534857|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
138534858|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138534859|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534860|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534861|NCT00046319|Ambrisentan|ambrisentan|mesh-list
138302567|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138302568|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138534862|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138534863|NCT00079833|Esomeprazole|esomeprazole|mesh-list
138302569|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
138302570|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138302571|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
138534864|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138534865|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138534866|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138534867|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138319399|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534868|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534869|NCT00079872|Pemetrexed|pemetrexed|mesh-list
138534870|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138534871|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166787|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
138534872|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534873|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138534874|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138534875|NCT00046358|Ibuprofen|ibuprofen|mesh-list
138534876|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138534877|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138534878|NCT00046358|Analgesics|analgesics|mesh-ancestor
138534879|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
138534880|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138534881|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385412|NCT01469520|Lamivudine|lamivudine|mesh-list
138534882|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138302774|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138302775|NCT00005647|Paclitaxel|paclitaxel|mesh-list
138302776|NCT00005647|Semaxinib|semaxinib|mesh-list
138302777|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138302778|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302790|NCT00005665|Interferons|interferons|mesh-list
138534883|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138534884|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138534885|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534886|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534887|NCT00130936|Carboplatin|carboplatin|mesh-list
138534888|NCT00130936|Capecitabine|capecitabine|mesh-list
138534890|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138302845|NCT00004759|Hormones|hormones|mesh-ancestor
138534891|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138534892|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
138534893|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534894|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138534895|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138534896|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138534897|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534898|NCT00130975|Candesartan|candesartan|mesh-list
138534899|NCT00130975|Candesartan cilexetil|candesartan cilexetil|mesh-list
138534900|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138534901|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138230096|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
138534902|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138534903|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534904|NCT00131053|Cytarabine|cytarabine|mesh-list
138534905|NCT00131053|Dexamethasone|dexamethasone|mesh-list
138534906|NCT00131053|Prednisolone|prednisolone|mesh-list
138534907|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
138534908|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
138534909|NCT00131053|Methotrexate|methotrexate|mesh-list
138534910|NCT00131053|Vincristine|vincristine|mesh-list
138534911|NCT00131053|Asparaginase|asparaginase|mesh-list
138534912|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
138534913|NCT00131053|Pirarubicin|pirarubicin|mesh-list
138303064|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
138534914|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138534915|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
138534916|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534917|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138534918|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138534919|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
138534920|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534921|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303122|NCT02145078|Gemcitabine|gemcitabine|mesh-list
138303123|NCT02145078|Docetaxel|docetaxel|mesh-list
138534922|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138534923|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138534924|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
138534925|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
138534926|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138534927|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138534928|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
138426422|NCT01698567|Antithrombins|antithrombins|mesh-list
138303198|NCT02122380|Incretins|incretins|mesh-ancestor
138534930|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138534931|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138534932|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138534933|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
138534934|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138534935|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138534936|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
138534937|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
138534938|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534939|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138534940|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138534941|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
138534942|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534943|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138534944|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
138534945|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
138534946|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
138534947|NCT00079911|Valacyclovir|valacyclovir|mesh-list
138534948|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
138534949|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534950|NCT00397592|Hormones|hormones|mesh-list
138534951|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138534952|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534953|NCT00131326|Hylan|hylan|mesh-list
138534954|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
138534955|NCT00131326|Protective Agents|protective agents|mesh-ancestor
138534956|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702097|NCT05424393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138426452|NCT01698645|Narcotics|narcotics|mesh-ancestor
138534957|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
138534958|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138534959|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138534960|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138534961|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303540|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
138303541|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303542|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303543|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534963|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138534964|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534965|NCT00131443|Topiramate|topiramate|mesh-list
138534966|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
138534967|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138534968|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138534969|NCT00079989|Tigecycline|tigecycline|mesh-list
138534970|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138534971|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534972|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138534973|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534974|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138534976|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
138534977|NCT00131482|Coagulants|coagulants|mesh-ancestor
138534978|NCT00397709|Rifampin|rifampin|mesh-list
138534979|NCT00397709|Isoniazid|isoniazid|mesh-list
138534980|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138303671|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138303672|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
138303673|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
138303675|NCT04182984|Azathioprine|azathioprine|mesh-list
138303676|NCT04182984|Bromides|bromides|mesh-list
138303677|NCT04182984|Tacrolimus|tacrolimus|mesh-list
138534981|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
138534982|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138534983|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138534984|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
138534985|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138534986|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138534987|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138303735|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
138534988|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138534989|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138534990|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138534991|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138534992|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138534993|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138534994|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138303804|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138303805|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
138303806|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
138303821|NCT02019420|Linezolid|linezolid|mesh-list
138534995|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138534996|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
138534997|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138534998|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
138534999|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
138535000|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535001|NCT00131521|Expectorants|expectorants|mesh-ancestor
138303869|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
138535002|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
138535003|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138535004|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
138535005|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535006|NCT00131521|Protective Agents|protective agents|mesh-ancestor
138535007|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535008|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
138535009|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535010|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138535011|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
138535012|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
138303936|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138303937|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
138535013|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
138304001|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138535014|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138535015|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
138535016|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138535017|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138535018|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535019|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138535020|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138304002|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138304003|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138304007|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
138535021|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535022|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138319462|NCT04023630|Ticagrelor|ticagrelor|mesh-list
138319487|NCT04021992|Rituximab|rituximab|mesh-list
138535023|NCT00080145|Risperidone|risperidone|mesh-list
138535024|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138535025|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
138535026|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138535027|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535028|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535029|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138535030|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138535031|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138535032|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138535033|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138535034|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
138535035|NCT00403663|Fentanyl|fentanyl|mesh-list
138535036|NCT00403663|Morphine|morphine|mesh-list
138535037|NCT00403663|Bupivacaine|bupivacaine|mesh-list
138535038|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
138535039|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
138535040|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138535041|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535042|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
138535043|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535044|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138535045|NCT00403663|Narcotics|narcotics|mesh-ancestor
138535046|NCT00403663|Analgesics|analgesics|mesh-ancestor
138230100|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
138535047|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138304284|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
138304285|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138535048|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138535049|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
138535050|NCT00403780|Pregabalin|pregabalin|mesh-list
138535051|NCT00403780|Analgesics|analgesics|mesh-ancestor
138535052|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
138535053|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138304427|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
138304428|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535054|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535055|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
138535056|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138535057|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138535058|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535059|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138535060|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138535061|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138304429|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535062|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138535063|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138304430|NCT01945086|Ustekinumab|ustekinumab|mesh-list
138304440|NCT01962948|Paclitaxel|paclitaxel|mesh-list
138535064|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138535065|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535066|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138535067|NCT00403819|Laxatives|laxatives|mesh-ancestor
138535068|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138535069|NCT00403858|Lactulose|lactulose|mesh-list
138535070|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138535071|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138535072|NCT00403858|Laxatives|laxatives|mesh-ancestor
138304489|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138304491|NCT01984242|Growth Substances|growth substances|mesh-ancestor
138535073|NCT00046553|Mifepristone|mifepristone|mesh-list
138535074|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138535075|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
138535076|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138535077|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535078|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138535079|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138535080|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138304624|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535081|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
138535082|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138535083|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138535084|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
138535085|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138535086|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
138535087|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138304625|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535088|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138535089|NCT00131989|Sorafenib|sorafenib|mesh-list
138535090|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535091|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138535092|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535093|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535094|NCT00132067|Vorinostat|vorinostat|mesh-list
138304687|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
138304688|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535095|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535096|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138535097|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535098|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535099|NCT00132106|Phentolamine|phentolamine|mesh-list
138535100|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138535101|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138535102|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
138535103|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426559|NCT01699412|Hormones|hormones|mesh-ancestor
138535104|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535105|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535106|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138304826|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138304828|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
138535108|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535109|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138535110|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535111|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535112|NCT00132184|Vitamin D|vitamin d|mesh-list
138535113|NCT00132184|Vitamins|vitamins|mesh-ancestor
138535114|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
138535115|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304896|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138304897|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138535116|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138535117|NCT00132379|Docetaxel|docetaxel|mesh-list
138535118|NCT00132379|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
138535120|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
138535121|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
138535122|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
138319508|NCT04020588|Minocycline|minocycline|mesh-list
138535123|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535124|NCT00132379|Immunoconjugates|immunoconjugates|mesh-ancestor
138535125|NCT00132379|Immunologic Factors|immunologic factors|mesh-ancestor
138535126|NCT00132379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535127|NCT00132418|Etanercept|etanercept|mesh-list
138535128|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138535129|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138535130|NCT00132418|Analgesics|analgesics|mesh-ancestor
138535131|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
138535132|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535133|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535134|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138535135|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138535136|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138535137|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535138|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
138535139|NCT00132535|Chloroquine|chloroquine|mesh-list
138535140|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
138535141|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
138535142|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138305345|NCT00983645|Tacrolimus|tacrolimus|mesh-list
138535143|NCT00132535|Amebicides|amebicides|mesh-ancestor
138535144|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138535145|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138535146|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535147|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
138535148|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138535149|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138305461|NCT01978535|Iron|iron|mesh-list
138535150|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166881|NCT05533567|Cisatracurium|cisatracurium|mesh-list
138535151|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535152|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138535154|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138535155|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535156|NCT00132652|Lamivudine|lamivudine|mesh-list
138535157|NCT00132652|Telbivudine|telbivudine|mesh-list
138535158|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138535159|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138535160|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535161|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535162|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
138535163|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535164|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138535165|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138535166|NCT00046748|Omalizumab|omalizumab|mesh-list
138535167|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138535168|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138535169|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
138535170|NCT00132886|Tolvaptan|tolvaptan|mesh-list
138535171|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138535172|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535173|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
138535174|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535175|NCT00080418|Paclitaxel|paclitaxel|mesh-list
138535176|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138305763|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138535177|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535178|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
138319542|NCT04022226|Ketamine|ketamine|mesh-list
138535179|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
138535180|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
138535181|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535183|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138535184|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
138535185|NCT00132925|Hormones|hormones|mesh-ancestor
138535186|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138305910|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138305916|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
138535187|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535188|NCT00133003|Abciximab|abciximab|mesh-list
138535189|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
138535190|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138535191|NCT00046787|Lurtotecan|lurtotecan|mesh-list
138535192|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535193|NCT00133042|Omalizumab|omalizumab|mesh-list
138535194|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138535195|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138166901|NCT05533567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138166903|NCT04026464|Acetaminophen|acetaminophen|mesh-list
138535196|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
138535198|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138306062|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138535199|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306063|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138535200|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
138535201|NCT00133198|Pramipexole|pramipexole|mesh-list
138535202|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
138535203|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535204|NCT00133198|Protective Agents|protective agents|mesh-ancestor
138535205|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535206|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138535207|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138535208|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
138535209|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
138535210|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138535211|NCT00046826|Thalidomide|thalidomide|mesh-list
138535212|NCT00046826|Docetaxel|docetaxel|mesh-list
138535213|NCT00046826|Estramustine|estramustine|mesh-list
138535214|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535215|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
138535216|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
138535217|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
138535218|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535219|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535220|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
138211476|NCT05299398|Serotonin Agents|serotonin agents|mesh-ancestor
138535221|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535222|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
138535223|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138535224|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535225|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138535226|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138535227|NCT00046826|Growth Substances|growth substances|mesh-ancestor
138535228|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
138306424|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138535229|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138535230|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
138535231|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138535232|NCT00133237|Sirolimus|sirolimus|mesh-list
138535233|NCT00133237|Paclitaxel|paclitaxel|mesh-list
138535234|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138306494|NCT00001067|Lamivudine|lamivudine|mesh-list
138535235|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535236|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
138535237|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
138535238|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
138535239|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535240|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138535241|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535242|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138306563|NCT00000299|Buprenorphine|buprenorphine|mesh-list
138306564|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138535243|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
138535244|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535245|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
138535246|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535247|NCT00399672|Interferons|interferons|mesh-list
138535248|NCT00399672|Ribavirin|ribavirin|mesh-list
138535249|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535250|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
138535251|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138306629|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
138306634|NCT00000329|Narcotics|narcotics|mesh-ancestor
138535252|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
138535253|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535254|NCT00133276|Escitalopram|escitalopram|mesh-list
138535255|NCT00133276|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138535256|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138535257|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138306697|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138306698|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138306699|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
138306700|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138535258|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535259|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138535260|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
138535261|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535263|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138306837|NCT04331327|Mitogens|mitogens|mesh-list
138535264|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
138535266|NCT00133315|Infliximab|infliximab|mesh-list
138535267|NCT00133315|Etanercept|etanercept|mesh-list
138535268|NCT00133315|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138535269|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138535270|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138535271|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
138535272|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138535273|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138535274|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138535275|NCT00133315|Analgesics|analgesics|mesh-ancestor
138535276|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
138306979|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138306981|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535277|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535278|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535279|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535280|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
138535281|NCT00080496|Imipenem|imipenem|mesh-list
138535282|NCT00080496|Tigecycline|tigecycline|mesh-list
138535283|NCT00080496|Cilastatin|cilastatin|mesh-list
138535284|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138535285|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535286|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138535287|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535288|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535289|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
138535290|NCT00133354|Anastrozole|anastrozole|mesh-list
138535291|NCT00133354|Hormones|hormones|mesh-list
138535292|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138319580|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
138535293|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535294|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138535295|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535296|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138535297|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138307195|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138307196|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
138307197|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138535298|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535299|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535300|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138535301|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
138535302|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
138535303|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138535304|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535305|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535306|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138535307|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138535308|NCT00133393|Protective Agents|protective agents|mesh-ancestor
138307336|NCT00002351|Indinavir|indinavir|mesh-list
138535309|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535311|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138535312|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
138535313|NCT00046904|Etanercept|etanercept|mesh-list
138535314|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138535315|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138535316|NCT00046904|Analgesics|analgesics|mesh-ancestor
138535317|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
138307407|NCT00002141|Abacavir|abacavir|mesh-list
138535318|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535319|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535320|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138535321|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138535322|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138535323|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535324|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
138535325|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138535326|NCT00403897|Laxatives|laxatives|mesh-ancestor
138535327|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138535328|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138307541|NCT00002423|Lamivudine|lamivudine|mesh-list
138307542|NCT00002423|Abacavir|abacavir|mesh-list
138535329|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138307543|NCT00002423|Nelfinavir|nelfinavir|mesh-list
138307544|NCT00002423|Indinavir|indinavir|mesh-list
138307546|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138535330|NCT00046943|Atrasentan|atrasentan|mesh-list
138307548|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535331|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535332|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138535333|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138535334|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535335|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138535336|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
138535337|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307607|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138307610|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138535338|NCT00080613|Exemestane|exemestane|mesh-list
138535339|NCT00080613|Hormones|hormones|mesh-list
138319596|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138535340|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138535341|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535342|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535343|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138307675|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
138307687|NCT00002471|Vitamins|vitamins|mesh-ancestor
138535344|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138535345|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535346|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535347|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138535348|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
138535350|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
138535351|NCT00047021|Sargramostim|sargramostim|mesh-list
138535352|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138307745|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
138535353|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
138535354|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535355|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535356|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
138535357|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535358|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535359|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
138535360|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138307811|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
138307812|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138307813|NCT00002171|Nelfinavir|nelfinavir|mesh-list
138307814|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307815|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138307816|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
138535361|NCT00047021|Analgesics|analgesics|mesh-ancestor
138535362|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
138535363|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138307877|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138535364|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138535365|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138535366|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535367|NCT00133627|Ketotifen|ketotifen|mesh-list
138307878|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
138307879|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138535368|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
138535369|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
138307880|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
138307881|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138307882|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138307883|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138535370|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138535371|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
138535372|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
138535373|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138535374|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535375|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535377|NCT00133744|Folic Acid|folic acid|mesh-list
138535378|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
138307938|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138307940|NCT00002225|Efavirenz|efavirenz|mesh-list
138535379|NCT00133744|Vitamins|vitamins|mesh-ancestor
138535380|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
138535381|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535382|NCT00133744|Hematinics|hematinics|mesh-ancestor
138535383|NCT00080808|Phentolamine|phentolamine|mesh-list
138535384|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
138535385|NCT00080808|Alprostadil|alprostadil|mesh-list
138535386|NCT00080808|Papaverine|papaverine|mesh-list
138167026|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138308008|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138535387|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535388|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
138535389|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138308082|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
138535390|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138535391|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535392|NCT00080808|Urological Agents|urological agents|mesh-ancestor
138535393|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138535394|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138535395|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
138535396|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138308157|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308158|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138308159|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
138535397|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535398|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138535399|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138535400|NCT00047099|Tamoxifen|tamoxifen|mesh-list
138535401|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
138535402|NCT00047099|Docetaxel|docetaxel|mesh-list
138535403|NCT00047099|Fluorouracil|fluorouracil|mesh-list
138535404|NCT00047099|Epirubicin|epirubicin|mesh-list
138535405|NCT00047099|Goserelin|goserelin|mesh-list
138535406|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535407|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
138535408|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535409|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138535410|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138535411|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
138535412|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535413|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535414|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138535415|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
138535416|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
138535417|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
138535418|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
138535419|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138535420|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138535421|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138535422|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138535423|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535424|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138535425|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
138535426|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138535427|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138535428|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138535429|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138308370|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308371|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
138535430|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138535431|NCT00133822|Risperidone|risperidone|mesh-list
138535432|NCT00133822|Sertraline|sertraline|mesh-list
138535433|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138535434|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
138535435|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138535436|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535437|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308425|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
138308426|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
138308427|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308428|NCT00002717|Paclitaxel|paclitaxel|mesh-list
138308429|NCT00002717|Cisplatin|cisplatin|mesh-list
138535438|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138535439|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138535440|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138535441|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138535442|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138535443|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
138535444|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
138319640|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319641|NCT04143282|Metformin|metformin|mesh-list
138535445|NCT00133822|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138535446|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138535447|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138535448|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
138535449|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138535450|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138535451|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535452|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
138535453|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138308492|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
138308493|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308494|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
138308499|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
138535454|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535455|NCT00134095|Irinotecan|irinotecan|mesh-list
138535456|NCT00134095|Tegafur|tegafur|mesh-list
138535457|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138535458|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138535459|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535460|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535461|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535462|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138535463|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
138535464|NCT00047138|Dactinomycin|dactinomycin|mesh-list
138535465|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
138535466|NCT00047138|Carboplatin|carboplatin|mesh-list
138535467|NCT00047138|Doxorubicin|doxorubicin|mesh-list
138535468|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138535469|NCT00047138|Etoposide|etoposide|mesh-list
138535470|NCT00047138|Vincristine|vincristine|mesh-list
138308618|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535471|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308619|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138308623|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138535473|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535474|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138535475|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138535476|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
138535477|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535478|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535479|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138308686|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138308687|NCT05215691|Narcotics|narcotics|mesh-ancestor
138308688|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138535480|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138535481|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138535482|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138535483|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535484|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138535485|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
138535486|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
138535487|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
138535488|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138535489|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535490|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138535491|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138308900|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535492|NCT00080847|Prednisone|prednisone|mesh-list
138535493|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
138535494|NCT00080847|Rituximab|rituximab|mesh-list
138535495|NCT00080847|Doxorubicin|doxorubicin|mesh-list
138535496|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138535497|NCT00080847|Vincristine|vincristine|mesh-list
138535498|NCT00080847|Oblimersen|oblimersen|mesh-list
138308901|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138535499|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138308902|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138308903|NCT00383591|Vaccines|vaccines|mesh-list
138308904|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
138535500|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
138535501|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535502|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138535503|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138535504|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
138535505|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535506|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138319666|NCT05581992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138535507|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138535508|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138535509|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138535510|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138535511|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138535512|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535513|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138309037|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138535514|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
138535515|NCT00080847|Hormones|hormones|mesh-ancestor
138535516|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138535517|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138535518|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138535519|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
138535520|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309106|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309107|NCT00003029|Fluorouracil|fluorouracil|mesh-list
138309110|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309113|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
138535521|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
138535522|NCT00134173|Atorvastatin|atorvastatin|mesh-list
138535523|NCT00134173|Torcetrapib|torcetrapib|mesh-list
138535524|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138535525|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138535526|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
138535527|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535528|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138535529|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138309174|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309175|NCT00003089|Paclitaxel|paclitaxel|mesh-list
138309176|NCT00003089|Carboplatin|carboplatin|mesh-list
138309177|NCT00003089|Amifostine|amifostine|mesh-list
138309179|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535530|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535531|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
138535532|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535533|NCT00134212|Epinephrine|epinephrine|mesh-list
138535534|NCT00134212|Norepinephrine|norepinephrine|mesh-list
138535535|NCT00134212|Dopexamine|dopexamine|mesh-list
138535536|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138535537|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138535538|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
138535539|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138309239|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138309245|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
138535540|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535541|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535542|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138535543|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138535544|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
138535545|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535546|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138535547|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
138535548|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
138535549|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
138535550|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138535551|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
138535552|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
138535553|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
138309382|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
138309384|NCT00001259|Estradiol|estradiol|mesh-list
138309385|NCT00001259|Progesterone|progesterone|mesh-list
138535554|NCT00134290|Metformin|metformin|mesh-list
138535555|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138535556|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535557|NCT00047216|Tipifarnib|tipifarnib|mesh-list
138535558|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535559|NCT00080925|Cytarabine|cytarabine|mesh-list
138535560|NCT00080925|Cyclosporine|cyclosporine|mesh-list
138535561|NCT00080925|Prednisone|prednisone|mesh-list
138535562|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
138535563|NCT00080925|Rituximab|rituximab|mesh-list
138535564|NCT00080925|Doxorubicin|doxorubicin|mesh-list
138535565|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138535566|NCT00080925|Fludarabine|fludarabine|mesh-list
138535567|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
138535568|NCT00080925|Etoposide|etoposide|mesh-list
138535569|NCT00080925|Vincristine|vincristine|mesh-list
138535570|NCT00080925|Cyclosporins|cyclosporins|mesh-list
138167071|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
138535571|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535572|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
138535573|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535574|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138535575|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138535576|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
138309518|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309519|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
138535577|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535578|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309590|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138535579|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138535580|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138535581|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138535582|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138535583|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309591|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138309592|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309593|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309594|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309595|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309596|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309597|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138309598|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
138309599|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309600|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309601|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138309602|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
138309603|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138535584|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535585|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138535586|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
138309647|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535587|NCT00080925|Hormones|hormones|mesh-ancestor
138535588|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138535589|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138535590|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138309648|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309649|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138309650|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309651|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309652|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138309653|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
138309654|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138309670|NCT00003173|Thiotepa|thiotepa|mesh-list
138535591|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
138309704|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
138535592|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138535593|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
138535594|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535595|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
138535596|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
138535597|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
138535598|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
138535599|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
138309705|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138309706|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138309714|NCT00003935|Etoposide|etoposide|mesh-list
138535600|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138535601|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138211854|NCT01657500|Dextrans|dextrans|mesh-list
138535602|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138535603|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535604|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
138535605|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138309771|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
138309772|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
138309773|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
138309774|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138535606|NCT00047255|Carboplatin|carboplatin|mesh-list
138535607|NCT00047255|Docetaxel|docetaxel|mesh-list
138309775|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138309776|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138535608|NCT00047255|Trastuzumab|trastuzumab|mesh-list
138535609|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535610|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
138535611|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
138535612|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
138535613|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535614|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138535615|NCT00134368|Etanercept|etanercept|mesh-list
138309833|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
138535616|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138535617|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138535618|NCT00134368|Analgesics|analgesics|mesh-ancestor
138535619|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
138535620|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535621|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535622|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138535623|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138309905|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535624|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138535625|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535626|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
138535627|NCT00134485|Atorvastatin|atorvastatin|mesh-list
138535628|NCT00134485|Torcetrapib|torcetrapib|mesh-list
138535629|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138535630|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138535631|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
138309974|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138309975|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535632|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535633|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138535634|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138535635|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535638|NCT00047294|Temozolomide|temozolomide|mesh-list
138535639|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138535640|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
138310044|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310045|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138310046|NCT00004001|Analgesics|analgesics|mesh-ancestor
138535641|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535642|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535643|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138535644|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138535645|NCT00047294|Analgesics|analgesics|mesh-ancestor
138535646|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
138535647|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138310109|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138310110|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138310111|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138310112|NCT00004067|Paclitaxel|paclitaxel|mesh-list
138535648|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535649|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138535650|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138535651|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138535652|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138535653|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535654|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535655|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
138535656|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
138535657|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138535658|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535659|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138535660|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138535661|NCT00047294|Growth Substances|growth substances|mesh-ancestor
138535662|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
138310251|NCT00004145|Fludarabine|fludarabine|mesh-list
138310252|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
138310253|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138535663|NCT00042822|Romidepsin|romidepsin|mesh-list
138535664|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138535665|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535666|NCT00042822|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138535667|NCT00042822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535668|NCT00042822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535669|NCT00134641|Gemcitabine|gemcitabine|mesh-list
138535670|NCT00134641|Vinorelbine|vinorelbine|mesh-list
138310319|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
138310321|NCT00003287|Protective Agents|protective agents|mesh-ancestor
138310322|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
138310323|NCT00003287|Vitamins|vitamins|mesh-ancestor
138310324|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
138535671|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138535672|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
138535673|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535674|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535675|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138535676|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
138535677|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
138535678|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310387|NCT00003305|Aminopterin|aminopterin|mesh-list
138310388|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138310389|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310390|NCT00003305|Antidotes|antidotes|mesh-ancestor
138310391|NCT00003305|Protective Agents|protective agents|mesh-ancestor
138535679|NCT00134680|Trastuzumab|trastuzumab|mesh-list
138535680|NCT00134680|Letrozole|letrozole|mesh-list
138535681|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138535682|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535683|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138310450|NCT00004217|Daunorubicin|daunorubicin|mesh-list
138535684|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138535685|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535686|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310451|NCT00004217|Sargramostim|sargramostim|mesh-list
138310452|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310453|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
138310454|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310455|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535687|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138535688|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
138535689|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138535690|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310514|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535691|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138310515|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138535692|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138310516|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
138310517|NCT00003335|Hormones|hormones|mesh-ancestor
138535693|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138310518|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138310519|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138310520|NCT00003335|Protective Agents|protective agents|mesh-ancestor
138310521|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138310525|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
138535694|NCT00081042|Paclitaxel|paclitaxel|mesh-list
138535695|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138319701|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
138319704|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
138535696|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138535697|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535698|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
138535699|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
138535700|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
138310578|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138310579|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
138535701|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535702|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138535703|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535704|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138535705|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535706|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535707|NCT00134875|Buprenorphine|buprenorphine|mesh-list
138310644|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138310645|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138310646|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138310647|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138310649|NCT00004889|Rituximab|rituximab|mesh-list
138535708|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138535709|NCT00134875|Naloxone|naloxone|mesh-list
138535710|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138310710|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535711|NCT00134875|Narcotics|narcotics|mesh-ancestor
138535712|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138535713|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535714|NCT00134875|Analgesics|analgesics|mesh-ancestor
138535715|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
138310711|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138310712|NCT00004919|Protective Agents|protective agents|mesh-ancestor
138310713|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535716|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535717|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138535718|NCT00134914|Buprenorphine|buprenorphine|mesh-list
138535719|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138535720|NCT00134914|Narcotics|narcotics|mesh-ancestor
138535721|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138535722|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535723|NCT00134914|Analgesics|analgesics|mesh-ancestor
138535724|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
138535725|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535726|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138310778|NCT00004583|Nelfinavir|nelfinavir|mesh-list
138310779|NCT00004583|Lamivudine|lamivudine|mesh-list
138310780|NCT00004583|Stavudine|stavudine|mesh-list
138535727|NCT00134953|Rivastigmine|rivastigmine|mesh-list
138535728|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138535729|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167130|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138535730|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535731|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
138535732|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138535733|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310842|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
138310844|NCT00004685|Albuterol|albuterol|mesh-list
138535734|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138535735|NCT00134953|Protective Agents|protective agents|mesh-ancestor
138535736|NCT00042861|Leucovorin|leucovorin|mesh-list
138535737|NCT00042861|Fluorouracil|fluorouracil|mesh-list
138535738|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138535739|NCT00042861|Calcium|calcium|mesh-list
138535740|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
138535741|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138535742|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138310907|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138535743|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
138535744|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535745|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138535746|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535747|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138535748|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
138535749|NCT00042861|Antidotes|antidotes|mesh-ancestor
138319712|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138310977|NCT00005093|Tacedinaline|tacedinaline|mesh-list
138310978|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138310996|NCT00004817|Phenytoin|phenytoin|mesh-list
138535750|NCT00042861|Protective Agents|protective agents|mesh-ancestor
138211993|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138535753|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
138535754|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138535755|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535756|NCT00134992|Prednisolone|prednisolone|mesh-list
138535757|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138535758|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
138535759|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138535760|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
138535761|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138535762|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
138535763|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138535764|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
138535766|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138535767|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535768|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138311121|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311122|NCT00005597|Temozolomide|temozolomide|mesh-list
138311123|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138311124|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
138311125|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311127|NCT00005603|Cytarabine|cytarabine|mesh-list
138535769|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535770|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
138535771|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
138535772|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535773|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138535774|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138535775|NCT00134992|Protective Agents|protective agents|mesh-ancestor
138535776|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
138311178|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
138311179|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311248|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138311249|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138311251|NCT00386399|Mitomycins|mitomycins|mesh-list
138535777|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138535778|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535779|NCT00135187|Dexamethasone|dexamethasone|mesh-list
138535780|NCT00135187|Bortezomib|bortezomib|mesh-list
138535781|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138535782|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
138535783|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
138535784|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535785|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311315|NCT05895123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311316|NCT05895123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138311317|NCT05895123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138311318|NCT05895123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311319|NCT05894954|Hormones|hormones|mesh-list
138311322|NCT05894889|Paclitaxel|paclitaxel|mesh-list
138535786|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138535787|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
138535788|NCT00135187|Hormones|hormones|mesh-ancestor
138535789|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138535790|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138535791|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535792|NCT00145093|Chromium|chromium|mesh-list
138535793|NCT00145093|Trace Elements|trace elements|mesh-ancestor
138535794|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
138311377|NCT05892913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138535795|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535796|NCT00047450|Citalopram|citalopram|mesh-list
138535797|NCT00047450|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138535798|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138535799|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138535800|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535801|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138535802|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
138535803|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535804|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138535805|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
138535806|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138535807|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
138311518|NCT05423106|Entecavir|entecavir|mesh-list
138535808|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535809|NCT00145171|Apomorphine|apomorphine|mesh-list
138535810|NCT00145171|Emetics|emetics|mesh-ancestor
138535811|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535812|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
138535813|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535814|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138535815|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
138311588|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138311589|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138535816|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
138535817|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138535818|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535820|NCT00145210|Nebivolol|nebivolol|mesh-list
138535821|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138535822|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138535823|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
138535824|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
138535825|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138311655|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138311656|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138311662|NCT04989829|Omeprazole|omeprazole|mesh-list
138535826|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535827|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138535828|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138535829|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138535830|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
138535831|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138535832|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535833|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
138535834|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138535835|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138535836|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138535837|NCT00081276|Cisplatin|cisplatin|mesh-list
138535838|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535839|NCT00145405|Octreotide|octreotide|mesh-list
138535840|NCT00145405|Lanreotide|lanreotide|mesh-list
138535841|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138167165|NCT03864211|Immunologic Factors|immunologic factors|mesh-ancestor
138535842|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138535843|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535844|NCT00145444|Olanzapine|olanzapine|mesh-list
138535845|NCT00145444|Ziprasidone|ziprasidone|mesh-list
138311794|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
138311795|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311796|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138535846|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
138311797|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138311798|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
138535847|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
138535848|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535849|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535850|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138535851|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138535852|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138535853|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138311858|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138311859|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138311860|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138311861|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311862|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
138311863|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138311864|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138311865|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138311866|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
138311867|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138311868|NCT04463693|Etonogestrel|etonogestrel|mesh-list
138311869|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138311870|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
138311871|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138311872|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138311873|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138311874|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
138535854|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138535855|NCT00145444|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138535856|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138535857|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138535858|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535859|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138535860|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
138311908|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138535861|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138535862|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138535863|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
138535864|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
138535865|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
138535866|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138535867|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138535868|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138311976|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138311977|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138311978|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138535869|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535870|NCT00145483|Urological Agents|urological agents|mesh-ancestor
138535871|NCT00145522|Tibolone|tibolone|mesh-list
138535872|NCT00145522|Estradiol|estradiol|mesh-list
138535873|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
138535874|NCT00145522|Estrogens|estrogens|mesh-ancestor
138535875|NCT00145522|Hormones|hormones|mesh-ancestor
138535876|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312041|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138312042|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312044|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138319751|NCT04140006|Alendronate|alendronate|mesh-list
138535877|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535878|NCT00145522|Progestins|progestins|mesh-ancestor
138535879|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
138535880|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
138535881|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138535882|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138535883|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312110|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312121|NCT02303444|Sorafenib|sorafenib|mesh-list
138535884|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138535885|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
138535886|NCT00081315|Amifostine|amifostine|mesh-list
138535887|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138535888|NCT00081315|Protective Agents|protective agents|mesh-ancestor
138535889|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535890|NCT00145561|Ritonavir|ritonavir|mesh-list
138535891|NCT00145561|Saquinavir|saquinavir|mesh-list
138535892|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138535893|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138535894|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
138535895|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535896|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535897|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138535898|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138535899|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
138535900|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535901|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138212136|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
138535902|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138535903|NCT00145639|Carboplatin|carboplatin|mesh-list
138312269|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138535904|NCT00145639|Doxorubicin|doxorubicin|mesh-list
138535906|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535907|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138535908|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138535909|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138312346|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138312347|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138535910|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535911|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535912|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138535913|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
138312348|NCT00003821|Aminopterin|aminopterin|mesh-list
138535914|NCT00047567|Zonisamide|zonisamide|mesh-list
138535915|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
138535916|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138535917|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138535918|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535919|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138535920|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535921|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138535922|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
138535923|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535924|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
138535926|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
138535927|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138535928|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535929|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138535930|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138312490|NCT04564001|Infliximab|infliximab|mesh-list
138535931|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
138312491|NCT04564001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138535932|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138535933|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138535934|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
138535935|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138535936|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535937|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
138535938|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138535939|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
138312581|NCT01972464|Progesterone|progesterone|mesh-list
138535940|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535941|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535942|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
138535943|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535944|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
138535945|NCT00081471|Hematinics|hematinics|mesh-ancestor
138535946|NCT00047645|Interferons|interferons|mesh-list
138535947|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
138535948|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535949|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
138535950|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535951|NCT00146146|Letrozole|letrozole|mesh-list
138535952|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
138535953|NCT00146146|Dutasteride|dutasteride|mesh-list
138535954|NCT00146146|Testosterone|testosterone|mesh-list
138535955|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
138535956|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
138535957|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138312645|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138312646|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138312647|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
138535958|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138535959|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138535960|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138535961|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138312648|NCT01618266|Hormones|hormones|mesh-ancestor
138535962|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167208|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138167209|NCT01796405|Clofarabine|clofarabine|mesh-list
138535963|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138535964|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
138535965|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138535966|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138535967|NCT00146146|Androgens|androgens|mesh-ancestor
138535968|NCT00146146|Hormones|hormones|mesh-ancestor
138535969|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138535970|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
138535971|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138535972|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
138535973|NCT00146224|Hematinics|hematinics|mesh-ancestor
138212235|NCT00533546|Protein C|protein c|mesh-list
138535974|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
138535975|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138312775|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138312776|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
138312777|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138312779|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138535976|NCT00146341|Telmisartan|telmisartan|mesh-list
138535977|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138535978|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138535979|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138535980|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535981|NCT00146380|Lamivudine|lamivudine|mesh-list
138535982|NCT00146380|Zidovudine|zidovudine|mesh-list
138535983|NCT00146380|Nevirapine|nevirapine|mesh-list
138535984|NCT00146380|Nelfinavir|nelfinavir|mesh-list
138535985|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138535986|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138535987|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138535988|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138535989|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
138535990|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138535991|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138535992|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138535993|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
138535994|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138535995|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138535996|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138535997|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138535998|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
138535999|NCT00081588|Darunavir|darunavir|mesh-list
138536000|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138536001|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138536002|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
138536003|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385983|NCT01473147|Incretins|incretins|mesh-ancestor
138536004|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138313060|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138313061|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138313062|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138313065|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
138536005|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138536006|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138536007|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
138536008|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536009|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138536010|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138536011|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536012|NCT00047723|Minocycline|minocycline|mesh-list
138536013|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138536014|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536016|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138536017|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138536018|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138536019|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
138313129|NCT01854918|Evolocumab|evolocumab|mesh-list
138536020|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536021|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536022|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138167225|NCT04149938|Lidocaine|lidocaine|mesh-list
138536023|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
138536024|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
138536025|NCT00146497|Hormones|hormones|mesh-ancestor
138536026|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138536027|NCT02957890|Vaccines|vaccines|mesh-list
138536028|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
138536029|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536030|NCT00146575|Sirolimus|sirolimus|mesh-list
138536031|NCT00146575|Paclitaxel|paclitaxel|mesh-list
138536032|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138313279|NCT01832766|Dronabinol|dronabinol|mesh-list
138536033|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536034|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
138536035|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
138536036|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
138536037|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536038|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138536039|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536040|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138536041|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
138536042|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138536043|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
138536044|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313373|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
138313374|NCT01803282|Vitamins|vitamins|mesh-ancestor
138536046|NCT00146614|Methotrexate|methotrexate|mesh-list
138536047|NCT00146614|Tacrolimus|tacrolimus|mesh-list
138313375|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
138536048|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138536049|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
138536050|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138230151|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138536051|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536052|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138536053|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
138536054|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536055|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536056|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
138536057|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536058|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138536059|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138313441|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313442|NCT01826370|Incretins|incretins|mesh-ancestor
138313443|NCT01826370|Hormones|hormones|mesh-ancestor
138313444|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138313445|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138536060|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
138536061|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138536062|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138536063|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138536064|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138536065|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536066|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138536067|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
138536068|NCT00047762|Bevacizumab|bevacizumab|mesh-list
138536069|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138536070|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138536071|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536072|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138536073|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138536074|NCT00047762|Growth Substances|growth substances|mesh-ancestor
138536075|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536076|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
138536077|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138536078|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536079|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536080|NCT00042978|Carboplatin|carboplatin|mesh-list
138536082|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
138536083|NCT00042978|Oblimersen|oblimersen|mesh-list
138313745|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
138536084|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536085|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138536086|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138536087|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138536088|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536089|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536090|NCT00405730|Ketorolac|ketorolac|mesh-list
138313818|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138313819|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536091|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138536092|NCT00405730|Nepafenac|nepafenac|mesh-list
138536093|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138536094|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138536095|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138536096|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138536097|NCT00405730|Analgesics|analgesics|mesh-ancestor
138536098|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
138536099|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536100|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536101|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138536102|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138536103|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138536104|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536105|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536106|NCT00405769|Red yeast rice|red yeast rice|mesh-list
138536107|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138536108|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138536109|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138536110|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
138313820|NCT01813890|Analgesics|analgesics|mesh-ancestor
138536111|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536112|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536113|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138536114|NCT00047801|Docetaxel|docetaxel|mesh-list
138536115|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536116|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
138536117|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
138536118|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
138313949|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138313951|NCT01809210|Carboplatin|carboplatin|mesh-list
138536119|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536120|NCT00146731|Artesunate|artesunate|mesh-list
138536121|NCT00146731|Amodiaquine|amodiaquine|mesh-list
138536122|NCT00146731|Dapsone|dapsone|mesh-list
138536123|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
138536124|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
138536125|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138536126|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138536127|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536128|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536129|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
138536130|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
138536131|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138314020|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138314021|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
138314022|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536132|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
138319850|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
138536133|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138536134|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314023|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536135|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536136|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
138536137|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138536138|NCT00047840|Docetaxel|docetaxel|mesh-list
138536139|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536141|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
138314177|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314179|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138314180|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138536142|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
138536143|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536144|NCT00146926|Lidocaine|lidocaine|mesh-list
138536145|NCT00146926|Ephedrine|ephedrine|mesh-list
138536146|NCT00146926|Ketamine|ketamine|mesh-list
138536147|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
138536148|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
138536149|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138536150|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536151|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
138536152|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536153|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138314250|NCT01732458|Ondansetron|ondansetron|mesh-list
138314251|NCT01732458|Aprepitant|aprepitant|mesh-list
138314252|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
138314253|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
138314254|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
138314255|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536154|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138536155|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138536156|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138536157|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536158|NCT00146926|Analgesics|analgesics|mesh-ancestor
138536159|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138536160|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138536161|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
138536162|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138314257|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138536163|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138536164|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536165|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138536166|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
138536167|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
138536168|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138536169|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
138314311|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138314312|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138314313|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536170|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
138536171|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138314314|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
138314315|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
138314316|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
138314317|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314318|NCT01755156|Metformin|metformin|mesh-list
138536172|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138314342|NCT01605396|Exemestane|exemestane|mesh-list
138536173|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138536174|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138314374|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138314375|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
138536175|NCT00147121|Rituximab|rituximab|mesh-list
138536176|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138536177|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536178|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
138536179|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536180|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138536181|NCT00147160|Temozolomide|temozolomide|mesh-list
138536182|NCT00147160|Cisplatin|cisplatin|mesh-list
138536183|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138536184|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
138536185|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536186|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536187|NCT04732104|Lidocaine|lidocaine|mesh-list
138314458|NCT01703286|Glimepiride|glimepiride|mesh-list
138314459|NCT01703286|Linagliptin|linagliptin|mesh-list
138314460|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138314461|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138314471|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138314473|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
138314474|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138314475|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138314476|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138314477|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138536188|NCT04732104|Xylometazoline|xylometazoline|mesh-list
138536189|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
138536190|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
138536191|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
138536192|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138314535|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138536193|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536194|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
138536195|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536196|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138230153|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138536197|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138536198|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138536199|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138536200|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536201|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138314618|NCT01700946|Teniposide|teniposide|mesh-list
138536202|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
138536204|NCT00147355|Ibuprofen|ibuprofen|mesh-list
138536205|NCT00147355|Codeine|codeine|mesh-list
138536206|NCT00147355|Ondansetron|ondansetron|mesh-list
138536207|NCT00147355|Metoclopramide|metoclopramide|mesh-list
138536208|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138536209|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138536210|NCT00147355|Analgesics|analgesics|mesh-ancestor
138536211|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
138536212|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536213|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536214|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138536215|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138536216|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138536217|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536218|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536219|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
138536220|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
138536221|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
138314846|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138314847|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138536222|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138536223|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
138536224|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
138536225|NCT00147355|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138536226|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138536227|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
138536228|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536229|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138536230|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138536231|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
138536232|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138536233|NCT00147355|Narcotics|narcotics|mesh-ancestor
138536234|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138536235|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
138536236|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
138536237|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
138536238|NCT00048152|Cyclosporine|cyclosporine|mesh-list
138536239|NCT00048152|Cyclosporins|cyclosporins|mesh-list
138536241|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138536242|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536243|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138536244|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
138536245|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138536246|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536247|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536248|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536249|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
138315081|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
138315082|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
138536250|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
138536251|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138536252|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
138536253|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536254|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138315083|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
138315086|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
138536255|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138536256|NCT00147394|Risperidone|risperidone|mesh-list
138536257|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138536258|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
138536259|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536260|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536261|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315148|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138315156|NCT04410354|Remdesivir|remdesivir|mesh-list
138536263|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138536264|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138536265|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138536266|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138536267|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
138536268|NCT04725682|Tacrolimus|tacrolimus|mesh-list
138315223|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138315224|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138315225|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138315226|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138315227|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138315228|NCT01562028|Growth Substances|growth substances|mesh-ancestor
138536269|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138536270|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
138536271|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315230|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
138536272|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138536273|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315297|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315298|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
138536274|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536275|NCT00147511|Linezolid|linezolid|mesh-list
138536276|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138536277|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536278|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138536279|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138315299|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315300|NCT01584648|Trametinib|trametinib|mesh-list
138536280|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536281|NCT00043095|Gemcitabine|gemcitabine|mesh-list
138536282|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138536283|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
138536284|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536285|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536286|NCT00048230|Bortezomib|bortezomib|mesh-list
138536287|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536288|NCT00147589|Eplerenone|eplerenone|mesh-list
138536289|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138536290|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
138319926|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
138536291|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138536292|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536293|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138536294|NCT00147589|Diuretics|diuretics|mesh-ancestor
138536295|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
138536296|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138536297|NCT00397332|Alefacept|alefacept|mesh-list
138536298|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
138536299|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
138536300|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536301|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
138536302|NCT00147628|Citric Acid|citric acid|mesh-list
138536303|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
138536304|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
138536305|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138536306|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
138536307|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
138536308|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536309|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
138536311|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138536312|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536313|NCT00147628|Urological Agents|urological agents|mesh-ancestor
138536314|NCT00147667|Erythromycin|erythromycin|mesh-list
138536315|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
138536316|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138536317|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
138315742|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315745|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315747|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536318|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138536319|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536320|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138536321|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138315748|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138536322|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536323|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536325|NCT00147784|Ribavirin|ribavirin|mesh-list
138536326|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536327|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
138536328|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315887|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138536329|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
138230156|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
138536330|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536331|NCT00081744|Tigecycline|tigecycline|mesh-list
138536332|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138536333|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138315888|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138315893|NCT01513590|Insulin|insulin|mesh-list
138536334|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138315958|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138315959|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138536335|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536336|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536337|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
138536338|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138536339|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138536340|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138315968|NCT01462266|Metformin|metformin|mesh-list
138536341|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
138536342|NCT00147862|Coagulants|coagulants|mesh-ancestor
138536343|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
138536344|NCT00147901|Fludarabine|fludarabine|mesh-list
138536345|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
138536346|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138536347|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
138427178|NCT01703130|Ropivacaine|ropivacaine|mesh-list
138536348|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536350|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138536351|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
138536352|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316107|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138536353|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536354|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138536355|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138536356|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
138536358|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
138536359|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
138536360|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138536361|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536362|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138536363|NCT02957851|Analgesics|analgesics|mesh-ancestor
138536364|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
138536365|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536366|NCT00147979|Heparin|heparin|mesh-list
138536367|NCT00147979|Calcium heparin|calcium heparin|mesh-list
138536368|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
138536369|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138536370|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138536371|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536372|NCT00148018|Dexamethasone|dexamethasone|mesh-list
138536373|NCT00148018|Bortezomib|bortezomib|mesh-list
138536374|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138536375|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
138536376|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
138536377|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536378|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536379|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138536380|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
138536381|NCT00148018|Hormones|hormones|mesh-ancestor
138316536|NCT05773846|Anesthetics, Local|anesthetics, local|mesh-ancestor
138536382|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138536383|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138536384|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536385|NCT00081822|Cytarabine|cytarabine|mesh-list
138536386|NCT00081822|Clofarabine|clofarabine|mesh-list
138536387|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138536388|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
138536389|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536390|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536391|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
138536392|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536393|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138536394|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
138536395|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536396|NCT00048425|Simendan|simendan|mesh-list
138536397|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138536398|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
138536399|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138536400|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138536401|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536402|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536403|NCT00048425|Protective Agents|protective agents|mesh-ancestor
138536404|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536405|NCT00148135|Carboplatin|carboplatin|mesh-list
138536406|NCT00148135|Gemcitabine|gemcitabine|mesh-list
138536407|NCT00148135|Capecitabine|capecitabine|mesh-list
138536408|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536409|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138536410|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
138536411|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536412|NCT00399711|Metformin|metformin|mesh-list
138536413|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
138536414|NCT00399711|Repaglinide|repaglinide|mesh-list
138536415|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138316785|NCT05084196|Melatonin|melatonin|mesh-list
138316786|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
138316787|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316790|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316792|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138316793|NCT05031234|Morphine|morphine|mesh-list
138316794|NCT05031234|Anesthetics|anesthetics|mesh-list
138316795|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138316796|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536416|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536417|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
138536418|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138536419|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536420|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138536421|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
138536422|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138536423|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536424|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536425|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536426|NCT00148291|Docetaxel|docetaxel|mesh-list
138536427|NCT00148291|Vinorelbine|vinorelbine|mesh-list
138536428|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536429|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
138536430|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
138536431|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
138188496|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536432|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536433|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138536435|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138536436|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
138536437|NCT00148330|Hormones|hormones|mesh-ancestor
138536438|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138536439|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536440|NCT00405808|Rimonabant|rimonabant|mesh-list
138536441|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138536442|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138536443|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138536444|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536445|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536446|NCT00405808|Hormones|hormones|mesh-ancestor
138320002|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
138536447|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138536448|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536449|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
138536450|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138536451|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536452|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
138536453|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138536454|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138536455|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536456|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138317253|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317254|NCT03665597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138536457|NCT00405847|Analgesics|analgesics|mesh-ancestor
138536458|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
138536459|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536460|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138536461|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138536462|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138536463|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
138536464|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536465|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536466|NCT00148408|Montelukast|montelukast|mesh-list
138536467|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138536468|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
138536469|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138536470|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
138536471|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138536472|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536473|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138317344|NCT03404778|Cimetidine|cimetidine|mesh-list
138536474|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138536475|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536476|NCT00048503|Tipifarnib|tipifarnib|mesh-list
138536477|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138167358|NCT04165135|Coagulants|coagulants|mesh-ancestor
138536479|NCT00148447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138536480|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138536481|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138536482|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317396|NCT03148327|Durvalumab|durvalumab|mesh-list
138317397|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138317398|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536483|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536484|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
138536485|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536486|NCT00043134|Decitabine|decitabine|mesh-list
138536487|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138536488|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
138536489|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536490|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536491|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317471|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138317472|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138317473|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138536492|NCT00148564|Olanzapine|olanzapine|mesh-list
138536493|NCT00148564|Ziprasidone|ziprasidone|mesh-list
138536494|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
138536495|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
138536496|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138317542|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536497|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536498|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138536499|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138536500|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138536501|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138488537|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320016|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138536502|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138536503|NCT00148564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138536504|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138536505|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138536506|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536507|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536509|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138536510|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138536511|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
138536512|NCT00148603|Montelukast|montelukast|mesh-list
138317787|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138317788|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138536513|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138536514|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
138536515|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138536516|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
138536517|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138536518|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536519|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138536520|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138536521|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536522|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
138536523|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138536524|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317948|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317952|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317954|NCT01470144|Tezosentan|tezosentan|mesh-list
138317955|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138317956|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138317957|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
138317959|NCT01443858|Nicotine|nicotine|mesh-list
138317960|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138317961|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
138317962|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138317963|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317964|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138317965|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138317966|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
138317967|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138317968|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536527|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
138536528|NCT00148681|Doxorubicin|doxorubicin|mesh-list
138536529|NCT00148681|Trastuzumab|trastuzumab|mesh-list
138536530|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138536531|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536532|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
138536533|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
138536534|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
138536535|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536536|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138536537|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
138536538|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536539|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138536540|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138536541|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
138536542|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138536543|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138536544|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138536545|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138320031|NCT03159936|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138536546|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536547|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138536549|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138536550|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
138536551|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536552|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536553|NCT00148837|Interferons|interferons|mesh-list
138536554|NCT00148837|Ribavirin|ribavirin|mesh-list
138536555|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
138536556|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
138536557|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138536558|NCT00148837|Prazosin|prazosin|mesh-list
138536559|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536560|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
138536561|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536562|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
138536563|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536564|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
138536565|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536566|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138536567|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138536568|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138536569|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138536570|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
138536571|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536572|NCT00148876|Capecitabine|capecitabine|mesh-list
138536573|NCT00148876|Trastuzumab|trastuzumab|mesh-list
138536574|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138536575|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
138536576|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536577|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536578|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138536579|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
138536580|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138536581|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536582|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138536583|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138536584|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138536585|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138536586|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536587|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536588|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536589|NCT00149110|Analgesics|analgesics|mesh-ancestor
138536590|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
138536591|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536592|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
138536593|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138536594|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
138536595|NCT00149188|Lanreotide|lanreotide|mesh-list
138536596|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536597|NCT00043212|Immunomodulating Agents|immunomodulating agents|mesh-list
138536598|NCT00043212|Immunologic Factors|immunologic factors|mesh-ancestor
138536599|NCT00043212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536600|NCT00048776|Cilostazol|cilostazol|mesh-list
138536601|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138536602|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
138536603|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536604|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536605|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138536606|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
138427322|NCT01704027|Androgens|androgens|mesh-list
138536607|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138536608|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138536609|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536610|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138536611|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
138536612|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138536613|NCT00048776|Protective Agents|protective agents|mesh-ancestor
138536614|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138536615|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138536616|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536617|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
138536618|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138365230|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
138365231|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138365232|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138365234|NCT01390896|Fondaparinux|fondaparinux|mesh-list
138365235|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138365236|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
138365237|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138365238|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
138365239|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365240|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365241|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
138365242|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138365243|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138365244|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
138365245|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138365246|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138365247|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138365248|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138365249|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365250|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
138365251|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365252|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365253|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138365254|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365255|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138365256|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
138365257|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138365258|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365259|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138365261|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
138365262|NCT01390961|Pheniramine|pheniramine|mesh-list
138365263|NCT01390961|Naphazoline|naphazoline|mesh-list
138365264|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365265|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138365266|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138365267|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
138365268|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138365269|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365270|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
138365271|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138365272|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
138365273|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138365274|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
138365275|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
138365276|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
138365277|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
138365278|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138365279|NCT01391052|Norethindrone|norethindrone|mesh-list
138365280|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
138365281|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138365282|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138365283|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138365284|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
138365285|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138365286|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365288|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138365289|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
138365290|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
138365291|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138365292|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138365293|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365294|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365295|NCT01391104|Urological Agents|urological agents|mesh-ancestor
138365296|NCT01391156|Minoxidil|minoxidil|mesh-list
138365299|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
138536619|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536620|NCT00048854|Sertraline|sertraline|mesh-list
138536621|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
138536622|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138536623|NCT00048854|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138536624|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138536625|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138536626|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536627|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536628|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
138536629|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536630|NCT00081978|Etravirine|etravirine|mesh-list
138536631|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138536632|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138536633|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536634|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536635|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
138536636|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536637|NCT00149539|Buprenorphine|buprenorphine|mesh-list
138536638|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138536639|NCT00149539|Naloxone|naloxone|mesh-list
138536640|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138536641|NCT00149539|Narcotics|narcotics|mesh-ancestor
138536642|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138536643|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536644|NCT00149539|Analgesics|analgesics|mesh-ancestor
138536645|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
138536646|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536647|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138536648|NCT00149578|Leucovorin|leucovorin|mesh-list
138536649|NCT00149578|Gemcitabine|gemcitabine|mesh-list
138536650|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
138536651|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138536652|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
138536653|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536654|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536655|NCT00149578|Antidotes|antidotes|mesh-ancestor
138536656|NCT00149578|Protective Agents|protective agents|mesh-ancestor
138536657|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536658|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
138536659|NCT00149578|Vitamins|vitamins|mesh-ancestor
138536660|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
138536661|NCT00149617|Buspirone|buspirone|mesh-list
138536662|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138536663|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138536664|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138536665|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536666|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138536667|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138536668|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
138427331|NCT01704092|Analgesics|analgesics|mesh-ancestor
138536669|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536670|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536671|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
138536672|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
138536673|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536674|NCT00149656|Selenium|selenium|mesh-list
138536675|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
138536676|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536677|NCT00149656|Protective Agents|protective agents|mesh-ancestor
138536678|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536679|NCT00149656|Trace Elements|trace elements|mesh-ancestor
138536680|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
138536681|NCT00082095|Doxorubicin|doxorubicin|mesh-list
138536682|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138536683|NCT00082095|Capecitabine|capecitabine|mesh-list
138536684|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138536685|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536686|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138536687|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138536688|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536689|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536690|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138536691|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
138536692|NCT00149851|Tegaserod|tegaserod|mesh-list
138536693|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138536694|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
138536695|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536696|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536697|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536698|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
138536699|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138536700|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320110|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138536701|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138536702|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
138536703|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138536704|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536705|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536706|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536707|NCT00049088|Bevacizumab|bevacizumab|mesh-list
138536708|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138536709|NCT00049088|Docetaxel|docetaxel|mesh-list
138536710|NCT00049088|Antibodies|antibodies|mesh-list
138536711|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
138536712|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138536713|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536714|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138536715|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138536716|NCT00049088|Growth Substances|growth substances|mesh-ancestor
138536717|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536718|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
138536719|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
138536720|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
138536721|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
138536723|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536724|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
138536725|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138536726|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536727|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138536728|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
138536729|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138536730|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536731|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536732|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536733|NCT04725448|Paclitaxel|paclitaxel|mesh-list
138536734|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138536735|NCT04725448|Bevacizumab|bevacizumab|mesh-list
138365548|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
138536736|NCT04725448|Carboplatin|carboplatin|mesh-list
138536737|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138536738|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536739|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
138536741|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
138536742|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536743|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138536744|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138536745|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138536746|NCT04725448|Growth Substances|growth substances|mesh-ancestor
138536747|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536748|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
138536749|NCT00405925|Lamivudine|lamivudine|mesh-list
138536750|NCT00405925|Zidovudine|zidovudine|mesh-list
138536751|NCT00405925|Abacavir|abacavir|mesh-list
138365549|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138365550|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
138365552|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138365553|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365554|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138365555|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365556|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
138365557|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
138365558|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138365559|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138365560|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138365561|NCT01392833|Protective Agents|protective agents|mesh-ancestor
138365562|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
138365563|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365564|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138365565|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138365566|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
138365567|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138365568|NCT01392898|Liraglutide|liraglutide|mesh-list
138365569|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138365570|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138365571|NCT01392898|Incretins|incretins|mesh-ancestor
138365572|NCT01392898|Hormones|hormones|mesh-ancestor
138365573|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138365574|NCT01392911|Rifampin|rifampin|mesh-list
138365575|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138365576|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
138365577|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138365578|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365579|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
138365580|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138365581|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365582|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365583|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138365584|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138365585|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138365586|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138365587|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138365588|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138365589|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
138365592|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138365593|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138365594|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138365595|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
138365596|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
138365597|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
138365598|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138365599|NCT01393145|Fluticasone|fluticasone|mesh-list
138365600|NCT01393145|Xhance|xhance|mesh-list
138365601|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
138365602|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138365603|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138365604|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138365605|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138365607|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536752|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138536753|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138536754|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536755|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536756|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
138536757|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536758|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138536759|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138536760|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
138536761|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138536762|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536763|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138536764|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536765|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536766|NCT00082212|Cetuximab|cetuximab|mesh-list
138536767|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138536768|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536769|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
138536770|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138536771|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536772|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138536773|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
138536774|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138536775|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536776|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536777|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536778|NCT00150046|Everolimus|everolimus|mesh-list
138536779|NCT00150046|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138536780|NCT00150046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138536781|NCT00150046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536782|NCT00150046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536783|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138366435|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138536784|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
138536785|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536786|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536787|NCT00150085|Cyclosporine|cyclosporine|mesh-list
138536788|NCT00150085|Cyclosporins|cyclosporins|mesh-list
138536789|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366436|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138366437|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138366438|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366439|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366441|NCT06105112|Hyaluronic Acid|hyaluronic acid|mesh-list
138366442|NCT06105112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138366443|NCT06105112|Immunologic Factors|immunologic factors|mesh-ancestor
138366444|NCT06105112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366445|NCT06105112|Viscosupplements|viscosupplements|mesh-ancestor
138366446|NCT06105112|Protective Agents|protective agents|mesh-ancestor
138366447|NCT06105008|Disitamab vedotin|disitamab vedotin|mesh-list
138366448|NCT06105008|Immunoconjugates|immunoconjugates|mesh-ancestor
138366454|NCT06104644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366455|NCT06104644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366457|NCT06104423|Nebivolol|nebivolol|mesh-list
138366458|NCT06104423|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138366459|NCT06104423|Protease Inhibitors|protease inhibitors|mesh-ancestor
138366460|NCT06104423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366461|NCT06104423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366466|NCT06104423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138366467|NCT06104423|Adrenergic Agents|adrenergic agents|mesh-ancestor
138366468|NCT06104423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366469|NCT06104423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366470|NCT06104111|Vitamin D|vitamin d|mesh-list
138366476|NCT06104111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138366477|NCT06104059|Fentanyl|fentanyl|mesh-list
138366478|NCT06104059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138366479|NCT06104059|Narcotics|narcotics|mesh-ancestor
138366480|NCT06104059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366490|NCT06103747|Vildagliptin|vildagliptin|mesh-list
138366491|NCT06103747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138366495|NCT06103747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366496|NCT06103747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366497|NCT06103188|Diazepam|diazepam|mesh-list
138366498|NCT06103188|Melatonin|melatonin|mesh-list
138366499|NCT06103188|Antioxidants|antioxidants|mesh-ancestor
138366503|NCT06103188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366504|NCT06103188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138366505|NCT06103188|Anticonvulsants|anticonvulsants|mesh-ancestor
138366506|NCT06103188|Antiemetics|antiemetics|mesh-ancestor
138366507|NCT06103188|Autonomic Agents|autonomic agents|mesh-ancestor
138366508|NCT06103188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366513|NCT06103188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138366514|NCT06103188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138366515|NCT06103188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138366516|NCT06103188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138366517|NCT06103188|Anesthetics, General|anesthetics, general|mesh-ancestor
138366529|NCT06100497|Mitosis Modulators|mitosis modulators|mesh-ancestor
138366530|NCT06100497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366531|NCT06100497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138366545|NCT06049576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138366546|NCT06049576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366547|NCT06049576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138366548|NCT06049576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366551|NCT06048809|Cariostatic Agents|cariostatic agents|mesh-ancestor
138366552|NCT06048809|Protective Agents|protective agents|mesh-ancestor
138366557|NCT06044142|Analgesics|analgesics|mesh-ancestor
138366559|NCT06044142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366560|NCT06044142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366561|NCT06044142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138366562|NCT06044142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138366563|NCT06044142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366564|NCT06044142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536790|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536791|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138536792|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
138536793|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536794|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
138536795|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536796|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
138536797|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138536798|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138536799|NCT00082251|Niacin|niacin|mesh-list
138536800|NCT00082251|Simvastatin|simvastatin|mesh-list
138536801|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138536802|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138536803|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
138536804|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536805|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138320149|NCT01671774|Analgesics|analgesics|mesh-ancestor
138536806|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138536807|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536808|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
138536809|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
138536810|NCT00082251|Vitamins|vitamins|mesh-ancestor
138536811|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
138536812|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536813|NCT00049244|Capecitabine|capecitabine|mesh-list
138536814|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138536815|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
138536816|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536817|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536818|NCT00150124|Methimazole|methimazole|mesh-list
138536819|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
138536820|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
138536821|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138536822|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536823|NCT00049283|Docetaxel|docetaxel|mesh-list
138536824|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138536825|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536826|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
138536827|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
138536828|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
138536829|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536830|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138536831|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536832|NCT00150241|Varenicline|varenicline|mesh-list
138536833|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138536834|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138536835|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
138536836|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138536837|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536838|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536839|NCT00150280|Ibuprofen|ibuprofen|mesh-list
138536840|NCT00150280|Celecoxib|celecoxib|mesh-list
138536841|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138536842|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138536843|NCT00150280|Analgesics|analgesics|mesh-ancestor
138536844|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
138536845|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536846|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536847|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138536848|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138536849|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138536850|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536851|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536852|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138536853|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
138536854|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536855|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
138536856|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138536857|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138536858|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536859|NCT00150358|Urological Agents|urological agents|mesh-ancestor
138536860|NCT00049361|Thalidomide|thalidomide|mesh-list
138536861|NCT00049361|Temozolomide|temozolomide|mesh-list
138536862|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138536863|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
138536864|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536865|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536866|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138536867|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
138536868|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536869|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
138536870|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138536871|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536872|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138213109|NCT05028348|Elotuzumab|elotuzumab|mesh-list
138536873|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138536875|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
138536876|NCT00150436|Pregabalin|pregabalin|mesh-list
138536877|NCT00150436|Analgesics|analgesics|mesh-ancestor
138536878|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
138536879|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536880|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536881|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
138536882|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138536883|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138536884|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536885|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138536886|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138536887|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138536888|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138536889|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138536890|NCT00150553|Carbamazepine|carbamazepine|mesh-list
138536891|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
138536892|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
138536893|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138536894|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138536895|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536896|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138536897|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138536898|NCT00150553|Analgesics|analgesics|mesh-ancestor
138536899|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
138536900|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320192|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
138536901|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138230243|NCT02491437|Progesterone|progesterone|mesh-list
138536902|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138536903|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536904|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138536905|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138536907|NCT00150631|Candesartan cilexetil|candesartan cilexetil|mesh-list
138536908|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138536909|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138536910|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138536911|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536912|NCT00082446|Vaccines|vaccines|mesh-list
138536913|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
138536914|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536915|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
138536916|NCT00049439|Lomustine|lomustine|mesh-list
138536917|NCT00049439|Etoposide|etoposide|mesh-list
138536918|NCT00049439|Procarbazine|procarbazine|mesh-list
138536919|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138536920|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
138536921|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536922|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138536923|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138536924|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
138536925|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536926|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536927|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138427443|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138536928|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138167514|NCT05362513|Ivermectin|ivermectin|mesh-list
138536929|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138536930|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138536933|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536934|NCT00150709|Levetiracetam|levetiracetam|mesh-list
138536935|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
138536936|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
138536937|NCT00150748|Levetiracetam|levetiracetam|mesh-list
138536938|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
138536939|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
138536940|NCT00150787|Levetiracetam|levetiracetam|mesh-list
138536941|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
138536942|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
138536943|NCT00150826|Quinapril|quinapril|mesh-list
138536944|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138320227|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138536945|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
138536946|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536947|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536948|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138536949|NCT00150865|Ropivacaine|ropivacaine|mesh-list
138536950|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
138536951|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
138536952|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138536953|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536954|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
138536955|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138536956|NCT00049556|Gefitinib|gefitinib|mesh-list
138536957|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536958|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138536959|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536960|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536961|NCT00150982|Alefacept|alefacept|mesh-list
138536962|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
138536963|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
138536964|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536965|NCT00049634|Cyclosporine|cyclosporine|mesh-list
138536966|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
138536967|NCT00049634|Busulfan|busulfan|mesh-list
138536968|NCT00049634|Methotrexate|methotrexate|mesh-list
138536969|NCT00049634|Cyclosporins|cyclosporins|mesh-list
138536970|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138536971|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
138536972|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138536973|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138536974|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138536975|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
138536976|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138536977|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536978|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138536979|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138536980|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
138536981|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138167532|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138536982|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138536983|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
138536984|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
138536985|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138536986|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138536987|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138536988|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
138536989|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138536990|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138536991|NCT00151060|Paclitaxel|paclitaxel|mesh-list
138536992|NCT00151060|Etoposide|etoposide|mesh-list
138536993|NCT00151060|Estramustine|estramustine|mesh-list
138536994|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138536995|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138536996|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
138536997|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
138536998|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
138536999|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537000|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138537001|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138537002|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537003|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138537004|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
138537005|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138537006|NCT00151138|Atenolol|atenolol|mesh-list
138537007|NCT00151138|Lisinopril|lisinopril|mesh-list
138366699|NCT05597878|Acetaminophen|acetaminophen|mesh-list
138366701|NCT05597878|Ketamine|ketamine|mesh-list
138366702|NCT05597878|Oxycodone|oxycodone|mesh-list
138537008|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138537009|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
138537010|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537011|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366703|NCT05597878|Analgesics|analgesics|mesh-ancestor
138366704|NCT05597878|Sensory System Agents|sensory system agents|mesh-ancestor
138366711|NCT05597878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366716|NCT05597878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138366717|NCT05597878|Antipyretics|antipyretics|mesh-ancestor
138366725|NCT05594589|Lemborexant|lemborexant|mesh-list
138366727|NCT05594589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366728|NCT05594589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366729|NCT05594589|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138366730|NCT05594589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138366731|NCT05594589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366732|NCT05594589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366733|NCT05589363|Bupivacaine|bupivacaine|mesh-list
138366734|NCT05589363|Anesthetics, Local|anesthetics, local|mesh-ancestor
138366735|NCT05589363|Anesthetics|anesthetics|mesh-ancestor
138366736|NCT05589363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366737|NCT05589363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366739|NCT05589363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366740|NCT05584657|Amoxicillin|amoxicillin|mesh-list
138366741|NCT05584657|Clavulanic Acid|clavulanic acid|mesh-list
138366742|NCT05584657|Clavulanic Acids|clavulanic acids|mesh-list
138366743|NCT05584657|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138366744|NCT05584657|Lactams|lactams|mesh-list
138366751|NCT05584657|Uricosuric Agents|uricosuric agents|mesh-ancestor
138366752|NCT05584657|Gout Suppressants|gout suppressants|mesh-ancestor
138366753|NCT05584657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138366755|NCT05568615|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138366756|NCT05568615|Antioxidants|antioxidants|mesh-ancestor
138366757|NCT05568615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366758|NCT05568615|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138366759|NCT05568615|Protective Agents|protective agents|mesh-ancestor
138366764|NCT05509634|Fosaprepitant|fosaprepitant|mesh-list
138366765|NCT05509634|Aprepitant|aprepitant|mesh-list
138366766|NCT05509634|BB 1101|bb 1101|mesh-list
138366767|NCT05509634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138366768|NCT05509634|Antiemetics|antiemetics|mesh-ancestor
138366770|NCT05509634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366771|NCT05509634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366772|NCT05509634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138366773|NCT05509634|Glucocorticoids|glucocorticoids|mesh-ancestor
138366774|NCT05509634|Hormones|hormones|mesh-ancestor
138366776|NCT05509634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138366777|NCT05509634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366778|NCT05509634|Protease Inhibitors|protease inhibitors|mesh-ancestor
138366779|NCT05509634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366780|NCT05509634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366781|NCT05509634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138366782|NCT05509634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138366783|NCT05509634|Serotonin Agents|serotonin agents|mesh-ancestor
138366784|NCT05509634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138366785|NCT05509634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138366786|NCT05430230|Naproxen|naproxen|mesh-list
138366787|NCT05430230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138366788|NCT05430230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138366789|NCT05430230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138366791|NCT05430230|Sensory System Agents|sensory system agents|mesh-ancestor
138366792|NCT05430230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366793|NCT05430230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138366794|NCT05430230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138366795|NCT05430230|Gout Suppressants|gout suppressants|mesh-ancestor
138537012|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138537013|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138537014|NCT00151138|Protective Agents|protective agents|mesh-ancestor
138537015|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537016|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138537017|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
138537018|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
138537019|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537020|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138537021|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138537022|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138537023|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
138537024|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537025|NCT00082485|Baclofen|baclofen|mesh-list
138230292|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
138537026|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138537027|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537028|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138537029|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537030|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138537031|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
138537032|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
138537033|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537034|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537035|NCT00151255|Cytarabine|cytarabine|mesh-list
138537036|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
138537037|NCT00151255|Idarubicin|idarubicin|mesh-list
138537038|NCT00151255|Tretinoin|tretinoin|mesh-list
138537039|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138537040|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
138537041|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537042|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537043|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
138537044|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537045|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138537046|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
138537047|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537048|NCT00151255|Analgesics|analgesics|mesh-ancestor
138537049|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
138537050|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537051|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138537052|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138537053|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537054|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138537055|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
138537056|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
138537058|NCT00049751|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138537059|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138537060|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138537061|NCT00151294|Dexetimide|dexetimide|mesh-list
138537062|NCT00151294|Citalopram|citalopram|mesh-list
138537063|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
138537064|NCT00151294|Escitalopram|escitalopram|mesh-list
138537065|NCT00151294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138537066|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138537067|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138537068|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537069|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537070|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
138537071|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537072|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138537073|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138537074|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
138537075|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
138537076|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537077|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138537078|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138537079|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
138537080|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138537081|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537082|NCT00151450|Pregabalin|pregabalin|mesh-list
138427506|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
138537083|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138537084|NCT00151450|Analgesics|analgesics|mesh-ancestor
138537085|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
138537086|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537087|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537088|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
138537089|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138537090|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138537091|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537092|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138537093|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138537094|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138537095|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138167591|NCT01797341|Tacrolimus|tacrolimus|mesh-list
138537097|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138537098|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138537099|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537100|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138537101|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
138537103|NCT00151489|Analgesics|analgesics|mesh-ancestor
138537104|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
138537105|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537106|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537107|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
138537108|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138537109|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138488538|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537110|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320290|NCT05353062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138537111|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138537112|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138537113|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138537114|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138537115|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537116|NCT00049790|Paclitaxel|paclitaxel|mesh-list
138537117|NCT00049790|Carboplatin|carboplatin|mesh-list
138537118|NCT00049790|Angiostatins|angiostatins|mesh-list
138537119|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138537120|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537121|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
138537122|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
138537123|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
138537124|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537125|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138537126|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138537127|NCT00049790|Growth Substances|growth substances|mesh-ancestor
138537128|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537129|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
138537130|NCT00082524|Caspofungin|caspofungin|mesh-list
138537131|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
138537132|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537133|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367558|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138537134|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537135|NCT00406003|Paroxetine|paroxetine|mesh-list
138537136|NCT00406003|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138537137|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138537138|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138537139|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537140|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537141|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
138367559|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138367560|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138367561|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
138367562|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367563|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138367564|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138367565|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367566|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138367567|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138367568|NCT01598363|Protective Agents|protective agents|mesh-ancestor
138367569|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367570|NCT01545141|Interferons|interferons|mesh-list
138367571|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
138367572|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
138367573|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138367574|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
138367575|NCT01545141|Poly I-C|poly i-c|mesh-list
138367576|NCT01545141|Celecoxib|celecoxib|mesh-list
138367577|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367578|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
138367579|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138367580|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
138367581|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367582|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138367586|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367588|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138367589|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138367590|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138367591|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367592|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367593|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
138367594|NCT01422759|Spironolactone|spironolactone|mesh-list
138367606|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
138367607|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367608|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367609|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138367610|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
138367611|NCT01421797|Hormones|hormones|mesh-ancestor
138367612|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367613|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138367614|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367615|NCT01404741|Azacitidine|azacitidine|mesh-list
138367616|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138367617|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
138367619|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367620|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138367621|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
138367622|NCT00777998|Thalidomide|thalidomide|mesh-list
138367623|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138367624|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
138367625|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367627|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138367628|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138367629|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138367630|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138367631|NCT00777998|Growth Substances|growth substances|mesh-ancestor
138367632|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
138367633|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367635|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
138367637|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138367638|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
138367639|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537142|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537143|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138537144|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
138537145|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537146|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138537147|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138537148|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537149|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
138367822|NCT05273528|Vaccines|vaccines|mesh-list
138367823|NCT05273528|Immunologic Factors|immunologic factors|mesh-ancestor
138367824|NCT05273528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367825|NCT05273398|Diazepam|diazepam|mesh-list
138367826|NCT05273398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138367827|NCT05273398|Anticonvulsants|anticonvulsants|mesh-ancestor
138367828|NCT05273398|Antiemetics|antiemetics|mesh-ancestor
138367829|NCT05273398|Autonomic Agents|autonomic agents|mesh-ancestor
138367830|NCT05273398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367831|NCT05273398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367832|NCT05273398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138367833|NCT05273398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138367834|NCT05273398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138367835|NCT05273398|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138367836|NCT05273398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138367837|NCT05273398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138367838|NCT05273398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138367840|NCT05273398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138367841|NCT05273398|Anesthetics, General|anesthetics, general|mesh-ancestor
138367842|NCT05273398|Anesthetics|anesthetics|mesh-ancestor
138367843|NCT05273398|GABA Modulators|gaba modulators|mesh-ancestor
138367844|NCT05273398|GABA Agents|gaba agents|mesh-ancestor
138367845|NCT05273398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138367846|NCT05273398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367847|NCT05272839|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138367848|NCT05272839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367849|NCT05272371|Dinutuximab|dinutuximab|mesh-list
138367850|NCT05272371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367851|NCT05271539|Dexamethasone|dexamethasone|mesh-list
138367852|NCT05271539|Ranibizumab|ranibizumab|mesh-list
138367853|NCT05271539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138367854|NCT05271539|Antiemetics|antiemetics|mesh-ancestor
138367855|NCT05271539|Autonomic Agents|autonomic agents|mesh-ancestor
138367856|NCT05271539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367857|NCT05271539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367858|NCT05271539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138367859|NCT05271539|Glucocorticoids|glucocorticoids|mesh-ancestor
138367860|NCT05271539|Hormones|hormones|mesh-ancestor
138367861|NCT05271539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138367862|NCT05271539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138367863|NCT05271539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367864|NCT05271539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138367865|NCT05271539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138367867|NCT05271539|Growth Inhibitors|growth inhibitors|mesh-ancestor
138367868|NCT05271370|Leronlimab|leronlimab|mesh-list
138367869|NCT05271370|HIV Antibodies|hiv antibodies|mesh-list
138367870|NCT05271370|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138367871|NCT05271370|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138367872|NCT05271370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138367873|NCT05271370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138367874|NCT05271370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138367875|NCT05271370|Antiviral Agents|antiviral agents|mesh-ancestor
138367881|NCT05271253|Anesthetics, Local|anesthetics, local|mesh-ancestor
138367882|NCT05271253|Anesthetics|anesthetics|mesh-ancestor
138367883|NCT05271253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138367884|NCT05271253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367885|NCT05271253|Sensory System Agents|sensory system agents|mesh-ancestor
138367886|NCT05271253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367887|NCT05271253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138367888|NCT05271253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138367889|NCT05271253|Analgesics|analgesics|mesh-ancestor
138367890|NCT05271253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138367891|NCT05271253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138367892|NCT05271253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138367893|NCT05271253|Adrenergic Agents|adrenergic agents|mesh-ancestor
138537150|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138537151|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537153|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138537154|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
138537155|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138537156|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
138537157|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138537158|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
138537159|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138537160|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
138537162|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138537163|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537164|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138537165|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537166|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
138537167|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
138537168|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537169|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138537170|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138537171|NCT00406042|Protective Agents|protective agents|mesh-ancestor
138537172|NCT00082563|Azithromycin|azithromycin|mesh-list
138537173|NCT00082563|Chloroquine|chloroquine|mesh-list
138537174|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138537175|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138537176|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537177|NCT00082563|Amebicides|amebicides|mesh-ancestor
138537178|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138537179|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138537180|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
138537181|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138537182|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138537183|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138537184|NCT00082563|Analgesics|analgesics|mesh-ancestor
138537185|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
138537186|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537187|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537188|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138537189|NCT00082563|Filaricides|filaricides|mesh-ancestor
138537190|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
138537191|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
138537193|NCT00151528|Analgesics|analgesics|mesh-ancestor
138537194|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
138537195|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537196|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537197|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
138537198|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138537199|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138488539|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138537200|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537201|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138537202|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138537203|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138537204|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138537205|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537206|NCT00397787|Sunitinib|sunitinib|mesh-list
138537207|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320342|NCT03150576|Carboplatin|carboplatin|mesh-list
138537209|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138537210|NCT00397787|Growth Substances|growth substances|mesh-ancestor
138537211|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537212|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
138537213|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138537214|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537215|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537216|NCT00082602|Galantamine|galantamine|mesh-list
138537217|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138537218|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537219|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537220|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
138537221|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537222|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537223|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138537224|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
138537225|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537226|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
138537228|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138537229|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138537230|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138537231|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
138537232|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537233|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537234|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537235|NCT00151567|Urological Agents|urological agents|mesh-ancestor
138537236|NCT00397826|Simvastatin|simvastatin|mesh-list
138537237|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138537238|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138537239|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
138537240|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537241|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138537242|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138537243|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537244|NCT00151684|Diazoxide|diazoxide|mesh-list
138537245|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138537247|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138537248|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138537249|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138537250|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
138537251|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537252|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138537253|NCT00151801|Interferons|interferons|mesh-list
138537254|NCT00151801|Interferon-beta|interferon-beta|mesh-list
138537255|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
138537256|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537257|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
138537258|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537259|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
138537260|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320373|NCT01675362|Selenium|selenium|mesh-list
138537261|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138537262|NCT04725253|Niacinamide|niacinamide|mesh-list
138537263|NCT04725253|Niacin|niacin|mesh-list
138537264|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
138537265|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
138537266|NCT04725253|Vitamins|vitamins|mesh-ancestor
138537267|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
138537268|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537269|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138537270|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
138537271|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537272|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138537273|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
138537274|NCT00082719|Interferons|interferons|mesh-list
138537275|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
138537276|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
138537277|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537278|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
138537279|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537280|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
138537281|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537282|NCT00151957|Methylphenidate|methylphenidate|mesh-list
138537283|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138537284|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537285|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138537286|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138537287|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138537288|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537289|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
138537290|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537291|NCT00049946|Risperidone|risperidone|mesh-list
138537292|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138537293|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
138537294|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138488540|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537295|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537296|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537297|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138537298|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138537299|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138537300|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537301|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138537302|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
138537303|NCT00152035|Amphetamine|amphetamine|mesh-list
138537304|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
138537305|NCT00152035|Adderall|adderall|mesh-list
138488541|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
138537306|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138537307|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537308|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
138537309|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
138537310|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537311|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
138537312|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537313|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537314|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
138537315|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138537316|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138537317|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138537318|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138537319|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
138320393|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
138213555|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
138537320|NCT00049985|Hematinics|hematinics|mesh-ancestor
138537321|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
138537322|NCT00152191|Fluorouracil|fluorouracil|mesh-list
138537324|NCT00152191|Tegafur|tegafur|mesh-list
138537325|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138537326|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
138537327|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537328|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138537329|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138537330|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
138537331|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537332|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537333|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138537335|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138537336|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138537337|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
138537338|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138537339|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
138537340|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537341|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138537342|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138537343|NCT00152230|Tegafur|tegafur|mesh-list
138537344|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138537345|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
138537346|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537347|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537348|NCT00152308|Sirolimus|sirolimus|mesh-list
138537349|NCT00152308|Ethanol|ethanol|mesh-list
138537350|NCT00152308|Temsirolimus|temsirolimus|mesh-list
138537351|NCT00152308|MTOR Inhibitors|mtor inhibitors|mesh-list
138537352|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138537353|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537354|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138537355|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537356|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
138537357|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138537358|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
138537359|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537360|NCT00152308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138537361|NCT00152308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537362|NCT00152308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537363|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138537364|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138537365|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
138537366|NCT00152386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138537367|NCT00152386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138537368|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138537369|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
138537370|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537371|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138537373|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138537374|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537375|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
138537376|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537377|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138537378|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
138537379|NCT00152425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138537380|NCT00152425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138537381|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138537382|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
138537383|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537384|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138537385|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
138537386|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138537388|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537389|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537390|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138537391|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
138537392|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138537393|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
138368461|NCT03858621|Fentanyl|fentanyl|mesh-list
138368462|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138368463|NCT03858621|Narcotics|narcotics|mesh-ancestor
138368464|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368465|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368466|NCT03858621|Analgesics|analgesics|mesh-ancestor
138368467|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
138368468|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368469|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138368470|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138368471|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
138368472|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
138368473|NCT03758170|Dexamethasone|dexamethasone|mesh-list
138368474|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138368475|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
138368476|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
138368477|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368478|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368479|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138368480|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
138368481|NCT03758170|Hormones|hormones|mesh-ancestor
138368482|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138368483|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138368484|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368485|NCT03733119|TIC10 compound|tic10 compound|mesh-list
138368486|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368487|NCT03705338|Propofol|propofol|mesh-list
138368488|NCT03705338|Anesthetics|anesthetics|mesh-list
138368489|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
138368490|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138368491|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368499|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368500|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138368501|NCT03696537|Fludarabine|fludarabine|mesh-list
138368502|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368503|NCT03661996|Lidocaine|lidocaine|mesh-list
138368504|NCT03661996|Epinephrine|epinephrine|mesh-list
138368505|NCT03661996|Capsaicin|capsaicin|mesh-list
138368506|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
138368507|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
138368508|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368509|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368510|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
138368511|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368512|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138368513|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138368514|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138368515|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138368516|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368517|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138368518|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138368519|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
138368520|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138368521|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138368522|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138368523|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
138368524|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138368525|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
138368527|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
138368528|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138368529|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
138368530|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
138368531|NCT03410355|Cortisone|cortisone|mesh-list
138368532|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138368533|NCT03399617|Micronutrients|micronutrients|mesh-list
138368534|NCT03399617|Trace Elements|trace elements|mesh-list
138368535|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537394|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537395|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537396|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138537397|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
138537398|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
138537399|NCT00152542|Protective Agents|protective agents|mesh-ancestor
138537400|NCT00043680|Celecoxib|celecoxib|mesh-list
138537401|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138537402|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138537403|NCT00043680|Analgesics|analgesics|mesh-ancestor
138537404|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
138537405|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537406|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537407|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138537408|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138537409|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138537410|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138537411|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537412|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537413|NCT00152581|Interferons|interferons|mesh-list
138537414|NCT00152581|Ribavirin|ribavirin|mesh-list
138537415|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
138537416|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
138537417|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138537418|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537419|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
138167636|NCT04147286|Atorvastatin|atorvastatin|mesh-list
138537421|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
138537422|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537423|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
138537424|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537425|NCT00152620|Dexamethasone|dexamethasone|mesh-list
138320433|NCT03873480|Epinephrine|epinephrine|mesh-list
138537426|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
138537427|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138537428|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138537430|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
138537431|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138537432|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
138537433|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138537434|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
138537435|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
138537436|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537437|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537438|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138537439|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
138537440|NCT00152620|Hormones|hormones|mesh-ancestor
138537441|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138537442|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138537443|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537444|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138537445|NCT00152620|Protective Agents|protective agents|mesh-ancestor
138537446|NCT00050141|Tipifarnib|tipifarnib|mesh-list
138537447|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537448|NCT04725214|Temozolomide|temozolomide|mesh-list
138537449|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138537450|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
138537451|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537452|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537453|NCT00050180|Indinavir|indinavir|mesh-list
138537454|NCT00050180|Saquinavir|saquinavir|mesh-list
138368536|NCT03386162|Fulvestrant|fulvestrant|mesh-list
138368537|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138368538|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537455|NCT00050180|Midazolam|midazolam|mesh-list
138537456|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138537457|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138537458|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368539|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138368540|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138368541|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
138368542|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138368543|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368544|NCT03360214|Bupivacaine|bupivacaine|mesh-list
138368545|NCT03360214|Ropivacaine|ropivacaine|mesh-list
138368546|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
138368547|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
138368548|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368549|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368550|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
138368551|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368552|NCT03359239|Atezolizumab|atezolizumab|mesh-list
138368553|NCT03359239|Poly ICLC|poly iclc|mesh-list
138368554|NCT03359239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138368555|NCT03359239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368556|NCT03359239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138368557|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368558|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
138368559|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
138368560|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368561|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
138368572|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
138368573|NCT03315039|Annamycin|annamycin|mesh-list
138368574|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138368575|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368576|NCT03276533|Lidocaine|lidocaine|mesh-list
138368577|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
138368578|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
138368579|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
138368580|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368581|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368582|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
138368583|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368584|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138368585|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138368586|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138368587|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138368588|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368589|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138368590|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138368591|NCT03276533|Analgesics|analgesics|mesh-ancestor
138368592|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138368593|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138368594|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138368595|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
138368596|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138368597|NCT03254394|Lidocaine|lidocaine|mesh-list
138368598|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
138368599|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
138368600|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368601|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368602|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
138368603|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368604|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138368605|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138368606|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138368607|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138368608|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368609|NCT03203876|Nivolumab|nivolumab|mesh-list
138537459|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537460|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138537461|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138537462|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537463|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138537464|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
138537465|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
138537466|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
138537467|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
138537468|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537469|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537470|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138537471|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138537472|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
138213705|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
138537473|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537474|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138537475|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138537476|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
138537477|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537478|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138167656|NCT00493805|Interferons|interferons|mesh-list
138537479|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138320456|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427648|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
138537480|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
138537481|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537483|NCT00152815|Antioxidants|antioxidants|mesh-list
138537484|NCT00152815|Vitamins|vitamins|mesh-ancestor
138537485|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
138537486|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537487|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537488|NCT00152815|Protective Agents|protective agents|mesh-ancestor
138537489|NCT00043719|Vitamin D|vitamin d|mesh-list
138368610|NCT03203876|Ipilimumab|ipilimumab|mesh-list
138368611|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138537490|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
138537491|NCT00043719|Calcium|calcium|mesh-list
138537492|NCT00043719|Vitamins|vitamins|mesh-ancestor
138537493|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
138537494|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537495|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138368612|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368613|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138368614|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368616|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
138368618|NCT03191240|Coagulants|coagulants|mesh-ancestor
138368619|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138368620|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138368621|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
138368622|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368623|NCT03180294|Bupropion|bupropion|mesh-list
138368624|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138368632|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138368633|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368634|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138368635|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138368636|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368637|NCT03071601|Lidocaine|lidocaine|mesh-list
138368638|NCT03071601|Epinephrine|epinephrine|mesh-list
138368640|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138368642|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
138368643|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138368644|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368645|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
138368646|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368647|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138368648|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138368651|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368652|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138368653|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138368654|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
138368655|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138368656|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138368657|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138368658|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
138368659|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138368660|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
138368663|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138368664|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138368665|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138368666|NCT03061903|Laxatives|laxatives|mesh-ancestor
138368667|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138368668|NCT03061643|Docetaxel|docetaxel|mesh-list
138368669|NCT03061643|Androgens|androgens|mesh-list
138368670|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368671|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
138368672|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
138368673|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
138368674|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368675|NCT03061643|Hormones|hormones|mesh-ancestor
138368676|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138368678|NCT03061630|Gemcitabine|gemcitabine|mesh-list
138368679|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368680|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138368681|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
138368682|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368683|NCT03055390|Scopolamine|scopolamine|mesh-list
138368684|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138368685|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138368686|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
138368687|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
138368695|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368697|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
138368698|NCT03012672|Cytarabine|cytarabine|mesh-list
138537496|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138537497|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
138537498|NCT00152854|Acetaminophen|acetaminophen|mesh-list
138537499|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138537500|NCT00152854|Analgesics|analgesics|mesh-ancestor
138537501|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
138537502|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537503|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537504|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
138537505|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
138537506|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138537507|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537508|NCT00152893|Chromium|chromium|mesh-list
138537509|NCT00152893|Niacin|niacin|mesh-list
138537510|NCT00152893|Trace Elements|trace elements|mesh-ancestor
138537511|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
138537512|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537513|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138537514|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
138537515|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537516|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138537517|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
138537518|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
138537519|NCT00152893|Vitamins|vitamins|mesh-ancestor
138537520|NCT00152932|Dorzolamide|dorzolamide|mesh-list
138537521|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138537522|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138537523|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537524|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537525|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
138537526|NCT00083031|Bevacizumab|bevacizumab|mesh-list
138537527|NCT00083031|Methotrexate|methotrexate|mesh-list
138537528|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138537529|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
138537530|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320476|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
138537531|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138537532|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138537533|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
138167673|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537534|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537535|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368889|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
138368890|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138368891|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138368892|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
138368894|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
138368895|NCT02539225|Ramucirumab|ramucirumab|mesh-list
138368896|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138368897|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368898|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
138368899|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
138368900|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
138368901|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368903|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368905|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138368906|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368907|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138368908|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368909|NCT02516657|Liraglutide|liraglutide|mesh-list
138368910|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138368911|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368912|NCT02516657|Incretins|incretins|mesh-ancestor
138368913|NCT02516657|Hormones|hormones|mesh-ancestor
138368914|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138368915|NCT02427581|Poly I-C|poly i-c|mesh-list
138368916|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138368917|NCT02427581|Poly ICLC|poly iclc|mesh-list
138368918|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
138368919|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
138368920|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368921|NCT02427581|Laxatives|laxatives|mesh-ancestor
138368922|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138368923|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
138368924|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368925|NCT02423525|Afatinib|afatinib|mesh-list
138368926|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368927|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138368928|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368929|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368932|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138368933|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
138368934|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138368935|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
138368936|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138368937|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368940|NCT02293109|Dexamethasone|dexamethasone|mesh-list
138368941|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
138368953|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
138368954|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
138368955|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138368956|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
138368957|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368958|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138368959|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138368960|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
138368961|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368962|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138368963|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138368964|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138368965|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
138368966|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
138368967|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138368968|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138368969|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
138537536|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138537537|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138537538|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138537539|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138537540|NCT00083031|Growth Substances|growth substances|mesh-ancestor
138537541|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
138537542|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138537543|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
138537544|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138537545|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138537546|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
138537547|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
138537548|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537549|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138537550|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138537551|NCT00050336|Lonafarnib|lonafarnib|mesh-list
138537552|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537553|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537554|NCT00043758|Tolvaptan|tolvaptan|mesh-list
138537555|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138537556|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537557|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
138537558|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537559|NCT00050375|Oregovomab|oregovomab|mesh-list
138537560|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138537561|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537562|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138537563|NCT00153049|Telmisartan|telmisartan|mesh-list
138537564|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
138537565|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138537566|NCT00153049|Diuretics|diuretics|mesh-ancestor
138537567|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
138537568|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537569|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138537570|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138537571|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537572|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138537573|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138537574|NCT00153088|Telmisartan|telmisartan|mesh-list
138537575|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138537576|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138537577|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138488542|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537578|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537579|NCT00083070|Temozolomide|temozolomide|mesh-list
138537580|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138320501|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
138537581|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
138537582|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537583|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537584|NCT00050414|Dexamethasone|dexamethasone|mesh-list
138537585|NCT00050414|Trabectedin|trabectedin|mesh-list
138537586|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138537587|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
138537588|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
138537589|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537590|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537591|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138537592|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
138537593|NCT00050414|Hormones|hormones|mesh-ancestor
138537594|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138537595|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138537596|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138488543|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
138537597|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138537598|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
138537599|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537600|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138537601|NCT00153127|Laxatives|laxatives|mesh-ancestor
138537602|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138537603|NCT00083109|Suramin|suramin|mesh-list
138537604|NCT00083109|Fluorouracil|fluorouracil|mesh-list
138537605|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
138537606|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537607|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138537608|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537609|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138537610|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
138537611|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537612|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
138537613|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
138537614|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138537615|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537616|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138537617|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138537618|NCT00153244|Lamotrigine|lamotrigine|mesh-list
138537619|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
138213854|NCT03243890|Vitamin D|vitamin d|mesh-list
138537620|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138537621|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138537622|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537623|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138537624|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537625|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138537626|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138537627|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427713|NCT01706627|Melatonin|melatonin|mesh-list
138537628|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537629|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138537631|NCT00153283|Analgesics|analgesics|mesh-ancestor
138537632|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
138537633|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537634|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537635|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
138537636|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138320522|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138537638|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138537639|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537640|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138537641|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138537642|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537643|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537644|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
138537645|NCT00050531|Interferons|interferons|mesh-list
138537646|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
138537647|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
138537648|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138537649|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138537650|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
138537651|NCT00050531|Molgramostim|molgramostim|mesh-list
138537652|NCT00050531|Sargramostim|sargramostim|mesh-list
138537653|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537654|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
138537655|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537656|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
138537657|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537658|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138537659|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537660|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537661|NCT00083148|Capecitabine|capecitabine|mesh-list
138537662|NCT00083148|Irinotecan|irinotecan|mesh-list
138537663|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138537664|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
138537665|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537666|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537667|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138537668|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138537669|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537670|NCT00153517|Metronidazole|metronidazole|mesh-list
138537671|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537672|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138537673|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138167765|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
138537674|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138537675|NCT00153556|Vaccines|vaccines|mesh-list
138537676|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
138537677|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537678|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
138537679|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537680|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
138537681|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537682|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537683|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138537684|NCT00153634|Azithromycin|azithromycin|mesh-list
138537685|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
138537686|NCT00153634|Meropenem|meropenem|mesh-list
138537687|NCT00153634|Tazobactam|tazobactam|mesh-list
138537688|NCT00153634|Piperacillin|piperacillin|mesh-list
138537689|NCT00153634|Tobramycin|tobramycin|mesh-list
138537690|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
138537691|NCT00153634|Amikacin|amikacin|mesh-list
138537692|NCT00153634|Ceftazidime|ceftazidime|mesh-list
138537693|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138537694|NCT00153634|Ticarcillin|ticarcillin|mesh-list
138537695|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
138537696|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138537697|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537698|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138537700|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537701|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537702|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537703|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138537704|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138537705|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138537706|NCT00050609|Tadalafil|tadalafil|mesh-list
138537707|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
138537708|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138537709|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138537710|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537711|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537712|NCT00050609|Urological Agents|urological agents|mesh-ancestor
138537713|NCT00153673|Celecoxib|celecoxib|mesh-list
138230429|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
138537714|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138537715|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138537716|NCT00153673|Analgesics|analgesics|mesh-ancestor
138537717|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
138537718|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537719|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537720|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138537721|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138537722|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138537723|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138537724|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537725|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537726|NCT00050648|Cyclosporine|cyclosporine|mesh-list
138537727|NCT00050648|Cyclosporins|cyclosporins|mesh-list
138537728|NCT00050648|Daclizumab|daclizumab|mesh-list
138537729|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537730|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537731|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138537732|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
138537733|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537734|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
138537735|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537736|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
138537737|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138537738|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138537739|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
138537740|NCT00153868|Hematinics|hematinics|mesh-ancestor
138537741|NCT00153907|Capecitabine|capecitabine|mesh-list
138537742|NCT00153907|Vinorelbine|vinorelbine|mesh-list
138537743|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138537744|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
138537745|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537746|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320554|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537747|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138537748|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
138537749|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
138537750|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
138537751|NCT00050726|Interleukin-2|interleukin-2|mesh-list
138537752|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537753|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138537754|NCT00050726|Analgesics|analgesics|mesh-ancestor
138537755|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
138537756|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537757|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537758|NCT00153946|Edaravone|edaravone|mesh-list
138537759|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138537760|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
138537761|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537762|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138537763|NCT00153946|Protective Agents|protective agents|mesh-ancestor
138537764|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537765|NCT00154024|Irbesartan|irbesartan|mesh-list
138537766|NCT00154024|Atorvastatin|atorvastatin|mesh-list
138537767|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138537768|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138537769|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
138537770|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537771|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138537772|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138537773|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537774|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138537775|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138537776|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138537777|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138537778|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
138537779|NCT00154141|Coagulants|coagulants|mesh-ancestor
138537780|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138537781|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138537782|NCT00154180|Estradiol|estradiol|mesh-list
138537783|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138537784|NCT00154180|Estrogens|estrogens|mesh-list
138537785|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138537786|NCT00154180|Progesterone|progesterone|mesh-list
138537788|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138537789|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537790|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138537791|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
138537792|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138537793|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138537794|NCT00154180|Progestins|progestins|mesh-ancestor
138537795|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
138537796|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138537797|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138537798|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427843|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537799|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537800|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138537801|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138537802|NCT00154219|Analgesics|analgesics|mesh-ancestor
138537803|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
138537804|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138537805|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537806|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138537807|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138537808|NCT00043875|Lamotrigine|lamotrigine|mesh-list
138537809|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
138537810|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138537811|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138537812|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537813|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138537814|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537815|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138537816|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138537817|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138537818|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537819|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138537820|NCT00154258|Clozapine|clozapine|mesh-list
138537821|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138537822|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
138537823|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537824|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537825|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537826|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138427861|NCT01707537|Vaccines|vaccines|mesh-list
138537828|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138537829|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537830|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
138537831|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
138537832|NCT00154336|Methotrexate|methotrexate|mesh-list
138537833|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
138537834|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138537835|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
138537836|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138537837|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537838|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138537839|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
138537840|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537841|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537842|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
138537843|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537844|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138537845|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138537846|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
138537847|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138537848|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138537849|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138537850|NCT00050804|Sertraline|sertraline|mesh-list
138537851|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
138537852|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537853|NCT00050804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138537854|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138537855|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138537856|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537857|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537859|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537860|NCT00043914|Lamotrigine|lamotrigine|mesh-list
138537861|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
138537862|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138537863|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138537864|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537865|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138537866|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537867|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138537868|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138537869|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138537870|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537871|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138537873|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
138537874|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138537875|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
138537876|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
138537877|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
138369143|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
138537878|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537879|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537880|NCT04705909|Pitavastatin|pitavastatin|mesh-list
138537881|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138537883|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138537884|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
138537885|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537886|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537887|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138537888|NCT00083304|Efaproxiral|efaproxiral|mesh-list
138537889|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
138537890|NCT00050843|Thalidomide|thalidomide|mesh-list
138537891|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138537892|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
138369144|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369145|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369147|NCT00962988|Nicotine|nicotine|mesh-list
138369148|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138369149|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
138369150|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369151|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369152|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138369153|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138369154|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
138369155|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369156|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369157|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138369158|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
138369159|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138369160|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138369161|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138369162|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138369163|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
138369164|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138369165|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138369166|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369167|NCT00768820|Risperidone|risperidone|mesh-list
138369168|NCT00768820|Methylphenidate|methylphenidate|mesh-list
138369169|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138369170|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
138369171|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369172|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369173|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369174|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138369175|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138369176|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138369177|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138369178|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138369179|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
138369180|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138369181|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138369182|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138369183|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138369185|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
138369186|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369187|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138369188|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138369189|NCT00678730|Analgesics|analgesics|mesh-ancestor
138369198|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138369199|NCT00600015|Sorafenib|sorafenib|mesh-list
138369200|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369201|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138369202|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369203|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369204|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138369205|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138369206|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537893|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537894|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
138537895|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138537896|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537897|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138537898|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138537899|NCT00050843|Growth Substances|growth substances|mesh-ancestor
138537900|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
138537901|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537902|NCT00406237|Tigecycline|tigecycline|mesh-list
138537903|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138537904|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537905|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138537906|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537907|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537908|NCT00406432|Paroxetine|paroxetine|mesh-list
138537909|NCT00406432|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138320620|NCT03826992|Cytarabine|cytarabine|mesh-list
138537910|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138537911|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138167817|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
138537912|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537913|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138537914|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
138537915|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537916|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138537917|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
138537918|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138537919|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138230438|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138537920|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138537921|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537922|NCT00083343|Caspofungin|caspofungin|mesh-list
138537923|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
138537924|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537925|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138537926|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537927|NCT00406471|Ranibizumab|ranibizumab|mesh-list
138537928|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138537929|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138537930|NCT00406471|Growth Substances|growth substances|mesh-ancestor
138537931|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537932|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
138537933|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537935|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138537936|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
138537937|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537938|NCT00154687|Paclitaxel|paclitaxel|mesh-list
138537939|NCT00154687|Fluorouracil|fluorouracil|mesh-list
138537940|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138537941|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537942|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
138537943|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
138537944|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
138537945|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537946|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
138537947|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138537948|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138537949|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
138537950|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537951|NCT00083460|Thalidomide|thalidomide|mesh-list
138537952|NCT00083460|Dexamethasone|dexamethasone|mesh-list
138537953|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138537954|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
138537955|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
138537956|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320645|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
138320668|NCT03825198|Dexamethasone|dexamethasone|mesh-list
138537957|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537958|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138537959|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
138537961|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138537962|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138537963|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537964|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138537965|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
138537966|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
138537967|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138537968|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138537969|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138369395|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
138369396|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138369397|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138369398|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138369399|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138369400|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138369401|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138369402|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369403|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138369404|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
138369405|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138369406|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369407|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138369408|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138369409|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138369410|NCT01398371|Digoxin|digoxin|mesh-list
138369411|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138369412|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138369413|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369414|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369415|NCT01398371|Protective Agents|protective agents|mesh-ancestor
138369416|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369417|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
138369418|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138369419|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
138369420|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369421|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369422|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138369423|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
138369424|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138369425|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
138369426|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369427|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369428|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138369429|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
138369430|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
138369440|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369441|NCT01398592|Incretins|incretins|mesh-ancestor
138369442|NCT01398592|Hormones|hormones|mesh-ancestor
138369443|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369444|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138369445|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
138369446|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369447|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369448|NCT01398618|Rifampin|rifampin|mesh-list
138369449|NCT01398618|Isoniazid|isoniazid|mesh-list
138369450|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138369451|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
138369452|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138369453|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138369454|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
138369455|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138369456|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369457|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369458|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138369459|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138369460|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138369461|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138369462|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138537970|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138537971|NCT00083460|Growth Substances|growth substances|mesh-ancestor
138167841|NCT00555321|Abatacept|abatacept|mesh-list
138537972|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
138537973|NCT00154726|Paclitaxel|paclitaxel|mesh-list
138537974|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138537975|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537976|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
138537977|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
138537978|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
138537979|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537980|NCT00154804|Paclitaxel|paclitaxel|mesh-list
138537981|NCT00154804|Cisplatin|cisplatin|mesh-list
138537982|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138537983|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537984|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
138537985|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
138537986|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
138537987|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537988|NCT00154843|Lycopene|lycopene|mesh-list
138427948|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
138537989|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138537990|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
138230447|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138537991|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138537992|NCT00154843|Protective Agents|protective agents|mesh-ancestor
138537993|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138537994|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138537995|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138537996|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138537997|NCT00043953|Ritonavir|ritonavir|mesh-list
138320669|NCT03825198|Ketorolac|ketorolac|mesh-list
138537998|NCT00043953|Lopinavir|lopinavir|mesh-list
138537999|NCT00043953|Saquinavir|saquinavir|mesh-list
138538000|NCT00043953|Lamivudine|lamivudine|mesh-list
138538001|NCT00043953|Zidovudine|zidovudine|mesh-list
138538002|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138538003|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138538004|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138538005|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
138538006|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538007|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538008|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138538009|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138538010|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
138538011|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538012|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138538013|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138538014|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138538015|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138538016|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
138538017|NCT00154882|Paclitaxel|paclitaxel|mesh-list
138538018|NCT00154882|Cisplatin|cisplatin|mesh-list
138538019|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138538020|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538021|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
138538022|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
138538023|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
138538024|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538025|NCT00051077|Ribavirin|ribavirin|mesh-list
138538026|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138538027|NCT00051077|Adefovir|adefovir|mesh-list
138538028|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138538029|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
138538030|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538031|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
138538032|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538033|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138538034|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138538035|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538036|NCT00155233|Morphine|morphine|mesh-list
138538037|NCT00155233|Nalbuphine|nalbuphine|mesh-list
138538038|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138538039|NCT00155233|Narcotics|narcotics|mesh-ancestor
138538040|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138320703|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538041|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538043|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
138538044|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138538045|NCT00051116|Lenalidomide|lenalidomide|mesh-list
138538046|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
138538047|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538048|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138538049|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138538050|NCT00051116|Growth Substances|growth substances|mesh-ancestor
138538051|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
138538052|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538053|NCT00155272|Thalidomide|thalidomide|mesh-list
138538054|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138538055|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
138538056|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538057|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
138538058|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138538059|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538060|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138538061|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138538062|NCT00155272|Growth Substances|growth substances|mesh-ancestor
138538063|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
138538064|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538065|NCT00155350|Pioglitazone|pioglitazone|mesh-list
138538066|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138538067|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538068|NCT00051155|Timolol|timolol|mesh-list
138538069|NCT00051155|Travoprost|travoprost|mesh-list
138538070|NCT00051155|Latanoprost|latanoprost|mesh-list
138538071|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138538072|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138538073|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
138428026|NCT01708707|Morphine|morphine|mesh-list
138538074|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138488544|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138538075|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538076|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538077|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138538078|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138538079|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138538080|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138538081|NCT00083538|Thalidomide|thalidomide|mesh-list
138538082|NCT00083538|Dexamethasone|dexamethasone|mesh-list
138538083|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
138538084|NCT00083538|Etoposide|etoposide|mesh-list
138538085|NCT00083538|Doxorubicin|doxorubicin|mesh-list
138538086|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138538087|NCT00083538|Cisplatin|cisplatin|mesh-list
138538088|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138538089|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
138538090|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538091|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138320740|NCT03817320|Antimetabolites|antimetabolites|mesh-ancestor
138538092|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138538093|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
138538094|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538095|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538096|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138167859|NCT05583266|Pentoxifylline|pentoxifylline|mesh-list
138538097|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138538098|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
138538099|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
138538100|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138538101|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138538102|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
138538103|NCT00083538|Hormones|hormones|mesh-ancestor
138538104|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138538105|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138538106|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138538107|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138538108|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138538109|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538110|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138538111|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
138538112|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138538113|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538114|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138538115|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138538116|NCT00083538|Growth Substances|growth substances|mesh-ancestor
138538117|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
138538118|NCT00083577|Thalidomide|thalidomide|mesh-list
138538119|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138538120|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
138538121|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538122|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
138538123|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138538124|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538125|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138538126|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138538127|NCT00083577|Growth Substances|growth substances|mesh-ancestor
138538128|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
138538129|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538130|NCT00154414|Liraglutide|liraglutide|mesh-list
138538131|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138538132|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538133|NCT00154414|Incretins|incretins|mesh-ancestor
138538134|NCT00154414|Hormones|hormones|mesh-ancestor
138538135|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138538136|NCT00406744|Bevacizumab|bevacizumab|mesh-list
138538137|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138538138|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538139|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138538140|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138538141|NCT00406744|Growth Substances|growth substances|mesh-ancestor
138538142|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538143|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
138538144|NCT00399750|Bevacizumab|bevacizumab|mesh-list
138214381|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138538145|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
138538146|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138538147|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538148|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138538149|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138538150|NCT00399750|Growth Substances|growth substances|mesh-ancestor
138538151|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538152|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
138538154|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538155|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538156|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
138538157|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538158|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138538159|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538160|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538161|NCT00156325|Escitalopram|escitalopram|mesh-list
138538162|NCT00156325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138538163|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138369549|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
138369550|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138369551|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369552|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
138369565|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138369566|NCT01399840|Talazoparib|talazoparib|mesh-list
138369567|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138369568|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369569|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369570|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538164|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138538165|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538166|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138538167|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
138538168|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538170|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138538171|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138538172|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138538173|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538174|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138538175|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538176|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
138538177|NCT00051272|Bupropion|bupropion|mesh-list
138538178|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138538179|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
138538180|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138538181|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138538183|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138538184|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538185|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
138538186|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138538187|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538188|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138538189|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138538190|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538191|NCT00044187|Sibutramine|sibutramine|mesh-list
138538192|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
138538193|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138538194|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
138538195|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138538196|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
138538197|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138538198|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138538199|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538200|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
138538201|NCT00156520|Coagulants|coagulants|mesh-ancestor
138538202|NCT00083694|Thalidomide|thalidomide|mesh-list
138538203|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138538204|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
138538205|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538206|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
138538207|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138538208|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538209|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138538210|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138538211|NCT00083694|Growth Substances|growth substances|mesh-ancestor
138538212|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
138538213|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538214|NCT00051389|Fosinopril|fosinopril|mesh-list
138538215|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138167886|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
138538216|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
138538217|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138320831|NCT06125184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138538218|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538220|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
138538221|NCT00156949|Hematinics|hematinics|mesh-ancestor
138538222|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
138538223|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138538224|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
138538225|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138538226|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538227|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138538228|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138538229|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
138538230|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138538231|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
138538233|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138538234|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538235|NCT00157066|Vitamins|vitamins|mesh-ancestor
138538236|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
138538237|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138538238|NCT00157105|Factor VIII|factor viii|mesh-list
138538239|NCT00157105|Coagulants|coagulants|mesh-ancestor
138538240|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138538241|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
138538242|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538243|NCT00157261|Tenecteplase|tenecteplase|mesh-list
138538244|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138538245|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138538246|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538247|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
138538248|NCT00157300|Hematinics|hematinics|mesh-ancestor
138538249|NCT00157378|Haloperidol|haloperidol|mesh-list
138538250|NCT00157378|Risperidone|risperidone|mesh-list
138188311|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188312|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188313|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138188314|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138188315|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138188316|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
138188317|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
138188318|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188319|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138188320|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
138188321|NCT03018535|Hormones|hormones|mesh-ancestor
138188322|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138320863|NCT06124729|Antibodies|antibodies|mesh-list
138188323|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138188325|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138188326|NCT00989911|Bosentan|bosentan|mesh-list
138188327|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138188328|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138188329|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188330|NCT02977065|Atorvastatin|atorvastatin|mesh-list
138188331|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138188332|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138188333|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138188334|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
138188335|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188336|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138188337|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138188339|NCT03146806|Ketamine|ketamine|mesh-list
138188340|NCT03146806|Analgesics|analgesics|mesh-ancestor
138188341|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
138188342|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188343|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428106|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
138188344|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138188345|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138188346|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
138188347|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
138188348|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188349|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138188350|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138538251|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
138538252|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138538253|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
138538254|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138538255|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538256|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538257|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138538258|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138538259|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138538260|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138538261|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138538262|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
138538264|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
138538265|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138538266|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138538267|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138538268|NCT00406861|Montelukast|montelukast|mesh-list
138538269|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138538270|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
138538271|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138538272|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
138637992|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538273|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138538274|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538275|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138538276|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138538277|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538278|NCT00044265|Ramipril|ramipril|mesh-list
138538279|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138538280|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
138538281|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538282|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538283|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138538284|NCT00398099|Ertapenem|ertapenem|mesh-list
138538285|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138538286|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538287|NCT00406978|Thalidomide|thalidomide|mesh-list
138538288|NCT00406978|Prednisone|prednisone|mesh-list
138538289|NCT00406978|Melphalan|melphalan|mesh-list
138538290|NCT00406978|Defibrotide|defibrotide|mesh-list
138538291|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138538292|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
138538293|NCT00406978|Hormones|hormones|mesh-ancestor
138538294|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138538295|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538296|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138538297|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538298|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138538299|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
138538300|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538301|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138538302|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138538303|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
138538304|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
138538305|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138538306|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538307|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138538308|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138538309|NCT00406978|Growth Substances|growth substances|mesh-ancestor
138538310|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
138538311|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138538312|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138538313|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138538314|NCT00157651|Warfarin|warfarin|mesh-list
138538315|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
138538316|NCT00044343|Lapatinib|lapatinib|mesh-list
138538317|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138320919|NCT06124417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138320931|NCT06124209|Hemostatics|hemostatics|mesh-ancestor
138538318|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138538319|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538320|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538321|NCT00157690|Alendronate|alendronate|mesh-list
138538322|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138538323|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538324|NCT00051506|Carboplatin|carboplatin|mesh-list
138538325|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538326|NCT00157729|Pyridoxal|pyridoxal|mesh-list
138538327|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
138538328|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138538329|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
138538330|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702098|NCT05424393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138538331|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538332|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
138538334|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
138538335|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538336|NCT00051545|Seocalcitol|seocalcitol|mesh-list
138538337|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538338|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138538339|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
138538340|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538341|NCT00157885|Artesunate|artesunate|mesh-list
138538342|NCT00157885|Amodiaquine|amodiaquine|mesh-list
138538343|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
138538344|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138538345|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138538346|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538347|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538348|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
138538349|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
138538350|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138538351|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
138538352|NCT00158002|Topiramate|topiramate|mesh-list
138538353|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
138538354|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138538355|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538356|NCT00158041|Amifostine|amifostine|mesh-list
138538357|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138538358|NCT00158041|Protective Agents|protective agents|mesh-ancestor
138538359|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538360|NCT00051584|Gemcitabine|gemcitabine|mesh-list
138538361|NCT00051584|Doxorubicin|doxorubicin|mesh-list
138538362|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
138538363|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138538364|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
138538365|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538366|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538367|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138538368|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138538369|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138538370|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538371|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
138538372|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538373|NCT00044382|Lenalidomide|lenalidomide|mesh-list
138538374|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
138538375|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538376|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138538377|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138538378|NCT00044382|Growth Substances|growth substances|mesh-ancestor
138538379|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
138538380|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538381|NCT00158158|Nicotine|nicotine|mesh-list
138538382|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138538383|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
138538384|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138538385|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538386|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138538387|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138538388|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
138538389|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138538390|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538392|NCT00051623|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138538393|NCT00051623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138538394|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
138538395|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138538396|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138538397|NCT00158236|Buprenorphine|buprenorphine|mesh-list
138538398|NCT00158236|Hydromorphone|hydromorphone|mesh-list
138538399|NCT00158236|Naloxone|naloxone|mesh-list
138538400|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138538401|NCT00158236|Narcotics|narcotics|mesh-ancestor
138538402|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230522|NCT02581839|BB 1101|bb 1101|mesh-list
138538403|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538404|NCT00158236|Analgesics|analgesics|mesh-ancestor
138538405|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
138538406|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320982|NCT06124157|Hormones|hormones|mesh-ancestor
138538408|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
138538409|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138538410|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
138538411|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538412|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538413|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
138538414|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138538415|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538416|NCT00158470|Lamivudine|lamivudine|mesh-list
138538417|NCT00158470|Efavirenz|efavirenz|mesh-list
138538418|NCT00158470|Didanosine|didanosine|mesh-list
138538419|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138538420|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138538422|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538423|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
138538424|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538425|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138538426|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138538427|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138538428|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138538429|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138538430|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138428209|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
138538431|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138538432|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138538434|NCT00158509|Valacyclovir|valacyclovir|mesh-list
138538435|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
138538436|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538437|NCT00158548|Artesunate|artesunate|mesh-list
138538438|NCT00158548|Chloroquine|chloroquine|mesh-list
138538439|NCT00158548|Primaquine|primaquine|mesh-list
138538440|NCT00158548|Amodiaquine|amodiaquine|mesh-list
138538441|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
138538442|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138538443|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138538444|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538445|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538446|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
138538447|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
138538448|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138538449|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
138538451|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138538452|NCT00158587|Primaquine|primaquine|mesh-list
138538453|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
138538454|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138538455|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138538456|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538457|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138538458|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
138538459|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538460|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138538461|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138538462|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538463|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167957|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538464|NCT00158782|Lapatinib|lapatinib|mesh-list
138538465|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538466|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138538467|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538468|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538469|NCT00158821|Tenofovir|tenofovir|mesh-list
138538470|NCT00158821|Lamivudine|lamivudine|mesh-list
138538471|NCT00158821|Efavirenz|efavirenz|mesh-list
138538472|NCT00158821|Stavudine|stavudine|mesh-list
138538473|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
138230530|NCT02581839|Hormones|hormones|mesh-ancestor
138538474|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538475|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138538476|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138538477|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538478|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538479|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138538480|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138538481|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138538482|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138538483|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138702099|NCT05424393|Analgesics|analgesics|mesh-ancestor
138538484|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138538485|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138538486|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138538487|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
138538488|NCT05568147|Aspirin|aspirin|mesh-list
138538489|NCT05568147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138321047|NCT06123624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138538490|NCT05568147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138538491|NCT05568147|Analgesics|analgesics|mesh-ancestor
138538492|NCT05568147|Sensory System Agents|sensory system agents|mesh-ancestor
138538493|NCT05568147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138538494|NCT05568147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538495|NCT05568147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138538496|NCT05568147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138538497|NCT05568147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138538498|NCT05568147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138538499|NCT05568147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538500|NCT05568147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138538501|NCT05568147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138538502|NCT05568147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538503|NCT05568147|Antipyretics|antipyretics|mesh-ancestor
138538504|NCT00051896|Vanoxerine|vanoxerine|mesh-list
138538505|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138538506|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138538507|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138167989|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138538508|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538509|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
138538510|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138538511|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538512|NCT04724473|Tretinoin|tretinoin|mesh-list
138538513|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538514|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
138538515|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
138538516|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
138538517|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538518|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138538519|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538520|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538521|NCT00159094|Vinorelbine|vinorelbine|mesh-list
138538522|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138538523|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538524|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
138538525|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
138538526|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
138538527|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538528|NCT02965053|Sevelamer|sevelamer|mesh-list
138538529|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
138538530|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
138538531|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538532|NCT00159133|Lorazepam|lorazepam|mesh-list
138538533|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
138538534|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
138538535|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
138538536|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
138321077|NCT06122948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138538537|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138538538|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538539|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138230537|NCT02504775|Acetaminophen|acetaminophen|mesh-list
138538540|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138538541|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138538542|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138538543|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138538544|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138538545|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
138538546|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
138538547|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138538548|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538549|NCT00051974|Bortezomib|bortezomib|mesh-list
138538550|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538551|NCT00159211|Pioglitazone|pioglitazone|mesh-list
138538552|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138538553|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538554|NCT05567718|Anesthetics|anesthetics|mesh-list
138538555|NCT05567718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138538556|NCT05567718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538557|NCT00052013|Vatalanib|vatalanib|mesh-list
138538558|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138538559|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538560|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538561|NCT00159445|Gemcitabine|gemcitabine|mesh-list
138538562|NCT00159445|Capecitabine|capecitabine|mesh-list
138538563|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138538564|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
138538565|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538566|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538567|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
138538568|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138538569|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538571|NCT00159484|Epothilone B|epothilone b|mesh-list
138538572|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138538573|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138538574|NCT00159484|Analgesics|analgesics|mesh-ancestor
138538575|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
138538576|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138538577|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538578|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138538579|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138538580|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138538581|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138538582|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538583|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538584|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538585|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
138538586|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
138538587|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
138538588|NCT00052052|Interferons|interferons|mesh-list
138538589|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
138538590|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538591|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
138538592|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538593|NCT00159679|Pregabalin|pregabalin|mesh-list
138538594|NCT00159679|Analgesics|analgesics|mesh-ancestor
138538595|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
138538596|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138538597|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538598|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
138538599|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138538600|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138538601|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538602|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138538603|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138538604|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138538605|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138538606|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138538608|NCT00159718|Atorvastatin|atorvastatin|mesh-list
138538609|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138538610|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138538611|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
138538612|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538613|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138369571|NCT01399853|Vaccines|vaccines|mesh-list
138369572|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
138369573|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369574|NCT01400009|Vitamin D|vitamin d|mesh-list
138369575|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
138369576|NCT01400009|Vitamins|vitamins|mesh-ancestor
138538614|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138538615|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538616|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138538617|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138538618|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138538619|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138538620|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538621|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
138538622|NCT00159757|Ziprasidone|ziprasidone|mesh-list
138538623|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138538624|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
138538625|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138321128|NCT06113640|Dopamine Agents|dopamine agents|mesh-ancestor
138538626|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538627|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538628|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138168036|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138538629|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138538630|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138538631|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138214872|NCT00612560|Anastrozole|anastrozole|mesh-list
138538632|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138538633|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
138538634|NCT00159835|Atorvastatin|atorvastatin|mesh-list
138538635|NCT00159835|Simvastatin|simvastatin|mesh-list
138538636|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138538637|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138538638|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
138538639|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538640|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138538641|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138538642|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538644|NCT00052169|Gefitinib|gefitinib|mesh-list
138538645|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538646|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
138538647|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
138538648|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
138538649|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538650|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138538651|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538652|NCT00159952|Insulin|insulin|mesh-list
138538653|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138538654|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538655|NCT00052208|Gefitinib|gefitinib|mesh-list
138538656|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538657|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138538658|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538659|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538660|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
138538661|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
138538662|NCT00407017|Ketorolac|ketorolac|mesh-list
138538663|NCT00407017|Nepafenac|nepafenac|mesh-list
138538664|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
138538665|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138538666|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538667|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138538668|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138538669|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538670|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538671|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538672|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538673|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138538674|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138538676|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
138538677|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138538678|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138538679|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138538680|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138538681|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138538682|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138538683|NCT00160030|Cisplatin|cisplatin|mesh-list
138538684|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538685|NCT00160069|Sagopilone|sagopilone|mesh-list
138538686|NCT00160069|Epothilones|epothilones|mesh-list
138538687|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538688|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
138538689|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
138538690|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
138538691|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538692|NCT00052286|Modafinil|modafinil|mesh-list
138538693|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138538694|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538695|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138168049|NCT00574171|Capecitabine|capecitabine|mesh-list
138538696|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138538697|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138538698|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538700|NCT00160186|Pancrelipase|pancrelipase|mesh-list
138538701|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138538702|NCT05567484|Itraconazole|itraconazole|mesh-list
138538703|NCT05567484|Antifungal Agents|antifungal agents|mesh-ancestor
138538704|NCT05567484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538705|NCT05567484|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138538706|NCT05567484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138538707|NCT05567484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538708|NCT05567484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538710|NCT05567484|Hormone Antagonists|hormone antagonists|mesh-ancestor
138538711|NCT05567484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321195|NCT06027723|Cholinergic Agents|cholinergic agents|mesh-ancestor
138321196|NCT06027723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138538712|NCT05567484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538713|NCT05567484|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138538715|NCT00160264|Lactulose|lactulose|mesh-list
138538716|NCT00160264|Calcium|calcium|mesh-list
138538718|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
138538719|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538720|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138538721|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138538722|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138538723|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
138538724|NCT00160342|Estrogens|estrogens|mesh-list
138538725|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
138538727|NCT00160342|Testosterone|testosterone|mesh-list
138538728|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
138538729|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
138538730|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138538731|NCT00160342|Hormones|hormones|mesh-ancestor
138538732|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138538733|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538734|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138538735|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538736|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
138538737|NCT00160342|Androgens|androgens|mesh-ancestor
138538738|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
138538739|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538740|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138538741|NCT00052403|Antibodies|antibodies|mesh-list
138538742|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
138538743|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138538744|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
138538745|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
138538746|NCT00052403|Mitogens|mitogens|mesh-list
138538747|NCT00052403|Immunomodulating Agents|immunomodulating agents|mesh-list
138538748|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538749|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538750|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
138369577|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
138369578|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369579|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138369580|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138369581|NCT01400022|Cortisone|cortisone|mesh-list
138369582|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138369583|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
138369584|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138369585|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138369586|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138369587|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138369588|NCT01400100|Octreotide|octreotide|mesh-list
138369589|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138538751|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538752|NCT00160498|Lercanidipine|lercanidipine|mesh-list
138538753|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138538754|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138538755|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138538756|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538757|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138538758|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538759|NCT00160537|Levocetirizine|levocetirizine|mesh-list
138538760|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138538761|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138538762|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
138538763|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
138538764|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138538765|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538766|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538767|NCT00160576|Levetiracetam|levetiracetam|mesh-list
138538768|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
138538769|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
138538770|NCT00160849|Lopinavir|lopinavir|mesh-list
138538771|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138538772|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138538773|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
138538774|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538775|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538776|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138538777|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138538778|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
138538779|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538780|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138215011|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
138538781|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138538782|NCT00160888|Nitroprusside|nitroprusside|mesh-list
138538783|NCT00160888|Acetylcholine|acetylcholine|mesh-list
138538784|NCT00160888|Bradykinin|bradykinin|mesh-list
138538785|NCT00160888|Kininogens|kininogens|mesh-list
138538786|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138538787|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
138538788|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138538789|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538790|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138538791|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
138538792|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138538793|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538794|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138538795|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
138538796|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538797|NCT00160927|Nitroprusside|nitroprusside|mesh-list
138538798|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138538799|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
138538800|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138538801|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538802|NCT00160966|Cyclosporine|cyclosporine|mesh-list
138538803|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
138538804|NCT00160966|Everolimus|everolimus|mesh-list
138538805|NCT00160966|Tacrolimus|tacrolimus|mesh-list
138538806|NCT00160966|Cyclosporins|cyclosporins|mesh-list
138538807|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138538808|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
138538809|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538810|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138538811|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538812|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538813|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
138538814|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538815|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
138538816|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138538817|NCT00160966|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138538818|NCT00160966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138538819|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538820|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138538821|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138538822|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
138538823|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138538825|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138538826|NCT00052559|Fluorouracil|fluorouracil|mesh-list
138538827|NCT00052559|Antibodies|antibodies|mesh-list
138538828|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
138538829|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138538830|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538831|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138538832|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138538833|NCT00052559|Growth Substances|growth substances|mesh-ancestor
138538834|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538835|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
138538836|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
138538837|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
138538838|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538839|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138538840|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138538841|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138321296|NCT05745350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538842|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138538843|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138538844|NCT00044577|Tenofovir|tenofovir|mesh-list
138538845|NCT00044577|Lamivudine|lamivudine|mesh-list
138538846|NCT00044577|Abacavir|abacavir|mesh-list
138538847|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
138538848|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
138538849|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538850|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138538851|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138538852|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538853|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538854|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138215086|NCT00619190|Aripiprazole|aripiprazole|mesh-list
138538855|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138538856|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
138538857|NCT00161122|Vaccines|vaccines|mesh-list
138538858|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138538859|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
138538860|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538861|NCT00161200|Pantoprazole|pantoprazole|mesh-list
138538862|NCT00161200|Ranitidine|ranitidine|mesh-list
138538863|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138168094|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
138538864|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138538865|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138538866|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138538867|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538868|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538869|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138538870|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
138538871|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
138538872|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138538873|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538874|NCT00161239|Prednisone|prednisone|mesh-list
138538875|NCT00161239|Methotrexate|methotrexate|mesh-list
138538876|NCT00161239|Asparaginase|asparaginase|mesh-list
138538877|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138538878|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
138538879|NCT00161239|Hormones|hormones|mesh-ancestor
138538880|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138538881|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538882|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138538883|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370155|NCT01403740|Rituximab|rituximab|mesh-list
138370156|NCT01403740|Azathioprine|azathioprine|mesh-list
138370157|NCT01403740|Cyclosporins|cyclosporins|mesh-list
138370159|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370160|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
138370161|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370162|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138370163|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370164|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370165|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138370166|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
138370167|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370168|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
138370169|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138538884|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138538885|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
138538886|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138538887|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138538888|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
138538889|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538890|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
138538891|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538892|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138538893|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138538894|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
138538895|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138538896|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138538897|NCT00161278|Paclitaxel|paclitaxel|mesh-list
138538898|NCT00161278|Carboplatin|carboplatin|mesh-list
138538899|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138538900|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538901|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
138538902|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
138538903|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
138538904|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538905|NCT00044616|Fluoxetine|fluoxetine|mesh-list
138538906|NCT00044616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138538907|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138538908|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138538909|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538910|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138538911|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
138538912|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538913|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138538914|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
138538915|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138538916|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138538917|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138538918|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538919|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138538920|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
138321348|NCT05523440|Growth Substances|growth substances|mesh-ancestor
138321349|NCT05523440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321350|NCT05523440|Growth Inhibitors|growth inhibitors|mesh-ancestor
138321355|NCT05482542|Rituximab|rituximab|mesh-list
138538921|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538922|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138538923|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138538924|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
138538925|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138637993|NCT00287352|Amantadine|amantadine|mesh-list
138538926|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538927|NCT00161434|Valacyclovir|valacyclovir|mesh-list
138538928|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
138538929|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138538930|NCT00044694|Exenatide|exenatide|mesh-list
138538931|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138538932|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538933|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138538934|NCT00044694|Incretins|incretins|mesh-ancestor
138538935|NCT00044694|Hormones|hormones|mesh-ancestor
138538936|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138538937|NCT00052754|Gefitinib|gefitinib|mesh-list
138538938|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538939|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138538940|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538941|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538942|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
138538943|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138538944|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538945|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
138538946|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138538947|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538948|NCT00161668|Immunotoxins|immunotoxins|mesh-ancestor
138538949|NCT00161668|Immunoconjugates|immunoconjugates|mesh-ancestor
138538950|NCT00161668|Immunologic Factors|immunologic factors|mesh-ancestor
138538951|NCT00161668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538952|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138538953|NCT00052832|Vitamins|vitamins|mesh-ancestor
138538954|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
138538955|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538956|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138428514|NCT01711528|Dexamethasone|dexamethasone|mesh-list
138538957|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138538958|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
138538959|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138538960|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138538961|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
138321389|NCT05390736|Vitamins|vitamins|mesh-ancestor
138538962|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538963|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538965|NCT00044538|IDN 5109|idn 5109|mesh-list
138538966|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538967|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
138538968|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138538969|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538970|NCT00044733|Immunotoxins|immunotoxins|mesh-ancestor
138538971|NCT00044733|Immunoconjugates|immunoconjugates|mesh-ancestor
138538972|NCT00044733|Immunologic Factors|immunologic factors|mesh-ancestor
138538973|NCT00044733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538974|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
138538975|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538976|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138538977|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138538978|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138538979|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138538980|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
138538981|NCT00161902|Coagulants|coagulants|mesh-ancestor
138538982|NCT00053027|Rituximab|rituximab|mesh-list
138538983|NCT00053027|Cladribine|cladribine|mesh-list
138538984|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138538985|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538986|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
138538987|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138538988|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138538989|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138538990|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138538991|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
138538992|NCT00161980|Coagulants|coagulants|mesh-ancestor
138538993|NCT00162019|Factor VIII|factor viii|mesh-list
138538994|NCT00162019|Coagulants|coagulants|mesh-ancestor
138538995|NCT00162214|Ketoconazole|ketoconazole|mesh-list
138538996|NCT00162214|Dasatinib|dasatinib|mesh-list
138538997|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138538998|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138538999|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539000|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539001|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
138539002|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539003|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138539004|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138539005|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138539006|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
138539007|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321421|NCT05335148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321422|NCT05321420|Pirfenidone|pirfenidone|mesh-list
138539008|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539009|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138539010|NCT04731116|Cannabidiol|cannabidiol|mesh-list
138539011|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
138539012|NCT00407056|Difluprednate|difluprednate|mesh-list
138539013|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
138539014|NCT00407056|Hormones|hormones|mesh-ancestor
138539015|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138539016|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539017|NCT00405457|Cyclosporine|cyclosporine|mesh-list
138539018|NCT00405457|Cyclosporins|cyclosporins|mesh-list
138539019|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539020|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539021|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539022|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
138539023|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539024|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
138539025|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539026|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
138539027|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138539028|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138539029|NCT00053105|Cytarabine|cytarabine|mesh-list
138539030|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
138539031|NCT00053105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138539032|NCT00053105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138539033|NCT00053105|Prednisolone|prednisolone|mesh-list
138539034|NCT00053105|Prednisolone acetate|prednisolone acetate|mesh-list
138539035|NCT00053105|Pixantrone|pixantrone|mesh-list
138539036|NCT00053105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138539037|NCT00053105|Prednisolone phosphate|prednisolone phosphate|mesh-list
138539038|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539039|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539040|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
138539041|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539042|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
138539043|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539044|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539045|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
138168144|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138539046|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539047|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138539048|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
138539049|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
138539050|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138539051|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138539052|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
138539053|NCT00053105|Hormones|hormones|mesh-ancestor
138539054|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138539055|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138539056|NCT00053105|Protective Agents|protective agents|mesh-ancestor
138539057|NCT00053105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138539058|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138539059|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138539060|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539061|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138539062|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138539063|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539064|NCT00162409|Folic Acid|folic acid|mesh-list
138539065|NCT00162409|Hematinics|hematinics|mesh-ancestor
138539066|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
138539067|NCT00162409|Vitamins|vitamins|mesh-ancestor
138539068|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
138539069|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539070|NCT00053144|Cytarabine|cytarabine|mesh-list
138539071|NCT00053144|Irinotecan|irinotecan|mesh-list
138539072|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138539073|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138539074|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539075|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539076|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539077|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539078|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
138539079|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
138539080|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539081|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539082|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
138539083|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539084|NCT00162487|Albuterol|albuterol|mesh-list
138539085|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138539086|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
138539087|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138539088|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539089|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138539090|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
138539091|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
138539092|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138539093|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138539094|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138539095|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138539096|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
138539097|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138539098|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539099|NCT00162526|Tocopherols|tocopherols|mesh-list
138539101|NCT00162526|Tocotrienols|tocotrienols|mesh-list
138539102|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
138539103|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
138168167|NCT00615433|Olanzapine|olanzapine|mesh-list
138539104|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539105|NCT00162526|Protective Agents|protective agents|mesh-ancestor
138539106|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539107|NCT00162526|Vitamins|vitamins|mesh-ancestor
138539108|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
138539109|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138539110|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138539111|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
138539112|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138539113|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539114|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539115|NCT00162604|Cefuroxime|cefuroxime|mesh-list
138539116|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
138539117|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138539118|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539119|NCT00162643|Ritonavir|ritonavir|mesh-list
138539120|NCT00162643|Lopinavir|lopinavir|mesh-list
138539121|NCT00162643|Lamivudine|lamivudine|mesh-list
138539122|NCT00162643|Zidovudine|zidovudine|mesh-list
138539123|NCT00162643|Efavirenz|efavirenz|mesh-list
138539124|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138539125|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138539126|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
138539127|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539128|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539129|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138539130|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138539131|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
138539132|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539133|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138539134|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138539135|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138539136|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138539138|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138539139|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138539140|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138539141|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138539142|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138539143|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138539144|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
138539145|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539146|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138539147|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138539148|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138539149|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138539150|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539151|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138539152|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539153|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138539154|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
138539155|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138539156|NCT00162721|Doxorubicin|doxorubicin|mesh-list
138539157|NCT00162721|Ifosfamide|ifosfamide|mesh-list
138539158|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539159|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138168177|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138321499|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138539160|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138539161|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138539162|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539163|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539164|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138539165|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
138539166|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
138539167|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539168|NCT00162760|Thalidomide|thalidomide|mesh-list
138539169|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539170|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
138342093|NCT01616082|Phentermine|phentermine|mesh-list
138539171|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539172|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
138539173|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138539174|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539175|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138539176|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138539177|NCT00162760|Growth Substances|growth substances|mesh-ancestor
138539178|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
138539179|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539180|NCT00162799|Triflusal|triflusal|mesh-list
138539181|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138539182|NCT00044811|Fexofenadine|fexofenadine|mesh-list
138539183|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138539184|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138539185|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138539186|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
138539187|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
138539188|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138539189|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539190|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539191|NCT00162877|Esomeprazole|esomeprazole|mesh-list
138539192|NCT00162877|Rabeprazole|rabeprazole|mesh-list
138539193|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138539194|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138539195|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138539196|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539197|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539198|NCT00162916|Citalopram|citalopram|mesh-list
138539199|NCT00162916|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138539200|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138539201|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138539202|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539203|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138539204|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
138539205|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539206|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138321527|NCT04865419|Voriconazole|voriconazole|mesh-list
138321541|NCT04827966|Calcium|calcium|mesh-list
138539208|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138539209|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
138539210|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138539211|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539212|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
138539213|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138539214|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539215|NCT00163111|Amphotericin B|amphotericin b|mesh-list
138539216|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138539217|NCT00163111|Fluconazole|fluconazole|mesh-list
138539218|NCT00163111|Amebicides|amebicides|mesh-ancestor
138539219|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138539220|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138539221|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539222|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138539223|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
138539224|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138539225|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138539226|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539227|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539228|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138539229|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
138539230|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138539231|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539232|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138539233|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138539234|NCT00163150|Atorvastatin|atorvastatin|mesh-list
138539235|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138539236|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138539237|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
138539238|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539239|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138539240|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138539241|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539242|NCT00163267|Clopidogrel|clopidogrel|mesh-list
138539243|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138539244|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138539245|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138539246|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138539247|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
138539248|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138539249|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539250|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539251|NCT00163306|Pantoprazole|pantoprazole|mesh-list
138321552|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
138321560|NCT04772300|Sirolimus|sirolimus|mesh-list
138539252|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138428667|NCT01712295|Analgesics|analgesics|mesh-ancestor
138539253|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138539254|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138539255|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539256|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539258|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539259|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
138539260|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539261|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539262|NCT00163345|Ciclesonide|ciclesonide|mesh-list
138539263|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
138539264|NCT00163345|Hormones|hormones|mesh-ancestor
138539265|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138539266|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539267|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138539268|NCT00163384|Ciclesonide|ciclesonide|mesh-list
138539269|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
138539270|NCT00163384|Hormones|hormones|mesh-ancestor
138168213|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
138539271|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138539272|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539273|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138539274|NCT00163423|Ciclesonide|ciclesonide|mesh-list
138539275|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
138539276|NCT00163423|Hormones|hormones|mesh-ancestor
138539277|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138539278|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539279|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138539280|NCT04731038|Paclitaxel|paclitaxel|mesh-list
138539281|NCT04731038|Carboplatin|carboplatin|mesh-list
138539282|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138539283|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539284|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
138539285|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
138539286|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
138539287|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539288|NCT00163462|Ciclesonide|ciclesonide|mesh-list
138539289|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
138539290|NCT00163462|Hormones|hormones|mesh-ancestor
138539291|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138539292|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539293|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138539294|NCT00053300|Thalidomide|thalidomide|mesh-list
138539295|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539296|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
138539297|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539298|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
138539299|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138539300|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539301|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138539302|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138539303|NCT00053300|Growth Substances|growth substances|mesh-ancestor
138539304|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
138539305|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539306|NCT00163501|Ciclesonide|ciclesonide|mesh-list
138539307|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
138370170|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
138370179|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138370180|NCT01403844|Carotenoids|carotenoids|mesh-list
138370181|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
138539309|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138539310|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539311|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138539312|NCT00163540|Formaldehyde|formaldehyde|mesh-list
138539313|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
138539314|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539315|NCT00053339|Tamoxifen|tamoxifen|mesh-list
138539316|NCT00053339|Trastuzumab|trastuzumab|mesh-list
138539317|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138539318|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539319|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138539320|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
138539321|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138539322|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539323|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138539324|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138539325|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138539326|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138539327|NCT00163618|Formaldehyde|formaldehyde|mesh-list
138539328|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
138539329|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539330|NCT00053378|Calcium|calcium|mesh-list
138539331|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138539332|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539333|NCT02970383|Narcotics|narcotics|mesh-list
138539334|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138539335|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539336|NCT02970383|Analgesics|analgesics|mesh-ancestor
138539337|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
138539338|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138539339|NCT00163969|Ketamine|ketamine|mesh-list
138539340|NCT00163969|Analgesics|analgesics|mesh-ancestor
138539341|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
138321613|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138539342|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138539343|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539344|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138539345|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138539346|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
138539347|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
138539348|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138539349|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138539351|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138539352|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539353|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
138539354|NCT00164008|Pamidronate|pamidronate|mesh-list
138539355|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138428705|NCT01712477|Propofol|propofol|mesh-list
138539356|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539357|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
138539358|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138539359|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
138539360|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
138539361|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138539362|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539363|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138539364|NCT00164047|Analgesics|analgesics|mesh-ancestor
138539365|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
138539366|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138539367|NCT00164086|Atorvastatin|atorvastatin|mesh-list
138539368|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138539369|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138539370|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
138539371|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539372|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138539373|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138539374|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539375|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138539376|NCT00164125|Laxatives|laxatives|mesh-ancestor
138539377|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138539378|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138539379|NCT00164164|Laxatives|laxatives|mesh-ancestor
138539380|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138539381|NCT00164242|Galantamine|galantamine|mesh-list
138539382|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138539383|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539384|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539385|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
138539386|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138539387|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539388|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138539389|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
138539390|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138539391|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
138539392|NCT00162955|Valsartan|valsartan|mesh-list
138539393|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138321640|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138321641|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539394|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138539395|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138539396|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539397|NCT00164281|Isoniazid|isoniazid|mesh-list
138539398|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
138539399|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138539400|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539401|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138539402|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138539403|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
138539404|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539405|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138539407|NCT00044928|Piperacillin|piperacillin|mesh-list
138539408|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138539409|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138342347|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539410|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539411|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138539412|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539413|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539414|NCT00164359|Artesunate|artesunate|mesh-list
138539415|NCT00164359|Amodiaquine|amodiaquine|mesh-list
138539416|NCT00164359|Dapsone|dapsone|mesh-list
138539417|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
138539418|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
138539419|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138539420|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138539421|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539422|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539423|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
138539424|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
138539425|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138539426|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
138539427|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138539428|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539429|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539430|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
138539431|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138539432|NCT00053612|Vitamin A|vitamin a|mesh-list
138539433|NCT00053612|Vitamins|vitamins|mesh-ancestor
138539434|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
138539435|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539436|NCT00045006|Vorinostat|vorinostat|mesh-list
138539437|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539438|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138539439|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539440|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539441|NCT00164710|Artesunate|artesunate|mesh-list
138539442|NCT00164710|Lumefantrine|lumefantrine|mesh-list
138321669|NCT04500275|Vancomycin|vancomycin|mesh-list
138539443|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
138539445|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
138539446|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138539447|NCT00164710|Amodiaquine|amodiaquine|mesh-list
138539448|NCT00164710|Dapsone|dapsone|mesh-list
138168263|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138539449|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
138539450|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
138539451|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138539452|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138539453|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539454|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539455|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
138539456|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
138539457|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138539458|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
138539459|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138539460|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539461|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539462|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138539463|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
138539464|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138342413|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138539465|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138539466|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138539467|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539469|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138539470|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138539471|NCT00164749|Analgesics|analgesics|mesh-ancestor
138539472|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
138539473|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138539474|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539475|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138539476|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138539477|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539478|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539479|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539480|NCT00164788|Esomeprazole|esomeprazole|mesh-list
138539481|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138539482|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138539483|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138539484|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539485|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539486|NCT00053768|Prednisone|prednisone|mesh-list
138539487|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
138539488|NCT00053768|Doxorubicin|doxorubicin|mesh-list
138539489|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138539490|NCT00053768|Etoposide|etoposide|mesh-list
138539491|NCT00053768|Vincristine|vincristine|mesh-list
138539492|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539493|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
138539494|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539495|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138539496|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138539497|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
138321691|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321693|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539498|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539499|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539500|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138539501|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138539502|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138539503|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138539504|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539505|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138539506|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
138539507|NCT00053768|Hormones|hormones|mesh-ancestor
138539508|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138539509|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138539510|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138539511|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
138539512|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
138539513|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
138539514|NCT00045123|Tarenflurbil|tarenflurbil|mesh-list
138539515|NCT00045123|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138168282|NCT00575965|Simvastatin|simvastatin|mesh-list
138539516|NCT00045123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539517|NCT00045123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539518|NCT00164866|Omeprazole|omeprazole|mesh-list
138539519|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138539520|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138539521|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138539522|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138342467|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
138342468|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138539523|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539524|NCT00407212|Maleic acid|maleic acid|mesh-list
138539525|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539526|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539527|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
138539528|NCT00165139|Melphalan|melphalan|mesh-list
138539529|NCT00165139|Ifosfamide|ifosfamide|mesh-list
138539530|NCT00165139|Carboplatin|carboplatin|mesh-list
138539531|NCT00165139|Etoposide|etoposide|mesh-list
138539532|NCT00165139|Vincristine|vincristine|mesh-list
138215763|NCT00593450|Bevacizumab|bevacizumab|mesh-list
138539533|NCT00165139|Doxorubicin|doxorubicin|mesh-list
138539534|NCT00165139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138539536|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539537|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
138539538|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539539|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138539540|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138539541|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
138539542|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539543|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539544|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138539545|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138539546|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138539547|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138539548|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539549|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
138539550|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
138539551|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
138539552|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138539553|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138539554|NCT00053807|Interferons|interferons|mesh-list
138539555|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
138539556|NCT00053807|Aldesleukin|aldesleukin|mesh-list
138539557|NCT00053807|Fluorouracil|fluorouracil|mesh-list
138539558|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
138539559|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539560|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539561|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539562|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539563|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
138539564|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539565|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
138539566|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539567|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138539568|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138539569|NCT00165178|Leucovorin|leucovorin|mesh-list
138539570|NCT00165178|Cytarabine|cytarabine|mesh-list
138539571|NCT00165178|Dexamethasone|dexamethasone|mesh-list
138539573|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
138539574|NCT00165178|Doxorubicin|doxorubicin|mesh-list
138539575|NCT00165178|Methotrexate|methotrexate|mesh-list
138539576|NCT00165178|Vincristine|vincristine|mesh-list
138539577|NCT00165178|Asparaginase|asparaginase|mesh-list
138539578|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
138539579|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138539580|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
138539581|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
138428856|NCT01713179|Ambroxol|ambroxol|mesh-list
138539582|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138539583|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539584|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138539585|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
138539587|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138539588|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138539589|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539590|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138539591|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138539592|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138539593|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539594|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539595|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138539596|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
138539597|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138539598|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539599|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
138539600|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
138539601|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138539602|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539603|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
138539604|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138539605|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138539606|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
138539607|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539608|NCT00165178|Antidotes|antidotes|mesh-ancestor
138539609|NCT00165178|Protective Agents|protective agents|mesh-ancestor
138539610|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
138539611|NCT00165178|Vitamins|vitamins|mesh-ancestor
138539612|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
138539613|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138539614|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
138539615|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
138539616|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
138539617|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138539618|NCT00165217|Thalidomide|thalidomide|mesh-list
138539619|NCT00165217|Capecitabine|capecitabine|mesh-list
138539620|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539621|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
138321788|NCT04068597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539622|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539623|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539624|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539625|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
138539626|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539627|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
138539628|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138539629|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539630|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138539631|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138539632|NCT00165217|Growth Substances|growth substances|mesh-ancestor
138539633|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
138539634|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
138539635|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539636|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
138539637|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138539638|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138539639|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539640|NCT00165295|Urological Agents|urological agents|mesh-ancestor
138539642|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138342604|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138342605|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138342606|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
138342607|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138342608|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138342609|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138539643|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539644|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539645|NCT00165334|Cetuximab|cetuximab|mesh-list
138539646|NCT00165334|Vinorelbine|vinorelbine|mesh-list
138539647|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138539648|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539649|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138539650|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
138539651|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
138539652|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
138539653|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539654|NCT00165373|Endostatins|endostatins|mesh-list
138539655|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539656|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138539657|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138539658|NCT00165373|Growth Substances|growth substances|mesh-ancestor
138539659|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539660|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
138539661|NCT00165451|Thalidomide|thalidomide|mesh-list
138539662|NCT00165451|Celecoxib|celecoxib|mesh-list
138539663|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
138539665|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539666|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
138539667|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539668|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138539669|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138539670|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
138539671|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539672|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539673|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138539674|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138539675|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138539676|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138539677|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539678|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138539679|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138539680|NCT00165451|Analgesics|analgesics|mesh-ancestor
138539681|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
138428912|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
138539682|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138539683|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138539684|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138539685|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138539686|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
138539687|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138539688|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539689|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138539690|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138539691|NCT00165451|Growth Substances|growth substances|mesh-ancestor
138539692|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
138539693|NCT00165490|Irinotecan|irinotecan|mesh-list
138539694|NCT00165490|Cetuximab|cetuximab|mesh-list
138539695|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539696|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138539697|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138539698|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539699|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539700|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138539702|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138539703|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539704|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138539705|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138539706|NCT00165568|Growth Substances|growth substances|mesh-ancestor
138539707|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539708|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
138539709|NCT00165685|Sibutramine|sibutramine|mesh-list
138539710|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
138539711|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138539712|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
138539713|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138539714|NCT00045279|Interferons|interferons|mesh-list
138539715|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
138539716|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
138539717|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138539718|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539720|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539721|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
138539722|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539723|NCT00053963|Romidepsin|romidepsin|mesh-list
138539724|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138539725|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539726|NCT00053963|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138539727|NCT00053963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539728|NCT00053963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539730|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138539731|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539732|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539733|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
138539734|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138539735|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539736|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
138539737|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
138539738|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539739|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138539740|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539741|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539743|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138539744|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138539745|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539746|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539747|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539748|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138539749|NCT00054002|Trioxsalen|trioxsalen|mesh-list
138539750|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539751|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
138539752|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138539753|NCT00054041|Vaccines|vaccines|mesh-list
138539754|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
138539755|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539756|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
138539757|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138539758|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539759|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138539760|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
138539761|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138539762|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539763|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168331|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539764|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539766|NCT00054197|Vinorelbine|vinorelbine|mesh-list
138539767|NCT00054197|Gemcitabine|gemcitabine|mesh-list
138539768|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138539769|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138539770|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539771|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
138539772|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
138539773|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
138539774|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539775|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539776|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
138539778|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539779|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
138539780|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539781|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138539782|NCT00166426|Protective Agents|protective agents|mesh-ancestor
138539783|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539784|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138539785|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539786|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539787|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138539788|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138539789|NCT00166426|Analgesics|analgesics|mesh-ancestor
138539790|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
138539791|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138539792|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138539793|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138539794|NCT00166465|Leucovorin|leucovorin|mesh-list
138539795|NCT00166465|Fluorouracil|fluorouracil|mesh-list
138539796|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
138539797|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
138539798|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539799|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539800|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539801|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539802|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
138539803|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539804|NCT00166465|Antidotes|antidotes|mesh-ancestor
138539805|NCT00166465|Protective Agents|protective agents|mesh-ancestor
138539806|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
138539807|NCT00166465|Vitamins|vitamins|mesh-ancestor
138321905|NCT03756298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138539809|NCT00166621|Buspirone|buspirone|mesh-list
138539810|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138539811|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138539812|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138539813|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539814|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138539815|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138539816|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
138539817|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138539818|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539819|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
138539820|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
138539821|NCT00054236|Fludarabine|fludarabine|mesh-list
138539822|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
138539823|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138539824|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539825|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
138539826|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539827|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138539828|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138539829|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
138539830|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539831|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539832|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138539833|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539834|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
138539835|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138539836|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
138539837|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
138539838|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138539839|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138539840|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
138539841|NCT00054236|Hormones|hormones|mesh-ancestor
138539842|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138539843|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138539844|NCT00054236|Protective Agents|protective agents|mesh-ancestor
138539845|NCT00054392|Paclitaxel|paclitaxel|mesh-list
138539846|NCT00054392|Carboplatin|carboplatin|mesh-list
138539847|NCT00054392|Gemcitabine|gemcitabine|mesh-list
138539848|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138539849|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539850|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
138539851|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
138539852|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
138539853|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539854|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539855|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
138539856|NCT00166816|Cyclosporine|cyclosporine|mesh-list
138539857|NCT00166816|Sirolimus|sirolimus|mesh-list
138539858|NCT00166816|Tacrolimus|tacrolimus|mesh-list
138539859|NCT00166816|Cyclosporins|cyclosporins|mesh-list
138321939|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321940|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138539860|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539861|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
138168365|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
138539862|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539863|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138539864|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539865|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539866|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
138539867|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539868|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
138539869|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138539870|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138539871|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138539872|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539874|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138539875|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138539876|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539877|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
138539878|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
138539879|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
138539880|NCT00054431|Decitabine|decitabine|mesh-list
138539881|NCT00054431|Azacitidine|azacitidine|mesh-list
138539882|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539883|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138539884|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539885|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539886|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539887|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
138539888|NCT00054470|Trastuzumab|trastuzumab|mesh-list
138539889|NCT00054470|Tipifarnib|tipifarnib|mesh-list
138539890|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138539891|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539892|NCT00054548|Paclitaxel|paclitaxel|mesh-list
138539893|NCT00054548|Oblimersen|oblimersen|mesh-list
138539894|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138539895|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539896|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
138539897|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
138539898|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
138539899|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539900|NCT00045513|Fludarabine|fludarabine|mesh-list
138539901|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
138539902|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138539903|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539904|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539905|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
138539906|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539907|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539908|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
138539909|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539910|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138539911|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539912|NCT00167401|Docetaxel|docetaxel|mesh-list
138539913|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539914|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
138539915|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
138539916|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
138539917|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539918|NCT00167479|Risperidone|risperidone|mesh-list
138539919|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138539920|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
138539921|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138539922|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539923|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539924|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138539925|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138539926|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138539927|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138539928|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138539929|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
138539930|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
138539932|NCT00054587|Fluorouracil|fluorouracil|mesh-list
138539933|NCT00054587|Trastuzumab|trastuzumab|mesh-list
138539934|NCT00054587|Epirubicin|epirubicin|mesh-list
138539935|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138539936|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
138539937|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539938|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138539939|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138539940|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
138539941|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539942|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539943|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138539944|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
138539945|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
138539946|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
138539947|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
138539948|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539949|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138539950|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138539951|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138539952|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138539953|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539954|NCT00167518|Triamcinolone|triamcinolone|mesh-list
138539955|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138539956|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
138539957|NCT00167518|Hormones|hormones|mesh-ancestor
138539958|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138539959|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539960|NCT00167557|Interferons|interferons|mesh-list
138539961|NCT00167557|Ribavirin|ribavirin|mesh-list
138539962|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539963|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
138539964|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539965|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
138539966|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539967|NCT00167674|Zidovudine|zidovudine|mesh-list
138539968|NCT00167674|Nevirapine|nevirapine|mesh-list
138539969|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
138539970|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539971|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138539972|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138539973|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539974|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
138539975|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138539976|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138539977|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138539978|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138539979|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138539980|NCT00054626|Gemcitabine|gemcitabine|mesh-list
138539981|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138539982|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138539983|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
138539984|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539985|NCT00167713|Ibuprofen|ibuprofen|mesh-list
138539986|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138539987|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138539988|NCT00167713|Analgesics|analgesics|mesh-ancestor
138539989|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
138539990|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138539991|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138539992|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138539993|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138168401|NCT05702762|Gentamicins|gentamicins|mesh-list
138539994|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138539995|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138539996|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138539997|NCT00167791|Rituximab|rituximab|mesh-list
138539998|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138539999|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540000|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
138540001|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540002|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540003|NCT00045591|Celecoxib|celecoxib|mesh-list
138540004|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138540005|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138540006|NCT00045591|Analgesics|analgesics|mesh-ancestor
138540007|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
138540008|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540009|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540010|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138540011|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540012|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138540013|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138540014|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540015|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540016|NCT00167908|Amifostine|amifostine|mesh-list
138540017|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138540018|NCT00167908|Protective Agents|protective agents|mesh-ancestor
138540019|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540020|NCT00167947|Cyclosporine|cyclosporine|mesh-list
138540021|NCT00167947|Sirolimus|sirolimus|mesh-list
138540022|NCT00167947|Cyclosporins|cyclosporins|mesh-list
138540023|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540024|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540025|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138540026|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
138540027|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540028|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
138540029|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322074|NCT03275285|Dexamethasone|dexamethasone|mesh-list
138540030|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
138540031|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540032|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138540033|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138540034|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138540035|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540037|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138540038|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138540039|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
138540040|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138540041|NCT00168025|Antibodies|antibodies|mesh-list
138540042|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
138540043|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540044|NCT00168181|Pilocarpine|pilocarpine|mesh-list
138540045|NCT00168181|Miotics|miotics|mesh-ancestor
138540046|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
138540047|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540048|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540049|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138540050|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138540051|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
138540052|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540053|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540055|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540056|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
138540057|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
138540058|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
138540059|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540060|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
138540061|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540062|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138540063|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540064|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540065|NCT00407290|Neostigmine|neostigmine|mesh-list
138216284|NCT01288859|Analgesics|analgesics|mesh-ancestor
138540066|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138540067|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540068|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540069|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
138540070|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540071|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540072|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138540073|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
138540074|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540076|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138540077|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540078|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
138540079|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
138540080|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138540081|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138540082|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540083|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540084|NCT00407446|Urological Agents|urological agents|mesh-ancestor
138540085|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
138540086|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138540087|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138540088|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138540089|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138540090|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540091|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
138540092|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540093|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540094|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138540095|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540096|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
138540097|NCT00168493|Serotonin|serotonin|mesh-list
138540098|NCT00168493|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138540099|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138540100|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138540101|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
138540102|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540103|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540104|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540105|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138540106|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138540107|NCT00168532|Trimethoprim|trimethoprim|mesh-list
138322126|NCT02957968|Paclitaxel|paclitaxel|mesh-list
138540108|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138168439|NCT03589040|Darunavir|darunavir|mesh-list
138540109|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
138540110|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138540111|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138540112|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
138540113|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138540114|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138540115|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138540116|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540117|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540118|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138540119|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138540120|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138540121|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138540122|NCT00168610|Vitamin A|vitamin a|mesh-list
138540123|NCT00168610|Vitamins|vitamins|mesh-ancestor
138540124|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
138540125|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540126|NCT04731948|Vitamins|vitamins|mesh-list
138540127|NCT04731948|Folic Acid|folic acid|mesh-list
138540128|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
138540129|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
138540130|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
138540131|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
138540132|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540133|NCT04731948|Hematinics|hematinics|mesh-ancestor
138540135|NCT00168649|Vitamins|vitamins|mesh-ancestor
138540136|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
138540137|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540138|NCT00168688|Micronutrients|micronutrients|mesh-list
138540139|NCT00168688|Trace Elements|trace elements|mesh-list
138540140|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138343083|NCT01794702|Cytarabine|cytarabine|mesh-list
138540141|NCT00168766|Interferons|interferons|mesh-list
138540142|NCT00168766|Interferon-beta|interferon-beta|mesh-list
138540143|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
138540144|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
138540145|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540146|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
138540147|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138540148|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138540149|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
138540150|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
138540151|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540152|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540153|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138540154|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
138540155|NCT00168766|Hormones|hormones|mesh-ancestor
138540156|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138540157|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138540158|NCT00168766|Protective Agents|protective agents|mesh-ancestor
138540159|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
138540160|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138540161|NCT00168883|Paclitaxel|paclitaxel|mesh-list
138540162|NCT00168883|Vinorelbine|vinorelbine|mesh-list
138540163|NCT00168883|Carboplatin|carboplatin|mesh-list
138540164|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138540165|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540166|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
138540167|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
138540168|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
138540169|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540171|NCT04731909|Carboplatin|carboplatin|mesh-list
138540172|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540173|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138540174|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138540175|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
138540176|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540177|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540178|NCT00054938|Aspirin|aspirin|mesh-list
138540179|NCT00054938|Ramipril|ramipril|mesh-list
138540180|NCT00054938|Pravastatin|pravastatin|mesh-list
138540181|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540182|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138540183|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138540184|NCT00054938|Analgesics|analgesics|mesh-ancestor
138540185|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
138540186|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540187|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138540188|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540189|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138540190|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138540191|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540192|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138540193|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138540194|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540195|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
138540196|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138540197|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
138540198|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138540199|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138540200|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138540201|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
138540202|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138540203|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138540204|NCT00169000|Docetaxel|docetaxel|mesh-list
138540205|NCT00169000|Capecitabine|capecitabine|mesh-list
138540206|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540207|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
138540208|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
138540209|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
138540210|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138322188|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540211|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138540212|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
138540213|NCT00045747|Fluorouracil|fluorouracil|mesh-list
138540214|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138540215|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
138540216|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540217|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138540218|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540219|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138540220|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
138540221|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540222|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138540223|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540224|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
138540225|NCT00169039|Clozapine|clozapine|mesh-list
138540226|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138540227|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
138540228|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540229|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540230|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540231|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138540232|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138540233|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138540234|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138540235|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
138540236|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
138540237|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
138540238|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
138540239|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540240|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138540241|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138540242|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
138540243|NCT00169078|Chloroquine|chloroquine|mesh-list
138540244|NCT00169078|Amebicides|amebicides|mesh-ancestor
138540245|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138540246|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138540247|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138540248|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
138540249|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540250|NCT00054977|Fluorouracil|fluorouracil|mesh-list
138540251|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
138540252|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540253|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138540254|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540255|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138540256|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
138540257|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540258|NCT00169156|Prednisone|prednisone|mesh-list
138540259|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
138540260|NCT00169156|Rituximab|rituximab|mesh-list
138540261|NCT00169156|Doxorubicin|doxorubicin|mesh-list
138540262|NCT00169156|Vincristine|vincristine|mesh-list
138540263|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138540264|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
138540265|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540266|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540267|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138540268|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
138540269|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540270|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540271|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138540272|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138540273|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138540274|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138540275|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138540276|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429139|NCT01714570|Tazobactam|tazobactam|mesh-list
138540277|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138540278|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
138540279|NCT00169156|Hormones|hormones|mesh-ancestor
138540280|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138540281|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138540282|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138540283|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
138540284|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
138540285|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
138540286|NCT00169195|Rituximab|rituximab|mesh-list
138540287|NCT00169195|Gemcitabine|gemcitabine|mesh-list
138540288|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
138540289|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138540290|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540291|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
138540292|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540293|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138216504|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138540294|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138540295|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
138540296|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540297|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138540298|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
138540299|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540300|NCT00169468|Rituximab|rituximab|mesh-list
138540301|NCT00169468|Bortezomib|bortezomib|mesh-list
138540302|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138540303|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540304|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
138637994|NCT00287352|Olanzapine|olanzapine|mesh-list
138540305|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138322254|NCT01678027|Clarithromycin|clarithromycin|mesh-list
138540307|NCT00169546|Fluticasone|fluticasone|mesh-list
138540309|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138540310|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138540311|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138540312|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
138540313|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540314|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540315|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138540316|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
138540317|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
138540318|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138540319|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138540320|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138540321|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138540322|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
138540323|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540324|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540325|NCT00398372|Rituximab|rituximab|mesh-list
138540326|NCT00398372|Epratuzumab|epratuzumab|mesh-list
138540327|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138540328|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540329|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
138540330|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540331|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540332|NCT00169585|Levofloxacin|levofloxacin|mesh-list
138540333|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138540334|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138540335|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138540336|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138540337|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138540338|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540339|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540340|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540341|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138540342|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138540344|NCT00169624|Gliclazide|gliclazide|mesh-list
138540345|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138540346|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540347|NCT00407641|Heparin|heparin|mesh-list
138540348|NCT00407641|Tinzaparin|tinzaparin|mesh-list
138540349|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138540350|NCT00407641|Dalteparin|dalteparin|mesh-list
138540351|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
138540352|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138540353|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138540354|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540355|NCT00407680|Valsartan|valsartan|mesh-list
138540356|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138540357|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138540358|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138540359|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540360|NCT00169819|Abciximab|abciximab|mesh-list
138540361|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
138540362|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138540363|NCT00055133|Paclitaxel|paclitaxel|mesh-list
138540364|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138540365|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540366|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
138540367|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
138540368|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
138540369|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540370|NCT00170053|Sirolimus|sirolimus|mesh-list
138540371|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138540372|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138168538|NCT03580070|Immunologic Factors|immunologic factors|mesh-ancestor
138540373|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138540374|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540375|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
138230660|NCT01191320|Enclomiphene|enclomiphene|mesh-list
138540376|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138540377|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
138540378|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540379|NCT00055250|Gemcitabine|gemcitabine|mesh-list
138540380|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138540381|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
138540382|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540383|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540384|NCT00170209|Rifampin|rifampin|mesh-list
138540385|NCT00170209|Isoniazid|isoniazid|mesh-list
138540386|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138540387|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
138540388|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138540389|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138540390|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
138540391|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138540392|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540393|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540394|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138540395|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138540396|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138540397|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138322297|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138540398|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138540399|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138540400|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138540401|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138540402|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
138540403|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138540404|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
138540405|NCT02964091|Ledipasvir|ledipasvir|mesh-list
138540406|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
138540407|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138540408|NCT00170404|Vitamins|vitamins|mesh-list
138540409|NCT00170404|Folic Acid|folic acid|mesh-list
138540410|NCT00170404|Vitamin A|vitamin a|mesh-list
138540411|NCT00170404|Thiamine|thiamine|mesh-list
138540412|NCT00170404|Selenium|selenium|mesh-list
138540413|NCT00170404|Micronutrients|micronutrients|mesh-list
138540414|NCT00170404|Trace Elements|trace elements|mesh-list
138540415|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540416|NCT00170404|Hematinics|hematinics|mesh-ancestor
138540417|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
138540418|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
138343375|NCT05962502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540419|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540420|NCT00170404|Protective Agents|protective agents|mesh-ancestor
138540421|NCT00055367|Natalizumab|natalizumab|mesh-list
138540422|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
138540423|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540424|NCT00170677|Topotecan|topotecan|mesh-list
138540425|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138540426|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138540427|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540428|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540429|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540430|NCT00170755|Darifenacin|darifenacin|mesh-list
138540431|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138168563|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540432|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138540433|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
138540434|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540435|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540436|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540437|NCT00170755|Urological Agents|urological agents|mesh-ancestor
138540439|NCT00170794|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138540440|NCT00170794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138540441|NCT00170794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540442|NCT00170794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540443|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138540444|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
138540445|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540446|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540447|NCT00170833|Everolimus|everolimus|mesh-list
138540448|NCT00170833|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138540449|NCT00170833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138540450|NCT00170833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540451|NCT00170833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540452|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138540453|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
138540454|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540455|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540456|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
138540457|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138540458|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138540459|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540460|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540461|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138540462|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138540463|NCT00170872|Analgesics|analgesics|mesh-ancestor
138540464|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
138540465|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540466|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540467|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138540468|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540470|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138540471|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138540472|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138540473|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138540474|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540475|NCT00170989|Diuretics|diuretics|mesh-ancestor
138540476|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
138540477|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540478|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138540479|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138540480|NCT00171028|Valsartan|valsartan|mesh-list
138540481|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138343437|NCT05833529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540482|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138540483|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138540484|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540486|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
138540487|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138540488|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138540489|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540490|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138540491|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540492|NCT00171067|Valsartan|valsartan|mesh-list
138540493|NCT00171067|Lisinopril|lisinopril|mesh-list
138540494|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138540495|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138540496|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138540497|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540498|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138540499|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
138540500|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540501|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138540502|NCT00171067|Protective Agents|protective agents|mesh-ancestor
138540503|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540504|NCT00171106|Valsartan|valsartan|mesh-list
138540505|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138540506|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138540507|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138540508|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540509|NCT00171145|Darifenacin|darifenacin|mesh-list
138540510|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138540511|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138540512|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
138540513|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540514|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540515|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540516|NCT00171145|Urological Agents|urological agents|mesh-ancestor
138540517|NCT00171184|Darifenacin|darifenacin|mesh-list
138540518|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138540519|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138540520|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
138540521|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138322397|NCT03564756|Vitamins|vitamins|mesh-ancestor
138540522|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540523|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540524|NCT00171184|Urological Agents|urological agents|mesh-ancestor
138540526|NCT00055523|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138540527|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138540528|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540529|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
138540530|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138540531|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540532|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138540533|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
138540534|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138540535|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138540536|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540537|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540538|NCT00171418|Tegaserod|tegaserod|mesh-list
138540539|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138540540|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
138540541|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540542|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540543|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540544|NCT00171457|Tegaserod|tegaserod|mesh-list
138540545|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138540546|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
138540547|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540548|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343510|NCT05677490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370272|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
138370273|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370274|NCT01404312|Pyridoxine|pyridoxine|mesh-list
138370275|NCT01404312|Pyridoxal|pyridoxal|mesh-list
138540549|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540550|NCT00055562|Lenalidomide|lenalidomide|mesh-list
138540551|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
138540552|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540553|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138540554|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138540555|NCT00055562|Growth Substances|growth substances|mesh-ancestor
138540556|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
138540557|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540558|NCT00171496|Cyclosporine|cyclosporine|mesh-list
138540559|NCT00171496|Tacrolimus|tacrolimus|mesh-list
138540560|NCT00171496|Cyclosporins|cyclosporins|mesh-list
138540561|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138540562|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
138540563|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540564|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138540565|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540566|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540567|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
138540568|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138322440|NCT03524508|Fluorouracil|fluorouracil|mesh-list
138540569|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
138540570|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540571|NCT00171535|Amlodipine|amlodipine|mesh-list
138540572|NCT00171535|Valsartan|valsartan|mesh-list
138540573|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138540574|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138540575|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138540576|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540577|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138540578|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540579|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
138540580|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138540581|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138540582|NCT00171574|Valsartan|valsartan|mesh-list
138540583|NCT00171574|Lisinopril|lisinopril|mesh-list
138540584|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138540585|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138540586|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138540587|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540588|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138540589|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
138540590|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540591|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138540592|NCT00171574|Protective Agents|protective agents|mesh-ancestor
138540593|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540594|NCT00171613|Octreotide|octreotide|mesh-list
138540595|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138540596|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138429269|NCT01715363|Leucovorin|leucovorin|mesh-list
138540597|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540598|NCT04920981|Atezolizumab|atezolizumab|mesh-list
138540599|NCT04920981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138540600|NCT04920981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540601|NCT04920981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138540602|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540603|NCT00055640|Prednisone|prednisone|mesh-list
138540604|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
138343579|NCT05528848|Carfentanil|carfentanil|mesh-list
138540605|NCT00055640|Rituximab|rituximab|mesh-list
138343580|NCT05528848|Naloxone|naloxone|mesh-list
138343594|NCT05525065|Hormones|hormones|mesh-ancestor
138540606|NCT00055640|Doxorubicin|doxorubicin|mesh-list
138540607|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138540608|NCT00055640|Vincristine|vincristine|mesh-list
138540609|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138540610|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
138540611|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540612|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540613|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138540614|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
138540615|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540616|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540617|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138540618|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138540619|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138540620|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138540621|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138540622|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540623|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138540624|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
138540625|NCT00055640|Hormones|hormones|mesh-ancestor
138540626|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138540627|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138540628|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138540629|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
138540630|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
138540631|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
138540632|NCT00171652|Diclofenac|diclofenac|mesh-list
138540633|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138540634|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138540635|NCT00171652|Analgesics|analgesics|mesh-ancestor
138540636|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
138540637|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540638|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540639|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138540640|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540641|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138540642|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540643|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540644|NCT00171691|Diclofenac|diclofenac|mesh-list
138540645|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138540646|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138168633|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
138540647|NCT00171691|Analgesics|analgesics|mesh-ancestor
138540648|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
138540649|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540650|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540651|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138540652|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540653|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138540654|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540655|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540656|NCT00171769|Certoparin|certoparin|mesh-list
138540657|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
138540658|NCT00171808|Letrozole|letrozole|mesh-list
138540659|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540660|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138540661|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138540662|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322490|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
138637995|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
138540663|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540664|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138540665|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
138540666|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138540667|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540668|NCT00171847|Trastuzumab|trastuzumab|mesh-list
138540669|NCT00171847|Letrozole|letrozole|mesh-list
138540670|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138540671|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540672|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138540673|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138540674|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540675|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540676|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138540677|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
138540678|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138540679|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540680|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
138540681|NCT00055679|Fluorouracil|fluorouracil|mesh-list
138540682|NCT00055679|Epirubicin|epirubicin|mesh-list
138540683|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138540684|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
138540685|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540686|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540687|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138540688|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
138540689|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540690|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540691|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138540692|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
138540693|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138540694|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138540695|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138540696|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138540697|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540698|NCT00171886|Octreotide|octreotide|mesh-list
138540699|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138540700|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138540701|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540702|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
138540703|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138540704|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540705|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
138540706|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138540707|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540708|NCT00055718|Silymarin|silymarin|mesh-list
138540709|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
138540710|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540711|NCT00055718|Protective Agents|protective agents|mesh-ancestor
138540712|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540713|NCT00055757|Gemcitabine|gemcitabine|mesh-list
138540714|NCT00055757|Tipifarnib|tipifarnib|mesh-list
138540715|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540716|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138540717|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
138540718|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540719|NCT00399867|Simvastatin|simvastatin|mesh-list
138540720|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138429308|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
138540721|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138540722|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
138540723|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540724|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138540725|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138540726|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540728|NCT00055835|Carboplatin|carboplatin|mesh-list
138540729|NCT00055835|Gemcitabine|gemcitabine|mesh-list
138540730|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138540731|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540732|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
138230672|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
138343708|NCT05175430|Paroxetine|paroxetine|mesh-list
138343709|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
138343714|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540733|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
138540734|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
138540735|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540736|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138540737|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
138540738|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
138540739|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138540740|NCT00055874|Interferons|interferons|mesh-list
138540741|NCT00055874|Cytarabine|cytarabine|mesh-list
138540742|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
138540743|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
138540744|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
138540745|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540746|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
138540747|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138540748|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138540749|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
138168664|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540750|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540751|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138540752|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
138540753|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540754|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138540755|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540756|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
138540757|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138540758|NCT00407719|Bevacizumab|bevacizumab|mesh-list
138540759|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138540760|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540761|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138540762|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138540763|NCT00407719|Growth Substances|growth substances|mesh-ancestor
138540764|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540765|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
138540766|NCT00055913|Bevacizumab|bevacizumab|mesh-list
138322531|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
138322539|NCT00087594|Ribavirin|ribavirin|mesh-list
138540767|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138540768|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138540769|NCT00055913|Antibodies|antibodies|mesh-list
138540770|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
138540771|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138540772|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540773|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138540774|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138540775|NCT00055913|Growth Substances|growth substances|mesh-ancestor
138540776|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540777|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
138540778|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
138540779|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138540780|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540781|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540782|NCT00045864|Aldesleukin|aldesleukin|mesh-list
138540783|NCT00045864|Rituximab|rituximab|mesh-list
138540784|NCT00045864|Interleukin-2|interleukin-2|mesh-list
138540785|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138343773|NCT04978298|Ozanimod|ozanimod|mesh-list
138540786|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540787|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
138540788|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168692|NCT03581630|Naltrexone|naltrexone|mesh-list
138540789|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540790|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138540791|NCT00045864|Analgesics|analgesics|mesh-ancestor
138540792|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
138540793|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540794|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138540795|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138540796|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
138540797|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138540798|NCT00055952|Exatecan|exatecan|mesh-list
138540799|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138540800|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138540801|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540802|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540803|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540804|NCT00055991|Bexarotene|bexarotene|mesh-list
138540805|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540807|NCT00056030|Fluorouracil|fluorouracil|mesh-list
138540808|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
138540809|NCT00056030|Cetuximab|cetuximab|mesh-list
138540810|NCT00056030|Calcium|calcium|mesh-list
138540811|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
138540812|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138540813|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540814|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
138322561|NCT03768960|Daratumumab|daratumumab|mesh-list
138540815|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540816|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138540817|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540818|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138540819|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
138540821|NCT00056030|Protective Agents|protective agents|mesh-ancestor
138540822|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
138540824|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
138540825|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138540826|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138540827|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138540828|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138540829|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138540830|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540831|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540832|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540833|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138540834|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
138540835|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138540836|NCT00173875|Gefitinib|gefitinib|mesh-list
138540837|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540838|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138540839|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540840|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540841|NCT00174226|Buspirone|buspirone|mesh-list
138540842|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138429332|NCT01715636|Tenofovir|tenofovir|mesh-list
138540843|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138540844|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138540845|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138343834|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
138540846|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540847|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
138540848|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540849|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540850|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138540851|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138540852|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138540853|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138540854|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138540855|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
138540857|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
138540858|NCT00174304|Atorvastatin|atorvastatin|mesh-list
138540859|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138540860|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138540861|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
138540862|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540863|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138540864|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138540865|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540866|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138540867|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138540868|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138540869|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138540870|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540871|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
138540872|NCT00174343|Exemestane|exemestane|mesh-list
138540873|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540874|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138540875|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138540876|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540877|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540878|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138540879|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
138540880|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138540881|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540882|NCT00174499|Nicotine|nicotine|mesh-list
138540883|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138540884|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
138540885|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540886|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540887|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138540888|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138540889|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
138540890|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138540891|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540892|NCT00174538|Codeine|codeine|mesh-list
138540893|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138540894|NCT00174538|Narcotics|narcotics|mesh-ancestor
138540895|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138540896|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540897|NCT00174538|Analgesics|analgesics|mesh-ancestor
138540898|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
138540899|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540900|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
138540901|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
138540903|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138540904|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
138322620|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540906|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540907|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540908|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138540909|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138540910|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138540911|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138540912|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138540914|NCT00046137|Teriparatide|teriparatide|mesh-list
138540915|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138540916|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138540917|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540918|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138540919|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138540920|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
138540921|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138540922|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138540923|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138540924|NCT00056225|Vitamins|vitamins|mesh-list
138540925|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
138540926|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
138540927|NCT00056225|Pyridoxal|pyridoxal|mesh-list
138540928|NCT00056225|Pyridoxine|pyridoxine|mesh-list
138540929|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
138540930|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
138540931|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540932|NCT00174616|Capecitabine|capecitabine|mesh-list
138540933|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
138540934|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138540935|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
138540936|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540937|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540938|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
138540939|NCT00174655|Docetaxel|docetaxel|mesh-list
138540940|NCT00174655|Doxorubicin|doxorubicin|mesh-list
138540941|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138540943|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
138322647|NCT00084318|Docetaxel|docetaxel|mesh-list
138540944|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540945|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540946|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138540947|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
138540948|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138343933|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
138540949|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540950|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138540951|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
138540952|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
138540953|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
138540954|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138540955|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138540956|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138540957|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540959|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138540960|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138540961|NCT00174733|Ciclesonide|ciclesonide|mesh-list
138540962|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
138540963|NCT00174733|Hormones|hormones|mesh-ancestor
138540964|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138540965|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540966|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138540968|NCT00056264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138540969|NCT00056264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138540970|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
138540971|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138540972|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540973|NCT00174772|Cisplatin|cisplatin|mesh-list
138540974|NCT00174772|Docetaxel|docetaxel|mesh-list
138540975|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138540976|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
138540977|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
138540978|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
138540979|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540980|NCT00174811|Telithromycin|telithromycin|mesh-list
138540981|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138540982|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138540983|NCT02963779|Apremilast|apremilast|mesh-list
138540984|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138540985|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138540986|NCT02963779|Analgesics|analgesics|mesh-ancestor
138540987|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
138540988|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138540989|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138540990|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138540991|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138540992|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138540993|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138540994|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138540995|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138540996|NCT00046176|Lamivudine|lamivudine|mesh-list
138540997|NCT00046176|Abacavir|abacavir|mesh-list
138540998|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
138540999|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138541000|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138541001|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541002|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541003|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
138541004|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541005|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138541006|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138541007|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
138541008|NCT00174928|Lansoprazole|lansoprazole|mesh-list
138541009|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
138541010|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138541011|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138541012|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138541013|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541014|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541015|NCT00175045|Lansoprazole|lansoprazole|mesh-list
138541016|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
138541018|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138541019|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138541020|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541021|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541022|NCT00056381|Anidulafungin|anidulafungin|mesh-list
138541023|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
138541024|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541025|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138541026|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138541027|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138541028|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541029|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541030|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138541031|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541032|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541033|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
138541035|NCT00175357|Methadone|methadone|mesh-list
138541037|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138541038|NCT00175357|Narcotics|narcotics|mesh-ancestor
138541039|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138541040|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217250|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138541041|NCT00175357|Analgesics|analgesics|mesh-ancestor
138541042|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
138541043|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541044|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
138541045|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
138541046|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
138541047|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138541048|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541049|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
138541050|NCT00175396|Leuprolide|leuprolide|mesh-list
138541051|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
138541052|NCT00175396|Flutamide|flutamide|mesh-list
138541053|NCT00175396|Bicalutamide|bicalutamide|mesh-list
138541054|NCT00175396|Nilutamide|nilutamide|mesh-list
138541055|NCT00175396|Buserelin|buserelin|mesh-list
138541056|NCT00175396|Androgens|androgens|mesh-list
138541057|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138541058|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138541059|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
138541060|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138541061|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541062|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138541063|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541064|NCT00175396|Hormones|hormones|mesh-ancestor
138541065|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138541066|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
138541067|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541068|NCT00175396|Protective Agents|protective agents|mesh-ancestor
138541069|NCT00175396|Vitamins|vitamins|mesh-ancestor
138541070|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
138541071|NCT00175396|Estrogens|estrogens|mesh-ancestor
138541072|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
138541073|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
138541074|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
138541075|NCT00056459|Vatalanib|vatalanib|mesh-list
138541076|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138541077|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541078|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541079|NCT00175435|Vaccines|vaccines|mesh-list
138541080|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
138344052|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138344053|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
138344054|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138541081|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541082|NCT00175513|Valacyclovir|valacyclovir|mesh-list
138541083|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
138541084|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541085|NCT00175591|Bupivacaine|bupivacaine|mesh-list
138541086|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
138541087|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
138541088|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138541089|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541090|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
138541091|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541093|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
138541094|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
138541095|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138541096|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541097|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
138541098|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541099|NCT00056537|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
138541100|NCT00056537|Immunoconjugates|immunoconjugates|mesh-ancestor
138541101|NCT00056537|Immunologic Factors|immunologic factors|mesh-ancestor
138541102|NCT00056537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541103|NCT00408031|Cycloserine|cycloserine|mesh-list
138541104|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138541105|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541106|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138541107|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
138541108|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138541109|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
138541110|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541111|NCT00175747|Budesonide|budesonide|mesh-list
138541112|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138541113|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138541114|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
138541115|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541116|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541117|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138541118|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
138541119|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
138541120|NCT00175747|Hormones|hormones|mesh-ancestor
138541121|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138541122|NCT04493619|Carboplatin|carboplatin|mesh-list
138541123|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541124|NCT00056576|Zonisamide|zonisamide|mesh-list
138541125|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
138541126|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138541127|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541128|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541129|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138541130|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541131|NCT00175903|Carbamazepine|carbamazepine|mesh-list
138541132|NCT00175903|Levetiracetam|levetiracetam|mesh-list
138541133|NCT00175903|Valproic Acid|valproic acid|mesh-list
138541134|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
138541135|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
138541136|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541137|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541138|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
138541139|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541140|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541141|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
138541142|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138541143|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138541144|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138541145|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138541146|NCT00175903|Analgesics|analgesics|mesh-ancestor
138541147|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
138541148|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541149|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138541150|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541151|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138541152|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138541153|NCT00056654|Leuprolide|leuprolide|mesh-list
138541154|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138541155|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
138541156|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138541157|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541158|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138541159|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541160|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
138541162|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
138541163|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138541164|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138541165|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541166|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541167|NCT00175981|Urological Agents|urological agents|mesh-ancestor
138541168|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138541169|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138541170|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138541171|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541172|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138541173|NCT00175981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138541174|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138541175|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541176|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541177|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
138541178|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138541179|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
138541180|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138541181|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138541182|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138541183|NCT04420533|Mirabegron|mirabegron|mesh-list
138541184|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138541185|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138541186|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138541187|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
138541188|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541189|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541190|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541191|NCT04420533|Urological Agents|urological agents|mesh-ancestor
138217399|NCT00723632|Ribavirin|ribavirin|mesh-list
138541192|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
138541194|NCT00176020|Niacinamide|niacinamide|mesh-list
138541195|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
138541196|NCT00176020|Vitamins|vitamins|mesh-ancestor
138541197|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
138541198|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541199|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138541200|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
138541201|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541202|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138541203|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
138541204|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
138541205|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138541206|NCT00176059|Antibodies|antibodies|mesh-list
138541207|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
138541208|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138541209|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
138541210|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541211|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138541212|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138541213|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541214|NCT00176293|Dexamethasone|dexamethasone|mesh-list
138541215|NCT00176293|Doxorubicin|doxorubicin|mesh-list
138541216|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138541217|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
138541218|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
138541219|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541220|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541221|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138541222|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
138541223|NCT00176293|Hormones|hormones|mesh-ancestor
138541224|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138541225|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138541226|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138344190|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
138541227|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138541228|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138541229|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138541230|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541231|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541232|NCT00056693|Sunitinib|sunitinib|mesh-list
138322843|NCT04761744|Nivolumab|nivolumab|mesh-list
138541233|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541234|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138541235|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138541236|NCT00056693|Growth Substances|growth substances|mesh-ancestor
138541237|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541238|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
138541239|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138541240|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541241|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541242|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138541243|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138541244|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138541245|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
138541246|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541247|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138541248|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138541249|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541250|NCT00176449|Bupropion|bupropion|mesh-list
138541251|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138541252|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
138541253|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138541254|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138541255|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138541256|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541257|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541258|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
138541259|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541260|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541261|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138541262|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138541263|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541264|NCT00398450|Interferons|interferons|mesh-list
138217478|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
138541265|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
138541266|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
138541267|NCT00398450|Azacitidine|azacitidine|mesh-list
138541268|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541269|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
138541270|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541271|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138541272|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
138541273|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541274|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541275|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
138541276|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541277|NCT00046293|Abciximab|abciximab|mesh-list
138541278|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
138541279|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138541280|NCT00176527|Interferons|interferons|mesh-list
138541281|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
138541282|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
138541283|NCT00176527|Docetaxel|docetaxel|mesh-list
138541284|NCT00176527|Estramustine|estramustine|mesh-list
138541285|NCT00176527|Isotretinoin|isotretinoin|mesh-list
138541286|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541287|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
138541288|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
138541289|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
138541290|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541291|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
138541292|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541293|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
138541294|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541295|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
138541296|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138541297|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
138541298|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138541299|NCT00398489|Tamoxifen|tamoxifen|mesh-list
138541300|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
138541301|NCT00398489|Docetaxel|docetaxel|mesh-list
138541302|NCT00398489|Trastuzumab|trastuzumab|mesh-list
138541303|NCT00398489|Epirubicin|epirubicin|mesh-list
138541304|NCT00398489|Anastrozole|anastrozole|mesh-list
138541305|NCT00398489|Goserelin|goserelin|mesh-list
138541306|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138541307|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
138541308|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541309|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138541310|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138541311|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
138541312|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541313|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541314|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138541315|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
138541316|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
138541317|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
138541318|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138541319|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138541320|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138541321|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138541322|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322894|NCT05684484|Salicylic Acid|salicylic acid|mesh-list
138541323|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138541324|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
138541325|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138541326|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138541327|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138541328|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138541329|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138541330|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138541331|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138541332|NCT00176761|Interleukin-2|interleukin-2|mesh-list
138541333|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429512|NCT01717027|Narcotics|narcotics|mesh-ancestor
138541334|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138541335|NCT00176761|Analgesics|analgesics|mesh-ancestor
138541336|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
138541337|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541338|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541339|NCT00176995|Eflornithine|eflornithine|mesh-list
138541340|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541341|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138541342|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138541343|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138541344|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541345|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138541346|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541347|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541348|NCT00423527|Levetiracetam|levetiracetam|mesh-list
138541349|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
138541350|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
138541351|NCT00408148|Rimonabant|rimonabant|mesh-list
138541352|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138541353|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138344341|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
138344343|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541354|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138541355|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541356|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541357|NCT00408148|Hormones|hormones|mesh-ancestor
138541358|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138541359|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541360|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
138541361|NCT00397566|BMS-707035|bms-707035|mesh-list
138541362|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
138541363|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541364|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541365|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138541366|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138541367|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
138541368|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541369|NCT00177424|Sertraline|sertraline|mesh-list
138322911|NCT03086382|Lacosamide|lacosamide|mesh-list
138541370|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
138541372|NCT00177424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138541373|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138541374|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138168875|NCT03029780|Nivolumab|nivolumab|mesh-list
138541375|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541376|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541377|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
138541378|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541380|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138541381|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138541382|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
138541383|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541384|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138702100|NCT05424393|Sensory System Agents|sensory system agents|mesh-ancestor
138541385|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138541386|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541387|NCT04723342|Blinatumomab|blinatumomab|mesh-list
138541388|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541389|NCT00177619|Alendronate|alendronate|mesh-list
138541390|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138541391|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541392|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
138541393|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138541394|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541395|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541397|NCT00177853|Irinotecan|irinotecan|mesh-list
138541398|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138541399|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138541400|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541401|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541402|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541403|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138541404|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138541405|NCT00177853|Analgesics|analgesics|mesh-ancestor
138541406|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
138344402|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370276|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
138370277|NCT01404312|Isoniazid|isoniazid|mesh-list
138370278|NCT01404312|Rifapentine|rifapentine|mesh-list
138370279|NCT01404312|Vitamins|vitamins|mesh-ancestor
138370280|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
138370281|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370282|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
138370283|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
138370284|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138370285|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138370286|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138370287|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138370288|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
138370289|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370290|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138370291|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138370292|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
138370293|NCT01404338|Halobetasol|halobetasol|mesh-list
138541407|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541408|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541409|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138541410|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138541411|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138541412|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138541413|NCT00178048|Paroxetine|paroxetine|mesh-list
138541414|NCT00178048|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138541415|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138541416|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541417|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541418|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541419|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
138322934|NCT03085992|Growth Substances|growth substances|mesh-ancestor
138541420|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541421|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138541422|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
138541423|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138541424|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138541425|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138541426|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541428|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
138541429|NCT00056966|Tacrolimus|tacrolimus|mesh-list
138541430|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541431|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541432|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138541433|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
138541434|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541435|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138541436|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138168881|NCT00624559|Celecoxib|celecoxib|mesh-list
138541437|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138541438|NCT00178828|Bupropion|bupropion|mesh-list
138541439|NCT00178828|Sertraline|sertraline|mesh-list
138541440|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138541441|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
138541442|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138541443|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138541444|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138541445|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541446|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541447|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
138541448|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541449|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541450|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138541451|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138541452|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541453|NCT00178828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138541454|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
138541456|NCT00408187|Cyclosporins|cyclosporins|mesh-list
138541457|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541458|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541459|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138541460|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
138541461|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541462|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
138541463|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541464|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
138541465|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138541466|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138541468|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541469|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541470|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541471|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138541472|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138541473|NCT02963896|Gentamicins|gentamicins|mesh-list
138541474|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138541475|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541476|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138541477|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541478|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541479|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
138541480|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138541481|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138541482|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138541483|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541484|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541485|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
138541486|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541487|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541488|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138541489|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541490|NCT00397722|Paroxetine|paroxetine|mesh-list
138541491|NCT00397722|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138541492|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138541493|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541494|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541495|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541496|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
138429566|NCT01717404|Mexiletine|mexiletine|mesh-list
138541497|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541498|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138541499|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
138541500|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138541501|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138541502|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138541503|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541504|NCT00179023|Trimethaphan|trimethaphan|mesh-list
138541505|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
138541506|NCT00179023|Ephedrine|ephedrine|mesh-list
138541507|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
138541508|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138541509|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
138541510|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541511|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541512|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138541514|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
138541515|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138541516|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138541517|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
138541518|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
138541519|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541520|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541521|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138541522|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138541523|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138541524|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138541525|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138541526|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
138541527|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
138541528|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
138541529|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
138541530|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138541531|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
138541532|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541533|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138541534|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138541535|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
138541536|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541537|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541538|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138541539|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138541540|NCT00179062|Olanzapine|olanzapine|mesh-list
138541541|NCT00179062|Risperidone|risperidone|mesh-list
138541542|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138541543|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
138541544|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138488545|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138541545|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541546|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541547|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138541548|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138541549|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138541550|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138541551|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138541552|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
138541553|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
138541554|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
138541555|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541556|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138541557|NCT00179062|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138541558|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138541559|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541560|NCT04723459|Ivermectin|ivermectin|mesh-list
138541561|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138541562|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541563|NCT00179257|Sertraline|sertraline|mesh-list
138541564|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
138541565|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138541566|NCT00179257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138541567|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138541568|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541569|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541570|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541571|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
138541572|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541573|NCT00408382|Atorvastatin|atorvastatin|mesh-list
138541574|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138541575|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138541576|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
138541577|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541578|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138541579|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138541580|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541581|NCT00057122|Rifampin|rifampin|mesh-list
138541582|NCT00057122|Rifapentine|rifapentine|mesh-list
138541583|NCT00057122|Isoniazid|isoniazid|mesh-list
138541584|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138541585|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
138541586|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138541587|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541588|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
138541589|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138541590|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541591|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541592|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138541593|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138541594|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138541595|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138541596|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138541597|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138541598|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138541599|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138541600|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
138541601|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138168935|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
138541602|NCT00179608|Lenalidomide|lenalidomide|mesh-list
138541603|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
138541604|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541605|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138541606|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138541607|NCT00179608|Growth Substances|growth substances|mesh-ancestor
138541608|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
138541609|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541610|NCT00179686|Lenalidomide|lenalidomide|mesh-list
138541611|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
138541612|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541613|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138541614|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138541615|NCT00179686|Growth Substances|growth substances|mesh-ancestor
138541616|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
138541617|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541618|NCT00179725|Doxorubicin|doxorubicin|mesh-list
138541619|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138541620|NCT00179725|Lenalidomide|lenalidomide|mesh-list
138541621|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138541622|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541623|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138541624|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138541625|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541626|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541627|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
138541628|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541629|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138541630|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138541631|NCT00179725|Growth Substances|growth substances|mesh-ancestor
138541632|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
138541633|NCT00179764|Busulfan|busulfan|mesh-list
138541634|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
138541635|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541636|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138541637|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
138541638|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541639|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138541640|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541641|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138541642|NCT00179881|Thalidomide|thalidomide|mesh-list
138541643|NCT00179881|Carboplatin|carboplatin|mesh-list
138541644|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541645|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138323071|NCT03082092|Prednisolone|prednisolone|mesh-list
138541646|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
138541647|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541648|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
138541649|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138541650|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541651|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138541652|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138541653|NCT00179881|Growth Substances|growth substances|mesh-ancestor
138541654|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
138541655|NCT00179920|Carboplatin|carboplatin|mesh-list
138541656|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541658|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
138541659|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
138541660|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541662|NCT00180076|Budesonide|budesonide|mesh-list
138541663|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138541664|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138541665|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
138541666|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541667|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541668|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138541669|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
138541670|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
138541671|NCT00180076|Hormones|hormones|mesh-ancestor
138702101|NCT05424393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541672|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138541673|NCT00180115|Cytarabine|cytarabine|mesh-list
138541674|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138541675|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
138541676|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541677|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541678|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
138541679|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541680|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138541681|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
138541682|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541683|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138541684|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541685|NCT00180310|Paclitaxel|paclitaxel|mesh-list
138541686|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138541687|NCT00180310|Everolimus|everolimus|mesh-list
138541688|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138541689|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541690|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
138541691|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
138541692|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
138541693|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541694|NCT00180310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138541695|NCT00180310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138323103|NCT03082482|Nicotine|nicotine|mesh-list
138541696|NCT00180310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541697|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138541698|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
138541699|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541700|NCT00057278|Gabapentin|gabapentin|mesh-list
138541701|NCT00057278|Analgesics|analgesics|mesh-ancestor
138541702|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
138541703|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541704|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541705|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
138541706|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138541707|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138541708|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138541709|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138541710|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138541711|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138541712|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541713|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541714|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
138541715|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
138541716|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
138541717|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138541718|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
138541719|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541720|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541721|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138541722|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
138541723|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138541724|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
138541725|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541726|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541727|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138541728|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
138541729|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
138541730|NCT00180622|Protective Agents|protective agents|mesh-ancestor
138541731|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
138541732|NCT00180895|Rituximab|rituximab|mesh-list
138541733|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138541734|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541735|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
138541736|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541737|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138541738|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
138541739|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541740|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
138541741|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541742|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541743|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138541744|NCT04729491|Azithromycin|azithromycin|mesh-list
138541745|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
138541746|NCT04729491|Dutasteride|dutasteride|mesh-list
138541747|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138541748|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541749|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138541750|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138541751|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541752|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541753|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
138541754|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138541755|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541756|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138541758|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138541759|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541760|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
138541761|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541762|NCT00181012|Lidocaine|lidocaine|mesh-list
138541763|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
138541764|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
138541765|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138541766|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541767|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
138541768|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541769|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138541770|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138541771|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138541772|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541773|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541774|NCT00181246|Fentanyl|fentanyl|mesh-list
138541775|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138541776|NCT00181246|Narcotics|narcotics|mesh-ancestor
138541777|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138541778|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541779|NCT00181246|Analgesics|analgesics|mesh-ancestor
138541780|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
138541781|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541782|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138541783|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138541784|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
138541787|NCT00181558|Atrasentan|atrasentan|mesh-list
138541788|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138541789|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541790|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541791|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138541792|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138541793|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541794|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
138541796|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138541797|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138541798|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
138541799|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138541800|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541801|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541802|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541803|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541804|NCT00181636|Galantamine|galantamine|mesh-list
138541805|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138541806|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541807|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541808|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
138541809|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541810|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541811|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138541812|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
138541813|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541814|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
138541815|NCT00181675|Galantamine|galantamine|mesh-list
138541816|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138541817|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541818|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541819|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
138541820|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541821|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541822|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138541823|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
138541824|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541825|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
138541826|NCT00181870|Carbamazepine|carbamazepine|mesh-list
138541827|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
138541828|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
138541829|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138488547|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
138541830|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138541831|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541832|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138541833|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138541834|NCT00181870|Analgesics|analgesics|mesh-ancestor
138541835|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
138541836|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541837|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138541838|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138429663|NCT01718054|Chloroquine|chloroquine|mesh-list
138541839|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541840|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138541841|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138541842|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138541843|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138541844|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138541845|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541846|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541847|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
138541848|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541849|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541850|NCT00181987|Methylphenidate|methylphenidate|mesh-list
138541851|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138541852|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541853|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138541854|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138541855|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541856|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541857|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
138541858|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541860|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
138541861|NCT00182143|Heparin|heparin|mesh-list
138541862|NCT00182143|Calcium heparin|calcium heparin|mesh-list
138541863|NCT00182143|Dalteparin|dalteparin|mesh-list
138541864|NCT00182143|Tinzaparin|tinzaparin|mesh-list
138541865|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138541866|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
138541867|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138541868|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138541869|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541870|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
138541871|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138541872|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138637996|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
138541873|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541874|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
138541875|NCT00182221|Coagulants|coagulants|mesh-ancestor
138541876|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138541877|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541878|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541879|NCT00408538|UC-781|uc-781|mesh-list
138541880|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
138541881|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138541882|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
138541883|NCT00408655|Sirolimus|sirolimus|mesh-list
138541884|NCT00408655|Paclitaxel|paclitaxel|mesh-list
138541885|NCT00408655|Carboplatin|carboplatin|mesh-list
138541886|NCT00408655|Temsirolimus|temsirolimus|mesh-list
138541887|NCT00408655|MTOR Inhibitors|mtor inhibitors|mesh-list
138541888|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138541889|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541890|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
138541891|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
138541892|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
138541893|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541894|NCT00408655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138541895|NCT00408655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541896|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138541897|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
138541898|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541899|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138541900|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541901|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138541902|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
138541903|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138541904|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
138541905|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
138541907|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
138541908|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138541909|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541910|NCT00182494|Metformin|metformin|mesh-list
138541911|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138541912|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541914|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
138541915|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138541916|NCT00182533|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138541917|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138541918|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138541919|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541920|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429726|NCT01718314|Lidocaine|lidocaine|mesh-list
138541922|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541923|NCT00182572|Naltrexone|naltrexone|mesh-list
138541924|NCT00182572|Buprenorphine|buprenorphine|mesh-list
138541925|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138541926|NCT00182572|Narcotics|narcotics|mesh-ancestor
138541927|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138541928|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541929|NCT00182572|Analgesics|analgesics|mesh-ancestor
138541930|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
138541931|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138541932|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138541933|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138541934|NCT00182611|Tegafur|tegafur|mesh-list
138541935|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541936|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138541937|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
138541938|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541939|NCT00182650|Aldesleukin|aldesleukin|mesh-list
138541940|NCT00182650|Rituximab|rituximab|mesh-list
138541941|NCT00182650|Fludarabine|fludarabine|mesh-list
138541942|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
138541943|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138541944|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541945|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
138541946|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541947|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138541948|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138541949|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
138541950|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541951|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138541952|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138541953|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138541954|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
138541955|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138541956|NCT00182806|Gemcitabine|gemcitabine|mesh-list
138541957|NCT00182806|Irinotecan|irinotecan|mesh-list
138541958|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138541959|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
138541960|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541961|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541962|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138541963|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138541964|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541965|NCT00182845|Donepezil|donepezil|mesh-list
138541966|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138541967|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541968|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541969|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
138541970|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541971|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541972|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
138541973|NCT00182884|Donepezil|donepezil|mesh-list
138541975|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138541976|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541977|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
138541978|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138541979|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541981|NCT00183001|Vitamin K|vitamin k|mesh-list
138541982|NCT00183001|Vitamins|vitamins|mesh-ancestor
138541983|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
138541984|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541985|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138541986|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138541987|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138541988|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
138541989|NCT00183001|Coagulants|coagulants|mesh-ancestor
138541990|NCT00183040|Hormones|hormones|mesh-list
138541991|NCT00183040|Testosterone|testosterone|mesh-list
138541992|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138541993|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138541994|NCT00183040|Androgens|androgens|mesh-ancestor
138541995|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
138541996|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138541997|NCT00183235|Aripiprazole|aripiprazole|mesh-list
138541998|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
138541999|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138542000|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138542001|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138542002|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138542003|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542004|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
138542005|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
138542006|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138542007|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542008|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138542009|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138542010|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
138542011|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138542012|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138542013|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138542014|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138542015|NCT00057512|Masoprocol|masoprocol|mesh-list
138542016|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
138542017|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542018|NCT00057512|Protective Agents|protective agents|mesh-ancestor
138542019|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542020|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138542021|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542022|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138542023|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138542024|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138542025|NCT00057512|Analgesics|analgesics|mesh-ancestor
138542026|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
138542027|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138542028|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138542029|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138542030|NCT00183742|Docetaxel|docetaxel|mesh-list
138542031|NCT00183742|Doxorubicin|doxorubicin|mesh-list
138542032|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138542033|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323308|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
138542034|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
138429771|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
138542035|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
138542036|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
138542037|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542038|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138542039|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138542040|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138542041|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542043|NCT02965248|Leucovorin|leucovorin|mesh-list
138542044|NCT02965248|Capecitabine|capecitabine|mesh-list
138542045|NCT02965248|Raltitrexed|raltitrexed|mesh-list
138542046|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
138542047|NCT02965248|Calcium|calcium|mesh-list
138542048|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
138542049|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138542050|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542051|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138542052|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138542053|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
138542054|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542055|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542056|NCT02965248|Antidotes|antidotes|mesh-ancestor
138542057|NCT02965248|Protective Agents|protective agents|mesh-ancestor
138542058|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
138542059|NCT02965248|Vitamins|vitamins|mesh-ancestor
138542060|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
138542061|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138542062|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542063|NCT00183820|Paclitaxel|paclitaxel|mesh-list
138542064|NCT00183820|Gemcitabine|gemcitabine|mesh-list
138542065|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
138542066|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138542067|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542068|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
138542069|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
138542070|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
138542071|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542072|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138542073|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
138542074|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
138542075|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
138542076|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138542077|NCT02969720|Protective Agents|protective agents|mesh-ancestor
138542078|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542079|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
138542080|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138542081|NCT00183859|Irinotecan|irinotecan|mesh-list
138542082|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138542083|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138542084|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542085|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542086|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542088|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
138542089|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138542090|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
138542091|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542092|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542093|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138542094|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542095|NCT00183937|Docetaxel|docetaxel|mesh-list
138542096|NCT00183937|Bortezomib|bortezomib|mesh-list
138542097|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542098|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
138542099|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
138542100|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
138542101|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542102|NCT00408772|Bevacizumab|bevacizumab|mesh-list
138542103|NCT00408772|Capecitabine|capecitabine|mesh-list
138542104|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
138542105|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138542106|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542107|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138542108|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138542109|NCT00408772|Growth Substances|growth substances|mesh-ancestor
138542110|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542111|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
138542112|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138542113|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
138542114|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542115|NCT00408850|Pioglitazone|pioglitazone|mesh-list
138542116|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138542117|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542118|NCT00183976|Rituximab|rituximab|mesh-list
138542119|NCT00183976|Doxorubicin|doxorubicin|mesh-list
138542120|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138542121|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138542122|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542123|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
138542124|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542125|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138542126|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138542127|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138542128|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138542129|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542130|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542131|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
138542132|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138542133|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542134|NCT00184015|Bevacizumab|bevacizumab|mesh-list
138542135|NCT00184015|Bortezomib|bortezomib|mesh-list
138542136|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138542137|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345184|NCT05290194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345187|NCT04774068|Romidepsin|romidepsin|mesh-list
138542138|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138542139|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138542140|NCT00184015|Growth Substances|growth substances|mesh-ancestor
138542141|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542142|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
138542143|NCT00184171|Budesonide|budesonide|mesh-list
138542144|NCT00184171|Bismuth|bismuth|mesh-list
138542145|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138542146|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138542147|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
138542148|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138542149|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542150|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138542151|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
138542152|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
138542153|NCT00184171|Hormones|hormones|mesh-ancestor
138542154|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138542155|NCT00184171|Antacids|antacids|mesh-ancestor
138542156|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542157|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138542158|NCT00057707|Modafinil|modafinil|mesh-list
138542159|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138542160|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542161|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138542162|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138542163|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138542164|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542165|NCT00184522|Esomeprazole|esomeprazole|mesh-list
138542166|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138542167|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138542168|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138169047|NCT03154814|Urinastatin|urinastatin|mesh-list
138542169|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542170|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542171|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
138542172|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
138542173|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138542174|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542175|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
138542176|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138542177|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542179|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542180|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138542181|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138542182|NCT00184795|Norethindrone|norethindrone|mesh-list
138542183|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
138542185|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138542186|NCT00184795|Estrogens|estrogens|mesh-ancestor
138542187|NCT00184795|Hormones|hormones|mesh-ancestor
138542188|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138542189|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138345196|NCT04103034|Coagulants|coagulants|mesh-ancestor
138345197|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138542190|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138542191|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
138542192|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138542193|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138542194|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138542195|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138542196|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138542197|NCT00058253|Docetaxel|docetaxel|mesh-list
138542198|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542199|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
138542200|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
138542201|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
138542202|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542203|NCT00046800|Lurtotecan|lurtotecan|mesh-list
138542204|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542205|NCT00058292|Cytarabine|cytarabine|mesh-list
138542206|NCT00058292|Rituximab|rituximab|mesh-list
138542207|NCT00058292|Etoposide|etoposide|mesh-list
138542208|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
138542209|NCT00058292|Melphalan|melphalan|mesh-list
138542210|NCT00058292|Carmustine|carmustine|mesh-list
138542211|NCT00058292|Lenograstim|lenograstim|mesh-list
138542212|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138542213|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542214|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
138542215|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542216|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138542217|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138542218|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138542219|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138542220|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542221|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138323410|NCT04130802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138542222|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138542223|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
138542224|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
138542225|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542226|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542227|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138542228|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138542229|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
138542230|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138542231|NCT03816774|Simethicone|simethicone|mesh-list
138542232|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
138542233|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542234|NCT03816774|Emollients|emollients|mesh-ancestor
138542235|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
138542237|NCT00184912|Annexin A5|annexin a5|mesh-list
138542238|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138542239|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542240|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138542241|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542242|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542243|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138542244|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138542245|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
138542246|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138542247|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138542248|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138542249|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138542250|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
138542251|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542252|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138542253|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138542254|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542255|NCT00184990|Pimagedine|pimagedine|mesh-list
138542256|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542257|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542258|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
138542259|NCT00058331|Hematinics|hematinics|mesh-ancestor
138542260|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138542261|NCT00185068|Olmesartan|olmesartan|mesh-list
138542262|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138542263|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138542264|NCT00185068|Diuretics|diuretics|mesh-ancestor
138542265|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
138542266|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542267|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138542268|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138429844|NCT01718717|Narcotics|narcotics|mesh-ancestor
138542269|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542270|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138542271|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138542273|NCT00185107|Ezetimibe|ezetimibe|mesh-list
138542274|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138542275|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138542276|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138542277|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
138542278|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542279|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138542280|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138542281|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542282|NCT00058448|Docetaxel|docetaxel|mesh-list
138542283|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542284|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
138542285|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
138542286|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
138542287|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542288|NCT00185185|Atenolol|atenolol|mesh-list
138542289|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138542290|NCT00185185|Olmesartan|olmesartan|mesh-list
138542291|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138542292|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138542293|NCT00185185|Diuretics|diuretics|mesh-ancestor
138542294|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
138542295|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542296|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138542297|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138542298|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542299|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138542300|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138542301|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138542302|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
138542303|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
138542304|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138542305|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138542306|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138542307|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138542308|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
138542309|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138542310|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138542311|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138542312|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138542313|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138542314|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
138345365|NCT03064542|Carbimazole|carbimazole|mesh-list
138542315|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138542316|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542317|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138542318|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138542319|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138542320|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138542321|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138542322|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138542324|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138542325|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542326|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542327|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542330|NCT03784014|Palbociclib|palbociclib|mesh-list
138542331|NCT03784014|Lapatinib|lapatinib|mesh-list
138542332|NCT03784014|Trametinib|trametinib|mesh-list
138542333|NCT03784014|Dabrafenib|dabrafenib|mesh-list
138542334|NCT03784014|Ceritinib|ceritinib|mesh-list
138542335|NCT03784014|Futibatinib|futibatinib|mesh-list
138542336|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138542337|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542338|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138542339|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542340|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542341|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138542342|NCT00058487|Thalidomide|thalidomide|mesh-list
138542343|NCT00058487|Epirubicin|epirubicin|mesh-list
138542344|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138542345|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542346|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138542347|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138542348|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542349|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542350|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542351|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
138542352|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542353|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
138542354|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138542355|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542356|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138542357|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138542358|NCT00058487|Growth Substances|growth substances|mesh-ancestor
138542359|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
138542360|NCT00185419|Desogestrel|desogestrel|mesh-list
138542361|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138542362|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542363|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138542364|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138542365|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138542366|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
138542367|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138542368|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138542369|NCT00185419|Progestins|progestins|mesh-ancestor
138542371|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138542372|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138542373|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138542374|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138542375|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138542376|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542377|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138542378|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542379|NCT00185575|Analgesics|analgesics|mesh-ancestor
138542380|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
138542381|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138345412|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
138542382|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
138542383|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138542384|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
138542385|NCT03731832|Dexamethasone|dexamethasone|mesh-list
138542387|NCT03731832|Pomalidomide|pomalidomide|mesh-list
138542388|NCT03731832|Ixazomib|ixazomib|mesh-list
138429872|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138542389|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542390|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
138542391|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542392|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138542393|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138542394|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
138542395|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542396|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542397|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138542398|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138542399|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
138542400|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
138542401|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138542402|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138542403|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
138542404|NCT03731832|Hormones|hormones|mesh-ancestor
138542405|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138542406|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138542407|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138542408|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138323521|NCT05248932|Autonomic Agents|autonomic agents|mesh-ancestor
138542409|NCT03731832|Growth Substances|growth substances|mesh-ancestor
138542410|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
138542411|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
138542412|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542413|NCT00185887|Terbutaline|terbutaline|mesh-list
138542414|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138542415|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
138542416|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138542417|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542418|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138542419|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
138542420|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
138542421|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
138542422|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138542423|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138542424|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138542425|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138542426|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
138542427|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138542428|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542429|NCT00186082|Cefoxitin|cefoxitin|mesh-list
138542430|NCT00186082|Cefotetan|cefotetan|mesh-list
138542431|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138542432|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542433|NCT00186277|Docetaxel|docetaxel|mesh-list
138542434|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
138542435|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542436|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
138542437|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
138542438|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
138542439|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542440|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138542441|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
138542442|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542443|NCT00058682|Anidulafungin|anidulafungin|mesh-list
138542444|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
138542445|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345480|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138542446|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138429886|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
138542447|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
138542448|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542450|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
138542451|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542452|NCT00186706|Protective Agents|protective agents|mesh-ancestor
138542453|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542454|NCT00186706|Trace Elements|trace elements|mesh-ancestor
138542455|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
138542457|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
138218675|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138542458|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138542459|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138542460|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138542461|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138542462|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542463|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
138542464|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138542465|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542466|NCT00046878|Carmustine|carmustine|mesh-list
138542467|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138542468|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138542469|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
138542470|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542471|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542472|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542473|NCT00186745|Tinzaparin|tinzaparin|mesh-list
138542474|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138542475|NCT00186745|Dalteparin|dalteparin|mesh-list
138542476|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
138542477|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138542478|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138542479|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542480|NCT00186823|Antibodies|antibodies|mesh-list
138542481|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
138542482|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542483|NCT00186862|Interleukin-2|interleukin-2|mesh-list
138542484|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542485|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542486|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138542487|NCT00186862|Analgesics|analgesics|mesh-ancestor
138542488|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
138542489|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138542490|NCT00186940|Rasburicase|rasburicase|mesh-list
138542491|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
138542492|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138542493|NCT00186979|Cefixime|cefixime|mesh-list
138542494|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
138542495|NCT00186979|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
138542496|NCT00186979|Irinotecan|irinotecan|mesh-list
138542497|NCT00186979|Vincristine|vincristine|mesh-list
138542498|NCT00186979|Gefitinib|gefitinib|mesh-list
138542499|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138542500|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138542501|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542502|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542503|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542504|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138542505|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
138542506|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
138542507|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
138542508|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138542509|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138542510|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345543|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138542511|NCT00187057|Cytarabine|cytarabine|mesh-list
138542512|NCT00187057|Dexamethasone|dexamethasone|mesh-list
138542513|NCT00187057|Prednisone|prednisone|mesh-list
138542514|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
138542515|NCT00187057|Doxorubicin|doxorubicin|mesh-list
138542516|NCT00187057|Methotrexate|methotrexate|mesh-list
138542517|NCT00187057|Etoposide|etoposide|mesh-list
138542518|NCT00187057|Vincristine|vincristine|mesh-list
138542519|NCT00187057|Daunorubicin|daunorubicin|mesh-list
138542520|NCT00187057|Asparaginase|asparaginase|mesh-list
138542521|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
138542522|NCT00187057|Vinblastine|vinblastine|mesh-list
138542523|NCT00187057|Procarbazine|procarbazine|mesh-list
138542524|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542525|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
138542526|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542527|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138542528|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138542529|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
138542530|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345606|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138542531|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542532|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138542533|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138542534|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
138542536|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138542537|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138218749|NCT06214468|Acetaminophen|acetaminophen|mesh-list
138542538|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
138542539|NCT00187057|Hormones|hormones|mesh-ancestor
138542540|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138542541|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138542542|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138542543|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138542544|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138542545|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542546|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138542547|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
138542548|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138542549|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138542550|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
138542551|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
138542552|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138542553|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138542554|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138542555|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
138542556|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542557|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
138542558|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
138542559|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
138542560|NCT00046917|Irinotecan|irinotecan|mesh-list
138542561|NCT00046917|Alvocidib|alvocidib|mesh-list
138542562|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542563|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138542564|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138542565|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542566|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542567|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
138542568|NCT00046917|Growth Substances|growth substances|mesh-ancestor
138542569|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542570|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138542571|NCT00187174|Everolimus|everolimus|mesh-list
138542572|NCT00187174|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138542573|NCT00187174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138542574|NCT00187174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542575|NCT00187174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542576|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542577|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
138542578|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542579|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542580|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
138542581|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138542582|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
138542583|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542584|NCT00187330|Expectorants|expectorants|mesh-ancestor
138542585|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
138542586|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138542587|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
138542588|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542589|NCT00187330|Protective Agents|protective agents|mesh-ancestor
138542590|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542591|NCT00187330|Antidotes|antidotes|mesh-ancestor
138542592|NCT00187408|Heparin|heparin|mesh-list
138542593|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138542594|NCT00187408|Tinzaparin|tinzaparin|mesh-list
138542595|NCT00187408|Dalteparin|dalteparin|mesh-list
138542596|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
138542597|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138542598|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138542599|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542600|NCT00187447|Indomethacin|indomethacin|mesh-list
138542601|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138542602|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138542603|NCT00187447|Analgesics|analgesics|mesh-ancestor
138542604|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
138542605|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138542606|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542607|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138542608|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138542609|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
138542610|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
138542611|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138429947|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138542612|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138542613|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542614|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542615|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
138542616|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138542617|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542619|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138542620|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138542621|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
138542622|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138542623|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542624|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542625|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138542626|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138542627|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
138542628|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
138542629|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542630|NCT00187564|Protective Agents|protective agents|mesh-ancestor
138542631|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542632|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
138542633|NCT00187564|Vitamins|vitamins|mesh-ancestor
138542634|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
138542635|NCT00046995|Leucovorin|leucovorin|mesh-list
138542636|NCT00046995|Carboplatin|carboplatin|mesh-list
138542637|NCT00046995|Fluorouracil|fluorouracil|mesh-list
138542638|NCT00046995|Calcium|calcium|mesh-list
138542639|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
138542640|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542641|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138542642|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542643|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
138542644|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542645|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138542646|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542647|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
138542648|NCT00046995|Antidotes|antidotes|mesh-ancestor
138542649|NCT00046995|Protective Agents|protective agents|mesh-ancestor
138542650|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
138542651|NCT00046995|Vitamins|vitamins|mesh-ancestor
138542652|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
138542653|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
138542654|NCT00058955|Triazolam|triazolam|mesh-list
138542655|NCT00058955|Pentobarbital|pentobarbital|mesh-list
138542656|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138542657|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138542658|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
138542659|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
138542660|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138323728|NCT01929252|Analgesics|analgesics|mesh-ancestor
138542661|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542662|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138542663|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138542664|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138542665|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
138542666|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
138542667|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138542668|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542669|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138542670|NCT00187759|Cephalexin|cephalexin|mesh-list
138542671|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138542672|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542673|NCT00187798|Metformin|metformin|mesh-list
138542674|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138542675|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542676|NCT00058994|Anecortave|anecortave|mesh-list
138542677|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138345697|NCT05739630|Tacrolimus|tacrolimus|mesh-list
138542678|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138542679|NCT00058994|Growth Substances|growth substances|mesh-ancestor
138542680|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542681|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
138542682|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542684|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
138542685|NCT00187915|Tacrolimus|tacrolimus|mesh-list
138542686|NCT00187915|Cyclosporins|cyclosporins|mesh-list
138542687|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542688|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
138542689|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542690|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138542691|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542692|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542693|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
138542694|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542695|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
138542696|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138542697|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138542698|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542699|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138542700|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
138542701|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138169226|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
138542703|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138542704|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542705|NCT00188071|Acetaminophen|acetaminophen|mesh-list
138542706|NCT00188071|Ketoprofen|ketoprofen|mesh-list
138542707|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138323767|NCT00634920|Hormones|hormones|mesh-ancestor
138542708|NCT00188071|Analgesics|analgesics|mesh-ancestor
138542709|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
138542710|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138542711|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542712|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
138542713|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138542714|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138345786|NCT05574894|Hormones|hormones|mesh-list
138542715|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138542716|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138542717|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542718|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542719|NCT00188227|Midazolam|midazolam|mesh-list
138542720|NCT00188227|Pirinitramide|pirinitramide|mesh-list
138542721|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138542722|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138542723|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138542724|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542725|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138542726|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138542727|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138542728|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138542729|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
138542730|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
138542731|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
138542732|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
138429988|NCT01719627|Maraviroc|maraviroc|mesh-list
138542733|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138542734|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542735|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138542736|NCT00188227|Narcotics|narcotics|mesh-ancestor
138542737|NCT00188227|Analgesics|analgesics|mesh-ancestor
138542738|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
138542739|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138542740|NCT00188266|Fluorouracil|fluorouracil|mesh-list
138542741|NCT00188266|Cisplatin|cisplatin|mesh-list
138542742|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
138542743|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542744|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138542745|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542746|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542747|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
138542748|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542749|NCT00047073|Sirolimus|sirolimus|mesh-list
138542750|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138542751|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542752|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138542754|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
138542755|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542756|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
138542757|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429997|NCT01719692|Rituximab|rituximab|mesh-list
138542760|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138542761|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
138542762|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542763|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
138542764|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138542765|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542766|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542767|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138542768|NCT00188383|Analgesics|analgesics|mesh-ancestor
138542769|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
138542770|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138542771|NCT02969447|Oxytocin|oxytocin|mesh-list
138542772|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
138542773|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138542774|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542775|NCT00188617|Gefitinib|gefitinib|mesh-list
138542776|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542777|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138542778|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542779|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542780|NCT00047112|Fluorouracil|fluorouracil|mesh-list
138542781|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542782|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
138542783|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542784|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138542785|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542786|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
138542787|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542788|NCT00409318|Etanercept|etanercept|mesh-list
138542789|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138542790|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138542791|NCT00409318|Analgesics|analgesics|mesh-ancestor
138542792|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
138542793|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138542794|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542795|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138542796|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138542797|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138542798|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542799|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
138542800|NCT00409357|Alfuzosin|alfuzosin|mesh-list
138542801|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138542802|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138542803|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138542804|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
138542805|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138542806|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542807|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542808|NCT00409357|Urological Agents|urological agents|mesh-ancestor
138542809|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138542810|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138542811|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138542812|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542813|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542814|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
138542815|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542816|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
138542817|NCT00188773|Heparin|heparin|mesh-list
138542818|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138542819|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138542820|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
138542821|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138542822|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138542823|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542825|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542826|NCT00188773|Expectorants|expectorants|mesh-ancestor
138542827|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
138542828|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138542829|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
138542830|NCT00188773|Protective Agents|protective agents|mesh-ancestor
138542831|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542832|NCT00188773|Antidotes|antidotes|mesh-ancestor
138542833|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138542834|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138542835|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138542836|NCT00188812|Donepezil|donepezil|mesh-list
138542837|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138542838|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542839|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542840|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
138542841|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138542842|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542843|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
138542844|NCT02963194|Oxytocin|oxytocin|mesh-list
138542845|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
138542846|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138542847|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542848|NCT00059306|Aspirin|aspirin|mesh-list
138542849|NCT00059306|Clopidogrel|clopidogrel|mesh-list
138542850|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138542851|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138542852|NCT00059306|Analgesics|analgesics|mesh-ancestor
138542853|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
138542854|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138542855|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542856|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138542857|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138542858|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138542859|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138542860|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542861|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138542862|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138542863|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542864|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
138542865|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138542866|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138430074|NCT01719952|Oxytocin|oxytocin|mesh-list
138542868|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
138542869|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138542870|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
138542871|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
138542872|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542873|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
138542874|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542875|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
138542876|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542877|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542878|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138542879|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
138542880|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138542881|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
138542882|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
138542883|NCT00189007|Allopurinol|allopurinol|mesh-list
138542884|NCT00189007|Mannitol|mannitol|mesh-list
138542885|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
138542886|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542887|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542888|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
138542889|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138542890|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138542892|NCT00189007|Protective Agents|protective agents|mesh-ancestor
138542893|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542894|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138542895|NCT00189007|Diuretics|diuretics|mesh-ancestor
138230751|NCT01195922|Sirolimus|sirolimus|mesh-list
138542896|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
138542897|NCT00399945|Tobramycin|tobramycin|mesh-list
138542898|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138542899|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542900|NCT00189085|Simvastatin|simvastatin|mesh-list
138542901|NCT00189085|Ezetimibe|ezetimibe|mesh-list
138542902|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
138542903|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138542904|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138542905|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
138542906|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542907|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138542908|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138542909|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542910|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138542911|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138542912|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
138542913|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542914|NCT00189163|Pioglitazone|pioglitazone|mesh-list
138542915|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138430091|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
138542916|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542917|NCT00189358|Tamoxifen|tamoxifen|mesh-list
138542918|NCT00189358|Gefitinib|gefitinib|mesh-list
138542919|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138542920|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
138542921|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138542922|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542923|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138542924|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542925|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138542926|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138542927|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138542928|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138542929|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542930|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542932|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
138542933|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542934|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138542935|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542936|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542937|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
138542938|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542939|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138542940|NCT00189514|Pramlintide|pramlintide|mesh-list
138542941|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138542942|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542944|NCT00189553|Carboplatin|carboplatin|mesh-list
138542945|NCT00189553|Doxorubicin|doxorubicin|mesh-list
138542946|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138542947|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138542948|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542949|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
138542950|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
138542951|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
138542952|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542953|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138542954|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138542955|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138542956|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542957|NCT00189709|Fluconazole|fluconazole|mesh-list
138542958|NCT00189709|Micafungin|micafungin|mesh-list
138542959|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
138542960|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138542961|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138542962|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138542963|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542964|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542965|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138542966|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
138542967|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138542968|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542969|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138542970|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138542971|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138542972|NCT00189748|Tacrolimus|tacrolimus|mesh-list
138430118|NCT01720719|Vitamin E|vitamin e|mesh-list
138542973|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542974|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
138542975|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323938|NCT00631488|Metformin|metformin|mesh-list
138542976|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138542977|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542978|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542980|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542981|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
138542982|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542983|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138542984|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542985|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138542986|NCT00059462|Interleukin-2|interleukin-2|mesh-list
138542987|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138542988|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138542989|NCT00059462|Analgesics|analgesics|mesh-ancestor
138542990|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
138542991|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219198|NCT06132958|Paclitaxel|paclitaxel|mesh-list
138542992|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542993|NCT00189826|Tacrolimus|tacrolimus|mesh-list
138542994|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138542995|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
138542996|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138542997|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138542998|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138542999|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543000|NCT00047190|Tipifarnib|tipifarnib|mesh-list
138543001|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543002|NCT00189904|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138543003|NCT00189904|Antiviral Agents|antiviral agents|mesh-ancestor
138543004|NCT00189904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138649754|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543005|NCT00189943|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138543006|NCT00189943|Antiviral Agents|antiviral agents|mesh-ancestor
138543007|NCT00189943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543008|NCT00189982|Factor VIII|factor viii|mesh-list
138543009|NCT00189982|Coagulants|coagulants|mesh-ancestor
138543010|NCT00190021|Donepezil|donepezil|mesh-list
138543011|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138543012|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543013|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543014|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
138543015|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543016|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543017|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
138543018|NCT00190060|Testosterone|testosterone|mesh-list
138543019|NCT00190060|Androgens|androgens|mesh-ancestor
138543020|NCT00190060|Hormones|hormones|mesh-ancestor
138543021|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138543022|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323971|NCT00987402|Ethanol|ethanol|mesh-list
138543023|NCT00047229|Doxorubicin|doxorubicin|mesh-list
138543024|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138543025|NCT00047229|Oblimersen|oblimersen|mesh-list
138543026|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138543027|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543028|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138543029|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138543030|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430134|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138543031|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543033|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138543034|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
138543035|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
138543036|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543037|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543038|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138543039|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
138543040|NCT00190099|Hormones|hormones|mesh-ancestor
138543041|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138543042|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138543043|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543044|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
138543045|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138543046|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138543047|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
138543048|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543049|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138543050|NCT00047268|Cytarabine|cytarabine|mesh-list
138543051|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
138543052|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543053|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
138543054|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543055|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543056|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
138219249|NCT06079775|Ceftibuten|ceftibuten|mesh-list
138219250|NCT06079775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138219251|NCT06079775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138219252|NCT06077721|Milrinone|milrinone|mesh-list
138219253|NCT06077721|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138219254|NCT06077721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138219255|NCT06077721|Vasodilator Agents|vasodilator agents|mesh-ancestor
138219256|NCT06077721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138219257|NCT06077721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138543057|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543058|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138543059|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
138543060|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543061|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543062|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323992|NCT01925352|Mitogens|mitogens|mesh-list
138543063|NCT00190294|Misoprostol|misoprostol|mesh-list
138543064|NCT00190294|Mifepristone|mifepristone|mesh-list
138543065|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138543066|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
138543067|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138543068|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543069|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138543070|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138543071|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
138543072|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138543073|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138543074|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138543075|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138543076|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
138543077|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138543078|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138543079|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
138543080|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138543081|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
138543082|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138543083|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138543084|NCT03238365|Nivolumab|nivolumab|mesh-list
138543086|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138543087|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543088|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138543089|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543090|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
138543091|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138543092|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138543093|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543094|NCT03238365|Urological Agents|urological agents|mesh-ancestor
138543095|NCT00059618|Carboplatin|carboplatin|mesh-list
138543096|NCT00059618|Bortezomib|bortezomib|mesh-list
138543097|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543098|NCT00190333|Escitalopram|escitalopram|mesh-list
138543099|NCT00190333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138543100|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543101|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543102|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543104|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
138543105|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543106|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138543107|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138543108|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543109|NCT00190411|Celiprolol|celiprolol|mesh-list
138543110|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138543111|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138543112|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
138543113|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
138543114|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543115|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543116|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
138543117|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138543118|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138543119|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138543120|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
138543121|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138346157|NCT02004132|Testosterone|testosterone|mesh-list
138543122|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543123|NCT00047307|Gemcitabine|gemcitabine|mesh-list
138543124|NCT00047307|Alvocidib|alvocidib|mesh-list
138543125|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543126|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
138543127|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543128|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543129|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
138543130|NCT00047307|Growth Substances|growth substances|mesh-ancestor
138543131|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543132|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138543133|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543134|NCT00190489|Docetaxel|docetaxel|mesh-list
138543135|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543136|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
138543137|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
138543138|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
138543139|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543140|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138543141|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138543142|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543143|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543144|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543145|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543146|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543147|NCT00190567|Analgesics|analgesics|mesh-ancestor
138543148|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
138543149|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543150|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
138543151|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138543152|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
138543153|NCT02969252|Rifamycins|rifamycins|mesh-list
138543154|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
138324049|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
138543155|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138543156|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543157|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138543158|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138543159|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138543160|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543161|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543162|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543163|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543164|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543165|NCT00190606|Analgesics|analgesics|mesh-ancestor
138543166|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
138543167|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543168|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
138543169|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138543170|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
138543171|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138543172|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138543173|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543174|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543175|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543176|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543177|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543178|NCT00190645|Analgesics|analgesics|mesh-ancestor
138543179|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
138543180|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543181|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
138543183|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
138543184|NCT00190762|Pemetrexed|pemetrexed|mesh-list
138543185|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543186|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543187|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543188|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138543189|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543190|NCT00190801|Pemetrexed|pemetrexed|mesh-list
138543191|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543192|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543193|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543194|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138543195|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543196|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138543197|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543198|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138543199|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543200|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543201|NCT00190840|Pemetrexed|pemetrexed|mesh-list
138543202|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543203|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543204|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543205|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138543206|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543207|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138430165|NCT01724450|Carvedilol|carvedilol|mesh-list
138543208|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138543209|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543210|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543211|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543212|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
138543213|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543214|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543215|NCT00190918|Pemetrexed|pemetrexed|mesh-list
138543216|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543217|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543218|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543219|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138543220|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543221|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138543222|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138543223|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543224|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543225|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543226|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
138543227|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543228|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543229|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138543230|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138543231|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138169385|NCT03157388|Vancomycin|vancomycin|mesh-list
138543232|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543233|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543234|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543235|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543236|NCT00190996|Analgesics|analgesics|mesh-ancestor
138543237|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
138230760|NCT02512575|Prednisolone|prednisolone|mesh-list
138543238|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543239|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
138543240|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138543241|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
138543242|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138543243|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138543244|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543245|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543246|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543247|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
138543248|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543249|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543250|NCT02922894|Trazodone|trazodone|mesh-list
138543251|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138543252|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138430180|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138543253|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138543254|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543255|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138543256|NCT02922894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138543257|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543258|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543259|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543260|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543261|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
138543262|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138543263|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
138543264|NCT00191230|Carboplatin|carboplatin|mesh-list
138543265|NCT00191230|Gemcitabine|gemcitabine|mesh-list
138543266|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543267|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543268|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
138543269|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543270|NCT00191347|Gemcitabine|gemcitabine|mesh-list
138543272|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543273|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
138543274|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543275|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543276|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543277|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138543278|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543280|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138543281|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138543282|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543283|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138169411|NCT03156842|Amlodipine|amlodipine|mesh-list
138543284|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138543285|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
138543286|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138543287|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138543288|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138543289|NCT00191464|Insulin|insulin|mesh-list
138543290|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138543291|NCT00191464|Metformin|metformin|mesh-list
138543292|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
138543293|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
138543294|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138543295|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543296|NCT04723030|Paclitaxel|paclitaxel|mesh-list
138543297|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138543298|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543299|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
138543300|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
138543301|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
138543302|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543303|NCT00191503|Gemcitabine|gemcitabine|mesh-list
138543304|NCT00191503|Pemetrexed|pemetrexed|mesh-list
138543305|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543306|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
138543307|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543308|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543309|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543310|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138543311|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543312|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138543313|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138543314|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543315|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138430206|NCT01727427|Nadroparin|nadroparin|mesh-list
138543316|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543317|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
138543318|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543319|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543320|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
138543321|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543322|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138543323|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543324|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543325|NCT00191581|Insulin|insulin|mesh-list
138543326|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
138543327|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138543328|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
138543329|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138543330|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543331|NCT00191620|Gemcitabine|gemcitabine|mesh-list
138543332|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543333|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543334|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
138543335|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543336|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138219549|NCT05723601|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138219551|NCT05723601|Hormones|hormones|mesh-ancestor
138219552|NCT05723601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138219553|NCT05723601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219555|NCT05723601|Contraceptive Agents|contraceptive agents|mesh-ancestor
138543337|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138543338|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543339|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543340|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543341|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
138543342|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543343|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543344|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138543345|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138543346|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543347|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543348|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543349|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
138543350|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543351|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543352|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138543353|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138543354|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543355|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543356|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543357|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
138543358|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543359|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543360|NCT00191893|Teriparatide|teriparatide|mesh-list
138543361|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138543362|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543363|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138543364|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138543365|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138430219|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138543366|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543367|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543368|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543370|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543371|NCT00191932|Analgesics|analgesics|mesh-ancestor
138543372|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
138543373|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543374|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
138543375|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138346448|NCT02064582|Leuprolide|leuprolide|mesh-list
138543376|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
138543377|NCT00059813|Interferons|interferons|mesh-list
138543378|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
138543379|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
138543380|NCT00059813|Oblimersen|oblimersen|mesh-list
138543381|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543382|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
138543383|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543384|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
138649755|NCT04392531|Cyclosporine|cyclosporine|mesh-list
138543385|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543386|NCT00191971|Gemcitabine|gemcitabine|mesh-list
138543387|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543388|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
138543389|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543390|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543391|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
138543392|NCT00047502|Lonafarnib|lonafarnib|mesh-list
138543393|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543394|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138543395|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543396|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543397|NCT00192049|Gemcitabine|gemcitabine|mesh-list
138543398|NCT00192049|Mitomycins|mitomycins|mesh-list
138543399|NCT00192049|Mitomycin|mitomycin|mesh-list
138543400|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543401|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
138543402|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543403|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138324206|NCT03423342|Niacinamide|niacinamide|mesh-list
138543404|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138543405|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
138543406|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543407|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543408|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
138543409|NCT00192088|Pemetrexed|pemetrexed|mesh-list
138543410|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543411|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543412|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543413|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138543414|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543415|NCT00059852|Gemcitabine|gemcitabine|mesh-list
138543416|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138543417|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543418|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
138543419|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543420|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543421|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138543422|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543423|NCT00047580|Tizanidine|tizanidine|mesh-list
138543424|NCT00047580|Analgesics|analgesics|mesh-ancestor
138543425|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
138543426|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543427|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543429|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138543430|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138543431|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
138543432|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
138543433|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138543434|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138543435|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138543436|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
138543437|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543438|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543439|NCT02968901|Tadalafil|tadalafil|mesh-list
138543440|NCT02968901|Macitentan|macitentan|mesh-list
138543441|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
138543442|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138543443|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138543444|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543445|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138169456|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
138169457|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543446|NCT02968901|Urological Agents|urological agents|mesh-ancestor
138543447|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138543448|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138543449|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138543450|NCT00192595|Tenofovir|tenofovir|mesh-list
138543451|NCT00192595|Lamivudine|lamivudine|mesh-list
138543452|NCT00192595|Zidovudine|zidovudine|mesh-list
138543453|NCT00192595|Efavirenz|efavirenz|mesh-list
138543454|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
138543455|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543456|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138543457|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543458|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543459|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543460|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138543461|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138543462|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
138543463|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138543464|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138543465|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138543466|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138543467|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138543468|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138543469|NCT00192634|Tenofovir|tenofovir|mesh-list
138543470|NCT00192634|Lamivudine|lamivudine|mesh-list
138543471|NCT00192634|Emtricitabine|emtricitabine|mesh-list
138543472|NCT00192634|Abacavir|abacavir|mesh-list
138543473|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
138543474|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543475|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138543476|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543477|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543478|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543479|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138543480|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138543481|NCT00192673|Asparaginase|asparaginase|mesh-list
138543482|NCT00192673|Pegaspargase|pegaspargase|mesh-list
138543483|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543484|NCT00192712|Gemcitabine|gemcitabine|mesh-list
138543485|NCT00192712|Irinotecan|irinotecan|mesh-list
138543486|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543487|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
138543488|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543489|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543490|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138324290|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
138543491|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138543492|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543493|NCT00047658|Interferons|interferons|mesh-list
138543494|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
138543495|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543496|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
138543497|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543499|NCT00193024|Epirubicin|epirubicin|mesh-list
138543500|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543501|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
138543502|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
138543503|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
138543504|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543505|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138543506|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138543507|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138543508|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543509|NCT00193102|Thalidomide|thalidomide|mesh-list
138543510|NCT00193102|Capecitabine|capecitabine|mesh-list
138543511|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543512|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
138543513|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543514|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543515|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138543516|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
138543517|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543518|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
138543519|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138346581|NCT02160990|Hormones|hormones|mesh-ancestor
138543520|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543521|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138543522|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138543523|NCT00193102|Growth Substances|growth substances|mesh-ancestor
138543524|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
138543525|NCT00193141|Paclitaxel|paclitaxel|mesh-list
138543526|NCT00193141|Carboplatin|carboplatin|mesh-list
138543527|NCT00193141|Fluorouracil|fluorouracil|mesh-list
138543528|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138543529|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543530|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
138543531|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
138543532|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
138543533|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543534|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
138543535|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543536|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138543537|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
138543538|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543539|NCT00193297|Paclitaxel|paclitaxel|mesh-list
138543540|NCT00193297|Carboplatin|carboplatin|mesh-list
138543541|NCT00193297|Topotecan|topotecan|mesh-list
138543542|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138543543|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543544|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
138543545|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
138543546|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
138543547|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543548|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138543549|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138543550|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543551|NCT00193336|Gefitinib|gefitinib|mesh-list
138543552|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543553|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138543554|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543555|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543556|NCT00193531|Paclitaxel|paclitaxel|mesh-list
138543557|NCT00193531|Etoposide|etoposide|mesh-list
138543558|NCT00193531|Carboplatin|carboplatin|mesh-list
138543559|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138543560|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543561|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
138543562|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
138543563|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
138543564|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543565|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138543566|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138543567|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543568|NCT00193570|Docetaxel|docetaxel|mesh-list
138543569|NCT00193570|Topotecan|topotecan|mesh-list
138543570|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543571|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
138543572|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
138543573|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
138543574|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543575|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138543576|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138543577|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543578|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138230783|NCT02512809|Analgesics|analgesics|mesh-ancestor
138543579|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543580|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138543581|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543582|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543584|NCT00409591|Lopinavir|lopinavir|mesh-list
138543585|NCT00409591|Zidovudine|zidovudine|mesh-list
138543586|NCT00409591|Nevirapine|nevirapine|mesh-list
138543587|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138543588|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138543589|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
138543590|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543591|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543592|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138543593|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138543594|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
138543595|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543596|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138543597|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138543598|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
138543599|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138543600|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543601|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138543602|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138543603|NCT00409630|Fluticasone|fluticasone|mesh-list
138543604|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138543605|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138543606|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
138543607|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543608|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543609|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138543610|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
138543611|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
138543612|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138543613|NCT00060125|Tipifarnib|tipifarnib|mesh-list
138543614|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543615|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
138543616|NCT00193648|Adalimumab|adalimumab|mesh-list
138543617|NCT00193648|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138543618|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138543619|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138543620|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138543621|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543622|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138543623|NCT00193726|Estradiol|estradiol|mesh-list
138543624|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138543625|NCT00193726|Estrogens|estrogens|mesh-ancestor
138543626|NCT00193726|Hormones|hormones|mesh-ancestor
138543627|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138543628|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543629|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138543630|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
138543631|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138543632|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138543633|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138543634|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138543635|NCT00193882|Cisplatin|cisplatin|mesh-list
138543636|NCT00193882|Fluorouracil|fluorouracil|mesh-list
138543637|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543639|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543640|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543641|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138543642|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
138543643|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543644|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
138543645|NCT00060242|Combretastatin|combretastatin|mesh-list
138543646|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138543647|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543648|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
138543649|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
138543650|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
138543651|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543652|NCT00193921|Cisplatin|cisplatin|mesh-list
138543653|NCT00193921|Gemcitabine|gemcitabine|mesh-list
138543654|NCT00193921|Vinorelbine|vinorelbine|mesh-list
138543655|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543656|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543657|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
138543658|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543659|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138543660|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
138543661|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
138543662|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
138543663|NCT00194038|Aripiprazole|aripiprazole|mesh-list
138543664|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
138543665|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138543666|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138543667|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138543668|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138543669|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543670|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
138543671|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
138543672|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543673|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543674|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138543675|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138543676|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
138543677|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138543678|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138543679|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138543680|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138543681|NCT00060359|Paclitaxel|paclitaxel|mesh-list
138543682|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138543683|NCT00060359|Carboplatin|carboplatin|mesh-list
138543684|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138543685|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138543686|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543687|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
138543688|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
138543689|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
138543690|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543691|NCT00194272|Methotrexate|methotrexate|mesh-list
138543692|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138219924|NCT05306340|Antiemetics|antiemetics|mesh-ancestor
138219925|NCT05306340|Autonomic Agents|autonomic agents|mesh-ancestor
138219926|NCT05306340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138219927|NCT05306340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219928|NCT05306340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138219929|NCT05306340|Glucocorticoids|glucocorticoids|mesh-ancestor
138219930|NCT05306340|Hormones|hormones|mesh-ancestor
138219931|NCT05306340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138219932|NCT05306340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138430332|NCT01726400|Ribavirin|ribavirin|mesh-list
138219933|NCT05306340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219934|NCT05306340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138219935|NCT05306340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138219936|NCT05306340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219937|NCT05306340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219938|NCT05306340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138219939|NCT05306340|Immunologic Factors|immunologic factors|mesh-ancestor
138219940|NCT05306340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138543693|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
138543694|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138543695|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543696|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543698|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543699|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543700|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
138543701|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543702|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138543703|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138543704|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
138543705|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138543706|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543707|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
138543708|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
138543709|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138543710|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
138543711|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543712|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138543713|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138543714|NCT00194467|Valganciclovir|valganciclovir|mesh-list
138543715|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
138543716|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543717|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
138543718|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138324443|NCT04129008|Aspirin|aspirin|mesh-list
138543719|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138543720|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138543721|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543722|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543723|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
138543724|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543725|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543726|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138543727|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543729|NCT00194740|Vinorelbine|vinorelbine|mesh-list
138543730|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543731|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
138543732|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
138543733|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
138543734|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543735|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138543736|NCT00194818|Mesalamine|mesalamine|mesh-list
138543737|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138543738|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138543739|NCT00194818|Analgesics|analgesics|mesh-ancestor
138543740|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
138543741|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543742|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543743|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138543744|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138543745|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
138543746|NCT00194857|Hematinics|hematinics|mesh-ancestor
138543747|NCT00194935|Topotecan|topotecan|mesh-list
138543748|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138543749|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138543750|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543751|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543753|NCT00194974|Clonidine|clonidine|mesh-list
138543754|NCT00194974|Labetalol|labetalol|mesh-list
138543755|NCT00194974|Methyldopa|methyldopa|mesh-list
138543756|NCT00194974|Nifedipine|nifedipine|mesh-list
138543757|NCT00194974|Analgesics|analgesics|mesh-ancestor
138543758|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
138543759|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543760|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543761|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138543762|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
138220000|NCT05257083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138220001|NCT05257083|Glucocorticoids|glucocorticoids|mesh-ancestor
138220002|NCT05257083|Hormones|hormones|mesh-ancestor
138479975|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220003|NCT05257083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138220004|NCT05257083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138220007|NCT05257083|Growth Substances|growth substances|mesh-ancestor
138543763|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
138543764|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138543765|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138543766|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138543767|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
138543768|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543769|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543770|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138543771|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138230800|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138543772|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138543774|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
138543775|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138543776|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138543777|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138543778|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
138543779|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138543780|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138543781|NCT00195208|Pantoprazole|pantoprazole|mesh-list
138543782|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138543783|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138543784|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138543785|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138346906|NCT02267772|Morphine|morphine|mesh-list
138543786|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543787|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138543788|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138543789|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138543790|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
138543791|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543792|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138543793|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138543794|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543795|NCT00195286|Tazobactam|tazobactam|mesh-list
138543796|NCT00195286|Piperacillin|piperacillin|mesh-list
138543797|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138543798|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138430364|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
138543799|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543800|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138543801|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543802|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543804|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138543805|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543807|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138543808|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138543809|NCT00195364|Analgesics|analgesics|mesh-ancestor
138543810|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
138543811|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543812|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230987|NCT02517021|Palonosetron|palonosetron|mesh-list
138543813|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138543814|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138543815|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138543816|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138543817|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
138543819|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138543820|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543821|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138543822|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543823|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
138543824|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138543825|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
138543826|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543827|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
138543828|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138543829|NCT00195559|Estradiol|estradiol|mesh-list
138543831|NCT00195559|Hormones|hormones|mesh-ancestor
138543832|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138543833|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543834|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138543835|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
138543836|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138169656|NCT00673075|Carvedilol|carvedilol|mesh-list
138543837|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138479977|NCT02044250|Clopidogrel|clopidogrel|mesh-list
138543838|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138543839|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138543840|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138543841|NCT00084240|Azithromycin|azithromycin|mesh-list
138543842|NCT00084240|Chloroquine|chloroquine|mesh-list
138543843|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138543844|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
138543845|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
138543846|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138543847|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138231176|NCT05554939|Doxorubicin|doxorubicin|mesh-list
138543848|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543849|NCT00084240|Amebicides|amebicides|mesh-ancestor
138543850|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138543851|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138543852|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
138543853|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138543854|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138543855|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138543856|NCT00084240|Analgesics|analgesics|mesh-ancestor
138543857|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
138543858|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543859|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543860|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138543861|NCT00084240|Filaricides|filaricides|mesh-ancestor
138543862|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
138543863|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
138543864|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138543865|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543866|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543867|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138543868|NCT00195598|Paroxetine|paroxetine|mesh-list
138543869|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138543870|NCT00195598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138543871|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138543872|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138543873|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543874|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543875|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
138543876|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543877|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138543878|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
138543879|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138543880|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138543881|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138543882|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543883|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138543884|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
138543885|NCT00195637|Antibodies|antibodies|mesh-list
138543886|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
138543887|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138543888|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138543889|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
138543890|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543891|NCT00195754|Valproic Acid|valproic acid|mesh-list
138543892|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
138543893|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543894|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543896|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138543897|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543898|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
138543899|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138543900|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138543901|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138543902|NCT00195793|Atorvastatin|atorvastatin|mesh-list
138543903|NCT00195793|Ezetimibe|ezetimibe|mesh-list
138543904|NCT00195793|Fenofibrate|fenofibrate|mesh-list
138543905|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138543906|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138543907|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
138543908|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543909|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138543910|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138543911|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543912|NCT00195871|Cytarabine|cytarabine|mesh-list
138543913|NCT00195871|Prednisone|prednisone|mesh-list
138543914|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
138543915|NCT00195871|Methotrexate|methotrexate|mesh-list
138543916|NCT00195871|Etoposide|etoposide|mesh-list
138543917|NCT00195871|Vincristine|vincristine|mesh-list
138543918|NCT00195871|Daunorubicin|daunorubicin|mesh-list
138543919|NCT00195871|Asparaginase|asparaginase|mesh-list
138543920|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138543921|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
138543922|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543923|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138543924|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138543925|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
138637997|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543926|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543927|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543928|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138649756|NCT04392531|Cyclosporins|cyclosporins|mesh-list
138169686|NCT00673153|Vorinostat|vorinostat|mesh-list
138543929|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138543930|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
138543931|NCT00195871|Hormones|hormones|mesh-ancestor
138543932|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138543933|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138543934|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138543935|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
138543936|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138543937|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138543938|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
138543939|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
138543940|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543941|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138543942|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138543943|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138543944|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138543946|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
138543947|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
138543948|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
138543949|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
138543950|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543951|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138543952|NCT00195910|Morphine|morphine|mesh-list
138543953|NCT00195910|Hydromorphone|hydromorphone|mesh-list
138543954|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138543955|NCT00195910|Narcotics|narcotics|mesh-ancestor
138543956|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138543957|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543958|NCT00195910|Analgesics|analgesics|mesh-ancestor
138543959|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
138543960|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430435|NCT01731158|Sunitinib|sunitinib|mesh-list
138543961|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
138543962|NCT00195988|Tacrolimus|tacrolimus|mesh-list
138543963|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138543964|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
138543965|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220230|NCT04858009|Antimitotic Agents|antimitotic agents|mesh-ancestor
138220231|NCT04858009|Mitosis Modulators|mitosis modulators|mesh-ancestor
138324619|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138220232|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220290|NCT04743661|Dexamethasone|dexamethasone|mesh-list
138220291|NCT04743661|Bevacizumab|bevacizumab|mesh-list
138220292|NCT04743661|Irinotecan|irinotecan|mesh-list
138220293|NCT04743661|Temozolomide|temozolomide|mesh-list
138220294|NCT04743661|Antiemetics|antiemetics|mesh-list
138220295|NCT04743661|Emetics|emetics|mesh-list
138220296|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
138220297|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138220298|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220299|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220300|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138220301|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138169723|NCT01670084|Leucovorin|leucovorin|mesh-list
138220302|NCT04743661|Growth Substances|growth substances|mesh-ancestor
138220303|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220304|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
138220305|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138220306|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
138220307|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138220308|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138543966|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138543967|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543968|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543969|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138543970|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543971|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138543972|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
138543973|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138543974|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543975|NCT00060476|Rofecoxib|rofecoxib|mesh-list
138543976|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138543977|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138347088|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
138231644|NCT02620865|Antidotes|antidotes|mesh-ancestor
138543978|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138543979|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543980|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138543981|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138543982|NCT00060476|Analgesics|analgesics|mesh-ancestor
138543983|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
138543984|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138543985|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138543986|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138543987|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138543988|NCT00084279|Interferons|interferons|mesh-list
138543990|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
138543991|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
138543992|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
138543993|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138543994|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
138543995|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138543996|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
138543997|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138543998|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
138430453|NCT01731184|Midazolam|midazolam|mesh-list
138543999|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544000|NCT00196378|Estrogens|estrogens|mesh-list
138231720|NCT01499953|PENTA|penta|mesh-list
138544002|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
138544003|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
138544004|NCT00196378|Hormones|hormones|mesh-ancestor
138544005|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138544006|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544007|NCT00196417|Heparin|heparin|mesh-list
138544008|NCT00196417|Certoparin|certoparin|mesh-list
138544009|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
138544010|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138544011|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138544012|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544013|NCT00060554|Heparin|heparin|mesh-list
138544014|NCT00060554|PENTA|penta|mesh-list
138544015|NCT00060554|Fondaparinux|fondaparinux|mesh-list
138544016|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
138544017|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138544018|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138637998|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544019|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544020|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138544022|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138544023|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
138544024|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544025|NCT00048087|Docetaxel|docetaxel|mesh-list
138220309|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
138220311|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138220312|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138220313|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138220314|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138220315|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220316|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220317|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138220318|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
138220320|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220335|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
138220336|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138544026|NCT00048087|Gefitinib|gefitinib|mesh-list
138544027|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544028|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
138231946|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
138544029|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
138544030|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
138544031|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544032|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138544033|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544034|NCT00196534|Thrombin|thrombin|mesh-list
138544035|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
138544036|NCT00196534|Coagulants|coagulants|mesh-ancestor
138544037|NCT00048126|Capecitabine|capecitabine|mesh-list
138544038|NCT00048126|Irinotecan|irinotecan|mesh-list
138544039|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138544040|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
138544041|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544042|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544043|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138544044|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138544045|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544047|NCT00196612|Efavirenz|efavirenz|mesh-list
138544048|NCT00196612|Didanosine|didanosine|mesh-list
138544049|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
138544050|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544051|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138169758|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138544053|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544054|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544055|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138544056|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138544057|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138544058|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138544059|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138544060|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138544061|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138544062|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138544064|NCT00196690|Donepezil|donepezil|mesh-list
138544065|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138544066|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544067|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544068|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
138544069|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544070|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544071|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
138544072|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
138544073|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544075|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544076|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138544077|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138544078|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544079|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544080|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138544081|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
138544082|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138544083|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544084|NCT00196846|Goserelin|goserelin|mesh-list
138544085|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138544086|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544088|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138544089|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544090|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138544091|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544092|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
138544093|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138544094|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
138544095|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544096|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
138544097|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138544098|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
138544099|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544100|NCT00196885|Expectorants|expectorants|mesh-ancestor
138544101|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
138544102|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138544103|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
138544104|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544105|NCT00196885|Protective Agents|protective agents|mesh-ancestor
138544106|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544107|NCT00196885|Antidotes|antidotes|mesh-ancestor
138544109|NCT00048204|Vestipitant|vestipitant|mesh-list
138544110|NCT00048204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138544111|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138544112|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138544113|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544114|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544115|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
138544116|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544117|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138544118|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
138544119|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138544120|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138544121|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138544122|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544123|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138544125|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138544126|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138544127|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
138544129|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544130|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544131|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544132|NCT00060671|Rituximab|rituximab|mesh-list
138544133|NCT00060671|Pixantrone|pixantrone|mesh-list
138544134|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138544135|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544136|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
138544137|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544138|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138544139|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138544140|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138544141|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544142|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544143|NCT00197197|Aplaviroc|aplaviroc|mesh-list
138544144|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138544145|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138544146|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544147|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138544148|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138544149|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
138544150|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544151|NCT00409903|Eprosartan|eprosartan|mesh-list
138544152|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138544153|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
138544154|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138544155|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544156|NCT00084435|Docetaxel|docetaxel|mesh-list
138544157|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544158|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
138544159|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
138544160|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
138544161|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544162|NCT00197353|Bupivacaine|bupivacaine|mesh-list
138347274|NCT02369172|Bupropion|bupropion|mesh-list
138544163|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
138544164|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
138544165|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544166|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544167|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
138544168|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544169|NCT02962999|Ketamine|ketamine|mesh-list
138544170|NCT02962999|Analgesics|analgesics|mesh-ancestor
138544171|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
138232700|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138544172|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544173|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544174|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138544175|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138544176|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
138544178|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544179|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138544180|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138544181|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544182|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544183|NCT00084513|Trastuzumab|trastuzumab|mesh-list
138544184|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
138544185|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138544186|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544187|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138544188|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544189|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544190|NCT00084591|Capecitabine|capecitabine|mesh-list
138544191|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138544192|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
138544193|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544194|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544195|NCT00197548|Folic Acid|folic acid|mesh-list
138544196|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
138544197|NCT00197548|Vitamins|vitamins|mesh-ancestor
138544198|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
138544199|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544200|NCT00197548|Hematinics|hematinics|mesh-ancestor
138544201|NCT00197587|Nevirapine|nevirapine|mesh-list
138544202|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138544203|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138544204|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544205|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544206|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
138544207|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544208|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138544209|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138544210|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138544211|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138544213|NCT00197743|Beta Carotene|beta carotene|mesh-list
138544214|NCT00197743|Carotenoids|carotenoids|mesh-list
138544215|NCT00197743|Vitamins|vitamins|mesh-ancestor
138544216|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
138544217|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544218|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
138544219|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544220|NCT00197743|Protective Agents|protective agents|mesh-ancestor
138544221|NCT00197743|Provitamins|provitamins|mesh-ancestor
138544222|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
138233024|NCT04522167|Growth Substances|growth substances|mesh-ancestor
138544223|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138347346|NCT02391714|Povidone|povidone|mesh-list
138370477|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
138370479|NCT01405079|Vinorelbine|vinorelbine|mesh-list
138370480|NCT01405079|Gefitinib|gefitinib|mesh-list
138370481|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138370482|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138370483|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
138370484|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
138370485|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
138370486|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370487|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138370488|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370489|NCT01405118|Metformin|metformin|mesh-list
138370490|NCT01405118|Tofacitinib|tofacitinib|mesh-list
138544224|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138544225|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544226|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544227|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138544228|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
138544229|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544231|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138544232|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138544233|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138544234|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138544235|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544236|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544237|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544238|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138544239|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
138544240|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138544241|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138544242|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138430493|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138544243|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544244|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138544246|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
138544247|NCT00060866|Propranolol|propranolol|mesh-list
138544248|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138544249|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138324855|NCT01454622|Metformin|metformin|mesh-list
138544250|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
138544251|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544252|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544253|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544254|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138544255|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138544256|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
138544257|NCT00048360|Bupropion|bupropion|mesh-list
138544258|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138544259|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
138544260|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138544261|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138233419|NCT01357148|Metformin|metformin|mesh-list
138544262|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138544264|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544265|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
138544266|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544267|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544268|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138544269|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138544270|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544271|NCT00198055|Aripiprazole|aripiprazole|mesh-list
138544272|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
138544273|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138544274|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138544275|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138233566|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138544276|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544278|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
138544279|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
138544280|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544281|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544282|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138544283|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138544284|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
138649757|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544285|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138544286|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138544287|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138233633|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
138544288|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138544290|NCT00198094|Sertraline|sertraline|mesh-list
138544291|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
138544292|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138544293|NCT00198094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138544294|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138544295|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138544296|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544297|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544298|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
138544299|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544300|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138544301|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138233693|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
138544302|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138544303|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138544304|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
138544305|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
138544306|NCT00198172|Epirubicin|epirubicin|mesh-list
138430503|NCT01731561|Rituximab|rituximab|mesh-list
138544307|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544308|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138544309|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138544310|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138544311|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544312|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544313|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138544314|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138544315|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138544316|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138544317|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544318|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544319|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544320|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138544321|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
138544324|NCT00084708|Dexamethasone|dexamethasone|mesh-list
138544326|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138544327|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
138544328|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
138544329|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138169856|NCT02115074|Celecoxib|celecoxib|mesh-list
138544330|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544331|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138544334|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138544335|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138544336|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544337|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138544338|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544339|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544340|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138544341|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138544342|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138544343|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138544345|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
138544346|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138544347|NCT00198367|Cisplatin|cisplatin|mesh-list
138544348|NCT00198367|Carboplatin|carboplatin|mesh-list
138544349|NCT00198367|Vinorelbine|vinorelbine|mesh-list
138544350|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544351|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544352|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138544353|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
138544354|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
138544355|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
138544356|NCT00198445|Bromfenac|bromfenac|mesh-list
138544357|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138544358|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138544359|NCT00198445|Analgesics|analgesics|mesh-ancestor
138544360|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
138544361|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544362|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544363|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138544364|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138544365|NCT00048399|Fludarabine|fludarabine|mesh-list
138544366|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
138544367|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544368|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138544369|NCT00060905|Valproic Acid|valproic acid|mesh-list
138544370|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
138544371|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544372|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544373|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
138544374|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544375|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544376|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
138544377|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138544378|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544379|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138544380|NCT00198523|Tobramycin|tobramycin|mesh-list
138544381|NCT00198523|Prednisolone|prednisolone|mesh-list
138544382|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138544383|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
138544384|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138544385|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
138544386|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138544387|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
138544388|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138544389|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
138544390|NCT00198523|Hormones|hormones|mesh-ancestor
138544391|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138544392|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544393|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138544394|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544396|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
138544397|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544398|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138544399|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138544400|NCT00198523|Protective Agents|protective agents|mesh-ancestor
138544401|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138544402|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544403|NCT00198562|Losartan|losartan|mesh-list
138544404|NCT00198562|Amlodipine|amlodipine|mesh-list
138544405|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
138544406|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138544407|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138324982|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544408|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544409|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138544410|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544411|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
138544412|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138544413|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138544414|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138544415|NCT00409942|Torsemide|torsemide|mesh-list
138544417|NCT00409942|Diuretics|diuretics|mesh-ancestor
138544418|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
138544419|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544420|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138544421|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138544422|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234168|NCT01373450|Hormones|hormones|mesh-ancestor
138544423|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138544425|NCT00084786|Gefitinib|gefitinib|mesh-list
138544426|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544427|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
138544428|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
138544429|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
138544430|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544431|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138544432|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544433|NCT00409981|Paclitaxel|paclitaxel|mesh-list
138544434|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138544435|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544436|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
138544437|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
138544438|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
138347558|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
138544439|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138234447|NCT01404260|Gefitinib|gefitinib|mesh-list
138544440|NCT00198601|Gentamicins|gentamicins|mesh-list
138544441|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138544442|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544443|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138544444|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544445|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544446|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138234509|NCT05588037|Dexamethasone|dexamethasone|mesh-list
138544447|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544448|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
138544449|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138544450|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544451|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
138544452|NCT00084825|Docetaxel|docetaxel|mesh-list
138544453|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
138169891|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
138544454|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544455|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
138544456|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
138544457|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
138544458|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544459|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138544460|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544461|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138544462|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544463|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220768|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
138220769|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
138220770|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220771|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138220772|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138544465|NCT00199147|Fludarabine|fludarabine|mesh-list
138544466|NCT00199147|Etoposide|etoposide|mesh-list
138544467|NCT00199147|Idarubicin|idarubicin|mesh-list
138544468|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544469|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138544470|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
138544471|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544472|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138544473|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
138544474|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544475|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138544476|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138544477|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138544478|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544479|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
138544480|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544481|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138544482|NCT00199186|Cytarabine|cytarabine|mesh-list
138544483|NCT00199186|Dexamethasone|dexamethasone|mesh-list
138544484|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
138544485|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
138544487|NCT00199186|Vincristine|vincristine|mesh-list
138544488|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
138544489|NCT00199186|Idarubicin|idarubicin|mesh-list
138544490|NCT00199186|BB 1101|bb 1101|mesh-list
138430536|NCT01731652|Imiquimod|imiquimod|mesh-list
138544491|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138544492|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
138544493|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544494|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138544495|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138544496|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
138234908|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138544497|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544498|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544499|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138544500|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138544502|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
138544503|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544504|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138544505|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
138544506|NCT00199186|Hormones|hormones|mesh-ancestor
138347635|NCT05720442|Mosapride|mosapride|mesh-list
138544507|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138544508|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138544509|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
138544510|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544511|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138544512|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
138544513|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138544514|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138544515|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
138544516|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
138544517|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138544518|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138235048|NCT02706249|Enoxaparin|enoxaparin|mesh-list
138544519|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138544520|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
138544521|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
138544522|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
138235117|NCT03206151|Leucovorin|leucovorin|mesh-list
138544523|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
138544524|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544525|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138544526|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138544527|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138544529|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
138544530|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138544531|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544532|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138544533|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138544534|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220841|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220842|NCT03568656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220851|NCT03564821|Ivosidenib|ivosidenib|mesh-list
138544535|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544536|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544537|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
138544538|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
138544539|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544540|NCT00061022|Protective Agents|protective agents|mesh-ancestor
138544541|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544543|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
138544544|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544545|NCT00199342|Ecromeximab|ecromeximab|mesh-list
138430542|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
138544546|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138544547|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544548|NCT00199420|Istradefylline|istradefylline|mesh-list
138544549|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138544550|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138544551|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138544552|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
138544553|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544554|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544555|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544556|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
138544557|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138544558|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138544559|NCT00199576|Prednisolone|prednisolone|mesh-list
138544560|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
138544561|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138544562|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
138544563|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138544564|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
138544565|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
138544566|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544567|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544568|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138544569|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
138544571|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138370491|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138370492|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370493|NCT01405118|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138370494|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138370495|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544572|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138544573|NCT00199576|Protective Agents|protective agents|mesh-ancestor
138544574|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138544575|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544577|NCT00084942|Capecitabine|capecitabine|mesh-list
138544578|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138544579|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
138544580|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544581|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544582|NCT02968394|Omalizumab|omalizumab|mesh-list
138544583|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138544584|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138544585|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
138544586|NCT00199771|Dextrans|dextrans|mesh-list
138544587|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
138544588|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
138544589|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
138544591|NCT00084981|Azacitidine|azacitidine|mesh-list
138544592|NCT00084981|Valproic Acid|valproic acid|mesh-list
138544593|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138544594|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
138325106|NCT04844268|Vaccines|vaccines|mesh-list
138544595|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544596|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544597|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544598|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
138544599|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
138544600|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544601|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544602|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
138430560|NCT01731756|Emollients|emollients|mesh-ancestor
138544603|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138544604|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544605|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138544606|NCT00199966|Valproic Acid|valproic acid|mesh-list
138544607|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
138544608|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544609|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544610|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
138220915|NCT03312400|Danazol|danazol|mesh-list
138220916|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138220917|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
138220919|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544611|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544612|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544613|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
138544614|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138544615|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544616|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138544617|NCT00085020|Trastuzumab|trastuzumab|mesh-list
138544618|NCT00085020|Lapatinib|lapatinib|mesh-list
138544619|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138544620|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544621|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138544622|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544623|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544625|NCT00410215|Cathartics|cathartics|mesh-ancestor
138544626|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138544627|NCT00410215|Laxatives|laxatives|mesh-ancestor
138544628|NCT00410254|Midazolam|midazolam|mesh-list
138235863|NCT01489826|HU 211|hu 211|mesh-list
138544629|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138544630|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138544631|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544632|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544633|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138544634|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138544635|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138544636|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138544637|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
138544639|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
138544640|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
138544641|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544642|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544643|NCT00061178|Bevacizumab|bevacizumab|mesh-list
138544644|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138544645|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544646|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138544647|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138544648|NCT00061178|Growth Substances|growth substances|mesh-ancestor
138544649|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544650|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
138544651|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138544652|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544653|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138544654|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544655|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544656|NCT00200434|Nebivolol|nebivolol|mesh-list
138544657|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138236029|NCT02867865|Gemcitabine|gemcitabine|mesh-list
138544658|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
138544659|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138544660|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138544661|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138544662|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
138544663|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544664|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544665|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544666|NCT00200473|Nebivolol|nebivolol|mesh-list
138544667|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138544668|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
138544669|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138544670|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138544671|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138544672|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
138544673|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544674|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544675|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544677|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138544678|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544679|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138544680|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544682|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138544683|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544684|NCT00200512|Apomorphine|apomorphine|mesh-list
138220988|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544685|NCT00200512|Emetics|emetics|mesh-ancestor
138544686|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544687|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
138544688|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544689|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138544690|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
138544691|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
138544692|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544693|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544694|NCT00200551|Cyclosporine|cyclosporine|mesh-list
138544695|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
138544696|NCT00200551|Cyclosporins|cyclosporins|mesh-list
138544697|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138544698|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544699|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544700|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138544701|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
138544702|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544703|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
138544704|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544705|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
138544706|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138544707|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138236499|NCT00552305|Lacosamide|lacosamide|mesh-list
138544709|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544710|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138544711|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
138544712|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138544713|NCT00061256|Vitamin D|vitamin d|mesh-list
138544714|NCT00061256|Alendronate|alendronate|mesh-list
138544715|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
138544716|NCT00061256|Calcium|calcium|mesh-list
138544717|NCT00061256|Vitamins|vitamins|mesh-ancestor
138544718|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
138544719|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544720|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138544721|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138544722|NCT00061256|Antacids|antacids|mesh-ancestor
138544723|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544724|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138544725|NCT00200590|Acetaminophen|acetaminophen|mesh-list
138544726|NCT00200590|Morphine|morphine|mesh-list
138544727|NCT00200590|Nalbuphine|nalbuphine|mesh-list
138544728|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138544729|NCT00200590|Narcotics|narcotics|mesh-ancestor
138236696|NCT01554488|Xhance|xhance|mesh-list
138544730|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544731|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544732|NCT00200590|Analgesics|analgesics|mesh-ancestor
138544733|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
138544734|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544735|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138544736|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
138544737|NCT00200629|Adenosine|adenosine|mesh-list
138544738|NCT00200629|Analgesics|analgesics|mesh-ancestor
138544739|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
138544740|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544741|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544742|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138169960|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544743|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
138544744|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138544745|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
138544746|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
138544747|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544748|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544749|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138544750|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138544751|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544752|NCT00048594|Aprepitant|aprepitant|mesh-list
138544753|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
138544754|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
138544755|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544756|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544757|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138544758|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138544759|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544760|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544762|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
138544763|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138544764|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544765|NCT00201253|Dimercaprol|dimercaprol|mesh-list
138544766|NCT00201253|Chelating Agents|chelating agents|mesh-ancestor
138544767|NCT00201253|Sequestering Agents|sequestering agents|mesh-ancestor
138236815|NCT01556594|Glucagon|glucagon|mesh-list
138544768|NCT00201253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544770|NCT00201331|Antidotes|antidotes|mesh-ancestor
138544771|NCT00201331|Protective Agents|protective agents|mesh-ancestor
138544772|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544773|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
138544774|NCT00201331|Vitamins|vitamins|mesh-ancestor
138544775|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
138544776|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
138325219|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
138544777|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544778|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138544779|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138637999|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138544780|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544781|NCT00201682|Etanercept|etanercept|mesh-list
138544782|NCT00201682|Rituximab|rituximab|mesh-list
138544783|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138544784|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544785|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
138544786|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544787|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138544788|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138544789|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138544791|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
138544792|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544793|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138544794|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138544795|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138544796|NCT00410371|Lamotrigine|lamotrigine|mesh-list
138544797|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
138544798|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138544799|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138544800|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544801|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138544802|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544803|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138544804|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138544805|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544806|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138544807|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138544808|NCT00410449|Tocopherols|tocopherols|mesh-list
138544809|NCT00410449|Vitamin E|vitamin e|mesh-list
138544810|NCT00410449|Tocotrienols|tocotrienols|mesh-list
138544811|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
138544813|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544814|NCT00410449|Protective Agents|protective agents|mesh-ancestor
138544815|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544816|NCT00410449|Vitamins|vitamins|mesh-ancestor
138544817|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
138544820|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138544821|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
138325244|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544822|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544823|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544824|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544825|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138544826|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138544827|NCT00410527|Meropenem|meropenem|mesh-list
138638000|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138544828|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138544829|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544830|NCT00048750|Micafungin|micafungin|mesh-list
138544831|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
138544832|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544833|NCT00221416|Aripiprazole|aripiprazole|mesh-list
138544834|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
138544835|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138544836|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138544837|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138544838|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544839|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544841|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
138544842|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544843|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544844|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138544845|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138544846|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
138544847|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138544848|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138544849|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138544850|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138544851|NCT00221494|Pindolol|pindolol|mesh-list
138544852|NCT00221494|Citalopram|citalopram|mesh-list
138544853|NCT00221494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138544854|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138544855|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138544856|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544857|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544858|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
138544859|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544860|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138544861|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
138544862|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138544863|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138544864|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138544865|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
138544866|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138544867|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138544868|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
138544870|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138544871|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544872|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138544873|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544874|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138544875|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
138544876|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
138325278|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
138544877|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544878|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544879|NCT00221650|Ribavirin|ribavirin|mesh-list
138544880|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138544881|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
138544882|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544883|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
138544884|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544885|NCT00221689|Baclofen|baclofen|mesh-list
138544886|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138544887|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544888|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138544889|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544890|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138544891|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
138544892|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
138544893|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544894|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544895|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
138544896|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
138544897|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544898|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544899|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544900|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
138544901|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
138544902|NCT00412789|Epothilone B|epothilone b|mesh-list
138544903|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138544904|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
138544905|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
138544906|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
138488548|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348043|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
138544907|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544910|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
138544911|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
138544912|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544913|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544914|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138544915|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138544916|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138544917|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544918|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138325297|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
138544919|NCT00048828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138544920|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138544921|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138544922|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544923|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544925|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138544926|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
138544927|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
138544928|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138544929|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138544930|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138544931|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138544932|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138544933|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138544934|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138544935|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
138544936|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544937|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544938|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544940|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138544941|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138544942|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138544943|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544944|NCT00085761|Capsaicin|capsaicin|mesh-list
138544945|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
138544946|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
138544947|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
138544948|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138544949|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544950|NCT00221962|Aripiprazole|aripiprazole|mesh-list
138544951|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
138544952|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138544953|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138544954|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138544955|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138544956|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544958|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
138544959|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544960|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544961|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138544962|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138544963|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
138544964|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138544965|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138237289|NCT00373503|Hormones|hormones|mesh-ancestor
138544966|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138544967|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138544968|NCT02968160|Telmisartan|telmisartan|mesh-list
138544969|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138544970|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138544971|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138544972|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
138544973|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544974|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138544975|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138544976|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544977|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138544978|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138544979|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138544981|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138544982|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138544983|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138544984|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138544985|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544986|NCT00222235|Cycloserine|cycloserine|mesh-list
138544987|NCT00222235|Glycine|glycine|mesh-list
138544988|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138544989|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138544990|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138544991|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
138544992|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138544993|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
138544994|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138544995|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
138544996|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138544997|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138544998|NCT00061646|Carboplatin|carboplatin|mesh-list
138544999|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545000|NCT00222469|Bevacizumab|bevacizumab|mesh-list
138545001|NCT00222469|Gemcitabine|gemcitabine|mesh-list
138545002|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
138545003|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138545004|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545005|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138545006|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138545007|NCT00222469|Growth Substances|growth substances|mesh-ancestor
138545008|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545009|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
138545010|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138545011|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
138545012|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545014|NCT00222547|Albendazole|albendazole|mesh-list
138545015|NCT00222547|Vitamins|vitamins|mesh-ancestor
138545016|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
138325355|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
138545017|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138170064|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545018|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545019|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545021|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138545022|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138545023|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
138545024|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138545025|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138545026|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
138545027|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
138545028|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
138545029|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
138545030|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545031|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138545032|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
138545033|NCT02968082|Scopolamine|scopolamine|mesh-list
138545034|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138545035|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138545036|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
138545037|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
138545038|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545039|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237441|NCT06195267|Sivelestat|sivelestat|mesh-list
138545040|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138545041|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
138545042|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138545043|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
138348188|NCT02452866|Secnidazole|secnidazole|mesh-list
138545044|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545045|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638001|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138545046|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138545049|NCT00222820|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138545050|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138545051|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138545052|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237573|NCT06194032|Moxifloxacin|moxifloxacin|mesh-list
138545053|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545054|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
138545055|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545056|NCT00085332|Docetaxel|docetaxel|mesh-list
138545057|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545058|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
138545059|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
138545060|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
138545061|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545063|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138545064|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138545065|NCT00222976|Analgesics|analgesics|mesh-ancestor
138545066|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
138545067|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545069|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138545070|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138545071|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
138545072|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138545073|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545074|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545075|NCT00223015|Tacrolimus|tacrolimus|mesh-list
138545076|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138545077|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
138430883|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
138545078|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545079|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138545081|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545082|NCT00061763|Deferasirox|deferasirox|mesh-list
138545083|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138545084|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
138545085|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
138545086|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545087|NCT00223054|Cyclosporine|cyclosporine|mesh-list
138545088|NCT00223054|Sirolimus|sirolimus|mesh-list
138545090|NCT00223054|Tacrolimus|tacrolimus|mesh-list
138545091|NCT00223054|Cyclosporins|cyclosporins|mesh-list
138348245|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138545092|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138545093|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
138545094|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545095|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138237681|NCT06190483|Diazepam|diazepam|mesh-list
138545096|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545097|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545098|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
138545099|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138545100|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
138545101|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138545102|NCT00223054|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138545103|NCT00223054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138545104|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545105|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138237748|NCT06190158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138237749|NCT06190158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237750|NCT06190158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138237751|NCT06190158|Glucocorticoids|glucocorticoids|mesh-ancestor
138237752|NCT06190158|Hormones|hormones|mesh-ancestor
138237753|NCT06190158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138237754|NCT06190158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138237761|NCT06190145|Teriflunomide|teriflunomide|mesh-list
138545106|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138545107|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138325424|NCT02359968|Paclitaxel|paclitaxel|mesh-list
138545108|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
138545109|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138545110|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138545111|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138545112|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138545113|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545115|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138545116|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138545117|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
138545118|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545119|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545120|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545121|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138545122|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138545123|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138545124|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138545125|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138545126|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
138545127|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
138545128|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138545129|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
138545130|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138545131|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138545132|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138545133|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138545134|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545135|NCT00223288|Escitalopram|escitalopram|mesh-list
138545136|NCT00223288|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138545137|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138545138|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138545139|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545140|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545141|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
138545142|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545143|NCT00085449|Cyclosporine|cyclosporine|mesh-list
138348290|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545144|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
138545145|NCT00085449|Fludarabine|fludarabine|mesh-list
138545146|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
138545148|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
138545149|NCT00085449|Cyclosporins|cyclosporins|mesh-list
138545150|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545151|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138545153|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545154|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138545155|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
138545156|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545157|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545158|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
138545159|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138545160|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
138545161|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138545162|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138545163|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138545164|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138545165|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
138545166|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138545167|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138545168|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
138545169|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138545170|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138545171|NCT00223561|Methylphenidate|methylphenidate|mesh-list
138545172|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138545173|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545174|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138545175|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138545176|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138545177|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545178|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
138431018|NCT01735318|Lisinopril|lisinopril|mesh-list
138545179|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545180|NCT00223639|Topiramate|topiramate|mesh-list
138545181|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
138545182|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138545183|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545184|NCT00223717|Aspirin|aspirin|mesh-list
138545185|NCT00223717|Losartan|losartan|mesh-list
138545186|NCT00223717|Metoprolol|metoprolol|mesh-list
138545187|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138545188|NCT00223717|Clonidine|clonidine|mesh-list
138545189|NCT00223717|Eplerenone|eplerenone|mesh-list
138545190|NCT00223717|Nebivolol|nebivolol|mesh-list
138545191|NCT00223717|Bosentan|bosentan|mesh-list
138545192|NCT00223717|Diltiazem|diltiazem|mesh-list
138545193|NCT00223717|Guanfacine|guanfacine|mesh-list
138545194|NCT00223717|Prazosin|prazosin|mesh-list
138545195|NCT00223717|Captopril|captopril|mesh-list
138545196|NCT00223717|Hydralazine|hydralazine|mesh-list
138545197|NCT00223717|Nifedipine|nifedipine|mesh-list
138545198|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138545199|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
138545201|NCT00223717|Dipyridamole|dipyridamole|mesh-list
138545202|NCT00223717|Carbidopa|carbidopa|mesh-list
138545203|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138545204|NCT00223717|Tamsulosin|tamsulosin|mesh-list
138545205|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138545206|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138545207|NCT00223717|Analgesics|analgesics|mesh-ancestor
138545208|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
138545209|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138325469|NCT01450956|Sevoflurane|sevoflurane|mesh-list
138545210|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545212|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138545213|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138545214|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138545215|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238090|NCT06104449|Glucocorticoids|glucocorticoids|mesh-ancestor
138545216|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138545218|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545219|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
138545221|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138545222|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138545223|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138545224|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
138545225|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138545226|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138545227|NCT00223717|Urological Agents|urological agents|mesh-ancestor
138545228|NCT00223717|Diuretics|diuretics|mesh-ancestor
138545229|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
138545230|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138545231|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138545232|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
138545233|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
138545234|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138545235|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138545236|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138545237|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
138545238|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545239|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138545240|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138238356|NCT05947448|Nifedipine|nifedipine|mesh-list
138545241|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138545242|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138545243|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138545244|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138545245|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138545246|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
138545247|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138545248|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138170126|NCT03781388|Bupivacaine|bupivacaine|mesh-list
138170128|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
138545249|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138545251|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138545252|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138545253|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
138545254|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138545255|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138431078|NCT01735669|Analgesics|analgesics|mesh-ancestor
138545256|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138545257|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138545258|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138545259|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
138545260|NCT00223717|Coagulants|coagulants|mesh-ancestor
138238568|NCT05837013|Anesthetics|anesthetics|mesh-list
138545261|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138545262|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138545263|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
138545264|NCT00061919|Thalidomide|thalidomide|mesh-list
138545265|NCT00061919|Carboplatin|carboplatin|mesh-list
138545266|NCT00061919|Etoposide|etoposide|mesh-list
138545267|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
138545268|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545269|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138545270|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138545271|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138545272|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638002|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138545273|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545275|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
138545276|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545277|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
138545278|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138545279|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138545280|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138545281|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138545282|NCT00061919|Growth Substances|growth substances|mesh-ancestor
138545283|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
138545284|NCT00085527|Romidepsin|romidepsin|mesh-list
138545285|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138545286|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545287|NCT00085527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138545289|NCT00085527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545290|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
138545291|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545292|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
138545293|NCT00224068|Hematinics|hematinics|mesh-ancestor
138545294|NCT00224146|Oxybutynin|oxybutynin|mesh-list
138545295|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
138545296|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
138545297|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545298|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545299|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138545300|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138545301|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
138545302|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545303|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545304|NCT00224146|Urological Agents|urological agents|mesh-ancestor
138545305|NCT00061997|Inositol|inositol|mesh-list
138545306|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
138545307|NCT00061997|Vitamins|vitamins|mesh-ancestor
138545308|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
138238824|NCT05669482|Paclitaxel|paclitaxel|mesh-list
138545309|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545311|NCT00224185|Chelating Agents|chelating agents|mesh-ancestor
138545312|NCT00224185|Sequestering Agents|sequestering agents|mesh-ancestor
138545313|NCT00224185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545314|NCT00062036|Aldesleukin|aldesleukin|mesh-list
138545315|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
138545316|NCT00062036|Fludarabine|fludarabine|mesh-list
138545317|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
138545318|NCT00062036|Interleukin-2|interleukin-2|mesh-list
138545319|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
138545320|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138545321|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
138545322|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545323|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138545324|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138545325|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
138545326|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545327|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545328|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138545329|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138545330|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
138545331|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138545332|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138545333|NCT00062036|Analgesics|analgesics|mesh-ancestor
138545334|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
138545335|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545336|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138545337|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138545338|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
138545339|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138545340|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138545341|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138545342|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138545343|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138325548|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138545344|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545345|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545346|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545347|NCT00224302|Analgesics|analgesics|mesh-ancestor
138545348|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
138545349|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545350|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
138545351|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138545352|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
138545353|NCT00062075|Romidepsin|romidepsin|mesh-list
138545354|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138545355|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545356|NCT00062075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138545357|NCT00062075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431201|NCT01736514|Allopurinol|allopurinol|mesh-list
138545358|NCT00062075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545359|NCT00224419|Nicotine|nicotine|mesh-list
138545360|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138545361|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
138545362|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545363|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545364|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138545365|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138545366|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
138239282|NCT05377242|Protective Agents|protective agents|mesh-ancestor
138239283|NCT05377242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138239285|NCT05369832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138239286|NCT05369832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239296|NCT05359861|Bevacizumab|bevacizumab|mesh-list
138545367|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545368|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545369|NCT00224458|Efavirenz|efavirenz|mesh-list
138545370|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138545371|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138545372|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138545373|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545374|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545375|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
138545376|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138545377|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138545378|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138545379|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138545380|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138545381|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138545382|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138545383|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138545384|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138545385|NCT00062114|Rituximab|rituximab|mesh-list
138545386|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138545387|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545388|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
138545389|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545390|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138545391|NCT00095043|Gaboxadol|gaboxadol|mesh-list
138545392|NCT00095043|Analgesics|analgesics|mesh-ancestor
138545393|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
138545394|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545395|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545396|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
138545397|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
138545399|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545400|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545401|NCT00095082|Insulin|insulin|mesh-list
138545402|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138545403|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
138545404|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
138545405|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
138545406|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138545407|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545408|NCT00062231|Amoxicillin|amoxicillin|mesh-list
138545409|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
138545410|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
138545411|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
138239452|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239453|NCT05184712|Carboplatin|carboplatin|mesh-list
138239454|NCT05184712|Pemetrexed|pemetrexed|mesh-list
138239455|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545412|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
138545413|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138545414|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138545415|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138545416|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138545417|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138545418|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138545419|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545420|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545421|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545422|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138545423|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
138545424|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138545425|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545426|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138545427|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138325597|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
138545428|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138545429|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138545430|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138545431|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138545432|NCT00224692|Ketamine|ketamine|mesh-list
138545433|NCT00224692|Analgesics|analgesics|mesh-ancestor
138545434|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
138545435|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545436|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545437|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138545438|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138545439|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
138545440|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
138545441|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138545442|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138545443|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138545444|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545445|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545447|NCT00224809|Spironolactone|spironolactone|mesh-list
138545448|NCT00224809|Clopidogrel|clopidogrel|mesh-list
138545449|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138545450|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138545451|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138545452|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138545453|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138545455|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
138545456|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545457|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545458|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138545459|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138545460|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138545461|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138545462|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545463|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138545464|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138545465|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
138545466|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138545467|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138545468|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138545469|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
138239786|NCT04868409|Rocuronium|rocuronium|mesh-list
138545470|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545471|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138545472|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
138545473|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138545474|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138545475|NCT00224809|Diuretics|diuretics|mesh-ancestor
138325625|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138545476|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
138545477|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
138545478|NCT00062270|Gemcitabine|gemcitabine|mesh-list
138545479|NCT00062270|Docetaxel|docetaxel|mesh-list
138545480|NCT00062270|Gefitinib|gefitinib|mesh-list
138545481|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545482|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138545484|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545486|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
138545487|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
138545488|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138545489|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545490|NCT00413023|Casopitant|casopitant|mesh-list
138545491|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
138545492|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
138545493|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545494|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545495|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138545496|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138348647|NCT02562924|Prednisone|prednisone|mesh-list
138545497|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545498|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545499|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
138545500|NCT00095277|Hematinics|hematinics|mesh-ancestor
138545501|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
138545502|NCT00413101|Hematinics|hematinics|mesh-ancestor
138545504|NCT00413179|Clomiphene|clomiphene|mesh-list
138545505|NCT00413179|Enclomiphene|enclomiphene|mesh-list
138545506|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
138545507|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138545508|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545509|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138545510|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
138545511|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138545512|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138545513|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
138545514|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138545515|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138545516|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138545517|NCT00413257|Nefopam|nefopam|mesh-list
138545518|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138545519|NCT00413257|Analgesics|analgesics|mesh-ancestor
138545520|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
138545521|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545522|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545523|NCT00095316|Caspofungin|caspofungin|mesh-list
138545524|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
138545525|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138545526|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545527|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545528|NCT00225043|Phenylephrine|phenylephrine|mesh-list
138545529|NCT00225043|Epinephrine|epinephrine|mesh-list
138545530|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
138545531|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138545532|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138545533|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
138431312|NCT01737294|Capsaicin|capsaicin|mesh-list
138545535|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545536|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545537|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138545538|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138545539|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
138545540|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545541|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138545542|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
138545543|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
138545544|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
138545545|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138545546|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138545547|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
138545548|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138545549|NCT00225043|Protective Agents|protective agents|mesh-ancestor
138170197|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
138545550|NCT00095355|Valproic Acid|valproic acid|mesh-list
138545551|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138545552|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138314664|NCT01721070|Sufentanil|sufentanil|mesh-list
138545553|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545554|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
138545555|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138545556|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138545557|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545558|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
138545559|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
138545560|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138348714|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545561|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
138545562|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
138545563|NCT00225160|Vitamins|vitamins|mesh-ancestor
138545564|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
138240209|NCT04344873|Abatacept|abatacept|mesh-list
138545565|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545566|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
138545567|NCT00225238|Esomeprazole|esomeprazole|mesh-list
138545568|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138545569|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138545570|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138545571|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545572|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545573|NCT00062426|Leucovorin|leucovorin|mesh-list
138545574|NCT00062426|Bevacizumab|bevacizumab|mesh-list
138545575|NCT00062426|Capecitabine|capecitabine|mesh-list
138545576|NCT00062426|Fluorouracil|fluorouracil|mesh-list
138545577|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
138545578|NCT00062426|Calcium|calcium|mesh-list
138545579|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
138545580|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138545581|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545582|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138545583|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138545584|NCT00062426|Growth Substances|growth substances|mesh-ancestor
138545585|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545586|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
138545587|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138545588|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138545589|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
138545590|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545591|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138545592|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
138545593|NCT00062426|Antidotes|antidotes|mesh-ancestor
138545594|NCT00062426|Protective Agents|protective agents|mesh-ancestor
138545595|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
138545597|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
138545598|NCT00095433|Ranibizumab|ranibizumab|mesh-list
138545599|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138431389|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
138545600|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138545601|NCT00095433|Growth Substances|growth substances|mesh-ancestor
138545602|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545603|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
138545604|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545606|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138545607|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545608|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138545609|NCT00225433|Ganirelix|ganirelix|mesh-list
138545610|NCT00225433|Hormones|hormones|mesh-ancestor
138545611|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138545612|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545613|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
138545614|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138545615|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545616|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545617|NCT02962258|Amlodipine|amlodipine|mesh-list
138545618|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138545619|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138545620|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138545621|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138545622|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545623|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138240535|NCT03869190|Gemcitabine|gemcitabine|mesh-list
138545624|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545625|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
138545626|NCT02962258|Diuretics|diuretics|mesh-ancestor
138545627|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
138545628|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138545629|NCT00225511|Milnacipran|milnacipran|mesh-list
138545630|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138545631|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
138545632|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138545633|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138545634|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138545635|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545636|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325695|NCT02442180|Prednisolone|prednisolone|mesh-list
138545637|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545638|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138545639|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
138545640|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138545641|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138545642|NCT00225511|Analgesics|analgesics|mesh-ancestor
138545643|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
138545644|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545645|NCT00095511|Aripiprazole|aripiprazole|mesh-list
138545646|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
138545647|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138545648|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138545649|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138545650|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138545651|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545652|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
138545653|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
138545654|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545655|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545656|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138545657|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138545658|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
138545659|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138545660|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138545661|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138545662|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138545663|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138545665|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138545666|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545667|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138545668|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138545669|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
138545670|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545671|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138545672|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138545673|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545674|NCT02967887|Fluorouracil|fluorouracil|mesh-list
138545675|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545676|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
138545677|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545678|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138348842|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138348843|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
138545680|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
138545681|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545683|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138545684|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138545685|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138545686|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545687|NCT00225706|Ibuprofen|ibuprofen|mesh-list
138545688|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138545689|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138545691|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
138545692|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545693|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545694|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138545695|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138545696|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138545697|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545698|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545699|NCT00095667|Lapatinib|lapatinib|mesh-list
138545700|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545701|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138545702|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545703|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545704|NCT00225862|Ropinirole|ropinirole|mesh-list
138545705|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138545706|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138545707|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
138545708|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
138545709|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545710|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545711|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545712|NCT00095706|Bevacizumab|bevacizumab|mesh-list
138545713|NCT00095706|Trastuzumab|trastuzumab|mesh-list
138431508|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
138545714|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138545715|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545716|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138545717|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138545718|NCT00095706|Growth Substances|growth substances|mesh-ancestor
138545719|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545720|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
138545721|NCT00225901|Mitogens|mitogens|mesh-list
138545722|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
138545723|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545724|NCT00225979|Octreotide|octreotide|mesh-list
138240726|NCT03535727|Cisplatin|cisplatin|mesh-list
138545725|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138545726|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138545727|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545728|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
138545729|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138545730|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
138545731|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138545732|NCT00095745|Aripiprazole|aripiprazole|mesh-list
138545734|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138545735|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138545737|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138545738|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545739|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
138545740|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
138545741|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545742|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545743|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138545744|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138545745|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
138545746|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138545747|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138545748|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138545749|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138545751|NCT00226096|Clonidine|clonidine|mesh-list
138545752|NCT00226096|Nitroprusside|nitroprusside|mesh-list
138545753|NCT00226096|Labetalol|labetalol|mesh-list
138348907|NCT02604810|Antibodies|antibodies|mesh-list
138545754|NCT00226096|Hydralazine|hydralazine|mesh-list
138545755|NCT00226096|Nicardipine|nicardipine|mesh-list
138545756|NCT00226096|Phentolamine|phentolamine|mesh-list
138545757|NCT00226096|Urapidil|urapidil|mesh-list
138545758|NCT00226096|Enalaprilat|enalaprilat|mesh-list
138545759|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
138545760|NCT00226096|Esmolol|esmolol|mesh-list
138545761|NCT00226096|Glycerol|glycerol|mesh-list
138545762|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138545763|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138545764|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
138545765|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
138545766|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545767|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545768|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138545769|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138545770|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138545771|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
138545772|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545773|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545774|NCT00226096|Analgesics|analgesics|mesh-ancestor
138545775|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
138545776|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138545777|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138545778|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138545779|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
138545780|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138545781|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138545782|NCT00226096|Protective Agents|protective agents|mesh-ancestor
138545783|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
138325767|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138545784|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138545785|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138545786|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138545787|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138545788|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138545789|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138545791|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138545792|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
138545793|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545794|NCT00226135|Lamotrigine|lamotrigine|mesh-list
138241174|NCT02489318|Hormones|hormones|mesh-ancestor
138545795|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138545796|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545797|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138545798|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138545799|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431590|NCT01739192|Bupropion|bupropion|mesh-list
138545801|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138545802|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138545803|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138241316|NCT02076009|Hormones|hormones|mesh-ancestor
138545805|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138545806|NCT00400374|Celecoxib|celecoxib|mesh-list
138545807|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138545808|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545809|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138545810|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545811|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545812|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138545813|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138545814|NCT00400374|Analgesics|analgesics|mesh-ancestor
138545815|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
138545816|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545817|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545818|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138545819|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138545820|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138545821|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138545822|NCT00226330|Pioglitazone|pioglitazone|mesh-list
138545823|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138545824|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545825|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
138545826|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545828|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
138545829|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
138545830|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545831|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
138545832|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138545833|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
138545834|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545835|NCT00226447|Interferons|interferons|mesh-list
138545836|NCT00226447|Lamivudine|lamivudine|mesh-list
138545837|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545838|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
138545839|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241677|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
138545840|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138545841|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138545842|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545843|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545845|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138545846|NCT00062660|Tipranavir|tipranavir|mesh-list
138545847|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138545848|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138545849|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
138241814|NCT02802501|Primaquine|primaquine|mesh-list
138545850|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138545852|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
138545853|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
138545854|NCT00413452|Etanercept|etanercept|mesh-list
138545855|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138545856|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138545857|NCT00413452|Analgesics|analgesics|mesh-ancestor
138545858|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
138545859|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545860|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545861|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138545862|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138545863|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138545864|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138545865|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
138545866|NCT00095823|Aripiprazole|aripiprazole|mesh-list
138545867|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
138545868|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138545869|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138545870|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138545871|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138545872|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545873|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
138545875|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545876|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545877|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138545878|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138545879|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
138545880|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138545881|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138349050|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138370680|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
138370681|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138370682|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370683|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138370684|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138370685|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138370686|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138370688|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138370689|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138370690|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138370691|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
138370692|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138370693|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
138370694|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
138370695|NCT01406080|Adapalene|adapalene|mesh-list
138370696|NCT01406080|Tretinoin|tretinoin|mesh-list
138370697|NCT01406080|Emollients|emollients|mesh-list
138370698|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138370699|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138370700|NCT01406080|Analgesics|analgesics|mesh-ancestor
138545882|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138545883|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138545884|NCT00226564|Alfentanil|alfentanil|mesh-list
138545885|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138545886|NCT00226564|Narcotics|narcotics|mesh-ancestor
138545887|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138545888|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545890|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
138545891|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545892|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138545893|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
138545894|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
138545895|NCT00062699|Calcitriol|calcitriol|mesh-list
138545896|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138545897|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545898|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138545899|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138545900|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545901|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138545902|NCT00062699|Vitamins|vitamins|mesh-ancestor
138545903|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
138545904|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138545905|NCT00226798|Capecitabine|capecitabine|mesh-list
138545906|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138242128|NCT02904915|Lidocaine|lidocaine|mesh-list
138545908|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545909|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545911|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138545912|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138545913|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138545914|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
138545915|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138545916|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545917|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545918|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
138545919|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138242181|NCT01536938|Vitamins|vitamins|mesh-ancestor
138545920|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
138545921|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
138545922|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138545923|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545924|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138545925|NCT00226837|Analgesics|analgesics|mesh-ancestor
138545926|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
138545927|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138545928|NCT00226915|Paclitaxel|paclitaxel|mesh-list
138545929|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138545930|NCT00226915|Carboplatin|carboplatin|mesh-list
138545931|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138545932|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545933|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
138545934|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
138545935|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
138545936|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545937|NCT00095862|Interferons|interferons|mesh-list
138545938|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
138545939|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
138545940|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138545941|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
138545942|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545943|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138545944|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138545945|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
138545946|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545947|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545948|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138545949|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
138545950|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138545951|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
138545952|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138545953|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545954|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138545955|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545956|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138545957|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545958|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431770|NCT01740518|Vitamins|vitamins|mesh-ancestor
138222267|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138545960|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138545962|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545963|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545965|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138545966|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545967|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
138545968|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545969|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138545970|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
138545971|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545972|NCT00096057|Antibodies|antibodies|mesh-list
138545973|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138545974|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
138545975|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545976|NCT00227461|Levetiracetam|levetiracetam|mesh-list
138545977|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
138545978|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
138545979|NCT00227500|Pravastatin|pravastatin|mesh-list
138545980|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138545981|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138545982|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
138325883|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138545983|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545984|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138545985|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138545986|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138545987|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
138545988|NCT00096096|Tacrolimus|tacrolimus|mesh-list
138545989|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138545990|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
138431819|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545991|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138545992|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138545994|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138545995|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138545996|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138545997|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138545998|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
138545999|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138546000|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138546001|NCT04721899|Vitamin D|vitamin d|mesh-list
138546002|NCT04721899|Vitamins|vitamins|mesh-ancestor
138546003|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
138546004|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546005|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138546006|NCT00062972|Donepezil|donepezil|mesh-list
138546007|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138546008|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546009|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546010|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
138546011|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546012|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546013|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
138546014|NCT00227656|Interferons|interferons|mesh-list
138546015|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
138546016|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
138546017|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138546018|NCT00227656|Capecitabine|capecitabine|mesh-list
138349181|NCT05510856|Antimanic Agents|antimanic agents|mesh-ancestor
138370801|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
138370802|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370803|NCT01406496|Insulin|insulin|mesh-list
138370804|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138370805|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138370806|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370807|NCT01406522|Tacrine|tacrine|mesh-list
138370808|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138370809|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370810|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546019|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138546020|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
138546021|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546022|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546023|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
138546024|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138243204|NCT05197751|Antacids|antacids|mesh-ancestor
138546025|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
138546026|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546027|NCT00227695|Rituximab|rituximab|mesh-list
138546028|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138546029|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546030|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
138546031|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546032|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138546034|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
138546035|NCT00227734|Cetuximab|cetuximab|mesh-list
138546037|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
138243266|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138546038|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546039|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546040|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138546042|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138546043|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546044|NCT00227773|Octreotide|octreotide|mesh-list
138546045|NCT00227773|Hormones|hormones|mesh-list
138546046|NCT00227773|Somatostatin|somatostatin|mesh-list
138546047|NCT00227773|Mitogens|mitogens|mesh-list
138243406|NCT04895579|Durvalumab|durvalumab|mesh-list
138546048|NCT00227773|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138546049|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138546050|NCT00227773|Vatalanib|vatalanib|mesh-list
138546051|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138546052|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546053|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
138546054|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546055|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138546056|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138546057|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546058|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138546059|NCT00227812|Bupropion|bupropion|mesh-list
138546060|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138243467|NCT01338740|Adalimumab|adalimumab|mesh-list
138546061|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
138546062|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546063|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138546064|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138546065|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138546066|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546067|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
138546068|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243526|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138546069|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546070|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138546071|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138546072|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546073|NCT00096291|Paclitaxel|paclitaxel|mesh-list
138546075|NCT00096291|Doxorubicin|doxorubicin|mesh-list
138546076|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138243602|NCT01916681|Oxytocin|oxytocin|mesh-list
138546077|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138546078|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546079|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
138349239|NCT02649192|Vitamin A|vitamin a|mesh-list
138349240|NCT02649192|Vitamins|vitamins|mesh-ancestor
138546080|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
138546081|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
138546082|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546083|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138243668|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138546084|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138546085|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138546087|NCT02967302|Triamcinolone|triamcinolone|mesh-list
138546088|NCT02967302|Morphine|morphine|mesh-list
138546089|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138546090|NCT02967302|Narcotics|narcotics|mesh-ancestor
138546091|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546092|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546093|NCT02967302|Analgesics|analgesics|mesh-ancestor
138546094|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
138546095|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138243800|NCT03270020|Denosumab|denosumab|mesh-list
138546096|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138546097|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
138546098|NCT02967302|Hormones|hormones|mesh-ancestor
138546099|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138546100|NCT00096330|Folic Acid|folic acid|mesh-list
138546101|NCT00096330|Hematinics|hematinics|mesh-ancestor
138546102|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
138546104|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
138546105|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546106|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
138546107|NCT02962492|Exenatide|exenatide|mesh-list
138546108|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138222416|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
138546109|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546110|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138325968|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
138546111|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546112|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138546114|NCT02962492|Hormones|hormones|mesh-ancestor
138546115|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138546116|NCT00096369|Tamoxifen|tamoxifen|mesh-list
138546117|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138546118|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
138546119|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138546120|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546121|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138546122|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546123|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138546124|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138546125|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138546126|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
138546127|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546128|NCT00228046|Valproic Acid|valproic acid|mesh-list
138546129|NCT00228046|Methylphenidate|methylphenidate|mesh-list
138546130|NCT00228046|Amphetamine|amphetamine|mesh-list
138546131|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
138546132|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138546133|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546135|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138546136|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138244085|NCT03093207|Aspirin|aspirin|mesh-list
138546137|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546138|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
138546139|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546140|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
138546141|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
138546142|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546143|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
138349305|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
138546144|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138546145|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
138546146|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546147|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
138546148|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
138546149|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138546150|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546151|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546152|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
138546153|NCT00063089|Antibodies|antibodies|mesh-list
138546154|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
138170344|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
138546155|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138546156|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138546157|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
138546158|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546159|NCT00228163|Teriflunomide|teriflunomide|mesh-list
138546160|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138546161|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138546162|NCT00228163|Analgesics|analgesics|mesh-ancestor
138546163|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
138546164|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546165|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546166|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138546167|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138546168|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546169|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
138546170|NCT00063128|Insulin|insulin|mesh-list
138546171|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138546172|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138546173|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546174|NCT00075465|Docetaxel|docetaxel|mesh-list
138546175|NCT00075465|Epirubicin|epirubicin|mesh-list
138546176|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546177|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
138546178|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
138546179|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
138244180|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138546180|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546182|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138222499|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
138546183|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138546184|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546186|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
138546187|NCT00228319|Vitamin E|vitamin e|mesh-list
138546188|NCT00228319|Vitamin A|vitamin a|mesh-list
138546189|NCT00228319|Carboplatin|carboplatin|mesh-list
138546190|NCT00228319|Carotenoids|carotenoids|mesh-list
138546191|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546192|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546193|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
138546194|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546195|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
138546196|NCT00228319|Protective Agents|protective agents|mesh-ancestor
138546197|NCT00096525|Lenalidomide|lenalidomide|mesh-list
138546198|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
138546199|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546200|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138546201|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138546202|NCT00096525|Growth Substances|growth substances|mesh-ancestor
138546203|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
138546204|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546205|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
138546206|NCT00228358|Interleukin-2|interleukin-2|mesh-list
138546207|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
138546208|NCT00228358|Immunotoxins|immunotoxins|mesh-list
138546209|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546210|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
138244436|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
138546211|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546212|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432062|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138546213|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138546214|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
138546215|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546216|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546217|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138546218|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138546220|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
138546221|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546223|NCT00228397|Temsirolimus|temsirolimus|mesh-list
138546224|NCT00228397|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138546225|NCT00228397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138546226|NCT00228397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546227|NCT00228397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546228|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546229|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
138546230|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546231|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546233|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
138546234|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546235|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
138546236|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
138546237|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
138546238|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546239|NCT00228475|Budesonide|budesonide|mesh-list
138546240|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138546241|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138546242|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
138546243|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546244|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546245|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138546246|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
138432098|NCT01742689|Indomethacin|indomethacin|mesh-list
138546247|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
138546249|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138546250|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138546251|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138546252|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138546253|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
138546254|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546255|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138546256|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138546257|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546258|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
138546259|NCT00228592|Antibodies|antibodies|mesh-list
138546260|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
138546261|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138546262|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138546263|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
138546264|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546266|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
138546267|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546268|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138546269|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
138546270|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546271|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546272|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138546273|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546274|NCT00228865|Insulin|insulin|mesh-list
138546275|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138546276|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
138546277|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138546278|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546279|NCT00228904|Insulin|insulin|mesh-list
138546280|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
138546281|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138546282|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
138546283|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138546284|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546285|NCT00228982|Vancomycin|vancomycin|mesh-list
138349439|NCT02695290|Afatinib|afatinib|mesh-list
138546286|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
138546287|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
138546288|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138326023|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
138546289|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138546290|NCT00229060|Doripenem|doripenem|mesh-list
138244965|NCT03170661|Rocuronium|rocuronium|mesh-list
138546291|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138546292|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138546294|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546295|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
138546296|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546297|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138546298|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546299|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546300|NCT00063323|Bupropion|bupropion|mesh-list
138546301|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138546302|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
138546304|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138245160|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138432194|NCT01743066|Vitamin E|vitamin e|mesh-list
138546305|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138546306|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138546307|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546308|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
138546309|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546310|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546311|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138546312|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138546314|NCT00229216|Tinidazole|tinidazole|mesh-list
138546315|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
138546316|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546317|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138546318|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138546319|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138546320|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138546321|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138546322|NCT02967653|Atorvastatin|atorvastatin|mesh-list
138546323|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138546324|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138546325|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
138546326|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546327|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138546328|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138546329|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546330|NCT00229333|Escitalopram|escitalopram|mesh-list
138326047|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326054|NCT01711632|Vemurafenib|vemurafenib|mesh-list
138546331|NCT00229333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138546332|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138546333|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138546334|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546335|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546336|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
138546337|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546338|NCT00229450|Estrogens|estrogens|mesh-list
138546339|NCT00229450|Hormones|hormones|mesh-ancestor
138546340|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138546341|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546343|NCT00229528|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138349508|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
138349509|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138370811|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
138370812|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370813|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138370814|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138370815|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
138370816|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138370817|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
138370818|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138370819|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
138546344|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138546345|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138546346|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546348|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
138245639|NCT04332627|Neostigmine|neostigmine|mesh-list
138546349|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546350|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138546351|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
138546352|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546353|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138546354|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138546355|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546356|NCT00075699|Vincristine|vincristine|mesh-list
138546357|NCT00075699|Vinorelbine|vinorelbine|mesh-list
138546358|NCT00075699|Mitomycins|mitomycins|mesh-list
138546359|NCT00075699|Mitomycin|mitomycin|mesh-list
138546360|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546361|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138546362|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
138546363|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
138546364|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
138546365|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245855|NCT01971593|Eplerenone|eplerenone|mesh-list
138546366|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138546367|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
138546368|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138546369|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546371|NCT00229567|Ketamine|ketamine|mesh-list
138546372|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
138546373|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
138546374|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546375|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546376|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
138546377|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546378|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138546379|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138546380|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138546381|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138546382|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546383|NCT00229567|Analgesics|analgesics|mesh-ancestor
138546384|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138546385|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138546386|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
138546387|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138546388|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138546389|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546390|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138546391|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
138546392|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546393|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138546394|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138546395|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546396|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546397|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
138546398|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138546399|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138546400|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138546401|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138546402|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546403|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546404|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546405|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138432317|NCT01743690|Ionophores|ionophores|mesh-ancestor
138546406|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138546408|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138546409|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546410|NCT00096720|Levodopa|levodopa|mesh-list
138546411|NCT00096720|Pramipexole|pramipexole|mesh-list
138546412|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138546413|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138546414|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
138546415|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546416|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546417|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546418|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
138546419|NCT00096720|Protective Agents|protective agents|mesh-ancestor
138546420|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
138546421|NCT00413608|Clopidogrel|clopidogrel|mesh-list
138546422|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138546423|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138546424|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138546425|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138546426|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
138546427|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138326165|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
138546428|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546429|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546430|NCT00229918|Triamcinolone|triamcinolone|mesh-list
138546431|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138546432|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138546433|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138546434|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138546435|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
138546436|NCT00229918|Hormones|hormones|mesh-ancestor
138546437|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138546438|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546439|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546440|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
138546441|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349611|NCT05122494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432369|NCT01743911|Tadalafil|tadalafil|mesh-list
138546442|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546443|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138546444|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138546445|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138546446|NCT00229996|Leuprolide|leuprolide|mesh-list
138546447|NCT00229996|Norethindrone|norethindrone|mesh-list
138546448|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
138546449|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
138546450|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
138546451|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138546453|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138546454|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546455|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138546456|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546457|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138546458|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138546459|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138546460|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138546461|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
138246594|NCT05718011|Ketamine|ketamine|mesh-list
138546462|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
138546464|NCT00230035|Methotrexate|methotrexate|mesh-list
138546465|NCT00230035|Azathioprine|azathioprine|mesh-list
138546466|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
138546467|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138546468|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138546469|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
138546470|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138546471|NCT00230035|Leflunomide|leflunomide|mesh-list
138546472|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
138546473|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138546474|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138546475|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432391|NCT01744184|Midazolam|midazolam|mesh-list
138546476|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
138546477|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246732|NCT03711188|Nivolumab|nivolumab|mesh-list
138546478|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138246783|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
138546479|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138546481|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138546482|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138546483|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
138546484|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546485|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
138546486|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546487|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138546488|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138546489|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138546490|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138546491|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
138546492|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138546493|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138546494|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138546495|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
138546496|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
138546497|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247436|NCT05328674|Mitosis Modulators|mitosis modulators|mesh-ancestor
138247510|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
138546498|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138546499|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
138546500|NCT00230035|Hormones|hormones|mesh-ancestor
138247659|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546501|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138546502|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138546503|NCT00230035|Protective Agents|protective agents|mesh-ancestor
138546504|NCT00063401|Paclitaxel|paclitaxel|mesh-list
138546505|NCT00063401|Carboplatin|carboplatin|mesh-list
138546507|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138546508|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546509|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
138546510|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
138546511|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
138546512|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546513|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138546514|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
138546515|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546516|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138546517|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
138546519|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138546520|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546521|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138546522|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
138546523|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546524|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546525|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
138546526|NCT00096915|Hematinics|hematinics|mesh-ancestor
138546527|NCT00230503|Adefovir|adefovir|mesh-list
138546528|NCT00230503|Pradefovir|pradefovir|mesh-list
138546529|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
138546530|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138546531|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138249140|NCT00558038|Lactulose|lactulose|mesh-list
138546532|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138546533|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249211|NCT03802227|Oxycodone|oxycodone|mesh-list
138249284|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138546534|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249357|NCT01309581|Analgesics|analgesics|mesh-ancestor
138546535|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138546536|NCT00424723|Pemetrexed|pemetrexed|mesh-list
138546537|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546538|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546539|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546540|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138546541|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138546542|NCT00230542|Carboplatin|carboplatin|mesh-list
138546544|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546545|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546546|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249730|NCT01048125|Nitroprusside|nitroprusside|mesh-list
138326292|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
138249793|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
138546548|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138249951|NCT00832299|Vitamins|vitamins|mesh-ancestor
138546549|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
138546550|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138250162|NCT05600673|Bimatoprost|bimatoprost|mesh-list
138546551|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546553|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138546554|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138546555|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
138250312|NCT01548651|Saxagliptin|saxagliptin|mesh-list
138546556|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546557|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546558|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546559|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138546560|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138349734|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138250457|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546561|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546562|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546563|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138546564|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
138250602|NCT04225611|Dexamethasone|dexamethasone|mesh-list
138546565|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
138546566|NCT02962336|Amlodipine|amlodipine|mesh-list
138250683|NCT00000117|Antibodies|antibodies|mesh-list
138546567|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138546569|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138546570|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138250749|NCT01807611|Melphalan|melphalan|mesh-list
138546572|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138250815|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
138546573|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546574|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138546575|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546576|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
138546578|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
138546579|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138251035|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
138251107|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251182|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
138546580|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138546581|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138546583|NCT00075738|Fluorouracil|fluorouracil|mesh-list
138546584|NCT00075738|Irinotecan|irinotecan|mesh-list
138546585|NCT00075738|Calcium|calcium|mesh-list
138546587|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546588|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138546589|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546590|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
138546591|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251625|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138546592|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138251775|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138546593|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546595|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138546596|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138546597|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546598|NCT00075738|Antidotes|antidotes|mesh-ancestor
138546599|NCT00075738|Protective Agents|protective agents|mesh-ancestor
138546600|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
138546601|NCT00075738|Vitamins|vitamins|mesh-ancestor
138546602|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
138546603|NCT00230698|Topiramate|topiramate|mesh-list
138546604|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
138546605|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138546606|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546607|NCT00230776|Pregabalin|pregabalin|mesh-list
138546608|NCT00230776|Analgesics|analgesics|mesh-ancestor
138546609|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
138546610|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546611|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546612|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
138170478|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
138546613|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138546614|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138546615|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546616|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138546617|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138546618|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138546619|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546620|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546621|NCT00075777|Valproic Acid|valproic acid|mesh-list
138546622|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
138349794|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138546623|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546624|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546625|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
138546626|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138252499|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
138546627|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546628|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
138546629|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138546630|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546631|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546632|NCT02967614|Timolol|timolol|mesh-list
138546633|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138546634|NCT02967614|Dorzolamide|dorzolamide|mesh-list
138432529|NCT01744886|Benzocaine|benzocaine|mesh-list
138546636|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138546637|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
138546638|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546639|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546640|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546641|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138546642|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138546643|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138546644|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138546645|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138546646|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138546647|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546648|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138546649|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138546651|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138546652|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546653|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138546655|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138546656|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
138546657|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
138546658|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138546659|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546660|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
138546661|NCT02967380|Antidotes|antidotes|mesh-ancestor
138546662|NCT02967380|Protective Agents|protective agents|mesh-ancestor
138546663|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546664|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
138546665|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
138546666|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546667|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138546668|NCT00075855|Testosterone|testosterone|mesh-list
138546669|NCT00075855|Androgens|androgens|mesh-ancestor
138546670|NCT00075855|Hormones|hormones|mesh-ancestor
138253971|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
138546671|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254046|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138432558|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546672|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546674|NCT00063596|Vitamins|vitamins|mesh-ancestor
138546675|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
138546676|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546677|NCT00231244|Sirolimus|sirolimus|mesh-list
138546678|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138546679|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138546680|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138254355|NCT00002691|Vitamins|vitamins|mesh-ancestor
138546681|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254417|NCT00002721|Doxorubicin|doxorubicin|mesh-list
138546683|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546684|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
138546685|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546686|NCT00231322|Praziquantel|praziquantel|mesh-list
138546687|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
138254647|NCT05713851|Dapagliflozin|dapagliflozin|mesh-list
138546688|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138546689|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138546691|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138546692|NCT00231517|Narcotics|narcotics|mesh-ancestor
138546693|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138254780|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
138546694|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546695|NCT00231517|Analgesics|analgesics|mesh-ancestor
138546696|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
138546697|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546698|NCT00075894|Alanosine|alanosine|mesh-list
138546699|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138546700|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546701|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
138546702|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
138546703|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546704|NCT00231556|Topiramate|topiramate|mesh-list
138546705|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
138546706|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138546707|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546708|NCT00231595|Topiramate|topiramate|mesh-list
138546709|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
138546710|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138546711|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546713|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
138546714|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138546715|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546716|NCT00231673|Topiramate|topiramate|mesh-list
138546718|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138546719|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546720|NCT00097188|Rituximab|rituximab|mesh-list
138546721|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138546722|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546723|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
138255203|NCT01940510|Rifampin|rifampin|mesh-list
138546724|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546725|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138546727|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138546728|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138546729|NCT00231829|Analgesics|analgesics|mesh-ancestor
138546730|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
138255341|NCT05095311|Cetirizine|cetirizine|mesh-list
138546731|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546732|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546733|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138546734|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138546735|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138546736|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138255628|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
138546737|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170495|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138546738|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546739|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
138546740|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138546741|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138255864|NCT00000669|Didanosine|didanosine|mesh-list
138546742|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138546743|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255920|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
138546744|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546745|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
138546746|NCT00063713|Bortezomib|bortezomib|mesh-list
138546747|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546748|NCT00232024|Tegaserod|tegaserod|mesh-list
138546749|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138546750|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
138546751|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546752|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546753|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546754|NCT00232063|Cyclosporine|cyclosporine|mesh-list
138546755|NCT00232063|Cyclosporins|cyclosporins|mesh-list
138546756|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349929|NCT02765256|Promethazine|promethazine|mesh-list
138371139|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
138371140|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546757|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256128|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138546758|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546759|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
138546760|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546761|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
138546762|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138546763|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
138546764|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138546765|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138546766|NCT00232102|Tegaserod|tegaserod|mesh-list
138546767|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138546768|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
138546769|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546770|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256410|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
138256493|NCT04997798|Exemestane|exemestane|mesh-list
138546771|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546773|NCT00097227|Carboplatin|carboplatin|mesh-list
138546774|NCT00097227|Cetuximab|cetuximab|mesh-list
138546775|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138546776|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546777|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
138546778|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
138546779|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
138546780|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546781|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138546782|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138546783|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
138546784|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546785|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138546786|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138546787|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546788|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546789|NCT00232375|Insulin|insulin|mesh-list
138546790|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138546791|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546792|NCT00063791|Bortezomib|bortezomib|mesh-list
138546793|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546794|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138546795|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
138546796|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546797|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138257024|NCT03083405|Opipramol|opipramol|mesh-list
138546798|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138546799|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546800|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546801|NCT00232492|Ketamine|ketamine|mesh-list
138546802|NCT00232492|Analgesics|analgesics|mesh-ancestor
138546803|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
138546804|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546805|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546806|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138546807|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138546808|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
138546809|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
138546810|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546811|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138546812|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138546813|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546814|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546815|NCT00075972|Nicotine|nicotine|mesh-list
138546816|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138546817|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
138546818|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546819|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546820|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138546821|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138546822|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
138546823|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546824|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546825|NCT00063869|Etanercept|etanercept|mesh-list
138546826|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138546827|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138546828|NCT00063869|Analgesics|analgesics|mesh-ancestor
138546829|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
138546830|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546831|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546832|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138546833|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138546834|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138170550|NCT03676556|Lidocaine|lidocaine|mesh-list
138546835|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546836|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
138546839|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138546840|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
138546841|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546842|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138546843|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
138546844|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
138546845|NCT00232531|Vitamins|vitamins|mesh-ancestor
138546846|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
138546847|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546848|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138546849|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
138546850|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546851|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138546852|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138546853|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546854|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546855|NCT00097266|Haloperidol|haloperidol|mesh-list
138546856|NCT00097266|Aripiprazole|aripiprazole|mesh-list
138546857|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
138546858|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
138546859|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546860|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138546861|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138546862|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546863|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546864|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
138546865|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
138546866|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546867|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546868|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138546869|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138546870|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
138546871|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138546872|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138546873|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138546874|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138546875|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
138546876|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
138546877|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546878|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138546879|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138546880|NCT00063947|Gemcitabine|gemcitabine|mesh-list
138546881|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138546882|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138546883|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
138546884|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546885|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546886|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138546887|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546888|NCT00232648|Budesonide|budesonide|mesh-list
138546889|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138546890|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138546891|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
138546892|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546893|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546894|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138546895|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
138546896|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
138546897|NCT00232648|Hormones|hormones|mesh-ancestor
138170557|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138546898|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138546899|NCT00232687|Aripiprazole|aripiprazole|mesh-list
138546900|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
138546901|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546902|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138546903|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138546904|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546905|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326524|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546907|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
138546909|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546910|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138546911|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138546912|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
138546913|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138546914|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138546915|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138546916|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138546917|NCT00232765|Sirolimus|sirolimus|mesh-list
138546918|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138546919|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138546920|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138546921|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138546922|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
138546923|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138546924|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
138546925|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546926|NCT02958566|Acetaminophen|acetaminophen|mesh-list
138546927|NCT02958566|Ketorolac|ketorolac|mesh-list
138546928|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138546929|NCT02958566|Lidocaine|lidocaine|mesh-list
138546930|NCT02958566|Fentanyl|fentanyl|mesh-list
138546931|NCT02958566|Ketamine|ketamine|mesh-list
138546932|NCT02958566|Morphine|morphine|mesh-list
138546933|NCT02958566|Gabapentin|gabapentin|mesh-list
138546934|NCT02958566|Tramadol|tramadol|mesh-list
138546935|NCT02958566|Methadone|methadone|mesh-list
138546936|NCT02958566|Hydrocodone|hydrocodone|mesh-list
138546938|NCT02958566|Orphenadrine|orphenadrine|mesh-list
138546939|NCT02958566|Bupivacaine|bupivacaine|mesh-list
138546940|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
138546941|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
138546942|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138546943|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546944|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
138326549|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138546945|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138546947|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138546948|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138546949|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138546950|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138546951|NCT02958566|Analgesics|analgesics|mesh-ancestor
138546952|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138546953|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138546954|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
138546955|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138546956|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138546957|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138546958|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138546959|NCT02958566|Narcotics|narcotics|mesh-ancestor
138546960|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138546961|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138546962|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
138546963|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
138546964|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138546965|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138546966|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138546967|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
138546968|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138546969|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138546970|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138546971|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138546972|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138546974|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
138546975|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138546976|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138546977|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138546978|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138546979|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
138546980|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
138546981|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138546982|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138432852|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
138546983|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
138546984|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
138546985|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138546986|NCT00097344|Toremifene|toremifene|mesh-list
138546987|NCT00097344|Letrozole|letrozole|mesh-list
138546988|NCT00097344|Hormones|hormones|mesh-list
138546989|NCT00097344|Atamestane|atamestane|mesh-list
138546990|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
138546991|NCT00097344|Estrogens|estrogens|mesh-list
138546992|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
138546993|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
138546994|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138546995|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138546996|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223314|NCT05531942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223315|NCT05531942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138223316|NCT05531942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138223317|NCT05531942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223318|NCT05531942|Antipyretics|antipyretics|mesh-ancestor
138223319|NCT05479916|Caseins|caseins|mesh-list
138223320|NCT05479916|Chelating Agents|chelating agents|mesh-ancestor
138223321|NCT05479916|Sequestering Agents|sequestering agents|mesh-ancestor
138223322|NCT05479916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223339|NCT05451940|Hydroxyurea|hydroxyurea|mesh-list
138223340|NCT05451940|Epoetin Alfa|epoetin alfa|mesh-list
138223341|NCT05451940|Hematinics|hematinics|mesh-list
138223342|NCT05451940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223343|NCT05451940|Antisickling Agents|antisickling agents|mesh-ancestor
138223344|NCT05451940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223347|NCT05447559|Cefazolin|cefazolin|mesh-list
138546997|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138546998|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138546999|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547000|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547001|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
138170589|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138547002|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138432882|NCT01747083|Metformin|metformin|mesh-list
138547003|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138547004|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138547005|NCT00232882|Atenolol|atenolol|mesh-list
138547006|NCT00232882|Candesartan|candesartan|mesh-list
138547007|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
138547008|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
138547009|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138547010|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138547011|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138547012|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257121|NCT00002949|Paclitaxel|paclitaxel|mesh-list
138547013|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138547014|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
138547015|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
138547016|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350211|NCT06084130|Zolpidem|zolpidem|mesh-list
138547017|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547018|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138547019|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138547020|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138547021|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
138547022|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547023|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138547024|NCT00232882|Diuretics|diuretics|mesh-ancestor
138547025|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
138547026|NCT00064064|Gemcitabine|gemcitabine|mesh-list
138547027|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138547028|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
138547029|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547030|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547031|NCT00413686|Gemcitabine|gemcitabine|mesh-list
138432922|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547032|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138547033|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
138547034|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547035|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547036|NCT00233038|Ethanol|ethanol|mesh-list
138547037|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138547038|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547039|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138547040|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547041|NCT00097383|Epirubicin|epirubicin|mesh-list
138547042|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138547043|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547044|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138547045|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138547046|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547047|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547048|NCT00233155|Capsaicin|capsaicin|mesh-list
138547049|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
138547050|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
138547051|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
138547052|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138547053|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547054|NCT00064142|Halofuginone|halofuginone|mesh-list
138547055|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547056|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
138326654|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
138547058|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138547059|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547060|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138547061|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547062|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350286|NCT06082232|Adrenergic Agents|adrenergic agents|mesh-ancestor
138350287|NCT06082232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138350288|NCT06082232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138350289|NCT06082232|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138350290|NCT06082232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138350291|NCT06082232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138350292|NCT06082232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138547063|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138547064|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138547065|NCT00064142|Growth Substances|growth substances|mesh-ancestor
138547066|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547067|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
138547068|NCT00064181|Leucovorin|leucovorin|mesh-list
138223393|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
138547069|NCT00064181|Celecoxib|celecoxib|mesh-list
138547070|NCT00064181|Capecitabine|capecitabine|mesh-list
138547071|NCT00064181|Fluorouracil|fluorouracil|mesh-list
138547072|NCT00064181|Irinotecan|irinotecan|mesh-list
138547073|NCT00064181|Calcium|calcium|mesh-list
138547074|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
138547075|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138547076|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547077|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138547078|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
138547079|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547080|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547081|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138547082|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
138547083|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138547084|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138547085|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547086|NCT00064181|Antidotes|antidotes|mesh-ancestor
138547087|NCT00064181|Protective Agents|protective agents|mesh-ancestor
138547088|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
138547089|NCT00064181|Vitamins|vitamins|mesh-ancestor
138326685|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
138547090|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
138547091|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138547092|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138547093|NCT00064181|Analgesics|analgesics|mesh-ancestor
138547094|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
138547095|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138547096|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138547097|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138547098|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138547099|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138547100|NCT00233545|Miltefosine|miltefosine|mesh-list
138547101|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
138547102|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547103|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547104|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138547105|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138547106|NCT00233584|Budesonide|budesonide|mesh-list
138547107|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138547108|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138547109|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
138547110|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138547111|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547112|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138547113|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
138547114|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
138547115|NCT00233584|Hormones|hormones|mesh-ancestor
138547116|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138547117|NCT00233623|Leucovorin|leucovorin|mesh-list
138547118|NCT00233623|Fluorouracil|fluorouracil|mesh-list
138547119|NCT00233623|Irinotecan|irinotecan|mesh-list
138547120|NCT00233623|Gefitinib|gefitinib|mesh-list
138547121|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
138547122|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547123|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138547124|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547125|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138547126|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
138547127|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547128|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138547129|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138547130|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547132|NCT00233623|Protective Agents|protective agents|mesh-ancestor
138547134|NCT00233623|Vitamins|vitamins|mesh-ancestor
138547135|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
138547136|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138547137|NCT00064220|Soblidotin|soblidotin|mesh-list
138547138|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547139|NCT00233779|Sirolimus|sirolimus|mesh-list
138547140|NCT00233779|Heparin|heparin|mesh-list
138547141|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138547142|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547143|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138223467|NCT04452214|Pemetrexed|pemetrexed|mesh-list
138547144|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547145|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
138547146|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138547147|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
138547148|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547149|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547151|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138547152|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138547153|NCT00233818|Sirolimus|sirolimus|mesh-list
138547154|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138547155|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257140|NCT00002955|Trimetrexate|trimetrexate|mesh-list
138547156|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138547157|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547158|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
138547159|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138547160|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
138547161|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547163|NCT00076206|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138547164|NCT00076206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138547165|NCT00076206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547166|NCT00076206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547167|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138547168|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
138547169|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547170|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547171|NCT00233896|Beclomethasone|beclomethasone|mesh-list
138547172|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138547173|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
138547174|NCT00233896|Hormones|hormones|mesh-ancestor
138547175|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138547176|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547177|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138547178|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
138547179|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138547181|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547182|NCT00233935|Protective Agents|protective agents|mesh-ancestor
138547183|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547184|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138547185|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138547186|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547188|NCT00234091|Ritonavir|ritonavir|mesh-list
138547189|NCT00234091|Lopinavir|lopinavir|mesh-list
138547190|NCT00234091|Nelfinavir|nelfinavir|mesh-list
138547191|NCT00234091|Lamivudine|lamivudine|mesh-list
138547192|NCT00234091|Zidovudine|zidovudine|mesh-list
138547193|NCT00234091|Nevirapine|nevirapine|mesh-list
138547194|NCT00234091|Abacavir|abacavir|mesh-list
138547195|NCT00234091|Efavirenz|efavirenz|mesh-list
138547196|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138547197|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138547198|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
138547199|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547200|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547201|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138547202|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138547203|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
138547204|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547205|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138547206|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138547207|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138547208|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138547209|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
138547210|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138547211|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138547212|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138547213|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138547214|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138547215|NCT04721704|Amoxicillin|amoxicillin|mesh-list
138547216|NCT04721704|Metronidazole|metronidazole|mesh-list
138547217|NCT04721704|Clarithromycin|clarithromycin|mesh-list
138547218|NCT04721704|Omeprazole|omeprazole|mesh-list
138547219|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138547220|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547221|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138547222|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138547223|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138547225|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138547227|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547228|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138547229|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138547230|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138547231|NCT00076284|Aplaviroc|aplaviroc|mesh-list
138547232|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138326800|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
138547233|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138547234|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547235|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138547236|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138547237|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
138547238|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547239|NCT00234403|Fulvestrant|fulvestrant|mesh-list
138547240|NCT00234403|Gefitinib|gefitinib|mesh-list
138547241|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138547242|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547243|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138547244|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138547245|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
138547246|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138547247|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547248|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138547249|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138170722|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138547250|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547252|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138547253|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138547254|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
138547255|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138350490|NCT05039801|Antibodies|antibodies|mesh-list
138547256|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433155|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
138547257|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138547258|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
138547259|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138547260|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138547261|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138547262|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
138547263|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547264|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547265|NCT00234442|Gefitinib|gefitinib|mesh-list
138547266|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547267|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138547268|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547269|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547270|NCT00076323|Primaquine|primaquine|mesh-list
138547271|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
138547272|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138547273|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138547274|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547275|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
138547276|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138547277|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138547278|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547279|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
138547280|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
138547281|NCT00234637|Memantine|memantine|mesh-list
138547282|NCT00234637|Rivastigmine|rivastigmine|mesh-list
138547283|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138547284|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138547285|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
138547286|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547287|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433197|NCT01748630|Narcotics|narcotics|mesh-ancestor
138547288|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547289|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138547290|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138547291|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138547292|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547293|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
138547294|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138547295|NCT00234637|Protective Agents|protective agents|mesh-ancestor
138223611|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138547296|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138547297|NCT00234676|Estrogens|estrogens|mesh-ancestor
138547298|NCT00234676|Hormones|hormones|mesh-ancestor
138547299|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138547300|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138350537|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138547301|NCT00076362|Octreotide|octreotide|mesh-list
138547302|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138547303|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138547304|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547306|NCT00234871|Amlodipine|amlodipine|mesh-list
138547307|NCT00234871|Benazepril|benazepril|mesh-list
138547308|NCT00234871|Trandolapril|trandolapril|mesh-list
138547309|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138547310|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138547311|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138547312|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547313|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138547314|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547315|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
138257178|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
138547316|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138547317|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138547318|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
138547319|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547321|NCT00234910|Lopinavir|lopinavir|mesh-list
138547322|NCT00234910|Tenofovir|tenofovir|mesh-list
138547323|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138547324|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138547325|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
138547326|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547327|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547328|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138547329|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138547330|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
138547331|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547332|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138326897|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
138547333|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138547334|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138547335|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138547336|NCT00234949|Cephalexin|cephalexin|mesh-list
138547337|NCT00234949|Cefdinir|cefdinir|mesh-list
138547338|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138547339|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547340|NCT00234988|Sibutramine|sibutramine|mesh-list
138547341|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
138547342|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138547343|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
138547344|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138547345|NCT00400491|Vitamin D|vitamin d|mesh-list
138547346|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
138547347|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
138547348|NCT00400491|Vitamins|vitamins|mesh-list
138547349|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
138547350|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547351|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138547352|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138547353|NCT00235105|Adalimumab|adalimumab|mesh-list
138547354|NCT00235105|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138547355|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138547356|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138547357|NCT00235144|Sirolimus|sirolimus|mesh-list
138547358|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138547359|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547360|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138547361|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547362|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
138547363|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138547364|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
138547365|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547366|NCT00400530|Alendronate|alendronate|mesh-list
138547367|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547368|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138547369|NCT00064610|Bortezomib|bortezomib|mesh-list
138547370|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547371|NCT00235222|Stavudine|stavudine|mesh-list
138223695|NCT02340962|Ribavirin|ribavirin|mesh-list
138547372|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
138547373|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547374|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138257202|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
138350599|NCT04977479|Vaccines|vaccines|mesh-list
138326949|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138326950|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326952|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
138326953|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547375|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138547376|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547377|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
138547378|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547379|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138547380|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138547381|NCT00235261|Dexamethasone|dexamethasone|mesh-list
138547382|NCT00235261|Pregabalin|pregabalin|mesh-list
138547383|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138547384|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
138547385|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
138547386|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138547387|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547388|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138547389|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
138547390|NCT00235261|Hormones|hormones|mesh-ancestor
138547391|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138547392|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138547393|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547394|NCT00235261|Analgesics|analgesics|mesh-ancestor
138547395|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
138547396|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
138547397|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138547398|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138547399|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547400|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138547401|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138547402|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138547403|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138547404|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138547405|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
138547406|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138547407|NCT00235300|Basiliximab|basiliximab|mesh-list
138547408|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
138547409|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547410|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138547411|NCT00064649|Finasteride|finasteride|mesh-list
138547413|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138547414|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138547415|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547416|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547417|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
138547418|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138547419|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547420|NCT00064649|Urological Agents|urological agents|mesh-ancestor
138547421|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138547422|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138326977|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326978|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326979|NCT00106392|Tacrolimus|tacrolimus|mesh-list
138326980|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138326981|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
138326982|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326983|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138326984|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138326985|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326987|NCT00211692|Ribavirin|ribavirin|mesh-list
138326988|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
138326989|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
138547423|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138344270|NCT03259503|Busulfan|busulfan|mesh-list
138547424|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
138547425|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547426|NCT00097734|Ertapenem|ertapenem|mesh-list
138547427|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138547428|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547429|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
138547430|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138547431|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547432|NCT00235651|Amphotericin B|amphotericin b|mesh-list
138547433|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138547434|NCT00235651|Amebicides|amebicides|mesh-ancestor
138547435|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138547436|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138547437|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547438|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138547439|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
138547441|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138547442|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547443|NCT00064766|Doxycycline|doxycycline|mesh-list
138547444|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138547445|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547446|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
138547447|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138547448|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138547449|NCT00235729|Lofexidine|lofexidine|mesh-list
138547450|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138547451|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138547452|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547453|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
138547454|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138547455|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138547456|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138547457|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138547458|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
138547459|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547460|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547461|NCT00235885|Adalimumab|adalimumab|mesh-list
138547462|NCT00235885|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138433342|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
138547463|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138547464|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138547465|NCT04728750|Pancrelipase|pancrelipase|mesh-list
138547466|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138547467|NCT00235963|Simvastatin|simvastatin|mesh-list
138547468|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138547469|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138547470|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
138547471|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138170780|NCT00591019|Modafinil|modafinil|mesh-list
138170787|NCT02996695|Artesunate|artesunate|mesh-list
138547472|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138547473|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138547474|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547475|NCT00236002|Alendronate|alendronate|mesh-list
138547476|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138547477|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547478|NCT00414037|Eszopiclone|eszopiclone|mesh-list
138547479|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138547480|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138547481|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547482|NCT00236275|Telbivudine|telbivudine|mesh-list
138547483|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
138547484|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547485|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138547486|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547487|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547488|NCT00236353|Risperidone|risperidone|mesh-list
138547489|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138547490|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
138547491|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547492|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547493|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547494|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138547495|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138547496|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138547497|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138547498|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138547499|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
138547500|NCT00236392|Rabeprazole|rabeprazole|mesh-list
138547501|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138547502|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138547503|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138547504|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547505|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547506|NCT00236431|Galantamine|galantamine|mesh-list
138547507|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138547508|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547509|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547510|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
138547511|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547512|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547513|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138547514|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
138547515|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138547516|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
138547517|NCT00097929|Vorinostat|vorinostat|mesh-list
138547518|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433371|NCT01749397|Veliparib|veliparib|mesh-list
138547519|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138547520|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547521|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547522|NCT00236470|Risperidone|risperidone|mesh-list
138547523|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138547525|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547526|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547527|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547528|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138547529|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138547530|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138547531|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138547532|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138547533|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
138547534|NCT00236509|Topiramate|topiramate|mesh-list
138547535|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
138547536|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138547537|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547538|NCT02962141|Paclitaxel|paclitaxel|mesh-list
138547539|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138547540|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547541|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
138547542|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
138547543|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257243|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
138547544|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547545|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
138547546|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547547|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138547548|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
138547549|NCT00236548|Risperidone|risperidone|mesh-list
138547550|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138547551|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
138547552|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547553|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327045|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138327046|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138327047|NCT00282828|Clonazepam|clonazepam|mesh-list
138327048|NCT00282828|Sertraline|sertraline|mesh-list
138327049|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138327050|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
138327051|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138327052|NCT00282828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138327053|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138327054|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138327055|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327056|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138327057|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
138327058|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327059|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138327060|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138327061|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
138547554|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547555|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138547556|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138547557|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138547558|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138547559|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138547560|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
138547561|NCT00236587|Risperidone|risperidone|mesh-list
138547562|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138547563|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
138547564|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547565|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547566|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547567|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138547568|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138547569|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138547570|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138547571|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138547572|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
138547573|NCT00236626|Topiramate|topiramate|mesh-list
138547574|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
138547575|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138547576|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547577|NCT00236665|Topiramate|topiramate|mesh-list
138547578|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
138547579|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138547580|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547581|NCT00399282|Vitamin E|vitamin e|mesh-list
138547582|NCT00399282|Vitamins|vitamins|mesh-ancestor
138547583|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
138547584|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547585|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
138547586|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547587|NCT00399282|Protective Agents|protective agents|mesh-ancestor
138547588|NCT00236704|Topiramate|topiramate|mesh-list
138547589|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
138547590|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138547591|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547592|NCT00236743|Topiramate|topiramate|mesh-list
138547593|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
138547594|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138547595|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547596|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138547597|NCT00236782|Norelgestromin|norelgestromin|mesh-list
138547598|NCT00236782|Estradiol|estradiol|mesh-list
138547599|NCT00236782|Estrogens|estrogens|mesh-ancestor
138170821|NCT02996227|Bupivacaine|bupivacaine|mesh-list
138547600|NCT00236782|Hormones|hormones|mesh-ancestor
138547601|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138547603|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138547604|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
138547605|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138547606|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138433408|NCT01749514|Luspatercept|luspatercept|mesh-list
138547607|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138547608|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138547610|NCT00097968|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138257269|NCT00003009|Aldesleukin|aldesleukin|mesh-list
138547611|NCT00097968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138547612|NCT00097968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547613|NCT00097968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547614|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138547615|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
138547616|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547617|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547619|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138547620|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547621|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138547622|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138350883|NCT03629327|Aspirin|aspirin|mesh-list
138547623|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138547624|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547625|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547626|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547627|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138547628|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138547629|NCT00236860|Topiramate|topiramate|mesh-list
138547630|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
138547631|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138547632|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547633|NCT00065117|Leucovorin|leucovorin|mesh-list
138547634|NCT00065117|Fluorouracil|fluorouracil|mesh-list
138547635|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
138547636|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
138547637|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138327103|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547638|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138547640|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138547641|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
138547642|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547643|NCT00065117|Antidotes|antidotes|mesh-ancestor
138547644|NCT00065117|Protective Agents|protective agents|mesh-ancestor
138547645|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
138547646|NCT00065117|Vitamins|vitamins|mesh-ancestor
138547647|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
138547648|NCT00237016|Doxycycline|doxycycline|mesh-list
138547649|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138547650|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547651|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
138547652|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138547653|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138547654|NCT00237133|Letrozole|letrozole|mesh-list
138547655|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547656|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138547657|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138547658|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547659|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547660|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138547661|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
138547662|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138547663|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547664|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
138547665|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547666|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138547667|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547668|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547669|NCT00237211|Letrozole|letrozole|mesh-list
138547670|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547671|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138547672|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138223984|NCT05310344|Bevacizumab|bevacizumab|mesh-list
138547673|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547674|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547675|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138547676|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
138547677|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138547678|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547679|NCT00098007|Everolimus|everolimus|mesh-list
138547680|NCT00098007|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138547681|NCT00098007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138547682|NCT00098007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547683|NCT00098007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547684|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138547685|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
138547686|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547687|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547689|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138547690|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547691|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138547692|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
138547693|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547694|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547695|NCT00237289|Topiramate|topiramate|mesh-list
138547696|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
138547697|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138547698|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547699|NCT00237328|Heparin|heparin|mesh-list
138547700|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
138547701|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138547702|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138547703|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547704|NCT00237367|Rabeprazole|rabeprazole|mesh-list
138547705|NCT00237367|Pantoprazole|pantoprazole|mesh-list
138547706|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138547707|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138547708|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138547709|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547710|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547711|NCT00098046|Famciclovir|famciclovir|mesh-list
138547712|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
138547713|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547714|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138547715|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547716|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547718|NCT00065273|Risperidone|risperidone|mesh-list
138547719|NCT00065273|Clozapine|clozapine|mesh-list
138547720|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138547721|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
138547722|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547723|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547724|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547725|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138547726|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138547727|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138547728|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138547729|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138547730|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
138547731|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
138547732|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
138547733|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138547734|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138547735|NCT00065273|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138547736|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138547737|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138547738|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
138547739|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
138547740|NCT00237445|Azithromycin|azithromycin|mesh-list
138547741|NCT00237445|Telithromycin|telithromycin|mesh-list
138547742|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138547743|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547745|NCT00237484|Ribavirin|ribavirin|mesh-list
138547746|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
138547747|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
138547748|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138547749|NCT00237484|Infliximab|infliximab|mesh-list
138547750|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547751|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
138547752|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138327206|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547753|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
138547754|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547755|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
138547756|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547757|NCT00237484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138547758|NCT00237484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138547759|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
138547760|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138547761|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138547763|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
138547764|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138547765|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547766|NCT00237523|Trace Elements|trace elements|mesh-ancestor
138547767|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
138547768|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547769|NCT00098124|Milnacipran|milnacipran|mesh-list
138547770|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
138547771|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138547772|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138547773|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138547774|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547775|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547776|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547777|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138547779|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
138547780|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138547781|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
138547782|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138547783|NCT04710160|Calcium|calcium|mesh-list
138547784|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138547785|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547786|NCT00065351|Lenalidomide|lenalidomide|mesh-list
138547787|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
138547788|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547789|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138327244|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
138547790|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138547791|NCT00065351|Growth Substances|growth substances|mesh-ancestor
138547792|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
138547793|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547794|NCT04709770|Simethicone|simethicone|mesh-list
138547795|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547796|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
138547797|NCT04709770|Emollients|emollients|mesh-ancestor
138547798|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
138547799|NCT04709731|Ponatinib|ponatinib|mesh-list
138547800|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547801|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138547802|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257297|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
138547803|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547805|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138547806|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138547807|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547808|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547809|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
138547810|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547811|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138547812|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138547813|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138547814|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138547815|NCT00076440|Leuprolide|leuprolide|mesh-list
138547816|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138547817|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
138547818|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138547819|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547820|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138547821|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547822|NCT00237874|Aripiprazole|aripiprazole|mesh-list
138547823|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
138547824|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138327284|NCT01899144|Procaterol|procaterol|mesh-list
138547825|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138547826|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138547827|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138547828|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547829|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
138547831|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547832|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547833|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138547834|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138547836|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138547837|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138547838|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138547839|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138547840|NCT00237913|Olanzapine|olanzapine|mesh-list
138547841|NCT00237913|Risperidone|risperidone|mesh-list
138547842|NCT00237913|Aripiprazole|aripiprazole|mesh-list
138547843|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138547844|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138547845|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
138344273|NCT03259503|Vorinostat|vorinostat|mesh-list
138371379|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547846|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138547847|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547848|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547849|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138547850|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138547851|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138547852|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138547853|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138547854|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
138547855|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
138547856|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
138547857|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138547858|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138327322|NCT00121836|Bevacizumab|bevacizumab|mesh-list
138547859|NCT00237913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138547860|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138547861|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138547862|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
138547863|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
138547864|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138547865|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138547866|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138547867|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138547868|NCT00237952|Chelating Agents|chelating agents|mesh-list
138547869|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
138547870|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547871|NCT00098241|Everolimus|everolimus|mesh-list
138547872|NCT00098241|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138547873|NCT00098241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138547874|NCT00098241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547875|NCT00098241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547876|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138547877|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
138547878|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547879|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547880|NCT04721119|Anesthetics|anesthetics|mesh-list
138547881|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138547882|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547883|NCT00238147|Carboplatin|carboplatin|mesh-list
138547884|NCT00238147|Docetaxel|docetaxel|mesh-list
138547885|NCT00238147|Capecitabine|capecitabine|mesh-list
138547886|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547887|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
138547888|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
138547889|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
138327363|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547890|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547891|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138547892|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
138547893|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
138344274|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138351175|NCT02573896|Growth Substances|growth substances|mesh-ancestor
138547894|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
138547895|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138547896|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138547897|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547898|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138547899|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547900|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547901|NCT00238225|Calcitriol|calcitriol|mesh-list
138547902|NCT00238225|Ketoconazole|ketoconazole|mesh-list
138547903|NCT00238225|Dexamethasone|dexamethasone|mesh-list
138547904|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138547905|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
138547906|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
138433659|NCT06175676|Fluorouracil|fluorouracil|mesh-list
138547907|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138547908|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547909|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138547910|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
138547911|NCT00238225|Hormones|hormones|mesh-ancestor
138547912|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138547913|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138547914|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547915|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
138547916|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547917|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138547918|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138547919|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547920|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547921|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138547922|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
138547923|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138547924|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138547925|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138547926|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138547927|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138547928|NCT00238225|Vitamins|vitamins|mesh-ancestor
138547929|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
138547930|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138547931|NCT00076518|Fenofibrate|fenofibrate|mesh-list
138547932|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138547933|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
138547934|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547935|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138547936|NCT00065546|Choline|choline|mesh-list
138547937|NCT00065546|Estrogens|estrogens|mesh-list
138547938|NCT00065546|Hormones|hormones|mesh-ancestor
138547939|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138547940|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547941|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
138547942|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138547943|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
138547944|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547945|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138547946|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138547947|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
138547949|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138547950|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138547951|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
138547952|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547953|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138547954|NCT00238459|Vaccines|vaccines|mesh-list
138547955|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
138547956|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547957|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
138547958|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138547959|NCT00238498|Vildagliptin|vildagliptin|mesh-list
138547960|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138547961|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327436|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
138547963|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
138547964|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138547965|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547966|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138547967|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138547968|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138547969|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138547970|NCT00098319|Folic Acid|folic acid|mesh-list
138547971|NCT00098319|Hematinics|hematinics|mesh-ancestor
138547972|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
138547973|NCT00098319|Vitamins|vitamins|mesh-ancestor
138547974|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
138547975|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547976|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
138547977|NCT00238732|Estrogens|estrogens|mesh-list
138547978|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138547979|NCT00238732|Hormones|hormones|mesh-ancestor
138547980|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138547981|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547982|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138547983|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138547984|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
138547985|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138547986|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
138547987|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138547988|NCT00238927|Fluticasone|fluticasone|mesh-list
138547989|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138547990|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138547991|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
138327484|NCT01899066|Ranibizumab|ranibizumab|mesh-list
138547992|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138547993|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138547994|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138547995|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
138547997|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138547998|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
138547999|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
138548000|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548001|NCT00065624|Protective Agents|protective agents|mesh-ancestor
138548002|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548003|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
138548004|NCT00065624|Vitamins|vitamins|mesh-ancestor
138548005|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
138548006|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
138548007|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138548008|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257369|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
138548009|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138548010|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
138548011|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138548012|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548013|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548014|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433771|NCT06100432|Vitamins|vitamins|mesh-list
138548015|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
138548016|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138548017|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548018|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138548019|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
138548020|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138548021|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548022|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548023|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548024|NCT00098358|Zileuton|zileuton|mesh-list
138548025|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138548026|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138548027|NCT00098358|Analgesics|analgesics|mesh-ancestor
138548028|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
138327529|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138327530|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138548029|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548030|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548031|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138548032|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138548034|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548035|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138344275|NCT03259503|Antibodies|antibodies|mesh-list
138548036|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138548037|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
138548038|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138548039|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
138548040|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138548041|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548042|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138548043|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
138548044|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138548045|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548046|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548047|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548048|NCT00239161|Levofloxacin|levofloxacin|mesh-list
138548049|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138548050|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548051|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138548052|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138548053|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138548054|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548055|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548056|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257774|NCT01764607|Sirolimus|sirolimus|mesh-list
138548057|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138548058|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138548059|NCT00239200|Lapatinib|lapatinib|mesh-list
138548060|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257841|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
138433800|NCT06093893|Sympathomimetics|sympathomimetics|mesh-ancestor
138548061|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138548062|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548063|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548065|NCT02961829|Dolutegravir|dolutegravir|mesh-list
138548067|NCT02961829|Auranofin|auranofin|mesh-list
138548068|NCT02961829|Vaccines|vaccines|mesh-list
138548069|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138548070|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
138548071|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548072|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138548073|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138548074|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548075|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548076|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138548077|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138548078|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
138548079|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548080|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138548081|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138548082|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138327564|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548083|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
138548084|NCT02961829|Vitamins|vitamins|mesh-ancestor
138548085|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
138548086|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258272|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
138548087|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
138548088|NCT00239239|Hematinics|hematinics|mesh-ancestor
138548089|NCT00414349|Analgesics|analgesics|mesh-list
138548090|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
138548091|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548092|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548093|NCT00065741|Silymarin|silymarin|mesh-list
138548094|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
138548095|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548096|NCT00065741|Protective Agents|protective agents|mesh-ancestor
138548097|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548098|NCT00098397|Romidepsin|romidepsin|mesh-list
138548099|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138548100|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548101|NCT00098397|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138548102|NCT00098397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548103|NCT00098397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548104|NCT00239278|Prednisolone|prednisolone|mesh-list
138548105|NCT00239278|Budesonide|budesonide|mesh-list
138548106|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
138548107|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138548108|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
138548109|NCT00239278|Hormones|hormones|mesh-ancestor
138548110|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138548111|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548112|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138548113|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548114|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
138548115|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548116|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138548117|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138548118|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
138224432|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138548119|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138548120|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138548121|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138548122|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
138327591|NCT01790022|Prednisolone|prednisolone|mesh-list
138548123|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548124|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548126|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138548127|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138548129|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
138548130|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433863|NCT05975307|Antimetabolites|antimetabolites|mesh-ancestor
138548131|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258822|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138548132|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138548133|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138548134|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138548135|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138548136|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548137|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548138|NCT00076635|Interferons|interferons|mesh-list
138548139|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
138548140|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548141|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
138548142|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548143|NCT00239434|Bromides|bromides|mesh-list
138258976|NCT02506673|Midazolam|midazolam|mesh-list
138548144|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
138548145|NCT00239434|Ipratropium|ipratropium|mesh-list
138548146|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138548147|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
138548148|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548149|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548150|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138548151|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
138548152|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
138327617|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138548153|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138548154|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
138548155|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548156|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548157|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
138548158|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138548159|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
138548160|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138548161|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
138548162|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548163|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548164|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138548165|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
138548166|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
138548167|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138433914|NCT05898724|Zinc Oxide|zinc oxide|mesh-list
138548168|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
138548169|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259247|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548170|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548171|NCT00239512|Ibuprofen|ibuprofen|mesh-list
138548172|NCT00239512|Indomethacin|indomethacin|mesh-list
138488549|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138548173|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138548174|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138548175|NCT00239512|Analgesics|analgesics|mesh-ancestor
138548176|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
138548177|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548178|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548179|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138548180|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138170986|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
138548181|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138548182|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548183|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548184|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
138548185|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
138548186|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138548187|NCT00076674|Levodopa|levodopa|mesh-list
138548188|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138548189|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138259307|NCT02585843|Diuretics|diuretics|mesh-ancestor
138548190|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
138548191|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548192|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548193|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548195|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138548196|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138548197|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138327661|NCT05266794|Trace Elements|trace elements|mesh-ancestor
138548199|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548201|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
138548202|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138548203|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548204|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138548205|NCT00098436|Temozolomide|temozolomide|mesh-list
138548206|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138548207|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
138548208|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548209|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548210|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
138548211|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138548212|NCT00239707|Incretins|incretins|mesh-ancestor
138548213|NCT00239707|Hormones|hormones|mesh-ancestor
138548214|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138548215|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548216|NCT00239746|Ibuprofen|ibuprofen|mesh-list
138548217|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138548218|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138548219|NCT00239746|Analgesics|analgesics|mesh-ancestor
138548220|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
138548221|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259484|NCT01840345|Protective Agents|protective agents|mesh-ancestor
138548222|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433987|NCT05728944|Miotics|miotics|mesh-ancestor
138548223|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138548224|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138548225|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138548226|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548227|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548228|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138548229|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138548230|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548231|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138548232|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
138548233|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548234|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138548235|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138548236|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548237|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138548238|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
138548239|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548240|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138548241|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138548242|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548243|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138548245|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548247|NCT00239980|Tinzaparin|tinzaparin|mesh-list
138548248|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138548249|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
138548250|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138548251|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138548252|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548253|NCT00240019|Furosemide|furosemide|mesh-list
138548254|NCT00240019|Diuretics|diuretics|mesh-ancestor
138548255|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
138548256|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548257|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138548258|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138548259|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548260|NCT00240058|Phenylephrine|phenylephrine|mesh-list
138548261|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
138548262|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
138548263|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138548264|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
138548265|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
138259740|NCT01847131|Protective Agents|protective agents|mesh-ancestor
138548266|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548267|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548268|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
138548270|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
138548271|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
138548272|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138548273|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138548274|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138548275|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
138548276|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548277|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548278|NCT00240058|Protective Agents|protective agents|mesh-ancestor
138548279|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138548280|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138548281|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138548282|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
138548283|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138327723|NCT00148668|Docetaxel|docetaxel|mesh-list
138548284|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
138548285|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
138548286|NCT00098553|Everolimus|everolimus|mesh-list
138548287|NCT00098553|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138548288|NCT00098553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138548289|NCT00098553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548290|NCT00098553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548291|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138548292|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
138548293|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548294|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548295|NCT00240214|Sirolimus|sirolimus|mesh-list
138548296|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138548297|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548298|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138548299|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548300|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
138548301|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138548302|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
138548303|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548304|NCT00240253|Pramlintide|pramlintide|mesh-list
138259937|NCT05688215|Leucovorin|leucovorin|mesh-list
138548305|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138548306|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548307|NCT00065936|Naltrexone|naltrexone|mesh-list
138548308|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138548309|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138344276|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
138548310|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548311|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
138548312|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548313|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138548314|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138548315|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138548316|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
138434118|NCT05501665|Ipilimumab|ipilimumab|mesh-list
138548317|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548318|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138548319|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138548320|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548322|NCT00240409|Bromocriptine|bromocriptine|mesh-list
138548323|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
138548324|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548325|NCT00240409|Protective Agents|protective agents|mesh-ancestor
138260057|NCT01868425|Analgesics|analgesics|mesh-ancestor
138548326|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548327|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138548328|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138548329|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
138548330|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
138548331|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548332|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
138548333|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138327751|NCT00151320|Rituximab|rituximab|mesh-list
138548335|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138548337|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138548338|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138548339|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138548340|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548341|NCT00240448|Diuretics|diuretics|mesh-ancestor
138548343|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548344|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138548345|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138548346|NCT00098631|Lapatinib|lapatinib|mesh-list
138548347|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548348|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138548349|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548350|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138171020|NCT00595153|Hormones|hormones|mesh-ancestor
138548351|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
138548352|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138548353|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548354|NCT00076791|Tenofovir|tenofovir|mesh-list
138548355|NCT00076791|Emtricitabine|emtricitabine|mesh-list
138548356|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138548357|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
138548358|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548359|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138548360|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138548361|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548362|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548363|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138548364|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138548365|NCT00240682|Cetuximab|cetuximab|mesh-list
138548366|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138548367|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548368|NCT00240721|Topiramate|topiramate|mesh-list
138548369|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
138548370|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138548371|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548372|NCT00240760|Memantine|memantine|mesh-list
138548373|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138344277|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138548374|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138548375|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
138548376|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548377|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548378|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548379|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138548380|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138548382|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138548383|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
138548384|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548385|NCT04720807|Letrozole|letrozole|mesh-list
138548386|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548387|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138548388|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138548389|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548390|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548391|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138548392|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
138548393|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138548394|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548395|NCT00240799|Acetaminophen|acetaminophen|mesh-list
138548396|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138548397|NCT00240799|Analgesics|analgesics|mesh-ancestor
138548398|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
138260729|NCT00369239|Risperidone|risperidone|mesh-list
138548399|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548400|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548402|NCT00240838|Acetaminophen|acetaminophen|mesh-list
138548403|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138548404|NCT00240838|Analgesics|analgesics|mesh-ancestor
138548405|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
138548406|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548407|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548408|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
138548409|NCT02965404|Vaccines|vaccines|mesh-list
138548410|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
138548411|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548412|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
138548413|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138548414|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548415|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138548416|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
138548417|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138548418|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548420|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548421|NCT00241072|Valsartan|valsartan|mesh-list
138548422|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138548423|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138548424|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138548425|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548426|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
138548427|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138488550|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
138351727|NCT02925858|Ketamine|ketamine|mesh-list
138548428|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548429|NCT00241150|Valsartan|valsartan|mesh-list
138548430|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138548431|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138548432|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138548433|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548434|NCT00076869|Amphotericin B|amphotericin b|mesh-list
138548435|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138548436|NCT00076869|Caspofungin|caspofungin|mesh-list
138548437|NCT00076869|Amebicides|amebicides|mesh-ancestor
138548438|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138548439|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138548440|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548441|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138548442|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
138548443|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548444|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548445|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
138548446|NCT00066248|Megestrol|megestrol|mesh-list
138548447|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
138548448|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138548449|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138434331|NCT05106296|Etoposide|etoposide|mesh-list
138548450|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138548451|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
138548452|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138548453|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548454|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138548455|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138548456|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138548457|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548458|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
138548459|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138548460|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
138548461|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
138548462|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138548463|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138548464|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
138548465|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
138548466|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548467|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548468|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138548469|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
138548470|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138548473|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138548474|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
138261540|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138548476|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548477|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138548478|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
138548479|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548480|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548481|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
138548482|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548483|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138548484|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138548485|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
138548486|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138548487|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138548488|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138548489|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548490|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138351782|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138548491|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
138548492|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
138548493|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548494|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138171086|NCT03087032|Hormones|hormones|mesh-ancestor
138548495|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548496|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548497|NCT00241345|Valganciclovir|valganciclovir|mesh-list
138548498|NCT00241345|Ganciclovir|ganciclovir|mesh-list
138548499|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138548500|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
138548501|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548502|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138548503|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548504|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548506|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138548507|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548508|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138548509|NCT00241423|Incretins|incretins|mesh-ancestor
138548510|NCT00241423|Hormones|hormones|mesh-ancestor
138548511|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138548512|NCT00241501|Esomeprazole|esomeprazole|mesh-list
138548513|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138548514|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138548515|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138548516|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548517|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548518|NCT00076986|Carmustine|carmustine|mesh-list
138548519|NCT00076986|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
138548520|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138261800|NCT02287909|Clopidogrel|clopidogrel|mesh-list
138548521|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
138548522|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548523|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548524|NCT00241540|Esomeprazole|esomeprazole|mesh-list
138548525|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138548526|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138548527|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138548528|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548529|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548530|NCT00098982|Leucovorin|leucovorin|mesh-list
138548531|NCT00098982|Fluorouracil|fluorouracil|mesh-list
138548532|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
138548533|NCT00098982|Bortezomib|bortezomib|mesh-list
138548534|NCT00098982|Calcium|calcium|mesh-list
138548535|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
138548536|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138548537|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548538|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
138548539|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548540|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138548541|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548542|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138548543|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
138548544|NCT00098982|Antidotes|antidotes|mesh-ancestor
138351844|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138548545|NCT00098982|Protective Agents|protective agents|mesh-ancestor
138548546|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
138548547|NCT00098982|Vitamins|vitamins|mesh-ancestor
138548548|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
138548549|NCT00241618|Interferons|interferons|mesh-list
138548550|NCT00241618|Ribavirin|ribavirin|mesh-list
138548551|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
138548552|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
138548553|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548554|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
138548555|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548556|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
138548557|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548558|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
138548559|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548560|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
138548561|NCT00066482|Cisplatin|cisplatin|mesh-list
138548562|NCT00066482|Etoposide|etoposide|mesh-list
138548563|NCT00066482|Bleomycin|bleomycin|mesh-list
138548564|NCT00066482|Lenograstim|lenograstim|mesh-list
138548565|NCT00066482|Mesna|mesna|mesh-list
138548566|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138548567|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
138548568|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548569|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434603|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548570|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138548572|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548573|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548574|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138262124|NCT05272787|Sunscreening Agents|sunscreening agents|mesh-list
138548575|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138548576|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138548577|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138548578|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548579|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138548580|NCT00066482|Protective Agents|protective agents|mesh-ancestor
138548582|NCT00099060|Lapatinib|lapatinib|mesh-list
138548583|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548584|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138548585|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548586|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548587|NCT00066599|Voriconazole|voriconazole|mesh-list
138548588|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
138548589|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548590|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138548591|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138548592|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548593|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548594|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138548595|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
138548596|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138548597|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548598|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138548599|NCT00242008|Rotigotine|rotigotine|mesh-list
138548600|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
138548602|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548603|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548604|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548605|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
138171160|NCT03086720|Eusol|eusol|mesh-list
138548606|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138548607|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
138548608|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
138548609|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138548610|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548611|NCT02962024|Morphine|morphine|mesh-list
138548612|NCT02962024|Bupivacaine|bupivacaine|mesh-list
138548613|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
138548614|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
138548615|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138548616|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488551|NCT00005852|Hormones|hormones|mesh-ancestor
138351900|NCT03012594|Lanreotide|lanreotide|mesh-list
138548617|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
138548618|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548619|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138548620|NCT02962024|Narcotics|narcotics|mesh-ancestor
138548621|NCT02962024|Analgesics|analgesics|mesh-ancestor
138262691|NCT04492358|Prednisone|prednisone|mesh-list
138548623|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138548624|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548625|NCT00066638|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138351975|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548626|NCT00066638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548627|NCT00066638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548628|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
138548629|NCT00242203|Docetaxel|docetaxel|mesh-list
138548630|NCT00242203|Trastuzumab|trastuzumab|mesh-list
138548631|NCT00242203|Epirubicin|epirubicin|mesh-list
138548632|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548633|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
138548634|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
138548635|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
138548636|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548637|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138548638|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138548639|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138548640|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138548641|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548642|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138224960|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548643|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548644|NCT00077025|Gefitinib|gefitinib|mesh-list
138548645|NCT00077025|Anastrozole|anastrozole|mesh-list
138548646|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548647|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138548648|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548649|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548650|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138548651|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138548652|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138548653|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138548654|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
138548655|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138548656|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548657|NCT00242359|Omalizumab|omalizumab|mesh-list
138548658|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138548659|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138548660|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
138548661|NCT00066716|Celecoxib|celecoxib|mesh-list
138548662|NCT00066716|Paclitaxel|paclitaxel|mesh-list
138548663|NCT00066716|Carboplatin|carboplatin|mesh-list
138548664|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138171171|NCT00597727|Glycerol|glycerol|mesh-list
138548665|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548666|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
138548667|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
138548668|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
138548669|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548670|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138548671|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138548672|NCT00066716|Analgesics|analgesics|mesh-ancestor
138548673|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
138548674|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548675|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548676|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138548677|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138548678|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138548679|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138548680|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548681|NCT00077103|Doxorubicin|doxorubicin|mesh-list
138548682|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138548683|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
138548684|NCT00077103|Combretastatin|combretastatin|mesh-list
138344278|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
138351987|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
138548685|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548686|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138548687|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138548688|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138548689|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548690|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548691|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138548692|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
138548693|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
138548694|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
138548695|NCT00242437|Hemostatics|hemostatics|mesh-list
138548696|NCT00242437|Thrombin|thrombin|mesh-list
138548698|NCT00066794|Cytarabine|cytarabine|mesh-list
138548699|NCT00066794|Cyclosporine|cyclosporine|mesh-list
138548700|NCT00066794|Daunorubicin|daunorubicin|mesh-list
138548701|NCT00066794|Cyclosporins|cyclosporins|mesh-list
138548702|NCT00066794|Sargramostim|sargramostim|mesh-list
138548703|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138548704|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
138548705|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548706|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548707|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
138548708|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548709|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138548710|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
138548711|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548712|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548713|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
138548714|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
138548715|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138548716|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138548717|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138548718|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138548719|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138548720|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
138548721|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138548722|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548724|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138548725|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548726|NCT00242749|Gefitinib|gefitinib|mesh-list
138548727|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138328015|NCT00354978|Vitamins|vitamins|mesh-ancestor
138548728|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138548730|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548731|NCT00242788|Capecitabine|capecitabine|mesh-list
138548732|NCT00242788|Gefitinib|gefitinib|mesh-list
138548733|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138548734|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
138548735|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548736|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548737|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138548738|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548739|NCT00066872|Imiquimod|imiquimod|mesh-list
138548740|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138263689|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
138548741|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
138548742|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548743|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548744|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
138548745|NCT00243100|Gemcitabine|gemcitabine|mesh-list
138548747|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138352046|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138352048|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
138548748|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
138548749|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548750|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548751|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138548752|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548753|NCT00099216|Rivastigmine|rivastigmine|mesh-list
138548754|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138548755|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548756|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548757|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
138548758|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548759|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263906|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
138548760|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138548762|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
138548763|NCT00066989|Antibodies|antibodies|mesh-list
138548764|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
138548765|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138548766|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138548767|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
138548768|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548769|NCT00243178|Clopidogrel|clopidogrel|mesh-list
138548770|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138548771|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138548772|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138263968|NCT03023891|Prednisone|prednisone|mesh-list
138548773|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138548774|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
138548775|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548776|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264029|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
138548777|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548779|NCT00243256|Vitamin D|vitamin d|mesh-list
138548780|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138548781|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548782|NCT00243256|Vitamins|vitamins|mesh-ancestor
138548783|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
138548784|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138548785|NCT00243646|Bicalutamide|bicalutamide|mesh-list
138548786|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548787|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548788|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
138548789|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
138548790|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138548791|NCT00099333|Exenatide|exenatide|mesh-list
138548792|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138548793|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548794|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138548796|NCT00099333|Hormones|hormones|mesh-ancestor
138434880|NCT03783936|Antidotes|antidotes|mesh-ancestor
138548797|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138548798|NCT00243724|Esomeprazole|esomeprazole|mesh-list
138548799|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138548800|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138548801|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138548802|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264226|NCT02975297|Exenatide|exenatide|mesh-list
138548803|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548804|NCT00243880|Lovastatin|lovastatin|mesh-list
138352107|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138548805|NCT00243880|L 647318|l 647318|mesh-list
138548806|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
138548807|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138548808|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138548809|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
138548810|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548811|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138264358|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138548812|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138548813|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548815|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138548816|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548817|NCT00244153|Dexamethasone|dexamethasone|mesh-list
138548818|NCT00244153|Morphine|morphine|mesh-list
138548819|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138548821|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
138548822|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548823|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548824|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138548825|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
138548826|NCT00244153|Hormones|hormones|mesh-ancestor
138264645|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138548827|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138548828|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138548829|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548830|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138548831|NCT00244153|Narcotics|narcotics|mesh-ancestor
138548832|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138548833|NCT00244153|Analgesics|analgesics|mesh-ancestor
138548834|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
138548835|NCT02967029|Remifentanil|remifentanil|mesh-list
138548837|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138548838|NCT02967029|Narcotics|narcotics|mesh-ancestor
138548840|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548841|NCT02967029|Analgesics|analgesics|mesh-ancestor
138548842|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
138171223|NCT00598507|Sagopilone|sagopilone|mesh-list
138548843|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548844|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138548845|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138548846|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138548847|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
138548848|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548849|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548850|NCT00244192|Infliximab|infliximab|mesh-list
138548851|NCT00244192|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138548852|NCT00244192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138548853|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
138548854|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138548856|NCT00077181|Cytarabine|cytarabine|mesh-list
138548857|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138548858|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
138548859|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548860|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548861|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
138548862|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548863|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138548864|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
138265364|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
138352164|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
138371694|NCT01413022|Antidotes|antidotes|mesh-ancestor
138371695|NCT01413022|Protective Agents|protective agents|mesh-ancestor
138371696|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
138371697|NCT01413022|Vitamins|vitamins|mesh-ancestor
138371698|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
138371699|NCT01413048|Carvedilol|carvedilol|mesh-list
138371700|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138371701|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138371702|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
138371703|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138371704|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138371705|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371706|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138371708|NCT01413048|Protective Agents|protective agents|mesh-ancestor
138548865|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548867|NCT00244309|Dutasteride|dutasteride|mesh-list
138548868|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138548869|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138548870|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138548871|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
138548872|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548873|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548874|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548875|NCT00244309|Urological Agents|urological agents|mesh-ancestor
138548876|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138352225|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352226|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548877|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138548878|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548879|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
138548880|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138548881|NCT00244348|Fluorouracil|fluorouracil|mesh-list
138548882|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
138548883|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
138548884|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548885|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138548886|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548887|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138548888|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
138548889|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548890|NCT00077220|Paclitaxel|paclitaxel|mesh-list
138548891|NCT00077220|Carboplatin|carboplatin|mesh-list
138548892|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138548893|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548894|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
138548895|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
138548896|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
138548897|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548899|NCT00244426|Indobufen|indobufen|mesh-list
138548900|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138548902|NCT00244426|Analgesics|analgesics|mesh-ancestor
138548903|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
138548904|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548905|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548907|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138548908|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138548909|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138171229|NCT00566813|Analgesics|analgesics|mesh-ancestor
138548910|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548911|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138548912|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138548913|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548915|NCT00398957|Naltrexone|naltrexone|mesh-list
138548916|NCT00398957|Hydromorphone|hydromorphone|mesh-list
138548917|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
138548918|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138548919|NCT00398957|Narcotics|narcotics|mesh-ancestor
138548920|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138548921|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548922|NCT00398957|Analgesics|analgesics|mesh-ancestor
138548923|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
138548924|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138548925|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138548927|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138548928|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138548929|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
138548930|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548931|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548932|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548933|NCT00244504|Moxonidine|moxonidine|mesh-list
138548934|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138548935|NCT00099489|Interferons|interferons|mesh-list
138548936|NCT00099489|Interferon-beta|interferon-beta|mesh-list
138548937|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
138548938|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548939|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
138548940|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138548941|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
138548942|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548943|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138548944|NCT00067262|Valproic Acid|valproic acid|mesh-list
138548945|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
138548946|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266028|NCT05603429|Antioxidants|antioxidants|mesh-list
138548947|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548948|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
138548949|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548950|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548951|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
138548952|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138548953|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138548954|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138548956|NCT00244738|Cathartics|cathartics|mesh-ancestor
138548957|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138548958|NCT00077259|Epothilones|epothilones|mesh-list
138548959|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
138548960|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
138548962|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
138548963|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548964|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548966|NCT00067301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138548967|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138548968|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138548969|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548970|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138548971|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
138548972|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548973|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138548974|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
138548975|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138548976|NCT00244972|Sorafenib|sorafenib|mesh-list
138548977|NCT00244972|Tipifarnib|tipifarnib|mesh-list
138548978|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138548979|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138548980|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138548981|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548982|NCT00245089|Dactinomycin|dactinomycin|mesh-list
138548983|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
138548984|NCT00245089|Vincristine|vincristine|mesh-list
138548985|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138548986|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
138548987|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138548988|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138548989|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138548990|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
138548991|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138548992|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266233|NCT05329766|Leucovorin|leucovorin|mesh-list
138548994|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138548995|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
138548996|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
138548997|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
138548998|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138548999|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549000|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138549001|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138549002|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549003|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138549004|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
138549005|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138549006|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549007|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
138352307|NCT03218592|Maraviroc|maraviroc|mesh-list
138352308|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
138549008|NCT00245206|Olanzapine|olanzapine|mesh-list
138549009|NCT00245206|Risperidone|risperidone|mesh-list
138549010|NCT00245206|Aripiprazole|aripiprazole|mesh-list
138549011|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138549012|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
138549013|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549014|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549015|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549016|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138549017|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138549018|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549019|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138549020|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138549022|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
138549023|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
138549024|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549025|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138549026|NCT00245206|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138549027|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138549028|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138549029|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
138549030|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
138549031|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138266325|NCT05273567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138549032|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138549033|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138549034|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138549036|NCT00245245|Coagulants|coagulants|mesh-ancestor
138549037|NCT00077298|Bevacizumab|bevacizumab|mesh-list
138549038|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138549039|NCT00077298|Cetuximab|cetuximab|mesh-list
138549040|NCT00077298|Irinotecan|irinotecan|mesh-list
138549041|NCT00077298|Antibodies|antibodies|mesh-list
138549042|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
138549043|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138549044|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549045|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138549046|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138549047|NCT00077298|Growth Substances|growth substances|mesh-ancestor
138549048|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549049|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
138549050|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
138549051|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138549052|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138549053|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549054|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549056|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138549057|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549058|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138549059|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549060|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
138549061|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138549062|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
138549063|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549064|NCT00245440|Azithromycin|azithromycin|mesh-list
138549065|NCT00245440|Telithromycin|telithromycin|mesh-list
138549066|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138549067|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549068|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138549069|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138549070|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
138549071|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549072|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549073|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138549074|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
138549075|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
138549076|NCT00400608|Hormones|hormones|mesh-ancestor
138266516|NCT05060965|Nicotine|nicotine|mesh-list
138549077|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138352371|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138352372|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
138549079|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
138549080|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
138549081|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138549082|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138266563|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
138549083|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549084|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549085|NCT00245596|Urological Agents|urological agents|mesh-ancestor
138549086|NCT00245674|Amisulpride|amisulpride|mesh-list
138549087|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138549088|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138549089|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549090|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549091|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138549092|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138549093|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
138549094|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549095|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549096|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138549097|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
138549098|NCT00245713|Levetiracetam|levetiracetam|mesh-list
138549099|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
138171266|NCT03086564|Hormones|hormones|mesh-ancestor
138549100|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
138549101|NCT00067457|Alosetron|alosetron|mesh-list
138549102|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138549103|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138549104|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
138549105|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549106|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549107|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549108|NCT00102843|Folic Acid|folic acid|mesh-list
138549109|NCT00102843|Betaine|betaine|mesh-list
138549110|NCT00102843|Hematinics|hematinics|mesh-ancestor
138549111|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
138549113|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
138549114|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549115|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138549116|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
138549117|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138549118|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
138549119|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549120|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138549121|NCT00245791|Levofloxacin|levofloxacin|mesh-list
138549122|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138549123|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549124|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138549125|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138549126|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138549127|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328355|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549128|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549129|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549130|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138549131|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138549132|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
138549133|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138549134|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549135|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138549136|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
138549137|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138549138|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549139|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549140|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549141|NCT00245908|Azithromycin|azithromycin|mesh-list
138549142|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138549143|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549144|NCT00067496|Modafinil|modafinil|mesh-list
138549145|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138549146|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549147|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138549148|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138549149|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138549150|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549152|NCT00246064|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138549153|NCT00246064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138549154|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
138549155|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138549156|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138549157|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
138549158|NCT00246103|Fluorouracil|fluorouracil|mesh-list
138549159|NCT00246103|Epirubicin|epirubicin|mesh-list
138549160|NCT00246103|Valproic Acid|valproic acid|mesh-list
138549161|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138549162|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
138549163|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549164|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138549165|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138549166|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
138549167|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549168|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549169|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138549170|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
138549171|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138549172|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138549173|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138549174|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138549175|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549176|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
138549177|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
138435286|NCT01718743|Ixazomib|ixazomib|mesh-list
138549178|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549179|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
138549180|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138549181|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549183|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
138549184|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138549185|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138549186|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138549187|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138549188|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549189|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
138549190|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352482|NCT03395808|Analgesics|analgesics|mesh-ancestor
138352483|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
138352484|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372263|NCT01417390|Cisplatin|cisplatin|mesh-list
138372264|NCT01417390|Gemcitabine|gemcitabine|mesh-list
138372265|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138372266|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138372267|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
138372268|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372269|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
138372270|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
138372271|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138372272|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138549191|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549192|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138549193|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549194|NCT00067535|Cocaine|cocaine|mesh-list
138549195|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
138549196|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
138549197|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549198|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549199|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
138549200|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549201|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138549202|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138549203|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138549204|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138267272|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549205|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549206|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
138549207|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549208|NCT00102882|Fluticasone|fluticasone|mesh-list
138549209|NCT00102882|Xhance|xhance|mesh-list
138549210|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138267328|NCT04023019|Coagulants|coagulants|mesh-ancestor
138549211|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138549212|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138549213|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138549214|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
138549215|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549216|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549217|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138549218|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
138549219|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
138549220|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138549221|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138549222|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138549223|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138549224|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
138549225|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549226|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549227|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
138549228|NCT00102882|Hormones|hormones|mesh-ancestor
138549229|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138549230|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
138435361|NCT00415233|Hormones|hormones|mesh-list
138549231|NCT00246220|Methylphenidate|methylphenidate|mesh-list
138549232|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138267398|NCT03938389|Valsartan|valsartan|mesh-list
138549233|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549234|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138549235|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138549236|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138549237|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549238|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
138549239|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549240|NCT00424801|Nicorandil|nicorandil|mesh-list
138549241|NCT00424801|Valsartan|valsartan|mesh-list
138549242|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138549243|NCT00424801|Doxazosin|doxazosin|mesh-list
138549245|NCT00424801|Pindolol|pindolol|mesh-list
138549246|NCT00424801|Moxonidine|moxonidine|mesh-list
138549247|NCT00424801|Amiloride|amiloride|mesh-list
138549248|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138267472|NCT03719326|Paclitaxel|paclitaxel|mesh-list
138549250|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138549251|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549252|NCT00424801|Diuretics|diuretics|mesh-ancestor
138549253|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
138549254|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549255|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138549256|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138549257|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138549258|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138549259|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138549260|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138549261|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138549262|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138549263|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138549264|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
138267602|NCT03474198|Levofloxacin|levofloxacin|mesh-list
138549265|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549266|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138549267|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
138549268|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
138549269|NCT00424801|Vitamins|vitamins|mesh-ancestor
138549270|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
138549271|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138549272|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138549273|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138549275|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
138549276|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
138549277|NCT00246298|Hematinics|hematinics|mesh-ancestor
138549279|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138549280|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138549281|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
138549282|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549283|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549284|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549285|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138549286|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138549288|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138549289|NCT00246532|Narcotics|narcotics|mesh-ancestor
138549290|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549291|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549292|NCT00246532|Analgesics|analgesics|mesh-ancestor
138549293|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
138549294|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549295|NCT00246610|Nelfinavir|nelfinavir|mesh-list
138549296|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138549297|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138549298|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
138549299|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435468|NCT01750463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138549300|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549302|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138549303|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
138549304|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549305|NCT00246688|Sagopilone|sagopilone|mesh-list
138352601|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
138352602|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138549306|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549307|NCT04728516|Amoxicillin|amoxicillin|mesh-list
138549309|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138549310|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549311|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138549312|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138549313|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138549314|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549315|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549316|NCT00400998|Fluticasone|fluticasone|mesh-list
138549317|NCT00400998|Xhance|xhance|mesh-list
138549318|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138549319|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138549320|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
138549321|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549322|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549323|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138549324|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
138549325|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
138549326|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138549327|NCT00247078|Antivenins|antivenins|mesh-list
138549328|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
138549329|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549330|NCT00247117|Metformin|metformin|mesh-list
138549331|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138549332|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549333|NCT00099606|Dasatinib|dasatinib|mesh-list
138549334|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549335|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138549336|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549337|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549338|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
138549339|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138549340|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
138549341|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549342|NCT00247507|Expectorants|expectorants|mesh-ancestor
138549343|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
138549344|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138328526|NCT00381810|Rituximab|rituximab|mesh-list
138549345|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
138549346|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549347|NCT00247507|Protective Agents|protective agents|mesh-ancestor
138549348|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549349|NCT00247507|Antidotes|antidotes|mesh-ancestor
138549350|NCT00247585|Ethanol|ethanol|mesh-list
138549351|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138549352|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549353|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549354|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549355|NCT00099645|Mifepristone|mifepristone|mesh-list
138549356|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138549357|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
138549358|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138549359|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549360|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138549361|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138549362|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138549363|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
138549364|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138549365|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138549366|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
138549367|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138549368|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
138549369|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138549370|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138549371|NCT00247663|Letrozole|letrozole|mesh-list
138549372|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549373|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138549374|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138549375|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549376|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549377|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138549378|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
138549379|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138549380|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549381|NCT00247702|Warfarin|warfarin|mesh-list
138549382|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
138549383|NCT01349660|Bevacizumab|bevacizumab|mesh-list
138549384|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138549385|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549386|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138549387|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138549388|NCT01349660|Growth Substances|growth substances|mesh-ancestor
138328564|NCT00459732|Zinc|zinc|mesh-list
138549390|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
138549392|NCT00247741|Carticaine|carticaine|mesh-list
138549393|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
138549394|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
138549395|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549396|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549397|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
138549398|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549399|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138549400|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138549401|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138549402|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138549403|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549405|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138549406|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138549407|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
138549408|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549409|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138549410|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138549411|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549412|NCT00248053|Curcumin|curcumin|mesh-list
138549413|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138549414|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138549415|NCT00248053|Analgesics|analgesics|mesh-ancestor
138549416|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
138549417|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549418|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549419|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138549420|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138549421|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549422|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549423|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549424|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138549425|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138549426|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549427|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138549428|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138549429|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138328589|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138549430|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549431|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
138549432|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549433|NCT00248131|Octreotide|octreotide|mesh-list
138549434|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138549435|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138268651|NCT02362321|Dexamethasone|dexamethasone|mesh-list
138549437|NCT00248209|Bupropion|bupropion|mesh-list
138549438|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138549439|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
138549440|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138549441|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138268705|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138549442|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138549443|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138549444|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549445|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
138549446|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549447|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549448|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138549449|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138549450|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549451|NCT00248248|Doxorubicin|doxorubicin|mesh-list
138549452|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138549453|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138549454|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549455|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138549456|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138549457|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549458|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549459|NCT00248443|Dimercaprol|dimercaprol|mesh-list
138549460|NCT00248443|Chelating Agents|chelating agents|mesh-ancestor
138549461|NCT00248443|Sequestering Agents|sequestering agents|mesh-ancestor
138549462|NCT00248443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549463|NCT00248482|Cisplatin|cisplatin|mesh-list
138549464|NCT00248482|Irinotecan|irinotecan|mesh-list
138549465|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
138225778|NCT01591733|Folfirinox|folfirinox|mesh-list
138549466|NCT00248482|Camptothecin|camptothecin|mesh-list
138549467|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549468|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138549469|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138549470|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549471|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549472|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138328621|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
138549473|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138549474|NCT00103233|Trastuzumab|trastuzumab|mesh-list
138549475|NCT00103233|Vinorelbine|vinorelbine|mesh-list
138549476|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138549477|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549478|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138549479|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
138549481|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
138549482|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549483|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
138549484|NCT00248716|Hematinics|hematinics|mesh-ancestor
138549485|NCT00067925|Calcium|calcium|mesh-list
138549486|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138549487|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549489|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549490|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138549491|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138549492|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
138549493|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549494|NCT00249106|Vaccines|vaccines|mesh-list
138268834|NCT02394457|Hormones|hormones|mesh-ancestor
138549495|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
138549496|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549497|NCT00068042|Octreotide|octreotide|mesh-list
138549498|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138549499|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138549500|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549501|NCT00249145|Risperidone|risperidone|mesh-list
138549502|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138549503|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
138549504|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549505|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549506|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549507|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138549508|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138549509|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549510|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138549511|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138549512|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
138549513|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138549514|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138549515|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435616|NCT01751347|Lidocaine|lidocaine|mesh-list
138549516|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138549517|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
138549518|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549520|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138549521|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549523|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
138549524|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
138549525|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
138549526|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549527|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549529|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138549530|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
138549531|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549532|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549533|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549534|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138549535|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138549536|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549537|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138549538|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138549539|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
138549540|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138549541|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549543|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138549544|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
138549545|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
138549546|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
138549547|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
138549548|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
138549549|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138549550|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549551|NCT00099918|Vildagliptin|vildagliptin|mesh-list
138435654|NCT01751854|Escitalopram|escitalopram|mesh-list
138549552|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138549553|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549554|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138549555|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
138549556|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549557|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549558|NCT00249574|Buprenorphine|buprenorphine|mesh-list
138549559|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138549560|NCT00249574|Naloxone|naloxone|mesh-list
138549561|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138549563|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549564|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549565|NCT00249574|Analgesics|analgesics|mesh-ancestor
138549566|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
138549567|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549568|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138549569|NCT00249691|Topiramate|topiramate|mesh-list
138549570|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
138549571|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138549572|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549573|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
138549574|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
138549575|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138549576|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138549577|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549578|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549579|NCT00249730|Urological Agents|urological agents|mesh-ancestor
138549580|NCT00249847|Paroxetine|paroxetine|mesh-list
138549581|NCT00249847|Estrogens|estrogens|mesh-list
138549582|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138549583|NCT00249847|Hormones|hormones|mesh-ancestor
138549584|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138352883|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138549585|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549586|NCT00249847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138549587|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138549588|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138549589|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549590|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549591|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
138549592|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138549593|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
138549594|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138549595|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138549596|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138549597|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549598|NCT00249886|Citalopram|citalopram|mesh-list
138549599|NCT00249886|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138549600|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138549601|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138549602|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549603|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549604|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
138549605|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549606|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138549607|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
138549608|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138549610|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138549611|NCT00249964|Carboplatin|carboplatin|mesh-list
138549612|NCT00249964|Temozolomide|temozolomide|mesh-list
138549613|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138225955|NCT05672537|Durvalumab|durvalumab|mesh-list
138269353|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
138549614|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549615|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
138549616|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
138549617|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
138549618|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269420|NCT01238211|Daunorubicin|daunorubicin|mesh-list
138549619|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138549621|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
138549622|NCT00068276|Vitamin D|vitamin d|mesh-list
138549623|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138549624|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549625|NCT00068276|Vitamins|vitamins|mesh-ancestor
138549626|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
138549627|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138549628|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
138549629|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
138549630|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549631|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138549632|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549633|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549634|NCT00068315|Rituximab|rituximab|mesh-list
138549635|NCT00068315|Fludarabine|fludarabine|mesh-list
138328748|NCT00385788|Methotrexate|methotrexate|mesh-list
138549636|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
138549637|NCT00068315|Bortezomib|bortezomib|mesh-list
138549638|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138549639|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549640|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
138549641|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549642|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138549643|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138549644|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
138549645|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549646|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138549647|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
138549648|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138549649|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138549650|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549651|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
138352950|NCT03730116|Bisoprolol|bisoprolol|mesh-list
138549652|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549653|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549654|NCT00250120|Camptothecin|camptothecin|mesh-list
138549656|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138549657|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549658|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138549659|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138549660|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549661|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549662|NCT04720573|Neostigmine|neostigmine|mesh-list
138549663|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138549664|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549665|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549666|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
138549667|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549668|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549669|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138549670|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
138549671|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549673|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138549674|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549676|NCT00068432|Gemcitabine|gemcitabine|mesh-list
138549677|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138549678|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
138549679|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549680|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549681|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138549682|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138549683|NCT00068432|Analgesics|analgesics|mesh-ancestor
138549684|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
138549685|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549686|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549687|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138549688|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138549689|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138549690|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138549691|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549693|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
138549694|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
138549695|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
138549696|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549697|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549698|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138549699|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138549700|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138549701|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549702|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138549703|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138549704|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
138549705|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435805|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
138549706|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549707|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138549709|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138549710|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549711|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138549712|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
138549713|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549714|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549716|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138549717|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
138549718|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
138549719|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549720|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549721|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138171399|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
138549722|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138549723|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138549724|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
138549725|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138328814|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138549726|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549727|NCT00250315|Protective Agents|protective agents|mesh-ancestor
138549729|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
138549730|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549731|NCT00250354|Risperidone|risperidone|mesh-list
138549732|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138549733|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
138549734|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549735|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549736|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549737|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138549738|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138549740|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138549741|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138549743|NCT00250393|Istradefylline|istradefylline|mesh-list
138549744|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
138549745|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138549746|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138549747|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
138549748|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549749|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549750|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549751|NCT02961634|Ciclopirox|ciclopirox|mesh-list
138549752|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
138549753|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549754|NCT02966717|Rituximab|rituximab|mesh-list
138549755|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138549756|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549757|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
138549758|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270034|NCT05922306|Interferons|interferons|mesh-list
138549760|NCT00099996|Ezetimibe|ezetimibe|mesh-list
138270098|NCT05920707|Vasopressins|vasopressins|mesh-list
138549762|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138171410|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
138549763|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
138549764|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549765|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138549766|NCT00250744|Gabapentin|gabapentin|mesh-list
138549767|NCT00250744|Aprepitant|aprepitant|mesh-list
138549768|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
138549769|NCT00250744|Analgesics|analgesics|mesh-ancestor
138549770|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
138549771|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549772|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549773|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
138549774|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138353086|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353087|NCT02434146|Protective Agents|protective agents|mesh-ancestor
138353088|NCT02382588|Ganciclovir|ganciclovir|mesh-list
138549775|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138270243|NCT05832892|Tubulin Modulators|tubulin modulators|mesh-ancestor
138549776|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138549777|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138549778|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138549779|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138549780|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549781|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549782|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
138549783|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
138549784|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
138549785|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138549786|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138549787|NCT00103623|Abarelix|abarelix|mesh-list
138549788|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
138549789|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138549790|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549792|NCT00250861|Rituximab|rituximab|mesh-list
138549793|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138549794|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549795|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
138549796|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549797|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138549798|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138549799|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138549800|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
138549801|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549802|NCT00068549|Gemcitabine|gemcitabine|mesh-list
138549803|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549804|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138549805|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
138549806|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549807|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
138549808|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549809|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138549810|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138549811|NCT04720183|Analgesics|analgesics|mesh-ancestor
138549812|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
138549813|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549814|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549815|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138549816|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138549817|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138549818|NCT00250978|Bevacizumab|bevacizumab|mesh-list
138549819|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138549820|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549821|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138549822|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138549823|NCT00250978|Growth Substances|growth substances|mesh-ancestor
138549824|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549825|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
138549826|NCT00068666|Temozolomide|temozolomide|mesh-list
138549827|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138549828|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
138171443|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549829|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549830|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549831|NCT00103701|Dasatinib|dasatinib|mesh-list
138549832|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549833|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138549834|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549835|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549836|NCT00251017|Vancomycin|vancomycin|mesh-list
138353137|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138353147|NCT02015910|Incretins|incretins|mesh-ancestor
138549837|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138549838|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549840|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138549841|NCT00251056|Diuretics|diuretics|mesh-ancestor
138549842|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
138549843|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549844|NCT00251095|Paclitaxel|paclitaxel|mesh-list
138549845|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138549846|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549847|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
138549848|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
138549849|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
138549850|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549851|NCT00100074|Lobeline|lobeline|mesh-list
138549852|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138549853|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
138549854|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549855|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549856|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138549857|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138549858|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
138549859|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549860|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549861|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
138549863|NCT00068744|Mitomycins|mitomycins|mesh-list
138549864|NCT00068744|Mitomycin|mitomycin|mesh-list
138549865|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549866|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
138549867|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549868|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138549869|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138549870|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
138549871|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549872|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138549873|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
138549874|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138549875|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549876|NCT00100113|Vanoxerine|vanoxerine|mesh-list
138549877|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138549878|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138549879|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138328953|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138549880|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549881|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
138549882|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549883|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549884|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
138549885|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549886|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138549887|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549888|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549889|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
138549890|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549891|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
138549892|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138549893|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549894|NCT00251407|Docetaxel|docetaxel|mesh-list
138549895|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549896|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
138549897|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
138549898|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
138549899|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549900|NCT02966522|Thalidomide|thalidomide|mesh-list
138549901|NCT02966522|Dexamethasone|dexamethasone|mesh-list
138549902|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138549903|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
138549904|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
138549905|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549906|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549907|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138549908|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
138549909|NCT02966522|Hormones|hormones|mesh-ancestor
138549910|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138549911|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138226225|NCT02461758|Vaccines|vaccines|mesh-list
138549912|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549913|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138549914|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
138549915|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
138549916|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138549917|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138549918|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138549919|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138436115|NCT01755559|Artesunate|artesunate|mesh-list
138549921|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
138549922|NCT00251485|Cetuximab|cetuximab|mesh-list
138549923|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138549924|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549925|NCT00100152|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
138549926|NCT00100152|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138549927|NCT00100152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549928|NCT00100152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549929|NCT00251524|Bevacizumab|bevacizumab|mesh-list
138549930|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
138549931|NCT00251524|Pemetrexed|pemetrexed|mesh-list
138549932|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138549933|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138549934|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138549935|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138549936|NCT00251524|Growth Substances|growth substances|mesh-ancestor
138549937|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549938|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
138549939|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138549940|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549941|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138549942|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138549944|NCT00068861|Clomiphene|clomiphene|mesh-list
138549945|NCT00068861|Enclomiphene|enclomiphene|mesh-list
138549946|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
138549947|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138549948|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549949|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138549950|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
138549951|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436153|NCT01754792|Inositol|inositol|mesh-list
138549952|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138549953|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
138549954|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138549955|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138549956|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138549957|NCT00251602|Propranolol|propranolol|mesh-list
138549958|NCT00251602|Atropine|atropine|mesh-list
138171467|NCT05220917|Glipizide|glipizide|mesh-list
138549959|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138549960|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138549961|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
138549962|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549963|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549964|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549965|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138436194|NCT01755923|Docetaxel|docetaxel|mesh-list
138549966|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138549967|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
138549968|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138549969|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138549970|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
138549971|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549972|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138549973|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
138549974|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
138549975|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
138549976|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138549977|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138353272|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
138549978|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
138549979|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
138549980|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138549981|NCT02961166|Antibodies|antibodies|mesh-list
138549982|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
138549983|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549984|NCT00103818|Gaboxadol|gaboxadol|mesh-list
138549985|NCT00103818|Analgesics|analgesics|mesh-ancestor
138549986|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
138549987|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138549988|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138549989|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
138549990|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
138549991|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
138549992|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138549993|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138549994|NCT00251680|Atorvastatin|atorvastatin|mesh-list
138549995|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138549996|NCT00251680|Simvastatin|simvastatin|mesh-list
138549997|NCT00251680|Fenofibrate|fenofibrate|mesh-list
138549998|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138549999|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138550000|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
138550001|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550003|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138550004|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550005|NCT00251797|Thalidomide|thalidomide|mesh-list
138550006|NCT00251797|Irinotecan|irinotecan|mesh-list
138550007|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138270373|NCT05648591|Iloperidone|iloperidone|mesh-list
138550008|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138550009|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550010|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550011|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550012|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138550013|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
138550014|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550015|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
138550016|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138550017|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138171475|NCT05220917|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138550018|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138550019|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138550021|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
138550022|NCT00251914|Esomeprazole|esomeprazole|mesh-list
138550023|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138550024|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138550025|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138550026|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550027|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550028|NCT00100269|Antioxidants|antioxidants|mesh-list
138550029|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550030|NCT00100269|Protective Agents|protective agents|mesh-ancestor
138550031|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550032|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
138550033|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
138550034|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138550035|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
138353345|NCT01292070|Histamine|histamine|mesh-list
138353346|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
138353347|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
138550036|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138550037|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138550038|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550039|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138550040|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550041|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550042|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138550044|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
138550045|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138550046|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138550047|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550048|NCT00251953|Metformin|metformin|mesh-list
138550049|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138550050|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550051|NCT00251992|Esomeprazole|esomeprazole|mesh-list
138550052|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138550053|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138550054|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138550055|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550056|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550057|NCT00103935|Exenatide|exenatide|mesh-list
138550058|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138550059|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550060|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138550061|NCT00103935|Incretins|incretins|mesh-ancestor
138550062|NCT00103935|Hormones|hormones|mesh-ancestor
138550063|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138550065|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550066|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138550067|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138550068|NCT00399152|Growth Substances|growth substances|mesh-ancestor
138550069|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550070|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
138550071|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138550072|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550073|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550074|NCT00104013|Xaliproden|xaliproden|mesh-list
138550075|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138550076|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138550077|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
138550078|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138171488|NCT05220917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138550079|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550080|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550082|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
138550083|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550085|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
138550086|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138550087|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138353402|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353409|NCT01115244|Dapsone|dapsone|mesh-list
138550088|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138550089|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138550090|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550091|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
138550092|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550093|NCT00252304|Astringents|astringents|mesh-ancestor
138550094|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
138550095|NCT00252343|Amibegron|amibegron|mesh-list
138550096|NCT00252343|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138550097|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138550098|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138550099|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
138550100|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550101|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550102|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550103|NCT00252343|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138550104|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
138550105|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
138550106|NCT00252655|Sirolimus|sirolimus|mesh-list
138550107|NCT00252655|Tacrolimus|tacrolimus|mesh-list
138550108|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138550109|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
138550110|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550111|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138550112|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550113|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550114|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138550115|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550116|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138550117|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550120|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550121|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138550122|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550123|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550124|NCT00069251|Bupropion|bupropion|mesh-list
138550125|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138550126|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
138550127|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138550128|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138550129|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138550130|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138550131|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550132|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
138550133|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550134|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550135|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138550136|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138550137|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550138|NCT00252889|Doxorubicin|doxorubicin|mesh-list
138550139|NCT00252889|Topotecan|topotecan|mesh-list
138550140|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
138550141|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138550142|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550143|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138550144|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138550145|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550146|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550147|NCT00252928|Troclosene|troclosene|mesh-list
138550148|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
138550149|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550150|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
138550151|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
138550152|NCT00253123|Risperidone|risperidone|mesh-list
138550153|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138550154|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
138550155|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550156|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550158|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138550159|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138550160|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138550161|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138550162|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138550163|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
138550164|NCT00253162|Risperidone|risperidone|mesh-list
138550165|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138550166|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
138550167|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550168|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550169|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550170|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138550171|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138550172|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138550173|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138550174|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138550175|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
138550176|NCT00253201|Galantamine|galantamine|mesh-list
138550177|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138550178|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550179|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550180|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
138550181|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550182|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550183|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138550185|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138550186|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
138550188|NCT00100464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138550189|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138550190|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138550191|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550192|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550193|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
138550194|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550195|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138550196|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
138550197|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138550198|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138270632|NCT05090384|Hormones|hormones|mesh-ancestor
138550199|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138550200|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550201|NCT00253396|Heparin|heparin|mesh-list
138226525|NCT04370288|Expectorants|expectorants|mesh-ancestor
138226526|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
138171514|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
138226527|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138226529|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226530|NCT02993705|Trabectedin|trabectedin|mesh-list
138226531|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138226532|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
138226534|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550202|NCT00253396|Enoxaparin|enoxaparin|mesh-list
138550203|NCT00253396|Calcium heparin|calcium heparin|mesh-list
138550204|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
138270777|NCT04662086|Camostat|camostat|mesh-list
138550205|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138550206|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138329237|NCT00538434|Reslizumab|reslizumab|mesh-list
138550207|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550208|NCT00253474|Interferons|interferons|mesh-list
138550209|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
138550210|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
138550211|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138550212|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550213|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
138550214|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550215|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
138550216|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550217|NCT00253552|Cyclosporine|cyclosporine|mesh-list
138550218|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
138550219|NCT00253552|Busulfan|busulfan|mesh-list
138550220|NCT00253552|Methotrexate|methotrexate|mesh-list
138550221|NCT00253552|Etoposide|etoposide|mesh-list
138550222|NCT00253552|Cyclosporins|cyclosporins|mesh-list
138550223|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138550224|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
138436611|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
138550226|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138353566|NCT00656916|Xhance|xhance|mesh-list
138550227|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138550228|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
138550229|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550230|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550231|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138550232|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138550233|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
138550234|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138550235|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138550236|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
138550237|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
138550238|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550239|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138550240|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138550241|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138550242|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138550243|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138550244|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
138550245|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550246|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138550247|NCT00253591|Vinorelbine|vinorelbine|mesh-list
138550248|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550249|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138436673|NCT01758367|Decitabine|decitabine|mesh-list
138550250|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
138550251|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
138550252|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
138550253|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550254|NCT04719481|Pravastatin|pravastatin|mesh-list
138550255|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138550256|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138550257|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
138550258|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550259|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138550260|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138550261|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550263|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138550264|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138271171|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
138550265|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550266|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138550267|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138550268|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
138550269|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550270|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550271|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
138550272|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
138550273|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
138550274|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
138226612|NCT02244242|Tamsulosin|tamsulosin|mesh-list
138550275|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550276|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550277|NCT00254020|Citalopram|citalopram|mesh-list
138550278|NCT00254020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138550279|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138550280|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138550281|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271375|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
138550282|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550283|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
138550284|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550285|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138550286|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
138550288|NCT00254137|Capecitabine|capecitabine|mesh-list
138550289|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
138550290|NCT00254137|Irinotecan|irinotecan|mesh-list
138550291|NCT00254137|Cetuximab|cetuximab|mesh-list
138550292|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138550293|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
138550294|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550295|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282934|NCT03001843|Narcotics|narcotics|mesh-list
138550296|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138550297|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138550298|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550299|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138550300|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
138550301|NCT00104169|Hematinics|hematinics|mesh-ancestor
138550302|NCT00415090|Nevirapine|nevirapine|mesh-list
138550303|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138550304|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138550305|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550306|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550307|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
138550308|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550309|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138550310|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138550311|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138550312|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138550313|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
138550314|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138550315|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138550316|NCT00254254|Exenatide|exenatide|mesh-list
138550317|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138550318|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550319|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138550320|NCT00254254|Incretins|incretins|mesh-ancestor
138550321|NCT00254254|Hormones|hormones|mesh-ancestor
138550322|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138550323|NCT00254371|Androgens|androgens|mesh-list
138550324|NCT00254371|Hormones|hormones|mesh-ancestor
138479978|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138282956|NCT02786719|Sargramostim|sargramostim|mesh-list
138550325|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138550326|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550327|NCT00254449|Capsaicin|capsaicin|mesh-list
138550328|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
138550329|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
138550330|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
138550331|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138550332|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550333|NCT00104286|Troxacitabine|troxacitabine|mesh-list
138550334|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550335|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138550336|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138550337|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
138550338|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550339|NCT00254800|Exenatide|exenatide|mesh-list
138550340|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138550341|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138550343|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138550344|NCT00254800|Estradiol|estradiol|mesh-list
138550345|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138550346|NCT00254800|Estrogens|estrogens|mesh-ancestor
138550347|NCT00254800|Hormones|hormones|mesh-ancestor
138550348|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138550349|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550350|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138550351|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
138226679|NCT04362332|Amebicides|amebicides|mesh-ancestor
138550352|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138550353|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138550354|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138550355|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138550356|NCT00254800|Incretins|incretins|mesh-ancestor
138550357|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138550358|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138550359|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138550360|NCT00104403|Dexamethasone|dexamethasone|mesh-list
138550361|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
138550362|NCT00104403|Ondansetron|ondansetron|mesh-list
138550363|NCT00104403|Casopitant|casopitant|mesh-list
138550364|NCT00104403|BB 1101|bb 1101|mesh-list
138271903|NCT00551928|Prednisone|prednisone|mesh-list
138550365|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138550366|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
138550368|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138550369|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550370|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138550371|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
138550372|NCT00104403|Hormones|hormones|mesh-ancestor
138550373|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138550374|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138550375|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550376|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
138550377|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272171|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
138550378|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550379|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
138550380|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
138550381|NCT00104403|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138550382|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138550383|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
138550384|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550385|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138550386|NCT00069836|Metformin|metformin|mesh-list
138550387|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
138550388|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138272250|NCT00002525|Antidotes|antidotes|mesh-ancestor
138550389|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550391|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138550392|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550393|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138550394|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138550395|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138550396|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550397|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
138550398|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550399|NCT00254917|Vaccines|vaccines|mesh-list
138550400|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
138550401|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550402|NCT00254956|Ciclesonide|ciclesonide|mesh-list
138550403|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
138550404|NCT00254956|Hormones|hormones|mesh-ancestor
138272453|NCT05646810|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138550405|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138550406|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550408|NCT00255073|Baclofen|baclofen|mesh-list
138550409|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138272522|NCT02257632|Growth Substances|growth substances|mesh-ancestor
138550410|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550411|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138550412|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138550413|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138550414|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
138550415|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
138550416|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550417|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550418|NCT00069875|Gemcitabine|gemcitabine|mesh-list
138550419|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550420|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138550421|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
138550422|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550423|NCT00255268|Goserelin|goserelin|mesh-list
138550424|NCT00255268|Bicalutamide|bicalutamide|mesh-list
138550425|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138550426|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550428|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
138272823|NCT05430048|Bisoprolol|bisoprolol|mesh-list
138550429|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138550430|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550431|NCT00104442|Rivastigmine|rivastigmine|mesh-list
138550432|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138550434|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550435|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
138550436|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550437|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550438|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138550439|NCT00104442|Protective Agents|protective agents|mesh-ancestor
138436942|NCT01760096|Levamisole|levamisole|mesh-list
138550441|NCT00255385|Trace Elements|trace elements|mesh-list
138550442|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550443|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138550444|NCT00255424|Hematinics|hematinics|mesh-ancestor
138273005|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
138550445|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138550446|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138550448|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
138550449|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550450|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138550451|NCT00255463|Gefitinib|gefitinib|mesh-list
138550452|NCT00255463|Anastrozole|anastrozole|mesh-list
138550453|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550454|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138550455|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550456|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550457|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138550458|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138550459|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138550460|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138550461|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
138273075|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
138550462|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138550463|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550465|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138550466|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138550468|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
138436974|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
138550469|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273141|NCT03674294|Dexamethasone|dexamethasone|mesh-list
138550470|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550471|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138550472|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138550473|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138550474|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
138550475|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550476|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550477|NCT00255541|Glyburide|glyburide|mesh-list
138550478|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138550479|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550480|NCT00255658|Sirolimus|sirolimus|mesh-list
138550481|NCT00255658|Sorafenib|sorafenib|mesh-list
138550482|NCT00255658|Temsirolimus|temsirolimus|mesh-list
138550483|NCT00255658|MTOR Inhibitors|mtor inhibitors|mesh-list
138550484|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550485|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138550486|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550487|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550488|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138550489|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
138550490|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550491|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138550492|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550493|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138283166|NCT03021343|Colchicine|colchicine|mesh-list
138550494|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
138550495|NCT00070148|Megestrol|megestrol|mesh-list
138273558|NCT02460133|Ritonavir|ritonavir|mesh-list
138550496|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
138550497|NCT00070148|Oxandrolone|oxandrolone|mesh-list
138550498|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138550499|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138550500|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138550501|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
138550502|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138273689|NCT02448368|Verinurad|verinurad|mesh-list
138550503|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550504|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138550505|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138550506|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138550507|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550508|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
138550509|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138550510|NCT00070148|Androgens|androgens|mesh-ancestor
138550511|NCT00070148|Hormones|hormones|mesh-ancestor
138550512|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138550513|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
138550514|NCT00100581|Interferons|interferons|mesh-list
138550515|NCT00100581|Ritonavir|ritonavir|mesh-list
138550516|NCT00100581|Tenofovir|tenofovir|mesh-list
138550517|NCT00100581|Ribavirin|ribavirin|mesh-list
138550518|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
138550519|NCT00100581|Lamivudine|lamivudine|mesh-list
138550521|NCT00100581|Efavirenz|efavirenz|mesh-list
138550522|NCT00100581|Lopinavir|lopinavir|mesh-list
138550523|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138550524|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550525|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
138550526|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550527|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138550528|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138550529|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
138550530|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274039|NCT00608972|Carboplatin|carboplatin|mesh-list
138550531|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550532|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138550533|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138550534|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138550535|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138550536|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138550537|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138550538|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
138550539|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
138550540|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550541|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138550542|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138550543|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138550544|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138550545|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138550547|NCT00070187|Cytarabine|cytarabine|mesh-list
138550548|NCT00070187|Aldesleukin|aldesleukin|mesh-list
138550549|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
138550550|NCT00070187|Cyclosporine|cyclosporine|mesh-list
138550551|NCT00070187|Etoposide|etoposide|mesh-list
138550552|NCT00070187|Melphalan|melphalan|mesh-list
138550553|NCT00070187|Interleukin-2|interleukin-2|mesh-list
138550554|NCT00070187|Carmustine|carmustine|mesh-list
138550555|NCT00070187|Cyclosporins|cyclosporins|mesh-list
138550556|NCT00070187|Lenograstim|lenograstim|mesh-list
138550557|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138550558|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550559|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138550560|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138550561|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550562|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550563|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
138550564|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550565|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138550567|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138550568|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
138550569|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550570|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138550571|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
138550572|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
138550573|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138550574|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138550575|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138550576|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
138550577|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138550578|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138550580|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
138550581|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138550582|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138550583|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138550584|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138550585|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
138353887|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
138550586|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138550587|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
138550588|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138550589|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550590|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138550591|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138550592|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550594|NCT00415285|Capecitabine|capecitabine|mesh-list
138550595|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550596|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
138550597|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
138550598|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
138550599|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550600|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138550601|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
138550602|NCT00256009|Misoprostol|misoprostol|mesh-list
138550603|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138550604|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
138550605|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138550606|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550607|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138550608|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138550609|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
138550610|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
138550611|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138550612|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550613|NCT00070265|Capecitabine|capecitabine|mesh-list
138550614|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
138550615|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138550616|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
138550617|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550618|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550620|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138550621|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
138550622|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138550623|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138550624|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138550625|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138550626|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550627|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
138550628|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550629|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550630|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138550631|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138550632|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550633|NCT00256321|Celecoxib|celecoxib|mesh-list
138550634|NCT00256321|Capecitabine|capecitabine|mesh-list
138550635|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
138550636|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138550637|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
138550638|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550639|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550640|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138550641|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138550643|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
138550644|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138550645|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550646|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138550647|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138550648|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138550649|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138550650|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550651|NCT00070304|Gemcitabine|gemcitabine|mesh-list
138550652|NCT00070304|Vinorelbine|vinorelbine|mesh-list
138550653|NCT00070304|Lenograstim|lenograstim|mesh-list
138550654|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138550655|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
138550656|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550657|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550658|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138550659|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
138550660|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550661|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138550662|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
138550663|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
138550664|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
138550666|NCT00100737|Interleukin-2|interleukin-2|mesh-list
138550667|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138550668|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550669|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
138550670|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550671|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138550672|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138550673|NCT00100737|Analgesics|analgesics|mesh-ancestor
138550674|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
138550675|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138550676|NCT00070343|Dacarbazine|dacarbazine|mesh-list
138550677|NCT00070343|Oblimersen|oblimersen|mesh-list
138550678|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138550679|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
138550680|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550681|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550682|NCT00104715|Docetaxel|docetaxel|mesh-list
138550683|NCT00104715|Goserelin|goserelin|mesh-list
138550684|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
138550685|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550686|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
138550687|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
138550688|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
138550689|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550690|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138550692|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138275644|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
138550693|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550694|NCT00256711|Vinorelbine|vinorelbine|mesh-list
138550695|NCT00256711|Gefitinib|gefitinib|mesh-list
138550696|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138550697|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550698|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
138550699|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
138550700|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275773|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
138550701|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550702|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138275849|NCT00003681|Amifostine|amifostine|mesh-list
138550703|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550704|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
138550705|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
138550706|NCT00070382|Hematinics|hematinics|mesh-ancestor
138550707|NCT00256828|Lamivudine|lamivudine|mesh-list
138550708|NCT00256828|Efavirenz|efavirenz|mesh-list
138550709|NCT00256828|Didanosine|didanosine|mesh-list
138550710|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138550711|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138437342|NCT01761669|Vitamin D|vitamin d|mesh-list
138550712|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550713|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550714|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
138550715|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550716|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138550717|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138550718|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138550719|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138550720|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138550721|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138171663|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550722|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138550723|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138550726|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
138550727|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
138550728|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138276190|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
138550729|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138354029|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
138550730|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138550731|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138550732|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138550733|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138550734|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138550735|NCT00100776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138550736|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138550737|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138550738|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550739|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550740|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
138550742|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138550743|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
138550744|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550745|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550747|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550748|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138550749|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
138550750|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550752|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138550753|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138550754|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138550755|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550757|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138550758|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138550760|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550761|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550762|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138550763|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138550764|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
138550765|NCT00257062|Levofloxacin|levofloxacin|mesh-list
138550766|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138550767|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550768|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138550769|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138550770|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138550771|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550772|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550773|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550774|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138550775|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138550777|NCT00100854|Fulvestrant|fulvestrant|mesh-list
138550778|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276946|NCT00005787|Hematinics|hematinics|mesh-ancestor
138437492|NCT01762514|Amifostine|amifostine|mesh-list
138550779|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138550780|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138171678|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
138550781|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550782|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138550783|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138550784|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138550785|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
138550786|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138550787|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550789|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138550790|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550791|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138550792|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138550793|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138550794|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550795|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550796|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550797|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138550798|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138550799|NCT00257257|Rimonabant|rimonabant|mesh-list
138550800|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138550801|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138550802|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138550803|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550804|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550806|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138550807|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550808|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
138550809|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
138550810|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138550811|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550812|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138550813|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138550814|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550815|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550816|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550817|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550818|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138550819|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
138550820|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138550821|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138550822|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
138550823|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
138550824|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138550825|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
138550826|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550827|NCT00257491|Telmisartan|telmisartan|mesh-list
138550828|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138550829|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138550830|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138550831|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550832|NCT00104793|Carboplatin|carboplatin|mesh-list
138277563|NCT02919787|Fluorouracil|fluorouracil|mesh-list
138550834|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437579|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
138550835|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138550836|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138550837|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550838|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550839|NCT00070655|Vitamin K|vitamin k|mesh-list
138550840|NCT00070655|Warfarin|warfarin|mesh-list
138550841|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
138550842|NCT00070655|Idraparinux|idraparinux|mesh-list
138550843|NCT00070655|Vitamins|vitamins|mesh-ancestor
138550844|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
138550845|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550846|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
138550847|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138550848|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138550849|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550850|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
138550851|NCT00070655|Coagulants|coagulants|mesh-ancestor
138550852|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138550853|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
138550854|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138550855|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
138550856|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550857|NCT00257530|Imiquimod|imiquimod|mesh-list
138550858|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138550859|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
138550860|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550861|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550862|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
138550863|NCT00257569|Cetirizine|cetirizine|mesh-list
138550864|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138550865|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138550866|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138550867|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
138550868|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
138278010|NCT04341038|Tacrolimus|tacrolimus|mesh-list
138550869|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138550870|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550871|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550872|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
138550873|NCT00100893|Procyanidin|procyanidin|mesh-list
138550874|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
138550875|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550876|NCT00100893|Protective Agents|protective agents|mesh-ancestor
138550877|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550878|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138550879|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138550880|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550882|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
138550883|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138550884|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550885|NCT00401115|Sirolimus|sirolimus|mesh-list
138550886|NCT00401115|Temsirolimus|temsirolimus|mesh-list
138550887|NCT00401115|MTOR Inhibitors|mtor inhibitors|mesh-list
138550888|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138550889|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550890|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138550891|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550892|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
138550893|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138550894|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
138550895|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550896|NCT00401115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138550897|NCT00401115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278401|NCT05360030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138550898|NCT00401115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550900|NCT00257959|Sotalol|sotalol|mesh-list
138550901|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138354192|NCT00000600|Vitamin E|vitamin e|mesh-list
138550902|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138550903|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
138278494|NCT00300768|Ivermectin|ivermectin|mesh-list
138550905|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550906|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550907|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138278541|NCT02629094|Eplerenone|eplerenone|mesh-list
138550908|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
138550909|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138550910|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138550911|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138550912|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138550913|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138550914|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550915|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138550916|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138550917|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138550918|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
138550919|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
138550920|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138550921|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
138550923|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
138550924|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
138550925|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138550927|NCT00070733|Hormones|hormones|mesh-ancestor
138550928|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138550929|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550930|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138550931|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550933|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
138550934|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138278882|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550935|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550936|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138550937|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138550938|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138550939|NCT00258115|Analgesics|analgesics|mesh-ancestor
138550940|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
138550941|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138550942|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550943|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138550944|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138550946|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138550947|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
138550948|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138227276|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138550949|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138550950|NCT00100971|Vaccines|vaccines|mesh-list
138550951|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
138550952|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550954|NCT00258232|Capecitabine|capecitabine|mesh-list
138550955|NCT00258232|Irinotecan|irinotecan|mesh-list
138550956|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138550957|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
138550958|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279165|NCT02502487|Ropivacaine|ropivacaine|mesh-list
138550959|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550960|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138550961|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138279242|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
138550962|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550963|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138550964|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138550966|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
138550967|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138550968|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550969|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138550970|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138550971|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138550972|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138550973|NCT00258271|Cytarabine|cytarabine|mesh-list
138550974|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
138550975|NCT00258271|Cladribine|cladribine|mesh-list
138550976|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138550977|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
138550978|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550979|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550980|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
138279541|NCT04743193|Sevoflurane|sevoflurane|mesh-list
138550981|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138550982|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138550983|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
138550984|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550985|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138550986|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550987|NCT00101088|Sirolimus|sirolimus|mesh-list
138550988|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
138550989|NCT00101088|Temsirolimus|temsirolimus|mesh-list
138550990|NCT00101088|MTOR Inhibitors|mtor inhibitors|mesh-list
138550991|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138550992|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138550993|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138550994|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138550995|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138550996|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
138550997|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138550998|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138550999|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279662|NCT04143607|Gefitinib|gefitinib|mesh-list
138437802|NCT01764295|Olmesartan|olmesartan|mesh-list
138551000|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138551001|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
138551002|NCT00258622|Lidocaine|lidocaine|mesh-list
138551003|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
138279822|NCT02630719|Timolol|timolol|mesh-list
138551005|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138551006|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551007|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
138279951|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
138551008|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551009|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138280020|NCT04776096|Analgesics|analgesics|mesh-ancestor
138551010|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138551011|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138551012|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138551013|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551014|NCT00423761|Midazolam|midazolam|mesh-list
138551015|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138551016|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138372352|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138372353|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138372354|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138372355|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138372356|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138372357|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
138372358|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372359|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138372360|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372362|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138372363|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
138372364|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
138372365|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138372366|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372367|NCT01417923|Vitamin D|vitamin d|mesh-list
138372368|NCT01417923|Vitamins|vitamins|mesh-ancestor
138372369|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
138372370|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372371|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138372372|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138372373|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
138372374|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138372375|NCT01418118|Dobutamine|dobutamine|mesh-list
138372376|NCT01418118|Epinephrine|epinephrine|mesh-list
138372377|NCT01418118|Norepinephrine|norepinephrine|mesh-list
138372378|NCT01418118|Dopexamine|dopexamine|mesh-list
138372379|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138372380|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138372381|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
138551017|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138551018|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551019|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138551020|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138551021|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138551022|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138551023|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
138551025|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
138551026|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
138551027|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280304|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138551028|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551030|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551031|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138551032|NCT00415324|Cisplatin|cisplatin|mesh-list
138551033|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551035|NCT00258739|Gemcitabine|gemcitabine|mesh-list
138551036|NCT00258739|Docetaxel|docetaxel|mesh-list
138551037|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551038|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138280374|NCT05441761|Analgesics|analgesics|mesh-ancestor
138551039|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
138551040|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551041|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
138551042|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
138551043|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
138551044|NCT00104949|Trastuzumab|trastuzumab|mesh-list
138551045|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138551046|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551047|NCT00101127|Gemcitabine|gemcitabine|mesh-list
138551048|NCT00101127|Docetaxel|docetaxel|mesh-list
138551049|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138551050|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
138551051|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551052|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551053|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
138280570|NCT02653183|Laxatives|laxatives|mesh-ancestor
138551054|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
138551055|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
138551057|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138551058|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138551059|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138551060|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551061|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551063|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280713|NCT00367939|Amlodipine|amlodipine|mesh-list
138551064|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138551065|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551066|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551067|NCT00259168|Nateglinide|nateglinide|mesh-list
138551068|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138551069|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551070|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
138551071|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551072|NCT00104988|Thalidomide|thalidomide|mesh-list
138551074|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138551075|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
138551076|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551077|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551078|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138551079|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
138551080|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551081|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
138551082|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138551083|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138551084|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138551085|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138551086|NCT00104988|Growth Substances|growth substances|mesh-ancestor
138551087|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
138551088|NCT00415402|Vitamin D|vitamin d|mesh-list
138551089|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
138551090|NCT00415402|Vitamins|vitamins|mesh-ancestor
138551091|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
138551092|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551093|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138551094|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138551095|NCT00259402|Fluorouracil|fluorouracil|mesh-list
138551096|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
138551097|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551098|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
138551099|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551100|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138551101|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138551102|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
138551103|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551106|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138551107|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
138281184|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
138551108|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551109|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138551110|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138551111|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551112|NCT00071201|Adefovir|adefovir|mesh-list
138551113|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138551114|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
138551115|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138551116|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138551117|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138551118|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551119|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551120|NCT00259636|Zonisamide|zonisamide|mesh-list
138551121|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
138551122|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138281486|NCT04417920|Mitomycins|mitomycins|mesh-list
138551123|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138551124|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551125|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138437959|NCT01765088|Temozolomide|temozolomide|mesh-list
138551127|NCT00259675|Carboplatin|carboplatin|mesh-list
138551128|NCT00259675|Gemcitabine|gemcitabine|mesh-list
138551129|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551130|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138551131|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
138551132|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551133|NCT00105105|Mifepristone|mifepristone|mesh-list
138551134|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138551135|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
138551136|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138281687|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
138551138|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138551139|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138551140|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138551141|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
138551142|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138551143|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138551144|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
138551145|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138551146|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
138551147|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138551148|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138551149|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
138438011|NCT01765608|Zonisamide|zonisamide|mesh-list
138551150|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138551152|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138551153|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551154|NCT00259792|Budesonide|budesonide|mesh-list
138551155|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
138551156|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138551157|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138551158|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
138551159|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551160|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551161|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138551162|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
138551163|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
138551164|NCT00259792|Hormones|hormones|mesh-ancestor
138551165|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138551166|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138551167|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138551168|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138551169|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
138282088|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
138551170|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138227509|NCT04359212|PENTA|penta|mesh-list
138551171|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551173|NCT00105144|Micafungin|micafungin|mesh-list
138551175|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138551176|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551177|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551179|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
138551180|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
138551181|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551182|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551183|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138551184|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138438051|NCT01765829|Asenapine|asenapine|mesh-list
138551185|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138551186|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138551187|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138551188|NCT00259870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138551189|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138551190|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138551191|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551192|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138551193|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
138551194|NCT00071279|Idraparinux|idraparinux|mesh-list
138551195|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138551196|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
138551197|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138551198|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
138551199|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551200|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551201|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
138551202|NCT00259987|Lapatinib|lapatinib|mesh-list
138551203|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551204|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138551205|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551206|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551207|NCT00260026|Docetaxel|docetaxel|mesh-list
138551208|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551209|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
138551210|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
138551211|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
138551212|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551213|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
138551214|NCT00260143|Testosterone|testosterone|mesh-list
138551215|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
138551216|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
138282364|NCT02973776|Clobetasol|clobetasol|mesh-list
138551217|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138551218|NCT00260143|Androgens|androgens|mesh-ancestor
138551219|NCT00260143|Hormones|hormones|mesh-ancestor
138551220|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138551221|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551222|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138551223|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551224|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
138551225|NCT00260260|Oxycodone|oxycodone|mesh-list
138551226|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138551228|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138551229|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551230|NCT00260260|Analgesics|analgesics|mesh-ancestor
138551231|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
138551232|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551233|NCT00105300|Adalimumab|adalimumab|mesh-list
138551234|NCT00105300|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138551235|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138551236|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138344281|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138551238|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
138551239|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138551240|NCT00260611|Docetaxel|docetaxel|mesh-list
138551242|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551243|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
138227574|NCT04358354|Irinotecan|irinotecan|mesh-list
138551244|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
138282833|NCT02888665|Doxorubicin|doxorubicin|mesh-list
138551245|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
138551246|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551248|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
138171785|NCT00557973|GABA Agonists|gaba agonists|mesh-ancestor
138551249|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551251|NCT00101205|Etoposide|etoposide|mesh-list
138551252|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
138551253|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551254|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138551255|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138551256|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138551257|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551258|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551259|NCT00261079|Fexofenadine|fexofenadine|mesh-list
138551260|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138551261|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138551262|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138551263|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
138551264|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
138282975|NCT03003949|Estradiol|estradiol|mesh-list
138551265|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138551266|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551267|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551268|NCT00261118|Rituximab|rituximab|mesh-list
138283041|NCT02933372|Varenicline|varenicline|mesh-list
138551269|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138551270|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551271|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
138551272|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551273|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138551274|NCT00071747|Lamotrigine|lamotrigine|mesh-list
138551275|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
138551276|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138551277|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138551278|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551279|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138551280|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551281|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138551282|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138551283|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138551284|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138551285|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138551286|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
138551287|NCT00261313|Hematinics|hematinics|mesh-ancestor
138551288|NCT00261352|Metformin|metformin|mesh-list
138551289|NCT00261352|Fenofibrate|fenofibrate|mesh-list
138283805|NCT05462236|Pembrolizumab|pembrolizumab|mesh-list
138551290|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138551291|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551292|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138551293|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
138551294|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551295|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138551297|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551298|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551299|NCT00071942|Metronidazole|metronidazole|mesh-list
138551301|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
138551302|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551303|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138551304|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138551305|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138551306|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138551307|NCT00261469|Topiramate|topiramate|mesh-list
138551308|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
138551309|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138551310|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551311|NCT00261508|Risperidone|risperidone|mesh-list
138551312|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138551313|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
138551314|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138551315|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551316|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551317|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138551318|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138551319|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138551320|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138551321|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138551322|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
138551323|NCT00261586|Aspirin|aspirin|mesh-list
138551324|NCT00261586|Acetaminophen|acetaminophen|mesh-list
138551325|NCT00261586|Ibuprofen|ibuprofen|mesh-list
138551326|NCT00261586|Celecoxib|celecoxib|mesh-list
138551327|NCT00261586|Naproxen|naproxen|mesh-list
138551328|NCT00261586|Rofecoxib|rofecoxib|mesh-list
138551329|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138551330|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138551331|NCT00261586|Analgesics|analgesics|mesh-ancestor
138551332|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
138551333|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551334|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551335|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138551336|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138551337|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138551338|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138551339|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551340|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138551341|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138551342|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551343|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
138551344|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138551345|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
138551346|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
138551347|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138551348|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551349|NCT00261625|Alendronate|alendronate|mesh-list
138283864|NCT05326087|Hormone Antagonists|hormone antagonists|mesh-ancestor
138551350|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138551351|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551352|NCT00261703|Cisplatin|cisplatin|mesh-list
138551353|NCT00261703|Docetaxel|docetaxel|mesh-list
138551354|NCT00261703|Fluorouracil|fluorouracil|mesh-list
138551355|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551356|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
138551357|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
138551358|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
138551359|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551360|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
138551361|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138551362|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138551363|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
138551364|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551365|NCT00261742|Penicillins|penicillins|mesh-list
138551366|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138551367|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138551368|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
138551369|NCT00072059|Hematinics|hematinics|mesh-ancestor
138551370|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
138551372|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
138551373|NCT00261820|Prednisolone|prednisolone|mesh-list
138551374|NCT00261820|Tacrolimus|tacrolimus|mesh-list
138551375|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138551377|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551378|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138551379|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551380|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551381|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138551382|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138284295|NCT02429687|Paclitaxel|paclitaxel|mesh-list
138551383|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138551384|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
138551385|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138551386|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138551387|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
138551388|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138551389|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
138551390|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
138551391|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551392|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138551394|NCT00261820|Hormones|hormones|mesh-ancestor
138551395|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138551396|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138551397|NCT00261820|Protective Agents|protective agents|mesh-ancestor
138551398|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138551399|NCT00072098|Interleukin-12|interleukin-12|mesh-list
138551401|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
138551402|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551403|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138551404|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138551405|NCT00072098|Growth Substances|growth substances|mesh-ancestor
138551406|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
138551407|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551408|NCT00261937|Furosemide|furosemide|mesh-list
138551409|NCT00261937|Diuretics|diuretics|mesh-ancestor
138551410|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
138551411|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551412|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138551413|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138551414|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551415|NCT00105495|Deferiprone|deferiprone|mesh-list
138551416|NCT00105495|Deferoxamine|deferoxamine|mesh-list
138551417|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138551418|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
138551419|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
138551420|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551421|NCT00105495|Siderophores|siderophores|mesh-ancestor
138551422|NCT00261976|Infliximab|infliximab|mesh-list
138354737|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138354738|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
138551423|NCT00261976|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138551424|NCT00261976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138551425|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
138551426|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138551427|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138551428|NCT00072137|Metronidazole|metronidazole|mesh-list
138551429|NCT00072137|Molgramostim|molgramostim|mesh-list
138551430|NCT00072137|Vaccines|vaccines|mesh-list
138551431|NCT00072137|Sargramostim|sargramostim|mesh-list
138551433|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
138551434|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551435|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551436|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138551437|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138551438|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138551439|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138551440|NCT00072137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138551441|NCT00262015|Vaccines|vaccines|mesh-list
138551442|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
138551443|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551444|NCT00262054|Heparin|heparin|mesh-list
138551445|NCT00262054|Calcium heparin|calcium heparin|mesh-list
138551446|NCT00262054|Bivalirudin|bivalirudin|mesh-list
138551447|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
138551448|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138551449|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138283885|NCT05322252|Hormone Antagonists|hormone antagonists|mesh-ancestor
138551450|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551451|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
138551452|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138551453|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
138551454|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551455|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
138551456|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138551457|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551458|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138551459|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
138551460|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138551461|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138551462|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551463|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551465|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
138551466|NCT00262210|Etoposide|etoposide|mesh-list
138551467|NCT00262210|Epirubicin|epirubicin|mesh-list
138551468|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138438369|NCT01768039|Vitamin D|vitamin d|mesh-list
138551469|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
138551470|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138285179|NCT03098420|Morphine|morphine|mesh-list
138551471|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138551472|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138551473|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
138551474|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551475|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551476|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138551477|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138551478|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138551479|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138551480|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551481|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138551482|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
138551483|NCT00262210|Hormones|hormones|mesh-ancestor
138551484|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138551485|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138551486|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138551487|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138551488|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138551489|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138551490|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
138551491|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551492|NCT00262327|Endostatins|endostatins|mesh-list
138551493|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551494|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138551495|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138551496|NCT00262327|Growth Substances|growth substances|mesh-ancestor
138551497|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551500|NCT02966288|Ketorolac|ketorolac|mesh-list
138551501|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138551502|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138551503|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138551504|NCT02966288|Analgesics|analgesics|mesh-ancestor
138551505|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
138551506|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138285593|NCT02995915|Bupropion|bupropion|mesh-list
138551507|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551508|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138551509|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138551510|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138551511|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551512|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551513|NCT00262405|Prednisone|prednisone|mesh-list
138551514|NCT00262405|Zileuton|zileuton|mesh-list
138551515|NCT00262405|Azathioprine|azathioprine|mesh-list
138551516|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138551517|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
138551518|NCT00262405|Hormones|hormones|mesh-ancestor
138551519|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138551520|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551521|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138551522|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551523|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
138551524|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551525|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138551526|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138551527|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
138551528|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138551529|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138551530|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138551532|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
138551533|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551535|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551536|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138551537|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
138551538|NCT00262483|Ribavirin|ribavirin|mesh-list
138551539|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138551540|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
138551541|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551542|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
138551543|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138551544|NCT00262561|Aspirin|aspirin|mesh-list
138551545|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138551546|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138551547|NCT00262561|Analgesics|analgesics|mesh-ancestor
138551548|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
138227878|NCT03033368|Rilpivirine|rilpivirine|mesh-list
138551549|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438458|NCT01768299|Misoprostol|misoprostol|mesh-list
138551550|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551551|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138551552|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138551553|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138551554|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138551555|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551556|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138551557|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138551558|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551560|NCT00072215|Paclitaxel|paclitaxel|mesh-list
138551561|NCT00072215|Vinblastine|vinblastine|mesh-list
138551562|NCT00072215|Ifosfamide|ifosfamide|mesh-list
138551563|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138354855|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138372776|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
138372777|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
138372778|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138372779|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138372780|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138372781|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138372782|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138551564|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551565|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
138551566|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
138551567|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
138551568|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138286211|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
138551569|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138551570|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
138551571|NCT00262795|Fludarabine|fludarabine|mesh-list
138551572|NCT00262795|Chlorambucil|chlorambucil|mesh-list
138551573|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551574|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551575|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138551576|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
138551578|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551579|NCT00263029|Capecitabine|capecitabine|mesh-list
138551580|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
138551581|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138551582|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
138551583|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551584|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551585|NCT00263068|Rotigotine|rotigotine|mesh-list
138551586|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
138551587|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
138551588|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138551589|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551591|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138551592|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138551593|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138551594|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138286555|NCT03581084|Antidotes|antidotes|mesh-ancestor
138551595|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438476|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
138551597|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138551598|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138551599|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
138286628|NCT03591068|Xhance|xhance|mesh-list
138551600|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138551601|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551602|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138551604|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
138551605|NCT00263185|Vitamin D|vitamin d|mesh-list
138551606|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
138551607|NCT00263185|Cholecalciferol|cholecalciferol|mesh-list
138551608|NCT00263185|Vitamins|vitamins|mesh-list
138551609|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
138551610|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
138551611|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551612|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138171889|NCT00571961|Buprenorphine|buprenorphine|mesh-list
138551614|NCT00263185|Antacids|antacids|mesh-ancestor
138551615|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551616|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138551617|NCT00263263|Sirolimus|sirolimus|mesh-list
138551618|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138551619|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138551620|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138551621|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138286985|NCT04337138|Immunotoxins|immunotoxins|mesh-ancestor
138551623|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138551624|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
138551625|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551626|NCT00101673|Vildagliptin|vildagliptin|mesh-list
138551627|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138551628|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551629|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138551630|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
138551631|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551632|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551633|NCT00263302|Dexamethasone|dexamethasone|mesh-list
138551634|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138354922|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551635|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
138551636|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
138551637|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551638|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551639|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138551640|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
138551641|NCT00263302|Hormones|hormones|mesh-ancestor
138551642|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138551643|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138551644|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551647|NCT00263458|Narcotics|narcotics|mesh-ancestor
138551648|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138551649|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551650|NCT00263458|Analgesics|analgesics|mesh-ancestor
138551651|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
138551652|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551653|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138551654|NCT00101712|Vildagliptin|vildagliptin|mesh-list
138551655|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138551656|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551657|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138551658|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
138551659|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551660|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551662|NCT00072527|Irinotecan|irinotecan|mesh-list
138551663|NCT00072527|Etoposide|etoposide|mesh-list
138551664|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551665|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138551666|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138551667|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551668|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551669|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138551670|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138551671|NCT00263965|Metformin|metformin|mesh-list
138551672|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138551673|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551674|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
138551675|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138287179|NCT03473665|Meloxicam|meloxicam|mesh-list
138551676|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551677|NCT00072683|Tolvaptan|tolvaptan|mesh-list
138551678|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138551679|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551680|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
138551681|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551682|NCT00101790|Pamidronate|pamidronate|mesh-list
138551683|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138551684|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551685|NCT00264277|Vitamin K|vitamin k|mesh-list
138551686|NCT00264277|Anticoagulants|anticoagulants|mesh-list
138551687|NCT00264277|Vitamins|vitamins|mesh-ancestor
138551688|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
138551689|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551690|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138551691|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138551692|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551693|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
138551694|NCT00264277|Coagulants|coagulants|mesh-ancestor
138551695|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138551696|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138551697|NCT04709029|Dexamethasone|dexamethasone|mesh-list
138551698|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
138551699|NCT04709029|BB 1101|bb 1101|mesh-list
138551700|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138551701|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
138551702|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
138551703|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551704|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551706|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
138551707|NCT04709029|Hormones|hormones|mesh-ancestor
138551708|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138551709|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138551710|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551711|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
138171921|NCT01953081|Metoclopramide|metoclopramide|mesh-list
138551712|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551713|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551714|NCT00072722|Pomalidomide|pomalidomide|mesh-list
138551715|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
138551716|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551717|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138551718|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138551719|NCT00072722|Growth Substances|growth substances|mesh-ancestor
138551720|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
138551721|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551723|NCT00264355|Cyclosporins|cyclosporins|mesh-list
138551724|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551725|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551726|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138551727|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
138551728|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551729|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
138551730|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138287423|NCT03806270|Midazolam|midazolam|mesh-list
138551731|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
138551732|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138284057|NCT04639180|Apatinib|apatinib|mesh-list
138551733|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138551735|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551736|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551738|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138551739|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551740|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
138551741|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551742|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138551743|NCT00072839|Teduglutide|teduglutide|mesh-list
138551744|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138551745|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138551746|NCT00072839|Protective Agents|protective agents|mesh-ancestor
138551747|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551748|NCT00264628|Casopitant|casopitant|mesh-list
138551749|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
138551750|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
138551751|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551752|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551753|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138551754|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138551755|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138551756|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551757|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
138551758|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138551759|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551761|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138551762|NCT00265018|Bleomycin|bleomycin|mesh-list
138551763|NCT00265018|Vinblastine|vinblastine|mesh-list
138551764|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138551765|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551766|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138551767|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138551768|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551769|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551770|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138551771|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
138284090|NCT04503460|Hormones|hormones|mesh-ancestor
138551772|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
138551773|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
138355065|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138551774|NCT00265135|Siltuximab|siltuximab|mesh-list
138551775|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228102|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
138551776|NCT00106197|Bupropion|bupropion|mesh-list
138551777|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138551778|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
138551779|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138551780|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138551781|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138551782|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138551783|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551784|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
138551785|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138551786|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551787|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138551788|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138551789|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551790|NCT00265252|Alendronate|alendronate|mesh-list
138551791|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138551792|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551793|NCT00265291|Fluoxetine|fluoxetine|mesh-list
138551794|NCT00265291|Desipramine|desipramine|mesh-list
138551795|NCT00265291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138287946|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138551796|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138551797|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138551798|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551799|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138551800|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
138551801|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551802|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138551803|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
138551804|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138288081|NCT03577171|Entecavir|entecavir|mesh-list
138551805|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138551806|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138551807|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551808|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138284122|NCT04150042|Ethanol|ethanol|mesh-list
138551809|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138551810|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
138551811|NCT00265408|Aspirin|aspirin|mesh-list
138551812|NCT00265408|Warfarin|warfarin|mesh-list
138551813|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138551814|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138551815|NCT00265408|Analgesics|analgesics|mesh-ancestor
138551816|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
138551817|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551818|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551819|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138551820|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138551821|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138171984|NCT01896921|Maraviroc|maraviroc|mesh-list
138551822|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138551823|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551824|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138551825|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138551826|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551827|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
138551828|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
138551829|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
138551830|NCT00265486|Hematinics|hematinics|mesh-ancestor
138551831|NCT00265642|Irbesartan|irbesartan|mesh-list
138551832|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138551833|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138551834|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138551835|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551836|NCT00265915|Rituximab|rituximab|mesh-list
138551837|NCT00265915|Sargramostim|sargramostim|mesh-list
138551838|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138551839|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551840|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
138551841|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551842|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138551843|NCT00265993|Enoxaparin|enoxaparin|mesh-list
138551844|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
138551845|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138551846|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138551847|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228176|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
138551848|NCT00266149|Lamotrigine|lamotrigine|mesh-list
138551849|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
138551850|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138551851|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138551852|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551853|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138551854|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551855|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138551856|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138551857|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138551858|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138551859|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138551860|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138551861|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138551862|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
138551863|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551864|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138551865|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138551866|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551867|NCT00415831|Levodopa|levodopa|mesh-list
138551868|NCT00415831|Carbidopa|carbidopa|mesh-list
138551869|NCT00415831|Entacapone|entacapone|mesh-list
138171994|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138551870|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138551871|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138551872|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138551873|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
138551874|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138551875|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551876|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551877|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138551878|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551879|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138551880|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138551881|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
138551882|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
138551883|NCT00102141|Drospirenone|drospirenone|mesh-list
138551884|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138551885|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138551886|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138551887|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138551889|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138551890|NCT00102141|Estrogens|estrogens|mesh-ancestor
138551891|NCT00102141|Hormones|hormones|mesh-ancestor
138551892|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138551893|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551894|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138551895|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
138551896|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138551897|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138438700|NCT01769183|Growth Substances|growth substances|mesh-ancestor
138551898|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138551901|NCT00102141|Diuretics|diuretics|mesh-ancestor
138551902|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
138551903|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138551904|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138551905|NCT00266344|Gaboxadol|gaboxadol|mesh-list
138551906|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138551907|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551908|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288426|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
138551909|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551910|NCT00266344|Analgesics|analgesics|mesh-ancestor
138551911|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
138551912|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
138551913|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
138551914|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
138551916|NCT00266539|Morphine|morphine|mesh-list
138551917|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138551918|NCT00266539|Narcotics|narcotics|mesh-ancestor
138551919|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138551920|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551921|NCT00266539|Analgesics|analgesics|mesh-ancestor
138228261|NCT02485158|Analgesics|analgesics|mesh-ancestor
138551922|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
138551923|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551924|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138551925|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138551926|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
138551927|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
138551928|NCT00266578|Fluticasone|fluticasone|mesh-list
138551929|NCT00266578|Xhance|xhance|mesh-list
138551930|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138551931|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138551932|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
138551933|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138551934|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551935|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138551936|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
138551937|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
138551938|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138551939|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
138551940|NCT00266617|Hematinics|hematinics|mesh-ancestor
138551941|NCT00102219|Doxorubicin|doxorubicin|mesh-list
138551942|NCT00102219|Pemetrexed|pemetrexed|mesh-list
138551943|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138551944|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551945|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138551946|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138551947|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551948|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551949|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138551950|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138551951|NCT01349569|Lenalidomide|lenalidomide|mesh-list
138551952|NCT01349569|Vaccines|vaccines|mesh-list
138551953|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
138551954|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551955|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138551956|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138551957|NCT01349569|Growth Substances|growth substances|mesh-ancestor
138551958|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
138551959|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551960|NCT00267163|Donepezil|donepezil|mesh-list
138551961|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138551962|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551963|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551964|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
138551965|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138551966|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551967|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
138551968|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
138551969|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
138551970|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138551971|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
138551972|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551973|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138551974|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138551975|NCT00073385|Docetaxel|docetaxel|mesh-list
138551976|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551977|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
138551978|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
138551979|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
138284256|NCT03004261|Foscarnet|foscarnet|mesh-list
138551980|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551982|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138355277|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138551983|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138551985|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
138551986|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
138551987|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551988|NCT00267553|Toremifene|toremifene|mesh-list
138551989|NCT00267553|Letrozole|letrozole|mesh-list
138551990|NCT00267553|Atamestane|atamestane|mesh-list
138551991|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138551992|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138288676|NCT00624650|Dobutamine|dobutamine|mesh-list
138551993|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138551994|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138551995|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138551996|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138551997|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
138551998|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138551999|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552000|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138552001|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138552002|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138552003|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138552005|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138552006|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
138552007|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138552008|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552009|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138552010|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
138552011|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552012|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552013|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
138284296|NCT02429687|Etoposide|etoposide|mesh-list
138552014|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552015|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138552016|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138552017|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
138552018|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138552019|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138552020|NCT00267709|Visilizumab|visilizumab|mesh-list
138552021|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
138552022|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552024|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138552025|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552026|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
138552027|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552028|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138552029|NCT00425620|Amphotericin B|amphotericin b|mesh-list
138552030|NCT00425620|Amebicides|amebicides|mesh-ancestor
138552031|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138552032|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138552033|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552034|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138172081|NCT01277731|Hormones|hormones|mesh-ancestor
138552035|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
138552036|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138552037|NCT00267943|Telmisartan|telmisartan|mesh-list
138552038|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138552039|NCT00267943|Diuretics|diuretics|mesh-ancestor
138552040|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
138552041|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552042|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138552043|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138552044|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552045|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138552046|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138552047|NCT04711265|Vaccines|vaccines|mesh-list
138552048|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
138552049|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552050|NCT00268138|Fluorides|fluorides|mesh-list
138552051|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
138552052|NCT00268138|Protective Agents|protective agents|mesh-ancestor
138552053|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552054|NCT00102375|Topotecan|topotecan|mesh-list
138552055|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138552056|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138552057|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552058|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552059|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552060|NCT00268177|Fluticasone|fluticasone|mesh-list
138552062|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138552063|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138552064|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138552065|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
138552066|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552067|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552068|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138552069|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
138552070|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
138552071|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138552072|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138552073|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138552074|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138552075|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
138552076|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552077|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552078|NCT00268216|Fluticasone|fluticasone|mesh-list
138552079|NCT00268216|Xhance|xhance|mesh-list
138552080|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138552081|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138552082|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138552083|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
138552084|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138288863|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
138552085|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552086|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138552087|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
138552088|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
138552089|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138552091|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138552092|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138552093|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
138438942|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
138552095|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552096|NCT00073580|Hirudins|hirudins|mesh-list
138552097|NCT00073580|Anticoagulants|anticoagulants|mesh-list
138552098|NCT00073580|Bivalirudin|bivalirudin|mesh-list
138552099|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
138552100|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138552101|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
138552102|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552103|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552104|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138552105|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138552106|NCT00073658|Risperidone|risperidone|mesh-list
138552107|NCT00073658|Citalopram|citalopram|mesh-list
138552108|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138552109|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
138552110|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552111|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552112|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552113|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138552114|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138552115|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138552116|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138552117|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138552118|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
138552119|NCT00073658|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138552120|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138552121|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138552122|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138552123|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
138552124|NCT00268255|Gefitinib|gefitinib|mesh-list
138552125|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138552126|NCT00268255|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138552127|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552128|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138552129|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552130|NCT00102414|Gemcitabine|gemcitabine|mesh-list
138552131|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138552132|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
138552133|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552134|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552135|NCT00268333|Leucovorin|leucovorin|mesh-list
138552136|NCT00268333|Fluorouracil|fluorouracil|mesh-list
138552137|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
138552138|NCT00268333|Calcium|calcium|mesh-list
138552139|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
138552140|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138552141|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552142|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
138172110|NCT05735145|Antimitotic Agents|antimitotic agents|mesh-ancestor
138552143|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552144|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138552145|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552146|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138552147|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
138228477|NCT01024010|Vidarabine|vidarabine|mesh-list
138552149|NCT00268333|Protective Agents|protective agents|mesh-ancestor
138552150|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
138552151|NCT00268333|Vitamins|vitamins|mesh-ancestor
138552152|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
138552153|NCT00073697|Dexetimide|dexetimide|mesh-list
138552154|NCT00073697|Citalopram|citalopram|mesh-list
138552155|NCT00073697|Escitalopram|escitalopram|mesh-list
138552156|NCT00073697|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138552157|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138552158|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138552159|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552160|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552161|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
138552162|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552163|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138552164|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138552165|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
138552166|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
138552167|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552168|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138552169|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138552170|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
138552171|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138552172|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
138552173|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138552174|NCT00268372|Docetaxel|docetaxel|mesh-list
138552175|NCT00268372|Fluorouracil|fluorouracil|mesh-list
138552176|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552177|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
138552178|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
138552179|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
138552180|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552181|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
138552182|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138552183|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138552184|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
138552185|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552186|NCT00268411|Gemcitabine|gemcitabine|mesh-list
138552187|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
138552188|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138552189|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
138552190|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552191|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552192|NCT00073736|Cytarabine|cytarabine|mesh-list
138552193|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138552194|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
138552195|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552196|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552197|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
138355498|NCT00002436|Zalcitabine|zalcitabine|mesh-list
138552198|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552199|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138552200|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
138552201|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552202|NCT00268489|Bevacizumab|bevacizumab|mesh-list
138552203|NCT00268489|Pemetrexed|pemetrexed|mesh-list
138552204|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138552205|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552206|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138552207|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138552208|NCT00268489|Growth Substances|growth substances|mesh-ancestor
138552209|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552210|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
138552211|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552212|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552213|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138552214|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138552215|NCT00268528|Methotrexate|methotrexate|mesh-list
138552216|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
138552217|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138552218|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
138552219|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138552220|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552221|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138552222|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
138552223|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552224|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552225|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
138552226|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289346|NCT00000842|Mitogens|mitogens|mesh-list
138552227|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138552228|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138552229|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
138552230|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138552231|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138552232|NCT00073814|Albuterol|albuterol|mesh-list
138552233|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138552234|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
138552235|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552236|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552237|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138552238|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
138552239|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
138552240|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138552241|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138552242|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138289383|NCT00000854|Nandrolone|nandrolone|mesh-list
138552243|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138552244|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
138552245|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284443|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
138552246|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552247|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
138552248|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138552249|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552250|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552251|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138552252|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138552253|NCT00102453|Protective Agents|protective agents|mesh-ancestor
138552254|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552255|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
138552256|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138552257|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
138552258|NCT00268567|Prednisone|prednisone|mesh-list
138552259|NCT00268567|Leflunomide|leflunomide|mesh-list
138439149|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552260|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138552261|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
138552262|NCT00268567|Hormones|hormones|mesh-ancestor
138552263|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138552264|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552265|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138552266|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552267|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289514|NCT00001790|Micafungin|micafungin|mesh-list
138552268|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552269|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138552270|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
138552271|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
138552272|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138552273|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552274|NCT00268684|Temozolomide|temozolomide|mesh-list
138552275|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138552276|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138552277|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
138552278|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552279|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552280|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138439216|NCT01772381|Hormones|hormones|mesh-ancestor
138552281|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552282|NCT00106821|Bromides|bromides|mesh-list
138552283|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
138552284|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138552285|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
138552286|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552287|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552288|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138552289|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
138552290|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
138552291|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138552292|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
138552293|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138284475|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
138552294|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552295|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
138228669|NCT00998426|Antibodies|antibodies|mesh-list
138552296|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
138552297|NCT00073931|Sargramostim|sargramostim|mesh-list
138552298|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
138552299|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552300|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552301|NCT00268723|Albuterol|albuterol|mesh-list
138552302|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138552303|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
138552304|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552305|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552306|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138552307|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
138552308|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
138552309|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138552310|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138552311|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138552312|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138552313|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
138552314|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552315|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552316|NCT00268840|Gemcitabine|gemcitabine|mesh-list
138552317|NCT00268840|Docetaxel|docetaxel|mesh-list
138552318|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138552319|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
138289696|NCT00000950|Vitamins|vitamins|mesh-ancestor
138552320|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552321|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552322|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
138552323|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
138552324|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
138552325|NCT00268879|Renzapride|renzapride|mesh-list
138552326|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138552327|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
138552328|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552329|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552330|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552331|NCT00268918|Docetaxel|docetaxel|mesh-list
138552332|NCT00268918|Vatalanib|vatalanib|mesh-list
138552333|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552334|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
138552335|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
138552336|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
138552337|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552338|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138552339|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138289743|NCT00000236|Naloxone|naloxone|mesh-list
138552341|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
138552342|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
138552343|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552344|NCT00073970|Celecoxib|celecoxib|mesh-list
138552345|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138552346|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138552347|NCT00073970|Analgesics|analgesics|mesh-ancestor
138552348|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
138552349|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552350|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552351|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138552352|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138552353|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138552354|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138552355|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552356|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552357|NCT00102492|Casopitant|casopitant|mesh-list
138552358|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
138552359|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
138552360|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552361|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552362|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138552363|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138552364|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552365|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552366|NCT00269035|Risperidone|risperidone|mesh-list
138552367|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138552368|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
138552369|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552370|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552371|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552372|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138552373|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138552374|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138552375|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138552376|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138552377|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
138552378|NCT00074009|Bortezomib|bortezomib|mesh-list
138552379|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552380|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
138552382|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138552383|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552384|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138552385|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552386|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552387|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138552388|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138552389|NCT00074087|Doxorubicin|doxorubicin|mesh-list
138552390|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138552391|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138552392|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552393|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138552394|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138552395|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552396|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552398|NCT00269542|Folic Acid|folic acid|mesh-list
138552399|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
138552400|NCT00269542|Trace Elements|trace elements|mesh-ancestor
138552401|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
138552402|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552403|NCT00269542|Hematinics|hematinics|mesh-ancestor
138552404|NCT00269542|Vitamins|vitamins|mesh-ancestor
138552405|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138552406|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138552407|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138552408|NCT00269620|Etonogestrel|etonogestrel|mesh-list
138552409|NCT00269620|NuvaRing|nuvaring|mesh-list
138552410|NCT00269620|Norelgestromin|norelgestromin|mesh-list
138552411|NCT00269620|Ortho Evra|ortho evra|mesh-list
138552412|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
138552413|NCT00269620|Estradiol|estradiol|mesh-list
138552414|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138552415|NCT00269620|Estrogens|estrogens|mesh-ancestor
138552416|NCT00269620|Hormones|hormones|mesh-ancestor
138552417|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138284558|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
138552418|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552419|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138552420|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138552421|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138439364|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552422|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138552423|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138552424|NCT00074204|Carboplatin|carboplatin|mesh-list
138552425|NCT00074204|Gemcitabine|gemcitabine|mesh-list
138552427|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552428|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138552429|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
138552430|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552431|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
138552432|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
138552433|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
138552434|NCT00416143|Prednisone|prednisone|mesh-list
138552435|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138552436|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
138552437|NCT00416143|Hormones|hormones|mesh-ancestor
138552438|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138552439|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552440|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138552441|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552442|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
138552443|NCT00416221|Escitalopram|escitalopram|mesh-list
138552444|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138552445|NCT00416221|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138552446|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138552447|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138552448|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552449|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552450|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
138552451|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552452|NCT00269737|Fentanyl|fentanyl|mesh-list
138552453|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138552454|NCT00269737|Narcotics|narcotics|mesh-ancestor
138439401|NCT01773616|Protective Agents|protective agents|mesh-ancestor
138552455|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138284595|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
138552456|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552458|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
138552459|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552460|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138552461|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138552462|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
138552463|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
138552464|NCT00269776|Methylphenidate|methylphenidate|mesh-list
138552465|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138552466|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552467|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138552468|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138552469|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138552470|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552472|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552473|NCT00269815|Methylphenidate|methylphenidate|mesh-list
138552474|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138552475|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552476|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138552477|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138552478|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138552479|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552480|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
138552481|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552482|NCT00269854|Infliximab|infliximab|mesh-list
138552483|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138552484|NCT00269854|Antibodies|antibodies|mesh-list
138552485|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
138552486|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138552487|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
138552488|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552489|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552490|NCT00269854|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138552491|NCT00269854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138552492|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
138552493|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138552494|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138552495|NCT00269893|Abciximab|abciximab|mesh-list
138552496|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
138552497|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138552498|NCT00074321|Capecitabine|capecitabine|mesh-list
138552499|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
138552500|NCT00074321|Irinotecan|irinotecan|mesh-list
138552501|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138290042|NCT00000326|Heroin|heroin|mesh-list
138552502|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
138552503|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552504|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552505|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138552506|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138552507|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552508|NCT00102609|Dexamethasone|dexamethasone|mesh-list
138552509|NCT00102609|Doxorubicin|doxorubicin|mesh-list
138552510|NCT00102609|Trabectedin|trabectedin|mesh-list
138552511|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138552512|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
138552513|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
138552514|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552515|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552516|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138552517|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
138552518|NCT00102609|Hormones|hormones|mesh-ancestor
138552519|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138552520|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138552521|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552522|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138552523|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138552524|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138552525|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552526|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552527|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138284666|NCT02846233|Dulaglutide|dulaglutide|mesh-list
138552528|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
138552530|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138552531|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552532|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138552533|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138552534|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138552535|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552536|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290135|NCT00001088|Bupivacaine|bupivacaine|mesh-list
138552537|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552538|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138552539|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138552540|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
138552541|NCT00269971|Hematinics|hematinics|mesh-ancestor
138552542|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
138552543|NCT00270010|Hematinics|hematinics|mesh-ancestor
138552544|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
138552545|NCT00270049|Hematinics|hematinics|mesh-ancestor
138552546|NCT00107016|Letrozole|letrozole|mesh-list
138552547|NCT00107016|Everolimus|everolimus|mesh-list
138552548|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552549|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138290202|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
138552550|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138552551|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552552|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552553|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138552554|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
138552555|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138552556|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552557|NCT00107016|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138552558|NCT00107016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138552559|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138552560|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
138552561|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
138552562|NCT00270088|Hematinics|hematinics|mesh-ancestor
138552563|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
138552564|NCT00270127|Hematinics|hematinics|mesh-ancestor
138552565|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
138552566|NCT00270166|Hematinics|hematinics|mesh-ancestor
138552567|NCT00074399|Nevirapine|nevirapine|mesh-list
138552568|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138552569|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138552570|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552571|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552572|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
138552573|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552574|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138552575|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138552576|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138552577|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138552578|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
138552579|NCT00270283|Hematinics|hematinics|mesh-ancestor
138552580|NCT00270322|Fentanyl|fentanyl|mesh-list
138552581|NCT00270322|Morphine|morphine|mesh-list
138552582|NCT00270322|Bupivacaine|bupivacaine|mesh-list
138552583|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138552584|NCT00270322|Narcotics|narcotics|mesh-ancestor
138552585|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138552586|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552587|NCT00270322|Analgesics|analgesics|mesh-ancestor
138552588|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
138552589|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172197|NCT01911351|Analgesics|analgesics|mesh-ancestor
138552590|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138552591|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138552592|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
138552593|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
138552594|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
138552595|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138552596|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
138552597|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552598|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
138552600|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
138552601|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138552602|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552603|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
138552604|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552605|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138552606|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
138552607|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552608|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138552609|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552610|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
138552611|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
138552612|NCT00270478|Hematinics|hematinics|mesh-ancestor
138552613|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552614|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
138552615|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552616|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552617|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138552618|NCT00270517|Telithromycin|telithromycin|mesh-list
138552619|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138552620|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552621|NCT00270556|Tenofovir|tenofovir|mesh-list
138552622|NCT00270556|Abacavir|abacavir|mesh-list
138552623|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
138552624|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552625|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138552626|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138552627|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552628|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552629|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138552630|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138552631|NCT00074438|Rituximab|rituximab|mesh-list
138552632|NCT00074438|Methotrexate|methotrexate|mesh-list
138552633|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138552634|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552635|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
138552636|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552637|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138552638|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138552639|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
138552640|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138552641|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138552642|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
138552643|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552644|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
138552645|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552646|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138552647|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138172201|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
138552648|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138552649|NCT00270751|Minocycline|minocycline|mesh-list
138552650|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138290413|NCT00000452|Naltrexone|naltrexone|mesh-list
138552651|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552652|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138552653|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
138552654|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552655|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
138552656|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138552657|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138552658|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552659|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138552661|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
138552662|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552663|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138552664|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138552665|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138552666|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
138552667|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552668|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552669|NCT00270907|Gemcitabine|gemcitabine|mesh-list
138552670|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138552671|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138552672|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
138373182|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138373183|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138373184|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138373185|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
138373186|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138373187|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
138373188|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373190|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138552673|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552674|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552676|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138552677|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552678|NCT00107523|Cytarabine|cytarabine|mesh-list
138552679|NCT00107523|Idarubicin|idarubicin|mesh-list
138552680|NCT00107523|Pravastatin|pravastatin|mesh-list
138552681|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138552682|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
138552683|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552684|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552685|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
138552686|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552687|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138552688|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
138552689|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552690|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138552691|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138552693|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552694|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138552695|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138552696|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138552697|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138552698|NCT00416377|Prednisolone|prednisolone|mesh-list
138552699|NCT00416377|Doxorubicin|doxorubicin|mesh-list
138552700|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138552701|NCT00416377|Bleomycin|bleomycin|mesh-list
138552702|NCT00416377|Vincristine|vincristine|mesh-list
138552703|NCT00416377|Dacarbazine|dacarbazine|mesh-list
138552704|NCT00416377|Vinblastine|vinblastine|mesh-list
138552705|NCT00416377|Procarbazine|procarbazine|mesh-list
138552706|NCT00416377|Chlorambucil|chlorambucil|mesh-list
138552707|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138552708|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552709|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138552710|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138552711|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552712|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552713|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138552714|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
138552715|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
138552716|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
138552717|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138552719|NCT00416377|Hormones|hormones|mesh-ancestor
138552720|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138552721|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552722|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138552723|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138552724|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
138552725|NCT02965859|Adefovir|adefovir|mesh-list
138552726|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138552727|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
138552728|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552729|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138552730|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138552731|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552732|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552733|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
138552734|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138552735|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290514|NCT00000512|Niacin|niacin|mesh-list
138552736|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552737|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138552738|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138552739|NCT00271336|Protective Agents|protective agents|mesh-ancestor
138552740|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552741|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
138552742|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138552743|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
138552744|NCT00271414|Fentanyl|fentanyl|mesh-list
138552745|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138552746|NCT00271414|Narcotics|narcotics|mesh-ancestor
138552747|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138356081|NCT00002682|Antacids|antacids|mesh-ancestor
138552748|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552750|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
138552751|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552752|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138552753|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138552754|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
138552755|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
138552756|NCT00271453|Fentanyl|fentanyl|mesh-list
138290676|NCT00000584|Antibodies|antibodies|mesh-list
138552757|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138552758|NCT00271453|Narcotics|narcotics|mesh-ancestor
138552759|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138552760|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552761|NCT00271453|Analgesics|analgesics|mesh-ancestor
138552762|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
138552763|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552764|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138552765|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138552766|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
138552767|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
138552768|NCT00271492|Atrasentan|atrasentan|mesh-list
138290806|NCT00000650|Ditiocarb|ditiocarb|mesh-list
138552769|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552770|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138552771|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138552772|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552773|NCT00271804|Bortezomib|bortezomib|mesh-list
138552774|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552775|NCT00107601|Insulin|insulin|mesh-list
138552776|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138552777|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552778|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
138172227|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552779|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138552780|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552782|NCT00272116|Vitamin A|vitamin a|mesh-list
138552783|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
138552784|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
138552785|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552786|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
138552787|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552788|NCT00272116|Protective Agents|protective agents|mesh-ancestor
138552789|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138552790|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552791|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
138552792|NCT00272428|Vitamin E|vitamin e|mesh-list
138552793|NCT00272428|Beta Carotene|beta carotene|mesh-list
138552794|NCT00272428|Selenium|selenium|mesh-list
138552795|NCT00272428|Carotenoids|carotenoids|mesh-list
138552796|NCT00272428|Vitamins|vitamins|mesh-ancestor
138552797|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
138552798|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552799|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
138552800|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138284990|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
138552801|NCT00272428|Protective Agents|protective agents|mesh-ancestor
138552802|NCT00272428|Trace Elements|trace elements|mesh-ancestor
138552803|NCT00272428|Provitamins|provitamins|mesh-ancestor
138552804|NCT00272467|Omeprazole|omeprazole|mesh-list
138552805|NCT00272467|Rebamipide|rebamipide|mesh-list
138552806|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138552807|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138291081|NCT00002222|Valganciclovir|valganciclovir|mesh-list
138552808|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138552809|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552810|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552811|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
138552812|NCT00272467|Protective Agents|protective agents|mesh-ancestor
138291143|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
138552813|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552815|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138356158|NCT00002700|Vitamins|vitamins|mesh-ancestor
138552816|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
138552817|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552818|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439788|NCT01777919|Temozolomide|temozolomide|mesh-list
138552819|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552820|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138552821|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138552822|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138552823|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138229144|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
138552824|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138552825|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
138552826|NCT00272701|Esomeprazole|esomeprazole|mesh-list
138552827|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138552828|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138552829|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138552830|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552831|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552832|NCT00272740|Fulvestrant|fulvestrant|mesh-list
138552833|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138291500|NCT00002396|Tenofovir|tenofovir|mesh-list
138552834|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552835|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138552836|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138552837|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
138291567|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
138552838|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138552839|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552840|NCT00074750|Molgramostim|molgramostim|mesh-list
138552841|NCT00074750|Sargramostim|sargramostim|mesh-list
138552842|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
138552843|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552844|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552845|NCT00416533|Prednisone|prednisone|mesh-list
138552846|NCT00416533|Docetaxel|docetaxel|mesh-list
138552847|NCT00416533|Doxorubicin|doxorubicin|mesh-list
138552848|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138552849|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138285034|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
138552851|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
138552852|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
138552853|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552854|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138291701|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
138552855|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138552856|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138552857|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138291769|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138552858|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138552860|NCT00416533|Hormones|hormones|mesh-ancestor
138552861|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138552862|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291842|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
138552863|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138552864|NCT00107796|Modafinil|modafinil|mesh-list
138552865|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138552866|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138291914|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
138552867|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138552868|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138552869|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138552870|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552871|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
138439882|NCT01778686|Pindolol|pindolol|mesh-list
138552872|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138552873|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
138552874|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138552875|NCT00272896|Protective Agents|protective agents|mesh-ancestor
138552876|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552877|NCT00272935|Estrogens|estrogens|mesh-list
138552878|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138292011|NCT00002552|Vitamins|vitamins|mesh-ancestor
138552879|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
138552880|NCT00272935|Hormones|hormones|mesh-ancestor
138552881|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138292048|NCT00002576|Vincristine|vincristine|mesh-list
138552882|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552883|NCT00273013|Montelukast|montelukast|mesh-list
138552884|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138552885|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
138552886|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138285061|NCT03090620|Miotics|miotics|mesh-ancestor
138552887|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
138552888|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138552889|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552890|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138552891|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138292189|NCT00002618|Leucovorin|leucovorin|mesh-list
138552892|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552894|NCT00107835|Tetracaine|tetracaine|mesh-list
138552895|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
138552896|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
138552897|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138552898|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552899|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
138552900|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138552901|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138552902|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138552903|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138552904|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138552905|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552906|NCT00107874|Misoprostol|misoprostol|mesh-list
138552907|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138552908|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
138552909|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138439926|NCT01779245|Calcium|calcium|mesh-list
138552910|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552911|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138552912|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138552913|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
138552915|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
138552916|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138552917|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138552918|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552919|NCT00273247|Interferons|interferons|mesh-list
138552920|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
138552921|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
138552922|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552923|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
138285089|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
138552924|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552925|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
138552926|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552927|NCT00273442|Timolol|timolol|mesh-list
138552928|NCT00273442|Dorzolamide|dorzolamide|mesh-list
138552929|NCT00273442|Maleic acid|maleic acid|mesh-list
138552930|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552931|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552932|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138552934|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
138552935|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552936|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552937|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138552938|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138552939|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138552940|NCT00401427|Trastuzumab|trastuzumab|mesh-list
138552941|NCT00401427|Vinorelbine|vinorelbine|mesh-list
138552942|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138552943|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552944|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138552945|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
138552946|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
138552947|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
138552948|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552949|NCT00273481|Timolol|timolol|mesh-list
138552951|NCT00273481|Latanoprost|latanoprost|mesh-list
138552952|NCT00273481|Maleic acid|maleic acid|mesh-list
138552953|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552954|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552955|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138552956|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138292663|NCT00002756|Hormones|hormones|mesh-ancestor
138552958|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138552959|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552960|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138552961|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138552962|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138552963|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138552964|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138552965|NCT00273520|Telithromycin|telithromycin|mesh-list
138552966|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138552967|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552969|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138552970|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
138292869|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138552972|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138552973|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552974|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138552976|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138552977|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138552978|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552979|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
138552980|NCT00273871|Cyclosporine|cyclosporine|mesh-list
138552981|NCT00273871|Tacrolimus|tacrolimus|mesh-list
138552982|NCT00273871|Cyclosporins|cyclosporins|mesh-list
138552983|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138552984|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
138552985|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138552986|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138552987|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552988|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138552989|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
138552990|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138552991|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
138552992|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138552993|NCT00273949|Lactulose|lactulose|mesh-list
138552994|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138552995|NCT00273988|Nevirapine|nevirapine|mesh-list
138552996|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138552997|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138552998|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138552999|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553000|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
138553001|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553002|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138553003|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138553004|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138553005|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138553006|NCT00274027|Bromides|bromides|mesh-list
138553007|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
138553008|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138553009|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
138553010|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553011|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553012|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138553013|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
138553014|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
138553015|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138553016|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
138356363|NCT05751252|Ganirelix|ganirelix|mesh-list
138356364|NCT05751252|Hormone Antagonists|hormone antagonists|mesh-ancestor
138553017|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138293513|NCT00703885|Alprazolam|alprazolam|mesh-list
138553018|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553019|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
138553020|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138553021|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138553022|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553023|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553024|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
138553026|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553027|NCT00274066|Fenoterol|fenoterol|mesh-list
138553028|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
138553029|NCT00274066|Ipratropium|ipratropium|mesh-list
138553030|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138553031|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
138553032|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138293719|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
138553033|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553034|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138440015|NCT01779492|Analgesics|analgesics|mesh-ancestor
138553035|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
138553036|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
138553037|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138553038|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
138553039|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553040|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553042|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
138553044|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138553045|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138553046|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138553047|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
138553048|NCT00274105|Telmisartan|telmisartan|mesh-list
138553049|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138553050|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138553051|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138293995|NCT00000373|Olanzapine|olanzapine|mesh-list
138553052|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553053|NCT00274144|Telmisartan|telmisartan|mesh-list
138553054|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138553055|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138553056|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138553057|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553058|NCT00108186|Celecoxib|celecoxib|mesh-list
138553059|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138553060|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138553061|NCT00108186|Analgesics|analgesics|mesh-ancestor
138553062|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
138553063|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553064|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553065|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138440060|NCT01779843|Idarubicin|idarubicin|mesh-list
138553066|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138553067|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138553068|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138553069|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553070|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553072|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138553073|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138553074|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138553075|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553076|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553077|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138553078|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
138553079|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553080|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138553081|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553082|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138553083|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553084|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553086|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138553087|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138553088|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553089|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553090|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
138553091|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138553092|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553095|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138553096|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
138553097|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553098|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
138553099|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553100|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138553101|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553102|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
138553103|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138553104|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138553105|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
138553106|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553107|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553108|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138553109|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
138553110|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
138553111|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138553112|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
138553113|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553114|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553115|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138553116|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138553117|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138553118|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
138553119|NCT00274573|Bromides|bromides|mesh-list
138553120|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
138229442|NCT01044758|Levetiracetam|levetiracetam|mesh-list
138553121|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138553122|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
138553123|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553124|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553125|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138553126|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
138294526|NCT00000697|Foscarnet|foscarnet|mesh-list
138553127|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
138553128|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138553129|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
138294596|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
138553130|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553131|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553132|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
138553133|NCT00274612|Telmisartan|telmisartan|mesh-list
138553135|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138553136|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138553137|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138553138|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553139|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138553140|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
138172300|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138553141|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553143|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553144|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
138553145|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
138356498|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356499|NCT04521114|Leronlimab|leronlimab|mesh-list
138553146|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
138553147|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553149|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
138553150|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
138294951|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
138553151|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553152|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553153|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138553154|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138553155|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553156|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553157|NCT00274807|Cytarabine|cytarabine|mesh-list
138553158|NCT00274807|Etoposide|etoposide|mesh-list
138553159|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
138553160|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138553161|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553162|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138553163|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138553164|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553165|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553166|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138553167|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
138553168|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
138553169|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553170|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138553171|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
138553172|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553173|NCT00274807|Analgesics|analgesics|mesh-ancestor
138553174|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
138553175|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553176|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
138553177|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553178|NCT00277225|Abatacept|abatacept|mesh-list
138440180|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138553179|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138553180|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553181|NCT00277225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138553182|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553183|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138553184|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
138553185|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553186|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138553187|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
138553188|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138553189|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
138553190|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553191|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553192|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138553193|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
138553194|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
138553195|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138553196|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
138553197|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553198|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553200|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138553201|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138553202|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138295131|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
138553203|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138553204|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
138553205|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138295197|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
138553206|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553207|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553208|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
138553209|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138356566|NCT03737370|Docetaxel|docetaxel|mesh-list
138553211|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138553212|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553214|NCT00277498|Latanoprost|latanoprost|mesh-list
138553215|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138553216|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138553217|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
138553218|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138285338|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
138553219|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553220|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553221|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138553222|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138553224|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138553225|NCT00108498|Mirtazapine|mirtazapine|mesh-list
138553226|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
138553227|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138553228|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138553229|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
138553230|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
138553231|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553232|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553233|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138295559|NCT00003068|Thiotepa|thiotepa|mesh-list
138553234|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138553235|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138553236|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138553237|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138553238|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138553239|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138553240|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
138553241|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138553242|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138553243|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
138553244|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138553245|NCT00277537|Mannitol|mannitol|mesh-list
138553246|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138553247|NCT00277537|Diuretics|diuretics|mesh-ancestor
138553248|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
138172322|NCT00580073|Leucovorin|leucovorin|mesh-list
138553249|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553252|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138553253|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
138553254|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553255|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553256|NCT00108537|Bupropion|bupropion|mesh-list
138553257|NCT00108537|Nicotine|nicotine|mesh-list
138553258|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138553259|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
138553260|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553261|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553262|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138553263|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138553264|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
138295895|NCT00003128|Paclitaxel|paclitaxel|mesh-list
138553265|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553266|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553267|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138553268|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
138553269|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138553270|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138553271|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138553272|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138553274|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138296043|NCT00002810|Melphalan|melphalan|mesh-list
138553275|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138553276|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553277|NCT00277654|Risperidone|risperidone|mesh-list
138553278|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138553279|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
138553280|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553281|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373191|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138373192|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
138373193|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440298|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138553282|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553283|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138296171|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
138553285|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138553286|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138553287|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138553288|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
138553289|NCT00277693|Spironolactone|spironolactone|mesh-list
138296317|NCT00384020|Escitalopram|escitalopram|mesh-list
138553290|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138553292|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138553293|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553294|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138553295|NCT00277693|Diuretics|diuretics|mesh-ancestor
138553296|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
138553298|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
138553299|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553300|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553301|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
138553302|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553303|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553304|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
138553305|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138553306|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138553307|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138553308|NCT00075491|Fenretinide|fenretinide|mesh-list
138553309|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553310|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138553311|NCT00075491|Protective Agents|protective agents|mesh-ancestor
138553312|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553313|NCT00108615|Metformin|metformin|mesh-list
138553314|NCT00108615|Pioglitazone|pioglitazone|mesh-list
138553315|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138553316|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553318|NCT00278122|Sargramostim|sargramostim|mesh-list
138553319|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138553320|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553321|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
138553322|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
138553323|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
138553324|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553325|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
138553326|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553327|NCT00075647|Sirolimus|sirolimus|mesh-list
138553328|NCT00075647|Temsirolimus|temsirolimus|mesh-list
138553329|NCT00075647|MTOR Inhibitors|mtor inhibitors|mesh-list
138553330|NCT00075647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138553331|NCT00075647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553332|NCT00075647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553333|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138553334|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
138553335|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553336|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553337|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138553338|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553339|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138553340|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
138553341|NCT00278278|Prednisone|prednisone|mesh-list
138553342|NCT00278278|Methotrexate|methotrexate|mesh-list
138553343|NCT00278278|Etoposide|etoposide|mesh-list
138553344|NCT00278278|Vincristine|vincristine|mesh-list
138553345|NCT00278278|Ifosfamide|ifosfamide|mesh-list
138553346|NCT00278278|Lomustine|lomustine|mesh-list
138553347|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553348|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138553349|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
138553351|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138553352|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553353|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138285425|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138553354|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138553355|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
138356706|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
138553356|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138553357|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138297417|NCT00002701|Analgesics|analgesics|mesh-ancestor
138553358|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
138440379|NCT01782274|Vaccines|vaccines|mesh-list
138553359|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553360|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
138553361|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553362|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138553363|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138553364|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
138553365|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138553366|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138553367|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138553368|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138553369|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138553370|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
138553371|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
138553372|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
138553373|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138297685|NCT00002749|Carboplatin|carboplatin|mesh-list
138553374|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
138553375|NCT00108771|Fentanyl|fentanyl|mesh-list
138553376|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138553377|NCT00108771|Narcotics|narcotics|mesh-ancestor
138553378|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138553379|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553380|NCT00108771|Analgesics|analgesics|mesh-ancestor
138553381|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
138553382|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553383|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138553384|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138553385|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
138553386|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
138553387|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
138553388|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138553389|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553390|NCT00075686|Gemcitabine|gemcitabine|mesh-list
138553391|NCT00075686|Cetuximab|cetuximab|mesh-list
138553392|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138553393|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
138553394|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553395|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553396|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138553397|NCT00278824|Fentanyl|fentanyl|mesh-list
138553398|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138553399|NCT00278824|Narcotics|narcotics|mesh-ancestor
138172389|NCT00604019|Dopamine|dopamine|mesh-list
138553400|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138553401|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553403|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
138553404|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553405|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138553406|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138553407|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
138553408|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
138553409|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138553410|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
138553411|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138553412|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138553413|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138553414|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138553415|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553416|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
138553417|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138553418|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
138553419|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553420|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553422|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
138440410|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
138553424|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138553425|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
138553426|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138298399|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
138553427|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553428|NCT00108849|Estradiol|estradiol|mesh-list
138553429|NCT00108849|Estrogens|estrogens|mesh-ancestor
138553430|NCT00108849|Hormones|hormones|mesh-ancestor
138298469|NCT00004922|Irinotecan|irinotecan|mesh-list
138553431|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138553432|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553433|NCT00279058|Immunomodulating Agents|immunomodulating agents|mesh-list
138553434|NCT00279058|Immunologic Factors|immunologic factors|mesh-ancestor
138285472|NCT02002130|Butyric Acid|butyric acid|mesh-list
138553435|NCT00279058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553436|NCT00279253|Clonidine|clonidine|mesh-list
138553437|NCT00279253|Analgesics|analgesics|mesh-ancestor
138553438|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
138553439|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553440|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553441|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138553442|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
138553443|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
138553444|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138553445|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138553446|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138553447|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
138553448|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553449|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553450|NCT00109044|Escitalopram|escitalopram|mesh-list
138553451|NCT00109044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138553452|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138553453|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138553454|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553455|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553456|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
138553457|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553458|NCT00279448|Tamoxifen|tamoxifen|mesh-list
138553459|NCT00279448|Exemestane|exemestane|mesh-list
138553460|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138553461|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
138553462|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138553463|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553464|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138553465|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553466|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138553467|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138553468|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138553469|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138553470|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138553471|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553472|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553474|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
138553475|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553476|NCT00075959|Protective Agents|protective agents|mesh-ancestor
138553477|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553478|NCT00279487|Gabapentin|gabapentin|mesh-list
138553479|NCT00279487|Analgesics|analgesics|mesh-ancestor
138553480|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
138553481|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553482|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553483|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
138553484|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138553485|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138553486|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138553487|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138553488|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138553489|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138553490|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553491|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553494|NCT00279565|Ribavirin|ribavirin|mesh-list
138553495|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
138553496|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
138299251|NCT04585477|Durvalumab|durvalumab|mesh-list
138553497|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138553498|NCT00279565|Buprenorphine|buprenorphine|mesh-list
138553499|NCT00279565|Methadone|methadone|mesh-list
138553500|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553501|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
138553502|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553503|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
138553504|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553505|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
138299320|NCT00004796|Lactulose|lactulose|mesh-list
138553506|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553507|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138553508|NCT00279565|Narcotics|narcotics|mesh-ancestor
138553509|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138553510|NCT00279565|Analgesics|analgesics|mesh-ancestor
138553511|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
138553512|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553513|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138553514|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
138553515|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
138553516|NCT00075998|Interferons|interferons|mesh-list
138553517|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
138553518|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553519|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
138299529|NCT00005768|Estrogens|estrogens|mesh-list
138553520|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553521|NCT00109161|Antibodies|antibodies|mesh-list
138440442|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
138285530|NCT02983981|Hormones|hormones|mesh-ancestor
138553522|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138553523|NCT00109161|Daclizumab|daclizumab|mesh-list
138299587|NCT00385970|Vitamins|vitamins|mesh-ancestor
138553524|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
138553525|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553526|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138553528|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138553529|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553530|NCT00279760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138553531|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553532|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138553533|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
138553534|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553535|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138553537|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138553538|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138553539|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
138553540|NCT00416728|Valsartan|valsartan|mesh-list
138553541|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138553542|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138553543|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138299792|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138553544|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553546|NCT00416767|Fluorouracil|fluorouracil|mesh-list
138553547|NCT00416767|Irinotecan|irinotecan|mesh-list
138553548|NCT00416767|Calcium|calcium|mesh-list
138553549|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
138553550|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138553551|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138299935|NCT00002911|Marimastat|marimastat|mesh-list
138553552|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
138553553|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553554|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138553555|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553556|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138553557|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
138553558|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138553559|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138553560|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553561|NCT00416767|Antidotes|antidotes|mesh-ancestor
138553562|NCT00416767|Protective Agents|protective agents|mesh-ancestor
138553563|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
138553566|NCT00076115|Risperidone|risperidone|mesh-list
138553567|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138553568|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
138553569|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553570|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553571|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553572|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138553574|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138553575|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138553576|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138553577|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
138553578|NCT00109239|Bevacizumab|bevacizumab|mesh-list
138553579|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138553580|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553581|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138300363|NCT00003031|Amphotericin B|amphotericin b|mesh-list
138553582|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138553583|NCT00109239|Growth Substances|growth substances|mesh-ancestor
138553584|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553586|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138553587|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138553588|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
138553589|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553590|NCT00280033|Antacids|antacids|mesh-ancestor
138553591|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553592|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138553593|NCT00109278|Vaccines|vaccines|mesh-list
138300508|NCT00002827|Razoxane|razoxane|mesh-list
138553594|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
138553595|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553596|NCT00280267|Testosterone|testosterone|mesh-list
138553597|NCT00280267|Androgens|androgens|mesh-ancestor
138553599|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138553600|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553601|NCT00076232|Acyclovir|acyclovir|mesh-list
138553602|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
138553603|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553604|NCT00280423|Casopitant|casopitant|mesh-list
138553605|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
138553606|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
138285613|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553607|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553608|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553609|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138553610|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138553611|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553612|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440573|NCT01783951|Cisplatin|cisplatin|mesh-list
138553614|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553615|NCT00280462|Nifedipine|nifedipine|mesh-list
138553616|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138553617|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138553618|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553619|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138553620|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553621|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
138553622|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
138553623|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138300718|NCT00003073|Cytarabine|cytarabine|mesh-list
138553625|NCT00280501|Sulpiride|sulpiride|mesh-list
138553626|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
138553627|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138553628|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138553629|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138300852|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138553630|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138553631|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553632|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138553633|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
138553634|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553635|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553636|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138553638|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138553639|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138553640|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138553641|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138553642|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553643|NCT00280540|Diuretics|diuretics|mesh-ancestor
138553644|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
138553645|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553646|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138553647|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138553648|NCT00076349|Rituximab|rituximab|mesh-list
138553649|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138553650|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138553651|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553652|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
138553653|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553654|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138553655|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138553656|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
138553657|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553659|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553660|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138553661|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138553662|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553663|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138553664|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
138553665|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553667|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
138553668|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
138553669|NCT00076388|Docetaxel|docetaxel|mesh-list
138553670|NCT00076388|Gefitinib|gefitinib|mesh-list
138553671|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138301200|NCT00003139|Miotics|miotics|mesh-ancestor
138553673|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
138553674|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
138553675|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553676|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138553677|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553678|NCT00280774|Memantine|memantine|mesh-list
138553679|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138553680|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138553681|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
138172458|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138553682|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553683|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553684|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553685|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138553686|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138553687|NCT00109551|Folic Acid|folic acid|mesh-list
138553688|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
138553689|NCT00109551|Hematinics|hematinics|mesh-ancestor
138553690|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
138553691|NCT00109551|Vitamins|vitamins|mesh-ancestor
138553692|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
138553693|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553694|NCT00109551|Astringents|astringents|mesh-ancestor
138553695|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
138553697|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553698|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138553699|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138553700|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553701|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553702|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138553703|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
138553704|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138553705|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138344282|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138553706|NCT00280969|Efavirenz|efavirenz|mesh-list
138301687|NCT00003829|Fludarabine|fludarabine|mesh-list
138553707|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138553708|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138553709|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138553710|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553711|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553712|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
138553713|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553714|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138553715|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138553716|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138553717|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138553718|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138553719|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138553720|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138553721|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138553722|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
138553723|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138553724|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138553725|NCT00281008|Mipomersen|mipomersen|mesh-list
138553726|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138553727|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138553728|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
138553729|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138302044|NCT00004261|Antibodies|antibodies|mesh-list
138553730|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138553732|NCT00281125|Vatalanib|vatalanib|mesh-list
138302114|NCT00003301|Irinotecan|irinotecan|mesh-list
138553733|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553735|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553736|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138553737|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138553738|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138553740|NCT00109746|Picolinic acid|picolinic acid|mesh-list
138553741|NCT00109746|Trace Elements|trace elements|mesh-ancestor
138553742|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
138553743|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553744|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138553745|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
138553746|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
138302329|NCT00004981|Lamivudine|lamivudine|mesh-list
138553747|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553748|NCT04730297|Acetaminophen|acetaminophen|mesh-list
138553749|NCT04730297|Ibuprofen|ibuprofen|mesh-list
138553750|NCT04730297|Codeine|codeine|mesh-list
138553751|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138553752|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138553753|NCT04730297|Analgesics|analgesics|mesh-ancestor
138553754|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
138302471|NCT00005029|Topotecan|topotecan|mesh-list
138553755|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553756|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553757|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138553758|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138553759|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138553760|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553761|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553762|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
138553763|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138553764|NCT04730297|Narcotics|narcotics|mesh-ancestor
138553765|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138553766|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
138302610|NCT00004495|Hematinics|hematinics|mesh-ancestor
138553767|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
138553768|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
138553769|NCT00399269|Hematinics|hematinics|mesh-ancestor
138553770|NCT00281281|Vancomycin|vancomycin|mesh-list
138553771|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138553772|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553773|NCT00109785|Idoxuridine|idoxuridine|mesh-list
138553774|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138553775|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138553776|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553777|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
138553778|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553779|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138553781|NCT00281476|Simvastatin|simvastatin|mesh-list
138553782|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138553783|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138553784|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
138553785|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553787|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138553788|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553789|NCT00416923|Rituximab|rituximab|mesh-list
138553790|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138553791|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553792|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
138553793|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553794|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138553795|NCT00416962|Oseltamivir|oseltamivir|mesh-list
138553797|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
138553798|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553799|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553800|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553801|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138553802|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138553803|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
138553804|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553805|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553806|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138553807|NCT00416962|Analgesics|analgesics|mesh-ancestor
138553808|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
138553809|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553810|NCT00109824|Decitabine|decitabine|mesh-list
138553811|NCT00109824|Azacitidine|azacitidine|mesh-list
138553812|NCT00109824|Valproic Acid|valproic acid|mesh-list
138553813|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138553814|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
138553815|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553816|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138303314|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
138553817|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553818|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
138553819|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
138553820|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553821|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553822|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
138553823|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138553824|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138553825|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138553826|NCT00281515|Lonafarnib|lonafarnib|mesh-list
138553827|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553828|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553829|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
138553831|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
138553832|NCT00109941|Narcotics|narcotics|mesh-ancestor
138553833|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138285757|NCT04736108|Prednisolone|prednisolone|mesh-list
138553834|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553835|NCT00109941|Analgesics|analgesics|mesh-ancestor
138553836|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
138553837|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553838|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
138553839|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553840|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138553841|NCT00281593|Telmisartan|telmisartan|mesh-list
138553842|NCT00281593|Ramipril|ramipril|mesh-list
138553843|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138553844|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138553845|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138553846|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553847|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138553848|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
138553849|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553850|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
138553851|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138553852|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138553853|NCT00281710|Prednisolone|prednisolone|mesh-list
138553854|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
138553855|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138553856|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
138553857|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138553858|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
138553859|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
138553860|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553861|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553862|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138553863|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
138553865|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138553866|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138553867|NCT00281710|Protective Agents|protective agents|mesh-ancestor
138230196|NCT02246894|Factor VIII|factor viii|mesh-list
138553868|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138553869|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553871|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138553872|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138553873|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553874|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138553875|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553876|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138553877|NCT00076544|Protective Agents|protective agents|mesh-ancestor
138553878|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138553880|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
138553881|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138553882|NCT00281788|Paclitaxel|paclitaxel|mesh-list
138553884|NCT00281788|Capecitabine|capecitabine|mesh-list
138553885|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138553886|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553887|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
138553888|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
138553889|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
138553890|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553891|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138553892|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
138553893|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138553894|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553895|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138553896|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553897|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553898|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
138553899|NCT00281905|Carboplatin|carboplatin|mesh-list
138553900|NCT00281905|Methotrexate|methotrexate|mesh-list
138553901|NCT00281905|Vincristine|vincristine|mesh-list
138553902|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138553903|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
138553904|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553905|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138553906|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138553908|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553909|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553910|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138553911|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138553912|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
138553913|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138553914|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138553915|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
138553916|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
138553918|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138553919|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138553920|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138553921|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
138553922|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
138303881|NCT02058108|Telbivudine|telbivudine|mesh-list
138553923|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
138553924|NCT00110058|Interferons|interferons|mesh-list
138553925|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
138553926|NCT00110058|Cyclosporine|cyclosporine|mesh-list
138553927|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
138553928|NCT00110058|Fludarabine|fludarabine|mesh-list
138553929|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
138553930|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
138553931|NCT00110058|Cyclosporins|cyclosporins|mesh-list
138553932|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553933|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138553934|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
138553935|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553936|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138553937|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
138553938|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553939|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
138553940|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138553941|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553942|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
138553943|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
138553944|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138553945|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138553946|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138553947|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138553948|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
138553949|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138553950|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138553952|NCT00281944|Fluorouracil|fluorouracil|mesh-list
138553953|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
138553954|NCT00281944|Calcium|calcium|mesh-list
138553955|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
138553956|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138553957|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553958|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
138304144|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138553959|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553960|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138553961|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553962|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138553963|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
138553965|NCT00281944|Protective Agents|protective agents|mesh-ancestor
138553966|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
138553967|NCT00281944|Vitamins|vitamins|mesh-ancestor
138553968|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
138553969|NCT00281983|Cyclosporine|cyclosporine|mesh-list
138553970|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
138553971|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
138553972|NCT00281983|Busulfan|busulfan|mesh-list
138553974|NCT00281983|Methotrexate|methotrexate|mesh-list
138553975|NCT00281983|Fludarabine|fludarabine|mesh-list
138553976|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
138172554|NCT00611897|Ketamine|ketamine|mesh-list
138553978|NCT00281983|Cyclosporins|cyclosporins|mesh-list
138553979|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138553980|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138553981|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
138553982|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138553983|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138553984|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138553985|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
138553986|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138553987|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138553988|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138553989|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138553990|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138553991|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
138553992|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138357366|NCT00003378|Paclitaxel|paclitaxel|mesh-list
138304420|NCT01945242|Alogliptin|alogliptin|mesh-list
138553993|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138553994|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
138553995|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
138553996|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138553997|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138553998|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138304482|NCT01984242|Bevacizumab|bevacizumab|mesh-list
138553999|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
138554000|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138554001|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138554002|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138554003|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138554004|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
138554005|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138554006|NCT00282061|Melatonin|melatonin|mesh-list
138554007|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
138554008|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554009|NCT00282061|Protective Agents|protective agents|mesh-ancestor
138554010|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554011|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554012|NCT00282100|Gefitinib|gefitinib|mesh-list
138554013|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554014|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138554015|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554016|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138285880|NCT04088786|Irinotecan|irinotecan|mesh-list
138554018|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
138554020|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138554021|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138554022|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554023|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554024|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
138554025|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
138554026|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554027|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554028|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138554030|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
138554031|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138554032|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138554033|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138554034|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138554036|NCT00110253|Tetracaine|tetracaine|mesh-list
138554037|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
138554038|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
138554039|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554040|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554041|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
138554042|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138554043|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138554044|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138554045|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138554046|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138554047|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554048|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138554049|NCT00282178|Candesartan|candesartan|mesh-list
138554050|NCT00282178|Candesartan cilexetil|candesartan cilexetil|mesh-list
138554051|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138554052|NCT00282178|Diuretics|diuretics|mesh-ancestor
138554053|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
138554054|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554055|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138554056|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138554057|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138305086|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373422|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
138373425|NCT01424241|Octreotide|octreotide|mesh-list
138373426|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138373427|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138373428|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373430|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138373431|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138373432|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138554058|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138305156|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
138554059|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138554060|NCT00282217|Sirolimus|sirolimus|mesh-list
138554061|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138554062|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138554063|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138554064|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554065|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
138305305|NCT01009931|Hormones|hormones|mesh-ancestor
138554066|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138554068|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554069|NCT00282451|Insulin|insulin|mesh-list
138554070|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138554071|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
138554072|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
138554073|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138554074|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
138554075|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138554076|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554078|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138554079|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138554080|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554081|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554082|NCT00282724|Liarozole|liarozole|mesh-list
138554083|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
138554084|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
138554085|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138554086|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554087|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
138554088|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554089|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230419|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138554090|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138554091|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554093|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138554094|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138554095|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138554096|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138554097|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554098|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
138554099|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138305644|NCT00625703|Linezolid|linezolid|mesh-list
138554100|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554101|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138554102|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138554103|NCT00282997|Pregabalin|pregabalin|mesh-list
138554104|NCT00282997|Analgesics|analgesics|mesh-ancestor
138554105|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
138554106|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138554107|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554108|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
138554110|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138554111|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554112|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138554113|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138554114|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138554115|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554116|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138554117|NCT00283036|Irbesartan|irbesartan|mesh-list
138554118|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138554119|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138554120|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138554121|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554122|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
138554123|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138554124|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554125|NCT00283114|Lintuzumab|lintuzumab|mesh-list
138554126|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138554127|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554128|NCT00076856|Temozolomide|temozolomide|mesh-list
138554129|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138554130|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
138305914|NCT00428207|Insulin|insulin|mesh-list
138554131|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554132|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554133|NCT00283192|Sertraline|sertraline|mesh-list
138554134|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
138554135|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138554136|NCT00283192|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138554137|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138554138|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138554139|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554140|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554141|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
138554142|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554143|NCT00283309|Riluzole|riluzole|mesh-list
138554144|NCT00283309|Memantine|memantine|mesh-list
138554145|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138554146|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138554148|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554149|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554150|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554151|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138554152|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138172596|NCT02780609|Aprepitant|aprepitant|mesh-list
138554154|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138554155|NCT00283309|Protective Agents|protective agents|mesh-ancestor
138554156|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138554158|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
138554159|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138554160|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230498|NCT02407704|Lorazepam|lorazepam|mesh-list
138554161|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138554162|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
138554163|NCT00283465|Hematinics|hematinics|mesh-ancestor
138554164|NCT00283543|Temozolomide|temozolomide|mesh-list
138554166|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138554167|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
138554168|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554169|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554170|NCT00283621|Doxorubicin|doxorubicin|mesh-list
138554171|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138554172|NCT00283621|Ifosfamide|ifosfamide|mesh-list
138554173|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
138554174|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138554175|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440848|NCT01785641|Cefazolin|cefazolin|mesh-list
138554176|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138554177|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138554178|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554179|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554180|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138554181|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
138554182|NCT00283621|Hematinics|hematinics|mesh-ancestor
138554183|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
138554184|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
138554185|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
138554186|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138554187|NCT00283660|Protective Agents|protective agents|mesh-ancestor
138554188|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554190|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
138554191|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554192|NCT00283699|Albendazole|albendazole|mesh-list
138554193|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
138554194|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138554195|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138554196|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
138554197|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138554198|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138554199|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
138554200|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
138554201|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
138554202|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554203|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554204|NCT00283777|Chromium|chromium|mesh-list
138554205|NCT00283777|Picolinic acid|picolinic acid|mesh-list
138554206|NCT00283777|Trace Elements|trace elements|mesh-ancestor
138554207|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
138554208|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554209|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138554210|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
138554211|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
138554212|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554214|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138554215|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138554216|NCT00110448|Analgesics|analgesics|mesh-ancestor
138554217|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
138554218|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138554219|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554220|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138554221|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138554222|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138554223|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138554224|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554225|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138554226|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138554227|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554228|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
138554229|NCT00284206|Risperidone|risperidone|mesh-list
138554230|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138554231|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
138554232|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554233|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554234|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554235|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138554236|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138554237|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554238|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138554239|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138554240|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
138554241|NCT00284323|Adenosine|adenosine|mesh-list
138554242|NCT00284323|Analgesics|analgesics|mesh-ancestor
138554243|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
138554244|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138554245|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554246|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138554247|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
138554248|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138554249|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
138554250|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
138554251|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554252|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554253|NCT04718701|Paclitaxel|paclitaxel|mesh-list
138286007|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
138554254|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138554255|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138307298|NCT00002105|Bleomycin|bleomycin|mesh-list
138554256|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
138554257|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
138554258|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
138554259|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554260|NCT00077168|Tamoxifen|tamoxifen|mesh-list
138554261|NCT00077168|Anastrozole|anastrozole|mesh-list
138554262|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554263|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138554264|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
138554265|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138554266|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554267|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138554268|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554269|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138554270|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138554271|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138554272|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138554273|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138554274|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554276|NCT00110604|Hematinics|hematinics|mesh-ancestor
138554277|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
138554278|NCT00110604|Vitamins|vitamins|mesh-ancestor
138554279|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
138554280|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554281|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138554282|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554284|NCT00284791|Sertraline|sertraline|mesh-list
138554285|NCT00284791|Fluoxetine|fluoxetine|mesh-list
138554286|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
138554287|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138554288|NCT00284791|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138554289|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138554290|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138554291|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554292|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554293|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
138554294|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138286037|NCT03297944|Zolpidem|zolpidem|mesh-list
138554295|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138554296|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138554297|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138554298|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554299|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
138554300|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138554301|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138554302|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138554303|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138440885|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
138554304|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554305|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138554307|NCT00284947|Prednisolone|prednisolone|mesh-list
138554308|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
138554309|NCT00284947|Basiliximab|basiliximab|mesh-list
138554310|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138554311|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
138554312|NCT00284947|Hormones|hormones|mesh-ancestor
138554313|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138554314|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554315|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138554316|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554317|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
138554318|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
138554319|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138554320|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138554321|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138554322|NCT00284947|Protective Agents|protective agents|mesh-ancestor
138554323|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138554324|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
138554326|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138554327|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
138554328|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554329|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554330|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
138554331|NCT00077246|Paclitaxel|paclitaxel|mesh-list
138554332|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138554333|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138554334|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554335|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
138554336|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
138554337|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
138554338|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554339|NCT00110721|Fluorouracil|fluorouracil|mesh-list
138554340|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
138344283|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
138290109|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290110|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
138290111|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290112|NCT00380276|Tarenflurbil|tarenflurbil|mesh-list
138290113|NCT00380276|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138554341|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554342|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138554343|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554344|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138554345|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
138554346|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554347|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
138554349|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138554350|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
138554351|NCT00425035|Panitumumab|panitumumab|mesh-list
138554352|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138554353|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554354|NCT00110760|Lidocaine|lidocaine|mesh-list
138554355|NCT00110760|Tetracaine|tetracaine|mesh-list
138554356|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
138554357|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
138554358|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554359|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554360|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
138554361|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138554362|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138554363|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138554364|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138554365|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138554366|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554367|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
138554368|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138554369|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554370|NCT00285181|Simvastatin|simvastatin|mesh-list
138554371|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138554372|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138554373|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
138554374|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554375|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138308462|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138554376|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138554377|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554378|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
138554379|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138554380|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138308611|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
138554381|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554382|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138230715|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
138554383|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138554384|NCT00285298|Protective Agents|protective agents|mesh-ancestor
138554385|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554386|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
138554387|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138554389|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138554390|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
138554391|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138554392|NCT00285376|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138554393|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138554394|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138554395|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554396|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554397|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
138554398|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138308750|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
138554399|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138554400|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138554402|NCT00077363|Tipifarnib|tipifarnib|mesh-list
138554403|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138554404|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
138554405|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554406|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554408|NCT00285415|Docetaxel|docetaxel|mesh-list
138554409|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554410|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
138554411|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
138554412|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
138554413|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554414|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138554415|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138309030|NCT03933293|Ezetimibe|ezetimibe|mesh-list
138554417|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138554418|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138554419|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
138554420|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
138188484|NCT03018301|Ketamine|ketamine|mesh-list
138554421|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554422|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554424|NCT00077402|Fenretinide|fenretinide|mesh-list
138554425|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554426|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138554427|NCT00077402|Protective Agents|protective agents|mesh-ancestor
138554428|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554429|NCT00285766|Selegiline|selegiline|mesh-list
138554430|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
138554431|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138554432|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138309244|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
138554433|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138554434|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138554435|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554436|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554437|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138554438|NCT00285766|Protective Agents|protective agents|mesh-ancestor
138554440|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
138554441|NCT00285805|Amiloride|amiloride|mesh-list
138554442|NCT00285805|Furosemide|furosemide|mesh-list
138554443|NCT00285805|Diuretics|diuretics|mesh-ancestor
138554444|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
138554445|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554446|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138554447|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138554448|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554449|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138554450|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138554451|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138554452|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138554453|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138554454|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
138554455|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138309669|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
138554456|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554457|NCT00077441|Bortezomib|bortezomib|mesh-list
138554458|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554459|NCT00285883|Saquinavir|saquinavir|mesh-list
138554460|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138309736|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138554461|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138554462|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
138554463|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554464|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554465|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138554466|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138554467|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
138554468|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138172644|NCT05346146|Tubulin Modulators|tubulin modulators|mesh-ancestor
138554469|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138554470|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138554472|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138554473|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138554474|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
138554475|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138309948|NCT00003995|Irinotecan|irinotecan|mesh-list
138702102|NCT05424393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554476|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554477|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138554478|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138554479|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
138554480|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138554482|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554483|NCT00286117|Tamoxifen|tamoxifen|mesh-list
138554484|NCT00286117|Anastrozole|anastrozole|mesh-list
138554485|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138554486|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
138554487|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138554488|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554489|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138554490|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554491|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138554492|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138554493|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138554494|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138554495|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138310164|NCT00004103|Irinotecan|irinotecan|mesh-list
138554496|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554497|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554498|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138554499|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138554500|NCT00077558|Fludarabine|fludarabine|mesh-list
138554501|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
138554502|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554503|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138554504|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
138310302|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
138554505|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554506|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138554507|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
138554508|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554510|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138554512|NCT00286273|Dalteparin|dalteparin|mesh-list
138554513|NCT00286273|Nadroparin|nadroparin|mesh-list
138554514|NCT00286273|Citric Acid|citric acid|mesh-list
138554515|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
138554516|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
138554517|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138554518|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
138554519|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
138554520|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554521|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138554522|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138554523|NCT00286312|Atorvastatin|atorvastatin|mesh-list
138554524|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138554525|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138554526|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
138554527|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172661|NCT01271725|Paclitaxel|paclitaxel|mesh-list
138554528|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138554529|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138554530|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554532|NCT00286351|Anastrozole|anastrozole|mesh-list
138554533|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138554534|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554535|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138554536|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138554537|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554538|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554539|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138554540|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
138554541|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138554542|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554543|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
138554544|NCT00110955|Hematinics|hematinics|mesh-ancestor
138554545|NCT00286585|Propofol|propofol|mesh-list
138554546|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
138554547|NCT00286585|Anesthetics|anesthetics|mesh-list
138554548|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138554549|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554550|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554551|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
138554552|NCT00111072|Dexamethasone|dexamethasone|mesh-list
138554553|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138554554|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
138554555|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
138554556|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138554557|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554558|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138554559|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
138554560|NCT00111072|Hormones|hormones|mesh-ancestor
138554561|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138554562|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138554563|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554564|NCT00286624|Cyclosporine|cyclosporine|mesh-list
138554565|NCT00286624|Everolimus|everolimus|mesh-list
138554566|NCT00286624|Cyclosporins|cyclosporins|mesh-list
138554568|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554569|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554570|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138554571|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
138554572|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554573|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
138554574|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138554575|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
138554576|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138554577|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138554578|NCT00286624|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138554579|NCT00286624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138554580|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554581|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
138554582|NCT00077597|Hematinics|hematinics|mesh-ancestor
138554583|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
138554584|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138554585|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554586|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138554587|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
138554588|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138554589|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554590|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138554591|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138554592|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138554593|NCT00111111|Etanercept|etanercept|mesh-list
138554594|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138554595|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138554596|NCT00111111|Analgesics|analgesics|mesh-ancestor
138310976|NCT00005093|Gemcitabine|gemcitabine|mesh-list
138554597|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
138554598|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138172672|NCT00587483|Lidocaine|lidocaine|mesh-list
138554599|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554600|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138554601|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138554602|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138554603|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138554604|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
138554605|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138554606|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138554607|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138311101|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
138554608|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554609|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554610|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138554611|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138554612|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138554613|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
138554614|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554615|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554616|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138554617|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138554618|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
138554620|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
138554621|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138554622|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138554623|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138554624|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554625|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554626|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138554627|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138554629|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138554630|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138311454|NCT05656352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138554631|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138554632|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138554633|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
138554634|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138554635|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554637|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
138554638|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
138554639|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138554640|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138554641|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554642|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138554643|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138554644|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138554645|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554646|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554647|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138554648|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138554649|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138554650|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
138554651|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554652|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554653|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138554654|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138554657|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
138554658|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
138554659|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138554660|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138554661|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554663|NCT00111267|Folic Acid|folic acid|mesh-list
138554664|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
138554665|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
138554666|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
138554667|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
138554668|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554669|NCT00111267|Hematinics|hematinics|mesh-ancestor
138554670|NCT00286936|Zolpidem|zolpidem|mesh-list
138172676|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554671|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138554672|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138554673|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554674|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554675|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138554676|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
138554677|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
138311945|NCT03912220|Niacin|niacin|mesh-list
138554678|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554679|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138312038|NCT03597594|Busulfan|busulfan|mesh-list
138286320|NCT00376285|Fenofibrate|fenofibrate|mesh-list
138554681|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138554682|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554683|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
138231012|NCT05859126|Antimetabolites|antimetabolites|mesh-ancestor
138554685|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554686|NCT00287170|Calcitriol|calcitriol|mesh-list
138554687|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
138554688|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138554689|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138358071|NCT00004050|Interleukin-2|interleukin-2|mesh-list
138554690|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138554691|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138554692|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554693|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138554694|NCT00287170|Vitamins|vitamins|mesh-ancestor
138554695|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
138554696|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138554697|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
138312142|NCT01832402|Analgesics|analgesics|mesh-ancestor
138554698|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138554699|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554700|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138554701|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
138554702|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138312217|NCT00003671|Antidotes|antidotes|mesh-ancestor
138554703|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554704|NCT00287209|Amiodarone|amiodarone|mesh-list
138554705|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138312277|NCT00003743|Aldesleukin|aldesleukin|mesh-list
138554707|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138554708|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138554709|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554710|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138554711|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138554712|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138554713|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554714|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138554715|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138286353|NCT03324451|Insulin|insulin|mesh-list
138554716|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138554719|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138554720|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138554721|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
138554722|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
138554723|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138554724|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554725|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138554726|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138554727|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138554728|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
138554729|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554730|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554731|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138554732|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
138554733|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138554734|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138554735|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554736|NCT00077948|Protective Agents|protective agents|mesh-ancestor
138554739|NCT00111345|Cladribine|cladribine|mesh-list
138554740|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138554741|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554742|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138554743|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138554744|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554745|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554746|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138554747|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
138554748|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554749|NCT00287326|Clonidine|clonidine|mesh-list
138554750|NCT00287326|Morphine|morphine|mesh-list
138554751|NCT00287326|Bupivacaine|bupivacaine|mesh-list
138554752|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
138554754|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554755|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554756|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
138231093|NCT05794971|Irinotecan|irinotecan|mesh-list
138554757|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138286382|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
138554758|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138554759|NCT00287326|Narcotics|narcotics|mesh-ancestor
138554760|NCT00287326|Analgesics|analgesics|mesh-ancestor
138554761|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138554762|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
138554763|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
138554764|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138554765|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138554766|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138554767|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
138554768|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554769|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554771|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138554772|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554774|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554775|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138554776|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138554777|NCT00077987|Growth Substances|growth substances|mesh-ancestor
138554778|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554779|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
138554780|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138554781|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554782|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554784|NCT00287521|Latanoprost|latanoprost|mesh-list
138554785|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554786|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138554787|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138554788|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
138554789|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554790|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554791|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138554792|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138554793|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138554794|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138554795|NCT00287560|Propofol|propofol|mesh-list
138554796|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138554797|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554798|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554799|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138554800|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
138554801|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
138554802|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
138554803|NCT00111462|Hematinics|hematinics|mesh-ancestor
138554805|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138554806|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554807|NCT00287794|Diazepam|diazepam|mesh-list
138554808|NCT00287794|Melatonin|melatonin|mesh-list
138554809|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
138554810|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554811|NCT00287794|Protective Agents|protective agents|mesh-ancestor
138554812|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554813|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554814|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138554815|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
138554816|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
138554817|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
138554818|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138554819|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138554820|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138554821|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138554822|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138554823|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138554824|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138554825|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138554826|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138554827|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
138554828|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
138554829|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
138554831|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554832|NCT00287911|Topotecan|topotecan|mesh-list
138554834|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138554835|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138554836|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373587|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373588|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138373589|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138373590|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138373591|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
138373592|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138554837|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554839|NCT00287950|Carboplatin|carboplatin|mesh-list
138554841|NCT00287950|Vincristine|vincristine|mesh-list
138554842|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138554843|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
138554844|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554845|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138441021|NCT01786538|Leucovorin|leucovorin|mesh-list
138554847|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
138554848|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554849|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554850|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138554851|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138554852|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138554853|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138554854|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554855|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
138554856|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
138554857|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
138554859|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554860|NCT00111540|Exenatide|exenatide|mesh-list
138554861|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138554862|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554863|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138554864|NCT00111540|Incretins|incretins|mesh-ancestor
138554865|NCT00111540|Hormones|hormones|mesh-ancestor
138554866|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138554867|NCT00288184|Allopurinol|allopurinol|mesh-list
138554868|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
138554869|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554870|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138554871|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
138554872|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138554873|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138554874|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
138554875|NCT00288184|Protective Agents|protective agents|mesh-ancestor
138554876|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554877|NCT00288223|Telithromycin|telithromycin|mesh-list
138554878|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138554879|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138554881|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
138554882|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554883|NCT00288262|Protective Agents|protective agents|mesh-ancestor
138554884|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138313836|NCT01813422|Protease Inhibitors|protease inhibitors|mesh-ancestor
138554885|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138554886|NCT00288379|Budesonide|budesonide|mesh-list
138554887|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
138554888|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138554889|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138554890|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
138554891|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138554892|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554893|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138554894|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
138554895|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
138554896|NCT00288379|Hormones|hormones|mesh-ancestor
138554897|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138554898|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138554899|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138554900|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138554901|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
138554902|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138314039|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
138554903|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554905|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
138554906|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138554907|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138554908|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138554910|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554911|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138554912|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138554913|NCT00111618|Vadimezan|vadimezan|mesh-list
138554914|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554915|NCT00399425|Heparin|heparin|mesh-list
138554916|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138554918|NCT00399425|Dalteparin|dalteparin|mesh-list
138554919|NCT00399425|Bemiparin|bemiparin|mesh-list
138554920|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
138554921|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138554922|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138554923|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554924|NCT00288535|Sirolimus|sirolimus|mesh-list
138554925|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138554926|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138554927|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138554928|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138554929|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
138554930|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138554931|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
138554932|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554933|NCT00399464|Alfuzosin|alfuzosin|mesh-list
138554934|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138554935|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138554936|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138554937|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
138554938|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554939|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554940|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554941|NCT00399464|Urological Agents|urological agents|mesh-ancestor
138554942|NCT00288652|Reboxetine|reboxetine|mesh-list
138286517|NCT02177838|Cetuximab|cetuximab|mesh-list
138554943|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
138554944|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138554945|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138554946|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138554947|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138554948|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554949|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
138554950|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138554951|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554952|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138554953|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
138554954|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554955|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
138554956|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
138554957|NCT00288769|Vitamins|vitamins|mesh-ancestor
138554958|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
138554959|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554960|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
138554961|NCT00288769|Hematinics|hematinics|mesh-ancestor
138554962|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
138554963|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138554964|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138554965|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554966|NCT00289042|Enoxaparin|enoxaparin|mesh-list
138172739|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138554967|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
138554968|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138554969|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138554970|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554972|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138554973|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
138554974|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554975|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138554976|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
138554977|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
138554978|NCT00111891|Vitamins|vitamins|mesh-ancestor
138554979|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
138554980|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554981|NCT00289354|Chromium|chromium|mesh-list
138554982|NCT00289354|Biotin|biotin|mesh-list
138554983|NCT00289354|Picolinic acid|picolinic acid|mesh-list
138231313|NCT04803422|Tazobactam|tazobactam|mesh-list
138554984|NCT00289354|Trace Elements|trace elements|mesh-ancestor
138554985|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
138554986|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554987|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
138554988|NCT00289354|Vitamins|vitamins|mesh-ancestor
138554989|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138314370|NCT01706328|Xhance|xhance|mesh-list
138554990|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
138554991|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
138554992|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138554994|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
138554995|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138554996|NCT00289588|Mupirocin|mupirocin|mesh-list
138554997|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138554998|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138314407|NCT01729728|Tapentadol|tapentadol|mesh-list
138554999|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138555000|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555001|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555002|NCT00289627|Ipilimumab|ipilimumab|mesh-list
138555003|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138555004|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555005|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138555006|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555007|NCT00401661|Alfuzosin|alfuzosin|mesh-list
138555008|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138555009|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138555010|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138314532|NCT01751178|Ethanol|ethanol|mesh-list
138555011|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
138555012|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555013|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555014|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555015|NCT00401661|Urological Agents|urological agents|mesh-ancestor
138555017|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138555018|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
138314676|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
138555019|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138172767|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138555020|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555021|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555022|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138555023|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138555024|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138555025|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138555026|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138555027|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
138555029|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555030|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555031|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555032|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138555033|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138555034|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
138555035|NCT00112008|Hematinics|hematinics|mesh-ancestor
138555037|NCT00112086|Carboplatin|carboplatin|mesh-list
138555038|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138555039|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555040|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
138555041|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
138555042|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
138555043|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555044|NCT00290173|Ritodrine|ritodrine|mesh-list
138555045|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
138555046|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
138555047|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555048|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555049|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
138555050|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138555051|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138358437|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555053|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138555054|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
138555055|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555056|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555057|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
138231386|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
138555058|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555059|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138555060|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555061|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555062|NCT00112164|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138555063|NCT00112164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555065|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555066|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555067|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555068|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138555069|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138555071|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138555072|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138555073|NCT00290602|Prednisolone|prednisolone|mesh-list
138555074|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
138555075|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138555076|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
138555077|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138555078|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
138555079|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
138172786|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
138555080|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555081|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555082|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138555083|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
138555084|NCT00290602|Hormones|hormones|mesh-ancestor
138555085|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138555086|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138555087|NCT00290602|Protective Agents|protective agents|mesh-ancestor
138555088|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138555089|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555090|NCT00290641|Cyclosporine|cyclosporine|mesh-list
138555091|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
138555092|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
138555094|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
138555095|NCT00290641|Cyclosporins|cyclosporins|mesh-list
138555096|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138555097|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
138555098|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555099|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138555100|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138555101|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
138555102|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555103|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555104|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138555105|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138555106|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
138555107|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555108|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
138555109|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555110|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
138555111|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138555112|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138555113|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138555114|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
138315409|NCT01534260|Bortezomib|bortezomib|mesh-list
138555115|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138555116|NCT00290680|Celecoxib|celecoxib|mesh-list
138555117|NCT00290680|Bortezomib|bortezomib|mesh-list
138555118|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555119|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138555120|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138555121|NCT00290680|Analgesics|analgesics|mesh-ancestor
138555122|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
138358513|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
138373593|NCT01425125|Tolvaptan|tolvaptan|mesh-list
138373594|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138373595|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555123|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555124|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555125|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138555126|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138555127|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138555129|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555130|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555132|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138555134|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555136|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
138555137|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138555138|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555139|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555141|NCT00290719|Gefitinib|gefitinib|mesh-list
138555142|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555143|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138555144|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138555145|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555146|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555147|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138555149|NCT00290836|Aprotinin|aprotinin|mesh-list
138555150|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
138555151|NCT00290836|Coagulants|coagulants|mesh-ancestor
138555152|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138555153|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138555154|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
138555155|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555156|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555157|NCT04729556|Chitosan|chitosan|mesh-list
138555158|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138555159|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138555160|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
138555161|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555162|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138555163|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
138555164|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
138555165|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
138555166|NCT04729556|Coagulants|coagulants|mesh-ancestor
138555167|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138555168|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
138555169|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138286734|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
138555170|NCT00290914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138555171|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138555172|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138555173|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555175|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
138555176|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555177|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138555178|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138555179|NCT00290992|Rasburicase|rasburicase|mesh-list
138555180|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
138555181|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138555182|NCT00291109|Letrozole|letrozole|mesh-list
138555183|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555184|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138555185|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138555186|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555187|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555188|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138555189|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
138555190|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138555191|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555192|NCT00291148|Pregabalin|pregabalin|mesh-list
138555193|NCT00291148|Paroxetine|paroxetine|mesh-list
138555194|NCT00291148|Analgesics|analgesics|mesh-ancestor
138555195|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
138555196|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555197|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555198|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
138555199|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138358599|NCT00004488|Vitamin D|vitamin d|mesh-list
138555200|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138555201|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555202|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138555203|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138555204|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138555205|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138555206|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138555207|NCT00291148|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138555208|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138555209|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555211|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138555212|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
138555213|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138555214|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138555215|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555218|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138555219|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138555220|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138555221|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
138555222|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555223|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555224|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138555225|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
138555226|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
138555227|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138555228|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138555229|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138555230|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138555231|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
138555232|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555233|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555234|NCT00112476|Sirolimus|sirolimus|mesh-list
138555235|NCT00112476|Temsirolimus|temsirolimus|mesh-list
138555236|NCT00112476|MTOR Inhibitors|mtor inhibitors|mesh-list
138555237|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
138555238|NCT00112476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138555239|NCT00112476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555240|NCT00112476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555241|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138555242|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
138555243|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555244|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555245|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138555246|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555247|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138555248|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
138555249|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138555250|NCT00291538|Bortezomib|bortezomib|mesh-list
138555251|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555252|NCT00291616|Interferons|interferons|mesh-list
138555253|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
138555254|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
138555255|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138555256|NCT00291616|Thymalfasin|thymalfasin|mesh-list
138555257|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555258|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
138555259|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555260|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
138555261|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555262|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138555263|NCT00078572|Capecitabine|capecitabine|mesh-list
138555264|NCT00078572|Lapatinib|lapatinib|mesh-list
138555265|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138555266|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
138555267|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555268|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555269|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138555270|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555271|NCT00291733|Levetiracetam|levetiracetam|mesh-list
138555272|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
138555273|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
138555274|NCT00112515|Modafinil|modafinil|mesh-list
138555275|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138555276|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555277|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138555278|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138555279|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138555280|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555281|NCT00291772|Pramlintide|pramlintide|mesh-list
138441113|NCT01787396|Metformin|metformin|mesh-list
138555282|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138555283|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555285|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
138555286|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555287|NCT00291811|Plerixafor|plerixafor|mesh-list
138555288|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138555289|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138555290|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
138555291|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555292|NCT00291850|Paclitaxel|paclitaxel|mesh-list
138555293|NCT00291850|Cisplatin|cisplatin|mesh-list
138555294|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138555295|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555296|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
138555297|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
138286841|NCT00377078|Lactoferrin|lactoferrin|mesh-list
138555298|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
138555299|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555300|NCT00112554|Cytarabine|cytarabine|mesh-list
138555301|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138555302|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
138555303|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555304|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555305|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
138555306|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555307|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138555308|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
138555309|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555310|NCT04718311|Tacrolimus|tacrolimus|mesh-list
138555311|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138555312|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
138172835|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
138555313|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555314|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138555315|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555316|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555317|NCT00078689|Daclizumab|daclizumab|mesh-list
138555318|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138555319|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
138555320|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555321|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
138555322|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555323|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138555324|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555325|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555326|NCT00078845|Amifostine|amifostine|mesh-list
138555327|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138555328|NCT00078845|Protective Agents|protective agents|mesh-ancestor
138555329|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555330|NCT00275314|Valganciclovir|valganciclovir|mesh-list
138555331|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
138555332|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555333|NCT00275275|Pramipexole|pramipexole|mesh-list
138555334|NCT00275275|Ropinirole|ropinirole|mesh-list
138286870|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555336|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555337|NCT00275275|Protective Agents|protective agents|mesh-ancestor
138555338|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555339|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138555340|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138555341|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
138555342|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
138555343|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555344|NCT00112710|Carboplatin|carboplatin|mesh-list
138555345|NCT00112710|Gemcitabine|gemcitabine|mesh-list
138555346|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555347|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138555348|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
138555349|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555350|NCT00275236|Rotigotine|rotigotine|mesh-list
138555351|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
138555352|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
138555353|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555354|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555355|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555356|NCT00275197|Sertraline|sertraline|mesh-list
138555357|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
138555358|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138555359|NCT00275197|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138555360|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138555361|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138555362|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555364|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
138555365|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555366|NCT00275119|Gemcitabine|gemcitabine|mesh-list
138555367|NCT00275119|Fluorouracil|fluorouracil|mesh-list
138555368|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
138555369|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138555370|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
138555371|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555372|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555373|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138555374|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
138555375|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555376|NCT00275080|Decitabine|decitabine|mesh-list
138555377|NCT00275080|Azacitidine|azacitidine|mesh-list
138555378|NCT00275080|Vorinostat|vorinostat|mesh-list
138555379|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138555380|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
138555381|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555382|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555383|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555384|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138555385|NCT00078962|Gemcitabine|gemcitabine|mesh-list
138555386|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138555387|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
138555388|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555389|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555390|NCT00275041|Irinotecan|irinotecan|mesh-list
138555391|NCT00275041|Cetuximab|cetuximab|mesh-list
138555392|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138555393|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138555394|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555395|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555396|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555397|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138555398|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138555399|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
138555400|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138555401|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
138555402|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555403|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555404|NCT00274963|Analgesics|analgesics|mesh-ancestor
138555405|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
138555406|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555407|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555408|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138555409|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138555410|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555411|NCT00102765|Fluticasone|fluticasone|mesh-list
138555413|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138555414|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138555415|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138555416|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138555417|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
138555418|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555419|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555420|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138555421|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
138555422|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
138555423|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138555424|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138555425|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138555426|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138555427|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
138555428|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555429|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555430|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
138555431|NCT00102765|Hormones|hormones|mesh-ancestor
138555432|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138555433|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
138555434|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
138555435|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138555436|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555437|NCT00130312|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
138555438|NCT00130312|Anticoagulants|anticoagulants|mesh-ancestor
138555439|NCT00130312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138555440|NCT00130312|Antimetabolites|antimetabolites|mesh-ancestor
138555441|NCT00130312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555442|NCT00130312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138555443|NCT00130312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138555444|NCT00130312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138555445|NCT00130312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138555446|NCT00130312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555447|NCT00130234|Omalizumab|omalizumab|mesh-list
138555448|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138555449|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138555450|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
138555451|NCT00119301|Leucovorin|leucovorin|mesh-list
138555452|NCT00119301|Trimetrexate|trimetrexate|mesh-list
138555453|NCT00119301|Methotrexate|methotrexate|mesh-list
138555454|NCT00119301|Calcium|calcium|mesh-list
138555455|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
138555456|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138555457|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555458|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138555459|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
138555460|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138555461|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138555462|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
138555463|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555464|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555465|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
138555466|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555467|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138555468|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138555469|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
138555470|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138555471|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138555472|NCT00119301|Antidotes|antidotes|mesh-ancestor
138555473|NCT00119301|Protective Agents|protective agents|mesh-ancestor
138555474|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
138555475|NCT00119301|Vitamins|vitamins|mesh-ancestor
138555476|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
138555477|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
138172902|NCT05688488|Mitomycin|mitomycin|mesh-list
138172903|NCT05688488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138555478|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555480|NCT00079118|Irinotecan|irinotecan|mesh-list
138555481|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555482|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
138555483|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
138555484|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
138555485|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555486|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138316286|NCT06173986|Paclitaxel|paclitaxel|mesh-list
138555487|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138555488|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555489|NCT00130195|Cytarabine|cytarabine|mesh-list
138555490|NCT00130195|Dexamethasone|dexamethasone|mesh-list
138555491|NCT00130195|Prednisolone|prednisolone|mesh-list
138555492|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
138555493|NCT00130195|Methotrexate|methotrexate|mesh-list
138555494|NCT00130195|Vincristine|vincristine|mesh-list
138555495|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
138555496|NCT00130195|Daunorubicin|daunorubicin|mesh-list
138555497|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138555498|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
138555499|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555500|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138555501|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138555502|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
138555503|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555504|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555505|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138555506|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138231840|NCT01650246|Lesinurad|lesinurad|mesh-list
138555507|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
138555508|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
138555509|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555510|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138555511|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
138555512|NCT00130195|Hormones|hormones|mesh-ancestor
138555513|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138555514|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138287009|NCT03329911|Paclitaxel|paclitaxel|mesh-list
138555515|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138555516|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
138555517|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138555518|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138555519|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
138555520|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
138555521|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555522|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138555523|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138555524|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
138555525|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555526|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138555527|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
138555528|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
138555529|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
138555530|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138555531|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138555532|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138555533|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138555535|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138555536|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555537|NCT00119340|Cyclosporine|cyclosporine|mesh-list
138555538|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
138555539|NCT00119340|Fludarabine|fludarabine|mesh-list
138555540|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
138555541|NCT00119340|Cyclosporins|cyclosporins|mesh-list
138555542|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555543|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138555544|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
138555545|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555546|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138555547|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
138555548|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555549|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555550|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
138555551|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555552|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
138555553|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138555554|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138358948|NCT00005046|Paclitaxel|paclitaxel|mesh-list
138555555|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138555556|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138555557|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
138555558|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138555560|NCT00130156|Bunazosin|bunazosin|mesh-list
138555561|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138555562|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138555563|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138555564|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138555565|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
138555566|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555567|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555568|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555569|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
138555570|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
138555571|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138555572|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138555573|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555574|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138555575|NCT00079157|Sargramostim|sargramostim|mesh-list
138555576|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
138555577|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
138555578|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555579|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138555580|NCT00130000|Eculizumab|eculizumab|mesh-list
138555581|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138555582|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138555583|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
138555584|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555585|NCT00079235|Sirolimus|sirolimus|mesh-list
138555586|NCT00079235|Temsirolimus|temsirolimus|mesh-list
138555587|NCT00079235|MTOR Inhibitors|mtor inhibitors|mesh-list
138555588|NCT00079235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138555589|NCT00079235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555590|NCT00079235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555591|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138555592|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
138555593|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555594|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555595|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138555596|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555597|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138555598|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
138555599|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
138555600|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555601|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138555602|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
138555603|NCT00129805|Aspirin|aspirin|mesh-list
138555604|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
138289125|NCT00368654|Methotrexate|methotrexate|mesh-list
138555605|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138555606|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138555607|NCT00129805|Analgesics|analgesics|mesh-ancestor
138555608|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
138555609|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555610|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555611|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138555612|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138555613|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138555614|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138555615|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555616|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138555617|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138555618|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555619|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
138555620|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138555621|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
138555622|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555623|NCT00129727|Paclitaxel|paclitaxel|mesh-list
138555625|NCT00129727|Carboplatin|carboplatin|mesh-list
138555626|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138359010|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138555627|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555628|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
138555629|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
138555631|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555632|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138555633|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138555634|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138555635|NCT00129727|Growth Substances|growth substances|mesh-ancestor
138555636|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555637|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
138555638|NCT00129688|Amikacin|amikacin|mesh-list
138555639|NCT00129688|Cloxacillin|cloxacillin|mesh-list
138555640|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138555641|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555642|NCT00079352|Gemcitabine|gemcitabine|mesh-list
138555643|NCT00079352|Irinotecan|irinotecan|mesh-list
138555644|NCT00079352|Alvocidib|alvocidib|mesh-list
138555645|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138555646|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
138441199|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555647|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555648|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555649|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138555650|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138555651|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555652|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
138555653|NCT00079352|Growth Substances|growth substances|mesh-ancestor
138555654|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555655|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138555656|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
138555657|NCT00119496|Beclomethasone|beclomethasone|mesh-list
138555658|NCT00119496|Theophylline|theophylline|mesh-list
138555659|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232016|NCT01289912|Everolimus|everolimus|mesh-list
138555660|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555661|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138555662|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138287149|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
138555663|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138555664|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
138555665|NCT00119496|Hormones|hormones|mesh-ancestor
138555666|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138555667|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138555668|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
138555669|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138555670|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
138555671|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555672|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138555673|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
138555674|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138555675|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138555676|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
138555677|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555678|NCT00298285|Enoxaparin|enoxaparin|mesh-list
138555679|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
138555680|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138555681|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138555682|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555683|NCT00298324|Cyclosporine|cyclosporine|mesh-list
138555684|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
138555685|NCT00298324|Prednisone|prednisone|mesh-list
138555686|NCT00298324|Cyclosporins|cyclosporins|mesh-list
138555687|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138555688|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
138555689|NCT00298324|Hormones|hormones|mesh-ancestor
138555690|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138555691|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555692|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138555693|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555694|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555695|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555696|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138555698|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
138555699|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555700|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
138555701|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138555702|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138555703|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138555704|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138555705|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
138555706|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138555707|NCT00079430|Paclitaxel|paclitaxel|mesh-list
138555708|NCT00079430|Bevacizumab|bevacizumab|mesh-list
138555709|NCT00079430|Carboplatin|carboplatin|mesh-list
138555710|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138555711|NCT00079430|Antibodies|antibodies|mesh-list
138555712|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
138555713|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138555714|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138555715|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555716|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
138555717|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
138555718|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
138555719|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555720|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138555721|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138555722|NCT00079430|Growth Substances|growth substances|mesh-ancestor
138555723|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555724|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
138555725|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
138555727|NCT00298597|Hematinics|hematinics|mesh-ancestor
138555728|NCT00298636|Adenosine|adenosine|mesh-list
138555729|NCT00298636|Analgesics|analgesics|mesh-ancestor
138555730|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
138555731|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555732|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555733|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138555734|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
138555735|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138555736|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
138555737|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
138555738|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555739|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555740|NCT00086112|Risperidone|risperidone|mesh-list
138555741|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138555742|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
138555743|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555744|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555745|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555746|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138555747|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138555748|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138555749|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138555750|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138555751|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
138555753|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138555754|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
138555755|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138555756|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138555757|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138555758|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138555759|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555760|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
138555761|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555762|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555763|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138555764|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138555765|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555766|NCT00298675|Irinotecan|irinotecan|mesh-list
138555767|NCT00298675|Iniparib|iniparib|mesh-list
138555768|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138555769|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138555770|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555771|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555772|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555773|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138555775|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138555776|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138555777|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138555778|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138555779|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555780|NCT00079508|Bivalirudin|bivalirudin|mesh-list
138555781|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
138555782|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138555783|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
138555784|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555785|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555786|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
138555787|NCT00298870|Isoniazid|isoniazid|mesh-list
138555788|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
138555789|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138555790|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555791|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138555792|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138555793|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
138555794|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555795|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138555796|NCT00298909|Niacin|niacin|mesh-list
138555797|NCT00298909|Niacinamide|niacinamide|mesh-list
138555798|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
138555799|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138555800|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
138555801|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555802|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138555803|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
138555804|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
138555805|NCT00298909|Vitamins|vitamins|mesh-ancestor
138555806|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
138555807|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555809|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138555810|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555811|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
138555812|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
138555813|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
138555814|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555815|NCT00299065|Zileuton|zileuton|mesh-list
138555816|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138555817|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138555818|NCT00299065|Analgesics|analgesics|mesh-ancestor
138555819|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
138555820|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555821|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555822|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138555823|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138555824|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138555825|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555826|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555827|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138555828|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
138555829|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138555830|NCT00079586|Heparin|heparin|mesh-list
138555831|NCT00079586|Bivalirudin|bivalirudin|mesh-list
138555832|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
138555834|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138555835|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555836|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
138555837|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138555838|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
138555839|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555840|NCT00418132|Thalidomide|thalidomide|mesh-list
138555841|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138555842|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
138555843|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555844|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
138555845|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138555846|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555847|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138555848|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138555849|NCT00418132|Growth Substances|growth substances|mesh-ancestor
138555850|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
138555851|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555852|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
138555853|NCT00119613|Hematinics|hematinics|mesh-ancestor
138555855|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
138555856|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138555857|NCT00299455|Amoxicillin|amoxicillin|mesh-list
138555858|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
138555859|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
138555860|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138555861|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138555862|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555863|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138555864|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555865|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555866|NCT00299572|Alendronate|alendronate|mesh-list
138555867|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138555868|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555869|NCT00299611|Levetiracetam|levetiracetam|mesh-list
138555870|NCT00299611|Sertraline|sertraline|mesh-list
138555871|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
138555872|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138555873|NCT00299611|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138555874|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138555875|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138555876|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555877|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555878|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
138555879|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555880|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
138555881|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
138555882|NCT00299650|Cisatracurium|cisatracurium|mesh-list
138555883|NCT00299650|Atracurium|atracurium|mesh-list
138555884|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138555885|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138555886|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555887|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555888|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138555889|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138555890|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138555891|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
138555892|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555893|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555894|NCT04727853|Irinotecan|irinotecan|mesh-list
138555895|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138555896|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138555897|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555898|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555899|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555900|NCT00299845|Lansoprazole|lansoprazole|mesh-list
138555901|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
138555902|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138555903|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138555904|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138555905|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555906|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555908|NCT00299884|Ezetimibe|ezetimibe|mesh-list
138555909|NCT00299884|Fenofibrate|fenofibrate|mesh-list
138555910|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138555911|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138555912|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
138555913|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138359297|NCT00356850|Azithromycin|azithromycin|mesh-list
138555914|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138555915|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138555916|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555917|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138555918|NCT00119652|Paroxetine|paroxetine|mesh-list
138555919|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
138555920|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138555921|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138555922|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138555923|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138555924|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555925|NCT00119652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138555926|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138555927|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138555928|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555929|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555930|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
138555931|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138555932|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138555933|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138555934|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555935|NCT00299923|Ribavirin|ribavirin|mesh-list
138555936|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138555937|NCT00299923|Amantadine|amantadine|mesh-list
138555938|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
138555939|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555940|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
138555941|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555942|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138555943|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138555944|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
138555945|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555946|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555947|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138555948|NCT00299923|Analgesics|analgesics|mesh-ancestor
138555949|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
138555950|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555951|NCT00299962|Interferons|interferons|mesh-list
138555952|NCT00299962|Interferon-beta|interferon-beta|mesh-list
138555953|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138555954|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
138555955|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138555956|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
138555957|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555959|NCT00418171|Ziprasidone|ziprasidone|mesh-list
138555960|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
138555961|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
138555962|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555963|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555964|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138555965|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138555966|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138555967|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138555968|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138555969|NCT00418171|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138555970|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138555971|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138555972|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555973|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138555974|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
138555975|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138555976|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138555977|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
138555978|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138555979|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
138555980|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555981|NCT00300040|Chrysarobin|chrysarobin|mesh-list
138555982|NCT00300040|HBOC 201|hboc 201|mesh-list
138555983|NCT00300040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138555984|NCT00300040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138555985|NCT00300040|Analgesics|analgesics|mesh-ancestor
138555986|NCT00300040|Sensory System Agents|sensory system agents|mesh-ancestor
138555987|NCT00300040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138555988|NCT00300040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555989|NCT00300040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138555990|NCT00300040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138555991|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
138555992|NCT00079820|Vaccines|vaccines|mesh-list
138555993|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
138555994|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138555995|NCT00300079|Brinzolamide|brinzolamide|mesh-list
138441369|NCT01789242|Hormones|hormones|mesh-ancestor
138555996|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138555997|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138555998|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138555999|NCT00300118|Budesonide|budesonide|mesh-list
138556000|NCT00300118|Mesalamine|mesalamine|mesh-list
138556001|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138556002|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138556003|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
138556004|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556005|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556006|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138556007|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
138556008|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
138556009|NCT00300118|Hormones|hormones|mesh-ancestor
138556010|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138556011|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138556012|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138556013|NCT00300118|Analgesics|analgesics|mesh-ancestor
138556014|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
138556015|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556016|NCT00119730|Rituximab|rituximab|mesh-list
138556017|NCT00119730|Fludarabine|fludarabine|mesh-list
138556018|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
138556019|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138556020|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556021|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
138556022|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556023|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556024|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556025|NCT00119730|Analgesics|analgesics|mesh-ancestor
138556026|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
138441383|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138556027|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556028|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138556029|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138556031|NCT00300196|Ancrod|ancrod|mesh-list
138556032|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
138287551|NCT00377546|Ketorolac|ketorolac|mesh-list
138556033|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138556034|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138556035|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556037|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138556038|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556039|NCT00300313|Escitalopram|escitalopram|mesh-list
138556040|NCT00300313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138556041|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138556042|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138556043|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556044|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556045|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
138556046|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556047|NCT00399659|Tegaserod|tegaserod|mesh-list
138556048|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138556049|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
138556050|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556051|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556052|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138359448|NCT00358488|Albuterol|albuterol|mesh-list
138556053|NCT00300352|Folic Acid|folic acid|mesh-list
138556054|NCT00300352|Hematinics|hematinics|mesh-ancestor
138556055|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
138556056|NCT00300352|Vitamins|vitamins|mesh-ancestor
138556057|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
138556058|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556059|NCT00300508|Anastrozole|anastrozole|mesh-list
138556060|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138556061|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556062|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138556063|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138441432|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
138556064|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556065|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556066|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138556067|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
138556068|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138556069|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556070|NCT00086463|Iloprost|iloprost|mesh-list
138556071|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138556072|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
138556073|NCT00079976|Tigecycline|tigecycline|mesh-list
138556074|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138556075|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556076|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138556077|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556078|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556079|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
138556080|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556081|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138556082|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556083|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138287624|NCT02973620|Simendan|simendan|mesh-list
138556084|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
138556085|NCT00086268|Carboplatin|carboplatin|mesh-list
138556086|NCT00086268|Docetaxel|docetaxel|mesh-list
138556087|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556088|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
138556089|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
138556090|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
138556091|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556092|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138556093|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556094|NCT00300586|Gemcitabine|gemcitabine|mesh-list
138556095|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138316352|NCT06138691|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138556096|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138556097|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
138556098|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556099|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556100|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138556101|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556102|NCT00086541|Interferons|interferons|mesh-list
138556103|NCT00086541|Ribavirin|ribavirin|mesh-list
138556104|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
138556105|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556106|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
138556107|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556108|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
138556109|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556110|NCT00300664|Hormones|hormones|mesh-list
138556111|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138556112|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556114|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138556115|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556116|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
138556117|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556118|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138556119|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
138556120|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
138359517|NCT00360048|Oxytocin|oxytocin|mesh-list
138556121|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
138556122|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138556123|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138556124|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556125|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556126|NCT04718233|Urological Agents|urological agents|mesh-ancestor
138556128|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138556129|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138556130|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556131|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
138556132|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556133|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556135|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
138556136|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
138556137|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556138|NCT00300937|Vitamins|vitamins|mesh-ancestor
138556139|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
138556140|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138556141|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
138556142|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556143|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556144|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138556145|NCT00418249|Protective Agents|protective agents|mesh-ancestor
138556146|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138556147|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138556148|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556149|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556150|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
138556151|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556153|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
138556154|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138556155|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
138556156|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138556157|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138556158|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556159|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138556160|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556161|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556162|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138556163|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
138556164|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556165|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138556166|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556167|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556169|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138556170|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138556171|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
138556172|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556173|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556174|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138556175|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
138556176|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
138556177|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138556178|NCT00301210|Tramadol|tramadol|mesh-list
138556179|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138556180|NCT00301210|Narcotics|narcotics|mesh-ancestor
138556181|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138556182|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556183|NCT00301210|Analgesics|analgesics|mesh-ancestor
138556184|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
138232526|NCT00365313|Celecoxib|celecoxib|mesh-list
138556185|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556187|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
138556188|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138556189|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138556190|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138556191|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138556192|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556193|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
138556194|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
138359592|NCT00362310|Indinavir|indinavir|mesh-list
138556195|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556196|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556197|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138556198|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138556200|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138556201|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138556202|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138556203|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138556204|NCT00301405|Thalidomide|thalidomide|mesh-list
138556205|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138556206|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
138556207|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556209|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138556210|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556211|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138441558|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138556212|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138556213|NCT00301405|Growth Substances|growth substances|mesh-ancestor
138556214|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
138556215|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556216|NCT00301483|Chrysarobin|chrysarobin|mesh-list
138556217|NCT00301483|HBOC 201|hboc 201|mesh-list
138316372|NCT06131905|Tocolytic Agents|tocolytic agents|mesh-ancestor
138556218|NCT00301483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138556219|NCT00301483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138556220|NCT00301483|Analgesics|analgesics|mesh-ancestor
138556221|NCT00301483|Sensory System Agents|sensory system agents|mesh-ancestor
138556222|NCT00301483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556223|NCT00301483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556224|NCT00301483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138556225|NCT00301483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556226|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
138556227|NCT00301522|Paclitaxel|paclitaxel|mesh-list
138556228|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138556229|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556230|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
138556231|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
138556232|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
138479979|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138556233|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556234|NCT00080405|Bortezomib|bortezomib|mesh-list
138556235|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556236|NCT00292123|Methadone|methadone|mesh-list
138556237|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138556238|NCT00292123|Narcotics|narcotics|mesh-ancestor
138556239|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138556240|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556241|NCT00292123|Analgesics|analgesics|mesh-ancestor
138556242|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
138556243|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556244|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
138556245|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
138556246|NCT00080444|Dexamethasone|dexamethasone|mesh-list
138556247|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
138556248|NCT00080444|Ondansetron|ondansetron|mesh-list
138556249|NCT00080444|Aprepitant|aprepitant|mesh-list
138556250|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
138556251|NCT00080444|BB 1101|bb 1101|mesh-list
138556252|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138316380|NCT06087328|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138316381|NCT06087328|Cholinergic Agents|cholinergic agents|mesh-ancestor
138316382|NCT06087328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316383|NCT06087328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138316384|NCT06078904|Colchicine|colchicine|mesh-list
138316385|NCT06078904|Gout Suppressants|gout suppressants|mesh-ancestor
138316386|NCT06078904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138316387|NCT06078904|Tubulin Modulators|tubulin modulators|mesh-ancestor
138316388|NCT06078904|Antimitotic Agents|antimitotic agents|mesh-ancestor
138316389|NCT06078904|Mitosis Modulators|mitosis modulators|mesh-ancestor
138316390|NCT06078904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556253|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
138556254|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
138441672|NCT01797718|Letrozole|letrozole|mesh-list
138556255|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556256|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556257|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138556258|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
138556259|NCT00080444|Hormones|hormones|mesh-ancestor
138556260|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138556261|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138556263|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
138173087|NCT03088358|Enoxaparin|enoxaparin|mesh-list
138556264|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556265|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556266|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
138556267|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
138556268|NCT00080444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138556269|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138556270|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
138556271|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556272|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138556273|NCT00086736|Eflornithine|eflornithine|mesh-list
138556274|NCT00086736|Bicalutamide|bicalutamide|mesh-list
138556275|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
138556276|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
138556277|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138556278|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556279|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556281|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138556282|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138556283|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138479980|NCT02044250|Analgesics|analgesics|mesh-ancestor
138556284|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138556285|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556286|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556287|NCT00292201|Atorvastatin|atorvastatin|mesh-list
138556288|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138556289|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138556290|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
138556291|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556292|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138556293|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138556294|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556295|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138556296|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138556297|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138556298|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138556299|NCT00080522|Ritonavir|ritonavir|mesh-list
138556300|NCT00080522|Lopinavir|lopinavir|mesh-list
138556301|NCT00080522|Lamivudine|lamivudine|mesh-list
138556302|NCT00080522|Zidovudine|zidovudine|mesh-list
138556303|NCT00080522|Didanosine|didanosine|mesh-list
138556304|NCT00080522|Stavudine|stavudine|mesh-list
138556305|NCT00080522|Efavirenz|efavirenz|mesh-list
138556306|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138316422|NCT06061809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556307|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138556308|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
138556309|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556310|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556312|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138556313|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
138556314|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556315|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138556316|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138556317|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138556318|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138556319|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
138556320|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138556321|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138556322|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138373596|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
138373597|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373598|NCT01425164|Carvedilol|carvedilol|mesh-list
138373599|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138556323|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138556324|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138556326|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
138556327|NCT00086775|Fludarabine|fludarabine|mesh-list
138556328|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
138556329|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138556330|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556331|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
138556332|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556333|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138232666|NCT01243112|Lidocaine|lidocaine|mesh-list
138556334|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138556335|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
138556336|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556337|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138556338|NCT00086892|Carboplatin|carboplatin|mesh-list
138556339|NCT00086892|Cetuximab|cetuximab|mesh-list
138556340|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556341|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138556342|NCT00292708|Cefmetazole|cefmetazole|mesh-list
138556343|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138556344|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556345|NCT00086931|Capecitabine|capecitabine|mesh-list
138556346|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
138556347|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138556348|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
138556349|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556350|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556351|NCT00292747|Ibuprofen|ibuprofen|mesh-list
138556352|NCT00292747|Drotaverin|drotaverin|mesh-list
138556353|NCT00292747|Papaverine|papaverine|mesh-list
138556354|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138556355|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138556356|NCT00292747|Analgesics|analgesics|mesh-ancestor
138556357|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
138556358|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556359|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556360|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138556361|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556362|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138556363|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556364|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556365|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
138556366|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
138556367|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
138556368|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138556369|NCT00292747|Urological Agents|urological agents|mesh-ancestor
138556370|NCT00120003|Candesartan|candesartan|mesh-list
138556371|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
138556372|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138556373|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138556374|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138288000|NCT03490916|Acetazolamide|acetazolamide|mesh-list
138556375|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556376|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
138556377|NCT00201721|Rituximab|rituximab|mesh-list
138556378|NCT00201721|Pentostatin|pentostatin|mesh-list
138556379|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138556380|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
138556381|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556382|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556383|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138556384|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
138556385|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556386|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556387|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138556388|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138556389|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138556390|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556391|NCT00201799|Infliximab|infliximab|mesh-list
138556392|NCT00201799|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138359804|NCT00368160|Eszopiclone|eszopiclone|mesh-list
138556393|NCT00201799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138556394|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
138556395|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138556396|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556398|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
138556399|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556400|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
138556401|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
138556402|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
138441843|NCT01800643|Busulfan|busulfan|mesh-list
138556403|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556404|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138556405|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556406|NCT00086970|Ifosfamide|ifosfamide|mesh-list
138556407|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138556408|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138556409|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
138556410|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556411|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556412|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556413|NCT00201955|Rebamipide|rebamipide|mesh-list
138556414|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138556415|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138556416|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
138556417|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556418|NCT00201955|Protective Agents|protective agents|mesh-ancestor
138556419|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556420|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556421|NCT00080795|Gemcitabine|gemcitabine|mesh-list
138556422|NCT00080795|Doxorubicin|doxorubicin|mesh-list
138556423|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138556425|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556426|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138556427|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
138556428|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556429|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138556430|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138556431|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138556432|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138173110|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
138173119|NCT00621179|Leuprolide|leuprolide|mesh-list
138556433|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138556434|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
138556435|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138556436|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138556437|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
138288084|NCT02367170|Midazolam|midazolam|mesh-list
138556438|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556440|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556441|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138556442|NCT00201994|Tolvaptan|tolvaptan|mesh-list
138556443|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138556444|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556445|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
138556446|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556447|NCT00120120|Lenalidomide|lenalidomide|mesh-list
138556448|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
138556449|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556450|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138556451|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138556452|NCT00120120|Growth Substances|growth substances|mesh-ancestor
138556453|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
138556454|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556455|NCT00202189|Budesonide|budesonide|mesh-list
138556456|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138556457|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138556458|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
138556459|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556460|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556461|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138556462|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
138556463|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
138556464|NCT00202189|Hormones|hormones|mesh-ancestor
138556465|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138556466|NCT00202228|Riboflavin|riboflavin|mesh-list
138556467|NCT00202228|Thiamine|thiamine|mesh-list
138556468|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
138556469|NCT00202228|Vitamins|vitamins|mesh-ancestor
138556470|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
138556471|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556472|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138556473|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
138556474|NCT00087009|Rituximab|rituximab|mesh-list
138556475|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138556476|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556477|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
138556478|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556479|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556480|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
138556481|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138316482|NCT05874141|Hormones|hormones|mesh-list
138556482|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556483|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138556484|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138556485|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556486|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556487|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556488|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
138556489|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
138556490|NCT00306358|Vitamins|vitamins|mesh-ancestor
138556491|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
138556492|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556493|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
138556494|NCT00306358|Hematinics|hematinics|mesh-ancestor
138556495|NCT00306397|Sirolimus|sirolimus|mesh-list
138556496|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138556497|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556498|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138556499|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556500|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
138556501|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138556502|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
138556503|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556504|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138556505|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
138556506|NCT00418600|Vitamins|vitamins|mesh-ancestor
138556507|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
138556508|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556509|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138556510|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138556511|NCT00087048|Topotecan|topotecan|mesh-list
138556512|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138556513|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138556514|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556515|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556516|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556517|NCT00080951|Leucovorin|leucovorin|mesh-list
138556518|NCT00080951|Fluorouracil|fluorouracil|mesh-list
138556519|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
138556520|NCT00080951|Irinotecan|irinotecan|mesh-list
138556521|NCT00080951|Calcium|calcium|mesh-list
138556522|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
138556523|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138556524|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556525|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
138556526|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556527|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138556528|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556529|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138556530|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
138556531|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138556532|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138556533|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556534|NCT00080951|Antidotes|antidotes|mesh-ancestor
138556535|NCT00080951|Protective Agents|protective agents|mesh-ancestor
138556536|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
138556537|NCT00080951|Vitamins|vitamins|mesh-ancestor
138556538|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
138556539|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
138556540|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138556541|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556542|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138556543|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
138556544|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138556545|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556546|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556547|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556548|NCT00301639|Methylphenidate|methylphenidate|mesh-list
138556549|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138556550|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556551|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138556552|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138556553|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138556554|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556555|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
138556556|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556557|NCT00087087|Pemetrexed|pemetrexed|mesh-list
138556558|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556559|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556560|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556561|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138556562|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138556563|NCT00301795|Rituximab|rituximab|mesh-list
138556564|NCT00301795|Oblimersen|oblimersen|mesh-list
138556565|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138556566|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556567|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
138556568|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556569|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556570|NCT00080990|Leucovorin|leucovorin|mesh-list
138556571|NCT00080990|Fluorouracil|fluorouracil|mesh-list
138556572|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
138556573|NCT00080990|Alvocidib|alvocidib|mesh-list
138556574|NCT00080990|Calcium|calcium|mesh-list
138556575|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
138556576|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138556577|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556578|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
138556579|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556580|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138556581|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556582|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138556583|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
138556584|NCT00080990|Antidotes|antidotes|mesh-ancestor
138556585|NCT00080990|Protective Agents|protective agents|mesh-ancestor
138556586|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
138556587|NCT00080990|Vitamins|vitamins|mesh-ancestor
138556588|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
138556589|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
138556590|NCT00080990|Growth Substances|growth substances|mesh-ancestor
138556591|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138556592|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556593|NCT00301912|Methotrexate|methotrexate|mesh-list
138556594|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
138556595|NCT00301912|Fludarabine|fludarabine|mesh-list
138556596|NCT00301912|Busulfan|busulfan|mesh-list
138556597|NCT00301912|Tacrolimus|tacrolimus|mesh-list
138556598|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138556599|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
138556600|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138556601|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556602|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138556603|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
138556604|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556605|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556606|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
138556607|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556608|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138556609|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138556610|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
138556611|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556612|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138556613|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138556614|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
138556615|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138556616|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138556617|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
138556619|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
138556620|NCT00301951|Busulfan|busulfan|mesh-list
138556621|NCT00301951|Tacrolimus|tacrolimus|mesh-list
138556622|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138556623|NCT00301951|Sargramostim|sargramostim|mesh-list
138556624|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556625|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138556626|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
138556627|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556628|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138556629|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
138556630|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556631|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138556632|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556633|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138556634|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138556635|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
138556636|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138556637|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556638|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
138556639|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138556640|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138556641|NCT00301990|Aldesleukin|aldesleukin|mesh-list
138556642|NCT00301990|Bevacizumab|bevacizumab|mesh-list
138556643|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138556644|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556645|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138556646|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138556647|NCT00301990|Growth Substances|growth substances|mesh-ancestor
138556648|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556649|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
138556650|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138556651|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138556652|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
138556653|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556654|NCT00120198|Rituximab|rituximab|mesh-list
138556655|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138556656|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556658|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556659|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556660|NCT00302224|Ketoconazole|ketoconazole|mesh-list
138556661|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
138556662|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556663|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138556664|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138556665|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556666|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556667|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138556668|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
138556669|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138556670|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556671|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138173188|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138173189|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
138556673|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138556674|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556675|NCT00087165|Prednisone|prednisone|mesh-list
138556677|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556678|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
138316519|NCT05824806|Viscosupplements|viscosupplements|mesh-ancestor
138556680|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
138556681|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556682|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138556683|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
138556684|NCT00087165|Hormones|hormones|mesh-ancestor
138556685|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138556686|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556687|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138556688|NCT00302341|Trimethoprim|trimethoprim|mesh-list
138556689|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138556690|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
138556691|NCT00302341|Pafuramidine|pafuramidine|mesh-list
138556692|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556693|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556694|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138556695|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556696|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
138556697|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138556698|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138556699|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138556700|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138556701|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138556702|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138556703|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138556704|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138556705|NCT00302419|Streptokinase|streptokinase|mesh-list
138556706|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138556707|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138556708|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556709|NCT00302497|Basiliximab|basiliximab|mesh-list
138556710|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138556711|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
138188351|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556712|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556713|NCT00081107|Epothilones|epothilones|mesh-list
138556714|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
138556715|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
138556716|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
138556717|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
138556718|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556719|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556721|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138556722|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
138556723|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556724|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138556725|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556726|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556727|NCT00081224|Celecoxib|celecoxib|mesh-list
138556728|NCT00081224|Capecitabine|capecitabine|mesh-list
138556729|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138556730|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
138556731|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556732|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556733|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138556734|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138556735|NCT00081224|Analgesics|analgesics|mesh-ancestor
138556736|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
138556737|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556738|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556739|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138556740|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556741|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138556742|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138556743|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556744|NCT00120237|Misoprostol|misoprostol|mesh-list
138556745|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138556746|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
138442259|NCT01804218|Nadolol|nadolol|mesh-list
138556747|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138556748|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556749|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138556750|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138556752|NCT00081302|Paclitaxel|paclitaxel|mesh-list
138556753|NCT00081302|Carboplatin|carboplatin|mesh-list
138556754|NCT00081302|Cetuximab|cetuximab|mesh-list
138556755|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138556756|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556757|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
138556758|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
138556759|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
138556760|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556761|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138556762|NCT00302653|Rasburicase|rasburicase|mesh-list
138556763|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
138556764|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556765|NCT00418288|Glucagon|glucagon|mesh-list
138556766|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138556767|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138556768|NCT00418288|Hormones|hormones|mesh-ancestor
138556769|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138556770|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556771|NCT00418288|Incretins|incretins|mesh-ancestor
138556772|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138556773|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556774|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138556775|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556776|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556778|NCT00087282|Alvocidib|alvocidib|mesh-list
138556779|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138556780|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138556781|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556782|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556783|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556784|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
138556785|NCT00087282|Growth Substances|growth substances|mesh-ancestor
138556786|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556787|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138556788|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138556789|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138556790|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556792|NCT00418366|Hormones|hormones|mesh-ancestor
138556793|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138556794|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138556795|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
138556796|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556797|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556798|NCT00120315|Esomeprazole|esomeprazole|mesh-list
138556799|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138556800|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138556801|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138556802|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556803|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556804|NCT00081380|Valproic Acid|valproic acid|mesh-list
138556805|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138556806|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
138556807|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
138556808|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138556809|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138556810|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138556811|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556812|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556813|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556814|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
138556815|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
138556816|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
138556817|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556818|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
138556819|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138556820|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138556821|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556822|NCT00302692|Metoprolol|metoprolol|mesh-list
138556824|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138556825|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138556826|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
138556827|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
138556828|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556829|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556830|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138173260|NCT05593653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173262|NCT05593653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556831|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138556832|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138556833|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
138556834|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138442294|NCT01804374|Everolimus|everolimus|mesh-list
138556835|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556836|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138556837|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
138556838|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138556839|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138556840|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138556841|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138556842|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556843|NCT00081536|Capecitabine|capecitabine|mesh-list
138556844|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138556845|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
138556846|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556847|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556849|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
138556850|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
138556851|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138556852|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138556853|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556854|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556855|NCT00303004|Urological Agents|urological agents|mesh-ancestor
138556856|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138556857|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138556858|NCT00081575|Levofloxacin|levofloxacin|mesh-list
138556859|NCT00081575|Tigecycline|tigecycline|mesh-list
138556860|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138556861|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556862|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138556863|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138556864|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138556865|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556866|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556867|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556868|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138556869|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138556870|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138556871|NCT00087399|Gabapentin|gabapentin|mesh-list
138556872|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
138556873|NCT00087399|Analgesics|analgesics|mesh-ancestor
138556874|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
138556875|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556876|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556877|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
138556878|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138556879|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138556880|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138556881|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138556882|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138556883|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138556884|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556885|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556886|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
138556888|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138556889|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138556890|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556891|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138556892|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138556893|NCT00081614|Growth Substances|growth substances|mesh-ancestor
138556894|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556895|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
138556896|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138556897|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556898|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556900|NCT00303277|Pravastatin|pravastatin|mesh-list
138556901|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138556902|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138556903|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
138556904|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556905|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138556906|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138556907|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556908|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138556909|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556910|NCT00303433|Memantine|memantine|mesh-list
138556911|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138556912|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138556913|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
138556914|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556915|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556916|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556917|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138556918|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138556919|NCT00303550|Linezolid|linezolid|mesh-list
138556920|NCT00303550|Iclaprim|iclaprim|mesh-list
138556921|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138556922|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556923|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138556924|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556925|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556926|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138556927|NCT00120354|Lamivudine|lamivudine|mesh-list
138556928|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138556929|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138556930|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556931|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556932|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
138556933|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556934|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138556935|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138556936|NCT00399698|Risperidone|risperidone|mesh-list
138556937|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138556938|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
138556939|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556940|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556941|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556942|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138556943|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138556944|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138556945|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138556946|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138556947|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
138556948|NCT00303589|Lactams|lactams|mesh-list
138556949|NCT00303589|beta-Lactams|beta-lactams|mesh-list
138556950|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138556951|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556953|NCT00081848|Celecoxib|celecoxib|mesh-list
138556954|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138556955|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138556956|NCT00081848|Analgesics|analgesics|mesh-ancestor
138556957|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
138556958|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556959|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556960|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138556961|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138556962|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138556963|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138556964|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138556965|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138288533|NCT00685880|Betamethasone|betamethasone|mesh-list
138556966|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138556967|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138556969|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138556971|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
138556972|NCT00120432|Tropicamide|tropicamide|mesh-list
138556973|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138556974|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
138556975|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
138556976|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138556977|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138556978|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
138556979|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138556980|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
138556981|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
138556982|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138556983|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138556984|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138556985|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
138556986|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138556987|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556988|NCT00120432|Protective Agents|protective agents|mesh-ancestor
138556989|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138556990|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138556991|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
138556992|NCT00303745|Capecitabine|capecitabine|mesh-list
138556993|NCT00303745|Irinotecan|irinotecan|mesh-list
138556994|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138556995|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
138556996|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138556997|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138556998|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138556999|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138557000|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557001|NCT00303784|Goserelin|goserelin|mesh-list
138557002|NCT00303784|Estradiol|estradiol|mesh-list
138557003|NCT00303784|Estrogens|estrogens|mesh-ancestor
138557004|NCT00303784|Hormones|hormones|mesh-ancestor
138557005|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557006|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557007|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138233347|NCT02991053|Ketamine|ketamine|mesh-list
138557008|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557009|NCT00081887|Clofarabine|clofarabine|mesh-list
138557010|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138557012|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557013|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557014|NCT00303940|Carboplatin|carboplatin|mesh-list
138557015|NCT00303940|Temozolomide|temozolomide|mesh-list
138557016|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557017|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138557018|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
138557019|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557020|NCT00304018|Prednisone|prednisone|mesh-list
138557021|NCT00304018|Fludarabine|fludarabine|mesh-list
138557022|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
138557024|NCT00304018|Busulfan|busulfan|mesh-list
138557025|NCT00304018|Tacrolimus|tacrolimus|mesh-list
138557026|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138557027|NCT00304018|Sargramostim|sargramostim|mesh-list
138557028|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138557029|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
138557030|NCT00304018|Hormones|hormones|mesh-ancestor
138557031|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557032|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557033|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138557034|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557035|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138557036|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
138557037|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557038|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138557039|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
138557040|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138557041|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138557042|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138557043|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557044|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138557045|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
138557046|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138557047|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138557048|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
138557049|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557050|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138288608|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
138557051|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557052|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557054|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
138557055|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557056|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138557057|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
138557058|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557060|NCT00304213|Androgens|androgens|mesh-ancestor
138557061|NCT00304213|Hormones|hormones|mesh-ancestor
138557062|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557063|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557064|NCT00304252|Interferons|interferons|mesh-list
138557065|NCT00304252|Interferon-beta|interferon-beta|mesh-list
138557066|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
138557067|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557068|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
138557069|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557070|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
138557071|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557072|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138557074|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
138557075|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557076|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138557077|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138557078|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557079|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557080|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138557081|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138557082|NCT00082043|Dutasteride|dutasteride|mesh-list
138557083|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138557084|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138557085|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557086|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557087|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
138557088|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557089|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138288638|NCT00634322|Leucovorin|leucovorin|mesh-list
138557090|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
138557091|NCT00304291|Analgesics|analgesics|mesh-ancestor
138557092|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
138557093|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557094|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557095|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557096|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138557097|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138557098|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557099|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557100|NCT00304369|Metronidazole|metronidazole|mesh-list
138557101|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557102|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138557103|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138557104|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138557105|NCT00082082|Thymalfasin|thymalfasin|mesh-list
138557106|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138557107|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
138557108|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557109|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
138173336|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138557110|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138557111|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557112|NCT00304447|Immunotoxins|immunotoxins|mesh-ancestor
138557113|NCT00304447|Immunoconjugates|immunoconjugates|mesh-ancestor
138557114|NCT00304447|Immunologic Factors|immunologic factors|mesh-ancestor
138557115|NCT00304447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557116|NCT00087711|Gemcitabine|gemcitabine|mesh-list
138557117|NCT00087711|Pemetrexed|pemetrexed|mesh-list
138557118|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557119|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138557120|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
138557121|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557122|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557123|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138557124|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138557125|NCT00304642|Dapivirine|dapivirine|mesh-list
138557126|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138557127|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138557128|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
138557129|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557130|NCT00304681|Methylphenidate|methylphenidate|mesh-list
138557131|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138557132|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557133|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138557134|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138557135|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138557136|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557137|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
138557138|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557139|NCT00304720|Tacrolimus|tacrolimus|mesh-list
138557140|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138557141|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
138557142|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138316565|NCT05757063|Anesthetics|anesthetics|mesh-ancestor
138557143|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138557144|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557145|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557147|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
138557148|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138557149|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138557150|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138557151|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138557152|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557153|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
138557154|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
138557155|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557156|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557157|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138557158|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138557159|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
138557160|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138557161|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138557162|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138557163|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138557165|NCT00120510|Zidovudine|zidovudine|mesh-list
138557166|NCT00120510|Efavirenz|efavirenz|mesh-list
138557167|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138557168|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138557169|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138557170|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557171|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173381|NCT00737737|Analgesics|analgesics|mesh-ancestor
138557172|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
138557173|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557174|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138557175|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138557176|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
138557177|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138557178|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138557179|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138557180|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138557181|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138557182|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138557183|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138557184|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
138557185|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138557186|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138557187|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138557188|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138557189|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557190|NCT00304993|Niacin|niacin|mesh-list
138557191|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
138557192|NCT00304993|Fenofibrate|fenofibrate|mesh-list
138557193|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138557194|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557195|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138557196|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
138557197|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557198|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138557199|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
138557200|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
138557201|NCT00304993|Vitamins|vitamins|mesh-ancestor
138557202|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
138557203|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
138557204|NCT00082277|Anastrozole|anastrozole|mesh-list
138557205|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138557206|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557207|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138557208|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138557209|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557210|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557211|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138288735|NCT03642457|Bupivacaine|bupivacaine|mesh-list
138557212|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
138557213|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557214|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557215|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138557216|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138557217|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138557218|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138557220|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
138557221|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557223|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
138557224|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
138557225|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
138173391|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138557226|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557227|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557228|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138557229|NCT00305383|Taribavirin|taribavirin|mesh-list
138557230|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
138557231|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557232|NCT00305422|Risperidone|risperidone|mesh-list
138557233|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138233593|NCT04351412|Fluorides|fluorides|mesh-list
138557234|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138557235|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
138557236|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557237|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557238|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557239|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138557240|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138557241|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138557242|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138557243|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138557244|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
138557245|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
138557246|NCT00305461|Ciclesonide|ciclesonide|mesh-list
138557247|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
138557248|NCT00305461|Hormones|hormones|mesh-ancestor
138557249|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557250|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557251|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138442560|NCT01808911|Rituximab|rituximab|mesh-list
138374152|NCT01425840|Lidocaine|lidocaine|mesh-list
138374153|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
138374154|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
138557253|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138557254|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138557255|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138557256|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
138557257|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557258|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557259|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138557260|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138557261|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
138557262|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557263|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138557264|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138557265|NCT00305500|Escitalopram|escitalopram|mesh-list
138557266|NCT00305500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138557267|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138557268|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138557269|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557270|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557271|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
138557272|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557273|NCT00305539|Adalimumab|adalimumab|mesh-list
138557274|NCT00305539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138557275|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138557276|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138557277|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
138557278|NCT00305734|Gemcitabine|gemcitabine|mesh-list
138557279|NCT00305734|Bortezomib|bortezomib|mesh-list
138557280|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138557281|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
138557282|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557283|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557284|NCT00082472|Docetaxel|docetaxel|mesh-list
138557285|NCT00082472|Doxorubicin|doxorubicin|mesh-list
138557286|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138557287|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557288|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
138557289|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
138557290|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
138557291|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557292|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138557293|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138557294|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138557295|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557297|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557298|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138557299|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138557300|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
138557301|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557302|NCT00306046|Diphosphonates|diphosphonates|mesh-list
138557303|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138557304|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557305|NCT00306124|Levodopa|levodopa|mesh-list
138557306|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138557307|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138233638|NCT01323140|Testosterone|testosterone|mesh-list
138557309|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557310|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557311|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557312|NCT00082589|Eplerenone|eplerenone|mesh-list
138557313|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138557314|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
138557315|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557316|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557317|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138557318|NCT00082589|Diuretics|diuretics|mesh-ancestor
138557319|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
138557320|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138557321|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138360745|NCT02992392|Dextrans|dextrans|mesh-list
138557322|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138557323|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138557324|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
138557325|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557326|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557327|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557328|NCT00313924|Urological Agents|urological agents|mesh-ancestor
138557329|NCT00306475|Valproic Acid|valproic acid|mesh-list
138557330|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
138557331|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557332|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557333|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
138557334|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557335|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557336|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
138557337|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138557338|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138557340|NCT00082667|Gefitinib|gefitinib|mesh-list
138442621|NCT01809444|Prednisone|prednisone|mesh-list
138557341|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557342|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138557343|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557344|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557345|NCT00306748|Linaclotide|linaclotide|mesh-list
138557346|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138557347|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
138557348|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557349|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138557351|NCT00082784|Alvocidib|alvocidib|mesh-list
138557352|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557353|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
138557354|NCT00082784|Growth Substances|growth substances|mesh-ancestor
138557355|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557356|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138557357|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557358|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557359|NCT00306826|Pioglitazone|pioglitazone|mesh-list
138557360|NCT00306826|Simvastatin|simvastatin|mesh-list
138557361|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138557362|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138557363|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
138557364|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442640|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
138557365|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138557366|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138557367|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557368|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138557369|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557370|NCT00082823|Aflibercept|aflibercept|mesh-list
138557371|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138557372|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138557373|NCT00082823|Growth Substances|growth substances|mesh-ancestor
138557374|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557375|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
138557376|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557377|NCT00087945|Lamivudine|lamivudine|mesh-list
138557378|NCT00087945|Zidovudine|zidovudine|mesh-list
138557380|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
138557381|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138557382|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138557383|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557384|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557385|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
138557386|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557387|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138557388|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138557389|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
138557390|NCT00082862|Interferons|interferons|mesh-list
138557391|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
138557392|NCT00082862|Gemcitabine|gemcitabine|mesh-list
138557393|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557394|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138557395|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
138557396|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557397|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
138557398|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557399|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
138557400|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557401|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138557402|NCT00307099|Meropenem|meropenem|mesh-list
138557403|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557404|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
138557405|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557406|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138557407|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
138557408|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
138557409|NCT00307177|Vaccines|vaccines|mesh-list
138557410|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
138557411|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557412|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
138557413|NCT00120705|Hematinics|hematinics|mesh-ancestor
138557414|NCT00307255|Paclitaxel|paclitaxel|mesh-list
138557415|NCT00307255|Gemcitabine|gemcitabine|mesh-list
138557416|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138557417|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138557418|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557419|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
138557420|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
138557421|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
138557422|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557423|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138557424|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
138557425|NCT00307411|Hormones|hormones|mesh-list
138557426|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557427|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557428|NCT00307450|Levetiracetam|levetiracetam|mesh-list
138557429|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
138557430|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
138557431|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138557432|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
138557433|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557434|NCT00120744|Ondansetron|ondansetron|mesh-list
138557435|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
138557436|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
138557437|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557438|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557439|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138557440|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
138557441|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
138557442|NCT00120744|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138557443|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138557444|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
138557445|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557446|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557447|NCT00083057|Paclitaxel|paclitaxel|mesh-list
138557448|NCT00083057|Gefitinib|gefitinib|mesh-list
138557449|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138442742|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
138557450|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557451|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
138557452|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
138233790|NCT05167643|Anastrozole|anastrozole|mesh-list
138557453|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
138557454|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557455|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138557456|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557457|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
138557458|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138557459|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138557460|NCT00307606|Prednisolone|prednisolone|mesh-list
138557461|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
138557462|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138557463|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
138557464|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138557465|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
138557466|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
138557467|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557468|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557469|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138557470|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
138557471|NCT00307606|Hormones|hormones|mesh-ancestor
138557472|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557473|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138557474|NCT00307606|Protective Agents|protective agents|mesh-ancestor
138557475|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138557476|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557477|NCT00083096|Temozolomide|temozolomide|mesh-list
138557478|NCT00083096|Lonafarnib|lonafarnib|mesh-list
138557479|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138557480|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
138557481|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557482|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557483|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557484|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
138557485|NCT00307645|Prednisone|prednisone|mesh-list
138557486|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
138557487|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
138557488|NCT00307645|Azathioprine|azathioprine|mesh-list
138557489|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138557490|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
138557491|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557492|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138557493|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138557494|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
138557495|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557496|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557497|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138557498|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138557499|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
138557500|NCT00307645|Hormones|hormones|mesh-ancestor
138479981|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
138557501|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557502|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138557503|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138557504|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138557505|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
138557506|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138557507|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557508|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557509|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
138557510|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
138557511|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557512|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138557513|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138557514|NCT00307645|Protective Agents|protective agents|mesh-ancestor
138557515|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
138557516|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138557517|NCT00120783|Ritonavir|ritonavir|mesh-list
138557518|NCT00120783|Indinavir|indinavir|mesh-list
138557519|NCT00120783|Lamivudine|lamivudine|mesh-list
138557520|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138557521|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138557522|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
138557523|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557524|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557525|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138557526|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138557527|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
138557528|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557529|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138557530|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138173482|NCT00632411|Nicotine|nicotine|mesh-list
138557531|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138557532|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138557533|NCT00307723|Bevacizumab|bevacizumab|mesh-list
138557534|NCT00307723|Gemcitabine|gemcitabine|mesh-list
138557535|NCT00307723|Fluorouracil|fluorouracil|mesh-list
138557536|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
138557537|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138557538|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557539|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138557540|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138557541|NCT00307723|Growth Substances|growth substances|mesh-ancestor
138557542|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557543|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
138557544|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138557545|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
138557546|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557547|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138557548|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
138557549|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138557550|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557551|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557552|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557553|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138557554|NCT00120822|Folic Acid|folic acid|mesh-list
138557555|NCT00120822|Hematinics|hematinics|mesh-ancestor
138557556|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
138557557|NCT00120822|Vitamins|vitamins|mesh-ancestor
138557558|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
138557559|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557560|NCT00083213|Aflibercept|aflibercept|mesh-list
138557561|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138557562|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138557563|NCT00083213|Growth Substances|growth substances|mesh-ancestor
138557564|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557565|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
138557566|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557567|NCT00307996|Ubiquinone|ubiquinone|mesh-list
138557568|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
138557569|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
138442854|NCT01811160|Melatonin|melatonin|mesh-list
138557570|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557571|NCT00307996|Vitamins|vitamins|mesh-ancestor
138557572|NCT00083252|Cisplatin|cisplatin|mesh-list
138557573|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557574|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
138557575|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138557576|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557577|NCT00418678|Nabilone|nabilone|mesh-list
138557578|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
138557579|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
138557580|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557581|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557582|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138557583|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138557584|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138557585|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138557586|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138289060|NCT03909763|Danazol|danazol|mesh-list
138557587|NCT00120861|Interferons|interferons|mesh-list
138557588|NCT00120861|Ribavirin|ribavirin|mesh-list
138557589|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557590|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
138557591|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557592|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
138557593|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557594|NCT05446142|Rabeprazole|rabeprazole|mesh-list
138557595|NCT05446142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138557596|NCT05446142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138557597|NCT05446142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138557599|NCT05446142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557600|NCT00308191|Bromides|bromides|mesh-list
138557601|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
138557602|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
138557603|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138557604|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
138557605|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557606|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557607|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138557608|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
138557609|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138557610|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138557611|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138557612|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
138557613|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702103|NCT05424393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138557614|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557616|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138557617|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
138557618|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
138557620|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
138557621|NCT00308269|Hematinics|hematinics|mesh-ancestor
138557622|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
138557623|NCT00308269|Vitamins|vitamins|mesh-ancestor
138557624|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
138557625|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557626|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557627|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
138557628|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
138557629|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
138557630|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557631|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
138557633|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138557634|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557635|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138557636|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
138557637|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138557638|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557639|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557640|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557641|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138557642|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138557643|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138557645|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138557646|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138557647|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557648|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138557649|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138557650|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
138557651|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557652|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557653|NCT00308542|Dexamethasone|dexamethasone|mesh-list
138557654|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138557655|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
138557656|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
138557657|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557658|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557659|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138557660|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
138557661|NCT00308542|Hormones|hormones|mesh-ancestor
138557662|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557663|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138557664|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557665|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
138557666|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138557667|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138557668|NCT00083408|Pamidronate|pamidronate|mesh-list
138557669|NCT00083408|Thalidomide|thalidomide|mesh-list
138557670|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138557671|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
138557672|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557673|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
138557674|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138557675|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557676|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138557677|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138557678|NCT00083408|Growth Substances|growth substances|mesh-ancestor
138557679|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
138557680|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557681|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138557682|NCT00308971|Vitamin E|vitamin e|mesh-list
138557683|NCT00308971|Tocopherols|tocopherols|mesh-list
138234065|NCT01267136|Tramadol|tramadol|mesh-list
138557684|NCT00308971|Tocotrienols|tocotrienols|mesh-list
138557685|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
138557686|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
138557687|NCT00308971|Vitamins|vitamins|mesh-ancestor
138557688|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
138557689|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442934|NCT01811836|Zinc|zinc|mesh-list
138557690|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
138557691|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138289096|NCT00448682|Antidotes|antidotes|mesh-ancestor
138557692|NCT00308971|Protective Agents|protective agents|mesh-ancestor
138557693|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
138557694|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
138557695|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557696|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138557697|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
138557699|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
138557700|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
138557701|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
138316619|NCT05628363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557702|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557704|NCT00309088|Tacrolimus|tacrolimus|mesh-list
138557705|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138557706|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
138557707|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557708|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138557709|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557710|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557711|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
138557712|NCT00083486|Hematinics|hematinics|mesh-ancestor
138557713|NCT00120978|Fluticasone|fluticasone|mesh-list
138557714|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138557715|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
138557716|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557717|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557718|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138557719|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
138557720|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138557721|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
138557722|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138557723|NCT00309205|Dapivirine|dapivirine|mesh-list
138557724|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138557725|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138557726|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
138702104|NCT05424393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138557727|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557728|NCT00309283|Somatostatin|somatostatin|mesh-list
138557729|NCT00309283|Hormones|hormones|mesh-ancestor
138557730|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557731|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557732|NCT00083525|Capecitabine|capecitabine|mesh-list
138557733|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138557735|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557736|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557737|NCT00309322|Phentolamine|phentolamine|mesh-list
138557738|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138557739|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138557740|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
138557741|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557742|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557743|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557744|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138557745|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138557746|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138557747|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138557748|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138557749|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557750|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557751|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557753|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
138557754|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557755|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
138557756|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138557757|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
138557758|NCT00309361|Phentolamine|phentolamine|mesh-list
138557759|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138557760|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138557761|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
138557762|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316620|NCT05626322|Lenalidomide|lenalidomide|mesh-list
138557763|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557764|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557765|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138557767|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
138557768|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
138557769|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443015|NCT01812356|Analgesics|analgesics|mesh-ancestor
138557770|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557771|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138557772|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138557773|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138557774|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138557775|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138557776|NCT00088491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138557777|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138557778|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138557779|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557780|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557781|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
138557783|NCT00309517|Edrecolomab|edrecolomab|mesh-list
138557784|NCT00309517|Antidotes|antidotes|mesh-ancestor
138557785|NCT00309517|Protective Agents|protective agents|mesh-ancestor
138557786|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557787|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
138557788|NCT00309517|Vitamins|vitamins|mesh-ancestor
138557789|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
138557790|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138557791|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
138557793|NCT00121017|Lopinavir|lopinavir|mesh-list
138557794|NCT00121017|Tenofovir|tenofovir|mesh-list
138361249|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361250|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138361251|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
138361252|NCT00241644|Vaccines|vaccines|mesh-list
138361253|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
138361254|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557795|NCT00121017|Emtricitabine|emtricitabine|mesh-list
138557796|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138557797|NCT00121017|Efavirenz|efavirenz|mesh-list
138557799|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138557800|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
138557801|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557802|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557803|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138557804|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138557805|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
138557806|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557807|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138557808|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138557809|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138557810|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138557811|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138557812|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138361290|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557813|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138557814|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138557815|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138557816|NCT00309556|Docetaxel|docetaxel|mesh-list
138557817|NCT00309556|Capecitabine|capecitabine|mesh-list
138557818|NCT00309556|Trastuzumab|trastuzumab|mesh-list
138557819|NCT00309556|Epirubicin|epirubicin|mesh-list
138557820|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361295|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138361297|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
138557821|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
138557822|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
138557823|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
138557824|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557825|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138557826|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
138557827|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138361304|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
138557828|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138557829|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138557830|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138557831|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557832|NCT00402207|Fluticasone|fluticasone|mesh-list
138557833|NCT00402207|Beclomethasone|beclomethasone|mesh-list
138557834|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138316633|NCT05590325|Dolutegravir|dolutegravir|mesh-list
138361311|NCT03801252|Azithromycin|azithromycin|mesh-list
138557835|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138557836|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
138557837|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557838|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557839|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138557840|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
138557841|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
138557842|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138557843|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
138557844|NCT00402207|Hormones|hormones|mesh-ancestor
138557845|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557846|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138361313|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138557847|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
138557848|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557849|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557850|NCT00309634|Vaccines|vaccines|mesh-list
138557851|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
138557852|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557853|NCT00309712|Simvastatin|simvastatin|mesh-list
138557854|NCT00309712|Fenofibrate|fenofibrate|mesh-list
138557855|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138361318|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361319|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138361320|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361321|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557856|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138557857|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
138557858|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557859|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138557860|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138557861|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557862|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138557863|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138557865|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
138557866|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138557867|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138361325|NCT05742750|Apatinib|apatinib|mesh-list
138557868|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557869|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557871|NCT00418873|Risperidone|risperidone|mesh-list
138557872|NCT00418873|Zotepine|zotepine|mesh-list
138557873|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138557874|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
138557875|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557876|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557877|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557878|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138557879|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138361328|NCT05742750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557880|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138557881|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138557882|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138557883|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
138557884|NCT00088608|Pasireotide|pasireotide|mesh-list
138557885|NCT00088608|Hormones|hormones|mesh-ancestor
138557886|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557887|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557888|NCT00310024|Bortezomib|bortezomib|mesh-list
138557889|NCT00310024|Vorinostat|vorinostat|mesh-list
138557890|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557891|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138557892|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557893|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557894|NCT00310141|Nicotine|nicotine|mesh-list
138557895|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138557896|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
138557897|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557898|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557899|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138557900|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138557901|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
138361334|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138361335|NCT04581408|Ivacaftor|ivacaftor|mesh-list
138557902|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138557903|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557905|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
138557906|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
138557908|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557909|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557910|NCT00083681|Thalidomide|thalidomide|mesh-list
138557911|NCT00083681|Dexamethasone|dexamethasone|mesh-list
138557912|NCT00083681|Etoposide|etoposide|mesh-list
138557913|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
138557914|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138557915|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
138557916|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
138557917|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557918|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557919|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138557920|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
138557921|NCT00083681|Hormones|hormones|mesh-ancestor
138557922|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557923|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138557924|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557925|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138173609|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
138361339|NCT04295772|Islatravir|islatravir|mesh-list
138557926|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138557927|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138557928|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138557929|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557930|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138557931|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
138557932|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138557933|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138557934|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
138361341|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557935|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138557936|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
138557937|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138557938|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557939|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138557940|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138557941|NCT00083681|Growth Substances|growth substances|mesh-ancestor
138557942|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
138557944|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
138557945|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557946|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
138557947|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
138453793|NCT01887379|Diuretics|diuretics|mesh-ancestor
138557949|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557950|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138557951|NCT00121095|Analgesics|analgesics|mesh-ancestor
138557952|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
138557953|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557954|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557955|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
138557956|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138557957|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557958|NCT00310336|Interferons|interferons|mesh-list
138557959|NCT00310336|Ribavirin|ribavirin|mesh-list
138557960|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
138557961|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
138557962|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138557964|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557965|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
138557966|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138557967|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
138557968|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138557969|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
138557970|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557971|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138557972|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
138557973|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138557974|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138557975|NCT05568602|Dexamethasone|dexamethasone|mesh-list
138557976|NCT05568602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138557977|NCT05568602|Antiemetics|antiemetics|mesh-ancestor
138557978|NCT05568602|Autonomic Agents|autonomic agents|mesh-ancestor
138557979|NCT05568602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138557980|NCT05568602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557981|NCT05568602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138557982|NCT05568602|Glucocorticoids|glucocorticoids|mesh-ancestor
138557983|NCT05568602|Hormones|hormones|mesh-ancestor
138557984|NCT05568602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557985|NCT05568602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138557986|NCT05568602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138557987|NCT00310492|Immunomodulating Agents|immunomodulating agents|mesh-list
138557988|NCT00310492|Immunologic Factors|immunologic factors|mesh-ancestor
138557989|NCT00310492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557990|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138557992|NCT00310531|Estrogens|estrogens|mesh-ancestor
138557993|NCT00310531|Hormones|hormones|mesh-ancestor
138557994|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138557995|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361368|NCT03467256|Glucocorticoids|glucocorticoids|mesh-ancestor
138557996|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138557997|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
138173620|NCT05315336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138557998|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138557999|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138558000|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138558002|NCT00309673|Prilocaine|prilocaine|mesh-list
138361371|NCT03467256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138558003|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138558004|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
138558005|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
138558006|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138558007|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558008|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
138558009|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558010|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138361380|NCT03265080|Pembrolizumab|pembrolizumab|mesh-list
138558011|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138558012|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138558013|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138558014|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558015|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138558016|NCT00310843|Nevirapine|nevirapine|mesh-list
138558017|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138558018|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138558019|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558020|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558022|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138558023|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138558024|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138558025|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138558026|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138558027|NCT00310921|Misoprostol|misoprostol|mesh-list
138558028|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138558029|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
138558030|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138361385|NCT05313282|Apatinib|apatinib|mesh-list
138558031|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558032|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138558033|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138558034|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
138558035|NCT05568212|Durvalumab|durvalumab|mesh-list
138558036|NCT05568212|Olaparib|olaparib|mesh-list
138558037|NCT05568212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138558038|NCT05568212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558039|NCT05568212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138558040|NCT05568212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558041|NCT05568212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558042|NCT00121329|Lidocaine|lidocaine|mesh-list
138558043|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
138558044|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
138558045|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138558046|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558047|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
138558048|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558049|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138558050|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138558051|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138558052|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138558053|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558054|NCT00311038|Landiolol|landiolol|mesh-list
138173627|NCT04746495|Diuretics|diuretics|mesh-ancestor
138558055|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138558056|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138443171|NCT01813318|Acamprosate|acamprosate|mesh-list
138558057|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
138558058|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558059|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558060|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558061|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138558062|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
138558063|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138558064|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558066|NCT00311116|Vitamins|vitamins|mesh-ancestor
138558067|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
138558068|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558069|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
138558070|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361394|NCT05311722|Tramadol|tramadol|mesh-list
138558071|NCT00311116|Protective Agents|protective agents|mesh-ancestor
138558072|NCT00088959|Celecoxib|celecoxib|mesh-list
138558073|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138558074|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558075|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138558076|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558077|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558078|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138558079|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138558080|NCT00088959|Analgesics|analgesics|mesh-ancestor
138558081|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
138558082|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558083|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558084|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138558085|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138558086|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138558087|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138558088|NCT05568017|Edotreotide|edotreotide|mesh-list
138558089|NCT05568017|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138443208|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
138558090|NCT05568017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558091|NCT00311389|Timolol|timolol|mesh-list
138558092|NCT00311389|Travoprost|travoprost|mesh-list
138558093|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138558094|NCT00311389|Latanoprost|latanoprost|mesh-list
138558095|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138558096|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558097|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138558098|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138558099|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
138558100|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558101|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558102|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138558103|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138558104|NCT00088998|Bevacizumab|bevacizumab|mesh-list
138558105|NCT00088998|Docetaxel|docetaxel|mesh-list
138558106|NCT00088998|Capecitabine|capecitabine|mesh-list
138558107|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138558108|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173638|NCT03286634|Cytarabine|cytarabine|mesh-list
138558109|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138558110|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138558111|NCT00088998|Growth Substances|growth substances|mesh-ancestor
138558112|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558113|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
138558114|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
138558115|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
138558116|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
138558117|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558118|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138558119|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
138558120|NCT00311467|Interferons|interferons|mesh-list
138558121|NCT00311467|Capecitabine|capecitabine|mesh-list
138558122|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138558123|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
138558124|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558125|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558126|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
138558127|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138558128|NCT00311545|Siltuximab|siltuximab|mesh-list
138558129|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558130|NCT00089037|Sirolimus|sirolimus|mesh-list
138558131|NCT00089037|Methotrexate|methotrexate|mesh-list
138558132|NCT00089037|Tacrolimus|tacrolimus|mesh-list
138558133|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138558134|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
138558135|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138558136|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558137|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138558138|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
138558139|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558140|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558141|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
138558142|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361420|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558143|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138558144|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138558145|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
138558146|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138558147|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138558148|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138558149|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138558150|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138558151|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138558152|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
138558153|NCT00311740|Valsartan|valsartan|mesh-list
138558154|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138558155|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138558156|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138558157|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138558158|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558159|NCT00311740|Diuretics|diuretics|mesh-ancestor
138558160|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
138558161|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361422|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138558162|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138558163|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138558164|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
138558165|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138558166|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558167|NCT00121407|Verteporfin|verteporfin|mesh-list
138558168|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138558169|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
138558171|NCT00311857|Temozolomide|temozolomide|mesh-list
138558172|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138558173|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558174|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138558175|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
138558176|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558178|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
138558179|NCT00121446|Enoxaparin|enoxaparin|mesh-list
138558180|NCT00121446|Tenecteplase|tenecteplase|mesh-list
138558181|NCT00121446|Clopidogrel|clopidogrel|mesh-list
138558182|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138558184|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138558185|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138558186|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
138558187|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558188|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558189|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558190|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
138558191|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138558192|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138558193|NCT00311974|Dihydralazine|dihydralazine|mesh-list
138558194|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138558195|NCT00312013|Nadroparin|nadroparin|mesh-list
138558196|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
138558197|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138558198|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138558199|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558200|NCT00121524|Atropine|atropine|mesh-list
138558201|NCT00121524|Amiodarone|amiodarone|mesh-list
138558202|NCT00121524|Epinephrine|epinephrine|mesh-list
138558203|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138558204|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138558205|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
138558206|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558207|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361427|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138558208|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443315|NCT01814059|Sirolimus|sirolimus|mesh-list
138558209|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138558210|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138558211|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
138558212|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558213|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138558214|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
138558216|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
138558217|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138558218|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138558219|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138558220|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
138558221|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138558222|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138558223|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
138558224|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
138558225|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138558226|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138558227|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138558228|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138558229|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138558230|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361432|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138558231|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138558232|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138558233|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138558234|NCT00312130|Vildagliptin|vildagliptin|mesh-list
138558235|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138558236|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558237|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138558238|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
138558239|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558240|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558241|NCT00089115|Rituximab|rituximab|mesh-list
138361433|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558243|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138558244|NCT00089115|Antibodies|antibodies|mesh-list
138558245|NCT00089115|Sargramostim|sargramostim|mesh-list
138558246|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138558247|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138558248|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558249|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
138558250|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558251|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138558252|NCT00312325|Prednisolone|prednisolone|mesh-list
138361437|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
138558253|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138558254|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
138558255|NCT00312325|Hormones|hormones|mesh-ancestor
138558256|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138558257|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558258|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138558259|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558260|NCT05567471|Vaccines|vaccines|mesh-list
138558261|NCT05567471|Immunologic Factors|immunologic factors|mesh-ancestor
138558262|NCT05567471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558263|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138558264|NCT00089154|Antibodies|antibodies|mesh-list
138558265|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
138558266|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138558267|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
138558268|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558269|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558270|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
138558271|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
138558272|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
138558273|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138558274|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558275|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
138558276|NCT00312481|Protective Agents|protective agents|mesh-ancestor
138558277|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558278|NCT00312481|Vitamins|vitamins|mesh-ancestor
138558279|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
138558280|NCT00312481|Cathartics|cathartics|mesh-ancestor
138558281|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138558282|NCT00312481|Laxatives|laxatives|mesh-ancestor
138361452|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
138558283|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
138558284|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138558285|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138558286|NCT00312520|Prednisolone|prednisolone|mesh-list
138234611|NCT01817855|AZD7624|azd7624|mesh-list
138558287|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
138558288|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138558289|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
138558290|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138558291|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
138558292|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
138558293|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558294|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454109|NCT01888757|Lamotrigine|lamotrigine|mesh-list
138361455|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138558295|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138558296|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
138558297|NCT00312520|Hormones|hormones|mesh-ancestor
138558298|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138558299|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138558300|NCT00312520|Protective Agents|protective agents|mesh-ancestor
138558301|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138173685|NCT04998032|Metformin|metformin|mesh-list
138558302|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558303|NCT00089193|Sargramostim|sargramostim|mesh-list
138558304|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
138558305|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
138558306|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558307|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138558308|NCT00293098|Deferiprone|deferiprone|mesh-list
138558309|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138558310|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
138361463|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
138558311|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
138558312|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558313|NCT00293176|Donepezil|donepezil|mesh-list
138558314|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138558315|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558316|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558317|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
138558318|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558319|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558321|NCT00121563|Thalidomide|thalidomide|mesh-list
138558322|NCT00121563|Ibuprofen|ibuprofen|mesh-list
138558323|NCT00121563|Diazepam|diazepam|mesh-list
138558324|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138558325|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138558326|NCT00121563|Analgesics|analgesics|mesh-ancestor
138558327|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
138558328|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558329|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558330|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138558331|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138558332|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138558333|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558334|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558335|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138558336|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
138558337|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
138558338|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138558339|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361469|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138558340|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138558341|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138558342|NCT00121563|Growth Substances|growth substances|mesh-ancestor
138558343|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
138558344|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558345|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138558346|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
138558347|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
138558348|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
138558349|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138558350|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138558351|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138558352|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138558353|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138558354|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138558355|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138558356|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138558357|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138558358|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
138558359|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
138558360|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
138234685|NCT01389284|Analgesics|analgesics|mesh-ancestor
138558361|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
138558362|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558364|NCT00293332|Carboplatin|carboplatin|mesh-list
138558365|NCT00293332|Docetaxel|docetaxel|mesh-list
138558366|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138558367|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558368|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138558369|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138558370|NCT00293332|Growth Substances|growth substances|mesh-ancestor
138558371|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558372|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
138558373|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
138558374|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
138558375|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
138558376|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558378|NCT00293371|Docetaxel|docetaxel|mesh-list
138558379|NCT00293371|Vatalanib|vatalanib|mesh-list
138558380|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558381|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
138558382|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
138558383|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
138558384|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558385|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138558386|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
138558387|NCT00293371|Hormones|hormones|mesh-ancestor
138558388|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138558389|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558390|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138558391|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138558393|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
138558394|NCT00293410|Clofarabine|clofarabine|mesh-list
138558395|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138558396|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
138558397|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558398|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138558399|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138558400|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
138558401|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558402|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361481|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138558403|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138558404|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138558405|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
138558406|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
138558407|NCT00121602|Hematinics|hematinics|mesh-ancestor
138558408|NCT00293527|Interferons|interferons|mesh-list
138558409|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
138558410|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
138558411|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558412|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
138558413|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138558414|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
138558415|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558416|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
138558417|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
138558418|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
138558419|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558421|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138558422|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138558423|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
138558424|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
138558425|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558426|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558427|NCT00293761|Travoprost|travoprost|mesh-list
138558428|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138558429|NCT00293800|Timolol|timolol|mesh-list
138558430|NCT00293800|Travoprost|travoprost|mesh-list
138558431|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138558432|NCT00293800|Latanoprost|latanoprost|mesh-list
138558433|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138558434|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138361488|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138558435|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138234757|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
138558436|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
138558437|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138173700|NCT04388033|Growth Substances|growth substances|mesh-ancestor
138558438|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558439|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558440|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138361497|NCT03216564|Calcitriol|calcitriol|mesh-list
138361498|NCT03216564|Vitamins|vitamins|mesh-ancestor
138558441|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138558442|NCT00423969|Galantamine|galantamine|mesh-list
138558443|NCT00423969|Escitalopram|escitalopram|mesh-list
138558444|NCT00423969|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138558445|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138558446|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138558447|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558448|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558449|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
138558450|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558451|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
138558452|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558453|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
138558454|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138558455|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558456|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138558457|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
138558458|NCT00293839|Oxybutynin|oxybutynin|mesh-list
138558459|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
138558460|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
138558461|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558462|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558463|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138558464|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138558465|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
138558466|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558467|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558468|NCT00293839|Urological Agents|urological agents|mesh-ancestor
138558470|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138558471|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
138558472|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558473|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138558474|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558475|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558476|NCT05567081|Triamcinolone|triamcinolone|mesh-list
138558477|NCT05567081|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138558478|NCT05567081|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138558479|NCT05567081|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138558480|NCT05567081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138558481|NCT05567081|Glucocorticoids|glucocorticoids|mesh-ancestor
138558482|NCT05567081|Hormones|hormones|mesh-ancestor
138558483|NCT05567081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138558484|NCT05567081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558485|NCT05567081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361509|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
138558486|NCT05567081|Immunologic Factors|immunologic factors|mesh-ancestor
138558487|NCT05567081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558488|NCT05567081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558489|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
138558490|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138558491|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
138558492|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138558493|NCT00417898|Aspirin|aspirin|mesh-list
138558494|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138558495|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138558496|NCT00417898|Analgesics|analgesics|mesh-ancestor
138558497|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
138558498|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361511|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558499|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558500|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138558501|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138558502|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138558503|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138558504|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558505|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138454291|NCT01889680|Vitamins|vitamins|mesh-ancestor
138454292|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
138558506|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138558507|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558508|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
138558509|NCT00294190|Topotecan|topotecan|mesh-list
138558510|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138558511|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138558512|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558513|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558514|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558515|NCT02960503|Azithromycin|azithromycin|mesh-list
138558516|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138558517|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138558518|NCT00294385|Gemcitabine|gemcitabine|mesh-list
138558519|NCT00294385|Docetaxel|docetaxel|mesh-list
138558520|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138558521|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
138558522|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558523|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558524|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
138558525|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
138558526|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
138558527|NCT00294463|Tibolone|tibolone|mesh-list
138558528|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138558529|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138558530|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138558531|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
138558532|NCT00294463|Estradiol|estradiol|mesh-list
138558533|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138558534|NCT00294463|Progesterone|progesterone|mesh-list
138558535|NCT00294463|Estrogens|estrogens|mesh-ancestor
138558536|NCT00294463|Hormones|hormones|mesh-ancestor
138558537|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138558538|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558539|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138361520|NCT03214770|Calcium|calcium|mesh-list
138558540|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
138558541|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138558542|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138558543|NCT00294463|Progestins|progestins|mesh-ancestor
138558544|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
138558545|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
138558546|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138558547|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138558548|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558549|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138558550|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
138558551|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138558552|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138558553|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138558554|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138558555|NCT00294502|Minocycline|minocycline|mesh-list
138558556|NCT00294502|Gentamicins|gentamicins|mesh-list
138558557|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558558|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138443581|NCT01815203|Caffeine|caffeine|mesh-list
138558559|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138173716|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
138361522|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173718|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
138558560|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138558561|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558562|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138558564|NCT00089349|Methotrexate|methotrexate|mesh-list
138558565|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
138558566|NCT00089349|Antibodies|antibodies|mesh-list
138558567|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
138558568|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138558569|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
138558570|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558571|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558572|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138558573|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
138558574|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138558575|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138558576|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
138558577|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558578|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
138558579|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558580|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138558581|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138558582|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138558583|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138558584|NCT00294619|Hormones|hormones|mesh-list
138558585|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138558586|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234906|NCT01412372|Mesalamine|mesalamine|mesh-list
138558587|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138558588|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558589|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138558590|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558591|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558592|NCT00294775|Candesartan|candesartan|mesh-list
138558593|NCT00294775|Candesartan cilexetil|candesartan cilexetil|mesh-list
138558594|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138558595|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138558596|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138558597|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361535|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
138558598|NCT00121680|Lenvatinib|lenvatinib|mesh-list
138558599|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558600|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138558601|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558602|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558603|NCT00294853|Calcium|calcium|mesh-list
138558604|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138558605|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558606|NCT00294892|Nevirapine|nevirapine|mesh-list
138558607|NCT00294892|Carbamazepine|carbamazepine|mesh-list
138558608|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138558609|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138558610|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558611|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558612|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
138558613|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138558614|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138558615|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138558616|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138558617|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138558618|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
138558619|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
138558620|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138558621|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138558622|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558623|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138558624|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138558625|NCT00294892|Analgesics|analgesics|mesh-ancestor
138558626|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
138558627|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558628|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138558629|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138558630|NCT00089427|Temozolomide|temozolomide|mesh-list
138558631|NCT00089427|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
138558632|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138558633|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
138558634|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558635|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558636|NCT00294931|Bevacizumab|bevacizumab|mesh-list
138558637|NCT00294931|Carboplatin|carboplatin|mesh-list
138558638|NCT00294931|Irinotecan|irinotecan|mesh-list
138558639|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138361540|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
138558640|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558641|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138558642|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138558643|NCT00294931|Growth Substances|growth substances|mesh-ancestor
138558644|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558645|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
138558646|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138558647|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138558648|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558649|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558650|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
138558651|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138558652|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
138558653|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558654|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558655|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558656|NCT00295165|Sargramostim|sargramostim|mesh-list
138558657|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
138558658|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558659|NCT00295243|Topotecan|topotecan|mesh-list
138558660|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138558661|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138558662|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558663|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558664|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558665|NCT00295282|Antibodies|antibodies|mesh-list
138558666|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138558667|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
138558668|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558669|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138558670|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138558671|NCT00089622|Levodopa|levodopa|mesh-list
138558672|NCT00089622|Lisuride|lisuride|mesh-list
138558673|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138361548|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138558674|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138558675|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
138558676|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558677|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558678|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558679|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138558681|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
138558682|NCT00295555|Doxazosin|doxazosin|mesh-list
138558683|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138558684|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138558685|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138558686|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138173753|NCT00638651|Imiquimod|imiquimod|mesh-list
138558687|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
138558688|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558689|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558690|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558691|NCT00295594|Tacrolimus|tacrolimus|mesh-list
138558692|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138558693|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
138558694|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558695|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138558696|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361552|NCT03211728|Analgesics|analgesics|mesh-ancestor
138361553|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
138290192|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290193|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
138290194|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138290195|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290196|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290197|NCT00002018|Interferons|interferons|mesh-list
138290198|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
138290199|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138290200|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
138290201|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290203|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290204|NCT00002024|Ganciclovir|ganciclovir|mesh-list
138290205|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138290206|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
138290207|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290208|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290209|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290210|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290211|NCT00001106|Zidovudine|zidovudine|mesh-list
138290212|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
138290213|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290215|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290217|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
138290218|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290219|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290220|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290221|NCT00000344|Buprenorphine|buprenorphine|mesh-list
138290222|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138290223|NCT00000344|Naloxone|naloxone|mesh-list
138290226|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138290228|NCT00000344|Analgesics|analgesics|mesh-ancestor
138290229|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
138290230|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290231|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138290232|NCT04103515|Cimetidine|cimetidine|mesh-list
138290233|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138290234|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138290235|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138290236|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
138290237|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
138290238|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290239|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290240|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290241|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138290242|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138290243|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290244|NCT00002030|Pentamidine|pentamidine|mesh-list
138290245|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
138290246|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290247|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138290248|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138290249|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138290250|NCT00001112|Interferons|interferons|mesh-list
138290251|NCT00001112|Zidovudine|zidovudine|mesh-list
138290252|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
138290253|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138290254|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
138290255|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290256|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
138290257|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290259|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138558697|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558698|NCT00121875|Hormones|hormones|mesh-list
138558699|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138558700|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558701|NCT00295672|Vinorelbine|vinorelbine|mesh-list
138558702|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138558703|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558704|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
138558705|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
138558706|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
138558707|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558708|NCT00295789|Paclitaxel|paclitaxel|mesh-list
138558709|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138558710|NCT00295789|Carboplatin|carboplatin|mesh-list
138558711|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138558712|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558713|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
138558714|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
138558715|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
138290260|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290261|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290262|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290263|NCT00002036|Immune Sera|immune sera|mesh-list
138290264|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
138290265|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290266|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138290267|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138290268|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138290269|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138290270|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138290271|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138290272|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138290273|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
138290274|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290275|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290276|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290277|NCT00000374|Olanzapine|olanzapine|mesh-list
138290278|NCT00000374|Risperidone|risperidone|mesh-list
138290279|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138290280|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
138290281|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290282|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290283|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290284|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138290285|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138290286|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138290289|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
138290290|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
138290291|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
138290292|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290293|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138290296|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138290299|NCT03789175|Niacinamide|niacinamide|mesh-list
138290300|NCT03789175|Niacin|niacin|mesh-list
138290301|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
138290302|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
138290303|NCT03789175|Vitamins|vitamins|mesh-ancestor
138290304|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
138290305|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290306|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138290307|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
138290308|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290309|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138290310|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
138290311|NCT00002048|Zidovudine|zidovudine|mesh-list
138290312|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
138290313|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290314|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290315|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290316|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290318|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290319|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290320|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290321|NCT00002054|Pentamidine|pentamidine|mesh-list
138290322|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
138290323|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290324|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138290325|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138290326|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138290327|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
138290328|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138290329|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
138290330|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290331|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
138290332|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290333|NCT00002066|Thymopentin|thymopentin|mesh-list
138290334|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138558716|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558717|NCT00089700|Ibalizumab|ibalizumab|mesh-list
138558718|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138558719|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138558720|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
138558721|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138558722|NCT04718584|Antibodies|antibodies|mesh-list
138558723|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138558724|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
138558725|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558726|NCT00417937|Azelaic acid|azelaic acid|mesh-list
138361564|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138361565|NCT03211572|Tamoxifen|tamoxifen|mesh-list
138558727|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558728|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
138558729|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138558730|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
138558731|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
138558732|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
138558733|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138558734|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
138558735|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558736|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138361569|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138558737|NCT00295945|Fentanyl|fentanyl|mesh-list
138558738|NCT00295945|Hydromorphone|hydromorphone|mesh-list
138558739|NCT00295945|Ropivacaine|ropivacaine|mesh-list
138558740|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
138558741|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
138558742|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138443688|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
138558743|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558744|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
138558745|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558746|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138558747|NCT00295945|Narcotics|narcotics|mesh-ancestor
138558749|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138558750|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138558751|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
138558752|NCT00121914|Ethanol|ethanol|mesh-list
138558753|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138558754|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138558755|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138558756|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558757|NCT00295984|Nicotine|nicotine|mesh-list
138558758|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138558759|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
138558760|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558761|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361579|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558762|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138558763|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138558764|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
138558765|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558766|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558767|NCT00296023|Methotrexate|methotrexate|mesh-list
138558768|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
138558769|NCT00296023|Fludarabine|fludarabine|mesh-list
138558770|NCT00296023|Busulfan|busulfan|mesh-list
138558771|NCT00296023|Tacrolimus|tacrolimus|mesh-list
138558772|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138454398|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
138558773|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138558774|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
138558775|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138558776|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558777|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138558778|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
138558779|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558780|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558781|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
138558782|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558783|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138558784|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138558785|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
138558786|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138558787|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138558788|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138558789|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
138558790|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138558791|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138558792|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
138361581|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138558793|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138558794|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558795|NCT00296062|Bevacizumab|bevacizumab|mesh-list
138558796|NCT00296062|Capecitabine|capecitabine|mesh-list
138558797|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
138558798|NCT00296062|Irinotecan|irinotecan|mesh-list
138558799|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138558800|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558801|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138558802|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138558803|NCT00296062|Growth Substances|growth substances|mesh-ancestor
138558804|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558805|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
138558806|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138558807|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
138558808|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361583|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558809|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138558810|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138558811|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558814|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138558815|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138558816|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558817|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138558818|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
138558819|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
138558820|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558821|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558822|NCT00296218|Irbesartan|irbesartan|mesh-list
138558823|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138558824|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138558825|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138558826|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558828|NCT00089856|Docetaxel|docetaxel|mesh-list
138558829|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138558830|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
138558831|NCT00089856|Hormones|hormones|mesh-ancestor
138558832|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138558833|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558834|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138558835|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558836|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
138558837|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
138558838|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
138558839|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558840|NCT00296257|Rimacalib|rimacalib|mesh-list
138443728|NCT01816555|Vitamin D|vitamin d|mesh-list
138558841|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138558842|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558843|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558844|NCT00296530|Fluticasone|fluticasone|mesh-list
138558845|NCT00296530|Xhance|xhance|mesh-list
138558846|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138558847|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138361589|NCT03211104|Analgesics|analgesics|mesh-ancestor
138558848|NCT00296530|Montelukast|montelukast|mesh-list
138558849|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138558850|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138558851|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
138558852|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558853|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558854|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138558855|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
138558856|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
138558857|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138558858|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138290335|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
138290336|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290338|NCT00002072|Hematinics|hematinics|mesh-ancestor
138290339|NCT00002078|Interferons|interferons|mesh-list
138290340|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
138290341|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138290342|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
138290343|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290344|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
138290345|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290347|NCT00000440|Sertraline|sertraline|mesh-list
138290348|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138290349|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138290350|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290351|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
138290352|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290353|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
138290354|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138290355|NCT00000440|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138290356|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138290357|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138290358|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290359|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290360|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
138290361|NCT00002084|Valacyclovir|valacyclovir|mesh-list
138290362|NCT00002084|Acyclovir|acyclovir|mesh-list
138290363|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
138290365|NCT00000446|Sertraline|sertraline|mesh-list
138290366|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
138290367|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138290368|NCT00000446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138290369|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138290370|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138290371|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290372|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138290373|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
138290374|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290375|NCT04131517|Padsevonil|padsevonil|mesh-list
138290376|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138290377|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138290378|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138290379|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
138290380|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138290381|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290382|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138290383|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138290384|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138290385|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138290386|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138290387|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138290388|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138290389|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138290390|NCT04131517|Anticonvulsants|anticonvulsants|mesh-ancestor
138290391|NCT00001256|Prednisone|prednisone|mesh-list
138290392|NCT00001256|Methotrexate|methotrexate|mesh-list
138290393|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138290394|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
138290395|NCT00001256|Hormones|hormones|mesh-ancestor
138290396|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138290397|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558859|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138558860|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138558861|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
138558862|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558863|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558864|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138558865|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
138558866|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138558867|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138361590|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
138558868|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138558869|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
138558870|NCT00296530|Hormones|hormones|mesh-ancestor
138558871|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
138173790|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138173795|NCT00686231|Lidocaine|lidocaine|mesh-list
138558872|NCT00090012|Olanzapine|olanzapine|mesh-list
138558873|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138558874|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
138558875|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
138361591|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558876|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558877|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558878|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138558879|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138558881|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138558882|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138558883|NCT00090012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138558884|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138235234|NCT02724033|Hormones|hormones|mesh-ancestor
138558885|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138558886|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558887|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558888|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
138558889|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
138558890|NCT00296608|Leucovorin|leucovorin|mesh-list
138558891|NCT00296608|Fluorouracil|fluorouracil|mesh-list
138558892|NCT00296608|Calcium|calcium|mesh-list
138558893|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
138558894|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138558895|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558896|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
138558897|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558898|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138558899|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558900|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138558901|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
138558902|NCT00296608|Antidotes|antidotes|mesh-ancestor
138558903|NCT00296608|Protective Agents|protective agents|mesh-ancestor
138558904|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
138558905|NCT00296608|Vitamins|vitamins|mesh-ancestor
138558906|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
138558907|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
138558908|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
138558909|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138558910|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558911|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138558912|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138558913|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138558914|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558915|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
138558916|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558917|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
138558918|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138558919|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138558920|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558921|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138558922|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138558923|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138558924|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138454473|NCT01896622|Ritonavir|ritonavir|mesh-list
138558925|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
138558926|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138558927|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138558928|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138558929|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138558930|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558931|NCT00296803|Clopidogrel|clopidogrel|mesh-list
138558932|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138558933|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138558934|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138558935|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138558936|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
138558937|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558938|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361609|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138558939|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558940|NCT00090090|Elsamicin A|elsamicin a|mesh-list
138558942|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138558944|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
138558945|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138558946|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558947|NCT00297076|Aplaviroc|aplaviroc|mesh-list
138558948|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138558949|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138558950|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558951|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138558952|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138558953|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
138558954|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138558955|NCT00297349|Topiramate|topiramate|mesh-list
138558956|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
138558957|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138558958|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558959|NCT00297388|Risperidone|risperidone|mesh-list
138558960|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138558961|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
138558962|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558963|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558964|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558965|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138558966|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138558967|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138558968|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138558969|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138558970|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
138558972|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138558973|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
138558974|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138558975|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558976|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138558977|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138558978|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
138558979|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558980|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558981|NCT00297505|Citalopram|citalopram|mesh-list
138558982|NCT00297505|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138558983|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138558984|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138558985|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138558986|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138558987|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
138558988|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138558989|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138558990|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
138558991|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138173818|NCT03335540|Ipilimumab|ipilimumab|mesh-list
138558992|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
138558993|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
138558994|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138558995|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138558996|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138558997|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361615|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138558998|NCT00297544|Urological Agents|urological agents|mesh-ancestor
138558999|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
138559000|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138559001|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559002|NCT00297661|Sirolimus|sirolimus|mesh-list
138559003|NCT00297661|Paclitaxel|paclitaxel|mesh-list
138559004|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138559005|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559006|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
138559007|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
138559008|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
138559009|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559010|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138361618|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138559011|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559012|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138559013|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
138559014|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138559015|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
138559016|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559017|NCT00090207|Ondansetron|ondansetron|mesh-list
138559019|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
138559020|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
138559021|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559022|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559023|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138559024|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
138559025|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
138454524|NCT01899105|Ivacaftor|ivacaftor|mesh-list
138454528|NCT01900015|Efavirenz|efavirenz|mesh-list
138559026|NCT00090207|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138559027|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138559028|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
138559029|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559030|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361623|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
138559031|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138559032|NCT00297739|Risperidone|risperidone|mesh-list
138559033|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138559034|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
138559035|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559036|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559037|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559038|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138361626|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138361627|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138361628|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
138361629|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
138361630|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138361631|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361632|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559039|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138559040|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138559041|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138559042|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138559043|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
138559044|NCT00090246|Ondansetron|ondansetron|mesh-list
138559046|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
138559047|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
138559048|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559049|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361634|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138361635|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361636|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361638|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138559050|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138559051|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
138559052|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
138559053|NCT00090246|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138559054|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138559056|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559057|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559058|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138559059|NCT00297817|Vaccines|vaccines|mesh-list
138559060|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
138559061|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559062|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138559063|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
138559064|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138559065|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138559066|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138559067|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138559068|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559069|NCT00122226|Ritonavir|ritonavir|mesh-list
138559070|NCT00122226|Lopinavir|lopinavir|mesh-list
138559071|NCT00122226|Lamivudine|lamivudine|mesh-list
138559072|NCT00122226|Zidovudine|zidovudine|mesh-list
138559073|NCT00122226|Nevirapine|nevirapine|mesh-list
138559074|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138559075|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138559076|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
138559077|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559078|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559079|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138559080|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138559081|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
138559082|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559083|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138559084|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138316736|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
138559085|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138559086|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138559087|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
138559088|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138559089|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138559091|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138559092|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
138559093|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138559094|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559095|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138559096|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
138559097|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559098|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361652|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138559099|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
138559100|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559101|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138559102|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138559103|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
138559104|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138559105|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138559106|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
138559107|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138235438|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
138559108|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
138559109|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559110|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138559111|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559112|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
138559113|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559114|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
138559115|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138361662|NCT01833312|Narcotics|narcotics|mesh-ancestor
138559116|NCT00298168|Protective Agents|protective agents|mesh-ancestor
138559117|NCT00122304|Eculizumab|eculizumab|mesh-list
138559118|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138559119|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138559120|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
138559121|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559122|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
138559123|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138559124|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138559125|NCT00322543|Analgesics|analgesics|mesh-ancestor
138361670|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
138559126|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
138559127|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559128|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559129|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138559130|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138559131|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
138559132|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138361673|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138361674|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138361675|NCT01834014|Growth Substances|growth substances|mesh-ancestor
138361676|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361677|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
138559133|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
138559134|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138559135|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559136|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559137|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
138559138|NCT00313963|Analgesics|analgesics|mesh-ancestor
138559139|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
138559140|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361680|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138559141|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559142|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
138559143|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138559144|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138559145|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
138559146|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138559147|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138559148|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559149|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138559150|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
138361688|NCT01835184|Vemurafenib|vemurafenib|mesh-list
138559151|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138559152|NCT00122343|Sirolimus|sirolimus|mesh-list
138559153|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138559154|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559155|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138559156|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138173845|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138559157|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
138559158|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138559159|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
138559160|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559161|NCT00314080|Antitoxins|antitoxins|mesh-list
138559162|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
138559163|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
138361699|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
138559164|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559165|NCT00314158|Timolol|timolol|mesh-list
138559166|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138559167|NCT00314158|Brinzolamide|brinzolamide|mesh-list
138559168|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138559169|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138559170|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138559171|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
138559172|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559173|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559174|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559175|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138559176|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138559177|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138559178|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559179|NCT00090480|Vaccines|vaccines|mesh-list
138559180|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
138559181|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361715|NCT01836900|Hemostatics|hemostatics|mesh-list
138361716|NCT01836900|Coagulants|coagulants|mesh-ancestor
138361717|NCT01837992|Primaquine|primaquine|mesh-list
138361718|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
138361719|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138361720|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138361721|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138361722|NCT01838460|Lobeline|lobeline|mesh-list
138361723|NCT01838460|Nicotine|nicotine|mesh-list
138559182|NCT00322660|Epinephrine|epinephrine|mesh-list
138559183|NCT00322660|Racepinephrine|racepinephrine|mesh-list
138559185|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138559186|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138559187|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
138559188|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559189|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559190|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361724|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138559191|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138559192|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138559193|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
138559194|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559195|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138559196|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
138559197|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
138559198|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
138361731|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361732|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361733|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
138361735|NCT01838538|Bevacizumab|bevacizumab|mesh-list
138361736|NCT01838538|Carboplatin|carboplatin|mesh-list
138559199|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138559200|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138559201|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
138559202|NCT00322699|Trioxsalen|trioxsalen|mesh-list
138559203|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559204|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
138559205|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138559206|NCT00322972|Azithromycin|azithromycin|mesh-list
138559207|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138361739|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
138361740|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
138559208|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559209|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
138559210|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
138559211|NCT00323011|Leucovorin|leucovorin|mesh-list
138559212|NCT00323011|Folic Acid|folic acid|mesh-list
138559213|NCT00323011|Bevacizumab|bevacizumab|mesh-list
138559215|NCT00323011|Irinotecan|irinotecan|mesh-list
138559216|NCT00323011|Dalteparin|dalteparin|mesh-list
138559217|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
138361747|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559218|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138559219|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559220|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138559221|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138559222|NCT00323011|Growth Substances|growth substances|mesh-ancestor
138559223|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559224|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
138559225|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
138361755|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559226|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559227|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138559229|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
138559230|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138559231|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138559232|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559233|NCT00323011|Antidotes|antidotes|mesh-ancestor
138559234|NCT00323011|Protective Agents|protective agents|mesh-ancestor
138361762|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361763|NCT01839084|Isoflurane|isoflurane|mesh-list
138559235|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
138559237|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
138559238|NCT00323011|Hematinics|hematinics|mesh-ancestor
138559239|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
138559240|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138559241|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138559242|NCT00323206|Interleukin-12|interleukin-12|mesh-list
138559243|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138559244|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
138361771|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
138361772|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138361773|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
138559245|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559246|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138559247|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138559248|NCT00323206|Growth Substances|growth substances|mesh-ancestor
138559249|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
138559250|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559251|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
138559252|NCT04717531|Docetaxel|docetaxel|mesh-list
138559253|NCT04717531|Trastuzumab|trastuzumab|mesh-list
138559254|NCT04717531|Epirubicin|epirubicin|mesh-list
138559255|NCT04717531|Pertuzumab|pertuzumab|mesh-list
138559256|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138559257|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
138559258|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138454653|NCT01900509|Hormones|hormones|mesh-ancestor
138559259|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138559260|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138559261|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
138559262|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559263|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559264|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138361779|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
138559265|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
138559266|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
138559267|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
138559268|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138559269|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138559270|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138559271|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138559272|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559273|NCT00323323|Prednisone|prednisone|mesh-list
138361784|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361785|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138559274|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
138559275|NCT00323323|Doxorubicin|doxorubicin|mesh-list
138559276|NCT00323323|Vincristine|vincristine|mesh-list
138559277|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
138559278|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138559279|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
138559280|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559281|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138559282|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138559283|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
138559284|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559285|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559286|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138559287|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138559288|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138559289|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138559290|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559291|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138559292|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
138559293|NCT00323323|Hormones|hormones|mesh-ancestor
138559294|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138559295|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138361797|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
138361798|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
138361799|NCT01839630|Sorafenib|sorafenib|mesh-list
138361800|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361801|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138361802|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361804|NCT01839864|Chrysarobin|chrysarobin|mesh-list
138559296|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138559297|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
138559298|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
138559299|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
138559300|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138559301|NCT00122499|Tadalafil|tadalafil|mesh-list
138559302|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
138559303|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138559304|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138559305|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559306|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559307|NCT00122499|Urological Agents|urological agents|mesh-ancestor
138559308|NCT00312598|Aripiprazole|aripiprazole|mesh-list
138454696|NCT01900717|Leucovorin|leucovorin|mesh-list
138559309|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
138559310|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138559311|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138361811|NCT01839864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138361813|NCT01834248|Poly I-C|poly i-c|mesh-list
138559312|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138559313|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138559314|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559315|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
138559316|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
138559317|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559318|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361820|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559319|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138559320|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138559321|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
138559322|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138559323|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138559324|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138559325|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138559326|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138361824|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361825|NCT01834248|Laxatives|laxatives|mesh-ancestor
138361826|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138559327|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138559328|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138559329|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
138559330|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559331|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559332|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138559333|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138559334|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
138559335|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559336|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
138559337|NCT00312871|Hematinics|hematinics|mesh-ancestor
138559338|NCT00090675|Gefitinib|gefitinib|mesh-list
138559339|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559340|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138559341|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559342|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559343|NCT00312988|Gemcitabine|gemcitabine|mesh-list
138559344|NCT00312988|Topotecan|topotecan|mesh-list
138559345|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138559346|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
138361840|NCT01836432|Folfirinox|folfirinox|mesh-list
138361841|NCT01836432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138290398|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138290399|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138290400|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138290401|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
138290402|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138290403|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138290404|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
138290406|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
138290407|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138290408|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138290409|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138290410|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
138290411|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138290412|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138290414|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138290415|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138290416|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290417|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
138290418|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290420|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
138290421|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138290422|NCT00000458|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138290423|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138290424|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138290425|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290427|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
138290431|NCT03782233|Rocuronium|rocuronium|mesh-list
138290432|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
138290433|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138290434|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138290435|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138290436|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138290437|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290438|NCT00002090|Azithromycin|azithromycin|mesh-list
138290439|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138290440|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290441|NCT00002096|Zidovudine|zidovudine|mesh-list
138290442|NCT00002096|Didanosine|didanosine|mesh-list
138290443|NCT00002096|Ganciclovir|ganciclovir|mesh-list
138290444|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138290445|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
138290446|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138290447|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138290450|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
138290451|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290452|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138290453|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138290455|NCT00002102|Trimetrexate|trimetrexate|mesh-list
138290456|NCT00002102|Calcium|calcium|mesh-list
138290457|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
138290458|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138290459|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138290460|NCT00002102|Antidotes|antidotes|mesh-ancestor
138290461|NCT00002102|Protective Agents|protective agents|mesh-ancestor
138290462|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
138290463|NCT00002102|Vitamins|vitamins|mesh-ancestor
138290464|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
138290465|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
138290466|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138290467|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138290468|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
138290469|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559347|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559348|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559349|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138559350|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138559351|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559352|NCT00122538|Lamivudine|lamivudine|mesh-list
138559353|NCT00122538|Efavirenz|efavirenz|mesh-list
138559354|NCT00122538|Didanosine|didanosine|mesh-list
138559355|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138559356|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138559357|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559358|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559359|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
138559360|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559361|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138559362|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138361858|NCT01836432|Vitamins|vitamins|mesh-ancestor
138559363|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138559364|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138559365|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138559366|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138559367|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138559368|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138361863|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
138361864|NCT01720056|Hormones|hormones|mesh-ancestor
138361866|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559369|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
138559370|NCT00313105|Lobeline|lobeline|mesh-list
138559371|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138559372|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
138559373|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559374|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559375|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138559376|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138361870|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138361871|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138361872|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361873|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138559377|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
138316768|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
138559378|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559379|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559380|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
138559381|NCT00313183|Pramlintide|pramlintide|mesh-list
138559382|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138361884|NCT01720290|Metformin|metformin|mesh-list
138559383|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559384|NCT06003270|Quercetin|quercetin|mesh-list
138559385|NCT06003270|Antioxidants|antioxidants|mesh-ancestor
138559386|NCT06003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559387|NCT06003270|Protective Agents|protective agents|mesh-ancestor
138559388|NCT06003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559389|NCT06003179|Cyclophosphamide|cyclophosphamide|mesh-list
138559390|NCT06003179|Fludarabine|fludarabine|mesh-list
138559391|NCT06003179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138559392|NCT06003179|Immunologic Factors|immunologic factors|mesh-ancestor
138559393|NCT06003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559394|NCT06003179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138559395|NCT06003179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138559396|NCT06003179|Alkylating Agents|alkylating agents|mesh-ancestor
138559397|NCT06003179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559398|NCT06003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559399|NCT06003179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138559400|NCT06003049|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138559401|NCT06003049|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138361890|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559402|NCT06003049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138559403|NCT06003049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559404|NCT06003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559405|NCT06003049|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138559406|NCT06003049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138559407|NCT06003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559408|NCT06003049|Cholinergic Agents|cholinergic agents|mesh-ancestor
138361900|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138559409|NCT06003049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559410|NCT06002854|Insulin|insulin|mesh-list
138559411|NCT06002854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138559412|NCT06002854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138559413|NCT06002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559414|NCT06002659|Cyclophosphamide|cyclophosphamide|mesh-list
138559415|NCT06002659|Fludarabine|fludarabine|mesh-list
138559416|NCT06002659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138559417|NCT06002659|Immunologic Factors|immunologic factors|mesh-ancestor
138361908|NCT01722396|Vitamins|vitamins|mesh-ancestor
138559418|NCT06002659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559420|NCT06002659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138559421|NCT06002659|Alkylating Agents|alkylating agents|mesh-ancestor
138559422|NCT06002659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559423|NCT06002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559424|NCT06002659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138559425|NCT06002646|Chromium|chromium|mesh-list
138559426|NCT06002646|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138559427|NCT06002646|Eusol|eusol|mesh-list
138559428|NCT06002646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138559429|NCT06002646|Trace Elements|trace elements|mesh-ancestor
138559430|NCT06002646|Micronutrients|micronutrients|mesh-ancestor
138559431|NCT06002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559432|NCT06002646|Disinfectants|disinfectants|mesh-ancestor
138559433|NCT06002646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559434|NCT06002035|Vitamin D|vitamin d|mesh-list
138559435|NCT06002035|Vitamins|vitamins|mesh-ancestor
138559436|NCT06002035|Micronutrients|micronutrients|mesh-ancestor
138559437|NCT06002035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559438|NCT06002035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138559439|NCT06001749|Psilocybin|psilocybin|mesh-list
138559440|NCT06001749|Hallucinogens|hallucinogens|mesh-ancestor
138454777|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
138559441|NCT06001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559442|NCT06001749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138559444|NCT06001619|Finasteride|finasteride|mesh-list
138559445|NCT06001619|Dutasteride|dutasteride|mesh-list
138559446|NCT06001619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138559447|NCT06001619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138559448|NCT06001619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138559449|NCT06001619|Adrenergic Agents|adrenergic agents|mesh-ancestor
138559450|NCT06001619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559451|NCT06001619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559452|NCT06001619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559453|NCT06001619|Urological Agents|urological agents|mesh-ancestor
138559454|NCT06001619|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138559455|NCT06001619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138559456|NCT06001619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559457|NCT06001619|Hormone Antagonists|hormone antagonists|mesh-ancestor
138559458|NCT06001619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138559459|NCT06001593|Betahistine|betahistine|mesh-list
138559460|NCT06001593|Vasodilator Agents|vasodilator agents|mesh-ancestor
138559461|NCT06001593|Histamine Agonists|histamine agonists|mesh-ancestor
138559462|NCT06001593|Histamine Agents|histamine agents|mesh-ancestor
138559463|NCT06001593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559464|NCT06001593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559465|NCT06001593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559466|NCT06001151|Carboplatin|carboplatin|mesh-list
138559467|NCT06001151|Pemetrexed|pemetrexed|mesh-list
138559468|NCT06001151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559469|NCT06001151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559470|NCT06001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559471|NCT06001151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138559472|NCT06001151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138559473|NCT06001125|Methotrexate|methotrexate|mesh-list
138559474|NCT06001125|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138559475|NCT06001125|Abortifacient Agents|abortifacient agents|mesh-ancestor
138559476|NCT06001125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138559477|NCT06001125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559478|NCT06001125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138559479|NCT06001125|Antimetabolites|antimetabolites|mesh-ancestor
138559480|NCT06001125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559481|NCT06001125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559482|NCT06001125|Dermatologic Agents|dermatologic agents|mesh-ancestor
138559483|NCT06001125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559484|NCT06001125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138235814|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559485|NCT06001125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138559487|NCT06001125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138559488|NCT06001125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138559489|NCT06000917|Paclitaxel|paclitaxel|mesh-list
138559490|NCT06000917|Carboplatin|carboplatin|mesh-list
138559491|NCT06000917|Trastuzumab|trastuzumab|mesh-list
138361938|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361939|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361940|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138361941|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138361943|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
138361944|NCT01724190|Vitamins|vitamins|mesh-ancestor
138559492|NCT06000917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138559493|NCT06000917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559494|NCT06000917|Tubulin Modulators|tubulin modulators|mesh-ancestor
138559495|NCT06000917|Antimitotic Agents|antimitotic agents|mesh-ancestor
138559496|NCT06000917|Mitosis Modulators|mitosis modulators|mesh-ancestor
138559497|NCT06000917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559498|NCT06000917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138559499|NCT06000657|Entecavir|entecavir|mesh-list
138559500|NCT06000657|Antiviral Agents|antiviral agents|mesh-ancestor
138559501|NCT06000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559502|NCT06000358|Pembrolizumab|pembrolizumab|mesh-list
138559503|NCT06000358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138559504|NCT06000358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361959|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559505|NCT06000358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138559506|NCT06000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559507|NCT06000137|Flurbiprofen|flurbiprofen|mesh-list
138559508|NCT06000137|Sufentanil|sufentanil|mesh-list
138559509|NCT06000137|Dsuvia|dsuvia|mesh-list
138559510|NCT06000137|Dezocine|dezocine|mesh-list
138559511|NCT06000137|Granisetron|granisetron|mesh-list
138559512|NCT06000137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138559513|NCT06000137|Narcotics|narcotics|mesh-ancestor
138559514|NCT06000137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138559515|NCT06000137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559516|NCT06000137|Analgesics|analgesics|mesh-ancestor
138559517|NCT06000137|Sensory System Agents|sensory system agents|mesh-ancestor
138559518|NCT06000137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559519|NCT06000137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138559520|NCT06000137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138559521|NCT06000137|Anesthetics, General|anesthetics, general|mesh-ancestor
138559522|NCT06000137|Anesthetics|anesthetics|mesh-ancestor
138559523|NCT06000137|Antiemetics|antiemetics|mesh-ancestor
138559524|NCT06000137|Autonomic Agents|autonomic agents|mesh-ancestor
138559525|NCT06000137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138559526|NCT06000137|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138559527|NCT06000137|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138559528|NCT06000137|Serotonin Agents|serotonin agents|mesh-ancestor
138361971|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138361972|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
138361973|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361974|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138361975|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
138361976|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
138361977|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138361978|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
138361979|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138361980|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138361981|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138361982|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138559529|NCT06000137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559530|NCT06000137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559531|NCT06000137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138559532|NCT06000137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138559533|NCT06000137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138559534|NCT06000137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138559535|NCT06000137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138361983|NCT01724424|Melatonin|melatonin|mesh-list
138361984|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
138361985|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138361986|NCT01724424|Protective Agents|protective agents|mesh-ancestor
138361987|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361988|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138361989|NCT01724814|Insulin|insulin|mesh-list
138559536|NCT06000137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559537|NCT06000033|Disitamab vedotin|disitamab vedotin|mesh-list
138559538|NCT06000033|Immunoconjugates|immunoconjugates|mesh-ancestor
138173932|NCT02143973|Nalbuphine|nalbuphine|mesh-list
138559539|NCT06000033|Immunologic Factors|immunologic factors|mesh-ancestor
138559540|NCT06000033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559542|NCT05999942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138559543|NCT05999942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559544|NCT05999890|Tapentadol|tapentadol|mesh-list
138559545|NCT05999890|Analgesics|analgesics|mesh-ancestor
138559546|NCT05999890|Sensory System Agents|sensory system agents|mesh-ancestor
138559547|NCT05999890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138361993|NCT01725048|Citalopram|citalopram|mesh-list
138559548|NCT05999890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559549|NCT05999890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138559550|NCT05999890|Narcotics|narcotics|mesh-ancestor
138559551|NCT05999890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138559552|NCT05999890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138559553|NCT05999890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138559554|NCT05999890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138559555|NCT05999890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559556|NCT05999890|Adrenergic Agents|adrenergic agents|mesh-ancestor
138559557|NCT05999890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559558|NCT05999487|Dobutamine|dobutamine|mesh-list
138559559|NCT05999487|Milrinone|milrinone|mesh-list
138559560|NCT05999487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138235904|NCT02375724|Bromides|bromides|mesh-list
138559561|NCT05999487|Sympathomimetics|sympathomimetics|mesh-ancestor
138559562|NCT05999487|Autonomic Agents|autonomic agents|mesh-ancestor
138559563|NCT05999487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559564|NCT05999487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559565|NCT05999487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138559566|NCT05999487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138559567|NCT05999487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138361999|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
138559568|NCT05999487|Adrenergic Agents|adrenergic agents|mesh-ancestor
138559569|NCT05999487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559570|NCT05999487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559571|NCT05999487|Protective Agents|protective agents|mesh-ancestor
138559572|NCT05999487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138559573|NCT05999487|Vasodilator Agents|vasodilator agents|mesh-ancestor
138559574|NCT05999487|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138362007|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138362008|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138559575|NCT05999487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138559576|NCT05999487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559577|NCT05999474|Tioconazole|tioconazole|mesh-list
138559578|NCT05999474|Antifungal Agents|antifungal agents|mesh-ancestor
138559579|NCT05999474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559580|NCT05999474|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138559581|NCT05999474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138559582|NCT05999474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559583|NCT05999474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559584|NCT05999474|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138559585|NCT05999474|Hormone Antagonists|hormone antagonists|mesh-ancestor
138362014|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138362015|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138559586|NCT05999474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138559587|NCT05999474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559588|NCT05999383|Nicotine|nicotine|mesh-list
138559589|NCT05999383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138316899|NCT04642391|Hormones|hormones|mesh-ancestor
138559591|NCT05999383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559592|NCT05999383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559593|NCT05999383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138362022|NCT01725360|Montelukast|montelukast|mesh-list
138559594|NCT05999383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138559595|NCT05999383|Cholinergic Agents|cholinergic agents|mesh-ancestor
138559596|NCT05999383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559597|NCT05999383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559598|NCT05999331|N-Methylaspartate|n-methylaspartate|mesh-list
138559599|NCT05999331|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138559600|NCT05999331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138559601|NCT05999331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559602|NCT05999331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559603|NCT05999331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559605|NCT05999227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138559606|NCT05999227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559607|NCT05998876|Methadone|methadone|mesh-list
138559608|NCT05998876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138559609|NCT05998876|Narcotics|narcotics|mesh-ancestor
138362033|NCT01725672|Glimepiride|glimepiride|mesh-list
138362034|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138362035|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362036|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138559610|NCT05998876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138559611|NCT05998876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559612|NCT05998876|Analgesics|analgesics|mesh-ancestor
138559613|NCT05998876|Sensory System Agents|sensory system agents|mesh-ancestor
138559614|NCT05998876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559615|NCT05998876|Antitussive Agents|antitussive agents|mesh-ancestor
138559616|NCT05998876|Respiratory System Agents|respiratory system agents|mesh-ancestor
138559617|NCT05998551|Fentanyl|fentanyl|mesh-list
138362041|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138362042|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
138362043|NCT01726530|Fentanyl|fentanyl|mesh-list
138362044|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138362045|NCT01726530|Narcotics|narcotics|mesh-ancestor
138559618|NCT05998551|Dexmedetomidine|dexmedetomidine|mesh-list
138559619|NCT05998551|Bupivacaine|bupivacaine|mesh-list
138559620|NCT05998551|Anesthetics, Local|anesthetics, local|mesh-ancestor
138559621|NCT05998551|Anesthetics|anesthetics|mesh-ancestor
138559622|NCT05998551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138559623|NCT05998551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559624|NCT05998551|Sensory System Agents|sensory system agents|mesh-ancestor
138559625|NCT05998551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362049|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
138362050|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362051|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138559626|NCT05998551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138559627|NCT05998551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138559629|NCT05998551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138559630|NCT05998551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138559631|NCT05998551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138559632|NCT05998551|Adrenergic Agents|adrenergic agents|mesh-ancestor
138559633|NCT05998551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235968|NCT04976595|Testosterone|testosterone|mesh-list
138559634|NCT05998551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559635|NCT05998551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138559636|NCT05998551|Narcotics|narcotics|mesh-ancestor
138559637|NCT05998551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138559638|NCT05998551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138559639|NCT05998551|Anesthetics, General|anesthetics, general|mesh-ancestor
138362057|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
138559640|NCT05998525|Dapagliflozin|dapagliflozin|mesh-list
138559641|NCT05998525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138559642|NCT05998525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559643|NCT05998525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138559644|NCT05998525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559645|NCT05998447|Pembrolizumab|pembrolizumab|mesh-list
138559646|NCT05998447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138362064|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362065|NCT01726920|Naproxen|naproxen|mesh-list
138559647|NCT05998447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559648|NCT05998447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138559649|NCT05998447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559650|NCT05998421|Aspirin|aspirin|mesh-list
138559651|NCT05998421|Heparin|heparin|mesh-list
138559652|NCT05998421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138559653|NCT05998421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138559654|NCT05998421|Analgesics|analgesics|mesh-ancestor
138559655|NCT05998421|Sensory System Agents|sensory system agents|mesh-ancestor
138559656|NCT05998421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559657|NCT05998421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559658|NCT05998421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138559659|NCT05998421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362072|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362073|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138362074|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362076|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138362077|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559660|NCT05998421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138559661|NCT05998421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138559662|NCT05998421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559670|NCT05998356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559672|NCT05998226|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138559673|NCT05998200|Glycolic acid|glycolic acid|mesh-list
138559674|NCT05998200|Keratolytic Agents|keratolytic agents|mesh-ancestor
138362091|NCT01728480|Cisplatin|cisplatin|mesh-list
138559675|NCT05998200|Dermatologic Agents|dermatologic agents|mesh-ancestor
138559676|NCT05998187|Botulinum Toxins|botulinum toxins|mesh-list
138559677|NCT05998187|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138559678|NCT05998187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138559679|NCT05998187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559680|NCT05998187|Cholinergic Agents|cholinergic agents|mesh-ancestor
138559681|NCT05998187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559682|NCT05998187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559683|NCT05998135|Atovaquone|atovaquone|mesh-list
138559684|NCT05998135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559685|NCT05998135|Antimalarials|antimalarials|mesh-ancestor
138559686|NCT05998135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138559687|NCT05998135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138559688|NCT05998135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559689|NCT05998135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559690|NCT05998096|Caffeine|caffeine|mesh-list
138559691|NCT05998096|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138559692|NCT05998096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559693|NCT05998096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138559694|NCT05998096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559695|NCT05998096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559696|NCT05998096|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138559697|NCT05998096|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138559698|NCT05998096|Purinergic Agents|purinergic agents|mesh-ancestor
138559699|NCT05998096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188352|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559707|NCT05997784|Nitric Oxide|nitric oxide|mesh-list
138559708|NCT05997784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138559709|NCT05997784|Autonomic Agents|autonomic agents|mesh-ancestor
138559710|NCT05997784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559711|NCT05997784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559712|NCT05997784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138559713|NCT05997784|Respiratory System Agents|respiratory system agents|mesh-ancestor
138559714|NCT05997784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138559715|NCT05997784|Antioxidants|antioxidants|mesh-ancestor
138559716|NCT05997784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559717|NCT05997784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559718|NCT05997784|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138559719|NCT05997784|Vasodilator Agents|vasodilator agents|mesh-ancestor
138559720|NCT05997784|Gasotransmitters|gasotransmitters|mesh-ancestor
138559721|NCT05997784|Protective Agents|protective agents|mesh-ancestor
138559723|NCT05997693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138559724|NCT05997693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138559725|NCT05997693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138559726|NCT05997693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138559727|NCT05997693|Purinergic Agents|purinergic agents|mesh-ancestor
138559728|NCT05997693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559729|NCT05997693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559730|NCT05997693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559731|NCT05997524|Capecitabine|capecitabine|mesh-list
138559732|NCT05997524|Oxaliplatin|oxaliplatin|mesh-list
138559733|NCT05997524|Trastuzumab|trastuzumab|mesh-list
138559734|NCT05997524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138559735|NCT05997524|Antimetabolites|antimetabolites|mesh-ancestor
138559736|NCT05997524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559737|NCT05997524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559738|NCT05997524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138559740|NCT05997485|Nirmatrelvir|nirmatrelvir|mesh-list
138559741|NCT05997485|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
138559742|NCT05997485|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138443976|NCT01818648|Exenatide|exenatide|mesh-list
138559743|NCT05997485|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138559744|NCT05997485|Protease Inhibitors|protease inhibitors|mesh-ancestor
138559745|NCT05997485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362127|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
138362128|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138559746|NCT05997485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559747|NCT05997485|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138559748|NCT05997485|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138559749|NCT05997485|Antiviral Agents|antiviral agents|mesh-ancestor
138559750|NCT05997485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138559751|NCT05997485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138559752|NCT05997485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138559753|NCT05997355|Gabapentin|gabapentin|mesh-list
138559754|NCT05997355|Analgesics|analgesics|mesh-ancestor
138559755|NCT05997355|Sensory System Agents|sensory system agents|mesh-ancestor
138559756|NCT05997355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559757|NCT05997355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559758|NCT05997355|Anticonvulsants|anticonvulsants|mesh-ancestor
138559759|NCT05997355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138559760|NCT05997355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138559761|NCT05997355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138559762|NCT05997355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138559763|NCT05997355|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138559764|NCT05997355|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138559765|NCT05997355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559766|NCT05997355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559767|NCT05997355|Antimanic Agents|antimanic agents|mesh-ancestor
138559768|NCT05997303|Norepinephrine|norepinephrine|mesh-list
138559769|NCT05997303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138559770|NCT05997303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138559771|NCT05997303|Adrenergic Agents|adrenergic agents|mesh-ancestor
138559772|NCT05997303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559773|NCT05997303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559774|NCT05997303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559775|NCT05997303|Sympathomimetics|sympathomimetics|mesh-ancestor
138559776|NCT05997303|Autonomic Agents|autonomic agents|mesh-ancestor
138316928|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138316936|NCT04564547|Islatravir|islatravir|mesh-list
138316937|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
138316938|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316939|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559777|NCT05997303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559778|NCT05997303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138362166|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138559780|NCT05997238|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138559781|NCT05997238|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138559782|NCT05997238|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138559783|NCT05997238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138559784|NCT05997238|Glucocorticoids|glucocorticoids|mesh-ancestor
138559785|NCT05997238|Hormones|hormones|mesh-ancestor
138559786|NCT05997238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138559787|NCT05997238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559788|NCT05997238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138559789|NCT05997238|Immunologic Factors|immunologic factors|mesh-ancestor
138559790|NCT05997238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559791|NCT05997238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362171|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
138559792|NCT05997043|Antiparkinson Agents|antiparkinson agents|mesh-list
138559793|NCT05997043|Botulinum Toxins|botulinum toxins|mesh-list
138559794|NCT05997043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138559795|NCT05997043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138702105|NCT05424393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138559796|NCT05997043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559797|NCT05997043|Cholinergic Agents|cholinergic agents|mesh-ancestor
138559798|NCT05997043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559799|NCT05997043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559800|NCT05997043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138559801|NCT05996588|Propofol|propofol|mesh-list
138559802|NCT05996588|Anesthetics|anesthetics|mesh-list
138559803|NCT05996588|Sevoflurane|sevoflurane|mesh-list
138362172|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138559804|NCT05996588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
138559805|NCT05996588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138559806|NCT05996588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138559807|NCT05996588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559808|NCT05996588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138559809|NCT05996588|Anesthetics, General|anesthetics, general|mesh-ancestor
138559810|NCT05996588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138559811|NCT05996549|Vaccines|vaccines|mesh-list
138362177|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138559812|NCT05996549|Immunologic Factors|immunologic factors|mesh-ancestor
138559813|NCT05996549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559814|NCT05996484|Paclitaxel|paclitaxel|mesh-list
138559815|NCT05996484|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138559816|NCT05996484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138559817|NCT05996484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559818|NCT05996484|Tubulin Modulators|tubulin modulators|mesh-ancestor
138559819|NCT05996484|Antimitotic Agents|antimitotic agents|mesh-ancestor
138362185|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362187|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
138559820|NCT05996484|Mitosis Modulators|mitosis modulators|mesh-ancestor
138559821|NCT05996484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559822|NCT05996445|Pembrolizumab|pembrolizumab|mesh-list
138559823|NCT05996445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138559824|NCT05996445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559825|NCT05996445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138559826|NCT05996445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559827|NCT05996406|Dexamethasone|dexamethasone|mesh-list
138559828|NCT05996406|Venetoclax|venetoclax|mesh-list
138559829|NCT05996406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138362192|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362193|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362195|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138362196|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559830|NCT05996406|Antiemetics|antiemetics|mesh-ancestor
138559831|NCT05996406|Autonomic Agents|autonomic agents|mesh-ancestor
138559832|NCT05996406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559833|NCT05996406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559834|NCT05996406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138559835|NCT05996406|Glucocorticoids|glucocorticoids|mesh-ancestor
138559836|NCT05996406|Hormones|hormones|mesh-ancestor
138559837|NCT05996406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138559838|NCT05996406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138559839|NCT05996406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559840|NCT05996393|Cyclosporine|cyclosporine|mesh-list
138559841|NCT05996393|Cyclosporins|cyclosporins|mesh-list
138559842|NCT05996393|Thymoglobulin|thymoglobulin|mesh-list
138559843|NCT05996393|Immunoglobulins|immunoglobulins|mesh-list
138559844|NCT05996393|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138559845|NCT05996393|Antibodies|antibodies|mesh-list
138559846|NCT05996393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559847|NCT05996393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559848|NCT05996393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138559849|NCT05996393|Immunologic Factors|immunologic factors|mesh-ancestor
138559850|NCT05996393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559852|NCT05996393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138236195|NCT01431014|BB 1101|bb 1101|mesh-list
138559853|NCT05996393|Dermatologic Agents|dermatologic agents|mesh-ancestor
138559854|NCT05996393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138559855|NCT05996393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138559856|NCT05996224|Hyaluronic Acid|hyaluronic acid|mesh-list
138559857|NCT05996224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138559858|NCT05996224|Immunologic Factors|immunologic factors|mesh-ancestor
138362208|NCT01044498|Norinyl|norinyl|mesh-list
138362209|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138559859|NCT05996224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559860|NCT05996224|Viscosupplements|viscosupplements|mesh-ancestor
138355062|NCT00002178|Nelfinavir|nelfinavir|mesh-list
138559861|NCT05996224|Protective Agents|protective agents|mesh-ancestor
138559863|NCT05995392|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138559864|NCT05995392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138559865|NCT05995392|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138559866|NCT05995392|Hormone Antagonists|hormone antagonists|mesh-ancestor
138214851|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214852|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138214853|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214854|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
138214855|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138214856|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214857|NCT00670982|Bevacizumab|bevacizumab|mesh-list
138214881|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138214882|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214885|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138214886|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
138214887|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214888|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138214889|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138214890|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
138214891|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214892|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214893|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138214894|NCT00613028|Bevacizumab|bevacizumab|mesh-list
138214895|NCT00613028|Etoposide|etoposide|mesh-list
138214896|NCT00613028|Temozolomide|temozolomide|mesh-list
138214897|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138214898|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214899|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138214900|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138214902|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214923|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138214924|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
138214925|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214926|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138214927|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138214928|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214929|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
138214930|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138214931|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
138214932|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138214933|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138214934|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138214935|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138214936|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
138214937|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138214938|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138214939|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
138214940|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138214941|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138214942|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138214943|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214944|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214946|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
138214948|NCT00673712|Narcotics|narcotics|mesh-ancestor
138214964|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138214965|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214966|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138214967|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138214969|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
138214970|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138214971|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
138214972|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138214973|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138214974|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138214975|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138214976|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559867|NCT05995392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138559868|NCT05995392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559869|NCT05995392|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138559871|NCT05995392|Natriuretic Agents|natriuretic agents|mesh-ancestor
138559873|NCT05995314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138559874|NCT05995314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559875|NCT05995314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138559876|NCT05995314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559877|NCT05995314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559878|NCT05995314|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138559879|NCT05995314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138559880|NCT05995314|Purinergic Agents|purinergic agents|mesh-ancestor
138559881|NCT05995314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559882|NCT05995119|Apixaban|apixaban|mesh-list
138559883|NCT05995119|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138559884|NCT05995119|Antithrombins|antithrombins|mesh-ancestor
138559885|NCT05995119|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138559886|NCT05995119|Protease Inhibitors|protease inhibitors|mesh-ancestor
138559887|NCT05995119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559888|NCT05995119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559889|NCT05995119|Anticoagulants|anticoagulants|mesh-ancestor
138559890|NCT05990985|Prednisolone|prednisolone|mesh-list
138559891|NCT05990985|Cyclophosphamide|cyclophosphamide|mesh-list
138559892|NCT05990985|Rituximab|rituximab|mesh-list
138559893|NCT05990985|Vincristine|vincristine|mesh-list
138559894|NCT05990985|Mitoxantrone|mitoxantrone|mesh-list
138362238|NCT03405870|SMOFlipid|smoflipid|mesh-list
138559895|NCT05990985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138559896|NCT05990985|Immunologic Factors|immunologic factors|mesh-ancestor
138559897|NCT05990985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559898|NCT05990985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138559899|NCT05990985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138559900|NCT05990985|Alkylating Agents|alkylating agents|mesh-ancestor
138559901|NCT05990985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559902|NCT05990985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559903|NCT05990985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138362239|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138362240|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138559904|NCT05990985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138454987|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
138559905|NCT05990985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138559906|NCT05990985|Tubulin Modulators|tubulin modulators|mesh-ancestor
138559907|NCT05990985|Antimitotic Agents|antimitotic agents|mesh-ancestor
138559908|NCT05990985|Mitosis Modulators|mitosis modulators|mesh-ancestor
138559909|NCT05990985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138559910|NCT05990985|Glucocorticoids|glucocorticoids|mesh-ancestor
138559912|NCT05990985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138559913|NCT05990985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138174062|NCT00649961|Protective Agents|protective agents|mesh-ancestor
138559915|NCT05990985|Analgesics|analgesics|mesh-ancestor
138559916|NCT05990985|Sensory System Agents|sensory system agents|mesh-ancestor
138559917|NCT05990985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138362246|NCT03408054|Oxytocin|oxytocin|mesh-list
138214977|NCT03722966|Nicotine|nicotine|mesh-list
138214978|NCT03722966|Varenicline|varenicline|mesh-list
138214980|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
138214981|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214982|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214983|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138214984|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138214985|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
138214986|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138214987|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138214988|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
138214989|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138214990|NCT01582477|Bupivacaine|bupivacaine|mesh-list
138214991|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
138214992|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
138214993|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138214994|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214995|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
138214996|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138214997|NCT03001687|Vitamin D|vitamin d|mesh-list
138214998|NCT03001687|Vitamins|vitamins|mesh-ancestor
138214999|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
138215000|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215008|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138215009|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138215012|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215013|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215014|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138215015|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138215016|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138215017|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215018|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215019|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138215020|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138215021|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138215022|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
138215023|NCT01585207|Vigabatrin|vigabatrin|mesh-list
138215024|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
138215025|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215026|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215027|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
138215028|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215029|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215030|NCT03007303|Olanzapine|olanzapine|mesh-list
138215032|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138215033|NCT03007303|Ziprasidone|ziprasidone|mesh-list
138215034|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
138215035|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138215036|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
138215037|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215038|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215039|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215040|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138215041|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138215042|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138215043|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138559918|NCT05990985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138559919|NCT05990985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138559920|NCT05984550|Niacinamide|niacinamide|mesh-list
138559921|NCT05984550|Vitamin B Complex|vitamin b complex|mesh-ancestor
138559922|NCT05984550|Vitamins|vitamins|mesh-ancestor
138559923|NCT05984550|Micronutrients|micronutrients|mesh-ancestor
138559924|NCT05984550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559925|NCT05980546|Dexamethasone|dexamethasone|mesh-list
138559926|NCT05980546|Dexamethasone acetate|dexamethasone acetate|mesh-list
138362251|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
138559927|NCT05980546|Fentanyl|fentanyl|mesh-list
138559928|NCT05980546|Bupivacaine|bupivacaine|mesh-list
138559929|NCT05980546|Mepivacaine|mepivacaine|mesh-list
138559930|NCT05980546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138559931|NCT05980546|Antiemetics|antiemetics|mesh-ancestor
138559932|NCT05980546|Autonomic Agents|autonomic agents|mesh-ancestor
138559933|NCT05980546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559934|NCT05980546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559935|NCT05980546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138362258|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362259|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
138559936|NCT05980546|Glucocorticoids|glucocorticoids|mesh-ancestor
138559938|NCT05980546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138559939|NCT05980546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138559940|NCT05980546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559941|NCT05980546|Anesthetics, Local|anesthetics, local|mesh-ancestor
138559942|NCT05980546|Anesthetics|anesthetics|mesh-ancestor
138559943|NCT05980546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138362263|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362264|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
138559944|NCT05980546|Sensory System Agents|sensory system agents|mesh-ancestor
138559945|NCT05980546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138559946|NCT05980546|Narcotics|narcotics|mesh-ancestor
138559947|NCT05980546|Analgesics|analgesics|mesh-ancestor
138559948|NCT05980546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138559949|NCT05980546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138559950|NCT05980546|Anesthetics, General|anesthetics, general|mesh-ancestor
138559951|NCT05975463|Bevacizumab|bevacizumab|mesh-list
138559952|NCT05975463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138559953|NCT05975463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559954|NCT05975463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138559955|NCT05975463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138559956|NCT05975463|Growth Substances|growth substances|mesh-ancestor
138559957|NCT05975463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559958|NCT05975463|Growth Inhibitors|growth inhibitors|mesh-ancestor
138362276|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138559959|NCT05966246|Prucalopride|prucalopride|mesh-list
138559960|NCT05966246|Mosapride|mosapride|mesh-list
138559961|NCT05966246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559962|NCT05966246|Laxatives|laxatives|mesh-ancestor
138559963|NCT05966246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138559964|NCT05966246|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138559965|NCT05966246|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138559966|NCT05966246|Serotonin Agents|serotonin agents|mesh-ancestor
138559967|NCT05966246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559968|NCT05966246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455006|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
138559970|NCT05966194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138559971|NCT05952713|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138559972|NCT05952713|Amitriptyline|amitriptyline|mesh-list
138559973|NCT05952713|Vortioxetine|vortioxetine|mesh-list
138559974|NCT05952713|Mirtazapine|mirtazapine|mesh-list
138362283|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559975|NCT05952713|Agomelatine|agomelatine|mesh-list
138559976|NCT05952713|Citalopram|citalopram|mesh-list
138559977|NCT05952713|Fluoxetine|fluoxetine|mesh-list
138559978|NCT05952713|Paroxetine|paroxetine|mesh-list
138559979|NCT05952713|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138559980|NCT05952713|Sertraline|sertraline|mesh-list
138559981|NCT05952713|Antidepressive Agents|antidepressive agents|mesh-list
138559982|NCT05952713|Reboxetine|reboxetine|mesh-list
138559983|NCT05952713|Imipramine|imipramine|mesh-list
138559984|NCT05952713|Escitalopram|escitalopram|mesh-list
138559985|NCT05952713|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138559986|NCT05952713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138559987|NCT05952713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138559988|NCT05952713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138559989|NCT05952713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138559990|NCT05952713|Serotonin Agents|serotonin agents|mesh-ancestor
138559991|NCT05952713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138559992|NCT05952713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138559993|NCT05952713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138559994|NCT05952713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138559995|NCT05952713|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138559996|NCT05952713|Analgesics|analgesics|mesh-ancestor
138559997|NCT05952713|Sensory System Agents|sensory system agents|mesh-ancestor
138559998|NCT05952713|Dopamine Agents|dopamine agents|mesh-ancestor
138559999|NCT05952713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138560000|NCT05952713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138560001|NCT05952713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362292|NCT03403140|Etanercept|etanercept|mesh-list
138560002|NCT05952713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138560003|NCT05952713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138560004|NCT05952713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560005|NCT05952713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138560006|NCT05952713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138560007|NCT05952713|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138560008|NCT05952713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138560009|NCT05952713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138560010|NCT05952713|Histamine Antagonists|histamine antagonists|mesh-ancestor
138362295|NCT03403140|Analgesics|analgesics|mesh-ancestor
138560011|NCT05952713|Histamine Agents|histamine agents|mesh-ancestor
138560012|NCT05952713|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138560013|NCT05952713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138455023|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
138560014|NCT05952713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138560015|NCT05952713|Adrenergic Agents|adrenergic agents|mesh-ancestor
138560016|NCT05952713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138560017|NCT05952713|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138560018|NCT05952713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138560019|NCT05952713|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138560020|NCT05952713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138560022|NCT05925023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138560023|NCT05925023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560024|NCT05925023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138560025|NCT05925023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560026|NCT05925023|Antifungal Agents|antifungal agents|mesh-ancestor
138560027|NCT05925023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138560028|NCT05925023|Immunologic Factors|immunologic factors|mesh-ancestor
138560029|NCT05925023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560030|NCT05905419|Analgesics, Opioid|analgesics, opioid|mesh-list
138560031|NCT05905419|Narcotics|narcotics|mesh-ancestor
138362308|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
138362312|NCT03402438|Fulacimstat|fulacimstat|mesh-list
138215044|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
138215045|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
138215046|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
138215047|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215048|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138215049|NCT03007303|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138215050|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138215051|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138215052|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
138215053|NCT01585441|Finasteride|finasteride|mesh-list
138215054|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138215055|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138215056|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215057|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215058|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
138215059|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138215060|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215074|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
138215075|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138215077|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138215079|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215080|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215081|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138215082|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138215083|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
138215084|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215085|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215087|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
138215088|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138215089|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138215090|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138215091|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138215092|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215093|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
138215094|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
138215095|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215096|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215097|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138215098|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138215099|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
138215100|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138215101|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138215102|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138215103|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138215105|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138215106|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138215107|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138215108|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
138215109|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138215110|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215111|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215112|NCT01589263|Urological Agents|urological agents|mesh-ancestor
138215113|NCT01590979|Ranolazine|ranolazine|mesh-list
138215129|NCT01592851|Protective Agents|protective agents|mesh-ancestor
138215130|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215132|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138215133|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138215134|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
138560032|NCT05905419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560033|NCT05905419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560034|NCT05905419|Analgesics|analgesics|mesh-ancestor
138560035|NCT05905419|Sensory System Agents|sensory system agents|mesh-ancestor
138560036|NCT05905419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560037|NCT05894928|Cholestyramine Resin|cholestyramine resin|mesh-list
138560038|NCT05894928|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138560039|NCT05894928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138560040|NCT05894928|Antimetabolites|antimetabolites|mesh-ancestor
138560041|NCT05894928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560042|NCT05894928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138560043|NCT05831358|Myeloma Proteins|myeloma proteins|mesh-list
138560044|NCT05831358|Paraproteins|paraproteins|mesh-list
138560045|NCT05831358|Immunologic Factors|immunologic factors|mesh-ancestor
138560046|NCT05831358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560047|NCT05828966|Magnesium Sulfate|magnesium sulfate|mesh-list
138560048|NCT05828966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138560050|NCT05828966|Sensory System Agents|sensory system agents|mesh-ancestor
138560051|NCT05828966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560052|NCT05828966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560053|NCT05828966|Anesthetics|anesthetics|mesh-ancestor
138560054|NCT05828966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560055|NCT05828966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138560056|NCT05828966|Anticonvulsants|anticonvulsants|mesh-ancestor
138560057|NCT05828966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138560058|NCT05828966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138560059|NCT05828966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560060|NCT05828966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138560061|NCT05828966|Tocolytic Agents|tocolytic agents|mesh-ancestor
138560062|NCT05828966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138560063|NCT05827042|Tenecteplase|tenecteplase|mesh-list
138362326|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560064|NCT05827042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138560065|NCT05827042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138560066|NCT05827042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560067|NCT05826964|Tamoxifen|tamoxifen|mesh-list
138560068|NCT05826964|Sirolimus|sirolimus|mesh-list
138560069|NCT05826964|Capecitabine|capecitabine|mesh-list
138560070|NCT05826964|Everolimus|everolimus|mesh-list
138560071|NCT05826964|Letrozole|letrozole|mesh-list
138560072|NCT05826964|Vinorelbine|vinorelbine|mesh-list
138362332|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138560073|NCT05826964|Fulvestrant|fulvestrant|mesh-list
138560074|NCT05826964|Palbociclib|palbociclib|mesh-list
138560075|NCT05826964|Anastrozole|anastrozole|mesh-list
138560076|NCT05826964|Exemestane|exemestane|mesh-list
138560077|NCT05826964|Temsirolimus|temsirolimus|mesh-list
138560078|NCT05826964|MTOR Inhibitors|mtor inhibitors|mesh-list
138560079|NCT05826964|Elafin|elafin|mesh-list
138560080|NCT05826964|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138560081|NCT05826964|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
138560082|NCT05826964|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
138560083|NCT05826964|Estrogens|estrogens|mesh-list
138560084|NCT05826964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138560085|NCT05826964|Antimetabolites|antimetabolites|mesh-ancestor
138560086|NCT05826964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560087|NCT05826964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560088|NCT05826964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138560089|NCT05826964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560090|NCT05826964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138560091|NCT05826964|Immunologic Factors|immunologic factors|mesh-ancestor
138560092|NCT05826964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362345|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
138560093|NCT05826964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138560094|NCT05826964|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138560095|NCT05826964|Hormone Antagonists|hormone antagonists|mesh-ancestor
138560096|NCT05826964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138560097|NCT05826964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138560098|NCT05826964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138316986|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560099|NCT05826964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138560100|NCT05826964|Antifungal Agents|antifungal agents|mesh-ancestor
138560101|NCT05826964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138560102|NCT05826964|Tubulin Modulators|tubulin modulators|mesh-ancestor
138560103|NCT05826964|Antimitotic Agents|antimitotic agents|mesh-ancestor
138560104|NCT05826964|Mitosis Modulators|mitosis modulators|mesh-ancestor
138560105|NCT05826964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138560106|NCT05826964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138560107|NCT05826964|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138560109|NCT05826964|Protease Inhibitors|protease inhibitors|mesh-ancestor
138560110|NCT05826574|Rifampin|rifampin|mesh-list
138560111|NCT05826574|Esomeprazole|esomeprazole|mesh-list
138560112|NCT05826574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138560113|NCT05826574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138560114|NCT05826574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138560115|NCT05826574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560116|NCT05826574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560117|NCT05826574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138560118|NCT05826574|Antitubercular Agents|antitubercular agents|mesh-ancestor
138560119|NCT05826574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138560120|NCT05826574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560121|NCT05826574|Leprostatic Agents|leprostatic agents|mesh-ancestor
138560122|NCT05826574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138560123|NCT05826574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138560124|NCT05826574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138560125|NCT05826574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138560126|NCT05826574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138560127|NCT05826574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138560128|NCT05826574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138560129|NCT05787613|Paclitaxel|paclitaxel|mesh-list
138560130|NCT05787613|Carboplatin|carboplatin|mesh-list
138560131|NCT05787613|Pemetrexed|pemetrexed|mesh-list
138560132|NCT05787613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138560133|NCT05787613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560134|NCT05787613|Tubulin Modulators|tubulin modulators|mesh-ancestor
138560135|NCT05787613|Antimitotic Agents|antimitotic agents|mesh-ancestor
138560136|NCT05787613|Mitosis Modulators|mitosis modulators|mesh-ancestor
138560137|NCT05787613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560138|NCT05787613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560139|NCT05787613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138560140|NCT05787613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138560141|NCT05741866|Chlorhexidine|chlorhexidine|mesh-list
138560142|NCT05741866|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138560143|NCT05741866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138362355|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
138560144|NCT05741866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560145|NCT05741866|Disinfectants|disinfectants|mesh-ancestor
138560146|NCT05741866|Dermatologic Agents|dermatologic agents|mesh-ancestor
138560147|NCT05733351|Docetaxel|docetaxel|mesh-list
138560148|NCT05733351|Antibodies|antibodies|mesh-list
138560149|NCT05733351|Immunoglobulins|immunoglobulins|mesh-list
138560150|NCT05733351|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138560151|NCT05733351|Immunologic Factors|immunologic factors|mesh-ancestor
138560152|NCT05733351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560153|NCT05733351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560154|NCT05733351|Tubulin Modulators|tubulin modulators|mesh-ancestor
138560155|NCT05733351|Antimitotic Agents|antimitotic agents|mesh-ancestor
138362358|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
138560156|NCT05733351|Mitosis Modulators|mitosis modulators|mesh-ancestor
138560157|NCT05733351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560159|NCT05722340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560160|NCT05722340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560161|NCT05721027|Dexamethasone|dexamethasone|mesh-list
138560162|NCT05721027|Ibuprofen|ibuprofen|mesh-list
138560163|NCT05721027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138560164|NCT05721027|Antiemetics|antiemetics|mesh-ancestor
138317000|NCT04359017|Lidocaine|lidocaine|mesh-list
138560165|NCT05721027|Autonomic Agents|autonomic agents|mesh-ancestor
138560166|NCT05721027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138362361|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362362|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138362363|NCT03401346|Analgesics|analgesics|mesh-ancestor
138362364|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
138560167|NCT05721027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560168|NCT05721027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138560169|NCT05721027|Glucocorticoids|glucocorticoids|mesh-ancestor
138560170|NCT05721027|Hormones|hormones|mesh-ancestor
138560171|NCT05721027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138560172|NCT05721027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138560173|NCT05721027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560174|NCT05721027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138560175|NCT05721027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138560177|NCT05721027|Sensory System Agents|sensory system agents|mesh-ancestor
138560178|NCT05721027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138560179|NCT05721027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138560180|NCT05721027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560181|NCT05721027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560182|NCT05714865|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138362373|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138362374|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560183|NCT05714865|Respiratory System Agents|respiratory system agents|mesh-ancestor
138560184|NCT05706753|Drospirenone|drospirenone|mesh-list
138560185|NCT05706753|Midazolam|midazolam|mesh-list
138560186|NCT05706753|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138560187|NCT05706753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138560188|NCT05706753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138560189|NCT05706753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560190|NCT05706753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560191|NCT05706753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138560192|NCT05706753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138560193|NCT05706753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138560194|NCT05706753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138560195|NCT05706753|Anesthetics, General|anesthetics, general|mesh-ancestor
138560196|NCT05706753|Anesthetics|anesthetics|mesh-ancestor
138560197|NCT05706753|GABA Modulators|gaba modulators|mesh-ancestor
138560198|NCT05706753|GABA Agents|gaba agents|mesh-ancestor
138560199|NCT05706753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138560200|NCT05706753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362390|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138560201|NCT05706753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138560202|NCT05706753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138560203|NCT05706753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138560204|NCT05706753|Contraceptive Agents|contraceptive agents|mesh-ancestor
138560205|NCT05706753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138560206|NCT05706753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138560207|NCT05706753|Estrogens|estrogens|mesh-ancestor
138560208|NCT05706753|Hormones|hormones|mesh-ancestor
138362395|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362396|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
138215135|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215136|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215137|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138215138|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
138215139|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
138215140|NCT00675584|Hormones|hormones|mesh-ancestor
138215141|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138215143|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138215144|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215145|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
138215146|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
138215147|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
138215148|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215149|NCT00676364|Lidocaine|lidocaine|mesh-list
138215150|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
138215152|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138215153|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215154|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
138215155|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215156|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138215162|NCT00676676|Androgens|androgens|mesh-ancestor
138215163|NCT00676676|Hormones|hormones|mesh-ancestor
138215164|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138215165|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215166|NCT00621530|Ketorolac|ketorolac|mesh-list
138215167|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138215168|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138215169|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138215170|NCT00621530|Analgesics|analgesics|mesh-ancestor
138215171|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
138215172|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138215173|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215174|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138215175|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138215176|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138215177|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215178|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215180|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138215181|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215182|NCT02513472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138215183|NCT02513472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215184|NCT00621686|Bevacizumab|bevacizumab|mesh-list
138215186|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138215187|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215188|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138215189|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138215191|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215192|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
138215193|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138215194|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215195|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215196|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
138215197|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138215198|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138215199|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138215200|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138215208|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
138215209|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560209|NCT05706753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138560210|NCT05706753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138560211|NCT05706753|Hormone Antagonists|hormone antagonists|mesh-ancestor
138560212|NCT05706753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138560213|NCT05706753|Diuretics|diuretics|mesh-ancestor
138560214|NCT05706753|Natriuretic Agents|natriuretic agents|mesh-ancestor
138560215|NCT05688098|Amlodipine|amlodipine|mesh-list
138560216|NCT05688098|Irbesartan|irbesartan|mesh-list
138560217|NCT05688098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138560218|NCT05688098|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138560219|NCT05688098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138560220|NCT05688098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560221|NCT05688098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138560222|NCT05688098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362403|NCT02240160|Nabiximols|nabiximols|mesh-list
138560223|NCT05688098|Vasodilator Agents|vasodilator agents|mesh-ancestor
138560224|NCT05688098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138560225|NCT05688098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138560226|NCT05688085|Amlodipine|amlodipine|mesh-list
138560227|NCT05688085|Irbesartan|irbesartan|mesh-list
138560228|NCT05688085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138560229|NCT05688085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138560230|NCT05688085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138560231|NCT05688085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455109|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138560232|NCT05688085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138560233|NCT05688085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560235|NCT05688085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138560236|NCT05688085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138560237|NCT05686863|Remifentanil|remifentanil|mesh-list
138560238|NCT05686863|Propofol|propofol|mesh-list
138560239|NCT05686863|Esketamine|esketamine|mesh-list
138560240|NCT05686863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138560241|NCT05686863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560242|NCT05686863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560243|NCT05686863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138560244|NCT05686863|Anesthetics, General|anesthetics, general|mesh-ancestor
138560245|NCT05686863|Anesthetics|anesthetics|mesh-ancestor
138560246|NCT05686863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138560247|NCT05686863|Narcotics|narcotics|mesh-ancestor
138560248|NCT05686863|Analgesics|analgesics|mesh-ancestor
138560249|NCT05686863|Sensory System Agents|sensory system agents|mesh-ancestor
138560250|NCT05686863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560251|NCT05686863|Antidepressive Agents|antidepressive agents|mesh-ancestor
138560252|NCT05686863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138560253|NCT05677373|Trametinib|trametinib|mesh-list
138560254|NCT05677373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560255|NCT05677373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138560256|NCT05677373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560257|NCT05677373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560258|NCT05665699|Allopurinol|allopurinol|mesh-list
138362409|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138560259|NCT05665699|Antimetabolites|antimetabolites|mesh-ancestor
138560260|NCT05665699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560261|NCT05665699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560262|NCT05665699|Gout Suppressants|gout suppressants|mesh-ancestor
138560263|NCT05665699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138560264|NCT05665699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138560265|NCT05665699|Antioxidants|antioxidants|mesh-ancestor
138560266|NCT05665699|Protective Agents|protective agents|mesh-ancestor
138560267|NCT05665699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560268|NCT05663073|Amlodipine|amlodipine|mesh-list
138560269|NCT05663073|Irbesartan|irbesartan|mesh-list
138560270|NCT05663073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138560271|NCT05663073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138560272|NCT05663073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138560273|NCT05663073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560274|NCT05663073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138174170|NCT00654329|Fentanyl|fentanyl|mesh-list
138560275|NCT05663073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560277|NCT05663073|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138560278|NCT05663073|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138560279|NCT05654506|Daratumumab|daratumumab|mesh-list
138444102|NCT01819285|Hormones|hormones|mesh-ancestor
138560280|NCT05654506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560281|NCT05620862|Irinotecan|irinotecan|mesh-list
138560282|NCT05620862|Vincristine|vincristine|mesh-list
138560283|NCT05620862|Mitoxantrone|mitoxantrone|mesh-list
138560284|NCT05620862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138560285|NCT05620862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138560286|NCT05620862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138362419|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560287|NCT05620862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560288|NCT05620862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560289|NCT05620862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138560290|NCT05620862|Tubulin Modulators|tubulin modulators|mesh-ancestor
138560291|NCT05620862|Antimitotic Agents|antimitotic agents|mesh-ancestor
138560292|NCT05620862|Mitosis Modulators|mitosis modulators|mesh-ancestor
138560293|NCT05620862|Analgesics|analgesics|mesh-ancestor
138560294|NCT05620862|Sensory System Agents|sensory system agents|mesh-ancestor
138560295|NCT05620862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560296|NCT05620862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560297|NCT05620862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138560298|NCT05617859|Lenvatinib|lenvatinib|mesh-list
138560299|NCT05617859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560300|NCT05617859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138560301|NCT05617859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560302|NCT05617859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560303|NCT05590624|Phentermine|phentermine|mesh-list
138560304|NCT05590624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138560305|NCT05590624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560306|NCT05590624|Appetite Depressants|appetite depressants|mesh-ancestor
138560307|NCT05590624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138560308|NCT05590624|Sympathomimetics|sympathomimetics|mesh-ancestor
138560309|NCT05590624|Autonomic Agents|autonomic agents|mesh-ancestor
138560310|NCT05590624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560311|NCT05590624|Adrenergic Agents|adrenergic agents|mesh-ancestor
138560312|NCT05590624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138560313|NCT05590624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560314|NCT05581030|Rituximab|rituximab|mesh-list
138560315|NCT05581030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138560316|NCT05581030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560317|NCT05581030|Immunologic Factors|immunologic factors|mesh-ancestor
138560318|NCT05581030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560319|NCT05581030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138362431|NCT02241564|Temsirolimus|temsirolimus|mesh-list
138560320|NCT05579574|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
138560321|NCT05579574|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138560322|NCT05579574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138560324|NCT05579574|Contraceptive Agents|contraceptive agents|mesh-ancestor
138560325|NCT05579574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138560326|NCT05579574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560327|NCT05579574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138560328|NCT05579574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138560329|NCT05579574|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
138560330|NCT05579574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138560331|NCT05569746|Immunoglobulins|immunoglobulins|mesh-list
138560332|NCT05569746|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
138560333|NCT05569746|Shiga Toxins|shiga toxins|mesh-list
138560334|NCT05569746|Immunologic Factors|immunologic factors|mesh-ancestor
138560335|NCT05569746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560336|NCT05569746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138455166|NCT01903681|Melatonin|melatonin|mesh-list
138560338|NCT05569746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560339|NCT05562063|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138560340|NCT05562063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138560341|NCT05562063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560342|NCT05562063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138560343|NCT05562063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560344|NCT05561751|Propranolol|propranolol|mesh-list
138560345|NCT05561751|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138560346|NCT05561751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138560347|NCT05561751|Adrenergic Agents|adrenergic agents|mesh-ancestor
138362446|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
138560348|NCT05561751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138560349|NCT05561751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560350|NCT05561751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560351|NCT05561751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138560352|NCT05561751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138560353|NCT05561751|Vasodilator Agents|vasodilator agents|mesh-ancestor
138560354|NCT05558982|Pembrolizumab|pembrolizumab|mesh-list
138560355|NCT05558982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138560356|NCT05558982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138174209|NCT00654953|Gabapentin|gabapentin|mesh-list
138560357|NCT05558982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138560358|NCT05558982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560360|NCT05540522|Immunologic Factors|immunologic factors|mesh-ancestor
138560361|NCT05540522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560362|NCT05518877|Ketamine|ketamine|mesh-list
138560363|NCT05518877|Analgesics|analgesics|mesh-ancestor
138560364|NCT05518877|Sensory System Agents|sensory system agents|mesh-ancestor
138560365|NCT05518877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560366|NCT05518877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560367|NCT05518877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138560368|NCT05518877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138560369|NCT05518877|Anesthetics, General|anesthetics, general|mesh-ancestor
138560370|NCT05518877|Anesthetics|anesthetics|mesh-ancestor
138560371|NCT05518877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560372|NCT05518877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138560373|NCT05518877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138560374|NCT05518877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138560375|NCT05518877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560376|NCT05512039|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138560378|NCT05512039|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138560379|NCT05512039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444141|NCT01819649|Selenium|selenium|mesh-list
138560380|NCT05512039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560381|NCT05512039|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138560383|NCT05512039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138362455|NCT02241876|Antidotes|antidotes|mesh-ancestor
138560384|NCT05512039|Cholinergic Agents|cholinergic agents|mesh-ancestor
138560385|NCT05512039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138560386|NCT05488457|Oxytocin|oxytocin|mesh-list
138560387|NCT05488457|Oxytocics|oxytocics|mesh-ancestor
138560388|NCT05488457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138560389|NCT05488457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560390|NCT05480865|Sotorasib|sotorasib|mesh-list
138560391|NCT05480865|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138560392|NCT05480865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560393|NCT05480865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138362463|NCT02242656|Opium|opium|mesh-list
138560394|NCT05480865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560395|NCT05476354|Amlodipine|amlodipine|mesh-list
138560396|NCT05476354|Irbesartan|irbesartan|mesh-list
138560397|NCT05476354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138560398|NCT05476354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138560399|NCT05476354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138560400|NCT05476354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560401|NCT05476354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138560402|NCT05476354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560403|NCT05476354|Vasodilator Agents|vasodilator agents|mesh-ancestor
138560404|NCT05476354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138560405|NCT05476354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138560408|NCT05475665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138560409|NCT05475665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138560410|NCT05475665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138560411|NCT05475665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560412|NCT05475665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138560413|NCT05475665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560414|NCT05475665|Vasodilator Agents|vasodilator agents|mesh-ancestor
138560415|NCT05475665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138560416|NCT05475665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138560417|NCT05467670|Doxorubicin|doxorubicin|mesh-list
138560418|NCT05467670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138560419|NCT05467670|Pembrolizumab|pembrolizumab|mesh-list
138560420|NCT05467670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138560421|NCT05467670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560422|NCT05467670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138560423|NCT05467670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138560424|NCT05467670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560425|NCT05467670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560426|NCT05467670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138560427|NCT05467670|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138560428|NCT05424445|Misoprostol|misoprostol|mesh-list
138560429|NCT05424445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138560430|NCT05424445|Abortifacient Agents|abortifacient agents|mesh-ancestor
138560431|NCT05424445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138560432|NCT05424445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560433|NCT05424445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138560434|NCT05424445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138560435|NCT05424445|Oxytocics|oxytocics|mesh-ancestor
138560436|NCT05407636|Aflibercept|aflibercept|mesh-list
138362474|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
138560437|NCT05407636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138560438|NCT05407636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138560439|NCT05407636|Growth Substances|growth substances|mesh-ancestor
138560440|NCT05407636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560441|NCT05407636|Growth Inhibitors|growth inhibitors|mesh-ancestor
138560442|NCT05407636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560444|NCT05406700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138362477|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138362481|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138560445|NCT05406700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138236795|NCT03708237|Gabapentin|gabapentin|mesh-list
138560446|NCT05406700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560447|NCT05406700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560448|NCT05405452|Ethyl Chloride|ethyl chloride|mesh-list
138560449|NCT05405452|Anesthetics|anesthetics|mesh-ancestor
138560450|NCT05405452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560451|NCT05405452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560452|NCT05405452|Anesthetics, Local|anesthetics, local|mesh-ancestor
138560453|NCT05405452|Sensory System Agents|sensory system agents|mesh-ancestor
138560454|NCT05405452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560455|NCT05401916|Acetaminophen|acetaminophen|mesh-list
138560456|NCT05401916|Ibuprofen|ibuprofen|mesh-list
138560457|NCT05401916|Tramadol|tramadol|mesh-list
138560458|NCT05401916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138560459|NCT05401916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138560460|NCT05401916|Analgesics|analgesics|mesh-ancestor
138560461|NCT05401916|Sensory System Agents|sensory system agents|mesh-ancestor
138560462|NCT05401916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560463|NCT05401916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560464|NCT05401916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138560465|NCT05401916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138560466|NCT05401916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138560467|NCT05401916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560468|NCT05401916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560469|NCT05401916|Antipyretics|antipyretics|mesh-ancestor
138560470|NCT05401916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138560471|NCT05401916|Narcotics|narcotics|mesh-ancestor
138560472|NCT05401916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560473|NCT05400265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138560474|NCT05400265|Antibodies|antibodies|mesh-list
138174299|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138560475|NCT05400265|Immunoglobulins|immunoglobulins|mesh-list
138560476|NCT05400265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138560477|NCT05400265|Immunologic Factors|immunologic factors|mesh-ancestor
138560478|NCT05400265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560479|NCT05400265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560480|NCT05384691|Luspatercept|luspatercept|mesh-list
138560481|NCT05384691|Hematinics|hematinics|mesh-ancestor
138560483|NCT05384496|Ipilimumab|ipilimumab|mesh-list
138560484|NCT05384496|Axitinib|axitinib|mesh-list
138560485|NCT05384496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138560486|NCT05384496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560487|NCT05384496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138560488|NCT05384496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560489|NCT05384496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138560490|NCT05384496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560491|NCT05382650|Immunoglobulins|immunoglobulins|mesh-list
138560492|NCT05382650|Antibodies|antibodies|mesh-list
138560493|NCT05382650|gamma-Globulins|gamma-globulins|mesh-list
138560494|NCT05382650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138560495|NCT05382650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138560496|NCT05382650|Immunologic Factors|immunologic factors|mesh-ancestor
138560497|NCT05382650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560498|NCT05375903|Gemcitabine|gemcitabine|mesh-list
138560499|NCT05375903|Imiquimod|imiquimod|mesh-list
138560500|NCT05375903|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138560501|NCT05375903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138560502|NCT05375903|Antimetabolites|antimetabolites|mesh-ancestor
138560503|NCT05375903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560504|NCT05375903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560505|NCT05375903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138560506|NCT05375903|Immunologic Factors|immunologic factors|mesh-ancestor
138560507|NCT05375903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560508|NCT05375903|Interferon Inducers|interferon inducers|mesh-ancestor
138560509|NCT05346354|Ravulizumab|ravulizumab|mesh-list
138560510|NCT05346354|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138560511|NCT05346354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138174343|NCT00652301|Simvastatin|simvastatin|mesh-list
138560512|NCT05346354|Immunologic Factors|immunologic factors|mesh-ancestor
138560513|NCT05346354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138362501|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138560514|NCT05342519|Sirolimus|sirolimus|mesh-list
138560515|NCT05342519|Temsirolimus|temsirolimus|mesh-list
138560516|NCT05342519|MTOR Inhibitors|mtor inhibitors|mesh-list
138560517|NCT05342519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138560518|NCT05342519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560519|NCT05342519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138560520|NCT05342519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560521|NCT05342519|Antifungal Agents|antifungal agents|mesh-ancestor
138560522|NCT05342519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138560523|NCT05342519|Immunologic Factors|immunologic factors|mesh-ancestor
138560524|NCT05342519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560525|NCT05342519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138560526|NCT05342519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560527|NCT05342519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560528|NCT05331664|Moxifloxacin|moxifloxacin|mesh-list
138560529|NCT05331664|Polymyxins|polymyxins|mesh-list
138362506|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138560530|NCT05331664|Trimethoprim|trimethoprim|mesh-list
138560531|NCT05331664|Prednisolone|prednisolone|mesh-list
138560532|NCT05331664|Prednisolone acetate|prednisolone acetate|mesh-list
138560533|NCT05331664|Triamcinolone|triamcinolone|mesh-list
138560534|NCT05331664|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138560535|NCT05331664|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138560536|NCT05331664|Atropine|atropine|mesh-list
138560537|NCT05331664|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138560538|NCT05331664|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138560539|NCT05331664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138455319|NCT01904643|Analgesics|analgesics|mesh-ancestor
138560542|NCT05331664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138560543|NCT05331664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560544|NCT05331664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138560545|NCT05331664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560546|NCT05331664|Autonomic Agents|autonomic agents|mesh-ancestor
138560547|NCT05331664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560548|NCT05331664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138560549|NCT05331664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560550|NCT05331664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138560551|NCT05331664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138560552|NCT05331664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560553|NCT05331664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560554|NCT05331664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138560555|NCT05331664|Contraceptive Agents|contraceptive agents|mesh-ancestor
138362518|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
138560556|NCT05331664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138560557|NCT05331664|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138560558|NCT05331664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138560559|NCT05331664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138560560|NCT05331664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138560561|NCT05331664|Immunologic Factors|immunologic factors|mesh-ancestor
138174394|NCT04575584|Molnupiravir|molnupiravir|mesh-list
138362520|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138560562|NCT05331664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138560563|NCT05331664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138560564|NCT05331664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138560565|NCT05331664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138560566|NCT05331664|Respiratory System Agents|respiratory system agents|mesh-ancestor
138560567|NCT05331664|Mydriatics|mydriatics|mesh-ancestor
138560568|NCT05331664|Parasympatholytics|parasympatholytics|mesh-ancestor
138560569|NCT05331664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138560570|NCT05331664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138560571|NCT05331664|Cholinergic Agents|cholinergic agents|mesh-ancestor
138560572|NCT05331664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444191|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
138560573|NCT05331664|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138159503|NCT05016947|Dexamethasone|dexamethasone|mesh-list
138159504|NCT05016947|Venetoclax|venetoclax|mesh-list
138159505|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138159507|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
138159508|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
138159509|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138159510|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138159511|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138159514|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138159515|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138159516|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159527|NCT04750616|Niacin|niacin|mesh-list
138560574|NCT05331664|Antimalarials|antimalarials|mesh-ancestor
138159562|NCT04673422|Montelukast|montelukast|mesh-list
138560575|NCT05331664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138560576|NCT05331664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138560577|NCT05331664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138560578|NCT05331664|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138560579|NCT05331664|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138159647|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
138560580|NCT05331664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138560581|NCT05321940|Interferons|interferons|mesh-list
138560582|NCT05321940|Vaccines|vaccines|mesh-list
138560583|NCT05321940|Immunologic Factors|immunologic factors|mesh-ancestor
138560584|NCT05321940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560585|NCT05321940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560586|NCT05321940|Antiviral Agents|antiviral agents|mesh-ancestor
138560587|NCT05321940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560588|NCT05307874|Aldesleukin|aldesleukin|mesh-list
138560589|NCT05307874|Pembrolizumab|pembrolizumab|mesh-list
138159709|NCT03599453|Poly I-C|poly i-c|mesh-list
138159710|NCT03599453|Celecoxib|celecoxib|mesh-list
138560590|NCT05307874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138560591|NCT05307874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560592|NCT05307874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138317153|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138159780|NCT03374956|Incretins|incretins|mesh-ancestor
138560593|NCT05307874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560594|NCT05307874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138560595|NCT05307874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138560596|NCT05307874|Antiviral Agents|antiviral agents|mesh-ancestor
138560597|NCT05307874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560598|NCT05290129|Oxytocin|oxytocin|mesh-list
138560600|NCT05290129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138159927|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
138560601|NCT05290129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560602|NCT05289830|Escitalopram|escitalopram|mesh-list
138560603|NCT05289830|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138560604|NCT05289830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138560605|NCT05289830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138560606|NCT05289830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560607|NCT05289830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138560608|NCT05289830|Serotonin Agents|serotonin agents|mesh-ancestor
138560609|NCT05289830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560610|NCT05288023|Azithromycin|azithromycin|mesh-list
138560611|NCT05288023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138560612|NCT05288023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560613|NCT05280405|Infliximab|infliximab|mesh-list
138560614|NCT05280405|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138560615|NCT05280405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138560616|NCT05280405|Dermatologic Agents|dermatologic agents|mesh-ancestor
138560617|NCT05280405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138560618|NCT05280405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138560619|NCT05253209|Plasma-lyte 148|plasma-lyte 148|mesh-list
138560620|NCT05253209|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138560621|NCT05253209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138560622|NCT05227742|Psilocybin|psilocybin|mesh-list
138560623|NCT05227742|Hallucinogens|hallucinogens|mesh-ancestor
138560624|NCT05227742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560625|NCT05227742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138560626|NCT05221749|Fluorides|fluorides|mesh-list
138560627|NCT05221749|Cariostatic Agents|cariostatic agents|mesh-ancestor
138560628|NCT05221749|Protective Agents|protective agents|mesh-ancestor
138560629|NCT05221749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560630|NCT05190471|Decitabine|decitabine|mesh-list
138560631|NCT05190471|Oblimersen|oblimersen|mesh-list
138444192|NCT01819870|Protective Agents|protective agents|mesh-ancestor
138560632|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138560633|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
138560651|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560652|NCT05111912|Liraglutide|liraglutide|mesh-list
138560653|NCT05111912|Glucagon|glucagon|mesh-list
138560654|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138560655|NCT05111912|Incretins|incretins|mesh-ancestor
138560656|NCT05111912|Hormones|hormones|mesh-ancestor
138560657|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138560658|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317170|NCT03935256|Paclitaxel|paclitaxel|mesh-list
138560659|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138560660|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138560661|NCT05065918|Ethanol|ethanol|mesh-list
138160620|NCT04046744|Lidocaine|lidocaine|mesh-list
138560662|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138560663|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560664|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560665|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560666|NCT05065424|Atropine|atropine|mesh-list
138560667|NCT05065424|Fentanyl|fentanyl|mesh-list
138560668|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138560669|NCT05065424|Narcotics|narcotics|mesh-ancestor
138560670|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560671|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560672|NCT05065424|Analgesics|analgesics|mesh-ancestor
138560673|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
138560674|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560676|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138560677|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
138560678|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
138560679|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560680|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138560681|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138560682|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
138560683|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138560684|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
138560685|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
138560686|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
138560687|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138560688|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138560689|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
138560690|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138560691|NCT05063734|Aflibercept|aflibercept|mesh-list
138560692|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138560693|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138560694|NCT05063734|Growth Substances|growth substances|mesh-ancestor
138560695|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560696|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
138560697|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560698|NCT05060822|Pirfenidone|pirfenidone|mesh-list
138560699|NCT05060822|Analgesics|analgesics|mesh-ancestor
138560700|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
138560701|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560702|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560703|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138560704|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138560705|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138560706|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138560707|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560708|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138560709|NCT05035407|Aldesleukin|aldesleukin|mesh-list
138560710|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
138560711|NCT05035407|Fludarabine|fludarabine|mesh-list
138560712|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138560713|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
138560714|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560715|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138174453|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
138174454|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
138560716|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138560717|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
138560718|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560719|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560720|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138560721|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138560722|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138560723|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
138161074|NCT00345371|Topiramate|topiramate|mesh-list
138560724|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560725|NCT05011383|Testosterone|testosterone|mesh-list
138560727|NCT05011383|Hormones|hormones|mesh-ancestor
138317181|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
138560728|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138560729|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560730|NCT04999761|Bevacizumab|bevacizumab|mesh-list
138560731|NCT04999761|Ramucirumab|ramucirumab|mesh-list
138560732|NCT04999761|Futibatinib|futibatinib|mesh-list
138560733|NCT04999761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138560734|NCT04999761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560735|NCT04999761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138560736|NCT04999761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138560737|NCT04999761|Growth Substances|growth substances|mesh-ancestor
138560738|NCT04999761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560739|NCT04999761|Growth Inhibitors|growth inhibitors|mesh-ancestor
138560740|NCT04989491|Rituximab|rituximab|mesh-list
138560741|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138161177|NCT05487456|Menthol|menthol|mesh-list
138560742|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560743|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
138560744|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560745|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138560746|NCT04984369|Cetuximab|cetuximab|mesh-list
138560747|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138560748|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560749|NCT04981158|Anesthetics|anesthetics|mesh-list
138560750|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
138560751|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560752|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138161222|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560753|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138560754|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
138560756|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
138560757|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560758|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560759|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
138161285|NCT02111863|Fludarabine|fludarabine|mesh-list
138560760|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560761|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138174487|NCT01967433|Promethazine|promethazine|mesh-list
138560762|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
138560763|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138560764|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138560765|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560766|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138161357|NCT00364819|Rituximab|rituximab|mesh-list
138560767|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
138560768|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138560769|NCT04935931|Naltrexone|naltrexone|mesh-list
138560770|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138560771|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138560772|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560773|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
138560774|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560775|NCT04926181|Androgens|androgens|mesh-list
138560776|NCT04926181|Hormones|hormones|mesh-ancestor
138560777|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138560778|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560779|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
138560780|NCT04921189|Thiamine|thiamine|mesh-list
138317194|NCT03832010|Hormones|hormones|mesh-ancestor
138560781|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
138560782|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
138560783|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560784|NCT04921189|Protective Agents|protective agents|mesh-ancestor
138455587|NCT01906762|Analgesics|analgesics|mesh-ancestor
138560785|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560787|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
138560788|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
138560789|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138560790|NCT04885530|Metformin|metformin|mesh-list
138560791|NCT04885530|Fluticasone|fluticasone|mesh-list
138560793|NCT04885530|Ivermectin|ivermectin|mesh-list
138560794|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
138560795|NCT04885530|Montelukast|montelukast|mesh-list
138560796|NCT04885530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138560797|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560798|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138560799|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138560800|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
138560801|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560802|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138560803|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
138560804|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
138560805|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138560806|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560807|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560808|NCT04885530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138560809|NCT04885530|Hormone Antagonists|hormone antagonists|mesh-ancestor
138560810|NCT04885530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138560811|NCT04885530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138560812|NCT04885530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138560813|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138560814|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560815|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138560816|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138560817|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138560818|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138560819|NCT04885530|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138560820|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138560821|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138560822|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138560823|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
138560824|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138560825|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
138560826|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138560827|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138560828|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138560830|NCT04872790|Cortisone|cortisone|mesh-list
138161842|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138560831|NCT04872790|Rituximab|rituximab|mesh-list
138560832|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138560833|NCT04872790|Methotrexate|methotrexate|mesh-list
138560834|NCT04872790|Venetoclax|venetoclax|mesh-list
138560835|NCT04872790|Dasatinib|dasatinib|mesh-list
138455643|NCT01907165|Copper|copper|mesh-list
138560836|NCT04872790|Blinatumomab|blinatumomab|mesh-list
138560837|NCT04872790|Antibodies|antibodies|mesh-list
138560838|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
138560839|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138560840|NCT04872790|Muromonab-CD3|muromonab-cd3|mesh-list
138560841|NCT04872790|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138560842|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
138560843|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560844|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560845|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138560846|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138560847|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
138560848|NCT04872790|Hormones|hormones|mesh-ancestor
138161901|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560849|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138560850|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138560851|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138560852|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
138560853|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138560854|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138560855|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
138560856|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560857|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
138560858|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444258|NCT01820442|Lofexidine|lofexidine|mesh-list
138560859|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138560860|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138560861|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138560862|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138560863|NCT04843111|Vaccines|vaccines|mesh-list
138560864|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
138560865|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560866|NCT04802837|Vancomycin|vancomycin|mesh-list
138560867|NCT04802837|Ridinilazole|ridinilazole|mesh-list
138560868|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138174535|NCT00658697|Docetaxel|docetaxel|mesh-list
138560903|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560904|NCT04708145|Aflibercept|aflibercept|mesh-list
138560905|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138560906|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138560907|NCT04708145|Growth Substances|growth substances|mesh-ancestor
138560908|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560909|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
138162100|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138560910|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560911|NCT04694846|Bupropion|bupropion|mesh-list
138560912|NCT04694846|Nicotine|nicotine|mesh-list
138560913|NCT04694846|Varenicline|varenicline|mesh-list
138560914|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138560915|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
138560916|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560917|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560918|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138560919|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138174557|NCT04399226|Ketamine|ketamine|mesh-list
138560920|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
138455650|NCT01907165|Trace Elements|trace elements|mesh-ancestor
138560921|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138560922|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560923|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138560924|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
138560925|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138560926|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138560927|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138560928|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138560929|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
138560930|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138560931|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138560932|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560933|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138560934|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138560935|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560936|NCT04680052|Rituximab|rituximab|mesh-list
138560937|NCT04680052|Lenalidomide|lenalidomide|mesh-list
138560938|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138560939|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560940|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
138162299|NCT00456625|Vaccines|vaccines|mesh-list
138560941|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560942|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138560943|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138560944|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138560945|NCT04680052|Growth Substances|growth substances|mesh-ancestor
138560946|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
138560947|NCT04659382|Bevacizumab|bevacizumab|mesh-list
138560948|NCT04659382|Atezolizumab|atezolizumab|mesh-list
138317244|NCT03695237|Leuprolide|leuprolide|mesh-list
138560949|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138560950|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560951|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138560952|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138560953|NCT04659382|Growth Substances|growth substances|mesh-ancestor
138560954|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560955|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
138560956|NCT04659382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138560957|NCT04659382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560958|NCT04652700|Tenofovir|tenofovir|mesh-list
138560959|NCT04652700|Emtricitabine|emtricitabine|mesh-list
138560960|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138560961|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138560962|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
138560963|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138560964|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138560965|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138162535|NCT00450073|Vitamins|vitamins|mesh-list
138162536|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
138162537|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138455672|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138560980|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138560981|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
138560982|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138560983|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138560984|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138560985|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138560986|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138560987|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560988|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
138560989|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138560990|NCT04630002|Ritonavir|ritonavir|mesh-list
138560991|NCT04630002|Darunavir|darunavir|mesh-list
138560992|NCT04630002|Etravirine|etravirine|mesh-list
138560993|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138560994|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138560995|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
138560996|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138560997|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138560998|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138560999|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138561000|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
138561001|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138561002|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138561003|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138561004|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138561005|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138561018|NCT04605393|Dronabinol|dronabinol|mesh-list
138561019|NCT04605393|Cannabidiol|cannabidiol|mesh-list
138561020|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
138561021|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
138162597|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138162634|NCT00405353|Hormones|hormones|mesh-ancestor
138561022|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561023|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138561024|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138561025|NCT04605393|Analgesics|analgesics|mesh-ancestor
138561026|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
138561027|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561028|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138561029|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138561030|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444319|NCT01820832|Vitamins|vitamins|mesh-ancestor
138561031|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561033|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138561034|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
138162641|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138561035|NCT04566133|Trametinib|trametinib|mesh-list
138561036|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
138561037|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138561038|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138561039|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138561040|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561041|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561042|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561043|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561044|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138162702|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138162706|NCT02111447|Propofol|propofol|mesh-list
138561045|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
138561046|NCT04558736|Fludarabine|fludarabine|mesh-list
138561047|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
138561048|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138174640|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138561049|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138561050|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
138561051|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561052|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561053|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138561054|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
138561055|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561056|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561057|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138561059|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
138561060|NCT04533451|Pemetrexed|pemetrexed|mesh-list
138561061|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561062|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561063|NCT04533451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138561064|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561065|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561066|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138162786|NCT05965076|Glycine|glycine|mesh-list
138561067|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138561068|NCT04526197|Celecoxib|celecoxib|mesh-list
138561069|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138561070|NCT04526197|Choline|choline|mesh-list
138561071|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138561072|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138561073|NCT04526197|Analgesics|analgesics|mesh-ancestor
138561074|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
138561075|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561076|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561077|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138561078|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561079|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138561080|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138561081|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561082|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138162823|NCT05939245|Natriuretic Agents|natriuretic agents|mesh-ancestor
138561083|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
138561084|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138561085|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
138561086|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138561087|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138561088|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
138561089|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
138561104|NCT04434664|Amlodipine|amlodipine|mesh-list
138561105|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138561106|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138561107|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138561108|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561109|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138561110|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561111|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
138561112|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138561113|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
138561114|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
138561115|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561116|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138561117|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138561118|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138561119|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
138561120|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138561121|NCT04430192|177Lu-PSMA-617|177lu-psma-617|mesh-list
138561122|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138561123|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561124|NCT04419272|Methylphenidate|methylphenidate|mesh-list
138317293|NCT03584373|Narcotics|narcotics|mesh-ancestor
138561125|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138174713|NCT04387565|Vanadium|vanadium|mesh-list
138237461|NCT06195137|Antioxidants|antioxidants|mesh-ancestor
138561126|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561127|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138561128|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138561129|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138163014|NCT05358535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561130|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561131|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
138561132|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138561133|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
138561134|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138561135|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561136|NCT04400175|Silicon|silicon|mesh-list
138561137|NCT04400175|Trace Elements|trace elements|mesh-ancestor
138561138|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
138561139|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561140|NCT04360551|Telmisartan|telmisartan|mesh-list
138561141|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138561142|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138561143|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138561144|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561145|NCT04288778|Metformin|metformin|mesh-list
138561146|NCT04288778|Canagliflozin|canagliflozin|mesh-list
138561147|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138561148|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561149|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138561150|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561151|NCT04278781|Ivosidenib|ivosidenib|mesh-list
138561152|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561153|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561154|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561155|NCT04270409|Dexamethasone|dexamethasone|mesh-list
138561156|NCT04270409|Lenalidomide|lenalidomide|mesh-list
138561157|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138561158|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
138293084|NCT00539617|Vitamins|vitamins|mesh-ancestor
138561160|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561161|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561162|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138561163|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
138561164|NCT04270409|Hormones|hormones|mesh-ancestor
138561165|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138174737|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
138163242|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138163244|NCT04384107|Vaccines|vaccines|mesh-list
138561166|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138561167|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561168|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
138561169|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138561170|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138561171|NCT04270409|Growth Substances|growth substances|mesh-ancestor
138561172|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
138561173|NCT04262687|Bevacizumab|bevacizumab|mesh-list
138561174|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
138561175|NCT04262687|Capecitabine|capecitabine|mesh-list
138561176|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
138561177|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138163380|NCT03531762|Tepotinib|tepotinib|mesh-list
138561178|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561179|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138561180|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138561181|NCT04262687|Growth Substances|growth substances|mesh-ancestor
138561182|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561184|NCT04262687|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138561185|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561186|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138561187|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
138561188|NCT04246697|Acetaminophen|acetaminophen|mesh-list
138561189|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138561190|NCT04246697|Morphine|morphine|mesh-list
138561191|NCT04246697|Oxycodone|oxycodone|mesh-list
138561192|NCT04246697|Gabapentin|gabapentin|mesh-list
138561193|NCT04246697|Bupivacaine|bupivacaine|mesh-list
138561194|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
138561195|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
138561196|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138561197|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561198|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
138561199|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561200|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138561201|NCT04246697|Narcotics|narcotics|mesh-ancestor
138561202|NCT04246697|Analgesics|analgesics|mesh-ancestor
138561203|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
138561204|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138561205|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138561206|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138561207|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138561208|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138561209|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138561210|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561211|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
138561212|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138561214|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138561215|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138561216|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561217|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138561218|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561219|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
138561220|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138561221|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138561223|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
138561224|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138561225|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
138561226|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138561227|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
138561228|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
138561229|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561230|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561231|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138561232|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
138561233|NCT04233164|Hormones|hormones|mesh-ancestor
138561234|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138561235|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138561236|NCT04233164|Protective Agents|protective agents|mesh-ancestor
138561237|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138561238|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561239|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
138561240|NCT04230265|Fludarabine|fludarabine|mesh-list
138561241|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138561242|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
138317327|NCT03439345|Fenofibrate|fenofibrate|mesh-list
138317329|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
138561243|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561245|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138561246|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
138163652|NCT04372927|Cisplatin|cisplatin|mesh-list
138561247|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561248|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561249|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138561257|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138561258|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
138561259|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561260|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561261|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138561262|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
138561263|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138561265|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
138561266|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138561267|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
138561329|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
138561330|NCT04119336|Nivolumab|nivolumab|mesh-list
138561331|NCT04119336|Ixazomib|ixazomib|mesh-list
138561332|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138561333|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
138561334|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561335|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561336|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138561337|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
138561338|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561339|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561340|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138561341|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138561342|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
138561343|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
138561344|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561345|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138561346|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
138561347|NCT04119336|Hormones|hormones|mesh-ancestor
138163705|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
138561348|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138561349|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138561350|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561351|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138561352|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
138561353|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561354|NCT04092101|Nicotine|nicotine|mesh-list
138561355|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138561356|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
138561357|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561358|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561359|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138561360|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138561361|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
138561362|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138561363|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561364|NCT04090879|Nicotine|nicotine|mesh-list
138561365|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138163750|NCT00410423|Cytarabine|cytarabine|mesh-list
138561366|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
138561367|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561368|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561369|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138561370|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138561371|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
138174921|NCT04397510|Heparin|heparin|mesh-list
138293439|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
138163891|NCT00481351|Ezetimibe|ezetimibe|mesh-list
138561372|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138561373|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561374|NCT04047797|Rituximab|rituximab|mesh-list
138561375|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138561376|NCT04047797|Ixazomib|ixazomib|mesh-list
138561377|NCT04047797|Antibodies|antibodies|mesh-list
138561378|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
138561379|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138561380|NCT04047797|Glycine|glycine|mesh-list
138561381|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
138561382|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561383|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561384|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561385|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561386|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
138561387|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561388|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
138561389|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138561390|NCT04039867|Gemcitabine|gemcitabine|mesh-list
138163958|NCT00482911|Lenalidomide|lenalidomide|mesh-list
138163959|NCT00482911|Sunitinib|sunitinib|mesh-list
138561391|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
138561392|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138561393|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
138561394|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561396|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
138561397|NCT04029038|Fludarabine|fludarabine|mesh-list
138561398|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138561399|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
138561400|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561401|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561402|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138561403|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
138561404|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561405|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561406|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138561407|NCT04024436|Fulvestrant|fulvestrant|mesh-list
138561408|NCT04024436|Futibatinib|futibatinib|mesh-list
138561409|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138561410|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561411|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138561412|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138164171|NCT00424619|Vitamins|vitamins|mesh-list
138561413|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
138561414|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138561415|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561416|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
138561417|NCT03996772|Apixaban|apixaban|mesh-list
138561418|NCT03996772|Edoxaban|edoxaban|mesh-list
138561419|NCT03996772|Dabigatran|dabigatran|mesh-list
138561420|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138561421|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
138164241|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138561422|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138561423|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
138561424|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561425|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561426|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
138561427|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
138561428|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138561429|NCT03977467|Atezolizumab|atezolizumab|mesh-list
138561430|NCT03977467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138317369|NCT03245658|Nabiximols|nabiximols|mesh-list
138164339|NCT02078180|Bupropion|bupropion|mesh-list
138561431|NCT03977467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561432|NCT03977467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561433|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561435|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138561436|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138561437|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138561438|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561439|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561440|NCT03901612|Ropivacaine|ropivacaine|mesh-list
138561441|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
138561442|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
138561443|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138164384|NCT00535925|Furosemide|furosemide|mesh-list
138561444|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561445|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
138561446|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561448|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138561449|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561450|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164446|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561451|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561452|NCT03840915|Paclitaxel|paclitaxel|mesh-list
138561453|NCT03840915|Docetaxel|docetaxel|mesh-list
138561454|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138561455|NCT03840915|Carboplatin|carboplatin|mesh-list
138561456|NCT03840915|Gemcitabine|gemcitabine|mesh-list
138561457|NCT03840915|Pemetrexed|pemetrexed|mesh-list
138561458|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138561459|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561460|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
138561461|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
138561462|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
138561463|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561464|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138561465|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
138561466|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561467|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138561468|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138561469|NCT03821792|Prednisone|prednisone|mesh-list
138561470|NCT03821792|Cortisone|cortisone|mesh-list
138561471|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
138561472|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138561473|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
138561474|NCT03821792|Hormones|hormones|mesh-ancestor
138561475|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138561476|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561477|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138561478|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561479|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138561480|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561481|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561482|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
138561483|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138561484|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
138561485|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138561487|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138561488|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138561489|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138561490|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138561491|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
138561492|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138164534|NCT03595046|BB 1101|bb 1101|mesh-list
138561493|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561494|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561495|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
138561496|NCT03766126|Fludarabine|fludarabine|mesh-list
138444521|NCT01822028|Miglustat|miglustat|mesh-list
138561497|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138561498|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
138317453|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138561499|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561500|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561501|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138561502|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
138237834|NCT06188026|Levonorgestrel|levonorgestrel|mesh-list
138175016|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138561503|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561504|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561505|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138561506|NCT03765788|Prednisolone|prednisolone|mesh-list
138561507|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138561508|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
138561509|NCT03765788|Hormones|hormones|mesh-ancestor
138561510|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138561511|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561512|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138561513|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561514|NCT03760822|Paclitaxel|paclitaxel|mesh-list
138561515|NCT03760822|Ramucirumab|ramucirumab|mesh-list
138561516|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138561517|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561518|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
138561519|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
138561520|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
138561521|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561522|NCT03754725|Deferiprone|deferiprone|mesh-list
138561523|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138561524|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
138561525|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
138561526|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138455889|NCT01908348|Erythritol|erythritol|mesh-list
138561527|NCT03744793|Pemetrexed|pemetrexed|mesh-list
138561528|NCT03744793|Avelumab|avelumab|mesh-list
138561529|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138561530|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561531|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561532|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561533|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138561534|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138561535|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561536|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
138561537|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561538|NCT03731923|Liver Extracts|liver extracts|mesh-list
138561539|NCT03731923|Hematinics|hematinics|mesh-ancestor
138561540|NCT03726268|Fentanyl|fentanyl|mesh-list
138561541|NCT03726268|Sufentanil|sufentanil|mesh-list
138561542|NCT03726268|Morphine|morphine|mesh-list
138561543|NCT03726268|Methadone|methadone|mesh-list
138561544|NCT03726268|Hydromorphone|hydromorphone|mesh-list
138561545|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138561546|NCT03726268|Narcotics|narcotics|mesh-ancestor
138561547|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138561548|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561549|NCT03726268|Analgesics|analgesics|mesh-ancestor
138561550|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
138561551|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138175049|NCT00705107|Ribavirin|ribavirin|mesh-list
138561552|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138561553|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138561554|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
138561555|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
138561556|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
138561557|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
138561558|NCT03713801|Metformin|metformin|mesh-list
138561559|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138561560|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561561|NCT03699995|Lidocaine|lidocaine|mesh-list
138561562|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
138561564|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138561565|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561566|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
138561567|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561568|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138561595|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
138561596|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561597|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561598|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561600|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
138561601|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
138561602|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561603|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561604|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138561605|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138561606|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138561607|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
138561608|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138561609|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561610|NCT03626545|Docetaxel|docetaxel|mesh-list
138561611|NCT03626545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561612|NCT03626545|Tubulin Modulators|tubulin modulators|mesh-ancestor
138561613|NCT03626545|Antimitotic Agents|antimitotic agents|mesh-ancestor
138561614|NCT03626545|Mitosis Modulators|mitosis modulators|mesh-ancestor
138561615|NCT03626545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317480|NCT02400255|Crenolanib|crenolanib|mesh-list
138561616|NCT03620201|Atezolizumab|atezolizumab|mesh-list
138561617|NCT03620201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138561618|NCT03620201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561619|NCT03620201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138293996|NCT00000373|Fluoxetine|fluoxetine|mesh-list
138561620|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561621|NCT03584711|Panitumumab|panitumumab|mesh-list
138561622|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561623|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561624|NCT03558867|Metformin|metformin|mesh-list
138561625|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138561626|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561627|NCT03557749|Dimercaprol|dimercaprol|mesh-list
138561628|NCT03557749|Chelating Agents|chelating agents|mesh-ancestor
138561629|NCT03557749|Sequestering Agents|sequestering agents|mesh-ancestor
138561630|NCT03557749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561631|NCT03548064|Vaccines|vaccines|mesh-list
138561632|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
138561633|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561634|NCT03535350|Temozolomide|temozolomide|mesh-list
138561635|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138561636|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
138561637|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561638|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561639|NCT03527108|Nivolumab|nivolumab|mesh-list
138561640|NCT03527108|Ramucirumab|ramucirumab|mesh-list
138561641|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561642|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561643|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138175087|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
138561644|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561645|NCT03514069|Temozolomide|temozolomide|mesh-list
138561646|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138561647|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
138561648|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561649|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561650|NCT03512197|Midostaurin|midostaurin|mesh-list
138561651|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561652|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138561653|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561654|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561655|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
138561656|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138561657|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138561658|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561659|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
138561660|NCT03505723|Coagulants|coagulants|mesh-ancestor
138561661|NCT03502330|Nivolumab|nivolumab|mesh-list
138561662|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561663|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561664|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138561665|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561666|NCT03463057|Atezolizumab|atezolizumab|mesh-list
138561667|NCT03463057|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138561668|NCT03463057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561669|NCT03463057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561670|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561671|NCT03460756|Ganaxolone|ganaxolone|mesh-list
138561672|NCT03460756|Neurosteroids|neurosteroids|mesh-ancestor
138561673|NCT03460756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138561674|NCT03460756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561675|NCT03460756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561676|NCT03460756|GABA Modulators|gaba modulators|mesh-ancestor
138561677|NCT03460756|GABA Agents|gaba agents|mesh-ancestor
138561678|NCT03443999|Sirolimus|sirolimus|mesh-list
138561679|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138455977|NCT01909557|Vitamins|vitamins|mesh-ancestor
138561680|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138561681|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138561682|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561683|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
138561684|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138561685|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
138561686|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175122|NCT03809923|Lidocaine|lidocaine|mesh-list
138561688|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138561689|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
138561690|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561691|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561692|NCT03425838|Letrozole|letrozole|mesh-list
138561693|NCT03425838|Fulvestrant|fulvestrant|mesh-list
138561694|NCT03425838|Palbociclib|palbociclib|mesh-list
138561695|NCT03425838|Anastrozole|anastrozole|mesh-list
138561696|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138561697|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561698|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138561699|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561700|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561701|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138561702|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
138561703|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138561704|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561705|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138444597|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561706|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138561707|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138561708|NCT03399981|Natalizumab|natalizumab|mesh-list
138561709|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
138561710|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561711|NCT03367013|Lactoferrin|lactoferrin|mesh-list
138561712|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138561713|NCT03336398|Ketamine|ketamine|mesh-list
138561714|NCT03336398|Analgesics|analgesics|mesh-ancestor
138561715|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
138561716|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561717|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561718|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138561719|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138561720|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
138561721|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
138561722|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138175158|NCT00602771|Etoposide|etoposide|mesh-list
138561723|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138561724|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138561725|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138561726|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561728|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561729|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561730|NCT03331731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138561731|NCT03331731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561733|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
138561734|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561735|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138561736|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561737|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138561738|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
138561739|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561740|NCT03319498|Peppermint oil|peppermint oil|mesh-list
138561741|NCT03319498|Mineral Oil|mineral oil|mesh-list
138561742|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
138561743|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
138561744|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561745|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561746|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138561747|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
138561748|NCT03319498|Emollients|emollients|mesh-ancestor
138561749|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
138561750|NCT03291847|Buprenorphine|buprenorphine|mesh-list
138561751|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138561752|NCT03291847|Naloxone|naloxone|mesh-list
138561753|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138561754|NCT03291847|Narcotics|narcotics|mesh-ancestor
138561755|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138561756|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561757|NCT03291847|Analgesics|analgesics|mesh-ancestor
138561758|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
138561759|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561760|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138561761|NCT03289962|Atezolizumab|atezolizumab|mesh-list
138175194|NCT00714233|Metformin|metformin|mesh-list
138561762|NCT03289962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138561763|NCT03289962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561764|NCT03289962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561765|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561767|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561768|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138561769|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138561770|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561771|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561772|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138561773|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
138561774|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138561775|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561776|NCT03260504|Aldesleukin|aldesleukin|mesh-list
138561777|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
138561778|NCT03260504|Interleukin-2|interleukin-2|mesh-list
138561779|NCT03260504|Immunoglobulins|immunoglobulins|mesh-list
138175258|NCT02990507|Hormones|hormones|mesh-ancestor
138561780|NCT03260504|Immunoglobulin G|immunoglobulin g|mesh-list
138561781|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561782|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561783|NCT03260504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138561784|NCT03260504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561785|NCT03260504|Immunologic Factors|immunologic factors|mesh-ancestor
138561786|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561787|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138164569|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
138561789|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
138561790|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138561791|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138561792|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138561793|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
138561794|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138561795|NCT03259074|Adalimumab|adalimumab|mesh-list
138561796|NCT03259074|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138175306|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
138561797|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138561798|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561799|NCT03246074|Paclitaxel|paclitaxel|mesh-list
138561800|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138561801|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561802|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
138561803|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
138561804|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
138561805|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561806|NCT03216967|Everolimus|everolimus|mesh-list
138561807|NCT03216967|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138561808|NCT03216967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138561809|NCT03216967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561810|NCT03216967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561811|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138561812|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
138561813|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561814|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561815|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
138561816|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561817|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561818|NCT03210662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138561819|NCT03210662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561820|NCT03132467|Durvalumab|durvalumab|mesh-list
138561821|NCT03132467|Ipilimumab|ipilimumab|mesh-list
138561822|NCT03132467|Tremelimumab|tremelimumab|mesh-list
138561823|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
138561824|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138561825|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
138561826|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561827|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561828|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
138444637|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138561829|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561830|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138561831|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561832|NCT03121586|Pimavanserin|pimavanserin|mesh-list
138561833|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138561834|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138561835|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138561836|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138561837|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138561838|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561839|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138561840|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138561841|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138561842|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
138561843|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138561844|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561845|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
138561846|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
138561848|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
138561849|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138561851|NCT03118492|Tacrolimus|tacrolimus|mesh-list
138561852|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138561853|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
138561854|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561855|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561856|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138561857|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
138561858|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561859|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561860|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138561861|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138561862|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561863|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138561864|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138561865|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
138561866|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138561867|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138561868|NCT03107793|Ustekinumab|ustekinumab|mesh-list
138561869|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
138561870|NCT02959619|Ensartinib|ensartinib|mesh-list
138561871|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561872|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138561873|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561874|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561875|NCT02912715|Paclitaxel|paclitaxel|mesh-list
138561876|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138561877|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561878|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
138561879|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
138561880|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
138561881|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561882|NCT02886962|Vitamin K|vitamin k|mesh-list
138561883|NCT02886962|Vitamins|vitamins|mesh-ancestor
138561884|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
138561885|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561886|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138561887|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138561888|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561889|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
138561890|NCT02886962|Coagulants|coagulants|mesh-ancestor
138561891|NCT02885753|Leucovorin|leucovorin|mesh-list
138561892|NCT02885753|Folic Acid|folic acid|mesh-list
138561893|NCT02885753|Bevacizumab|bevacizumab|mesh-list
138561894|NCT02885753|Panitumumab|panitumumab|mesh-list
138444655|NCT01822951|Donepezil|donepezil|mesh-list
138561895|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
138561896|NCT02885753|Irinotecan|irinotecan|mesh-list
138561897|NCT02885753|Fluorouracil|fluorouracil|mesh-list
138561898|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
138561899|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138561900|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561901|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138561902|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138561903|NCT02885753|Growth Substances|growth substances|mesh-ancestor
138561904|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561905|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
138561906|NCT02885753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138561907|NCT02885753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138175440|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
138561908|NCT02885753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561909|NCT02885753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317558|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
138561911|NCT02885753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138561912|NCT02885753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138561913|NCT02885753|Immunologic Factors|immunologic factors|mesh-ancestor
138561914|NCT02885753|Antidotes|antidotes|mesh-ancestor
138561915|NCT02885753|Protective Agents|protective agents|mesh-ancestor
138561916|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
138561917|NCT02885753|Vitamins|vitamins|mesh-ancestor
138561918|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
138561919|NCT02885753|Hematinics|hematinics|mesh-ancestor
138561920|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138561921|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561922|NCT02754583|Azithromycin|azithromycin|mesh-list
138561923|NCT02754583|Tetracycline|tetracycline|mesh-list
138561924|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138561925|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138561926|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138561927|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561928|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561929|NCT02741323|Maraviroc|maraviroc|mesh-list
138561930|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138456016|NCT01909843|Gontivimab|gontivimab|mesh-list
138561931|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138561932|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561933|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138561934|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138561935|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
138561936|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138561937|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138561938|NCT02703220|Acetazolamide|acetazolamide|mesh-list
138561939|NCT02703220|Finasteride|finasteride|mesh-list
138561940|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
138561941|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138561942|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561943|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561944|NCT02703220|Diuretics|diuretics|mesh-ancestor
138561945|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
138561946|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561947|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138561948|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138561949|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
138561950|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138188353|NCT04706806|Acetic Acid|acetic acid|mesh-list
138561951|NCT02703220|Urological Agents|urological agents|mesh-ancestor
138561952|NCT02677051|Sulforaphane|sulforaphane|mesh-list
138561953|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138561954|NCT02677051|Protective Agents|protective agents|mesh-ancestor
138561955|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561956|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561957|NCT02638701|Infliximab|infliximab|mesh-list
138561958|NCT02638701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138561959|NCT02638701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138561960|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
138561961|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138561962|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138561963|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
138561964|NCT02615184|Lansoprazole|lansoprazole|mesh-list
138561965|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138561966|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138561967|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138561968|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561969|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561970|NCT02480803|Levodopa|levodopa|mesh-list
138561971|NCT02480803|Carbidopa|carbidopa|mesh-list
138561972|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138561973|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138561974|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138561975|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
138561976|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138561977|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561978|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561979|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138561980|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138561981|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138561982|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
138561983|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
138561984|NCT02471391|Venetoclax|venetoclax|mesh-list
138561985|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561986|NCT02426125|Docetaxel|docetaxel|mesh-list
138561987|NCT02426125|Ramucirumab|ramucirumab|mesh-list
138561988|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138561989|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
138561990|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
138561991|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
138175538|NCT01279681|Vitamins|vitamins|mesh-ancestor
138561992|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138561993|NCT02395497|Antibodies|antibodies|mesh-list
138561994|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138561995|NCT02395497|Tacrolimus|tacrolimus|mesh-list
138561996|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
138561997|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138561998|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138561999|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138562000|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562001|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562002|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
138562003|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138562004|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562005|NCT02362594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138562006|NCT02362594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562007|NCT02355379|Capecitabine|capecitabine|mesh-list
138562008|NCT02355379|Fluorouracil|fluorouracil|mesh-list
138562009|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138562010|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
138562011|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562012|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562013|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562014|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
138562015|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562017|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138562018|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562019|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138562020|NCT02157974|Incretins|incretins|mesh-ancestor
138562021|NCT02157974|Hormones|hormones|mesh-ancestor
138562022|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562023|NCT02140255|Ritonavir|ritonavir|mesh-list
138562024|NCT02140255|Lopinavir|lopinavir|mesh-list
138562025|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
138562026|NCT02140255|Nevirapine|nevirapine|mesh-list
138562027|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138175545|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562028|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138562029|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138562030|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
138562031|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562032|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562034|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138562035|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
138562036|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562037|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138294295|NCT02994836|Adalimumab|adalimumab|mesh-list
138562038|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138562039|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138562040|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138562041|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138562042|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138562043|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138562044|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
138562046|NCT02046395|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138562047|NCT02046395|Hydralazine|hydralazine|mesh-list
138562048|NCT02046395|Terazosin|terazosin|mesh-list
138562049|NCT02046395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138562050|NCT02046395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138562051|NCT02046395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138562052|NCT02046395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562053|NCT02046395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138562054|NCT02046395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562055|NCT02046395|Vasodilator Agents|vasodilator agents|mesh-ancestor
138562056|NCT02046395|Diuretics|diuretics|mesh-ancestor
138562057|NCT02046395|Natriuretic Agents|natriuretic agents|mesh-ancestor
138562058|NCT02046395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138562059|NCT02046395|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138562060|NCT02046395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138562061|NCT02046395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138562062|NCT02046395|Adrenergic Agents|adrenergic agents|mesh-ancestor
138562063|NCT02046395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562064|NCT02046395|Urological Agents|urological agents|mesh-ancestor
138562065|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
138562066|NCT02037126|Promethazine|promethazine|mesh-list
138562068|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138562069|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138562070|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138562071|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562072|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
138562073|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
138562074|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
138562075|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562076|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
138562077|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
138562078|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138562079|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138562080|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
138562081|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
138562082|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562083|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562084|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138562085|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
138562086|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
138562087|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
138562088|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138562089|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138562091|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138562092|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
138562093|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562094|NCT01851642|Albuterol|albuterol|mesh-list
138562095|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138562096|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
138562097|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562098|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562099|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138562100|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
138562101|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
138562102|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138562103|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138562104|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138562105|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138175621|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562106|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
138562107|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562108|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562109|NCT01838187|Vorinostat|vorinostat|mesh-list
138562110|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138562111|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562112|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138562113|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562114|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562115|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138562116|NCT01454154|Glyburide|glyburide|mesh-list
138562117|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138562118|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562119|NCT01367301|Paclitaxel|paclitaxel|mesh-list
138562120|NCT01367301|Carboplatin|carboplatin|mesh-list
138562121|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138562122|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562123|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
138562124|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
138562125|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
138562126|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562127|NCT01220583|Cisplatin|cisplatin|mesh-list
138562128|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562129|NCT01166594|Bevacizumab|bevacizumab|mesh-list
138562130|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138562131|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562132|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138562133|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138562134|NCT01166594|Growth Substances|growth substances|mesh-ancestor
138562135|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562136|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
138562137|NCT00871013|Thalidomide|thalidomide|mesh-list
138562138|NCT00871013|Dexamethasone|dexamethasone|mesh-list
138562139|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
138562140|NCT00871013|Melphalan|melphalan|mesh-list
138562141|NCT00871013|Doxorubicin|doxorubicin|mesh-list
138562142|NCT00871013|Etoposide|etoposide|mesh-list
138562143|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138562144|NCT00871013|Bortezomib|bortezomib|mesh-list
138562145|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562146|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
138562147|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562148|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138562149|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138562150|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
138562151|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562152|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562153|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138562154|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138562155|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
138562156|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
138562157|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562158|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138562159|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
138562160|NCT00871013|Hormones|hormones|mesh-ancestor
138562161|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562162|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138562163|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138562164|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138562165|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138562166|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562167|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138562168|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
138562169|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138562170|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562171|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138562172|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138562173|NCT00871013|Growth Substances|growth substances|mesh-ancestor
138562174|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
138562175|NCT00585650|Etanercept|etanercept|mesh-list
138562176|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138562177|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138562178|NCT00585650|Analgesics|analgesics|mesh-ancestor
138562179|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
138562180|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562181|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562182|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138562183|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138562184|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138562185|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562186|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
138562187|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
138562188|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138456117|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562189|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562190|NCT00039130|Leucovorin|leucovorin|mesh-list
138562191|NCT00039130|Cytarabine|cytarabine|mesh-list
138562192|NCT00039130|Dexamethasone|dexamethasone|mesh-list
138562193|NCT00039130|Prednisone|prednisone|mesh-list
138562194|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
138562195|NCT00039130|Ifosfamide|ifosfamide|mesh-list
138562196|NCT00039130|Rituximab|rituximab|mesh-list
138562197|NCT00039130|Doxorubicin|doxorubicin|mesh-list
138562198|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138562199|NCT00039130|Methotrexate|methotrexate|mesh-list
138562200|NCT00039130|Etoposide|etoposide|mesh-list
138562201|NCT00039130|Vincristine|vincristine|mesh-list
138562202|NCT00039130|Allopurinol|allopurinol|mesh-list
138562203|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
138562204|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562205|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
138562206|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562207|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138175686|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138562208|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138562209|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
138562210|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562211|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562212|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138562213|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138562214|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
138562215|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
138562216|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562217|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138562218|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
138562219|NCT00039130|Hormones|hormones|mesh-ancestor
138562220|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562221|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138562222|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138562223|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138562224|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138562225|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138562226|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562227|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138562228|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
138562229|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138562230|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138562231|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
138562232|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
138562233|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138562234|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138562235|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138562236|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
138562237|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562238|NCT00039130|Antidotes|antidotes|mesh-ancestor
138562239|NCT00039130|Protective Agents|protective agents|mesh-ancestor
138562240|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
138562241|NCT00039130|Vitamins|vitamins|mesh-ancestor
138562242|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
138562243|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
138562244|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
138562245|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
138562246|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
138562247|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138562248|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
138562249|NCT00002889|Leuprolide|leuprolide|mesh-list
138562250|NCT00002889|Goserelin|goserelin|mesh-list
138562251|NCT00002889|Flutamide|flutamide|mesh-list
138562252|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138562253|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
138562254|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138562255|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562256|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138562257|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562259|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
138562260|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562261|NCT00122577|Ritonavir|ritonavir|mesh-list
138562262|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138562263|NCT00122577|Tenofovir|tenofovir|mesh-list
138562264|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138562265|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138562266|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
138562267|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562268|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562269|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138562270|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138562271|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
138562272|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562273|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138562274|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138562275|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138562276|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138562277|NCT00313261|Clevudine|clevudine|mesh-list
138562278|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
138562279|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562280|NCT00425074|Aspirin|aspirin|mesh-list
138562281|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
138562282|NCT00425074|Salicylates|salicylates|mesh-list
138562283|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562284|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
138562285|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
138562286|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
138562287|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138562288|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138562289|NCT00425074|Analgesics|analgesics|mesh-ancestor
138562290|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
138164605|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562291|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562292|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562293|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138562294|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138562295|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138562296|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562297|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562298|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138562299|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138562300|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138562303|NCT00425152|Levamisole|levamisole|mesh-list
138562304|NCT00425152|Fluorouracil|fluorouracil|mesh-list
138562305|NCT00425152|Calcium|calcium|mesh-list
138562306|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
138562307|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138562308|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562309|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
138456174|NCT01910428|Eryaspase|eryaspase|mesh-list
138562310|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562311|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138562312|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562313|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562314|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
138562315|NCT00425152|Antidotes|antidotes|mesh-ancestor
138562316|NCT00425152|Protective Agents|protective agents|mesh-ancestor
138562317|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
138562318|NCT00425152|Vitamins|vitamins|mesh-ancestor
138562319|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
138562320|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138562321|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
138562322|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
138562323|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138562324|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562325|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138562326|NCT00314314|Insulin|insulin|mesh-list
138562327|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138562328|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562329|NCT00122616|Ribavirin|ribavirin|mesh-list
138562330|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138562331|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138562332|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
138562333|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562334|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
138238671|NCT05765266|Hormones|hormones|mesh-ancestor
138562335|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562336|NCT04984070|Metformin|metformin|mesh-list
138562337|NCT04984070|Drospirenone|drospirenone|mesh-list
138562338|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
138562339|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138562340|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
138562341|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138562342|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138562343|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138562344|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562345|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138562346|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138562347|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138562348|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138562349|NCT04984070|Estrogens|estrogens|mesh-ancestor
138562350|NCT04984070|Hormones|hormones|mesh-ancestor
138175773|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
138562351|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562352|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138562354|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138562355|NCT04984070|Diuretics|diuretics|mesh-ancestor
138562356|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
138562357|NCT00314509|Ciclesonide|ciclesonide|mesh-list
138562358|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
138562359|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138562360|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
138562361|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562362|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562363|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138562364|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
138562365|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138562366|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138562367|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138562368|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
138562369|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562370|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562371|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
138562372|NCT00314509|Hormones|hormones|mesh-ancestor
138562373|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562374|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138562375|NCT00314548|Epoprostenol|epoprostenol|mesh-list
138562376|NCT00314548|Alprostadil|alprostadil|mesh-list
138562377|NCT00314548|Tezosentan|tezosentan|mesh-list
138562378|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138562379|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
138562380|NCT00314548|Urological Agents|urological agents|mesh-ancestor
138562381|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138562382|NCT00314626|Lamivudine|lamivudine|mesh-list
138562383|NCT00314626|Efavirenz|efavirenz|mesh-list
138562384|NCT00314626|Abacavir|abacavir|mesh-list
138562385|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138562386|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138562387|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562388|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562389|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
138562390|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562391|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138562392|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138562393|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138562394|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138562395|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138562396|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138562397|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138562398|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138562399|NCT00314665|Thalidomide|thalidomide|mesh-list
138562400|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562401|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
138562402|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562403|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
138562404|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138562405|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562406|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138562407|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138562408|NCT00314665|Growth Substances|growth substances|mesh-ancestor
138562409|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
138562410|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562412|NCT00314704|Norepinephrine|norepinephrine|mesh-list
138562413|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138562414|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138562415|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
138562416|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562417|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444871|NCT01824758|Esmolol|esmolol|mesh-list
138562418|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562419|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
138562420|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
138562421|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562422|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138562423|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138562424|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
138562425|NCT00314704|Protective Agents|protective agents|mesh-ancestor
138562426|NCT00090909|Dexamethasone|dexamethasone|mesh-list
138562427|NCT00090909|Gemcitabine|gemcitabine|mesh-list
138562428|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138562429|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
138562430|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
138562431|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562432|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562433|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138562434|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
138562435|NCT00090909|Hormones|hormones|mesh-ancestor
138562436|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562437|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138562438|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562439|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138562440|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
138562441|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562442|NCT04943627|Gemcitabine|gemcitabine|mesh-list
138562443|NCT04943627|Irinotecan|irinotecan|mesh-list
138562444|NCT04943627|Pemetrexed|pemetrexed|mesh-list
138562445|NCT04943627|Topotecan|topotecan|mesh-list
138562446|NCT04943627|Vinorelbine|vinorelbine|mesh-list
138562447|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138562448|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
138562449|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562450|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562451|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138562452|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138562453|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562454|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138562455|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138562456|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138562457|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
138562458|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
138562459|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
138562460|NCT00314743|Dexamethasone|dexamethasone|mesh-list
138562461|NCT00314743|Ondansetron|ondansetron|mesh-list
138562462|NCT00314743|Aprepitant|aprepitant|mesh-list
138562463|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138562464|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
138562465|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
138562466|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562467|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562468|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138562470|NCT00314743|Hormones|hormones|mesh-ancestor
138562471|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562472|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138562473|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562474|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
138562475|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
138562476|NCT00314743|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138562477|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138562478|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
138562479|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562480|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562481|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138562482|NCT00314782|Docetaxel|docetaxel|mesh-list
138562483|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562484|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
138562485|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
138562486|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
138562487|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562488|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
138562489|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
138562490|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
138562491|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138562493|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562494|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
138562495|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562496|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138562497|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138562498|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138562499|NCT00314821|Ropinirole|ropinirole|mesh-list
138562500|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138562501|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138562502|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
138562503|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
138562504|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138175900|NCT00720629|Methotrexate|methotrexate|mesh-list
138562505|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562506|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562507|NCT00314860|Ropinirole|ropinirole|mesh-list
138562508|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138562509|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138562510|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
138562511|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
138562512|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562513|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562514|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562515|NCT00091104|Aldesleukin|aldesleukin|mesh-list
138562516|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
138562517|NCT00091104|Fludarabine|fludarabine|mesh-list
138562518|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
138562519|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
138562520|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562521|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
138562522|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562523|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138562524|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138562525|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
138562526|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562527|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562528|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138562529|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138562530|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
138562531|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138562532|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138562533|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138562534|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
138562535|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562536|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
138562537|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
138562538|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562539|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
138562540|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562541|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562542|NCT00313456|Satraplatin|satraplatin|mesh-list
138562543|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562544|NCT00313534|Masoprocol|masoprocol|mesh-list
138562545|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
138562546|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562547|NCT00313534|Protective Agents|protective agents|mesh-ancestor
138562548|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562549|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138562550|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562551|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138175946|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
138562552|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138562553|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138562554|NCT00313534|Analgesics|analgesics|mesh-ancestor
138562555|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
138562556|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562557|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138562558|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138562560|NCT00313690|Bortezomib|bortezomib|mesh-list
138562561|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562562|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
138238875|NCT05627557|Hormones|hormones|mesh-ancestor
138562565|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562566|NCT00313885|SR 46349B|sr 46349b|mesh-list
138562567|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138562568|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138562569|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562570|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138562571|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138562572|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
138562573|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562574|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562575|NCT00091143|Fludarabine|fludarabine|mesh-list
138562576|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
138562577|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
138562578|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138562579|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562580|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138562581|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
138562582|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562583|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562584|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
138562585|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562586|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138308305|NCT00002657|Hormones|hormones|mesh-ancestor
138562588|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562589|NCT04635280|Pancrelipase|pancrelipase|mesh-list
138175985|NCT02144675|Cytarabine|cytarabine|mesh-list
138562590|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138562592|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138562593|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138562594|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138562595|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562596|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138562597|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138562598|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
138562599|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562600|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562601|NCT00091299|Warfarin|warfarin|mesh-list
138562602|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
138562603|NCT04607603|Cannabidiol|cannabidiol|mesh-list
138562604|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
138562605|NCT00122772|Cisplatin|cisplatin|mesh-list
138562606|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562607|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
138562608|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138562609|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
138562610|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562611|NCT00122811|Perindopril|perindopril|mesh-list
138562612|NCT00122811|Indapamide|indapamide|mesh-list
138562613|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138562614|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
138562615|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562616|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562617|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138562618|NCT00122811|Diuretics|diuretics|mesh-ancestor
138562619|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
138562620|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562621|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138562622|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138562623|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138562624|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138562625|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138562626|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138562627|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138562628|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562629|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562630|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562631|NCT00122850|Analgesics|analgesics|mesh-ancestor
138562632|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
138562633|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562634|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
138562635|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138562636|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
138562637|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138403917|NCT01568684|Citalopram|citalopram|mesh-list
138562639|NCT03975439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138456282|NCT01911195|Isoflurane|isoflurane|mesh-list
138562640|NCT03975439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138562641|NCT03975439|Analgesics|analgesics|mesh-ancestor
138562642|NCT03975439|Sensory System Agents|sensory system agents|mesh-ancestor
138562643|NCT03975439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562644|NCT03975439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562645|NCT03975439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138562646|NCT03975439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138562647|NCT00091377|Paclitaxel|paclitaxel|mesh-list
138562648|NCT00091377|Cisplatin|cisplatin|mesh-list
138562649|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138562650|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562651|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
138562652|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
138562653|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
138562654|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562655|NCT03897868|Losartan|losartan|mesh-list
138562656|NCT03897868|Amlodipine|amlodipine|mesh-list
138562657|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138562658|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138562659|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138562660|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562661|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138562662|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562663|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
138562664|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138562665|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138562666|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138562667|NCT00122889|Allicin|allicin|mesh-list
138562668|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
138562669|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
138562670|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562671|NCT00122889|Protective Agents|protective agents|mesh-ancestor
138562672|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562673|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138562674|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562675|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138456303|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
138562677|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562678|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138562679|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
138562680|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138562681|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138562682|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138562683|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
138562684|NCT04729868|Bupivacaine|bupivacaine|mesh-list
138562685|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
138562686|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
138562688|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138562689|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562690|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
138562691|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562692|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138562693|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138562694|NCT04729868|Analgesics|analgesics|mesh-ancestor
138562695|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138562696|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138562697|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138562698|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
138562699|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562700|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562701|NCT00419887|Vildagliptin|vildagliptin|mesh-list
138562702|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138562703|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562704|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138562705|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
138562706|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562707|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562708|NCT03690544|Apremilast|apremilast|mesh-list
138562709|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138562710|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138562712|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
138562713|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562714|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562715|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138562716|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138562717|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138562718|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138562719|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562720|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562721|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
138562722|NCT00314977|Docetaxel|docetaxel|mesh-list
138562723|NCT00314977|Doxorubicin|doxorubicin|mesh-list
138562724|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138562725|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562726|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
138456338|NCT01911468|Metformin|metformin|mesh-list
138562727|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562728|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138562729|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138562730|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
138562731|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562732|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562733|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138562734|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
138562735|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
138562736|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
138562737|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138562738|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138562739|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138562740|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562742|NCT00315016|Fosinopril|fosinopril|mesh-list
138562743|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138562744|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
138562745|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562746|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562747|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138562748|NCT00315016|Diuretics|diuretics|mesh-ancestor
138562749|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
138562750|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138562751|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138562752|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
138562753|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562754|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562755|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
138562756|NCT00419068|Vitamin D|vitamin d|mesh-list
138562757|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138562758|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562759|NCT00419068|Vitamins|vitamins|mesh-ancestor
138562760|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
138562761|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138562762|NCT00419146|Vitamins|vitamins|mesh-list
138562763|NCT00419146|Vitamin E|vitamin e|mesh-list
138562764|NCT00419146|Tocopherols|tocopherols|mesh-list
138562765|NCT00419146|Tocotrienols|tocotrienols|mesh-list
138562766|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
138562767|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138562769|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562770|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
138562771|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562772|NCT00419146|Protective Agents|protective agents|mesh-ancestor
138562773|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138562774|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138562775|NCT02965196|Dexamethasone|dexamethasone|mesh-list
138562776|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138562778|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
138562779|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562780|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562781|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138562782|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
138562783|NCT02965196|Hormones|hormones|mesh-ancestor
138239111|NCT05498272|Olaparib|olaparib|mesh-list
138562784|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562785|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138562786|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562787|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
138562788|NCT00091611|Fludarabine|fludarabine|mesh-list
138562789|NCT00091611|Interleukin-2|interleukin-2|mesh-list
138562790|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562791|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
138562792|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562793|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138562794|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138562795|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
138562796|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562797|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562798|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138562799|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138562800|NCT00091611|Analgesics|analgesics|mesh-ancestor
138562801|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
138562802|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562803|NCT00123201|Dronabinol|dronabinol|mesh-list
138562804|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
138562805|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562806|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138562807|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138562808|NCT00123201|Analgesics|analgesics|mesh-ancestor
138562809|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
138562810|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562811|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138562812|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138562813|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562814|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562815|NCT00123201|Hormones|hormones|mesh-ancestor
138176148|NCT00735917|Saracatinib|saracatinib|mesh-list
138562816|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562817|NCT03031483|Clarithromycin|clarithromycin|mesh-list
138562818|NCT03031483|Lenalidomide|lenalidomide|mesh-list
138562819|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
138562820|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562821|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138562822|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138562823|NCT03031483|Growth Substances|growth substances|mesh-ancestor
138445004|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
138562824|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
138562825|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562826|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138562827|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562828|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138562829|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562830|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562831|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138562832|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138562833|NCT00091650|Olanzapine|olanzapine|mesh-list
138562834|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
138562835|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
138562836|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562837|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562838|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138562839|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138562840|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138562841|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138562842|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138176157|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562843|NCT00091650|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138562844|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138562845|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138562846|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562847|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138562848|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
138562850|NCT01691833|Vitamins|vitamins|mesh-ancestor
138562851|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
138562852|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562853|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138562854|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138562855|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
138562856|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
138562857|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
138562858|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138562859|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138562860|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176202|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562861|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138562862|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138562863|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138562864|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138562865|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138562866|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138562867|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562868|NCT00123279|Plasminogen|plasminogen|mesh-list
138562869|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138562870|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138562871|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562873|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138562874|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562876|NCT00123318|Fluorouracil|fluorouracil|mesh-list
138562877|NCT00123318|Epirubicin|epirubicin|mesh-list
138562878|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562879|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
138562880|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562881|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138562882|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562883|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
138562884|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562885|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138562886|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138562887|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138562888|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562889|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
138562890|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
138562891|NCT00327535|Hematinics|hematinics|mesh-ancestor
138562892|NCT00327691|Atorvastatin|atorvastatin|mesh-list
138562893|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138562894|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138562895|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
138562896|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562897|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138562898|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138562899|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562900|NCT03913832|Sirolimus|sirolimus|mesh-list
138562901|NCT03913832|Paclitaxel|paclitaxel|mesh-list
138562902|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138562903|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562904|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
138562905|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
138562906|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
138562907|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562908|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138562909|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138562910|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138562911|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
138562912|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562913|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
138562914|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562916|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
138562917|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138562918|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138562919|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562920|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138562921|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562922|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138562923|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138364447|NCT01386294|Tenofovir|tenofovir|mesh-list
138562924|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562925|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
138562926|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
138562927|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
138562928|NCT04716868|Levan|levan|mesh-list
138562929|NCT04716868|Psyllium|psyllium|mesh-list
138562930|NCT04716868|Cathartics|cathartics|mesh-ancestor
138562931|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138562932|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562933|NCT00327769|Fulvestrant|fulvestrant|mesh-list
138562934|NCT00327769|Anastrozole|anastrozole|mesh-list
138562935|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138562936|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562937|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138562938|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138562939|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
138562940|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562941|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562942|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138562943|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138562944|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562945|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562946|NCT00092001|Sunitinib|sunitinib|mesh-list
138562947|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562948|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138562949|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138562950|NCT00092001|Growth Substances|growth substances|mesh-ancestor
138562951|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562952|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
138562953|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138562954|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562955|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562956|NCT03883919|Vitamin D|vitamin d|mesh-list
138562957|NCT03883919|Leucovorin|leucovorin|mesh-list
138562958|NCT03883919|Fluorouracil|fluorouracil|mesh-list
138562959|NCT03883919|Irinotecan|irinotecan|mesh-list
138562960|NCT03883919|Vitamins|vitamins|mesh-ancestor
138562961|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
138562962|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562963|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138562964|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
138562965|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138562966|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138562967|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138562968|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138562969|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
138562970|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138562971|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138562972|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138562973|NCT03883919|Antidotes|antidotes|mesh-ancestor
138562974|NCT03883919|Protective Agents|protective agents|mesh-ancestor
138562975|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
138562976|NCT00327808|Budesonide|budesonide|mesh-list
138562977|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138562978|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138562979|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
138562980|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138562981|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562982|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138562983|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
138562984|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
138562985|NCT00327808|Hormones|hormones|mesh-ancestor
138562986|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138562987|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
138562988|NCT00092079|Vitamin D|vitamin d|mesh-list
138562989|NCT00092079|Alendronate|alendronate|mesh-list
138562990|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138562991|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138562992|NCT00092079|Vitamins|vitamins|mesh-ancestor
138562993|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
138562994|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138562995|NCT00327847|Vitamin D|vitamin d|mesh-list
138562996|NCT00327847|Vitamins|vitamins|mesh-ancestor
138562997|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
138562998|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138176329|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138562999|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138563001|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
138563002|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563003|NCT03709550|Decitabine|decitabine|mesh-list
138563004|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138563005|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
138563006|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563007|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563008|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239323|NCT05351541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563010|NCT00315211|Topotecan|topotecan|mesh-list
138563011|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563012|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
138563013|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
138563014|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
138563015|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563016|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138563017|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138563018|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563019|NCT00315367|Donepezil|donepezil|mesh-list
138563020|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138563021|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563022|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563023|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
138563024|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563025|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563026|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
138563027|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
138563028|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
138563029|NCT00315484|Hematinics|hematinics|mesh-ancestor
138563030|NCT00315523|Levocetirizine|levocetirizine|mesh-list
138563031|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138563032|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138563033|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
138563034|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
138456476|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
138563035|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563036|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563037|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563038|NCT00092196|Aprepitant|aprepitant|mesh-list
138563039|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
138563040|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
138563041|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563042|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563043|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138563044|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138563045|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563046|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563047|NCT00315601|Azithromycin|azithromycin|mesh-list
138563048|NCT00315601|Telithromycin|telithromycin|mesh-list
138563049|NCT00315601|Dimercaprol|dimercaprol|mesh-list
138563050|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138563051|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563052|NCT00315601|Chelating Agents|chelating agents|mesh-ancestor
138563053|NCT00315601|Sequestering Agents|sequestering agents|mesh-ancestor
138563054|NCT00315601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563055|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
138563056|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138563057|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563058|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563059|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138563060|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138563061|NCT00315679|Protective Agents|protective agents|mesh-ancestor
138563062|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563063|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
138563064|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138563065|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
138563066|NCT00092274|Ofatumumab|ofatumumab|mesh-list
138563067|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563068|NCT00315835|Buprenorphine|buprenorphine|mesh-list
138563069|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138563070|NCT00315835|Narcotics|narcotics|mesh-ancestor
138563071|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138563072|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563073|NCT00315835|Analgesics|analgesics|mesh-ancestor
138563074|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
138563075|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563076|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138563077|NCT00315874|Buprenorphine|buprenorphine|mesh-list
138563078|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138563079|NCT00315874|Narcotics|narcotics|mesh-ancestor
138563080|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138563081|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563082|NCT00315874|Analgesics|analgesics|mesh-ancestor
138563083|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
138563084|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563086|NCT00315913|Propranolol|propranolol|mesh-list
138563087|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138563088|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138563089|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
138563090|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563091|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563092|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563093|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138563094|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138563095|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
138176379|NCT01279499|Analgesics|analgesics|mesh-ancestor
138563097|NCT00092313|Rofecoxib|rofecoxib|mesh-list
138563098|NCT00092313|Oxycodone|oxycodone|mesh-list
138563099|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138563100|NCT00092313|Analgesics|analgesics|mesh-ancestor
138563101|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
138563102|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563103|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563104|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
138563105|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138563106|NCT00092313|Narcotics|narcotics|mesh-ancestor
138563107|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138563108|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138563109|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138563110|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563111|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563112|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138563113|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138563114|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138563115|NCT00399971|Immunomodulating Agents|immunomodulating agents|mesh-list
138563116|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
138563117|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563118|NCT00316030|Bexarotene|bexarotene|mesh-list
138563119|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563120|NCT00123552|Artesunate|artesunate|mesh-list
138563121|NCT00123552|Lumefantrine|lumefantrine|mesh-list
138563122|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
138563123|NCT00123552|Artemether|artemether|mesh-list
138563124|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
138563125|NCT00123552|Amodiaquine|amodiaquine|mesh-list
138563126|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138563127|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
138563128|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138456534|NCT01912677|Methyldopa|methyldopa|mesh-list
138563129|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138563130|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563131|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563132|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
138563133|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
138563134|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138563135|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
138563136|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138563137|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563138|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563139|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138563142|NCT03352427|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138563143|NCT03352427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138563144|NCT03352427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563145|NCT03352427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563146|NCT03352427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138563147|NCT03352427|Immunologic Factors|immunologic factors|mesh-ancestor
138563148|NCT03352427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563149|NCT03352427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563150|NCT00316420|Gemcitabine|gemcitabine|mesh-list
138563151|NCT00316420|Capecitabine|capecitabine|mesh-list
138563152|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138563153|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
138563154|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563155|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563156|NCT00092352|Celecoxib|celecoxib|mesh-list
138563157|NCT00092352|Rofecoxib|rofecoxib|mesh-list
138563158|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138563159|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138563160|NCT00092352|Analgesics|analgesics|mesh-ancestor
138563161|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
138563162|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563163|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563164|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138563165|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138563166|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138563167|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138563168|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563169|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563170|NCT00316498|Miglustat|miglustat|mesh-list
138563171|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138296248|NCT05751421|Analgesics|analgesics|mesh-ancestor
138563172|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563173|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138563174|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138563175|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
138563176|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563177|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138563178|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138563179|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563180|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
138563181|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
138563182|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138563183|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563184|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
138563185|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563186|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138563187|NCT00092391|Vaccines|vaccines|mesh-list
138563188|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
138563189|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563190|NCT00316849|Sirolimus|sirolimus|mesh-list
138563191|NCT00316849|Temozolomide|temozolomide|mesh-list
138563192|NCT00316849|Temsirolimus|temsirolimus|mesh-list
138563193|NCT00316849|MTOR Inhibitors|mtor inhibitors|mesh-list
138563194|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138563195|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
138563196|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563197|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563198|NCT00316849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138563199|NCT00316849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563200|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138563201|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
138563202|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138317779|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
138563203|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138563204|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563205|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138563206|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
138563207|NCT02959957|Cefotaxime|cefotaxime|mesh-list
138563208|NCT02959957|Cefoxitin|cefoxitin|mesh-list
138563209|NCT02959957|Temocillin|temocillin|mesh-list
138563210|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138563211|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563212|NCT00316927|Aspirin|aspirin|mesh-list
138563213|NCT00316927|Dexamethasone|dexamethasone|mesh-list
138563214|NCT00316927|Fosfestrol|fosfestrol|mesh-list
138563215|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
138563216|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138563217|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
138563218|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
138563219|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563220|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563221|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138563222|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
138563223|NCT00316927|Hormones|hormones|mesh-ancestor
138563224|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138456601|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
138563225|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138563226|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563227|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138563228|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138563230|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
138563231|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138563232|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138563233|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138563234|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563235|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138563236|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138563237|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563238|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
138563239|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138563240|NCT00316927|Estrogens|estrogens|mesh-ancestor
138563241|NCT00123669|Progesterone|progesterone|mesh-list
138563242|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138563243|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138563244|NCT00123669|Progestins|progestins|mesh-ancestor
138563245|NCT00123669|Hormones|hormones|mesh-ancestor
138563246|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138563247|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563248|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138563249|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
138563250|NCT00317200|Paclitaxel|paclitaxel|mesh-list
138563251|NCT00317200|Bevacizumab|bevacizumab|mesh-list
138563252|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138563253|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563254|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
138563255|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
138563256|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
138563257|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563258|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138563259|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138563260|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138563261|NCT00317200|Growth Substances|growth substances|mesh-ancestor
138445166|NCT01827059|Bosentan|bosentan|mesh-list
138563262|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563263|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
138563264|NCT02960035|Etanercept|etanercept|mesh-list
138563265|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138563266|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138563267|NCT02960035|Analgesics|analgesics|mesh-ancestor
138563268|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
138563269|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563270|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563271|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138563272|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138563273|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138563274|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138563275|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
138563277|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563278|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138563279|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563280|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563281|NCT00328120|Fulvestrant|fulvestrant|mesh-list
138563282|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138563283|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138164674|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138164678|NCT00495079|Vincristine|vincristine|mesh-list
138563284|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138563285|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138563286|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
138563287|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138563288|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563289|NCT00328393|Pioglitazone|pioglitazone|mesh-list
138563290|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138563291|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563292|NCT00328432|Celecoxib|celecoxib|mesh-list
138563293|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138563294|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138563295|NCT00328432|Analgesics|analgesics|mesh-ancestor
138176473|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138176474|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138176476|NCT00782821|Bortezomib|bortezomib|mesh-list
138176477|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
138176478|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138176479|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138563296|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
138563297|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563298|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563299|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138563300|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138563301|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138563302|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138563303|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563304|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563305|NCT00328549|Interferons|interferons|mesh-list
138563306|NCT00328549|Ribavirin|ribavirin|mesh-list
138563307|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563308|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
138563309|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563310|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
138563311|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563312|NCT00092508|Mesalamine|mesalamine|mesh-list
138563313|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138563314|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138563315|NCT00092508|Analgesics|analgesics|mesh-ancestor
138563316|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
138563317|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563318|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563319|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138563320|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138563321|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138563322|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
138563323|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138563324|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138563325|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138563326|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138563327|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563328|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
138563329|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563330|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138563331|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563332|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563333|NCT00420082|Cetirizine|cetirizine|mesh-list
138563334|NCT00420082|Fexofenadine|fexofenadine|mesh-list
138563335|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138563336|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138563337|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138563338|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
138563339|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
138563340|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563341|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563342|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563344|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138563345|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563346|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
138563347|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
138563348|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
138563349|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563350|NCT00328900|Atropine|atropine|mesh-list
138563351|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138563352|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138563353|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138563354|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
138563355|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563356|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563357|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138563358|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
138563359|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
138563360|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
138563361|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138563362|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138563363|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
138563364|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563365|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563366|NCT00328939|Enoxaparin|enoxaparin|mesh-list
138563367|NCT00328939|PENTA|penta|mesh-list
138563368|NCT00328939|Fondaparinux|fondaparinux|mesh-list
138563369|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
138563370|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138563371|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138563372|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563373|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138563374|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
138563375|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138456717|NCT01913990|Hormones|hormones|mesh-ancestor
138563376|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
138563377|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563378|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138563379|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
138563380|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138563381|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138563382|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138563383|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138563384|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563385|NCT00329095|Bimatoprost|bimatoprost|mesh-list
138563386|NCT00329095|Travoprost|travoprost|mesh-list
138563387|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
138563388|NCT00329095|Latanoprost|latanoprost|mesh-list
138563389|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138563390|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138563391|NCT00329134|Quinine|quinine|mesh-list
138563392|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
138563393|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138563394|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138563395|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563396|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138563397|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563398|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138563399|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563400|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138563401|NCT00329134|Analgesics|analgesics|mesh-ancestor
138563402|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
138563403|NCT00329173|Atorvastatin|atorvastatin|mesh-list
138563404|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138563405|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138563406|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138563407|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
138563408|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563409|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138563410|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138563411|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563412|NCT00123825|Gemcitabine|gemcitabine|mesh-list
138563413|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563414|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138563415|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
138563416|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563417|NCT00329329|Capecitabine|capecitabine|mesh-list
138563418|NCT00329329|Satraplatin|satraplatin|mesh-list
138563419|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138563420|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
138563421|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164685|NCT03594188|Anesthetics|anesthetics|mesh-list
138563422|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563423|NCT00329368|Folic Acid|folic acid|mesh-list
138563424|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
138563425|NCT00329368|Interferons|interferons|mesh-list
138563426|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
138563427|NCT00329368|Interleukin-2|interleukin-2|mesh-list
138563428|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138563429|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563430|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
138563431|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563432|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
138563433|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563434|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138563435|NCT00329368|Analgesics|analgesics|mesh-ancestor
138563436|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
138563437|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563438|NCT00329368|Hematinics|hematinics|mesh-ancestor
138563439|NCT00329368|Vitamins|vitamins|mesh-ancestor
138563440|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
138563441|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138563442|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138563443|NCT00329446|Escitalopram|escitalopram|mesh-list
138563444|NCT00329446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138563445|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138563447|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563448|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563449|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
138563450|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563451|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
138563452|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138563453|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138563454|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138563455|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138563456|NCT00092937|Busulfan|busulfan|mesh-list
138563457|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
138563458|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563459|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138563460|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
138563461|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563462|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138563463|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563464|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138563465|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138563466|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138563467|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
138563468|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
138563469|NCT04716751|Paclitaxel|paclitaxel|mesh-list
138563470|NCT04716751|Carboplatin|carboplatin|mesh-list
138563471|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138563472|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563473|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
138563474|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
138563475|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
138563476|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563477|NCT00123903|Metoprolol|metoprolol|mesh-list
138563478|NCT00123903|Carvedilol|carvedilol|mesh-list
138563479|NCT00123903|Lisinopril|lisinopril|mesh-list
138563480|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138563481|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138563482|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
138176605|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
138563483|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
138563484|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563485|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563486|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138563487|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138563488|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138563489|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
138563490|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563491|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563492|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
138563493|NCT00123903|Protective Agents|protective agents|mesh-ancestor
138563494|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138563495|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138563496|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138563497|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
138563498|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138563499|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138563500|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138563501|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
138563502|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563503|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138445316|NCT01827878|Lisinopril|lisinopril|mesh-list
138563504|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
138563505|NCT00329680|Antioxidants|antioxidants|mesh-list
138563506|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563507|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563508|NCT00329680|Protective Agents|protective agents|mesh-ancestor
138563509|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138563510|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138563511|NCT00329680|Analgesics|analgesics|mesh-ancestor
138563512|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
138563513|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563514|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138563515|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138563516|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138563517|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
138563518|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138563519|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
138176623|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
138563521|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138563522|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138563523|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
138563524|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563525|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138563526|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138563527|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563528|NCT00329914|Progesterone|progesterone|mesh-list
138563529|NCT00329914|Progestins|progestins|mesh-ancestor
138563530|NCT00329914|Hormones|hormones|mesh-ancestor
138563531|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138563532|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563533|NCT00092976|Factor VIII|factor viii|mesh-list
138563534|NCT00092976|Coagulants|coagulants|mesh-ancestor
138563535|NCT00083876|Thalidomide|thalidomide|mesh-list
138563536|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138563537|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
138563538|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563539|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
138563540|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138563541|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563542|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138563543|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138563544|NCT00083876|Growth Substances|growth substances|mesh-ancestor
138563545|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
138563546|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563547|NCT00330148|Eflornithine|eflornithine|mesh-list
138563548|NCT00330148|Nifurtimox|nifurtimox|mesh-list
138563549|NCT00330148|Melarsoprol|melarsoprol|mesh-list
138563550|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563551|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138563552|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138563553|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138563554|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563555|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138563556|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563557|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563558|NCT00093093|Interferons|interferons|mesh-list
138563559|NCT00093093|Ribavirin|ribavirin|mesh-list
138563560|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
138563561|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
138563562|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138563563|NCT00093093|Taribavirin|taribavirin|mesh-list
138563564|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563565|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
138445331|NCT01828125|Glucagon|glucagon|mesh-list
138563566|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563567|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
138563568|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563569|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
138563570|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563571|NCT00330304|Isoniazid|isoniazid|mesh-list
138176660|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
138563572|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138563573|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
138563574|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138563575|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563576|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138563577|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138563578|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
138563579|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563580|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138563581|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138563582|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
138563583|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138563584|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138563585|NCT00330499|Cisplatin|cisplatin|mesh-list
138563586|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563587|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138563588|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
138563589|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138563590|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138563591|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138563592|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138563593|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563594|NCT00330577|Timolol|timolol|mesh-list
138563595|NCT00330577|Latanoprost|latanoprost|mesh-list
138563596|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
138563597|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563598|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138563599|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138563600|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
138563601|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563602|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563603|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138563604|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138563605|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138563606|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138563607|NCT00083993|Sirolimus|sirolimus|mesh-list
138563608|NCT00083993|Letrozole|letrozole|mesh-list
138563609|NCT00083993|Temsirolimus|temsirolimus|mesh-list
138563610|NCT00083993|MTOR Inhibitors|mtor inhibitors|mesh-list
138563611|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563612|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138563613|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138563614|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563615|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188354|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138563616|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138563617|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
138563618|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138563619|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563620|NCT00083993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138563621|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138563622|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
138563623|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138389597|NCT01495715|Idebenone|idebenone|mesh-list
138563624|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563625|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138563626|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
138563627|NCT00323791|Gemcitabine|gemcitabine|mesh-list
138563628|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
138563629|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138563630|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
138563631|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563632|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563633|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138563634|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563635|NCT00323830|Capecitabine|capecitabine|mesh-list
138563636|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563637|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138563638|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
138563639|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563640|NCT00317512|Chrysarobin|chrysarobin|mesh-list
138563641|NCT00317512|HBOC 201|hboc 201|mesh-list
138563642|NCT00317512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138563643|NCT00317512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138563644|NCT00317512|Analgesics|analgesics|mesh-ancestor
138563645|NCT00317512|Sensory System Agents|sensory system agents|mesh-ancestor
138563646|NCT00317512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563647|NCT00317512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563648|NCT00317512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138563649|NCT00317512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138563650|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
138563651|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138563652|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
138563653|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138563654|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138563655|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138563656|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138563657|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563658|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138563659|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
138563660|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563661|NCT00323947|Methylphenidate|methylphenidate|mesh-list
138563662|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138563663|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563664|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138563665|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138563666|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138563667|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563668|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
138563669|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563670|NCT00323986|Azithromycin|azithromycin|mesh-list
138563671|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138563672|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563674|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
138563675|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563676|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138563677|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
138563678|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138563679|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
138563680|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563681|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563682|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138563683|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
138563684|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138563685|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
138563686|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563687|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563688|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138240000|NCT04551144|Androgens|androgens|mesh-ancestor
138563689|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
138563690|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
138563691|NCT00317629|Protective Agents|protective agents|mesh-ancestor
138563692|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138563693|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138563694|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563696|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138563697|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138563698|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563699|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138563700|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563701|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
138563703|NCT00324142|Tinidazole|tinidazole|mesh-list
138563704|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
138563705|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138164698|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
138563706|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138563707|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563708|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138563709|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138563710|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138563711|NCT00324298|Etoposide|etoposide|mesh-list
138563712|NCT00324298|Bleomycin|bleomycin|mesh-list
138563713|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563714|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138563715|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138563716|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138563717|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563718|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563719|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138563720|NCT00124137|Diuretics|diuretics|mesh-list
138563721|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
138563722|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563723|NCT00324376|Sevelamer|sevelamer|mesh-list
138563724|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
138563725|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
138176730|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138563726|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563727|NCT00084227|Azithromycin|azithromycin|mesh-list
138563728|NCT00084227|Chloroquine|chloroquine|mesh-list
138563729|NCT00084227|Atovaquone|atovaquone|mesh-list
138563730|NCT00084227|Proguanil|proguanil|mesh-list
138563731|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138563732|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138563733|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563734|NCT00084227|Amebicides|amebicides|mesh-ancestor
138563735|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138563736|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138563737|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
138563738|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138563739|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563740|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563741|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
138563742|NCT00317746|Citalopram|citalopram|mesh-list
138563743|NCT00317746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138563744|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138563746|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563747|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563748|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
138563749|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563750|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138563751|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
138563752|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138563753|NCT00317785|Cyclosporine|cyclosporine|mesh-list
138563754|NCT00317785|Sirolimus|sirolimus|mesh-list
138563755|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
138563756|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
138563757|NCT00317785|Methotrexate|methotrexate|mesh-list
138563758|NCT00317785|Tacrolimus|tacrolimus|mesh-list
138563759|NCT00317785|Cyclosporins|cyclosporins|mesh-list
138563760|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138563761|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
138563762|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563763|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138563764|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138563765|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
138176753|NCT00945269|Immunotoxins|immunotoxins|mesh-list
138563766|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563767|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563768|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138563769|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138563770|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
138563771|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138563772|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138563773|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
138563774|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
138563775|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563776|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138164703|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
138563777|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138563778|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138563779|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
138563780|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563781|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138563782|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138563783|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
138563784|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138563786|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138563787|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
138563788|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138563789|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138563790|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138563791|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138563792|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563793|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
138563794|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563795|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563796|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138563797|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138563798|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563800|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
138563801|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
138563802|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
138563803|NCT00317902|Hematinics|hematinics|mesh-ancestor
138563804|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138563805|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138563806|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138563807|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563808|NCT00324571|Calcium|calcium|mesh-list
138563809|NCT00324571|Sevelamer|sevelamer|mesh-list
138563810|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138563811|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563812|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
138563813|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
138563814|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563816|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138563817|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563818|NCT00084461|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138563819|NCT00084461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176792|NCT01276457|Everolimus|everolimus|mesh-list
138563820|NCT00084461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563822|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138563823|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
138563824|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563825|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563826|NCT00093366|Etanercept|etanercept|mesh-list
138563827|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
138563828|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138563829|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138563830|NCT00093366|Analgesics|analgesics|mesh-ancestor
138563831|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
138563832|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563833|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563834|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138563835|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138563836|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138563837|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138563838|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
138563839|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563841|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
138563842|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563843|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138563844|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138563845|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563846|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563848|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138563849|NCT00324727|Melphalan|melphalan|mesh-list
138563850|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138563851|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
138176809|NCT03804931|Mesalamine|mesalamine|mesh-list
138563852|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563853|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563854|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138563855|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138563856|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
138563857|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563858|NCT00324766|Simendan|simendan|mesh-list
138563859|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138563860|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
138563861|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138563862|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138563863|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563864|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563865|NCT00324766|Protective Agents|protective agents|mesh-ancestor
138563866|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563867|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
138563868|NCT00084578|Celecoxib|celecoxib|mesh-list
138563869|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138563870|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138563871|NCT00084578|Analgesics|analgesics|mesh-ancestor
138563872|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
138563873|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563874|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563875|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138563876|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138563877|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138563878|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138563879|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563880|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563881|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138563882|NCT00318175|Bosentan|bosentan|mesh-list
138563883|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138563884|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138563885|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563886|NCT00093444|Doxorubicin|doxorubicin|mesh-list
138563887|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138563888|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138563889|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563890|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138563891|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138563892|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176853|NCT00761345|Gemcitabine|gemcitabine|mesh-list
138176854|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138563893|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563894|NCT00325000|Amitriptyline|amitriptyline|mesh-list
138563895|NCT00325000|Sertraline|sertraline|mesh-list
138563896|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
138563897|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138563898|NCT00325000|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138563899|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138563900|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138563901|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563902|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563903|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
138563904|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563905|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138563906|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138563907|NCT00325000|Analgesics|analgesics|mesh-ancestor
138563908|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
138457153|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138563909|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563910|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138563911|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
138563912|NCT00318448|Zolpidem|zolpidem|mesh-list
138563913|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138563914|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138164712|NCT03590210|Nivolumab|nivolumab|mesh-list
138563915|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138563916|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563917|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138563918|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
138563919|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
138563920|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563921|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563922|NCT00325117|Vildagliptin|vildagliptin|mesh-list
138563923|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138563924|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563925|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138563926|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
138563927|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563928|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563929|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
138563930|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
138563931|NCT00084695|Melphalan|melphalan|mesh-list
138563932|NCT00084695|Busulfan|busulfan|mesh-list
138563933|NCT00084695|Fludarabine|fludarabine|mesh-list
138563934|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
138563935|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138563936|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138563937|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
138563938|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563939|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138563940|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138563941|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
138563942|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563943|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563944|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138563945|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138563946|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
138563947|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138563948|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
138563949|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
138563950|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138563951|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138563952|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
138563953|NCT00084695|Hormones|hormones|mesh-ancestor
138563954|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138563955|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138563956|NCT00084695|Protective Agents|protective agents|mesh-ancestor
138563957|NCT00325351|Carboplatin|carboplatin|mesh-list
138563958|NCT00325351|Sagopilone|sagopilone|mesh-list
138563959|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563960|NCT00093483|Cytarabine|cytarabine|mesh-list
138563961|NCT00093483|Idarubicin|idarubicin|mesh-list
138563962|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
138563963|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138176922|NCT01276379|Leucovorin|leucovorin|mesh-list
138563964|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
138563965|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563966|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563967|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
138563968|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138563969|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138563970|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
138563971|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563972|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138563973|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138563974|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138563975|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563976|NCT00325390|Clopidogrel|clopidogrel|mesh-list
138563977|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138317817|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563978|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138563979|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138563980|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138563982|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138563983|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563984|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138563985|NCT00325429|Vildagliptin|vildagliptin|mesh-list
138563986|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138563987|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138457202|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
138563988|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138563989|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
138563990|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138563991|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563992|NCT00093522|Fludarabine|fludarabine|mesh-list
138563993|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
138563994|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138563995|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138563996|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138563997|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
138563998|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138563999|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138564000|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
138564001|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564002|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138564003|NCT00084773|Fluorouracil|fluorouracil|mesh-list
138564004|NCT00084773|Cetuximab|cetuximab|mesh-list
138564005|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
138564006|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564007|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138564008|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564009|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138564010|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
138564011|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564012|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138564013|NCT00325546|Rimonabant|rimonabant|mesh-list
138564014|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138564015|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138564016|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138564017|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564018|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564019|NCT00325546|Hormones|hormones|mesh-ancestor
138176968|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138176971|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
138564020|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138564021|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564022|NCT00084812|Safingol|safingol|mesh-list
138564023|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564024|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564026|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564027|NCT04717609|Ropivacaine|ropivacaine|mesh-list
138564028|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
138564029|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
138564030|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138564031|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564032|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
138564033|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564034|NCT00318760|Clonidine|clonidine|mesh-list
138564035|NCT00318760|Analgesics|analgesics|mesh-ancestor
138564036|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
138564037|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564038|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564039|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138564040|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
138564041|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
138564042|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138564043|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138564044|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138564045|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
138564046|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564047|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564048|NCT00093561|Lycopene|lycopene|mesh-list
138564049|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138564050|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
138564051|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564052|NCT00093561|Protective Agents|protective agents|mesh-ancestor
138564053|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564054|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138564055|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138564056|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564057|NCT00084890|Carboplatin|carboplatin|mesh-list
138564058|NCT00084890|Docetaxel|docetaxel|mesh-list
138564059|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564060|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
138564061|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
138564062|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
138564063|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564065|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138564066|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138564067|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138564068|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564069|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138564070|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564071|NCT00085124|Cytarabine|cytarabine|mesh-list
138564072|NCT00085124|Daunorubicin|daunorubicin|mesh-list
138564073|NCT00085124|Oblimersen|oblimersen|mesh-list
138564074|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138564075|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
138564076|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564077|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564078|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
138564079|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138564080|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138564081|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
138564082|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564083|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138176988|NCT03803449|Fentanyl|fentanyl|mesh-list
138564084|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138564085|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138564086|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564087|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
138564088|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138564089|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138564090|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564091|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138564092|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564093|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138564094|NCT00325858|Tramadol|tramadol|mesh-list
138564095|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138564097|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138564098|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564100|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
138317836|NCT01447446|Ribavirin|ribavirin|mesh-list
138564101|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564102|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
138564103|NCT00318955|Propofol|propofol|mesh-list
138564104|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138564105|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138564106|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564107|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138564108|NCT00318955|Analgesics|analgesics|mesh-ancestor
138564109|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
138564110|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564111|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138564112|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138564113|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138564114|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
138564115|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564116|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564117|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138564118|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
138564119|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
138564120|NCT00325936|Cilnidipine|cilnidipine|mesh-list
138564121|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138564122|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138564123|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564124|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138564125|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564126|NCT00318994|Meropenem|meropenem|mesh-list
138564127|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138564128|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138564129|NCT00093600|Cytarabine|cytarabine|mesh-list
138564130|NCT00093600|Daunorubicin|daunorubicin|mesh-list
138564131|NCT00093600|Midostaurin|midostaurin|mesh-list
138564132|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138564133|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
138564134|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564136|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
138564137|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138564138|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138564139|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
138564140|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445494|NCT01829659|Ticagrelor|ticagrelor|mesh-list
138564141|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138564142|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138564143|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138564144|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564145|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564146|NCT00319033|Bosentan|bosentan|mesh-list
138564147|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138564148|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138564149|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564150|NCT00085163|Leucovorin|leucovorin|mesh-list
138564151|NCT00085163|Celecoxib|celecoxib|mesh-list
138564152|NCT00085163|Fluorouracil|fluorouracil|mesh-list
138564153|NCT00085163|Calcium|calcium|mesh-list
138564154|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
138564155|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138564156|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564157|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
138564158|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564159|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138564160|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564161|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138564162|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
138564164|NCT00085163|Protective Agents|protective agents|mesh-ancestor
138564165|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
138564166|NCT00085163|Vitamins|vitamins|mesh-ancestor
138564167|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
138564168|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138564169|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138564170|NCT00085163|Analgesics|analgesics|mesh-ancestor
138564171|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
138564172|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564173|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138564174|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138564175|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138564176|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138564177|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564179|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138564180|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564181|NCT00093639|Everolimus|everolimus|mesh-list
138564182|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
138564183|NCT00093639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138564184|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564185|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564186|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564187|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138564188|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
138564189|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564190|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564191|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
138564192|NCT00319150|Hematinics|hematinics|mesh-ancestor
138564193|NCT00326053|Budesonide|budesonide|mesh-list
138564194|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
138564195|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138564196|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138564197|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
138564198|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564199|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564200|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138564201|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
138564202|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
138564203|NCT00326053|Hormones|hormones|mesh-ancestor
138177073|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138564204|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138564205|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138564206|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138564207|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138564208|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
138564209|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564210|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564211|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
138564213|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
138564214|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138564215|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564216|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564217|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
138564218|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138564219|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138564220|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564221|NCT00400088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138564222|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138564223|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138416370|NCT01664845|Metformin|metformin|mesh-list
138564224|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564225|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
138564226|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138564227|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138564228|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138564230|NCT00326092|Brinzolamide|brinzolamide|mesh-list
138564231|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138564232|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138564233|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
138564234|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564235|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564236|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564237|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138564238|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138564239|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138564240|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564241|NCT00326131|Taxane|taxane|mesh-list
138564242|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564243|NCT00319189|Nateglinide|nateglinide|mesh-list
138177101|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138564245|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564247|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138564248|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138564249|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564250|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138564252|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564253|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457461|NCT01918358|Valsartan|valsartan|mesh-list
138564254|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564256|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
138564257|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
138564258|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564259|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564260|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138564261|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138564262|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564263|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564264|NCT00319306|Budesonide|budesonide|mesh-list
138564265|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
138564266|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138564267|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138564268|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138564269|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
138564270|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564271|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564272|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138564273|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
138564274|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
138564275|NCT00319306|Hormones|hormones|mesh-ancestor
138564276|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138564277|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138564278|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138564279|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138164764|NCT03985514|Tazobactam|tazobactam|mesh-list
138564280|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
138564281|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564282|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177136|NCT00775411|Hormones|hormones|mesh-ancestor
138564284|NCT00085358|Docetaxel|docetaxel|mesh-list
138564285|NCT00085358|Bevacizumab|bevacizumab|mesh-list
138564286|NCT00085358|Carboplatin|carboplatin|mesh-list
138564287|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138564288|NCT00085358|Antibodies|antibodies|mesh-list
138564289|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
138564290|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138564291|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138564292|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564293|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
138564294|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
138564295|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
138564296|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564297|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138564298|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138564299|NCT00085358|Growth Substances|growth substances|mesh-ancestor
138564300|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138164873|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138564301|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
138564302|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
138564303|NCT00093678|Celecoxib|celecoxib|mesh-list
138564304|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138564305|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138564306|NCT00093678|Analgesics|analgesics|mesh-ancestor
138564307|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
138564308|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564309|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564310|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177170|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138564312|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138564313|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138564314|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564315|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564316|NCT00319345|Mannitol|mannitol|mesh-list
138564317|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138564318|NCT00319345|Diuretics|diuretics|mesh-ancestor
138564319|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
138564320|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564321|NCT00419536|Panobinostat|panobinostat|mesh-list
138564322|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564323|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138564324|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564325|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564326|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138564327|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138564328|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138564329|NCT00326404|Desogestrel|desogestrel|mesh-list
138564330|NCT00326404|Estradiol|estradiol|mesh-list
138564331|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138165030|NCT00506857|Busulfan|busulfan|mesh-list
138564332|NCT00326404|Estrogens|estrogens|mesh-ancestor
138564333|NCT00326404|Hormones|hormones|mesh-ancestor
138564334|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138564335|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564336|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138564337|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
138564338|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138564339|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138564340|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138564341|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138564342|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138564344|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
138564345|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564346|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564347|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564348|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564349|NCT00319618|Docetaxel|docetaxel|mesh-list
138564350|NCT00319618|Gefitinib|gefitinib|mesh-list
138165142|NCT00219284|Levodopa|levodopa|mesh-list
138564351|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564352|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
138564353|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
138564354|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
138564355|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177220|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
138564356|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564357|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564359|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138564360|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138165213|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138564361|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138564362|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564363|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564364|NCT00124332|Hormones|hormones|mesh-ancestor
138564365|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138564366|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564367|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138564368|NCT00085553|Tipifarnib|tipifarnib|mesh-list
138457603|NCT01919047|Mirabegron|mirabegron|mesh-list
138564369|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564370|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564371|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564372|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564373|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
138165280|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138165285|NCT00216086|Capecitabine|capecitabine|mesh-list
138564374|NCT00400335|Testosterone|testosterone|mesh-list
138564375|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
138564376|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
138564377|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138564378|NCT00400335|Dutasteride|dutasteride|mesh-list
138564379|NCT00400335|Androgens|androgens|mesh-ancestor
138564380|NCT00400335|Hormones|hormones|mesh-ancestor
138317865|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564381|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138564383|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138564384|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564385|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
138564386|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138564387|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138564388|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564389|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564390|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
138564391|NCT00319852|Vaccines|vaccines|mesh-list
138564392|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
138564393|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564394|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
138564395|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
138564396|NCT00326833|Vitamins|vitamins|mesh-ancestor
138165410|NCT06068686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564398|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564399|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
138564400|NCT00326833|Hematinics|hematinics|mesh-ancestor
138564401|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138564402|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138564403|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138445596|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138564404|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138564405|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564406|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138165480|NCT06068023|Oxaliplatin|oxaliplatin|mesh-list
138564407|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138564408|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138564409|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
138564410|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564411|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564412|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138564413|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138564414|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
138564415|NCT04717102|Desflurane|desflurane|mesh-list
138564416|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138564417|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
138564418|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
138564419|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138564420|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564421|NCT00320047|Baclofen|baclofen|mesh-list
138564422|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138564423|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564424|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138564425|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138457663|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
138564426|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138564427|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
138564428|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
138564429|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564430|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240746|NCT03502577|Fludarabine|fludarabine|mesh-list
138564431|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
138564432|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564433|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138564434|NCT00085826|Protective Agents|protective agents|mesh-ancestor
138564435|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329334|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
138329335|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138564436|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138564437|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564438|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564439|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138564440|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138564441|NCT00085826|Analgesics|analgesics|mesh-ancestor
138564442|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
138329402|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138329408|NCT00504660|Celecoxib|celecoxib|mesh-list
138564443|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564444|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138445623|NCT01832350|Quinidine|quinidine|mesh-list
138564445|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138564446|NCT00320125|Calcium|calcium|mesh-list
138564447|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138564448|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564449|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
138564450|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564451|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564452|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564454|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138564455|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138564456|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138457707|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564457|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564458|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564459|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
138564460|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138564461|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138564462|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564463|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
138564464|NCT00327106|Coagulants|coagulants|mesh-ancestor
138177269|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138564466|NCT00320359|Etoposide|etoposide|mesh-list
138564467|NCT00320359|Topotecan|topotecan|mesh-list
138564468|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564469|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138564470|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138564471|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138564472|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564473|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564474|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138564475|NCT00093912|Nitroprusside|nitroprusside|mesh-list
138564476|NCT00093912|Clevidipine|clevidipine|mesh-list
138564477|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138564478|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
138564479|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138329528|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138329529|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138564480|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564481|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138564482|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138564483|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138564484|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564485|NCT00327145|Amlodipine|amlodipine|mesh-list
138564487|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138564488|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138564489|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138564490|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138564491|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564492|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138564493|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564494|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
138564495|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138564496|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138564497|NCT00327145|Diuretics|diuretics|mesh-ancestor
138564498|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
138564499|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138564500|NCT00085943|Ritonavir|ritonavir|mesh-list
138564501|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
138564502|NCT00085943|Lamivudine|lamivudine|mesh-list
138564503|NCT00085943|Abacavir|abacavir|mesh-list
138564504|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138240822|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
138564506|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
138564508|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329588|NCT01797198|Repaglinide|repaglinide|mesh-list
138329589|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
138329590|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138564509|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138564510|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138564511|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
138564512|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138564513|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138564514|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138564515|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138564516|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138564518|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
138564519|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138564520|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138416743|NCT01667211|Paclitaxel|paclitaxel|mesh-list
138564521|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329633|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564523|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138564524|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564525|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
138564526|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138564527|NCT00093951|Protective Agents|protective agents|mesh-ancestor
138564528|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564529|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
138564530|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
138564531|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564532|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564533|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
138564534|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
138564535|NCT00320476|Bortezomib|bortezomib|mesh-list
138564536|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445670|NCT01834820|Hormones|hormones|mesh-ancestor
138564538|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564539|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564540|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564541|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564542|NCT00093990|Tipifarnib|tipifarnib|mesh-list
138564543|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564544|NCT00327379|Aprotinin|aprotinin|mesh-list
138564545|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
138564546|NCT00327379|Coagulants|coagulants|mesh-ancestor
138564547|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138564548|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138564549|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
138564550|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177309|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
138564551|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564552|NCT00327418|Atorvastatin|atorvastatin|mesh-list
138564553|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138564554|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138564555|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
138564556|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564557|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138564558|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138564559|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564561|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564562|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138564563|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138564564|NCT00094029|Growth Substances|growth substances|mesh-ancestor
138564565|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564566|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
138564567|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564568|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564569|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564570|NCT00086099|Amifostine|amifostine|mesh-list
138564571|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138329747|NCT00527124|Cediranib|cediranib|mesh-list
138564572|NCT00086099|Protective Agents|protective agents|mesh-ancestor
138564573|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564574|NCT00320632|Desipramine|desipramine|mesh-list
138564575|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138564576|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
138564577|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138564578|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564579|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564580|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138564581|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138564582|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138564583|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
138564584|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564585|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564586|NCT00320827|Antibodies|antibodies|mesh-list
138564587|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
138564588|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564589|NCT00320983|Topotecan|topotecan|mesh-list
138564590|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564591|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138564592|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138564593|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177355|NCT02986503|Cisplatin|cisplatin|mesh-list
138329798|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
138329799|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
138564594|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564596|NCT00086177|Progestins|progestins|mesh-ancestor
138564597|NCT00086177|Hormones|hormones|mesh-ancestor
138564598|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138564599|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564600|NCT00094146|Octreotide|octreotide|mesh-list
138564602|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138564603|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564605|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
138564606|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
138564607|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138564608|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138564609|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564610|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
138564611|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564612|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564613|NCT00321178|Clarithromycin|clarithromycin|mesh-list
138564614|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138564615|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138564616|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138564617|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564618|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564619|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138564620|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138329851|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138564621|NCT00124527|Capecitabine|capecitabine|mesh-list
138564622|NCT00124527|Irofulven|irofulven|mesh-list
138564623|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138564624|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
138564625|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564626|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564627|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138564628|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
138564629|NCT00086294|Levodopa|levodopa|mesh-list
138564630|NCT00086294|Pimavanserin|pimavanserin|mesh-list
138564631|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138564632|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138564633|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
138564634|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564635|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138329899|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
138329903|NCT03416244|Nivolumab|nivolumab|mesh-list
138564636|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564637|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138564638|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138564639|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138564640|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138564641|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138564642|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138564643|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
138564644|NCT05458492|Sirolimus|sirolimus|mesh-list
138564645|NCT05458492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138564646|NCT05458492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138564647|NCT05458492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138564648|NCT05458492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564649|NCT05458492|Antifungal Agents|antifungal agents|mesh-ancestor
138564650|NCT05458492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138564651|NCT05458492|Immunologic Factors|immunologic factors|mesh-ancestor
138564652|NCT05458492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564654|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564655|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
138564656|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
138564657|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
138564658|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564660|NCT05458180|Cyclophosphamide|cyclophosphamide|mesh-list
138564661|NCT05458180|Etoposide|etoposide|mesh-list
138564662|NCT05458180|Vincristine|vincristine|mesh-list
138564663|NCT05458180|Mitoxantrone|mitoxantrone|mesh-list
138564664|NCT05458180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138457903|NCT01930019|Thiopental|thiopental|mesh-list
138564666|NCT05458180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564667|NCT05458180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138564668|NCT05458180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138564669|NCT05458180|Alkylating Agents|alkylating agents|mesh-ancestor
138564670|NCT05458180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564671|NCT05458180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564672|NCT05458180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138564673|NCT05458180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138564674|NCT05458180|Glucocorticoids|glucocorticoids|mesh-ancestor
138564675|NCT05458180|Hormones|hormones|mesh-ancestor
138564676|NCT05458180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138564677|NCT05458180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138564678|NCT05458180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138564679|NCT05458180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138564680|NCT05458180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138564681|NCT05458180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564682|NCT05458180|Tubulin Modulators|tubulin modulators|mesh-ancestor
138564683|NCT05458180|Antimitotic Agents|antimitotic agents|mesh-ancestor
138330009|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564684|NCT05458180|Mitosis Modulators|mitosis modulators|mesh-ancestor
138564685|NCT05458180|Analgesics|analgesics|mesh-ancestor
138564686|NCT05458180|Sensory System Agents|sensory system agents|mesh-ancestor
138564687|NCT05458180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564688|NCT00419653|Haloperidol|haloperidol|mesh-list
138564689|NCT00419653|Olanzapine|olanzapine|mesh-list
138564690|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
138564691|NCT00419653|Amisulpride|amisulpride|mesh-list
138564692|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
138564693|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
138564694|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564695|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564696|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138564697|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138564698|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138564699|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138564700|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138564701|NCT00419653|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138445738|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138564702|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138564703|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138564704|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564705|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564706|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
138564707|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138564708|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
138330062|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138177407|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138564709|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138564710|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138564711|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
138564713|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138564714|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138564715|NCT00094341|Analgesics|analgesics|mesh-ancestor
138330112|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
138330113|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564716|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
138564717|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564718|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564719|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138564720|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138564721|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138564722|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138564723|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
138564724|NCT00086489|Tremelimumab|tremelimumab|mesh-list
138564725|NCT00086489|Ipilimumab|ipilimumab|mesh-list
138564726|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564727|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138564728|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138564729|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564730|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
138564731|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138564732|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
138564733|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564734|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138564735|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138564736|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
138564737|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564738|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564739|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138564740|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138564741|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138564742|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
138564743|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138564744|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138564745|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138564746|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138564747|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330178|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564748|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138564749|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138564750|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138564751|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564752|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564753|NCT00321490|Analgesics|analgesics|mesh-ancestor
138564754|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
138564755|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564756|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
138564758|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564759|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564760|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564761|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564762|NCT05457829|Doxorubicin|doxorubicin|mesh-list
138564763|NCT05457829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138564764|NCT05457829|Irinotecan|irinotecan|mesh-list
138564765|NCT05457829|Vincristine|vincristine|mesh-list
138564766|NCT05457829|Temozolomide|temozolomide|mesh-list
138564767|NCT05457829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138564768|NCT05457829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564769|NCT05457829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138330234|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
138564770|NCT05457829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138564771|NCT05457829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564772|NCT05457829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564773|NCT05457829|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138177416|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
138564774|NCT05457829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138564775|NCT05457829|Tubulin Modulators|tubulin modulators|mesh-ancestor
138564776|NCT05457829|Antimitotic Agents|antimitotic agents|mesh-ancestor
138564777|NCT05457829|Mitosis Modulators|mitosis modulators|mesh-ancestor
138564778|NCT05457829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138564779|NCT05457829|Alkylating Agents|alkylating agents|mesh-ancestor
138564781|NCT05457751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138564782|NCT05457751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138458012|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138564783|NCT05457751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138564784|NCT05457751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564785|NCT05457751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564786|NCT00086606|Omalizumab|omalizumab|mesh-list
138330286|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138330287|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
138330288|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330289|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330290|NCT00611442|Lubiprostone|lubiprostone|mesh-list
138330291|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138564787|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138564788|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138564789|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
138564790|NCT00124566|Prednisone|prednisone|mesh-list
138564791|NCT00124566|Capecitabine|capecitabine|mesh-list
138564792|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
138564793|NCT00124566|Irofulven|irofulven|mesh-list
138564794|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138564796|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330340|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
138330341|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330342|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138330343|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138564797|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564798|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138564799|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
138564800|NCT00124566|Hormones|hormones|mesh-ancestor
138564801|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138564802|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564803|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138564804|NCT00124566|Analgesics|analgesics|mesh-ancestor
138564805|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
138564806|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564807|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138564808|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138564809|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564810|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138564811|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
138564812|NCT00321724|Cediranib|cediranib|mesh-list
138564813|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564814|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564815|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138330406|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138564816|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564817|NCT00086645|Dexetimide|dexetimide|mesh-list
138564818|NCT00086645|Citalopram|citalopram|mesh-list
138564819|NCT00086645|Escitalopram|escitalopram|mesh-list
138564820|NCT00086645|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138564821|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138564822|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138564823|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564824|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564825|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
138458050|NCT01930812|Listerine|listerine|mesh-list
138445781|NCT01837446|Narcotics|narcotics|mesh-ancestor
138564827|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138564828|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
138564829|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138564830|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138564831|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138564832|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
138564833|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
138564834|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564835|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138330463|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564836|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138564837|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
138564838|NCT00321802|Simvastatin|simvastatin|mesh-list
138564839|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138564840|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138564841|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
138564842|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564843|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138564844|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138564845|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564846|NCT00124605|Pamidronate|pamidronate|mesh-list
138564847|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
138564848|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564849|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138564850|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564851|NCT05457361|Azacitidine|azacitidine|mesh-list
138564852|NCT05457361|Homoharringtonine|homoharringtonine|mesh-list
138564853|NCT05457361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138564854|NCT05457361|Antimetabolites|antimetabolites|mesh-ancestor
138564855|NCT05457361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564856|NCT05457361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564857|NCT05457361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564858|NCT05457361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138564859|NCT05457361|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138564861|NCT00086801|Doxorubicin|doxorubicin|mesh-list
138564862|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138564863|NCT00086801|Vinblastine|vinblastine|mesh-list
138564864|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138564865|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138564866|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
138564867|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564868|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564869|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138564870|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138564871|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138564872|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564873|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138564874|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138564875|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
138564876|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
138564877|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
138564878|NCT00124644|Cytarabine|cytarabine|mesh-list
138564879|NCT00124644|Etoposide|etoposide|mesh-list
138564880|NCT00124644|Daunorubicin|daunorubicin|mesh-list
138564881|NCT00124644|Tipifarnib|tipifarnib|mesh-list
138564882|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138564883|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138564884|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564885|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138564886|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138564887|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564888|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138564889|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
138564890|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
138564891|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138564892|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138564893|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
138564894|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564895|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138564897|NCT00086840|Temsirolimus|temsirolimus|mesh-list
138564898|NCT00086840|MTOR Inhibitors|mtor inhibitors|mesh-list
138177445|NCT03802565|Tolperisone|tolperisone|mesh-list
138564899|NCT00086840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564900|NCT00086840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564901|NCT00086840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564902|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138564903|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
138564904|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564905|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564906|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138564907|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138330614|NCT05766436|Antioxidants|antioxidants|mesh-ancestor
138564908|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138564909|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
138564910|NCT00124683|Bupropion|bupropion|mesh-list
138564911|NCT00124683|Nicotine|nicotine|mesh-list
138564912|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138564913|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
138564914|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564915|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564916|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138564917|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138564918|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
138564919|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564920|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564921|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138330678|NCT05765240|Hyaluronic Acid|hyaluronic acid|mesh-list
138330682|NCT05765240|Viscosupplements|viscosupplements|mesh-ancestor
138564922|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
138564923|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138564924|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138564925|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138564926|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138564927|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
138564928|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138564929|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138564930|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564931|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138564932|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138564933|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138564934|NCT00086879|Temozolomide|temozolomide|mesh-list
138564935|NCT00086879|Carmustine|carmustine|mesh-list
138177450|NCT04382443|Colchicine|colchicine|mesh-list
138177451|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
138564936|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138564937|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138564938|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
138317907|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
138564939|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564940|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564941|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564942|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564944|NCT00124722|Rocuronium|rocuronium|mesh-list
138564945|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
138564946|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138564947|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138564948|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138564949|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564950|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564951|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
138241281|NCT02192398|Guanfacine|guanfacine|mesh-list
138564952|NCT00322036|Tarenflurbil|tarenflurbil|mesh-list
138564953|NCT00322036|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138564954|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564955|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564956|NCT00322036|Analgesics|analgesics|mesh-ancestor
138564957|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
138564958|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564959|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564960|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138564961|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138564962|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138564963|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138564964|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138564965|NCT00094614|Atropine|atropine|mesh-list
138564966|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138564967|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138564968|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138564969|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
138564970|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138564971|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564972|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138330853|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564973|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
138564974|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
138564975|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
138564976|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138564977|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138564978|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
138177487|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138564979|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138564980|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564981|NCT00087035|Docetaxel|docetaxel|mesh-list
138564982|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138330929|NCT04908176|Midazolam|midazolam|mesh-list
138564983|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138564984|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
138564985|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
138458161|NCT01931410|Misoprostol|misoprostol|mesh-list
138564986|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
138564987|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564988|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138564989|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138564990|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
138564991|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138564992|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564993|NCT00322114|Lycopene|lycopene|mesh-list
138564994|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138564995|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
138564996|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138564997|NCT00322114|Protective Agents|protective agents|mesh-ancestor
138564998|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138564999|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138565000|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138565001|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565002|NCT00087074|Sirolimus|sirolimus|mesh-list
138330988|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138330989|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
138565003|NCT00087074|Temsirolimus|temsirolimus|mesh-list
138565004|NCT00087074|MTOR Inhibitors|mtor inhibitors|mesh-list
138565005|NCT00087074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138565006|NCT00087074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317908|NCT01445886|Calcitriol|calcitriol|mesh-list
138565007|NCT00087074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565008|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138565009|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
138565010|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565011|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565012|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138565013|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565014|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138331052|NCT04521335|Copper|copper|mesh-list
138565015|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
138565017|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138565018|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
138479982|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565019|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565020|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
138565021|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565022|NCT00087113|Pemetrexed|pemetrexed|mesh-list
138565023|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565024|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565025|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565026|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138565027|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138565028|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138565029|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138565030|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
138565031|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138565032|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138565033|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138565034|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138565035|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565036|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138565037|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138565038|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565039|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331106|NCT04119453|Apatinib|apatinib|mesh-list
138331107|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331108|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138565040|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565041|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138565042|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
138565043|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138565044|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565045|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138565046|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138565047|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138565048|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
138565049|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138565050|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
138565051|NCT00094692|Atropine|atropine|mesh-list
138565052|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138565053|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138565054|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138565055|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
138565056|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565057|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565058|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138565059|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
138565060|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
138565061|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
138565062|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138565063|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138177543|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138177544|NCT02151487|Dexamethasone|dexamethasone|mesh-list
138565064|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
138565065|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565066|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565067|NCT05181007|Valproic Acid|valproic acid|mesh-list
138331153|NCT03775460|Prednisolone|prednisolone|mesh-list
138565068|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
138565069|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565070|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565071|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
138565072|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565073|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565074|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
138565075|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138565076|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565077|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138565078|NCT00124839|Naltrexone|naltrexone|mesh-list
138565079|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138565080|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138565081|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565082|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
138565083|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565084|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138565085|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565086|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138565087|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138458275|NCT01932229|Afatinib|afatinib|mesh-list
138565088|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565089|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138565090|NCT00087347|Hematinics|hematinics|mesh-ancestor
138331195|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
138565091|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138565092|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138565093|NCT00419692|Ropinirole|ropinirole|mesh-list
138565094|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138565095|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138565096|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
138565097|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
138565098|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565099|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565100|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565102|NCT00419731|Bupropion|bupropion|mesh-list
138177576|NCT05318339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138565104|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138565105|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565106|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
138565107|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565108|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138565109|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
138565110|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138565111|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138565112|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138565113|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138565114|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565115|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
138565116|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565117|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138565118|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138565119|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565120|NCT00419848|Azithromycin|azithromycin|mesh-list
138565121|NCT00419848|Doxycycline|doxycycline|mesh-list
138565122|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138565123|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565124|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
138565125|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138565126|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138458307|NCT01932372|Etanercept|etanercept|mesh-list
138565128|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565129|NCT00087425|Rituximab|rituximab|mesh-list
138565131|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138565132|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565133|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
138565134|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565135|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331245|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138331252|NCT02564263|Paclitaxel|paclitaxel|mesh-list
138331253|NCT02564263|Docetaxel|docetaxel|mesh-list
138331254|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
138331255|NCT02564263|Irinotecan|irinotecan|mesh-list
138331256|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138331257|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138331258|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
138565136|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138565137|NCT00330655|Memantine|memantine|mesh-list
138565138|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138565139|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138565140|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
138565141|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177611|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565142|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565143|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565144|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138565145|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138565146|NCT00330772|Aspirin|aspirin|mesh-list
138565147|NCT00330772|Clopidogrel|clopidogrel|mesh-list
138565148|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138565149|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138565150|NCT00330772|Analgesics|analgesics|mesh-ancestor
138565151|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
138565152|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565153|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565154|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565155|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138565156|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138565157|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138565158|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565159|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138565160|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138565161|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565162|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
138565163|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138565164|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138565165|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138565166|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
138331279|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565167|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565168|NCT00094926|Risperidone|risperidone|mesh-list
138565169|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138565170|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
138565171|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565172|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565173|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241507|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565174|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138565175|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138565176|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138331319|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138331320|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138331329|NCT02099188|Antidotes|antidotes|mesh-ancestor
138565177|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138565178|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138565179|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
138565180|NCT00087464|Tenofovir|tenofovir|mesh-list
138565181|NCT00087464|Emtricitabine|emtricitabine|mesh-list
138565182|NCT00087464|Nevirapine|nevirapine|mesh-list
138565183|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
138565184|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565185|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138331385|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138565186|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138565188|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565189|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138565190|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138565191|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138565192|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138565193|NCT00331045|Alvimopan|alvimopan|mesh-list
138565194|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138565195|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138565196|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
138331450|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138331451|NCT01105975|Simvastatin|simvastatin|mesh-list
138331452|NCT01105975|Evacetrapib|evacetrapib|mesh-list
138565197|NCT00331084|Dexamethasone|dexamethasone|mesh-list
138565198|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
138565199|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138565200|NCT00331084|BB 1101|bb 1101|mesh-list
138565201|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565202|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
138565203|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
138565204|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565205|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565206|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138458392|NCT01932580|Docetaxel|docetaxel|mesh-list
138565208|NCT00331084|Hormones|hormones|mesh-ancestor
138565209|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138565210|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138565211|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565212|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
138565213|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565214|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565215|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138331516|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
138331517|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
138331518|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
138565216|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138565217|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138565218|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138565219|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
138565220|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138317920|NCT01470612|Tofacitinib|tofacitinib|mesh-list
138565221|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138565222|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138565223|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138565224|NCT00420355|Ritonavir|ritonavir|mesh-list
138565225|NCT00420355|Lopinavir|lopinavir|mesh-list
138565226|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138331571|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138331572|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138565227|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138565228|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138565229|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
138565230|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565231|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565232|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138565233|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138177680|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138565234|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
138565235|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565236|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138565237|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138565238|NCT00331123|Testosterone|testosterone|mesh-list
138565239|NCT00331123|Androgens|androgens|mesh-ancestor
138565240|NCT00331123|Hormones|hormones|mesh-ancestor
138565241|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138565242|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565243|NCT00087542|Pimavanserin|pimavanserin|mesh-list
138565244|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138565245|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138565246|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138565247|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138565248|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565249|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565251|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138565252|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138565253|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
138565254|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565255|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565256|NCT00331240|Timolol|timolol|mesh-list
138565257|NCT00331240|Travoprost|travoprost|mesh-list
138565258|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
138565259|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138565260|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138565261|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
138445871|NCT01840774|Ketamine|ketamine|mesh-list
138565262|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138331702|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
138331716|NCT04366596|Paclitaxel|paclitaxel|mesh-list
138565263|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565264|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565265|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138565266|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138565267|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138565268|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138565269|NCT00124956|Doxorubicin|doxorubicin|mesh-list
138565270|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138565271|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565272|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138565273|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138565274|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565275|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565277|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
138565278|NCT00087581|Tacrolimus|tacrolimus|mesh-list
138565279|NCT00087581|Cyclosporins|cyclosporins|mesh-list
138565280|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138565281|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
138565282|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565283|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138565284|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138177702|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138565285|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565287|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565288|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
138565289|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138565290|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138565291|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565292|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138565293|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
138565294|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138565295|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
138331752|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
138565296|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565297|NCT00331435|Verteporfin|verteporfin|mesh-list
138565298|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138565299|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
138565300|NCT00331513|Vorinostat|vorinostat|mesh-list
138565301|NCT00331513|Idarubicin|idarubicin|mesh-list
138565302|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565303|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138565304|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565305|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565306|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138565307|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138565308|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138565309|NCT00087620|Capecitabine|capecitabine|mesh-list
138565310|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138565311|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
138331801|NCT04362384|Vitamin E|vitamin e|mesh-list
138565312|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565313|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565314|NCT00124995|Terbutaline|terbutaline|mesh-list
138565315|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138565316|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
138565317|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565318|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565319|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138565320|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
138565321|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
138565322|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
138565323|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138241658|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
138565324|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138565325|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138565326|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138565327|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
138565328|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565329|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565332|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
138565333|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138565334|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
138565335|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138331855|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138331856|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138565336|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138565337|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565338|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565339|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
138565340|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
138565341|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138565342|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
138565343|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138565344|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565345|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565346|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138565347|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
138565349|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138565350|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
138331909|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
138565351|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565352|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138565353|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138565354|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
138565355|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138565356|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565357|NCT00331786|Aspirin|aspirin|mesh-list
138565358|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
138565359|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
138565360|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138565361|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138565362|NCT00331786|Analgesics|analgesics|mesh-ancestor
138565363|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
138565364|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565365|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565366|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565367|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138565368|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138565369|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138331970|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138331971|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
138331972|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138565370|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565371|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138565372|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138565373|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565374|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
138565375|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138565376|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
138565377|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138565378|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
138565379|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138565380|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
138565381|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565382|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138565383|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
138565384|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
138565385|NCT00331786|Protective Agents|protective agents|mesh-ancestor
138565386|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138565387|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
138565388|NCT00331825|Olanzapine|olanzapine|mesh-list
138565389|NCT00331825|Risperidone|risperidone|mesh-list
138445900|NCT01841008|Tacrolimus|tacrolimus|mesh-list
138565390|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138565391|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
138565392|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565393|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565394|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565395|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138565396|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138241765|NCT02802111|Albuterol|albuterol|mesh-list
138565397|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565398|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138332026|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
138565399|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138565400|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
138565401|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
138565402|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
138565403|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565404|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138565405|NCT00331825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138565406|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138565407|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138565408|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
138565409|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138565410|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565411|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138565412|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
138565413|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138332072|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138565414|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565415|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565416|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565417|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138565418|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138565419|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138565420|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138565421|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565422|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565423|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565424|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138565425|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
138565426|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138565427|NCT00331981|Amisulpride|amisulpride|mesh-list
138565428|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138565429|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138565430|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565431|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565432|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138565433|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138565434|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
138565435|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565436|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565437|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138565438|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
138565440|NCT00126633|Gemcitabine|gemcitabine|mesh-list
138332134|NCT04345458|Analgesics|analgesics|mesh-ancestor
138565441|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138565442|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565443|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138565444|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138565445|NCT00126633|Growth Substances|growth substances|mesh-ancestor
138565446|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565447|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
138565448|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138565449|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
138565450|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565451|NCT00332020|Enoxaparin|enoxaparin|mesh-list
138565452|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
138332184|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
138332185|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332186|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565453|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138565454|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
138565455|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138565456|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
138565457|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565458|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565459|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
138565460|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138565461|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138565462|NCT02965274|Fluoxetine|fluoxetine|mesh-list
138565463|NCT02965274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138565464|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138565465|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138565466|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565467|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565468|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
138177807|NCT02003625|Meloxicam|meloxicam|mesh-list
138565469|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565470|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138458626|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
138565471|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
138565472|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138565473|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138565474|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138565475|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565476|NCT00332059|Timolol|timolol|mesh-list
138565477|NCT00332059|Bimatoprost|bimatoprost|mesh-list
138565478|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138565479|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138565480|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
138565481|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565482|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565483|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565484|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138565485|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138565486|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138565487|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138565488|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138565489|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
138565490|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565491|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565492|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565493|NCT00332137|Urological Agents|urological agents|mesh-ancestor
138565494|NCT00126789|Fentanyl|fentanyl|mesh-list
138565495|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138565496|NCT00126789|Narcotics|narcotics|mesh-ancestor
138565497|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565498|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565499|NCT00126789|Analgesics|analgesics|mesh-ancestor
138565500|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
138565501|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565502|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138565503|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138565504|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
138565505|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
138565506|NCT05831969|Lenalidomide|lenalidomide|mesh-list
138565507|NCT05831969|Immunologic Factors|immunologic factors|mesh-ancestor
138332297|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138332298|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138565508|NCT05831969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565509|NCT05831969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138565510|NCT05831969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138445916|NCT01841112|BI 409306|bi 409306|mesh-list
138565511|NCT05831969|Growth Substances|growth substances|mesh-ancestor
138565512|NCT05831969|Growth Inhibitors|growth inhibitors|mesh-ancestor
138565513|NCT05831969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565515|NCT05831761|Analgesics|analgesics|mesh-list
138565516|NCT05831761|Anesthetics, Local|anesthetics, local|mesh-ancestor
138565517|NCT05831761|Anesthetics|anesthetics|mesh-ancestor
138177841|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138177843|NCT00816829|Fenofibrate|fenofibrate|mesh-list
138565518|NCT05831761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565519|NCT05831761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565520|NCT05831761|Sensory System Agents|sensory system agents|mesh-ancestor
138565521|NCT05831761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565522|NCT05831761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138565523|NCT05831761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138565524|NCT05831761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138565525|NCT05831761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138332378|NCT04332978|Xhance|xhance|mesh-list
138565526|NCT05831761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565527|NCT05831566|Budesonide|budesonide|mesh-list
138565528|NCT05831566|Formoterol Fumarate|formoterol fumarate|mesh-list
138565529|NCT05831566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565530|NCT05831566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138565531|NCT05831566|Autonomic Agents|autonomic agents|mesh-ancestor
138565532|NCT05831566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565533|NCT05831566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565534|NCT05831566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138565535|NCT05831566|Respiratory System Agents|respiratory system agents|mesh-ancestor
138565536|NCT05831566|Glucocorticoids|glucocorticoids|mesh-ancestor
138565537|NCT05831566|Hormones|hormones|mesh-ancestor
138458715|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138565538|NCT05831566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138565539|NCT05831566|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138565540|NCT05831566|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138565541|NCT05831566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138565542|NCT05831566|Adrenergic Agents|adrenergic agents|mesh-ancestor
138565543|NCT05831566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138332395|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332397|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
138565544|NCT05831566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565545|NCT05831462|Ticagrelor|ticagrelor|mesh-list
138565546|NCT05831462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138565547|NCT05831462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138565548|NCT05831462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138565549|NCT05831462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138565550|NCT05831462|Purinergic Agents|purinergic agents|mesh-ancestor
138565551|NCT05831462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565552|NCT05831462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565553|NCT05831462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565554|NCT05831345|Sufentanil|sufentanil|mesh-list
138565555|NCT05831345|Dsuvia|dsuvia|mesh-list
138565556|NCT05831345|Methadone|methadone|mesh-list
138565557|NCT05831345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138565558|NCT05831345|Narcotics|narcotics|mesh-ancestor
138565559|NCT05831345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565560|NCT05831345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565561|NCT05831345|Analgesics|analgesics|mesh-ancestor
138565562|NCT05831345|Sensory System Agents|sensory system agents|mesh-ancestor
138565563|NCT05831345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565564|NCT05831345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138565565|NCT05831345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138565566|NCT05831345|Anesthetics, General|anesthetics, general|mesh-ancestor
138565567|NCT05831345|Anesthetics|anesthetics|mesh-ancestor
138565568|NCT05831345|Antitussive Agents|antitussive agents|mesh-ancestor
138332450|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
138332451|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565569|NCT05831345|Respiratory System Agents|respiratory system agents|mesh-ancestor
138177869|NCT00816907|Metformin|metformin|mesh-list
138565570|NCT05831267|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138565572|NCT05831267|Coagulants|coagulants|mesh-ancestor
138565573|NCT05830916|Antibodies|antibodies|mesh-list
138458758|NCT01935505|Nicotine|nicotine|mesh-list
138565574|NCT05830916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
138565575|NCT05830916|Immunologic Factors|immunologic factors|mesh-ancestor
138565576|NCT05830916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565577|NCT05830864|Isoflurane|isoflurane|mesh-list
138317934|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
138565578|NCT05830864|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138565579|NCT05830864|Anesthetics, General|anesthetics, general|mesh-ancestor
138565581|NCT05830864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565582|NCT05830864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565583|NCT05830747|Prednisone|prednisone|mesh-list
138565584|NCT05830747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565585|NCT05830747|Glucocorticoids|glucocorticoids|mesh-ancestor
138565586|NCT05830747|Hormones|hormones|mesh-ancestor
138565587|NCT05830747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138565588|NCT05830747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332501|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
138332503|NCT03033732|Methadone|methadone|mesh-list
138565589|NCT05830747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138565590|NCT05830747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565591|NCT05830604|Salicylic Acid|salicylic acid|mesh-list
138565592|NCT05830604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565593|NCT05830604|Antifungal Agents|antifungal agents|mesh-ancestor
138565594|NCT05830604|Keratolytic Agents|keratolytic agents|mesh-ancestor
138565595|NCT05830604|Dermatologic Agents|dermatologic agents|mesh-ancestor
138565596|NCT05828758|Amoxicillin|amoxicillin|mesh-list
138565597|NCT05828758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138565598|NCT05828758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565599|NCT05820997|Ropivacaine|ropivacaine|mesh-list
138565600|NCT05820997|Anesthetics, Local|anesthetics, local|mesh-ancestor
138565601|NCT05820997|Anesthetics|anesthetics|mesh-ancestor
138565602|NCT05820997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565603|NCT05820997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565604|NCT05820997|Sensory System Agents|sensory system agents|mesh-ancestor
138565605|NCT05820997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565606|NCT05776017|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138565607|NCT05776017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138565608|NCT05776017|Immunologic Factors|immunologic factors|mesh-ancestor
138565609|NCT05776017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565610|NCT05776017|Antacids|antacids|mesh-ancestor
138565611|NCT05776017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565612|NCT05776017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138565613|NCT05665270|Prednisolone|prednisolone|mesh-list
138565614|NCT05665270|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138565615|NCT05665270|Methylprednisolone|methylprednisolone|mesh-list
138565616|NCT05665270|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138565617|NCT05665270|Prednisolone acetate|prednisolone acetate|mesh-list
138565618|NCT05665270|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138565619|NCT05665270|Prednisolone phosphate|prednisolone phosphate|mesh-list
138565620|NCT05665270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565621|NCT05665270|Glucocorticoids|glucocorticoids|mesh-ancestor
138565622|NCT05665270|Hormones|hormones|mesh-ancestor
138565623|NCT05665270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138565624|NCT05665270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565625|NCT05665270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138565626|NCT05665270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138332614|NCT03017430|Phenazepam|phenazepam|mesh-list
138565627|NCT05665270|Antiemetics|antiemetics|mesh-ancestor
138565628|NCT05665270|Autonomic Agents|autonomic agents|mesh-ancestor
138565629|NCT05665270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565630|NCT05665270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138565631|NCT05665270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138565632|NCT05665270|Protective Agents|protective agents|mesh-ancestor
138565633|NCT05660447|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138565634|NCT05660447|Lubricant Eye Drops|lubricant eye drops|mesh-list
138565635|NCT05660447|Glycerol|glycerol|mesh-list
138565636|NCT05660447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138565637|NCT05660447|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138565638|NCT05660447|Protective Agents|protective agents|mesh-ancestor
138565639|NCT05660447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565640|NCT05653973|Acetylcholine|acetylcholine|mesh-list
138565641|NCT05653973|Vasodilator Agents|vasodilator agents|mesh-ancestor
138565642|NCT05653973|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138565643|NCT05653973|Cholinergic Agents|cholinergic agents|mesh-ancestor
138565644|NCT05653973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565645|NCT05653973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565646|NCT05653973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565647|NCT05574400|Caffeine|caffeine|mesh-list
138458833|NCT01935674|Ritonavir|ritonavir|mesh-list
138565648|NCT05574400|Caffeine citrate|caffeine citrate|mesh-list
138565649|NCT05574400|Citric Acid|citric acid|mesh-list
138565650|NCT05574400|Sodium Citrate|sodium citrate|mesh-list
138565651|NCT05574400|Anticoagulants|anticoagulants|mesh-ancestor
138332672|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
138332673|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332674|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138565652|NCT05574400|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138565653|NCT05574400|Chelating Agents|chelating agents|mesh-ancestor
138565654|NCT05574400|Sequestering Agents|sequestering agents|mesh-ancestor
138565655|NCT05574400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565656|NCT05574400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138565657|NCT05574400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565658|NCT05574400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138565659|NCT05574400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565660|NCT05574400|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138565661|NCT05574400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138565662|NCT05574400|Purinergic Agents|purinergic agents|mesh-ancestor
138565663|NCT05574400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565664|NCT05546359|Dexamethasone|dexamethasone|mesh-list
138565665|NCT05546359|Amisulpride|amisulpride|mesh-list
138565666|NCT05546359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565667|NCT05546359|Antiemetics|antiemetics|mesh-ancestor
138565668|NCT05546359|Autonomic Agents|autonomic agents|mesh-ancestor
138565669|NCT05546359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138332722|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
138332725|NCT03015168|Capecitabine|capecitabine|mesh-list
138565670|NCT05546359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565671|NCT05546359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138565672|NCT05546359|Glucocorticoids|glucocorticoids|mesh-ancestor
138565673|NCT05546359|Hormones|hormones|mesh-ancestor
138565674|NCT05546359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138565675|NCT05546359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138177904|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138565676|NCT05546359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565677|NCT05546359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138565678|NCT05546359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138565679|NCT05546359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565680|NCT05546359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138565681|NCT05546359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138565682|NCT05546359|Dopamine Agents|dopamine agents|mesh-ancestor
138565683|NCT05546359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565684|NCT05546359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565685|NCT05546359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138565686|NCT05546359|Antidepressive Agents|antidepressive agents|mesh-ancestor
138332781|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
138565687|NCT05413330|Triamcinolone|triamcinolone|mesh-list
138565688|NCT05413330|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138565689|NCT05413330|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138565690|NCT05413330|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138565691|NCT05413330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565692|NCT05413330|Glucocorticoids|glucocorticoids|mesh-ancestor
138565693|NCT05413330|Hormones|hormones|mesh-ancestor
138565694|NCT05413330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138242037|NCT01584518|Furosemide|furosemide|mesh-list
138565695|NCT05413330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565696|NCT05413330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138565697|NCT05413330|Immunologic Factors|immunologic factors|mesh-ancestor
138565698|NCT05413330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565699|NCT05413330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565701|NCT05254639|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138565702|NCT05254639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565703|NCT05254639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565704|NCT05254639|Cholinergic Agents|cholinergic agents|mesh-ancestor
138565705|NCT05254639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565706|NCT05254639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565707|NCT05254639|Nootropic Agents|nootropic agents|mesh-ancestor
138565708|NCT05243940|Lidocaine|lidocaine|mesh-list
138565709|NCT05243940|Dexmedetomidine|dexmedetomidine|mesh-list
138565710|NCT05243940|Ketamine|ketamine|mesh-list
138565711|NCT05243940|Remifentanil|remifentanil|mesh-list
138565712|NCT05243940|Anesthetics, Local|anesthetics, local|mesh-ancestor
138565713|NCT05243940|Anesthetics|anesthetics|mesh-ancestor
138565714|NCT05243940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565715|NCT05243940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565716|NCT05243940|Sensory System Agents|sensory system agents|mesh-ancestor
138565717|NCT05243940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565718|NCT05243940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138565719|NCT05243940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138565720|NCT05243940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138565721|NCT05243940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138565722|NCT05243940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565723|NCT05243940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138565724|NCT05243940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138565725|NCT05243940|Analgesics|analgesics|mesh-ancestor
138565726|NCT05243940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138565727|NCT05243940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138565728|NCT05243940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138565729|NCT05243940|Adrenergic Agents|adrenergic agents|mesh-ancestor
138565730|NCT05243940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138332890|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138332892|NCT03005184|Analgesics|analgesics|mesh-ancestor
138565731|NCT05243940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138458899|NCT01935973|Trametinib|trametinib|mesh-list
138565732|NCT05243940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138565733|NCT05243940|Anesthetics, General|anesthetics, general|mesh-ancestor
138565734|NCT05243940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138565735|NCT05243940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138565736|NCT05243940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138565737|NCT05243940|Narcotics|narcotics|mesh-ancestor
138332942|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565738|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
138565739|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138565740|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
138565741|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565742|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
138565743|NCT05198544|Protective Agents|protective agents|mesh-ancestor
138565745|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
138565746|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
138565747|NCT05167734|Hematinics|hematinics|mesh-ancestor
138565748|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
138332943|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
138565749|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
138565750|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
138565751|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
138565752|NCT05145309|Cathartics|cathartics|mesh-ancestor
138565753|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138565754|NCT05141474|Aldesleukin|aldesleukin|mesh-list
138565755|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
138565756|NCT05141474|Fludarabine|fludarabine|mesh-list
138565757|NCT05141474|Interleukin-2|interleukin-2|mesh-list
138565758|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138565759|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
138565760|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565761|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138565762|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138565763|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
138565764|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565765|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565766|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138565767|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138565768|NCT05141474|Analgesics|analgesics|mesh-ancestor
138458930|NCT01936064|Epirubicin|epirubicin|mesh-list
138332999|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138565769|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
138565770|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565771|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138565772|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138565773|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
138565774|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565775|NCT05126719|Docetaxel|docetaxel|mesh-list
138565776|NCT05126719|Capecitabine|capecitabine|mesh-list
138565777|NCT05126719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565778|NCT05126719|Tubulin Modulators|tubulin modulators|mesh-ancestor
138565779|NCT05126719|Antimitotic Agents|antimitotic agents|mesh-ancestor
138565780|NCT05126719|Mitosis Modulators|mitosis modulators|mesh-ancestor
138565781|NCT05126719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565782|NCT05126719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138565783|NCT05126719|Antimetabolites|antimetabolites|mesh-ancestor
138565784|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
138565785|NCT05119140|Mesalamine|mesalamine|mesh-list
138565786|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
138565787|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138565788|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138333054|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333055|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333056|NCT02980926|Bupivacaine|bupivacaine|mesh-list
138333057|NCT02980926|Mepivacaine|mepivacaine|mesh-list
138565789|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565790|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565791|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565792|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138565793|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138565794|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138565795|NCT05119140|Analgesics|analgesics|mesh-ancestor
138565796|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
138565797|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565798|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565799|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565800|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
138565801|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138565802|NCT05097261|Ketamine|ketamine|mesh-list
138565803|NCT05097261|Analgesics|analgesics|mesh-ancestor
138565804|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
138565805|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565806|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565807|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138333108|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565808|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138565809|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
138565810|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
138565811|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565812|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138565813|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138565814|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565815|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565816|NCT05037032|Naltrexone|naltrexone|mesh-list
138565817|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138565818|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138565819|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565821|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565822|NCT04857931|Colchicine|colchicine|mesh-list
138565823|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
138565824|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138565825|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
138565826|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
138565827|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
138565828|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333164|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
138565829|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565830|NCT04800393|Propofol|propofol|mesh-list
138565831|NCT04800393|Sevoflurane|sevoflurane|mesh-list
138565832|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138565833|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565834|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565835|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138565836|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
138565837|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
138565838|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138565839|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138565840|NCT04521868|Sulforaphane|sulforaphane|mesh-list
138565841|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138565842|NCT04521868|Protective Agents|protective agents|mesh-ancestor
138565843|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565844|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565845|NCT04419493|Heparin|heparin|mesh-list
138565846|NCT04419493|Calcium heparin|calcium heparin|mesh-list
138565847|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138565848|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
138565849|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138333220|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138565850|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138565851|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565853|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138565854|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
138459075|NCT06070740|Durvalumab|durvalumab|mesh-list
138565855|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138565857|NCT04394975|Axitinib|axitinib|mesh-list
138565858|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565859|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138565860|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138565861|NCT04394975|Growth Substances|growth substances|mesh-ancestor
138565862|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565863|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
138565864|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138565865|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138317950|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
138565866|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565867|NCT04381910|Irinotecan|irinotecan|mesh-list
138565868|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138565869|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138565870|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565871|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565872|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565873|NCT04334876|Antibodies|antibodies|mesh-list
138565874|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
138565875|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
138565876|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565878|NCT04231214|Olodaterol|olodaterol|mesh-list
138565879|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138565880|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
138565881|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565882|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565883|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138565884|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
138565885|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
138565886|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138565887|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
138565888|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565889|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565890|NCT04229095|Suvorexant|suvorexant|mesh-list
138565891|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138565892|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138565893|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565894|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565895|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138565896|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565897|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565898|NCT04088604|Fluorouracil|fluorouracil|mesh-list
138565899|NCT04088604|Irinotecan|irinotecan|mesh-list
138565900|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
138565901|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565902|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138565903|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565904|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138565906|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565907|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138565908|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138565909|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565910|NCT04006288|Aspirin|aspirin|mesh-list
138565911|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
138565912|NCT04006288|Clopidogrel|clopidogrel|mesh-list
138565913|NCT04006288|Ticagrelor|ticagrelor|mesh-list
138565914|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138565915|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138565916|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138565917|NCT04006288|Analgesics|analgesics|mesh-ancestor
138565918|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
138565919|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565920|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565921|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565922|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138565923|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138565924|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138565925|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565926|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138565927|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138565928|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565929|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
138565930|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138565931|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138565932|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138565933|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
138565934|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565935|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138565936|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
138565937|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138565938|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
138565939|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
138565940|NCT03979131|Avelumab|avelumab|mesh-list
138565941|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138459144|NCT06066866|Phenobarbital|phenobarbital|mesh-list
138565942|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565943|NCT03952273|Sirolimus|sirolimus|mesh-list
138565944|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138565945|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565946|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138565947|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565948|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
138565949|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138565950|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
138565951|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565952|NCT03843645|Anesthetics|anesthetics|mesh-list
138565953|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565954|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565955|NCT03728881|Vaccines|vaccines|mesh-list
138565956|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
138565957|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565958|NCT03711253|Tenofovir|tenofovir|mesh-list
138565959|NCT03711253|Emtricitabine|emtricitabine|mesh-list
138565960|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
138565961|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138565962|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138565963|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138565964|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565965|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565966|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138565967|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138565968|NCT03643822|Dexamethasone|dexamethasone|mesh-list
138565969|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
138565970|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
138565971|NCT03643822|BB 1101|bb 1101|mesh-list
138565972|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138565973|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
138565974|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
138565975|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138565976|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138565977|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138565978|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
138565979|NCT03643822|Hormones|hormones|mesh-ancestor
138565980|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138565981|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138565982|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565983|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
138565984|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138565985|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138565986|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138565987|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138565988|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138565989|NCT03643822|Analgesics|analgesics|mesh-ancestor
138565990|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
138565991|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138565992|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138565993|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138565994|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
138565995|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138565996|NCT03603964|Guadecitabine|guadecitabine|mesh-list
138565997|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138565998|NCT03575000|Bromocriptine|bromocriptine|mesh-list
138333521|NCT00166530|Atorvastatin|atorvastatin|mesh-list
138333522|NCT00166530|Simvastatin|simvastatin|mesh-list
138333523|NCT00166530|Ezetimibe|ezetimibe|mesh-list
138565999|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138566000|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138566001|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
138566002|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566003|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566004|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
138566005|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
138566006|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566007|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138317958|NCT01443858|Meclizine|meclizine|mesh-list
138566009|NCT03498261|Analgesics|analgesics|mesh-ancestor
138566010|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
138566011|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566012|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566013|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
138566014|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138566015|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138566016|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138566017|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138566018|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138566019|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138566020|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566021|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566022|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
138566023|NCT03495921|Irinotecan|irinotecan|mesh-list
138566024|NCT03495921|Camptothecin|camptothecin|mesh-list
138566025|NCT03495921|Temozolomide|temozolomide|mesh-list
138566026|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138566027|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138566028|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566029|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566030|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566031|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138566032|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
138566033|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138566034|NCT03191864|Fluticasone|fluticasone|mesh-list
138178078|NCT02070237|Enoxaparin|enoxaparin|mesh-list
138566036|NCT03191864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138566037|NCT03191864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138566038|NCT03191864|Autonomic Agents|autonomic agents|mesh-ancestor
138566039|NCT03191864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566040|NCT03191864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566041|NCT03191864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138566042|NCT03191864|Respiratory System Agents|respiratory system agents|mesh-ancestor
138566043|NCT03191864|Dermatologic Agents|dermatologic agents|mesh-ancestor
138566044|NCT03191864|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138566045|NCT03123978|Niclosamide|niclosamide|mesh-list
138566046|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
138566047|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138566048|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
138566049|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138566050|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566051|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
138566052|NCT03114072|Methamphetamine|methamphetamine|mesh-list
138566053|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138566054|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566055|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
138566056|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
138459262|NCT06001762|Hormone Antagonists|hormone antagonists|mesh-ancestor
138566057|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566058|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
138566059|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566060|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566061|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
138566062|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138566063|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138566064|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138566065|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138566067|NCT03063619|Afimoxifene|afimoxifene|mesh-list
138566068|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138566069|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
138566070|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566071|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566072|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138566073|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566074|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138566075|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138566076|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138333585|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
138566078|NCT03002103|Gemcitabine|gemcitabine|mesh-list
138566079|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138566080|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566081|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
138566082|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
138566083|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
138566084|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566085|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138566086|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
138566087|NCT02898207|Olaparib|olaparib|mesh-list
138566088|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138566089|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566090|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566091|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566092|NCT02682485|Metronidazole|metronidazole|mesh-list
138566093|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
138566094|NCT02682485|Neomycin|neomycin|mesh-list
138566095|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138333646|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566096|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138566097|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138178101|NCT02406885|Apixaban|apixaban|mesh-list
138566098|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138566099|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138459365|NCT05741502|Clozapine|clozapine|mesh-list
138566100|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138566101|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566102|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566103|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566104|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138566105|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138566106|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138566108|NCT02636725|Axitinib|axitinib|mesh-list
138566109|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138566110|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566111|NCT02636725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138566112|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566113|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138566114|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566115|NCT02573493|Paclitaxel|paclitaxel|mesh-list
138566116|NCT02573493|Cisplatin|cisplatin|mesh-list
138566117|NCT02573493|Cetuximab|cetuximab|mesh-list
138566118|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138566119|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566120|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
138566121|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
138566122|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
138566123|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566124|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138566125|NCT02327078|Nivolumab|nivolumab|mesh-list
138333701|NCT00626340|Hormones|hormones|mesh-ancestor
138333702|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138333703|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
138566126|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138566127|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566128|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138566129|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566130|NCT02304458|Nivolumab|nivolumab|mesh-list
138566131|NCT02304458|Ipilimumab|ipilimumab|mesh-list
138566132|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138566133|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566134|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138566135|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566136|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
138566137|NCT02219373|Gabapentin|gabapentin|mesh-list
138566138|NCT02219373|Analgesics|analgesics|mesh-ancestor
138566139|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
138566140|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138333743|NCT00637494|Mifepristone|mifepristone|mesh-list
138566141|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566142|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
138566143|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138566144|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138566145|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138566146|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138566147|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138178108|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
138242484|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
138459482|NCT05617625|Fludarabine|fludarabine|mesh-list
138566148|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138566149|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566150|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566151|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
138566152|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138566153|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138566154|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138566155|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138333802|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566156|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138566158|NCT02187224|Progestins|progestins|mesh-ancestor
138566159|NCT02187224|Hormones|hormones|mesh-ancestor
138566160|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566161|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566162|NCT02159066|Infigratinib|infigratinib|mesh-list
138566163|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566164|NCT02099825|Cycloserine|cycloserine|mesh-list
138566165|NCT02099825|Mifepristone|mifepristone|mesh-list
138566166|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138566167|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
138566168|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138566169|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566170|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138566171|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138566172|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138566173|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
138566174|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138566175|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138566176|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
138566177|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566178|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
138566179|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138566180|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138566181|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138566182|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566183|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138566184|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
138566185|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138566186|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
138566187|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566188|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
138566189|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138566190|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138566191|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566192|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
138566193|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
138566194|NCT01958021|Letrozole|letrozole|mesh-list
138566195|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566196|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138566197|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138566198|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446095|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
138566199|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566200|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138566201|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
138566202|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566216|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138566217|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566218|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
138566219|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138566220|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138566222|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
138566223|NCT05953168|Trastuzumab|trastuzumab|mesh-list
138566224|NCT05953168|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138566225|NCT05953168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138566226|NCT05953168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566227|NCT05953168|Immunoconjugates|immunoconjugates|mesh-ancestor
138566228|NCT05953168|Immunologic Factors|immunologic factors|mesh-ancestor
138566229|NCT05953168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138333860|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
138566243|NCT05952947|Cyclophosphamide|cyclophosphamide|mesh-list
138566244|NCT05952947|Fludarabine|fludarabine|mesh-list
138566245|NCT05952947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138566246|NCT05952947|Immunologic Factors|immunologic factors|mesh-ancestor
138566247|NCT05952947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566248|NCT05952947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138566249|NCT05952947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138566250|NCT05952947|Alkylating Agents|alkylating agents|mesh-ancestor
138566251|NCT05952947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566252|NCT05952947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566253|NCT05952947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138566255|NCT05952921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138566256|NCT05952921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566257|NCT05952921|Disinfectants|disinfectants|mesh-ancestor
138566258|NCT05952596|Vaccines|vaccines|mesh-list
138566259|NCT05952596|Immunologic Factors|immunologic factors|mesh-ancestor
138446187|NCT01842932|Bromides|bromides|mesh-list
138566260|NCT05952596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566262|NCT05952505|Immunologic Factors|immunologic factors|mesh-ancestor
138566263|NCT05952505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566264|NCT05952206|Sirolimus|sirolimus|mesh-list
138566265|NCT05952206|Temsirolimus|temsirolimus|mesh-list
138566266|NCT05952206|MTOR Inhibitors|mtor inhibitors|mesh-list
138566267|NCT05952206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138566268|NCT05952206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566269|NCT05952206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138566270|NCT05952206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566271|NCT05952206|Antifungal Agents|antifungal agents|mesh-ancestor
138566272|NCT05952206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138566273|NCT05952206|Immunologic Factors|immunologic factors|mesh-ancestor
138333873|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138566274|NCT05952206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566275|NCT05952206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138566276|NCT05952206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566277|NCT05952206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566278|NCT05952128|Fluzoparib|fluzoparib|mesh-list
138459650|NCT05224336|Micronutrients|micronutrients|mesh-ancestor
138566279|NCT05952128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138566280|NCT05952128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566281|NCT05952128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566282|NCT05952128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566283|NCT05952050|Dexmedetomidine|dexmedetomidine|mesh-list
138566284|NCT05952050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138566285|NCT05952050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138566286|NCT05952050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566287|NCT05952050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138566289|NCT05952050|Sensory System Agents|sensory system agents|mesh-ancestor
138566290|NCT05952050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566291|NCT05952050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138566292|NCT05952050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138566293|NCT05952050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138566294|NCT05952050|Adrenergic Agents|adrenergic agents|mesh-ancestor
138566295|NCT05952050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566296|NCT05952050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566297|NCT05951842|Anesthetics|anesthetics|mesh-list
138566298|NCT05951842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138566299|NCT05951842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566300|NCT05951816|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
138566301|NCT05951816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138566302|NCT05951816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566303|NCT05951725|Vaccines|vaccines|mesh-list
138566304|NCT05951725|Immunologic Factors|immunologic factors|mesh-ancestor
138566305|NCT05951725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566306|NCT05951686|Remifentanil|remifentanil|mesh-list
138566307|NCT05951686|Propofol|propofol|mesh-list
138566308|NCT05951686|Desflurane|desflurane|mesh-list
138566309|NCT05951686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138566310|NCT05951686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138566311|NCT05951686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566312|NCT05951686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138566313|NCT05951686|Anesthetics, General|anesthetics, general|mesh-ancestor
138566314|NCT05951686|Anesthetics|anesthetics|mesh-ancestor
138566315|NCT05951686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138566316|NCT05951686|Narcotics|narcotics|mesh-ancestor
138566317|NCT05951686|Analgesics|analgesics|mesh-ancestor
138566318|NCT05951686|Sensory System Agents|sensory system agents|mesh-ancestor
138566319|NCT05951686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566320|NCT05951686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138566321|NCT05951569|Insulin|insulin|mesh-list
138566322|NCT05951569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138566323|NCT05951569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566324|NCT05951413|Sildenafil Citrate|sildenafil citrate|mesh-list
138566325|NCT05951413|Estradiol|estradiol|mesh-list
138459745|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
138566326|NCT05951413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566328|NCT05951413|Hormones|hormones|mesh-ancestor
138566329|NCT05951413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566330|NCT05951413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566331|NCT05951413|Vasodilator Agents|vasodilator agents|mesh-ancestor
138566332|NCT05951413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138566333|NCT05951413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138566334|NCT05951413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566335|NCT05951413|Urological Agents|urological agents|mesh-ancestor
138566336|NCT05951361|Triamcinolone|triamcinolone|mesh-list
138566337|NCT05951361|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138566338|NCT05951361|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138566339|NCT05951361|Benzocaine|benzocaine|mesh-list
138566340|NCT05951361|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138566341|NCT05951361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138566342|NCT05951361|Glucocorticoids|glucocorticoids|mesh-ancestor
138566343|NCT05951361|Hormones|hormones|mesh-ancestor
138566344|NCT05951361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566345|NCT05951361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566346|NCT05951361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138566347|NCT05951361|Immunologic Factors|immunologic factors|mesh-ancestor
138566348|NCT05951361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566349|NCT05951361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566350|NCT05951361|Anesthetics, Local|anesthetics, local|mesh-ancestor
138566351|NCT05951361|Anesthetics|anesthetics|mesh-ancestor
138566352|NCT05951361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138566353|NCT05951361|Sensory System Agents|sensory system agents|mesh-ancestor
138566354|NCT05951361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566355|NCT05951309|Metformin|metformin|mesh-list
138566356|NCT05951309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138566357|NCT05951309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566358|NCT05947435|Tranexamic Acid|tranexamic acid|mesh-list
138566359|NCT05947435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138333927|NCT00672438|Analgesics|analgesics|mesh-ancestor
138333932|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
138566360|NCT05947435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138317977|NCT01443078|Gemcitabine|gemcitabine|mesh-list
138566361|NCT05947435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566362|NCT05947435|Hemostatics|hemostatics|mesh-ancestor
138566363|NCT05947435|Coagulants|coagulants|mesh-ancestor
138566364|NCT05936671|Remifentanil|remifentanil|mesh-list
138566365|NCT05936671|Anesthetics|anesthetics|mesh-list
138566366|NCT05936671|Sevoflurane|sevoflurane|mesh-list
138566367|NCT05936671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138566368|NCT05936671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566369|NCT05936671|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138566370|NCT05936671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138566372|NCT05936671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138566373|NCT05936671|Narcotics|narcotics|mesh-ancestor
138333982|NCT00679380|Budesonide|budesonide|mesh-list
138333991|NCT00679380|Hormones|hormones|mesh-ancestor
138566374|NCT05936671|Analgesics|analgesics|mesh-ancestor
138566375|NCT05936671|Sensory System Agents|sensory system agents|mesh-ancestor
138566376|NCT05936671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566377|NCT05933499|Vitamin D|vitamin d|mesh-list
138566378|NCT05933499|Calcium|calcium|mesh-list
138566379|NCT05933499|Vitamins|vitamins|mesh-ancestor
138566380|NCT05933499|Micronutrients|micronutrients|mesh-ancestor
138566381|NCT05933499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566382|NCT05933499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138566383|NCT05933499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138566384|NCT05925179|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138566385|NCT05925179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138566386|NCT05925179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566387|NCT05925179|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138566388|NCT05925179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566389|NCT05925179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566391|NCT05921968|Lactoferrin|lactoferrin|mesh-list
138566392|NCT05921968|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138566393|NCT05921968|Trace Elements|trace elements|mesh-ancestor
138566394|NCT05921968|Micronutrients|micronutrients|mesh-ancestor
138566395|NCT05921968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566396|NCT05921968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566397|NCT05921968|Hematinics|hematinics|mesh-ancestor
138566398|NCT05904379|Paclitaxel|paclitaxel|mesh-list
138566399|NCT05904379|Docetaxel|docetaxel|mesh-list
138566400|NCT05904379|Pemetrexed|pemetrexed|mesh-list
138334045|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138334046|NCT00690924|Calcitriol|calcitriol|mesh-list
138334048|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566401|NCT05904379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138566402|NCT05904379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566403|NCT05904379|Tubulin Modulators|tubulin modulators|mesh-ancestor
138566404|NCT05904379|Antimitotic Agents|antimitotic agents|mesh-ancestor
138566405|NCT05904379|Mitosis Modulators|mitosis modulators|mesh-ancestor
138459889|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566406|NCT05904379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566407|NCT05904379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566408|NCT05904379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138566409|NCT05904379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138566411|NCT05901974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566412|NCT05871333|Losartan|losartan|mesh-list
138566413|NCT05871333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138566414|NCT05871333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138566415|NCT05871333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138566416|NCT05871333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138334093|NCT00701376|Liver Extracts|liver extracts|mesh-list
138334103|NCT00704028|Dextrans|dextrans|mesh-list
138566417|NCT05871333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566418|NCT05846750|Lenalidomide|lenalidomide|mesh-list
138566419|NCT05846750|Obinutuzumab|obinutuzumab|mesh-list
138566420|NCT05846750|Immunologic Factors|immunologic factors|mesh-ancestor
138566421|NCT05846750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566422|NCT05846750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138178218|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138566423|NCT05846750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138566425|NCT05846750|Growth Inhibitors|growth inhibitors|mesh-ancestor
138566426|NCT05846750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566427|NCT05846750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138566428|NCT05811390|Erythritol|erythritol|mesh-list
138446265|NCT01843257|Ethanol|ethanol|mesh-list
138566430|NCT05794997|Propranolol|propranolol|mesh-list
138566431|NCT05794997|Atenolol|atenolol|mesh-list
138566432|NCT05794997|Sotalol|sotalol|mesh-list
138566433|NCT05794997|Carvedilol|carvedilol|mesh-list
138566434|NCT05794997|Bisoprolol|bisoprolol|mesh-list
138459935|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
138334153|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138334154|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334155|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138566435|NCT05794997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138566436|NCT05794997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138566437|NCT05794997|Adrenergic Agents|adrenergic agents|mesh-ancestor
138566438|NCT05794997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566439|NCT05794997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566440|NCT05794997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566441|NCT05794997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138566442|NCT05794997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138566443|NCT05794997|Vasodilator Agents|vasodilator agents|mesh-ancestor
138566445|NCT05794997|Protective Agents|protective agents|mesh-ancestor
138566446|NCT05794997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138566447|NCT05794997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138566448|NCT05794997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138566449|NCT05794997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138566450|NCT05794997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138566452|NCT05794997|Autonomic Agents|autonomic agents|mesh-ancestor
138566453|NCT05794997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334212|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138566454|NCT05794997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138566455|NCT05742399|Hyaluronic Acid|hyaluronic acid|mesh-list
138566456|NCT05742399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138566457|NCT05742399|Immunologic Factors|immunologic factors|mesh-ancestor
138566458|NCT05742399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566459|NCT05742399|Viscosupplements|viscosupplements|mesh-ancestor
138566460|NCT05742399|Protective Agents|protective agents|mesh-ancestor
138566461|NCT05734560|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
138566462|NCT05734560|Immunoconjugates|immunoconjugates|mesh-ancestor
138566463|NCT05734560|Immunologic Factors|immunologic factors|mesh-ancestor
138566464|NCT05734560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566466|NCT05726110|Daunorubicin|daunorubicin|mesh-list
138566467|NCT05726110|Homoharringtonine|homoharringtonine|mesh-list
138566468|NCT05726110|Aclacinomycins|aclacinomycins|mesh-list
138566469|NCT05726110|Lenograstim|lenograstim|mesh-list
138566470|NCT05726110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138566471|NCT05726110|Antimetabolites|antimetabolites|mesh-ancestor
138566472|NCT05726110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566473|NCT05726110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566474|NCT05726110|Antiviral Agents|antiviral agents|mesh-ancestor
138566475|NCT05726110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334271|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138334272|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138178231|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
138566476|NCT05726110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138566477|NCT05726110|Immunologic Factors|immunologic factors|mesh-ancestor
138566478|NCT05726110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566479|NCT05726110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138566480|NCT05726110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138566481|NCT05726110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138566482|NCT05726110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566483|NCT05726110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138566484|NCT05726110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138566485|NCT05726110|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138566486|NCT05641298|Fusidic Acid|fusidic acid|mesh-list
138566487|NCT05641298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138566488|NCT05641298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566489|NCT05641298|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138566490|NCT05641298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566491|NCT05641298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566493|NCT05635370|Pentoxifylline|pentoxifylline|mesh-list
138566494|NCT05635370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138566495|NCT05635370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566496|NCT05635370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566497|NCT05635370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138566498|NCT05635370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138566499|NCT05635370|Protective Agents|protective agents|mesh-ancestor
138566500|NCT05635370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566501|NCT05635370|Vasodilator Agents|vasodilator agents|mesh-ancestor
138566502|NCT05635370|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138566503|NCT05635370|Antioxidants|antioxidants|mesh-ancestor
138566504|NCT05635370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138566505|NCT05635370|Autonomic Agents|autonomic agents|mesh-ancestor
138460009|NCT04489589|Midodrine|midodrine|mesh-list
138566506|NCT05635370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334389|NCT00735462|Imiquimod|imiquimod|mesh-list
138334390|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138566507|NCT05635370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138566508|NCT05635370|Respiratory System Agents|respiratory system agents|mesh-ancestor
138566510|NCT05635370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138566511|NCT05635370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138566512|NCT05635370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138566514|NCT05635357|Anastrozole|anastrozole|mesh-list
138566515|NCT05635357|Exemestane|exemestane|mesh-list
138566516|NCT05635357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566517|NCT05635357|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138566518|NCT05635357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138566519|NCT05635357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566520|NCT05635357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566521|NCT05635357|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138566522|NCT05635357|Hormone Antagonists|hormone antagonists|mesh-ancestor
138566523|NCT05635357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460056|NCT04419181|Docetaxel|docetaxel|mesh-list
138566524|NCT05635357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566525|NCT05635357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138178258|NCT02346903|Capsaicin|capsaicin|mesh-list
138178259|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
138178260|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
138178274|NCT02153671|Vaccines|vaccines|mesh-list
138566527|NCT05633966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566528|NCT05633966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566530|NCT05614089|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138566531|NCT05614089|Insulin Glargine|insulin glargine|mesh-list
138566532|NCT05614089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138566533|NCT05614089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566534|NCT05491083|Pembrolizumab|pembrolizumab|mesh-list
138566535|NCT05491083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138566536|NCT05491083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566537|NCT05491083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138566538|NCT05491083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566539|NCT05481112|Buprenorphine|buprenorphine|mesh-list
138566540|NCT05481112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138566541|NCT05481112|Narcotics|narcotics|mesh-ancestor
138566542|NCT05481112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138566543|NCT05481112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566544|NCT05481112|Analgesics|analgesics|mesh-ancestor
138566545|NCT05481112|Sensory System Agents|sensory system agents|mesh-ancestor
138566546|NCT05481112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566548|NCT05473585|Nicotine|nicotine|mesh-list
138566549|NCT05473585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138566550|NCT05473585|Autonomic Agents|autonomic agents|mesh-ancestor
138566551|NCT05473585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566552|NCT05473585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566553|NCT05473585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138566554|NCT05473585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138566555|NCT05473585|Cholinergic Agents|cholinergic agents|mesh-ancestor
138566556|NCT05473585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566557|NCT05473585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566558|NCT05457855|Fluticasone|fluticasone|mesh-list
138566559|NCT05457855|Montelukast|montelukast|mesh-list
138566560|NCT05457855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138566561|NCT05457855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138566562|NCT05457855|Autonomic Agents|autonomic agents|mesh-ancestor
138566563|NCT05457855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566564|NCT05457855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566565|NCT05457855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138566566|NCT05457855|Respiratory System Agents|respiratory system agents|mesh-ancestor
138566567|NCT05457855|Dermatologic Agents|dermatologic agents|mesh-ancestor
138566568|NCT05457855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138566569|NCT05457855|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138566570|NCT05457855|Hormone Antagonists|hormone antagonists|mesh-ancestor
138566571|NCT05457855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566572|NCT05457855|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138178290|NCT02153983|Colchicine|colchicine|mesh-list
138566573|NCT05457855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138566574|NCT05457855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566576|NCT05381948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138566577|NCT05381948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138566578|NCT05381948|Growth Substances|growth substances|mesh-ancestor
138334465|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334466|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138334471|NCT00743574|Vitamin D|vitamin d|mesh-list
138566579|NCT05381948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566580|NCT05381948|Growth Inhibitors|growth inhibitors|mesh-ancestor
138566581|NCT05381948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566582|NCT05379491|Linaclotide|linaclotide|mesh-list
138566583|NCT05379491|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138566584|NCT05379491|Enzyme Activators|enzyme activators|mesh-ancestor
138566585|NCT05379491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566586|NCT05379491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138566587|NCT05376111|Azacitidine|azacitidine|mesh-list
138566588|NCT05376111|Venetoclax|venetoclax|mesh-list
138566589|NCT05376111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138566590|NCT05376111|Antimetabolites|antimetabolites|mesh-ancestor
138566591|NCT05376111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566592|NCT05376111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566593|NCT05376111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566594|NCT05322902|Propofol|propofol|mesh-list
138566595|NCT05322902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138566596|NCT05322902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138566597|NCT05322902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334525|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566598|NCT05322902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138566599|NCT05322902|Anesthetics, General|anesthetics, general|mesh-ancestor
138566600|NCT05322902|Anesthetics|anesthetics|mesh-ancestor
138566601|NCT05291299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138566602|NCT05286060|Pembrolizumab|pembrolizumab|mesh-list
138566603|NCT05286060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138566604|NCT05286060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566605|NCT05286060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138566606|NCT05286060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566607|NCT05242458|Ustekinumab|ustekinumab|mesh-list
138566608|NCT05242458|Dermatologic Agents|dermatologic agents|mesh-ancestor
138566609|NCT05170893|Ubiquinone|ubiquinone|mesh-list
138566610|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
138566611|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
138566612|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566613|NCT05170893|Vitamins|vitamins|mesh-ancestor
138566614|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138566615|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138566616|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138566617|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138178313|NCT00828061|Prednisone|prednisone|mesh-list
138566618|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566619|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566620|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138566621|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138566622|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566624|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566625|NCT05125276|Aspirin|aspirin|mesh-list
138566626|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138566627|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138566628|NCT05125276|Analgesics|analgesics|mesh-ancestor
138566629|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
138566630|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566631|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566632|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138566633|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138566634|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138566635|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138566636|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566637|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138566638|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138566639|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566640|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
138566641|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
138566642|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
138566643|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
138566644|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138566645|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138566646|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566647|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460233|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138566648|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566650|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138566651|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566652|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138566653|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566654|NCT05074823|Ketamine|ketamine|mesh-list
138566655|NCT05074823|Analgesics|analgesics|mesh-ancestor
138566656|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
138566657|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566658|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566659|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138566660|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138566661|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
138566662|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
138566663|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138566664|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138566665|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138178344|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
138566666|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138243003|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138309755|NCT00003953|Tamoxifen|tamoxifen|mesh-list
138702106|NCT05424393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138334592|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334593|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138334595|NCT00760578|Pioglitazone|pioglitazone|mesh-list
138566667|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566670|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
138566671|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138566672|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566673|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
138566674|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566675|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566676|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
138566677|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
138566678|NCT05049902|Amoxicillin|amoxicillin|mesh-list
138566679|NCT05049902|Metronidazole|metronidazole|mesh-list
138566680|NCT05049902|Clarithromycin|clarithromycin|mesh-list
138566681|NCT05049902|Tetracycline|tetracycline|mesh-list
138566682|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
138566683|NCT05049902|Bismuth|bismuth|mesh-list
138566684|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566685|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138566686|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566687|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138566688|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138566689|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138566690|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138460346|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566691|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138566692|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138566694|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138334657|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138334662|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
138566695|NCT05049902|Diuretics|diuretics|mesh-ancestor
138566696|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
138566697|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566698|NCT05049902|Expectorants|expectorants|mesh-ancestor
138566699|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
138566700|NCT05026593|Carboplatin|carboplatin|mesh-list
138566701|NCT05026593|Etoposide|etoposide|mesh-list
138566702|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566703|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138566704|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138566705|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138566706|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566707|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566708|NCT04971109|Tecovirimat|tecovirimat|mesh-list
138566709|NCT04971109|Antiviral Agents|antiviral agents|mesh-ancestor
138566710|NCT04971109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566711|NCT04957485|Tecovirimat|tecovirimat|mesh-list
138566712|NCT04957485|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138566713|NCT04957485|Antiviral Agents|antiviral agents|mesh-ancestor
138460394|NCT03605719|Nivolumab|nivolumab|mesh-list
138566714|NCT04957485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138334707|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138566715|NCT04833959|Panitumumab|panitumumab|mesh-list
138566716|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138566717|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566718|NCT04793906|Iron|iron|mesh-list
138566719|NCT04793906|Trace Elements|trace elements|mesh-ancestor
138566720|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
138566721|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566722|NCT04716413|Dsuvia|dsuvia|mesh-list
138566723|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138566724|NCT04716413|Narcotics|narcotics|mesh-ancestor
138566725|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138317992|NCT01439880|Evolocumab|evolocumab|mesh-list
138566726|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566728|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
138566729|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566730|NCT04696042|Lanreotide|lanreotide|mesh-list
138566731|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566732|NCT04635189|Dexamethasone|dexamethasone|mesh-list
138566733|NCT04635189|Lenalidomide|lenalidomide|mesh-list
138566734|NCT04635189|Daratumumab|daratumumab|mesh-list
138566735|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138566736|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
138566737|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
138566738|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566739|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566740|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138566741|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
138566742|NCT04635189|Hormones|hormones|mesh-ancestor
138566743|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566744|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138566745|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138460448|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
138566746|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
138566747|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138566748|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138566749|NCT04635189|Growth Substances|growth substances|mesh-ancestor
138566750|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
138566751|NCT04608448|Sirolimus|sirolimus|mesh-list
138566752|NCT04608448|Petrolatum|petrolatum|mesh-list
138566753|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138566754|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566755|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138566756|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566757|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
138566758|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138566759|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
138566760|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566761|NCT04608448|Emollients|emollients|mesh-ancestor
138566762|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
138566763|NCT04562285|Antibodies|antibodies|mesh-list
138566764|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
138566765|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566766|NCT04528004|Niacinamide|niacinamide|mesh-list
138566767|NCT04528004|Niacin|niacin|mesh-list
138566768|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
138566769|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
138566770|NCT04528004|Vitamins|vitamins|mesh-ancestor
138566771|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
138566772|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566773|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138566774|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
138566775|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566777|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
138566778|NCT04500899|Phenylephrine|phenylephrine|mesh-list
138566779|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138566780|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
138566781|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
138566782|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566783|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566784|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
138334762|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
138566785|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138566786|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
138460504|NCT03219359|Hormones|hormones|mesh-ancestor
138566787|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
138566788|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138566789|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138566790|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138566791|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
138566792|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566793|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566794|NCT04500899|Protective Agents|protective agents|mesh-ancestor
138566797|NCT04485039|Calcium acetate|calcium acetate|mesh-list
138566798|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
138566799|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
138566800|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566801|NCT04485039|Antiviral Agents|antiviral agents|mesh-ancestor
138566802|NCT04485039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566803|NCT04428671|Cemiplimab|cemiplimab|mesh-list
138566804|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138566805|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566807|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
138566808|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138566809|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566810|NCT04318405|Iron|iron|mesh-list
138566811|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138566812|NCT04318405|Trace Elements|trace elements|mesh-ancestor
138566813|NCT04318405|Micronutrients|micronutrients|mesh-ancestor
138566814|NCT04318405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334779|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
138566815|NCT04318405|Hematinics|hematinics|mesh-ancestor
138178410|NCT00240071|Tamoxifen|tamoxifen|mesh-list
138566817|NCT04313790|Calcium heparin|calcium heparin|mesh-list
138566818|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
138566819|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138566820|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138566821|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566822|NCT04293393|Paclitaxel|paclitaxel|mesh-list
138566823|NCT04293393|Docetaxel|docetaxel|mesh-list
138566824|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
138566825|NCT04293393|Doxorubicin|doxorubicin|mesh-list
138566826|NCT04293393|Letrozole|letrozole|mesh-list
138566827|NCT04293393|Leuprolide|leuprolide|mesh-list
138566828|NCT04293393|Goserelin|goserelin|mesh-list
138566830|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138566831|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566833|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
138566834|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
138334820|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
138334821|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334822|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138566835|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566836|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138566837|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
138566838|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566839|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138566840|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138566841|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
138566842|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138702107|NCT05424393|Immunologic Factors|immunologic factors|mesh-ancestor
138566843|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138566844|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138566845|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138566846|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566847|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138566848|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138566849|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138566850|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
138566851|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138566852|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138566853|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
138566854|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138566855|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138566856|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
138566857|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138566859|NCT04285567|Fludarabine|fludarabine|mesh-list
138566860|NCT04285567|Venetoclax|venetoclax|mesh-list
138566861|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
138566862|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138566863|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
138566864|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566865|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138566866|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138566867|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
138566868|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566869|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566870|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138334943|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138334944|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334945|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
138566871|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138566872|NCT04276480|Tazobactam|tazobactam|mesh-list
138566873|NCT04276480|Piperacillin|piperacillin|mesh-list
138178446|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566874|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138566875|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138566876|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566877|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138566879|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566880|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138566882|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138566883|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
138566884|NCT04153487|Vitamins|vitamins|mesh-ancestor
138566885|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
138566886|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566887|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
138566888|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138334993|NCT00803400|Alprazolam|alprazolam|mesh-list
138566889|NCT04153487|Protective Agents|protective agents|mesh-ancestor
138566891|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138566892|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138566893|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138566894|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566895|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138566896|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566897|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
138566898|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
138566899|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566900|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138566901|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138243247|NCT04850846|Metformin|metformin|mesh-list
138566902|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566904|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138566905|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566906|NCT03774810|Zolpidem|zolpidem|mesh-list
138566907|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138566908|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138566909|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138566910|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138566911|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138566913|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
138566914|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138566915|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566916|NCT03688178|Temozolomide|temozolomide|mesh-list
138566917|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138566918|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
138566919|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566920|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138566921|NCT03671109|Piperaquine|piperaquine|mesh-list
138566922|NCT03671109|Artenimol|artenimol|mesh-list
138566923|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
138566924|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138566925|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138566926|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138566927|NCT03582774|Edetic Acid|edetic acid|mesh-list
138566928|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138566929|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
138566930|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
138566931|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566933|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138566934|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138566935|NCT03532399|Bivalirudin|bivalirudin|mesh-list
138566936|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
138566937|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138566938|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
138566939|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335113|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335116|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138566940|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138566941|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
138566942|NCT03504956|Metoprolol|metoprolol|mesh-list
138566943|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138566944|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138566945|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138566946|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
138566948|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138566949|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693518|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138693519|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138693521|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
138693522|NCT04772274|Ustekinumab|ustekinumab|mesh-list
138693523|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
138693524|NCT04362527|Milrinone|milrinone|mesh-list
138693525|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138693526|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138335164|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
138693527|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138693528|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
138693529|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138693530|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138693531|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693532|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693533|NCT04362527|Protective Agents|protective agents|mesh-ancestor
138693534|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693535|NCT01614171|Hormones|hormones|mesh-list
138693536|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138460772|NCT01446133|Rituximab|rituximab|mesh-list
138693537|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693538|NCT05567367|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138178488|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
138693540|NCT05567367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138693541|NCT05567367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138693542|NCT05567367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693543|NCT05567367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138335216|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138335233|NCT00824460|Iron|iron|mesh-list
138693544|NCT05567367|Urological Agents|urological agents|mesh-ancestor
138693545|NCT04656951|Daratumumab|daratumumab|mesh-list
138693546|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693547|NCT04173533|Azacitidine|azacitidine|mesh-list
138693548|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138693549|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
138693550|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693551|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693552|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693553|NCT01258348|Sunitinib|sunitinib|mesh-list
138693554|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693556|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138693557|NCT01258348|Growth Substances|growth substances|mesh-ancestor
138693558|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693559|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
138693560|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138335271|NCT00830076|Incretins|incretins|mesh-ancestor
138335272|NCT00830076|Hormones|hormones|mesh-ancestor
138693561|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693562|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693563|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138693564|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138693565|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138693566|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
138693567|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693568|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138693570|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138693571|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138693572|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693573|NCT05116774|Eculizumab|eculizumab|mesh-list
138693574|NCT05116774|Ravulizumab|ravulizumab|mesh-list
138693575|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138693576|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138693577|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
138693578|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693579|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138693580|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138693581|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
138693582|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693583|NCT04687566|Memantine|memantine|mesh-list
138693584|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
138693585|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138693586|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138693587|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
138335395|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335396|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
138693588|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693589|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693590|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693591|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138693592|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138693593|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
138693594|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
138693595|NCT01256476|Pravastatin|pravastatin|mesh-list
138693596|NCT01256476|Pitavastatin|pitavastatin|mesh-list
138693597|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138693598|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138693599|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
138693600|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693601|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138693602|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138693604|NCT05507892|Canagliflozin|canagliflozin|mesh-list
138693605|NCT05507892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138693606|NCT05507892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693607|NCT05507892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138693608|NCT05507892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693609|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
138693610|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138693611|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693612|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693613|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138693615|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
138693616|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693617|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138693618|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138693619|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138693620|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
138693621|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693622|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693623|NCT05003089|Prednisolone|prednisolone|mesh-list
138693624|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138693625|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
138693628|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693629|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138693630|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693631|NCT04207021|Curcumin|curcumin|mesh-list
138693632|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138335511|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693633|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138693634|NCT04207021|Analgesics|analgesics|mesh-ancestor
138693635|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
138693636|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693637|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693638|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138693639|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138693640|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693641|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178537|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138460939|NCT00080886|Carmustine|carmustine|mesh-list
138335562|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138335563|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
138335565|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693642|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693644|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138693645|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138693646|NCT01255423|Analgesics|analgesics|mesh-ancestor
138693647|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
138693648|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693649|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693650|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138693651|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138693652|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138693653|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693654|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693655|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138693656|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138693657|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138693658|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138693660|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
138335626|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693661|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693662|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693663|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693664|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138693665|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
138693666|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138693667|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138693668|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138693669|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693670|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693672|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138460995|NCT01937104|Desflurane|desflurane|mesh-list
138693673|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138693674|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138693675|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
138693676|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693677|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693678|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138693679|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138693682|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693683|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693684|NCT04390698|Narcotics|narcotics|mesh-ancestor
138693685|NCT04390698|Analgesics|analgesics|mesh-ancestor
138693686|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
138693687|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693688|NCT04673578|Celecoxib|celecoxib|mesh-list
138693689|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138693690|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138693691|NCT04673578|Analgesics|analgesics|mesh-ancestor
138693692|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
138335684|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335685|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138693693|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138461041|NCT01937338|AZD7624|azd7624|mesh-list
138693694|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693696|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138693697|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138693698|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138178572|NCT05718609|Bismuth|bismuth|mesh-list
138693699|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693700|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693701|NCT05414058|Methylphenidate|methylphenidate|mesh-list
138693702|NCT05414058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138693703|NCT05414058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693704|NCT05414058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138693705|NCT05414058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138693706|NCT05414058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138693707|NCT05414058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693708|NCT05414058|Dopamine Agents|dopamine agents|mesh-ancestor
138335726|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138693709|NCT05414058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693710|NCT03757403|Mebendazole|mebendazole|mesh-list
138693711|NCT03757403|Piperazine|piperazine|mesh-list
138693712|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
138693713|NCT03757403|DMP 777|dmp 777|mesh-list
138693714|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
138693715|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
138693716|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138461092|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
138693717|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693718|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
138693719|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
138693720|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
138693721|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693722|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693723|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693724|NCT00537342|Immunomodulating Agents|immunomodulating agents|mesh-list
138693725|NCT00537342|Immunologic Factors|immunologic factors|mesh-ancestor
138693726|NCT00537342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693727|NCT00537420|Sibutramine|sibutramine|mesh-list
138693728|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
138693729|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138693730|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
138693731|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138335782|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
138335784|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138335785|NCT00911742|Narcotics|narcotics|mesh-ancestor
138335796|NCT00913068|Lidocaine|lidocaine|mesh-list
138693732|NCT03534284|Trazodone|trazodone|mesh-list
138693733|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138693734|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138461147|NCT01937806|Tenofovir|tenofovir|mesh-list
138693735|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693736|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693737|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138693738|NCT03534284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138693739|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138693740|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138693741|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693742|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335836|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138335839|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
138693743|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
138693744|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138693745|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
138693747|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138693749|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138693750|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693751|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138693752|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138693753|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138693755|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138693756|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138693757|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693758|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
138693760|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
138693761|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693762|NCT01253317|Mecasermin|mecasermin|mesh-list
138693763|NCT01253317|Growth Substances|growth substances|mesh-ancestor
138693764|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693765|NCT00537537|Telbivudine|telbivudine|mesh-list
138693766|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
138693767|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693768|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138693769|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693770|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693771|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
138693772|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138693773|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
138693774|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693775|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
138693776|NCT04319770|Protective Agents|protective agents|mesh-ancestor
138335902|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
138693777|NCT01253200|Acifluorfen|acifluorfen|mesh-list
138693778|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693779|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693780|NCT04515901|Lidocaine|lidocaine|mesh-list
138693781|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
138693782|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
138693783|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693784|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693785|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
138693786|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693787|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138693788|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138693789|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138693790|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138693791|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693792|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
138693793|NCT04320589|Anesthetics|anesthetics|mesh-list
138693795|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138693796|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693797|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693798|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138693799|NCT04320589|Analgesics|analgesics|mesh-ancestor
138693800|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
138693801|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693802|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138335944|NCT00931242|Thalidomide|thalidomide|mesh-list
138693803|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138693804|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138693805|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
138693806|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693807|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693808|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
138693809|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138693810|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
138693811|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693812|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693813|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138693814|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
138693815|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138693816|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
138693817|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693818|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138370657|NCT01405989|Darexaban|darexaban|mesh-list
138335992|NCT00939120|Urological Agents|urological agents|mesh-ancestor
138335993|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
138335994|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138335995|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693819|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138693820|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
138693821|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
138693822|NCT04397692|Protective Agents|protective agents|mesh-ancestor
138693823|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
138693825|NCT01252186|Desogestrel|desogestrel|mesh-list
138693826|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
138693827|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138336049|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
138693828|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693829|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138693830|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138693831|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138693832|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138693833|NCT01252186|Progestins|progestins|mesh-ancestor
138693834|NCT01252186|Hormones|hormones|mesh-ancestor
138693835|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138693836|NCT01731782|Bupivacaine|bupivacaine|mesh-list
138693837|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
138693838|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
138693839|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693840|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446555|NCT01845038|Timolol|timolol|mesh-list
138693841|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
138461340|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
138693842|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693843|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
138693844|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693846|NCT04356430|Goserelin|goserelin|mesh-list
138693847|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
138693848|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138693849|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
138693850|NCT04356430|Hormones|hormones|mesh-ancestor
138693851|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138336116|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138693852|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693853|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138693855|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138693856|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693857|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693858|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
138693859|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138693860|NCT04320238|Interferons|interferons|mesh-list
138693861|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
138693862|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138693863|NCT04320238|Thymalfasin|thymalfasin|mesh-list
138693864|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693865|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
138693867|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
138693868|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693869|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138336166|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
138693870|NCT01229072|Heparin|heparin|mesh-list
138693871|NCT01229072|Calcium heparin|calcium heparin|mesh-list
138693872|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
138693873|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138693874|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138693875|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693876|NCT01199978|Losartan|losartan|mesh-list
138693877|NCT01199978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138693878|NCT01199978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138693879|NCT01199978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138693880|NCT01199978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138693881|NCT01199978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693882|NCT00532116|Selegiline|selegiline|mesh-list
138693883|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
138693884|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138693885|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138693886|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138693887|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138693888|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693889|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693890|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138336226|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
138693891|NCT00532116|Protective Agents|protective agents|mesh-ancestor
138693892|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693893|NCT04283513|Ribavirin|ribavirin|mesh-list
138693894|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
138693895|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693896|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
138693897|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693899|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138693900|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138693901|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138693902|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138336277|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138336278|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
138336279|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138336280|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138336281|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138336282|NCT00993798|Bupivacaine|bupivacaine|mesh-list
138336283|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
138693903|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693904|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
138693905|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693906|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693908|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693910|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138693911|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138693912|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138693913|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693914|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693915|NCT04685148|Estradiol|estradiol|mesh-list
138693916|NCT04685148|Estrogens|estrogens|mesh-ancestor
138693917|NCT04685148|Hormones|hormones|mesh-ancestor
138693918|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138693919|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693920|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
138693921|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138693922|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138693923|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138693924|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138461501|NCT01939743|Analgesics|analgesics|mesh-ancestor
138336335|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138693925|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693926|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
138693927|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693928|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693929|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138693930|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693931|NCT03883893|Acetaminophen|acetaminophen|mesh-list
138693932|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138693933|NCT03883893|Analgesics|analgesics|mesh-ancestor
138693934|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
138693935|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693936|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693937|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
138693938|NCT00537732|Omeprazole|omeprazole|mesh-list
138693939|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138693940|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138693941|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138693942|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693943|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693944|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
138693947|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138693948|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
138336388|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138693949|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693950|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693951|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
138693952|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138178663|NCT02368431|Zonisamide|zonisamide|mesh-list
138693953|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693954|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138693955|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693956|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693957|NCT04320277|Ritonavir|ritonavir|mesh-list
138693958|NCT04320277|Lopinavir|lopinavir|mesh-list
138693959|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138693960|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138693961|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
138693962|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693963|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693964|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138693965|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138336443|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
138693966|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
138693967|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693968|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138446656|NCT01845298|Rifampin|rifampin|mesh-list
138693969|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138693970|NCT01250002|Lidocaine|lidocaine|mesh-list
138693971|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
138693972|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
138693973|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693974|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693975|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
138693976|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693977|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138693978|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138693979|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138693980|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138693981|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138461598|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
138693984|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693985|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138693986|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693987|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
138693988|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138693989|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
138693990|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693991|NCT05329116|Lidocaine|lidocaine|mesh-list
138693992|NCT05329116|Pentoxifylline|pentoxifylline|mesh-list
138693993|NCT05329116|Anesthetics, Local|anesthetics, local|mesh-ancestor
138693994|NCT05329116|Anesthetics|anesthetics|mesh-ancestor
138693995|NCT05329116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693996|NCT05329116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693997|NCT05329116|Sensory System Agents|sensory system agents|mesh-ancestor
138693998|NCT05329116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693999|NCT05329116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138694000|NCT05329116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138694001|NCT05329116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138694002|NCT05329116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138694003|NCT05329116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694004|NCT05329116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138694005|NCT05329116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694006|NCT05329116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138694007|NCT05329116|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138694008|NCT05329116|Protective Agents|protective agents|mesh-ancestor
138694009|NCT05329116|Vasodilator Agents|vasodilator agents|mesh-ancestor
138694010|NCT05329116|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138694011|NCT05329116|Antioxidants|antioxidants|mesh-ancestor
138694012|NCT00537888|Fluconazole|fluconazole|mesh-list
138694013|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
138694014|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694015|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138694016|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138694017|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694018|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694019|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138694020|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
138694021|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694022|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694023|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138694024|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138694025|NCT05264142|Voriconazole|voriconazole|mesh-list
138694026|NCT05264142|Fluvoxamine|fluvoxamine|mesh-list
138694027|NCT05264142|Omeprazole|omeprazole|mesh-list
138694029|NCT05264142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138694030|NCT05264142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138694031|NCT05264142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694032|NCT05264142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694033|NCT05264142|Antifungal Agents|antifungal agents|mesh-ancestor
138694034|NCT05264142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694035|NCT05264142|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138694036|NCT05264142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138694037|NCT05264142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138694038|NCT05264142|Hormone Antagonists|hormone antagonists|mesh-ancestor
138694039|NCT05264142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694040|NCT05264142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694041|NCT05264142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138694042|NCT05264142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138694043|NCT05264142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138694044|NCT05264142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138694045|NCT05264142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138694046|NCT05264142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138694047|NCT05264142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138694048|NCT05264142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138694049|NCT05264142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138694050|NCT05264142|Serotonin Agents|serotonin agents|mesh-ancestor
138694051|NCT05264142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138694052|NCT05264142|Antidepressive Agents|antidepressive agents|mesh-ancestor
138694053|NCT05264142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138694054|NCT05264142|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138694055|NCT01246960|Leucovorin|leucovorin|mesh-list
138694056|NCT01246960|Fluorouracil|fluorouracil|mesh-list
138694057|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
138694058|NCT01246960|Ramucirumab|ramucirumab|mesh-list
138694059|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
138694060|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694061|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138694062|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694063|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138694064|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
138694065|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694066|NCT01246960|Antidotes|antidotes|mesh-ancestor
138694067|NCT01246960|Protective Agents|protective agents|mesh-ancestor
138336561|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138694068|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
138694069|NCT01246960|Vitamins|vitamins|mesh-ancestor
138694070|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
138336620|NCT01029054|Hormones|hormones|mesh-ancestor
138694071|NCT00544986|Anastrozole|anastrozole|mesh-list
138694072|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138694073|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694074|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138694075|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138694076|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694077|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694078|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138694079|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
138694080|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694081|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694083|NCT01244620|Tadalafil|tadalafil|mesh-list
138694084|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
138694085|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
138694086|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138694087|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138694088|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694089|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694090|NCT01244620|Urological Agents|urological agents|mesh-ancestor
138694091|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138694092|NCT04319692|Acetic Acid|acetic acid|mesh-list
138694093|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138694094|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694095|NCT00545142|Valproic Acid|valproic acid|mesh-list
138694096|NCT00545142|Aripiprazole|aripiprazole|mesh-list
138694097|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
138694098|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138694099|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138694100|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138694101|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138694102|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694103|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
138694104|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
138694105|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138694106|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694107|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138694108|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138694109|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
138694110|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138694111|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138694112|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138694113|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138694114|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
138694115|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694116|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
138694117|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
138694118|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
138694120|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138694122|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
138694123|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138694124|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
138694125|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138694126|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
138694127|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
138694128|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138694129|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694130|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138694131|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
138694132|NCT01267201|Hormones|hormones|mesh-ancestor
138694133|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694134|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138694135|NCT01267201|Protective Agents|protective agents|mesh-ancestor
138694136|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138694137|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694138|NCT03736616|Cytarabine|cytarabine|mesh-list
138694139|NCT03736616|Rituximab|rituximab|mesh-list
138694140|NCT03736616|Carboplatin|carboplatin|mesh-list
138694141|NCT03736616|Etoposide|etoposide|mesh-list
138694142|NCT03736616|Melphalan|melphalan|mesh-list
138694143|NCT03736616|Ifosfamide|ifosfamide|mesh-list
138694144|NCT03736616|Carmustine|carmustine|mesh-list
138694145|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
138694146|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138694147|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694148|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
138694149|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694150|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138694151|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138694152|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138694153|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138694154|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694155|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694156|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138694157|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
138694158|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
138694159|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694161|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138694162|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
138694163|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138694164|NCT03718403|Theophylline|theophylline|mesh-list
138694166|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
138694167|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138694168|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694169|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138694170|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
138694171|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138694172|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694173|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694174|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
138694175|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138694176|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138694177|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
138694178|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138694179|NCT00537966|Ritonavir|ritonavir|mesh-list
138694180|NCT00537966|Darunavir|darunavir|mesh-list
138694181|NCT00537966|Tenofovir|tenofovir|mesh-list
138694182|NCT00537966|Lamivudine|lamivudine|mesh-list
138694183|NCT00537966|Emtricitabine|emtricitabine|mesh-list
138694184|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
138694185|NCT00537966|Dolutegravir|dolutegravir|mesh-list
138336627|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
138694186|NCT00537966|Abacavir|abacavir|mesh-list
138694187|NCT00537966|Cobicistat|cobicistat|mesh-list
138694188|NCT00537966|Rilpivirine|rilpivirine|mesh-list
138694189|NCT00537966|Elvitegravir|elvitegravir|mesh-list
138694190|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138694191|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138694193|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694194|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694195|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138694196|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138694197|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
138694198|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694199|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138694200|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138702109|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
138694201|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138694202|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138694203|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138694204|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138694205|NCT01266967|Dabrafenib|dabrafenib|mesh-list
138694206|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694207|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138694208|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694209|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694210|NCT00538005|Bevacizumab|bevacizumab|mesh-list
138694211|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
138694213|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138694214|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694215|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138694216|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138694217|NCT00538005|Growth Substances|growth substances|mesh-ancestor
138694218|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694219|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
138694220|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138694221|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694222|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694225|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694226|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138694227|NCT00538044|Simvastatin|simvastatin|mesh-list
138694228|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138694229|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138694230|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
138694231|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694232|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138694233|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138694234|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694235|NCT00545493|Tacrolimus|tacrolimus|mesh-list
138694236|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
138694237|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138694238|NCT00545493|Antibodies|antibodies|mesh-list
138694239|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138694240|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
138694241|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694242|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138694243|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461932|NCT01942291|Vitamins|vitamins|mesh-ancestor
138694244|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694246|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
138694247|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694249|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138694250|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
138694251|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694253|NCT01266265|Bosentan|bosentan|mesh-list
138694254|NCT01266265|Ambrisentan|ambrisentan|mesh-list
138694255|NCT01266265|Epoprostenol|epoprostenol|mesh-list
138694256|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
138694257|NCT01266265|Tadalafil|tadalafil|mesh-list
138694258|NCT01266265|Iloprost|iloprost|mesh-list
138694259|NCT01266265|Tezosentan|tezosentan|mesh-list
138694260|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
138694261|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
138694262|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138694263|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694264|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694266|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138694267|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138178814|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
138694268|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138694270|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138694271|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138694272|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694273|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138694274|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138694275|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138461968|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694276|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694278|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
138694279|NCT01266148|Everolimus|everolimus|mesh-list
138694281|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138694282|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336667|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
138336668|NCT01034592|Lenalidomide|lenalidomide|mesh-list
138336669|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
138336671|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138694283|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694284|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138694285|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
138694286|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694287|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
138694288|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694289|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
138694290|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138694291|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138694292|NCT01266148|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138694293|NCT01266148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138694294|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694295|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138694296|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138694297|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
138694298|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138694299|NCT00538239|Sirolimus|sirolimus|mesh-list
138694300|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138694301|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694302|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138694303|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694304|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
138694305|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138694306|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
138694307|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694308|NCT00538317|Tirofiban|tirofiban|mesh-list
138694309|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138694310|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138336778|NCT05822453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694311|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694312|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138694313|NCT01265953|Sulforaphane|sulforaphane|mesh-list
138694314|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138694315|NCT01265953|Protective Agents|protective agents|mesh-ancestor
138694316|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694318|NCT01265875|Secretin|secretin|mesh-list
138694319|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138694320|NCT01265875|Hormones|hormones|mesh-ancestor
138694321|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694322|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694323|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
138694324|NCT00538395|Doxorubicin|doxorubicin|mesh-list
138694325|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138694326|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138694327|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
138694328|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694329|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702110|NCT00448838|Cetuximab|cetuximab|mesh-list
138694330|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138694331|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
138694332|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694333|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694334|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138694335|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138336838|NCT05821192|Dexamethasone|dexamethasone|mesh-list
138336839|NCT05821192|Rituximab|rituximab|mesh-list
138694336|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138694337|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138694338|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694339|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
138694340|NCT01265563|Silybin|silybin|mesh-list
138694341|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138694343|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694344|NCT01265563|Expectorants|expectorants|mesh-ancestor
138371179|NCT01409174|Analgesics|analgesics|mesh-ancestor
138694345|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
138694346|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138336888|NCT05821062|Purinergic Agents|purinergic agents|mesh-ancestor
138694347|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
138694348|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694349|NCT01265563|Protective Agents|protective agents|mesh-ancestor
138694350|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694351|NCT01265563|Antidotes|antidotes|mesh-ancestor
138694352|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138694353|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694354|NCT01265056|Gabapentin|gabapentin|mesh-list
138694355|NCT01265056|Analgesics|analgesics|mesh-ancestor
138694356|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
138694357|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178875|NCT00771875|Rituximab|rituximab|mesh-list
138694358|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694359|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
138694360|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138694361|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138694362|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138694363|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138336954|NCT06024031|Antidotes|antidotes|mesh-ancestor
138694365|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138694366|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138694367|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694368|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
138694369|NCT02942498|Vitamins|vitamins|mesh-list
138694370|NCT02942498|Vitamin E|vitamin e|mesh-list
138694372|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694373|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
138694374|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694375|NCT02942498|Protective Agents|protective agents|mesh-ancestor
138694377|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
138694378|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
138694379|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138694380|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138694381|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694382|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138694383|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694384|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337007|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138694385|NCT01264939|Omalizumab|omalizumab|mesh-list
138694386|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
138694387|NCT01264939|Promethazine|promethazine|mesh-list
138694388|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
138694389|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
138694390|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
138694391|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138694392|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138694393|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
138694394|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138694395|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138694396|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138694397|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337067|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138337068|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
138694398|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
138694399|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
138694400|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
138694401|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138694402|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
138694403|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
138694404|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138694405|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
138694406|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138694407|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694408|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
138337130|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138337132|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
138694409|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
138694410|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
138694411|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694412|NCT02889367|Odalasvir|odalasvir|mesh-list
138694413|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
138694414|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694415|NCT00546039|Genistein|genistein|mesh-list
138178905|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
138694416|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138694417|NCT00546039|Protective Agents|protective agents|mesh-ancestor
138694418|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694419|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694420|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138694421|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694422|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694423|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
138694424|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138694425|NCT00546039|Estrogens|estrogens|mesh-ancestor
138694426|NCT00546039|Hormones|hormones|mesh-ancestor
138694427|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694428|NCT01264081|Lapatinib|lapatinib|mesh-list
138694429|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694430|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138694432|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694433|NCT02711969|Apatinib|apatinib|mesh-list
138694434|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694435|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138694436|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694437|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694438|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
138694439|NCT01263925|Alprostadil|alprostadil|mesh-list
138694440|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138694441|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694442|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694443|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138694444|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138694445|NCT01263925|Protective Agents|protective agents|mesh-ancestor
138694446|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694447|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
138694448|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138337243|NCT05124691|Albendazole|albendazole|mesh-list
138694450|NCT01263925|Urological Agents|urological agents|mesh-ancestor
138694451|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
138694452|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
138694453|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138694454|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138694455|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694456|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694457|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694458|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138694459|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
138694460|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138694461|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
138694462|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138694463|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694464|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138694465|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
138694466|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
138694467|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138694468|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
138694469|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138694470|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694471|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
138694472|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138694473|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
138694474|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694475|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138694476|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138694477|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
138694478|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694479|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694480|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138694482|NCT00539331|Carboplatin|carboplatin|mesh-list
138694483|NCT00539331|Cediranib|cediranib|mesh-list
138694484|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138694485|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694487|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
138694488|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
138694489|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694490|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138694491|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694492|NCT02236013|Cytarabine|cytarabine|mesh-list
138694493|NCT02236013|Daunorubicin|daunorubicin|mesh-list
138694494|NCT02236013|Idarubicin|idarubicin|mesh-list
138337305|NCT04838379|Dexmedetomidine|dexmedetomidine|mesh-list
138337306|NCT04838379|Bupivacaine|bupivacaine|mesh-list
138337307|NCT04838379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138694495|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138447079|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
138694497|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694498|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694499|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
138694500|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694501|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138694502|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
138694503|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694504|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138694505|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138694506|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138694507|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337335|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337336|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138337337|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
138337339|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694508|NCT00539409|Insulin|insulin|mesh-list
138694509|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138694510|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
138694511|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138694512|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694513|NCT01263691|Vaccines|vaccines|mesh-list
138462321|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138694514|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
138694515|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694516|NCT02178410|Vitamin D|vitamin d|mesh-list
138694517|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
138694518|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
138694519|NCT02178410|Vitamins|vitamins|mesh-list
138694520|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
138178928|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138694521|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694522|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138694523|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138337394|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
138694525|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138694526|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
138694527|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
138694528|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138694529|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694530|NCT01808456|Vaccines|vaccines|mesh-list
138694531|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
138694532|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694533|NCT01715714|Atorvastatin|atorvastatin|mesh-list
138694534|NCT01715714|Simvastatin|simvastatin|mesh-list
138694535|NCT01715714|Pravastatin|pravastatin|mesh-list
138694536|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138694537|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138694538|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
138694539|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694540|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138694541|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138694542|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138337450|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
138694543|NCT01540253|Docetaxel|docetaxel|mesh-list
138694544|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694545|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
138694546|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
138694547|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
138694548|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694549|NCT01497392|Gemcitabine|gemcitabine|mesh-list
138694550|NCT01497392|Capecitabine|capecitabine|mesh-list
138694551|NCT01497392|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138694552|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138694553|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
138694554|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694555|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694556|NCT01497392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138694559|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
138694560|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138337510|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
138337512|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138694561|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
138694562|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694563|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138694564|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138694565|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
138694566|NCT00539565|Prednisolone|prednisolone|mesh-list
138694567|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138694568|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
138694569|NCT00539565|Hormones|hormones|mesh-ancestor
138694570|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138371417|NCT01411124|Gabapentin|gabapentin|mesh-list
138694571|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694572|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138694573|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694574|NCT00539799|Prednisolone|prednisolone|mesh-list
138694575|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138694576|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
138694577|NCT00539799|Hormones|hormones|mesh-ancestor
138479983|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694578|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694579|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694580|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138694581|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694582|NCT00945152|Vancomycin|vancomycin|mesh-list
138694583|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138694584|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694585|NCT00546507|Celecoxib|celecoxib|mesh-list
138694587|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138694588|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138694589|NCT00546507|Analgesics|analgesics|mesh-ancestor
138694590|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
138694591|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138694592|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694593|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138694594|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337629|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138337630|NCT02596880|Ribavirin|ribavirin|mesh-list
138694595|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138694596|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138462529|NCT04476979|Hormones|hormones|mesh-ancestor
138694597|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694598|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694599|NCT00546546|Methotrexate|methotrexate|mesh-list
138694600|NCT00546546|Azathioprine|azathioprine|mesh-list
138694601|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138694602|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138694603|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
138694604|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138694605|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694606|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138694607|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
138694608|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694609|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694610|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
138694611|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694612|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138694613|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
138694614|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138337690|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694615|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138694616|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138694617|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138694618|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694619|NCT00659711|Incretins|incretins|mesh-ancestor
138694621|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694622|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138694623|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
138694624|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138178990|NCT05742425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694625|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694626|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
138694628|NCT02581007|Fludarabine|fludarabine|mesh-list
138694629|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138694630|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
138694631|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462590|NCT03970694|Capecitabine|capecitabine|mesh-list
138694632|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138694633|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138694634|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
138694635|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694636|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694637|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138694638|NCT00546741|Metformin|metformin|mesh-list
138694639|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
138694640|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138694641|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694642|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138694643|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694644|NCT02540330|Fulvestrant|fulvestrant|mesh-list
138371480|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694645|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138694646|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694647|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138694648|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138694649|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
138694650|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694651|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694653|NCT00546936|Verteporfin|verteporfin|mesh-list
138694654|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138694655|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138694656|NCT00546936|Growth Substances|growth substances|mesh-ancestor
138694657|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694658|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
138462621|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138694659|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694660|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138694661|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
138694663|NCT01263496|Voglibose|voglibose|mesh-list
138694664|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138694665|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694666|NCT01263496|Incretins|incretins|mesh-ancestor
138694667|NCT01263496|Hormones|hormones|mesh-ancestor
138694668|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694669|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138694670|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
138694671|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694672|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694673|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138694674|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
138694675|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138694676|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138694678|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
138694679|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138694680|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
138694681|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
138337925|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
138337926|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138337927|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
138337928|NCT01103934|Vitamin D|vitamin d|mesh-list
138694682|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138694683|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
138179007|NCT03801629|Morphine|morphine|mesh-list
138694684|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
138694685|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138694686|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694687|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138694688|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
138694690|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694691|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138694692|NCT04681937|Protective Agents|protective agents|mesh-ancestor
138694693|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138694694|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694695|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138337979|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138337983|NCT01105650|Analgesics|analgesics|mesh-ancestor
138694696|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
138694697|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
138694698|NCT00547053|Amiloride|amiloride|mesh-list
138694699|NCT00547053|Diuretics|diuretics|mesh-ancestor
138694700|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
138694701|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694702|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138694703|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138694704|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138694705|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694706|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138694707|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138694710|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
138694711|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138694712|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138694713|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694714|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694715|NCT00547092|Urological Agents|urological agents|mesh-ancestor
138694716|NCT00547131|Temozolomide|temozolomide|mesh-list
138694717|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138694718|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
138694719|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694720|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694721|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138694722|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138694723|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694724|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
138694725|NCT00547170|Doxycycline|doxycycline|mesh-list
138368930|NCT02369653|Apixaban|apixaban|mesh-list
138694726|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138694727|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694728|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
138694729|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138694730|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138694731|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
138694732|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138694733|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
138694734|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
138694735|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138694736|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179027|NCT04383977|Etoposide|etoposide|mesh-list
138694737|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138694738|NCT00547209|Analgesics|analgesics|mesh-ancestor
138694739|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
138694740|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138694741|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
138694742|NCT00547287|Tadalafil|tadalafil|mesh-list
138694743|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
138694744|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138694745|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138694746|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694747|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694748|NCT00547287|Urological Agents|urological agents|mesh-ancestor
138694749|NCT01263106|Theophylline|theophylline|mesh-list
138694750|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138694751|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
138338085|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338086|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138338087|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
138338088|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138338089|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138694752|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462755|NCT05412576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462756|NCT05412576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462757|NCT05412576|Sensory System Agents|sensory system agents|mesh-ancestor
138694753|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694754|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138694755|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
138694756|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138694757|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694758|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694759|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
138694760|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138694761|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138694762|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
138694763|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138694764|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
138694765|NCT01263028|Vitamin D|vitamin d|mesh-list
138694766|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138694767|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694768|NCT01263028|Vitamins|vitamins|mesh-ancestor
138694769|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
138338133|NCT03697356|Bortezomib|bortezomib|mesh-list
138694770|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138694771|NCT00547443|Paclitaxel|paclitaxel|mesh-list
138694772|NCT00547443|Carboplatin|carboplatin|mesh-list
138694773|NCT00547443|Sorafenib|sorafenib|mesh-list
138694774|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138694775|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694776|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
138694777|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
138694778|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
138694779|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694780|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138694781|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694782|NCT00547560|Begacestat|begacestat|mesh-list
138338187|NCT01128972|Protective Agents|protective agents|mesh-ancestor
138338189|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138694783|NCT00547560|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138694784|NCT00547560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694785|NCT00547560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694786|NCT00547599|Tadalafil|tadalafil|mesh-list
138694788|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138694789|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138694791|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179044|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
138694792|NCT00547599|Urological Agents|urological agents|mesh-ancestor
138371630|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138338254|NCT01139190|Naproxen|naproxen|mesh-list
138694793|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138694794|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138694795|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
138694796|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694798|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
138694799|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
138694800|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138694801|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694802|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
138694803|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138694804|NCT02908295|Misoprostol|misoprostol|mesh-list
138694805|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138694806|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
138165810|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
138694807|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138694808|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694809|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138694810|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138694812|NCT03809442|Dexamethasone|dexamethasone|mesh-list
138694813|NCT03809442|Midazolam|midazolam|mesh-list
138694814|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
138694815|NCT03809442|Ketamine|ketamine|mesh-list
138694816|NCT03809442|Tramadol|tramadol|mesh-list
138694817|NCT03809442|Ropivacaine|ropivacaine|mesh-list
138694818|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138694819|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
138694820|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
138694821|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138694822|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694823|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138694824|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
138694825|NCT03809442|Hormones|hormones|mesh-ancestor
138694826|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694827|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138694828|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694829|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138694830|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138694831|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138694832|NCT03809442|Analgesics|analgesics|mesh-ancestor
138694833|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
138694834|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138694835|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138694836|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138694837|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
138694838|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138694839|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694840|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138694841|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138694842|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
138694844|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138694845|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138694846|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
138694847|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138694848|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138694849|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138694850|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138694851|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
138694852|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
138694853|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138694854|NCT03809442|Narcotics|narcotics|mesh-ancestor
138694855|NCT00534729|Carboplatin|carboplatin|mesh-list
138694856|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694857|NCT00547989|Bupivacaine|bupivacaine|mesh-list
138694858|NCT00547989|Ropivacaine|ropivacaine|mesh-list
138694859|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
138694860|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
138694861|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138694862|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694863|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
138694864|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138694865|NCT00534807|Rifampin|rifampin|mesh-list
138694866|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138694867|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
138694871|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138694872|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694873|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694874|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138694875|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138694876|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138694877|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138694878|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138694879|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138694881|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138694882|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338321|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138694883|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138165955|NCT04688788|Protective Agents|protective agents|mesh-ancestor
138694884|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138694885|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
138694886|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694887|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694888|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138694889|NCT00548067|Amlodipine|amlodipine|mesh-list
138694890|NCT00548067|Valsartan|valsartan|mesh-list
138694891|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138694892|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138694893|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138694894|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138694895|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694896|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138694897|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694898|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
138694899|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138694900|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138694901|NCT00548067|Diuretics|diuretics|mesh-ancestor
138694902|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
138694903|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138694904|NCT02907749|Carvedilol|carvedilol|mesh-list
138694905|NCT02907749|Spironolactone|spironolactone|mesh-list
138694906|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138694908|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694910|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138694912|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
138694913|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138694914|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138694915|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
138694916|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138694917|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694918|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138694919|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
138694920|NCT02907749|Protective Agents|protective agents|mesh-ancestor
138694921|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138694922|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138694923|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138694924|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
138694925|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138694926|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138694927|NCT02907593|Budesonide|budesonide|mesh-list
138694928|NCT02907593|Calfactant|calfactant|mesh-list
138694929|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138694930|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138694931|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
138447316|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
138694932|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138694933|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694934|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138694935|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
138694936|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
138694937|NCT02907593|Hormones|hormones|mesh-ancestor
138694938|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138694939|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138694940|NCT00548301|Cyclosporine|cyclosporine|mesh-list
138694941|NCT00548301|Cyclosporins|cyclosporins|mesh-list
138694942|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694943|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694944|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138166129|NCT04035187|Itraconazole|itraconazole|mesh-list
138694946|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694947|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
138694948|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138694949|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
138694950|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138694951|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138694953|NCT02907710|Endostatins|endostatins|mesh-list
138694954|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138694955|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138694956|NCT02907710|Growth Substances|growth substances|mesh-ancestor
138694957|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694958|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
138694959|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694960|NCT03781362|Capecitabine|capecitabine|mesh-list
138694961|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138694962|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
138479984|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138179155|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694963|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694964|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694965|NCT04682249|Apatinib|apatinib|mesh-list
138694966|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694967|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138694968|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694969|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694970|NCT00548379|Vitamin D|vitamin d|mesh-list
138694971|NCT00548379|Vitamins|vitamins|mesh-ancestor
138694972|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
138694973|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694974|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138694975|NCT04972617|Furosemide|furosemide|mesh-list
138694976|NCT04972617|Diuretics|diuretics|mesh-ancestor
138694977|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
138694978|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447346|NCT01850680|Hematinics|hematinics|mesh-ancestor
138694979|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138694980|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138694981|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694982|NCT04682210|Bevacizumab|bevacizumab|mesh-list
138694983|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138694984|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138694985|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138694986|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138694987|NCT04682210|Growth Substances|growth substances|mesh-ancestor
138694988|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694989|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
138694992|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138694993|NCT02907554|Cyclosporine|cyclosporine|mesh-list
138694994|NCT02907554|Cyclosporins|cyclosporins|mesh-list
138694995|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138694996|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138694997|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138694998|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
138694999|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695000|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
138695001|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695002|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
138695003|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138695004|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138695005|NCT02907632|Metoclopramide|metoclopramide|mesh-list
138695006|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
138695007|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
138695008|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695009|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695010|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138695011|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138695012|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138695013|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
138695014|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138338383|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138695015|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695018|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695020|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138695021|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
138695022|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695023|NCT00548574|Mesalamine|mesalamine|mesh-list
138695024|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138695025|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138695026|NCT00548574|Analgesics|analgesics|mesh-ancestor
138695027|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
138695028|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695029|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695030|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138695031|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138695032|NCT01262677|Pregabalin|pregabalin|mesh-list
138695033|NCT01262677|Analgesics|analgesics|mesh-ancestor
138695034|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
138695035|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695036|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695037|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
138695038|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138695039|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138695040|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695041|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138695042|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138695043|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138695044|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695045|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138695046|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
138695047|NCT02899364|Antidotes|antidotes|mesh-ancestor
138695048|NCT02899364|Protective Agents|protective agents|mesh-ancestor
138695049|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695050|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
138338392|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338394|NCT01168908|Urological Agents|urological agents|mesh-ancestor
138695051|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695052|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
138695053|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138695054|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695056|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
138695057|NCT04206865|Valsartan|valsartan|mesh-list
138695058|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
138695059|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138695060|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138695061|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138695062|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138695063|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695064|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138695065|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138695066|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138695067|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
138695068|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138695069|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138695070|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
138695071|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695072|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138695073|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179265|NCT05664971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338433|NCT01175148|Atorvastatin|atorvastatin|mesh-list
138695074|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138695075|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695077|NCT00535119|Carboplatin|carboplatin|mesh-list
138695078|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138695079|NCT00535119|Veliparib|veliparib|mesh-list
138695080|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138695081|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695082|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
138695083|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
138695084|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
138695085|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695086|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138695087|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695088|NCT00535158|Vitamin D|vitamin d|mesh-list
138695089|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
138695090|NCT00535158|Vitamins|vitamins|mesh-ancestor
138695091|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
138695093|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138695094|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138695095|NCT03436992|Resveratrol|resveratrol|mesh-list
138695096|NCT03436992|Antioxidants|antioxidants|mesh-list
138695097|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338497|NCT01188876|Folic Acid|folic acid|mesh-list
138695098|NCT03436992|Protective Agents|protective agents|mesh-ancestor
138695099|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695100|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695101|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138695102|NCT04207450|Glutaral|glutaral|mesh-list
138695103|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
138695104|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695105|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
138695106|NCT04070443|Ponatinib|ponatinib|mesh-list
138695107|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695108|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138695109|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138338534|NCT01197612|Hormones|hormones|mesh-ancestor
138338536|NCT01198158|Bevacizumab|bevacizumab|mesh-list
138695110|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695111|NCT04043494|Cytarabine|cytarabine|mesh-list
138695112|NCT04043494|Dexamethasone|dexamethasone|mesh-list
138695113|NCT04043494|Prednisone|prednisone|mesh-list
138695114|NCT04043494|Prednisolone|prednisolone|mesh-list
138695115|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
138695116|NCT04043494|Ifosfamide|ifosfamide|mesh-list
138695117|NCT04043494|Doxorubicin|doxorubicin|mesh-list
138695118|NCT04043494|Methotrexate|methotrexate|mesh-list
138695119|NCT04043494|Vincristine|vincristine|mesh-list
138695120|NCT04043494|Daunorubicin|daunorubicin|mesh-list
138695123|NCT04043494|Thioguanine|thioguanine|mesh-list
138695124|NCT04043494|Pegaspargase|pegaspargase|mesh-list
138338598|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138338603|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
138695125|NCT04043494|Vindesine|vindesine|mesh-list
138695126|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138695127|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
138695128|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695129|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138695130|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138179304|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
138695131|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
138695132|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695133|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695134|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138695135|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138695136|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
138695137|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
138695138|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695139|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138695140|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
138695141|NCT04043494|Hormones|hormones|mesh-ancestor
138695142|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138695143|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138695144|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138338668|NCT01222260|Dexamethasone|dexamethasone|mesh-list
138695145|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138695146|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138695147|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695148|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138695149|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
138695150|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138695151|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138695153|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
138695154|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138695155|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138695156|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
138695157|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695158|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138695160|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
138695161|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
138695162|NCT02899286|BCT-100|bct-100|mesh-list
138695163|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695164|NCT04322422|Montelukast|montelukast|mesh-list
138695165|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138695166|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
138695167|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138695168|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
138695169|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138695170|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695171|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138695172|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138695173|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695174|NCT02899169|Tretinoin|tretinoin|mesh-list
138695175|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
138695176|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
138695177|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138179329|NCT03835013|Exenatide|exenatide|mesh-list
138695178|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
138695179|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
138695180|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
138338715|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695181|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695182|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695183|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138695184|NCT00548964|Ketamine|ketamine|mesh-list
138695185|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
138695186|NCT00548964|Analgesics|analgesics|mesh-ancestor
138695187|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
138695188|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695189|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695190|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138695191|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138695192|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
138695193|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
138695194|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695195|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138695196|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138695197|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138695198|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338756|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138338758|NCT01232946|Incretins|incretins|mesh-ancestor
138695199|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
138695200|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138695201|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695202|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
138695203|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138695205|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
138695206|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138166530|NCT00521989|Hormones|hormones|mesh-ancestor
138695208|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695210|NCT00549120|Albuterol|albuterol|mesh-list
138695211|NCT00549120|Ipratropium|ipratropium|mesh-list
138695212|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138695213|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138695214|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
138695215|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138695216|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695217|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695218|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138695219|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138695220|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
138695221|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138695222|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
138338812|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338813|NCT01249872|Analgesics|analgesics|mesh-ancestor
138338814|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
138338815|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695223|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695224|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138695225|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
138695226|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
138695227|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138695228|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138695229|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138695230|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138695232|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
138695233|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
138695234|NCT04680884|Clotrimazole|clotrimazole|mesh-list
138695236|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695237|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138695238|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138695239|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138695240|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179352|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179353|NCT04383275|Capecitabine|capecitabine|mesh-list
138695241|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695242|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138695244|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138695245|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695246|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138338863|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
138338864|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
138338865|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338866|NCT01244724|Escitalopram|escitalopram|mesh-list
138338867|NCT01244724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138338871|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138695247|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138695248|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
138695249|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
138695250|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695251|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138695252|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695254|NCT00535509|Docetaxel|docetaxel|mesh-list
138695255|NCT00535509|Trastuzumab|trastuzumab|mesh-list
138695256|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695257|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
138695258|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
138166645|NCT00526591|Everolimus|everolimus|mesh-list
138338908|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
138338909|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
138338911|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
138338912|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138338913|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
138338914|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138695260|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695261|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138695262|NCT01262365|Epratuzumab|epratuzumab|mesh-list
138695263|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138695264|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695265|NCT03244176|Avelumab|avelumab|mesh-list
138179365|NCT03782103|Ethanol|ethanol|mesh-list
138695266|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138695267|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695268|NCT00535665|Vaccines|vaccines|mesh-list
138695269|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
138695270|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695271|NCT03971110|Goserelin|goserelin|mesh-list
138695272|NCT03971110|Bicalutamide|bicalutamide|mesh-list
138695273|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138338970|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138338972|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138338973|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138338974|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338975|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138338976|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138338983|NCT01280058|Paclitaxel|paclitaxel|mesh-list
138695274|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695275|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
138695276|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
138695277|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138695278|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695279|NCT01262287|Dutasteride|dutasteride|mesh-list
138695280|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138695281|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138695282|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479985|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138695283|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339024|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339025|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339026|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138339027|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
138695285|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138695286|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695287|NCT01262092|Buprenorphine|buprenorphine|mesh-list
138695288|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138695289|NCT01262092|Narcotics|narcotics|mesh-ancestor
138695290|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695291|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695292|NCT01262092|Analgesics|analgesics|mesh-ancestor
138695293|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
138179411|NCT04340505|Hormones|hormones|mesh-ancestor
138695294|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695295|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138695296|NCT04680962|Rituximab|rituximab|mesh-list
138695297|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138695298|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695299|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
138695300|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695301|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138695302|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
138695303|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138695304|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138695305|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138695306|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138695307|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695308|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
138695309|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138166720|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
138339083|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138339084|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
138339085|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339086|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339111|NCT01304238|PENTA|penta|mesh-list
138695312|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695313|NCT03088410|Zidovudine|zidovudine|mesh-list
138695314|NCT03088410|Nevirapine|nevirapine|mesh-list
138695315|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
138695316|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695317|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138695318|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138695319|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695320|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
138695321|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695322|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138695323|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138695324|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138695325|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138695327|NCT02897765|Poly ICLC|poly iclc|mesh-list
138695328|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
138695329|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339129|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138339130|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138339131|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339132|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339134|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138339135|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
138339136|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138179457|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138695330|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138695331|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695332|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138695333|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695334|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
138695335|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
138695336|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138695337|NCT00549588|Protective Agents|protective agents|mesh-ancestor
138695338|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695339|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
138695340|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
138695341|NCT04321642|Entonox|entonox|mesh-list
138695342|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138695343|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
138695344|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695345|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695346|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138695347|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
138695348|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138695349|NCT04321642|Analgesics|analgesics|mesh-ancestor
138695350|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
138695351|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695352|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
138339183|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
138339184|NCT01312818|Vorinostat|vorinostat|mesh-list
138339185|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138339186|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
138339187|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
138339191|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
138695353|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138695354|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695355|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138179500|NCT04923113|Antacids|antacids|mesh-ancestor
138695356|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695357|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
138695358|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
138695359|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695360|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138695361|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695362|NCT04321837|Vitamin D|vitamin d|mesh-list
138695363|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
138695364|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
138695365|NCT04321837|Vitamins|vitamins|mesh-ancestor
138695366|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
138695367|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695368|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138695369|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138695370|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
138339232|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138339233|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339234|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138339235|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
138339236|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
138339237|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138695371|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695372|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138695373|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479986|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138695374|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695377|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138695378|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138695379|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138695380|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695381|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695382|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138695383|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138695384|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138695385|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138695386|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
138339287|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138339288|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138339289|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138339290|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
138339291|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138339292|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339293|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138339295|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138695387|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138372236|NCT01417169|Micafungin|micafungin|mesh-list
138695388|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695389|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138695390|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138695391|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
138695392|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138695393|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138695394|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
138695395|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138179545|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179546|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138695396|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
138695397|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138695398|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138695399|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138166857|NCT00553969|Carvedilol|carvedilol|mesh-list
138695411|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138695412|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695413|NCT00551577|Carboplatin|carboplatin|mesh-list
138695414|NCT00551577|Docetaxel|docetaxel|mesh-list
138695415|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695416|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
138695417|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
138695418|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
138695419|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695420|NCT04321096|Camostat|camostat|mesh-list
138339335|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138339340|NCT01330290|Rotigotine|rotigotine|mesh-list
138695421|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
138695422|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695423|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695424|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138695425|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138695426|NCT03556696|Remifentanil|remifentanil|mesh-list
138695429|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695430|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695431|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138695432|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
138695433|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
138695434|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138339383|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138339384|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
138339385|NCT01333098|Mifepristone|mifepristone|mesh-list
138339386|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138695437|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
138447543|NCT01851941|Vitamins|vitamins|mesh-ancestor
138695438|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695439|NCT04320706|Oxytocin|oxytocin|mesh-list
138695440|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
138695441|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138695442|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695443|NCT00553709|Nicotine|nicotine|mesh-list
138695444|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138695445|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
138695446|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695447|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695448|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138695449|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138695450|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
138695451|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138339439|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
138339440|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339441|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
138339442|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138339443|NCT01339260|Dexamethasone|dexamethasone|mesh-list
138339444|NCT01339260|Palonosetron|palonosetron|mesh-list
138339445|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138695452|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695454|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138695455|NCT00551733|Carboplatin|carboplatin|mesh-list
138695456|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138166938|NCT01797991|Hormones|hormones|mesh-ancestor
138695458|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695459|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
138695460|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
138695461|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
138695462|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339495|NCT01351740|Ritonavir|ritonavir|mesh-list
138695463|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
138695464|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138695465|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695466|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138695467|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
138695468|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138695469|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695470|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695471|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695472|NCT04922424|Atorvastatin|atorvastatin|mesh-list
138695473|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138695474|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138695475|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
138695476|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695477|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138695478|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138695479|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695480|NCT00553748|Alovudine|alovudine|mesh-list
138695481|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
138695482|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695484|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695485|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138447580|NCT01852266|Vaccines|vaccines|mesh-list
138695486|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695487|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695488|NCT00550095|Valsartan|valsartan|mesh-list
138695489|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138695490|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138695491|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138695492|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695493|NCT00551889|Celecoxib|celecoxib|mesh-list
138695494|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
138695495|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138695496|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
138695497|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695499|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138695500|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
138695501|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695502|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695503|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138695504|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138695505|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138695506|NCT00551889|Analgesics|analgesics|mesh-ancestor
138695507|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
138695508|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695509|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138695510|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138695511|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138695512|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695513|NCT03455764|Trametinib|trametinib|mesh-list
138695514|NCT03455764|Dabrafenib|dabrafenib|mesh-list
138695516|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138695517|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695518|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695519|NCT04902495|Pemetrexed|pemetrexed|mesh-list
138695520|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695521|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695522|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695523|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138695524|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138695525|NCT02895659|Norepinephrine|norepinephrine|mesh-list
138695526|NCT02895659|Epinephrine|epinephrine|mesh-list
138695527|NCT02895659|Racepinephrine|racepinephrine|mesh-list
138447613|NCT01852461|Beractant|beractant|mesh-list
138695529|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138339561|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695530|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138695531|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
138695532|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138695533|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695534|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695535|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
138695536|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
138167016|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138372384|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695537|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695538|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138179626|NCT03834753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138695539|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138695540|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138695541|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138339569|NCT01363128|Hormones|hormones|mesh-ancestor
138339572|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138695542|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
138695544|NCT00552201|Tacrolimus|tacrolimus|mesh-list
138695545|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138695546|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
138695547|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695548|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138695549|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695550|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695551|NCT03391882|Apomorphine|apomorphine|mesh-list
138695552|NCT03391882|Emetics|emetics|mesh-ancestor
138695553|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339629|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138339630|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
138339635|NCT01379664|Isoflurane|isoflurane|mesh-list
138695554|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
138695555|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695556|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138695557|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
138695558|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
138695559|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138695560|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695561|NCT00550329|Glipizide|glipizide|mesh-list
138695562|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138695563|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695565|NCT00550485|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138695566|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138179644|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
138695567|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138695568|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695569|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138695571|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695572|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
138695573|NCT00550563|Vitamin D|vitamin d|mesh-list
138695574|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138695575|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695576|NCT00550563|Vitamins|vitamins|mesh-ancestor
138695577|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
138695578|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138695579|NCT02895191|Urinastatin|urinastatin|mesh-list
138695580|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
138695581|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138695582|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
138695583|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695584|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695585|NCT04680650|Anesthetics|anesthetics|mesh-list
138695586|NCT04680650|Propofol|propofol|mesh-list
138695587|NCT04680650|Sevoflurane|sevoflurane|mesh-list
138695588|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138167095|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695589|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695590|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138695591|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138695592|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
138695593|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138695594|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138695596|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138695597|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138695598|NCT02895113|Analgesics|analgesics|mesh-ancestor
138695599|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
138695600|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695601|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695602|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138695603|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138695604|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138695605|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138695606|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695607|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138695608|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138695609|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695610|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
138695611|NCT00552630|Penicillamine|penicillamine|mesh-list
138695612|NCT00552630|Antidotes|antidotes|mesh-ancestor
138695613|NCT00552630|Protective Agents|protective agents|mesh-ancestor
138695614|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695615|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
138695616|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
138695617|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695618|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138695619|NCT02894957|Varenicline|varenicline|mesh-list
138695620|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138695621|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138695622|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
138167145|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
138695623|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138695624|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695625|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695626|NCT00550992|Leucovorin|leucovorin|mesh-list
138695627|NCT00550992|Cytarabine|cytarabine|mesh-list
138339717|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138339718|NCT01399866|Cycloserine|cycloserine|mesh-list
138339719|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138339720|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695628|NCT00550992|Cyclosporine|cyclosporine|mesh-list
138695629|NCT00550992|Prednisone|prednisone|mesh-list
138695630|NCT00550992|Prednisolone|prednisolone|mesh-list
138695631|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
138695632|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138695633|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138695634|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138695635|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
138695636|NCT00550992|Melphalan|melphalan|mesh-list
138695637|NCT00550992|Busulfan|busulfan|mesh-list
138695638|NCT00550992|Methotrexate|methotrexate|mesh-list
138695639|NCT00550992|Etoposide|etoposide|mesh-list
138695640|NCT00550992|Vincristine|vincristine|mesh-list
138695641|NCT00550992|Daunorubicin|daunorubicin|mesh-list
138695642|NCT00550992|Asparaginase|asparaginase|mesh-list
138695643|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
138695644|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
138695645|NCT00550992|Pegaspargase|pegaspargase|mesh-list
138695646|NCT00550992|Thioguanine|thioguanine|mesh-list
138695647|NCT00550992|Cyclosporins|cyclosporins|mesh-list
138695648|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138695649|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
138695650|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138695651|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
138339770|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
138695652|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695653|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138695654|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138695655|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
138695656|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695657|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695658|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138695659|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138695660|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
138695661|NCT00550992|Hormones|hormones|mesh-ancestor
138695662|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138695663|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138695664|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138695665|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
138339825|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138695666|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138167189|NCT00450983|Thiotepa|thiotepa|mesh-list
138695669|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
138695670|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695671|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138695672|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138695673|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138695674|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138695676|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
138695677|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695678|NCT00550992|Antidotes|antidotes|mesh-ancestor
138695679|NCT00550992|Protective Agents|protective agents|mesh-ancestor
138695680|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
138695681|NCT00550992|Vitamins|vitamins|mesh-ancestor
138695682|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
138695683|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
138695684|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
138695685|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
138695686|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
138695687|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138695688|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695689|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138695690|NCT00550992|Analgesics|analgesics|mesh-ancestor
138695691|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
138695692|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
138695693|NCT02895074|Tropicamide|tropicamide|mesh-list
138695694|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
138695695|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
138695696|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695697|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695698|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138695699|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138695700|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
138695701|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138695702|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695703|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
138695704|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
138695705|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695706|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
138339940|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695707|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138695708|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
138695709|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695711|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
138695712|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
138695713|NCT00551265|Oregovomab|oregovomab|mesh-list
138695714|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138695715|NCT00551265|Antibodies|antibodies|mesh-list
138695716|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
138695717|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138695718|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138695719|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
138695720|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695721|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138695722|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138695723|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
138695724|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695725|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695726|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138695727|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
138695728|NCT02894606|Basiliximab|basiliximab|mesh-list
138695729|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
138695730|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695731|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138179734|NCT00849251|Bortezomib|bortezomib|mesh-list
138695732|NCT00551343|Exenatide|exenatide|mesh-list
138339997|NCT01474590|Doxycycline|doxycycline|mesh-list
138695733|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138695734|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695735|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138695736|NCT00551343|Incretins|incretins|mesh-ancestor
138695737|NCT00551343|Hormones|hormones|mesh-ancestor
138695738|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138695739|NCT00551382|Montelukast|montelukast|mesh-list
138695740|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138167261|NCT04149626|Analgesics|analgesics|mesh-ancestor
138695742|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138695743|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
138695744|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138695745|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695746|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138695747|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138695748|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340048|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695749|NCT02894684|Aztreonam|aztreonam|mesh-list
138695750|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138695751|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695752|NCT02894645|Cytarabine|cytarabine|mesh-list
138695753|NCT02894645|Dexamethasone|dexamethasone|mesh-list
138695754|NCT02894645|Prednisolone|prednisolone|mesh-list
138695755|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
138695756|NCT02894645|Doxorubicin|doxorubicin|mesh-list
138695757|NCT02894645|Methotrexate|methotrexate|mesh-list
138695758|NCT02894645|Fludarabine|fludarabine|mesh-list
138695759|NCT02894645|Vincristine|vincristine|mesh-list
138695760|NCT02894645|Daunorubicin|daunorubicin|mesh-list
138695761|NCT02894645|Asparaginase|asparaginase|mesh-list
138695762|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
138695763|NCT02894645|Thioguanine|thioguanine|mesh-list
138695764|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138695765|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
138695766|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695767|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138695768|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138695770|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695771|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695772|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138695773|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138695774|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
138695775|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
138695776|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695777|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138695778|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
138695779|NCT02894645|Hormones|hormones|mesh-ancestor
138695780|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138695781|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138695782|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138695783|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138695784|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138695785|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695786|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138695787|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
138695788|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138447725|NCT01853449|Analgesics|analgesics|mesh-ancestor
138695789|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138695791|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
138695792|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138695793|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138695794|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
138695795|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340157|NCT01519284|Carbidopa|carbidopa|mesh-list
138340158|NCT01519284|Opicapone|opicapone|mesh-list
138340159|NCT01519284|Entacapone|entacapone|mesh-list
138695796|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138695798|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
138695799|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
138695800|NCT00552747|Fenofibrate|fenofibrate|mesh-list
138695801|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138695802|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
138695803|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695804|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138695805|NCT05427617|Fulvestrant|fulvestrant|mesh-list
138695806|NCT05427617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138695807|NCT05427617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138695808|NCT05427617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695809|NCT05427617|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138695810|NCT05427617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138695811|NCT05427617|Hormone Antagonists|hormone antagonists|mesh-ancestor
138695812|NCT05427617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138340213|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138340214|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340215|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138695813|NCT05427617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695814|NCT05427617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695815|NCT05427617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695817|NCT05427500|Anesthetics, Local|anesthetics, local|mesh-ancestor
138695818|NCT05427500|Anesthetics|anesthetics|mesh-ancestor
138695819|NCT05427500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695820|NCT05427500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695821|NCT05427500|Sensory System Agents|sensory system agents|mesh-ancestor
138695822|NCT05427500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695823|NCT05427305|Bevacizumab|bevacizumab|mesh-list
138695824|NCT05427305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138695825|NCT05427305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695826|NCT05427305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138695827|NCT05427305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138695828|NCT05427305|Growth Substances|growth substances|mesh-ancestor
138695829|NCT05427305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695830|NCT05427305|Growth Inhibitors|growth inhibitors|mesh-ancestor
138695831|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
138695832|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
138695834|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138695835|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695836|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695837|NCT01099449|Analgesics|analgesics|mesh-ancestor
138695838|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
138179774|NCT05254288|Chlorhexidine|chlorhexidine|mesh-list
138179776|NCT05254288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138340269|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138695839|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695840|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
138372678|NCT01419821|Cholecalciferol|cholecalciferol|mesh-list
138695842|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138695843|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
138695844|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138695845|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138695846|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695847|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
138695848|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138695849|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
138340322|NCT06114953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695850|NCT04680143|Hematinics|hematinics|mesh-ancestor
138695851|NCT05426798|Azacitidine|azacitidine|mesh-list
138695852|NCT05426798|Decitabine|decitabine|mesh-list
138695853|NCT05426798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138695854|NCT05426798|Antimetabolites|antimetabolites|mesh-ancestor
138695855|NCT05426798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695856|NCT05426798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695857|NCT05426798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695858|NCT01234402|Capecitabine|capecitabine|mesh-list
138695859|NCT01234402|Ramucirumab|ramucirumab|mesh-list
138695860|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138695861|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
138695862|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695863|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695864|NCT01260922|Donepezil|donepezil|mesh-list
138695865|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138695866|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695867|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695868|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
138695869|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138695870|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695871|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
138695872|NCT01212094|Rituximab|rituximab|mesh-list
138695873|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138695874|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695875|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
138695876|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695877|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138340453|NCT06113809|Pembrolizumab|pembrolizumab|mesh-list
138340454|NCT06113809|Palbociclib|palbociclib|mesh-list
138340455|NCT06113809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138695878|NCT05409885|Anesthetics|anesthetics|mesh-list
138695879|NCT05409885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695880|NCT05409885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695881|NCT00552864|Ropivacaine|ropivacaine|mesh-list
138695882|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
138695883|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
138695884|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
138695885|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695886|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138167496|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138695887|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
138695888|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695889|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
138695890|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138695891|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138695892|NCT01211665|Prednisolone|prednisolone|mesh-list
138695893|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
138695894|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138695895|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
138695896|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138695897|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
138695898|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
138695899|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695900|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695901|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138695902|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
138695904|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138695905|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138695906|NCT01211665|Protective Agents|protective agents|mesh-ancestor
138695907|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138695908|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695909|NCT04401176|Lidocaine|lidocaine|mesh-list
138695910|NCT04401176|Heparin|heparin|mesh-list
138695911|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
138695912|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
138179840|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138372752|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138695913|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138695914|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695916|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138695918|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138695919|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138695920|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138340567|NCT05935917|Antiviral Agents|antiviral agents|mesh-ancestor
138695921|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695922|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
138695923|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138695924|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138695925|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
138695926|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138695927|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695928|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
138695929|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138695930|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695931|NCT04335305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138695932|NCT04335305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695933|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
138340618|NCT05804708|Hallucinogens|hallucinogens|mesh-ancestor
138340619|NCT05804708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340620|NCT05804708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138340621|NCT05804708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138340622|NCT05804708|Serotonin Agents|serotonin agents|mesh-ancestor
138340623|NCT05804708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138340624|NCT05804708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138340627|NCT05800275|Trastuzumab|trastuzumab|mesh-list
138695934|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138695935|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695936|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695937|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138695938|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138695939|NCT04152980|Protective Agents|protective agents|mesh-ancestor
138695940|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695941|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
138695942|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138695943|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
138340681|NCT05712018|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138340682|NCT05712018|Plasma Substitutes|plasma substitutes|mesh-ancestor
138340683|NCT05712018|Blood Substitutes|blood substitutes|mesh-ancestor
138340684|NCT05705492|Olanzapine|olanzapine|mesh-list
138340685|NCT05705492|Antiemetics|antiemetics|mesh-ancestor
138340686|NCT05705492|Autonomic Agents|autonomic agents|mesh-ancestor
138340687|NCT05705492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138340688|NCT05705492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695944|NCT01232452|Pemetrexed|pemetrexed|mesh-list
138695945|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695946|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138167603|NCT04145492|Vitamin D|vitamin d|mesh-list
138695947|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695949|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138695951|NCT01211197|Empagliflozin|empagliflozin|mesh-list
138695952|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138695953|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179870|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
138695954|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138340738|NCT05475873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695955|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695956|NCT00553137|Fluconazole|fluconazole|mesh-list
138695957|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
138695958|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138695959|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138695960|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138695961|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695962|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695964|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
138695965|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138695966|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695967|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138695968|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138695969|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
138695970|NCT04090775|Nivolumab|nivolumab|mesh-list
138695971|NCT04090775|Ipilimumab|ipilimumab|mesh-list
138695972|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138695973|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
138695974|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138695975|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138695976|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138695977|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
138695978|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695979|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695980|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138695981|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138340806|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340818|NCT04982874|Furosemide|furosemide|mesh-list
138695982|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138695983|NCT01232296|Sorafenib|sorafenib|mesh-list
138695984|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695985|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138695986|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695987|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695988|NCT04041011|Fluzoparib|fluzoparib|mesh-list
138167694|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138695989|NCT04041011|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138695990|NCT04041011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179902|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138179904|NCT00828841|Carboplatin|carboplatin|mesh-list
138695991|NCT04041011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695992|NCT04041011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138695993|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138695994|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138695995|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138695996|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
138695997|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138695998|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138695999|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138696000|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696001|NCT01231555|Efavirenz|efavirenz|mesh-list
138696002|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138696003|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138696004|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696005|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696006|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
138696007|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696008|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138696009|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138696010|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138696012|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138696013|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138696014|NCT05288907|Lidocaine|lidocaine|mesh-list
138696015|NCT05288907|Anesthetics, Local|anesthetics, local|mesh-ancestor
138696016|NCT05288907|Anesthetics|anesthetics|mesh-ancestor
138340913|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696017|NCT05288907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696018|NCT05288907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696019|NCT05288907|Sensory System Agents|sensory system agents|mesh-ancestor
138696020|NCT05288907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696021|NCT05288907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138696022|NCT05288907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138696023|NCT05288907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138696024|NCT05288907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138696025|NCT05288907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696026|NCT03911336|Acetaminophen|acetaminophen|mesh-list
138179935|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
138696027|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138696029|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138696030|NCT03911336|Analgesics|analgesics|mesh-ancestor
138696031|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
138696032|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696033|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696035|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138340963|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138696036|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138696037|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138696038|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696039|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696040|NCT03850535|Cytarabine|cytarabine|mesh-list
138696041|NCT03850535|Daunorubicin|daunorubicin|mesh-list
138696042|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138696043|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
138696044|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696045|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696046|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
138696047|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696048|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138696049|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
138696050|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696051|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138696052|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138341019|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
138341020|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
138696053|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138696054|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696055|NCT03850301|Etifoxine|etifoxine|mesh-list
138696056|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138696057|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138696058|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696059|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696060|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138696062|NCT05255367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138696063|NCT05255367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696064|NCT05255367|Disinfectants|disinfectants|mesh-ancestor
138696065|NCT05255367|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138696066|NCT05255367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138696067|NCT03653000|Anesthetics|anesthetics|mesh-list
138696068|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
138696069|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696070|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696071|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
138696072|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696073|NCT03639389|Morphine|morphine|mesh-list
138696074|NCT03639389|Analgesics|analgesics|mesh-list
138696075|NCT03639389|Bupivacaine|bupivacaine|mesh-list
138179971|NCT00853333|Analgesics|analgesics|mesh-ancestor
138696076|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
138696077|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
138696078|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696079|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341077|NCT04003285|Pregnanolone|pregnanolone|mesh-list
138341078|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
138341081|NCT03967288|Bupivacaine|bupivacaine|mesh-list
138696080|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
138696081|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696082|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138696083|NCT03639389|Narcotics|narcotics|mesh-ancestor
138696084|NCT05172531|Cisatracurium|cisatracurium|mesh-list
138696085|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138696086|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138696087|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696088|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696089|NCT03570983|Cytarabine|cytarabine|mesh-list
138696090|NCT03570983|Etoposide|etoposide|mesh-list
138696091|NCT03570983|Melphalan|melphalan|mesh-list
138696093|NCT03570983|Allopurinol|allopurinol|mesh-list
138696094|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138696095|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696096|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138696097|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138696098|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696099|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696100|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138696101|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
138696102|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
138696103|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138341124|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138341125|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138696105|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
138696106|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696107|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138696108|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
138696109|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138696110|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
138696111|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138696112|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138696113|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
138696114|NCT03570983|Protective Agents|protective agents|mesh-ancestor
138696116|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
138696117|NCT03540758|Niacinamide|niacinamide|mesh-list
138696118|NCT03540758|Diazoxide|diazoxide|mesh-list
138696119|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138696120|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
138696121|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696122|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138696123|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
138696124|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
138696125|NCT03540758|Vitamins|vitamins|mesh-ancestor
138696126|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
138341176|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138341177|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
138696127|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696128|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138696129|NCT03187379|Bupivacaine|bupivacaine|mesh-list
138696131|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
138696132|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696133|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696134|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
138696135|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696136|NCT03182231|Exenatide|exenatide|mesh-list
138696137|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138696138|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696139|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138696140|NCT03182231|Incretins|incretins|mesh-ancestor
138696141|NCT03182231|Hormones|hormones|mesh-ancestor
138696142|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138696143|NCT02964884|Lovastatin|lovastatin|mesh-list
138696144|NCT02964884|L 647318|l 647318|mesh-list
138696145|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
138696146|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138696147|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138696148|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
138696149|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696150|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138696151|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138696152|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696153|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
138696154|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138696155|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138168041|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138168046|NCT04140578|Ertapenem|ertapenem|mesh-list
138341291|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138341292|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138696156|NCT02837042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138696157|NCT02837042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696158|NCT05098470|Metformin|metformin|mesh-list
138696159|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
138696160|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138180037|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
138696161|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696162|NCT02710643|Ofatumumab|ofatumumab|mesh-list
138696163|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696164|NCT05093205|Midazolam|midazolam|mesh-list
138696165|NCT05093205|Atorvastatin|atorvastatin|mesh-list
138696166|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
138696167|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138696168|NCT05093205|Estradiol|estradiol|mesh-list
138696169|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138696170|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138696171|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696172|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696173|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138696174|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138696175|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138696176|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138696177|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
138696179|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
138696180|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
138696181|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138168089|NCT00575029|Megestrol|megestrol|mesh-list
138696182|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696183|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138696184|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138696185|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
138696186|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138696187|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138696188|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696189|NCT05093205|Estrogens|estrogens|mesh-ancestor
138696191|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138696192|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138696193|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
138696194|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138696195|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138696196|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138696197|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138696198|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138696199|NCT02623751|Exemestane|exemestane|mesh-list
138696200|NCT02623751|Entinostat|entinostat|mesh-list
138696201|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696202|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138696203|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138696204|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696205|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696206|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138696207|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
138696208|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138696209|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138168140|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696210|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138696212|NCT02469155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138696214|NCT02469155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180062|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
138180071|NCT00860171|Antibodies|antibodies|mesh-list
138696215|NCT02469155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138341459|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138341463|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
138696216|NCT02469155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696217|NCT02469155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138696218|NCT02469155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138696219|NCT02469155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696220|NCT02469155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138696221|NCT02469155|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138696222|NCT02469155|Dopamine Agents|dopamine agents|mesh-ancestor
138696223|NCT02465606|Triamcinolone|triamcinolone|mesh-list
138696224|NCT02465606|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138696225|NCT02465606|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138696226|NCT02465606|Hydrocortisone|hydrocortisone|mesh-list
138696227|NCT02465606|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138696228|NCT02465606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138696229|NCT02465606|Glucocorticoids|glucocorticoids|mesh-ancestor
138696231|NCT02465606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138341518|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138696232|NCT02465606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696233|NCT02465606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138696234|NCT02465606|Immunologic Factors|immunologic factors|mesh-ancestor
138696235|NCT02465606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696236|NCT02465606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696238|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
138696239|NCT05080530|Vitamins|vitamins|mesh-ancestor
138696240|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
138696241|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696242|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138696243|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138696244|NCT00554177|Mifepristone|mifepristone|mesh-list
138696245|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138696246|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
138696247|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138696248|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696249|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138696251|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138696252|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
138696253|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138696254|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138696255|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
138696256|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138696257|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
138180087|NCT00823043|Timolol|timolol|mesh-list
138696258|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138696259|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138696260|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
138696262|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696263|NCT03425565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138696264|NCT03425565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696265|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
138696266|NCT05073627|Dabigatran|dabigatran|mesh-list
138696267|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
138696268|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138696270|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696271|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696272|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
138696273|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138696274|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696275|NCT04678739|Remdesivir|remdesivir|mesh-list
138696276|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
138696277|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696278|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
138696279|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696280|NCT03368196|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138696281|NCT03368196|Immunoconjugates|immunoconjugates|mesh-ancestor
138341625|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138341626|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341627|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138696282|NCT03368196|Immunologic Factors|immunologic factors|mesh-ancestor
138696283|NCT03368196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696284|NCT03230565|Ropivacaine|ropivacaine|mesh-list
138696285|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
138696286|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
138696287|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696288|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696289|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
138696290|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696291|NCT02389985|Paclitaxel|paclitaxel|mesh-list
138696292|NCT02389985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138696293|NCT02389985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696294|NCT02389985|Tubulin Modulators|tubulin modulators|mesh-ancestor
138696295|NCT02389985|Antimitotic Agents|antimitotic agents|mesh-ancestor
138696296|NCT02389985|Mitosis Modulators|mitosis modulators|mesh-ancestor
138696297|NCT02389985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696298|NCT02377895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138696299|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
138696300|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138696301|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
138696302|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138696303|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341681|NCT01559922|Protective Agents|protective agents|mesh-ancestor
138696304|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138696305|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138696306|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138696307|NCT05007132|Trifluridine|trifluridine|mesh-list
138696308|NCT05007132|Bevacizumab|bevacizumab|mesh-list
138696309|NCT05007132|Panitumumab|panitumumab|mesh-list
138168264|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138696310|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138696312|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138696313|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138696314|NCT05007132|Growth Substances|growth substances|mesh-ancestor
138696315|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696316|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
138696317|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
138696318|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696319|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
138696320|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696321|NCT04684017|Carboplatin|carboplatin|mesh-list
138696322|NCT04684017|Etoposide|etoposide|mesh-list
138696323|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696324|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138696325|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138696326|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138180162|NCT04860856|Ropivacaine|ropivacaine|mesh-list
138696327|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696330|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138696331|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696332|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138696333|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696334|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
138696335|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138696336|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696337|NCT00554528|Meloxicam|meloxicam|mesh-list
138696338|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138696339|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138696340|NCT00554528|Analgesics|analgesics|mesh-ancestor
138696341|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
138696342|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696343|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696344|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138696345|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138696346|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138696347|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138696348|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696349|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696350|NCT04683198|Carboplatin|carboplatin|mesh-list
138696351|NCT04683198|Etoposide|etoposide|mesh-list
138341791|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341792|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
138341793|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138341794|NCT01588158|Narcotics|narcotics|mesh-ancestor
138341795|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138341796|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
138696352|NCT04683198|Apatinib|apatinib|mesh-list
138696353|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696354|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138696355|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138696356|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138696357|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696358|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180199|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138696359|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138696360|NCT02342249|Oseltamivir|oseltamivir|mesh-list
138696361|NCT02342249|Antiviral Agents|antiviral agents|mesh-ancestor
138696363|NCT02342249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138479987|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138696364|NCT02342249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696366|NCT02339129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138696367|NCT02339129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138696369|NCT02339129|Sensory System Agents|sensory system agents|mesh-ancestor
138696370|NCT02339129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696371|NCT02339129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341836|NCT05564442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696372|NCT02339129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138696373|NCT02339129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138696374|NCT02339129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138696375|NCT02339129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696376|NCT02339129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696378|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138696379|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138696380|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138696381|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138696382|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696383|NCT04961541|Vaccines|vaccines|mesh-list
138696384|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
138696385|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341915|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138696386|NCT02326454|Talaporfin|talaporfin|mesh-list
138696387|NCT02326454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696388|NCT02326454|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138696389|NCT02326454|Dermatologic Agents|dermatologic agents|mesh-ancestor
138696390|NCT02324309|Insulin Lispro|insulin lispro|mesh-list
138696391|NCT02324309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138696392|NCT02324309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696393|NCT02306291|Cytarabine|cytarabine|mesh-list
138696395|NCT02306291|Mitoxantrone|mitoxantrone|mesh-list
138696396|NCT02306291|Idarubicin|idarubicin|mesh-list
138696397|NCT02306291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138696398|NCT02306291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696399|NCT02306291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138696400|NCT02306291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138696401|NCT02306291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696402|NCT02306291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696403|NCT02306291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138696404|NCT02306291|Antimetabolites|antimetabolites|mesh-ancestor
138696405|NCT02306291|Antiviral Agents|antiviral agents|mesh-ancestor
138696406|NCT02306291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696407|NCT02306291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138696408|NCT02306291|Immunologic Factors|immunologic factors|mesh-ancestor
138696409|NCT02306291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696410|NCT02306291|Analgesics|analgesics|mesh-ancestor
138696411|NCT02306291|Sensory System Agents|sensory system agents|mesh-ancestor
138696412|NCT02306291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696413|NCT02306291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138696414|NCT02302079|Ranibizumab|ranibizumab|mesh-list
138696415|NCT02302079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138168454|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
138696416|NCT02302079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138696417|NCT02302079|Growth Substances|growth substances|mesh-ancestor
138696418|NCT02302079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696420|NCT02302079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696421|NCT01210495|Axitinib|axitinib|mesh-list
138696422|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188497|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696423|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138696424|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696425|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696426|NCT02289716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138696427|NCT02289716|Immunologic Factors|immunologic factors|mesh-ancestor
138696428|NCT02289716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696429|NCT04678076|Ketoprofen|ketoprofen|mesh-list
138696430|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
138696431|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138696432|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138696433|NCT04678076|Analgesics|analgesics|mesh-ancestor
138696434|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
138696435|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696436|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696437|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138188556|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188560|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
138696438|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138180259|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180271|NCT02834247|Nivolumab|nivolumab|mesh-list
138696440|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696441|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696442|NCT02257619|Docetaxel|docetaxel|mesh-list
138696443|NCT02257619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696444|NCT02257619|Tubulin Modulators|tubulin modulators|mesh-ancestor
138696445|NCT02257619|Antimitotic Agents|antimitotic agents|mesh-ancestor
138696446|NCT02257619|Mitosis Modulators|mitosis modulators|mesh-ancestor
138696447|NCT02257619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696448|NCT04891302|Clevudine|clevudine|mesh-list
138696449|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
138696450|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696451|NCT02224235|Aspirin|aspirin|mesh-list
138696452|NCT02224235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138696454|NCT02224235|Analgesics|analgesics|mesh-ancestor
138696455|NCT02224235|Sensory System Agents|sensory system agents|mesh-ancestor
138696456|NCT02224235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696457|NCT02224235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188617|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696458|NCT02224235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138696459|NCT02224235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138696460|NCT02224235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138696461|NCT02224235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138696462|NCT02224235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696463|NCT02224235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138696464|NCT02224235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138696465|NCT02224235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696466|NCT02224235|Antipyretics|antipyretics|mesh-ancestor
138696467|NCT02529852|Prednisone|prednisone|mesh-list
138696468|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
138696469|NCT02529852|Doxorubicin|doxorubicin|mesh-list
138696470|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138696471|NCT02529852|Vincristine|vincristine|mesh-list
138696472|NCT02529852|Lenalidomide|lenalidomide|mesh-list
138696473|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
138696474|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138696475|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
138696476|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696477|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138696478|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138696479|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
138696480|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696481|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696482|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138696483|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138168557|NCT00578539|Cytarabine|cytarabine|mesh-list
138696484|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138696485|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138696486|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696487|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138696488|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
138696489|NCT02529852|Hormones|hormones|mesh-ancestor
138696490|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138696491|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138696492|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138696493|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
138696494|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
138696495|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
138696496|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138696497|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138696498|NCT02529852|Growth Substances|growth substances|mesh-ancestor
138696499|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
138696500|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138696501|NCT02221232|Ethanol|ethanol|mesh-list
138696502|NCT02221232|Chlorhexidine|chlorhexidine|mesh-list
138696503|NCT02221232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138696504|NCT02221232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138696505|NCT02221232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696506|NCT02221232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696507|NCT02221232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696508|NCT02221232|Disinfectants|disinfectants|mesh-ancestor
138696509|NCT02221232|Dermatologic Agents|dermatologic agents|mesh-ancestor
138696510|NCT02206100|Enoxaparin|enoxaparin|mesh-list
138696511|NCT02206100|Anticoagulants|anticoagulants|mesh-ancestor
138696512|NCT02206100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138696513|NCT02206100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138696514|NCT02206100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696515|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
138696516|NCT01231516|Dolutegravir|dolutegravir|mesh-list
138696517|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138696518|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138696519|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
138696520|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696521|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138696522|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138696523|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696524|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696525|NCT01231321|Adalimumab|adalimumab|mesh-list
138696526|NCT01231321|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138696527|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138696528|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138696529|NCT01210222|Trebananib|trebananib|mesh-list
138696530|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138696531|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138696532|NCT01210222|Growth Substances|growth substances|mesh-ancestor
138696533|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180344|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
138696534|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
138448024|NCT01855529|Ropivacaine|ropivacaine|mesh-list
138696535|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696536|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138696537|NCT01210144|Hormones|hormones|mesh-list
138696538|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138696539|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138696540|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696541|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138696542|NCT01209949|Adapalene|adapalene|mesh-list
138696543|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138696544|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
138696545|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138696546|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138696547|NCT01209949|Analgesics|analgesics|mesh-ancestor
138696548|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
138696549|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696550|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696551|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138696552|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138696553|NCT04831593|Anesthetics|anesthetics|mesh-list
138696554|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696555|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696556|NCT04667897|Ranibizumab|ranibizumab|mesh-list
138696557|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138696558|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138696559|NCT04667897|Growth Substances|growth substances|mesh-ancestor
138696560|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696561|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
138696562|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696563|NCT01209832|Midazolam|midazolam|mesh-list
138696564|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138696565|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138696566|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696567|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696568|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138696569|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138696570|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138696571|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138696572|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
138696573|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
138696574|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
138696575|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
138696576|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138696577|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696578|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
138696579|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138696580|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
138696581|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696583|NCT04667819|Protective Agents|protective agents|mesh-ancestor
138180372|NCT02635828|Promethazine|promethazine|mesh-list
138373429|NCT01424319|Atrasentan|atrasentan|mesh-list
138696585|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138696586|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138696587|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138696588|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138696589|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
138696590|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138696591|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696592|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188753|NCT05363722|Bevacizumab|bevacizumab|mesh-list
138696595|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138696596|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138696597|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
138696598|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
138696599|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696600|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696601|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138696602|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138696603|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138696604|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
138696605|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138696606|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696607|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
138696608|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138696609|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138696610|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138696611|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138696612|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138696613|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138696614|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138696615|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696616|NCT04667351|Fluorouracil|fluorouracil|mesh-list
138696617|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
138696618|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168690|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
138696619|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138696620|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696621|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138696622|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
138696623|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696624|NCT01230814|Metronidazole|metronidazole|mesh-list
138696625|NCT01230814|Miconazole|miconazole|mesh-list
138696626|NCT01230814|Clotrimazole|clotrimazole|mesh-list
138696627|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696628|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138696629|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138696630|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138696631|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
138696632|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138696633|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138696634|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696635|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696636|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138696637|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
138696638|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138696639|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696640|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138696641|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138696642|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138696644|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
138696645|NCT01230307|Vitamins|vitamins|mesh-ancestor
138696646|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
138696647|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696648|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138696649|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138696650|NCT01209598|Palbociclib|palbociclib|mesh-list
138696651|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696652|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138696653|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188766|NCT03127137|Lidocaine|lidocaine|mesh-list
138180435|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
138168732|NCT00621049|Bevacizumab|bevacizumab|mesh-list
138696654|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696657|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138696658|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696659|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696661|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696662|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138696663|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138696664|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138696665|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138696666|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138696667|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138696668|NCT01209520|Paclitaxel|paclitaxel|mesh-list
138696669|NCT01209520|Vinorelbine|vinorelbine|mesh-list
138696670|NCT01209520|Docetaxel|docetaxel|mesh-list
138696671|NCT01209520|Cisplatin|cisplatin|mesh-list
138696672|NCT01209520|Carboplatin|carboplatin|mesh-list
138188780|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
138696673|NCT01209520|Pemetrexed|pemetrexed|mesh-list
138696674|NCT01209520|Azacitidine|azacitidine|mesh-list
138696675|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138696676|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696677|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
138696678|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
138696679|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
138696680|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696682|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138696683|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138696684|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138696685|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
138696686|NCT04805541|Tropicamide|tropicamide|mesh-list
138696687|NCT04805541|Mydriatics|mydriatics|mesh-list
138696688|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
138696689|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696690|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696691|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138696692|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138696694|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188833|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
138696695|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696696|NCT04784754|Melatonin|melatonin|mesh-list
138696697|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
138696698|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696699|NCT04784754|Protective Agents|protective agents|mesh-ancestor
138696700|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696701|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696702|NCT04666805|Tamoxifen|tamoxifen|mesh-list
138696703|NCT04666805|Toremifene|toremifene|mesh-list
138696704|NCT04666805|Letrozole|letrozole|mesh-list
138696705|NCT04666805|Anastrozole|anastrozole|mesh-list
138696706|NCT04666805|Exemestane|exemestane|mesh-list
138696707|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696708|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138696709|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138696710|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696711|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696712|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138696713|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
138696714|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138188889|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
138696715|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696716|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138696717|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138696718|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138696719|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138696720|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
138696721|NCT04721457|Listerine|listerine|mesh-list
138696722|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138696723|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
138696724|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138696725|NCT04721457|Eusol|eusol|mesh-list
138696726|NCT04721457|Povidone|povidone|mesh-list
138180496|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
138696727|NCT04721457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138696728|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
138696729|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
138696730|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
138696731|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138696732|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696733|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
138696735|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696736|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
138188944|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138188945|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138188947|NCT03574779|Growth Substances|growth substances|mesh-ancestor
138696737|NCT04665986|Docetaxel|docetaxel|mesh-list
138696739|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696740|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
138696741|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
138696742|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
138696743|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696744|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138696745|NCT04638309|Azacitidine|azacitidine|mesh-list
138168859|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696746|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138696747|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
138448089|NCT01855724|Gemcitabine|gemcitabine|mesh-list
138696748|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180550|NCT05588518|Propolis|propolis|mesh-list
138696749|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696750|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696752|NCT04665830|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138696753|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138696754|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138696755|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
138188994|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138188995|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
138188996|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138188997|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
138188998|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696756|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696757|NCT04665830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138696758|NCT04665830|Protease Inhibitors|protease inhibitors|mesh-ancestor
138696759|NCT04665830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696760|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138696761|NCT04683237|Liraglutide|liraglutide|mesh-list
138696763|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
138696764|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138696765|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696767|NCT04683237|Hormones|hormones|mesh-ancestor
138189046|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138189047|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138189059|NCT03287674|Nivolumab|nivolumab|mesh-list
138696768|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138696769|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138696770|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138696771|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138696772|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
138696773|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138696774|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138696776|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138696777|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696778|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
138696779|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138696781|NCT04665362|Antibodies|antibodies|mesh-list
138696782|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
138696783|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696784|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696785|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138189112|NCT01922804|Vitamins|vitamins|mesh-list
138696786|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696787|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696789|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138180605|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
138696790|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696791|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138696792|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696793|NCT04432974|Anesthetics|anesthetics|mesh-list
138696794|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448113|NCT01855984|Tocovid|tocovid|mesh-list
138696795|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696796|NCT04664894|Ribavirin|ribavirin|mesh-list
138696797|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
138696798|NCT04664894|Velpatasvir|velpatasvir|mesh-list
138696799|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
138696800|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696801|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
138189175|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
138189176|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138696802|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696803|NCT00557102|Leucovorin|leucovorin|mesh-list
138696804|NCT00557102|Fluorouracil|fluorouracil|mesh-list
138696805|NCT00557102|Irinotecan|irinotecan|mesh-list
138696806|NCT00557102|Cetuximab|cetuximab|mesh-list
138696807|NCT00557102|Calcium|calcium|mesh-list
138696808|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
138696810|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696811|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
138696812|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696813|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138696814|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696815|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138696816|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
138696817|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138696818|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138696819|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696820|NCT00557102|Antidotes|antidotes|mesh-ancestor
138696821|NCT00557102|Protective Agents|protective agents|mesh-ancestor
138696822|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
138696823|NCT00557102|Vitamins|vitamins|mesh-ancestor
138696824|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
138696825|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138696826|NCT04682691|Erythromycin|erythromycin|mesh-list
138696827|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
138696828|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138696829|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
138696830|NCT04682691|Metoclopramide|metoclopramide|mesh-list
138696831|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
138189234|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
138696832|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
138696833|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696834|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696835|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138696836|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138696837|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138696838|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
138696839|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138696840|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696841|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138696842|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696843|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138696844|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696845|NCT01209286|Blinatumomab|blinatumomab|mesh-list
138696846|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696847|NCT04663763|Capecitabine|capecitabine|mesh-list
138696848|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
138696849|NCT04663763|Antibodies|antibodies|mesh-list
138696850|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
138696852|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138696854|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696855|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138189283|NCT01923194|Hormones|hormones|mesh-ancestor
138189288|NCT00633152|Linezolid|linezolid|mesh-list
138696856|NCT04351737|Dexamethasone|dexamethasone|mesh-list
138696857|NCT04351737|Prednisolone|prednisolone|mesh-list
138696858|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138696859|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
138696860|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138696861|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
138696862|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138696863|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
138696864|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138696865|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
138696866|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
138696867|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696868|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696869|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138696870|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
138696871|NCT04351737|Hormones|hormones|mesh-ancestor
138696872|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138696873|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138696875|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138189338|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696876|NCT04351737|Protective Agents|protective agents|mesh-ancestor
138696877|NCT04347915|Clevudine|clevudine|mesh-list
138696878|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
138696879|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138696880|NCT04185051|Aticaprant|aticaprant|mesh-list
138696881|NCT04185051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138696882|NCT04185051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696883|NCT04185051|Sensory System Agents|sensory system agents|mesh-ancestor
138696884|NCT04185051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138180660|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
138180665|NCT00867529|Rituximab|rituximab|mesh-list
138373725|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
138696886|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138696887|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
138696888|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696889|NCT04662866|Metformin|metformin|mesh-list
138696890|NCT04662866|Pioglitazone|pioglitazone|mesh-list
138696891|NCT04662866|Empagliflozin|empagliflozin|mesh-list
138696892|NCT04662866|Linagliptin|linagliptin|mesh-list
138696893|NCT04662866|Biguanides|biguanides|mesh-list
138189401|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
138696894|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
138696895|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138696896|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696897|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138696898|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696899|NCT04662866|Incretins|incretins|mesh-ancestor
138696900|NCT04662866|Hormones|hormones|mesh-ancestor
138696901|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138696902|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138696903|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138696904|NCT04662476|Vitamin D|vitamin d|mesh-list
138696905|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
138696906|NCT04662476|Vitamins|vitamins|mesh-ancestor
138696907|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
138696908|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696909|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138696910|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138696911|NCT03986424|Memantine|memantine|mesh-list
138696912|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138696913|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138696914|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
138696915|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138696916|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696917|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696918|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138696919|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138696920|NCT00557180|Beclomethasone|beclomethasone|mesh-list
138696921|NCT00557180|Bromides|bromides|mesh-list
138696922|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
138696923|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138696924|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138696925|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
138696927|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696928|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138696929|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
138696930|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
138696931|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138696932|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
138189518|NCT01921868|Vitamins|vitamins|mesh-ancestor
138696933|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138696934|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696935|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138696936|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138696937|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138696938|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
138696939|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
138696940|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138696941|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
138696942|NCT00557180|Hormones|hormones|mesh-ancestor
138696943|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138696944|NCT00557219|Fenoldopam|fenoldopam|mesh-list
138696945|NCT00557219|Ketanserin|ketanserin|mesh-list
138169102|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
138696946|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138696947|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
138696948|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
138696949|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
138696950|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138696951|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696952|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696953|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138696954|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138696955|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
138696956|NCT00539877|Irinotecan|irinotecan|mesh-list
138696957|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138696958|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138696959|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138373806|NCT05386121|Fentanyl|fentanyl|mesh-list
138696960|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696961|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696962|NCT03798405|Analgesics|analgesics|mesh-list
138696963|NCT03798405|Narcotics|narcotics|mesh-list
138696964|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
138696965|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696966|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696967|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696968|NCT04661696|Paclitaxel|paclitaxel|mesh-list
138696969|NCT04661696|Carboplatin|carboplatin|mesh-list
138696970|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138696971|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696972|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
138696973|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
138696974|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
138696975|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696977|NCT06087289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138696978|NCT06087211|Magnesium Sulfate|magnesium sulfate|mesh-list
138696979|NCT06087211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138696980|NCT06087211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138696981|NCT06087211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138180725|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
138448163|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138696983|NCT06087211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138696984|NCT06087211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138696985|NCT06087211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138696987|NCT06087211|Sensory System Agents|sensory system agents|mesh-ancestor
138696988|NCT06087211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138696989|NCT06087211|Antidepressive Agents|antidepressive agents|mesh-ancestor
138696990|NCT06087211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138696991|NCT06087211|Dopamine Agents|dopamine agents|mesh-ancestor
138696992|NCT06087211|Anesthetics|anesthetics|mesh-ancestor
138696993|NCT06087211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138696994|NCT06087211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138696995|NCT06087211|Anticonvulsants|anticonvulsants|mesh-ancestor
138696996|NCT06087211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138696997|NCT06087211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138696998|NCT06087211|Tocolytic Agents|tocolytic agents|mesh-ancestor
138696999|NCT06087211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138697000|NCT06087055|Ritonavir|ritonavir|mesh-list
138697001|NCT06087055|Itraconazole|itraconazole|mesh-list
138697002|NCT06087055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138697003|NCT06087055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138697004|NCT06087055|Protease Inhibitors|protease inhibitors|mesh-ancestor
138697005|NCT06087055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697006|NCT06087055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697007|NCT06087055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138697008|NCT06087055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138697009|NCT06087055|Antiviral Agents|antiviral agents|mesh-ancestor
138697010|NCT06087055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138697011|NCT06087055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138697012|NCT06087055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138697013|NCT06087055|Antifungal Agents|antifungal agents|mesh-ancestor
138448182|NCT01856374|Atorvastatin|atorvastatin|mesh-list
138697014|NCT06087055|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138697015|NCT06087055|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138697016|NCT06087055|Hormone Antagonists|hormone antagonists|mesh-ancestor
138189807|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
138697017|NCT06087055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138697018|NCT06087055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697019|NCT06087003|Thymoglobulin|thymoglobulin|mesh-list
138697020|NCT06087003|Basiliximab|basiliximab|mesh-list
138697021|NCT06087003|Immunologic Factors|immunologic factors|mesh-ancestor
138697022|NCT06087003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697023|NCT06087003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138697024|NCT06086665|Niraparib|niraparib|mesh-list
138697025|NCT06086665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138697026|NCT06086665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697027|NCT06086665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697028|NCT06086665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697030|NCT06086483|Anesthetics, Local|anesthetics, local|mesh-ancestor
138697031|NCT06086483|Anesthetics|anesthetics|mesh-ancestor
138697032|NCT06086483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697033|NCT06086483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138373875|NCT05379413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138697035|NCT06086483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697036|NCT06086457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138697037|NCT06086457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697038|NCT06086457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697039|NCT06086457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697040|NCT06086288|Carboplatin|carboplatin|mesh-list
138189868|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138697041|NCT06086288|Pembrolizumab|pembrolizumab|mesh-list
138697042|NCT06086288|Etoposide|etoposide|mesh-list
138169234|NCT03158246|Vitamin D|vitamin d|mesh-list
138697044|NCT06086288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697045|NCT06086288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138697046|NCT06086288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697047|NCT06086288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138697048|NCT06086288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138697049|NCT06086288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138697050|NCT06086288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697051|NCT06086106|Analgesics, Opioid|analgesics, opioid|mesh-list
138697052|NCT06086106|Analgesics|analgesics|mesh-list
138697053|NCT06086106|Anesthetics|anesthetics|mesh-list
138697054|NCT06086106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697055|NCT06086106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697056|NCT06086106|Narcotics|narcotics|mesh-ancestor
138697057|NCT06086106|Sensory System Agents|sensory system agents|mesh-ancestor
138697058|NCT06086106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697059|NCT06085976|Octreotide|octreotide|mesh-list
138697060|NCT06085976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138697061|NCT06085976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138697062|NCT06085976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697063|NCT06085937|Ketamine|ketamine|mesh-list
138697064|NCT06085937|Analgesics|analgesics|mesh-ancestor
138697065|NCT06085937|Sensory System Agents|sensory system agents|mesh-ancestor
138697066|NCT06085937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697067|NCT06085937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697068|NCT06085937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138697069|NCT06085937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138697070|NCT06085937|Anesthetics, General|anesthetics, general|mesh-ancestor
138697071|NCT06085937|Anesthetics|anesthetics|mesh-ancestor
138697072|NCT06085937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697073|NCT06085937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138697074|NCT06085937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138697075|NCT06085937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697076|NCT06085937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697078|NCT06085703|Gliclazide|gliclazide|mesh-list
138697079|NCT06085703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138697080|NCT06085703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697081|NCT06085417|Dexamethasone|dexamethasone|mesh-list
138697082|NCT06085417|Magnesium Sulfate|magnesium sulfate|mesh-list
138697083|NCT06085417|Bupivacaine|bupivacaine|mesh-list
138697084|NCT06085417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138697085|NCT06085417|Antiemetics|antiemetics|mesh-ancestor
138697086|NCT06085417|Autonomic Agents|autonomic agents|mesh-ancestor
138697087|NCT06085417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697088|NCT06085417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697089|NCT06085417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138697090|NCT06085417|Glucocorticoids|glucocorticoids|mesh-ancestor
138697091|NCT06085417|Hormones|hormones|mesh-ancestor
138697092|NCT06085417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138697093|NCT06085417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138180824|NCT03215875|Diuretics|diuretics|mesh-ancestor
138697094|NCT06085417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697096|NCT06085417|Anesthetics|anesthetics|mesh-ancestor
138697097|NCT06085417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697098|NCT06085417|Sensory System Agents|sensory system agents|mesh-ancestor
138697099|NCT06085417|Analgesics|analgesics|mesh-ancestor
138697100|NCT06085417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138697101|NCT06085417|Anticonvulsants|anticonvulsants|mesh-ancestor
138697102|NCT06085417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138697103|NCT06085417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138697104|NCT06085417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697105|NCT06085417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138373952|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138697108|NCT06084520|Analgesics, Opioid|analgesics, opioid|mesh-list
138697109|NCT06084520|Narcotics|narcotics|mesh-ancestor
138697110|NCT06084520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697111|NCT06084520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697112|NCT06084520|Analgesics|analgesics|mesh-ancestor
138697113|NCT06084520|Sensory System Agents|sensory system agents|mesh-ancestor
138697114|NCT06084520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697115|NCT06084000|Paclitaxel|paclitaxel|mesh-list
138697116|NCT06084000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138697117|NCT06084000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697118|NCT06084000|Tubulin Modulators|tubulin modulators|mesh-ancestor
138697119|NCT06084000|Antimitotic Agents|antimitotic agents|mesh-ancestor
138697120|NCT06084000|Mitosis Modulators|mitosis modulators|mesh-ancestor
138697121|NCT06084000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697122|NCT06080347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138697123|NCT06078969|Prednisone|prednisone|mesh-list
138697124|NCT06078969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138697125|NCT06078969|Glucocorticoids|glucocorticoids|mesh-ancestor
138180860|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138697126|NCT06078969|Hormones|hormones|mesh-ancestor
138697127|NCT06078969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138697128|NCT06078969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138189966|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697129|NCT06078969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138697130|NCT06078969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697131|NCT06078306|Azacitidine|azacitidine|mesh-list
138697132|NCT06078306|Venetoclax|venetoclax|mesh-list
138697133|NCT06078306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138697134|NCT06078306|Antimetabolites|antimetabolites|mesh-ancestor
138697135|NCT06078306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697136|NCT06078306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697137|NCT06078306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697138|NCT06078228|Atropine|atropine|mesh-list
138697139|NCT06078228|Fentanyl|fentanyl|mesh-list
138697140|NCT06078228|Atracurium|atracurium|mesh-list
138697141|NCT06078228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138697142|NCT06078228|Narcotics|narcotics|mesh-ancestor
138697143|NCT06078228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697144|NCT06078228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697145|NCT06078228|Analgesics|analgesics|mesh-ancestor
138697146|NCT06078228|Sensory System Agents|sensory system agents|mesh-ancestor
138697147|NCT06078228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697148|NCT06078228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138697149|NCT06078228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138697150|NCT06078228|Anesthetics, General|anesthetics, general|mesh-ancestor
138697151|NCT06078228|Anesthetics|anesthetics|mesh-ancestor
138697152|NCT06078228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138697153|NCT06078228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138697154|NCT06078228|Autonomic Agents|autonomic agents|mesh-ancestor
138697155|NCT06078228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138697156|NCT06078228|Respiratory System Agents|respiratory system agents|mesh-ancestor
138697157|NCT06078228|Mydriatics|mydriatics|mesh-ancestor
138697158|NCT06078228|Parasympatholytics|parasympatholytics|mesh-ancestor
138697159|NCT06078228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138697160|NCT06078228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138697161|NCT06078228|Cholinergic Agents|cholinergic agents|mesh-ancestor
138169426|NCT01672580|Vitamins|vitamins|mesh-list
138697163|NCT06078228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697164|NCT06078228|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138697166|NCT06078228|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138697167|NCT06078228|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138697168|NCT06077981|Hyaluronic Acid|hyaluronic acid|mesh-list
138697169|NCT06077981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138697170|NCT06077981|Immunologic Factors|immunologic factors|mesh-ancestor
138697171|NCT06077981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697172|NCT06077981|Viscosupplements|viscosupplements|mesh-ancestor
138697173|NCT06077981|Protective Agents|protective agents|mesh-ancestor
138697175|NCT06076668|Melatonin|melatonin|mesh-list
138697176|NCT06076668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138697177|NCT06076668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697178|NCT06076668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697179|NCT06076668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138374030|NCT03708198|Bupivacaine|bupivacaine|mesh-list
138697180|NCT06076668|Analgesics|analgesics|mesh-ancestor
138169450|NCT00636805|Hormones|hormones|mesh-ancestor
138697181|NCT06076668|Sensory System Agents|sensory system agents|mesh-ancestor
138697182|NCT06076668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697183|NCT06076668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138697184|NCT06076668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138697185|NCT06076668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138697186|NCT06076668|Adrenergic Agents|adrenergic agents|mesh-ancestor
138697187|NCT06076668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138180971|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
138697188|NCT06076668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697190|NCT06076668|Protective Agents|protective agents|mesh-ancestor
138697191|NCT06072521|Lactoferrin|lactoferrin|mesh-list
138697192|NCT06072521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138697193|NCT06053983|Atorvastatin|atorvastatin|mesh-list
138697194|NCT06053983|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138697195|NCT06053983|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138697196|NCT06053983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138697197|NCT06053983|Antimetabolites|antimetabolites|mesh-ancestor
138697198|NCT06053983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697199|NCT06053983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138697200|NCT06053983|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138697201|NCT06053983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697202|NCT06053840|Chloral Hydrate|chloral hydrate|mesh-list
138697203|NCT06053840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138697204|NCT06053840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697205|NCT06053840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697207|NCT06049693|Hematinics|hematinics|mesh-ancestor
138697208|NCT06049160|Misoprostol|misoprostol|mesh-list
138697209|NCT06049160|Oxytocin|oxytocin|mesh-list
138697210|NCT06049160|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138697211|NCT06049160|Abortifacient Agents|abortifacient agents|mesh-ancestor
138697212|NCT06049160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138697213|NCT06049160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697215|NCT06049160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138697217|NCT06047834|Lofexidine|lofexidine|mesh-list
138697218|NCT06047834|Clonidine|clonidine|mesh-list
138697219|NCT06047834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138697220|NCT06047834|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138697221|NCT06047834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697222|NCT06047834|Sensory System Agents|sensory system agents|mesh-ancestor
138697223|NCT06047834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697224|NCT06047834|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138697225|NCT06047834|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138697226|NCT06047834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138697227|NCT06047834|Adrenergic Agents|adrenergic agents|mesh-ancestor
138697228|NCT06047834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181008|NCT00887575|Paclitaxel|paclitaxel|mesh-list
138697229|NCT06047834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697230|NCT06047834|Analgesics|analgesics|mesh-ancestor
138697231|NCT06047834|Sympatholytics|sympatholytics|mesh-ancestor
138697232|NCT06047834|Autonomic Agents|autonomic agents|mesh-ancestor
138697233|NCT06046937|Mupirocin|mupirocin|mesh-list
138697234|NCT06046937|Monolaurin|monolaurin|mesh-list
138697235|NCT06046937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138697236|NCT06046937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138697237|NCT06046937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138697238|NCT06046937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697239|NCT06046937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697240|NCT06046937|Cariostatic Agents|cariostatic agents|mesh-ancestor
138697241|NCT06046937|Protective Agents|protective agents|mesh-ancestor
138697242|NCT06046937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697243|NCT06036108|Brexpiprazole|brexpiprazole|mesh-list
138697244|NCT06036108|Serotonin Agents|serotonin agents|mesh-ancestor
138697245|NCT06036108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697246|NCT06036108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697247|NCT06036108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697248|NCT06036108|Dopamine Agonists|dopamine agonists|mesh-ancestor
138697249|NCT06036108|Dopamine Agents|dopamine agents|mesh-ancestor
138697250|NCT05986266|Carbetocin|carbetocin|mesh-list
138697251|NCT05986266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697252|NCT05986266|Oxytocics|oxytocics|mesh-ancestor
138697253|NCT05986266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138697254|NCT05978687|Lidocaine|lidocaine|mesh-list
138697255|NCT05978687|Epinephrine|epinephrine|mesh-list
138374107|NCT02010385|Octreotide|octreotide|mesh-list
138697256|NCT05978687|Anesthetics, Local|anesthetics, local|mesh-ancestor
138697257|NCT05978687|Anesthetics|anesthetics|mesh-ancestor
138697258|NCT05978687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697259|NCT05978687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697260|NCT05978687|Sensory System Agents|sensory system agents|mesh-ancestor
138697261|NCT05978687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697262|NCT05978687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138697263|NCT05978687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138697264|NCT05978687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138697265|NCT05978687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138697266|NCT05978687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697267|NCT05978687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138697268|NCT05978687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138697269|NCT05978687|Adrenergic Agents|adrenergic agents|mesh-ancestor
138697270|NCT05978687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697271|NCT05978687|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138697272|NCT05978687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138697273|NCT05978687|Autonomic Agents|autonomic agents|mesh-ancestor
138697274|NCT05978687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138697275|NCT05978687|Respiratory System Agents|respiratory system agents|mesh-ancestor
138697276|NCT05978687|Mydriatics|mydriatics|mesh-ancestor
138697277|NCT05978687|Sympathomimetics|sympathomimetics|mesh-ancestor
138697278|NCT05978687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138697279|NCT05961059|Detox adjuvant|detox adjuvant|mesh-list
138697280|NCT05961059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138697281|NCT05961059|Immunologic Factors|immunologic factors|mesh-ancestor
138697282|NCT05961059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181037|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138697283|NCT05948813|Osimertinib|osimertinib|mesh-list
138697284|NCT05948813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697285|NCT05948813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138697286|NCT05948813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697287|NCT05948813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697288|NCT05948267|Lidocaine|lidocaine|mesh-list
138697289|NCT05948267|Fentanyl|fentanyl|mesh-list
138697290|NCT05948267|Ketamine|ketamine|mesh-list
138697291|NCT05948267|Propofol|propofol|mesh-list
138697292|NCT05948267|Anesthetics, Local|anesthetics, local|mesh-ancestor
138697293|NCT05948267|Anesthetics|anesthetics|mesh-ancestor
138697294|NCT05948267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697295|NCT05948267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697296|NCT05948267|Sensory System Agents|sensory system agents|mesh-ancestor
138697297|NCT05948267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697298|NCT05948267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138697299|NCT05948267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138697300|NCT05948267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138697301|NCT05948267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138697302|NCT05948267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697303|NCT05948267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138697304|NCT05948267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138697305|NCT05948267|Anesthetics, General|anesthetics, general|mesh-ancestor
138697306|NCT05948267|Analgesics|analgesics|mesh-ancestor
138697307|NCT05948267|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138697308|NCT05948267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138169639|NCT00671515|Pioglitazone|pioglitazone|mesh-list
138697309|NCT05948267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138697310|NCT05948267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697311|NCT05948267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138697312|NCT05948267|Narcotics|narcotics|mesh-ancestor
138697313|NCT05948267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138697314|NCT05944965|Oxybutynin|oxybutynin|mesh-list
138697315|NCT05944965|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138697316|NCT05944965|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138697317|NCT05944965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138697318|NCT05944965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138697319|NCT05944965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697320|NCT05944965|Adrenergic Agents|adrenergic agents|mesh-ancestor
138697321|NCT05944965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697322|NCT05944965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697323|NCT05944965|Parasympatholytics|parasympatholytics|mesh-ancestor
138697324|NCT05944965|Autonomic Agents|autonomic agents|mesh-ancestor
138697325|NCT05944965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697326|NCT05944965|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138697327|NCT05944965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138697328|NCT05944965|Cholinergic Agents|cholinergic agents|mesh-ancestor
138697329|NCT05944965|Urological Agents|urological agents|mesh-ancestor
138697330|NCT05921149|Paclitaxel|paclitaxel|mesh-list
138697331|NCT05921149|Carboplatin|carboplatin|mesh-list
138697332|NCT05921149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138697333|NCT05921149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181058|NCT05311813|Anticoagulants|anticoagulants|mesh-ancestor
138697334|NCT05921149|Tubulin Modulators|tubulin modulators|mesh-ancestor
138697335|NCT05921149|Antimitotic Agents|antimitotic agents|mesh-ancestor
138697336|NCT05921149|Mitosis Modulators|mitosis modulators|mesh-ancestor
138697337|NCT05921149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697340|NCT05886972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697341|NCT05886972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697342|NCT05886972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138697343|NCT05886972|Anesthetics, General|anesthetics, general|mesh-ancestor
138697344|NCT05886972|Anesthetics|anesthetics|mesh-ancestor
138697345|NCT05867030|Rituximab|rituximab|mesh-list
138697346|NCT05867030|Lenalidomide|lenalidomide|mesh-list
138697347|NCT05867030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697348|NCT05867030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697349|NCT05867030|Immunologic Factors|immunologic factors|mesh-ancestor
138697350|NCT05867030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697351|NCT05867030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138697352|NCT05867030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138697353|NCT05867030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138697354|NCT05867030|Growth Substances|growth substances|mesh-ancestor
138697355|NCT05867030|Growth Inhibitors|growth inhibitors|mesh-ancestor
138697357|NCT05827081|Leuprolide|leuprolide|mesh-list
138697358|NCT05827081|Goserelin|goserelin|mesh-list
138697359|NCT05827081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697360|NCT05827081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138697361|NCT05827081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138697362|NCT05827081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697363|NCT05827081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697364|NCT05827081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138697365|NCT05827081|Hormone Antagonists|hormone antagonists|mesh-ancestor
138697366|NCT05827081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138697367|NCT05827081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697368|NCT05827081|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138697369|NCT05827081|Fertility Agents|fertility agents|mesh-ancestor
138697370|NCT05827081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138697371|NCT05827081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138697372|NCT05788094|Chloroquine|chloroquine|mesh-list
138697373|NCT05788094|Piperaquine|piperaquine|mesh-list
138697375|NCT05788094|Tafenoquine|tafenoquine|mesh-list
138697376|NCT05788094|Amebicides|amebicides|mesh-ancestor
138697378|NCT05788094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138697379|NCT05788094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138697380|NCT05788094|Antimalarials|antimalarials|mesh-ancestor
138697381|NCT05788094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138697382|NCT05764733|Diphosphonates|diphosphonates|mesh-list
138697383|NCT05764733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138697384|NCT05764733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697385|NCT05756673|Listerine|listerine|mesh-list
138697386|NCT05756673|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138697387|NCT05756673|Sodium Fluoride|sodium fluoride|mesh-list
138697388|NCT05756673|Cariostatic Agents|cariostatic agents|mesh-ancestor
138697389|NCT05756673|Protective Agents|protective agents|mesh-ancestor
138697390|NCT05756673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697391|NCT05756673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138697392|NCT05745935|Oxytocin|oxytocin|mesh-list
138697393|NCT05745935|Oxytocics|oxytocics|mesh-ancestor
138697394|NCT05745935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138697395|NCT05745935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697396|NCT05693077|Vancomycin|vancomycin|mesh-list
138697397|NCT05693077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138697398|NCT05693077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138697399|NCT05692271|Propranolol|propranolol|mesh-list
138697400|NCT05692271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138697401|NCT05692271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138181085|NCT03214159|Ritonavir|ritonavir|mesh-list
138169768|NCT01670084|Antidotes|antidotes|mesh-ancestor
138697402|NCT05692271|Adrenergic Agents|adrenergic agents|mesh-ancestor
138697403|NCT05692271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697404|NCT05692271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697405|NCT05692271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697406|NCT05692271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138697407|NCT05692271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138697408|NCT05692271|Vasodilator Agents|vasodilator agents|mesh-ancestor
138697409|NCT05664711|Bupivacaine|bupivacaine|mesh-list
138697410|NCT05664711|Anesthetics, Local|anesthetics, local|mesh-ancestor
138697411|NCT05664711|Anesthetics|anesthetics|mesh-ancestor
138697412|NCT05664711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697413|NCT05664711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697414|NCT05664711|Sensory System Agents|sensory system agents|mesh-ancestor
138697415|NCT05664711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697416|NCT05647889|Lidocaine|lidocaine|mesh-list
138697417|NCT05647889|Anesthetics, Local|anesthetics, local|mesh-ancestor
138697418|NCT05647889|Anesthetics|anesthetics|mesh-ancestor
138697419|NCT05647889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697420|NCT05647889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697421|NCT05647889|Sensory System Agents|sensory system agents|mesh-ancestor
138697422|NCT05647889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697423|NCT05647889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138697424|NCT05647889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138697425|NCT05647889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138697426|NCT05647889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138697427|NCT05647889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697428|NCT05526469|Bupivacaine|bupivacaine|mesh-list
138169816|NCT04404686|Indomethacin|indomethacin|mesh-list
138697429|NCT05526469|Anesthetics, Local|anesthetics, local|mesh-ancestor
138697430|NCT05526469|Anesthetics|anesthetics|mesh-ancestor
138697431|NCT05526469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697432|NCT05526469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697433|NCT05526469|Sensory System Agents|sensory system agents|mesh-ancestor
138697434|NCT05526469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697436|NCT05498480|Relatlimab|relatlimab|mesh-list
138697437|NCT05498480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138448328|NCT01857141|Analgesics|analgesics|mesh-ancestor
138697438|NCT05498480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697439|NCT05498480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138697440|NCT05498480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697441|NCT05490511|Cannabidiol|cannabidiol|mesh-list
138181092|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138697443|NCT05490511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138697444|NCT05490511|Immunologic Factors|immunologic factors|mesh-ancestor
138697445|NCT05490511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697446|NCT05490511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138697447|NCT05490511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697448|NCT05490511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697449|NCT05490511|Anticonvulsants|anticonvulsants|mesh-ancestor
138697450|NCT05488067|Atorvastatin|atorvastatin|mesh-list
138697451|NCT05488067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138697452|NCT05488067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138697453|NCT05488067|Antimetabolites|antimetabolites|mesh-ancestor
138697454|NCT05488067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697455|NCT05488067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138697456|NCT05488067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138697458|NCT05423210|Atezolizumab|atezolizumab|mesh-list
138697459|NCT05423210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138697460|NCT05423210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697461|NCT05423210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697462|NCT05423210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697463|NCT05419362|Avelumab|avelumab|mesh-list
138697464|NCT05419362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697465|NCT05419362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697466|NCT05359731|Dexamethasone|dexamethasone|mesh-list
138697467|NCT05359731|Bupivacaine|bupivacaine|mesh-list
138697468|NCT05359731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138697469|NCT05359731|Antiemetics|antiemetics|mesh-ancestor
138697470|NCT05359731|Autonomic Agents|autonomic agents|mesh-ancestor
138697471|NCT05359731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697472|NCT05359731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697473|NCT05359731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138697474|NCT05359731|Glucocorticoids|glucocorticoids|mesh-ancestor
138697475|NCT05359731|Hormones|hormones|mesh-ancestor
138697476|NCT05359731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138697477|NCT05359731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138697478|NCT05359731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697479|NCT05359731|Anesthetics, Local|anesthetics, local|mesh-ancestor
138697480|NCT05359731|Anesthetics|anesthetics|mesh-ancestor
138697481|NCT05359731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697482|NCT05359731|Sensory System Agents|sensory system agents|mesh-ancestor
138697483|NCT05355337|Pramipexole|pramipexole|mesh-list
138374322|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
138697484|NCT05355337|Antioxidants|antioxidants|mesh-ancestor
138697485|NCT05355337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697486|NCT05355337|Protective Agents|protective agents|mesh-ancestor
138697487|NCT05355337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697488|NCT05355337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138697489|NCT05355337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138697490|NCT05355337|Dopamine Agonists|dopamine agonists|mesh-ancestor
138697491|NCT05355337|Dopamine Agents|dopamine agents|mesh-ancestor
138697492|NCT05355337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697493|NCT05341817|Letrozole|letrozole|mesh-list
138697494|NCT05341817|Mifepristone|mifepristone|mesh-list
138697495|NCT05341817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697496|NCT05341817|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138697497|NCT05341817|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138697498|NCT05341817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697499|NCT05341817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697500|NCT05341817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138448338|NCT01857154|Vitamin D|vitamin d|mesh-list
138697501|NCT05341817|Hormone Antagonists|hormone antagonists|mesh-ancestor
138697502|NCT05341817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138697503|NCT05341817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697504|NCT05341817|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138697505|NCT05341817|Abortifacient Agents|abortifacient agents|mesh-ancestor
138697506|NCT05341817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138697507|NCT05341817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138697508|NCT05341817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138697509|NCT05341817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138697510|NCT05341817|Contraceptive Agents|contraceptive agents|mesh-ancestor
138697511|NCT05341817|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138169944|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697512|NCT05341817|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138697513|NCT05341817|Luteolytic Agents|luteolytic agents|mesh-ancestor
138697514|NCT05341817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138697515|NCT05341817|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138697516|NCT05296317|Cyclophosphamide|cyclophosphamide|mesh-list
138697517|NCT05296317|Epirubicin|epirubicin|mesh-list
138697518|NCT05296317|Lenograstim|lenograstim|mesh-list
138697519|NCT05296317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138697520|NCT05296317|Immunologic Factors|immunologic factors|mesh-ancestor
138697521|NCT05296317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697522|NCT05296317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138697523|NCT05296317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138697524|NCT05296317|Alkylating Agents|alkylating agents|mesh-ancestor
138697525|NCT05296317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697526|NCT05296317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697527|NCT05296317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138697528|NCT05296317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138697529|NCT05296317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138697530|NCT05296317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138697531|NCT05296317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138697532|NCT05296317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697533|NCT05290090|Rituximab|rituximab|mesh-list
138697534|NCT05290090|Lenalidomide|lenalidomide|mesh-list
138697535|NCT05290090|Zanubrutinib|zanubrutinib|mesh-list
138697536|NCT05290090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697537|NCT05290090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697538|NCT05290090|Immunologic Factors|immunologic factors|mesh-ancestor
138697539|NCT05290090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697540|NCT05290090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138697541|NCT05290090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138697542|NCT05290090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138697543|NCT05290090|Growth Substances|growth substances|mesh-ancestor
138697544|NCT05290090|Growth Inhibitors|growth inhibitors|mesh-ancestor
138181205|NCT03212833|Insulin|insulin|mesh-list
138697545|NCT05290090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138697546|NCT05290090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138169990|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138697548|NCT05275725|Sildenafil Citrate|sildenafil citrate|mesh-list
138448342|NCT01857154|Vitamins|vitamins|mesh-ancestor
138697550|NCT05275725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138697551|NCT05275725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138697552|NCT05275725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697553|NCT05275725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697554|NCT05275725|Urological Agents|urological agents|mesh-ancestor
138697555|NCT05260021|Tirzepatide|tirzepatide|mesh-list
138697556|NCT05260021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138697557|NCT05260021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697558|NCT05260021|Incretins|incretins|mesh-ancestor
138697559|NCT05260021|Hormones|hormones|mesh-ancestor
138697560|NCT05260021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138697561|NCT05259319|Atezolizumab|atezolizumab|mesh-list
138697562|NCT05259319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138697563|NCT05259319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697564|NCT05259319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697565|NCT05259319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697566|NCT05231460|Narcotics|narcotics|mesh-list
138697567|NCT05231460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697568|NCT05231460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697569|NCT05231460|Analgesics|analgesics|mesh-ancestor
138697570|NCT05231460|Sensory System Agents|sensory system agents|mesh-ancestor
138697571|NCT05231460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697572|NCT05213208|Propofol|propofol|mesh-list
138697573|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138697574|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697575|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697576|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138697577|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
138697578|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
138697579|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
138697580|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697581|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697582|NCT05204290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138697583|NCT05204290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697584|NCT05197426|Azacitidine|azacitidine|mesh-list
138697585|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138697586|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
138697587|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697588|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697589|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697591|NCT05193227|Bupivacaine|bupivacaine|mesh-list
138697592|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
138697593|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
138697594|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697595|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697596|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
138697597|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697598|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138697599|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138697600|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138697601|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138697602|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697603|NCT05125328|Remifentanil|remifentanil|mesh-list
138697604|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138697605|NCT05125328|Narcotics|narcotics|mesh-ancestor
138697606|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697607|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697608|NCT05125328|Analgesics|analgesics|mesh-ancestor
138697609|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
138697610|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697611|NCT05097599|Pembrolizumab|pembrolizumab|mesh-list
138697612|NCT05097599|Trastuzumab|trastuzumab|mesh-list
138697613|NCT05097599|Axitinib|axitinib|mesh-list
138697614|NCT05097599|Talazoparib|talazoparib|mesh-list
138697615|NCT05097599|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138697616|NCT05097599|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138697617|NCT05097599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697618|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697619|NCT05097599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138697620|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697621|NCT05097599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138697622|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697623|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138697624|NCT05097599|Immunoconjugates|immunoconjugates|mesh-ancestor
138697625|NCT05097599|Immunologic Factors|immunologic factors|mesh-ancestor
138697626|NCT05097599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697627|NCT05048719|Dulaglutide|dulaglutide|mesh-list
138697628|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138697629|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697630|NCT05048498|Azacitidine|azacitidine|mesh-list
138697631|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138697632|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
138697633|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697635|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697636|NCT05009862|Aspirin|aspirin|mesh-list
138697637|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
138697638|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138697639|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138697640|NCT05009862|Analgesics|analgesics|mesh-ancestor
138697641|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
138697642|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181264|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138697643|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697645|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138697646|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138697647|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138697648|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697649|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138697650|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138697651|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697652|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
138697653|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138697654|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
138697655|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138697656|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
138697657|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
138697658|NCT04938583|Paclitaxel|paclitaxel|mesh-list
138697659|NCT04938583|Bevacizumab|bevacizumab|mesh-list
138697660|NCT04938583|Carboplatin|carboplatin|mesh-list
138697661|NCT04938583|Oregovomab|oregovomab|mesh-list
138697662|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138697663|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697664|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
138697665|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
138697666|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
138697667|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697668|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697670|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138697671|NCT04938583|Growth Substances|growth substances|mesh-ancestor
138697672|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697675|NCT04858269|Carboplatin|carboplatin|mesh-list
138697676|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
138697677|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138697678|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697679|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
138697680|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
138697681|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
138697682|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697683|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697684|NCT04858269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138697685|NCT04763564|Liraglutide|liraglutide|mesh-list
138697686|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138697687|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697688|NCT04763564|Incretins|incretins|mesh-ancestor
138697689|NCT04763564|Hormones|hormones|mesh-ancestor
138697690|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138697691|NCT04743505|Osimertinib|osimertinib|mesh-list
138697692|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697693|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138697694|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697695|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697696|NCT04742504|Benralizumab|benralizumab|mesh-list
138697697|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138697698|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
138697699|NCT04683315|Paclitaxel|paclitaxel|mesh-list
138697700|NCT04683315|Gemcitabine|gemcitabine|mesh-list
138697701|NCT04683315|Fluorouracil|fluorouracil|mesh-list
138697702|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138697703|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697704|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
138697706|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
138697707|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697708|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138697709|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
138697710|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138697711|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
138371448|NCT01411189|Menthol|menthol|mesh-list
138697712|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697713|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
138697714|NCT04673617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138697715|NCT04673617|Rituximab|rituximab|mesh-list
138697716|NCT04673617|Fludarabine|fludarabine|mesh-list
138697717|NCT04673617|Interleukin-2|interleukin-2|mesh-list
138697718|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138697719|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
138697720|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697721|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138697722|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138697723|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
138697724|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697725|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697726|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138697727|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697728|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138697729|NCT04673617|Analgesics|analgesics|mesh-ancestor
138697730|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
138697731|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697732|NCT04649229|Aprepitant|aprepitant|mesh-list
138697733|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138697734|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
138697735|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
138697736|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697737|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697738|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138697739|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138697740|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697741|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697742|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138697744|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138697745|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
138697746|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697747|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138697748|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697749|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697751|NCT04644029|Emtricitabine|emtricitabine|mesh-list
138697752|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138697753|NCT04644029|Islatravir|islatravir|mesh-list
138697754|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
138697755|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138697756|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138697757|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138697758|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697759|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697760|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138697761|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138697762|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
138697763|NCT04621526|Ketamine|ketamine|mesh-list
138697764|NCT04621526|Propofol|propofol|mesh-list
138697765|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138697766|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697767|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697768|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138697769|NCT04621526|Analgesics|analgesics|mesh-ancestor
138697770|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
138697771|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697772|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138697773|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138697774|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138448417|NCT01857596|Trazodone|trazodone|mesh-list
138697775|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
138697776|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697777|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697778|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138697779|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
138697780|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
138697781|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138697782|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138697783|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138697784|NCT04592809|Midazolam|midazolam|mesh-list
138697785|NCT04592809|Ketamine|ketamine|mesh-list
138697786|NCT04592809|Analgesics|analgesics|mesh-ancestor
138697787|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
138697788|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697789|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697790|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138697793|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
138697794|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697795|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138697796|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138697797|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697798|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697799|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138697800|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138697801|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138697802|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138697803|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138697804|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
138697805|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
138697806|NCT04584255|Niraparib|niraparib|mesh-list
138697807|NCT04584255|Dostarlimab|dostarlimab|mesh-list
138697808|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138697809|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697810|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697811|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697812|NCT04567407|Ropivacaine|ropivacaine|mesh-list
138697813|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
138697814|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
138697815|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138697816|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697817|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
138697818|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697819|NCT04465097|Exemestane|exemestane|mesh-list
138697820|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697821|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138697822|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138697823|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697824|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697825|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138697826|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
138697827|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138697828|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697829|NCT04462588|Metronidazole|metronidazole|mesh-list
138697830|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138697831|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138697832|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138697833|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138697834|NCT04404140|Docetaxel|docetaxel|mesh-list
138697835|NCT04404140|Atezolizumab|atezolizumab|mesh-list
138697836|NCT04404140|Ipatasertib|ipatasertib|mesh-list
138697837|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697838|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
138697839|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
138697840|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
138697841|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138181373|NCT01832935|Insulin|insulin|mesh-list
138697842|NCT04404140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138697843|NCT04404140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697844|NCT04404140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138697845|NCT04404140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697846|NCT04346654|Dexamethasone|dexamethasone|mesh-list
138697847|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138697848|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
138697849|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
138697850|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697851|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697852|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138697853|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
138697855|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138697856|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138697857|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697858|NCT04291508|Acetaminophen|acetaminophen|mesh-list
138190007|NCT02604537|Ketorolac|ketorolac|mesh-list
138697859|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697860|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138697861|NCT04291508|Analgesics|analgesics|mesh-ancestor
138697862|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
138697863|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697864|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
138697865|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
138697866|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697867|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
138697868|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138697869|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138697870|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697871|NCT04169191|Urological Agents|urological agents|mesh-ancestor
138697872|NCT04160325|Azathioprine|azathioprine|mesh-list
138697873|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
138697874|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697875|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138697876|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697877|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138697878|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
138170385|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
138697879|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697880|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138697881|NCT04154189|Etoposide|etoposide|mesh-list
138697882|NCT04154189|Lenvatinib|lenvatinib|mesh-list
138697883|NCT04154189|Ifosfamide|ifosfamide|mesh-list
138697884|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138697885|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697886|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138697887|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138697888|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697889|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697890|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138697891|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138697892|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
138697893|NCT04108481|Durvalumab|durvalumab|mesh-list
138697894|NCT04108481|Methamphetamine|methamphetamine|mesh-list
138697895|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138697896|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697897|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697898|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
138170438|NCT00663793|Urological Agents|urological agents|mesh-ancestor
138697899|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697900|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138697902|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
138697903|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697905|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697906|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697907|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
138697908|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138697909|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138697910|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138697911|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138697912|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
138697913|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138697914|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138697915|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138697916|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138697917|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697918|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
138697919|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697920|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697921|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138697922|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697923|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
138697924|NCT04048161|Tacrolimus|tacrolimus|mesh-list
138697925|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138697926|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
138697927|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697928|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138697929|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697930|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697931|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138697932|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697933|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138697934|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
138697935|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138697936|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138697937|NCT04032964|Doxorubicin|doxorubicin|mesh-list
138697938|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138697939|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697940|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138697941|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138697942|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697943|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697944|NCT03949673|Celecoxib|celecoxib|mesh-list
138697945|NCT03949673|Diclofenac|diclofenac|mesh-list
138697946|NCT03949673|Naproxen|naproxen|mesh-list
138697947|NCT03949673|Fasinumab|fasinumab|mesh-list
138697948|NCT03949673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138697949|NCT03949673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138697950|NCT03949673|Analgesics|analgesics|mesh-ancestor
138697951|NCT03949673|Sensory System Agents|sensory system agents|mesh-ancestor
138697952|NCT03949673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697953|NCT03949673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697954|NCT03949673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138697955|NCT03949673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138697956|NCT03949673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138697957|NCT03949673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138697958|NCT03949673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138697959|NCT03949673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697960|NCT03949673|Gout Suppressants|gout suppressants|mesh-ancestor
138697962|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138697963|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138697964|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138697965|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138697966|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697967|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
138697968|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138697969|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697970|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
138697971|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
138697972|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138697973|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138697974|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138697975|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
138697976|NCT03919955|Urological Agents|urological agents|mesh-ancestor
138697978|NCT03871036|Durvalumab|durvalumab|mesh-list
138697979|NCT03871036|Tremelimumab|tremelimumab|mesh-list
138697980|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138697981|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138697982|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
138697983|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
138697984|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
138697985|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138697986|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138697987|NCT03830164|Vitamins|vitamins|mesh-list
138697988|NCT03830164|Vitamin E|vitamin e|mesh-list
138697989|NCT03830164|Tocopherols|tocopherols|mesh-list
138697990|NCT03830164|Tocotrienols|tocotrienols|mesh-list
138697991|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
138697992|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
138697993|NCT03830164|Atorvastatin|atorvastatin|mesh-list
138697994|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
138697995|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138697996|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138697997|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138697998|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
138190011|NCT02604537|Analgesics|analgesics|mesh-ancestor
138697999|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698000|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138698001|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138698002|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698003|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
138698004|NCT03830164|Protective Agents|protective agents|mesh-ancestor
138698005|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138698006|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138698007|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138698008|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
138698012|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698013|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698014|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138698015|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138698016|NCT03795311|Growth Substances|growth substances|mesh-ancestor
138698017|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138181432|NCT05393050|Antimetabolites|antimetabolites|mesh-ancestor
138698018|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
138698019|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
138698020|NCT03776136|Lenvatinib|lenvatinib|mesh-list
138698021|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698022|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698023|NCT03776136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138698024|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698025|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138698026|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698027|NCT03769181|Cemiplimab|cemiplimab|mesh-list
138698028|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698029|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138170684|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
138698036|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
138698037|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698038|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698039|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698040|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138698041|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138698042|NCT03638297|Analgesics|analgesics|mesh-ancestor
138698043|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
138698044|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698045|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138698046|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698047|NCT03621696|Cisplatin|cisplatin|mesh-list
138698048|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698049|NCT03594747|Paclitaxel|paclitaxel|mesh-list
138698050|NCT03594747|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138698051|NCT03594747|Carboplatin|carboplatin|mesh-list
138698052|NCT03594747|Tislelizumab|tislelizumab|mesh-list
138698053|NCT03594747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138698054|NCT03594747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698055|NCT03594747|Tubulin Modulators|tubulin modulators|mesh-ancestor
138698056|NCT03594747|Antimitotic Agents|antimitotic agents|mesh-ancestor
138698057|NCT03594747|Mitosis Modulators|mitosis modulators|mesh-ancestor
138698058|NCT03594747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698059|NCT03594747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698060|NCT03565783|Cemiplimab|cemiplimab|mesh-list
138698061|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698062|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698063|NCT03504397|Leucovorin|leucovorin|mesh-list
138698064|NCT03504397|Folic Acid|folic acid|mesh-list
138698065|NCT03504397|Fluorouracil|fluorouracil|mesh-list
138698066|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
138698067|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
138698068|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
138698069|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698070|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138698071|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698072|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138698073|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
138698074|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698075|NCT03504397|Antidotes|antidotes|mesh-ancestor
138698076|NCT03504397|Protective Agents|protective agents|mesh-ancestor
138698077|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
138698078|NCT03504397|Vitamins|vitamins|mesh-ancestor
138698079|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
138698080|NCT03504397|Hematinics|hematinics|mesh-ancestor
138698082|NCT03468985|Ipilimumab|ipilimumab|mesh-list
138698083|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698084|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698085|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138698086|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698088|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698089|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138698090|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698091|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698092|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
138698093|NCT03386539|Everolimus|everolimus|mesh-list
138698094|NCT03386539|Tacrolimus|tacrolimus|mesh-list
138698095|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138698096|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
138698097|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448488|NCT01857843|Everolimus|everolimus|mesh-list
138698098|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138698099|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698100|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698101|NCT03386539|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138698102|NCT03386539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138698103|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698104|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138698105|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138698106|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
138698107|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138698108|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170838|NCT00698035|Hormones|hormones|mesh-ancestor
138698109|NCT03376659|Bevacizumab|bevacizumab|mesh-list
138698110|NCT03376659|Durvalumab|durvalumab|mesh-list
138698111|NCT03376659|Capecitabine|capecitabine|mesh-list
138698112|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698113|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698114|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138698115|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138698116|NCT03376659|Growth Substances|growth substances|mesh-ancestor
138698117|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698118|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
138698119|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138698120|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
138698121|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698122|NCT03366103|Navitoclax|navitoclax|mesh-list
138698123|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698124|NCT03304821|Sargramostim|sargramostim|mesh-list
138698125|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
138698126|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698127|NCT03267121|Apatinib|apatinib|mesh-list
138698128|NCT03267121|Tegafur|tegafur|mesh-list
138698129|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698130|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138698131|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698132|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698133|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138698134|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
138698135|NCT03253679|Adavosertib|adavosertib|mesh-list
138698136|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138181518|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
138698137|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698139|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698140|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698141|NCT03149822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138698142|NCT03149822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698143|NCT03095352|Carboplatin|carboplatin|mesh-list
138170884|NCT03487016|Paclitaxel|paclitaxel|mesh-list
138698144|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
138698145|NCT03095352|Trastuzumab|trastuzumab|mesh-list
138698146|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698147|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698148|NCT03095352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138698149|NCT03095352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698150|NCT03088813|Irinotecan|irinotecan|mesh-list
138698151|NCT03088813|Topotecan|topotecan|mesh-list
138698152|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138698153|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138698154|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698155|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698156|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698157|NCT03061474|Niacinamide|niacinamide|mesh-list
138698159|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
138698160|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
138698162|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
138698163|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698164|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138698165|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
138698166|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698167|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138698168|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
138698169|NCT03040726|Palonosetron|palonosetron|mesh-list
138698170|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
138698171|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
138698172|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698173|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698174|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138698175|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138698176|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138698177|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
138698178|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181552|NCT01834885|Fluticasone|fluticasone|mesh-list
138698179|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698180|NCT02899728|Cisplatin|cisplatin|mesh-list
138698181|NCT02899728|Carboplatin|carboplatin|mesh-list
138698182|NCT02899728|Etoposide|etoposide|mesh-list
138698183|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
138698184|NCT02899728|Olaparib|olaparib|mesh-list
138698185|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
138698186|NCT02899728|Cediranib|cediranib|mesh-list
138698187|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138698188|NCT02899728|Maleic acid|maleic acid|mesh-list
138698189|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698190|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138698191|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138698192|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138698193|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698194|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698195|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
138698196|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
138698197|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
138698198|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
138698199|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
138698200|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138698202|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698203|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138698204|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698205|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698206|NCT02604459|Fentanyl|fentanyl|mesh-list
138698207|NCT02604459|Anesthetics|anesthetics|mesh-list
138698208|NCT02604459|Propofol|propofol|mesh-list
138698209|NCT02604459|Sevoflurane|sevoflurane|mesh-list
138698210|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138698211|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698212|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138698213|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138698214|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
138698215|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138698216|NCT02604459|Narcotics|narcotics|mesh-ancestor
138698217|NCT02604459|Analgesics|analgesics|mesh-ancestor
138698218|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
138698219|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698220|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138698221|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138698222|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138698223|NCT02543268|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
138698224|NCT02543268|Antiviral Agents|antiviral agents|mesh-ancestor
138698225|NCT02543268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138170956|NCT03088046|Progesterone|progesterone|mesh-list
138698227|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698228|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138698229|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698230|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698231|NCT02500797|Nivolumab|nivolumab|mesh-list
138698232|NCT02500797|Ipilimumab|ipilimumab|mesh-list
138698233|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698234|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138181587|NCT04380103|Bevacizumab|bevacizumab|mesh-list
138698235|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138698236|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698239|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138698240|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138698241|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138698242|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698243|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138342043|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
138698244|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138698245|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138698246|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698247|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
138698248|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698249|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138698250|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
138698251|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138698252|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138698253|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138698254|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138698255|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138698256|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698258|NCT02017704|Capecitabine|capecitabine|mesh-list
138698259|NCT02017704|Fluorouracil|fluorouracil|mesh-list
138698260|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
138698261|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138698262|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
138698263|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698264|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698265|NCT02017704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138698266|NCT02017704|Immunologic Factors|immunologic factors|mesh-ancestor
138698267|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698268|NCT02017704|Antidotes|antidotes|mesh-ancestor
138698269|NCT02017704|Protective Agents|protective agents|mesh-ancestor
138698270|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
138698271|NCT02017704|Vitamins|vitamins|mesh-ancestor
138698272|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
138698273|NCT02005471|Rituximab|rituximab|mesh-list
138698274|NCT02005471|Venetoclax|venetoclax|mesh-list
138698275|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138698276|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698277|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698278|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
138698279|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698280|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698281|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138698282|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
138698283|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698285|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698286|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
138698287|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
138698288|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
138698289|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698290|NCT01892722|Interferons|interferons|mesh-list
138698291|NCT01892722|Interferon-beta|interferon-beta|mesh-list
138698292|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
138698293|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138698294|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698295|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
138698296|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138698297|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
138190029|NCT01384773|Vitamins|vitamins|mesh-ancestor
138698298|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698299|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138698300|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138698301|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698302|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138698303|NCT01872260|Letrozole|letrozole|mesh-list
138698304|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698305|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138698306|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138698307|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698308|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698309|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138698310|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
138698311|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138698312|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698313|NCT01711658|Lapatinib|lapatinib|mesh-list
138698314|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698315|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138698316|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698317|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698319|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698320|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138698321|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698322|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698323|NCT01518556|Idarubicin|idarubicin|mesh-list
138698324|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138698325|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698326|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138698327|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138698328|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698329|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698330|NCT01351103|Spartalizumab|spartalizumab|mesh-list
138698332|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138698333|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698334|NCT01351103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698335|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698336|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698338|NCT00317720|Everolimus|everolimus|mesh-list
138698339|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698340|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698341|NCT00317720|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138698342|NCT00317720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138698343|NCT00317720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698344|NCT00317720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698345|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138698346|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
138698347|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698348|NCT04661345|Coagulase|coagulase|mesh-list
138698349|NCT04661345|Coagulants|coagulants|mesh-ancestor
138698350|NCT00540072|Daptomycin|daptomycin|mesh-list
138448538|NCT01858025|Fluorouracil|fluorouracil|mesh-list
138698351|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138698352|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138698353|NCT04660916|Isotretinoin|isotretinoin|mesh-list
138698354|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
138698355|NCT00540150|Immunomodulating Agents|immunomodulating agents|mesh-list
138698356|NCT00540150|Immunologic Factors|immunologic factors|mesh-ancestor
138698357|NCT00540150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698358|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
138698359|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138698360|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138698361|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698362|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698363|NCT04660565|Prednisone|prednisone|mesh-list
138698364|NCT04660565|Belimumab|belimumab|mesh-list
138698365|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138698366|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
138698367|NCT04660565|Hormones|hormones|mesh-ancestor
138190031|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698368|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138342350|NCT01667796|Vitamins|vitamins|mesh-ancestor
138698369|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698370|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138698371|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698372|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138698373|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
138698375|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
138698376|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698377|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
138698378|NCT01208038|Testosterone|testosterone|mesh-list
138698379|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
138698380|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
138698381|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138698382|NCT01208038|Androgens|androgens|mesh-ancestor
138698383|NCT01208038|Hormones|hormones|mesh-ancestor
138698384|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138698385|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698386|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138698387|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698388|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
138698389|NCT04659785|Apatinib|apatinib|mesh-list
138698390|NCT04659785|Fluzoparib|fluzoparib|mesh-list
138698391|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698392|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138698393|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698394|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698395|NCT04659785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138698396|NCT01207687|Bevacizumab|bevacizumab|mesh-list
138698397|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138698398|NCT01207687|Antibodies|antibodies|mesh-list
138698399|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
138698400|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138698401|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698402|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138698403|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138698404|NCT01207687|Growth Substances|growth substances|mesh-ancestor
138698405|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698406|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
138698407|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
138698408|NCT01207453|Milnacipran|milnacipran|mesh-list
138171129|NCT01678430|Chlorambucil|chlorambucil|mesh-list
138698409|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
138698410|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138698411|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138698412|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138698413|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698414|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698415|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698416|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138698417|NCT01207453|Analgesics|analgesics|mesh-ancestor
138698418|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
138181682|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698419|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698420|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
138698421|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138698422|NCT00540345|Interferons|interferons|mesh-list
138698423|NCT00540345|Ribavirin|ribavirin|mesh-list
138698424|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
138342641|NCT01723722|Methadone|methadone|mesh-list
138698426|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138698427|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698428|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
138698429|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138698430|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
138698431|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698432|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
138698433|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698434|NCT01207414|Iloperidone|iloperidone|mesh-list
138698435|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138698436|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138698437|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138698438|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698439|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138698440|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
138698441|NCT00540384|Hematinics|hematinics|mesh-ancestor
138698442|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
138698443|NCT04659551|Nivolumab|nivolumab|mesh-list
138698444|NCT04659551|Epirubicin|epirubicin|mesh-list
138698445|NCT04659551|Exemestane|exemestane|mesh-list
138343791|NCT04921527|Paclitaxel|paclitaxel|mesh-list
138698446|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138698447|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138698448|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
138698449|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698450|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698451|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138698452|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
138698453|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698454|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698455|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138698456|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698457|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138698458|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138698459|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138698460|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138698461|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698462|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138698463|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138698464|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138698465|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
138181719|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138181720|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138181736|NCT02490670|Cephalexin|cephalexin|mesh-list
138698466|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138698467|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
138698468|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138698469|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
138698470|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138698471|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138698472|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138698473|NCT01206517|Asenapine|asenapine|mesh-list
138698474|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138698475|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138698476|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138698477|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698478|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138698479|NCT01206439|Nebivolol|nebivolol|mesh-list
138698480|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138698481|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
138698482|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138698483|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138698484|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138698485|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
138698486|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698487|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698488|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698489|NCT01206322|Insulin|insulin|mesh-list
138698490|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138698491|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698492|NCT00540501|Oseltamivir|oseltamivir|mesh-list
138698493|NCT00540501|Zanamivir|zanamivir|mesh-list
138698494|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
138698495|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138698496|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698497|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698498|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138171265|NCT03086564|Estrogens|estrogens|mesh-ancestor
138698499|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138698500|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138698501|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
138698502|NCT01207102|Paclitaxel|paclitaxel|mesh-list
138698503|NCT01207102|Carboplatin|carboplatin|mesh-list
138698504|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138698505|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138698506|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698507|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
138698508|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
138698509|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
138698510|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698511|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
138698512|NCT04658732|Gabapentin|gabapentin|mesh-list
138698513|NCT04658732|Alprazolam|alprazolam|mesh-list
138698514|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138698515|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138698516|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698517|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138698518|NCT04658732|Analgesics|analgesics|mesh-ancestor
138181747|NCT03218059|Methotrexate|methotrexate|mesh-list
138698519|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
138698520|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342748|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138698521|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138698522|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138698523|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138698524|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
138698525|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698526|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698527|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
138698528|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138698529|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138698530|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138698531|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138698532|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138698533|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
138698534|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
138698536|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
138698537|NCT00540696|Hematinics|hematinics|mesh-ancestor
138698539|NCT04658420|Analgesics|analgesics|mesh-ancestor
138171299|NCT05245721|Analgesics|analgesics|mesh-ancestor
138698541|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698542|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698543|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138698544|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138698545|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
138698546|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
138698547|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138698548|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138698549|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138698550|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698551|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698553|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138698554|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138698555|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138698556|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
138698557|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698558|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698559|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698560|NCT00540891|Urological Agents|urological agents|mesh-ancestor
138698561|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
138698562|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138698563|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138698564|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
138698565|NCT00540930|Ranibizumab|ranibizumab|mesh-list
138698566|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138698567|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138698568|NCT00540930|Growth Substances|growth substances|mesh-ancestor
138698569|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698570|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
138698571|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698572|NCT00541008|Sunitinib|sunitinib|mesh-list
138698573|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698574|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138698575|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138698576|NCT00541008|Growth Substances|growth substances|mesh-ancestor
138698577|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698578|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
138698579|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138698580|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698581|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698583|NCT00541086|Letrozole|letrozole|mesh-list
138698584|NCT00541086|Anastrozole|anastrozole|mesh-list
138698585|NCT00541086|Exemestane|exemestane|mesh-list
138698586|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698587|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698588|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138698589|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138342829|NCT01746264|Vitamin D|vitamin d|mesh-list
138698590|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698591|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138698592|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
138698593|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138698594|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698595|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138698596|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138698597|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138698598|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138698599|NCT04657484|Prednisolone|prednisolone|mesh-list
138698600|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138698601|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
138698602|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138698603|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
138698604|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138698605|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
138698606|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138698607|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
138698608|NCT04657484|Hormones|hormones|mesh-ancestor
138698609|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138698610|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698611|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138698612|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698613|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
138698614|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
138171372|NCT00087152|Capecitabine|capecitabine|mesh-list
138698615|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698616|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138698617|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138698618|NCT04657484|Protective Agents|protective agents|mesh-ancestor
138698619|NCT00541125|Leucovorin|leucovorin|mesh-list
138698620|NCT00541125|Bevacizumab|bevacizumab|mesh-list
138698621|NCT00541125|Fluorouracil|fluorouracil|mesh-list
138698622|NCT00541125|Irinotecan|irinotecan|mesh-list
138698623|NCT00541125|Calcium|calcium|mesh-list
138698624|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
138698625|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698626|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698627|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138698628|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138698630|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698631|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
138698632|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138698633|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
138698634|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698635|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138698636|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138698638|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138698639|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138698640|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698641|NCT00541125|Antidotes|antidotes|mesh-ancestor
138698642|NCT00541125|Protective Agents|protective agents|mesh-ancestor
138698643|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
138698644|NCT00541125|Vitamins|vitamins|mesh-ancestor
138698645|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
138698646|NCT00541164|Ubiquinone|ubiquinone|mesh-list
138698647|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
138698648|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
138698649|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698650|NCT00541164|Vitamins|vitamins|mesh-ancestor
138698651|NCT00541281|Prednisone|prednisone|mesh-list
138698652|NCT00541281|Docetaxel|docetaxel|mesh-list
138698653|NCT00541281|Estramustine|estramustine|mesh-list
138698654|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698655|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
138698656|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
138698657|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
138698658|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698659|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138698660|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
138698661|NCT00541281|Hormones|hormones|mesh-ancestor
138698662|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138698663|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698664|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138698665|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138698666|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
138698667|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
138698669|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
138698670|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138698671|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
138698672|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698673|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698675|NCT04657172|Pilocarpine|pilocarpine|mesh-list
138698676|NCT04657172|Miotics|miotics|mesh-ancestor
138698677|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
138698678|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698679|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698680|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138698681|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138375534|NCT01434225|Bumetanide|bumetanide|mesh-list
138698682|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
138698683|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698684|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698686|NCT03199794|Coagulants|coagulants|mesh-ancestor
138698687|NCT00541359|Bortezomib|bortezomib|mesh-list
138698688|NCT00541359|Topotecan|topotecan|mesh-list
138698689|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698690|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138698691|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138698692|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698693|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698694|NCT03096249|Oxytocin|oxytocin|mesh-list
138698695|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
138698696|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138343025|NCT01785810|Maraviroc|maraviroc|mesh-list
138698697|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698698|NCT04656665|Aspirin|aspirin|mesh-list
138698699|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138698700|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138698701|NCT04656665|Analgesics|analgesics|mesh-ancestor
138698702|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
138698703|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698704|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698705|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138698706|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698707|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138698708|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138698709|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698710|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138698711|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138698712|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698714|NCT03014622|Botulinum Toxins|botulinum toxins|mesh-list
138698715|NCT03014622|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138698716|NCT03014622|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138698717|NCT03014622|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138698718|NCT03014622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138698719|NCT03014622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698720|NCT03014622|Cholinergic Agents|cholinergic agents|mesh-ancestor
138698721|NCT03014622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698722|NCT03014622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698723|NCT03014622|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138698724|NCT03014622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698726|NCT04655807|Ustekinumab|ustekinumab|mesh-list
138698727|NCT04655807|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138698728|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138698729|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698730|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
138698731|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
138698732|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138698733|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138698734|NCT00541515|Insulin|insulin|mesh-list
138698735|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138698736|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698737|NCT04655729|Infliximab|infliximab|mesh-list
138698738|NCT04655729|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138698739|NCT04655729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138698740|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
138698741|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138698742|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698743|NCT00541554|Aripiprazole|aripiprazole|mesh-list
138698744|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
138698745|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138698746|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138698747|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138698748|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138698749|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698750|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
138698751|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
138698752|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698753|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698754|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138343316|NCT05997134|Ketamine|ketamine|mesh-list
138698755|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138698756|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
138698757|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138698758|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138698759|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138698760|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138698761|NCT04655183|Niraparib|niraparib|mesh-list
138698762|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138698763|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698764|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698765|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698766|NCT00541710|Genistein|genistein|mesh-list
138698767|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138698768|NCT00541710|Protective Agents|protective agents|mesh-ancestor
138698769|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698770|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698771|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138698772|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698773|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698774|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
138698775|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138698776|NCT00541710|Estrogens|estrogens|mesh-ancestor
138698777|NCT00541710|Hormones|hormones|mesh-ancestor
138698778|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138698779|NCT04654676|Vildagliptin|vildagliptin|mesh-list
138698780|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138698781|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698782|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138698783|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
138698784|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698785|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698786|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138698787|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138698788|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698789|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698790|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138698791|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138698792|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698793|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
138698794|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698795|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
138698796|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138698797|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138698798|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
138698799|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698800|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698801|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698802|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
138698803|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
138698804|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698805|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
138698806|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138698807|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
138698808|NCT01205581|Vaccines|vaccines|mesh-list
138698809|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
138698810|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698811|NCT00542139|Betamethasone|betamethasone|mesh-list
138698812|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138698813|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
138698814|NCT00542139|Hormones|hormones|mesh-ancestor
138698815|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138698816|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698817|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138698818|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
138698819|NCT00542295|Mebeverine|mebeverine|mesh-list
138698820|NCT00542295|Alverine|alverine|mesh-list
138698821|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
138698822|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
138698823|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698824|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698825|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
138698826|NCT03454841|Ticagrelor|ticagrelor|mesh-list
138698827|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138698828|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138343507|NCT05677490|Antimetabolites|antimetabolites|mesh-ancestor
138698829|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138698830|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138698831|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138698832|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
138698833|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698834|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698835|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698836|NCT04653506|Acetaminophen|acetaminophen|mesh-list
138698838|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138698839|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138698840|NCT04653506|Analgesics|analgesics|mesh-ancestor
138698841|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
138181942|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
138698842|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138171668|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138698843|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698844|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138698846|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138698847|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698848|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698850|NCT00542412|Riluzole|riluzole|mesh-list
138698851|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
138698852|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138698853|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138698854|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190066|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138698855|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698856|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698857|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138698858|NCT00542412|Protective Agents|protective agents|mesh-ancestor
138343597|NCT05420948|Paclitaxel|paclitaxel|mesh-list
138698859|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
138698860|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138698861|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138698862|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698863|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
138698864|NCT04653623|Coagulants|coagulants|mesh-ancestor
138698865|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
138698866|NCT00542568|Hematinics|hematinics|mesh-ancestor
138698867|NCT04653779|Metformin|metformin|mesh-list
138698868|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138698869|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698870|NCT00542607|Levocetirizine|levocetirizine|mesh-list
138698871|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138698872|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138698873|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
138698874|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
138698875|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138698876|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698877|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698878|NCT04685031|Clobetasol|clobetasol|mesh-list
138698879|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
138698880|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
138698881|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138343663|NCT05348200|Clobetasol|clobetasol|mesh-list
138698883|NCT04685031|Hormones|hormones|mesh-ancestor
138698884|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138698885|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698886|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
138698887|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138698888|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698889|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138698890|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
138698891|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138698892|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138698893|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698894|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698895|NCT01854684|Temoporfin|temoporfin|mesh-list
138698896|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698897|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138698898|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
138698899|NCT00542802|Carbamazepine|carbamazepine|mesh-list
138698900|NCT00542802|Levetiracetam|levetiracetam|mesh-list
138698901|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
138698902|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
138698903|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
138698904|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138698905|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138698906|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698907|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138698908|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138698910|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
138698911|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698912|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138698913|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138698914|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698915|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138698916|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138698917|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
138698918|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
138698919|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138698920|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138698921|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138698922|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698923|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698924|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698926|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138698927|NCT04652492|Tislelizumab|tislelizumab|mesh-list
138698928|NCT04652492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698929|NCT04652492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698930|NCT00543075|Oblimersen|oblimersen|mesh-list
138698931|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698932|NCT00543114|Rituximab|rituximab|mesh-list
138698933|NCT00543114|Fludarabine|fludarabine|mesh-list
138698934|NCT00543114|Lenalidomide|lenalidomide|mesh-list
138698935|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138698936|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698937|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
138698938|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698939|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698940|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138343759|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698941|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138698942|NCT00543114|Growth Substances|growth substances|mesh-ancestor
138698943|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
138698944|NCT03454724|Sirolimus|sirolimus|mesh-list
138698945|NCT03454724|Everolimus|everolimus|mesh-list
138698946|NCT03454724|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138698947|NCT03454724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138698948|NCT03454724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698949|NCT03454724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698950|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138698951|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
138698952|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698953|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698954|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138698955|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138698956|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138698957|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
138698958|NCT01014546|Vitamins|vitamins|mesh-list
138698959|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
138698960|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
138698961|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
138698962|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698963|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
138698964|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698965|NCT01014546|Protective Agents|protective agents|mesh-ancestor
138698966|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698967|NCT00543231|Oblimersen|oblimersen|mesh-list
138698968|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138698969|NCT00557843|Bupivacaine|bupivacaine|mesh-list
138698970|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
138698971|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
138698972|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138698973|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698974|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
138698975|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698976|NCT04651556|Acetaminophen|acetaminophen|mesh-list
138698977|NCT04651556|Ketorolac|ketorolac|mesh-list
138698978|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
138698979|NCT04651556|Bupivacaine|bupivacaine|mesh-list
138698980|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
138698981|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
138698982|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138698983|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138698984|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
138698985|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138698986|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138698987|NCT04651556|Analgesics|analgesics|mesh-ancestor
138698988|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
138698989|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138698990|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138698991|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138698992|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138698993|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138698994|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138698995|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138698996|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
138698997|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138698998|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138182035|NCT01726465|Hormones|hormones|mesh-ancestor
138343982|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138698999|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138699000|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
138699001|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138699003|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138699004|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138699005|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
138699006|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699007|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699008|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699009|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138699010|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138699011|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
138699012|NCT04651205|Thiamine|thiamine|mesh-list
138699013|NCT04651205|Vitamins|vitamins|mesh-ancestor
138699014|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
138699015|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699016|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
138699017|NCT03456648|Apixaban|apixaban|mesh-list
138699018|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138699019|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
138699020|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138699021|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
138699022|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699023|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699024|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
138699025|NCT00557921|Aspirin|aspirin|mesh-list
138699026|NCT00557921|Omeprazole|omeprazole|mesh-list
138699027|NCT00557921|Clopidogrel|clopidogrel|mesh-list
138699028|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138699029|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138699031|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
138699032|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699033|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699034|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138699035|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138171856|NCT00571259|Gentamicins|gentamicins|mesh-list
138699036|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138699037|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138699038|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699039|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138699040|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138699041|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699043|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138699044|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138699045|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138699046|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
138699047|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699048|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138182046|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
138699049|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138699050|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138699051|NCT02324283|Propofol|propofol|mesh-list
138699052|NCT02324283|Desflurane|desflurane|mesh-list
138699053|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138699054|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699055|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699056|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138699057|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
138375905|NCT01437046|Doxazosin|doxazosin|mesh-list
138699059|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138699061|NCT00557960|Adderall|adderall|mesh-list
138699062|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138699063|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138699064|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138699065|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138699066|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699067|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
138699068|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699069|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699070|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138699071|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
138699072|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
138699073|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699074|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
138699075|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138699077|NCT00558077|Clomiphene|clomiphene|mesh-list
138699078|NCT00558077|Enclomiphene|enclomiphene|mesh-list
138699079|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
138699080|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138699081|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699082|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138699083|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
138702111|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138699084|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138699085|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138699086|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
138699087|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138699088|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138699089|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138699090|NCT00543504|Bevacizumab|bevacizumab|mesh-list
138699091|NCT00543504|Trastuzumab|trastuzumab|mesh-list
138699092|NCT00543504|Cetuximab|cetuximab|mesh-list
138699093|NCT00543504|Sunitinib|sunitinib|mesh-list
138699094|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138699095|NCT00543504|Sorafenib|sorafenib|mesh-list
138699096|NCT00543504|Lapatinib|lapatinib|mesh-list
138699097|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138699098|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699099|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138699100|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138699101|NCT00543504|Growth Substances|growth substances|mesh-ancestor
138699102|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699103|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
138699104|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138699105|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699106|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699107|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
138344186|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
138171933|NCT00572897|Melphalan|melphalan|mesh-list
138344187|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138344188|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138344189|NCT03974932|Analgesics|analgesics|mesh-ancestor
138699109|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
138182072|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182075|NCT05532306|Ribavirin|ribavirin|mesh-list
138699110|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699111|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699112|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138699113|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
138699114|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138699115|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
138699116|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699117|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699118|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138699119|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
138699120|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
138699121|NCT00543933|Protective Agents|protective agents|mesh-ancestor
138699122|NCT00544011|Bevacizumab|bevacizumab|mesh-list
138699123|NCT00544011|Capecitabine|capecitabine|mesh-list
138699124|NCT00544011|Fluorouracil|fluorouracil|mesh-list
138699125|NCT00544011|Irinotecan|irinotecan|mesh-list
138699126|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138699127|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699128|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138699129|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138699130|NCT00544011|Growth Substances|growth substances|mesh-ancestor
138699131|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699132|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
138699133|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138699134|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
138699135|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699136|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138699137|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
138699138|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138699139|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138699140|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699141|NCT00544050|Levetiracetam|levetiracetam|mesh-list
138699142|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
138699143|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
138699144|NCT04649723|Rifampin|rifampin|mesh-list
138699145|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138699146|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
138699147|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138699148|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138699149|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
138699150|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138699151|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699152|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699153|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138699154|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138699155|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138699156|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138699157|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138699158|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138699159|NCT02909088|Ecopipam|ecopipam|mesh-list
138699160|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138699161|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138699162|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699163|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699164|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138699165|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138699166|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
138699167|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138344350|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
138699168|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699169|NCT04649645|Nicotine|nicotine|mesh-list
138699170|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138699171|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
138699172|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699173|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699174|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138699175|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138699176|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
138699177|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699178|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699179|NCT00544128|Ritonavir|ritonavir|mesh-list
138699180|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138699181|NCT00544128|Tenofovir|tenofovir|mesh-list
138699182|NCT00544128|Lamivudine|lamivudine|mesh-list
138699183|NCT00544128|Emtricitabine|emtricitabine|mesh-list
138699184|NCT00544128|Abacavir|abacavir|mesh-list
138699185|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138699186|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138699187|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
138699188|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702112|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
138699189|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699190|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138699191|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138699192|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
138699193|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138699194|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138699195|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138699196|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138699197|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138699198|NCT05476432|Leucovorin|leucovorin|mesh-list
138699199|NCT05476432|Fluorouracil|fluorouracil|mesh-list
138699200|NCT05476432|Oxaliplatin|oxaliplatin|mesh-list
138699201|NCT05476432|Antimetabolites|antimetabolites|mesh-ancestor
138182117|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138699202|NCT05476432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699203|NCT05476432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138699204|NCT05476432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699205|NCT05476432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138699206|NCT05476432|Immunologic Factors|immunologic factors|mesh-ancestor
138699207|NCT05476432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699208|NCT05476432|Antidotes|antidotes|mesh-ancestor
138699209|NCT05476432|Protective Agents|protective agents|mesh-ancestor
138699210|NCT05476432|Vitamin B Complex|vitamin b complex|mesh-ancestor
138699211|NCT05476432|Vitamins|vitamins|mesh-ancestor
138699212|NCT05476432|Micronutrients|micronutrients|mesh-ancestor
138699213|NCT01239745|Exemestane|exemestane|mesh-list
138699214|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699215|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138699216|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138699217|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699218|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699219|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138699220|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
138699221|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182140|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182146|NCT00363844|Incretins|incretins|mesh-ancestor
138699222|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699224|NCT01239472|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138699225|NCT01239472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138699226|NCT01239472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699227|NCT01239472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699228|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138699229|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
138699230|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699231|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699233|NCT00544284|Bortezomib|bortezomib|mesh-list
138699234|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138699235|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
138344568|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138699236|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699237|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699238|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
138699239|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138699240|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699241|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699242|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138699243|NCT02888275|Analgesics|analgesics|mesh-ancestor
138699244|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
138699245|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699246|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138699247|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138699248|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138699249|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
138699250|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699251|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699252|NCT03456531|Aspirin|aspirin|mesh-list
138699253|NCT03456531|Analgesics|analgesics|mesh-list
138699254|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138699255|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138699256|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
138699257|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699258|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699259|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138699260|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138699261|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138699262|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138699263|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699264|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138699265|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138699266|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699267|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
138699268|NCT02909049|Midazolam|midazolam|mesh-list
138699269|NCT02909049|Ketamine|ketamine|mesh-list
138699270|NCT02909049|Mepivacaine|mepivacaine|mesh-list
138699271|NCT02909049|Analgesics|analgesics|mesh-ancestor
138699272|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
138699273|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699274|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699275|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138699276|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138699277|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
138699278|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
138699279|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699280|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138699281|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138344764|NCT00160680|Levocetirizine|levocetirizine|mesh-list
138699283|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699284|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138699285|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138699286|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138699287|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138699288|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138699289|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
138699290|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
138699291|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
138699292|NCT01229449|Acetaminophen|acetaminophen|mesh-list
138699293|NCT01229449|Ibuprofen|ibuprofen|mesh-list
138699294|NCT01229449|Codeine|codeine|mesh-list
138699295|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138699296|NCT01229449|Analgesics|analgesics|mesh-ancestor
138699297|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
138699298|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699299|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699300|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
138699301|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138699302|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138699303|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138699304|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138699305|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699306|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699307|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138699308|NCT01229449|Narcotics|narcotics|mesh-ancestor
138699309|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699311|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
138699312|NCT01238575|Guanfacine|guanfacine|mesh-list
138699313|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138699314|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138699315|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138699316|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138699317|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
138699318|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699319|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699320|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699322|NCT06022419|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138699323|NCT06022419|Protease Inhibitors|protease inhibitors|mesh-ancestor
138699324|NCT06022419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699325|NCT06022419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699327|NCT06022276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138699328|NCT06022276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699329|NCT06022237|Vitamin D|vitamin d|mesh-list
138699330|NCT06022237|Cholecalciferol|cholecalciferol|mesh-list
138699331|NCT06022237|Ibandronic Acid|ibandronic acid|mesh-list
138699332|NCT06022237|Calcium|calcium|mesh-list
138699333|NCT06022237|Vitamins|vitamins|mesh-ancestor
138699334|NCT06022237|Micronutrients|micronutrients|mesh-ancestor
138699335|NCT06022237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699336|NCT06022237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138699337|NCT06022237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138699338|NCT06022198|Dimercaprol|dimercaprol|mesh-list
138699339|NCT06022198|Chelating Agents|chelating agents|mesh-ancestor
138699340|NCT06022198|Sequestering Agents|sequestering agents|mesh-ancestor
138699341|NCT06022198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699342|NCT06021951|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138699343|NCT06021951|Ezetimibe|ezetimibe|mesh-list
138699344|NCT06021951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138699345|NCT06021951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138699347|NCT06021951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699348|NCT06021951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138699349|NCT06021951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699350|NCT06021951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138699351|NCT06021951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182256|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
138699354|NCT06021912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699355|NCT06021847|Chlorhexidine|chlorhexidine|mesh-list
138699356|NCT06021847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138699357|NCT06021847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138699358|NCT06021847|Disinfectants|disinfectants|mesh-ancestor
138699360|NCT06021756|Analgesics|analgesics|mesh-ancestor
138699361|NCT06021756|Sensory System Agents|sensory system agents|mesh-ancestor
138699362|NCT06021756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699363|NCT06021756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699364|NCT06021756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138699365|NCT06021756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138699367|NCT06021756|Anesthetics|anesthetics|mesh-ancestor
138699368|NCT06021756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699369|NCT06021756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138699370|NCT06021756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138699371|NCT06021756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699372|NCT06021756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699373|NCT06021717|Ketamine|ketamine|mesh-list
138699374|NCT06021717|Morphine|morphine|mesh-list
138699375|NCT06021717|Analgesics|analgesics|mesh-ancestor
138699376|NCT06021717|Sensory System Agents|sensory system agents|mesh-ancestor
138699377|NCT06021717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699378|NCT06021717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699379|NCT06021717|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138699380|NCT06021717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138699381|NCT06021717|Anesthetics, General|anesthetics, general|mesh-ancestor
138699382|NCT06021717|Anesthetics|anesthetics|mesh-ancestor
138699383|NCT06021717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699384|NCT06021717|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138699385|NCT06021717|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138699386|NCT06021717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699387|NCT06021717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699388|NCT06021717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138699389|NCT06021717|Narcotics|narcotics|mesh-ancestor
138182289|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
138699395|NCT06021587|Vasodilator Agents|vasodilator agents|mesh-ancestor
138699396|NCT06021587|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138699397|NCT06021587|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138699398|NCT06021587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699399|NCT06021587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699400|NCT06021587|Protective Agents|protective agents|mesh-ancestor
138699401|NCT06021587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699403|NCT06021522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138699404|NCT06021522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138699405|NCT06021522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138345159|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138699406|NCT06021522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699407|NCT06021522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138699408|NCT06021522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138699409|NCT06021522|Dopamine Agents|dopamine agents|mesh-ancestor
138699410|NCT06021522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699411|NCT06021522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138172366|NCT00580853|Bupropion|bupropion|mesh-list
138699413|NCT06021210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138699414|NCT06021210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699415|NCT06021210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699416|NCT06021210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699417|NCT06021210|Antiviral Agents|antiviral agents|mesh-ancestor
138699418|NCT06021210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138699419|NCT06021119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138699420|NCT06021119|Protease Inhibitors|protease inhibitors|mesh-ancestor
138699421|NCT06021119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699422|NCT06021119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182324|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138345208|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138345209|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345211|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
138345212|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
138345213|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699423|NCT06021119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138699424|NCT06021119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699426|NCT06021015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138699427|NCT06021015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138699428|NCT06021015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699429|NCT06021015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699430|NCT06021015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699431|NCT06020989|Carboplatin|carboplatin|mesh-list
138699432|NCT06020989|Pemetrexed|pemetrexed|mesh-list
138699433|NCT06020989|Lazertinib|lazertinib|mesh-list
138699434|NCT06020989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699435|NCT06020989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699436|NCT06020989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699437|NCT06020989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138699438|NCT06020989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138699439|NCT06020989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138699441|NCT06020963|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138699442|NCT06020963|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138699443|NCT06020963|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138699444|NCT06020963|Adrenergic Agents|adrenergic agents|mesh-ancestor
138699445|NCT06020963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699446|NCT06020963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699447|NCT06020963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699448|NCT06020963|Urological Agents|urological agents|mesh-ancestor
138699449|NCT06020898|Valproic Acid|valproic acid|mesh-list
138699450|NCT06020898|Anticonvulsants|anticonvulsants|mesh-ancestor
138699451|NCT06020898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699452|NCT06020898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699453|NCT06020898|GABA Agents|gaba agents|mesh-ancestor
138345276|NCT05151588|Docetaxel|docetaxel|mesh-list
138345277|NCT05151588|Fluorouracil|fluorouracil|mesh-list
138345278|NCT05151588|Cisplatin|cisplatin|mesh-list
138345279|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138345280|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
138345281|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
138345282|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
138345283|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138345284|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
138345285|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138345286|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138699454|NCT06020898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699455|NCT06020898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699456|NCT06020898|Antimanic Agents|antimanic agents|mesh-ancestor
138699457|NCT06020898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138699458|NCT06020898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699459|NCT06020898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138699460|NCT06020885|Immunomodulating Agents|immunomodulating agents|mesh-list
138699461|NCT06020885|Immunologic Factors|immunologic factors|mesh-ancestor
138699462|NCT06020885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182367|NCT04077424|Agglutinins|agglutinins|mesh-ancestor
138699464|NCT06020833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699465|NCT06020833|Keratolytic Agents|keratolytic agents|mesh-ancestor
138699466|NCT06020833|Dermatologic Agents|dermatologic agents|mesh-ancestor
138699467|NCT06020716|Amoxicillin|amoxicillin|mesh-list
138699468|NCT06020716|Clavulanic Acid|clavulanic acid|mesh-list
138699469|NCT06020716|Clavulanic Acids|clavulanic acids|mesh-list
138699470|NCT06020716|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138699471|NCT06020716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138172440|NCT00581867|Insulin|insulin|mesh-list
138699472|NCT06020716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138699473|NCT06020716|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138699474|NCT06020716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699475|NCT06020716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699476|NCT06009185|Zamicastat|zamicastat|mesh-list
138699477|NCT06009185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699478|NCT06009185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699479|NCT06004739|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138699480|NCT06004739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138699481|NCT06004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138699482|NCT06004739|Antitubercular Agents|antitubercular agents|mesh-ancestor
138699483|NCT05993182|Ephedrine|ephedrine|mesh-list
138699484|NCT05993182|Pseudoephedrine|pseudoephedrine|mesh-list
138699485|NCT05993182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138699486|NCT05993182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699487|NCT05993182|Sympathomimetics|sympathomimetics|mesh-ancestor
138699488|NCT05993182|Autonomic Agents|autonomic agents|mesh-ancestor
138699489|NCT05993182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699490|NCT05993182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138699491|NCT05993182|Adrenergic Agents|adrenergic agents|mesh-ancestor
138699492|NCT05993182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190086|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
138699493|NCT05993182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699494|NCT05993182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138699495|NCT05993182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138699496|NCT05993182|Respiratory System Agents|respiratory system agents|mesh-ancestor
138699497|NCT05993182|Nasal Decongestants|nasal decongestants|mesh-ancestor
138699498|NCT05989217|Salicylic Acid|salicylic acid|mesh-list
138699499|NCT05989217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138699500|NCT05989217|Antifungal Agents|antifungal agents|mesh-ancestor
138699501|NCT05989217|Keratolytic Agents|keratolytic agents|mesh-ancestor
138699502|NCT05989217|Dermatologic Agents|dermatologic agents|mesh-ancestor
138699503|NCT05975580|Topiramate|topiramate|mesh-list
138699504|NCT05975580|Phentermine|phentermine|mesh-list
138699505|NCT05975580|Anticonvulsants|anticonvulsants|mesh-ancestor
138699506|NCT05975580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138699507|NCT05975580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699508|NCT05975580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138699509|NCT05975580|Appetite Depressants|appetite depressants|mesh-ancestor
138699510|NCT05975580|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138699511|NCT05975580|Sympathomimetics|sympathomimetics|mesh-ancestor
138699512|NCT05975580|Autonomic Agents|autonomic agents|mesh-ancestor
138699513|NCT05975580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699514|NCT05975580|Adrenergic Agents|adrenergic agents|mesh-ancestor
138699515|NCT05975580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699516|NCT05975580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699517|NCT05963347|Prednisone|prednisone|mesh-list
138699518|NCT05963347|Cyclophosphamide|cyclophosphamide|mesh-list
138699519|NCT05963347|Doxorubicin|doxorubicin|mesh-list
138699520|NCT05963347|Vincristine|vincristine|mesh-list
138699521|NCT05963347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138699522|NCT05963347|Immunologic Factors|immunologic factors|mesh-ancestor
138699523|NCT05963347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699524|NCT05963347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138699525|NCT05963347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138699526|NCT05963347|Alkylating Agents|alkylating agents|mesh-ancestor
138699527|NCT05963347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699528|NCT05963347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699529|NCT05963347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138172504|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
138699530|NCT05963347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138699531|NCT05963347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138699532|NCT05963347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138699533|NCT05963347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699534|NCT05963347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138699535|NCT05963347|Glucocorticoids|glucocorticoids|mesh-ancestor
138699536|NCT05963347|Hormones|hormones|mesh-ancestor
138699537|NCT05963347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138699538|NCT05963347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138699539|NCT05963347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138699540|NCT05963347|Tubulin Modulators|tubulin modulators|mesh-ancestor
138699542|NCT05963347|Mitosis Modulators|mitosis modulators|mesh-ancestor
138699543|NCT05932966|Insulin|insulin|mesh-list
138699544|NCT05932966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138699545|NCT05932966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699546|NCT05857748|Lifitegrast|lifitegrast|mesh-list
138699547|NCT05857748|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138699548|NCT05857748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138699549|NCT05847517|Metoprolol|metoprolol|mesh-list
138699550|NCT05847517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138699551|NCT05847517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138699552|NCT05847517|Sympatholytics|sympatholytics|mesh-ancestor
138699553|NCT05847517|Autonomic Agents|autonomic agents|mesh-ancestor
138699554|NCT05847517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699555|NCT05847517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699556|NCT05847517|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138699557|NCT05847517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138699558|NCT05847517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138699559|NCT05847517|Adrenergic Agents|adrenergic agents|mesh-ancestor
138699560|NCT05847517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699561|NCT05847517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699562|NCT05797623|Cyclosporine|cyclosporine|mesh-list
138699563|NCT05797623|Cyclosporins|cyclosporins|mesh-list
138699564|NCT05797623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699565|NCT05797623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699566|NCT05797623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138699567|NCT05797623|Immunologic Factors|immunologic factors|mesh-ancestor
138699568|NCT05797623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699569|NCT05797623|Antifungal Agents|antifungal agents|mesh-ancestor
138699570|NCT05797623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138699571|NCT05797623|Dermatologic Agents|dermatologic agents|mesh-ancestor
138699572|NCT05797623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138699573|NCT05797623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138699574|NCT05753007|Cannabidiol|cannabidiol|mesh-list
138699575|NCT05753007|Anticonvulsants|anticonvulsants|mesh-ancestor
138699576|NCT05746065|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138699577|NCT05746065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138699578|NCT05746065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138699579|NCT05746065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699580|NCT05746065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699581|NCT05746065|Antiviral Agents|antiviral agents|mesh-ancestor
138699582|NCT05746065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138699583|NCT05746065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138376423|NCT03200015|Metformin|metformin|mesh-list
138699584|NCT05746065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138699585|NCT05708989|Dexmedetomidine|dexmedetomidine|mesh-list
138699586|NCT05708989|Ropivacaine|ropivacaine|mesh-list
138699587|NCT05708989|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138699588|NCT05708989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699589|NCT05708989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699590|NCT05708989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138699591|NCT05708989|Analgesics|analgesics|mesh-ancestor
138699592|NCT05708989|Sensory System Agents|sensory system agents|mesh-ancestor
138699593|NCT05708989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699594|NCT05708989|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138699595|NCT05708989|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138699596|NCT05708989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138699597|NCT05708989|Adrenergic Agents|adrenergic agents|mesh-ancestor
138699598|NCT05708989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699599|NCT05708989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699600|NCT05708989|Anesthetics, Local|anesthetics, local|mesh-ancestor
138699601|NCT05708989|Anesthetics|anesthetics|mesh-ancestor
138699602|NCT05670795|Clomiphene|clomiphene|mesh-list
138699603|NCT05670795|Enclomiphene|enclomiphene|mesh-list
138699604|NCT05670795|Zuclomiphene|zuclomiphene|mesh-list
138699605|NCT05670795|Hormones|hormones|mesh-list
138699606|NCT05670795|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138699607|NCT05670795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138699608|NCT05670795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699609|NCT05670795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138699610|NCT05670795|Hormone Antagonists|hormone antagonists|mesh-ancestor
138699611|NCT05670795|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138699612|NCT05670795|Fertility Agents|fertility agents|mesh-ancestor
138699613|NCT05670795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138699614|NCT05670795|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138699615|NCT05670795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138699617|NCT05669833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138699618|NCT05669833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138699619|NCT05669833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138699620|NCT05669833|Immunologic Factors|immunologic factors|mesh-ancestor
138699621|NCT05669833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699622|NCT05657496|Triamcinolone|triamcinolone|mesh-list
138699623|NCT05657496|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138699624|NCT05657496|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138699625|NCT05657496|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138699626|NCT05657496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138699627|NCT05657496|Glucocorticoids|glucocorticoids|mesh-ancestor
138699628|NCT05657496|Hormones|hormones|mesh-ancestor
138345748|NCT05735028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138699629|NCT05657496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138699630|NCT05657496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699631|NCT05657496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138699632|NCT05657496|Immunologic Factors|immunologic factors|mesh-ancestor
138699633|NCT05657496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190093|NCT02153541|Analgesics|analgesics|mesh-ancestor
138699634|NCT05657496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699635|NCT05609929|Omeprazole|omeprazole|mesh-list
138699636|NCT05609929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138699637|NCT05609929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138699638|NCT05609929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138699639|NCT05609929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699640|NCT05609929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699641|NCT05607407|Methimazole|methimazole|mesh-list
138699642|NCT05607407|Antithyroid Agents|antithyroid agents|mesh-ancestor
138699643|NCT05607407|Hormone Antagonists|hormone antagonists|mesh-ancestor
138699644|NCT05607407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138699645|NCT05607407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699646|NCT05594563|Eflornithine|eflornithine|mesh-list
138699647|NCT05594563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699648|NCT05594563|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138699649|NCT05594563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138699650|NCT05594563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138699651|NCT05594563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138345874|NCT03616236|Buprenorphine|buprenorphine|mesh-list
138699653|NCT05594563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699654|NCT05594563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699655|NCT05591755|Ketotifen|ketotifen|mesh-list
138699656|NCT05591755|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138699657|NCT05591755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138699658|NCT05591755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138699659|NCT05591755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138699660|NCT05591755|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138699661|NCT05591755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138699662|NCT05591755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138699663|NCT05591755|Adrenergic Agents|adrenergic agents|mesh-ancestor
138699664|NCT05591755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699665|NCT05591755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699666|NCT05591755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699667|NCT05591755|Antipruritics|antipruritics|mesh-ancestor
138699668|NCT05591755|Dermatologic Agents|dermatologic agents|mesh-ancestor
138699669|NCT05591755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138172662|NCT01271725|Vinorelbine|vinorelbine|mesh-list
138699670|NCT05591755|Histamine Antagonists|histamine antagonists|mesh-ancestor
138699671|NCT05591755|Histamine Agents|histamine agents|mesh-ancestor
138699672|NCT05591755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138699673|NCT05591144|Prednisone|prednisone|mesh-list
138699674|NCT05591144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138699675|NCT05591144|Glucocorticoids|glucocorticoids|mesh-ancestor
138699676|NCT05591144|Hormones|hormones|mesh-ancestor
138699677|NCT05591144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138699678|NCT05591144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138346002|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
138699679|NCT05591144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138699680|NCT05591144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699681|NCT05585229|Psilocybin|psilocybin|mesh-list
138699682|NCT05585229|Hallucinogens|hallucinogens|mesh-ancestor
138699683|NCT05585229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699684|NCT05585229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138699685|NCT05579730|Ketotifen|ketotifen|mesh-list
138699686|NCT05579730|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138699687|NCT05579730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138699688|NCT05579730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138699689|NCT05579730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138699690|NCT05579730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138699691|NCT05579730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138699692|NCT05579730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138699693|NCT05579730|Adrenergic Agents|adrenergic agents|mesh-ancestor
138699694|NCT05579730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699695|NCT05579730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699696|NCT05579730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699697|NCT05579730|Antipruritics|antipruritics|mesh-ancestor
138699698|NCT05579730|Dermatologic Agents|dermatologic agents|mesh-ancestor
138699699|NCT05579730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138699700|NCT05579730|Histamine Antagonists|histamine antagonists|mesh-ancestor
138699701|NCT05579730|Histamine Agents|histamine agents|mesh-ancestor
138699702|NCT05579730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138699703|NCT05548361|Chlorhexidine|chlorhexidine|mesh-list
138699704|NCT05548361|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138699705|NCT05548361|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138699706|NCT05548361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138699707|NCT05548361|Disinfectants|disinfectants|mesh-ancestor
138699708|NCT05548361|Dermatologic Agents|dermatologic agents|mesh-ancestor
138699709|NCT05542667|Fluorides|fluorides|mesh-list
138699710|NCT05542667|Fluorides, Topical|fluorides, topical|mesh-list
138699711|NCT05542667|Cariostatic Agents|cariostatic agents|mesh-ancestor
138699712|NCT05542667|Protective Agents|protective agents|mesh-ancestor
138699713|NCT05542667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699714|NCT05528588|Furosemide|furosemide|mesh-list
138699715|NCT05528588|Diuretics|diuretics|mesh-list
138699716|NCT05528588|Natriuretic Agents|natriuretic agents|mesh-ancestor
138699717|NCT05528588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699718|NCT05528588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138699719|NCT05528588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138699720|NCT05528588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699721|NCT05481684|Progesterone|progesterone|mesh-list
138699722|NCT05481684|Progestins|progestins|mesh-ancestor
138699724|NCT05481684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138699725|NCT05481684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699726|NCT05473715|Aflibercept|aflibercept|mesh-list
138699727|NCT05473715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138699728|NCT05473715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138699729|NCT05473715|Growth Substances|growth substances|mesh-ancestor
138699730|NCT05473715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699731|NCT05473715|Growth Inhibitors|growth inhibitors|mesh-ancestor
138699732|NCT05473715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699733|NCT05403450|Decitabine|decitabine|mesh-list
138699734|NCT05403450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138699735|NCT05403450|Antimetabolites|antimetabolites|mesh-ancestor
138699736|NCT05403450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699737|NCT05403450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699738|NCT05403450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699739|NCT05384951|Vitamin D|vitamin d|mesh-list
138699740|NCT05384951|Cholecalciferol|cholecalciferol|mesh-list
138699741|NCT05384951|Vitamins|vitamins|mesh-ancestor
138699742|NCT05384951|Micronutrients|micronutrients|mesh-ancestor
138346235|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
138699743|NCT05384951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699744|NCT05384951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138699745|NCT05384951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138699747|NCT05338619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138699748|NCT05338619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699749|NCT05338619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699750|NCT05320380|Cytarabine|cytarabine|mesh-list
138699751|NCT05320380|Prednisolone|prednisolone|mesh-list
138448886|NCT01860014|Poractant alfa|poractant alfa|mesh-list
138699752|NCT05320380|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138699753|NCT05320380|Methylprednisolone|methylprednisolone|mesh-list
138699754|NCT05320380|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138699756|NCT05320380|Hydrocortisone|hydrocortisone|mesh-list
138699757|NCT05320380|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138699758|NCT05320380|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138699759|NCT05320380|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138699760|NCT05320380|Cortisone|cortisone|mesh-list
138699761|NCT05320380|Methotrexate|methotrexate|mesh-list
138699762|NCT05320380|Fludarabine phosphate|fludarabine phosphate|mesh-list
138699763|NCT05320380|Fludarabine|fludarabine|mesh-list
138699764|NCT05320380|Daunorubicin|daunorubicin|mesh-list
138699765|NCT05320380|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138699766|NCT05320380|Prednisolone phosphate|prednisolone phosphate|mesh-list
138699767|NCT05320380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138699768|NCT05320380|Abortifacient Agents|abortifacient agents|mesh-ancestor
138699769|NCT05320380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138699770|NCT05320380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699771|NCT05320380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138699773|NCT05320380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699774|NCT05320380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699775|NCT05320380|Dermatologic Agents|dermatologic agents|mesh-ancestor
138699776|NCT05320380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699777|NCT05320380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138699778|NCT05320380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138699779|NCT05320380|Immunologic Factors|immunologic factors|mesh-ancestor
138699780|NCT05320380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138699781|NCT05320380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138699782|NCT05320380|Antiviral Agents|antiviral agents|mesh-ancestor
138699783|NCT05320380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138346426|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138699784|NCT05320380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138699785|NCT05320380|Glucocorticoids|glucocorticoids|mesh-ancestor
138699786|NCT05320380|Hormones|hormones|mesh-ancestor
138699787|NCT05320380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138699788|NCT05320380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138699789|NCT05320380|Antiemetics|antiemetics|mesh-ancestor
138699790|NCT05320380|Autonomic Agents|autonomic agents|mesh-ancestor
138699791|NCT05320380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699792|NCT05320380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138699793|NCT05320380|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138699794|NCT05320380|Protective Agents|protective agents|mesh-ancestor
138699795|NCT05320380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138699796|NCT05320380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138699797|NCT05320380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138699798|NCT05124275|Pilocarpine|pilocarpine|mesh-list
138699799|NCT05124275|Miotics|miotics|mesh-ancestor
138699800|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
138182545|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699801|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699802|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699803|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138699804|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138699805|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
138699806|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699807|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699808|NCT05092360|Paclitaxel|paclitaxel|mesh-list
138699809|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138699810|NCT05092360|Gemcitabine|gemcitabine|mesh-list
138699811|NCT05092360|Doxorubicin|doxorubicin|mesh-list
138346627|NCT02181426|Ketorolac|ketorolac|mesh-list
138699812|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138699813|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
138699814|NCT05092360|Topotecan|topotecan|mesh-list
138699815|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138699816|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699817|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
138699818|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
138699819|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
138699820|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699821|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138699822|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
138699823|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138699824|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138699825|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138699826|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699827|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138699828|NCT05092360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138448963|NCT01860391|Fluorides|fluorides|mesh-list
138699829|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138699830|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138699831|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699832|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138699833|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699834|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
138699835|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699836|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138699837|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699838|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699839|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
138699840|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138699841|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699842|NCT05005442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138699843|NCT05005442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699845|NCT04953910|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138699846|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138699847|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
138699848|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699849|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699850|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699851|NCT04902261|Paclitaxel|paclitaxel|mesh-list
138699852|NCT04902261|Gemcitabine|gemcitabine|mesh-list
138699853|NCT04902261|Tislelizumab|tislelizumab|mesh-list
138699854|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138699855|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699856|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
138699857|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
138699858|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
138699859|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699860|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138699861|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
138172900|NCT05688488|Curcumin|curcumin|mesh-list
138699862|NCT04902261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138699863|NCT04873596|Midazolam|midazolam|mesh-list
138699864|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
138699865|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138699866|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699867|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699868|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138699869|NCT04873596|Analgesics|analgesics|mesh-ancestor
138699870|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
138699871|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699872|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138699873|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138699875|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
138699876|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699877|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699878|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138699879|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138699880|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138699881|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138699882|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138699883|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
138376728|NCT01439178|Growth Substances|growth substances|mesh-ancestor
138699884|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
138699885|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
138699886|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
138699887|NCT04841434|Methotrexate|methotrexate|mesh-list
138699888|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138699889|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
138699890|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138699891|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699892|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138699894|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699895|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699896|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
138699897|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699898|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138699899|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138699900|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
138699901|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138699902|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138699903|NCT04838301|Pregnanolone|pregnanolone|mesh-list
138699904|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
138699905|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699906|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699907|NCT04817189|Dexamethasone|dexamethasone|mesh-list
138699908|NCT04817189|Ondansetron|ondansetron|mesh-list
138699909|NCT04817189|Palonosetron|palonosetron|mesh-list
138699910|NCT04817189|Granisetron|granisetron|mesh-list
138699911|NCT04817189|Tropisetron|tropisetron|mesh-list
138699912|NCT04817189|Dolasetron|dolasetron|mesh-list
138699913|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138699914|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
138699915|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
138699916|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699917|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699918|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138699919|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
138699920|NCT04817189|Hormones|hormones|mesh-ancestor
138699921|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138699922|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138699923|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138346875|NCT02258412|Ethanol|ethanol|mesh-list
138699924|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
138699925|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
138699926|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138699927|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138699928|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
138699929|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138699930|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699931|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
138699932|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138699933|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699934|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138699935|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699936|NCT04603001|Azacitidine|azacitidine|mesh-list
138699937|NCT04603001|Venetoclax|venetoclax|mesh-list
138699938|NCT04603001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138699939|NCT04603001|Antimetabolites|antimetabolites|mesh-ancestor
138699940|NCT04603001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699941|NCT04603001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699942|NCT04603001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699943|NCT04588922|Azacitidine|azacitidine|mesh-list
138699944|NCT04588922|Venetoclax|venetoclax|mesh-list
138699945|NCT04588922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138699946|NCT04588922|Antimetabolites|antimetabolites|mesh-ancestor
138449004|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138699947|NCT04588922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699948|NCT04588922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699949|NCT04588922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699950|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
138699951|NCT04576364|Analgesics|analgesics|mesh-ancestor
138699952|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
138182626|NCT05529888|Isotretinoin|isotretinoin|mesh-list
138699953|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138699954|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699955|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
138699956|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138699957|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138699958|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
138699959|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138699960|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138699961|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699962|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138699963|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
138699964|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138699965|NCT04547790|Psyllium|psyllium|mesh-list
138699966|NCT04547790|Cathartics|cathartics|mesh-ancestor
138699967|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138699968|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
138699969|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
138699970|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138699971|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138699972|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138699973|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699974|NCT04538976|Urological Agents|urological agents|mesh-ancestor
138699975|NCT04522544|Durvalumab|durvalumab|mesh-list
138699976|NCT04522544|Tremelimumab|tremelimumab|mesh-list
138346972|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138699977|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138699978|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699979|NCT04521686|Gemcitabine|gemcitabine|mesh-list
138699980|NCT04521686|Durvalumab|durvalumab|mesh-list
138699981|NCT04521686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699982|NCT04521686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138699983|NCT04521686|Antimetabolites|antimetabolites|mesh-ancestor
138699984|NCT04521686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699985|NCT04521686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138699986|NCT04431635|Rituximab|rituximab|mesh-list
138699987|NCT04431635|Nivolumab|nivolumab|mesh-list
138699988|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138699989|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138699990|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
138699991|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138699992|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138699993|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138699994|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138699995|NCT04324307|Paclitaxel|paclitaxel|mesh-list
138699996|NCT04324307|Gemcitabine|gemcitabine|mesh-list
138699997|NCT04324307|Fluorouracil|fluorouracil|mesh-list
138699998|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
138700000|NCT04324307|Folfirinox|folfirinox|mesh-list
138700001|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138700002|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700003|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
138700004|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
138700005|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
138700006|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700007|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138700008|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
138700009|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700010|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138700011|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
138700012|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138700013|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138700014|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700015|NCT04216628|Oxytocin|oxytocin|mesh-list
138700016|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
138700017|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138700018|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700019|NCT04192019|Glucagon|glucagon|mesh-list
138700020|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138700021|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138700022|NCT04192019|Hormones|hormones|mesh-ancestor
138700023|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700024|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700025|NCT04192019|Incretins|incretins|mesh-ancestor
138700026|NCT04174170|Sertraline|sertraline|mesh-list
138700027|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
138700028|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
138700029|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138700030|NCT04174170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138700031|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138700032|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138700033|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700034|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700035|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
138700036|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700037|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
138700038|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
138700039|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138700040|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700041|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138700042|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700043|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700044|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
138700045|NCT04146298|Fludarabine|fludarabine|mesh-list
138700046|NCT04146298|Antibodies|antibodies|mesh-list
138700047|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138700048|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138700049|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
138700050|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700051|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138700052|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138700053|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
138700054|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700055|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700056|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138700057|NCT04124614|Sertraline|sertraline|mesh-list
138700058|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
138700059|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
138700060|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138700061|NCT04124614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138700062|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138700063|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138700064|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700065|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700067|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700068|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
138700069|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
138700070|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
138700071|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
138700072|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700073|NCT04042935|Protective Agents|protective agents|mesh-ancestor
138700074|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700075|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
138700076|NCT04042935|Vitamins|vitamins|mesh-ancestor
138700077|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
138700078|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138700080|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
138700081|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700082|NCT03936517|Prednisolone|prednisolone|mesh-list
138700083|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
138700084|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138700085|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
138700086|NCT03936517|Hormones|hormones|mesh-ancestor
138700087|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700088|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700089|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138700090|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700092|NCT03889795|Digoxin|digoxin|mesh-list
138182703|NCT01729897|Analgesics|analgesics|mesh-ancestor
138700093|NCT03889795|Simvastatin|simvastatin|mesh-list
138700094|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138700095|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700096|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138700097|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138700098|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
138700099|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700100|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138700101|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138700102|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700103|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138700104|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138700105|NCT03889795|Protective Agents|protective agents|mesh-ancestor
138700106|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
138700107|NCT03808025|Narcotics|narcotics|mesh-ancestor
138376953|NCT01440842|Insulin|insulin|mesh-list
138700108|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138700109|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700110|NCT03808025|Analgesics|analgesics|mesh-ancestor
138449066|NCT01860833|Ibuprofen|ibuprofen|mesh-list
138700112|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700113|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
138700114|NCT03802084|Vactosertib|vactosertib|mesh-list
138700115|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700116|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138700117|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700118|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700119|NCT03777462|Paclitaxel|paclitaxel|mesh-list
138700120|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138700121|NCT03777462|Gemcitabine|gemcitabine|mesh-list
138700122|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138700123|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700124|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
138700125|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
138700126|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
138700127|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700128|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138700129|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
138700130|NCT03745326|Aldesleukin|aldesleukin|mesh-list
138700131|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
138700132|NCT03745326|Fludarabine|fludarabine|mesh-list
138700133|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138700134|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
138700135|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700136|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138700137|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138700138|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
138700139|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700140|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700141|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138700142|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138700143|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138700144|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
138700145|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700147|NCT03730181|Rifapentine|rifapentine|mesh-list
138700148|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
138700149|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138700150|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700151|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138700152|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138700153|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
138700154|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700155|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138700156|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138700157|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
138700158|NCT03674671|Ketamine|ketamine|mesh-list
138700159|NCT03674671|Analgesics|analgesics|mesh-ancestor
138700160|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
138700161|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700162|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700163|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138700164|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138700165|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
138700166|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
138700167|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138700168|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138700169|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138700170|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700171|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700172|NCT03668119|Nivolumab|nivolumab|mesh-list
138700173|NCT03668119|Ipilimumab|ipilimumab|mesh-list
138700174|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138700175|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700176|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138700177|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700178|NCT03659799|Insulin|insulin|mesh-list
138700179|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138700180|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
138700181|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138700182|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700183|NCT03653364|Baloxavir|baloxavir|mesh-list
138700184|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
138700185|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700186|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700187|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700188|NCT03624244|Letrozole|letrozole|mesh-list
138700189|NCT03624244|Exemestane|exemestane|mesh-list
138700190|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138700191|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700192|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138700193|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700194|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700195|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138700196|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
138700197|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700198|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700200|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
138700201|NCT03620019|Nivolumab|nivolumab|mesh-list
138700202|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138700203|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700204|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138700205|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700206|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138700207|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700208|NCT03591770|Vaccines|vaccines|mesh-list
138700209|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
138347557|NCT02834052|Poly I-C|poly i-c|mesh-list
138700210|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700211|NCT03559647|Atezolizumab|atezolizumab|mesh-list
138700212|NCT03559647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138173375|NCT00737737|Morphine|morphine|mesh-list
138700213|NCT03559647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700214|NCT03559647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138700215|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700216|NCT03321734|Caffeine|caffeine|mesh-list
138700217|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138700218|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700219|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138700220|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700221|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700222|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138700223|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138347613|NCT05722002|Acetaminophen|acetaminophen|mesh-list
138700224|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
138700225|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700226|NCT03261830|Clindamycin|clindamycin|mesh-list
138700227|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
138700228|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
138700230|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138700231|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700232|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138700233|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700234|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700235|NCT03064568|Misoprostol|misoprostol|mesh-list
138700236|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138700237|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
138700238|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138347673|NCT05715840|Paclitaxel|paclitaxel|mesh-list
138700239|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700240|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138700241|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138700242|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
138700243|NCT02691078|Octreotide|octreotide|mesh-list
138700244|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138700245|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138700246|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700247|NCT02549573|Apomorphine|apomorphine|mesh-list
138700248|NCT02549573|Emetics|emetics|mesh-ancestor
138700249|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182837|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
138700250|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
138700251|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700252|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138700253|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
138700254|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
138700255|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700256|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700257|NCT02542657|Clarithromycin|clarithromycin|mesh-list
138700258|NCT02542657|Dexamethasone|dexamethasone|mesh-list
138700259|NCT02542657|Pomalidomide|pomalidomide|mesh-list
138377110|NCT01441804|Ribavirin|ribavirin|mesh-list
138700260|NCT02542657|Ixazomib|ixazomib|mesh-list
138700261|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138700262|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
138700263|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
138700264|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700265|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700266|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138700267|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
138700268|NCT02542657|Hormones|hormones|mesh-ancestor
138700269|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700270|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138700271|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700272|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700273|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138700274|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700275|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138700276|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700277|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138700278|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138700279|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
138700280|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138700281|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138700282|NCT02542657|Growth Substances|growth substances|mesh-ancestor
138700283|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
138700284|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
138700285|NCT02485418|Propofol|propofol|mesh-list
138700286|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138182878|NCT00370630|Hormones|hormones|mesh-ancestor
138700287|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138700288|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700289|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138700291|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
138700292|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
138700293|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138700294|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138700295|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138173534|NCT00738361|Paclitaxel|paclitaxel|mesh-list
138700296|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
138700297|NCT02229968|Coagulants|coagulants|mesh-ancestor
138700298|NCT02201108|Teriflunomide|teriflunomide|mesh-list
138700299|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138700300|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138700302|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
138700303|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700304|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700305|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138700306|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138700307|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138700308|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
138700309|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138700310|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700311|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
138700312|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138700313|NCT01789879|Efavirenz|efavirenz|mesh-list
138700314|NCT01789879|Nevirapine|nevirapine|mesh-list
138700315|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
138700316|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138700317|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138700318|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700319|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700320|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
138700321|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700322|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138700323|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138700324|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138700325|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138700326|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138700327|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138700328|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138700329|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
138700330|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138700331|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700332|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138700333|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138700334|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138700335|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138700336|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138700337|NCT01772563|Itraconazole|itraconazole|mesh-list
138700338|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
138700339|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700340|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138700341|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138700342|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700343|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700344|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138700345|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
138700346|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700347|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700348|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138700350|NCT01316523|Lenalidomide|lenalidomide|mesh-list
138700351|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138700352|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700353|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
138700354|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700355|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138700356|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138700357|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138700358|NCT01316523|Growth Substances|growth substances|mesh-ancestor
138700359|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
138700360|NCT01258933|Ofatumumab|ofatumumab|mesh-list
138700361|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700362|NCT01042561|Vitamin D|vitamin d|mesh-list
138700363|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
138700364|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
138700365|NCT01042561|Vitamins|vitamins|mesh-list
138700366|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
138700367|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700368|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138700369|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138700370|NCT00848328|Rituximab|rituximab|mesh-list
138700371|NCT00848328|Lenalidomide|lenalidomide|mesh-list
138700372|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138700373|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700374|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
138700375|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700376|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138700377|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138700378|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138700379|NCT00848328|Growth Substances|growth substances|mesh-ancestor
138700380|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
138700381|NCT00492050|Valacyclovir|valacyclovir|mesh-list
138700382|NCT00492050|Rituximab|rituximab|mesh-list
138700383|NCT00492050|Bortezomib|bortezomib|mesh-list
138700384|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138700385|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700386|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
138700387|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700388|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138700389|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
138173662|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
138700390|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700391|NCT01237951|Dexamethasone|dexamethasone|mesh-list
138700392|NCT01237951|Gemcitabine|gemcitabine|mesh-list
138700394|NCT01237951|Busulfan|busulfan|mesh-list
138700395|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138700396|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
138700397|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
138700398|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700399|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700400|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138700401|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
138700402|NCT01237951|Hormones|hormones|mesh-ancestor
138700403|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700404|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138700405|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700406|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138700407|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
138700408|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700409|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138700410|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
138700411|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138700412|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138700413|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
138700414|NCT02908581|Folic Acid|folic acid|mesh-list
138700415|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
138700416|NCT02908581|Hematinics|hematinics|mesh-ancestor
138700417|NCT02908581|Vitamins|vitamins|mesh-ancestor
138700418|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
138700419|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700420|NCT00544362|Fluorouracil|fluorouracil|mesh-list
138700421|NCT00544362|Cetuximab|cetuximab|mesh-list
138700422|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700423|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
138700424|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700425|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138173707|NCT02980497|Ethanol|ethanol|mesh-list
138700426|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138700427|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
138700428|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700429|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138700430|NCT01239394|Ofatumumab|ofatumumab|mesh-list
138700431|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700432|NCT00553293|Hormones|hormones|mesh-list
138700433|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138700434|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700435|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700436|NCT00544518|Metformin|metformin|mesh-list
138700437|NCT00544518|Benfluorex|benfluorex|mesh-list
138700438|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138182964|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
138700439|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700440|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138700441|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
138700442|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700443|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138700444|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
138700445|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138700446|NCT02908698|Prednisone|prednisone|mesh-list
138700447|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138700448|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
138700449|NCT02908698|Hormones|hormones|mesh-ancestor
138173759|NCT02584647|Sirolimus|sirolimus|mesh-list
138700450|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700451|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700452|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138700454|NCT00544596|Acetic Acid|acetic acid|mesh-list
138700455|NCT00544596|Etoposide|etoposide|mesh-list
138700456|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
138700457|NCT00544596|Retinol acetate|retinol acetate|mesh-list
138700458|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
138700459|NCT00544596|Gossypol|gossypol|mesh-list
138700460|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700461|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138190161|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138700462|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138700463|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138700464|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700465|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700466|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138700467|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700468|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138700469|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
138700470|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700471|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138700472|NCT00544596|Protective Agents|protective agents|mesh-ancestor
138700473|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138700474|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
138700475|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138700476|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138700477|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138700478|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138700480|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138700481|NCT02908191|Entecavir|entecavir|mesh-list
138700482|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
138700483|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700484|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138700485|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138377326|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
138700486|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700487|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700488|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138700489|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138700490|NCT00544791|Melatonin|melatonin|mesh-list
138700491|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
138700492|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700493|NCT00544791|Protective Agents|protective agents|mesh-ancestor
138700494|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700495|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138700496|NCT04647773|Pregabalin|pregabalin|mesh-list
138700497|NCT04647773|Analgesics|analgesics|mesh-ancestor
138182985|NCT05515770|Cabotegravir|cabotegravir|mesh-list
138700498|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
138700499|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700500|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700501|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
138700502|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138347945|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138700503|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138700504|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700505|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138700506|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138700507|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138700508|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138700509|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138700511|NCT01237678|Etoposide|etoposide|mesh-list
138700512|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
138700513|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700514|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138700515|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138700516|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138700517|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700518|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700519|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138700520|NCT01237678|Immunotoxins|immunotoxins|mesh-ancestor
138700521|NCT01237678|Immunoconjugates|immunoconjugates|mesh-ancestor
138700522|NCT01237678|Immunologic Factors|immunologic factors|mesh-ancestor
138700523|NCT01237678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700524|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138700525|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138700526|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138700527|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138700528|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138700529|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138700530|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138700531|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
138700532|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700533|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700534|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700537|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700538|NCT02908152|Curcumin|curcumin|mesh-list
138700539|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138700540|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138700541|NCT02908152|Analgesics|analgesics|mesh-ancestor
138700542|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
138700543|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700544|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138173893|NCT03793439|Tofacitinib|tofacitinib|mesh-list
138700545|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138700546|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138700547|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700548|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700549|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700551|NCT01237327|Megestrol|megestrol|mesh-list
138700552|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
138700553|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700554|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138700555|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138700556|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700557|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700558|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138700559|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
138700560|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700561|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700562|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138700563|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138700564|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138700565|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
138700566|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138700567|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138700568|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138700569|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138700570|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
138700571|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138700572|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138700573|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138700574|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
138700575|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700576|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700577|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700578|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138700579|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138700580|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700581|NCT04647695|Interferons|interferons|mesh-list
138700582|NCT04647695|Interferon-beta|interferon-beta|mesh-list
138700583|NCT04647695|Remdesivir|remdesivir|mesh-list
138700584|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
138700585|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700586|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
138700587|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700588|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
138700589|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700590|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
138700591|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700592|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138700594|NCT04647344|Carboplatin|carboplatin|mesh-list
138700595|NCT04647344|Pemetrexed|pemetrexed|mesh-list
138700596|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138700597|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700598|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
138700599|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
138700600|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
138700601|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700602|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700603|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138700604|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138700605|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
138700606|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138700607|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700608|NCT02907957|Anesthetics|anesthetics|mesh-list
138700609|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138700610|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700611|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
138700612|NCT04646876|Analgesics|analgesics|mesh-ancestor
138700613|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
138700614|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700615|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700616|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
138700617|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138700618|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138700619|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
138700620|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138700621|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138173958|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
138700622|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700623|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138183073|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138700624|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
138700625|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138700626|NCT02908035|Sirolimus|sirolimus|mesh-list
138700627|NCT02908035|Temsirolimus|temsirolimus|mesh-list
138700628|NCT02908035|MTOR Inhibitors|mtor inhibitors|mesh-list
138700629|NCT02908035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138700630|NCT02908035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700631|NCT02908035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700632|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138700634|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700635|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700636|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138700637|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700638|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138700639|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
138700640|NCT04646759|Capecitabine|capecitabine|mesh-list
138700641|NCT04646759|Fulvestrant|fulvestrant|mesh-list
138700642|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138700643|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
138700644|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700645|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700646|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138700647|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138700648|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138700649|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
138700650|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700651|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700652|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138700653|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
138700654|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
138700655|NCT04646135|Lorazepam|lorazepam|mesh-list
138700656|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
138700657|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
138700658|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
138700659|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700660|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700661|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138700662|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138700663|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138700665|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138700666|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138700669|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700670|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700671|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
138700672|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
138700673|NCT04682184|Propranolol|propranolol|mesh-list
138700674|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
138700675|NCT04682184|Ephedrine|ephedrine|mesh-list
138700676|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138700677|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138700678|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
138700679|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700680|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700681|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700682|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138700683|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138700684|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
138700685|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138700686|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
138700687|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700688|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138700689|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
138700690|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
138700691|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138700692|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138700693|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
138700694|NCT04645940|Rabeprazole|rabeprazole|mesh-list
138700695|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138700696|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138700697|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138700698|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700699|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700700|NCT00558506|Abatacept|abatacept|mesh-list
138700701|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138700702|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700703|NCT00558506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138700704|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700705|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138700706|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
138700707|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700708|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138700709|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
138700711|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138700712|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700713|NCT00558623|Antacids|antacids|mesh-ancestor
138700714|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700715|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138449269|NCT01862835|Androgens|androgens|mesh-ancestor
138700717|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
138700718|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700719|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138700720|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138700721|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
138700722|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
138700723|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
138700724|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700725|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700726|NCT00558662|Ionophores|ionophores|mesh-ancestor
138700727|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138700728|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
138700729|NCT02905890|Norethindrone|norethindrone|mesh-list
138700730|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
138700731|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
138700732|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138700733|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138700734|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138700735|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
138700736|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138700737|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700738|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138700739|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138700741|NCT02906163|Afatinib|afatinib|mesh-list
138700742|NCT02906163|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138700743|NCT02906163|Thymalfasin|thymalfasin|mesh-list
138700744|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700745|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138700746|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700747|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700748|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138700749|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
138348304|NCT02484222|Fentanyl|fentanyl|mesh-list
138700750|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700752|NCT04645745|Inositol|inositol|mesh-list
138700753|NCT04645745|Hematinics|hematinics|mesh-ancestor
138700754|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
138700755|NCT04645745|Vitamins|vitamins|mesh-ancestor
138700756|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
138700757|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700758|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
138700759|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
138700760|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
138700761|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138183179|NCT01049035|Vaccines|vaccines|mesh-list
138700762|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700763|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
138700764|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700765|NCT00558818|Clevudine|clevudine|mesh-list
138700766|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
138700767|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700768|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
138700769|NCT04681911|Paclitaxel|paclitaxel|mesh-list
138700770|NCT04681911|Vinorelbine|vinorelbine|mesh-list
138700771|NCT04681911|Carboplatin|carboplatin|mesh-list
138700772|NCT04681911|Gemcitabine|gemcitabine|mesh-list
138700773|NCT04681911|Capecitabine|capecitabine|mesh-list
138700774|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138700775|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700776|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
138700777|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
138700778|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
138700779|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700780|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138700782|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138700783|NCT02905539|Hematinics|hematinics|mesh-ancestor
138700784|NCT02905734|Nicotine|nicotine|mesh-list
138700785|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138700786|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
138700787|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700788|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700789|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138355465|NCT00002424|Lamivudine|lamivudine|mesh-list
138700790|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138700791|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
138700792|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700793|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700794|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
138700796|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
138700797|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700798|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
138700799|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138700800|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700801|NCT02905305|Dexamethasone|dexamethasone|mesh-list
138190187|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
138700802|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138700803|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
138700804|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
138190188|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700805|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700806|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700807|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138700808|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
138700810|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700811|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138700812|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700813|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
138700814|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138700815|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
138700816|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
138700817|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138700818|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700819|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138700820|NCT02899182|Analgesics|analgesics|mesh-ancestor
138700821|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
138700822|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700823|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
138700824|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138700825|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138700826|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
138700827|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700828|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700829|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700830|NCT04643483|Adalimumab|adalimumab|mesh-list
138700831|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
138700832|NCT04643483|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138700833|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138700834|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138700835|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138700836|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
138700837|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700838|NCT00559052|Pancrelipase|pancrelipase|mesh-list
138700839|NCT00559052|Pancreatin|pancreatin|mesh-list
138700840|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138700841|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138700842|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700843|NCT04643132|Ketamine|ketamine|mesh-list
138700844|NCT04643132|Esketamine|esketamine|mesh-list
138700845|NCT04643132|Analgesics|analgesics|mesh-ancestor
138700846|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
138700847|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700848|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700849|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138700850|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138700851|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
138700852|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
138700853|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138700854|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138700855|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138700856|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700857|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700858|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
138700859|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138700860|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138700861|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700862|NCT02899026|Prednisone|prednisone|mesh-list
138700863|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138700864|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190203|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138700865|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
138700866|NCT02899026|Hormones|hormones|mesh-ancestor
138700867|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700868|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700869|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138700870|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700871|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
138700872|NCT00559169|Verapamil|verapamil|mesh-list
138700873|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138700874|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138700875|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138700876|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700877|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138700878|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700879|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
138700880|NCT04642664|Apatinib|apatinib|mesh-list
138700881|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700882|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138700883|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700884|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700885|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138700886|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
138700887|NCT02904759|Coagulants|coagulants|mesh-ancestor
138700888|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138700889|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
138700890|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700891|NCT02898792|Remifentanil|remifentanil|mesh-list
138700892|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138700893|NCT02898792|Narcotics|narcotics|mesh-ancestor
138700894|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138700895|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700896|NCT02898792|Analgesics|analgesics|mesh-ancestor
138700897|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
138700898|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700899|NCT02904564|Fluorouracil|fluorouracil|mesh-list
138700900|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
138700901|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700902|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138700904|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138700905|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
138700906|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700908|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
138700909|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
138700910|NCT04642001|Protective Agents|protective agents|mesh-ancestor
138700911|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700912|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138700913|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700914|NCT00559286|Telmisartan|telmisartan|mesh-list
138700915|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138700916|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138700917|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138700918|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700919|NCT04640870|Afatinib|afatinib|mesh-list
138700920|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700921|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138700922|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700923|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700924|NCT02897934|Bupivacaine|bupivacaine|mesh-list
138700925|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
138700926|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
138700927|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138700928|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700929|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
138700930|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700931|NCT04640129|Interferons|interferons|mesh-list
138700932|NCT04640129|Tenofovir|tenofovir|mesh-list
138377778|NCT01445431|Mineral Oil|mineral oil|mesh-list
138700933|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
138700934|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700935|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
138700936|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138700937|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138700938|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138700939|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138700940|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700941|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138700942|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138700943|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
138700944|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700945|NCT02898012|Bevacizumab|bevacizumab|mesh-list
138700946|NCT02898012|Temozolomide|temozolomide|mesh-list
138700947|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138700948|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138348736|NCT05248152|Ibuprofen|ibuprofen|mesh-list
138700949|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138700950|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138700951|NCT02898012|Growth Substances|growth substances|mesh-ancestor
138700952|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700953|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
138183270|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700954|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138700955|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
138700956|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700958|NCT04640324|Vitamins|vitamins|mesh-list
138700959|NCT04640324|Vitamin E|vitamin e|mesh-list
138700960|NCT04640324|Silybin|silybin|mesh-list
138700961|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
138700962|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700963|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138700964|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
138700965|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700966|NCT04640324|Protective Agents|protective agents|mesh-ancestor
138700967|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138700968|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700969|NCT04640285|Menthol|menthol|mesh-list
138700970|NCT04640285|Nicotine|nicotine|mesh-list
138700971|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138700972|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
138700973|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700974|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700975|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138700976|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138700977|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
138700978|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138700979|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138700980|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
138700981|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
138700982|NCT00559481|Ketoconazole|ketoconazole|mesh-list
138700983|NCT00559481|Dexamethasone|dexamethasone|mesh-list
138700984|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
138700985|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138700986|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138700987|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138700988|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138700989|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
138700990|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
138700991|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138700992|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138700993|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138700994|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
138355781|NCT00002580|Fluorouracil|fluorouracil|mesh-list
138700995|NCT00559481|Hormones|hormones|mesh-ancestor
138700996|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138700997|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138700998|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138700999|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
138701000|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701001|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138701002|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138701003|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701004|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701005|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138701007|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138377854|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
138701008|NCT02897856|Midazolam|midazolam|mesh-list
138701009|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138701010|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138701011|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701012|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701013|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138701014|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138701015|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138701016|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138701017|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
138701018|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
138701019|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
138701020|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
138701021|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701022|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701023|NCT01236118|Ixekizumab|ixekizumab|mesh-list
138701024|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
138701025|NCT04206631|Doxycycline|doxycycline|mesh-list
138701026|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138701027|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701028|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
138701029|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138701030|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138701031|NCT04639817|Levofloxacin|levofloxacin|mesh-list
138701032|NCT04639817|Trimethoprim|trimethoprim|mesh-list
138701033|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138701034|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
138701035|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138701036|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701037|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138701038|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138701039|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138701040|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701041|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701042|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701043|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138701044|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138701045|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
138174496|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
138701046|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138701047|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138701048|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138701049|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138701050|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138701051|NCT01236001|Lacosamide|lacosamide|mesh-list
138701052|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
138701053|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138701054|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138701055|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138701056|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701057|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
138701058|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138701059|NCT01229254|Amiodarone|amiodarone|mesh-list
138701060|NCT01229254|Betrixaban|betrixaban|mesh-list
138701061|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138701062|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
138190228|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138190229|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701063|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138701064|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138701065|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701066|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138701067|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138701068|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138701069|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701070|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138701071|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138701072|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138701073|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138701074|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
138701075|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138701076|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
138701077|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
138701078|NCT04639232|Probenecid|probenecid|mesh-list
138701079|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
138701080|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
138701081|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138701082|NCT01235728|Calcitriol|calcitriol|mesh-list
138701083|NCT01235728|MK 0873|mk 0873|mesh-list
138701084|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138701085|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701086|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138701087|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138701088|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701089|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138701092|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138701093|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138701094|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138701095|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701096|NCT00559676|Leucovorin|leucovorin|mesh-list
138701097|NCT00559676|Capecitabine|capecitabine|mesh-list
138701098|NCT00559676|Fluorouracil|fluorouracil|mesh-list
138701099|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
138701100|NCT00559676|Irinotecan|irinotecan|mesh-list
138701101|NCT00559676|Calcium|calcium|mesh-list
138701102|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
138701103|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138349141|NCT02634684|Amphetamine|amphetamine|mesh-list
138701104|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701105|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138701106|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
138701107|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701108|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701109|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138701110|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
138701111|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138701112|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138701113|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701114|NCT00559676|Antidotes|antidotes|mesh-ancestor
138701115|NCT00559676|Protective Agents|protective agents|mesh-ancestor
138701116|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
138701118|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
138701119|NCT04639271|Trastuzumab|trastuzumab|mesh-list
138701120|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138701121|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138701122|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701123|NCT04681053|Ivermectin|ivermectin|mesh-list
138183380|NCT05513664|Osimertinib|osimertinib|mesh-list
138701124|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138701125|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701126|NCT04639193|Acetazolamide|acetazolamide|mesh-list
138701127|NCT04639193|Eszopiclone|eszopiclone|mesh-list
138349266|NCT02653560|Citric Acid|citric acid|mesh-list
138701128|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138701129|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138701130|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138701131|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138701132|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701133|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190244|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138701134|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701135|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138701136|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
138701137|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138701138|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
138701139|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138701140|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701141|NCT04639193|Diuretics|diuretics|mesh-ancestor
138701142|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
138701143|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138701144|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701145|NCT01235689|Prednisone|prednisone|mesh-list
138701146|NCT01235689|Adalimumab|adalimumab|mesh-list
138701147|NCT01235689|Azathioprine|azathioprine|mesh-list
138701148|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138701149|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
138701150|NCT01235689|Hormones|hormones|mesh-ancestor
138701151|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138701152|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701153|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138701154|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701155|NCT01235689|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138701156|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138701157|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
138701158|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701159|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138701160|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138701163|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701164|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
138701165|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701166|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138701167|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701168|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701169|NCT00559715|Bevacizumab|bevacizumab|mesh-list
138701170|NCT00559715|Ranibizumab|ranibizumab|mesh-list
138701171|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138349382|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
138701172|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701173|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138701174|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138701175|NCT00559715|Growth Substances|growth substances|mesh-ancestor
138701176|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701177|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
138701178|NCT02896803|Fluorouracil|fluorouracil|mesh-list
138701179|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
138701180|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
138701181|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701182|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138701183|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701184|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138701185|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
138701186|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701187|NCT02897037|Heparin|heparin|mesh-list
138701188|NCT02897037|Bivalirudin|bivalirudin|mesh-list
138701189|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
138701190|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138183430|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
138701191|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138174671|NCT00250445|Etoricoxib|etoricoxib|mesh-list
138701192|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701194|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138701195|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
138701196|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701197|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
138701199|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138701200|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
138701201|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701202|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138701203|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138701204|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
138701205|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701206|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701207|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138701208|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
138190254|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138190256|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
138701209|NCT01229176|Vaccines|vaccines|mesh-list
138701210|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138701211|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
138701212|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701213|NCT01228747|Levetiracetam|levetiracetam|mesh-list
138701214|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
138701215|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
138701216|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
138701217|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138701218|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701219|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701220|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138701221|NCT02896413|Analgesics|analgesics|mesh-ancestor
138701222|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
138701223|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701224|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138701225|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138701226|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138701227|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
138701228|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701229|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701230|NCT00553722|Eplerenone|eplerenone|mesh-list
138378079|NCT01447212|Narcotics|narcotics|mesh-ancestor
138701231|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138701232|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
138701233|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138701234|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701235|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138701236|NCT00553722|Diuretics|diuretics|mesh-ancestor
138701237|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
138701238|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138701239|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138701240|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138701241|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138701242|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138701243|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138701244|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701245|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701246|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701247|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138701248|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
138701249|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138701250|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138701251|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138701252|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
138701253|NCT01234675|Milnacipran|milnacipran|mesh-list
138701254|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
138701255|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138701256|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138701257|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138701258|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701259|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701260|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701261|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138701262|NCT01234675|Analgesics|analgesics|mesh-ancestor
138701263|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
138701264|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701265|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
138701266|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138701267|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
138701268|NCT02896101|Tacrolimus|tacrolimus|mesh-list
138701269|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138701270|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138701271|NCT02896101|Analgesics|analgesics|mesh-ancestor
138701272|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
138701273|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701274|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701275|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138701276|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138701277|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
138701278|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138701279|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
138701280|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138701281|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701282|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701283|NCT02896023|Menotropins|menotropins|mesh-list
138183477|NCT03400735|Cefdinir|cefdinir|mesh-list
138701284|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138701285|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
138701286|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138701287|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701288|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
138701289|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138701290|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138701291|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
138701292|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138701293|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701294|NCT02895672|Exenatide|exenatide|mesh-list
138701295|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138701296|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701297|NCT02895672|Incretins|incretins|mesh-ancestor
138701299|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138701300|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138701301|NCT01227967|Ribavirin|ribavirin|mesh-list
138701302|NCT01227967|Oseltamivir|oseltamivir|mesh-list
138701303|NCT01227967|Amantadine|amantadine|mesh-list
138701304|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
138701305|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701306|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
138701307|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701308|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701309|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138701310|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138701311|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
138701312|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701313|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701314|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138701315|NCT01227967|Analgesics|analgesics|mesh-ancestor
138701316|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
138349595|NCT05266404|Dapagliflozin|dapagliflozin|mesh-list
138701317|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701319|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
138701320|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701321|NCT04637204|Axitinib|axitinib|mesh-list
138701322|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701323|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138701324|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701325|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701326|NCT04637360|Calcitriol|calcitriol|mesh-list
138701327|NCT04637360|Cinacalcet|cinacalcet|mesh-list
138701328|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138701329|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190263|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138190264|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
138701330|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138701331|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138701332|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701333|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138701334|NCT04637360|Vitamins|vitamins|mesh-ancestor
138701335|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
138701336|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138449479|NCT01863719|Colistin|colistin|mesh-list
138701337|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138701338|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
138701339|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138701340|NCT04317703|Metformin|metformin|mesh-list
138701341|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138701342|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701343|NCT00560222|Lactoferrin|lactoferrin|mesh-list
138701344|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701345|NCT04317508|Benzocaine|benzocaine|mesh-list
138701346|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
138701347|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
138701348|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701349|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701350|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
138701351|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701352|NCT00560300|Vitamin D|vitamin d|mesh-list
138701353|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
138701354|NCT00560300|Calcitriol|calcitriol|mesh-list
138701355|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
138701356|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138701357|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
138701358|NCT00560300|Calcium|calcium|mesh-list
138701359|NCT00560300|Sevelamer|sevelamer|mesh-list
138701360|NCT00560300|Vitamins|vitamins|mesh-ancestor
138701361|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
138183523|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
138701362|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701363|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138701364|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138701365|NCT00560300|Antacids|antacids|mesh-ancestor
138701366|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701367|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138701368|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138701369|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138701370|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138701371|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
138349650|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
138701372|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
138701374|NCT02904369|Emtricitabine|emtricitabine|mesh-list
138701375|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
138701376|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701377|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138701378|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138701379|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701380|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701381|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138701382|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138701383|NCT00560378|Tacrolimus|tacrolimus|mesh-list
138701384|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138701385|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
138701386|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701387|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138701388|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701389|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701390|NCT02895321|Listerine|listerine|mesh-list
138701391|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
138701392|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
138701393|NCT02895321|Protective Agents|protective agents|mesh-ancestor
138701394|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701395|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138701396|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701397|NCT02894892|Esomeprazole|esomeprazole|mesh-list
138701398|NCT02894892|Bismuth|bismuth|mesh-list
138701399|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138701400|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138701401|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138701402|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701403|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701405|NCT04635566|Mebeverine|mebeverine|mesh-list
138701406|NCT04635566|Alverine|alverine|mesh-list
138701407|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
138701408|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
138701409|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
138701410|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701411|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701412|NCT04635293|Simendan|simendan|mesh-list
138701413|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138701414|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
138701415|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138701416|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138701417|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701418|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701419|NCT04635293|Protective Agents|protective agents|mesh-ancestor
138701420|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701421|NCT01227889|Dacarbazine|dacarbazine|mesh-list
138701422|NCT01227889|Dabrafenib|dabrafenib|mesh-list
138701423|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138701424|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
138701425|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701426|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701427|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138183561|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701428|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701429|NCT02888392|Psyllium|psyllium|mesh-list
138701430|NCT02888392|Cathartics|cathartics|mesh-ancestor
138701431|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138701432|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
138701433|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
138174956|NCT04317404|Hormones|hormones|mesh-ancestor
138701434|NCT00624676|Salicylates|salicylates|mesh-list
138701435|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138701436|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
138701437|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701438|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
138701439|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
138701440|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138701441|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138701442|NCT00624676|Analgesics|analgesics|mesh-ancestor
138701443|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
138701444|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701445|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701446|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138701447|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138701448|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138701449|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701450|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701451|NCT05655754|Methohexital|methohexital|mesh-list
138701452|NCT05655754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138701453|NCT05655754|Anesthetics, General|anesthetics, general|mesh-ancestor
138701454|NCT05655754|Anesthetics|anesthetics|mesh-ancestor
138701455|NCT05655754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701456|NCT05655754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701457|NCT05655715|Nivolumab|nivolumab|mesh-list
138701458|NCT05655715|Ipilimumab|ipilimumab|mesh-list
138701459|NCT05655715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138701460|NCT05655715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701461|NCT05655715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138701462|NCT05655715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701463|NCT04317235|Ropivacaine|ropivacaine|mesh-list
138701464|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
138701465|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
138701466|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701467|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138174981|NCT00667589|Tazarotene|tazarotene|mesh-list
138701469|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190275|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
138701470|NCT00560690|Metformin|metformin|mesh-list
138701471|NCT00560690|Interferons|interferons|mesh-list
138701472|NCT00560690|Ribavirin|ribavirin|mesh-list
138701473|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138701474|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701475|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701476|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
138701477|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701478|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
138701479|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701480|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
138701481|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138701482|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701483|NCT02903901|Melatonin|melatonin|mesh-list
138701484|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
138701485|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701486|NCT02903901|Protective Agents|protective agents|mesh-ancestor
138701487|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183570|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
138701488|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701489|NCT04634981|Anesthetics|anesthetics|mesh-list
138701490|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701491|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701492|NCT00553449|Rabeprazole|rabeprazole|mesh-list
138701493|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138701494|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138701495|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138701497|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701498|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
138701499|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138701500|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701501|NCT04633850|Dexamethasone|dexamethasone|mesh-list
138701502|NCT04633850|Bupivacaine|bupivacaine|mesh-list
138701503|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138701504|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
138701505|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
138701506|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701507|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701508|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138701509|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
138701510|NCT04633850|Hormones|hormones|mesh-ancestor
138701511|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138701512|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138701513|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701514|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
138701515|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
138701516|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701517|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
138349853|NCT03341676|Hormones|hormones|mesh-ancestor
138449531|NCT01864057|Thiamine|thiamine|mesh-list
138701519|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138701520|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
138701521|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701522|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138701523|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701524|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701526|NCT05427942|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138701527|NCT05427942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138701528|NCT05427942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138701529|NCT05427903|Epinephrine|epinephrine|mesh-list
138701530|NCT05427903|Anesthetics|anesthetics|mesh-list
138701532|NCT05427903|Anesthetics, Local|anesthetics, local|mesh-list
138701533|NCT05427903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701534|NCT05427903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701535|NCT05427903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138378379|NCT01448993|Azithromycin|azithromycin|mesh-list
138701536|NCT05427903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138701537|NCT05427903|Adrenergic Agents|adrenergic agents|mesh-ancestor
138701538|NCT05427903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701539|NCT05427903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701540|NCT05427903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138701541|NCT05427903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138190281|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138701543|NCT05427903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701544|NCT05427903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138701545|NCT05427903|Respiratory System Agents|respiratory system agents|mesh-ancestor
138701546|NCT05427903|Mydriatics|mydriatics|mesh-ancestor
138701547|NCT05427903|Sympathomimetics|sympathomimetics|mesh-ancestor
138701548|NCT05427903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138701549|NCT05427903|Sensory System Agents|sensory system agents|mesh-ancestor
138701550|NCT05427747|Meropenem|meropenem|mesh-list
138701552|NCT05427747|Cefoxitin|cefoxitin|mesh-list
138701553|NCT05427747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138701554|NCT05427747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701555|NCT00445406|Bevacizumab|bevacizumab|mesh-list
138701556|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138701557|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701558|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138701559|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138701560|NCT00445406|Growth Substances|growth substances|mesh-ancestor
138701561|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701562|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
138701563|NCT00445523|Interferons|interferons|mesh-list
138701564|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
138701565|NCT00445523|Vaccines|vaccines|mesh-list
138701566|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701567|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
138701568|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701569|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
138701570|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701571|NCT02903004|Paclitaxel|paclitaxel|mesh-list
138701572|NCT02903004|Carboplatin|carboplatin|mesh-list
138701573|NCT02903004|Gemcitabine|gemcitabine|mesh-list
138701574|NCT02903004|Doxorubicin|doxorubicin|mesh-list
138701575|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138701576|NCT02903004|Topotecan|topotecan|mesh-list
138701577|NCT02903004|Trabectedin|trabectedin|mesh-list
138701578|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138701580|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
138701581|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
138701582|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
138183626|NCT05455918|Ifosfamide|ifosfamide|mesh-list
138449546|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
138701583|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701584|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138701585|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
138701586|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138701587|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138701588|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138701589|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701590|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138701591|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138701592|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
138701593|NCT00445796|Artesunate|artesunate|mesh-list
138701594|NCT00445796|Amodiaquine|amodiaquine|mesh-list
138701595|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
138701596|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138701597|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138701598|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701599|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701600|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
138701601|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
138701602|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138701603|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
138701604|NCT01225822|Enoxaparin|enoxaparin|mesh-list
138701605|NCT01225822|Dabigatran|dabigatran|mesh-list
138701606|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
138701607|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138701608|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138701609|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701610|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
138378461|NCT01449357|Zalutumumab|zalutumumab|mesh-list
138701611|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138701612|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
138701613|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701614|NCT00445874|Ketotifen|ketotifen|mesh-list
138701615|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
138701616|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
138701617|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138190288|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
138701618|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
138701619|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
138701620|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701621|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701622|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701623|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138701624|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138701625|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138701627|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138701628|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138701629|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
138701630|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701631|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701632|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138701633|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
138701634|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
138701635|NCT01225549|Hormones|hormones|mesh-ancestor
138701636|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138701637|NCT05469685|Amoxicillin|amoxicillin|mesh-list
138701638|NCT05469685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138701639|NCT05469685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701640|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
138701641|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701642|NCT00446069|Morphine|morphine|mesh-list
138701643|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138701644|NCT00446069|Narcotics|narcotics|mesh-ancestor
138701645|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701646|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701647|NCT00446069|Analgesics|analgesics|mesh-ancestor
138701648|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
138175278|NCT00721513|Docetaxel|docetaxel|mesh-list
138701649|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701650|NCT02902653|Misoprostol|misoprostol|mesh-list
138701651|NCT02902653|Dinoprostone|dinoprostone|mesh-list
138701652|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138701653|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
138701654|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138701655|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701656|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138701657|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138701658|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
138701659|NCT00446303|Azacitidine|azacitidine|mesh-list
138701660|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138701661|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
138701662|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701663|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701664|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701665|NCT01223404|Mecamylamine|mecamylamine|mesh-list
138701666|NCT01223404|Nicotine|nicotine|mesh-list
138701667|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138701668|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
138701669|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701670|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701671|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138701672|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138701673|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
138701674|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701675|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701676|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138701677|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138701678|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138701679|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138701680|NCT00446420|Midazolam|midazolam|mesh-list
138701681|NCT00446420|Fentanyl|fentanyl|mesh-list
138701682|NCT00446420|Propofol|propofol|mesh-list
138701683|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138701684|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701685|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701686|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138701688|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
138701689|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138701690|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138701691|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138701692|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138701693|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
138701694|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
138701695|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701696|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701697|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138701698|NCT00446420|Narcotics|narcotics|mesh-ancestor
138701699|NCT00446420|Analgesics|analgesics|mesh-ancestor
138701700|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
138701701|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701702|NCT00446537|Methylphenidate|methylphenidate|mesh-list
138449569|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
138701703|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138701704|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701705|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138701706|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138701707|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138701708|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701709|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
138701710|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701711|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
138701712|NCT00446576|Hematinics|hematinics|mesh-ancestor
138701713|NCT02902302|Ibuprofen|ibuprofen|mesh-list
138701714|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138701715|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138701716|NCT02902302|Analgesics|analgesics|mesh-ancestor
138701717|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
138701718|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701719|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138175365|NCT03809455|Analgesics|analgesics|mesh-ancestor
138701720|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138701721|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138701722|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138701723|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701724|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701725|NCT01223365|Hydrocodone|hydrocodone|mesh-list
138701726|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138701727|NCT01223365|Narcotics|narcotics|mesh-ancestor
138701728|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701729|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701730|NCT01223365|Analgesics|analgesics|mesh-ancestor
138701731|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
138701732|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701733|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
138701734|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
138701735|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
138701736|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138701737|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701738|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138701739|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701740|NCT04319419|Micronutrients|micronutrients|mesh-list
138701741|NCT04319419|Trace Elements|trace elements|mesh-list
138701742|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701743|NCT05657704|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138701744|NCT05657704|Tramadol|tramadol|mesh-list
138701745|NCT05657704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138701746|NCT05657704|Narcotics|narcotics|mesh-ancestor
138701747|NCT05657704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701748|NCT05657704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701749|NCT05657704|Analgesics|analgesics|mesh-ancestor
138701750|NCT05657704|Sensory System Agents|sensory system agents|mesh-ancestor
138701751|NCT05657704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449604|NCT01864616|Vitamin D|vitamin d|mesh-list
138701752|NCT05657704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138701753|NCT05657704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138701754|NCT05657704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138701755|NCT05657704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138701756|NCT00446771|Mannitol|mannitol|mesh-list
138701757|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138701758|NCT00446771|Diuretics|diuretics|mesh-ancestor
138701759|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
138701760|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701761|NCT04317157|Caffeine|caffeine|mesh-list
138701762|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138701763|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701764|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138701765|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701766|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701767|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138701768|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138701769|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
138701770|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701771|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
138701772|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701773|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
138701774|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701775|NCT04317079|Protective Agents|protective agents|mesh-ancestor
138175452|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
138701776|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701777|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138701779|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138701780|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
138701781|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701782|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138701783|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701784|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701785|NCT04699214|Endostar protein|endostar protein|mesh-list
138701786|NCT04699214|Endostatins|endostatins|mesh-list
138701787|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138701788|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138701789|NCT04699214|Growth Substances|growth substances|mesh-ancestor
138701790|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701791|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
138701792|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701793|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
138350192|NCT06084624|Antioxidants|antioxidants|mesh-ancestor
138701795|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701796|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701797|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138701798|NCT02902380|Analgesics|analgesics|mesh-ancestor
138701799|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
138701800|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701801|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138701802|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138701803|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138701804|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
138701805|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701806|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701807|NCT01221727|Denosumab|denosumab|mesh-list
138701808|NCT01221727|Midazolam|midazolam|mesh-list
138701809|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138701810|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138701811|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138701812|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701813|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138701815|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138701816|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138701817|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
138701818|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
138701819|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
138701820|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
138701821|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701822|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138183751|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138183752|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
138701823|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138701824|NCT01221181|Eculizumab|eculizumab|mesh-list
138701825|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138701826|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138701827|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
138701828|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701829|NCT03277079|Ezetimibe|ezetimibe|mesh-list
138701830|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138701831|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138701832|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138701833|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
138701834|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701835|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138701836|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701837|NCT01220557|Insulin|insulin|mesh-list
138701838|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138350233|NCT06083935|Contraceptives, Oral|contraceptives, oral|mesh-list
138701839|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701840|NCT04317001|Modafinil|modafinil|mesh-list
138701842|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701843|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138701844|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138701845|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138701846|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701847|NCT05426499|Fluconazole|fluconazole|mesh-list
138701848|NCT05426499|Isavuconazole|isavuconazole|mesh-list
138701849|NCT05426499|Anidulafungin|anidulafungin|mesh-list
138701850|NCT05426499|Meropenem|meropenem|mesh-list
138701851|NCT05426499|Cefotaxime|cefotaxime|mesh-list
138701852|NCT05426499|Cefoxitin|cefoxitin|mesh-list
138701853|NCT05426499|Antifungal Agents|antifungal agents|mesh-ancestor
138701854|NCT05426499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701855|NCT05426499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138701856|NCT05426499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138701857|NCT05426499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701858|NCT05426499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701859|NCT05426499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138701860|NCT05426499|Hormone Antagonists|hormone antagonists|mesh-ancestor
138701861|NCT05426499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138701862|NCT05426499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701863|NCT05426499|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138701864|NCT05426499|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138701865|NCT05426499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138701866|NCT00446810|Benphothiamine|benphothiamine|mesh-list
138175579|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
138701867|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138701868|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
138701869|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701870|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
138701871|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
138701872|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701873|NCT01220167|Ondansetron|ondansetron|mesh-list
138701874|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
138701875|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
138701876|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701877|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701878|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138701879|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
138701880|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
138701881|NCT01220167|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138701882|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138701883|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
138701884|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701885|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701886|NCT00447239|Insulin|insulin|mesh-list
138701887|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138701888|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701889|NCT05425914|Vitamin D|vitamin d|mesh-list
138701890|NCT05425914|Lubricant Eye Drops|lubricant eye drops|mesh-list
138701891|NCT05425914|Vitamins|vitamins|mesh-ancestor
138701892|NCT05425914|Micronutrients|micronutrients|mesh-ancestor
138701893|NCT05425914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701894|NCT05425914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138701895|NCT05425914|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138701896|NCT05425914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138701897|NCT00447356|Interferons|interferons|mesh-list
138701898|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
138701899|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701900|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
138183825|NCT02778880|Fentanyl|fentanyl|mesh-list
138701901|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701902|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
138701903|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701905|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
138701906|NCT00447473|Analgesics|analgesics|mesh-ancestor
138701907|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
138701908|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701909|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701910|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701911|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138701912|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138701913|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138701914|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701915|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
138701916|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138701917|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138701918|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138701919|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138701920|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
138701921|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138701922|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138701923|NCT00553488|Insulin|insulin|mesh-list
138701924|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138701925|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
138701926|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138701927|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701928|NCT03455322|Octreotide|octreotide|mesh-list
138701929|NCT03455322|Norepinephrine|norepinephrine|mesh-list
138701930|NCT03455322|Midodrine|midodrine|mesh-list
138701931|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138701932|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138701933|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
138701934|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701935|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701936|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701937|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
138701939|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138701940|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138701941|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138701942|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138701943|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701944|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138701946|NCT05425368|Cariostatic Agents|cariostatic agents|mesh-ancestor
138701947|NCT05425368|Protective Agents|protective agents|mesh-ancestor
138701948|NCT05425368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701949|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
138701950|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138701951|NCT00447863|Estradiol|estradiol|mesh-list
138701952|NCT00447863|Estrogens|estrogens|mesh-ancestor
138701953|NCT00447863|Hormones|hormones|mesh-ancestor
138701954|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138701955|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701956|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138701957|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
138701958|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138701959|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138701960|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138701961|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138701962|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138701963|NCT00448097|Docetaxel|docetaxel|mesh-list
138701964|NCT00448097|Cetuximab|cetuximab|mesh-list
138701965|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138701966|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
138701967|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
138701968|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
138701969|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701970|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138701972|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
138701973|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
138701974|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
138701975|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701976|NCT00448292|Naluzotan|naluzotan|mesh-list
138701977|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138701978|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138701979|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
138701980|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138701981|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138701982|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701983|NCT02901561|Misoprostol|misoprostol|mesh-list
138701984|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138701985|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
138701986|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138701987|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701988|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138701989|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138701990|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
138701991|NCT00448409|Sargramostim|sargramostim|mesh-list
138378836|NCT05961761|Pembrolizumab|pembrolizumab|mesh-list
138701992|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
138701993|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138701994|NCT02901366|Dotinurad|dotinurad|mesh-list
138701995|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
138701996|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
138701997|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138701998|NCT03276689|Pregabalin|pregabalin|mesh-list
138350370|NCT05612984|Aspirin|aspirin|mesh-list
138701999|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138702000|NCT03276689|Analgesics|analgesics|mesh-ancestor
138702001|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
138702002|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702003|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702005|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138702006|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138702007|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702008|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138702009|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138702010|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138702011|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138702012|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138702013|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138702014|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138702015|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702016|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
138702017|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
138702018|NCT01220128|Paclitaxel|paclitaxel|mesh-list
138702019|NCT01220128|Docetaxel|docetaxel|mesh-list
138702020|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
138702021|NCT01220128|Carboplatin|carboplatin|mesh-list
138702022|NCT01220128|Doxorubicin|doxorubicin|mesh-list
138702023|NCT01220128|Fluorouracil|fluorouracil|mesh-list
138702024|NCT01220128|Trastuzumab|trastuzumab|mesh-list
138702025|NCT01220128|Epirubicin|epirubicin|mesh-list
138702026|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138702027|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138702028|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702029|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
138702030|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
138702031|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
138702032|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702033|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138702034|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
138702035|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702036|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702037|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138702038|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
138702039|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138702040|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138702041|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138702042|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138702043|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702044|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
138702045|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138702046|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138702047|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138702048|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138702049|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
138183974|NCT01832363|Xenon|xenon|mesh-list
138183975|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138702050|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702052|NCT04698941|Simvastatin|simvastatin|mesh-list
138702053|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138702054|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702055|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
138702056|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
138702057|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
138702058|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702059|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138702060|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138702061|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
138702062|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138702063|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138702064|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138378911|NCT05960617|Empagliflozin|empagliflozin|mesh-list
138702066|NCT02901288|Rifampin|rifampin|mesh-list
138702068|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
138702069|NCT02901288|Ethambutol|ethambutol|mesh-list
138702070|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138702071|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702072|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138702073|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138702074|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138702075|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702076|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702077|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702078|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138702079|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138702080|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138702081|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
138702082|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
138702083|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138702084|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138702085|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138702086|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138702087|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138702088|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138702089|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138702090|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138788173|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138788175|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138788176|NCT00640588|Telbivudine|telbivudine|mesh-list
138788177|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
138788178|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788179|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138788180|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138788181|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788182|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788183|NCT05663398|Ibuprofen|ibuprofen|mesh-list
138788184|NCT05663398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138788185|NCT05663398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138788186|NCT05663398|Analgesics|analgesics|mesh-ancestor
138788187|NCT05663398|Sensory System Agents|sensory system agents|mesh-ancestor
138788188|NCT05663398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788189|NCT05663398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788190|NCT05663398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138788191|NCT05663398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138788192|NCT05663398|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138788193|NCT05663398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788194|NCT05663398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788195|NCT00640744|Atorvastatin|atorvastatin|mesh-list
138788196|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138788197|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138788198|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
138788199|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788200|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138788201|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138788202|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788203|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
138788204|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138788205|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138788206|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788207|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
138788208|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
138788209|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138184049|NCT00013897|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138788211|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
138788212|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138788213|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138788214|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788215|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
138788216|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138788217|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138702091|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138788218|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138788219|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788220|NCT04183114|Vaccines|vaccines|mesh-list
138788221|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
138788222|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788224|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
138788225|NCT00996996|Antibodies|antibodies|mesh-list
138788226|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
138788227|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
138788228|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788229|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138788230|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138175987|NCT02144675|Salicylates|salicylates|mesh-list
138788231|NCT00996996|Trace Elements|trace elements|mesh-ancestor
138788232|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
138788233|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788234|NCT04182568|Paclitaxel|paclitaxel|mesh-list
138788235|NCT04182568|Docetaxel|docetaxel|mesh-list
138788236|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
138788237|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138788238|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788239|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
138788240|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
138788241|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
138788242|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788243|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138788244|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
138788245|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788246|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138788247|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138788248|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
138788249|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138788250|NCT00641446|Budesonide|budesonide|mesh-list
138788251|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138788252|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138788253|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
138788254|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788255|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184070|NCT04347577|Analgesics|analgesics|mesh-ancestor
138788256|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138788257|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
138788260|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138788261|NCT05663164|Thiamine|thiamine|mesh-list
138788262|NCT05663164|Vitamins|vitamins|mesh-ancestor
138788263|NCT05663164|Micronutrients|micronutrients|mesh-ancestor
138788264|NCT05663164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788265|NCT05663164|Vitamin B Complex|vitamin b complex|mesh-ancestor
138788266|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
138788267|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138788268|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788269|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138788270|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788271|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
138788272|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138788273|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788274|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788275|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138788276|NCT02678728|Analgesics|analgesics|mesh-ancestor
138788277|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
138788278|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788279|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138788280|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138788281|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138788282|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
138788283|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788284|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788285|NCT04180072|Bevacizumab|bevacizumab|mesh-list
138788286|NCT04180072|Atezolizumab|atezolizumab|mesh-list
138788287|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138788288|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788289|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138176073|NCT00638456|Budesonide|budesonide|mesh-list
138788290|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138788291|NCT04180072|Growth Substances|growth substances|mesh-ancestor
138788292|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788293|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
138788294|NCT04180072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138788295|NCT04180072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788296|NCT02678650|Anesthetics|anesthetics|mesh-list
138788297|NCT02678650|Propofol|propofol|mesh-list
138788298|NCT02678650|Isoflurane|isoflurane|mesh-list
138788299|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788300|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788301|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138788302|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138788303|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
138788304|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138788305|NCT04180150|Entecavir|entecavir|mesh-list
138788306|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
138788307|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788308|NCT02678338|Magrolimab|magrolimab|mesh-list
138788309|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138788310|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788311|NCT00642226|Triamcinolone|triamcinolone|mesh-list
138788312|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138788313|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
138788314|NCT00642226|Hormones|hormones|mesh-ancestor
138788315|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138788316|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788317|NCT02675530|Ketamine|ketamine|mesh-list
138788318|NCT02675530|Analgesics|analgesics|mesh-ancestor
138788319|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
138788320|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788321|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788322|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138788323|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138788324|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
138788325|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
138788326|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788327|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138788328|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138788329|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788330|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788331|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
138788332|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138788333|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
138788334|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
138788335|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788336|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788337|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788338|NCT02678260|Spartalizumab|spartalizumab|mesh-list
138788339|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138788340|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788341|NCT02678260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138788342|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788343|NCT04179604|Simendan|simendan|mesh-list
138788344|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138788345|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
138184138|NCT03219671|Nivolumab|nivolumab|mesh-list
138788346|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138788347|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138788348|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788349|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788350|NCT04179604|Protective Agents|protective agents|mesh-ancestor
138788351|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788352|NCT02675140|Vitamins|vitamins|mesh-list
138788353|NCT02675140|Vitamin A|vitamin a|mesh-list
138788354|NCT02675140|Albendazole|albendazole|mesh-list
138788355|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
138788356|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
138788357|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788358|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
138788359|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788360|NCT02675140|Protective Agents|protective agents|mesh-ancestor
138788361|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138788362|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788363|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
138788364|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138788365|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788366|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
138788367|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138788368|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138788369|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
138788370|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
138788371|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
138788373|NCT02674906|Calcium heparin|calcium heparin|mesh-list
138788374|NCT02674906|Anticoagulants|anticoagulants|mesh-list
138788375|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788376|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138788377|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138788378|NCT01160744|Carboplatin|carboplatin|mesh-list
138788379|NCT01160744|Gemcitabine|gemcitabine|mesh-list
138788380|NCT01160744|Pemetrexed|pemetrexed|mesh-list
138788381|NCT01160744|Ramucirumab|ramucirumab|mesh-list
138788382|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138788383|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788384|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138788385|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
138788386|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788388|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138788389|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138788390|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
138788391|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788392|NCT02677246|Denosumab|denosumab|mesh-list
138788393|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138788394|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788395|NCT01160354|Plerixafor|plerixafor|mesh-list
138788396|NCT01160354|Clofarabine|clofarabine|mesh-list
138788397|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138788398|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
138788399|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788400|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788401|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138788402|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138788403|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
138788404|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788405|NCT04178512|Dexamethasone|dexamethasone|mesh-list
138788406|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
138788407|NCT04178512|Fentanyl|fentanyl|mesh-list
138788408|NCT04178512|BB 1101|bb 1101|mesh-list
138788409|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138788410|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
138788411|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
138788412|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788413|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788414|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138788415|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
138788416|NCT04178512|Hormones|hormones|mesh-ancestor
138788417|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138788418|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138788419|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788420|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
138788421|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788422|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788423|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138788424|NCT04178512|Narcotics|narcotics|mesh-ancestor
138788425|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788426|NCT04178512|Analgesics|analgesics|mesh-ancestor
138788427|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
138788428|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138788430|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
138788431|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
138788432|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
138788433|NCT01160198|Chelating Agents|chelating agents|mesh-list
138788434|NCT01160198|Glycine|glycine|mesh-list
138788435|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
138788436|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788437|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
138788438|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788439|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788440|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
138788441|NCT01160198|Protective Agents|protective agents|mesh-ancestor
138788442|NCT01160198|Vitamins|vitamins|mesh-ancestor
138788443|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
138788444|NCT02676934|Anesthetics|anesthetics|mesh-list
138788445|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788446|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788447|NCT05351086|Dihydroergotamine|dihydroergotamine|mesh-list
138788448|NCT05351086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138788449|NCT05351086|Dopamine Agonists|dopamine agonists|mesh-ancestor
138788450|NCT05351086|Dopamine Agents|dopamine agents|mesh-ancestor
138788451|NCT05351086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788452|NCT05351086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788453|NCT05351086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788454|NCT05351086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138788455|NCT05351086|Analgesics|analgesics|mesh-ancestor
138788456|NCT05351086|Sensory System Agents|sensory system agents|mesh-ancestor
138788457|NCT05351086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788458|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
138788459|NCT02885168|Phenylephrine|phenylephrine|mesh-list
138788460|NCT02885168|Protein C|protein c|mesh-list
138788461|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
138788462|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138788463|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
138788464|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
138788465|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788466|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788467|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
138788468|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138788469|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
138788470|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
138788471|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138190342|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788472|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138788473|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138788474|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
138788475|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788476|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788477|NCT02885168|Protective Agents|protective agents|mesh-ancestor
138184211|NCT02240719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138788478|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
138788479|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138788480|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138788481|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788482|NCT01159574|Clarithromycin|clarithromycin|mesh-list
138788483|NCT01159574|Dexamethasone|dexamethasone|mesh-list
138788484|NCT01159574|Pomalidomide|pomalidomide|mesh-list
138788485|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138788486|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
138788487|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
138788488|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788489|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788490|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138788491|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
138788492|NCT01159574|Hormones|hormones|mesh-ancestor
138788493|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138788494|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138788495|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788496|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138788497|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702092|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
138788498|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138788499|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788500|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788501|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138788502|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138788503|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
138176325|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
138788504|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138788505|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138788506|NCT01159574|Growth Substances|growth substances|mesh-ancestor
138788507|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
138788509|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138788510|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138788511|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138788512|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788513|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788514|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
138788515|NCT00910234|Hematinics|hematinics|mesh-ancestor
138788516|NCT05652322|Furosemide|furosemide|mesh-list
138788517|NCT05652322|Diuretics|diuretics|mesh-ancestor
138788518|NCT05652322|Natriuretic Agents|natriuretic agents|mesh-ancestor
138788519|NCT05652322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788520|NCT05652322|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138788521|NCT05652322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138184250|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788522|NCT05652322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788523|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
138165951|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
138788524|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138788525|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
138788526|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788528|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
138788529|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138788530|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
138788531|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788532|NCT01172288|Protective Agents|protective agents|mesh-ancestor
138788533|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788534|NCT01172288|Antidotes|antidotes|mesh-ancestor
138788535|NCT02676622|Aldesleukin|aldesleukin|mesh-list
138788536|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
138788537|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
138788538|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138788539|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
138788540|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190347|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
138788541|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138788542|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138788543|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
138449929|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138788544|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788545|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788546|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138788547|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138788548|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138788549|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
138788550|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788551|NCT00644020|Fluorouracil|fluorouracil|mesh-list
138788553|NCT00644020|Mitomycin|mitomycin|mesh-list
138788554|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
138176409|NCT01275287|Eculizumab|eculizumab|mesh-list
138788555|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788556|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138788557|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788558|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138788559|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
138788560|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788561|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138788562|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
138788563|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138788564|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788565|NCT04178980|Simvastatin|simvastatin|mesh-list
138788566|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138788567|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138788568|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
138788569|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788570|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138788571|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138788572|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788573|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
138788574|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138788575|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
138788577|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
138788578|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138788579|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138788580|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788581|NCT02672488|Metformin|metformin|mesh-list
138788582|NCT02672488|Sorafenib|sorafenib|mesh-list
138788583|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138788584|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788585|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788586|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138788587|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788588|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788589|NCT02537392|Folic Acid|folic acid|mesh-list
138788590|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
138788591|NCT02537392|Vitamins|vitamins|mesh-ancestor
138788592|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
138788593|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788594|NCT02537392|Hematinics|hematinics|mesh-ancestor
138788595|NCT02673814|Durvalumab|durvalumab|mesh-list
138788596|NCT02673814|Bavituximab|bavituximab|mesh-list
138788597|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138788598|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788599|NCT00644176|Azithromycin|azithromycin|mesh-list
138788600|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138788601|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788602|NCT04178200|Lidocaine|lidocaine|mesh-list
138788603|NCT04178200|Bupivacaine|bupivacaine|mesh-list
138788604|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138788605|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
138788606|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
138788607|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788608|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788609|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
138788610|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788611|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138788612|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138788613|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138190349|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788614|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138788615|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788616|NCT02537158|Sorafenib|sorafenib|mesh-list
138788617|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788618|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138788619|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788620|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788621|NCT02676154|Fesoterodine|fesoterodine|mesh-list
138788622|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138788623|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138788624|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
138788625|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788626|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788627|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788628|NCT02676154|Urological Agents|urological agents|mesh-ancestor
138788629|NCT02676310|Bimatoprost|bimatoprost|mesh-list
138788630|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138788631|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
138788632|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138788633|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138788634|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788635|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
138788636|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788637|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788638|NCT04180384|Paclitaxel|paclitaxel|mesh-list
138788639|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138788640|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138788641|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788642|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
138788643|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
138788644|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
138788645|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788646|NCT00643240|Antibodies|antibodies|mesh-list
138788647|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138788648|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
138788649|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788650|NCT04176328|Teicoplanin|teicoplanin|mesh-list
138788651|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138788652|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788653|NCT04177342|Fentanyl|fentanyl|mesh-list
138788654|NCT04177342|Oxycodone|oxycodone|mesh-list
138788655|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138788656|NCT04177342|Narcotics|narcotics|mesh-ancestor
138788657|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788658|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788659|NCT04177342|Analgesics|analgesics|mesh-ancestor
138788660|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
138788661|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788662|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138788663|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138788664|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
138788665|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
138788666|NCT04175158|Bevacizumab|bevacizumab|mesh-list
138788667|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
138788668|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138788669|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788670|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138788671|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138788672|NCT04175158|Growth Substances|growth substances|mesh-ancestor
138176596|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138176598|NCT01279343|Misoprostol|misoprostol|mesh-list
138788673|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788674|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
138788675|NCT02671318|Sirolimus|sirolimus|mesh-list
138788676|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138788677|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788678|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138788679|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788680|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
138788681|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138788682|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
138788683|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788684|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
138788685|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
138788686|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
138788687|NCT02668588|Octreotide|octreotide|mesh-list
138788688|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138788689|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138788690|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788691|NCT02671084|Sevoflurane|sevoflurane|mesh-list
138788692|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138788693|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138788694|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
138788695|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
138788696|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788697|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788698|NCT00644800|Ziprasidone|ziprasidone|mesh-list
138788699|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138788700|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
138788701|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788702|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788703|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788704|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138788705|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138788706|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788707|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138788708|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138788709|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
138788710|NCT02670616|Prednisolone|prednisolone|mesh-list
138176646|NCT04387097|Analgesics|analgesics|mesh-ancestor
138788711|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
138788713|NCT02670616|Doxorubicin|doxorubicin|mesh-list
138788714|NCT02670616|Vincristine|vincristine|mesh-list
138788715|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138788716|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
138788717|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788718|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138788719|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138788720|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
138788721|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788722|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788723|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138788724|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138788725|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138788726|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138788727|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138788728|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788729|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138788730|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
138788731|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
138788732|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
138788733|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138788734|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
138788735|NCT02670616|Hormones|hormones|mesh-ancestor
138788736|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138176688|NCT00750815|Bortezomib|bortezomib|mesh-list
138788737|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138788738|NCT00645502|Risperidone|risperidone|mesh-list
138788739|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138788740|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
138788741|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788742|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788743|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788744|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138788745|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138788746|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788747|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138788748|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138788749|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
138788750|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
138788752|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
138788753|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138788754|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138788755|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788756|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788757|NCT00644956|Urological Agents|urological agents|mesh-ancestor
138788758|NCT04175002|Progesterone|progesterone|mesh-list
138190352|NCT02178241|Gemcitabine|gemcitabine|mesh-list
138788759|NCT04175002|Progestins|progestins|mesh-ancestor
138788761|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138788762|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788764|NCT02670772|Stavudine|stavudine|mesh-list
138788765|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
138788766|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788767|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138788768|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138788769|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138184396|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
138788770|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788771|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138788772|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138788773|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
138788774|NCT02667730|Acetaminophen|acetaminophen|mesh-list
138788776|NCT02667730|Naproxen|naproxen|mesh-list
138788777|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138788778|NCT02667730|Analgesics|analgesics|mesh-ancestor
138788779|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
138788780|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788781|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788782|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
138788783|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138788784|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138788785|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138788786|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138788787|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138788788|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788789|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788790|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
138788791|NCT04294992|Ondansetron|ondansetron|mesh-list
138788792|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
138788793|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
138788794|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788795|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788796|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138788797|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
138788798|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
138788799|NCT04294992|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138788800|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138788801|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
138788802|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788803|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788804|NCT00628914|Dexetimide|dexetimide|mesh-list
138788806|NCT00628914|Citalopram|citalopram|mesh-list
138788807|NCT00628914|Escitalopram|escitalopram|mesh-list
138788808|NCT00628914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138788809|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138788810|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138788811|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788812|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788813|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
138788814|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788815|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138788816|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138788817|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
138788818|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
138788819|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788820|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138788821|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138788822|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
138788823|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138788824|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
138788825|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138788826|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138788827|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788828|NCT02870634|Copper|copper|mesh-list
138788830|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
138788831|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788832|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
138788833|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138788834|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138788835|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788836|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788837|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138788838|NCT00645580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138788839|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138788840|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138788841|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788842|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788843|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
138788844|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138788845|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
138788846|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138788847|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138788848|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788849|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138788850|NCT02670304|Aspirin|aspirin|mesh-list
138788851|NCT02670304|Letrozole|letrozole|mesh-list
138788852|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138788853|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138788854|NCT02670304|Analgesics|analgesics|mesh-ancestor
138788855|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
138788856|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788857|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788858|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138788859|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138788860|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138788861|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138788862|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788863|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138788864|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138788865|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788866|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
138788867|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788868|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138788869|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138788870|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138788871|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
138788872|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138788873|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
138788874|NCT02671708|Busulfan|busulfan|mesh-list
138788875|NCT02671708|Idarubicin|idarubicin|mesh-list
138788876|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138788877|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
138788878|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788879|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138788880|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138788881|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
138788882|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788883|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788884|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138788885|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138788886|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138788887|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138788888|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788889|NCT00998946|Vitamins|vitamins|mesh-list
138788890|NCT00998946|Folic Acid|folic acid|mesh-list
138788891|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
138788892|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
138788893|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
138788894|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
138788895|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788896|NCT00998946|Hematinics|hematinics|mesh-ancestor
138788897|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788898|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138788899|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138166319|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
138788900|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788901|NCT01158404|LY900009|ly900009|mesh-list
138788902|NCT01158404|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138788903|NCT01158404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788904|NCT01158404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788905|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138788906|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138788907|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138788908|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
138788909|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788910|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138788911|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138788912|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788913|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
138788914|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
138788915|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138788916|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138788917|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788918|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788919|NCT00645034|Urological Agents|urological agents|mesh-ancestor
138788920|NCT04173832|Amantadine|amantadine|mesh-list
138788921|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138788922|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138788923|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
138788924|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788925|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
138788926|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138788927|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788928|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788929|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138788930|NCT04173832|Analgesics|analgesics|mesh-ancestor
138788931|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
138788932|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788933|NCT00645658|Testosterone|testosterone|mesh-list
138788934|NCT00645658|Androgens|androgens|mesh-ancestor
138788936|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138788937|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788938|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
138788939|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
138788940|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788941|NCT02666170|Protective Agents|protective agents|mesh-ancestor
138788942|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788943|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
138788944|NCT02666170|Vitamins|vitamins|mesh-ancestor
138788945|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
138788946|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
138788947|NCT02667262|Narcotics|narcotics|mesh-ancestor
138788948|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138788949|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788950|NCT02667262|Analgesics|analgesics|mesh-ancestor
138788951|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
138788952|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138788953|NCT00646126|Artesunate|artesunate|mesh-list
138788954|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
138788955|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
138788956|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
138788957|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138788958|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138788959|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788960|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138788961|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
138788962|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
138788963|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138788964|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
138788965|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138788966|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138788967|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788968|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138788969|NCT02537080|Nimodipine|nimodipine|mesh-list
138788970|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138788971|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138788972|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138176917|NCT00786643|Antidotes|antidotes|mesh-ancestor
138788973|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138788974|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138190361|NCT03015727|Docetaxel|docetaxel|mesh-list
138788975|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788976|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
138788977|NCT02667496|Sargramostim|sargramostim|mesh-list
138788978|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
138788979|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788980|NCT00645112|Azithromycin|azithromycin|mesh-list
138788981|NCT00645112|Cefdinir|cefdinir|mesh-list
138788982|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138788983|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138788984|NCT02666092|Antibodies|antibodies|mesh-list
138788985|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
138788986|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788987|NCT00645814|Adalimumab|adalimumab|mesh-list
138788988|NCT00645814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138788989|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138788990|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138788991|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138788992|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
138788993|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138788994|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
138788995|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138788996|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138788997|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138788998|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138788999|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789000|NCT00645892|Adalimumab|adalimumab|mesh-list
138789001|NCT00645892|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138789002|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138789003|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138789004|NCT00645190|Galantamine|galantamine|mesh-list
138789005|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138789006|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789007|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789008|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
138789009|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138176963|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138789010|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789011|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138789012|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
138789013|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789014|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
138789015|NCT00910390|Ethylene|ethylene|mesh-list
138789016|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
138789017|NCT00910390|Growth Substances|growth substances|mesh-ancestor
138789018|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789019|NCT02665936|Dexamethasone|dexamethasone|mesh-list
138789020|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
138789021|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
138789022|NCT02665936|BB 1101|bb 1101|mesh-list
138789023|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138789024|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
138789025|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
138789026|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789027|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789028|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138789029|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
138789030|NCT02665936|Hormones|hormones|mesh-ancestor
138789031|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789032|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138789033|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789034|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
138789035|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789036|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789037|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
138789038|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
138789039|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789040|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
138789041|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
138789042|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138789043|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789045|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789046|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138789047|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
138789048|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789049|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138166546|NCT04029350|Osimertinib|osimertinib|mesh-list
138789050|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789051|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138177013|NCT00789997|Prednisone|prednisone|mesh-list
138789052|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138789053|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138789054|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
138789055|NCT04292418|Tacrolimus|tacrolimus|mesh-list
138184488|NCT01836575|Carboplatin|carboplatin|mesh-list
138789056|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138789057|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
138789058|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789059|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138789060|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789061|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789062|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138789063|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789064|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138789065|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
138789066|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138789067|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789069|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
138789070|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789071|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138789072|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138789073|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789074|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789075|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138789076|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
138789077|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789078|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789079|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138789080|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138789081|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138789082|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138789083|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138789084|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789085|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789086|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138789087|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138789088|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138789089|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
138789090|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789091|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789092|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138789093|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138789094|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
138789095|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
138789096|NCT02669368|Rocuronium|rocuronium|mesh-list
138789097|NCT02669368|Analgesics|analgesics|mesh-ancestor
138789098|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
138789099|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789100|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789101|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
138789102|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138184506|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
138177040|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
138789103|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138789104|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
138789105|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138789106|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138789107|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789108|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138789109|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
138789110|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138789111|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138789112|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138789113|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138789114|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
138789115|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
138789116|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138789117|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138789118|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789119|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789120|NCT00645268|Urological Agents|urological agents|mesh-ancestor
138789121|NCT02666014|Neostigmine|neostigmine|mesh-list
138789122|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138789123|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789124|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789125|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
138789126|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789127|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789128|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138789129|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
138789130|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789131|NCT02665702|Cisplatin|cisplatin|mesh-list
138789132|NCT02665702|Vinorelbine|vinorelbine|mesh-list
138789133|NCT02665702|Endostar protein|endostar protein|mesh-list
138789134|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789135|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138789136|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
138789137|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
138789138|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
138789139|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789141|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138789142|NCT02665702|Growth Substances|growth substances|mesh-ancestor
138789143|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789144|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
138789145|NCT00646750|Rituximab|rituximab|mesh-list
138789146|NCT00646750|Melphalan|melphalan|mesh-list
138789147|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138789148|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789149|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
138789150|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789151|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138789152|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138789153|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
138184524|NCT01837043|Cyclosporine|cyclosporine|mesh-list
138789154|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789155|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138789156|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138789157|NCT00646516|Budesonide|budesonide|mesh-list
138789158|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
138789159|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138789160|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138789161|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138789162|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
138789163|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789164|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789165|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138789166|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
138789167|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
138789168|NCT00646516|Hormones|hormones|mesh-ancestor
138789169|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789170|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138789171|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138789172|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138789173|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
138789174|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789175|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789176|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
138789177|NCT02665624|Sennosides|sennosides|mesh-list
138789178|NCT02665624|Senna Extract|senna extract|mesh-list
138789179|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138789180|NCT02665624|Calcium|calcium|mesh-list
138789181|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138789182|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789183|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138789184|NCT02665624|Laxatives|laxatives|mesh-ancestor
138789185|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138789186|NCT02665624|Cathartics|cathartics|mesh-ancestor
138789187|NCT00646594|Fluticasone|fluticasone|mesh-list
138789188|NCT00646594|Budesonide|budesonide|mesh-list
138789189|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
138789190|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138789191|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138789192|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138789193|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138789194|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138789195|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
138789196|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789197|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789198|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138789199|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
138789200|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
138789201|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138789202|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
138789203|NCT00646594|Hormones|hormones|mesh-ancestor
138789204|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789205|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138789206|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138789207|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138789208|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
138789209|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789210|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789211|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
138789212|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138789213|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
138789214|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789215|NCT00647140|Levodopa|levodopa|mesh-list
138789216|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
138789217|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789218|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789219|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789220|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138789221|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138789222|NCT00647218|Paclitaxel|paclitaxel|mesh-list
138789223|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138789224|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789225|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
138789226|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
138789227|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
138789228|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789229|NCT00994890|Tanezumab|tanezumab|mesh-list
138789230|NCT00994890|Analgesics|analgesics|mesh-ancestor
138789231|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
138789232|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789233|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789234|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
138789235|NCT02663830|Clomiphene|clomiphene|mesh-list
138789236|NCT02663830|Enclomiphene|enclomiphene|mesh-list
138789237|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
138789238|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789239|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
138789240|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138789241|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138789242|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789243|NCT02663830|Urological Agents|urological agents|mesh-ancestor
138789244|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138789245|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
138789246|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789247|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789248|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138789249|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
138789250|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138789251|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138789252|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138789253|NCT00648544|Pravastatin|pravastatin|mesh-list
138789254|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138789255|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138789256|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
138789257|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789258|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138789259|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138789260|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789261|NCT00648622|Carvedilol|carvedilol|mesh-list
138789262|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138789263|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138789264|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
138789265|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789266|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789267|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789268|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138789269|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
138789270|NCT00648622|Protective Agents|protective agents|mesh-ancestor
138789271|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138789272|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138789273|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138789274|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
138789275|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138450188|NCT01869621|Metformin|metformin|mesh-list
138789276|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138789278|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138789279|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789280|NCT00648778|Loxapine|loxapine|mesh-list
138789281|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138789282|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138789283|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789284|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789285|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138789286|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138789287|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
138789288|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789289|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789290|NCT00645424|Atorvastatin|atorvastatin|mesh-list
138789291|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138789292|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138789293|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
138789294|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789295|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138789296|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138789297|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789298|NCT04172740|Calcium|calcium|mesh-list
138789299|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138789300|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789301|NCT02663596|Vancomycin|vancomycin|mesh-list
138789302|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138789303|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789304|NCT00647530|Capecitabine|capecitabine|mesh-list
138789305|NCT00647530|Fluorouracil|fluorouracil|mesh-list
138789306|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
138789307|NCT00647530|Panitumumab|panitumumab|mesh-list
138789308|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138789309|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
138789310|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789311|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789312|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138789313|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
138789314|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789315|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138789316|NCT00647608|Propranolol|propranolol|mesh-list
138789317|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138789318|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138789319|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
138789320|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789321|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789322|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789323|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138789324|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138789325|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
138789326|NCT02663440|Temozolomide|temozolomide|mesh-list
138789327|NCT02663440|Molgramostim|molgramostim|mesh-list
138789328|NCT02663440|Sargramostim|sargramostim|mesh-list
138789329|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138789330|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
138789331|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789332|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789333|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
138789334|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789335|NCT04171180|Budesonide|budesonide|mesh-list
138789336|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
138789337|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138789338|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138789339|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
138789340|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789341|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789342|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138789343|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
138789345|NCT04171180|Hormones|hormones|mesh-ancestor
138789346|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789347|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138789348|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138789349|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138789350|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
138789351|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789352|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789353|NCT02660008|Glucagon|glucagon|mesh-list
138789354|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138789355|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138789356|NCT02660008|Hormones|hormones|mesh-ancestor
138789357|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789358|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789359|NCT02660008|Incretins|incretins|mesh-ancestor
138789360|NCT00649168|Bromocriptine|bromocriptine|mesh-list
138789361|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138789362|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138789363|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
138789364|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789365|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789366|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
138789367|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
138789368|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789369|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789370|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
138789371|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138789372|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138789373|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789374|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
138789375|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789376|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789377|NCT02663284|Ropivacaine|ropivacaine|mesh-list
138789378|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
138789379|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
138789380|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789381|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789382|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
138789383|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789384|NCT00647686|Fentanyl|fentanyl|mesh-list
138789385|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138190393|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789386|NCT00647686|Narcotics|narcotics|mesh-ancestor
138789387|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789388|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789389|NCT00647686|Analgesics|analgesics|mesh-ancestor
138789390|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
138789391|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789392|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138789393|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138789394|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
138789395|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
138789396|NCT02663050|Diclofenac|diclofenac|mesh-list
138177266|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
138789397|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138789398|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138789399|NCT02663050|Analgesics|analgesics|mesh-ancestor
138789400|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
138789401|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789402|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789403|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138789405|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138789406|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789407|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789408|NCT00648856|Sertraline|sertraline|mesh-list
138789409|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
138789410|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138789411|NCT00648856|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138789412|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138789413|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138789414|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789415|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789416|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
138789417|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789418|NCT01171976|Ranibizumab|ranibizumab|mesh-list
138789419|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138789420|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138789421|NCT01171976|Growth Substances|growth substances|mesh-ancestor
138789422|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789423|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
138789424|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789425|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
138789426|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789427|NCT00647842|Fentanyl|fentanyl|mesh-list
138789428|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138789429|NCT00647842|Narcotics|narcotics|mesh-ancestor
138789430|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789431|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789432|NCT00647842|Analgesics|analgesics|mesh-ancestor
138789433|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
138184675|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138789434|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789435|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138789436|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138789437|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
138789438|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
138789439|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
138789440|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138789441|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138789442|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138789443|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138789444|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789445|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
138789446|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789447|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789448|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138789449|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789450|NCT02662894|Valsartan|valsartan|mesh-list
138789451|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138789452|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138190395|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138789453|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138789454|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
138789455|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789456|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138789457|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138789458|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789459|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138789460|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138789461|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138789462|NCT04291794|Propofol|propofol|mesh-list
138789463|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138702094|NCT00448643|Cisplatin|cisplatin|mesh-list
138789464|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789465|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789466|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138789467|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
138789468|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
138789469|NCT02662660|Acetaminophen|acetaminophen|mesh-list
138789470|NCT02662660|Dipyrone|dipyrone|mesh-list
138789471|NCT02662660|Bupivacaine|bupivacaine|mesh-list
138789472|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
138789473|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
138789474|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
138789475|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789476|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789477|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
138789478|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789479|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138789480|NCT02662660|Analgesics|analgesics|mesh-ancestor
138789481|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
138789482|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138789483|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138789484|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138789485|NCT02868606|Insulin|insulin|mesh-list
138789486|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138789487|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138789488|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789489|NCT00647920|Adalimumab|adalimumab|mesh-list
138789490|NCT00647920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138789491|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138166921|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138789492|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138789493|NCT00830869|Ixazomib|ixazomib|mesh-list
138789494|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789495|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
138789496|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789497|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789498|NCT02662504|Cisplatin|cisplatin|mesh-list
138789499|NCT02662504|Pemetrexed|pemetrexed|mesh-list
138789500|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138789501|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789502|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789503|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789504|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138789505|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138789506|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
138789507|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138789508|NCT00648934|Topiramate|topiramate|mesh-list
138789509|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
138789510|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138789511|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789512|NCT02659228|Anesthetics|anesthetics|mesh-list
138789513|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
138789514|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789515|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789516|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
138789517|NCT00844519|Maraviroc|maraviroc|mesh-list
138789518|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138789519|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138789520|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789521|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138789522|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138789523|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
138789524|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789525|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138789527|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138789528|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138789529|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
138789530|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789531|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789532|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789533|NCT02662426|Oseltamivir|oseltamivir|mesh-list
138789534|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
138789535|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789536|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789537|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789538|NCT00994110|Pasireotide|pasireotide|mesh-list
138789540|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789541|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789542|NCT02662348|Aldesleukin|aldesleukin|mesh-list
138789543|NCT02662348|Interleukin-2|interleukin-2|mesh-list
138789544|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789545|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138789546|NCT02662348|Analgesics|analgesics|mesh-ancestor
138789547|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
138789548|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789549|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789550|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138789551|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138789552|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
138789553|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789554|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
138789555|NCT02868372|Povidone|povidone|mesh-list
138789556|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
138789557|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
138789558|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138789559|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789560|NCT00629148|Capecitabine|capecitabine|mesh-list
138789561|NCT00629148|Vinorelbine|vinorelbine|mesh-list
138789562|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138789563|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
138789564|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789565|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789566|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138789567|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
138789568|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
138789569|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
138789570|NCT01157234|Metoprolol|metoprolol|mesh-list
138789571|NCT01157234|Nebivolol|nebivolol|mesh-list
138789572|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138789573|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138789574|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
138789575|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
138789576|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789577|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789578|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138789579|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138789580|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138789581|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
138789582|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789583|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789584|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
138789585|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138789586|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138789588|NCT04170790|Saxagliptin|saxagliptin|mesh-list
138789589|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
138789590|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
138789591|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138789592|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138789593|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789594|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789595|NCT04170790|Urological Agents|urological agents|mesh-ancestor
138789597|NCT04170790|Hormones|hormones|mesh-ancestor
138190402|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138789598|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789599|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789600|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138789601|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
138789602|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138789603|NCT00995670|Sevoflurane|sevoflurane|mesh-list
138789604|NCT00995670|Simvastatin|simvastatin|mesh-list
138789605|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789606|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138789607|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138789608|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
138789609|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789610|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138789611|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138789612|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789613|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138789614|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138789615|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
138789616|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
138789617|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789618|NCT02658838|Heparin|heparin|mesh-list
138789619|NCT02658838|Calcium heparin|calcium heparin|mesh-list
138789620|NCT02658838|Enoxaparin|enoxaparin|mesh-list
138789621|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138789622|NCT02658838|Tinzaparin|tinzaparin|mesh-list
138789623|NCT02658838|Dalteparin|dalteparin|mesh-list
138177402|NCT03806335|Anesthetics|anesthetics|mesh-list
138789625|NCT02658838|Ticagrelor|ticagrelor|mesh-list
138789626|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138789627|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
138789628|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138789629|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138789630|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789631|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138789632|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138184794|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138789633|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138789634|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
138789635|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789636|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789638|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
138789639|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789640|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789641|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
138167076|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
138177436|NCT01979445|Cangrelor|cangrelor|mesh-list
138789642|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789643|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789644|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
138789645|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138789646|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789647|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138789648|NCT00649012|Pioglitazone|pioglitazone|mesh-list
138789649|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138789650|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789651|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
138789652|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138789653|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138789654|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789655|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
138789656|NCT04170088|Coagulants|coagulants|mesh-ancestor
138789658|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789659|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138450256|NCT01870024|Lorazepam|lorazepam|mesh-list
138789660|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138789661|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789662|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789663|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138789664|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
138789665|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789666|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789667|NCT02664142|Anesthetics|anesthetics|mesh-list
138789668|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789669|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789670|NCT04169854|Lidocaine|lidocaine|mesh-list
138789671|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
138789672|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
138789673|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789674|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789675|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
138789676|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789677|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138789678|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138789679|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138789680|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138789681|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789682|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
138789683|NCT02661100|Poly ICLC|poly iclc|mesh-list
138789684|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138789685|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789686|NCT02661100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138789687|NCT02661100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789688|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
138789689|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
138789690|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789691|NCT00601354|Orlistat|orlistat|mesh-list
138789692|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789693|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789694|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138789695|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138789696|NCT02660866|Vorapaxar|vorapaxar|mesh-list
138789697|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138789698|NCT00853099|Adalimumab|adalimumab|mesh-list
138789699|NCT00853099|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138789700|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138789701|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138789702|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138789703|NCT00648310|Estrogens|estrogens|mesh-list
138789704|NCT00648310|Hormones|hormones|mesh-ancestor
138789705|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789706|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789707|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138789708|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138789709|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
138789710|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789711|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789712|NCT00648310|Urological Agents|urological agents|mesh-ancestor
138789713|NCT00702871|Ranitidine|ranitidine|mesh-list
138789714|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138789715|NCT00702871|Sucralfate|sucralfate|mesh-list
138789716|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138789717|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138789718|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138789719|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
138789720|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
138789721|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789722|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450266|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138789723|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789724|NCT00830167|Pregabalin|pregabalin|mesh-list
138789725|NCT00830167|Analgesics|analgesics|mesh-ancestor
138789726|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
138789727|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789728|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789729|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
138789730|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138789731|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138789732|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789733|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138789734|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138789735|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138789736|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789737|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138789738|NCT00992394|Etanercept|etanercept|mesh-list
138789739|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138789740|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138789741|NCT00992394|Analgesics|analgesics|mesh-ancestor
138789742|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
138789743|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789744|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789745|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138789746|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138789747|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138789748|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138789749|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
138789750|NCT00829933|Warfarin|warfarin|mesh-list
138789751|NCT00829933|Edoxaban|edoxaban|mesh-list
138789752|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
138789753|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138789754|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
138789755|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138789756|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
138789757|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789758|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789759|NCT01170962|Ribavirin|ribavirin|mesh-list
138789760|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138789761|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
138789762|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789763|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
138789764|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789765|NCT00843193|Fluticasone|fluticasone|mesh-list
138789766|NCT00843193|Xhance|xhance|mesh-list
138789767|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138789768|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138789769|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
138789770|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789771|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789772|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138789773|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
138789774|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
138789775|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138789776|NCT00853021|Aldesleukin|aldesleukin|mesh-list
138789777|NCT00853021|Bevacizumab|bevacizumab|mesh-list
138789778|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138789779|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789780|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138789781|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138789782|NCT00853021|Growth Substances|growth substances|mesh-ancestor
138789783|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789784|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
138184868|NCT03402295|Bortezomib|bortezomib|mesh-list
138789785|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138789786|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138789787|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
138789788|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789789|NCT00913237|Desipramine|desipramine|mesh-list
138789790|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138789791|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
138789792|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138789794|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789795|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138789796|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138789797|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138789798|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
138789799|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789800|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789801|NCT05367284|Testosterone|testosterone|mesh-list
138789802|NCT05367284|Androgens|androgens|mesh-ancestor
138789803|NCT05367284|Hormones|hormones|mesh-ancestor
138789804|NCT05367284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138190414|NCT03372382|Acetaminophen|acetaminophen|mesh-list
138190415|NCT03372382|Ibuprofen|ibuprofen|mesh-list
138789805|NCT05367284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789806|NCT00843115|Donepezil|donepezil|mesh-list
138789807|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138789808|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789809|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789810|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
138789811|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789812|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789813|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
138789814|NCT01156376|Listerine|listerine|mesh-list
138789815|NCT01156376|Fluorides|fluorides|mesh-list
138789816|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
138789817|NCT01156376|Protective Agents|protective agents|mesh-ancestor
138789818|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789819|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138789820|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138789821|NCT01156142|Doxepin|doxepin|mesh-list
138789822|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138789823|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138789824|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789825|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789826|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138789827|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
138789828|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138789829|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
138789830|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
138789831|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789832|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789833|NCT00842257|Panitumumab|panitumumab|mesh-list
138789834|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138789835|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789836|NCT00706069|Capecitabine|capecitabine|mesh-list
138789837|NCT00706069|Vinorelbine|vinorelbine|mesh-list
138789838|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138789839|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
138789840|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789841|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789842|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138789843|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
138789844|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
138789845|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
138789846|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138789847|NCT01155284|Lansoprazole|lansoprazole|mesh-list
138789848|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
138789849|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138789850|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789851|NCT01155284|Incretins|incretins|mesh-ancestor
138789853|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789854|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138789855|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
138789856|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789857|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789858|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138789859|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138789860|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138789862|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138789863|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
138789864|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138789865|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
138789866|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789867|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789868|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
138789869|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
138789870|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138789871|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
138789872|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789873|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
138789874|NCT00852241|Protective Agents|protective agents|mesh-ancestor
138789875|NCT02612233|Pregabalin|pregabalin|mesh-list
138789876|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138789877|NCT02612233|Analgesics|analgesics|mesh-ancestor
138789878|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
138789879|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789880|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789881|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
138789882|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138789883|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138789884|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789885|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138789886|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138789887|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138789888|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789889|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138789890|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138789891|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138789892|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138789893|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
138789894|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
138789895|NCT01169636|Carboplatin|carboplatin|mesh-list
138789896|NCT01169636|Etoposide|etoposide|mesh-list
138789897|NCT01169636|Ifosfamide|ifosfamide|mesh-list
138789898|NCT01169636|Panobinostat|panobinostat|mesh-list
138789899|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789900|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138177657|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789901|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138789902|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138789903|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789904|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450306|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
138789905|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138789907|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138789908|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
138789909|NCT00706225|Estrogens|estrogens|mesh-list
138789910|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138789911|NCT00706225|Hormones|hormones|mesh-ancestor
138789912|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789913|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789914|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138789915|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138789916|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
138789917|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138789918|NCT04117009|Remifentanil|remifentanil|mesh-list
138789919|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138789920|NCT04117009|Narcotics|narcotics|mesh-ancestor
138789921|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138789922|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789923|NCT04117009|Analgesics|analgesics|mesh-ancestor
138789924|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
138789925|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789926|NCT04117243|Misoprostol|misoprostol|mesh-list
138789927|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
138789928|NCT04117243|Oxytocin|oxytocin|mesh-list
138789929|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
138789930|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138789931|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789932|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138789933|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138789934|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789935|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
138789936|NCT04117243|Coagulants|coagulants|mesh-ancestor
138789937|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138789938|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
138789939|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138789940|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138167371|NCT00567229|Lenalidomide|lenalidomide|mesh-list
138789942|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138789943|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138789944|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138789945|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138789946|NCT01169558|Growth Substances|growth substances|mesh-ancestor
138789947|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190425|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138789948|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
138789950|NCT00700687|Celecoxib|celecoxib|mesh-list
138789951|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138789952|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138789953|NCT00700687|Analgesics|analgesics|mesh-ancestor
138789954|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
138789955|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138789956|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789957|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138789958|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138789959|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138789960|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138789961|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789962|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138789963|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138789964|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138789965|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
138789966|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138789967|NCT00840463|Ambrisentan|ambrisentan|mesh-list
138789968|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138789969|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
138789970|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138789971|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789972|NCT00839527|Metformin|metformin|mesh-list
138789973|NCT00839527|Pioglitazone|pioglitazone|mesh-list
138789974|NCT00839527|Glimepiride|glimepiride|mesh-list
138789975|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
138789976|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138789977|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138789978|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789979|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138789980|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138789981|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
138789982|NCT00839527|Incretins|incretins|mesh-ancestor
138789983|NCT00839527|Hormones|hormones|mesh-ancestor
138789984|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138789985|NCT00706927|Timolol|timolol|mesh-list
138789986|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138789987|NCT00706927|Latanoprost|latanoprost|mesh-list
138789988|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138789989|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138789990|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
138789991|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138177721|NCT00800839|Fludarabine|fludarabine|mesh-list
138789992|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138789993|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138789994|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138789995|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138789996|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138789997|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138789998|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138789999|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138790000|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138184946|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138184947|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138790001|NCT00707083|Dexamethasone|dexamethasone|mesh-list
138790002|NCT00707083|Methotrexate|methotrexate|mesh-list
138790003|NCT00707083|Vincristine|vincristine|mesh-list
138790004|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
138790005|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138790006|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
138790007|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
138790008|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790009|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790010|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138790011|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
138790013|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138790014|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138790015|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790016|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138790017|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
138790018|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138790019|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138790020|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
138790021|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790022|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
138790023|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790024|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138790025|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138790026|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
138790027|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138790028|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138790029|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138790030|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
138790031|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
138790032|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
138790033|NCT05500261|Dexmedetomidine|dexmedetomidine|mesh-list
138790034|NCT05500261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138790035|NCT05500261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790036|NCT05500261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790037|NCT05500261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138790038|NCT05500261|Analgesics|analgesics|mesh-ancestor
138790039|NCT05500261|Sensory System Agents|sensory system agents|mesh-ancestor
138790040|NCT05500261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790041|NCT05500261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138790042|NCT05500261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138790043|NCT05500261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138790044|NCT05500261|Adrenergic Agents|adrenergic agents|mesh-ancestor
138790045|NCT05500261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790046|NCT05500261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138184973|NCT03401593|Midazolam|midazolam|mesh-list
138790048|NCT04116931|Ticagrelor|ticagrelor|mesh-list
138790049|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138790050|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138790051|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138790052|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138790053|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
138790054|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790055|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790056|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790057|NCT00600886|Octreotide|octreotide|mesh-list
138790058|NCT00600886|Pasireotide|pasireotide|mesh-list
138790059|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138790060|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138790061|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790062|NCT00600886|Hormones|hormones|mesh-ancestor
138790063|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138790064|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790065|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138790066|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138790067|NCT00649324|Diuretics|diuretics|mesh-ancestor
138790068|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
138450353|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790069|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790070|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138790071|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138790072|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790073|NCT00648388|Cilostazol|cilostazol|mesh-list
138790074|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138790075|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
138790076|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790077|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790078|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138790079|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
138790080|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138167521|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
138177780|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138167522|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138167523|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
138167524|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138167525|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
138167527|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
138167528|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
138167529|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138190428|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138790081|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138790082|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790083|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138790084|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
138790085|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138790086|NCT00648388|Protective Agents|protective agents|mesh-ancestor
138790087|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138790088|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138790089|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790090|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
138790091|NCT02658760|Bupivacaine|bupivacaine|mesh-list
138790092|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
138790093|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
138790094|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790095|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790096|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
138790097|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790098|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138790099|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138790100|NCT02658760|Analgesics|analgesics|mesh-ancestor
138790101|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138790102|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138790103|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138790104|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
138790105|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790106|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790107|NCT02536690|Midazolam|midazolam|mesh-list
138790108|NCT02536690|Remifentanil|remifentanil|mesh-list
138790109|NCT02536690|Propofol|propofol|mesh-list
138790110|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138790111|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790112|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790113|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138790114|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
138790115|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
138790116|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138790117|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138790118|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138790119|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138790120|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
138790122|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790123|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790124|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138790126|NCT02536690|Analgesics|analgesics|mesh-ancestor
138790127|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
138790128|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790129|NCT00649090|Exemestane|exemestane|mesh-list
138790130|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790131|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138790132|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138790133|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790134|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790135|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138790136|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
138790137|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138790138|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790139|NCT00838903|Metformin|metformin|mesh-list
138790140|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138790141|NCT00838903|Glimepiride|glimepiride|mesh-list
138790142|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
138790143|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138790144|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138790145|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790146|NCT00838903|Incretins|incretins|mesh-ancestor
138790147|NCT00838903|Hormones|hormones|mesh-ancestor
138790148|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138190429|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138190430|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138790149|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138790150|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
138790151|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790152|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790153|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138790154|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138167598|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138790155|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
138790156|NCT00648466|Sumatriptan|sumatriptan|mesh-list
138790157|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138790158|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138790159|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138790161|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790162|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790163|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790164|NCT00649402|Amlodipine|amlodipine|mesh-list
138790165|NCT00649402|Benazepril|benazepril|mesh-list
138790166|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138790167|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138790168|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138790169|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138177835|NCT02396511|Bevacizumab|bevacizumab|mesh-list
138790170|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138790171|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790173|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138790174|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
138790175|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790176|NCT00649480|Balsalazide|balsalazide|mesh-list
138790177|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138790178|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138790179|NCT00649480|Analgesics|analgesics|mesh-ancestor
138790180|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
138790181|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790182|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790183|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138790184|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138790185|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138790186|NCT02656342|Cycloserine|cycloserine|mesh-list
138790187|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138790188|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790189|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138790190|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
138790191|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138790192|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
138790193|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790194|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
138790195|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
138790196|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790197|NCT00650416|Carvedilol|carvedilol|mesh-list
138790198|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138790199|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138790200|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
138790201|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185015|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790202|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790203|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790204|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138790205|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
138790206|NCT00650416|Protective Agents|protective agents|mesh-ancestor
138790207|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138790208|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138790209|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138790210|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
138790211|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138790212|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138790213|NCT00649948|Metformin|metformin|mesh-list
138790214|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138790215|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790216|NCT04167982|Isotretinoin|isotretinoin|mesh-list
138790217|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138790218|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
138790219|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138790221|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138790222|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790223|NCT02658526|Anesthetics|anesthetics|mesh-list
138790224|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790225|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790226|NCT00650494|Valacyclovir|valacyclovir|mesh-list
138790227|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
138790228|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790229|NCT02655874|Vaccines|vaccines|mesh-list
138790230|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
138790231|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790232|NCT00828139|Aflibercept|aflibercept|mesh-list
138790233|NCT00828139|Topotecan|topotecan|mesh-list
138450410|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
138790234|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
138790235|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138790236|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138790237|NCT00828139|Growth Substances|growth substances|mesh-ancestor
138790238|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790239|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
138790240|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790241|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138790242|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138790243|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790244|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790245|NCT02658214|Leucovorin|leucovorin|mesh-list
138790246|NCT02658214|Folic Acid|folic acid|mesh-list
138790247|NCT02658214|Paclitaxel|paclitaxel|mesh-list
138790248|NCT02658214|Etoposide|etoposide|mesh-list
138790249|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138790250|NCT02658214|Carboplatin|carboplatin|mesh-list
138790251|NCT02658214|Gemcitabine|gemcitabine|mesh-list
138790252|NCT02658214|Fluorouracil|fluorouracil|mesh-list
138790253|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
138790254|NCT02658214|Durvalumab|durvalumab|mesh-list
138790255|NCT02658214|Tremelimumab|tremelimumab|mesh-list
138790256|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
138790257|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138790258|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790259|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
138790260|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
138790261|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
138790262|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790263|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138790264|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
138790265|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790266|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138790267|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
138790268|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138790269|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138790270|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790271|NCT02658214|Antidotes|antidotes|mesh-ancestor
138790272|NCT02658214|Protective Agents|protective agents|mesh-ancestor
138790273|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
138790274|NCT02658214|Vitamins|vitamins|mesh-ancestor
138790275|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
138177886|NCT00817843|Simvastatin|simvastatin|mesh-list
138790276|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138790277|NCT02658214|Hematinics|hematinics|mesh-ancestor
138790278|NCT04169230|Citalopram|citalopram|mesh-list
138790279|NCT04169230|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138790280|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138790281|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138790282|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790283|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790284|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
138790285|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790286|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138790287|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
138185078|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138190440|NCT03374176|Clindamycin|clindamycin|mesh-list
138790288|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138790289|NCT04201756|Afatinib|afatinib|mesh-list
138790290|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790291|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138790292|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790293|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790294|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
138790295|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138790296|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138790297|NCT02651350|Prednisolone|prednisolone|mesh-list
138790299|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138790300|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
138790301|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138790302|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
138790303|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
138790304|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790305|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790306|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138790307|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
138790308|NCT02651350|Hormones|hormones|mesh-ancestor
138790309|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138790310|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138790311|NCT02651350|Protective Agents|protective agents|mesh-ancestor
138790312|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138790313|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790314|NCT02658292|Naftifine|naftifine|mesh-list
138790315|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
138790316|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790317|NCT02651038|Micafungin|micafungin|mesh-list
138790318|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
138790319|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790320|NCT00650026|Adalimumab|adalimumab|mesh-list
138790321|NCT00650026|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138790322|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138790323|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138790324|NCT00838513|Eculizumab|eculizumab|mesh-list
138790325|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138790326|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138790327|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
138790328|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790329|NCT00649636|Fluoxetine|fluoxetine|mesh-list
138790330|NCT00649636|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138790331|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138790332|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138790333|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790334|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790336|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790337|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138790338|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
138790339|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138790340|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138790341|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138790342|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790343|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
138790344|NCT04030663|Papaverine|papaverine|mesh-list
138790345|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
138790346|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138790347|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790348|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790349|NCT04030663|Urological Agents|urological agents|mesh-ancestor
138790350|NCT00700921|Lovastatin|lovastatin|mesh-list
138790351|NCT00700921|L 647318|l 647318|mesh-list
138790352|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
138790353|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138790354|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138790355|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
138790356|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790357|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138790358|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138790359|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790360|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
138790361|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790362|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790363|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
138790364|NCT02657512|Charcoal|charcoal|mesh-list
138790365|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138790366|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
138790367|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138790368|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
138790369|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790370|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790371|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
138790372|NCT02657512|Antidotes|antidotes|mesh-ancestor
138790373|NCT02657512|Protective Agents|protective agents|mesh-ancestor
138790374|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790375|NCT00818779|Amlodipine|amlodipine|mesh-list
138790376|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138177928|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
138790377|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138790378|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138790379|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790380|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138790381|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790382|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
138790383|NCT00649714|Zonisamide|zonisamide|mesh-list
138790384|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
138790385|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138790386|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138790387|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185129|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
138790388|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138790389|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790391|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138790392|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
138450454|NCT01870674|YH12852|yh12852|mesh-list
138790393|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790394|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
138790395|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138790396|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790397|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138790398|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138790399|NCT00600028|Growth Substances|growth substances|mesh-ancestor
138790400|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
138790401|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790403|NCT02650102|Risperidone|risperidone|mesh-list
138790404|NCT02650102|Aripiprazole|aripiprazole|mesh-list
138790405|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138790406|NCT02650102|Ziprasidone|ziprasidone|mesh-list
138790407|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138790408|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
138790409|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790410|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790411|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790412|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138790413|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138790414|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790415|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138790416|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138790417|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
138790418|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
138790419|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
138790420|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790421|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138790422|NCT02650102|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138790423|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138790424|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138790425|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
138790426|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
138790427|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138177953|NCT02062905|Dexamethasone|dexamethasone|mesh-list
138790428|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138790429|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138790430|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138790431|NCT00650182|Fentanyl|fentanyl|mesh-list
138790432|NCT00650182|Naltrexone|naltrexone|mesh-list
138790433|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138790434|NCT00650182|Narcotics|narcotics|mesh-ancestor
138790435|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790436|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790437|NCT00650182|Analgesics|analgesics|mesh-ancestor
138790438|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
138790439|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790440|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138790441|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138790442|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
138790443|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
138790444|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138790445|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138790446|NCT00910780|Olanzapine|olanzapine|mesh-list
138790447|NCT00910780|Aripiprazole|aripiprazole|mesh-list
138790448|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
138790449|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138790450|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138790451|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138790452|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790453|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790454|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
138790455|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
138790456|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790457|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790458|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138790459|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138790460|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
138790461|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138790462|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138790463|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138790464|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138790466|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
138790467|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790468|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138790469|NCT00910780|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138790470|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138790471|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138790472|NCT02656810|Teriparatide|teriparatide|mesh-list
138790473|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138790474|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790475|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138790476|NCT02649478|Fluticasone|fluticasone|mesh-list
138790477|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138790478|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138790479|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138790480|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138790481|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
138790482|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790483|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790484|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138790485|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
138790486|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
138790487|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138790488|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138790489|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138790490|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138790491|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
138790492|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790493|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790494|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
138790495|NCT02649478|Hormones|hormones|mesh-ancestor
138790496|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138790497|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
138790498|NCT04167592|Benzydamine|benzydamine|mesh-list
138790499|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138790500|NCT04168294|Propofol|propofol|mesh-list
138790501|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138790502|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790503|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790504|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138790505|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
138790506|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
138790507|NCT04168138|Cytarabine|cytarabine|mesh-list
138790508|NCT04168138|Decitabine|decitabine|mesh-list
138790509|NCT04168138|Aclarubicin|aclarubicin|mesh-list
138790510|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138790511|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
138790512|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790513|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790514|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
138790515|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790516|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138790517|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
138790518|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790519|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790520|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138790521|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138790522|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138790523|NCT00649870|Valacyclovir|valacyclovir|mesh-list
138790524|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
138790525|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790526|NCT04167280|Ipratropium|ipratropium|mesh-list
138790527|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138790528|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
138790529|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790530|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790531|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138790532|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
138790533|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138790535|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790536|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790537|NCT02648854|Metformin|metformin|mesh-list
138790538|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138790539|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790540|NCT02652598|Tolcapone|tolcapone|mesh-list
138790541|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138790542|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138790543|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138790544|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790545|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790546|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138790547|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790548|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790549|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
138790550|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
138790551|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138790552|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138790553|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790554|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790555|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790556|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138790557|NCT02645032|Vaccines|vaccines|mesh-list
138790558|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
138790559|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790560|NCT02644954|Metformin|metformin|mesh-list
138790561|NCT02644954|Calcipotriene|calcipotriene|mesh-list
138790562|NCT02644954|Coal Tar|coal tar|mesh-list
138790563|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138790564|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790565|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
138790566|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
138790567|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138790568|NCT00650338|Latanoprost|latanoprost|mesh-list
138790569|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138790570|NCT02644720|Dexamethasone|dexamethasone|mesh-list
138790571|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138790572|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
138790573|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
138790574|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190456|NCT03281200|Immunologic Factors|immunologic factors|mesh-ancestor
138790575|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790576|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138790577|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
138790579|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138790580|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138790581|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790583|NCT03542266|Cc-486|cc-486|mesh-list
138790584|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138790585|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
138790586|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790587|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790588|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790589|NCT00652600|Propranolol|propranolol|mesh-list
138790590|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138790591|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138790592|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
138790593|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790594|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790595|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790596|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138790597|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138790598|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
138790599|NCT04166578|Lidocaine|lidocaine|mesh-list
138790600|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
138790601|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
138790602|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790603|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790604|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
138790605|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790606|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138790607|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138790608|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138790609|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138790610|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790611|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
138790612|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138790613|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790614|NCT04166734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138790615|NCT04166734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790616|NCT00651352|Nicotine|nicotine|mesh-list
138790617|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138790618|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
138790619|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790620|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790621|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138790622|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138790623|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
138790624|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790625|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790626|NCT02641210|Albendazole|albendazole|mesh-list
138790627|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
138790628|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138790629|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790630|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
138790631|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138790632|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138790633|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
138790634|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
138790635|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
138790636|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790637|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790638|NCT02644408|Megestrol|megestrol|mesh-list
138790639|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138790640|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138790641|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138790642|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
138790643|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138790644|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790645|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138790646|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138790647|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138790648|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790649|NCT02644486|Irbesartan|irbesartan|mesh-list
138790650|NCT02644486|Sevelamer|sevelamer|mesh-list
138790651|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138790652|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138790653|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138790654|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790655|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
138790656|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
138790657|NCT00827359|Everolimus|everolimus|mesh-list
138790658|NCT00827359|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138790659|NCT00827359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138790660|NCT00827359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790661|NCT00827359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790662|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138790663|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
138790664|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790665|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790666|NCT02641288|Ropivacaine|ropivacaine|mesh-list
138790667|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
138790668|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
138790669|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790670|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790671|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
138790672|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790673|NCT04165174|Apatinib|apatinib|mesh-list
138790674|NCT04165174|Antibodies|antibodies|mesh-list
138790675|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138790676|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
138790677|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790678|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790679|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138790680|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790681|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790683|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
138790684|NCT02613247|Protective Agents|protective agents|mesh-ancestor
138790685|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790686|NCT02641132|Mitomycins|mitomycins|mesh-list
138790687|NCT02641132|Mitomycin|mitomycin|mesh-list
138790688|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138790689|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790690|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
138790691|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790692|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138790694|NCT00653614|Drospirenone|drospirenone|mesh-list
138790695|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138790696|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
138790697|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138790698|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790699|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138790700|NCT00653614|Diuretics|diuretics|mesh-ancestor
138790701|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
138790702|NCT02644252|Tocotrienols|tocotrienols|mesh-list
138790703|NCT02644252|Vitamin E|vitamin e|mesh-list
138790704|NCT02644252|Tocopherols|tocopherols|mesh-list
138790705|NCT02644252|Carboplatin|carboplatin|mesh-list
138790706|NCT02644252|Vinorelbine|vinorelbine|mesh-list
138790707|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790708|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138790709|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
138790710|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
138790711|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
138790712|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790713|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
138790714|NCT02644252|Protective Agents|protective agents|mesh-ancestor
138790715|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790716|NCT02644252|Vitamins|vitamins|mesh-ancestor
138790717|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
138790718|NCT00818389|Riluzole|riluzole|mesh-list
138790719|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
138790720|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
138790721|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138790722|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790723|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790724|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
138790725|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138790726|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790727|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790728|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
138790729|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138790730|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138790731|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790732|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138790733|NCT00818389|Protective Agents|protective agents|mesh-ancestor
138790734|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138790735|NCT02640976|Cetrorelix|cetrorelix|mesh-list
138790736|NCT02640976|Menotropins|menotropins|mesh-list
138790737|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138790738|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790739|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138790740|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
138790741|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
138790742|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185315|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
138790743|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
138790744|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
138790745|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790746|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138790747|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138790748|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790749|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138790750|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790751|NCT02640898|Docetaxel|docetaxel|mesh-list
138790752|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790753|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
138790754|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
138790755|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
138168192|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
138790756|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790758|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
138790759|NCT02535910|Calcifediol|calcifediol|mesh-list
138790760|NCT02535910|Vitamins|vitamins|mesh-ancestor
138790761|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
138790762|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790763|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138790764|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138790765|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138790766|NCT00849901|Fluoxetine|fluoxetine|mesh-list
138790767|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138790768|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138790769|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138790770|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790771|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790772|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790773|NCT00849901|Analgesics|analgesics|mesh-ancestor
138790774|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
138790775|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790776|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
138790777|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138790778|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
138790779|NCT00849901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138790780|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
138790781|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138790782|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138790783|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138790784|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790785|NCT02641054|Levodopa|levodopa|mesh-list
138790786|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138790787|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138790788|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
138790789|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790790|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790791|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790792|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138790793|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138790794|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138790795|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
138790796|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790797|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138790798|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138790799|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790800|NCT04166890|Epinephrine|epinephrine|mesh-list
138790801|NCT04166890|Carticaine|carticaine|mesh-list
138790802|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138790803|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138790804|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
138790805|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790806|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790807|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790808|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138790809|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138790810|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
138790811|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790812|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138790813|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
138790814|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
138790815|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
138790816|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138790817|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
138790818|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
138790819|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790820|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
138790821|NCT00652912|Clonazepam|clonazepam|mesh-list
138790822|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
138790823|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
138790824|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
138790825|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790826|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790827|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790828|NCT01168232|Epothilones|epothilones|mesh-list
138790829|NCT01168232|Epothilone B|epothilone b|mesh-list
138790831|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
138790832|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
138178145|NCT02019069|Cytarabine|cytarabine|mesh-list
138790833|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790834|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790835|NCT00817531|Dasatinib|dasatinib|mesh-list
138790836|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790837|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138790838|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790839|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790840|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
138790841|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
138790842|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138790843|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138790844|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138790845|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790846|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138790847|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138790848|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790849|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790850|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790851|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138790852|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138790853|NCT02640508|Lenvatinib|lenvatinib|mesh-list
138790854|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450601|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
138790855|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138790856|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790857|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790858|NCT05312606|Chlorhexidine|chlorhexidine|mesh-list
138790859|NCT05312606|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138790860|NCT05312606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138790861|NCT05312606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790862|NCT05312606|Disinfectants|disinfectants|mesh-ancestor
138790863|NCT05312606|Dermatologic Agents|dermatologic agents|mesh-ancestor
138790865|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138790866|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790867|NCT00817063|Alitretinoin|alitretinoin|mesh-list
138790868|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790869|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
138790870|NCT04313270|Evolocumab|evolocumab|mesh-list
138790871|NCT04313270|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138790872|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138790873|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138790874|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
138790875|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790876|NCT04313270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138790877|NCT04313270|Protease Inhibitors|protease inhibitors|mesh-ancestor
138790878|NCT04313270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790879|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138790880|NCT02640118|Lixisenatide|lixisenatide|mesh-list
138790881|NCT02640118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138790882|NCT02640118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790883|NCT00826267|Trastuzumab|trastuzumab|mesh-list
138790884|NCT00826267|Lapatinib|lapatinib|mesh-list
138790885|NCT00826267|Afatinib|afatinib|mesh-list
138790886|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138790887|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790888|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138790889|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185395|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790890|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790892|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790893|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
138790894|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
138790895|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
138790896|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790897|NCT00707551|Ketoconazole|ketoconazole|mesh-list
138790898|NCT00707551|Verapamil|verapamil|mesh-list
138790899|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
138790900|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138790901|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138790902|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138790903|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790904|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790905|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138790906|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
138790907|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138790908|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790909|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138790910|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138790911|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138790912|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138790913|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138790914|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
138790916|NCT00986154|Calcium heparin|calcium heparin|mesh-list
138790917|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138790918|NCT00986154|Tinzaparin|tinzaparin|mesh-list
138790919|NCT00986154|Dalteparin|dalteparin|mesh-list
138790920|NCT00986154|Warfarin|warfarin|mesh-list
138790921|NCT00986154|Edoxaban|edoxaban|mesh-list
138790922|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
138790923|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138790924|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138790925|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790926|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138790927|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
138790928|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138790929|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
138790930|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790931|NCT00653926|Epinephrine|epinephrine|mesh-list
138790932|NCT00653926|Ropivacaine|ropivacaine|mesh-list
138790933|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
138790934|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
138790935|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138790936|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790937|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
138790938|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790939|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138178198|NCT02410707|Propofol|propofol|mesh-list
138790940|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138790941|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
138790942|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790943|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790944|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138790945|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138790946|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
138790947|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138790948|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
138790949|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
138790950|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
138790951|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138790952|NCT02613091|Clemastine|clemastine|mesh-list
138790953|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
138790954|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
138790955|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138790956|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
138790957|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
138790958|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138790959|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790960|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790961|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138790962|NCT02646904|Beclomethasone|beclomethasone|mesh-list
138790963|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138790964|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
138790965|NCT02646904|Hormones|hormones|mesh-ancestor
138790966|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138790967|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790968|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138790969|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
138790971|NCT00848965|Xhance|xhance|mesh-list
138790972|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138790973|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138790974|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
138790975|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138790976|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790977|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138790978|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
138790979|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
138790980|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138790981|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
138790982|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
138790983|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138790984|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138790985|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138790986|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790987|NCT00654082|Urological Agents|urological agents|mesh-ancestor
138790989|NCT00654160|Fluorouracil|fluorouracil|mesh-list
138790990|NCT00654160|Irinotecan|irinotecan|mesh-list
138790991|NCT00654160|Calcium|calcium|mesh-list
138790992|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
138185437|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138190484|NCT01079143|Basiliximab|basiliximab|mesh-list
138190485|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190486|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790993|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138790994|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138790995|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
138790996|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138790997|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138790998|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138790999|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138791000|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
138791001|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138791002|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138791003|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791004|NCT00654160|Antidotes|antidotes|mesh-ancestor
138791005|NCT00654160|Protective Agents|protective agents|mesh-ancestor
138791006|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
138791007|NCT00654160|Vitamins|vitamins|mesh-ancestor
138791008|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
138791009|NCT02642380|Dexamethasone|dexamethasone|mesh-list
138791010|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
138791011|NCT02642380|BB 1101|bb 1101|mesh-list
138791012|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138791013|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
138791014|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
138791015|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791016|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791017|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138791018|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
138791019|NCT02642380|Hormones|hormones|mesh-ancestor
138791020|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138791021|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138791022|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791023|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
138791024|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791025|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791026|NCT01154036|Atorvastatin|atorvastatin|mesh-list
138791027|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138791028|NCT01154036|Ezetimibe|ezetimibe|mesh-list
138791029|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138791030|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138791031|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
138791032|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791033|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138791034|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138791035|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791036|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
138791037|NCT00816595|Bevacizumab|bevacizumab|mesh-list
138791038|NCT00816595|Rituximab|rituximab|mesh-list
138791040|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138791041|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
138185468|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791042|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791043|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138791044|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138791045|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
138791046|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791047|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791048|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138791049|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138791050|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138791051|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138791052|NCT00816595|Growth Substances|growth substances|mesh-ancestor
138791053|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
138791054|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138791055|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791056|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
138791057|NCT01166438|Trospium chloride|trospium chloride|mesh-list
138791058|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
138791059|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138791060|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138791061|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138791062|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138791063|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791064|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
138791065|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791066|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791067|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138791068|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791069|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138791070|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138791071|NCT01166438|Urological Agents|urological agents|mesh-ancestor
138791072|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
138791073|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
138791074|NCT00707707|Paclitaxel|paclitaxel|mesh-list
138791075|NCT00707707|Olaparib|olaparib|mesh-list
138791076|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138791077|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791078|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
138791079|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
138791080|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
138791081|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791082|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138791083|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791084|NCT01153958|Metronidazole|metronidazole|mesh-list
138791085|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
138791086|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791087|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138791088|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138791089|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138791090|NCT00707785|Vitamin A|vitamin a|mesh-list
138791091|NCT00707785|Vitamins|vitamins|mesh-ancestor
138791092|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
138791093|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791094|NCT00599638|Pregabalin|pregabalin|mesh-list
138791095|NCT00599638|Analgesics|analgesics|mesh-ancestor
138791096|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
138791097|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791098|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791099|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
138791100|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138791101|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138791102|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791103|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138791104|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138791105|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138791106|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138791107|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138791108|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
138791110|NCT02642146|Calcium|calcium|mesh-list
138791111|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
138791112|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138791113|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791114|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138791115|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791116|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791117|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138791118|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138791119|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138791120|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
138791121|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791122|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138791123|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138791124|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791125|NCT00653302|Metformin|metformin|mesh-list
138791126|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
138190499|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138450691|NCT01871935|Sufentanil|sufentanil|mesh-list
138791127|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138791128|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791129|NCT02638870|Amitriptyline|amitriptyline|mesh-list
138791130|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138791131|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
138791133|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138791134|NCT02638870|Analgesics|analgesics|mesh-ancestor
138791135|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
138791136|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791137|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791138|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138791139|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138791140|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138791141|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791142|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
138791143|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791144|NCT02641990|Exenatide|exenatide|mesh-list
138791145|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138791146|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791147|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138791148|NCT02641990|Incretins|incretins|mesh-ancestor
138791150|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138791151|NCT00653380|Doxycycline|doxycycline|mesh-list
138791152|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138791153|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791154|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
138791155|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138791156|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138791157|NCT02646592|Alfentanil|alfentanil|mesh-list
138791158|NCT02646592|Propofol|propofol|mesh-list
138791159|NCT02646592|Sevoflurane|sevoflurane|mesh-list
138791160|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138791161|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138791162|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791163|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138791164|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
138791165|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
138791166|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138791167|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138791168|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138791169|NCT02646592|Narcotics|narcotics|mesh-ancestor
138791170|NCT02646592|Analgesics|analgesics|mesh-ancestor
138791171|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
138791172|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791173|NCT02646670|Ranibizumab|ranibizumab|mesh-list
138791174|NCT02646670|Aflibercept|aflibercept|mesh-list
138791175|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138791176|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138791177|NCT02646670|Growth Substances|growth substances|mesh-ancestor
138361875|NCT01720212|Mirabegron|mirabegron|mesh-list
138791178|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791179|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
138791180|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791181|NCT00651976|Letrozole|letrozole|mesh-list
138791182|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791183|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138791184|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138791185|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791186|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791187|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138791188|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
138791189|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138791190|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791191|NCT01166282|Adalimumab|adalimumab|mesh-list
138791192|NCT01166282|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138791193|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138185538|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791194|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138791195|NCT01153724|Fluconazole|fluconazole|mesh-list
138791196|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
138791197|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791198|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138791199|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138791200|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791201|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791202|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138791203|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
138791204|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138791205|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791206|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138791207|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138791208|NCT02884388|Anesthetics|anesthetics|mesh-list
138791209|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138791210|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791212|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138791213|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791214|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
138791215|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791216|NCT01152788|Dacarbazine|dacarbazine|mesh-list
138791217|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138791218|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
138791219|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791220|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791221|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
138791222|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138791223|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
138791224|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138791225|NCT00598702|Acetaminophen|acetaminophen|mesh-list
138791226|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138791227|NCT00598702|Analgesics|analgesics|mesh-ancestor
138791228|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
138791229|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791230|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791231|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
138791232|NCT01148810|Siponimod|siponimod|mesh-list
138791233|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138791234|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791235|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138791236|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
138791237|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791238|NCT02884310|Remifentanil|remifentanil|mesh-list
138791239|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138791240|NCT02884310|Narcotics|narcotics|mesh-ancestor
138791241|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138791242|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791243|NCT02884310|Analgesics|analgesics|mesh-ancestor
138791244|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
138791245|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791246|NCT01164956|Methylphenidate|methylphenidate|mesh-list
138791247|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138791248|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791249|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138791250|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138791251|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138791252|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791253|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
138791254|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791255|NCT01151540|Rufinamide|rufinamide|mesh-list
138791256|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
138791257|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138791258|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138791259|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138791260|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791261|NCT01163786|Bortezomib|bortezomib|mesh-list
138791262|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791263|NCT00984282|Sorafenib|sorafenib|mesh-list
138791264|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791265|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138791266|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791267|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791268|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
138791269|NCT04292184|Antidotes|antidotes|mesh-ancestor
138791270|NCT04292184|Protective Agents|protective agents|mesh-ancestor
138791271|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791272|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
138791273|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791274|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
138791275|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138791276|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791277|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
138178389|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
138791279|NCT01147640|Metronidazole|metronidazole|mesh-list
138791280|NCT01147640|Meropenem|meropenem|mesh-list
138791281|NCT01147640|Tazobactam|tazobactam|mesh-list
138791282|NCT01147640|Ceftolozane|ceftolozane|mesh-list
138791283|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791284|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138791285|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138791286|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138791287|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138791288|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791289|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791290|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138791291|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791292|NCT01121900|Trazodone|trazodone|mesh-list
138791293|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138791294|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138791295|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138791296|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791297|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138791298|NCT01121900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138791299|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138791300|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138791301|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791302|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791303|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
138791304|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138791305|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
138791306|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138791307|NCT01121666|Hormones|hormones|mesh-ancestor
138791308|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185579|NCT00939367|Zolpidem|zolpidem|mesh-list
138791309|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791310|NCT00984126|Factor VIII|factor viii|mesh-list
138791311|NCT00984126|Coagulants|coagulants|mesh-ancestor
138791312|NCT02868996|Kallikreins|kallikreins|mesh-list
138791313|NCT02868996|Coagulants|coagulants|mesh-ancestor
138791314|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
138791315|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
138791316|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138791317|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791318|NCT00629226|Cetuximab|cetuximab|mesh-list
138791319|NCT00629226|Bortezomib|bortezomib|mesh-list
138791320|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791321|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138791322|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
138791323|NCT00629304|Antithrombins|antithrombins|mesh-list
138791324|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138791325|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
138791326|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791327|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791328|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
138791329|NCT05297929|Irbesartan|irbesartan|mesh-list
138791330|NCT05297929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138791331|NCT05297929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138791332|NCT05297929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138190515|NCT04735042|Saxagliptin|saxagliptin|mesh-list
138791333|NCT05297929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791334|NCT00826111|Eszopiclone|eszopiclone|mesh-list
138791335|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138791336|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138791337|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791338|NCT00982644|Insulin|insulin|mesh-list
138791339|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138791340|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
138791341|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138791342|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791343|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138791344|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138791345|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138791346|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
138791347|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791348|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138791349|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138791350|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791351|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
138791352|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138791353|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138791354|NCT02867904|Prednisolone|prednisolone|mesh-list
138791355|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
138791356|NCT02867904|Bupivacaine|bupivacaine|mesh-list
138791357|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138791358|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
138791359|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138791360|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
138791361|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
138791362|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791363|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791364|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138791365|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
138791366|NCT02867904|Hormones|hormones|mesh-ancestor
138791367|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138791368|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138791369|NCT02867904|Protective Agents|protective agents|mesh-ancestor
138791370|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138178509|NCT00767507|Cangrelor|cangrelor|mesh-list
138791371|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791372|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
138791373|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
138791374|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138791375|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
138791377|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
138791378|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791379|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138791380|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138791381|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791382|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791383|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138791384|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138791385|NCT00707941|Oseltamivir|oseltamivir|mesh-list
138791386|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
138791387|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791388|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791389|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791390|NCT00824473|Azelastine|azelastine|mesh-list
138791391|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138791392|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
138791393|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791394|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791395|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138791396|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
138791397|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138791398|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791399|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791400|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138791401|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138791402|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138190524|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
138791403|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
138791404|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
138791405|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791406|NCT04291092|Immunomodulating Agents|immunomodulating agents|mesh-list
138791407|NCT04291092|Immunologic Factors|immunologic factors|mesh-ancestor
138791408|NCT04291092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791409|NCT02867280|Sorafenib|sorafenib|mesh-list
138791410|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791411|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138791412|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791413|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791414|NCT04290390|Itraconazole|itraconazole|mesh-list
138791415|NCT04290390|Rifampin|rifampin|mesh-list
138791416|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138185609|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138791417|NCT04290390|Estradiol|estradiol|mesh-list
138791418|NCT04290390|Estrogens|estrogens|mesh-ancestor
138791419|NCT04290390|Hormones|hormones|mesh-ancestor
138791420|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138791421|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138178543|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138791422|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138791423|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
138791424|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138791425|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138791426|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
138791427|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791428|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138791429|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138791430|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791431|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791432|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138791433|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
138791434|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138791435|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138791436|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
138791437|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138791438|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
138791439|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138791440|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138791441|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138791442|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138791443|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138791444|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138791445|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138791446|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138791447|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138791449|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138791450|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
138791451|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791452|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791453|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138791454|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
138791455|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138791456|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
138791457|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791458|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791459|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138791460|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
138791461|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
138791462|NCT04290858|Protective Agents|protective agents|mesh-ancestor
138791470|NCT02610829|Tocotrienols|tocotrienols|mesh-list
138791471|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
138791472|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
138791473|NCT02610829|Vitamins|vitamins|mesh-ancestor
138791474|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
138791475|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791477|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190527|NCT00376012|Isoniazid|isoniazid|mesh-list
138190529|NCT00376012|Ethambutol|ethambutol|mesh-list
138791478|NCT02610829|Protective Agents|protective agents|mesh-ancestor
138791486|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
138791487|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138791488|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138791489|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138791490|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
138791491|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791492|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138791493|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138791494|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791495|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791496|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138791497|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138791498|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
138791499|NCT00814801|Galantamine|galantamine|mesh-list
138791500|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138791501|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791502|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138168934|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
138791503|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
138791504|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791505|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791506|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138791507|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
138791508|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791509|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
138791510|NCT00653458|Ondansetron|ondansetron|mesh-list
138791511|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
138791512|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
138185653|NCT02920918|Incretins|incretins|mesh-ancestor
138791513|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791514|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791515|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138791516|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
138791517|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
138791518|NCT00653458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138791519|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138791520|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
138791521|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791522|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791524|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138791525|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
138791526|NCT00812461|Nalmefene|nalmefene|mesh-list
138791527|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138791528|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791529|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
138791530|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791532|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138791533|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
138791534|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
138791535|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791536|NCT00978432|Everolimus|everolimus|mesh-list
138791537|NCT00978432|Panobinostat|panobinostat|mesh-list
138791538|NCT00978432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138791539|NCT00978432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138791540|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791541|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791542|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138791543|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
138791544|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791545|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791546|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138791547|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
138791548|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138791549|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
138791550|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791551|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791552|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138791553|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
138791554|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138791555|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
138791556|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791557|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791558|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138791559|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
138791560|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
138791561|NCT04166812|Protective Agents|protective agents|mesh-ancestor
138791562|NCT00708799|Azithromycin|azithromycin|mesh-list
138791563|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138791564|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791565|NCT02610127|Factor VIII|factor viii|mesh-list
138791566|NCT02610127|Coagulants|coagulants|mesh-ancestor
138791567|NCT00814333|Thrombin|thrombin|mesh-list
138791568|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
138791569|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
138791570|NCT00814333|Coagulants|coagulants|mesh-ancestor
138791571|NCT01147250|Lixisenatide|lixisenatide|mesh-list
138791572|NCT01147250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138791573|NCT01147250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791574|NCT00813943|Temozolomide|temozolomide|mesh-list
138791575|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138791576|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
138791577|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791578|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791579|NCT00821509|Disinfectants|disinfectants|mesh-list
138791580|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791581|NCT00913861|Fentanyl|fentanyl|mesh-list
138791582|NCT00913861|Propofol|propofol|mesh-list
138791583|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138178673|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791584|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138791585|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791586|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138791587|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
138791588|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
138791589|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138791590|NCT00913861|Narcotics|narcotics|mesh-ancestor
138791591|NCT00913861|Analgesics|analgesics|mesh-ancestor
138791592|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
138791593|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138791594|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138791595|NCT00709189|Folic Acid|folic acid|mesh-list
138791596|NCT00709189|Norgestimate|norgestimate|mesh-list
138791597|NCT00709189|Estradiol|estradiol|mesh-list
138791598|NCT00709189|Estrogens|estrogens|mesh-ancestor
138791599|NCT00709189|Hormones|hormones|mesh-ancestor
138791600|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138791601|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791602|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138791603|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
138791604|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138791605|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138791606|NCT00709189|Hematinics|hematinics|mesh-ancestor
138791607|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
138791608|NCT00709189|Vitamins|vitamins|mesh-ancestor
138791609|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
138791610|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138791611|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138791612|NCT00709267|Folic Acid|folic acid|mesh-list
138791613|NCT00709267|Hematinics|hematinics|mesh-ancestor
138791614|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
138791615|NCT00709267|Vitamins|vitamins|mesh-ancestor
138791616|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
138791617|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791618|NCT00591565|Acamprosate|acamprosate|mesh-list
138185703|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791619|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138791621|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
138791622|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791623|NCT01133678|Paclitaxel|paclitaxel|mesh-list
138791624|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138791625|NCT01133678|Cisplatin|cisplatin|mesh-list
138791626|NCT01133678|Cetuximab|cetuximab|mesh-list
138791627|NCT01133678|Everolimus|everolimus|mesh-list
138791628|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138791629|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138791630|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
138791631|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
138791632|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
138791633|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791634|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138791635|NCT01133678|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138791636|NCT01133678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138791637|NCT01133678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138791638|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138791639|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
138791640|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791641|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
138791642|NCT00652132|Antidotes|antidotes|mesh-ancestor
138791643|NCT00652132|Protective Agents|protective agents|mesh-ancestor
138791644|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138791645|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
138791646|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791647|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
138791648|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138791649|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138791650|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
138169080|NCT00630253|Fludarabine|fludarabine|mesh-list
138791651|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
138791652|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
138791653|NCT00655174|Sertraline|sertraline|mesh-list
138791654|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
138791655|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138791656|NCT00655174|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138791657|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138791658|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138791659|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138791660|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138791661|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
138791662|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450870|NCT01872858|Aspirin|aspirin|mesh-list
138791665|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138791666|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138791667|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138791668|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138791669|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185736|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138685653|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138685654|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
138685655|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685656|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138685657|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138685658|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138685659|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138685660|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138685661|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138685662|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138685663|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138685664|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138685666|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138685667|NCT02947334|Bococizumab|bococizumab|mesh-list
138685668|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138685669|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138685670|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
138685671|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685672|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138685673|NCT00525278|Levocetirizine|levocetirizine|mesh-list
138685674|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138178779|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138685675|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138177717|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
138685676|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
138685677|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
138685678|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138685679|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685680|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685682|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685683|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
138685685|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138685686|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138685687|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216507|NCT00667004|Ecabet|ecabet|mesh-list
138685688|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685689|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
138685690|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138685692|NCT02929524|Analgesics|analgesics|mesh-ancestor
138685693|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
138685694|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685695|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685696|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138685697|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138685698|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
138685699|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
138685700|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685701|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138685702|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138685703|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138685704|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685705|NCT00525473|Azathioprine|azathioprine|mesh-list
138685706|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
138685707|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685708|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138685709|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685710|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138685711|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
138685715|NCT00526175|Prednisone|prednisone|mesh-list
138685716|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
138685717|NCT00526175|Methotrexate|methotrexate|mesh-list
138685719|NCT00526175|Daunorubicin|daunorubicin|mesh-list
138685720|NCT00526175|Asparaginase|asparaginase|mesh-list
138685721|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
138685722|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138685723|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
138685724|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685725|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138685726|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138685727|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
138216608|NCT01294163|Propofol|propofol|mesh-list
138685728|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685729|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685730|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138685731|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138685732|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
138685733|NCT00526175|Hormones|hormones|mesh-ancestor
138685734|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685735|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138685736|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138685738|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138685739|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138685740|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
138685741|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
138685742|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685743|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138685744|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138685745|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138685746|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
138685747|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
138685748|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
138685749|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
138685750|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685751|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138685752|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138685753|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138685754|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
138685755|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138685756|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
138685757|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685758|NCT02930031|Expectorants|expectorants|mesh-ancestor
138685759|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
138685760|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138685761|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
138685762|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685763|NCT02930031|Protective Agents|protective agents|mesh-ancestor
138685764|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685765|NCT02930031|Antidotes|antidotes|mesh-ancestor
138685766|NCT02929563|Pantoprazole|pantoprazole|mesh-list
138685767|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138685770|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685771|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685772|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
138685773|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138685774|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
138685775|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685776|NCT00525551|Expectorants|expectorants|mesh-ancestor
138685777|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
138685778|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138685779|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
138685780|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685781|NCT00525551|Protective Agents|protective agents|mesh-ancestor
138685782|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685783|NCT00525551|Antidotes|antidotes|mesh-ancestor
138685784|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
138685785|NCT04288323|Edetic Acid|edetic acid|mesh-list
138685786|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
138685787|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138685788|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685789|NCT04288323|Antidotes|antidotes|mesh-ancestor
138685790|NCT04288323|Protective Agents|protective agents|mesh-ancestor
138685791|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685792|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
138685793|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
138685794|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138685795|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
138685796|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138685797|NCT02946359|Bevacizumab|bevacizumab|mesh-list
138685798|NCT02946359|Crizotinib|crizotinib|mesh-list
138178962|NCT05742503|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138685803|NCT02946359|Growth Substances|growth substances|mesh-ancestor
138685804|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685805|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
138685806|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138685807|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685808|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685810|NCT02946437|Propofol|propofol|mesh-list
138685811|NCT02946437|Sevoflurane|sevoflurane|mesh-list
138685812|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138685813|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685814|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685815|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138685816|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
138685817|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
138685818|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138685819|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138685820|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138685821|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138685822|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
138685823|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
138685824|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138685825|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190550|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138685826|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138685827|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138685828|NCT02946632|Metformin|metformin|mesh-list
138685829|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
138685830|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138685831|NCT02946632|Glimepiride|glimepiride|mesh-list
138685832|NCT02946632|Saxagliptin|saxagliptin|mesh-list
138685834|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685835|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138685836|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685837|NCT02946632|Incretins|incretins|mesh-ancestor
138685838|NCT02946632|Hormones|hormones|mesh-ancestor
138685839|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685840|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138685841|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
138685842|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685843|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138685844|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138685845|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
138685846|NCT02929134|Doxycycline|doxycycline|mesh-list
138685847|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138685848|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685849|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
138685850|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138685851|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138685852|NCT02929212|Acetaminophen|acetaminophen|mesh-list
138685853|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138685854|NCT02929212|Analgesics|analgesics|mesh-ancestor
138685855|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
138685856|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685857|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138216835|NCT01270412|Mitogens|mitogens|mesh-list
138685859|NCT02929251|Adalimumab|adalimumab|mesh-list
138685861|NCT02929251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138685862|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138685863|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138685864|NCT02929095|Midazolam|midazolam|mesh-list
138685865|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
138685866|NCT02929095|Remifentanil|remifentanil|mesh-list
138685867|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138685868|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138177834|NCT04251247|Coagulants|coagulants|mesh-ancestor
138685869|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685871|NCT02929095|Analgesics|analgesics|mesh-ancestor
138685872|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
138685873|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685874|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138685875|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138685876|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138685877|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
138685878|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138685879|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685880|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138685881|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138685882|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138685883|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138216885|NCT02992652|Allopurinol|allopurinol|mesh-list
138685884|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138685885|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
138685886|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
138685887|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
138685888|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
138685889|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138685890|NCT02929095|Narcotics|narcotics|mesh-ancestor
138685891|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138685892|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138685893|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685894|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138685895|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
138685896|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685897|NCT00525668|Protective Agents|protective agents|mesh-ancestor
138685898|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685899|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138685900|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138685901|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685902|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138685904|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
138685905|NCT00526214|Celecoxib|celecoxib|mesh-list
138685906|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138685907|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138685908|NCT00526214|Analgesics|analgesics|mesh-ancestor
138685909|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
138685910|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685911|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685912|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138685913|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138685914|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138685915|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138685916|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685917|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685918|NCT02928510|Idelalisib|idelalisib|mesh-list
138685919|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685920|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685921|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685922|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
138685923|NCT02946944|Apixaban|apixaban|mesh-list
138685924|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
138685925|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138685926|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138685927|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685928|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685929|NCT02946944|Urological Agents|urological agents|mesh-ancestor
138685930|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138685931|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
138685932|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138685933|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
138685934|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
138685935|NCT02947061|Docetaxel|docetaxel|mesh-list
138685936|NCT02947061|Capecitabine|capecitabine|mesh-list
138685937|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685939|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
138685940|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
138685941|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685942|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138685943|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
138685944|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
138685945|NCT02928315|Analgesics|analgesics|mesh-ancestor
138685946|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
138685947|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138685948|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685949|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
138685950|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138685951|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138685952|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
138685953|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138685954|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138685955|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138685956|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138685957|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
138685958|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138685960|NCT00526409|Prednisolone|prednisolone|mesh-list
138685961|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
138685962|NCT00526409|Methotrexate|methotrexate|mesh-list
138685963|NCT00526409|Vincristine|vincristine|mesh-list
138685964|NCT00526409|Daunorubicin|daunorubicin|mesh-list
138685965|NCT00526409|Asparaginase|asparaginase|mesh-list
138685966|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138685967|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
138685968|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138685969|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138685970|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138685971|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
138685972|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138217019|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138685973|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138685974|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138685975|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138685976|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
138685977|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138685978|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138685979|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
138685980|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
138685981|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138685982|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138685983|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138685984|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138685985|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
138685986|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
138685987|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
138685988|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138685989|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
138685990|NCT00526409|Hormones|hormones|mesh-ancestor
138685991|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138685992|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138685993|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
138685994|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138685995|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138685996|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138685997|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138685998|NCT00526448|Ribavirin|ribavirin|mesh-list
138685999|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138686000|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
138686001|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686002|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
138686003|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686004|NCT02946671|Nivolumab|nivolumab|mesh-list
138686005|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
138686006|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138686007|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686008|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138686009|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686010|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
138686011|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138686012|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138686013|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686014|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
138686015|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686016|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686017|NCT00526643|Gemcitabine|gemcitabine|mesh-list
138686018|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686019|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138686021|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686023|NCT02945163|Lamivudine|lamivudine|mesh-list
138686024|NCT02945163|Efavirenz|efavirenz|mesh-list
138686025|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
138686026|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686027|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138686028|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138686030|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686031|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138686032|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138686033|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138686034|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138686035|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138686036|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138686037|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138686038|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138686039|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
138686040|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138190561|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190566|NCT01084759|Etoposide|etoposide|mesh-list
138686041|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138686042|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686043|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138686044|NCT00526760|Analgesics|analgesics|mesh-ancestor
138686045|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
138686046|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686047|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138686048|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138686049|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138686050|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
138686051|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686052|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686053|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
138686054|NCT02927379|Ketamine|ketamine|mesh-list
138686055|NCT02927379|Bupivacaine|bupivacaine|mesh-list
138686056|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
138686057|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
138686058|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138686059|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686060|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
138686061|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686062|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138686063|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138686064|NCT02927379|Analgesics|analgesics|mesh-ancestor
138686065|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138686066|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138686067|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138686068|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
138686070|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686071|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138686072|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138686073|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
138217205|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138686074|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138686075|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138686077|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138686078|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
138686079|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686080|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686081|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686082|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138686083|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138686084|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138686085|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138686086|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138686087|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
138686089|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138686090|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686091|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
138686092|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138686093|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138686094|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
138686095|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138686097|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138686098|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138686099|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138686100|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
138686101|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686102|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190569|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
138190570|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
138190571|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138190572|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138686103|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686104|NCT00527033|Urological Agents|urological agents|mesh-ancestor
138686106|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138686107|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138686108|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
138686109|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
138686110|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138686111|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686112|NCT02924922|Mannitol|mannitol|mesh-list
138686113|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138686114|NCT02924922|Diuretics|diuretics|mesh-ancestor
138686115|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
138686116|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686117|NCT04692896|Lidocaine|lidocaine|mesh-list
138686118|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
138686119|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
138217315|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138179268|NCT05664971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686121|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686122|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
138686123|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686124|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138686125|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138686126|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138686127|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138686128|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686129|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
138177942|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686130|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138686132|NCT00528008|Povidone|povidone|mesh-list
138686133|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138686134|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686135|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
138686136|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
138686137|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
138686138|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
138686139|NCT04692740|Chlorambucil|chlorambucil|mesh-list
138686140|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138686141|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
138686142|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686143|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686144|NCT02925000|Vinorelbine|vinorelbine|mesh-list
138686145|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138686146|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686147|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
138686148|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
138686149|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
138686150|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686151|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
138686152|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138686153|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138686154|NCT02945696|Ropivacaine|ropivacaine|mesh-list
138686155|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
138686156|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
138686157|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138686158|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686159|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
138686160|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686161|NCT02924766|Prednisone|prednisone|mesh-list
138686162|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
138686163|NCT02924766|Niraparib|niraparib|mesh-list
138686164|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138177961|NCT02062905|Hormones|hormones|mesh-ancestor
138686165|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
138686166|NCT02924766|Hormones|hormones|mesh-ancestor
138686167|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138686168|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686169|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138686170|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686171|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138686172|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686173|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686174|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
138686175|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138190579|NCT01084759|Hormones|hormones|mesh-ancestor
138686176|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138686177|NCT00528281|Pemetrexed|pemetrexed|mesh-list
138686178|NCT00528281|Lapatinib|lapatinib|mesh-list
138686179|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686180|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686181|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686182|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138686183|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138686184|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138686185|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
138686186|NCT01580501|Tadalafil|tadalafil|mesh-list
138686187|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
138686188|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138686189|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138686190|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686191|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686192|NCT01580501|Urological Agents|urological agents|mesh-ancestor
138686193|NCT02924532|Hormones|hormones|mesh-list
138686194|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
138686195|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138686196|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686197|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138686198|NCT00528359|Olanzapine|olanzapine|mesh-list
138686199|NCT00528359|Risperidone|risperidone|mesh-list
138686200|NCT00528359|Aripiprazole|aripiprazole|mesh-list
138686201|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138686202|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138686203|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
138686204|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686205|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686206|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686207|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138686208|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138686209|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138686210|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138686211|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138686212|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
138686213|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
138686214|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
138179317|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
138686215|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686217|NCT00528359|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138686218|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138686219|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138686220|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
138686221|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
138217521|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138686222|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138686223|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138686224|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138686225|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138686226|NCT00527150|Varenicline|varenicline|mesh-list
138686227|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138686228|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138686229|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
138686230|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686231|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686232|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686233|NCT00527228|Deflazacort|deflazacort|mesh-list
138686234|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138686235|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138686236|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
138686237|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686238|NCT00527267|Cinacalcet|cinacalcet|mesh-list
138686239|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138686240|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190580|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138686241|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138686243|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138686244|NCT02924454|Metoprolol|metoprolol|mesh-list
138686245|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138686246|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138686247|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
138217568|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
138686248|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138686249|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138686250|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
138686251|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
138686252|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686253|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686254|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138686255|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138686256|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138686257|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
138686258|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686259|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686260|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138686261|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
138686262|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138686263|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686264|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138686265|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138686266|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686267|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686268|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686269|NCT00528515|Propofol|propofol|mesh-list
138686270|NCT00528515|Desflurane|desflurane|mesh-list
138686271|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138686272|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138686273|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686274|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138686275|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
138686276|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
138686277|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138686278|NCT02923986|Dasatinib|dasatinib|mesh-list
138686279|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686280|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138686281|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686282|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686283|NCT02926248|Colchicine|colchicine|mesh-list
138686284|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
138686285|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138686286|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
138217617|NCT00244712|Tenofovir|tenofovir|mesh-list
138686288|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
138686289|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686290|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686291|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
138686292|NCT00528593|Hematinics|hematinics|mesh-ancestor
138686293|NCT02926326|Azithromycin|azithromycin|mesh-list
138686294|NCT02926326|Acumapimod|acumapimod|mesh-list
138686295|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138686296|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686297|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138686299|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686300|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
138686301|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
138686302|NCT00528827|Nicardipine|nicardipine|mesh-list
138686303|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138686304|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138686305|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138686306|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686307|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138686308|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686309|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
138686310|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
138686311|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138190587|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138686312|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
138179381|NCT05319015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217652|NCT03807362|CC-11050|cc-11050|mesh-list
138686316|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686317|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
138686318|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138686319|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138686320|NCT04691687|Furosemide|furosemide|mesh-list
138686321|NCT04691687|Diuretics|diuretics|mesh-ancestor
138686322|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
138686323|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686324|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138686325|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138686326|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686328|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
138686329|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
138686330|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
138686331|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138686332|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686333|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
138686334|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686335|NCT02923791|Lenograstim|lenograstim|mesh-list
138686336|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138686337|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
138686338|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686339|NCT00527540|Interferons|interferons|mesh-list
138686340|NCT00527540|Ribavirin|ribavirin|mesh-list
138686341|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
138686342|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
138686343|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138686344|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217702|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
138686351|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
138686352|NCT02926053|Fludarabine|fludarabine|mesh-list
138686353|NCT02926053|Interleukin-2|interleukin-2|mesh-list
138686354|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138686355|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
138686356|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686357|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138686358|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138686359|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
138686360|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686361|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686362|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138686363|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138686364|NCT02926053|Analgesics|analgesics|mesh-ancestor
138686365|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
138686366|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686367|NCT00527657|Thalidomide|thalidomide|mesh-list
138686368|NCT00527657|Temozolomide|temozolomide|mesh-list
138686369|NCT00527657|Lomustine|lomustine|mesh-list
138686370|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138686371|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
138686372|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686373|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686374|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138686375|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
138686376|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686377|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
138686378|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138686379|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686380|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138686381|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138686382|NCT00527657|Growth Substances|growth substances|mesh-ancestor
138686383|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
138686384|NCT00528983|Azacitidine|azacitidine|mesh-list
138686386|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138686387|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
138686388|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686389|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686390|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686391|NCT00529022|Carboplatin|carboplatin|mesh-list
138686392|NCT00529022|Azacitidine|azacitidine|mesh-list
138686393|NCT00529022|Valproic Acid|valproic acid|mesh-list
138686394|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686395|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138686396|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
138217790|NCT00780026|Insulin|insulin|mesh-list
138686397|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686398|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686399|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
138686401|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686402|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686403|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
138686404|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138686405|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138686406|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138686407|NCT02923557|Pirarubicin|pirarubicin|mesh-list
138686408|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686409|NCT02925975|Carvedilol|carvedilol|mesh-list
138686410|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138686411|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138686412|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
138686413|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686414|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686415|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686416|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138686417|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
138686418|NCT02925975|Protective Agents|protective agents|mesh-ancestor
138686419|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138686420|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138686421|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138686422|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
138686423|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138686424|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138686425|NCT02945033|Aspirin|aspirin|mesh-list
138686426|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138686427|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138686428|NCT02945033|Analgesics|analgesics|mesh-ancestor
138686429|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
138686430|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686431|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686432|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138686433|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138686434|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138686435|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138686436|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686443|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686444|NCT00529295|Misoprostol|misoprostol|mesh-list
138686445|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138686446|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
138686447|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138686448|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686449|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138686450|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138686451|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
138686452|NCT02922933|Entinostat|entinostat|mesh-list
138686453|NCT02922933|Omeprazole|omeprazole|mesh-list
138686454|NCT02922933|Famotidine|famotidine|mesh-list
138686455|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138686456|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138686457|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138686458|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686459|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686460|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138686461|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
138686462|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
138686463|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686464|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686465|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138217956|NCT05316428|Ethanol|ethanol|mesh-list
138686466|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138686467|NCT02945267|Tegafur|tegafur|mesh-list
138686468|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
138190595|NCT01110421|Cefepime|cefepime|mesh-list
138686469|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138686470|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
138686471|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686472|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686473|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138686474|NCT00529646|APD791|apd791|mesh-list
138686475|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138686478|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686479|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686480|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686482|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686484|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138686485|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138686486|NCT00529880|Cytarabine|cytarabine|mesh-list
138686487|NCT00529880|Fludarabine|fludarabine|mesh-list
138686488|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686489|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138686490|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
138686491|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686492|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138686493|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
138686494|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686495|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
138686496|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686497|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138686498|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686499|NCT00531089|Rituximab|rituximab|mesh-list
138686500|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138686501|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686502|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
138686503|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686504|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138686505|NCT02922699|Omeprazole|omeprazole|mesh-list
138686506|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138686507|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138686508|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138686509|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686510|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686511|NCT02922660|Remifentanil|remifentanil|mesh-list
138686512|NCT02922660|Anesthetics|anesthetics|mesh-list
138686513|NCT02922660|Propofol|propofol|mesh-list
138686514|NCT02922660|Desflurane|desflurane|mesh-list
138686515|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138179523|NCT00807209|Fentanyl|fentanyl|mesh-list
138686517|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138686518|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138686519|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
138686520|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138686521|NCT02922660|Narcotics|narcotics|mesh-ancestor
138686522|NCT02922660|Analgesics|analgesics|mesh-ancestor
138686523|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
138686524|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686525|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138686526|NCT02922465|Clopidogrel|clopidogrel|mesh-list
138686527|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138686528|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138686529|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138686530|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138686531|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
138686532|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686533|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686534|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686535|NCT02944292|Propofol|propofol|mesh-list
138686536|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138686537|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138686538|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686539|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138686540|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
138686541|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
138686542|NCT02922426|Olanzapine|olanzapine|mesh-list
138686543|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
138686544|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
138190598|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138686545|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686546|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686547|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138686548|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138178253|NCT00827983|Progesterone|progesterone|mesh-list
138686549|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138686550|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138686551|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138686552|NCT02922426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138686553|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138686554|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138686555|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686556|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686557|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
138686558|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
138686559|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138686560|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
138686561|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686562|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138686564|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138686565|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
138686566|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686567|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686569|NCT00531167|Adefovir|adefovir|mesh-list
138686570|NCT00531167|Entecavir|entecavir|mesh-list
138686571|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138686572|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138686573|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686574|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686575|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
138686576|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686577|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138686578|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138686579|NCT02944214|Febuxostat|febuxostat|mesh-list
138686580|NCT02944214|Benzbromarone|benzbromarone|mesh-list
138686581|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
138686582|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138686583|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
138686584|NCT02922075|Amoxicillin|amoxicillin|mesh-list
138686585|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
138686586|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138686587|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686588|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138686589|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
138686590|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
138686591|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686592|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138686593|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138686594|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138686595|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
138686596|NCT02922348|Norgestimate|norgestimate|mesh-list
138686597|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
138686598|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
138686599|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138686602|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138686603|NCT02922348|Progestins|progestins|mesh-list
138686604|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138218176|NCT05310968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138686605|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686606|NCT02922348|Estrogens|estrogens|mesh-ancestor
138686607|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138686608|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138686609|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138686610|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138686611|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138686612|NCT00527501|Travoprost|travoprost|mesh-list
138686613|NCT00527501|Brinzolamide|brinzolamide|mesh-list
138686614|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138686615|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138686616|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686617|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686618|NCT02922387|Varenicline|varenicline|mesh-list
138686620|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138686621|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
138686622|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686623|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686624|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686626|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138686627|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138686628|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686629|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686630|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
138686631|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686632|NCT00531362|Aspirin|aspirin|mesh-list
138686633|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138686634|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138686635|NCT00531362|Analgesics|analgesics|mesh-ancestor
138218225|NCT01337687|Oxytocin|oxytocin|mesh-list
138686636|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
138686637|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686638|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686639|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138686640|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138686641|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138686642|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138686643|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686644|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138686645|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138178310|NCT02348775|Antidotes|antidotes|mesh-ancestor
138686646|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686648|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
138686649|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686650|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686651|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686652|NCT00531440|Everolimus|everolimus|mesh-list
138686653|NCT00531440|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138686654|NCT00531440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138686655|NCT00531440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686656|NCT00531440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686657|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138686658|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
138686659|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686660|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686661|NCT02944526|Ropivacaine|ropivacaine|mesh-list
138686662|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
138686663|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
138686664|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138686665|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138179609|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
138686666|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
138686667|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686669|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138686670|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686671|NCT00530387|Ibuprofen|ibuprofen|mesh-list
138686672|NCT00530387|Diclofenac|diclofenac|mesh-list
138686673|NCT00530387|Ketoprofen|ketoprofen|mesh-list
138686674|NCT00530387|Piroxicam|piroxicam|mesh-list
138686675|NCT00530387|Salicylates|salicylates|mesh-list
138686676|NCT00530387|Etofenamate|etofenamate|mesh-list
138686677|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
138686679|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
138686680|NCT00530387|Benzophenone|benzophenone|mesh-list
138686681|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138686682|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138686683|NCT00530387|Analgesics|analgesics|mesh-ancestor
138686684|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
138686685|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686686|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686687|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138686688|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138686689|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138686690|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686691|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686692|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138686693|NCT00530387|Protective Agents|protective agents|mesh-ancestor
138363516|NCT04854512|Metformin|metformin|mesh-list
138686694|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
138686695|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138686696|NCT04689165|Vaccines|vaccines|mesh-list
138686697|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
138686698|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686700|NCT00530582|Progestins|progestins|mesh-ancestor
138686701|NCT00530582|Hormones|hormones|mesh-ancestor
138686702|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138686703|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686704|NCT02944175|Neostigmine|neostigmine|mesh-list
138686705|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138686706|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218331|NCT00772304|Azelastine|azelastine|mesh-list
138686707|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686708|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
138686709|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686710|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686711|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138686712|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
138686713|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686714|NCT02917746|Imiquimod|imiquimod|mesh-list
138686715|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138686716|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
138686717|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686718|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686719|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
138686722|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138686723|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138686724|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
138686725|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686726|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686727|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138686728|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138686729|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
138686730|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686731|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138686732|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138686733|NCT00531596|Selegiline|selegiline|mesh-list
138686734|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
138686735|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138686736|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138686737|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138686738|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138686739|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686740|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686741|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138686742|NCT00531596|Protective Agents|protective agents|mesh-ancestor
138686743|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686744|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138686745|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138686746|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138686747|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
138178356|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
138686748|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138686749|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686750|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138686751|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
138686752|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138686753|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686754|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686755|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686756|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138686757|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138686758|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686759|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
138686760|NCT00531674|Tocopherols|tocopherols|mesh-list
138686761|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
138686762|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686763|NCT00531674|Protective Agents|protective agents|mesh-ancestor
138686764|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686765|NCT00531674|Vitamins|vitamins|mesh-ancestor
138686766|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
138686767|NCT00530972|Ribavirin|ribavirin|mesh-list
138686768|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138686769|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
138686770|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686772|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686773|NCT02943317|Avelumab|avelumab|mesh-list
138686774|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138686775|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686776|NCT02943356|Tadalafil|tadalafil|mesh-list
138686777|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
138686778|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138686779|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138686780|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686781|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686782|NCT02943356|Urological Agents|urological agents|mesh-ancestor
138686783|NCT02917512|Cyclosporine|cyclosporine|mesh-list
138686784|NCT02917512|Cyclosporins|cyclosporins|mesh-list
138686785|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686786|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686787|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138686788|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
138686789|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686790|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
138686791|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686792|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
138686793|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138686794|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138686795|NCT02943902|Vaccines|vaccines|mesh-list
138686796|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138686797|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
138686798|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686799|NCT00531908|Furosemide|furosemide|mesh-list
138686800|NCT00531908|Diuretics|diuretics|mesh-ancestor
138686801|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
138686802|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686803|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138686804|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138686805|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686807|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138686808|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686809|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138686810|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
138686811|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138686812|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138686813|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
138686814|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138686815|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
138686816|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686817|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686818|NCT00531791|Prednisone|prednisone|mesh-list
138686819|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138179683|NCT03092895|Apatinib|apatinib|mesh-list
138686820|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
138686821|NCT00531791|Hormones|hormones|mesh-ancestor
138686822|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138686823|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686824|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138686825|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686826|NCT02921178|Omalizumab|omalizumab|mesh-list
138686827|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138686828|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138686829|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
138686830|NCT00531986|Lopinavir|lopinavir|mesh-list
138190614|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
138686831|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138686832|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138686833|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
138686834|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686835|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686836|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138686838|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
138686839|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686840|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138686841|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138686842|NCT02920827|Dapivirine|dapivirine|mesh-list
138363664|NCT04469959|Levodopa|levodopa|mesh-list
138686843|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138686844|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138686845|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
138686846|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686847|NCT02920905|Lidocaine|lidocaine|mesh-list
138686848|NCT02920905|Atracurium|atracurium|mesh-list
138686849|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
138686850|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
138686851|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138686852|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686853|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
138686854|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686855|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138686856|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138686857|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138686858|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138686859|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686860|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138686861|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138686862|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138686863|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138686864|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138686865|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
138686866|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686868|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138686869|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686870|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138686871|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138686872|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686873|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686874|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686876|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138686877|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
138686878|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138686879|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686880|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138686881|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686882|NCT02917005|Palbociclib|palbociclib|mesh-list
138686883|NCT02917005|Exemestane|exemestane|mesh-list
138686884|NCT02917005|Goserelin|goserelin|mesh-list
138686885|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686886|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138686887|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686888|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686889|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138686890|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138686891|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138686892|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
138178421|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138686893|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138686894|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686895|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138686896|NCT02942810|Cefepime|cefepime|mesh-list
138686897|NCT02942810|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
138686898|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138686899|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138686900|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138686901|NCT02920710|Hormones|hormones|mesh-ancestor
138686902|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138686903|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686905|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
138686906|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
138686907|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686908|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686909|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138179732|NCT00849251|Doxorubicin|doxorubicin|mesh-list
138686910|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138686911|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138686912|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
138686913|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138686914|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686916|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686917|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138686918|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138686919|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686920|NCT02920593|Vitamin D|vitamin d|mesh-list
138686921|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
138686922|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
138686923|NCT02920593|Vitamins|vitamins|mesh-list
138686924|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
138686925|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686926|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138686927|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138686928|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
138686929|NCT02942732|Vitamin D|vitamin d|mesh-list
138686930|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138686931|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686932|NCT02942732|Vitamins|vitamins|mesh-ancestor
138686933|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
138686934|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138686935|NCT02942420|Bucillamine|bucillamine|mesh-list
138686936|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138686937|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138686938|NCT02942420|Analgesics|analgesics|mesh-ancestor
138686939|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
138178456|NCT00766649|Sirolimus|sirolimus|mesh-list
138686940|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138686941|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686942|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138686943|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138686944|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
138686945|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686946|NCT02942420|Protective Agents|protective agents|mesh-ancestor
138686947|NCT02920359|Leuprolide|leuprolide|mesh-list
138686948|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138686949|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
138686950|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138686951|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686952|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138686953|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686954|NCT02916654|Iron|iron|mesh-list
138686955|NCT02916654|Trace Elements|trace elements|mesh-ancestor
138686956|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
138686957|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686958|NCT02941562|Leucovorin|leucovorin|mesh-list
138686959|NCT02941562|Fluorouracil|fluorouracil|mesh-list
138686960|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
138686961|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
138686962|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686963|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138686964|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138218640|NCT01342523|Nicotine|nicotine|mesh-list
138190625|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138190627|NCT05620277|Tocopherols|tocopherols|mesh-list
138686965|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138686966|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
138686967|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686968|NCT02941562|Antidotes|antidotes|mesh-ancestor
138686969|NCT02941562|Protective Agents|protective agents|mesh-ancestor
138686970|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
138686971|NCT02941562|Vitamins|vitamins|mesh-ancestor
138686972|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
138686973|NCT02942888|Niacinamide|niacinamide|mesh-list
138686975|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
138686976|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
138686977|NCT02942888|Vitamins|vitamins|mesh-ancestor
138686978|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
138686979|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686980|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138686981|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
138686982|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138686983|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138686984|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
138686985|NCT02916420|Dexamethasone|dexamethasone|mesh-list
138686986|NCT02916420|Pomalidomide|pomalidomide|mesh-list
138686987|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138686988|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
138686989|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
138686990|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138178485|NCT00783965|Tazarotene|tazarotene|mesh-list
138686991|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138686992|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138686993|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
138363827|NCT03785587|Bromides|bromides|mesh-list
138686995|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138686996|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138686997|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138686998|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
138686999|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138687000|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138687001|NCT02916420|Growth Substances|growth substances|mesh-ancestor
138687002|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
138687003|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
138687004|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
138687005|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138687006|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138687007|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138687008|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179784|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138687009|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687010|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138687011|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
138687012|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138687013|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138687014|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687015|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
138687016|NCT03458468|Coagulants|coagulants|mesh-ancestor
138687017|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138687018|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138687019|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138687020|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687021|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
138687022|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687023|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687024|NCT02916381|Anesthetics|anesthetics|mesh-list
138687025|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687026|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687027|NCT02920047|Amlodipine|amlodipine|mesh-list
138687028|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138687029|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138687030|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138687031|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218731|NCT06214572|Oxaliplatin|oxaliplatin|mesh-list
138190635|NCT05620277|Micronutrients|micronutrients|mesh-ancestor
138190636|NCT01110499|Bimatoprost|bimatoprost|mesh-list
138687032|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138687033|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687036|NCT02941016|Alirocumab|alirocumab|mesh-list
138687037|NCT02941016|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138687038|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138687039|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138687040|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
138687041|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687042|NCT02941016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138687043|NCT02941016|Protease Inhibitors|protease inhibitors|mesh-ancestor
138687044|NCT02941016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687045|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138687047|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138687048|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138687049|NCT02941445|Metformin|metformin|mesh-list
138687050|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138687051|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138687052|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687053|NCT02941445|Incretins|incretins|mesh-ancestor
138687054|NCT02941445|Hormones|hormones|mesh-ancestor
138687055|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138687056|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138687057|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
138687058|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687059|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687060|NCT02919501|Vortioxetine|vortioxetine|mesh-list
138687061|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
138687062|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138687063|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138687064|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138687065|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687066|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687067|NCT02919501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138687068|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138687069|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138687070|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687071|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687072|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
138687073|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138687074|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138178549|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
138687075|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138687076|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138687077|NCT02919579|Esketamine|esketamine|mesh-list
138687078|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
138687079|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138687080|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138687081|NCT02940821|Fluorides|fluorides|mesh-list
138687082|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
138687083|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
138687084|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
138687085|NCT02940821|Protective Agents|protective agents|mesh-ancestor
138687086|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687087|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138687088|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138687089|NCT02941601|Carboplatin|carboplatin|mesh-list
138687090|NCT02941601|Gemcitabine|gemcitabine|mesh-list
138687091|NCT02941601|Necitumumab|necitumumab|mesh-list
138687092|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687093|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138687094|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
138687095|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687096|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138687097|NCT03160638|Azithromycin|azithromycin|mesh-list
138687098|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138687099|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138687100|NCT02919462|Cisplatin|cisplatin|mesh-list
138687101|NCT02919462|Pemetrexed|pemetrexed|mesh-list
138687102|NCT02919462|Vinorelbine|vinorelbine|mesh-list
138687103|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687104|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687105|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687106|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138687107|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138687108|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138687109|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
138687110|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
138687111|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
138687113|NCT02941367|Lixisenatide|lixisenatide|mesh-list
138687114|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138687115|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687117|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
138687118|NCT03153150|Dabigatran|dabigatran|mesh-list
138687119|NCT03153150|Apixaban|apixaban|mesh-list
138687120|NCT03153150|Edoxaban|edoxaban|mesh-list
138687121|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
138687122|NCT03153150|Phenindione|phenindione|mesh-list
138687123|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
138687124|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138687125|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
138687126|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138687127|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
138687128|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687129|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687130|NCT02916147|Propofol|propofol|mesh-list
138687131|NCT02916147|Sevoflurane|sevoflurane|mesh-list
138687132|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138687133|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687134|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687135|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138687136|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
138687137|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
138687138|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138687139|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138687140|NCT06026163|Caffeine|caffeine|mesh-list
138687141|NCT06026163|Caffeine citrate|caffeine citrate|mesh-list
138687142|NCT06026163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687143|NCT06026163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138687144|NCT06026163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687145|NCT06026163|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138687146|NCT06026163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687147|NCT06026163|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138687148|NCT06026163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138687149|NCT06026163|Purinergic Agents|purinergic agents|mesh-ancestor
138687150|NCT06026163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687152|NCT06025916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138687153|NCT06025916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138687154|NCT06025916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687155|NCT06025916|Hemostatics|hemostatics|mesh-ancestor
138687156|NCT06025916|Coagulants|coagulants|mesh-ancestor
138687157|NCT06025851|Antibodies|antibodies|mesh-list
138218987|NCT06212830|Antimanic Agents|antimanic agents|mesh-ancestor
138687158|NCT06025851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138687159|NCT06025851|Immunologic Factors|immunologic factors|mesh-ancestor
138687160|NCT06025851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687162|NCT06025825|Epinephrine|epinephrine|mesh-list
138687163|NCT06025825|Racepinephrine|racepinephrine|mesh-list
138687164|NCT06025825|Carticaine|carticaine|mesh-list
138687165|NCT06025825|Epinephryl borate|epinephryl borate|mesh-list
138687166|NCT06025825|Anesthetics, Local|anesthetics, local|mesh-ancestor
138687167|NCT06025825|Anesthetics|anesthetics|mesh-ancestor
138687168|NCT06025825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687169|NCT06025825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687170|NCT06025825|Sensory System Agents|sensory system agents|mesh-ancestor
138687171|NCT06025825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687172|NCT06025825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138687173|NCT06025825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138687174|NCT06025825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138687175|NCT06025825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138282895|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138687176|NCT06025825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687177|NCT06025825|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138687178|NCT06025825|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138687179|NCT06025825|Adrenergic Agents|adrenergic agents|mesh-ancestor
138687180|NCT06025825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687181|NCT06025825|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138687182|NCT06025825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138687183|NCT06025825|Autonomic Agents|autonomic agents|mesh-ancestor
138687184|NCT06025825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138687185|NCT06025825|Respiratory System Agents|respiratory system agents|mesh-ancestor
138687187|NCT06025825|Sympathomimetics|sympathomimetics|mesh-ancestor
138687188|NCT06025825|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138687190|NCT06025812|Immunologic Factors|immunologic factors|mesh-ancestor
138687191|NCT06025812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687192|NCT06025773|Lansoprazole|lansoprazole|mesh-list
138687193|NCT06025773|Dexlansoprazole|dexlansoprazole|mesh-list
138687194|NCT06025773|Calcium Carbonate|calcium carbonate|mesh-list
138687195|NCT06025773|Calcium|calcium|mesh-list
138687196|NCT06025773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138687197|NCT06025773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687198|NCT06025773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138687199|NCT06025773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138687200|NCT06025773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138687201|NCT06025773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179897|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
138687202|NCT06025773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687204|NCT06025474|Pregabalin|pregabalin|mesh-list
138687205|NCT06025474|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138687206|NCT06025474|Vortioxetine|vortioxetine|mesh-list
138687207|NCT06025474|Citalopram|citalopram|mesh-list
138687208|NCT06025474|Sertraline|sertraline|mesh-list
138687209|NCT06025474|Paroxetine|paroxetine|mesh-list
138687210|NCT06025474|Escitalopram|escitalopram|mesh-list
138687211|NCT06025474|Analgesics|analgesics|mesh-ancestor
138687212|NCT06025474|Sensory System Agents|sensory system agents|mesh-ancestor
138687213|NCT06025474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687214|NCT06025474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687215|NCT06025474|Anticonvulsants|anticonvulsants|mesh-ancestor
138687216|NCT06025474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138687217|NCT06025474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138687218|NCT06025474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219146|NCT06190249|Aldesleukin|aldesleukin|mesh-list
138687219|NCT06025474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138687220|NCT06025474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138687221|NCT06025474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138687222|NCT06025474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687223|NCT06025474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138687224|NCT06025474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138687225|NCT06025474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138687226|NCT06025474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687227|NCT06025474|Serotonin Agents|serotonin agents|mesh-ancestor
138687228|NCT06025474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138687229|NCT06025474|Antidepressive Agents|antidepressive agents|mesh-ancestor
138687230|NCT06025474|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138687231|NCT06025474|Dopamine Agents|dopamine agents|mesh-ancestor
138687232|NCT06025474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138687233|NCT06025474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138687234|NCT06025474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687235|NCT06025474|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138687236|NCT06025474|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138687237|NCT06025474|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138687238|NCT06025474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138179931|NCT00833365|Ibuprofen|ibuprofen|mesh-list
138687240|NCT06025409|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138687241|NCT06025409|Fertility Agents|fertility agents|mesh-ancestor
138687242|NCT06025409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138687243|NCT06025409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687244|NCT06025409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138687245|NCT06025409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687246|NCT06025240|Antibodies|antibodies|mesh-list
138687247|NCT06025240|Immunologic Factors|immunologic factors|mesh-ancestor
138687248|NCT06025240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687249|NCT06025214|Fluticasone|fluticasone|mesh-list
138687251|NCT06025214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138687252|NCT06025214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138687253|NCT06025214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138687254|NCT06025214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138687255|NCT06025214|Autonomic Agents|autonomic agents|mesh-ancestor
138687256|NCT06025214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687257|NCT06025214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687258|NCT06025214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138687259|NCT06025214|Respiratory System Agents|respiratory system agents|mesh-ancestor
138687260|NCT06025214|Dermatologic Agents|dermatologic agents|mesh-ancestor
138687261|NCT06025214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138687262|NCT06025214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138687263|NCT06025214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138687264|NCT06025214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138687265|NCT06025214|Adrenergic Agents|adrenergic agents|mesh-ancestor
138687266|NCT06025214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687267|NCT06025214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687268|NCT06025214|Glucocorticoids|glucocorticoids|mesh-ancestor
138687270|NCT06025214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138687271|NCT06025214|Sympathomimetics|sympathomimetics|mesh-ancestor
138687272|NCT06025162|Enoxaparin|enoxaparin|mesh-list
138687273|NCT06025162|Anticoagulants|anticoagulants|mesh-ancestor
138687274|NCT06025162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138687275|NCT06025162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138687276|NCT06025162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687277|NCT06025097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138687278|NCT06025097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138687279|NCT06025097|Glucocorticoids|glucocorticoids|mesh-ancestor
138687280|NCT06025097|Hormones|hormones|mesh-ancestor
138687281|NCT06025097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138687282|NCT06025097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687283|NCT06025097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138687284|NCT06025097|Protective Agents|protective agents|mesh-ancestor
138687285|NCT06025097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138687286|NCT06025097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687287|NCT06025084|Titanium dioxide|titanium dioxide|mesh-list
138687288|NCT06025084|Sunscreening Agents|sunscreening agents|mesh-ancestor
138687289|NCT06025084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138687290|NCT06025084|Protective Agents|protective agents|mesh-ancestor
138687291|NCT06025084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687292|NCT06025084|Dermatologic Agents|dermatologic agents|mesh-ancestor
138687293|NCT06025084|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138687295|NCT06025071|Gout Suppressants|gout suppressants|mesh-ancestor
138687296|NCT06025071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138687298|NCT06025071|Antimitotic Agents|antimitotic agents|mesh-ancestor
138687299|NCT06025071|Mitosis Modulators|mitosis modulators|mesh-ancestor
138687300|NCT06025071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687301|NCT06025071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687302|NCT06024915|Itraconazole|itraconazole|mesh-list
138687304|NCT06024915|Antifungal Agents|antifungal agents|mesh-ancestor
138687305|NCT06024915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138687306|NCT06024915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138687307|NCT06024915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138687308|NCT06024915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687309|NCT06024915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687310|NCT06024915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138687311|NCT06024915|Hormone Antagonists|hormone antagonists|mesh-ancestor
138219296|NCT06047548|Hormones|hormones|mesh-ancestor
138687312|NCT06024915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138687313|NCT06024915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687314|NCT06024915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138687315|NCT06024915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138687316|NCT06024915|Antitubercular Agents|antitubercular agents|mesh-ancestor
138687317|NCT06024915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138687318|NCT06024915|Leprostatic Agents|leprostatic agents|mesh-ancestor
138687319|NCT06024915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138687320|NCT06024915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138687321|NCT06024915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138687322|NCT06024915|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138687323|NCT06024915|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138687324|NCT06024915|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138687325|NCT06024915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138687327|NCT06024746|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138687328|NCT06024746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687329|NCT06024746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138687330|NCT06024746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687331|NCT06024525|Paclitaxel|paclitaxel|mesh-list
138687332|NCT06024525|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138687333|NCT06024525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138687334|NCT06024525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687335|NCT06024525|Tubulin Modulators|tubulin modulators|mesh-ancestor
138687336|NCT06024525|Antimitotic Agents|antimitotic agents|mesh-ancestor
138687337|NCT06024525|Mitosis Modulators|mitosis modulators|mesh-ancestor
138687338|NCT06024525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687339|NCT06024421|Favipiravir|favipiravir|mesh-list
138687340|NCT06024421|Antiviral Agents|antiviral agents|mesh-ancestor
138687341|NCT06024421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138687342|NCT06024356|Thymalfasin|thymalfasin|mesh-list
138687343|NCT06024356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138687344|NCT06024356|Immunologic Factors|immunologic factors|mesh-ancestor
138687345|NCT06024356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687346|NCT06024252|Atezolizumab|atezolizumab|mesh-list
138687347|NCT06024252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138687348|NCT06024252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687349|NCT06024252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138687350|NCT06024252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687351|NCT06024213|Methylene Blue|methylene blue|mesh-list
138687352|NCT06024213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687354|NCT06023459|Buprenorphine|buprenorphine|mesh-list
138687355|NCT06023459|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138687356|NCT06023459|Naloxone|naloxone|mesh-list
138687357|NCT06023459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138687358|NCT06023459|Narcotics|narcotics|mesh-ancestor
138687359|NCT06023459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687360|NCT06023459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687361|NCT06023459|Analgesics|analgesics|mesh-ancestor
138687362|NCT06023459|Sensory System Agents|sensory system agents|mesh-ancestor
138687363|NCT06023459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687364|NCT06023459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138687365|NCT06023225|Analgesics, Opioid|analgesics, opioid|mesh-list
138687366|NCT06023225|Narcotics|narcotics|mesh-ancestor
138687367|NCT06023225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687368|NCT06023225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687369|NCT06023225|Analgesics|analgesics|mesh-ancestor
138687370|NCT06023225|Sensory System Agents|sensory system agents|mesh-ancestor
138687371|NCT06023225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687372|NCT06023043|Dexamethasone|dexamethasone|mesh-list
138687373|NCT06023043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138687374|NCT06023043|Antiemetics|antiemetics|mesh-ancestor
138687375|NCT06023043|Autonomic Agents|autonomic agents|mesh-ancestor
138687376|NCT06023043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687377|NCT06023043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687378|NCT06023043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138687379|NCT06023043|Glucocorticoids|glucocorticoids|mesh-ancestor
138687380|NCT06023043|Hormones|hormones|mesh-ancestor
138687381|NCT06023043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138687382|NCT06023043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138687383|NCT06023043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687384|NCT06022939|Dexamethasone|dexamethasone|mesh-list
138687385|NCT06022939|Dexamethasone acetate|dexamethasone acetate|mesh-list
138687386|NCT06022939|Cyclophosphamide|cyclophosphamide|mesh-list
138687387|NCT06022939|Melphalan|melphalan|mesh-list
138687388|NCT06022939|Mechlorethamine|mechlorethamine|mesh-list
138687389|NCT06022939|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138687390|NCT06022939|Bortezomib|bortezomib|mesh-list
138178694|NCT02038023|Iron|iron|mesh-list
138687391|NCT06022939|Daratumumab|daratumumab|mesh-list
138687392|NCT06022939|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138687393|NCT06022939|BB 1101|bb 1101|mesh-list
138687394|NCT06022939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138687395|NCT06022939|Immunologic Factors|immunologic factors|mesh-ancestor
138687396|NCT06022939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180008|NCT05236907|Anesthetics|anesthetics|mesh-ancestor
138687397|NCT06022939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138687398|NCT06022939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138687399|NCT06022939|Alkylating Agents|alkylating agents|mesh-ancestor
138687400|NCT06022939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687401|NCT06022939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687402|NCT06022939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138687403|NCT06022939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138687404|NCT06022939|Antiemetics|antiemetics|mesh-ancestor
138687405|NCT06022939|Autonomic Agents|autonomic agents|mesh-ancestor
138687406|NCT06022939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687407|NCT06022939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138687408|NCT06022939|Glucocorticoids|glucocorticoids|mesh-ancestor
138687409|NCT06022939|Hormones|hormones|mesh-ancestor
138687410|NCT06022939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138687411|NCT06022939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138687412|NCT06022939|Protease Inhibitors|protease inhibitors|mesh-ancestor
138687413|NCT06022939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687414|NCT06022861|Fluorouracil|fluorouracil|mesh-list
138687415|NCT06022861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687416|NCT06022861|Antimetabolites|antimetabolites|mesh-ancestor
138687417|NCT06022861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687418|NCT06022861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138687419|NCT06022861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138687420|NCT06022861|Immunologic Factors|immunologic factors|mesh-ancestor
138687421|NCT06022861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687422|NCT06022835|Chlorhexidine|chlorhexidine|mesh-list
138687423|NCT06022835|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138687424|NCT06022835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138687425|NCT06022835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138687426|NCT06022835|Disinfectants|disinfectants|mesh-ancestor
138687427|NCT06022835|Dermatologic Agents|dermatologic agents|mesh-ancestor
138687428|NCT06022692|Tislelizumab|tislelizumab|mesh-list
138687429|NCT06022692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138687430|NCT06022692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138687431|NCT06022692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687432|NCT06022692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687433|NCT06022614|Dexmedetomidine|dexmedetomidine|mesh-list
138687434|NCT06022614|Bupivacaine|bupivacaine|mesh-list
138687435|NCT06022614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138687436|NCT06022614|Anesthetics, Local|anesthetics, local|mesh-ancestor
138687437|NCT06022614|Anesthetics|anesthetics|mesh-ancestor
138219594|NCT05670236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138687438|NCT06022614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687439|NCT06022614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687440|NCT06022614|Sensory System Agents|sensory system agents|mesh-ancestor
138687441|NCT06022614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687442|NCT06022614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138687443|NCT06022614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138364275|NCT01384994|Panitumumab|panitumumab|mesh-list
138687445|NCT06022614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138687446|NCT06022614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138687448|NCT06022614|Adrenergic Agents|adrenergic agents|mesh-ancestor
138687449|NCT06022614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687450|NCT06022614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687451|NCT06022588|Butyric Acid|butyric acid|mesh-list
138687452|NCT06022588|Histamine Antagonists|histamine antagonists|mesh-ancestor
138687453|NCT06022588|Histamine Agents|histamine agents|mesh-ancestor
138687454|NCT06022588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687455|NCT06022588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687456|NCT06022588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687457|NCT06020755|Dactinomycin|dactinomycin|mesh-list
138687458|NCT06020755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138687459|NCT06020755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138687460|NCT06020755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138687461|NCT06020755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687462|NCT06020755|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138219663|NCT05604131|Deferiprone|deferiprone|mesh-list
138687463|NCT06020755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190661|NCT01086475|Cycloserine|cycloserine|mesh-list
138687464|NCT06020755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687465|NCT06020755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138687467|NCT06019741|Rivaroxaban|rivaroxaban|mesh-list
138687468|NCT06019741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138687469|NCT06019741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138687470|NCT06019741|Analgesics|analgesics|mesh-ancestor
138687471|NCT06019741|Sensory System Agents|sensory system agents|mesh-ancestor
138687472|NCT06019741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687473|NCT06019741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687474|NCT06019741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138687475|NCT06019741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138687476|NCT06019741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138687477|NCT06019741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138687478|NCT06019741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687479|NCT06019741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138687480|NCT06019741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138687481|NCT06019741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687482|NCT06019741|Antipyretics|antipyretics|mesh-ancestor
138687483|NCT06019741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138687484|NCT06019741|Antithrombins|antithrombins|mesh-ancestor
138687485|NCT06019741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138687486|NCT06019741|Protease Inhibitors|protease inhibitors|mesh-ancestor
138687487|NCT06019741|Anticoagulants|anticoagulants|mesh-ancestor
138687488|NCT06017362|Lubricant Eye Drops|lubricant eye drops|mesh-list
138687489|NCT06017362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138687490|NCT06017362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138687491|NCT06016218|Simvastatin|simvastatin|mesh-list
138687492|NCT06016218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138687493|NCT06016218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138178742|NCT00768599|Econazole|econazole|mesh-list
138687494|NCT06016218|Antimetabolites|antimetabolites|mesh-ancestor
138687495|NCT06016218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687496|NCT06016218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138687497|NCT06016218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138687498|NCT06016218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687500|NCT06013618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
138687501|NCT06013618|Temozolomide|temozolomide|mesh-list
138687502|NCT06013618|Molgramostim|molgramostim|mesh-list
138687503|NCT06013618|Sargramostim|sargramostim|mesh-list
138687504|NCT06013618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138687505|NCT06013618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687506|NCT06013618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687507|NCT06013618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687508|NCT06013618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138219774|NCT05444699|Antiemetics|antiemetics|mesh-ancestor
138687509|NCT06013618|Alkylating Agents|alkylating agents|mesh-ancestor
138687510|NCT06013618|Immunologic Factors|immunologic factors|mesh-ancestor
138687511|NCT06013618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687512|NCT06012734|Atezolizumab|atezolizumab|mesh-list
138687514|NCT06012734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138687515|NCT06012734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687517|NCT06012734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687518|NCT06012734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687519|NCT06009991|Propofol|propofol|mesh-list
138687520|NCT06009991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138687521|NCT06009991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687522|NCT06009991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687523|NCT06009991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138687524|NCT06009991|Anesthetics, General|anesthetics, general|mesh-ancestor
138687525|NCT06009991|Anesthetics|anesthetics|mesh-ancestor
138687526|NCT06008405|Azacitidine|azacitidine|mesh-list
138687527|NCT06008405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138687528|NCT06008405|Antimetabolites|antimetabolites|mesh-ancestor
138687529|NCT06008405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687530|NCT06008405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687532|NCT05993390|Neostigmine|neostigmine|mesh-list
138687533|NCT05993390|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138687534|NCT05993390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687535|NCT05993390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138190669|NCT01112683|Memantine|memantine|mesh-list
138687536|NCT05993390|Cholinergic Agents|cholinergic agents|mesh-ancestor
138687537|NCT05993390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687538|NCT05993390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687539|NCT05993390|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138687540|NCT05993390|Autonomic Agents|autonomic agents|mesh-ancestor
138687541|NCT05993390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687542|NCT05990790|Propofol|propofol|mesh-list
138687543|NCT05990790|Sevoflurane|sevoflurane|mesh-list
138687544|NCT05990790|Desflurane|desflurane|mesh-list
138687545|NCT05990790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138282896|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
138687546|NCT05990790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687547|NCT05990790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687548|NCT05990790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138687549|NCT05990790|Anesthetics, General|anesthetics, general|mesh-ancestor
138687550|NCT05990790|Anesthetics|anesthetics|mesh-ancestor
138687551|NCT05990790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138687552|NCT05990790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138687553|NCT05986136|Dapagliflozin|dapagliflozin|mesh-list
138687554|NCT05986136|Mesalamine|mesalamine|mesh-list
138687555|NCT05986136|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138687556|NCT05986136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687557|NCT05986136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138687558|NCT05986136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687559|NCT05986136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138687563|NCT05986136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687564|NCT05986136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138687565|NCT05986136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138687566|NCT05982392|Naproxen|naproxen|mesh-list
138687567|NCT05982392|Tramadol|tramadol|mesh-list
138687568|NCT05982392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138687569|NCT05982392|Narcotics|narcotics|mesh-ancestor
138687570|NCT05982392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687571|NCT05982392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687572|NCT05982392|Analgesics|analgesics|mesh-ancestor
138687573|NCT05982392|Sensory System Agents|sensory system agents|mesh-ancestor
138687574|NCT05982392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687575|NCT05982392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138687576|NCT05982392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138687577|NCT05982392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138687578|NCT05982392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138687579|NCT05982392|Gout Suppressants|gout suppressants|mesh-ancestor
138687580|NCT05982392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138687581|NCT05982392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687582|NCT05982392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687583|NCT05971810|Chlorhexidine|chlorhexidine|mesh-list
138687584|NCT05971810|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138687585|NCT05971810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138687586|NCT05971810|Disinfectants|disinfectants|mesh-ancestor
138687587|NCT05942313|Buprenorphine|buprenorphine|mesh-list
138687588|NCT05942313|Methadone|methadone|mesh-list
138687589|NCT05942313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138687590|NCT05942313|Narcotics|narcotics|mesh-ancestor
138687591|NCT05942313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687592|NCT05942313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687593|NCT05942313|Analgesics|analgesics|mesh-ancestor
138687594|NCT05942313|Sensory System Agents|sensory system agents|mesh-ancestor
138687595|NCT05942313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138364435|NCT01386255|Baclofen|baclofen|mesh-list
138687597|NCT05942313|Antitussive Agents|antitussive agents|mesh-ancestor
138178786|NCT00354627|Etravirine|etravirine|mesh-list
138687598|NCT05942313|Respiratory System Agents|respiratory system agents|mesh-ancestor
138687599|NCT05933044|Durvalumab|durvalumab|mesh-list
138687600|NCT05933044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138687601|NCT05933044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687602|NCT05930119|Rabeprazole|rabeprazole|mesh-list
138687603|NCT05930119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138687604|NCT05930119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138687605|NCT05930119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138687606|NCT05930119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687607|NCT05930119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687608|NCT05926427|Rituximab|rituximab|mesh-list
138687609|NCT05926427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138687611|NCT05926427|Immunologic Factors|immunologic factors|mesh-ancestor
138687612|NCT05926427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687614|NCT05924321|Moxifloxacin|moxifloxacin|mesh-list
138687615|NCT05924321|Carbetocin|carbetocin|mesh-list
138687616|NCT05924321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138687617|NCT05924321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138687618|NCT05924321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138220098|NCT05079230|Venetoclax|venetoclax|mesh-list
138687619|NCT05924321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138687620|NCT05924321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687621|NCT05924321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687622|NCT05924321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687623|NCT05924321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138687624|NCT05924321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687625|NCT05924321|Oxytocics|oxytocics|mesh-ancestor
138687626|NCT05917275|Amlodipine|amlodipine|mesh-list
138687627|NCT05917275|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138687628|NCT05917275|Olmesartan|olmesartan|mesh-list
138687629|NCT05917275|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138687630|NCT05917275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138687631|NCT05917275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138687632|NCT05917275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138687633|NCT05917275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687634|NCT05917275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138687635|NCT05917275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687636|NCT05917275|Vasodilator Agents|vasodilator agents|mesh-ancestor
138687637|NCT05917275|Diuretics|diuretics|mesh-ancestor
138687638|NCT05917275|Natriuretic Agents|natriuretic agents|mesh-ancestor
138687639|NCT05917275|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138687640|NCT05917275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138687641|NCT05917275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138687642|NCT05911321|Dexamethasone|dexamethasone|mesh-list
138687643|NCT05911321|Pomalidomide|pomalidomide|mesh-list
138687644|NCT05911321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138687645|NCT05911321|Antiemetics|antiemetics|mesh-ancestor
138687646|NCT05911321|Autonomic Agents|autonomic agents|mesh-ancestor
138687647|NCT05911321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687648|NCT05911321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687649|NCT05911321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138687650|NCT05911321|Glucocorticoids|glucocorticoids|mesh-ancestor
138687651|NCT05911321|Hormones|hormones|mesh-ancestor
138687652|NCT05911321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138687653|NCT05911321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138687654|NCT05911321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687655|NCT05911321|Immunologic Factors|immunologic factors|mesh-ancestor
138687656|NCT05911321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138687657|NCT05911321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138687659|NCT05911321|Growth Inhibitors|growth inhibitors|mesh-ancestor
138687660|NCT05903417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138687661|NCT05903417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138687662|NCT05903417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138687663|NCT05903417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687664|NCT05896007|Rituximab|rituximab|mesh-list
138687665|NCT05896007|Methotrexate|methotrexate|mesh-list
138687666|NCT05896007|Temozolomide|temozolomide|mesh-list
138687667|NCT05896007|Zanubrutinib|zanubrutinib|mesh-list
138687668|NCT05896007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138220181|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
138687669|NCT05896007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687670|NCT05896007|Immunologic Factors|immunologic factors|mesh-ancestor
138687671|NCT05896007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687673|NCT05896007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138687674|NCT05896007|Abortifacient Agents|abortifacient agents|mesh-ancestor
138687675|NCT05896007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138687676|NCT05896007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138687677|NCT05896007|Antimetabolites|antimetabolites|mesh-ancestor
138687678|NCT05896007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687679|NCT05896007|Dermatologic Agents|dermatologic agents|mesh-ancestor
138687680|NCT05896007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190680|NCT04355273|Heparin|heparin|mesh-list
138687681|NCT05896007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138687682|NCT05896007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138687683|NCT05896007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138687684|NCT05896007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138687685|NCT05896007|Alkylating Agents|alkylating agents|mesh-ancestor
138687686|NCT05896007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138687688|NCT05891132|Prilocaine|prilocaine|mesh-list
138687689|NCT05891132|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138687690|NCT05891132|Anesthetics|anesthetics|mesh-list
138687691|NCT05891132|Anesthetics, Local|anesthetics, local|mesh-ancestor
138687692|NCT05891132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687693|NCT05891132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687694|NCT05891132|Sensory System Agents|sensory system agents|mesh-ancestor
138178836|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138687695|NCT05891132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687696|NCT05891132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138687697|NCT05891132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138687698|NCT05891132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138687699|NCT05891132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138687700|NCT05891132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687701|NCT05891132|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138687702|NCT05890638|Albuterol|albuterol|mesh-list
138687703|NCT05890638|Ipratropium|ipratropium|mesh-list
138687704|NCT05890638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138687705|NCT05890638|Autonomic Agents|autonomic agents|mesh-ancestor
138687706|NCT05890638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687707|NCT05890638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687708|NCT05890638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138687709|NCT05890638|Respiratory System Agents|respiratory system agents|mesh-ancestor
138687710|NCT05890638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138687711|NCT05890638|Cholinergic Agents|cholinergic agents|mesh-ancestor
138687712|NCT05890638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687713|NCT05890638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687714|NCT05890638|Tocolytic Agents|tocolytic agents|mesh-ancestor
138687715|NCT05890638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138687716|NCT05890638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138687717|NCT05890638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138687718|NCT05890638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138687719|NCT05890638|Adrenergic Agents|adrenergic agents|mesh-ancestor
138687720|NCT05885503|Aflibercept|aflibercept|mesh-list
138687721|NCT05885503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138687722|NCT05885503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138687723|NCT05885503|Growth Substances|growth substances|mesh-ancestor
138687724|NCT05885503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687725|NCT05885503|Growth Inhibitors|growth inhibitors|mesh-ancestor
138687726|NCT05885503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687727|NCT05881915|Phenylephrine|phenylephrine|mesh-list
138687728|NCT05881915|Epinephrine|epinephrine|mesh-list
138687729|NCT05881915|Oxymetazoline|oxymetazoline|mesh-list
138687730|NCT05881915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138687731|NCT05881915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138687732|NCT05881915|Adrenergic Agents|adrenergic agents|mesh-ancestor
138687733|NCT05881915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687734|NCT05881915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687735|NCT05881915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687736|NCT05881915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138687737|NCT05881915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138687738|NCT05881915|Autonomic Agents|autonomic agents|mesh-ancestor
138687739|NCT05881915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687740|NCT05881915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138687741|NCT05881915|Respiratory System Agents|respiratory system agents|mesh-ancestor
138687742|NCT05881915|Mydriatics|mydriatics|mesh-ancestor
138687743|NCT05881915|Sympathomimetics|sympathomimetics|mesh-ancestor
138687744|NCT05881915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138687745|NCT05881915|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138687746|NCT05881915|Nasal Decongestants|nasal decongestants|mesh-ancestor
138687747|NCT05881915|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138687750|NCT05876949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138687751|NCT05876949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687752|NCT05869812|Calcium, Dietary|calcium, dietary|mesh-list
138687753|NCT05869812|Calcium|calcium|mesh-list
138687754|NCT05869812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138687755|NCT05869812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687756|NCT05869812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138687757|NCT05839899|Misoprostol|misoprostol|mesh-list
138687758|NCT05839899|Mifepristone|mifepristone|mesh-list
138687759|NCT05839899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138687760|NCT05839899|Abortifacient Agents|abortifacient agents|mesh-ancestor
138687761|NCT05839899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138687762|NCT05839899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687764|NCT05839899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138687765|NCT05839899|Oxytocics|oxytocics|mesh-ancestor
138687766|NCT05839899|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138687767|NCT05839899|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138687768|NCT05839899|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138687769|NCT05839899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138687770|NCT05839899|Contraceptive Agents|contraceptive agents|mesh-ancestor
138687771|NCT05839899|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138687772|NCT05839899|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138687773|NCT05839899|Hormone Antagonists|hormone antagonists|mesh-ancestor
138687774|NCT05839899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138687775|NCT05839899|Luteolytic Agents|luteolytic agents|mesh-ancestor
138687776|NCT05839899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138687777|NCT05839899|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138687779|NCT05838560|Quercetin|quercetin|mesh-list
138687780|NCT05838560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687781|NCT05838560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138687782|NCT05838560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687783|NCT05838560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687784|NCT05838560|Antioxidants|antioxidants|mesh-ancestor
138687785|NCT05838560|Protective Agents|protective agents|mesh-ancestor
138687786|NCT05838560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687787|NCT05835011|Decitabine|decitabine|mesh-list
138687788|NCT05835011|Magrolimab|magrolimab|mesh-list
138687789|NCT05835011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138687790|NCT05835011|Antimetabolites|antimetabolites|mesh-ancestor
138687791|NCT05835011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687792|NCT05835011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687793|NCT05835011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687794|NCT05835011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138687795|NCT05834569|Acetaminophen|acetaminophen|mesh-list
138687796|NCT05834569|Ibuprofen|ibuprofen|mesh-list
138687797|NCT05834569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138687798|NCT05834569|Analgesics|analgesics|mesh-ancestor
138687799|NCT05834569|Sensory System Agents|sensory system agents|mesh-ancestor
138178885|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138687800|NCT05834569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687801|NCT05834569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687803|NCT05834569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138180293|NCT00836407|Ipilimumab|ipilimumab|mesh-list
138687805|NCT05834569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138687806|NCT05834569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138687807|NCT05834569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687808|NCT05834569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687809|NCT05831683|Anesthetics|anesthetics|mesh-list
138687810|NCT05831683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687811|NCT05831683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687812|NCT05820347|Rocuronium|rocuronium|mesh-list
138687813|NCT05820347|Succinylcholine|succinylcholine|mesh-list
138687814|NCT05820347|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138687815|NCT05820347|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138687816|NCT05820347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138687817|NCT05820347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190689|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364645|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
138687818|NCT05820347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687819|NCT05820347|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138687820|NCT05819710|Zopiclone|zopiclone|mesh-list
138687821|NCT05819710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138687822|NCT05819710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687823|NCT05819710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687824|NCT05811403|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138687825|NCT05811403|Eusol|eusol|mesh-list
138687826|NCT05811403|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138687827|NCT05811403|Disinfectants|disinfectants|mesh-ancestor
138687828|NCT05811403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138687829|NCT05811403|Antioxidants|antioxidants|mesh-ancestor
138687830|NCT05811403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687831|NCT05811403|Protective Agents|protective agents|mesh-ancestor
138687832|NCT05811403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687833|NCT05811403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138687834|NCT05811403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138687835|NCT05811403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687836|NCT05811403|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138687837|NCT05789043|Apatinib|apatinib|mesh-list
138687838|NCT05789043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687839|NCT05789043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138687840|NCT05789043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687841|NCT05789043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687842|NCT05763771|Nicotine|nicotine|mesh-list
138687843|NCT05763771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138687844|NCT05763771|Autonomic Agents|autonomic agents|mesh-ancestor
138180306|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
138687845|NCT05763771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687846|NCT05763771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687847|NCT05763771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138687848|NCT05763771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138687849|NCT05763771|Cholinergic Agents|cholinergic agents|mesh-ancestor
138687850|NCT05763771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687851|NCT05763771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687853|NCT05701215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687854|NCT05700422|Varenicline|varenicline|mesh-list
138687855|NCT05700422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138687856|NCT05700422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138687857|NCT05700422|Cholinergic Agents|cholinergic agents|mesh-ancestor
138687858|NCT05700422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687859|NCT05700422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687860|NCT05700422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687861|NCT05681377|Flumazenil|flumazenil|mesh-list
138687862|NCT05681377|Antidotes|antidotes|mesh-ancestor
138687863|NCT05681377|Protective Agents|protective agents|mesh-ancestor
138687864|NCT05681377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687865|NCT05681377|GABA Modulators|gaba modulators|mesh-ancestor
138687866|NCT05681377|GABA Agents|gaba agents|mesh-ancestor
138687867|NCT05681377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220643|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687868|NCT05681377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687870|NCT05661279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687871|NCT05661279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687872|NCT05660681|Glycerol|glycerol|mesh-list
138687873|NCT05660681|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138687874|NCT05660681|Protective Agents|protective agents|mesh-ancestor
138687875|NCT05660681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687876|NCT05642923|Thiamine|thiamine|mesh-list
138687877|NCT05642923|Vitamins|vitamins|mesh-ancestor
138687878|NCT05642923|Micronutrients|micronutrients|mesh-ancestor
138687879|NCT05642923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687880|NCT05642923|Vitamin B Complex|vitamin b complex|mesh-ancestor
138687881|NCT05641363|Ketorolac|ketorolac|mesh-list
138687882|NCT05641363|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138687883|NCT05641363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138687884|NCT05641363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138687885|NCT05641363|Analgesics|analgesics|mesh-ancestor
138687886|NCT05641363|Sensory System Agents|sensory system agents|mesh-ancestor
138687887|NCT05641363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687888|NCT05641363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687889|NCT05641363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138687890|NCT05641363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138365198|NCT01390662|Vitamin D|vitamin d|mesh-list
138687892|NCT05641363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687893|NCT05641363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687894|NCT05595083|Dexmedetomidine|dexmedetomidine|mesh-list
138687895|NCT05595083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138687896|NCT05595083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687897|NCT05595083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687898|NCT05595083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138687899|NCT05595083|Analgesics|analgesics|mesh-ancestor
138687900|NCT05595083|Sensory System Agents|sensory system agents|mesh-ancestor
138687901|NCT05595083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687902|NCT05595083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138687903|NCT05595083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138687904|NCT05595083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138687905|NCT05595083|Adrenergic Agents|adrenergic agents|mesh-ancestor
138687906|NCT05595083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687907|NCT05595083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687908|NCT05594043|Pembrolizumab|pembrolizumab|mesh-list
138687909|NCT05594043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138687910|NCT05594043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687911|NCT05594043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138687912|NCT05594043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687913|NCT05563155|Dexamethasone|dexamethasone|mesh-list
138687914|NCT05563155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138687915|NCT05563155|Antiemetics|antiemetics|mesh-ancestor
138687916|NCT05563155|Autonomic Agents|autonomic agents|mesh-ancestor
138687917|NCT05563155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138687918|NCT05563155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687919|NCT05563155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138687920|NCT05563155|Glucocorticoids|glucocorticoids|mesh-ancestor
138687921|NCT05563155|Hormones|hormones|mesh-ancestor
138687922|NCT05563155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138687923|NCT05563155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138687924|NCT05563155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687925|NCT05552859|Insulin|insulin|mesh-list
138687926|NCT05552859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138687927|NCT05552859|Insulin Glargine|insulin glargine|mesh-list
138687928|NCT05552859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138687929|NCT05552859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687930|NCT05754710|Tofacitinib|tofacitinib|mesh-list
138687931|NCT05754710|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138687932|NCT05754710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138687933|NCT05754710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687934|NCT05754710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687936|NCT05526586|Listerine|listerine|mesh-list
138687937|NCT05526586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138687938|NCT05526586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138687939|NCT05526586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138687940|NCT05526586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687942|NCT05497843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687943|NCT05497843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138687944|NCT05497843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687945|NCT05497843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687946|NCT05488626|Immunomodulating Agents|immunomodulating agents|mesh-list
138687947|NCT05488626|Immunologic Factors|immunologic factors|mesh-ancestor
138687948|NCT05488626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687949|NCT05474846|Melatonin|melatonin|mesh-list
138687950|NCT05474846|Methylphenidate|methylphenidate|mesh-list
138687951|NCT05474846|Antioxidants|antioxidants|mesh-ancestor
138687952|NCT05474846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687954|NCT05474846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687955|NCT05474846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138178948|NCT02051595|Vancomycin|vancomycin|mesh-list
138687956|NCT05474846|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138687957|NCT05474846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138687958|NCT05474846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138687959|NCT05474846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138687960|NCT05474846|Dopamine Agents|dopamine agents|mesh-ancestor
138687961|NCT05474846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138687962|NCT05411718|Aspirin|aspirin|mesh-list
138687963|NCT05411718|Naproxen|naproxen|mesh-list
138687964|NCT05411718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138687965|NCT05411718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138687966|NCT05411718|Analgesics|analgesics|mesh-ancestor
138687967|NCT05411718|Sensory System Agents|sensory system agents|mesh-ancestor
138687969|NCT05411718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687970|NCT05411718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138180427|NCT04344483|Lidocaine|lidocaine|mesh-list
138687971|NCT05411718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138687972|NCT05411718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138687973|NCT05411718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138687974|NCT05411718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687975|NCT05411718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138687976|NCT05411718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138687977|NCT05411718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687978|NCT05411718|Antipyretics|antipyretics|mesh-ancestor
138687979|NCT05411718|Gout Suppressants|gout suppressants|mesh-ancestor
138687980|NCT05385432|Mycophenolic Acid|mycophenolic acid|mesh-list
138687981|NCT05385432|Tacrolimus|tacrolimus|mesh-list
138687982|NCT05385432|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138687983|NCT05385432|Basiliximab|basiliximab|mesh-list
138687984|NCT05385432|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138687985|NCT05385432|Thymoglobulin|thymoglobulin|mesh-list
138687986|NCT05385432|Immunologic Factors|immunologic factors|mesh-ancestor
138687987|NCT05385432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138687988|NCT05385432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138687989|NCT05385432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138687990|NCT05385432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138687991|NCT05385432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138687992|NCT05385432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138687993|NCT05385432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138687994|NCT05385432|Antitubercular Agents|antitubercular agents|mesh-ancestor
138687997|NCT05376579|Siponimod|siponimod|mesh-list
138687998|NCT05376579|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138687999|NCT05376579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688000|NCT05376579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138688001|NCT05376579|Immunologic Factors|immunologic factors|mesh-ancestor
138688002|NCT05376579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688003|NCT05320731|Lidocaine|lidocaine|mesh-list
138688004|NCT05320731|Anesthetics, Local|anesthetics, local|mesh-ancestor
138688005|NCT05320731|Anesthetics|anesthetics|mesh-ancestor
138688006|NCT05320731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138688007|NCT05320731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688008|NCT05320731|Sensory System Agents|sensory system agents|mesh-ancestor
138688009|NCT05320731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688010|NCT05320731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138688011|NCT05320731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138688012|NCT05320731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138688013|NCT05320731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138180443|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138688014|NCT05320731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688015|NCT05304351|Vaccines|vaccines|mesh-list
138688016|NCT05304351|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
138688017|NCT05304351|Immunologic Factors|immunologic factors|mesh-ancestor
138688018|NCT05304351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688019|NCT05304351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138688020|NCT05304273|Letrozole|letrozole|mesh-list
138688021|NCT05304273|Misoprostol|misoprostol|mesh-list
138688022|NCT05304273|Mifepristone|mifepristone|mesh-list
138688023|NCT05304273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688024|NCT05304273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138688025|NCT05304273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138688026|NCT05304273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688027|NCT05304273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688028|NCT05304273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138688029|NCT05304273|Hormone Antagonists|hormone antagonists|mesh-ancestor
138190701|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
138188448|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188449|NCT03161158|Diuretics|diuretics|mesh-list
138188450|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
138188451|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188452|NCT03161938|Dexamethasone|dexamethasone|mesh-list
138188453|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138188454|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
138188456|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188457|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188458|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138188460|NCT03161938|Hormones|hormones|mesh-ancestor
138688030|NCT05304273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138688031|NCT05304273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688032|NCT05304273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138688033|NCT05304273|Abortifacient Agents|abortifacient agents|mesh-ancestor
138688034|NCT05304273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138688035|NCT05304273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138688036|NCT05304273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138688037|NCT05304273|Oxytocics|oxytocics|mesh-ancestor
138688038|NCT05304273|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138688039|NCT05304273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138688040|NCT05304273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138688041|NCT05304273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138688042|NCT05304273|Contraceptive Agents|contraceptive agents|mesh-ancestor
138688043|NCT05304273|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138688044|NCT05304273|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138688045|NCT05304273|Luteolytic Agents|luteolytic agents|mesh-ancestor
138688046|NCT05304273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138688047|NCT05304273|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138688048|NCT05303805|Sevoflurane|sevoflurane|mesh-list
138688049|NCT05303805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138688050|NCT05303805|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138688051|NCT05303805|Anesthetics, General|anesthetics, general|mesh-ancestor
138688052|NCT05303805|Anesthetics|anesthetics|mesh-ancestor
138688053|NCT05303805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138688054|NCT05303805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688056|NCT05302921|Ipilimumab|ipilimumab|mesh-list
138688057|NCT05302921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688058|NCT05302921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688059|NCT05302921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688060|NCT05302921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688061|NCT05296772|Pembrolizumab|pembrolizumab|mesh-list
138688062|NCT05296772|Antibodies|antibodies|mesh-list
138688064|NCT05296772|Immunologic Factors|immunologic factors|mesh-ancestor
138688065|NCT05296772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688066|NCT05296772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688067|NCT05296772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688068|NCT05296772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688069|NCT05296772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688071|NCT05288374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138688072|NCT05288374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138688073|NCT05288374|Analgesics|analgesics|mesh-ancestor
138688074|NCT05288374|Sensory System Agents|sensory system agents|mesh-ancestor
138688075|NCT05288374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688076|NCT05288374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688077|NCT05288374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138688078|NCT05288374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138688079|NCT05288374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138688080|NCT05288374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138688081|NCT05288374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688082|NCT05288374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688083|NCT05245916|Rituximab|rituximab|mesh-list
138688084|NCT05245916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688085|NCT05245916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688086|NCT05245916|Immunologic Factors|immunologic factors|mesh-ancestor
138688087|NCT05245916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688088|NCT05245916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138688089|NCT05237947|Vaccines|vaccines|mesh-list
138688090|NCT05237947|Immunologic Factors|immunologic factors|mesh-ancestor
138688091|NCT05237947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688092|NCT05230368|Decitabine|decitabine|mesh-list
138688093|NCT05230368|Romidepsin|romidepsin|mesh-list
138688094|NCT05230368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138688095|NCT05230368|Antimetabolites|antimetabolites|mesh-ancestor
138688096|NCT05230368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688097|NCT05230368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688098|NCT05230368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688099|NCT05230368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138688100|NCT05230368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138688101|NCT05223478|Phentolamine|phentolamine|mesh-list
138688102|NCT05223478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138688103|NCT05223478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138688104|NCT05223478|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138688105|NCT05223478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138688106|NCT05223478|Adrenergic Agents|adrenergic agents|mesh-ancestor
138688107|NCT05223478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138688108|NCT05223478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688109|NCT05223478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688110|NCT05223478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138688111|NCT05206084|Sirolimus|sirolimus|mesh-list
138688112|NCT05206084|Everolimus|everolimus|mesh-list
138688113|NCT05206084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138688114|NCT05206084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138688115|NCT05206084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688116|NCT05206084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688117|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138688118|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
138180488|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138688120|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688121|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138688122|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688123|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138688124|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
138688125|NCT05205499|Sirolimus|sirolimus|mesh-list
138688126|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138688127|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688128|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138688129|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688130|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
138688131|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138688132|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
138688133|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688134|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138688136|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138688137|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
138688138|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138688139|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688140|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138688141|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138688142|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138688143|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
138688144|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138688145|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138688146|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
138688147|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138688148|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
138688149|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138688150|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138688151|NCT05168475|Infliximab|infliximab|mesh-list
138688152|NCT05168475|Rituximab|rituximab|mesh-list
138688153|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688154|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688155|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
138688156|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688157|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138688158|NCT05168475|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138688159|NCT05168475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138688160|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
138688161|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138688162|NCT05164861|Vitamins|vitamins|mesh-list
138688163|NCT05164861|Micronutrients|micronutrients|mesh-ancestor
138688164|NCT05164861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688165|NCT05159453|Insulin|insulin|mesh-list
138688166|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138688167|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138688168|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688169|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
138688171|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
138688172|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
138688173|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138688174|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688175|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
138688176|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688177|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138365011|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
138688178|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138688179|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138688180|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138688181|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688182|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138688183|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688185|NCT05144854|Tegafur|tegafur|mesh-list
138688186|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
138688187|NCT05144854|Nivolumab|nivolumab|mesh-list
138688188|NCT05144854|Ipilimumab|ipilimumab|mesh-list
138688189|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138688190|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
138688191|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688192|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688193|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688194|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688195|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138688196|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138688197|NCT05133297|Tofacitinib|tofacitinib|mesh-list
138688198|NCT05133297|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138688199|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138688200|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688201|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688203|NCT05117398|Dalbavancin|dalbavancin|mesh-list
138688204|NCT05117398|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138688205|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688206|NCT05117398|Antitubercular Agents|antitubercular agents|mesh-ancestor
138688207|NCT05110781|Atezolizumab|atezolizumab|mesh-list
138688208|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138688209|NCT05110781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688210|NCT05110781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688211|NCT05110781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688212|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688213|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
138688216|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190719|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138190720|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
138688217|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138688218|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688219|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688220|NCT05084222|Budesonide|budesonide|mesh-list
138688221|NCT05084222|Albuterol|albuterol|mesh-list
138221129|NCT00923013|Rituximab|rituximab|mesh-list
138688222|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
138688223|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138688224|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138688225|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
138688226|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688227|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688228|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138688229|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
138688231|NCT05084222|Hormones|hormones|mesh-ancestor
138688232|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138688233|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138688234|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138688235|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138688236|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
138688237|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138688238|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688239|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
138688240|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138688241|NCT05080322|Fluticasone|fluticasone|mesh-list
138688243|NCT05080322|Azelastine|azelastine|mesh-list
138688244|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138688245|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138688246|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
138688247|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688248|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688249|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138688250|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
138688251|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
138688252|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138688253|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138688254|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688255|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138179086|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
138221192|NCT01321151|Resveratrol|resveratrol|mesh-list
138688256|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138688258|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
138688259|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
138688260|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138688262|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
138688264|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688265|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138688266|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688267|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688268|NCT05027048|Calcium|calcium|mesh-list
138688269|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138688270|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688271|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
138688272|NCT05014776|Ipilimumab|ipilimumab|mesh-list
138688274|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688275|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688276|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688277|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688278|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
138688279|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138688280|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138688281|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688282|NCT05014776|Urological Agents|urological agents|mesh-ancestor
138688283|NCT05013216|Poly ICLC|poly iclc|mesh-list
138688284|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
138688285|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
138688286|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688287|NCT05005312|Ritonavir|ritonavir|mesh-list
138688288|NCT05005312|Nirmatrelvir|nirmatrelvir|mesh-list
138190739|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
138688289|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138688290|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138688291|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
138688292|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688293|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688294|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138688295|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138688296|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
138688297|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688298|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138688299|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138688300|NCT05001984|Alirocumab|alirocumab|mesh-list
138688301|NCT05001984|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138688302|NCT05001984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138688303|NCT05001984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138688304|NCT05001984|Antimetabolites|antimetabolites|mesh-ancestor
138688305|NCT05001984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688306|NCT05001984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138688307|NCT05001984|Protease Inhibitors|protease inhibitors|mesh-ancestor
138688308|NCT05001984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688309|NCT05001984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138688310|NCT04988945|Durvalumab|durvalumab|mesh-list
138688311|NCT04988945|Tremelimumab|tremelimumab|mesh-list
138221282|NCT05168462|Norepinephrine|norepinephrine|mesh-list
138688312|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688313|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688315|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
138688316|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688317|NCT04956692|Paclitaxel|paclitaxel|mesh-list
138688318|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138688320|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
138688321|NCT04956692|Pemetrexed|pemetrexed|mesh-list
138688322|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138688323|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688324|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
138688325|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
138688326|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
138688327|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688328|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688329|NCT04956692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688330|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688331|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138688332|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138688333|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138688334|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138688335|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688336|NCT04943588|Antibodies|antibodies|mesh-list
138688337|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
138688338|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
138688339|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688340|NCT04910022|Temozolomide|temozolomide|mesh-list
138688341|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138688342|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
138688343|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688344|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688345|NCT04889066|Durvalumab|durvalumab|mesh-list
138688346|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688348|NCT04883528|Valsartan|valsartan|mesh-list
138688349|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138688350|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138688351|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138688352|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138688353|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688354|NCT04870645|Chelating Agents|chelating agents|mesh-list
138688355|NCT04870645|Sequestering Agents|sequestering agents|mesh-ancestor
138688356|NCT04870645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688357|NCT04824911|Aspirin|aspirin|mesh-list
138688358|NCT04824911|Clopidogrel|clopidogrel|mesh-list
138688359|NCT04824911|Atorvastatin|atorvastatin|mesh-list
138688360|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138688361|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138688362|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138688363|NCT04824911|Analgesics|analgesics|mesh-ancestor
138688364|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
138688365|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688366|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688367|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138688368|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138688369|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138688370|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138688371|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688372|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138179120|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
138688373|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138688374|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688375|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
138688376|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138688377|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138688378|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
138688379|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138688380|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138221369|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688381|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138688382|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138688383|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138688384|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
138688385|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138688386|NCT04818489|Colchicine|colchicine|mesh-list
138688387|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
138688388|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138688389|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
138688390|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
138688391|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
138688392|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688393|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688394|NCT04803474|Hormones|hormones|mesh-list
138688395|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138688396|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688397|NCT04780659|Vaccines|vaccines|mesh-list
138688398|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
138688399|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688401|NCT04768023|Vitamins|vitamins|mesh-ancestor
138688402|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
138688403|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688404|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138688406|NCT04753879|Gemcitabine|gemcitabine|mesh-list
138688407|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
138688408|NCT04753879|Capecitabine|capecitabine|mesh-list
138688409|NCT04753879|Irinotecan|irinotecan|mesh-list
138688410|NCT04753879|Olaparib|olaparib|mesh-list
138688411|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138688412|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688413|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
138688414|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
138688415|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
138688416|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138180629|NCT05342818|Dermatologic Agents|dermatologic agents|mesh-ancestor
138688418|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
138688419|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688421|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138688422|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138688423|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688424|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138688425|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
138688426|NCT04751812|Narcotics|narcotics|mesh-ancestor
138688427|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138688428|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688429|NCT04751812|Analgesics|analgesics|mesh-ancestor
138688430|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
138688431|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688432|NCT04742634|Decitabine|decitabine|mesh-list
138688433|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138179145|NCT00795275|Hormones|hormones|mesh-ancestor
138688434|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
138688435|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688436|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688437|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688438|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138688439|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
138688440|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688441|NCT04675827|Trastuzumab|trastuzumab|mesh-list
138688442|NCT04675827|Pertuzumab|pertuzumab|mesh-list
138688443|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138688444|NCT04675827|Maytansine|maytansine|mesh-list
138688445|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688446|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688447|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138688448|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
138688449|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
138688450|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
138688451|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688452|NCT04675827|Immunotoxins|immunotoxins|mesh-ancestor
138688453|NCT04675827|Immunoconjugates|immunoconjugates|mesh-ancestor
138688454|NCT04675827|Immunologic Factors|immunologic factors|mesh-ancestor
138688455|NCT04675827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688456|NCT04623944|Cytarabine|cytarabine|mesh-list
138688457|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
138688458|NCT04623944|Fludarabine|fludarabine|mesh-list
138688459|NCT04623944|Decitabine|decitabine|mesh-list
138688460|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138688461|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
138688462|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688463|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138221504|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138688464|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138688465|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
138688466|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688467|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688468|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138688469|NCT04623944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138688470|NCT04623944|Antimetabolites|antimetabolites|mesh-ancestor
138688471|NCT04623944|Antiviral Agents|antiviral agents|mesh-ancestor
138688472|NCT04623944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688473|NCT04623944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688474|NCT04590937|Metformin|metformin|mesh-list
138688475|NCT04590937|Digoxin|digoxin|mesh-list
138688476|NCT04590937|Furosemide|furosemide|mesh-list
138688477|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138688478|NCT04590937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138688479|NCT04590937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688480|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138688481|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138688482|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
138179154|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688483|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688484|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138688485|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138688486|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688487|NCT04590937|Diuretics|diuretics|mesh-ancestor
138688488|NCT04590937|Natriuretic Agents|natriuretic agents|mesh-ancestor
138688489|NCT04590937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138688490|NCT04590937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138688491|NCT04590937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138688492|NCT04590937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138688493|NCT04590937|Protective Agents|protective agents|mesh-ancestor
138688494|NCT04563923|Avdoralimab|avdoralimab|mesh-list
138688495|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138688496|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
138688497|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688498|NCT04562558|Leucovorin|leucovorin|mesh-list
138688499|NCT04562558|Dactinomycin|dactinomycin|mesh-list
138190743|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138190745|NCT01089517|Ranibizumab|ranibizumab|mesh-list
138688500|NCT04562558|Methotrexate|methotrexate|mesh-list
138688501|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688502|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138688503|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
138688504|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138688505|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138688506|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
138688507|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688508|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688509|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
138688510|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688511|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138688512|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138688513|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
138688514|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138688515|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138688517|NCT04562558|Protective Agents|protective agents|mesh-ancestor
138688518|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
138688519|NCT04562558|Vitamins|vitamins|mesh-ancestor
138688520|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
138688521|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138688522|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688523|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138688524|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138688525|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138688526|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138688527|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138688528|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138688529|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688530|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138688531|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688532|NCT04560673|Analgesics|analgesics|mesh-ancestor
138688533|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
138688534|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688535|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
138688536|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138688537|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
138688538|NCT04530409|Dexamethasone|dexamethasone|mesh-list
138688539|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
138688540|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138688541|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
138688542|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
138688543|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688544|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688545|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138688546|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
138688547|NCT04530409|Hormones|hormones|mesh-ancestor
138688548|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138688549|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138688550|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688551|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138688552|NCT04530409|Protective Agents|protective agents|mesh-ancestor
138688553|NCT04528329|Dexamethasone|dexamethasone|mesh-list
138365385|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688554|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
138688556|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138688557|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
138688558|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
138688559|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688560|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688561|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138688562|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
138688563|NCT04528329|Hormones|hormones|mesh-ancestor
138688564|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138688565|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138688566|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688567|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
138688568|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688569|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688570|NCT04526288|Cytarabine|cytarabine|mesh-list
138688571|NCT04526288|Daunorubicin|daunorubicin|mesh-list
138688572|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138688573|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
138688574|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688575|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688576|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
138688577|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688578|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138688579|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
138688580|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688581|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138688582|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138688583|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138688584|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688586|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
138688587|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688588|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138688589|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138688590|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688591|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688592|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138688593|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
138688594|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138688595|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688596|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138688597|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138688598|NCT04478838|Olanzapine|olanzapine|mesh-list
138688599|NCT04478838|Risperidone|risperidone|mesh-list
138688600|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138688601|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
138688602|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138688603|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688604|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688605|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138688606|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138688607|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138688608|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138688609|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138688610|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
138688611|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
138688612|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
138688613|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688614|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138688615|NCT04478838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138688616|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138688617|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138688618|NCT04446416|Bevacizumab|bevacizumab|mesh-list
138688619|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688620|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688621|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138688622|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138688623|NCT04446416|Growth Substances|growth substances|mesh-ancestor
138688624|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688625|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
138365466|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
138688626|NCT04421378|Bevacizumab|bevacizumab|mesh-list
138688627|NCT04421378|Temozolomide|temozolomide|mesh-list
138688628|NCT04421378|Carmustine|carmustine|mesh-list
138688629|NCT04421378|Lomustine|lomustine|mesh-list
138688630|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688631|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688632|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138688633|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138688634|NCT04421378|Growth Substances|growth substances|mesh-ancestor
138688635|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688636|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
138179233|NCT00355953|Estrogens|estrogens|mesh-ancestor
138688637|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138688638|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
138688639|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688640|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
138688642|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138688643|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688644|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
138688645|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138688646|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688648|NCT04381832|Quemliclustat|quemliclustat|mesh-list
138688649|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688650|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
138688651|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
138688652|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
138688653|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688654|NCT04381832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688655|NCT04381832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688656|NCT04322305|Pregabalin|pregabalin|mesh-list
138688657|NCT04322305|Analgesics|analgesics|mesh-ancestor
138688658|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
138688659|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688660|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688661|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
138688662|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138688663|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138688664|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688665|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138688666|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138688667|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138688668|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138688669|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138688670|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
138688671|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138688673|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
138688674|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138688675|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688676|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138688677|NCT04305158|Analgesics|analgesics|mesh-ancestor
138688678|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
138688679|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688680|NCT04301778|Durvalumab|durvalumab|mesh-list
138688681|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688682|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688683|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
138180814|NCT00895531|Morphine|morphine|mesh-list
138688684|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138688685|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
138688686|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688687|NCT04291209|Expectorants|expectorants|mesh-ancestor
138688688|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
138688689|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138688690|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
138688691|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688692|NCT04291209|Protective Agents|protective agents|mesh-ancestor
138688693|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688694|NCT04291209|Antidotes|antidotes|mesh-ancestor
138688695|NCT04266912|Avelumab|avelumab|mesh-list
138688696|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138688697|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688698|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688699|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
138688700|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688702|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138688703|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688704|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138190760|NCT01089751|Trospium chloride|trospium chloride|mesh-list
138688705|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138688706|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
138688707|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688708|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138688709|NCT04256213|Nivolumab|nivolumab|mesh-list
138688710|NCT04256213|Ipilimumab|ipilimumab|mesh-list
138688711|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688712|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688713|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688714|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688715|NCT04248829|Gefitinib|gefitinib|mesh-list
138688716|NCT04248829|Lazertinib|lazertinib|mesh-list
138180842|NCT02715700|Analgesics|analgesics|mesh-ancestor
138688718|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138688719|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688720|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688721|NCT04247074|Botulinum Toxins|botulinum toxins|mesh-list
138688722|NCT04247074|Neurotransmitter Agents|neurotransmitter agents|mesh-list
138688723|NCT04247074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138688724|NCT04247074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138688725|NCT04247074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688726|NCT04247074|Cholinergic Agents|cholinergic agents|mesh-ancestor
138688727|NCT04247074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688728|NCT04231448|Prednisone|prednisone|mesh-list
138688729|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
138688730|NCT04231448|Rituximab|rituximab|mesh-list
138688731|NCT04231448|Doxorubicin|doxorubicin|mesh-list
138688732|NCT04231448|Vincristine|vincristine|mesh-list
138688733|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138688734|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
138688735|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688736|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138688737|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138688738|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
138688739|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688740|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688741|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138688742|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688743|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138688744|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138688745|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138688746|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688747|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138688748|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
138688749|NCT04231448|Hormones|hormones|mesh-ancestor
138688750|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138688751|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138688752|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138688753|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
138688754|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
138688755|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
138688756|NCT04224051|Metformin|metformin|mesh-list
138688757|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138688758|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688759|NCT04209686|Paclitaxel|paclitaxel|mesh-list
138688760|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
138688761|NCT04209686|Olaparib|olaparib|mesh-list
138688762|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138688763|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138180888|NCT05310331|Paclitaxel|paclitaxel|mesh-list
138688766|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
138688767|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221950|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
138688769|NCT04209686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688770|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138688771|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688772|NCT04209114|Nivolumab|nivolumab|mesh-list
138688773|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688774|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688775|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138190768|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138688776|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688777|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138688778|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138688779|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138688780|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
138688781|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688782|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138688783|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138688784|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688785|NCT04166435|Temozolomide|temozolomide|mesh-list
138688786|NCT04166435|Olaparib|olaparib|mesh-list
138688787|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138688788|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
138688789|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688790|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688791|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138688792|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688793|NCT04152941|Olaparib|olaparib|mesh-list
138688794|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138688795|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688796|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688797|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688798|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
138688799|NCT04150900|Bavituximab|bavituximab|mesh-list
138688800|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688801|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688802|NCT04150900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688803|NCT04150900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688804|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
138688805|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138688806|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
138688807|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688808|NCT04117087|Nivolumab|nivolumab|mesh-list
138688809|NCT04117087|Ipilimumab|ipilimumab|mesh-list
138688810|NCT04117087|Poly ICLC|poly iclc|mesh-list
138688811|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688812|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688813|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688814|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688815|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
138688816|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
138688817|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688818|NCT04116073|Antibodies|antibodies|mesh-list
138688819|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
138688820|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688821|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
138688822|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688823|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688824|NCT04098068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688825|NCT04098068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688827|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688828|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688829|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138688830|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
138688831|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688832|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138688833|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
138688834|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138688835|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688836|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138688837|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138688838|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138688839|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
138688840|NCT04025879|Paclitaxel|paclitaxel|mesh-list
138688841|NCT04025879|Docetaxel|docetaxel|mesh-list
138688842|NCT04025879|Carboplatin|carboplatin|mesh-list
138688843|NCT04025879|Nivolumab|nivolumab|mesh-list
138688844|NCT04025879|Pemetrexed|pemetrexed|mesh-list
138688845|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138688846|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688847|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
138688848|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
138688849|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
138688850|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688851|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688852|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688853|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688854|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138688855|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138688856|NCT04022967|Ritonavir|ritonavir|mesh-list
138688857|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138688858|NCT04022967|Tenofovir|tenofovir|mesh-list
138688859|NCT04022967|Lamivudine|lamivudine|mesh-list
138688860|NCT04022967|Dolutegravir|dolutegravir|mesh-list
138688861|NCT04022967|Efavirenz|efavirenz|mesh-list
138688862|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138688863|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138688864|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
138688865|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688866|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688867|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138688868|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138688869|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
138688870|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688871|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138688872|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138688873|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138688874|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138688875|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138688876|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138688877|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138688878|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138688879|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138688880|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138688881|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138688882|NCT04021862|Antibodies|antibodies|mesh-list
138688883|NCT04021862|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138688884|NCT04021862|Immunologic Factors|immunologic factors|mesh-ancestor
138688885|NCT04021862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688886|NCT03998813|Ropivacaine|ropivacaine|mesh-list
138688887|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
138688888|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
138688889|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138688890|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688891|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
138688892|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688893|NCT03997786|Etanercept|etanercept|mesh-list
138688894|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138688895|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138688896|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138688897|NCT03997786|Analgesics|analgesics|mesh-ancestor
138688898|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
138688899|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688900|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138180983|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
138688901|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138688902|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138688903|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138688904|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138190779|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138190780|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688905|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
138688906|NCT03991091|Oxytocin|oxytocin|mesh-list
138688908|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138688909|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688910|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
138688911|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138688912|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
138688913|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688914|NCT03945656|Insulin|insulin|mesh-list
138688915|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138688916|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
138688917|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138688918|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688919|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138688920|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138688921|NCT03927079|Dimercaprol|dimercaprol|mesh-list
138688922|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138688923|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
138688924|NCT03927079|Chelating Agents|chelating agents|mesh-ancestor
138688925|NCT03927079|Sequestering Agents|sequestering agents|mesh-ancestor
138688926|NCT03927079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688928|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688929|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138688930|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688931|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688932|NCT03822962|Acetaminophen|acetaminophen|mesh-list
138688933|NCT03822962|Ibuprofen|ibuprofen|mesh-list
138688934|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138688935|NCT03822962|Analgesics|analgesics|mesh-ancestor
138688936|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
138688937|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688938|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688940|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138688941|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138688942|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138688943|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138688944|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138688945|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688946|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
138688947|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688948|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688950|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138688951|NCT03770260|Pevonedistat|pevonedistat|mesh-list
138688952|NCT03770260|Glycine|glycine|mesh-list
138688953|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688954|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688955|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
138688956|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
138688957|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138688960|NCT03767582|Vaccines|vaccines|mesh-list
138688961|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
138688962|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688963|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138688965|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138688966|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688967|NCT03762850|Dapagliflozin|dapagliflozin|mesh-list
138688968|NCT03762850|Irbesartan|irbesartan|mesh-list
138222266|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138688969|NCT03762850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138688970|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688971|NCT03762850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138688972|NCT03762850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688973|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138688974|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138688975|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138688976|NCT03759093|Thalidomide|thalidomide|mesh-list
138688977|NCT03759093|Dexamethasone|dexamethasone|mesh-list
138688978|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
138688979|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
138688980|NCT03759093|Lenalidomide|lenalidomide|mesh-list
138688982|NCT03759093|BB 1101|bb 1101|mesh-list
138688983|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138190789|NCT03537274|Interferons|interferons|mesh-list
138688984|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
138688985|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138688986|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138688987|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138688988|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
138688989|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138688990|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138688991|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138688992|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138688993|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
138688994|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
138688995|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138688996|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138688997|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
138688998|NCT03759093|Hormones|hormones|mesh-ancestor
138688999|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689000|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138689001|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
138689002|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179392|NCT03761277|Narcotics|narcotics|mesh-ancestor
138689003|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138689004|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138689005|NCT03759093|Growth Substances|growth substances|mesh-ancestor
138689008|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138689009|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689011|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
138689012|NCT03756961|Remifentanil|remifentanil|mesh-list
138689013|NCT03756961|Oxycodone|oxycodone|mesh-list
138689014|NCT03756961|Propofol|propofol|mesh-list
138689017|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
138689018|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
138689019|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138689020|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689021|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
138689022|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138689023|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138689024|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138689025|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138222348|NCT05236166|Anticonvulsants|anticonvulsants|mesh-list
138689026|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138689027|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689028|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138689029|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138689031|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138689032|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138689033|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138689034|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
138689035|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138689036|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138689037|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
138689038|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138689039|NCT03756961|Narcotics|narcotics|mesh-ancestor
138689040|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
138689041|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138689042|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138689043|NCT03737110|Rilonacept|rilonacept|mesh-list
138689044|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138689045|NCT03735901|Levodopa|levodopa|mesh-list
138689046|NCT03735901|Carbidopa|carbidopa|mesh-list
138689047|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138689048|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138689049|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
138689050|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138689051|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689052|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689053|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138689054|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689055|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
138689056|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138689057|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
138181062|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138181063|NCT03214627|Hematinics|hematinics|mesh-list
138689059|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
138689060|NCT03723590|Protective Agents|protective agents|mesh-ancestor
138689062|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138689063|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689064|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
138689065|NCT03698669|Narcotics|narcotics|mesh-ancestor
138689066|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138689067|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689068|NCT03698669|Analgesics|analgesics|mesh-ancestor
138689069|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
138689070|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138689071|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
138689072|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
138689073|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689075|NCT03642067|Relatlimab|relatlimab|mesh-list
138689076|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689077|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689078|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138689079|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689080|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
138689081|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138689082|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689083|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689084|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138689085|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138689086|NCT03625648|Protective Agents|protective agents|mesh-ancestor
138689087|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689088|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
138689089|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138689090|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
138689091|NCT03602157|Fludarabine|fludarabine|mesh-list
138689092|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138689093|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689094|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689095|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138179442|NCT00801827|Fallypride|fallypride|mesh-list
138689097|NCT03601442|Tisagenlecleucel|tisagenlecleucel|mesh-list
138689098|NCT03601442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689099|NCT03601442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689100|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138689101|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689102|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689103|NCT03587740|Immunotoxins|immunotoxins|mesh-ancestor
138689104|NCT03587740|Immunoconjugates|immunoconjugates|mesh-ancestor
138689105|NCT03587740|Immunologic Factors|immunologic factors|mesh-ancestor
138689106|NCT03587740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689108|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
138689109|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
138689110|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689111|NCT03586999|Prednisolone|prednisolone|mesh-list
138689112|NCT03586999|Cyclophosphamide|cyclophosphamide|mesh-list
138689113|NCT03586999|Nivolumab|nivolumab|mesh-list
138689114|NCT03586999|Etoposide|etoposide|mesh-list
138689115|NCT03586999|Vincristine|vincristine|mesh-list
138689116|NCT03586999|Doxorubicin|doxorubicin|mesh-list
138689117|NCT03586999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138689118|NCT03586999|Prednisolone phosphate|prednisolone phosphate|mesh-list
138689119|NCT03586999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138190796|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
138190797|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138190798|NCT00939653|Cytarabine|cytarabine|mesh-list
138190799|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
138190800|NCT00939653|Etoposide|etoposide|mesh-list
138190801|NCT00939653|Clofarabine|clofarabine|mesh-list
138190802|NCT00939653|Lenograstim|lenograstim|mesh-list
138190803|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138190805|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689120|NCT03586999|Immunologic Factors|immunologic factors|mesh-ancestor
138689121|NCT03586999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689122|NCT03586999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138689123|NCT03586999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138689125|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689126|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689127|NCT03586999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138689128|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689129|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138689130|NCT03586999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138689131|NCT03586999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138689132|NCT03586999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138689133|NCT03586999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689134|NCT03586999|Tubulin Modulators|tubulin modulators|mesh-ancestor
138689135|NCT03586999|Antimitotic Agents|antimitotic agents|mesh-ancestor
138689136|NCT03586999|Mitosis Modulators|mitosis modulators|mesh-ancestor
138689137|NCT03586999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138689138|NCT03586999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138689139|NCT03586999|Glucocorticoids|glucocorticoids|mesh-ancestor
138689141|NCT03586999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689142|NCT03586999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138689143|NCT03537495|Linezolid|linezolid|mesh-list
138689144|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138689145|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138179468|NCT00803543|Valacyclovir|valacyclovir|mesh-list
138689146|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138689147|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689148|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689149|NCT03522168|Risperidone|risperidone|mesh-list
138689150|NCT03522168|Aripiprazole|aripiprazole|mesh-list
138689151|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138365986|NCT01395199|Amlodipine|amlodipine|mesh-list
138689152|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
138689153|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138689154|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689155|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689156|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138689157|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138689158|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138689159|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138689160|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138689161|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
138689162|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
138689163|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
138689164|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138689165|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138689166|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138689167|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138689168|NCT03518606|Durvalumab|durvalumab|mesh-list
138689169|NCT03518606|Vinorelbine|vinorelbine|mesh-list
138689170|NCT03518606|Tremelimumab|tremelimumab|mesh-list
138689171|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689172|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689173|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138689174|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
138689175|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
138689176|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
138689177|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689178|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
138689179|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689180|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689181|NCT03480672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138689182|NCT03480672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689183|NCT03475186|Ramipril|ramipril|mesh-list
138689184|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138190806|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138689185|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
138689186|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179489|NCT04923113|Bismuth|bismuth|mesh-list
138689187|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689188|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138689189|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138689190|NCT03390296|Avelumab|avelumab|mesh-list
138689191|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
138689192|NCT03390296|Azacitidine|azacitidine|mesh-list
138689193|NCT03390296|Venetoclax|venetoclax|mesh-list
138689194|NCT03390296|Calicheamicins|calicheamicins|mesh-list
138689195|NCT03390296|Antibodies|antibodies|mesh-list
138689196|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
138689197|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138689198|NCT03390296|Maleic acid|maleic acid|mesh-list
138689199|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
138689200|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689201|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689202|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138689203|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
138689204|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689205|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689206|NCT03390296|Immunotoxins|immunotoxins|mesh-ancestor
138689207|NCT03390296|Immunoconjugates|immunoconjugates|mesh-ancestor
138689208|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138689209|NCT03386240|Triclosan|triclosan|mesh-list
138689210|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138689211|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689212|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138689213|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138689214|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
138689215|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689216|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138689217|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
138689218|NCT03384537|Listerine|listerine|mesh-list
138689219|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138689221|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
138689222|NCT03338387|Acipimox|acipimox|mesh-list
138689224|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
138689225|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366060|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
138689226|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138689227|NCT03334253|Atropine|atropine|mesh-list
138689228|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138689229|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138689230|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138689231|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138689232|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
138689233|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138689234|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689235|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138689236|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
138689237|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
138689238|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
138689239|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138689241|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
138689242|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138689243|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689244|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138689246|NCT03306264|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138689247|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138689248|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
138190813|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138190814|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138190815|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190816|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138190817|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
138689249|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689250|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689251|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689254|NCT03304080|Palbociclib|palbociclib|mesh-list
138689255|NCT03304080|Anastrozole|anastrozole|mesh-list
138689256|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689257|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689258|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138689260|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689261|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138689262|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138689263|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138689264|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138689265|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
138689266|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689267|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689268|NCT03275506|Bevacizumab|bevacizumab|mesh-list
138689269|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
138689270|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689271|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689272|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138689273|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138179571|NCT04845490|Mitomycins|mitomycins|mesh-list
138689274|NCT03275506|Growth Substances|growth substances|mesh-ancestor
138689275|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689276|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
138689277|NCT03275506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138689278|NCT03275506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689279|NCT03267680|Indomethacin|indomethacin|mesh-list
138689280|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
138689281|NCT03267680|Omeprazole|omeprazole|mesh-list
138689282|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138689283|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
138689284|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689285|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138689286|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138689287|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
138689288|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689289|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689290|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138689291|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138689292|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138689293|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138689294|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689295|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138689296|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138689298|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
138689299|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138689300|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138689301|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
138689302|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
138689303|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138689304|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138689305|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138689306|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689309|NCT03249870|Immunotoxins|immunotoxins|mesh-ancestor
138689310|NCT03249870|Immunoconjugates|immunoconjugates|mesh-ancestor
138689311|NCT03249870|Immunologic Factors|immunologic factors|mesh-ancestor
138689312|NCT03249870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689314|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138689315|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689316|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
138689317|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138689318|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
138689319|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138689320|NCT03210688|Prednisone|prednisone|mesh-list
138689321|NCT03210688|Prednisolone|prednisolone|mesh-list
138689322|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190823|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138689323|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
138689324|NCT03210688|Hormones|hormones|mesh-ancestor
138689325|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689326|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689327|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138689328|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689329|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138689330|NCT03210688|Vitamins|vitamins|mesh-ancestor
138689331|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
138689355|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
138689359|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138689361|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138689362|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
138689363|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138689365|NCT02980510|Folic Acid|folic acid|mesh-list
138689366|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
138689367|NCT02980510|Irinotecan|irinotecan|mesh-list
138689368|NCT02980510|Panitumumab|panitumumab|mesh-list
138689369|NCT02980510|Fluorouracil|fluorouracil|mesh-list
138689370|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
138689371|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689372|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138689373|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138689374|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689375|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689377|NCT02980510|Protective Agents|protective agents|mesh-ancestor
138689378|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689379|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
138689380|NCT02980510|Vitamins|vitamins|mesh-ancestor
138689381|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
138689382|NCT02980510|Hematinics|hematinics|mesh-ancestor
138689383|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689384|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
138689385|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138689386|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138689387|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
138689388|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
138689389|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689390|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689391|NCT02971956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138689392|NCT02971956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689394|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138689395|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138689396|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689397|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689398|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689400|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138689401|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
138689402|NCT02939742|Hormones|hormones|mesh-ancestor
138689403|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689404|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689405|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138689406|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
138689408|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689409|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138689410|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689411|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689412|NCT02891811|Thalidomide|thalidomide|mesh-list
138689413|NCT02891811|Dexamethasone|dexamethasone|mesh-list
138689414|NCT02891811|Lenalidomide|lenalidomide|mesh-list
138689415|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138689416|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
138689417|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
138689418|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138689419|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689420|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138689421|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
138689422|NCT02891811|Hormones|hormones|mesh-ancestor
138689423|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689424|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138689425|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689426|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
138689427|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138689428|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138689429|NCT02891811|Growth Substances|growth substances|mesh-ancestor
138689430|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
138689431|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138689432|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
138689433|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138689434|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689435|NCT02845882|Cytarabine|cytarabine|mesh-list
138689436|NCT02845882|Dexamethasone|dexamethasone|mesh-list
138689437|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
138689438|NCT02845882|Prednisone|prednisone|mesh-list
138689439|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
138689440|NCT02845882|Ifosfamide|ifosfamide|mesh-list
138689441|NCT02845882|Doxorubicin|doxorubicin|mesh-list
138689442|NCT02845882|Methotrexate|methotrexate|mesh-list
138689443|NCT02845882|Etoposide|etoposide|mesh-list
138689444|NCT02845882|Vincristine|vincristine|mesh-list
138689446|NCT02845882|Asparaginase|asparaginase|mesh-list
138689447|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
138689448|NCT02845882|Vindesine|vindesine|mesh-list
138689449|NCT02845882|Pegaspargase|pegaspargase|mesh-list
138689450|NCT02845882|BB 1101|bb 1101|mesh-list
138689452|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
138689453|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689454|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138689455|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138689456|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
138689457|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689458|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689459|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138689461|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
138689462|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
138689463|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138689464|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138689465|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
138179747|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138689467|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689468|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138689470|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689471|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138689472|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138689473|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138689474|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138689475|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
138689477|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138689478|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
138689479|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
138689480|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138223034|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
138689481|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138689482|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138689483|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
138689484|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689485|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
138689486|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
138689487|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
138689489|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689490|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689491|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138689492|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689493|NCT02789020|Rasagiline|rasagiline|mesh-list
138689494|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138689495|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689496|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689497|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138689498|NCT02789020|Protective Agents|protective agents|mesh-ancestor
138190829|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
138181316|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138689500|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
138689501|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
138689502|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138689503|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
138689504|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
138689505|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138689506|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689507|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138689508|NCT02719314|Hormones|hormones|mesh-ancestor
138689509|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689510|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138689511|NCT02719314|Protective Agents|protective agents|mesh-ancestor
138689512|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
138689513|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138689514|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689515|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138689516|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138689517|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689518|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689520|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138689521|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138689523|NCT02585388|Vinorelbine|vinorelbine|mesh-list
138689524|NCT02585388|Anastrozole|anastrozole|mesh-list
138689525|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689526|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138689527|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138689528|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689529|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689530|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138689531|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
138689532|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689533|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689534|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138689535|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
138689536|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
138689537|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
138689538|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138689539|NCT02584465|Tamoxifen|tamoxifen|mesh-list
138689540|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138689541|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
138181350|NCT02470390|Narcotics|narcotics|mesh-ancestor
138689542|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689544|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138689545|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689546|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138689547|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138689548|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138689549|NCT02579161|Ciprofloxacin|ciprofloxacin|mesh-list
138689550|NCT02579161|Clindamycin|clindamycin|mesh-list
138689551|NCT02579161|Gentamicins|gentamicins|mesh-list
138689552|NCT02579161|Penicillins|penicillins|mesh-list
138689554|NCT02579161|Cephalosporins|cephalosporins|mesh-list
138689555|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
138689556|NCT02579161|Lincosamides|lincosamides|mesh-list
138689557|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138689558|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689559|NCT02579161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138689560|NCT02579161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138689561|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138223169|NCT05945342|Antidepressive Agents|antidepressive agents|mesh-ancestor
138689562|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689563|NCT02579161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689564|NCT02579161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138689565|NCT02579161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138689566|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138689567|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138190836|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138689568|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
138689569|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138689570|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138689571|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689572|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
138689573|NCT02568124|Coagulants|coagulants|mesh-ancestor
138689574|NCT02535533|Selenium|selenium|mesh-list
138689575|NCT02535533|Axitinib|axitinib|mesh-list
138689576|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689577|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138689578|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689579|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689580|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
138689581|NCT02535533|Protective Agents|protective agents|mesh-ancestor
138689582|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689583|NCT02535533|Trace Elements|trace elements|mesh-ancestor
138689584|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
138689585|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
138689586|NCT02498912|Fludarabine|fludarabine|mesh-list
138689587|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138689588|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
138689589|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689590|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138689591|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138689592|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
138689593|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689594|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689595|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138689597|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138689598|NCT02431897|Hormones|hormones|mesh-ancestor
138689599|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689600|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689601|NCT02427841|Paclitaxel|paclitaxel|mesh-list
138689602|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138689603|NCT02427841|Gemcitabine|gemcitabine|mesh-list
138689604|NCT02427841|Fluorouracil|fluorouracil|mesh-list
138689605|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138689606|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689607|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
138689608|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
138689609|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
138179814|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
138689610|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689611|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138689612|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
138689613|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138689614|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
138689615|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689617|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
138689618|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
138689619|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
138689620|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138689621|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138689622|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
138689624|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138689625|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689626|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138689627|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138689628|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
138689629|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138689630|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689632|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138689633|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
138689634|NCT02386735|Hormones|hormones|mesh-ancestor
138689635|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689636|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689637|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138689638|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689639|NCT02383251|Paclitaxel|paclitaxel|mesh-list
138689640|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138689641|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689642|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
138689643|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
138689644|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
138689645|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689646|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
138689647|NCT02348216|Fludarabine|fludarabine|mesh-list
138689648|NCT02348216|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
138689649|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138689650|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
138689651|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689652|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138689653|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138689654|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
138689655|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689656|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689657|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138689658|NCT02348216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689659|NCT02204683|Aflibercept|aflibercept|mesh-list
138689660|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138689661|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138689662|NCT02204683|Growth Substances|growth substances|mesh-ancestor
138689663|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689664|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
138689665|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689666|NCT02134301|Oritavancin|oritavancin|mesh-list
138689667|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138689668|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689669|NCT02037529|Paclitaxel|paclitaxel|mesh-list
138689670|NCT02037529|Halichondrin B|halichondrin b|mesh-list
138689671|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138689672|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138689673|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689674|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
138689675|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
138689676|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
138689677|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689678|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138689679|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
138689680|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
138689681|NCT02030028|Hormones|hormones|mesh-ancestor
138689682|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689683|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689684|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138689685|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689686|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138689687|NCT01956123|Hormones|hormones|mesh-ancestor
138689688|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689689|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689690|NCT01906814|Carboplatin|carboplatin|mesh-list
138689691|NCT01906814|Etoposide|etoposide|mesh-list
138689692|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
138689693|NCT01906814|Vincristine|vincristine|mesh-list
138689694|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689695|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138689696|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138689697|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138689698|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689699|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689700|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
138689701|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
138689702|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
138190849|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
138190851|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
138689703|NCT01894308|Testosterone|testosterone|mesh-list
138689704|NCT01894308|Androgens|androgens|mesh-ancestor
138689705|NCT01894308|Hormones|hormones|mesh-ancestor
138689706|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138223422|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138689707|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689708|NCT01705158|Carboplatin|carboplatin|mesh-list
138689709|NCT01705158|Doxorubicin|doxorubicin|mesh-list
138689710|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138689711|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689712|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138689713|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138689714|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138689715|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689716|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689717|NCT01583322|Nintedanib|nintedanib|mesh-list
138689718|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689719|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138689720|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689721|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689722|NCT01571037|Milrinone|milrinone|mesh-list
138689723|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138689724|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138689725|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
138689726|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138689727|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138689728|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689729|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689730|NCT01571037|Protective Agents|protective agents|mesh-ancestor
138689731|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689732|NCT01469650|Vitamin D|vitamin d|mesh-list
138689733|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
138689734|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
138689735|NCT01469650|Vitamins|vitamins|mesh-list
138689736|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
138689737|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689738|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138689739|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138689740|NCT01431326|Vancomycin|vancomycin|mesh-list
138689741|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
138689742|NCT01431326|Tazobactam|tazobactam|mesh-list
138689743|NCT01431326|Piperacillin|piperacillin|mesh-list
138689744|NCT01431326|Tobramycin|tobramycin|mesh-list
138689745|NCT01431326|Amikacin|amikacin|mesh-list
138689747|NCT01431326|Fosfomycin|fosfomycin|mesh-list
138689748|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138689749|NCT01431326|Nafcillin|nafcillin|mesh-list
138689750|NCT01431326|Cidofovir|cidofovir|mesh-list
138689751|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
138689752|NCT01431326|Bosentan|bosentan|mesh-list
138689753|NCT01431326|Labetalol|labetalol|mesh-list
138689754|NCT01431326|Nifedipine|nifedipine|mesh-list
138689755|NCT01431326|Spironolactone|spironolactone|mesh-list
138689756|NCT01431326|Pentobarbital|pentobarbital|mesh-list
138689757|NCT01431326|Oxycodone|oxycodone|mesh-list
138689758|NCT01431326|Alfentanil|alfentanil|mesh-list
138689759|NCT01431326|Haloperidol|haloperidol|mesh-list
138689760|NCT01431326|Zolpidem|zolpidem|mesh-list
138689761|NCT01431326|Ziprasidone|ziprasidone|mesh-list
138689762|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138689763|NCT01431326|Clozapine|clozapine|mesh-list
138689764|NCT01431326|Molindone|molindone|mesh-list
138689765|NCT01431326|Warfarin|warfarin|mesh-list
138689766|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
138689767|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
138689768|NCT01431326|Rocuronium|rocuronium|mesh-list
138689769|NCT01431326|Vecuronium Bromide|vecuronium bromide|mesh-list
138689770|NCT01431326|Sevelamer|sevelamer|mesh-list
138689771|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138689772|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
138689773|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
138689774|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138689775|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689777|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
138689778|NCT01431326|Hormones|hormones|mesh-ancestor
138689779|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138190857|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
138689780|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138689781|NCT01431326|Protective Agents|protective agents|mesh-ancestor
138689782|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689783|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138689784|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138689785|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689786|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
138689787|NCT01431326|Coagulants|coagulants|mesh-ancestor
138689788|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138689789|NCT01431326|Narcotics|narcotics|mesh-ancestor
138689790|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138689791|NCT01431326|Analgesics|analgesics|mesh-ancestor
138689792|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
138689793|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
138689794|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138689795|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689796|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138689797|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138689798|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138689799|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138689800|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138689801|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138179930|NCT00821795|Coagulants|coagulants|mesh-ancestor
138689802|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138689803|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138223559|NCT03919435|Trimethoprim|trimethoprim|mesh-list
138689804|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138689805|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
138689806|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138689807|NCT01431326|Diuretics|diuretics|mesh-ancestor
138689808|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
138689809|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138689810|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138689811|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138689812|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
138689813|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
138689814|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138689815|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138689816|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138689817|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138689818|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138689819|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138689820|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
138689821|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138689822|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138689823|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138689824|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138689825|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138689826|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
138689827|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
138689828|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138689829|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
138689830|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138689831|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138689832|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
138689833|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
138689834|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138366662|NCT05795647|Tocopherols|tocopherols|mesh-list
138689835|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138689836|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138689837|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
138689838|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138689839|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138689840|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
138689841|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138689842|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
138689843|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138689844|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138689845|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
138689846|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
138689847|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
138689848|NCT01431326|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138689849|NCT01431326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138689850|NCT01431326|Cholinergic Agents|cholinergic agents|mesh-ancestor
138689851|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138689852|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
138689853|NCT01303679|Paclitaxel|paclitaxel|mesh-list
138689854|NCT01303679|Bevacizumab|bevacizumab|mesh-list
138689855|NCT01303679|Exemestane|exemestane|mesh-list
138689856|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138689857|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689858|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
138689859|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
138689860|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
138223642|NCT03356483|Vitamins|vitamins|mesh-ancestor
138689861|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689862|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689863|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138689864|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138689865|NCT01303679|Growth Substances|growth substances|mesh-ancestor
138689866|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689867|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
138689868|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138689869|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138689870|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689871|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138689872|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
138689873|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689874|NCT01298713|Tamoxifen|tamoxifen|mesh-list
138689875|NCT01298713|Everolimus|everolimus|mesh-list
138689876|NCT01298713|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138689877|NCT01298713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138689878|NCT01298713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689879|NCT01298713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689880|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138689881|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
138689882|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689883|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689884|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138689885|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
138689886|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138689887|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138689888|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138689889|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138689890|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138689891|NCT01191697|Bevacizumab|bevacizumab|mesh-list
138689892|NCT01191697|Trastuzumab|trastuzumab|mesh-list
138689893|NCT01191697|Capecitabine|capecitabine|mesh-list
138689894|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
138689895|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689896|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689897|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138689898|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138689899|NCT01191697|Growth Substances|growth substances|mesh-ancestor
138689900|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689901|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
138689902|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138689903|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
138689904|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689905|NCT01189643|Bevacizumab|bevacizumab|mesh-list
138689906|NCT01189643|Irinotecan|irinotecan|mesh-list
138689907|NCT01189643|Temozolomide|temozolomide|mesh-list
138689908|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689909|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138190870|NCT03587428|Zinc|zinc|mesh-list
138190872|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
138190874|NCT03398278|Oxycodone|oxycodone|mesh-list
138689910|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138689911|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138689912|NCT01189643|Growth Substances|growth substances|mesh-ancestor
138689913|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689914|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
138689915|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138689916|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138689917|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689918|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689919|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138689920|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
138689921|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
138689922|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
138689924|NCT01044745|Rituximab|rituximab|mesh-list
138689925|NCT01044745|Fludarabine|fludarabine|mesh-list
138689926|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
138689927|NCT01044745|Tacrolimus|tacrolimus|mesh-list
138689928|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
138689929|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138689930|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138689931|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
138689932|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689933|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138689934|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138689935|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
138689936|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689937|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689938|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138689939|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689940|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138689941|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
138689942|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138689943|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689944|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138689945|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138689946|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
138689947|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138689948|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689950|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138689951|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689952|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138689953|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689954|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138689955|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138689956|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138689957|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689958|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
138689959|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138181628|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
138689963|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
138689964|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689965|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
138689967|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689968|NCT02277041|Misoprostol|misoprostol|mesh-list
138689969|NCT02277041|Carbetocin|carbetocin|mesh-list
138689970|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138689971|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
138689972|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138689973|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689975|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138689976|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
138689977|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
138689978|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138689979|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
138689980|NCT02915289|Povidone|povidone|mesh-list
138689981|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138689982|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138689983|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
138689984|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
138689985|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
138689986|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
138689987|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
138366813|NCT05328258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689988|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138689989|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689991|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138689992|NCT02939417|Protective Agents|protective agents|mesh-ancestor
138689993|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138689995|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
138689996|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138689997|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138689998|NCT05034536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138689999|NCT05034536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690000|NCT05034536|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138690001|NCT05034536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690002|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
138690003|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138690004|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138690005|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138690006|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138690007|NCT02915172|Capecitabine|capecitabine|mesh-list
138690008|NCT02915172|Lenvatinib|lenvatinib|mesh-list
138690009|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138690010|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
138690011|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690012|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690013|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138690015|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
138690016|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138690018|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690019|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690020|NCT02915055|Acetaminophen|acetaminophen|mesh-list
138690021|NCT02915055|Ibuprofen|ibuprofen|mesh-list
138690022|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138690023|NCT02915055|Oxycodone|oxycodone|mesh-list
138690024|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138690025|NCT02915055|Analgesics|analgesics|mesh-ancestor
138690026|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
138690027|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690028|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690029|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
138690030|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138690031|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690032|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138690033|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138690034|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690035|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223999|NCT00837902|Atenolol|atenolol|mesh-list
138690036|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138690037|NCT02915055|Narcotics|narcotics|mesh-ancestor
138690038|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138690039|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
138690040|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138690041|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690042|NCT01295827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138690043|NCT01295827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690044|NCT02918760|Gabapentin|gabapentin|mesh-list
138690045|NCT02918760|Analgesics|analgesics|mesh-ancestor
138690046|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
138690047|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190884|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138190885|NCT03593902|Prednisolone|prednisolone|mesh-list
138190886|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
138190887|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
138190889|NCT03593902|Fludarabine|fludarabine|mesh-list
138190890|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
138190891|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138690048|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690049|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
138690050|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138690051|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138690052|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138690053|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138690054|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138690055|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138690056|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690057|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690058|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
138690059|NCT04690751|Cenobamate|cenobamate|mesh-list
138366900|NCT05201248|Hormones|hormones|mesh-ancestor
138690060|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
138690062|NCT03458078|Midazolam|midazolam|mesh-list
138690063|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138690064|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138690065|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138181688|NCT01839643|Meloxicam|meloxicam|mesh-list
138690066|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690067|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138690068|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138690069|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138690070|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138690071|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
138690073|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
138690074|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
138224093|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
138690075|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690076|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690078|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
138690079|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690080|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138690081|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
138690082|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138690083|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138690084|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138690085|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
138690086|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138690087|NCT04690556|Ranibizumab|ranibizumab|mesh-list
138690088|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138690089|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138690090|NCT04690556|Growth Substances|growth substances|mesh-ancestor
138690091|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690092|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
138690093|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690094|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138690095|NCT01294579|Ofatumumab|ofatumumab|mesh-list
138690096|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138690097|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
138690098|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690100|NCT02914626|Ranibizumab|ranibizumab|mesh-list
138690101|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138690102|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138690103|NCT02914626|Growth Substances|growth substances|mesh-ancestor
138690104|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690105|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
138690106|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690107|NCT02918331|Dexamethasone|dexamethasone|mesh-list
138690108|NCT02918331|Lenalidomide|lenalidomide|mesh-list
138690109|NCT02918331|Daratumumab|daratumumab|mesh-list
138690110|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690111|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
138690112|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
138690113|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690114|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690115|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138690116|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
138190894|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138190895|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
138690118|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138690119|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138690120|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690121|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
138690122|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138690123|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138690124|NCT02918331|Growth Substances|growth substances|mesh-ancestor
138690125|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
138690126|NCT02918136|Cortisone|cortisone|mesh-list
138690127|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690128|NCT01294462|Aspirin|aspirin|mesh-list
138690129|NCT01294462|Clopidogrel|clopidogrel|mesh-list
138690130|NCT01294462|Ticagrelor|ticagrelor|mesh-list
138690131|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138690132|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138690133|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138690134|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138690135|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
138690136|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690137|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690138|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224252|NCT05311514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138690139|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138180170|NCT00827099|Fludarabine|fludarabine|mesh-list
138690141|NCT01294462|Analgesics|analgesics|mesh-ancestor
138690142|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
138181739|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
138690143|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690144|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690145|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138690146|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138690147|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138690148|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138690149|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690150|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
138690151|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
138690152|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138690153|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690154|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138690155|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690156|NCT02910570|Liraglutide|liraglutide|mesh-list
138690157|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138690158|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690159|NCT02910570|Incretins|incretins|mesh-ancestor
138690160|NCT02910570|Hormones|hormones|mesh-ancestor
138180281|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138690161|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138690163|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138690164|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138690165|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690167|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
138690168|NCT04817033|Anesthetics|anesthetics|mesh-list
138690169|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138690170|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690171|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138690172|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138690174|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
138690175|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690176|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138690177|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138690178|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138180411|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
138690179|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
138690180|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690181|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690182|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138690183|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138690186|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138690187|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
138690189|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
138690191|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138690192|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138690193|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
138690194|NCT02938286|Epinephrine|epinephrine|mesh-list
138690195|NCT02938286|Carticaine|carticaine|mesh-list
138690196|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138690197|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138690198|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
138180485|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
138690200|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690201|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690202|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138690203|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138690204|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
138690205|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690206|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138690207|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
138690209|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
138690210|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138690211|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
138690212|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
138690213|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138690214|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
138690216|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138690217|NCT01292239|Simeprevir|simeprevir|mesh-list
138690218|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
138180531|NCT05588908|Hormones|hormones|mesh-ancestor
138690219|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690221|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690222|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
138690223|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690224|NCT05600179|Dexamethasone|dexamethasone|mesh-list
138690225|NCT05600179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690226|NCT05600179|Antiemetics|antiemetics|mesh-ancestor
138690227|NCT05600179|Autonomic Agents|autonomic agents|mesh-ancestor
138690228|NCT05600179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690229|NCT05600179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690230|NCT05600179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138690231|NCT05600179|Glucocorticoids|glucocorticoids|mesh-ancestor
138690232|NCT05600179|Hormones|hormones|mesh-ancestor
138690233|NCT05600179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138224663|NCT00895232|Iron|iron|mesh-list
138690235|NCT05600179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690236|NCT02937662|Cytarabine|cytarabine|mesh-list
138690237|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
138690238|NCT02937662|Idarubicin|idarubicin|mesh-list
138690239|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138690240|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
138690241|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690243|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138690244|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
138690245|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690246|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690247|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138690248|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138690249|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
138690250|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
138690251|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690252|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138690253|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138690254|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138690255|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690256|NCT01290757|Dabigatran|dabigatran|mesh-list
138690257|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
138690258|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138690260|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690261|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690262|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
138690263|NCT02937857|Antipyretics|antipyretics|mesh-list
138690264|NCT02937857|Expectorants|expectorants|mesh-list
138690265|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
138690266|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690267|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
138690268|NCT04324060|Danazol|danazol|mesh-list
138690269|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138690270|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
138690271|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138690272|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690273|NCT01290718|Capecitabine|capecitabine|mesh-list
138690274|NCT01290718|Trastuzumab|trastuzumab|mesh-list
138690275|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138690276|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
138690277|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690278|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690279|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138690280|NCT02937896|Ketorolac|ketorolac|mesh-list
138690281|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138690282|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138690283|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138690284|NCT02937896|Analgesics|analgesics|mesh-ancestor
138690285|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
138690286|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690287|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690288|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690289|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138224792|NCT01837628|Emollients|emollients|mesh-ancestor
138690290|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138690291|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690293|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
138690294|NCT02937896|Coagulants|coagulants|mesh-ancestor
138690295|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138690296|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
138690298|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
138690299|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690300|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138690301|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138690302|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690303|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690304|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138690305|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138690308|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138690309|NCT01290679|Simeprevir|simeprevir|mesh-list
138690310|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
138690311|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690312|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
138690313|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690314|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
138690315|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690316|NCT03457389|Cabergoline|cabergoline|mesh-list
138690317|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138690318|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138690319|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
138690321|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690322|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690323|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690324|NCT02890186|Remifentanil|remifentanil|mesh-list
138690326|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138690327|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138690328|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690329|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138690330|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
138690331|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
138690332|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138690333|NCT02890186|Narcotics|narcotics|mesh-ancestor
138690334|NCT02890186|Analgesics|analgesics|mesh-ancestor
138690335|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
138690336|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690337|NCT02909751|Tocotrienols|tocotrienols|mesh-list
138690338|NCT02909751|Vitamin E|vitamin e|mesh-list
138690339|NCT02909751|Tocopherols|tocopherols|mesh-list
138690340|NCT02909751|Docetaxel|docetaxel|mesh-list
138690341|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
138690342|NCT02909751|Trastuzumab|trastuzumab|mesh-list
138690343|NCT02909751|Epirubicin|epirubicin|mesh-list
138690344|NCT02909751|Pertuzumab|pertuzumab|mesh-list
138690345|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690348|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
138690349|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690350|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138690351|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
138690352|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690353|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138690354|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138690355|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
138690356|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138690357|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138690358|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138690359|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138690360|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138690361|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690362|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
138690363|NCT02909751|Protective Agents|protective agents|mesh-ancestor
138690364|NCT02909751|Vitamins|vitamins|mesh-ancestor
138690365|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
138690366|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
138690367|NCT02909712|Piperaquine|piperaquine|mesh-list
138690368|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
138690369|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138690370|NCT02909712|Artenimol|artenimol|mesh-list
138690371|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
138690372|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138690373|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138690374|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690375|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138690376|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690377|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690378|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138690379|NCT02913885|Fluorides|fluorides|mesh-list
138690380|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
138690381|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
138690382|NCT02913885|Protective Agents|protective agents|mesh-ancestor
138690383|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690384|NCT01290601|Chloroquine|chloroquine|mesh-list
138690393|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138690394|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138690395|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138690396|NCT01290601|Analgesics|analgesics|mesh-ancestor
138690397|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
138690398|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138225068|NCT01569191|Epinastine|epinastine|mesh-list
138690399|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690401|NCT01290601|Filaricides|filaricides|mesh-ancestor
138690402|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
138690403|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
138690404|NCT02978391|Epinephrine|epinephrine|mesh-list
138690405|NCT02978391|Hemostatics|hemostatics|mesh-list
138690406|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138690407|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138690408|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
138690409|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690410|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690411|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690412|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138690413|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138690414|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
138180939|NCT02726620|Epinephrine|epinephrine|mesh-list
138690415|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690416|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138690417|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
138690418|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
138690419|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
138690420|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138690422|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
138690423|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138367467|NCT03016871|Nivolumab|nivolumab|mesh-list
138690445|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690446|NCT01289821|Antidotes|antidotes|mesh-ancestor
138690447|NCT01289821|Protective Agents|protective agents|mesh-ancestor
138690448|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690452|NCT01289821|Hematinics|hematinics|mesh-ancestor
138690453|NCT02913768|Ondansetron|ondansetron|mesh-list
138690454|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
138690455|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
138690456|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690457|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690458|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138690459|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
138690460|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
138690461|NCT02913768|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138690462|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138690463|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
138690464|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690465|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690467|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138690468|NCT01289782|Simeprevir|simeprevir|mesh-list
138690469|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
138690470|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690471|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
138690472|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690473|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
138690474|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690475|NCT02913417|Nivolumab|nivolumab|mesh-list
138690476|NCT02913417|Ipilimumab|ipilimumab|mesh-list
138690477|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138690478|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690479|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138690480|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690482|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690483|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
138690485|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138690486|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690487|NCT02913573|Bupivacaine|bupivacaine|mesh-list
138181160|NCT05444452|Sirolimus|sirolimus|mesh-list
138690488|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
138690490|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138690491|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690492|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
138690493|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690495|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690496|NCT02913300|Lidocaine|lidocaine|mesh-list
138690497|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138690498|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
138690499|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
138690500|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138690501|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690502|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
138690503|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690504|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138690505|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138690506|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138690507|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138690508|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690509|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
138690510|NCT02936375|Azathioprine|azathioprine|mesh-list
138190929|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138190930|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690511|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138690512|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
138690513|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690514|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138690515|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138690516|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
138690517|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690518|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690519|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138367344|NCT03636373|Analgesics|analgesics|mesh-ancestor
138690520|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
138690521|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138690522|NCT02913690|Vitamin E|vitamin e|mesh-list
138690523|NCT02913690|Vitamins|vitamins|mesh-ancestor
138690524|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
138690525|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690526|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
138690527|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690528|NCT02913690|Protective Agents|protective agents|mesh-ancestor
138690529|NCT01289119|Metformin|metformin|mesh-list
138690531|NCT01289119|Alogliptin|alogliptin|mesh-list
138690532|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138690533|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690535|NCT01289119|Hormones|hormones|mesh-ancestor
138690536|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138690537|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138690538|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
138690539|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690540|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690541|NCT01287832|Vancomycin|vancomycin|mesh-list
138690542|NCT01287832|Daptomycin|daptomycin|mesh-list
138690543|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138690544|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690545|NCT02913066|Cisplatin|cisplatin|mesh-list
138690547|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138690548|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690549|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138690550|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690551|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690552|NCT02912793|Betadex|betadex|mesh-list
138690553|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
138690554|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690555|NCT02935751|Apixaban|apixaban|mesh-list
138225333|NCT03006965|BAX 855|bax 855|mesh-list
138690556|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138690557|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
138690558|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138690559|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
138690560|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690561|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690562|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
138690564|NCT02935790|Ipilimumab|ipilimumab|mesh-list
138690565|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138690566|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690567|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138181442|NCT03166228|Glycine|glycine|mesh-list
138690570|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138690571|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
138690572|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
138690573|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138690574|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690575|NCT02912910|Labetalol|labetalol|mesh-list
138690576|NCT02912910|Nifedipine|nifedipine|mesh-list
138690577|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138690578|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138190936|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138190937|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
138190938|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190942|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
138690579|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690580|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138690581|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690582|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
138690583|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
138690584|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138690585|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138690586|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138690587|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
138690588|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690589|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138690590|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
138690591|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
138690592|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690593|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138690594|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138690595|NCT02935829|Locust bean gum|locust bean gum|mesh-list
138690596|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
138690597|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138690599|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
138690600|NCT02912676|Thioguanine|thioguanine|mesh-list
138690603|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138690604|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690605|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138690606|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
138690607|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690608|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690609|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
138690610|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690611|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138690612|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138690613|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
138690614|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138690615|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138690616|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
138690617|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138690618|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138690619|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690620|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
138690621|NCT02935985|Coagulants|coagulants|mesh-ancestor
138690622|NCT02912169|Anesthetics|anesthetics|mesh-list
138690623|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138181753|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
138690624|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690625|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138690626|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690627|NCT02935959|Midazolam|midazolam|mesh-list
138690628|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
138690629|NCT02935959|Ketamine|ketamine|mesh-list
138690630|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138690631|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138690632|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690633|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138690634|NCT02935959|Analgesics|analgesics|mesh-ancestor
138690635|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
138690636|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138181848|NCT02495038|Rocuronium|rocuronium|mesh-list
138690637|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138690638|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138690640|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
138690641|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690642|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690643|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138690644|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138690645|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
138690646|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
138690647|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138690648|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138690649|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138690650|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138190944|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690651|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138690652|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138690653|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
138690654|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
138690655|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
138690656|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138690657|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138690658|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690659|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
138690660|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
138690661|NCT02935647|Propofol|propofol|mesh-list
138690662|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138690663|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138690664|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690665|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138690666|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
138690668|NCT02912247|Adalimumab|adalimumab|mesh-list
138690669|NCT02912247|Antibodies|antibodies|mesh-list
138690670|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138690671|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
138367488|NCT03004443|Infliximab|infliximab|mesh-list
138690672|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690673|NCT02912247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138690674|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690676|NCT02935010|Amoxicillin|amoxicillin|mesh-list
138690677|NCT02935010|Metronidazole|metronidazole|mesh-list
138690678|NCT02935010|Clarithromycin|clarithromycin|mesh-list
138690679|NCT02935010|Levofloxacin|levofloxacin|mesh-list
138690680|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
138690681|NCT02935010|Esomeprazole|esomeprazole|mesh-list
138690683|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690684|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138690685|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690687|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138690688|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138690689|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138690690|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138690691|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690692|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138690693|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138690694|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138690695|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138690696|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138690697|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138690698|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690699|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138690701|NCT02935010|Diuretics|diuretics|mesh-ancestor
138690702|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
138690703|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690704|NCT02935010|Expectorants|expectorants|mesh-ancestor
138690705|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
138225636|NCT01046396|Analgesics|analgesics|mesh-ancestor
138690706|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138690707|NCT02935530|Tinzaparin|tinzaparin|mesh-list
138690708|NCT02935530|Dalteparin|dalteparin|mesh-list
138690709|NCT02935530|Argatroban|argatroban|mesh-list
138690710|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
138690711|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138690712|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138690713|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690714|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
138690715|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138690716|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
138690717|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690718|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138690719|NCT02934464|Leucovorin|leucovorin|mesh-list
138690720|NCT02934464|Paclitaxel|paclitaxel|mesh-list
138690721|NCT02934464|Ramucirumab|ramucirumab|mesh-list
138690722|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
138690723|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
138690724|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138690725|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690726|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
138690727|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
138690728|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
138690729|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690730|NCT02934464|Antidotes|antidotes|mesh-ancestor
138690731|NCT02934464|Protective Agents|protective agents|mesh-ancestor
138690732|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690733|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
138690735|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
138182124|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138690736|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138690738|NCT02934035|Paroxetine|paroxetine|mesh-list
138690739|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138690740|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
138690741|NCT02934035|Escitalopram|escitalopram|mesh-list
138690742|NCT02934035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138690743|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138690744|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138225683|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138690745|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138182330|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138690746|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690747|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
138690748|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690749|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690750|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138690751|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138690752|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138690753|NCT02934035|Analgesics|analgesics|mesh-ancestor
138690754|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
138690755|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
138690756|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138690757|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138690758|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690759|NCT02934152|Amoxicillin|amoxicillin|mesh-list
138690760|NCT02934152|Clarithromycin|clarithromycin|mesh-list
138690761|NCT02934152|Rabeprazole|rabeprazole|mesh-list
138690762|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138690763|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690764|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138690765|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138182452|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690766|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690767|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138690768|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138690769|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138690770|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138690771|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138690772|NCT02935335|Menotropins|menotropins|mesh-list
138690773|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138690774|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
138690775|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138690776|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690778|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
138690779|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138690780|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690781|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138690782|NCT02935101|Prednisolone|prednisolone|mesh-list
138690783|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138690784|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
138690785|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138690786|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
138690787|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138690788|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
138690789|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690790|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
138690791|NCT02935101|Hormones|hormones|mesh-ancestor
138690792|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138690793|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690794|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138690795|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690796|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
138690797|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
138690798|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690799|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138690800|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138690801|NCT02935101|Protective Agents|protective agents|mesh-ancestor
138690802|NCT04689971|Vitamins|vitamins|mesh-list
138690803|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
138690804|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
138690805|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690806|NCT02934945|Budesonide|budesonide|mesh-list
138690807|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
138690808|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138690809|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138690810|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
138690811|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690812|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690813|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138690814|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
138690815|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
138690816|NCT02934945|Hormones|hormones|mesh-ancestor
138690817|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138182192|NCT05532072|Sirolimus|sirolimus|mesh-list
138690819|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138690820|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138690821|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
138690822|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690823|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690824|NCT02933645|Insulin|insulin|mesh-list
138690825|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138367636|NCT00529113|Gemcitabine|gemcitabine|mesh-list
138690826|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138690827|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690829|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138690830|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690831|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138690832|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
138690833|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138690834|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
138690835|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690836|NCT02933333|Molgramostim|molgramostim|mesh-list
138690837|NCT02933333|Lenograstim|lenograstim|mesh-list
138690838|NCT02933333|Sargramostim|sargramostim|mesh-list
138690839|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138690840|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
138690841|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690842|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690843|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
138690844|NCT02670252|Busulfan|busulfan|mesh-list
138690845|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138690846|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
138690847|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690848|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138690849|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138690850|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
138690851|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690852|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690853|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138690854|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
138690855|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
138690856|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138690857|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138690858|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690859|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138690860|NCT02933099|Dexamethasone|dexamethasone|mesh-list
138690861|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
138690863|NCT02933099|Palonosetron|palonosetron|mesh-list
138690864|NCT02933099|BB 1101|bb 1101|mesh-list
138182219|NCT00864539|Vitamin D|vitamin d|mesh-list
138690868|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690869|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690870|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138690871|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
138690872|NCT02933099|Hormones|hormones|mesh-ancestor
138690873|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138183023|NCT05348980|Phenylephrine|phenylephrine|mesh-list
138690875|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690876|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
138225937|NCT05014919|Vortioxetine|vortioxetine|mesh-list
138690877|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183089|NCT02748070|Prednisone|prednisone|mesh-list
138690878|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690879|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138690880|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138690881|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138690882|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138690883|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
138690884|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
138690885|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138690886|NCT02934906|Antibodies|antibodies|mesh-list
138690887|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
138690888|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138690889|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
138690890|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690891|NCT02911350|Paclitaxel|paclitaxel|mesh-list
138690892|NCT02911350|Hormones|hormones|mesh-list
138690893|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138690894|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690895|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
138690896|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
138690897|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
138690898|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690899|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138690900|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690903|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138690904|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690905|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138690907|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
138690908|NCT02911272|Oxytocin|oxytocin|mesh-list
138690909|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
138690910|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138690911|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690912|NCT02932436|Empagliflozin|empagliflozin|mesh-list
138690913|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138690914|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690915|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138690916|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690918|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138690919|NCT02932007|Amebicides|amebicides|mesh-ancestor
138690920|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138690921|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138690922|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690924|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138690925|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138690926|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138690927|NCT02932007|Analgesics|analgesics|mesh-ancestor
138183410|NCT01044433|Lapatinib|lapatinib|mesh-list
138690928|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
138690929|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690930|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690931|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138190971|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138690932|NCT02932007|Filaricides|filaricides|mesh-ancestor
138690933|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
138690934|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
138690935|NCT02910882|Gemcitabine|gemcitabine|mesh-list
138690936|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138690937|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
138690938|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690939|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690940|NCT02910765|Methylene Blue|methylene blue|mesh-list
138690941|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138690942|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690943|NCT02925026|Lactoferrin|lactoferrin|mesh-list
138690944|NCT02925026|Muramidase|muramidase|mesh-list
138690945|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138690946|NCT02924987|Aflibercept|aflibercept|mesh-list
138690947|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138690948|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138690949|NCT02924987|Growth Substances|growth substances|mesh-ancestor
138183483|NCT01041859|Tapentadol|tapentadol|mesh-list
138690950|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690951|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
138690952|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690953|NCT02924909|Paclitaxel|paclitaxel|mesh-list
138690954|NCT02924909|Carboplatin|carboplatin|mesh-list
138690955|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138690956|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690957|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
138690958|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
138690959|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
138690960|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690961|NCT02934321|Erythritol|erythritol|mesh-list
138690962|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
138690963|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
138690964|NCT02924753|Fludarabine|fludarabine|mesh-list
138690965|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138690966|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
138690967|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690969|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138690970|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
138690971|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690972|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138690973|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138690974|NCT02924675|Pregabalin|pregabalin|mesh-list
138690975|NCT02924675|Analgesics|analgesics|mesh-ancestor
138690976|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
138690977|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138690978|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138690980|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138690981|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138690982|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690983|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138690984|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138690985|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138690986|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138690988|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
138690989|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138690990|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138182317|NCT00913003|Lidocaine|lidocaine|mesh-list
138690991|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690992|NCT02924285|Amiodarone|amiodarone|mesh-list
138690993|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138690994|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
138690995|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138690996|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138690997|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138690998|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138690999|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138691000|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138691001|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138183569|NCT03400189|Sulthiame|sulthiame|mesh-list
138691002|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138691003|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138691004|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138691005|NCT01287520|Carboplatin|carboplatin|mesh-list
138691006|NCT01287520|Pemetrexed|pemetrexed|mesh-list
138691007|NCT01287520|Ranitidine|ranitidine|mesh-list
138183652|NCT05314127|Imiquimod|imiquimod|mesh-list
138691008|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138691009|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691010|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691011|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691012|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138691013|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138691014|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138691015|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138691016|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138691017|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
138691018|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
138691019|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691020|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691021|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
138183771|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138691022|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138691023|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138691024|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138691025|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138691027|NCT01287364|Ciclesonide|ciclesonide|mesh-list
138691028|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138691029|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
138691030|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138691031|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
138691032|NCT01287364|Hormones|hormones|mesh-ancestor
138691033|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138691034|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691035|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
138691036|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138691037|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691038|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
138691039|NCT02924090|Ketamine|ketamine|mesh-list
138691040|NCT02924090|Etomidate|etomidate|mesh-list
138691041|NCT02924090|Analgesics|analgesics|mesh-ancestor
138691042|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
138691043|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138183972|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691044|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691045|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138691046|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138691047|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
138691048|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
138691049|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138691050|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138691051|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138691052|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691053|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691054|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138691055|NCT04137770|Ketorolac|ketorolac|mesh-list
138691056|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138691057|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138691058|NCT04137770|Analgesics|analgesics|mesh-ancestor
138691059|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
138691060|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691061|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691062|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138691063|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138691064|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138691065|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138190986|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
138691066|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691067|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
138691068|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
138691069|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691070|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138691071|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138691072|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691073|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691074|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138691075|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138691076|NCT02923856|Clarithromycin|clarithromycin|mesh-list
138691077|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138691078|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691079|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138691080|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691081|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691082|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138691083|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138691084|NCT02934204|Methotrexate|methotrexate|mesh-list
138691085|NCT02934204|Temozolomide|temozolomide|mesh-list
138691086|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138691087|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
138182380|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
138691088|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138691089|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691090|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138691091|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
138691092|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691093|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691095|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691096|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138691097|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138691098|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
138691099|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138691100|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138691101|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138691102|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
138691103|NCT01286077|Bortezomib|bortezomib|mesh-list
138226276|NCT02223065|Incretins|incretins|mesh-ancestor
138691104|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691106|NCT05590936|Dimenhydrinate|dimenhydrinate|mesh-list
138691107|NCT05590936|Antiemetics|antiemetics|mesh-ancestor
138691108|NCT05590936|Autonomic Agents|autonomic agents|mesh-ancestor
138691109|NCT05590936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691110|NCT05590936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691111|NCT05590936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138691112|NCT05590936|Antipruritics|antipruritics|mesh-ancestor
138691113|NCT05590936|Dermatologic Agents|dermatologic agents|mesh-ancestor
138184287|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
138691114|NCT05590936|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138691115|NCT05590936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138691116|NCT05590936|Serotonin Agents|serotonin agents|mesh-ancestor
138691117|NCT05590936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691118|NCT05590936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691119|NCT05590936|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138691120|NCT05590936|Histamine Antagonists|histamine antagonists|mesh-ancestor
138691121|NCT05590936|Histamine Agents|histamine agents|mesh-ancestor
138691122|NCT02933814|Bupivacaine|bupivacaine|mesh-list
138691123|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
138691124|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
138691125|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138691126|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691127|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
138691128|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691129|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
138691130|NCT02933775|Fludarabine|fludarabine|mesh-list
138190994|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191001|NCT00362895|Hormones|hormones|mesh-ancestor
138691131|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138691132|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
138691133|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691134|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138691135|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138691136|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
138691137|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691138|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691139|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138691141|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138691142|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691143|NCT02923583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138691144|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691145|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138691146|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
138691147|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691148|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138691149|NCT02933580|JNJ-56136379|jnj-56136379|mesh-list
138691150|NCT02933580|Antiviral Agents|antiviral agents|mesh-ancestor
138691151|NCT02933580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691152|NCT02923388|Vitamins|vitamins|mesh-list
138691153|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
138691155|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
138691156|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
138691157|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
138691158|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691159|NCT02933658|Amlodipine|amlodipine|mesh-list
138691160|NCT02933658|Telmisartan|telmisartan|mesh-list
138691161|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138691162|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138691163|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138691164|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138691165|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691166|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138691167|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691168|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
138691169|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138691170|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138691171|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
138184593|NCT02241421|Amoxicillin|amoxicillin|mesh-list
138691172|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138691173|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138691174|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691175|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138691176|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138691177|NCT02933853|Insulin|insulin|mesh-list
138691178|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138691179|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
138691180|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
138691181|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138691182|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138691183|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691185|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691186|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138691187|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691188|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691189|NCT02665143|Nintedanib|nintedanib|mesh-list
138691190|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691191|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138691192|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691193|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691194|NCT00532272|Letrozole|letrozole|mesh-list
138691195|NCT00532272|Goserelin|goserelin|mesh-list
138691196|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691197|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138691198|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138691199|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691200|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691201|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138691202|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
138691203|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138691204|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691205|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138691206|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
138691208|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
138184789|NCT02982577|Miotics|miotics|mesh-ancestor
138691209|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
138691210|NCT02922803|Vitamins|vitamins|mesh-list
138691211|NCT02922803|Calcium|calcium|mesh-list
138691212|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
138691213|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691214|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138691215|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138691216|NCT02834559|Fluorouracil|fluorouracil|mesh-list
138691219|NCT02834559|Tinzaparin|tinzaparin|mesh-list
138691220|NCT02834559|Dalteparin|dalteparin|mesh-list
138691221|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
138691222|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691223|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138691224|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691225|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138691226|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
138691227|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691228|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
138691229|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138691230|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138691231|NCT02922686|Floxacillin|floxacillin|mesh-list
138691232|NCT02922686|Penicillin V|penicillin v|mesh-list
138691233|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138691234|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691235|NCT02922491|Vitamin E|vitamin e|mesh-list
138691236|NCT02922491|Vitamins|vitamins|mesh-ancestor
138691237|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
138691238|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691239|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
138184907|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138691240|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691241|NCT02922491|Protective Agents|protective agents|mesh-ancestor
138691242|NCT02922179|Insulin|insulin|mesh-list
138691243|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
138691244|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138691245|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691246|NCT02921984|Docetaxel|docetaxel|mesh-list
138691247|NCT02921984|Pemetrexed|pemetrexed|mesh-list
138691248|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691249|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
138691250|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
138691251|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
138691252|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691253|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691254|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138691255|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138691257|NCT01285609|Carboplatin|carboplatin|mesh-list
138691258|NCT01285609|Ipilimumab|ipilimumab|mesh-list
138691259|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138691260|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691261|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
138691262|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
138691263|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
138691264|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691265|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138691266|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138691267|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
138691269|NCT03981341|Hormones|hormones|mesh-ancestor
138691270|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138691271|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691272|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138191013|NCT04744623|Dapsone|dapsone|mesh-list
138691273|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138691274|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
138691275|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138691277|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
138185098|NCT04366609|Methylphenidate|methylphenidate|mesh-list
138691279|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691280|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138691281|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
138691282|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138691283|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138691284|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
138691285|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138691286|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
138691287|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691288|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691289|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138691290|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
138691291|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
138691293|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
138691294|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691295|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691296|NCT04615143|Tislelizumab|tislelizumab|mesh-list
138691297|NCT04615143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138185289|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
138691298|NCT04615143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691299|NCT01284634|Cannabidiol|cannabidiol|mesh-list
138691300|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
138691301|NCT02932722|Anesthetics|anesthetics|mesh-list
138691302|NCT02932722|Propofol|propofol|mesh-list
138691303|NCT02932722|Sevoflurane|sevoflurane|mesh-list
138691304|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138691305|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185355|NCT04355845|Sumatriptan|sumatriptan|mesh-list
138691306|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138691307|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138691308|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
138691309|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138691310|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138691311|NCT02932761|Goserelin|goserelin|mesh-list
138691312|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138691313|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691314|NCT01283971|Adalimumab|adalimumab|mesh-list
138691315|NCT01283971|Methotrexate|methotrexate|mesh-list
138691316|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138691317|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
138691318|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138691319|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185424|NCT02909140|Lidocaine|lidocaine|mesh-list
138691320|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138691321|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
138691322|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691323|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691324|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
138691325|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691326|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138691327|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138691328|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
138691329|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138691330|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138691331|NCT01283971|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138691332|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138691333|NCT02921282|Dopamine|dopamine|mesh-list
138691334|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138691335|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
138691336|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
138691337|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138182575|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
138691339|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
138691340|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691341|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691343|NCT02921360|Aspirin|aspirin|mesh-list
138691344|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138691345|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138691346|NCT02921360|Analgesics|analgesics|mesh-ancestor
138691347|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
138691348|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691349|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691350|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138691351|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138691352|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138226584|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
138691353|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138691354|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691355|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138691356|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138691357|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691359|NCT02932605|Cannabidiol|cannabidiol|mesh-list
138691360|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
138691361|NCT02921204|Vitamin D|vitamin d|mesh-list
138691362|NCT02921204|Vitamins|vitamins|mesh-ancestor
138691363|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
138691364|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691365|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138691366|NCT01283581|Vancomycin|vancomycin|mesh-list
138691367|NCT01283581|Linezolid|linezolid|mesh-list
138691368|NCT01283581|Delafloxacin|delafloxacin|mesh-list
138691369|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138691370|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691371|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138691372|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691373|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691374|NCT01283542|Pasireotide|pasireotide|mesh-list
138691375|NCT01283542|Hormones|hormones|mesh-ancestor
138691376|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138691377|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691378|NCT02932488|Sumatriptan|sumatriptan|mesh-list
138691379|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138691380|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138691381|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138691382|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
138691383|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138226620|NCT02244242|Urological Agents|urological agents|mesh-ancestor
138691384|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691385|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691387|NCT02921165|Analgesics|analgesics|mesh-list
138691388|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138691389|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138691390|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
138691391|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691392|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691393|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138691394|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138691395|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138691396|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138691397|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691398|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138691399|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138691400|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691402|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
138691403|NCT01283386|Chlorambucil|chlorambucil|mesh-list
138691404|NCT01283386|Rituximab|rituximab|mesh-list
138691405|NCT01283386|Fludarabine|fludarabine|mesh-list
138691406|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138691407|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
138691408|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691409|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138691410|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138691411|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
138691412|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691413|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691414|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138691415|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138691416|NCT02920931|Tenofovir|tenofovir|mesh-list
138691417|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
138691418|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691419|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138691420|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138691422|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691423|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138691424|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138691425|NCT01283152|Lactulose|lactulose|mesh-list
138691426|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138185831|NCT03871465|Hormones|hormones|mesh-ancestor
138691427|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138691428|NCT01283152|Laxatives|laxatives|mesh-ancestor
138691431|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691432|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
138691433|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
138691434|NCT01283464|Vitamins|vitamins|mesh-ancestor
138691436|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691437|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138691438|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138691439|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138691440|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138691441|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691442|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691443|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691444|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138691445|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
138691447|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
138691448|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138691449|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
138691450|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691451|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691452|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138691453|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
138691454|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
138691455|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138691456|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
138691457|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691458|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691460|NCT02932566|Analgesics|analgesics|mesh-ancestor
138691461|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
138691462|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691463|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691464|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138691466|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138691467|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138691468|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691469|NCT00532389|Panobinostat|panobinostat|mesh-list
138691470|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691471|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138691472|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691473|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691475|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
138691476|NCT02932644|Cholecalciferol|cholecalciferol|mesh-list
138691477|NCT02932644|Vitamins|vitamins|mesh-list
138691478|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
138182657|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
138691480|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138691481|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138691482|NCT05466708|Dexmedetomidine|dexmedetomidine|mesh-list
138691483|NCT05466708|Ketamine|ketamine|mesh-list
138691484|NCT05466708|Esketamine|esketamine|mesh-list
138691485|NCT05466708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138691486|NCT05466708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138691487|NCT05466708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191022|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138191024|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
138691489|NCT05466708|Analgesics|analgesics|mesh-ancestor
138691490|NCT05466708|Sensory System Agents|sensory system agents|mesh-ancestor
138691491|NCT05466708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691492|NCT05466708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138691493|NCT05466708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138691494|NCT05466708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138691495|NCT05466708|Adrenergic Agents|adrenergic agents|mesh-ancestor
138691496|NCT05466708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691497|NCT05466708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691498|NCT05466708|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138691499|NCT05466708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138691500|NCT05466708|Anesthetics, General|anesthetics, general|mesh-ancestor
138691501|NCT05466708|Anesthetics|anesthetics|mesh-ancestor
138691502|NCT05466708|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138691503|NCT05466708|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138691504|NCT05466708|Antidepressive Agents|antidepressive agents|mesh-ancestor
138691505|NCT05466708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138691506|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
138691508|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138691509|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691510|NCT02920502|Vitamins|vitamins|mesh-ancestor
138691511|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
138691512|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138691513|NCT01282216|Vaccines|vaccines|mesh-list
138691514|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138691515|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
138691516|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691517|NCT01281865|Everolimus|everolimus|mesh-list
138691518|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
138691519|NCT01281865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138691520|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138691521|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691522|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691523|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138691524|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
138691525|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691526|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691527|NCT02920658|Betamethasone|betamethasone|mesh-list
138691528|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
138691529|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138691530|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
138691531|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138691533|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
138691534|NCT02920658|Hormones|hormones|mesh-ancestor
138691535|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138691536|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691537|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138691538|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
138691540|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
138691541|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691542|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691543|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
138691544|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691545|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691546|NCT01281124|Azacitidine|azacitidine|mesh-list
138691547|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138691548|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
138691549|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691550|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691551|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691552|NCT00623857|Vitamins|vitamins|mesh-list
138691553|NCT00623857|Zinc|zinc|mesh-list
138691554|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
138691555|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691556|NCT00623857|Trace Elements|trace elements|mesh-ancestor
138691557|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138691558|NCT01280968|Vaccines|vaccines|mesh-list
138691559|NCT01280968|Nicotine|nicotine|mesh-list
138691560|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
138691561|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691562|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138691563|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
138691564|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691565|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138691566|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138691567|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
138691568|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186285|NCT03031249|Tretinoin|tretinoin|mesh-list
138691569|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691570|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138691571|NCT01280968|Antacids|antacids|mesh-ancestor
138691572|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138691573|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138691574|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
138691575|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138691576|NCT02932020|Prednisolone|prednisolone|mesh-list
138691577|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
138691578|NCT02932020|Bupivacaine|bupivacaine|mesh-list
138691579|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138691580|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
138691581|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
138691582|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
138691583|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138691584|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691585|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
138691586|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691587|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138691588|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
138691589|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
138691590|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138691591|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
138691592|NCT02932020|Hormones|hormones|mesh-ancestor
138691593|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138691594|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138691596|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138691597|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691598|NCT01280656|Interferons|interferons|mesh-list
138691599|NCT01280656|Ribavirin|ribavirin|mesh-list
138226919|NCT02459418|Hormones|hormones|mesh-ancestor
138691600|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138691601|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138691602|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691603|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
138691604|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691605|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
138691606|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691607|NCT03741530|Glyburide|glyburide|mesh-list
138691608|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138691609|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691610|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
138691611|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138691612|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
138691613|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691614|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138691615|NCT02932137|Interleukin-2|interleukin-2|mesh-list
138691616|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691617|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138691619|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
138691620|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691621|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691622|NCT01280266|Amlodipine|amlodipine|mesh-list
138691623|NCT01280266|Udenafil|udenafil|mesh-list
138691624|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138691625|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138691626|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138691627|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691628|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138691629|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691630|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
138691631|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138691632|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138691633|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691634|NCT01279447|Bupivacaine|bupivacaine|mesh-list
138691635|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
138691636|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
138691637|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138691638|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691639|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
138691640|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691641|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
138691642|NCT02932254|Analgesics|analgesics|mesh-ancestor
138691643|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
138691644|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691645|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691647|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138691648|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138691649|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
138691650|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138691651|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138691652|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691653|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138691655|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138691656|NCT02920190|Liraglutide|liraglutide|mesh-list
138691657|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138226973|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138691658|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691660|NCT02920190|Hormones|hormones|mesh-ancestor
138691661|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138186669|NCT04358341|Irinotecan|irinotecan|mesh-list
138691663|NCT02919878|Capecitabine|capecitabine|mesh-list
138691664|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138691665|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
138691666|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691667|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691668|NCT02931786|Ketamine|ketamine|mesh-list
138691669|NCT02931786|Propofol|propofol|mesh-list
138691670|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138691671|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138691672|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691673|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138691674|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
138691675|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
138691676|NCT02931786|Analgesics|analgesics|mesh-ancestor
138691677|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
138691678|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691679|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138691680|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138691681|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138691682|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691683|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691684|NCT02919605|Pentamidine|pentamidine|mesh-list
138691685|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
138691686|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691687|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138691688|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138691689|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138691690|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138691691|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138691692|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
138691693|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138691694|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691695|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138691696|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138691697|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138691699|NCT05465733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691700|NCT05465733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691701|NCT05465733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691702|NCT05465733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138691703|NCT05465733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138691705|NCT03673787|Ipatasertib|ipatasertib|mesh-list
138691706|NCT03673787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138691707|NCT03673787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691708|NCT03673787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138691709|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691710|NCT03673787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138691711|NCT03673787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691712|NCT03571802|Simvastatin|simvastatin|mesh-list
138691713|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138691714|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138186718|NCT02240459|Oxybutynin|oxybutynin|mesh-list
138691715|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
138691716|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691717|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138691718|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138691719|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691720|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
138691721|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138691722|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138691723|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691724|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
138691725|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
138691726|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691728|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
138691729|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691730|NCT02919371|Bevacizumab|bevacizumab|mesh-list
138691731|NCT02919371|Sunitinib|sunitinib|mesh-list
138691732|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138691733|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691734|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138691735|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138691736|NCT02919371|Growth Substances|growth substances|mesh-ancestor
138691737|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138182841|NCT00883103|Lidocaine|lidocaine|mesh-list
138691739|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138691741|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691742|NCT04736901|Enoxaparin|enoxaparin|mesh-list
138691743|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
138691744|NCT04736901|Apixaban|apixaban|mesh-list
138691745|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
138691746|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138691747|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
138691748|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138691750|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691751|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691752|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
138691753|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138691754|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138691755|NCT02919176|Pioglitazone|pioglitazone|mesh-list
138691756|NCT02919176|Mirabegron|mirabegron|mesh-list
138691757|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138691758|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691759|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138691760|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138691761|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138691762|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
138691763|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691764|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691765|NCT02919176|Urological Agents|urological agents|mesh-ancestor
138691766|NCT04734678|Infliximab|infliximab|mesh-list
138691767|NCT04734678|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138691768|NCT04734678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138691769|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
138691770|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138691771|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138691772|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
138691773|NCT02919059|Glimepiride|glimepiride|mesh-list
138691774|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138691775|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691776|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138691777|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691778|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138691780|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
138691782|NCT04727775|Favipiravir|favipiravir|mesh-list
138691783|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
138691784|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691785|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
138691786|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691787|NCT02918825|Olanzapine|olanzapine|mesh-list
138691788|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138691789|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
138691790|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
138691791|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691792|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691793|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138691794|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138691795|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138691796|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138691797|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138691798|NCT02918825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138691799|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138368615|NCT03191240|Vasopressins|vasopressins|mesh-list
138186884|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
138691800|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138691801|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691802|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691803|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
138691804|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138691805|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138691806|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138691808|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
138691809|NCT02918747|Dexamethasone|dexamethasone|mesh-list
138691810|NCT02918747|Prednisone|prednisone|mesh-list
138691811|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
138691812|NCT02918747|Gemcitabine|gemcitabine|mesh-list
138691813|NCT02918747|Doxorubicin|doxorubicin|mesh-list
138691814|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
138691815|NCT02918747|Vincristine|vincristine|mesh-list
138691816|NCT02918747|Pegaspargase|pegaspargase|mesh-list
138691817|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138691818|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
138691819|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691820|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138691821|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138691822|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
138691823|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691824|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138182916|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138691825|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138691826|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138691828|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
138691829|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691830|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138691831|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
138691832|NCT02918747|Hormones|hormones|mesh-ancestor
138187077|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138691833|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138691834|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138691835|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138691836|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
138691837|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138691838|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138691839|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138191051|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
138187151|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
138691840|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691841|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138691842|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
138691843|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
138691844|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
138691845|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138691846|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
138691847|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691849|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138187270|NCT05595993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138227213|NCT04942470|Propolis|propolis|mesh-list
138691850|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691851|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138691852|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691853|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
138691855|NCT02918045|Coagulants|coagulants|mesh-ancestor
138691856|NCT00532545|Teriparatide|teriparatide|mesh-list
138691857|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138691858|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691859|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138691860|NCT00533520|Ranibizumab|ranibizumab|mesh-list
138691861|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138691862|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138187422|NCT04344405|Vitamin D|vitamin d|mesh-list
138691863|NCT00533520|Growth Substances|growth substances|mesh-ancestor
138691864|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691865|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
138691866|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691867|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138691868|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691869|NCT03685253|Niacinamide|niacinamide|mesh-list
138691870|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
138691872|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
138691873|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691874|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
138691875|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138691876|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691878|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138691879|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
138691880|NCT00532584|Hormones|hormones|mesh-ancestor
138691881|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138691882|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691883|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138691884|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
138691886|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138691887|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
138691888|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138691890|NCT05467709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138691891|NCT05467709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138691892|NCT05467709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138691893|NCT05467709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691894|NCT05467709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138691895|NCT05467709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138691896|NCT05467709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138691897|NCT05467709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138691898|NCT05467709|Anesthetics, General|anesthetics, general|mesh-ancestor
138691899|NCT05467709|Anesthetics|anesthetics|mesh-ancestor
138691900|NCT05467709|GABA Modulators|gaba modulators|mesh-ancestor
138691901|NCT05467709|GABA Agents|gaba agents|mesh-ancestor
138691902|NCT05467709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691903|NCT05467709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691904|NCT00532623|Gemcitabine|gemcitabine|mesh-list
138691905|NCT00532623|Vinorelbine|vinorelbine|mesh-list
138691906|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138691907|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
138691908|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691909|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691910|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138691911|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
138691912|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
138691913|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
138691914|NCT00532662|Ketamine|ketamine|mesh-list
138691915|NCT00532662|Analgesics|analgesics|mesh-ancestor
138691916|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
138691917|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691918|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691919|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138691920|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138691921|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
138691923|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138691924|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138691925|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138691926|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691927|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691928|NCT05467436|Analgesics|analgesics|mesh-list
138691929|NCT05467436|Anesthetics|anesthetics|mesh-list
138227369|NCT01653509|Acyclovir|acyclovir|mesh-list
138691930|NCT05467436|Anesthetics, Local|anesthetics, local|mesh-list
138691931|NCT05467436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187872|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691932|NCT05467436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691933|NCT05467436|Sensory System Agents|sensory system agents|mesh-ancestor
138691934|NCT05467436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691935|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
138691936|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138691937|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138691938|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
138691939|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138691940|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691941|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691942|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
138691943|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
138691944|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138691945|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
138691946|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138691947|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
138691948|NCT05467319|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138691950|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
138691951|NCT04484610|Narcotics|narcotics|mesh-ancestor
138691952|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138691953|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691954|NCT04484610|Analgesics|analgesics|mesh-ancestor
138691955|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
138691956|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369231|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
138691959|NCT05466149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188087|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138691960|NCT05466149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691962|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
138691963|NCT00532701|Ribavirin|ribavirin|mesh-list
138691964|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
138227401|NCT00943202|Vaccines|vaccines|mesh-list
138691965|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138691966|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
138691967|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691968|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
138691969|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691970|NCT01276639|Tofacitinib|tofacitinib|mesh-list
138691971|NCT01276639|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138191067|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138191068|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191069|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
138191070|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691972|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138691973|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691974|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691975|NCT00532415|Triamcinolone|triamcinolone|mesh-list
138691976|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138691977|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138691978|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138691979|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138691982|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138691983|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691984|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138691985|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
138691986|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138691987|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138691988|NCT00532454|Tamoxifen|tamoxifen|mesh-list
138691989|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138691990|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
138691991|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138691992|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138691993|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138691994|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138691995|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138691996|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138691997|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138691999|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138692000|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138692001|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692002|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138692003|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138692004|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
138692005|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692006|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138692007|NCT05459792|Lidocaine|lidocaine|mesh-list
138692008|NCT05459792|Bupivacaine|bupivacaine|mesh-list
138692009|NCT05459792|Anesthetics, Local|anesthetics, local|mesh-ancestor
138692010|NCT05459792|Anesthetics|anesthetics|mesh-ancestor
138692011|NCT05459792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692012|NCT05459792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692013|NCT05459792|Sensory System Agents|sensory system agents|mesh-ancestor
138692014|NCT05459792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692015|NCT05459792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138692016|NCT05459792|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138692017|NCT05459792|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138692018|NCT05459792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138692019|NCT05459792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692021|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138692022|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138692023|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
138368844|NCT02684253|Nivolumab|nivolumab|mesh-list
138692024|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692025|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692026|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692027|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
138692028|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138692029|NCT00533637|Cetirizine|cetirizine|mesh-list
138692030|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138692031|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138692032|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138692033|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
138692034|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
138692035|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191074|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191075|NCT03162731|Nivolumab|nivolumab|mesh-list
138191076|NCT03162731|Ipilimumab|ipilimumab|mesh-list
138692036|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692037|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692038|NCT05466695|Sildenafil Citrate|sildenafil citrate|mesh-list
138692039|NCT05466695|Tadalafil|tadalafil|mesh-list
138692040|NCT05466695|Vasodilator Agents|vasodilator agents|mesh-ancestor
138692041|NCT05466695|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138692042|NCT05466695|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138692043|NCT05466695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692044|NCT05466695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692045|NCT05466695|Urological Agents|urological agents|mesh-ancestor
138692046|NCT05281185|Factor VIII|factor viii|mesh-list
138692047|NCT05281185|Coagulants|coagulants|mesh-ancestor
138692048|NCT00532532|Tolperisone|tolperisone|mesh-list
138463090|NCT05413902|Narcotics|narcotics|mesh-list
138692049|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138692050|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692051|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138692052|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692053|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
138692054|NCT00532571|Vitamins|vitamins|mesh-ancestor
138692056|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692058|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
138692059|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138692060|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
138692061|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
138692062|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
138227529|NCT01620047|Narcotics|narcotics|mesh-ancestor
138692063|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692064|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692066|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138692067|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
138692068|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692069|NCT00532688|Expectorants|expectorants|mesh-ancestor
138692070|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
138692071|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138692072|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
138692073|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692074|NCT00532688|Protective Agents|protective agents|mesh-ancestor
138692075|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692076|NCT00532688|Antidotes|antidotes|mesh-ancestor
138692077|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138692078|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
138692079|NCT00534144|Hematinics|hematinics|mesh-ancestor
138692080|NCT00534183|Haloperidol|haloperidol|mesh-list
138692081|NCT00534183|Olanzapine|olanzapine|mesh-list
138692082|NCT00534183|Risperidone|risperidone|mesh-list
138692083|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
138692084|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138692085|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
138692086|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692087|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692088|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692090|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138692091|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463366|NCT03491267|Tretinoin|tretinoin|mesh-list
138692092|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138692093|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138692094|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
138692095|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
138692096|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
138692097|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692098|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138692099|NCT00534183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138692100|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138692101|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138191083|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
138191084|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138191085|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191086|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692102|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138692103|NCT00532727|Carboplatin|carboplatin|mesh-list
138692104|NCT00532727|Docetaxel|docetaxel|mesh-list
138692105|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692106|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
138692107|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
138692108|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
138692109|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692111|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138692112|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692113|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
138692114|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
138692115|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
138692116|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692118|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138692119|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138692120|NCT04687449|Analgesics|analgesics|mesh-ancestor
138692121|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
138463483|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
138692122|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692123|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692124|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138692125|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138692126|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692127|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463556|NCT01946295|Famotidine|famotidine|mesh-list
138692128|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692129|NCT00532818|Hydralazine|hydralazine|mesh-list
138692130|NCT00532818|Valproic Acid|valproic acid|mesh-list
138692131|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
138692132|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692133|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692134|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
138692135|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692136|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692137|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
138692138|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138692139|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692140|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138692141|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138692142|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
138692143|NCT05209035|Trazodone|trazodone|mesh-list
138692144|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138692145|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138692146|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692147|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692148|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138692149|NCT05209035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138692150|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138692151|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138692152|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692153|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692154|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
138692155|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138692156|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
138692157|NCT00534261|Interferons|interferons|mesh-list
138692158|NCT00534261|Interferon-beta|interferon-beta|mesh-list
138692159|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
138692160|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692161|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
138692162|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692163|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
138692164|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692165|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138692167|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138692168|NCT00532857|Gemcitabine|gemcitabine|mesh-list
138692169|NCT00532857|Trastuzumab|trastuzumab|mesh-list
138692170|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138463792|NCT01947920|Analgesics|analgesics|mesh-ancestor
138692171|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692172|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
138692173|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
138692174|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
138692175|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692176|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138692178|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138692179|NCT05152004|Amoxicillin|amoxicillin|mesh-list
138692180|NCT05152004|Metronidazole|metronidazole|mesh-list
138692181|NCT05152004|Clarithromycin|clarithromycin|mesh-list
138692182|NCT05152004|Rabeprazole|rabeprazole|mesh-list
138692183|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138692184|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692185|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138692186|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138692187|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138692188|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227692|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138692189|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692190|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138183138|NCT02756572|Cytarabine|cytarabine|mesh-list
138692192|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138692193|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138692194|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138692196|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138692197|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138692198|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
138692199|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138692200|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138692201|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692202|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692203|NCT05132153|Protective Agents|protective agents|mesh-ancestor
138692204|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692206|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138692207|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138692208|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692209|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692210|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138692211|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138227735|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
138692212|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138692213|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138692214|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
138692215|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
138692216|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
138463977|NCT01949038|Alprazolam|alprazolam|mesh-list
138692218|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692219|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692220|NCT05131997|Atorvastatin|atorvastatin|mesh-list
138692221|NCT05131997|Ezetimibe|ezetimibe|mesh-list
138692222|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138692223|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138692224|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
138692225|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692226|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138692227|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138692228|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692229|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
138692230|NCT00534456|Hematinics|hematinics|mesh-ancestor
138692231|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138692232|NCT00532961|Tobramycin|tobramycin|mesh-list
138692233|NCT00532961|Dexamethasone|dexamethasone|mesh-list
138692234|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138692235|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
138692236|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
138692237|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464035|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138692238|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692239|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138692240|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
138692241|NCT00532961|Hormones|hormones|mesh-ancestor
138183172|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
138692242|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138692243|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138692244|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692245|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138692246|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692247|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138692248|NCT00534573|Amisulpride|amisulpride|mesh-list
138692249|NCT00534573|Moclobemide|moclobemide|mesh-list
138692250|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138692251|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138692252|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692253|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692254|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138692255|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138692256|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
138692257|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692258|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692259|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138692260|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
138692261|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138692262|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692263|NCT04686890|Acetaminophen|acetaminophen|mesh-list
138692265|NCT04686890|Analgesics|analgesics|mesh-list
138692266|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138692267|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
138692268|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692269|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692270|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
138692271|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138692272|NCT04686890|Narcotics|narcotics|mesh-ancestor
138692273|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692274|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
138692275|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138692276|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692277|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692278|NCT05103306|Empagliflozin|empagliflozin|mesh-list
138692279|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138692280|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692281|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138692282|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692284|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138692285|NCT00534651|Analgesics|analgesics|mesh-ancestor
138692286|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
138692287|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692288|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692290|NCT05080959|Ropivacaine|ropivacaine|mesh-list
138692291|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
138692292|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
138692293|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692294|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692295|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
138692296|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692297|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
138692298|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
138692300|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138692301|NCT04942730|Fludarabine|fludarabine|mesh-list
138692302|NCT04942730|Tacrolimus|tacrolimus|mesh-list
138692303|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138692304|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
138692305|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692306|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138692307|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138692308|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
138191105|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
138191106|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138692309|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692310|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692311|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138692312|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138692313|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692314|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138464395|NCT01951729|Atropine|atropine|mesh-list
138692315|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138692316|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
138692317|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138692318|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692319|NCT01272193|Insulin|insulin|mesh-list
138692320|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138692321|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
138692322|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
138692323|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138369146|NCT00962988|Bupropion|bupropion|mesh-list
138692324|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692325|NCT04899206|Antidepressive Agents|antidepressive agents|mesh-list
138692326|NCT04899206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138692327|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
138692328|NCT04687163|Fluorouracil|fluorouracil|mesh-list
138692329|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692330|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
138692331|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692332|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138692333|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138692334|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
138692335|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692336|NCT01270828|Pregabalin|pregabalin|mesh-list
138692337|NCT01270828|Analgesics|analgesics|mesh-ancestor
138692338|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
138692339|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692340|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692341|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
138692342|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138692343|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138692344|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692345|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138692346|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138692347|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138692348|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692349|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138692350|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
138692351|NCT00533195|Methoxsalen|methoxsalen|mesh-list
138692352|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138692353|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
138692354|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138692355|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138692356|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138692357|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692358|NCT01269385|Rituximab|rituximab|mesh-list
138692359|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138692360|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
138692362|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
138692363|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138692364|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
138692365|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692366|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692367|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138692368|NCT02071862|Paclitaxel|paclitaxel|mesh-list
138692369|NCT02071862|Docetaxel|docetaxel|mesh-list
138692370|NCT02071862|Everolimus|everolimus|mesh-list
138692371|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138692372|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191113|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191114|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692374|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
138692375|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
138692376|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692377|NCT02071862|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138692378|NCT02071862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138692379|NCT02071862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692380|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138692381|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
138692382|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692383|NCT00535691|Tacrolimus|tacrolimus|mesh-list
138692384|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138692385|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
138692386|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692387|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138692388|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464689|NCT05874778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138692389|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692390|NCT01268683|Glyburide|glyburide|mesh-list
138692391|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138692392|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692393|NCT02021474|Phenol|phenol|mesh-list
138692394|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138692395|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692396|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
138692397|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138692398|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138692399|NCT04959825|Melatonin|melatonin|mesh-list
138692400|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
138227996|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692401|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692402|NCT04959825|Protective Agents|protective agents|mesh-ancestor
138692403|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138183281|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138692407|NCT05471453|Tocopherols|tocopherols|mesh-list
138692408|NCT05471453|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138692409|NCT05471453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138692410|NCT05471453|Immunologic Factors|immunologic factors|mesh-ancestor
138692411|NCT05471453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692412|NCT05471453|Antioxidants|antioxidants|mesh-ancestor
138692413|NCT05471453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692414|NCT05471453|Protective Agents|protective agents|mesh-ancestor
138692415|NCT05471453|Vitamins|vitamins|mesh-ancestor
138692416|NCT05471453|Micronutrients|micronutrients|mesh-ancestor
138692417|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138692418|NCT03457233|Cetrorelix|cetrorelix|mesh-list
138692419|NCT03457233|Menotropins|menotropins|mesh-list
138692420|NCT03457233|Progesterone|progesterone|mesh-list
138692421|NCT03457233|Progestins|progestins|mesh-ancestor
138692422|NCT03457233|Hormones|hormones|mesh-ancestor
138692423|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138692424|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692425|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138692426|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138692428|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
138692430|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
138692431|NCT00535808|Sevoflurane|sevoflurane|mesh-list
138692432|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138692433|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138692434|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
138692435|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
138692436|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692437|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692438|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
138692439|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138692440|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138692441|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692442|NCT05471063|Fluconazole|fluconazole|mesh-list
138692443|NCT05471063|Amphotericin B|amphotericin b|mesh-list
138692444|NCT05471063|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138692445|NCT05471063|Flucytosine|flucytosine|mesh-list
138692446|NCT05471063|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
138692447|NCT05471063|Antifungal Agents|antifungal agents|mesh-ancestor
138692448|NCT05471063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692449|NCT05471063|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138692450|NCT05471063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138692451|NCT05471063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692452|NCT05471063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692455|NCT05471063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138692456|NCT05471063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692457|NCT05471063|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138692458|NCT05471063|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138692460|NCT05471063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138692461|NCT05471063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138692462|NCT05471063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138692463|NCT05471063|Antimetabolites|antimetabolites|mesh-ancestor
138692464|NCT05471063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138692465|NCT05471063|Protease Inhibitors|protease inhibitors|mesh-ancestor
138692466|NCT05471063|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138692467|NCT05471063|Protective Agents|protective agents|mesh-ancestor
138692468|NCT05471063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692469|NCT04910100|Timolol|timolol|mesh-list
138692470|NCT04910100|Nebivolol|nebivolol|mesh-list
138692471|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138692472|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138692473|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138692474|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138692475|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
138692476|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692477|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692478|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692479|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138692480|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138692482|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138692483|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138692484|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138692485|NCT01268059|Paclitaxel|paclitaxel|mesh-list
138692486|NCT01268059|Carboplatin|carboplatin|mesh-list
138692487|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138692488|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692489|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
138692490|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
138692491|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
138692492|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692494|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
138692495|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
138692496|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692497|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692498|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
138228143|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138692499|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692500|NCT00536003|Progesterone|progesterone|mesh-list
138692501|NCT00536003|Progestins|progestins|mesh-ancestor
138692502|NCT00536003|Hormones|hormones|mesh-ancestor
138692503|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138692504|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692505|NCT00533091|Sifalimumab|sifalimumab|mesh-list
138692506|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
138692507|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692508|NCT00536042|Minocycline|minocycline|mesh-list
138692509|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138692510|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191128|NCT01120639|Temozolomide|temozolomide|mesh-list
138191129|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138191130|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
138191131|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191132|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692511|NCT01606384|Vasopressins|vasopressins|mesh-list
138692512|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
138692513|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
138692514|NCT01606384|Coagulants|coagulants|mesh-ancestor
138692515|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138692516|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138692517|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
138692518|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692519|NCT01606462|Oxytocin|oxytocin|mesh-list
138692520|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
138692521|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138692522|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692523|NCT01606540|Ibuprofen|ibuprofen|mesh-list
138692524|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138692525|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138692526|NCT01606540|Analgesics|analgesics|mesh-ancestor
138692527|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
138692528|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692529|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692530|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138692531|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138692532|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138692533|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692534|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692537|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692538|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
138692539|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
138692540|NCT00593710|Losartan|losartan|mesh-list
138692541|NCT00593710|Atenolol|atenolol|mesh-list
138692542|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138692543|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138692544|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138692545|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138692546|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692547|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
138692548|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
138692549|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692550|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692551|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138692552|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138369366|NCT01398202|Vitamin D|vitamin d|mesh-list
138692553|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138692556|NCT04885686|Formaldehyde|formaldehyde|mesh-list
138692558|NCT04885686|Dexamethasone|dexamethasone|mesh-list
138692559|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
138692560|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138692561|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
138692562|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
138692563|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692564|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692565|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138692566|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
138692567|NCT04885686|Hormones|hormones|mesh-ancestor
138692568|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138692569|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138692570|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692571|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
138228223|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138692572|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692573|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138692574|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
138692575|NCT00594217|Progesterone|progesterone|mesh-list
138692576|NCT00594217|Progestins|progestins|mesh-ancestor
138692577|NCT00594217|Hormones|hormones|mesh-ancestor
138692578|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138692579|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692581|NCT00536237|Niacinamide|niacinamide|mesh-list
138692582|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
138465555|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138191137|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692583|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692584|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692585|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138692586|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
138692587|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138692588|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
138692589|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
138692590|NCT00536237|Vitamins|vitamins|mesh-ancestor
138692591|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
138692592|NCT00533247|Celecoxib|celecoxib|mesh-list
138692593|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138692594|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138692595|NCT00533247|Analgesics|analgesics|mesh-ancestor
138692596|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
138692598|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692599|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138692600|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138692601|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138692602|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138692603|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692604|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692605|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138692606|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692607|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138692608|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692609|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692611|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
138692612|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
138692613|NCT00536276|Vitamins|vitamins|mesh-list
138692614|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
138692615|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692616|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138692617|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138692619|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
138692620|NCT02690064|Vitamin E|vitamin e|mesh-list
138692621|NCT02690064|Tocopherols|tocopherols|mesh-list
138692622|NCT02690064|Tocotrienols|tocotrienols|mesh-list
138692623|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
138692624|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
138692625|NCT02690064|Ubiquinone|ubiquinone|mesh-list
138692626|NCT02690064|Resveratrol|resveratrol|mesh-list
138692627|NCT02690064|Antioxidants|antioxidants|mesh-list
138692628|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
138692629|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692630|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692631|NCT02690064|Protective Agents|protective agents|mesh-ancestor
138692632|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692633|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138692635|NCT00594373|Tenofovir|tenofovir|mesh-list
138692636|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
138692637|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692638|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138692639|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138692640|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692641|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692642|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138692643|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138692644|NCT05470166|Lidocaine|lidocaine|mesh-list
138692645|NCT05470166|Anesthetics, Local|anesthetics, local|mesh-ancestor
138692646|NCT05470166|Anesthetics|anesthetics|mesh-ancestor
138692647|NCT05470166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692648|NCT05470166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692649|NCT05470166|Sensory System Agents|sensory system agents|mesh-ancestor
138692651|NCT05470166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138465881|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
138692652|NCT05470166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138692653|NCT05470166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138692654|NCT05470166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138692655|NCT05470166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692656|NCT01260142|Propofol|propofol|mesh-list
138692657|NCT01260142|Fospropofol|fospropofol|mesh-list
138692658|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138692659|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692660|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692661|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138692662|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
138692663|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
138692664|NCT02116335|Bosentan|bosentan|mesh-list
138692665|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138692666|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138692667|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692668|NCT05469659|Metformin|metformin|mesh-list
138692669|NCT05469659|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
138692670|NCT05469659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138692671|NCT05469659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692672|NCT05469659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138692673|NCT05469659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692674|NCT01808820|Imiquimod|imiquimod|mesh-list
138692675|NCT01808820|Vaccines|vaccines|mesh-list
138692676|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
138692677|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692678|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138692679|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692680|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
138692681|NCT05469386|Methylphenidate|methylphenidate|mesh-list
138692682|NCT05469386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138692683|NCT05469386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692684|NCT05469386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138692685|NCT05469386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138692686|NCT05469386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138692687|NCT05469386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692688|NCT05469386|Dopamine Agents|dopamine agents|mesh-ancestor
138692689|NCT05469386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692690|NCT01462890|Paclitaxel|paclitaxel|mesh-list
138692691|NCT01462890|Bevacizumab|bevacizumab|mesh-list
138692692|NCT01462890|Carboplatin|carboplatin|mesh-list
138183472|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138692693|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138692694|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692695|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
138692696|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
138692697|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
138692698|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692699|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138692700|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138692701|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138692702|NCT01462890|Growth Substances|growth substances|mesh-ancestor
138692703|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692704|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
138692705|NCT05469113|Repaglinide|repaglinide|mesh-list
138692706|NCT05469113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138692707|NCT05469113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692708|NCT01259713|Amphotericin B|amphotericin b|mesh-list
138692709|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138692710|NCT01259713|Amebicides|amebicides|mesh-ancestor
138692711|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138692712|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138692713|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692714|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138692715|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
138692716|NCT05469035|Heparin|heparin|mesh-list
138692717|NCT05469035|Calcium heparin|calcium heparin|mesh-list
138692718|NCT05469035|Anticoagulants|anticoagulants|mesh-ancestor
138692719|NCT05469035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138191150|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138191151|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
138191152|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191155|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138692720|NCT05469035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138692721|NCT05469035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692722|NCT05468879|Glimepiride|glimepiride|mesh-list
138692723|NCT05468879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138692724|NCT05468879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138692725|NCT05468879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692726|NCT05468879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138692727|NCT05468879|Immunologic Factors|immunologic factors|mesh-ancestor
138692728|NCT05471427|Docetaxel|docetaxel|mesh-list
138692729|NCT05471427|Taxane|taxane|mesh-list
138692730|NCT05471427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692731|NCT05471427|Tubulin Modulators|tubulin modulators|mesh-ancestor
138692732|NCT05471427|Antimitotic Agents|antimitotic agents|mesh-ancestor
138466146|NCT01956929|Metformin|metformin|mesh-list
138692733|NCT05471427|Mitosis Modulators|mitosis modulators|mesh-ancestor
138692734|NCT05471427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692735|NCT05558449|Midazolam|midazolam|mesh-list
138692736|NCT05558449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138692737|NCT05558449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138692738|NCT05558449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692739|NCT05558449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692740|NCT05558449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138692741|NCT05558449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138692742|NCT05558449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138692743|NCT05558449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138692744|NCT05558449|Anesthetics, General|anesthetics, general|mesh-ancestor
138692746|NCT05558449|GABA Modulators|gaba modulators|mesh-ancestor
138692747|NCT05558449|GABA Agents|gaba agents|mesh-ancestor
138692748|NCT05558449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692749|NCT05558449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692750|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
138692751|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138692752|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
138692753|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692754|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
138692756|NCT00536393|Doxorubicin|doxorubicin|mesh-list
138692757|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138692758|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138692759|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692760|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138692761|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138692762|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692763|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692765|NCT00595543|Ketorolac|ketorolac|mesh-list
138692766|NCT00595543|Bromfenac|bromfenac|mesh-list
138692767|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138692768|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138692769|NCT00595543|Analgesics|analgesics|mesh-ancestor
138692770|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
138692771|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692772|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692773|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138692774|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138692775|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138692776|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692777|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692778|NCT04326868|Albendazole|albendazole|mesh-list
138692779|NCT04326868|Mebendazole|mebendazole|mesh-list
138692780|NCT04326868|Benzimidazole|benzimidazole|mesh-list
138692781|NCT04326868|Pyrantel|pyrantel|mesh-list
138692782|NCT04326868|Anthelmintics|anthelmintics|mesh-list
138692783|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138692784|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692785|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
138692786|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138692787|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138692788|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
138692789|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
138692790|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
138692791|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692792|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692793|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
138692794|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138692795|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138692796|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138692797|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692798|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692799|NCT00595972|Endostar protein|endostar protein|mesh-list
138692800|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138692801|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138692802|NCT00595972|Growth Substances|growth substances|mesh-ancestor
138692803|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692804|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
138692805|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692806|NCT00596050|Lidocaine|lidocaine|mesh-list
138692807|NCT00596050|Midazolam|midazolam|mesh-list
138692808|NCT00596050|Fentanyl|fentanyl|mesh-list
138692809|NCT00596050|Ketamine|ketamine|mesh-list
138692810|NCT00596050|Etomidate|etomidate|mesh-list
138692811|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
138692812|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
138692813|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138692814|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692815|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
138692816|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692817|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138692818|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138692819|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138692820|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138692821|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692822|NCT00596050|Analgesics|analgesics|mesh-ancestor
138692823|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138692824|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138228577|NCT02455050|Laxatives|laxatives|mesh-ancestor
138692826|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138692827|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138466395|NCT01958996|Idarubicin|idarubicin|mesh-list
138692828|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692829|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138692844|NCT05468645|Hemay005|hemay005|mesh-list
138692845|NCT05468645|Dermatologic Agents|dermatologic agents|mesh-ancestor
138692846|NCT05468645|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138692847|NCT05468645|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138692848|NCT05468645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692849|NCT05468645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692851|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138692852|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692853|NCT00596206|Leflunomide|leflunomide|mesh-list
138692854|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692855|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692856|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138692857|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
138466464|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
138692858|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692859|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
138692861|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138692862|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692863|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138692864|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138692865|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138692866|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191164|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138191165|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138191166|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138692868|NCT05468450|Sclerosing Solutions|sclerosing solutions|mesh-list
138692869|NCT05468450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138692871|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138692872|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692873|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138692874|NCT00596479|Lenograstim|lenograstim|mesh-list
138692875|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138692876|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
138692877|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692878|NCT04207957|Olorofim|olorofim|mesh-list
138692879|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
138692880|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692881|NCT00596557|Everolimus|everolimus|mesh-list
138692882|NCT00596557|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138692883|NCT00596557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138692884|NCT00596557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692885|NCT00596557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692886|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138692887|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
138692888|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692889|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692890|NCT00596596|Prucalopride|prucalopride|mesh-list
138692891|NCT00596596|Laxatives|laxatives|mesh-ancestor
138692892|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138692893|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138692894|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138692895|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
138692896|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692897|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692898|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692899|NCT05468294|Nivolumab|nivolumab|mesh-list
138692900|NCT05468294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138466660|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
138692901|NCT05468294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692902|NCT05468294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138692903|NCT05468294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692904|NCT05312866|Acetaminophen|acetaminophen|mesh-list
138692905|NCT05312866|Dexamethasone|dexamethasone|mesh-list
138692906|NCT05312866|Magnesium Sulfate|magnesium sulfate|mesh-list
138692907|NCT05312866|Fentanyl|fentanyl|mesh-list
138692908|NCT05312866|Bupivacaine|bupivacaine|mesh-list
138692909|NCT05312866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138692910|NCT05312866|Antiemetics|antiemetics|mesh-ancestor
138692911|NCT05312866|Autonomic Agents|autonomic agents|mesh-ancestor
138692912|NCT05312866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138692913|NCT05312866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692914|NCT05312866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138692915|NCT05312866|Glucocorticoids|glucocorticoids|mesh-ancestor
138692916|NCT05312866|Hormones|hormones|mesh-ancestor
138183613|NCT02973724|Propofol|propofol|mesh-list
138692927|NCT05312866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138692928|NCT05312866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138692929|NCT05312866|Anesthetics, General|anesthetics, general|mesh-ancestor
138692930|NCT05312866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138692931|NCT05312866|Antipyretics|antipyretics|mesh-ancestor
138692932|NCT05312866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138692933|NCT05312866|Anticonvulsants|anticonvulsants|mesh-ancestor
138692934|NCT05312866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138369742|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
138692935|NCT05312866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138692936|NCT05312866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466913|NCT01963559|Prilocaine|prilocaine|mesh-list
138692937|NCT05312866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138692938|NCT05312866|Tocolytic Agents|tocolytic agents|mesh-ancestor
138692939|NCT05312866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138692940|NCT04326790|Colchicine|colchicine|mesh-list
138191173|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138191174|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
138191176|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138692941|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
138692943|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
138692944|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
138692945|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
138692946|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692947|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692948|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138692949|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138692950|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138692951|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138692952|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466970|NCT01963832|Fluoxetine|fluoxetine|mesh-list
138692953|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138692954|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692956|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
138467028|NCT01964040|Analgesics|analgesics|mesh-ancestor
138692958|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
138692959|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138692960|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
138692961|NCT00597064|Prednisone|prednisone|mesh-list
138692962|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138692963|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
138692964|NCT00597064|Hormones|hormones|mesh-ancestor
138692965|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138692966|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692967|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138467086|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
138692968|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692969|NCT00597181|Mitomycins|mitomycins|mesh-list
138692970|NCT00597181|Mitomycin|mitomycin|mesh-list
138692971|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138692972|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138692973|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
138692974|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692975|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138692976|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692977|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138692978|NCT00597259|Entecavir|entecavir|mesh-list
138692979|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
138692980|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138692982|NCT05470764|Perindopril|perindopril|mesh-list
138692984|NCT05470764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138692985|NCT05470764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138692986|NCT05470764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138692987|NCT05470764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138692988|NCT05470764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138692989|NCT05470764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138692991|NCT05470764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138692992|NCT05470764|Protease Inhibitors|protease inhibitors|mesh-ancestor
138692993|NCT05470764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138692994|NCT05470764|Diuretics|diuretics|mesh-ancestor
138692995|NCT05470764|Natriuretic Agents|natriuretic agents|mesh-ancestor
138692996|NCT05470764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138692997|NCT00597415|Celecoxib|celecoxib|mesh-list
138692998|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138692999|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138693000|NCT00597415|Analgesics|analgesics|mesh-ancestor
138191181|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191182|NCT00467987|Testosterone|testosterone|mesh-list
138191183|NCT00467987|Androgens|androgens|mesh-ancestor
138191184|NCT00467987|Hormones|hormones|mesh-ancestor
138191185|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138191187|NCT00433589|Tamoxifen|tamoxifen|mesh-list
138693001|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
138693002|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228817|NCT02170376|Levodopa|levodopa|mesh-list
138693003|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693004|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138693006|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138693007|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138693008|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467261|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693009|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693011|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138693012|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693014|NCT05470530|Dexamethasone|dexamethasone|mesh-list
138693015|NCT05470530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138693016|NCT05470530|Antiemetics|antiemetics|mesh-ancestor
138693017|NCT05470530|Autonomic Agents|autonomic agents|mesh-ancestor
138693018|NCT05470530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693019|NCT05470530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693020|NCT05470530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138693021|NCT05470530|Glucocorticoids|glucocorticoids|mesh-ancestor
138693022|NCT05470530|Hormones|hormones|mesh-ancestor
138693023|NCT05470530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138693024|NCT05470530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138693025|NCT05470530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693026|NCT02891980|Vaccines|vaccines|mesh-list
138467338|NCT01965626|Oseltamivir|oseltamivir|mesh-list
138693027|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
138693028|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693029|NCT05467826|Ribavirin|ribavirin|mesh-list
138693030|NCT05467826|Sofosbuvir|sofosbuvir|mesh-list
138693031|NCT05467826|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138693032|NCT05467826|Velpatasvir|velpatasvir|mesh-list
138693033|NCT05467826|Antimetabolites|antimetabolites|mesh-ancestor
138693034|NCT05467826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693035|NCT05467826|Antiviral Agents|antiviral agents|mesh-ancestor
138693036|NCT05467826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693037|NCT00598156|Bevacizumab|bevacizumab|mesh-list
138693038|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138693039|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138693040|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693041|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138693042|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138693043|NCT00598156|Growth Substances|growth substances|mesh-ancestor
138693044|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467389|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
138693045|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
138693046|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138693048|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693049|NCT00598195|Ketamine|ketamine|mesh-list
138693050|NCT00598195|Analgesics|analgesics|mesh-ancestor
138693051|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
138693052|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693053|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693054|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138693055|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138693056|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
138693057|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
138467445|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
138228917|NCT01066520|Diclofenac|diclofenac|mesh-list
138693058|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693059|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138191194|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
138191195|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191196|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138693060|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138693061|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693062|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693064|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138693065|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138693066|NCT00598234|Analgesics|analgesics|mesh-ancestor
138693067|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
138693068|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693069|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693070|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138693071|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138693072|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138693073|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138693074|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693075|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693076|NCT00598429|Alprostadil|alprostadil|mesh-list
138693077|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138693078|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
138693079|NCT00598429|Urological Agents|urological agents|mesh-ancestor
138693080|NCT00598624|Treosulfan|treosulfan|mesh-list
138369889|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138693081|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138693082|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
138693083|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693084|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693085|NCT02891785|Antipain|antipain|mesh-list
138693086|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
138693087|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693088|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693089|NCT00598858|Prednisone|prednisone|mesh-list
138693090|NCT00598858|Cortisone|cortisone|mesh-list
138693091|NCT00598858|Docetaxel|docetaxel|mesh-list
138693092|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693095|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
138693096|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467682|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
138693097|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138693098|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
138693099|NCT00598858|Hormones|hormones|mesh-ancestor
138693100|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138693101|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693102|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138693103|NCT05466305|Cobalt|cobalt|mesh-list
138693104|NCT05466305|Trace Elements|trace elements|mesh-ancestor
138693105|NCT05466305|Micronutrients|micronutrients|mesh-ancestor
138693106|NCT05466305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693107|NCT04207684|Testosterone|testosterone|mesh-list
138693108|NCT04207684|Androgens|androgens|mesh-ancestor
138693109|NCT04207684|Hormones|hormones|mesh-ancestor
138693110|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138693111|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693112|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
138693113|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
138693114|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693115|NCT02909400|Protective Agents|protective agents|mesh-ancestor
138693116|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693117|NCT02909478|Dexamethasone|dexamethasone|mesh-list
138693118|NCT02909478|Aprepitant|aprepitant|mesh-list
138693119|NCT02909478|Tropisetron|tropisetron|mesh-list
138693120|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138191204|NCT00433589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191205|NCT00433589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138191206|NCT00433589|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138693121|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
138693122|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
138693123|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693124|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693125|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138693126|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
138693127|NCT02909478|Hormones|hormones|mesh-ancestor
138228988|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693128|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138693129|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138693130|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693131|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138693132|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693133|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693134|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138693135|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138693136|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
138693138|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138693139|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693140|NCT00536705|Montelukast|montelukast|mesh-list
138693141|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138693142|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
138693144|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
138693145|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138693146|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693147|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138693148|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138693149|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693150|NCT00624208|Droperidol|droperidol|mesh-list
138693151|NCT00624208|Ondansetron|ondansetron|mesh-list
138693152|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
138693153|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
138693154|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138369963|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138693156|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138693157|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
138693158|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
138693159|NCT00624208|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138693160|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138693161|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
138693162|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693163|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693164|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138693165|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138693166|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138693167|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693168|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138693169|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138693170|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138693171|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
138693172|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138693173|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
138693174|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138693175|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138693176|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138693177|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693178|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693180|NCT04685642|Atorvastatin|atorvastatin|mesh-list
138693181|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138693182|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138693183|NCT04685642|Analgesics|analgesics|mesh-ancestor
138693184|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
138693185|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693186|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693187|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138693188|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138693189|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138693190|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138693191|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229074|NCT02740868|Xenon|xenon|mesh-list
138693192|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138693193|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138693194|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693195|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
138693196|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138693197|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138693198|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
138693199|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138693200|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138693201|NCT05312346|Hydroxocobalamin|hydroxocobalamin|mesh-list
138693202|NCT05312346|Vitamin B 12|vitamin b 12|mesh-list
138693203|NCT05312346|Hematinics|hematinics|mesh-ancestor
138693204|NCT05312346|Vitamin B Complex|vitamin b complex|mesh-ancestor
138693205|NCT05312346|Vitamins|vitamins|mesh-ancestor
138693206|NCT05312346|Micronutrients|micronutrients|mesh-ancestor
138693207|NCT05312346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693208|NCT05568563|Ethyl Chloride|ethyl chloride|mesh-list
138693209|NCT05568563|Anesthetics, Local|anesthetics, local|mesh-ancestor
138693210|NCT05568563|Anesthetics|anesthetics|mesh-ancestor
138693211|NCT05568563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693212|NCT05568563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693213|NCT05568563|Sensory System Agents|sensory system agents|mesh-ancestor
138468187|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
138693214|NCT05568563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693215|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138693216|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693217|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138693218|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693219|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693220|NCT05469984|Gentamicins|gentamicins|mesh-list
138693221|NCT05469984|Ampicillin|ampicillin|mesh-list
138693222|NCT05469984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138693223|NCT05469984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693224|NCT05469984|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138693227|NCT05312190|Progesterone|progesterone|mesh-list
138693228|NCT05312190|Progestins|progestins|mesh-ancestor
138693229|NCT05312190|Hormones|hormones|mesh-ancestor
138693230|NCT05312190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138693231|NCT05312190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693233|NCT00537173|Bevacizumab|bevacizumab|mesh-list
138693234|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138693235|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693236|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
138693237|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
138693238|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
138693239|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693240|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138693241|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138693242|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138693243|NCT00537173|Growth Substances|growth substances|mesh-ancestor
138693244|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693245|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
138693246|NCT02503839|Etoricoxib|etoricoxib|mesh-list
138693247|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138693248|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138693249|NCT02503839|Analgesics|analgesics|mesh-ancestor
138693250|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
138693251|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693252|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693253|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138693254|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138229155|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138693255|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138693256|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138693257|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693258|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693259|NCT05469750|Capecitabine|capecitabine|mesh-list
138693260|NCT05469750|Letrozole|letrozole|mesh-list
138693261|NCT05469750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138693262|NCT05469750|Antimetabolites|antimetabolites|mesh-ancestor
138693263|NCT05469750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693264|NCT05469750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693265|NCT05469750|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138693266|NCT05469750|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138693267|NCT05469750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693268|NCT05469750|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138693269|NCT05469750|Hormone Antagonists|hormone antagonists|mesh-ancestor
138693270|NCT05469750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138693271|NCT05469750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693272|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
138468481|NCT01973660|Tamoxifen|tamoxifen|mesh-list
138693273|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138693274|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693275|NCT03457194|Vaccines|vaccines|mesh-list
138693276|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
138693277|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693278|NCT04319926|Lidocaine|lidocaine|mesh-list
138693279|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
138693280|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
138693281|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693282|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693283|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
138693284|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138229199|NCT01085786|Metronidazole|metronidazole|mesh-list
138693285|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138693286|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138693287|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138693288|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138693289|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693290|NCT01313923|Sirolimus|sirolimus|mesh-list
138693291|NCT01313923|Temsirolimus|temsirolimus|mesh-list
138693292|NCT01313923|MTOR Inhibitors|mtor inhibitors|mesh-list
138693293|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138693294|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693295|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138693296|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693297|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
138693298|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138693299|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
138693300|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693301|NCT01313923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138693302|NCT01313923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693303|NCT01313923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693304|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
138693305|NCT01313884|Temozolomide|temozolomide|mesh-list
138693306|NCT01313884|Doxorubicin|doxorubicin|mesh-list
138693307|NCT01313884|Irinotecan|irinotecan|mesh-list
138693308|NCT01313884|Vincristine|vincristine|mesh-list
138693309|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138693310|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
138468603|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138693311|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693312|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138693313|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138693314|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
138693315|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693316|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693317|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138693318|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138693319|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138693320|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138693321|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693322|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138693323|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138693324|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
138191229|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138693325|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
138693326|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
138693328|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
138693329|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693330|NCT00537563|Telithromycin|telithromycin|mesh-list
138693331|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138693332|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693333|NCT00537602|Miglustat|miglustat|mesh-list
138693334|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693335|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693336|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138693337|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138693339|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693340|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138693342|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693343|NCT01259284|Atorvastatin|atorvastatin|mesh-list
138693344|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138693345|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138693347|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693348|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138468850|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693349|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138693350|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693351|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
138693352|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693353|NCT00537836|Estradiol|estradiol|mesh-list
138693354|NCT00537836|Estrogens|estrogens|mesh-ancestor
138693355|NCT00537836|Hormones|hormones|mesh-ancestor
138693356|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138693357|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693359|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138693360|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
138693361|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693362|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693363|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138229342|NCT01094522|Morphine|morphine|mesh-list
138693364|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
138693365|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138693366|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
138693367|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693368|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693369|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138693370|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
138693371|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
138693372|NCT02277171|Protective Agents|protective agents|mesh-ancestor
138693373|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
138693374|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138693375|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693376|NCT05105061|Ketamine|ketamine|mesh-list
138693377|NCT05105061|Analgesics|analgesics|mesh-ancestor
138693378|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
138693379|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693380|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693381|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138693382|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138693383|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
138469111|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
138693385|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693386|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138693387|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138693388|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138229386|NCT00585195|Rifampin|rifampin|mesh-list
138693389|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693391|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138693392|NCT05056584|Hormones|hormones|mesh-ancestor
138693393|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138693394|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693395|NCT00551954|Acarbose|acarbose|mesh-list
138469178|NCT01978873|Androgens|androgens|mesh-list
138693396|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138693397|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693398|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693399|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138693400|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693401|NCT00552149|Cetuximab|cetuximab|mesh-list
138693402|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138693403|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693404|NCT05467878|Anesthetics|anesthetics|mesh-list
138693405|NCT05467878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138693406|NCT05467878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693407|NCT00536640|Bevacizumab|bevacizumab|mesh-list
138183946|NCT01832129|Vitamins|vitamins|mesh-list
138693408|NCT00536640|Gemcitabine|gemcitabine|mesh-list
138693409|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138693410|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138693411|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693412|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138693413|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138693414|NCT00536640|Growth Substances|growth substances|mesh-ancestor
138693415|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693417|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138693418|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
138693419|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693420|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138693421|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693422|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
138693423|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693424|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693425|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138693426|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693427|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138693428|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469374|NCT01980667|Cisplatin|cisplatin|mesh-list
138693429|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693430|NCT00552266|Methylphenidate|methylphenidate|mesh-list
138693431|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138693432|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693433|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138693434|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138693435|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138693436|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693437|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
138693438|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693439|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
138693440|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138693441|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138693442|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
138693443|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693445|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138693446|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
138693447|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693448|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693449|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138693450|NCT00552500|Valproic Acid|valproic acid|mesh-list
138693451|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
138693452|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693453|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693454|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
138693455|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138693456|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693457|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
138693458|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138693459|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191236|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191237|NCT01097785|Simvastatin|simvastatin|mesh-list
138693460|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138693461|NCT01258738|Etanercept|etanercept|mesh-list
138693462|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138693463|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138693464|NCT01258738|Analgesics|analgesics|mesh-ancestor
138693466|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138693467|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693468|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138693469|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138693470|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138693471|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138693472|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
138693473|NCT00552656|Sirolimus|sirolimus|mesh-list
138693474|NCT00552656|Temsirolimus|temsirolimus|mesh-list
138693475|NCT00552656|MTOR Inhibitors|mtor inhibitors|mesh-list
138693476|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138693477|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138693478|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138693479|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138693480|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
138693481|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138693482|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
138693483|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693484|NCT00552656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138693485|NCT00552656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138693486|NCT00552656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693488|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
138693489|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693490|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
138693491|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138693492|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138693493|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138693494|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
138693495|NCT04863339|Coagulants|coagulants|mesh-ancestor
138693496|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
138693497|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138693498|NCT00552734|Insulin|insulin|mesh-list
138693499|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138693500|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138693501|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693502|NCT04543682|Iloprost|iloprost|mesh-list
138469814|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138693503|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138693504|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
138693505|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
138693506|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138693507|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
138693510|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
138693511|NCT01258660|Drospirenone|drospirenone|mesh-list
138693512|NCT01258660|Hematinics|hematinics|mesh-ancestor
138693513|NCT01258660|Vitamins|vitamins|mesh-ancestor
138693514|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
138693515|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138693516|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138693517|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
138252823|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138252824|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138252825|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
138252826|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252827|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138252828|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138252829|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138252832|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
138252833|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138252834|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
138252836|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138252837|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138252838|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
138252839|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
138252840|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138252841|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138469947|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
138252842|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138252843|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138252845|NCT00002487|Dipyridamole|dipyridamole|mesh-list
138252846|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138252847|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
138252848|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138252849|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470016|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
138252850|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138252852|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229618|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
138229619|NCT01118624|Aminopterin|aminopterin|mesh-list
138252853|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252854|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
138252855|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252856|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138252857|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138252858|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
138252859|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138252860|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252861|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138470082|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
138252862|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138252863|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
138252864|NCT00002493|Doxorubicin|doxorubicin|mesh-list
138252865|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138252866|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252867|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138252868|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138252869|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138252870|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252871|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252872|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
138252873|NCT00002259|Analgesics|analgesics|mesh-ancestor
138252874|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
138252875|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138252876|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252877|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252878|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138252879|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138252880|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252881|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252882|NCT00002499|Cytarabine|cytarabine|mesh-list
138252883|NCT00002499|Dexamethasone|dexamethasone|mesh-list
138252884|NCT00002499|Prednisone|prednisone|mesh-list
138252885|NCT00002499|Methotrexate|methotrexate|mesh-list
138252886|NCT00002499|Vincristine|vincristine|mesh-list
138252887|NCT00002499|Daunorubicin|daunorubicin|mesh-list
138252888|NCT00002499|Asparaginase|asparaginase|mesh-list
138252889|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138229655|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229656|NCT02180828|Fluconazole|fluconazole|mesh-list
138229657|NCT02180828|Clotrimazole|clotrimazole|mesh-list
138229660|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138229663|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252891|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
138252892|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138252893|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252894|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138252895|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
138252896|NCT00002499|Hormones|hormones|mesh-ancestor
138191252|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191253|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
138191255|NCT03035357|Daratumumab|daratumumab|mesh-list
138184055|NCT03219983|Bupivacaine|bupivacaine|mesh-list
138252898|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138252899|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252900|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138252901|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
138252902|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138252903|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138252904|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
138252905|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252906|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
138252907|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252908|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138252909|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138252910|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
138252911|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138470331|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
138252912|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138229687|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138229688|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229689|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138252913|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
138252914|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252915|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138252916|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
138252917|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
138252918|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
138252919|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138252920|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138252921|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138252922|NCT00002505|Interferons|interferons|mesh-list
138252923|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
138252925|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252926|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
138252927|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252928|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
138252929|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252931|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
138252932|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252933|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138252934|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138252935|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252936|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
138252937|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252938|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138252939|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138252940|NCT00002271|Alovudine|alovudine|mesh-list
138252941|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
138252942|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252943|NCT00002517|Cytarabine|cytarabine|mesh-list
138252944|NCT00002517|Dexamethasone|dexamethasone|mesh-list
138252945|NCT00002517|Etoposide|etoposide|mesh-list
138252947|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
138252948|NCT00002517|Idarubicin|idarubicin|mesh-list
138252949|NCT00002517|Thioguanine|thioguanine|mesh-list
138252950|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138252951|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
138252952|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
138252953|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138252954|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252955|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138252956|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
138252957|NCT00002517|Hormones|hormones|mesh-ancestor
138252958|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138252959|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138252960|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252961|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138252962|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138252963|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138252964|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252965|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252966|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138252967|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
138252968|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
138470589|NCT01989507|Nicotine|nicotine|mesh-list
138252969|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252970|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138252971|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
138252972|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138252973|NCT00002517|Analgesics|analgesics|mesh-ancestor
138229779|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229780|NCT01125098|Amoxicillin|amoxicillin|mesh-list
138252974|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
138252975|NCT00002277|Fluconazole|fluconazole|mesh-list
138252976|NCT00002277|Amphotericin B|amphotericin b|mesh-list
138252977|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138252978|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
138252979|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138252980|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138252981|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138252982|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252983|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252984|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138252985|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
138252986|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138252987|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252988|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138252989|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138252990|NCT00002277|Amebicides|amebicides|mesh-ancestor
138252991|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138252992|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138252993|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138252995|NCT00002523|Fluorouracil|fluorouracil|mesh-list
138252996|NCT00002523|Calcium|calcium|mesh-list
138252997|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
138252998|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138252999|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253000|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
138253001|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253002|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138253004|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253005|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
138229836|NCT02481219|Bisacodyl|bisacodyl|mesh-list
138253007|NCT00002523|Protective Agents|protective agents|mesh-ancestor
138253008|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
138253010|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
138253011|NCT00002529|Tamoxifen|tamoxifen|mesh-list
138253012|NCT00002529|Toremifene|toremifene|mesh-list
138253013|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
138253014|NCT00002529|Doxorubicin|doxorubicin|mesh-list
138253015|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138253016|NCT00002529|Epirubicin|epirubicin|mesh-list
138253017|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253018|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
138253019|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253021|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138253022|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
138253023|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253024|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253025|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138253026|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138253027|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138253028|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138253029|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253030|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138253031|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
138253032|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253033|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138253034|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138229868|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229870|NCT01165112|Rituximab|rituximab|mesh-list
138229871|NCT01165112|Carboplatin|carboplatin|mesh-list
138253036|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138253037|NCT00002217|Lamivudine|lamivudine|mesh-list
138253038|NCT00002217|Zidovudine|zidovudine|mesh-list
138253039|NCT00002217|Abacavir|abacavir|mesh-list
138253040|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
138253041|NCT00002217|Amprenavir|amprenavir|mesh-list
138253042|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138253043|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138253044|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253045|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253046|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
138253047|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253048|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138253049|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138253050|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
138253051|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138253052|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
138253053|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138253054|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138253055|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138253056|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
138253057|NCT00002283|Trimethoprim|trimethoprim|mesh-list
138253058|NCT00002283|Dapsone|dapsone|mesh-list
138253059|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
138253060|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138253062|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
138253063|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138253064|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138253065|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138253066|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253067|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253068|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138253069|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138229915|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138253070|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138253071|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
138253072|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138253074|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
138253075|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138253076|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138253078|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
138253079|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138253080|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138253081|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
138253082|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138253084|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
138253085|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253086|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253087|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138253088|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
138253089|NCT04826237|Hormones|hormones|mesh-ancestor
138471128|NCT01993472|Capecitabine|capecitabine|mesh-list
138253091|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138253092|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253093|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138253094|NCT04826237|Protective Agents|protective agents|mesh-ancestor
138253095|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138253096|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138253097|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
138229956|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138229957|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138253098|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253099|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253100|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138253101|NCT00002535|Aldesleukin|aldesleukin|mesh-list
138253102|NCT00002535|Indomethacin|indomethacin|mesh-list
138253103|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
138191274|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
138191275|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
138253104|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253105|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
138253106|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253107|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138253108|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138253109|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
138253110|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253111|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253112|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138253113|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138253114|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138253115|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
138253116|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253117|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138253118|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138253119|NCT00002535|Analgesics|analgesics|mesh-ancestor
138253120|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
138253121|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253122|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138253123|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
138253124|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
138253125|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138230005|NCT02384850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138230006|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230007|NCT02384850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138230008|NCT02384850|Immunologic Factors|immunologic factors|mesh-ancestor
138253126|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138253127|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253129|NCT00002547|Cyclosporine|cyclosporine|mesh-list
138253130|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
138253131|NCT00002547|Busulfan|busulfan|mesh-list
138253132|NCT00002547|Methotrexate|methotrexate|mesh-list
138253133|NCT00002547|Cyclosporins|cyclosporins|mesh-list
138253134|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253135|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
138253137|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138253138|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138253139|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
138253140|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253141|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253142|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138230052|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230053|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138230054|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138230055|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138230056|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138230057|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138253143|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138253144|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
138253145|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138253146|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138253148|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
138253149|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253150|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138253151|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138253153|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253154|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
138253155|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138253156|NCT00002289|Thymopentin|thymopentin|mesh-list
138253157|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138253158|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
138253159|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253160|NCT00002553|Cobalt|cobalt|mesh-list
138230108|NCT01172600|Analgesics|analgesics|mesh-ancestor
138230109|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
138230110|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230111|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138230113|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138230114|NCT02246816|Narcotics|narcotics|mesh-ancestor
138253161|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
138253162|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253163|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
138253164|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253165|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138253168|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253169|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253170|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138253171|NCT00002553|Trace Elements|trace elements|mesh-ancestor
138253172|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
138253173|NCT00002559|Paclitaxel|paclitaxel|mesh-list
138253174|NCT00002559|Ifosfamide|ifosfamide|mesh-list
138253175|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138253176|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253178|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
138253179|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
138253180|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253181|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138253182|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
138253183|NCT00002565|Cytarabine|cytarabine|mesh-list
138253184|NCT00002565|Prednisone|prednisone|mesh-list
138253185|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
138253186|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
138253187|NCT00002565|Ifosfamide|ifosfamide|mesh-list
138253188|NCT00002565|Doxorubicin|doxorubicin|mesh-list
138253189|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138253190|NCT00002565|Etoposide|etoposide|mesh-list
138253191|NCT00002565|Vincristine|vincristine|mesh-list
138253192|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
138253193|NCT00002565|Idarubicin|idarubicin|mesh-list
138253194|NCT00002565|Bleomycin|bleomycin|mesh-list
138253195|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253196|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
138230163|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
138253197|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253199|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138253200|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
138253201|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253202|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253203|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138253204|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138253205|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138253206|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138253207|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253208|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138253209|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
138253210|NCT00002565|Hormones|hormones|mesh-ancestor
138253211|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253212|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138253213|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138253214|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138253216|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
138184242|NCT01833611|Entecavir|entecavir|mesh-list
138253217|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253218|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
138253219|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
138471600|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
138253220|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
138253221|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
138253222|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
138253223|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253224|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138253225|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138253226|NCT00002565|Protective Agents|protective agents|mesh-ancestor
138253227|NCT00002565|Analgesics|analgesics|mesh-ancestor
138253228|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
138230211|NCT01178216|Rituximab|rituximab|mesh-list
138253229|NCT00002571|Leucovorin|leucovorin|mesh-list
138253230|NCT00002571|Cytarabine|cytarabine|mesh-list
138253231|NCT00002571|Trimethoprim|trimethoprim|mesh-list
138253232|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
138191288|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138253233|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138253234|NCT00002571|Prednisone|prednisone|mesh-list
138253235|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
138253236|NCT00002571|Doxorubicin|doxorubicin|mesh-list
138253237|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138253238|NCT00002571|Methotrexate|methotrexate|mesh-list
138253239|NCT00002571|Etoposide|etoposide|mesh-list
138471691|NCT01997203|Ribavirin|ribavirin|mesh-list
138253240|NCT00002571|Vincristine|vincristine|mesh-list
138253241|NCT00002571|Bleomycin|bleomycin|mesh-list
138253242|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
138253243|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253244|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
138253245|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253246|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138253247|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138253248|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
138253249|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253250|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253251|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138253252|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138253253|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138253254|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138230249|NCT02383758|Bisacodyl|bisacodyl|mesh-list
138230250|NCT02383758|Glycerol|glycerol|mesh-list
138230251|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138253255|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253256|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138253257|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
138253258|NCT00002571|Hormones|hormones|mesh-ancestor
138253259|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253260|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138253261|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138253262|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
138253263|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138253264|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138253265|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
138253266|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
138253267|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138253268|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138253269|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138253270|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
138253271|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253272|NCT00002571|Antidotes|antidotes|mesh-ancestor
138253273|NCT00002571|Protective Agents|protective agents|mesh-ancestor
138253274|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
138253276|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
138253277|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
138253278|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
138253279|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
138253280|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138253281|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
138253282|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138253283|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138253284|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138253285|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138253286|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138471726|NCT01997593|Ropivacaine|ropivacaine|mesh-list
138253287|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138253288|NCT00360815|Insulin|insulin|mesh-list
138253289|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138253290|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253291|NCT00002583|Vinorelbine|vinorelbine|mesh-list
138230299|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138253292|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253293|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138253294|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
138253295|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
138253296|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
138253297|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253298|NCT00002589|Aldesleukin|aldesleukin|mesh-list
138253299|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
138253300|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253301|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138253302|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138253303|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
138253304|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253305|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
138253306|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253307|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253308|NCT02223871|Lumefantrine|lumefantrine|mesh-list
138253309|NCT02223871|Artemether|artemether|mesh-list
138253310|NCT02223871|Primaquine|primaquine|mesh-list
138253311|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
138253312|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138253313|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138253314|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253315|NCT00002595|Toremifene|toremifene|mesh-list
138253316|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138253317|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253318|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138253319|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138471750|NCT01997658|Hormones|hormones|mesh-ancestor
138253320|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
138253321|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253322|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253323|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138253324|NCT03004339|Betamethasone|betamethasone|mesh-list
138253325|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
138253326|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138230334|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253327|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
138253328|NCT03004339|Calcipotriene|calcipotriene|mesh-list
138253329|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138253330|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138253331|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
138253332|NCT03004339|Hormones|hormones|mesh-ancestor
138253333|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253334|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253335|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138253336|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
138253337|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
138253338|NCT00002619|Carboplatin|carboplatin|mesh-list
138253339|NCT00002619|Thiotepa|thiotepa|mesh-list
138253340|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253341|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
138253342|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253343|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138253344|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
138253345|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253346|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138253347|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253348|NCT00002625|Topotecan|topotecan|mesh-list
138253349|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138253350|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138253351|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253352|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253353|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253354|NCT00360737|Antitoxins|antitoxins|mesh-list
138253355|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
138253356|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
138253357|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253358|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
138253359|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138253360|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138253361|NCT04343729|Prednisolone|prednisolone|mesh-list
138230374|NCT01143818|Hormones|hormones|mesh-ancestor
138253362|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
138253363|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138253364|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
138191307|NCT03605914|Narcotics|narcotics|mesh-ancestor
138253365|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138253367|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
138253368|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253369|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253370|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138253371|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
138253372|NCT04343729|Hormones|hormones|mesh-ancestor
138253373|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253374|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138253375|NCT04343729|Protective Agents|protective agents|mesh-ancestor
138253376|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138253377|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253378|NCT00002631|Fluorouracil|fluorouracil|mesh-list
138253379|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253380|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
138253381|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253382|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138253383|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253384|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
138253385|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253386|NCT00002637|Interferons|interferons|mesh-list
138253387|NCT00002637|Aldesleukin|aldesleukin|mesh-list
138253388|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
138230410|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253389|NCT00002637|Vaccines|vaccines|mesh-list
138253390|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253391|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
138253392|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253393|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138253394|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138253395|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
138253396|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253397|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138253398|NCT02977013|Dalteparin|dalteparin|mesh-list
138253399|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
138253400|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138253401|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138253402|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253403|NCT05806918|Interferons|interferons|mesh-list
138253404|NCT05806918|Interferon alpha-2|interferon alpha-2|mesh-list
138253405|NCT05806918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253406|NCT05806918|Antiviral Agents|antiviral agents|mesh-ancestor
138253407|NCT05806918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253408|NCT00002241|Ritonavir|ritonavir|mesh-list
138253409|NCT00002241|Indinavir|indinavir|mesh-list
138253410|NCT00002241|Lamivudine|lamivudine|mesh-list
138253411|NCT00002241|Stavudine|stavudine|mesh-list
138253412|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138253413|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138253414|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
138253415|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253416|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253418|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138253419|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
138253420|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253421|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138253422|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138253423|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138253424|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138253425|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
138253426|NCT05806853|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138253427|NCT05806853|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138230462|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138253428|NCT05806853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253429|NCT05806723|Atorvastatin|atorvastatin|mesh-list
138191308|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138253430|NCT05806723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138253431|NCT05806723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138253432|NCT05806723|Antimetabolites|antimetabolites|mesh-ancestor
138253433|NCT05806723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253434|NCT05806723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138253435|NCT05806723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138253436|NCT05806723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253437|NCT05806697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138253438|NCT05806697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138253439|NCT05806697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253441|NCT05806671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138253442|NCT05806671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253443|NCT05806671|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138253444|NCT05806671|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138253445|NCT05806671|Hormone Antagonists|hormone antagonists|mesh-ancestor
138253446|NCT05806671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253447|NCT05806671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253449|NCT05806476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138253450|NCT05806476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253451|NCT05806476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138253452|NCT05806476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253453|NCT05806476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253454|NCT05806476|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138253455|NCT05806476|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138253456|NCT05806476|Purinergic Agents|purinergic agents|mesh-ancestor
138253457|NCT05806476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138253458|NCT05806307|Vasopressins|vasopressins|mesh-list
138253459|NCT05806307|Arginine Vasopressin|arginine vasopressin|mesh-list
138230499|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138230502|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138253460|NCT05806307|Epinephrine|epinephrine|mesh-list
138253461|NCT05806307|Bupivacaine|bupivacaine|mesh-list
138253462|NCT05806307|Misoprostol|misoprostol|mesh-list
138253463|NCT05806307|Ethamsylate|ethamsylate|mesh-list
138253465|NCT05806307|Carbetocin|carbetocin|mesh-list
138253466|NCT05806307|Anesthetics, Local|anesthetics, local|mesh-ancestor
138253467|NCT05806307|Anesthetics|anesthetics|mesh-ancestor
138253468|NCT05806307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138253469|NCT05806307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253470|NCT05806307|Sensory System Agents|sensory system agents|mesh-ancestor
138253471|NCT05806307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253472|NCT05806307|Oxytocics|oxytocics|mesh-ancestor
138253473|NCT05806307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138253474|NCT05806307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138253475|NCT05806307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138253476|NCT05806307|Adrenergic Agents|adrenergic agents|mesh-ancestor
138253477|NCT05806307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138253478|NCT05806307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253479|NCT05806307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138253480|NCT05806307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138253481|NCT05806307|Autonomic Agents|autonomic agents|mesh-ancestor
138253482|NCT05806307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138253483|NCT05806307|Respiratory System Agents|respiratory system agents|mesh-ancestor
138253484|NCT05806307|Mydriatics|mydriatics|mesh-ancestor
138253485|NCT05806307|Sympathomimetics|sympathomimetics|mesh-ancestor
138253486|NCT05806307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138253487|NCT05806307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138253488|NCT05806307|Abortifacient Agents|abortifacient agents|mesh-ancestor
138253489|NCT05806307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138253490|NCT05806307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138253491|NCT05806307|Hemostatics|hemostatics|mesh-ancestor
138253492|NCT05806307|Coagulants|coagulants|mesh-ancestor
138253493|NCT05806307|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138253494|NCT05806307|Natriuretic Agents|natriuretic agents|mesh-ancestor
138253495|NCT05806047|Fulvestrant|fulvestrant|mesh-list
138253496|NCT05806047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138253497|NCT05806047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230540|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
138253498|NCT05806047|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138253499|NCT05806047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138253500|NCT05806047|Hormone Antagonists|hormone antagonists|mesh-ancestor
138191319|NCT03608488|Vitamin D|vitamin d|mesh-list
138253501|NCT05806047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253502|NCT05806047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253503|NCT05805930|Prednisone|prednisone|mesh-list
138253504|NCT05805930|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138253505|NCT05805930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138253506|NCT05805930|Glucocorticoids|glucocorticoids|mesh-ancestor
138253508|NCT05805930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253509|NCT05805930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253510|NCT05805930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138253512|NCT05805930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138253513|NCT05805631|Pemetrexed|pemetrexed|mesh-list
138253514|NCT05805631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253515|NCT05805631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472439|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
138253516|NCT05805631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253517|NCT05805631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138253518|NCT05805631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138253519|NCT05805553|Nandrolone Decanoate|nandrolone decanoate|mesh-list
138253520|NCT05805553|Propranolol|propranolol|mesh-list
138253522|NCT05805553|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
138253523|NCT05805553|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138230577|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
138230578|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253525|NCT05805553|Adrenergic Agents|adrenergic agents|mesh-ancestor
138253526|NCT05805553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138253527|NCT05805553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253528|NCT05805553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253529|NCT05805553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138253530|NCT05805553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138253531|NCT05805553|Vasodilator Agents|vasodilator agents|mesh-ancestor
138253532|NCT05805553|Androgens|androgens|mesh-ancestor
138253533|NCT05805553|Hormones|hormones|mesh-ancestor
138253534|NCT05805553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253535|NCT05805553|Anabolic Agents|anabolic agents|mesh-ancestor
138253536|NCT05805553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138253538|NCT05804747|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138253539|NCT05804747|Antithrombins|antithrombins|mesh-ancestor
138253540|NCT05804747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138253541|NCT05804747|Protease Inhibitors|protease inhibitors|mesh-ancestor
138253542|NCT05804747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253543|NCT05804747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253544|NCT05804747|Anticoagulants|anticoagulants|mesh-ancestor
138253545|NCT05800938|Isosorbide|isosorbide|mesh-list
138253546|NCT05800938|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138253547|NCT05800938|Diuretics|diuretics|mesh-ancestor
138253549|NCT05800938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253550|NCT05797935|Dapagliflozin|dapagliflozin|mesh-list
138253551|NCT05797935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138253552|NCT05797935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253553|NCT05797935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138253554|NCT05797935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253555|NCT05775237|Vitamins|vitamins|mesh-list
138253556|NCT05775237|Ascorbic Acid|ascorbic acid|mesh-list
138230624|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
138230625|NCT01189292|Hormones|hormones|mesh-ancestor
138230626|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230629|NCT01189370|Sorafenib|sorafenib|mesh-list
138253557|NCT05775237|Curcumin|curcumin|mesh-list
138253558|NCT05775237|Micronutrients|micronutrients|mesh-ancestor
138253559|NCT05775237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253560|NCT05775237|Antioxidants|antioxidants|mesh-ancestor
138253561|NCT05775237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253562|NCT05775237|Protective Agents|protective agents|mesh-ancestor
138253563|NCT05775237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138253564|NCT05775237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138191321|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
138253565|NCT05775237|Analgesics|analgesics|mesh-ancestor
138253566|NCT05775237|Sensory System Agents|sensory system agents|mesh-ancestor
138253567|NCT05775237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253568|NCT05775237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138253569|NCT05775237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138253570|NCT05775237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253571|NCT05775237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253572|NCT05751044|Cytarabine|cytarabine|mesh-list
138253573|NCT05751044|Dexamethasone|dexamethasone|mesh-list
138253574|NCT05751044|Cyclophosphamide|cyclophosphamide|mesh-list
138253575|NCT05751044|Venetoclax|venetoclax|mesh-list
138253576|NCT05751044|Dasatinib|dasatinib|mesh-list
138253577|NCT05751044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253578|NCT05751044|Immunologic Factors|immunologic factors|mesh-ancestor
138253579|NCT05751044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253580|NCT05751044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138230664|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
138230665|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230666|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230667|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138230668|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
138253581|NCT05751044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138472691|NCT02003768|Propofol|propofol|mesh-list
138253583|NCT05751044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253584|NCT05751044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253585|NCT05751044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138253586|NCT05751044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138253587|NCT05751044|Antiemetics|antiemetics|mesh-ancestor
138253588|NCT05751044|Autonomic Agents|autonomic agents|mesh-ancestor
138253589|NCT05751044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253590|NCT05751044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138253591|NCT05751044|Glucocorticoids|glucocorticoids|mesh-ancestor
138253592|NCT05751044|Hormones|hormones|mesh-ancestor
138253593|NCT05751044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253594|NCT05751044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138253595|NCT05751044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138253597|NCT05751044|Antiviral Agents|antiviral agents|mesh-ancestor
138253598|NCT05751044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253599|NCT05751044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138253600|NCT05751044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253601|NCT05709093|Azacitidine|azacitidine|mesh-list
138253602|NCT05709093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138253603|NCT05709093|Antimetabolites|antimetabolites|mesh-ancestor
138253604|NCT05709093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253605|NCT05709093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253606|NCT05709093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253607|NCT05690646|Ritonavir|ritonavir|mesh-list
138253608|NCT05690646|Nirmatrelvir|nirmatrelvir|mesh-list
138253609|NCT05690646|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
138253610|NCT05690646|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138253611|NCT05690646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138253612|NCT05690646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138230710|NCT01194674|Plasminogen|plasminogen|mesh-list
138230711|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138230712|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138230713|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230714|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138253613|NCT05690646|Protease Inhibitors|protease inhibitors|mesh-ancestor
138253614|NCT05690646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253615|NCT05690646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253616|NCT05690646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138253617|NCT05690646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138253618|NCT05690646|Antiviral Agents|antiviral agents|mesh-ancestor
138253619|NCT05690646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253620|NCT05690646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138253621|NCT05690646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138253622|NCT05690646|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138253623|NCT05690646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138253624|NCT05648201|Raltegravir Potassium|raltegravir potassium|mesh-list
138253625|NCT05648201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138253626|NCT05648201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138253627|NCT05648201|Antiviral Agents|antiviral agents|mesh-ancestor
138253628|NCT05648201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253629|NCT05648201|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138253630|NCT05648201|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138253631|NCT05648201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253632|NCT05648201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253633|NCT05511870|Etripamil|etripamil|mesh-list
138253634|NCT05511870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138253635|NCT05511870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138253636|NCT05511870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253637|NCT05511870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138253638|NCT05511870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253639|NCT05492851|Hylan|hylan|mesh-list
138253640|NCT05492851|Viscosupplements|viscosupplements|mesh-ancestor
138253641|NCT05492851|Protective Agents|protective agents|mesh-ancestor
138253642|NCT05492851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253643|NCT05423535|Fibrin Foam|fibrin foam|mesh-list
138253644|NCT05423535|Hemostatics|hemostatics|mesh-ancestor
138253645|NCT05423535|Coagulants|coagulants|mesh-ancestor
138253646|NCT05414409|Metformin|metformin|mesh-list
138472927|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
138253647|NCT05414409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138253648|NCT05414409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253649|NCT05411575|Plerixafor|plerixafor|mesh-list
138253650|NCT05411575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138253651|NCT05411575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138253652|NCT05411575|Antiviral Agents|antiviral agents|mesh-ancestor
138253653|NCT05411575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253654|NCT05367401|Azacitidine|azacitidine|mesh-list
138253655|NCT05367401|Magrolimab|magrolimab|mesh-list
138253656|NCT05367401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138253658|NCT05367401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253659|NCT05367401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253660|NCT05367401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253661|NCT05367401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138253662|NCT05297448|Rifaximin|rifaximin|mesh-list
138253663|NCT05297448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138253664|NCT05297448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253665|NCT05297448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138253666|NCT05161156|Bromides|bromides|mesh-list
138253667|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
138253668|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138230792|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138253670|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253671|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253672|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138253673|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
138253674|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
138253675|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138253676|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
138253677|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138253678|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253679|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
138253680|NCT05132101|Palbociclib|palbociclib|mesh-list
138253681|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253682|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138253683|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253684|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253685|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
138253686|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138253687|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138253688|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253689|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
138253690|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
138253691|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253692|NCT05045950|Memantine|memantine|mesh-list
138253693|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138253694|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138253695|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
138253696|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138253697|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253698|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253699|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138253700|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138253701|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
138253702|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138253703|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138253704|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253705|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
138253706|NCT04947514|Coagulants|coagulants|mesh-ancestor
138253707|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
138253709|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138371869|NCT01414881|Mipomersen|mipomersen|mesh-list
138253710|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253711|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138473312|NCT05966818|Dapagliflozin|dapagliflozin|mesh-list
138253712|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253713|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138253714|NCT04860011|Diuretics|diuretics|mesh-ancestor
138253715|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
138253716|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138253717|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138253718|NCT04704050|Dronedarone|dronedarone|mesh-list
138253719|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138253720|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
138253721|NCT04669210|Tacrolimus|tacrolimus|mesh-list
138253722|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253723|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
138253724|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253725|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138253726|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253727|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253728|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138253729|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253730|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138253731|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
138253732|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138473418|NCT05760677|Metformin|metformin|mesh-list
138253733|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253734|NCT04655157|Nivolumab|nivolumab|mesh-list
138253735|NCT04655157|Ipilimumab|ipilimumab|mesh-list
138230883|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138253736|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138253737|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253738|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138253739|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253740|NCT04650269|Emtricitabine|emtricitabine|mesh-list
138191345|NCT05512416|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138191346|NCT05512416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138253741|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
138253742|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253743|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138253744|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138253745|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253746|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253747|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138253748|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138253749|NCT04629196|Ustekinumab|ustekinumab|mesh-list
138253750|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
138253751|NCT04578600|Lenalidomide|lenalidomide|mesh-list
138253753|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
138253754|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
138253755|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253756|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138253757|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138253758|NCT04578600|Growth Substances|growth substances|mesh-ancestor
138253759|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
138253760|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253761|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138253762|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
138253763|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253764|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253765|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138253766|NCT04405037|Alvimopan|alvimopan|mesh-list
138253767|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138253768|NCT04389177|Paclitaxel|paclitaxel|mesh-list
138253769|NCT04389177|Cisplatin|cisplatin|mesh-list
138253770|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
138253771|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138253772|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230922|NCT00363909|Citalopram|citalopram|mesh-list
138253773|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
138253774|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
138253775|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
138253776|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253777|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138253778|NCT04389177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138253779|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138253781|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
138253782|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
138253783|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138253784|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138253785|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
138253786|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138253787|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253788|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253789|NCT04341545|Letrozole|letrozole|mesh-list
138253790|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253791|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138473807|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138253792|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138253793|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191365|NCT05512728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191366|NCT05512728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138191367|NCT05512728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138191368|NCT05512728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138191369|NCT05512728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138191370|NCT05512728|Anesthetics, General|anesthetics, general|mesh-ancestor
138191371|NCT05512728|Anesthetics|anesthetics|mesh-ancestor
138191372|NCT05512728|GABA Modulators|gaba modulators|mesh-ancestor
138191373|NCT05512728|GABA Agents|gaba agents|mesh-ancestor
138191374|NCT05512728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138253794|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253795|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138253796|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
138253797|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138253798|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253799|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
138253800|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138253801|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
138253802|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253803|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
138253804|NCT04219722|Protective Agents|protective agents|mesh-ancestor
138253806|NCT04186299|Epinephrine|epinephrine|mesh-list
138253807|NCT04186299|Carticaine|carticaine|mesh-list
138253808|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138253809|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138253810|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
138253811|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138253812|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253813|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253814|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138253815|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138253816|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
138253817|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253818|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138253819|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
138253820|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
138253821|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
138253822|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138253823|NCT04186299|Analgesics|analgesics|mesh-ancestor
138253824|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
138253825|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138253826|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
138253827|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138253828|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
138253829|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
138253830|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138253831|NCT04165096|Acetaminophen|acetaminophen|mesh-list
138253832|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
138253833|NCT04165096|Promethazine|promethazine|mesh-list
138253834|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
138253835|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138253836|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253837|NCT04165096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138253838|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253839|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138253840|NCT04165096|Analgesics|analgesics|mesh-ancestor
138253841|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
138253842|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253843|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253844|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
138253845|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138253846|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138253847|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138253848|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
138253849|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
138253850|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
138253851|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
138253852|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138253853|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138253854|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
138253855|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
138253856|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138253857|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138253858|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
138253859|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
138253860|NCT03927222|Temozolomide|temozolomide|mesh-list
138253862|NCT03927222|Sargramostim|sargramostim|mesh-list
138253863|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
138191375|NCT05512728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253864|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253865|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138253866|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
138474051|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138253867|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253868|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253869|NCT03822663|Caffeine|caffeine|mesh-list
138253870|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138253871|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253872|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138253873|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253874|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253875|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138253876|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138253877|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
138253878|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138253879|NCT03801525|Venetoclax|venetoclax|mesh-list
138253880|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253881|NCT03767933|Acetaminophen|acetaminophen|mesh-list
138253882|NCT03767933|Ibuprofen|ibuprofen|mesh-list
138253883|NCT03767933|Hydromorphone|hydromorphone|mesh-list
138253884|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138253885|NCT03767933|Analgesics|analgesics|mesh-ancestor
138253886|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
138253887|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253888|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253889|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
138253890|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138253891|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138253893|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138253894|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253895|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253896|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138253897|NCT03767933|Narcotics|narcotics|mesh-ancestor
138253898|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138253899|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
138253900|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138253901|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138253902|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138253903|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253904|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
138253905|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138253906|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138474219|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
138253907|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138253908|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253909|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
138253910|NCT03636152|Chloroquine|chloroquine|mesh-list
138253911|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
138253912|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138253913|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138253914|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191382|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138191383|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138191384|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191385|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191386|NCT00940901|Urological Agents|urological agents|mesh-ancestor
138191387|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138191389|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138474288|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
138253915|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253916|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253917|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138253919|NCT03633604|HBOC 201|hboc 201|mesh-list
138253920|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
138253921|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138253922|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138253923|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138253924|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253925|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138253926|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138253927|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253928|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
138253929|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138253930|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
138253931|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138253932|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138253933|NCT03474497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138253934|NCT03474497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253935|NCT03395223|Methylene Blue|methylene blue|mesh-list
138253936|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253937|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253938|NCT03289650|Tacrolimus|tacrolimus|mesh-list
138253939|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253940|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
138253941|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253943|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253944|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253945|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
138253946|NCT03192397|Sirolimus|sirolimus|mesh-list
138253947|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
138253948|NCT03192397|Melphalan|melphalan|mesh-list
138253950|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
138253951|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138253952|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
138253953|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253954|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138253955|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138253956|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
138253957|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138474546|NCT03607175|Triamcinolone|triamcinolone|mesh-list
138253959|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138253960|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138253961|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
138253962|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138253963|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138253964|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
138253965|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138253966|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253967|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253968|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
138253970|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
138253972|NCT02975492|Vitamins|vitamins|mesh-list
138253973|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
138253974|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191390|NCT03565666|Insulin|insulin|mesh-list
138191391|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138191392|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
138191393|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
138191394|NCT03565666|Pancrelipase|pancrelipase|mesh-list
138253975|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138253976|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138253977|NCT02867267|Thymalfasin|thymalfasin|mesh-list
138253978|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138253979|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
138253980|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138253981|NCT02821832|Rifampin|rifampin|mesh-list
138253982|NCT02821832|Isoniazid|isoniazid|mesh-list
138253983|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
138253984|NCT02821832|Ethambutol|ethambutol|mesh-list
138253985|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138253986|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
138253987|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138253988|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138253989|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
138253990|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138253991|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138253992|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138253993|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138253994|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138253995|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138231292|NCT04936841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138253996|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138253997|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138253998|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138253999|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138254000|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138254001|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
138254002|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138254003|NCT02813148|Naloxegol|naloxegol|mesh-list
138254004|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138254005|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254006|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
138254007|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254008|NCT02756611|Venetoclax|venetoclax|mesh-list
138254009|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254010|NCT02673359|Progesterone|progesterone|mesh-list
138254011|NCT02673359|Progestins|progestins|mesh-ancestor
138254012|NCT02673359|Hormones|hormones|mesh-ancestor
138254013|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254014|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254015|NCT02624518|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
138254016|NCT02624518|Bombesin|bombesin|mesh-list
138254017|NCT02624518|Gastrins|gastrins|mesh-list
138254018|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138254019|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254020|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254021|NCT02624518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138254022|NCT02624518|Hormones|hormones|mesh-ancestor
138254023|NCT02624518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254024|NCT02287623|Bupivacaine|bupivacaine|mesh-list
138254025|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
138254026|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
138254027|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138254028|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254029|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
138254030|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254031|NCT01794520|Dexamethasone|dexamethasone|mesh-list
138254032|NCT01794520|Venetoclax|venetoclax|mesh-list
138254033|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138254034|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
138254035|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
138254036|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254037|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254038|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138254039|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
138254040|NCT01794520|Hormones|hormones|mesh-ancestor
138231395|NCT04165824|Edaravone|edaravone|mesh-list
138254041|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254042|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138254043|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254044|NCT01370811|Mandelic Acids|mandelic acids|mesh-list
138254045|NCT01370811|Clonidine|clonidine|mesh-list
138254047|NCT01370811|Oxybutynin|oxybutynin|mesh-list
138254048|NCT01370811|Analgesics|analgesics|mesh-ancestor
138254049|NCT01370811|Sensory System Agents|sensory system agents|mesh-ancestor
138184735|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
138254050|NCT01370811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254051|NCT01370811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254052|NCT01370811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138254053|NCT01370811|Sympatholytics|sympatholytics|mesh-ancestor
138254054|NCT01370811|Autonomic Agents|autonomic agents|mesh-ancestor
138254055|NCT01370811|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138254056|NCT01370811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138254057|NCT01370811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138254058|NCT01370811|Adrenergic Agents|adrenergic agents|mesh-ancestor
138254059|NCT01370811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138254060|NCT01370811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254061|NCT01370811|Parasympatholytics|parasympatholytics|mesh-ancestor
138254062|NCT01370811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138254063|NCT01370811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138254064|NCT01370811|Cholinergic Agents|cholinergic agents|mesh-ancestor
138254065|NCT01370811|Urological Agents|urological agents|mesh-ancestor
138254066|NCT01370811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138254067|NCT01370811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254069|NCT01323569|Dronabinol|dronabinol|mesh-list
138254070|NCT01323569|Analgesics|analgesics|mesh-ancestor
138254071|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
138254072|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254073|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254074|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
138254075|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138254076|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138254077|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138254078|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138254079|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138254080|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254081|NCT01323569|Hormones|hormones|mesh-ancestor
138254082|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254083|NCT01323465|Rifampin|rifampin|mesh-list
138254084|NCT01323465|Ketoconazole|ketoconazole|mesh-list
138254085|NCT01323465|Nabiximols|nabiximols|mesh-list
138254086|NCT01323465|Omeprazole|omeprazole|mesh-list
138254087|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138254088|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138254089|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138254090|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254091|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254092|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138254093|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
138254094|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138254095|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254096|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
138254097|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138231492|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254098|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138254099|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138254100|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138254101|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138254102|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138254103|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138254104|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
138254105|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138254106|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138254107|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138254108|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
138254109|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254110|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254111|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138254113|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
138254114|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254115|NCT01322464|Nabiximols|nabiximols|mesh-list
138254116|NCT01322464|Analgesics|analgesics|mesh-ancestor
138254117|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
138254118|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254119|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254120|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
138254121|NCT01322139|Nabiximols|nabiximols|mesh-list
138254122|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138254123|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138254124|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138231539|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138254125|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138254126|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138254127|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254128|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254129|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254130|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138254131|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
138254132|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138254133|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254134|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138254135|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138372246|NCT01417351|Vitamins|vitamins|mesh-list
138254137|NCT01322139|Analgesics|analgesics|mesh-ancestor
138254138|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
138254139|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254140|NCT01019850|Vorinostat|vorinostat|mesh-list
138254141|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138254142|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254143|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138254144|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254145|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254146|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138254148|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
138254149|NCT00885326|Bevacizumab|bevacizumab|mesh-list
138254150|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138254151|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
138254152|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231586|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
138254153|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138254154|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138254155|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
138254156|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138475173|NCT02008201|Vitamin D|vitamin d|mesh-list
138254157|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254158|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138254159|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138254160|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138254161|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138254162|NCT00885326|Growth Substances|growth substances|mesh-ancestor
138254163|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
138254164|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138254165|NCT00606138|Ranibizumab|ranibizumab|mesh-list
138254166|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138254167|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138254168|NCT00606138|Growth Substances|growth substances|mesh-ancestor
138254169|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254170|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
138254171|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254172|NCT00005835|Melphalan|melphalan|mesh-list
138254173|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
138191417|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
138191418|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191419|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191420|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138191421|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
138254174|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
138254175|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138184817|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138254176|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138254177|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
138254178|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254179|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254180|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138254181|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138254183|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138254184|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254185|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138254186|NCT00005835|Protective Agents|protective agents|mesh-ancestor
138254187|NCT04401995|Nivolumab|nivolumab|mesh-list
138254188|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138254190|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138254191|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254193|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
138254194|NCT00002643|Ifosfamide|ifosfamide|mesh-list
138254195|NCT00002643|Doxorubicin|doxorubicin|mesh-list
138254196|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138254197|NCT00002643|Etoposide|etoposide|mesh-list
138254198|NCT00002643|Vincristine|vincristine|mesh-list
138254199|NCT00002643|Topotecan|topotecan|mesh-list
138254200|NCT00002643|Amifostine|amifostine|mesh-list
138254201|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138254202|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
138254203|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254204|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138254205|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138254206|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
138254207|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254208|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254209|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138254210|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138254211|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138254212|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138254213|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254214|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138254215|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
138254216|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
138254217|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
138254218|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138254219|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138254220|NCT00002643|Protective Agents|protective agents|mesh-ancestor
138254221|NCT00002643|Trace Elements|trace elements|mesh-ancestor
138254222|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
138254223|NCT00002649|Aldesleukin|aldesleukin|mesh-list
138254224|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
138254225|NCT00002649|Etoposide|etoposide|mesh-list
138254226|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
138254227|NCT00002649|Interleukin-2|interleukin-2|mesh-list
138231734|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
138254228|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138254229|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
138254230|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254231|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138254232|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138254233|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
138254234|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254235|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254236|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138254237|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138254238|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138254239|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138254240|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254241|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138254242|NCT00002649|Analgesics|analgesics|mesh-ancestor
138254243|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
138254244|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254245|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138254247|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
138191428|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191429|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138254248|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254249|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
138254250|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138475601|NCT04050280|Cytarabine|cytarabine|mesh-list
138254252|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254254|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
138254255|NCT00995059|Sirolimus|sirolimus|mesh-list
138254256|NCT00995059|Bortezomib|bortezomib|mesh-list
138254257|NCT00995059|Melphalan|melphalan|mesh-list
138254258|NCT00995059|Tacrolimus|tacrolimus|mesh-list
138254259|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
138254260|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138254262|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138254263|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
138254264|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254265|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138254266|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254267|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254268|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254269|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138254270|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254271|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138254272|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
138254273|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138254274|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
138475669|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
138254275|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138254276|NCT02249299|Nabiximols|nabiximols|mesh-list
138254277|NCT02249299|Analgesics|analgesics|mesh-ancestor
138254278|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
138254279|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254280|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254281|NCT00002679|Tamoxifen|tamoxifen|mesh-list
138254282|NCT00002679|Paclitaxel|paclitaxel|mesh-list
138254283|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
138254284|NCT00002679|Doxorubicin|doxorubicin|mesh-list
138254285|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138254286|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138254287|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254288|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
138254289|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
138254290|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
138231832|NCT05220813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254291|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254292|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138475783|NCT03127007|Atezolizumab|atezolizumab|mesh-list
138254294|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254295|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138254296|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138254297|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
138254298|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138254299|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138254300|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138254301|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138254302|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254303|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138254304|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
138475851|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138254305|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254306|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138191430|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138254307|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138254308|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138191431|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
138254309|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138254312|NCT00002691|Dexamethasone|dexamethasone|mesh-list
138254313|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
138254314|NCT00002691|Methotrexate|methotrexate|mesh-list
138254315|NCT00002691|Etoposide|etoposide|mesh-list
138254316|NCT00002691|Vincristine|vincristine|mesh-list
138254317|NCT00002691|Daunorubicin|daunorubicin|mesh-list
138254318|NCT00002691|Asparaginase|asparaginase|mesh-list
138254319|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
138254320|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138254321|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
138254322|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254323|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138254324|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138254326|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254327|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138476051|NCT02009488|Canagliflozin|canagliflozin|mesh-list
138254329|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138254330|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
138254331|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
138254332|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254333|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138254334|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
138254336|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254337|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138476123|NCT02010762|Vitamin D|vitamin d|mesh-list
138254338|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138254339|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
138254340|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138254341|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138254342|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
138254343|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
138254344|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254345|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138254346|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138254347|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138254348|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138254349|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138254350|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
138254351|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254352|NCT00002691|Antidotes|antidotes|mesh-ancestor
138254353|NCT00002691|Protective Agents|protective agents|mesh-ancestor
138254354|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
138254356|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
138254357|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
138254358|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
138254359|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
138254360|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138254361|NCT04054115|Alprostadil|alprostadil|mesh-list
138254362|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138254363|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
138254364|NCT04054115|Urological Agents|urological agents|mesh-ancestor
138254365|NCT00002697|Carboplatin|carboplatin|mesh-list
138254366|NCT00002697|Etoposide|etoposide|mesh-list
138254367|NCT00002697|Ifosfamide|ifosfamide|mesh-list
138254368|NCT00002697|Sargramostim|sargramostim|mesh-list
138254369|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254370|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138254371|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138254372|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138254373|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254374|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254375|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
138254376|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254377|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138254378|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
138254380|NCT05032807|Anticonvulsants|anticonvulsants|mesh-ancestor
138254381|NCT00002715|Prednisone|prednisone|mesh-list
138254382|NCT00002715|Doxorubicin|doxorubicin|mesh-list
138254383|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138254384|NCT00002715|Bleomycin|bleomycin|mesh-list
138191438|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
138254386|NCT00002715|Vincristine|vincristine|mesh-list
138254387|NCT00002715|Vinblastine|vinblastine|mesh-list
138254388|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
138254389|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138254390|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254391|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138254392|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138254393|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138476368|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254394|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254395|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138254396|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
138254398|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254399|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254400|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138254401|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138254402|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
138254403|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
138254404|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
138254405|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
138254407|NCT02976467|Fulacimstat|fulacimstat|mesh-list
138254408|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254409|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254410|NCT02981095|Bupivacaine|bupivacaine|mesh-list
138254411|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
138254412|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
138254413|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138254414|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254415|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
138254416|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254418|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138254419|NCT00002721|Estramustine|estramustine|mesh-list
138254420|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138254421|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254422|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138254423|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138254424|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254425|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254426|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138254427|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
138254428|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138254429|NCT04739345|Pentoxifylline|pentoxifylline|mesh-list
138254430|NCT04739345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138254431|NCT04739345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254432|NCT04739345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254434|NCT04739345|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138254436|NCT04739345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254437|NCT04739345|Vasodilator Agents|vasodilator agents|mesh-ancestor
138254438|NCT04739345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138254439|NCT04739345|Antioxidants|antioxidants|mesh-ancestor
138254440|NCT01625455|Aprepitant|aprepitant|mesh-list
138254441|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
138254442|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
138254443|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254444|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254445|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138254446|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138254447|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138254448|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254449|NCT05751681|Cetrorelix|cetrorelix|mesh-list
138254450|NCT05751681|Dydrogesterone|dydrogesterone|mesh-list
138254451|NCT05751681|Progestins|progestins|mesh-list
138254452|NCT05751681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138254453|NCT05751681|Fertility Agents|fertility agents|mesh-ancestor
138254454|NCT05751681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138254455|NCT05751681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254456|NCT05751681|Hormone Antagonists|hormone antagonists|mesh-ancestor
138191441|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191442|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
138191443|NCT03023189|Coagulants|coagulants|mesh-ancestor
138254457|NCT05751681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254458|NCT05751681|Hormones|hormones|mesh-ancestor
138254460|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254461|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138254462|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138254463|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138254464|NCT00002733|Interferons|interferons|mesh-list
138254465|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
138254466|NCT00002733|Aldesleukin|aldesleukin|mesh-list
138254467|NCT00002733|Cimetidine|cimetidine|mesh-list
138254468|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138232115|NCT00003407|Cytarabine|cytarabine|mesh-list
138254469|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
138254470|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254471|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
138254472|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254473|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138254474|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138254475|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138254476|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138254477|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138254478|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
138254479|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
138254480|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138254481|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254482|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138254483|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138254484|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254486|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
138254487|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
138254488|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254489|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254490|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138254491|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138254493|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138254494|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138254495|NCT01625923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138254496|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138254497|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138254498|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254500|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
138254502|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138254503|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
138254504|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254505|NCT00002757|Cytarabine|cytarabine|mesh-list
138254506|NCT00002757|Prednisone|prednisone|mesh-list
138254507|NCT00002757|Prednisolone|prednisolone|mesh-list
138254508|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
138254509|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138254510|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138254511|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138254512|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
138254513|NCT00002757|Doxorubicin|doxorubicin|mesh-list
138254514|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138254515|NCT00002757|Methotrexate|methotrexate|mesh-list
138254516|NCT00002757|Etoposide|etoposide|mesh-list
138254517|NCT00002757|Vincristine|vincristine|mesh-list
138254518|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138254519|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
138254520|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254521|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138254522|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138254523|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
138254524|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138476993|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254525|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254526|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138254527|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138254528|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138254529|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138254530|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254531|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138254533|NCT00002757|Hormones|hormones|mesh-ancestor
138254534|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254535|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138254536|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138254537|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
138254538|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138254539|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138254540|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
138254541|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
138254542|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138254543|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138254544|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138254545|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
138254546|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254547|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
138254548|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
138254549|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
138254550|NCT00002763|Interferons|interferons|mesh-list
138254551|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
138184990|NCT03401593|Narcotics|narcotics|mesh-ancestor
138254553|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
138254554|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254555|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
138254556|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254557|NCT00002775|Docetaxel|docetaxel|mesh-list
138254559|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254560|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
138254561|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
138254562|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
138254563|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232240|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
138254564|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138254565|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
138254566|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138254567|NCT01631149|Rocuronium|rocuronium|mesh-list
138254568|NCT01631149|Atracurium|atracurium|mesh-list
138254569|NCT01631149|Mivacurium|mivacurium|mesh-list
138254570|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138254571|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138254572|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138254573|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254574|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254575|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138254576|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138254577|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
138254578|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138254579|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254580|NCT00002787|Aldesleukin|aldesleukin|mesh-list
138254581|NCT00002787|Interleukin-2|interleukin-2|mesh-list
138254582|NCT00002787|Vaccines|vaccines|mesh-list
138254583|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
138254584|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138254585|NCT00002787|Antibodies|antibodies|mesh-list
138254586|NCT00002787|Sargramostim|sargramostim|mesh-list
138254587|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138254588|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
138254589|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
138254590|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254591|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254592|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138254593|NCT00002787|Analgesics|analgesics|mesh-ancestor
138254594|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
138254595|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254596|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138254597|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138254598|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
138477374|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
138254599|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254600|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138254601|NCT00002793|Leucovorin|leucovorin|mesh-list
138254602|NCT00002793|Fluorouracil|fluorouracil|mesh-list
138254603|NCT00002793|Calcium|calcium|mesh-list
138254604|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
138254605|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138254606|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254607|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
138254608|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254609|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138254611|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138254612|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
138254613|NCT00002793|Antidotes|antidotes|mesh-ancestor
138254614|NCT00002793|Protective Agents|protective agents|mesh-ancestor
138254615|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
138254616|NCT00002793|Vitamins|vitamins|mesh-ancestor
138254617|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
138254619|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
138254620|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
138254621|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138254622|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254623|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
138254624|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254625|NCT05751291|Bupivacaine|bupivacaine|mesh-list
138254626|NCT05751291|Anesthetics, Local|anesthetics, local|mesh-ancestor
138254627|NCT05751291|Anesthetics|anesthetics|mesh-ancestor
138254628|NCT05751291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138254629|NCT05751291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254630|NCT05751291|Sensory System Agents|sensory system agents|mesh-ancestor
138254631|NCT05751291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254632|NCT01634191|Apremilast|apremilast|mesh-list
138254633|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138254634|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138254635|NCT01634191|Analgesics|analgesics|mesh-ancestor
138254636|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
138254637|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254638|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254639|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138254640|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138254641|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138254642|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138254643|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254644|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254645|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138254646|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254648|NCT05713851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138254649|NCT05713851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254650|NCT05713851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138254651|NCT05713851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254653|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138254654|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138254655|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254656|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
138477573|NCT02019836|Vitamin D|vitamin d|mesh-list
138254659|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138254660|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254661|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254662|NCT04266197|Urological Agents|urological agents|mesh-ancestor
138254663|NCT05669313|Rivaroxaban|rivaroxaban|mesh-list
138254664|NCT05669313|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138254665|NCT05669313|Antithrombins|antithrombins|mesh-ancestor
138254666|NCT05669313|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138254667|NCT05669313|Protease Inhibitors|protease inhibitors|mesh-ancestor
138254668|NCT05669313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232353|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
138254669|NCT05669313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254671|NCT04343963|Bromides|bromides|mesh-list
138254672|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138254673|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
138254674|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138254675|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254676|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254677|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
138254678|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138254679|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254680|NCT04248179|Sufentanil|sufentanil|mesh-list
138254681|NCT04248179|Ropivacaine|ropivacaine|mesh-list
138254682|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
138254683|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
138254684|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138254685|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477599|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138254686|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
138254687|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138232398|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138232431|NCT01337336|Xhance|xhance|mesh-list
138254688|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138254689|NCT04248179|Narcotics|narcotics|mesh-ancestor
138254690|NCT04248179|Analgesics|analgesics|mesh-ancestor
138254691|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138254692|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138254693|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
138254694|NCT00361517|Amphotericin B|amphotericin b|mesh-list
138254695|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138254696|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
138254697|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
138254698|NCT00361517|Amebicides|amebicides|mesh-ancestor
138254699|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138254700|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138254701|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254702|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138254703|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
138254704|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138254705|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138254706|NCT05447507|Dexmedetomidine|dexmedetomidine|mesh-list
138254707|NCT05447507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138185055|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
138254709|NCT05447507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254710|NCT05447507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138254711|NCT05447507|Analgesics|analgesics|mesh-ancestor
138254712|NCT05447507|Sensory System Agents|sensory system agents|mesh-ancestor
138254713|NCT05447507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254714|NCT05447507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138254715|NCT05447507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138254716|NCT05447507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138254717|NCT05447507|Adrenergic Agents|adrenergic agents|mesh-ancestor
138254718|NCT05447507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138254719|NCT05447507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254720|NCT01635439|Dinoprostone|dinoprostone|mesh-list
138254721|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
138254722|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138254723|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254724|NCT01636063|Misoprostol|misoprostol|mesh-list
138254725|NCT01636063|Mifepristone|mifepristone|mesh-list
138254726|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138254727|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
138254728|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138254729|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254730|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138254731|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138254732|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
138254733|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138254734|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138254735|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138477707|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
138254736|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138254737|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
138254738|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138254739|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138254740|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
138254741|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254742|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
138191464|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254743|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138254744|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138254745|NCT05635305|Zoliflodacin|zoliflodacin|mesh-list
138254746|NCT05635305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138254747|NCT05635305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138254748|NCT05635305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254749|NCT05635305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254750|NCT05635305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254751|NCT05749575|Paclitaxel|paclitaxel|mesh-list
138254752|NCT05749575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138254753|NCT05749575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254754|NCT05749575|Tubulin Modulators|tubulin modulators|mesh-ancestor
138185086|NCT01727843|Coagulants|coagulants|mesh-ancestor
138254756|NCT05749575|Mitosis Modulators|mitosis modulators|mesh-ancestor
138254757|NCT05749575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254758|NCT05623761|Fluorides|fluorides|mesh-list
138254759|NCT05623761|Cariostatic Agents|cariostatic agents|mesh-ancestor
138254760|NCT05623761|Protective Agents|protective agents|mesh-ancestor
138254761|NCT05623761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254762|NCT00361985|Esomeprazole|esomeprazole|mesh-list
138254763|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138254764|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138254765|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138254766|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254767|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254768|NCT00362063|Hormones|hormones|mesh-list
138254769|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254770|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254771|NCT00382239|Exenatide|exenatide|mesh-list
138254772|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138254773|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254774|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138254775|NCT00382239|Incretins|incretins|mesh-ancestor
138254776|NCT00382239|Hormones|hormones|mesh-ancestor
138254777|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254778|NCT04004845|Misoprostol|misoprostol|mesh-list
138254779|NCT04004845|Oxytocin|oxytocin|mesh-list
138254781|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138254782|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138477744|NCT02021201|Sertindole|sertindole|mesh-list
138254783|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138254784|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
138254785|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138254786|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138254787|NCT01637935|Pioglitazone|pioglitazone|mesh-list
138254788|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138254789|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254790|NCT00382083|Acetaminophen|acetaminophen|mesh-list
138254791|NCT00382083|Ibuprofen|ibuprofen|mesh-list
138254792|NCT00382083|Lidocaine|lidocaine|mesh-list
138254793|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
138254794|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
138254795|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138185107|NCT03407105|Ipilimumab|ipilimumab|mesh-list
138254796|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254797|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
138254798|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254799|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138254800|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138254802|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138254803|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254804|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138254805|NCT00382083|Analgesics|analgesics|mesh-ancestor
138254806|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
138254807|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138254808|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138254809|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138254810|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138254811|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254812|NCT01640197|Resveratrol|resveratrol|mesh-list
138254813|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
138254814|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254815|NCT01640197|Protective Agents|protective agents|mesh-ancestor
138254816|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254817|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254818|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138254819|NCT01641445|Topiramate|topiramate|mesh-list
138254820|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
138254821|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138232637|NCT02613897|Hormones|hormones|mesh-ancestor
138254822|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254823|NCT04185311|Nivolumab|nivolumab|mesh-list
138254824|NCT04185311|Ipilimumab|ipilimumab|mesh-list
138254825|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138254827|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254828|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138254829|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254830|NCT05513937|Amlodipine|amlodipine|mesh-list
138254831|NCT05513937|Nebivolol|nebivolol|mesh-list
138254832|NCT05513937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138254833|NCT05513937|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138254834|NCT05513937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138254835|NCT05513937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185171|NCT03406793|Iron|iron|mesh-list
138254836|NCT05513937|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138254838|NCT05513937|Vasodilator Agents|vasodilator agents|mesh-ancestor
138254839|NCT05513937|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138254840|NCT05513937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138254841|NCT05513937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138254842|NCT05513937|Adrenergic Agents|adrenergic agents|mesh-ancestor
138254843|NCT05513937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138254844|NCT01642147|Anesthetics|anesthetics|mesh-list
138254845|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138254846|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254847|NCT04584749|Lidocaine|lidocaine|mesh-list
138254848|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
138254849|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
138254850|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138254851|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254852|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
138254853|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254854|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138254855|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138254856|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138254857|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138254858|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254860|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138254861|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254862|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
138254863|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254864|NCT00362141|Levetiracetam|levetiracetam|mesh-list
138254865|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
138254866|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
138254867|NCT05733897|Hydroxychloroquine|hydroxychloroquine|mesh-list
138254868|NCT05733897|Antimalarials|antimalarials|mesh-ancestor
138477802|NCT02021422|Fluorouracil|fluorouracil|mesh-list
138254869|NCT05733897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138254870|NCT05733897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138254871|NCT05733897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254872|NCT05733897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254873|NCT05733897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254874|NCT05733897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138254875|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138254876|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138254877|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254878|NCT03561259|Vorinostat|vorinostat|mesh-list
138232788|NCT01307930|Anidulafungin|anidulafungin|mesh-list
138191472|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138191474|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191475|NCT05506488|Dasatinib|dasatinib|mesh-list
138254879|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138254880|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254881|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138254882|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254883|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254884|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138254885|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
138254886|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
138254887|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254888|NCT03002935|Vitamins|vitamins|mesh-ancestor
138254889|NCT03788291|Rituximab|rituximab|mesh-list
138254890|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
138254891|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138254892|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254893|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
138254894|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254895|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138254897|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138254898|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254899|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
138254900|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
138254901|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138254902|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138254903|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254904|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254905|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254906|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138254907|NCT03775109|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138254908|NCT03775109|Immunologic Factors|immunologic factors|mesh-ancestor
138254909|NCT03775109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254910|NCT03251924|Nivolumab|nivolumab|mesh-list
138254911|NCT03251924|Ipilimumab|ipilimumab|mesh-list
138254912|NCT03251924|Antibodies|antibodies|mesh-list
138254913|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
138254914|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
138254915|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
138254916|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254917|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138254918|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254919|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138254920|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254921|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
138254922|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138254923|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254924|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254925|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138254926|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138254928|NCT03762317|Analgesics|analgesics|mesh-ancestor
138254929|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
138254930|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254931|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254932|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138254933|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
138254934|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
138254935|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138254936|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138254937|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138254938|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
138254939|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138254940|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254941|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
138254942|NCT02975921|Povidone|povidone|mesh-list
138254943|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
138254944|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
138254945|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138254946|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254947|NCT05452785|Minocycline|minocycline|mesh-list
138254948|NCT05452785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138254949|NCT05452785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138254950|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
138254951|NCT03002545|Cathartics|cathartics|mesh-ancestor
138254952|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138254953|NCT04517747|Ramucirumab|ramucirumab|mesh-list
138254954|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254955|NCT02219581|Dexamethasone|dexamethasone|mesh-list
138254956|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
138254957|NCT02219581|BB 1101|bb 1101|mesh-list
138254958|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138254959|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
138254960|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
138254961|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138254962|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254963|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138254966|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254967|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138254968|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254969|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
138254970|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254971|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254972|NCT01912274|Azacitidine|azacitidine|mesh-list
138254973|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138254974|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
138254975|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254976|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254977|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138254978|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
138254979|NCT01654861|Gemcitabine|gemcitabine|mesh-list
138254980|NCT01654861|Vitamins|vitamins|mesh-ancestor
138254981|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
138254982|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254983|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138254984|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
138254985|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138254986|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138254987|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
138254988|NCT01654861|Protective Agents|protective agents|mesh-ancestor
138254989|NCT05184777|Estradiol|estradiol|mesh-list
138254990|NCT05184777|Progesterone|progesterone|mesh-list
138254991|NCT05184777|Estrogens|estrogens|mesh-ancestor
138254992|NCT05184777|Hormones|hormones|mesh-ancestor
138254993|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138254994|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254995|NCT05184777|Progestins|progestins|mesh-ancestor
138254996|NCT01912352|Methylphenidate|methylphenidate|mesh-list
138254997|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138232999|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
138254998|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138254999|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138255000|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138255001|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255002|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255003|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
138255004|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255005|NCT02975843|Beclomethasone|beclomethasone|mesh-list
138255006|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
138255007|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
138255008|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138255010|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255011|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255012|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138255013|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
138255014|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138255015|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138255016|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138255017|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
138255018|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255019|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255020|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138255021|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138255022|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138191483|NCT05506488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255024|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138255025|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
138255026|NCT02975843|Hormones|hormones|mesh-ancestor
138255027|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138255028|NCT01655563|Tacrolimus|tacrolimus|mesh-list
138255029|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138255030|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
138255031|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255032|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138255033|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255034|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255035|NCT01655719|Pioglitazone|pioglitazone|mesh-list
138255036|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138255037|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255038|NCT05735756|Citalopram|citalopram|mesh-list
138255039|NCT05735756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138255040|NCT05735756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138255041|NCT05735756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255042|NCT05735756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255043|NCT05735756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255044|NCT05735756|Serotonin Agents|serotonin agents|mesh-ancestor
138255045|NCT05735756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255046|NCT05735756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138255047|NCT05735756|Antidepressive Agents|antidepressive agents|mesh-ancestor
138255048|NCT05735756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138255049|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138255050|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138255051|NCT02987348|Insulin|insulin|mesh-list
138477924|NCT02022358|Antidotes|antidotes|mesh-ancestor
138255052|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138255053|NCT02987348|Exenatide|exenatide|mesh-list
138255054|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
138255055|NCT02987348|Glucagon|glucagon|mesh-list
138255056|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138255057|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138255058|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255059|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138255060|NCT02987348|Incretins|incretins|mesh-ancestor
138255061|NCT02987348|Hormones|hormones|mesh-ancestor
138233078|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138255062|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138255063|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138255064|NCT01656031|Cytarabine|cytarabine|mesh-list
138255065|NCT01656031|Clofarabine|clofarabine|mesh-list
138255066|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138255067|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
138255068|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255069|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255070|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
138255071|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255072|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138255073|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
138255074|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255075|NCT01656187|Memantine|memantine|mesh-list
138255076|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138255077|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138255078|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
138255079|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255080|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255081|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255082|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138255083|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138255084|NCT01658839|Travoprost|travoprost|mesh-list
138255086|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138233127|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138255087|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138255088|NCT01658995|Doxycycline|doxycycline|mesh-list
138255089|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138255090|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255091|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
138255092|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138255093|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138255094|NCT01350141|Bococizumab|bococizumab|mesh-list
138255095|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138255096|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138255097|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
138255098|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255099|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138255100|NCT01662115|Nicotine|nicotine|mesh-list
138255102|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
138255103|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255104|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255105|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138255106|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138255107|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
138255108|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255109|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255110|NCT01598545|Hydromorphone|hydromorphone|mesh-list
138255111|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138255112|NCT01598545|Narcotics|narcotics|mesh-ancestor
138233174|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
138255113|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255114|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255116|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
138255117|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255118|NCT01598701|Acetaminophen|acetaminophen|mesh-list
138255119|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138255120|NCT01598701|Analgesics|analgesics|mesh-ancestor
138255121|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
138255122|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255123|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255124|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
138255125|NCT00000309|Risperidone|risperidone|mesh-list
138255126|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138255127|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
138255128|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185375|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
138255129|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255130|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255131|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138255132|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138255133|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255134|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138255135|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138255136|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
138255138|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
138255139|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
138255140|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255141|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255142|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
138255143|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255144|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138255145|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138255146|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138477980|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
138255147|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255148|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255149|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
138255150|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191497|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138191498|NCT03022253|Acetaminophen|acetaminophen|mesh-list
138255152|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138191499|NCT03022253|Ibuprofen|ibuprofen|mesh-list
138191500|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138191501|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138191502|NCT03022253|Analgesics|analgesics|mesh-ancestor
138191503|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
138255153|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
138255154|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138255155|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255156|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255157|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138255158|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138255159|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255160|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
138255161|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255162|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255163|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
138255164|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138185408|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138255166|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255167|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
138255168|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255169|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255172|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138255173|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
138255174|NCT01940276|Hormones|hormones|mesh-ancestor
138255175|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138255176|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255177|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138255178|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255179|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138255180|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255181|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255182|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
138255183|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138255184|NCT00000327|Heroin|heroin|mesh-list
138255185|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138255186|NCT00000327|Narcotics|narcotics|mesh-ancestor
138255187|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255188|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255189|NCT00000327|Analgesics|analgesics|mesh-ancestor
138255190|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
138255191|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255192|NCT01919216|Citalopram|citalopram|mesh-list
138255193|NCT01919216|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138255194|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138255195|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255196|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255197|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233328|NCT01759277|Anesthetics|anesthetics|mesh-list
138255198|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
138255199|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255200|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138255201|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
138255202|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138255204|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138255205|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
138255206|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138255207|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255208|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
138255209|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138255210|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255211|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255212|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138255213|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138255214|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138255215|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138255216|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138185447|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138255218|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138255219|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138255220|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
138255221|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255222|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255223|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255224|NCT05364645|Carboplatin|carboplatin|mesh-list
138255225|NCT05364645|Pemetrexed|pemetrexed|mesh-list
138255226|NCT05364645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255227|NCT05364645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255228|NCT05364645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255229|NCT05364645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138255230|NCT05364645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138255231|NCT01919450|Regadenoson|regadenoson|mesh-list
138255232|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138255233|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138255234|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
138255235|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
138255236|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255237|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255238|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255239|NCT01602679|Progesterone|progesterone|mesh-list
138255240|NCT01602679|Progestins|progestins|mesh-ancestor
138255241|NCT01602679|Hormones|hormones|mesh-ancestor
138478038|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255242|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138255243|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255244|NCT01919606|Bupivacaine|bupivacaine|mesh-list
138255245|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
138255246|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
138255247|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255248|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255249|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
138255250|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255251|NCT01919996|Azithromycin|azithromycin|mesh-list
138255252|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138255253|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255254|NCT05735132|Lidocaine|lidocaine|mesh-list
138255255|NCT05735132|Anesthetics, Local|anesthetics, local|mesh-ancestor
138255256|NCT05735132|Anesthetics|anesthetics|mesh-ancestor
138255257|NCT05735132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255258|NCT05735132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255259|NCT05735132|Sensory System Agents|sensory system agents|mesh-ancestor
138185475|NCT03403985|Calcium|calcium|mesh-list
138255260|NCT05735132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255261|NCT05735132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138255262|NCT05735132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138255263|NCT05735132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138255264|NCT05735132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255265|NCT05735132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255266|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
138255267|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255268|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138255269|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138255270|NCT01667029|Analgesics|analgesics|mesh-ancestor
138255271|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
138255272|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191509|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191510|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191511|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
138191513|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138191514|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138255273|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255274|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138255275|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138255276|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138255278|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255279|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138255280|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255281|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255282|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138255283|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138255284|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
138255285|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138255286|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
138255287|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138255288|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255289|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138255290|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138255291|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255292|NCT00000333|Benztropine|benztropine|mesh-list
138255293|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138255294|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138255295|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
138255296|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
138233442|NCT02322788|Terbutaline|terbutaline|mesh-list
138255297|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255298|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255299|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138255300|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138255302|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255303|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255304|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138255305|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138255306|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255307|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
138255308|NCT00000339|Risperidone|risperidone|mesh-list
138255309|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138255310|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
138255311|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255312|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255313|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255314|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138255315|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138255316|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255317|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138255318|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138255319|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
138255320|NCT00000345|Lofexidine|lofexidine|mesh-list
138255321|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138478093|NCT02023359|Everolimus|everolimus|mesh-list
138255322|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138255323|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255324|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
138255325|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233476|NCT02253173|Estradiol|estradiol|mesh-list
138255326|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138255327|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138255328|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138255329|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
138255330|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255331|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255332|NCT00000357|Buprenorphine|buprenorphine|mesh-list
138255333|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138255334|NCT00000357|Narcotics|narcotics|mesh-ancestor
138255335|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255336|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255337|NCT00000357|Analgesics|analgesics|mesh-ancestor
138255338|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
138191527|NCT03017807|Antibodies|antibodies|mesh-list
138255339|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255340|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138255342|NCT05095311|Nedocromil|nedocromil|mesh-list
138255343|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138255344|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138255345|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138255346|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
138255347|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
138255348|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255349|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255350|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255351|NCT05095311|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
138255352|NCT05095311|Immunologic Factors|immunologic factors|mesh-ancestor
138255353|NCT05095311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138255354|NCT05095311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138255355|NCT05095311|Respiratory System Agents|respiratory system agents|mesh-ancestor
138255356|NCT01922336|Infliximab|infliximab|mesh-list
138255357|NCT01922336|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138255358|NCT01922336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138255359|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
138255360|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138255361|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138255363|NCT04330755|Simendan|simendan|mesh-list
138255364|NCT04330755|Analgesics|analgesics|mesh-ancestor
138255365|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
138255366|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255367|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255368|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
138255369|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255370|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138255371|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
138255372|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138255373|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255374|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255375|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138255376|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
138255377|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138255378|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138255379|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
138255380|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138255381|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138255382|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255383|NCT04330755|Protective Agents|protective agents|mesh-ancestor
138255384|NCT01608295|Paroxetine|paroxetine|mesh-list
138255385|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
138255386|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138255387|NCT01608295|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138255388|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138255389|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255390|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255391|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255392|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
138233568|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
138255393|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255394|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138255395|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138255396|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138255397|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138255398|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255399|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138255400|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138255402|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138255403|NCT04713189|Narcotics|narcotics|mesh-ancestor
138255404|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255405|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255406|NCT04713189|Analgesics|analgesics|mesh-ancestor
138191533|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138255407|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
138255408|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255409|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138255410|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138255411|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
138255412|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
138255413|NCT01610011|Glycine|glycine|mesh-list
138255414|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
138255415|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138478146|NCT02023567|Serotonin|serotonin|mesh-list
138255416|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255417|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255419|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138233610|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
138255420|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255421|NCT02237989|Acetaminophen|acetaminophen|mesh-list
138255422|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138255423|NCT02237989|Analgesics|analgesics|mesh-ancestor
138255424|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
138255425|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255426|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255427|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
138255428|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
138255429|NCT00000429|Calcium|calcium|mesh-list
138255430|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138255431|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255432|NCT00000429|Antacids|antacids|mesh-ancestor
138255433|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255434|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138255435|NCT01673191|Dexamethasone|dexamethasone|mesh-list
138255436|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
138255437|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138255438|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138255439|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
138255440|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
138255441|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255442|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255445|NCT01673191|Hormones|hormones|mesh-ancestor
138255446|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138255447|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138255448|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255449|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138255450|NCT01925144|Omeprazole|omeprazole|mesh-list
138255451|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138255452|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138255453|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138255454|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255455|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255456|NCT00000441|Carbamazepine|carbamazepine|mesh-list
138255457|NCT00000441|Lorazepam|lorazepam|mesh-list
138255458|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
138255459|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
138255460|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
138255461|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255462|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255463|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138255464|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138255465|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255466|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138255467|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138255468|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138255469|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
138255470|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
138255471|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255472|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255473|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
138255474|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138255475|NCT00000441|Analgesics|analgesics|mesh-ancestor
138191538|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255476|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
138255477|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138255478|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255479|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138233697|NCT01365650|Ketorolac|ketorolac|mesh-list
138255480|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138255482|NCT00000447|Nicotine|nicotine|mesh-list
138255483|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138255484|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
138255486|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255487|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138255488|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138255489|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
138255490|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255491|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255492|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138255493|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138255494|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
138255495|NCT01927718|Thalidomide|thalidomide|mesh-list
138255496|NCT01927718|Lenalidomide|lenalidomide|mesh-list
138478205|NCT02023931|Sulforaphane|sulforaphane|mesh-list
138255497|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
138255498|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255499|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138255500|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138255501|NCT01927718|Growth Substances|growth substances|mesh-ancestor
138255502|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
138255503|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255504|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138255505|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
138255506|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138255507|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255508|NCT05066607|Dexamethasone|dexamethasone|mesh-list
138255509|NCT05066607|Pomalidomide|pomalidomide|mesh-list
138233752|NCT04769297|Ketamine|ketamine|mesh-list
138255510|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138255512|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
138255513|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255514|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255515|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138255516|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
138255517|NCT05066607|Hormones|hormones|mesh-ancestor
138255518|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138255519|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138255520|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255521|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
138255522|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138255523|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138255525|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
138255526|NCT01948310|Ranolazine|ranolazine|mesh-list
138255527|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138255528|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255529|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255531|NCT01948388|Hormones|hormones|mesh-ancestor
138255532|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138255533|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255534|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
138255535|NCT01675297|Vitamin D|vitamin d|mesh-list
138255536|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
138255537|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
138255538|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138478243|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
138233791|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138255539|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255541|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
138255542|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138255543|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138255544|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255545|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255546|NCT05295537|Liver Extracts|liver extracts|mesh-list
138255547|NCT05295537|Hematinics|hematinics|mesh-ancestor
138255548|NCT02287376|Diclofenac|diclofenac|mesh-list
138255549|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138255550|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138255551|NCT02287376|Analgesics|analgesics|mesh-ancestor
138255552|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
138255553|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255554|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255555|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138255556|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138255557|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138255558|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255559|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255560|NCT01928186|Alovudine|alovudine|mesh-list
138255561|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
138255562|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255563|NCT01611571|Teriparatide|teriparatide|mesh-list
138255564|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
138255565|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
138255566|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
138255567|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138255568|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255569|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138255570|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138255571|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255572|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255573|NCT00000477|Lovastatin|lovastatin|mesh-list
138255574|NCT00000477|L 647318|l 647318|mesh-list
138255575|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
138185670|NCT00944047|Paclitaxel|paclitaxel|mesh-list
138255576|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138255577|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138255579|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255580|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138255581|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138255582|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255583|NCT00000483|Niacin|niacin|mesh-list
138255584|NCT00000483|Clofibrate|clofibrate|mesh-list
138255585|NCT00000483|Estrogens|estrogens|mesh-list
138255586|NCT00000483|Hormones|hormones|mesh-ancestor
138255587|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138255588|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255589|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138255590|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
138255591|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255592|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138255593|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
138255594|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
138255595|NCT00000483|Vitamins|vitamins|mesh-ancestor
138255596|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
138255598|NCT00000507|Streptokinase|streptokinase|mesh-list
138255599|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138255600|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138255601|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255602|NCT00380445|Vildagliptin|vildagliptin|mesh-list
138255603|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138255604|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191551|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
138191552|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
138191553|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
138191554|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191556|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138191557|NCT01039207|Rilotumumab|rilotumumab|mesh-list
138191558|NCT01039207|Antibodies|antibodies|mesh-list
138255605|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138255606|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
138255607|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255608|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255609|NCT01950260|Hormones|hormones|mesh-list
138255610|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138255611|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255612|NCT01676311|Huperzine A|huperzine a|mesh-list
138255613|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138255614|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255616|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
138255617|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255618|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255619|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138255620|NCT01676311|Protective Agents|protective agents|mesh-ancestor
138255621|NCT01951118|Donepezil|donepezil|mesh-list
138255622|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138255623|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255624|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255625|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
138255626|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255627|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255629|NCT01951820|Lidocaine|lidocaine|mesh-list
138255630|NCT01951820|Tetracaine|tetracaine|mesh-list
138255631|NCT01951820|Carticaine|carticaine|mesh-list
138255632|NCT01951820|Benzocaine|benzocaine|mesh-list
138255633|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
138255634|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
138255635|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255636|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255637|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
138255638|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255639|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138255640|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138255641|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138255642|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255643|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255644|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
138255645|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138255646|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255647|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138255648|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138255649|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255650|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255651|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255652|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138255653|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138255654|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
138233973|NCT01786343|Decitabine|decitabine|mesh-list
138255655|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138255656|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138255657|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
138255659|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255660|NCT00382629|Protective Agents|protective agents|mesh-ancestor
138255661|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255662|NCT00000513|Atenolol|atenolol|mesh-list
138255663|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
138255664|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138255665|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138255666|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
138255667|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
138255668|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191565|NCT01125163|Trace Elements|trace elements|mesh-ancestor
138191568|NCT03019991|Ritonavir|ritonavir|mesh-list
138255669|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255670|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138255671|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138255672|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138255673|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
138255674|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255675|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255676|NCT00000513|Diuretics|diuretics|mesh-ancestor
138255677|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
138255678|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138255679|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255680|NCT00000543|Calcium|calcium|mesh-list
138255681|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138255682|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255683|NCT00000549|Hormones|hormones|mesh-list
138255684|NCT00000549|Estrogens|estrogens|mesh-list
138255685|NCT00000549|Progestins|progestins|mesh-list
138255686|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138255687|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255688|NCT01617577|Lenograstim|lenograstim|mesh-list
138255689|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138255690|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
138255691|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255692|NCT01701037|Trametinib|trametinib|mesh-list
138255693|NCT01701037|Dabrafenib|dabrafenib|mesh-list
138255694|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255695|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138255696|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255697|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255698|NCT00000585|Penicillins|penicillins|mesh-list
138255699|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138255700|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255701|NCT01701115|Bupivacaine|bupivacaine|mesh-list
138216523|NCT01028846|Diazoxide|diazoxide|mesh-list
138255703|NCT01701115|Mepivacaine|mepivacaine|mesh-list
138255704|NCT01701115|Anesthetics|anesthetics|mesh-list
138255705|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255706|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255707|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
138255708|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255709|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
138255710|NCT00000597|Nandrolone|nandrolone|mesh-list
138255711|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
138255712|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138255713|NCT00000597|Androgens|androgens|mesh-ancestor
138255714|NCT00000597|Hormones|hormones|mesh-ancestor
138255715|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138255716|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255717|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
138255718|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138255719|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
138255720|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138255721|NCT01621009|Bupropion|bupropion|mesh-list
138255722|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138255723|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
138255724|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138234133|NCT01372202|Paclitaxel|paclitaxel|mesh-list
138255725|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138255726|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138255727|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255728|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255729|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
138255730|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255731|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255732|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138478347|NCT02024594|Analgesics|analgesics|mesh-ancestor
138255733|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138255734|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255735|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
138255736|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138255737|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138255738|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255739|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
138255740|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
138255741|NCT01683331|Insulin|insulin|mesh-list
138255742|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138255743|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255744|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
138255745|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138255746|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138255747|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138255748|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255749|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255750|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
138255751|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255752|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255753|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138255754|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255755|NCT02290106|Pitavastatin|pitavastatin|mesh-list
138255756|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138255757|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138255758|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138255760|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255761|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255762|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138255764|NCT00000621|Isotretinoin|isotretinoin|mesh-list
138255765|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255766|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
138255767|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
138255768|NCT04818957|Vitamin D|vitamin d|mesh-list
138255769|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
138255770|NCT04818957|Vitamins|vitamins|mesh-ancestor
138255771|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
138255772|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255773|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138255774|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138255775|NCT01621477|Cytarabine|cytarabine|mesh-list
138255776|NCT01621477|Plerixafor|plerixafor|mesh-list
138255777|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
138255778|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
138255779|NCT01621477|Busulfan|busulfan|mesh-list
138255780|NCT01621477|Clofarabine|clofarabine|mesh-list
138255781|NCT01621477|Tacrolimus|tacrolimus|mesh-list
138255782|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
138255783|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138255784|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138255785|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
138255786|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255787|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138255788|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138255789|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
138255790|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255791|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255792|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138255793|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138255795|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
138255796|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255797|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138255798|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255799|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138255800|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138191581|NCT05307835|Sargramostim|sargramostim|mesh-list
138191582|NCT05307835|Immunologic Factors|immunologic factors|mesh-ancestor
138191587|NCT03019835|Neostigmine|neostigmine|mesh-list
138216562|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
138255801|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
138255802|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138255803|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138255804|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138255805|NCT00000627|Fluconazole|fluconazole|mesh-list
138255806|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
138255807|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255808|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138255809|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138255810|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255811|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255812|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138255813|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
138255814|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138255815|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234259|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
138255816|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138255817|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138255818|NCT00000633|Vaccines|vaccines|mesh-list
138255819|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
138255820|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255821|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138255822|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138255823|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255824|NCT05479214|Metformin|metformin|mesh-list
138255825|NCT05479214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138255826|NCT05479214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255827|NCT00000657|Zidovudine|zidovudine|mesh-list
138255828|NCT00000657|Didanosine|didanosine|mesh-list
138255829|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
138255830|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255831|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138255832|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138255833|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255834|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
138255835|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255836|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138255837|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138255838|NCT01701505|Phenylephrine|phenylephrine|mesh-list
138255839|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
138255840|NCT01701505|Tetracaine|tetracaine|mesh-list
138255841|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
138255842|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
138255843|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255844|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255845|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
138255846|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255847|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138255848|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138255849|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
138255850|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255851|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255852|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
138255853|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
138255854|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
138255855|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138255856|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
138255857|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138255858|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
138255859|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138255860|NCT01701505|Protective Agents|protective agents|mesh-ancestor
138255861|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
138255862|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
138255863|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255865|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
138255866|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255867|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138255868|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138191595|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
138255869|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255870|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
138255871|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255872|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138255873|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138255874|NCT01622257|Metformin|metformin|mesh-list
138255875|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138255876|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234346|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255877|NCT04942899|Capecitabine|capecitabine|mesh-list
138255878|NCT04942899|Letrozole|letrozole|mesh-list
138255879|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138255880|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
138255881|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255882|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255883|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138255884|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138255885|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255886|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138255887|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
138255888|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138255889|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255890|NCT00000693|Zidovudine|zidovudine|mesh-list
138255891|NCT00000693|Acyclovir|acyclovir|mesh-list
138255892|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
138255893|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255894|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138255895|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138255897|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
138255898|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255899|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138255900|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138255901|NCT04752033|Morphine|morphine|mesh-list
138255902|NCT04752033|Hydromorphone|hydromorphone|mesh-list
138255903|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138255904|NCT04752033|Narcotics|narcotics|mesh-ancestor
138255905|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255906|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255907|NCT04752033|Analgesics|analgesics|mesh-ancestor
138255908|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
138255909|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255910|NCT02987270|Piperaquine|piperaquine|mesh-list
138255912|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
138255913|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138255914|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138255915|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255916|NCT00000699|Ribavirin|ribavirin|mesh-list
138255917|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
138255918|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
138255919|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255921|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255922|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138255923|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
138255924|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255925|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
138255926|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138255927|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255928|NCT04931979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138255929|NCT04931979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255930|NCT00000723|Leucovorin|leucovorin|mesh-list
138255931|NCT00000723|Zidovudine|zidovudine|mesh-list
138255932|NCT00000723|Dexamethasone|dexamethasone|mesh-list
138255933|NCT00000723|Methotrexate|methotrexate|mesh-list
138255934|NCT00000723|Calcium|calcium|mesh-list
138255935|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
138255936|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138255937|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
138255938|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
138255939|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255940|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191605|NCT03960658|Ketamine|ketamine|mesh-list
138255941|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138255942|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
138255943|NCT00000723|Hormones|hormones|mesh-ancestor
138255944|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138234454|NCT02235909|Losartan|losartan|mesh-list
138255945|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138255946|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138255947|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138255948|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138255949|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
138255950|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138255951|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138255952|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
138255953|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255955|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255956|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138255957|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138255958|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
138255959|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138255960|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138255961|NCT00000723|Antidotes|antidotes|mesh-ancestor
138255962|NCT00000723|Protective Agents|protective agents|mesh-ancestor
138255963|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
138255964|NCT00000723|Vitamins|vitamins|mesh-ancestor
138255965|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
138255966|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138255967|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
138255968|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138255969|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138255970|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138255971|NCT02329964|Neostigmine|neostigmine|mesh-list
138255972|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138255973|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138255974|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138255975|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255976|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
138255977|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138255978|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255979|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138255980|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
138255981|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255982|NCT04750395|Haloperidol|haloperidol|mesh-list
138255983|NCT04750395|Olanzapine|olanzapine|mesh-list
138255984|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
138255986|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
138255987|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138255988|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138255989|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138255990|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138255991|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138255992|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138255993|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138255994|NCT04750395|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138255995|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138255996|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138255997|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138255998|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256000|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138256001|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
138256002|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138256003|NCT00000729|Foscarnet|foscarnet|mesh-list
138256004|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138256005|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
138256006|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138256007|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138256008|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138256009|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191612|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
138256010|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256011|NCT03438773|Tacrolimus|tacrolimus|mesh-list
138256012|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138256013|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
138256014|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256015|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138256016|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256017|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256018|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
138256019|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138256020|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
138256021|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256022|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
138256023|NCT02974985|Protective Agents|protective agents|mesh-ancestor
138256025|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
138256026|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256027|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138256028|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138256029|NCT01704781|Growth Substances|growth substances|mesh-ancestor
138256030|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
138256031|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256032|NCT02288156|Capsaicin|capsaicin|mesh-list
138256033|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
138256034|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
138256035|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
138256036|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138478576|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256037|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256038|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
138256040|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
138256041|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256042|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256043|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
138256044|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138256045|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138256046|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
138256047|NCT04699383|Protective Agents|protective agents|mesh-ancestor
138234540|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138256048|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256049|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138256050|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138256051|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138256052|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
138256053|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138256054|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
138256055|NCT05423132|Ropivacaine|ropivacaine|mesh-list
138256056|NCT05423132|Anesthetics, Local|anesthetics, local|mesh-ancestor
138256057|NCT05423132|Anesthetics|anesthetics|mesh-ancestor
138256058|NCT05423132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256059|NCT05423132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256060|NCT05423132|Sensory System Agents|sensory system agents|mesh-ancestor
138256061|NCT05423132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256063|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138256064|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256065|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138256066|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138256067|NCT02975219|Growth Substances|growth substances|mesh-ancestor
138256068|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256069|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
138256070|NCT01686451|Simvastatin|simvastatin|mesh-list
138256071|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138256072|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138256074|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256075|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138256076|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138191615|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138191616|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138256077|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256078|NCT00361751|Fenofibrate|fenofibrate|mesh-list
138256079|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138256080|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
138256081|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256082|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138256084|NCT05681702|Clopidogrel|clopidogrel|mesh-list
138256085|NCT05681702|Ticagrelor|ticagrelor|mesh-list
138256086|NCT05681702|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138256087|NCT05681702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138256088|NCT05681702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138256089|NCT05681702|Analgesics|analgesics|mesh-ancestor
138256092|NCT05681702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256093|NCT05681702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138256094|NCT05681702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138256095|NCT05681702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138256096|NCT05681702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138256097|NCT05681702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138478604|NCT02026050|Hormones|hormones|mesh-ancestor
138256098|NCT05681702|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138256099|NCT05681702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138256100|NCT05681702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256101|NCT05681702|Antipyretics|antipyretics|mesh-ancestor
138256102|NCT05681702|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138256103|NCT05681702|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138256104|NCT05681702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138256105|NCT05681702|Purinergic Agents|purinergic agents|mesh-ancestor
138256106|NCT05681702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256107|NCT04675983|Capecitabine|capecitabine|mesh-list
138256108|NCT04675983|Fluorouracil|fluorouracil|mesh-list
138256109|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
138256110|NCT04675983|Ramucirumab|ramucirumab|mesh-list
138256111|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256112|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138256113|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
138256114|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256115|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138256116|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
138234635|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
138256118|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
138256119|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138256120|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256121|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256122|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138256123|NCT03668951|Analgesics|analgesics|mesh-ancestor
138256124|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
138256125|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256126|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138256127|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138256129|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
138256130|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256131|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256132|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
138256133|NCT04889703|Salicylates|salicylates|mesh-list
138256134|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138256135|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
138256136|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
138256137|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
138191622|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
138191623|NCT03633448|Guaifenesin|guaifenesin|mesh-list
138191624|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
138256138|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138256139|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138256140|NCT04889703|Analgesics|analgesics|mesh-ancestor
138256141|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
138256142|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256143|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256144|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138216788|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256145|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138256146|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138256147|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256148|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256150|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138256151|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
138256152|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256153|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256154|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138256155|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138256156|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
138256157|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256158|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138256159|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
138256160|NCT01706263|Salicylates|salicylates|mesh-list
138256161|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138256162|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
138256163|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
138256164|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
138256165|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138256166|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138256167|NCT01706263|Analgesics|analgesics|mesh-ancestor
138256168|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
138256169|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256170|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256171|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138256172|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138256173|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138256174|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256175|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256176|NCT05738798|Immunomodulating Agents|immunomodulating agents|mesh-list
138256177|NCT05738798|Immunologic Factors|immunologic factors|mesh-ancestor
138256178|NCT05738798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256179|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
138256180|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138256181|NCT04342247|Testosterone|testosterone|mesh-list
138234735|NCT01473368|Amoxicillin|amoxicillin|mesh-list
138256182|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
138256183|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
138256184|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138256185|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256186|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
138256188|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256189|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256191|NCT05738642|Thrombin|thrombin|mesh-list
138256192|NCT05738642|Hemostatics|hemostatics|mesh-ancestor
138256193|NCT05738642|Coagulants|coagulants|mesh-ancestor
138256194|NCT01690663|Dexamethasone|dexamethasone|mesh-list
138256195|NCT01690663|Bupivacaine|bupivacaine|mesh-list
138256197|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
138256198|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
138256199|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256200|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256201|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138256202|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
138256203|NCT01690663|Hormones|hormones|mesh-ancestor
138256204|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256205|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138256206|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256207|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
138256208|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
138256209|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256210|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
138256211|NCT05738564|Lidocaine|lidocaine|mesh-list
138256212|NCT05738564|Epinephrine|epinephrine|mesh-list
138256214|NCT05738564|Anesthetics, Local|anesthetics, local|mesh-ancestor
138256215|NCT05738564|Anesthetics|anesthetics|mesh-ancestor
138256216|NCT05738564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256217|NCT05738564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256218|NCT05738564|Sensory System Agents|sensory system agents|mesh-ancestor
138256219|NCT05738564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256220|NCT05738564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138256221|NCT05738564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138256222|NCT05738564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138256223|NCT05738564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138256224|NCT05738564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256225|NCT05738564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138478676|NCT02026765|Heparin|heparin|mesh-list
138256227|NCT05738564|Adrenergic Agents|adrenergic agents|mesh-ancestor
138256228|NCT05738564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256229|NCT05738564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138256230|NCT05738564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138256231|NCT05738564|Autonomic Agents|autonomic agents|mesh-ancestor
138256232|NCT05738564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138256233|NCT05738564|Respiratory System Agents|respiratory system agents|mesh-ancestor
138256234|NCT05738564|Mydriatics|mydriatics|mesh-ancestor
138256235|NCT05738564|Sympathomimetics|sympathomimetics|mesh-ancestor
138256236|NCT05738564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138256237|NCT05738564|Nasal Decongestants|nasal decongestants|mesh-ancestor
138256238|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
138256239|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138256240|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256241|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256242|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138256244|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
138256245|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256246|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138256247|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138256248|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138256249|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
138256250|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256251|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256252|NCT05738408|Nicotine|nicotine|mesh-list
138256253|NCT05738408|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138256254|NCT05738408|Autonomic Agents|autonomic agents|mesh-ancestor
138256255|NCT05738408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256256|NCT05738408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256257|NCT05738408|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138256258|NCT05738408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138216866|NCT00729482|Everolimus|everolimus|mesh-list
138256259|NCT05738408|Cholinergic Agents|cholinergic agents|mesh-ancestor
138256260|NCT05738408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256261|NCT05738408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256262|NCT01352117|Tenofovir|tenofovir|mesh-list
138256263|NCT01352117|Emtricitabine|emtricitabine|mesh-list
138256264|NCT01352117|Efavirenz|efavirenz|mesh-list
138256265|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138256266|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138256268|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138478714|NCT02026869|Metformin|metformin|mesh-list
138256269|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256270|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138256271|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138256272|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256273|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191644|NCT05313958|Cladribine|cladribine|mesh-list
138191646|NCT05313958|Antimetabolites|antimetabolites|mesh-ancestor
138256274|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
138256275|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138256276|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138256277|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138256278|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138256279|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138256280|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138256281|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138256282|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138256283|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138256284|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138256285|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138256287|NCT03379207|Chelating Agents|chelating agents|mesh-ancestor
138256288|NCT03379207|Sequestering Agents|sequestering agents|mesh-ancestor
138256289|NCT03379207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256291|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138256292|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138256293|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138256294|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256295|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138256296|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256297|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
138256298|NCT03340727|Caffeine|caffeine|mesh-list
138256299|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
138216872|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
138256300|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256302|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256303|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138256304|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256305|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138256306|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138256307|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
138256308|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256309|NCT04612179|Sirolimus|sirolimus|mesh-list
138256310|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138256311|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138256312|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138256313|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256314|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
138256315|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138256316|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
138256317|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256320|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
138256321|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138256322|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
138256323|NCT01707043|Calcipotriene|calcipotriene|mesh-list
138256324|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138256325|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138256326|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
138256327|NCT01707043|Hormones|hormones|mesh-ancestor
138256328|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256329|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256330|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138256331|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
138256332|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
138256333|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138256334|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138256335|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138256336|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256337|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138256338|NCT01707043|Vitamins|vitamins|mesh-ancestor
138256339|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
138256340|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138256341|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
138256342|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
138191656|NCT05313958|Analgesics|analgesics|mesh-ancestor
138256343|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256344|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256345|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256346|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
138256347|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
138256348|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
138256349|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256350|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138256351|NCT01708525|Protective Agents|protective agents|mesh-ancestor
138256352|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234925|NCT01833845|Ribavirin|ribavirin|mesh-list
138256353|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
138256355|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
138256357|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138256358|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256359|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138256360|NCT03634917|Antacids|antacids|mesh-ancestor
138256361|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256362|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138256363|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138256364|NCT04595565|Carboplatin|carboplatin|mesh-list
138256365|NCT04595565|Capecitabine|capecitabine|mesh-list
138256366|NCT04595565|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138256367|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256368|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138256369|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
138256370|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256371|NCT04595565|Immunoconjugates|immunoconjugates|mesh-ancestor
138256372|NCT04595565|Immunologic Factors|immunologic factors|mesh-ancestor
138256373|NCT04595565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256374|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138256375|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
138256376|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138256377|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138256378|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138256379|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256380|NCT03538899|Busulfan|busulfan|mesh-list
138256381|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
138256382|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256383|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138256384|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
138256385|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256386|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138256387|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256388|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138256389|NCT04230681|Fentanyl|fentanyl|mesh-list
138256390|NCT04230681|Hydromorphone|hydromorphone|mesh-list
138234956|NCT02698215|Naltrexone|naltrexone|mesh-list
138256391|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138256392|NCT04230681|Narcotics|narcotics|mesh-ancestor
138256393|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256394|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256395|NCT04230681|Analgesics|analgesics|mesh-ancestor
138256396|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
138256397|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256398|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138256399|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138256400|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
138256401|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
138256402|NCT01708603|Ustekinumab|ustekinumab|mesh-list
138256403|NCT01708603|Brodalumab|brodalumab|mesh-list
138256404|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138256405|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
138256406|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
138256407|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256408|NCT03523221|Dexamethasone|dexamethasone|mesh-list
138256409|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138256411|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
138256412|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256413|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256414|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138256415|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
138256416|NCT03523221|Hormones|hormones|mesh-ancestor
138256417|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256418|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138256419|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256420|NCT03590171|Bortezomib|bortezomib|mesh-list
138256421|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256422|NCT00362765|Metformin|metformin|mesh-list
138256423|NCT00362765|Fenofibrate|fenofibrate|mesh-list
138256424|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138256425|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256426|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138256427|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
138256428|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256429|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138256430|NCT03543839|Belimumab|belimumab|mesh-list
138256431|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138256432|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
138256433|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256434|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
138256436|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138256437|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256438|NCT05033756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138256439|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256440|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138256441|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256442|NCT03522077|Hemostatics|hemostatics|mesh-list
138256443|NCT03522077|Coagulants|coagulants|mesh-ancestor
138256444|NCT02980562|Bisacodyl|bisacodyl|mesh-list
138256445|NCT02980562|Cathartics|cathartics|mesh-ancestor
138256446|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138256447|NCT02980562|Laxatives|laxatives|mesh-ancestor
138256448|NCT03266393|Tacrolimus|tacrolimus|mesh-list
138256449|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138256450|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
138256451|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256452|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138256453|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256454|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256455|NCT00421967|Ketorolac|ketorolac|mesh-list
138256456|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138256457|NCT00421967|Epinephrine|epinephrine|mesh-list
138256458|NCT00421967|Racepinephrine|racepinephrine|mesh-list
138256459|NCT00421967|Ropivacaine|ropivacaine|mesh-list
138256460|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
138256461|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
138256462|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
138256463|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256464|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256465|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
138256466|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256467|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138256468|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138256469|NCT00421967|Analgesics|analgesics|mesh-ancestor
138256470|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138256471|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138216948|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256472|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138256473|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256474|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256475|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138256476|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138256477|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
138256478|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256479|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138256480|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138256481|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
138256482|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138191668|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138256483|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
138256484|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
138256485|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
138256486|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138256487|NCT03209687|Menotropins|menotropins|mesh-list
138256488|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138256489|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
138256490|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138256491|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256492|NCT04997798|Trastuzumab|trastuzumab|mesh-list
138256494|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138256495|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256496|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138256497|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138256498|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256499|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256500|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138256501|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
138256502|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256503|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256504|NCT00362531|Prednisone|prednisone|mesh-list
138256505|NCT00362531|Tacrolimus|tacrolimus|mesh-list
138256506|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138256507|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
138256508|NCT00362531|Hormones|hormones|mesh-ancestor
138256509|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256510|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256511|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138256512|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256513|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138256514|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
138256515|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138256516|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256517|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256518|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138256519|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
138256521|NCT04330677|Estrogens|estrogens|mesh-list
138256523|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138256524|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256525|NCT04330677|Hormones|hormones|mesh-ancestor
138256526|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256527|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
138256528|NCT04965116|Progestins|progestins|mesh-list
138256529|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138256530|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256531|NCT04965116|Hormones|hormones|mesh-ancestor
138256532|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256533|NCT02259517|Guanfacine|guanfacine|mesh-list
138256534|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138256535|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138256536|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256537|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138256538|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138256539|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138235118|NCT03206151|Folic Acid|folic acid|mesh-list
138256540|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256542|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256543|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138256544|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138256545|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138256546|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138256547|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
138256548|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
138256549|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138256550|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
138256551|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256552|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191670|NCT03633526|Ivacaftor|ivacaftor|mesh-list
138256553|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138256554|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
138256555|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138256556|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
138256557|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256558|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256559|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138256560|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
138256561|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
138256562|NCT04358588|Protective Agents|protective agents|mesh-ancestor
138256563|NCT03166761|Dexamethasone|dexamethasone|mesh-list
138256564|NCT03166761|Triamcinolone|triamcinolone|mesh-list
138256565|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138256566|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138256567|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138256568|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138256569|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
138256570|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
138256571|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256572|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256573|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138256574|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
138256575|NCT03166761|Hormones|hormones|mesh-ancestor
138256576|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256577|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138256578|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256579|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138256580|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
138256581|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216977|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
138256582|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256585|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138256586|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256587|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256588|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138256589|NCT04195256|Analgesics|analgesics|mesh-ancestor
138256590|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
138256591|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256592|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138256593|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138256594|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138256595|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
138256596|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256597|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256598|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138256599|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138256600|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
138256602|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138256603|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138256604|NCT00002901|Docetaxel|docetaxel|mesh-list
138256605|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256606|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
138256607|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
138256608|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
138256609|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256610|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
138256611|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138256612|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
138256613|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256614|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256615|NCT01710787|Phenylephrine|phenylephrine|mesh-list
138256616|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
138256617|NCT01710787|Tetracaine|tetracaine|mesh-list
138256618|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
138256620|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256621|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191677|NCT03019523|Caffeine|caffeine|mesh-list
138256622|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
138256623|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256624|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138256625|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138256626|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
138256627|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235242|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
138235243|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
138256628|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256629|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
138256630|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
138217003|NCT01271582|Antidotes|antidotes|mesh-ancestor
138256631|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
138256632|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138256633|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
138256634|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138256635|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
138256636|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138256637|NCT01710787|Protective Agents|protective agents|mesh-ancestor
138256638|NCT01711177|Travoprost|travoprost|mesh-list
138256639|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138256640|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138256641|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138256642|NCT01715233|Leucovorin|leucovorin|mesh-list
138256643|NCT01715233|Carboplatin|carboplatin|mesh-list
138256644|NCT01715233|Docetaxel|docetaxel|mesh-list
138256646|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256647|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
138256648|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
138256649|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
138256650|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256651|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
138256652|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138256653|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138256654|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
138256655|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256656|NCT01715233|Antidotes|antidotes|mesh-ancestor
138256657|NCT01715233|Protective Agents|protective agents|mesh-ancestor
138256658|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
138256660|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
138256661|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138256662|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138256663|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138256664|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
138256665|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256666|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
138256667|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138256668|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138256669|NCT04826588|Prednisolone|prednisolone|mesh-list
138256670|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
138256671|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138256672|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
138256673|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
138256674|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138256675|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
138256676|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
138256677|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256678|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256679|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138256680|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
138256681|NCT04826588|Hormones|hormones|mesh-ancestor
138256682|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256683|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138256684|NCT04826588|Protective Agents|protective agents|mesh-ancestor
138256685|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138256686|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256687|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
138256688|NCT01719367|Atenolol|atenolol|mesh-list
138256689|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138256690|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138256691|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
138256692|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
138256693|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256694|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256695|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138256696|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138256697|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138256698|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
138256699|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256700|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256701|NCT02276040|Bupivacaine|bupivacaine|mesh-list
138256702|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
138256703|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
138256704|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256705|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256706|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
138256707|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256708|NCT02250703|Midazolam|midazolam|mesh-list
138256709|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
138256710|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138256711|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256712|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217060|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138256713|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138256714|NCT02250703|Analgesics|analgesics|mesh-ancestor
138256715|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
138256716|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256717|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138256718|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138256719|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138256720|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
138256721|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256722|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256723|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138256724|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138256725|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138256726|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138256727|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138256728|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
138256729|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
138256730|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
138256731|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
138256732|NCT02314728|Misoprostol|misoprostol|mesh-list
138256733|NCT02314728|Oxytocin|oxytocin|mesh-list
138256734|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
138256735|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138256736|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256737|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138256738|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
138256739|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138256740|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138256741|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
138256742|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138256743|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
138256744|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256745|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256746|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138256747|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
138256748|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138256749|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
138256750|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256751|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256752|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138256753|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
138256754|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
138256755|NCT03135860|Protective Agents|protective agents|mesh-ancestor
138256756|NCT02275338|Lanreotide|lanreotide|mesh-list
138256757|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256758|NCT01646268|Rotigotine|rotigotine|mesh-list
138256759|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
138256760|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
138256761|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138217093|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138217097|NCT01275170|Imipenem|imipenem|mesh-list
138191690|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256762|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256764|NCT03988634|Valsartan|valsartan|mesh-list
138256765|NCT03988634|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138256766|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138256767|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138256768|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138256769|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256770|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138256771|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
138256772|NCT01722487|Chlorambucil|chlorambucil|mesh-list
138256773|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138256775|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256776|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256777|NCT02795858|Octreotide|octreotide|mesh-list
138256778|NCT02795858|Ramucirumab|ramucirumab|mesh-list
138256779|NCT02795858|Lanreotide|lanreotide|mesh-list
138256780|NCT02795858|Somatostatin|somatostatin|mesh-list
138256781|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138256782|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138256783|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256784|NCT02795858|Hormones|hormones|mesh-ancestor
138256785|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256786|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256788|NCT02730962|Clindamycin|clindamycin|mesh-list
138256789|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
138256790|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
138256791|NCT02730962|Neomycin|neomycin|mesh-list
138256792|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138256793|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138256794|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138256795|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256796|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256797|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138256798|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138256799|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
138256800|NCT02296346|Prednisolone|prednisolone|mesh-list
138256801|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
138256802|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138256803|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
138256804|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138256805|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
138256806|NCT02296346|Hormones|hormones|mesh-ancestor
138256807|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256808|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256809|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138256810|NCT02296346|Protective Agents|protective agents|mesh-ancestor
138256811|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138256812|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256813|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
138256814|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
138235448|NCT01860287|Buprenorphine|buprenorphine|mesh-list
138256815|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256816|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138479071|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
138256818|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138256819|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256820|NCT02372630|Linagliptin|linagliptin|mesh-list
138256821|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138256822|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256823|NCT02372630|Incretins|incretins|mesh-ancestor
138256824|NCT02372630|Hormones|hormones|mesh-ancestor
138256825|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256826|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138256827|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
138256828|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256829|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256830|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138256831|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
138256832|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
138256833|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256834|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256835|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
138256836|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256837|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138256838|NCT04349930|Cannabidiol|cannabidiol|mesh-list
138256839|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
138256840|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
138256841|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138256842|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256843|NCT02303990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138256844|NCT02303990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256845|NCT01727089|Bevacizumab|bevacizumab|mesh-list
138256846|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138256847|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
138256848|NCT01727089|Antibodies|antibodies|mesh-list
138256849|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
138256850|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138256851|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
138256854|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138256855|NCT01727089|Growth Substances|growth substances|mesh-ancestor
138256856|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256857|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
138256858|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
138256859|NCT01727791|Pregabalin|pregabalin|mesh-list
138256860|NCT01727791|Analgesics|analgesics|mesh-ancestor
138256861|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
138256862|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256863|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256864|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
138256865|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138256866|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138256867|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256868|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138256869|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138256870|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138256871|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256872|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138256873|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
138256874|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138256875|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138256876|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138256877|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138256878|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256879|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
138256880|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256881|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256882|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138256883|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235530|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
138256884|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
138256885|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138256886|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138256887|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138256888|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138256889|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191700|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191701|NCT01010009|Resveratrol|resveratrol|mesh-list
138191702|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
138191703|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256890|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
138256891|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256892|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256893|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138256894|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256895|NCT02245087|Atorvastatin|atorvastatin|mesh-list
138256896|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138256897|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138256898|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
138256899|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256900|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138256901|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138256902|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256903|NCT03174275|Paclitaxel|paclitaxel|mesh-list
138256904|NCT03174275|Carboplatin|carboplatin|mesh-list
138256905|NCT03174275|Durvalumab|durvalumab|mesh-list
138217179|NCT00741104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138256907|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256908|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
138256909|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
138256910|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
138256911|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256912|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138256913|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
138256914|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138256915|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256916|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256917|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138256918|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138256919|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138256920|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138256921|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138256922|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
138256923|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256925|NCT02975141|Gemcitabine|gemcitabine|mesh-list
138256926|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138256928|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138256929|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256930|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
138256931|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
138256932|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
138256933|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256934|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138256935|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
138256936|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138256937|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256938|NCT04341935|Linagliptin|linagliptin|mesh-list
138256939|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138256940|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256941|NCT04341935|Incretins|incretins|mesh-ancestor
138256942|NCT04341935|Hormones|hormones|mesh-ancestor
138256943|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138256944|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138256945|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
138256946|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256947|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256948|NCT05317039|Calcium|calcium|mesh-list
138191713|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256949|NCT05317039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138256950|NCT05317039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256951|NCT05316883|Clozapine|clozapine|mesh-list
138256952|NCT05316883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138256953|NCT05316883|Serotonin Agents|serotonin agents|mesh-ancestor
138256954|NCT05316883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138256955|NCT05316883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256956|NCT05316883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256957|NCT05316883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138256958|NCT05316883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138479147|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138256959|NCT05316883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138256960|NCT05316883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138256961|NCT05316883|GABA Antagonists|gaba antagonists|mesh-ancestor
138217195|NCT01270802|Tenofovir|tenofovir|mesh-list
138256962|NCT05316883|GABA Agents|gaba agents|mesh-ancestor
138256963|NCT05316649|Chrysarobin|chrysarobin|mesh-list
138256964|NCT05316649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138256965|NCT05316649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138256966|NCT05316649|Analgesics|analgesics|mesh-ancestor
138256967|NCT05316649|Sensory System Agents|sensory system agents|mesh-ancestor
138256968|NCT05316649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138256969|NCT05316649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256970|NCT05316649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138256971|NCT05316649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138256972|NCT03990363|Allopurinol|allopurinol|mesh-list
138256973|NCT03990363|Verinurad|verinurad|mesh-list
138256974|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
138256975|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256976|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256977|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
138256978|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138256979|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138256980|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
138256981|NCT03990363|Protective Agents|protective agents|mesh-ancestor
138256982|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256983|NCT04341857|Antibodies|antibodies|mesh-list
138256984|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138256985|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
138256986|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138256987|NCT00002913|Paclitaxel|paclitaxel|mesh-list
138256988|NCT00002913|Topotecan|topotecan|mesh-list
138256989|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138256990|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138256991|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
138256992|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
138256993|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
138256994|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138256995|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138256996|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138256997|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138256998|NCT00002919|Doxorubicin|doxorubicin|mesh-list
138256999|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138257000|NCT00002919|Methotrexate|methotrexate|mesh-list
138257001|NCT00002919|Vinblastine|vinblastine|mesh-list
138257002|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257003|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138235696|NCT02945813|Metformin|metformin|mesh-list
138257004|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138257005|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138257006|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257007|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138479178|NCT02029599|Analgesics|analgesics|mesh-ancestor
138257008|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138257009|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
138257010|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138257011|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257012|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138191727|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138257013|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
138257014|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
138257015|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138257016|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257017|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
138257018|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138257019|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138257020|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257021|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257022|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257023|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257025|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138257026|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
138257027|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138257028|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138257029|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138257030|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138257031|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257032|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
138257033|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138257034|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257035|NCT00383799|Amiodarone|amiodarone|mesh-list
138257036|NCT00383799|Procainamide|procainamide|mesh-list
138257037|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138257038|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
138257039|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138257040|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138257041|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257042|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138257043|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138257044|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138257045|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257046|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138257047|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138257048|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138257049|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138257051|NCT04635241|Calcium heparin|calcium heparin|mesh-list
138257052|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
138257053|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138257054|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138257055|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257056|NCT03954483|Triazolam|triazolam|mesh-list
138257057|NCT03954483|Buspirone|buspirone|mesh-list
138257058|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138257059|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138479222|NCT02029937|Proflavine|proflavine|mesh-list
138257061|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257062|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138257063|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138257064|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
138257065|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138257066|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257067|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138257068|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
138257069|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
138257070|NCT04545541|Heparin|heparin|mesh-list
138257071|NCT04545541|Calcium heparin|calcium heparin|mesh-list
138257072|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
138257073|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138257074|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138257075|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257076|NCT00002925|Aldesleukin|aldesleukin|mesh-list
138257077|NCT00002925|Etoposide|etoposide|mesh-list
138257078|NCT00002925|Daunorubicin|daunorubicin|mesh-list
138257079|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257080|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257081|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138257082|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138257083|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257084|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257085|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138257086|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138257087|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138257089|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257090|NCT00002937|Paclitaxel|paclitaxel|mesh-list
138257091|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257092|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257093|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257094|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257095|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257096|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257097|NCT02922777|Docetaxel|docetaxel|mesh-list
138257098|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257099|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257100|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257101|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257102|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257103|NCT02918955|Cisplatin|cisplatin|mesh-list
138257104|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257105|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
138257107|NCT00002943|Etoposide|etoposide|mesh-list
138257108|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257109|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
138257110|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257112|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138257113|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
138257114|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257115|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257116|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138257117|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257118|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138257119|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138257120|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257122|NCT00002949|Vinorelbine|vinorelbine|mesh-list
138257123|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257124|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257125|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257126|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257127|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257128|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257129|NCT05315557|Terlipressin|terlipressin|mesh-list
138257130|NCT05315557|Vasopressins|vasopressins|mesh-list
138257131|NCT05315557|Arginine Vasopressin|arginine vasopressin|mesh-list
138257132|NCT05315557|Hemostatics|hemostatics|mesh-ancestor
138257133|NCT05315557|Coagulants|coagulants|mesh-ancestor
138257134|NCT05315557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138257135|NCT05315557|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138257136|NCT05315557|Natriuretic Agents|natriuretic agents|mesh-ancestor
138257137|NCT05315557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257138|NCT05315557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138257139|NCT00002955|Leucovorin|leucovorin|mesh-list
138257141|NCT00002955|Fluorouracil|fluorouracil|mesh-list
138257142|NCT00002955|Calcium|calcium|mesh-list
138257143|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
138257144|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138257145|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257146|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
138257157|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
138257158|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257159|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138257160|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257161|NCT00002961|Cyclosporine|cyclosporine|mesh-list
138257162|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
138257163|NCT00002961|Busulfan|busulfan|mesh-list
138257164|NCT00002961|Methotrexate|methotrexate|mesh-list
138257165|NCT00002961|Etoposide|etoposide|mesh-list
138257166|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
138257167|NCT00002961|Cyclosporins|cyclosporins|mesh-list
138257168|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257169|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
138257170|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257171|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138257172|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138257173|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
138257174|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257175|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257176|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138257177|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138257179|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138257180|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257181|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
138257182|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
138257183|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257184|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138257185|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138257186|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257187|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138257188|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138257189|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
138257190|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257191|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138257193|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
138257194|NCT00002967|Doxorubicin|doxorubicin|mesh-list
138257195|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138257196|NCT00002967|Octreotide|octreotide|mesh-list
138257197|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257198|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
138257199|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257200|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138257201|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138257203|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257207|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138257208|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138257209|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257210|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138257211|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
138257212|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138257213|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138257214|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138257215|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138257216|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138257217|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138257218|NCT00002973|Melphalan|melphalan|mesh-list
138257219|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138257220|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
138257221|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257222|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257223|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138257224|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257225|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
138257226|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257227|NCT00002985|Doxorubicin|doxorubicin|mesh-list
138257228|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138257229|NCT00002985|Daunorubicin|daunorubicin|mesh-list
138257230|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138257231|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257232|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138257233|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138257234|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257235|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257236|NCT00363389|Misoprostol|misoprostol|mesh-list
138257237|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138257238|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
138257239|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138257240|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257241|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138235839|NCT01874951|Naltrexone|naltrexone|mesh-list
138257242|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138257244|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138257245|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138257246|NCT03057431|Diuretics|diuretics|mesh-ancestor
138257247|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
138257248|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257249|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138217348|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138257250|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138257251|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257252|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
138257253|NCT00003003|Mitomycins|mitomycins|mesh-list
138257254|NCT00003003|Mitomycin|mitomycin|mesh-list
138257255|NCT00003003|Sargramostim|sargramostim|mesh-list
138257256|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
138257257|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257258|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257259|NCT00003003|Analgesics|analgesics|mesh-ancestor
138257260|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
138257261|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138257262|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138257263|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138257264|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257265|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257266|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138257267|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
138257268|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138479335|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
138257271|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138257272|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138257273|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
138257274|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257275|NCT00003015|Carboplatin|carboplatin|mesh-list
138257276|NCT00003015|Vincristine|vincristine|mesh-list
138257277|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257278|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257279|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257280|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257281|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257282|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257283|NCT04204837|Nivolumab|nivolumab|mesh-list
138257284|NCT04204837|Relatlimab|relatlimab|mesh-list
138257285|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138257286|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257287|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138257288|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257290|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138257291|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257292|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138257293|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
138257294|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257295|NCT00003039|Alvocidib|alvocidib|mesh-list
138257296|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257298|NCT00003039|Growth Substances|growth substances|mesh-ancestor
138257299|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257300|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138257301|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217373|NCT00746954|Acetazolamide|acetazolamide|mesh-list
138257320|NCT00003063|Antidotes|antidotes|mesh-ancestor
138257321|NCT00003063|Protective Agents|protective agents|mesh-ancestor
138257322|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
138257323|NCT00003063|Vitamins|vitamins|mesh-ancestor
138257324|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
138257325|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138257326|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
138257327|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
138257328|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138257329|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138257330|NCT00003075|Fenretinide|fenretinide|mesh-list
138257331|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257332|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138257333|NCT00003075|Protective Agents|protective agents|mesh-ancestor
138257334|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257335|NCT00003081|Melphalan|melphalan|mesh-list
138257336|NCT00003081|Busulfan|busulfan|mesh-list
138257337|NCT00003081|Thiotepa|thiotepa|mesh-list
138257338|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
138257339|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257340|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138257341|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
138257342|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257343|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257344|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138257345|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257346|NCT02348385|Amphetamine|amphetamine|mesh-list
138257347|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
138257348|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138257349|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257374|NCT00003093|Molgramostim|molgramostim|mesh-list
138257375|NCT00003093|Lenograstim|lenograstim|mesh-list
138257376|NCT00003093|Sargramostim|sargramostim|mesh-list
138257377|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257378|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
138257379|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257380|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138257381|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138257382|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
138257383|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257384|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257385|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138257386|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138236056|NCT04766463|Morphine|morphine|mesh-list
138257387|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138257388|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138257389|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257390|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257391|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138257392|NCT00003099|Tamoxifen|tamoxifen|mesh-list
138257393|NCT00003099|Fenretinide|fenretinide|mesh-list
138257394|NCT00003099|Retinamide|retinamide|mesh-list
138257395|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138257396|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
138257397|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138257398|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257399|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138257400|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257401|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138257402|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138257403|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138257404|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138257405|NCT00003099|Protective Agents|protective agents|mesh-ancestor
138257406|NCT00003105|Paclitaxel|paclitaxel|mesh-list
138257407|NCT00003105|Gemcitabine|gemcitabine|mesh-list
138257408|NCT00003105|Doxorubicin|doxorubicin|mesh-list
138257409|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138257410|NCT00003105|Ifosfamide|ifosfamide|mesh-list
138257411|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257412|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236076|NCT00369837|Clevidipine|clevidipine|mesh-list
138257413|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257414|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257415|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257416|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257417|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257418|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
138191751|NCT03928522|Tobramycin|tobramycin|mesh-list
138191752|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191753|NCT01010399|Ritonavir|ritonavir|mesh-list
138191754|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
138191755|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138191756|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138257419|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138257420|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138257421|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138257422|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257423|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138257424|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
138257425|NCT00003111|Paclitaxel|paclitaxel|mesh-list
138257426|NCT00003111|Carboplatin|carboplatin|mesh-list
138257427|NCT00003111|Irinotecan|irinotecan|mesh-list
138257428|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257429|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257430|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257431|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257432|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257433|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257434|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138257435|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138257436|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257437|NCT00003117|Paclitaxel|paclitaxel|mesh-list
138257438|NCT00003117|Carboplatin|carboplatin|mesh-list
138257440|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257441|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257442|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257443|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257444|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257445|NCT02240329|Capsaicin|capsaicin|mesh-list
138257446|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
138257447|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
138257448|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
138257449|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138257450|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257451|NCT00003123|Amifostine|amifostine|mesh-list
138257452|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138257453|NCT00003123|Protective Agents|protective agents|mesh-ancestor
138257454|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257455|NCT03981523|Benzonidazole|benzonidazole|mesh-list
138257456|NCT03981523|Nifurtimox|nifurtimox|mesh-list
138257457|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257458|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
138257459|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257460|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138257461|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138257462|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138257463|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257464|NCT03965923|Tenofovir|tenofovir|mesh-list
138257465|NCT03965923|Emtricitabine|emtricitabine|mesh-list
138257466|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138257467|NCT03965923|Dapivirine|dapivirine|mesh-list
138257468|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
138257469|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257470|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138257471|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138257472|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257473|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257474|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138257475|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138257476|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
138257477|NCT03962725|Ketamine|ketamine|mesh-list
138191760|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138191761|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138191762|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
138191763|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138191764|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138191765|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138191766|NCT03638908|Fluoxetine|fluoxetine|mesh-list
138191767|NCT03638908|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138191768|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138257478|NCT03962725|Propofol|propofol|mesh-list
138257479|NCT03962725|Anesthetics|anesthetics|mesh-list
138257480|NCT03962725|Rocuronium|rocuronium|mesh-list
138257481|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
138257482|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138257483|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138257484|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257485|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138257487|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
138257488|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138257489|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138257492|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
138257493|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138257494|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257495|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138257496|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
138257497|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138257498|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138257499|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138257500|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138257501|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138257502|NCT02210559|Paclitaxel|paclitaxel|mesh-list
138257503|NCT02210559|Gemcitabine|gemcitabine|mesh-list
138257504|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257505|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257506|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257507|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257508|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257509|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257510|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257511|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
138257512|NCT00003135|Doxorubicin|doxorubicin|mesh-list
138257513|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138257514|NCT00003135|Fluorouracil|fluorouracil|mesh-list
138257515|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138257516|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257517|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138257518|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138257519|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257520|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257521|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
138257522|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257523|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257524|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
138257525|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257526|NCT03439891|Nivolumab|nivolumab|mesh-list
138257527|NCT03439891|Sorafenib|sorafenib|mesh-list
138257528|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138257529|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257530|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138257531|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257532|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138257533|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257534|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
138257535|NCT00003141|Thiotepa|thiotepa|mesh-list
138257536|NCT00003141|Cisplatin|cisplatin|mesh-list
138257538|NCT00003141|Etoposide|etoposide|mesh-list
138257539|NCT00003141|Vincristine|vincristine|mesh-list
138257540|NCT00003141|Lenograstim|lenograstim|mesh-list
138257541|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257542|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
138257543|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257544|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138257545|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138257546|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
138257547|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257548|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257549|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138257550|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257551|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138217481|NCT04272320|Bupivacaine|bupivacaine|mesh-list
138257553|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257554|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138257555|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257556|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257557|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257558|NCT04867135|Amikacin|amikacin|mesh-list
138257559|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138257560|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257561|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138257562|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138257563|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138257564|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138257565|NCT04581343|Paclitaxel|paclitaxel|mesh-list
138257566|NCT04581343|Gemcitabine|gemcitabine|mesh-list
138257567|NCT04581343|Spartalizumab|spartalizumab|mesh-list
138257568|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257569|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257570|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257571|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257572|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257573|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257574|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257575|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
138257576|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138257577|NCT04581343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138257578|NCT01743859|Lenalidomide|lenalidomide|mesh-list
138257579|NCT01743859|Azacitidine|azacitidine|mesh-list
138257580|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
138257581|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257582|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138257583|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138257584|NCT01743859|Growth Substances|growth substances|mesh-ancestor
138257585|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
138257586|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257587|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257589|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257590|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257591|NCT01746043|Minocycline|minocycline|mesh-list
138257592|NCT01746043|Modafinil|modafinil|mesh-list
138257593|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138257594|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257595|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138257596|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257597|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138257598|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138257599|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138257600|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257601|NCT05635903|Diazepam|diazepam|mesh-list
138257602|NCT05635903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138257603|NCT05635903|Anticonvulsants|anticonvulsants|mesh-ancestor
138217502|NCT00249002|Paclitaxel|paclitaxel|mesh-list
138257604|NCT05635903|Antiemetics|antiemetics|mesh-ancestor
138257605|NCT05635903|Autonomic Agents|autonomic agents|mesh-ancestor
138257606|NCT05635903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138257607|NCT05635903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257608|NCT05635903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138257609|NCT05635903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138257610|NCT05635903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138257611|NCT05635903|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138257612|NCT05635903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138257613|NCT05635903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138257614|NCT05635903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138257615|NCT05635903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138257616|NCT05635903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138257617|NCT05635903|Anesthetics, General|anesthetics, general|mesh-ancestor
138257619|NCT05635903|GABA Modulators|gaba modulators|mesh-ancestor
138191772|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
138191773|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191774|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138257620|NCT05635903|GABA Agents|gaba agents|mesh-ancestor
138257621|NCT05635903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138257622|NCT05635903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257623|NCT01746511|Glycerol|glycerol|mesh-list
138257624|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138257625|NCT01746511|Protective Agents|protective agents|mesh-ancestor
138257626|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257627|NCT01746979|Gemcitabine|gemcitabine|mesh-list
138257628|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257629|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
138257630|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257631|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257632|NCT05614453|Tislelizumab|tislelizumab|mesh-list
138257633|NCT05614453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138257634|NCT05614453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257635|NCT01754389|Sirolimus|sirolimus|mesh-list
138257636|NCT01754389|Methotrexate|methotrexate|mesh-list
138257637|NCT01754389|Bortezomib|bortezomib|mesh-list
138257638|NCT01754389|Tacrolimus|tacrolimus|mesh-list
138257639|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138257640|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
138257641|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138257642|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257643|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257644|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
138257645|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257646|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257647|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
138217516|NCT00246740|Doxycycline|doxycycline|mesh-list
138257649|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138257650|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257651|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
138257652|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138257653|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138257654|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138257655|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138257656|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257657|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138257658|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
138257659|NCT01754623|Gemcitabine|gemcitabine|mesh-list
138257660|NCT01754623|Capecitabine|capecitabine|mesh-list
138257661|NCT01754623|Fluorouracil|fluorouracil|mesh-list
138257662|NCT01754623|Docetaxel|docetaxel|mesh-list
138257663|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257664|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
138257665|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257666|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257667|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257668|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257669|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257670|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257671|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
138257672|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257673|NCT01755169|Ketamine|ketamine|mesh-list
138257674|NCT01755169|Analgesics|analgesics|mesh-ancestor
138257675|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
138257676|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138257677|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257678|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138257679|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138257680|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
138257681|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
138257682|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138257685|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138257686|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257687|NCT01755949|Colchicine|colchicine|mesh-list
138257688|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
138257689|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138257690|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257691|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257692|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257693|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191781|NCT01041781|Carboplatin|carboplatin|mesh-list
138257694|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257695|NCT01756885|Varenicline|varenicline|mesh-list
138257696|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138257697|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138257698|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
138257699|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138257700|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257701|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257702|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
138257703|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
138257704|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138257705|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257706|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257707|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138257709|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
138257710|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257711|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257712|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
138257713|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138257714|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257715|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
138257716|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138257717|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138257718|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138257719|NCT04062097|Vitamin K|vitamin k|mesh-list
138257720|NCT04062097|Dabigatran|dabigatran|mesh-list
138257721|NCT04062097|Vitamins|vitamins|mesh-ancestor
138257722|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
138257723|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257724|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
138257725|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138257726|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
138257727|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257728|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257729|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
138257730|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138257731|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138257732|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
138257733|NCT04062097|Coagulants|coagulants|mesh-ancestor
138257734|NCT02241655|Anesthetics|anesthetics|mesh-list
138257735|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138257736|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257738|NCT04005079|Prednisolone|prednisolone|mesh-list
138257739|NCT04005079|Pilocarpine|pilocarpine|mesh-list
138257740|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138257741|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
138257743|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138257744|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257746|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257747|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
138257748|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138257749|NCT04005079|Miotics|miotics|mesh-ancestor
138257750|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138257751|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138257752|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
138257753|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138257754|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257755|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138257756|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257757|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138257758|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138257759|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138257760|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257761|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138257762|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138257763|NCT01762501|Amlodipine|amlodipine|mesh-list
138257764|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138257765|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138191783|NCT01041781|Pemetrexed|pemetrexed|mesh-list
138191786|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
138257766|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138257767|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138257768|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257769|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138257770|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257771|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
138257772|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138257773|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138257775|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138257776|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257777|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138257778|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257779|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
138257780|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257781|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
138217618|NCT00244712|Lamivudine|lamivudine|mesh-list
138257782|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257783|NCT01764685|Topiramate|topiramate|mesh-list
138257784|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
138257785|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138257786|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257787|NCT05115409|Rituximab|rituximab|mesh-list
138257788|NCT05115409|Antibodies|antibodies|mesh-list
138257789|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
138257790|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257791|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138257792|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257793|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138257794|NCT01766713|Ezetimibe|ezetimibe|mesh-list
138257795|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138257796|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138257797|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
138236533|NCT01555281|Hormones|hormones|mesh-ancestor
138257798|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257799|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138257801|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138257803|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
138257804|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257805|NCT01769209|Cytarabine|cytarabine|mesh-list
138257806|NCT01769209|Dexamethasone|dexamethasone|mesh-list
138257807|NCT01769209|Doxorubicin|doxorubicin|mesh-list
138257808|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138257809|NCT01769209|Methotrexate|methotrexate|mesh-list
138257810|NCT01769209|Vincristine|vincristine|mesh-list
138257811|NCT01769209|Bortezomib|bortezomib|mesh-list
138257812|NCT01769209|Asparaginase|asparaginase|mesh-list
138257813|NCT01769209|Pegaspargase|pegaspargase|mesh-list
138257814|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138257815|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
138257816|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
138257817|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138257818|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257819|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138257820|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
138257821|NCT01769209|Hormones|hormones|mesh-ancestor
138191790|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138191791|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138257822|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138257823|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138257824|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257825|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138257826|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138257827|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138257828|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257829|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257830|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138257831|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
138257833|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257834|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
138257835|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
138257836|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138257837|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138257838|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
138257839|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138257840|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138257842|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257843|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257844|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257845|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257846|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257848|NCT01769365|Metronidazole|metronidazole|mesh-list
138257849|NCT01769365|Clarithromycin|clarithromycin|mesh-list
138257850|NCT01769365|Pantoprazole|pantoprazole|mesh-list
138257851|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138257852|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257853|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138257854|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138257855|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138236615|NCT04849377|Cisplatin|cisplatin|mesh-list
138257856|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257857|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257858|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138257859|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138257860|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138257861|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138257862|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138257863|NCT01771627|Nicotine|nicotine|mesh-list
138257864|NCT01771627|Varenicline|varenicline|mesh-list
138257865|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138257866|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
138257867|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138257868|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257869|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138257870|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138257871|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
138257872|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138257873|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257875|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
138257876|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138257877|NCT03499483|Tenofovir|tenofovir|mesh-list
138257878|NCT03499483|Emtricitabine|emtricitabine|mesh-list
138257879|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138257880|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
138257881|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257882|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138257884|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138257885|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257886|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138257887|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138257888|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
138191809|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138191810|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191811|NCT03921190|Anesthetics|anesthetics|mesh-list
138257889|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138257890|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
138257891|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257892|NCT01673867|Docetaxel|docetaxel|mesh-list
138257893|NCT01673867|Nivolumab|nivolumab|mesh-list
138257894|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257895|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257896|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257897|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257898|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257899|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138257900|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138257901|NCT01777945|Docetaxel|docetaxel|mesh-list
138257902|NCT01777945|Capecitabine|capecitabine|mesh-list
138257903|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257904|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257905|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257906|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257907|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257908|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257909|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
138257910|NCT03012581|Nivolumab|nivolumab|mesh-list
138257911|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138257912|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257913|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138257914|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257915|NCT05451043|Paclitaxel|paclitaxel|mesh-list
138257916|NCT05451043|Gemcitabine|gemcitabine|mesh-list
138257917|NCT05451043|Durvalumab|durvalumab|mesh-list
138257918|NCT05451043|Tremelimumab|tremelimumab|mesh-list
138257919|NCT05451043|Propranolol|propranolol|mesh-list
138257920|NCT05451043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257921|NCT05451043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257922|NCT05451043|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257923|NCT05451043|Antimitotic Agents|antimitotic agents|mesh-ancestor
138236754|NCT05451381|Analgesics|analgesics|mesh-ancestor
138257924|NCT05451043|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257925|NCT05451043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257926|NCT05451043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257927|NCT05451043|Antimetabolites|antimetabolites|mesh-ancestor
138257928|NCT05451043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138257929|NCT05451043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138257930|NCT05451043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138257931|NCT05451043|Adrenergic Agents|adrenergic agents|mesh-ancestor
138257932|NCT05451043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138257933|NCT05451043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257934|NCT05451043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138257935|NCT05451043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138257936|NCT05451043|Vasodilator Agents|vasodilator agents|mesh-ancestor
138257938|NCT02652169|Teicoplanin|teicoplanin|mesh-list
138257939|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138257940|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138257941|NCT02478775|Cetrorelix|cetrorelix|mesh-list
138257942|NCT02478775|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138257943|NCT02478775|Fertility Agents|fertility agents|mesh-ancestor
138257944|NCT02478775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138257945|NCT02478775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257946|NCT02478775|Hormone Antagonists|hormone antagonists|mesh-ancestor
138257947|NCT02478775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138257949|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
138257950|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257951|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138257952|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257953|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138257955|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138257956|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138257957|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
138257958|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138257959|NCT02452931|Leuprolide|leuprolide|mesh-list
138191819|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138257960|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138257961|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
138257962|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138257963|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257964|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138257965|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257966|NCT04744727|Acetaminophen|acetaminophen|mesh-list
138257967|NCT04744727|Meperidine|meperidine|mesh-list
138257968|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138257969|NCT04744727|Analgesics|analgesics|mesh-ancestor
138257970|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
138257971|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138257972|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138257973|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
138257974|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138257975|NCT04744727|Narcotics|narcotics|mesh-ancestor
138257976|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138257977|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138257978|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
138257979|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
138479821|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
138257980|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138257981|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257982|NCT02454179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138217720|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138257983|NCT02454179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257984|NCT02041533|Paclitaxel|paclitaxel|mesh-list
138257985|NCT02041533|Carboplatin|carboplatin|mesh-list
138257986|NCT02041533|Gemcitabine|gemcitabine|mesh-list
138257987|NCT02041533|Nivolumab|nivolumab|mesh-list
138257988|NCT02041533|Pemetrexed|pemetrexed|mesh-list
138257989|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138257990|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138257991|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
138257992|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
138257993|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
138257994|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138257995|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138257996|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
138257997|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138257998|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138257999|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258000|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138258001|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138258003|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138258004|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258005|NCT02458235|Azacitidine|azacitidine|mesh-list
138258006|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138258007|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
138258008|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258009|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258010|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258011|NCT02115997|Prednisone|prednisone|mesh-list
138258012|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
138258013|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138258014|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138258015|NCT02115997|Prednisolone|prednisolone|mesh-list
138258016|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
138258017|NCT02115997|Rituximab|rituximab|mesh-list
138258018|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138258019|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
138258020|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138258021|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258022|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
138258023|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258024|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138217750|NCT01213199|Adapalene|adapalene|mesh-list
138217752|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138258026|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
138258028|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138258029|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138258030|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
138258031|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
138258032|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258033|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138258034|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138258035|NCT02115997|Protective Agents|protective agents|mesh-ancestor
138258036|NCT01805323|Dexamethasone|dexamethasone|mesh-list
138258037|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138258038|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
138258039|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
138258040|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258041|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258042|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138236906|NCT00371553|Sunitinib|sunitinib|mesh-list
138258043|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
138258044|NCT01805323|Hormones|hormones|mesh-ancestor
138258045|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138258046|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138258047|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258048|NCT01641055|Caseins|caseins|mesh-list
138258049|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
138258050|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
138258051|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258052|NCT01788631|Regadenoson|regadenoson|mesh-list
138258053|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138258054|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138258055|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
138258056|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
138258057|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258058|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258059|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258060|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138258061|NCT00907283|Deferiprone|deferiprone|mesh-list
138258062|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138258063|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
138258064|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
138258065|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258066|NCT01789255|Cyclosporine|cyclosporine|mesh-list
138258067|NCT01789255|Methotrexate|methotrexate|mesh-list
138258068|NCT01789255|Vorinostat|vorinostat|mesh-list
138258070|NCT01789255|Cyclosporins|cyclosporins|mesh-list
138258071|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138258072|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
138258073|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138258074|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258075|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138258076|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
138258077|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138236922|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
138258078|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258079|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
138258080|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258081|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138258082|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138258083|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
138258084|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258085|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138258086|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138258087|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
138258088|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258089|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138258090|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
138258091|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
138258092|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
138258093|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258094|NCT02464163|Coagulants|coagulants|mesh-ancestor
138258095|NCT01808755|Trimethoprim|trimethoprim|mesh-list
138258096|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
138258097|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138258098|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258099|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
138258100|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138258101|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138258102|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138258103|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258104|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258105|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138258106|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138258107|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138258110|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138258111|NCT02694809|Hormones|hormones|mesh-ancestor
138258112|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138258113|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258114|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138258115|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138258116|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
138258117|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138258118|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
138258119|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138258120|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138258121|NCT00568997|Analgesics|analgesics|mesh-ancestor
138258122|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
138217819|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258123|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258124|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258125|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138258126|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258127|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
138258128|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138258129|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
138258130|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138258131|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258132|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258133|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138258134|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138258135|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138258136|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138217836|NCT00780494|Capecitabine|capecitabine|mesh-list
138258137|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258139|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258140|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138258141|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138258142|NCT01790659|Gentamicins|gentamicins|mesh-list
138258143|NCT01790659|Paromomycin|paromomycin|mesh-list
138258144|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138258145|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258146|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138258147|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258148|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258149|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138258150|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138258152|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138258153|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258154|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138258155|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258156|NCT01733953|Atorvastatin|atorvastatin|mesh-list
138258158|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138258159|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
138258160|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191830|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138191831|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138191834|NCT00953849|Vitamins|vitamins|mesh-ancestor
138258161|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138258162|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138258163|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258164|NCT00362921|Carmustine|carmustine|mesh-list
138258165|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138258166|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138258167|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
138258168|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258169|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258170|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258171|NCT01734889|Nitisinone|nitisinone|mesh-list
138258172|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258173|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258174|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138258175|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138258176|NCT01796665|Clindamycin|clindamycin|mesh-list
138258177|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
138258178|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
138258179|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138258180|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138258181|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258182|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138258183|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258184|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258185|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
138258186|NCT01798225|Doxycycline|doxycycline|mesh-list
138258187|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138258188|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258189|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
138258190|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138237022|NCT02770521|Treprostinil|treprostinil|mesh-list
138258191|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138258193|NCT01800877|Dopamine|dopamine|mesh-list
138258194|NCT01800877|Vasopressins|vasopressins|mesh-list
138258195|NCT01800877|Epinephrine|epinephrine|mesh-list
138258196|NCT01800877|Norepinephrine|norepinephrine|mesh-list
138258197|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138258198|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138258199|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138258200|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
138258201|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258202|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258203|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258204|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138258205|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138258206|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
138258207|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258208|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138480035|NCT02044952|Triptolide|triptolide|mesh-list
138258209|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
138258210|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
138258211|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
138258212|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138258213|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
138258214|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138258215|NCT01800877|Protective Agents|protective agents|mesh-ancestor
138258216|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
138258217|NCT01800877|Coagulants|coagulants|mesh-ancestor
138258218|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138237072|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258219|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
138258220|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
138258221|NCT02471651|Dexamethasone|dexamethasone|mesh-list
138258222|NCT02471651|Ranibizumab|ranibizumab|mesh-list
138258223|NCT02471651|Aflibercept|aflibercept|mesh-list
138258224|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258225|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138258226|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138258227|NCT02471651|Growth Substances|growth substances|mesh-ancestor
138258228|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138217914|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
138258229|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
138258230|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138258231|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
138258232|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
138258233|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258234|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138258235|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
138258237|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138258238|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138258239|NCT02477423|Gentamicins|gentamicins|mesh-list
138258240|NCT02477423|Ampicillin|ampicillin|mesh-list
138258241|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138258242|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258243|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138258244|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258245|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258246|NCT00363701|Esomeprazole|esomeprazole|mesh-list
138258247|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138258248|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138258249|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138258250|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258251|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258252|NCT04744571|Aspirin|aspirin|mesh-list
138258253|NCT04744571|Metoprolol|metoprolol|mesh-list
138258254|NCT04744571|Clopidogrel|clopidogrel|mesh-list
138258255|NCT04744571|Ticagrelor|ticagrelor|mesh-list
138258256|NCT04744571|Atorvastatin|atorvastatin|mesh-list
138258257|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138258258|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138258259|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138258260|NCT04744571|Analgesics|analgesics|mesh-ancestor
138258261|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
138258262|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258263|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258264|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138258265|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258266|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138258267|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138258268|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258269|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138258270|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138258271|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258273|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138258274|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138258275|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
138237162|NCT05437965|Glucocorticoids|glucocorticoids|mesh-list
138258276|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138258277|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138258278|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138258279|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138258280|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138258281|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
138258282|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258283|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138258284|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138258286|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
138258287|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138258288|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138258289|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138258290|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
138258291|NCT00363155|KRN 7000|krn 7000|mesh-list
138258292|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138258293|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
138258294|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258295|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258296|NCT02519387|Buprenorphine|buprenorphine|mesh-list
138258297|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138258298|NCT02519387|Narcotics|narcotics|mesh-ancestor
138258299|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138191845|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
138258300|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258301|NCT02519387|Analgesics|analgesics|mesh-ancestor
138258302|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
138258303|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258304|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138258305|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138258307|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138258308|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138258309|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
138258310|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258311|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
138258312|NCT02257957|Protective Agents|protective agents|mesh-ancestor
138258313|NCT02524769|Estrogens|estrogens|mesh-list
138258314|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138258315|NCT02524769|Hormones|hormones|mesh-ancestor
138258316|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138258317|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258318|NCT02525549|Adapalene|adapalene|mesh-list
138258319|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138258320|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
138258321|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138258322|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138258323|NCT02525549|Analgesics|analgesics|mesh-ancestor
138258324|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
138258325|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258326|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258327|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138258328|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258329|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
138258330|NCT01878799|Ledipasvir|ledipasvir|mesh-list
138258331|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
138258332|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258333|NCT02527265|Insulin|insulin|mesh-list
138258334|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138258335|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258337|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
138258338|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138258339|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138258340|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138258341|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258343|NCT01804075|Methadone|methadone|mesh-list
138258344|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138258345|NCT01804075|Narcotics|narcotics|mesh-ancestor
138258346|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258347|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258349|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
138258350|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258351|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
138258352|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
138258354|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
138258355|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
138258356|NCT02416193|Vitamins|vitamins|mesh-list
138258357|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
138258358|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258359|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138258360|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138258361|NCT02530151|Clonidine|clonidine|mesh-list
138258362|NCT02530151|Morphine|morphine|mesh-list
138258363|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138258364|NCT02530151|Narcotics|narcotics|mesh-ancestor
138258365|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258366|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258367|NCT02530151|Analgesics|analgesics|mesh-ancestor
138258368|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
138258369|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258371|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
138258372|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
138191853|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138258373|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138258374|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138258375|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138258376|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
138258377|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258378|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258379|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
138258380|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138258381|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138258382|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258383|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
138258384|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
138258385|NCT01804465|Ipilimumab|ipilimumab|mesh-list
138258386|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138258387|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258388|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138258389|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258390|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
138258391|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138258392|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138258393|NCT02531321|Estradiol|estradiol|mesh-list
138258394|NCT02531321|Estrogens|estrogens|mesh-ancestor
138258395|NCT02531321|Hormones|hormones|mesh-ancestor
138258396|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138258397|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258398|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138258399|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
138258400|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138258401|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138258402|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138258403|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138258404|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138258405|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138258406|NCT01805089|Melatonin|melatonin|mesh-list
138258407|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
138258408|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258409|NCT01805089|Protective Agents|protective agents|mesh-ancestor
138258410|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258411|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258412|NCT02417129|Rituximab|rituximab|mesh-list
138258414|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258415|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
138258416|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258417|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258418|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
138258419|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138258421|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138258422|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138258423|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138258424|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
138258425|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258426|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258427|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258428|NCT02417831|Urological Agents|urological agents|mesh-ancestor
138258429|NCT02419547|Midazolam|midazolam|mesh-list
138258430|NCT02419547|Fentanyl|fentanyl|mesh-list
138258431|NCT02419547|Propofol|propofol|mesh-list
138258432|NCT02419547|Sevoflurane|sevoflurane|mesh-list
138258433|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138258434|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258435|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258436|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138258439|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138258440|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138191860|NCT03644212|Vitamin D|vitamin d|mesh-list
138191861|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
138191862|NCT03644212|Vitamins|vitamins|mesh-list
138191863|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
138191867|NCT03906448|Temozolomide|temozolomide|mesh-list
138258441|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138258442|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138258443|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
138258444|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
138258445|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258446|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258447|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138258448|NCT02419547|Narcotics|narcotics|mesh-ancestor
138258449|NCT02419547|Analgesics|analgesics|mesh-ancestor
138258450|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
138258451|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258452|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138258453|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138258454|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138258455|NCT02533427|Norgestimate|norgestimate|mesh-list
138258456|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138258457|NCT02533427|Estradiol|estradiol|mesh-list
138258458|NCT02533427|Estrogens|estrogens|mesh-ancestor
138258459|NCT02533427|Hormones|hormones|mesh-ancestor
138258460|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138258461|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258462|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138258463|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
138258464|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138258465|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138258466|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138258467|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138480317|NCT02046577|Vitamin D|vitamin d|mesh-list
138258468|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138258469|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138258470|NCT05328817|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138258471|NCT05328817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138258472|NCT05328817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258473|NCT05328817|Antitubercular Agents|antitubercular agents|mesh-ancestor
138258474|NCT05328427|Tin Fluorides|tin fluorides|mesh-list
138258475|NCT05328427|Cariostatic Agents|cariostatic agents|mesh-ancestor
138258476|NCT05328427|Protective Agents|protective agents|mesh-ancestor
138258477|NCT05328427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258478|NCT02533505|Budesonide|budesonide|mesh-list
138258479|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
138258480|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138258481|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138258482|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
138258483|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258484|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258485|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138258486|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
138258487|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
138258489|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138258490|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138258491|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138258492|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138258493|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
138258494|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258495|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258496|NCT02420015|Bupropion|bupropion|mesh-list
138258497|NCT02420015|Nicotine|nicotine|mesh-list
138258498|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138258499|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
138258500|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258501|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258502|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138258503|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138258504|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
138258505|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258506|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258507|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138258508|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
138258509|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138258510|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138258511|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138258512|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138258513|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
138258514|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138258515|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138258516|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258517|NCT05326867|Lidocaine|lidocaine|mesh-list
138258518|NCT05326867|Anesthetics, Local|anesthetics, local|mesh-ancestor
138258519|NCT05326867|Anesthetics|anesthetics|mesh-ancestor
138258520|NCT05326867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258521|NCT05326867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258522|NCT05326867|Sensory System Agents|sensory system agents|mesh-ancestor
138258523|NCT05326867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258524|NCT05326867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138258525|NCT05326867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138258526|NCT05326867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138258527|NCT05326867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138258528|NCT05326867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258530|NCT05324995|Epinephrine|epinephrine|mesh-list
138258531|NCT05324995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138258532|NCT05324995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138258533|NCT05324995|Adrenergic Agents|adrenergic agents|mesh-ancestor
138258534|NCT05324995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258535|NCT05324995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258536|NCT05324995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258537|NCT05324995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138258538|NCT05324995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138258539|NCT05324995|Autonomic Agents|autonomic agents|mesh-ancestor
138258540|NCT05324995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258541|NCT05324995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138258542|NCT05324995|Respiratory System Agents|respiratory system agents|mesh-ancestor
138258543|NCT05324995|Mydriatics|mydriatics|mesh-ancestor
138258545|NCT05324995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138258546|NCT05324995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138258547|NCT05324995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138258548|NCT05324995|Analgesics|analgesics|mesh-ancestor
138258549|NCT05324995|Sensory System Agents|sensory system agents|mesh-ancestor
138258550|NCT05324995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138258551|NCT05324995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258552|NCT05324995|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138258553|NCT05324995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138258554|NCT05324995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258556|NCT05318521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138258557|NCT05318521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138258558|NCT05318521|Analgesics|analgesics|mesh-ancestor
138258559|NCT05318521|Sensory System Agents|sensory system agents|mesh-ancestor
138258560|NCT05318521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258561|NCT05318521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258562|NCT05318521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138258563|NCT05318521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258564|NCT05318521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138258565|NCT05318521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258566|NCT05318521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258567|NCT02420873|Maytansine|maytansine|mesh-list
138258568|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
138258569|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138258570|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258571|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
138258572|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
138258573|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
138258574|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258575|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138258576|NCT02420873|Immunotoxins|immunotoxins|mesh-ancestor
138258577|NCT02420873|Immunoconjugates|immunoconjugates|mesh-ancestor
138191873|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138191874|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138258578|NCT02420873|Immunologic Factors|immunologic factors|mesh-ancestor
138237621|NCT06191094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258579|NCT02420873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258581|NCT02534129|Emollients|emollients|mesh-ancestor
138258582|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
138258583|NCT02420951|Bupivacaine|bupivacaine|mesh-list
138258584|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
138258585|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
138258586|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258587|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258588|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
138258589|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258590|NCT02267083|Doxorubicin|doxorubicin|mesh-list
138258591|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138258592|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258593|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138258594|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138258595|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258596|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258597|NCT02535611|Memantine|memantine|mesh-list
138258598|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138258599|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138258600|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
138258601|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258602|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258603|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258604|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138258605|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138258606|NCT01823497|Morphine|morphine|mesh-list
138258607|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138258608|NCT01823497|Narcotics|narcotics|mesh-ancestor
138258609|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258610|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258611|NCT01823497|Analgesics|analgesics|mesh-ancestor
138258612|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
138258613|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258614|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
138258615|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138258616|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258617|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258618|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138258619|NCT00363935|Analgesics|analgesics|mesh-ancestor
138258620|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
138258621|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258622|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138258623|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138258624|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138258625|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
138258626|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218133|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
138258628|NCT05747521|Doxorubicin|doxorubicin|mesh-list
138258629|NCT05747521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138258630|NCT05747521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138258632|NCT05747521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138258633|NCT05747521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138258634|NCT05747521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258635|NCT05747521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258637|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
138258639|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258640|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258641|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
138191879|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138191880|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138191881|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138258642|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258643|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138258644|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138258645|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138258646|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138237699|NCT06190483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138258647|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258648|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
138258649|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258651|NCT02537951|Prilocaine|prilocaine|mesh-list
138258652|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138258653|NCT02537951|Capsaicin|capsaicin|mesh-list
138258654|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
138258655|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
138258656|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258657|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258658|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
138258659|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258660|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138258661|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138258662|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138258663|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138258664|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258665|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
138258666|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
138258667|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138258668|NCT02487485|Sirolimus|sirolimus|mesh-list
138258669|NCT02487485|Ketamine|ketamine|mesh-list
138258670|NCT02487485|Analgesics|analgesics|mesh-ancestor
138258671|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
138258672|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258673|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258674|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138258675|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138258676|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
138258677|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
138258678|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258679|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138258680|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138258681|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237746|NCT06190158|Antiemetics|antiemetics|mesh-ancestor
138258684|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258685|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138258686|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258687|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
138258688|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138258689|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
138258691|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138258692|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
138258693|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258694|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258695|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258696|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138258697|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258698|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258699|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
138258700|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138258701|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258702|NCT02489357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138258703|NCT02489357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258704|NCT02490293|Cephalosporins|cephalosporins|mesh-list
138258705|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138258706|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258707|NCT02539511|Ketamine|ketamine|mesh-list
138258708|NCT02539511|Analgesics|analgesics|mesh-ancestor
138258709|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
138258710|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258711|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258712|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138258713|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138258714|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
138258715|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
138258716|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258717|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138258718|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138258719|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258720|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258721|NCT02493257|Ethanol|ethanol|mesh-list
138258722|NCT02493257|Capsaicin|capsaicin|mesh-list
138258723|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138258724|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258725|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258726|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258727|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
138258728|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
138258729|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
138258730|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258731|NCT02430389|Remifentanil|remifentanil|mesh-list
138258732|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138258733|NCT02430389|Narcotics|narcotics|mesh-ancestor
138258734|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258736|NCT02430389|Analgesics|analgesics|mesh-ancestor
138258737|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
138258738|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258739|NCT02431637|Piperaquine|piperaquine|mesh-list
138258740|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
138258741|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138258742|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138258743|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258744|NCT02545907|Thalidomide|thalidomide|mesh-list
138258745|NCT02545907|Dexamethasone|dexamethasone|mesh-list
138258746|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138258747|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
138258748|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
138258749|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258750|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258751|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138258752|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
138258753|NCT02545907|Hormones|hormones|mesh-ancestor
138258754|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138258755|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138258756|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258757|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138258758|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
138258759|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
138258760|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138258761|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258762|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138258763|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138258764|NCT02545907|Growth Substances|growth substances|mesh-ancestor
138258765|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
138258766|NCT02495831|Diclofenac|diclofenac|mesh-list
138258767|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138258768|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138258769|NCT02495831|Analgesics|analgesics|mesh-ancestor
138258770|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
138258771|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258772|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258773|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138258774|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258775|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138258776|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258777|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258778|NCT02498483|Acetaminophen|acetaminophen|mesh-list
138258779|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138258780|NCT02498483|Analgesics|analgesics|mesh-ancestor
138258781|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
138258782|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258783|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258784|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
138258785|NCT02547623|Dexamethasone|dexamethasone|mesh-list
138258786|NCT02547623|Prednisolone|prednisolone|mesh-list
138258787|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238027|NCT06132685|Hormones|hormones|mesh-ancestor
138258790|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258791|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258792|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138258793|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
138258795|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138258796|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138258797|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258798|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
138258799|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138258800|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138258801|NCT00559585|Abatacept|abatacept|mesh-list
138238074|NCT06120140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258802|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138258803|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258804|NCT00559585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138258805|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258806|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138258808|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258809|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258810|NCT01824901|Docetaxel|docetaxel|mesh-list
138258811|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258812|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
138258813|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
138258814|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
138258815|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258816|NCT00559507|Saracatinib|saracatinib|mesh-list
138258817|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258818|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258819|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258820|NCT04969627|Metformin|metformin|mesh-list
138258821|NCT04969627|Exenatide|exenatide|mesh-list
138258823|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258824|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138258825|NCT04969627|Incretins|incretins|mesh-ancestor
138258826|NCT04969627|Hormones|hormones|mesh-ancestor
138258827|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138258828|NCT04953325|Vaccines|vaccines|mesh-list
138258829|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138218219|NCT01218971|Naltrexone|naltrexone|mesh-list
138258830|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
138258831|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258832|NCT01826851|Bupivacaine|bupivacaine|mesh-list
138258833|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
138258834|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
138258835|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258836|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258837|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
138258838|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258839|NCT02499497|Androgens|androgens|mesh-list
138258840|NCT02499497|Hormones|hormones|mesh-ancestor
138258841|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138258842|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258843|NCT01827475|Acetaminophen|acetaminophen|mesh-list
138258844|NCT01827475|Ibuprofen|ibuprofen|mesh-list
138258845|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138258847|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
138258848|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258849|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258850|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
138258851|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138258852|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138258853|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258854|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138258855|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258856|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258858|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138191897|NCT01104025|Dexamethasone|dexamethasone|mesh-list
138258859|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
138258860|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138258861|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138258862|NCT02434523|Analgesics|analgesics|mesh-ancestor
138258863|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
138258864|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258865|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258866|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138258867|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138258868|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138258869|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258870|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
138258871|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258872|NCT02501135|Bupivacaine|bupivacaine|mesh-list
138258873|NCT02501135|Ropivacaine|ropivacaine|mesh-list
138258874|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
138258876|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258877|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258878|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
138258879|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258880|NCT02550743|Capecitabine|capecitabine|mesh-list
138258881|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138258882|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
138258883|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258884|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258885|NCT02437253|Adalimumab|adalimumab|mesh-list
138258886|NCT02437253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138258887|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138258888|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258889|NCT01829503|Cytarabine|cytarabine|mesh-list
138258890|NCT01829503|Decitabine|decitabine|mesh-list
138258891|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138258892|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
138258893|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258894|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258895|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
138258896|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138258897|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138258898|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
138258899|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258901|NCT05742763|Acetaminophen|acetaminophen|mesh-list
138258902|NCT05742763|Ibuprofen|ibuprofen|mesh-list
138258903|NCT05742763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138258904|NCT05742763|Analgesics|analgesics|mesh-ancestor
138258905|NCT05742763|Sensory System Agents|sensory system agents|mesh-ancestor
138258906|NCT05742763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258907|NCT05742763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258908|NCT05742763|Antipyretics|antipyretics|mesh-ancestor
138258909|NCT05742763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138258910|NCT05742763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138258911|NCT05742763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138258912|NCT05742763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138258913|NCT05742763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258914|NCT05742763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258915|NCT02504723|Carvedilol|carvedilol|mesh-list
138258916|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138258917|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138258918|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
138258919|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138238261|NCT06026852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138238265|NCT06023329|Ropivacaine|ropivacaine|mesh-list
138258920|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258921|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258923|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
138258924|NCT02504723|Protective Agents|protective agents|mesh-ancestor
138258925|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138258926|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138258927|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138258928|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
138258929|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138258930|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138258932|NCT02439281|Ropivacaine|ropivacaine|mesh-list
138258933|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
138258934|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
138258935|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258936|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258937|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
138258938|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138258939|NCT02439281|Analgesics|analgesics|mesh-ancestor
138258940|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138258941|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
138258942|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
138258943|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138258944|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138258945|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138258946|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
138258947|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138258948|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258949|NCT02505269|Doxorubicin|doxorubicin|mesh-list
138258950|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138258951|NCT02505269|Dacarbazine|dacarbazine|mesh-list
138258952|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138258953|NCT02505269|Imidazole|imidazole|mesh-list
138258954|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138258955|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258956|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138258957|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138258958|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138258959|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258960|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138258961|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
138258962|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138258964|NCT02505269|Immunoconjugates|immunoconjugates|mesh-ancestor
138258965|NCT02505269|Immunologic Factors|immunologic factors|mesh-ancestor
138258966|NCT02505269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258967|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138258968|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
138258969|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138258970|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138258971|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138258972|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258973|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138258974|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
138258975|NCT00559273|Hematinics|hematinics|mesh-ancestor
138258977|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138258978|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138258979|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138258980|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238353|NCT05947760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138258981|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138258982|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138258983|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138258985|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
138258986|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
138258987|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
138258988|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
138258989|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138480582|NCT00005853|Analgesics|analgesics|mesh-ancestor
138258990|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138258991|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
138258992|NCT02508077|Leucovorin|leucovorin|mesh-list
138258993|NCT02508077|Folic Acid|folic acid|mesh-list
138258994|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138258995|NCT02508077|Panitumumab|panitumumab|mesh-list
138258996|NCT02508077|Fluorouracil|fluorouracil|mesh-list
138258997|NCT02508077|Irinotecan|irinotecan|mesh-list
138258998|NCT02508077|Camptothecin|camptothecin|mesh-list
138191912|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138258999|NCT02508077|Antibodies|antibodies|mesh-list
138259000|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
138259001|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138259002|NCT02508077|Calcium|calcium|mesh-list
138259003|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
138259004|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
138259005|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259006|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259007|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138259008|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138259009|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
138259010|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259011|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138259012|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138259013|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138259014|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138259015|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259016|NCT02508077|Antidotes|antidotes|mesh-ancestor
138259017|NCT02508077|Protective Agents|protective agents|mesh-ancestor
138259018|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
138259019|NCT02508077|Vitamins|vitamins|mesh-ancestor
138238400|NCT05934448|Pembrolizumab|pembrolizumab|mesh-list
138259021|NCT02508077|Hematinics|hematinics|mesh-ancestor
138259022|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138259023|NCT00558259|Dabigatran|dabigatran|mesh-list
138259024|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
138259025|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138259026|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
138259027|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259028|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259029|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
138259030|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
138259031|NCT02508389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138259032|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
138259033|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259034|NCT02508389|Protective Agents|protective agents|mesh-ancestor
138259035|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259036|NCT02509481|Ivermectin|ivermectin|mesh-list
138259037|NCT02509481|Albendazole|albendazole|mesh-list
138259038|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138259039|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259040|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
138259041|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
138259042|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138259043|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138259044|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
138480636|NCT00005877|Rubitecan|rubitecan|mesh-list
138259045|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
138259046|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
138259047|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259048|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259049|NCT04341077|Fluzoparib|fluzoparib|mesh-list
138259050|NCT04341077|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138259051|NCT04341077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259052|NCT04341077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259053|NCT04341077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259054|NCT02561897|Warfarin|warfarin|mesh-list
138259055|NCT02561897|Edoxaban|edoxaban|mesh-list
138259056|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
138259057|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138259058|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
138259059|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138259060|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
138259061|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259062|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259063|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
138259064|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138259065|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
138259066|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259067|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138259068|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138259069|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
138191916|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138259070|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259071|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259072|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138259073|NCT02562521|Nicotine|nicotine|mesh-list
138259074|NCT02562521|Varenicline|varenicline|mesh-list
138259075|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138259076|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
138259077|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259078|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259079|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138259080|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138259081|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
138259082|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218350|NCT00772304|Analgesics|analgesics|mesh-ancestor
138259083|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259085|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259086|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138259087|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259088|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259089|NCT05446883|Paclitaxel|paclitaxel|mesh-list
138259090|NCT05446883|Carboplatin|carboplatin|mesh-list
138259091|NCT05446883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138259092|NCT05446883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259093|NCT05446883|Tubulin Modulators|tubulin modulators|mesh-ancestor
138259094|NCT05446883|Antimitotic Agents|antimitotic agents|mesh-ancestor
138259095|NCT05446883|Mitosis Modulators|mitosis modulators|mesh-ancestor
138259096|NCT05446883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259098|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138259099|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138259100|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
138259101|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
138259102|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259103|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259104|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259105|NCT00558103|Lapatinib|lapatinib|mesh-list
138259106|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259107|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138259108|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238531|NCT05848687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138259109|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259110|NCT02974361|Ibuprofen|ibuprofen|mesh-list
138259111|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138259112|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138259113|NCT02974361|Analgesics|analgesics|mesh-ancestor
138259114|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
138259115|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259116|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259117|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138259118|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138259119|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138259120|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259121|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259122|NCT05690815|Tenofovir|tenofovir|mesh-list
138259123|NCT05690815|Emtricitabine|emtricitabine|mesh-list
138259124|NCT05690815|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138259125|NCT05690815|Antiviral Agents|antiviral agents|mesh-ancestor
138259126|NCT05690815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259127|NCT05690815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138259128|NCT05690815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138259129|NCT05690815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259130|NCT05690815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259131|NCT05690815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138259132|NCT05690815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138259133|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
138259134|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138259136|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138259138|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259139|NCT04477733|Butorphanol|butorphanol|mesh-list
138259140|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138259141|NCT04477733|Narcotics|narcotics|mesh-ancestor
138259142|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138259143|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259144|NCT04477733|Analgesics|analgesics|mesh-ancestor
138259145|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
138259146|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259147|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
138259148|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
138259149|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138259150|NCT00558025|Pramipexole|pramipexole|mesh-list
138259151|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
138259152|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259153|NCT00558025|Protective Agents|protective agents|mesh-ancestor
138259154|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259155|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138259156|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138259157|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
138259158|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
138259159|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259160|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
138259161|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138259162|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138259163|NCT02576249|Prednisolone|prednisolone|mesh-list
138259164|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
138259166|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138259167|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
138259168|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
138259169|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
138259170|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138259171|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259172|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
138259173|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259174|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138259175|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
138259176|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
138259177|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138259178|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
138259179|NCT02576249|Hormones|hormones|mesh-ancestor
138259180|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138259181|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138259182|NCT02576249|Protective Agents|protective agents|mesh-ancestor
138259183|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138259184|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259185|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
138259186|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138218396|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138259187|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259188|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138259189|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138259190|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259191|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259192|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259194|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
138259195|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138259196|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259197|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
138259198|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138191926|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138191927|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138191928|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138259199|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138191929|NCT03649750|Guaifenesin|guaifenesin|mesh-list
138259200|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191932|NCT04343092|Ivermectin|ivermectin|mesh-list
138259201|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
138259202|NCT02578901|Coagulants|coagulants|mesh-ancestor
138259203|NCT02579057|Furosemide|furosemide|mesh-list
138259204|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138259205|NCT02579057|Diuretics|diuretics|mesh-ancestor
138259206|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
138259207|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259208|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138259209|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138259210|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259211|NCT00557245|Tenofovir|tenofovir|mesh-list
138259212|NCT00557245|Emtricitabine|emtricitabine|mesh-list
138259213|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138259214|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
138259215|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259216|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138259217|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138259218|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259219|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259220|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138259221|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138259222|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138259223|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138259224|NCT04743011|Heparin|heparin|mesh-list
138259225|NCT04743011|Calcium heparin|calcium heparin|mesh-list
138259226|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138259227|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
138259228|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138259229|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138259230|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259232|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138259233|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138259234|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138218421|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138259235|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259236|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
138259237|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259238|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138259239|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138259240|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138259241|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259242|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138259243|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259244|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259245|NCT00365183|Pemetrexed|pemetrexed|mesh-list
138259246|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
138259249|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259250|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138259251|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138259252|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138259253|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
138259255|NCT01837069|Lisinopril|lisinopril|mesh-list
138259256|NCT01837069|Atorvastatin|atorvastatin|mesh-list
138259257|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138259258|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138259259|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138259260|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
138259261|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259262|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138259263|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138259264|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259265|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138259266|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138259267|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
138259268|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
138259269|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259270|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191940|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
138259271|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138259272|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138259273|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138259274|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
138259275|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259276|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
138259277|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138259278|NCT01837069|Protective Agents|protective agents|mesh-ancestor
138259279|NCT02289690|Carboplatin|carboplatin|mesh-list
138259280|NCT02289690|Etoposide|etoposide|mesh-list
138259281|NCT02289690|Veliparib|veliparib|mesh-list
138259282|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259283|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138259284|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138259285|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138259286|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259287|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259288|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138259289|NCT02268955|Ibuprofen|ibuprofen|mesh-list
138259290|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138259291|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138259292|NCT02268955|Analgesics|analgesics|mesh-ancestor
138259293|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
138259294|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259295|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259296|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138259297|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138259298|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138259299|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259300|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259301|NCT02585843|Spironolactone|spironolactone|mesh-list
138259302|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138259303|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
138259304|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138259305|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259306|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138259308|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
138259309|NCT01838317|Pioglitazone|pioglitazone|mesh-list
138259310|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138259311|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259312|NCT05249231|Fluorides|fluorides|mesh-list
138259313|NCT05249231|Cariostatic Agents|cariostatic agents|mesh-ancestor
138259314|NCT05249231|Protective Agents|protective agents|mesh-ancestor
138259315|NCT05249231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259316|NCT05249153|Sufentanil|sufentanil|mesh-list
138259317|NCT05249153|Dexmedetomidine|dexmedetomidine|mesh-list
138259318|NCT05249153|Dsuvia|dsuvia|mesh-list
138259319|NCT05249153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138259320|NCT05249153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138259321|NCT05249153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259322|NCT05249153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138259323|NCT05249153|Analgesics|analgesics|mesh-ancestor
138259324|NCT05249153|Sensory System Agents|sensory system agents|mesh-ancestor
138259325|NCT05249153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259326|NCT05249153|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138259327|NCT05249153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138259328|NCT05249153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138259329|NCT05249153|Adrenergic Agents|adrenergic agents|mesh-ancestor
138259330|NCT05249153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259331|NCT05249153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259332|NCT05249153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138259333|NCT05249153|Narcotics|narcotics|mesh-ancestor
138259334|NCT05249153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138259335|NCT05249153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138259336|NCT05249153|Anesthetics, General|anesthetics, general|mesh-ancestor
138259337|NCT05249153|Anesthetics|anesthetics|mesh-ancestor
138259338|NCT02961257|Prednisone|prednisone|mesh-list
138259339|NCT02961257|Lenograstim|lenograstim|mesh-list
138259340|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138218471|NCT03801668|Paclitaxel|paclitaxel|mesh-list
138259341|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
138259342|NCT02961257|Hormones|hormones|mesh-ancestor
138191943|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259343|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138259344|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259345|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138259346|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259347|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138259348|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
138259349|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
138259350|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138259351|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138259352|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259353|NCT02989519|Progesterone|progesterone|mesh-list
138259354|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
138259355|NCT02989519|Progestins|progestins|mesh-ancestor
138259357|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138259358|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259359|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138259360|NCT02429375|Mocetinostat|mocetinostat|mesh-list
138259361|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138259362|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259363|NCT02429375|Immunotoxins|immunotoxins|mesh-ancestor
138259364|NCT02429375|Immunoconjugates|immunoconjugates|mesh-ancestor
138259365|NCT02429375|Immunologic Factors|immunologic factors|mesh-ancestor
138259366|NCT02429375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259367|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138259368|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259369|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259370|NCT02289456|Paclitaxel|paclitaxel|mesh-list
138259371|NCT02289456|Carboplatin|carboplatin|mesh-list
138259372|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138259373|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259374|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
138259375|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
138259376|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
138238996|NCT05578092|Adagrasib|adagrasib|mesh-list
138239019|NCT05570409|Hormones|hormones|mesh-ancestor
138259377|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259378|NCT02589977|Regadenoson|regadenoson|mesh-list
138259379|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138259380|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138259381|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
138259382|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
138259383|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259384|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259385|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259386|NCT02274948|Metformin|metformin|mesh-list
138259387|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138259388|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259389|NCT02274792|Etanercept|etanercept|mesh-list
138259390|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138259391|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138259392|NCT02274792|Analgesics|analgesics|mesh-ancestor
138259393|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
138259394|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138218504|NCT02199041|Melphalan|melphalan|mesh-list
138239055|NCT05555615|Pimavanserin|pimavanserin|mesh-list
138259395|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259396|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138259397|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138259398|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138259399|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138259400|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
138259401|NCT02592629|Triamcinolone|triamcinolone|mesh-list
138259402|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138259404|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
138259405|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
138259406|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
138259407|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138259408|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191946|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259409|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
138259410|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259411|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138259412|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138259413|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138259414|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138259415|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259416|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138259417|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
138259418|NCT02592629|Hormones|hormones|mesh-ancestor
138259419|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138259420|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138259421|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
138259422|NCT02596451|Diclofenac|diclofenac|mesh-list
138259423|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138259424|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138259425|NCT02596451|Analgesics|analgesics|mesh-ancestor
138259426|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
138259427|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259428|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259429|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138259430|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138259431|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138259432|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138480834|NCT00005949|Aldesleukin|aldesleukin|mesh-list
138259433|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259434|NCT01839799|Paclitaxel|paclitaxel|mesh-list
138259435|NCT01839799|Gemcitabine|gemcitabine|mesh-list
138259436|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138259437|NCT01839799|Folfirinox|folfirinox|mesh-list
138259438|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138259439|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259440|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
138259441|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
138259442|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
138259443|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259444|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138259445|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
138259446|NCT03062059|Gemcitabine|gemcitabine|mesh-list
138259447|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138259448|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
138259449|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259450|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259451|NCT02597543|Regadenoson|regadenoson|mesh-list
138259452|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138259453|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138259454|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
138259455|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
138259456|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259457|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259458|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259460|NCT00553501|Epratuzumab|epratuzumab|mesh-list
138259461|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138259462|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239203|NCT05455697|Antimitotic Agents|antimitotic agents|mesh-ancestor
138259463|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
138259464|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259465|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138259466|NCT02599649|Nivolumab|nivolumab|mesh-list
138259467|NCT02599649|Azacitidine|azacitidine|mesh-list
138259468|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138259469|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259470|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138259471|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259472|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138259473|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
138259474|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259475|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
138259477|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
138259478|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259479|NCT01840345|Expectorants|expectorants|mesh-ancestor
138259480|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
138218541|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
138259482|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
138259483|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259485|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259486|NCT01840345|Antidotes|antidotes|mesh-ancestor
138259487|NCT00364481|Omeprazole|omeprazole|mesh-list
138259488|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138259489|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138259490|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138259491|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259492|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259493|NCT02601833|Fluorides|fluorides|mesh-list
138259494|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
138259495|NCT02601833|Protective Agents|protective agents|mesh-ancestor
138259496|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259497|NCT00553267|Amlodipine|amlodipine|mesh-list
138259498|NCT00553267|Telmisartan|telmisartan|mesh-list
138259499|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138259500|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138259501|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138259502|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138259503|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259504|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138259505|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259506|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
138259507|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138259508|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138259509|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138259510|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138259511|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138259512|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
138259513|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259514|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138259515|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138259516|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259517|NCT02271984|Praziquantel|praziquantel|mesh-list
138259518|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
138259519|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138259520|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259521|NCT02604173|Budesonide|budesonide|mesh-list
138259522|NCT02604173|Acetazolamide|acetazolamide|mesh-list
138259524|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138259525|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
138259526|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259527|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259528|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138259529|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
138259530|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
138259532|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138259533|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
138259534|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138259535|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259536|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259537|NCT02604173|Diuretics|diuretics|mesh-ancestor
138259539|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138259540|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138259541|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138218577|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138259542|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138259543|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239384|NCT05257824|Sensory System Agents|sensory system agents|mesh-ancestor
138259544|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
138259545|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259546|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259547|NCT00365339|Ritonavir|ritonavir|mesh-list
138259548|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138259549|NCT00365339|Tenofovir|tenofovir|mesh-list
138259550|NCT00365339|Aripiprazole|aripiprazole|mesh-list
138259551|NCT00365339|Famotidine|famotidine|mesh-list
138259552|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138259553|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138259554|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
138259555|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259556|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259557|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138259558|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138259559|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
138259560|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259561|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138239416|NCT05248984|Ketorolac|ketorolac|mesh-list
138259562|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138259563|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138259564|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138259565|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
138259566|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138259567|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138259568|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138259569|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138259570|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138480941|NCT00005976|NSC 366140|nsc 366140|mesh-list
138259571|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
138259572|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
138259573|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259574|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138259575|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138259576|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
138259577|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138259578|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138259579|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138259580|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138259581|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138259582|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138259583|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138259584|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
138259585|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
138259586|NCT02815033|Choline|choline|mesh-list
138259587|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
138259588|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138259589|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
138218594|NCT01259063|Gemcitabine|gemcitabine|mesh-list
138239476|NCT05171647|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138239478|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259590|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259591|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138259592|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138259593|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
138259594|NCT00366119|Ramipril|ramipril|mesh-list
138259595|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138259596|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
138259597|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259598|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259599|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138259600|NCT05371301|Paclitaxel|paclitaxel|mesh-list
138259601|NCT05371301|Carboplatin|carboplatin|mesh-list
138259602|NCT05371301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138259603|NCT05371301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259604|NCT05371301|Tubulin Modulators|tubulin modulators|mesh-ancestor
138259605|NCT05371301|Antimitotic Agents|antimitotic agents|mesh-ancestor
138259606|NCT05371301|Mitosis Modulators|mitosis modulators|mesh-ancestor
138259607|NCT05371301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259608|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
138259609|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
138191952|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138191953|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
138191954|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
138191955|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138191956|NCT03885154|Analgesics|analgesics|mesh-ancestor
138191959|NCT01106833|Sirolimus|sirolimus|mesh-list
138259610|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259611|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138239524|NCT05112965|Pemetrexed|pemetrexed|mesh-list
138259613|NCT02605187|Ibuprofen|ibuprofen|mesh-list
138259614|NCT02605187|Morphine|morphine|mesh-list
138259615|NCT02605187|Gabapentin|gabapentin|mesh-list
138259616|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138259617|NCT02605187|Narcotics|narcotics|mesh-ancestor
138259618|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138259619|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259620|NCT02605187|Analgesics|analgesics|mesh-ancestor
138259621|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
138259622|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259623|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138259624|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
138259625|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138259626|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138259627|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138259628|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138259629|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259630|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259631|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
138259632|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138259633|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138259634|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138259635|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138259637|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259638|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
138259639|NCT05592197|Lenvatinib|lenvatinib|mesh-list
138259640|NCT05592197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259641|NCT05592197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138259642|NCT05592197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259643|NCT05592197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259645|NCT02989207|Mitomycin|mitomycin|mesh-list
138259646|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138259647|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259648|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
138259649|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259650|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138259651|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259652|NCT01843621|Vaccines|vaccines|mesh-list
138259653|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
138259654|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259655|NCT02608229|Paclitaxel|paclitaxel|mesh-list
138259656|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138259657|NCT02608229|Gemcitabine|gemcitabine|mesh-list
138259658|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138259659|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259660|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
138259661|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
138259662|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
138259663|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259664|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138259665|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
138259666|NCT00555061|Retapamulin|retapamulin|mesh-list
138259667|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138259668|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259669|NCT01642212|Budesonide|budesonide|mesh-list
138259670|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138259671|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138259672|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
138259673|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259674|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259675|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138259676|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
138259678|NCT01642212|Hormones|hormones|mesh-ancestor
138259679|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138259680|NCT05649618|Cyclophosphamide|cyclophosphamide|mesh-list
138191962|NCT01106833|MTOR Inhibitors|mtor inhibitors|mesh-list
138259681|NCT05649618|Fludarabine|fludarabine|mesh-list
138259682|NCT05649618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138259683|NCT05649618|Immunologic Factors|immunologic factors|mesh-ancestor
138259684|NCT05649618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259685|NCT05649618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138259686|NCT05649618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138259687|NCT05649618|Alkylating Agents|alkylating agents|mesh-ancestor
138259688|NCT05649618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259689|NCT05649618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259690|NCT05649618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138259691|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138259692|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138259693|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138259694|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138259695|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259696|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259697|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259699|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
138259700|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259701|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
138259702|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138259703|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
138259704|NCT01644474|Ezetimibe|ezetimibe|mesh-list
138259705|NCT01644474|Alirocumab|alirocumab|mesh-list
138259706|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138259707|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138259708|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138259709|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
138259710|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138480998|NCT00005988|Leucovorin|leucovorin|mesh-list
138259711|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138259713|NCT01644474|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138259714|NCT01644474|Protease Inhibitors|protease inhibitors|mesh-ancestor
138259715|NCT01644474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259716|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
138259717|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259718|NCT02989129|Quercetin|quercetin|mesh-list
138259719|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
138259720|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259721|NCT02989129|Protective Agents|protective agents|mesh-ancestor
138259722|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259723|NCT01847131|Phenylephrine|phenylephrine|mesh-list
138259724|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
138259725|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138239772|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138239773|NCT04873362|Maytansine|maytansine|mesh-list
138259726|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138259727|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
138259728|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259729|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259730|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259731|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
138259732|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
138259733|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259734|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
138259735|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138259736|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
138259737|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138259738|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
138259739|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138259741|NCT02285010|Pregabalin|pregabalin|mesh-list
138259742|NCT02285010|Analgesics|analgesics|mesh-ancestor
138259743|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
138259744|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259745|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259746|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
138259747|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138259748|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138191970|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259749|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259750|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138259751|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138259752|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138259753|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138259754|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138259755|NCT02617667|Cyclosporine|cyclosporine|mesh-list
138259756|NCT02617667|Cyclosporins|cyclosporins|mesh-list
138259757|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259758|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259759|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138259760|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
138259761|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259762|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
138259763|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259764|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
138259765|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138259766|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138259767|NCT01848067|Prednisone|prednisone|mesh-list
138259768|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
138259769|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138259770|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
138259771|NCT01848067|Hormones|hormones|mesh-ancestor
138239880|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259772|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138259773|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259774|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138259775|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259776|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138259777|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259778|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259779|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
138259780|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138191976|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
138191977|NCT01106833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138191978|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138191979|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191980|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138191981|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
138191982|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138191983|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138191984|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138191985|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259781|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
138259782|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138259783|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138259784|NCT05068349|Protective Agents|protective agents|mesh-ancestor
138259785|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259787|NCT05452577|Anticonvulsants|anticonvulsants|mesh-ancestor
138259788|NCT05452577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138259789|NCT05452577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138259790|NCT05452577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138259791|NCT05452577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259793|NCT05452577|GABA Modulators|gaba modulators|mesh-ancestor
138259794|NCT05452577|GABA Agents|gaba agents|mesh-ancestor
138259795|NCT05452577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259796|NCT05452577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259798|NCT00364871|Bupropion|bupropion|mesh-list
138259799|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138259800|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138259801|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259802|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
138259803|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259804|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138259805|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
138259806|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138259807|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138191987|NCT00957359|Psilocybin|psilocybin|mesh-list
138191988|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138191989|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138191990|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
138191991|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138191992|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138191993|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
138191994|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
138191995|NCT00957359|Vitamins|vitamins|mesh-ancestor
138191996|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
138191997|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138191998|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
138191999|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138192000|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138192001|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
138192002|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192003|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138192004|NCT00957593|Oxytocin|oxytocin|mesh-list
138192005|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
138192006|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138192007|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192008|NCT00957671|Hormones|hormones|mesh-list
138192009|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138192010|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259808|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138259809|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138259810|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259811|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
138259812|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259813|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138259814|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138259815|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259816|NCT00551161|Memantine|memantine|mesh-list
138259817|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138259818|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138259819|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
138259820|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259821|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259822|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259823|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138240003|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
138259824|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138259826|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138259827|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
138259828|NCT00550771|Doxorubicin|doxorubicin|mesh-list
138259829|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138259830|NCT00550771|Trastuzumab|trastuzumab|mesh-list
138259831|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138259832|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259833|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
138259834|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
138259836|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259837|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138259838|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
138259839|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259840|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138259841|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138259842|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
138259843|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138259845|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138259846|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138259847|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259848|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138259850|NCT01852669|Diuretics|diuretics|mesh-ancestor
138259851|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
138259852|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259853|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138259854|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138259855|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259856|NCT04741295|Heparin|heparin|mesh-list
138259857|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138259858|NCT04741295|Tinzaparin|tinzaparin|mesh-list
138259859|NCT04741295|Dalteparin|dalteparin|mesh-list
138259860|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
138259861|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138259862|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138259863|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259864|NCT00550537|Paclitaxel|paclitaxel|mesh-list
138259865|NCT00550537|Bevacizumab|bevacizumab|mesh-list
138259866|NCT00550537|Carboplatin|carboplatin|mesh-list
138259867|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138259868|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138259869|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259871|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
138259872|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
138259873|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259874|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138259875|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138259876|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138259877|NCT00550537|Growth Substances|growth substances|mesh-ancestor
138259878|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259879|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
138218740|NCT06214572|Antimetabolites|antimetabolites|mesh-ancestor
138192014|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
138259880|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138259881|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259882|NCT04801043|Imipenem|imipenem|mesh-list
138259883|NCT04801043|Cilastatin|cilastatin|mesh-list
138259884|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138259885|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259886|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
138259887|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259888|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259889|NCT04734197|Cyclosporine|cyclosporine|mesh-list
138259890|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
138259891|NCT04734197|Betamethasone|betamethasone|mesh-list
138259892|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
138259893|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138259894|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
138259895|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138259896|NCT04734197|Lifitegrast|lifitegrast|mesh-list
138259899|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138259900|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259901|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259902|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138259903|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
138259904|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259905|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
138259906|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259907|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
138259908|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138259909|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138259910|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138259911|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
138259912|NCT04734197|Hormones|hormones|mesh-ancestor
138259913|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138259914|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138259915|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
138259916|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138240193|NCT04374877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259917|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259918|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138259919|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
138259920|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138259921|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138259922|NCT00550147|Methylphenidate|methylphenidate|mesh-list
138259923|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138259924|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259925|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138348608|NCT02548728|Oxytocin|oxytocin|mesh-list
138259927|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138259928|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192017|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138192018|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138192019|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
138192020|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
138192021|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192022|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138192023|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138192024|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192027|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138259929|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
138259930|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259931|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
138259932|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138259933|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138259934|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138259935|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138259936|NCT05688215|Calcium, Dietary|calcium, dietary|mesh-list
138259938|NCT05688215|Folic Acid|folic acid|mesh-list
138259939|NCT05688215|Fluorouracil|fluorouracil|mesh-list
138259940|NCT05688215|Oxaliplatin|oxaliplatin|mesh-list
138259941|NCT05688215|Irinotecan|irinotecan|mesh-list
138259942|NCT05688215|Quemliclustat|quemliclustat|mesh-list
138259943|NCT05688215|Calcium|calcium|mesh-list
138259944|NCT05688215|Levoleucovorin|levoleucovorin|mesh-list
138259945|NCT05688215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138259946|NCT05688215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259947|NCT05688215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138259948|NCT05688215|Antimetabolites|antimetabolites|mesh-ancestor
138259949|NCT05688215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259950|NCT05688215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138259951|NCT05688215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138259952|NCT05688215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138259953|NCT05688215|Immunologic Factors|immunologic factors|mesh-ancestor
138259954|NCT05688215|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138240311|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138259955|NCT05688215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138259956|NCT05688215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259957|NCT05688215|Antidotes|antidotes|mesh-ancestor
138259958|NCT05688215|Protective Agents|protective agents|mesh-ancestor
138259959|NCT05688215|Vitamin B Complex|vitamin b complex|mesh-ancestor
138259961|NCT05688215|Micronutrients|micronutrients|mesh-ancestor
138259962|NCT05688215|Hematinics|hematinics|mesh-ancestor
138259963|NCT05688215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138259964|NCT05688215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138259965|NCT00557401|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
138259966|NCT00557401|Baclofen|baclofen|mesh-list
138259967|NCT00557401|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138259968|NCT00557401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259969|NCT00557401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138259970|NCT00557401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259971|NCT00557401|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138259972|NCT00557401|GABA Agonists|gaba agonists|mesh-ancestor
138259973|NCT00557401|GABA Agents|gaba agents|mesh-ancestor
138259974|NCT00557401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218804|NCT06214078|Vitamins|vitamins|mesh-ancestor
138259975|NCT00557401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259977|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138259978|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138259979|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138259980|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
138259981|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138259982|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192033|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138259983|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
138192034|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192035|NCT00958919|Naloxone|naloxone|mesh-list
138192036|NCT00958919|Endorphins|endorphins|mesh-list
138259985|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
138259986|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259987|NCT02624843|Ethanol|ethanol|mesh-list
138259988|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
138259989|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138259990|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138259991|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138259992|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138259993|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
138259994|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
138259995|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
138240365|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138259996|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138259998|NCT02279641|Verinurad|verinurad|mesh-list
138259999|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
138260000|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260001|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260002|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
138260003|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260004|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138260005|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
138260006|NCT02279641|Protective Agents|protective agents|mesh-ancestor
138260007|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260008|NCT02629991|Oxytocin|oxytocin|mesh-list
138260009|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
138260010|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138260011|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260012|NCT00553657|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138260013|NCT00553657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138192053|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192054|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192055|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138192056|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
138192057|NCT04323592|Hormones|hormones|mesh-ancestor
138192058|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138192059|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138192060|NCT04323592|Protective Agents|protective agents|mesh-ancestor
138192061|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138192062|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192063|NCT01047241|Sufentanil|sufentanil|mesh-list
138192064|NCT01047241|Ketamine|ketamine|mesh-list
138192065|NCT01047241|Analgesics|analgesics|mesh-ancestor
138192066|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
138192067|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192068|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192069|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138192070|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138260014|NCT00553657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138260015|NCT00553657|Cholinergic Agents|cholinergic agents|mesh-ancestor
138260016|NCT00553657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138218829|NCT06213948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138260017|NCT00553657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260018|NCT00553657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260019|NCT00553657|Urological Agents|urological agents|mesh-ancestor
138260021|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138481226|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
138260022|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138260023|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260024|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260025|NCT04485065|Azacitidine|azacitidine|mesh-list
138260026|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138260027|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
138260028|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260029|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260030|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260031|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
138260032|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138260033|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260034|NCT03769129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138240456|NCT03980184|Guanfacine|guanfacine|mesh-list
138260035|NCT03769129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260036|NCT00367445|Insulin|insulin|mesh-list
138260037|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138260038|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
138260039|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138260040|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260041|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
138260042|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138260043|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138260044|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260045|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
138260046|NCT01866943|Coagulants|coagulants|mesh-ancestor
138260047|NCT01868425|Acetaminophen|acetaminophen|mesh-list
138260048|NCT01868425|Ketamine|ketamine|mesh-list
138260049|NCT01868425|Gabapentin|gabapentin|mesh-list
138260050|NCT01868425|Bupivacaine|bupivacaine|mesh-list
138260051|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
138260052|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
138260053|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138240519|NCT03904693|Tadalafil|tadalafil|mesh-list
138260054|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260055|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
138260056|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260058|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138260059|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138260060|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
138260061|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138260062|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138260063|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260064|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260065|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138260066|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
138260067|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
138260068|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138260069|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138260070|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138192071|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
138192072|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
138192073|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192074|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138192075|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138192076|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192077|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260071|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
138260073|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138260074|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260075|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
138260076|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240573|NCT03834883|Ibutilide|ibutilide|mesh-list
138260077|NCT01871077|Ketorolac|ketorolac|mesh-list
138260078|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138260079|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138260080|NCT01871077|Analgesics|analgesics|mesh-ancestor
138260081|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
138260082|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260083|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260084|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138260085|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260086|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138260087|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260088|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260089|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
138260091|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
138240617|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138240621|NCT03747939|Growth Substances|growth substances|mesh-ancestor
138260093|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260094|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260095|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138260096|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138260097|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260098|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260099|NCT02823145|Fenfluramine|fenfluramine|mesh-list
138260100|NCT02823145|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138260101|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138260102|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138260103|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260104|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260105|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
138192080|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138192081|NCT01012661|Lidocaine|lidocaine|mesh-list
138192082|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
138192083|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
138192084|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192085|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192086|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
138192087|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192088|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138192089|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138192090|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138260106|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260107|NCT02280811|Aldesleukin|aldesleukin|mesh-list
138260108|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
138260109|NCT02280811|Fludarabine|fludarabine|mesh-list
138240745|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
138260110|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138260111|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
138260112|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260113|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138481284|NCT05679453|Analgesics|analgesics|mesh-ancestor
138260114|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138260115|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
138260116|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260117|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260118|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138260119|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138260120|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138260121|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
138260122|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260123|NCT01930747|Remifentanil|remifentanil|mesh-list
138260124|NCT01930747|Sevoflurane|sevoflurane|mesh-list
138260125|NCT01930747|Rocuronium|rocuronium|mesh-list
138260126|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138260127|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138260128|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
138260129|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
138260130|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138260131|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260132|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138260133|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138260134|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138260135|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260136|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138260137|NCT01930747|Narcotics|narcotics|mesh-ancestor
138260138|NCT01930747|Analgesics|analgesics|mesh-ancestor
138260139|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
138260140|NCT01931527|Rasburicase|rasburicase|mesh-list
138260141|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
138260142|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260143|NCT02639429|Misoprostol|misoprostol|mesh-list
138260144|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138260145|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
138260146|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138260147|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260148|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138260149|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138260150|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
138260151|NCT01936363|Niacinamide|niacinamide|mesh-list
138260152|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
138260153|NCT01936363|Vitamins|vitamins|mesh-ancestor
138260154|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
138192091|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138192092|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192093|NCT03655444|Nivolumab|nivolumab|mesh-list
138192094|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138192095|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192096|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138192097|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192098|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138260155|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260156|NCT04893629|Digoxin|digoxin|mesh-list
138260157|NCT04893629|Captopril|captopril|mesh-list
138260158|NCT04893629|Furosemide|furosemide|mesh-list
138260159|NCT04893629|Diuretics|diuretics|mesh-ancestor
138260160|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
138260161|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260162|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138260163|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138260164|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260165|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138218910|NCT06213116|Lidocaine|lidocaine|mesh-list
138260167|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260168|NCT04893629|Protective Agents|protective agents|mesh-ancestor
138260169|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138260170|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
138260171|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138260172|NCT01936519|Cyclosporine|cyclosporine|mesh-list
138260173|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
138260174|NCT01936519|Everolimus|everolimus|mesh-list
138260175|NCT01936519|Tacrolimus|tacrolimus|mesh-list
138260176|NCT01936519|Cyclosporins|cyclosporins|mesh-list
138240849|NCT03337698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138260177|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138260178|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138260179|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
138260180|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260181|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260182|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260183|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
138260184|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260185|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
138260186|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260187|NCT01936519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138260188|NCT01936519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138260189|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260190|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138260191|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138260192|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
138260193|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138260194|NCT04507841|Niraparib|niraparib|mesh-list
138260195|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138260196|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260197|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192099|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192100|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192101|NCT03018821|Tenofovir|tenofovir|mesh-list
138192102|NCT03018821|Entecavir|entecavir|mesh-list
138192103|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
138192104|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192105|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138192106|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138192107|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192108|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260198|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260199|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138260200|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260203|NCT01938079|Analgesics|analgesics|mesh-ancestor
138260204|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
138260205|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260206|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260207|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138260208|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138260209|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
138260211|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138260212|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138260213|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138260214|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260215|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260217|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
138260218|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
138260220|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
138260221|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
138260222|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
138260223|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260224|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138260225|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260226|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138260227|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
138260228|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260229|NCT02641691|Antidotes|antidotes|mesh-ancestor
138260230|NCT02641691|Protective Agents|protective agents|mesh-ancestor
138260231|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
138260232|NCT02641691|Vitamins|vitamins|mesh-ancestor
138260233|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
138260234|NCT05588999|Salicylic Acid|salicylic acid|mesh-list
138260235|NCT05588999|Salicylates|salicylates|mesh-list
138260236|NCT05588999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260237|NCT05588999|Antifungal Agents|antifungal agents|mesh-ancestor
138260238|NCT05588999|Keratolytic Agents|keratolytic agents|mesh-ancestor
138260239|NCT05588999|Dermatologic Agents|dermatologic agents|mesh-ancestor
138260240|NCT05588999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138260241|NCT05588999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138260242|NCT05588999|Analgesics|analgesics|mesh-ancestor
138260243|NCT05588999|Sensory System Agents|sensory system agents|mesh-ancestor
138260244|NCT05588999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260245|NCT05588999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260246|NCT05588999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138260247|NCT05588999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260248|NCT05588999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138260249|NCT05588999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260250|NCT05588999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260251|NCT01643928|Rituximab|rituximab|mesh-list
138481374|NCT04921722|MTOR Inhibitors|mtor inhibitors|mesh-list
138260252|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138260254|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
138260255|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260256|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260258|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138260259|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260260|NCT05588531|Cefepime|cefepime|mesh-list
138260261|NCT05588531|Avibactam|avibactam|mesh-list
138260262|NCT05588531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138260263|NCT05588531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260264|NCT05588531|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138192109|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138192110|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138192111|NCT03866434|Anagrelide|anagrelide|mesh-list
138192112|NCT03866434|Omeprazole|omeprazole|mesh-list
138260265|NCT05588531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260266|NCT05588531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260267|NCT05588297|Bevacizumab|bevacizumab|mesh-list
138260269|NCT05588297|Capecitabine|capecitabine|mesh-list
138260270|NCT05588297|Oxaliplatin|oxaliplatin|mesh-list
138260271|NCT05588297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138260272|NCT05588297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260273|NCT05588297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138260274|NCT05588297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138260275|NCT05588297|Growth Substances|growth substances|mesh-ancestor
138260276|NCT05588297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260277|NCT05588297|Growth Inhibitors|growth inhibitors|mesh-ancestor
138260278|NCT05588297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138260279|NCT05588297|Antimetabolites|antimetabolites|mesh-ancestor
138260280|NCT05588297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260281|NCT05588297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138260283|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
138260284|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138241049|NCT02932410|Macitentan|macitentan|mesh-list
138260285|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260286|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
138260287|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138260288|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138260289|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260290|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260291|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260292|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260293|NCT02164955|Pomalidomide|pomalidomide|mesh-list
138260294|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
138260295|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260296|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138260297|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138260308|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138260309|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260310|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
138260311|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
138260312|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
138260313|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260314|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
138260315|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260316|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138260329|NCT00367211|Naproxen|naproxen|mesh-list
138260330|NCT00367211|Omeprazole|omeprazole|mesh-list
138260331|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138260332|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138260333|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138260334|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260335|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260336|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138192120|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138192121|NCT00962039|Citalopram|citalopram|mesh-list
138192122|NCT00962039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138192123|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138192124|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138192125|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192126|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138192127|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
138192128|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192130|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
138260337|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138260338|NCT00367211|Analgesics|analgesics|mesh-ancestor
138260339|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
138260340|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260341|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260342|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138260343|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260344|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
138260345|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138260346|NCT02646449|Mirtazapine|mirtazapine|mesh-list
138260347|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
138260348|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138219027|NCT06212648|Vasodilator Agents|vasodilator agents|mesh-ancestor
138260350|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
138260352|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260353|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260354|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260355|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138260356|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138260357|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138260358|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138260359|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138260360|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138241149|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
138260361|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
138260362|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138260363|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138260364|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
138260365|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138260366|NCT04339361|Lidocaine|lidocaine|mesh-list
138260367|NCT04339361|Dinoprostone|dinoprostone|mesh-list
138260368|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
138260369|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
138260370|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138260371|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260372|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
138260373|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260374|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138481485|NCT03002259|Hormones|hormones|mesh-ancestor
138260375|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138260376|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138260377|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138260378|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260379|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
138260380|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138260381|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138260382|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138260383|NCT02654483|Serlopitant|serlopitant|mesh-list
138260384|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138260385|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260386|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260387|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241224|NCT02257736|Prednisone|prednisone|mesh-list
138260388|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
138192134|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138192135|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192136|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192137|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138192138|NCT03375385|Analgesics|analgesics|mesh-ancestor
138192139|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
138192140|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192141|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138260389|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
138260390|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138260391|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138260392|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260393|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
138260394|NCT02655653|Coagulants|coagulants|mesh-ancestor
138260395|NCT03081143|Paclitaxel|paclitaxel|mesh-list
138260396|NCT03081143|Ramucirumab|ramucirumab|mesh-list
138260397|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138260398|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260399|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
138260400|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
138260403|NCT02658461|Trastuzumab|trastuzumab|mesh-list
138260404|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138260405|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260406|NCT00367913|Clarithromycin|clarithromycin|mesh-list
138260407|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
138260408|NCT00367913|Rifampin|rifampin|mesh-list
138260409|NCT00367913|Ethambutol|ethambutol|mesh-list
138260410|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138260411|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260412|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138260413|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260414|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260415|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138260416|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138260417|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138260418|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138260419|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260420|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138260421|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138260422|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
138260423|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
138260424|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138260425|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138260426|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138260427|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138260428|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138260429|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138260430|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138260431|NCT02659787|Buprenorphine|buprenorphine|mesh-list
138260432|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138260433|NCT02659787|Narcotics|narcotics|mesh-ancestor
138260434|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138260435|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260436|NCT02659787|Analgesics|analgesics|mesh-ancestor
138260437|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
138260438|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241350|NCT02037048|Antidotes|antidotes|mesh-ancestor
138260439|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138260441|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138260442|NCT05044871|Bevacizumab|bevacizumab|mesh-list
138260443|NCT05044871|Tislelizumab|tislelizumab|mesh-list
138260444|NCT05044871|Pamiparib|pamiparib|mesh-list
138260445|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138260446|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260447|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
138192142|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138192143|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138192149|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
138219070|NCT06212583|Hormones|hormones|mesh-ancestor
138260448|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
138260449|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
138260450|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260451|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138260452|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138260453|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138260454|NCT05044871|Growth Substances|growth substances|mesh-ancestor
138260455|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260456|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
138260457|NCT05044871|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138260458|NCT05044871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260459|NCT04931693|Acetaminophen|acetaminophen|mesh-list
138260460|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138260461|NCT04931693|Analgesics|analgesics|mesh-ancestor
138260462|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
138260463|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260464|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260465|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
138260466|NCT02271594|Insulin|insulin|mesh-list
138260467|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138260468|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260469|NCT05649228|Capsaicin|capsaicin|mesh-list
138260470|NCT05649228|Antipruritics|antipruritics|mesh-ancestor
138260471|NCT05649228|Dermatologic Agents|dermatologic agents|mesh-ancestor
138260472|NCT05649228|Sensory System Agents|sensory system agents|mesh-ancestor
138260473|NCT05649228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260474|NCT05649228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260475|NCT02350517|Paclitaxel|paclitaxel|mesh-list
138260476|NCT02350517|Endostar protein|endostar protein|mesh-list
138260477|NCT02350517|Endostatins|endostatins|mesh-list
138260478|NCT02350517|Nedaplatin|nedaplatin|mesh-list
138260479|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138260480|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260481|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
138260482|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
138260483|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
138260484|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241395|NCT01776840|Rituximab|rituximab|mesh-list
138260485|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138260486|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138260487|NCT02350517|Growth Substances|growth substances|mesh-ancestor
138260488|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260489|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
138260491|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138260492|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138260493|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138260494|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138192159|NCT03012763|Fexofenadine|fexofenadine|mesh-list
138192160|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
138192161|NCT03012763|Valsartan|valsartan|mesh-list
138192162|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138192163|NCT03012763|Analgesics|analgesics|mesh-ancestor
138192164|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
138192165|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192166|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192167|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
138192168|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138192169|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138192170|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138260495|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138260496|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219100|NCT06209606|Antiemetics|antiemetics|mesh-ancestor
138260497|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
138260498|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260499|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260500|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138260501|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260503|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
138260504|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260505|NCT04878198|Protective Agents|protective agents|mesh-ancestor
138260506|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260507|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138260508|NCT04651595|Morphine|morphine|mesh-list
138260509|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138260510|NCT04651595|Narcotics|narcotics|mesh-ancestor
138260511|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138260512|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260513|NCT04651595|Analgesics|analgesics|mesh-ancestor
138260514|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
138260515|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260516|NCT02669615|Melphalan|melphalan|mesh-list
138241488|NCT01175356|Topotecan|topotecan|mesh-list
138260518|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
138260519|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260520|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260521|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138260522|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138260523|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
138260524|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260525|NCT02672111|Buprenorphine|buprenorphine|mesh-list
138260526|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138260527|NCT02672111|Narcotics|narcotics|mesh-ancestor
138260528|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138260529|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260530|NCT02672111|Analgesics|analgesics|mesh-ancestor
138260531|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
138260532|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260533|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138260534|NCT00586391|Ipilimumab|ipilimumab|mesh-list
138260535|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138260536|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260537|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138260538|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260540|NCT05432843|Analgesics|analgesics|mesh-ancestor
138260541|NCT05432843|Sensory System Agents|sensory system agents|mesh-ancestor
138481622|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
138260543|NCT05432843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260544|NCT05432843|Anticonvulsants|anticonvulsants|mesh-ancestor
138260545|NCT05432843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138260546|NCT05432843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138260547|NCT05432843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192172|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138260548|NCT05432843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138260549|NCT05432843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138260550|NCT05432843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138260551|NCT05432843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138241536|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138260552|NCT05432843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138260554|NCT02679911|Amorolfine|amorolfine|mesh-list
138260555|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
138260556|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260557|NCT02680301|Triamcinolone|triamcinolone|mesh-list
138260558|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138260559|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138260560|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138260561|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138260562|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
138260563|NCT02680301|Hormones|hormones|mesh-ancestor
138260564|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138260565|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260566|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138260567|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
138260568|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260569|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260570|NCT02680457|Insulin|insulin|mesh-list
138260571|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138260572|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
138241660|NCT00373581|Cocaine|cocaine|mesh-list
138260573|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138260574|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260576|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
138260577|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260578|NCT02692391|Indomethacin|indomethacin|mesh-list
138260579|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138260580|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138260581|NCT02692391|Analgesics|analgesics|mesh-ancestor
138260582|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
138260583|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260584|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260586|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260587|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
138192191|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138192192|NCT01048879|Oseltamivir|oseltamivir|mesh-list
138192193|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
138192194|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138192195|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
138192196|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192198|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192199|NCT04290676|Dexamethasone|dexamethasone|mesh-list
138192200|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
138192201|NCT04290676|BB 1101|bb 1101|mesh-list
138192202|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192203|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
138192204|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
138192205|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260589|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138260590|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138260591|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260592|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260593|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138260594|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
138260596|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138260597|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260598|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138260599|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260600|NCT02697071|Ketamine|ketamine|mesh-list
138260601|NCT02697071|Analgesics|analgesics|mesh-ancestor
138260602|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
138260603|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260604|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260605|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138260606|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138260607|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
138260609|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138260610|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138260611|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138260612|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260613|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260614|NCT02283294|Warfarin|warfarin|mesh-list
138260615|NCT02283294|Apixaban|apixaban|mesh-list
138260616|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
138260617|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138260618|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
138260619|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138260620|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
138260621|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260622|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260623|NCT05648994|Paclitaxel|paclitaxel|mesh-list
138260624|NCT05648994|Cyclophosphamide|cyclophosphamide|mesh-list
138260625|NCT05648994|Fludarabine|fludarabine|mesh-list
138260626|NCT05648994|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138260627|NCT05648994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138260628|NCT05648994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192206|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192207|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138192208|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
138192209|NCT04290676|Hormones|hormones|mesh-ancestor
138260629|NCT05648994|Tubulin Modulators|tubulin modulators|mesh-ancestor
138192210|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138192211|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138192212|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192213|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
138192214|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192215|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260630|NCT05648994|Antimitotic Agents|antimitotic agents|mesh-ancestor
138260631|NCT05648994|Mitosis Modulators|mitosis modulators|mesh-ancestor
138260632|NCT05648994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219179|NCT06174688|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138219186|NCT06164951|Infigratinib|infigratinib|mesh-list
138260635|NCT05648994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260636|NCT05648994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260637|NCT05648994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138481677|NCT00006081|Paclitaxel|paclitaxel|mesh-list
138241836|NCT01578278|Xhance|xhance|mesh-list
138260638|NCT05648994|Alkylating Agents|alkylating agents|mesh-ancestor
138260639|NCT05648994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138260640|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
138260641|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138260642|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
138260643|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260644|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
138260645|NCT04869306|Protective Agents|protective agents|mesh-ancestor
138260647|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
138260648|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260649|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
138260650|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260651|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260652|NCT02703779|Plerixafor|plerixafor|mesh-list
138260654|NCT02703779|Lenograstim|lenograstim|mesh-list
138260655|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138260656|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
138260657|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260658|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260659|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138260660|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138260661|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
138260662|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260663|NCT04738955|Micafungin|micafungin|mesh-list
138260664|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
138260665|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138241871|NCT02806869|Analgesics|analgesics|mesh-ancestor
138260667|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
138260668|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138481693|NCT00006096|Cisplatin|cisplatin|mesh-list
138260669|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
138260670|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260671|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260672|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138260673|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
138260674|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138260675|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138260676|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138260677|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
138260678|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260679|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260680|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138260681|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138260682|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138260683|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
138260684|NCT05648526|Ketamine|ketamine|mesh-list
138260685|NCT05648526|Analgesics|analgesics|mesh-ancestor
138260686|NCT05648526|Sensory System Agents|sensory system agents|mesh-ancestor
138260687|NCT05648526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260688|NCT05648526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260689|NCT05648526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138481738|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260691|NCT05648526|Anesthetics, General|anesthetics, general|mesh-ancestor
138260692|NCT05648526|Anesthetics|anesthetics|mesh-ancestor
138260693|NCT05648526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138260694|NCT05648526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138260695|NCT05648526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138192216|NCT03112993|Neostigmine|neostigmine|mesh-list
138192217|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138260696|NCT05648526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260697|NCT05648526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260698|NCT02705807|Epoprostenol|epoprostenol|mesh-list
138260700|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138260701|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138260702|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
138260703|NCT01643772|Oxycodone|oxycodone|mesh-list
138260704|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138260705|NCT01643772|Narcotics|narcotics|mesh-ancestor
138260706|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138260707|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260708|NCT01643772|Analgesics|analgesics|mesh-ancestor
138260709|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
138260710|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260711|NCT02707523|Azithromycin|azithromycin|mesh-list
138260712|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138260713|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260714|NCT02712047|Fluticasone|fluticasone|mesh-list
138260716|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138260717|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138260718|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
138260719|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260720|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260721|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138260722|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
138260723|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
138260724|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138260725|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138260726|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138260728|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
138260730|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138260731|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
138260732|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260733|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219233|NCT06089577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138219234|NCT06089577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138219235|NCT06089577|Purinergic Agents|purinergic agents|mesh-ancestor
138219236|NCT06089577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138219237|NCT06089577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219238|NCT06089577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219239|NCT06089395|Ubiquinone|ubiquinone|mesh-list
138219240|NCT06089395|Coenzyme Q10|coenzyme q10|mesh-list
138219241|NCT06089395|Micronutrients|micronutrients|mesh-ancestor
138219242|NCT06089395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219243|NCT06089395|Vitamins|vitamins|mesh-ancestor
138260734|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260735|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138260736|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138260737|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138260738|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138260739|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138260740|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
138260741|NCT05215925|Carboplatin|carboplatin|mesh-list
138242074|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
138260742|NCT05215925|Docetaxel|docetaxel|mesh-list
138260743|NCT05215925|Pemetrexed|pemetrexed|mesh-list
138260744|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260745|NCT05215925|Tubulin Modulators|tubulin modulators|mesh-ancestor
138260746|NCT05215925|Antimitotic Agents|antimitotic agents|mesh-ancestor
138260747|NCT05215925|Mitosis Modulators|mitosis modulators|mesh-ancestor
138260748|NCT05215925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260749|NCT05215925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260750|NCT05215925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138260751|NCT05215925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138260752|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138260753|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138192224|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
138192226|NCT03670030|Sirolimus|sirolimus|mesh-list
138260754|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138260755|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138260756|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260757|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
138260758|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260759|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260760|NCT02721017|Fentanyl|fentanyl|mesh-list
138260761|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138260762|NCT02721017|Narcotics|narcotics|mesh-ancestor
138260763|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138242130|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
138260764|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260765|NCT02721017|Analgesics|analgesics|mesh-ancestor
138260766|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
138260767|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260768|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138260769|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138260770|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
138260771|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
138260772|NCT02721641|Trastuzumab|trastuzumab|mesh-list
138260773|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138260774|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138219258|NCT06077721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138219259|NCT06077721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219260|NCT06077721|Protective Agents|protective agents|mesh-ancestor
138219261|NCT06077721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219262|NCT06074588|Docetaxel|docetaxel|mesh-list
138219263|NCT06074588|Pemetrexed|pemetrexed|mesh-list
138260777|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138260778|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138260779|NCT03649061|Analgesics|analgesics|mesh-ancestor
138260780|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
138260781|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192234|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192235|NCT03859960|Insulin|insulin|mesh-list
138192236|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138192237|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138192238|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192239|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138192240|NCT03857230|Hormones|hormones|mesh-ancestor
138192241|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138260782|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260783|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138260784|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260785|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138260786|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138260787|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
138260788|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260789|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260791|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
138260792|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260793|NCT05109143|Indomethacin|indomethacin|mesh-list
138260795|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138260796|NCT05109143|Analgesics|analgesics|mesh-ancestor
138260797|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
138260798|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260799|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260800|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138260801|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260802|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
138260803|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
138260804|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138260805|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138260806|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260807|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260809|NCT03614663|Anticonvulsants|anticonvulsants|mesh-ancestor
138260810|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
138260811|NCT00085735|Lomustine|lomustine|mesh-list
138260812|NCT00085735|Cisplatin|cisplatin|mesh-list
138260813|NCT00085735|Vincristine|vincristine|mesh-list
138260814|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138242247|NCT02988089|Ofloxacin|ofloxacin|mesh-list
138260815|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
138260816|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260817|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260818|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138260819|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
138260820|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260821|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260822|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138260823|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138260824|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
138219312|NCT05916690|Bleomycin|bleomycin|mesh-list
138260826|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
138260827|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138260828|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
138260829|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
138260830|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138260831|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260832|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
138192242|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192243|NCT02181127|Glucagon|glucagon|mesh-list
138192244|NCT02181127|Pancrelipase|pancrelipase|mesh-list
138192245|NCT02181127|Pancreatin|pancreatin|mesh-list
138192246|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138192248|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138192249|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192250|NCT04332094|Azithromycin|azithromycin|mesh-list
138192251|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
138192252|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138192253|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192254|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
138260833|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138260834|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138260836|NCT05544786|Nirmatrelvir|nirmatrelvir|mesh-list
138260837|NCT05544786|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
138260838|NCT05544786|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138242286|NCT01589978|Analgesics|analgesics|mesh-ancestor
138260840|NCT05544786|Protease Inhibitors|protease inhibitors|mesh-ancestor
138260841|NCT05544786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260842|NCT05544786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260843|NCT05544786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138260844|NCT05544786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138260845|NCT05544786|Antiviral Agents|antiviral agents|mesh-ancestor
138260846|NCT05544786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260847|NCT05544786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138260848|NCT05544786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138260849|NCT02726789|Interferons|interferons|mesh-list
138260850|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
138260851|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
138260852|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138260853|NCT02726789|Entecavir|entecavir|mesh-list
138260854|NCT02726789|REP 2139|rep 2139|mesh-list
138260855|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260856|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
138260857|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260858|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
138260859|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260860|NCT02731313|Trastuzumab|trastuzumab|mesh-list
138260861|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138260862|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260863|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138260864|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
138260865|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138260866|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138260867|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138260868|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260869|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
138260870|NCT02731469|Hematinics|hematinics|mesh-ancestor
138260871|NCT01944319|Meropenem|meropenem|mesh-list
138260872|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138260873|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260874|NCT00368303|Paroxetine|paroxetine|mesh-list
138260875|NCT00368303|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138260876|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138260877|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138260878|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260879|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260881|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260882|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138260883|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
138260884|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138260885|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138260886|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138260887|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260889|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138260890|NCT05020145|Vaccines|vaccines|mesh-list
138260891|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
138260892|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260893|NCT02734355|Amlodipine|amlodipine|mesh-list
138260894|NCT02734355|Telmisartan|telmisartan|mesh-list
138260895|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138260896|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138260897|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138260898|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138260899|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260900|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138260901|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260903|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138192259|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260904|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138260905|NCT00369395|Volociximab|volociximab|mesh-list
138260906|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138260907|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138260908|NCT00369395|Growth Substances|growth substances|mesh-ancestor
138260909|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260910|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
138260911|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260912|NCT01947907|Hormones|hormones|mesh-list
138260913|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138260915|NCT01948141|Nintedanib|nintedanib|mesh-list
138260916|NCT01948141|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138260917|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260918|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138219391|NCT05834738|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138260919|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260920|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260921|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
138260922|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138260923|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
138260924|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260926|NCT05446493|Vasodilator Agents|vasodilator agents|mesh-ancestor
138260927|NCT05446493|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138260928|NCT05446493|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138242414|NCT03006614|Docetaxel|docetaxel|mesh-list
138242415|NCT03006614|Capecitabine|capecitabine|mesh-list
138260929|NCT05446493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260930|NCT05446493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260931|NCT05446493|Urological Agents|urological agents|mesh-ancestor
138260932|NCT05445479|Doxycycline|doxycycline|mesh-list
138260933|NCT05445479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138260934|NCT05445479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260935|NCT05445479|Antimalarials|antimalarials|mesh-ancestor
138260936|NCT05445479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138260937|NCT05445479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138260938|NCT02711735|Vaccines|vaccines|mesh-list
138260939|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
138260940|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260941|NCT05445011|Cyclophosphamide|cyclophosphamide|mesh-list
138260942|NCT05445011|Fludarabine|fludarabine|mesh-list
138260943|NCT05445011|Fludarabine phosphate|fludarabine phosphate|mesh-list
138260944|NCT05445011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138260945|NCT05445011|Immunologic Factors|immunologic factors|mesh-ancestor
138260946|NCT05445011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260947|NCT05445011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138260948|NCT05445011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138260949|NCT05445011|Alkylating Agents|alkylating agents|mesh-ancestor
138260950|NCT05445011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260951|NCT05445011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260952|NCT05445011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138260953|NCT05445011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138260954|NCT05445011|Antimetabolites|antimetabolites|mesh-ancestor
138260955|NCT04744181|Folic Acid|folic acid|mesh-list
138260956|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
138260957|NCT04744181|Vitamins|vitamins|mesh-ancestor
138260958|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
138260959|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260960|NCT04744181|Hematinics|hematinics|mesh-ancestor
138260961|NCT01970345|Mecasermin|mecasermin|mesh-list
138260962|NCT01970345|Growth Substances|growth substances|mesh-ancestor
138260963|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260964|NCT00619931|APD791|apd791|mesh-list
138260965|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138260966|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138260967|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
138260968|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138260969|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219421|NCT05776875|Growth Substances|growth substances|mesh-ancestor
138260973|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138260974|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
138260975|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260976|NCT04768231|Rifampin|rifampin|mesh-list
138260977|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138192264|NCT01167829|Testosterone|testosterone|mesh-list
138260978|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
138260979|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138260980|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138260981|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
138260982|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138260983|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138260984|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138260985|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138481905|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
138260986|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138260987|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138260988|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138260989|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138260990|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138260991|NCT05452187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138260992|NCT05452187|Immunologic Factors|immunologic factors|mesh-ancestor
138260993|NCT05452187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138260994|NCT01889797|Rituximab|rituximab|mesh-list
138260995|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
138260996|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138260997|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138260998|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
138260999|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261000|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138261001|NCT00369551|Paclitaxel|paclitaxel|mesh-list
138261003|NCT00369551|Carboplatin|carboplatin|mesh-list
138261004|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138261005|NCT00369551|Antibodies|antibodies|mesh-list
138261006|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
138261007|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138261008|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138261009|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261010|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
138261011|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
138261012|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
138261013|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261014|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138261015|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138261016|NCT00369551|Growth Substances|growth substances|mesh-ancestor
138261017|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261018|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
138261019|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
138261020|NCT04537793|Ivacaftor|ivacaftor|mesh-list
138261021|NCT04537793|Elexacaftor|elexacaftor|mesh-list
138261022|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138261023|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138261024|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261025|NCT05437601|Carotenoids|carotenoids|mesh-list
138261026|NCT05437601|Antioxidants|antioxidants|mesh-ancestor
138261027|NCT05437601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261028|NCT05437601|Protective Agents|protective agents|mesh-ancestor
138261029|NCT05437601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261030|NCT05447039|Montelukast|montelukast|mesh-list
138261031|NCT05447039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138261032|NCT05447039|Respiratory System Agents|respiratory system agents|mesh-ancestor
138261033|NCT05447039|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138261034|NCT05447039|Hormone Antagonists|hormone antagonists|mesh-ancestor
138261035|NCT05447039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261036|NCT05447039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261037|NCT05447039|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138261038|NCT05447039|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138261039|NCT05447039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261040|NCT05446805|Corticosterone|corticosterone|mesh-list
138261041|NCT05446805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192268|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261042|NCT05446415|Glucagon|glucagon|mesh-list
138261044|NCT05446415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138261045|NCT05446415|Hormones|hormones|mesh-ancestor
138261046|NCT05446415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261047|NCT05446415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261048|NCT05448365|Vitamin D|vitamin d|mesh-list
138261049|NCT05448365|Vitamins|vitamins|mesh-list
138261050|NCT05448365|Inositol|inositol|mesh-list
138261051|NCT05448365|Vitamin B 6|vitamin b 6|mesh-list
138261052|NCT05448365|Pyridoxal|pyridoxal|mesh-list
138261053|NCT05448365|Pyridoxine|pyridoxine|mesh-list
138261054|NCT05448365|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138261055|NCT05448365|Micronutrients|micronutrients|mesh-ancestor
138261056|NCT05448365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261057|NCT05448365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138261058|NCT05448365|Vitamin B Complex|vitamin b complex|mesh-ancestor
138261059|NCT05448365|Antioxidants|antioxidants|mesh-ancestor
138261060|NCT05448365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261061|NCT05448365|Protective Agents|protective agents|mesh-ancestor
138261062|NCT05448365|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138261063|NCT05448365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138261064|NCT05448365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261065|NCT05448365|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138261066|NCT00370799|Betamethasone|betamethasone|mesh-list
138261067|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
138261068|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138261069|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
138261070|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138261071|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138219494|NCT05761171|Antiemetics|antiemetics|mesh-ancestor
138261074|NCT00370799|Hormones|hormones|mesh-ancestor
138261075|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261076|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261077|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138261078|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
138261079|NCT02661971|Leucovorin|leucovorin|mesh-list
138261080|NCT02661971|Docetaxel|docetaxel|mesh-list
138261081|NCT02661971|Fluorouracil|fluorouracil|mesh-list
138261082|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
138261083|NCT02661971|Ramucirumab|ramucirumab|mesh-list
138261084|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261085|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
138261086|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
138261087|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
138261088|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261089|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
138261090|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138261091|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138261092|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
138261093|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261094|NCT02661971|Antidotes|antidotes|mesh-ancestor
138261095|NCT02661971|Protective Agents|protective agents|mesh-ancestor
138261096|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
138261097|NCT02661971|Vitamins|vitamins|mesh-ancestor
138261098|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
138261099|NCT05442905|Anesthetics|anesthetics|mesh-list
138261100|NCT05442905|Propofol|propofol|mesh-list
138261101|NCT05442905|Sevoflurane|sevoflurane|mesh-list
138261102|NCT05442905|Atracurium|atracurium|mesh-list
138261103|NCT05442905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261104|NCT05442905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261105|NCT05442905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138261106|NCT05442905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138261107|NCT05442905|Anesthetics, General|anesthetics, general|mesh-ancestor
138261108|NCT05442905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138261109|NCT05442905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138261110|NCT05442905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138261111|NCT05442905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138261112|NCT05442905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138261113|NCT05442905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138192280|NCT04974151|Folic Acid|folic acid|mesh-list
138261114|NCT05442905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138261115|NCT05442905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138261116|NCT05442905|Cholinergic Agents|cholinergic agents|mesh-ancestor
138261117|NCT05442905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138261118|NCT05442905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261119|NCT00369863|Triamcinolone|triamcinolone|mesh-list
138261120|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138261121|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138261122|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138261124|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
138261126|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261127|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261128|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138261129|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
138261130|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261131|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261132|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138261133|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138261134|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261136|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138261137|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138261138|NCT02588027|Analgesics|analgesics|mesh-ancestor
138261139|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
138261140|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261141|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261142|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138261143|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138261144|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138242878|NCT02863263|Povidone|povidone|mesh-list
138261145|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138481988|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261146|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261147|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
138261148|NCT04449965|Povidone|povidone|mesh-list
138261149|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
138261150|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
138261151|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138261152|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261153|NCT05431673|Doxycycline|doxycycline|mesh-list
138261154|NCT05431673|Ciprofloxacin|ciprofloxacin|mesh-list
138261155|NCT05431673|Rifampin|rifampin|mesh-list
138261156|NCT05431673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138261157|NCT05431673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261158|NCT05431673|Antimalarials|antimalarials|mesh-ancestor
138261159|NCT05431673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138261160|NCT05431673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138261161|NCT05431673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138261162|NCT05431673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138261163|NCT05431673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261164|NCT05431673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242931|NCT00374205|Artemether|artemether|mesh-list
138261165|NCT05431673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261166|NCT05431673|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138261167|NCT05431673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138261168|NCT05431673|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138261169|NCT05431673|Antitubercular Agents|antitubercular agents|mesh-ancestor
138261170|NCT05431673|Leprostatic Agents|leprostatic agents|mesh-ancestor
138261171|NCT05431673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138261172|NCT05431673|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138261173|NCT05431673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138261175|NCT05431673|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138261176|NCT05431673|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138261178|NCT01951651|Exenatide|exenatide|mesh-list
138261179|NCT01951651|Glipizide|glipizide|mesh-list
138261180|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138261181|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261182|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138261183|NCT01951651|Incretins|incretins|mesh-ancestor
138261184|NCT01951651|Hormones|hormones|mesh-ancestor
138261185|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261186|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
138261187|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
138261188|NCT02466581|Prednisolone|prednisolone|mesh-list
138261189|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138261190|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
138261191|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138261192|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
138261193|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
138261194|NCT02466581|Abatacept|abatacept|mesh-list
138261195|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138261196|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
138261197|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138261198|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
138261199|NCT02466581|Hormones|hormones|mesh-ancestor
138261200|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261201|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138482009|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
138261202|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138261203|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261204|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
138261205|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
138261206|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261207|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138261208|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138261209|NCT02466581|Protective Agents|protective agents|mesh-ancestor
138261210|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
138261211|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138261212|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138261213|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261214|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261215|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261216|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138261218|NCT02466581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138261219|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138261220|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
138261221|NCT02466581|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138261222|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138261223|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138261225|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
138261226|NCT01951963|Ketamine|ketamine|mesh-list
138261227|NCT01951963|Morphine|morphine|mesh-list
138261228|NCT01951963|Analgesics|analgesics|mesh-ancestor
138261229|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
138261230|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261231|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261232|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138261233|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138261234|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
138261237|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138261238|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138261239|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138261240|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261241|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138261242|NCT01951963|Narcotics|narcotics|mesh-ancestor
138261243|NCT02377271|Bosentan|bosentan|mesh-list
138261244|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138261245|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138261246|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261247|NCT01894555|Aspirin|aspirin|mesh-list
138261248|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138261249|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138261250|NCT01894555|Analgesics|analgesics|mesh-ancestor
138261251|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
138261252|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261253|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261254|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138261255|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138261256|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138261257|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138261258|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261259|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138261260|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138261262|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
138261263|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
138261264|NCT01953211|Norinyl|norinyl|mesh-list
138261265|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
138261266|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138261267|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138261268|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261269|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138261270|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138261271|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138261272|NCT02028221|Metformin|metformin|mesh-list
138261273|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138261274|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261275|NCT05735197|Dapagliflozin|dapagliflozin|mesh-list
138261276|NCT05735197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138261277|NCT05735197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261278|NCT05735197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138261279|NCT05735197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261280|NCT00370097|Fluticasone|fluticasone|mesh-list
138261282|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138261283|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138261284|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
138261285|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261286|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261287|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138261288|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
138261289|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
138261290|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138261291|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138261292|NCT01897285|Laxatives|laxatives|mesh-ancestor
138261293|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138261294|NCT00370253|Terlipressin|terlipressin|mesh-list
138243176|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261296|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138261297|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138261298|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138261299|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138261300|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
138261301|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138261302|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261303|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261304|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
138261305|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
138261306|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261307|NCT01491815|Abatacept|abatacept|mesh-list
138261308|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138261309|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261310|NCT01491815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138261311|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261312|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138261313|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
138261314|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261316|NCT04359953|Azithromycin|azithromycin|mesh-list
138261317|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
138261318|NCT04359953|Telmisartan|telmisartan|mesh-list
138261319|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138261320|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261321|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
138261322|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138261323|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138261324|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261325|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261326|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138261327|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138261328|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138261329|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138261330|NCT05364515|Clobetasol|clobetasol|mesh-list
138261331|NCT05364515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138261332|NCT05364515|Glucocorticoids|glucocorticoids|mesh-ancestor
138261333|NCT05364515|Hormones|hormones|mesh-ancestor
138261335|NCT05364515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261336|NCT01438073|Hormones|hormones|mesh-list
138261337|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261338|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261339|NCT00371033|Pregabalin|pregabalin|mesh-list
138261340|NCT00371033|Analgesics|analgesics|mesh-ancestor
138261341|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
138261342|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261343|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261344|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
138261345|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138261346|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138261347|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261348|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138261349|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138261350|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138261351|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261352|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138261353|NCT00371111|Triamcinolone|triamcinolone|mesh-list
138261354|NCT00371111|Bevacizumab|bevacizumab|mesh-list
138261355|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138261356|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261357|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138261358|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138261359|NCT00371111|Growth Substances|growth substances|mesh-ancestor
138261361|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
138261362|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138261363|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
138261365|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261366|NCT05454683|Melatonin|melatonin|mesh-list
138261367|NCT05454683|Antioxidants|antioxidants|mesh-ancestor
138261368|NCT05454683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261369|NCT05454683|Protective Agents|protective agents|mesh-ancestor
138261370|NCT05454683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261371|NCT05454683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261372|NCT05139095|Apatinib|apatinib|mesh-list
138261373|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261374|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138261375|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261376|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261377|NCT04108247|Fluzoparib|fluzoparib|mesh-list
138261378|NCT04108247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138261379|NCT04108247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261380|NCT04108247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261381|NCT04108247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261382|NCT05453435|Entecavir|entecavir|mesh-list
138261383|NCT05453435|Antiviral Agents|antiviral agents|mesh-ancestor
138261384|NCT05453435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261385|NCT03029845|Propranolol|propranolol|mesh-list
138261386|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138261387|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138261388|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
138261389|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138261390|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261391|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261392|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138261393|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138261394|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
138261396|NCT05451719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138261398|NCT05451719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261399|NCT05451719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261400|NCT01955629|Capecitabine|capecitabine|mesh-list
138261401|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
138261402|NCT01955629|Aflibercept|aflibercept|mesh-list
138261403|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138261404|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
138261405|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243508|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138261406|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261407|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138261408|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138261409|NCT01955629|Growth Substances|growth substances|mesh-ancestor
138261410|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261411|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
138261413|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
138261414|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
138261415|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261416|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261417|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
138261418|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261419|NCT05062577|Buprenorphine|buprenorphine|mesh-list
138261420|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138261421|NCT05062577|ASP8062|asp8062|mesh-list
138261422|NCT05062577|Naloxone|naloxone|mesh-list
138261423|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138261424|NCT05062577|Narcotics|narcotics|mesh-ancestor
138261425|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261426|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261427|NCT05062577|Analgesics|analgesics|mesh-ancestor
138261428|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
138261429|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261430|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138261431|NCT05062577|GABA Modulators|gaba modulators|mesh-ancestor
138243570|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138261433|NCT05062577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138261434|NCT05062577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261435|NCT05448989|Atropine|atropine|mesh-list
138261436|NCT05448989|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138261437|NCT05448989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138261438|NCT05448989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138261439|NCT05448989|Autonomic Agents|autonomic agents|mesh-ancestor
138261440|NCT05448989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261441|NCT05448989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261442|NCT05448989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138261443|NCT05448989|Respiratory System Agents|respiratory system agents|mesh-ancestor
138261444|NCT05448989|Mydriatics|mydriatics|mesh-ancestor
138261445|NCT05448989|Parasympatholytics|parasympatholytics|mesh-ancestor
138261446|NCT05448989|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138261447|NCT05448989|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138261450|NCT05448989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261451|NCT00370565|Insulin|insulin|mesh-list
138261452|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138261453|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138261454|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261455|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138261456|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138261457|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261458|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261459|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138261460|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138261461|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261462|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
138261463|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138261464|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138261465|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
138261467|NCT00370019|Estrogens|estrogens|mesh-ancestor
138261468|NCT00370019|Hormones|hormones|mesh-ancestor
138261469|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261470|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261471|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138261472|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
138261473|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138261474|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138261475|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138261476|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138261477|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138261478|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138261479|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138261480|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138482158|NCT00005827|Genistein|genistein|mesh-list
138261481|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138261482|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138261483|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
138261484|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138261485|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138261486|NCT04969211|Iloperidone|iloperidone|mesh-list
138261487|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138261488|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138261489|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261490|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261491|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138261492|NCT01901575|Remifentanil|remifentanil|mesh-list
138261493|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138261494|NCT01901575|Narcotics|narcotics|mesh-ancestor
138261495|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261496|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261497|NCT01901575|Analgesics|analgesics|mesh-ancestor
138261498|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
138261499|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261500|NCT01901809|Dopamine|dopamine|mesh-list
138261501|NCT01901809|Furosemide|furosemide|mesh-list
138261502|NCT01901809|Diuretics|diuretics|mesh-ancestor
138261503|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
138261504|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261505|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138261506|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138261507|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243712|NCT01691690|Analgesics|analgesics|mesh-ancestor
138261508|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138261509|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
138261510|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
138261511|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261512|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
138261513|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138261514|NCT01901809|Protective Agents|protective agents|mesh-ancestor
138261515|NCT03029533|Leuprolide|leuprolide|mesh-list
138261516|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138261517|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
138261518|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138261519|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261520|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138261521|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261522|NCT04921007|Bupivacaine|bupivacaine|mesh-list
138261523|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
138261524|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
138261525|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138482193|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
138261526|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261527|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
138261528|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261530|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138261531|NCT01904071|Narcotics|narcotics|mesh-ancestor
138261532|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261533|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261534|NCT01904071|Analgesics|analgesics|mesh-ancestor
138261535|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
138261536|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261537|NCT01907113|Empagliflozin|empagliflozin|mesh-list
138261538|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138261539|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261541|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261542|NCT00370643|Insulin|insulin|mesh-list
138261543|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138219725|NCT05497778|Antimetabolites|antimetabolites|mesh-ancestor
138261545|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192306|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192307|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138261546|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
138261547|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261548|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
138261549|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
138261550|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
138261552|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
138261553|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138261554|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261555|NCT01908751|Vitamin D|vitamin d|mesh-list
138261556|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
138261557|NCT01908751|Cholecalciferol|cholecalciferol|mesh-list
138261558|NCT01908751|Vitamins|vitamins|mesh-list
138261559|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
138261560|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261561|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138261562|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138261563|NCT00370721|Bevacizumab|bevacizumab|mesh-list
138261564|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138261565|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261566|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138261567|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138261568|NCT00370721|Growth Substances|growth substances|mesh-ancestor
138261569|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261570|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
138261571|NCT01909141|Metformin|metformin|mesh-list
138261572|NCT01909141|Pioglitazone|pioglitazone|mesh-list
138261573|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
138261574|NCT01909141|Letrozole|letrozole|mesh-list
138261575|NCT01909141|Clomiphene|clomiphene|mesh-list
138261576|NCT01909141|Enclomiphene|enclomiphene|mesh-list
138261577|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
138261578|NCT01909141|Hormones|hormones|mesh-list
138261579|NCT01909141|Estradiol|estradiol|mesh-list
138261580|NCT01909141|Testosterone|testosterone|mesh-list
138261581|NCT01909141|Progesterone|progesterone|mesh-list
138261582|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138261583|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138261584|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138219743|NCT05487235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138261585|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261586|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261587|NCT01909141|Estrogens|estrogens|mesh-ancestor
138261588|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138261589|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261590|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138261591|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138261592|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261593|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138261594|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
138261595|NCT01909141|Androgens|androgens|mesh-ancestor
138261596|NCT01909141|Progestins|progestins|mesh-ancestor
138261597|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138261598|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261599|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138261600|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
138261601|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138261602|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138261603|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
138261604|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138261605|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
138261606|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138261607|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
138261608|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261609|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261611|NCT01910311|Rifampin|rifampin|mesh-list
138261612|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138261613|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
138261614|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138261615|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261616|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
138261617|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138261618|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261619|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261620|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138192315|NCT01924819|Vitamins|vitamins|mesh-ancestor
138261621|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138261622|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138261623|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138261624|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138261625|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138261626|NCT04404959|Ropivacaine|ropivacaine|mesh-list
138261627|NCT04404959|Anesthetics|anesthetics|mesh-list
138261628|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
138261629|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261630|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261631|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
138261632|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261633|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
138261634|NCT04403711|Anesthetics|anesthetics|mesh-list
138261635|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
138261636|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138261637|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138219833|NCT05356104|Exenatide|exenatide|mesh-list
138261638|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261639|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138261641|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
138261642|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261643|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138261644|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138261645|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138261646|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
138261647|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138261648|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261650|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
138261652|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
138261653|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138244027|NCT03837860|Narcotics|narcotics|mesh-ancestor
138261654|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138261655|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138261656|NCT04403087|Trimebutine|trimebutine|mesh-list
138261657|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138261658|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
138261659|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
138261660|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261661|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261662|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
138261663|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138261664|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
138261665|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261666|NCT04748887|Protective Agents|protective agents|mesh-ancestor
138261667|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261668|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
138261669|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138261670|NCT01916629|Protective Agents|protective agents|mesh-ancestor
138261671|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261672|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
138261674|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138261675|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138261676|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138261677|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138261678|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
138219867|NCT05328908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138261680|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138244101|NCT05482451|Nivolumab|nivolumab|mesh-list
138261681|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261682|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
138261683|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261684|NCT04210037|Paclitaxel|paclitaxel|mesh-list
138261685|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138261686|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261687|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
138261688|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
138261689|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
138261690|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261691|NCT00371501|Aspirin|aspirin|mesh-list
138261692|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138261693|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138261694|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138261695|NCT00371501|Analgesics|analgesics|mesh-ancestor
138261696|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
138261697|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261698|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261699|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138261700|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138261701|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138261702|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138261703|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261704|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138261705|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138261706|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261707|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
138261708|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138261709|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138261710|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
138261711|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138261712|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138261713|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
138261715|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138261716|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261717|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261718|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138261719|NCT03251651|Analgesics|analgesics|mesh-ancestor
138261720|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
138261721|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261722|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138261723|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138261724|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138261725|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
138261726|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138261727|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261728|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138261729|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
138261730|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
138261731|NCT05738707|Vaccines|vaccines|mesh-list
138261732|NCT05738707|Immunologic Factors|immunologic factors|mesh-ancestor
138261733|NCT05738707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261734|NCT05738629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138261735|NCT05738629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138261736|NCT05349071|Methylprednisolone|methylprednisolone|mesh-list
138261737|NCT05349071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138261738|NCT05349071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138261739|NCT05349071|Prednisolone|prednisolone|mesh-list
138261740|NCT05349071|Prednisolone acetate|prednisolone acetate|mesh-list
138261741|NCT05349071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138261742|NCT05349071|Prednisolone phosphate|prednisolone phosphate|mesh-list
138261743|NCT05349071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138261744|NCT05349071|Antiemetics|antiemetics|mesh-ancestor
138261745|NCT05349071|Autonomic Agents|autonomic agents|mesh-ancestor
138261746|NCT05349071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261747|NCT05349071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261748|NCT05349071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138261749|NCT05349071|Glucocorticoids|glucocorticoids|mesh-ancestor
138261750|NCT05349071|Hormones|hormones|mesh-ancestor
138482287|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261751|NCT05349071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261753|NCT05349071|Protective Agents|protective agents|mesh-ancestor
138261754|NCT05349071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138261755|NCT05349071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261756|NCT01929889|Iloperidone|iloperidone|mesh-list
138261757|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138261758|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138261759|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261760|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261761|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138261762|NCT05738473|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138261763|NCT05738473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261764|NCT05725135|Propofol|propofol|mesh-list
138261765|NCT05725135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138261766|NCT05725135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138261767|NCT05725135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261768|NCT05725135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138261769|NCT05725135|Anesthetics, General|anesthetics, general|mesh-ancestor
138261770|NCT05725135|Anesthetics|anesthetics|mesh-ancestor
138261771|NCT05738317|Paclitaxel|paclitaxel|mesh-list
138261772|NCT05738317|Bevacizumab|bevacizumab|mesh-list
138261773|NCT05738317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138261774|NCT05738317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261775|NCT05738317|Tubulin Modulators|tubulin modulators|mesh-ancestor
138261776|NCT05738317|Antimitotic Agents|antimitotic agents|mesh-ancestor
138261777|NCT05738317|Mitosis Modulators|mitosis modulators|mesh-ancestor
138261778|NCT05738317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138220040|NCT05171075|Dalteparin|dalteparin|mesh-list
138261780|NCT05738317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138261781|NCT05738317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138261782|NCT05738317|Growth Substances|growth substances|mesh-ancestor
138261783|NCT05738317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261784|NCT05738317|Growth Inhibitors|growth inhibitors|mesh-ancestor
138261785|NCT02284555|Mupirocin|mupirocin|mesh-list
138261786|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138261787|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261788|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138261789|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261790|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261791|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
138261792|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138261793|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138261795|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261796|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138261797|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138261798|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261799|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261801|NCT02287909|Ticagrelor|ticagrelor|mesh-list
138261802|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138261803|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138261804|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138261805|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138244266|NCT04707027|Aflibercept|aflibercept|mesh-list
138244273|NCT01602068|Dexamethasone|dexamethasone|mesh-list
138261806|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
138261807|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138482302|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138261808|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261809|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261810|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138261811|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138261812|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138261813|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
138261814|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261815|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138261816|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138261817|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261818|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
138261819|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
138261820|NCT02833805|Fludarabine|fludarabine|mesh-list
138261821|NCT02833805|Tacrolimus|tacrolimus|mesh-list
138261822|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
138261823|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138261824|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138261825|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
138261826|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261827|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138261828|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138261829|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
138261830|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261831|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261832|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138261833|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138261834|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261835|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138261836|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138261837|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
138261838|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138261839|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261840|NCT02327195|Methylphenidate|methylphenidate|mesh-list
138261841|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138261842|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261843|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138261844|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138261845|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138261846|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261847|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
138261848|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138261849|NCT04768465|Prednisone|prednisone|mesh-list
138261850|NCT04768465|Bromides|bromides|mesh-list
138261851|NCT04768465|Tacrolimus|tacrolimus|mesh-list
138261852|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138261853|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138261854|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
138261855|NCT04768465|Hormones|hormones|mesh-ancestor
138261856|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261857|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261858|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138261860|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138261861|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
138261862|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138261863|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261864|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261865|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
138261866|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138261867|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
138261868|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138261869|NCT01614665|Tacrolimus|tacrolimus|mesh-list
138261870|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138261871|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
138261872|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261873|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138261874|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261875|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261876|NCT00371735|Artesunate|artesunate|mesh-list
138261877|NCT00371735|Dapsone|dapsone|mesh-list
138192349|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
138192350|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261878|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
138261879|NCT00371735|Proguanil|proguanil|mesh-list
138261880|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
138261881|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138261882|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138261883|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261884|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261885|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
138261886|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
138261887|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138261888|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
138261889|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138261890|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138220103|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261891|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261893|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138261894|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
138261896|NCT05417659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138261897|NCT05417659|Antimetabolites|antimetabolites|mesh-ancestor
138261898|NCT05417659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261899|NCT05417659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138261900|NCT05417659|Vasodilator Agents|vasodilator agents|mesh-ancestor
138261901|NCT05417659|Vitamin B Complex|vitamin b complex|mesh-ancestor
138261902|NCT05417659|Vitamins|vitamins|mesh-ancestor
138261903|NCT05417659|Micronutrients|micronutrients|mesh-ancestor
138261904|NCT05417659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261905|NCT02762513|Axitinib|axitinib|mesh-list
138261906|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261907|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138261908|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261909|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261910|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
138261911|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138261912|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
138261913|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261914|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
138261915|NCT02958761|Protective Agents|protective agents|mesh-ancestor
138261916|NCT05215535|Liver Extracts|liver extracts|mesh-list
138261917|NCT05215535|Hematinics|hematinics|mesh-ancestor
138261918|NCT02767271|Luliconazole|luliconazole|mesh-list
138261919|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
138261920|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261921|NCT05647993|Azithromycin|azithromycin|mesh-list
138261922|NCT05647993|Cefazolin|cefazolin|mesh-list
138261923|NCT05647993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138261924|NCT05647993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261926|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138261927|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
138261928|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138261929|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
138261930|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
138261931|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
138261932|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138261933|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261934|NCT02741687|Incretins|incretins|mesh-ancestor
138261935|NCT02741687|Hormones|hormones|mesh-ancestor
138261936|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261937|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138261938|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
138261939|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261940|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261941|NCT05361499|Amoxicillin|amoxicillin|mesh-list
138261942|NCT05361499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138261943|NCT05361499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138261944|NCT04337099|Tempol|tempol|mesh-list
138261945|NCT04337099|TEMPO|tempo|mesh-list
138261946|NCT04337099|TEMPOL-H|tempol-h|mesh-list
138261947|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
138261948|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261949|NCT04337099|Protective Agents|protective agents|mesh-ancestor
138261950|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261951|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138261952|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192356|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261953|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138261954|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138261955|NCT05630677|Rabeprazole|rabeprazole|mesh-list
138261956|NCT05630677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138261957|NCT05630677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138261958|NCT05630677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138261959|NCT05630677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261960|NCT05630677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261961|NCT05627791|Oxytocin|oxytocin|mesh-list
138261962|NCT05627791|Oxytocics|oxytocics|mesh-ancestor
138261963|NCT05627791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138261964|NCT05627791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261965|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
138261967|NCT04337879|Calcium|calcium|mesh-list
138261968|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138261969|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261970|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261971|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138261972|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138261973|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261974|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261975|NCT02745353|Naloxegol|naloxegol|mesh-list
138261976|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138482359|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138261977|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261978|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
138261979|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138261981|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138261982|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138261983|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138261984|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
138261985|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
138261986|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
138261987|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261988|NCT05602207|Abrocitinib|abrocitinib|mesh-list
138261989|NCT05602207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138261990|NCT05602207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138261991|NCT05602207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138261992|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138261993|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138261994|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
138261995|NCT02746991|Hormones|hormones|mesh-ancestor
138261996|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138261997|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138261998|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
138261999|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138262000|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138262001|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262002|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
138262003|NCT02747615|Coagulants|coagulants|mesh-ancestor
138262004|NCT02775617|Azithromycin|azithromycin|mesh-list
138262005|NCT02775617|Ivermectin|ivermectin|mesh-list
138262006|NCT02775617|Permethrin|permethrin|mesh-list
138220140|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
138262007|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138262008|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262009|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138262010|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262011|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262013|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138262014|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138262015|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
138262016|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262017|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262018|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262019|NCT02748785|Methotrexate|methotrexate|mesh-list
138262020|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138262021|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
138192364|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262022|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138262023|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262024|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138262025|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
138262026|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262027|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262028|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
138262029|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262030|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138262031|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138262032|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
138262033|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262034|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138262036|NCT02295553|Propofol|propofol|mesh-list
138262037|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138262038|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262039|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262040|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138244630|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138262041|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
138262042|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
138262043|NCT02295553|Analgesics|analgesics|mesh-ancestor
138262044|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
138262045|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262046|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138220162|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
138262047|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138262049|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262050|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262051|NCT02296099|Bupivacaine|bupivacaine|mesh-list
138262052|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
138244673|NCT02290613|Ambrisentan|ambrisentan|mesh-list
138262053|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
138262054|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262055|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262056|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
138262057|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262058|NCT05455073|Folic Acid|folic acid|mesh-list
138262059|NCT05455073|Hematinics|hematinics|mesh-ancestor
138262060|NCT05455073|Vitamin B Complex|vitamin b complex|mesh-ancestor
138262061|NCT05455073|Vitamins|vitamins|mesh-ancestor
138262062|NCT05455073|Micronutrients|micronutrients|mesh-ancestor
138262063|NCT05455073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262064|NCT04334993|Blinatumomab|blinatumomab|mesh-list
138262065|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262066|NCT05349929|Ibuprofen|ibuprofen|mesh-list
138262067|NCT05349929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138262068|NCT05349929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138262069|NCT05349929|Analgesics|analgesics|mesh-ancestor
138262070|NCT05349929|Sensory System Agents|sensory system agents|mesh-ancestor
138262071|NCT05349929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262072|NCT05349929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262073|NCT05349929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138262074|NCT05349929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262075|NCT05349929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138262076|NCT05349929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262077|NCT05349929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262078|NCT04669171|Rituximab|rituximab|mesh-list
138262079|NCT04669171|Lenalidomide|lenalidomide|mesh-list
138262080|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138262081|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262082|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
138262083|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262084|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262085|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138262086|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138262087|NCT04669171|Growth Substances|growth substances|mesh-ancestor
138262088|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
138262089|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
138262090|NCT04757675|Ketamine|ketamine|mesh-list
138262091|NCT04757675|Esketamine|esketamine|mesh-list
138262092|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138262093|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262094|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262095|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138262096|NCT04757675|Analgesics|analgesics|mesh-ancestor
138262097|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
138262098|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262099|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138262100|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138262101|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138262102|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
138262103|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262104|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262105|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138262106|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138262107|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
138262109|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138262110|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138262111|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
138262112|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138262113|NCT05288075|Glycopyrrolate|glycopyrrolate|mesh-list
138262114|NCT05288075|Charcoal|charcoal|mesh-list
138262115|NCT05288075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138262116|NCT05288075|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138262117|NCT05288075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138262118|NCT05288075|Cholinergic Agents|cholinergic agents|mesh-ancestor
138262119|NCT05288075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262120|NCT05288075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262121|NCT05288075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262123|NCT05288075|Protective Agents|protective agents|mesh-ancestor
138262126|NCT05272787|Protective Agents|protective agents|mesh-ancestor
138262127|NCT05272787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262128|NCT05272787|Dermatologic Agents|dermatologic agents|mesh-ancestor
138262129|NCT05145569|Paclitaxel|paclitaxel|mesh-list
138262130|NCT05145569|Carboplatin|carboplatin|mesh-list
138262131|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138262132|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262133|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
138262134|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
138262135|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
138262136|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262137|NCT04566991|Deferoxamine|deferoxamine|mesh-list
138262138|NCT04566991|Siderophores|siderophores|mesh-ancestor
138262139|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138262140|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
138262141|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
138262142|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262143|NCT03763175|Lovastatin|lovastatin|mesh-list
138262144|NCT03763175|L 647318|l 647318|mesh-list
138262145|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
138262146|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138262147|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138262148|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
138262149|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262150|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138262151|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138262152|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262154|NCT04365049|Gemcitabine|gemcitabine|mesh-list
138262155|NCT04365049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138262156|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262157|NCT04365049|Tubulin Modulators|tubulin modulators|mesh-ancestor
138262158|NCT04365049|Antimitotic Agents|antimitotic agents|mesh-ancestor
138262159|NCT04365049|Mitosis Modulators|mitosis modulators|mesh-ancestor
138262160|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138245018|NCT04348695|Simvastatin|simvastatin|mesh-list
138262161|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138262162|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
138262163|NCT03092011|Clonidine|clonidine|mesh-list
138262164|NCT03092011|Morphine|morphine|mesh-list
138262165|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138262166|NCT03092011|Narcotics|narcotics|mesh-ancestor
138262167|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262168|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262169|NCT03092011|Analgesics|analgesics|mesh-ancestor
138262170|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
138262171|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262172|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138262173|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
138262174|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
138262175|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138262176|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138262177|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138262178|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
138262179|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262180|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262182|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262183|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138262184|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262185|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262186|NCT04448119|Favipiravir|favipiravir|mesh-list
138262187|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
138262188|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262189|NCT03047473|Avelumab|avelumab|mesh-list
138262190|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138262191|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262192|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
138262193|NCT02990845|Leuprolide|leuprolide|mesh-list
138262194|NCT02990845|Exemestane|exemestane|mesh-list
138262195|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138262196|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262197|NCT02990845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138262198|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262199|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138220358|NCT04623216|Azacitidine|azacitidine|mesh-list
138262200|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
138262201|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138262202|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262203|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138262204|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138262205|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138262206|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262207|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138262208|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
138262209|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138262210|NCT01987219|Bromides|bromides|mesh-list
138262211|NCT01987219|Albuterol|albuterol|mesh-list
138262212|NCT01987219|Ipratropium|ipratropium|mesh-list
138262213|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
138262214|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138262215|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
138262216|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262217|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262218|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138262219|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
138262220|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
138262221|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138262222|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138262223|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138262224|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138262225|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
138262226|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262227|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262228|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138262229|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
138262230|NCT04265053|Ketorolac|ketorolac|mesh-list
138262231|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138262232|NCT04265053|Estradiol|estradiol|mesh-list
138262233|NCT04265053|Testosterone|testosterone|mesh-list
138262234|NCT04265053|Ganirelix|ganirelix|mesh-list
138262235|NCT04265053|Estrogens|estrogens|mesh-ancestor
138262237|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138262238|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192380|NCT01170247|Analgesics|analgesics|mesh-ancestor
138262239|NCT04265053|Androgens|androgens|mesh-ancestor
138262240|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138262241|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138262242|NCT04265053|Analgesics|analgesics|mesh-ancestor
138262243|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
138262244|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262245|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138262246|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262247|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138262248|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262249|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262250|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
138262251|NCT04332497|Ibuprofen|ibuprofen|mesh-list
138262252|NCT04332497|Fentanyl|fentanyl|mesh-list
138262253|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138262254|NCT04332497|Narcotics|narcotics|mesh-ancestor
138262255|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262256|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262257|NCT04332497|Analgesics|analgesics|mesh-ancestor
138262258|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
138245158|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138262259|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262260|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138262261|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138262262|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
138262264|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138262265|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138262266|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138262267|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262268|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138262269|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262270|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262271|NCT04258397|Pirfenidone|pirfenidone|mesh-list
138262272|NCT04258397|Analgesics|analgesics|mesh-ancestor
138262273|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
138262274|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262275|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262276|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138262277|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138262278|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138262279|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262280|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262281|NCT04707209|Sirolimus|sirolimus|mesh-list
138262282|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138262283|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262284|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138262285|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262286|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
138245208|NCT05201859|Capecitabine|capecitabine|mesh-list
138262287|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138262288|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
138262289|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262290|NCT01989793|Losartan|losartan|mesh-list
138262291|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138262293|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138262294|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138262295|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262297|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138262298|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138262299|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138262300|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138262301|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
138262302|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262303|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262304|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262305|NCT00373373|Sorafenib|sorafenib|mesh-list
138262306|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262307|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138262308|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262309|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262310|NCT00373451|Heparin|heparin|mesh-list
138245250|NCT02249936|Omeprazole|omeprazole|mesh-list
138262311|NCT00373451|Calcium heparin|calcium heparin|mesh-list
138262313|NCT00373451|Abciximab|abciximab|mesh-list
138262314|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
138262315|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138262316|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138262317|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262318|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
138262319|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138262320|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
138262321|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262322|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138220399|NCT04527991|Docetaxel|docetaxel|mesh-list
138262324|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
138262325|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
138262326|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138262327|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138262328|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
138262329|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262331|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262332|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
138262333|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262334|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
138262335|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262336|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262337|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138262338|NCT00373061|Omalizumab|omalizumab|mesh-list
138262339|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138262340|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138262341|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
138262342|NCT00707213|Deoxyglucose|deoxyglucose|mesh-list
138262343|NCT00707213|Antimetabolites|antimetabolites|mesh-ancestor
138262344|NCT00707213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262345|NCT00707213|Antiviral Agents|antiviral agents|mesh-ancestor
138262346|NCT00707213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262347|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
138262348|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138262349|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
138262350|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262351|NCT01993849|Expectorants|expectorants|mesh-ancestor
138262352|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
138262353|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138262354|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
138482587|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
138262355|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262356|NCT01993849|Protective Agents|protective agents|mesh-ancestor
138262357|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262358|NCT01993849|Antidotes|antidotes|mesh-ancestor
138262360|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138262361|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138262362|NCT02778113|Hormones|hormones|mesh-ancestor
138262363|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138262364|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262365|NCT02778113|Incretins|incretins|mesh-ancestor
138262366|NCT04982237|Paclitaxel|paclitaxel|mesh-list
138262367|NCT04982237|Bevacizumab|bevacizumab|mesh-list
138262368|NCT04982237|Carboplatin|carboplatin|mesh-list
138262369|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138262370|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262371|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
138262372|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
138262373|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
138220409|NCT04527991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262374|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262375|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138192390|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138262376|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138262377|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138262378|NCT04982237|Growth Substances|growth substances|mesh-ancestor
138262379|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262380|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
138262382|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
138262383|NCT02316379|Xenon|xenon|mesh-list
138262384|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138262385|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
138262386|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
138262387|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262388|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262389|NCT02303977|Gemcitabine|gemcitabine|mesh-list
138262390|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138262391|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138262392|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
138262393|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262394|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262395|NCT01997515|Ketamine|ketamine|mesh-list
138262396|NCT01997515|Analgesics|analgesics|mesh-ancestor
138262397|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
138262398|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262399|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262400|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138262401|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138262402|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
138262403|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
138262404|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262405|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138262406|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138262407|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262408|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262409|NCT01997905|Protein S|protein s|mesh-list
138482603|NCT00005971|Alvocidib|alvocidib|mesh-list
138262410|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
138262411|NCT02788019|Ropivacaine|ropivacaine|mesh-list
138262412|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
138262413|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
138262414|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262415|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262416|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
138262418|NCT02788097|Progesterone|progesterone|mesh-list
138262419|NCT02788097|Progestins|progestins|mesh-ancestor
138262420|NCT02788097|Hormones|hormones|mesh-ancestor
138262421|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138262422|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262423|NCT02789033|Isosorbide|isosorbide|mesh-list
138262424|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138262425|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138262426|NCT02789033|Chitosan|chitosan|mesh-list
138262427|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138262428|NCT02789033|Diuretics|diuretics|mesh-ancestor
138262429|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
138245433|NCT03224403|Ibuprofen|ibuprofen|mesh-list
138262430|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262431|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
138262432|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138262433|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262434|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138262435|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138262436|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
138262437|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138262438|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
138262439|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
138262441|NCT02789033|Coagulants|coagulants|mesh-ancestor
138262442|NCT00372827|Travoprost|travoprost|mesh-list
138262443|NCT00372827|Brinzolamide|brinzolamide|mesh-list
138262444|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138262445|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138192398|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
138262446|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262447|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262448|NCT02278315|Dexamethasone|dexamethasone|mesh-list
138262449|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138262450|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
138245487|NCT04499573|Hormones|hormones|mesh-ancestor
138262451|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
138262452|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262453|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262454|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138262455|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
138262456|NCT02278315|Hormones|hormones|mesh-ancestor
138262457|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138262458|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138262459|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262460|NCT02795117|Ivermectin|ivermectin|mesh-list
138262461|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138262462|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262463|NCT02882633|Bupivacaine|bupivacaine|mesh-list
138262464|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
138262465|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
138262466|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262467|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262468|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
138262469|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262470|NCT00373607|Artesunate|artesunate|mesh-list
138262471|NCT00373607|Piperaquine|piperaquine|mesh-list
138262472|NCT00373607|Mefloquine|mefloquine|mesh-list
138262473|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
138262474|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138262475|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138262476|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262477|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262478|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
138262479|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
138262480|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138262482|NCT02882711|Ketamine|ketamine|mesh-list
138262483|NCT02882711|Analgesics|analgesics|mesh-ancestor
138262484|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
138262485|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262486|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262487|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138262488|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138262489|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
138262491|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262492|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138262493|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138262494|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262495|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262496|NCT02794337|Sorafenib|sorafenib|mesh-list
138262497|NCT02794337|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138262498|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262499|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138262500|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262501|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262502|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
138262503|NCT02590523|Vancomycin|vancomycin|mesh-list
138262504|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138262505|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262506|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138262507|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138262508|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262509|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262510|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262511|NCT02895035|Ketorolac|ketorolac|mesh-list
138262512|NCT02895035|Phenylephrine|phenylephrine|mesh-list
138262513|NCT02895035|Epinephrine|epinephrine|mesh-list
138262514|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
138262515|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138192405|NCT01170715|Analgesics|analgesics|mesh-ancestor
138192406|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
138262516|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138262517|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
138262518|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262519|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262520|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262521|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138262522|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138262523|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
138262524|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262525|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138262526|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
138262527|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
138262528|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
138262529|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138262530|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138262531|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138262532|NCT02895035|Analgesics|analgesics|mesh-ancestor
138262533|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
138262534|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138262535|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262536|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138262537|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138245652|NCT01963091|Oxytocin|oxytocin|mesh-list
138262538|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138262539|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
138262540|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138262541|NCT02895035|Protective Agents|protective agents|mesh-ancestor
138262542|NCT02802449|Vitamin D|vitamin d|mesh-list
138262543|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
138262544|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
138262545|NCT02802449|Calcifediol|calcifediol|mesh-list
138262546|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138262547|NCT02802449|Vitamins|vitamins|mesh-list
138262548|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
138262549|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262550|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138262551|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138262552|NCT02803229|Amphetamine|amphetamine|mesh-list
138262553|NCT02803229|Adderall|adderall|mesh-list
138262554|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138262555|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262556|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
138262557|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
138262558|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262560|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262561|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262562|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
138262563|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138262564|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138262565|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138262566|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138262567|NCT01938001|Rituximab|rituximab|mesh-list
138262568|NCT01938001|Lenalidomide|lenalidomide|mesh-list
138262569|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138262570|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262571|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
138262572|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262573|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262574|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138262575|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138262576|NCT01938001|Growth Substances|growth substances|mesh-ancestor
138262577|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
138262578|NCT02805179|Temozolomide|temozolomide|mesh-list
138262579|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138262580|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
138262581|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262582|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262584|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138220524|NCT04254107|Immunotoxins|immunotoxins|mesh-ancestor
138262585|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262587|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138262588|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262590|NCT04147351|Atezolizumab|atezolizumab|mesh-list
138262591|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138262592|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262593|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138262594|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138262595|NCT04147351|Growth Substances|growth substances|mesh-ancestor
138262596|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262597|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
138262598|NCT04147351|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138262599|NCT04147351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262600|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
138262601|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138262602|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262603|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262604|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138262605|NCT02004613|Analgesics|analgesics|mesh-ancestor
138262606|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
138262607|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262608|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138262609|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138262610|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138262611|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
138262612|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262613|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262614|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
138262615|NCT01754779|Citric Acid|citric acid|mesh-list
138262616|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
138262617|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
138262618|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138262619|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
138262620|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
138262621|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262622|NCT01754779|Diuretics|diuretics|mesh-ancestor
138262623|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
138262624|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262625|NCT01754779|Expectorants|expectorants|mesh-ancestor
138262626|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
138262627|NCT02149277|Lenograstim|lenograstim|mesh-list
138262629|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
138262630|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262631|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
138262632|NCT02896907|Vitamins|vitamins|mesh-list
138262633|NCT02896907|Leucovorin|leucovorin|mesh-list
138262634|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
138262635|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
138262636|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
138262637|NCT02896907|Fluorouracil|fluorouracil|mesh-list
138262641|NCT02896907|Calcium|calcium|mesh-list
138262642|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
138262643|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
138262644|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262645|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138262646|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138262647|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
138262648|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262649|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138262650|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262651|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138262652|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
138262653|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138262654|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138262655|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262656|NCT02896907|Antidotes|antidotes|mesh-ancestor
138262657|NCT02896907|Protective Agents|protective agents|mesh-ancestor
138262658|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
138262659|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
138262660|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138262661|NCT02005549|Bevacizumab|bevacizumab|mesh-list
138262662|NCT02005549|Docetaxel|docetaxel|mesh-list
138262663|NCT02005549|Capecitabine|capecitabine|mesh-list
138262664|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138262665|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262666|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138262667|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138262668|NCT02005549|Growth Substances|growth substances|mesh-ancestor
138245878|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
138262669|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262670|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
138262671|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
138262672|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
138262673|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
138262674|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262675|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138262676|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
138262677|NCT04349696|Mitiglinide|mitiglinide|mesh-list
138262678|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138262679|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262680|NCT02810873|Copper|copper|mesh-list
138262681|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
138262682|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138262683|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138262684|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262685|NCT02810873|Trace Elements|trace elements|mesh-ancestor
138262686|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
138262687|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262689|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
138262690|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262693|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138262694|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
138262696|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138262697|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262698|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138262699|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262700|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
138262701|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262702|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
138262703|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
138262704|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
138262705|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262706|NCT03488420|Edoxaban|edoxaban|mesh-list
138262707|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138262708|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
138262709|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138262710|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
138262711|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262712|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262713|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
138262714|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
138262715|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
138262716|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138262717|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138262718|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262719|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138262720|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262721|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262722|NCT01959685|Enclomiphene|enclomiphene|mesh-list
138262723|NCT01959685|Clomiphene|clomiphene|mesh-list
138262724|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
138262725|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138262726|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
138262727|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138262728|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262729|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138262730|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
138262731|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138262732|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138262733|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138262734|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
138262735|NCT02901899|Guadecitabine|guadecitabine|mesh-list
138192423|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262736|NCT02901899|Azacitidine|azacitidine|mesh-list
138262737|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138262738|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262739|NCT02901899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138482727|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
138262740|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262741|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138262742|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
138262743|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262744|NCT04333589|Favipiravir|favipiravir|mesh-list
138262745|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
138262746|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262748|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138262749|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138262750|NCT02902913|Analgesics|analgesics|mesh-ancestor
138262751|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
138262752|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262753|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262754|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138262755|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262756|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138262757|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262758|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262759|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
138262760|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
138262761|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
138262762|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262763|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262764|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138262765|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138262766|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
138262767|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262768|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262769|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
138262770|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
138262771|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138262772|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138262773|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262774|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262775|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262776|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262777|NCT02301416|Topiramate|topiramate|mesh-list
138262778|NCT02301416|Phentermine|phentermine|mesh-list
138262779|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
138262780|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138262781|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262782|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138262783|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
138262784|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138262785|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
138262786|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
138262787|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262788|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
138262789|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262790|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262791|NCT02815709|Morphine|morphine|mesh-list
138262792|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138262793|NCT02815709|Narcotics|narcotics|mesh-ancestor
138262794|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262795|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220625|NCT03983850|Sirolimus|sirolimus|mesh-list
138262800|NCT02912195|Morphine|morphine|mesh-list
138262801|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
138262802|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
138262803|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262804|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262805|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
138262806|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262807|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138262808|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138262809|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138262810|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138262811|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262812|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138262813|NCT02912195|Narcotics|narcotics|mesh-ancestor
138262814|NCT02912195|Analgesics|analgesics|mesh-ancestor
138262815|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
138262816|NCT01960075|Levetiracetam|levetiracetam|mesh-list
138262817|NCT01960075|Valproic Acid|valproic acid|mesh-list
138262818|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
138262819|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
138262820|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262821|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262822|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
138262823|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262824|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246179|NCT01717742|Plasminogen|plasminogen|mesh-list
138262825|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
138262826|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138262827|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262828|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138262829|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138262830|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138262831|NCT01988246|Aflibercept|aflibercept|mesh-list
138262832|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138262833|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138262834|NCT01988246|Growth Substances|growth substances|mesh-ancestor
138220641|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138220642|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138220644|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
138220645|NCT03973268|Complement Factor H|complement factor h|mesh-list
138220646|NCT03973268|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138220647|NCT03973268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138220648|NCT03973268|Immunologic Factors|immunologic factors|mesh-ancestor
138220649|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220651|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
138220652|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220653|NCT03947827|Minocycline|minocycline|mesh-list
138220654|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138220655|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262835|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262836|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
138262837|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262839|NCT01990898|Cyclosporins|cyclosporins|mesh-list
138262840|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262841|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262842|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138262843|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
138262844|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262845|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
138262846|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262847|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
138262848|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262849|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138262851|NCT01960387|Clofarabine|clofarabine|mesh-list
138262852|NCT01960387|Antimetabolites|antimetabolites|mesh-list
138262853|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138262854|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262855|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138262856|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
138262857|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262858|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138262859|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
138262860|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262861|NCT02823431|Lidocaine|lidocaine|mesh-list
138262862|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
138262863|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
138262864|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262865|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262866|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
138192436|NCT01170949|Miltefosine|miltefosine|mesh-list
138262867|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262868|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138262869|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138262870|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138262871|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138262872|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262873|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138262874|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138262875|NCT03008213|Palonosetron|palonosetron|mesh-list
138262876|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
138262877|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
138262878|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262879|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262880|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138262881|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138262882|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138262883|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
138262884|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262885|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262886|NCT02059070|Bupivacaine|bupivacaine|mesh-list
138262887|NCT02059070|Ropivacaine|ropivacaine|mesh-list
138262888|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
138262889|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
138262890|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262891|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262892|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
138246320|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262893|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262894|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
138262895|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138262896|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
138262897|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262898|NCT01962961|Expectorants|expectorants|mesh-ancestor
138262899|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
138262900|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138262901|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
138262902|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262904|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262905|NCT01962961|Antidotes|antidotes|mesh-ancestor
138262906|NCT03010631|Lubiprostone|lubiprostone|mesh-list
138262907|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138262908|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138262909|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262911|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138262912|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138262913|NCT00374621|Misoprostol|misoprostol|mesh-list
138262914|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138262915|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
138262916|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138262917|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262918|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138262919|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138262921|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138262922|NCT00374621|Diuretics|diuretics|mesh-ancestor
138262923|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
138262924|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
138262925|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138262926|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262927|NCT03012191|Gentamicins|gentamicins|mesh-list
138262928|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138262929|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262930|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138262931|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262932|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262934|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
138262935|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262936|NCT01967641|Buprenorphine|buprenorphine|mesh-list
138262937|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138262939|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138246426|NCT02037893|Analgesics|analgesics|mesh-ancestor
138262940|NCT01967641|Narcotics|narcotics|mesh-ancestor
138262941|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138262942|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262943|NCT01967641|Analgesics|analgesics|mesh-ancestor
138262944|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
138262945|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262946|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138262947|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
138262948|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138262949|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
138262950|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262951|NCT02913521|Diclofenac|diclofenac|mesh-list
138262952|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138262953|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138262954|NCT02913521|Analgesics|analgesics|mesh-ancestor
138262956|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262957|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262958|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138262959|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262960|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138262961|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262962|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262963|NCT01969201|Hormones|hormones|mesh-list
138262964|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138262965|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262967|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138262968|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138262969|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138262970|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138262971|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
138262972|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138262973|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262974|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262975|NCT01999400|Mesalamine|mesalamine|mesh-list
138262976|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138262977|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138262978|NCT01999400|Analgesics|analgesics|mesh-ancestor
138262979|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
138262980|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138262981|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138262982|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138262983|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138262984|NCT01969435|Cytarabine|cytarabine|mesh-list
138262985|NCT01969435|Etoposide|etoposide|mesh-list
138262986|NCT01969435|Melphalan|melphalan|mesh-list
138246531|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
138262988|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
138262989|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138262991|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138262992|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138262993|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138262994|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138262995|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138262996|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
138262997|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
138262998|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138262999|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138263000|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
138263001|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263002|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138263003|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
138263004|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138220742|NCT03860987|Prednisone|prednisone|mesh-list
138220743|NCT03860987|Goserelin|goserelin|mesh-list
138220744|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138220745|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
138220746|NCT03860987|Hormones|hormones|mesh-ancestor
138220747|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138220748|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138220749|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138263007|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138263008|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138263009|NCT01965002|Analgesics|analgesics|mesh-ancestor
138263010|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
138263011|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263012|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263013|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138263014|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138263015|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138263016|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138263017|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263018|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138263019|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138263020|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263022|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
138263023|NCT02304757|Alendronate|alendronate|mesh-list
138263024|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
138263025|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138263026|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263027|NCT01969747|Empagliflozin|empagliflozin|mesh-list
138263028|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138263029|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263030|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138263031|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263032|NCT02002832|Risperidone|risperidone|mesh-list
138263033|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138263034|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138263035|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
138263036|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263037|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263038|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263039|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138263040|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138263041|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263042|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138263043|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138263044|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
138263045|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138263046|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138263047|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138263048|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
138263049|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138263050|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138263051|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138263052|NCT01966718|Hormones|hormones|mesh-ancestor
138263056|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138263057|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
138263058|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
138263059|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263060|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263061|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263062|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138246677|NCT01749956|Leucovorin|leucovorin|mesh-list
138263064|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138263065|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138263066|NCT02006342|Insulin|insulin|mesh-list
138263067|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138263068|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
138263069|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138263070|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263071|NCT01968356|Ethanol|ethanol|mesh-list
138263072|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
138263073|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138263074|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138192452|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263075|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138263076|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263077|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263078|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
138263079|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
138263080|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138263081|NCT02008682|Liraglutide|liraglutide|mesh-list
138263082|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138263083|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263084|NCT02008682|Incretins|incretins|mesh-ancestor
138263085|NCT02008682|Hormones|hormones|mesh-ancestor
138263086|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263087|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138263088|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
138263089|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263090|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263091|NCT01969916|Regadenoson|regadenoson|mesh-list
138263092|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138263093|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138263094|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
138263095|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
138263096|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263097|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263098|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263099|NCT00373919|Erythromycin|erythromycin|mesh-list
138263100|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
138220785|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263102|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
138263103|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138263104|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138263105|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138263106|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138263107|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263108|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263110|NCT02916407|Desflurane|desflurane|mesh-list
138263111|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138482878|NCT00006037|Fluorouracil|fluorouracil|mesh-list
138263112|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138263113|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
138263115|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263116|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263117|NCT02918357|Edetic Acid|edetic acid|mesh-list
138263118|NCT02918357|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138263119|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
138263120|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
138263121|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263122|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
138263123|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138263124|NCT02918357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138263125|NCT02829983|Clarithromycin|clarithromycin|mesh-list
138263126|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138263128|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138263129|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263130|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263131|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138263132|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138263134|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138263135|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263136|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
138263137|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
138263138|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
138263139|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263140|NCT02066792|Cycloserine|cycloserine|mesh-list
138263141|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138263142|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138263143|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138220818|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138220819|NCT03672292|Voriconazole|voriconazole|mesh-list
138220820|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
138220821|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
138220822|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138220823|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138263146|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
138263147|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263149|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263150|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
138263151|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263152|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138263153|NCT02014363|Amitriptyline|amitriptyline|mesh-list
138263154|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138263155|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
138263156|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138263157|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138263158|NCT02014363|Analgesics|analgesics|mesh-ancestor
138263159|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
138263160|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263161|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263162|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138263163|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138263164|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138263165|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263166|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
138263167|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263168|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
138482901|NCT00006363|Cytarabine|cytarabine|mesh-list
138263169|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
138263170|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
138263171|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263172|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263173|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
138263174|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263175|NCT02833415|Empagliflozin|empagliflozin|mesh-list
138263176|NCT02833415|Glycerol|glycerol|mesh-list
138263177|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138263178|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263179|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138263180|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263181|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138263182|NCT02833415|Protective Agents|protective agents|mesh-ancestor
138263183|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138263184|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
138263185|NCT02012348|Triclocarban|triclocarban|mesh-list
138263186|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138263187|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138263188|NCT02834663|Ranibizumab|ranibizumab|mesh-list
138263189|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138263190|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138263191|NCT02834663|Growth Substances|growth substances|mesh-ancestor
138263192|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263193|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
138263194|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263195|NCT01973036|Oxytocin|oxytocin|mesh-list
138263196|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
138263197|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138263198|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263199|NCT02017327|Bimatoprost|bimatoprost|mesh-list
138263200|NCT02017327|Latanoprost|latanoprost|mesh-list
138263201|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138263202|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138263203|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138263204|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138263205|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
138263206|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
138263207|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263208|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263209|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138263210|NCT02837237|Diuretics|diuretics|mesh-ancestor
138263211|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
138192464|NCT03797872|Methotrexate|methotrexate|mesh-list
138263213|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138263214|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138263215|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263217|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
138263218|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
138263219|NCT02018653|Calcium|calcium|mesh-list
138263220|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138263221|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263222|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138263223|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138263224|NCT02923895|Fluorides|fluorides|mesh-list
138263225|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
138263226|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
138263228|NCT02923895|Protective Agents|protective agents|mesh-ancestor
138263229|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263230|NCT01973348|Methamphetamine|methamphetamine|mesh-list
138263231|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138263232|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263233|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
138263234|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
138263235|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263236|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
138263237|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263238|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263239|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
138263240|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138263241|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138263242|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138263243|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138263244|NCT02839889|Naloxegol|naloxegol|mesh-list
138263245|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138263246|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263247|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
138263248|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263249|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138263250|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
138263251|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138263252|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
138263253|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263254|NCT02925611|Desflurane|desflurane|mesh-list
138263255|NCT02925611|Isoflurane|isoflurane|mesh-list
138263256|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138263257|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
138263258|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
138263259|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263260|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263261|NCT01973335|Spironolactone|spironolactone|mesh-list
138263262|NCT01973335|Acetazolamide|acetazolamide|mesh-list
138263263|NCT01973335|Bumetanide|bumetanide|mesh-list
138263264|NCT01973335|Diuretics|diuretics|mesh-list
138263265|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138263266|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138263267|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
138263268|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263269|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263270|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138263271|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
138263272|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
138263273|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138263274|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263275|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263276|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138263277|NCT01973413|Insulin|insulin|mesh-list
138263278|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138263279|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263280|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138263281|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
138263282|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138192467|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138263283|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138263284|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138263285|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263286|NCT02929667|Fluoxetine|fluoxetine|mesh-list
138263287|NCT02929667|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138263288|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138263289|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138263290|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263291|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263292|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
138263293|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263294|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138263295|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
138263296|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138263297|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138263298|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138263299|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263300|NCT02021929|Sorafenib|sorafenib|mesh-list
138263301|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263302|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138263303|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263304|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263305|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138263306|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138263307|NCT02023411|Teriparatide|teriparatide|mesh-list
138263309|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
138263310|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263311|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263312|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138263313|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138263314|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
138263315|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
138263316|NCT02068820|Protective Agents|protective agents|mesh-ancestor
138263317|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263318|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138263319|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
138263320|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263321|NCT02934191|Acetaminophen|acetaminophen|mesh-list
138263322|NCT02934191|Celecoxib|celecoxib|mesh-list
138263323|NCT02934191|Oxycodone|oxycodone|mesh-list
138263324|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
138263325|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263326|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138263327|NCT02934191|Analgesics|analgesics|mesh-ancestor
138263328|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
138263329|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263330|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
138263331|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138263332|NCT02934191|Narcotics|narcotics|mesh-ancestor
138263333|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263334|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138263335|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138263336|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138263337|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138263338|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138263339|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263340|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263341|NCT02934191|Antacids|antacids|mesh-ancestor
138263342|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138263343|NCT02937623|Calcium|calcium|mesh-list
138263344|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138263345|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263346|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
138263347|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138263348|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138263349|NCT01977781|Prednisolone|prednisolone|mesh-list
138263350|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
138192474|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
138263351|NCT01977781|Tacrolimus|tacrolimus|mesh-list
138263352|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138263353|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
138263354|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138263355|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
138263356|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263357|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138263358|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263359|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263360|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138263361|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
138263362|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
138263363|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263364|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138263365|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
138263367|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263368|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138263369|NCT01977781|Protective Agents|protective agents|mesh-ancestor
138263370|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138263371|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263372|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
138263373|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138263374|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138263375|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138263376|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138263377|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263378|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
138263379|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263380|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263381|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138263382|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263383|NCT02938949|Alirocumab|alirocumab|mesh-list
138263384|NCT02938949|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138263385|NCT02938949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138263386|NCT02938949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138263387|NCT02938949|Antimetabolites|antimetabolites|mesh-ancestor
138263388|NCT02938949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263389|NCT02938949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138263390|NCT02938949|Protease Inhibitors|protease inhibitors|mesh-ancestor
138263392|NCT02938949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138263394|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138263395|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138263396|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
138263397|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138263399|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263400|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263401|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263402|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138263403|NCT02025439|Analgesics|analgesics|mesh-ancestor
138263404|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
138263405|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263406|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
138263407|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138263408|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263409|NCT02939651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138263410|NCT02939651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263411|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
138263412|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138263413|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138263414|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263415|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
138263416|NCT02026297|Coagulants|coagulants|mesh-ancestor
138263417|NCT02070692|Tamoxifen|tamoxifen|mesh-list
138263418|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138263419|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
138263420|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263421|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263422|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138263423|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263424|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138263425|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138263426|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138263427|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
138263428|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138263429|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
138263430|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138263431|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138263432|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263433|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138263434|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263435|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138263436|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263437|NCT02869451|Bupropion|bupropion|mesh-list
138263438|NCT02869451|Nicotine|nicotine|mesh-list
138263439|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138263440|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
138263441|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263442|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263443|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138263444|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138263445|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
138263446|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138220991|NCT02861573|Dexamethasone|dexamethasone|mesh-list
138263447|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263449|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
138263450|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138263451|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138263452|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138263453|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138263454|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
138263455|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138263456|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138263457|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263458|NCT02305316|Opicapone|opicapone|mesh-list
138263459|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138263460|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263461|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263462|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138263463|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138263464|NCT02944565|Daratumumab|daratumumab|mesh-list
138263465|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263466|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138263467|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138263468|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138263469|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
138263470|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263471|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263472|NCT01979276|Dexamethasone|dexamethasone|mesh-list
138263473|NCT01979276|Pomalidomide|pomalidomide|mesh-list
138263474|NCT01979276|Romidepsin|romidepsin|mesh-list
138263475|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138263476|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
138263477|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
138263478|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263479|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263480|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138263481|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
138263482|NCT01979276|Hormones|hormones|mesh-ancestor
138263483|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263484|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138263485|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263486|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
138263487|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138263488|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138263489|NCT01979276|Growth Substances|growth substances|mesh-ancestor
138263490|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
138192482|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138263491|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138263492|NCT01979276|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138263493|NCT01979276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263494|NCT01979276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263495|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
138263496|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138263497|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
138263498|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263499|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263500|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138263501|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
138263502|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138263503|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
138263504|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263505|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263506|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138263507|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
138263508|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
138263509|NCT02871011|Protective Agents|protective agents|mesh-ancestor
138263510|NCT02344238|Riboflavin|riboflavin|mesh-list
138263511|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
138263512|NCT02344238|Vitamins|vitamins|mesh-ancestor
138263513|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
138263514|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263515|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138263516|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
138263517|NCT02344316|Melatonin|melatonin|mesh-list
138263518|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
138263519|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263520|NCT02344316|Protective Agents|protective agents|mesh-ancestor
138263521|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221040|NCT02667587|Nivolumab|nivolumab|mesh-list
138221041|NCT02667587|Temozolomide|temozolomide|mesh-list
138263523|NCT02344628|Azithromycin|azithromycin|mesh-list
138263524|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138263525|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138263526|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
138263527|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138263528|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138263529|NCT02019758|Fluticasone|fluticasone|mesh-list
138263530|NCT02019758|Budesonide|budesonide|mesh-list
138263531|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138263532|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138263533|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
138263534|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263535|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263536|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138263537|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
138263538|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
138263539|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138263540|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
138263541|NCT02019758|Hormones|hormones|mesh-ancestor
138263542|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263543|NCT01980589|Dexamethasone|dexamethasone|mesh-list
138263544|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
138263545|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138263546|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
138483030|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138247634|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263548|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138263549|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138263550|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
138263551|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263552|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263553|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138221078|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
138263555|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
138263556|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
138263557|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263558|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138263559|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
138263560|NCT01980589|Hormones|hormones|mesh-ancestor
138192488|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138263561|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263562|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138263563|NCT02021942|Pasireotide|pasireotide|mesh-list
138263564|NCT02021942|Hormones|hormones|mesh-ancestor
138263565|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263566|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263567|NCT01981759|Cycloserine|cycloserine|mesh-list
138263568|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138263569|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138263570|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138263571|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
138263572|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138263573|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
138263574|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263575|NCT01980524|Acipimox|acipimox|mesh-list
138263576|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138263577|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
138263578|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263579|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138263580|NCT01982539|Diclofenac|diclofenac|mesh-list
138263581|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138263582|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138263584|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
138263585|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263586|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263587|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138263588|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138263589|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138263590|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263591|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263592|NCT01982695|Losartan|losartan|mesh-list
138263593|NCT01982695|Lisinopril|lisinopril|mesh-list
138263594|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138263596|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138263597|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138263598|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263599|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138263600|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
138263601|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247709|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138247711|NCT03352323|Phenylephrine|phenylephrine|mesh-list
138263602|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138263603|NCT01982695|Protective Agents|protective agents|mesh-ancestor
138263604|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263606|NCT01981772|Epinephrine|epinephrine|mesh-list
138263607|NCT01981772|Racepinephrine|racepinephrine|mesh-list
138263608|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
138263609|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
138263610|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
138263611|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263612|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263613|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
138263614|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263615|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138263616|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138263617|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138263618|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138263619|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263620|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138263621|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138263622|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
138263623|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263624|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138263625|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138263626|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
138263627|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138263628|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
138263629|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
138192492|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138263630|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
138263631|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138263632|NCT01982240|Bisacodyl|bisacodyl|mesh-list
138263633|NCT01982240|Plecanatide|plecanatide|mesh-list
138263634|NCT01982240|Cathartics|cathartics|mesh-ancestor
138263635|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138263636|NCT01982240|Laxatives|laxatives|mesh-ancestor
138263637|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138263638|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
138263639|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263640|NCT02029495|Brodalumab|brodalumab|mesh-list
138263641|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138263642|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
138263643|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
138263644|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263645|NCT01985425|Colchicine|colchicine|mesh-list
138263646|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
138263647|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138263648|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
138263649|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
138263650|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
138263651|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263652|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263653|NCT02348918|Bevacizumab|bevacizumab|mesh-list
138263654|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138263655|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263657|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138263658|NCT02348918|Growth Substances|growth substances|mesh-ancestor
138263659|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263660|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
138263662|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138263663|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138263664|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138263665|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138263666|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
138263667|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263668|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263669|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263670|NCT02024204|Fluticasone|fluticasone|mesh-list
138263671|NCT02024204|Xhance|xhance|mesh-list
138263672|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138263673|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138263674|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138263675|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138263676|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
138263677|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263678|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263679|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138263680|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
138263681|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
138263682|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138263683|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138263684|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138263685|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138263686|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
138263687|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263688|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263690|NCT02024204|Hormones|hormones|mesh-ancestor
138247859|NCT02363478|Buspirone|buspirone|mesh-list
138263691|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263692|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
138263694|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138263695|NCT02034019|Dexamethasone|dexamethasone|mesh-list
138263696|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138263697|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
138263698|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
138263699|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263700|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263701|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138263702|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
138263703|NCT02034019|Hormones|hormones|mesh-ancestor
138192498|NCT03797872|Analgesics|analgesics|mesh-ancestor
138263704|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263705|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138263706|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263707|NCT02349152|Fentanyl|fentanyl|mesh-list
138263708|NCT02349152|Remifentanil|remifentanil|mesh-list
138263709|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138263710|NCT02349152|Narcotics|narcotics|mesh-ancestor
138263711|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263712|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263713|NCT02349152|Analgesics|analgesics|mesh-ancestor
138263714|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
138263715|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263716|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138263717|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138263718|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
138263719|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
138263720|NCT02035345|Carboplatin|carboplatin|mesh-list
138263721|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263722|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
138263723|NCT01986361|Analgesics|analgesics|mesh-ancestor
138263724|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
138263725|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263726|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263727|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138263728|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138263729|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138263730|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138263731|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138263733|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263735|NCT01983020|Ketamine|ketamine|mesh-list
138263736|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
138263737|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
138221211|NCT01269047|Hormones|hormones|mesh-ancestor
138263738|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263739|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263740|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
138263741|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263742|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138263743|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138263744|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138263745|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138263746|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263747|NCT01983020|Analgesics|analgesics|mesh-ancestor
138263748|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138263749|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138263750|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
138263751|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138263752|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138263753|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263754|NCT02058511|Anesthetics|anesthetics|mesh-list
138263755|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263756|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263757|NCT01983566|Omeprazole|omeprazole|mesh-list
138263758|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138263759|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138263760|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138263761|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263762|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263763|NCT01983878|Ramucirumab|ramucirumab|mesh-list
138263764|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263765|NCT02396732|Aspirin|aspirin|mesh-list
138263766|NCT02396732|Enoxaparin|enoxaparin|mesh-list
138263767|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138263768|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138263769|NCT02396732|Analgesics|analgesics|mesh-ancestor
138263770|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
138263771|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263772|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263773|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138263774|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138263775|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138263776|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138263777|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263778|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138263779|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138263780|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263781|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
138263782|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
138263783|NCT02352974|Vitamin D|vitamin d|mesh-list
138263784|NCT02352974|Vitamins|vitamins|mesh-ancestor
138263785|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
138221248|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
138263787|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138263788|NCT02353754|Morphine|morphine|mesh-list
138263789|NCT02353754|Bupivacaine|bupivacaine|mesh-list
138263790|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
138263791|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
138263792|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263793|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263794|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
138263795|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263797|NCT02353754|Narcotics|narcotics|mesh-ancestor
138263798|NCT02353754|Analgesics|analgesics|mesh-ancestor
138263799|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
138263800|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138263801|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263802|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263803|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138263804|NCT02354378|Analgesics|analgesics|mesh-ancestor
138263805|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
138263806|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263807|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138263808|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138263809|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138263810|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
138263811|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263812|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263814|NCT02059213|Leuprolide|leuprolide|mesh-list
138263815|NCT02059213|Goserelin|goserelin|mesh-list
138263816|NCT02059213|Bicalutamide|bicalutamide|mesh-list
138263817|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263818|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138263819|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263820|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263821|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138263822|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
138263823|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138263824|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263825|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138263826|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
138263827|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
138263828|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263829|NCT02037061|Bupivacaine|bupivacaine|mesh-list
138263830|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
138263831|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
138263832|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263833|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263834|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
138263835|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263837|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
138263838|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138263839|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138221269|NCT01354145|Celecoxib|celecoxib|mesh-list
138221271|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138263840|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138263841|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263842|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
138263843|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
138263844|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138192507|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263845|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
138263846|NCT02355158|Clonidine|clonidine|mesh-list
138263847|NCT02355158|Analgesics|analgesics|mesh-ancestor
138263848|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
138263849|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263850|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263851|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138263852|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
138263853|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
138263854|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138263855|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138263856|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138263857|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
138263858|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263859|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263860|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138263861|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138263862|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138263863|NCT02061397|Sirolimus|sirolimus|mesh-list
138263864|NCT02061397|Everolimus|everolimus|mesh-list
138263865|NCT02061397|Simvastatin|simvastatin|mesh-list
138263866|NCT02061397|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138263867|NCT02061397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138263868|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263869|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263870|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138263871|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
138263872|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263873|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263874|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138263875|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138263876|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138263877|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
138263878|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138263879|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138263880|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
138263881|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138263882|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138263883|NCT02062177|Midazolam|midazolam|mesh-list
138263884|NCT02062177|Propofol|propofol|mesh-list
138263885|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138263886|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263888|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138263889|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
138263890|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
138263891|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138263892|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138263893|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138263894|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138263895|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
138263896|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
138483151|NCT05285683|Carbidopa|carbidopa|mesh-list
138263898|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263899|NCT02034578|Apixaban|apixaban|mesh-list
138263900|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138263901|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
138263902|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138263903|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
138263904|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263905|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263907|NCT02403830|Morphine|morphine|mesh-list
138263908|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
138263909|NCT02403830|Ticagrelor|ticagrelor|mesh-list
138263910|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138263911|NCT02403830|Narcotics|narcotics|mesh-ancestor
138263912|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263913|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263914|NCT02403830|Analgesics|analgesics|mesh-ancestor
138263915|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
138192511|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138263916|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263917|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138263918|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138263919|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138263920|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138263921|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
138263922|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263923|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263924|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138263925|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138263926|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138263927|NCT02951195|Ivacaftor|ivacaftor|mesh-list
138263928|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138263929|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138221321|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138263931|NCT02037230|Gemcitabine|gemcitabine|mesh-list
138263932|NCT02037230|Adavosertib|adavosertib|mesh-list
138263933|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138263934|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
138263935|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263936|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263937|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263938|NCT02312882|Tofacitinib|tofacitinib|mesh-list
138263939|NCT02312882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138263940|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138263941|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263942|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263943|NCT02877095|Furosemide|furosemide|mesh-list
138263944|NCT02877095|Diuretics|diuretics|mesh-ancestor
138263945|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
138263946|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263947|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138263948|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138263949|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263950|NCT02877485|Triamcinolone|triamcinolone|mesh-list
138263951|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138263952|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138263953|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138263954|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138263955|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
138263957|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263958|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138248351|NCT03666663|Lidocaine|lidocaine|mesh-list
138263959|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138263960|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
138263961|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138263962|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263963|NCT00374387|NuvaRing|nuvaring|mesh-list
138263964|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138263965|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
138263966|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138263967|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263969|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138263970|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
138263971|NCT03023891|Hormones|hormones|mesh-ancestor
138263972|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138263973|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263974|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138263975|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263977|NCT03028025|Coagulants|coagulants|mesh-ancestor
138263978|NCT02955329|Nicotine|nicotine|mesh-list
138263979|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138263980|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
138263981|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138263982|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263983|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138263984|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138263985|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
138248387|NCT01865708|Ethanol|ethanol|mesh-list
138263986|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138263987|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263988|NCT02359058|Capecitabine|capecitabine|mesh-list
138263989|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
138263990|NCT02359058|Ramucirumab|ramucirumab|mesh-list
138263991|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138263992|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138263993|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
138263994|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138263995|NCT02404610|Propofol|propofol|mesh-list
138263996|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138263997|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138263998|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138263999|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138264000|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
138264001|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
138264002|NCT03110003|Bupivacaine|bupivacaine|mesh-list
138264003|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
138264004|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
138264005|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264006|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264007|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
138264008|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264009|NCT03114995|Tirofiban|tirofiban|mesh-list
138264010|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138264011|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138264012|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264013|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138264015|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138264016|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264017|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138264018|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138264019|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264020|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264021|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138264022|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
138264023|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264024|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264026|NCT00374465|Carvedilol|carvedilol|mesh-list
138264027|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138264028|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138264030|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264031|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264032|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264033|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138264034|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
138264035|NCT00374465|Protective Agents|protective agents|mesh-ancestor
138264036|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138264037|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138264038|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138264039|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
138264040|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138264041|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138264042|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138264043|NCT02040116|Rituximab|rituximab|mesh-list
138264044|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138264045|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264046|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
138264047|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264048|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138264049|NCT02360774|Canagliflozin|canagliflozin|mesh-list
138264050|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138264051|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264052|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138264053|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264054|NCT02361476|Clonidine|clonidine|mesh-list
138264055|NCT02361476|Analgesics|analgesics|mesh-ancestor
138264056|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
138264057|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264058|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264059|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138264060|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
138264061|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
138264062|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138264063|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138264064|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138264065|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
138264066|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264067|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264068|NCT02363270|Ketamine|ketamine|mesh-list
138264069|NCT02363270|Analgesics|analgesics|mesh-ancestor
138264070|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
138264071|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138221413|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
138264072|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264073|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138264074|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138264075|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
138264076|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
138264077|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264078|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138264079|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138264080|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264081|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264082|NCT02042534|Warfarin|warfarin|mesh-list
138264083|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
138264084|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
138264085|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138264086|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
138264087|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138264088|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
138264089|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264090|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264091|NCT02043704|Acetaminophen|acetaminophen|mesh-list
138264092|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138264093|NCT02043704|Analgesics|analgesics|mesh-ancestor
138264094|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
138264095|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264096|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264097|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
138264098|NCT02410382|Dexamethasone|dexamethasone|mesh-list
138264099|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138264100|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
138264101|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
138264102|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264103|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264104|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138264105|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
138264106|NCT02410382|Hormones|hormones|mesh-ancestor
138483217|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138264107|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264108|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138264109|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264110|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138264111|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138264112|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138264113|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138264114|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264115|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138221433|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
138264116|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264117|NCT03038867|Analgesics|analgesics|mesh-ancestor
138264118|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
138264119|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264120|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
138264121|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138264123|NCT03119831|Ethanol|ethanol|mesh-list
138264124|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
138264125|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138264126|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138264127|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264128|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264129|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264130|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
138264131|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
138264132|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
138264133|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138264134|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
138264135|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264136|NCT03124121|Golimumab|golimumab|mesh-list
138264137|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138264138|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138264139|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138264140|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
138264141|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264142|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138264143|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138264144|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138264145|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264146|NCT00374699|Bortezomib|bortezomib|mesh-list
138264147|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264148|NCT00374777|Nitrazepam|nitrazepam|mesh-list
138264149|NCT00374777|Zolpidem|zolpidem|mesh-list
138264150|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138264151|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138264152|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264153|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264154|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138264155|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
138264156|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
138264157|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264158|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264160|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138264162|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138264163|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
138264164|NCT02044796|Cytarabine|cytarabine|mesh-list
138264165|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
138264166|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
138264167|NCT02044796|Cladribine|cladribine|mesh-list
138264168|NCT02044796|Lenograstim|lenograstim|mesh-list
138264169|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138264170|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
138264171|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264172|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264173|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
138264174|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264175|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138264176|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
138264177|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264178|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138264179|NCT02044796|Analgesics|analgesics|mesh-ancestor
138264180|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
138264181|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264182|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138264183|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138264184|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264185|NCT02973503|Grazoprevir|grazoprevir|mesh-list
138264186|NCT02973503|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138264187|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
138264188|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264189|NCT03127943|Lidocaine|lidocaine|mesh-list
138264190|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
138264191|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
138264192|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138192533|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138264193|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264194|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
138264195|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264197|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138264198|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138264199|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138264200|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264201|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138264202|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138264203|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138264204|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264205|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264206|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138264207|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138264208|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264209|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
138264210|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264211|NCT02045264|Icatibant|icatibant|mesh-list
138264212|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138264213|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138264214|NCT02045264|Analgesics|analgesics|mesh-ancestor
138264215|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
138264216|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264217|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264218|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138264219|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138264220|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
138264221|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
138264222|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264223|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138264224|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138264225|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
138264227|NCT02975297|Nicotine|nicotine|mesh-list
138264228|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138264229|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
138264230|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264231|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264232|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138264233|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138264234|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
138264235|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264236|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264237|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138264238|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138264239|NCT02975297|Incretins|incretins|mesh-ancestor
138264240|NCT02975297|Hormones|hormones|mesh-ancestor
138248813|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
138264241|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264242|NCT02046200|Ethanol|ethanol|mesh-list
138264243|NCT02046200|Ivermectin|ivermectin|mesh-list
138264244|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138221558|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
138264246|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264247|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264248|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138264249|NCT02978339|Curcumin|curcumin|mesh-list
138264250|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138264251|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138264252|NCT02978339|Analgesics|analgesics|mesh-ancestor
138264253|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
138264254|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264255|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264256|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138264257|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138264258|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264259|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264260|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192539|NCT02186665|Vitamins|vitamins|mesh-ancestor
138264261|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
138248851|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
138264263|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264264|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138264265|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138264266|NCT00374855|Diuretics|diuretics|mesh-ancestor
138264267|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
138264268|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264269|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138264270|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138264271|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264273|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138264274|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138264275|NCT02412644|Analgesics|analgesics|mesh-ancestor
138264276|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
138264277|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264278|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264279|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138264280|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138264281|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138264282|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138264283|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264284|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264285|NCT02413034|Vancomycin|vancomycin|mesh-list
138264286|NCT02413034|Cefazolin|cefazolin|mesh-list
138264287|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138264288|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264289|NCT04737473|Anesthetics|anesthetics|mesh-list
138264290|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264291|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264292|NCT02369900|Esmolol|esmolol|mesh-list
138264293|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138264294|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138264295|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
138264296|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264297|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264298|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264299|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138264300|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
138264301|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138264302|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264303|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264304|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138264305|NCT03054857|Analgesics|analgesics|mesh-ancestor
138264306|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
138264307|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248973|NCT03026348|Vaccines|vaccines|mesh-list
138264308|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138264309|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138264310|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138264311|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
138264312|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264313|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264314|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
138264315|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
138264316|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138264317|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138264318|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264319|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264320|NCT02414204|Urological Agents|urological agents|mesh-ancestor
138264321|NCT02989493|Doxazosin|doxazosin|mesh-list
138264322|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138221596|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
138264323|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138264324|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138264325|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138264326|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
138264327|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264328|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264329|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264330|NCT02050334|Caffeic acid|caffeic acid|mesh-list
138264331|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
138264332|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249013|NCT04690322|BAX 855|bax 855|mesh-list
138264333|NCT02050334|Protective Agents|protective agents|mesh-ancestor
138264334|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264336|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138264337|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
138264338|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264339|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264340|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138264341|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138264342|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
138264343|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264344|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264345|NCT03144635|Grazoprevir|grazoprevir|mesh-list
138264346|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
138264347|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264348|NCT03145259|Diclofenac|diclofenac|mesh-list
138264349|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
138264350|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138264351|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138249059|NCT02985801|Pancrelipase|pancrelipase|mesh-list
138264352|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138264353|NCT03145259|Analgesics|analgesics|mesh-ancestor
138264354|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
138264355|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264356|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264357|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138264359|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138264360|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264361|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264362|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138264363|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
138264364|NCT00354692|Hematinics|hematinics|mesh-ancestor
138264365|NCT02989727|Lamotrigine|lamotrigine|mesh-list
138264366|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
138264367|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138264368|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138264369|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264370|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138264371|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264372|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138264373|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138264374|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264375|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138264376|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138264378|NCT02039947|Dabrafenib|dabrafenib|mesh-list
138264379|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264380|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138264381|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264382|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264383|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138264384|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
138264385|NCT02996591|Dexamethasone|dexamethasone|mesh-list
138264386|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
138264387|NCT02996591|Midazolam|midazolam|mesh-list
138264388|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
138264389|NCT02996591|Ketamine|ketamine|mesh-list
138264390|NCT02996591|Bupivacaine|bupivacaine|mesh-list
138264391|NCT02996591|Mepivacaine|mepivacaine|mesh-list
138264392|NCT02996591|Anesthetics|anesthetics|mesh-list
138264393|NCT02996591|Propofol|propofol|mesh-list
138264394|NCT02996591|Sevoflurane|sevoflurane|mesh-list
138264395|NCT02996591|BB 1101|bb 1101|mesh-list
138264396|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138264397|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
138264398|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
138264399|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264400|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264401|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138264402|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
138264404|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264405|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138264406|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264407|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
138264408|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264409|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264410|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
138264411|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264412|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
138264413|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138264414|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138264415|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
138264416|NCT02996591|Analgesics|analgesics|mesh-ancestor
138264417|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138264418|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138264419|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138264420|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264421|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138264422|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138264423|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138264424|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138264425|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
138264426|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
138264427|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138264428|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138264429|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138264430|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138264432|NCT03066947|Interferons|interferons|mesh-list
138264433|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
138264434|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
138264435|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
138264436|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138264437|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
138264438|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264439|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138264440|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138264441|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
138264442|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264443|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264444|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138264445|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
138264446|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264447|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
138264448|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138264449|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138264450|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138264451|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138264452|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264453|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
138264454|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264455|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264456|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138264457|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264458|NCT02062801|Ephedrine|ephedrine|mesh-list
138264459|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138264460|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264461|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
138264462|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
138264463|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264464|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138264465|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
138264466|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264467|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264468|NCT03152591|Licogliflozin|licogliflozin|mesh-list
138264469|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138264470|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264471|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138264472|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264473|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
138264474|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138264475|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138264476|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264477|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
138264478|NCT02063035|Coagulants|coagulants|mesh-ancestor
138264479|NCT00375245|Sirolimus|sirolimus|mesh-list
138264480|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138264481|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264482|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138264483|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264484|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
138264485|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138264486|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
138264487|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264488|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138264489|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
138264490|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264491|NCT02054156|Azithromycin|azithromycin|mesh-list
138264492|NCT02054156|Tobramycin|tobramycin|mesh-list
138264493|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138264494|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264495|NCT03159143|Docetaxel|docetaxel|mesh-list
138264496|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
138264497|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264498|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
138264499|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
138264500|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
138264501|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264502|NCT03068897|Ibuprofen|ibuprofen|mesh-list
138264503|NCT03068897|Tizanidine|tizanidine|mesh-list
138264504|NCT03068897|Baclofen|baclofen|mesh-list
138264505|NCT03068897|Metaxalone|metaxalone|mesh-list
138264506|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138264507|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138264508|NCT03068897|Analgesics|analgesics|mesh-ancestor
138264509|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
138264510|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264511|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264512|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138264513|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138264514|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138264515|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264516|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264517|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138264518|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138264519|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138264520|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
138264521|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
138264522|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264523|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
138264524|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
138249364|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
138264525|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
138264526|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138264527|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138264528|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138264529|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
138264530|NCT02049476|Dexamethasone|dexamethasone|mesh-list
138264531|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138264532|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
138264533|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
138264534|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264535|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264536|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138264537|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
138264538|NCT02049476|Hormones|hormones|mesh-ancestor
138264539|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264540|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138192564|NCT03746002|Metolazone|metolazone|mesh-list
138264541|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264542|NCT02299297|Tofacitinib|tofacitinib|mesh-list
138264543|NCT02299297|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138264544|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138264545|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264546|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264547|NCT03069677|Midazolam|midazolam|mesh-list
138264548|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138264549|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138264550|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264551|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264552|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138264553|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138264554|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138264555|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138264556|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
138264557|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
138264558|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
138264559|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
138264560|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264561|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264562|NCT02044393|Itraconazole|itraconazole|mesh-list
138264563|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
138264564|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264565|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138264566|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138264567|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264568|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264569|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138264570|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
138264571|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264572|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264573|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138264574|NCT05405465|Golimumab|golimumab|mesh-list
138264575|NCT05405465|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138264576|NCT05405465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138264577|NCT05405465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138264578|NCT05405465|Immunologic Factors|immunologic factors|mesh-ancestor
138264579|NCT05405465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264581|NCT02064907|Lansoprazole|lansoprazole|mesh-list
138264582|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138264583|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138264584|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138264585|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264586|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264587|NCT02064985|Ticagrelor|ticagrelor|mesh-list
138264588|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138264589|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138264590|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138264591|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138264592|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
138264593|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264594|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264595|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264597|NCT03170219|Diuretics|diuretics|mesh-ancestor
138264598|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
138264599|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264600|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138264601|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138264602|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264603|NCT00375557|Valproic Acid|valproic acid|mesh-list
138264604|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138264605|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
138264606|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138264607|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138192566|NCT03746002|Diuretics|diuretics|mesh-ancestor
138192567|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
138264608|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138264609|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264610|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264612|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264613|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264614|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
138264615|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264616|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
138264617|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
138264618|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138264619|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
138264620|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264621|NCT03177395|Expectorants|expectorants|mesh-ancestor
138264622|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
138264625|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264626|NCT03177395|Protective Agents|protective agents|mesh-ancestor
138264627|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264629|NCT03179345|Pregabalin|pregabalin|mesh-list
138264630|NCT03179345|Gabapentin|gabapentin|mesh-list
138264631|NCT03179345|Analgesics|analgesics|mesh-ancestor
138264632|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
138264633|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264634|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264635|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
138264636|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138264637|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138264638|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264639|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138264640|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138264641|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138264642|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264643|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138249537|NCT03781479|Amifampridine|amifampridine|mesh-list
138264644|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138264646|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264647|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
138264648|NCT03086213|Lidocaine|lidocaine|mesh-list
138264649|NCT03086213|Sufentanil|sufentanil|mesh-list
138264650|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
138264651|NCT03086213|Dsuvia|dsuvia|mesh-list
138264652|NCT03086213|Ropivacaine|ropivacaine|mesh-list
138264653|NCT03086213|Propofol|propofol|mesh-list
138264654|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
138264655|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
138264656|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264657|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264658|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
138264659|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264660|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138264661|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138264662|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138264663|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138264664|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264665|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138264666|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138264667|NCT03086213|Analgesics|analgesics|mesh-ancestor
138264668|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138264669|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138264671|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
138264672|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264673|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138264674|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
138264675|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138264676|NCT03086213|Narcotics|narcotics|mesh-ancestor
138264677|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138264678|NCT02378714|Varenicline|varenicline|mesh-list
138264679|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138264680|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138264681|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
138264682|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264683|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192574|NCT04089982|Varenicline|varenicline|mesh-list
138264684|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264685|NCT03091673|Glucagon|glucagon|mesh-list
138264686|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138264687|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138264688|NCT03091673|Hormones|hormones|mesh-ancestor
138264689|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264690|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264691|NCT03091673|Incretins|incretins|mesh-ancestor
138264692|NCT02382848|Prazosin|prazosin|mesh-list
138264693|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138264694|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138264695|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138264696|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138264697|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
138264698|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264699|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249619|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
138264700|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264703|NCT02065687|Carboplatin|carboplatin|mesh-list
138264704|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138264705|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138264706|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264707|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
138264708|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
138264709|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
138264710|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264711|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138264712|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264713|NCT03096353|Naloxone|naloxone|mesh-list
138264714|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138264715|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264717|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264718|NCT03098615|Efinaconazole|efinaconazole|mesh-list
138264719|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
138264720|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264722|NCT05363501|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138264723|NCT05363501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264724|NCT05363501|Sensory System Agents|sensory system agents|mesh-ancestor
138264725|NCT05363501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264726|NCT04736927|Midazolam|midazolam|mesh-list
138264727|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138264728|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138264729|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264730|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264731|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138264732|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138264733|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138264734|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138264735|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
138264736|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
138264737|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
138264738|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
138264739|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264740|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264741|NCT03810703|Amphetamine|amphetamine|mesh-list
138264742|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
138264743|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138264744|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264745|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
138264746|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
138264747|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264748|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
138264749|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264750|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264752|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138264753|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138264754|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138264755|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138264756|NCT02389088|Letrozole|letrozole|mesh-list
138264757|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264758|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138264759|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138264760|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264761|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264762|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138264763|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
138221841|NCT01472549|Ethanol|ethanol|mesh-list
138264764|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264765|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264767|NCT02068027|Analgesics|analgesics|mesh-ancestor
138264768|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
138264769|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264770|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264772|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
138264773|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
138264774|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138264775|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138264776|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138264777|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
138264778|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264779|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264780|NCT02392208|Telavancin|telavancin|mesh-list
138264781|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138264782|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264783|NCT05185583|Methylphenidate|methylphenidate|mesh-list
138264784|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138264785|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264786|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138264787|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138264788|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138264789|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264790|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
138264791|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264792|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
138264793|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
138264794|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264795|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
138264796|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264797|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264798|NCT02392286|Prednisone|prednisone|mesh-list
138264799|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
138264800|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138221890|NCT01474109|Macitentan|macitentan|mesh-list
138264802|NCT02392286|Hormones|hormones|mesh-ancestor
138264803|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264804|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264805|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138264806|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264807|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
138264808|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
138264809|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264810|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138264811|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138264812|NCT02392286|Protective Agents|protective agents|mesh-ancestor
138264813|NCT04586153|Meplazumab|meplazumab|mesh-list
138264814|NCT04586153|Antiviral Agents|antiviral agents|mesh-ancestor
138264815|NCT04586153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264816|NCT02393378|Folic Acid|folic acid|mesh-list
138264817|NCT02393378|Adalimumab|adalimumab|mesh-list
138264818|NCT02393378|Methotrexate|methotrexate|mesh-list
138264819|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138264820|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
138264821|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138264822|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264823|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138264824|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
138264825|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264826|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264827|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
138264828|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264829|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138264830|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138264831|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
138264832|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138264833|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138264834|NCT02393378|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138264835|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138264836|NCT02393378|Hematinics|hematinics|mesh-ancestor
138264837|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
138264839|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
138264840|NCT04949477|Acetaminophen|acetaminophen|mesh-list
138264841|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
138264842|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138264843|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264844|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264845|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138264846|NCT04949477|Analgesics|analgesics|mesh-ancestor
138264847|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
138264848|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264849|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138264850|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138264851|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138264852|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
138264853|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264854|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264855|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
138264857|NCT05717582|Hormones|hormones|mesh-ancestor
138264858|NCT05717582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264859|NCT05717582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264860|NCT03101033|Betamethasone|betamethasone|mesh-list
138264861|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
138221939|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138221940|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
138221941|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
138264862|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138264863|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
138264864|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138264865|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138264866|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
138264868|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264869|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264870|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138264871|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
138264873|NCT02069041|Fluorouracil|fluorouracil|mesh-list
138264874|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
138264875|NCT02069041|Ramucirumab|ramucirumab|mesh-list
138264876|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
138264877|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264878|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138264879|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264880|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138264881|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
138264882|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264883|NCT02069041|Antidotes|antidotes|mesh-ancestor
138264884|NCT02069041|Protective Agents|protective agents|mesh-ancestor
138264885|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
138264887|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
138264888|NCT03101111|Vaccines|vaccines|mesh-list
138264889|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
138264890|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264891|NCT05423834|Tenofovir|tenofovir|mesh-list
138264892|NCT05423834|Entecavir|entecavir|mesh-list
138264893|NCT05423834|Antiviral Agents|antiviral agents|mesh-ancestor
138264894|NCT05423834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264895|NCT05423834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138264896|NCT05423834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138264897|NCT05423834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264898|NCT05423834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264899|NCT05423834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138264900|NCT05423834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138264901|NCT03103061|Regadenoson|regadenoson|mesh-list
138264902|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138264903|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138264904|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
138264905|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
138264906|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138264907|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264908|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264909|NCT03105479|Vancomycin|vancomycin|mesh-list
138264910|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138264911|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264912|NCT00355862|Cyclosporine|cyclosporine|mesh-list
138264913|NCT00355862|Sirolimus|sirolimus|mesh-list
138264914|NCT00355862|Prednisolone|prednisolone|mesh-list
138264916|NCT00355862|Azathioprine|azathioprine|mesh-list
138264917|NCT00355862|MTOR Inhibitors|mtor inhibitors|mesh-list
138264918|NCT00355862|Tacrolimus|tacrolimus|mesh-list
138264919|NCT00355862|Cyclosporins|cyclosporins|mesh-list
138264920|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138264921|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
138264922|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264923|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138264924|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138264925|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264926|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
138264927|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138264928|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
138264929|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138264930|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138264931|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138264932|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264933|NCT00355862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138264934|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138264936|NCT00355862|Hormones|hormones|mesh-ancestor
138264937|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138264938|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138264940|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138264941|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
138264942|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138264943|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
138264944|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264945|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138264946|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138264947|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
138264948|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264950|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138264952|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138264953|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138264954|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138264955|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138264956|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264957|NCT00355628|Fentanyl|fentanyl|mesh-list
138264958|NCT00355628|Citric Acid|citric acid|mesh-list
138264959|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
138264960|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138264961|NCT00355628|Narcotics|narcotics|mesh-ancestor
138264962|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138264963|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138264964|NCT00355628|Analgesics|analgesics|mesh-ancestor
138264965|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
138264966|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138264967|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138264978|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
138264979|NCT03717155|Carboplatin|carboplatin|mesh-list
138264980|NCT03717155|Gemcitabine|gemcitabine|mesh-list
138264981|NCT03717155|Cetuximab|cetuximab|mesh-list
138264982|NCT03717155|Avelumab|avelumab|mesh-list
138264983|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138264984|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138192594|NCT00983918|Propofol|propofol|mesh-list
138264985|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
138250099|NCT00642603|Bevacizumab|bevacizumab|mesh-list
138264986|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138264987|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138264997|NCT03655613|Nivolumab|nivolumab|mesh-list
138264998|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138264999|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265000|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138265001|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265003|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138265004|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138265005|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
138265006|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
138265007|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138222036|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138222037|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138265008|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265009|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138265010|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138265011|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138265012|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
138265013|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265014|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265015|NCT02051335|Scopolamine|scopolamine|mesh-list
138265016|NCT02051335|Donepezil|donepezil|mesh-list
138265017|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138265018|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138265019|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265020|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265021|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
138265022|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265023|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265024|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
138265025|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138265026|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
138265027|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
138250140|NCT04706247|Anesthetics|anesthetics|mesh-list
138265028|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265029|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138265030|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
138265031|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138265032|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138265033|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
138265034|NCT03290027|Tazarotene|tazarotene|mesh-list
138265035|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
138265036|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
138265037|NCT02300077|Fentanyl|fentanyl|mesh-list
138265038|NCT02300077|Morphine|morphine|mesh-list
138265039|NCT02300077|Methadone|methadone|mesh-list
138265040|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138265041|NCT02300077|Narcotics|narcotics|mesh-ancestor
138265042|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265043|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265044|NCT02300077|Analgesics|analgesics|mesh-ancestor
138265045|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
138265046|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265047|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138265048|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138265049|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
138265050|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
138265051|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
138265052|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
138265053|NCT03291197|Bupivacaine|bupivacaine|mesh-list
138265054|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
138265055|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
138265056|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265057|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265058|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
138265059|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265060|NCT05638880|Empagliflozin|empagliflozin|mesh-list
138265061|NCT05638880|Valsartan|valsartan|mesh-list
138265062|NCT05638880|Levocetirizine|levocetirizine|mesh-list
138265063|NCT05638880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138265064|NCT05638880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138265065|NCT05638880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138265066|NCT05638880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250170|NCT01784991|Analgesics|analgesics|mesh-ancestor
138265067|NCT05638880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138265068|NCT05638880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138265069|NCT05638880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265070|NCT05638880|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138265071|NCT05638880|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138265072|NCT05638880|Histamine Antagonists|histamine antagonists|mesh-ancestor
138265073|NCT05638880|Histamine Agents|histamine agents|mesh-ancestor
138265074|NCT05638880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265075|NCT00356096|Pramipexole|pramipexole|mesh-list
138265076|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
138265077|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265078|NCT00356096|Protective Agents|protective agents|mesh-ancestor
138265079|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265080|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138265081|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138265082|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
138265083|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
138265084|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265086|NCT05637086|Pentoxifylline|pentoxifylline|mesh-list
138265087|NCT05637086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138265088|NCT05637086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265089|NCT05637086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265090|NCT05637086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138265091|NCT05637086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138265092|NCT05637086|Protective Agents|protective agents|mesh-ancestor
138265093|NCT05637086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265094|NCT05637086|Vasodilator Agents|vasodilator agents|mesh-ancestor
138265095|NCT05637086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138265096|NCT05637086|Antioxidants|antioxidants|mesh-ancestor
138265097|NCT05637086|Anticonvulsants|anticonvulsants|mesh-ancestor
138265098|NCT05637086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138265099|NCT05637086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138265100|NCT05637086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138265101|NCT05637086|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138265102|NCT05637086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138265103|NCT03243461|Temozolomide|temozolomide|mesh-list
138265104|NCT03243461|Valproic Acid|valproic acid|mesh-list
138265105|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138265106|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
138265107|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265108|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265109|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
138265110|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265111|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
138265112|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265113|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265114|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
138265115|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138265116|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265117|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138265118|NCT03296345|Ketamine|ketamine|mesh-list
138265119|NCT03296345|Analgesics|analgesics|mesh-ancestor
138265120|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
138265121|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265122|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138483849|NCT00006133|Estrogens|estrogens|mesh-ancestor
138265123|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138265124|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138265125|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
138265126|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
138250255|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
138192603|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
138265127|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265128|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138265129|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138265130|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265131|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265132|NCT00421694|Bicalutamide|bicalutamide|mesh-list
138265133|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
138265134|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
138265135|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138265136|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265137|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265138|NCT00376181|Pioglitazone|pioglitazone|mesh-list
138265139|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138265140|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138265141|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265142|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138265143|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138265144|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265145|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
138265146|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138265147|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138265148|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265149|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138265150|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
138265151|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138265152|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138265153|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138265155|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138265156|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
138250296|NCT01549977|Febuxostat|febuxostat|mesh-list
138265158|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138265159|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265160|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138265161|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265162|NCT04630964|Niacin|niacin|mesh-list
138265163|NCT04630964|Psilocybin|psilocybin|mesh-list
138265164|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138265165|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
138265166|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265167|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138265168|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
138265169|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
138265170|NCT04630964|Vitamins|vitamins|mesh-ancestor
138265171|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
138265172|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265173|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
138265174|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138265175|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
138265176|NCT04736381|Abatacept|abatacept|mesh-list
138265177|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138265178|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265179|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138265180|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
138265181|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138265182|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265183|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265184|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265185|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138265186|NCT04736381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138265187|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138265188|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
138265189|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265190|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138265191|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
138265192|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138265193|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138192609|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
138192610|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
138265194|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265195|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
138265196|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138483918|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265197|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265198|NCT05573828|Parathyroid Hormone|parathyroid hormone|mesh-list
138265199|NCT05573828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138265200|NCT05573828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265201|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
138265202|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265203|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265205|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
138265206|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
138265207|NCT04525820|Vitamins|vitamins|mesh-list
138222275|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
138265209|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
138265210|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265211|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138265212|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138265213|NCT05570708|Psilocybin|psilocybin|mesh-list
138265214|NCT05570708|Hallucinogens|hallucinogens|mesh-ancestor
138265215|NCT05570708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265216|NCT05570708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138265217|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
138265218|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138265219|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
138265220|NCT03305159|Povidone|povidone|mesh-list
138265221|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138265222|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265223|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
138265224|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
138265225|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
138265226|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
138265227|NCT05552144|Listerine|listerine|mesh-list
138265228|NCT05552144|Sodium Fluoride|sodium fluoride|mesh-list
138265229|NCT05552144|Cariostatic Agents|cariostatic agents|mesh-ancestor
138265230|NCT05552144|Protective Agents|protective agents|mesh-ancestor
138265231|NCT05552144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265232|NCT05552144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138265233|NCT05552144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265234|NCT03308669|Topiramate|topiramate|mesh-list
138265235|NCT03308669|Lasmiditan|lasmiditan|mesh-list
138265236|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
138265237|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138265238|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265239|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138265240|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
138265241|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265242|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265243|NCT00356252|Carotenoids|carotenoids|mesh-list
138265244|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
138265245|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265246|NCT00356252|Protective Agents|protective agents|mesh-ancestor
138222317|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265247|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265248|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138265249|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
138265250|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138265251|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138265252|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138265253|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265254|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265256|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138265257|NCT03312023|Ledipasvir|ledipasvir|mesh-list
138265258|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
138265259|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265260|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138265261|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
138265262|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138265263|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
138265264|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138192614|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265265|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265266|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138265267|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138265268|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265269|NCT02344225|Ibuprofen|ibuprofen|mesh-list
138265270|NCT02344225|Ketorolac|ketorolac|mesh-list
138265271|NCT02344225|Caffeine|caffeine|mesh-list
138265272|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
138265273|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265274|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138265276|NCT02344225|Analgesics|analgesics|mesh-ancestor
138265277|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
138265278|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265279|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265280|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138265281|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138265282|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138265284|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138265285|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138265286|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138265287|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138265288|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
138265289|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265290|NCT04319588|Anesthetics|anesthetics|mesh-list
138265291|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
138265292|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265293|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265294|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
138265295|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265296|NCT03769844|Molgramostim|molgramostim|mesh-list
138265297|NCT03769844|Sargramostim|sargramostim|mesh-list
138265298|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
138265299|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265300|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265302|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138265303|NCT02347345|Ledipasvir|ledipasvir|mesh-list
138265304|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
138265305|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265306|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
138265307|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138265308|NCT03319277|Narcotics|narcotics|mesh-ancestor
138265309|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265310|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265311|NCT03319277|Analgesics|analgesics|mesh-ancestor
138265313|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265314|NCT04624295|Aspirin|aspirin|mesh-list
138265315|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138265316|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138265317|NCT04624295|Analgesics|analgesics|mesh-ancestor
138265318|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
138265319|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265320|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265321|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138265322|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138265323|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138265324|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138265325|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265326|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138265327|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138265328|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265329|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
138265330|NCT03323801|Tretinoin|tretinoin|mesh-list
138265331|NCT03323801|Isotretinoin|isotretinoin|mesh-list
138265332|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265333|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
138265334|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
138265335|NCT04450355|Nefopam|nefopam|mesh-list
138265336|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138265337|NCT04450355|Analgesics|analgesics|mesh-ancestor
138265338|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
138265339|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265340|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265341|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
138265342|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138265343|NCT02352259|Bleomycin|bleomycin|mesh-list
138265344|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138265345|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265346|NCT03326999|Bupivacaine|bupivacaine|mesh-list
138265347|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
138265348|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
138265349|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265350|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265351|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
138265352|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265354|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138265355|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265356|NCT00356720|Azithromycin|azithromycin|mesh-list
138265357|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138265358|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265359|NCT04121780|Hormones|hormones|mesh-list
138265360|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138265361|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265365|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
138265366|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138265367|NCT03198221|Citric Acid|citric acid|mesh-list
138265368|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
138265369|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138265370|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
138265371|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
138265372|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265373|NCT03198221|Cathartics|cathartics|mesh-ancestor
138265374|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138265375|NCT03198221|Antacids|antacids|mesh-ancestor
138265376|NCT03198221|Laxatives|laxatives|mesh-ancestor
138265377|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
138265378|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138265380|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
138265381|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
138265382|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138265383|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265384|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
138265385|NCT03203681|Hormones|hormones|mesh-ancestor
138265386|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138265387|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265388|NCT03203681|Androgens|androgens|mesh-ancestor
138265389|NCT05993858|Cetuximab|cetuximab|mesh-list
138265390|NCT05993858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138265391|NCT05993858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265392|NCT05993767|Tenofovir|tenofovir|mesh-list
138265393|NCT05993767|Emtricitabine|emtricitabine|mesh-list
138265394|NCT05993767|Dolutegravir|dolutegravir|mesh-list
138265395|NCT05993767|Antiviral Agents|antiviral agents|mesh-ancestor
138265396|NCT05993767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265397|NCT05993767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138265398|NCT05993767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138265399|NCT05993767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265400|NCT05993767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265401|NCT05993767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138265402|NCT05993767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138265403|NCT05993767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138265404|NCT05993767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138265405|NCT05993455|Panitumumab|panitumumab|mesh-list
138265407|NCT05993455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138265408|NCT05993455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265409|NCT05993455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138222475|NCT00825734|Sorafenib|sorafenib|mesh-list
138265410|NCT05993455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265411|NCT05993299|Cyclophosphamide|cyclophosphamide|mesh-list
138265412|NCT05993299|Fludarabine|fludarabine|mesh-list
138265413|NCT05993299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138265414|NCT05993299|Immunologic Factors|immunologic factors|mesh-ancestor
138265415|NCT05993299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265416|NCT05993299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138192629|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
138265417|NCT05993299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138265418|NCT05993299|Alkylating Agents|alkylating agents|mesh-ancestor
138265419|NCT05993299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265420|NCT05993299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265421|NCT05993299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138265422|NCT05993143|Ivermectin|ivermectin|mesh-list
138265423|NCT05993143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138265424|NCT05993143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265425|NCT05992987|Adenosine|adenosine|mesh-list
138265426|NCT05992987|Antibodies|antibodies|mesh-list
138265427|NCT05992987|Immunologic Factors|immunologic factors|mesh-ancestor
138265428|NCT05992987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265429|NCT05992987|Analgesics|analgesics|mesh-ancestor
138265430|NCT05992987|Sensory System Agents|sensory system agents|mesh-ancestor
138265431|NCT05992987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138484213|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
138250699|NCT02959229|Lactoferrin|lactoferrin|mesh-list
138265432|NCT05992987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138265433|NCT05992987|Vasodilator Agents|vasodilator agents|mesh-ancestor
138222500|NCT02513160|Beclomethasone|beclomethasone|mesh-list
138265434|NCT05992987|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138265436|NCT05992987|Purinergic Agents|purinergic agents|mesh-ancestor
138265437|NCT05992987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265438|NCT05992987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265440|NCT05992883|Ketorolac|ketorolac|mesh-list
138265441|NCT05992883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138265442|NCT05992883|Glucocorticoids|glucocorticoids|mesh-ancestor
138265443|NCT05992883|Hormones|hormones|mesh-ancestor
138265444|NCT05992883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138265445|NCT05992883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265446|NCT05992883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265447|NCT05992883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265448|NCT05992883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138265449|NCT05992883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138265450|NCT05992883|Analgesics|analgesics|mesh-ancestor
138265451|NCT05992883|Sensory System Agents|sensory system agents|mesh-ancestor
138265452|NCT05992883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265454|NCT05992883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138265455|NCT05992610|Paclitaxel|paclitaxel|mesh-list
138265456|NCT05992610|Carboplatin|carboplatin|mesh-list
138265457|NCT05992610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138265458|NCT05992610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265459|NCT05992610|Tubulin Modulators|tubulin modulators|mesh-ancestor
138265460|NCT05992610|Antimitotic Agents|antimitotic agents|mesh-ancestor
138265461|NCT05992610|Mitosis Modulators|mitosis modulators|mesh-ancestor
138265462|NCT05992610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265463|NCT05992220|Bevacizumab|bevacizumab|mesh-list
138265464|NCT05992220|Atezolizumab|atezolizumab|mesh-list
138265465|NCT05992220|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138265466|NCT05992220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138265467|NCT05992220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265468|NCT05992220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138265469|NCT05992220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138222550|NCT01507181|Ketamine|ketamine|mesh-list
138265470|NCT05992220|Growth Substances|growth substances|mesh-ancestor
138265471|NCT05992220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265472|NCT05992220|Growth Inhibitors|growth inhibitors|mesh-ancestor
138265473|NCT05992220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138265474|NCT05992220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265475|NCT05992220|Immunologic Factors|immunologic factors|mesh-ancestor
138265477|NCT05992077|Antiviral Agents|antiviral agents|mesh-ancestor
138265478|NCT05992077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265479|NCT05991856|Antihypertensive Agents|antihypertensive agents|mesh-list
138265480|NCT05991830|Anesthetics|anesthetics|mesh-list
138265481|NCT05991830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265482|NCT05991830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265483|NCT05990894|Methylprednisolone|methylprednisolone|mesh-list
138265484|NCT05990894|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138265485|NCT05990894|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138265486|NCT05990894|Prednisolone|prednisolone|mesh-list
138265487|NCT05990894|Prednisolone acetate|prednisolone acetate|mesh-list
138265488|NCT05990894|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138265489|NCT05990894|Prednisolone phosphate|prednisolone phosphate|mesh-list
138265490|NCT05990894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138265491|NCT05990894|Antiemetics|antiemetics|mesh-ancestor
138265492|NCT05990894|Autonomic Agents|autonomic agents|mesh-ancestor
138265493|NCT05990894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250787|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138265494|NCT05990894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265495|NCT05990894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138265496|NCT05990894|Glucocorticoids|glucocorticoids|mesh-ancestor
138265497|NCT05990894|Hormones|hormones|mesh-ancestor
138265498|NCT05990894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138265499|NCT05990894|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138265500|NCT05990894|Protective Agents|protective agents|mesh-ancestor
138265501|NCT05990894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138265502|NCT05990894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265503|NCT05989386|Povidone-Iodine|povidone-iodine|mesh-list
138265504|NCT05989386|Povidone|povidone|mesh-list
138265505|NCT05989386|Plasma Substitutes|plasma substitutes|mesh-ancestor
138265506|NCT05989386|Blood Substitutes|blood substitutes|mesh-ancestor
138222593|NCT00878228|Ondansetron|ondansetron|mesh-list
138265507|NCT05989386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138265508|NCT05989386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265509|NCT05988814|Folfirinox|folfirinox|mesh-list
138265510|NCT05988814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265511|NCT05988788|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138265512|NCT05988788|Eusol|eusol|mesh-list
138265513|NCT05988788|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138265514|NCT05988788|Disinfectants|disinfectants|mesh-ancestor
138265515|NCT05988788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265516|NCT05988788|Antioxidants|antioxidants|mesh-ancestor
138265517|NCT05988788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265518|NCT05988788|Protective Agents|protective agents|mesh-ancestor
138265519|NCT05988788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265520|NCT05988788|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138265521|NCT05988788|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138265522|NCT05988788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265523|NCT05988788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138265524|NCT05988684|Metformin|metformin|mesh-list
138265526|NCT05988684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138484352|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
138265529|NCT05988177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265530|NCT05988177|Coccidiostats|coccidiostats|mesh-ancestor
138265531|NCT05988177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138265532|NCT05988177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138265534|NCT05988034|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138265535|NCT05988034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138265536|NCT05988034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265537|NCT05988034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138265538|NCT05988034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138265539|NCT05988034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265540|NCT05988034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265541|NCT05988034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265542|NCT05988034|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138265543|NCT05988034|Contraceptive Agents|contraceptive agents|mesh-ancestor
138265544|NCT05988034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138265545|NCT05988034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265546|NCT05988034|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138265547|NCT05988034|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138265548|NCT05988034|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138265549|NCT05987722|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
138265550|NCT05987722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138265551|NCT05987696|Cytarabine|cytarabine|mesh-list
138265553|NCT05987696|Fludarabine|fludarabine|mesh-list
138265554|NCT05987696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138265555|NCT05987696|Immunologic Factors|immunologic factors|mesh-ancestor
138265556|NCT05987696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265557|NCT05987696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138265558|NCT05987696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138265559|NCT05987696|Alkylating Agents|alkylating agents|mesh-ancestor
138265560|NCT05987696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265561|NCT05987696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250880|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
138265562|NCT05987696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138265563|NCT05987696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138265564|NCT05987696|Antimetabolites|antimetabolites|mesh-ancestor
138265565|NCT05987696|Antiviral Agents|antiviral agents|mesh-ancestor
138265566|NCT05987696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265568|NCT05987397|Idebenone|idebenone|mesh-list
138265569|NCT05987397|Antioxidants|antioxidants|mesh-ancestor
138265570|NCT05987397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265571|NCT05987397|Protective Agents|protective agents|mesh-ancestor
138265572|NCT05987397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265573|NCT05987397|Micronutrients|micronutrients|mesh-ancestor
138265574|NCT05987345|Antibodies|antibodies|mesh-list
138265575|NCT05987345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138265576|NCT05987345|Immunologic Factors|immunologic factors|mesh-ancestor
138265577|NCT05987345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265578|NCT05987176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138265579|NCT05987176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138265580|NCT05987176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265581|NCT05986968|Aspirin|aspirin|mesh-list
138265582|NCT05986968|Ticagrelor|ticagrelor|mesh-list
138265583|NCT05986968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138265584|NCT05986968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138265585|NCT05986968|Analgesics|analgesics|mesh-ancestor
138265586|NCT05986968|Sensory System Agents|sensory system agents|mesh-ancestor
138265587|NCT05986968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265588|NCT05986968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265589|NCT05986968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138265590|NCT05986968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138265591|NCT05986968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138265592|NCT05986968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138265593|NCT05986968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265594|NCT05986968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138250916|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138265595|NCT05986968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138265596|NCT05986968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138222735|NCT01654536|Ciclesonide|ciclesonide|mesh-list
138222737|NCT01654536|Hormones|hormones|mesh-ancestor
138265597|NCT05986968|Antipyretics|antipyretics|mesh-ancestor
138265598|NCT05986968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138265599|NCT05986968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138265600|NCT05986968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138265601|NCT05986968|Purinergic Agents|purinergic agents|mesh-ancestor
138265602|NCT05986968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265604|NCT05986838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138265605|NCT05986838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265606|NCT05986734|Immunoglobulins|immunoglobulins|mesh-list
138265607|NCT05986734|Immunologic Factors|immunologic factors|mesh-ancestor
138265608|NCT05986734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265609|NCT05986591|Bromides|bromides|mesh-list
138265610|NCT05986591|Tiotropium Bromide|tiotropium bromide|mesh-list
138265611|NCT05986591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138265612|NCT05986591|Autonomic Agents|autonomic agents|mesh-ancestor
138265613|NCT05986591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265614|NCT05986591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265615|NCT05986591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138265616|NCT05986591|Respiratory System Agents|respiratory system agents|mesh-ancestor
138265617|NCT05986591|Parasympatholytics|parasympatholytics|mesh-ancestor
138265618|NCT05986591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138265619|NCT05986591|Cholinergic Agents|cholinergic agents|mesh-ancestor
138265620|NCT05986591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265621|NCT05986591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265622|NCT05986591|Anticonvulsants|anticonvulsants|mesh-ancestor
138265623|NCT05986344|Copper|copper|mesh-list
138265624|NCT05986344|Contraceptive Agents|contraceptive agents|mesh-list
138484474|NCT00006394|Hormones|hormones|mesh-list
138265625|NCT05986344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138265626|NCT05986344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265628|NCT05986344|Micronutrients|micronutrients|mesh-ancestor
138265629|NCT05986201|Hemostatics|hemostatics|mesh-list
138265630|NCT05986201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138265631|NCT05986201|Coagulants|coagulants|mesh-ancestor
138265632|NCT05986084|Cabotegravir|cabotegravir|mesh-list
138265633|NCT05986084|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138265634|NCT05986084|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138265635|NCT05986084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265636|NCT05986084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265637|NCT05986084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138265638|NCT05986084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138265639|NCT05986084|Antiviral Agents|antiviral agents|mesh-ancestor
138265640|NCT05986084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265641|NCT05986071|Fulvestrant|fulvestrant|mesh-list
138265648|NCT05986071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265650|NCT05985798|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138265651|NCT05985798|Estrogens|estrogens|mesh-ancestor
138265653|NCT05985798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138265654|NCT05985798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265655|NCT05985798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138265656|NCT05985798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265658|NCT05985278|Antioxidants|antioxidants|mesh-ancestor
138265659|NCT05985278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265660|NCT05985278|Protective Agents|protective agents|mesh-ancestor
138265661|NCT05985278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265662|NCT05985187|Docetaxel|docetaxel|mesh-list
138265663|NCT05985187|Trastuzumab|trastuzumab|mesh-list
138265664|NCT05985187|Pertuzumab|pertuzumab|mesh-list
138265665|NCT05985187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265666|NCT05985187|Tubulin Modulators|tubulin modulators|mesh-ancestor
138265667|NCT05985187|Antimitotic Agents|antimitotic agents|mesh-ancestor
138265668|NCT05985187|Mitosis Modulators|mitosis modulators|mesh-ancestor
138265669|NCT05985187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265670|NCT05985187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138265671|NCT05985070|Vitamin D|vitamin d|mesh-list
138265672|NCT05985070|Cholecalciferol|cholecalciferol|mesh-list
138265673|NCT05985070|Vitamins|vitamins|mesh-ancestor
138265674|NCT05985070|Micronutrients|micronutrients|mesh-ancestor
138265675|NCT05985070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265676|NCT05985070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138265677|NCT05985070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138265678|NCT05984511|Bevacizumab|bevacizumab|mesh-list
138265679|NCT05984511|Atezolizumab|atezolizumab|mesh-list
138265680|NCT05984511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138265681|NCT05984511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138265682|NCT05984511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265683|NCT05984511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138265684|NCT05984511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138265685|NCT05984511|Growth Substances|growth substances|mesh-ancestor
138265686|NCT05984511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265687|NCT05984511|Growth Inhibitors|growth inhibitors|mesh-ancestor
138251113|NCT00001713|Plasminogen|plasminogen|mesh-list
138265688|NCT05984511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138484562|NCT00008151|Immunotoxins|immunotoxins|mesh-ancestor
138265689|NCT05984511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265690|NCT05984511|Immunologic Factors|immunologic factors|mesh-ancestor
138192649|NCT00983294|Azithromycin|azithromycin|mesh-list
138192650|NCT00983294|Colchicine|colchicine|mesh-list
138192651|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138192652|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192653|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
138192654|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138192655|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
138192656|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
138192657|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
138265692|NCT05983952|Immunologic Factors|immunologic factors|mesh-ancestor
138265693|NCT05983952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265694|NCT05983237|Temozolomide|temozolomide|mesh-list
138265695|NCT05983237|Fluzoparib|fluzoparib|mesh-list
138265696|NCT05983237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138265697|NCT05983237|Alkylating Agents|alkylating agents|mesh-ancestor
138265698|NCT05983237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265699|NCT05983237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265700|NCT05983237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138265701|NCT05983237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265702|NCT05983055|Dexamethasone|dexamethasone|mesh-list
138265703|NCT05983055|Dexamethasone acetate|dexamethasone acetate|mesh-list
138265704|NCT05983055|BB 1101|bb 1101|mesh-list
138265705|NCT05983055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138265706|NCT05983055|Antiemetics|antiemetics|mesh-ancestor
138265707|NCT05983055|Autonomic Agents|autonomic agents|mesh-ancestor
138265708|NCT05983055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265709|NCT05983055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265710|NCT05983055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138265711|NCT05983055|Glucocorticoids|glucocorticoids|mesh-ancestor
138265712|NCT05983055|Hormones|hormones|mesh-ancestor
138265713|NCT05983055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138265714|NCT05983055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138265715|NCT05983055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265716|NCT05983055|Protease Inhibitors|protease inhibitors|mesh-ancestor
138265717|NCT05983055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265718|NCT05983055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265719|NCT05970380|Anesthetics|anesthetics|mesh-list
138265720|NCT05970380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265721|NCT05970380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265722|NCT05969756|Fluorides|fluorides|mesh-list
138265723|NCT05969756|Fluorides, Topical|fluorides, topical|mesh-list
138265724|NCT05969756|Cariostatic Agents|cariostatic agents|mesh-ancestor
138265725|NCT05969756|Protective Agents|protective agents|mesh-ancestor
138265726|NCT05969756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265727|NCT05955222|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138265728|NCT05955222|Vasodilator Agents|vasodilator agents|mesh-ancestor
138222876|NCT00882206|Hormones|hormones|mesh-ancestor
138265730|NCT05955222|Protective Agents|protective agents|mesh-ancestor
138265731|NCT05955222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265732|NCT05920967|Dexamethasone|dexamethasone|mesh-list
138265733|NCT05920967|Dexamethasone acetate|dexamethasone acetate|mesh-list
138265734|NCT05920967|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138265735|NCT05920967|BB 1101|bb 1101|mesh-list
138265736|NCT05920967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138265737|NCT05920967|Antiemetics|antiemetics|mesh-ancestor
138265738|NCT05920967|Autonomic Agents|autonomic agents|mesh-ancestor
138265739|NCT05920967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265740|NCT05920967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265741|NCT05920967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138265742|NCT05920967|Glucocorticoids|glucocorticoids|mesh-ancestor
138265743|NCT05920967|Hormones|hormones|mesh-ancestor
138265744|NCT05920967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138265745|NCT05920967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138265747|NCT05920967|Protease Inhibitors|protease inhibitors|mesh-ancestor
138265748|NCT05920967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265749|NCT05920967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265750|NCT05916287|Antihypertensive Agents|antihypertensive agents|mesh-list
138265751|NCT05911594|Solifenacin Succinate|solifenacin succinate|mesh-list
138265752|NCT05911594|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138265753|NCT05911594|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138265754|NCT05911594|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138265755|NCT05911594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265756|NCT05911594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192660|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
138265757|NCT05911594|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138265758|NCT05911594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138265759|NCT05911594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265760|NCT05911594|Cholinergic Agents|cholinergic agents|mesh-ancestor
138265761|NCT05911594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265762|NCT05911594|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138265763|NCT05911594|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138265764|NCT05911594|Urological Agents|urological agents|mesh-ancestor
138265765|NCT05900882|Dexamethasone|dexamethasone|mesh-list
138265766|NCT05900882|Lenalidomide|lenalidomide|mesh-list
138265767|NCT05900882|Bortezomib|bortezomib|mesh-list
138265768|NCT05900882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138265769|NCT05900882|Antiemetics|antiemetics|mesh-ancestor
138265770|NCT05900882|Autonomic Agents|autonomic agents|mesh-ancestor
138265771|NCT05900882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265772|NCT05900882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265773|NCT05900882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138265774|NCT05900882|Glucocorticoids|glucocorticoids|mesh-ancestor
138265775|NCT05900882|Hormones|hormones|mesh-ancestor
138265776|NCT05900882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138265777|NCT05900882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138265778|NCT05900882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265779|NCT05900882|Immunologic Factors|immunologic factors|mesh-ancestor
138265780|NCT05900882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138265781|NCT05900882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138265782|NCT05900882|Growth Substances|growth substances|mesh-ancestor
138265783|NCT05900882|Growth Inhibitors|growth inhibitors|mesh-ancestor
138265784|NCT05883540|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
138265785|NCT05883540|Hallucinogens|hallucinogens|mesh-ancestor
138265786|NCT05883540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265787|NCT05883540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138265788|NCT05883540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138265789|NCT05883540|Serotonin Agents|serotonin agents|mesh-ancestor
138265790|NCT05883540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265791|NCT05883540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265792|NCT05883540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138265793|NCT05875857|Analgesics, Opioid|analgesics, opioid|mesh-list
138265794|NCT05875857|Narcotics|narcotics|mesh-ancestor
138265795|NCT05875857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265796|NCT05875857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265797|NCT05875857|Analgesics|analgesics|mesh-ancestor
138265798|NCT05875857|Sensory System Agents|sensory system agents|mesh-ancestor
138265799|NCT05875857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265800|NCT05871424|Buprenorphine|buprenorphine|mesh-list
138265801|NCT05871424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138265802|NCT05871424|Narcotics|narcotics|mesh-ancestor
138265803|NCT05871424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265804|NCT05871424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265805|NCT05871424|Analgesics|analgesics|mesh-ancestor
138265806|NCT05871424|Sensory System Agents|sensory system agents|mesh-ancestor
138222954|NCT02203019|Analgesics|analgesics|mesh-ancestor
138265807|NCT05871424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265808|NCT05871424|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138265809|NCT05862233|Cyclosporine|cyclosporine|mesh-list
138265810|NCT05862233|Cyclosporins|cyclosporins|mesh-list
138265811|NCT05862233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265813|NCT05862233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138265814|NCT05862233|Immunologic Factors|immunologic factors|mesh-ancestor
138265815|NCT05862233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265817|NCT05862233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265818|NCT05862233|Dermatologic Agents|dermatologic agents|mesh-ancestor
138265819|NCT05862233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138265820|NCT05862233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138192671|NCT05601830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138265821|NCT05856851|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138265822|NCT05856851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138265823|NCT05856851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138265824|NCT05856851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265825|NCT05840861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138265826|NCT05840861|Vortioxetine|vortioxetine|mesh-list
138265827|NCT05840861|Antidepressive Agents|antidepressive agents|mesh-ancestor
138265828|NCT05840861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138265829|NCT05840861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138265830|NCT05840861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138265831|NCT05840861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265832|NCT05840861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265833|NCT05840861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138265834|NCT05840861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138265835|NCT05840861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138265836|NCT05840861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138251357|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265838|NCT05840861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265839|NCT05840861|Serotonin Agents|serotonin agents|mesh-ancestor
138265840|NCT05840861|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138265841|NCT05840861|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138265842|NCT05840861|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138265843|NCT05840861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138265844|NCT05825625|Atezolizumab|atezolizumab|mesh-list
138265845|NCT05825625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138265846|NCT05825625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265847|NCT05825625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138265848|NCT05825625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265849|NCT05815186|Sotorasib|sotorasib|mesh-list
138265850|NCT05815186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138265851|NCT05815186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265852|NCT05815186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138265853|NCT05815186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265854|NCT05814640|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138265855|NCT05814640|Olanzapine|olanzapine|mesh-list
138265856|NCT05814640|Aripiprazole|aripiprazole|mesh-list
138265857|NCT05814640|Lithium Carbonate|lithium carbonate|mesh-list
138265858|NCT05814640|Vortioxetine|vortioxetine|mesh-list
138265859|NCT05814640|Sertraline|sertraline|mesh-list
138265860|NCT05814640|Fluoxetine|fluoxetine|mesh-list
138265861|NCT05814640|Antiemetics|antiemetics|mesh-ancestor
138265862|NCT05814640|Autonomic Agents|autonomic agents|mesh-ancestor
138265863|NCT05814640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265864|NCT05814640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265865|NCT05814640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138265866|NCT05814640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138265867|NCT05814640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138265868|NCT05814640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265869|NCT05814640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138265870|NCT05814640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138265871|NCT05814640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138265872|NCT05814640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138223040|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138265873|NCT05814640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265874|NCT05814640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265875|NCT05814640|Serotonin Agents|serotonin agents|mesh-ancestor
138265876|NCT05814640|Antidepressive Agents|antidepressive agents|mesh-ancestor
138265877|NCT05814640|Dopamine Agonists|dopamine agonists|mesh-ancestor
138265878|NCT05814640|Dopamine Agents|dopamine agents|mesh-ancestor
138265879|NCT05814640|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138265880|NCT05814640|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138265881|NCT05814640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138265882|NCT05814640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138265883|NCT05814640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138265884|NCT05814640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138265885|NCT05814640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138265886|NCT05814640|Analgesics|analgesics|mesh-ancestor
138265887|NCT05814640|Sensory System Agents|sensory system agents|mesh-ancestor
138265888|NCT05814640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138265889|NCT05814640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138265890|NCT05814640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138265891|NCT05814640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265892|NCT05814640|Antimanic Agents|antimanic agents|mesh-ancestor
138265893|NCT05814640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138265894|NCT05814640|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138265895|NCT05810597|Tirzepatide|tirzepatide|mesh-list
138265896|NCT05810597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138265897|NCT05810597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265898|NCT05810597|Incretins|incretins|mesh-ancestor
138265899|NCT05810597|Hormones|hormones|mesh-ancestor
138265900|NCT05810597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138265901|NCT05804084|Acetazolamide|acetazolamide|mesh-list
138265902|NCT05804084|Anticonvulsants|anticonvulsants|mesh-ancestor
138265903|NCT05804084|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138265904|NCT05804084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265905|NCT05804084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265906|NCT05804084|Diuretics|diuretics|mesh-ancestor
138265907|NCT05804084|Natriuretic Agents|natriuretic agents|mesh-ancestor
138265908|NCT05804084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265909|NCT05758831|Rituximab|rituximab|mesh-list
138265910|NCT05758831|Ocrelizumab|ocrelizumab|mesh-list
138265911|NCT05758831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138265913|NCT05758831|Immunologic Factors|immunologic factors|mesh-ancestor
138265914|NCT05758831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265915|NCT05758831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138265916|NCT05752916|Clopidogrel|clopidogrel|mesh-list
138265917|NCT05752916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138265918|NCT05752916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265919|NCT05752916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265920|NCT05752916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138265921|NCT05752916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138265922|NCT05752916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138265923|NCT05752916|Purinergic Agents|purinergic agents|mesh-ancestor
138265924|NCT05752916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265925|NCT05752409|Ketamine|ketamine|mesh-list
138265926|NCT05752409|Propofol|propofol|mesh-list
138265927|NCT05752409|Esketamine|esketamine|mesh-list
138265928|NCT05752409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138265929|NCT05752409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265930|NCT05752409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265931|NCT05752409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138265932|NCT05752409|Anesthetics, General|anesthetics, general|mesh-ancestor
138265933|NCT05752409|Anesthetics|anesthetics|mesh-ancestor
138265934|NCT05752409|Analgesics|analgesics|mesh-ancestor
138265935|NCT05752409|Sensory System Agents|sensory system agents|mesh-ancestor
138265936|NCT05752409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265937|NCT05752409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138265938|NCT05752409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138265939|NCT05752409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138265940|NCT05752409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265941|NCT05752409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265942|NCT05752409|Antidepressive Agents|antidepressive agents|mesh-ancestor
138484754|NCT00006484|Paclitaxel|paclitaxel|mesh-list
138265944|NCT05746481|Carboplatin|carboplatin|mesh-list
138265946|NCT05746481|Atezolizumab|atezolizumab|mesh-list
138265947|NCT05746481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265948|NCT05746481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265949|NCT05746481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265950|NCT05746481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138265951|NCT05746481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138265952|NCT05746481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138265953|NCT05746481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138265954|NCT05721937|Abrocitinib|abrocitinib|mesh-list
138265955|NCT05721937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138265956|NCT05721937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138265957|NCT05721937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265958|NCT05715411|Methamphetamine|methamphetamine|mesh-list
138265959|NCT05715411|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138223165|NCT05945342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265960|NCT05715411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265962|NCT05715411|Autonomic Agents|autonomic agents|mesh-ancestor
138265963|NCT05715411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138265964|NCT05715411|Dopamine Agents|dopamine agents|mesh-ancestor
138265965|NCT05715411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265966|NCT05715411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265967|NCT05715411|Adrenergic Agents|adrenergic agents|mesh-ancestor
138265968|NCT05715411|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138251589|NCT05503901|Timolol|timolol|mesh-list
138265969|NCT05715411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138265970|NCT05715411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138265971|NCT05715411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138265972|NCT05714384|Calcium|calcium|mesh-list
138265973|NCT05714384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138265974|NCT05714384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265975|NCT05692960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
138265976|NCT05692960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138265977|NCT05692960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265978|NCT05661955|Tislelizumab|tislelizumab|mesh-list
138265979|NCT05661955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138265980|NCT05661955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138484786|NCT00006508|Insulin|insulin|mesh-list
138265981|NCT05646082|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138265982|NCT05646082|Dostarlimab|dostarlimab|mesh-list
138265983|NCT05646082|Antiviral Agents|antiviral agents|mesh-ancestor
138265984|NCT05646082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138265985|NCT05646082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265986|NCT05634707|Temozolomide|temozolomide|mesh-list
138265987|NCT05634707|Fluoxetine|fluoxetine|mesh-list
138265988|NCT05634707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138265989|NCT05634707|Alkylating Agents|alkylating agents|mesh-ancestor
138265990|NCT05634707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138265991|NCT05634707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138265992|NCT05634707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138265993|NCT05634707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138265994|NCT05634707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138265995|NCT05634707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138265996|NCT05634707|Serotonin Agents|serotonin agents|mesh-ancestor
138265997|NCT05634707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138265998|NCT05634707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138265999|NCT05634707|Antidepressive Agents|antidepressive agents|mesh-ancestor
138266000|NCT05634707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138266001|NCT05634707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138266002|NCT05634707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138266004|NCT05632133|Ibuprofen|ibuprofen|mesh-list
138266005|NCT05632133|Lacosamide|lacosamide|mesh-list
138192703|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138192704|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
138266006|NCT05632133|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138266007|NCT05632133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138266008|NCT05632133|Analgesics|analgesics|mesh-ancestor
138266009|NCT05632133|Sensory System Agents|sensory system agents|mesh-ancestor
138266010|NCT05632133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266011|NCT05632133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266013|NCT05632133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138266014|NCT05632133|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138266015|NCT05632133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266016|NCT05632133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266017|NCT05632133|Anticonvulsants|anticonvulsants|mesh-ancestor
138266018|NCT05632133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138266019|NCT05632133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138266020|NCT05632133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138266021|NCT05621811|ATI 7505|ati 7505|mesh-list
138266022|NCT05621811|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138266023|NCT05621811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138266024|NCT05621811|Serotonin Agents|serotonin agents|mesh-ancestor
138266025|NCT05621811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266026|NCT05621811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266027|NCT05621811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266029|NCT05603429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266030|NCT05603429|Protective Agents|protective agents|mesh-ancestor
138266031|NCT05603429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266032|NCT05586776|Chlorhexidine|chlorhexidine|mesh-list
138266033|NCT05586776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138266034|NCT05586776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138266035|NCT05586776|Mupirocin|mupirocin|mesh-list
138266036|NCT05586776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138266037|NCT05586776|Disinfectants|disinfectants|mesh-ancestor
138266038|NCT05586776|Dermatologic Agents|dermatologic agents|mesh-ancestor
138266039|NCT05586776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138266040|NCT05586776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138266041|NCT05586776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266042|NCT05586776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266043|NCT05584137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138266044|NCT05584137|Antibodies|antibodies|mesh-list
138266045|NCT05584137|Immunoglobulins|immunoglobulins|mesh-list
138266046|NCT05584137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138266047|NCT05584137|Immunologic Factors|immunologic factors|mesh-ancestor
138266048|NCT05584137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266049|NCT05584137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266050|NCT05576207|Micronutrients|micronutrients|mesh-list
138266051|NCT05576207|Trace Elements|trace elements|mesh-list
138223293|NCT05674565|Anticonvulsants|anticonvulsants|mesh-ancestor
138266052|NCT05576207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266053|NCT05543850|Pancrelipase|pancrelipase|mesh-list
138266054|NCT05543850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138266055|NCT05539989|Vaccines|vaccines|mesh-list
138266056|NCT05539989|BCG Vaccine|bcg vaccine|mesh-list
138266057|NCT05539989|Immunologic Factors|immunologic factors|mesh-ancestor
138266058|NCT05539989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266059|NCT05539989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138266060|NCT05529147|Antihypertensive Agents|antihypertensive agents|mesh-list
138266062|NCT05526690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138266063|NCT05526690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266064|NCT05526430|Harmine|harmine|mesh-list
138266065|NCT05526430|Hallucinogens|hallucinogens|mesh-ancestor
138266066|NCT05526430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266067|NCT05526430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138266068|NCT05526430|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138266069|NCT05526430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266070|NCT05526430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266071|NCT05520138|Abiraterone Acetate|abiraterone acetate|mesh-list
138266072|NCT05520138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266073|NCT05520138|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138266074|NCT05520138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266075|NCT05520138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266076|NCT05520138|Hormone Antagonists|hormone antagonists|mesh-ancestor
138266077|NCT05520138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138266078|NCT05520138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266079|NCT05520138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138266080|NCT05516849|Oxandrolone|oxandrolone|mesh-list
138266081|NCT05516849|Androgens|androgens|mesh-ancestor
138266082|NCT05516849|Hormones|hormones|mesh-ancestor
138266083|NCT05516849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138266084|NCT05516849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266085|NCT05516849|Anabolic Agents|anabolic agents|mesh-ancestor
138266086|NCT05510427|Bevacizumab|bevacizumab|mesh-list
138266087|NCT05510427|Atezolizumab|atezolizumab|mesh-list
138266088|NCT05510427|Infigratinib|infigratinib|mesh-list
138266089|NCT05510427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266090|NCT05510427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266091|NCT05510427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138266092|NCT05510427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138266094|NCT05510427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266095|NCT05510427|Growth Inhibitors|growth inhibitors|mesh-ancestor
138266096|NCT05510427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138266097|NCT05510427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266098|NCT05505292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138266099|NCT05505292|Lifitegrast|lifitegrast|mesh-list
138266100|NCT05505292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138266101|NCT05493501|Paclitaxel|paclitaxel|mesh-list
138266102|NCT05493501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138266103|NCT05493501|Carboplatin|carboplatin|mesh-list
138266104|NCT05493501|Gemcitabine|gemcitabine|mesh-list
138266105|NCT05493501|Pemetrexed|pemetrexed|mesh-list
138266106|NCT05493501|Osimertinib|osimertinib|mesh-list
138266107|NCT05493501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138266108|NCT05493501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266109|NCT05493501|Tubulin Modulators|tubulin modulators|mesh-ancestor
138266110|NCT05493501|Antimitotic Agents|antimitotic agents|mesh-ancestor
138266111|NCT05493501|Mitosis Modulators|mitosis modulators|mesh-ancestor
138266112|NCT05493501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266113|NCT05493501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138266115|NCT05493501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266116|NCT05493501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138266117|NCT05493501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138266118|NCT05493501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138266119|NCT05478278|Moxifloxacin|moxifloxacin|mesh-list
138266120|NCT05478278|Psilocybin|psilocybin|mesh-list
138266121|NCT05478278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138266122|NCT05478278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138266123|NCT05478278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138266124|NCT05478278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138266125|NCT05478278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266126|NCT05478278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266127|NCT05478278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266128|NCT05478278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266129|NCT05478278|Hallucinogens|hallucinogens|mesh-ancestor
138266130|NCT05478278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138266131|NCT05475210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138266132|NCT05475210|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
138266133|NCT05475210|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138266134|NCT05475210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266135|NCT05470283|Cyclophosphamide|cyclophosphamide|mesh-list
138266136|NCT05470283|Fludarabine|fludarabine|mesh-list
138266137|NCT05470283|Fludarabine phosphate|fludarabine phosphate|mesh-list
138266139|NCT05470283|Acetazolamide|acetazolamide|mesh-list
138266140|NCT05470283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138266141|NCT05470283|Immunologic Factors|immunologic factors|mesh-ancestor
138266142|NCT05470283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266143|NCT05470283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138266144|NCT05470283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138266145|NCT05470283|Alkylating Agents|alkylating agents|mesh-ancestor
138266146|NCT05470283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266147|NCT05470283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266148|NCT05470283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138266149|NCT05470283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138266150|NCT05470283|Antimetabolites|antimetabolites|mesh-ancestor
138266151|NCT05470283|Diuretics|diuretics|mesh-ancestor
138266152|NCT05470283|Natriuretic Agents|natriuretic agents|mesh-ancestor
138266153|NCT05470283|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138266154|NCT05470283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138266155|NCT05470283|Anticonvulsants|anticonvulsants|mesh-ancestor
138266156|NCT05470283|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138266157|NCT05470283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266158|NCT05461755|Tretinoin|tretinoin|mesh-list
138266159|NCT05461755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266160|NCT05461755|Keratolytic Agents|keratolytic agents|mesh-ancestor
138266161|NCT05461755|Dermatologic Agents|dermatologic agents|mesh-ancestor
138266162|NCT05450965|Onvansertib|onvansertib|mesh-list
138266163|NCT05450965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138266165|NCT05450965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266166|NCT05444582|Levonorgestrel|levonorgestrel|mesh-list
138266167|NCT05444582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138266168|NCT05444582|Contraceptive Agents|contraceptive agents|mesh-ancestor
138266169|NCT05444582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138266170|NCT05444582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266171|NCT05444582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138266172|NCT05444582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138266173|NCT05444582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138266174|NCT05442034|Mitogens|mitogens|mesh-list
138266175|NCT05442034|Mitosis Modulators|mitosis modulators|mesh-ancestor
138266176|NCT05442034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266177|NCT05425875|Dimercaprol|dimercaprol|mesh-list
138266178|NCT05425875|Chelating Agents|chelating agents|mesh-ancestor
138266179|NCT05425875|Sequestering Agents|sequestering agents|mesh-ancestor
138223445|NCT04512365|Dronabinol|dronabinol|mesh-list
138266180|NCT05425875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266182|NCT05414240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138266183|NCT05414240|Autonomic Agents|autonomic agents|mesh-ancestor
138266184|NCT05414240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266185|NCT05414240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266186|NCT05414240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138266187|NCT05414240|Respiratory System Agents|respiratory system agents|mesh-ancestor
138266188|NCT05414240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138266189|NCT05414240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266190|NCT05414240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266191|NCT05414240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138266192|NCT05414240|Vasodilator Agents|vasodilator agents|mesh-ancestor
138266193|NCT05401227|Ketamine|ketamine|mesh-list
138266194|NCT05401227|Analgesics|analgesics|mesh-ancestor
138266195|NCT05401227|Sensory System Agents|sensory system agents|mesh-ancestor
138484961|NCT00007891|Antibodies|antibodies|mesh-list
138266197|NCT05401227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266198|NCT05401227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138251903|NCT05031455|Analgesics|analgesics|mesh-ancestor
138266199|NCT05401227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138266200|NCT05401227|Anesthetics, General|anesthetics, general|mesh-ancestor
138266201|NCT05401227|Anesthetics|anesthetics|mesh-ancestor
138266202|NCT05401227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266203|NCT05401227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138266204|NCT05401227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138266205|NCT05401227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266206|NCT05401227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266207|NCT05398653|Cyclosporine|cyclosporine|mesh-list
138266208|NCT05398653|Cyclosporins|cyclosporins|mesh-list
138266209|NCT05398653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266210|NCT05398653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266211|NCT05398653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138266212|NCT05398653|Immunologic Factors|immunologic factors|mesh-ancestor
138266213|NCT05398653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266214|NCT05398653|Antifungal Agents|antifungal agents|mesh-ancestor
138266215|NCT05398653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138266216|NCT05398653|Dermatologic Agents|dermatologic agents|mesh-ancestor
138266217|NCT05398653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138251944|NCT00380835|Amrubicin|amrubicin|mesh-list
138266218|NCT05398653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138266219|NCT05378555|Ketamine|ketamine|mesh-list
138266220|NCT05378555|Analgesics|analgesics|mesh-ancestor
138266221|NCT05378555|Sensory System Agents|sensory system agents|mesh-ancestor
138266222|NCT05378555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266223|NCT05378555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266224|NCT05378555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138266225|NCT05378555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138266226|NCT05378555|Anesthetics, General|anesthetics, general|mesh-ancestor
138266227|NCT05378555|Anesthetics|anesthetics|mesh-ancestor
138266228|NCT05378555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266229|NCT05378555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138266230|NCT05378555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138266231|NCT05378555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266232|NCT05378555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266234|NCT05329766|Fluorouracil|fluorouracil|mesh-list
138266235|NCT05329766|Oxaliplatin|oxaliplatin|mesh-list
138266236|NCT05329766|Quemliclustat|quemliclustat|mesh-list
138266237|NCT05329766|Antimetabolites|antimetabolites|mesh-ancestor
138266238|NCT05329766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266239|NCT05329766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138266240|NCT05329766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266241|NCT05329766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138266242|NCT05329766|Immunologic Factors|immunologic factors|mesh-ancestor
138266243|NCT05329766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266244|NCT05329766|Antidotes|antidotes|mesh-ancestor
138266245|NCT05329766|Protective Agents|protective agents|mesh-ancestor
138266246|NCT05329766|Vitamin B Complex|vitamin b complex|mesh-ancestor
138266247|NCT05329766|Vitamins|vitamins|mesh-ancestor
138266248|NCT05329766|Micronutrients|micronutrients|mesh-ancestor
138266249|NCT05329766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138266250|NCT05329766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266251|NCT05324852|Midazolam|midazolam|mesh-list
138266252|NCT05324852|Loxapine|loxapine|mesh-list
138266253|NCT05324852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138266254|NCT05324852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138266255|NCT05324852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266256|NCT05324852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266257|NCT05324852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138266258|NCT05324852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138266259|NCT05324852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138266260|NCT05324852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138266261|NCT05324852|Anesthetics, General|anesthetics, general|mesh-ancestor
138266262|NCT05324852|Anesthetics|anesthetics|mesh-ancestor
138192755|NCT00980798|Hydromorphone|hydromorphone|mesh-list
138266263|NCT05324852|GABA Modulators|gaba modulators|mesh-ancestor
138266264|NCT05324852|GABA Agents|gaba agents|mesh-ancestor
138266265|NCT05324852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266266|NCT05324852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266267|NCT05324852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138266268|NCT05324852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138266269|NCT05324852|Dopamine Agents|dopamine agents|mesh-ancestor
138266271|NCT05319756|Gabapentin|gabapentin|mesh-list
138266272|NCT05319756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138266273|NCT05319756|Narcotics|narcotics|mesh-ancestor
138266274|NCT05319756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266275|NCT05319756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266276|NCT05319756|Analgesics|analgesics|mesh-ancestor
138266277|NCT05319756|Sensory System Agents|sensory system agents|mesh-ancestor
138266278|NCT05319756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266279|NCT05319756|Anticonvulsants|anticonvulsants|mesh-ancestor
138266280|NCT05319756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138266281|NCT05319756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138266282|NCT05319756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138266283|NCT05319756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138266284|NCT05319756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138266285|NCT05319756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266286|NCT05319756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266287|NCT05319756|Antimanic Agents|antimanic agents|mesh-ancestor
138266288|NCT05308901|Pembrolizumab|pembrolizumab|mesh-list
138266289|NCT05308901|Lenvatinib|lenvatinib|mesh-list
138266290|NCT05308901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266291|NCT05308901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266292|NCT05308901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138266293|NCT05308901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266295|NCT05308901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266296|NCT05305105|Psilocybin|psilocybin|mesh-list
138266297|NCT05305105|Hallucinogens|hallucinogens|mesh-ancestor
138266298|NCT05305105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266299|NCT05305105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138266300|NCT05301608|Psilocybin|psilocybin|mesh-list
138266301|NCT05301608|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138266302|NCT05301608|Hallucinogens|hallucinogens|mesh-ancestor
138266303|NCT05301608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266304|NCT05301608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138266305|NCT05301608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138266306|NCT05301608|Serotonin Agents|serotonin agents|mesh-ancestor
138266307|NCT05301608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266308|NCT05301608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252124|NCT05210465|Dobutamine|dobutamine|mesh-list
138266309|NCT05301608|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138266310|NCT05301361|Methylphenidate|methylphenidate|mesh-list
138266311|NCT05301361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138266312|NCT05301361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266313|NCT05301361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138266314|NCT05301361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138266315|NCT05301361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138266316|NCT05301361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266317|NCT05301361|Dopamine Agents|dopamine agents|mesh-ancestor
138266319|NCT05280340|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138266320|NCT05280340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138266322|NCT05273567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138266323|NCT05273567|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138266324|NCT05273567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138266326|NCT05273567|Adrenergic Agents|adrenergic agents|mesh-ancestor
138266327|NCT05273567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266328|NCT05273567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266329|NCT05273567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266330|NCT05266729|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
138266331|NCT05266729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138266332|NCT05266729|Antimetabolites|antimetabolites|mesh-ancestor
138266333|NCT05266729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266334|NCT05266729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138266335|NCT05257018|Doxorubicin|doxorubicin|mesh-list
138266336|NCT05257018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138266337|NCT05257018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138223579|NCT03911414|Expectorants|expectorants|mesh-ancestor
138266339|NCT05257018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138266340|NCT05257018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266341|NCT05257018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266342|NCT05243862|Atezolizumab|atezolizumab|mesh-list
138266343|NCT05243862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138266344|NCT05243862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266345|NCT05243862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266346|NCT05243862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266347|NCT05186779|Progestins|progestins|mesh-list
138266349|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138266350|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266351|NCT05180825|Trametinib|trametinib|mesh-list
138252136|NCT05210465|Protective Agents|protective agents|mesh-ancestor
138266352|NCT05180825|Vinblastine|vinblastine|mesh-list
138266353|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266354|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138266355|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266356|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266357|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138266358|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
138266359|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
138266360|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
138266361|NCT05177146|Ketamine|ketamine|mesh-list
138266362|NCT05177146|Analgesics|analgesics|mesh-ancestor
138266363|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
138266364|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266365|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266366|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138266367|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138266368|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
138266369|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
138266370|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266371|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138266372|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138252185|NCT00380913|Nabilone|nabilone|mesh-list
138266373|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266374|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266375|NCT05166421|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
138266376|NCT05166421|Antiviral Agents|antiviral agents|mesh-ancestor
138266377|NCT05166421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138266379|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138485139|NCT05636566|Propofol|propofol|mesh-list
138266380|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138266381|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266382|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266383|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
138266384|NCT05156268|Olaparib|olaparib|mesh-list
138266385|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266386|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266387|NCT05156268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138266388|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266389|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138266390|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266391|NCT05154136|Itraconazole|itraconazole|mesh-list
138192775|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
138266392|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
138266393|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138266394|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138266395|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138266396|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266397|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266398|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138266399|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
138266400|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138266401|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266402|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138266403|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138266404|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138266405|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138266406|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266407|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266408|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138266409|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138485175|NCT05637268|Paclitaxel|paclitaxel|mesh-list
138266410|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266411|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
138266412|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266413|NCT05137938|Ketamine|ketamine|mesh-list
138266414|NCT05137938|Analgesics|analgesics|mesh-ancestor
138266415|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
138266416|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266417|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266418|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138266419|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138266420|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
138266421|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
138266422|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266423|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138266424|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138266425|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266426|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266427|NCT05117125|Heparin|heparin|mesh-list
138266428|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
138266429|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138266430|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138266431|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266432|NCT05114460|Naloxone|naloxone|mesh-list
138266433|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138266434|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266435|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
138266436|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266437|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
138266438|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
138266439|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
138266440|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266441|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266442|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
138266443|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266444|NCT05105841|Venetoclax|venetoclax|mesh-list
138266445|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
138266446|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266447|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266448|NCT05099848|Leucovorin|leucovorin|mesh-list
138266449|NCT05099848|Fluorouracil|fluorouracil|mesh-list
138266450|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
138266451|NCT05099848|Apatinib|apatinib|mesh-list
138266452|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
138266453|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266454|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138266455|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266456|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138266457|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
138266458|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266459|NCT05099848|Antidotes|antidotes|mesh-ancestor
138266460|NCT05099848|Protective Agents|protective agents|mesh-ancestor
138266461|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
138266462|NCT05099848|Vitamins|vitamins|mesh-ancestor
138266463|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
138266464|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138266465|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266466|NCT05098327|Pioglitazone|pioglitazone|mesh-list
138266467|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138266468|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266469|NCT05092373|Paclitaxel|paclitaxel|mesh-list
138266470|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138266471|NCT05092373|Atezolizumab|atezolizumab|mesh-list
138266472|NCT05092373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138266473|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138266474|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266475|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
138266476|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
138266477|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
138266478|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138223730|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
138266479|NCT05092373|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138252297|NCT00002325|Fluconazole|fluconazole|mesh-list
138266480|NCT05092373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266481|NCT05092373|Immunologic Factors|immunologic factors|mesh-ancestor
138266482|NCT05092373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266483|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
138266484|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266485|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266486|NCT05082610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138266487|NCT05082610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266489|NCT05074589|Fluorouracil|fluorouracil|mesh-list
138266490|NCT05074589|Irinotecan|irinotecan|mesh-list
138266491|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
138266492|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
138266493|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266494|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138266495|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266496|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138266497|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
138266498|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266499|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138266500|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138266501|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266502|NCT05074589|Antidotes|antidotes|mesh-ancestor
138266503|NCT05074589|Protective Agents|protective agents|mesh-ancestor
138266504|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
138266505|NCT05074589|Vitamins|vitamins|mesh-ancestor
138266506|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
138266507|NCT05061654|Tazobactam|tazobactam|mesh-list
138266508|NCT05061654|Ceftolozane|ceftolozane|mesh-list
138266509|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
138266510|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138266511|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138266512|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138266513|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266514|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266515|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138266517|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138266518|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
138266519|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266520|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266521|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138266522|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138266523|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
138266524|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266525|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266526|NCT05053126|Pregabalin|pregabalin|mesh-list
138266527|NCT05053126|Oxycodone|oxycodone|mesh-list
138266528|NCT05053126|Analgesics|analgesics|mesh-ancestor
138266529|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
138266530|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266531|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266532|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
138266533|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138266534|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138266535|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266536|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138266537|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138266538|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138266539|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266540|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138266541|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138266542|NCT05053126|Narcotics|narcotics|mesh-ancestor
138266543|NCT05049616|Nifedipine|nifedipine|mesh-list
138266544|NCT05049616|Diuretics|diuretics|mesh-list
138266545|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138266546|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138266547|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138266548|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266549|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138266550|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266551|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
138266553|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138192827|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138266554|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
138266555|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
138266556|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266558|NCT05049213|Povidone|povidone|mesh-list
138266559|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
138266560|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
138266561|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138266562|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138266564|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138266565|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266566|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266567|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138266568|NCT05025605|Analgesics|analgesics|mesh-ancestor
138266569|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
138266570|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266571|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138266572|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138266573|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138266574|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
138266575|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266576|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266577|NCT05020600|Pregabalin|pregabalin|mesh-list
138266578|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138266579|NCT05020600|Amitriptyline|amitriptyline|mesh-list
138266580|NCT05020600|Analgesics|analgesics|mesh-ancestor
138266581|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
138266582|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266583|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266584|NCT05020600|Anticonvulsants|anticonvulsants|mesh-ancestor
138266585|NCT05020600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138266586|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138266587|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266588|NCT05020600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138266590|NCT05020600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138266591|NCT05020600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266592|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138485294|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138266593|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138266594|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138266596|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
138266597|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
138266598|NCT05020600|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138266599|NCT05020600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138266600|NCT05020600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138266601|NCT05020600|Adrenergic Agents|adrenergic agents|mesh-ancestor
138266602|NCT05011266|Buprenorphine|buprenorphine|mesh-list
138266603|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138266605|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138266606|NCT05011266|Narcotics|narcotics|mesh-ancestor
138266607|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266608|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266609|NCT05011266|Analgesics|analgesics|mesh-ancestor
138266610|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
138266611|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266612|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138266613|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
138266614|NCT05000450|Fludarabine|fludarabine|mesh-list
138192848|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
138266615|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138266616|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
138266617|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266618|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138266619|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138266620|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
138266621|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266622|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266623|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138266624|NCT04998279|Lenograstim|lenograstim|mesh-list
138266625|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138266626|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
138266627|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266628|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138266629|NCT04973930|Escitalopram|escitalopram|mesh-list
138266630|NCT04973930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138266631|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138266632|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138266633|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266634|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138223874|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138266668|NCT04939480|Atezolizumab|atezolizumab|mesh-list
138266669|NCT04939480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138252417|NCT00002367|Saquinavir|saquinavir|mesh-list
138266670|NCT04939480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266671|NCT04939480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138485357|NCT00000457|Bupropion|bupropion|mesh-list
138266672|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266673|NCT04927780|Leucovorin|leucovorin|mesh-list
138266674|NCT04927780|Fluorouracil|fluorouracil|mesh-list
138266675|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
138266676|NCT04927780|Irinotecan|irinotecan|mesh-list
138266677|NCT04927780|Calcium|calcium|mesh-list
138266678|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
138266679|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138266680|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266681|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
138266682|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266683|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138266684|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266685|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138266686|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
138266687|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138266688|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138266689|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266690|NCT04927780|Antidotes|antidotes|mesh-ancestor
138266691|NCT04927780|Protective Agents|protective agents|mesh-ancestor
138266692|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
138266693|NCT04927780|Vitamins|vitamins|mesh-ancestor
138266694|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
138266695|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
138266696|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
138266697|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266698|NCT04880863|Docetaxel|docetaxel|mesh-list
138266699|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
138266700|NCT04880863|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
138266701|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266702|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
138266703|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
138223946|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138266704|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
138266705|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266708|NCT04880863|Immunologic Factors|immunologic factors|mesh-ancestor
138266709|NCT04880863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266710|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
138266711|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
138266712|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266713|NCT04871529|Carboplatin|carboplatin|mesh-list
138266714|NCT04871529|Gemcitabine|gemcitabine|mesh-list
138266715|NCT04871529|Avelumab|avelumab|mesh-list
138266716|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
138266717|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
138266718|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138266719|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266720|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138266721|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
138252490|NCT00002199|Lamivudine|lamivudine|mesh-list
138252491|NCT00002199|Zidovudine|zidovudine|mesh-list
138266722|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266723|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
138266724|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266725|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266726|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
138266727|NCT04865887|Lenvatinib|lenvatinib|mesh-list
138266728|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266729|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266730|NCT04865887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138266731|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266732|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138266733|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266734|NCT04864444|Piperaquine|piperaquine|mesh-list
138266735|NCT04864444|Primaquine|primaquine|mesh-list
138266736|NCT04864444|Artenimol|artenimol|mesh-list
138266737|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
138266738|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138266739|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138266740|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138266741|NCT04853043|Cetuximab|cetuximab|mesh-list
138266742|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266745|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138266746|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138266747|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266748|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138266749|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138266750|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266751|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138266752|NCT04826133|Vitamins|vitamins|mesh-ancestor
138266753|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
138266754|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138266755|NCT04792645|Memantine|memantine|mesh-list
138266756|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138266757|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138266758|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
138266759|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266760|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266761|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266762|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138485446|NCT00000487|Diuretics|diuretics|mesh-list
138266763|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138266764|NCT04791228|Doxorubicin|doxorubicin|mesh-list
138266765|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138266766|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138266767|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266768|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138266769|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138266770|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266771|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266772|NCT04768296|Topotecan|topotecan|mesh-list
138266773|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138266774|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138266775|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266776|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266777|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266778|NCT04760626|Insulin|insulin|mesh-list
138266779|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138266780|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
138266781|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138266782|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266783|NCT04757376|Denosumab|denosumab|mesh-list
138266784|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138266785|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266786|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138266789|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138266792|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138266793|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138266794|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138266795|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138266796|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
138266797|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138266798|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266799|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138266800|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138266801|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
138266802|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138266803|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266804|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266805|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138266806|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138266807|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138266808|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138266809|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
138266810|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138266811|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138266812|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
138266813|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138266814|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
138266815|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138266816|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138192900|NCT00986882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266817|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138266819|NCT04729725|Antibodies|antibodies|mesh-list
138266820|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138266821|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
138266822|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266823|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266824|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266825|NCT04723004|Bevacizumab|bevacizumab|mesh-list
138266826|NCT04723004|Sorafenib|sorafenib|mesh-list
138266827|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266828|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252624|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
138266829|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138266830|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138266831|NCT04723004|Growth Substances|growth substances|mesh-ancestor
138266832|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266833|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
138266834|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138266835|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266836|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266837|NCT04706741|Prednisone|prednisone|mesh-list
138266838|NCT04706741|Prednisolone|prednisolone|mesh-list
138266839|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138266840|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
138266841|NCT04706741|Hormones|hormones|mesh-ancestor
138266842|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138266843|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266844|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138266845|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266846|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138266847|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
138266848|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266849|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138266850|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138266851|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
138266852|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266853|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266854|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138266855|NCT04676334|Rucaparib|rucaparib|mesh-list
138266856|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138266857|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266858|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266859|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266860|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
138266862|NCT04669197|Gemcitabine|gemcitabine|mesh-list
138252663|NCT00002451|Ritonavir|ritonavir|mesh-list
138252664|NCT00002451|Indinavir|indinavir|mesh-list
138266863|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138224092|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138266864|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138266865|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266866|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
138266867|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
138266868|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
138266869|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266870|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138266871|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
138266872|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
138266873|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138266874|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138266875|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138266876|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138266877|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138266879|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266880|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266881|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138266882|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138266883|NCT04660812|Growth Substances|growth substances|mesh-ancestor
138266884|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266885|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
138266886|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138266887|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
138266888|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266889|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138266890|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138266891|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
138266892|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266893|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266894|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138266895|NCT04610398|Dexamethasone|dexamethasone|mesh-list
138266896|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
138266897|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138266898|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
138266899|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
138266900|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266901|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266902|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138266903|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
138266904|NCT04610398|Hormones|hormones|mesh-ancestor
138266905|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138266906|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138266907|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266908|NCT04607460|Coal Tar|coal tar|mesh-list
138266909|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
138266910|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
138266911|NCT04606069|Regadenoson|regadenoson|mesh-list
138266912|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138266913|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138266914|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
138266915|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
138266916|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266917|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266918|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266919|NCT04595981|Cisplatin|cisplatin|mesh-list
138266920|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266921|NCT04575311|Quemliclustat|quemliclustat|mesh-list
138266922|NCT04575311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138266923|NCT04575311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266924|NCT04575311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266925|NCT04575311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266926|NCT04565730|Anesthetics|anesthetics|mesh-list
138266927|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138266928|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266929|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138266930|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138266931|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138266932|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266933|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138266934|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138266935|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266936|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
138266937|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138252803|NCT04862585|Paclitaxel|paclitaxel|mesh-list
138266938|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
138266939|NCT04523480|Testosterone|testosterone|mesh-list
138266940|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
138266941|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
138266942|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138266943|NCT04523480|Androgens|androgens|mesh-ancestor
138266944|NCT04523480|Hormones|hormones|mesh-ancestor
138192932|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138266945|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138266946|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266947|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138485613|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138266948|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266949|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
138266950|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
138266951|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266952|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266953|NCT04521621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138266954|NCT04521621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266955|NCT04521569|Regadenoson|regadenoson|mesh-list
138266956|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138266957|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138266958|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
138266959|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
138266960|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138266961|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266962|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138266963|NCT04497142|Levetiracetam|levetiracetam|mesh-list
138266964|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
138266965|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
138266966|NCT04495257|Nivolumab|nivolumab|mesh-list
138266967|NCT04495257|Ipilimumab|ipilimumab|mesh-list
138266968|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266969|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266970|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138266971|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266972|NCT04477759|Atezolizumab|atezolizumab|mesh-list
138266973|NCT04477759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138266974|NCT04477759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138266975|NCT04477759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266976|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266977|NCT04477343|Nivolumab|nivolumab|mesh-list
138266978|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138266979|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138266980|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138374483|NCT01427985|Atropine|atropine|mesh-list
138267003|NCT04414475|Pomalidomide|pomalidomide|mesh-list
138267004|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138224188|NCT05312294|Vaccines|vaccines|mesh-list
138267005|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
138267006|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
138267007|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267008|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267009|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138267010|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
138267012|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138267013|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138267014|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267015|NCT04414475|Immunologic Factors|immunologic factors|mesh-ancestor
138267016|NCT04414475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138267017|NCT04414475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138267019|NCT04414475|Growth Inhibitors|growth inhibitors|mesh-ancestor
138267021|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267022|NCT04354246|Pembrolizumab|pembrolizumab|mesh-list
138267023|NCT04354246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267024|NCT04354246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267025|NCT04354246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267026|NCT04354246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267028|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138267029|NCT04352166|Narcotics|narcotics|mesh-ancestor
138267030|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138267031|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267032|NCT04352166|Analgesics|analgesics|mesh-ancestor
138267033|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
138267034|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267035|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138267036|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138267037|NCT04316702|Analgesics|analgesics|mesh-ancestor
138267038|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
138267039|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267040|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267041|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138267042|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267043|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138267044|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138267045|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138224228|NCT02504268|Methotrexate|methotrexate|mesh-list
138267046|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267047|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
138267048|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
138267049|NCT04292457|Propofol|propofol|mesh-list
138267050|NCT04292457|Sevoflurane|sevoflurane|mesh-list
138267051|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138267052|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138267053|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267054|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138267055|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
138267056|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
138267057|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138267058|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138267059|NCT04291599|Ketorolac|ketorolac|mesh-list
138267060|NCT04291599|Morphine|morphine|mesh-list
138267061|NCT04291599|Hydromorphone|hydromorphone|mesh-list
138267062|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138374567|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267063|NCT04291599|Narcotics|narcotics|mesh-ancestor
138267064|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138267065|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267066|NCT04291599|Analgesics|analgesics|mesh-ancestor
138267067|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
138267068|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267069|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138267070|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138267071|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138267072|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138267073|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138267074|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138192969|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
138192970|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
138192971|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
138267075|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267076|NCT04274179|Lamotrigine|lamotrigine|mesh-list
138267077|NCT04274179|Valproic Acid|valproic acid|mesh-list
138267078|NCT04274179|Ethosuximide|ethosuximide|mesh-list
138267079|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
138267080|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138267081|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138267082|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267083|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138224261|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
138224277|NCT01832558|Diuretics|diuretics|mesh-ancestor
138267084|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267085|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138267086|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138267087|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138267088|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138267089|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138267090|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267091|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
138267092|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267093|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
138267094|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
138267095|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
138267096|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138267097|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267098|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267099|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
138267100|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138267101|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138267102|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267103|NCT04272086|Bupivacaine|bupivacaine|mesh-list
138267104|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
138267105|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
138267106|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138267107|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267108|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
138267109|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267111|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
138267112|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267113|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
138267114|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
138267115|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
138267116|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267117|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267118|NCT04256707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267120|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138267121|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267122|NCT04249427|Analgesics|analgesics|mesh-ancestor
138224297|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
138267123|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
138374645|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138267124|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267125|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267128|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267129|NCT04230304|Daratumumab|daratumumab|mesh-list
138267130|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267132|NCT04205552|Relatlimab|relatlimab|mesh-list
138267133|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138267134|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267135|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267136|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267137|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267138|NCT04192136|Niacinamide|niacinamide|mesh-list
138267139|NCT04192136|Niacin|niacin|mesh-list
138267140|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
138192978|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138267141|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
138267142|NCT04192136|Vitamins|vitamins|mesh-ancestor
138267143|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
138267144|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267145|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138267146|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
138267147|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267148|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138267149|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
138267150|NCT04181996|Colchicine|colchicine|mesh-list
138267151|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
138267152|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138267153|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
138267154|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
138267155|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
138267156|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267157|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267158|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
138267159|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
138267160|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267161|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267162|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267163|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
138267164|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
138267166|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138267167|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138267168|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138267169|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
138267170|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138485771|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138267171|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267172|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138267173|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
138267174|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
138267175|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
138267176|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138267177|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138267178|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
138267179|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267180|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267181|NCT04167111|Vitamin D|vitamin d|mesh-list
138267182|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
138267183|NCT04167111|Vitamins|vitamins|mesh-ancestor
138267184|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
138267185|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267186|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138267187|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138267188|NCT04139304|Prednisone|prednisone|mesh-list
138267190|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
138267191|NCT04139304|Doxorubicin|doxorubicin|mesh-list
138267192|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138267193|NCT04139304|Etoposide|etoposide|mesh-list
138267194|NCT04139304|Vincristine|vincristine|mesh-list
138267195|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
138267196|NCT04139304|Daunorubicin|daunorubicin|mesh-list
138267197|NCT04139304|Daratumumab|daratumumab|mesh-list
138267198|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
138374744|NCT01429545|Nifedipine|nifedipine|mesh-list
138267199|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138267200|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
138267201|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267202|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138267203|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138267204|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
138267205|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267206|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267207|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138192986|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138267208|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138267209|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138267210|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138267211|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267212|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138267213|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
138267215|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138267216|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138267217|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138267218|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
138267219|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
138267220|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
138267221|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
138267222|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
138267223|NCT04135690|Sorafenib|sorafenib|mesh-list
138267224|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267225|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138267226|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267227|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267228|NCT04126317|Aflibercept|aflibercept|mesh-list
138267229|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138267230|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138267231|NCT04126317|Growth Substances|growth substances|mesh-ancestor
138267232|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267233|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
138224418|NCT03219710|Hormones|hormones|mesh-ancestor
138267235|NCT04123314|Psilocybin|psilocybin|mesh-list
138267236|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
138267237|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267238|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138267239|NCT04109924|Trifluridine|trifluridine|mesh-list
138267240|NCT04109924|Bevacizumab|bevacizumab|mesh-list
138267241|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138267242|NCT04109924|Irinotecan|irinotecan|mesh-list
138267243|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
138267244|NCT04109924|Antibodies|antibodies|mesh-list
138267245|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
138267246|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138267247|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267248|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138267249|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138267250|NCT04109924|Growth Substances|growth substances|mesh-ancestor
138267251|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267252|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
138267253|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
138267254|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138267255|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138267256|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267257|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267258|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
138267259|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
138267260|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138267261|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138267262|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
138267263|NCT04093596|Fludarabine|fludarabine|mesh-list
138267264|NCT04093596|Nirogacestat|nirogacestat|mesh-list
138267265|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138267266|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
138267267|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267268|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138267269|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138267270|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
138267271|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267273|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138267274|NCT04093596|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138224456|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
138267277|NCT04091750|Ipilimumab|ipilimumab|mesh-list
138267278|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267279|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267280|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267281|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267282|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
138267283|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267284|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267285|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
138267287|NCT04043195|Ipilimumab|ipilimumab|mesh-list
138267288|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267289|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267290|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267291|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267292|NCT04038255|Nicotine|nicotine|mesh-list
138267293|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138267294|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
138267295|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267296|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267297|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138267298|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138267299|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
138267300|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267301|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267302|NCT04031729|Aspirin|aspirin|mesh-list
138267303|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138267304|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138267305|NCT04031729|Analgesics|analgesics|mesh-ancestor
138267306|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
138267307|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267308|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267309|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138267310|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138267311|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138267312|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138267313|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267314|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138267315|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138267316|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267317|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
138267318|NCT04024163|Benzonidazole|benzonidazole|mesh-list
138267319|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138267320|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
138267321|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267322|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138267323|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138267324|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138224484|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
138267325|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138267326|NCT04023019|Thrombin|thrombin|mesh-list
138267329|NCT04014387|Zolpidem|zolpidem|mesh-list
138267330|NCT04014387|Suvorexant|suvorexant|mesh-list
138267331|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138267332|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138267333|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138267334|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267335|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138267336|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
138267337|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
138267338|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267339|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267340|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138267341|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
138267342|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138267343|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
138267344|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138267345|NCT04005053|Expectorants|expectorants|mesh-ancestor
138267346|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
138267347|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138267348|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
138267349|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267350|NCT04005053|Protective Agents|protective agents|mesh-ancestor
138267351|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267352|NCT04005053|Antidotes|antidotes|mesh-ancestor
138267353|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
138267354|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138267355|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
138267356|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267357|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138267358|NCT03981796|Paclitaxel|paclitaxel|mesh-list
138267359|NCT03981796|Carboplatin|carboplatin|mesh-list
138267360|NCT03981796|Niraparib|niraparib|mesh-list
138267361|NCT03981796|Dostarlimab|dostarlimab|mesh-list
138267362|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138267363|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267364|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
138374957|NCT01430923|Latanoprost|latanoprost|mesh-list
138267365|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
138267366|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
138267367|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267368|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138267369|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267370|NCT03968406|Talazoparib|talazoparib|mesh-list
138267371|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138267372|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267373|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267374|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267376|NCT03961698|Bevacizumab|bevacizumab|mesh-list
138267377|NCT03961698|Atezolizumab|atezolizumab|mesh-list
138267378|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138267379|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267380|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
138193047|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
138267381|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
138267382|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
138485956|NCT00000799|Cidofovir|cidofovir|mesh-list
138267383|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267384|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267385|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138267386|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138267387|NCT03961698|Growth Substances|growth substances|mesh-ancestor
138267388|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267389|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
138267390|NCT03961698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267391|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
138267392|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
138267393|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138267394|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138267395|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374988|NCT01431118|Camphor|camphor|mesh-list
138267396|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267397|NCT03945643|Urological Agents|urological agents|mesh-ancestor
138267399|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138267400|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138267401|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138267402|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138267403|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267428|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138267430|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
138267431|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267432|NCT03905928|Nicotine|nicotine|mesh-list
138267433|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138267434|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
138267435|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267436|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267437|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138267438|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138267439|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
138267440|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267441|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267442|NCT03872700|Fentanyl|fentanyl|mesh-list
138267443|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138267444|NCT03872700|Narcotics|narcotics|mesh-ancestor
138267445|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138267446|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267448|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
138267449|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267450|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138267451|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138267452|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
138267453|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
138267454|NCT03846310|Carboplatin|carboplatin|mesh-list
138267455|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
138267456|NCT03846310|Pemetrexed|pemetrexed|mesh-list
138267457|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267458|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138193054|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193055|NCT04550546|Nystatin|nystatin|mesh-list
138267459|NCT03846310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267460|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267462|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138267463|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138267464|NCT03818776|Durvalumab|durvalumab|mesh-list
138267465|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267466|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267467|NCT03738800|Trifarotene|trifarotene|mesh-list
138267468|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
138224580|NCT01558661|Axitinib|axitinib|mesh-list
138267469|NCT03736889|Tislelizumab|tislelizumab|mesh-list
138267470|NCT03736889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267471|NCT03736889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267473|NCT03719326|Doxorubicin|doxorubicin|mesh-list
138267474|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138267475|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138267476|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138267477|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267478|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
138267479|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
138267480|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
138267481|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267482|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138267483|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138267484|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138267485|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267486|NCT03717909|Valproic Acid|valproic acid|mesh-list
138267487|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
138267488|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267489|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267490|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
138267491|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267492|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267493|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
138375068|NCT01431612|Phenylephrine|phenylephrine|mesh-list
138267494|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138267495|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138267496|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138267497|NCT03715478|Dexamethasone|dexamethasone|mesh-list
138267498|NCT03715478|Pomalidomide|pomalidomide|mesh-list
138267499|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138267500|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
138267501|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
138267502|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267503|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267504|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138267505|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
138267506|NCT03715478|Hormones|hormones|mesh-ancestor
138267507|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138267508|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138224612|NCT03217448|Dabigatran|dabigatran|mesh-list
138267509|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267510|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
138267511|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138267512|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138267513|NCT03715478|Growth Substances|growth substances|mesh-ancestor
138267514|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
138267515|NCT03709043|Ethanol|ethanol|mesh-list
138267516|NCT03709043|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138267517|NCT03709043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138267518|NCT03709043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138193074|NCT05506410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138267519|NCT03709043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267520|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138267521|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
138267522|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267523|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
138267524|NCT03688464|Promethazine|promethazine|mesh-list
138267525|NCT03688464|Melatonin|melatonin|mesh-list
138267526|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
138267527|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267529|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267530|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138375112|NCT01431924|Xhance|xhance|mesh-list
138267531|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138267532|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138267533|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
138267534|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
138267535|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
138267536|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267537|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
138267538|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
138267539|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138267540|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138267541|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
138267543|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267544|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138267545|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
138267546|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
138267547|NCT03677973|Quemliclustat|quemliclustat|mesh-list
138267548|NCT03677973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267549|NCT03677973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267550|NCT03677973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267551|NCT03677973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267552|NCT03666065|Insulin|insulin|mesh-list
138267553|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138267554|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
138224648|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
138267555|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138267556|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267557|NCT03654716|Cytarabine|cytarabine|mesh-list
138267558|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138267559|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
138267560|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375147|NCT01432028|Diuretics|diuretics|mesh-ancestor
138267561|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267562|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
138267563|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138267564|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138267565|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
138267566|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267567|NCT03629613|Antioxidants|antioxidants|mesh-list
138267568|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267569|NCT03629613|Protective Agents|protective agents|mesh-ancestor
138267570|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267571|NCT03583086|Nivolumab|nivolumab|mesh-list
138267572|NCT03583086|Vorolanib|vorolanib|mesh-list
138267573|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267574|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267575|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267576|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486075|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267577|NCT03583086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138267578|NCT03583086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193088|NCT05506332|Mercaptopurine|mercaptopurine|mesh-list
138267579|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
138267580|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267581|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267582|NCT03534804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267583|NCT03534804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267584|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138267585|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138267586|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138267587|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138267588|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267589|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267590|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267591|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138224687|NCT01457885|Busulfan|busulfan|mesh-list
138267593|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138267594|NCT03493412|Verapamil|verapamil|mesh-list
138267595|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138267596|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138267597|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138267598|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267599|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138267600|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267601|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
138267603|NCT03474198|Rifampin|rifampin|mesh-list
138267604|NCT03474198|Isoniazid|isoniazid|mesh-list
138267605|NCT03474198|Linezolid|linezolid|mesh-list
138267606|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
138267607|NCT03474198|Ethambutol|ethambutol|mesh-list
138267608|NCT03474198|Rifapentine|rifapentine|mesh-list
138267609|NCT03474198|Bedaquiline|bedaquiline|mesh-list
138267611|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138267612|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138267613|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138267614|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138267615|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138267616|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267617|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267618|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267619|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138267620|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138267621|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138267622|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
138267623|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
138267624|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138267625|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138267626|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138267627|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138267628|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138267629|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138267630|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138267631|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138267632|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138267633|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
138267634|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138267636|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138267638|NCT03421288|Docetaxel|docetaxel|mesh-list
138375288|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138267639|NCT03421288|Fluorouracil|fluorouracil|mesh-list
138267640|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
138267641|NCT03421288|Atezolizumab|atezolizumab|mesh-list
138267642|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267643|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
138267644|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
138193099|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
138267645|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
138267646|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267647|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
138267648|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138267649|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138267650|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
138267651|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267652|NCT03421288|Antidotes|antidotes|mesh-ancestor
138267653|NCT03421288|Protective Agents|protective agents|mesh-ancestor
138267654|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
138267655|NCT03421288|Vitamins|vitamins|mesh-ancestor
138267656|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
138267657|NCT03421288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267658|NCT03421288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267659|NCT03418922|Nivolumab|nivolumab|mesh-list
138267660|NCT03418922|Lenvatinib|lenvatinib|mesh-list
138267661|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267662|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267663|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267664|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267665|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138267666|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267667|NCT03342027|Bupropion|bupropion|mesh-list
138486145|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
138267668|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138267669|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
138267670|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138267671|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138267672|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138267673|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138267674|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267675|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
138267676|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267677|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267678|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138267679|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138267680|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267681|NCT03245541|Durvalumab|durvalumab|mesh-list
138267682|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267683|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267684|NCT03245489|Aspirin|aspirin|mesh-list
138267685|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
138267686|NCT03245489|Clopidogrel|clopidogrel|mesh-list
138267687|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267689|NCT03245489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267690|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267691|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138267692|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138267693|NCT03245489|Analgesics|analgesics|mesh-ancestor
138267694|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
138267695|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267696|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267697|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138267698|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138267699|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138267700|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138267701|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138267702|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138267703|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267704|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
138267705|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138267706|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138267707|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138267709|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267710|NCT03240809|Brodalumab|brodalumab|mesh-list
138267711|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138267712|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
138267713|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
138267714|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267715|NCT03192995|Cocaine|cocaine|mesh-list
138267716|NCT03192995|Anesthetics, Local|anesthetics, local|mesh-ancestor
138267717|NCT03192995|Anesthetics|anesthetics|mesh-ancestor
138267718|NCT03192995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138267719|NCT03192995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267721|NCT03192995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267722|NCT03192995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138267723|NCT03192995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138267724|NCT03192995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138267725|NCT03192995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138267726|NCT03192995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267727|NCT03192995|Dopamine Agents|dopamine agents|mesh-ancestor
138267728|NCT03192995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138267729|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
138267730|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138267731|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138267732|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
138267733|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138267734|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138267735|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138267736|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267737|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267738|NCT03150511|Tesamorelin|tesamorelin|mesh-list
138267739|NCT03150511|Growth Substances|growth substances|mesh-ancestor
138267740|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267741|NCT03121677|Poly I-C|poly i-c|mesh-list
138267742|NCT03121677|Rituximab|rituximab|mesh-list
138267743|NCT03121677|Nivolumab|nivolumab|mesh-list
138267744|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138267745|NCT03121677|Poly ICLC|poly iclc|mesh-list
138267746|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267747|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267748|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
138267749|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267750|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138267751|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267752|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267753|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
138267754|NCT03121677|Laxatives|laxatives|mesh-ancestor
138267755|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138267756|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
138486182|NCT00000940|Ritonavir|ritonavir|mesh-list
138267757|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138267758|NCT03110926|Leucovorin|leucovorin|mesh-list
138267759|NCT03110926|Paclitaxel|paclitaxel|mesh-list
138267760|NCT03110926|Carboplatin|carboplatin|mesh-list
138267761|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
138267762|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138267763|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267764|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
138267765|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
138193129|NCT01016483|Gemcitabine|gemcitabine|mesh-list
138267766|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
138267767|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267768|NCT03110926|Antidotes|antidotes|mesh-ancestor
138267769|NCT03110926|Protective Agents|protective agents|mesh-ancestor
138267770|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267771|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
138267772|NCT03110926|Vitamins|vitamins|mesh-ancestor
138375524|NCT01434212|Ribavirin|ribavirin|mesh-list
138267773|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
138267774|NCT03092856|Axitinib|axitinib|mesh-list
138267775|NCT03092856|Antibodies|antibodies|mesh-list
138267776|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
138267777|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267778|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267779|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138267780|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267781|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267782|NCT03043950|Panitumumab|panitumumab|mesh-list
138224855|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267783|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267784|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267785|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
138267786|NCT03035331|Vaccines|vaccines|mesh-list
138267787|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
138267788|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267789|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267790|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267791|NCT03035331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267792|NCT03035331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267793|NCT02944500|Liraglutide|liraglutide|mesh-list
138267794|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138267795|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267796|NCT02944500|Incretins|incretins|mesh-ancestor
138267797|NCT02944500|Hormones|hormones|mesh-ancestor
138267798|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138267799|NCT02935361|Atezolizumab|atezolizumab|mesh-list
138267800|NCT02935361|Guadecitabine|guadecitabine|mesh-list
138267801|NCT02935361|Azacitidine|azacitidine|mesh-list
138267802|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138267803|NCT02935361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267804|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486224|NCT00000643|Leucovorin|leucovorin|mesh-list
138267806|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267807|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
138267808|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267809|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138267810|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
138267811|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267812|NCT02923934|Nivolumab|nivolumab|mesh-list
138267813|NCT02923934|Ipilimumab|ipilimumab|mesh-list
138267814|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267815|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267816|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267817|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267818|NCT02913313|Nivolumab|nivolumab|mesh-list
138267819|NCT02913313|Ipilimumab|ipilimumab|mesh-list
138267820|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267821|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267822|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138193139|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267823|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267826|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
138267827|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
138267828|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
138267829|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267830|NCT02754726|Paclitaxel|paclitaxel|mesh-list
138267831|NCT02754726|Gemcitabine|gemcitabine|mesh-list
138267832|NCT02754726|Nivolumab|nivolumab|mesh-list
138267833|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138267834|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138267835|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267836|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
138267837|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
138267838|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
138267839|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267840|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138267841|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
138267842|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138267843|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138267844|NCT02733185|Vitamins|vitamins|mesh-list
138267845|NCT02733185|Edetic Acid|edetic acid|mesh-list
138267846|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
138267847|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
138267848|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267849|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
138267850|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138267851|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
138267852|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
138267853|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267854|NCT02733185|Antidotes|antidotes|mesh-ancestor
138267855|NCT02733185|Protective Agents|protective agents|mesh-ancestor
138267856|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138267857|NCT02713997|Etanercept|etanercept|mesh-list
138267858|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138267859|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
138267860|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138267861|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138267863|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
138267864|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267865|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267866|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138224931|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138267867|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138267868|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138267869|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138267870|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
138267871|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138267872|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138267873|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
138267874|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267875|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267876|NCT02684227|Paclitaxel|paclitaxel|mesh-list
138267877|NCT02684227|Carboplatin|carboplatin|mesh-list
138267878|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138267879|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138267880|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267881|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
138267882|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
138267883|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
138267884|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267885|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
138267886|NCT02623972|Doxorubicin|doxorubicin|mesh-list
138267887|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138267888|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138267889|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
138193156|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138267890|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267891|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138267892|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138267893|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
138267894|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267895|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267896|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138267897|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138267898|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138375781|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267899|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138267900|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267902|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
138267903|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267904|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267905|NCT02536300|Idelalisib|idelalisib|mesh-list
138267906|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267907|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267908|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267909|NCT02525692|TIC10 compound|tic10 compound|mesh-list
138267910|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267911|NCT02522715|Prednisone|prednisone|mesh-list
138267912|NCT02522715|Cortisone|cortisone|mesh-list
138267913|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138267916|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138267917|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267918|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138267919|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267920|NCT02514382|Dexamethasone|dexamethasone|mesh-list
138267921|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
138267922|NCT02514382|Bortezomib|bortezomib|mesh-list
138267923|NCT02514382|Ichthammol|ichthammol|mesh-list
138267924|NCT02514382|BB 1101|bb 1101|mesh-list
138267925|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138267927|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
138267928|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138267981|NCT02458274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267982|NCT02420613|Sirolimus|sirolimus|mesh-list
138267983|NCT02420613|Temsirolimus|temsirolimus|mesh-list
138267984|NCT02420613|Vorinostat|vorinostat|mesh-list
138267985|NCT02420613|MTOR Inhibitors|mtor inhibitors|mesh-list
138267986|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138267987|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138267988|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138267989|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138267990|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
138267991|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138267992|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
138267993|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138267994|NCT02420613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138267995|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138267996|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138267997|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138267999|NCT02409147|Prednisone|prednisone|mesh-list
138268000|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
138268001|NCT02409147|Basiliximab|basiliximab|mesh-list
138268002|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138268003|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
138268004|NCT02409147|Hormones|hormones|mesh-ancestor
138268005|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138268006|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268007|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138268008|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268009|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268010|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138268011|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
138193171|NCT01017653|Panitumumab|panitumumab|mesh-list
138268012|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138268013|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268014|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
138268015|NCT02409147|Ionophores|ionophores|mesh-ancestor
138268016|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138268017|NCT02402439|Pancrelipase|pancrelipase|mesh-list
138225012|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268019|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138268020|NCT02392026|Metronidazole|metronidazole|mesh-list
138268021|NCT02392026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268022|NCT02392026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138268023|NCT02392026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138268024|NCT02392026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138268025|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138268026|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
138268027|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
138268028|NCT02389036|Tobramycin|tobramycin|mesh-list
138268029|NCT02389036|Colistin|colistin|mesh-list
138268030|NCT02389036|Nystatin|nystatin|mesh-list
138268031|NCT02389036|Cefotaxime|cefotaxime|mesh-list
138268032|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268033|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138268034|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138268035|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268036|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268037|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268038|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138268039|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138268040|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
138268041|NCT02389036|Ionophores|ionophores|mesh-ancestor
138268042|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138268044|NCT02369523|Ropivacaine|ropivacaine|mesh-list
138268045|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
138268046|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
138268047|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138268048|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268049|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
138268050|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268051|NCT02339064|Apomorphine|apomorphine|mesh-list
138268052|NCT02339064|Emetics|emetics|mesh-ancestor
138268053|NCT02339064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268054|NCT02339064|Autonomic Agents|autonomic agents|mesh-ancestor
138268055|NCT02339064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268056|NCT02339064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138268057|NCT02339064|Dopamine Agonists|dopamine agonists|mesh-ancestor
138268058|NCT02339064|Dopamine Agents|dopamine agents|mesh-ancestor
138268059|NCT02339064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268060|NCT02339064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193175|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268061|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
138268062|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138268064|NCT02289209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138268065|NCT02289209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268066|NCT02277717|Trastuzumab|trastuzumab|mesh-list
138268067|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138268068|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268069|NCT02269280|Azacitidine|azacitidine|mesh-list
138268070|NCT02269280|Decitabine|decitabine|mesh-list
138268071|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138268072|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
138268073|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268074|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268075|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268077|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138268078|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138268079|NCT02207712|Growth Substances|growth substances|mesh-ancestor
138268080|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268081|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
138268082|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268083|NCT02187991|Paclitaxel|paclitaxel|mesh-list
138268084|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138268085|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268086|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
138268087|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
138268088|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
138268089|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268090|NCT02108860|Abatacept|abatacept|mesh-list
138268091|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138268092|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268093|NCT02108860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138268094|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268095|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138268096|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
138268097|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268098|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138268099|NCT02079181|Fluorides|fluorides|mesh-list
138268100|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
138268101|NCT02079181|Protective Agents|protective agents|mesh-ancestor
138268102|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376032|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
138268104|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138268105|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268106|NCT01949662|Lorazepam|lorazepam|mesh-list
138268107|NCT01949662|Haloperidol|haloperidol|mesh-list
138268108|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
138268109|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
138268110|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
138268111|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268112|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268113|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138268114|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138268115|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138268116|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138268117|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138268118|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138268119|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
138268120|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268121|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268122|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138268123|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
138193201|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138268124|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138268125|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138268126|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
138268127|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
138268128|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
138268129|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138268130|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
138268131|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268132|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138268133|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138268134|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
138268135|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268136|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268137|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138268138|NCT01770145|Levodopa|levodopa|mesh-list
138268139|NCT01770145|Carbidopa|carbidopa|mesh-list
138268140|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138268141|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
138268142|NCT01770145|Apomorphine|apomorphine|mesh-list
138268143|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138268144|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138268145|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
138268146|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268147|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268148|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268149|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138268150|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268151|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138268152|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
138268153|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
138268154|NCT01770145|Emetics|emetics|mesh-ancestor
138268155|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
138268156|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268157|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138268158|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
138268160|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
138268161|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
138268162|NCT01758081|Vitamins|vitamins|mesh-list
138225106|NCT05562089|Paclitaxel|paclitaxel|mesh-list
138268163|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
138268164|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268165|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138268166|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138268167|NCT01726582|Leucovorin|leucovorin|mesh-list
138268168|NCT01726582|Paclitaxel|paclitaxel|mesh-list
138268169|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138268170|NCT01726582|Gemcitabine|gemcitabine|mesh-list
138268171|NCT01726582|Capecitabine|capecitabine|mesh-list
138268172|NCT01726582|Fluorouracil|fluorouracil|mesh-list
138268173|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
138268174|NCT01726582|Irinotecan|irinotecan|mesh-list
138268175|NCT01726582|Cisplatin|cisplatin|mesh-list
138268176|NCT01726582|Folfirinox|folfirinox|mesh-list
138268177|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138268178|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268179|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
138268180|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
138268181|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
138268182|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138486600|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
138268183|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138268185|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138268186|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
138268187|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268188|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138268189|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138268190|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268191|NCT01726582|Antidotes|antidotes|mesh-ancestor
138268192|NCT01726582|Protective Agents|protective agents|mesh-ancestor
138268193|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
138268194|NCT01726582|Vitamins|vitamins|mesh-ancestor
138268195|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
138268196|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
138268197|NCT01701986|Rituximab|rituximab|mesh-list
138268198|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138268199|NCT01701986|Gemcitabine|gemcitabine|mesh-list
138268200|NCT01701986|Busulfan|busulfan|mesh-list
138268201|NCT01701986|Clofarabine|clofarabine|mesh-list
138268202|NCT01701986|Antibodies|antibodies|mesh-list
138268203|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
138268204|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138268205|NCT01701986|Tacrolimus|tacrolimus|mesh-list
138268206|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
138268207|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138268208|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
138268209|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268210|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268211|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138268212|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138268213|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
138268214|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268215|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138268216|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138268217|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268218|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138268219|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138268220|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
138268221|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138268222|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268223|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
138268224|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138268225|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138268226|NCT01687127|Folic Acid|folic acid|mesh-list
138268227|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
138268229|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138268230|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268231|NCT01687127|Hematinics|hematinics|mesh-ancestor
138268232|NCT01687127|Vitamins|vitamins|mesh-ancestor
138268233|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
138268234|NCT01565200|Trastuzumab|trastuzumab|mesh-list
138268235|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138268236|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138268237|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268238|NCT01565200|Immunotoxins|immunotoxins|mesh-ancestor
138268239|NCT01565200|Immunoconjugates|immunoconjugates|mesh-ancestor
138268240|NCT01565200|Immunologic Factors|immunologic factors|mesh-ancestor
138268241|NCT01565200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268242|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
138268243|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
138268244|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
138268245|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268247|NCT01476787|Lenalidomide|lenalidomide|mesh-list
138268248|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138268249|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138268250|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268251|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
138268252|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268253|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138193231|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138268254|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138225163|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
138268256|NCT01476787|Growth Substances|growth substances|mesh-ancestor
138268257|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
138268258|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138268259|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
138268260|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268261|NCT01059786|Rituximab|rituximab|mesh-list
138268262|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138376196|NCT05343507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138268264|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138268265|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268266|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
138268267|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268268|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138268269|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138268270|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
138268271|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268272|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138268273|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268274|NCT00993408|Selexipag|selexipag|mesh-list
138268275|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138268276|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
138268277|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268278|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
138486650|NCT00388635|Hormones|hormones|mesh-ancestor
138268279|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138268280|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138268281|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268282|NCT00871065|Urological Agents|urological agents|mesh-ancestor
138268283|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138268284|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138268285|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268287|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138268288|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268289|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138268290|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138268291|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138268292|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268293|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
138268294|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268295|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
138268296|NCT00786682|Docetaxel|docetaxel|mesh-list
138268297|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268298|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
138268299|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
138268300|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
138268301|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268302|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
138268303|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138268304|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138268305|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268306|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268307|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138268308|NCT00675844|Dexelvucitabine|dexelvucitabine|mesh-list
138268309|NCT00675844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138268310|NCT00675844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138268311|NCT00675844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268312|NCT00675844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268313|NCT00675844|Antiviral Agents|antiviral agents|mesh-ancestor
138268314|NCT00675844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268315|NCT00675844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138268316|NCT00675844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138268317|NCT00571714|Ribavirin|ribavirin|mesh-list
138268318|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138268319|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
138268320|NCT00571714|Betaine|betaine|mesh-list
138268321|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
138268322|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268323|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
138268324|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268325|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
138268326|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268327|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138268328|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
138268329|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138268330|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138268331|NCT00506662|Insulin|insulin|mesh-list
138268332|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138268333|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
138268334|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
138268335|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
138268336|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
138268337|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138268338|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268339|NCT00455039|Lapatinib|lapatinib|mesh-list
138268340|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268341|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138268342|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268343|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268344|NCT00410956|Dexamethasone|dexamethasone|mesh-list
138268345|NCT00410956|Bevacizumab|bevacizumab|mesh-list
138268346|NCT00410956|Floxuridine|floxuridine|mesh-list
138268347|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138268348|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268349|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138268350|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138268351|NCT00410956|Growth Substances|growth substances|mesh-ancestor
138268352|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138225205|NCT01573949|Metformin|metformin|mesh-list
138268354|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138268355|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
138268356|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
138268357|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268358|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138268359|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
138268360|NCT00410956|Hormones|hormones|mesh-ancestor
138268361|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138268362|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138268363|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138268364|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
138268365|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268366|NCT00380159|Lamivudine|lamivudine|mesh-list
138268367|NCT00380159|Emtricitabine|emtricitabine|mesh-list
138268368|NCT00380159|Dexelvucitabine|dexelvucitabine|mesh-list
138268369|NCT00380159|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138268370|NCT00380159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138268371|NCT00380159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268372|NCT00380159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193266|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268373|NCT00380159|Antiviral Agents|antiviral agents|mesh-ancestor
138268374|NCT00380159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268375|NCT00380159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138268376|NCT00380159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138268377|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
138268378|NCT00338377|Fludarabine|fludarabine|mesh-list
138268379|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
138268380|NCT00338377|Interleukin-2|interleukin-2|mesh-list
138268382|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138268383|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
138268384|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268385|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138268386|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138225238|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138268388|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268389|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268390|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138376287|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
138268391|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138268393|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138268394|NCT00338377|Analgesics|analgesics|mesh-ancestor
138268395|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
138268396|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268397|NCT00338377|Protective Agents|protective agents|mesh-ancestor
138268398|NCT00161213|Gemcitabine|gemcitabine|mesh-list
138268399|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
138268400|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138268401|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
138268402|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268403|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268404|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138268405|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268406|NCT00118131|Docetaxel|docetaxel|mesh-list
138268407|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268408|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
138268409|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
138268410|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
138268411|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268412|NCT00006436|Prednisone|prednisone|mesh-list
138268413|NCT00006436|Cyclophosphamide|cyclophosphamide|mesh-list
138268414|NCT00006436|Rituximab|rituximab|mesh-list
138268415|NCT00006436|Doxorubicin|doxorubicin|mesh-list
138268416|NCT00006436|Etoposide|etoposide|mesh-list
138268417|NCT00006436|Vincristine|vincristine|mesh-list
138268418|NCT00006436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138268419|NCT00006436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138268420|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
138268421|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268422|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138268423|NCT00006436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138268424|NCT00006436|Alkylating Agents|alkylating agents|mesh-ancestor
138268425|NCT00006436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268426|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268427|NCT00006436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138268428|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138268429|NCT00006436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138268430|NCT00006436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138268431|NCT00006436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138268432|NCT00006436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268433|NCT00006436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138268434|NCT00006436|Glucocorticoids|glucocorticoids|mesh-ancestor
138268435|NCT00006436|Hormones|hormones|mesh-ancestor
138268436|NCT00006436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138268437|NCT00006436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138268438|NCT00006436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138268440|NCT00006436|Antimitotic Agents|antimitotic agents|mesh-ancestor
138268441|NCT00006436|Mitosis Modulators|mitosis modulators|mesh-ancestor
138268442|NCT02399917|Azacitidine|azacitidine|mesh-list
138268443|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138268444|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
138268445|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268446|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268447|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268448|NCT00356486|Ribavirin|ribavirin|mesh-list
138268449|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138268450|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
138268451|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
138268452|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268453|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
138268454|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268455|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
138268456|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268458|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
138268460|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138268461|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268462|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
138268463|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
138268464|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
138268465|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268466|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138268467|NCT02354833|Phenylephrine|phenylephrine|mesh-list
138268468|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
138268469|NCT02354833|Norepinephrine|norepinephrine|mesh-list
138268470|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138268471|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
138268472|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
138268473|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268474|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268476|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138268477|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
138268478|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
138268479|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138268480|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138376365|NCT03860077|Nicotine|nicotine|mesh-list
138268481|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138268482|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
138268483|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268484|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268485|NCT02354833|Protective Agents|protective agents|mesh-ancestor
138268486|NCT03337724|Paclitaxel|paclitaxel|mesh-list
138268487|NCT03337724|Ipatasertib|ipatasertib|mesh-list
138268488|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138268489|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268490|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
138268491|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
138268492|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
138268493|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268494|NCT03337724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138268495|NCT03337724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268496|NCT03838484|Nicotine|nicotine|mesh-list
138268497|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138268498|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
138268499|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268500|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268501|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138268502|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138268503|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
138268504|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268505|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268506|NCT05721872|Arsenic Trioxide|arsenic trioxide|mesh-list
138268507|NCT05721872|Isoascorbic acid|isoascorbic acid|mesh-list
138268508|NCT05721872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268509|NCT05721872|Antioxidants|antioxidants|mesh-ancestor
138268510|NCT05721872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268511|NCT05721872|Protective Agents|protective agents|mesh-ancestor
138268512|NCT05721872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268513|NCT02408965|Methylergonovine|methylergonovine|mesh-list
138268514|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
138268515|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138193272|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138268516|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268517|NCT03299426|Vaccines|vaccines|mesh-list
138268518|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
138268519|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268520|NCT03216356|Cycloserine|cycloserine|mesh-list
138268521|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138268522|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268523|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138268524|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
138268525|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138268526|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
138268527|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268528|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
138268529|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138268530|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268531|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138268532|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268533|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
138268534|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
138225325|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138268536|NCT00356954|Protective Agents|protective agents|mesh-ancestor
138268537|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268538|NCT00356954|Vitamins|vitamins|mesh-ancestor
138268539|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
138268540|NCT02358889|Ranibizumab|ranibizumab|mesh-list
138268541|NCT02358889|hI-con1|hi-con1|mesh-list
138268542|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
138268543|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138268544|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138268545|NCT02358889|Growth Substances|growth substances|mesh-ancestor
138268546|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268547|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
138268548|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268549|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
138268551|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
138268552|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
138268553|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138268554|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268555|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
138268556|NCT00358202|Cefepime|cefepime|mesh-list
138268557|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138268558|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268560|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
138268561|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268562|NCT04736225|Insulin|insulin|mesh-list
138268563|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138268564|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268565|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138268566|NCT03344861|Trioxsalen|trioxsalen|mesh-list
138268567|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268568|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
138268569|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138268570|NCT03348683|Propranolol|propranolol|mesh-list
138268571|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138268572|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138268573|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
138268574|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268575|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268576|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268577|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138268578|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138268579|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
138268580|NCT04344782|Bevacizumab|bevacizumab|mesh-list
138268581|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138268582|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268583|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138268584|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138268585|NCT04344782|Growth Substances|growth substances|mesh-ancestor
138193283|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138268586|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268587|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
138268588|NCT00357188|Ritonavir|ritonavir|mesh-list
138268589|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138268590|NCT00357188|Efavirenz|efavirenz|mesh-list
138268591|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138268592|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138487016|NCT00000381|Fluoxetine|fluoxetine|mesh-list
138268593|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
138268594|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268595|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268596|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138268597|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138268598|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
138268599|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268600|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138268601|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138268602|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138268603|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138268604|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138268605|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138268606|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138268607|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138268608|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138268609|NCT02360215|Memantine|memantine|mesh-list
138268610|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138268611|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138268612|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
138268613|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376507|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268614|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268615|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268616|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138268617|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138268618|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
138268619|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138268620|NCT01349192|Minocycline|minocycline|mesh-list
138268621|NCT01349192|Rifampin|rifampin|mesh-list
138268622|NCT01349192|Trimethoprim|trimethoprim|mesh-list
138268623|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
138268625|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138268626|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268627|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
138268628|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
138268629|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138268630|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138268631|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
138268632|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
138268633|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138268634|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268635|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268636|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138268637|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138268638|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138268639|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138268640|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138268641|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138268642|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138268643|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
138268644|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138268645|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138193292|NCT00972725|Chloroquine|chloroquine|mesh-list
138268646|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138268647|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138268648|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138268649|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138268650|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138268652|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138268653|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
138268654|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
138268655|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268656|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268657|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138268658|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
138268660|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138268661|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138268662|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268663|NCT00354991|Losartan|losartan|mesh-list
138268664|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138268665|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138268666|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138268667|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138268668|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138268669|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268670|NCT00354991|Diuretics|diuretics|mesh-ancestor
138268671|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
138268672|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268673|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138268674|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138268675|NCT02112578|Meclizine|meclizine|mesh-list
138268676|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
138268677|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
138268678|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
138268679|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268680|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268681|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138268682|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138268683|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
138268685|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268686|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268687|NCT02112578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138268688|NCT02112578|Cholinergic Agents|cholinergic agents|mesh-ancestor
138487139|NCT05349838|Dolutegravir|dolutegravir|mesh-list
138268689|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138268690|NCT00358280|Bupivacaine|bupivacaine|mesh-list
138268691|NCT00358280|Ropivacaine|ropivacaine|mesh-list
138268692|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
138268693|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
138268694|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138268695|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268696|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
138268703|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
138268704|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268706|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138268707|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138268708|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138268709|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268710|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
138268711|NCT03417193|Anesthetics|anesthetics|mesh-list
138268712|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138268713|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268714|NCT03417193|Narcotics|narcotics|mesh-ancestor
138268715|NCT03417193|Analgesics|analgesics|mesh-ancestor
138268716|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
138268717|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268724|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
138268725|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
138268726|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
138268727|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138268728|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138268729|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268730|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268731|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268732|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
138268733|NCT03342937|Capecitabine|capecitabine|mesh-list
138268734|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
138268735|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138268736|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268737|NCT03342937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138225422|NCT01722656|Growth Substances|growth substances|mesh-ancestor
138268739|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138268740|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
138268741|NCT05718661|Methamphetamine|methamphetamine|mesh-list
138268742|NCT05718661|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138268743|NCT05718661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268744|NCT05718661|Sympathomimetics|sympathomimetics|mesh-ancestor
138268745|NCT05718661|Autonomic Agents|autonomic agents|mesh-ancestor
138268746|NCT05718661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268747|NCT05718661|Dopamine Agents|dopamine agents|mesh-ancestor
138268748|NCT05718661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268749|NCT05718661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268750|NCT05718661|Adrenergic Agents|adrenergic agents|mesh-ancestor
138268751|NCT05718661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138268752|NCT05718661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138268753|NCT05718661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138268754|NCT05718661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138268755|NCT00354757|Rabeprazole|rabeprazole|mesh-list
138268756|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138268757|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138268758|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138268759|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268760|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268761|NCT02376283|Clopidogrel|clopidogrel|mesh-list
138268762|NCT02376283|Ticagrelor|ticagrelor|mesh-list
138268763|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138268764|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138268765|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138268766|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138268767|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138268768|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
138268769|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268770|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268771|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268772|NCT00425347|Elotuzumab|elotuzumab|mesh-list
138268773|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268774|NCT05718037|Vaccines|vaccines|mesh-list
138268775|NCT05718037|Immunologic Factors|immunologic factors|mesh-ancestor
138268776|NCT05718037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268778|NCT05717881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268779|NCT00355303|Misoprostol|misoprostol|mesh-list
138268780|NCT00355303|Dinoprostone|dinoprostone|mesh-list
138268781|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138268782|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
138268783|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138268784|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268785|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138268786|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138268787|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
138268788|NCT05717569|Vitamin D|vitamin d|mesh-list
138268789|NCT05717569|Vitamins|vitamins|mesh-ancestor
138268790|NCT05717569|Micronutrients|micronutrients|mesh-ancestor
138268791|NCT05717569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268792|NCT05717569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138268793|NCT02385097|Ropivacaine|ropivacaine|mesh-list
138268794|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
138268795|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
138268796|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
138225457|NCT03007121|Narcotics|narcotics|mesh-ancestor
138225458|NCT03007121|Analgesics|analgesics|mesh-ancestor
138268797|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138268798|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268800|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268802|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138268803|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
138268804|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268805|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138268806|NCT00355459|Doxycycline|doxycycline|mesh-list
138268807|NCT00355459|Tetracycline|tetracycline|mesh-list
138268808|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138268809|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268810|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
138268811|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138268812|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138268813|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138268814|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268815|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268816|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
138268817|NCT02393677|Ropivacaine|ropivacaine|mesh-list
138268818|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138268819|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138268820|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268821|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138268822|NCT02393677|Analgesics|analgesics|mesh-ancestor
138268823|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
138268824|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268825|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138268826|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138268827|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138268828|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
138268829|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268830|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268831|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
138268832|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
138268833|NCT02394457|Cosyntropin|cosyntropin|mesh-list
138268835|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138268836|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268837|NCT00355771|Levocetirizine|levocetirizine|mesh-list
138268838|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138268839|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138268840|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
138268841|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
138268842|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268843|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268844|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138487360|NCT00000579|Ketoconazole|ketoconazole|mesh-list
138268846|NCT05664139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138268848|NCT05664139|Tubulin Modulators|tubulin modulators|mesh-ancestor
138268849|NCT05664139|Antimitotic Agents|antimitotic agents|mesh-ancestor
138268850|NCT05664139|Mitosis Modulators|mitosis modulators|mesh-ancestor
138268851|NCT05664139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268852|NCT03224351|Ivacaftor|ivacaftor|mesh-list
138268854|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138268855|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138268856|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268857|NCT05658055|Amoxicillin|amoxicillin|mesh-list
138268858|NCT05658055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138268859|NCT05658055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268860|NCT01721876|Cytarabine|cytarabine|mesh-list
138268861|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138268862|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
138268863|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268864|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268865|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
138268866|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268867|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138268868|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
138268869|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268870|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138268871|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138268872|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
138268873|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268874|NCT01112072|Riboflavin|riboflavin|mesh-list
138268875|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
138268876|NCT01112072|Vitamins|vitamins|mesh-ancestor
138268877|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
138268878|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268879|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138268880|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
138268881|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138225500|NCT01580423|Aprepitant|aprepitant|mesh-list
138268883|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268884|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268885|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138376842|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138268886|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268888|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138268889|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268890|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
138268891|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
138268892|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268893|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
138268894|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138268895|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268896|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
138487390|NCT00000588|Pyridoxal|pyridoxal|mesh-list
138268897|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138268898|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138268899|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138268900|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138268901|NCT05620771|Bevacizumab|bevacizumab|mesh-list
138268902|NCT05620771|Atezolizumab|atezolizumab|mesh-list
138268903|NCT05620771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138268904|NCT05620771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268905|NCT05620771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138268906|NCT05620771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138268907|NCT05620771|Growth Substances|growth substances|mesh-ancestor
138268908|NCT05620771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268909|NCT05620771|Growth Inhibitors|growth inhibitors|mesh-ancestor
138268910|NCT05620771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138268911|NCT05620771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268912|NCT05419297|Buprenorphine|buprenorphine|mesh-list
138268913|NCT05419297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138268914|NCT05419297|Narcotics|narcotics|mesh-ancestor
138268915|NCT05419297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138268916|NCT05419297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268917|NCT05419297|Analgesics|analgesics|mesh-ancestor
138193340|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
138268918|NCT05419297|Sensory System Agents|sensory system agents|mesh-ancestor
138268919|NCT05419297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268920|NCT05419297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138268921|NCT03226457|Empagliflozin|empagliflozin|mesh-list
138268923|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138268924|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268925|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138225543|NCT02494596|Capecitabine|capecitabine|mesh-list
138268926|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268929|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138268930|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138268931|NCT00003159|Paclitaxel|paclitaxel|mesh-list
138268932|NCT00003159|Vinorelbine|vinorelbine|mesh-list
138268933|NCT00003159|Vinblastine|vinblastine|mesh-list
138268934|NCT00003159|Docetaxel|docetaxel|mesh-list
138268935|NCT00003159|Carboplatin|carboplatin|mesh-list
138268936|NCT00003159|Gemcitabine|gemcitabine|mesh-list
138268937|NCT00003159|Ifosfamide|ifosfamide|mesh-list
138268938|NCT00003159|Mitomycins|mitomycins|mesh-list
138268939|NCT00003159|Mitomycin|mitomycin|mesh-list
138268940|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138268941|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268942|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
138268943|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
138268944|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
138268945|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138268946|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138268947|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
138268948|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138268949|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
138268950|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138268951|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138268952|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268953|NCT03228017|Aspirin|aspirin|mesh-list
138268954|NCT03228017|Atorvastatin|atorvastatin|mesh-list
138268955|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138268956|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138268957|NCT03228017|Analgesics|analgesics|mesh-ancestor
138268958|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
138268959|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138268960|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268961|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138268962|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138268963|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138268964|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138268965|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138487451|NCT00000612|Estrogens|estrogens|mesh-list
138268966|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138268967|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138268968|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138268969|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
138268970|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138268971|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138268972|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
138268973|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138268974|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138268975|NCT00355927|Propofol|propofol|mesh-list
138268976|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138268977|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138268978|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268979|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138268980|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
138268981|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
138268982|NCT00357422|Ethanol|ethanol|mesh-list
138268983|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138268984|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268985|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138268986|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138268987|NCT00356005|Azithromycin|azithromycin|mesh-list
138268988|NCT00356005|Artesunate|artesunate|mesh-list
138268989|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138268990|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138268991|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
138268992|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138268993|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138268994|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138268995|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
138268996|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
138268997|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138268998|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
138268999|NCT00376337|Micafungin|micafungin|mesh-list
138269000|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
138269001|NCT00376337|Clotrimazole|clotrimazole|mesh-list
138269002|NCT00376337|Miconazole|miconazole|mesh-list
138269003|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138269004|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138269005|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138269006|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138269007|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269008|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269009|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138269010|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
138269011|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269012|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269013|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138487531|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138269014|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138269016|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138269017|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269018|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138269019|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138269020|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269021|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269022|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
138269023|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138269024|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
138269025|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269026|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269027|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
138269028|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269029|NCT00003183|Analgesics|analgesics|mesh-ancestor
138269030|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
138269031|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269032|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269033|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138269034|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138269035|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269036|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269038|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
138269039|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
138269040|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269041|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
138269042|NCT02979223|Protective Agents|protective agents|mesh-ancestor
138269043|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269045|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
138269046|NCT02979223|Cathartics|cathartics|mesh-ancestor
138193365|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
138269047|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138269048|NCT01805271|Everolimus|everolimus|mesh-list
138269049|NCT01805271|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138269050|NCT01805271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138269051|NCT01805271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269052|NCT01805271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269053|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138269054|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
138269055|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269056|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269057|NCT01768767|Ketamine|ketamine|mesh-list
138269058|NCT01768767|Analgesics|analgesics|mesh-ancestor
138269059|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
138269060|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269061|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269062|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138269063|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138269064|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
138269065|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
138269066|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269067|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138269068|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138269069|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269070|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269071|NCT00376493|Metronidazole|metronidazole|mesh-list
138269072|NCT00376493|Doxycycline|doxycycline|mesh-list
138269073|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138269074|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138269075|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138269076|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138269077|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
138269079|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
138269080|NCT00003195|Busulfan|busulfan|mesh-list
138269081|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269082|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
138269083|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138269084|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
138269085|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269086|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
138269087|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269088|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138269089|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138269090|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138269091|NCT05716256|Urinastatin|urinastatin|mesh-list
138269092|NCT05716256|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138269093|NCT05716256|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138269094|NCT05716256|Protease Inhibitors|protease inhibitors|mesh-ancestor
138269095|NCT05716256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269096|NCT05716256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269097|NCT00356083|Methadone|methadone|mesh-list
138269098|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138269099|NCT00356083|Narcotics|narcotics|mesh-ancestor
138269100|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269101|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269102|NCT00356083|Analgesics|analgesics|mesh-ancestor
138225607|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269103|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
138269104|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269105|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
138487684|NCT00000705|Zidovudine|zidovudine|mesh-list
138269106|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
138269107|NCT02977832|Alfuzosin|alfuzosin|mesh-list
138269108|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138269109|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138269110|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138269111|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
138269112|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269113|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269114|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269115|NCT02977832|Urological Agents|urological agents|mesh-ancestor
138269116|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
138269117|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
138269118|NCT04344236|Povidone|povidone|mesh-list
138269119|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138269120|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138269121|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
138269122|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
138269123|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
138269124|NCT00355537|Testosterone|testosterone|mesh-list
138269125|NCT00355537|Androgens|androgens|mesh-ancestor
138269126|NCT00355537|Hormones|hormones|mesh-ancestor
138269127|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269128|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269129|NCT00003207|Doxorubicin|doxorubicin|mesh-list
138269130|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138269131|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138269132|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269133|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138269134|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138269135|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269136|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269137|NCT00003387|Paclitaxel|paclitaxel|mesh-list
138269138|NCT00003387|Carboplatin|carboplatin|mesh-list
138269139|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138269140|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138225614|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138225621|NCT03006107|Piroxicam|piroxicam|mesh-list
138269141|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
138269142|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
138269143|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
138269144|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269145|NCT01542021|Androgens|androgens|mesh-list
138269146|NCT01542021|Hormones|hormones|mesh-ancestor
138269147|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269148|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269149|NCT04706897|Lidocaine|lidocaine|mesh-list
138269150|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
138269151|NCT04706897|Ketamine|ketamine|mesh-list
138269152|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
138269153|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
138269154|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269155|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269156|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
138269157|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269158|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138269159|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138269160|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138269161|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138269162|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269163|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138269164|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138269165|NCT04706897|Analgesics|analgesics|mesh-ancestor
138269166|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138269167|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138269168|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138269169|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
138269170|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269171|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138269172|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138269173|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
138269174|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138269175|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138269176|NCT00003213|Dexamethasone|dexamethasone|mesh-list
138269177|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
138269178|NCT00003213|Metoclopramide|metoclopramide|mesh-list
138269179|NCT00003213|Granisetron|granisetron|mesh-list
138269180|NCT00003213|BB 1101|bb 1101|mesh-list
138269181|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138269182|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
138269183|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
138269184|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269185|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269186|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138269187|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
138269189|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269190|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138269191|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269192|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
138269193|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269194|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269195|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138269196|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138269197|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
138269198|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269199|NCT00003213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138193439|NCT03827876|Vitamins|vitamins|mesh-ancestor
138269200|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138269201|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
138269203|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
138269204|NCT01445067|Katacalcin|katacalcin|mesh-list
138269205|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
138269206|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138269207|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269208|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138269209|NCT02978066|Anesthetics|anesthetics|mesh-list
138269210|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269211|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269212|NCT00003399|Dexamethasone|dexamethasone|mesh-list
138269213|NCT00003399|Paclitaxel|paclitaxel|mesh-list
138269214|NCT00003399|Etoposide|etoposide|mesh-list
138269215|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
138269216|NCT00003399|Melphalan|melphalan|mesh-list
138269217|NCT00003399|Carmustine|carmustine|mesh-list
138269218|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138269219|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269220|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
138269221|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
138269222|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
138269223|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269224|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138269225|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
138269226|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269227|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138269228|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138269229|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
138269230|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138269231|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138269232|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
138269233|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
138269234|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269235|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138269236|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
138269238|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269239|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138269240|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138269241|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138269242|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269243|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
138269244|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138269246|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269247|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
138269248|NCT03376061|Coagulants|coagulants|mesh-ancestor
138269249|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
138269250|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138269251|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
138269252|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269253|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269254|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138269255|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
138269257|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138269258|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
138269259|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269260|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269261|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
138269262|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269263|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269264|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269265|NCT05715788|Nitric Oxide|nitric oxide|mesh-list
138269266|NCT05715788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138269267|NCT05715788|Autonomic Agents|autonomic agents|mesh-ancestor
138269268|NCT05715788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269269|NCT05715788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269270|NCT05715788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138269271|NCT05715788|Respiratory System Agents|respiratory system agents|mesh-ancestor
138269272|NCT05715788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138269273|NCT05715788|Antioxidants|antioxidants|mesh-ancestor
138269274|NCT05715788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269275|NCT05715788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269276|NCT05715788|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138269277|NCT05715788|Vasodilator Agents|vasodilator agents|mesh-ancestor
138269278|NCT05715788|Gasotransmitters|gasotransmitters|mesh-ancestor
138269279|NCT05715788|Protective Agents|protective agents|mesh-ancestor
138269280|NCT00003225|Irinotecan|irinotecan|mesh-list
138269281|NCT00003225|Amifostine|amifostine|mesh-list
138487953|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138269284|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269285|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269286|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269287|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138269288|NCT00003225|Protective Agents|protective agents|mesh-ancestor
138269289|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269290|NCT03838094|Calcium|calcium|mesh-list
138269291|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138269292|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269293|NCT03441269|Ibuprofen|ibuprofen|mesh-list
138269294|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138269295|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138269296|NCT03441269|Analgesics|analgesics|mesh-ancestor
138269297|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
138269298|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269299|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269300|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138269301|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138269302|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138269303|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269304|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269305|NCT03252353|Octreotide|octreotide|mesh-list
138269306|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138488006|NCT00000867|Memantine|memantine|mesh-list
138193472|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269307|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138269308|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269309|NCT00358358|Fluticasone|fluticasone|mesh-list
138269311|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138269312|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138269313|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138269314|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138269315|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
138269316|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269317|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269318|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138269319|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
138269320|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
138269321|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138269322|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138269323|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138269324|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138269325|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
138269326|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269327|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269328|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
138269330|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269331|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
138269332|NCT03441581|Eluxadoline|eluxadoline|mesh-list
138269333|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138269334|NCT02265510|Dexamethasone|dexamethasone|mesh-list
138269335|NCT02265510|Paclitaxel|paclitaxel|mesh-list
138269336|NCT02265510|Gemcitabine|gemcitabine|mesh-list
138269337|NCT02265510|Lenalidomide|lenalidomide|mesh-list
138269338|NCT02265510|Azacitidine|azacitidine|mesh-list
138269339|NCT02265510|Bortezomib|bortezomib|mesh-list
138269340|NCT02265510|Pomalidomide|pomalidomide|mesh-list
138269341|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138269343|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
138269344|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
138269345|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
138269346|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269347|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138269348|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
138269349|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
138269350|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269351|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269352|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138269354|NCT02265510|Hormones|hormones|mesh-ancestor
138269355|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269356|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138269357|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138269358|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
138269359|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
138269360|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138269361|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138269362|NCT02265510|Growth Substances|growth substances|mesh-ancestor
138269363|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
138269364|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269365|NCT03254147|Warfarin|warfarin|mesh-list
138269366|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
138269367|NCT03254147|Dabigatran|dabigatran|mesh-list
138269368|NCT03254147|Apixaban|apixaban|mesh-list
138269369|NCT03254147|Edoxaban|edoxaban|mesh-list
138269370|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
138269371|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138269372|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
138269373|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138488102|NCT00000891|Ritonavir|ritonavir|mesh-list
138269374|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
138269375|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193492|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
138269376|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269377|NCT03384329|Resveratrol|resveratrol|mesh-list
138269378|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
138269379|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269380|NCT03384329|Protective Agents|protective agents|mesh-ancestor
138269381|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269382|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269383|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138269384|NCT03443063|Lemborexant|lemborexant|mesh-list
138269385|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138269386|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269387|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269388|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138269389|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138269390|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269391|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269392|NCT05327972|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138269393|NCT05327972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138269394|NCT05327972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269395|NCT05327972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269396|NCT05327972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138269397|NCT05327972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138269398|NCT05327972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269399|NCT05327972|Cholinergic Agents|cholinergic agents|mesh-ancestor
138269402|NCT03256253|Analgesics|analgesics|mesh-ancestor
138269403|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
138269404|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269405|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269406|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
138269407|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138269408|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138269409|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269410|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138269411|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138269412|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138269413|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269414|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138269415|NCT03256799|Ivacaftor|ivacaftor|mesh-list
138269416|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138269417|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138269418|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269419|NCT01238211|Cytarabine|cytarabine|mesh-list
138269421|NCT01238211|Dasatinib|dasatinib|mesh-list
138269422|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138269423|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
138269424|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269425|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269426|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
138269427|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138488198|NCT00000966|Leucovorin|leucovorin|mesh-list
138269428|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138269429|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
138269430|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269431|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138269432|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138269433|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138269434|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269435|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138269437|NCT04735445|Hematinics|hematinics|mesh-ancestor
138269439|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269440|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
138269441|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
138269442|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
138269443|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269444|NCT00003405|Interferons|interferons|mesh-list
138269445|NCT00003405|Cytarabine|cytarabine|mesh-list
138269446|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
138269447|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
138269448|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
138269449|NCT00003405|Idoxuridine|idoxuridine|mesh-list
138269450|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
138269451|NCT00003405|Idarubicin|idarubicin|mesh-list
138269452|NCT00003405|Isotretinoin|isotretinoin|mesh-list
138269453|NCT00003405|Amifostine|amifostine|mesh-list
138269455|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
138269456|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138269457|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138269458|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
138269459|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269460|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138269461|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
138269462|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269463|NCT00003405|Analgesics|analgesics|mesh-ancestor
138269464|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
138269465|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269466|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138269467|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138269468|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269469|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138269470|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
138269471|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138269472|NCT00003405|Protective Agents|protective agents|mesh-ancestor
138269473|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138269474|NCT05131646|Axitinib|axitinib|mesh-list
138269475|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269476|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138269477|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269478|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269479|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
138269480|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269481|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138269482|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
138269483|NCT00003243|Aldesleukin|aldesleukin|mesh-list
138269484|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
138269485|NCT00003243|Doxorubicin|doxorubicin|mesh-list
138269486|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138269487|NCT00003243|Etoposide|etoposide|mesh-list
138269488|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138269489|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
138269490|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269491|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138269492|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138269493|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
138225796|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269494|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269496|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138269497|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138269498|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138269499|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138269500|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269501|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138269502|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138269503|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138269504|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
138269505|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193516|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138269506|NCT04344158|Sorafenib|sorafenib|mesh-list
138269507|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269508|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138269509|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269510|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269511|NCT00003249|Ketoconazole|ketoconazole|mesh-list
138269512|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
138269513|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
138269514|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138269515|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138269516|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138269517|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269518|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269519|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138269520|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
138269521|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269522|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269523|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138269524|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269526|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138269527|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138269528|NCT00003255|Carboplatin|carboplatin|mesh-list
138269529|NCT00003255|Topotecan|topotecan|mesh-list
138269530|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269531|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138269532|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138269534|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269536|NCT03269435|Bupivacaine|bupivacaine|mesh-list
138269537|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
138269538|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
138269539|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269540|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269541|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
138269542|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269543|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
138269544|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
138269545|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138269546|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138269547|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138269548|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
138269549|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269550|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269551|NCT00003261|Zidovudine|zidovudine|mesh-list
138269552|NCT00003261|Methotrexate|methotrexate|mesh-list
138269553|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138269554|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
138269555|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138269556|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269557|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138269558|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
138269559|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269560|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269561|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
138269562|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269563|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138269564|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138269566|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138269567|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138269568|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138269570|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138269571|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138269572|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138269573|NCT03279731|Liraglutide|liraglutide|mesh-list
138269574|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138269575|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269576|NCT03279731|Incretins|incretins|mesh-ancestor
138269577|NCT03279731|Hormones|hormones|mesh-ancestor
138269578|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269579|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
138269580|NCT04477837|Apixaban|apixaban|mesh-list
138269581|NCT04477837|Edoxaban|edoxaban|mesh-list
138269582|NCT04477837|Dabigatran|dabigatran|mesh-list
138269583|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138269584|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
138269585|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138269586|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
138269587|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269588|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269589|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
138377513|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138269590|NCT05267821|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138269591|NCT05267821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138269592|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
138269593|NCT02264574|Chlorambucil|chlorambucil|mesh-list
138269594|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138269595|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269596|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138269597|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
138269598|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269599|NCT04412863|Interferons|interferons|mesh-list
138269600|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
138269601|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
138269602|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138269603|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269604|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
138269605|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138269606|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
138269607|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269608|NCT03400475|Simvastatin|simvastatin|mesh-list
138269609|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138269610|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138269611|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
138269612|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269613|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138269614|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138269615|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269616|NCT01641900|Eszopiclone|eszopiclone|mesh-list
138269617|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138269618|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269619|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269620|NCT03834571|Paclitaxel|paclitaxel|mesh-list
138269621|NCT03834571|Cisplatin|cisplatin|mesh-list
138269622|NCT03834571|Carboplatin|carboplatin|mesh-list
138269623|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138269624|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138269625|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269626|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
138269627|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
138269628|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
138269629|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269630|NCT00376727|Cetuximab|cetuximab|mesh-list
138269631|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138269632|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269633|NCT05468606|Imiquimod|imiquimod|mesh-list
138269634|NCT05468606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138269635|NCT05468606|Immunologic Factors|immunologic factors|mesh-ancestor
138269636|NCT05468606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269637|NCT05468606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269638|NCT05468606|Interferon Inducers|interferon inducers|mesh-ancestor
138269639|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
138269640|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138269641|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
138225948|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269644|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138269645|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
138193537|NCT05510310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138269646|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138269647|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
138269648|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269649|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269650|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138269651|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
138269652|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
138269653|NCT04290871|Protective Agents|protective agents|mesh-ancestor
138269654|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138269655|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138488486|NCT00001038|Acyclovir|acyclovir|mesh-list
138269656|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
138269657|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138269658|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138269659|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138269660|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269661|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269662|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138269663|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138269664|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138269665|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
138269666|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269667|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269668|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138269669|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138269670|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
138269671|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138269672|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138269673|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
138269674|NCT05071352|Nefopam|nefopam|mesh-list
138269675|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138269676|NCT05071352|Analgesics|analgesics|mesh-ancestor
138269677|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
138269678|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269679|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269680|NCT00376025|Antioxidants|antioxidants|mesh-list
138269681|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269682|NCT00376025|Protective Agents|protective agents|mesh-ancestor
138269683|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269684|NCT00376103|Temozolomide|temozolomide|mesh-list
138269685|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138269686|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
138269687|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269688|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269689|NCT03403517|Dexamethasone|dexamethasone|mesh-list
138269690|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
138269691|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138269692|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138269693|NCT03403517|Prednisolone|prednisolone|mesh-list
138269694|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
138269695|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138269696|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
138269697|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138269698|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
138269699|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
138269701|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269702|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138269704|NCT03403517|Hormones|hormones|mesh-ancestor
138269705|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269706|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138269707|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269708|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138269709|NCT03403517|Protective Agents|protective agents|mesh-ancestor
138269710|NCT05247788|Ethanol|ethanol|mesh-list
138193546|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138269711|NCT05247788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138269712|NCT05247788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138269713|NCT05247788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269714|NCT05247788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269715|NCT02263326|Lamivudine|lamivudine|mesh-list
138269716|NCT02263326|Dolutegravir|dolutegravir|mesh-list
138269717|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138269718|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138269719|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138269720|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269721|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226016|NCT02462928|Ranibizumab|ranibizumab|mesh-list
138269722|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
138269723|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138269724|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138269725|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138269726|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138269728|NCT00356395|Candesartan cilexetil|candesartan cilexetil|mesh-list
138269730|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138269731|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138269732|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138269733|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269734|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138269735|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
138269736|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269737|NCT00356473|Atorvastatin|atorvastatin|mesh-list
138269738|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138269739|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138269740|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
138269741|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269742|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138269743|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138269744|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269745|NCT00356941|Docetaxel|docetaxel|mesh-list
138269746|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
138269747|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269748|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
138269749|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
138269750|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
138269751|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269752|NCT03450083|Benralizumab|benralizumab|mesh-list
138269753|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138269754|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
138269755|NCT03580343|Tofacitinib|tofacitinib|mesh-list
138269756|NCT03580343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138269757|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138269758|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269759|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269760|NCT05445440|Leucovorin|leucovorin|mesh-list
138269761|NCT05445440|Sulfasalazine|sulfasalazine|mesh-list
138269762|NCT05445440|Methotrexate|methotrexate|mesh-list
138269763|NCT05445440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138269764|NCT05445440|Abortifacient Agents|abortifacient agents|mesh-ancestor
138269765|NCT05445440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138269766|NCT05445440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269767|NCT05445440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138269768|NCT05445440|Antimetabolites|antimetabolites|mesh-ancestor
138226050|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138269769|NCT05445440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193554|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
138193560|NCT04127396|Sorafenib|sorafenib|mesh-list
138269770|NCT05445440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269771|NCT05445440|Dermatologic Agents|dermatologic agents|mesh-ancestor
138269772|NCT05445440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269773|NCT05445440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138269774|NCT05445440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138269775|NCT05445440|Immunologic Factors|immunologic factors|mesh-ancestor
138269776|NCT05445440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138269777|NCT05445440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138269778|NCT05445440|Antidotes|antidotes|mesh-ancestor
138269779|NCT05445440|Protective Agents|protective agents|mesh-ancestor
138269780|NCT05445440|Vitamin B Complex|vitamin b complex|mesh-ancestor
138269781|NCT05445440|Vitamins|vitamins|mesh-ancestor
138269782|NCT05445440|Micronutrients|micronutrients|mesh-ancestor
138269783|NCT05445440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138269784|NCT05445440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138269785|NCT05445440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138269786|NCT05445440|Analgesics|analgesics|mesh-ancestor
138269787|NCT05445440|Sensory System Agents|sensory system agents|mesh-ancestor
138269788|NCT05445440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269789|NCT05445440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138269790|NCT05445440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138269791|NCT05041322|Buspirone|buspirone|mesh-list
138269792|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138269793|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138269794|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269795|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269796|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138269797|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138269798|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
138269799|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269800|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269801|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
138269802|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269803|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138269804|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269805|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269806|NCT05229614|Pembrolizumab|pembrolizumab|mesh-list
138269807|NCT05229614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138269808|NCT05229614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269809|NCT05229614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138269810|NCT05229614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269812|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
138269813|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269815|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
138269816|NCT05647356|Bicalutamide|bicalutamide|mesh-list
138269817|NCT05647356|Androgen Antagonists|androgen antagonists|mesh-ancestor
138269818|NCT05647356|Hormone Antagonists|hormone antagonists|mesh-ancestor
138269819|NCT05647356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269820|NCT05647356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138488697|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
138269821|NCT05647356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269822|NCT05647278|Esomeprazole|esomeprazole|mesh-list
138269823|NCT05647278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138269824|NCT05647278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138269825|NCT05647278|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138269826|NCT05647278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269827|NCT05647278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269828|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
138269829|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138269830|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
138269831|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
138269832|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269833|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
138269834|NCT00359840|Hematinics|hematinics|mesh-ancestor
138269835|NCT02259582|Carboplatin|carboplatin|mesh-list
138269836|NCT02259582|Pemetrexed|pemetrexed|mesh-list
138269837|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269838|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193573|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
138269839|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269840|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138269841|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138269842|NCT00360386|Clopidogrel|clopidogrel|mesh-list
138269843|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138269844|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138269845|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138269846|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138269847|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
138269848|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269849|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269850|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269851|NCT02977208|Gabapentin|gabapentin|mesh-list
138269852|NCT02977208|Analgesics|analgesics|mesh-ancestor
138269853|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
138269854|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269855|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269856|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
138269857|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138269858|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138269859|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269860|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138269861|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138269862|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138269863|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269864|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269865|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
138269866|NCT04866108|Capecitabine|capecitabine|mesh-list
138269867|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138269868|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
138269869|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269871|NCT04343768|Interferons|interferons|mesh-list
138269872|NCT04343768|Ritonavir|ritonavir|mesh-list
138269873|NCT04343768|Lopinavir|lopinavir|mesh-list
138269874|NCT04343768|Interferon-beta|interferon-beta|mesh-list
138269875|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
138269876|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
138269877|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
138269878|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269879|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
138269880|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138269881|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138269882|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138269883|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
138269884|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269885|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269886|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138269887|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138269888|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138269889|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138269890|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
138269891|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138269892|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138269893|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138269894|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
138269895|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269896|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138269898|NCT05925790|Immunologic Factors|immunologic factors|mesh-ancestor
138269899|NCT05925790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269900|NCT05925504|Luspatercept|luspatercept|mesh-list
138269901|NCT05925504|Hematinics|hematinics|mesh-ancestor
138269902|NCT05925491|Pembrolizumab|pembrolizumab|mesh-list
138269903|NCT05925491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138269904|NCT05925491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269905|NCT05925491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138269906|NCT05925491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269907|NCT05925283|Midazolam|midazolam|mesh-list
138269908|NCT05925283|Esketamine|esketamine|mesh-list
138269909|NCT05925283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138269910|NCT05925283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138269911|NCT05925283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269912|NCT05925283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269913|NCT05925283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138269914|NCT05925283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138269915|NCT05925283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138269916|NCT05925283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138269917|NCT05925283|Anesthetics, General|anesthetics, general|mesh-ancestor
138269918|NCT05925283|Anesthetics|anesthetics|mesh-ancestor
138269919|NCT05925283|GABA Modulators|gaba modulators|mesh-ancestor
138269920|NCT05925283|GABA Agents|gaba agents|mesh-ancestor
138269921|NCT05925283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269922|NCT05925283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269923|NCT05925283|Antidepressive Agents|antidepressive agents|mesh-ancestor
138269924|NCT05924893|Naltrexone|naltrexone|mesh-list
138269925|NCT05924893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138269926|NCT05924893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138269927|NCT05924893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269928|NCT05924893|Sensory System Agents|sensory system agents|mesh-ancestor
138269929|NCT05924893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269930|NCT05924165|Ketorolac|ketorolac|mesh-list
138269931|NCT05924165|Oxycodone|oxycodone|mesh-list
138269932|NCT05924165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138269933|NCT05924165|Narcotics|narcotics|mesh-ancestor
138269934|NCT05924165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138269935|NCT05924165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269936|NCT05924165|Analgesics|analgesics|mesh-ancestor
138269937|NCT05924165|Sensory System Agents|sensory system agents|mesh-ancestor
138269938|NCT05924165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269939|NCT05924165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138269940|NCT05924165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138269941|NCT05924165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138269942|NCT05924165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138269943|NCT05924165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138269944|NCT05924165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269945|NCT05924165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269947|NCT05924100|Hematinics|hematinics|mesh-ancestor
138269949|NCT05923879|Lenalidomide|lenalidomide|mesh-list
138269950|NCT05923879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138269951|NCT05923879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269952|NCT05923879|Immunologic Factors|immunologic factors|mesh-ancestor
138269953|NCT05923879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269954|NCT05923879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138269955|NCT05923879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138269956|NCT05923879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138269957|NCT05923879|Growth Substances|growth substances|mesh-ancestor
138269958|NCT05923879|Growth Inhibitors|growth inhibitors|mesh-ancestor
138269960|NCT05923021|Antidepressive Agents|antidepressive agents|mesh-ancestor
138269961|NCT05923021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138269962|NCT05923021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138226149|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138226159|NCT03401372|Bortezomib|bortezomib|mesh-list
138269963|NCT05923021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138269964|NCT05923021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138488931|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
138269965|NCT05923021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269966|NCT05923021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138269968|NCT05923021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269970|NCT05922839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138269971|NCT05922839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138193591|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269972|NCT05922839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138269973|NCT05922839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269974|NCT05922800|Gamma-oryzanol|gamma-oryzanol|mesh-list
138269975|NCT05922800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138269976|NCT05922800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138269977|NCT05922800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138269978|NCT05922800|Antimetabolites|antimetabolites|mesh-ancestor
138269979|NCT05922800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138269980|NCT05922800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138269981|NCT05922696|Vitamin D|vitamin d|mesh-list
138269982|NCT05922696|Cholecalciferol|cholecalciferol|mesh-list
138269983|NCT05922696|Vitamins|vitamins|mesh-ancestor
138269984|NCT05922696|Micronutrients|micronutrients|mesh-ancestor
138269985|NCT05922696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269986|NCT05922696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138269987|NCT05922696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138269988|NCT05922501|Dexamethasone|dexamethasone|mesh-list
138269989|NCT05922501|Pomalidomide|pomalidomide|mesh-list
138488975|NCT00010075|Leucovorin|leucovorin|mesh-list
138269990|NCT05922501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138269991|NCT05922501|Antiemetics|antiemetics|mesh-ancestor
138269992|NCT05922501|Autonomic Agents|autonomic agents|mesh-ancestor
138269993|NCT05922501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138269994|NCT05922501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138269995|NCT05922501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138269996|NCT05922501|Glucocorticoids|glucocorticoids|mesh-ancestor
138269998|NCT05922501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138269999|NCT05922501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138270000|NCT05922501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270001|NCT05922501|Immunologic Factors|immunologic factors|mesh-ancestor
138270002|NCT05922501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138270003|NCT05922501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138270004|NCT05922501|Growth Substances|growth substances|mesh-ancestor
138270005|NCT05922501|Growth Inhibitors|growth inhibitors|mesh-ancestor
138270006|NCT05922436|Clevidipine|clevidipine|mesh-list
138270007|NCT05922436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138270008|NCT05922436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138270009|NCT05922436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270010|NCT05922436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138270011|NCT05922436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270014|NCT05922384|Carmustine|carmustine|mesh-list
138270015|NCT05922384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138270016|NCT05922384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270017|NCT05922384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138270018|NCT05922384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138270019|NCT05922384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270020|NCT05922384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270021|NCT05922384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138270022|NCT05922384|Alkylating Agents|alkylating agents|mesh-ancestor
138270023|NCT05922384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138270024|NCT05922384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138270025|NCT05922384|Immunologic Factors|immunologic factors|mesh-ancestor
138270026|NCT05922384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270027|NCT05922358|Anti-Allergic Agents|anti-allergic agents|mesh-list
138270028|NCT05922345|Docetaxel|docetaxel|mesh-list
138270029|NCT05922345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270030|NCT05922345|Tubulin Modulators|tubulin modulators|mesh-ancestor
138270031|NCT05922345|Antimitotic Agents|antimitotic agents|mesh-ancestor
138270032|NCT05922345|Mitosis Modulators|mitosis modulators|mesh-ancestor
138270033|NCT05922345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270035|NCT05922306|Interferon-alpha|interferon-alpha|mesh-list
138270036|NCT05922306|Interferon alpha-2|interferon alpha-2|mesh-list
138270037|NCT05922306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377907|NCT01446211|Hormones|hormones|mesh-ancestor
138270038|NCT05922306|Antiviral Agents|antiviral agents|mesh-ancestor
138270039|NCT05922306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138193600|NCT05505006|Micronutrients|micronutrients|mesh-ancestor
138270040|NCT05922306|Immunologic Factors|immunologic factors|mesh-ancestor
138270041|NCT05922306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270043|NCT05921942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138270044|NCT05921942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270045|NCT05921370|Silodosin|silodosin|mesh-list
138270047|NCT05921370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138270048|NCT05921370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138270049|NCT05921370|Adrenergic Agents|adrenergic agents|mesh-ancestor
138270050|NCT05921370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138270051|NCT05921370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270052|NCT05921370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270053|NCT05921370|Urological Agents|urological agents|mesh-ancestor
138270054|NCT05921292|Lidocaine|lidocaine|mesh-list
138270055|NCT05921292|Anesthetics, Local|anesthetics, local|mesh-ancestor
138270056|NCT05921292|Anesthetics|anesthetics|mesh-ancestor
138270057|NCT05921292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270058|NCT05921292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270059|NCT05921292|Sensory System Agents|sensory system agents|mesh-ancestor
138270060|NCT05921292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270061|NCT05921292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138270062|NCT05921292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138270063|NCT05921292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138270064|NCT05921292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138270065|NCT05921292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270066|NCT05921097|Histamine|histamine|mesh-list
138270067|NCT05921097|Histamine Agonists|histamine agonists|mesh-ancestor
138270068|NCT05921097|Histamine Agents|histamine agents|mesh-ancestor
138270069|NCT05921097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138270070|NCT05921097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270071|NCT05921097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270072|NCT05921071|Tranexamic Acid|tranexamic acid|mesh-list
138270073|NCT05921071|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138270074|NCT05921071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138270075|NCT05921071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270076|NCT05921071|Hemostatics|hemostatics|mesh-ancestor
138270077|NCT05921071|Coagulants|coagulants|mesh-ancestor
138270078|NCT05920980|Lidocaine|lidocaine|mesh-list
138270079|NCT05920980|Anesthetics, Local|anesthetics, local|mesh-ancestor
138270080|NCT05920980|Anesthetics|anesthetics|mesh-ancestor
138270081|NCT05920980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270082|NCT05920980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270083|NCT05920980|Sensory System Agents|sensory system agents|mesh-ancestor
138270084|NCT05920980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270085|NCT05920980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138270086|NCT05920980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138270087|NCT05920980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138270088|NCT05920980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138270089|NCT05920980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270090|NCT05920928|Capecitabine|capecitabine|mesh-list
138270091|NCT05920928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138270092|NCT05920928|Antimetabolites|antimetabolites|mesh-ancestor
138270093|NCT05920928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270094|NCT05920928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270095|NCT05920876|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138270096|NCT05920876|Immunologic Factors|immunologic factors|mesh-ancestor
138270097|NCT05920876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270099|NCT05920707|Arginine Vasopressin|arginine vasopressin|mesh-list
138270100|NCT05920707|Oxytocin|oxytocin|mesh-list
138270101|NCT05920707|Oxytocics|oxytocics|mesh-ancestor
138270102|NCT05920707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138270103|NCT05920707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270104|NCT05920707|Hemostatics|hemostatics|mesh-ancestor
138270105|NCT05920707|Coagulants|coagulants|mesh-ancestor
138270106|NCT05920707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138270107|NCT05920707|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138270108|NCT05920707|Natriuretic Agents|natriuretic agents|mesh-ancestor
138270109|NCT05920538|Nicardipine|nicardipine|mesh-list
138270110|NCT05920538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138270111|NCT05920538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138270112|NCT05920538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138270113|NCT05920538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270114|NCT05920538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138270115|NCT05920538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270116|NCT05920538|Vasodilator Agents|vasodilator agents|mesh-ancestor
138270117|NCT05920512|Calcitriol|calcitriol|mesh-list
138270118|NCT05920512|Sirolimus|sirolimus|mesh-list
138270119|NCT05920512|Valproic Acid|valproic acid|mesh-list
138270120|NCT05920512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138270121|NCT05920512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138270122|NCT05920512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138270123|NCT05920512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270124|NCT05920512|Antifungal Agents|antifungal agents|mesh-ancestor
138270125|NCT05920512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138270126|NCT05920512|Immunologic Factors|immunologic factors|mesh-ancestor
138270127|NCT05920512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270128|NCT05920512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270129|NCT05920512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270130|NCT05920512|Anticonvulsants|anticonvulsants|mesh-ancestor
138270131|NCT05920512|GABA Agents|gaba agents|mesh-ancestor
138226282|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138270133|NCT05920512|Antimanic Agents|antimanic agents|mesh-ancestor
138270134|NCT05920512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138270135|NCT05920512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270136|NCT05920512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138270137|NCT05920512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138270138|NCT05920512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138270139|NCT05920512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138270140|NCT05920512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138270142|NCT05920512|Micronutrients|micronutrients|mesh-ancestor
138270143|NCT05920512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138270144|NCT05920187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138270145|NCT05919992|Hydrocortisone|hydrocortisone|mesh-list
138270146|NCT05919992|Metyrapone|metyrapone|mesh-list
138270147|NCT05919992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138270148|NCT05919992|Antimetabolites|antimetabolites|mesh-ancestor
138270149|NCT05919992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270150|NCT05919992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270151|NCT05919966|Chlorhexidine|chlorhexidine|mesh-list
138270152|NCT05919966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138270153|NCT05919966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138270154|NCT05919966|Disinfectants|disinfectants|mesh-ancestor
138270155|NCT05919316|Mometasone Furoate|mometasone furoate|mesh-list
138270156|NCT05919316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138270157|NCT05919316|Dermatologic Agents|dermatologic agents|mesh-ancestor
138270158|NCT05919316|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138270159|NCT05918133|Paclitaxel|paclitaxel|mesh-list
138270160|NCT05918133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138270161|NCT05918133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270162|NCT05918133|Tubulin Modulators|tubulin modulators|mesh-ancestor
138270163|NCT05918133|Antimitotic Agents|antimitotic agents|mesh-ancestor
138270164|NCT05918133|Mitosis Modulators|mitosis modulators|mesh-ancestor
138270165|NCT05918133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270166|NCT05918107|Carboplatin|carboplatin|mesh-list
138270167|NCT05918107|Pemetrexed|pemetrexed|mesh-list
138270168|NCT05918107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270169|NCT05918107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270170|NCT05918107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270171|NCT05918107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138193620|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138193621|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138270172|NCT05918107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138270173|NCT05916950|Calcium|calcium|mesh-list
138270174|NCT05916950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138270175|NCT05916950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270176|NCT05897268|Lenvatinib|lenvatinib|mesh-list
138270177|NCT05897268|Tislelizumab|tislelizumab|mesh-list
138270178|NCT05897268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270179|NCT05897268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138270180|NCT05897268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270182|NCT05897268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138270183|NCT05895019|Propofol|propofol|mesh-list
138270184|NCT05895019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138270185|NCT05895019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270186|NCT05895019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270187|NCT05895019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138270188|NCT05895019|Anesthetics, General|anesthetics, general|mesh-ancestor
138270189|NCT05895019|Anesthetics|anesthetics|mesh-ancestor
138270190|NCT05893056|Lenvatinib|lenvatinib|mesh-list
138270191|NCT05893056|Tislelizumab|tislelizumab|mesh-list
138270192|NCT05893056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270193|NCT05893056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138270194|NCT05893056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270195|NCT05893056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270196|NCT05893056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138270197|NCT05891379|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138270198|NCT05891379|Immunologic Factors|immunologic factors|mesh-ancestor
138270199|NCT05891379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270200|NCT05883852|Cyclophosphamide|cyclophosphamide|mesh-list
138270201|NCT05883852|Carboplatin|carboplatin|mesh-list
138270202|NCT05883852|Docetaxel|docetaxel|mesh-list
138270203|NCT05883852|Trastuzumab|trastuzumab|mesh-list
138270204|NCT05883852|Epirubicin|epirubicin|mesh-list
138270205|NCT05883852|Pertuzumab|pertuzumab|mesh-list
138378015|NCT01446783|Mecasermin|mecasermin|mesh-list
138270207|NCT05883852|Immunologic Factors|immunologic factors|mesh-ancestor
138270208|NCT05883852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270209|NCT05883852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138270210|NCT05883852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138270211|NCT05883852|Alkylating Agents|alkylating agents|mesh-ancestor
138270212|NCT05883852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270213|NCT05883852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270214|NCT05883852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138270215|NCT05883852|Tubulin Modulators|tubulin modulators|mesh-ancestor
138270216|NCT05883852|Antimitotic Agents|antimitotic agents|mesh-ancestor
138270217|NCT05883852|Mitosis Modulators|mitosis modulators|mesh-ancestor
138270218|NCT05883852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138270219|NCT05883852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138226334|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
138270220|NCT05883852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138270221|NCT05883852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138270223|NCT05857514|Indomethacin|indomethacin|mesh-list
138270224|NCT05857514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138270225|NCT05857514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138270226|NCT05857514|Analgesics|analgesics|mesh-ancestor
138270227|NCT05857514|Sensory System Agents|sensory system agents|mesh-ancestor
138270228|NCT05857514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270229|NCT05857514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270230|NCT05857514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138270231|NCT05857514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138270232|NCT05857514|Gout Suppressants|gout suppressants|mesh-ancestor
138270233|NCT05857514|Tocolytic Agents|tocolytic agents|mesh-ancestor
138270234|NCT05857514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138193632|NCT04393610|Lidocaine|lidocaine|mesh-list
138270235|NCT05857514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138270236|NCT05857514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270237|NCT05857514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270238|NCT05832892|Paclitaxel|paclitaxel|mesh-list
138270239|NCT05832892|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138270240|NCT05832892|Gemcitabine|gemcitabine|mesh-list
138270241|NCT05832892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138270242|NCT05832892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270244|NCT05832892|Antimitotic Agents|antimitotic agents|mesh-ancestor
138270245|NCT05832892|Mitosis Modulators|mitosis modulators|mesh-ancestor
138270246|NCT05832892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270247|NCT05832892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138270248|NCT05832892|Antimetabolites|antimetabolites|mesh-ancestor
138270249|NCT05832398|Leucovorin|leucovorin|mesh-list
138270250|NCT05832398|Fluorouracil|fluorouracil|mesh-list
138270251|NCT05832398|Oxaliplatin|oxaliplatin|mesh-list
138270253|NCT05832398|Antimetabolites|antimetabolites|mesh-ancestor
138318036|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
138270254|NCT05832398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270255|NCT05832398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138378049|NCT01447069|Albuterol|albuterol|mesh-list
138270256|NCT05832398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270257|NCT05832398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138270258|NCT05832398|Immunologic Factors|immunologic factors|mesh-ancestor
138270259|NCT05832398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270260|NCT05832398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138270261|NCT05832398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138270262|NCT05832398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270263|NCT05832398|Antidotes|antidotes|mesh-ancestor
138270264|NCT05832398|Protective Agents|protective agents|mesh-ancestor
138270265|NCT05832398|Vitamin B Complex|vitamin b complex|mesh-ancestor
138270267|NCT05832398|Micronutrients|micronutrients|mesh-ancestor
138270268|NCT05828147|Rituximab|rituximab|mesh-list
138270269|NCT05828147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138270270|NCT05828147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270271|NCT05828147|Immunologic Factors|immunologic factors|mesh-ancestor
138270272|NCT05828147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270273|NCT05828147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138270274|NCT05823987|Lenvatinib|lenvatinib|mesh-list
138270275|NCT05823987|Tislelizumab|tislelizumab|mesh-list
138270276|NCT05823987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270277|NCT05823987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138270278|NCT05823987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270279|NCT05823987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270280|NCT05823987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138270281|NCT05823467|Trimethoprim|trimethoprim|mesh-list
138270282|NCT05823467|Sulfamethoxazole|sulfamethoxazole|mesh-list
138270283|NCT05823467|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138270284|NCT05823467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138270285|NCT05823467|Antimalarials|antimalarials|mesh-ancestor
138270286|NCT05823467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138270287|NCT05823467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138270288|NCT05823467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138270289|NCT05823467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270290|NCT05823467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270291|NCT05823467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138270292|NCT05823467|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138270293|NCT05823467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138270294|NCT05823337|Selenium|selenium|mesh-list
138270295|NCT05823337|Antioxidants|antioxidants|mesh-ancestor
138270296|NCT05823337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270297|NCT05823337|Protective Agents|protective agents|mesh-ancestor
138193643|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138193646|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138270298|NCT05823337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270299|NCT05823337|Trace Elements|trace elements|mesh-ancestor
138270300|NCT05823337|Micronutrients|micronutrients|mesh-ancestor
138270301|NCT05796791|Ketamine|ketamine|mesh-list
138270302|NCT05796791|Analgesics|analgesics|mesh-ancestor
138270303|NCT05796791|Sensory System Agents|sensory system agents|mesh-ancestor
138270304|NCT05796791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270305|NCT05796791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270306|NCT05796791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138270307|NCT05796791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138270308|NCT05796791|Anesthetics, General|anesthetics, general|mesh-ancestor
138270309|NCT05796791|Anesthetics|anesthetics|mesh-ancestor
138270310|NCT05796791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270311|NCT05796791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138270312|NCT05796791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138226395|NCT04364906|Anesthetics|anesthetics|mesh-list
138270314|NCT05796791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270316|NCT05759364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138270317|NCT05759364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270318|NCT05759364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270319|NCT05759364|Vasodilator Agents|vasodilator agents|mesh-ancestor
138270320|NCT05759364|Urological Agents|urological agents|mesh-ancestor
138270321|NCT05749926|Vaccines|vaccines|mesh-list
138270322|NCT05749926|Immunologic Factors|immunologic factors|mesh-ancestor
138270323|NCT05749926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270324|NCT05730205|Etonogestrel|etonogestrel|mesh-list
138270325|NCT05730205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138270326|NCT05730205|Contraceptive Agents|contraceptive agents|mesh-ancestor
138270327|NCT05730205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138270328|NCT05730205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270329|NCT05730205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138270330|NCT05706233|Analgesics|analgesics|mesh-list
138270331|NCT05706233|Sensory System Agents|sensory system agents|mesh-ancestor
138270332|NCT05706233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270333|NCT05706233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270334|NCT05705050|Aminophylline|aminophylline|mesh-list
138270335|NCT05705050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138270336|NCT05705050|Autonomic Agents|autonomic agents|mesh-ancestor
138270337|NCT05705050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270338|NCT05705050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270339|NCT05705050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138270340|NCT05705050|Respiratory System Agents|respiratory system agents|mesh-ancestor
138270341|NCT05705050|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138270342|NCT05705050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138270343|NCT05705050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270344|NCT05705050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270345|NCT05705050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138270346|NCT05705050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138270347|NCT05705050|Purinergic Agents|purinergic agents|mesh-ancestor
138270348|NCT05705050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138270349|NCT05705050|Protective Agents|protective agents|mesh-ancestor
138270350|NCT05693454|Tramadol|tramadol|mesh-list
138270351|NCT05693454|Levobupivacaine|levobupivacaine|mesh-list
138270354|NCT05693454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270355|NCT05693454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270356|NCT05693454|Analgesics|analgesics|mesh-ancestor
138270357|NCT05693454|Sensory System Agents|sensory system agents|mesh-ancestor
138270358|NCT05693454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270359|NCT05693454|Anesthetics, Local|anesthetics, local|mesh-ancestor
138270360|NCT05693454|Anesthetics|anesthetics|mesh-ancestor
138270361|NCT05672108|Mitomycins|mitomycins|mesh-list
138270362|NCT05672108|Mitomycin|mitomycin|mesh-list
138270363|NCT05672108|Ethiodized Oil|ethiodized oil|mesh-list
138270364|NCT05672108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138270366|NCT05672108|Alkylating Agents|alkylating agents|mesh-ancestor
138270367|NCT05672108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270368|NCT05672108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138270369|NCT05672108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270370|NCT05668429|Ibrexafungerp|ibrexafungerp|mesh-list
138270371|NCT05668429|Antifungal Agents|antifungal agents|mesh-ancestor
138270372|NCT05668429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138270374|NCT05648591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138270375|NCT05648591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138270376|NCT05648591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270377|NCT05648591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270378|NCT05648591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138270379|NCT05613426|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138270381|NCT05613426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138270382|NCT05613426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138270383|NCT05613426|Antimetabolites|antimetabolites|mesh-ancestor
138270384|NCT05613426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270385|NCT05613426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138270386|NCT05613426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138270387|NCT05613426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270388|NCT05613426|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138270389|NCT05613426|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138270390|NCT05613426|Protease Inhibitors|protease inhibitors|mesh-ancestor
138270392|NCT05603065|Tislelizumab|tislelizumab|mesh-list
138270393|NCT05603065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138270394|NCT05603065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270395|NCT05603065|Tubulin Modulators|tubulin modulators|mesh-ancestor
138270396|NCT05603065|Antimitotic Agents|antimitotic agents|mesh-ancestor
138270397|NCT05603065|Mitosis Modulators|mitosis modulators|mesh-ancestor
138270398|NCT05603065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138226462|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138270399|NCT05603065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138270402|NCT05601700|Letrozole|letrozole|mesh-list
138270403|NCT05601700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138270404|NCT05601700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270405|NCT05601700|Tubulin Modulators|tubulin modulators|mesh-ancestor
138270406|NCT05601700|Antimitotic Agents|antimitotic agents|mesh-ancestor
138270407|NCT05601700|Mitosis Modulators|mitosis modulators|mesh-ancestor
138270408|NCT05601700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270409|NCT05601700|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138270410|NCT05601700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138270411|NCT05601700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270412|NCT05601700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138270413|NCT05601700|Hormone Antagonists|hormone antagonists|mesh-ancestor
138270414|NCT05601700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138270415|NCT05601700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270416|NCT05558150|Aceclofenac|aceclofenac|mesh-list
138270417|NCT05558150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138270418|NCT05558150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138270419|NCT05558150|Analgesics|analgesics|mesh-ancestor
138270420|NCT05558150|Sensory System Agents|sensory system agents|mesh-ancestor
138270421|NCT05558150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270422|NCT05558150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270423|NCT05558150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138270424|NCT05558150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138193679|NCT03826004|Clemastine|clemastine|mesh-list
138270425|NCT05467748|Pembrolizumab|pembrolizumab|mesh-list
138270426|NCT05467748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138270427|NCT05467748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270428|NCT05467748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138270429|NCT05467748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270430|NCT05460871|Pregabalin|pregabalin|mesh-list
138270431|NCT05460871|Analgesics|analgesics|mesh-ancestor
138270432|NCT05460871|Sensory System Agents|sensory system agents|mesh-ancestor
138270433|NCT05460871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270434|NCT05460871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270435|NCT05460871|Anticonvulsants|anticonvulsants|mesh-ancestor
138270436|NCT05460871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138270437|NCT05460871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138270438|NCT05460871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270439|NCT05460871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138270440|NCT05460871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138270441|NCT05460871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138270442|NCT05460871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270443|NCT05460871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138270444|NCT05457998|Flutemetamol|flutemetamol|mesh-list
138270445|NCT05457998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138270446|NCT05457998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270448|NCT05438316|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138270449|NCT05438316|Protease Inhibitors|protease inhibitors|mesh-ancestor
138270450|NCT05438316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270451|NCT05438316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270452|NCT05438316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138270453|NCT05426525|Empagliflozin|empagliflozin|mesh-list
138270454|NCT05426525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138270455|NCT05426525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270456|NCT05426525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138270457|NCT05426525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270460|NCT05353140|Aspirin|aspirin|mesh-list
138270461|NCT05353140|Rivaroxaban|rivaroxaban|mesh-list
138270462|NCT05353140|Clopidogrel|clopidogrel|mesh-list
138270463|NCT05353140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138270464|NCT05353140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138270465|NCT05353140|Analgesics|analgesics|mesh-ancestor
138270466|NCT05353140|Sensory System Agents|sensory system agents|mesh-ancestor
138270467|NCT05353140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270468|NCT05353140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270469|NCT05353140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138270470|NCT05353140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138270471|NCT05353140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138270472|NCT05353140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138270473|NCT05353140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270474|NCT05353140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138270475|NCT05353140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138270476|NCT05353140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270478|NCT05353140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138270479|NCT05353140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138270480|NCT05353140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138270481|NCT05353140|Purinergic Agents|purinergic agents|mesh-ancestor
138270482|NCT05353140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138270483|NCT05353140|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138270484|NCT05353140|Antithrombins|antithrombins|mesh-ancestor
138270485|NCT05353140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138270486|NCT05353140|Protease Inhibitors|protease inhibitors|mesh-ancestor
138270487|NCT05353140|Anticoagulants|anticoagulants|mesh-ancestor
138270488|NCT05351944|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138270489|NCT05351944|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138270490|NCT05351944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138193692|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138270491|NCT05351944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138270492|NCT05351944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270493|NCT05351944|Adrenergic Agents|adrenergic agents|mesh-ancestor
138270494|NCT05351944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138270495|NCT05351944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270496|NCT05340465|Iron|iron|mesh-list
138270497|NCT05340465|Dextrans|dextrans|mesh-list
138270498|NCT05340465|Darbepoetin alfa|darbepoetin alfa|mesh-list
138270499|NCT05340465|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138270500|NCT05340465|Iron-Dextran Complex|iron-dextran complex|mesh-list
138270501|NCT05340465|Trace Elements|trace elements|mesh-ancestor
138270502|NCT05340465|Micronutrients|micronutrients|mesh-ancestor
138270503|NCT05340465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270504|NCT05340465|Hematinics|hematinics|mesh-ancestor
138270505|NCT05340465|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138270506|NCT05340465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138226508|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
138270508|NCT05340465|Plasma Substitutes|plasma substitutes|mesh-ancestor
138270509|NCT05340465|Blood Substitutes|blood substitutes|mesh-ancestor
138270511|NCT05303090|Tislelizumab|tislelizumab|mesh-list
138270512|NCT05303090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270513|NCT05303090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138270514|NCT05303090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270515|NCT05303090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270516|NCT05303090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138270517|NCT05243329|Psilocybin|psilocybin|mesh-list
138270518|NCT05243329|Hallucinogens|hallucinogens|mesh-ancestor
138270519|NCT05243329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270520|NCT05243329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138270521|NCT05237297|Celecoxib|celecoxib|mesh-list
138270522|NCT05237297|Naproxen|naproxen|mesh-list
138270523|NCT05237297|Aceclofenac|aceclofenac|mesh-list
138270524|NCT05237297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138270525|NCT05237297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138270526|NCT05237297|Analgesics|analgesics|mesh-ancestor
138270527|NCT05237297|Sensory System Agents|sensory system agents|mesh-ancestor
138270528|NCT05237297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270529|NCT05237297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270530|NCT05237297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138270531|NCT05237297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138270532|NCT05237297|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138270533|NCT05237297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138270534|NCT05237297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270535|NCT05237297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270536|NCT05237297|Gout Suppressants|gout suppressants|mesh-ancestor
138270537|NCT05216952|Misoprostol|misoprostol|mesh-list
138270538|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
138270539|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138270540|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
138270541|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138270542|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270543|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138270544|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138270545|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
138270546|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138270547|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
138270548|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138270549|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
138193701|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
138270550|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138270551|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
138270552|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270553|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270554|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138270555|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
138270556|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138270557|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
138270558|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270559|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138270560|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138270561|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
138270562|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
138270563|NCT05213676|Protective Agents|protective agents|mesh-ancestor
138270564|NCT05206110|Ketorolac|ketorolac|mesh-list
138270565|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138270566|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138270567|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138270568|NCT05206110|Analgesics|analgesics|mesh-ancestor
138270569|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
138270570|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270571|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270572|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138270573|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138270574|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138270575|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270576|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270577|NCT05144243|Azacitidine|azacitidine|mesh-list
138270578|NCT05144243|Venetoclax|venetoclax|mesh-list
138270579|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138270580|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
138270581|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270582|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270583|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270584|NCT05139238|Labetalol|labetalol|mesh-list
138270585|NCT05139238|Nifedipine|nifedipine|mesh-list
138270586|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138270587|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138270588|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270589|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138270590|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270591|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
138270592|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
138270593|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138270594|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138270595|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138270596|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
138270597|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138270598|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138270599|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
138270600|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
138270601|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270602|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138270603|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138270604|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
138270605|NCT05138614|Narcotics|narcotics|mesh-ancestor
138270606|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270607|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270608|NCT05138614|Analgesics|analgesics|mesh-ancestor
138270609|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
138270610|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270612|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138378275|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138193721|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138270613|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138270614|NCT05103904|Lenvatinib|lenvatinib|mesh-list
138270615|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270616|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138270617|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270618|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270619|NCT05093582|Cromakalim|cromakalim|mesh-list
138270620|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138270621|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138270622|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
138270623|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270624|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270625|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138270626|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
138270627|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
138226611|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
138270629|NCT05090384|Prednisone|prednisone|mesh-list
138270630|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138270631|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
138270633|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138270634|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270635|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138270636|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270637|NCT05045703|Vitamin A|vitamin a|mesh-list
138270638|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
138270639|NCT05045703|Vitamins|vitamins|mesh-ancestor
138270640|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
138270641|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270642|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
138270643|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270644|NCT05045703|Protective Agents|protective agents|mesh-ancestor
138270645|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138270646|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270647|NCT05005728|Carboplatin|carboplatin|mesh-list
138270648|NCT05005728|Docetaxel|docetaxel|mesh-list
138270649|NCT05005728|Olaparib|olaparib|mesh-list
138270650|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270651|NCT05005728|Tubulin Modulators|tubulin modulators|mesh-ancestor
138270652|NCT05005728|Antimitotic Agents|antimitotic agents|mesh-ancestor
138270653|NCT05005728|Mitosis Modulators|mitosis modulators|mesh-ancestor
138270654|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270655|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138270656|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270658|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270659|NCT04949828|Pancrelipase|pancrelipase|mesh-list
138270660|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138270661|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
138270662|NCT04927884|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138270663|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138270664|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
138270665|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270666|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138270667|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138270668|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
138226650|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138226651|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
138270669|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270670|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270671|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138270672|NCT04927884|Immunoconjugates|immunoconjugates|mesh-ancestor
138270673|NCT04868773|Trifluridine|trifluridine|mesh-list
138270674|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
138270675|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270676|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
138270677|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138270678|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138270679|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138270680|NCT04865029|Estradiol|estradiol|mesh-list
138270681|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138270682|NCT04865029|Progesterone|progesterone|mesh-list
138270683|NCT04865029|Estrogens|estrogens|mesh-ancestor
138270684|NCT04865029|Hormones|hormones|mesh-ancestor
138270685|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138270686|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270687|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138270688|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
138270689|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138270690|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138270691|NCT04865029|Progestins|progestins|mesh-ancestor
138270692|NCT04859660|Tamsulosin|tamsulosin|mesh-list
138270693|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138378343|NCT01448772|Dronabinol|dronabinol|mesh-list
138270694|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138270695|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138270696|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
138270697|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138270698|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270699|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270700|NCT04859660|Urological Agents|urological agents|mesh-ancestor
138270701|NCT04806919|Progesterone|progesterone|mesh-list
138270702|NCT04806919|Progestins|progestins|mesh-ancestor
138270704|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138270705|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270706|NCT04805957|Sulforaphane|sulforaphane|mesh-list
138270707|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138270708|NCT04805957|Protective Agents|protective agents|mesh-ancestor
138270709|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270710|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270711|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
138270712|NCT04796779|Trace Elements|trace elements|mesh-ancestor
138270713|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
138270714|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270715|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
138270716|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138270717|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270718|NCT04793815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138270719|NCT04793815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270720|NCT04762134|Doxycycline|doxycycline|mesh-list
138270721|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138270722|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138270723|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
138378382|NCT01449045|Lumefantrine|lumefantrine|mesh-list
138270724|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138270725|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138270726|NCT04743934|Androgens|androgens|mesh-list
138270727|NCT04743934|Hormones|hormones|mesh-ancestor
138270728|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138270729|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270731|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138270732|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138270733|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138270734|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138193744|NCT01142323|Fenofibrate|fenofibrate|mesh-list
138270735|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
138270736|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
138270737|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138270738|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138270739|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138270740|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270741|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270742|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138270743|NCT04721548|Minoxidil|minoxidil|mesh-list
138270744|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138270745|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
138270746|NCT04717089|Anesthetics|anesthetics|mesh-list
138270747|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270748|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270749|NCT04712799|Xylometazoline|xylometazoline|mesh-list
138270750|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
138270752|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
138270753|NCT04712734|Iloperidone|iloperidone|mesh-list
138270754|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138270755|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138270756|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270757|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270758|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138270759|NCT04687098|Idarubicin|idarubicin|mesh-list
138270760|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138270761|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270762|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138270763|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138270764|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270765|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378433|NCT01449344|Cytarabine|cytarabine|mesh-list
138270766|NCT04683406|Oseltamivir|oseltamivir|mesh-list
138270767|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
138270768|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138270769|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270770|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270771|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
138270772|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
138270774|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
138270775|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270776|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270778|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
138270779|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270780|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270781|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138270782|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138270783|NCT04662073|Camostat|camostat|mesh-list
138270784|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
138270785|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270786|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270787|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138270788|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138270789|NCT04647877|Phenytoin|phenytoin|mesh-list
138270790|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
138270791|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138270792|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138270793|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138378457|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
138270794|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270795|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138270796|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138270797|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
138270798|NCT04617938|Narcotics|narcotics|mesh-ancestor
138270799|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270800|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270801|NCT04617938|Analgesics|analgesics|mesh-ancestor
138270802|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
138270803|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270804|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
138270805|NCT04608539|Hematinics|hematinics|mesh-ancestor
138270806|NCT04586166|Imidacloprid|imidacloprid|mesh-list
138270807|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
138270808|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138270809|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270810|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270811|NCT04575597|Molnupiravir|molnupiravir|mesh-list
138270812|NCT04575597|Antiviral Agents|antiviral agents|mesh-ancestor
138270813|NCT04575597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138270814|NCT04562792|Daunorubicin|daunorubicin|mesh-list
138270815|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138270816|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270817|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138270818|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138270819|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270820|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270821|NCT04550377|Cannabidiol|cannabidiol|mesh-list
138270822|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
138270823|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138270824|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138270825|NCT04501367|Dexamethasone|dexamethasone|mesh-list
138270826|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
138270828|NCT04501367|BB 1101|bb 1101|mesh-list
138270829|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138270830|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
138270831|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
138270832|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270833|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270834|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138270835|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
138270836|NCT04501367|Hormones|hormones|mesh-ancestor
138270837|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138270838|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138270839|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270840|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
138270841|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270842|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270843|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
138270844|NCT04491617|Narcotics|narcotics|mesh-ancestor
138270845|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270846|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270847|NCT04491617|Analgesics|analgesics|mesh-ancestor
138270848|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
138270849|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270852|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138270853|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270854|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138270855|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138270856|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
138270857|NCT04427293|Lenvatinib|lenvatinib|mesh-list
138270858|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138270859|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270860|NCT04427293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138270861|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270862|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138270863|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270864|NCT04391842|Diclofenac|diclofenac|mesh-list
138270865|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138270866|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138270867|NCT04391842|Analgesics|analgesics|mesh-ancestor
138270868|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
138270869|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270870|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270871|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138270872|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138318471|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270874|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270875|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378537|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
138270876|NCT04383262|Fosamprenavir|fosamprenavir|mesh-list
138270877|NCT04383262|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138270878|NCT04383262|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138270879|NCT04383262|Protease Inhibitors|protease inhibitors|mesh-ancestor
138270880|NCT04383262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270881|NCT04383262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270882|NCT04383262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138270883|NCT04383262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138270884|NCT04383262|Antiviral Agents|antiviral agents|mesh-ancestor
138270885|NCT04383262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138270886|NCT04360681|Lofexidine|lofexidine|mesh-list
138270887|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138270888|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138270889|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270890|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
138270891|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270892|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138270893|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138270894|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138270895|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
138270896|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138270897|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270899|NCT04330248|Anticonvulsants|anticonvulsants|mesh-ancestor
138270900|NCT04330248|Antimanic Agents|antimanic agents|mesh-ancestor
138270901|NCT04330248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138270902|NCT04330248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270903|NCT04330248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270904|NCT04330248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138270905|NCT04330248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138270906|NCT04330248|Analgesics|analgesics|mesh-ancestor
138270907|NCT04330248|Sensory System Agents|sensory system agents|mesh-ancestor
138270908|NCT04330248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270909|NCT04330248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138270910|NCT04330248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138270911|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270912|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138270913|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138270915|NCT04328844|Avelumab|avelumab|mesh-list
138270916|NCT04328844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270917|NCT04328844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226854|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270919|NCT04328844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138270920|NCT04328844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138270921|NCT04328844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138270922|NCT04327024|Allopurinol|allopurinol|mesh-list
138270923|NCT04327024|Verinurad|verinurad|mesh-list
138270924|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
138270925|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270926|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138270927|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
138270928|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138270929|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138270930|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
138270931|NCT04327024|Protective Agents|protective agents|mesh-ancestor
138270932|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270933|NCT04315272|Azithromycin|azithromycin|mesh-list
138270934|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138270935|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138270936|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
138270937|NCT04304352|Capecitabine|capecitabine|mesh-list
138270938|NCT04304352|Vinorelbine|vinorelbine|mesh-list
138270939|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138270940|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
138270941|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270942|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138270943|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138270944|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
138270945|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270946|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138270947|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138270948|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138270950|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138270951|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
138270952|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
138270953|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
138270954|NCT04297592|Doxycycline|doxycycline|mesh-list
138270955|NCT04297592|Cephalexin|cephalexin|mesh-list
138270956|NCT04297592|Cefadroxil|cefadroxil|mesh-list
138270957|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138270958|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138270960|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138270962|NCT04294459|Acetaminophen|acetaminophen|mesh-list
138270963|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
138270964|NCT04294459|Promethazine|promethazine|mesh-list
138270965|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
138270966|NCT04294459|Ranitidine|ranitidine|mesh-list
138270967|NCT04294459|Montelukast|montelukast|mesh-list
138270968|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138270969|NCT04294459|Analgesics|analgesics|mesh-ancestor
138270970|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
138270971|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138270972|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138270973|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
138270974|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138270975|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
138270976|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
138270977|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138270978|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
138270979|NCT04294459|Hormones|hormones|mesh-ancestor
138270980|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138270981|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138270982|NCT04294459|Protective Agents|protective agents|mesh-ancestor
138270983|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138270984|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
138270985|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138270986|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
138270987|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138270988|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138270989|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138270990|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138270991|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138270992|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138270993|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
138270994|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
138270995|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138270996|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
138270997|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
138270998|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138270999|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138271000|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
138271001|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
138193800|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138271002|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138271003|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138271005|NCT04268121|Etoposide|etoposide|mesh-list
138271006|NCT04268121|Etoposide phosphate|etoposide phosphate|mesh-list
138271007|NCT04268121|Carboplatin|carboplatin|mesh-list
138271008|NCT04268121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271009|NCT04268121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138271010|NCT04268121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138271011|NCT04268121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138271013|NCT04268121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271014|NCT04252612|Pramlintide|pramlintide|mesh-list
138271015|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138271016|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271017|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
138271018|NCT04210505|Povidone|povidone|mesh-list
138271019|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
138271020|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
138271021|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138271022|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138271023|NCT04194528|Acetaminophen|acetaminophen|mesh-list
138271024|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138271025|NCT04194528|Oxycodone|oxycodone|mesh-list
138271026|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138271027|NCT04194528|Analgesics|analgesics|mesh-ancestor
138271028|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
138271029|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271030|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271031|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
138271032|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138271033|NCT04194528|Narcotics|narcotics|mesh-ancestor
138271034|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138271035|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138271036|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138271037|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271038|NCT04189614|Cofetuzumab pelidotin|cofetuzumab pelidotin|mesh-list
138271039|NCT04189614|Immunoconjugates|immunoconjugates|mesh-ancestor
138271040|NCT04189614|Immunologic Factors|immunologic factors|mesh-ancestor
138271041|NCT04189614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271042|NCT04179396|Rucaparib|rucaparib|mesh-list
138271043|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138271044|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138226971|NCT04361474|Budesonide|budesonide|mesh-list
138271046|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271048|NCT04158440|Docetaxel|docetaxel|mesh-list
138271049|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138271050|NCT04158440|Cisplatin|cisplatin|mesh-list
138271051|NCT04158440|Carboplatin|carboplatin|mesh-list
138271052|NCT04158440|Pemetrexed|pemetrexed|mesh-list
138271053|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138271054|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271055|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
138271056|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
138271057|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
138271058|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271059|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271060|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138271061|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138271063|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138193808|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138271064|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138271065|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138271066|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271067|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271068|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138271069|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
138271070|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271071|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271073|NCT04085458|Coagulants|coagulants|mesh-ancestor
138271074|NCT04077580|Methenamine|methenamine|mesh-list
138271075|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
138271076|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
138271077|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138271078|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138271079|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138271081|NCT03974217|Talazoparib|talazoparib|mesh-list
138271082|NCT03974217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138271083|NCT03974217|Antimetabolites|antimetabolites|mesh-ancestor
138271084|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271085|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271086|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271087|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138271088|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
138271089|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
138271090|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271091|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
138271092|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271093|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271094|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271095|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
138271096|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271097|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271098|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138271099|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271100|NCT03971045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138271101|NCT03940235|Androgens|androgens|mesh-list
138271102|NCT03940235|Hormones|hormones|mesh-ancestor
138271103|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271104|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271105|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
138271106|NCT03935893|Fludarabine|fludarabine|mesh-list
138271107|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271108|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
138271109|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271110|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271111|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271112|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
138271113|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271114|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271116|NCT03916510|Capecitabine|capecitabine|mesh-list
138271117|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138271118|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
138271119|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271120|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271121|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
138271122|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138271123|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
138271124|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
138271125|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138271126|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271127|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271128|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138271130|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
138271131|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271132|NCT03853317|Avelumab|avelumab|mesh-list
138271133|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271134|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271135|NCT03845010|Verapamil|verapamil|mesh-list
138271136|NCT03845010|Flecainide|flecainide|mesh-list
138271137|NCT03845010|Sotalol|sotalol|mesh-list
138271138|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138271139|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138271140|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138271141|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271142|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138271143|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271144|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
138271145|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138271146|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138271147|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138271148|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138271149|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
138271150|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138271151|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
138271152|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
138271153|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271154|NCT03829371|Dexamethasone|dexamethasone|mesh-list
138271155|NCT03829371|Prednisone|prednisone|mesh-list
138271156|NCT03829371|Lenalidomide|lenalidomide|mesh-list
138271157|NCT03829371|Melphalan|melphalan|mesh-list
138271158|NCT03829371|Bortezomib|bortezomib|mesh-list
138271159|NCT03829371|Daratumumab|daratumumab|mesh-list
138271160|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138271161|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
138271162|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
138271163|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271164|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271165|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138271166|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
138271167|NCT03829371|Hormones|hormones|mesh-ancestor
138271168|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271169|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271170|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271172|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138271173|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138271175|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
138271176|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271177|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
138271178|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271179|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138271180|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271181|NCT03785964|Nirogacestat|nirogacestat|mesh-list
138271182|NCT03785964|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138271183|NCT03785964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271184|NCT03785964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271185|NCT03743428|Bevacizumab|bevacizumab|mesh-list
138271186|NCT03743428|Apatinib|apatinib|mesh-list
138271187|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271188|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271189|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138271190|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138271191|NCT03743428|Growth Substances|growth substances|mesh-ancestor
138271192|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271193|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
138271194|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138271195|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271196|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271197|NCT03739710|Docetaxel|docetaxel|mesh-list
138271198|NCT03739710|Ipilimumab|ipilimumab|mesh-list
138271199|NCT03739710|Dostarlimab|dostarlimab|mesh-list
138704128|NCT06136624|Hormones|hormones|mesh-ancestor
138271200|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271201|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
138271202|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
138271203|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
138271204|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271205|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271206|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138271207|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138271208|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138271209|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271210|NCT03690921|Cisplatin|cisplatin|mesh-list
138271211|NCT03690921|Fluorouracil|fluorouracil|mesh-list
138271212|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271213|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
138271214|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271215|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138271216|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271217|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
138271218|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271219|NCT03635489|Paclitaxel|paclitaxel|mesh-list
138271220|NCT03635489|Bevacizumab|bevacizumab|mesh-list
138271221|NCT03635489|Carboplatin|carboplatin|mesh-list
138271222|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138271223|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271224|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
138271225|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
138271226|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
138271227|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271228|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271229|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138271230|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138271231|NCT03635489|Growth Substances|growth substances|mesh-ancestor
138271232|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271233|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
138271235|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138271236|NCT03631784|Carboplatin|carboplatin|mesh-list
138271239|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138271240|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271241|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
138271242|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
138271243|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
138378774|NCT05963204|Mannitol|mannitol|mesh-list
138271244|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271245|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271246|NCT03631784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138271247|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271248|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138271249|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138271250|NCT03617705|Ethanol|ethanol|mesh-list
138271251|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138271252|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138271253|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138271254|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271255|NCT03607422|Upadacitinib|upadacitinib|mesh-list
138271256|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138271257|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138271258|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271259|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271260|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271261|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
138271262|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138271263|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
138271264|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271265|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271266|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138271267|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
138271268|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138271269|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
138271270|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271271|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138271272|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138271273|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
138271274|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
138271275|NCT03576885|Protective Agents|protective agents|mesh-ancestor
138271276|NCT03576612|Valacyclovir|valacyclovir|mesh-list
138271277|NCT03576612|Acyclovir|acyclovir|mesh-list
138271278|NCT03576612|Nivolumab|nivolumab|mesh-list
138271279|NCT03576612|Temozolomide|temozolomide|mesh-list
138271280|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271281|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271283|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271284|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271285|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
138271286|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
138271287|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138271288|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
138271289|NCT03576105|Methylene Blue|methylene blue|mesh-list
138271290|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271291|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271292|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
138271293|NCT03568318|Upadacitinib|upadacitinib|mesh-list
138271294|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138271295|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138271296|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271297|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271298|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271299|NCT03550794|Thiamine|thiamine|mesh-list
138271300|NCT03550794|Vitamins|vitamins|mesh-ancestor
138271301|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
138271302|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271303|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
138271304|NCT03456102|Pravastatin|pravastatin|mesh-list
138271305|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138271306|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138271307|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
138271308|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271309|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138271310|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138271312|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
138271313|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271314|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271315|NCT03448666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138271316|NCT03448666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271318|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138271319|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138271320|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271321|NCT03436654|Prednisone|prednisone|mesh-list
138271322|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
138271323|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138271324|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
138271325|NCT03436654|Hormones|hormones|mesh-ancestor
138271326|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271327|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138378844|NCT05961761|Adrenergic Agents|adrenergic agents|mesh-ancestor
138271328|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271329|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271330|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138271331|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271332|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271333|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
138271334|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138271335|NCT03427125|Sevelamer|sevelamer|mesh-list
138271336|NCT03427125|Chelating Agents|chelating agents|mesh-ancestor
138271337|NCT03427125|Sequestering Agents|sequestering agents|mesh-ancestor
138271338|NCT03427125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271339|NCT03359863|Pirfenidone|pirfenidone|mesh-list
138271340|NCT03359863|Analgesics|analgesics|mesh-ancestor
138271341|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
138271342|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271343|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271344|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138271345|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138271346|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138271347|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271348|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271349|NCT03341273|Azithromycin|azithromycin|mesh-list
138271350|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138271351|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138271352|NCT03319901|Venetoclax|venetoclax|mesh-list
138271353|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271354|NCT03301766|Lidocaine|lidocaine|mesh-list
138271355|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
138271356|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
138271357|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227251|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138227254|NCT04641104|Thiamine|thiamine|mesh-list
138271380|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271381|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271383|NCT03198728|Testosterone|testosterone|mesh-list
138271384|NCT03198728|Androgens|androgens|mesh-ancestor
138271385|NCT03198728|Hormones|hormones|mesh-ancestor
138271386|NCT03198728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271387|NCT03198728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271417|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271418|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
138378904|NCT05960721|Purinergic Agents|purinergic agents|mesh-ancestor
138271419|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138271420|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138271421|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138271422|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
138271423|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271424|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271425|NCT03142334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138704259|NCT06048718|Trastuzumab|trastuzumab|mesh-list
138271426|NCT03142334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271428|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138271429|NCT03126539|Protective Agents|protective agents|mesh-ancestor
138271430|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271431|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271432|NCT03107923|Dobutamine|dobutamine|mesh-list
138271433|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138271434|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
138193868|NCT05394233|Growth Inhibitors|growth inhibitors|mesh-ancestor
138271435|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
138271436|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271437|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271438|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138271439|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138271440|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138271441|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
138271442|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138271443|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271444|NCT03107923|Protective Agents|protective agents|mesh-ancestor
138271445|NCT03092817|Dexamethasone|dexamethasone|mesh-list
138271446|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138271447|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
138271448|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
138271449|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271450|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271451|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138271453|NCT03092817|Hormones|hormones|mesh-ancestor
138271454|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271455|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271456|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271457|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
138271458|NCT03043664|Lanreotide|lanreotide|mesh-list
138271459|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271460|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271461|NCT03043664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138271462|NCT03043664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271463|NCT02992522|Lenalidomide|lenalidomide|mesh-list
138271464|NCT02992522|Venetoclax|venetoclax|mesh-list
138271465|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
138271466|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
138271467|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271468|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138271469|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138271470|NCT02992522|Growth Substances|growth substances|mesh-ancestor
138271471|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
138271472|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271473|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271474|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
138271475|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271476|NCT02969681|Vitamins|vitamins|mesh-ancestor
138271477|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
138271478|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
138271479|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271480|NCT02969681|Protective Agents|protective agents|mesh-ancestor
138271481|NCT02956590|Pitavastatin|pitavastatin|mesh-list
138271482|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138271483|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138271484|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138271485|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
138271486|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271487|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271488|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138271491|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271492|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138271493|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138271494|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138271495|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
138271496|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271497|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271498|NCT02864550|Doxycycline|doxycycline|mesh-list
138271499|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138271500|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138271501|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
138271502|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138271503|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138193893|NCT04392128|Azithromycin|azithromycin|mesh-list
138271504|NCT02841995|Belumosudil|belumosudil|mesh-list
138271505|NCT02841995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138271506|NCT02841995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271507|NCT02841995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271509|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138271510|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271511|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
138271512|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138271513|NCT02586038|Thalidomide|thalidomide|mesh-list
138271514|NCT02586038|Dexamethasone|dexamethasone|mesh-list
138271515|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
138271516|NCT02586038|Ixazomib|ixazomib|mesh-list
138271517|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271518|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
138271520|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271521|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271522|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
138271523|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271524|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271525|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138271526|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138271527|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
138271528|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
138271529|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271530|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138271531|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
138271532|NCT02586038|Hormones|hormones|mesh-ancestor
138271533|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271534|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271535|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
138271536|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138271537|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138271538|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138271539|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138271540|NCT02586038|Growth Substances|growth substances|mesh-ancestor
138271541|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
138271542|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
138271543|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271544|NCT02579811|Axitinib|axitinib|mesh-list
138271545|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271546|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138271547|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271548|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271549|NCT02554383|Amoxicillin|amoxicillin|mesh-list
138271550|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
138271551|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
138271552|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138271553|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138378995|NCT05867550|Analgesics|analgesics|mesh-ancestor
138271555|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138271556|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271557|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271558|NCT02519439|Ganaxolone|ganaxolone|mesh-list
138271559|NCT02519439|Neurosteroids|neurosteroids|mesh-ancestor
138271560|NCT02519439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138271561|NCT02519439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271562|NCT02519439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271563|NCT02519439|GABA Modulators|gaba modulators|mesh-ancestor
138271564|NCT02519439|GABA Agents|gaba agents|mesh-ancestor
138271565|NCT02359175|Acetaminophen|acetaminophen|mesh-list
138271566|NCT02359175|Fentanyl|fentanyl|mesh-list
138271567|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
138271568|NCT02359175|Bupivacaine|bupivacaine|mesh-list
138271570|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
138271571|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138193900|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271572|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271573|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
138271574|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271575|NCT02359175|Narcotics|narcotics|mesh-ancestor
138271577|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138271578|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138271579|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
138271580|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138227340|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271582|NCT02215980|Dexamethasone|dexamethasone|mesh-list
138271583|NCT02215980|Lenalidomide|lenalidomide|mesh-list
138271584|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138271585|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
138271586|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
138271587|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271588|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271589|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138271590|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
138271591|NCT02215980|Hormones|hormones|mesh-ancestor
138271592|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271593|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271594|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271595|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
138271596|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138271597|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138271598|NCT02215980|Growth Substances|growth substances|mesh-ancestor
138271599|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
138271601|NCT02101021|Gemcitabine|gemcitabine|mesh-list
138271602|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
138271603|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138271604|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271605|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
138271606|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
138271607|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
138271608|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271609|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138271610|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
138271611|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138271612|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271613|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138271614|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138271615|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271616|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271617|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138271618|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138271619|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271620|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
138271621|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138271622|NCT02031536|Everolimus|everolimus|mesh-list
138271623|NCT02031536|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138271624|NCT02031536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138271625|NCT02031536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271626|NCT02031536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271627|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271628|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
138271629|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271630|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271631|NCT02023996|Trastuzumab|trastuzumab|mesh-list
138271632|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271633|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271634|NCT02020720|Fluorides|fluorides|mesh-list
138271635|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
138271636|NCT02020720|Protective Agents|protective agents|mesh-ancestor
138271637|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227365|NCT04355468|Narcotics|narcotics|mesh-ancestor
138271639|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138271640|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
138271641|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271642|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271643|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138271644|NCT01964430|Paclitaxel|paclitaxel|mesh-list
138271645|NCT01964430|Gemcitabine|gemcitabine|mesh-list
138271646|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138271647|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271648|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
138271649|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
138271650|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
138271651|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271652|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138271653|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
138271654|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138271655|NCT01898494|Cisplatin|cisplatin|mesh-list
138271656|NCT01898494|Carboplatin|carboplatin|mesh-list
138271657|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271658|NCT01841359|Pramlintide|pramlintide|mesh-list
138271659|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138271660|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271661|NCT01579734|Tamoxifen|tamoxifen|mesh-list
138271662|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138271663|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
138271664|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138704543|NCT05836584|Vitamin B Complex|vitamin b complex|mesh-ancestor
138271665|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271666|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271667|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271668|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138271669|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138271670|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138271672|NCT01566240|Carboplatin|carboplatin|mesh-list
138271673|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138271674|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271675|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
138271676|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
138271677|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
138271678|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271679|NCT01390584|Prednisone|prednisone|mesh-list
138227372|NCT01614509|Triamcinolone|triamcinolone|mesh-list
138271681|NCT01390584|Dacarbazine|dacarbazine|mesh-list
138271682|NCT01390584|Doxorubicin|doxorubicin|mesh-list
138271683|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138271685|NCT01390584|Vincristine|vincristine|mesh-list
138271686|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
138271687|NCT01390584|Bleomycin|bleomycin|mesh-list
138271688|NCT01390584|Vinblastine|vinblastine|mesh-list
138271689|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
138271690|NCT01390584|Procarbazine|procarbazine|mesh-list
138271691|NCT01390584|Imidazole|imidazole|mesh-list
138271692|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271693|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
138271694|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271695|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271696|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271697|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
138271698|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271699|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271700|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138271701|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138193927|NCT05509374|Growth Substances|growth substances|mesh-ancestor
138193929|NCT04124822|Prednisolone|prednisolone|mesh-list
138271702|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138271703|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138271704|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271705|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138271706|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
138271707|NCT01390584|Hormones|hormones|mesh-ancestor
138271708|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271709|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271710|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138271711|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
138271712|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
138271713|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
138271715|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
138271716|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
138271717|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271718|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
138271719|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271720|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271721|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271722|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
138271723|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271724|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271725|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138271726|NCT01216683|Rituximab|rituximab|mesh-list
138271727|NCT01216683|Lenalidomide|lenalidomide|mesh-list
138271728|NCT01216683|Bortezomib|bortezomib|mesh-list
138271729|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138271730|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271731|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271732|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
138271733|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271734|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271735|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138271736|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138271737|NCT01216683|Growth Substances|growth substances|mesh-ancestor
138271738|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
138271739|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271740|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
138227404|NCT01654445|Tenecteplase|tenecteplase|mesh-list
138271741|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271742|NCT01166113|Prednisone|prednisone|mesh-list
138271743|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
138271744|NCT01166113|Pomalidomide|pomalidomide|mesh-list
138271745|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271746|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
138271747|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271748|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271749|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271750|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
138271751|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271752|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271753|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138271754|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138271756|NCT01166113|Hormones|hormones|mesh-ancestor
138271757|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271758|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271759|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138271760|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138271761|NCT01166113|Growth Substances|growth substances|mesh-ancestor
138271762|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
138271764|NCT01160107|Melphalan|melphalan|mesh-list
138271765|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138271766|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
138271767|NCT01160107|Hormones|hormones|mesh-ancestor
138271768|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271769|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271770|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271771|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271772|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271773|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
138271774|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271775|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138271776|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271777|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
138271778|NCT01145495|Rituximab|rituximab|mesh-list
138271779|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138271780|NCT01145495|Lenalidomide|lenalidomide|mesh-list
138271781|NCT01145495|Antibodies|antibodies|mesh-list
138271782|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
138271783|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138271784|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
138271785|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271786|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271787|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271788|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138271789|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138271790|NCT01145495|Growth Substances|growth substances|mesh-ancestor
138271791|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
138271792|NCT01124695|Tamoxifen|tamoxifen|mesh-list
138271793|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138271794|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
138271795|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271796|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271797|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271798|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227418|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271800|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138271801|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138271802|NCT01084083|Paclitaxel|paclitaxel|mesh-list
138271803|NCT01084083|Cetuximab|cetuximab|mesh-list
138271804|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138271805|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271806|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
138271807|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
138271808|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
138271809|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271810|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271811|NCT01079780|Irinotecan|irinotecan|mesh-list
138271812|NCT01079780|Cetuximab|cetuximab|mesh-list
138271814|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138271815|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138271816|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271817|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271818|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271819|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271820|NCT01063179|Thalidomide|thalidomide|mesh-list
138271821|NCT01063179|Prednisone|prednisone|mesh-list
138271822|NCT01063179|Bortezomib|bortezomib|mesh-list
138271823|NCT01063179|Melphalan|melphalan|mesh-list
138271824|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138271825|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
138271826|NCT01063179|Hormones|hormones|mesh-ancestor
138193958|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138271827|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271828|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271829|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271830|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271831|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271832|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
138271833|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271834|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138271835|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271836|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
138271837|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
138271838|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138271839|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138271840|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138271841|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138271843|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
138271844|NCT01013961|Rituximab|rituximab|mesh-list
138271845|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
138271846|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271847|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271848|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
138271849|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271850|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271851|NCT00834093|Immunomodulating Agents|immunomodulating agents|mesh-list
138271852|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
138271853|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271854|NCT00783510|Adalimumab|adalimumab|mesh-list
138271855|NCT00783510|Methotrexate|methotrexate|mesh-list
138271856|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138271857|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
138271858|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138271859|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271860|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138271861|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
138271862|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271863|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271864|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
138271865|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271866|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138271867|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271868|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
138271869|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271870|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138271871|NCT00783510|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138271872|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138271874|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138271875|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138271876|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138271877|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271878|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
138271879|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271880|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
138271881|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271882|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138271883|NCT00665600|Albuterol|albuterol|mesh-list
138271884|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138271885|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
138271886|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138271887|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271888|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138271889|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
138193966|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271890|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
138704758|NCT05634057|Antioxidants|antioxidants|mesh-ancestor
138271892|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138271893|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138271894|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138271895|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
138271896|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138271897|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271898|NCT00606294|Misonidazole|misonidazole|mesh-list
138271899|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271900|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138271901|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138271902|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138271904|NCT00551928|Lenalidomide|lenalidomide|mesh-list
138271905|NCT00551928|Melphalan|melphalan|mesh-list
138271906|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138271907|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
138271908|NCT00551928|Hormones|hormones|mesh-ancestor
138271909|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271910|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271911|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271912|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271913|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
138271914|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138271915|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138271916|NCT00551928|Growth Substances|growth substances|mesh-ancestor
138271917|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
138271918|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271919|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
138271920|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271921|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138271922|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271923|NCT00330564|Sunitinib|sunitinib|mesh-list
138271924|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271925|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138271926|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138271927|NCT00330564|Growth Substances|growth substances|mesh-ancestor
138271928|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271929|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
138271930|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138271931|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271932|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271933|NCT00316888|Cisplatin|cisplatin|mesh-list
138271934|NCT00316888|Fluorouracil|fluorouracil|mesh-list
138271935|NCT00316888|Cetuximab|cetuximab|mesh-list
138271936|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271937|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
138271938|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271939|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138271940|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271941|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
138271942|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271943|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138271945|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
138271946|NCT00309478|Fluorouracil|fluorouracil|mesh-list
138271947|NCT00309478|Methotrexate|methotrexate|mesh-list
138271948|NCT00309478|Goserelin|goserelin|mesh-list
138271949|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138271951|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271952|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138271953|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138271954|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
138271955|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271956|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271957|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138271958|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
138271959|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138271960|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138271961|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
138704904|NCT05502315|Nivolumab|nivolumab|mesh-list
138271962|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138271963|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
138271964|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271965|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138271966|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138271967|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138271968|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
138271969|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271970|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271971|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138271972|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138271973|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138271974|NCT00295646|Tamoxifen|tamoxifen|mesh-list
138271975|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
138271976|NCT00295646|Anastrozole|anastrozole|mesh-list
138271977|NCT00295646|Goserelin|goserelin|mesh-list
138271978|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138271979|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
138271980|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138271981|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138271982|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138271983|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138271984|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138271985|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138271986|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138271987|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138271988|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138271989|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138271990|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138271993|NCT00274924|Ifosfamide|ifosfamide|mesh-list
138271994|NCT00274924|Rituximab|rituximab|mesh-list
138271995|NCT00274924|Carboplatin|carboplatin|mesh-list
138271996|NCT00274924|Doxorubicin|doxorubicin|mesh-list
138271997|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138271998|NCT00274924|Etoposide|etoposide|mesh-list
138271999|NCT00274924|Vincristine|vincristine|mesh-list
138272000|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
138272001|NCT00274924|Lenograstim|lenograstim|mesh-list
138272002|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138272003|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
138272005|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272006|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138272007|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
138272008|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272009|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272010|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138272011|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138194003|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272012|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138272013|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138272014|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138272015|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272016|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138272017|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
138272019|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138272020|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138272021|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138272022|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138272023|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
138272024|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
138272025|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
138272026|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
138272027|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
138272028|NCT00104884|Romidepsin|romidepsin|mesh-list
138272029|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138272030|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272031|NCT00104884|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138272032|NCT00104884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272033|NCT00104884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272035|NCT00096174|Cetuximab|cetuximab|mesh-list
138272036|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272037|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138272038|NCT00080938|Temozolomide|temozolomide|mesh-list
138272039|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138272040|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
138272041|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272042|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272043|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
138272044|NCT00074282|Rituximab|rituximab|mesh-list
138272045|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
138272046|NCT00074282|Pentostatin|pentostatin|mesh-list
138272047|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138272049|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272050|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272051|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138272052|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
138272053|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272054|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272055|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138272056|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138272057|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138272058|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272059|NCT00071981|Molgramostim|molgramostim|mesh-list
138272061|NCT00071981|Sargramostim|sargramostim|mesh-list
138272062|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
138272063|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
138272064|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272065|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138705029|NCT05382286|Immunoconjugates|immunoconjugates|mesh-ancestor
138272066|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138272067|NCT00070291|Cyclosporine|cyclosporine|mesh-list
138272068|NCT00070291|Cyclosporins|cyclosporins|mesh-list
138272069|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272070|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272071|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138272072|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
138272073|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272074|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
138272075|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272076|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
138272077|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272078|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138272079|NCT00064350|Sorafenib|sorafenib|mesh-list
138272080|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272081|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138272082|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272083|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272084|NCT00060346|Prednisone|prednisone|mesh-list
138272085|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
138272086|NCT00060346|Rituximab|rituximab|mesh-list
138272087|NCT00060346|Doxorubicin|doxorubicin|mesh-list
138272088|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138272089|NCT00060346|Vincristine|vincristine|mesh-list
138272090|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138272091|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
138379285|NCT05275738|Niacin|niacin|mesh-list
138272092|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272093|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272094|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138272095|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
138272098|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138272099|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138272100|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138272101|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138272102|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138272104|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138272106|NCT00060346|Hormones|hormones|mesh-ancestor
138272107|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138272108|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138272109|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138272110|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
138272111|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
138272112|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
138272113|NCT00057954|Cyclosporine|cyclosporine|mesh-list
138272114|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
138272115|NCT00057954|Methotrexate|methotrexate|mesh-list
138272116|NCT00057954|Pentostatin|pentostatin|mesh-list
138272117|NCT00057954|Cyclosporins|cyclosporins|mesh-list
138272118|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138272119|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
138272120|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138272121|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272122|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138272123|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
138272124|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272125|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272126|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
138272127|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272128|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138272129|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138272130|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
138272131|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272132|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138272133|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
138272134|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272135|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138272136|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138272137|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138272138|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
138272139|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138272140|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138272141|NCT00049530|Interferons|interferons|mesh-list
138272142|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
138272143|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
138272144|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138272145|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272146|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
138272147|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272148|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
138272149|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272150|NCT00045305|Cyclosporine|cyclosporine|mesh-list
138272151|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
138272152|NCT00045305|Methotrexate|methotrexate|mesh-list
138272153|NCT00045305|Pentostatin|pentostatin|mesh-list
138272154|NCT00045305|Methoxsalen|methoxsalen|mesh-list
138272155|NCT00045305|Cyclosporins|cyclosporins|mesh-list
138272156|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138272157|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
138272158|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138272159|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272160|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138272161|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
138705115|NCT05308446|Immunoglobulins|immunoglobulins|mesh-list
138272162|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272163|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272164|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
138272165|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272166|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138272167|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138272168|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
138272169|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272170|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138272172|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272173|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138272174|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138272175|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138272176|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
138272177|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138272178|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
138272179|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138272181|NCT00033657|Camptothecin|camptothecin|mesh-list
138272182|NCT00033657|Cisplatin|cisplatin|mesh-list
138272183|NCT00033657|Irinotecan|irinotecan|mesh-list
138272184|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138272185|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227626|NCT03032042|Azithromycin|azithromycin|mesh-list
138272186|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
138272187|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
138272188|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
138272189|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272190|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138272191|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138272192|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272195|NCT00003389|Dacarbazine|dacarbazine|mesh-list
138272196|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
138272197|NCT00003389|Doxorubicin|doxorubicin|mesh-list
138272198|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138272199|NCT00003389|Etoposide|etoposide|mesh-list
138272200|NCT00003389|Vincristine|vincristine|mesh-list
138272201|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
138272202|NCT00003389|Bleomycin|bleomycin|mesh-list
138272203|NCT00003389|Vinblastine|vinblastine|mesh-list
138272204|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
138272205|NCT00003389|Imidazole|imidazole|mesh-list
138272206|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138272207|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
138272208|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272209|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272210|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138272211|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
138272212|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194049|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272213|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272214|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138272215|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138272216|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138272217|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138272218|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272219|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138272220|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
138272222|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138272223|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138272224|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138272225|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
138272226|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
138272227|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
138272228|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
138272229|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
138272230|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
138272231|NCT00003138|Lenograstim|lenograstim|mesh-list
138272232|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138272233|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
138272234|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272235|NCT00003138|Hematinics|hematinics|mesh-ancestor
138272236|NCT00002525|Leucovorin|leucovorin|mesh-list
138272237|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
138272238|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
138272239|NCT00002525|Fluorouracil|fluorouracil|mesh-list
138272240|NCT00002525|Calcium|calcium|mesh-list
138272241|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
138272242|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138272244|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
138272245|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272246|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138272247|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272248|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138272249|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
138272251|NCT00002525|Protective Agents|protective agents|mesh-ancestor
138272252|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
138272253|NCT00002525|Vitamins|vitamins|mesh-ancestor
138272254|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
138272255|NCT05475522|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138272256|NCT05475522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138272257|NCT05475522|Dermatologic Agents|dermatologic agents|mesh-ancestor
138272258|NCT02259348|Aldesleukin|aldesleukin|mesh-list
138272259|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
138272261|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
138272262|NCT02259348|Thiotepa|thiotepa|mesh-list
138272263|NCT02259348|Rituximab|rituximab|mesh-list
138272264|NCT02259348|Fludarabine|fludarabine|mesh-list
138272265|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
138272266|NCT02259348|Interleukin-2|interleukin-2|mesh-list
138272267|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138272268|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
138272269|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272270|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272271|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138272272|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
138272273|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272274|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272275|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138272276|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138272277|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138272278|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
138272279|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
138272280|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272281|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138272283|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
138272284|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272285|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138272286|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138272287|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
138272288|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138272289|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
138272290|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272291|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272292|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138272293|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
138272294|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138272295|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
138272297|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138318618|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138379378|NCT05162183|Incretins|incretins|mesh-ancestor
138379379|NCT05162183|Hormones|hormones|mesh-ancestor
138272298|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272299|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138272300|NCT00357019|Protective Agents|protective agents|mesh-ancestor
138272301|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138272302|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
138272304|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138272305|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
138272306|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272307|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272308|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138272309|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
138272310|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272311|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272312|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138272314|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
138272315|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272316|NCT03592121|Phenylephrine|phenylephrine|mesh-list
138272317|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138272318|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
138272319|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
138272320|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272321|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272322|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
138272323|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138227716|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138272324|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
138272325|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
138272326|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138272327|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138272328|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138272329|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
138272330|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272331|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272332|NCT03592121|Protective Agents|protective agents|mesh-ancestor
138272334|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138272335|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272336|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138272337|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272338|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272339|NCT03596723|Prednisolone|prednisolone|mesh-list
138272340|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138272341|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
138272342|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138272343|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
138272344|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138272345|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
138272347|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
138272348|NCT03596723|Hormones|hormones|mesh-ancestor
138272349|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138272350|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272351|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138272352|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272354|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
138272355|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194077|NCT02566902|Albuterol|albuterol|mesh-list
138272356|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138272357|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138272358|NCT03596723|Protective Agents|protective agents|mesh-ancestor
138272359|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138272360|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138272361|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272362|NCT03472469|Acetaminophen|acetaminophen|mesh-list
138272364|NCT03472469|Naproxen|naproxen|mesh-list
138272365|NCT03472469|Celecoxib|celecoxib|mesh-list
138272366|NCT03472469|Lidocaine|lidocaine|mesh-list
138272367|NCT03472469|Pregabalin|pregabalin|mesh-list
138272368|NCT03472469|Gabapentin|gabapentin|mesh-list
138272369|NCT03472469|Tramadol|tramadol|mesh-list
138272370|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
138272371|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
138272372|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138227749|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
138272373|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272374|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
138272375|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272376|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138272377|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138272378|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138272379|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138272380|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272381|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138272382|NCT03472469|Analgesics|analgesics|mesh-ancestor
138272383|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
138272384|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
138272385|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138272386|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138272387|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138272389|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138272390|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138272391|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138272392|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272393|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
138272394|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138272395|NCT03472469|Narcotics|narcotics|mesh-ancestor
138272396|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138272397|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138272398|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272399|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138272400|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272401|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
138272402|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138272404|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
138272406|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138272407|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
138272408|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272409|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272410|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138272411|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
138272412|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
138272413|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138272414|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
138272415|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272416|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272417|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
138272418|NCT04943159|Afamelanotide|afamelanotide|mesh-list
138272419|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
138272420|NCT04734665|Bevacizumab|bevacizumab|mesh-list
138272421|NCT04734665|Niraparib|niraparib|mesh-list
138272422|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138272423|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272424|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138272425|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138272426|NCT04734665|Growth Substances|growth substances|mesh-ancestor
138272427|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272428|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
138272429|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138272430|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272431|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272433|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
138272434|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272435|NCT03478163|Clindamycin|clindamycin|mesh-list
138272436|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
138272437|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
138272438|NCT03478163|Cefazolin|cefazolin|mesh-list
138272439|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138272440|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272441|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138272442|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379465|NCT05062304|Xhance|xhance|mesh-list
138272443|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272445|NCT05646810|Anesthetics, Local|anesthetics, local|mesh-ancestor
138272446|NCT05646810|Anesthetics|anesthetics|mesh-ancestor
138272447|NCT05646810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138272448|NCT05646810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272449|NCT05646810|Sensory System Agents|sensory system agents|mesh-ancestor
138272450|NCT05646810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272451|NCT05646810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138272452|NCT05646810|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138272454|NCT05646810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138272455|NCT05646810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272457|NCT04960202|Nirmatrelvir|nirmatrelvir|mesh-list
138272458|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138272459|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138272460|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
138272461|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272462|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272463|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138272464|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138272465|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
138272466|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272467|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138272468|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138272469|NCT02959112|Indomethacin|indomethacin|mesh-list
138272470|NCT02959112|Epinephrine|epinephrine|mesh-list
138272471|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138272472|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138272473|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
138272474|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272475|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272476|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272477|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138272478|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138272479|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
138272480|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272481|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138272482|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
138272483|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
138272484|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
138272485|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138272486|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138194087|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138705523|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138272487|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138272488|NCT02959112|Analgesics|analgesics|mesh-ancestor
138272489|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
138272490|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138272491|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272492|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
138272493|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
138272494|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138272495|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138272496|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272497|NCT05377034|Bevacizumab|bevacizumab|mesh-list
138272498|NCT05377034|Atezolizumab|atezolizumab|mesh-list
138272499|NCT05377034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138272500|NCT05377034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272501|NCT05377034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138272502|NCT05377034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138272503|NCT05377034|Growth Substances|growth substances|mesh-ancestor
138272504|NCT05377034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272505|NCT05377034|Growth Inhibitors|growth inhibitors|mesh-ancestor
138272506|NCT05377034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138272507|NCT05377034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272508|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138272509|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138272510|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
138272511|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138272512|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272513|NCT04428359|Vitamin D|vitamin d|mesh-list
138272514|NCT04428359|Vitamins|vitamins|mesh-ancestor
138272515|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
138272516|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272517|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138272518|NCT02257632|Ranibizumab|ranibizumab|mesh-list
138272519|NCT02257632|Aflibercept|aflibercept|mesh-list
138272520|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138272521|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138272523|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272524|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
138272525|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272526|NCT05436054|Picosulfate sodium|picosulfate sodium|mesh-list
138272527|NCT05436054|Cathartics|cathartics|mesh-ancestor
138272528|NCT05436054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138272529|NCT01642914|Linaclotide|linaclotide|mesh-list
138272530|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138272531|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
138379523|NCT04951115|Durvalumab|durvalumab|mesh-list
138272532|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272533|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138272534|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
138272535|NCT01642602|Lansoprazole|lansoprazole|mesh-list
138272536|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138272537|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138272538|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138272539|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272540|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272541|NCT02256540|Resveratrol|resveratrol|mesh-list
138272542|NCT02256540|Estradiol|estradiol|mesh-list
138272544|NCT02256540|Hormones|hormones|mesh-ancestor
138272545|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138272546|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272547|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
138272548|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272549|NCT02256540|Protective Agents|protective agents|mesh-ancestor
138272550|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272551|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138272552|NCT05646264|Agomelatine|agomelatine|mesh-list
138272553|NCT05646264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138194102|NCT05508516|Antidepressive Agents|antidepressive agents|mesh-ancestor
138272554|NCT05646264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138272555|NCT05646264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272557|NCT01640184|Vitamins|vitamins|mesh-ancestor
138272558|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
138272559|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272560|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138272561|NCT04904978|Listerine|listerine|mesh-list
138272562|NCT04904978|Sodium Fluoride|sodium fluoride|mesh-list
138272563|NCT04904978|Cariostatic Agents|cariostatic agents|mesh-ancestor
138272564|NCT04904978|Protective Agents|protective agents|mesh-ancestor
138272565|NCT04904978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272566|NCT04904978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138272567|NCT04904978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272568|NCT03631433|Acetaminophen|acetaminophen|mesh-list
138272569|NCT03631433|Ibuprofen|ibuprofen|mesh-list
138272570|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138272571|NCT03631433|Analgesics|analgesics|mesh-ancestor
138272572|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
138272573|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272574|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272575|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
138272576|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138272577|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138272578|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272579|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138272580|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272581|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272583|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
138272584|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
138272585|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272586|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272587|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138272588|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138272589|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
138379556|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272590|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272591|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272592|NCT02973659|Urological Agents|urological agents|mesh-ancestor
138272593|NCT04439396|Ketorolac|ketorolac|mesh-list
138272594|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138272595|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138272596|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138272597|NCT04439396|Analgesics|analgesics|mesh-ancestor
138272598|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
138272599|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272600|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272601|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138272602|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272603|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138272604|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272605|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272606|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138272607|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
138272608|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272609|NCT00360464|Azithromycin|azithromycin|mesh-list
138194114|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194115|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
138272610|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138272611|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272612|NCT05651256|Botulinum Toxins|botulinum toxins|mesh-list
138272613|NCT05651256|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138272614|NCT05651256|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138272615|NCT05651256|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138272616|NCT05651256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138272617|NCT05651256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272618|NCT05651256|Cholinergic Agents|cholinergic agents|mesh-ancestor
138272619|NCT05651256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272620|NCT05651256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272621|NCT05651256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138272622|NCT05651256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272623|NCT04297631|Tobramycin|tobramycin|mesh-list
138272624|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138272625|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272626|NCT04812470|Melphalan|melphalan|mesh-list
138272627|NCT04812470|Interleukin-2|interleukin-2|mesh-list
138272628|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138272629|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
138272630|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379573|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138272631|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138227866|NCT03030560|Lidocaine|lidocaine|mesh-list
138272632|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138272633|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138272634|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
138272635|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272636|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138272638|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
138272639|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272640|NCT02976194|Ranibizumab|ranibizumab|mesh-list
138272641|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138272642|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138272643|NCT02976194|Growth Substances|growth substances|mesh-ancestor
138272644|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272645|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
138272646|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272647|NCT00360776|Tipifarnib|tipifarnib|mesh-list
138272648|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272649|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
138272650|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272651|NCT04342910|Paclitaxel|paclitaxel|mesh-list
138272652|NCT04342910|Irinotecan|irinotecan|mesh-list
138272653|NCT04342910|Apatinib|apatinib|mesh-list
138272654|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138272655|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272656|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
138272657|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
138272659|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272660|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138272661|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138272662|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272663|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138272664|NCT04714073|Itraconazole|itraconazole|mesh-list
138272665|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
138272666|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272667|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138272668|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138272669|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272670|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272671|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138272672|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
138272673|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138272674|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272675|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138272676|NCT04342676|Panitumumab|panitumumab|mesh-list
138272677|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138272678|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272679|NCT01641822|Tobramycin|tobramycin|mesh-list
138272680|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138272681|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272683|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138272684|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272685|NCT04342598|Vitamin D|vitamin d|mesh-list
138272686|NCT04342598|Vitamins|vitamins|mesh-ancestor
138272687|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
138272688|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272689|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138272690|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138272691|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272692|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138272693|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272694|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272695|NCT05641818|Vitamin D|vitamin d|mesh-list
138272696|NCT05641818|Vitamins|vitamins|mesh-ancestor
138272697|NCT05641818|Micronutrients|micronutrients|mesh-ancestor
138272698|NCT05641818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272699|NCT05641818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138272700|NCT04762082|Tadalafil|tadalafil|mesh-list
138272701|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
138272702|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138272703|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138272704|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272705|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272706|NCT04762082|Urological Agents|urological agents|mesh-ancestor
138272707|NCT03514277|Bupivacaine|bupivacaine|mesh-list
138272708|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
138272709|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
138272710|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138272711|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272712|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
138272713|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272715|NCT05334108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138272716|NCT05334108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138272717|NCT05334108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138272718|NCT05334108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272719|NCT05334108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138272720|NCT05334108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138272721|NCT05334108|Dopamine Agents|dopamine agents|mesh-ancestor
138272722|NCT05334108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272723|NCT05334108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272724|NCT03984656|Lidocaine|lidocaine|mesh-list
138272725|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
138272726|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
138272727|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138272728|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272729|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
138272730|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272731|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138272732|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138272733|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138272734|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138272735|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272736|NCT05299944|Cannabidiol|cannabidiol|mesh-list
138272737|NCT05299944|Anticonvulsants|anticonvulsants|mesh-ancestor
138272738|NCT03655301|Metformin|metformin|mesh-list
138272739|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138272740|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272741|NCT04870866|Niacinamide|niacinamide|mesh-list
138272742|NCT04870866|Niacin|niacin|mesh-list
138272743|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
138272744|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
138272745|NCT04870866|Vitamins|vitamins|mesh-ancestor
138272746|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
138272747|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272748|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138272749|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
138272750|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272751|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138272753|NCT03657407|Glycerol|glycerol|mesh-list
138272754|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138272755|NCT03657407|Protective Agents|protective agents|mesh-ancestor
138272756|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272757|NCT01639560|Varenicline|varenicline|mesh-list
138272758|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138272759|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138272760|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
138272761|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272762|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272763|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272764|NCT04243616|Paclitaxel|paclitaxel|mesh-list
138272765|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
138272766|NCT04243616|Carboplatin|carboplatin|mesh-list
138272767|NCT04243616|Doxorubicin|doxorubicin|mesh-list
138272768|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138272769|NCT04243616|Cemiplimab|cemiplimab|mesh-list
138272770|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138272771|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272772|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
138272773|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
138272774|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
138272775|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272776|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138272777|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
138272778|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272779|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272780|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138272781|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
138272782|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138272783|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138272784|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138272785|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138272786|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272787|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138272788|NCT03952130|Insulin|insulin|mesh-list
138272789|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138272790|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
138272791|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
138272792|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138227929|NCT03017222|Ramosetron|ramosetron|mesh-list
138227930|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
138272794|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
138272795|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138272796|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
138272797|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272798|NCT03925532|Denosumab|denosumab|mesh-list
138272799|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138272800|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272801|NCT01640964|Terlipressin|terlipressin|mesh-list
138272802|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138272803|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138272805|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
138272806|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138272807|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138272808|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
138272809|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
138272810|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138272811|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272812|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
138272813|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194161|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
138272814|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138272815|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138272816|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138272817|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138272818|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272819|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138272820|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
138272821|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272822|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138272824|NCT05430048|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138272825|NCT05430048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138272826|NCT05430048|Sympatholytics|sympatholytics|mesh-ancestor
138272827|NCT05430048|Autonomic Agents|autonomic agents|mesh-ancestor
138272828|NCT05430048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272829|NCT05430048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272830|NCT05430048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138272831|NCT05430048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138272832|NCT05430048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138272833|NCT05430048|Adrenergic Agents|adrenergic agents|mesh-ancestor
138272834|NCT05430048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272835|NCT05430048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272838|NCT05430048|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138272839|NCT05430048|Natriuretic Agents|natriuretic agents|mesh-ancestor
138272841|NCT02975570|Linezolid|linezolid|mesh-list
138272842|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
138272843|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138272844|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272845|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138272846|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138272847|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138272848|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272849|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272850|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272851|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138272852|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138272853|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138272854|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
138272855|NCT03524339|Tamsulosin|tamsulosin|mesh-list
138272856|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138272857|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138272858|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138272859|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
138272860|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138705951|NCT03685890|Nivolumab|nivolumab|mesh-list
138272861|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272862|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272863|NCT03524339|Urological Agents|urological agents|mesh-ancestor
138194170|NCT01455896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138272864|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
138272865|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138272866|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138272867|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
138272868|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272869|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138272870|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138272871|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272872|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272873|NCT00361010|Levetiracetam|levetiracetam|mesh-list
138379709|NCT06040255|Prednisolone phosphate|prednisolone phosphate|mesh-list
138272874|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
138272875|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
138272876|NCT00361088|Bortezomib|bortezomib|mesh-list
138272877|NCT00361088|Tipifarnib|tipifarnib|mesh-list
138272878|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272879|NCT04172402|Gemcitabine|gemcitabine|mesh-list
138272880|NCT04172402|Nivolumab|nivolumab|mesh-list
138272881|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138272882|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
138272883|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272884|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272885|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138705992|NCT03504241|Hormones|hormones|mesh-ancestor
138272886|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138272887|NCT04662242|Selenium|selenium|mesh-list
138272888|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
138272889|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272890|NCT04662242|Protective Agents|protective agents|mesh-ancestor
138272891|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272892|NCT04662242|Trace Elements|trace elements|mesh-ancestor
138272893|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
138272894|NCT03675581|Nintedanib|nintedanib|mesh-list
138272895|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138272896|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138272897|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272898|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138272899|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272900|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272901|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138272902|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
138272903|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138272904|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272905|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138272906|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138272907|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138272908|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138272909|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138272910|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138272911|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138272912|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138272913|NCT05142228|Erenumab|erenumab|mesh-list
138272914|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138272915|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272916|NCT05142228|Analgesics|analgesics|mesh-ancestor
138272917|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
138272918|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272919|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272920|NCT00362102|Cetuximab|cetuximab|mesh-list
138194195|NCT05560542|Respiratory System Agents|respiratory system agents|mesh-ancestor
138272921|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138272922|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272923|NCT05122026|Isoniazid|isoniazid|mesh-list
138272924|NCT05122026|Rifapentine|rifapentine|mesh-list
138272926|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138272927|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138272928|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138272929|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138272930|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
138272931|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272932|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138272933|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138272934|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
138272935|NCT02958878|Tamsulosin|tamsulosin|mesh-list
138272936|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138272937|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138272938|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138272939|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
138272940|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272941|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272942|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272943|NCT02958878|Urological Agents|urological agents|mesh-ancestor
138272944|NCT02976116|Gefitinib|gefitinib|mesh-list
138272945|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272947|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138272948|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272949|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
138272950|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138272951|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138272952|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138272953|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138272954|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272955|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
138272956|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272957|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272958|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138272959|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272960|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
138272961|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
138272962|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138272963|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
138272964|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138272965|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272966|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138272967|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
138272968|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138272969|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
138272970|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138272971|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138272972|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138272973|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
138272974|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
138272975|NCT02975258|Protective Agents|protective agents|mesh-ancestor
138272977|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138272978|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138272979|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138272980|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138272981|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
138272983|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138272984|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138272985|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
138272986|NCT04844814|Hormones|hormones|mesh-ancestor
138194215|NCT05560308|Immunotoxins|immunotoxins|mesh-ancestor
138272987|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138272988|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272989|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138272990|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138272991|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138272992|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138272993|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138272995|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138272996|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138272997|NCT05314673|Bevacizumab|bevacizumab|mesh-list
138272998|NCT05314673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138272999|NCT05314673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273000|NCT05314673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138273001|NCT05314673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138273002|NCT05314673|Growth Substances|growth substances|mesh-ancestor
138273003|NCT05314673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273004|NCT05314673|Growth Inhibitors|growth inhibitors|mesh-ancestor
138273006|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
138273007|NCT04112069|Pancrelipase|pancrelipase|mesh-list
138273008|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138273009|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273010|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138273011|NCT04098575|Empagliflozin|empagliflozin|mesh-list
138273012|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138273013|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273014|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138273015|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273016|NCT03776240|Trastuzumab|trastuzumab|mesh-list
138273023|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273024|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273025|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
138273026|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138273027|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138273028|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273029|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138273030|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138273031|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138273032|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273033|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138273034|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138273035|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
138273036|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138273037|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138273038|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
138273039|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273041|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273042|NCT00361790|Aripiprazole|aripiprazole|mesh-list
138273043|NCT00361790|Escitalopram|escitalopram|mesh-list
138273044|NCT00361790|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138273045|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138273046|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138273047|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273048|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273049|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
138273050|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273051|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
138273052|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138273053|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138273054|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138273055|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273056|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
138273057|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
138273058|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138273059|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138273060|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138273061|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138273062|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138273063|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138273069|NCT00361868|Metformin|metformin|mesh-list
138273070|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
138273071|NCT00361868|Fenofibrate|fenofibrate|mesh-list
138273072|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138273073|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273074|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138273076|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273077|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138273078|NCT04564872|Linagliptin|linagliptin|mesh-list
138273079|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138273080|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273081|NCT04564872|Incretins|incretins|mesh-ancestor
138273082|NCT04564872|Hormones|hormones|mesh-ancestor
138273083|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138273084|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138273085|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
138273086|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273087|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273088|NCT04343144|Nivolumab|nivolumab|mesh-list
138273089|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138273090|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273091|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138273092|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273093|NCT04075409|Padsevonil|padsevonil|mesh-list
138273094|NCT04075409|Anticonvulsants|anticonvulsants|mesh-ancestor
138273095|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
138273097|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138273099|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273100|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138228084|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138228085|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138273101|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138273103|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273104|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273105|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138273106|NCT05346666|Midazolam|midazolam|mesh-list
138273107|NCT05346666|Phenobarbital|phenobarbital|mesh-list
138273108|NCT05346666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138273109|NCT05346666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138273110|NCT05346666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273111|NCT05346666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273112|NCT05346666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138273113|NCT05346666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138273114|NCT05346666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138273115|NCT05346666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138273116|NCT05346666|Anesthetics, General|anesthetics, general|mesh-ancestor
138273117|NCT05346666|Anesthetics|anesthetics|mesh-ancestor
138273119|NCT05346666|GABA Agents|gaba agents|mesh-ancestor
138273120|NCT05346666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273121|NCT05346666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273122|NCT05346666|Anticonvulsants|anticonvulsants|mesh-ancestor
138273123|NCT05346666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138273124|NCT05346666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138194251|NCT03826550|Diclofenac|diclofenac|mesh-list
138273125|NCT05346666|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138273126|NCT05346666|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138273127|NCT05346666|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138273128|NCT00361166|Pimavanserin|pimavanserin|mesh-list
138273129|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138273130|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138273131|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138273132|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138273133|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273134|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273135|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138273136|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138273137|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138273138|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
138273139|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273140|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273142|NCT03674294|Aprepitant|aprepitant|mesh-list
138273143|NCT03674294|Palonosetron|palonosetron|mesh-list
138273144|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138273145|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
138273146|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
138273147|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273148|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273149|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138273150|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
138273151|NCT03674294|Hormones|hormones|mesh-ancestor
138273152|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138273153|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138273154|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273155|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138273156|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273157|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273158|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138273159|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138273160|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
138273161|NCT00377273|Fluorouracil|fluorouracil|mesh-list
138273162|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
138273163|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273164|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138273165|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273166|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138273167|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
138273168|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273169|NCT03706313|Bupivacaine|bupivacaine|mesh-list
138273170|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
138273171|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
138273172|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138706313|NCT01081951|Olaparib|olaparib|mesh-list
138273174|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
138273175|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273176|NCT05369364|Dexamethasone|dexamethasone|mesh-list
138273177|NCT05369364|Zanubrutinib|zanubrutinib|mesh-list
138273178|NCT05369364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138273179|NCT05369364|Antiemetics|antiemetics|mesh-ancestor
138273180|NCT05369364|Autonomic Agents|autonomic agents|mesh-ancestor
138273181|NCT05369364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273182|NCT05369364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273183|NCT05369364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138273184|NCT05369364|Glucocorticoids|glucocorticoids|mesh-ancestor
138273185|NCT05369364|Hormones|hormones|mesh-ancestor
138273186|NCT05369364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138273187|NCT05369364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138273188|NCT05369364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273189|NCT05369364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138273190|NCT05369364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194254|NCT03826550|Analgesics|analgesics|mesh-ancestor
138273191|NCT05369364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273192|NCT00361244|Irinotecan|irinotecan|mesh-list
138273193|NCT00361244|Cetuximab|cetuximab|mesh-list
138273194|NCT00361244|Sunitinib|sunitinib|mesh-list
138273195|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138273196|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138273197|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273198|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273199|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273200|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138273202|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138273203|NCT00361244|Growth Substances|growth substances|mesh-ancestor
138706352|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
138273204|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273205|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
138273206|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138273207|NCT03381482|Anesthetics|anesthetics|mesh-list
138273208|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273209|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273210|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138273211|NCT03545165|177Lu-PSMA-617|177lu-psma-617|mesh-list
138273212|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138273213|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273214|NCT04968522|Methylphenidate|methylphenidate|mesh-list
138273215|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
138273216|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138273217|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273218|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138273219|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138273220|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138273221|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273222|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
138273223|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273224|NCT00361322|Clindamycin|clindamycin|mesh-list
138273225|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
138273226|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
138273227|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
138273228|NCT00361322|Salicylates|salicylates|mesh-list
138273229|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138273230|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273231|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138273232|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273233|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273234|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
138273235|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
138273236|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
138273237|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138273238|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138273239|NCT00361322|Analgesics|analgesics|mesh-ancestor
138273240|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
138273241|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273242|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273243|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138273244|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138273245|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138273247|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138273248|NCT02974712|Narcotics|narcotics|mesh-ancestor
138273249|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273250|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273251|NCT02974712|Analgesics|analgesics|mesh-ancestor
138273252|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
138194269|NCT05325762|Analgesics|analgesics|mesh-ancestor
138273253|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379920|NCT06037811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273255|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138273256|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
138273257|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
138273258|NCT02974556|Capecitabine|capecitabine|mesh-list
138273259|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
138273260|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138273261|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
138273262|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273263|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273264|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138273265|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138273266|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
138273267|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138273268|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
138273269|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
138273270|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273271|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273272|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273273|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138273275|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
138273276|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273278|NCT04818450|Analgesics|analgesics|mesh-ancestor
138273279|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
138273280|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273281|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273282|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
138273283|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138273284|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138273285|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273286|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138273287|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138273288|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138273289|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273290|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273291|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
138273292|NCT05448872|Valsartan|valsartan|mesh-list
138273293|NCT05448872|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138273294|NCT05448872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138273295|NCT05448872|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138273296|NCT05448872|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138273297|NCT05448872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273298|NCT00362258|Irbesartan|irbesartan|mesh-list
138273299|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138273300|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138273301|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138273302|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379959|NCT06010927|Ketamine|ketamine|mesh-list
138273303|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
138273304|NCT00362726|Ritonavir|ritonavir|mesh-list
138273305|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138273306|NCT00362726|Maleic acid|maleic acid|mesh-list
138273307|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138273308|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138273309|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
138273310|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273311|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273312|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138273313|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138273314|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
138228192|NCT03019562|Fentanyl|fentanyl|mesh-list
138273315|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273316|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138273317|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138273318|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138194278|NCT05325762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138273319|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273320|NCT05330754|Caffeine|caffeine|mesh-list
138273321|NCT05330754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138273322|NCT05330754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273323|NCT05330754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138273324|NCT05330754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273325|NCT05330754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273326|NCT05330754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138273327|NCT05330754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138273328|NCT05330754|Purinergic Agents|purinergic agents|mesh-ancestor
138273329|NCT05330754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273330|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138273331|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273332|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138273333|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
138273334|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273335|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
138273336|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138273337|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138273338|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
138273339|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138273340|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273341|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138273342|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138273343|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
138273345|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138273346|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
138273347|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273348|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273349|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138273350|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
138273351|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
138273352|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138273353|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
138273354|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273355|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273356|NCT04031885|Paclitaxel|paclitaxel|mesh-list
138273357|NCT04031885|Docetaxel|docetaxel|mesh-list
138273358|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138273359|NCT04031885|Capecitabine|capecitabine|mesh-list
138273360|NCT04031885|Fulvestrant|fulvestrant|mesh-list
138273361|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138273362|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273363|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
138273364|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
138273365|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
138273366|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273367|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138273368|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
138273369|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138273370|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138273371|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138273372|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
138273373|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138273374|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273375|NCT01638000|Mirabegron|mirabegron|mesh-list
138273376|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
138273377|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138273378|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138273379|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138273380|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
138273381|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273382|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273383|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273384|NCT01638000|Urological Agents|urological agents|mesh-ancestor
138273385|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138273386|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138273387|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
138273388|NCT04023695|Lidocaine|lidocaine|mesh-list
138273389|NCT04023695|Epinephrine|epinephrine|mesh-list
138273390|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
138273391|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
138273392|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273393|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273394|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
138273395|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273396|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138379996|NCT05814523|GABA Agents|gaba agents|mesh-ancestor
138273397|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138273398|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138273399|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138273400|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273401|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138273403|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
138273404|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273405|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138273406|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138273408|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138273409|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
138273412|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138273413|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
138273414|NCT04211909|Velpatasvir|velpatasvir|mesh-list
138273415|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
138273416|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273417|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
138273418|NCT04223843|Olodaterol|olodaterol|mesh-list
138273419|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138273420|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
138273421|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273422|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273423|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138273424|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
138273425|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
138273426|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138273427|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
138273428|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273429|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273430|NCT05722951|Metformin|metformin|mesh-list
138273431|NCT05722951|Levetiracetam|levetiracetam|mesh-list
138273432|NCT05722951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138273433|NCT05722951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273434|NCT05722951|Anticonvulsants|anticonvulsants|mesh-ancestor
138273435|NCT05722951|Nootropic Agents|nootropic agents|mesh-ancestor
138273436|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
138273437|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138273438|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273439|NCT04838652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138273440|NCT04838652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273441|NCT05722795|Imatinib Mesylate|imatinib mesylate|mesh-list
138273442|NCT05722795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273443|NCT05722795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138273444|NCT05722795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273445|NCT05722795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273446|NCT04810494|Lidocaine|lidocaine|mesh-list
138273447|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
138273448|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
138273449|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273450|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273451|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
138273452|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273453|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138273454|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138273455|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138273456|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138273457|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273458|NCT05722405|Lenalidomide|lenalidomide|mesh-list
138273459|NCT05722405|Ixazomib|ixazomib|mesh-list
138273460|NCT05722405|Glycine|glycine|mesh-list
138273461|NCT05722405|Immunologic Factors|immunologic factors|mesh-ancestor
138318763|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138273462|NCT05722405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273463|NCT05722405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138273464|NCT05722405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138273465|NCT05722405|Growth Substances|growth substances|mesh-ancestor
138273466|NCT05722405|Growth Inhibitors|growth inhibitors|mesh-ancestor
138273467|NCT05722405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273468|NCT05722405|Protease Inhibitors|protease inhibitors|mesh-ancestor
138273469|NCT05722405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273470|NCT05722405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273471|NCT05722405|Glycine Agents|glycine agents|mesh-ancestor
138273472|NCT05722405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273473|NCT02767531|Orlistat|orlistat|mesh-list
138273474|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273475|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273476|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138273477|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138273478|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
138273479|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138273480|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138273481|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273483|NCT04419246|Coagulants|coagulants|mesh-ancestor
138273484|NCT02521753|Metformin|metformin|mesh-list
138273485|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138273486|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273487|NCT04229303|Voriconazole|voriconazole|mesh-list
138273488|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
138273489|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273490|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138273491|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138273492|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380060|NCT05548985|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138273493|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273494|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138273495|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
138273496|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138273497|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273498|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138273499|NCT05263986|Adagrasib|adagrasib|mesh-list
138273500|NCT05263986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273501|NCT00357643|Vitamin D|vitamin d|mesh-list
138273502|NCT00357643|Calcium|calcium|mesh-list
138273503|NCT00357643|Vitamins|vitamins|mesh-ancestor
138273504|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
138273505|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273506|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138273507|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138273508|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138273509|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138273510|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138273511|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
138273512|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273513|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273514|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138273515|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138273516|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
138273517|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273518|NCT03504410|Cytarabine|cytarabine|mesh-list
138273519|NCT03504410|Fludarabine|fludarabine|mesh-list
138273520|NCT03504410|Etoposide|etoposide|mesh-list
138273521|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
138273522|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273523|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138273524|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
138273525|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273526|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138273527|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
138273528|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273529|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138273530|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138273531|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138273533|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
138273534|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273535|NCT03504410|Analgesics|analgesics|mesh-ancestor
138273536|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
138273537|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273538|NCT02464969|Apixaban|apixaban|mesh-list
138273539|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138273540|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
138273541|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138273542|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
138273543|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273544|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273545|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
138273546|NCT05392530|Macitentan|macitentan|mesh-list
138273547|NCT05392530|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138273548|NCT05392530|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138273549|NCT05392530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273550|NCT05392530|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138273551|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
138273552|NCT03498014|Narcotics|narcotics|mesh-ancestor
138273553|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273554|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273555|NCT03498014|Analgesics|analgesics|mesh-ancestor
138273556|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
138228323|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
138273557|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273559|NCT02460133|Ribavirin|ribavirin|mesh-list
138273560|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138273561|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138273562|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
138273563|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273564|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273565|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138318887|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138273566|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138273567|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
138273568|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273569|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138273570|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138273571|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
138273572|NCT02220452|Anesthetics|anesthetics|mesh-list
138273573|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273574|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273575|NCT04256603|Gabapentin|gabapentin|mesh-list
138273576|NCT04256603|Analgesics|analgesics|mesh-ancestor
138273577|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
138273578|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273579|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273580|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
138273581|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138273582|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138273583|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273584|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138273585|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138273586|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138273587|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273588|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273589|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
138273590|NCT05721079|Methoxsalen|methoxsalen|mesh-list
138273591|NCT05721079|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138273592|NCT05721079|Dermatologic Agents|dermatologic agents|mesh-ancestor
138273593|NCT00362570|Temozolomide|temozolomide|mesh-list
138273594|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138273595|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
138273596|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273597|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273598|NCT00357253|Capecitabine|capecitabine|mesh-list
138273599|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138273600|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
138273601|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273602|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273603|NCT02068430|Riboflavin|riboflavin|mesh-list
138273604|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
138273605|NCT02068430|Vitamins|vitamins|mesh-ancestor
138273606|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
138273607|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273608|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138273609|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
138228338|NCT05388500|Paclitaxel|paclitaxel|mesh-list
138228339|NCT05388500|Trastuzumab|trastuzumab|mesh-list
138273610|NCT03127592|Etodolac|etodolac|mesh-list
138273611|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
138273612|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138273613|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
138273614|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138273615|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138273616|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273617|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138273618|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273619|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138273620|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273621|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138273622|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138194379|NCT04042324|Heparin|heparin|mesh-list
138273623|NCT03127592|Analgesics|analgesics|mesh-ancestor
138273624|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
138273625|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138273626|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138273627|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138273628|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138273629|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273630|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273631|NCT02444234|Tedizolid|tedizolid|mesh-list
138273632|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
138273633|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138273634|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273635|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138273636|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273637|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273638|NCT02444936|Vaccines|vaccines|mesh-list
138273639|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
138273640|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273641|NCT02445326|Dexamethasone|dexamethasone|mesh-list
138273642|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138273643|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
138273644|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
138273645|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138380126|NCT05353361|Pertuzumab|pertuzumab|mesh-list
138273646|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273647|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138273648|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
138273649|NCT02445326|Hormones|hormones|mesh-ancestor
138273650|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138273651|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138273652|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273653|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
138273654|NCT04344457|Azithromycin|azithromycin|mesh-list
138273655|NCT04344457|Indomethacin|indomethacin|mesh-list
138273656|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
138273657|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138273658|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138273659|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273660|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273661|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273662|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138273663|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138273664|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138273665|NCT04344457|Analgesics|analgesics|mesh-ancestor
138273666|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
138273667|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273668|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273669|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138273670|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
138273671|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
138273672|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138273673|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138273674|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138273675|NCT05720533|Disitamab vedotin|disitamab vedotin|mesh-list
138273676|NCT05720533|Immunoconjugates|immunoconjugates|mesh-ancestor
138273677|NCT05720533|Immunologic Factors|immunologic factors|mesh-ancestor
138273678|NCT05720533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273679|NCT02446496|Cefadroxil|cefadroxil|mesh-list
138273680|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138273681|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273682|NCT00355693|Propofol|propofol|mesh-list
138273683|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138273684|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273685|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273686|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138273687|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
138273688|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
138319068|NCT03598374|Folic Acid|folic acid|mesh-list
138273690|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
138273691|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138273692|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138273693|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138273694|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
138273695|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273696|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138273697|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138273698|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
138273699|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
138273700|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273701|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273702|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
138273703|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138273705|NCT01152541|Dextrans|dextrans|mesh-list
138273706|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138273707|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
138273708|NCT01152541|Vitamins|vitamins|mesh-ancestor
138273709|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
138273710|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273711|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138273712|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
138273713|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
138273714|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
138273715|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
138273716|NCT01638546|Temozolomide|temozolomide|mesh-list
138273717|NCT01638546|Veliparib|veliparib|mesh-list
138273718|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138273719|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
138273720|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273721|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273722|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138273723|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273724|NCT04948489|Norethindrone|norethindrone|mesh-list
138273725|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
138273726|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138273727|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138273728|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138273729|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
138273730|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138273731|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273732|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138273733|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138273735|NCT05723341|Bupivacaine|bupivacaine|mesh-list
138273737|NCT05723341|Anesthetics|anesthetics|mesh-ancestor
138273738|NCT05723341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273739|NCT05723341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273740|NCT05723341|Sensory System Agents|sensory system agents|mesh-ancestor
138273741|NCT05723341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273742|NCT05723341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138273743|NCT05723341|Narcotics|narcotics|mesh-ancestor
138273744|NCT05723341|Analgesics|analgesics|mesh-ancestor
138273745|NCT00363350|Rituximab|rituximab|mesh-list
138273746|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138273747|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273748|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
138273749|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319156|NCT04197570|Anesthetics|anesthetics|mesh-list
138273750|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138273752|NCT05717335|Hemostatics|hemostatics|mesh-ancestor
138273753|NCT05717335|Coagulants|coagulants|mesh-ancestor
138273754|NCT05717257|Dapagliflozin|dapagliflozin|mesh-list
138273755|NCT05717257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138273756|NCT05717257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273757|NCT05717257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138273758|NCT05717257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194404|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138273759|NCT04341818|Vitamin D|vitamin d|mesh-list
138273760|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
138273761|NCT04341818|Cholecalciferol|cholecalciferol|mesh-list
138273762|NCT04341818|Vitamins|vitamins|mesh-list
138273763|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
138273764|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273765|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138273766|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138273767|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
138273768|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138273769|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138273770|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138273771|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273772|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
138273773|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273774|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273776|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
138273777|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273778|NCT03172494|Insulin|insulin|mesh-list
138273779|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138273780|NCT03172494|Liraglutide|liraglutide|mesh-list
138273781|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
138273782|NCT03172494|Xultophy|xultophy|mesh-list
138273783|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138273784|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273785|NCT03172494|Incretins|incretins|mesh-ancestor
138228395|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138273786|NCT03172494|Hormones|hormones|mesh-ancestor
138273787|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138273788|NCT02452346|Tosedostat|tosedostat|mesh-list
138273789|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273790|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273792|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138273793|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138273794|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138273795|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273796|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273797|NCT05716945|Fluorometholone|fluorometholone|mesh-list
138380207|NCT05168163|Lenvatinib|lenvatinib|mesh-list
138273798|NCT05716945|Dexamethasone|dexamethasone|mesh-list
138273799|NCT05716945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138273801|NCT05716945|Autonomic Agents|autonomic agents|mesh-ancestor
138273802|NCT05716945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273803|NCT05716945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273804|NCT05716945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138273805|NCT05716945|Glucocorticoids|glucocorticoids|mesh-ancestor
138273806|NCT05716945|Hormones|hormones|mesh-ancestor
138273807|NCT05716945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138273808|NCT05716945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138273809|NCT05716945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273810|NCT05716945|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138273811|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
138273812|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138273813|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273814|NCT03012620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138273815|NCT03012620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273816|NCT05716867|Cystatins|cystatins|mesh-list
138273817|NCT05716867|Salivary Cystatins|salivary cystatins|mesh-list
138273818|NCT05716867|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138273819|NCT05716867|Protease Inhibitors|protease inhibitors|mesh-ancestor
138273820|NCT05716867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194412|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138273821|NCT05716867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273822|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138273823|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138273824|NCT01345136|Everolimus|everolimus|mesh-list
138273825|NCT01345136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138273826|NCT01345136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138273827|NCT01345136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273828|NCT01345136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273829|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138273830|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
138273831|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273832|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273833|NCT04341428|Lansoprazole|lansoprazole|mesh-list
138273834|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
138273835|NCT04341428|Fexuprazan|fexuprazan|mesh-list
138273836|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138273838|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138273839|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273840|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273841|NCT02453360|Bupivacaine|bupivacaine|mesh-list
138273842|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
138273843|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
138273844|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273845|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273846|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
138273847|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228412|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138273849|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138273850|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273851|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138273852|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138273853|NCT02453672|Growth Substances|growth substances|mesh-ancestor
138273854|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273855|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
138273856|NCT03119064|Irinotecan|irinotecan|mesh-list
138273857|NCT03119064|Temozolomide|temozolomide|mesh-list
138273858|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138273859|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138273860|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273861|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273862|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273863|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138273864|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
138273865|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
138273866|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
138273867|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273868|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273869|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138273870|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
138273871|NCT02454296|Lidocaine|lidocaine|mesh-list
138273872|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
138273873|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
138273874|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138319270|NCT04194294|Lidocaine|lidocaine|mesh-list
138273875|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273876|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
138273877|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273878|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138273879|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138273880|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138273881|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138273882|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273883|NCT03836833|Lamivudine|lamivudine|mesh-list
138273884|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138273885|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138273886|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273887|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273888|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
138273889|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273890|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138273891|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138273892|NCT05710471|Aflibercept|aflibercept|mesh-list
138273893|NCT05710471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138273894|NCT05710471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138273895|NCT05710471|Growth Substances|growth substances|mesh-ancestor
138273896|NCT05710471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273897|NCT05710471|Growth Inhibitors|growth inhibitors|mesh-ancestor
138273898|NCT05710471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273899|NCT00358969|Guanfacine|guanfacine|mesh-list
138273901|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138273902|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138273903|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138273904|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
138273905|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273906|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273907|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273908|NCT02896712|Modafinil|modafinil|mesh-list
138273909|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138273910|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273911|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138273912|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138273913|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138273914|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273916|NCT05346601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138273917|NCT05346601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138273918|NCT05346601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273919|NCT05346601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273920|NCT04344379|Azithromycin|azithromycin|mesh-list
138273921|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
138273922|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138273923|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273924|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
138273925|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138273926|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138273927|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273928|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273929|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138273930|NCT00359125|Mifepristone|mifepristone|mesh-list
138273931|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138273932|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
138273933|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138273934|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273935|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138273937|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138273938|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
138273939|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138273940|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138273941|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
138194438|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273942|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138273943|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
138273944|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138273945|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138273948|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138273949|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273951|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
138273952|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273953|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
138273954|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273955|NCT05679193|Propranolol|propranolol|mesh-list
138273956|NCT05679193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138273957|NCT05679193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138273958|NCT05679193|Adrenergic Agents|adrenergic agents|mesh-ancestor
138273959|NCT05679193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273960|NCT05679193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273961|NCT05679193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273962|NCT05679193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138273963|NCT05679193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138273964|NCT05679193|Vasodilator Agents|vasodilator agents|mesh-ancestor
138273965|NCT04795752|Cyclosporine|cyclosporine|mesh-list
138273966|NCT04795752|Cyclosporins|cyclosporins|mesh-list
138273967|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138273968|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273969|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138273970|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
138273971|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273972|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
138273973|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138273974|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
138273975|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138273976|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138273977|NCT02977741|Olanzapine|olanzapine|mesh-list
138273978|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
138273979|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
138273980|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138273981|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138273982|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138273983|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138273984|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138273985|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138273986|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138273987|NCT02977741|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138273988|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138273989|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138273990|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138273991|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138273993|NCT05292001|Dextrans|dextrans|mesh-list
138273994|NCT05292001|Iron-Dextran Complex|iron-dextran complex|mesh-list
138273995|NCT05292001|Anticoagulants|anticoagulants|mesh-ancestor
138273996|NCT05292001|Plasma Substitutes|plasma substitutes|mesh-ancestor
138273997|NCT05292001|Blood Substitutes|blood substitutes|mesh-ancestor
138273998|NCT05292001|Hematinics|hematinics|mesh-ancestor
138273999|NCT01634178|Apremilast|apremilast|mesh-list
138274000|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138274001|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138274002|NCT01634178|Analgesics|analgesics|mesh-ancestor
138274004|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274005|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274006|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138274008|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138274009|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138274010|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274011|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274013|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274014|NCT04782804|Capecitabine|capecitabine|mesh-list
138274015|NCT04782804|Tislelizumab|tislelizumab|mesh-list
138274016|NCT04782804|Antibodies|antibodies|mesh-list
138274017|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
138274018|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274019|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138274020|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
138274021|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274022|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380347|NCT04561206|Nivolumab|nivolumab|mesh-list
138274023|NCT04782804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138274025|NCT02978443|Ipilimumab|ipilimumab|mesh-list
138274026|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138274027|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274028|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138274029|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274030|NCT02465450|Lenabasum|lenabasum|mesh-list
138274031|NCT02465450|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138274032|NCT02465450|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138274033|NCT02465450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274034|NCT02465450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274035|NCT02465450|Hormones|hormones|mesh-ancestor
138274036|NCT02465450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138274037|NCT02465450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274038|NCT00608972|Bevacizumab|bevacizumab|mesh-list
138274040|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138274041|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274042|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138274043|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138274044|NCT00608972|Growth Substances|growth substances|mesh-ancestor
138274045|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274046|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
138274047|NCT02729714|Suvorexant|suvorexant|mesh-list
138274048|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138274049|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138274050|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138274051|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274052|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138274053|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274054|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274055|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
138274056|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138274057|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138228495|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274058|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274059|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
138274060|NCT04802382|Coagulants|coagulants|mesh-ancestor
138274061|NCT05648916|Celecoxib|celecoxib|mesh-list
138274062|NCT05648916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138274063|NCT05648916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138274064|NCT05648916|Analgesics|analgesics|mesh-ancestor
138274065|NCT05648916|Sensory System Agents|sensory system agents|mesh-ancestor
138274066|NCT05648916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274067|NCT05648916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274068|NCT05648916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138274069|NCT05648916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274071|NCT05648916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138274072|NCT05648916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194477|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
138194481|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274073|NCT05648916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274074|NCT05458609|Naltrexone|naltrexone|mesh-list
138274075|NCT05458609|Lemborexant|lemborexant|mesh-list
138274076|NCT05458609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138274078|NCT05458609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274079|NCT05458609|Sensory System Agents|sensory system agents|mesh-ancestor
138274080|NCT05458609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274081|NCT05458609|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138274082|NCT05458609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274083|NCT05458609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274084|NCT05458609|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138274085|NCT05458609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138274086|NCT05458609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138274087|NCT05648058|Diphenhydramine|diphenhydramine|mesh-list
138274088|NCT05648058|Promethazine|promethazine|mesh-list
138274089|NCT05648058|Nefopam|nefopam|mesh-list
138274090|NCT05648058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138274091|NCT05648058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138274092|NCT05648058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138274093|NCT05648058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274094|NCT05648058|Anesthetics, Local|anesthetics, local|mesh-ancestor
138274095|NCT05648058|Anesthetics|anesthetics|mesh-ancestor
138274096|NCT05648058|Sensory System Agents|sensory system agents|mesh-ancestor
138274097|NCT05648058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274098|NCT05648058|Antiemetics|antiemetics|mesh-ancestor
138274099|NCT05648058|Autonomic Agents|autonomic agents|mesh-ancestor
138274100|NCT05648058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138274101|NCT05648058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138274103|NCT05648058|Histamine Agents|histamine agents|mesh-ancestor
138274104|NCT05648058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274105|NCT05648058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274106|NCT05648058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138274107|NCT05648058|Antipruritics|antipruritics|mesh-ancestor
138274108|NCT05648058|Dermatologic Agents|dermatologic agents|mesh-ancestor
138274109|NCT05648058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138274110|NCT05648058|Analgesics|analgesics|mesh-ancestor
138274111|NCT05210101|Sotrovimab|sotrovimab|mesh-list
138274112|NCT05210101|Antiviral Agents|antiviral agents|mesh-ancestor
138274113|NCT05210101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274114|NCT02959411|Tolvaptan|tolvaptan|mesh-list
138274115|NCT02959411|Diuretics|diuretics|mesh-list
138274116|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
138274117|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274118|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138274119|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274120|NCT05426161|Botulinum Toxins|botulinum toxins|mesh-list
138274121|NCT05426161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138274122|NCT05426161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138274123|NCT05426161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138274124|NCT05426161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138274125|NCT05426161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274126|NCT05426161|Cholinergic Agents|cholinergic agents|mesh-ancestor
138274127|NCT05426161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274128|NCT05426161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274129|NCT05426161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138274130|NCT05426161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274131|NCT05630833|Nitrofurantoin|nitrofurantoin|mesh-list
138274132|NCT05630833|Gepotidacin|gepotidacin|mesh-list
138194494|NCT01457690|Vitamin E|vitamin e|mesh-list
138274133|NCT05630833|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138274134|NCT05630833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274135|NCT05630833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138274136|NCT05630833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138274137|NCT05630833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274138|NCT05630833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274139|NCT05630833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274140|NCT00359671|Docetaxel|docetaxel|mesh-list
138274141|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274142|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
138274143|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
138274144|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
138274145|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274146|NCT02977897|Octreotide|octreotide|mesh-list
138274147|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138274148|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138274149|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274150|NCT00359905|Tamsulosin|tamsulosin|mesh-list
138274151|NCT00359905|Silodosin|silodosin|mesh-list
138228544|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138274152|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138274153|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138274154|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138274155|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
138274156|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274157|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274158|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274159|NCT00359905|Urological Agents|urological agents|mesh-ancestor
138274161|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138274162|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
138274163|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274164|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
138274165|NCT05086939|Protective Agents|protective agents|mesh-ancestor
138274167|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
138274168|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
138274169|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274170|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274171|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138274172|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138274173|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274174|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274175|NCT04871191|Rituximab|rituximab|mesh-list
138274176|NCT04871191|Abatacept|abatacept|mesh-list
138274177|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138274178|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274179|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
138274180|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274181|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274182|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138274183|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274184|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138274186|NCT02976805|Cathartics|cathartics|mesh-ancestor
138274187|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138274188|NCT02976805|Laxatives|laxatives|mesh-ancestor
138274189|NCT04835623|Cyclosporine|cyclosporine|mesh-list
138274190|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138274191|NCT04835623|Cyclosporins|cyclosporins|mesh-list
138274192|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274193|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274195|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
138194514|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194515|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138194516|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
138274196|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274197|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
138274198|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274199|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
138274200|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274201|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138274202|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138274204|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
138274205|NCT04500613|Bupivacaine|bupivacaine|mesh-list
138274206|NCT04500613|BB 1101|bb 1101|mesh-list
138274207|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138274208|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
138274209|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
138274210|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274211|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274212|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138274213|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
138274214|NCT04500613|Hormones|hormones|mesh-ancestor
138274215|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138274216|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138274217|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274218|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
138274219|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274220|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274221|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
138319658|NCT05581992|Sotorasib|sotorasib|mesh-list
138274222|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
138274223|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138274224|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
138274225|NCT02976259|Dolutegravir|dolutegravir|mesh-list
138274226|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138274227|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138274228|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274229|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274230|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138274231|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138274232|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
138274233|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274234|NCT00360295|Azithromycin|azithromycin|mesh-list
138274235|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138274236|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274237|NCT02976727|Vitamin D|vitamin d|mesh-list
138274238|NCT02976727|Lidocaine|lidocaine|mesh-list
138274239|NCT02976727|Prilocaine|prilocaine|mesh-list
138274240|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138274241|NCT02976727|Calcipotriene|calcipotriene|mesh-list
138274242|NCT02976727|Vitamins|vitamins|mesh-ancestor
138194525|NCT01451294|Phenylephrine|phenylephrine|mesh-list
138274243|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
138274244|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194527|NCT01451294|Ephedrine|ephedrine|mesh-list
138274245|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
138274246|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
138274247|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138274248|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
138274249|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274250|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138274251|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138274252|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138274253|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138274254|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274255|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138274256|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
138274257|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138274258|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
138274259|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138274260|NCT00360607|Metronidazole|metronidazole|mesh-list
138274262|NCT00360607|Ceftazidime|ceftazidime|mesh-list
138274263|NCT00360607|Sulbactam|sulbactam|mesh-list
138274264|NCT00360607|Cefoperazone|cefoperazone|mesh-list
138274265|NCT00360607|Sulperazone|sulperazone|mesh-list
138274266|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274267|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138274268|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138274269|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138274270|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138274271|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274272|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274273|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138274274|NCT00360763|Candesartan|candesartan|mesh-list
138274275|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
138274276|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138274277|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138274278|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138274279|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274280|NCT04032301|Ketamine|ketamine|mesh-list
138274281|NCT04032301|Analgesics|analgesics|mesh-ancestor
138274282|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
138274283|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274284|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274285|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138274286|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138274287|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
138274288|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
138274289|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138274290|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138274291|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138274292|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274293|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274294|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
138274295|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138274296|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138274297|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274298|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138274300|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
138274301|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274302|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138274303|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138274304|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138274305|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
138274306|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274307|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274309|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
138194557|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
138274310|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274311|NCT02976571|Bupivacaine|bupivacaine|mesh-list
138274312|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
138274313|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
138274314|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138274315|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274316|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
138274317|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274318|NCT04731025|Vancomycin|vancomycin|mesh-list
138274319|NCT04731025|Gentamicins|gentamicins|mesh-list
138274320|NCT04731025|Cefazolin|cefazolin|mesh-list
138274321|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138274322|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274323|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138274324|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274325|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274326|NCT04730635|Donepezil|donepezil|mesh-list
138274327|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138274328|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274329|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274330|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
138274331|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274332|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274333|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
138274334|NCT04676035|Vitamin K|vitamin k|mesh-list
138274335|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
138274336|NCT04676035|Midazolam|midazolam|mesh-list
138274337|NCT04676035|Omeprazole|omeprazole|mesh-list
138274338|NCT04676035|Warfarin|warfarin|mesh-list
138274339|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138274340|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138274341|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138274342|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274343|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138274344|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138274345|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138274346|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138228644|NCT01031498|Ondansetron|ondansetron|mesh-list
138274349|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
138274350|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
138274351|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274352|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274353|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
138274354|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138274355|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138274356|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138274357|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274358|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138274359|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138274360|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
138274361|NCT04676035|Coagulants|coagulants|mesh-ancestor
138274362|NCT04676035|Vitamins|vitamins|mesh-ancestor
138274363|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
138274364|NCT04359199|Cisplatin|cisplatin|mesh-list
138274365|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
138274366|NCT04359199|Nivolumab|nivolumab|mesh-list
138274367|NCT04359199|Cetuximab|cetuximab|mesh-list
138274368|NCT04359199|Durvalumab|durvalumab|mesh-list
138274369|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274370|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138274371|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138274372|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274373|NCT00361075|Estradiol|estradiol|mesh-list
138274374|NCT00361075|Estrogens|estrogens|mesh-list
138274375|NCT00361075|Progesterone|progesterone|mesh-list
138274376|NCT00361075|Hormones|hormones|mesh-ancestor
138274377|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138274378|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274379|NCT00361075|Progestins|progestins|mesh-ancestor
138274380|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138274381|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
138274382|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138274383|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
138274384|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138274385|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319867|NCT03580590|Diltiazem|diltiazem|mesh-list
138274386|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138274387|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138274388|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138274389|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274390|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138274391|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138274392|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138274393|NCT00362089|Dronabinol|dronabinol|mesh-list
138274394|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
138274395|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274396|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138274397|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138274398|NCT00362089|Analgesics|analgesics|mesh-ancestor
138274399|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
138274400|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274401|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138274402|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138274403|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274404|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274405|NCT00362089|Hormones|hormones|mesh-ancestor
138274406|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138274407|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
138274408|NCT03822637|Albuterol|albuterol|mesh-list
138274409|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138274410|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138274411|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
138274412|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274413|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138319908|NCT03585738|Folic Acid|folic acid|mesh-list
138274414|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138274415|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
138274416|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
138274417|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138274418|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138274419|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138274420|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138274421|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
138274422|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274423|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274424|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
138274425|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274426|NCT03822637|Expectorants|expectorants|mesh-ancestor
138274427|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138274428|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
138274429|NCT03822637|Protective Agents|protective agents|mesh-ancestor
138274430|NCT03822637|Antidotes|antidotes|mesh-ancestor
138274431|NCT05444101|Nicotine|nicotine|mesh-list
138274432|NCT05444101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138274433|NCT05444101|Autonomic Agents|autonomic agents|mesh-ancestor
138274434|NCT05444101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274435|NCT05444101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274436|NCT05444101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138274438|NCT05444101|Cholinergic Agents|cholinergic agents|mesh-ancestor
138274439|NCT05444101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274440|NCT05444101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274442|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274443|NCT05616468|Cyclophosphamide|cyclophosphamide|mesh-list
138274445|NCT05616468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138274446|NCT05616468|Immunologic Factors|immunologic factors|mesh-ancestor
138194583|NCT01451840|Analgesics|analgesics|mesh-ancestor
138274447|NCT05616468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274448|NCT05616468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274449|NCT05616468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138274450|NCT05616468|Alkylating Agents|alkylating agents|mesh-ancestor
138274451|NCT05616468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274452|NCT05616468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274453|NCT05616468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138274454|NCT01352221|Ferric maltol|ferric maltol|mesh-list
138274455|NCT01352221|Hematinics|hematinics|mesh-ancestor
138274456|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
138274457|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138274458|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138274459|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274460|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138274461|NCT05195034|Analgesics|analgesics|mesh-ancestor
138274462|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
138320009|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
138274463|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274464|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138274465|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138274466|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138274467|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
138274468|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274469|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274470|NCT05496894|Mitoxantrone|mitoxantrone|mesh-list
138274471|NCT05496894|Analgesics|analgesics|mesh-ancestor
138274472|NCT05496894|Sensory System Agents|sensory system agents|mesh-ancestor
138274473|NCT05496894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274474|NCT05496894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274475|NCT05496894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274476|NCT05496894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138274477|NCT05496894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138274478|NCT05496894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274479|NCT05496894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274480|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
138274481|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
138274482|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274483|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138228734|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138274484|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274486|NCT03518034|Androgens|androgens|mesh-ancestor
138274487|NCT03518034|Hormones|hormones|mesh-ancestor
138274488|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138274489|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274491|NCT02389218|Sotalol|sotalol|mesh-list
138274492|NCT02389218|Propafenone|propafenone|mesh-list
138274493|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138274494|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138274495|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138274496|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138274497|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274498|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138274499|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138274500|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
138274501|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274502|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274503|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
138274504|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
138274505|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274506|NCT01953120|Abatacept|abatacept|mesh-list
138274507|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138274508|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274509|NCT01953120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138274510|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274511|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138274512|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
138274513|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138320103|NCT03158142|Atropine|atropine|mesh-list
138274514|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274516|NCT01634100|Rifampin|rifampin|mesh-list
138274517|NCT01634100|Probenecid|probenecid|mesh-list
138274518|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138274519|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274521|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274522|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138274523|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
138274524|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138274525|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274526|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
138274527|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138274528|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274529|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138274530|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138274531|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138274532|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138274533|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138274534|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138274535|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
138274536|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
138274537|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274539|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
138274540|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
138274541|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138274542|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138274543|NCT03661645|BB 1101|bb 1101|mesh-list
138274544|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138274545|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
138274546|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
138274547|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138320154|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
138274548|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274549|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138274550|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
138274551|NCT03661645|Hormones|hormones|mesh-ancestor
138274552|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138274553|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138274554|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274555|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
138274556|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274557|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274558|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138274559|NCT03661645|Protective Agents|protective agents|mesh-ancestor
138274560|NCT01633944|Buprenorphine|buprenorphine|mesh-list
138274561|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138274562|NCT01633944|Narcotics|narcotics|mesh-ancestor
138274563|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138194613|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
138274564|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274565|NCT01633944|Analgesics|analgesics|mesh-ancestor
138274566|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
138274567|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274568|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138274569|NCT04592419|Aflibercept|aflibercept|mesh-list
138274570|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138274571|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138274572|NCT04592419|Growth Substances|growth substances|mesh-ancestor
138274573|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274574|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
138274575|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274576|NCT00589316|Iodine|iodine|mesh-list
138274577|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
138274578|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
138274579|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
138274580|NCT00589316|Fludarabine|fludarabine|mesh-list
138228798|NCT01054742|Ribavirin|ribavirin|mesh-list
138274582|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138274583|NCT00589316|Tacrolimus|tacrolimus|mesh-list
138274584|NCT00589316|Antibodies|antibodies|mesh-list
138274585|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
138274586|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138274587|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138274588|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
138274589|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274590|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274591|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138274592|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
138274593|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274594|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274595|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138274596|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138274597|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
138274598|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138274599|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274600|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138274601|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138274602|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
138274603|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138274605|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138274606|NCT00589316|Trace Elements|trace elements|mesh-ancestor
138274607|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
138274609|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138274610|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274611|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
138274612|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138274613|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
138274614|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138274615|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274616|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138274617|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138274618|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138274620|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138274621|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
138274622|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274623|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274624|NCT00003423|Cytarabine|cytarabine|mesh-list
138274625|NCT00003423|Dexamethasone|dexamethasone|mesh-list
138274626|NCT00003423|Prednisolone|prednisolone|mesh-list
138274627|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
138274628|NCT00003423|Methotrexate|methotrexate|mesh-list
138274629|NCT00003423|Etoposide|etoposide|mesh-list
138274630|NCT00003423|Vincristine|vincristine|mesh-list
138274631|NCT00003423|Daunorubicin|daunorubicin|mesh-list
138274632|NCT00003423|Asparaginase|asparaginase|mesh-list
138274633|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
138274634|NCT00003423|Thioguanine|thioguanine|mesh-list
138274635|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138228818|NCT02170376|Carbidopa|carbidopa|mesh-list
138274637|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274638|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274639|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138274640|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
138274641|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274642|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274643|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138274644|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138274645|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
138274646|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
138274647|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274648|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138274649|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
138274650|NCT00003423|Hormones|hormones|mesh-ancestor
138274651|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138274652|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138274653|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138274654|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
138274655|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138274656|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138274657|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
138274658|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
138274659|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274660|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138274661|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138274662|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138274663|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138274664|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138274665|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
138274666|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274667|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
138274668|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
138274669|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
138274670|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138274672|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
138274673|NCT00003273|Temozolomide|temozolomide|mesh-list
138274674|NCT00003273|Thiotepa|thiotepa|mesh-list
138274675|NCT00003273|Carboplatin|carboplatin|mesh-list
138274676|NCT00003273|Methotrexate|methotrexate|mesh-list
138274677|NCT00003273|Etoposide|etoposide|mesh-list
138274678|NCT00003273|Vincristine|vincristine|mesh-list
138274679|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
138274680|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138274681|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
138274682|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274683|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274684|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138274685|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
138274686|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274687|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138228840|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138274688|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138274689|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138274691|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138274692|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138274693|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
138274694|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
138274695|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274696|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138274697|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138274698|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138274699|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138274700|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138274701|NCT00003273|Antidotes|antidotes|mesh-ancestor
138274702|NCT00003273|Protective Agents|protective agents|mesh-ancestor
138274703|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
138274704|NCT00003273|Vitamins|vitamins|mesh-ancestor
138274705|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
138274706|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
138274707|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
138274708|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
138274709|NCT04329585|Flumazenil|flumazenil|mesh-list
138274710|NCT04329585|Antidotes|antidotes|mesh-ancestor
138274711|NCT04329585|Protective Agents|protective agents|mesh-ancestor
138274712|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274713|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
138274714|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
138274715|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138274716|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274718|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138274719|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
138274720|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
138274721|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274722|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138274723|NCT00383487|Calcitriol|calcitriol|mesh-list
138274724|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138274725|NCT00383487|Naproxen|naproxen|mesh-list
138274726|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
138274727|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138274728|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138274729|NCT00383487|Analgesics|analgesics|mesh-ancestor
138274730|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
138274731|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274732|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274733|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138274734|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274735|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
138274736|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138274737|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274738|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274739|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138274740|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138274741|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138274742|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138274744|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
138274745|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138274746|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138274747|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138274748|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138274749|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274750|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
138274751|NCT00003435|Melphalan|melphalan|mesh-list
138274752|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138274753|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138274754|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
138274755|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274756|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274757|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138274758|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138274759|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
138274760|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274761|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274762|NCT00003441|Irofulven|irofulven|mesh-list
138274763|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138274764|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
138274765|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274766|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274768|NCT00002805|Cytarabine|cytarabine|mesh-list
138274769|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
138274770|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138274771|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138274772|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138274773|NCT00002805|Methotrexate|methotrexate|mesh-list
138274774|NCT00002805|Etoposide|etoposide|mesh-list
138274775|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
138274776|NCT00002805|Cladribine|cladribine|mesh-list
138274777|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138274778|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
138274779|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138274780|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274781|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138274782|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
138274783|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274784|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274785|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
138274787|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138274788|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138274789|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
138274790|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274792|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138274793|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138274794|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138274795|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
138274796|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274797|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138274798|NCT00002805|Analgesics|analgesics|mesh-ancestor
138274799|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
138274800|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274801|NCT00002805|Trace Elements|trace elements|mesh-ancestor
138274802|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
138274803|NCT00003297|Topotecan|topotecan|mesh-list
138274804|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
138274805|NCT00003297|Thiotepa|thiotepa|mesh-list
138274806|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138274807|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138274808|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274809|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274810|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274811|NCT00003297|Analgesics|analgesics|mesh-ancestor
138274812|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
138274813|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138274814|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274815|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138274816|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138274817|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
138274818|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138274819|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138274820|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
138274821|NCT00003447|Gemcitabine|gemcitabine|mesh-list
138274822|NCT00003447|Vinorelbine|vinorelbine|mesh-list
138194674|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
138274823|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138274824|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
138274825|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274826|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274827|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138274828|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
138274829|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
138274830|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
138274831|NCT00003315|Amphotericin B|amphotericin b|mesh-list
138274832|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138274833|NCT00003315|Sargramostim|sargramostim|mesh-list
138274834|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
138274835|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274837|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138274838|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138274839|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274840|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138274841|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
138274842|NCT00002817|Sargramostim|sargramostim|mesh-list
138274843|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
138274844|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274845|NCT00003465|Temozolomide|temozolomide|mesh-list
138274846|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138274847|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
138274848|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274849|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274850|NCT00002823|Etoposide|etoposide|mesh-list
138274851|NCT00002823|Vinorelbine|vinorelbine|mesh-list
138274852|NCT00002823|Vinblastine|vinblastine|mesh-list
138274853|NCT00002823|Vindesine|vindesine|mesh-list
138274854|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274855|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138274856|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138274857|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138274858|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274859|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274860|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
138274861|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
138274862|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
138274863|NCT00361621|Prednisone|prednisone|mesh-list
138274864|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
138274865|NCT00361621|Rituximab|rituximab|mesh-list
138274866|NCT00361621|Doxorubicin|doxorubicin|mesh-list
138274867|NCT00361621|Vincristine|vincristine|mesh-list
138274868|NCT00361621|Bortezomib|bortezomib|mesh-list
138274869|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138274870|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
138274871|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274872|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274873|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138274874|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
138274875|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274876|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274877|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138274878|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138274879|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138274880|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138274881|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138274882|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274883|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138274884|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
138274886|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138274887|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138274888|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138274889|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
138274890|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
138274892|NCT00003327|Paclitaxel|paclitaxel|mesh-list
138274893|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138274894|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274895|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
138274896|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
138274897|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
138320629|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138274898|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274899|NCT00003339|Interleukin-12|interleukin-12|mesh-list
138274900|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
138274901|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138274902|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
138274903|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274904|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138274905|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138380899|NCT04749641|Vaccines|vaccines|mesh-list
138274906|NCT00003339|Growth Substances|growth substances|mesh-ancestor
138274907|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
138274908|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274909|NCT00002829|Interferons|interferons|mesh-list
138274910|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
138274911|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
138274912|NCT00002829|Etoposide|etoposide|mesh-list
138274913|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138274914|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
138274915|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274916|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274917|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138274918|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
138274919|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274920|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274921|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138274922|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138274923|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138274924|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138274925|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274926|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
138274927|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274929|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138274930|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
138274931|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274932|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138274933|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194714|NCT02559414|Aspirin|aspirin|mesh-list
138274934|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274935|NCT00003345|Irinotecan|irinotecan|mesh-list
138274936|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138274938|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138274939|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274940|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274942|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138274943|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
138274944|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274945|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138274946|NCT00002835|Leucovorin|leucovorin|mesh-list
138274947|NCT00002835|Interferons|interferons|mesh-list
138274948|NCT00002835|Cytarabine|cytarabine|mesh-list
138274949|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
138274950|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
138274951|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138274952|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138274953|NCT00002835|Prednisolone|prednisolone|mesh-list
138274954|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
138274955|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
138274956|NCT00002835|Melphalan|melphalan|mesh-list
138274957|NCT00002835|Ifosfamide|ifosfamide|mesh-list
138274958|NCT00002835|Carmustine|carmustine|mesh-list
138274959|NCT00002835|Cisplatin|cisplatin|mesh-list
138274960|NCT00002835|Methotrexate|methotrexate|mesh-list
138274961|NCT00002835|Etoposide|etoposide|mesh-list
138274962|NCT00002835|Vincristine|vincristine|mesh-list
138274963|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
138274964|NCT00002835|Idarubicin|idarubicin|mesh-list
138274965|NCT00002835|Bleomycin|bleomycin|mesh-list
138274966|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
138274967|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138274968|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
138274969|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138274970|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
138274971|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138274972|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138274973|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138274974|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
138274975|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138274977|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138274978|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138274979|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
138274980|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138274981|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138274982|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
138274983|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
138274984|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138274985|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138274986|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138274987|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138274988|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138274989|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138274990|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
138274991|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138274992|NCT00002835|Antidotes|antidotes|mesh-ancestor
138274993|NCT00002835|Protective Agents|protective agents|mesh-ancestor
138274994|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
138274996|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
138274997|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
138274998|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
138274999|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275000|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138275001|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
138275002|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
138275003|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138275004|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138275005|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
138275006|NCT00002835|Hormones|hormones|mesh-ancestor
138275007|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138275008|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138275009|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138275010|NCT00002835|Analgesics|analgesics|mesh-ancestor
138275011|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
138275012|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138275014|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138275015|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275016|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275017|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275018|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275019|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138275020|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138275021|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138275022|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
138275023|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275024|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138275025|NCT00002847|Interferons|interferons|mesh-list
138275026|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
138275027|NCT00002847|Aldesleukin|aldesleukin|mesh-list
138275028|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275029|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
138275030|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138275031|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
138275032|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229038|NCT02174432|Nalbuphine|nalbuphine|mesh-list
138275033|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138275034|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138275035|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
138275036|NCT03576001|Testosterone|testosterone|mesh-list
138320873|NCT06124573|Metformin|metformin|mesh-list
138275037|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
138275038|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
138275039|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138275041|NCT03576001|Hormones|hormones|mesh-ancestor
138275042|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138275043|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275044|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138275045|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275046|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
138275047|NCT04220827|Paclitaxel|paclitaxel|mesh-list
138275048|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138275049|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275050|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275051|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275052|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
138194764|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275053|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275054|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275057|NCT00002865|Cytarabine|cytarabine|mesh-list
138275058|NCT00002865|Dexamethasone|dexamethasone|mesh-list
138275060|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138275061|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138275062|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138275063|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
138275064|NCT00002865|Ifosfamide|ifosfamide|mesh-list
138275065|NCT00002865|Doxorubicin|doxorubicin|mesh-list
138275066|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138275067|NCT00002865|Methotrexate|methotrexate|mesh-list
138275068|NCT00002865|Etoposide|etoposide|mesh-list
138275069|NCT00002865|Vincristine|vincristine|mesh-list
138275070|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
138275071|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275072|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
138275073|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275074|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138275075|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275076|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
138229058|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138275077|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275078|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275079|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138275080|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138275081|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
138275082|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
138275083|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138275084|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138275085|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
138275087|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138275088|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138275089|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138275090|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138275091|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275092|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275093|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138275094|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
138275095|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138275096|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275097|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
138275098|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
138275099|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138275100|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138275101|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275102|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
138275103|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138275104|NCT00002865|Antidotes|antidotes|mesh-ancestor
138275105|NCT00002865|Protective Agents|protective agents|mesh-ancestor
138275106|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
138275107|NCT00002865|Vitamins|vitamins|mesh-ancestor
138275108|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
138275109|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275110|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275111|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275112|NCT00002865|Trace Elements|trace elements|mesh-ancestor
138275113|NCT00361309|Sunitinib|sunitinib|mesh-list
138275114|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275115|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138275116|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138275117|NCT00361309|Growth Substances|growth substances|mesh-ancestor
138275118|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275119|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
138275120|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138194798|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
138275121|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229093|NCT03013790|Melatonin|melatonin|mesh-list
138275122|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275124|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138275125|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275127|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138275128|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275129|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138275130|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138275131|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138275132|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275133|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
138275134|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138275135|NCT00003369|Tirapazamine|tirapazamine|mesh-list
138275136|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275137|NCT04342351|Valsartan|valsartan|mesh-list
138275138|NCT04342351|Perindopril|perindopril|mesh-list
138275139|NCT04342351|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138275140|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138275141|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138275142|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138275143|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275144|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138275145|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
138275146|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275147|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
138275148|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138275149|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138275150|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138275151|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275152|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275153|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275154|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275180|NCT00003375|Vincristine|vincristine|mesh-list
138275181|NCT00003375|Lomustine|lomustine|mesh-list
138275182|NCT00003375|Procarbazine|procarbazine|mesh-list
138275183|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275184|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275185|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275186|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275187|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275188|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275189|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275190|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
138275191|NCT03498391|Ketamine|ketamine|mesh-list
138275192|NCT03498391|Propofol|propofol|mesh-list
138275193|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138275194|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138275195|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275196|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138275197|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
138275198|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
138275199|NCT03498391|Analgesics|analgesics|mesh-ancestor
138275200|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
138194804|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138275201|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138275202|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138275203|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138275204|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138275205|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138275206|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275207|NCT00003939|Trabectedin|trabectedin|mesh-list
138275208|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275209|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
138275210|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275211|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275212|NCT00003543|Fluorouracil|fluorouracil|mesh-list
138275213|NCT00003543|Vincristine|vincristine|mesh-list
138275214|NCT00003543|Carmustine|carmustine|mesh-list
138275215|NCT00003543|Streptozocin|streptozocin|mesh-list
138275216|NCT00003543|Antibodies|antibodies|mesh-list
138275217|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138275218|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
138275219|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275220|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
138275221|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275222|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275223|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275224|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275225|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275226|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275227|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275228|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275229|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275230|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
138275231|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138275232|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
138275233|NCT00003549|Fluorouracil|fluorouracil|mesh-list
138275234|NCT00003549|Methotrexate|methotrexate|mesh-list
138275235|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275236|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
138275237|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275238|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138381129|NCT04228289|Oxytocin|oxytocin|mesh-list
138275239|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275240|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
138275241|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275242|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275243|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138275244|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
138275245|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275246|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138321157|NCT06083883|Fludarabine|fludarabine|mesh-list
138275247|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
138275248|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138275249|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
138275250|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275251|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138275252|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138275253|NCT00002883|Fluorouracil|fluorouracil|mesh-list
138275254|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275255|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
138275256|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275257|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275258|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275259|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
138275260|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275261|NCT03492463|Nicotine|nicotine|mesh-list
138275262|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138275263|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
138275264|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138275265|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275266|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138275267|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138275268|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
138275269|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138275270|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275271|NCT00003945|Topotecan|topotecan|mesh-list
138275272|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275273|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138275274|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275275|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275276|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275277|NCT00003951|Exatecan|exatecan|mesh-list
138275278|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138275279|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275280|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275281|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275282|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275283|NCT00003957|Cytarabine|cytarabine|mesh-list
138275284|NCT00003957|Paclitaxel|paclitaxel|mesh-list
138275285|NCT00003957|Etoposide|etoposide|mesh-list
138275286|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
138275287|NCT00003957|Melphalan|melphalan|mesh-list
138363756|NCT04040959|Niacin|niacin|mesh-list
138275288|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
138275289|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275290|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275291|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275292|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275293|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
138381158|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275294|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275295|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275296|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
138321257|NCT05895266|Anesthetics|anesthetics|mesh-ancestor
138275297|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275298|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138275299|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275300|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
138275301|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138275302|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138275303|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275304|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275305|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275306|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
138275307|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
138275308|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138275310|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
138275311|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138275312|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
138275314|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
138275315|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138275316|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138275317|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
138275318|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275319|NCT00003555|Paclitaxel|paclitaxel|mesh-list
138275320|NCT00003555|Amifostine|amifostine|mesh-list
138275321|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275322|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275323|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275324|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275325|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275326|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275327|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138275328|NCT00003555|Protective Agents|protective agents|mesh-ancestor
138275329|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194830|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138275330|NCT00003963|Rituximab|rituximab|mesh-list
138275331|NCT00003963|Vinorelbine|vinorelbine|mesh-list
138381180|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138275332|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138275333|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275334|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
138275335|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275336|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138275337|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275338|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275339|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275340|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275341|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275342|NCT00004845|Naproxen|naproxen|mesh-list
138275343|NCT00004845|Rofecoxib|rofecoxib|mesh-list
138275344|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138275345|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138275346|NCT00004845|Analgesics|analgesics|mesh-ancestor
138275347|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
138275348|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138275349|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275350|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138275351|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138275352|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
138275353|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138275354|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275355|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275356|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138275357|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
138275358|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275359|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138275360|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275361|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275362|NCT00003993|Aldesleukin|aldesleukin|mesh-list
138275364|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275365|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138275366|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138275367|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
138275368|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138275369|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138275370|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
138275371|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275372|NCT00004857|Fludarabine|fludarabine|mesh-list
138275373|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
138275374|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
138275375|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275376|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275377|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
138381215|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138381219|NCT03936062|Hormones|hormones|mesh-ancestor
138275378|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275379|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275380|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
138275381|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275382|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138275383|NCT03476239|Blinatumomab|blinatumomab|mesh-list
138275384|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275385|NCT00004863|Paclitaxel|paclitaxel|mesh-list
138275386|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138321369|NCT05432778|Letermovir|letermovir|mesh-list
138275387|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275389|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275390|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275391|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275392|NCT00004875|Heparin|heparin|mesh-list
138275393|NCT00004875|Enoxaparin|enoxaparin|mesh-list
138275394|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
138275395|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138275396|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138275397|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275398|NCT00003561|Interferons|interferons|mesh-list
138275399|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
138275400|NCT00003561|Sargramostim|sargramostim|mesh-list
138275401|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275402|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
138275403|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138275404|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
138275405|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275406|NCT00003567|Temozolomide|temozolomide|mesh-list
138275407|NCT00003567|Carmustine|carmustine|mesh-list
138275408|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138275409|NCT00003567|Sargramostim|sargramostim|mesh-list
138275410|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
138381245|NCT03936010|Canagliflozin|canagliflozin|mesh-list
138275411|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275412|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275413|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
138275414|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275415|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275416|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275418|NCT00003573|Cisplatin|cisplatin|mesh-list
138275419|NCT00003573|Etoposide|etoposide|mesh-list
138275420|NCT00003573|Vincristine|vincristine|mesh-list
138275421|NCT00003573|Lenograstim|lenograstim|mesh-list
138275422|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275423|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
138275424|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275425|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138275426|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275427|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
138275428|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275429|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275430|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138229254|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138275431|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275432|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138275433|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275434|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275435|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138275436|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275437|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275438|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275439|NCT00003585|Interferons|interferons|mesh-list
138321470|NCT05171179|Bupivacaine|bupivacaine|mesh-list
138275440|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
138275441|NCT00003585|Aldesleukin|aldesleukin|mesh-list
138275442|NCT00003585|Fluorouracil|fluorouracil|mesh-list
138275443|NCT00003585|Isotretinoin|isotretinoin|mesh-list
138275444|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
138275445|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275446|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275447|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138194854|NCT01459250|Agomelatine|agomelatine|mesh-list
138194855|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138275448|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275449|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
138275450|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275451|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
138275452|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138275453|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138275454|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138275455|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
138275456|NCT00003591|Paclitaxel|paclitaxel|mesh-list
138275457|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275458|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275459|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275460|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275461|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275462|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275463|NCT02975323|Carvedilol|carvedilol|mesh-list
138275464|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138275465|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138275466|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
138275467|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138275468|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275469|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275470|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138275471|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
138275472|NCT02975323|Protective Agents|protective agents|mesh-ancestor
138275473|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138275474|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138275475|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138275476|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
138275477|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138275478|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138275479|NCT00003597|Carboplatin|carboplatin|mesh-list
138275482|NCT00003597|Lenograstim|lenograstim|mesh-list
138275483|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275484|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275485|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138275486|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138229284|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138275488|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275489|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275490|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
138275491|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138275492|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
138275493|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275494|NCT00004005|Leucovorin|leucovorin|mesh-list
138275495|NCT00004005|Fluorouracil|fluorouracil|mesh-list
138275496|NCT00004005|Irinotecan|irinotecan|mesh-list
138275497|NCT00004005|Calcium|calcium|mesh-list
138275498|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
138275499|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138275500|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275501|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
138275502|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275503|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275504|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275505|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275506|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
138275507|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138275508|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275509|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275510|NCT00004005|Antidotes|antidotes|mesh-ancestor
138275511|NCT00004005|Protective Agents|protective agents|mesh-ancestor
138275512|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
138275513|NCT00004005|Vitamins|vitamins|mesh-ancestor
138275514|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
138275515|NCT00003603|Dexamethasone|dexamethasone|mesh-list
138275516|NCT00003603|Prednisolone|prednisolone|mesh-list
138275517|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
138275518|NCT00003603|Melphalan|melphalan|mesh-list
138275519|NCT00003603|Lomustine|lomustine|mesh-list
138275520|NCT00003603|Idarubicin|idarubicin|mesh-list
138275521|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275522|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
138275523|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275524|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138275525|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275526|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
138275527|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275528|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275529|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138275530|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138275531|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
138275532|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
138275533|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138275534|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138275535|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
138275537|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138275538|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138275539|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138275540|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138275541|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275554|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275555|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275557|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138275558|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138275559|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275560|NCT00004893|Interleukin-12|interleukin-12|mesh-list
138275561|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138275562|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
138275563|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275564|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138275565|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138275566|NCT00004893|Growth Substances|growth substances|mesh-ancestor
138275567|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
138275568|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275570|NCT00004011|Carboplatin|carboplatin|mesh-list
138321657|NCT04533997|Furosemide|furosemide|mesh-list
138275572|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275573|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275574|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275575|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275576|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275578|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138275579|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
138275580|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275581|NCT00004905|Interferons|interferons|mesh-list
138275582|NCT00004905|Cytarabine|cytarabine|mesh-list
138275583|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
138275584|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
138275585|NCT00004905|Etoposide|etoposide|mesh-list
138275586|NCT00004905|Idarubicin|idarubicin|mesh-list
138275587|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275588|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
138275589|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275590|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138275591|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275592|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
138275593|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194885|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194886|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194887|NCT02880020|Nivolumab|nivolumab|mesh-list
138275595|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138275596|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275597|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138275598|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275600|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
138275601|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138275602|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275603|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
138275604|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138275605|NCT00004029|Sargramostim|sargramostim|mesh-list
138275606|NCT00004029|Vaccines|vaccines|mesh-list
138275607|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
138275608|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275609|NCT00362323|Metformin|metformin|mesh-list
138275610|NCT00362323|Fenofibrate|fenofibrate|mesh-list
138275611|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138275612|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275613|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138275614|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
138275615|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275616|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138275617|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
138275618|NCT00004917|Hematinics|hematinics|mesh-ancestor
138275619|NCT00421915|Etanercept|etanercept|mesh-list
138275620|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138275621|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138275622|NCT00421915|Analgesics|analgesics|mesh-ancestor
138275623|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
138275624|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138275625|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275626|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138275627|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138275628|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138275629|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275630|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
138275631|NCT00362713|Ipilimumab|ipilimumab|mesh-list
138275632|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138275633|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275634|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138275635|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275636|NCT00004047|Exatecan|exatecan|mesh-list
138275637|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138275638|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275639|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275640|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275641|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275642|NCT00003627|Fluorouracil|fluorouracil|mesh-list
138275643|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275645|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275646|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275647|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275648|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
138275649|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275650|NCT00004059|Fluorouracil|fluorouracil|mesh-list
138275651|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138275652|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
138275653|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275654|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275655|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275656|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275657|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
138229353|NCT02178800|Cabotegravir|cabotegravir|mesh-list
138275666|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
138194892|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138194894|NCT03150160|Travoprost|travoprost|mesh-list
138275667|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275668|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275669|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275670|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138275671|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
138275672|NCT00003633|Hormones|hormones|mesh-ancestor
138275673|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138275674|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275675|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138275676|NCT00003633|Analgesics|analgesics|mesh-ancestor
138275677|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
138275678|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138275679|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138275680|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275681|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275682|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275683|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
138275685|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
138275686|NCT00003639|Dexamethasone|dexamethasone|mesh-list
138275687|NCT00003639|Idarubicin|idarubicin|mesh-list
138275688|NCT00003639|Chlorambucil|chlorambucil|mesh-list
138275689|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138275690|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
138275691|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
138275692|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138275693|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275694|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138275695|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
138275697|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138275698|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138275699|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275700|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
138275701|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138275702|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
138275703|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138275704|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138275705|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275706|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275707|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275708|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275709|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
138275710|NCT00004923|Docetaxel|docetaxel|mesh-list
138275711|NCT00004923|Irinotecan|irinotecan|mesh-list
138229362|NCT01044212|Psyllium|psyllium|mesh-list
138275717|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138275718|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275719|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275721|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
138275722|NCT00004071|Leflunomide|leflunomide|mesh-list
138275723|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138275724|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
138275725|NCT00004071|Hormones|hormones|mesh-ancestor
138275726|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138275727|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275728|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138275729|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275730|NCT00004071|Analgesics|analgesics|mesh-ancestor
138275731|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
138275732|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138194903|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138194905|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275733|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138275734|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275735|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275736|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275737|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275738|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
138275739|NCT00004077|Paclitaxel|paclitaxel|mesh-list
138275740|NCT00004077|Ifosfamide|ifosfamide|mesh-list
138275741|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275742|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275743|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275744|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275745|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
138321898|NCT03756298|Capecitabine|capecitabine|mesh-list
138275746|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275747|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275748|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
138275749|NCT00004083|Cisplatin|cisplatin|mesh-list
138275750|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275751|NCT00004941|Infliximab|infliximab|mesh-list
138275752|NCT00004941|Antibodies|antibodies|mesh-list
138275753|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138275754|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
138275755|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275756|NCT00004941|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138275758|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
138275759|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138275760|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138275761|NCT00003657|Carboplatin|carboplatin|mesh-list
138275762|NCT00003657|Etoposide|etoposide|mesh-list
138275763|NCT00003657|Ifosfamide|ifosfamide|mesh-list
138275764|NCT00003657|Amifostine|amifostine|mesh-list
138275765|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275766|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275767|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138275768|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275769|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275770|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275771|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275772|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275774|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138275775|NCT00003657|Protective Agents|protective agents|mesh-ancestor
138275777|NCT00004089|Fluorouracil|fluorouracil|mesh-list
138275778|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
138275779|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275780|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275781|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275782|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275783|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275784|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275785|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
138275786|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275787|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138194920|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
138275788|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
138275789|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275790|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
138275791|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138322010|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
138275792|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138275793|NCT00004095|Gemcitabine|gemcitabine|mesh-list
138275795|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275796|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
138275797|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275798|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275799|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138275800|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275801|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275802|NCT00003663|Dexamethasone|dexamethasone|mesh-list
138275803|NCT00003663|Rituximab|rituximab|mesh-list
138275804|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138275805|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
138275806|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
138275807|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138275808|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275809|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138275810|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
138275811|NCT00003663|Hormones|hormones|mesh-ancestor
138275812|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138275813|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138275814|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275815|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138275816|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
138275817|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138275819|NCT00004107|Antibodies|antibodies|mesh-list
138275820|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138275821|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
138275822|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275823|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138275824|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275825|NCT00004113|Temozolomide|temozolomide|mesh-list
138275826|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275828|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275829|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275830|NCT00003675|Topotecan|topotecan|mesh-list
138275831|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138275832|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275833|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275834|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275835|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275836|NCT00004137|Paclitaxel|paclitaxel|mesh-list
138275837|NCT00004137|Carboplatin|carboplatin|mesh-list
138275838|NCT00004137|Topotecan|topotecan|mesh-list
138275839|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275840|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275841|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275842|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275843|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275844|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275845|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138275846|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275847|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275848|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
138275850|NCT00003681|Hematinics|hematinics|mesh-ancestor
138275851|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138194943|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138194944|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138194952|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138275852|NCT00003681|Protective Agents|protective agents|mesh-ancestor
138275853|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275854|NCT00005007|Etanercept|etanercept|mesh-list
138275855|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138275856|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138275857|NCT00005007|Analgesics|analgesics|mesh-ancestor
138275858|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
138275859|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138275860|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275861|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138275862|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138275863|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138275864|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138229420|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
138275865|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
138275866|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
138275867|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138275868|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138275869|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275870|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
138275871|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138275872|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275873|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
138275874|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275876|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138275877|NCT00384657|Trace Elements|trace elements|mesh-ancestor
138275878|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
138275879|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275881|NCT00005013|Sertraline|sertraline|mesh-list
138275882|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
138275883|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138275884|NCT00005013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138275885|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138275886|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138275887|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275888|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138275889|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
138275890|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275891|NCT00004161|Fenretinide|fenretinide|mesh-list
138275892|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275893|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138275894|NCT00004161|Protective Agents|protective agents|mesh-ancestor
138275895|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275896|NCT00004173|Paclitaxel|paclitaxel|mesh-list
138275897|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
138275898|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275899|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275900|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275901|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275902|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275903|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275904|NCT00005025|Ganciclovir|ganciclovir|mesh-list
138275905|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138275906|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
138275907|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138275908|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138275918|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
138275919|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138194956|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138194957|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138194959|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138275920|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138275921|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275922|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
138275923|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275924|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275925|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138275926|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138275927|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138275928|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138275929|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138275930|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275933|NCT00004179|Hormones|hormones|mesh-ancestor
138275934|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138275935|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138275936|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275937|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275938|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275939|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275941|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
138275942|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138275943|NCT00003687|Narcotics|narcotics|mesh-ancestor
138275944|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138275945|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138275946|NCT00003687|Analgesics|analgesics|mesh-ancestor
138275947|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
138275948|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138275949|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
138275950|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
138275951|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138275952|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138275953|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138275954|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275955|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
138275956|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275958|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275959|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
138322276|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138275960|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275961|NCT00005031|Irofulven|irofulven|mesh-list
138275962|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275963|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
138275964|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275965|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275966|NCT00005037|Temozolomide|temozolomide|mesh-list
138275967|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138275968|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
138275969|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275970|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275971|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
138275972|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275973|NCT00004209|Mitomycins|mitomycins|mesh-list
138194969|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275974|NCT00004209|Mitomycin|mitomycin|mesh-list
138275975|NCT00004209|Vinblastine|vinblastine|mesh-list
138275976|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275977|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138275978|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
138275979|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275980|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138275981|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138275982|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138275983|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
138275984|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
138275985|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
138275986|NCT00005049|Carboplatin|carboplatin|mesh-list
138275987|NCT00005049|Floxuridine|floxuridine|mesh-list
138275988|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275989|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275990|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
138275991|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275992|NCT00004215|Cytarabine|cytarabine|mesh-list
138275994|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138275995|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
138275996|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138275997|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138275998|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
138275999|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276000|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276001|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
138276002|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276003|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138229506|NCT01098500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276004|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138276005|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276006|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276007|NCT00004221|Paclitaxel|paclitaxel|mesh-list
138276008|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
138276009|NCT00004221|Carboplatin|carboplatin|mesh-list
138276010|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138276011|NCT00004221|Topotecan|topotecan|mesh-list
138276012|NCT00004221|Lenograstim|lenograstim|mesh-list
138322381|NCT04403568|Curcumin|curcumin|mesh-list
138276013|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138276015|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
138276016|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
138276017|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
138276018|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276019|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276020|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
138276021|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276022|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138276023|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138276024|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
138276025|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138276026|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138276027|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138276028|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276029|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276030|NCT00003711|Irinotecan|irinotecan|mesh-list
138276031|NCT00003711|Pemetrexed|pemetrexed|mesh-list
138276032|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138276033|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276034|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276035|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276036|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276037|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138194989|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
138276038|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138276039|NCT00004227|Cetuximab|cetuximab|mesh-list
138276040|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138276041|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276042|NCT00003621|Etoposide|etoposide|mesh-list
138276043|NCT00003621|Carmustine|carmustine|mesh-list
138276044|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276045|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138276046|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138276047|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276048|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276049|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276050|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138276052|NCT00385359|Albuterol|albuterol|mesh-list
138276053|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138276054|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
138276055|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138276056|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276057|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138276059|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
138276060|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138276061|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138276062|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138276063|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138276064|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
138276065|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138276066|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276067|NCT00004233|Leucovorin|leucovorin|mesh-list
138276068|NCT00004233|Fluorouracil|fluorouracil|mesh-list
138276069|NCT00004233|Calcium|calcium|mesh-list
138276070|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
138276071|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138276072|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276073|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
138276074|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276075|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276076|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276077|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276079|NCT00004233|Antidotes|antidotes|mesh-ancestor
138276081|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
138276082|NCT00004233|Vitamins|vitamins|mesh-ancestor
138276083|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
138276084|NCT00003717|Paclitaxel|paclitaxel|mesh-list
138276085|NCT00003717|Estramustine|estramustine|mesh-list
138276086|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138276087|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276088|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
138276089|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
138276090|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
138276091|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276092|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138276093|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
138276094|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138276095|NCT00003723|Gemcitabine|gemcitabine|mesh-list
138276096|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276097|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
138276098|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276099|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276100|NCT00005061|Bevacizumab|bevacizumab|mesh-list
138276101|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138276102|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276103|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138276105|NCT00005061|Growth Substances|growth substances|mesh-ancestor
138276106|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276109|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
138276110|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138276111|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138276112|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138276113|NCT00004245|Analgesics|analgesics|mesh-ancestor
138276114|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
138276115|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138276116|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276117|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138276118|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138276119|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138276120|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276121|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276122|NCT00004251|Letrozole|letrozole|mesh-list
138276123|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276124|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138276125|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138276126|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276127|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276128|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138276129|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
138276130|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138276131|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276132|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
138276133|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138276134|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
138276135|NCT00003729|Cytarabine|cytarabine|mesh-list
138276136|NCT00003729|Fludarabine|fludarabine|mesh-list
138276137|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
138276138|NCT00003729|Idarubicin|idarubicin|mesh-list
138276139|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276140|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276141|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
138276142|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276143|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276144|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
138276145|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276146|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
138276147|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276148|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138276149|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138276150|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276151|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276152|NCT00004263|Cytarabine|cytarabine|mesh-list
138276153|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138276154|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276155|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
138276156|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276157|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138229583|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138276169|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276170|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276171|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276172|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138276173|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
138276174|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138276175|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276176|NCT00004275|Hormones|hormones|mesh-list
138276177|NCT00004275|Oxandrolone|oxandrolone|mesh-list
138276178|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195010|NCT01472692|Febuxostat|febuxostat|mesh-list
138195011|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
138276179|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276180|NCT00004275|Androgens|androgens|mesh-ancestor
138276181|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
138276182|NCT00003741|Antibodies|antibodies|mesh-list
138276183|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138276184|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
138276185|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276186|NCT00003747|Carboplatin|carboplatin|mesh-list
138276187|NCT00003747|Temozolomide|temozolomide|mesh-list
138276188|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276189|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138276191|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276192|NCT00004311|Leuprolide|leuprolide|mesh-list
138276193|NCT00004311|Spironolactone|spironolactone|mesh-list
138276194|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138276195|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
138276196|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138276197|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276198|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138276199|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276200|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138276201|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
138276202|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138276203|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138276219|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
138276220|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138276221|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138276222|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276223|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138276224|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276225|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276226|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138276227|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
138276229|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138276230|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276231|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276232|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276233|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276234|NCT00004323|Cyclosporine|cyclosporine|mesh-list
138276235|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
138276237|NCT00004323|Methotrexate|methotrexate|mesh-list
138276238|NCT00004323|Cyclosporins|cyclosporins|mesh-list
138276239|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138276240|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276241|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
138276242|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276243|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138276244|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138276245|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
138276246|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276247|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276248|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138276249|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138276250|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
138276251|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138276252|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138195024|NCT01446250|Ribavirin|ribavirin|mesh-list
138195025|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138276253|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
138276255|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276256|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138276257|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138276258|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
138276259|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276260|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138276261|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138276262|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
138276263|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
138276264|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138276265|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138276266|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
138276267|NCT00004323|Hormones|hormones|mesh-ancestor
138276268|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138276269|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138276270|NCT00004323|Protective Agents|protective agents|mesh-ancestor
138276271|NCT00003753|Dexamethasone|dexamethasone|mesh-list
138276272|NCT00003753|Irinotecan|irinotecan|mesh-list
138276274|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138276275|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
138276276|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
138276277|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138276278|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276280|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
138276281|NCT00003753|Hormones|hormones|mesh-ancestor
138276282|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138276283|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138276284|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276285|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138276286|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276287|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276288|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276289|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276290|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
138276291|NCT00003759|Valrubicin|valrubicin|mesh-list
138276292|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
138276293|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138276294|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
138276295|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276296|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276297|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138276298|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276299|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276300|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276301|NCT00003765|Carmustine|carmustine|mesh-list
138276302|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138276303|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138276304|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
138276305|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276306|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276307|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276308|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138276309|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138276310|NCT00003771|Norethindrone|norethindrone|mesh-list
138195042|NCT05493618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195043|NCT05493618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138276311|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
138276312|NCT00003771|Estradiol|estradiol|mesh-list
138276313|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138276314|NCT00003771|Estrogens|estrogens|mesh-ancestor
138276315|NCT00003771|Hormones|hormones|mesh-ancestor
138276316|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138276317|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276318|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138276319|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
138276320|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138276321|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138276322|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138276323|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138276324|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138276325|NCT00004359|Methoxsalen|methoxsalen|mesh-list
138276326|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138276327|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
138276328|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
138276329|NCT00004401|Antibodies|antibodies|mesh-list
138276330|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
138276331|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138276332|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138276333|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
138276334|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276336|NCT00003783|Cytarabine|cytarabine|mesh-list
138276337|NCT00003783|Dexamethasone|dexamethasone|mesh-list
138276338|NCT00003783|Prednisone|prednisone|mesh-list
138276339|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
138276340|NCT00003783|Methotrexate|methotrexate|mesh-list
138276341|NCT00003783|Etoposide|etoposide|mesh-list
138276342|NCT00003783|Vincristine|vincristine|mesh-list
138276343|NCT00003783|Daunorubicin|daunorubicin|mesh-list
138276344|NCT00003783|Asparaginase|asparaginase|mesh-list
138276345|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
138276346|NCT00003783|Idarubicin|idarubicin|mesh-list
138276347|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
138276348|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276349|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
138276350|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276351|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138276352|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138276353|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
138276354|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276355|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276356|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138276357|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138276358|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
138276359|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
138276360|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138276361|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138276362|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
138276363|NCT00003783|Hormones|hormones|mesh-ancestor
138276364|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138276365|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138276366|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138276367|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
138276368|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138276369|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276370|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
138276371|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
138276372|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276373|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138195062|NCT01891526|Alitretinoin|alitretinoin|mesh-list
138276374|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138276375|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138276376|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138276377|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276378|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
138276379|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276380|NCT00003783|Antidotes|antidotes|mesh-ancestor
138276381|NCT00003783|Protective Agents|protective agents|mesh-ancestor
138276382|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
138276383|NCT00003783|Vitamins|vitamins|mesh-ancestor
138276384|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
138276385|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
138276386|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
138276387|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
138276388|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138276389|NCT00003789|Melphalan|melphalan|mesh-list
138276390|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138276391|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
138322833|NCT01679652|Nebivolol|nebivolol|mesh-list
138276392|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276393|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276394|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138276395|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276396|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
138276397|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276399|NCT00004407|Antibodies|antibodies|mesh-list
138276400|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
138276401|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138276402|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138276403|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
138276404|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276405|NCT00004419|Mitogens|mitogens|mesh-list
138276406|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
138276407|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276408|NCT00004431|Baclofen|baclofen|mesh-list
138276409|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138276410|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276411|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138276412|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138276413|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138276414|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
138276415|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
138276416|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138276417|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276418|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
138276419|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138276420|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
138276421|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276422|NCT00384969|Sorafenib|sorafenib|mesh-list
138276423|NCT00384969|Everolimus|everolimus|mesh-list
138276424|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276425|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138276426|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276427|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276428|NCT00384969|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138276429|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276430|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
138276431|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276432|NCT00385437|Mirtazapine|mirtazapine|mesh-list
138276433|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
138276434|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138276435|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138276436|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
138276437|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
138276438|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138276439|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276440|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276442|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138195080|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
138195081|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138195084|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
138276443|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138276444|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138276445|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138276446|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138276447|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
138276448|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138276449|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138276450|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
138276451|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138276452|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
138276454|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
138276455|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276456|NCT00004467|Expectorants|expectorants|mesh-ancestor
138276457|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
138276458|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138276459|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
138276460|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276461|NCT00004467|Protective Agents|protective agents|mesh-ancestor
138276462|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276463|NCT00004467|Antidotes|antidotes|mesh-ancestor
138276464|NCT00004479|Midodrine|midodrine|mesh-list
138276465|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
138229666|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
138276467|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138276468|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276469|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138276470|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138276471|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138276472|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138276473|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
138276474|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138276475|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276476|NCT00004485|Cyclosporine|cyclosporine|mesh-list
138276477|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
138276478|NCT00004485|Fludarabine|fludarabine|mesh-list
138276479|NCT00004485|Cyclosporins|cyclosporins|mesh-list
138276480|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276481|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276482|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276483|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
138276484|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276485|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276486|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
138276487|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276488|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
138276489|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138276490|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138276491|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138276492|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138276494|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138276496|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138276497|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138276498|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276499|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
138276500|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276501|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138276502|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138276503|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
138195086|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276504|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276505|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138276506|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138276507|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
138276508|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276509|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
138276510|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
138276511|NCT00004551|Nicotine|nicotine|mesh-list
138276512|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138276513|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
138276514|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138276515|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276516|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138276517|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138276518|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
138276519|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138276520|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276522|NCT02678312|Enalaprilat|enalaprilat|mesh-list
138276523|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138276524|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138276525|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
138276526|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276527|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276528|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138276529|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138276530|NCT00003843|Irinotecan|irinotecan|mesh-list
138276531|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138276532|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276533|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276534|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276535|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276536|NCT00003849|Rituximab|rituximab|mesh-list
138276537|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138276538|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276539|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
138276540|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276541|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138276542|NCT00004575|Miconazole|miconazole|mesh-list
138276543|NCT00004575|Bradykinin|bradykinin|mesh-list
138276544|NCT00004575|Kininogens|kininogens|mesh-list
138276545|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276546|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276547|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
138276548|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276549|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138276550|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138276551|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138276552|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
138276553|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138276554|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276555|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138276556|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138276557|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
138276558|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138276559|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
138276560|NCT00004581|Ritonavir|ritonavir|mesh-list
138276561|NCT00004581|Lopinavir|lopinavir|mesh-list
138195103|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
138276562|NCT00004581|Nevirapine|nevirapine|mesh-list
138276563|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138276564|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138276565|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
138276566|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276567|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276568|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138276569|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138276570|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
138276571|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276572|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138276573|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138276574|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138276575|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138276576|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138276577|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138276578|NCT00004257|Fluorouracil|fluorouracil|mesh-list
138276579|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
138276580|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
138276581|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276582|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276583|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276584|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276585|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
138276586|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276587|NCT00004647|Mexiletine|mexiletine|mesh-list
138276588|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138276589|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138276590|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138276591|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138276592|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276593|NCT02469116|Carboplatin|carboplatin|mesh-list
138276594|NCT02469116|Docetaxel|docetaxel|mesh-list
138276595|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276596|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
138276597|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
138276598|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
138276599|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276600|NCT00362960|Losartan|losartan|mesh-list
138276601|NCT00362960|Olmesartan|olmesartan|mesh-list
138276602|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138276603|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138276604|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138276605|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138276606|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138276607|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276608|NCT00003867|Capecitabine|capecitabine|mesh-list
138276609|NCT00003867|Irinotecan|irinotecan|mesh-list
138276610|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276611|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
138276612|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276613|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276614|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138276615|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276616|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276617|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138276618|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138276619|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
138276620|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276621|NCT00363584|Capecitabine|capecitabine|mesh-list
138195118|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
138195119|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
138195122|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
138276622|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276623|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
138276624|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276625|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276626|NCT00003873|Fluorouracil|fluorouracil|mesh-list
138276627|NCT00003873|Eniluracil|eniluracil|mesh-list
138276628|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
138276629|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276630|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276631|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276632|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276633|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
138276634|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276635|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276636|NCT00363116|Daclizumab|daclizumab|mesh-list
138276637|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276638|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
138276639|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276640|NCT00004689|Clarithromycin|clarithromycin|mesh-list
138276641|NCT00004689|Rifampin|rifampin|mesh-list
138276642|NCT00004689|Ethambutol|ethambutol|mesh-list
138276643|NCT00004689|Streptomycin|streptomycin|mesh-list
138276644|NCT00004689|Thioacetazone|thioacetazone|mesh-list
138276645|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138276646|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382010|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
138276647|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138276648|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276649|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276650|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138276651|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138276652|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138276653|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
138276654|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
138276655|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138276656|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138276657|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138322938|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138276658|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138276659|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138276660|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138276661|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138276663|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276664|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138276665|NCT00004695|Analgesics|analgesics|mesh-ancestor
138276666|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
138276667|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138276668|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276669|NCT02570984|Omalizumab|omalizumab|mesh-list
138276670|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138276671|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138276672|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
138276673|NCT00004731|Ubiquinone|ubiquinone|mesh-list
138276674|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
138276675|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
138276676|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276677|NCT00004731|Vitamins|vitamins|mesh-ancestor
138276678|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
138276679|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276680|NCT00003891|Lurtotecan|lurtotecan|mesh-list
138195130|NCT05599828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138276681|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276682|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138276684|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
138276685|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276686|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276687|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
138276688|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138276689|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138276690|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
138276691|NCT00004755|Protective Agents|protective agents|mesh-ancestor
138276692|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276693|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138276694|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138276695|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276696|NCT00003897|Sargramostim|sargramostim|mesh-list
138276697|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
138276698|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276699|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
138276700|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276701|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138276702|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
138276703|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
138276704|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138276705|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
138276706|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276707|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276708|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
138276709|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276710|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
138276711|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276713|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
138276714|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138276715|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138276716|NCT00004785|Prednisolone|prednisolone|mesh-list
138276717|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
138276718|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138276719|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
138276720|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138276721|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
138276722|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
138276723|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138276724|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276725|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138276726|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
138276727|NCT00004785|Hormones|hormones|mesh-ancestor
138276728|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138276729|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138276730|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276731|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138276732|NCT00004785|Protective Agents|protective agents|mesh-ancestor
138276733|NCT00004815|Hormones|hormones|mesh-list
138276734|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138276735|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276736|NCT02279823|Minoxidil|minoxidil|mesh-list
138276737|NCT02279823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138276738|NCT02279823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138276739|NCT02279823|Vasodilator Agents|vasodilator agents|mesh-ancestor
138276740|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
138276741|NCT04040361|Ramucirumab|ramucirumab|mesh-list
138276742|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138276743|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276744|NCT04040361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138276745|NCT04040361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276746|NCT00386061|Rimonabant|rimonabant|mesh-list
138276747|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138276748|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138276749|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138276750|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195144|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
138195145|NCT01350232|Rituximab|rituximab|mesh-list
138276751|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276752|NCT00386061|Hormones|hormones|mesh-ancestor
138276753|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138365233|NCT01390896|PENTA|penta|mesh-list
138276754|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276756|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138276757|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276758|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
138276759|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276760|NCT00005577|Gemcitabine|gemcitabine|mesh-list
138276761|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276762|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
138276763|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276764|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276765|NCT00005583|Doxorubicin|doxorubicin|mesh-list
138322990|NCT03085368|Lapatinib|lapatinib|mesh-list
138276766|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138276767|NCT00005583|Epirubicin|epirubicin|mesh-list
138276768|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276769|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138276770|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138276771|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276772|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276773|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276774|NCT00005589|Cytarabine|cytarabine|mesh-list
138276775|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
138276776|NCT00005589|Melphalan|melphalan|mesh-list
138276777|NCT00005589|Carmustine|carmustine|mesh-list
138276778|NCT00005589|Rituximab|rituximab|mesh-list
138276779|NCT00005589|Etoposide|etoposide|mesh-list
138276780|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276781|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
138276782|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276783|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138276784|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138382105|NCT01461018|Antibodies|antibodies|mesh-list
138276785|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
138276786|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276787|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276788|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138276789|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138276790|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138276791|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138276792|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276793|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276794|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276796|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
138276797|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276798|NCT00005601|Cytarabine|cytarabine|mesh-list
138276799|NCT00005601|Dexamethasone|dexamethasone|mesh-list
138276800|NCT00005601|Rituximab|rituximab|mesh-list
138276801|NCT00005601|Sargramostim|sargramostim|mesh-list
138276802|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138276803|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
138276804|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
138195154|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195155|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276805|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138276806|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276807|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138276808|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
138276809|NCT00005601|Hormones|hormones|mesh-ancestor
138276810|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138276811|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138276812|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276813|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138276814|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
138276815|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138276816|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276817|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
138276818|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276819|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
138322998|NCT05687760|Calcium|calcium|mesh-list
138276820|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276821|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276823|NCT00005607|Fluorouracil|fluorouracil|mesh-list
138276824|NCT00005607|Irinotecan|irinotecan|mesh-list
138276825|NCT00005607|Calcium|calcium|mesh-list
138276826|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
138276827|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138276828|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276830|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276831|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276832|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276833|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276834|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
138276835|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138276836|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276837|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276838|NCT00005607|Antidotes|antidotes|mesh-ancestor
138276839|NCT00005607|Protective Agents|protective agents|mesh-ancestor
138276840|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
138276841|NCT00005607|Vitamins|vitamins|mesh-ancestor
138276842|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
138276843|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
138276844|NCT00005613|Carmustine|carmustine|mesh-list
138276845|NCT00005613|Etoposide|etoposide|mesh-list
138276846|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276847|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
138276848|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276849|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138276850|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138276851|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
138276852|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276853|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276854|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138276855|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138276856|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138276857|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276858|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276859|NCT00005625|Trabectedin|trabectedin|mesh-list
138195173|NCT05493228|Adrenergic Agents|adrenergic agents|mesh-ancestor
138195174|NCT05493228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195175|NCT05493228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195176|NCT02758132|Denosumab|denosumab|mesh-list
138276860|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138276861|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
138276862|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276863|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276864|NCT00005631|Rituximab|rituximab|mesh-list
138276865|NCT00005631|Carboplatin|carboplatin|mesh-list
138276866|NCT00005631|Etoposide|etoposide|mesh-list
138276867|NCT00005631|Ifosfamide|ifosfamide|mesh-list
138276868|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138276869|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276870|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
138276871|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276872|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138276873|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138276874|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138276875|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276876|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276877|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276878|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138276879|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
138276881|NCT00005637|Carmustine|carmustine|mesh-list
138276882|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138276883|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
138276884|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276885|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138323020|NCT05345574|Analgesics|analgesics|mesh-ancestor
138276890|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138276892|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276893|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276894|NCT00005649|Paclitaxel|paclitaxel|mesh-list
138276895|NCT00005649|Capecitabine|capecitabine|mesh-list
138276896|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138276897|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276898|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
138276899|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
138276900|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
138276901|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276902|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276903|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
138276904|NCT00005673|Capravirine|capravirine|mesh-list
138276906|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138276907|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276908|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276909|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
138276910|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276911|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138276912|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138276914|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138323025|NCT05345574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138276915|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276916|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138276917|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276918|NCT03390673|Bevacizumab|bevacizumab|mesh-list
138276919|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138276920|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276921|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138276922|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138276923|NCT03390673|Growth Substances|growth substances|mesh-ancestor
138195190|NCT01313416|Gemcitabine|gemcitabine|mesh-list
138195191|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138195194|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276924|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276925|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
138276926|NCT02974933|Pemetrexed|pemetrexed|mesh-list
138276927|NCT02974933|Apatinib|apatinib|mesh-list
138276928|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276929|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276930|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276931|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138382182|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
138276932|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138276933|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138276935|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138276936|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276937|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
138276938|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138276939|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138276940|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
138276941|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
138276942|NCT00005787|Sargramostim|sargramostim|mesh-list
138276943|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138276944|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
138276945|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276947|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138276948|NCT00005787|Protective Agents|protective agents|mesh-ancestor
138276949|NCT00005793|Cytarabine|cytarabine|mesh-list
138276950|NCT00005793|Etoposide|etoposide|mesh-list
138276951|NCT00005793|Daunorubicin|daunorubicin|mesh-list
138276952|NCT00005793|Topotecan|topotecan|mesh-list
138276953|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138276954|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276955|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138276956|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276957|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276958|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276959|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276960|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
138276961|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
138323076|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
138276962|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276963|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276964|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
138276965|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276966|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138382212|NCT01462500|Miltefosine|miltefosine|mesh-list
138276968|NCT00005799|Cyclosporine|cyclosporine|mesh-list
138276969|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
138276970|NCT00005799|Fludarabine|fludarabine|mesh-list
138276971|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
138276972|NCT00005799|Cyclosporins|cyclosporins|mesh-list
138276973|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276974|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138276975|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
138276976|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276977|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138276978|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
138276979|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138276980|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276981|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
138276982|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138276983|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
138276984|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138276985|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138276986|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138276987|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138276988|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
138276989|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138276990|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
138195206|NCT05499234|Sensory System Agents|sensory system agents|mesh-ancestor
138195211|NCT05499234|Narcotics|narcotics|mesh-ancestor
138276991|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138276992|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138276993|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276994|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138276995|NCT00005811|Topotecan|topotecan|mesh-list
138276996|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138276997|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138276998|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138276999|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277000|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277001|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
138277002|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138277003|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277004|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138277005|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277006|NCT01689987|Sirolimus|sirolimus|mesh-list
138277007|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
138277008|NCT01689987|Dexamethasone|dexamethasone|mesh-list
138277009|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
138277012|NCT01689987|BB 1101|bb 1101|mesh-list
138277013|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138323096|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
138277014|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
138277015|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277016|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138277017|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138277018|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
138277019|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277020|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277021|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138277022|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138277023|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
138277024|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
138277025|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277026|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138277027|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
138277028|NCT01689987|Hormones|hormones|mesh-ancestor
138277029|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138277030|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138277031|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138277032|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277033|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138277034|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
138277035|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277036|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
138277037|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138277038|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138277039|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
138277040|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
138277041|NCT01680939|Ibuprofen|ibuprofen|mesh-list
138277042|NCT01680939|Morphine|morphine|mesh-list
138277043|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138277044|NCT01680939|Narcotics|narcotics|mesh-ancestor
138195216|NCT01269034|Exenatide|exenatide|mesh-list
138195217|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
138277045|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277046|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277047|NCT01680939|Analgesics|analgesics|mesh-ancestor
138277048|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
138277049|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277050|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138277051|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138277052|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138277053|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138277054|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138277055|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277056|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277057|NCT01689597|Morphine|morphine|mesh-list
138277058|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138277059|NCT01689597|Narcotics|narcotics|mesh-ancestor
138277060|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277061|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277062|NCT01689597|Analgesics|analgesics|mesh-ancestor
138277063|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
138382280|NCT01463280|Lidocaine|lidocaine|mesh-list
138277064|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277066|NCT02483000|Cytarabine|cytarabine|mesh-list
138277067|NCT02483000|Etoposide|etoposide|mesh-list
138277068|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
138277069|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
138277070|NCT02483000|Melphalan|melphalan|mesh-list
138277071|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
138277072|NCT02483000|Carmustine|carmustine|mesh-list
138277073|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138277074|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138277075|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138277076|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277077|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138277078|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138277079|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277080|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277081|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138277082|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
138277083|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
138277084|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277085|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138277086|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
138277087|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277088|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138277089|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
138277090|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138277091|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
138277092|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
138277093|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
138277094|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
138277095|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
138277096|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
138277097|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
138277098|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
138277100|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
138277101|NCT02420210|Dexamethasone|dexamethasone|mesh-list
138277102|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138277103|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
138277104|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138277105|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
138277106|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
138277107|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277108|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277109|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138277110|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
138277111|NCT02420210|Hormones|hormones|mesh-ancestor
138195240|NCT05599126|GABA Agents|gaba agents|mesh-ancestor
138195241|NCT05599126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277112|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138277113|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138277115|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138277117|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277118|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138277119|NCT04829799|Ketorolac|ketorolac|mesh-list
138277120|NCT04829799|Lidocaine|lidocaine|mesh-list
138277121|NCT04829799|Phenylephrine|phenylephrine|mesh-list
138277122|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
138277123|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
138277124|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
138277125|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277126|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277127|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
138277128|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277129|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138277130|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138277131|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138277132|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138277133|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277134|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138277135|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138277137|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138277138|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138277139|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138277140|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277141|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138277142|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
138277143|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
138277144|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
138277145|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138277146|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
138277147|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
138277148|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138277149|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138277150|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138277151|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
138277152|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277153|NCT04829799|Protective Agents|protective agents|mesh-ancestor
138277154|NCT01789333|Riboflavin|riboflavin|mesh-list
138277155|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138277156|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138277157|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
138277158|NCT01789333|Vitamins|vitamins|mesh-ancestor
138277159|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
138323160|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138277160|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277162|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
138277163|NCT02524106|Bococizumab|bococizumab|mesh-list
138277164|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138277165|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138277166|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
138277167|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277168|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138277169|NCT01761877|Sulindac|sulindac|mesh-list
138277170|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138277171|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138277172|NCT01761877|Analgesics|analgesics|mesh-ancestor
138277173|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
138277174|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277175|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277176|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138277177|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138277178|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277179|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138195249|NCT05599126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138277180|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277181|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277182|NCT02488070|Edetic Acid|edetic acid|mesh-list
138277183|NCT02488070|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138277184|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
138277185|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
138277186|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277187|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
138277188|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138277189|NCT02488070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138277190|NCT00362869|Levofloxacin|levofloxacin|mesh-list
138277191|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138277192|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277193|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138277194|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138277195|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138277197|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277198|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277199|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138277200|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138277201|NCT03257215|Vitamin D|vitamin d|mesh-list
138277202|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
138277203|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
138277204|NCT03257215|Vitamins|vitamins|mesh-list
138277205|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
138277206|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277207|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138277208|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138277209|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
138277210|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138277211|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138277212|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277213|NCT00588523|Temozolomide|temozolomide|mesh-list
138277214|NCT00588523|Busulfan|busulfan|mesh-list
138277215|NCT00588523|Thiotepa|thiotepa|mesh-list
138277216|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138277217|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
138277218|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277219|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277220|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138277221|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
138277222|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277223|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138277224|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138277225|NCT02974387|Fluorometholone|fluorometholone|mesh-list
138277226|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138277227|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138195257|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
138277228|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
138277229|NCT02974387|Hormones|hormones|mesh-ancestor
138277230|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138195258|NCT02663752|Deferasirox|deferasirox|mesh-list
138195259|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138277231|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277232|NCT00430183|Docetaxel|docetaxel|mesh-list
138277233|NCT00430183|Leuprolide|leuprolide|mesh-list
138277234|NCT00430183|Goserelin|goserelin|mesh-list
138277235|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277236|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
138277237|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
138277238|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
138277239|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277240|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138277241|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
138277242|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138277243|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277244|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138277245|NCT00362947|Parnaparin|parnaparin|mesh-list
138277246|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
138277247|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138277248|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138277249|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277250|NCT00363025|Daunorubicin|daunorubicin|mesh-list
138277251|NCT00363025|Idarubicin|idarubicin|mesh-list
138277252|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138277253|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277254|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138277255|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138277256|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277257|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277258|NCT02444143|Tacrolimus|tacrolimus|mesh-list
138277259|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138277260|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
138277261|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277262|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138277263|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277264|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277265|NCT02445859|Cefuroxime|cefuroxime|mesh-list
138277266|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
138277267|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138277268|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277269|NCT02446483|Rabeprazole|rabeprazole|mesh-list
138277270|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138277271|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138277272|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138277273|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277274|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277275|NCT00362635|Clevudine|clevudine|mesh-list
138277276|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
138277277|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277278|NCT04744753|Calcimycin|calcimycin|mesh-list
138277279|NCT04744753|Calcium|calcium|mesh-list
138277280|NCT04744753|Ionophores|ionophores|mesh-list
138277281|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
138277282|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138277283|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277284|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138277285|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382361|NCT01463956|Ribavirin|ribavirin|mesh-list
138277286|NCT04744753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138277287|NCT04744753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277289|NCT02420041|Lidocaine|lidocaine|mesh-list
138277290|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
138195282|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277291|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
138277292|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195286|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
138277293|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277294|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
138277295|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277296|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138277297|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138277298|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138277299|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138277300|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277301|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138277302|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
138277303|NCT02420041|Hormones|hormones|mesh-ancestor
138277304|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138277305|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
138277306|NCT02421211|Ledipasvir|ledipasvir|mesh-list
138277307|NCT02421211|Simeprevir|simeprevir|mesh-list
138277308|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
138277309|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277310|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
138277311|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277312|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277313|NCT00363259|Ribavirin|ribavirin|mesh-list
138277314|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138277315|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
138277316|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277317|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
138277318|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277319|NCT02424968|Cyclosporine|cyclosporine|mesh-list
138277320|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
138277321|NCT02424968|Cyclosporins|cyclosporins|mesh-list
138277322|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
138277323|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138277324|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277325|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277326|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138277327|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
138277328|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277329|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
138277330|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277331|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
138277332|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138277333|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138277334|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138277335|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277336|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138277337|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
138277338|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138277340|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138277341|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277342|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277343|NCT02492750|Dexamethasone|dexamethasone|mesh-list
138277344|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
138277345|NCT02492750|Lenalidomide|lenalidomide|mesh-list
138277346|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138277347|NCT02492750|Ichthammol|ichthammol|mesh-list
138277348|NCT02492750|BB 1101|bb 1101|mesh-list
138277349|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138277350|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
138277351|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
138277352|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277353|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277354|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138277355|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
138277356|NCT02492750|Hormones|hormones|mesh-ancestor
138277357|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138277358|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138277359|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277360|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
138195296|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138277361|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138277362|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138277363|NCT02492750|Growth Substances|growth substances|mesh-ancestor
138277364|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
138277365|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
138277366|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277367|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277368|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138277369|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
138277370|NCT00363337|Aripiprazole|aripiprazole|mesh-list
138277371|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
138277372|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138277373|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138277374|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138277375|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277376|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277377|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
138277378|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
138277379|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277380|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277381|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138277382|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138277383|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
138277384|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138277385|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138277386|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138277387|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138277388|NCT02493452|Plecanatide|plecanatide|mesh-list
138323252|NCT04685538|Tetracaine|tetracaine|mesh-list
138277389|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138277390|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
138277391|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277392|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138277393|NCT02429869|Everolimus|everolimus|mesh-list
138277394|NCT02429869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138277395|NCT02429869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138277396|NCT02429869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277397|NCT02429869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277398|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138277399|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
138277400|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277401|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277402|NCT02428478|Desipramine|desipramine|mesh-list
138277403|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138277404|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
138277405|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138277406|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277407|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277408|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138277409|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138277410|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138277411|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
138277412|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277413|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277414|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
138277415|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
138277416|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
138277417|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138277418|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138277419|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277420|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277421|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277422|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138277423|NCT02432287|Metformin|metformin|mesh-list
138277424|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138277425|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195302|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
138277426|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
138277427|NCT02532998|Eplerenone|eplerenone|mesh-list
138277428|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138277429|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
138277430|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138277431|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277432|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138277433|NCT02532998|Diuretics|diuretics|mesh-ancestor
138277434|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
138277435|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138277436|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138277437|NCT02453581|Artefenomel|artefenomel|mesh-list
138277438|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
138277439|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138323270|NCT03249558|Narcotics|narcotics|mesh-ancestor
138277441|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277442|NCT02533466|Listerine|listerine|mesh-list
138277443|NCT02533466|Fluorides|fluorides|mesh-list
138277444|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
138277445|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
138277446|NCT02533466|Protective Agents|protective agents|mesh-ancestor
138277447|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277448|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138277449|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277450|NCT02974244|Exenatide|exenatide|mesh-list
138277451|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138277452|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277453|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138277454|NCT02974244|Incretins|incretins|mesh-ancestor
138277455|NCT02974244|Hormones|hormones|mesh-ancestor
138277456|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138277457|NCT02436031|Desipramine|desipramine|mesh-list
138277458|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138277459|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
138277460|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138277461|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277462|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277463|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138277464|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138277465|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138277466|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
138277467|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277468|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277469|NCT02454283|Vanoxerine|vanoxerine|mesh-list
138277470|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138277471|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138323291|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138277473|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277475|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277476|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277477|NCT02437669|Hydromorphone|hydromorphone|mesh-list
138277478|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138277479|NCT02437669|Narcotics|narcotics|mesh-ancestor
138277480|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277481|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277482|NCT02437669|Analgesics|analgesics|mesh-ancestor
138277483|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
138277484|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277485|NCT02430818|Ketamine|ketamine|mesh-list
138277486|NCT02430818|Morphine|morphine|mesh-list
138277487|NCT02430818|Analgesics|analgesics|mesh-ancestor
138277488|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
138277489|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277490|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277491|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138277492|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138277493|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
138277494|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
138195310|NCT05488860|Triamcinolone|triamcinolone|mesh-list
138195311|NCT05488860|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138195312|NCT05488860|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138382458|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138277495|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277496|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138277497|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138277498|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277499|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277500|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138277501|NCT02430818|Narcotics|narcotics|mesh-ancestor
138277502|NCT02455453|Estradiol|estradiol|mesh-list
138277503|NCT02455453|Estrogens|estrogens|mesh-ancestor
138277504|NCT02455453|Hormones|hormones|mesh-ancestor
138277505|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138277506|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138323339|NCT05158062|Paclitaxel|paclitaxel|mesh-list
138277507|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138277508|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
138277509|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277511|NCT02519023|Ibuprofen|ibuprofen|mesh-list
138277512|NCT02519023|Epinephrine|epinephrine|mesh-list
138277513|NCT02519023|Oxycodone|oxycodone|mesh-list
138277514|NCT02519023|Bupivacaine|bupivacaine|mesh-list
138277515|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
138277516|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
138277517|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277518|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277519|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
138277520|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277521|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138277522|NCT02519023|Analgesics|analgesics|mesh-ancestor
138277523|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
138277524|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138277525|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138277526|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138277527|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138277528|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277529|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277530|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138277531|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138277532|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
138277533|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277534|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138277535|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138277536|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
138277537|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138277538|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
138277539|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
138277540|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
138277541|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138277542|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138277543|NCT02519023|Narcotics|narcotics|mesh-ancestor
138277544|NCT02497040|Bupivacaine|bupivacaine|mesh-list
138277545|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
138277546|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
138277547|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
138277548|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138382469|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138277549|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277550|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
138277551|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277553|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
138277554|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
138277555|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277556|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277557|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
138277558|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277559|NCT02498522|Metformin|metformin|mesh-list
138277561|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277562|NCT02919787|Irinotecan|irinotecan|mesh-list
138277564|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
138195317|NCT05488860|Glucocorticoids|glucocorticoids|mesh-ancestor
138277565|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138277566|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138277567|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323375|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277568|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277569|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277570|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
138277571|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138277572|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138277573|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
138277574|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277575|NCT02459275|Metoclopramide|metoclopramide|mesh-list
138277576|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
138277577|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
138277578|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277579|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277580|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138277581|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138277582|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138277583|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
138277584|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277585|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277586|NCT02524561|Estradiol|estradiol|mesh-list
138277587|NCT02524561|Progesterone|progesterone|mesh-list
138277588|NCT02524561|Estrogens|estrogens|mesh-ancestor
138277589|NCT02524561|Hormones|hormones|mesh-ancestor
138277590|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138277591|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277592|NCT02524561|Progestins|progestins|mesh-ancestor
138277593|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
138277594|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
138277595|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
138229708|NCT03013634|Analgesics|analgesics|mesh-ancestor
138277596|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277597|NCT04743739|Cyclosporine|cyclosporine|mesh-list
138277598|NCT04743739|Rituximab|rituximab|mesh-list
138277599|NCT04743739|Cyclosporins|cyclosporins|mesh-list
138277600|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138277601|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277602|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
138277603|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277604|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138277605|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277606|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277607|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138277608|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
138277609|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277610|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
138277611|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138277613|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138277614|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277615|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138277616|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277617|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277618|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138195324|NCT05488860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277619|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138277620|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
138277621|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277622|NCT02525653|Paclitaxel|paclitaxel|mesh-list
138277623|NCT02525653|Gemcitabine|gemcitabine|mesh-list
138277624|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138277625|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138277626|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277627|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
138277628|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
138277629|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
138277630|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277631|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138277632|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
138277633|NCT02431754|Tadalafil|tadalafil|mesh-list
138277634|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
138277635|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138277636|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138277637|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277638|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277639|NCT02431754|Urological Agents|urological agents|mesh-ancestor
138277640|NCT02500628|Metformin|metformin|mesh-list
138277641|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138277642|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277643|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
138277644|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138277645|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138323421|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277646|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277647|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
138277648|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
138277650|NCT02535806|Dexamethasone|dexamethasone|mesh-list
138277651|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
138277652|NCT02535806|Methotrexate|methotrexate|mesh-list
138277653|NCT02535806|Vincristine|vincristine|mesh-list
138277654|NCT02535806|Bortezomib|bortezomib|mesh-list
138277655|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
138277656|NCT02535806|Pegaspargase|pegaspargase|mesh-list
138277657|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138277658|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
138277659|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
138277660|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277661|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277662|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138277663|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
138277665|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138277666|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138229736|NCT03013322|Miotics|miotics|mesh-ancestor
138277667|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277668|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138277669|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
138277670|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138277671|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138277672|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
138277673|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277674|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
138277675|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277676|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138277677|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138195344|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
138277678|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
138277679|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138277680|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138277681|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
138277682|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277683|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138277684|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
138277685|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
138277686|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
138277687|NCT02535806|Analgesics|analgesics|mesh-ancestor
138277688|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
138277689|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138277690|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138277691|NCT02536040|Fluorides|fluorides|mesh-list
138277692|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
138277693|NCT02536040|Protective Agents|protective agents|mesh-ancestor
138277695|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
138277696|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
138277697|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138277698|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277699|NCT02537444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138277700|NCT02537444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277701|NCT02464033|Vitamin D|vitamin d|mesh-list
138277702|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
138277703|NCT02464033|Etanercept|etanercept|mesh-list
138277704|NCT02464033|Vitamins|vitamins|mesh-ancestor
138277705|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
138277706|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277707|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138277708|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138277709|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138277710|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138277711|NCT02464033|Analgesics|analgesics|mesh-ancestor
138277712|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
138277713|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277714|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138277715|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138277716|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138277717|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138277718|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
138277720|NCT02432456|Ibuprofen|ibuprofen|mesh-list
138277721|NCT02432456|Ketamine|ketamine|mesh-list
138277722|NCT02432456|Narcotics|narcotics|mesh-list
138277723|NCT02432456|Methocarbamol|methocarbamol|mesh-list
138277724|NCT02432456|Pantoprazole|pantoprazole|mesh-list
138277725|NCT02432456|Analgesics|analgesics|mesh-ancestor
138277726|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
138277727|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277728|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277729|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138277730|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138277731|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
138277732|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
138277733|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277734|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138277735|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138277736|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277737|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277738|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138277739|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
138277740|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138277741|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138277742|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138277743|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138277744|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277745|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138277746|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138277747|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138277748|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138195360|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138277749|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138277750|NCT02531971|Fentanyl|fentanyl|mesh-list
138277751|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138277753|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277754|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277755|NCT02531971|Analgesics|analgesics|mesh-ancestor
138277756|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
138277757|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277758|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138277759|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138277760|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
138277762|NCT02464657|Cytarabine|cytarabine|mesh-list
138277763|NCT02464657|Dexamethasone|dexamethasone|mesh-list
138277764|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
138277765|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138277766|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138277767|NCT02464657|Prednisolone|prednisolone|mesh-list
138277768|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
138277769|NCT02464657|Nivolumab|nivolumab|mesh-list
138277770|NCT02464657|Idarubicin|idarubicin|mesh-list
138277771|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138277772|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
138277773|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138277774|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
138277775|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
138277776|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277777|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277778|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138277779|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
138277780|NCT02464657|Hormones|hormones|mesh-ancestor
138277781|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138277782|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138277783|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277784|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138323666|NCT00637572|Megestrol|megestrol|mesh-list
138277785|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138277786|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277787|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138277789|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
138277790|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277791|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138277792|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
138277793|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138277794|NCT02464657|Protective Agents|protective agents|mesh-ancestor
138277795|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138277796|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138277797|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138277798|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277799|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
138277800|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138277801|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138277802|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277803|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
138277804|NCT02535949|Coagulants|coagulants|mesh-ancestor
138277805|NCT02536105|Methylphenidate|methylphenidate|mesh-list
138277806|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138277807|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277808|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138277809|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138277810|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138277811|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138229746|NCT02183792|Furosemide|furosemide|mesh-list
138277812|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
138277813|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277814|NCT02758951|Bevacizumab|bevacizumab|mesh-list
138277815|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138277816|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277817|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138323712|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
138277818|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138277819|NCT02758951|Growth Substances|growth substances|mesh-ancestor
138277820|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277821|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
138277823|NCT02436668|Gemcitabine|gemcitabine|mesh-list
138277824|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138277825|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277826|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
138277827|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
138277828|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
138277829|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277830|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138277831|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
138277832|NCT02503982|Valganciclovir|valganciclovir|mesh-list
138195382|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
138277833|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
138277834|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277835|NCT02438540|Metformin|metformin|mesh-list
138277836|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138277837|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277838|NCT02506634|Esomeprazole|esomeprazole|mesh-list
138277839|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138277840|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138277841|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138277842|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277843|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277844|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
138277845|NCT02506868|Hematinics|hematinics|mesh-ancestor
138277846|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
138277847|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138277848|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
138277849|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277850|NCT02541422|Expectorants|expectorants|mesh-ancestor
138277851|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
138277852|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138277853|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
138277854|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277855|NCT02541422|Protective Agents|protective agents|mesh-ancestor
138382620|NCT01467401|Insulin|insulin|mesh-list
138277856|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277858|NCT02439164|Midazolam|midazolam|mesh-list
138277859|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138277860|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138277861|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277862|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277863|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138277864|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138277865|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138277866|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138277867|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
138277868|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
138277869|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
138277870|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
138277871|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277872|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277873|NCT02440178|Micafungin|micafungin|mesh-list
138277874|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
138277875|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277876|NCT05078606|Anesthetics|anesthetics|mesh-list
138277877|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277878|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277879|NCT02546570|Oxytocin|oxytocin|mesh-list
138277880|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
138277881|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138277882|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277883|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
138277884|NCT02548910|Citric Acid|citric acid|mesh-list
138277885|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
138277886|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138277887|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
138277888|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
138277889|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277891|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138277892|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138277893|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277894|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
138277895|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
138277896|NCT02538679|Epinephrine|epinephrine|mesh-list
138277897|NCT02538679|Racepinephrine|racepinephrine|mesh-list
138195451|NCT01194856|Ritonavir|ritonavir|mesh-list
138277898|NCT02538679|Bupivacaine|bupivacaine|mesh-list
138277899|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
138277900|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
138277902|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277903|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277904|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
138277905|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277906|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138277907|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138277908|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
138277909|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277910|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277911|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138277912|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138277913|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
138277914|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138277915|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
138277916|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
138277917|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
138277918|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138277919|NCT02511236|Nicotine|nicotine|mesh-list
138277920|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138277921|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
138277922|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138277923|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277924|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138277925|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138323890|NCT00633360|Diuretics|diuretics|mesh-ancestor
138277926|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
138277927|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277928|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277929|NCT02551094|Colchicine|colchicine|mesh-list
138277930|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
138277931|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138277932|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
138277933|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
138277934|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
138277935|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277936|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277938|NCT02513498|Glycine|glycine|mesh-list
138277939|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277940|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277941|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
138277942|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138277943|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
138277944|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277945|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277946|NCT04787354|Capecitabine|capecitabine|mesh-list
138277947|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
138277948|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138277949|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
138277950|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277951|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138277953|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
138277954|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138277955|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277956|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138277957|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138277958|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138277959|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277960|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
138195453|NCT01194856|Efavirenz|efavirenz|mesh-list
138277961|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277962|NCT02555228|Simethicone|simethicone|mesh-list
138277963|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
138277964|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277965|NCT02555228|Emollients|emollients|mesh-ancestor
138277966|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
138277967|NCT02556788|Trifarotene|trifarotene|mesh-list
138277968|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
138277969|NCT02516150|Ethanol|ethanol|mesh-list
138277970|NCT02516150|Glucagon|glucagon|mesh-list
138277971|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138277972|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277973|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138277974|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277975|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138277976|NCT02516150|Hormones|hormones|mesh-ancestor
138277977|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138277978|NCT04025060|Caffeine|caffeine|mesh-list
138277979|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138277980|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138277981|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138277982|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138323989|NCT00630552|Conatumumab|conatumumab|mesh-list
138277983|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138277984|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138277985|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138277986|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
138382692|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
138277987|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138277989|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
138277990|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138277991|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
138277992|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138277993|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138277994|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
138277995|NCT04186286|Propranolol|propranolol|mesh-list
138277996|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138277997|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138277998|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
138277999|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278000|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278001|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278002|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138278003|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138278004|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
138278005|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
138278006|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138278007|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138278008|NCT04341038|Prednisolone|prednisolone|mesh-list
138278009|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
138278011|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138278012|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
138278013|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138278014|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
138278015|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278016|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138278017|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278018|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278019|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138278020|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
138278021|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
138278022|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278023|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138278024|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
138278025|NCT04341038|Hormones|hormones|mesh-ancestor
138278026|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138278028|NCT04341038|Protective Agents|protective agents|mesh-ancestor
138278029|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138278030|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278031|NCT02561702|Mexiletine|mexiletine|mesh-list
138278032|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138278033|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138278034|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138278035|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138278036|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278037|NCT02563496|Chloroquine|chloroquine|mesh-list
138278038|NCT02563496|Tafenoquine|tafenoquine|mesh-list
138278039|NCT02563496|Amebicides|amebicides|mesh-ancestor
138278040|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138278041|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138278042|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278043|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
138278044|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138278045|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138278046|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
138278047|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278049|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138278050|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138278051|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138278052|NCT02568644|Analgesics|analgesics|mesh-ancestor
138278053|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
138278054|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278055|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278056|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138278057|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138278058|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278059|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278060|NCT02541409|Interferons|interferons|mesh-list
138278061|NCT02541409|Ribavirin|ribavirin|mesh-list
138278062|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
138278063|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
138278064|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138278065|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
138278066|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278067|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
138278068|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278069|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
138278070|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278071|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
138278072|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278073|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
138278074|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138278075|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138278076|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278077|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
138278078|NCT02569658|Coagulants|coagulants|mesh-ancestor
138278079|NCT02541565|Prednisone|prednisone|mesh-list
138278080|NCT02541565|Cortisone|cortisone|mesh-list
138278081|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
138278082|NCT02541565|Rituximab|rituximab|mesh-list
138278083|NCT02541565|Doxorubicin|doxorubicin|mesh-list
138278084|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138278085|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
138278086|NCT02541565|Vincristine|vincristine|mesh-list
138278087|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138278088|NCT02541565|Antibodies|antibodies|mesh-list
138278089|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
138278090|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138278091|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138278093|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278094|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138278095|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138278096|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
138278097|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278098|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278099|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138278100|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138278101|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138278102|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138278103|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278104|NCT02541565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138278105|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138278106|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
138278107|NCT02541565|Hormones|hormones|mesh-ancestor
138278108|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138278109|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138278110|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138278111|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
138278112|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
138278113|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
138278114|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
138278115|NCT04707950|Oxytocin|oxytocin|mesh-list
138278116|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
138278117|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138278118|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278119|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138278120|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138278121|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278122|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
138278123|NCT04707950|Coagulants|coagulants|mesh-ancestor
138278124|NCT04044560|Blinatumomab|blinatumomab|mesh-list
138278125|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278126|NCT03256916|Nelfinavir|nelfinavir|mesh-list
138278127|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138278128|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138278129|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
138278130|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278131|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278132|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138278133|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138324092|NCT01926132|Vitamins|vitamins|mesh-ancestor
138278135|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278136|NCT02579876|Immunomodulating Agents|immunomodulating agents|mesh-list
138278137|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
138278138|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278139|NCT00364052|Valganciclovir|valganciclovir|mesh-list
138278140|NCT00364052|Ganciclovir|ganciclovir|mesh-list
138278141|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138278142|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
138278143|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278144|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138278145|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278146|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278147|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
138382795|NCT01468441|Cetrorelix|cetrorelix|mesh-list
138278148|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138278149|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278150|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138278151|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278152|NCT00364988|Pioglitazone|pioglitazone|mesh-list
138278153|NCT00364988|Losartan|losartan|mesh-list
138278154|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138278155|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278156|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138278157|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138278158|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138278159|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138278160|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278161|NCT00365222|Temozolomide|temozolomide|mesh-list
138278162|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138278163|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
138278164|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195482|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
138278165|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278166|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138278167|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
138278168|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
138278169|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138278170|NCT02791568|Hematinics|hematinics|mesh-ancestor
138278171|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138278172|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138278173|NCT05247554|Hydroxychloroquine|hydroxychloroquine|mesh-list
138278174|NCT05247554|Prednisone|prednisone|mesh-list
138278175|NCT05247554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138278176|NCT05247554|Glucocorticoids|glucocorticoids|mesh-ancestor
138278177|NCT05247554|Hormones|hormones|mesh-ancestor
138278178|NCT05247554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138278179|NCT05247554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229762|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
138278180|NCT05247554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138278181|NCT05247554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278182|NCT05247554|Antimalarials|antimalarials|mesh-ancestor
138278183|NCT05247554|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138278184|NCT05247554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138278185|NCT05247554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278186|NCT05247554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278187|NCT05247554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278188|NCT05247554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138278189|NCT02596022|Ketamine|ketamine|mesh-list
138278190|NCT02596022|Analgesics|analgesics|mesh-ancestor
138278191|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
138278192|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278193|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278195|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138278196|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
138278197|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
138278198|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138278199|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138278200|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138278201|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278202|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278203|NCT00364442|Fluticasone|fluticasone|mesh-list
138278204|NCT00364442|Xhance|xhance|mesh-list
138278205|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138278206|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138278207|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138278208|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
138278209|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278210|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278211|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138278212|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
138278213|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
138278214|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138278215|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138278216|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138278217|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138278218|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
138278219|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278220|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278221|NCT05371574|Clonidine|clonidine|mesh-list
138278222|NCT05371574|Analgesics|analgesics|mesh-ancestor
138278223|NCT05371574|Sensory System Agents|sensory system agents|mesh-ancestor
138278224|NCT05371574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278225|NCT05371574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278226|NCT05371574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138278227|NCT05371574|Sympatholytics|sympatholytics|mesh-ancestor
138278228|NCT05371574|Autonomic Agents|autonomic agents|mesh-ancestor
138278229|NCT05371574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138195489|NCT05491902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138195491|NCT05485896|Pembrolizumab|pembrolizumab|mesh-list
138278230|NCT05371574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138278231|NCT05371574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138278232|NCT05371574|Adrenergic Agents|adrenergic agents|mesh-ancestor
138278233|NCT05371574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278234|NCT05371574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278235|NCT05371340|Quercetin|quercetin|mesh-list
138278236|NCT05371340|Antioxidants|antioxidants|mesh-ancestor
138278237|NCT05371340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278238|NCT05371340|Protective Agents|protective agents|mesh-ancestor
138278239|NCT05371340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278240|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
138278241|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138278242|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
138278243|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278244|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
138278245|NCT02601170|Protective Agents|protective agents|mesh-ancestor
138278246|NCT00366002|Darifenacin|darifenacin|mesh-list
138278247|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138278248|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138278249|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
138278250|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278251|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278252|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278253|NCT00366002|Urological Agents|urological agents|mesh-ancestor
138278255|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
138278256|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138278257|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
138278258|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138278259|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138278260|NCT00422240|Analgesics|analgesics|mesh-ancestor
138278261|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
138278262|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278263|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278264|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138278265|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138278266|NCT02605304|Ribavirin|ribavirin|mesh-list
138278267|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
138278268|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138278269|NCT02605304|Ledipasvir|ledipasvir|mesh-list
138278270|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
138278271|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278272|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
138278274|NCT05365880|Lidocaine|lidocaine|mesh-list
138278275|NCT05365880|Anesthetics, Local|anesthetics, local|mesh-ancestor
138278276|NCT05365880|Anesthetics|anesthetics|mesh-ancestor
138278277|NCT05365880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138278278|NCT05365880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278279|NCT05365880|Sensory System Agents|sensory system agents|mesh-ancestor
138278280|NCT05365880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278281|NCT05365880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138278282|NCT05365880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138278283|NCT05365880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138278284|NCT05365880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138278285|NCT05365880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278286|NCT02607254|Pregabalin|pregabalin|mesh-list
138195497|NCT05485896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138195498|NCT05485896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195499|NCT05507398|Metformin|metformin|mesh-list
138278287|NCT02607254|Analgesics|analgesics|mesh-ancestor
138278288|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
138278289|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278290|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278291|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
138278292|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138278293|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138278294|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278295|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138278296|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138278297|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138278298|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138278299|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138278300|NCT02611154|Testosterone|testosterone|mesh-list
138278301|NCT02611154|Androgens|androgens|mesh-ancestor
138278302|NCT02611154|Hormones|hormones|mesh-ancestor
138278303|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138278304|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278305|NCT02617784|Oseltamivir|oseltamivir|mesh-list
138278306|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
138278307|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278308|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278309|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278311|NCT00365612|Emtricitabine|emtricitabine|mesh-list
138278312|NCT00365612|Efavirenz|efavirenz|mesh-list
138278313|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
138278314|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278315|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138278316|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138278317|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278318|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278319|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138278320|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138278321|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138278322|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138278323|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138278324|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138278325|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138278326|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138278328|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138278330|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138278331|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138278332|NCT02974166|Analgesics|analgesics|mesh-ancestor
138278333|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
138278334|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278335|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278336|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138278337|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138278339|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278340|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138278341|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
138278342|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138278343|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138278344|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138278345|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138278346|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138278347|NCT05731778|Listerine|listerine|mesh-list
138195517|NCT01147042|Interferons|interferons|mesh-list
138278348|NCT05731778|Fluorides|fluorides|mesh-list
138278349|NCT05731778|Sodium Fluoride|sodium fluoride|mesh-list
138278350|NCT05731778|Tin Fluorides|tin fluorides|mesh-list
138278351|NCT05731778|Cariostatic Agents|cariostatic agents|mesh-ancestor
138278352|NCT05731778|Protective Agents|protective agents|mesh-ancestor
138278353|NCT05731778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278354|NCT05731778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138278355|NCT05731778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278356|NCT05477264|Tislelizumab|tislelizumab|mesh-list
138278357|NCT05477264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138278358|NCT05477264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278359|NCT00422318|Benzbromarone|benzbromarone|mesh-list
138278360|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
138278361|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
138278362|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138278363|NCT00364754|Tesmilifene|tesmilifene|mesh-list
138278364|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
138278365|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
138278366|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278367|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278368|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278369|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138278371|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138278372|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278373|NCT04741880|Lidocaine|lidocaine|mesh-list
138278374|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
138278375|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
138278376|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138278377|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278378|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
138278379|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278380|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138278381|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138278382|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138278383|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138278384|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278385|NCT00365924|Teriparatide|teriparatide|mesh-list
138278386|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138278387|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278388|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138278389|NCT05360030|Ketamine|ketamine|mesh-list
138278390|NCT05360030|Naloxone|naloxone|mesh-list
138278391|NCT05360030|Analgesics|analgesics|mesh-ancestor
138278392|NCT05360030|Sensory System Agents|sensory system agents|mesh-ancestor
138278393|NCT05360030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278394|NCT05360030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278395|NCT05360030|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138278397|NCT05360030|Anesthetics, General|anesthetics, general|mesh-ancestor
138278398|NCT05360030|Anesthetics|anesthetics|mesh-ancestor
138278400|NCT05360030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138278402|NCT05360030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382956|NCT06077292|Analgesics|analgesics|mesh-ancestor
138278403|NCT05360030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278404|NCT05360030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138278405|NCT05272202|Propofol|propofol|mesh-list
138278406|NCT05272202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138278407|NCT05272202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138278408|NCT05272202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278409|NCT05272202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138278410|NCT05272202|Anesthetics, General|anesthetics, general|mesh-ancestor
138278411|NCT05272202|Anesthetics|anesthetics|mesh-ancestor
138278412|NCT01575834|Denosumab|denosumab|mesh-list
138195531|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278413|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138278414|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278415|NCT05707442|Acetazolamide|acetazolamide|mesh-list
138278416|NCT05707442|Anticonvulsants|anticonvulsants|mesh-ancestor
138278417|NCT05707442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138278418|NCT05707442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278419|NCT05707442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278420|NCT05707442|Diuretics|diuretics|mesh-ancestor
138278421|NCT05707442|Natriuretic Agents|natriuretic agents|mesh-ancestor
138278422|NCT05707442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278423|NCT04604132|Paclitaxel|paclitaxel|mesh-list
138278424|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138278425|NCT04604132|Atezolizumab|atezolizumab|mesh-list
138278426|NCT04604132|Ramucirumab|ramucirumab|mesh-list
138278427|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138278428|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138278429|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278430|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
138278431|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
138278432|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
138278433|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278434|NCT04604132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138278435|NCT04604132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138278436|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
138278437|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278438|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138278439|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278440|NCT05193188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138278441|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278442|NCT04799262|Prednisone|prednisone|mesh-list
138278443|NCT04799262|Tofacitinib|tofacitinib|mesh-list
138278444|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138278446|NCT04799262|Hormones|hormones|mesh-ancestor
138278447|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138278448|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278449|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138278450|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278451|NCT04799262|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138278452|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138278453|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382992|NCT06076837|Analgesics|analgesics|mesh-ancestor
138278454|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278456|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138278458|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138278459|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138278460|NCT00851136|Growth Substances|growth substances|mesh-ancestor
138278461|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278462|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
138278463|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
138278464|NCT00366470|Vitamin D|vitamin d|mesh-list
138278465|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138278466|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278467|NCT00366470|Vitamins|vitamins|mesh-ancestor
138278468|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
138278469|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138278470|NCT04537286|Paclitaxel|paclitaxel|mesh-list
138278471|NCT04537286|Cisplatin|cisplatin|mesh-list
138278472|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138278473|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278474|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
138278475|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
138278476|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
138278477|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278478|NCT02620904|Mifepristone|mifepristone|mesh-list
138278479|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138278480|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
138278481|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138278482|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278483|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138278484|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138278485|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138278486|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
138278487|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138278488|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138278489|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
138278490|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138278491|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
138278492|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138278493|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138278495|NCT00300768|Moxidectin|moxidectin|mesh-list
138278496|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138278497|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278498|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
138278499|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
138278500|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
138278502|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278503|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138278505|NCT04740554|Deflazacort|deflazacort|mesh-list
138278506|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138278507|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
138278508|NCT04740554|Hormones|hormones|mesh-ancestor
138278509|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138278510|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278511|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138278512|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278513|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138278514|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
138278515|NCT02624180|Colchicine|colchicine|mesh-list
138278516|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
138278517|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138278518|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
138278519|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
138278520|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
138278521|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278522|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278523|NCT05068232|Carboplatin|carboplatin|mesh-list
138278524|NCT05068232|Etoposide|etoposide|mesh-list
138278525|NCT05068232|Durvalumab|durvalumab|mesh-list
138278526|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278527|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138278528|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138278529|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138278530|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278531|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278532|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138278533|NCT04326764|Panobinostat|panobinostat|mesh-list
138278534|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278535|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138278536|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278537|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278538|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138278539|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138278540|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
138278542|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138278543|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
138278544|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138278545|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278546|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138278547|NCT02629094|Diuretics|diuretics|mesh-ancestor
138195552|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138195553|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138278548|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
138278549|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138278550|NCT02630030|Ixazomib|ixazomib|mesh-list
138324281|NCT05605002|Serotonin|serotonin|mesh-list
138278551|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278552|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
138278553|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278554|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278556|NCT04289792|Gemcitabine|gemcitabine|mesh-list
138278557|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138278558|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278559|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
138278560|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
138278561|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
138278562|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278563|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138278564|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
138278565|NCT02631590|Gemcitabine|gemcitabine|mesh-list
138278566|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278567|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138278568|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
138278569|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278570|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
138278571|NCT02253654|Hematinics|hematinics|mesh-ancestor
138278572|NCT02252406|Ranolazine|ranolazine|mesh-list
138278573|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138278574|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138278575|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278576|NCT02252016|Grazoprevir|grazoprevir|mesh-list
138278577|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
138278578|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278579|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
138278580|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138278581|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
138278582|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278583|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138278584|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278585|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138278586|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278587|NCT02706847|Upadacitinib|upadacitinib|mesh-list
138278588|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138278589|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138278590|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278591|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383085|NCT06074185|Hormones|hormones|mesh-ancestor
138278592|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138278593|NCT02470741|Letrozole|letrozole|mesh-list
138278594|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278595|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138278596|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138229794|NCT02322320|Lenalidomide|lenalidomide|mesh-list
138278598|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278600|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
138195559|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278601|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138278602|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278604|NCT02544607|Analgesics|analgesics|mesh-ancestor
138278605|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
138278606|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278607|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278609|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138278610|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
138278611|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
138278612|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138278613|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138278614|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138278615|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278616|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278617|NCT00363571|Acetazolamide|acetazolamide|mesh-list
138278618|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
138278619|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138278620|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278621|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278622|NCT00363571|Diuretics|diuretics|mesh-ancestor
138278623|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
138278624|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278625|NCT04744675|Triamcinolone|triamcinolone|mesh-list
138278626|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138278627|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138278628|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138278629|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138278630|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
138278631|NCT04744675|Hormones|hormones|mesh-ancestor
138278632|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138278633|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278634|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138278635|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
138278636|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278637|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278638|NCT02471521|Rocuronium|rocuronium|mesh-list
138278639|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138278640|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138278642|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278643|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278644|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
138278645|NCT02624479|Antidotes|antidotes|mesh-ancestor
138278646|NCT02624479|Protective Agents|protective agents|mesh-ancestor
138278647|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278648|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
138278649|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278650|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
138278651|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138278652|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278653|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
138278654|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
138278655|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
138278656|NCT02472223|Povidone|povidone|mesh-list
138278657|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
138278658|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
138195582|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278659|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
138278660|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138278661|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278662|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138278663|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138278664|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
138278665|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138278666|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278667|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138278668|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138278669|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383130|NCT06072963|Insulin|insulin|mesh-list
138278670|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278671|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278672|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138278673|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138278674|NCT02473783|Sertraline|sertraline|mesh-list
138278675|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
138278676|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138278677|NCT02473783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138278678|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138278679|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138278680|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278681|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278682|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
138278683|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278684|NCT02247804|Timolol|timolol|mesh-list
138278685|NCT02247804|Bimatoprost|bimatoprost|mesh-list
138278686|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138278687|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138278688|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
138278689|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278690|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278691|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278692|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138278693|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138278694|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
138278695|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138278696|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138278697|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278698|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278699|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138278700|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138278701|NCT00366938|Analgesics|analgesics|mesh-ancestor
138278702|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
138278703|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278704|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278705|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138278706|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138278707|NCT05026320|Diclofenac|diclofenac|mesh-list
138278708|NCT05026320|Naproxen|naproxen|mesh-list
138278709|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138278710|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138278711|NCT05026320|Analgesics|analgesics|mesh-ancestor
138278712|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
138278713|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278714|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278715|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138278717|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138278718|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278719|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278722|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138278723|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138278724|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278725|NCT02243202|Canagliflozin|canagliflozin|mesh-list
138278726|NCT02243202|Phentermine|phentermine|mesh-list
138278727|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138278728|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278729|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138278730|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278731|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138278732|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
138278733|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138278734|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
138278735|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
138278736|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278737|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
138278738|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278741|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
138278742|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138278743|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138278744|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
138278745|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138278746|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138278747|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278748|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
138278749|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278750|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278751|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138278752|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278753|NCT04235036|Rituximab|rituximab|mesh-list
138278754|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138278755|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278756|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
138324341|NCT04760262|Remifentanil|remifentanil|mesh-list
138278758|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138278759|NCT02560051|Ketoconazole|ketoconazole|mesh-list
138278760|NCT02560051|Docetaxel|docetaxel|mesh-list
138278761|NCT02560051|Doxorubicin|doxorubicin|mesh-list
138278762|NCT02560051|Estramustine|estramustine|mesh-list
138278763|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278764|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
138278765|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
138278766|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
138278767|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278768|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138278769|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138278770|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138278771|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278772|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
138278773|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383201|NCT06072118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138278774|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138278775|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138278776|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138278777|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
138278778|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138278779|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278780|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138278781|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138278782|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
138278783|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138278784|NCT03786770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138278785|NCT03786770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138278786|NCT03786770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138278787|NCT03786770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278788|NCT03786770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195606|NCT05479032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278789|NCT03786770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138278790|NCT03786770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138278791|NCT03786770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278792|NCT03786770|Cholinergic Agents|cholinergic agents|mesh-ancestor
138278793|NCT03786770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278795|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278797|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138278798|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
138278799|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
138278800|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
138278801|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278802|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278803|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138278804|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138278805|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138278806|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138278807|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138383222|NCT06071806|Fluorouracil|fluorouracil|mesh-list
138278808|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138278809|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138278810|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138278811|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138278814|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
138278815|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
138278816|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278817|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278818|NCT05588492|Rifamycins|rifamycins|mesh-list
138278819|NCT05588492|Rifamycin SV|rifamycin sv|mesh-list
138278820|NCT05588492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138278821|NCT05588492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278822|NCT05588492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138278823|NCT03777956|Lacosamide|lacosamide|mesh-list
138278824|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
138278825|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138278826|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138278827|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138278828|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278829|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
138278830|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
138278831|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
138278832|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138278833|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278834|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
138278835|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278836|NCT02563093|Vaccines|vaccines|mesh-list
138278837|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
138278838|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278839|NCT02564029|Lorazepam|lorazepam|mesh-list
138278840|NCT02564029|PF-06372865|pf-06372865|mesh-list
138278841|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
138278842|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
138278843|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
138278844|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278845|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278846|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138278847|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138278848|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138278849|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138195616|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
138195617|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278850|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138278851|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138278852|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
138278853|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
138278854|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278855|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278857|NCT05588336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138278858|NCT05588336|Narcotics|narcotics|mesh-ancestor
138278859|NCT05588336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138278860|NCT05588336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278861|NCT05588336|Analgesics|analgesics|mesh-ancestor
138278862|NCT05588336|Sensory System Agents|sensory system agents|mesh-ancestor
138278863|NCT05588336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278865|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138278866|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278867|NCT02564497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138278868|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278869|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138278870|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
138278871|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278872|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138278873|NCT02565901|Sirolimus|sirolimus|mesh-list
138278874|NCT02565901|Carboplatin|carboplatin|mesh-list
138278876|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278877|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
138278878|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
138278879|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
138278880|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278881|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138278883|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138278884|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
138278885|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138278886|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
138278887|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278889|NCT03926624|Fludarabine|fludarabine|mesh-list
138278890|NCT03926624|Etoposide|etoposide|mesh-list
138278891|NCT03926624|Azacitidine|azacitidine|mesh-list
138278892|NCT03926624|Decitabine|decitabine|mesh-list
138278893|NCT03926624|Venetoclax|venetoclax|mesh-list
138278894|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
138278895|NCT03926624|Idarubicin|idarubicin|mesh-list
138278896|NCT03926624|Cladribine|cladribine|mesh-list
138278897|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278898|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138278899|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
138278900|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278901|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138278903|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278904|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138278905|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138278906|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138278907|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278908|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
138278909|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278911|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
138278912|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278913|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138278914|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138278915|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278916|NCT03551210|Levofloxacin|levofloxacin|mesh-list
138278917|NCT03551210|Ofloxacin|ofloxacin|mesh-list
138278918|NCT03551210|Nemonoxacin|nemonoxacin|mesh-list
138278919|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138278920|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278921|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138278922|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138278923|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138278924|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278925|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278926|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278927|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138278928|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138278929|NCT02482675|Caseins|caseins|mesh-list
138278930|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
138278931|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
138278932|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278933|NCT00364195|Tesmilifene|tesmilifene|mesh-list
138278934|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
138278935|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
138278936|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138278937|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278938|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278939|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138278940|NCT02566369|Trifarotene|trifarotene|mesh-list
138278941|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
138278942|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
138278943|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278944|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138278945|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138278946|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
138278947|NCT02571439|Ropivacaine|ropivacaine|mesh-list
138383323|NCT05998317|Dexamethasone|dexamethasone|mesh-list
138278948|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
138278949|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
138278950|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138278951|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278952|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
138278953|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138278954|NCT02573857|Artefenomel|artefenomel|mesh-list
138278955|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
138278956|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138278957|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138278958|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138278959|NCT03678428|Leucovorin|leucovorin|mesh-list
138278960|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
138278961|NCT03678428|Irinotecan|irinotecan|mesh-list
138278962|NCT03678428|Floxuridine|floxuridine|mesh-list
138278963|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138278964|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138278965|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138278966|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138278967|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138278968|NCT03678428|Antidotes|antidotes|mesh-ancestor
138278969|NCT03678428|Protective Agents|protective agents|mesh-ancestor
138278970|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278971|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
138278972|NCT03678428|Vitamins|vitamins|mesh-ancestor
138278973|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
138278974|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138278975|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
138278976|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
138278977|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138278978|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
138278979|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
138278980|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138278981|NCT02577601|Estradiol|estradiol|mesh-list
138278982|NCT02577601|Estrogens|estrogens|mesh-ancestor
138278983|NCT02577601|Hormones|hormones|mesh-ancestor
138324440|NCT03200808|Methylene Blue|methylene blue|mesh-list
138278984|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138278985|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278986|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138278987|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
138278988|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138278989|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138383347|NCT05974852|Immunologic Factors|immunologic factors|mesh-ancestor
138278990|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138278991|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138278993|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138278994|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138278995|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
138278996|NCT02577991|Hormones|hormones|mesh-ancestor
138278997|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138278998|NCT02207634|Evolocumab|evolocumab|mesh-list
138278999|NCT02207634|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138279000|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138279001|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138279002|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
138279003|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279004|NCT02207634|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138279005|NCT02207634|Protease Inhibitors|protease inhibitors|mesh-ancestor
138279006|NCT02207634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279007|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138279008|NCT04341727|Azithromycin|azithromycin|mesh-list
138279009|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
138279010|NCT04341727|Chloroquine|chloroquine|mesh-list
138279011|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138279012|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138279013|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279014|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
138279015|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138279016|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138279017|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279018|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279020|NCT04341727|Amebicides|amebicides|mesh-ancestor
138279021|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138279022|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138279024|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
138279025|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324447|NCT04129008|Analgesics|analgesics|mesh-ancestor
138279026|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279027|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138279028|NCT04341727|Filaricides|filaricides|mesh-ancestor
138279029|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
138279030|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
138279031|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138279032|NCT00367094|Benazepril|benazepril|mesh-list
138279033|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138279034|NCT00367094|Diuretics|diuretics|mesh-ancestor
138279035|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
138279036|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279037|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138279038|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138279039|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279040|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138279041|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
138279042|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279043|NCT02581111|Naloxone|naloxone|mesh-list
138279044|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138279045|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279046|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
138279047|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279048|NCT05587400|Dobutamine|dobutamine|mesh-list
138279049|NCT05587400|Nitric Oxide|nitric oxide|mesh-list
138279050|NCT05587400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138279051|NCT05587400|Autonomic Agents|autonomic agents|mesh-ancestor
138279052|NCT05587400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279053|NCT05587400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279054|NCT05587400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138279055|NCT05587400|Respiratory System Agents|respiratory system agents|mesh-ancestor
138279056|NCT05587400|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138279057|NCT05587400|Antioxidants|antioxidants|mesh-ancestor
138279058|NCT05587400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279059|NCT05587400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279060|NCT05587400|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138279061|NCT05587400|Vasodilator Agents|vasodilator agents|mesh-ancestor
138279062|NCT05587400|Gasotransmitters|gasotransmitters|mesh-ancestor
138279063|NCT05587400|Protective Agents|protective agents|mesh-ancestor
138279064|NCT05587400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138279065|NCT05587400|Sympathomimetics|sympathomimetics|mesh-ancestor
138279066|NCT05587400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138279067|NCT05587400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138279068|NCT05587400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138279069|NCT05587400|Adrenergic Agents|adrenergic agents|mesh-ancestor
138279070|NCT04339868|Terlipressin|terlipressin|mesh-list
138279071|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138279072|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138279073|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138279074|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
138279075|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279076|NCT00367250|Trastuzumab|trastuzumab|mesh-list
138279077|NCT00367250|Cetuximab|cetuximab|mesh-list
138279078|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138279079|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279080|NCT02489227|Adalimumab|adalimumab|mesh-list
138279081|NCT02489227|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138279082|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138279083|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138279084|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
138383411|NCT05798481|Acetylcysteine|acetylcysteine|mesh-list
138279085|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138229832|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
138279086|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138279087|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279088|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
138279089|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
138279090|NCT02207556|Doxycycline|doxycycline|mesh-list
138279091|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138279092|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279093|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
138279094|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138279095|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138279096|NCT02572609|Ambroxol|ambroxol|mesh-list
138279097|NCT02572609|Expectorants|expectorants|mesh-ancestor
138279098|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
138279099|NCT02587117|Prednisolone|prednisolone|mesh-list
138279100|NCT02587117|Lycopene|lycopene|mesh-list
138279101|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138279102|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
138279103|NCT02587117|Hormones|hormones|mesh-ancestor
138279104|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138279105|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279106|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138279107|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279108|NCT02587117|Protective Agents|protective agents|mesh-ancestor
138279109|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
138279110|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279111|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138279112|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138279113|NCT02587351|Metoprolol|metoprolol|mesh-list
138279114|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138279115|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138279116|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
138279117|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
138279118|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279119|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279120|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138279121|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138195664|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138279122|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138279123|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
138279124|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279125|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279127|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138279128|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
138279129|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279130|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138279131|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138279132|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138279133|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
138279134|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279135|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279136|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138279137|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
138279138|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138279139|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138279140|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138279141|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
138279142|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279143|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279144|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
138279145|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
138279146|NCT05249023|Butyric Acid|butyric acid|mesh-list
138279147|NCT05249023|Histamine Antagonists|histamine antagonists|mesh-ancestor
138279148|NCT05249023|Histamine Agents|histamine agents|mesh-ancestor
138279149|NCT05249023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279150|NCT05249023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279151|NCT05249023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279152|NCT02495779|Tenofovir|tenofovir|mesh-list
138279153|NCT02495779|Emtricitabine|emtricitabine|mesh-list
138279154|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
138279155|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279156|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138279157|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138279159|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279160|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138279161|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138279162|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
138279163|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
138279164|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279166|NCT02502487|Tetracaine|tetracaine|mesh-list
138279167|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
138279168|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
138279169|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138279170|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279171|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
138279172|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279173|NCT03238196|Fulvestrant|fulvestrant|mesh-list
138279174|NCT03238196|Palbociclib|palbociclib|mesh-list
138279175|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138279176|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279177|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138279178|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138279179|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
138279180|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138279181|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279182|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138279183|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279184|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279185|NCT02632045|Fulvestrant|fulvestrant|mesh-list
138279186|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138279187|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279188|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138279189|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138279190|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
138279191|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138279192|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279193|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
138279194|NCT02503735|Ledipasvir|ledipasvir|mesh-list
138279195|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
138279196|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279197|NCT04001881|Anesthetics|anesthetics|mesh-list
138279198|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138279199|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279200|NCT03019640|Cytarabine|cytarabine|mesh-list
138279201|NCT03019640|Rituximab|rituximab|mesh-list
138279202|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138279203|NCT03019640|Etoposide|etoposide|mesh-list
138279204|NCT03019640|Lenalidomide|lenalidomide|mesh-list
138279205|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
138279206|NCT03019640|Melphalan|melphalan|mesh-list
138279207|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
138279208|NCT03019640|Carmustine|carmustine|mesh-list
138279209|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
138279210|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138279212|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
138279213|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138279214|NCT03019640|Lenograstim|lenograstim|mesh-list
138279215|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
138279216|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279217|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279218|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138279219|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138279220|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138279221|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138279223|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279224|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138279225|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
138279226|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
138279227|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279228|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138279229|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138279230|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138279231|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138279232|NCT03019640|Growth Substances|growth substances|mesh-ancestor
138279233|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
138279234|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138279235|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
138279236|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138279237|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
138279238|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
138279239|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
138279240|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
138279241|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
138279243|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138279244|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
138279245|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279246|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
138279247|NCT02136901|Protective Agents|protective agents|mesh-ancestor
138279248|NCT02507011|Carvedilol|carvedilol|mesh-list
138279249|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138279250|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138279251|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
138279252|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279253|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279254|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279255|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138279256|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
138279257|NCT02507011|Protective Agents|protective agents|mesh-ancestor
138279258|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138279259|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138279260|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138195681|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138195683|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138279261|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
138279262|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138279263|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138279264|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
138279265|NCT02977286|Naloxegol|naloxegol|mesh-list
138279266|NCT02977286|Bisacodyl|bisacodyl|mesh-list
138279267|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
138279268|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138279269|NCT02977286|Cathartics|cathartics|mesh-ancestor
138279270|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138279271|NCT02977286|Laxatives|laxatives|mesh-ancestor
138279272|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138383533|NCT05733364|Vitamin B Complex|vitamin b complex|mesh-list
138279273|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279274|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
138279275|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279276|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
138279277|NCT05345210|Amoxicillin|amoxicillin|mesh-list
138279278|NCT05345210|Clarithromycin|clarithromycin|mesh-list
138279279|NCT05345210|Tetracycline|tetracycline|mesh-list
138279280|NCT05345210|Furazolidone|furazolidone|mesh-list
138279281|NCT05345210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138279282|NCT05345210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279283|NCT05345210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138279284|NCT05345210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279285|NCT05345210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279286|NCT05345210|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138279287|NCT05345210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138279288|NCT05345210|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138279289|NCT05345210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138279290|NCT05345210|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138279291|NCT05345210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138279292|NCT05345210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138279293|NCT05345210|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138279294|NCT02976896|Apatinib|apatinib|mesh-list
138279295|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279296|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138279297|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279298|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279299|NCT01810705|Asparaginase|asparaginase|mesh-list
138279300|NCT01810705|Eryaspase|eryaspase|mesh-list
138279301|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279304|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138279305|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279306|NCT02508259|Suramin|suramin|mesh-list
138279307|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
138279308|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
138279309|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138279310|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279311|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279312|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138279313|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138279314|NCT00534469|Cytarabine|cytarabine|mesh-list
138279315|NCT00534469|Aldesleukin|aldesleukin|mesh-list
138279316|NCT00534469|Etoposide|etoposide|mesh-list
138279317|NCT00534469|Idarubicin|idarubicin|mesh-list
138279318|NCT00534469|Busulfan|busulfan|mesh-list
138279319|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138279320|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279321|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138279322|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138279323|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279324|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279325|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138279326|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
138279327|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
138279328|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279329|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138279330|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
138279331|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279332|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
138195688|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279333|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138279334|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138279335|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138279336|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138279337|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138279338|NCT02240628|Lidocaine|lidocaine|mesh-list
138279339|NCT02240628|Tetracaine|tetracaine|mesh-list
138279340|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
138279341|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
138279342|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138383628|NCT05646199|Metformin|metformin|mesh-list
138279343|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279344|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
138279345|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279346|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138279347|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138279348|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138279349|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138279350|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279351|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
138279352|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138324580|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
138279353|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138279354|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279355|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
138279356|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
138279357|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138279358|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138279359|NCT02207400|Listerine|listerine|mesh-list
138279360|NCT02207400|Fluorides|fluorides|mesh-list
138279361|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
138279362|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
138279363|NCT02207400|Protective Agents|protective agents|mesh-ancestor
138279364|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279365|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138279366|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279368|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
138279369|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279370|NCT03545035|Rituximab|rituximab|mesh-list
138279371|NCT03545035|Idelalisib|idelalisib|mesh-list
138279372|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138279373|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279374|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
138279375|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279376|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138279377|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279378|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279379|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138279380|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138279381|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279382|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
138279383|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
138279384|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138279385|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279386|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138279387|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279388|NCT02512783|Lidocaine|lidocaine|mesh-list
138279389|NCT02512783|Propofol|propofol|mesh-list
138279390|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
138279391|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
138279392|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138279393|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279394|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
138279395|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279396|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138279397|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138279398|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138195699|NCT05478876|Immunologic Factors|immunologic factors|mesh-ancestor
138279399|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138279400|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279401|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138279402|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138279403|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
138279405|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138279406|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279407|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138279408|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279409|NCT02513719|Everolimus|everolimus|mesh-list
138279410|NCT02513719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138279411|NCT02513719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138279412|NCT02513719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279413|NCT02513719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279414|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138279415|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
138279416|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279417|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279418|NCT00363727|Ropinirole|ropinirole|mesh-list
138279419|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138279420|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138279421|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
138279422|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
138279423|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279424|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279425|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279426|NCT04340869|Theobromine|theobromine|mesh-list
138279427|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138279428|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
138279429|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279430|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279431|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138279432|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
138279434|NCT00366067|Phenytoin|phenytoin|mesh-list
138279435|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
138279436|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138279437|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138279438|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138279439|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279440|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138279441|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138279442|NCT00364429|Lorazepam|lorazepam|mesh-list
138279443|NCT00364429|Risperidone|risperidone|mesh-list
138279444|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138279445|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
138279446|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279447|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279448|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279449|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138279450|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138229857|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
138279451|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138279453|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138279454|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
138279455|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
138279456|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
138279457|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
138279458|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279459|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138279460|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138279461|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138279462|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
138279463|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
138279464|NCT02593903|Trimethoprim|trimethoprim|mesh-list
138195701|NCT01188421|Clonidine|clonidine|mesh-list
138195702|NCT01188421|Buprenorphine|buprenorphine|mesh-list
138279465|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138279466|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
138279467|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138279468|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279469|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
138279470|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138279471|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138279472|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138279473|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279474|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279475|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138279476|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138279477|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138279478|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138279479|NCT02596867|Propranolol|propranolol|mesh-list
138279480|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138279481|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138279482|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
138279483|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138324684|NCT03821454|Capecitabine|capecitabine|mesh-list
138279484|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279485|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279486|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138279487|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138279488|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
138279490|NCT02597101|Saxagliptin|saxagliptin|mesh-list
138279491|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138279492|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279493|NCT02597101|Incretins|incretins|mesh-ancestor
138279494|NCT02597101|Hormones|hormones|mesh-ancestor
138279495|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138279496|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138279497|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
138279498|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279499|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279500|NCT02600611|Vancomycin|vancomycin|mesh-list
138279501|NCT02600611|Iclaprim|iclaprim|mesh-list
138279502|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138279503|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279504|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138279505|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279506|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279507|NCT02600767|Lumefantrine|lumefantrine|mesh-list
138279508|NCT02600767|Artemether|artemether|mesh-list
138279509|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138279510|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
138279511|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138279512|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138279513|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279515|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
138279516|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
138279517|NCT00365287|Fludarabine|fludarabine|mesh-list
138279518|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
138279519|NCT00365287|Cyclosporins|cyclosporins|mesh-list
138279520|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138279521|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138279522|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
138279523|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279524|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138279525|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138279527|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279528|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279529|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138279530|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138383731|NCT05469178|Pemetrexed|pemetrexed|mesh-list
138279531|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
138279532|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279533|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
138279534|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279535|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
138279536|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138279537|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138279538|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138279539|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
138279540|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138279542|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
138279543|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138279544|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279545|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138279546|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138279547|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
138279548|NCT05572645|Trastuzumab|trastuzumab|mesh-list
138279549|NCT05572645|Pertuzumab|pertuzumab|mesh-list
138279550|NCT05572645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138279551|NCT05572645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279552|NCT02608177|Linagliptin|linagliptin|mesh-list
138279553|NCT02608177|Glipizide|glipizide|mesh-list
138279554|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138279555|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279557|NCT02608177|Hormones|hormones|mesh-ancestor
138279558|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138279559|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138279560|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
138279561|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279562|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279563|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
138279564|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138279565|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
138279566|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279567|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
138279568|NCT02608489|Protective Agents|protective agents|mesh-ancestor
138279569|NCT02611765|Penicillins|penicillins|mesh-list
138279570|NCT02611765|Penicillin G|penicillin g|mesh-list
138279571|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
138279572|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
138279573|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138279574|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279575|NCT02616523|Lidocaine|lidocaine|mesh-list
138279576|NCT02616523|Fentanyl|fentanyl|mesh-list
138279577|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
138279578|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
138279580|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138279581|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279582|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
138279583|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279584|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138279585|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138279586|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138279587|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138279588|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279589|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138279590|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138279592|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138279593|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138279594|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138279595|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
138279596|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279597|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138279598|NCT02616523|Narcotics|narcotics|mesh-ancestor
138279599|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138279600|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138279601|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
138279602|NCT05732155|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138279603|NCT05732155|Hallucinogens|hallucinogens|mesh-ancestor
138279604|NCT05732155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279605|NCT05732155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138279606|NCT05732155|Serotonin Agents|serotonin agents|mesh-ancestor
138279607|NCT05732155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279608|NCT05732155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279609|NCT05732155|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138279610|NCT05732155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138279611|NCT05732155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138279612|NCT05732155|Adrenergic Agents|adrenergic agents|mesh-ancestor
138279613|NCT05528419|Valsartan|valsartan|mesh-list
138279614|NCT05528419|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138279615|NCT05528419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138279616|NCT05528419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138279617|NCT05528419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138279618|NCT05528419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279619|NCT05480293|Ranibizumab|ranibizumab|mesh-list
138279620|NCT05480293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138195733|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195735|NCT00996502|Bevacizumab|bevacizumab|mesh-list
138195736|NCT00996502|Docetaxel|docetaxel|mesh-list
138195737|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138279621|NCT05480293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138279622|NCT05480293|Growth Substances|growth substances|mesh-ancestor
138279623|NCT05480293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279624|NCT05480293|Growth Inhibitors|growth inhibitors|mesh-ancestor
138279625|NCT05480293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279626|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
138279627|NCT00365755|Melphalan|melphalan|mesh-list
138279628|NCT00365755|Carboplatin|carboplatin|mesh-list
138279629|NCT00365755|Etoposide|etoposide|mesh-list
138279630|NCT00365755|Vincristine|vincristine|mesh-list
138279631|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138279632|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
138279633|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279634|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138279635|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138279636|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
138279637|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279638|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279639|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138279640|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138279641|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138279642|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138279644|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
138279645|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
138279646|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
138279648|NCT05730907|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138279649|NCT05730907|Vasodilator Agents|vasodilator agents|mesh-ancestor
138279650|NCT05730907|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138279651|NCT05730907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138279652|NCT05730907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279653|NCT05730907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279654|NCT05730907|Protective Agents|protective agents|mesh-ancestor
138279655|NCT05730907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279656|NCT04340401|Capecitabine|capecitabine|mesh-list
138279657|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
138279658|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138279659|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
138279660|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279661|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279663|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279664|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138279665|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279666|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279667|NCT04802863|Imipenem|imipenem|mesh-list
138279668|NCT04802863|Cilastatin|cilastatin|mesh-list
138279669|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138279670|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279671|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
138279672|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279673|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279674|NCT04622839|Acetaminophen|acetaminophen|mesh-list
138279675|NCT04622839|Ibuprofen|ibuprofen|mesh-list
138279676|NCT04622839|Diclofenac|diclofenac|mesh-list
138279677|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138279678|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138279679|NCT04622839|Analgesics|analgesics|mesh-ancestor
138279680|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
138279681|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279682|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279683|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138279684|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138279685|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138279687|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279688|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
138279689|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
138279690|NCT02619799|Midazolam|midazolam|mesh-list
138279691|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138195781|NCT05475444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279692|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138279693|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138279694|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279695|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138279696|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138279697|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138279698|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138279699|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
138279700|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
138279701|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
138279702|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
138279703|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279704|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279705|NCT02619799|Analgesics|analgesics|mesh-ancestor
138279706|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
138279707|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279708|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138279709|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
138279710|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138279711|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138279712|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138279713|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
138279714|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138279715|NCT04741165|Bevacizumab|bevacizumab|mesh-list
138279716|NCT04741165|Lenvatinib|lenvatinib|mesh-list
138279717|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138279718|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279719|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138279720|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138279721|NCT04741165|Growth Substances|growth substances|mesh-ancestor
138279722|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279723|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
138279724|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138279725|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279726|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279727|NCT02625181|Promethazine|promethazine|mesh-list
138279728|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
138279729|NCT02625181|Meclizine|meclizine|mesh-list
138279730|NCT02625181|Dexamethasone|dexamethasone|mesh-list
138279731|NCT02625181|Fentanyl|fentanyl|mesh-list
138279732|NCT02625181|Sufentanil|sufentanil|mesh-list
138279733|NCT02625181|Scopolamine|scopolamine|mesh-list
138279734|NCT02625181|Oxymorphone|oxymorphone|mesh-list
138279735|NCT02625181|Meperidine|meperidine|mesh-list
138279736|NCT02625181|Droperidol|droperidol|mesh-list
138279737|NCT02625181|Ketamine|ketamine|mesh-list
138279738|NCT02625181|Morphine|morphine|mesh-list
138279739|NCT02625181|Remifentanil|remifentanil|mesh-list
138279740|NCT02625181|Oxycodone|oxycodone|mesh-list
138279741|NCT02625181|Methadone|methadone|mesh-list
138279742|NCT02625181|Hydromorphone|hydromorphone|mesh-list
138279743|NCT02625181|Hydrocodone|hydrocodone|mesh-list
138279744|NCT02625181|Alfentanil|alfentanil|mesh-list
138279745|NCT02625181|Haloperidol|haloperidol|mesh-list
138279746|NCT02625181|Ondansetron|ondansetron|mesh-list
138279747|NCT02625181|Aprepitant|aprepitant|mesh-list
138279748|NCT02625181|Metoclopramide|metoclopramide|mesh-list
138279749|NCT02625181|Palonosetron|palonosetron|mesh-list
138279750|NCT02625181|Granisetron|granisetron|mesh-list
138279751|NCT02625181|Ramosetron|ramosetron|mesh-list
138279752|NCT02625181|Tropisetron|tropisetron|mesh-list
138279753|NCT02625181|Dolasetron|dolasetron|mesh-list
138279754|NCT02625181|Anesthetics|anesthetics|mesh-list
138279755|NCT02625181|Propofol|propofol|mesh-list
138279756|NCT02625181|Sevoflurane|sevoflurane|mesh-list
138279757|NCT02625181|Desflurane|desflurane|mesh-list
138279758|NCT02625181|Isoflurane|isoflurane|mesh-list
138279759|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138279760|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138279761|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
138279762|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
138279763|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279764|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279765|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138279766|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
138195786|NCT05475444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138279767|NCT02625181|Hormones|hormones|mesh-ancestor
138279768|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138279769|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138279770|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279771|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138279772|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138279773|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138279774|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
138279775|NCT02625181|Analgesics|analgesics|mesh-ancestor
138279776|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
138279777|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138279778|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138279779|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138279780|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279781|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279782|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138279783|NCT02625181|Narcotics|narcotics|mesh-ancestor
138279784|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138279785|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138279786|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138279787|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
138279788|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
138279789|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138279790|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138279791|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
138279792|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
138279793|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
138279794|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138279795|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138279796|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138279797|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138279798|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138279799|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
138279800|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138279801|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138279802|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
138279803|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138279804|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
138279805|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138279806|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
138279807|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138279808|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
138279809|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
138279810|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138279811|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138279812|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
138279813|NCT02630017|Methylphenidate|methylphenidate|mesh-list
138279814|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138279815|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279816|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138279817|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138383834|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279819|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279820|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
138279821|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279823|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138279824|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
138279825|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138279826|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138279827|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138279828|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
138279829|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279830|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279831|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279832|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138195799|NCT03472092|Analgesics|analgesics|mesh-ancestor
138279833|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138279834|NCT02633371|Oxybutynin|oxybutynin|mesh-list
138279835|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
138279836|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
138279837|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279838|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279839|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138279840|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138279841|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
138279842|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279843|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279844|NCT02633371|Urological Agents|urological agents|mesh-ancestor
138279845|NCT04159519|Budesonide|budesonide|mesh-list
138279846|NCT04159519|Albuterol|albuterol|mesh-list
138279847|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
138279848|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138279849|NCT04159519|Benralizumab|benralizumab|mesh-list
138279850|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138279851|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138279852|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
138279853|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279854|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279855|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138279856|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
138279857|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
138279858|NCT04159519|Hormones|hormones|mesh-ancestor
138279859|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138279860|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138279861|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138383855|NCT05187377|Hormones|hormones|mesh-list
138279862|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138279863|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
138279864|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279865|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279866|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
138279867|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138279868|NCT02634073|Lamivudine|lamivudine|mesh-list
138279869|NCT02634073|Sorbitol|sorbitol|mesh-list
138279870|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138279871|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138279872|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279873|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279874|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
138279875|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279876|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138279877|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138279878|NCT02634073|Cathartics|cathartics|mesh-ancestor
138279879|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138279880|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138279881|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138279882|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
138279883|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138279884|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138279885|NCT00367393|Analgesics|analgesics|mesh-ancestor
138279886|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
138195803|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138279887|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279888|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279889|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138279890|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138279891|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
138279892|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138279893|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
138279894|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138279896|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279897|NCT00367471|Paclitaxel|paclitaxel|mesh-list
138279898|NCT00367471|Carboplatin|carboplatin|mesh-list
138279899|NCT00367471|Trastuzumab|trastuzumab|mesh-list
138279900|NCT00367471|Lapatinib|lapatinib|mesh-list
138279901|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138279902|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279903|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
138279904|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
138279905|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
138279906|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279907|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138279908|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138279909|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279911|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138279912|NCT02207244|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138279913|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138279914|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138279915|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
138279916|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279917|NCT02207088|Ritonavir|ritonavir|mesh-list
138279918|NCT02207088|Ribavirin|ribavirin|mesh-list
138279919|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138279920|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138279921|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
138279922|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279923|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279924|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138279925|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138279926|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
138279927|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279928|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138279929|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138279930|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
138279932|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138279933|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
138279934|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279935|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138279936|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138279937|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138279938|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279939|NCT02206620|Donepezil|donepezil|mesh-list
138279940|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138195827|NCT04331626|Nivolumab|nivolumab|mesh-list
138279941|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279942|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279943|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
138279944|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138279945|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279946|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
138279947|NCT02239926|Ranolazine|ranolazine|mesh-list
138279948|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138279949|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138279950|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279953|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138279954|NCT02641561|Indomethacin|indomethacin|mesh-list
138279955|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138229882|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138229886|NCT01129778|Omeprazole|omeprazole|mesh-list
138279956|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138279958|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
138279959|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138279960|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279962|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138279963|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
138279964|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
138279965|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138279966|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138279967|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279968|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279969|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
138279970|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138279971|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
138279972|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279974|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
138279975|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138279976|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
138279977|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279978|NCT02206152|Protective Agents|protective agents|mesh-ancestor
138279979|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138279980|NCT02206152|Antidotes|antidotes|mesh-ancestor
138279981|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
138279982|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138279983|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
138279984|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
138279985|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138279986|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138279987|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138279988|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138279989|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279990|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279991|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138279992|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138279993|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
138279994|NCT04146571|Ensartinib|ensartinib|mesh-list
138279995|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138279996|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138279997|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138279998|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138279999|NCT05342376|Dexmedetomidine|dexmedetomidine|mesh-list
138324907|NCT02983344|Ropivacaine|ropivacaine|mesh-list
138280000|NCT05342376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138280001|NCT05342376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280002|NCT05342376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280003|NCT05342376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138280004|NCT05342376|Analgesics|analgesics|mesh-ancestor
138280005|NCT05342376|Sensory System Agents|sensory system agents|mesh-ancestor
138280006|NCT05342376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138195845|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138195846|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
138195847|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138195848|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138280007|NCT05342376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138280008|NCT05342376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138280009|NCT05342376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138280010|NCT05342376|Adrenergic Agents|adrenergic agents|mesh-ancestor
138280011|NCT05342376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280012|NCT05342376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280013|NCT02237196|Immunomodulating Agents|immunomodulating agents|mesh-list
138280014|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
138280015|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280016|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138280018|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138280019|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138280022|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280023|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280024|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138280025|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138280026|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138280027|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138280028|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138280029|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
138280030|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
138280031|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280032|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280033|NCT02203032|Ustekinumab|ustekinumab|mesh-list
138280034|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138280035|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
138280036|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
138280037|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280038|NCT02169414|Levodopa|levodopa|mesh-list
138280039|NCT02169414|Carbidopa|carbidopa|mesh-list
138280040|NCT02169414|Opicapone|opicapone|mesh-list
138280041|NCT02169414|Benserazide|benserazide|mesh-list
138280042|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138280043|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138280044|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
138280045|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280046|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280047|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280048|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138280049|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280050|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138280052|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138280053|NCT02201940|Velpatasvir|velpatasvir|mesh-list
138280054|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
138280055|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280056|NCT05588869|Cyclosporine|cyclosporine|mesh-list
138280057|NCT05588869|Cyclosporins|cyclosporins|mesh-list
138280058|NCT05588869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280059|NCT05588869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280060|NCT05588869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138324940|NCT03823638|Mannitol|mannitol|mesh-list
138280061|NCT05588869|Immunologic Factors|immunologic factors|mesh-ancestor
138280062|NCT05588869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280063|NCT05588869|Antifungal Agents|antifungal agents|mesh-ancestor
138280064|NCT05588869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280065|NCT05588869|Dermatologic Agents|dermatologic agents|mesh-ancestor
138280066|NCT05588869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138280067|NCT05588869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138280068|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
138280069|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138280070|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280071|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280072|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138280073|NCT02169336|Analgesics|analgesics|mesh-ancestor
138195858|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138195859|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
138280074|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
138280075|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280076|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138280077|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138280078|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138280079|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
138280080|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280081|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280082|NCT03043807|Docetaxel|docetaxel|mesh-list
138280083|NCT03043807|Leuprolide|leuprolide|mesh-list
138280084|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
138280085|NCT03043807|Bicalutamide|bicalutamide|mesh-list
138280086|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280087|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
138280088|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
138280089|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
138280090|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280091|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138280092|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
138280093|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138280094|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280095|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138280096|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138280097|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280098|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
138280099|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138280100|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138280101|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
138280102|NCT02609828|Tanezumab|tanezumab|mesh-list
138280103|NCT02609828|Analgesics|analgesics|mesh-ancestor
138280104|NCT02609828|Sensory System Agents|sensory system agents|mesh-ancestor
138280105|NCT02609828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280106|NCT02609828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280107|NCT05588557|Bupivacaine|bupivacaine|mesh-list
138280108|NCT05588557|Anesthetics, Local|anesthetics, local|mesh-ancestor
138280109|NCT05588557|Anesthetics|anesthetics|mesh-ancestor
138280110|NCT05588557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280111|NCT05588557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280112|NCT05588557|Sensory System Agents|sensory system agents|mesh-ancestor
138280113|NCT05588557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280114|NCT01632306|Leucovorin|leucovorin|mesh-list
138280115|NCT01632306|Paclitaxel|paclitaxel|mesh-list
138280116|NCT01632306|Gemcitabine|gemcitabine|mesh-list
138280117|NCT01632306|Fluorouracil|fluorouracil|mesh-list
138280118|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
138280119|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138280120|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280121|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
138280122|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
138280123|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
138280124|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280125|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138280126|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
138280127|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138195867|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138280128|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
138280129|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280130|NCT01632306|Antidotes|antidotes|mesh-ancestor
138280131|NCT01632306|Protective Agents|protective agents|mesh-ancestor
138280132|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
138280133|NCT01632306|Vitamins|vitamins|mesh-ancestor
138229935|NCT02557035|Hormones|hormones|mesh-ancestor
138280137|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
138280138|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
138280139|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280140|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280141|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
138280142|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280143|NCT05587933|Parasympatholytics|parasympatholytics|mesh-list
138280144|NCT05587933|Autonomic Agents|autonomic agents|mesh-ancestor
138280145|NCT05587933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280146|NCT05587933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280147|NCT02018263|Cocaine|cocaine|mesh-list
138280148|NCT02018263|Nicotine|nicotine|mesh-list
138280149|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138280150|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
138280151|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280152|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280153|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138280154|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138280155|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
138280156|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280157|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280158|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
138280159|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
138280161|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
138280162|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138280163|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138280164|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138280165|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138280166|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
138280167|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138280168|NCT02168946|Meropenem|meropenem|mesh-list
138280169|NCT02168946|Vaborbactam|vaborbactam|mesh-list
138280170|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138280171|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
138280172|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280173|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
138280174|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280175|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280176|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
138280177|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138280178|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138280179|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280180|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
138280181|NCT02650856|Coagulants|coagulants|mesh-ancestor
138280182|NCT02168478|Neomycin|neomycin|mesh-list
138280183|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138280184|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280185|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138280186|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280187|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280188|NCT00367874|Buprenorphine|buprenorphine|mesh-list
138280189|NCT00367874|Valproic Acid|valproic acid|mesh-list
138280190|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138280191|NCT00367874|Narcotics|narcotics|mesh-ancestor
138280192|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138195887|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
138280193|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280195|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
138280196|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280197|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138368661|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
138280200|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280201|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
138280202|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280203|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
138280204|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138280205|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138280207|NCT00367562|Enalapril|enalapril|mesh-list
138280208|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138280209|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138280210|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138280211|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280212|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138280213|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
138280214|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280215|NCT02302976|Exenatide|exenatide|mesh-list
138280216|NCT02302976|Cocaine|cocaine|mesh-list
138280217|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138280218|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280219|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138280220|NCT02302976|Incretins|incretins|mesh-ancestor
138280221|NCT02302976|Hormones|hormones|mesh-ancestor
138325003|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280223|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
138280224|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
138280225|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280226|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
138280227|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280228|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138280229|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138280230|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138280231|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138280232|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280233|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
138280234|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280235|NCT02244164|Liraglutide|liraglutide|mesh-list
138280237|NCT02244164|Lixisenatide|lixisenatide|mesh-list
138280238|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138280239|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138280240|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280241|NCT02244164|Incretins|incretins|mesh-ancestor
138280242|NCT02244164|Hormones|hormones|mesh-ancestor
138280243|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138280244|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138280245|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
138280246|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280247|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280248|NCT02152670|Raclopride|raclopride|mesh-list
138280249|NCT02152670|Methylphenidate|methylphenidate|mesh-list
138280250|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
138384082|NCT04933695|Sotorasib|sotorasib|mesh-list
138280252|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280253|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138280254|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138280255|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138195904|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
138280256|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280257|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
138280258|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280259|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138280260|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138280261|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280262|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138280263|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138280264|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280265|NCT02028806|Leucovorin|leucovorin|mesh-list
138280266|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
138280267|NCT02028806|Irinotecan|irinotecan|mesh-list
138280268|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280269|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138280270|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138280271|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280272|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280273|NCT02028806|Antidotes|antidotes|mesh-ancestor
138280274|NCT02028806|Protective Agents|protective agents|mesh-ancestor
138280275|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280276|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
138280277|NCT02028806|Vitamins|vitamins|mesh-ancestor
138280278|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
138280279|NCT01756118|Dactolisib|dactolisib|mesh-list
138280280|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280281|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138325024|NCT03822546|Nicotine|nicotine|mesh-list
138280282|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138280283|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
138280284|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138280285|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138280286|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280287|NCT02657252|Polidocanol|polidocanol|mesh-list
138280288|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138280289|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138280290|NCT04740086|Calcium|calcium|mesh-list
138280291|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138280292|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280293|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
138280294|NCT04739618|Ipilimumab|ipilimumab|mesh-list
138280295|NCT04739618|Sargramostim|sargramostim|mesh-list
138280296|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138280297|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280298|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138280299|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280300|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
138280301|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280302|NCT02684942|Fentanyl|fentanyl|mesh-list
138280303|NCT02684942|Meperidine|meperidine|mesh-list
138280305|NCT02684942|Narcotics|narcotics|mesh-ancestor
138280306|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280307|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280308|NCT02684942|Analgesics|analgesics|mesh-ancestor
138280309|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
138280310|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280311|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138280312|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138280313|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
138280314|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
138280315|NCT04739774|Itraconazole|itraconazole|mesh-list
138280316|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
138280317|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280318|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138280319|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138280320|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280322|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138280323|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
138280324|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138280325|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280326|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138280327|NCT02660918|Bupivacaine|bupivacaine|mesh-list
138280328|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
138280329|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
138280330|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280331|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280332|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
138280333|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280334|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
138280335|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138280336|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138280337|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280338|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280339|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138280340|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138280341|NCT00367315|Analgesics|analgesics|mesh-ancestor
138280342|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
138280344|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280345|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138280346|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138280348|NCT01192555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138280349|NCT01192555|Immunologic Factors|immunologic factors|mesh-ancestor
138280350|NCT01192555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280351|NCT01192555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138280352|NCT01192555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138280353|NCT01192555|Alkylating Agents|alkylating agents|mesh-ancestor
138280354|NCT01192555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280355|NCT01192555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280356|NCT01192555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138280358|NCT05441761|Gemcitabine|gemcitabine|mesh-list
138280359|NCT05441761|Mitoxantrone|mitoxantrone|mesh-list
138280360|NCT05441761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138280361|NCT05441761|Antiemetics|antiemetics|mesh-ancestor
138280362|NCT05441761|Autonomic Agents|autonomic agents|mesh-ancestor
138384117|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
138280363|NCT05441761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280364|NCT05441761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280365|NCT05441761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138280366|NCT05441761|Glucocorticoids|glucocorticoids|mesh-ancestor
138280367|NCT05441761|Hormones|hormones|mesh-ancestor
138280368|NCT05441761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138280369|NCT05441761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138280370|NCT05441761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280371|NCT05441761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138280372|NCT05441761|Antimetabolites|antimetabolites|mesh-ancestor
138280373|NCT05441761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280375|NCT05441761|Sensory System Agents|sensory system agents|mesh-ancestor
138280376|NCT05441761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138280377|NCT05441761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138280378|NCT05441761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280380|NCT05587621|Ezetimibe|ezetimibe|mesh-list
138280381|NCT05587621|Evolocumab|evolocumab|mesh-list
138280382|NCT05587621|Alirocumab|alirocumab|mesh-list
138280383|NCT05587621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138280384|NCT05587621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138280385|NCT05587621|Antimetabolites|antimetabolites|mesh-ancestor
138280386|NCT05587621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280387|NCT05587621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138280388|NCT05587621|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138280389|NCT05587621|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138280390|NCT05587621|Protease Inhibitors|protease inhibitors|mesh-ancestor
138280391|NCT05587621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280392|NCT05587621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138280393|NCT05587621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280394|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
138280395|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138280396|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280397|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138325046|NCT01455870|Hormones|hormones|mesh-ancestor
138280398|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280400|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138280401|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280402|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138280403|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280404|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
138280405|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138280406|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
138280407|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280408|NCT02689063|Acetaminophen|acetaminophen|mesh-list
138280409|NCT02689063|Ibuprofen|ibuprofen|mesh-list
138280410|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138280411|NCT02689063|Analgesics|analgesics|mesh-ancestor
138280412|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
138280413|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280414|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280415|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
138280416|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138280417|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138280418|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138280419|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138280420|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280421|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280422|NCT02690935|Immunomodulating Agents|immunomodulating agents|mesh-list
138280423|NCT02690935|Immunologic Factors|immunologic factors|mesh-ancestor
138280424|NCT02690935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280426|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280427|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138280428|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280429|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280430|NCT02666846|Ibuprofen|ibuprofen|mesh-list
138280431|NCT02666846|Diclofenac|diclofenac|mesh-list
138280432|NCT02666846|Salicylates|salicylates|mesh-list
138280433|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
138280434|NCT02666846|Menthol|menthol|mesh-list
138280435|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138280436|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138280437|NCT02666846|Analgesics|analgesics|mesh-ancestor
138230023|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
138230026|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
138280438|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
138280439|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280440|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280441|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138280443|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138280444|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280445|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280446|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
138280447|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
138280449|NCT02643979|Propofol|propofol|mesh-list
138280450|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138280451|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280452|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280453|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138280454|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
138280455|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
138280456|NCT02643979|Analgesics|analgesics|mesh-ancestor
138280457|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
138280458|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280459|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138280460|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138280461|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138280462|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195936|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138280463|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280464|NCT05587231|Fluorometholone|fluorometholone|mesh-list
138280465|NCT05587231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138280466|NCT05587231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280467|NCT05587231|Glucocorticoids|glucocorticoids|mesh-ancestor
138280468|NCT05587231|Hormones|hormones|mesh-ancestor
138280469|NCT05587231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138280470|NCT05587231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138280472|NCT02667704|Bosentan|bosentan|mesh-list
138280473|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280474|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138280475|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384213|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280476|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280477|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138280478|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138280479|NCT02645617|Imidacloprid|imidacloprid|mesh-list
138280480|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
138280481|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280482|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280483|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280484|NCT02694601|Caffeine|caffeine|mesh-list
138280485|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138280486|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280487|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138280488|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280489|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280490|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138280491|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138280492|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
138280493|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280494|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
138280495|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138280496|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280497|NCT02690948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138280504|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280506|NCT02691416|Sevoflurane|sevoflurane|mesh-list
138280507|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138280508|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280509|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280510|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138280511|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
138280512|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
138280513|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138280515|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
138280516|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138280517|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280518|NCT02650999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138280519|NCT02650999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280520|NCT05502211|Lidocaine|lidocaine|mesh-list
138280521|NCT05502211|Fentanyl|fentanyl|mesh-list
138280522|NCT05502211|Anesthetics, Local|anesthetics, local|mesh-ancestor
138280523|NCT05502211|Anesthetics|anesthetics|mesh-ancestor
138280524|NCT05502211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280525|NCT05502211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280526|NCT05502211|Sensory System Agents|sensory system agents|mesh-ancestor
138280527|NCT05502211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280528|NCT05502211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138280529|NCT05502211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138280530|NCT05502211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138280531|NCT05502211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138280532|NCT05502211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138195944|NCT03428958|Protective Agents|protective agents|mesh-ancestor
138195945|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
138195946|NCT03428958|Vitamins|vitamins|mesh-ancestor
138195947|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
138195949|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138280533|NCT05502211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138280534|NCT05502211|Narcotics|narcotics|mesh-ancestor
138280535|NCT05502211|Analgesics|analgesics|mesh-ancestor
138280536|NCT05502211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138280537|NCT05502211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138280538|NCT05502211|Anesthetics, General|anesthetics, general|mesh-ancestor
138280540|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138280541|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138280542|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280543|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280544|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138280545|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138280546|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
138280547|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280548|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280549|NCT04708106|Menthol|menthol|mesh-list
138280550|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
138280551|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
138280552|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
138280553|NCT02697188|Testosterone|testosterone|mesh-list
138280554|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
138280555|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
138280556|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138280559|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138280560|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280561|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138280563|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
138280564|NCT04707560|Heparin|heparin|mesh-list
138280565|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
138280566|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138280567|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138280568|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280569|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138325151|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
138280571|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138280572|NCT02701400|Durvalumab|durvalumab|mesh-list
138280573|NCT02701400|Ipilimumab|ipilimumab|mesh-list
138280574|NCT02701400|Tremelimumab|tremelimumab|mesh-list
138280575|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138280576|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280577|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138280578|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280579|NCT05403710|Botulinum Toxins|botulinum toxins|mesh-list
138280580|NCT05403710|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138280581|NCT05403710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138280582|NCT05403710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280583|NCT05403710|Cholinergic Agents|cholinergic agents|mesh-ancestor
138280584|NCT05403710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280585|NCT05403710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280586|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
138280587|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138280588|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280589|NCT05470465|Oxycodone|oxycodone|mesh-list
138280590|NCT05470465|Paroxetine|paroxetine|mesh-list
138280591|NCT05470465|Escitalopram|escitalopram|mesh-list
138280592|NCT05470465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138280593|NCT05470465|Narcotics|narcotics|mesh-ancestor
138280594|NCT05470465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280595|NCT05470465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280596|NCT05470465|Analgesics|analgesics|mesh-ancestor
138280597|NCT05470465|Sensory System Agents|sensory system agents|mesh-ancestor
138280598|NCT05470465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280599|NCT05470465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138195950|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280600|NCT05470465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138280601|NCT05470465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138280602|NCT05470465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280603|NCT05470465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280604|NCT05470465|Serotonin Agents|serotonin agents|mesh-ancestor
138280605|NCT05470465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138280606|NCT05470465|Antidepressive Agents|antidepressive agents|mesh-ancestor
138280607|NCT05470465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138280608|NCT05470465|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138280609|NCT05470465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138280610|NCT05470465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280611|NCT00368030|Eszopiclone|eszopiclone|mesh-list
138280612|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138280613|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280614|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280615|NCT02656069|Glucagon|glucagon|mesh-list
138280616|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138280617|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138280618|NCT02656069|Hormones|hormones|mesh-ancestor
138280619|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138325204|NCT05027100|Irinotecan|irinotecan|mesh-list
138280620|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280621|NCT02656069|Incretins|incretins|mesh-ancestor
138280622|NCT05351762|Paclitaxel|paclitaxel|mesh-list
138280623|NCT05351762|Nimotuzumab|nimotuzumab|mesh-list
138280624|NCT05351762|Nedaplatin|nedaplatin|mesh-list
138280625|NCT05351762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138280626|NCT05351762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280627|NCT05351762|Tubulin Modulators|tubulin modulators|mesh-ancestor
138280628|NCT05351762|Antimitotic Agents|antimitotic agents|mesh-ancestor
138280629|NCT05351762|Mitosis Modulators|mitosis modulators|mesh-ancestor
138280630|NCT05351762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280631|NCT05351762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138280632|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
138280633|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138280634|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280635|NCT02708641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138280636|NCT02708641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280637|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
138280638|NCT02710981|Clomiphene|clomiphene|mesh-list
138280639|NCT02710981|Enclomiphene|enclomiphene|mesh-list
138280640|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
138280641|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280642|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
138280643|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138280644|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138280645|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280646|NCT02710981|Urological Agents|urological agents|mesh-ancestor
138280647|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138280648|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
138280649|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138280650|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280651|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138280652|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
138280653|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138280654|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138280655|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138280656|NCT04738838|Oxytocin|oxytocin|mesh-list
138280657|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
138280658|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138280659|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280660|NCT04739917|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138280661|NCT04739917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138280662|NCT04739917|Immunologic Factors|immunologic factors|mesh-ancestor
138280663|NCT04739917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280664|NCT02659501|Acetaminophen|acetaminophen|mesh-list
138280665|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138280666|NCT02659501|Epinephrine|epinephrine|mesh-list
138280667|NCT02659501|Diazepam|diazepam|mesh-list
138280668|NCT02659501|Morphine|morphine|mesh-list
138280669|NCT02659501|Hydrocodone|hydrocodone|mesh-list
138280670|NCT02659501|Bupivacaine|bupivacaine|mesh-list
138280671|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
138280672|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
138280673|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280674|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280675|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
138280676|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280677|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138280678|NCT02659501|Narcotics|narcotics|mesh-ancestor
138280679|NCT02659501|Analgesics|analgesics|mesh-ancestor
138280680|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138280681|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
138280682|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138280683|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138280684|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
138280685|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138230081|NCT05296460|Leprostatic Agents|leprostatic agents|mesh-ancestor
138280687|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138280688|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138280689|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
138280690|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138280691|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
138280692|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
138280693|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
138384369|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
138280694|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138280695|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
138280696|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138280697|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
138280698|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
138280699|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138280700|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138280701|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138280702|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138280703|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138280704|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138280705|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138280706|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138280707|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
138280708|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
138280709|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
138280710|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138280711|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138280712|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138280714|NCT00367939|Valsartan|valsartan|mesh-list
138280715|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138280716|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138280717|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138280718|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280719|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138280720|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280721|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
138280722|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138195969|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
138280723|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138280724|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138280725|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138280726|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280727|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138280728|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
138280729|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280730|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
138280731|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138280732|NCT02722837|Velpatasvir|velpatasvir|mesh-list
138280733|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
138280734|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280737|NCT02710526|Narcotics|narcotics|mesh-ancestor
138280738|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280739|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280740|NCT02710526|Analgesics|analgesics|mesh-ancestor
138280741|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
138280742|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280743|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138280744|NCT02664961|Bevacizumab|bevacizumab|mesh-list
138280745|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138280746|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280747|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138280748|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138280750|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280751|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
138280752|NCT02665273|Bupivacaine|bupivacaine|mesh-list
138280753|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
138280754|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
138280755|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280756|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280757|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
138280758|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280759|NCT02713178|Bupivacaine|bupivacaine|mesh-list
138280760|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
138280761|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
138280762|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138280763|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280764|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
138280765|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280766|NCT04048850|Grazoprevir|grazoprevir|mesh-list
138280767|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138280768|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
138280769|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280770|NCT02714504|Voriconazole|voriconazole|mesh-list
138280771|NCT02714504|Posaconazole|posaconazole|mesh-list
138280772|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
138280773|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280774|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138280775|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138280776|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280777|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280778|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138280779|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
138280780|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138280781|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280782|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138280783|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138280784|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138280785|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138280786|NCT00368576|Darapladib|darapladib|mesh-list
138280787|NCT00368576|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138280788|NCT00368576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195987|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
138280789|NCT00368576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280790|NCT02730247|Paclitaxel|paclitaxel|mesh-list
138280791|NCT02730247|Ramucirumab|ramucirumab|mesh-list
138280792|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138280793|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280794|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
138280795|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
138280796|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
138280797|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280798|NCT03889106|Ribavirin|ribavirin|mesh-list
138280799|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
138230101|NCT01172600|Entonox|entonox|mesh-list
138280800|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280801|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
138280802|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280803|NCT00368329|Carboplatin|carboplatin|mesh-list
138280804|NCT00368329|Capecitabine|capecitabine|mesh-list
138280805|NCT00368329|Fluorouracil|fluorouracil|mesh-list
138280806|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138280807|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280808|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138280809|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
138280810|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280811|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138280812|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
138280813|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280814|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138280815|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
138280816|NCT02670343|Testosterone|testosterone|mesh-list
138280817|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
138280818|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
138280819|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138280820|NCT02670343|Androgens|androgens|mesh-ancestor
138280822|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138280823|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280824|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138280825|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280826|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
138280827|NCT02730884|ON 01910|on 01910|mesh-list
138280828|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280829|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138280830|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280831|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280832|NCT02732587|Saracatinib|saracatinib|mesh-list
138280833|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280834|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280835|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280836|NCT02731820|Vitamin D|vitamin d|mesh-list
138280837|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
138280838|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
138280839|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
138280840|NCT02731820|Calcium|calcium|mesh-list
138280842|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
138280843|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280844|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138280845|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138280846|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280848|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138280849|NCT02731820|Diuretics|diuretics|mesh-ancestor
138280850|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
138280851|NCT02731820|Expectorants|expectorants|mesh-ancestor
138280852|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
138280853|NCT02732899|Sirolimus|sirolimus|mesh-list
138280854|NCT02732899|Aflibercept|aflibercept|mesh-list
138280855|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138280856|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280857|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138280858|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280859|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
138280860|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138280861|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
138280862|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280863|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138280864|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138280865|NCT02732899|Growth Substances|growth substances|mesh-ancestor
138280866|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
138280867|NCT02733757|Clonidine|clonidine|mesh-list
138280868|NCT02733757|Analgesics|analgesics|mesh-ancestor
138280869|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
138280870|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138230133|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
138280872|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138280873|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
138280874|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
138280875|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138280876|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138280877|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138280878|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
138280879|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138280880|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280881|NCT00368264|Infliximab|infliximab|mesh-list
138280882|NCT00368264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138280883|NCT00368264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138280884|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
138280885|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138280886|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138280887|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
138280888|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
138280889|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280890|NCT02734147|Protective Agents|protective agents|mesh-ancestor
138280891|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280892|NCT02734147|Vitamins|vitamins|mesh-ancestor
138280893|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
138280894|NCT00368342|Azithromycin|azithromycin|mesh-list
138280895|NCT00368342|Clarithromycin|clarithromycin|mesh-list
138280896|NCT00368342|Erythromycin|erythromycin|mesh-list
138280897|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
138280898|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138325289|NCT02716974|Leuprolide|leuprolide|mesh-list
138280899|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
138280900|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138280901|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280902|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138280903|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280904|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280905|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138280906|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138280907|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138280908|NCT03609008|Cromakalim|cromakalim|mesh-list
138280909|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138280910|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138280911|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
138280912|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280913|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280914|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138280915|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
138280916|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
138280917|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
138280918|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
138280919|NCT02734238|Testosterone|testosterone|mesh-list
138280920|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
138280921|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
138280922|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138280923|NCT02734238|Androgens|androgens|mesh-ancestor
138280924|NCT02734238|Hormones|hormones|mesh-ancestor
138280925|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138280926|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280927|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138280928|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280929|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
138280930|NCT04707547|Nivolumab|nivolumab|mesh-list
138280931|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138230142|NCT01138124|Gabapentin|gabapentin|mesh-list
138280932|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280933|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138280934|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280935|NCT02736175|Dexamethasone|dexamethasone|mesh-list
138280936|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138280937|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
138280938|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
138280939|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280940|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280941|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138280942|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
138280944|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138280945|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138280946|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280947|NCT00369356|Prednisone|prednisone|mesh-list
138325304|NCT01459380|Bevacizumab|bevacizumab|mesh-list
138280948|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138280950|NCT00369356|Hormones|hormones|mesh-ancestor
138280951|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138280952|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280953|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138280954|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280955|NCT03357224|Atezolizumab|atezolizumab|mesh-list
138280956|NCT03357224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138280957|NCT03357224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280958|NCT03357224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138280959|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280960|NCT02679469|Nalmefene|nalmefene|mesh-list
138280961|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138280962|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280963|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
138280964|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138280965|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
138280966|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138280967|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138280968|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280969|NCT05445661|Mannitol|mannitol|mesh-list
138280970|NCT05445661|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138280971|NCT05445661|Diuretics|diuretics|mesh-ancestor
138280972|NCT05445661|Natriuretic Agents|natriuretic agents|mesh-ancestor
138280973|NCT05445661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280974|NCT04805125|Vaccines|vaccines|mesh-list
138280975|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
138280976|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280977|NCT00368017|Pioglitazone|pioglitazone|mesh-list
138280978|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138280979|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138280980|NCT00367627|Albendazole|albendazole|mesh-list
138280982|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138280983|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138280984|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
138280985|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138384548|NCT03635892|Nivolumab|nivolumab|mesh-list
138280986|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138280987|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
138280988|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
138280989|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
138196013|NCT05292976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138196014|NCT05292976|Cholinergic Agents|cholinergic agents|mesh-ancestor
138196015|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
138196016|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138196017|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138280990|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280991|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138280992|NCT05443789|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138280993|NCT05443789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138280994|NCT05443789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138280996|NCT05424523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138280997|NCT05424523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138280999|NCT05442931|Magnesium Sulfate|magnesium sulfate|mesh-list
138281001|NCT05442931|Nitroglycerin|nitroglycerin|mesh-list
138281002|NCT05442931|Analgesics|analgesics|mesh-ancestor
138281003|NCT05442931|Sensory System Agents|sensory system agents|mesh-ancestor
138281004|NCT05442931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281005|NCT05442931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281006|NCT05442931|Anticonvulsants|anticonvulsants|mesh-ancestor
138281007|NCT05442931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138281008|NCT05442931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138281009|NCT05442931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281010|NCT05442931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138281011|NCT05442931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138281012|NCT05442931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138281013|NCT05442931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138281014|NCT05442931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138281015|NCT05442931|Anesthetics|anesthetics|mesh-ancestor
138281016|NCT05442931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138281017|NCT05442931|Tocolytic Agents|tocolytic agents|mesh-ancestor
138281018|NCT05442931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138281019|NCT05442931|Vasodilator Agents|vasodilator agents|mesh-ancestor
138281020|NCT05439499|Letrozole|letrozole|mesh-list
138281021|NCT05439499|Anastrozole|anastrozole|mesh-list
138281022|NCT05439499|Goserelin|goserelin|mesh-list
138281023|NCT05439499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281024|NCT05439499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138281025|NCT05439499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138281026|NCT05439499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281027|NCT05439499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281028|NCT05439499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138281029|NCT05439499|Hormone Antagonists|hormone antagonists|mesh-ancestor
138196022|NCT00850720|Coagulants|coagulants|mesh-ancestor
138281030|NCT05439499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138281031|NCT05439499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281032|NCT05439499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138281034|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
138281035|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
138281036|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138281037|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281038|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
138281039|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281040|NCT05448001|Lansoprazole|lansoprazole|mesh-list
138281041|NCT05448001|Dexlansoprazole|dexlansoprazole|mesh-list
138281042|NCT05448001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138281043|NCT05448001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138281044|NCT05448001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138281046|NCT05448001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281047|NCT05447455|Anesthetics|anesthetics|mesh-list
138281048|NCT05447455|Anesthetics, Local|anesthetics, local|mesh-list
138281049|NCT05447455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138281050|NCT05447455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281051|NCT05447455|Sensory System Agents|sensory system agents|mesh-ancestor
138281052|NCT05447455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281053|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
138281054|NCT00369733|Hematinics|hematinics|mesh-ancestor
138281055|NCT00368719|Tacrolimus|tacrolimus|mesh-list
138281056|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138281057|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
138281058|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281059|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138281060|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281061|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281062|NCT00369811|Fentanyl|fentanyl|mesh-list
138281063|NCT00369811|Oxycodone|oxycodone|mesh-list
138281064|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138281065|NCT00369811|Narcotics|narcotics|mesh-ancestor
138281066|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138230169|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281067|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281068|NCT00369811|Analgesics|analgesics|mesh-ancestor
138281069|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
138281070|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281071|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138281072|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138281073|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
138281075|NCT03615547|Clomiphene|clomiphene|mesh-list
138281076|NCT03615547|Enclomiphene|enclomiphene|mesh-list
138281077|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
138281078|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138281079|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
138281080|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138281081|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281082|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138281083|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
138281084|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138281085|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138281086|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138281087|NCT03105128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138281088|NCT03105128|Immunologic Factors|immunologic factors|mesh-ancestor
138281089|NCT03105128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281090|NCT03122509|Durvalumab|durvalumab|mesh-list
138281091|NCT03122509|Tremelimumab|tremelimumab|mesh-list
138281092|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138196062|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
138196063|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138196064|NCT01675960|Gabapentin|gabapentin|mesh-list
138281093|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281095|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
138281096|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
138281097|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281098|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138281099|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138281100|NCT03113695|Growth Substances|growth substances|mesh-ancestor
138281101|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
138281102|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281104|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138281105|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138281106|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138281107|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138281108|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281109|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281110|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281111|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
138281112|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138281113|NCT05444738|Oxytocin|oxytocin|mesh-list
138281114|NCT05444738|Oxytocics|oxytocics|mesh-ancestor
138281115|NCT05444738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138281116|NCT05444738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281117|NCT05243953|Cromakalim|cromakalim|mesh-list
138281118|NCT05243953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138384653|NCT03435250|Paclitaxel|paclitaxel|mesh-list
138281119|NCT05243953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138281121|NCT05243953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281122|NCT05243953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281123|NCT05243953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138281124|NCT05243953|Respiratory System Agents|respiratory system agents|mesh-ancestor
138281125|NCT05243953|Parasympatholytics|parasympatholytics|mesh-ancestor
138281126|NCT05243953|Vasodilator Agents|vasodilator agents|mesh-ancestor
138281127|NCT02757313|Dronabinol|dronabinol|mesh-list
138281128|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
138281129|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281130|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138281131|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138281132|NCT02757313|Analgesics|analgesics|mesh-ancestor
138281133|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
138281134|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281135|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138281136|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138281137|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281138|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281139|NCT02757313|Hormones|hormones|mesh-ancestor
138281140|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138281141|NCT02379806|Enoxaparin|enoxaparin|mesh-list
138281142|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
138281143|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138281144|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138281145|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281146|NCT02358356|Capecitabine|capecitabine|mesh-list
138281147|NCT02358356|Temozolomide|temozolomide|mesh-list
138281148|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138281149|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
138281150|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281151|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281152|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138281153|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
138281154|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
138281155|NCT04700761|Anesthetics|anesthetics|mesh-list
138281156|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138281157|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281158|NCT04700761|Narcotics|narcotics|mesh-ancestor
138281159|NCT04700761|Analgesics|analgesics|mesh-ancestor
138281160|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
138384671|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
138281161|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281163|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138281164|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138281166|NCT05172817|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138281167|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138281168|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138281169|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
138281170|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138281171|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281172|NCT05145907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138281173|NCT05145907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281174|NCT00961142|Fludarabine|fludarabine|mesh-list
138281175|NCT00961142|Melphalan|melphalan|mesh-list
138281176|NCT00961142|Thiotepa|thiotepa|mesh-list
138281177|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
138281178|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281179|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281180|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138281181|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
138281182|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281183|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138281185|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138281186|NCT04338373|Atropine|atropine|mesh-list
138281187|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138281188|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138281189|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138281190|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
138281191|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281192|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281193|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138281194|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
138281195|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
138281196|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
138281197|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138281198|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138281199|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
138281200|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281201|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281202|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
138281203|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138281204|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
138281205|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281206|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138281207|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281208|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
138281209|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138281210|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
138281211|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138281212|NCT00369031|Protective Agents|protective agents|mesh-ancestor
138281213|NCT05061901|Lisinopril|lisinopril|mesh-list
138281214|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138281215|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
138281216|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281217|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281218|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138281219|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138281220|NCT05061901|Protective Agents|protective agents|mesh-ancestor
138281221|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281224|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138281225|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138281226|NCT04338919|Analgesics|analgesics|mesh-ancestor
138281227|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
138281228|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281229|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281230|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138281231|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138281232|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138281233|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138281234|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281235|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138281236|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138281237|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281238|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
138281239|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138281240|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138281241|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138281242|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
138281243|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281244|NCT05451290|Gemcitabine|gemcitabine|mesh-list
138281245|NCT05451290|Tegafur|tegafur|mesh-list
138281246|NCT05451290|Oxaliplatin|oxaliplatin|mesh-list
138281247|NCT05451290|Apatinib|apatinib|mesh-list
138281248|NCT05451290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138281249|NCT05451290|Antimetabolites|antimetabolites|mesh-ancestor
138281250|NCT05451290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281251|NCT05451290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281252|NCT05451290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138281253|NCT05451290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281254|NCT00369889|Bevacizumab|bevacizumab|mesh-list
138281255|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138281256|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138281257|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281258|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138281259|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138325454|NCT01451736|Risperidone|risperidone|mesh-list
138281260|NCT00369889|Growth Substances|growth substances|mesh-ancestor
138281261|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281262|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
138281263|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138281264|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281265|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281266|NCT00369044|Prednisone|prednisone|mesh-list
138281267|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138281268|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
138281269|NCT00369044|Hormones|hormones|mesh-ancestor
138281270|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138281271|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281272|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138281273|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281274|NCT00370045|Bivalirudin|bivalirudin|mesh-list
138281275|NCT00370045|Eptifibatide|eptifibatide|mesh-list
138281276|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
138281277|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138281278|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
138281279|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281280|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281281|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
138281282|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138281283|NCT05451056|Sotorasib|sotorasib|mesh-list
138281284|NCT05451056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138281285|NCT05451056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281286|NCT05451056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138281287|NCT05451056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281289|NCT05441150|Analgesics|analgesics|mesh-ancestor
138281290|NCT05441150|Sensory System Agents|sensory system agents|mesh-ancestor
138281291|NCT05441150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281292|NCT05441150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281293|NCT05441150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138196093|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
138281294|NCT05441150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138281295|NCT05441150|Anesthetics, General|anesthetics, general|mesh-ancestor
138281296|NCT05441150|Anesthetics|anesthetics|mesh-ancestor
138281297|NCT05441150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138281298|NCT05441150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138281299|NCT05441150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138281300|NCT05441150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281301|NCT05441150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281302|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138281303|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138281304|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138325470|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138281305|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281306|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
138281307|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281308|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281309|NCT05438810|Fulvestrant|fulvestrant|mesh-list
138281310|NCT05438810|Goserelin|goserelin|mesh-list
138281311|NCT05438810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138281312|NCT05438810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281313|NCT05438810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138281314|NCT05438810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138281315|NCT05438810|Hormone Antagonists|hormone antagonists|mesh-ancestor
138281316|NCT05438810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138281317|NCT05438810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281318|NCT05451121|Dexmedetomidine|dexmedetomidine|mesh-list
138281319|NCT05451121|Propofol|propofol|mesh-list
138281320|NCT05451121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138281321|NCT05451121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138281322|NCT05451121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281323|NCT05451121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138281324|NCT05451121|Analgesics|analgesics|mesh-ancestor
138281325|NCT05451121|Sensory System Agents|sensory system agents|mesh-ancestor
138281326|NCT05451121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281327|NCT05451121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138281328|NCT05451121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138281329|NCT05451121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138281330|NCT05451121|Adrenergic Agents|adrenergic agents|mesh-ancestor
138281331|NCT05451121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281332|NCT05451121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281333|NCT05451121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138281334|NCT05451121|Anesthetics, General|anesthetics, general|mesh-ancestor
138281335|NCT05451121|Anesthetics|anesthetics|mesh-ancestor
138281336|NCT04967443|Prazosin|prazosin|mesh-list
138281337|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138281338|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138281339|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138281340|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138281341|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
138281342|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281343|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281344|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281345|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
138281346|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196100|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138281347|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
138281348|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
138281349|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
138281350|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
138230182|NCT01173848|Vitamins|vitamins|mesh-ancestor
138281351|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138281352|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138281353|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138384782|NCT02966665|Phentolamine|phentolamine|mesh-list
138281354|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138281355|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281356|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
138281357|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281358|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281359|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138281360|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281362|NCT05447936|Vitamins|vitamins|mesh-ancestor
138281363|NCT05447936|Micronutrients|micronutrients|mesh-ancestor
138281364|NCT05447936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281365|NCT05447936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138281366|NCT04739384|Ticagrelor|ticagrelor|mesh-list
138281367|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138281368|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138281369|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138281370|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138281371|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
138281372|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281373|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281374|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281375|NCT04704596|Anesthetics|anesthetics|mesh-list
138281376|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138281377|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281378|NCT05450497|Dexmedetomidine|dexmedetomidine|mesh-list
138281379|NCT05450497|Propofol|propofol|mesh-list
138281380|NCT05450497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138281381|NCT05450497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138281382|NCT05450497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281384|NCT05450497|Analgesics|analgesics|mesh-ancestor
138281385|NCT05450497|Sensory System Agents|sensory system agents|mesh-ancestor
138281386|NCT05450497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281387|NCT05450497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138281388|NCT05450497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138281389|NCT05450497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138281390|NCT05450497|Adrenergic Agents|adrenergic agents|mesh-ancestor
138281391|NCT05450497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281392|NCT05450497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281393|NCT05450497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138281394|NCT05450497|Anesthetics, General|anesthetics, general|mesh-ancestor
138281395|NCT05450497|Anesthetics|anesthetics|mesh-ancestor
138281396|NCT02230332|Alendronate|alendronate|mesh-list
138281397|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138281398|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281399|NCT05449028|Bismuth|bismuth|mesh-list
138281400|NCT05449028|Antacids|antacids|mesh-ancestor
138281401|NCT05449028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281402|NCT05449028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138281403|NCT04845139|Nivolumab|nivolumab|mesh-list
138281404|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138384825|NCT02945241|Vancomycin|vancomycin|mesh-list
138281405|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281406|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138281407|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281408|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
138281409|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
138281410|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138281411|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281412|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281413|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
138281414|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138281415|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138281416|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281418|NCT05449483|Tislelizumab|tislelizumab|mesh-list
138281419|NCT05449483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138281420|NCT05449483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281421|NCT05449483|Tubulin Modulators|tubulin modulators|mesh-ancestor
138281422|NCT05449483|Antimitotic Agents|antimitotic agents|mesh-ancestor
138281423|NCT05449483|Mitosis Modulators|mitosis modulators|mesh-ancestor
138281424|NCT05449483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281425|NCT05449483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138281426|NCT05448404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138281427|NCT05448404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138281428|NCT05448404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281429|NCT04793659|Fasudil|fasudil|mesh-list
138281430|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
138281431|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138281432|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138281433|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281434|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138281435|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281437|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138281438|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281439|NCT05448937|Eugenol|eugenol|mesh-list
138281440|NCT05448937|Zinc Oxide|zinc oxide|mesh-list
138281441|NCT05448937|Dermatologic Agents|dermatologic agents|mesh-ancestor
138281442|NCT05448937|Sunscreening Agents|sunscreening agents|mesh-ancestor
138281443|NCT05448937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138281444|NCT05448937|Protective Agents|protective agents|mesh-ancestor
138384830|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
138281445|NCT05448937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281446|NCT05448937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138281447|NCT00370201|Colchicine|colchicine|mesh-list
138281448|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
138281449|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138281450|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
138281451|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
138281452|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
138281453|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281454|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281455|NCT05448781|Paclitaxel|paclitaxel|mesh-list
138281456|NCT05448781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138281457|NCT05448781|Carboplatin|carboplatin|mesh-list
138281458|NCT05448781|Pemetrexed|pemetrexed|mesh-list
138281459|NCT05448781|Endostatins|endostatins|mesh-list
138281460|NCT05448781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138281461|NCT05448781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281462|NCT05448781|Tubulin Modulators|tubulin modulators|mesh-ancestor
138281463|NCT05448781|Antimitotic Agents|antimitotic agents|mesh-ancestor
138281464|NCT05448781|Mitosis Modulators|mitosis modulators|mesh-ancestor
138281465|NCT05448781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281466|NCT05448781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281467|NCT05448781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138281468|NCT05448781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138281469|NCT05448781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138281470|NCT05448781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138281471|NCT05448781|Growth Substances|growth substances|mesh-ancestor
138281472|NCT05448781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281473|NCT05448781|Growth Inhibitors|growth inhibitors|mesh-ancestor
138281474|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138281475|NCT00370825|Miltefosine|miltefosine|mesh-list
138281476|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
138196130|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
138281477|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138281478|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138281479|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138281480|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281481|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
138281482|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138281483|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281484|NCT02535247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138281485|NCT02535247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281488|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138281489|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281490|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
138281491|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281492|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138281493|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281494|NCT02626130|Tremelimumab|tremelimumab|mesh-list
138281495|NCT02626130|Ipilimumab|ipilimumab|mesh-list
138281496|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384866|NCT02773030|Hormones|hormones|mesh-ancestor
138281497|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138281498|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138281499|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281501|NCT02618720|Amebicides|amebicides|mesh-ancestor
138281502|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138281503|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138281504|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138281505|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138281506|NCT02042989|Vorinostat|vorinostat|mesh-list
138281507|NCT02042989|Ixazomib|ixazomib|mesh-list
138281508|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281509|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138281510|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281511|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281512|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
138281513|NCT04093531|Ustekinumab|ustekinumab|mesh-list
138281514|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
138281515|NCT05208944|Cemiplimab|cemiplimab|mesh-list
138281516|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138281517|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281518|NCT01809379|Cisplatin|cisplatin|mesh-list
138281519|NCT01809379|Doxorubicin|doxorubicin|mesh-list
138281520|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281521|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138281522|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138281523|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138281524|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281525|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281526|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
138281527|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138281528|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281529|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138281530|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281531|NCT05202158|Gentamicins|gentamicins|mesh-list
138281532|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138281533|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138281534|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138281535|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281536|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281537|NCT00370370|Triamcinolone|triamcinolone|mesh-list
138281538|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138281539|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138281540|NCT00370370|Bevacizumab|bevacizumab|mesh-list
138281541|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138281542|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138281543|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281544|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138230217|NCT01178528|Carvedilol|carvedilol|mesh-list
138281545|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138281546|NCT00370370|Growth Substances|growth substances|mesh-ancestor
138281547|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281548|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
138281549|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138281550|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
138281552|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138281553|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138281554|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
138281555|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281556|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281557|NCT02197416|Dabigatran|dabigatran|mesh-list
138281558|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
138281559|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138281560|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
138281561|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281562|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281563|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
138281566|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138281567|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138281568|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138281569|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
138281570|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281571|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281572|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138281573|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
138281574|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
138281575|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138281576|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138281577|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138281578|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138281579|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
138281580|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138325564|NCT02549898|Cilostazol|cilostazol|mesh-list
138281581|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281582|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138281583|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281584|NCT00371527|Ipratropium|ipratropium|mesh-list
138281585|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138281586|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
138281587|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281588|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281589|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138281590|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
138281591|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138281592|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
138281593|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281594|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281595|NCT00392756|Hormones|hormones|mesh-list
138281596|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138281597|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281598|NCT04027322|Dexamethasone|dexamethasone|mesh-list
138196156|NCT01558492|Paclitaxel|paclitaxel|mesh-list
138281599|NCT04027322|Budesonide|budesonide|mesh-list
138281600|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138281601|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
138281602|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
138281603|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281604|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281605|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138281606|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
138281607|NCT04027322|Hormones|hormones|mesh-ancestor
138281608|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138281609|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138281610|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281611|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138281612|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138281613|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
138281614|NCT03845257|Dimercaprol|dimercaprol|mesh-list
138281615|NCT03845257|Chelating Agents|chelating agents|mesh-ancestor
138281616|NCT03845257|Sequestering Agents|sequestering agents|mesh-ancestor
138281617|NCT03845257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281618|NCT00371072|Mitomycins|mitomycins|mesh-list
138281619|NCT00371072|Mitomycin|mitomycin|mesh-list
138281620|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138281621|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281622|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
138281623|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281624|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138281625|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281626|NCT05454332|Caffeine|caffeine|mesh-list
138281627|NCT05454332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138281628|NCT05454332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138325586|NCT02513784|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138281630|NCT05454332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281631|NCT05454332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281632|NCT05454332|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138281633|NCT05454332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138281634|NCT05454332|Purinergic Agents|purinergic agents|mesh-ancestor
138281635|NCT05454332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281636|NCT03924518|Granisetron|granisetron|mesh-list
138281637|NCT03924518|Serotonin|serotonin|mesh-list
138281638|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
138281639|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
138281640|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281641|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281642|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138281643|NCT03924518|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138281644|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138281645|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
138281646|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281647|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281648|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138281649|NCT05454085|Bisphenol A|bisphenol a|mesh-list
138384945|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138281650|NCT05454085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138281651|NCT05454085|Estrogens|estrogens|mesh-ancestor
138281652|NCT05454085|Hormones|hormones|mesh-ancestor
138281653|NCT05454085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138281654|NCT05454085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281655|NCT05454085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138281656|NCT05454085|Antioxidants|antioxidants|mesh-ancestor
138281657|NCT05454085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281658|NCT05454085|Protective Agents|protective agents|mesh-ancestor
138281659|NCT03886922|Cromakalim|cromakalim|mesh-list
138281660|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138281661|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138196166|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281662|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
138281663|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281664|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281665|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138281666|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
138281667|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
138281668|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
138281669|NCT05453552|Cyclophosphamide|cyclophosphamide|mesh-list
138281671|NCT05453552|Fludarabine|fludarabine|mesh-list
138281672|NCT05453552|Decitabine|decitabine|mesh-list
138281673|NCT05453552|Lenograstim|lenograstim|mesh-list
138281674|NCT05453552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138281675|NCT05453552|Immunologic Factors|immunologic factors|mesh-ancestor
138281676|NCT05453552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281677|NCT05453552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138281678|NCT05453552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138281679|NCT05453552|Alkylating Agents|alkylating agents|mesh-ancestor
138281680|NCT05453552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281681|NCT05453552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281682|NCT05453552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138281683|NCT05453552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138281684|NCT05453552|Antimetabolites|antimetabolites|mesh-ancestor
138281685|NCT05453552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281686|NCT05453552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138281688|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138384961|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
138281689|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138281690|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138281691|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
138281692|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
138281693|NCT02165202|Rilpivirine|rilpivirine|mesh-list
138281694|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138281695|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138281696|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281697|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281698|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
138281699|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138281700|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138281701|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138281703|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138281704|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
138281705|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
138281706|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138281707|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281708|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
138281709|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281710|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138281711|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138281712|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138281713|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138281714|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281715|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138281717|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138281718|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196178|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
138196183|NCT05482464|Caseins|caseins|mesh-list
138281719|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138281720|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281721|NCT03770689|Capecitabine|capecitabine|mesh-list
138281722|NCT03770689|Peposertib|peposertib|mesh-list
138281723|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138281724|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
138281725|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281726|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281727|NCT03770689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138281728|NCT03770689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281729|NCT00371306|Metformin|metformin|mesh-list
138281730|NCT00371306|Glyburide|glyburide|mesh-list
138281731|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138281732|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281733|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
138281734|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
138281735|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138281736|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
138281737|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281738|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281739|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138281740|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
138281741|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138281742|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138281743|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138281744|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
138281745|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281746|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281747|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138281748|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138281749|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138281753|NCT00370760|Heparin|heparin|mesh-list
138281754|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138281755|NCT00370760|Tinzaparin|tinzaparin|mesh-list
138281756|NCT00370760|Dalteparin|dalteparin|mesh-list
138281757|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138281758|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
138281759|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
138281760|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281761|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281762|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138281763|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
138281765|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138281766|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138281767|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281768|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
138281769|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138281770|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138281771|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281772|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
138281773|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138281774|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
138281775|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
138281776|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
138281777|NCT05203562|Letrozole|letrozole|mesh-list
138281778|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281779|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138281780|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138281781|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281782|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281783|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138281784|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
138325727|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
138196196|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138281785|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138281786|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281789|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138281790|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138281791|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281792|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138281793|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281794|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138281795|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
138281796|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
138281797|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281798|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
138281799|NCT04330040|Olaparib|olaparib|mesh-list
138281800|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138281801|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281802|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281803|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281805|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138281806|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138281807|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
138281808|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
138281809|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281810|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281811|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138281812|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138281813|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138281814|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
138281815|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281816|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281817|NCT02196558|Quetmolimab|quetmolimab|mesh-list
138281818|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138281819|NCT04809662|Imiquimod|imiquimod|mesh-list
138281820|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138281821|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
138281822|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281823|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281824|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
138281825|NCT02196324|Serlopitant|serlopitant|mesh-list
138281826|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138281827|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281828|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281829|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281831|NCT05450419|Cholecalciferol|cholecalciferol|mesh-list
138281832|NCT05450419|Vitamins|vitamins|mesh-ancestor
138281833|NCT05450419|Micronutrients|micronutrients|mesh-ancestor
138281834|NCT05450419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138230224|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138281835|NCT05450419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138281836|NCT05450419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138281838|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138281839|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138281840|NCT00370669|Bevacizumab|bevacizumab|mesh-list
138281841|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138281842|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138281843|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281844|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138281845|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138281846|NCT00370669|Growth Substances|growth substances|mesh-ancestor
138281847|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281848|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
138281849|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138281850|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
138281851|NCT00370669|Hormones|hormones|mesh-ancestor
138281852|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138281853|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138281854|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
138281855|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281856|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281857|NCT02740543|Fluticasone|fluticasone|mesh-list
138281858|NCT02740543|Xhance|xhance|mesh-list
138281859|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138281860|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138281861|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
138281862|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281863|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281864|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138281865|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
138281866|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
138281867|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138281868|NCT00370747|Ecabet|ecabet|mesh-list
138281869|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138281870|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138281871|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138281872|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
138281873|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281874|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281875|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138281876|NCT00370747|Protective Agents|protective agents|mesh-ancestor
138281877|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281878|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281879|NCT02752256|Plasminogen|plasminogen|mesh-list
138325787|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138281880|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138281881|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138281882|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138281883|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281884|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138281885|NCT02227446|Vancomycin|vancomycin|mesh-list
138281886|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138281887|NCT04738058|Lactoferrin|lactoferrin|mesh-list
138281888|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138281889|NCT02227368|Ticagrelor|ticagrelor|mesh-list
138281890|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281891|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281892|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138281893|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138281894|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138281895|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138281896|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
138281897|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281898|NCT02162862|Bupropion|bupropion|mesh-list
138281899|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138281900|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
138281901|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138281902|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138281903|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138281904|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138230227|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138281905|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281906|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
138281907|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281908|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281909|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138281910|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138281911|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281913|NCT05277727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138281914|NCT05277727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138196217|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138196218|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138196219|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281915|NCT05277727|Anticoagulants|anticoagulants|mesh-ancestor
138281916|NCT05277727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281917|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138281918|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138281919|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138281920|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
138281921|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281922|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138281923|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138281924|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281926|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138281927|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138281928|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138325823|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
138281929|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138281930|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281931|NCT02751385|Nintedanib|nintedanib|mesh-list
138281932|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138281933|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138281934|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138281935|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138281936|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281937|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281938|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138281939|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
138281940|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138281941|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281942|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138281943|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138281944|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138281945|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138281946|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138281947|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138281948|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138385154|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
138281949|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138281950|NCT05349032|Curcumin|curcumin|mesh-list
138281951|NCT05349032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138281952|NCT05349032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138281953|NCT05349032|Analgesics|analgesics|mesh-ancestor
138281954|NCT05349032|Sensory System Agents|sensory system agents|mesh-ancestor
138281955|NCT05349032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281956|NCT05349032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281957|NCT05349032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138281958|NCT05349032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138281959|NCT05349032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138230233|NCT02980250|Domperidone|domperidone|mesh-list
138281960|NCT05349032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138281961|NCT05349032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281962|NCT05057689|Midazolam|midazolam|mesh-list
138281963|NCT05057689|Fentanyl|fentanyl|mesh-list
138281964|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
138281965|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138281966|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138281967|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281968|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138281970|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
138281971|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281972|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138281973|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138281974|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138281975|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
138281976|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138281977|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138281978|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138281979|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138281980|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138281981|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138281982|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138281983|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
138281984|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
138281985|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
138281986|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
138281987|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138281988|NCT05057689|Narcotics|narcotics|mesh-ancestor
138281989|NCT04737980|Dexamethasone|dexamethasone|mesh-list
138281990|NCT04737980|Bupivacaine|bupivacaine|mesh-list
138281991|NCT04737980|Ropivacaine|ropivacaine|mesh-list
138281992|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138281993|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
138281994|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
138281995|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138281996|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138281997|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138281998|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
138281999|NCT04737980|Hormones|hormones|mesh-ancestor
138282000|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282001|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138282002|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282003|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
138282004|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
138282005|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282006|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
138282007|NCT00371696|Acetaminophen|acetaminophen|mesh-list
138282008|NCT00371696|Diclofenac|diclofenac|mesh-list
138282009|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138282010|NCT00371696|Analgesics|analgesics|mesh-ancestor
138282011|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
138282012|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282013|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282014|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
138282015|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138282016|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282017|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138282018|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138282019|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282020|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282021|NCT02756624|Cetirizine|cetirizine|mesh-list
138282022|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138282023|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138282024|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138282025|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
138282026|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
138325857|NCT01331148|Vitamin D|vitamin d|mesh-list
138282027|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282028|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282029|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282031|NCT02958800|Risperidone|risperidone|mesh-list
138282033|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
138282034|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138282035|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
138282036|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282037|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282038|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282039|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138282040|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282041|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138282042|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138282043|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
138282044|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
138282045|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
138282046|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282047|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138282048|NCT02958800|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138282049|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138282050|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138282051|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
138282052|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
138282053|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138282054|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282055|NCT04738045|Ritonavir|ritonavir|mesh-list
138282057|NCT04738045|Remdesivir|remdesivir|mesh-list
138282058|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138282059|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138282060|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
138282061|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282062|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282063|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138282064|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138282065|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
138282066|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282067|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138282068|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138282069|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
138282070|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138282071|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138282072|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282074|NCT04587973|Ropivacaine|ropivacaine|mesh-list
138282075|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138282076|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282077|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282078|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138282079|NCT04587973|Analgesics|analgesics|mesh-ancestor
138282080|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
138282081|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282082|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138282083|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138282084|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138282085|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
138282086|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282087|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282090|NCT02753881|Doxorubicin|doxorubicin|mesh-list
138282091|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138282092|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138282093|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282094|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138282095|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138282096|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282097|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282098|NCT00425360|Gemcitabine|gemcitabine|mesh-list
138282099|NCT00425360|Capecitabine|capecitabine|mesh-list
138282100|NCT00425360|Sargramostim|sargramostim|mesh-list
138282101|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138282102|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
138282103|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282104|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282105|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
138282106|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282107|NCT04337606|Decitabine|decitabine|mesh-list
138282108|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138282109|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
138282110|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282111|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196240|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
138282112|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282113|NCT01190306|Riboflavin|riboflavin|mesh-list
138282114|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
138282115|NCT01190306|Vitamins|vitamins|mesh-ancestor
138282116|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
138282117|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282118|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138282119|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
138282120|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
138282121|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282122|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138282123|NCT02759575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138282124|NCT02759575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282125|NCT05320718|Ropivacaine|ropivacaine|mesh-list
138325980|NCT05320692|Estrogens|estrogens|mesh-ancestor
138282127|NCT05320718|Anesthetics|anesthetics|mesh-ancestor
138282128|NCT05320718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282129|NCT05320718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282130|NCT05320718|Sensory System Agents|sensory system agents|mesh-ancestor
138282131|NCT05320718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282132|NCT02739698|Paclitaxel|paclitaxel|mesh-list
138282133|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138282134|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282135|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
138282136|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
138282137|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
138282138|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282139|NCT04336904|Favipiravir|favipiravir|mesh-list
138282140|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
138282141|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282142|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
138282143|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138282144|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282145|NCT02767934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138282146|NCT02767934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282147|NCT02194998|Ritonavir|ritonavir|mesh-list
138282148|NCT02194998|Ribavirin|ribavirin|mesh-list
138282149|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138282150|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138282151|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
138282152|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385255|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138282153|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282154|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138282155|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138282156|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
138282157|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282158|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138282159|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138282160|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
138282161|NCT02194062|Fluticasone|fluticasone|mesh-list
138282162|NCT02194062|Xhance|xhance|mesh-list
138282163|NCT02194062|Budesonide|budesonide|mesh-list
138282164|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282165|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138282166|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
138282167|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282168|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282169|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138282170|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
138282171|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
138282172|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138282173|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
138282175|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282176|NCT02768558|Nivolumab|nivolumab|mesh-list
138282177|NCT02768558|Etoposide|etoposide|mesh-list
138326075|NCT04779060|Hormones|hormones|mesh-ancestor
138282178|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282179|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138282180|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138385278|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
138385279|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138282181|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282182|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138282183|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138282184|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138282185|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282187|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138282188|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282189|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138282190|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138282191|NCT02192970|Growth Substances|growth substances|mesh-ancestor
138282192|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282193|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
138282194|NCT05457296|Hydrocortisone|hydrocortisone|mesh-list
138282195|NCT05457296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282196|NCT05456438|Tea Tree Oil|tea tree oil|mesh-list
138282197|NCT05456438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138282198|NCT05456438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282199|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138282200|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282201|NCT02762071|Bupivacaine|bupivacaine|mesh-list
138282202|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
138282203|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
138282204|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282205|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282206|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
138282207|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282208|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
138282209|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138282210|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138282211|NCT04336891|Estradiol|estradiol|mesh-list
138282212|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138282214|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
138282215|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
138282216|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138282217|NCT04336891|Estrogens|estrogens|mesh-ancestor
138282218|NCT04336891|Hormones|hormones|mesh-ancestor
138282219|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282220|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282221|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138282222|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
138282223|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138282224|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138282225|NCT04336891|Androgens|androgens|mesh-ancestor
138282226|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138282227|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282228|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
138282229|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
138282230|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138282231|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138282232|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
138282233|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282234|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282235|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138282236|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
138282237|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138282238|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
138282239|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282240|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282241|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138282242|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
138282243|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
138282244|NCT04337918|Protective Agents|protective agents|mesh-ancestor
138282246|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
138196258|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138282247|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
138282248|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282249|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282250|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
138282251|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282252|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138282253|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138282254|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138282255|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138282256|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282257|NCT02766517|Capsaicin|capsaicin|mesh-list
138282258|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
138282259|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
138282260|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
138282261|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282262|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282264|NCT05348239|Chlorophyllin|chlorophyllin|mesh-list
138282265|NCT05348239|Trace Elements|trace elements|mesh-ancestor
138326148|NCT03012984|Narcotics|narcotics|mesh-ancestor
138282266|NCT05348239|Micronutrients|micronutrients|mesh-ancestor
138282267|NCT05348239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282268|NCT05348239|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138282269|NCT05348239|Protective Agents|protective agents|mesh-ancestor
138282270|NCT02766673|Albuterol|albuterol|mesh-list
138282271|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138282272|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
138282273|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282274|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282275|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138282276|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
138282277|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
138282278|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138282279|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138282280|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138282281|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138282282|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
138282283|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282284|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282285|NCT00372008|Testosterone|testosterone|mesh-list
138282286|NCT00372008|Androgens|androgens|mesh-ancestor
138282287|NCT00372008|Hormones|hormones|mesh-ancestor
138282288|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282289|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282290|NCT02973763|Aflutinib|aflutinib|mesh-list
138282291|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138282292|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282293|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282294|NCT04337593|Pegaspargase|pegaspargase|mesh-list
138282295|NCT04337593|Basiliximab|basiliximab|mesh-list
138282296|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282297|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138282298|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
138282299|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282300|NCT05339581|Pembrolizumab|pembrolizumab|mesh-list
138282301|NCT05339581|Tislelizumab|tislelizumab|mesh-list
138282302|NCT05339581|Lenvatinib|lenvatinib|mesh-list
138282303|NCT05339581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138282304|NCT05339581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282305|NCT05339581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138282306|NCT05339581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282307|NCT05339581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138282308|NCT05339581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282309|NCT04064684|Budesonide|budesonide|mesh-list
138282310|NCT04064684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282311|NCT04064684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138282312|NCT04064684|Autonomic Agents|autonomic agents|mesh-ancestor
138282313|NCT04064684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138196265|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282314|NCT04064684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282315|NCT04064684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138282316|NCT04064684|Respiratory System Agents|respiratory system agents|mesh-ancestor
138282318|NCT04064684|Hormones|hormones|mesh-ancestor
138282319|NCT04064684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282320|NCT02192190|Celecoxib|celecoxib|mesh-list
138282321|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138282322|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138282323|NCT02192190|Analgesics|analgesics|mesh-ancestor
138282324|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
138282325|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282326|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282327|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282328|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138282329|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138282330|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138282331|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282332|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282333|NCT02748889|Carboplatin|carboplatin|mesh-list
138282334|NCT02748889|Etoposide|etoposide|mesh-list
138282335|NCT02748889|Atezolizumab|atezolizumab|mesh-list
138282336|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282337|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138282338|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138282339|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138282341|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282342|NCT02748889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138282343|NCT02748889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138282344|NCT04654988|Prednisone|prednisone|mesh-list
138282345|NCT04654988|Azathioprine|azathioprine|mesh-list
138282346|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282347|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
138282348|NCT04654988|Hormones|hormones|mesh-ancestor
138282349|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282350|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282351|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138282352|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282353|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
138282354|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282355|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138282356|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138282357|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
138282358|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138282359|NCT02224560|Cannabidiol|cannabidiol|mesh-list
138282360|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
138282361|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
138282362|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138282363|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282365|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138282366|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282367|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
138282369|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282370|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282371|NCT02161458|Dexetimide|dexetimide|mesh-list
138282372|NCT02161458|Citalopram|citalopram|mesh-list
138282373|NCT02161458|Escitalopram|escitalopram|mesh-list
138282374|NCT02161458|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138282375|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138282376|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138196274|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
138196275|NCT02598778|Protective Agents|protective agents|mesh-ancestor
138196276|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282377|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282378|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282379|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
138282380|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282381|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138230278|NCT01181258|Rituximab|rituximab|mesh-list
138282382|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138282383|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
138282384|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
138282385|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282386|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138282387|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138282388|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
138282389|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138282390|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
138282391|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138282392|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138282393|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138282395|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138282396|NCT04507022|Progesterone|progesterone|mesh-list
138282397|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138282398|NCT04507022|Estrogens|estrogens|mesh-ancestor
138282400|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282401|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282402|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138282403|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
138282404|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138282405|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138282406|NCT04507022|Progestins|progestins|mesh-ancestor
138282407|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138282408|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282409|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282410|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138282411|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
138282412|NCT00372788|Pemetrexed|pemetrexed|mesh-list
138282413|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282414|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282415|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282416|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138282417|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138282418|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
138282419|NCT00372476|Vinorelbine|vinorelbine|mesh-list
138282420|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282421|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138282422|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282423|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282424|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138282425|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
138282426|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
138282427|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
138282429|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138282430|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138282431|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138282432|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
138282433|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282434|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282435|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282436|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138282437|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138196286|NCT00642382|Protective Agents|protective agents|mesh-ancestor
138282438|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138282439|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138326274|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
138282440|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138282441|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138282442|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
138282443|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138282444|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
138282445|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138282446|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
138282447|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282448|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
138282449|NCT04766918|Protective Agents|protective agents|mesh-ancestor
138282450|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138282451|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
138282452|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282453|NCT00371995|Amphotericin B|amphotericin b|mesh-list
138282454|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138282455|NCT00371995|Miltefosine|miltefosine|mesh-list
138282456|NCT00371995|Amebicides|amebicides|mesh-ancestor
138282457|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138282458|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138282459|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282460|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138282461|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
138282462|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282463|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
138282464|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138282465|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138282466|NCT00372307|Analgesics|analgesics|mesh-ancestor
138282467|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
138282468|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282469|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282470|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282471|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138282472|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
138282473|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138282474|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
138282475|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138282476|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282477|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282478|NCT04647110|Crizotinib|crizotinib|mesh-list
138282479|NCT04647110|Ceritinib|ceritinib|mesh-list
138282480|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282481|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138282482|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282483|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282484|NCT04061330|Ketamine|ketamine|mesh-list
138282485|NCT04061330|Morphine|morphine|mesh-list
138282487|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
138282488|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282489|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282490|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138282491|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138282492|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
138282493|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
138282494|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282495|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138282496|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138282497|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282498|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282499|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138282500|NCT04061330|Narcotics|narcotics|mesh-ancestor
138282501|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
138282502|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
138282503|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138282504|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
138282505|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138282506|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138282507|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282508|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138282509|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282510|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282511|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138282512|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
138282513|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138282514|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
138282515|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282516|NCT04792021|Expectorants|expectorants|mesh-ancestor
138282517|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
138282518|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138282519|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
138282520|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282521|NCT04792021|Protective Agents|protective agents|mesh-ancestor
138282522|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282523|NCT04792021|Antidotes|antidotes|mesh-ancestor
138282524|NCT04333927|Immunomodulating Agents|immunomodulating agents|mesh-list
138282525|NCT04333927|Immunologic Factors|immunologic factors|mesh-ancestor
138282526|NCT04333927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282527|NCT04334005|Vitamin D|vitamin d|mesh-list
138282528|NCT04334005|Vitamins|vitamins|mesh-ancestor
138282529|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
138282530|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282531|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138282532|NCT00966914|Paclitaxel|paclitaxel|mesh-list
138282533|NCT00966914|Docetaxel|docetaxel|mesh-list
138282534|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138282535|NCT00966914|Cisplatin|cisplatin|mesh-list
138282536|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
138282537|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138282538|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282539|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
138282540|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
138282541|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
138282542|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282543|NCT00966914|Protective Agents|protective agents|mesh-ancestor
138282544|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282546|NCT04430959|Candesartan cilexetil|candesartan cilexetil|mesh-list
138282547|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138282548|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138282549|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138282550|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282551|NCT04737655|Beclomethasone|beclomethasone|mesh-list
138282552|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
138282553|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
138282554|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138282555|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
138282556|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282557|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282558|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138282559|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
138282560|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138282561|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138282562|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138282563|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
138282564|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282565|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282566|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138282567|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138282568|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138282569|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
138282570|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282571|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
138196309|NCT00529282|Cefepime|cefepime|mesh-list
138282572|NCT04737655|Hormones|hormones|mesh-ancestor
138282573|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282574|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
138282575|NCT05063396|Anesthetics|anesthetics|mesh-list
138282576|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282577|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282578|NCT05063396|Narcotics|narcotics|mesh-ancestor
138282579|NCT05063396|Analgesics|analgesics|mesh-ancestor
138282580|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
138282581|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282582|NCT05055752|Aspirin|aspirin|mesh-list
138282583|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138282584|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138282585|NCT05055752|Analgesics|analgesics|mesh-ancestor
138282586|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
138282587|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282588|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282589|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282590|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138282591|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138282592|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138282593|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282594|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138282595|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138282596|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282597|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
138282598|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
138282599|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
138282600|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138282601|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282602|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282603|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
138282604|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138282605|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282606|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282607|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
138282608|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138282609|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282610|NCT04762381|Dexamethasone|dexamethasone|mesh-list
138282611|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
138282612|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138282613|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282614|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
138282615|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
138282616|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282617|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282618|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138282620|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282621|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138282622|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282623|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
138282624|NCT01547468|Narcotics|narcotics|mesh-ancestor
138282625|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282626|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282627|NCT01547468|Analgesics|analgesics|mesh-ancestor
138282628|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
138282629|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282630|NCT04333628|Chloroquine|chloroquine|mesh-list
138282631|NCT04333628|Amebicides|amebicides|mesh-ancestor
138282632|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138282633|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138282634|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282635|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
138282636|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138282638|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
138282639|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282640|NCT00373178|Metformin|metformin|mesh-list
138282641|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
138282642|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138282643|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282644|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
138282645|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138282646|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282647|NCT03254732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138282648|NCT03254732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282649|NCT02923466|Interferon-beta|interferon-beta|mesh-list
138282650|NCT02923466|Avelumab|avelumab|mesh-list
138282651|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138282652|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282653|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
138282654|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385580|NCT01470339|Analgesics|analgesics|mesh-ancestor
138282655|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
138282656|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282657|NCT00813566|Deoxyglucose|deoxyglucose|mesh-list
138282658|NCT00813566|Antimetabolites|antimetabolites|mesh-ancestor
138282659|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282660|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
138282661|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282662|NCT02885012|Ambrisentan|ambrisentan|mesh-list
138282663|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138282664|NCT00372853|Tremelimumab|tremelimumab|mesh-list
138282665|NCT00372853|Ipilimumab|ipilimumab|mesh-list
138282666|NCT00372853|Sunitinib|sunitinib|mesh-list
138282667|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282668|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138282669|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138326390|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
138282670|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282671|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138282672|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138282673|NCT00372853|Growth Substances|growth substances|mesh-ancestor
138282674|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282675|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
138282676|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138282677|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282679|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138282680|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
138282681|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282682|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282683|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138282684|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
138282685|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
138282686|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138282687|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138282688|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138282689|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138282690|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
138282691|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282692|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282693|NCT00373087|Entacapone|entacapone|mesh-list
138282694|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138282695|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138282696|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282697|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138282698|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282699|NCT02892110|Varenicline|varenicline|mesh-list
138282700|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138282701|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138282702|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
138282703|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282704|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282705|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196326|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
138196327|NCT02550288|Atorvastatin|atorvastatin|mesh-list
138282706|NCT02779166|Celecoxib|celecoxib|mesh-list
138282707|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138282708|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138282709|NCT02779166|Analgesics|analgesics|mesh-ancestor
138282710|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
138282711|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282712|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282713|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282714|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138282715|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138282716|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138282717|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282718|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282719|NCT00373165|Ganciclovir|ganciclovir|mesh-list
138282720|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138282721|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
138282722|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282723|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138282724|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282725|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282726|NCT04333550|Deferoxamine|deferoxamine|mesh-list
138282727|NCT04333550|Siderophores|siderophores|mesh-ancestor
138282728|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138282729|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
138282730|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
138282731|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282732|NCT02827838|Durvalumab|durvalumab|mesh-list
138282733|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
138282734|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138282735|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
138282736|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138282737|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282738|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
138282739|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282740|NCT02902172|Acetaminophen|acetaminophen|mesh-list
138282741|NCT02902172|Ibuprofen|ibuprofen|mesh-list
138282742|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138282743|NCT02902172|Analgesics|analgesics|mesh-ancestor
138282744|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
138282745|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282746|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282747|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
138282748|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138282749|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282750|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138282751|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138282752|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282753|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282754|NCT02777749|Bupivacaine|bupivacaine|mesh-list
138282755|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
138282756|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
138282757|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282758|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282759|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
138282760|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282761|NCT02785172|Clobetasol|clobetasol|mesh-list
138282762|NCT02785172|Halobetasol|halobetasol|mesh-list
138282763|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138282764|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282765|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
138282766|NCT02785172|Hormones|hormones|mesh-ancestor
138282767|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282768|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282769|NCT02582125|Nivolumab|nivolumab|mesh-list
138282770|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138282771|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282772|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138282773|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282774|NCT02785406|Suvorexant|suvorexant|mesh-list
138282775|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138282776|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138282777|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138282778|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282779|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138282780|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282781|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282783|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138282784|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
138282785|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282786|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282787|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138282788|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282789|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138282790|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138282791|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138282792|NCT02780869|Thrombin|thrombin|mesh-list
138282793|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
138282794|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
138282795|NCT02780869|Coagulants|coagulants|mesh-ancestor
138282796|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
138282797|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
138282798|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138282799|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138282800|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282801|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282802|NCT02908490|Urological Agents|urological agents|mesh-ancestor
138282803|NCT02911844|Fulvestrant|fulvestrant|mesh-list
138282804|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138282805|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282806|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138282807|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138282808|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
138282809|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282810|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282811|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
138282812|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138282813|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138282815|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
138282816|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
138282817|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138282818|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138282819|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
138282820|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138282821|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
138282822|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
138282823|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282824|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282825|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138282827|NCT02790788|Hormones|hormones|mesh-ancestor
138282828|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138282829|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138282830|NCT02790788|Protective Agents|protective agents|mesh-ancestor
138282831|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138282832|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282834|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138282835|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
138282836|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138282837|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138282838|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138282839|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138282840|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282841|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282842|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138282843|NCT02888665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138282844|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
138282845|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138282846|NCT02781571|Velpatasvir|velpatasvir|mesh-list
138282847|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
138282848|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282849|NCT02918630|Nicotine|nicotine|mesh-list
138282850|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138282851|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
138282852|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138282853|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138282854|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138282855|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138282856|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
138282857|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282858|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282859|NCT02781649|Ribavirin|ribavirin|mesh-list
138282860|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
138282861|NCT02781649|Grazoprevir|grazoprevir|mesh-list
138282862|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
138282863|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
138282864|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138282865|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
138282866|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138282867|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138282868|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282869|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702113|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702114|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702115|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138702116|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
138702117|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138702118|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138702119|NCT01219933|Prednisolone|prednisolone|mesh-list
138702120|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
138702121|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138702122|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
138350548|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
138702123|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138702124|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
138702125|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
138702126|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702127|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702128|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138702129|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
138702130|NCT01219933|Hormones|hormones|mesh-ancestor
138196361|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138702131|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702132|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138702133|NCT01219933|Protective Agents|protective agents|mesh-ancestor
138702134|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138702135|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702136|NCT05368441|Midazolam|midazolam|mesh-list
138702137|NCT05368441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138702138|NCT05368441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138702139|NCT05368441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138702140|NCT05368441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702141|NCT05368441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138702142|NCT05368441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138702143|NCT05368441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138702144|NCT05368441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138702145|NCT05368441|Anesthetics, General|anesthetics, general|mesh-ancestor
138702146|NCT05368441|Anesthetics|anesthetics|mesh-ancestor
138702147|NCT05368441|GABA Modulators|gaba modulators|mesh-ancestor
138702148|NCT05368441|GABA Agents|gaba agents|mesh-ancestor
138702149|NCT05368441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702150|NCT05368441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702151|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138702152|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138702153|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702154|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138702155|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138702156|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138702157|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
138702158|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138326538|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
138702159|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138350584|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
138702160|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138702161|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702162|NCT02887222|Bupivacaine|bupivacaine|mesh-list
138702163|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
138702164|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
138702165|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138702166|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702167|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
138702168|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702169|NCT01218646|Vaccines|vaccines|mesh-list
138702170|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
138702171|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702172|NCT00449423|Acipimox|acipimox|mesh-list
138702173|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138702174|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
138702175|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702176|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138702177|NCT00449501|Budesonide|budesonide|mesh-list
138702178|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
138702179|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138702180|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138702181|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
138702182|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702183|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702184|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138196381|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138196382|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138702185|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
138702186|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
138350620|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138702188|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702189|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138702190|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138702191|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138702192|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
138702193|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702194|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702195|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138702196|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138702197|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702198|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
138702199|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
138702200|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
138702201|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702202|NCT01188655|Etanercept|etanercept|mesh-list
138702203|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138702204|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138702205|NCT01188655|Analgesics|analgesics|mesh-ancestor
138702206|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
138702207|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702208|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702209|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138702210|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702211|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138702212|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138702213|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
138702214|NCT00449618|Aspirin|aspirin|mesh-list
138702215|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138702216|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138702217|NCT00449618|Analgesics|analgesics|mesh-ancestor
138702218|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
138702219|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702220|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702221|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138196399|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138196400|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138702222|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702223|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138702224|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138702225|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702226|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138702227|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138702228|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385752|NCT01471704|Verapamil|verapamil|mesh-list
138702229|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
138702230|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
138702231|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138702232|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138702233|NCT01188538|Analgesics|analgesics|mesh-ancestor
138702234|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
138702235|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702236|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702237|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138702238|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702239|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
138702241|NCT00449657|Carboplatin|carboplatin|mesh-list
138702242|NCT00449657|Gemcitabine|gemcitabine|mesh-list
138702243|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138702244|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702245|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
138702246|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
138702247|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
138702248|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702249|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138702250|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
138702251|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
138702252|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
138702253|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138702254|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138702255|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702256|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702257|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702258|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702259|NCT03276143|Enoxaparin|enoxaparin|mesh-list
138702260|NCT03276143|Apixaban|apixaban|mesh-list
138702261|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
138702262|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138702263|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138702264|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702265|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138702266|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
138326580|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
138702267|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138702268|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
138702269|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702270|NCT00449774|Lamotrigine|lamotrigine|mesh-list
138702271|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
138702272|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138702273|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138702274|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702275|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138702276|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702277|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138702278|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138702279|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138702280|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138702281|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138702282|NCT02900742|Gemcitabine|gemcitabine|mesh-list
138702283|NCT02900742|Docetaxel|docetaxel|mesh-list
138702284|NCT02900742|Pemetrexed|pemetrexed|mesh-list
138702285|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138702286|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
138702287|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702288|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702289|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
138702290|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
138702291|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
138702292|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702293|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138702294|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138702295|NCT00449813|Pantoprazole|pantoprazole|mesh-list
138702296|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138702297|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138702298|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138702299|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702300|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702301|NCT01218100|Lisinopril|lisinopril|mesh-list
138702302|NCT01218100|Nebivolol|nebivolol|mesh-list
138702303|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138702304|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
138702305|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138350739|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
138702306|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702307|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138702308|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138702309|NCT01218100|Protective Agents|protective agents|mesh-ancestor
138702310|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702311|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
138702312|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138702313|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138702314|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138702315|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
138702316|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702317|NCT00450008|Thalidomide|thalidomide|mesh-list
138702318|NCT00450008|Docetaxel|docetaxel|mesh-list
138702319|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702320|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
138702321|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
138702322|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
138702323|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702324|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138702325|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
138702326|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702327|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
138702328|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138702329|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702330|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138702331|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138702333|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
138702334|NCT02900469|Denosumab|denosumab|mesh-list
138702335|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138230311|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138702336|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702337|NCT00450086|Budesonide|budesonide|mesh-list
138702338|NCT00450086|Mesalamine|mesalamine|mesh-list
138702339|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138702340|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138702341|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
138702342|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702343|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702344|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138702345|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
138702346|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
138702347|NCT00450086|Hormones|hormones|mesh-ancestor
138702348|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702349|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138350790|NCT04155424|Eculizumab|eculizumab|mesh-list
138702350|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138702351|NCT00450086|Analgesics|analgesics|mesh-ancestor
138702352|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
138702353|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702354|NCT05422911|Abiraterone Acetate|abiraterone acetate|mesh-list
138702355|NCT05422911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702356|NCT05422911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138702357|NCT05422911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702358|NCT05422911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702359|NCT05422911|Hormone Antagonists|hormone antagonists|mesh-ancestor
138702360|NCT05422911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702361|NCT05422911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702362|NCT05422911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138702363|NCT00450164|Nadolol|nadolol|mesh-list
138702364|NCT00450164|Prazosin|prazosin|mesh-list
138702365|NCT00450164|Isosorbide|isosorbide|mesh-list
138702366|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138702367|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138702368|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138702370|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
138702371|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702372|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
138702373|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138702374|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702375|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138702376|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138702377|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138702378|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138702379|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
138702380|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702381|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138702382|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138702383|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
138702384|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
138702385|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702386|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
138702387|NCT02900430|Clotrimazole|clotrimazole|mesh-list
138702388|NCT02900430|Miconazole|miconazole|mesh-list
138702389|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196477|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196478|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702390|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138702391|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138702392|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138702393|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702394|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702395|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138702396|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
138702397|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702398|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702399|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138702400|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138702401|NCT00450203|Bevacizumab|bevacizumab|mesh-list
138702402|NCT00450203|Capecitabine|capecitabine|mesh-list
138702404|NCT00450203|Lapatinib|lapatinib|mesh-list
138702405|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138702406|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702407|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138702408|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138702409|NCT00450203|Growth Substances|growth substances|mesh-ancestor
138702410|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702411|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
138702412|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138702413|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
138702414|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702415|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138702416|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138702417|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138702418|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702419|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138702420|NCT00450281|Antibodies|antibodies|mesh-list
138702421|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
138702422|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702423|NCT04699097|Azithromycin|azithromycin|mesh-list
138702424|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138702425|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702426|NCT00450320|Sirolimus|sirolimus|mesh-list
138702427|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138702428|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702429|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138702430|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702431|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
138702432|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138702433|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
138702434|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702435|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
138702436|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138351034|NCT03350516|Antacids|antacids|mesh-ancestor
138702438|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379279|NCT05289323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702439|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138702440|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702441|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
138702442|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702443|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
138702444|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138702445|NCT00450398|Protective Agents|protective agents|mesh-ancestor
138702446|NCT00450515|Capecitabine|capecitabine|mesh-list
138702447|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138702448|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
138702449|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702450|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702451|NCT00450827|Bevacizumab|bevacizumab|mesh-list
138702453|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138702454|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138702455|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702456|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138702457|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138702458|NCT00450827|Growth Substances|growth substances|mesh-ancestor
138702459|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702460|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
138702461|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
138702462|NCT00450944|Immunotoxins|immunotoxins|mesh-list
138702463|NCT00450944|Immunoconjugates|immunoconjugates|mesh-ancestor
138702464|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
138702465|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702466|NCT00451061|Tamsulosin|tamsulosin|mesh-list
138702467|NCT00451061|Alfuzosin|alfuzosin|mesh-list
138702468|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138702469|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138702470|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138702471|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
138702472|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702473|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702474|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702475|NCT00451061|Urological Agents|urological agents|mesh-ancestor
138702477|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138702478|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702479|NCT02931383|Incretins|incretins|mesh-ancestor
138702480|NCT02931383|Hormones|hormones|mesh-ancestor
138702481|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702482|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
138702483|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
138702484|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138702485|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138702486|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138326733|NCT00186498|Memantine|memantine|mesh-list
138702487|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702488|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702489|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702491|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138702492|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
138702493|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702494|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138702495|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702496|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702497|NCT02900157|Durvalumab|durvalumab|mesh-list
138702498|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138702499|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702500|NCT04262817|Nicotine|nicotine|mesh-list
138702501|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138702502|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
138702503|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702504|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702505|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138702506|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138702507|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
138702508|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702509|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702510|NCT02931188|Anacetrapib|anacetrapib|mesh-list
138702511|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138379360|NCT05179512|Hormones|hormones|mesh-ancestor
138702513|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
138702514|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702515|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138702516|NCT01217944|Ranibizumab|ranibizumab|mesh-list
138702517|NCT01217944|Verteporfin|verteporfin|mesh-list
138702518|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138702519|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138702520|NCT01217944|Growth Substances|growth substances|mesh-ancestor
138702521|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702522|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
138702523|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702524|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138196502|NCT00000802|Atovaquone|atovaquone|mesh-list
138702525|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
138702526|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
138702527|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702528|NCT01187446|Vorinostat|vorinostat|mesh-list
138702529|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702530|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138702531|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702532|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702533|NCT02931071|Plerixafor|plerixafor|mesh-list
138326764|NCT00189228|Omalizumab|omalizumab|mesh-list
138702535|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138702536|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
138702537|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702538|NCT01187407|Serotonin|serotonin|mesh-list
138702539|NCT01187407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
138702540|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138702541|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
138702542|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702543|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702544|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702545|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138702546|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138702547|NCT01186939|Azacitidine|azacitidine|mesh-list
138702548|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138702549|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
138702550|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702551|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702552|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702553|NCT04447040|Acetaminophen|acetaminophen|mesh-list
138702554|NCT04447040|Naproxen|naproxen|mesh-list
138702555|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138702556|NCT04447040|Analgesics|analgesics|mesh-ancestor
138702557|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
138702558|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702559|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702560|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
138702561|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138702562|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138702563|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702564|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
138702565|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138702566|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138351383|NCT03556800|Estradiol|estradiol|mesh-list
138702567|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702568|NCT02930954|Bevacizumab|bevacizumab|mesh-list
138702569|NCT02930954|Carboplatin|carboplatin|mesh-list
138702570|NCT02930954|Gemcitabine|gemcitabine|mesh-list
138702571|NCT02930954|Pemetrexed|pemetrexed|mesh-list
138702572|NCT02930954|Gefitinib|gefitinib|mesh-list
138702573|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138702574|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702575|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138702576|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138702577|NCT02930954|Growth Substances|growth substances|mesh-ancestor
138702578|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702579|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
138702580|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138702581|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
138702582|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702583|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702584|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138385918|NCT01472653|Cetuximab|cetuximab|mesh-list
138702585|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138702586|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138702587|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
138702588|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138702589|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196510|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
138702590|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702591|NCT02930057|Betamethasone|betamethasone|mesh-list
138702592|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138702593|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
138702595|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702596|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702597|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138702598|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
138702600|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138702601|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702602|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138702603|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702604|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702605|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138702606|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138702607|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
138702608|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702609|NCT02929706|Azathioprine|azathioprine|mesh-list
138702610|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
138702611|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702612|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138702613|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702614|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138702615|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
138702616|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702617|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702618|NCT03993132|Empagliflozin|empagliflozin|mesh-list
138702619|NCT03993132|Glucagon|glucagon|mesh-list
138702620|NCT03993132|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138230332|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
138702621|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138702622|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702624|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702625|NCT03993132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138702626|NCT03993132|Hormones|hormones|mesh-ancestor
138351481|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138385941|NCT01472796|Vitamins|vitamins|mesh-ancestor
138702627|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702628|NCT03993132|Incretins|incretins|mesh-ancestor
138702629|NCT00553878|Dutasteride|dutasteride|mesh-list
138702630|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138702631|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138702632|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702633|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702634|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
138702635|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702636|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702637|NCT00624325|Interferons|interferons|mesh-list
138702638|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
138702639|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
138702640|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702641|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
138702642|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702643|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
138702644|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702645|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138702646|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
138702647|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
138702648|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702649|NCT05184192|Gabapentin|gabapentin|mesh-list
138702650|NCT05184192|Analgesics|analgesics|mesh-ancestor
138702651|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
138702652|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702653|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702654|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
138702655|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138702656|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138702657|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138326854|NCT04118556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138702658|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138702659|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138702660|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138702661|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702662|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702663|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
138702664|NCT02929121|Doxycycline|doxycycline|mesh-list
138702665|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138702666|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702667|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
138702668|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138702669|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138702670|NCT02929394|Trabectedin|trabectedin|mesh-list
138702671|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138702672|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
138702673|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702674|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702675|NCT02929316|Vedolizumab|vedolizumab|mesh-list
138702676|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138702677|NCT02928965|Minocycline|minocycline|mesh-list
138351587|NCT02880228|Ichthammol|ichthammol|mesh-list
138702678|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138702679|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702680|NCT02928692|Minocycline|minocycline|mesh-list
138702681|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138702682|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702683|NCT04679142|Baclofen|baclofen|mesh-list
138702684|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138702685|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702686|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138702687|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702688|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138702689|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
138702690|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
138702691|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702692|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702693|NCT02928419|Lenalidomide|lenalidomide|mesh-list
138702694|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
138702695|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702696|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138351606|NCT02880228|Growth Substances|growth substances|mesh-ancestor
138702697|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138702698|NCT02928419|Growth Substances|growth substances|mesh-ancestor
138702699|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
138702700|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702701|NCT02928614|Liraglutide|liraglutide|mesh-list
138702702|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138702703|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702704|NCT02928614|Incretins|incretins|mesh-ancestor
138702706|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702707|NCT03685500|Emtricitabine|emtricitabine|mesh-list
138702708|NCT03685500|Darunavir|darunavir|mesh-list
138702709|NCT03685500|Cobicistat|cobicistat|mesh-list
138702710|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
138702711|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702712|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138196530|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196531|NCT00268450|Paclitaxel|paclitaxel|mesh-list
138196532|NCT00268450|Bevacizumab|bevacizumab|mesh-list
138196533|NCT00268450|Gemcitabine|gemcitabine|mesh-list
138196537|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
138702713|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138702714|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702715|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702716|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138702717|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138702718|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138702719|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138702720|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
138702721|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138386000|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
138702722|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138702723|NCT02928575|Temozolomide|temozolomide|mesh-list
138702725|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138702726|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
138702727|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702728|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702729|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138702730|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138702731|NCT02928575|Growth Substances|growth substances|mesh-ancestor
138702732|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702733|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
138702734|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138702735|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702737|NCT02927951|Analgesics|analgesics|mesh-ancestor
138702738|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
138702739|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702740|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702741|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
138702742|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138702743|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138702744|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702745|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138702746|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138702747|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138702748|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138702749|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138702750|NCT02927405|Gabapentin|gabapentin|mesh-list
138702751|NCT02927405|Analgesics|analgesics|mesh-ancestor
138702752|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
138702753|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702754|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702755|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
138702756|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138702757|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138326942|NCT00202722|Narcotics|narcotics|mesh-ancestor
138326943|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138326944|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138326945|NCT00202722|Analgesics|analgesics|mesh-ancestor
138326946|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
138326947|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702758|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138702759|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138702760|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138702761|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138386022|NCT01473303|Irinotecan|irinotecan|mesh-list
138702762|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702763|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702764|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
138702765|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138702766|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
138702767|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702768|NCT02927522|Donepezil|donepezil|mesh-list
138196547|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
138702769|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138702770|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196549|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138702771|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702772|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
138702773|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702774|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702775|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
138702776|NCT02926976|Valproic Acid|valproic acid|mesh-list
138702777|NCT02926976|Risperidone|risperidone|mesh-list
138702778|NCT02926976|Aripiprazole|aripiprazole|mesh-list
138702779|NCT02926976|Clozapine|clozapine|mesh-list
138702780|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138702781|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
138702782|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702783|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702784|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702785|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138702786|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138702787|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138702788|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138702789|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138702790|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
138702791|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
138702792|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
138702793|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138702794|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138702795|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138326986|NCT00211692|Interferons|interferons|mesh-list
138702796|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138702798|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702799|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
138702800|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
138702801|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
138702802|NCT02927015|Iproplatin|iproplatin|mesh-list
138702803|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702804|NCT04680195|Thalidomide|thalidomide|mesh-list
138702805|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138702806|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
138702807|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702808|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
138702809|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138702810|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702811|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138702812|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138702814|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
138702816|NCT04864431|Vitamin D|vitamin d|mesh-list
138702817|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
138702818|NCT04864431|Vitamins|vitamins|mesh-ancestor
138702819|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
138702820|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702821|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138702822|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138702823|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
138702824|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138702825|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138702826|NCT00553995|Analgesics|analgesics|mesh-ancestor
138702827|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
138702828|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702829|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702830|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138702831|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702835|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
138702836|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
138702837|NCT04798287|Etanercept|etanercept|mesh-list
138702838|NCT04798287|Tofacitinib|tofacitinib|mesh-list
138702839|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138702840|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702841|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
138702842|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138702843|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138702844|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138702845|NCT04798287|Analgesics|analgesics|mesh-ancestor
138702846|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
138702847|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702848|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138351899|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
138702849|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138702850|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
138702851|NCT04798287|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138702852|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138702853|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702854|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702855|NCT04689191|Vaccines|vaccines|mesh-list
138386086|NCT01473914|Zinc|zinc|mesh-list
138702856|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
138702857|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702858|NCT02925299|Insulin|insulin|mesh-list
138702859|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138702860|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702861|NCT02925416|Oritavancin|oritavancin|mesh-list
138702862|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138702863|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702864|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
138702865|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138702866|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702867|NCT02925533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138702868|NCT02925533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702869|NCT02917889|Caffeine|caffeine|mesh-list
138702870|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138702871|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702872|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138702873|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702874|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702875|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138702876|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138702877|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
138702878|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702879|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
138702880|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138702881|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138702882|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702883|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
138702884|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702885|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702886|NCT04485273|Anesthetics|anesthetics|mesh-list
138702887|NCT04485273|Sevoflurane|sevoflurane|mesh-list
138702888|NCT04485273|Bupivacaine|bupivacaine|mesh-list
138702889|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
138196558|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138196560|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138702890|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138702891|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138702892|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702893|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138702894|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138702895|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
138702896|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
138702897|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702898|NCT02205528|Metformin|metformin|mesh-list
138702899|NCT02205528|Liraglutide|liraglutide|mesh-list
138702900|NCT02205528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138702901|NCT02205528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702902|NCT02205528|Incretins|incretins|mesh-ancestor
138702903|NCT02205528|Hormones|hormones|mesh-ancestor
138702904|NCT02205528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702905|NCT03532022|Dexamethasone|dexamethasone|mesh-list
138702906|NCT03532022|Prednisone|prednisone|mesh-list
138702907|NCT03532022|Prednisolone|prednisolone|mesh-list
138702908|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
138702909|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138702910|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138702911|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138702912|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138702913|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
138702914|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
138702915|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702916|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702917|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138702918|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
138702919|NCT03532022|Hormones|hormones|mesh-ancestor
138702920|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702921|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138702922|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138702923|NCT02200380|Plerixafor|plerixafor|mesh-list
138702924|NCT02200380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138702925|NCT02200380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138702926|NCT02200380|Antiviral Agents|antiviral agents|mesh-ancestor
138702927|NCT02200380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702929|NCT02191878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138702930|NCT02191878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702931|NCT02191878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702932|NCT02160678|Tazarotene|tazarotene|mesh-list
138702933|NCT02160678|Dermatologic Agents|dermatologic agents|mesh-ancestor
138702934|NCT02160678|Keratolytic Agents|keratolytic agents|mesh-ancestor
138702935|NCT02153502|Quinidine|quinidine|mesh-list
138702936|NCT02153502|Quinidine gluconate|quinidine gluconate|mesh-list
138702937|NCT02153502|Dextromethorphan|dextromethorphan|mesh-list
138702938|NCT02153502|Antitussive Agents|antitussive agents|mesh-ancestor
138702939|NCT02153502|Respiratory System Agents|respiratory system agents|mesh-ancestor
138702940|NCT02153502|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138702941|NCT02153502|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138702942|NCT02153502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352119|NCT03107754|Lidocaine|lidocaine|mesh-list
138702943|NCT02153502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702944|NCT02153502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702945|NCT02153502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138196579|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138196580|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138702946|NCT02153502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138702947|NCT02153502|Adrenergic Agents|adrenergic agents|mesh-ancestor
138702948|NCT02153502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138702949|NCT02153502|Antimalarials|antimalarials|mesh-ancestor
138702950|NCT02153502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138702951|NCT02153502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138702952|NCT02153502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702953|NCT02153502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702954|NCT02153502|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138702955|NCT02153502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138702956|NCT02153502|Cholinergic Agents|cholinergic agents|mesh-ancestor
138702957|NCT02153502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138702958|NCT02153502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138702959|NCT02153502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138702960|NCT02153502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138702961|NCT02153502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138702962|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138702963|NCT02130687|Aprepitant|aprepitant|mesh-list
138702964|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138702965|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702966|NCT02130687|Incretins|incretins|mesh-ancestor
138702967|NCT02130687|Hormones|hormones|mesh-ancestor
138702968|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138702969|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138702970|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
138702971|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138702972|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702973|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
138702974|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
138702975|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702976|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138702977|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138702978|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138702979|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
138702980|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
138702981|NCT01228656|Salicylates|salicylates|mesh-list
138702982|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138702983|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
138702984|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138702985|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138702986|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
138702987|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
138702988|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138702989|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138702990|NCT01228656|Analgesics|analgesics|mesh-ancestor
138702991|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
138702992|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138702993|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138702994|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138702995|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138702996|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282871|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138702997|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138702999|NCT02125266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138703000|NCT02125266|Abortifacient Agents|abortifacient agents|mesh-ancestor
138703001|NCT02125266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138703002|NCT02125266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703003|NCT02125266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138703004|NCT02125266|Antimetabolites|antimetabolites|mesh-ancestor
138703005|NCT02125266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703006|NCT02125266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703007|NCT02125266|Dermatologic Agents|dermatologic agents|mesh-ancestor
138703008|NCT02125266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196598|NCT00088972|Celecoxib|celecoxib|mesh-list
138703009|NCT02125266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138703010|NCT02125266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138703011|NCT02125266|Immunologic Factors|immunologic factors|mesh-ancestor
138703012|NCT02125266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138703013|NCT02125266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138703014|NCT02116998|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138703015|NCT02116998|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138703016|NCT02116998|Immunologic Factors|immunologic factors|mesh-ancestor
138703017|NCT02116998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703018|NCT02116998|Antacids|antacids|mesh-ancestor
138703019|NCT02116998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703020|NCT02116998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138703021|NCT02110368|Methyltestosterone|methyltestosterone|mesh-list
138703022|NCT02110368|Testosterone|testosterone|mesh-list
138703023|NCT02110368|Testosterone undecanoate|testosterone undecanoate|mesh-list
138703024|NCT02110368|Testosterone enanthate|testosterone enanthate|mesh-list
138703025|NCT02110368|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138703026|NCT02110368|Androgens|androgens|mesh-ancestor
138703027|NCT02110368|Hormones|hormones|mesh-ancestor
138703028|NCT02110368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138703029|NCT02110368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703030|NCT02110368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138703031|NCT02110368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703032|NCT02110368|Anabolic Agents|anabolic agents|mesh-ancestor
138703033|NCT02916485|Sirolimus|sirolimus|mesh-list
138703034|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138703035|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379880|NCT06039124|Bevacizumab|bevacizumab|mesh-list
138230354|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
138703036|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138703037|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703038|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
138703039|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138703040|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
138703041|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703043|NCT01709214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138703044|NCT01709214|Narcotics|narcotics|mesh-ancestor
138703045|NCT01709214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138352374|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
138703046|NCT01709214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703047|NCT01709214|Analgesics|analgesics|mesh-ancestor
138703048|NCT01709214|Sensory System Agents|sensory system agents|mesh-ancestor
138703049|NCT01709214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703050|NCT02916602|Losartan|losartan|mesh-list
138703051|NCT02916602|Amlodipine|amlodipine|mesh-list
138703052|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
138703053|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138703054|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138703055|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138703056|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703057|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138703058|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703059|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
138703060|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138703061|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138703062|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138703063|NCT02916602|Diuretics|diuretics|mesh-ancestor
138703064|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
138703065|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138703067|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138703068|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138703069|NCT02916251|Hormones|hormones|mesh-ancestor
138703070|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138703071|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703072|NCT02916251|Incretins|incretins|mesh-ancestor
138703073|NCT02106546|Paclitaxel|paclitaxel|mesh-list
138703074|NCT02106546|Carboplatin|carboplatin|mesh-list
138703075|NCT02106546|Veliparib|veliparib|mesh-list
138703076|NCT02106546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138703077|NCT02106546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703078|NCT02106546|Tubulin Modulators|tubulin modulators|mesh-ancestor
138703079|NCT02106546|Antimitotic Agents|antimitotic agents|mesh-ancestor
138703080|NCT02106546|Mitosis Modulators|mitosis modulators|mesh-ancestor
138703081|NCT02106546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703082|NCT02106546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138703083|NCT02106546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703084|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138703086|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138703087|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703088|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138703089|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138703090|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703091|NCT02104245|Ciprofloxacin|ciprofloxacin|mesh-list
138703092|NCT02104245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138703093|NCT02104245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703094|NCT02104245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138703095|NCT02104245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138703096|NCT02104245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703097|NCT02104245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703098|NCT02104245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703099|NCT02104245|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138703100|NCT02104245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138703101|NCT01699737|Glimepiride|glimepiride|mesh-list
138703102|NCT01699737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138703103|NCT01699737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138327193|NCT00227760|Cediranib|cediranib|mesh-list
138703104|NCT01699737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703105|NCT01699737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138703106|NCT01699737|Immunologic Factors|immunologic factors|mesh-ancestor
138703107|NCT04688723|Dabigatran|dabigatran|mesh-list
138703108|NCT04688723|Clopidogrel|clopidogrel|mesh-list
138703109|NCT04688723|Ticagrelor|ticagrelor|mesh-list
138703110|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138379958|NCT06010927|Midazolam|midazolam|mesh-list
138703111|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138703112|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138703113|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138703114|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
138703115|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138703116|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703117|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703118|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
138703119|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138703120|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
138703121|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703122|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
138703124|NCT01699464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138703125|NCT01699464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138703126|NCT01699464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386250|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138703127|NCT01699464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138703128|NCT01699464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138703129|NCT01699464|Adrenergic Agents|adrenergic agents|mesh-ancestor
138703130|NCT01699464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138703131|NCT01699464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703132|NCT01699464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138703133|NCT01699464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138703134|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138703135|NCT02104050|Dapansutrile|dapansutrile|mesh-list
138703136|NCT02104050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138703137|NCT01694277|Sunitinib|sunitinib|mesh-list
138703138|NCT01694277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703139|NCT01694277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138703140|NCT01694277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138703141|NCT01694277|Growth Substances|growth substances|mesh-ancestor
138703142|NCT01694277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703143|NCT01694277|Growth Inhibitors|growth inhibitors|mesh-ancestor
138703144|NCT01694277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138703145|NCT01694277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703146|NCT01694277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703147|NCT01669980|Vancomycin|vancomycin|mesh-list
138703148|NCT01669980|Ceftriaxone|ceftriaxone|mesh-list
138703149|NCT01669980|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138703150|NCT01669980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138703151|NCT01669980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703152|NCT02915666|Trametinib|trametinib|mesh-list
138703153|NCT02915666|Dabrafenib|dabrafenib|mesh-list
138703154|NCT02915666|Digoxin|digoxin|mesh-list
138703155|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703156|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138703157|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703158|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703159|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138703160|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138703161|NCT02915666|Protective Agents|protective agents|mesh-ancestor
138327219|NCT01898676|Valproic Acid|valproic acid|mesh-list
138703162|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703164|NCT02092935|Ridinilazole|ridinilazole|mesh-list
138386280|NCT01475708|Doxycycline|doxycycline|mesh-list
138703165|NCT02092935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138703166|NCT02092935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703167|NCT01666977|Carboplatin|carboplatin|mesh-list
138703169|NCT01666977|Trebananib|trebananib|mesh-list
138703170|NCT01666977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703171|NCT01666977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703172|NCT01666977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703173|NCT01666977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138703174|NCT01666977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138703175|NCT01666977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138703176|NCT01666977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138703177|NCT01666977|Growth Substances|growth substances|mesh-ancestor
138703178|NCT01666977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703179|NCT01666977|Growth Inhibitors|growth inhibitors|mesh-ancestor
138703181|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138703182|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138703183|NCT02915354|Analgesics|analgesics|mesh-ancestor
138703184|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
138703185|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138380034|NCT05710783|Vaccines|vaccines|mesh-list
138703186|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703187|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138703188|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138703189|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138703190|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138703191|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
138703192|NCT01661634|Ularitide|ularitide|mesh-list
138703193|NCT01661634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138703194|NCT01661634|Autonomic Agents|autonomic agents|mesh-ancestor
138386321|NCT01476124|Narcotics|narcotics|mesh-ancestor
138703196|NCT01661634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703197|NCT01661634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138703198|NCT01661634|Respiratory System Agents|respiratory system agents|mesh-ancestor
138703199|NCT01661634|Diuretics|diuretics|mesh-ancestor
138703200|NCT01661634|Natriuretic Agents|natriuretic agents|mesh-ancestor
138703201|NCT01661166|Fesoterodine|fesoterodine|mesh-list
138196627|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196628|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
138196635|NCT00001768|Antibodies|antibodies|mesh-list
138703202|NCT01661166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138703203|NCT01661166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138703204|NCT01661166|Cholinergic Agents|cholinergic agents|mesh-ancestor
138703205|NCT01661166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138352631|NCT03541356|Levodopa|levodopa|mesh-list
138703206|NCT01661166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703207|NCT01661166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703208|NCT01661166|Urological Agents|urological agents|mesh-ancestor
138703209|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
138703210|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138703211|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138703212|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703213|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138703214|NCT02915042|Analgesics|analgesics|mesh-ancestor
138703215|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
138703216|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703217|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138703218|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138703219|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138703220|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
138703221|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138703222|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703223|NCT01658826|Valacyclovir|valacyclovir|mesh-list
138703225|NCT01658826|Antiviral Agents|antiviral agents|mesh-ancestor
138703226|NCT01658826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703227|NCT01658826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703228|NCT01658826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703229|NCT02092077|Hormones|hormones|mesh-list
138703230|NCT02092077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138703231|NCT02092077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703232|NCT02914886|Insulin|insulin|mesh-list
138703233|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138703234|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138352652|NCT03574818|Gemcitabine|gemcitabine|mesh-list
138703235|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703237|NCT01643226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138703238|NCT01643226|Vitamin B Complex|vitamin b complex|mesh-ancestor
138703239|NCT01643226|Vitamins|vitamins|mesh-ancestor
138703240|NCT01643226|Micronutrients|micronutrients|mesh-ancestor
138703241|NCT01643226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703242|NCT01643226|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138703243|NCT01643226|Dermatologic Agents|dermatologic agents|mesh-ancestor
138703244|NCT02914652|Albuterol|albuterol|mesh-list
138703245|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138703246|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
138703247|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703248|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703249|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138703250|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
138703251|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
138327271|NCT04752852|Dexamethasone|dexamethasone|mesh-list
138703252|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138703253|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138703254|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138703255|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138703256|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
138703257|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138703258|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703260|NCT02081118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138380105|NCT05401214|Niraparib|niraparib|mesh-list
138703261|NCT02081118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703262|NCT02081118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138703263|NCT02081118|Incretins|incretins|mesh-ancestor
138703264|NCT02081118|Hormones|hormones|mesh-ancestor
138703265|NCT02081118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138196640|NCT00000844|Interferons|interferons|mesh-list
138703267|NCT02077881|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138703268|NCT02077881|Gemcitabine|gemcitabine|mesh-list
138703269|NCT02077881|Tryptophan|tryptophan|mesh-list
138703270|NCT02077881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138703271|NCT02077881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703272|NCT02077881|Tubulin Modulators|tubulin modulators|mesh-ancestor
138703273|NCT02077881|Antimitotic Agents|antimitotic agents|mesh-ancestor
138703274|NCT02077881|Mitosis Modulators|mitosis modulators|mesh-ancestor
138703275|NCT02077881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703276|NCT02077881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138703277|NCT02077881|Antimetabolites|antimetabolites|mesh-ancestor
138703278|NCT02077881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138703279|NCT02077881|Antidepressive Agents|antidepressive agents|mesh-ancestor
138703280|NCT02077881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138703281|NCT01632228|Bevacizumab|bevacizumab|mesh-list
138703282|NCT01632228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138703283|NCT01632228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703284|NCT01632228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138703285|NCT01632228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138703286|NCT01632228|Growth Substances|growth substances|mesh-ancestor
138703287|NCT01632228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703288|NCT01632228|Growth Inhibitors|growth inhibitors|mesh-ancestor
138703289|NCT01628094|Ritonavir|ritonavir|mesh-list
138703291|NCT01628094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138703292|NCT01628094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138703293|NCT01628094|Protease Inhibitors|protease inhibitors|mesh-ancestor
138703294|NCT01628094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703295|NCT01628094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703296|NCT01628094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138703297|NCT01628094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138703298|NCT01628094|Antiviral Agents|antiviral agents|mesh-ancestor
138703299|NCT01628094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703300|NCT01628094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138703301|NCT01628094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138703302|NCT01628094|Antimetabolites|antimetabolites|mesh-ancestor
138703303|NCT02073123|Pembrolizumab|pembrolizumab|mesh-list
138703304|NCT02073123|Nivolumab|nivolumab|mesh-list
138703305|NCT02073123|Ipilimumab|ipilimumab|mesh-list
138703306|NCT02073123|Tryptophan|tryptophan|mesh-list
138703307|NCT02073123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138703308|NCT02073123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703309|NCT02073123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138703310|NCT02073123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703311|NCT02073123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138703312|NCT02073123|Antidepressive Agents|antidepressive agents|mesh-ancestor
138703313|NCT02073123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138703314|NCT02914145|Piperaquine|piperaquine|mesh-list
138703315|NCT02914145|Artenimol|artenimol|mesh-list
138703316|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
138703317|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138386456|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
138703318|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138703319|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703320|NCT02914028|Acetaminophen|acetaminophen|mesh-list
138703321|NCT02914028|Tramadol|tramadol|mesh-list
138703322|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138327346|NCT00296322|Mitomycins|mitomycins|mesh-list
138703323|NCT02914028|Analgesics|analgesics|mesh-ancestor
138703324|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
138703325|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703326|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703327|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
138703328|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138703329|NCT02914028|Narcotics|narcotics|mesh-ancestor
138703330|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138703331|NCT02064426|Epoetin Alfa|epoetin alfa|mesh-list
138703332|NCT02064426|Hematinics|hematinics|mesh-ancestor
138703334|NCT02063997|Allopurinol|allopurinol|mesh-list
138703335|NCT02063997|Gout Suppressants|gout suppressants|mesh-ancestor
138703336|NCT02063997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138703337|NCT02063997|Tubulin Modulators|tubulin modulators|mesh-ancestor
138703338|NCT02063997|Antimitotic Agents|antimitotic agents|mesh-ancestor
138703339|NCT02063997|Mitosis Modulators|mitosis modulators|mesh-ancestor
138703340|NCT02063997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703341|NCT02063997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703342|NCT02063997|Antimetabolites|antimetabolites|mesh-ancestor
138703343|NCT02063997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703344|NCT02063997|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138703345|NCT02063997|Antioxidants|antioxidants|mesh-ancestor
138703346|NCT02063997|Protective Agents|protective agents|mesh-ancestor
138703347|NCT02063997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703348|NCT00585507|Fulvestrant|fulvestrant|mesh-list
138703349|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138703350|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703351|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138703352|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138703353|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
138703354|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138703355|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703356|NCT02063685|Prednisone|prednisone|mesh-list
138703357|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
138703358|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138703359|NCT02063685|Rituximab|rituximab|mesh-list
138703360|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138703361|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138703362|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
138703363|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703364|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138703365|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138703366|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
138703367|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703368|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703369|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138703370|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138703371|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138703373|NCT02063685|Hormones|hormones|mesh-ancestor
138703374|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138327370|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138703375|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138703377|NCT02063295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138703378|NCT02063295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138703379|NCT02063295|Growth Substances|growth substances|mesh-ancestor
138352882|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
138703380|NCT02063295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703381|NCT02063295|Growth Inhibitors|growth inhibitors|mesh-ancestor
138703382|NCT02063295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703384|NCT02057172|Exenatide|exenatide|mesh-list
138703385|NCT02057172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138703386|NCT02057172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703387|NCT02057172|Incretins|incretins|mesh-ancestor
138703388|NCT02057172|Hormones|hormones|mesh-ancestor
138703389|NCT02057172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138703390|NCT02057172|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138703391|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
138703392|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138703393|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
138703394|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138703395|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
138703396|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703397|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703398|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
138703400|NCT02052648|Temozolomide|temozolomide|mesh-list
138703401|NCT02052648|Tryptophan|tryptophan|mesh-list
138703402|NCT02052648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138703403|NCT02052648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703404|NCT02052648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138196658|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138703405|NCT02052648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138703406|NCT02052648|Growth Substances|growth substances|mesh-ancestor
138703407|NCT02052648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703408|NCT02052648|Growth Inhibitors|growth inhibitors|mesh-ancestor
138703409|NCT02052648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138703410|NCT02052648|Alkylating Agents|alkylating agents|mesh-ancestor
138703411|NCT02052648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703412|NCT02052648|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138703413|NCT02052648|Antidepressive Agents|antidepressive agents|mesh-ancestor
138703415|NCT01186744|Tofacitinib|tofacitinib|mesh-list
138703416|NCT01186744|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138703417|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138703418|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703419|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703421|NCT02044341|Glycerol|glycerol|mesh-list
138703422|NCT02044341|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138703423|NCT02044341|Protective Agents|protective agents|mesh-ancestor
138703424|NCT02044341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703425|NCT02044341|Anesthetics, Local|anesthetics, local|mesh-ancestor
138703426|NCT02044341|Anesthetics|anesthetics|mesh-ancestor
138703427|NCT02044341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138703428|NCT02044341|Sensory System Agents|sensory system agents|mesh-ancestor
138703429|NCT02044341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703430|NCT00555399|Temozolomide|temozolomide|mesh-list
138703431|NCT00555399|Vorinostat|vorinostat|mesh-list
138703432|NCT00555399|Isotretinoin|isotretinoin|mesh-list
138703433|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138703434|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
138703435|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703436|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386527|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138703437|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138703438|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703439|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
138703440|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
138703441|NCT02912663|Verapamil|verapamil|mesh-list
138703442|NCT02912663|Analgesics|analgesics|mesh-ancestor
138703443|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
138703444|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703445|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703446|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
138703447|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138703448|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138703449|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
138703450|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138703451|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138703452|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703453|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138703454|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
138703455|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138703456|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
138703457|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138703458|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
138703459|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138703460|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138703461|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138703462|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
138703463|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138703464|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703465|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138703466|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138352966|NCT03370536|Ibutilide|ibutilide|mesh-list
138703467|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138703468|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138703469|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703470|NCT02912702|Dexamethasone|dexamethasone|mesh-list
138703471|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
138703472|NCT02912702|Doxorubicin|doxorubicin|mesh-list
138703473|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138703474|NCT02912702|Etoposide|etoposide|mesh-list
138703475|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
138703476|NCT02912702|Pegaspargase|pegaspargase|mesh-list
138703477|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138703478|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
138703479|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
138703480|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703481|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703482|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138703483|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
138703484|NCT02912702|Hormones|hormones|mesh-ancestor
138386572|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138703485|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138703486|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138703487|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703488|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138703489|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138703490|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138703491|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703492|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703493|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138703494|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138327457|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
138703495|NCT02912702|Protective Agents|protective agents|mesh-ancestor
138703496|NCT02010333|Benzyl Alcohol|benzyl alcohol|mesh-list
138703497|NCT02010333|Anesthetics, Local|anesthetics, local|mesh-ancestor
138703498|NCT02010333|Anesthetics|anesthetics|mesh-ancestor
138703499|NCT02010333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138703500|NCT02010333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703501|NCT02010333|Sensory System Agents|sensory system agents|mesh-ancestor
138703502|NCT02010333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703503|NCT02008344|Favipiravir|favipiravir|mesh-list
138703504|NCT02008344|Antiviral Agents|antiviral agents|mesh-ancestor
138703505|NCT02008344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703506|NCT02912156|Voriconazole|voriconazole|mesh-list
138353004|NCT02985840|Hormones|hormones|mesh-ancestor
138703507|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
138703508|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703509|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138703510|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138703511|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703512|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703513|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138703514|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
138703515|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138703516|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703517|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138703518|NCT03455049|Andrographolide|andrographolide|mesh-list
138703519|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138703520|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138703521|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138703522|NCT03455049|Analgesics|analgesics|mesh-ancestor
138703523|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
138703524|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703525|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703526|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138196681|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138703527|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138703528|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138703529|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703530|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
138703531|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138703532|NCT02912234|Clarithromycin|clarithromycin|mesh-list
138703534|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138703535|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703536|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138703537|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138327498|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
138703538|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703539|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138703540|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138703541|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138703542|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
138703543|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138703544|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
138703545|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
138703546|NCT04676139|Fluoxetine|fluoxetine|mesh-list
138703547|NCT04676139|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138703548|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138703549|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138703550|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703551|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138703552|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
138703553|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703554|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138703555|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
138703556|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138703557|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138353069|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
138703558|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138703559|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380406|NCT04225988|Tacrolimus|tacrolimus|mesh-list
138703560|NCT01999764|Retinol acetate|retinol acetate|mesh-list
138703561|NCT01999764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138703562|NCT01999764|Immunologic Factors|immunologic factors|mesh-ancestor
138703563|NCT01999764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703564|NCT01999764|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138703565|NCT01999764|Protective Agents|protective agents|mesh-ancestor
138703566|NCT01999764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703567|NCT02911961|Acetaminophen|acetaminophen|mesh-list
138703568|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138703569|NCT02911961|Analgesics|analgesics|mesh-ancestor
138703570|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
138703571|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703572|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703573|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
138703574|NCT01998828|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
138703575|NCT01998828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138703576|NCT01998828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703577|NCT01998828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703578|NCT04676061|Norethindrone|norethindrone|mesh-list
138703579|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
138703580|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138703581|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138703582|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138196685|NCT02634008|Ritonavir|ritonavir|mesh-list
138196686|NCT02634008|Ribavirin|ribavirin|mesh-list
138196687|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138703583|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
138703584|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138703585|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703586|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138703587|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138703588|NCT04675944|Treprostinil|treprostinil|mesh-list
138703590|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138703591|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703592|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703593|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
138703594|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138703595|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138703596|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703597|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
138703598|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
138703599|NCT01993641|Azacitidine|azacitidine|mesh-list
138703600|NCT01993641|Decitabine|decitabine|mesh-list
138703601|NCT01993641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138703602|NCT01993641|Antimetabolites|antimetabolites|mesh-ancestor
138703603|NCT01993641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703604|NCT01993641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703605|NCT01993641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703606|NCT01989429|Vitamin D|vitamin d|mesh-list
138703607|NCT01989429|Vitamins|vitamins|mesh-ancestor
138703608|NCT01989429|Micronutrients|micronutrients|mesh-ancestor
138703609|NCT01989429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703610|NCT01989429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138703611|NCT02911298|Metronidazole|metronidazole|mesh-list
138703612|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703613|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138703614|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138703615|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138703616|NCT01983306|Dolcanatide|dolcanatide|mesh-list
138703617|NCT01983306|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138703618|NCT01983306|Enzyme Activators|enzyme activators|mesh-ancestor
138703619|NCT01983306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703620|NCT01983306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138703621|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
138703622|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138703623|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703624|NCT01975818|Epoetin Alfa|epoetin alfa|mesh-list
138703625|NCT01975818|Hematinics|hematinics|mesh-ancestor
138703627|NCT01973049|Asunaprevir|asunaprevir|mesh-list
138703628|NCT01973049|Antimetabolites|antimetabolites|mesh-ancestor
138703629|NCT01973049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703630|NCT01973049|Antiviral Agents|antiviral agents|mesh-ancestor
138703631|NCT01973049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703632|NCT01973049|Protease Inhibitors|protease inhibitors|mesh-ancestor
138703633|NCT01973049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703634|NCT01185964|Doxorubicin|doxorubicin|mesh-list
138703635|NCT01185964|Olaratumab|olaratumab|mesh-list
138703636|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138703637|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703638|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138703639|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138703640|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703641|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703643|NCT01972854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138703644|NCT01972854|Vitamin B Complex|vitamin b complex|mesh-ancestor
138703645|NCT01972854|Vitamins|vitamins|mesh-ancestor
138703646|NCT01972854|Micronutrients|micronutrients|mesh-ancestor
138703647|NCT01972854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703648|NCT01972854|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138703649|NCT01972854|Dermatologic Agents|dermatologic agents|mesh-ancestor
138703650|NCT02550470|Sevoflurane|sevoflurane|mesh-list
138703651|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138703652|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138703653|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
138703654|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
138703655|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138703656|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703657|NCT02910518|Insulin|insulin|mesh-list
138703658|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138703659|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
138703660|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
138703661|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
138703662|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
138703663|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
138703664|NCT02910518|Heparin|heparin|mesh-list
138703666|NCT02910518|Glucagon|glucagon|mesh-list
138703667|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138703668|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703669|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
138703670|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138703671|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138703672|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703673|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138703675|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138703676|NCT01217437|Bevacizumab|bevacizumab|mesh-list
138703677|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138703678|NCT01217437|Irinotecan|irinotecan|mesh-list
138703679|NCT01217437|Temozolomide|temozolomide|mesh-list
138703680|NCT01217437|Camptothecin|camptothecin|mesh-list
138703681|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
138703682|NCT01217437|Antibodies|antibodies|mesh-list
138703683|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
138703684|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138703686|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703687|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138703688|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138703689|NCT01217437|Growth Substances|growth substances|mesh-ancestor
138703690|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703691|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
138703692|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
138703693|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138703694|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138703695|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703696|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703697|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138703698|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
138196732|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703699|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138703700|NCT00624364|Metformin|metformin|mesh-list
138703701|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
138703702|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
138703703|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138353248|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
138703704|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703706|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138703707|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
138703708|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703709|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703713|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138703714|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703715|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
138703716|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
138703717|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138703718|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138703719|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138703720|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703721|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703722|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138703723|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
138703724|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138703725|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138703726|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138703727|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138703728|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703729|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
138703730|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138703731|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703732|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138703733|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703735|NCT06227429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703736|NCT06227429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703740|NCT06227325|Disitamab vedotin|disitamab vedotin|mesh-list
138703741|NCT06227325|Immunoconjugates|immunoconjugates|mesh-ancestor
138703742|NCT06227325|Immunologic Factors|immunologic factors|mesh-ancestor
138703743|NCT06227325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703745|NCT06227221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703746|NCT06227221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138703747|NCT06227221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703748|NCT06227221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703749|NCT06227156|Disitamab vedotin|disitamab vedotin|mesh-list
138703750|NCT06227156|Immunoconjugates|immunoconjugates|mesh-ancestor
138703751|NCT06227156|Immunologic Factors|immunologic factors|mesh-ancestor
138703752|NCT06227156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703753|NCT06227143|Anesthetics|anesthetics|mesh-list
138703754|NCT06227143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138703755|NCT06227143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703756|NCT06227117|Cyclophosphamide|cyclophosphamide|mesh-list
138703757|NCT06227117|Carboplatin|carboplatin|mesh-list
138196738|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138703758|NCT06227117|Epirubicin|epirubicin|mesh-list
138703759|NCT06227117|Disitamab vedotin|disitamab vedotin|mesh-list
138703760|NCT06227117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138703761|NCT06227117|Immunologic Factors|immunologic factors|mesh-ancestor
138703762|NCT06227117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703763|NCT06227117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138703764|NCT06227117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138703765|NCT06227117|Alkylating Agents|alkylating agents|mesh-ancestor
138373009|NCT01422096|Leuprolide|leuprolide|mesh-list
138196739|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196740|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
138196741|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138196742|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138703766|NCT06227117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703767|NCT06227117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703768|NCT06227117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138703769|NCT06227117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138703770|NCT06227117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138703771|NCT06227117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138703772|NCT06227117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703773|NCT06227117|Immunoconjugates|immunoconjugates|mesh-ancestor
138703776|NCT06227065|Epirubicin|epirubicin|mesh-list
138703777|NCT06227065|Mitomycins|mitomycins|mesh-list
138703778|NCT06227065|Mitomycin|mitomycin|mesh-list
138703779|NCT06227065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138703780|NCT06227065|Antimetabolites|antimetabolites|mesh-ancestor
138703781|NCT06227065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703782|NCT06227065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703783|NCT06227065|Tubulin Modulators|tubulin modulators|mesh-ancestor
138703784|NCT06227065|Antimitotic Agents|antimitotic agents|mesh-ancestor
138703785|NCT06227065|Mitosis Modulators|mitosis modulators|mesh-ancestor
138703786|NCT06227065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138703787|NCT06227065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138703788|NCT06227065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138703789|NCT06227065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703790|NCT06227065|Alkylating Agents|alkylating agents|mesh-ancestor
138703791|NCT06227065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138703809|NCT06226532|Sensory System Agents|sensory system agents|mesh-ancestor
138703810|NCT06226532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703811|NCT06226532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138703812|NCT06226532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138703813|NCT06226532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138703814|NCT06226532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138703815|NCT06226532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703816|NCT06226519|Carbon-11 methionine|carbon-11 methionine|mesh-list
138703817|NCT06226519|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138703818|NCT06226519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703819|NCT06226506|Aprepitant|aprepitant|mesh-list
138703820|NCT06226506|Fosaprepitant|fosaprepitant|mesh-list
138703821|NCT06226506|Antiemetics|antiemetics|mesh-ancestor
138703822|NCT06226506|Autonomic Agents|autonomic agents|mesh-ancestor
138703823|NCT06226506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703824|NCT06226506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703825|NCT06226506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138703826|NCT06226506|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138703827|NCT06226506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138703828|NCT06226506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703829|NCT06226363|Antibodies|antibodies|mesh-list
138703830|NCT06226363|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138703831|NCT06226363|Immunologic Factors|immunologic factors|mesh-ancestor
138703832|NCT06226363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703833|NCT06226350|Antibodies|antibodies|mesh-list
138703834|NCT06226350|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138703835|NCT06226350|Immunologic Factors|immunologic factors|mesh-ancestor
138703836|NCT06226350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703847|NCT06225999|Antimetabolites|antimetabolites|mesh-ancestor
138703848|NCT06225999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703849|NCT06225999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138703850|NCT06225999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703851|NCT06225999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138703852|NCT06225999|Immunologic Factors|immunologic factors|mesh-ancestor
138703853|NCT06225999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138353530|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
138703854|NCT06225999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138703855|NCT06225999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138703856|NCT06225999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703857|NCT06225999|Antidotes|antidotes|mesh-ancestor
138703858|NCT06225999|Protective Agents|protective agents|mesh-ancestor
138703859|NCT06225999|Vitamin B Complex|vitamin b complex|mesh-ancestor
138703860|NCT06225999|Vitamins|vitamins|mesh-ancestor
138703861|NCT06225999|Micronutrients|micronutrients|mesh-ancestor
138703870|NCT06225895|Bupivacaine|bupivacaine|mesh-list
138703871|NCT06225895|Anesthetics, Local|anesthetics, local|mesh-ancestor
138703872|NCT06225895|Anesthetics|anesthetics|mesh-ancestor
138703873|NCT06225895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138703874|NCT06225895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703876|NCT06225895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138703877|NCT06225869|Levodopa|levodopa|mesh-list
138703878|NCT06225869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138703879|NCT06225869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138703880|NCT06225869|Dopamine Agents|dopamine agents|mesh-ancestor
138703881|NCT06225869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138353572|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138703882|NCT06225869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703883|NCT06225869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703885|NCT06225752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138703886|NCT06225752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138703887|NCT06225752|Antimetabolites|antimetabolites|mesh-ancestor
138703888|NCT06225752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703889|NCT06225752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138703890|NCT06225752|Antioxidants|antioxidants|mesh-ancestor
138703891|NCT06225752|Protective Agents|protective agents|mesh-ancestor
138703892|NCT06225752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703893|NCT06225622|Bevacizumab|bevacizumab|mesh-list
138703894|NCT06225622|Cetuximab|cetuximab|mesh-list
138703895|NCT06225622|Oxaliplatin|oxaliplatin|mesh-list
138703896|NCT06225622|Irinotecan|irinotecan|mesh-list
138703897|NCT06225622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138703898|NCT06225622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138703899|NCT06225622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138703900|NCT06225622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138703901|NCT06225622|Growth Substances|growth substances|mesh-ancestor
138703902|NCT06225622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138703903|NCT06225622|Growth Inhibitors|growth inhibitors|mesh-ancestor
138703904|NCT06225622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138703905|NCT06225622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138703906|NCT06225622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703907|NCT06225622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703908|NCT06225596|Carboplatin|carboplatin|mesh-list
138703909|NCT06225596|Gemcitabine|gemcitabine|mesh-list
138703910|NCT06225596|Pembrolizumab|pembrolizumab|mesh-list
138703917|NCT06225596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138703918|NCT06225570|Tetracycline|tetracycline|mesh-list
138703919|NCT06225570|Isotretinoin|isotretinoin|mesh-list
138703920|NCT06225570|Dermatologic Agents|dermatologic agents|mesh-ancestor
138703921|NCT06225570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138703923|NCT06225570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138703924|NCT06225570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138703925|NCT06225570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138703927|NCT06225544|Renal Agents|renal agents|mesh-ancestor
138703928|NCT06225505|FAPI-46|fapi-46|mesh-list
138703929|NCT06225505|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138703930|NCT06225505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380781|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138421800|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138421801|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
138421802|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421803|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138353659|NCT04954638|Eusol|eusol|mesh-list
138421804|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138421805|NCT01683760|Fluconazole|fluconazole|mesh-list
138421806|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
138421807|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138421808|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138421809|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138421810|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421811|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421812|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138421813|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
138421814|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138421815|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421816|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138421817|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138421818|NCT01684813|Clopidogrel|clopidogrel|mesh-list
138421819|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138421820|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138421821|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138421822|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138421823|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138421824|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
138421825|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138421826|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421827|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421829|NCT01684982|Everolimus|everolimus|mesh-list
138421830|NCT01684982|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138421831|NCT01684982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138421832|NCT01684982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138353708|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421833|NCT01684982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421834|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138421835|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
138421836|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421837|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421838|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138421839|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138421840|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138421841|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
138421842|NCT01685034|Immunomodulating Agents|immunomodulating agents|mesh-list
138421843|NCT01685034|Immunologic Factors|immunologic factors|mesh-ancestor
138421844|NCT01685034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421846|NCT01685489|Docetaxel|docetaxel|mesh-list
138421847|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421848|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
138421849|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
138421850|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
138421851|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421852|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138196789|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421853|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
138421854|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421855|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138421856|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
138421857|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138421858|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
138421859|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138421860|NCT01685489|Protective Agents|protective agents|mesh-ancestor
138421861|NCT01686386|Dexamethasone|dexamethasone|mesh-list
138421862|NCT01686386|Lenalidomide|lenalidomide|mesh-list
138421863|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138421864|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138421866|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
138421867|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138421868|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421869|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138421870|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
138421871|NCT01686386|Hormones|hormones|mesh-ancestor
138421872|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138421873|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138421875|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
138421876|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138421877|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138421878|NCT01686386|Growth Substances|growth substances|mesh-ancestor
138421879|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
138421880|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138421881|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
138421882|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421883|NCT01686594|Methoxsalen|methoxsalen|mesh-list
138421884|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138421885|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
138421887|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
138421888|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421889|NCT01687751|Midazolam|midazolam|mesh-list
138421890|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
138421891|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138421892|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138421893|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421894|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138421895|NCT01687751|Analgesics|analgesics|mesh-ancestor
138421896|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
138421897|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138421898|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138421899|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138421900|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138421901|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
138421902|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138421903|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421904|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138421905|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138421906|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138421907|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138421908|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138421909|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
138421910|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
138421911|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
138421912|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
138421913|NCT01688362|Dexamethasone|dexamethasone|mesh-list
138421914|NCT01688362|Bupivacaine|bupivacaine|mesh-list
138421915|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138421916|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
138421917|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
138421918|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138421919|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421920|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138421921|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
138421923|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138196800|NCT05586464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138421924|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138421925|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421926|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
138421927|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
138421928|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138421929|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
138421930|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138421931|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138421932|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138421933|NCT01689753|Citric Acid|citric acid|mesh-list
138421934|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
138421935|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
138421936|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138421937|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
138421938|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
138421939|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421940|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
138421941|NCT01690039|Furosemide|furosemide|mesh-list
138421942|NCT01690039|Diuretics|diuretics|mesh-ancestor
138421943|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
138421944|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421945|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138421946|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138421947|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421948|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138421949|NCT01690091|Metformin|metformin|mesh-list
138421950|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138421951|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421952|NCT01690104|Rifampin|rifampin|mesh-list
138421953|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138421954|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
138353829|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
138421955|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138421956|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138421957|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
138421958|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138421959|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421960|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230389|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
138421961|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138421962|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138421963|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138421964|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138196824|NCT02268656|Propofol|propofol|mesh-list
138421965|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138421966|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138421968|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138421969|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138421970|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138353866|NCT00000138|Acyclovir|acyclovir|mesh-list
138421971|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421972|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138421973|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421974|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
138421975|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138421976|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
138421977|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421978|NCT01690286|Ketoconazole|ketoconazole|mesh-list
138421979|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
138421980|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138421981|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138421982|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138421983|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421984|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421985|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138421986|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
138327967|NCT03709914|Fosfomycin|fosfomycin|mesh-list
138421987|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138421988|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421989|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138421990|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
138421991|NCT01690325|Bevacizumab|bevacizumab|mesh-list
138421992|NCT01690325|Docetaxel|docetaxel|mesh-list
138421993|NCT01690325|Trastuzumab|trastuzumab|mesh-list
138421994|NCT01690325|Epirubicin|epirubicin|mesh-list
138421995|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138421996|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
138421997|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421998|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138421999|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138422000|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
138422001|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422002|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422003|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138422004|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138422005|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138422006|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138422007|NCT01690325|Growth Substances|growth substances|mesh-ancestor
138422008|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
138422009|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
138422010|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
138422011|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
138422012|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138422013|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138422014|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138422015|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422016|NCT01690338|Bromides|bromides|mesh-list
138422017|NCT01690338|Rocuronium|rocuronium|mesh-list
138422018|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
138381008|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
138422019|NCT01690338|Cisatracurium|cisatracurium|mesh-list
138422020|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
138196839|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138196840|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138196841|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422021|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138422022|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138422023|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138422024|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422025|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422027|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138422028|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
138422029|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422030|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422031|NCT01690364|Anesthetics|anesthetics|mesh-list
138422032|NCT01690364|Cisatracurium|cisatracurium|mesh-list
138422033|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
138422034|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422035|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422036|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138422037|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138422038|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422039|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138422040|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138422041|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138422042|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
138422043|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422044|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422045|NCT01690403|Rifapentine|rifapentine|mesh-list
138422046|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138422047|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
138422048|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138422049|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422050|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
138422051|NCT01690468|Carboplatin|carboplatin|mesh-list
138422052|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422053|NCT01690507|Cytarabine|cytarabine|mesh-list
138422054|NCT01690507|Decitabine|decitabine|mesh-list
138422055|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
138422056|NCT01690507|Lenograstim|lenograstim|mesh-list
138422057|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138422058|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
138422059|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422060|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422061|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
138422062|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422063|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138422064|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
138422065|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422066|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422067|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138422068|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138422069|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
138387327|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422070|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138422071|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138422072|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422073|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138422074|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138422075|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422076|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422077|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422078|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138422079|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
138422080|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138422081|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138328018|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138196852|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138196853|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
138196855|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
138196856|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138196857|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138196858|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
138422082|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138422083|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138422084|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138422085|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
138422086|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138422087|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422088|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138230404|NCT02579343|Dexetimide|dexetimide|mesh-list
138422089|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138422090|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422091|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381083|NCT04291820|Anesthetics|anesthetics|mesh-list
138422092|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387379|NCT01482156|Everolimus|everolimus|mesh-list
138422093|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138422094|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138422095|NCT01690572|Paclitaxel|paclitaxel|mesh-list
138422096|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
138422097|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138422098|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422099|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
138422100|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
138422101|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
138422102|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422103|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138422104|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
138422105|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422106|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
138422107|NCT01690572|Protective Agents|protective agents|mesh-ancestor
138422108|NCT01690598|Topotecan|topotecan|mesh-list
138422109|NCT01690598|Veliparib|veliparib|mesh-list
138422110|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138422111|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138422112|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422113|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422114|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422115|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138387423|NCT01482416|Estrogens|estrogens|mesh-list
138422117|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
138422118|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422119|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422120|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422121|NCT01690702|Paclitaxel|paclitaxel|mesh-list
138422122|NCT01690702|Docetaxel|docetaxel|mesh-list
138422123|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
138422124|NCT01690702|Epirubicin|epirubicin|mesh-list
138422125|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138422126|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422127|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
138422128|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
138422129|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
138422130|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422131|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138422132|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
138422133|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422134|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138422135|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138422136|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
138422137|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138422138|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138422139|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138422140|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138422141|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422142|NCT01690767|Lidocaine|lidocaine|mesh-list
138422143|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
138422144|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
138422145|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422146|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422147|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
138422148|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422149|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138422150|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138422151|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138422152|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138422153|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422154|NCT01690780|Ibuprofen|ibuprofen|mesh-list
138422155|NCT01690780|Morphine|morphine|mesh-list
138422156|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138422157|NCT01690780|Narcotics|narcotics|mesh-ancestor
138422158|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422159|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422160|NCT01690780|Analgesics|analgesics|mesh-ancestor
138422161|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
138422162|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422163|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138422164|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138422165|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138422166|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138422167|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138422168|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422169|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422170|NCT01690832|Fenoldopam|fenoldopam|mesh-list
138422171|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138422172|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
138422173|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
138422174|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
138422175|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422176|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422177|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422178|NCT01690871|Dactolisib|dactolisib|mesh-list
138422179|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422180|NCT01690884|Adenosine|adenosine|mesh-list
138422181|NCT01690884|Analgesics|analgesics|mesh-ancestor
138422182|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
138422183|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422184|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422185|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138422186|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
138422187|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138422188|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
138422189|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
138422190|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422191|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422192|NCT01690962|Vitamins|vitamins|mesh-list
138422193|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
138422194|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
138422195|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
138422196|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
138422197|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422198|NCT01690962|Hematinics|hematinics|mesh-ancestor
138422199|NCT01690975|Benzonatate|benzonatate|mesh-list
138422200|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
138422201|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
138422202|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
138422203|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138422204|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422205|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422206|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138422207|NCT01691001|Analgesics|analgesics|mesh-ancestor
138422208|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
138422209|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422210|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138422211|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138422212|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138422213|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
138422214|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422215|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422216|NCT01691053|Spironolactone|spironolactone|mesh-list
138422217|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138422218|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
138422219|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138422220|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422221|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138422222|NCT01691053|Diuretics|diuretics|mesh-ancestor
138422223|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
138422224|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
138422225|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
138422226|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138422227|NCT01691365|Vitamins|vitamins|mesh-list
138422228|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
138422229|NCT01691365|Antioxidants|antioxidants|mesh-list
138422230|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
138422231|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387554|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138422232|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422233|NCT01691365|Protective Agents|protective agents|mesh-ancestor
138422234|NCT01691404|Quercetin|quercetin|mesh-list
138422235|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
138328086|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
138422236|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422237|NCT01691404|Protective Agents|protective agents|mesh-ancestor
138422238|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422239|NCT01691456|Montelukast|montelukast|mesh-list
138422240|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138422241|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
138422242|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138422243|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
138422244|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138422245|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422246|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138422247|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138422248|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422249|NCT01691469|Montelukast|montelukast|mesh-list
138422250|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138422251|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
138422252|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138422253|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
138422254|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138422255|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422256|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138422257|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138422258|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422259|NCT01691495|PENTA|penta|mesh-list
138422260|NCT01691495|Fondaparinux|fondaparinux|mesh-list
138422261|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138422262|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
138422263|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138422264|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
138422265|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422266|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422268|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138422269|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138196885|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
138422270|NCT01691625|Immunomodulating Agents|immunomodulating agents|mesh-list
138422271|NCT01691625|Immunologic Factors|immunologic factors|mesh-ancestor
138422272|NCT01691625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422273|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
138422274|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138422275|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138422276|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138422277|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138422278|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422279|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
138422280|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422281|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422282|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138422283|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422284|NCT01691677|Beclomethasone|beclomethasone|mesh-list
138422285|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138422286|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
138422287|NCT01691677|Hormones|hormones|mesh-ancestor
138422288|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138422289|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422290|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138422291|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
138422292|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138422293|NCT01691742|Laxatives|laxatives|mesh-list
138422295|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138422296|NCT01691807|Ofatumumab|ofatumumab|mesh-list
138422297|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138422298|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
138422299|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422300|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422301|NCT01691872|Ezogabine|ezogabine|mesh-list
138422302|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
138422303|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138422304|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422305|NCT01691937|Sufentanil|sufentanil|mesh-list
138422306|NCT01691937|Ropivacaine|ropivacaine|mesh-list
138422307|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
138422308|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
138422309|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422310|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422311|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
138422312|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422313|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138422314|NCT01691937|Narcotics|narcotics|mesh-ancestor
138381306|NCT03777982|Hormones|hormones|mesh-ancestor
138422315|NCT01691937|Analgesics|analgesics|mesh-ancestor
138422316|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138422317|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138422318|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
138422319|NCT01691976|Estrogens|estrogens|mesh-list
138422320|NCT01691976|Hormones|hormones|mesh-ancestor
138422321|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138422322|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422323|NCT01692132|Prucalopride|prucalopride|mesh-list
138422324|NCT01692132|Laxatives|laxatives|mesh-ancestor
138422325|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138422326|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138422327|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138422328|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
138422329|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138196891|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138196892|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138196893|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138196894|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138196895|NCT03252600|Growth Substances|growth substances|mesh-ancestor
138422330|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422331|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422332|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
138422333|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138422334|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422335|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422336|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138422337|NCT01692210|Analgesics|analgesics|mesh-ancestor
138422338|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
138422339|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422340|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138422341|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138422342|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138422343|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
138422344|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422345|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422347|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138422348|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138422349|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138422350|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
138422351|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422353|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
138328125|NCT00360672|Lenalidomide|lenalidomide|mesh-list
138422354|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138422355|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
138422356|NCT01692483|Hormones|hormones|mesh-ancestor
138422357|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138422358|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422359|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138422360|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422361|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138422362|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422363|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422364|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
138422365|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138422366|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138422367|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138422368|NCT01692678|Dacarbazine|dacarbazine|mesh-list
138422369|NCT01692678|Trabectedin|trabectedin|mesh-list
138422370|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138422371|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
138422372|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422373|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422374|NCT01692704|Gemcitabine|gemcitabine|mesh-list
138422375|NCT01692704|Floxuridine|floxuridine|mesh-list
138422376|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422377|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138422378|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
138422379|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422380|NCT01692808|Vitamin D|vitamin d|mesh-list
138422381|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
138422382|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
138422383|NCT01692808|Vitamins|vitamins|mesh-list
138422384|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
138422385|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422386|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138422387|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138422389|NCT01692834|Cyclosporins|cyclosporins|mesh-list
138422390|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422391|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422392|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138422393|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
138422394|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422395|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
138422396|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422397|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
138422398|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138422399|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138422400|NCT01692886|Vaccines|vaccines|mesh-list
138422401|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138422402|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
138422403|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422404|NCT01692925|Factor VIII|factor viii|mesh-list
138422405|NCT01692925|Coagulants|coagulants|mesh-ancestor
138422406|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
138422407|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138422408|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
138422409|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422410|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422411|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138422412|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
138422413|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
138422414|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138422415|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
138422416|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422417|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422418|NCT01693081|Apomorphine|apomorphine|mesh-list
138422420|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422421|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
138422422|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422423|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138422424|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
138422425|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
138422426|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422427|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422428|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
138422429|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
138422430|NCT01693159|Coagulants|coagulants|mesh-ancestor
138422431|NCT01693276|Paclitaxel|paclitaxel|mesh-list
138422432|NCT01693276|Gemcitabine|gemcitabine|mesh-list
138422433|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138422434|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138422435|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422436|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
138422437|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
138422438|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
138230424|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138422439|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422440|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138422441|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
138422442|NCT01693289|Metformin|metformin|mesh-list
138422443|NCT01693289|Letrozole|letrozole|mesh-list
138354521|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
138422444|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138422445|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422446|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422447|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138422448|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138422449|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422450|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422451|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138422452|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
138422453|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138422455|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138422456|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138422457|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422458|NCT01693328|Fentanyl|fentanyl|mesh-list
138422459|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138422460|NCT01693328|Narcotics|narcotics|mesh-ancestor
138422461|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422462|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387781|NCT01485692|Midazolam|midazolam|mesh-list
138422464|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
138422465|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422466|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138422467|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138422468|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
138422469|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
138422470|NCT01693393|Cyclosporine|cyclosporine|mesh-list
138422471|NCT01693393|Cyclosporins|cyclosporins|mesh-list
138422472|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422473|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422474|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138422475|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
138422476|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422477|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
138422478|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422479|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
138422480|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138422481|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138422482|NCT01693419|Gemcitabine|gemcitabine|mesh-list
138422483|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138422484|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138422485|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
138422486|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422487|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422488|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138422489|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422490|NCT01693432|Docetaxel|docetaxel|mesh-list
138422491|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422492|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
138422493|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
138422494|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
138422495|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422496|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
138422497|NCT01693445|Irinotecan|irinotecan|mesh-list
138422508|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138422509|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
138422510|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422511|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138422513|NCT01693679|Adefovir|adefovir|mesh-list
138422514|NCT01693679|Telbivudine|telbivudine|mesh-list
138422515|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138422516|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138422517|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422518|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422519|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
138422520|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422521|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138422522|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138422535|NCT01693809|Caffeine|caffeine|mesh-list
138422536|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138422537|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422538|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138387850|NCT01485744|Antidotes|antidotes|mesh-ancestor
138196924|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138422540|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422541|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138422542|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138422543|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
138422544|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422545|NCT01693822|Axitinib|axitinib|mesh-list
138422546|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422547|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138422548|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422549|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422550|NCT01694017|Tenofovir|tenofovir|mesh-list
138422551|NCT01694017|Zidovudine|zidovudine|mesh-list
138422552|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
138422553|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422554|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138422555|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138422556|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138354643|NCT00001296|Interferons|interferons|mesh-list
138422557|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422558|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138422559|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138422560|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
138422562|NCT05288816|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138422563|NCT05288816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138422564|NCT05288816|Immunologic Factors|immunologic factors|mesh-ancestor
138422565|NCT05288816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422566|NCT05288738|Dexmedetomidine|dexmedetomidine|mesh-list
138422567|NCT05288738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138422568|NCT05288738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422569|NCT05288738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422570|NCT05288738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138422571|NCT05288738|Analgesics|analgesics|mesh-ancestor
138422572|NCT05288738|Sensory System Agents|sensory system agents|mesh-ancestor
138422573|NCT05288738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422574|NCT05288738|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138422575|NCT05288738|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138422576|NCT05288738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138422577|NCT05288738|Adrenergic Agents|adrenergic agents|mesh-ancestor
138422578|NCT05288738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422579|NCT05288738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422580|NCT05288725|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138422581|NCT05288725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138387879|NCT01485926|Carboplatin|carboplatin|mesh-list
138422582|NCT05288725|Glucocorticoids|glucocorticoids|mesh-ancestor
138422584|NCT05288725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138422585|NCT05288725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422586|NCT05288725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138422587|NCT05288725|Immunologic Factors|immunologic factors|mesh-ancestor
138422588|NCT05288465|Cerebrolysin|cerebrolysin|mesh-list
138422589|NCT05288465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138422590|NCT05288465|Protective Agents|protective agents|mesh-ancestor
138422591|NCT05288465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422592|NCT05288465|Nootropic Agents|nootropic agents|mesh-ancestor
138422593|NCT05288192|Triamcinolone|triamcinolone|mesh-list
138422594|NCT05288192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138422595|NCT05288192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138422596|NCT05288192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138422597|NCT05288192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138422598|NCT05288192|Glucocorticoids|glucocorticoids|mesh-ancestor
138196942|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
138422599|NCT05288192|Hormones|hormones|mesh-ancestor
138422600|NCT05288192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138422601|NCT05288192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196943|NCT00000178|Hormones|hormones|mesh-ancestor
138422602|NCT05288192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138422603|NCT05288192|Immunologic Factors|immunologic factors|mesh-ancestor
138422604|NCT05288192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422605|NCT05288192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422606|NCT05288179|Pirfenidone|pirfenidone|mesh-list
138422607|NCT05288179|Analgesics|analgesics|mesh-ancestor
138422608|NCT05288179|Sensory System Agents|sensory system agents|mesh-ancestor
138422609|NCT05288179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422610|NCT05288179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422611|NCT05288179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138422612|NCT05288179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138422613|NCT05288179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138422614|NCT05288179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138422615|NCT05288179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387905|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
138422617|NCT05288127|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138422618|NCT05288127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422619|NCT05288127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422620|NCT05288127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422622|NCT05291455|Phenobarbital|phenobarbital|mesh-list
138422623|NCT05291455|Anticonvulsants|anticonvulsants|mesh-ancestor
138422624|NCT05291455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138422625|NCT05291455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138422626|NCT05291455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138422627|NCT05291455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422628|NCT05291455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138422629|NCT05291455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422630|NCT05291455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422631|NCT05291455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138422632|NCT05291455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138422633|NCT05291455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422634|NCT05291455|GABA Modulators|gaba modulators|mesh-ancestor
138422635|NCT05291455|GABA Agents|gaba agents|mesh-ancestor
138422636|NCT05291455|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138422637|NCT05291455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138422638|NCT05291455|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138422639|NCT05291195|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138422640|NCT05291195|Eusol|eusol|mesh-list
138422641|NCT05291195|Disinfectants|disinfectants|mesh-ancestor
138422642|NCT05291195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422643|NCT05291104|Folic Acid|folic acid|mesh-list
138422644|NCT05291104|Choline|choline|mesh-list
138422645|NCT05291104|Hematinics|hematinics|mesh-ancestor
138422646|NCT05291104|Vitamin B Complex|vitamin b complex|mesh-ancestor
138422647|NCT05291104|Vitamins|vitamins|mesh-ancestor
138422648|NCT05291104|Micronutrients|micronutrients|mesh-ancestor
138422649|NCT05291104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422650|NCT05291104|Lipotropic Agents|lipotropic agents|mesh-ancestor
138422651|NCT05291104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138422652|NCT05291104|Antimetabolites|antimetabolites|mesh-ancestor
138422653|NCT05291104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422654|NCT05291104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138422656|NCT05291104|Nootropic Agents|nootropic agents|mesh-ancestor
138422657|NCT05291052|Capecitabine|capecitabine|mesh-list
138422658|NCT05291052|Oxaliplatin|oxaliplatin|mesh-list
138422659|NCT05291052|Lenvatinib|lenvatinib|mesh-list
138422660|NCT05291052|Tislelizumab|tislelizumab|mesh-list
138422661|NCT05291052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138422662|NCT05291052|Antimetabolites|antimetabolites|mesh-ancestor
138422663|NCT05291052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138196954|NCT05480280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422664|NCT05291052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422665|NCT05291052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138422666|NCT05291052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422667|NCT05291052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138422668|NCT05290948|Bevacizumab|bevacizumab|mesh-list
138422669|NCT05290948|Acetazolamide|acetazolamide|mesh-list
138422670|NCT05290948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138422671|NCT05290948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422672|NCT05290948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138422673|NCT05290948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138422675|NCT05290948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422676|NCT05290948|Growth Inhibitors|growth inhibitors|mesh-ancestor
138422677|NCT05290948|Anticonvulsants|anticonvulsants|mesh-ancestor
138422678|NCT05290948|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138422679|NCT05290948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422680|NCT05290948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422681|NCT05290948|Diuretics|diuretics|mesh-ancestor
138422682|NCT05290948|Natriuretic Agents|natriuretic agents|mesh-ancestor
138422683|NCT05290935|Paclitaxel|paclitaxel|mesh-list
138422684|NCT05290935|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138422686|NCT05290935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138422687|NCT05290935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422688|NCT05290935|Tubulin Modulators|tubulin modulators|mesh-ancestor
138422689|NCT05290935|Antimitotic Agents|antimitotic agents|mesh-ancestor
138422690|NCT05290935|Mitosis Modulators|mitosis modulators|mesh-ancestor
138422691|NCT05290935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422692|NCT05290935|Immunologic Factors|immunologic factors|mesh-ancestor
138422693|NCT05290935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422694|NCT05290506|Linagliptin|linagliptin|mesh-list
138422695|NCT05290506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138422696|NCT05290506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138422697|NCT05290506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422698|NCT05290506|Incretins|incretins|mesh-ancestor
138422699|NCT05290506|Hormones|hormones|mesh-ancestor
138422700|NCT05290506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138422701|NCT05290506|Protease Inhibitors|protease inhibitors|mesh-ancestor
138422702|NCT05290506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422703|NCT05290506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422704|NCT05290337|Zanubrutinib|zanubrutinib|mesh-list
138422705|NCT05290337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422706|NCT05290337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138422707|NCT05290337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422708|NCT05290337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422709|NCT05290324|Midazolam|midazolam|mesh-list
138422710|NCT05290324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138422711|NCT05290324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138422712|NCT05290324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422713|NCT05290324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422714|NCT05290324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138422715|NCT05290324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138422716|NCT05290324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138422717|NCT05290324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138422718|NCT05290324|Anesthetics, General|anesthetics, general|mesh-ancestor
138422719|NCT05290324|Anesthetics|anesthetics|mesh-ancestor
138422720|NCT05290324|GABA Modulators|gaba modulators|mesh-ancestor
138422721|NCT05290324|GABA Agents|gaba agents|mesh-ancestor
138422722|NCT05290324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422723|NCT05290324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138354839|NCT00002028|Didanosine|didanosine|mesh-list
138422724|NCT05292742|Capecitabine|capecitabine|mesh-list
138422725|NCT05292742|Trastuzumab|trastuzumab|mesh-list
138422726|NCT05292742|Pertuzumab|pertuzumab|mesh-list
138422727|NCT05292742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138422728|NCT05292742|Antimetabolites|antimetabolites|mesh-ancestor
138422729|NCT05292742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422730|NCT05292742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422731|NCT05292742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138422732|NCT05292677|Anesthetics|anesthetics|mesh-list
138422733|NCT05292677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422734|NCT05292677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422735|NCT05292573|Metformin|metformin|mesh-list
138422736|NCT05292573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138422737|NCT05292573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422738|NCT05291910|Paclitaxel|paclitaxel|mesh-list
138422739|NCT05291910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138422740|NCT05291910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138422741|NCT05291910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422742|NCT05291910|Tubulin Modulators|tubulin modulators|mesh-ancestor
138422743|NCT05291910|Antimitotic Agents|antimitotic agents|mesh-ancestor
138422745|NCT05291910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422746|NCT05291793|Methylprednisolone|methylprednisolone|mesh-list
138422747|NCT05291793|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138422748|NCT05291793|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138422749|NCT05291793|Prednisolone|prednisolone|mesh-list
138422750|NCT05291793|Prednisolone acetate|prednisolone acetate|mesh-list
138422751|NCT05291793|Tenoxicam|tenoxicam|mesh-list
138422752|NCT05291793|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138422753|NCT05291793|Prednisolone phosphate|prednisolone phosphate|mesh-list
138422754|NCT05291793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138422755|NCT05291793|Antiemetics|antiemetics|mesh-ancestor
138422756|NCT05291793|Autonomic Agents|autonomic agents|mesh-ancestor
138422757|NCT05291793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422758|NCT05291793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422759|NCT05291793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138422760|NCT05291793|Glucocorticoids|glucocorticoids|mesh-ancestor
138422761|NCT05291793|Hormones|hormones|mesh-ancestor
138422762|NCT05291793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138422763|NCT05291793|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138422764|NCT05291793|Protective Agents|protective agents|mesh-ancestor
138422765|NCT05291793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138422766|NCT05291793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422767|NCT05291793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138422768|NCT05291793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138422769|NCT05291793|Analgesics|analgesics|mesh-ancestor
138422770|NCT05291793|Sensory System Agents|sensory system agents|mesh-ancestor
138422771|NCT05291793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138422772|NCT05291793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138422773|NCT05291793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422774|NCT05291793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422776|NCT05294926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138422777|NCT05294926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138422778|NCT05294926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138422779|NCT05294926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422780|NCT05294926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422781|NCT05294887|Bisoprolol|bisoprolol|mesh-list
138422782|NCT05294887|Diltiazem|diltiazem|mesh-list
138422783|NCT05294887|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138422784|NCT05294887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138422785|NCT05294887|Adrenergic Agents|adrenergic agents|mesh-ancestor
138422786|NCT05294887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422787|NCT05294887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422788|NCT05294887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422789|NCT05294887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138422790|NCT05294887|Sympatholytics|sympatholytics|mesh-ancestor
138422791|NCT05294887|Autonomic Agents|autonomic agents|mesh-ancestor
138422792|NCT05294887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422793|NCT05294887|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138422794|NCT05294887|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138422795|NCT05294887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138422796|NCT05294887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138422797|NCT05294887|Vasodilator Agents|vasodilator agents|mesh-ancestor
138422798|NCT05294822|Insulin|insulin|mesh-list
138422799|NCT05294822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138422800|NCT05294822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422801|NCT05294744|Acetylcysteine|acetylcysteine|mesh-list
138422802|NCT05294744|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138422803|NCT05294744|Antiviral Agents|antiviral agents|mesh-ancestor
138422804|NCT05294744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422805|NCT05294744|Expectorants|expectorants|mesh-ancestor
138422806|NCT05294744|Respiratory System Agents|respiratory system agents|mesh-ancestor
138422807|NCT05294744|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138422808|NCT05294744|Antioxidants|antioxidants|mesh-ancestor
138422809|NCT05294744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422810|NCT05294744|Protective Agents|protective agents|mesh-ancestor
138422811|NCT05294744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422812|NCT05294744|Antidotes|antidotes|mesh-ancestor
138422813|NCT05294666|Cyclosporine|cyclosporine|mesh-list
138422814|NCT05294666|Tacrolimus|tacrolimus|mesh-list
138422815|NCT05294666|Cyclosporins|cyclosporins|mesh-list
138422816|NCT05294666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138422817|NCT05294666|Immunologic Factors|immunologic factors|mesh-ancestor
138422818|NCT05294666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422819|NCT05294666|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138422820|NCT05294666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422821|NCT05294666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422822|NCT05294666|Antifungal Agents|antifungal agents|mesh-ancestor
138422823|NCT05294666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422824|NCT05294666|Dermatologic Agents|dermatologic agents|mesh-ancestor
138422825|NCT05294666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138422826|NCT05294536|Liraglutide|liraglutide|mesh-list
138422827|NCT05294536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138422828|NCT05294536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422829|NCT05294536|Incretins|incretins|mesh-ancestor
138422830|NCT05294536|Hormones|hormones|mesh-ancestor
138422831|NCT05294536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138422832|NCT05294484|Indapamide|indapamide|mesh-list
138422833|NCT05294484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138422834|NCT05294484|Diuretics|diuretics|mesh-ancestor
138422836|NCT05294484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422837|NCT05294484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138422838|NCT05294484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138422839|NCT05294484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422840|NCT05294406|Piperaquine|piperaquine|mesh-list
138422842|NCT05294406|Antimalarials|antimalarials|mesh-ancestor
138422843|NCT05294406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138422844|NCT05294406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138422845|NCT05294406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422846|NCT05294393|Magnesium Sulfate|magnesium sulfate|mesh-list
138422847|NCT05294393|Ropivacaine|ropivacaine|mesh-list
138422848|NCT05294393|Anesthetics, Local|anesthetics, local|mesh-ancestor
138422849|NCT05294393|Anesthetics|anesthetics|mesh-ancestor
138422850|NCT05294393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422851|NCT05294393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422852|NCT05294393|Sensory System Agents|sensory system agents|mesh-ancestor
138422853|NCT05294393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422854|NCT05294393|Analgesics|analgesics|mesh-ancestor
138196995|NCT00000946|Protective Agents|protective agents|mesh-ancestor
138196996|NCT02543346|Cetirizine|cetirizine|mesh-list
138354933|NCT00002094|Atevirdine|atevirdine|mesh-list
138422855|NCT05294393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138422856|NCT05294393|Anticonvulsants|anticonvulsants|mesh-ancestor
138422857|NCT05294393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138422858|NCT05294393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138388267|NCT01488266|Analgesics|analgesics|mesh-ancestor
138422859|NCT05294393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422860|NCT05294393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138422861|NCT05294393|Tocolytic Agents|tocolytic agents|mesh-ancestor
138422862|NCT05294393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138422863|NCT05293977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138422864|NCT05293977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422865|NCT05293808|Aspirin|aspirin|mesh-list
138422866|NCT05293808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138422867|NCT05293808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138422868|NCT05293808|Analgesics|analgesics|mesh-ancestor
138422869|NCT05293808|Sensory System Agents|sensory system agents|mesh-ancestor
138422870|NCT05293808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422871|NCT05293808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422872|NCT05293808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138422873|NCT05293808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138422874|NCT05293808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138422875|NCT05293808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138422876|NCT05293808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422877|NCT05293808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138422878|NCT05293808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138422879|NCT05293808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422880|NCT05293808|Antipyretics|antipyretics|mesh-ancestor
138422881|NCT05293704|Mizoribine|mizoribine|mesh-list
138422882|NCT05293704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138422883|NCT05293704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138422884|NCT05293704|Analgesics|analgesics|mesh-ancestor
138422885|NCT05293704|Sensory System Agents|sensory system agents|mesh-ancestor
138422886|NCT05293704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388310|NCT01488552|Metformin|metformin|mesh-list
138422887|NCT05293704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422888|NCT05293704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138422889|NCT05293704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138422891|NCT05293704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422892|NCT05293704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138422893|NCT05293704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422894|NCT05293704|Antimalarials|antimalarials|mesh-ancestor
138422895|NCT05293704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138422896|NCT05293704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138422897|NCT05293704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422898|NCT05293704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422899|NCT05293704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138422900|NCT05293704|Immunologic Factors|immunologic factors|mesh-ancestor
138422901|NCT05293574|Norethindrone|norethindrone|mesh-list
138422902|NCT05293574|Norethindrone Acetate|norethindrone acetate|mesh-list
138422903|NCT05293574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138422904|NCT05293574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138422905|NCT05293574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138422906|NCT05293574|Contraceptive Agents|contraceptive agents|mesh-ancestor
138422907|NCT05293574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138422908|NCT05293574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422909|NCT05293574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138422910|NCT05293574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138197006|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
138197007|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138197008|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
138422911|NCT05293119|Mometasone Furoate|mometasone furoate|mesh-list
138422912|NCT05293119|Tofacitinib|tofacitinib|mesh-list
138422913|NCT05293119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138422914|NCT05293119|Dermatologic Agents|dermatologic agents|mesh-ancestor
138422915|NCT05293119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138422916|NCT05293119|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138422917|NCT05293119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138422918|NCT05293119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138422919|NCT05293119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422921|NCT05296863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138422922|NCT05296863|Vasodilator Agents|vasodilator agents|mesh-ancestor
138422923|NCT05296369|Folic Acid|folic acid|mesh-list
138422924|NCT05296369|Hematinics|hematinics|mesh-ancestor
138422925|NCT05296369|Vitamin B Complex|vitamin b complex|mesh-ancestor
138422926|NCT05296369|Vitamins|vitamins|mesh-ancestor
138422927|NCT05296369|Micronutrients|micronutrients|mesh-ancestor
138422928|NCT05296369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422929|NCT05296005|Leucovorin|leucovorin|mesh-list
138422930|NCT05296005|Docetaxel|docetaxel|mesh-list
138422931|NCT05296005|Capecitabine|capecitabine|mesh-list
138422932|NCT05296005|Fluorouracil|fluorouracil|mesh-list
138422933|NCT05296005|Oxaliplatin|oxaliplatin|mesh-list
138422934|NCT05296005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422935|NCT05296005|Tubulin Modulators|tubulin modulators|mesh-ancestor
138422936|NCT05296005|Antimitotic Agents|antimitotic agents|mesh-ancestor
138422937|NCT05296005|Mitosis Modulators|mitosis modulators|mesh-ancestor
138422938|NCT05296005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422939|NCT05296005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138422940|NCT05296005|Antimetabolites|antimetabolites|mesh-ancestor
138422941|NCT05296005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138422942|NCT05296005|Immunologic Factors|immunologic factors|mesh-ancestor
138422943|NCT05296005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422944|NCT05296005|Antidotes|antidotes|mesh-ancestor
138422945|NCT05296005|Protective Agents|protective agents|mesh-ancestor
138422946|NCT05296005|Vitamin B Complex|vitamin b complex|mesh-ancestor
138422947|NCT05296005|Vitamins|vitamins|mesh-ancestor
138422949|NCT05295836|Glycerol|glycerol|mesh-list
138422950|NCT05295836|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138422951|NCT05295836|Protective Agents|protective agents|mesh-ancestor
138422952|NCT05295836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422954|NCT05294900|Carboplatin|carboplatin|mesh-list
138422955|NCT05294900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138422956|NCT05294900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422957|NCT05294900|Tubulin Modulators|tubulin modulators|mesh-ancestor
138422958|NCT05294900|Antimitotic Agents|antimitotic agents|mesh-ancestor
138422959|NCT05294900|Mitosis Modulators|mitosis modulators|mesh-ancestor
138422960|NCT05294900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422961|NCT05275647|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138422962|NCT05275647|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138422963|NCT05275647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422964|NCT05275647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422965|NCT05275647|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138422966|NCT05275647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138422967|NCT05275647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138422968|NCT05275647|Cholinergic Agents|cholinergic agents|mesh-ancestor
138422969|NCT05275647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138422970|NCT05273242|Artesunate|artesunate|mesh-list
138422971|NCT05273242|Infliximab|infliximab|mesh-list
138422972|NCT05273242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138422973|NCT05273242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138422974|NCT05273242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138422975|NCT05273242|Dermatologic Agents|dermatologic agents|mesh-ancestor
138328451|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
138422976|NCT05273242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138422977|NCT05273242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138422978|NCT05273242|Antimalarials|antimalarials|mesh-ancestor
138355123|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138422979|NCT05273242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138422980|NCT05273242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138422981|NCT05273242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138422982|NCT05273242|Antiviral Agents|antiviral agents|mesh-ancestor
138422983|NCT05273242|Schistosomicides|schistosomicides|mesh-ancestor
138422984|NCT05273242|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138422985|NCT05273242|Anthelmintics|anthelmintics|mesh-ancestor
138422986|NCT05269095|Anesthetics|anesthetics|mesh-list
138422987|NCT05269095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422988|NCT05269095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422989|NCT05267938|Lidocaine|lidocaine|mesh-list
138422990|NCT05267938|Epinephrine|epinephrine|mesh-list
138422991|NCT05267938|Anesthetics, Local|anesthetics, local|mesh-list
138422992|NCT05267938|Anesthetics|anesthetics|mesh-list
138422993|NCT05267938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138422994|NCT05267938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138422995|NCT05267938|Sensory System Agents|sensory system agents|mesh-ancestor
138422996|NCT05267938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138422997|NCT05267938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138422998|NCT05267938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138422999|NCT05267938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138423000|NCT05267938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138423001|NCT05267938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423002|NCT05267938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138423003|NCT05267938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138423004|NCT05267938|Adrenergic Agents|adrenergic agents|mesh-ancestor
138423005|NCT05267938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423006|NCT05267938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138423007|NCT05267938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138423008|NCT05267938|Autonomic Agents|autonomic agents|mesh-ancestor
138423009|NCT05267938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138423010|NCT05267938|Respiratory System Agents|respiratory system agents|mesh-ancestor
138423011|NCT05267938|Mydriatics|mydriatics|mesh-ancestor
138423012|NCT05267938|Sympathomimetics|sympathomimetics|mesh-ancestor
138423013|NCT05267938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138423014|NCT05267431|Methotrexate|methotrexate|mesh-list
138423015|NCT05267431|Hydroquinone|hydroquinone|mesh-list
138423016|NCT05267431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138423017|NCT05267431|Abortifacient Agents|abortifacient agents|mesh-ancestor
138423018|NCT05267431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138423019|NCT05267431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423020|NCT05267431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138423021|NCT05267431|Antimetabolites|antimetabolites|mesh-ancestor
138388537|NCT01489696|Tamsulosin|tamsulosin|mesh-list
138423022|NCT05267431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423023|NCT05267431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423024|NCT05267431|Dermatologic Agents|dermatologic agents|mesh-ancestor
138423025|NCT05267431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423026|NCT05267431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138423027|NCT05267431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138423028|NCT05267431|Immunologic Factors|immunologic factors|mesh-ancestor
138423029|NCT05267431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423030|NCT05267431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197037|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
138197038|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197040|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423032|NCT05267431|Protective Agents|protective agents|mesh-ancestor
138423033|NCT05267431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138423035|NCT05266248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138423036|NCT05266248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423037|NCT05266248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138423038|NCT05266248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423039|NCT05266248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423040|NCT05266248|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138423041|NCT05266248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138423042|NCT05266248|Purinergic Agents|purinergic agents|mesh-ancestor
138423043|NCT05266248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423044|NCT05264584|Acetylcysteine|acetylcysteine|mesh-list
138423046|NCT05264584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138423047|NCT05264584|Antiviral Agents|antiviral agents|mesh-ancestor
138423048|NCT05264584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423050|NCT05264584|Respiratory System Agents|respiratory system agents|mesh-ancestor
138423051|NCT05264584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138423052|NCT05264584|Antioxidants|antioxidants|mesh-ancestor
138423053|NCT05264584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423054|NCT05264584|Protective Agents|protective agents|mesh-ancestor
138423055|NCT05264584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423056|NCT05264584|Antidotes|antidotes|mesh-ancestor
138423057|NCT05264584|Gout Suppressants|gout suppressants|mesh-ancestor
138423058|NCT05264584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423059|NCT05262686|Aldesleukin|aldesleukin|mesh-list
138423060|NCT05262686|Interleukin-2|interleukin-2|mesh-list
138423061|NCT05262686|Belimumab|belimumab|mesh-list
138423062|NCT05262686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423063|NCT05262686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138423064|NCT05262686|Analgesics|analgesics|mesh-ancestor
138423065|NCT05262686|Sensory System Agents|sensory system agents|mesh-ancestor
138423066|NCT05262686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423067|NCT05262686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423068|NCT05262686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138423069|NCT05262686|Immunologic Factors|immunologic factors|mesh-ancestor
138423070|NCT05262686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138423071|NCT05262686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138423072|NCT05262686|Antiviral Agents|antiviral agents|mesh-ancestor
138423073|NCT05262686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423074|NCT05236608|Nivolumab|nivolumab|mesh-list
138423075|NCT05236608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138423076|NCT05236608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423077|NCT05236608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138423078|NCT05236608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423079|NCT05225402|Norepinephrine|norepinephrine|mesh-list
138423080|NCT05225402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138423081|NCT05225402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138423082|NCT05225402|Adrenergic Agents|adrenergic agents|mesh-ancestor
138423083|NCT05225402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423084|NCT05225402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423085|NCT05225402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423086|NCT05225402|Sympathomimetics|sympathomimetics|mesh-ancestor
138423087|NCT05225402|Autonomic Agents|autonomic agents|mesh-ancestor
138423088|NCT05225402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423089|NCT05225402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138423091|NCT05220826|Ethylene|ethylene|mesh-list
138423092|NCT05220826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138355236|NCT00002286|Zidovudine|zidovudine|mesh-list
138328514|NCT00405288|Pramoxine|pramoxine|mesh-list
138423093|NCT05220826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423094|NCT05220826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138423095|NCT05220826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423096|NCT05220826|Plant Growth Regulators|plant growth regulators|mesh-ancestor
138423097|NCT05220826|Growth Substances|growth substances|mesh-ancestor
138423098|NCT05210413|Spartalizumab|spartalizumab|mesh-list
138423099|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138423100|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197053|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
138197054|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197056|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423101|NCT05210413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138423102|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423103|NCT05203705|Enoxaparin|enoxaparin|mesh-list
138423104|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
138423105|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138423106|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138423107|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423108|NCT05202561|Vaccines|vaccines|mesh-list
138423109|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
138423110|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423111|NCT05192629|Midazolam|midazolam|mesh-list
138423112|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
138423113|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138423114|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138423115|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423116|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138423117|NCT05192629|Analgesics|analgesics|mesh-ancestor
138423118|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
138423119|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423120|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138423121|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138423122|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138423123|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
138423124|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423125|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423126|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138423127|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138423128|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138423129|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138423130|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138423131|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
138423132|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
138423133|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
138423134|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
138423135|NCT05189444|Amoxicillin|amoxicillin|mesh-list
138423136|NCT05189444|Clarithromycin|clarithromycin|mesh-list
138423137|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
138423138|NCT05189444|Esomeprazole|esomeprazole|mesh-list
138423139|NCT05189444|Bismuth|bismuth|mesh-list
138423140|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423141|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138423142|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423143|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138423144|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138423145|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138423146|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423147|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138328528|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423148|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138423149|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138423150|NCT05189444|Antacids|antacids|mesh-ancestor
138423151|NCT05189444|Diuretics|diuretics|mesh-ancestor
138423152|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
138423153|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423154|NCT05189444|Expectorants|expectorants|mesh-ancestor
138423155|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
138423156|NCT05175274|Colchicine|colchicine|mesh-list
138423157|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
138423158|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423159|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
138423160|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
138423161|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
138355311|NCT00002340|Atovaquone|atovaquone|mesh-list
138423162|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423163|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197061|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423164|NCT05129137|Acetaminophen|acetaminophen|mesh-list
138423165|NCT05129137|Nefopam|nefopam|mesh-list
138423166|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138423167|NCT05129137|Analgesics|analgesics|mesh-ancestor
138423168|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
138423169|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423170|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423171|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
138423172|NCT05110898|Olmesartan|olmesartan|mesh-list
138423173|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138423174|NCT05110898|Indapamide|indapamide|mesh-list
138423175|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138423176|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138423177|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138423178|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423179|NCT05110898|Diuretics|diuretics|mesh-ancestor
138423180|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
138423181|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423182|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138423183|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138423184|NCT05096325|Insulin|insulin|mesh-list
138423185|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138423186|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423187|NCT05096065|Leuprolide|leuprolide|mesh-list
138423188|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138423189|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
138423190|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138423191|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423192|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138423193|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423194|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138423196|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423197|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138423198|NCT05030025|Lamivudine|lamivudine|mesh-list
138423199|NCT05030025|Abacavir|abacavir|mesh-list
138423200|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
138423201|NCT05030025|Dolutegravir|dolutegravir|mesh-list
138423202|NCT05030025|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
138423203|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138328549|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
138423204|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138423205|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423206|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423207|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
138423208|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423209|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138423210|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138423211|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138423212|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138423213|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
138423214|NCT05013567|Ibuprofen|ibuprofen|mesh-list
138423215|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138423216|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138423217|NCT05013567|Analgesics|analgesics|mesh-ancestor
138423218|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
138423219|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382222|NCT01462669|Ezogabine|ezogabine|mesh-list
138423220|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423221|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138423222|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423224|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423225|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388875|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
138423232|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138197075|NCT00000226|Buprenorphine|buprenorphine|mesh-list
138423233|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423234|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
138423235|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423236|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423237|NCT04989049|Folic Acid|folic acid|mesh-list
138423238|NCT04989049|Hematinics|hematinics|mesh-ancestor
138423239|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
138423240|NCT04989049|Vitamins|vitamins|mesh-ancestor
138423241|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
138423242|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423243|NCT04984044|Vitamin D|vitamin d|mesh-list
138423245|NCT04984044|Vitamins|vitamins|mesh-ancestor
138423246|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
138423247|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423248|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138423249|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138423250|NCT04975802|Caffeine|caffeine|mesh-list
138423251|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138423252|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423253|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138423254|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138328571|NCT00459810|Paclitaxel|paclitaxel|mesh-list
138423255|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423256|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138423258|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
138423259|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423260|NCT04964700|Natalizumab|natalizumab|mesh-list
138423261|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
138423262|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423263|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138423264|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
138423265|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138423266|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138423267|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138423268|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138423269|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423270|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
138423271|NCT04899843|Astringents|astringents|mesh-ancestor
138423272|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423273|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
138423274|NCT04897802|Exenatide|exenatide|mesh-list
138423275|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138423276|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423277|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138423279|NCT04897802|Hormones|hormones|mesh-ancestor
138282872|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423280|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138423281|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
138423282|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
138423283|NCT04882332|Vitamins|vitamins|mesh-ancestor
138423284|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
138423285|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423286|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
138423287|NCT04882332|Hematinics|hematinics|mesh-ancestor
138423288|NCT04871425|Fentanyl|fentanyl|mesh-list
138423289|NCT04871425|Ketamine|ketamine|mesh-list
138423290|NCT04871425|Analgesics|analgesics|mesh-ancestor
138423291|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
138423292|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423293|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423294|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138423295|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138423296|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
138423297|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
138355546|NCT00002460|Goserelin|goserelin|mesh-list
138423298|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138382297|NCT01463332|Analgesics|analgesics|mesh-ancestor
138423300|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138423301|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423302|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423303|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138423304|NCT04871425|Narcotics|narcotics|mesh-ancestor
138423305|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138423306|NCT04869605|Chrysarobin|chrysarobin|mesh-list
138197078|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197084|NCT00000982|Zidovudine|zidovudine|mesh-list
138423307|NCT04869605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138423308|NCT04869605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138423309|NCT04869605|Analgesics|analgesics|mesh-ancestor
138423310|NCT04869605|Sensory System Agents|sensory system agents|mesh-ancestor
138423311|NCT04869605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423312|NCT04869605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423313|NCT04869605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138423314|NCT04869605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423315|NCT04835584|Dasatinib|dasatinib|mesh-list
138388952|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423316|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423317|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138423318|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423319|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423320|NCT04774315|Omalizumab|omalizumab|mesh-list
138423321|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138423322|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138423323|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
138423325|NCT04767503|Desflurane|desflurane|mesh-list
138423326|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138423327|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138423328|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423329|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138423330|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
138423331|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
138423332|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138423333|NCT04722679|Anticoagulants|anticoagulants|mesh-list
138423334|NCT04696380|Nicotine|nicotine|mesh-list
138423335|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138423336|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
138355651|NCT00002532|Leucovorin|leucovorin|mesh-list
138423337|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423338|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423339|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138423340|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138423341|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
138423342|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423343|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423344|NCT04672772|Paclitaxel|paclitaxel|mesh-list
138423345|NCT04672772|Cetuximab|cetuximab|mesh-list
138423346|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138423347|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423348|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
138423349|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
138423350|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
138423351|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423352|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138423353|NCT04671082|Tolperisone|tolperisone|mesh-list
138423354|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138423355|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423356|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138423357|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423358|NCT04669587|Palbociclib|palbociclib|mesh-list
138423359|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423360|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138423361|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423362|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423363|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
138423364|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138423365|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
138423366|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423367|NCT04658823|Vitamin E|vitamin e|mesh-list
138423368|NCT04658823|Tocopherols|tocopherols|mesh-list
138423369|NCT04658823|Tocotrienols|tocotrienols|mesh-list
138423370|NCT04658823|Tocovid|tocovid|mesh-list
138423371|NCT04658823|Vitamins|vitamins|mesh-ancestor
138423372|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
138423373|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423374|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
138423375|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138355779|NCT00002580|Tamoxifen|tamoxifen|mesh-list
138423376|NCT04658823|Protective Agents|protective agents|mesh-ancestor
138423377|NCT04640818|Rituximab|rituximab|mesh-list
138423378|NCT04640818|Cladribine|cladribine|mesh-list
138423379|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
138423380|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138423381|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423382|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
138423383|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423384|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423385|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138423386|NCT04588857|Dexamethasone|dexamethasone|mesh-list
138423387|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138423388|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
138423389|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
138423390|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423391|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423392|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138423393|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
138423394|NCT04588857|Hormones|hormones|mesh-ancestor
138423395|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138423396|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138423397|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423398|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
138423399|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
138423400|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423401|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423402|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423403|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
138423404|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
138423405|NCT04542980|Autoantibodies|autoantibodies|mesh-list
138423406|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
138423407|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423408|NCT04529499|Favipiravir|favipiravir|mesh-list
138423409|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
138423410|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423411|NCT04523428|Venetoclax|venetoclax|mesh-list
138423412|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
138423413|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423414|NCT04508504|Ropivacaine|ropivacaine|mesh-list
138423415|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
138423416|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
138423417|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138423418|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423419|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
138423420|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423421|NCT04490707|Lenalidomide|lenalidomide|mesh-list
138423422|NCT04490707|Azacitidine|azacitidine|mesh-list
138423423|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
138423424|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423425|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138423426|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138423427|NCT04490707|Growth Substances|growth substances|mesh-ancestor
138423428|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
138423429|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423430|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138423431|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
138423432|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423433|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423434|NCT04464577|Itraconazole|itraconazole|mesh-list
138423435|NCT04464577|Fluconazole|fluconazole|mesh-list
138423436|NCT04464577|Bupropion|bupropion|mesh-list
138423437|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138423438|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
138423439|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138423440|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138423441|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138423442|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138230504|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423443|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423444|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
138423445|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423446|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423447|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138423448|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138423449|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423450|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
138423451|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423452|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138423453|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138423454|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
138423455|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138423456|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138423457|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138423458|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138423459|NCT04402658|Albuterol|albuterol|mesh-list
138423460|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138423461|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
138423462|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423463|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423464|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138423465|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
138423466|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
138423467|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138423468|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138423469|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138423470|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138423471|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
138423472|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423473|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423474|NCT04391179|Dipyridamole|dipyridamole|mesh-list
138423475|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138423476|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423477|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138356011|NCT00002670|Cobalt|cobalt|mesh-list
138423478|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138423479|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
138423480|NCT04375683|Flumatinib|flumatinib|mesh-list
138423481|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138423482|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423483|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423484|NCT04356742|Metformin|metformin|mesh-list
138423485|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
138423486|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138423487|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423488|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138423489|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423490|NCT04353284|Gabexate|gabexate|mesh-list
138423491|NCT04353284|Camostat|camostat|mesh-list
138423492|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
138423493|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423494|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423495|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138197111|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138197112|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423496|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138423497|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
138423498|NCT04348864|Antibodies|antibodies|mesh-list
138423499|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
138423500|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423501|NCT04328012|Losartan|losartan|mesh-list
138423502|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138423503|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138423504|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138423505|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138423506|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423507|NCT04310150|Hemostatics|hemostatics|mesh-list
138423508|NCT04310150|Coagulants|coagulants|mesh-ancestor
138423509|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
138356034|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
138423511|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138423512|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423513|NCT04294147|Analgesics|analgesics|mesh-ancestor
138423514|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
138423515|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423516|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423517|NCT04264637|Azelastine|azelastine|mesh-list
138423518|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138423519|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
138423520|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423521|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382541|NCT01467115|Leucovorin|leucovorin|mesh-list
138423522|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138423523|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
138423524|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138423525|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423526|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423527|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138423528|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138423529|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138423530|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
138423531|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
138423532|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423533|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138423534|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423535|NCT04169451|Letrozole|letrozole|mesh-list
138423536|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423537|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138423538|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138423539|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423540|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423541|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138423543|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138423544|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423545|NCT04169438|Petrolatum|petrolatum|mesh-list
138423546|NCT04169438|Emollients|emollients|mesh-ancestor
138423547|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
138423548|NCT04159818|Doxorubicin|doxorubicin|mesh-list
138423549|NCT04159818|Nivolumab|nivolumab|mesh-list
138423550|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423551|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138423552|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138423553|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138423554|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423555|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423556|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138423557|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138423558|NCT04157881|Rabeprazole|rabeprazole|mesh-list
138423559|NCT04157881|Dabigatran|dabigatran|mesh-list
138423560|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
138389210|NCT01493635|Analgesics|analgesics|mesh-list
138423561|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138423562|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
138423563|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423564|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423565|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
138423566|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138423567|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138423568|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138423569|NCT04136262|Methotrexate|methotrexate|mesh-list
138423570|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138423571|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
138423572|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138423573|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423574|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138423575|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
138356138|NCT00002700|Hormones|hormones|mesh-ancestor
138230514|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138423576|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423577|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423578|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
138423579|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423580|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138423581|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138423582|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
138423583|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423584|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138423586|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138423587|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423588|NCT04115059|Dasatinib|dasatinib|mesh-list
138423589|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423590|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138423591|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423592|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423593|NCT04114890|Tenofovir|tenofovir|mesh-list
138423594|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
138423595|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423596|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138423597|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138423598|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423599|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423600|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138423601|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138423602|NCT04082676|Bupivacaine|bupivacaine|mesh-list
138423603|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
138423604|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
138423605|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138356155|NCT00002700|Antidotes|antidotes|mesh-ancestor
138423606|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423607|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
138423608|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423609|NCT04012177|Niacinamide|niacinamide|mesh-list
138423611|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
138423612|NCT04012177|Azithromycin|azithromycin|mesh-list
138423613|NCT04012177|Choline|choline|mesh-list
138423614|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138423615|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423616|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
138423617|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138423618|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
138389295|NCT01494259|Epinephrine|epinephrine|mesh-list
138423619|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423620|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138423621|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138423622|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
138423623|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
138423625|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
138423626|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423627|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
138423628|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
138423629|NCT03993249|Nivolumab|nivolumab|mesh-list
138423630|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138423631|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423632|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138423633|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423634|NCT03990883|Lidocaine|lidocaine|mesh-list
138423635|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
138423636|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
138423637|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138423638|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423639|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
138423640|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423641|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138423642|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138423643|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138423644|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138423645|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423647|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
138423648|NCT03984890|Vitamins|vitamins|mesh-ancestor
138423649|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
138423650|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423651|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138423652|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138423653|NCT03924427|Deucravacitinib|deucravacitinib|mesh-list
138423654|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
138423655|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138423656|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423657|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423658|NCT03922451|Cefazolin|cefazolin|mesh-list
138423659|NCT03922451|Tazobactam|tazobactam|mesh-list
138423660|NCT03922451|Piperacillin|piperacillin|mesh-list
138423661|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138423662|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138423663|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423664|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138423665|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423666|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423667|NCT05802433|Vitamin D|vitamin d|mesh-list
138423668|NCT05802433|Cholecalciferol|cholecalciferol|mesh-list
138423669|NCT05802433|Vitamins|vitamins|mesh-ancestor
138423670|NCT05802433|Micronutrients|micronutrients|mesh-ancestor
138423671|NCT05802433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423672|NCT05802433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138423673|NCT05802433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138423674|NCT05802303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138423675|NCT05802303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138423677|NCT05802303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138423679|NCT05802303|Hormones|hormones|mesh-ancestor
138423680|NCT05802303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138197138|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197139|NCT00000994|Zidovudine|zidovudine|mesh-list
138197140|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
138423681|NCT05802303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423682|NCT05802303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138423683|NCT05802303|Contraceptive Agents|contraceptive agents|mesh-ancestor
138423684|NCT05802303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138423685|NCT05802303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138423686|NCT05802290|Nivolumab|nivolumab|mesh-list
138356234|NCT00002754|Antibodies|antibodies|mesh-list
138423687|NCT05802290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138423688|NCT05802290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423689|NCT05802290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138423690|NCT05802290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423691|NCT05802212|Metformin|metformin|mesh-list
138423692|NCT05802212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138423693|NCT05802212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423694|NCT05802121|Acetic Acid|acetic acid|mesh-list
138423695|NCT05802121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138423696|NCT05802121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423697|NCT05802108|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138423698|NCT05802108|Evolocumab|evolocumab|mesh-list
138423699|NCT05802108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138389453|NCT01495039|Nystatin|nystatin|mesh-list
138423700|NCT05802108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138423701|NCT05802108|Antimetabolites|antimetabolites|mesh-ancestor
138423702|NCT05802108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423703|NCT05802108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423704|NCT05802108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138423705|NCT05802108|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138423706|NCT05802108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138423707|NCT05802108|Protease Inhibitors|protease inhibitors|mesh-ancestor
138423708|NCT05802082|Anesthetics|anesthetics|mesh-list
138423709|NCT05802082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138423710|NCT05802082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423711|NCT05801900|Ibuprofen|ibuprofen|mesh-list
138423712|NCT05801900|Ketorolac|ketorolac|mesh-list
138423713|NCT05801900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138423714|NCT05801900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138423715|NCT05801900|Analgesics|analgesics|mesh-ancestor
138423716|NCT05801900|Sensory System Agents|sensory system agents|mesh-ancestor
138423717|NCT05801900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423718|NCT05801900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423719|NCT05801900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138423720|NCT05801900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423721|NCT05801900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138423722|NCT05801900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423723|NCT05801900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423724|NCT05801523|Ethanol|ethanol|mesh-list
138423725|NCT05801523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138423726|NCT05801523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423727|NCT05801523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138423728|NCT05801523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423729|NCT05801484|Linezolid|linezolid|mesh-list
138423730|NCT05801484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138423731|NCT05801484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423732|NCT05801484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138423733|NCT05801484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423734|NCT05801484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423735|NCT05801380|Memantine|memantine|mesh-list
138423736|NCT05801380|Donepezil|donepezil|mesh-list
138423737|NCT05801380|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138423738|NCT05801380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423739|NCT05801380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423740|NCT05801380|Cholinergic Agents|cholinergic agents|mesh-ancestor
138423741|NCT05801380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423742|NCT05801380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423743|NCT05801380|Nootropic Agents|nootropic agents|mesh-ancestor
138423744|NCT05801380|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138423745|NCT05801380|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138197160|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
138423746|NCT05801380|Dopamine Agents|dopamine agents|mesh-ancestor
138382788|NCT01468415|Phenol|phenol|mesh-list
138423747|NCT05801380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138423748|NCT05801380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138423749|NCT05801367|Allyl sulfide|allyl sulfide|mesh-list
138423750|NCT05801367|Antioxidants|antioxidants|mesh-ancestor
138423751|NCT05801367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423752|NCT05801367|Protective Agents|protective agents|mesh-ancestor
138423753|NCT05801367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423754|NCT05801367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138423755|NCT05801367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423756|NCT05801367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138423757|NCT05801367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423758|NCT05801328|Salicylic Acid|salicylic acid|mesh-list
138423759|NCT05801328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423760|NCT05801328|Antifungal Agents|antifungal agents|mesh-ancestor
138423761|NCT05801328|Keratolytic Agents|keratolytic agents|mesh-ancestor
138423762|NCT05801328|Dermatologic Agents|dermatologic agents|mesh-ancestor
138423763|NCT05801289|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138423764|NCT05801289|Antidepressive Agents|antidepressive agents|mesh-ancestor
138423765|NCT05801289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138423766|NCT05801289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138423767|NCT05801289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138423768|NCT05801289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138356308|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138423769|NCT05801289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423771|NCT05801133|Analgesics|analgesics|mesh-ancestor
138423772|NCT05801133|Sensory System Agents|sensory system agents|mesh-ancestor
138423773|NCT05801133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423774|NCT05801133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423775|NCT05801133|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138423776|NCT05801133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138423777|NCT05801133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138423778|NCT05801133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423779|NCT05801133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423780|NCT05801068|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
138423781|NCT05801068|Antithrombins|antithrombins|mesh-ancestor
138423782|NCT05801068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138423783|NCT05801068|Protease Inhibitors|protease inhibitors|mesh-ancestor
138423784|NCT05801068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423785|NCT05801068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423786|NCT05801068|Anticoagulants|anticoagulants|mesh-ancestor
138423788|NCT05800847|Analgesics|analgesics|mesh-ancestor
138423789|NCT05800847|Sensory System Agents|sensory system agents|mesh-ancestor
138423790|NCT05800847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423791|NCT05800847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423792|NCT05800847|Anticonvulsants|anticonvulsants|mesh-ancestor
138423793|NCT05800847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138423794|NCT05800847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138423795|NCT05800847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138423796|NCT05800847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138423797|NCT05800847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138423798|NCT05800847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138423799|NCT05800847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423800|NCT05800847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423801|NCT05800847|Antimanic Agents|antimanic agents|mesh-ancestor
138423802|NCT05800756|Trastuzumab|trastuzumab|mesh-list
138423803|NCT05800756|Letrozole|letrozole|mesh-list
138282873|NCT00373568|Miltefosine|miltefosine|mesh-list
138423804|NCT05800756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138423805|NCT05800756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423806|NCT05800756|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138423807|NCT05800756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138423808|NCT05800756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423809|NCT05800756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423810|NCT05800756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138423811|NCT05800756|Hormone Antagonists|hormone antagonists|mesh-ancestor
138197165|NCT00001954|Analgesics|analgesics|mesh-ancestor
138423812|NCT05800756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138423813|NCT05800756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423814|NCT05800197|Tamoxifen|tamoxifen|mesh-list
138423815|NCT05800197|Letrozole|letrozole|mesh-list
138423816|NCT05800197|Anastrozole|anastrozole|mesh-list
138423817|NCT05800197|Goserelin|goserelin|mesh-list
138423818|NCT05800197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138423819|NCT05800197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382817|NCT01468545|Iloprost|iloprost|mesh-list
138423820|NCT05800197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138423821|NCT05800197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138423822|NCT05800197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423823|NCT05800197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423824|NCT05800197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138423825|NCT05800197|Hormone Antagonists|hormone antagonists|mesh-ancestor
138423826|NCT05800197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138423827|NCT05800197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423828|NCT05800197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138423829|NCT05800197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138423830|NCT05800197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138423831|NCT05800197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138423832|NCT05800197|Luteolytic Agents|luteolytic agents|mesh-ancestor
138389692|NCT01496326|Ibuprofen|ibuprofen|mesh-list
138423833|NCT05800197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138423835|NCT05800197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138423836|NCT05800197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138423838|NCT05797597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138423839|NCT05797597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138423840|NCT05797597|Analgesics|analgesics|mesh-ancestor
138423841|NCT05797597|Sensory System Agents|sensory system agents|mesh-ancestor
138423842|NCT05797597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423843|NCT05797597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423844|NCT05797597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138423845|NCT05797597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423846|NCT05797597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138423847|NCT05797597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138423848|NCT05797597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423850|NCT05797597|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138423851|NCT05797597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423852|NCT05797597|Antipyretics|antipyretics|mesh-ancestor
138423853|NCT05794750|Capecitabine|capecitabine|mesh-list
138423854|NCT05794750|Oxaliplatin|oxaliplatin|mesh-list
138423855|NCT05794750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138423856|NCT05794750|Antimetabolites|antimetabolites|mesh-ancestor
138423857|NCT05794750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423858|NCT05794750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423859|NCT05792293|Atorvastatin|atorvastatin|mesh-list
138423860|NCT05792293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138423861|NCT05792293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138423862|NCT05792293|Antimetabolites|antimetabolites|mesh-ancestor
138423863|NCT05792293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423864|NCT05792293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138423865|NCT05792293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138423866|NCT05792293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423867|NCT05785689|Dexmedetomidine|dexmedetomidine|mesh-list
138423868|NCT05785689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138423869|NCT05785689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138423870|NCT05785689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423871|NCT05785689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138423873|NCT05785689|Sensory System Agents|sensory system agents|mesh-ancestor
138423874|NCT05785689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423875|NCT05785689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138423876|NCT05785689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138197170|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423877|NCT05785689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138423878|NCT05785689|Adrenergic Agents|adrenergic agents|mesh-ancestor
138423879|NCT05785689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423880|NCT05785689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423881|NCT05753644|Ropivacaine|ropivacaine|mesh-list
138423882|NCT05753644|Anesthetics, Local|anesthetics, local|mesh-ancestor
138423883|NCT05753644|Anesthetics|anesthetics|mesh-ancestor
138423884|NCT05753644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138423885|NCT05753644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423886|NCT05753644|Sensory System Agents|sensory system agents|mesh-ancestor
138423887|NCT05753644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423888|NCT05756504|Ketorolac|ketorolac|mesh-list
138423889|NCT05756504|Tramadol|tramadol|mesh-list
138423890|NCT05756504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138423891|NCT05756504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138423892|NCT05756504|Analgesics|analgesics|mesh-ancestor
138382890|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138423893|NCT05756504|Sensory System Agents|sensory system agents|mesh-ancestor
138423894|NCT05756504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423895|NCT05756504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423896|NCT05756504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138423897|NCT05756504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423898|NCT05756504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138423899|NCT05756504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423900|NCT05756504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423901|NCT05756504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138423902|NCT05756504|Narcotics|narcotics|mesh-ancestor
138423903|NCT05756504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138423904|NCT05697510|Siltuximab|siltuximab|mesh-list
138423905|NCT05697510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423906|NCT05657925|Ondansetron|ondansetron|mesh-list
138423907|NCT05657925|Antiemetics|antiemetics|mesh-ancestor
138423908|NCT05657925|Autonomic Agents|autonomic agents|mesh-ancestor
138423909|NCT05657925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423910|NCT05657925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423912|NCT05657925|Antipruritics|antipruritics|mesh-ancestor
138423913|NCT05657925|Dermatologic Agents|dermatologic agents|mesh-ancestor
138423914|NCT05657925|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138423915|NCT05657925|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138423916|NCT05657925|Serotonin Agents|serotonin agents|mesh-ancestor
138423917|NCT05657925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423918|NCT05657925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423919|NCT05611229|Pembrolizumab|pembrolizumab|mesh-list
138423920|NCT05611229|Nivolumab|nivolumab|mesh-list
138423921|NCT05611229|Ipilimumab|ipilimumab|mesh-list
138423922|NCT05611229|Trametinib|trametinib|mesh-list
138423923|NCT05611229|Dabrafenib|dabrafenib|mesh-list
138423924|NCT05611229|Vemurafenib|vemurafenib|mesh-list
138423925|NCT05611229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138423926|NCT05611229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423927|NCT05611229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138423928|NCT05611229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423929|NCT05611229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138423930|NCT05611229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423932|NCT05601154|Fluorides|fluorides|mesh-list
138423933|NCT05601154|Sodium Fluoride|sodium fluoride|mesh-list
138423934|NCT05601154|Cariostatic Agents|cariostatic agents|mesh-ancestor
138423935|NCT05601154|Protective Agents|protective agents|mesh-ancestor
138423936|NCT05601154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423937|NCT05601154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138423938|NCT05601154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423939|NCT05566665|Meropenem|meropenem|mesh-list
138423940|NCT05566665|Tazobactam|tazobactam|mesh-list
138423941|NCT05566665|Ceftazidime|ceftazidime|mesh-list
138423942|NCT05566665|Avibactam|avibactam|mesh-list
138423943|NCT05566665|Ceftolozane|ceftolozane|mesh-list
138423944|NCT05566665|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
138423945|NCT05566665|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
138423946|NCT05566665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138423947|NCT05566665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138423948|NCT05566665|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138423949|NCT05566665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138423950|NCT05566665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423951|NCT05566665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138423952|NCT05521984|Dapagliflozin|dapagliflozin|mesh-list
138423953|NCT05521984|Carmustine|carmustine|mesh-list
138423954|NCT05521984|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138423955|NCT05521984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423956|NCT05521984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138423957|NCT05521984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423958|NCT05521984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138423959|NCT05521984|Alkylating Agents|alkylating agents|mesh-ancestor
138423960|NCT05521984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138423961|NCT05497323|Adapalene|adapalene|mesh-list
138423962|NCT05497323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138423963|NCT05497323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138423964|NCT05497323|Analgesics|analgesics|mesh-ancestor
138423965|NCT05497323|Sensory System Agents|sensory system agents|mesh-ancestor
138423966|NCT05497323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138423967|NCT05497323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423968|NCT05497323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138423969|NCT05497323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138423970|NCT05497323|Dermatologic Agents|dermatologic agents|mesh-ancestor
138423971|NCT05345782|Bupivacaine|bupivacaine|mesh-list
138423972|NCT05345782|Anesthetics, Local|anesthetics, local|mesh-ancestor
138423973|NCT05345782|Anesthetics|anesthetics|mesh-ancestor
138423974|NCT05345782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138423975|NCT05345782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423976|NCT05345782|Sensory System Agents|sensory system agents|mesh-ancestor
138423977|NCT05345782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138389921|NCT01497561|Insulin|insulin|mesh-list
138423978|NCT05297903|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138423980|NCT05297903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423981|NCT05265767|Factor VIII|factor viii|mesh-list
138423982|NCT05265767|Coagulants|coagulants|mesh-ancestor
138423983|NCT05219799|Propranolol|propranolol|mesh-list
138423984|NCT05219799|Phentolamine|phentolamine|mesh-list
138423985|NCT05219799|Isoproterenol|isoproterenol|mesh-list
138423986|NCT05219799|Norepinephrine|norepinephrine|mesh-list
138423987|NCT05219799|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138423988|NCT05219799|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138423989|NCT05219799|Adrenergic Agents|adrenergic agents|mesh-ancestor
138423990|NCT05219799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138423991|NCT05219799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138423992|NCT05219799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138423993|NCT05219799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138423994|NCT05219799|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138423995|NCT05219799|Vasodilator Agents|vasodilator agents|mesh-ancestor
138423996|NCT05219799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138423997|NCT05219799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138423998|NCT05219799|Sympathomimetics|sympathomimetics|mesh-ancestor
138423999|NCT05219799|Autonomic Agents|autonomic agents|mesh-ancestor
138424000|NCT05219799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424001|NCT05219799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138424002|NCT05219799|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138424003|NCT05219799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138424004|NCT05219799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138424005|NCT05219799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138424006|NCT05219799|Respiratory System Agents|respiratory system agents|mesh-ancestor
138424008|NCT05219799|Protective Agents|protective agents|mesh-ancestor
138424009|NCT05215951|Osimertinib|osimertinib|mesh-list
138424010|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424011|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138424012|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424013|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424014|NCT05161468|Triamcinolone|triamcinolone|mesh-list
138424015|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138424016|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138424018|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
138424019|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
138424020|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138424021|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
138424022|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
138424023|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138424024|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424025|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
138424026|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424027|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138424028|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138424029|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138424030|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138424031|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424032|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
138424033|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138424034|NCT05161468|Hormones|hormones|mesh-ancestor
138424035|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138424037|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
138424038|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424039|NCT05108389|Hemostatics|hemostatics|mesh-list
138424040|NCT05108389|Coagulants|coagulants|mesh-ancestor
138424041|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
138424042|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138424043|NCT05104762|Antibodies|antibodies|mesh-list
138383044|NCT06076759|Analgesics|analgesics|mesh-ancestor
138424044|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
138424045|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138424046|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
138424047|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424048|NCT05027425|Durvalumab|durvalumab|mesh-list
138424049|NCT05027425|Tremelimumab|tremelimumab|mesh-list
138424050|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138329138|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
138424051|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424052|NCT05003648|Pramipexole|pramipexole|mesh-list
138424053|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
138424054|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424055|NCT05003648|Protective Agents|protective agents|mesh-ancestor
138424056|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424057|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138424058|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138424059|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
138424060|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
138424061|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424062|NCT04880278|Nabilone|nabilone|mesh-list
138424063|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
138424064|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
138424065|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424066|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424067|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138424068|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138424069|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138424070|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138424071|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138424072|NCT04858425|Niclosamide|niclosamide|mesh-list
138424073|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
138424074|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138424075|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
138424076|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138424077|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424078|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
138424079|NCT04762758|Naltrexone|naltrexone|mesh-list
138424080|NCT04762758|Baclofen|baclofen|mesh-list
138424081|NCT04762758|Sorbitol|sorbitol|mesh-list
138424082|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138356731|NCT00002832|Cyclosporine|cyclosporine|mesh-list
138424083|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138197196|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197197|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197198|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138197199|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138424084|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424085|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
138424086|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424087|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138424088|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138424089|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138424090|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
138424091|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
138424092|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424093|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424094|NCT04762758|Cathartics|cathartics|mesh-ancestor
138424095|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138424097|NCT04717908|Cycloserine|cycloserine|mesh-list
138424098|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
138424099|NCT04717908|Bedaquiline|bedaquiline|mesh-list
138424100|NCT04717908|Clofazimine|clofazimine|mesh-list
138424101|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138424102|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424103|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138424104|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424105|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424106|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138424107|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138424108|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
138424109|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
138424110|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138424111|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
138424112|NCT04665895|Fluticasone|fluticasone|mesh-list
138424113|NCT04665895|Xhance|xhance|mesh-list
138424114|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138424115|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138424116|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
138424117|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424118|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138356775|NCT00002880|Etoposide|etoposide|mesh-list
138424119|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138424120|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
138424121|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
138424122|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138424123|NCT04559230|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
138424124|NCT04559230|Immunoconjugates|immunoconjugates|mesh-ancestor
138424125|NCT04559230|Immunologic Factors|immunologic factors|mesh-ancestor
138424126|NCT04559230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424128|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
138424129|NCT04545554|Vitamin D|vitamin d|mesh-list
138424130|NCT04545554|Calcium|calcium|mesh-list
138424131|NCT04545554|Vitamins|vitamins|mesh-ancestor
138424132|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
138424133|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424134|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138424135|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138424136|NCT04500574|Latanoprost|latanoprost|mesh-list
138197200|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138424137|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138424138|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138424139|NCT04416282|Terlipressin|terlipressin|mesh-list
138424140|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138424141|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138424142|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
138424143|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138424144|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424145|NCT04375150|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138424146|NCT04375150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138390146|NCT01499108|Hormones|hormones|mesh-ancestor
138424147|NCT04375150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424148|NCT04375150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424149|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
138424150|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138424151|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138424152|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424153|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138424154|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424155|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138424156|NCT04112498|Nivolumab|nivolumab|mesh-list
138424157|NCT04112498|Relatlimab|relatlimab|mesh-list
138424158|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424159|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424160|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138424161|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424162|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
138424163|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424164|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424165|NCT04104893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138424166|NCT04104893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424167|NCT04042051|Trastuzumab|trastuzumab|mesh-list
138424168|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138424169|NCT04042051|Maytansine|maytansine|mesh-list
138424170|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424171|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424172|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138424173|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
138424174|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
138424175|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
138424176|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424177|NCT04042051|Immunotoxins|immunotoxins|mesh-ancestor
138424178|NCT04042051|Immunoconjugates|immunoconjugates|mesh-ancestor
138424179|NCT04042051|Immunologic Factors|immunologic factors|mesh-ancestor
138424180|NCT04042051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424181|NCT04033991|Sunitinib|sunitinib|mesh-list
138424182|NCT04033991|Axitinib|axitinib|mesh-list
138424183|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424184|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138424185|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138424186|NCT04033991|Growth Substances|growth substances|mesh-ancestor
138424188|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
138424189|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138424190|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424191|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424193|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138424194|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138424195|NCT03961360|Analgesics|analgesics|mesh-ancestor
138424196|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
138424197|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424198|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424199|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138424200|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138424201|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138356971|NCT00003060|Methotrexate|methotrexate|mesh-list
138424202|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138424203|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424204|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138424205|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138424206|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424207|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
138424208|NCT03924401|Abatacept|abatacept|mesh-list
138424209|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138424210|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424211|NCT03924401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424212|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424213|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138424214|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
138424215|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424216|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138424217|NCT03769285|Niacinamide|niacinamide|mesh-list
138424218|NCT03769285|Niacin|niacin|mesh-list
138424219|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
138424220|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
138424221|NCT03769285|Vitamins|vitamins|mesh-ancestor
138424222|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
138424223|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424224|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138424225|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
138424226|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390203|NCT01499602|Norethindrone|norethindrone|mesh-list
138424227|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138424228|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
138424231|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138424232|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138424233|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
138329241|NCT00538824|Dexamethasone|dexamethasone|mesh-list
138424234|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424235|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424236|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424237|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
138424238|NCT03642132|Bevacizumab|bevacizumab|mesh-list
138424239|NCT03642132|Avelumab|avelumab|mesh-list
138424240|NCT03642132|Talazoparib|talazoparib|mesh-list
138424241|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424242|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424243|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138424244|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138424245|NCT03642132|Growth Substances|growth substances|mesh-ancestor
138424246|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424247|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
138424248|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138424249|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424250|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424251|NCT03632330|Midazolam|midazolam|mesh-list
138424252|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
138424253|NCT03632330|Propofol|propofol|mesh-list
138357088|NCT00003126|Aldesleukin|aldesleukin|mesh-list
138424255|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138424256|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424257|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138424258|NCT03632330|Analgesics|analgesics|mesh-ancestor
138424259|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
138424260|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424261|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138424262|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138424263|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138424264|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
138424265|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424266|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424267|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138424268|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
138424269|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
138424270|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138424271|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138424272|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138424274|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
138424275|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
138424276|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
138424277|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138424278|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138424279|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424280|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
138424281|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
138424282|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424283|NCT03572764|Cytarabine|cytarabine|mesh-list
138424284|NCT03572764|Daunorubicin|daunorubicin|mesh-list
138357132|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138424285|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138424286|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
138424287|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424288|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424289|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
138424290|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424291|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138424292|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
138424293|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424294|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138424295|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138424296|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138424297|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424299|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
138424300|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424301|NCT03506061|Ivacaftor|ivacaftor|mesh-list
138424302|NCT03506061|Elexacaftor|elexacaftor|mesh-list
138424303|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138424304|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138424305|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138357183|NCT00003198|Topotecan|topotecan|mesh-list
138424306|NCT03452930|Benzimidazole|benzimidazole|mesh-list
138424307|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
138424308|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138424309|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424310|NCT03253289|Meclizine|meclizine|mesh-list
138424311|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
138424312|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
138424313|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424314|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424315|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138424316|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138424317|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
138424318|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
138424319|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282874|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
138424320|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424321|NCT03253289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138424322|NCT03253289|Cholinergic Agents|cholinergic agents|mesh-ancestor
138424323|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138197254|NCT00982865|Niacinamide|niacinamide|mesh-list
138424325|NCT03227705|Progestins|progestins|mesh-ancestor
138424326|NCT03227705|Hormones|hormones|mesh-ancestor
138424327|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138424328|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424329|NCT03150004|Cytarabine|cytarabine|mesh-list
138424331|NCT03150004|Cladribine|cladribine|mesh-list
138424332|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138424333|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
138424334|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424335|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424336|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
138424337|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424338|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138424339|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
138424340|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424341|NCT03150004|Analgesics|analgesics|mesh-ancestor
138424342|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
138424343|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424344|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138424345|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138424346|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424347|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
138424348|NCT03082534|Cetuximab|cetuximab|mesh-list
138424349|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424350|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424351|NCT03082534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138424352|NCT03082534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424353|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
138424354|NCT03056339|Fludarabine|fludarabine|mesh-list
138424355|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
138424356|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138424357|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
138424358|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424359|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138424360|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138424361|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
138357276|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
138424362|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424363|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424364|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138424365|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138424366|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
138424367|NCT02351869|Midazolam|midazolam|mesh-list
138424368|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
138424369|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138424370|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138424371|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138424372|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424373|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138424374|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138424375|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138424376|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138424377|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
138424379|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
138424380|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
138424381|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424382|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424383|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138424384|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138424385|NCT02351869|Analgesics|analgesics|mesh-ancestor
138424386|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
138424387|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424388|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
138357328|NCT00003336|Hormones|hormones|mesh-ancestor
138424389|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424390|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424391|NCT02311582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138197265|NCT01226719|Irinotecan|irinotecan|mesh-list
138424392|NCT02311582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424393|NCT02237820|Dexamethasone|dexamethasone|mesh-list
138424394|NCT02237820|Prednisone|prednisone|mesh-list
138424395|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138424396|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
138424397|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
138424399|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424400|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138424401|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
138424403|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138424404|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138357376|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
138424405|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424406|NCT02160353|Prednisolone|prednisolone|mesh-list
138424407|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
138424408|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138424409|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
138424411|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138424412|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138390522|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138424413|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138424414|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424415|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138424416|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424417|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424418|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
138424419|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138424420|NCT02152358|Acyclovir|acyclovir|mesh-list
138424421|NCT02152358|Ganciclovir|ganciclovir|mesh-list
138424422|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138424423|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
138424424|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424425|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138424427|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424428|NCT01819064|Atropine|atropine|mesh-list
138424429|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138424430|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138424431|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138424432|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
138424433|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424434|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424435|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138424436|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
138424437|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
138424438|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
138424439|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138424440|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138424441|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
138424442|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424443|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424445|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
138424446|NCT01817751|Valproic Acid|valproic acid|mesh-list
138390639|NCT01501448|Estradiol|estradiol|mesh-list
138424447|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424448|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424449|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138424450|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424451|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
138424452|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138424453|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138424454|NCT01817751|Urological Agents|urological agents|mesh-ancestor
138424455|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
138424456|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
138424457|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424458|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424459|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
138424460|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138424461|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138424462|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138424463|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138424464|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138424465|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424466|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
138424467|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138424468|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424469|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
138424470|NCT00812669|Rituximab|rituximab|mesh-list
138424471|NCT00812669|Fludarabine|fludarabine|mesh-list
138424472|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
138424473|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138424474|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
138424475|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424476|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138424477|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138424478|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
138424479|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424480|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424481|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138424482|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424483|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138424484|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
138424485|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138424486|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138424487|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138424488|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
138424489|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424490|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138424491|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138424492|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424494|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138424495|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
138424496|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424497|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390743|NCT01501760|Bevacizumab|bevacizumab|mesh-list
138424499|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138424500|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138424501|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138424502|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138424503|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138424504|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
138424506|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138424507|NCT03861377|Narcotics|narcotics|mesh-ancestor
138424508|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138424509|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424510|NCT03861377|Analgesics|analgesics|mesh-ancestor
138424511|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
138424512|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424513|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138424514|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138424515|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138424516|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
138424517|NCT03836144|Diuretics|diuretics|mesh-ancestor
138424518|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
138424519|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424520|NCT03836144|Expectorants|expectorants|mesh-ancestor
138424521|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
138424522|NCT03796416|Misoprostol|misoprostol|mesh-list
138424523|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138424524|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
138424525|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138390794|NCT01501916|Vitamin D|vitamin d|mesh-list
138357518|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
138424526|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424527|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138424528|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138424529|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
138424531|NCT03785106|Pyridoxine|pyridoxine|mesh-list
138424532|NCT03785106|Pyridoxal|pyridoxal|mesh-list
138424533|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
138424534|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
138424535|NCT03785106|Isoniazid|isoniazid|mesh-list
138424536|NCT03785106|Rifapentine|rifapentine|mesh-list
138424537|NCT03785106|Rifampin|rifampin|mesh-list
138424538|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
138424539|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424540|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
138424541|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138424542|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138329386|NCT00504504|Rituximab|rituximab|mesh-list
138230596|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138424544|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138424545|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
138424546|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424547|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138424548|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138424549|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
138424550|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138424551|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424552|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138424553|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138424554|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138424555|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138424556|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138424557|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138424558|NCT03782142|Tenofovir|tenofovir|mesh-list
138424559|NCT03782142|Dolutegravir|dolutegravir|mesh-list
138424560|NCT03782142|Rilpivirine|rilpivirine|mesh-list
138424561|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
138424562|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
138424563|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424564|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138424565|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138424566|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424567|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424568|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138424569|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138424570|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138424572|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
138424573|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138424574|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138424575|NCT03770299|Paclitaxel|paclitaxel|mesh-list
138424576|NCT03770299|Vinorelbine|vinorelbine|mesh-list
138424577|NCT03770299|Docetaxel|docetaxel|mesh-list
138424578|NCT03770299|Carboplatin|carboplatin|mesh-list
138424579|NCT03770299|Gemcitabine|gemcitabine|mesh-list
138424580|NCT03770299|Nivolumab|nivolumab|mesh-list
138424581|NCT03770299|Pemetrexed|pemetrexed|mesh-list
138424582|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138424583|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424584|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
138424585|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
138424586|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
138197301|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138424587|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424588|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138424589|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
138424590|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424591|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138424592|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424593|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138424594|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138424595|NCT03760835|Dexamethasone|dexamethasone|mesh-list
138424596|NCT03760835|Prednisone|prednisone|mesh-list
138424597|NCT03760835|Prednisolone|prednisolone|mesh-list
138424598|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
138424599|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138424600|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138424601|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138424602|NCT03760835|Cortisone|cortisone|mesh-list
138424603|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
138424604|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138424605|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
138424606|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
138424607|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424608|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424609|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138424611|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138424612|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138424613|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424614|NCT03759496|Durvalumab|durvalumab|mesh-list
138424615|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424616|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424617|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
138424618|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424619|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424620|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
138424621|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424622|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424623|NCT03727750|Immunotoxins|immunotoxins|mesh-ancestor
138424624|NCT03727750|Immunoconjugates|immunoconjugates|mesh-ancestor
138424625|NCT03727750|Immunologic Factors|immunologic factors|mesh-ancestor
138424626|NCT03727750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424627|NCT03715829|PF-06700841|pf-06700841|mesh-list
138424628|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138424629|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424630|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424631|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
138424632|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
138329449|NCT02115048|Letrozole|letrozole|mesh-list
138424633|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138424634|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138424635|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424636|NCT03704441|Bupivacaine|bupivacaine|mesh-list
138424637|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
138424638|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
138424639|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138424640|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424641|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
138424642|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424643|NCT03660839|Artefenomel|artefenomel|mesh-list
138424644|NCT03660839|Ferroquine|ferroquine|mesh-list
138424645|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
138424646|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138424647|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138424649|NCT03660241|Abrocitinib|abrocitinib|mesh-list
138424650|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138197309|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197310|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138424651|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424652|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424653|NCT03651102|Thalidomide|thalidomide|mesh-list
138424654|NCT03651102|Hydroxyurea|hydroxyurea|mesh-list
138424655|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138424656|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
138424657|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424658|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
138424659|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138424660|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424661|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138424662|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138424663|NCT03651102|Growth Substances|growth substances|mesh-ancestor
138424664|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
138391052|NCT01503450|Olanzapine|olanzapine|mesh-list
138424665|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424666|NCT03651102|Antisickling Agents|antisickling agents|mesh-ancestor
138424667|NCT03651102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424668|NCT03651102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424669|NCT03651102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138424671|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
138424672|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
138424673|NCT03649802|Vitamins|vitamins|mesh-list
138424674|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
138424675|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138329472|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
138424676|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138357780|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
138424677|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138424679|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138424680|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
138424681|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138424682|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138424683|NCT03573115|Analgesics|analgesics|mesh-ancestor
138424684|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
138424685|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424686|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424687|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138424688|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138424689|NCT03569475|Milnacipran|milnacipran|mesh-list
138424690|NCT03569475|Fluoxetine|fluoxetine|mesh-list
138424691|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
138424692|NCT03569475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138424693|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138424694|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138424695|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424696|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424697|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
138424698|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424699|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138424700|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
138391135|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
138424701|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138424702|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138424703|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138424704|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424705|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138424706|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138424707|NCT03569475|Analgesics|analgesics|mesh-ancestor
138424708|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
138424709|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424710|NCT03546556|Alovudine|alovudine|mesh-list
138424711|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
138424712|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
138424713|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424714|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
138424715|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424716|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138424717|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138424718|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424719|NCT03533712|Folic Acid|folic acid|mesh-list
138424720|NCT03533712|Hematinics|hematinics|mesh-ancestor
138424721|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
138424722|NCT03533712|Vitamins|vitamins|mesh-ancestor
138424723|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
138424724|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424725|NCT03523520|Naltrexone|naltrexone|mesh-list
138424726|NCT03523520|Bromides|bromides|mesh-list
138424727|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
138424729|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
138424730|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138424731|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424732|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
138391192|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424735|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
138424736|NCT03518242|Capecitabine|capecitabine|mesh-list
138424737|NCT03518242|Methotrexate|methotrexate|mesh-list
138424738|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138424739|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
138424740|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424741|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138424742|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138424743|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
138424744|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424745|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424746|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138424747|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138424748|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
138424749|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138424750|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
138424751|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138424752|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
138424753|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424754|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138424755|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138424757|NCT03500549|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138424758|NCT03500549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138424759|NCT03500549|Immunologic Factors|immunologic factors|mesh-ancestor
138424760|NCT03500549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424761|NCT03435185|Lidocaine|lidocaine|mesh-list
138358010|NCT00003972|Tamoxifen|tamoxifen|mesh-list
138424762|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
138424764|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138424765|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424766|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
138424767|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424768|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138424769|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138424770|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138424771|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138197329|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138424772|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424773|NCT03383380|Sirolimus|sirolimus|mesh-list
138391237|NCT01504139|Progestins|progestins|mesh-ancestor
138424775|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424776|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138424777|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424778|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
138329537|NCT00511992|Paclitaxel|paclitaxel|mesh-list
138424779|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138424780|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
138424781|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424782|NCT03242772|Amphetamine|amphetamine|mesh-list
138424783|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138424784|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424785|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
138424786|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
138424787|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424788|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
138424789|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424790|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424791|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
138424792|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138424793|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138424794|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138424795|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138424796|NCT03236311|Adenosine|adenosine|mesh-list
138424797|NCT03236311|Regadenoson|regadenoson|mesh-list
138424798|NCT03236311|Analgesics|analgesics|mesh-ancestor
138424799|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
138424800|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424801|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424802|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138424803|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
138424804|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138424805|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
138424806|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
138424807|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424808|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424809|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138424810|NCT03234686|Deferiprone|deferiprone|mesh-list
138424811|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138424812|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
138424813|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
138424814|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424815|NCT03223974|Paclitaxel|paclitaxel|mesh-list
138424816|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138230619|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
138424818|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
138424819|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
138424820|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
138424821|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424822|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
138424823|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138424824|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424825|NCT03190369|Hylan|hylan|mesh-list
138424826|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
138424827|NCT03190369|Protective Agents|protective agents|mesh-ancestor
138424828|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424829|NCT05438342|Immunomodulating Agents|immunomodulating agents|mesh-list
138424830|NCT05438342|Immunologic Factors|immunologic factors|mesh-ancestor
138424831|NCT05438342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424833|NCT05438108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424834|NCT05438108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424835|NCT05438108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138424836|NCT05438108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138424837|NCT05438108|Growth Substances|growth substances|mesh-ancestor
138424838|NCT05438108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424839|NCT05438108|Growth Inhibitors|growth inhibitors|mesh-ancestor
138424840|NCT05437783|Azithromycin|azithromycin|mesh-list
138424841|NCT05437783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138424842|NCT05437783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424843|NCT05437718|Ropivacaine|ropivacaine|mesh-list
138424844|NCT05437718|Anesthetics, Local|anesthetics, local|mesh-ancestor
138424845|NCT05437718|Anesthetics|anesthetics|mesh-ancestor
138424846|NCT05437718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138424847|NCT05437718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424848|NCT05437718|Sensory System Agents|sensory system agents|mesh-ancestor
138424849|NCT05437718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424850|NCT05437497|Propofol|propofol|mesh-list
138424851|NCT05437497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138424852|NCT05437497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138424853|NCT05437497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424854|NCT05437497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138358149|NCT00004104|Interferons|interferons|mesh-list
138424855|NCT05437497|Anesthetics, General|anesthetics, general|mesh-ancestor
138424856|NCT05437497|Anesthetics|anesthetics|mesh-ancestor
138424857|NCT05437471|Letrozole|letrozole|mesh-list
138424858|NCT05437471|Dydrogesterone|dydrogesterone|mesh-list
138424859|NCT05437471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424860|NCT05437471|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138424861|NCT05437471|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138424862|NCT05437471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424863|NCT05437471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424864|NCT05437471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138424865|NCT05437471|Hormone Antagonists|hormone antagonists|mesh-ancestor
138424866|NCT05437471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138424867|NCT05437471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424868|NCT05437471|Progestins|progestins|mesh-ancestor
138424869|NCT05437471|Hormones|hormones|mesh-ancestor
138424870|NCT05437432|Lithium Carbonate|lithium carbonate|mesh-list
138424871|NCT05437432|Methamphetamine|methamphetamine|mesh-list
138424872|NCT05437432|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138424873|NCT05437432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424874|NCT05437432|Sympathomimetics|sympathomimetics|mesh-ancestor
138424875|NCT05437432|Autonomic Agents|autonomic agents|mesh-ancestor
138424876|NCT05437432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424877|NCT05437432|Dopamine Agents|dopamine agents|mesh-ancestor
138424878|NCT05437432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424879|NCT05437432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424880|NCT05437432|Adrenergic Agents|adrenergic agents|mesh-ancestor
138424881|NCT05437432|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138424882|NCT05437432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138391348|NCT01504659|Ketamine|ketamine|mesh-list
138424883|NCT05437432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138424884|NCT05437432|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138424885|NCT05437432|Antidepressive Agents|antidepressive agents|mesh-ancestor
138197361|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138424886|NCT05437432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138424887|NCT05437432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424888|NCT05437432|Antimanic Agents|antimanic agents|mesh-ancestor
138424889|NCT05437432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138424890|NCT05437432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138424891|NCT05437224|Ambrisentan|ambrisentan|mesh-list
138424892|NCT05437224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138424893|NCT05436990|Pembrolizumab|pembrolizumab|mesh-list
138424894|NCT05436990|Vactosertib|vactosertib|mesh-list
138424895|NCT05436990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424896|NCT05436990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424897|NCT05436990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138424898|NCT05436990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424899|NCT05436990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138424900|NCT05436990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424901|NCT05426811|Raltitrexed|raltitrexed|mesh-list
138424902|NCT05426811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138424903|NCT05426811|Antimetabolites|antimetabolites|mesh-ancestor
138424904|NCT05426811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424905|NCT05426811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424906|NCT05426811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138424907|NCT05426811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424908|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
138424909|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138424910|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
138424911|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138424912|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
138424913|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424914|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424915|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
138424917|NCT04895046|Dostarlimab|dostarlimab|mesh-list
138424918|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138424919|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138358241|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
138424920|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424921|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424927|NCT04590586|Thalidomide|thalidomide|mesh-list
138424928|NCT04590586|Apremilast|apremilast|mesh-list
138424929|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138424930|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138424931|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138424932|NCT04590586|Analgesics|analgesics|mesh-ancestor
138424933|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
138424934|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138424935|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424936|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138424937|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138424938|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138424939|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138424940|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424941|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424942|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138424943|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
138358303|NCT00004206|Leucovorin|leucovorin|mesh-list
138424944|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
138424945|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138424946|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424947|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138424948|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138424949|NCT04590586|Growth Substances|growth substances|mesh-ancestor
138424950|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
138383951|NCT05073484|Antibodies|antibodies|mesh-list
138424951|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424953|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138424954|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138424955|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138424956|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138424957|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424958|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
138424960|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138424961|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424962|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424963|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
138424964|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
138424966|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138424967|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424968|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424969|NCT03563742|Tenofovir|tenofovir|mesh-list
138424970|NCT03563742|Lamivudine|lamivudine|mesh-list
138424971|NCT03563742|Rilpivirine|rilpivirine|mesh-list
138424972|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
138424973|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138424974|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138424975|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138424976|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424977|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424978|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138424979|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138424980|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
138424981|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424982|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424983|NCT03473925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138424984|NCT03473925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424985|NCT03424122|Rituximab|rituximab|mesh-list
138424986|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138424987|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138424988|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138424989|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
138424990|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138424991|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138424992|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138424993|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
138424994|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424996|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138424997|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138424998|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138424999|NCT02968940|Avelumab|avelumab|mesh-list
138425000|NCT02968940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138425001|NCT02968940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425003|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138425004|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
138425005|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138197410|NCT01188577|Epinephrine|epinephrine|mesh-list
138425006|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425007|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138425008|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425009|NCT02333292|Ritonavir|ritonavir|mesh-list
138425010|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
138425011|NCT02333292|Grazoprevir|grazoprevir|mesh-list
138425012|NCT02333292|Ledipasvir|ledipasvir|mesh-list
138425013|NCT02333292|Velpatasvir|velpatasvir|mesh-list
138425014|NCT02333292|Simeprevir|simeprevir|mesh-list
138425015|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138425016|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138425017|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
138425018|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425019|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425020|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138425021|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138425022|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
138425023|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138384045|NCT04962230|Analgesics|analgesics|mesh-ancestor
138425024|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138425026|NCT02203773|Posaconazole|posaconazole|mesh-list
138425027|NCT02203773|Azacitidine|azacitidine|mesh-list
138425028|NCT02203773|Decitabine|decitabine|mesh-list
138425029|NCT02203773|Venetoclax|venetoclax|mesh-list
138425030|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138425031|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
138391637|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
138425032|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425033|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425034|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425035|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
138425036|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425037|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138425038|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138425039|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138425040|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138425041|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138425042|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138425043|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
138425044|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138425045|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425048|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138425049|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
138425050|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138425051|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425052|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138425053|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138425054|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138425055|NCT02175030|Trace Elements|trace elements|mesh-ancestor
138425056|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
138425057|NCT01555541|Cytarabine|cytarabine|mesh-list
138425058|NCT01555541|Etoposide|etoposide|mesh-list
138425060|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138425061|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197419|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138197420|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138197421|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
138197422|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197423|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138197424|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
138197425|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
138425062|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138425063|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138425064|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425065|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425066|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138425067|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
138425068|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
138425069|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425070|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138425071|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
138425072|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425073|NCT01398852|Riboflavin|riboflavin|mesh-list
138425074|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
138425075|NCT01398852|Vitamins|vitamins|mesh-ancestor
138425076|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
138425077|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425078|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138425079|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
138425080|NCT01398839|Riboflavin|riboflavin|mesh-list
138425081|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
138425082|NCT01398839|Vitamins|vitamins|mesh-ancestor
138425083|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
138425084|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425085|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138425086|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
138425088|NCT00496795|Epirubicin|epirubicin|mesh-list
138425089|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425090|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
138425091|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
138425092|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
138425093|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425094|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138425095|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138425096|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138425097|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425098|NCT03164889|Entecavir|entecavir|mesh-list
138425099|NCT03164889|Molgramostim|molgramostim|mesh-list
138425100|NCT03164889|Sargramostim|sargramostim|mesh-list
138425101|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
138425102|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425103|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
138425104|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425106|NCT03133260|Aspirin|aspirin|mesh-list
138425107|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138425108|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138425109|NCT03133260|Analgesics|analgesics|mesh-ancestor
138425110|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
138425111|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425112|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425113|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138425114|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138425115|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138425116|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138425117|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425118|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138425119|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138425120|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425121|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
138425122|NCT03096834|Erenumab|erenumab|mesh-list
138425123|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
138425124|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425125|NCT03096834|Analgesics|analgesics|mesh-ancestor
138425126|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
138425127|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425128|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425129|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
138425130|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138425131|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
138425132|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138197435|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138425133|NCT03056014|Expectorants|expectorants|mesh-ancestor
138425134|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
138425135|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138425136|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
138425137|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425138|NCT03056014|Protective Agents|protective agents|mesh-ancestor
138425139|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425140|NCT03056014|Antidotes|antidotes|mesh-ancestor
138425142|NCT03126812|Carboplatin|carboplatin|mesh-list
138425143|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
138425144|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138425145|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425146|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
138425147|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
138425148|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
138425149|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425150|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138425151|NCT03126812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138425152|NCT03026972|Vaccines|vaccines|mesh-list
138425153|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
138425154|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425155|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
138425156|NCT03012815|Gabapentin|gabapentin|mesh-list
138425157|NCT03012815|Lorazepam|lorazepam|mesh-list
138425158|NCT03012815|Valproic Acid|valproic acid|mesh-list
138425159|NCT03012815|Analgesics|analgesics|mesh-ancestor
138425160|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
138425161|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425162|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425163|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
138425164|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138425165|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138391803|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138425166|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138425167|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138425168|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138425169|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138425170|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138425171|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425172|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
138425173|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
138425175|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138425176|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138425177|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
138425178|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
138425179|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425180|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138425182|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
138425183|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
138425184|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425185|NCT02993757|Vaccines|vaccines|mesh-list
138425186|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
138425187|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425188|NCT02979535|Vaccines|vaccines|mesh-list
138425189|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
138425190|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425191|NCT02978716|Carboplatin|carboplatin|mesh-list
138425192|NCT02978716|Gemcitabine|gemcitabine|mesh-list
138425193|NCT02978716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425194|NCT02978716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138425195|NCT02978716|Antimetabolites|antimetabolites|mesh-ancestor
138425196|NCT02978716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425197|NCT02973321|Metformin|metformin|mesh-list
138425198|NCT02973321|Liraglutide|liraglutide|mesh-list
138425199|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138425200|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425201|NCT02973321|Incretins|incretins|mesh-ancestor
138425202|NCT02973321|Hormones|hormones|mesh-ancestor
138425203|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138425204|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138425205|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138425206|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138425207|NCT02943785|Edoxaban|edoxaban|mesh-list
138425208|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138425209|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
138425210|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138425211|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
138425212|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425213|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425215|NCT02908334|Sertraline|sertraline|mesh-list
138425216|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
138425217|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138425218|NCT02908334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138425219|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138425220|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138425221|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425222|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138425224|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425225|NCT02886286|Fentanyl|fentanyl|mesh-list
138425226|NCT02886286|Morphine|morphine|mesh-list
138425227|NCT02886286|Hydromorphone|hydromorphone|mesh-list
138425228|NCT02886286|Bupivacaine|bupivacaine|mesh-list
138425229|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
138425230|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
138329748|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425231|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138425232|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425233|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
138425234|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425235|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138425236|NCT02886286|Narcotics|narcotics|mesh-ancestor
138425237|NCT02886286|Analgesics|analgesics|mesh-ancestor
138425238|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138425239|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138425240|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
138425241|NCT02865187|Vitamin D|vitamin d|mesh-list
138425243|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
138425244|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425245|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138425246|NCT02787551|Metformin|metformin|mesh-list
138425247|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
138425248|NCT02787551|Pioglitazone|pioglitazone|mesh-list
138425249|NCT02787551|Liraglutide|liraglutide|mesh-list
138425250|NCT02787551|Exenatide|exenatide|mesh-list
138425251|NCT02787551|Dulaglutide|dulaglutide|mesh-list
138425252|NCT02787551|Lixisenatide|lixisenatide|mesh-list
138425253|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138425254|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138384256|NCT04527003|Cannabidiol|cannabidiol|mesh-list
138197461|NCT00000298|Analgesics|analgesics|mesh-ancestor
138197462|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
138197464|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138425255|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
138425256|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425257|NCT02787551|Incretins|incretins|mesh-ancestor
138425258|NCT02787551|Hormones|hormones|mesh-ancestor
138425259|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138425260|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138425261|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425262|NCT02735044|Insulin|insulin|mesh-list
138425263|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138425264|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
138425265|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138425266|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425267|NCT02692651|Vancomycin|vancomycin|mesh-list
138425268|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
138425269|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138425270|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425271|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
138425272|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138425273|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425274|NCT02674061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138425275|NCT02674061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425276|NCT02654314|Melatonin|melatonin|mesh-list
138425277|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
138425278|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425279|NCT02654314|Protective Agents|protective agents|mesh-ancestor
138425280|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425281|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138425282|NCT02626962|Nivolumab|nivolumab|mesh-list
138425283|NCT02626962|Ipilimumab|ipilimumab|mesh-list
138425284|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138425285|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425286|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138425287|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425288|NCT02623998|Metformin|metformin|mesh-list
138425289|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
138425290|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138425291|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138425292|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425293|NCT02623998|Incretins|incretins|mesh-ancestor
138425294|NCT02623998|Hormones|hormones|mesh-ancestor
138425295|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138425296|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138425297|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
138425298|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425299|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425300|NCT02608684|Gemcitabine|gemcitabine|mesh-list
138425301|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
138425302|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425303|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138425304|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
138425305|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425306|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138425307|NCT02608684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138425308|NCT02587520|Vaccines|vaccines|mesh-list
138425309|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
138425310|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425311|NCT02584829|Interferons|interferons|mesh-list
138425312|NCT02584829|Interferon-beta|interferon-beta|mesh-list
138425313|NCT02584829|Avelumab|avelumab|mesh-list
138425314|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138425315|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425316|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
138425317|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425318|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138425319|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
138425320|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425321|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
138425322|NCT02512172|Azacitidine|azacitidine|mesh-list
138425323|NCT02512172|Romidepsin|romidepsin|mesh-list
138425324|NCT02512172|Cc-486|cc-486|mesh-list
138425325|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138425326|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425327|NCT02512172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138425328|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425329|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138425330|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
138425331|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425332|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138425333|NCT02512172|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138425334|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
138425336|NCT02499367|Nivolumab|nivolumab|mesh-list
138425337|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138425338|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
138425339|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138392021|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
138425340|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138425341|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138425342|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
138425343|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138358577|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
138425344|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425345|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138425346|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138425347|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138425348|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138425349|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425350|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138425351|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138425352|NCT02497612|Artefenomel|artefenomel|mesh-list
138425353|NCT02497612|Ferroquine|ferroquine|mesh-list
138425354|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
138425355|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138425356|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138425357|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425358|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138425359|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138425360|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425361|NCT02497131|Immunotoxins|immunotoxins|mesh-ancestor
138425362|NCT02497131|Immunoconjugates|immunoconjugates|mesh-ancestor
138425363|NCT02497131|Immunologic Factors|immunologic factors|mesh-ancestor
138425364|NCT02497131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425365|NCT02491333|Metformin|metformin|mesh-list
138425366|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138425367|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425368|NCT02469987|Bevacizumab|bevacizumab|mesh-list
138425369|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138425370|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425371|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138425372|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138425373|NCT02469987|Growth Substances|growth substances|mesh-ancestor
138425374|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425375|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
138425376|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138425377|NCT02439307|Rifaximin|rifaximin|mesh-list
138425378|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425379|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138425380|NCT02381652|Triamcinolone|triamcinolone|mesh-list
138425381|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138425382|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138425383|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
138425384|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138425385|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138425386|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
138425387|NCT02381652|Hormones|hormones|mesh-ancestor
138425388|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138425389|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425390|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138425391|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
138425392|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425393|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425394|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138425395|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
138425396|NCT02381652|Protective Agents|protective agents|mesh-ancestor
138425398|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138425399|NCT02367794|Carboplatin|carboplatin|mesh-list
138425400|NCT02367794|Atezolizumab|atezolizumab|mesh-list
138425401|NCT02367794|Antibodies|antibodies|mesh-list
138425402|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138425403|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425404|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
138425405|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
138425406|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
138425407|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425408|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
138384401|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138425409|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425410|NCT02367794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138425411|NCT02367794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138425413|NCT02363998|Clonidine|clonidine|mesh-list
138425414|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138425415|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138425416|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425417|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
138425418|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425419|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138425420|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138425421|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138425422|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
138425423|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138425424|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425425|NCT02363998|Analgesics|analgesics|mesh-ancestor
138425426|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
138425427|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
138425428|NCT02325466|Aspirin|aspirin|mesh-list
138425430|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138425431|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138425432|NCT02325466|Analgesics|analgesics|mesh-ancestor
138425433|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
138425434|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425435|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425436|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138425437|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138425438|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138425439|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138425440|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425441|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138425442|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138425443|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425444|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
138425445|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138425446|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138425447|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138425448|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
138425449|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138425450|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138425452|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138425453|NCT02323100|Protective Agents|protective agents|mesh-ancestor
138425454|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425455|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425456|NCT02322710|Petrolatum|petrolatum|mesh-list
138425457|NCT02322710|Emollients|emollients|mesh-ancestor
138425458|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
138425459|NCT02283281|Dronabinol|dronabinol|mesh-list
138425460|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
138425461|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425462|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138425463|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138425464|NCT02283281|Analgesics|analgesics|mesh-ancestor
138425465|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
138425466|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425467|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138358681|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
138425468|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138425469|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138425470|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425472|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138425473|NCT02162563|Leucovorin|leucovorin|mesh-list
138425474|NCT02162563|Bevacizumab|bevacizumab|mesh-list
138425475|NCT02162563|Panitumumab|panitumumab|mesh-list
138425476|NCT02162563|Fluorouracil|fluorouracil|mesh-list
138425477|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
138425478|NCT02162563|Irinotecan|irinotecan|mesh-list
138425479|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
138425480|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138425481|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425482|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138425483|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138425484|NCT02162563|Growth Substances|growth substances|mesh-ancestor
138425485|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425487|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
138425488|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425489|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138425490|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138425491|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
138425492|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138425493|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138425494|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425495|NCT02162563|Antidotes|antidotes|mesh-ancestor
138425496|NCT02162563|Protective Agents|protective agents|mesh-ancestor
138425497|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
138425498|NCT02162563|Vitamins|vitamins|mesh-ancestor
138425499|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
138425500|NCT02127086|Analgesics|analgesics|mesh-list
138425501|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
138425502|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425503|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425504|NCT02120079|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138425505|NCT02120079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138425507|NCT02120079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138425508|NCT02120079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138425509|NCT02106195|Belumosudil|belumosudil|mesh-list
138425510|NCT02106195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138425511|NCT02106195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425512|NCT02106195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425513|NCT02075177|Ketoconazole|ketoconazole|mesh-list
138425514|NCT02075177|Fenretinide|fenretinide|mesh-list
138425515|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
138425516|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425517|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138425518|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138425519|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425520|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197502|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138425521|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138425522|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
138425523|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138425524|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425525|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138425526|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425527|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138425528|NCT02075177|Protective Agents|protective agents|mesh-ancestor
138425529|NCT02050919|Sorafenib|sorafenib|mesh-list
138425530|NCT02050919|Epirubicin|epirubicin|mesh-list
138425531|NCT02050919|Ifosfamide|ifosfamide|mesh-list
138425532|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
138425533|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425534|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138425536|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425537|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138425538|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138425539|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138425540|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138425541|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
138425542|NCT01997463|Albuterol|albuterol|mesh-list
138425543|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138425544|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
138425545|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425546|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425547|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138425548|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
138425549|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
138425550|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138425551|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138425552|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138425553|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138425554|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
138425555|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138358804|NCT00004866|Exatecan|exatecan|mesh-list
138425556|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425558|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138425559|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138425560|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425561|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138425562|NCT01976754|Analgesics|analgesics|mesh-ancestor
138425563|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
138425564|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425565|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138392328|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
138425566|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138425567|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138425568|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
138425569|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138425570|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425571|NCT01943825|Vaccines|vaccines|mesh-list
138425572|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
138425573|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425575|NCT01863186|Clonidine|clonidine|mesh-list
138425576|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138425577|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138425578|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425579|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
138425580|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425581|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138425582|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138425583|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138197519|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138425584|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
138425585|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138425586|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425588|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
138425589|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
138425590|NCT01828840|Fentanyl|fentanyl|mesh-list
138425591|NCT01828840|Morphine|morphine|mesh-list
138425592|NCT01828840|Methadone|methadone|mesh-list
138425593|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138425594|NCT01828840|Narcotics|narcotics|mesh-ancestor
138358972|NCT00005094|Celecoxib|celecoxib|mesh-list
138425595|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138425596|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425597|NCT01828840|Analgesics|analgesics|mesh-ancestor
138425598|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
138425599|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425600|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138425601|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138425602|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
138425605|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
138425606|NCT01817426|Infliximab|infliximab|mesh-list
138425607|NCT01817426|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138425608|NCT01817426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138425609|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
138425610|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138425611|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138425612|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138425613|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138425614|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425615|NCT01741103|Incretins|incretins|mesh-ancestor
138425616|NCT01741103|Hormones|hormones|mesh-ancestor
138359039|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
138425617|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138425618|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138425620|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425621|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425622|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138425623|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
138425624|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425625|NCT01630590|Androgens|androgens|mesh-list
138425626|NCT01630590|Hormones|hormones|mesh-ancestor
138425627|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138425628|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425629|NCT01619085|Nintedanib|nintedanib|mesh-list
138425630|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384629|NCT03500328|Siponimod|siponimod|mesh-list
138425631|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138425632|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425633|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425634|NCT01499095|Insulin|insulin|mesh-list
138425635|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138425636|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
138425637|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138425638|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425639|NCT01499082|Insulin|insulin|mesh-list
138425640|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138425641|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
138425642|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138425643|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425644|NCT01488890|Vaccines|vaccines|mesh-list
138425645|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
138425646|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425647|NCT01436396|Vaccines|vaccines|mesh-list
138425648|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
138425649|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425650|NCT01414777|Ondansetron|ondansetron|mesh-list
138425651|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
138425652|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
138425653|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425654|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425655|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138425656|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
138425657|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
138425658|NCT01414777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138425659|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138425660|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
138425661|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138425662|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425663|NCT01411241|Vaccines|vaccines|mesh-list
138425664|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138425665|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
138425666|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425667|NCT01380938|Ribavirin|ribavirin|mesh-list
138425668|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138425669|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
138425670|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
138425671|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425672|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
138425673|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425674|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
138425675|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425676|NCT01374516|Vaccines|vaccines|mesh-list
138425677|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
138425678|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425679|NCT01373281|Vaccines|vaccines|mesh-list
138425680|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
138425681|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425682|NCT01254422|Vaccines|vaccines|mesh-list
138425683|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
138425684|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425685|NCT01204242|Lidocaine|lidocaine|mesh-list
138425686|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
138425687|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
138425688|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138359201|NCT00355290|Vitamin K|vitamin k|mesh-list
138425689|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425690|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
138425691|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425692|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138425693|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138425694|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138425695|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138425696|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425697|NCT01187433|Vaccines|vaccines|mesh-list
138425698|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
138425699|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425700|NCT01150045|Leucovorin|leucovorin|mesh-list
138425701|NCT01150045|Celecoxib|celecoxib|mesh-list
138425702|NCT01150045|Fluorouracil|fluorouracil|mesh-list
138425703|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
138425704|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
138425705|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425706|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138425707|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425708|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138425709|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
138425710|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425711|NCT01150045|Antidotes|antidotes|mesh-ancestor
138425712|NCT01150045|Protective Agents|protective agents|mesh-ancestor
138425713|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
138425715|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
138425716|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138197545|NCT00001990|Atovaquone|atovaquone|mesh-list
138425717|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138425718|NCT01150045|Analgesics|analgesics|mesh-ancestor
138425719|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
138425720|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425721|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138425722|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138425723|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138425724|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138425725|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425726|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
138425727|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
138425728|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425730|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
138425731|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138425732|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
138425733|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425734|NCT01098032|Protective Agents|protective agents|mesh-ancestor
138425735|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425736|NCT00945009|Dactinomycin|dactinomycin|mesh-list
138425737|NCT00945009|Cactinomycin|cactinomycin|mesh-list
138425738|NCT00945009|Doxorubicin|doxorubicin|mesh-list
138425739|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138425740|NCT00945009|Vincristine|vincristine|mesh-list
138330080|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
138425741|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138425742|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425743|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138425744|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138425746|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425747|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138425748|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
138425749|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
138425750|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
138425751|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138425752|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425754|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138425755|NCT00942877|Cediranib|cediranib|mesh-list
138425756|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425757|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138425758|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425759|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425760|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138425761|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138425762|NCT00896389|Diuretics|diuretics|mesh-ancestor
138425763|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
138425764|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425765|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138425766|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138425767|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425768|NCT00880893|Vaccines|vaccines|mesh-list
138425769|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
138425770|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425771|NCT00579527|Cyclosporine|cyclosporine|mesh-list
138425772|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
138425773|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
138425774|NCT00579527|Prednisolone|prednisolone|mesh-list
138425775|NCT00579527|Tacrolimus|tacrolimus|mesh-list
138425776|NCT00579527|Cyclosporins|cyclosporins|mesh-list
138425777|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
138425778|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138425779|NCT00579527|Daclizumab|daclizumab|mesh-list
138425780|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
138359412|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138425781|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138425782|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
138425783|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425784|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138425785|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425786|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425787|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
138425788|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425789|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
138425790|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138425791|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138425792|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425793|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138425794|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
138425795|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138425798|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
138425799|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425800|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138425801|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
138425802|NCT00579527|Hormones|hormones|mesh-ancestor
138425803|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138359469|NCT00359112|Metformin|metformin|mesh-list
138425804|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138425805|NCT00579527|Protective Agents|protective agents|mesh-ancestor
138425806|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138425807|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138425808|NCT01904123|Tyrphostins|tyrphostins|mesh-list
138425809|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425810|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425811|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425812|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
138230701|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
138425813|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138425814|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425815|NCT00531232|Clofarabine|clofarabine|mesh-list
138392743|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
138425816|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138425817|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
138425818|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425819|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425820|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
138425821|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138425822|NCT00066950|Fluorides|fluorides|mesh-list
138425823|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
138425824|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
138425825|NCT00066950|Protective Agents|protective agents|mesh-ancestor
138425826|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425827|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138425828|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425829|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
138425830|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
138425831|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138425832|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
138425833|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138425834|NCT01694134|Prednisolone|prednisolone|mesh-list
138425835|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
138425836|NCT01694134|Lidocaine|lidocaine|mesh-list
138425837|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138425838|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
138425839|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
138425840|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
138392796|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
138425841|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138425842|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425843|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
138197564|NCT01026623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138197565|NCT01026623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197566|NCT01026623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197567|NCT00001996|Atovaquone|atovaquone|mesh-list
138425844|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138330126|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
138425845|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138425846|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138425847|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138425848|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138425849|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425850|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138425851|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
138425852|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
138425853|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138425854|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
138425855|NCT01694134|Hormones|hormones|mesh-ancestor
138359563|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138425856|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138425857|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138425858|NCT01694134|Protective Agents|protective agents|mesh-ancestor
138425859|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138425860|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425861|NCT01694212|Diclofenac|diclofenac|mesh-list
138425862|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138425863|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138425864|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138425865|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138425866|NCT01694212|Analgesics|analgesics|mesh-ancestor
138425867|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
138425868|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425869|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425870|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138230704|NCT02508207|Ivacaftor|ivacaftor|mesh-list
138425871|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138425872|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138425873|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425874|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425875|NCT01694264|Entecavir|entecavir|mesh-list
138425876|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
138425877|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425878|NCT01694355|Vitamin D|vitamin d|mesh-list
138425879|NCT01694355|Vitamins|vitamins|mesh-ancestor
138425880|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
138425881|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425882|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138425883|NCT01694381|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138425884|NCT01694381|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138425885|NCT01694381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138425886|NCT01694381|Immunologic Factors|immunologic factors|mesh-ancestor
138425887|NCT01694381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425888|NCT01694407|Tenofovir|tenofovir|mesh-list
138425889|NCT01694407|Emtricitabine|emtricitabine|mesh-list
138425890|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
138425891|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425892|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138425893|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138425894|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425895|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425896|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138425897|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138425898|NCT01694459|Heparin|heparin|mesh-list
138425899|NCT01694459|Calcium heparin|calcium heparin|mesh-list
138425900|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
138425901|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138425902|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138425903|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425904|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138359664|NCT00364026|Darusentan|darusentan|mesh-list
138425905|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
138425906|NCT01694498|Coagulants|coagulants|mesh-ancestor
138425907|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138392992|NCT01512537|Vitamin D|vitamin d|mesh-list
138425908|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
138425909|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425911|NCT01694576|Nedaplatin|nedaplatin|mesh-list
138425912|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138425913|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425914|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
138425915|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
138425916|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
138425917|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425918|NCT01694693|Abatacept|abatacept|mesh-list
138425919|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138425920|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425921|NCT01694693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138425922|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425923|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138425924|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
138425925|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425926|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138425927|NCT01694732|Varenicline|varenicline|mesh-list
138425928|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138425929|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138425930|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
138425931|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138425932|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425933|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425934|NCT01694797|Metoprolol|metoprolol|mesh-list
138425935|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138425936|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138425937|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
138425938|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
138425939|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138425940|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425941|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138425942|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138425943|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138425944|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
138425945|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138425946|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425947|NCT01695005|Prednisone|prednisone|mesh-list
138425948|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138425949|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
138425951|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138425952|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425953|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138425954|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425955|NCT01695057|Vorinostat|vorinostat|mesh-list
138425956|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138425957|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138425958|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425959|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425960|NCT01695070|Melatonin|melatonin|mesh-list
138425961|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
138425962|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425963|NCT01695070|Protective Agents|protective agents|mesh-ancestor
138425964|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425965|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138425966|NCT01695109|Liraglutide|liraglutide|mesh-list
138425967|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138425968|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425969|NCT01695109|Incretins|incretins|mesh-ancestor
138425970|NCT01695109|Hormones|hormones|mesh-ancestor
138425971|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138425972|NCT01695122|Valproic Acid|valproic acid|mesh-list
138425973|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
138425974|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425975|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425976|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
138359752|NCT00366834|Hormones|hormones|mesh-ancestor
138425977|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138425978|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425979|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
138425980|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138425981|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138425982|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138425983|NCT01695148|Carotenoids|carotenoids|mesh-list
138425984|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
138425985|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425986|NCT01695148|Protective Agents|protective agents|mesh-ancestor
138425987|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138425988|NCT01695174|Rifaximin|rifaximin|mesh-list
138425989|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138425990|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138425991|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138425992|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
138425993|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
138425994|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138425995|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138425996|NCT01695226|Celecoxib|celecoxib|mesh-list
138425997|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138425998|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138425999|NCT01695226|Analgesics|analgesics|mesh-ancestor
138426000|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
138230778|NCT02512809|Isoflurane|isoflurane|mesh-list
138426002|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426003|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138426004|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138426005|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138426006|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138426007|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426008|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426009|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
138385024|NCT02303431|Edoxaban|edoxaban|mesh-list
138426011|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
138426012|NCT01695356|Avobenzone|avobenzone|mesh-list
138426013|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
138426014|NCT01695356|Benzophenone|benzophenone|mesh-list
138426015|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138426016|NCT01695356|Protective Agents|protective agents|mesh-ancestor
138426017|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426018|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
138426019|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138426020|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
138426021|NCT01695460|Vitamins|vitamins|mesh-list
138426022|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
138426023|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426024|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138426025|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138426026|NCT01695707|Pioglitazone|pioglitazone|mesh-list
138426027|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138426028|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426029|NCT01695733|Vaccines|vaccines|mesh-list
138426030|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
138426031|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426032|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
138426033|NCT01695759|Hematinics|hematinics|mesh-ancestor
138426034|NCT01695798|Vaccines|vaccines|mesh-list
138426035|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
138426036|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426037|NCT01695824|Warfarin|warfarin|mesh-list
138426038|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
138426039|NCT01695850|Sennosides|sennosides|mesh-list
138426040|NCT01695850|Laxatives|laxatives|mesh-ancestor
138426041|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138426042|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
138426043|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138426044|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
138426045|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138426046|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426047|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138426048|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138426049|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138426050|NCT01696110|Heparin|heparin|mesh-list
138426051|NCT01696110|Calcium heparin|calcium heparin|mesh-list
138426052|NCT01696110|Tirofiban|tirofiban|mesh-list
138426053|NCT01696110|Bivalirudin|bivalirudin|mesh-list
138426054|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
138426055|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138426056|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138426057|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426058|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
138426059|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138426060|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
138426061|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426062|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138426063|NCT01696240|Udenafil|udenafil|mesh-list
138426064|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138426065|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138426066|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426067|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426068|NCT01696370|Trimetazidine|trimetazidine|mesh-list
138426069|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
138426070|NCT01696383|Timolol|timolol|mesh-list
138426071|NCT01696383|Travoprost|travoprost|mesh-list
138426072|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138426073|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138426074|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
138426075|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426076|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426077|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426078|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138426079|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138426080|NCT01696409|Vitamin D|vitamin d|mesh-list
138426081|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
138426082|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
138426083|NCT01696409|Vitamins|vitamins|mesh-list
138426084|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
138426085|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426086|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138230861|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
138426087|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138426088|NCT01696422|Vaccines|vaccines|mesh-list
138393159|NCT01513668|Analgesics|analgesics|mesh-ancestor
138426090|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426091|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
138197604|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138197612|NCT00000328|Narcotics|narcotics|mesh-ancestor
138426092|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
138426093|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426094|NCT01696448|Protective Agents|protective agents|mesh-ancestor
138426095|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426096|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
138426098|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
138426099|NCT01696474|Bortezomib|bortezomib|mesh-list
138426100|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426101|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
138426102|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138426103|NCT01696500|Antibodies|antibodies|mesh-list
138426104|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
138426105|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138426106|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
138426107|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426108|NCT01696526|Vitamin D|vitamin d|mesh-list
138426109|NCT01696526|Vitamins|vitamins|mesh-ancestor
138426110|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
138426111|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426112|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138426113|NCT01696552|Cimetidine|cimetidine|mesh-list
138426114|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138426115|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138426116|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138426117|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
138426118|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
138426119|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426120|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426121|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138330312|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
138426122|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138426123|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138426124|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426126|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
138426127|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138426128|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138426129|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138426130|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138426131|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426132|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
138426133|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
138426134|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426135|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426136|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138426137|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138426138|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
138426139|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138426140|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138426141|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138426142|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138426144|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138426145|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
138426146|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
138426147|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138426148|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426149|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138426150|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
138360087|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
138426151|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426152|NCT01696799|Econazole|econazole|mesh-list
138426153|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
138426154|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426155|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138426156|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138426157|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426158|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197626|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197628|NCT00380224|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138426159|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138426160|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
138426161|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138426162|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426163|NCT01696825|Diazepam|diazepam|mesh-list
138426164|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138426165|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
138426166|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
138426167|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
138426168|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426169|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426170|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138426171|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138426172|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138426173|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138426174|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138426175|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138426176|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138426177|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138426178|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138426179|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
138426180|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
138426181|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
138426182|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
138426183|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426184|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426185|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
138426186|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
138426187|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426188|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138426189|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426190|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138426191|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
138426192|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426193|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138426194|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138360197|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426195|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138426196|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
138426197|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138426198|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138426199|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426200|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426202|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426203|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138426204|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138426205|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138426206|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138426208|NCT01697059|Piperacillin|piperacillin|mesh-list
138426209|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138426210|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138197631|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426211|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426212|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138426213|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426214|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426215|NCT01697098|Dexamethasone|dexamethasone|mesh-list
138426216|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
138360251|NCT00380484|Budesonide|budesonide|mesh-list
138426217|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
138426218|NCT01697098|BB 1101|bb 1101|mesh-list
138426219|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138426220|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
138426221|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
138426222|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426223|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426224|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138426225|NCT01697098|Hormones|hormones|mesh-ancestor
138426226|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138426227|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138426228|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426229|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
138426230|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426231|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426232|NCT01697111|Dienogest|dienogest|mesh-list
138426233|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138426234|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
138426235|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138426236|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426237|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138426238|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138426239|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138426240|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138426241|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
138393362|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138426242|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138426243|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138426244|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426245|NCT01697150|Pancrelipase|pancrelipase|mesh-list
138426246|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138426247|NCT01697228|Vitamin D|vitamin d|mesh-list
138426248|NCT01697228|Vitamins|vitamins|mesh-ancestor
138230919|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138426250|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426251|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138426252|NCT01697293|Paclitaxel|paclitaxel|mesh-list
138426253|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
138426254|NCT01697293|Doxorubicin|doxorubicin|mesh-list
138426255|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138426256|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138426257|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138426258|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426259|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
138426260|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
138426261|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
138426262|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426263|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138360347|NCT00383136|Tirofiban|tirofiban|mesh-list
138426265|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426266|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138426267|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138426268|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
138426269|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138426270|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138426271|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138426272|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138426273|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426274|NCT01697306|Gemcitabine|gemcitabine|mesh-list
138426275|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
138426276|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138426277|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
138426278|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426279|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426280|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138426281|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
138426282|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426283|NCT01697410|Terlipressin|terlipressin|mesh-list
138426284|NCT01697410|Norepinephrine|norepinephrine|mesh-list
138426285|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138426286|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138426287|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
138426288|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426289|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426290|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426291|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
138426292|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
138426293|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426294|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138426295|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138426296|NCT01697436|Ribavirin|ribavirin|mesh-list
138426297|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
138426298|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426299|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
138426300|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426301|NCT01697605|Infigratinib|infigratinib|mesh-list
138426302|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426303|NCT01697618|Insulin|insulin|mesh-list
138330426|NCT00569010|Cytarabine|cytarabine|mesh-list
138426304|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138426305|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
138426306|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
138426307|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138426308|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138426309|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426310|NCT01697631|Insulin|insulin|mesh-list
138426311|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138426312|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
138426313|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
138426314|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138360458|NCT00385554|UC-781|uc-781|mesh-list
138426315|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
138426316|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138426317|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138426318|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426320|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138426321|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
138426322|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
138426323|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
138426324|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
138197661|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426325|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
138426326|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138426327|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426328|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138426329|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138426330|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
138426331|NCT01697722|Beclomethasone|beclomethasone|mesh-list
138426332|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138426333|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
138426334|NCT01697722|Hormones|hormones|mesh-ancestor
138426335|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138230995|NCT02517021|Hormones|hormones|mesh-ancestor
138426337|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138426338|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
138426339|NCT01697735|Atorvastatin|atorvastatin|mesh-list
138426340|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138426341|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138426342|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138426343|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
138426344|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426345|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138426346|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138426347|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426348|NCT01697787|Artesunate|artesunate|mesh-list
138426349|NCT01697787|Lumefantrine|lumefantrine|mesh-list
138426350|NCT01697787|Artemether|artemether|mesh-list
138426351|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138426352|NCT01697787|Amodiaquine|amodiaquine|mesh-list
138426353|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
138426354|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138426355|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138426356|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426357|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426358|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
138426359|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
138426360|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138426361|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
138426362|NCT01697826|Clindamycin|clindamycin|mesh-list
138426363|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
138426364|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
138426365|NCT01697826|Clotrimazole|clotrimazole|mesh-list
138426366|NCT01697826|Miconazole|miconazole|mesh-list
138426367|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138426368|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426369|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138426370|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426371|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426372|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138426373|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
138426374|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138426375|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138426376|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138426377|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
138426378|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138426379|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426380|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138426381|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138426382|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138426383|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138426385|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138426386|NCT01698164|Progesterone|progesterone|mesh-list
138426387|NCT01698164|Estrogens|estrogens|mesh-ancestor
138426388|NCT01698164|Hormones|hormones|mesh-ancestor
138426389|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138426390|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426391|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138426392|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
138426393|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138426395|NCT01698164|Progestins|progestins|mesh-ancestor
138426396|NCT01698177|Vaccines|vaccines|mesh-list
138197680|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426397|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
138426398|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426399|NCT01698203|Ropivacaine|ropivacaine|mesh-list
138426400|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
138426401|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
138330465|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138426402|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231002|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426403|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426404|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
138426405|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426407|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
138426408|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138426409|NCT01698476|Vitamins|vitamins|mesh-ancestor
138426410|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
138426411|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426412|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138426413|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138426414|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426415|NCT01698541|Tacrolimus|tacrolimus|mesh-list
138426416|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138426417|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
138426418|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426419|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138426420|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426421|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426423|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
138426424|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138393564|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
138426426|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426427|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426428|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
138426429|NCT01698593|Epinephrine|epinephrine|mesh-list
138426430|NCT01698593|Bupivacaine|bupivacaine|mesh-list
138426431|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
138426432|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
138426433|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138426434|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426435|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
138426436|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426437|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138426438|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138426439|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
138426440|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426441|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426442|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138426443|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138426444|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
138426445|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138426446|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
138426447|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
138426448|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
138426450|NCT01698645|Fentanyl|fentanyl|mesh-list
138426451|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138426453|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138426454|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426455|NCT01698645|Analgesics|analgesics|mesh-ancestor
138426456|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
138426457|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426458|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138426459|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138426460|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
138426461|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
138426462|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
138426463|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138197688|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138426464|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426465|NCT01698723|Ribavirin|ribavirin|mesh-list
138426466|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
138426467|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426468|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
138426469|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426470|NCT01698749|Dexamethasone|dexamethasone|mesh-list
138426471|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138426472|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
138426473|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
138426474|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426475|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426476|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138426477|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
138426478|NCT01698749|Hormones|hormones|mesh-ancestor
138426479|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138426480|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138426482|NCT01698788|Dexamethasone|dexamethasone|mesh-list
138426483|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
138426484|NCT01698788|BB 1101|bb 1101|mesh-list
138426485|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138426486|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
138426487|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
138426488|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426489|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426490|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138426491|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
138426492|NCT01698788|Hormones|hormones|mesh-ancestor
138426493|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138426494|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138426495|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426496|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
138426497|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426498|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426499|NCT01698931|Glyburide|glyburide|mesh-list
138426500|NCT01698931|Repaglinide|repaglinide|mesh-list
138426501|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138426502|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426503|NCT01699113|Rabeprazole|rabeprazole|mesh-list
138426504|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138426505|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138426506|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138426507|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426508|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426509|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138426510|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138426511|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138426512|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
138426513|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426514|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138426515|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138426516|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426518|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138426519|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
138426520|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426521|NCT01699204|Expectorants|expectorants|mesh-ancestor
138426522|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
138426523|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138426524|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
138426525|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426526|NCT01699204|Protective Agents|protective agents|mesh-ancestor
138426527|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426528|NCT01699204|Antidotes|antidotes|mesh-ancestor
138426529|NCT01699282|Antivitamins K|antivitamins k|mesh-list
138426530|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
138426531|NCT01699347|Picibanil|picibanil|mesh-list
138426532|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426534|NCT01699360|Sirolimus|sirolimus|mesh-list
138426535|NCT01699360|Tacrolimus|tacrolimus|mesh-list
138385542|NCT01470092|Hormones|hormones|mesh-ancestor
138426536|NCT01699360|Cyclosporins|cyclosporins|mesh-list
138426537|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138426538|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
138426539|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426540|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138426541|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426542|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426543|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
138426544|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426545|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
138426546|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138426547|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138426548|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138426549|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426550|NCT01699412|Dexamethasone|dexamethasone|mesh-list
138426551|NCT01699412|Clobetasol|clobetasol|mesh-list
138426552|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138426553|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
138426554|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
138360742|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138426555|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426556|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426557|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138426558|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
138426560|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138426561|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138426562|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426563|NCT01699438|Mesalamine|mesalamine|mesh-list
138426564|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138426565|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138426566|NCT01699438|Analgesics|analgesics|mesh-ancestor
138426567|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
138426568|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426569|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426570|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138426571|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138426572|NCT01699490|Valsartan|valsartan|mesh-list
138426573|NCT01699490|Fluoxetine|fluoxetine|mesh-list
138360787|NCT02999958|Vitamins|vitamins|mesh-ancestor
138426574|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138426575|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138330600|NCT05766436|Melatonin|melatonin|mesh-list
138426576|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138426577|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426578|NCT01699490|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138426579|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138426580|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138426581|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426582|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
138393788|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
138426583|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426584|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138426585|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
138426586|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138426587|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138426588|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138426589|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138197709|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426590|NCT01699594|Mannitol|mannitol|mesh-list
138426591|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
138426592|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138426593|NCT01699594|Diuretics|diuretics|mesh-ancestor
138426594|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
138426595|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426596|NCT01699594|Miotics|miotics|mesh-ancestor
138426597|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
138426598|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426599|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138426600|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138426601|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
138426602|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138426603|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138426604|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
138426605|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426606|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426607|NCT01699659|Immunomodulating Agents|immunomodulating agents|mesh-list
138426608|NCT01699659|Immunologic Factors|immunologic factors|mesh-ancestor
138426609|NCT01699659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426610|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138426611|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
138426612|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426613|NCT01699711|Protective Agents|protective agents|mesh-ancestor
138426614|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426616|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138426618|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138426619|NCT01699724|Sertraline|sertraline|mesh-list
138426620|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
138426621|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138426622|NCT01699724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138426623|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138426624|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138426625|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426626|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426627|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
138426628|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426629|NCT01699776|Digoxin|digoxin|mesh-list
138426630|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138426631|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138426632|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426633|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426634|NCT01699776|Protective Agents|protective agents|mesh-ancestor
138426635|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426636|NCT01699802|Anesthetics|anesthetics|mesh-list
138426637|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138426638|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426639|NCT01699828|Buspirone|buspirone|mesh-list
138426640|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138426641|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138426642|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138426643|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426644|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138426645|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138426646|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
138426647|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426648|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426649|NCT01699854|Capsaicin|capsaicin|mesh-list
138197717|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138197718|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
138197719|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138197721|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426650|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
138426651|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
138426652|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
138426653|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426654|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426655|NCT01699919|Lidocaine|lidocaine|mesh-list
138426656|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
138426657|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
138426658|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138426659|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426660|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
138426661|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426662|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138426663|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138426664|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138426665|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138426666|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426667|NCT01699932|Metformin|metformin|mesh-list
138426668|NCT01699932|Glimepiride|glimepiride|mesh-list
138426669|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138426670|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426671|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138426672|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138426673|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
138426674|NCT01699997|Oxytocin|oxytocin|mesh-list
138426675|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
138426676|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138426677|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426678|NCT01700010|Paclitaxel|paclitaxel|mesh-list
138426679|NCT01700010|Lapatinib|lapatinib|mesh-list
138426680|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138426681|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426682|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
138426683|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
138426684|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
138426685|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426686|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138426687|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426688|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
138385681|NCT01471158|Maleic acid|maleic acid|mesh-list
138426689|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138426690|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138231145|NCT05624151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138426691|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138426692|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426693|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138426694|NCT01700270|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138330696|NCT05765097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138426695|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138426696|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138426697|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426698|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426700|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138426701|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
138426702|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138393973|NCT01517997|Paclitaxel|paclitaxel|mesh-list
138426703|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138426704|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426705|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138426706|NCT01700322|Clopidogrel|clopidogrel|mesh-list
138426708|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138426709|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138426710|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138426711|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138426712|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138197743|NCT00000340|Pemoline|pemoline|mesh-list
138426713|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
138426714|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426715|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426716|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426717|NCT01700400|Bevacizumab|bevacizumab|mesh-list
138426719|NCT01700400|Pemetrexed|pemetrexed|mesh-list
138426720|NCT01700400|Everolimus|everolimus|mesh-list
138426721|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138426722|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426723|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138426724|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138426725|NCT01700400|Growth Substances|growth substances|mesh-ancestor
138426726|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426727|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
138426728|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426729|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426730|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138426731|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138426732|NCT01700400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138426733|NCT01700400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138426734|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138426735|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
138426736|NCT01700413|Idarubicin|idarubicin|mesh-list
138426737|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138426738|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426739|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138426740|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138426741|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426742|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426745|NCT01700426|Tocopherols|tocopherols|mesh-list
138426746|NCT01700426|Tocotrienols|tocotrienols|mesh-list
138426747|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
138426748|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
138426749|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426750|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
138426751|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426752|NCT01700426|Protective Agents|protective agents|mesh-ancestor
138426753|NCT01700478|Vasopressins|vasopressins|mesh-list
138361056|NCT01275222|Everolimus|everolimus|mesh-list
138426754|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
138426755|NCT01700478|Misoprostol|misoprostol|mesh-list
138426756|NCT01700478|Diuretics|diuretics|mesh-list
138426757|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426758|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138426759|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
138426760|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138426761|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138426762|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138426763|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
138426764|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
138426765|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
138426766|NCT01700478|Coagulants|coagulants|mesh-ancestor
138426767|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138426768|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138426769|NCT01700491|Ropivacaine|ropivacaine|mesh-list
138426770|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
138426771|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
138426772|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138426773|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426774|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
138426775|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426776|NCT01700504|Gentamicins|gentamicins|mesh-list
138426777|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138426778|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426779|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138426780|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426781|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426782|NCT01700608|Plerixafor|plerixafor|mesh-list
138426783|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138426784|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138426785|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
138426786|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426787|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138426788|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138426789|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426790|NCT01700751|Immunotoxins|immunotoxins|mesh-ancestor
138426791|NCT01700751|Immunoconjugates|immunoconjugates|mesh-ancestor
138426792|NCT01700751|Immunologic Factors|immunologic factors|mesh-ancestor
138426793|NCT01700751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426794|NCT01700790|Ritonavir|ritonavir|mesh-list
138426795|NCT01700790|Lopinavir|lopinavir|mesh-list
138426796|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138426797|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138426798|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
138426799|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426800|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426801|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138426802|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138426803|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
138330825|NCT05177588|Metformin|metformin|mesh-list
138426804|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426805|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138426806|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138426807|NCT01700803|Iodine|iodine|mesh-list
138426808|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
138426809|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
138426810|NCT01700803|Povidone|povidone|mesh-list
138426811|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138426812|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426813|NCT01700803|Trace Elements|trace elements|mesh-ancestor
138426814|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
138426815|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426816|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
138426817|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
138426818|NCT01700881|Vitamin E|vitamin e|mesh-list
138426819|NCT01700881|Vitamins|vitamins|mesh-ancestor
138426820|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
138426821|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426822|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
138394070|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138426823|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426825|NCT01701076|Dexamethasone|dexamethasone|mesh-list
138426826|NCT01701076|Lenalidomide|lenalidomide|mesh-list
138426827|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138426828|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138426829|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
138426830|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
138426831|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426832|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426833|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138426834|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
138426835|NCT01701076|Hormones|hormones|mesh-ancestor
138426836|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138426837|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138330862|NCT05059873|Prednisone|prednisone|mesh-list
138426838|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361283|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
138426839|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426840|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
138426841|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138426842|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138426843|NCT01701076|Growth Substances|growth substances|mesh-ancestor
138426844|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
138426845|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138426846|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
138426847|NCT01701089|Selegiline|selegiline|mesh-list
138197759|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
138426848|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
138426849|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138426850|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138426851|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138426852|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138426853|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426854|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426855|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138231218|NCT05467761|Psilocybin|psilocybin|mesh-list
138231219|NCT05467761|Hallucinogens|hallucinogens|mesh-ancestor
138231220|NCT05467761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138231221|NCT05467761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138231222|NCT05418361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138231223|NCT05418361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138231224|NCT05418361|Protease Inhibitors|protease inhibitors|mesh-ancestor
138231225|NCT05418361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426856|NCT01701089|Protective Agents|protective agents|mesh-ancestor
138361330|NCT05740332|Hand Sanitizers|hand sanitizers|mesh-list
138426857|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426858|NCT01701180|Oxytocin|oxytocin|mesh-list
138426859|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
138426860|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138426861|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426862|NCT01701219|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138426863|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138426864|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426865|NCT01701232|Rituximab|rituximab|mesh-list
138426866|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138426867|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426868|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
138426869|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426870|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138426871|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138426872|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138426873|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426874|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138426875|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
138426876|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138426877|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138426878|NCT01701323|Cytarabine|cytarabine|mesh-list
138426879|NCT01701323|Fludarabine|fludarabine|mesh-list
138426880|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
138426881|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426882|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138426883|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
138426884|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426885|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138426886|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
138426887|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426888|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
138426889|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426890|NCT01701336|Cloricromen|cloricromen|mesh-list
138394151|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
138426891|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138426892|NCT01701349|Paclitaxel|paclitaxel|mesh-list
138426893|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
138426894|NCT01701349|Combretastatin|combretastatin|mesh-list
138426895|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138426896|NCT01701349|Carboplatin|carboplatin|mesh-list
138426897|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138426898|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426899|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
138426900|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
138426901|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
138197775|NCT01229527|Narcotics|narcotics|mesh-ancestor
138197776|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138197777|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197778|NCT01229527|Analgesics|analgesics|mesh-ancestor
138426902|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426903|NCT01701453|Clopidogrel|clopidogrel|mesh-list
138426904|NCT01701453|Ticagrelor|ticagrelor|mesh-list
138426905|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138426906|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138426907|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138231238|NCT05272605|Vaccines|vaccines|mesh-list
138231239|NCT05272605|Immunologic Factors|immunologic factors|mesh-ancestor
138426908|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138426909|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138426910|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
138426911|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426912|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426913|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426914|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
138426915|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138426916|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138385916|NCT01472640|Hormones|hormones|mesh-ancestor
138426917|NCT01701479|Aldesleukin|aldesleukin|mesh-list
138426918|NCT01701479|Interleukin-2|interleukin-2|mesh-list
138426919|NCT01701479|Dinutuximab|dinutuximab|mesh-list
138426920|NCT01701479|Isotretinoin|isotretinoin|mesh-list
138426921|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138361496|NCT03216564|Vitamin D|vitamin d|mesh-list
138426922|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138426923|NCT01701479|Analgesics|analgesics|mesh-ancestor
138426924|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
138426925|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426926|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426927|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138426928|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138426929|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
138426930|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426931|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
138426932|NCT01701518|Dexamethasone|dexamethasone|mesh-list
138426933|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138426934|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
138426935|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
138426936|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138426937|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426938|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138426939|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
138426940|NCT01701518|Hormones|hormones|mesh-ancestor
138426941|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138426942|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138426943|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426944|NCT01701583|Omalizumab|omalizumab|mesh-list
138426945|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138426946|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138426947|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
138426948|NCT01701739|Digoxin|digoxin|mesh-list
138426949|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138426950|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138426951|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138426952|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426953|NCT01701739|Protective Agents|protective agents|mesh-ancestor
138426954|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426955|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
138426956|NCT01701778|Sevoflurane|sevoflurane|mesh-list
138426957|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
138330978|NCT04778267|Hormones|hormones|mesh-ancestor
138426958|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138426959|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138426960|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426961|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138426963|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
138426964|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138197785|NCT02723162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138197791|NCT02723162|Antiviral Agents|antiviral agents|mesh-ancestor
138426965|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138426966|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138426967|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138426968|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
138426969|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138426970|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138426971|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138426972|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138426973|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
138426974|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
138426975|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
138426976|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
138426977|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
138426978|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
138426979|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138426980|NCT01701843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138426981|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138426982|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138426983|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
138426985|NCT01701856|Interferon-beta|interferon-beta|mesh-list
138426986|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
138426987|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138426988|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
138426989|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426990|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
138426991|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138361651|NCT01833312|Buspirone|buspirone|mesh-list
138426992|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138426993|NCT01701882|Tenofovir|tenofovir|mesh-list
138426994|NCT01701882|Emtricitabine|emtricitabine|mesh-list
138426995|NCT01701882|Rilpivirine|rilpivirine|mesh-list
138426996|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
138426997|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138426998|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138426999|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138427000|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427001|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138330998|NCT04718181|Risdiplam|risdiplam|mesh-list
138427002|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138427003|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138427004|NCT01701921|Pregabalin|pregabalin|mesh-list
138427005|NCT01701921|Analgesics|analgesics|mesh-ancestor
138427006|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
138427007|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427008|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427009|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
138427010|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138427011|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138231286|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
138427012|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427013|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138427015|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138427016|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427017|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138427018|NCT01702038|Rituximab|rituximab|mesh-list
138427019|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138427020|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427022|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427023|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138427024|NCT01702090|Ritonavir|ritonavir|mesh-list
138427025|NCT01702090|Darunavir|darunavir|mesh-list
138427026|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138427027|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138427028|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
138427029|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138361693|NCT01835340|Anesthetics|anesthetics|mesh-list
138427030|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427031|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138427032|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138427033|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
138427034|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427035|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138427036|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138427037|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
138427038|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138427039|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
138427040|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138427041|NCT01702129|Doxorubicin|doxorubicin|mesh-list
138427042|NCT01702129|Cetuximab|cetuximab|mesh-list
138427043|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138427044|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427045|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138427046|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138427047|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427048|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427049|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138427050|NCT01702181|Tacrolimus|tacrolimus|mesh-list
138427051|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138427052|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
138427053|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427054|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138427055|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427056|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427057|NCT01702207|Tacrolimus|tacrolimus|mesh-list
138427058|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138427059|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
138427060|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427061|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138427062|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231302|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138231303|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
138427063|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427064|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
138427065|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138427066|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427067|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138427068|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138427069|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427070|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427071|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427072|NCT01702389|Remifentanil|remifentanil|mesh-list
138427073|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138427074|NCT01702389|Narcotics|narcotics|mesh-ancestor
138427075|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427076|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427077|NCT01702389|Analgesics|analgesics|mesh-ancestor
138427078|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
138427079|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427080|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
138427081|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138427082|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427083|NCT01702506|Antacids|antacids|mesh-list
138427084|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427085|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138427086|NCT01702610|Temozolomide|temozolomide|mesh-list
138427087|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138197805|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138427088|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
138427089|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427090|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427091|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
138427092|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
138427093|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138427094|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138427095|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138427096|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427097|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138427098|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138427099|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
138427100|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138427101|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138427102|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427103|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
138427104|NCT01702636|Coagulants|coagulants|mesh-ancestor
138427105|NCT01702649|Biapenem|biapenem|mesh-list
138427106|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138231330|NCT04715568|Losartan|losartan|mesh-list
138427107|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
138427108|NCT01702688|Giapreza|giapreza|mesh-list
138427109|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
138427110|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138427111|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138427112|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
138427113|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427114|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427115|NCT01702701|Fluticasone|fluticasone|mesh-list
138427116|NCT01702701|Montelukast|montelukast|mesh-list
138427117|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138427118|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138427119|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
138427120|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427121|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427122|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138427123|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
138427124|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
138427125|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138427126|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138427127|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
138427128|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138427129|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138427130|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138427131|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427132|NCT01702714|Paclitaxel|paclitaxel|mesh-list
138427134|NCT01702714|Gemcitabine|gemcitabine|mesh-list
138427135|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138427136|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427137|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
138427138|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
138427139|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
138427140|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427141|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138427142|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
138427143|NCT01702792|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138427144|NCT01702792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138427145|NCT01702792|Immunologic Factors|immunologic factors|mesh-ancestor
138197818|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138197819|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138427146|NCT01702792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427147|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138427149|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
138427150|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
138427151|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427152|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138427153|NCT01702857|Antacids|antacids|mesh-ancestor
138427154|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427155|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138427156|NCT01702974|Vitamin D|vitamin d|mesh-list
138427157|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
138427158|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138427159|NCT01702974|Vitamins|vitamins|mesh-ancestor
138231355|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
138231358|NCT04421339|Melatonin|melatonin|mesh-list
138427160|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
138427161|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427162|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138427163|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138427164|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427165|NCT01703104|Folic Acid|folic acid|mesh-list
138427166|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
138427167|NCT01703104|Proguanil|proguanil|mesh-list
138427168|NCT01703104|Hematinics|hematinics|mesh-ancestor
138427169|NCT01703104|Vitamins|vitamins|mesh-ancestor
138427170|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
138427171|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427172|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
138427173|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138427174|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138427175|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427176|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
138427177|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427179|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
138427180|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
138427181|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427182|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427183|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
138427184|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427185|NCT01703234|Ramipril|ramipril|mesh-list
138427186|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138427187|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
138427188|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427189|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427190|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138427191|NCT01703312|Omalizumab|omalizumab|mesh-list
138427192|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138394401|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
138427193|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138427194|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
138427195|NCT01703325|Triamcinolone|triamcinolone|mesh-list
138427196|NCT01703325|Clobetasol|clobetasol|mesh-list
138427197|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138427198|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
138427199|NCT01703325|Hormones|hormones|mesh-ancestor
138427200|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138427201|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427202|NCT01703351|Fentanyl|fentanyl|mesh-list
138427203|NCT01703351|Ropivacaine|ropivacaine|mesh-list
138427204|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
138427205|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
138427206|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427207|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427208|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
138427209|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138331119|NCT04002011|Warfarin|warfarin|mesh-list
138427210|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138427211|NCT01703351|Narcotics|narcotics|mesh-ancestor
138427212|NCT01703351|Analgesics|analgesics|mesh-ancestor
138427213|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138427214|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138427215|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
138427216|NCT01703364|Lenalidomide|lenalidomide|mesh-list
138427217|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
138427218|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427219|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138427220|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138427221|NCT01703364|Growth Substances|growth substances|mesh-ancestor
138427222|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
138427223|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427225|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138427226|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427227|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
138427228|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
138427229|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138427230|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138427231|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138362075|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
138427232|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427233|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138427234|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138427235|NCT01703559|Phentolamine|phentolamine|mesh-list
138427236|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138427237|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138427238|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138427239|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138427240|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
138427241|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138427242|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427243|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427244|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138427245|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
138427247|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
138427248|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138427249|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138427250|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138427251|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
138427252|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138427253|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427254|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427255|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138427257|NCT01703637|Saxagliptin|saxagliptin|mesh-list
138427258|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138427259|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427260|NCT01703637|Incretins|incretins|mesh-ancestor
138427262|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138427263|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138231402|NCT04108039|Cetrorelix|cetrorelix|mesh-list
138427264|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
138427265|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427266|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427267|NCT01703728|Menotropins|menotropins|mesh-list
138427268|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138427269|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
138427270|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138427271|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427272|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
138427274|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138427275|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
138427276|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427277|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427278|NCT01703910|Paclitaxel|paclitaxel|mesh-list
138427279|NCT01703910|Etoposide|etoposide|mesh-list
138427280|NCT01703910|Vinorelbine|vinorelbine|mesh-list
138427281|NCT01703910|Docetaxel|docetaxel|mesh-list
138427282|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138427283|NCT01703910|Cisplatin|cisplatin|mesh-list
138427284|NCT01703910|Gemcitabine|gemcitabine|mesh-list
138197841|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138197842|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138427285|NCT01703910|Doxorubicin|doxorubicin|mesh-list
138427286|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138427287|NCT01703910|Capecitabine|capecitabine|mesh-list
138427288|NCT01703910|Fluorouracil|fluorouracil|mesh-list
138427289|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
138427290|NCT01703910|Irinotecan|irinotecan|mesh-list
138427291|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
138427292|NCT01703910|Pemetrexed|pemetrexed|mesh-list
138427293|NCT01703910|Cetuximab|cetuximab|mesh-list
138427294|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138427295|NCT01703910|Sorafenib|sorafenib|mesh-list
138427296|NCT01703910|Topotecan|topotecan|mesh-list
138427297|NCT01703910|Dasatinib|dasatinib|mesh-list
138427298|NCT01703910|Mitomycins|mitomycins|mesh-list
138427299|NCT01703910|Mitomycin|mitomycin|mesh-list
138427300|NCT01703910|Raltitrexed|raltitrexed|mesh-list
138427301|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138427302|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427303|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
138427304|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
138427305|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
138427306|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427307|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138427308|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
138427309|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138427310|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138427311|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138427312|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138231429|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427313|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138427314|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
138427315|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427316|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138427317|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138427318|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138427319|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138427320|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138427321|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
138427323|NCT01704027|Hormones|hormones|mesh-ancestor
138427324|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138427325|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427326|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
138427327|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138362287|NCT03403452|Apatinib|apatinib|mesh-list
138427328|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427329|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427330|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138427332|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
138427333|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427334|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138427335|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138427336|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138427337|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
138427338|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138427339|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427340|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138427341|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138427342|NCT01704339|Capsaicin|capsaicin|mesh-list
138427343|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
138427344|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
138427345|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
138427346|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427347|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427348|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
138427349|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
138427350|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138427351|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427352|NCT01704417|Insulin|insulin|mesh-list
138427353|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138427354|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
138427355|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138427356|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427357|NCT01704469|Anesthetics|anesthetics|mesh-list
138427358|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
138427359|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427360|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427361|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
138427362|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427363|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
138427364|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138427365|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
138427366|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427367|NCT01704482|Expectorants|expectorants|mesh-ancestor
138427368|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
138231461|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
138427369|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138427370|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
138427371|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427372|NCT01704482|Protective Agents|protective agents|mesh-ancestor
138427373|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427374|NCT01704482|Antidotes|antidotes|mesh-ancestor
138427375|NCT01704508|Lumefantrine|lumefantrine|mesh-list
138427377|NCT01704508|Piperaquine|piperaquine|mesh-list
138427378|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138427379|NCT01704508|Artenimol|artenimol|mesh-list
138427380|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
138427381|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138427382|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138427383|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427384|NCT01704534|Ustekinumab|ustekinumab|mesh-list
138427385|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
138427386|NCT01704612|Ropivacaine|ropivacaine|mesh-list
138427387|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
138427388|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
138427389|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427390|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427391|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
138427392|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427393|NCT01704638|Digoxin|digoxin|mesh-list
138427394|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
138427395|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138427396|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138427397|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427398|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427399|NCT01704638|Protective Agents|protective agents|mesh-ancestor
138427400|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427401|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138427402|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138427403|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427404|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138427405|NCT01704638|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138427406|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138427407|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138427408|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138427409|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
138427410|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138427411|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
138427412|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138427413|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138231499|NCT03524937|Melatonin|melatonin|mesh-list
138427415|NCT01704690|Paclitaxel|paclitaxel|mesh-list
138427416|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138427417|NCT01704690|Cisplatin|cisplatin|mesh-list
138427418|NCT01704690|Fluorouracil|fluorouracil|mesh-list
138427419|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138427420|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427421|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
138427422|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
138427423|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
138427424|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427425|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
138427426|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138427427|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138427428|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
138427429|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427430|NCT01704703|Panitumumab|panitumumab|mesh-list
138427431|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138427432|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427433|NCT01704716|Aldesleukin|aldesleukin|mesh-list
138427434|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
138427435|NCT01704716|Melphalan|melphalan|mesh-list
138427436|NCT01704716|Busulfan|busulfan|mesh-list
138427437|NCT01704716|Carboplatin|carboplatin|mesh-list
138427438|NCT01704716|Doxorubicin|doxorubicin|mesh-list
138427439|NCT01704716|Etoposide|etoposide|mesh-list
138427440|NCT01704716|Vincristine|vincristine|mesh-list
138427441|NCT01704716|Interleukin-2|interleukin-2|mesh-list
138427442|NCT01704716|Dinutuximab|dinutuximab|mesh-list
138362559|NCT02244294|Tamsulosin|tamsulosin|mesh-list
138427444|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
138427445|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427446|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138427447|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138427448|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
138427449|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427450|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427451|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138427452|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138427453|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138427454|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138427455|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427456|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138427457|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
138427458|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
138427459|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
138427460|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138427461|NCT01704716|Analgesics|analgesics|mesh-ancestor
138427462|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
138427463|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427464|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138427465|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138427466|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
138427467|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427468|NCT01704794|Folic Acid|folic acid|mesh-list
138427469|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
138427470|NCT01704794|Proguanil|proguanil|mesh-list
138427471|NCT01704794|Hematinics|hematinics|mesh-ancestor
138427472|NCT01704794|Vitamins|vitamins|mesh-ancestor
138427473|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
138362662|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138427474|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427475|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
138427476|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138427477|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138427478|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427479|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
138427480|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427481|NCT01704872|Dinutuximab|dinutuximab|mesh-list
138427482|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427483|NCT01704898|Efavirenz|efavirenz|mesh-list
138427484|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138427485|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138427486|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138282875|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427487|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427488|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
138427489|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427490|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138427491|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138427492|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138427493|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138427494|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138427495|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138427496|NCT01705002|Bevacizumab|bevacizumab|mesh-list
138427497|NCT01705002|Capecitabine|capecitabine|mesh-list
138394749|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138427498|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138427499|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427500|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138362721|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
138427501|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138427502|NCT01705002|Growth Substances|growth substances|mesh-ancestor
138427503|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427504|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
138427505|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138427507|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427509|NCT01705041|Hematinics|hematinics|mesh-ancestor
138427510|NCT01705223|Vaccines|vaccines|mesh-list
138427511|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
138427512|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427513|NCT01705249|Norethindrone|norethindrone|mesh-list
138427514|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
138427515|NCT01705249|Estradiol|estradiol|mesh-list
138427516|NCT01705249|Estrogens|estrogens|mesh-ancestor
138427517|NCT01705249|Hormones|hormones|mesh-ancestor
138427518|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138427519|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427520|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138427521|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
138427522|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138427523|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138427524|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138427525|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138427526|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138427527|NCT01705314|Vitamin D|vitamin d|mesh-list
138427528|NCT01705314|Vitamins|vitamins|mesh-ancestor
138427529|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
138427530|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427531|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138427532|NCT01705340|Trastuzumab|trastuzumab|mesh-list
138427533|NCT01705340|Lapatinib|lapatinib|mesh-list
138427534|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138427535|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427536|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138394793|NCT01522989|Fluorouracil|fluorouracil|mesh-list
138427537|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427538|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427539|NCT01705379|Lactitol|lactitol|mesh-list
138427540|NCT01705379|Cathartics|cathartics|mesh-ancestor
138427541|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138427542|NCT01705392|Bevacizumab|bevacizumab|mesh-list
138427543|NCT01705392|Dacarbazine|dacarbazine|mesh-list
138427544|NCT01705392|Propranolol|propranolol|mesh-list
138427545|NCT01705392|Enalapril|enalapril|mesh-list
138427546|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138427547|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427548|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138427549|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138427550|NCT01705392|Growth Substances|growth substances|mesh-ancestor
138427551|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197876|NCT00002044|Zidovudine|zidovudine|mesh-list
138197877|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
138197878|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427552|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
138427553|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138427554|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138427555|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
138427556|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138427557|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427558|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138427559|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138427560|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
138427561|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138427562|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
138427563|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138427564|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
138427565|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427566|NCT01705457|Vitamin A|vitamin a|mesh-list
138427567|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
138427568|NCT01705457|Vitamins|vitamins|mesh-ancestor
138427569|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
138427570|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427571|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
138427572|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427573|NCT01705457|Protective Agents|protective agents|mesh-ancestor
138427574|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138427575|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427576|NCT01705470|Furosemide|furosemide|mesh-list
138427577|NCT01705470|Diuretics|diuretics|mesh-ancestor
138427578|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
138427579|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427580|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138427581|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138427582|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427583|NCT01705483|Paclitaxel|paclitaxel|mesh-list
138427584|NCT01705483|Docetaxel|docetaxel|mesh-list
138427585|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138427586|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427587|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
138427588|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
138427589|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
138427590|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427591|NCT01705639|Melatonin|melatonin|mesh-list
138427592|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
138427593|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427594|NCT01705639|Protective Agents|protective agents|mesh-ancestor
138427595|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427596|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427597|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
138427598|NCT01705743|Sevoflurane|sevoflurane|mesh-list
138427599|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138394938|NCT01523431|Protective Agents|protective agents|mesh-ancestor
138427600|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138427601|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
138427602|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
138427603|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427604|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427605|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138427606|NCT01705743|Analgesics|analgesics|mesh-ancestor
138427607|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
138197880|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138427608|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427609|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138427610|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138427611|NCT01705769|Micronutrients|micronutrients|mesh-list
138427612|NCT01705769|Trace Elements|trace elements|mesh-list
138427613|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427614|NCT01705795|Antibodies|antibodies|mesh-list
138427615|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
138362974|NCT03029676|Midazolam|midazolam|mesh-list
138427616|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427617|NCT01705808|Protein C|protein c|mesh-list
138427618|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
138427619|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138427620|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138427621|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427622|NCT01705938|Dolcanatide|dolcanatide|mesh-list
138427623|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138427624|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
138427625|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427626|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138427627|NCT01705951|Nicotine|nicotine|mesh-list
138427628|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138427629|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
138427630|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427631|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427632|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138427633|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138427634|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
138363024|NCT03839160|Analgesics|analgesics|mesh-ancestor
138427635|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138427636|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427637|NCT01706055|Interferons|interferons|mesh-list
138427638|NCT01706055|Interferon-beta|interferon-beta|mesh-list
138427639|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
138427640|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427641|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
138427642|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427643|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
138427644|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427645|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138427646|NCT01706172|Lidocaine|lidocaine|mesh-list
138427647|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
138427649|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427650|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427651|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
138427652|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427653|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138427654|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138427655|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138427656|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138427657|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427658|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
138427659|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138427660|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427662|NCT01706315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138427663|NCT01706315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427664|NCT01706315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427665|NCT01706315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427666|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138427667|NCT01706354|Anesthetics|anesthetics|mesh-list
138427668|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
138427669|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427670|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427671|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
138427672|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427673|NCT01706367|Vaccines|vaccines|mesh-list
138427674|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
138427675|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427676|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
138427677|NCT01706471|Everolimus|everolimus|mesh-list
138427678|NCT01706471|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138427679|NCT01706471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138427680|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427681|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427682|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138427683|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
138427684|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427685|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427686|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138427687|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138427688|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
138427689|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138427690|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427691|NCT01706510|Clopidogrel|clopidogrel|mesh-list
138427692|NCT01706510|Ticagrelor|ticagrelor|mesh-list
138427693|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138427694|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138427695|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138427696|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138427697|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
138427698|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138427699|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427700|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427701|NCT01706562|Itraconazole|itraconazole|mesh-list
138231650|NCT02620865|Analgesics|analgesics|mesh-ancestor
138427703|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427704|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138427705|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138427706|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395065|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138427707|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427708|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138427709|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
138427710|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138427711|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427712|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138427714|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
138427715|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427716|NCT01706627|Protective Agents|protective agents|mesh-ancestor
138427717|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427718|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427719|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
138427720|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138331407|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
138427721|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427722|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138427723|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138427724|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427725|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427726|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427727|NCT01706874|Listerine|listerine|mesh-list
138427728|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138427729|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427730|NCT01706887|Amiloride|amiloride|mesh-list
138427731|NCT01706887|Diuretics|diuretics|mesh-ancestor
138427732|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
138427733|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427734|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138427735|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138197909|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427736|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138427737|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395165|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
138427738|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138427739|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138427740|NCT01707082|Midazolam|midazolam|mesh-list
138427741|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138427742|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138427743|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427744|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427745|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138427746|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138427747|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138427748|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138427749|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
138427750|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
138386742|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
138427751|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
138427752|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
138427753|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138427754|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427755|NCT01707134|Insulin|insulin|mesh-list
138427756|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138427757|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
138427758|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
138427759|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
138427760|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
138427761|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138427762|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427763|NCT01707160|Insulin|insulin|mesh-list
138427764|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138427765|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
138427766|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
138427767|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138427768|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138427769|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427770|NCT01707199|Artesunate|artesunate|mesh-list
138427771|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
138427772|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
138427773|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138427774|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
138427775|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138427776|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138427777|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427778|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427779|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
138427780|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
138427781|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138427782|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
138427783|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138427784|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427785|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427786|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138427787|NCT01707251|Ibuprofen|ibuprofen|mesh-list
138427788|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138427789|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138427790|NCT01707251|Analgesics|analgesics|mesh-ancestor
138427791|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
138427792|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427793|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427794|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138363399|NCT05543837|Capsaicin|capsaicin|mesh-list
138197917|NCT00000400|Teriparatide|teriparatide|mesh-list
138427795|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138427796|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138427797|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427798|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427799|NCT01707316|Canagliflozin|canagliflozin|mesh-list
138427800|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138427801|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427802|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138427803|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427805|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
138427806|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427807|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
138427808|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427809|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427810|NCT01707394|Apixaban|apixaban|mesh-list
138427811|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138427812|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
138427813|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138427814|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
138427815|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427816|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427817|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
138427818|NCT01707407|Ketoconazole|ketoconazole|mesh-list
138427819|NCT01707407|Pomalidomide|pomalidomide|mesh-list
138427820|NCT01707407|Carbamazepine|carbamazepine|mesh-list
138427821|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
138427822|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
138427823|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427824|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138427825|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138427826|NCT01707407|Growth Substances|growth substances|mesh-ancestor
138386814|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138427827|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
138427828|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427829|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
138427830|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427831|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138427832|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138427833|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427834|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427835|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138427836|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
138427837|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138427838|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138427839|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
138427840|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
138427841|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138427842|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427844|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138427846|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
138427847|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427848|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138427849|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138427850|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138427851|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138427852|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138427853|NCT01707407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138197930|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138197931|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
138427854|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138427855|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138427856|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
138427857|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138427858|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
138427859|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138427860|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138427862|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
138427863|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427864|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
138427865|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
138427866|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427867|NCT01707615|Protective Agents|protective agents|mesh-ancestor
138427868|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427869|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138427870|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138427871|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427874|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138427875|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138427876|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427877|NCT01707745|Bevacizumab|bevacizumab|mesh-list
138427878|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138427879|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427880|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138427881|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138427882|NCT01707745|Growth Substances|growth substances|mesh-ancestor
138427883|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427884|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
138427885|NCT01707823|Aspirin|aspirin|mesh-list
138427886|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138427887|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138427888|NCT01707823|Analgesics|analgesics|mesh-ancestor
138427889|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
138427890|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427891|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427892|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138427893|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138427894|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138427895|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138427896|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427897|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138427898|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138427899|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427900|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
138427901|NCT01707849|Everolimus|everolimus|mesh-list
138427902|NCT01707849|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138395381|NCT06051370|Hormones|hormones|mesh-ancestor
138427903|NCT01707849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138427904|NCT01707849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427905|NCT01707849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427906|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138427907|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
138197944|NCT00000412|Alendronate|alendronate|mesh-list
138197945|NCT00000412|Calcitriol|calcitriol|mesh-list
138197949|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138427908|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427909|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138427910|NCT01707940|Ketoconazole|ketoconazole|mesh-list
138427911|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
138427912|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427913|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138427914|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138427915|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427916|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427917|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138427918|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
138427919|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138427920|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427921|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138427923|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
138427924|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
138427925|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427926|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427927|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138427928|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138427929|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138427930|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138427931|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
138427932|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138427933|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427934|NCT01708005|Vitamin D|vitamin d|mesh-list
138427935|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
138427936|NCT01708005|Vitamins|vitamins|mesh-ancestor
138427937|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
138427938|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427939|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138427940|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138427941|NCT01708044|Pramlintide|pramlintide|mesh-list
138427942|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138427943|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427944|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
138427945|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138427946|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138427947|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427949|NCT01708239|Coagulants|coagulants|mesh-ancestor
138427950|NCT01708330|Lidocaine|lidocaine|mesh-list
138427951|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
138427952|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
138395425|NCT05973786|Sertraline|sertraline|mesh-list
138427953|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427954|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427955|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
138427956|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427957|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138427958|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138427959|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138427960|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138427961|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427962|NCT01708369|Aspirin|aspirin|mesh-list
138427963|NCT01708369|Ethanol|ethanol|mesh-list
138427964|NCT01708369|Oseltamivir|oseltamivir|mesh-list
138427965|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138427966|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138427967|NCT01708369|Analgesics|analgesics|mesh-ancestor
138427968|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
138427969|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427970|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427971|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138427972|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138427973|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138197968|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138427974|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138427975|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427976|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138427977|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138427978|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138427979|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
138427980|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138427981|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138427982|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427983|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
138427985|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
138427986|NCT01708447|Anesthetics|anesthetics|mesh-list
138395451|NCT05973786|GABA Agents|gaba agents|mesh-ancestor
138427987|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138427988|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138427989|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
138427990|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138427991|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138427992|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138427993|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138427994|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138427995|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138427996|NCT01708616|Risperidone|risperidone|mesh-list
138427997|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138427998|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
138427999|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428000|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428001|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428002|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138428003|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138428004|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428005|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138428006|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138428007|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
138428009|NCT01708642|Racepinephrine|racepinephrine|mesh-list
138428010|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
138428011|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138428012|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138428013|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
138428014|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428015|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428016|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428017|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138428018|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138428019|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
138331658|NCT04374006|Propolis|propolis|mesh-list
138428020|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428021|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138428022|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
138428024|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
138428025|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138428027|NCT01708707|Buprenorphine|buprenorphine|mesh-list
138428028|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138428029|NCT01708707|Narcotics|narcotics|mesh-ancestor
138428030|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428031|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428032|NCT01708707|Analgesics|analgesics|mesh-ancestor
138428033|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
138428034|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428035|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138428036|NCT01708720|Vaccines|vaccines|mesh-list
138428037|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
138197973|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138197974|NCT00380614|Lamivudine|lamivudine|mesh-list
138428038|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428039|NCT01708798|Eplerenone|eplerenone|mesh-list
138428040|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138428041|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
138428042|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138428043|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428044|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138428045|NCT01708798|Diuretics|diuretics|mesh-ancestor
138428046|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
138428047|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138428049|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138428050|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428051|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428052|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138428053|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
138428054|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
138428055|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
138428056|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138428057|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
138428058|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138428059|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
138428060|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428061|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428062|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
138428063|NCT01708876|Artesunate|artesunate|mesh-list
138428064|NCT01708876|Chloroquine|chloroquine|mesh-list
138428065|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138428066|NCT01708876|Primaquine|primaquine|mesh-list
138428067|NCT01708876|Mefloquine|mefloquine|mesh-list
138428068|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
138428069|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138428070|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138428071|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138428072|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428073|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
138363862|NCT03426904|Antidotes|antidotes|mesh-ancestor
138428075|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138428076|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
138428077|NCT01708876|Amebicides|amebicides|mesh-ancestor
138428078|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138428079|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138428080|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138428081|NCT01708876|Analgesics|analgesics|mesh-ancestor
138428082|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
138428083|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428084|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428085|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138428086|NCT01708876|Filaricides|filaricides|mesh-ancestor
138428087|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
138428088|NCT01709019|Vaccines|vaccines|mesh-list
138428089|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
138428090|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428091|NCT01709071|Vaccines|vaccines|mesh-list
138428092|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
138428093|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428094|NCT01709370|Letrozole|letrozole|mesh-list
138428095|NCT01709370|Palbociclib|palbociclib|mesh-list
138428096|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428097|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138428098|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138428099|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428100|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428101|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138428102|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
138428103|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138428104|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428105|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138428107|NCT01709630|Analgesics|analgesics|mesh-ancestor
138428108|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
138197984|NCT00000430|Estrogens|estrogens|mesh-list
138197985|NCT00000430|Progestins|progestins|mesh-list
138428109|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428110|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428111|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
138428112|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428113|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138428114|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
138428115|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138428116|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138428117|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428118|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138428119|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
138428120|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138387117|NCT01480765|Pregabalin|pregabalin|mesh-list
138428121|NCT01709656|Celecoxib|celecoxib|mesh-list
138428122|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138363965|NCT02689778|Pirfenidone|pirfenidone|mesh-list
138428123|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138428124|NCT01709656|Analgesics|analgesics|mesh-ancestor
138428125|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
138428126|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428127|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428128|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138428129|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138428130|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138428131|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138428132|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428133|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428134|NCT01709682|Amiodarone|amiodarone|mesh-list
138428135|NCT01709682|Flecainide|flecainide|mesh-list
138428136|NCT01709682|Sotalol|sotalol|mesh-list
138428137|NCT01709682|Propafenone|propafenone|mesh-list
138428138|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138428139|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
138428140|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138428141|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138282876|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428142|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428143|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138428144|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138428145|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138428146|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138364017|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
138428147|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138428148|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138428149|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138428150|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138428151|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138428152|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138428153|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
138428154|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428155|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428156|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
138428157|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
138428158|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428159|NCT01709760|Methotrexate|methotrexate|mesh-list
138428160|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138428161|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
138428162|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138428163|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197992|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
138198003|NCT01231399|Leucovorin|leucovorin|mesh-list
138428164|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138428165|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
138428166|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428167|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428168|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
138428169|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138395664|NCT05252429|Docetaxel|docetaxel|mesh-list
138428170|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138428171|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138428172|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
138428173|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138428174|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138428175|NCT01709825|Sulfalene|sulfalene|mesh-list
138428176|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138428177|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138428178|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
138428179|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138428180|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138428181|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
138428182|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138428183|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428184|NCT01709942|Cetrorelix|cetrorelix|mesh-list
138428185|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138428186|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
138428187|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138428188|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428189|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
138428190|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138428191|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
138428192|NCT01709955|Cathartics|cathartics|mesh-ancestor
138428193|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138428194|NCT01709994|Aspirin|aspirin|mesh-list
138428195|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138428196|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138428197|NCT01709994|Analgesics|analgesics|mesh-ancestor
138428198|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
138428199|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428200|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428201|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138428202|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138428203|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138428204|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138428205|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428206|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138428207|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138428208|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428210|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
138428211|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
138428212|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428213|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428214|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428215|NCT01710072|Aspirin|aspirin|mesh-list
138428216|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138428217|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138428218|NCT01710072|Analgesics|analgesics|mesh-ancestor
138428219|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
138428220|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428221|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428222|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138428223|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138428224|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138428225|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138428226|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428227|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138428228|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138428229|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428230|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
138428231|NCT01710163|Aripiprazole|aripiprazole|mesh-list
138428232|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
138428233|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138428234|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138428235|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138428236|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428237|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428238|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
138428240|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428241|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428242|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138428243|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138428245|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138428246|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138428247|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138428248|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138428249|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
138428250|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138428251|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
138428252|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138428253|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138428254|NCT01710228|Prednisolone|prednisolone|mesh-list
138364204|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
138428255|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
138428256|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138428257|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
138428258|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138428259|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
138428260|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
138428261|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428262|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428263|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138428264|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
138428265|NCT01710228|Hormones|hormones|mesh-ancestor
138428266|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138428267|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138428268|NCT01710228|Protective Agents|protective agents|mesh-ancestor
138428269|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138428270|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138387261|NCT01481519|Hormones|hormones|mesh-ancestor
138428271|NCT01710384|Betamethasone|betamethasone|mesh-list
138428272|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138428273|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
138428274|NCT01710384|Hormones|hormones|mesh-ancestor
138395803|NCT04784247|Lenvatinib|lenvatinib|mesh-list
138395822|NCT04597619|Analgesics|analgesics|mesh-ancestor
138428275|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138428276|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428277|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138428278|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
138428279|NCT01710462|Domperidone|domperidone|mesh-list
138428280|NCT01710462|Pantoprazole|pantoprazole|mesh-list
138428281|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138428282|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138428283|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138428284|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428285|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428286|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
138428287|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
138428289|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428290|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138428291|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
138198012|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
138428292|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428293|NCT01710488|Levofloxacin|levofloxacin|mesh-list
138428294|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
138428295|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138428296|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138428297|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138428298|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138428299|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138428300|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428301|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428302|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428303|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138428304|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138428305|NCT01710540|Metformin|metformin|mesh-list
138428306|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138428307|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428308|NCT01710553|Metformin|metformin|mesh-list
138428310|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428311|NCT01710566|Misoprostol|misoprostol|mesh-list
138428312|NCT01710566|Oxytocin|oxytocin|mesh-list
138428313|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
138428314|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138428315|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428316|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138428317|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
138428318|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138428319|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138428320|NCT01710592|Docetaxel|docetaxel|mesh-list
138428321|NCT01710592|Capecitabine|capecitabine|mesh-list
138428322|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
138428323|NCT01710592|Epirubicin|epirubicin|mesh-list
138428324|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428325|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
138428326|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
138428327|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
138428328|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428329|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138428330|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
138428331|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138428332|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138428333|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138428334|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428335|NCT01710631|Eszopiclone|eszopiclone|mesh-list
138428336|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138428337|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428338|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428339|NCT01710670|Ethanol|ethanol|mesh-list
138428340|NCT01710670|Brivaracetam|brivaracetam|mesh-list
138428341|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138428342|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138428343|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428344|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428345|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
138428346|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138428347|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138428349|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138428350|NCT01710696|Estrogens|estrogens|mesh-ancestor
138198026|NCT00002062|Spiramycin|spiramycin|mesh-list
138428351|NCT01710696|Hormones|hormones|mesh-ancestor
138395889|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
138428352|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138428353|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428354|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138428355|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
138364337|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428356|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138428357|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138428359|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
138428360|NCT01710722|Caffeine|caffeine|mesh-list
138428361|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138428362|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428363|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138428364|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428365|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428366|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138428367|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138428368|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
138428369|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428370|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
138428371|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
138428372|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428373|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138428374|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
138428375|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138428376|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138428377|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
138428378|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
138428379|NCT01710748|Everolimus|everolimus|mesh-list
138428380|NCT01710748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138428381|NCT01710748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138428382|NCT01710748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428383|NCT01710748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428384|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138428385|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
138428386|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428387|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428388|NCT01710826|Venglustat|venglustat|mesh-list
138428389|NCT01710826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428390|NCT01710826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428391|NCT01710904|Oxycodone|oxycodone|mesh-list
138428392|NCT01710904|Naloxone|naloxone|mesh-list
138428393|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138428394|NCT01710904|Narcotics|narcotics|mesh-ancestor
138428395|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428396|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428397|NCT01710904|Analgesics|analgesics|mesh-ancestor
138428398|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
138364441|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
138428399|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428400|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138428401|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
138428402|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138428403|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428404|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428405|NCT01711060|Oxytocin|oxytocin|mesh-list
138428406|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
138428407|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138428408|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428409|NCT01711073|Plerixafor|plerixafor|mesh-list
138428410|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138428411|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138428412|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
138428413|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198058|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138428414|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
138428415|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138428416|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
138428417|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428418|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428419|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138428420|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
138428421|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138428422|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138428423|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138428424|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
138428425|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428426|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428427|NCT01711112|Docetaxel|docetaxel|mesh-list
138428428|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428429|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
138428430|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
138428431|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
138428432|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428433|NCT01711125|Baclofen|baclofen|mesh-list
138428434|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138428435|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428436|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138428437|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428438|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138428439|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
138428440|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
138428441|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428442|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428443|NCT01711229|Acetaminophen|acetaminophen|mesh-list
138428444|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138428445|NCT01711229|Analgesics|analgesics|mesh-ancestor
138428446|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
138364565|NCT01386658|Icatibant|icatibant|mesh-list
138428447|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428448|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428449|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
138428450|NCT01711320|Omeprazole|omeprazole|mesh-list
138428451|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138428452|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138428453|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138428454|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428455|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428456|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
138428457|NCT01711437|Simethicone|simethicone|mesh-list
138428458|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
138428459|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
138428460|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138428461|NCT01711437|Citric Acid|citric acid|mesh-list
138428462|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
138428463|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138428464|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
138428465|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138428466|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
138428467|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
138428468|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428469|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
138428470|NCT01711437|Protective Agents|protective agents|mesh-ancestor
138428471|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428472|NCT01711437|Vitamins|vitamins|mesh-ancestor
138428473|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
138428474|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
138428475|NCT01711437|Emollients|emollients|mesh-ancestor
138428476|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
138428477|NCT01711437|Cathartics|cathartics|mesh-ancestor
138428478|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138428479|NCT01711437|Antacids|antacids|mesh-ancestor
138428480|NCT01711437|Laxatives|laxatives|mesh-ancestor
138428481|NCT01711463|Fluticasone|fluticasone|mesh-list
138428482|NCT01711463|Xhance|xhance|mesh-list
138428483|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138428484|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138428485|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
138428486|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428487|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428488|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138428489|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
138428490|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
138428491|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138428492|NCT01711476|Complement Factor H|complement factor h|mesh-list
138428493|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138428494|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138428495|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
138428496|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387486|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
138428497|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
138428498|NCT01711489|Isavuconazole|isavuconazole|mesh-list
138428499|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138428500|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428501|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138428502|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
138428503|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138428504|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138428505|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428506|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428507|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
138428508|NCT01711515|Cisplatin|cisplatin|mesh-list
138428509|NCT01711515|Ipilimumab|ipilimumab|mesh-list
138428510|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428511|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138428512|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138428513|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428515|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
138428516|NCT01711528|Bortezomib|bortezomib|mesh-list
138428517|NCT01711528|Ichthammol|ichthammol|mesh-list
138428518|NCT01711528|BB 1101|bb 1101|mesh-list
138428519|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138428520|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
138428521|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
138428522|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428523|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428525|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
138428526|NCT01711528|Hormones|hormones|mesh-ancestor
138428527|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138198068|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428528|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138428529|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428530|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
138428531|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198069|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138428532|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428533|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
138428534|NCT01711567|Tenofovir|tenofovir|mesh-list
138428535|NCT01711567|Entecavir|entecavir|mesh-list
138428536|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
138428537|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138428538|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138428539|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138428540|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428541|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428542|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138428543|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138428544|NCT01711593|Dimercaprol|dimercaprol|mesh-list
138428545|NCT01711593|Chelating Agents|chelating agents|mesh-ancestor
138428546|NCT01711593|Sequestering Agents|sequestering agents|mesh-ancestor
138428547|NCT01711593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428548|NCT01711671|Dexamethasone|dexamethasone|mesh-list
138428549|NCT01711671|Lenalidomide|lenalidomide|mesh-list
138428550|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138428551|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
138428552|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
138428553|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428554|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428555|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138428556|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
138428557|NCT01711671|Hormones|hormones|mesh-ancestor
138428558|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138428559|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138428560|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428561|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
138428562|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138428563|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138428564|NCT01711671|Growth Substances|growth substances|mesh-ancestor
138232117|NCT00003407|Amifostine|amifostine|mesh-list
138428565|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
138428566|NCT01711697|Paclitaxel|paclitaxel|mesh-list
138428567|NCT01711697|Carboplatin|carboplatin|mesh-list
138428568|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138428569|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428570|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
138428571|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
138428572|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
138428573|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428574|NCT01711723|Darapladib|darapladib|mesh-list
138364739|NCT01388088|Amiloride|amiloride|mesh-list
138428575|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138428576|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428577|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428578|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138428579|NCT01711749|Calcium|calcium|mesh-list
138428580|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138428581|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428582|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138428583|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138428584|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
138428585|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428586|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138428587|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138428588|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428589|NCT01711814|Peficitinib|peficitinib|mesh-list
138428590|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428591|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428592|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138428593|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
138428594|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396084|NCT03630042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138428595|NCT01711827|Isavuconazole|isavuconazole|mesh-list
138428596|NCT01711827|Prednisone|prednisone|mesh-list
138428597|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138428598|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
138428599|NCT01711827|Hormones|hormones|mesh-ancestor
138428600|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138428601|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428602|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138428603|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428604|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
138428605|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138428607|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
138428608|NCT01711905|Vitamins|vitamins|mesh-ancestor
138428609|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
138428610|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428611|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138428612|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138428613|NCT01711931|Everolimus|everolimus|mesh-list
138428614|NCT01711931|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138428615|NCT01711931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138428616|NCT01711931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428617|NCT01711931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428618|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138428619|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
138428620|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428621|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428622|NCT01711957|Liver Extracts|liver extracts|mesh-list
138428623|NCT01711957|Hematinics|hematinics|mesh-ancestor
138428624|NCT01711970|Paclitaxel|paclitaxel|mesh-list
138428625|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138428626|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428627|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
138428628|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
138428629|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
138428630|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428631|NCT01712100|Irbesartan|irbesartan|mesh-list
138428632|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138428633|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138428634|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138428635|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428636|NCT01712113|Irbesartan|irbesartan|mesh-list
138364873|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
138232192|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138428637|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138428638|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138428639|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138428640|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428641|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138428642|NCT01712126|Irbesartan|irbesartan|mesh-list
138428643|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138428644|NCT01712126|Diuretics|diuretics|mesh-ancestor
138428645|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
138428646|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428647|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138428648|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138428649|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428650|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138428651|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138428654|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138428655|NCT01712139|Diuretics|diuretics|mesh-ancestor
138428656|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
138428657|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428658|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138428659|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138428660|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428661|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138428662|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138428663|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
138428664|NCT01712295|Salicylates|salicylates|mesh-list
138428665|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138428666|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138428668|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
138428669|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428670|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332116|NCT04345848|Heparin|heparin|mesh-list
138428671|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138428672|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138428673|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138428674|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428675|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428676|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138428677|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
138428678|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
138428679|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
138428680|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138428681|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
138428682|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138428683|NCT01712321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138428684|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138364970|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428685|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138428686|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428687|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428688|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
138428689|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428690|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138428691|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138428692|NCT01712347|Bevacizumab|bevacizumab|mesh-list
138428693|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138428694|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428695|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138428696|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138428697|NCT01712347|Growth Substances|growth substances|mesh-ancestor
138428698|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428699|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
138428701|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
138428702|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138428703|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428704|NCT01712477|Midazolam|midazolam|mesh-list
138428706|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138428707|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428708|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428709|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138428710|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
138428711|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
138428712|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138428713|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138428714|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138428715|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138428716|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
138428717|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
138428718|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428719|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428720|NCT01710761|Caffeine|caffeine|mesh-list
138428721|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138387711|NCT01485211|Riboflavin|riboflavin|mesh-list
138428722|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428723|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138198106|NCT00001354|Interleukin-2|interleukin-2|mesh-list
138198107|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198108|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138198109|NCT00001354|Analgesics|analgesics|mesh-ancestor
138428724|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428725|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428726|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138428727|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138428728|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
138428729|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428730|NCT01712568|Ropinirole|ropinirole|mesh-list
138428731|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138428732|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138428733|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
138428734|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
138428735|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282877|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138428736|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428737|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428738|NCT01712646|Oxytocin|oxytocin|mesh-list
138428739|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
138428740|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138428741|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428742|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
138428743|NCT01712828|Promethazine|promethazine|mesh-list
138428744|NCT01712828|Sirolimus|sirolimus|mesh-list
138428745|NCT01712828|Quinidine|quinidine|mesh-list
138428746|NCT01712828|Lenalidomide|lenalidomide|mesh-list
138428747|NCT01712828|Temsirolimus|temsirolimus|mesh-list
138428748|NCT01712828|MTOR Inhibitors|mtor inhibitors|mesh-list
138428749|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
138428750|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428751|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138428752|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138428753|NCT01712828|Growth Substances|growth substances|mesh-ancestor
138428754|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
138428755|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428756|NCT01712828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138428757|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138232288|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138428758|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428759|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138428760|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138428761|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138428762|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138428763|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
138198112|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428764|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138428765|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138428766|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428767|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
138428768|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
138428769|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
138428770|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428771|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
138428772|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
138198114|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198115|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198116|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138198118|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
138198119|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198120|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198121|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198122|NCT00000454|Nicotine|nicotine|mesh-list
138198125|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198126|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428773|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138428774|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138428775|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
138428776|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
138428777|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428778|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138428779|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
138332241|NCT04340388|Tenofovir|tenofovir|mesh-list
138428780|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
138428781|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138396320|NCT00591851|Paclitaxel|paclitaxel|mesh-list
138428782|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138428783|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
138428784|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138428785|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
138428786|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138428787|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138428788|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138428789|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138428790|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
138428791|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138428792|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138428793|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138428794|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138428795|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138428796|NCT01712893|Goserelin|goserelin|mesh-list
138428797|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138428798|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428799|NCT01712919|Paclitaxel|paclitaxel|mesh-list
138428800|NCT01712919|Cetuximab|cetuximab|mesh-list
138428801|NCT01712919|Nedaplatin|nedaplatin|mesh-list
138428802|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138428803|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428804|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
138428805|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
138428806|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
138428807|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428808|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138428809|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
138428810|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138428811|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428812|NCT01712997|Bosentan|bosentan|mesh-list
138428813|NCT01712997|Iloprost|iloprost|mesh-list
138428814|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138428815|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138365224|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138428816|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428817|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138428818|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
138428819|NCT01713049|Alovudine|alovudine|mesh-list
138428820|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
138396341|NCT00336024|Calcium, Dietary|calcium, dietary|mesh-list
138428821|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138428822|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
138428823|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
138428824|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
138428825|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138428826|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428827|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
138428828|NCT01713101|Coagulants|coagulants|mesh-ancestor
138428829|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
138428830|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138428831|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138428832|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198128|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138428833|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138428834|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138198129|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
138428835|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428836|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198130|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428837|NCT01713127|Remifentanil|remifentanil|mesh-list
138428838|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138428839|NCT01713127|Narcotics|narcotics|mesh-ancestor
138428840|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428841|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428842|NCT01713127|Analgesics|analgesics|mesh-ancestor
138428843|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
138428844|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428845|NCT01713153|Misoprostol|misoprostol|mesh-list
138428846|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138428847|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
138428848|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138428849|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428850|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138428851|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138428852|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
138428853|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
138428854|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138428855|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138428857|NCT01713179|Expectorants|expectorants|mesh-ancestor
138428858|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
138428859|NCT01713218|Gemcitabine|gemcitabine|mesh-list
138396383|NCT00336024|Vitamins|vitamins|mesh-ancestor
138428860|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138428861|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
138428862|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428863|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428864|NCT01713231|Vitamin D|vitamin d|mesh-list
138428865|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
138428866|NCT01713231|Cholecalciferol|cholecalciferol|mesh-list
138428867|NCT01713231|Vitamins|vitamins|mesh-list
138428868|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
138332306|NCT04337268|Hormones|hormones|mesh-ancestor
138428869|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428870|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138188481|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428871|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138428872|NCT01713309|Lenograstim|lenograstim|mesh-list
138428873|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138428874|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
138428875|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428877|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
138428878|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138428879|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138428880|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428881|NCT01713387|Gemcitabine|gemcitabine|mesh-list
138232390|NCT01721603|Trametinib|trametinib|mesh-list
138428882|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138428883|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
138428884|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428885|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428886|NCT01713426|Pregabalin|pregabalin|mesh-list
138428887|NCT01713426|Capsaicin|capsaicin|mesh-list
138428888|NCT01713426|Analgesics|analgesics|mesh-ancestor
138428889|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
138428890|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428891|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428892|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
138428893|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138428894|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138428895|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428896|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138428897|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138198134|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198135|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138428898|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138198136|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
138198138|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138428899|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428900|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138428901|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
138428902|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
138428903|NCT01713556|Propranolol|propranolol|mesh-list
138428904|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138428905|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138428906|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
138428907|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428908|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428909|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428910|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138428911|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138365361|NCT01391598|Lidocaine|lidocaine|mesh-list
138428913|NCT01713647|Losartan|losartan|mesh-list
138428914|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138428915|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138428916|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138428917|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138428918|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428919|NCT01713725|Omalizumab|omalizumab|mesh-list
138232456|NCT01242644|Ketorolac|ketorolac|mesh-list
138428920|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138428921|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138428922|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
138428923|NCT01713738|Rituximab|rituximab|mesh-list
138428924|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138428925|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428926|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
138428927|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428928|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138428929|NCT01713777|Lamotrigine|lamotrigine|mesh-list
138428930|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
138396443|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
138428931|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138428932|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138428933|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428934|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138428935|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428936|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138428937|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138428938|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428939|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138428940|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138428941|NCT01713803|Buprenorphine|buprenorphine|mesh-list
138428942|NCT01713803|Naloxone|naloxone|mesh-list
138428943|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138428944|NCT01713803|Narcotics|narcotics|mesh-ancestor
138428945|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428946|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428947|NCT01713803|Analgesics|analgesics|mesh-ancestor
138428948|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
138428949|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138428951|NCT01713920|Amlodipine|amlodipine|mesh-list
138428952|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138428953|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138428954|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138428955|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428956|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138428957|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428958|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
138198144|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428959|NCT01713972|Dabrafenib|dabrafenib|mesh-list
138428960|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198146|NCT00000496|Dipyridamole|dipyridamole|mesh-list
138428961|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138428962|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428963|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428964|NCT01714011|Aripiprazole|aripiprazole|mesh-list
138428965|NCT01714011|Ziprasidone|ziprasidone|mesh-list
138428966|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
138428967|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138428968|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138428969|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138428970|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138428971|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138428972|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
138428973|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
138428974|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138428975|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428976|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138428977|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138428978|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
138428979|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138428980|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138428981|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138428982|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138428983|NCT01714037|Gemcitabine|gemcitabine|mesh-list
138428984|NCT01714037|Docetaxel|docetaxel|mesh-list
138428985|NCT01714037|Pemetrexed|pemetrexed|mesh-list
138396539|NCT01526161|Fluticasone|fluticasone|mesh-list
138428986|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138428987|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138428988|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
138428989|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138428990|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
138428991|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
138428992|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
138428993|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138428994|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138428995|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138428996|NCT01714089|Interferons|interferons|mesh-list
138428997|NCT01714089|Interferon-beta|interferon-beta|mesh-list
138428998|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
138428999|NCT01714089|RNS60|rns60|mesh-list
138429000|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429001|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
138429002|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429003|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
138429004|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429005|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138429006|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138429007|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138429008|NCT01714089|Analgesics|analgesics|mesh-ancestor
138429009|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
138429010|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429011|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138429012|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429013|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138429014|NCT01714102|Resveratrol|resveratrol|mesh-list
138429015|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
138232504|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429016|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429017|NCT01714102|Protective Agents|protective agents|mesh-ancestor
138429018|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429019|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429020|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138429021|NCT01714115|Aflibercept|aflibercept|mesh-list
138388040|NCT01486888|Insulin|insulin|mesh-list
138429022|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138429023|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138429024|NCT01714115|Growth Substances|growth substances|mesh-ancestor
138198154|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429025|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429026|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
138429027|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429028|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138429029|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138429031|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138429032|NCT01714128|Estrogens|estrogens|mesh-ancestor
138429033|NCT01714128|Hormones|hormones|mesh-ancestor
138429034|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138429035|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429036|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138429037|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
138429038|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138429039|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138429040|NCT01714154|Ritonavir|ritonavir|mesh-list
138429041|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138429042|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138429043|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
138429044|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396635|NCT01526525|Parecoxib|parecoxib|mesh-list
138429045|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429046|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138429047|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138429048|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
138429049|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429050|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138429051|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138429053|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
138429054|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
138429055|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138429056|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429057|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138429058|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429059|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138429060|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138429061|NCT01714206|Canagliflozin|canagliflozin|mesh-list
138429062|NCT01714206|Digoxin|digoxin|mesh-list
138429063|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138429064|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138429065|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429066|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429067|NCT01714206|Protective Agents|protective agents|mesh-ancestor
138429068|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429069|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138429070|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138429071|NCT01714297|Dalteparin|dalteparin|mesh-list
138429072|NCT01714297|Tinzaparin|tinzaparin|mesh-list
138429073|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138429074|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
138429075|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138429076|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138429077|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429078|NCT01714388|Remifentanil|remifentanil|mesh-list
138429079|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138429080|NCT01714388|Narcotics|narcotics|mesh-ancestor
138429081|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429082|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429083|NCT01714388|Analgesics|analgesics|mesh-ancestor
138429084|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
138429085|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429086|NCT01714401|Albuterol|albuterol|mesh-list
138429087|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138429088|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
138429089|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429090|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198162|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138198163|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
138198164|NCT00002086|Interferons|interferons|mesh-list
138198165|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
138198166|NCT00002086|Zidovudine|zidovudine|mesh-list
138429091|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138429092|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
138429093|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
138429094|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138396717|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138429095|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138429096|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138429097|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138429098|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
138429099|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429100|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429101|NCT01714414|Lamivudine|lamivudine|mesh-list
138429102|NCT01714414|Zidovudine|zidovudine|mesh-list
138429103|NCT01714414|Efavirenz|efavirenz|mesh-list
138429104|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138429105|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138429106|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138365901|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
138429107|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429108|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
138429109|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429110|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138429111|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138232554|NCT04343001|Analgesics|analgesics|mesh-ancestor
138429112|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
138429113|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138429114|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138429115|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138429116|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138429117|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138396766|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
138429118|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138429120|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138429121|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
138429122|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
138429123|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429124|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429125|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138429126|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
138429127|NCT01714427|Hormones|hormones|mesh-ancestor
138429128|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138429129|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138429130|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429131|NCT01714557|Tazobactam|tazobactam|mesh-list
138429132|NCT01714557|Piperacillin|piperacillin|mesh-list
138429133|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138429134|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138429135|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138365953|NCT01395069|Ketorolac|ketorolac|mesh-list
138429136|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138429137|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429138|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429140|NCT01714570|Piperacillin|piperacillin|mesh-list
138429141|NCT01714570|Imipenem|imipenem|mesh-list
138429142|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138429143|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138429144|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429145|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138429146|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429147|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429148|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138429149|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198170|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198171|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
138198172|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198173|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
138429150|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138429151|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
138429152|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138429153|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
138429154|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138429155|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429156|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138429157|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138429158|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429159|NCT01714765|Everolimus|everolimus|mesh-list
138429160|NCT01714765|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138429161|NCT01714765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138429162|NCT01714765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429163|NCT01714765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429164|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138429165|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
138429166|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429167|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429168|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
138429169|NCT01714817|Prednisone|prednisone|mesh-list
138429170|NCT01714817|Abatacept|abatacept|mesh-list
138429171|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138429172|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
138429173|NCT01714817|Hormones|hormones|mesh-ancestor
138429174|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138429175|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429176|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138429177|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429178|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138429179|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138429180|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
138429181|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138429182|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429183|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138366036|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
138429184|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429185|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138429186|NCT01714817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138429187|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138429188|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
138429189|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429190|NCT01714843|Linaclotide|linaclotide|mesh-list
138429191|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
138429192|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
138366096|NCT01395667|Protective Agents|protective agents|mesh-ancestor
138429193|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429194|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138429195|NCT01714856|Ropinirole|ropinirole|mesh-list
138429196|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138429197|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138429198|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
138429199|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
138429200|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138198177|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198178|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198179|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138342036|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138342037|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138342038|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
138342039|NCT01605942|Hormones|hormones|mesh-ancestor
138198182|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429201|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429202|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429203|NCT01714895|Insulin|insulin|mesh-list
138429204|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138429205|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138396921|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138429206|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429208|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138429209|NCT01714908|Cisplatin|cisplatin|mesh-list
138429210|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138429211|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429212|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138429213|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138429214|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429215|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429216|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138429217|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138429218|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138429219|NCT01715077|Ipilimumab|ipilimumab|mesh-list
138429220|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138429221|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429222|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138429223|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429224|NCT01715090|Insulin|insulin|mesh-list
138429225|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138396956|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
138429226|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429228|NCT01715142|Gemcitabine|gemcitabine|mesh-list
138429229|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138429230|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138429231|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429232|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
138429233|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
138429234|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
138429235|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429236|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138429237|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
138429238|NCT01715168|Doxorubicin|doxorubicin|mesh-list
138429239|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138429240|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138429241|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429242|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138429243|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138429244|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429245|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429246|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
138429247|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
138429248|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
138429249|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429250|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138429251|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429252|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429253|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
138397005|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429254|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138429256|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138429257|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
138429258|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138429259|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
138429260|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429261|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429262|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138198186|NCT00001384|Doxorubicin|doxorubicin|mesh-list
138198187|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138198188|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138198189|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429263|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
138429264|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
138429265|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138429266|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
138429267|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138282878|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138429268|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429270|NCT01715363|Folic Acid|folic acid|mesh-list
138429271|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
138429273|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429274|NCT01715363|Antidotes|antidotes|mesh-ancestor
138429275|NCT01715363|Protective Agents|protective agents|mesh-ancestor
138429276|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429277|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
138429278|NCT01715363|Vitamins|vitamins|mesh-ancestor
138429279|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
138429280|NCT01715363|Hematinics|hematinics|mesh-ancestor
138429281|NCT01715441|Irinotecan|irinotecan|mesh-list
138429282|NCT01715441|Sorafenib|sorafenib|mesh-list
138429283|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138429284|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138429285|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429286|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429287|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429288|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138429289|NCT01715493|Muramidase|muramidase|mesh-list
138429290|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429291|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138429292|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
138429293|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138429294|NCT01715519|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138366312|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138429295|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138429296|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138429297|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429298|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429299|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
138429300|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429301|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138429302|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138429303|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
138429304|NCT01715584|Sevoflurane|sevoflurane|mesh-list
138397098|NCT01528865|Tenofovir|tenofovir|mesh-list
138429305|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138429306|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138429307|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
138429309|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429310|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429311|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138232646|NCT05732181|Lidocaine|lidocaine|mesh-list
138429313|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
138429314|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429315|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
138429316|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
138366420|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
138429317|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429318|NCT01715597|Protective Agents|protective agents|mesh-ancestor
138429319|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429321|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
138429322|NCT01715610|Clindamycin|clindamycin|mesh-list
138429323|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
138429324|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
138429325|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138429326|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138198193|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198194|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138198195|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
138429327|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429328|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138429329|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429330|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429331|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138429333|NCT01715636|Emtricitabine|emtricitabine|mesh-list
138429334|NCT01715636|Rilpivirine|rilpivirine|mesh-list
138429335|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
138429336|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429337|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138429338|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138429339|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429340|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429341|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138429342|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138429343|NCT01715688|Lidocaine|lidocaine|mesh-list
138429344|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
138429345|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
138429346|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138366549|NCT06048809|Fluorides|fluorides|mesh-list
138429347|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429348|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
138429349|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429350|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138429351|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138429352|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138429353|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138429354|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429356|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138429357|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429358|NCT01715701|Trace Elements|trace elements|mesh-ancestor
138429359|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
138397273|NCT01529320|Hormones|hormones|mesh-ancestor
138429360|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429361|NCT01715909|Oseltamivir|oseltamivir|mesh-list
138429362|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
138429363|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429364|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429365|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429366|NCT01715922|Fluconazole|fluconazole|mesh-list
138429367|NCT01715922|Flucytosine|flucytosine|mesh-list
138429368|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
138429369|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429370|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138429371|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138429372|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429373|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429374|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138429375|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
138429376|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138429377|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429378|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138429379|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138198196|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429380|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
138429381|NCT01715935|Everolimus|everolimus|mesh-list
138429382|NCT01715935|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138282879|NCT03002012|Fluconazole|fluconazole|mesh-list
138429383|NCT01715935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138429384|NCT01715935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429385|NCT01715935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429386|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138429387|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
138429388|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429389|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429390|NCT01715987|Tenofovir|tenofovir|mesh-list
138429391|NCT01715987|Entecavir|entecavir|mesh-list
138429392|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
138429393|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429394|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138429395|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138429396|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429397|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429398|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138429399|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138429400|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138429401|NCT01716273|Laxatives|laxatives|mesh-ancestor
138429402|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138429403|NCT01716338|Glyburide|glyburide|mesh-list
138429404|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138429405|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429406|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138429407|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138429408|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138429409|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138429410|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429411|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429412|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429413|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138429414|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
138429415|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138429417|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138429418|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429420|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138429421|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429422|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
138429423|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429424|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429425|NCT01716572|Erythromycin|erythromycin|mesh-list
138429426|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
138429427|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138429428|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
138366835|NCT05312645|Analgesics|analgesics|mesh-ancestor
138429429|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138429430|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429431|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138429432|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138429433|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429434|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429435|NCT01716611|Tolvaptan|tolvaptan|mesh-list
138429436|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138429437|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429438|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
138429439|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429440|NCT01716624|Oxybutynin|oxybutynin|mesh-list
138429441|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
138429442|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138429443|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138429444|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138429445|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138397488|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
138429446|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429447|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
138429448|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429449|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429450|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138429451|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429452|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
138429453|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
138429454|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138232715|NCT00361803|Topotecan|topotecan|mesh-list
138429456|NCT01716624|Urological Agents|urological agents|mesh-ancestor
138198203|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138429458|NCT01716637|Curcumin|curcumin|mesh-list
138429459|NCT01716637|Resveratrol|resveratrol|mesh-list
138429460|NCT01716637|Quercetin|quercetin|mesh-list
138429461|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138429462|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138429463|NCT01716637|Analgesics|analgesics|mesh-ancestor
138429464|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
138429465|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388474|NCT01489488|Riociguat|riociguat|mesh-list
138429466|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429468|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429469|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138429470|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138429471|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
138429472|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429473|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429474|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429475|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
138429476|NCT01716637|Protective Agents|protective agents|mesh-ancestor
138429477|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138429478|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
138429479|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138429480|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
138429481|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429482|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429483|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138429484|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
138429485|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429486|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429487|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138429488|NCT01716767|Analgesics|analgesics|mesh-list
138429489|NCT01716767|Menthol|menthol|mesh-list
138429490|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
138429491|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138366953|NCT05007873|Dasatinib|dasatinib|mesh-list
138366954|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138366955|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
138366956|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138366957|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138366967|NCT04983901|Vancomycin|vancomycin|mesh-list
138429492|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429493|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
138429494|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
138429495|NCT01716858|Sulforaphane|sulforaphane|mesh-list
138429496|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138429497|NCT01716858|Protective Agents|protective agents|mesh-ancestor
138429498|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429499|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429500|NCT01716949|Capecitabine|capecitabine|mesh-list
138429501|NCT01716949|Fluorouracil|fluorouracil|mesh-list
138429502|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
138429503|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138429504|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
138429505|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429506|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429507|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138397583|NCT01531140|Bisacodyl|bisacodyl|mesh-list
138429508|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
138429509|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198213|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198214|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138198215|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
138198216|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198218|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138198219|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138198220|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138198222|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
138429510|NCT01717027|Oxycodone|oxycodone|mesh-list
138429511|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138429513|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429514|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429515|NCT01717027|Analgesics|analgesics|mesh-ancestor
138429516|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
138429517|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429518|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
138429519|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138429520|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429521|NCT01717118|Vaccines|vaccines|mesh-list
138429522|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
138429523|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429524|NCT01717157|Fentanyl|fentanyl|mesh-list
138429525|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138429526|NCT01717157|Narcotics|narcotics|mesh-ancestor
138429527|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429528|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429529|NCT01717157|Analgesics|analgesics|mesh-ancestor
138429530|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
138429531|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429532|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138429533|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138429534|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
138429535|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
138429536|NCT01717222|Lidocaine|lidocaine|mesh-list
138429537|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
138429538|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
138429539|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429540|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429541|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
138429542|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429543|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138429544|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138429545|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138429546|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138367106|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138429547|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429548|NCT01717235|Ropinirole|ropinirole|mesh-list
138429549|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138429550|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138429551|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
138429552|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
138429553|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429554|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429555|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429556|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
138429557|NCT01717300|Anacetrapib|anacetrapib|mesh-list
138429558|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138429559|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138429560|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
138429561|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429562|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138429563|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429564|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138429565|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429567|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138429568|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138429569|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138429570|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138429571|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429572|NCT01717599|Diclofenac|diclofenac|mesh-list
138429573|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138198223|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138198224|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198225|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429574|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138429575|NCT01717599|Analgesics|analgesics|mesh-ancestor
138429576|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
138429577|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429578|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138367215|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429579|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138429580|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429581|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138429582|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429583|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429584|NCT01717612|Thrombin|thrombin|mesh-list
138429585|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
138429586|NCT01717612|Coagulants|coagulants|mesh-ancestor
138429587|NCT01717625|Montelukast|montelukast|mesh-list
138429588|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138429589|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
138429590|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138429591|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
138367272|NCT03884439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138429592|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138429593|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429594|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138429595|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138429596|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429597|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
138429598|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138429599|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
138429600|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429601|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
138429602|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
138429603|NCT01717729|Iodine|iodine|mesh-list
138429604|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138429605|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429606|NCT01717729|Trace Elements|trace elements|mesh-ancestor
138429607|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
138429608|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429609|NCT01716260|Chloroquine|chloroquine|mesh-list
138429610|NCT01716260|Primaquine|primaquine|mesh-list
138429611|NCT01716260|Amebicides|amebicides|mesh-ancestor
138429612|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138429613|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138429614|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429615|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
138429616|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429617|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138429618|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429619|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138429620|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429621|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429623|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138429624|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429625|NCT01717846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138429626|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138367404|NCT03417284|Melphalan|melphalan|mesh-list
138429627|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138429628|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
138429629|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429630|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429631|NCT01717911|Metformin|metformin|mesh-list
138429632|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138198227|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138198228|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198229|NCT00002098|Didanosine|didanosine|mesh-list
138198230|NCT00002098|Lentinan|lentinan|mesh-list
138198231|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
138198232|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429633|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
138429634|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138429635|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429636|NCT01717911|Incretins|incretins|mesh-ancestor
138429637|NCT01717911|Hormones|hormones|mesh-ancestor
138429638|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138429639|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138429640|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
138429641|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429642|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429643|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138429644|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138429645|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
138429646|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429647|NCT01717950|Antacids|antacids|mesh-ancestor
138429648|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429649|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138429650|NCT01717963|Naltrexone|naltrexone|mesh-list
138397866|NCT01532960|Poly ICLC|poly iclc|mesh-list
138429651|NCT01717963|Buprenorphine|buprenorphine|mesh-list
138367460|NCT03195478|Nivolumab|nivolumab|mesh-list
138429652|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138429654|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138429655|NCT01717963|Narcotics|narcotics|mesh-ancestor
138429656|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429657|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429658|NCT01717963|Analgesics|analgesics|mesh-ancestor
138429659|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
138232795|NCT01746095|Vancomycin|vancomycin|mesh-list
138429660|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429661|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138429662|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138429664|NCT01718054|Amebicides|amebicides|mesh-ancestor
138429665|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138429666|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138429667|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429668|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
138429669|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429671|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138429672|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138429673|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429674|NCT01718093|Incretins|incretins|mesh-ancestor
138429675|NCT01718093|Hormones|hormones|mesh-ancestor
138429676|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138429677|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138429678|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
138429679|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429680|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429681|NCT01718223|Temoporfin|temoporfin|mesh-list
138429682|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429683|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138429684|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
138429686|NCT01718236|Succinylcholine|succinylcholine|mesh-list
138429687|NCT01718236|Neostigmine|neostigmine|mesh-list
138429688|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138429689|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138429690|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138429691|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429692|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138332987|NCT02989038|Nicotine|nicotine|mesh-list
138429693|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138429694|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429695|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429696|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
138429697|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429698|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138429699|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
138198233|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198234|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138429700|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138429702|NCT01718288|Iloprost|iloprost|mesh-list
138429703|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138429704|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138429705|NCT01718288|Analgesics|analgesics|mesh-ancestor
138429706|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
138429707|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429708|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138232827|NCT04425239|Hematinics|hematinics|mesh-ancestor
138429709|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138429710|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429711|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138429712|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138429713|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429714|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138429715|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138429716|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429718|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
138429719|NCT01718301|Ribavirin|ribavirin|mesh-list
138429720|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138429721|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138429722|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
138429723|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429724|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
138429725|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429727|NCT01718314|Misoprostol|misoprostol|mesh-list
138429728|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
138429729|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
138429730|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429731|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429732|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
138429733|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429734|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138429735|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138429736|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138429737|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138429738|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429739|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138429740|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
138429741|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138429742|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138429743|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138429744|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
138429746|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429747|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138429748|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138367667|NCT03283813|Inositol|inositol|mesh-list
138429749|NCT01718327|Growth Substances|growth substances|mesh-ancestor
138429750|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429751|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
138429752|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138429753|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429754|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429755|NCT01718340|Metformin|metformin|mesh-list
138429756|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138429757|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429758|NCT01718366|Vitamin D|vitamin d|mesh-list
138429759|NCT01718366|Azacitidine|azacitidine|mesh-list
138429760|NCT01718366|Deferasirox|deferasirox|mesh-list
138429761|NCT01718366|Vitamins|vitamins|mesh-ancestor
138429762|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
138429763|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429764|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138429765|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138198240|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138429767|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429768|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429769|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429770|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138429772|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
138429773|NCT01718379|Lenalidomide|lenalidomide|mesh-list
138429774|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
138429775|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429776|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138429777|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138429778|NCT01718379|Growth Substances|growth substances|mesh-ancestor
138429779|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
138429780|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429782|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138429783|NCT01718496|Narcotics|narcotics|mesh-ancestor
138429784|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429785|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429786|NCT01718496|Analgesics|analgesics|mesh-ancestor
138429787|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
138429788|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429789|NCT01718587|Lamivudine|lamivudine|mesh-list
138429790|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
138429791|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138429792|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138429793|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429794|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429795|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138398108|NCT01534169|Hormones|hormones|mesh-ancestor
138429797|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138429798|NCT01718613|Vasopressins|vasopressins|mesh-list
138429799|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
138429800|NCT01718613|Norepinephrine|norepinephrine|mesh-list
138429801|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138429802|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138429803|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
138429804|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429805|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429806|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429807|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
138429808|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
138429809|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138367811|NCT05274100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138429810|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138429811|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
138429812|NCT01718613|Coagulants|coagulants|mesh-ancestor
138429813|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138429814|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
138429815|NCT01718626|Docetaxel|docetaxel|mesh-list
138429816|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429817|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
138429818|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
138429819|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
138398153|NCT01534585|Paclitaxel|paclitaxel|mesh-list
138429820|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429821|NCT01718652|Canagliflozin|canagliflozin|mesh-list
138429822|NCT01718652|Cyclosporine|cyclosporine|mesh-list
138429823|NCT01718652|Cyclosporins|cyclosporins|mesh-list
138429824|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429825|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429826|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138429827|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
138429828|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429829|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
138429830|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138232872|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138198250|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
138198251|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
138429831|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
138429832|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429833|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138429834|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138429835|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138429837|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
138429838|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429839|NCT01718678|Protective Agents|protective agents|mesh-ancestor
138429840|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429841|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429842|NCT01718717|Morphine|morphine|mesh-list
138429843|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138429845|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429846|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429847|NCT01718717|Analgesics|analgesics|mesh-ancestor
138429848|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
138429849|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429850|NCT01718808|Capecitabine|capecitabine|mesh-list
138429851|NCT01718808|Cetuximab|cetuximab|mesh-list
138429852|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138429853|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
138429854|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429855|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429856|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138429857|NCT01718834|Vaccines|vaccines|mesh-list
138429858|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
138429859|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429860|NCT01718899|Lenalidomide|lenalidomide|mesh-list
138429861|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
138429862|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429863|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138429864|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138429865|NCT01718899|Growth Substances|growth substances|mesh-ancestor
138429866|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
138429867|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429868|NCT01718912|Metronidazole|metronidazole|mesh-list
138429869|NCT01718912|Nystatin|nystatin|mesh-list
138429870|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138429871|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138429873|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138429874|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
138429875|NCT01718912|Ionophores|ionophores|mesh-ancestor
138429876|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138429877|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138232894|NCT01346072|Tolvaptan|tolvaptan|mesh-list
138429879|NCT01718951|Golimumab|golimumab|mesh-list
138429880|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138429881|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138429882|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138429883|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
138429884|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138368106|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
138429885|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138429887|NCT01718964|Mannitol|mannitol|mesh-list
138429888|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138429889|NCT01718964|Diuretics|diuretics|mesh-ancestor
138429890|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
138429891|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429892|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138429893|NCT01719042|Ondansetron|ondansetron|mesh-list
138429894|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
138429895|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
138198259|NCT00001426|Paclitaxel|paclitaxel|mesh-list
138198260|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
138198261|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138198262|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198263|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
138198264|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
138429896|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429897|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429898|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138429899|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
138429900|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
138429901|NCT01719042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138429902|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138429903|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
138429904|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429905|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429906|NCT01719133|Histamine|histamine|mesh-list
138429907|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
138429908|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
138429909|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
138429910|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429911|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429912|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429913|NCT01719159|Rituximab|rituximab|mesh-list
138429914|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138429915|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429916|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
138429917|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429918|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138429919|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
138429920|NCT01719185|Phentermine|phentermine|mesh-list
138429921|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138429922|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429923|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
138232911|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
138429924|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138429925|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
138429926|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
138429927|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429928|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
138429929|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429930|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429931|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
138429932|NCT01719185|Vitamins|vitamins|mesh-ancestor
138429933|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
138368238|NCT04886284|Ertapenem|ertapenem|mesh-list
138398415|NCT01536132|Simendan|simendan|mesh-list
138429935|NCT01719302|Docetaxel|docetaxel|mesh-list
138429936|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138429937|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
138429938|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429939|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138429940|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
138429941|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
138429942|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
138429943|NCT01719419|Orlistat|orlistat|mesh-list
138429944|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429945|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429946|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138429948|NCT01719588|Tapentadol|tapentadol|mesh-list
138429949|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138429950|NCT01719588|Narcotics|narcotics|mesh-ancestor
138429951|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429952|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429953|NCT01719588|Analgesics|analgesics|mesh-ancestor
138429954|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
138429955|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429956|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138429957|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138429958|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138429959|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429960|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
138429961|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429963|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138429964|NCT01719601|Narcotics|narcotics|mesh-ancestor
138232943|NCT05343429|Antipyretics|antipyretics|mesh-ancestor
138429965|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138429966|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429967|NCT01719601|Analgesics|analgesics|mesh-ancestor
138429968|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
138429969|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138429970|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138429971|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138429972|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138429973|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429974|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
138429975|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138429976|NCT01719614|Metformin|metformin|mesh-list
138429977|NCT01719614|Rilpivirine|rilpivirine|mesh-list
138429978|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138429979|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138429980|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138429981|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138429982|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138429983|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429984|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
138429985|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138368393|NCT04245644|Analgesics|analgesics|mesh-ancestor
138429987|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138429989|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138429990|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138429991|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138429992|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138429993|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138429994|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
138429995|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138388997|NCT01492166|Insulin|insulin|mesh-list
138429996|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138429998|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138429999|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430000|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
138430001|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430002|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138430003|NCT01719705|Pregabalin|pregabalin|mesh-list
138430004|NCT01719705|Analgesics|analgesics|mesh-ancestor
138430005|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
138430006|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430007|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430008|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
138430009|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138430010|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138430011|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430012|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138430013|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138430014|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138430015|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138430016|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138430017|NCT01719770|Rocuronium|rocuronium|mesh-list
138430018|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138430019|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138398553|NCT01536717|Carticaine|carticaine|mesh-list
138430020|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138430021|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430022|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430023|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
138430025|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
138430026|NCT01719835|Gemcitabine|gemcitabine|mesh-list
138430027|NCT01719835|Doxorubicin|doxorubicin|mesh-list
138430028|NCT01719835|Vincristine|vincristine|mesh-list
138430029|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138430030|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
138430031|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430032|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138430033|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138430034|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
138430035|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430036|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430037|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138430038|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138430039|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
138430040|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138430041|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138430042|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138333155|NCT02973204|Everolimus|everolimus|mesh-list
138430043|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430044|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138430045|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
138430046|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
138430047|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
138430048|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138430049|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
138430050|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
138430051|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430052|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138430053|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
138430054|NCT01719835|Hormones|hormones|mesh-ancestor
138430055|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138430056|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138430057|NCT01719835|Protective Agents|protective agents|mesh-ancestor
138232995|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
138430058|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138430059|NCT01719926|Indomethacin|indomethacin|mesh-list
138430060|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138430061|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138430062|NCT01719926|Analgesics|analgesics|mesh-ancestor
138430063|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
138430064|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430065|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430066|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138398653|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
138430067|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138430068|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
138430069|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
138430070|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138430071|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138430072|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430073|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430075|NCT01719952|Carbetocin|carbetocin|mesh-list
138430076|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
138430077|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138198296|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198297|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430078|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430079|NCT01719978|Epinephrine|epinephrine|mesh-list
138430080|NCT01719978|Racepinephrine|racepinephrine|mesh-list
138430081|NCT01719978|Mepivacaine|mepivacaine|mesh-list
138430082|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
138430083|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138430084|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138430085|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
138430086|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138430087|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430088|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430089|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138430090|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138430092|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430093|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138430094|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
138430095|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
138430096|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
138430097|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138430098|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
138430099|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
138430100|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138430101|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
138430102|NCT01720459|Resveratrol|resveratrol|mesh-list
138430103|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
138430104|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430105|NCT01720459|Protective Agents|protective agents|mesh-ancestor
138430106|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430107|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430108|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138430109|NCT01720537|Bococizumab|bococizumab|mesh-list
138430110|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138430111|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138430112|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138430113|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
138430114|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430115|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138430116|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
138430117|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430119|NCT01720719|Atorvastatin|atorvastatin|mesh-list
138430120|NCT01720719|Vitamins|vitamins|mesh-ancestor
138430121|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
138430122|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430123|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138430124|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138430125|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
138430126|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430127|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138430128|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138430129|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430130|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
138430131|NCT01720719|Protective Agents|protective agents|mesh-ancestor
138430132|NCT01722214|Adalimumab|adalimumab|mesh-list
138430133|NCT01722214|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138430135|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138430136|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
138430137|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
138430138|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138430139|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138430140|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430141|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430142|NCT01723852|Vitamin D|vitamin d|mesh-list
138430143|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
138430144|NCT01723852|Cholecalciferol|cholecalciferol|mesh-list
138430145|NCT01723852|Vitamins|vitamins|mesh-list
138430146|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
138198309|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198310|NCT00002110|Zidovudine|zidovudine|mesh-list
138198311|NCT00002110|Cysteamine|cysteamine|mesh-list
138430147|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430148|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138430149|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138430150|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
138430151|NCT01724229|Clotrimazole|clotrimazole|mesh-list
138430152|NCT01724229|Miconazole|miconazole|mesh-list
138430153|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430154|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138430155|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138430156|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138430157|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430158|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138368809|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
138430159|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138430160|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
138398927|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138430161|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138430162|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430163|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138430164|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138233054|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138430166|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138430167|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138430168|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
138430169|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138430170|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430171|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430172|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138430173|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
138430174|NCT01724450|Protective Agents|protective agents|mesh-ancestor
138430175|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138430176|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138430177|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138430178|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
138368944|NCT02293109|Prednisolone|prednisolone|mesh-list
138430179|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138430181|NCT01724723|Entecavir|entecavir|mesh-list
138430182|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
138430183|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430184|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138430185|NCT01724892|Dexamethasone|dexamethasone|mesh-list
138198316|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198317|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
138198318|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198319|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198320|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138398999|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
138430186|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138198321|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
138198322|NCT00001450|Paclitaxel|paclitaxel|mesh-list
138198323|NCT00001450|Cisplatin|cisplatin|mesh-list
138198324|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138198325|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198326|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
138198327|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
138198328|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
138198329|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198330|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
138430188|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
138430189|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430190|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430191|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138430192|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
138430193|NCT01724892|Hormones|hormones|mesh-ancestor
138430194|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138430195|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138430196|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430197|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138430198|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138430199|NCT01727427|Aspirin|aspirin|mesh-list
138430200|NCT01727427|Vitamin K|vitamin k|mesh-list
138430201|NCT01727427|Heparin|heparin|mesh-list
138430202|NCT01727427|Enoxaparin|enoxaparin|mesh-list
138430203|NCT01727427|Dalteparin|dalteparin|mesh-list
138430204|NCT01727427|Tinzaparin|tinzaparin|mesh-list
138430205|NCT01727427|PENTA|penta|mesh-list
138430207|NCT01727427|Warfarin|warfarin|mesh-list
138430208|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
138430209|NCT01727427|Dabigatran|dabigatran|mesh-list
138430210|NCT01727427|Apixaban|apixaban|mesh-list
138430211|NCT01727427|Fondaparinux|fondaparinux|mesh-list
138430212|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
138430213|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
138430214|NCT01727427|Bemiparin|bemiparin|mesh-list
138430215|NCT01727427|Vitamins|vitamins|mesh-ancestor
138430216|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
138430217|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138369058|NCT01622998|Nicotine|nicotine|mesh-list
138430218|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138430220|NCT01727427|Analgesics|analgesics|mesh-ancestor
138430221|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
138430222|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430223|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138430224|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138430225|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138430227|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430228|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138430229|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138430230|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430231|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
138430232|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
138430233|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138430234|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
138430235|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138399081|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138430236|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
138430237|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138430238|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
138430239|NCT01727427|Coagulants|coagulants|mesh-ancestor
138430240|NCT01727778|Antibodies|antibodies|mesh-list
138430241|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
138430242|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
138430243|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430244|NCT01728025|Ranolazine|ranolazine|mesh-list
138430245|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138430246|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138430247|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430248|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
138430249|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138430250|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430251|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138430252|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138430253|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198333|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
138430254|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430255|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430256|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138430257|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138430258|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
138198334|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138430259|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138430260|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430261|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138430262|NCT01730157|Ipilimumab|ipilimumab|mesh-list
138430263|NCT01730157|Antibodies|antibodies|mesh-list
138430264|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
138430265|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138430266|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
138430267|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430268|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430269|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138430270|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430271|NCT01730209|Everolimus|everolimus|mesh-list
138430272|NCT01730209|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138430273|NCT01730209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138430274|NCT01730209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430275|NCT01730209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430276|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138430277|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
138430278|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430279|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430280|NCT01730222|Paclitaxel|paclitaxel|mesh-list
138430281|NCT01730222|Gemcitabine|gemcitabine|mesh-list
138430282|NCT01730222|Capecitabine|capecitabine|mesh-list
138369240|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
138430283|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138430284|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399182|NCT01540136|Nedaplatin|nedaplatin|mesh-list
138430285|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
138430286|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
138430287|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
138430288|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430289|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138430291|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
138430292|NCT01730287|Calcium|calcium|mesh-list
138430293|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138369279|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
138430294|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430295|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138430296|NCT01730326|Acetaminophen|acetaminophen|mesh-list
138430297|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138430298|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138430299|NCT01730326|Analgesics|analgesics|mesh-ancestor
138430300|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
138430301|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430302|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430303|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
138430304|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138333412|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
138430305|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138430306|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138430307|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138430308|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430309|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430310|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430311|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138430313|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138430314|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138430315|NCT01730495|Analgesics|analgesics|mesh-ancestor
138430316|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
138430317|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430318|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430319|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138430320|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138430321|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138198341|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198342|NCT00001498|Leucovorin|leucovorin|mesh-list
138430322|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138430323|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
138430324|NCT01730508|Interferons|interferons|mesh-list
138430325|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
138430326|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430327|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
138430328|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430329|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
138430330|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430331|NCT01726400|Interferons|interferons|mesh-list
138430333|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
138430334|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430335|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
138430336|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430337|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
138430338|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430339|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
138430340|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430343|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
138430344|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
138430345|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138430346|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430347|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430348|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
138430349|NCT01730664|Ertapenem|ertapenem|mesh-list
138430350|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138430351|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430352|NCT01730677|Vinorelbine|vinorelbine|mesh-list
138430353|NCT01730677|Lapatinib|lapatinib|mesh-list
138430354|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138430355|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430356|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
138430357|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
138430358|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
138430359|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233154|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138430360|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138430361|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430362|NCT01730976|Vitamin D|vitamin d|mesh-list
138430363|NCT01730976|Vitamins|vitamins|mesh-list
138430365|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430366|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138430367|NCT01731067|Fexofenadine|fexofenadine|mesh-list
138430368|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
138430369|NCT01731067|Midazolam|midazolam|mesh-list
138430370|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
138430371|NCT01731067|Caffeine|caffeine|mesh-list
138430372|NCT01731067|Bupropion|bupropion|mesh-list
138430373|NCT01731067|Omeprazole|omeprazole|mesh-list
138430374|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138430375|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138430376|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138430377|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430378|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138430379|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138430380|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138430381|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138430382|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
138430383|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
138430384|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
138430385|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
138430386|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138430387|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430388|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138430389|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138430390|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430391|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138430393|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
138430394|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138430395|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138430396|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138430397|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138430398|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
138430399|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138430400|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138430401|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138430402|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
138430403|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138430404|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138430405|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
138430406|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
138430407|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138233186|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
138430408|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138430409|NCT01731067|Analgesics|analgesics|mesh-ancestor
138430410|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
138430411|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430412|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138430414|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138430415|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138430416|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138430417|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138430418|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138430419|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138430420|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
138430421|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
138430423|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
138430424|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138430425|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
138430426|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138430427|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430428|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138430429|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138430430|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138430431|NCT01731132|Trace Elements|trace elements|mesh-ancestor
138430432|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
138430433|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
138430434|NCT01731158|Bevacizumab|bevacizumab|mesh-list
138430436|NCT01731158|Everolimus|everolimus|mesh-list
138430437|NCT01731158|Sorafenib|sorafenib|mesh-list
138430438|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138430439|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138399540|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138430440|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138282880|NCT03002012|Sertraline|sertraline|mesh-list
138430441|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138430442|NCT01731158|Growth Substances|growth substances|mesh-ancestor
138430443|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430444|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
138430445|NCT01731158|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138430446|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138430447|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430448|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430449|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138430450|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
138430451|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
138430452|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430454|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138430455|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138430456|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138430457|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430458|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138430459|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138430460|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138430461|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138430462|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
138430464|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
138430465|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
138430466|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138430467|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430468|NCT01731275|Quetmolimab|quetmolimab|mesh-list
138430469|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138430470|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138430471|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
138430472|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430473|NCT01731301|Ribavirin|ribavirin|mesh-list
138430474|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
138399661|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430475|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430477|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430478|NCT01731327|Tofacitinib|tofacitinib|mesh-list
138430479|NCT01731327|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138430480|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138430481|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430482|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430483|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
138430484|NCT01731340|Calcium|calcium|mesh-list
138430485|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138430486|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430487|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138430488|NCT01731431|Glyburide|glyburide|mesh-list
138430489|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138430490|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430491|NCT01731457|Etanercept|etanercept|mesh-list
138430492|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138430494|NCT01731457|Analgesics|analgesics|mesh-ancestor
138430495|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
138430496|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430497|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430498|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138430499|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138399740|NCT01543399|Hormones|hormones|mesh-ancestor
138430500|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138430501|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138430502|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
138430504|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138430505|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430506|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
138430507|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430508|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138430509|NCT01731574|Dapivirine|dapivirine|mesh-list
138430510|NCT01731574|Miconazole|miconazole|mesh-list
138430511|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138430512|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138430513|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
138430514|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430515|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
138430516|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138430517|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138430518|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138333570|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
138233238|NCT04267809|Vitamin D|vitamin d|mesh-list
138430519|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430520|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138430521|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
138370184|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430522|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138430523|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430524|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138430525|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138430526|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
138399773|NCT01543906|Retinol acetate|retinol acetate|mesh-list
138430527|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138389518|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
138430528|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
138370247|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
138430529|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430530|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138198359|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
138198364|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430531|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138430532|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
138430533|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430534|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430535|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138430537|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138430538|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
138430539|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430540|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430541|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
138430544|NCT01731756|Petrolatum|petrolatum|mesh-list
138430545|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430547|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
138430548|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
138430549|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138430550|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138430551|NCT01731756|Analgesics|analgesics|mesh-ancestor
138430552|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
138430553|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430554|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430555|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138430556|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138430557|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138430558|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430559|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430561|NCT01731795|Dexamethasone|dexamethasone|mesh-list
138430562|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
138430564|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138430565|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
138430566|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
138430567|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430568|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430570|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
138430571|NCT01731795|Hormones|hormones|mesh-ancestor
138430572|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138430573|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138430574|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430575|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
138430576|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430577|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430578|NCT01731899|Agomelatine|agomelatine|mesh-list
138430579|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138430580|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138430581|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430582|NCT01731925|Sunitinib|sunitinib|mesh-list
138430583|NCT01731925|Lanreotide|lanreotide|mesh-list
138430584|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430585|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138430586|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138430587|NCT01731925|Growth Substances|growth substances|mesh-ancestor
138430588|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430589|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
138430590|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138430591|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430592|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430593|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
138430594|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138430595|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138430596|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
138430597|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138430598|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
138430599|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138430600|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198368|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
138198369|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138198370|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
138430601|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138430602|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138430603|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430604|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138430605|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
138430606|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138430607|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
138430608|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138430609|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430610|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138430611|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138430612|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430614|NCT01732146|Hematinics|hematinics|mesh-ancestor
138430615|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138430616|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
138430617|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430619|NCT01732224|Telbivudine|telbivudine|mesh-list
138430620|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
138430621|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430622|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138430623|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138430624|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430625|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430626|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138430627|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138430628|NCT01732250|Meropenem|meropenem|mesh-list
138430629|NCT01732250|Colistin|colistin|mesh-list
138430630|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138233337|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430631|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430632|NCT01732276|Gefitinib|gefitinib|mesh-list
138430633|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430634|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138430635|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138370532|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138430636|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430637|NCT01732328|Vitamin D|vitamin d|mesh-list
138430638|NCT01732328|Calcium|calcium|mesh-list
138430639|NCT01732328|Vitamins|vitamins|mesh-ancestor
138430640|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
138430641|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430642|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138430643|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138430645|NCT01732367|Lamivudine|lamivudine|mesh-list
138430646|NCT01732367|Adefovir|adefovir|mesh-list
138430647|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
138430648|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430649|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138430650|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138430651|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430652|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430653|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138430654|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138430655|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
138430656|NCT01732380|Raltitrexed|raltitrexed|mesh-list
138430657|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430658|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138430659|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
138430660|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430661|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138430662|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430663|NCT01732393|Quercetin|quercetin|mesh-list
138430664|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
138430665|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430666|NCT01732393|Protective Agents|protective agents|mesh-ancestor
138430667|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430668|NCT01732666|Remifentanil|remifentanil|mesh-list
138430669|NCT01732666|Nefopam|nefopam|mesh-list
138430670|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138430671|NCT01732666|Narcotics|narcotics|mesh-ancestor
138430672|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138430673|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430674|NCT01732666|Analgesics|analgesics|mesh-ancestor
138430675|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
138430676|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430677|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138430678|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138430679|NCT01732744|Eusol|eusol|mesh-list
138430680|NCT01732744|Castor Oil|castor oil|mesh-list
138430681|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138430682|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
138430683|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430684|NCT01732744|Cathartics|cathartics|mesh-ancestor
138430685|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138430686|NCT01732861|Lenalidomide|lenalidomide|mesh-list
138430687|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
138430688|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430689|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138430690|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138430691|NCT01732861|Growth Substances|growth substances|mesh-ancestor
138430692|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
138430693|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430694|NCT01733017|Lycopene|lycopene|mesh-list
138370636|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
138430695|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138430696|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
138430697|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430698|NCT01733017|Protective Agents|protective agents|mesh-ancestor
138430699|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430700|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138430701|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138430702|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430703|NCT01733030|Cycloserine|cycloserine|mesh-list
138430704|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138430705|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430706|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138430707|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
138430708|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138430709|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
138430710|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138233408|NCT01253642|Docetaxel|docetaxel|mesh-list
138430711|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
138430712|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138430713|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138430714|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430715|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138430717|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
138430718|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430719|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138430720|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138430721|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138430722|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
138430723|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138430724|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430725|NCT01733095|Ambrisentan|ambrisentan|mesh-list
138430726|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138430727|NCT01733108|Canagliflozin|canagliflozin|mesh-list
138430728|NCT01733108|Glyburide|glyburide|mesh-list
138430729|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138430730|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430731|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138430732|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430733|NCT01733134|Tolvaptan|tolvaptan|mesh-list
138198391|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138400383|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430734|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138430735|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430737|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430738|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
138430739|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138430740|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138430741|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138430742|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138430743|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430744|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
138430745|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138430746|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430747|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138430748|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430749|NCT01733342|Anesthetics|anesthetics|mesh-list
138400438|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
138430750|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138430751|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430752|NCT01733394|Lamotrigine|lamotrigine|mesh-list
138430753|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
138430754|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138430755|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138430756|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430757|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138430758|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430759|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138430760|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138430761|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138430762|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138430763|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138430765|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138430766|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430767|NCT01733485|Aspirin|aspirin|mesh-list
138430768|NCT01733485|Indomethacin|indomethacin|mesh-list
138430769|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138430770|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138430771|NCT01733485|Analgesics|analgesics|mesh-ancestor
138430772|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
138430773|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430774|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430775|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138430776|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138430777|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138430778|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138430779|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430780|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138430781|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138430782|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430783|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
138430784|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
138430785|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
138430786|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138430787|NCT01733589|Etoposide|etoposide|mesh-list
138430788|NCT01733589|Cisplatin|cisplatin|mesh-list
138430789|NCT01733589|Endostatins|endostatins|mesh-list
138430790|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138430791|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430792|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138430793|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138430794|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430795|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138333759|NCT00638820|Busulfan|busulfan|mesh-list
138430796|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138430797|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138430798|NCT01733589|Growth Substances|growth substances|mesh-ancestor
138430799|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430800|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
138430801|NCT01733706|Nicotine|nicotine|mesh-list
138430802|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138430803|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
138430804|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430805|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430806|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138430807|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138430808|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
138430809|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233462|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138430810|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430812|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138430813|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138430814|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138430815|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430816|NCT01733836|Metformin|metformin|mesh-list
138430817|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138430818|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430819|NCT01733966|Amoxicillin|amoxicillin|mesh-list
138430820|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
138430821|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
138370796|NCT01406470|Antibodies|antibodies|mesh-list
138430822|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138430823|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
138430824|NCT01733966|Secnidazole|secnidazole|mesh-list
138430825|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138430826|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430827|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430828|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430829|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138430830|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138430831|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138430832|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138430833|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138430834|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430835|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138430836|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138430839|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
138430840|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430841|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138430842|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138430843|NCT01734044|Dexamethasone|dexamethasone|mesh-list
138430844|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
138430845|NCT01734044|BB 1101|bb 1101|mesh-list
138430846|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138430847|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
138430848|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
138430849|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430850|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430851|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138430852|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
138430853|NCT01734044|Hormones|hormones|mesh-ancestor
138430854|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138430855|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138430856|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430857|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
138430858|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430859|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430860|NCT01734057|Dexamethasone|dexamethasone|mesh-list
138430862|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138430863|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
138430864|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
138430865|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138400788|NCT01550354|Alfentanil|alfentanil|mesh-list
138430866|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430867|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138430868|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
138430869|NCT01734057|Hormones|hormones|mesh-ancestor
138430870|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138430871|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138430872|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430873|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138430874|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
138430875|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138430876|NCT01734096|Candesartan|candesartan|mesh-list
138430877|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
138430878|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138430879|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138430880|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138430881|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430882|NCT01734252|Argatroban|argatroban|mesh-list
138430884|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138430885|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
138430886|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138430887|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430888|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
138430889|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138430890|NCT01734330|Nicotine|nicotine|mesh-list
138430891|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138430892|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
138430893|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430894|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430895|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138430896|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138430897|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
138430898|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138430899|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430900|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138430901|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
138430902|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138430903|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
138430904|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400833|NCT01550653|Hormones|hormones|mesh-ancestor
138400835|NCT01550770|Propofol|propofol|mesh-list
138430906|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430907|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138430909|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
138430910|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
138430911|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430913|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138430914|NCT01734564|Poly ICLC|poly iclc|mesh-list
138430915|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
138430916|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
138430917|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430918|NCT01734564|Laxatives|laxatives|mesh-ancestor
138430919|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138430920|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
138430921|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138430922|NCT01734798|Gemcitabine|gemcitabine|mesh-list
138430923|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430924|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138430925|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
138430926|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430927|NCT01734824|Denosumab|denosumab|mesh-list
138430928|NCT01734824|Teriparatide|teriparatide|mesh-list
138430929|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
138430930|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138430931|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430932|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138430933|NCT01734915|Iproplatin|iproplatin|mesh-list
138430934|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430935|NCT01734954|Midazolam|midazolam|mesh-list
138430936|NCT01734954|Analgesics|analgesics|mesh-list
138430937|NCT01734954|Anesthetics|anesthetics|mesh-list
138430938|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
138430939|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
138430940|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138430941|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430942|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138430943|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138430944|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138430945|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138430946|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138233539|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
138233540|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
138233544|NCT01322360|Morphine|morphine|mesh-list
138430947|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138430948|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
138430949|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
138430950|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
138430951|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138430952|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430953|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
138430954|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430956|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
138430957|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430958|NCT01735019|Remifentanil|remifentanil|mesh-list
138430959|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138430960|NCT01735019|Narcotics|narcotics|mesh-ancestor
138430961|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138430962|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430963|NCT01735019|Analgesics|analgesics|mesh-ancestor
138430964|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
138430965|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138430966|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
138430967|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138430968|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
138430969|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430970|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
138430971|NCT01735058|Protective Agents|protective agents|mesh-ancestor
138430972|NCT01735071|Bevacizumab|bevacizumab|mesh-list
138430973|NCT01735071|Carboplatin|carboplatin|mesh-list
138430974|NCT01735071|Trabectedin|trabectedin|mesh-list
138430975|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138430976|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138430977|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138430978|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138430979|NCT01735071|Growth Substances|growth substances|mesh-ancestor
138400894|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
138430980|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430981|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
138430982|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138430983|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
138430984|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430985|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138430986|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
138430987|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430988|NCT01735097|Vitamin E|vitamin e|mesh-list
138430989|NCT01735097|Vitamins|vitamins|mesh-ancestor
138430990|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
138430991|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138430992|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
138430993|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430994|NCT01735097|Protective Agents|protective agents|mesh-ancestor
138430995|NCT01735123|Caseins|caseins|mesh-list
138430996|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
138430997|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
138430998|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138430999|NCT01735227|Omeprazole|omeprazole|mesh-list
138431000|NCT01735227|Pantoprazole|pantoprazole|mesh-list
138333872|NCT00666978|Bupropion|bupropion|mesh-list
138431001|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138431002|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138431003|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138431004|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431005|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431006|NCT01735240|Ketoconazole|ketoconazole|mesh-list
138431007|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
138431008|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138431009|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138431010|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138431011|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431012|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431013|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138431014|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
138431015|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431016|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431017|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138431019|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138431020|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
138431021|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431022|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431023|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138431024|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138431025|NCT01735318|Protective Agents|protective agents|mesh-ancestor
138431026|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431028|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138431030|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431031|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431032|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138431033|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138431034|NCT01735344|Protective Agents|protective agents|mesh-ancestor
138431035|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431036|NCT01735370|Etodolac|etodolac|mesh-list
138431037|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138431038|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138431039|NCT01735370|Analgesics|analgesics|mesh-ancestor
138431040|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
138371046|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
138431041|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431042|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431043|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138431044|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138431045|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138431046|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138431047|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431048|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431049|NCT01735383|Etodolac|etodolac|mesh-list
138431050|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138431051|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138431052|NCT01735383|Analgesics|analgesics|mesh-ancestor
138431053|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
138431054|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138233648|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138431055|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431056|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138431057|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138431058|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138431059|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138431060|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431061|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431062|NCT01735487|Nicotine|nicotine|mesh-list
138431063|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138431064|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
138431065|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431066|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431067|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138431068|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138431069|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
138431070|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431071|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431072|NCT01735669|Remifentanil|remifentanil|mesh-list
138431073|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
138431074|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138431075|NCT01735669|Narcotics|narcotics|mesh-ancestor
138431076|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138431077|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431079|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
138431080|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431081|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138431082|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
138431083|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
138333918|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
138431084|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138431085|NCT01735747|Vincristine|vincristine|mesh-list
138431086|NCT01735747|Temozolomide|temozolomide|mesh-list
138431088|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138431089|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431090|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
138431091|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
138198408|NCT02688140|Analgesics|analgesics|mesh-ancestor
138431092|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
138431093|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431094|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138431095|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
138431096|NCT01735864|Indirubin|indirubin|mesh-list
138431097|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138431098|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431099|NCT01735890|Amlodipine|amlodipine|mesh-list
138431100|NCT01735890|Valsartan|valsartan|mesh-list
138401010|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138431101|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
138431102|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138431103|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138431104|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138431105|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431106|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138431107|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431108|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
138431109|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138431110|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138431111|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
138431112|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
138431114|NCT01736020|Propofol|propofol|mesh-list
138431115|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138431116|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138431117|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431118|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138431119|NCT01736020|Analgesics|analgesics|mesh-ancestor
138431120|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
138431121|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431122|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138431123|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138431124|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138431125|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
138431126|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431127|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431128|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138431129|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
138390113|NCT01498913|Repaglinide|repaglinide|mesh-list
138431130|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
138431131|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138431132|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138431133|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138431134|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138431136|NCT01736033|Finasteride|finasteride|mesh-list
138431137|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138431138|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138431139|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138431140|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
138431141|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431142|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431143|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431144|NCT01736033|Urological Agents|urological agents|mesh-ancestor
138431145|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138431146|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138431147|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431148|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
138431149|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431150|NCT01736150|Sevelamer|sevelamer|mesh-list
138431151|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
138233787|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
138431152|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
138431153|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431154|NCT01736163|Hormones|hormones|mesh-list
138431155|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431156|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431157|NCT01736371|Propofol|propofol|mesh-list
138431158|NCT01736371|Sevoflurane|sevoflurane|mesh-list
138198416|NCT00002122|Rifabutin|rifabutin|mesh-list
138431159|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138431160|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138431161|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431162|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138431163|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
138431164|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
138431165|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138431166|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138431167|NCT01736410|Trastuzumab|trastuzumab|mesh-list
138431168|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431169|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138431170|NCT01736423|Ramosetron|ramosetron|mesh-list
138431171|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
138431172|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
138431173|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431174|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431175|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138431176|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138431177|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
138431178|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431179|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431180|NCT01736449|Bevacizumab|bevacizumab|mesh-list
138431181|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138431182|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431183|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138431184|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138431185|NCT01736449|Growth Substances|growth substances|mesh-ancestor
138431186|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431187|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
138431188|NCT01736488|Atenolol|atenolol|mesh-list
138431189|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138431190|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138431191|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
138431192|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
138431193|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431194|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431195|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138431196|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138233831|NCT02251379|Xhance|xhance|mesh-list
138431197|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138431198|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
138431199|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431200|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431202|NCT01736514|Febuxostat|febuxostat|mesh-list
138431203|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
138431204|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401145|NCT01552863|Oxycodone|oxycodone|mesh-list
138431205|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431206|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
138431207|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138431208|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138431209|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
138431210|NCT01736514|Protective Agents|protective agents|mesh-ancestor
138431211|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431212|NCT01736670|Triamcinolone|triamcinolone|mesh-list
138431213|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138431214|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138431215|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138431216|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138431217|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
138431218|NCT01736670|Hormones|hormones|mesh-ancestor
138431219|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431220|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431221|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138431222|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
138431223|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431224|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431225|NCT01736761|Ritonavir|ritonavir|mesh-list
138431226|NCT01736761|Darunavir|darunavir|mesh-list
138431227|NCT01736761|Rilpivirine|rilpivirine|mesh-list
138198418|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138198419|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198420|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
138431228|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138431229|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138431230|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
138431231|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431232|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431233|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138431234|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138431235|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
138431236|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138431237|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138431238|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138431239|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138431240|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138431241|NCT01736800|Temozolomide|temozolomide|mesh-list
138431242|NCT01736800|Topotecan|topotecan|mesh-list
138431243|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138431244|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
138233848|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138233853|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
138431245|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431246|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431247|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138431248|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138431249|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431251|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138431252|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138431253|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431254|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138431255|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138431256|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
138431257|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138431258|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138431259|NCT01736878|Sorafenib|sorafenib|mesh-list
138431260|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431261|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138431262|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431263|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431264|NCT01736891|Rasagiline|rasagiline|mesh-list
138431265|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138431266|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431267|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431268|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138431269|NCT01736891|Protective Agents|protective agents|mesh-ancestor
138431270|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431271|NCT01737008|Cisplatin|cisplatin|mesh-list
138431272|NCT01737008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431273|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
138431274|NCT01737073|Narcotics|narcotics|mesh-ancestor
138431275|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138431276|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431277|NCT01737073|Analgesics|analgesics|mesh-ancestor
138390263|NCT01500018|Phentermine|phentermine|mesh-list
138431279|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431280|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
138431281|NCT01737086|Astringents|astringents|mesh-ancestor
138431282|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431283|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
138431284|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
138431285|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138431286|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431287|NCT01737177|Rituximab|rituximab|mesh-list
138431288|NCT01737177|Lenalidomide|lenalidomide|mesh-list
138431289|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138431290|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138431291|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431292|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
138431293|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431294|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138401200|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
138431295|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138431296|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138431297|NCT01737177|Growth Substances|growth substances|mesh-ancestor
138431298|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
138431299|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138431300|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
138431301|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431302|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
138431303|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431304|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
138431305|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138431306|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138431307|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431308|NCT01737203|Urological Agents|urological agents|mesh-ancestor
138334070|NCT00691002|Vitamins|vitamins|mesh-ancestor
138431309|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
138431310|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138431311|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431313|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
138431314|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
138431315|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
138431316|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431317|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431318|NCT01737307|Fluorides|fluorides|mesh-list
138431319|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
138431320|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
138431321|NCT01737307|Protective Agents|protective agents|mesh-ancestor
138431322|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431323|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138431324|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138431325|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138431326|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
138431328|NCT01737346|Procarbazine|procarbazine|mesh-list
138431329|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138431330|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
138431331|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431332|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431333|NCT01737359|Tenofovir|tenofovir|mesh-list
138431334|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
138431335|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138431336|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138431337|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138431338|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431339|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431340|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138431341|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138431342|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
138431343|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138431344|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138431345|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
138431346|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431347|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431348|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138371416|NCT01411124|Promethazine|promethazine|mesh-list
138431349|NCT01737411|Urological Agents|urological agents|mesh-ancestor
138431350|NCT01737541|Fluoxetine|fluoxetine|mesh-list
138431351|NCT01737541|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138431352|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138431353|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138431354|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431355|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431356|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
138431357|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431358|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138431359|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
138431360|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138233941|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138431361|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138431362|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138198421|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138431363|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431364|NCT01737671|Leucovorin|leucovorin|mesh-list
138431365|NCT01737671|Methotrexate|methotrexate|mesh-list
138431366|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138431367|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
138431368|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138431369|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431370|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138431371|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
138431372|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431373|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431374|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
138431375|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431376|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138431377|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138431378|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
138431379|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138431380|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138431382|NCT01737671|Protective Agents|protective agents|mesh-ancestor
138431383|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
138431384|NCT01737671|Vitamins|vitamins|mesh-ancestor
138431385|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
138431386|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
138431387|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138431388|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138371445|NCT01411176|Menthol|menthol|mesh-list
138431390|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431391|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431392|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431394|NCT01738035|Budesonide|budesonide|mesh-list
138431395|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138431396|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138431397|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
138431398|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431399|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431400|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138431401|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
138431402|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
138431403|NCT01738035|Hormones|hormones|mesh-ancestor
138431404|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431405|NCT01738087|Fluticasone|fluticasone|mesh-list
138431406|NCT01738087|Xhance|xhance|mesh-list
138431407|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
138431408|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138431409|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138431410|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
138431411|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431412|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431413|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138431414|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
138334173|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
138431415|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
138431416|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138431417|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138431418|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138431419|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138431420|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
138431421|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431422|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431423|NCT01738100|Morphine|morphine|mesh-list
138431424|NCT01738100|Clopidogrel|clopidogrel|mesh-list
138431425|NCT01738100|Ticagrelor|ticagrelor|mesh-list
138390416|NCT01500863|Estradiol|estradiol|mesh-list
138401287|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
138431426|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138431428|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138198422|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138431429|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431430|NCT01738100|Analgesics|analgesics|mesh-ancestor
138431431|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
138431432|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198423|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431433|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138431434|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138431435|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138431436|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138431437|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
138431438|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234021|NCT01263938|Atorvastatin|atorvastatin|mesh-list
138431439|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431441|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138431442|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431443|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138431444|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431445|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431446|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138431447|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138431448|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
138431449|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431450|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
138431451|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138431452|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
138431453|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431454|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
138431455|NCT01738243|Protective Agents|protective agents|mesh-ancestor
138431456|NCT01738282|Baclofen|baclofen|mesh-list
138401318|NCT01554852|Thalidomide|thalidomide|mesh-list
138431457|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138431458|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138334220|NCT00717054|Scopolamine|scopolamine|mesh-list
138431459|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138431460|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431461|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138431462|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
138431463|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
138431464|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431465|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431466|NCT01738295|Donepezil|donepezil|mesh-list
138431467|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138431468|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431469|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431470|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
138431471|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431472|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431473|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
138431474|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
138431475|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431476|NCT01738373|Plerixafor|plerixafor|mesh-list
138431477|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138431478|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138431479|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
138234048|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
138234049|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138234050|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138234051|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138234052|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431480|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138431481|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
138431482|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
138431483|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431484|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431485|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431486|NCT01738451|Dabrafenib|dabrafenib|mesh-list
138431487|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431488|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138431489|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431490|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431491|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
138431492|NCT01738542|Bosentan|bosentan|mesh-list
138431493|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138198428|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431494|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431495|NCT01738724|Goserelin|goserelin|mesh-list
138431496|NCT01738724|Dienogest|dienogest|mesh-list
138431497|NCT01738724|Desogestrel|desogestrel|mesh-list
138431498|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138431499|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138390503|NCT01501136|Mesna|mesna|mesh-list
138431500|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138431502|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138431503|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431504|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138431505|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138431506|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138431507|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138431509|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431510|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138431511|NCT01738724|Progestins|progestins|mesh-ancestor
138431512|NCT01738724|Hormones|hormones|mesh-ancestor
138431513|NCT01738763|Inositol|inositol|mesh-list
138431514|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
138431516|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
138431517|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431518|NCT01738802|Micronutrients|micronutrients|mesh-list
138431519|NCT01738802|Trace Elements|trace elements|mesh-list
138431520|NCT01738802|Antioxidants|antioxidants|mesh-list
138431521|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431522|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431523|NCT01738802|Protective Agents|protective agents|mesh-ancestor
138431524|NCT01738815|Valproic Acid|valproic acid|mesh-list
138431525|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
138431526|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138234080|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234083|NCT00367263|Hormones|hormones|mesh-ancestor
138431527|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431528|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
138431529|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431530|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431531|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
138431532|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138431533|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138431534|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138431535|NCT01738867|Naltrexone|naltrexone|mesh-list
138431536|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138431537|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138431538|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431539|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
138431540|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431541|NCT01738893|Gabapentin|gabapentin|mesh-list
138431542|NCT01738893|Analgesics|analgesics|mesh-ancestor
138431543|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
138198431|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138431544|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431545|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431546|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
138198432|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
138198433|NCT00001534|Losartan|losartan|mesh-list
138198434|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138431547|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138431548|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138198435|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138431549|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138431550|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138431551|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138431552|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138431553|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431554|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431555|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
138431556|NCT01738945|Amlodipine|amlodipine|mesh-list
138431557|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138431558|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138431559|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138431560|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431561|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138431562|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431563|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
138431564|NCT01739049|Liraglutide|liraglutide|mesh-list
138431565|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138431566|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431567|NCT01739049|Incretins|incretins|mesh-ancestor
138431568|NCT01739049|Hormones|hormones|mesh-ancestor
138431569|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431570|NCT01739127|Risperidone|risperidone|mesh-list
138431571|NCT01739127|Aripiprazole|aripiprazole|mesh-list
138431572|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138431573|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138431574|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
138431575|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431576|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431577|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431578|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138431579|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138431580|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138431582|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138431583|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
138371632|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
138431584|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
138431585|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
138431586|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138431587|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138431588|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138431589|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138431591|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138431592|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
138431593|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138431594|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138431595|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138431596|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138431597|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431598|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
138431599|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431600|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431601|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138431602|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138431603|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431604|NCT01739218|Paclitaxel|paclitaxel|mesh-list
138431605|NCT01739218|Bevacizumab|bevacizumab|mesh-list
138431606|NCT01739218|Carboplatin|carboplatin|mesh-list
138431607|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138431608|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431609|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
138431610|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
138431611|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
138334294|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138431612|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431613|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138431614|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138431615|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138431616|NCT01739218|Growth Substances|growth substances|mesh-ancestor
138431617|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431618|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
138431620|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138431621|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431622|NCT01739439|Gemcitabine|gemcitabine|mesh-list
138431623|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138431624|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
138431625|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431626|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431627|NCT01739504|Anesthetics|anesthetics|mesh-list
138431628|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138431629|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431630|NCT01739556|Aspirin|aspirin|mesh-list
138431631|NCT01739556|Ticagrelor|ticagrelor|mesh-list
138431632|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138431633|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138431634|NCT01739556|Analgesics|analgesics|mesh-ancestor
138431635|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
138431636|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431637|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431638|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138431639|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138431640|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138431641|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138431642|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431643|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138431644|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138431645|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390642|NCT01501448|Hormones|hormones|mesh-ancestor
138431646|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
138431647|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138431648|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138431649|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138431650|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
138431651|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431653|NCT01739582|Clomiphene|clomiphene|mesh-list
138431654|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
138431655|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138431656|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
138431657|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431658|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431659|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138431660|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
138431661|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138431662|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138431663|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138431664|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
138431665|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
138431666|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138431667|NCT01739673|Riboflavin|riboflavin|mesh-list
138431668|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
138431669|NCT01739673|Vitamins|vitamins|mesh-ancestor
138431670|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
138431671|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431672|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138431673|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
138431674|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
138431675|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
138431676|NCT01739855|Calcium|calcium|mesh-list
138431677|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138431678|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431679|NCT01739855|Antacids|antacids|mesh-ancestor
138431680|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431681|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138431682|NCT01739855|Vitamins|vitamins|mesh-ancestor
138431683|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
138431684|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138431685|NCT01739894|Paclitaxel|paclitaxel|mesh-list
138431686|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138198451|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
138431687|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431688|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
138431689|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
138431690|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
138431691|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431692|NCT01739907|Vitamin D|vitamin d|mesh-list
138431693|NCT01739907|Vitamins|vitamins|mesh-ancestor
138431694|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
138431695|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138234195|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431696|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138431697|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
138431698|NCT01739920|Povidone|povidone|mesh-list
138431699|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
138431700|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
138431701|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138431702|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138431703|NCT01739985|Dexamethasone|dexamethasone|mesh-list
138431704|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
138431705|NCT01739985|Droperidol|droperidol|mesh-list
138431706|NCT01739985|Ondansetron|ondansetron|mesh-list
138431707|NCT01739985|BB 1101|bb 1101|mesh-list
138431708|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138431709|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
138431710|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
138431711|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431712|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431713|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138431714|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
138431715|NCT01739985|Hormones|hormones|mesh-ancestor
138431716|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431717|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138431718|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431719|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
138431720|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390720|NCT01501747|Cephalexin|cephalexin|mesh-list
138431721|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431722|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
138431723|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
138431724|NCT01739985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138431725|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138431726|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
138431727|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431728|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138431729|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138431730|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138431731|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138431732|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138431733|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138431734|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138431735|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
138431736|NCT01740245|Biguanides|biguanides|mesh-list
138431737|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
138431738|NCT01740245|Polihexanide|polihexanide|mesh-list
138431739|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138431740|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138234244|NCT01812005|Rituximab|rituximab|mesh-list
138431741|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
138431742|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138431743|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431745|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138431746|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431747|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138431748|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138431749|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431750|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431751|NCT01740336|Paclitaxel|paclitaxel|mesh-list
138431752|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138431753|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431754|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
138431755|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
138431756|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
138431757|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431758|NCT01740453|Ropivacaine|ropivacaine|mesh-list
138431759|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
138431760|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
138431761|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138431762|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431763|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
138431764|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431765|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
138431766|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
138431767|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431768|NCT01740518|Protective Agents|protective agents|mesh-ancestor
138431769|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431771|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
138431773|NCT01740921|Liraglutide|liraglutide|mesh-list
138431774|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138431775|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138431776|NCT01740921|Analgesics|analgesics|mesh-ancestor
138431777|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
138431778|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431779|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431780|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138431781|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138431782|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138431783|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138234267|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
138431784|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431785|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138431786|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138431787|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431788|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
138431789|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138431790|NCT01740921|Incretins|incretins|mesh-ancestor
138431791|NCT01740921|Hormones|hormones|mesh-ancestor
138431792|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431793|NCT01740947|Amphotericin B|amphotericin b|mesh-list
138431794|NCT01740947|Tobramycin|tobramycin|mesh-list
138431795|NCT01740947|Colistin|colistin|mesh-list
138431796|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138431797|NCT01740947|Amebicides|amebicides|mesh-ancestor
138431798|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138431799|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138431800|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138431801|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138431802|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
138431803|NCT01740960|Dronabinol|dronabinol|mesh-list
138431804|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
138431805|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431806|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138431807|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138431808|NCT01740960|Analgesics|analgesics|mesh-ancestor
138431809|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
138431810|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431811|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138431812|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138431813|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431814|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431815|NCT01740960|Hormones|hormones|mesh-ancestor
138431816|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431817|NCT01741038|Cetuximab|cetuximab|mesh-list
138431818|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138431821|NCT01741077|Hematinics|hematinics|mesh-ancestor
138431822|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
138431823|NCT01741077|Vitamins|vitamins|mesh-ancestor
138431824|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
138431825|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431826|NCT01741142|Escitalopram|escitalopram|mesh-list
138431827|NCT01741142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138431828|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138431829|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138431830|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198460|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
138431831|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431832|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
138431833|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431834|NCT01741181|Vitamin D|vitamin d|mesh-list
138431835|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
138431836|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
138431837|NCT01741181|Vitamins|vitamins|mesh-list
138431838|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
138431839|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431840|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138431841|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138431842|NCT01741285|Fluticasone|fluticasone|mesh-list
138431844|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138431845|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138431846|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
138431847|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431848|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431849|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138431850|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
138431851|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
138431852|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138431853|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
138431854|NCT01741285|Hormones|hormones|mesh-ancestor
138431855|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431856|NCT01741324|Vitamin D|vitamin d|mesh-list
138431857|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
138431858|NCT01741324|Cholecalciferol|cholecalciferol|mesh-list
138431859|NCT01741324|Vitamins|vitamins|mesh-list
138431860|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
138431861|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431862|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138431863|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138431864|NCT01741376|Progesterone|progesterone|mesh-list
138431865|NCT01741376|Progestins|progestins|mesh-ancestor
138431866|NCT01741376|Hormones|hormones|mesh-ancestor
138431867|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431868|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431869|NCT01741389|Melatonin|melatonin|mesh-list
138431870|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
138431871|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431872|NCT01741389|Protective Agents|protective agents|mesh-ancestor
138431873|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431874|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138431876|NCT01741493|Tofacitinib|tofacitinib|mesh-list
138431878|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138431879|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401451|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431880|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431881|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138431882|NCT01741506|Dalteparin|dalteparin|mesh-list
138431883|NCT01741506|Tinzaparin|tinzaparin|mesh-list
138431884|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138431885|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
138431886|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138431887|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138431888|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431889|NCT01741519|Landiolol|landiolol|mesh-list
138431890|NCT01741519|Esmolol|esmolol|mesh-list
138431891|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138431892|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138431893|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138431894|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
138431895|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431896|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431897|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431898|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138431899|NCT01741558|Riboflavin|riboflavin|mesh-list
138431900|NCT01741558|Methotrexate|methotrexate|mesh-list
138431901|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138431902|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
138431903|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138431904|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431905|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138431906|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
138234369|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431907|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431908|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431909|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
138431910|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431911|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138431912|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138431913|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
138431914|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138431915|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138431916|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
138431917|NCT01741558|Vitamins|vitamins|mesh-ancestor
138431918|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
138431919|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138431920|NCT01741623|Bisoprolol|bisoprolol|mesh-list
138431921|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138431922|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
138431923|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
138431924|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431925|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431926|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138431927|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138431928|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138431929|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
138431930|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431931|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431932|NCT01741649|Povidone|povidone|mesh-list
138431933|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
138431934|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
138431935|NCT01741727|ABT-414|abt-414|mesh-list
138431936|NCT01741727|Immunoconjugates|immunoconjugates|mesh-ancestor
138431937|NCT01741727|Immunologic Factors|immunologic factors|mesh-ancestor
138431938|NCT01741727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431939|NCT01741753|Prednisone|prednisone|mesh-list
138431940|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138431941|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
138431942|NCT01741753|Hormones|hormones|mesh-ancestor
138431943|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431944|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431945|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138431946|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138431947|NCT01741831|Darunavir|darunavir|mesh-list
138234402|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138431948|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138431949|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138431951|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138431952|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431953|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138431954|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138431955|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
138431956|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138431957|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
138431958|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138431959|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431960|NCT01742247|Palmidrol|palmidrol|mesh-list
138431961|NCT01742247|Analgesics|analgesics|mesh-ancestor
138431962|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
138431963|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138431964|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431965|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138431966|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138431967|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138431968|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138431969|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
138431970|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138431971|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138431972|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138431973|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138431974|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431975|NCT01742247|Hormones|hormones|mesh-ancestor
138431976|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431977|NCT01742273|Vitamin K|vitamin k|mesh-list
138431978|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
138431979|NCT01742273|Vitamins|vitamins|mesh-ancestor
138431980|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
138431981|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138431982|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138431983|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138334550|NCT00758784|Bromfenac|bromfenac|mesh-list
138431984|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138431985|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
138431986|NCT01742273|Coagulants|coagulants|mesh-ancestor
138431987|NCT01742338|Prednisone|prednisone|mesh-list
138431988|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
138431989|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138431990|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138431991|NCT01742338|Prednisolone|prednisolone|mesh-list
138431992|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
138431993|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138431994|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
138431995|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138431996|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
138431997|NCT01742338|Hormones|hormones|mesh-ancestor
138431998|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138431999|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432000|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138432001|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432002|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
138432003|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
138432004|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432005|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138432006|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138432007|NCT01742338|Protective Agents|protective agents|mesh-ancestor
138432008|NCT01742390|Risperidone|risperidone|mesh-list
138432009|NCT01742390|Aripiprazole|aripiprazole|mesh-list
138432010|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138432011|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138432013|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432014|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432015|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432016|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138432017|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138432018|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432019|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138432020|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138432021|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
138432022|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
138432023|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
138432024|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138432025|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138432026|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138432027|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138432028|NCT01742429|Amoxicillin|amoxicillin|mesh-list
138432029|NCT01742429|Metronidazole|metronidazole|mesh-list
138432030|NCT01742429|Levofloxacin|levofloxacin|mesh-list
138432031|NCT01742429|Tetracycline|tetracycline|mesh-list
138432032|NCT01742429|Bismuth|bismuth|mesh-list
138432033|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
138432034|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
138432035|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138432036|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138432037|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138432038|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138234450|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
138432039|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138432040|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138198478|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432041|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138432042|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432043|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432044|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432045|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138432046|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138432047|NCT01742429|Antacids|antacids|mesh-ancestor
138432048|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138432049|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138432050|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
138432051|NCT01742533|Hormones|hormones|mesh-list
138432052|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138432053|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432054|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
138432055|NCT01742624|Tacrolimus|tacrolimus|mesh-list
138432056|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138432057|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
138432058|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432059|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138432060|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432061|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432063|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432064|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138432065|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
138432066|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138432067|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138432068|NCT01742637|Adapalene|adapalene|mesh-list
138432069|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138234496|NCT01383200|Lidocaine|lidocaine|mesh-list
138432070|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
138432071|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138432072|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138432073|NCT01742637|Analgesics|analgesics|mesh-ancestor
138432074|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
138432075|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432076|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432077|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138432078|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432079|NCT01742663|Diclofenac|diclofenac|mesh-list
138432080|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138432081|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138432082|NCT01742663|Analgesics|analgesics|mesh-ancestor
138432083|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
138432084|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432085|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432086|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138432087|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432088|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138432089|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432090|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432091|NCT01742676|Tacrolimus|tacrolimus|mesh-list
138432092|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138372104|NCT01416220|Paroxetine|paroxetine|mesh-list
138432093|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
138432094|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432095|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138432096|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432097|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432099|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138432100|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138432101|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138432103|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
138432104|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432105|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432106|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138432107|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432108|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
138432109|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
138198483|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138432110|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138432111|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138432112|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432113|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432114|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
138432115|NCT01742689|Coagulants|coagulants|mesh-ancestor
138432116|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138432117|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
138432118|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
138432119|NCT01742702|Bisoprolol|bisoprolol|mesh-list
138432120|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
138432121|NCT01742702|Albuterol|albuterol|mesh-list
138432122|NCT01742702|Caseins|caseins|mesh-list
138432123|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138432124|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
138432125|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432126|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432127|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138432128|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
138432129|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
138432130|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138432131|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138432132|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138432133|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138432134|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
138432135|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432136|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432137|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
138432138|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
138432139|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
138432140|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138432141|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
138432142|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138432143|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138432144|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138432145|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138432146|NCT01742767|Pemetrexed|pemetrexed|mesh-list
138432147|NCT01742767|Cisplatin|cisplatin|mesh-list
138432148|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432149|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138401549|NCT01556334|Azithromycin|azithromycin|mesh-list
138432150|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432151|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138432152|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138432153|NCT01742793|Lenalidomide|lenalidomide|mesh-list
138432155|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
138432156|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432157|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138432158|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138432159|NCT01742793|Growth Substances|growth substances|mesh-ancestor
138432160|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
138432161|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432162|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138198490|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138198491|NCT01661790|Growth Substances|growth substances|mesh-ancestor
138198492|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198493|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
138198494|NCT00002134|Ganciclovir|ganciclovir|mesh-list
138432163|NCT01742793|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138198495|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138432164|NCT01742793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198501|NCT00985907|Bortezomib|bortezomib|mesh-list
138432165|NCT01742793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432166|NCT01742845|Ropivacaine|ropivacaine|mesh-list
138432167|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
138432168|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
138432169|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432170|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432171|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
138432172|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432173|NCT01742988|Rituximab|rituximab|mesh-list
138432174|NCT01742988|Venetoclax|venetoclax|mesh-list
138432175|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138432176|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432177|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
138432178|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432179|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432180|NCT01743014|Ramipril|ramipril|mesh-list
138432181|NCT01743014|Clopidogrel|clopidogrel|mesh-list
138432182|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138432183|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138432184|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138432185|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138432186|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
138432187|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234605|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
138432188|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432189|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432190|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138432191|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
138432192|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432193|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138432195|NCT01743066|Vitamins|vitamins|mesh-ancestor
138432196|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
138432197|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432198|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
138432199|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432200|NCT01743066|Protective Agents|protective agents|mesh-ancestor
138432201|NCT01743079|Lamivudine|lamivudine|mesh-list
138432202|NCT01743079|Telbivudine|telbivudine|mesh-list
138432204|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138432205|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432206|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432207|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
138432208|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138432209|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138432210|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138432211|NCT01743118|Calcipotriene|calcipotriene|mesh-list
138432212|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
138432213|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
138432214|NCT01743144|Analgesics|analgesics|mesh-ancestor
138432215|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
138432216|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432217|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432218|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
138432219|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432220|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138432221|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
138432222|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138432223|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138432224|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432225|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138432226|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
138334663|NCT00766116|Azacitidine|azacitidine|mesh-list
138432227|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138234654|NCT00367497|Hormones|hormones|mesh-ancestor
138432228|NCT01743157|Bevacizumab|bevacizumab|mesh-list
138432230|NCT01743157|Interleukin-2|interleukin-2|mesh-list
138432231|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138432232|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432233|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138198506|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
138432234|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138432235|NCT01743157|Growth Substances|growth substances|mesh-ancestor
138432236|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432237|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
138432238|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138432239|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432240|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138432241|NCT01743157|Analgesics|analgesics|mesh-ancestor
138432242|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
138432243|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432244|NCT01743235|Buspirone|buspirone|mesh-list
138432245|NCT01743235|Testosterone|testosterone|mesh-list
138432246|NCT01743235|Androgens|androgens|mesh-ancestor
138432247|NCT01743235|Hormones|hormones|mesh-ancestor
138432248|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138432249|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432250|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138432251|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138432252|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432253|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138432254|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138432255|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
138432256|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432257|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432259|NCT01743300|Midazolam|midazolam|mesh-list
138432260|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138432261|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138432262|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432263|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432264|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138432265|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138432266|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138432267|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138432268|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
138432269|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
138432270|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
138432271|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
138432272|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138234675|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432273|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432274|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432275|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138432276|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138432277|NCT01743300|Growth Substances|growth substances|mesh-ancestor
138432278|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
138432279|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138432280|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432281|NCT01743326|Anesthetics|anesthetics|mesh-list
138432282|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138334706|NCT00775944|Nicotine|nicotine|mesh-list
138432283|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432284|NCT01743365|Afatinib|afatinib|mesh-list
138432285|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432286|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138432287|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432288|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432289|NCT01743378|Ropivacaine|ropivacaine|mesh-list
138432290|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
138432291|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
138432292|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432293|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432294|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
138432295|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432296|NCT01743456|Anesthetics|anesthetics|mesh-list
138432297|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432298|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432299|NCT01743508|Misoprostol|misoprostol|mesh-list
138432300|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138432301|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
138198510|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
138432302|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138432303|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432304|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138432305|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138432306|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
138432307|NCT01743690|Nystatin|nystatin|mesh-list
138432308|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138234705|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432309|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138432310|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
138432312|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138372256|NCT01417364|Androgens|androgens|mesh-ancestor
138432313|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432314|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138432315|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138432316|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
138432318|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138432319|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432320|NCT01743755|Dexamethasone|dexamethasone|mesh-list
138432321|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138432322|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
138432323|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
138432324|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432325|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432326|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138432327|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
138432328|NCT01743755|Hormones|hormones|mesh-ancestor
138432329|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138432330|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138432331|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432332|NCT01743794|Ropivacaine|ropivacaine|mesh-list
138432333|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
138432334|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
138432335|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432336|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432337|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
138432338|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432339|NCT01743820|Piperaquine|piperaquine|mesh-list
138432340|NCT01743820|Primaquine|primaquine|mesh-list
138432341|NCT01743820|Artenimol|artenimol|mesh-list
138432342|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
138432343|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138432344|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138432345|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138432346|NCT01743885|Propranolol|propranolol|mesh-list
138432347|NCT01743885|Acebutolol|acebutolol|mesh-list
138432348|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138372289|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432349|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138432350|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
138432351|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432352|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432353|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432354|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138432355|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138432356|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
138432357|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
138432358|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
138432359|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432360|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138432361|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
138432362|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138432363|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
138432364|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138432365|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
138432366|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432367|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432368|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
138432370|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
138432371|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138432372|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138432373|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432374|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432375|NCT01743911|Urological Agents|urological agents|mesh-ancestor
138432376|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
138432377|NCT01744106|Ephedrine|ephedrine|mesh-list
138432378|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138432379|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
138432380|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432381|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432382|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138432383|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
138432384|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
138432385|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138432386|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138432387|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
138432388|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
138432389|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432390|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432392|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
138432393|NCT01744184|Entonox|entonox|mesh-list
138432394|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138432395|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138432396|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432397|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432398|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138432399|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138432400|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138432401|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138432402|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
138432403|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
138432404|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
138391406|NCT01505049|Vaccines|vaccines|mesh-list
138432405|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
138432406|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432407|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432408|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138432409|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138432410|NCT01744184|Analgesics|analgesics|mesh-ancestor
138432411|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
138432412|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432413|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138432414|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138432415|NCT01744236|Liraglutide|liraglutide|mesh-list
138432416|NCT01744236|Exenatide|exenatide|mesh-list
138432417|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138432418|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432419|NCT01744236|Incretins|incretins|mesh-ancestor
138432420|NCT01744236|Hormones|hormones|mesh-ancestor
138401740|NCT05840406|Antipyretics|antipyretics|mesh-ancestor
138432421|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138198520|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198521|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138432422|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138432423|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
138432424|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432425|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432426|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138432427|NCT01744249|Axitinib|axitinib|mesh-list
138198522|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138198523|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
138198525|NCT00000658|Cytarabine|cytarabine|mesh-list
138432428|NCT01744249|Octreotide|octreotide|mesh-list
138198526|NCT00000658|Dexamethasone|dexamethasone|mesh-list
138198527|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
138432429|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432430|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138432431|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432432|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432434|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138432435|NCT01744288|Clopidogrel|clopidogrel|mesh-list
138432436|NCT01744288|Ticagrelor|ticagrelor|mesh-list
138432437|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138432438|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138432439|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138432440|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138432441|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
138432442|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432443|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432444|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432445|NCT01744314|Indomethacin|indomethacin|mesh-list
138432446|NCT01744314|Pantoprazole|pantoprazole|mesh-list
138432447|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138432448|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138432449|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138432450|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432451|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432452|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138432453|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138432454|NCT01744314|Analgesics|analgesics|mesh-ancestor
138432455|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
138432456|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432457|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432458|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138372399|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
138432459|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432460|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
138432461|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
138432462|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138432463|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138432464|NCT01744366|Goserelin|goserelin|mesh-list
138432465|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138432466|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432468|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
138432469|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432470|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
138432471|NCT01744444|Gabapentin|gabapentin|mesh-list
138432472|NCT01744444|Memantine|memantine|mesh-list
138432473|NCT01744444|Analgesics|analgesics|mesh-ancestor
138432474|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
138432475|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432476|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432477|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
138334789|NCT00788892|Cytarabine|cytarabine|mesh-list
138432478|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138432479|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138432480|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432481|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138401760|NCT05840328|Analgesics|analgesics|mesh-ancestor
138432482|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138432483|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138432484|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432485|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432486|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
138432487|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138432488|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138432489|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
138432490|NCT01744470|Tacrolimus|tacrolimus|mesh-list
138432491|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138432492|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
138372471|NCT01418534|Isosorbide|isosorbide|mesh-list
138432493|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198534|NCT00000658|Sargramostim|sargramostim|mesh-list
138432494|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138432495|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432496|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432497|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138432498|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
138432499|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432500|NCT01744587|Protective Agents|protective agents|mesh-ancestor
138432501|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432502|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138432503|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138432504|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432505|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138432506|NCT01744262|Anesthetics|anesthetics|mesh-list
138234884|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432507|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432508|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432509|NCT01744756|Bevacizumab|bevacizumab|mesh-list
138432510|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138432511|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432512|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138432513|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138432514|NCT01744756|Growth Substances|growth substances|mesh-ancestor
138432515|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432516|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
138432517|NCT01744873|Bisoprolol|bisoprolol|mesh-list
138432518|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138432519|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
138432520|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
138432521|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432522|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432523|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138432524|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138432525|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138432526|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
138432527|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432528|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432530|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
138432531|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
138432532|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432533|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198542|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198543|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432534|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
138432536|NCT01744626|Rituximab|rituximab|mesh-list
138432537|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138432538|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198544|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138198545|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138432539|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
138432540|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198546|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
138198551|NCT00000658|Hormones|hormones|mesh-ancestor
138432541|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432542|NCT01744964|Apomorphine|apomorphine|mesh-list
138432543|NCT01744964|Emetics|emetics|mesh-ancestor
138432544|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432545|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
138432546|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432547|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138432548|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
138432549|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
138432550|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432551|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432552|NCT01745081|Mannitol|mannitol|mesh-list
138432553|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138432554|NCT01745081|Diuretics|diuretics|mesh-ancestor
138432555|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
138432556|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432557|NCT01745159|Tacrolimus|tacrolimus|mesh-list
138432559|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
138432560|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432561|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138432562|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432563|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432564|NCT01745263|Vitamin D|vitamin d|mesh-list
138432565|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
138432566|NCT01745263|Vitamins|vitamins|mesh-ancestor
138432567|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
138432568|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432569|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138432570|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138432571|NCT01745302|Gefitinib|gefitinib|mesh-list
138432572|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432573|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138432574|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432575|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432576|NCT01745328|Amoxicillin|amoxicillin|mesh-list
138432577|NCT01745328|Levofloxacin|levofloxacin|mesh-list
138432578|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138234965|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
138432580|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138432581|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138432582|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138432583|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432584|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432585|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138334842|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432586|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138432587|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138432588|NCT01745549|Insulin|insulin|mesh-list
138432589|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138432590|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138432591|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432592|NCT01745562|Alprazolam|alprazolam|mesh-list
138372571|NCT01419041|Crizotinib|crizotinib|mesh-list
138432593|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138432594|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432595|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432596|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138432597|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138432598|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138432599|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
138432600|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
138432601|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432602|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432603|NCT01745575|Alprazolam|alprazolam|mesh-list
138432604|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138432605|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432606|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432607|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138432608|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138432609|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138432610|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
138432611|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
138432612|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432613|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432614|NCT01745601|Dexetimide|dexetimide|mesh-list
138432615|NCT01745601|Citalopram|citalopram|mesh-list
138432616|NCT01745601|Escitalopram|escitalopram|mesh-list
138432617|NCT01745601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138432618|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138432619|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138432620|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432621|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432622|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
138432623|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432624|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138432625|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138432626|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
138432627|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
138432628|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432629|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138432630|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138432631|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
138432632|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138432633|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
138432634|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138432635|NCT01745614|Nimesulide|nimesulide|mesh-list
138432636|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138432637|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138432638|NCT01745614|Analgesics|analgesics|mesh-ancestor
138432639|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
138432640|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432641|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432642|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138432643|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432644|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138432645|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432646|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432647|NCT01745640|Dexamethasone|dexamethasone|mesh-list
138432648|NCT01745640|Pomalidomide|pomalidomide|mesh-list
138432649|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138432650|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
138432651|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
138432652|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432653|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432654|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138432655|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
138432656|NCT01745640|Hormones|hormones|mesh-ancestor
138432657|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138432658|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138432659|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432660|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
138432661|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138432662|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138432663|NCT01745640|Growth Substances|growth substances|mesh-ancestor
138432664|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
138432665|NCT01745666|Epinephrine|epinephrine|mesh-list
138432666|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138432668|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
138432669|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432670|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432671|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432672|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138432673|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138432674|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
138432675|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432676|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138432677|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
138432678|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
138432679|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
138432680|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138432681|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
138198569|NCT00000658|Protective Agents|protective agents|mesh-ancestor
138198570|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
138432682|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138432683|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138432684|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138432685|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138432686|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138432687|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432688|NCT01745770|Mesalamine|mesalamine|mesh-list
138432689|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138432690|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138432691|NCT01745770|Analgesics|analgesics|mesh-ancestor
138432692|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
138432693|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138334878|NCT00795366|Vasopressins|vasopressins|mesh-list
138432694|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432695|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138432696|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432697|NCT01745809|Dimercaprol|dimercaprol|mesh-list
138432698|NCT01745809|Chelating Agents|chelating agents|mesh-ancestor
138432699|NCT01745809|Sequestering Agents|sequestering agents|mesh-ancestor
138432700|NCT01745809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432701|NCT01745835|Bisacodyl|bisacodyl|mesh-list
138432702|NCT01745835|Cathartics|cathartics|mesh-ancestor
138432703|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138235055|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432704|NCT01745835|Laxatives|laxatives|mesh-ancestor
138391690|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432705|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
138432706|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
138432707|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138432708|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138432709|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
138432710|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
138432711|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138432712|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138432713|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138432714|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138432715|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432716|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432717|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138432718|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138432719|NCT01746251|Afatinib|afatinib|mesh-list
138432720|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432721|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138432722|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432723|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432724|NCT01746277|Docetaxel|docetaxel|mesh-list
138432725|NCT01746277|Pemetrexed|pemetrexed|mesh-list
138432726|NCT01746277|Gefitinib|gefitinib|mesh-list
138432727|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432728|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
138432729|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
138432730|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
138432731|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432732|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432733|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138432734|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138432735|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138432736|NCT01746485|Treprostinil|treprostinil|mesh-list
138432737|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138432738|NCT01746563|Ranibizumab|ranibizumab|mesh-list
138432739|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138432740|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138432741|NCT01746563|Growth Substances|growth substances|mesh-ancestor
138432742|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432743|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
138432744|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198574|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
138198575|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
138432745|NCT01746602|Timolol|timolol|mesh-list
138432746|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138432747|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138432748|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
138432749|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432750|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432751|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432752|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138432753|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138432754|NCT01746641|Remifentanil|remifentanil|mesh-list
138432755|NCT01746641|Propofol|propofol|mesh-list
138432756|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138432757|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432758|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432759|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138432760|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
138432761|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
138432762|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138432763|NCT01746641|Narcotics|narcotics|mesh-ancestor
138432764|NCT01746641|Analgesics|analgesics|mesh-ancestor
138432765|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
138432766|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432767|NCT01746680|Methotrexate|methotrexate|mesh-list
138432768|NCT01746680|Tacrolimus|tacrolimus|mesh-list
138432769|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138432770|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
138432771|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138432772|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432773|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138432774|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
138432775|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432776|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432777|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
138432778|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432779|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138432780|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138432781|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
138432782|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432783|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138432784|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138432785|NCT01746719|Etodolac|etodolac|mesh-list
138432786|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138432787|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138432788|NCT01746719|Analgesics|analgesics|mesh-ancestor
138432789|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
138432790|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432791|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432792|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138432793|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432794|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138432795|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138432796|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432797|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432798|NCT01746771|Paclitaxel|paclitaxel|mesh-list
138432799|NCT01746771|Trastuzumab|trastuzumab|mesh-list
138432800|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138432801|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432802|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
138372806|NCT01420692|Gliclazide|gliclazide|mesh-list
138432803|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
138432804|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
138432805|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432806|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138432807|NCT01746823|Cyclosporine|cyclosporine|mesh-list
138432808|NCT01746823|Cyclosporins|cyclosporins|mesh-list
138432809|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432810|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432811|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138432812|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
138432813|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432814|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
138432815|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138432816|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
138432817|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432818|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138432819|NCT01746875|Aflibercept|aflibercept|mesh-list
138432820|NCT01746875|Verteporfin|verteporfin|mesh-list
138432821|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138432822|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138432823|NCT01746875|Growth Substances|growth substances|mesh-ancestor
138432824|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432825|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
138401922|NCT05552443|Hydromorphone|hydromorphone|mesh-list
138432826|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432827|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138432828|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
138432830|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
138432831|NCT01746992|Ifosfamide|ifosfamide|mesh-list
138432832|NCT01746992|Doxorubicin|doxorubicin|mesh-list
138432833|NCT01746992|Methotrexate|methotrexate|mesh-list
138432834|NCT01746992|Etoposide|etoposide|mesh-list
138432835|NCT01746992|Vincristine|vincristine|mesh-list
138432836|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
138432837|NCT01746992|Pirarubicin|pirarubicin|mesh-list
138432838|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138432839|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
138432840|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432841|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138432842|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138432843|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
138432844|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432845|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432846|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138372840|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138432847|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138432848|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138432849|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138432850|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432851|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138432853|NCT01746992|Hormones|hormones|mesh-ancestor
138432854|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138391840|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138432855|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138432856|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138432857|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
138432858|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138432859|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138432860|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
138432861|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
138432862|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138432863|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138432864|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138432865|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
138432866|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
138432867|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
138432868|NCT01747044|Milnacipran|milnacipran|mesh-list
138235188|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138432869|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
138432870|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138432871|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138432872|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138432873|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432874|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432875|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432876|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138432877|NCT01747044|Analgesics|analgesics|mesh-ancestor
138432878|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
138432879|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432880|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
138432881|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138432883|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138432884|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432886|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
138432887|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432888|NCT01747148|Radavirsen|radavirsen|mesh-list
138432889|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
138432890|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138432891|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
138432892|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138432893|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138432894|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432895|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
138432896|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432897|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432898|NCT01747174|Adenosine|adenosine|mesh-list
138432899|NCT01747174|Nitroprusside|nitroprusside|mesh-list
138432900|NCT01747174|Analgesics|analgesics|mesh-ancestor
138235221|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
138432901|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
138432902|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138432903|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432904|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138432905|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
138432906|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138432907|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
138432908|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
138432909|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432910|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432911|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138432912|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138432913|NCT01747226|Fluorides|fluorides|mesh-list
138432914|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
138432915|NCT01747226|Protective Agents|protective agents|mesh-ancestor
138334970|NCT00803010|Sirolimus|sirolimus|mesh-list
138432916|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432917|NCT01747252|Resveratrol|resveratrol|mesh-list
138432918|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
138432919|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432920|NCT01747252|Protective Agents|protective agents|mesh-ancestor
138432921|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432923|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138432924|NCT01747278|Trimethoprim|trimethoprim|mesh-list
138432925|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
138432926|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138432927|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138432928|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
138432929|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138432930|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138432931|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138432932|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138235263|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138235266|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
138432933|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432934|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138432935|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138432936|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138432938|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138432939|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138432940|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138432941|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
138432942|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432943|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432944|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432945|NCT01747564|Urological Agents|urological agents|mesh-ancestor
138198599|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
138432947|NCT01747590|Alprazolam|alprazolam|mesh-list
138432948|NCT01747590|Caffeine|caffeine|mesh-list
138432949|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138432950|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432951|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138432952|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138432953|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432954|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138432955|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138432956|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
138432957|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138432958|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138432959|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138432960|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138432961|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138432962|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
138432963|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
138372959|NCT01421901|Ertapenem|ertapenem|mesh-list
138432964|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138432965|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138432966|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138432967|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
138432968|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
138432969|NCT01747616|Chitosan|chitosan|mesh-list
138432970|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138432971|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138432972|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138432973|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
138432974|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138432975|NCT01747616|Expectorants|expectorants|mesh-ancestor
138432976|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
138432977|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138432978|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
138334975|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138432979|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432980|NCT01747616|Protective Agents|protective agents|mesh-ancestor
138432981|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138432982|NCT01747616|Antidotes|antidotes|mesh-ancestor
138432983|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138432984|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138432985|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
138432986|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138432987|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
138432988|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
138432990|NCT01747616|Coagulants|coagulants|mesh-ancestor
138432991|NCT01747642|Sorafenib|sorafenib|mesh-list
138432992|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138432993|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138432995|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138432996|NCT01747668|Tocopherols|tocopherols|mesh-list
138432997|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
138432998|NCT01747668|Vitamin E|vitamin e|mesh-list
138432999|NCT01747668|Vitamins|vitamins|mesh-ancestor
138433000|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
138433001|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433002|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
138433003|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433004|NCT01747668|Protective Agents|protective agents|mesh-ancestor
138433005|NCT01747707|Docetaxel|docetaxel|mesh-list
138433006|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433007|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
138433008|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
138433009|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
138433010|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433012|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
138433013|NCT01747720|Vitamins|vitamins|mesh-ancestor
138433014|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
138198605|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433015|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433016|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138433017|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138433018|NCT01747746|Enoxaparin|enoxaparin|mesh-list
138433019|NCT01747746|Warfarin|warfarin|mesh-list
138433020|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
138433021|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
138433022|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138433023|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
138433024|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138433025|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
138433026|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433027|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433028|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138433029|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138433030|NCT01747798|Auranofin|auranofin|mesh-list
138433031|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138433032|NCT01747993|Tamsulosin|tamsulosin|mesh-list
138433033|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138433034|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138433036|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
138433037|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433038|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433039|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433040|NCT01747993|Urological Agents|urological agents|mesh-ancestor
138433041|NCT01748019|Namitecan|namitecan|mesh-list
138433042|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138433043|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433044|NCT01748084|Rituximab|rituximab|mesh-list
138402080|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138433046|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433047|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
138433048|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433049|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138433050|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138433051|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
138433052|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138433053|NCT01748123|Diuretics|diuretics|mesh-ancestor
138433054|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
138433055|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433056|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138433057|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138373006|NCT01422018|Growth Substances|growth substances|mesh-ancestor
138433058|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433059|NCT01748253|Amlodipine|amlodipine|mesh-list
138433060|NCT01748253|Telmisartan|telmisartan|mesh-list
138433061|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
138433062|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138433063|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138433064|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138198615|NCT01029587|Eculizumab|eculizumab|mesh-list
138433065|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198616|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138198617|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138198618|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
138198619|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433066|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138433067|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433068|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
138433069|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138433070|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138433071|NCT01748279|Atorvastatin|atorvastatin|mesh-list
138433072|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
138433073|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138433074|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138433075|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
138433076|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433077|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138235354|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138433078|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138433079|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433080|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138433081|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
138433082|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433083|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433084|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138433085|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
138433086|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138433087|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138433088|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138433089|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
138433090|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433091|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138433092|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138433093|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138433094|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138433095|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
138433096|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138433097|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138433099|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138433100|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138433101|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138433102|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
138433103|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
138433104|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433105|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433106|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433107|NCT01748370|Vitamin D|vitamin d|mesh-list
138433109|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
138433110|NCT01748370|Vitamins|vitamins|mesh-list
138433111|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
138433112|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433113|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138373076|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
138433114|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138433115|NCT01748396|Calcitriol|calcitriol|mesh-list
138433116|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
138433117|NCT01748396|Calcium|calcium|mesh-list
138433118|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138433119|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433120|NCT01748396|Antacids|antacids|mesh-ancestor
138433121|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198636|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198638|NCT00000670|Probenecid|probenecid|mesh-list
138433122|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138433123|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138433124|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138433125|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138433126|NCT01748396|Vitamins|vitamins|mesh-ancestor
138433127|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
138433128|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138433130|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
138433131|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
138433132|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
138433133|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433134|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433135|NCT01748435|Capsaicin|capsaicin|mesh-list
138433136|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
138433137|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
138433138|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
138335040|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138433139|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433140|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433141|NCT01748487|Dexamethasone|dexamethasone|mesh-list
138433142|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
138433143|NCT01748487|BB 1101|bb 1101|mesh-list
138433144|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138433145|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
138433146|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
138433147|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433148|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433149|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138433150|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
138433151|NCT01748487|Hormones|hormones|mesh-ancestor
138235428|NCT01421186|Dexamethasone|dexamethasone|mesh-list
138433152|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138433153|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138433154|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433156|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433157|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433158|NCT01748500|Pantoprazole|pantoprazole|mesh-list
138433159|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138433160|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138433161|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138433162|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433163|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433164|NCT01748526|Canagliflozin|canagliflozin|mesh-list
138433165|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138433166|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433167|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138433168|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433169|NCT01748539|Brodalumab|brodalumab|mesh-list
138433170|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
138433171|NCT01748630|Midazolam|midazolam|mesh-list
138433172|NCT01748630|Fentanyl|fentanyl|mesh-list
138433173|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
138433174|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138433175|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138433176|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433177|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138433178|NCT01748630|Analgesics|analgesics|mesh-ancestor
138433179|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
138433180|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433181|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138433182|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138433183|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138433184|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
138433185|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433186|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138235463|NCT01860521|Sufentanil|sufentanil|mesh-list
138433187|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138433188|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138402183|NCT04305444|Pomalidomide|pomalidomide|mesh-list
138433189|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138433190|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138433191|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138433192|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
138433193|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
138433194|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
138433195|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
138433196|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138433198|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
138433199|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
138433200|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433201|NCT01748669|Protective Agents|protective agents|mesh-ancestor
138433202|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433203|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138433204|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433205|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138433206|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433208|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138433209|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
138433210|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433211|NCT01748747|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138433212|NCT01748747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138433213|NCT01748747|Immunologic Factors|immunologic factors|mesh-ancestor
138433214|NCT01748747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433215|NCT01748773|Capecitabine|capecitabine|mesh-list
138433216|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
138433217|NCT01748773|Trastuzumab|trastuzumab|mesh-list
138433218|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138433219|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
138433220|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433221|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433222|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138433223|NCT01748838|Mannitol|mannitol|mesh-list
138433224|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138433225|NCT01748838|Diuretics|diuretics|mesh-ancestor
138433226|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
138433227|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138235505|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433228|NCT01748929|Albendazole|albendazole|mesh-list
138433229|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
138433230|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138433231|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138433232|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
138433233|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138433234|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138392218|NCT01508572|Bevacizumab|bevacizumab|mesh-list
138433235|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
138433236|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
138433237|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
138433238|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433239|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433240|NCT01749072|Vinorelbine|vinorelbine|mesh-list
138433241|NCT01749072|Ifosfamide|ifosfamide|mesh-list
138433242|NCT01749072|Gefitinib|gefitinib|mesh-list
138433243|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138433244|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433245|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
138433246|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
138433247|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
138433248|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433249|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138433250|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
138433251|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138433252|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433253|NCT01749085|Ketoconazole|ketoconazole|mesh-list
138433254|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
138433255|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138433256|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138433257|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138433258|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433259|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433260|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138433261|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
138433262|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138433263|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433264|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138433265|NCT01749098|Ketamine|ketamine|mesh-list
138235540|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
138433266|NCT01749098|Analgesics|analgesics|mesh-ancestor
138433267|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
138433268|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433269|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433270|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138433271|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138433272|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
138433273|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
138433274|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138433275|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138433276|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138433277|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433278|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433279|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
138433280|NCT01749111|Methotrexate|methotrexate|mesh-list
138433281|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
138433282|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138433283|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
138433284|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433285|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138433286|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138433287|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
138433288|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433289|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433290|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138433291|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138433292|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
138433293|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138433294|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138433295|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
138433296|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
138433297|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433298|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138433299|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138433300|NCT01749150|Ritonavir|ritonavir|mesh-list
138433301|NCT01749150|Ribavirin|ribavirin|mesh-list
138433302|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138433303|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
138433304|NCT01749150|Lactams|lactams|mesh-list
138433305|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138433306|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138235569|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
138433307|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
138392291|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138433308|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433309|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433310|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138433311|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138433312|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
138433313|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138433314|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138433315|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138433316|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
138433317|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
138433318|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433319|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138433321|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138433322|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138433323|NCT01749228|Analgesics|analgesics|mesh-ancestor
138433324|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
138433325|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433326|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433327|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138433328|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138433329|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138433330|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138433331|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335135|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
138433332|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433333|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138433334|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138433335|NCT01749319|Baclofen|baclofen|mesh-list
138433336|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138433337|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433338|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138373322|NCT01423708|Everolimus|everolimus|mesh-list
138433339|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433340|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138433341|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
138433343|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433344|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433345|NCT01749371|Vitamins|vitamins|mesh-list
138433346|NCT01749371|Vitamin E|vitamin e|mesh-list
138433347|NCT01749371|Tocopherols|tocopherols|mesh-list
138433348|NCT01749371|Tocotrienols|tocotrienols|mesh-list
138433349|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
138433350|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
138433351|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433353|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433354|NCT01749371|Protective Agents|protective agents|mesh-ancestor
138433355|NCT01749384|Bevacizumab|bevacizumab|mesh-list
138433356|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138433357|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
138433358|NCT01749384|Antibodies|antibodies|mesh-list
138433359|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
138433360|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138433361|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
138433362|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433363|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138433364|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138433365|NCT01749384|Growth Substances|growth substances|mesh-ancestor
138433366|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433367|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
138433368|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
138433369|NCT01749397|Fluorouracil|fluorouracil|mesh-list
138433370|NCT01749397|Floxuridine|floxuridine|mesh-list
138433372|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
138433373|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
138433374|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433375|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138433376|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433377|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138433378|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
138433379|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433380|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138433381|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433382|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
138433383|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138433384|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138433385|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138433386|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138433387|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433388|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
138433389|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433390|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433391|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138433392|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433393|NCT01749475|Midazolam|midazolam|mesh-list
138433394|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138433395|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138433396|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138433397|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433398|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138433399|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138433400|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138433401|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138433402|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
138433404|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
138433405|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
138433406|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433407|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433409|NCT01749514|Hematinics|hematinics|mesh-ancestor
138433410|NCT01749540|Luspatercept|luspatercept|mesh-list
138433411|NCT01749540|Hematinics|hematinics|mesh-ancestor
138433412|NCT01749566|Maraviroc|maraviroc|mesh-list
138215210|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138215211|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433413|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138433414|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138433415|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433416|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138433417|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138433418|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
138433419|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138433420|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138433421|NCT01749579|Midazolam|midazolam|mesh-list
138433422|NCT01749579|Fentanyl|fentanyl|mesh-list
138433424|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138433425|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138433426|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433427|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138433428|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
138433429|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
138433430|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138433431|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138433432|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138433433|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138433434|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
138433435|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
138433436|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433437|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433438|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138433439|NCT01749579|Narcotics|narcotics|mesh-ancestor
138433440|NCT01749579|Analgesics|analgesics|mesh-ancestor
138433441|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
138335189|NCT00821886|Carboplatin|carboplatin|mesh-list
138433442|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433443|NCT01750060|Fentanyl|fentanyl|mesh-list
138433444|NCT01750060|Naltrexone|naltrexone|mesh-list
138433445|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138433446|NCT01750060|Narcotics|narcotics|mesh-ancestor
138433447|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138433448|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433449|NCT01750060|Analgesics|analgesics|mesh-ancestor
138433450|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
138373518|NCT01424761|Ubiquinone|ubiquinone|mesh-list
138433451|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433452|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138433453|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138433454|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
138433455|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
138433456|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138433457|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138433458|NCT01750099|Lidocaine|lidocaine|mesh-list
138433459|NCT01750099|Epinephrine|epinephrine|mesh-list
138433460|NCT01750099|Fentanyl|fentanyl|mesh-list
138433461|NCT01750099|Bupivacaine|bupivacaine|mesh-list
138433462|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
138433464|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138433465|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433466|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
138433467|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433468|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138433469|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138433470|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138433471|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138433472|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433473|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138433474|NCT01750099|Narcotics|narcotics|mesh-ancestor
138433475|NCT01750099|Analgesics|analgesics|mesh-ancestor
138433476|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138433477|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138433478|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
138433479|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138433480|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138433481|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
138402259|NCT04175262|Sunitinib|sunitinib|mesh-list
138433482|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433483|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138433484|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138433485|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
138433486|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138433487|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
138433488|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
138433489|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
138433490|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138433491|NCT06176573|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138433492|NCT06176573|Chlorhexidine|chlorhexidine|mesh-list
138433493|NCT06176573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138433494|NCT06176573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138433495|NCT06176573|Disinfectants|disinfectants|mesh-ancestor
138433496|NCT06176560|Mesalamine|mesalamine|mesh-list
138373544|NCT01424839|Cisplatin|cisplatin|mesh-list
138433497|NCT06176560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138433499|NCT06176560|Analgesics|analgesics|mesh-ancestor
138433500|NCT06176560|Sensory System Agents|sensory system agents|mesh-ancestor
138433501|NCT06176560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433502|NCT06176560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433503|NCT06176560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138433504|NCT06176560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138433505|NCT06176534|Capecitabine|capecitabine|mesh-list
138433506|NCT06176534|Vinorelbine|vinorelbine|mesh-list
138433507|NCT06176534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138433508|NCT06176534|Antimetabolites|antimetabolites|mesh-ancestor
138433509|NCT06176534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433510|NCT06176534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433511|NCT06176534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138433512|NCT06176534|Tubulin Modulators|tubulin modulators|mesh-ancestor
138433513|NCT06176534|Antimitotic Agents|antimitotic agents|mesh-ancestor
138433514|NCT06176534|Mitosis Modulators|mitosis modulators|mesh-ancestor
138433515|NCT06176508|Tofacitinib|tofacitinib|mesh-list
138433516|NCT06176508|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138433517|NCT06176508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138433518|NCT06176508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433519|NCT06176508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433520|NCT06176352|Ranibizumab|ranibizumab|mesh-list
138433521|NCT06176352|Faricimab|faricimab|mesh-list
138433522|NCT06176352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138433523|NCT06176352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138433524|NCT06176352|Growth Substances|growth substances|mesh-ancestor
138433525|NCT06176352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433526|NCT06176352|Growth Inhibitors|growth inhibitors|mesh-ancestor
138433527|NCT06176352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433528|NCT06176339|Cyclophosphamide|cyclophosphamide|mesh-list
138433529|NCT06176339|Doxorubicin|doxorubicin|mesh-list
138433530|NCT06176339|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138433531|NCT06176339|Taxane|taxane|mesh-list
138433532|NCT06176339|Pentoxifylline|pentoxifylline|mesh-list
138433533|NCT06176339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138433534|NCT06176339|Immunologic Factors|immunologic factors|mesh-ancestor
138433535|NCT06176339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433536|NCT06176339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138433537|NCT06176339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138433538|NCT06176339|Alkylating Agents|alkylating agents|mesh-ancestor
138433539|NCT06176339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433540|NCT06176339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433541|NCT06176339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138433542|NCT06176339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138235720|NCT05439993|Paclitaxel|paclitaxel|mesh-list
138433543|NCT06176339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138433544|NCT06176339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138433545|NCT06176339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433546|NCT06176339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138433547|NCT06176339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138433548|NCT06176339|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138433549|NCT06176339|Protective Agents|protective agents|mesh-ancestor
138433550|NCT06176339|Vasodilator Agents|vasodilator agents|mesh-ancestor
138198659|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198660|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
138433551|NCT06176339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138433552|NCT06176339|Antioxidants|antioxidants|mesh-ancestor
138433553|NCT06176248|Triamcinolone|triamcinolone|mesh-list
138198661|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138433554|NCT06176248|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138433555|NCT06176248|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138433556|NCT06176248|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138433557|NCT06176248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138433558|NCT06176248|Glucocorticoids|glucocorticoids|mesh-ancestor
138433559|NCT06176248|Hormones|hormones|mesh-ancestor
138433560|NCT06176248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138433561|NCT06176248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433562|NCT06176248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138433563|NCT06176248|Immunologic Factors|immunologic factors|mesh-ancestor
138433564|NCT06176248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433565|NCT06176248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433566|NCT06176222|Dexmedetomidine|dexmedetomidine|mesh-list
138433567|NCT06176222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138433568|NCT06176222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138433569|NCT06176222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433570|NCT06176222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138433571|NCT06176222|Analgesics|analgesics|mesh-ancestor
138433572|NCT06176222|Sensory System Agents|sensory system agents|mesh-ancestor
138433573|NCT06176222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433574|NCT06176222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138433575|NCT06176222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138433576|NCT06176222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138433577|NCT06176222|Adrenergic Agents|adrenergic agents|mesh-ancestor
138433578|NCT06176222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433579|NCT06176222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433580|NCT06176157|Vitamin D|vitamin d|mesh-list
138433587|NCT06176157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138433589|NCT06176144|Desflurane|desflurane|mesh-list
138433590|NCT06176144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138433591|NCT06176144|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138433592|NCT06176144|Anesthetics, General|anesthetics, general|mesh-ancestor
138433593|NCT06176144|Anesthetics|anesthetics|mesh-ancestor
138402319|NCT03983993|Panitumumab|panitumumab|mesh-list
138433594|NCT06176144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138433595|NCT06176144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433602|NCT06175806|Ondansetron|ondansetron|mesh-list
138433603|NCT06175806|Granisetron|granisetron|mesh-list
138433604|NCT06175806|Antiemetics|antiemetics|mesh-ancestor
138433605|NCT06175806|Autonomic Agents|autonomic agents|mesh-ancestor
138433606|NCT06175806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433607|NCT06175806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433608|NCT06175806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138433609|NCT06175806|Antipruritics|antipruritics|mesh-ancestor
138433610|NCT06175806|Dermatologic Agents|dermatologic agents|mesh-ancestor
138433611|NCT06175806|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138433612|NCT06175806|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138433613|NCT06175806|Serotonin Agents|serotonin agents|mesh-ancestor
138433614|NCT06175806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433615|NCT06175806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433616|NCT06175702|Cytarabine|cytarabine|mesh-list
138433617|NCT06175702|Dexamethasone|dexamethasone|mesh-list
138433618|NCT06175702|Cyclophosphamide|cyclophosphamide|mesh-list
138433619|NCT06175702|Methotrexate|methotrexate|mesh-list
138433620|NCT06175702|Fludarabine|fludarabine|mesh-list
138433621|NCT06175702|Vincristine|vincristine|mesh-list
138433622|NCT06175702|Imatinib Mesylate|imatinib mesylate|mesh-list
138433623|NCT06175702|Mercaptopurine|mercaptopurine|mesh-list
138433624|NCT06175702|Ponatinib|ponatinib|mesh-list
138433625|NCT06175702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138433626|NCT06175702|Immunologic Factors|immunologic factors|mesh-ancestor
138433627|NCT06175702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433628|NCT06175702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138433629|NCT06175702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138433630|NCT06175702|Alkylating Agents|alkylating agents|mesh-ancestor
138433631|NCT06175702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433632|NCT06175702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433633|NCT06175702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138433634|NCT06175702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138433635|NCT06175702|Antiemetics|antiemetics|mesh-ancestor
138433636|NCT06175702|Autonomic Agents|autonomic agents|mesh-ancestor
138433637|NCT06175702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433638|NCT06175702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138433639|NCT06175702|Glucocorticoids|glucocorticoids|mesh-ancestor
138433640|NCT06175702|Hormones|hormones|mesh-ancestor
138433641|NCT06175702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138433642|NCT06175702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138433643|NCT06175702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138433644|NCT06175702|Abortifacient Agents|abortifacient agents|mesh-ancestor
138433645|NCT06175702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138433646|NCT06175702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138402381|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
138433648|NCT06175702|Dermatologic Agents|dermatologic agents|mesh-ancestor
138433649|NCT06175702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433650|NCT06175702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138433651|NCT06175702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138433652|NCT06175702|Antiviral Agents|antiviral agents|mesh-ancestor
138433653|NCT06175702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138433654|NCT06175702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138433655|NCT06175702|Tubulin Modulators|tubulin modulators|mesh-ancestor
138433656|NCT06175702|Antimitotic Agents|antimitotic agents|mesh-ancestor
138433657|NCT06175702|Mitosis Modulators|mitosis modulators|mesh-ancestor
138433658|NCT06175702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138433660|NCT06175676|Chitosan|chitosan|mesh-list
138433661|NCT06175676|Antimetabolites|antimetabolites|mesh-ancestor
138433662|NCT06175676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433663|NCT06175676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138433664|NCT06175676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433665|NCT06175676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138433666|NCT06175676|Immunologic Factors|immunologic factors|mesh-ancestor
138335267|NCT00830076|Metformin|metformin|mesh-list
138433667|NCT06175676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433668|NCT06175676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138433669|NCT06175676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138433670|NCT06175676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138433671|NCT06175676|Chelating Agents|chelating agents|mesh-ancestor
138433672|NCT06175676|Sequestering Agents|sequestering agents|mesh-ancestor
138433673|NCT06175676|Hemostatics|hemostatics|mesh-ancestor
138433674|NCT06175676|Coagulants|coagulants|mesh-ancestor
138433675|NCT06175663|Antihypertensive Agents|antihypertensive agents|mesh-list
138433676|NCT06175507|Baclofen|baclofen|mesh-list
138433677|NCT06175507|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138433678|NCT06175507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433679|NCT06175507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138433680|NCT06175507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433681|NCT06175507|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138433682|NCT06175507|GABA Agonists|gaba agonists|mesh-ancestor
138433683|NCT06175507|GABA Agents|gaba agents|mesh-ancestor
138433684|NCT06175507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433685|NCT06175507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433686|NCT06174883|Folic Acid|folic acid|mesh-list
138392671|NCT01511263|Diuretics|diuretics|mesh-list
138433687|NCT06174883|Hematinics|hematinics|mesh-ancestor
138433688|NCT06174883|Vitamin B Complex|vitamin b complex|mesh-ancestor
138433689|NCT06174883|Vitamins|vitamins|mesh-ancestor
138433690|NCT06174883|Micronutrients|micronutrients|mesh-ancestor
138433691|NCT06174883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433692|NCT06168214|Amoxicillin|amoxicillin|mesh-list
138433693|NCT06168214|Clarithromycin|clarithromycin|mesh-list
138433694|NCT06168214|Tetracycline|tetracycline|mesh-list
138433695|NCT06168214|Furazolidone|furazolidone|mesh-list
138433697|NCT06168214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138433698|NCT06168214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138433699|NCT06168214|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138433700|NCT06168214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433701|NCT06168214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433702|NCT06168214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138433703|NCT06168214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138433704|NCT06168214|Antacids|antacids|mesh-ancestor
138433705|NCT06168214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138433706|NCT06168214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138433707|NCT06168214|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138433708|NCT06168214|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138433709|NCT06168214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138433710|NCT06168214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138433711|NCT06168214|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138433712|NCT06162611|Levonorgestrel|levonorgestrel|mesh-list
138433713|NCT06162611|Etonogestrel|etonogestrel|mesh-list
138433714|NCT06162611|Desogestrel|desogestrel|mesh-list
138433715|NCT06162611|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138433716|NCT06162611|Contraceptive Agents|contraceptive agents|mesh-ancestor
138235840|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138433717|NCT06162611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138433718|NCT06162611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433719|NCT06162611|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138433720|NCT06162611|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138433721|NCT06162611|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138433722|NCT06162611|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138433723|NCT06162611|Progestins|progestins|mesh-ancestor
138433725|NCT06162611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138433727|NCT06152172|Fludarabine|fludarabine|mesh-list
138433728|NCT06152172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138433729|NCT06152172|Immunologic Factors|immunologic factors|mesh-ancestor
138433730|NCT06152172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433731|NCT06152172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138433732|NCT06152172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138433733|NCT06152172|Alkylating Agents|alkylating agents|mesh-ancestor
138433734|NCT06152172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433735|NCT06152172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433736|NCT06152172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138433737|NCT06135493|Losartan|losartan|mesh-list
138433738|NCT06135493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138433739|NCT06135493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138433740|NCT06135493|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138433741|NCT06135493|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138433742|NCT06135493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433743|NCT06111079|Aspirin|aspirin|mesh-list
138433744|NCT06111079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138433745|NCT06111079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138433746|NCT06111079|Analgesics|analgesics|mesh-ancestor
138433747|NCT06111079|Sensory System Agents|sensory system agents|mesh-ancestor
138433748|NCT06111079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433749|NCT06111079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433750|NCT06111079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138433751|NCT06111079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138433752|NCT06111079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138433753|NCT06111079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138433754|NCT06111079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433755|NCT06111079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138433756|NCT06111079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138433757|NCT06111079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433758|NCT06111079|Antipyretics|antipyretics|mesh-ancestor
138433759|NCT06109402|Paclitaxel|paclitaxel|mesh-list
138433760|NCT06109402|Carboplatin|carboplatin|mesh-list
138433761|NCT06109402|Pemetrexed|pemetrexed|mesh-list
138433762|NCT06109402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138433763|NCT06109402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392752|NCT01511627|Anesthetics|anesthetics|mesh-list
138433764|NCT06109402|Tubulin Modulators|tubulin modulators|mesh-ancestor
138433765|NCT06109402|Antimitotic Agents|antimitotic agents|mesh-ancestor
138373896|NCT05113615|Bromides|bromides|mesh-list
138433767|NCT06109402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433768|NCT06109402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433769|NCT06109402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138433770|NCT06109402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138433772|NCT06100432|Vitamin E|vitamin e|mesh-list
138433773|NCT06100432|Beta Carotene|beta carotene|mesh-list
138433774|NCT06100432|Carotenoids|carotenoids|mesh-list
138433775|NCT06100432|Micronutrients|micronutrients|mesh-ancestor
138433776|NCT06100432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433777|NCT06100432|Antioxidants|antioxidants|mesh-ancestor
138433778|NCT06100432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433779|NCT06100432|Protective Agents|protective agents|mesh-ancestor
138433780|NCT06100432|Provitamins|provitamins|mesh-ancestor
138433781|NCT06093893|Labetalol|labetalol|mesh-list
138433782|NCT06093893|Nicardipine|nicardipine|mesh-list
138433783|NCT06093893|Dexmedetomidine|dexmedetomidine|mesh-list
138433784|NCT06093893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138433785|NCT06093893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138335304|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
138433786|NCT06093893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433787|NCT06093893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138433788|NCT06093893|Analgesics|analgesics|mesh-ancestor
138433789|NCT06093893|Sensory System Agents|sensory system agents|mesh-ancestor
138433790|NCT06093893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433791|NCT06093893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138433792|NCT06093893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138433793|NCT06093893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138433794|NCT06093893|Adrenergic Agents|adrenergic agents|mesh-ancestor
138433795|NCT06093893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433796|NCT06093893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433797|NCT06093893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138433798|NCT06093893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138433799|NCT06093893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138433801|NCT06093893|Autonomic Agents|autonomic agents|mesh-ancestor
138433802|NCT06093893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138433803|NCT06093893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138433804|NCT06093893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138433805|NCT06093893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138433806|NCT06093893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138433807|NCT06093893|Vasodilator Agents|vasodilator agents|mesh-ancestor
138433808|NCT06060847|Liver Extracts|liver extracts|mesh-list
138433809|NCT06060847|Hematinics|hematinics|mesh-ancestor
138433810|NCT06028464|Carbamazepine|carbamazepine|mesh-list
138433811|NCT06028464|Anticonvulsants|anticonvulsants|mesh-ancestor
138433812|NCT06028464|Antimanic Agents|antimanic agents|mesh-ancestor
138433813|NCT06028464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138433814|NCT06028464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138433815|NCT06028464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433816|NCT06028464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138433817|NCT06028464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138433818|NCT06028464|Analgesics|analgesics|mesh-ancestor
138433819|NCT06028464|Sensory System Agents|sensory system agents|mesh-ancestor
138433820|NCT06028464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433821|NCT06028464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138433822|NCT06028464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138433823|NCT06028464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433824|NCT06028464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138433825|NCT06028464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138433826|NCT06011629|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138433827|NCT06011629|Laxatives|laxatives|mesh-ancestor
138433828|NCT06011629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138433833|NCT05996133|Antiemetics|antiemetics|mesh-ancestor
138433834|NCT05996133|Autonomic Agents|autonomic agents|mesh-ancestor
138433835|NCT05996133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433836|NCT05996133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433837|NCT05996133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138433838|NCT05996133|Glucocorticoids|glucocorticoids|mesh-ancestor
138433839|NCT05996133|Hormones|hormones|mesh-ancestor
138433840|NCT05996133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138433841|NCT05996133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138433842|NCT05996133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433843|NCT05996133|Anesthetics, Local|anesthetics, local|mesh-ancestor
138433845|NCT05996133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138433846|NCT05996133|Sensory System Agents|sensory system agents|mesh-ancestor
138433847|NCT05996133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138433848|NCT05996133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138433849|NCT05996133|Adrenergic Agents|adrenergic agents|mesh-ancestor
138433850|NCT05996133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433851|NCT05996133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433852|NCT05996133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138433853|NCT05996133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138235938|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
138433854|NCT05996133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138433855|NCT05996133|Respiratory System Agents|respiratory system agents|mesh-ancestor
138433856|NCT05996133|Mydriatics|mydriatics|mesh-ancestor
138433857|NCT05996133|Sympathomimetics|sympathomimetics|mesh-ancestor
138433858|NCT05996133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138433859|NCT05975307|Carboplatin|carboplatin|mesh-list
138433860|NCT05975307|Gemcitabine|gemcitabine|mesh-list
138433861|NCT05975307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138374007|NCT03882463|Insulin|insulin|mesh-list
138433862|NCT05975307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138433864|NCT05975307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433865|NCT05974267|Atovaquone|atovaquone|mesh-list
138433866|NCT05974267|Pyronaridine|pyronaridine|mesh-list
138433867|NCT05974267|Proguanil|proguanil|mesh-list
138433868|NCT05974267|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138433869|NCT05974267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138433870|NCT05974267|Antimalarials|antimalarials|mesh-ancestor
138433871|NCT05974267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138433872|NCT05974267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138433873|NCT05974267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433874|NCT05974267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433875|NCT05974267|Antimetabolites|antimetabolites|mesh-ancestor
138433879|NCT05924971|Aspirin|aspirin|mesh-list
138433880|NCT05924971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138433881|NCT05924971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138433882|NCT05924971|Analgesics|analgesics|mesh-ancestor
138433883|NCT05924971|Sensory System Agents|sensory system agents|mesh-ancestor
138433884|NCT05924971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138402445|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
138433885|NCT05924971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433886|NCT05924971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138433887|NCT05924971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138433888|NCT05924971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138433889|NCT05924971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138433890|NCT05924971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433891|NCT05924971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138433892|NCT05924971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138433893|NCT05924971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433894|NCT05924971|Antipyretics|antipyretics|mesh-ancestor
138433895|NCT05924815|Moxifloxacin|moxifloxacin|mesh-list
138433896|NCT05924815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138433897|NCT05924815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138433898|NCT05924815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138433899|NCT05924815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138433900|NCT05924815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433901|NCT05924815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433902|NCT05924815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433903|NCT05922930|Cyclophosphamide|cyclophosphamide|mesh-list
138433904|NCT05922930|Fludarabine|fludarabine|mesh-list
138433905|NCT05922930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138433906|NCT05922930|Immunologic Factors|immunologic factors|mesh-ancestor
138433907|NCT05922930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433908|NCT05922930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138433909|NCT05922930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138433910|NCT05922930|Alkylating Agents|alkylating agents|mesh-ancestor
138433911|NCT05922930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433912|NCT05922930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433913|NCT05922930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138433915|NCT05898724|Dermatologic Agents|dermatologic agents|mesh-ancestor
138433916|NCT05898724|Sunscreening Agents|sunscreening agents|mesh-ancestor
138433917|NCT05898724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138433918|NCT05898724|Protective Agents|protective agents|mesh-ancestor
138433919|NCT05898724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433920|NCT05846789|Carboplatin|carboplatin|mesh-list
138433921|NCT05846789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433922|NCT05806515|Carboplatin|carboplatin|mesh-list
138433923|NCT05806515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433924|NCT05781620|Vitamin D|vitamin d|mesh-list
138433925|NCT05781620|Vitamins|vitamins|mesh-ancestor
138433926|NCT05781620|Micronutrients|micronutrients|mesh-ancestor
138235970|NCT04976595|Hormones|hormones|mesh-ancestor
138433927|NCT05781620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433928|NCT05781620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138433929|NCT05769881|Anesthetics|anesthetics|mesh-list
138433930|NCT05769881|Anesthetics, Local|anesthetics, local|mesh-list
138433931|NCT05769881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138433932|NCT05769881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433933|NCT05769881|Sensory System Agents|sensory system agents|mesh-ancestor
138433934|NCT05769881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433935|NCT05765500|Leuprolide|leuprolide|mesh-list
138198672|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138198673|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138198674|NCT01894412|Analgesics|analgesics|mesh-ancestor
138433936|NCT05765500|Relugolix|relugolix|mesh-list
138433937|NCT05765500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138433938|NCT05765500|Fertility Agents|fertility agents|mesh-ancestor
138433939|NCT05765500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138433940|NCT05765500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374077|NCT02767882|Hormones|hormones|mesh-ancestor
138433941|NCT05765500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138433942|NCT05765500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433943|NCT05765500|Androgen Antagonists|androgen antagonists|mesh-ancestor
138433944|NCT05765500|Hormone Antagonists|hormone antagonists|mesh-ancestor
138335435|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138433945|NCT05765500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138433947|NCT05757466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138433948|NCT05757466|Alkylating Agents|alkylating agents|mesh-ancestor
138433949|NCT05757466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433950|NCT05757466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433951|NCT05753189|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138433952|NCT05753189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138433953|NCT05753189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138433954|NCT05753189|Aceclidine|aceclidine|mesh-list
138433955|NCT05753189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138433956|NCT05753189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138433957|NCT05753189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138433958|NCT05753189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138433959|NCT05753189|Adrenergic Agents|adrenergic agents|mesh-ancestor
138433960|NCT05753189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433961|NCT05753189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433962|NCT05753189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433963|NCT05753189|Miotics|miotics|mesh-ancestor
138433964|NCT05753189|Autonomic Agents|autonomic agents|mesh-ancestor
138433965|NCT05753189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433966|NCT05753189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138433967|NCT05746208|Pembrolizumab|pembrolizumab|mesh-list
138433968|NCT05746208|Lenvatinib|lenvatinib|mesh-list
138433969|NCT05746208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138433970|NCT05746208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433971|NCT05746208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138433972|NCT05746208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433973|NCT05746208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138335462|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138433974|NCT05746208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138433975|NCT05728944|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138433976|NCT05728944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138433977|NCT05728944|Aceclidine|aceclidine|mesh-list
138433978|NCT05728944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138433979|NCT05728944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138433980|NCT05728944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138433981|NCT05728944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138433982|NCT05728944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138433983|NCT05728944|Adrenergic Agents|adrenergic agents|mesh-ancestor
138433984|NCT05728944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138433985|NCT05728944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433986|NCT05728944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433988|NCT05728944|Autonomic Agents|autonomic agents|mesh-ancestor
138433989|NCT05728944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138433990|NCT05728944|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138433992|NCT05715814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138433993|NCT05715814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138433994|NCT05715814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138198681|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138198683|NCT00000700|Zidovudine|zidovudine|mesh-list
138198684|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
138433995|NCT05715814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138433996|NCT05701527|Pembrolizumab|pembrolizumab|mesh-list
138433997|NCT05701527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138433998|NCT05701527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138433999|NCT05701527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138434000|NCT05701527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434001|NCT05696613|Rituximab|rituximab|mesh-list
138434002|NCT05696613|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138434003|NCT05696613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434004|NCT05696613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434006|NCT05696613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434007|NCT05696613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434008|NCT05696613|Hormones|hormones|mesh-ancestor
138434009|NCT05696613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138434010|NCT05661461|Sirolimus|sirolimus|mesh-list
138434011|NCT05661461|Temsirolimus|temsirolimus|mesh-list
138434012|NCT05661461|MTOR Inhibitors|mtor inhibitors|mesh-list
138434013|NCT05661461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138434014|NCT05661461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138434015|NCT05661461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138434016|NCT05661461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434017|NCT05661461|Antifungal Agents|antifungal agents|mesh-ancestor
138434018|NCT05661461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138434019|NCT05661461|Immunologic Factors|immunologic factors|mesh-ancestor
138434020|NCT05661461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434021|NCT05661461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138434022|NCT05661461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434023|NCT05661461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434024|NCT05656027|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138434025|NCT05656027|Aceclidine|aceclidine|mesh-list
138434026|NCT05656027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138434027|NCT05656027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138434028|NCT05656027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138434030|NCT05656027|Adrenergic Agents|adrenergic agents|mesh-ancestor
138434031|NCT05656027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138434032|NCT05656027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434033|NCT05656027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434034|NCT05656027|Miotics|miotics|mesh-ancestor
138434035|NCT05656027|Autonomic Agents|autonomic agents|mesh-ancestor
138434036|NCT05656027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138434037|NCT05656027|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138434038|NCT05636514|Decitabine|decitabine|mesh-list
138434039|NCT05636514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138434040|NCT05636514|Antimetabolites|antimetabolites|mesh-ancestor
138434041|NCT05636514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434042|NCT05636514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434043|NCT05636514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434044|NCT05634369|Dexamethasone|dexamethasone|mesh-list
138434045|NCT05634369|Gemcitabine|gemcitabine|mesh-list
138434046|NCT05634369|Docetaxel|docetaxel|mesh-list
138434047|NCT05634369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138434048|NCT05634369|Antiemetics|antiemetics|mesh-ancestor
138434049|NCT05634369|Autonomic Agents|autonomic agents|mesh-ancestor
138198694|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138434050|NCT05634369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138434051|NCT05634369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198695|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138198696|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
138198697|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434052|NCT05634369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138434053|NCT05634369|Glucocorticoids|glucocorticoids|mesh-ancestor
138434054|NCT05634369|Hormones|hormones|mesh-ancestor
138434055|NCT05634369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335539|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138434056|NCT05634369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138434057|NCT05634369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138402492|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138402493|NCT03384784|Galantamine|galantamine|mesh-list
138434058|NCT05634369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434060|NCT05634369|Antimetabolites|antimetabolites|mesh-ancestor
138434061|NCT05634369|Tubulin Modulators|tubulin modulators|mesh-ancestor
138434062|NCT05634369|Antimitotic Agents|antimitotic agents|mesh-ancestor
138434063|NCT05634369|Mitosis Modulators|mitosis modulators|mesh-ancestor
138434065|NCT05615636|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138434066|NCT05615636|Immunologic Factors|immunologic factors|mesh-ancestor
138434067|NCT05615636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434068|NCT05615636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138434069|NCT05615636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138434070|NCT05615636|Growth Substances|growth substances|mesh-ancestor
138434071|NCT05615636|Growth Inhibitors|growth inhibitors|mesh-ancestor
138434072|NCT05615636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434073|NCT05615636|Immunoconjugates|immunoconjugates|mesh-ancestor
138402509|NCT03344419|Ketamine|ketamine|mesh-list
138434074|NCT05604560|Tislelizumab|tislelizumab|mesh-list
138434075|NCT05604560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434076|NCT05604560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434077|NCT05590377|Daratumumab|daratumumab|mesh-list
138434078|NCT05590377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434079|NCT05584644|Palbociclib|palbociclib|mesh-list
138434080|NCT05584644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434081|NCT05584644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138434082|NCT05584644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434083|NCT05584644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434085|NCT05574101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434086|NCT05574101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434087|NCT05538663|Gemcitabine|gemcitabine|mesh-list
138434088|NCT05538663|Docetaxel|docetaxel|mesh-list
138434089|NCT05538663|BCG Vaccine|bcg vaccine|mesh-list
138434090|NCT05538663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138434091|NCT05538663|Antimetabolites|antimetabolites|mesh-ancestor
138434092|NCT05538663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434093|NCT05538663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434094|NCT05538663|Tubulin Modulators|tubulin modulators|mesh-ancestor
138434095|NCT05538663|Antimitotic Agents|antimitotic agents|mesh-ancestor
138434096|NCT05538663|Mitosis Modulators|mitosis modulators|mesh-ancestor
138434097|NCT05538663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138434098|NCT05538663|Immunologic Factors|immunologic factors|mesh-ancestor
138434099|NCT05538663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434100|NCT05533892|Lenvatinib|lenvatinib|mesh-list
138434101|NCT05533892|Tislelizumab|tislelizumab|mesh-list
138434102|NCT05533892|Cell Wall Skeleton|cell wall skeleton|mesh-list
138434103|NCT05533892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434104|NCT05533892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138434105|NCT05533892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434106|NCT05533892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434107|NCT05533892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434108|NCT05533892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138434109|NCT05533892|Immunologic Factors|immunologic factors|mesh-ancestor
138434110|NCT05533892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434111|NCT05501665|Deoxyglucose|deoxyglucose|mesh-list
138434112|NCT05501665|Paclitaxel|paclitaxel|mesh-list
138434113|NCT05501665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138434114|NCT05501665|Carboplatin|carboplatin|mesh-list
138434115|NCT05501665|Pembrolizumab|pembrolizumab|mesh-list
138434116|NCT05501665|Nivolumab|nivolumab|mesh-list
138434117|NCT05501665|Pemetrexed|pemetrexed|mesh-list
138434119|NCT05501665|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138434120|NCT05501665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138434121|NCT05501665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434122|NCT05501665|Tubulin Modulators|tubulin modulators|mesh-ancestor
138434123|NCT05501665|Antimitotic Agents|antimitotic agents|mesh-ancestor
138434124|NCT05501665|Mitosis Modulators|mitosis modulators|mesh-ancestor
138198710|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198711|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
138290470|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434125|NCT05501665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434126|NCT05501665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434127|NCT05501665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138434128|NCT05501665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434129|NCT05501665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138434130|NCT05501665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138434131|NCT05501665|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138434132|NCT05501665|Antimetabolites|antimetabolites|mesh-ancestor
138434133|NCT05501665|Antiviral Agents|antiviral agents|mesh-ancestor
138434134|NCT05501665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138434135|NCT05483010|Atorvastatin|atorvastatin|mesh-list
138434136|NCT05483010|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138434137|NCT05483010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138434138|NCT05483010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138434139|NCT05483010|Antimetabolites|antimetabolites|mesh-ancestor
138434140|NCT05483010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434141|NCT05483010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138434178|NCT05426252|Abatacept|abatacept|mesh-list
138434179|NCT05426252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138434180|NCT05426252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138434181|NCT05426252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138434182|NCT05426252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434183|NCT05426252|Antifungal Agents|antifungal agents|mesh-ancestor
138434184|NCT05426252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138434185|NCT05426252|Immunologic Factors|immunologic factors|mesh-ancestor
138434186|NCT05426252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434187|NCT05426252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434188|NCT05426252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138434189|NCT05426252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434190|NCT05426252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434191|NCT05366777|Acetaminophen|acetaminophen|mesh-list
138434192|NCT05366777|Ibuprofen|ibuprofen|mesh-list
138434193|NCT05366777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138434194|NCT05366777|Analgesics|analgesics|mesh-ancestor
138434195|NCT05366777|Sensory System Agents|sensory system agents|mesh-ancestor
138335615|NCT00887640|Sirolimus|sirolimus|mesh-list
138434196|NCT05366777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138434197|NCT05366777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434198|NCT05366777|Antipyretics|antipyretics|mesh-ancestor
138434199|NCT05366777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138434200|NCT05366777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138434201|NCT05366777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434202|NCT05366777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138434203|NCT05366777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434204|NCT05366777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434205|NCT05335915|Nicotine|nicotine|mesh-list
138434206|NCT05335915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138434207|NCT05335915|Autonomic Agents|autonomic agents|mesh-ancestor
138434208|NCT05335915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138434209|NCT05335915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434210|NCT05335915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138434211|NCT05335915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138434212|NCT05335915|Cholinergic Agents|cholinergic agents|mesh-ancestor
138434213|NCT05335915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138434214|NCT05335915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434215|NCT05295784|Caffeine|caffeine|mesh-list
138434216|NCT05295784|Caffeine citrate|caffeine citrate|mesh-list
138434217|NCT05295784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434219|NCT05295784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434220|NCT05295784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138434221|NCT05295784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434222|NCT05295784|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138434223|NCT05295784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138434224|NCT05295784|Purinergic Agents|purinergic agents|mesh-ancestor
138434225|NCT05295784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138434226|NCT05289687|Daratumumab|daratumumab|mesh-list
138434227|NCT05289687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138434228|NCT05289687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434229|NCT05289687|Immunologic Factors|immunologic factors|mesh-ancestor
138434230|NCT05289687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434231|NCT05259722|Alitretinoin|alitretinoin|mesh-list
138434232|NCT05259722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434233|NCT05259722|Dermatologic Agents|dermatologic agents|mesh-ancestor
138434234|NCT05249959|Cytarabine|cytarabine|mesh-list
138434235|NCT05249959|Rituximab|rituximab|mesh-list
138434236|NCT05249959|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
138434237|NCT05249959|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138434238|NCT05249959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434239|NCT05249959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434240|NCT05249959|Immunologic Factors|immunologic factors|mesh-ancestor
138434241|NCT05249959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434242|NCT05249959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434243|NCT05249959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138434244|NCT05249959|Antimetabolites|antimetabolites|mesh-ancestor
138374269|NCT01426646|Cisplatin|cisplatin|mesh-list
138434245|NCT05249959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434246|NCT05249959|Antiviral Agents|antiviral agents|mesh-ancestor
138434247|NCT05249959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138434248|NCT05249959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138434249|NCT05249959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138434250|NCT05249959|Alkylating Agents|alkylating agents|mesh-ancestor
138434251|NCT05231629|Dexamethasone|dexamethasone|mesh-list
138434252|NCT05231629|Dexamethasone acetate|dexamethasone acetate|mesh-list
138434253|NCT05231629|Melphalan|melphalan|mesh-list
138434254|NCT05231629|Lenalidomide|lenalidomide|mesh-list
138434255|NCT05231629|Bortezomib|bortezomib|mesh-list
138434256|NCT05231629|Daratumumab|daratumumab|mesh-list
138434257|NCT05231629|BB 1101|bb 1101|mesh-list
138434258|NCT05231629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138434259|NCT05231629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138434260|NCT05231629|Antiemetics|antiemetics|mesh-ancestor
138434261|NCT05231629|Autonomic Agents|autonomic agents|mesh-ancestor
138434262|NCT05231629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138434263|NCT05231629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434264|NCT05231629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138434265|NCT05231629|Glucocorticoids|glucocorticoids|mesh-ancestor
138434267|NCT05231629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138434268|NCT05231629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138434269|NCT05231629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434270|NCT05231629|Protease Inhibitors|protease inhibitors|mesh-ancestor
138434271|NCT05231629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434272|NCT05231629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434273|NCT05231629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138434274|NCT05231629|Alkylating Agents|alkylating agents|mesh-ancestor
138434275|NCT05231629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138434276|NCT05231629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138434277|NCT05231629|Immunologic Factors|immunologic factors|mesh-ancestor
138434278|NCT05231629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138434287|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138434288|NCT05173298|Growth Substances|growth substances|mesh-ancestor
138434289|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434290|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
138434291|NCT05173298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138434292|NCT05173298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434294|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138434295|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
138434296|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138434297|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434298|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138434299|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
138434300|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
138434301|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138434302|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
138434303|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138434304|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434305|NCT05140525|Macitentan|macitentan|mesh-list
138434306|NCT05140525|Riociguat|riociguat|mesh-list
138434307|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
138434308|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138434309|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434310|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
138434320|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138434321|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
138434322|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434323|NCT05107856|Azacitidine|azacitidine|mesh-list
138434324|NCT05107856|Venetoclax|venetoclax|mesh-list
138198712|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138434325|NCT05107856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138434326|NCT05107856|Antimetabolites|antimetabolites|mesh-ancestor
138434327|NCT05107856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434328|NCT05107856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434329|NCT05107856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434330|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
138434332|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138434333|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
138434334|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434335|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434336|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138434337|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
138434338|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434339|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434340|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138434341|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138434342|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138434343|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138434344|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434345|NCT05106192|Triamcinolone|triamcinolone|mesh-list
138434346|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138434347|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138434348|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
138434349|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
138434350|NCT05106192|Bexarotene|bexarotene|mesh-list
138434351|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138434352|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138434353|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
138434354|NCT05106192|Hormones|hormones|mesh-ancestor
138434355|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138434356|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434357|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138335681|NCT00896064|Vaccines|vaccines|mesh-list
138236149|NCT01547000|Guanfacine|guanfacine|mesh-list
138434358|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
138434359|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434360|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434361|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
138434362|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138434363|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434364|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
138434365|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138434366|NCT05103007|Estrogens|estrogens|mesh-ancestor
138434367|NCT05103007|Hormones|hormones|mesh-ancestor
138434368|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138434369|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434370|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138434371|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434372|NCT05094128|Upadacitinib|upadacitinib|mesh-list
138434373|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138434374|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138434375|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434376|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434377|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434378|NCT05087030|Denosumab|denosumab|mesh-list
138434379|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138434380|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434381|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
138434382|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138434383|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
138434384|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138434385|NCT05081479|Expectorants|expectorants|mesh-ancestor
138434386|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
138434387|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138434388|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
138434389|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434390|NCT05081479|Protective Agents|protective agents|mesh-ancestor
138434391|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434392|NCT05081479|Antidotes|antidotes|mesh-ancestor
138434393|NCT05065216|Kallikreins|kallikreins|mesh-list
138434394|NCT05065216|Coagulants|coagulants|mesh-ancestor
138434395|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
138434396|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
138434397|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138434398|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434399|NCT05062044|Folic Acid|folic acid|mesh-list
138434400|NCT05062044|Hematinics|hematinics|mesh-ancestor
138434405|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
138434406|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434407|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434408|NCT05043090|Durvalumab|durvalumab|mesh-list
138434409|NCT05043090|Sunitinib|sunitinib|mesh-list
138434410|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434411|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434412|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138434413|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138434414|NCT05043090|Growth Substances|growth substances|mesh-ancestor
138434415|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434416|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
138434417|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138434418|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434419|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434420|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138434421|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138434422|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434423|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
138434424|NCT05003895|Fludarabine|fludarabine|mesh-list
138434425|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138434426|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
138434427|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374401|NCT01427283|Oxycodone|oxycodone|mesh-list
138434428|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434429|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138434430|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
138434431|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434432|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434433|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138434434|NCT04994522|Belzutifan|belzutifan|mesh-list
138434435|NCT04994522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393430|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
138434452|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434453|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138434456|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138434457|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138434458|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434459|NCT04946734|Aspirin|aspirin|mesh-list
138434460|NCT04946734|Clopidogrel|clopidogrel|mesh-list
138434461|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138434462|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138434463|NCT04946734|Analgesics|analgesics|mesh-ancestor
138434464|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
138434465|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138434466|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434467|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138434468|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434469|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138434470|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138434471|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434472|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138434473|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138434474|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434475|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
138434476|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138434477|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138434478|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138434479|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
138434480|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138434481|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138434482|NCT04944888|Eliglustat|eliglustat|mesh-list
138434483|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434484|NCT04944888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434485|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434486|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434500|NCT04924101|Cisplatin|cisplatin|mesh-list
138434501|NCT04924101|Carboplatin|carboplatin|mesh-list
138434502|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
138434503|NCT04924101|Etoposide|etoposide|mesh-list
138434504|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
138434505|NCT04924101|Lenvatinib|lenvatinib|mesh-list
138434506|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434507|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434508|NCT04924101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138434509|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434510|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138434511|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138434512|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138434513|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434514|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138434515|NCT04921943|Azithromycin|azithromycin|mesh-list
138434516|NCT04921943|Rifampin|rifampin|mesh-list
138434517|NCT04921943|Ethambutol|ethambutol|mesh-list
138434518|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138434519|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138434520|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138434521|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
138434522|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
138434523|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138434524|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138335757|NCT00908466|Sirolimus|sirolimus|mesh-list
138434525|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434526|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138434527|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138434528|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138434529|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138434530|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138434531|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138434532|NCT04919382|Temozolomide|temozolomide|mesh-list
138434533|NCT04919382|Atezolizumab|atezolizumab|mesh-list
138434534|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138434535|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138434536|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
138434537|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434538|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236313|NCT05358873|Antibodies|antibodies|mesh-list
138434539|NCT04919382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138434540|NCT04919382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434541|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
138434542|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434543|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
138434544|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434545|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434546|NCT04816643|Vaccines|vaccines|mesh-list
138402733|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
138434547|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
138198715|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
138434548|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434549|NCT04797780|Azacitidine|azacitidine|mesh-list
138434550|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138434551|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
138434552|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198716|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138434553|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434554|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434555|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
138434556|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138434557|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434558|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138434559|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434560|NCT04786548|Celecoxib|celecoxib|mesh-list
138434561|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138434562|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138434563|NCT04786548|Analgesics|analgesics|mesh-ancestor
138434564|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
138434565|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138434566|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434567|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138434568|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434569|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138434570|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138434571|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434572|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434573|NCT04733547|Furosemide|furosemide|mesh-list
138434574|NCT04733547|Diuretics|diuretics|mesh-ancestor
138434575|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
138434576|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434577|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138434578|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138236314|NCT05358873|Immunologic Factors|immunologic factors|mesh-ancestor
138434579|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434580|NCT04632992|Maytansine|maytansine|mesh-list
138434581|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138434582|NCT04632992|Trastuzumab|trastuzumab|mesh-list
138434583|NCT04632992|Atezolizumab|atezolizumab|mesh-list
138434584|NCT04632992|Pertuzumab|pertuzumab|mesh-list
138434585|NCT04632992|Tucatinib|tucatinib|mesh-list
138434586|NCT04632992|Ipatasertib|ipatasertib|mesh-list
138434587|NCT04632992|Pralsetinib|pralsetinib|mesh-list
138434588|NCT04632992|Entrectinib|entrectinib|mesh-list
138434589|NCT04632992|Inavolisib|inavolisib|mesh-list
138434598|NCT04632992|Immunotoxins|immunotoxins|mesh-ancestor
138434599|NCT04632992|Immunoconjugates|immunoconjugates|mesh-ancestor
138434600|NCT04632992|Immunologic Factors|immunologic factors|mesh-ancestor
138374463|NCT01427686|Protective Agents|protective agents|mesh-ancestor
138434601|NCT04632992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434602|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138434604|NCT04632992|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
138434614|NCT04622319|Trastuzumab|trastuzumab|mesh-list
138434615|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138434616|NCT04622319|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138434617|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434618|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434619|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
138434620|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
138434621|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
138434622|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434623|NCT04622319|Immunotoxins|immunotoxins|mesh-ancestor
138434624|NCT04622319|Immunoconjugates|immunoconjugates|mesh-ancestor
138434625|NCT04622319|Immunologic Factors|immunologic factors|mesh-ancestor
138434626|NCT04622319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434627|NCT04543591|Ravulizumab|ravulizumab|mesh-list
138434628|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138434629|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138434630|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
138434631|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198736|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434632|NCT04518306|Amlodipine|amlodipine|mesh-list
138198737|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
138434633|NCT04518306|Telmisartan|telmisartan|mesh-list
138434634|NCT04518306|Indapamide|indapamide|mesh-list
138434635|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138434636|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138434637|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138434638|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434639|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138434640|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434641|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
138434642|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138434643|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138434644|NCT04518306|Diuretics|diuretics|mesh-ancestor
138434645|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
138434646|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138434647|NCT04450212|Vitamin K|vitamin k|mesh-list
138434648|NCT04450212|Vitamins|vitamins|mesh-ancestor
138434649|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
138335783|NCT00911742|Tramadol|tramadol|mesh-list
138434650|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434651|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138434652|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138434653|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434654|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
138434655|NCT04450212|Coagulants|coagulants|mesh-ancestor
138434661|NCT04408118|Paclitaxel|paclitaxel|mesh-list
138434662|NCT04408118|Bevacizumab|bevacizumab|mesh-list
138434663|NCT04408118|Atezolizumab|atezolizumab|mesh-list
138434664|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138434666|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
138402782|NCT01599234|Nabiximols|nabiximols|mesh-list
138434667|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
138434668|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
138434669|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434670|NCT04408118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434671|NCT04408118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138434672|NCT04408118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138434673|NCT04408118|Growth Substances|growth substances|mesh-ancestor
138434674|NCT04408118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434675|NCT04408118|Growth Inhibitors|growth inhibitors|mesh-ancestor
138434676|NCT04408118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138434677|NCT04385368|Durvalumab|durvalumab|mesh-list
138434678|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434679|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434680|NCT04380636|Paclitaxel|paclitaxel|mesh-list
138434681|NCT04380636|Etoposide|etoposide|mesh-list
138434682|NCT04380636|Carboplatin|carboplatin|mesh-list
138236377|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434683|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
138434684|NCT04380636|Pemetrexed|pemetrexed|mesh-list
138434685|NCT04380636|Durvalumab|durvalumab|mesh-list
138434686|NCT04380636|Olaparib|olaparib|mesh-list
138434687|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138434688|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434689|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
138434690|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
138434691|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
138434692|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434693|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434694|NCT04380636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138434695|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138434696|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138434697|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138198746|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198747|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138434698|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138434699|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138434700|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138434701|NCT04370054|Factor VIII|factor viii|mesh-list
138434702|NCT04370054|Coagulants|coagulants|mesh-ancestor
138434703|NCT04323280|Dexamethasone|dexamethasone|mesh-list
138434704|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138434705|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
138434706|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
138434707|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138434708|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434709|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138434710|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
138434711|NCT04323280|Hormones|hormones|mesh-ancestor
138434712|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138335809|NCT00916032|Factor VIII|factor viii|mesh-list
138434713|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138434714|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434715|NCT04318548|Vaccines|vaccines|mesh-list
138434716|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
138434717|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434718|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
138434719|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434720|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434721|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138434722|NCT04307134|Immunotoxins|immunotoxins|mesh-ancestor
138434723|NCT04307134|Immunoconjugates|immunoconjugates|mesh-ancestor
138434724|NCT04307134|Immunologic Factors|immunologic factors|mesh-ancestor
138236411|NCT00370851|Bevacizumab|bevacizumab|mesh-list
138434725|NCT04307134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434726|NCT04221438|Alovudine|alovudine|mesh-list
138434727|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
138434728|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138434729|NCT04181749|Aspirin|aspirin|mesh-list
138434730|NCT04181749|Atorvastatin|atorvastatin|mesh-list
138434731|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138434732|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138434733|NCT04181749|Analgesics|analgesics|mesh-ancestor
138434734|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
138434735|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138434736|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434737|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138434738|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434739|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138434740|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138434750|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138434752|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138434753|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
138434754|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434755|NCT04161898|Prednisolone|prednisolone|mesh-list
138434756|NCT04161898|Upadacitinib|upadacitinib|mesh-list
138434757|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138434758|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
138434759|NCT04161898|Hormones|hormones|mesh-ancestor
138434760|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138434761|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138335828|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
138434762|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138434763|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434764|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138434765|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138434766|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434767|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434768|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434769|NCT04161755|Atezolizumab|atezolizumab|mesh-list
138434770|NCT04161755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138434771|NCT04161755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434772|NCT04161755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434773|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434774|NCT04151563|Docetaxel|docetaxel|mesh-list
138434775|NCT04151563|Nivolumab|nivolumab|mesh-list
138434776|NCT04151563|Ipilimumab|ipilimumab|mesh-list
138434777|NCT04151563|Ramucirumab|ramucirumab|mesh-list
138434778|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434780|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
138434781|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
138198757|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
138434782|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434783|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434784|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138434785|NCT04142242|Vaccines|vaccines|mesh-list
138434786|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
138434787|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434788|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
138434789|NCT04123366|Olaparib|olaparib|mesh-list
138434790|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434791|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434792|NCT04123366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138434793|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434794|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138434795|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434806|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
138434807|NCT04049669|Temozolomide|temozolomide|mesh-list
138434808|NCT04049669|Lomustine|lomustine|mesh-list
138434809|NCT04049669|Etoposide|etoposide|mesh-list
138434810|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138434811|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
138434812|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434813|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434814|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138434815|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
138434816|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434817|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434818|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138434819|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138434820|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138434821|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138434822|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434823|NCT04023331|Copper|copper|mesh-list
138434824|NCT04023331|Trace Elements|trace elements|mesh-ancestor
138434825|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
138434826|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434827|NCT04023305|Sevoflurane|sevoflurane|mesh-list
138434828|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138434829|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138434830|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
138434831|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
138434832|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138434833|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434834|NCT03912259|Emollients|emollients|mesh-list
138434835|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
138434836|NCT03871829|Dexamethasone|dexamethasone|mesh-list
138434837|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
138434838|NCT03871829|BB 1101|bb 1101|mesh-list
138434839|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138434840|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
138434841|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
138198759|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138198760|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138198761|NCT00000724|Leucovorin|leucovorin|mesh-list
138434842|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138434843|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138236470|NCT02420262|Insulin|insulin|mesh-list
138434844|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138434845|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
138198762|NCT00000724|Trimetrexate|trimetrexate|mesh-list
138434846|NCT03871829|Hormones|hormones|mesh-ancestor
138198763|NCT00000724|Calcium|calcium|mesh-list
138198764|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
138198765|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138198766|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434847|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138434848|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138434849|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434850|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
138434851|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434852|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434853|NCT03862859|Warfarin|warfarin|mesh-list
138434854|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
138434855|NCT03845270|Docetaxel|docetaxel|mesh-list
138434856|NCT03845270|Trastuzumab|trastuzumab|mesh-list
138434857|NCT03845270|Pertuzumab|pertuzumab|mesh-list
138434858|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434859|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
138434860|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
138434861|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
138434862|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434863|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434864|NCT03831464|Metformin|metformin|mesh-list
138434865|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138434866|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434867|NCT03783936|Leucovorin|leucovorin|mesh-list
138434868|NCT03783936|Fluorouracil|fluorouracil|mesh-list
138434869|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
138434870|NCT03783936|Trastuzumab|trastuzumab|mesh-list
138434871|NCT03783936|Avelumab|avelumab|mesh-list
138434872|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
138434873|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434874|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138434875|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434876|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138434877|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
138434878|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434879|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434881|NCT03783936|Protective Agents|protective agents|mesh-ancestor
138434882|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
138434883|NCT03783936|Vitamins|vitamins|mesh-ancestor
138434884|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
138434885|NCT03742986|Paclitaxel|paclitaxel|mesh-list
138434886|NCT03742986|Docetaxel|docetaxel|mesh-list
138434887|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138434888|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
138434889|NCT03742986|Doxorubicin|doxorubicin|mesh-list
138434890|NCT03742986|Nivolumab|nivolumab|mesh-list
138434891|NCT03742986|Trastuzumab|trastuzumab|mesh-list
138434892|NCT03742986|Pertuzumab|pertuzumab|mesh-list
138393888|NCT01517490|Insulin|insulin|mesh-list
138434893|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138434894|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434901|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434902|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434903|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138434904|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
138434905|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138434906|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138434907|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138434908|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138434909|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434910|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434911|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138434912|NCT03736720|Leucovorin|leucovorin|mesh-list
138434913|NCT03736720|Fluorouracil|fluorouracil|mesh-list
138434914|NCT03736720|Irinotecan|irinotecan|mesh-list
138434915|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
138434916|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434917|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138434918|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434919|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138434920|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
138434921|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434922|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138434923|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138434924|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434925|NCT03736720|Antidotes|antidotes|mesh-ancestor
138434926|NCT03736720|Protective Agents|protective agents|mesh-ancestor
138434927|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
138434929|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
138434936|NCT03703167|Rituximab|rituximab|mesh-list
138434937|NCT03703167|Lenalidomide|lenalidomide|mesh-list
138434938|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138434939|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434940|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
138434941|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434942|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138434943|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138434944|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138434945|NCT03703167|Growth Substances|growth substances|mesh-ancestor
138434946|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
138434947|NCT03672630|Azithromycin|azithromycin|mesh-list
138434948|NCT03672630|Rifampin|rifampin|mesh-list
138434949|NCT03672630|Ethambutol|ethambutol|mesh-list
138434950|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138434951|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138434952|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138434953|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
138434954|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
138434955|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138434956|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434957|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434958|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138434959|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138434960|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138434961|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138434962|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138434963|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138434964|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
138434965|NCT03659734|Narcotics|narcotics|mesh-ancestor
138434966|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138434967|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434968|NCT03659734|Analgesics|analgesics|mesh-ancestor
138402888|NCT01556815|Estrogens|estrogens|mesh-ancestor
138434969|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
138434970|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138434971|NCT03642028|Suvorexant|suvorexant|mesh-list
138434972|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138434973|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138434974|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138434975|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138434976|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138434977|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138374752|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
138434978|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434979|NCT03636295|Warfarin|warfarin|mesh-list
138434980|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
138434981|NCT03551691|Omeprazole|omeprazole|mesh-list
138434982|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138434983|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138434984|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138434985|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138434986|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434987|NCT03493425|Cisplatin|cisplatin|mesh-list
138434988|NCT03493425|Carboplatin|carboplatin|mesh-list
138434989|NCT03493425|Docetaxel|docetaxel|mesh-list
138434990|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434991|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
138434992|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
138434993|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
138434994|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138434995|NCT03373383|Padsevonil|padsevonil|mesh-list
138434996|NCT03373383|Anticonvulsants|anticonvulsants|mesh-ancestor
138434997|NCT03332797|Palbociclib|palbociclib|mesh-list
138434998|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138434999|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138435000|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435001|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435002|NCT03320018|Minocycline|minocycline|mesh-list
138435003|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138435004|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435005|NCT03274492|Prednisone|prednisone|mesh-list
138435006|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
138435007|NCT03274492|Rituximab|rituximab|mesh-list
138435008|NCT03274492|Doxorubicin|doxorubicin|mesh-list
138435009|NCT03274492|Vincristine|vincristine|mesh-list
138435010|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138435011|NCT03274492|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138435012|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
138435013|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138435014|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
138435015|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435016|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138435017|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138435018|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
138435019|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435020|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435021|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138435022|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138402930|NCT01557153|Amlodipine|amlodipine|mesh-list
138435023|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138435024|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138435025|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138435026|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435027|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138435028|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
138435029|NCT03274492|Hormones|hormones|mesh-ancestor
138435030|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138435031|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138435032|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138435034|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
138435035|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
138435036|NCT03269136|Thalidomide|thalidomide|mesh-list
138435037|NCT03269136|Dexamethasone|dexamethasone|mesh-list
138435038|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
138435039|NCT03269136|Lenalidomide|lenalidomide|mesh-list
138435040|NCT03269136|Pomalidomide|pomalidomide|mesh-list
138435041|NCT03269136|Antibodies|antibodies|mesh-list
138435042|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
138435043|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138435044|NCT03269136|BB 1101|bb 1101|mesh-list
138435045|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
138435046|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435047|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138435048|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
138435049|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
138435050|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435051|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138435052|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
138435053|NCT03269136|Hormones|hormones|mesh-ancestor
138435054|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138435055|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138435056|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435057|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
138435058|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138336026|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
138435059|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435060|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138402938|NCT01557257|Naltrexone|naltrexone|mesh-list
138435061|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138435062|NCT03269136|Growth Substances|growth substances|mesh-ancestor
138435063|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
138198776|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198777|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198778|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138435064|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138435065|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
138435066|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138435067|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435068|NCT03250975|Azithromycin|azithromycin|mesh-list
138435069|NCT03250975|Budesonide|budesonide|mesh-list
138435070|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138435071|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138435072|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
138435073|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435074|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435075|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138435076|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
138236616|NCT04849377|Carboplatin|carboplatin|mesh-list
138435077|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
138435078|NCT03250975|Hormones|hormones|mesh-ancestor
138236617|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435079|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138435080|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138435081|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435082|NCT03191162|Benzonidazole|benzonidazole|mesh-list
138435083|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138435084|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
138435085|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435086|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138435087|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138435088|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138435089|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435090|NCT03169972|Factor VIII|factor viii|mesh-list
138435092|NCT03169972|Coagulants|coagulants|mesh-ancestor
138435093|NCT03080883|Apixaban|apixaban|mesh-list
138435094|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138435095|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
138435096|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138435097|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
138435098|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435099|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435100|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
138435101|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
138435102|NCT03025035|Olaparib|olaparib|mesh-list
138435103|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138435104|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435105|NCT03025035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138435106|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435107|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138435108|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435109|NCT02953509|Rituximab|rituximab|mesh-list
138435110|NCT02953509|Magrolimab|magrolimab|mesh-list
138435111|NCT02953509|Gemcitabine|gemcitabine|mesh-list
138435112|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
138435113|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138435114|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435115|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
138435116|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435117|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138435118|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138435119|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
138435120|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435121|NCT02939872|Aspirin|aspirin|mesh-list
138435122|NCT02939872|Clopidogrel|clopidogrel|mesh-list
138435123|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138435124|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138236656|NCT05454345|Antimetabolites|antimetabolites|mesh-ancestor
138435126|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
138435127|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435128|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435129|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138435131|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138435132|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138435133|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435134|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138374899|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
138435135|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138435136|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435137|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
138435138|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138435139|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138435140|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138435141|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
138435142|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435143|NCT02856438|Dexamethasone|dexamethasone|mesh-list
138435144|NCT02856438|Lenalidomide|lenalidomide|mesh-list
138435145|NCT02856438|Elotuzumab|elotuzumab|mesh-list
138435146|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138435147|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
138435148|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
138435149|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435150|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435151|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138435152|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
138435153|NCT02856438|Hormones|hormones|mesh-ancestor
138403009|NCT01557478|Protective Agents|protective agents|mesh-ancestor
138435154|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138435155|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138403099|NCT01558167|Growth Substances|growth substances|mesh-ancestor
138435156|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435157|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
138435158|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138435159|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138435160|NCT02856438|Growth Substances|growth substances|mesh-ancestor
138435161|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
138435162|NCT02647099|Aspirin|aspirin|mesh-list
138435163|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138435164|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138435165|NCT02647099|Analgesics|analgesics|mesh-ancestor
138435166|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
138435168|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435169|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138435170|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138435171|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138435172|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138435173|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435174|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138435175|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138435176|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435177|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
138435178|NCT02626715|Vidarabine|vidarabine|mesh-list
138435179|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
138435180|NCT02626715|Fludarabine|fludarabine|mesh-list
138435181|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
138435182|NCT02626715|Thiotepa|thiotepa|mesh-list
138435183|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138435184|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
138435185|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435186|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435187|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138435188|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
138435189|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435190|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
138435191|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435192|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138435193|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138435194|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
138435195|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138435197|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394177|NCT01519011|Azacitidine|azacitidine|mesh-list
138435198|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435199|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435200|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138374954|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435201|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138435202|NCT02471690|Oritavancin|oritavancin|mesh-list
138435203|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138435204|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435205|NCT02470702|Oritavancin|oritavancin|mesh-list
138435206|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138435207|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435208|NCT02357524|Oritavancin|oritavancin|mesh-list
138435209|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138435210|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435211|NCT02340988|Oritavancin|oritavancin|mesh-list
138435212|NCT02340988|Warfarin|warfarin|mesh-list
138435213|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
138435214|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138435215|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435216|NCT02153437|Sotalol|sotalol|mesh-list
138435217|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138435218|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138435219|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
138435220|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435221|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435222|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435223|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138435224|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
138435225|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
138435226|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435227|NCT01950520|Topiramate|topiramate|mesh-list
138435228|NCT01950520|Phentermine|phentermine|mesh-list
138435229|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
138435230|NCT01950520|Propranolol|propranolol|mesh-list
138236758|NCT05451381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138435232|NCT01950520|Naltrexone|naltrexone|mesh-list
138435233|NCT01950520|Caffeine|caffeine|mesh-list
138435234|NCT01950520|Dantrolene|dantrolene|mesh-list
138435235|NCT01950520|Mirabegron|mirabegron|mesh-list
138435236|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138435237|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138435238|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435239|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
138435240|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435241|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138435242|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138435243|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435244|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435245|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138435246|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138435247|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
138435248|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435249|NCT01950520|Analgesics|analgesics|mesh-ancestor
138435250|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
138435251|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138435252|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138435253|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
138435254|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138435255|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138435256|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138435257|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
138435258|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138435259|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138435260|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138435261|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
138435262|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138435263|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
138435264|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138435265|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138435266|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138435267|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138435268|NCT01950520|Urological Agents|urological agents|mesh-ancestor
138435269|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
138435270|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138435272|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
138435273|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138435274|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
138236796|NCT03708237|Ropinirole|ropinirole|mesh-list
138435275|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138435276|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138435277|NCT01884038|Treprostinil|treprostinil|mesh-list
138435278|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138435279|NCT01801072|Levetiracetam|levetiracetam|mesh-list
138435280|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
138435281|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
138435282|NCT01784536|Oritavancin|oritavancin|mesh-list
138403181|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
138435284|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435285|NCT01718743|Lenalidomide|lenalidomide|mesh-list
138435287|NCT01718743|Glycine|glycine|mesh-list
138435288|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
138435289|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435290|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138198793|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
138435291|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138435292|NCT01718743|Growth Substances|growth substances|mesh-ancestor
138435293|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
138435294|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435295|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435296|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
138435297|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435298|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
138435299|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435300|NCT01605084|Ritonavir|ritonavir|mesh-list
138435301|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138435302|NCT01605084|Darunavir|darunavir|mesh-list
138435303|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138435304|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138435305|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
138435306|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435307|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435308|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138435309|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138435310|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
138435311|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375095|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138435312|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138435313|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138435314|NCT01514864|Dasatinib|dasatinib|mesh-list
138435315|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435316|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138435317|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435318|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435319|NCT01502917|Antibodies|antibodies|mesh-list
138435320|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138435321|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
138435322|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435323|NCT01458366|Carboplatin|carboplatin|mesh-list
138435324|NCT01458366|Etoposide|etoposide|mesh-list
138435325|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
138435326|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138435327|NCT01458366|Ofatumumab|ofatumumab|mesh-list
138435328|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435329|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138435330|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138435331|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138435332|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435333|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435334|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138435335|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
138435336|NCT00968760|Cytarabine|cytarabine|mesh-list
138435337|NCT00968760|Etoposide|etoposide|mesh-list
138435338|NCT00968760|Melphalan|melphalan|mesh-list
138435339|NCT00968760|Interleukin-2|interleukin-2|mesh-list
138435340|NCT00968760|Carmustine|carmustine|mesh-list
138435341|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138435342|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435343|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138435344|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138435345|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435346|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435347|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138435348|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
138435349|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
138435350|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435351|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138435352|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
138435353|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435354|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138198794|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138435355|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
138198800|NCT00000730|Hormones|hormones|mesh-ancestor
138435356|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138435357|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138435358|NCT00968760|Analgesics|analgesics|mesh-ancestor
138435359|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
138435360|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435362|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138435363|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435364|NCT00364286|Dasatinib|dasatinib|mesh-list
138435365|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435366|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138435367|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435368|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435369|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
138435370|NCT00328614|Goserelin|goserelin|mesh-list
138435371|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
138435372|NCT00328614|Bicalutamide|bicalutamide|mesh-list
138435373|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
138435374|NCT00328614|Androgens|androgens|mesh-list
138435375|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138435376|NCT00328614|Ethylene|ethylene|mesh-list
138435377|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138435378|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435379|NCT00328614|Hormones|hormones|mesh-ancestor
138435380|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138435381|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435382|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
138435383|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435384|NCT00328614|Protective Agents|protective agents|mesh-ancestor
138435385|NCT00328614|Vitamins|vitamins|mesh-ancestor
138435386|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
138435387|NCT00328614|Estrogens|estrogens|mesh-ancestor
138435388|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
138435389|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
138435390|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
138435391|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
138435392|NCT00328614|Growth Substances|growth substances|mesh-ancestor
138435393|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138435394|NCT00328614|Analgesics|analgesics|mesh-ancestor
138435395|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
138435396|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435397|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
138435398|NCT00217737|Leucovorin|leucovorin|mesh-list
138435399|NCT00217737|Folic Acid|folic acid|mesh-list
138435400|NCT00217737|Bevacizumab|bevacizumab|mesh-list
138435401|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138435402|NCT00217737|Fluorouracil|fluorouracil|mesh-list
138435403|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
138435404|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
138435405|NCT00217737|Antibodies|antibodies|mesh-list
138435406|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
138435407|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138435408|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
138435409|NCT00217737|Calcium|calcium|mesh-list
138435410|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
138236880|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435411|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435415|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435417|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
138435418|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138435419|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138435420|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
138435421|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336199|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
138435422|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138435423|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138435424|NCT00217737|Antidotes|antidotes|mesh-ancestor
138435425|NCT00217737|Protective Agents|protective agents|mesh-ancestor
138435426|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
138435428|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
138435429|NCT00217737|Hematinics|hematinics|mesh-ancestor
138435443|NCT01750359|Analgesics|analgesics|mesh-ancestor
138435444|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
138435445|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435446|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435447|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138435448|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138435449|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435450|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435451|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435452|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138435453|NCT01750385|Cephalosporins|cephalosporins|mesh-list
138435454|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435455|NCT01750437|Esomeprazole|esomeprazole|mesh-list
138435456|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138435457|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138435458|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138435459|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435460|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435461|NCT01750463|Chrysarobin|chrysarobin|mesh-list
138435462|NCT01750463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138435463|NCT01750463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138435464|NCT01750463|Analgesics|analgesics|mesh-ancestor
138435465|NCT01750463|Sensory System Agents|sensory system agents|mesh-ancestor
138236913|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138236916|NCT01507220|Morphine|morphine|mesh-list
138435466|NCT01750463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435467|NCT01750463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435469|NCT01750463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138435470|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138435471|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
138435472|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138435473|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
138435474|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138435475|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435476|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138435477|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138435478|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138435479|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138435480|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138435481|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435482|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138435483|NCT01750541|Valproic Acid|valproic acid|mesh-list
138435484|NCT01750541|Haloperidol|haloperidol|mesh-list
138435485|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
138435486|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
138435487|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
138435488|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435489|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435490|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138435491|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138435492|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138435493|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138435494|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138435495|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138435496|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
138435497|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435498|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435499|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138435500|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
138435501|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435502|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
138435503|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
138435504|NCT01750580|Ipilimumab|ipilimumab|mesh-list
138198803|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198804|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138198805|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198806|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
138198807|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138435505|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138435506|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435507|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138435508|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435509|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
138435510|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138435511|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138435512|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435513|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
138435514|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435515|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435516|NCT01750723|Acetazolamide|acetazolamide|mesh-list
138435517|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
138435518|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138435519|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435520|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435521|NCT01750723|Diuretics|diuretics|mesh-ancestor
138435522|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
138336252|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138435523|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435525|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
138435526|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435527|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138435528|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138435529|NCT01750762|Growth Substances|growth substances|mesh-ancestor
138435530|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
138435531|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435532|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
138435533|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138435534|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
138435535|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138435536|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
138435537|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435538|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435539|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
138435540|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
138435541|NCT01750801|Propolis|propolis|mesh-list
138435542|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138435543|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435544|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
138435545|NCT01750866|Prednisone|prednisone|mesh-list
138435546|NCT01750866|Lenograstim|lenograstim|mesh-list
138435547|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138435548|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
138435549|NCT01750866|Hormones|hormones|mesh-ancestor
138435550|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138435551|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435552|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138435553|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435554|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138435555|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
138435556|NCT01750983|Lenalidomide|lenalidomide|mesh-list
138435557|NCT01750983|Ipilimumab|ipilimumab|mesh-list
138435558|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
138435559|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435560|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138375295|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138435561|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138435562|NCT01750983|Growth Substances|growth substances|mesh-ancestor
138435563|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
138435564|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435565|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138435566|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138435567|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435568|NCT01751009|Vitamins|vitamins|mesh-list
138435569|NCT01751009|Vitamin A|vitamin a|mesh-list
138435570|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
138435571|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
138435572|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435573|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
138435574|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435575|NCT01751009|Protective Agents|protective agents|mesh-ancestor
138435576|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138435577|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435578|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138435579|NCT01751074|Darapladib|darapladib|mesh-list
138435580|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138435581|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138435582|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
138435583|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435584|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138435585|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138435586|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435587|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138435588|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
138435589|NCT01751204|Calcium|calcium|mesh-list
138435590|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138435591|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435592|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138435593|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
138435594|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435595|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435596|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138435597|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435598|NCT01751295|Atorvastatin|atorvastatin|mesh-list
138435599|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138435600|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138435601|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
138435602|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435603|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138435604|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138435605|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435606|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138435607|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138435608|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435609|NCT01751321|Incretins|incretins|mesh-ancestor
138435610|NCT01751321|Hormones|hormones|mesh-ancestor
138403320|NCT01559727|Hormones|hormones|mesh-ancestor
138375387|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
138435611|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138435612|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138435613|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
138435614|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435615|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138336314|NCT00999102|Metoprolol|metoprolol|mesh-list
138435618|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
138435619|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
138435620|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138435621|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435622|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
138435623|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435624|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138435625|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138435626|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138435627|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138435628|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435629|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
138435630|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138435631|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138435632|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138435633|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435634|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
138435635|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435636|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435637|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138435638|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435639|NCT01751763|Sorafenib|sorafenib|mesh-list
138435640|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435641|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138435642|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435643|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435644|NCT01751828|Sertraline|sertraline|mesh-list
138435645|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
138435646|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138435647|NCT01751828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138435648|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138198816|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138435649|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138435650|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435651|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435652|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
138375440|NCT01434069|Antidotes|antidotes|mesh-ancestor
138435653|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188482|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435655|NCT01751854|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138435656|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138435657|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138435658|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435659|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435660|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
138435661|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435662|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
138435663|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435664|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138237079|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
138435666|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435667|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
138435668|NCT01752010|Immunomodulating Agents|immunomodulating agents|mesh-list
138435669|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435670|NCT01752075|Lenalidomide|lenalidomide|mesh-list
138435671|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
138435672|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435673|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138435674|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138435675|NCT01752075|Growth Substances|growth substances|mesh-ancestor
138435676|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
138435677|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435678|NCT01752153|Silymarin|silymarin|mesh-list
138435679|NCT01752153|Deferoxamine|deferoxamine|mesh-list
138435680|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
138435681|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435682|NCT01752153|Protective Agents|protective agents|mesh-ancestor
138435683|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435684|NCT01752153|Siderophores|siderophores|mesh-ancestor
138435685|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138435686|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
138435687|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
138435688|NCT01752205|Paclitaxel|paclitaxel|mesh-list
138435689|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138435690|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138435691|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198818|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138198819|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
138198820|NCT00002176|Nelfinavir|nelfinavir|mesh-list
138198821|NCT00002176|Stavudine|stavudine|mesh-list
138198822|NCT00002176|Didanosine|didanosine|mesh-list
138198823|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
138435692|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
138435693|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
138435694|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
138435695|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435696|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138435697|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435698|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
138435699|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138435700|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138435701|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435702|NCT01752244|Vitamins|vitamins|mesh-ancestor
138435703|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
138435704|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
138435705|NCT01752270|Cyproterone|cyproterone|mesh-list
138435706|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
138435707|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
138435708|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
138435709|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138435710|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435711|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435712|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138435713|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
138435714|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138435716|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
138435717|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
138435718|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138435719|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435720|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
138435721|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435722|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138403339|NCT01559753|Cefotaxime|cefotaxime|mesh-list
138435723|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138435724|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138435725|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138435726|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435728|NCT01752517|Ifosfamide|ifosfamide|mesh-list
138435729|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138435730|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435731|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
138435732|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
138435733|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
138435734|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435735|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138435736|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
138435737|NCT01752543|Conivaptan|conivaptan|mesh-list
138435738|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138435739|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435740|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
138435741|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435742|NCT01752686|Carboplatin|carboplatin|mesh-list
138435743|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435744|NCT01752699|Methadone|methadone|mesh-list
138435745|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138435746|NCT01752699|Narcotics|narcotics|mesh-ancestor
138435747|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138435748|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435749|NCT01752699|Analgesics|analgesics|mesh-ancestor
138435750|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
138435751|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435752|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
138435753|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
138435755|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138435756|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
138435757|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435758|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138435759|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435760|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138435761|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
138435762|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435763|NCT01752881|Vaccines|vaccines|mesh-list
138435764|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
138336377|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
138435765|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435766|NCT01752959|Remifentanil|remifentanil|mesh-list
138435768|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138435769|NCT01752959|Narcotics|narcotics|mesh-ancestor
138435770|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138435771|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435772|NCT01752959|Analgesics|analgesics|mesh-ancestor
138435773|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
138435774|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435775|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138435776|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138435777|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138435778|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
138435779|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435780|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435781|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
138435783|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138435784|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435785|NCT01752998|Analgesics|analgesics|mesh-ancestor
138435786|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
138435787|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435788|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138435789|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138435790|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
138435791|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435792|NCT01753102|Estradiol|estradiol|mesh-list
138435793|NCT01753102|Estrogens|estrogens|mesh-ancestor
138435794|NCT01753102|Hormones|hormones|mesh-ancestor
138435795|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138435796|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435797|NCT01753128|Imipramine|imipramine|mesh-list
138435798|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138435799|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
138435800|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138435801|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138394768|NCT01522872|Bortezomib|bortezomib|mesh-list
138435802|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138375583|NCT01434862|Pramlintide|pramlintide|mesh-list
138435803|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138435804|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435806|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435807|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435808|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138435809|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
138435810|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138435811|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138435812|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138435813|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138435814|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435815|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
138435816|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435817|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435818|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138435819|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435821|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
138435822|NCT01753375|Vitamins|vitamins|mesh-ancestor
138435823|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
138435824|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435825|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138435826|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138435827|NCT01753453|Plerixafor|plerixafor|mesh-list
138435828|NCT01753453|Lenograstim|lenograstim|mesh-list
138435829|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138435830|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
138435831|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435832|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138435833|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138435834|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
138435835|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435836|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138435837|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138435838|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
138435839|NCT01753752|Chitosan|chitosan|mesh-list
138435840|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138435841|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138237200|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138435842|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138435843|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
138435844|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435845|NCT01753752|Expectorants|expectorants|mesh-ancestor
138435846|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
138435847|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138435849|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435850|NCT01753752|Protective Agents|protective agents|mesh-ancestor
138435851|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435852|NCT01753752|Antidotes|antidotes|mesh-ancestor
138435853|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138435854|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138435855|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
138435856|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138435857|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
138435858|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
138435859|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
138435860|NCT01753752|Coagulants|coagulants|mesh-ancestor
138435861|NCT01753882|Escitalopram|escitalopram|mesh-list
138435862|NCT01753882|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138435863|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138435864|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138435865|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435866|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138435867|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
138435868|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435869|NCT01754116|Cabotegravir|cabotegravir|mesh-list
138435870|NCT01754116|Midazolam|midazolam|mesh-list
138435871|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138435872|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138435873|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138435874|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435875|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138435876|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138435877|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138435878|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138375662|NCT01435252|Cetuximab|cetuximab|mesh-list
138435879|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
138435880|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
138435881|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
138435882|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
138435883|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138237228|NCT05456763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435884|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435885|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138435886|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138435887|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435889|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138435890|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
138435891|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435892|NCT01754181|Insulin|insulin|mesh-list
138435893|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138435894|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435895|NCT01754220|Montelukast|montelukast|mesh-list
138435896|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138435897|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
138435898|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138435899|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
138435900|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138435901|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435902|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138435903|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138435904|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435906|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138435907|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138198848|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435908|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435909|NCT01754324|Methadone|methadone|mesh-list
138435910|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138435911|NCT01754324|Narcotics|narcotics|mesh-ancestor
138435912|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138435913|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435914|NCT01754324|Analgesics|analgesics|mesh-ancestor
138435915|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
138435916|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138435917|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
138435918|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
138435919|NCT01754649|Misoprostol|misoprostol|mesh-list
138435920|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138435921|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
138435922|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138435923|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237262|NCT05455359|Famotidine|famotidine|mesh-list
138435924|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138435925|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138435926|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
138435927|NCT01754701|Iron|iron|mesh-list
138435928|NCT01754701|Trace Elements|trace elements|mesh-ancestor
138435929|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
138435930|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435931|NCT01754805|Methotrexate|methotrexate|mesh-list
138435932|NCT01754805|Peficitinib|peficitinib|mesh-list
138435933|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138435934|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
138435935|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138435936|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435937|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138435938|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
138435939|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435940|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435941|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
138435942|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435943|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138435944|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138435945|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
138435946|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138435947|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138435948|NCT01754831|Fluorides|fluorides|mesh-list
138435949|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
138435950|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
138435951|NCT01754831|Protective Agents|protective agents|mesh-ancestor
138435952|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138394919|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138435954|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138435955|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435956|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435957|NCT01754870|Rituximab|rituximab|mesh-list
138435958|NCT01754870|Lenalidomide|lenalidomide|mesh-list
138435959|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138435960|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138435961|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138435962|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
138435963|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435964|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138435965|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138375719|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138435966|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138435967|NCT01754870|Growth Substances|growth substances|mesh-ancestor
138435968|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
138435969|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138435970|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
138435971|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435973|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
138435974|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138435975|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138435976|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435977|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
138435978|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138435979|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138435980|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435981|NCT01754961|Vitamin D|vitamin d|mesh-list
138435982|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
138435983|NCT01754961|Cholecalciferol|cholecalciferol|mesh-list
138435984|NCT01754961|Vitamins|vitamins|mesh-list
138435985|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
138237295|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138435986|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138435987|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138435988|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138435989|NCT01754974|Ribavirin|ribavirin|mesh-list
138435990|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138435991|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
138435992|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138435993|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
138435994|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138435995|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
138435996|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
138435997|NCT01755078|Calcium|calcium|mesh-list
138435998|NCT01755078|Sevelamer|sevelamer|mesh-list
138435999|NCT01755078|Calcium acetate|calcium acetate|mesh-list
138436000|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138436001|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436002|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138436003|NCT01755078|Antacids|antacids|mesh-ancestor
138436004|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436005|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138436006|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
138375764|NCT01435954|Doxazosin|doxazosin|mesh-list
138436007|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
138436008|NCT01755117|Ropivacaine|ropivacaine|mesh-list
138436009|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
138436010|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
138436011|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436012|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436013|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
138436014|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436015|NCT01755182|Somatostatin|somatostatin|mesh-list
138436017|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436018|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436019|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
138436020|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138436021|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436022|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138436023|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138436024|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436025|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436026|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394996|NCT01523860|Rituximab|rituximab|mesh-list
138436027|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138436028|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138436030|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138436031|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436032|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138436033|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436034|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436035|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138436036|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138436037|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
138198852|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138198853|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
138198854|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138198855|NCT00002320|Lamivudine|lamivudine|mesh-list
138198856|NCT00002320|Zidovudine|zidovudine|mesh-list
138198857|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198859|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436038|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138436039|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
138436040|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138436041|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138436042|NCT01755338|Prednisolone|prednisolone|mesh-list
138436043|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
138436044|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138436045|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
138436046|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138436047|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
138436048|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
138436049|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436050|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436051|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138436052|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
138436053|NCT01755338|Hormones|hormones|mesh-ancestor
138436054|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436055|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138436056|NCT01755338|Protective Agents|protective agents|mesh-ancestor
138436057|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138436058|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436059|NCT01755377|Benzonidazole|benzonidazole|mesh-list
138436060|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138436061|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
138436062|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436063|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138436064|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138436065|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138436066|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436067|NCT01755403|Benzonidazole|benzonidazole|mesh-list
138436068|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138436069|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
138436070|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436071|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138436072|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138436073|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138436074|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436076|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138436077|NCT01755468|Metformin|metformin|mesh-list
138436078|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
138436079|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
138436080|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138436081|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436083|NCT01755494|Saxagliptin|saxagliptin|mesh-list
138436084|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138436085|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436086|NCT01755494|Incretins|incretins|mesh-ancestor
138436087|NCT01755494|Hormones|hormones|mesh-ancestor
138436088|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436089|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138436090|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
138436091|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436092|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436093|NCT01755520|Aspirin|aspirin|mesh-list
138436094|NCT01755520|Ticagrelor|ticagrelor|mesh-list
138436095|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138436096|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138436097|NCT01755520|Analgesics|analgesics|mesh-ancestor
138436098|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
138436099|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436100|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436101|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138436102|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138436103|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138436104|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138436105|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436106|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138436107|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138436108|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436110|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138436111|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138436112|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138436113|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
138436114|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138436116|NCT01755559|Lumefantrine|lumefantrine|mesh-list
138436117|NCT01755559|Artemether|artemether|mesh-list
138436118|NCT01755559|Piperaquine|piperaquine|mesh-list
138436119|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138436120|NCT01755559|Amodiaquine|amodiaquine|mesh-list
138436121|NCT01755559|Artenimol|artenimol|mesh-list
138436122|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
138436123|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138436124|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138436125|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436126|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436127|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
138436128|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
138436129|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138436130|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
138436131|NCT01755572|Liraglutide|liraglutide|mesh-list
138436132|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138436133|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436134|NCT01755572|Incretins|incretins|mesh-ancestor
138436136|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436137|NCT01755611|Minocycline|minocycline|mesh-list
138436138|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138436139|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436140|NCT01755663|Metoprolol|metoprolol|mesh-list
138436141|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138436142|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138436143|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
138436144|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
138436145|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436146|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436147|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138436148|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138436149|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138436150|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
138436151|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138436152|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436154|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
138436155|NCT01754792|Vitamins|vitamins|mesh-ancestor
138436156|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
138436157|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436158|NCT01755676|Orlistat|orlistat|mesh-list
138436159|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436160|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436161|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138436162|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138436163|NCT01755728|Acetaminophen|acetaminophen|mesh-list
138436164|NCT01755728|Ibuprofen|ibuprofen|mesh-list
138436165|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138436166|NCT01755728|Analgesics|analgesics|mesh-ancestor
138436167|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
138436168|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436169|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436170|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
138436171|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138436172|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138436173|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138436174|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138436175|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436176|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436177|NCT01755845|Paclitaxel|paclitaxel|mesh-list
138436178|NCT01755845|Cisplatin|cisplatin|mesh-list
138436179|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138436180|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436181|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
138436182|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
138436183|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
138436184|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436185|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138403537|NCT04705051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436186|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138436187|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436188|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138436189|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
138436190|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436191|NCT01755884|Immunomodulating Agents|immunomodulating agents|mesh-list
138436192|NCT01755884|Immunologic Factors|immunologic factors|mesh-ancestor
138436193|NCT01755884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436195|NCT01755923|Gefitinib|gefitinib|mesh-list
138436196|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436197|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
138436198|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
138436199|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
138436200|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436201|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138436202|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436203|NCT01756105|Insulin|insulin|mesh-list
138436204|NCT01756105|Metformin|metformin|mesh-list
138436205|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
138403578|NCT04047004|Doxorubicin|doxorubicin|mesh-list
138436206|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
138436207|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
138436208|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138436209|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436210|NCT01756131|Cabotegravir|cabotegravir|mesh-list
138436211|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138436212|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138436213|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436214|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436215|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138436216|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138436217|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
138436218|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436219|NCT01756170|Paclitaxel|paclitaxel|mesh-list
138436220|NCT01756170|Cisplatin|cisplatin|mesh-list
138436221|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138436222|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436223|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
138436224|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
138436225|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
138336600|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138436226|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436228|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138436229|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436230|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
138436231|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
138436232|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
138436233|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436234|NCT01756261|Aflibercept|aflibercept|mesh-list
138436235|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138436236|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138436237|NCT01756261|Growth Substances|growth substances|mesh-ancestor
138436238|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436239|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
138436240|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436241|NCT01756404|Canagliflozin|canagliflozin|mesh-list
138436242|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138436243|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436244|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138436245|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436246|NCT01756417|Metformin|metformin|mesh-list
138436247|NCT01756417|Canagliflozin|canagliflozin|mesh-list
138436248|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138436249|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436250|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138436251|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436252|NCT01756430|Carvedilol|carvedilol|mesh-list
138436253|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138436254|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138436255|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
138436256|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138198871|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138198872|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
138436257|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436258|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436259|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138436260|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
138436261|NCT01756430|Protective Agents|protective agents|mesh-ancestor
138436262|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138436263|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138436264|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138436265|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
138436266|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138436267|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138436268|NCT01756443|Lidocaine|lidocaine|mesh-list
138436269|NCT01756443|Epinephrine|epinephrine|mesh-list
138436270|NCT01756443|Racepinephrine|racepinephrine|mesh-list
138436271|NCT01756443|Bupivacaine|bupivacaine|mesh-list
138436274|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
138436275|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436276|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436277|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
138436278|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436279|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138436280|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138436281|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138436282|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138282881|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
138436283|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436284|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138436285|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138436286|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
138436287|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138436288|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138436289|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138436290|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
138436291|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138436292|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
138436293|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
138436294|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
138436295|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138436296|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
138436297|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138436298|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138436299|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436300|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138436301|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138436302|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436303|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436304|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436305|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138436306|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
138436307|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138436308|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436309|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138436310|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138237474|NCT06194968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138237475|NCT06194877|Panitumumab|panitumumab|mesh-list
138237476|NCT06194877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138237477|NCT06194877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138403763|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
138436311|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138436312|NCT01756508|Eculizumab|eculizumab|mesh-list
138436313|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138436314|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138436315|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
138436316|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436317|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
138436318|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138436319|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436320|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138436321|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138436322|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138347171|NCT02330094|Analgesics|analgesics|mesh-ancestor
138436323|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436324|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436325|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
138436326|NCT01756547|Diuretics|diuretics|mesh-ancestor
138436327|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
138436328|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436329|NCT01756547|Expectorants|expectorants|mesh-ancestor
138403820|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138436330|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
138436331|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
138436332|NCT01756612|Hematinics|hematinics|mesh-ancestor
138436333|NCT01756638|Prednisolone|prednisolone|mesh-list
138436334|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138336639|NCT05402826|Vitamin E|vitamin e|mesh-list
138436336|NCT01756638|Hormones|hormones|mesh-ancestor
138436337|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436338|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436339|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138436340|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436341|NCT01756651|Fentanyl|fentanyl|mesh-list
138436342|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138436343|NCT01756651|Narcotics|narcotics|mesh-ancestor
138436344|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436345|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436346|NCT01756651|Analgesics|analgesics|mesh-ancestor
138436347|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
138436348|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436349|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138436350|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138237510|NCT06194851|Oxytocin|oxytocin|mesh-list
138237511|NCT06194851|Oxytocics|oxytocics|mesh-ancestor
138237512|NCT06194851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138237513|NCT06194851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237514|NCT06194734|Docetaxel|docetaxel|mesh-list
138237515|NCT06194734|Irinotecan|irinotecan|mesh-list
138237516|NCT06194734|Tegafur|tegafur|mesh-list
138436351|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
138436352|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
138436353|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
138436354|NCT01756664|Petrolatum|petrolatum|mesh-list
138436355|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138436356|NCT01756664|Protective Agents|protective agents|mesh-ancestor
138436357|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436358|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
138436359|NCT01756664|Emollients|emollients|mesh-ancestor
138436360|NCT01756768|Palbociclib|palbociclib|mesh-list
138436361|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436362|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138436363|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436364|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436365|NCT01756781|Palbociclib|palbociclib|mesh-list
138436366|NCT01756781|Midazolam|midazolam|mesh-list
138436367|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138436368|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138436369|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436370|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436371|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138436372|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138436373|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138436374|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138436375|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
138436376|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
138436377|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
138436378|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
138436379|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138436380|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436381|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436382|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138436383|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436384|NCT01756989|Thalidomide|thalidomide|mesh-list
138436385|NCT01756989|Celecoxib|celecoxib|mesh-list
138436386|NCT01756989|Etoposide|etoposide|mesh-list
138436387|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
138436388|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138436389|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436390|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138436391|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138436392|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138237537|NCT06194617|Anticoagulants|anticoagulants|mesh-list
138436393|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436394|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138436395|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138436396|NCT01756989|Analgesics|analgesics|mesh-ancestor
138375991|NCT01437592|Insulin|insulin|mesh-list
138436397|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
138436398|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436399|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436400|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138436401|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138436402|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138395366|NCT06051370|Lidocaine|lidocaine|mesh-list
138436403|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138436404|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138436405|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
138436406|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
138436407|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138436408|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436409|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138436410|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138436411|NCT01756989|Growth Substances|growth substances|mesh-ancestor
138436412|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
138436413|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
138436414|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138436415|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138436416|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138436417|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
138436418|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138436419|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436420|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436421|NCT01757106|Sevoflurane|sevoflurane|mesh-list
138436422|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138436423|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138436424|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
138436425|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
138436426|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436427|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436428|NCT01757236|Vancomycin|vancomycin|mesh-list
138436429|NCT01757236|Rifampin|rifampin|mesh-list
138436430|NCT01757236|Clindamycin|clindamycin|mesh-list
138436431|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
138436432|NCT01757236|Linezolid|linezolid|mesh-list
138436433|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138237572|NCT06194058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436434|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
138436435|NCT01757236|Trimethoprim|trimethoprim|mesh-list
138436436|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
138436437|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138436438|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436439|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138436440|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
138436441|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
138375996|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436442|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138436443|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436444|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436445|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138436446|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138436447|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138436448|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138436449|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138436450|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138436451|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138436452|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138436453|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
138436454|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138436455|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138436456|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138436457|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138436458|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138198881|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
138436459|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138436460|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
138436461|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
138436462|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
138436463|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
138436464|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138436465|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138436466|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436467|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138436468|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138436469|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138436470|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138436471|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
138436472|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138436473|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138436475|NCT01757262|Ticagrelor|ticagrelor|mesh-list
138436476|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138436477|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138436478|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138436479|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138436480|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
138436481|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138436482|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436483|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138403971|NCT01570569|Caffeine|caffeine|mesh-list
138436484|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
138436485|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138436486|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436487|NCT01757431|Eculizumab|eculizumab|mesh-list
138436488|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138436489|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138436490|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
138436491|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436492|NCT01757457|Abciximab|abciximab|mesh-list
138436493|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
138436494|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138436495|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
138436496|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138436497|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436498|NCT01757587|Insulin|insulin|mesh-list
138436499|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138436500|NCT01757587|Metformin|metformin|mesh-list
138436501|NCT01757587|Vildagliptin|vildagliptin|mesh-list
138436502|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138436503|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436504|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138436505|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
138436506|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436507|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436508|NCT01757639|Ipilimumab|ipilimumab|mesh-list
138436509|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138436510|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436511|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138237642|NCT06190782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436512|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436514|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138436515|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138436516|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436517|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436518|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138436519|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138436520|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138436521|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138436522|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
138436523|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
138436524|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
138436525|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
138436526|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138404014|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138198882|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436527|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436528|NCT01757769|Silodosin|silodosin|mesh-list
138436529|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138436530|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138436531|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138436532|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
138436533|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138436534|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436535|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436536|NCT01757769|Urological Agents|urological agents|mesh-ancestor
138436537|NCT01757795|Otaplimastat|otaplimastat|mesh-list
138436538|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138436539|NCT01757795|Protective Agents|protective agents|mesh-ancestor
138436540|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436541|NCT01757808|Ranolazine|ranolazine|mesh-list
138436542|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138436543|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138436544|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436545|NCT01757860|Vitamin D|vitamin d|mesh-list
138436546|NCT01757860|Vitamins|vitamins|mesh-ancestor
138436547|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
138436548|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436549|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138436550|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
138436551|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138436552|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138436554|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
138436555|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138436556|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
138436557|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138436558|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
138436559|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
138237667|NCT06190600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436560|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436561|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436563|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
138436564|NCT01757899|Hormones|hormones|mesh-ancestor
138436565|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436566|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138436567|NCT01757899|Protective Agents|protective agents|mesh-ancestor
138436568|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138436569|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436570|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
138436572|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
138436573|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
138436574|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138436575|NCT01758029|Androgens|androgens|mesh-ancestor
138436576|NCT01758029|Hormones|hormones|mesh-ancestor
138436577|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436578|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436579|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138436580|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436581|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
138436582|NCT01758094|Testosterone|testosterone|mesh-list
138436583|NCT01758094|Androgens|androgens|mesh-ancestor
138436584|NCT01758094|Hormones|hormones|mesh-ancestor
138436585|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436586|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436587|NCT01758107|Cyclosporine|cyclosporine|mesh-list
138436588|NCT01758107|Cyclosporins|cyclosporins|mesh-list
138436589|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436590|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436591|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138436592|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
138436593|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436594|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
138436595|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436596|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
138436597|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138436598|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138436599|NCT01758120|Prednisone|prednisone|mesh-list
138436600|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
138436601|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138436602|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
138436603|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436604|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138436605|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138436606|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
138436607|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436608|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436609|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138436610|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138436612|NCT01758120|Hormones|hormones|mesh-ancestor
138436613|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436614|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138436615|NCT01758146|Tamoxifen|tamoxifen|mesh-list
138436616|NCT01758146|Letrozole|letrozole|mesh-list
138436617|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436618|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138436619|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138436620|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436621|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436622|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138436623|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
138436624|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436625|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436626|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138436627|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138436628|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138436629|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138436630|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138436631|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
138436632|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
138436633|NCT01758185|Vaccines|vaccines|mesh-list
138436634|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
138436635|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436636|NCT01758198|Methotrexate|methotrexate|mesh-list
138436637|NCT01758198|Abatacept|abatacept|mesh-list
138436638|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138436639|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
138436640|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138436641|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436642|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138436643|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
138436644|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436645|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436646|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
138436647|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436648|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138436649|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138436650|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
138436651|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138436652|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138436653|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138436654|NCT01758198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138436656|NCT01758263|Nebivolol|nebivolol|mesh-list
138436657|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138436658|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138436659|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
138436660|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
138436661|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436662|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436663|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138282882|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138237772|NCT06190132|Gabapentin|gabapentin|mesh-list
138436664|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138436665|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138436666|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
138436667|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138436668|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436669|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
138436670|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138436671|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138436672|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138436674|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138436675|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
138436676|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436677|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436678|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436681|NCT01758380|Gliclazide|gliclazide|mesh-list
138436682|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138436683|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436684|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138436685|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
138436686|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436687|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436688|NCT01758393|Prednisone|prednisone|mesh-list
138436689|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138436690|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
138436691|NCT01758393|Hormones|hormones|mesh-ancestor
138436692|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436693|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436694|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138436695|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436696|NCT01758471|Acarbose|acarbose|mesh-list
138436697|NCT01758471|Glipizide|glipizide|mesh-list
138336850|NCT05821192|Glucocorticoids|glucocorticoids|mesh-ancestor
138436698|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138436699|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436700|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436701|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138436702|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436704|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
138436705|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138436706|NCT01758640|Warfarin|warfarin|mesh-list
138436707|NCT01758640|Phenindione|phenindione|mesh-list
138436708|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
138436709|NCT01758666|Leucovorin|leucovorin|mesh-list
138436710|NCT01758666|Methotrexate|methotrexate|mesh-list
138436711|NCT01758666|Calcium|calcium|mesh-list
138376185|NCT05343507|Ketamine|ketamine|mesh-list
138436712|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
138436713|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138436714|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436715|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138436716|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
138436717|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138436718|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138436719|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
138436720|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436721|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436722|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
138436723|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436724|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138436725|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138436726|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
138436727|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138436728|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138436729|NCT01758666|Antidotes|antidotes|mesh-ancestor
138436730|NCT01758666|Protective Agents|protective agents|mesh-ancestor
138198886|NCT00002326|Zidovudine|zidovudine|mesh-list
138198887|NCT00002326|Adefovir|adefovir|mesh-list
138436731|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
138198888|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
138436732|NCT01758666|Vitamins|vitamins|mesh-ancestor
138436733|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
138436734|NCT01758744|Treprostinil|treprostinil|mesh-list
138198889|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198890|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198892|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436735|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138436736|NCT01758809|Bupivacaine|bupivacaine|mesh-list
138436737|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
138436739|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436740|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436741|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
138436742|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436743|NCT01758835|Calpastatin|calpastatin|mesh-list
138436744|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
138436745|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
138436746|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436747|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436748|NCT01758913|Ibuprofen|ibuprofen|mesh-list
138436749|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138436750|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138436751|NCT01758913|Analgesics|analgesics|mesh-ancestor
138436752|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
138436753|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436754|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436755|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138436756|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138436757|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138436758|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436759|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436760|NCT01758978|Hydrocodone|hydrocodone|mesh-list
138436761|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138436762|NCT01758978|Narcotics|narcotics|mesh-ancestor
138436763|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436764|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436765|NCT01758978|Analgesics|analgesics|mesh-ancestor
138436766|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
138436767|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436768|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
138436769|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
138436770|NCT01759030|Rituximab|rituximab|mesh-list
138436771|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138436772|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436773|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
138436774|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436775|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138436776|NCT01759108|Rebamipide|rebamipide|mesh-list
138436777|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138237922|NCT06179160|Cetuximab|cetuximab|mesh-list
138436778|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138436779|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
138436780|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436781|NCT01759108|Protective Agents|protective agents|mesh-ancestor
138436782|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436783|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436784|NCT01759394|Maleic acid|maleic acid|mesh-list
138436785|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436786|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436787|NCT01759485|Vitamin D|vitamin d|mesh-list
138436788|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
138436789|NCT01759485|Vitamins|vitamins|mesh-ancestor
138436791|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436792|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138436793|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138436794|NCT01759524|Lidocaine|lidocaine|mesh-list
138436795|NCT01759524|Clonidine|clonidine|mesh-list
138436796|NCT01759524|Bupivacaine|bupivacaine|mesh-list
138376233|NCT04956939|Levodopa|levodopa|mesh-list
138436797|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
138436798|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
138436799|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436800|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436801|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
138436802|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436803|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138436804|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138436805|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138436806|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138436807|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436808|NCT01759524|Analgesics|analgesics|mesh-ancestor
138404241|NCT01571921|Vitamin E|vitamin e|mesh-list
138436809|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138436811|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
138347896|NCT04307550|Ethanol|ethanol|mesh-list
138347897|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138347898|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436812|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138436813|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138436814|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138436815|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
138237945|NCT06157827|Cisplatin|cisplatin|mesh-list
138436816|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138436817|NCT01759576|Canagliflozin|canagliflozin|mesh-list
138436818|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138436819|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436820|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138436821|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436822|NCT01759589|Remifentanil|remifentanil|mesh-list
138436823|NCT01759589|Propofol|propofol|mesh-list
138436824|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
138436825|NCT01759589|Anesthetics|anesthetics|mesh-list
138436826|NCT01759589|Sevoflurane|sevoflurane|mesh-list
138436827|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138436828|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436829|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436830|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
138436831|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138436832|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138436833|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138436834|NCT01759589|Narcotics|narcotics|mesh-ancestor
138436835|NCT01759589|Analgesics|analgesics|mesh-ancestor
138436836|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
138436837|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436838|NCT01759706|Dexamethasone|dexamethasone|mesh-list
138436839|NCT01759706|Sufentanil|sufentanil|mesh-list
138436840|NCT01759706|Diazepam|diazepam|mesh-list
138436841|NCT01759706|Ondansetron|ondansetron|mesh-list
138436842|NCT01759706|Anesthetics|anesthetics|mesh-list
138436843|NCT01759706|Ropivacaine|ropivacaine|mesh-list
138436844|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138436845|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
138436846|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
138436847|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436848|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436849|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138436850|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
138436851|NCT01759706|Hormones|hormones|mesh-ancestor
138436852|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436853|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138395818|NCT04626141|Abaloparatide|abaloparatide|mesh-list
138436854|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436855|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436856|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
138436857|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
138436858|NCT01759706|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138436859|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138436860|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
138436861|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138436862|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436863|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138436864|NCT01759706|Narcotics|narcotics|mesh-ancestor
138436865|NCT01759706|Analgesics|analgesics|mesh-ancestor
138436866|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
138436867|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138436868|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138436869|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
138436870|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
138436871|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
138436872|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138436873|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138436874|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138436875|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138436876|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138436877|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138238020|NCT06132685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238021|NCT06132685|Antiemetics|antiemetics|mesh-ancestor
138238022|NCT06132685|Autonomic Agents|autonomic agents|mesh-ancestor
138238023|NCT06132685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238024|NCT06132685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238025|NCT06132685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138238026|NCT06132685|Glucocorticoids|glucocorticoids|mesh-ancestor
138198895|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138238028|NCT06132685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436878|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
138436879|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
138436880|NCT01759719|Chromium|chromium|mesh-list
138436881|NCT01759719|Trace Elements|trace elements|mesh-ancestor
138436882|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
138436883|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436884|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
138436885|NCT01759732|Fludarabine|fludarabine|mesh-list
138436886|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138436887|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138436888|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
138376296|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
138436889|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436890|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138436891|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138436892|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
138436893|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436894|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436895|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138436896|NCT01759771|Vitamin D|vitamin d|mesh-list
138436897|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
138436898|NCT01759771|Vitamins|vitamins|mesh-ancestor
138436899|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
138436900|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436901|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138436902|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138436903|NCT01759810|Vaccines|vaccines|mesh-list
138436904|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
138404383|NCT01572350|Hormones|hormones|mesh-ancestor
138436905|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436906|NCT01759875|Ritonavir|ritonavir|mesh-list
138436907|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138436908|NCT01759875|Rabeprazole|rabeprazole|mesh-list
138436909|NCT01759875|Betaine|betaine|mesh-list
138436910|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138436911|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138436912|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
138436913|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436914|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436915|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138436916|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138436917|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
138436918|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436919|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138436920|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138436921|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138436922|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138436923|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138436924|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
138436925|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138436926|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
138436927|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138436928|NCT01759940|Ropivacaine|ropivacaine|mesh-list
138436929|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
138436930|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
138436931|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436932|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436933|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
138436934|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138436936|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138436937|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
138436938|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
138436939|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138436940|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436941|NCT01760096|Cyclosporine|cyclosporine|mesh-list
138436943|NCT01760096|Cyclosporins|cyclosporins|mesh-list
138436944|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
138436945|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238075|NCT06113913|Infliximab|infliximab|mesh-list
138436946|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436947|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138436949|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436950|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
138436951|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436952|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
138436953|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138436954|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138436955|NCT01760096|Hormones|hormones|mesh-ancestor
138436956|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138436957|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138436958|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
138436959|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
138436960|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138436961|NCT01760109|Piperacillin|piperacillin|mesh-list
138436962|NCT01760109|Sulbactam|sulbactam|mesh-list
138436963|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138436964|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436965|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138436966|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138436967|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436968|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138436969|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
138436970|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436971|NCT01760148|Interferons|interferons|mesh-list
138436972|NCT01760148|Ribavirin|ribavirin|mesh-list
138436973|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
138436975|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138436976|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
138436977|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138436978|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
138436979|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138436980|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
138436981|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138436982|NCT01760161|Ropivacaine|ropivacaine|mesh-list
138436983|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
138436984|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
138238091|NCT06104449|Hormones|hormones|mesh-ancestor
138437046|NCT01760278|Hormones|hormones|mesh-list
138437047|NCT01760278|Progesterone|progesterone|mesh-list
138437048|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138437049|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138437050|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437051|NCT01760278|Progestins|progestins|mesh-ancestor
138437052|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138437053|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
138404537|NCT01573377|Metformin|metformin|mesh-list
138437054|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138437055|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
138437056|NCT01760330|Acetaminophen|acetaminophen|mesh-list
138437057|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138437058|NCT01760330|Analgesics|analgesics|mesh-ancestor
138437059|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
138437060|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437061|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437062|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
138437063|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
138437064|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
138437065|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138437066|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138437067|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437068|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437069|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437070|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138437071|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
138437072|NCT01760460|Anacetrapib|anacetrapib|mesh-list
138437073|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138437074|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138437075|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
138437076|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437077|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138238164|NCT06061575|Acetaminophen|acetaminophen|mesh-list
138238165|NCT06061575|Ibuprofen|ibuprofen|mesh-list
138238166|NCT06061575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138238167|NCT06061575|Analgesics|analgesics|mesh-ancestor
138238168|NCT06061575|Sensory System Agents|sensory system agents|mesh-ancestor
138238169|NCT06061575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138238170|NCT06061575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138238171|NCT06061575|Antipyretics|antipyretics|mesh-ancestor
138238172|NCT06061575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138238173|NCT06061575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138238174|NCT06061575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138437078|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437079|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138437080|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437082|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437083|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437084|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138437085|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138437086|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
138437087|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437088|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138437089|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138437090|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437091|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
138437092|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138437093|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138437094|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
138437095|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138437096|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138376456|NCT02655315|Deferiprone|deferiprone|mesh-list
138437097|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437098|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
138437099|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437100|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437101|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138437102|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437103|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138404619|NCT01573975|Clarithromycin|clarithromycin|mesh-list
138437104|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
138437105|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
138437106|NCT01760577|Protective Agents|protective agents|mesh-ancestor
138437108|NCT01760642|Ketoconazole|ketoconazole|mesh-list
138437109|NCT01760642|Midazolam|midazolam|mesh-list
138437110|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138437111|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138437112|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138437113|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437114|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138437115|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138238175|NCT06061575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138238176|NCT06061575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138238177|NCT06061575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238178|NCT06060405|Durvalumab|durvalumab|mesh-list
138238179|NCT06060405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138238180|NCT06060405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437116|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138437117|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138198904|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138198905|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138437118|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
138198906|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138437119|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
138437120|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
138198907|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138437121|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
138437122|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437123|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437124|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138437125|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
138437126|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138437127|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437128|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
138437129|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138437130|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437131|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138437132|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138437133|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138437134|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138437135|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138437136|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138437137|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
138437138|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138437139|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138437140|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138437141|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
138437142|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138437143|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138437145|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
138437146|NCT01760694|Irinotecan|irinotecan|mesh-list
138437147|NCT01760694|Folfirinox|folfirinox|mesh-list
138437148|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437149|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138437150|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138437151|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437152|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437153|NCT01760694|Antidotes|antidotes|mesh-ancestor
138437154|NCT01760694|Protective Agents|protective agents|mesh-ancestor
138437155|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437156|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
138437157|NCT01760694|Vitamins|vitamins|mesh-ancestor
138437158|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
138437159|NCT01760746|Bevacizumab|bevacizumab|mesh-list
138437160|NCT01760746|Ranibizumab|ranibizumab|mesh-list
138437161|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138437162|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437163|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138437164|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138437165|NCT01760746|Growth Substances|growth substances|mesh-ancestor
138437166|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437167|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
138437168|NCT01760798|Teriparatide|teriparatide|mesh-list
138437169|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138437170|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437171|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138437172|NCT01760811|Cetuximab|cetuximab|mesh-list
138437173|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138437174|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437175|NCT01760824|Amoxicillin|amoxicillin|mesh-list
138437176|NCT01760824|Metronidazole|metronidazole|mesh-list
138437177|NCT01760824|Clarithromycin|clarithromycin|mesh-list
138437178|NCT01760824|Tetracycline|tetracycline|mesh-list
138437179|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138437181|NCT01760824|Bismuth|bismuth|mesh-list
138437182|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138337145|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
138437183|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437184|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138437185|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138437186|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138437187|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138437188|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138437189|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437190|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437191|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138437192|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138198924|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437193|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138437194|NCT01760824|Antacids|antacids|mesh-ancestor
138437195|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138437196|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138376521|NCT01877837|Melphalan|melphalan|mesh-list
138437197|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
138437198|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138437199|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138437200|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437201|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138437202|NCT01760967|Analgesics|analgesics|mesh-ancestor
138437203|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
138437204|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437205|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138437206|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138437207|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138437208|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
138437209|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437210|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437211|NCT01760980|Exemestane|exemestane|mesh-list
138437212|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437213|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138437214|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138437215|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437216|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437217|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138437218|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
138437219|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138437220|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437221|NCT01761071|Diclofenac|diclofenac|mesh-list
138437222|NCT01761071|Ketorolac|ketorolac|mesh-list
138437223|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138437224|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138437225|NCT01761071|Analgesics|analgesics|mesh-ancestor
138437226|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
138437227|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437228|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437229|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138337167|NCT05498116|Montelukast|montelukast|mesh-list
138437230|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138437231|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138437232|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437233|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437234|NCT01761110|Buprenorphine|buprenorphine|mesh-list
138437235|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138437236|NCT01761110|Narcotics|narcotics|mesh-ancestor
138437237|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138437238|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437239|NCT01761110|Analgesics|analgesics|mesh-ancestor
138437240|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
138437241|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437242|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138437243|NCT01761149|Remifentanil|remifentanil|mesh-list
138437244|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138437245|NCT01761149|Narcotics|narcotics|mesh-ancestor
138437246|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138437247|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437248|NCT01761149|Analgesics|analgesics|mesh-ancestor
138238283|NCT06008860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437249|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
138437250|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138198927|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
138198931|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138198932|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198933|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138198934|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437253|NCT01761201|Isoniazid|isoniazid|mesh-list
138437254|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138437255|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437256|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138376552|NCT01375764|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138437257|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138437258|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138437259|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437260|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437261|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437262|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138437263|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138437264|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
138437265|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138437266|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138437267|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
138437268|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138437269|NCT01761214|Amoxicillin|amoxicillin|mesh-list
138437270|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
138437271|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
138437272|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
138437273|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138437274|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
138437275|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138437276|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437277|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138437278|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138437279|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437280|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404838|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437281|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437282|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138437283|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138437284|NCT01761318|Liraglutide|liraglutide|mesh-list
138437285|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138437286|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437287|NCT01761318|Incretins|incretins|mesh-ancestor
138437288|NCT01761318|Hormones|hormones|mesh-ancestor
138437289|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138437290|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
138437291|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138437292|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
138437293|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437294|NCT01761487|Gentamicins|gentamicins|mesh-list
138437295|NCT01761487|Polymyxins|polymyxins|mesh-list
138437296|NCT01761487|Colistin|colistin|mesh-list
138437297|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138437298|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437299|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138437300|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437301|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437302|NCT01761513|Esomeprazole|esomeprazole|mesh-list
138437303|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138437304|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138437305|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138437306|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437307|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437308|NCT01761526|Rotigotine|rotigotine|mesh-list
138437309|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
138437311|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437312|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437313|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437314|NCT01761552|Atropine|atropine|mesh-list
138437315|NCT01761552|Neostigmine|neostigmine|mesh-list
138437316|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138437317|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138437318|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138437319|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
138437320|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437321|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437322|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138437323|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
138437324|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
138198938|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138238337|NCT05950945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437325|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
138437326|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138437327|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138437328|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
138437329|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437330|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437331|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138437332|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437333|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138437335|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138437336|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138437337|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
138376600|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
138437338|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437339|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138437340|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138437341|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437343|NCT01761669|Vitamins|vitamins|mesh-ancestor
138437344|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
138437345|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437346|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138437347|NCT01761916|Clonidine|clonidine|mesh-list
138437348|NCT01761916|Captopril|captopril|mesh-list
138437349|NCT01761916|Analgesics|analgesics|mesh-ancestor
138437350|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
138437351|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437352|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437353|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138437354|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
138437355|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
138437356|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138437357|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138437358|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138437359|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
138437360|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437361|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437362|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138437363|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
138437364|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437365|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
138437366|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138437367|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437368|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437370|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138337255|NCT05014087|Digoxin|digoxin|mesh-list
138437371|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138437373|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
138404955|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
138437374|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437375|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437376|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138437377|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138437378|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
138437379|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
138437380|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437381|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437382|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138437383|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138437384|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138437385|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138437386|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
138437387|NCT01762046|Metformin|metformin|mesh-list
138437388|NCT01762046|Glipizide|glipizide|mesh-list
138437389|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138437390|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437391|NCT01762150|Gemcitabine|gemcitabine|mesh-list
138437392|NCT01762150|Sorafenib|sorafenib|mesh-list
138437393|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437394|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138437395|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
138198940|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
138437396|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437397|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138437398|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437399|NCT01762163|Aspirin|aspirin|mesh-list
138437400|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138437401|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138437402|NCT01762163|Analgesics|analgesics|mesh-ancestor
138437403|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
138437404|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437405|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437406|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138437408|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138437409|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138437410|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437411|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138437412|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138437413|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437414|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
138437416|NCT01762202|Fludarabine|fludarabine|mesh-list
138437417|NCT01762202|Ofatumumab|ofatumumab|mesh-list
138437418|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138437419|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
138437420|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437421|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138437422|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138437423|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
138437424|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437425|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437426|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138437427|NCT01762306|Folic Acid|folic acid|mesh-list
138437428|NCT01762306|Diclofenac|diclofenac|mesh-list
138437429|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138437430|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138437431|NCT01762306|Analgesics|analgesics|mesh-ancestor
138437432|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
138437433|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437434|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437435|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138437436|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138437437|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138437438|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437439|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437440|NCT01762306|Hematinics|hematinics|mesh-ancestor
138437441|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
138437442|NCT01762306|Vitamins|vitamins|mesh-ancestor
138437443|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
138437444|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
138437446|NCT01762319|Pyridoxine|pyridoxine|mesh-list
138437447|NCT01762319|Misoprostol|misoprostol|mesh-list
138437448|NCT01762319|Vitamins|vitamins|mesh-ancestor
138437449|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
138437450|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437451|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138437452|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
138437453|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138437454|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138437455|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138437456|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
138437457|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
138437458|NCT01762332|Remifentanil|remifentanil|mesh-list
138396423|NCT01525537|Sufentanil|sufentanil|mesh-list
138437459|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138437460|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138437461|NCT01762332|Narcotics|narcotics|mesh-ancestor
138437462|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138437463|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437465|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
138437466|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437467|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138437469|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437470|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437471|NCT01762436|Atenolol|atenolol|mesh-list
138437472|NCT01762436|Bisoprolol|bisoprolol|mesh-list
138437473|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138437474|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138437475|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
138437476|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
138437477|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138376692|NCT01438944|Nicotine|nicotine|mesh-list
138437478|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437479|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138437480|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138437481|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138437482|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
138437483|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437484|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437485|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
138437486|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
138437487|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138437488|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138437489|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437490|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437491|NCT01762475|Urological Agents|urological agents|mesh-ancestor
138437493|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138437494|NCT01762514|Protective Agents|protective agents|mesh-ancestor
138437495|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437496|NCT01762540|Prednisolone|prednisolone|mesh-list
138437498|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
138437499|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138437500|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437501|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138437502|NCT01762540|Hormones|hormones|mesh-ancestor
138437503|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138437504|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138437505|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437506|NCT01762644|Cyclosporine|cyclosporine|mesh-list
138437507|NCT01762644|Omeprazole|omeprazole|mesh-list
138437508|NCT01762644|Cyclosporins|cyclosporins|mesh-list
138437509|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437510|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437511|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138437512|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
138437513|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437514|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
138437515|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437516|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
138437517|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138437518|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138437519|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138437520|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138437521|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138437523|NCT01762657|Lansoprazole|lansoprazole|mesh-list
138437524|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
138437525|NCT01762657|Cyclosporins|cyclosporins|mesh-list
138437526|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437527|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437528|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138437529|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
138437530|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437531|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
138437532|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437533|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
138396509|NCT01526083|Lacosamide|lacosamide|mesh-list
138437534|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138437535|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138437536|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138376723|NCT01439178|Bevacizumab|bevacizumab|mesh-list
138437537|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138437538|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138437540|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437541|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138437542|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138437543|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138437544|NCT01762787|Aspirin|aspirin|mesh-list
138437545|NCT01762787|Prednisolone|prednisolone|mesh-list
138437546|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138437547|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
138437548|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138437549|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
138437550|NCT01762787|Cantharidin|cantharidin|mesh-list
138437551|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138437552|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
138437553|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138437554|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138437555|NCT01762787|Analgesics|analgesics|mesh-ancestor
138437556|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
138437557|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437558|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437559|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138437560|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138437561|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138437562|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138437563|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138337359|NCT04812366|Hormones|hormones|mesh-ancestor
138437564|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138437565|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138437566|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437567|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
138437568|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
138437569|NCT01762787|Hormones|hormones|mesh-ancestor
138437570|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138437571|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138437572|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437573|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
138437574|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
138437575|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138437576|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138437577|NCT01762787|Protective Agents|protective agents|mesh-ancestor
138437578|NCT01762826|Inositol|inositol|mesh-list
138437580|NCT01762826|Vitamins|vitamins|mesh-ancestor
138437581|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
138437582|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437583|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
138437584|NCT01762839|Oritavancin|oritavancin|mesh-list
138437585|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138437586|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437587|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138437588|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138437589|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437590|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437591|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437592|NCT01762852|Belimumab|belimumab|mesh-list
138437593|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138437594|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
138437595|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437596|NCT01762878|Nemiralisib|nemiralisib|mesh-list
138437597|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138437598|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437599|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437600|NCT01762891|Acetaminophen|acetaminophen|mesh-list
138437601|NCT01762891|Celecoxib|celecoxib|mesh-list
138437602|NCT01762891|Rofecoxib|rofecoxib|mesh-list
138437603|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138437604|NCT01762891|Analgesics|analgesics|mesh-ancestor
138437605|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
138238533|NCT05848687|Hormones|hormones|mesh-ancestor
138437606|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437607|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437608|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
138198946|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
138198950|NCT04756622|Expectorants|expectorants|mesh-ancestor
138437609|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138437610|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138437611|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138437612|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138437613|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138437614|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437615|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437616|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
138437617|NCT01762995|Dolutegravir|dolutegravir|mesh-list
138437618|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
138437620|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138437621|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437622|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138437623|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138437624|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437625|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437626|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138437627|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138437628|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
138437629|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437630|NCT01762995|Antacids|antacids|mesh-ancestor
138437631|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138437632|NCT01762995|Trace Elements|trace elements|mesh-ancestor
138437633|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
138437634|NCT01763021|Rifampin|rifampin|mesh-list
138437635|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138437636|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
138437637|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138437638|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437639|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
138437640|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138437641|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437642|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437643|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138437644|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138437645|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138437646|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138437647|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138437648|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138437649|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
138437650|NCT01763281|Hormones|hormones|mesh-ancestor
138437651|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138437652|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437653|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138437654|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437655|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138437656|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437657|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437658|NCT01763437|Tetracycline|tetracycline|mesh-list
138437659|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138437660|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437661|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138437662|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437663|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437664|NCT01763450|Bevacizumab|bevacizumab|mesh-list
138437665|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138437666|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437667|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138437668|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138437669|NCT01763450|Growth Substances|growth substances|mesh-ancestor
138437670|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437671|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
138437672|NCT01763463|Fluticasone|fluticasone|mesh-list
138437674|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138437675|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138437676|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
138437677|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138437678|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
138437679|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437680|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437681|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138437682|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
138437683|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
138238606|NCT05817851|Vitamins|vitamins|mesh-list
138437684|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138437685|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138437686|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138437687|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138437688|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
138437689|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138405399|NCT01579227|Vitamins|vitamins|mesh-ancestor
138437690|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437691|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
138437692|NCT01763463|Hormones|hormones|mesh-ancestor
138437693|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138437694|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
138437695|NCT01763476|Paclitaxel|paclitaxel|mesh-list
138437696|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138437697|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437698|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
138437699|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
138437700|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
138437701|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437702|NCT01763541|Anastrozole|anastrozole|mesh-list
138437703|NCT01763541|Leuprolide|leuprolide|mesh-list
138437704|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138437705|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437706|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138437707|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138437708|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437709|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437710|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138437711|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
138437712|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138437713|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437714|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138437715|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
138437716|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138437717|NCT01763658|Dexamethasone|dexamethasone|mesh-list
138437718|NCT01763658|Prednisolone|prednisolone|mesh-list
138437719|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138437720|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
138437721|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138437722|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
138437723|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138437724|NCT01763658|Antioxidants|antioxidants|mesh-list
138437725|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138437726|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
138238613|NCT05799105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138437727|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
138437728|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437729|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437730|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138437731|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
138437732|NCT01763658|Hormones|hormones|mesh-ancestor
138437733|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138437734|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138437735|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437736|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437737|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138437738|NCT01763658|Protective Agents|protective agents|mesh-ancestor
138437739|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
138437740|NCT01763710|Paclitaxel|paclitaxel|mesh-list
138437741|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138437742|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138437743|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437744|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
138437745|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
138437746|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
138437747|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437748|NCT01763749|Clopidogrel|clopidogrel|mesh-list
138437749|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138437750|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138437751|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138437752|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138437753|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
138437754|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437755|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437756|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437757|NCT01763788|Gemcitabine|gemcitabine|mesh-list
138437758|NCT01763788|Necitumumab|necitumumab|mesh-list
138437759|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437760|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138437761|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
138437762|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437763|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138437764|NCT01764087|Paclitaxel|paclitaxel|mesh-list
138437766|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138437767|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437768|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
138437769|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
138437771|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437772|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437773|NCT01764126|Vaccines|vaccines|mesh-list
138437774|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
138437775|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437776|NCT01764139|Vitamin D|vitamin d|mesh-list
138437777|NCT01764139|Vitamins|vitamins|mesh-ancestor
138437778|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
138437779|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437780|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138437781|NCT01764178|Valsartan|valsartan|mesh-list
138437782|NCT01764178|Pitavastatin|pitavastatin|mesh-list
138437783|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138437784|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138437785|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138337499|NCT04432207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138437786|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437787|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138437788|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138437789|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138437790|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
138437791|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437792|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138437793|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138437794|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
138437795|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138437796|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
138437797|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138437798|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437799|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138437800|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138437801|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437803|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138437804|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138437805|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138437806|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
138437807|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437808|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138437809|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138437810|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437811|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138437812|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138437813|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138437815|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138437816|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138437817|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
138437818|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437819|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138437820|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138437821|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437822|NCT01763424|Calcitriol|calcitriol|mesh-list
138437823|NCT01763424|Niacinamide|niacinamide|mesh-list
138437824|NCT01763424|Niacin|niacin|mesh-list
138437825|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
138437826|NCT01763424|Calcipotriene|calcipotriene|mesh-list
138437827|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
138437828|NCT01763424|Vitamins|vitamins|mesh-ancestor
138437829|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
138437830|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437831|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138396791|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138437832|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
138437833|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437835|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
138437836|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
138437837|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138437838|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138437839|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138437840|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138437841|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138437843|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138437844|NCT01764555|Analgesics|analgesics|mesh-ancestor
138437845|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
138437846|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437847|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437848|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
138437850|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138437851|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
138437852|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437853|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138437854|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437855|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437856|NCT01764672|Methylphenidate|methylphenidate|mesh-list
138437857|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138437858|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437859|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138437860|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138437861|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138405670|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
138437862|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437863|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
138437864|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437866|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138437867|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437868|NCT01764828|Gemcitabine|gemcitabine|mesh-list
138437869|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138437870|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
138437871|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437872|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437873|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138437874|NCT01764867|Dexetimide|dexetimide|mesh-list
138376972|NCT01440985|Nicotine|nicotine|mesh-list
138437876|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
138437877|NCT01764867|Trazodone|trazodone|mesh-list
138437878|NCT01764867|Citalopram|citalopram|mesh-list
138437879|NCT01764867|Bupropion|bupropion|mesh-list
138437880|NCT01764867|Fluoxetine|fluoxetine|mesh-list
138437881|NCT01764867|Paroxetine|paroxetine|mesh-list
138437882|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138437883|NCT01764867|Sertraline|sertraline|mesh-list
138437884|NCT01764867|Escitalopram|escitalopram|mesh-list
138437885|NCT01764867|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138437886|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138437887|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138437888|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437889|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437890|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
138437891|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437892|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138437893|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138437894|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
138437895|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
138437896|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138437897|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138437898|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138437899|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
138437900|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138198966|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
138437901|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
138437902|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138437903|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138437905|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138437906|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138437907|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138396866|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
138437908|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138437909|NCT01764867|Analgesics|analgesics|mesh-ancestor
138437910|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
138437911|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138437912|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
138437913|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
138437914|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138437915|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138437916|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138437917|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138376997|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437919|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138437920|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
138437921|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138437922|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138437923|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138437924|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138437925|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138437926|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
138437927|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138437928|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138437929|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
138437930|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437931|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437932|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437933|NCT01764893|Urological Agents|urological agents|mesh-ancestor
138437934|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
138437935|NCT01765010|Vitamin D|vitamin d|mesh-list
138437936|NCT01765010|Calcitriol|calcitriol|mesh-list
138437937|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
138437938|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138437939|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138437940|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437941|NCT01765010|Vitamins|vitamins|mesh-ancestor
138437942|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
138437943|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138437944|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138437945|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138437946|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437947|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138437948|NCT01765023|Metformin|metformin|mesh-list
138437949|NCT01765023|Atorvastatin|atorvastatin|mesh-list
138437950|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138437951|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437952|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138437953|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138437954|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
138437955|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437956|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138437957|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138437958|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437960|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138437962|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437963|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437964|NCT01765231|Entecavir|entecavir|mesh-list
138437965|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
138437966|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138437967|NCT01765257|Rasagiline|rasagiline|mesh-list
138437968|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138437969|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138437970|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437971|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138437972|NCT01765257|Protective Agents|protective agents|mesh-ancestor
138437973|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437974|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
138437975|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138437976|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138437977|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437978|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
138437979|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437980|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437981|NCT01765374|Rituximab|rituximab|mesh-list
138437982|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138437983|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138437984|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
138437985|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437986|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138437987|NCT01765452|Clopidogrel|clopidogrel|mesh-list
138437988|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138437989|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138437990|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138437991|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138437992|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
138437993|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138437994|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138437995|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138437996|NCT01765556|Ketoconazole|ketoconazole|mesh-list
138437997|NCT01765556|Vemurafenib|vemurafenib|mesh-list
138437998|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
138437999|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438000|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138438001|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138438002|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438003|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438004|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138438005|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
138438006|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138438007|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438008|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138438009|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438010|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138438012|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
138438013|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138438014|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138438015|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438016|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138438017|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438018|NCT01765738|Minocycline|minocycline|mesh-list
138438020|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138438021|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438022|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138438023|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
138438024|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
138438025|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138438026|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438027|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438028|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138438029|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138438030|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138438031|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138438032|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138438033|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138438034|NCT01765790|Antibodies|antibodies|mesh-list
138438035|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
138438036|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
138438037|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438038|NCT01765829|Droperidol|droperidol|mesh-list
138438039|NCT01765829|Haloperidol|haloperidol|mesh-list
138438040|NCT01765829|Pimozide|pimozide|mesh-list
138438041|NCT01765829|Olanzapine|olanzapine|mesh-list
138438042|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
138438043|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
138438044|NCT01765829|Risperidone|risperidone|mesh-list
138438045|NCT01765829|Aripiprazole|aripiprazole|mesh-list
138438046|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138438047|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138438048|NCT01765829|Ziprasidone|ziprasidone|mesh-list
138438049|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
138438050|NCT01765829|Clozapine|clozapine|mesh-list
138438052|NCT01765829|Amisulpride|amisulpride|mesh-list
138438053|NCT01765829|Perphenazine|perphenazine|mesh-list
138438054|NCT01765829|Sertindole|sertindole|mesh-list
138438055|NCT01765829|Sulpiride|sulpiride|mesh-list
138438056|NCT01765829|Clopenthixol|clopenthixol|mesh-list
138438057|NCT01765829|Clothiapine|clothiapine|mesh-list
138438058|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138438059|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
138438060|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438061|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438062|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438063|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138238809|NCT05685277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438064|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138438065|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138438066|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138438067|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
138438068|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
138438069|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
138405792|NCT01590537|Trace Elements|trace elements|mesh-ancestor
138438070|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438071|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138438072|NCT01765829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138438073|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138438074|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138438075|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
138438076|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
138438077|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138438078|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138438079|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138438080|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138438081|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138438082|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
138438083|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
138438084|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138438085|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138438086|NCT01765842|Rituximab|rituximab|mesh-list
138438087|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138438088|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438089|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
138438090|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438091|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138438092|NCT01765881|Misoprostol|misoprostol|mesh-list
138438093|NCT01765881|Dinoprostone|dinoprostone|mesh-list
138438094|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138438095|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
138438096|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138438097|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438098|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138438099|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138198972|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438100|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
138438101|NCT01765946|Metformin|metformin|mesh-list
138198973|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
138198974|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438102|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138438103|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438104|NCT01766063|Interferons|interferons|mesh-list
138438105|NCT01766063|Interferon-beta|interferon-beta|mesh-list
138198975|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138438106|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
138438107|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438108|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
138405812|NCT01590732|Carboplatin|carboplatin|mesh-list
138438109|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438110|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
138337722|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138438111|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438113|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
138438114|NCT01766089|Remifentanil|remifentanil|mesh-list
138438115|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138438116|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138438117|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438118|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138438119|NCT01766089|Analgesics|analgesics|mesh-ancestor
138438120|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
138438121|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438122|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138438123|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138438124|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138438125|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
138438126|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438127|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438128|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138438129|NCT01766089|Narcotics|narcotics|mesh-ancestor
138438130|NCT01766154|Tirofiban|tirofiban|mesh-list
138438131|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138438132|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138438133|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438134|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138438135|NCT01766180|Resveratrol|resveratrol|mesh-list
138438136|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
138438137|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438138|NCT01766180|Protective Agents|protective agents|mesh-ancestor
138438139|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438140|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377151|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438141|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138438142|NCT01766258|Carbidopa|carbidopa|mesh-list
138438143|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138405842|NCT01590836|Insulin|insulin|mesh-list
138438144|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138438145|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
138438146|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438147|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438148|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438149|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138438150|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438151|NCT01766323|Modafinil|modafinil|mesh-list
138438152|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138438153|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438154|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138438155|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138438156|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138438157|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238850|NCT05644665|Ozanimod|ozanimod|mesh-list
138438159|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
138438160|NCT01766375|Methotrexate|methotrexate|mesh-list
138438161|NCT01766375|Cyclosporins|cyclosporins|mesh-list
138438162|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138438163|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
138438164|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138438165|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438166|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138438167|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
138438168|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438169|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438170|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
138438171|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438172|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138438173|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138438174|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
138198984|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138438175|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138438176|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138438177|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
138438178|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438179|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138438180|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138438181|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138438182|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
138438183|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138438184|NCT01766414|Complement C1s|complement c1s|mesh-list
138438185|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138438186|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
138438187|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
138377177|NCT01442272|Vitamins|vitamins|mesh-ancestor
138438188|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438189|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138438190|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138438191|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
138438192|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138238879|NCT05627557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438193|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438194|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138438195|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
138438196|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138438197|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438198|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438199|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438200|NCT01766583|Lenalidomide|lenalidomide|mesh-list
138438201|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
138438202|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438203|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138438204|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138438205|NCT01766583|Growth Substances|growth substances|mesh-ancestor
138438206|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
138438207|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438208|NCT01766609|Triamcinolone|triamcinolone|mesh-list
138438209|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138438210|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138438211|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138438212|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138438213|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
138438214|NCT01766609|Hormones|hormones|mesh-ancestor
138438215|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138438216|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438217|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138438218|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
138438219|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438220|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438221|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
138438222|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
138438223|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
138438224|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438225|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138438227|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138438228|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
138438229|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138377209|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
138438230|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438231|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138438232|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
138438233|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
138438234|NCT01766843|Hormones|hormones|mesh-ancestor
138238918|NCT05623020|Immunologic Factors|immunologic factors|mesh-ancestor
138438235|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138438236|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
138438237|NCT01766843|Antidotes|antidotes|mesh-ancestor
138438238|NCT01766843|Protective Agents|protective agents|mesh-ancestor
138438239|NCT01766960|Morphine|morphine|mesh-list
138438240|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138438241|NCT01766960|Narcotics|narcotics|mesh-ancestor
138438242|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138438243|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438244|NCT01766960|Analgesics|analgesics|mesh-ancestor
138438245|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
138438246|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438247|NCT01767025|Oxytocin|oxytocin|mesh-list
138438248|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
138438249|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138438250|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438252|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138438253|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
138438254|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138438255|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138406030|NCT01592032|Vancomycin|vancomycin|mesh-list
138438256|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138438257|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438258|NCT01767259|Valsartan|valsartan|mesh-list
138438259|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138438260|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138438261|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138438262|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138438263|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438264|NCT01767259|Diuretics|diuretics|mesh-ancestor
138438265|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
138438266|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438267|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138438268|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138438269|NCT01767272|Fexofenadine|fexofenadine|mesh-list
138438270|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138438271|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138438272|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138438273|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
138438274|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
138438275|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438276|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438277|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438278|NCT01767298|Valsartan|valsartan|mesh-list
138438279|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138438280|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138438281|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138438282|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138239009|NCT05570409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138438283|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438284|NCT01767298|Diuretics|diuretics|mesh-ancestor
138438285|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
138438286|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438287|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138438288|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138438289|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
138438290|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
138438291|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138438292|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
138438293|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138377277|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138438294|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438295|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438296|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138438297|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438298|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
138438299|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138438300|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138438301|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
138438302|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438303|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438304|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138438305|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438306|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138438307|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
138438308|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438309|NCT01767428|Acetaminophen|acetaminophen|mesh-list
138438310|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138438311|NCT01767428|Analgesics|analgesics|mesh-ancestor
138438312|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
138348142|NCT02430090|Fentanyl|fentanyl|mesh-list
138348143|NCT02430090|Sufentanil|sufentanil|mesh-list
138348147|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138438313|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438314|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438315|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
138438317|NCT01767454|Trametinib|trametinib|mesh-list
138438318|NCT01767454|Dabrafenib|dabrafenib|mesh-list
138438319|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138438320|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438321|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138438322|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438323|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138438324|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438325|NCT01767532|Cephalexin|cephalexin|mesh-list
138438327|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438328|NCT01767545|Dexamethasone|dexamethasone|mesh-list
138438329|NCT01767545|Bevacizumab|bevacizumab|mesh-list
138377323|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
138438330|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138438331|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438332|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138438333|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138438334|NCT01767545|Growth Substances|growth substances|mesh-ancestor
138438335|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438336|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
138438337|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138438339|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
138438340|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438341|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138438342|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
138438343|NCT01767545|Hormones|hormones|mesh-ancestor
138438344|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138438345|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138438346|NCT01767571|Cephalexin|cephalexin|mesh-list
138438347|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138438348|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438349|NCT01767584|Cephalexin|cephalexin|mesh-list
138438350|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138438351|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438352|NCT01767623|Vemurafenib|vemurafenib|mesh-list
138438353|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438354|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138438355|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438356|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438357|NCT01767714|Plerixafor|plerixafor|mesh-list
138438358|NCT01767714|Lenograstim|lenograstim|mesh-list
138239104|NCT05511038|Aflibercept|aflibercept|mesh-list
138438359|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138438360|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
138438361|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438362|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138438363|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138438364|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
138438365|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138198986|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438366|NCT01767896|Vaccines|vaccines|mesh-list
138198987|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138198988|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138377370|NCT01443065|Leucovorin|leucovorin|mesh-list
138438367|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
138198989|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438368|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438370|NCT01768039|Vitamins|vitamins|mesh-ancestor
138438371|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
138438372|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438373|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138438375|NCT01767610|Fenofibrate|fenofibrate|mesh-list
138438376|NCT01767610|Pitavastatin|pitavastatin|mesh-list
138438377|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138438378|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
138438379|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438380|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138438381|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138438382|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138438383|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438384|NCT01767610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138438385|NCT01767610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138438386|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
138438387|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138438388|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138438389|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138438390|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138438391|NCT01768078|Betamethasone|betamethasone|mesh-list
138438392|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438393|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
138438394|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138438395|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
138406179|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138438397|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138438398|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438399|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138438400|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
138438402|NCT01768182|Folic Acid|folic acid|mesh-list
138438403|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
138438404|NCT01768182|Antidotes|antidotes|mesh-ancestor
138438405|NCT01768182|Protective Agents|protective agents|mesh-ancestor
138438406|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438407|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
138438408|NCT01768182|Vitamins|vitamins|mesh-ancestor
138438409|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
138438410|NCT01768182|Hematinics|hematinics|mesh-ancestor
138438411|NCT01768195|Entecavir|entecavir|mesh-list
138438412|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
138438413|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438414|NCT01768208|Saxagliptin|saxagliptin|mesh-list
138438415|NCT01768208|Incretins|incretins|mesh-ancestor
138438416|NCT01768208|Hormones|hormones|mesh-ancestor
138337922|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138438417|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138438418|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438419|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138438420|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
138438421|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438422|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438423|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138438424|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138438425|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138438426|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438428|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138438429|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138438430|NCT01768260|Analgesics|analgesics|mesh-ancestor
138438431|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
138438432|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438433|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438434|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138438435|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138438436|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138438437|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138438438|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438439|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138438440|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138438441|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438442|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
138438443|NCT01768273|Midazolam|midazolam|mesh-list
138438444|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138438445|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138438446|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138438447|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438448|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138438449|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138438450|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138438451|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138438452|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
138438453|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
138438454|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
138438455|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
138438456|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438457|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438459|NCT01768299|Mifepristone|mifepristone|mesh-list
138438460|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138438461|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
138438462|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138438463|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438464|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138438465|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138438466|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
138438467|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138438468|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138438469|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138438470|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138438471|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
138438472|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138337972|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
138438473|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138438474|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
138438475|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138438477|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138438478|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138438479|NCT01768312|Cyclosporine|cyclosporine|mesh-list
138438480|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138438481|NCT01768312|Cyclosporins|cyclosporins|mesh-list
138438482|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438483|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438484|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138438485|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
138438486|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438487|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
138239197|NCT05455697|Glucocorticoids|glucocorticoids|mesh-ancestor
138438488|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438490|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138438491|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138438492|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138438494|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138438495|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438496|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138438497|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138438498|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438499|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138438500|NCT01768351|Vitamins|vitamins|mesh-ancestor
138438501|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
138438502|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138438503|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138377519|NCT01443780|Protective Agents|protective agents|mesh-ancestor
138438504|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138438505|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138397469|NCT01530503|Mitomycins|mitomycins|mesh-list
138438506|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138199005|NCT00002362|Emtricitabine|emtricitabine|mesh-list
138199006|NCT00002362|Efavirenz|efavirenz|mesh-list
138438508|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138438509|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138438510|NCT01768377|Lidocaine|lidocaine|mesh-list
138438511|NCT01768377|Midazolam|midazolam|mesh-list
138438512|NCT01768377|Fentanyl|fentanyl|mesh-list
138438513|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
138438514|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
138438515|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138438516|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138337977|NCT01105650|Hormones|hormones|mesh-ancestor
138406360|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
138438517|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
138438518|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438519|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138438520|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138438521|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138438522|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138438523|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438524|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138239221|NCT05443971|Durvalumab|durvalumab|mesh-list
138438525|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138438526|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138438527|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138438528|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138438529|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138438530|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
138438531|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
138438532|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
138438533|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438534|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138438535|NCT01768377|Narcotics|narcotics|mesh-ancestor
138438536|NCT01768377|Analgesics|analgesics|mesh-ancestor
138438537|NCT01768390|Fluorides|fluorides|mesh-list
138438538|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
138438539|NCT01768390|Protective Agents|protective agents|mesh-ancestor
138438540|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438541|NCT01768455|Glimepiride|glimepiride|mesh-list
138438542|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138438543|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138438544|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438545|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138438546|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
138438547|NCT01768481|Atorvastatin|atorvastatin|mesh-list
138438548|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138438549|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138438550|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
138438551|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438552|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138438553|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138438555|NCT01768507|Resveratrol|resveratrol|mesh-list
138438556|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
138438557|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438558|NCT01768507|Protective Agents|protective agents|mesh-ancestor
138438559|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438560|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438561|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138438562|NCT01768663|Itraconazole|itraconazole|mesh-list
138438563|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
138438564|NCT01768663|Rifampin|rifampin|mesh-list
138438565|NCT01768663|Ivacaftor|ivacaftor|mesh-list
138438566|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
138438567|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199016|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199017|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138438568|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138438569|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138438570|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438571|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438572|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138199018|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138438573|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
138406456|NCT01594268|Everolimus|everolimus|mesh-list
138438574|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138438575|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438576|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138438577|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138438578|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138438579|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138438580|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438581|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138438582|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138438583|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
138438584|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
138438585|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138438586|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138438587|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138438588|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138438589|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138438590|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138438591|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138438592|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138438593|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138438594|NCT01768741|Liver Extracts|liver extracts|mesh-list
138438595|NCT01768741|Hematinics|hematinics|mesh-ancestor
138438596|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
138438597|NCT01768780|Bupivacaine|bupivacaine|mesh-list
138438598|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138438599|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
138438600|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
138438601|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138438602|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438603|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
138438604|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438605|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138438606|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138438607|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
138438608|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438609|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438610|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
138438611|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138438612|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
138438613|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138338037|NCT01119222|Analgesics|analgesics|mesh-ancestor
138438614|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438615|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138438616|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
138438617|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138438619|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438620|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438621|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138438622|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
138438624|NCT01768884|Protective Agents|protective agents|mesh-ancestor
138438625|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
138438626|NCT01768897|Cytarabine|cytarabine|mesh-list
138438627|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
138438628|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138438629|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
138438630|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438631|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438632|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
138438633|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438634|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138438635|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
138438636|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438637|NCT01768897|Analgesics|analgesics|mesh-ancestor
138438638|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
138438639|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438640|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138438641|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138438642|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199023|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
138438643|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
138438644|NCT01768897|Protective Agents|protective agents|mesh-ancestor
138438645|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
138438646|NCT01768897|Vitamins|vitamins|mesh-ancestor
138438647|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
138438648|NCT01768988|Pregabalin|pregabalin|mesh-list
138438650|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
138438651|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438652|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438653|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
138438654|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138438655|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138438656|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438657|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138438658|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138438659|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138438660|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138438661|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138438662|NCT01769040|Rifaximin|rifaximin|mesh-list
138239320|NCT05351541|Psilocybin|psilocybin|mesh-list
138438663|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138438664|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438665|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138438666|NCT01769066|Pemetrexed|pemetrexed|mesh-list
138438667|NCT01769066|Gefitinib|gefitinib|mesh-list
138438668|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438669|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438670|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438671|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138438672|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138438673|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138438674|NCT01769079|Isosorbide|isosorbide|mesh-list
138438675|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138438676|NCT01769079|Diuretics|diuretics|mesh-ancestor
138438677|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
138438678|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438679|NCT01769118|Caffeine|caffeine|mesh-list
138438680|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138438681|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438682|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138438683|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438684|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438685|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138438686|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138438687|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
138438688|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438689|NCT01769183|Squalamine|squalamine|mesh-list
138438690|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138438691|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138438692|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138438693|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438694|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138438695|NCT01769183|Protective Agents|protective agents|mesh-ancestor
138438696|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438697|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438698|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138406650|NCT01595685|Entecavir|entecavir|mesh-list
138438699|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138438701|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
138438702|NCT01769235|Clindamycin|clindamycin|mesh-list
138338093|NCT05307042|Vasopressins|vasopressins|mesh-list
138438703|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
138438704|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
138438705|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138438706|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138438707|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438708|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138438709|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438710|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438711|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
138438712|NCT01769482|Udenafil|udenafil|mesh-list
138438713|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138438714|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138438715|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438716|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438717|NCT01769625|Vitamin D|vitamin d|mesh-list
138438718|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
138438719|NCT01769625|Celecoxib|celecoxib|mesh-list
138438720|NCT01769625|Vitamins|vitamins|mesh-ancestor
138438721|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
138438722|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438723|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138438724|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138438725|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138438726|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138438727|NCT01769625|Analgesics|analgesics|mesh-ancestor
138438728|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
138438729|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438730|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138438731|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138438732|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138438733|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138438734|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438735|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438736|NCT01769651|Methadone|methadone|mesh-list
138438737|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138438739|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138438740|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438741|NCT01769651|Analgesics|analgesics|mesh-ancestor
138438742|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
138438743|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438744|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
138438745|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
138438746|NCT01769664|Clindamycin|clindamycin|mesh-list
138438747|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
138438748|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
138438749|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138438750|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138438751|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138239378|NCT05259566|Dermatologic Agents|dermatologic agents|mesh-ancestor
138239379|NCT05257824|Aspirin|aspirin|mesh-list
138239380|NCT05257824|Clopidogrel|clopidogrel|mesh-list
138239381|NCT05257824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138239382|NCT05257824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138438752|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138438753|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438754|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438755|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
138438756|NCT01769677|Hydrocodone|hydrocodone|mesh-list
138438757|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138438758|NCT01769677|Narcotics|narcotics|mesh-ancestor
138438759|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138438760|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438761|NCT01769677|Analgesics|analgesics|mesh-ancestor
138438762|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
138438763|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438764|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
138438765|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
138438766|NCT01769703|Dabigatran|dabigatran|mesh-list
138438767|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
138438768|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138438769|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
138438770|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438771|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438772|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
138438773|NCT01769768|Bupropion|bupropion|mesh-list
138438774|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138438775|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
138438776|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138438777|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138338162|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438778|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138438779|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138438780|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438781|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
138438782|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438783|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199025|NCT02168309|Nifedipine|nifedipine|mesh-list
138438784|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138438785|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138438786|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438787|NCT01769781|Anastrozole|anastrozole|mesh-list
138438788|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138438789|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438790|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138438791|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138438792|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438793|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406762|NCT01596010|Estradiol|estradiol|mesh-list
138438794|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138438795|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
138438796|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138438797|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438798|NCT01769820|Dexamethasone|dexamethasone|mesh-list
138438799|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138438800|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
138438801|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
138438802|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438803|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397782|NCT01532466|Rocuronium|rocuronium|mesh-list
138438804|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138438805|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
138338195|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
138438807|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138438808|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138438809|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438810|NCT01769833|Interferons|interferons|mesh-list
138438811|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
138438812|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
138438813|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138438814|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438815|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
138438816|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438817|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
138438818|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438819|NCT01769898|Budesonide|budesonide|mesh-list
138438820|NCT01769898|Theophylline|theophylline|mesh-list
138438821|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
138438822|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138438823|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138438824|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
138438825|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438826|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438827|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138438828|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
138438829|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
138438830|NCT01769898|Hormones|hormones|mesh-ancestor
138438831|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138438832|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138438833|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138438834|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138438835|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
138438836|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438837|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438838|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138438839|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438840|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
138199028|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438841|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138199029|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138199030|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438842|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138438843|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
138438844|NCT01769911|Cytarabine|cytarabine|mesh-list
138438845|NCT01769911|Etoposide|etoposide|mesh-list
138438846|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
138438847|NCT01769911|Melphalan|melphalan|mesh-list
138438848|NCT01769911|Carmustine|carmustine|mesh-list
138438849|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138438850|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138438851|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438852|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138438853|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138438854|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377936|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438855|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438856|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138438857|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
138438858|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
138438859|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438860|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138438861|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
138438862|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438863|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138438864|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
138438865|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138438866|NCT01769950|Choline|choline|mesh-list
138438867|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
138438868|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138438869|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
138438870|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438871|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138438872|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138438873|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
138438874|NCT01770041|Acetaminophen|acetaminophen|mesh-list
138438875|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138438876|NCT01770041|Analgesics|analgesics|mesh-ancestor
138438877|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
138438878|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438879|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438881|NCT01770080|Peppermint oil|peppermint oil|mesh-list
138438882|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138438883|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
138438884|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
138438885|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438886|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438887|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138438888|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
138438889|NCT01770106|Denosumab|denosumab|mesh-list
138438890|NCT01770106|Alendronate|alendronate|mesh-list
138438891|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138438892|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438893|NCT01770132|Gemcitabine|gemcitabine|mesh-list
138377975|NCT01446484|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138438894|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138438895|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
138438896|NCT01770132|Trioxsalen|trioxsalen|mesh-list
138438897|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138438898|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
138438899|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438900|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438901|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
138438902|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138438903|NCT01770171|Paclitaxel|paclitaxel|mesh-list
138438904|NCT01770171|Bevacizumab|bevacizumab|mesh-list
138438905|NCT01770171|Carboplatin|carboplatin|mesh-list
138438906|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138438907|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138406877|NCT01596556|Nicotine|nicotine|mesh-list
138438908|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
138438909|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
138438910|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
138438911|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438912|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138438913|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138438914|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138438915|NCT01770171|Growth Substances|growth substances|mesh-ancestor
138438916|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438917|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
138438918|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138438919|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138438920|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138438921|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438922|NCT01770210|Atorvastatin|atorvastatin|mesh-list
138438923|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138438924|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138438925|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
138438926|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438927|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138438928|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138438929|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138438930|NCT01770223|Ribavirin|ribavirin|mesh-list
138438931|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138438932|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
138438933|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438934|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
138438935|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438936|NCT01770236|Acetaminophen|acetaminophen|mesh-list
138438937|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138438938|NCT01770236|Analgesics|analgesics|mesh-ancestor
138438939|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
138438940|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138438941|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438943|NCT01770301|Paclitaxel|paclitaxel|mesh-list
138438944|NCT01770301|Bevacizumab|bevacizumab|mesh-list
138438945|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138438946|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438947|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
138438948|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
138438949|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
138438950|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239497|NCT05139420|Phentermine|phentermine|mesh-list
138438951|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138438952|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138438953|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138438954|NCT01770301|Growth Substances|growth substances|mesh-ancestor
138438955|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438958|NCT01770444|Thioguanine|thioguanine|mesh-list
138438959|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138438960|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
138438961|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438962|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138438963|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
138438964|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138438965|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138438966|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
138438967|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438968|NCT01770470|Chitosan|chitosan|mesh-list
138438969|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138438970|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138438971|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
138438972|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138338421|NCT01171794|Ibuprofen|ibuprofen|mesh-list
138438973|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138438974|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
138438975|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
138438977|NCT01770470|Coagulants|coagulants|mesh-ancestor
138438978|NCT01770600|Risperidone|risperidone|mesh-list
138438979|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138438980|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
138438981|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138438982|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438983|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138438984|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138438985|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138378030|NCT01446952|Vitamin E|vitamin e|mesh-list
138438986|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138438987|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138438988|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138438990|NCT01770769|Cloxacillin|cloxacillin|mesh-list
138438991|NCT01770769|Cephalothin|cephalothin|mesh-list
138438992|NCT01770769|Dalteparin|dalteparin|mesh-list
138438993|NCT01770769|Tinzaparin|tinzaparin|mesh-list
138438994|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138438997|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138438998|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138438999|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138439000|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439001|NCT01770795|Gemcitabine|gemcitabine|mesh-list
138439002|NCT01770795|genexol-PM|genexol-pm|mesh-list
138439003|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138439004|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
138439005|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439006|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439007|NCT01770795|Tubulin Modulators|tubulin modulators|mesh-ancestor
138439008|NCT01770795|Antimitotic Agents|antimitotic agents|mesh-ancestor
138439009|NCT01770795|Mitosis Modulators|mitosis modulators|mesh-ancestor
138439010|NCT01770899|Montelukast|montelukast|mesh-list
138439011|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138439012|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
138439013|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138439014|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
138406974|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138439015|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138439016|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439017|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138439018|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138439019|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439020|NCT01770964|Pregabalin|pregabalin|mesh-list
138439021|NCT01770964|Analgesics|analgesics|mesh-ancestor
138439022|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
138439023|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439024|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439025|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
138439026|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138439027|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138239551|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439028|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138398001|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
138439029|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138439030|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138439031|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138439032|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138439033|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138439034|NCT01771081|Ranibizumab|ranibizumab|mesh-list
138439035|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138439036|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138439037|NCT01771081|Growth Substances|growth substances|mesh-ancestor
138439038|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138338494|NCT01184898|Analgesics|analgesics|mesh-ancestor
138439039|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
138439040|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439041|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
138439042|NCT01771146|Irinotecan|irinotecan|mesh-list
138439043|NCT01771146|Folfirinox|folfirinox|mesh-list
138439044|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439045|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138439046|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138439047|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439048|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439050|NCT01771185|Gliclazide|gliclazide|mesh-list
138439051|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138439052|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439053|NCT01771198|Simvastatin|simvastatin|mesh-list
138439054|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138439055|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138439056|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
138439057|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439058|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138439059|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138439060|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439061|NCT01771289|Docetaxel|docetaxel|mesh-list
138439062|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439063|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
138439064|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
138439065|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
138439066|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439067|NCT01771302|Calcium|calcium|mesh-list
138439068|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138407071|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
138439069|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439071|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138439072|NCT01771328|Cortisone|cortisone|mesh-list
138239587|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239588|NCT05061550|Tubulin Modulators|tubulin modulators|mesh-ancestor
138239589|NCT05061550|Antimitotic Agents|antimitotic agents|mesh-ancestor
138439073|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439075|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138439076|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
138439077|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138439078|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138439079|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138439080|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
138439081|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439082|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439083|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439084|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138439085|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439086|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138439087|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138439088|NCT01771458|Tamoxifen|tamoxifen|mesh-list
138439089|NCT01771458|Trastuzumab|trastuzumab|mesh-list
138439090|NCT01771458|Everolimus|everolimus|mesh-list
138439091|NCT01771458|Sorafenib|sorafenib|mesh-list
138439092|NCT01771458|Letrozole|letrozole|mesh-list
138439093|NCT01771458|Dasatinib|dasatinib|mesh-list
138439094|NCT01771458|Lapatinib|lapatinib|mesh-list
138439095|NCT01771458|Vemurafenib|vemurafenib|mesh-list
138439096|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138439097|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439098|NCT01771458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138439099|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138439100|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439101|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439102|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138439103|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
138378140|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138338571|NCT01207908|Mecasermin|mecasermin|mesh-list
138239615|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138439104|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439105|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138439106|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138439107|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138439108|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
138439109|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138439110|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138439111|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138439112|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138439113|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138439114|NCT05318365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138439115|NCT05318365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138439116|NCT05318365|Laxatives|laxatives|mesh-ancestor
138439117|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138439118|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138439119|NCT01771783|Renin Inhibitors|renin inhibitors|mesh-list
138439120|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138439121|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439122|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
138439123|NCT01771822|Ibuprofen|ibuprofen|mesh-list
138439124|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138439125|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138439126|NCT01771822|Analgesics|analgesics|mesh-ancestor
138439127|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
138439128|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439129|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138239657|NCT04963296|Acetaminophen|acetaminophen|mesh-list
138439130|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439131|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138439132|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138439133|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439134|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439135|NCT01771874|Bupropion|bupropion|mesh-list
138439136|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
138439137|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138439138|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
138439139|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138439140|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138439141|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138439142|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138439143|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439144|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
138439145|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378168|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138439146|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439147|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138439148|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138439150|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
138439151|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
138439152|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138239705|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439153|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
138439154|NCT01771978|Diltiazem|diltiazem|mesh-list
138439155|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138439156|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138439157|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138439158|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439159|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138439160|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439161|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
138439162|NCT01772056|Fluticasone|fluticasone|mesh-list
138439163|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439164|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138439165|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
138439166|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439167|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439168|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138439169|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
138439170|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
138239707|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138439171|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138439172|NCT01772212|Terbinafine|terbinafine|mesh-list
138439173|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
138439174|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439175|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439176|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439177|NCT01772238|Amoxicillin|amoxicillin|mesh-list
138439178|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138439179|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
138439180|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
138439181|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138439182|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439184|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439185|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439186|NCT01772251|Insulin|insulin|mesh-list
138439187|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138439188|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439189|NCT01772290|Itraconazole|itraconazole|mesh-list
138439190|NCT01772290|Fluconazole|fluconazole|mesh-list
138439191|NCT01772290|Rabeprazole|rabeprazole|mesh-list
138439192|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
138439193|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439194|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138439195|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138439196|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439197|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439198|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138439199|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
138439200|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138439201|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439202|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138439203|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138439204|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138439205|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138239734|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138439206|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138439207|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138439209|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439211|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
138439212|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439213|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439214|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138439215|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
138439217|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138439218|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138439219|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439220|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
138439221|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
138439222|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
138439223|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
138439224|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138439225|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439226|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138439227|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138439228|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439229|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439230|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439231|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138439232|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138439233|NCT01772641|Varenicline|varenicline|mesh-list
138439234|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138439235|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138439236|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
138439237|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439238|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138239770|NCT04873362|Trastuzumab|trastuzumab|mesh-list
138239771|NCT04873362|Atezolizumab|atezolizumab|mesh-list
138239774|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138239775|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138239779|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
138439239|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439240|NCT01772797|Ceritinib|ceritinib|mesh-list
138338665|NCT01218984|Narcotics|narcotics|mesh-ancestor
138439241|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439242|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138439243|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439244|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439245|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
138439246|NCT01772836|Biapenem|biapenem|mesh-list
138439247|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439248|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439250|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439251|NCT01772940|Ritonavir|ritonavir|mesh-list
138439252|NCT01772940|Lopinavir|lopinavir|mesh-list
138439253|NCT01772940|Tenofovir|tenofovir|mesh-list
138439254|NCT01772940|Lamivudine|lamivudine|mesh-list
138439255|NCT01772940|Emtricitabine|emtricitabine|mesh-list
138439256|NCT01772940|Zidovudine|zidovudine|mesh-list
138439257|NCT01772940|Nevirapine|nevirapine|mesh-list
138439258|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138439259|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138439260|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
138439261|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439262|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439263|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138439264|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138439265|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
138439266|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439267|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138439268|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138407473|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138439269|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138439270|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138439271|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
138439272|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138439273|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138439274|NCT01772953|Treosulfan|treosulfan|mesh-list
138439275|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138439276|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
138439277|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439278|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439279|NCT01772979|Trabectedin|trabectedin|mesh-list
138239814|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138439280|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138439281|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
138378253|NCT01448330|Clopidogrel|clopidogrel|mesh-list
138439282|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439283|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439284|NCT01773005|Acetaminophen|acetaminophen|mesh-list
138439285|NCT01773005|Ibuprofen|ibuprofen|mesh-list
138439286|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138439287|NCT01773005|Analgesics|analgesics|mesh-ancestor
138439288|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
138439289|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439290|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439292|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138439293|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439294|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138439295|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138439296|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439297|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439299|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
138439300|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
138439301|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138439302|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439303|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
138439304|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439305|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138439306|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138439307|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138439308|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138439309|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439310|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
138439311|NCT01773096|Bisacodyl|bisacodyl|mesh-list
138439312|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138439313|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
138439315|NCT01773096|Cathartics|cathartics|mesh-ancestor
138439316|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138439317|NCT01773096|Laxatives|laxatives|mesh-ancestor
138439318|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138239847|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439319|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439320|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
138439321|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439322|NCT01773096|Antacids|antacids|mesh-ancestor
138439323|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439324|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
138439325|NCT01773174|Dabigatran|dabigatran|mesh-list
138439326|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
138439327|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138439328|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
138439329|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439330|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439331|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
138439332|NCT01773408|Cytarabine|cytarabine|mesh-list
138439333|NCT01773408|Daunorubicin|daunorubicin|mesh-list
138439334|NCT01773408|Idarubicin|idarubicin|mesh-list
138439335|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138439336|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
138439337|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439338|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439339|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
138439340|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439341|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138407636|NCT05344911|Anesthetics|anesthetics|mesh-ancestor
138439342|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
138439343|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439344|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138439345|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138199041|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439346|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138439347|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439348|NCT01773460|Everolimus|everolimus|mesh-list
138439349|NCT01773460|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138439350|NCT01773460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138439351|NCT01773460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239883|NCT04653246|Dexamethasone|dexamethasone|mesh-list
138239884|NCT04653246|Lenalidomide|lenalidomide|mesh-list
138439352|NCT01773460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439353|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138439354|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
138439355|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439356|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439357|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138439358|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138439359|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138439360|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
138439361|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439362|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138378322|NCT01448733|Clindamycin|clindamycin|mesh-list
138439363|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138439365|NCT01773538|Rifaximin|rifaximin|mesh-list
138439366|NCT01773538|Lactulose|lactulose|mesh-list
138439367|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138439368|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439369|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138439370|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
138439371|NCT01773616|Prednisolone|prednisolone|mesh-list
138439372|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138439373|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
138439374|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138439375|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
138439376|NCT01773616|Rituximab|rituximab|mesh-list
138439377|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138439378|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
138439379|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138439380|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439381|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
138439382|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439383|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138439384|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138439385|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138439386|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
138439387|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138439388|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439389|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439390|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439391|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439392|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
138439394|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138439395|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138439396|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
138439397|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
138439398|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439399|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138439400|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138439402|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
138199042|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138439404|NCT01773681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138199043|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138439405|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138439406|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
138439407|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439408|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138439409|NCT01773772|Progesterone|progesterone|mesh-list
138439410|NCT01773772|Progestins|progestins|mesh-ancestor
138439411|NCT01773772|Hormones|hormones|mesh-ancestor
138439412|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138439413|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439414|NCT01773798|Insulin|insulin|mesh-list
138439415|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138439416|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
138439417|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
138439418|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138439419|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138439420|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439421|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138439422|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439423|NCT01773837|Methylphenidate|methylphenidate|mesh-list
138439424|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138439425|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439426|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138439427|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138439428|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138439429|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439430|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
138439431|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439432|NCT01773876|Micafungin|micafungin|mesh-list
138439433|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
138439434|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439435|NCT01774370|Dabigatran|dabigatran|mesh-list
138439436|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
138439437|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138439438|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
138439439|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439440|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378396|NCT01449123|Mannitol|mannitol|mesh-list
138439441|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
138439442|NCT01774396|Lidocaine|lidocaine|mesh-list
138439443|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
138439444|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
138439445|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138439446|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439447|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
138439448|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439449|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138439450|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138439451|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138439452|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138439453|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439455|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
138439456|NCT01774474|Triamcinolone|triamcinolone|mesh-list
138439457|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138439458|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138439459|NCT01774474|Bromfenac|bromfenac|mesh-list
138439460|NCT01774474|Bevacizumab|bevacizumab|mesh-list
138439461|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138439462|NCT01774474|BB 1101|bb 1101|mesh-list
138439463|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138439464|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138439465|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439466|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138439467|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138439468|NCT01774474|Growth Substances|growth substances|mesh-ancestor
138439469|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439470|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
138439471|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439472|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
138439473|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
138439474|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439475|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138439476|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
138439477|NCT01774474|Hormones|hormones|mesh-ancestor
138439478|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138439479|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138439480|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
138439481|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439482|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439483|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138239992|NCT04551144|Estrogens|estrogens|mesh-ancestor
138439484|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138439485|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
138439486|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138439487|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138439488|NCT01774474|Analgesics|analgesics|mesh-ancestor
138439489|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
138439490|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138439491|NCT01774565|Insulin|insulin|mesh-list
138439492|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138439493|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138439494|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439495|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
138439496|NCT01774812|Vitamin D|vitamin d|mesh-list
138439497|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
138439498|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
138439499|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138378488|NCT01449448|Analgesics|analgesics|mesh-ancestor
138439500|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439501|NCT01774812|Vitamins|vitamins|mesh-ancestor
138439502|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
138439503|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138439504|NCT01774838|Clopidogrel|clopidogrel|mesh-list
138439505|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138439506|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138439507|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138439508|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138439509|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138439510|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
138439511|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439512|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439513|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439514|NCT01774864|Udenafil|udenafil|mesh-list
138439515|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138439516|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138439517|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439518|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439519|NCT01774877|Leflunomide|leflunomide|mesh-list
138439520|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439521|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439522|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138439523|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
138240021|NCT04523922|Oxytocin|oxytocin|mesh-list
138439524|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439525|NCT01775098|Allopurinol|allopurinol|mesh-list
138439526|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
138439527|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439528|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439529|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
138439530|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138439531|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138439532|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
138439533|NCT01775098|Protective Agents|protective agents|mesh-ancestor
138439534|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439535|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138439536|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
138439537|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439538|NCT01775397|Vancomycin|vancomycin|mesh-list
138439539|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
138439540|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138439541|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439542|NCT01775540|Dexamethasone|dexamethasone|mesh-list
138439543|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
138378540|NCT01449799|Xhance|xhance|mesh-list
138439544|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439545|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
138439546|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
138439547|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439548|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439549|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138439550|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
138439551|NCT01775540|Hormones|hormones|mesh-ancestor
138439552|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138439553|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138439554|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439556|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138439557|NCT01775579|Metformin|metformin|mesh-list
138439559|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138439560|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439561|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138439562|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138439563|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
138439564|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439565|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138439566|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138439567|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439568|NCT01775618|Factor VIII|factor viii|mesh-list
138439569|NCT01775618|Coagulants|coagulants|mesh-ancestor
138439570|NCT01775631|Rituximab|rituximab|mesh-list
138439571|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138439572|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439573|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
138240065|NCT04429321|Nivolumab|nivolumab|mesh-list
138439574|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439575|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138439576|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
138439577|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138439578|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439579|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138439580|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138439581|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439582|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439585|NCT01775839|Digoxin|digoxin|mesh-list
138439586|NCT01775839|Clopidogrel|clopidogrel|mesh-list
138439587|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138439588|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138439589|NCT01775839|Analgesics|analgesics|mesh-ancestor
138439590|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
138439591|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439592|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439593|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439594|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138439595|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138439596|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138439597|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439598|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138439599|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138439600|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439601|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
138439602|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138439603|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138439604|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138439605|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
138439606|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439607|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138439608|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138439609|NCT01775839|Protective Agents|protective agents|mesh-ancestor
138199065|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
138439611|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138439612|NCT01775891|Propafenone|propafenone|mesh-list
138199066|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199067|NCT00995501|Insulin|insulin|mesh-list
138439613|NCT01775891|Pilsicainide|pilsicainide|mesh-list
138439614|NCT01775891|Lidocaine|lidocaine|mesh-list
138439615|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138439616|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138240086|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138439617|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138439618|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439619|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
138439620|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
138439621|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138439622|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439623|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
138439624|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439625|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
138439626|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138439627|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138439628|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
138439629|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138439630|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138439631|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138439632|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
138439633|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138439634|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439635|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138439636|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138439637|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138439638|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138439639|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439640|NCT01776320|Alprostadil|alprostadil|mesh-list
138439641|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138439642|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
138439643|NCT01776320|Urological Agents|urological agents|mesh-ancestor
138439644|NCT01776437|Talazoparib|talazoparib|mesh-list
138439645|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138439646|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439647|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439648|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439649|NCT01776515|Acetaminophen|acetaminophen|mesh-list
138439651|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138439652|NCT01776515|Analgesics|analgesics|mesh-ancestor
138439653|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
138439654|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439655|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439656|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
138439657|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138439658|NCT01776515|Narcotics|narcotics|mesh-ancestor
138240117|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
138439659|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138439660|NCT01776567|Everolimus|everolimus|mesh-list
138439661|NCT01776567|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138439662|NCT01776567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138439663|NCT01776567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439664|NCT01776567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439665|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138439666|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
138439667|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439668|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439669|NCT01776671|Gabapentin|gabapentin|mesh-list
138439670|NCT01776671|Analgesics|analgesics|mesh-ancestor
138439671|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
138439672|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439673|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439674|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
138439675|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138439676|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138439677|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138439678|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138439679|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138439680|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138439681|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439682|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439683|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
138439684|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138439685|NCT01776684|Gefitinib|gefitinib|mesh-list
138439686|NCT01776684|Afatinib|afatinib|mesh-list
138439687|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439688|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138439689|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439690|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439691|NCT01776788|Insulin|insulin|mesh-list
138439692|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138439693|NCT01776788|Exenatide|exenatide|mesh-list
138439694|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
138439695|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138439696|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439698|NCT01776788|Incretins|incretins|mesh-ancestor
138439699|NCT01776788|Hormones|hormones|mesh-ancestor
138439700|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138439702|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439703|NCT01776970|Nabiximols|nabiximols|mesh-list
138439704|NCT01776970|Analgesics|analgesics|mesh-ancestor
138439705|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
138439706|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439707|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439708|NCT01777087|Capsaicin|capsaicin|mesh-list
138439709|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
138439710|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
138439711|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
138439712|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439713|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439714|NCT01777100|Sufentanil|sufentanil|mesh-list
138439715|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138439716|NCT01777100|Narcotics|narcotics|mesh-ancestor
138439717|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138439718|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439719|NCT01777100|Analgesics|analgesics|mesh-ancestor
138439720|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
138439721|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439722|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138439723|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138439724|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
138439725|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
138439726|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138439727|NCT01777464|Histamine|histamine|mesh-list
138439728|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
138439729|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
138439730|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439731|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439732|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439733|NCT01777477|Chloroquine|chloroquine|mesh-list
138439734|NCT01777477|Gemcitabine|gemcitabine|mesh-list
138439735|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138439736|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
138378692|NCT05964387|Lidocaine|lidocaine|mesh-list
138439737|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439738|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439740|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138439741|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138439742|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439743|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
138439744|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138439745|NCT01777503|Clopidogrel|clopidogrel|mesh-list
138240187|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
138439746|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138439747|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138439748|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138439749|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138439751|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
138439752|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439753|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439754|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439755|NCT01777685|Sulpiride|sulpiride|mesh-list
138439756|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138439757|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138439758|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138439759|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439760|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138439761|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138439762|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
138439763|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439764|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439765|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138439766|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
138439767|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138408034|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
138439768|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138439769|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439770|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138439771|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
138439772|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138439773|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138439774|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
138439775|NCT01777867|Miotics|miotics|mesh-ancestor
138439776|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
138439777|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138339101|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
138439778|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439779|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138439780|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138439781|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
138439782|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138439783|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138439784|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
138439785|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439786|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439789|NCT01777919|Disulfiram|disulfiram|mesh-list
138439790|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138439791|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
138439792|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439793|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439794|NCT01777919|Trace Elements|trace elements|mesh-ancestor
138439795|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
138439796|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439797|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138439798|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138439799|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439800|NCT01778075|Acetaminophen|acetaminophen|mesh-list
138439801|NCT01778075|Tramadol|tramadol|mesh-list
138439802|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138439803|NCT01778075|Analgesics|analgesics|mesh-ancestor
138439804|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
138439805|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439806|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439807|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
138439808|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138439809|NCT01778075|Narcotics|narcotics|mesh-ancestor
138439810|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138439811|NCT01778101|Lansoprazole|lansoprazole|mesh-list
138439812|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
138439813|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138439814|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138439815|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138439816|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439817|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439818|NCT01778114|Vitamin D|vitamin d|mesh-list
138439819|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
138439820|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
138439821|NCT01778114|Vitamins|vitamins|mesh-list
138439822|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
138439823|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439824|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138439825|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138439826|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
138439827|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
138439828|NCT01778192|Citric Acid|citric acid|mesh-list
138439829|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
138439830|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
138439831|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138439832|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
138439833|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
138378763|NCT05963217|Cyclophosphamide|cyclophosphamide|mesh-list
138339133|NCT01305252|Urological Agents|urological agents|mesh-ancestor
138240247|NCT04310540|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138439834|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439836|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138439837|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
138439838|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
138439839|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439840|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
138439841|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439842|NCT01778244|Metformin|metformin|mesh-list
138439843|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138439844|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439845|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
138439846|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138439847|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
138439848|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138439849|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
138439850|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439851|NCT01778309|Expectorants|expectorants|mesh-ancestor
138408134|NCT03736863|Apatinib|apatinib|mesh-list
138439853|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138439854|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
138439855|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439856|NCT01778309|Protective Agents|protective agents|mesh-ancestor
138439857|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439858|NCT01778309|Antidotes|antidotes|mesh-ancestor
138439859|NCT01778400|Ethanol|ethanol|mesh-list
138439860|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138439861|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439862|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138439863|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439864|NCT01778413|Tenofovir|tenofovir|mesh-list
138439865|NCT01778413|Emtricitabine|emtricitabine|mesh-list
138439866|NCT01778413|Efavirenz|efavirenz|mesh-list
138439867|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138439868|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
138439869|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439870|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138439871|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138439872|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439873|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439874|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138439875|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138439876|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138439877|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138439878|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138439879|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138439880|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138439881|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138439883|NCT01778686|Citalopram|citalopram|mesh-list
138439884|NCT01778686|Tryptophan|tryptophan|mesh-list
138439885|NCT01778686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138439886|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138439887|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138439888|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439889|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439890|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
138439891|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439892|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138439893|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
138439894|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138439895|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138439896|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138439897|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
138439898|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138439899|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138439900|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
138439902|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138439903|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138439904|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
138439905|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
138439906|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
138199076|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439907|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439909|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138439910|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138439911|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138439912|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138439913|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138439914|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
138439915|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439916|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439917|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439918|NCT01779089|Minocycline|minocycline|mesh-list
138439919|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138439920|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138439921|NCT01779232|Danazol|danazol|mesh-list
138439922|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138439923|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
138439924|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138439925|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439927|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138439928|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439929|NCT01779258|Desonide|desonide|mesh-list
138439930|NCT01779258|Glycerol|glycerol|mesh-list
138439931|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138439932|NCT01779258|Protective Agents|protective agents|mesh-ancestor
138439933|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439934|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439935|NCT01779271|Loxoprofen|loxoprofen|mesh-list
138439936|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138439937|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138439938|NCT01779271|Analgesics|analgesics|mesh-ancestor
138439939|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
138439940|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439941|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439942|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439943|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138439944|NCT01779284|Timolol|timolol|mesh-list
138439945|NCT01779284|Travoprost|travoprost|mesh-list
138439946|NCT01779284|Latanoprost|latanoprost|mesh-list
138439947|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138439948|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138439949|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
138439950|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439951|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439952|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439953|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138439954|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138439955|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138439956|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138439957|NCT01779362|Metformin|metformin|mesh-list
138439958|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
138439959|NCT01779362|Liraglutide|liraglutide|mesh-list
138439960|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138439961|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439962|NCT01779362|Incretins|incretins|mesh-ancestor
138439963|NCT01779362|Hormones|hormones|mesh-ancestor
138439964|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138439965|NCT01779401|Aspirin|aspirin|mesh-list
138439966|NCT01779401|Cilostazol|cilostazol|mesh-list
138439967|NCT01779401|Clopidogrel|clopidogrel|mesh-list
138439968|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138439969|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138439970|NCT01779401|Analgesics|analgesics|mesh-ancestor
138439971|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
138439972|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138439973|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138439974|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138439975|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138439976|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138439977|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138439978|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138439979|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138439980|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138439981|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138439982|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
138439983|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138439984|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138439985|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138439986|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
138439987|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138439988|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138439989|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
138439990|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138439991|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
138439992|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
138439993|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138439994|NCT01779401|Protective Agents|protective agents|mesh-ancestor
138439995|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138439996|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138439997|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138439998|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
138439999|NCT01779466|Coagulants|coagulants|mesh-ancestor
138440000|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138188483|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138440001|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
138408331|NCT03136731|Antibodies|antibodies|mesh-list
138440002|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440004|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138440005|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440006|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
138440007|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
138440008|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
138440009|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440010|NCT01779492|Oxycodone|oxycodone|mesh-list
138440011|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138440012|NCT01779492|Narcotics|narcotics|mesh-ancestor
138440013|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138378937|NCT05917912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138440014|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440016|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
138440017|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440018|NCT01779518|Interferons|interferons|mesh-list
138440019|NCT01779518|Ribavirin|ribavirin|mesh-list
138440020|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
138440021|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440022|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
138240355|NCT04106557|Analgesics|analgesics|mesh-ancestor
138440023|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440025|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440026|NCT01779596|Bosentan|bosentan|mesh-list
138440027|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138440028|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138440029|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440030|NCT01779609|Bosentan|bosentan|mesh-list
138440031|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138440032|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138440033|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339241|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
138440034|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
138440035|NCT01779687|Atorvastatin|atorvastatin|mesh-list
138440036|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138440037|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138440038|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
138440039|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440040|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138440041|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138440042|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440043|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138440044|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138440045|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
138440046|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440047|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138440048|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138440049|NCT01779830|Zolpidem|zolpidem|mesh-list
138440050|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138440051|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138440052|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138440053|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440054|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138440055|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
138440056|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
138440057|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440058|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440061|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138440062|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
138440063|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440064|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440065|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
138440066|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440067|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138440068|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
138440069|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440070|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138440071|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138440072|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138440073|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440074|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
138440075|NCT01779882|Busulfan|busulfan|mesh-list
138440076|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138440077|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
138440078|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440079|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138440080|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138440081|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
138440082|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440083|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440084|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138440086|NCT01779908|Vitamins|vitamins|mesh-ancestor
138440087|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
138440088|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440089|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138440091|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
138440092|NCT01779921|Coagulants|coagulants|mesh-ancestor
138440093|NCT01780051|Metformin|metformin|mesh-list
138440094|NCT01780051|Repaglinide|repaglinide|mesh-list
138440095|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138440096|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440097|NCT01780181|Gemcitabine|gemcitabine|mesh-list
138440098|NCT01780181|Docetaxel|docetaxel|mesh-list
138440099|NCT01780181|Vinorelbine|vinorelbine|mesh-list
138440100|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138440101|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
138440102|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440103|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240430|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138440104|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
138440105|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
138440106|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
138440107|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138440108|NCT01780233|Fentanyl|fentanyl|mesh-list
138440109|NCT01780233|Naltrexone|naltrexone|mesh-list
138440110|NCT01780233|Citric Acid|citric acid|mesh-list
138440111|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
138440112|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138440113|NCT01780233|Narcotics|narcotics|mesh-ancestor
138440114|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138440115|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440117|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
138440118|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440119|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138440120|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138440121|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
138440122|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
138440123|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
138440124|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138440125|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
138440126|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
138440127|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440128|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138199080|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138440129|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138440130|NCT01780259|Triazolam|triazolam|mesh-list
138440131|NCT01780259|Esketamine|esketamine|mesh-list
138440132|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
138440133|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138440134|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138440135|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138440136|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138440137|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138440138|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440139|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
138440140|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
138440141|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440142|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440143|NCT01780311|Flecainide|flecainide|mesh-list
138440144|NCT01780311|Sotalol|sotalol|mesh-list
138440145|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138440146|NCT01780311|Propafenone|propafenone|mesh-list
138440147|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138440148|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138339279|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
138440149|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138440150|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440151|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138440152|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138440154|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440155|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440156|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
138440157|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
138440158|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440159|NCT01780467|Dopamine|dopamine|mesh-list
138440160|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138440161|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
138240465|NCT03969212|Baloxavir|baloxavir|mesh-list
138440162|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
138440163|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440164|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440165|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
138440166|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440167|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440168|NCT01780467|Protective Agents|protective agents|mesh-ancestor
138440169|NCT01780519|Lorazepam|lorazepam|mesh-list
138440170|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
138440171|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
138440172|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
138440173|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440174|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440175|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138440176|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138440177|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138440178|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138440179|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138440181|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
138440182|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
138440183|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440184|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440185|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138440186|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138440187|NCT01780558|Hormones|hormones|mesh-list
138440188|NCT01780558|Estradiol|estradiol|mesh-list
138440189|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138440190|NCT01780558|Progesterone|progesterone|mesh-list
138440191|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138440192|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440193|NCT01780558|Estrogens|estrogens|mesh-ancestor
138440194|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138440195|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
138440196|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138440197|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138440198|NCT01780558|Progestins|progestins|mesh-ancestor
138440199|NCT01780610|Letrozole|letrozole|mesh-list
138440200|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138440201|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138199085|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440202|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138440203|NCT01780610|Hormones|hormones|mesh-list
138440204|NCT01780610|Estradiol|estradiol|mesh-list
138440205|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138440206|NCT01780610|Progesterone|progesterone|mesh-list
138440207|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138440208|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440209|NCT01780610|Estrogens|estrogens|mesh-ancestor
138440210|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138440211|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
138440212|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138440213|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138440214|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440215|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138440216|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138440217|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440218|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440219|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138440220|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
138440221|NCT01780610|Progestins|progestins|mesh-ancestor
138440222|NCT01780740|Atorvastatin|atorvastatin|mesh-list
138440223|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138440224|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138440225|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
138440226|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440227|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138440228|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138440229|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440230|NCT01780753|Primaquine|primaquine|mesh-list
138440231|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
138440232|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138440233|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138440234|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440235|NCT01780909|Paromomycin|paromomycin|mesh-list
138440236|NCT01780909|Domperidone|domperidone|mesh-list
138440237|NCT01780909|Loperamide|loperamide|mesh-list
138440238|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
138440239|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
138440240|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
138440241|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440242|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440243|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138440244|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138440245|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
138440246|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440247|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440248|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138440249|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440250|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138339321|NCT01328964|Hormones|hormones|mesh-ancestor
138440251|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138440252|NCT01780948|Everolimus|everolimus|mesh-list
138440253|NCT01780948|Atorvastatin|atorvastatin|mesh-list
138440254|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138440255|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138440256|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
138440257|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440258|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138440259|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138440260|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440261|NCT01780948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138440262|NCT01780948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138440263|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138440264|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
138440265|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440266|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440267|NCT01781052|Iloprost|iloprost|mesh-list
138440268|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138440269|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
138440270|NCT01781273|Ethanol|ethanol|mesh-list
138440271|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138408662|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138440272|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440273|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138440274|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440275|NCT01781377|Metoclopramide|metoclopramide|mesh-list
138440276|NCT01781377|Propofol|propofol|mesh-list
138440277|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138440278|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138440279|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440280|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138440281|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
138440282|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
138440283|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
138440284|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
138440285|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440286|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138440287|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138440288|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138440289|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
138440290|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440291|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440292|NCT01781442|Sirolimus|sirolimus|mesh-list
138440293|NCT01781442|Temsirolimus|temsirolimus|mesh-list
138440294|NCT01781442|MTOR Inhibitors|mtor inhibitors|mesh-list
138440295|NCT01781442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138440296|NCT01781442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440297|NCT01781442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440299|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
138440300|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440301|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440302|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138440304|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138440305|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
138440306|NCT01781507|Cetirizine|cetirizine|mesh-list
138440307|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138440308|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138440309|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138440310|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
138240520|NCT03904693|Macitentan|macitentan|mesh-list
138440311|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
138440312|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440313|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440314|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440315|NCT01781663|Petrolatum|petrolatum|mesh-list
138440316|NCT01781663|Emollients|emollients|mesh-ancestor
138440317|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
138440318|NCT01781702|Celecoxib|celecoxib|mesh-list
138440319|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138440320|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138440321|NCT01781702|Analgesics|analgesics|mesh-ancestor
138440322|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
138440323|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440324|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440325|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138440326|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138440327|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138440328|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138440329|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440330|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440331|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138440332|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
138440333|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440334|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
138440335|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
138440336|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440337|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440338|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440340|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138440341|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138440342|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
138440343|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440344|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440345|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440346|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
138440347|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138440348|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
138440349|NCT01781936|Hormones|hormones|mesh-ancestor
138440350|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138440351|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440352|NCT01781988|Carboplatin|carboplatin|mesh-list
138440353|NCT01781988|Gemcitabine|gemcitabine|mesh-list
138440354|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440355|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138440356|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
138440357|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440358|NCT01782001|Vitamins|vitamins|mesh-list
138440359|NCT01782001|Vitamin A|vitamin a|mesh-list
138408801|NCT01610869|Nintedanib|nintedanib|mesh-list
138440360|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
138440361|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
138240558|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
138440362|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440364|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440365|NCT01782001|Protective Agents|protective agents|mesh-ancestor
138440366|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138440367|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440368|NCT01782261|Liraglutide|liraglutide|mesh-list
138440369|NCT01782261|Saxagliptin|saxagliptin|mesh-list
138440370|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138440371|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440372|NCT01782261|Incretins|incretins|mesh-ancestor
138440373|NCT01782261|Hormones|hormones|mesh-ancestor
138440374|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138440375|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138440376|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
138440377|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339410|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138440378|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440380|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
138440381|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440383|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
138440384|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138399361|NCT01541189|Valsartan|valsartan|mesh-list
138440385|NCT01782300|Vaccines|vaccines|mesh-list
138440386|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
138440387|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440388|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
138440389|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138440390|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440391|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
138440392|NCT01782508|Interferons|interferons|mesh-list
138440393|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
138440394|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440395|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
138440396|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440397|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138440398|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440399|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440401|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138440402|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138440403|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138440404|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440405|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440406|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
138440407|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138440408|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138440409|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440411|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
138440413|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
138440414|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440415|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440416|NCT01782651|Capecitabine|capecitabine|mesh-list
138440417|NCT01782651|Lapatinib|lapatinib|mesh-list
138440418|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138240580|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138440420|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199099|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199100|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138199101|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199102|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
138199103|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199104|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138199105|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138199106|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
138339452|NCT01339260|Hormones|hormones|mesh-ancestor
138440421|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440422|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138440423|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440424|NCT01782781|Epinephrine|epinephrine|mesh-list
138440425|NCT01782781|Ropivacaine|ropivacaine|mesh-list
138440426|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
138440427|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
138440428|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138440429|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440430|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
138440431|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199107|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138440432|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138199108|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199109|NCT00002380|Nelfinavir|nelfinavir|mesh-list
138199110|NCT00002380|Saquinavir|saquinavir|mesh-list
138199111|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138440433|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138440434|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
138440435|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440436|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440437|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138440438|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138440439|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
138440440|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138440441|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
138440443|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
138440444|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138440445|NCT01782846|Codeine|codeine|mesh-list
138440446|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138440447|NCT01782846|Narcotics|narcotics|mesh-ancestor
138440448|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138440449|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440450|NCT01782846|Analgesics|analgesics|mesh-ancestor
138440451|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
138440452|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440453|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
138440454|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
138440455|NCT01782911|Resveratrol|resveratrol|mesh-list
138440456|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
138440457|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440458|NCT01782911|Protective Agents|protective agents|mesh-ancestor
138440459|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440461|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138440462|NCT01782924|Brodalumab|brodalumab|mesh-list
138440463|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
138440465|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
138440466|NCT01782950|Rifampin|rifampin|mesh-list
138440467|NCT01782950|Isoniazid|isoniazid|mesh-list
138440468|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
138440469|NCT01782950|Ethambutol|ethambutol|mesh-list
138440470|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138440471|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
138440472|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138440473|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440474|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
138440475|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138440476|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440477|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440478|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138440479|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138440480|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138440481|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138440482|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138408917|NCT01611480|Imiquimod|imiquimod|mesh-list
138440483|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138440484|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138440485|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138440486|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
138440487|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138440488|NCT01782976|Bevacizumab|bevacizumab|mesh-list
138440489|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138440490|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440491|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138440492|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138440493|NCT01782976|Growth Substances|growth substances|mesh-ancestor
138440494|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440495|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
138440496|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
138440497|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138440498|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440499|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
138440500|NCT01783106|Doxycycline|doxycycline|mesh-list
138440501|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
138440502|NCT01783106|Budesonide|budesonide|mesh-list
138440503|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138440504|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138440505|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
138440506|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440507|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440508|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138199147|NCT01153711|Ketoconazole|ketoconazole|mesh-list
138440510|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
138440511|NCT01783106|Hormones|hormones|mesh-ancestor
138440512|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138440513|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
138440514|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138440515|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138440516|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440517|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440518|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440519|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138440520|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138440521|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138440522|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138440523|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440524|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138440525|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138440527|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138440528|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440529|NCT01783379|Micafungin|micafungin|mesh-list
138440530|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
138440531|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440532|NCT01783431|Poly ICLC|poly iclc|mesh-list
138440533|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
138440534|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
138440535|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440536|NCT01783587|Docetaxel|docetaxel|mesh-list
138440537|NCT01783587|Afatinib|afatinib|mesh-list
138440538|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440540|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
138440541|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
138440542|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440543|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138440544|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440545|NCT01783717|Exenatide|exenatide|mesh-list
138440546|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138440547|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440548|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138440549|NCT01783717|Incretins|incretins|mesh-ancestor
138440550|NCT01783717|Hormones|hormones|mesh-ancestor
138440551|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138440552|NCT01783756|Capecitabine|capecitabine|mesh-list
138440553|NCT01783756|Everolimus|everolimus|mesh-list
138440554|NCT01783756|Lapatinib|lapatinib|mesh-list
138440555|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138440556|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
138440557|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440558|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440559|NCT01783756|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138440560|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138440561|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138339534|NCT01363050|Analgesics|analgesics|mesh-ancestor
138440562|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138240661|NCT03652961|Abatacept|abatacept|mesh-list
138440564|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440565|NCT01783834|Pemetrexed|pemetrexed|mesh-list
138440566|NCT01783834|Gefitinib|gefitinib|mesh-list
138440567|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440568|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440569|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440570|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138440571|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138440572|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138440574|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440575|NCT01783964|Cytarabine|cytarabine|mesh-list
138440576|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138440577|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
138440578|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440579|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440580|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
138440581|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440582|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138440583|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
138440584|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440585|NCT01783977|Vaccines|vaccines|mesh-list
138440586|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
138440587|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440588|NCT01784107|Ifosfamide|ifosfamide|mesh-list
138440589|NCT01784107|Belotecan|belotecan|mesh-list
138440590|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138440591|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
138440592|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440593|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440594|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138440595|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138440596|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440597|NCT01784120|Doxorubicin|doxorubicin|mesh-list
138440598|NCT01784120|genexol-PM|genexol-pm|mesh-list
138440599|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138440600|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440601|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138440602|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138440603|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440604|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440605|NCT01784120|Tubulin Modulators|tubulin modulators|mesh-ancestor
138440606|NCT01784120|Antimitotic Agents|antimitotic agents|mesh-ancestor
138440607|NCT01784120|Mitosis Modulators|mitosis modulators|mesh-ancestor
138440608|NCT01784250|Propranolol|propranolol|mesh-list
138440609|NCT01784250|Clonidine|clonidine|mesh-list
138440610|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138440611|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138440612|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
138440613|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138399578|NCT01542424|Insulin|insulin|mesh-list
138440614|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440615|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440616|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138240690|NCT03646617|Nivolumab|nivolumab|mesh-list
138440617|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138440619|NCT01784250|Analgesics|analgesics|mesh-ancestor
138440620|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
138440621|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440622|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
138440623|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
138440624|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138440625|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138440626|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138440627|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
138440628|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138199151|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138199152|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440629|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199153|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440630|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
138440631|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440632|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138440633|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138440634|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440635|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440636|NCT01784315|Chloroquine|chloroquine|mesh-list
138199154|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138199155|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
138199157|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440637|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138440638|NCT01784315|Primaquine|primaquine|mesh-list
138440639|NCT01784315|Artemisinins|artemisinins|mesh-list
138440640|NCT01784315|Artemisinin|artemisinin|mesh-list
138440641|NCT01784315|Amebicides|amebicides|mesh-ancestor
138440642|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138440643|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138440644|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440645|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
138440646|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138440647|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138440648|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138440649|NCT01784315|Analgesics|analgesics|mesh-ancestor
138440650|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
138440651|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379639|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
138440652|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440653|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138440654|NCT01784315|Filaricides|filaricides|mesh-ancestor
138440655|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
138440656|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
138440657|NCT01784380|Metformin|metformin|mesh-list
138440658|NCT01784380|Clomiphene|clomiphene|mesh-list
138440659|NCT01784380|Enclomiphene|enclomiphene|mesh-list
138440660|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
138440661|NCT01784380|Menotropins|menotropins|mesh-list
138440662|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
138440663|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138440664|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440665|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138440666|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
138440667|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138440668|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138440669|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
138440670|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138379702|NCT06040255|Prednisone|prednisone|mesh-list
138440671|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138440672|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138440673|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
138440674|NCT01784445|Ceftazidime|ceftazidime|mesh-list
138440675|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138440676|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440677|NCT01784549|Gemcitabine|gemcitabine|mesh-list
138440679|NCT01784549|Pemetrexed|pemetrexed|mesh-list
138440680|NCT01784549|Vinorelbine|vinorelbine|mesh-list
138440682|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440683|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138440684|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
138440685|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440686|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
138440687|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
138440688|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
138440689|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440690|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138440691|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138440692|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138440693|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138440694|NCT01784562|Riociguat|riociguat|mesh-list
138440695|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
138440696|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440697|NCT01784640|Pemetrexed|pemetrexed|mesh-list
138440698|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440699|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440700|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440701|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138440702|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138440703|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138440704|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440705|NCT01784900|Catumaxomab|catumaxomab|mesh-list
138240760|NCT03491540|Gentamicins|gentamicins|mesh-list
138440707|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138440708|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
138440709|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440710|NCT01784913|Sargramostim|sargramostim|mesh-list
138440711|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
138440712|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440713|NCT01784978|Everolimus|everolimus|mesh-list
138440714|NCT01784978|Sunitinib|sunitinib|mesh-list
138199164|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138440715|NCT01784978|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138440716|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138440717|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440718|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440719|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138440720|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
138440721|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440722|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440723|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138440724|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138339604|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
138440725|NCT01784978|Growth Substances|growth substances|mesh-ancestor
138440726|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
138440727|NCT01785004|Vitamin D|vitamin d|mesh-list
138440728|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
138440729|NCT01785004|Vitamins|vitamins|mesh-ancestor
138440730|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
138440731|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440732|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138440733|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138440734|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
138440735|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138440736|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
138440737|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
138440738|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138440739|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440740|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138440741|NCT01785030|Analgesics|analgesics|mesh-ancestor
138440742|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
138440743|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440744|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138440745|NCT01785043|Liraglutide|liraglutide|mesh-list
138440746|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138379858|NCT06039202|Growth Substances|growth substances|mesh-ancestor
138440747|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440748|NCT01785043|Incretins|incretins|mesh-ancestor
138440750|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138440751|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138440752|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
138440753|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440754|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440755|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138440756|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
138440757|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440758|NCT01785108|Vitamin D|vitamin d|mesh-list
138440759|NCT01785108|Ibuprofen|ibuprofen|mesh-list
138440760|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
138440761|NCT01785108|Vitamins|vitamins|mesh-ancestor
138440762|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
138440763|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440764|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138440765|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138399730|NCT01543399|Tibolone|tibolone|mesh-list
138440766|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138440767|NCT01785108|Analgesics|analgesics|mesh-ancestor
138440768|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
138440769|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440770|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138440771|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138440772|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138440773|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440774|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440775|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138440776|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
138440777|NCT01785290|Haloperidol|haloperidol|mesh-list
138440778|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
138440779|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
138440780|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
138440781|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440782|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440783|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138440784|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138440785|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138440786|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138440787|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138440788|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138440789|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
138440790|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440791|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440792|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138440793|NCT01785329|Alirocumab|alirocumab|mesh-list
138440794|NCT01785329|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138440795|NCT01785329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138440796|NCT01785329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138440797|NCT01785329|Antimetabolites|antimetabolites|mesh-ancestor
138440798|NCT01785329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440799|NCT01785329|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138440800|NCT01785329|Protease Inhibitors|protease inhibitors|mesh-ancestor
138440801|NCT01785329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440802|NCT01785329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138440803|NCT01785446|Sufentanil|sufentanil|mesh-list
138440804|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
138440805|NCT01785446|Dsuvia|dsuvia|mesh-list
138440806|NCT01785446|Atracurium|atracurium|mesh-list
138440807|NCT01785446|Cisatracurium|cisatracurium|mesh-list
138440808|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138440809|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138440810|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440811|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138440812|NCT01785446|Analgesics|analgesics|mesh-ancestor
138440813|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
138440814|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440815|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138440816|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138440817|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138440818|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
138440819|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440820|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440821|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138440822|NCT01785446|Narcotics|narcotics|mesh-ancestor
138440823|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138440824|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138440825|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
138440826|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
138440827|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138440828|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138440829|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138440830|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
138440831|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138440832|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
138440834|NCT01785589|Analgesics|analgesics|mesh-ancestor
138440835|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
138440836|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440837|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440838|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138440839|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
138440840|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138440841|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
138440842|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
138399803|NCT01543945|Hormones|hormones|mesh-ancestor
138440843|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440844|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440845|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138440846|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
138440847|NCT01785641|Gentamicins|gentamicins|mesh-list
138440849|NCT01785641|Ceftazidime|ceftazidime|mesh-list
138440850|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138440851|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440852|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
138440853|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138440854|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138440855|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440856|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440857|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199171|NCT05751850|Gemcitabine|gemcitabine|mesh-list
138199172|NCT05751850|Fluorouracil|fluorouracil|mesh-list
138440858|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138440859|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138440860|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138440861|NCT01785693|Clonidine|clonidine|mesh-list
138440862|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
138440863|NCT01785693|Analgesics|analgesics|mesh-ancestor
138440864|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
138440865|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440866|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440867|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138440868|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
138440869|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
138440870|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138440871|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138440872|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138440873|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
138440874|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138440875|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138339748|NCT01404936|Interferons|interferons|mesh-list
138440876|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
138440877|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
138440878|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138440880|NCT01785797|Trace Elements|trace elements|mesh-ancestor
138440881|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
138440882|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440883|NCT01785836|Dapsone|dapsone|mesh-list
138440884|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440886|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138440887|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138440888|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138440889|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440890|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440891|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
138440892|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138440893|NCT01785862|Ibuprofen|ibuprofen|mesh-list
138440894|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138440895|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138440896|NCT01785862|Analgesics|analgesics|mesh-ancestor
138440897|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
138440898|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440899|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440900|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138440901|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138440902|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138440903|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440904|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440905|NCT01785979|Chloroquine|chloroquine|mesh-list
138440906|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138440907|NCT01785979|Prednisone|prednisone|mesh-list
138440908|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138440909|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
138440910|NCT01785979|Hormones|hormones|mesh-ancestor
138440911|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138380293|NCT04809766|Fludarabine|fludarabine|mesh-list
138440912|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440913|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138440914|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138440915|NCT01785979|Amebicides|amebicides|mesh-ancestor
138440916|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138440917|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138440919|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
138440920|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138440921|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138440922|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138440923|NCT01785979|Analgesics|analgesics|mesh-ancestor
138440924|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
138380349|NCT04561206|Antibodies|antibodies|mesh-list
138440925|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440926|NCT01785979|Filaricides|filaricides|mesh-ancestor
138440927|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
138440928|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
138440929|NCT01786018|Cyclosporine|cyclosporine|mesh-list
138440930|NCT01786018|Methotrexate|methotrexate|mesh-list
138440931|NCT01786018|Busulfan|busulfan|mesh-list
138440932|NCT01786018|Thiotepa|thiotepa|mesh-list
138440933|NCT01786018|Cyclosporins|cyclosporins|mesh-list
138440934|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138440935|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
138440936|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138440937|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440938|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138440939|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
138440940|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440941|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138240888|NCT03298945|Laxatives|laxatives|mesh-ancestor
138440942|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
138440943|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138440944|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138440945|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138440946|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
138440947|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138440948|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138440949|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
138440950|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138440951|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138440952|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
138440953|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138440954|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138440955|NCT01786070|Budesonide|budesonide|mesh-list
138440956|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138440957|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138440958|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
138440959|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440960|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440961|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138440962|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
138440963|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
138440964|NCT01786070|Hormones|hormones|mesh-ancestor
138440965|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138440966|NCT01786200|Aspirin|aspirin|mesh-list
138440967|NCT01786200|Ibuprofen|ibuprofen|mesh-list
138380535|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138440968|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138440969|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138440970|NCT01786200|Analgesics|analgesics|mesh-ancestor
138440971|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
138440972|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138440973|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440974|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138440975|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138440976|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138440977|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138440978|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138440979|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138440980|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138440982|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
138440983|NCT01786226|Mifepristone|mifepristone|mesh-list
138440984|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138440985|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
138440986|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138440987|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138440988|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138440989|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138440990|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138440991|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
138440992|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138440993|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138440994|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
138440995|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138440996|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
138440997|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138440998|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138440999|NCT01786382|Midazolam|midazolam|mesh-list
138441000|NCT01786382|Omeprazole|omeprazole|mesh-list
138441001|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138380653|NCT02940496|Ribavirin|ribavirin|mesh-list
138441002|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138199178|NCT05751850|Tubulin Modulators|tubulin modulators|mesh-ancestor
138441003|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138441004|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409513|NCT01615081|Insulin|insulin|mesh-list
138441005|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138441006|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138441007|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138441008|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138339855|NCT01434186|Metformin|metformin|mesh-list
138441009|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
138441010|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
138441011|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
138441012|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
138441013|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441014|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441015|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138441016|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138441017|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138441018|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441019|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
138441020|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138441022|NCT01786538|Fluorouracil|fluorouracil|mesh-list
138441023|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
138441024|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
138441025|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240951|NCT03167905|Fentanyl|fentanyl|mesh-list
138441026|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138441027|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441028|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138441029|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
138441030|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441031|NCT01786538|Antidotes|antidotes|mesh-ancestor
138441032|NCT01786538|Protective Agents|protective agents|mesh-ancestor
138441033|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
138441034|NCT01786538|Vitamins|vitamins|mesh-ancestor
138441035|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
138441036|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
138441037|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138441038|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
138441039|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441040|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441041|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138441042|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
138441043|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138441044|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138380843|NCT00716066|Cytarabine|cytarabine|mesh-list
138441045|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138441046|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
138441047|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441048|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441049|NCT01786655|Epinephrine|epinephrine|mesh-list
138199180|NCT05751850|Mitosis Modulators|mitosis modulators|mesh-ancestor
138441050|NCT01786655|Bupivacaine|bupivacaine|mesh-list
138441051|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
138441052|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
138199181|NCT05751850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441053|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
138199183|NCT05751850|Antimetabolites|antimetabolites|mesh-ancestor
138441054|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138441055|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441056|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
138441057|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441058|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138441059|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138441060|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
138441061|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441062|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441063|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138441064|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138441065|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
138441066|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138441067|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
138188485|NCT03018301|Analgesics|analgesics|mesh-ancestor
138441068|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
138441069|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
138441070|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138441071|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138441072|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138441073|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138441074|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138441075|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138441076|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138441077|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
138441078|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138441079|NCT01787123|Protective Agents|protective agents|mesh-ancestor
138441080|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441081|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
138441082|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
138441083|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
138441084|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
138441085|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138441086|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138441087|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441088|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441089|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441090|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
138381096|NCT04279054|Analgesics|analgesics|mesh-ancestor
138441091|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138441092|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138441093|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138441094|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138441095|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441096|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
138441097|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441098|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441099|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138441100|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441101|NCT01787357|Canagliflozin|canagliflozin|mesh-list
138441102|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
138441103|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138441104|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441105|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138441106|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138441107|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441108|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441109|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138241003|NCT03126214|Warfarin|warfarin|mesh-list
138441110|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441111|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138441112|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138441114|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138441115|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441116|NCT01787474|Cytarabine|cytarabine|mesh-list
138199198|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138199199|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199200|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199201|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
138199202|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441117|NCT01787474|Fludarabine|fludarabine|mesh-list
138441118|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
138441119|NCT01787474|Lenograstim|lenograstim|mesh-list
138441120|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441121|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138441122|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
138441123|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441124|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138441125|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
138441126|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441127|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
138441128|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441129|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138441130|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
138441131|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138441132|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
138441133|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441134|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
138441135|NCT01787630|Protective Agents|protective agents|mesh-ancestor
138441136|NCT01787669|Dexamethasone|dexamethasone|mesh-list
138441137|NCT01787669|Bevacizumab|bevacizumab|mesh-list
138441138|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138441139|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441140|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138441141|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138441142|NCT01787669|Growth Substances|growth substances|mesh-ancestor
138381286|NCT03821272|Vaccines|vaccines|mesh-list
138441143|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441144|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
138441145|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138441146|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
138441147|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
138441148|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138241054|NCT02915198|Metformin|metformin|mesh-list
138441149|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138441150|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
138441151|NCT01787669|Hormones|hormones|mesh-ancestor
138441152|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441153|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138441154|NCT01788007|Imiquimod|imiquimod|mesh-list
138441155|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138441156|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
138441157|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441158|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441159|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
138441160|NCT01788072|Oxytocin|oxytocin|mesh-list
138441161|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
138441162|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138441163|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441164|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
138441165|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138441166|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409645|NCT01615978|Hormones|hormones|mesh-ancestor
138441167|NCT01788189|Lenalidomide|lenalidomide|mesh-list
138441168|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
138441169|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441170|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138441171|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138441172|NCT01788189|Growth Substances|growth substances|mesh-ancestor
138441173|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
138441174|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441176|NCT01788254|Torsemide|torsemide|mesh-list
138441177|NCT01788254|Midazolam|midazolam|mesh-list
138441178|NCT01788254|Codeine|codeine|mesh-list
138441179|NCT01788254|Pravastatin|pravastatin|mesh-list
138441180|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138441181|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138441182|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138441183|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441184|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138441185|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138441186|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138441187|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138441188|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
138441189|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
138441190|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
138441191|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
138441192|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441193|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441194|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138441195|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138441196|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
138441197|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138441198|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138441200|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138441201|NCT01788254|Narcotics|narcotics|mesh-ancestor
138441202|NCT01788254|Analgesics|analgesics|mesh-ancestor
138441203|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
138441204|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441205|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
138441206|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
138441207|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138441208|NCT01788254|Diuretics|diuretics|mesh-ancestor
138441209|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
138441210|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138381571|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
138441211|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138441212|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138441213|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138441214|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
138441215|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138441216|NCT01788280|Bevacizumab|bevacizumab|mesh-list
138441217|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138441218|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441219|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138441220|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138441221|NCT01788280|Growth Substances|growth substances|mesh-ancestor
138441222|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441223|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
138441224|NCT01788332|Olaparib|olaparib|mesh-list
138441225|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138441226|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441227|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441228|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441229|NCT01788371|Lamivudine|lamivudine|mesh-list
138241114|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441230|NCT01788371|Telbivudine|telbivudine|mesh-list
138441231|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138441232|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138441233|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441234|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441235|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
138441236|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441237|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138441238|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138441239|NCT01788384|Clindamycin|clindamycin|mesh-list
138441240|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
138441241|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
138441242|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138441243|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138441244|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441245|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138441246|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441247|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441248|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
138441249|NCT01788462|Tesamorelin|tesamorelin|mesh-list
138441250|NCT01788462|Growth Substances|growth substances|mesh-ancestor
138441251|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441252|NCT01788501|Cyclosporine|cyclosporine|mesh-list
138441253|NCT01788501|Methotrexate|methotrexate|mesh-list
138441254|NCT01788501|Tacrolimus|tacrolimus|mesh-list
138441255|NCT01788501|Cyclosporins|cyclosporins|mesh-list
138381703|NCT01614197|Cytarabine|cytarabine|mesh-list
138441256|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138441257|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
138441258|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138441259|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441260|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138441261|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
138441262|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441263|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441264|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
138441265|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340049|NCT01483560|Metformin|metformin|mesh-list
138441266|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138441267|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138441268|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
138441269|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138409695|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
138441270|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138441271|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138441272|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
138441273|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441274|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138441275|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138441276|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138441277|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138441278|NCT01788605|Ramosetron|ramosetron|mesh-list
138441279|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
138441280|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
138441281|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441282|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441283|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138441284|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138441285|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
138441286|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441287|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441288|NCT01788670|Ethanol|ethanol|mesh-list
138441289|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138441290|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441291|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138381738|NCT01422148|Minocycline|minocycline|mesh-list
138441292|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441293|NCT01788722|Dienogest|dienogest|mesh-list
138441294|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138441295|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
138441296|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138441297|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441298|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138441299|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138441300|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138441301|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138441302|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
138241177|NCT02477826|Paclitaxel|paclitaxel|mesh-list
138441303|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441304|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138441305|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441307|NCT01788969|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138441308|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138441309|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138441310|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441311|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441313|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441315|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441316|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138441317|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441318|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441319|NCT01789086|Liraglutide|liraglutide|mesh-list
138441320|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138441321|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441322|NCT01789086|Incretins|incretins|mesh-ancestor
138441323|NCT01789086|Hormones|hormones|mesh-ancestor
138441324|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441325|NCT01789099|Sargramostim|sargramostim|mesh-list
138441326|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
138441327|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441328|NCT01789125|Nicotine|nicotine|mesh-list
138441329|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138199207|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138441330|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
138441331|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441332|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441333|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138441334|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138441335|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
138441336|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441337|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441338|NCT01789216|Ketorolac|ketorolac|mesh-list
138441339|NCT01789216|Meloxicam|meloxicam|mesh-list
138441340|NCT01789216|Pregabalin|pregabalin|mesh-list
138441341|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138441342|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138441343|NCT01789216|Analgesics|analgesics|mesh-ancestor
138441344|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
138441345|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441346|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441347|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138441348|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138441349|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138441350|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340099|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
138441351|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441352|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
138441353|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138441354|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138441355|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138441356|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138441357|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138441358|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138441359|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138441360|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138441361|NCT01789242|Dexamethasone|dexamethasone|mesh-list
138441362|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138441363|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
138441364|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
138441365|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441366|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441367|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138441368|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
138441370|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441371|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138441372|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441373|NCT01789294|Mesalamine|mesalamine|mesh-list
138441374|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138441375|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138441376|NCT01789294|Analgesics|analgesics|mesh-ancestor
138441377|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
138441378|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441379|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441380|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138441381|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138441382|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
138381958|NCT01459445|Hormones|hormones|mesh-ancestor
138441384|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138441385|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441386|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138441387|NCT01789385|Analgesics|analgesics|mesh-ancestor
138441388|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
138441389|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441390|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138441391|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138441392|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138441393|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
138441394|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441395|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441397|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138441399|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
138441400|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441401|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441402|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138441403|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
138441404|NCT01789437|Hormones|hormones|mesh-ancestor
138441405|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441406|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138441407|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441408|NCT01789619|Tacrolimus|tacrolimus|mesh-list
138441409|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138441410|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
138441411|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441412|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138441413|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409896|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138441414|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441415|NCT01789710|Bupropion|bupropion|mesh-list
138441416|NCT01789710|Nicotine|nicotine|mesh-list
138441417|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138441418|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
138441419|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441420|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241425|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
138441421|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138441422|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138441423|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
138441424|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138381988|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138441425|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441426|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138441427|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
138441428|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138441429|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138441430|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138441431|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138441433|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138441434|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138441435|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441436|NCT01789723|Leucovorin|leucovorin|mesh-list
138441437|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
138340156|NCT01519284|Levodopa|levodopa|mesh-list
138441438|NCT01789723|Antidotes|antidotes|mesh-ancestor
138441439|NCT01789723|Protective Agents|protective agents|mesh-ancestor
138441440|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441441|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
138441442|NCT01789723|Vitamins|vitamins|mesh-ancestor
138441443|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
138441444|NCT01789827|Interleukin-2|interleukin-2|mesh-list
138441445|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441446|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138441447|NCT01789827|Analgesics|analgesics|mesh-ancestor
138441448|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
138441449|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441450|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441451|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
138441452|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138441453|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138441454|NCT01789892|Prednisolone|prednisolone|mesh-list
138441455|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
138441456|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138441457|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
138441458|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138441459|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138441460|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
138441461|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
138382017|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
138441462|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441463|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441464|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138441465|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
138441466|NCT01789892|Hormones|hormones|mesh-ancestor
138441467|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441468|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138441469|NCT01789892|Protective Agents|protective agents|mesh-ancestor
138441470|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138441471|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199216|NCT03009877|Propofol|propofol|mesh-list
138441472|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138441473|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441474|NCT01789957|Exenatide|exenatide|mesh-list
138441475|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138441476|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441477|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138441478|NCT01789957|Incretins|incretins|mesh-ancestor
138441479|NCT01789957|Hormones|hormones|mesh-ancestor
138441480|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441481|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138441482|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138441483|NCT01792063|Sevoflurane|sevoflurane|mesh-list
138441484|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138441485|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138441486|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
138441487|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
138441488|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138241521|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
138441489|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441490|NCT01792570|Darunavir|darunavir|mesh-list
138441491|NCT01792570|Rilpivirine|rilpivirine|mesh-list
138441492|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138441493|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138441494|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
138441495|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441496|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441497|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138441498|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138441499|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
138441500|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441501|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138441502|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138441503|NCT01792804|Vancomycin|vancomycin|mesh-list
138441504|NCT01792804|Clindamycin|clindamycin|mesh-list
138441505|NCT01792804|Cefazolin|cefazolin|mesh-list
138441506|NCT01792804|Linezolid|linezolid|mesh-list
138441507|NCT01792804|Daptomycin|daptomycin|mesh-list
138441508|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138441509|NCT01792804|Floxacillin|floxacillin|mesh-list
138441510|NCT01792804|Cloxacillin|cloxacillin|mesh-list
138441511|NCT01792804|Trimethoprim|trimethoprim|mesh-list
138441512|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
138441513|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138441514|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441515|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138441517|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241563|NCT00781612|Immunoconjugates|immunoconjugates|mesh-ancestor
138241564|NCT00781612|Immunologic Factors|immunologic factors|mesh-ancestor
138441519|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
138441520|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138441521|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138441522|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138441523|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138441524|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138441525|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138441527|NCT01793038|Enclomiphene|enclomiphene|mesh-list
138441528|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
138441529|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138441530|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441531|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138441532|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
138441533|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441534|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441535|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138441536|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
138441537|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138441538|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138441539|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138441540|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138441541|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441542|NCT01794182|Glyburide|glyburide|mesh-list
138441543|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138348306|NCT02484222|Narcotics|narcotics|mesh-ancestor
138441544|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441545|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138441546|NCT01794208|Hormones|hormones|mesh-ancestor
138410070|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441547|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441548|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441549|NCT01794247|Lidocaine|lidocaine|mesh-list
138441550|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
138441551|NCT01794247|Fentanyl|fentanyl|mesh-list
138441552|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
138441553|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
138441554|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138441555|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441556|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
138441557|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138382154|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
138441559|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138441560|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138441561|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138441562|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441563|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138441564|NCT01794247|Narcotics|narcotics|mesh-ancestor
138441565|NCT01794247|Analgesics|analgesics|mesh-ancestor
138441566|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138441567|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138441568|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
138441569|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
138441570|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138441571|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138441572|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
138441573|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138441575|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138441576|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441577|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138441578|NCT01794429|Incretins|incretins|mesh-ancestor
138441579|NCT01794429|Hormones|hormones|mesh-ancestor
138410113|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138441580|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441582|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138441583|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441584|NCT01795248|Incretins|incretins|mesh-ancestor
138441585|NCT01795248|Hormones|hormones|mesh-ancestor
138441586|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441587|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
138441588|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
138441589|NCT01796132|Citalopram|citalopram|mesh-list
138441590|NCT01796132|Fluoxetine|fluoxetine|mesh-list
138441591|NCT01796132|Paroxetine|paroxetine|mesh-list
138441592|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138441593|NCT01796132|Sertraline|sertraline|mesh-list
138441594|NCT01796132|Escitalopram|escitalopram|mesh-list
138441595|NCT01796132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138441596|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138441597|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138441598|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441599|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441600|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
138441601|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441602|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441603|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138441604|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
138199221|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138441605|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138441606|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138441607|NCT01796132|Analgesics|analgesics|mesh-ancestor
138441608|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
138441609|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
138441610|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138382188|NCT01462214|Everolimus|everolimus|mesh-list
138441611|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138441612|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441613|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138441614|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138441615|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138441616|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138441617|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138441618|NCT01796418|Beraprost|beraprost|mesh-list
138441619|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138441620|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
138441621|NCT01796522|Nifedipine|nifedipine|mesh-list
138441622|NCT01796522|Progesterone|progesterone|mesh-list
138441623|NCT01796522|Progestins|progestins|mesh-ancestor
138441624|NCT01796522|Hormones|hormones|mesh-ancestor
138441625|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441626|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441627|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138441628|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138441629|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441630|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138441631|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
138441633|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138441634|NCT01796730|Bambuterol|bambuterol|mesh-list
138441635|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138441636|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
138441637|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441638|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441639|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138441640|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
138441641|NCT01796808|Lidocaine|lidocaine|mesh-list
138441642|NCT01796808|Epinephrine|epinephrine|mesh-list
138441643|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
138441644|NCT01796808|Anesthetics|anesthetics|mesh-list
138441645|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138441646|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441647|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
138441648|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441649|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138441650|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138441652|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138441653|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441654|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138441655|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138441656|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
138441657|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441658|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138441659|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138441660|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
138382210|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441661|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138441662|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
138441664|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
138441665|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138441666|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
138441667|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138441668|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138441669|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441670|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
138441671|NCT01797289|Coagulants|coagulants|mesh-ancestor
138441673|NCT01797718|Testosterone|testosterone|mesh-list
138441674|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441675|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138441676|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138441677|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199235|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
138348466|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
138441678|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441679|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138410244|NCT01619527|Darunavir|darunavir|mesh-list
138441680|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
138441681|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441682|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441683|NCT01797718|Androgens|androgens|mesh-ancestor
138441684|NCT01797718|Hormones|hormones|mesh-ancestor
138441685|NCT01797796|Capsaicin|capsaicin|mesh-list
138441686|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
138441687|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
138441688|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
138441689|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441690|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441691|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138441692|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441693|NCT01798446|Axitinib|axitinib|mesh-list
138441694|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441695|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138441696|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441697|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441698|NCT01798680|Vitamin D|vitamin d|mesh-list
138441699|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
138441700|NCT01798680|Vitamins|vitamins|mesh-ancestor
138441701|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
138441702|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441703|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138441704|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138441705|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138441706|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138441707|NCT01798836|Estradiol|estradiol|mesh-list
138441708|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138241847|NCT02803749|Buspirone|buspirone|mesh-list
138441709|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138441710|NCT01798836|Estrogens|estrogens|mesh-ancestor
138441711|NCT01798836|Hormones|hormones|mesh-ancestor
138441712|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441713|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441714|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138441716|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138441717|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138441718|NCT01798901|Decitabine|decitabine|mesh-list
138441719|NCT01798901|Azacitidine|azacitidine|mesh-list
138441720|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
138441721|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138441722|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
138441723|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441724|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441725|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441726|NCT01799863|Ketorolac|ketorolac|mesh-list
138441727|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138441728|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138441729|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
138441730|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138441731|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138441733|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
138441734|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441735|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441736|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138441737|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138441738|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138441739|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441740|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441741|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138441742|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138441743|NCT01799863|Laxatives|laxatives|mesh-ancestor
138441744|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138441745|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
138441746|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138441747|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
138441748|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138441749|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
138441751|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441752|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
138441753|NCT01800019|Nicotine|nicotine|mesh-list
138441754|NCT01800019|Varenicline|varenicline|mesh-list
138441755|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138441756|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
138441757|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441758|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441760|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138441761|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
138441762|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138441763|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441764|NCT01800097|Modafinil|modafinil|mesh-list
138441765|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138441766|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441767|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138441768|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138441769|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138441770|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441771|NCT01800227|Metformin|metformin|mesh-list
138441772|NCT01800227|Pioglitazone|pioglitazone|mesh-list
138441773|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138441774|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441775|NCT01800240|Metformin|metformin|mesh-list
138441776|NCT01800240|Pioglitazone|pioglitazone|mesh-list
138441777|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138441778|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441779|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
138441780|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441781|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
138441782|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138441783|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138441784|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138241977|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138241978|NCT03581409|Analgesics|analgesics|mesh-ancestor
138241979|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
138241980|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441785|NCT01800292|Urological Agents|urological agents|mesh-ancestor
138441786|NCT01800357|Aspirin|aspirin|mesh-list
138441787|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
138441788|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138441789|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138441790|NCT01800357|Analgesics|analgesics|mesh-ancestor
138410357|NCT01620229|Antibodies|antibodies|mesh-list
138441791|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
138441792|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441793|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441794|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138441795|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138441796|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138441797|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138441798|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441799|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138441800|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138382306|NCT01463592|Iodine|iodine|mesh-list
138441801|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441802|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
138441803|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138441804|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
138441805|NCT01800396|Caseins|caseins|mesh-list
138441806|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
138441807|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
138441808|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441809|NCT01800422|Progesterone|progesterone|mesh-list
138441810|NCT01800422|Progestins|progestins|mesh-ancestor
138441811|NCT01800422|Hormones|hormones|mesh-ancestor
138441812|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138242022|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242023|NCT03510741|Expectorants|expectorants|mesh-ancestor
138242024|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
138242025|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138242026|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
138242027|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242028|NCT03510741|Protective Agents|protective agents|mesh-ancestor
138242029|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441813|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441814|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
138441815|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
138441816|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138441817|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138441818|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441820|NCT01800435|Coagulants|coagulants|mesh-ancestor
138441821|NCT01800487|Silymarin|silymarin|mesh-list
138441822|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
138441823|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441824|NCT01800487|Protective Agents|protective agents|mesh-ancestor
138441825|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441826|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
138441827|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138441828|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
138441829|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441830|NCT01800526|Expectorants|expectorants|mesh-ancestor
138441831|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
138441832|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138441834|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441835|NCT01800526|Protective Agents|protective agents|mesh-ancestor
138441836|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441837|NCT01800526|Antidotes|antidotes|mesh-ancestor
138441838|NCT01800630|Gemcitabine|gemcitabine|mesh-list
138441839|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138441840|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
138242058|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138441841|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441842|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441844|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
138441845|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441846|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138441847|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
138441848|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441849|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138441850|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441851|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138441852|NCT01800695|Temozolomide|temozolomide|mesh-list
138441853|NCT01800695|ABT-414|abt-414|mesh-list
138441854|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138441855|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
138441856|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382367|NCT01464008|Interferons|interferons|mesh-list
138441857|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441858|NCT01800695|Immunoconjugates|immunoconjugates|mesh-ancestor
138441859|NCT01800695|Immunologic Factors|immunologic factors|mesh-ancestor
138242106|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
138441860|NCT01800695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441862|NCT01800708|Triamcinolone|triamcinolone|mesh-list
138410422|NCT01620463|Incretins|incretins|mesh-ancestor
138441864|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138441865|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138441866|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138441867|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
138441868|NCT01800708|Hormones|hormones|mesh-ancestor
138340383|NCT06114537|Acetazolamide|acetazolamide|mesh-list
138441869|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441870|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441871|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138441872|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441873|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138441874|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
138441875|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441876|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441877|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138441878|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441879|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
138441881|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138441882|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138441883|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138199239|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138441884|NCT01800799|Analgesics|analgesics|mesh-ancestor
138441885|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
138441886|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441887|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441888|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138441889|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138441890|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138441891|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441892|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441893|NCT01800825|Clindamycin|clindamycin|mesh-list
138441894|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
138441895|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
138441896|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138441897|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441898|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138441899|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382411|NCT01464125|Azithromycin|azithromycin|mesh-list
138441900|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441901|NCT01800942|Azithromycin|azithromycin|mesh-list
138441902|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138441903|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441904|NCT01801046|Cytarabine|cytarabine|mesh-list
138441905|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
138441906|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138441907|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
138441908|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441909|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441910|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
138441911|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138441912|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138441913|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
138441914|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441915|NCT01801046|Analgesics|analgesics|mesh-ancestor
138441916|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
138441917|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138441918|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138441919|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138441920|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441921|NCT01801137|Everolimus|everolimus|mesh-list
138441922|NCT01801137|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138441923|NCT01801137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138441924|NCT01801137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441925|NCT01801137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441926|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138441927|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
138441928|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441929|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441930|NCT01801163|Sorafenib|sorafenib|mesh-list
138441931|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441932|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138441933|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382457|NCT01464489|Atropine|atropine|mesh-list
138441934|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441935|NCT01801228|Eplerenone|eplerenone|mesh-list
138441936|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138199242|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
138199243|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199244|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
138199245|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138199246|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199247|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138199248|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138441937|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
138441938|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441939|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441940|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138441941|NCT01801228|Diuretics|diuretics|mesh-ancestor
138441942|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
138441943|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138441945|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138441946|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
138441947|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138441948|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138340471|NCT06110130|Empagliflozin|empagliflozin|mesh-list
138441949|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138441950|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138441951|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
138441952|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
138441953|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441954|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
138441955|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441956|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441957|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138441958|NCT01801644|Cisplatin|cisplatin|mesh-list
138441959|NCT01801644|Gemcitabine|gemcitabine|mesh-list
138441960|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138441961|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138441962|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
138441963|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441964|NCT01801774|Triamcinolone|triamcinolone|mesh-list
138441965|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138441966|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138242310|NCT01592006|Ribavirin|ribavirin|mesh-list
138441968|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138441970|NCT01801774|Hormones|hormones|mesh-ancestor
138410612|NCT01621698|Fentanyl|fentanyl|mesh-list
138441971|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138441972|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441973|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138441974|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
138441975|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138441976|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441977|NCT01802255|Midazolam|midazolam|mesh-list
138441978|NCT01802255|Sevoflurane|sevoflurane|mesh-list
138441979|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138441980|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138441981|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138441982|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138441983|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138441984|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138441985|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138441986|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138441987|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
138441988|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
138441989|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
138441990|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
138441991|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138242358|NCT01594424|Antibodies|antibodies|mesh-list
138441992|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138441993|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138441994|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138441996|NCT01802268|Tacrolimus|tacrolimus|mesh-list
138441997|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138441998|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
138441999|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442000|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138442001|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442002|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199261|NCT00997139|Neomycin|neomycin|mesh-list
138442003|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138442004|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442005|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138442006|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442007|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
138442008|NCT01802450|Dasatinib|dasatinib|mesh-list
138442009|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442010|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138442011|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442012|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442013|NCT01802476|Palbociclib|palbociclib|mesh-list
138442014|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442015|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138442016|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442017|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442018|NCT01802489|Amiloride|amiloride|mesh-list
138442020|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
138442021|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442022|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138442023|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138442024|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138442025|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442026|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138442027|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138442028|NCT01802502|Rifampin|rifampin|mesh-list
138442029|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138442030|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
138442031|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138442032|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442033|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
138442034|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138442035|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442036|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442037|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138442038|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138442039|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138442040|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138442041|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138442042|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138442044|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
138442045|NCT01802593|Azathioprine|azathioprine|mesh-list
138410691|NCT01622361|Tamoxifen|tamoxifen|mesh-list
138442046|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138442047|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
138442048|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138442049|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442050|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138442051|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
138442052|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442053|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442054|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
138442055|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442056|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138442057|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138242456|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
138442058|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
138442059|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138442060|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138442061|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
138442062|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138442063|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
138442064|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442065|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442066|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138442067|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
138442068|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138442069|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
138340554|NCT05941858|Carbon Monoxide|carbon monoxide|mesh-list
138442070|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199271|NCT00002236|Zidovudine|zidovudine|mesh-list
138442071|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138442072|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138442073|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
138442074|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
138442075|NCT01802619|Protective Agents|protective agents|mesh-ancestor
138442076|NCT01802645|Leucovorin|leucovorin|mesh-list
138442077|NCT01802645|Folic Acid|folic acid|mesh-list
138442078|NCT01802645|Bevacizumab|bevacizumab|mesh-list
138442079|NCT01802645|Cetuximab|cetuximab|mesh-list
138442080|NCT01802645|Fluorouracil|fluorouracil|mesh-list
138442081|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
138442082|NCT01802645|Irinotecan|irinotecan|mesh-list
138442083|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
138442084|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138442085|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442086|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138442087|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138442088|NCT01802645|Growth Substances|growth substances|mesh-ancestor
138442089|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442090|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
138442091|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
138442092|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442093|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138442094|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138442095|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
138242489|NCT03005678|Denosumab|denosumab|mesh-list
138442096|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138442097|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138442098|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442099|NCT01802645|Antidotes|antidotes|mesh-ancestor
138442100|NCT01802645|Protective Agents|protective agents|mesh-ancestor
138442101|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
138442103|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
138442104|NCT01802645|Hematinics|hematinics|mesh-ancestor
138442105|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
138442106|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138442107|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442108|NCT01802684|Aflibercept|aflibercept|mesh-list
138442109|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138442110|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138442111|NCT01802684|Growth Substances|growth substances|mesh-ancestor
138442112|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442113|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
138188486|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
138442114|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442115|NCT01802814|Epratuzumab|epratuzumab|mesh-list
138442116|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138442117|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442118|NCT01802892|Plerixafor|plerixafor|mesh-list
138442119|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138442120|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138442121|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
138442122|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442123|NCT01802918|Ritonavir|ritonavir|mesh-list
138442124|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
138442125|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138442126|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138442127|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
138442128|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340593|NCT05891249|Hematinics|hematinics|mesh-ancestor
138442129|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138410761|NCT01622556|Busulfan|busulfan|mesh-list
138442130|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138382644|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138442131|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138442132|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
138442133|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442134|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138442135|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138442136|NCT01802931|Ketoconazole|ketoconazole|mesh-list
138442137|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
138442138|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442139|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138442140|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138442141|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442142|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442143|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138442144|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
138442145|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138442146|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442147|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138442149|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138442150|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442151|NCT01802970|Paclitaxel|paclitaxel|mesh-list
138442152|NCT01802970|Vinorelbine|vinorelbine|mesh-list
138442153|NCT01802970|Capecitabine|capecitabine|mesh-list
138442154|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138442155|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138442156|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442157|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
138442158|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
138442159|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
138410788|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138242569|NCT02999126|Propofol|propofol|mesh-list
138442160|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442162|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
138442163|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138442164|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
138442165|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138442166|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
138442167|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442168|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442169|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138442170|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
138442171|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138442172|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138442173|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138442174|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
138442175|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138442176|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442177|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
138442178|NCT01803191|Fosfomycin|fosfomycin|mesh-list
138442179|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138442180|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442181|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138442182|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138442183|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442184|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442185|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442186|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138442187|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138242607|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138442189|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138442190|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138442191|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
138442192|NCT01803347|Coagulants|coagulants|mesh-ancestor
138442193|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
138442194|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138442195|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442196|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138442197|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138442198|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138340646|NCT05724316|Vitamin D|vitamin d|mesh-list
138340648|NCT05724316|Vitamins|vitamins|mesh-ancestor
138442199|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442200|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442201|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
138442202|NCT01803503|Docetaxel|docetaxel|mesh-list
138442203|NCT01803503|Sunitinib|sunitinib|mesh-list
138442204|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442205|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
138442206|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
138242649|NCT02248142|Protective Agents|protective agents|mesh-ancestor
138242651|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138442207|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
138442208|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199277|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138442209|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138442210|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138442211|NCT01803503|Growth Substances|growth substances|mesh-ancestor
138442212|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442213|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
138442214|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138442215|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442216|NCT01803659|Vitamin A|vitamin a|mesh-list
138442217|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
138442218|NCT01803659|Carotenoids|carotenoids|mesh-list
138442219|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
138442220|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442221|NCT01803659|Protective Agents|protective agents|mesh-ancestor
138442222|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442223|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138442224|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442225|NCT01803659|Vitamins|vitamins|mesh-ancestor
138442226|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
138442227|NCT01803763|Omalizumab|omalizumab|mesh-list
138442228|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138442229|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138442230|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
138442231|NCT01803828|Tadalafil|tadalafil|mesh-list
138442232|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
138442233|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138442234|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138242705|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
138242706|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242710|NCT02859441|Ranibizumab|ranibizumab|mesh-list
138442235|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442236|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442237|NCT01803828|Urological Agents|urological agents|mesh-ancestor
138442239|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138442240|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442241|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
138442242|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442243|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138442244|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
138442245|NCT01804205|Analgesics|analgesics|mesh-ancestor
138442246|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
138442247|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442248|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442249|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
138442250|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138442251|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138442252|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
138442253|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138442254|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138242754|NCT03003884|Propofol|propofol|mesh-list
138442255|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442256|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138442257|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
138442258|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138442260|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138442261|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138442262|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
138442263|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138442264|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442265|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442266|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138442267|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138442268|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
138442269|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
138442270|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442271|NCT01804244|Rilpivirine|rilpivirine|mesh-list
138410961|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
138442272|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138442273|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138442274|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442275|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442276|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
138442277|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442278|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138199279|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
138442279|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138442280|NCT01804335|Trifarotene|trifarotene|mesh-list
138442281|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
138442282|NCT01804361|Cyclosporine|cyclosporine|mesh-list
138442283|NCT01804361|Cyclosporins|cyclosporins|mesh-list
138442284|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442285|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442286|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138442287|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
138442288|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442289|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
138442290|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442291|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
138442292|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138442293|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138442296|NCT01804374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138442297|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138442298|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138242811|NCT05672810|Hemostatics|hemostatics|mesh-ancestor
138442299|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442300|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138442301|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
138442302|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442303|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442304|NCT01804387|Lamivudine|lamivudine|mesh-list
138442305|NCT01804387|Adefovir|adefovir|mesh-list
138442306|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
138442307|NCT01804387|Telbivudine|telbivudine|mesh-list
138442308|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138442309|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138442310|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138411023|NCT01624246|Avibactam|avibactam|mesh-list
138442311|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442312|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
138442313|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442314|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138442315|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138442316|NCT01804400|Montelukast|montelukast|mesh-list
138442317|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138442318|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
138442319|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138442320|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
138442321|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138442322|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442323|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138442324|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138442325|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442326|NCT01804413|Insulin|insulin|mesh-list
138442327|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138442328|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138442329|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442330|NCT01804543|Ranolazine|ranolazine|mesh-list
138442331|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138442332|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138442333|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442334|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
138442335|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138442336|NCT01804595|Protective Agents|protective agents|mesh-ancestor
138442337|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442338|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
138442339|NCT01804712|Rituximab|rituximab|mesh-list
138442340|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138442341|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442342|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
138442343|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442344|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138442345|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138442346|NCT01804777|Amiloride|amiloride|mesh-list
138442347|NCT01804777|Diuretics|diuretics|mesh-ancestor
138442348|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
138442349|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442350|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138442351|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138199281|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138411054|NCT01624649|Methylphenidate|methylphenidate|mesh-list
138442352|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138442353|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382837|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
138442354|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138442355|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138442356|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138242896|NCT01887587|Ixazomib|ixazomib|mesh-list
138442358|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
138442359|NCT01804985|Dasatinib|dasatinib|mesh-list
138442360|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442361|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138442362|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442363|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442364|NCT01805115|Misoprostol|misoprostol|mesh-list
138442365|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138442366|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
138442367|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138442368|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382885|NCT01469143|Insulin|insulin|mesh-list
138442369|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138442370|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138442371|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
138442372|NCT01805232|Artesunate|artesunate|mesh-list
138442373|NCT01805232|Quinine|quinine|mesh-list
138442374|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
138442375|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138442376|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138442377|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442378|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442379|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
138442380|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
138442381|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138442382|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
138442383|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138340780|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138442384|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442385|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138442386|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138242929|NCT00374205|Artesunate|artesunate|mesh-list
138442387|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138442388|NCT01805232|Analgesics|analgesics|mesh-ancestor
138442389|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
138442390|NCT01805258|Efavirenz|efavirenz|mesh-list
138442391|NCT01805258|Nevirapine|nevirapine|mesh-list
138442392|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138442393|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138442394|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442395|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442396|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
138442397|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442398|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138442399|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138382943|NCT06077539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138442400|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138442401|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138442402|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138442403|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138442404|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138442405|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138442406|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
138442407|NCT01805310|Cathartics|cathartics|mesh-ancestor
138442408|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138442409|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138442410|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411129|NCT01625429|Paclitaxel|paclitaxel|mesh-list
138401388|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138442411|NCT01807741|Asenapine|asenapine|mesh-list
138442412|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138442413|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138442414|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138442415|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442416|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138442417|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
138442419|NCT01807767|Tacrolimus|tacrolimus|mesh-list
138442420|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138442421|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
138442422|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442423|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138442424|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442425|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442426|NCT01807767|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138442427|NCT01807767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138442428|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442429|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138442430|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138442431|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
138442432|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138442433|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442435|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
138442436|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
138442437|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
138442438|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442439|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442440|NCT01807910|Choline|choline|mesh-list
138442441|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
138442442|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138442443|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
138442444|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442445|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138442446|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138442447|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
138442448|NCT01807962|Lidocaine|lidocaine|mesh-list
138442449|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
138442450|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
138442451|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138442452|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442453|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
138442454|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442455|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138442456|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138442457|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138442458|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138411222|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138442459|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442461|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138442462|NCT01808014|Analgesics|analgesics|mesh-ancestor
138442463|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
138442464|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442465|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442466|NCT01808131|Lesinurad|lesinurad|mesh-list
138442467|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
138442468|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138442469|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
138442470|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
138442471|NCT01808300|Pregabalin|pregabalin|mesh-list
138442472|NCT01808300|Analgesics|analgesics|mesh-ancestor
138442473|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
138442474|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442475|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442476|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
138442477|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138442478|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138442479|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442480|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138442481|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138442482|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138442483|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138442484|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138442485|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
138442486|NCT01808300|Protective Agents|protective agents|mesh-ancestor
138442487|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
138442489|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
138442490|NCT01808469|Antibodies|antibodies|mesh-list
138442491|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138442492|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
138442493|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199282|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138442494|NCT01808495|Mitomycins|mitomycins|mesh-list
138442495|NCT01808495|Mitomycin|mitomycin|mesh-list
138442496|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138442497|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442498|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
138442499|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442500|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138442501|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442502|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
138442503|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138442504|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
138442505|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442506|NCT01808521|Expectorants|expectorants|mesh-ancestor
138442507|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
138442508|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138442509|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
138442510|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243115|NCT02870283|Carbamazepine|carbamazepine|mesh-list
138442511|NCT01808521|Protective Agents|protective agents|mesh-ancestor
138442512|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442513|NCT01808521|Antidotes|antidotes|mesh-ancestor
138442514|NCT01808586|Dexamethasone|dexamethasone|mesh-list
138442515|NCT01808586|Betamethasone|betamethasone|mesh-list
138442516|NCT01808586|Lidocaine|lidocaine|mesh-list
138442517|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138442518|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
138442519|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
138442520|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442521|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383134|NCT06072898|Niacin|niacin|mesh-list
138442522|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138442523|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
138442524|NCT01808586|Hormones|hormones|mesh-ancestor
138442525|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138442526|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138442527|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442528|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
138442529|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
138442530|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138442531|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
138442532|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138442533|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138442534|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138442535|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138442536|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442537|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138442538|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
138442539|NCT01808638|Gemcitabine|gemcitabine|mesh-list
138442540|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138442541|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
138442542|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442543|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442544|NCT01808768|Alcaftadine|alcaftadine|mesh-list
138442545|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138442546|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
138442547|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
138442548|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138442549|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442550|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442551|NCT01808898|Bupivacaine|bupivacaine|mesh-list
138442552|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
138442553|NCT01808898|Mepivacaine|mepivacaine|mesh-list
138442554|NCT01808898|Anesthetics|anesthetics|mesh-list
138442555|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138442556|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442557|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
138442558|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442559|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
138442561|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138442562|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
138442563|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199285|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
138199286|NCT01241539|Dabigatran|dabigatran|mesh-list
138442564|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138442565|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138442566|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
138442567|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442568|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442569|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138442570|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138442571|NCT01809158|Minocycline|minocycline|mesh-list
138442572|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138442573|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442575|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
138442576|NCT01809171|Vitamins|vitamins|mesh-ancestor
138442577|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
138442578|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442579|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138442580|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138442582|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138442583|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
138442584|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138442585|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442587|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
138442588|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138442589|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
138442590|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442591|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138442592|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
138442593|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
138442595|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
138442596|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442597|NCT01809340|Minocycline|minocycline|mesh-list
138442598|NCT01809340|Ketamine|ketamine|mesh-list
138442599|NCT01809340|Analgesics|analgesics|mesh-ancestor
138442600|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
138442601|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442602|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442603|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138442604|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138442605|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
138442606|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
138442607|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138442608|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138442609|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138442610|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138442611|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442612|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138442613|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442614|NCT01809392|Decitabine|decitabine|mesh-list
138243252|NCT05166083|Hormones|hormones|mesh-ancestor
138442615|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138442616|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
138442617|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442618|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442619|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442620|NCT01809444|Doxycycline|doxycycline|mesh-list
138442622|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138442623|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
138442624|NCT01809444|Hormones|hormones|mesh-ancestor
138442625|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138442626|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442627|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138442628|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442629|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138442630|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442632|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138442633|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138442634|NCT01809626|Zolpidem|zolpidem|mesh-list
138442635|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138442636|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138442637|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138442638|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442639|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138383317|NCT05999955|Neomycin|neomycin|mesh-list
138442641|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
138442642|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138442643|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442644|NCT01809743|Adenosine|adenosine|mesh-list
138442645|NCT01809743|Regadenoson|regadenoson|mesh-list
138442646|NCT01809743|Analgesics|analgesics|mesh-ancestor
138442647|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
138442648|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442649|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442650|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138442651|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
138442652|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138442653|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
138442654|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
138442655|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411411|NCT01627353|Dexamethasone|dexamethasone|mesh-list
138442656|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442657|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138442658|NCT01809847|Ofatumumab|ofatumumab|mesh-list
138442659|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442660|NCT01809860|Sirolimus|sirolimus|mesh-list
138442661|NCT01809860|Isavuconazole|isavuconazole|mesh-list
138442662|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138442663|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442664|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138442665|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138243324|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138243325|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138442666|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
138442667|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138442668|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
138442669|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442670|NCT01809886|Neostigmine|neostigmine|mesh-list
138442671|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138442672|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442673|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442674|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
138442675|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138442676|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442677|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138442678|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
138442679|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442680|NCT01809925|Psyllium|psyllium|mesh-list
138442681|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
138442682|NCT01809925|Cathartics|cathartics|mesh-ancestor
138442683|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138442684|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
138199293|NCT00002404|Valacyclovir|valacyclovir|mesh-list
138199294|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
138199295|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442685|NCT01810185|Naltrexone|naltrexone|mesh-list
138442686|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138442687|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138442688|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199296|NCT01242241|Propofol|propofol|mesh-list
138199297|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138199298|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138383352|NCT05965895|Dexmedetomidine|dexmedetomidine|mesh-list
138383353|NCT05965895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138383357|NCT05965895|Analgesics|analgesics|mesh-ancestor
138442689|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
138442690|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442691|NCT01810237|Dabigatran|dabigatran|mesh-list
138442692|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
138442693|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138442694|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
138442695|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442696|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442697|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
138442698|NCT01810315|Estradiol|estradiol|mesh-list
138442700|NCT01810315|Hormones|hormones|mesh-ancestor
138442701|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138442702|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442703|NCT01810354|Cefazolin|cefazolin|mesh-list
138243373|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
138243374|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138243375|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138442704|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138442705|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442706|NCT01810367|Cisplatin|cisplatin|mesh-list
138442707|NCT01810367|Gemcitabine|gemcitabine|mesh-list
138442708|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442709|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138442710|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
138442711|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442712|NCT01810393|Trastuzumab|trastuzumab|mesh-list
138442713|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138442714|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442715|NCT01810458|Acetaminophen|acetaminophen|mesh-list
138442716|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138442717|NCT01810458|Lidocaine|lidocaine|mesh-list
138442718|NCT01810458|Midazolam|midazolam|mesh-list
138442719|NCT01810458|Fentanyl|fentanyl|mesh-list
138442720|NCT01810458|Oxycodone|oxycodone|mesh-list
138442721|NCT01810458|Lorazepam|lorazepam|mesh-list
138442722|NCT01810458|Ondansetron|ondansetron|mesh-list
138442723|NCT01810458|Liver Extracts|liver extracts|mesh-list
138442724|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
138442725|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
138442726|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138442727|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442728|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
138442729|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442730|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138442731|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138442732|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138442733|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138442734|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442735|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138442736|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138442737|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138442738|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138442739|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138442740|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138442741|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
138442744|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138442745|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138442746|NCT01810458|Narcotics|narcotics|mesh-ancestor
138442747|NCT01810458|Analgesics|analgesics|mesh-ancestor
138442748|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138442749|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
138442750|NCT01810458|Hematinics|hematinics|mesh-ancestor
138442751|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
138442752|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
138442753|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138442754|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
138442755|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
138442756|NCT01810458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138442757|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138442758|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
138442759|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
138442760|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138442761|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138442762|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138442763|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138199310|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
138442764|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138442766|NCT01810601|Progestins|progestins|mesh-ancestor
138442768|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138411523|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138442769|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442770|NCT01810640|Liver Extracts|liver extracts|mesh-list
138442771|NCT01810640|Hematinics|hematinics|mesh-ancestor
138442773|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
138442774|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442775|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
138442776|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442777|NCT01810796|Ranolazine|ranolazine|mesh-list
138442778|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138442779|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138442780|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442781|NCT01810809|Hylan|hylan|mesh-list
138442782|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
138442783|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
138442784|NCT01810809|Protective Agents|protective agents|mesh-ancestor
138442785|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442786|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138442787|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
138442788|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
138442789|NCT01810848|Hylan|hylan|mesh-list
138442790|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138442791|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
138442792|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442793|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
138442794|NCT01810848|Protective Agents|protective agents|mesh-ancestor
138442795|NCT01810887|Ritonavir|ritonavir|mesh-list
138442796|NCT01810887|Darunavir|darunavir|mesh-list
138442797|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138442798|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138442799|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
138442800|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442801|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442802|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138442803|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138442804|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
138442805|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442806|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138442807|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138442808|NCT01810926|Cyclosporine|cyclosporine|mesh-list
138442809|NCT01810926|Rituximab|rituximab|mesh-list
138442810|NCT01810926|Methotrexate|methotrexate|mesh-list
138442811|NCT01810926|Fludarabine|fludarabine|mesh-list
138442812|NCT01810926|Thiotepa|thiotepa|mesh-list
138442813|NCT01810926|Treosulfan|treosulfan|mesh-list
138442814|NCT01810926|Antibodies|antibodies|mesh-list
138442815|NCT01810926|Cyclosporins|cyclosporins|mesh-list
138442816|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
138442817|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442818|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138442819|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442820|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138442821|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138442822|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
138442823|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138442824|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138442825|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
138442826|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442827|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
138442828|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442829|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138442830|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138442831|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138442833|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442834|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138442835|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138442836|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
138442837|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138442838|NCT01811056|Mifepristone|mifepristone|mesh-list
138442839|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138442840|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
138442841|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138442842|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442843|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138442844|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138442845|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138442846|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
138442847|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138442848|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138243595|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
138442849|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
138411609|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
138442850|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138442851|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
138442852|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138442853|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138442856|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442857|NCT01811160|Protective Agents|protective agents|mesh-ancestor
138442858|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442859|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138442860|NCT01811251|Dexamethasone|dexamethasone|mesh-list
138442861|NCT01811251|Pregabalin|pregabalin|mesh-list
138442862|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138442863|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
138442864|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
138442865|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442866|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442867|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138442868|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
138442869|NCT01811251|Hormones|hormones|mesh-ancestor
138442870|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138442871|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138442872|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442874|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
138442876|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138442877|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138442878|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442879|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138442880|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138442881|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138442882|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138442883|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138442884|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
138442885|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442886|NCT01811381|Curcumin|curcumin|mesh-list
138442887|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138442888|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138442889|NCT01811381|Analgesics|analgesics|mesh-ancestor
138442890|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
138442891|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442892|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442893|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138442894|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138442895|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442896|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442897|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442898|NCT01811459|Haloperidol|haloperidol|mesh-list
138442899|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138442900|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
138442901|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
138442902|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138442903|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138442904|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138442905|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138411696|NCT01629251|Insulin|insulin|mesh-list
138442906|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442908|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
138442909|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138442910|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138442911|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138442912|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
138442913|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138442914|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442915|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138442917|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138442918|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442919|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138243749|NCT01626092|Cyclosporins|cyclosporins|mesh-list
138442920|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442921|NCT01811667|Sirolimus|sirolimus|mesh-list
138442922|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138442923|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138442924|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138442925|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442926|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
138442927|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138442928|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
138442929|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442930|NCT01811810|Androgens|androgens|mesh-list
138442931|NCT01811810|Hormones|hormones|mesh-ancestor
138453596|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138442932|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138442933|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442935|NCT01811836|Trace Elements|trace elements|mesh-ancestor
138442936|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
138442937|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442938|NCT01811849|Insulin|insulin|mesh-list
138442939|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138442940|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
138442941|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138442942|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442943|NCT01812018|Gemcitabine|gemcitabine|mesh-list
138442944|NCT01812018|Docetaxel|docetaxel|mesh-list
138442945|NCT01812018|Endostar protein|endostar protein|mesh-list
138442946|NCT01812018|Endostatins|endostatins|mesh-list
138442947|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138243803|NCT01921751|Paclitaxel|paclitaxel|mesh-list
138442948|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
138442949|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442950|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442951|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
138442952|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
138442953|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
138442954|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138341126|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
138442955|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138442956|NCT01812018|Growth Substances|growth substances|mesh-ancestor
138442957|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442958|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
138442960|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138442962|NCT01812122|Vildagliptin|vildagliptin|mesh-list
138442963|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138442964|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138442965|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442966|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138442967|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
138442968|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138442969|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
138442970|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442971|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442972|NCT01812135|Vaccines|vaccines|mesh-list
138442973|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
138442974|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383676|NCT05558124|Cytarabine|cytarabine|mesh-list
138442975|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
138442976|NCT01812200|Dabigatran|dabigatran|mesh-list
138442977|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
138442978|NCT01812200|Ticagrelor|ticagrelor|mesh-list
138442979|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138442980|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
138442981|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138442982|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
138442983|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138442984|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442985|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
138442986|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138199313|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138215212|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138442987|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138442988|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138442989|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138442990|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
138442991|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138442992|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442993|NCT01812239|Progesterone|progesterone|mesh-list
138442994|NCT01812239|Progestins|progestins|mesh-list
138442995|NCT01812239|Hormones|hormones|mesh-ancestor
138442996|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138442997|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138442998|NCT01812330|Clopidogrel|clopidogrel|mesh-list
138442999|NCT01812330|Ticagrelor|ticagrelor|mesh-list
138443001|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138443002|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138443003|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138443004|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
138443005|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443006|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443007|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443008|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
138443009|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138443010|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
138443011|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
138443012|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138383713|NCT05487196|Anesthetics|anesthetics|mesh-ancestor
138443013|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443014|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138443016|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
138443017|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443018|NCT01812369|Gemcitabine|gemcitabine|mesh-list
138443019|NCT01812369|Doxorubicin|doxorubicin|mesh-list
138443020|NCT01812369|Vinblastine|vinblastine|mesh-list
138443021|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138443022|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
138443023|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401988|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
138443024|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443025|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138443026|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138443027|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138443028|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443029|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138443030|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
138443031|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
138443032|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
138443033|NCT01812382|Retapamulin|retapamulin|mesh-list
138443034|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138443035|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443036|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
138443037|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
138443038|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138443039|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138443040|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443041|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443042|NCT01812434|Urological Agents|urological agents|mesh-ancestor
138443043|NCT01812538|Diclofenac|diclofenac|mesh-list
138443044|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138443045|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138443046|NCT01812538|Analgesics|analgesics|mesh-ancestor
138443047|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
138341171|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138443048|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443049|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443050|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138411849|NCT01630226|Cisplatin|cisplatin|mesh-list
138443052|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138443053|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443054|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443055|NCT01812551|Alendronate|alendronate|mesh-list
138443056|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138443057|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215213|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138443058|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
138443059|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138443060|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138443061|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
138443062|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443063|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443064|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443065|NCT01812720|Dexamethasone|dexamethasone|mesh-list
138443066|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138443067|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
138443068|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
138443069|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443070|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443071|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138443073|NCT01812720|Hormones|hormones|mesh-ancestor
138443074|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443075|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138443076|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443077|NCT01812889|TOL-463|tol-463|mesh-list
138443078|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443079|NCT01812928|Diclofenac|diclofenac|mesh-list
138443080|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138443081|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138443082|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138443083|NCT01812928|Analgesics|analgesics|mesh-ancestor
138443084|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
138443085|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443086|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443087|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138443088|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138443089|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443090|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443091|NCT01812954|Cyclosporine|cyclosporine|mesh-list
138443092|NCT01812954|Adalimumab|adalimumab|mesh-list
138443093|NCT01812954|Infliximab|infliximab|mesh-list
138443094|NCT01812954|Etanercept|etanercept|mesh-list
138443095|NCT01812954|Methotrexate|methotrexate|mesh-list
138443096|NCT01812954|Ustekinumab|ustekinumab|mesh-list
138443098|NCT01812954|Cyclosporins|cyclosporins|mesh-list
138443099|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138443100|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
138443101|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138443102|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443103|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138443105|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443106|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443107|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
138443108|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443109|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138443110|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138443111|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
138443112|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138443113|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138443114|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
138443115|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443116|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138443117|NCT01812954|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138443118|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138443119|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138443120|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138443121|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138199317|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
138199327|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
138443122|NCT01812954|Analgesics|analgesics|mesh-ancestor
138443123|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
138443124|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443125|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
138443126|NCT01812967|Caseins|caseins|mesh-list
138443127|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
138443128|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
138244075|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443129|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443131|NCT01813162|Metronidazole|metronidazole|mesh-list
138443132|NCT01813162|Terconazole|terconazole|mesh-list
138443133|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
138443134|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
138443135|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138411909|NCT01630655|Felodipine|felodipine|mesh-list
138443136|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138443137|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138443138|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443139|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443140|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138443141|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138443142|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138443143|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138443144|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138443145|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138443146|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443147|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
138443148|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
138443149|NCT01813201|Testosterone|testosterone|mesh-list
138443150|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
138443151|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
138443152|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138443153|NCT01813201|Androgens|androgens|mesh-ancestor
138443154|NCT01813201|Hormones|hormones|mesh-ancestor
138443155|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443156|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443157|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138443158|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443159|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
138443160|NCT01813240|Minocycline|minocycline|mesh-list
138443161|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138443162|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443163|NCT01813253|Irinotecan|irinotecan|mesh-list
138443164|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
138443165|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138443166|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138443167|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443168|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443169|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443170|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138443172|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138443173|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
138443174|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138443175|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443176|NCT01813461|Isavuconazole|isavuconazole|mesh-list
138443177|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
138443178|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443179|NCT01813487|Entecavir|entecavir|mesh-list
138443180|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
138443181|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443182|NCT01813513|Simeprevir|simeprevir|mesh-list
138443183|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
138443184|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443185|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
138443186|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443187|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443188|NCT01813552|Ritonavir|ritonavir|mesh-list
138443189|NCT01813552|Omeprazole|omeprazole|mesh-list
138443190|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138443191|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138443192|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
138443193|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443194|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443195|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138443196|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138443197|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
138443198|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443199|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138443200|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138443201|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138443202|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138443203|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138443204|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
138443205|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138443207|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443209|NCT01813565|Protective Agents|protective agents|mesh-ancestor
138443210|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138443211|NCT01813591|Hormones|hormones|mesh-ancestor
138443212|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443213|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443214|NCT01813604|Vaccines|vaccines|mesh-list
138443215|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
138443216|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443217|NCT01813617|Prednisone|prednisone|mesh-list
138443218|NCT01813617|Methotrexate|methotrexate|mesh-list
138443219|NCT01813617|Azathioprine|azathioprine|mesh-list
138443220|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138443221|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138443222|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
138443223|NCT01813617|Hormones|hormones|mesh-ancestor
138443224|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443225|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443226|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138443227|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443228|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138443229|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
138443230|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138244195|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138244202|NCT01635062|Vitamins|vitamins|mesh-ancestor
138443231|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138443232|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
138443233|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443234|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
138443235|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443236|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138443237|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
138443238|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138443239|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138443241|NCT01813643|Aripiprazole|aripiprazole|mesh-list
138443242|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138443243|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
138443244|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443245|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443246|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443247|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138443248|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138384079|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
138443249|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138443250|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138443251|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138244249|NCT02287415|Warfarin|warfarin|mesh-list
138443252|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
138443253|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
138199331|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138199332|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138443254|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
138443255|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138199333|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199335|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
138443256|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138443257|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138443258|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138443259|NCT01813656|Aripiprazole|aripiprazole|mesh-list
138443260|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
138443261|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138443262|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138443263|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138443264|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138244299|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138244312|NCT02978157|Antacids|antacids|mesh-ancestor
138443265|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443266|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
138443267|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
138443268|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443269|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443270|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138341318|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
138443271|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138443272|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
138443273|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138443274|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138443275|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138443276|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138443277|NCT01813773|Aflibercept|aflibercept|mesh-list
138443278|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138443279|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138443280|NCT01813773|Growth Substances|growth substances|mesh-ancestor
138443281|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443282|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
138443283|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443284|NCT01813812|Rebamipide|rebamipide|mesh-list
138443285|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138443286|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138443287|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
138443288|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443289|NCT01813812|Protective Agents|protective agents|mesh-ancestor
138443290|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443291|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443292|NCT01813955|Papaverine|papaverine|mesh-list
138443293|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138443294|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443295|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443296|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
138443297|NCT01813955|Urological Agents|urological agents|mesh-ancestor
138443298|NCT01813981|Caffeine|caffeine|mesh-list
138443299|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138412127|NCT01631838|Tocopherols|tocopherols|mesh-list
138443300|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443301|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138443302|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443303|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443304|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138443305|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138443306|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
138443307|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443308|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
138443309|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138443310|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138443311|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
138443312|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443313|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443314|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138443316|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138443317|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443318|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138443319|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443320|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
138443321|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138199343|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
138443322|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
138443323|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443325|NCT01814085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138443326|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138443327|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138443328|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412167|NCT01632371|Paclitaxel|paclitaxel|mesh-list
138443329|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443330|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
138443331|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443332|NCT01814098|Escitalopram|escitalopram|mesh-list
138443333|NCT01814098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138443334|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138443335|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138443336|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443337|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443338|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
138443339|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443340|NCT01814163|Paclitaxel|paclitaxel|mesh-list
138443341|NCT01814163|Bevacizumab|bevacizumab|mesh-list
138443342|NCT01814163|Carboplatin|carboplatin|mesh-list
138443343|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138443344|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443345|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
138341378|NCT01508949|Liraglutide|liraglutide|mesh-list
138443346|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
138443347|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
138443348|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443349|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138443350|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138443351|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138443352|NCT01814163|Growth Substances|growth substances|mesh-ancestor
138443353|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443354|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
138443355|NCT01814189|Promethazine|promethazine|mesh-list
138443356|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
138443357|NCT01814189|Sumatriptan|sumatriptan|mesh-list
138443358|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138443359|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138443360|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138443361|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
138443362|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443363|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443364|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443365|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
138443366|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
138199347|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138199348|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443367|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138443368|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
138443369|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
138199349|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
138199350|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
138199351|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199352|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138443370|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138443371|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138443372|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138443373|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138443374|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
138443375|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
138443376|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
138443377|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443378|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
138443379|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
138443380|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138443381|NCT01814319|Probenecid|probenecid|mesh-list
138443382|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
138341437|NCT00653068|Thiotepa|thiotepa|mesh-list
138443384|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138443385|NCT01814410|Ethanol|ethanol|mesh-list
138443386|NCT01814410|Nicotine|nicotine|mesh-list
138443387|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138443388|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
138443389|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443390|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443391|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138443392|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138443393|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
138244556|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
138443394|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443395|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443396|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138443398|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138443399|NCT01814423|Chloroquine|chloroquine|mesh-list
138384226|NCT04591405|Vaccines|vaccines|mesh-list
138443400|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138443401|NCT01814423|Amebicides|amebicides|mesh-ancestor
138443402|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138443403|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138443404|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443405|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
138443406|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138443407|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138443408|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138443409|NCT01814423|Analgesics|analgesics|mesh-ancestor
138443410|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
138443411|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443412|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443413|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138443414|NCT01814423|Filaricides|filaricides|mesh-ancestor
138443415|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
138443416|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
138443417|NCT01814449|Letrozole|letrozole|mesh-list
138443418|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443419|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138443420|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138443421|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443422|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443424|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
138443425|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443426|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443427|NCT01814475|Vidarabine|vidarabine|mesh-list
138443428|NCT01814475|Fludarabine|fludarabine|mesh-list
138443429|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
138443430|NCT01814475|Busulfan|busulfan|mesh-list
138443431|NCT01814475|Thiotepa|thiotepa|mesh-list
138443432|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443433|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138443434|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
138443435|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443436|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138443437|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
138443438|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443439|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
138244602|NCT05738681|Expectorants|expectorants|mesh-ancestor
138443440|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443441|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
138443442|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138443443|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138443444|NCT01814501|Leucovorin|leucovorin|mesh-list
138443445|NCT01814501|Fluorouracil|fluorouracil|mesh-list
138443446|NCT01814501|Irinotecan|irinotecan|mesh-list
138443447|NCT01814501|Panitumumab|panitumumab|mesh-list
138443448|NCT01814501|Calcium|calcium|mesh-list
138443449|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
138443450|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138443451|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443452|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
138443453|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443454|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138443455|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443456|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138443457|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
138443458|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138443459|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138443460|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443461|NCT01814501|Antidotes|antidotes|mesh-ancestor
138443462|NCT01814501|Protective Agents|protective agents|mesh-ancestor
138443463|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
138443465|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
138443466|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138443468|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138443469|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138402442|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
138443470|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
138443471|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443472|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443473|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443474|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138443475|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138443476|NCT01814618|Budesonide|budesonide|mesh-list
138443477|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138443478|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138443479|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
138443480|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443481|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443482|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138443483|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
138443484|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
138443485|NCT01814618|Hormones|hormones|mesh-ancestor
138443486|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443487|NCT01814683|Primaquine|primaquine|mesh-list
138443488|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
138443489|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138443490|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138443491|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443492|NCT01814709|Itraconazole|itraconazole|mesh-list
138443493|NCT01814709|Rifampin|rifampin|mesh-list
138443494|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
138443495|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443496|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138443497|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138443498|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443499|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443500|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138443501|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
138443502|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443503|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138341543|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
138443504|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138443505|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138443506|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
138443507|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138443508|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
138443509|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138443510|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138443511|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138443512|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138443513|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138443514|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138443515|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138384397|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384398|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
138384399|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384400|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
138384413|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138244717|NCT04997525|Estradiol|estradiol|mesh-list
138384414|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
138384415|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138384416|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138384417|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
138443516|NCT01814826|Azacitidine|azacitidine|mesh-list
138443517|NCT01814826|Pevonedistat|pevonedistat|mesh-list
138443518|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138443519|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
138443520|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443521|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443522|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443523|NCT01814865|Prednisone|prednisone|mesh-list
138443524|NCT01814865|Anastrozole|anastrozole|mesh-list
138443525|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
138443526|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138443527|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138443528|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
138443529|NCT01814865|Hormones|hormones|mesh-ancestor
138443530|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443531|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443532|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138443533|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443534|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138443535|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443536|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443537|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138443538|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
138341581|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443539|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138443541|NCT01814891|Vitamins|vitamins|mesh-ancestor
138443542|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
138443543|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443544|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
138443545|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138443546|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
138443547|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138443548|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443550|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
138443551|NCT01815021|Calcium|calcium|mesh-list
138453597|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138443552|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138443553|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443554|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138443555|NCT01815021|Antacids|antacids|mesh-ancestor
138443556|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443557|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138443558|NCT01815047|Vitamin D|vitamin d|mesh-list
138443559|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
138443560|NCT01815047|Vitamins|vitamins|mesh-ancestor
138443561|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
138443562|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443563|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138443564|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138199373|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
138443565|NCT01815073|Vaccines|vaccines|mesh-list
138199374|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199375|NCT01243567|Timolol|timolol|mesh-list
138443566|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
138443567|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443568|NCT01815125|Ondansetron|ondansetron|mesh-list
138244815|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
138443570|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
138443571|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443572|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443573|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138443574|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
138443575|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
138443576|NCT01815125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138384502|NCT03765918|Cisplatin|cisplatin|mesh-list
138443577|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138443578|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
138443579|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443580|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443582|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138443583|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443584|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138443585|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443586|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443587|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138443588|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138443589|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
138443590|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443591|NCT01815255|Tenofovir|tenofovir|mesh-list
138443592|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
138443593|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443594|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138443595|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138443596|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443597|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443598|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138443599|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138443600|NCT01815268|Vaccines|vaccines|mesh-list
138443601|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
138443602|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443603|NCT01815294|Doxorubicin|doxorubicin|mesh-list
138443604|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138443605|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138443606|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443607|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138443608|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138443609|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443610|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443611|NCT01815307|Gemcitabine|gemcitabine|mesh-list
138443612|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138443613|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
138443614|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443615|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443616|NCT01815437|Vitamin D|vitamin d|mesh-list
138443617|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
138443618|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
138402580|NCT03153111|Macitentan|macitentan|mesh-list
138443619|NCT01815437|Vitamins|vitamins|mesh-list
138443620|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
138412557|NCT01635296|Cytarabine|cytarabine|mesh-list
138443621|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443622|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138443623|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138443624|NCT01815528|Catumaxomab|catumaxomab|mesh-list
138443625|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138443626|NCT01815541|Teicoplanin|teicoplanin|mesh-list
138443627|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138244942|NCT03000309|Apremilast|apremilast|mesh-list
138443628|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443629|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
138443630|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138443631|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443632|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138443633|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
138443634|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138443635|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
138443636|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443637|NCT01815892|Furosemide|furosemide|mesh-list
138443638|NCT01815892|Diuretics|diuretics|mesh-ancestor
138443639|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
138443640|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443641|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138443642|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138443643|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443644|NCT01815944|Ropivacaine|ropivacaine|mesh-list
138443645|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
138443646|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
138443647|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138443648|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443649|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
138443650|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443651|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138443652|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443653|NCT01816035|Trastuzumab|trastuzumab|mesh-list
138443654|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
138443655|NCT01816035|Maytansine|maytansine|mesh-list
138443656|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
138443657|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138443658|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443659|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138443660|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
138443661|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
138443662|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
138443663|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443664|NCT01816035|Immunotoxins|immunotoxins|mesh-ancestor
138443665|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
138443666|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443668|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138244997|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138443669|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138443670|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138443671|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443672|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138443673|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443674|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
138443675|NCT01816321|Ganirelix|ganirelix|mesh-list
138443676|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
138443677|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443678|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443679|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
138443680|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138443681|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138443682|NCT01816334|Prednisolone|prednisolone|mesh-list
138199388|NCT01001195|Bimatoprost|bimatoprost|mesh-list
138199389|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138443683|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
138443684|NCT01816334|Ketoprofen|ketoprofen|mesh-list
138199390|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138199392|NCT00381472|Ropinirole|ropinirole|mesh-list
138443685|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138245050|NCT03325647|Testosterone|testosterone|mesh-list
138443686|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
138443687|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138384690|NCT03357757|Avelumab|avelumab|mesh-list
138443689|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
138443690|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443691|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443692|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138443693|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
138443694|NCT01816334|Hormones|hormones|mesh-ancestor
138443695|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443696|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138443697|NCT01816334|Protective Agents|protective agents|mesh-ancestor
138443698|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138443699|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443700|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138443701|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138443702|NCT01816334|Analgesics|analgesics|mesh-ancestor
138443703|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
138443704|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138443705|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138443706|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443707|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443708|NCT01816412|Paclitaxel|paclitaxel|mesh-list
138443709|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138443710|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443711|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
138443712|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
138443713|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
138443714|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443715|NCT01816490|Silybin|silybin|mesh-list
138443716|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138443717|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443718|NCT01816490|Protective Agents|protective agents|mesh-ancestor
138443719|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443720|NCT01816529|Diltiazem|diltiazem|mesh-list
138443721|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138443722|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138443723|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138443724|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443725|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138384773|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443726|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443727|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
138443729|NCT01816555|Vitamins|vitamins|mesh-ancestor
138443730|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
138443731|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443732|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138443733|NCT01816581|Morphine|morphine|mesh-list
138443734|NCT01816581|Naloxone|naloxone|mesh-list
138199413|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138199414|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
138199415|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138443735|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138443736|NCT01816581|Narcotics|narcotics|mesh-ancestor
138199416|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
138199417|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199418|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199420|NCT00002266|Protective Agents|protective agents|mesh-ancestor
138443737|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138443738|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443739|NCT01816581|Analgesics|analgesics|mesh-ancestor
138443740|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
138443741|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443742|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138443744|NCT01816620|Lenalidomide|lenalidomide|mesh-list
138443745|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138443746|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
138443747|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
138443748|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443749|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443750|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138443751|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
138443752|NCT01816620|Hormones|hormones|mesh-ancestor
138443753|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443754|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138443755|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443756|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
138443757|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138443758|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138443759|NCT01816620|Growth Substances|growth substances|mesh-ancestor
138443760|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
138443761|NCT01816646|Cidofovir|cidofovir|mesh-list
138443762|NCT01816646|Probenecid|probenecid|mesh-list
138443763|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
138443764|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
138443765|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138443766|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
138443767|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443768|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443769|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443770|NCT01816659|Metformin|metformin|mesh-list
138443771|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138443772|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443773|NCT01816789|Buserelin|buserelin|mesh-list
138443774|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138443775|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
138443776|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138443777|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443778|NCT01816958|Ketamine|ketamine|mesh-list
138443779|NCT01816958|Analgesics|analgesics|mesh-ancestor
138443780|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
138443781|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443782|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443783|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138443784|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138443785|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
138443786|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
138443787|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138443788|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138443789|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138443790|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443791|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443793|NCT01816997|Pravastatin|pravastatin|mesh-list
138443794|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138385034|NCT02248597|Busulfan|busulfan|mesh-list
138443795|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138443796|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
138199428|NCT05751304|Ketamine|ketamine|mesh-list
138199429|NCT05751304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138443797|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199430|NCT05751304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138443798|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138443799|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138245236|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138443800|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443801|NCT01817023|Cisplatin|cisplatin|mesh-list
138443802|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443803|NCT01817036|Vitamin D|vitamin d|mesh-list
138443804|NCT01817036|Vitamins|vitamins|mesh-ancestor
138443805|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
138443806|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443807|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138443808|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
138385074|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
138443809|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138443810|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138443811|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138443812|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138443813|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
138443814|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138443816|NCT01817257|Enoxaparin|enoxaparin|mesh-list
138443817|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138443818|NCT01817257|Tinzaparin|tinzaparin|mesh-list
138443819|NCT01817257|Dalteparin|dalteparin|mesh-list
138443820|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
138443821|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138443822|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138443823|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443824|NCT01817283|Triptolide|triptolide|mesh-list
138443825|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138443826|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443827|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138443828|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
138443829|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138443830|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138443831|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
138443832|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138443833|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
138443834|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443835|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443836|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
138443837|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
138443838|NCT01817322|Prednisolone|prednisolone|mesh-list
138443839|NCT01817322|Deflazacort|deflazacort|mesh-list
138443840|NCT01817322|Basiliximab|basiliximab|mesh-list
138443841|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138443842|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
138443843|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
138443844|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443845|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443846|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138443847|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
138443848|NCT01817322|Hormones|hormones|mesh-ancestor
138443849|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443850|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138443851|NCT01817322|Protective Agents|protective agents|mesh-ancestor
138443852|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138245332|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
138443853|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443854|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138443855|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138443856|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
138443857|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138443858|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443859|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138341774|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138443860|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443862|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
138443863|NCT01817348|Lidocaine|lidocaine|mesh-list
138443864|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
138443865|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
138443866|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138443867|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443868|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
138385413|NCT01469520|Zidovudine|zidovudine|mesh-list
138443869|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443870|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138443871|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138443873|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138443874|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443875|NCT01817400|Aspirin|aspirin|mesh-list
138443876|NCT01817400|Pioglitazone|pioglitazone|mesh-list
138443877|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
138443878|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138443879|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138443880|NCT01817400|Analgesics|analgesics|mesh-ancestor
138443881|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
138443882|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443883|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138385444|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
138443884|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138443885|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138443886|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138443887|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138443888|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443889|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138443890|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138443891|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443892|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
138443893|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138443894|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138443895|NCT01817439|Amiodarone|amiodarone|mesh-list
138443896|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138443897|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
138245428|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
138245432|NCT03224403|Acetaminophen|acetaminophen|mesh-list
138443898|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138443899|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138443900|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443901|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138443902|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138443903|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138443905|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138443906|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138443907|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138443908|NCT01817699|Vitamin D|vitamin d|mesh-list
138443909|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
138443910|NCT01817699|Vitamins|vitamins|mesh-ancestor
138443911|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
138443912|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443913|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138443914|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138443915|NCT01817803|Metolazone|metolazone|mesh-list
138443916|NCT01817803|Furosemide|furosemide|mesh-list
138443917|NCT01817803|Spironolactone|spironolactone|mesh-list
138443918|NCT01817803|Diuretics|diuretics|mesh-ancestor
138443919|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
138443920|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443921|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138443922|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138245473|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
138199445|NCT05751304|Anesthetics|anesthetics|mesh-ancestor
138245474|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245482|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
138443923|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443924|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138443925|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
138443926|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443927|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138443928|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138443929|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138443930|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138443931|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138443932|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138443933|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443934|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443935|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138443936|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138443937|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443938|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
138443939|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443940|NCT01817829|Acetaminophen|acetaminophen|mesh-list
138443941|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138443942|NCT01817829|Analgesics|analgesics|mesh-ancestor
138443943|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
138443944|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138443945|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443946|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
138443947|NCT01817868|Factor VIII|factor viii|mesh-list
138443948|NCT01817868|Coagulants|coagulants|mesh-ancestor
138443949|NCT01817894|Eflornithine|eflornithine|mesh-list
138443950|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443951|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138443952|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138245520|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
138245521|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138245522|NCT01769027|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138245523|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138245524|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138443954|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443955|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
138443956|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443957|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443958|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
138443959|NCT01817972|Azathioprine|azathioprine|mesh-list
138443961|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443962|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138443963|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443964|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138443965|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
138443966|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443967|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138443968|NCT01817972|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138443969|NCT01817972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138443970|NCT01817985|Velpatasvir|velpatasvir|mesh-list
138443971|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
138443972|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443973|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138443974|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
138443975|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199461|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
138199462|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
138199463|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138443977|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138443978|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199464|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138199468|NCT01002755|Lenalidomide|lenalidomide|mesh-list
138443979|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138443980|NCT01818648|Incretins|incretins|mesh-ancestor
138443981|NCT01818648|Hormones|hormones|mesh-ancestor
138443982|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138443983|NCT01818713|Doxorubicin|doxorubicin|mesh-list
138443984|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138443985|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138443986|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138443987|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138443988|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138443989|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138443990|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443991|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
138443992|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
138443993|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138443994|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
138443995|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138443996|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138443998|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138443999|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138385772|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
138444000|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138444001|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
138444002|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444003|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444004|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138444005|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138444006|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
138444007|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444008|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138444009|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138444011|NCT01818869|Analgesics|analgesics|mesh-ancestor
138444012|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
138444013|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444014|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444015|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138444016|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
138245605|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444017|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138413060|NCT01637545|Ramosetron|ramosetron|mesh-list
138444018|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
138444019|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
138444020|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444021|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444022|NCT01818908|Prednisone|prednisone|mesh-list
138444023|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
138444024|NCT01818908|Doxorubicin|doxorubicin|mesh-list
138444025|NCT01818908|Etoposide|etoposide|mesh-list
138444026|NCT01818908|Vincristine|vincristine|mesh-list
138444027|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138444028|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
138444029|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444030|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138444031|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138444032|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
138444033|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444034|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444035|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138444036|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138444037|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138444038|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138444039|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444040|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138444041|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
138444042|NCT01818908|Hormones|hormones|mesh-ancestor
138444043|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138444044|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138444045|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138444046|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
138444047|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
138444048|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
138444049|NCT01818973|Bevacizumab|bevacizumab|mesh-list
138444050|NCT01818973|Capecitabine|capecitabine|mesh-list
138444051|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
138444052|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138199469|NCT01002755|Ofatumumab|ofatumumab|mesh-list
138199471|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
138199472|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199473|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138199474|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138199475|NCT01002755|Growth Substances|growth substances|mesh-ancestor
138199476|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
138199477|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199478|NCT00002434|Leucovorin|leucovorin|mesh-list
138444053|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444054|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138444055|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138444056|NCT01818973|Growth Substances|growth substances|mesh-ancestor
138245701|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
138444058|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
138444059|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138444060|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
138444061|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444062|NCT01819012|Isoflurane|isoflurane|mesh-list
138444063|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138444064|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
138444065|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
138444066|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138444067|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444068|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
138199479|NCT00002434|Trimetrexate|trimetrexate|mesh-list
138199480|NCT00002434|Calcium|calcium|mesh-list
138199481|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
138199482|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138444069|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138444070|NCT01819155|Vaccines|vaccines|mesh-list
138444071|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
138444072|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444074|NCT01819220|Valsartan|valsartan|mesh-list
138444075|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138444076|NCT01819220|Telmisartan|telmisartan|mesh-list
138444077|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
138444078|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
138444079|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138444080|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138444081|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444082|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444083|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138386138|NCT01474460|Vitamins|vitamins|mesh-ancestor
138444084|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444085|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
138444086|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138444087|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138444088|NCT01819220|Diuretics|diuretics|mesh-ancestor
138444089|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
138444090|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138444091|NCT01819259|Nicotine|nicotine|mesh-list
138444092|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138444093|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
138444094|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444095|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444096|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138444097|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138444098|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
138444099|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453598|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138444100|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444101|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138444103|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138444104|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444105|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
138444106|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444107|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138444108|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444109|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444111|NCT01819402|Glimepiride|glimepiride|mesh-list
138444112|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138444113|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444114|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138444115|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138444116|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
138444117|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138444118|NCT01819441|Perindopril|perindopril|mesh-list
138453599|NCT01886196|Analgesics|analgesics|mesh-ancestor
138444119|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138444120|NCT01819441|Diuretics|diuretics|mesh-ancestor
138444121|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
138444122|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444123|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138245794|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444124|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444125|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444126|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138444127|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
138444128|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444130|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138444131|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138444132|NCT01819610|Analgesics|analgesics|mesh-ancestor
138444133|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
138444134|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138342015|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
138444135|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444136|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138199520|NCT00002440|Saquinavir|saquinavir|mesh-list
138199524|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138199525|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
138199526|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199527|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199528|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138444137|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138199529|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138199530|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
138199531|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199532|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138386318|NCT01476007|Hematinics|hematinics|mesh-ancestor
138444138|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138444139|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444140|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444142|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
138444143|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444144|NCT01819649|Protective Agents|protective agents|mesh-ancestor
138444145|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444146|NCT01819649|Trace Elements|trace elements|mesh-ancestor
138444147|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
138444148|NCT01819701|Ubiquinone|ubiquinone|mesh-list
138444150|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
138444151|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444152|NCT01819701|Vitamins|vitamins|mesh-ancestor
138444153|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138199533|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138444154|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138444155|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444156|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138188514|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138444157|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444158|NCT01819779|Amlodipine|amlodipine|mesh-list
138245837|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444159|NCT01819779|Valsartan|valsartan|mesh-list
138444160|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
138199534|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138199541|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
138386374|NCT01476358|Protective Agents|protective agents|mesh-ancestor
138444161|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138444162|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138444163|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444164|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444165|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138444166|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444167|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
138199561|NCT01243957|Fluoxetine|fluoxetine|mesh-list
138199562|NCT01243957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138444168|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138444169|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138444170|NCT01819857|Ondansetron|ondansetron|mesh-list
138444171|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
138444172|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
138444173|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444174|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444175|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138444176|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
138444177|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
138444178|NCT01819857|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138444179|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138444180|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
138444181|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444182|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444183|NCT01819870|Carvedilol|carvedilol|mesh-list
138444184|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138444185|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138444186|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
138444187|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444188|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444189|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444190|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138444193|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138444194|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444195|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138413257|NCT01638299|Insulin|insulin|mesh-list
138444197|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138444198|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138444199|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138444200|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138444201|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138444202|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138444204|NCT01820026|Azithromycin|azithromycin|mesh-list
138444205|NCT01820026|Vancomycin|vancomycin|mesh-list
138444206|NCT01820026|Imipenem|imipenem|mesh-list
138444207|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138444208|NCT01820026|Cefotaxime|cefotaxime|mesh-list
138444209|NCT01820026|Cefoxitin|cefoxitin|mesh-list
138444210|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138444211|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444212|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138444213|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444214|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444215|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
138444216|NCT01820091|Antidotes|antidotes|mesh-ancestor
138444217|NCT01820091|Protective Agents|protective agents|mesh-ancestor
138444218|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444219|NCT01820104|Lansoprazole|lansoprazole|mesh-list
138444220|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
138444221|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138188606|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
138444222|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138444223|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138444224|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444225|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444226|NCT01820143|Esomeprazole|esomeprazole|mesh-list
138444227|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138444228|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138444229|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138444230|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444231|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444232|NCT01820299|Vitamin D|vitamin d|mesh-list
138444233|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
138444235|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
138444236|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444237|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138386729|NCT01478308|Docetaxel|docetaxel|mesh-list
138444238|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138444239|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199625|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444240|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
138444241|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444242|NCT01820299|Protective Agents|protective agents|mesh-ancestor
138444243|NCT01820312|Paclitaxel|paclitaxel|mesh-list
138444244|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138444245|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444246|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
138444247|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
138444248|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
138245891|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138245892|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
138245893|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245894|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
138245895|NCT03245463|Protective Agents|protective agents|mesh-ancestor
138245896|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
138444249|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444251|NCT01820325|Carboplatin|carboplatin|mesh-list
138444252|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138444253|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444254|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
138444255|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
138188648|NCT00362583|Fentanyl|fentanyl|mesh-list
138444256|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
138444257|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444260|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138444261|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138444262|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444263|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
138444264|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444265|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138444266|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138444267|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138444268|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
138444269|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444270|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444271|NCT01820442|Analgesics|analgesics|mesh-ancestor
138444272|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
138444273|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
138444274|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
138444275|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138444276|NCT01820455|Mupirocin|mupirocin|mesh-list
138444277|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138444278|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444279|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
138444280|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
138444281|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138444282|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138444283|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413318|NCT01638689|Escitalopram|escitalopram|mesh-list
138444284|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444285|NCT01820624|Tretinoin|tretinoin|mesh-list
138444286|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
138444287|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
138444288|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138444289|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444290|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444291|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
138444292|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138444293|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138444294|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444295|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444297|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
138444299|NCT01820767|Atorvastatin|atorvastatin|mesh-list
138199630|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
138199631|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138199633|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138444300|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138444301|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138444302|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
138444303|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444304|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138444305|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138444306|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444307|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138444308|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444309|NCT01820767|Vitamins|vitamins|mesh-ancestor
138444310|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
138444311|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138444312|NCT01820793|Cefoxitin|cefoxitin|mesh-list
138444313|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138444314|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444315|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
138444316|NCT01820832|Calcitriol|calcitriol|mesh-list
138444317|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138386960|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
138444318|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444320|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
138444321|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138444322|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138444323|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444324|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444325|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138444326|NCT01820897|Trimethoprim|trimethoprim|mesh-list
138444327|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138444328|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
138444329|NCT01820897|Fosfomycin|fosfomycin|mesh-list
138444330|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138245951|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444331|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444332|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
138444333|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138444334|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138444335|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138444336|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387011|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
138444337|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444338|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138444339|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138444340|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138444341|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138444342|NCT01820962|Heparin|heparin|mesh-list
138444343|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
138444344|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444345|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138199640|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444346|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138199642|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138444347|NCT01821001|Bromocriptine|bromocriptine|mesh-list
138444348|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138444349|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138444350|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
138444351|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138444352|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444353|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
138444354|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
138444355|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444356|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444357|NCT01821027|Canagliflozin|canagliflozin|mesh-list
138444358|NCT01821027|Simvastatin|simvastatin|mesh-list
138444359|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138444360|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138444361|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
138444362|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444363|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138444364|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138444365|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444366|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138444367|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138444368|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444369|NCT01821040|Prednisone|prednisone|mesh-list
138444370|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138444372|NCT01821040|Hormones|hormones|mesh-ancestor
138444373|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138444374|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444375|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138444376|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444377|NCT01821066|Tamoxifen|tamoxifen|mesh-list
138444378|NCT01821066|Palbociclib|palbociclib|mesh-list
138444379|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138444380|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
138444381|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138444382|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444383|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138444384|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444385|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138444386|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138444387|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138444388|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138444389|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444390|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444391|NCT01821170|Methylphenidate|methylphenidate|mesh-list
138444392|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138444393|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444394|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138444395|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138444396|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444397|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444398|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
138444399|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444400|NCT01821235|Gabapentin|gabapentin|mesh-list
138444401|NCT01821235|Analgesics|analgesics|mesh-ancestor
138444402|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
138413410|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
138444403|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138387160|NCT01480817|Sorafenib|sorafenib|mesh-list
138444404|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444405|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
138444406|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138444407|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138444408|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138444409|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138444410|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138444411|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138444412|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444413|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444415|NCT01821248|Cisplatin|cisplatin|mesh-list
138444416|NCT01821248|Gemcitabine|gemcitabine|mesh-list
138444417|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444418|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138444419|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
138444420|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444422|NCT01821261|Fluorides|fluorides|mesh-list
138444423|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
138444424|NCT01821261|Protective Agents|protective agents|mesh-ancestor
138444425|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444426|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138444427|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444428|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
138444429|NCT01821274|Diltiazem|diltiazem|mesh-list
138444430|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138444431|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138444432|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444433|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444434|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138444435|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444436|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
138444437|NCT01821404|Atorvastatin|atorvastatin|mesh-list
138444438|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138444439|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138444441|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444442|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138444443|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138444444|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444445|NCT01821430|Pregabalin|pregabalin|mesh-list
138444446|NCT01821430|Analgesics|analgesics|mesh-ancestor
138444447|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
138444448|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444449|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444450|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
138444451|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138444452|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444453|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444454|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138444455|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138444456|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138444457|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138444458|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138444459|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
138444460|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
138444461|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
138444462|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138246047|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138444463|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138444464|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138444465|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444466|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444467|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
138444468|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444469|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444470|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138444471|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444472|NCT01821612|Leucovorin|leucovorin|mesh-list
138444473|NCT01821612|Gemcitabine|gemcitabine|mesh-list
138444474|NCT01821612|Capecitabine|capecitabine|mesh-list
138444475|NCT01821612|Fluorouracil|fluorouracil|mesh-list
138199668|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444476|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
138199669|NCT00002476|Leucovorin|leucovorin|mesh-list
138199670|NCT00002476|Cobalt|cobalt|mesh-list
138444477|NCT01821612|Irinotecan|irinotecan|mesh-list
138199671|NCT00002476|Fluorouracil|fluorouracil|mesh-list
138444478|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138444479|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
138444480|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444481|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444482|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138444483|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
138444484|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444485|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138444486|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138444487|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444488|NCT01821612|Antidotes|antidotes|mesh-ancestor
138444489|NCT01821612|Protective Agents|protective agents|mesh-ancestor
138444490|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
138444491|NCT01821612|Vitamins|vitamins|mesh-ancestor
138444492|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
138444493|NCT01821664|Heparin|heparin|mesh-list
138444494|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
138444495|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138444496|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138444497|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138413549|NCT01640743|Everolimus|everolimus|mesh-list
138444499|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138444500|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
138444501|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138444502|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444503|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138444504|NCT01821703|Diuretics|diuretics|mesh-ancestor
138444505|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
138444506|NCT01821846|Liraglutide|liraglutide|mesh-list
138444507|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138444508|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444509|NCT01821846|Incretins|incretins|mesh-ancestor
138444510|NCT01821846|Hormones|hormones|mesh-ancestor
138444511|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138444512|NCT01821872|Acetaminophen|acetaminophen|mesh-list
138444513|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138444514|NCT01821872|Analgesics|analgesics|mesh-ancestor
138444515|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
138444516|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444517|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444518|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
138444519|NCT01821989|Lactoferrin|lactoferrin|mesh-list
138444520|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444522|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
138444523|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188843|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
138246120|NCT02013245|Vaccines|vaccines|mesh-list
138444524|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444525|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138413586|NCT01642771|Docetaxel|docetaxel|mesh-list
138444527|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
138444528|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444529|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138444530|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138444531|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444532|NCT01822080|Dienogest|dienogest|mesh-list
138444533|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138444534|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
138444535|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138444536|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444537|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138444538|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138444539|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138444540|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138444541|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
138444542|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138444543|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138444544|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444545|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
138444546|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138444547|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444548|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444549|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
138444550|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444551|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444552|NCT01822405|Tocopherols|tocopherols|mesh-list
138444553|NCT01822405|Vitamin E|vitamin e|mesh-list
138444554|NCT01822405|Tocotrienols|tocotrienols|mesh-list
138444555|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
138444556|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
138444557|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138444558|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444559|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444560|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138444561|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138444562|NCT01822405|Protective Agents|protective agents|mesh-ancestor
138444563|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444564|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
138444565|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138444566|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
138444567|NCT01822405|Vitamins|vitamins|mesh-ancestor
138444568|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
138444569|NCT01822418|Agomelatine|agomelatine|mesh-list
138444570|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138444571|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138444572|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444573|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138444574|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444575|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246204|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
138444576|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444577|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138444578|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
138188865|NCT00375778|Memantine|memantine|mesh-list
138444579|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138444580|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444581|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138444582|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
138444583|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138444584|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444585|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444586|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444587|NCT01822600|Omeprazole|omeprazole|mesh-list
138444588|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138444589|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138444590|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138444591|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444592|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444593|NCT01822613|Paclitaxel|paclitaxel|mesh-list
138444594|NCT01822613|Docetaxel|docetaxel|mesh-list
138444595|NCT01822613|Irinotecan|irinotecan|mesh-list
138444596|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138444598|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
138444599|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
138444600|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
138444601|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444602|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138444603|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138444604|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444605|NCT01822639|Amlodipine|amlodipine|mesh-list
138444606|NCT01822639|Enalapril|enalapril|mesh-list
138444607|NCT01822639|Enalaprilat|enalaprilat|mesh-list
138444608|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138444609|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138444610|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444611|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444612|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138444613|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444614|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
138444615|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444616|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138444617|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
138444618|NCT01822730|Risperidone|risperidone|mesh-list
138444619|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138444620|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138444621|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
138444622|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444623|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444624|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444625|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138387704|NCT01485198|Acetaminophen|acetaminophen|mesh-list
138444626|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138444627|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138444628|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138444629|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138444630|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
138444631|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138444632|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138444633|NCT01822808|Hydralazine|hydralazine|mesh-list
138444634|NCT01822808|Isosorbide|isosorbide|mesh-list
138444635|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138444636|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138444638|NCT01822808|Diuretics|diuretics|mesh-ancestor
138444639|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
138444640|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444641|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
138444642|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138444643|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444644|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138444645|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138444646|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
138444647|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138444648|NCT01822860|Diuretics|diuretics|mesh-ancestor
138444649|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
138444650|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444651|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138444652|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444653|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444654|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
138444656|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138444657|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246351|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
138444658|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444659|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
138444660|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444661|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444662|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
138444663|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138444664|NCT01822951|Protective Agents|protective agents|mesh-ancestor
138444665|NCT01822977|Omeprazole|omeprazole|mesh-list
138444666|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138444667|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138444668|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138444669|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444670|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444671|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
138444672|NCT01823029|Hematinics|hematinics|mesh-ancestor
138444673|NCT01822509|Nivolumab|nivolumab|mesh-list
138444674|NCT01822509|Ipilimumab|ipilimumab|mesh-list
138444675|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138444676|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444677|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138444678|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444679|NCT01823042|Azathioprine|azathioprine|mesh-list
138444680|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
138444681|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444682|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138444683|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444684|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138444686|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444687|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138444688|NCT01823081|Bevacizumab|bevacizumab|mesh-list
138444689|NCT01823081|Fasudil|fasudil|mesh-list
138444690|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138444691|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444692|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138444693|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138444694|NCT01823081|Growth Substances|growth substances|mesh-ancestor
138444695|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444696|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
138444697|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138388004|NCT01486602|Paclitaxel|paclitaxel|mesh-list
138444698|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444699|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444700|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138444701|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
138444702|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138444703|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444704|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138444705|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138444706|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138444707|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
138444708|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444709|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138444710|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138444711|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444713|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
138444714|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444715|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444716|NCT01823172|Methylene Blue|methylene blue|mesh-list
138444717|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444718|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444719|NCT01823185|Clopidogrel|clopidogrel|mesh-list
138444720|NCT01823185|Ticagrelor|ticagrelor|mesh-list
138444721|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138444722|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138444723|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138444724|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138413847|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
138444725|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138388111|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
138444727|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444728|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444729|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444730|NCT01823393|Heparin|heparin|mesh-list
138444731|NCT01823393|Calcium heparin|calcium heparin|mesh-list
138444732|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
138444733|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138444734|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138444735|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138403697|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138444736|NCT01823523|Clindamycin|clindamycin|mesh-list
138444737|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
138444738|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
138444739|NCT01823523|Cefazolin|cefazolin|mesh-list
138444740|NCT01823523|Cephalexin|cephalexin|mesh-list
138444741|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138444742|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444743|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138444744|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246439|NCT01723514|Erenumab|erenumab|mesh-list
138444745|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444746|NCT01823744|Micronutrients|micronutrients|mesh-list
138444747|NCT01823744|Trace Elements|trace elements|mesh-list
138444748|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444749|NCT01823770|Rotigotine|rotigotine|mesh-list
138444750|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
138444751|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
138444752|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444753|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444754|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444755|NCT01823809|Adenosine|adenosine|mesh-list
138444756|NCT01823809|Analgesics|analgesics|mesh-ancestor
138444757|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
138444758|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444759|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444760|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138444761|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
138199693|NCT00002476|Antidotes|antidotes|mesh-ancestor
138444762|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138444763|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
138444764|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
138444765|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444766|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444767|NCT01823965|Ranibizumab|ranibizumab|mesh-list
138388234|NCT01488266|Bupropion|bupropion|mesh-list
138444768|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138444769|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138444770|NCT01823965|Growth Substances|growth substances|mesh-ancestor
138444771|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444772|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
138444773|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444774|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138444775|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138444776|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444777|NCT01824199|Omeprazole|omeprazole|mesh-list
138444778|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138444779|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138444780|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138444781|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444782|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444783|NCT01824225|Aflibercept|aflibercept|mesh-list
138444784|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138444785|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138444786|NCT01824225|Growth Substances|growth substances|mesh-ancestor
138444787|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444789|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444790|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
138444791|NCT01824238|Anacetrapib|anacetrapib|mesh-list
138444792|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138444793|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138444794|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
138444795|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444796|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138444797|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444798|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138444799|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444800|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
138444801|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138444802|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
138444803|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138444804|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
138444805|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444806|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138444807|NCT01824264|Licogliflozin|licogliflozin|mesh-list
138444808|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138444809|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444810|NCT01824264|Incretins|incretins|mesh-ancestor
138444811|NCT01824264|Hormones|hormones|mesh-ancestor
138444812|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138444813|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138444814|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
138444815|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444816|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444817|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138444819|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138444820|NCT01824420|Oxybutynin|oxybutynin|mesh-list
138444821|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138444822|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138444823|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
138444824|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444825|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444826|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444827|NCT01824420|Urological Agents|urological agents|mesh-ancestor
138444828|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
138444829|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
138246499|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
138444830|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444831|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138444832|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138199699|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
138444834|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138444835|NCT01824433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138444836|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138444837|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444838|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444839|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444840|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
138444841|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444842|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138444843|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
138444844|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138444845|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138444846|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138444847|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414015|NCT01651416|Artemether|artemether|mesh-list
138444848|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138444849|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
138444850|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444851|NCT01824524|Hydromorphone|hydromorphone|mesh-list
138444852|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138444853|NCT01824524|Narcotics|narcotics|mesh-ancestor
138444854|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138444855|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444856|NCT01824524|Analgesics|analgesics|mesh-ancestor
138444857|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
138444858|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444859|NCT01824615|Sunitinib|sunitinib|mesh-list
138444860|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444861|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138189004|NCT03041883|Vitamins|vitamins|mesh-ancestor
138444862|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138444863|NCT01824615|Growth Substances|growth substances|mesh-ancestor
138444864|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444865|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
138444866|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138444867|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444868|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444869|NCT01824758|Lidocaine|lidocaine|mesh-list
138444870|NCT01824758|Rocuronium|rocuronium|mesh-list
138444872|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
138444873|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
138444874|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138444875|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444876|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
138444877|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444878|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138444879|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138444880|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138444881|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444882|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444883|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138444884|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138444885|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138444886|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138444887|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138444888|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138444889|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
138444890|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138444891|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
138444892|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138444893|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138199702|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138199704|NCT01876628|Clindamycin|clindamycin|mesh-list
138444894|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138444895|NCT01824992|Interferons|interferons|mesh-list
138388402|NCT01489137|Remifentanil|remifentanil|mesh-list
138444896|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444897|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
138444898|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444899|NCT01825031|Azithromycin|azithromycin|mesh-list
138444900|NCT01825031|Isoniazid|isoniazid|mesh-list
138444901|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
138444902|NCT01825031|Fluconazole|fluconazole|mesh-list
138444903|NCT01825031|Albendazole|albendazole|mesh-list
138444904|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138444905|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138246614|NCT05717933|Hormones|hormones|mesh-list
138444906|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138444907|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138444908|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
138444909|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138444910|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138444911|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444912|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444913|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
138444914|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138444915|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138444916|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138414077|NCT01651923|Heparin|heparin|mesh-list
138444917|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
138444918|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138444919|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444920|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138444921|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138444922|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
138444923|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138444924|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138444925|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
138444926|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138444927|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
138246663|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
138246664|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138444928|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138444929|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
138444930|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138444931|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138444932|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
138444933|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
138444934|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
138444935|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138444936|NCT01825044|Cyclosporine|cyclosporine|mesh-list
138444937|NCT01825044|Cyclosporins|cyclosporins|mesh-list
138444938|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444939|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444940|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138444941|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
138444942|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444943|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
138444944|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444945|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
138444946|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138444947|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138444948|NCT01825083|Ketamine|ketamine|mesh-list
138444949|NCT01825083|Analgesics|analgesics|mesh-ancestor
138444950|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
138444951|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138388592|NCT01489917|Heparin|heparin|mesh-list
138444952|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444953|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138444954|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138444955|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
138444956|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
138444957|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138444958|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138444959|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138444961|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444962|NCT01825109|Vaccines|vaccines|mesh-list
138444963|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
138444964|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444965|NCT01825395|Amifampridine|amifampridine|mesh-list
138444966|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138444967|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444968|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444969|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138444970|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138444971|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444972|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138444973|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444974|NCT01825447|Naltrexone|naltrexone|mesh-list
138444975|NCT01825447|Oxycodone|oxycodone|mesh-list
138444976|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138444977|NCT01825447|Narcotics|narcotics|mesh-ancestor
138388622|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444978|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138246763|NCT01754480|Coagulants|coagulants|mesh-ancestor
138444979|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138444980|NCT01825447|Analgesics|analgesics|mesh-ancestor
138444981|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
138444982|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138444983|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138444984|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138444985|NCT01825473|Erythromycin|erythromycin|mesh-list
138388668|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
138444986|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
138444987|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138444988|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
138444989|NCT01825473|Phenobarbital|phenobarbital|mesh-list
138444990|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138444991|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138444992|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138444993|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138444994|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138444995|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138444996|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
138444997|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138444998|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138444999|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445000|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138445001|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138445002|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445003|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
138445005|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138445006|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138445007|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138445008|NCT01824043|Ranibizumab|ranibizumab|mesh-list
138445009|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138445010|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138445011|NCT01824043|Growth Substances|growth substances|mesh-ancestor
138445012|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138246832|NCT00354653|Lamivudine|lamivudine|mesh-list
138445013|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
138445014|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445015|NCT01825551|Lenograstim|lenograstim|mesh-list
138445016|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138445017|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
138445018|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445019|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
138445020|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138445022|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
138445023|NCT01825616|Vitamins|vitamins|mesh-ancestor
138445024|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
138445025|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445026|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138445027|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138445028|NCT01825720|Insulin|insulin|mesh-list
138445029|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138445030|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445031|NCT01825733|Palonosetron|palonosetron|mesh-list
138445032|NCT01825733|Ramosetron|ramosetron|mesh-list
138445033|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
138445034|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
138445035|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138199715|NCT01004705|Simvastatin|simvastatin|mesh-list
138445036|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445037|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138388857|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
138445038|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138445039|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138445040|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
138445041|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414257|NCT01652417|Hormones|hormones|mesh-ancestor
138445042|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445043|NCT01825850|Irbesartan|irbesartan|mesh-list
138445044|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138445045|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138445046|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138445047|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445048|NCT01825863|Ropivacaine|ropivacaine|mesh-list
138445049|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
138246857|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138445051|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445052|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445053|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
138445054|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445055|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138445056|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138445057|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445058|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138445059|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138445060|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138445061|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445062|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445063|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138445064|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138445065|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138445066|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
138445067|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445068|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445069|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138445070|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138445071|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
138445073|NCT01825993|Bupivacaine|bupivacaine|mesh-list
138445074|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
138445075|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
138445076|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445077|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445078|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
138189193|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
138445079|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445080|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138445081|NCT01825993|Narcotics|narcotics|mesh-ancestor
138445082|NCT01825993|Analgesics|analgesics|mesh-ancestor
138445084|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138445085|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445086|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445087|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138445088|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
138445089|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
138445090|NCT01826175|Clopidogrel|clopidogrel|mesh-list
138445091|NCT01826175|Ticagrelor|ticagrelor|mesh-list
138445092|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138445093|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138445094|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138445095|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138445096|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
138445097|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445098|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445099|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445100|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138445101|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
138445102|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
138445103|NCT01826279|Resveratrol|resveratrol|mesh-list
138445104|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
138445105|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445106|NCT01826279|Protective Agents|protective agents|mesh-ancestor
138445107|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445108|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445109|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138445110|NCT01826396|Irinotecan|irinotecan|mesh-list
138445111|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138389075|NCT01492881|Doxorubicin|doxorubicin|mesh-list
138445112|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138445113|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445114|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445115|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445117|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445118|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138445119|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445120|NCT01826747|Progesterone|progesterone|mesh-list
138445121|NCT01826747|Progestins|progestins|mesh-ancestor
138445122|NCT01826747|Hormones|hormones|mesh-ancestor
138445123|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138445124|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445125|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
138445126|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138189201|NCT00634010|Narcotics|narcotics|mesh-ancestor
138445127|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445128|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
138445129|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445130|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445131|NCT01826864|Sargramostim|sargramostim|mesh-list
138445132|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
138445133|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445134|NCT01826916|Ecallantide|ecallantide|mesh-list
138445135|NCT01826916|Analgesics|analgesics|mesh-ancestor
138445136|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
138445137|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445138|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445139|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138445140|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138445141|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138445142|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138445144|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
138445145|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
138445146|NCT01827020|Lidocaine|lidocaine|mesh-list
138445147|NCT01827020|Ketamine|ketamine|mesh-list
138445148|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
138445149|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
138445150|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445151|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445152|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
138445153|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445154|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138445155|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138445156|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138445157|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138445158|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247104|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138445159|NCT01827020|Analgesics|analgesics|mesh-ancestor
138445160|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138445161|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138445162|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
138445163|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138445164|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138445165|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445167|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138445168|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138445169|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445170|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
138445171|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
138445172|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445174|NCT01827124|Carbetocin|carbetocin|mesh-list
138445175|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
138445176|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138445177|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445178|NCT01827137|Lenalidomide|lenalidomide|mesh-list
138445179|NCT01827137|Molgramostim|molgramostim|mesh-list
138445180|NCT01827137|Sargramostim|sargramostim|mesh-list
138445181|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
138445182|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445183|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138445184|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138445185|NCT01827137|Growth Substances|growth substances|mesh-ancestor
138445186|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
138445187|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445188|NCT01827202|Candesartan|candesartan|mesh-list
138445189|NCT01827202|Candesartan cilexetil|candesartan cilexetil|mesh-list
138445190|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138445191|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138445192|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138445193|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445194|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
138445195|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
138445196|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445197|NCT01827280|Vildagliptin|vildagliptin|mesh-list
138445198|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138445199|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445200|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138445201|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
138445202|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445203|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445204|NCT01827293|Promethazine|promethazine|mesh-list
138445206|NCT01827293|Lorazepam|lorazepam|mesh-list
138445207|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
138445208|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
138445209|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
138445210|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445211|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445212|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138445213|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138445214|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445215|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138445216|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138445217|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138445218|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
138445219|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
138445220|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453600|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
138445221|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445222|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
138445224|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138445225|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
138445226|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
138445227|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138445228|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138445229|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
138445230|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
138445231|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
138445232|NCT01827345|Vitamin D|vitamin d|mesh-list
138445233|NCT01827345|Vitamins|vitamins|mesh-ancestor
138445234|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
138445235|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445236|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138445237|NCT01827397|Vaccines|vaccines|mesh-list
138445238|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
138445239|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445240|NCT01827540|Dolutegravir|dolutegravir|mesh-list
138445241|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
138445242|NCT01827540|Midazolam|midazolam|mesh-list
138445243|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138445244|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138445245|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445246|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445247|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138247179|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445248|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138445249|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138445250|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138445251|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
138445252|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
138445253|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
138445254|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
138445255|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445256|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445257|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138445258|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138445259|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445261|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138445262|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
138445263|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445264|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138445265|NCT01827618|Sirolimus|sirolimus|mesh-list
138445266|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138445267|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445268|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138445269|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445270|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
138445271|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138445272|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
138445273|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445274|NCT01827722|Dexamethasone|dexamethasone|mesh-list
138445275|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
138445276|NCT01827722|Ranibizumab|ranibizumab|mesh-list
138445277|NCT01827722|BB 1101|bb 1101|mesh-list
138445278|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138445279|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
138445280|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
138414539|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445281|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247209|NCT02260622|Aspirin|aspirin|mesh-list
138445282|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445283|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138445286|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138445287|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138445288|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445289|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
138445290|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445291|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445292|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138445293|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138445294|NCT01827722|Growth Substances|growth substances|mesh-ancestor
138445295|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
138445296|NCT01827735|Aldesleukin|aldesleukin|mesh-list
138445297|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445298|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138445299|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138445300|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
138445301|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445302|NCT01827865|Etodolac|etodolac|mesh-list
138189335|NCT01929512|Metformin|metformin|mesh-list
138445303|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138445304|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138445305|NCT01827865|Analgesics|analgesics|mesh-ancestor
138445306|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
138445307|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445308|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445309|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138445310|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138414605|NCT01654562|Simvastatin|simvastatin|mesh-list
138445311|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138445312|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138445313|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445314|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445315|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138445317|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
138445318|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138445320|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
138445321|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247249|NCT01787240|Escitalopram|escitalopram|mesh-list
138445322|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138445323|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138445324|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199723|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138445325|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138445326|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
138445327|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445328|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138445329|NCT01827878|Protective Agents|protective agents|mesh-ancestor
138445330|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138445332|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138445333|NCT01828125|Hormones|hormones|mesh-ancestor
138453601|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445334|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138445335|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445336|NCT01828203|Minocycline|minocycline|mesh-list
138445337|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138445338|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445339|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
138445340|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138445342|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
138445343|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445344|NCT01828346|Azacitidine|azacitidine|mesh-list
138189375|NCT01929668|Vitamins|vitamins|mesh-ancestor
138445345|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138445346|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
138445347|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445348|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445349|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445350|NCT01828359|Losartan|losartan|mesh-list
138445351|NCT01828359|Amlodipine|amlodipine|mesh-list
138445352|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138445353|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138445354|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138445355|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445356|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138445357|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445358|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
138445359|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138247283|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247286|NCT03064295|Adenosine|adenosine|mesh-list
138445360|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138445361|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138445363|NCT01828385|Analgesics|analgesics|mesh-ancestor
138445364|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
138445365|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445366|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445367|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
138445368|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445369|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138445370|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
138445371|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138445372|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138445373|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445374|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138445375|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
138445376|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138445377|NCT01828437|Pyridoxine|pyridoxine|mesh-list
138445378|NCT01828437|Prednisolone|prednisolone|mesh-list
138445379|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138247316|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
138247317|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138445380|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
138445381|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138445382|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
138389773|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
138445383|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138445384|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
138445385|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138445387|NCT01828437|Hormones|hormones|mesh-ancestor
138445388|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138445389|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445390|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138445391|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445392|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
138445393|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
138199726|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
138445394|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445395|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138445396|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138445397|NCT01828437|Protective Agents|protective agents|mesh-ancestor
138445398|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
138445399|NCT01828437|Vitamins|vitamins|mesh-ancestor
138445400|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
138445401|NCT01828463|Nitisinone|nitisinone|mesh-list
138445402|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138389906|NCT01497535|Insulin|insulin|mesh-list
138445403|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445404|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
138445405|NCT01828489|Analgesics|analgesics|mesh-ancestor
138445406|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
138445407|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445408|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445409|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445410|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138445411|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138445412|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404367|NCT01572324|Vitamins|vitamins|mesh-ancestor
138445413|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445414|NCT01828606|Monensin|monensin|mesh-list
138445415|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
138445416|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138414714|NCT01655095|Cathartics|cathartics|mesh-ancestor
138445417|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138445418|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138445419|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
138445420|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
138445421|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
138445422|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445423|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445424|NCT01828606|Ionophores|ionophores|mesh-ancestor
138445425|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138445426|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
138445427|NCT01828736|Cisplatin|cisplatin|mesh-list
138445428|NCT01828736|Carboplatin|carboplatin|mesh-list
138445429|NCT01828736|Gemcitabine|gemcitabine|mesh-list
138445430|NCT01828736|Trastuzumab|trastuzumab|mesh-list
138247370|NCT02266472|Metformin|metformin|mesh-list
138445431|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445432|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138445433|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
138445434|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445435|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138445436|NCT01828788|Ropivacaine|ropivacaine|mesh-list
138445437|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
138445438|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
138445439|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445440|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445441|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
138445442|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445443|NCT01828879|Tacrolimus|tacrolimus|mesh-list
138445444|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138445445|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
138390006|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138445446|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445447|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138445448|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445449|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445450|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138445451|NCT01828892|Vancomycin|vancomycin|mesh-list
138445452|NCT01828892|Meropenem|meropenem|mesh-list
138445453|NCT01828892|Ceftazidime|ceftazidime|mesh-list
138445454|NCT01828892|Cefotaxime|cefotaxime|mesh-list
138445455|NCT01828892|Cefoxitin|cefoxitin|mesh-list
138445456|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445457|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
138445458|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138445459|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445460|NCT01829178|Cisplatin|cisplatin|mesh-list
138445461|NCT01829178|Docetaxel|docetaxel|mesh-list
138445462|NCT01829178|Fluorouracil|fluorouracil|mesh-list
138445463|NCT01829178|Silymarin|silymarin|mesh-list
138445464|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445465|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
138445466|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
138445467|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
138445468|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445469|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
138445470|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138445471|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138445472|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
138445473|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445474|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
138445475|NCT01829178|Protective Agents|protective agents|mesh-ancestor
138445476|NCT01829334|Listerine|listerine|mesh-list
138445477|NCT01829334|Fluorides|fluorides|mesh-list
138445478|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
138445479|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
138445480|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
138445481|NCT01829334|Protective Agents|protective agents|mesh-ancestor
138445482|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445483|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138445484|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445485|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
138445486|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138445487|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
138445488|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445489|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
138445490|NCT01829451|Protective Agents|protective agents|mesh-ancestor
138445491|NCT01829529|Amoxicillin|amoxicillin|mesh-list
138445492|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138189450|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
138445495|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138445496|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138445497|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138445498|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138445499|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
138445500|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445501|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138189470|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
138445502|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445503|NCT01829685|Entecavir|entecavir|mesh-list
138445504|NCT01829685|Adefovir|adefovir|mesh-list
138445505|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
138445506|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445507|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138445508|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138445509|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445510|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445511|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138445512|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138445513|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138445514|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
138445515|NCT01829711|Protective Agents|protective agents|mesh-list
138445516|NCT01829711|Immunotoxins|immunotoxins|mesh-ancestor
138247419|NCT03974789|Hormones|hormones|mesh-ancestor
138445518|NCT01829711|Immunologic Factors|immunologic factors|mesh-ancestor
138445519|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445520|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445521|NCT01829802|Ritonavir|ritonavir|mesh-list
138445522|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138445523|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
138445524|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138445525|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138445526|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
138445527|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445528|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445529|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138445530|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138189675|NCT01052701|Ribavirin|ribavirin|mesh-list
138445531|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
138445532|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445533|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138445534|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138445535|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138445536|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138199730|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138445537|NCT01829841|Sunitinib|sunitinib|mesh-list
138445538|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445539|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138445540|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138445541|NCT01829841|Growth Substances|growth substances|mesh-ancestor
138445542|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445543|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
138445544|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138445545|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445546|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445547|NCT01829893|Tamsulosin|tamsulosin|mesh-list
138445548|NCT01829893|Finasteride|finasteride|mesh-list
138445549|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138445550|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138445551|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138445552|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
138414860|NCT01655810|Vitamin D|vitamin d|mesh-list
138445553|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445554|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445555|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445556|NCT01829893|Urological Agents|urological agents|mesh-ancestor
138445557|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138445558|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138445559|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445560|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
138390269|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138445561|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138445563|NCT01830153|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138445564|NCT01830153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138445565|NCT01830153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138404522|NCT01573286|Glucagon|glucagon|mesh-list
138445566|NCT01830153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445567|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138445568|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
138445569|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445570|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445571|NCT01830244|Paclitaxel|paclitaxel|mesh-list
138445572|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138445573|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445574|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
138445575|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
138445576|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
138445577|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445578|NCT01830270|Paclitaxel|paclitaxel|mesh-list
138445579|NCT01830270|Epirubicin|epirubicin|mesh-list
138445580|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138445581|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445582|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
138445583|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
138445584|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
138445585|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445587|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138445588|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138445589|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445590|NCT01830530|Telmisartan|telmisartan|mesh-list
138445591|NCT01830530|Nifedipine|nifedipine|mesh-list
138445592|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138189908|NCT02226159|Lidocaine|lidocaine|mesh-list
138445593|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138445594|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138445595|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445597|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138445598|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138189979|NCT03242590|Hormones|hormones|mesh-ancestor
138445599|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445600|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
138445601|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
138445602|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138445603|NCT01830907|Vitamins|vitamins|mesh-list
138445604|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
138445605|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445606|NCT01831050|Vaccines|vaccines|mesh-list
138445607|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
138445608|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445609|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
138445610|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138445611|NCT01832311|Ketorolac|ketorolac|mesh-list
138445612|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138445613|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138445614|NCT01832311|Analgesics|analgesics|mesh-ancestor
138445615|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
138445616|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445617|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445618|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138445619|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138445620|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138445621|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445622|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445624|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
138445625|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
138445626|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
138445627|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138445628|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138445629|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445630|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445631|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445632|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138445633|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138445634|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
138445635|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138445636|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
138445637|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138445638|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138445639|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445640|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445641|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138445642|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138445643|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
138445644|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138445645|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138445646|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138445647|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138445648|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138390438|NCT01500928|Insulin|insulin|mesh-list
138445650|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
138445651|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
138190364|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
138445652|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445653|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445654|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
138445655|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445656|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138445657|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138445658|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138445659|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138445660|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445661|NCT01834820|Dexamethasone|dexamethasone|mesh-list
138445662|NCT01834820|Epinephrine|epinephrine|mesh-list
138445663|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138445664|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
138445665|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
138445666|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445667|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445668|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138445669|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
138445671|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138445672|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138445673|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445674|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138445675|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138445676|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
138445677|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445678|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445679|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138445680|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138445681|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138445682|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
138445683|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
138445684|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
138445685|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138445686|NCT01835197|Abrocitinib|abrocitinib|mesh-list
138445687|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138445688|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445689|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445691|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138445692|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138445693|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138445694|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445695|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138445696|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445697|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
138445698|NCT01835678|Linagliptin|linagliptin|mesh-list
138445699|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138415091|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
138445700|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445701|NCT01835678|Incretins|incretins|mesh-ancestor
138445702|NCT01835678|Hormones|hormones|mesh-ancestor
138445703|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138445704|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138445705|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
138445706|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445707|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445708|NCT01836614|Lidocaine|lidocaine|mesh-list
138445709|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
138445710|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
138445711|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445712|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445713|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
138445714|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445715|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138445716|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138445717|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138445718|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138445719|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445720|NCT01837251|Bevacizumab|bevacizumab|mesh-list
138445721|NCT01837251|Carboplatin|carboplatin|mesh-list
138445722|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138445723|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445724|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138247579|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138445725|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138445726|NCT01837251|Growth Substances|growth substances|mesh-ancestor
138445727|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445728|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
138445730|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
138445731|NCT01837290|Bupivacaine|bupivacaine|mesh-list
138445732|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
138445733|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
138445734|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138199749|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138199750|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138445735|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445736|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
138415136|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445737|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445739|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138445740|NCT01837290|Analgesics|analgesics|mesh-ancestor
138445741|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138445742|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138445743|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138445744|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
138445745|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138190871|NCT03587428|Trace Elements|trace elements|mesh-ancestor
138445746|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445747|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138445748|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138445749|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138445750|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138445751|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138445752|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
138445753|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
138445754|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
138445755|NCT01837433|Prednisone|prednisone|mesh-list
138445756|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
138445757|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138445758|NCT01837433|Hormones|hormones|mesh-ancestor
138445759|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138445760|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445761|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138445762|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445763|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
138445764|NCT01837446|Promethazine|promethazine|mesh-list
138445765|NCT01837446|Lidocaine|lidocaine|mesh-list
138445766|NCT01837446|Morphine|morphine|mesh-list
138445767|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138191078|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445768|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
138445770|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
138445771|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445772|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445773|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
138191146|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
138445774|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445775|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138445776|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138445777|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138191213|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
138445778|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138445779|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445780|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138445782|NCT01837446|Analgesics|analgesics|mesh-ancestor
138445783|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138445784|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138445785|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
138445786|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
138404744|NCT01575483|Saxagliptin|saxagliptin|mesh-list
138445787|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138445788|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138445789|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
138445790|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
138445791|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445792|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138445793|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
138445794|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
138445795|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138445796|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
138445797|NCT01837446|Antacids|antacids|mesh-ancestor
138445798|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
138445799|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138445800|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138445801|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138199757|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445802|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445804|NCT01839344|Quercetin|quercetin|mesh-list
138445805|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138445806|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445807|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445808|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138445809|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445810|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
138445811|NCT01839344|Protective Agents|protective agents|mesh-ancestor
138445812|NCT01839578|Heparin|heparin|mesh-list
138445813|NCT01839578|Calcium heparin|calcium heparin|mesh-list
138445814|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
138445815|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445816|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138445817|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138445818|NCT01839994|Androgens|androgens|mesh-list
138445819|NCT01839994|Hormones|hormones|mesh-ancestor
138445820|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138445821|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445822|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
138445823|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138445824|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138445825|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138445826|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138445827|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
138445828|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138445829|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445830|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445831|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138445832|NCT01840254|Analgesics|analgesics|mesh-ancestor
138445833|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
138445834|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445835|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138445836|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138445837|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138445838|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
138445839|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445840|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445841|NCT01840384|Micronutrients|micronutrients|mesh-list
138445842|NCT01840384|Trace Elements|trace elements|mesh-list
138445843|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445844|NCT01840423|Levodopa|levodopa|mesh-list
138445845|NCT01840423|Carbidopa|carbidopa|mesh-list
138445846|NCT01840423|Entacapone|entacapone|mesh-list
138445847|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138445848|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138445849|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
138445850|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445851|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445852|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445853|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138445854|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415244|NCT01657669|Aflibercept|aflibercept|mesh-list
138445855|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138445857|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138445858|NCT01840683|Heparin|heparin|mesh-list
138445859|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
138404817|NCT01576029|Docetaxel|docetaxel|mesh-list
138445860|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138445861|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138445862|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445864|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
138445865|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
138445866|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
138191515|NCT01037881|Analgesics|analgesics|mesh-ancestor
138445868|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445869|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445870|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445872|NCT01840774|Analgesics|analgesics|mesh-list
138445873|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
138445874|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138191571|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
138445875|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445876|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138445877|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138445878|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
138445880|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445881|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138445882|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138445883|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445884|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445886|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
138445887|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
138445888|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445889|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445890|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
138415273|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445891|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445893|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138445894|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
138191780|NCT01041781|Celecoxib|celecoxib|mesh-list
138445895|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138445896|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445897|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138445898|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138445899|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
138445901|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138445902|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
138445903|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445904|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138445905|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445906|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445907|NCT01841099|Mesalamine|mesalamine|mesh-list
138445908|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138445909|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138445911|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
138445912|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445913|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445914|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138445915|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138445917|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138445918|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138445919|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445920|NCT01841125|Escitalopram|escitalopram|mesh-list
138445921|NCT01841125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138445922|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138445923|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138415315|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138453602|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445924|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445925|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138445926|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
138445927|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445928|NCT01841164|Montelukast|montelukast|mesh-list
138445929|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138445930|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
138445931|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138445932|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
138445933|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138445936|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138445937|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445938|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
138445939|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
138445940|NCT01841242|Povidone|povidone|mesh-list
138391564|NCT01505894|BI 409306|bi 409306|mesh-list
138445941|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138445942|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445943|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
138445944|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
138445945|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
138445946|NCT01841294|Lidocaine|lidocaine|mesh-list
138445947|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
138445949|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445950|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445951|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
138445952|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445953|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138445954|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138445955|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138445956|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138445957|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445958|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
138445959|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
138445960|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
138445961|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445962|NCT01841307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138445963|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138445964|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138445965|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
138445966|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138445968|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138445969|NCT01841320|Narcotics|narcotics|mesh-ancestor
138445970|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445971|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445972|NCT01841320|Analgesics|analgesics|mesh-ancestor
138445973|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
138445974|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138445975|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
138445976|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
138445977|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
138445978|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445979|NCT01841411|Metronidazole|metronidazole|mesh-list
138445980|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
138445981|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138445982|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138445983|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138445984|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138445985|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138445986|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
138445987|NCT01841411|Expectorants|expectorants|mesh-ancestor
138445988|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
138445989|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138445990|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
138445991|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138445992|NCT01841411|Protective Agents|protective agents|mesh-ancestor
138445993|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138445994|NCT01841411|Antidotes|antidotes|mesh-ancestor
138445995|NCT01841424|Benzocaine|benzocaine|mesh-list
138445996|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
138445997|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
138445998|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138445999|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446000|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
138446001|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446002|NCT01841463|Vemurafenib|vemurafenib|mesh-list
138446003|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391785|NCT01506713|Clopidogrel|clopidogrel|mesh-list
138446004|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138446005|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415453|NCT01658462|Docetaxel|docetaxel|mesh-list
138446006|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446007|NCT01841502|Paroxetine|paroxetine|mesh-list
138446008|NCT01841502|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138446009|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138446010|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138446011|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446012|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446013|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
138446014|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446015|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138446016|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
138446017|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138446018|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138446019|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138446020|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446021|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138446023|NCT01841515|Coagulants|coagulants|mesh-ancestor
138446024|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138446025|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
138446026|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446028|NCT01841658|Hematinics|hematinics|mesh-ancestor
138446029|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
138446030|NCT01841658|Vitamins|vitamins|mesh-ancestor
138446031|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
138446032|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446033|NCT01841684|Anacetrapib|anacetrapib|mesh-list
138446034|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138446035|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138446036|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
138446037|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446038|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138446039|NCT01841775|Interferons|interferons|mesh-list
138446040|NCT01841775|Ribavirin|ribavirin|mesh-list
138446041|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446043|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446044|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
138446045|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446046|NCT01841827|Cilostazol|cilostazol|mesh-list
138446047|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138446048|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
138446049|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446050|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446051|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138446052|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
138446053|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138446054|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138446055|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446056|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138446057|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
138446058|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138446059|NCT01841827|Protective Agents|protective agents|mesh-ancestor
138446060|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138446061|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138446062|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446063|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138446064|NCT01842074|Bortezomib|bortezomib|mesh-list
138446065|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446066|NCT01842087|Iproplatin|iproplatin|mesh-list
138247621|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138446067|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446068|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138446069|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446070|NCT01842113|Rifaximin|rifaximin|mesh-list
138446071|NCT01842113|Lactulose|lactulose|mesh-list
138453603|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138446072|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138446073|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446074|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138446075|NCT01842139|Poly I-C|poly i-c|mesh-list
138446076|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138446077|NCT01842139|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138446078|NCT01842139|Poly ICLC|poly iclc|mesh-list
138446079|NCT01842139|Basiliximab|basiliximab|mesh-list
138446080|NCT01842139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138446081|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
138446082|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199776|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446083|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
138446084|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138446086|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138446087|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
138446088|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446090|NCT01842230|Amlodipine|amlodipine|mesh-list
138446091|NCT01842230|Telmisartan|telmisartan|mesh-list
138446092|NCT01842230|Atorvastatin|atorvastatin|mesh-list
138446093|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138446094|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138446096|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446097|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138446098|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138446099|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446100|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138446101|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138446102|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138446103|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138446104|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446105|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
138446106|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138446107|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138446108|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
138446109|NCT01842230|Vitamins|vitamins|mesh-ancestor
138446110|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
138446111|NCT01842256|Amlodipine|amlodipine|mesh-list
138446112|NCT01842256|Telmisartan|telmisartan|mesh-list
138446113|NCT01842256|Atorvastatin|atorvastatin|mesh-list
138446114|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138446115|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138446116|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
138446117|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446118|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138446119|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138446120|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138415632|NCT01659437|Clarithromycin|clarithromycin|mesh-list
138446121|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138446122|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138446123|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138446124|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138446125|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446126|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
138446127|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138446128|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138446130|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138446131|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446132|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138446133|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
138446134|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138446135|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446136|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138392201|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138247632|NCT00376077|Protective Agents|protective agents|mesh-ancestor
138446137|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446138|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
138446139|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446140|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138446141|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446142|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446143|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
138446144|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138446145|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199782|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138199783|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
138199784|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138446146|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138446147|NCT01842373|Lidocaine|lidocaine|mesh-list
138446149|NCT01842373|Benzocaine|benzocaine|mesh-list
138446150|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
138446151|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
138446152|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138446153|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446154|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
138446155|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446156|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138446157|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138446158|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138446159|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138446160|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446161|NCT01842516|Delpazolid|delpazolid|mesh-list
138446162|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
138446163|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138446164|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446165|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138446166|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446167|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446168|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
138446169|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138446170|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138446171|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446172|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
138415730|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
138446173|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446174|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446175|NCT01842893|Fentanyl|fentanyl|mesh-list
138446176|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138446177|NCT01842893|Narcotics|narcotics|mesh-ancestor
138446178|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138446179|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446180|NCT01842893|Analgesics|analgesics|mesh-ancestor
138446181|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
138192197|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446182|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446183|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138446184|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138446185|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
138446186|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
138446188|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138446189|NCT01842932|Cimetropium|cimetropium|mesh-list
138446190|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
138446191|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
138446192|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446193|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446194|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446195|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
138446196|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
138446197|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446198|NCT01843010|Parecoxib|parecoxib|mesh-list
138446199|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138446200|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138446201|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247636|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
138446202|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446203|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138446204|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138446205|NCT01843010|Analgesics|analgesics|mesh-ancestor
138446206|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
138446207|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138415780|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138446208|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446209|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138446210|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138446212|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138446213|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199790|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
138446214|NCT01843075|Incretins|incretins|mesh-ancestor
138446215|NCT01843075|Hormones|hormones|mesh-ancestor
138446216|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138446217|NCT01843088|Mannitol|mannitol|mesh-list
138446218|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138446219|NCT01843088|Diuretics|diuretics|mesh-ancestor
138446220|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
138446221|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446222|NCT01843127|Exenatide|exenatide|mesh-list
138446223|NCT01843127|Ranolazine|ranolazine|mesh-list
138446224|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138446225|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446226|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138446227|NCT01843127|Incretins|incretins|mesh-ancestor
138446228|NCT01843127|Hormones|hormones|mesh-ancestor
138446229|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138446230|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138446231|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138446232|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138405186|NCT01578343|BB 1101|bb 1101|mesh-list
138446233|NCT01843153|Ropivacaine|ropivacaine|mesh-list
138446234|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
138446235|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
138446236|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138446237|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446238|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
138446239|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446240|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138446241|NCT01843166|Estrogens|estrogens|mesh-ancestor
138446242|NCT01843166|Hormones|hormones|mesh-ancestor
138446243|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138446244|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446245|NCT01843179|Cytarabine|cytarabine|mesh-list
138446246|NCT01843179|Sulindac|sulindac|mesh-list
138446247|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138446248|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
138446249|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138392293|NCT01508923|Incretins|incretins|mesh-ancestor
138446250|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446251|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
138446252|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446253|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138446254|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
138446255|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446256|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138446257|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138446258|NCT01843179|Analgesics|analgesics|mesh-ancestor
138446259|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
138446260|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446261|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138446262|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138446263|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138446264|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446266|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138446267|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446268|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138446269|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446270|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
138446271|NCT01843296|Fentanyl|fentanyl|mesh-list
138446272|NCT01843296|Bupivacaine|bupivacaine|mesh-list
138446273|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
138446274|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
138446275|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138446276|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446277|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
138446278|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446279|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138446280|NCT01843296|Narcotics|narcotics|mesh-ancestor
138446281|NCT01843296|Analgesics|analgesics|mesh-ancestor
138199794|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138446282|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138446283|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138446284|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
138446285|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138446286|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
138446287|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138192247|NCT02181127|Hormones|hormones|mesh-ancestor
138446288|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138446289|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446290|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138446291|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
138446292|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138446293|NCT01843309|Spironolactone|spironolactone|mesh-list
138446294|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138446295|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
138446296|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138446297|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446298|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138446299|NCT01843309|Diuretics|diuretics|mesh-ancestor
138446300|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
138446301|NCT01843439|Pyridoxine|pyridoxine|mesh-list
138446302|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
138446303|NCT01843439|Vitamins|vitamins|mesh-ancestor
138446304|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
138446305|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446306|NCT01843452|Capecitabine|capecitabine|mesh-list
138446307|NCT01843452|Mitomycins|mitomycins|mesh-list
138446308|NCT01843452|Mitomycin|mitomycin|mesh-list
138446310|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138446311|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
138446312|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446313|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446314|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138446315|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
138446316|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138446317|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446318|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138247648|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138446319|NCT01843647|Cisplatin|cisplatin|mesh-list
138446320|NCT01843647|Vinorelbine|vinorelbine|mesh-list
138446321|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446322|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138446323|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
138446324|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
138446325|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
138392577|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
138446326|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446327|NCT01843699|Topiramate|topiramate|mesh-list
138446328|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
138446329|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138446330|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446331|NCT01843725|Capecitabine|capecitabine|mesh-list
138446332|NCT01843725|Aflibercept|aflibercept|mesh-list
138446333|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138446334|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
138446335|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446336|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446337|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138446338|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138446339|NCT01843725|Growth Substances|growth substances|mesh-ancestor
138446340|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446341|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
138446342|NCT01843738|Vemurafenib|vemurafenib|mesh-list
138446343|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138392691|NCT01511302|RNS60|rns60|mesh-list
138446344|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138446345|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446346|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446347|NCT01843829|Paclitaxel|paclitaxel|mesh-list
138446348|NCT01843829|Carboplatin|carboplatin|mesh-list
138446349|NCT01843829|Capecitabine|capecitabine|mesh-list
138446350|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
138446351|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138446352|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446353|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
138446355|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
138446356|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446357|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138446358|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
138446359|NCT01843868|Prednisolone|prednisolone|mesh-list
138446360|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
138446361|NCT01843868|Doxorubicin|doxorubicin|mesh-list
138446362|NCT01843868|Vincristine|vincristine|mesh-list
138446363|NCT01843868|Lorazepam|lorazepam|mesh-list
138446364|NCT01843868|Ondansetron|ondansetron|mesh-list
138446365|NCT01843868|Aprepitant|aprepitant|mesh-list
138446366|NCT01843868|Metoclopramide|metoclopramide|mesh-list
138446367|NCT01843868|Palonosetron|palonosetron|mesh-list
138446368|NCT01843868|Granisetron|granisetron|mesh-list
138446369|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
138446370|NCT01843868|Tropisetron|tropisetron|mesh-list
138446371|NCT01843868|Antiemetics|antiemetics|mesh-list
138446372|NCT01843868|Emetics|emetics|mesh-list
138446373|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138446374|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
138446375|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446376|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138446377|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138446378|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
138446379|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446380|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446381|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138446382|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138446383|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138446384|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138446385|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446386|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138446388|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
138446389|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
138446390|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138446393|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138446394|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138446395|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
138446396|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446397|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138446398|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
138446399|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
138446400|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138446401|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138446402|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
138446403|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446404|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138446405|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138446406|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138446407|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
138446408|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
138446409|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138446410|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138446411|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138446412|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138446413|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138392872|NCT01511887|Ibuprofen|ibuprofen|mesh-list
138446414|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
138446415|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
138446416|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138446417|NCT01843998|Sirolimus|sirolimus|mesh-list
138446418|NCT01843998|Temsirolimus|temsirolimus|mesh-list
138446419|NCT01843998|MTOR Inhibitors|mtor inhibitors|mesh-list
138446420|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138446421|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446422|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138446423|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446424|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
138446425|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138446426|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
138446427|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446428|NCT01843998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138446429|NCT01843998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446430|NCT01843998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446432|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138446433|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
138446434|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138446435|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446436|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138446437|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138446438|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
138446439|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
138446440|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446441|NCT01844141|Ethanol|ethanol|mesh-list
138446442|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
138446443|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138446444|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138446445|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138247672|NCT03530631|Adderall|adderall|mesh-list
138446446|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138446447|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446448|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
138446449|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
138446451|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446452|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138392936|NCT01512199|Paclitaxel|paclitaxel|mesh-list
138446453|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446454|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446455|NCT01844401|Albuterol|albuterol|mesh-list
138446456|NCT01844401|Procaterol|procaterol|mesh-list
138446457|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138446458|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
138446459|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446460|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446461|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138446462|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
138446464|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138446465|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138446466|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138446467|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138392973|NCT01512485|Clopidogrel|clopidogrel|mesh-list
138446468|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
138446469|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446470|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446471|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
138446472|NCT01844427|Memantine|memantine|mesh-list
138446473|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138446474|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138446476|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446477|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446478|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446479|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138446480|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138393070|NCT01513070|Aspirin|aspirin|mesh-list
138446481|NCT01844622|Domperidone|domperidone|mesh-list
138446482|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
138446483|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
138446484|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446485|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446486|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138446487|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138446488|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
138446489|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446490|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446491|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
138446492|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
138446493|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192348|NCT01169467|Analgesics|analgesics|mesh-ancestor
138446494|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138446495|NCT01844648|Tropicamide|tropicamide|mesh-list
138446496|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
138446497|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
138446498|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446499|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446500|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138446501|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138446502|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
138199803|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138446503|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446504|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446505|NCT01844674|Vemurafenib|vemurafenib|mesh-list
138446506|NCT01844674|Tizanidine|tizanidine|mesh-list
138416159|NCT01662804|Analgesics|analgesics|mesh-ancestor
138446507|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138393091|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
138446508|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138446509|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446510|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446511|NCT01844674|Analgesics|analgesics|mesh-ancestor
138446512|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
138446513|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446514|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446515|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
138446516|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138446517|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138446518|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
138446519|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
138446520|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138446521|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138446522|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138446523|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
138446524|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446525|NCT01844791|Pentamidine|pentamidine|mesh-list
138446526|NCT01844791|Gemcitabine|gemcitabine|mesh-list
138446527|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138446528|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
138446529|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446530|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446531|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
138446532|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446533|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138446534|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138446535|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138446536|NCT01844804|Infliximab|infliximab|mesh-list
138446537|NCT01844804|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138446538|NCT01844804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138446539|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
138446540|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138446541|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138446542|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
138446543|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138446544|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446545|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138446546|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446547|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446548|NCT01844947|Sorafenib|sorafenib|mesh-list
138446549|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446550|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138446551|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446552|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446553|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
138446554|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138446556|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446557|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138446558|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138446559|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
138446560|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446561|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446562|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138446563|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138446564|NCT01845064|Kallikreins|kallikreins|mesh-list
138446565|NCT01845064|Coagulants|coagulants|mesh-ancestor
138446566|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
138446567|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
138393257|NCT01514123|Bevacizumab|bevacizumab|mesh-list
138446568|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138446569|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446570|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
138446571|NCT01845090|Calcium|calcium|mesh-list
138199807|NCT00002494|Doxorubicin|doxorubicin|mesh-list
138199808|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138446572|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138446573|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446574|NCT01845090|Antacids|antacids|mesh-ancestor
138446575|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446576|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138446577|NCT01845142|Vitamin D|vitamin d|mesh-list
138446578|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
138446579|NCT01845142|Vitamins|vitamins|mesh-ancestor
138446580|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
138446581|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446582|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138446583|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138446584|NCT01845194|Metoprolol|metoprolol|mesh-list
138446585|NCT01845194|Talinolol|talinolol|mesh-list
138446586|NCT01845194|Torsemide|torsemide|mesh-list
138446587|NCT01845194|Midazolam|midazolam|mesh-list
138446588|NCT01845194|Codeine|codeine|mesh-list
138446589|NCT01845194|Caffeine|caffeine|mesh-list
138446590|NCT01845194|Pravastatin|pravastatin|mesh-list
138446591|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138446592|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138446593|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138446594|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446595|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138446596|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138446597|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138446598|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138446599|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
138446600|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
138446601|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
138192393|NCT01126099|Prazosin|prazosin|mesh-list
138446602|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
138446603|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446604|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446605|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138446606|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138446607|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446608|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138446609|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138446610|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
138446611|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138446612|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138446613|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
138446614|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
138446615|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446616|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138446617|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138446618|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138446619|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
138446620|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138446621|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138446622|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
138446623|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138446624|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138446625|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138446626|NCT01845194|Narcotics|narcotics|mesh-ancestor
138446627|NCT01845194|Analgesics|analgesics|mesh-ancestor
138446628|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
138446629|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
138446630|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
138446631|NCT01845194|Diuretics|diuretics|mesh-ancestor
138446632|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
138446633|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138446634|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138446635|NCT01845246|Colistin|colistin|mesh-list
138192410|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138446636|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138446637|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446638|NCT01845259|Liraglutide|liraglutide|mesh-list
138446639|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138446640|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446641|NCT01845259|Incretins|incretins|mesh-ancestor
138199811|NCT00002494|Vincristine|vincristine|mesh-list
138199812|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
138446642|NCT01845259|Hormones|hormones|mesh-ancestor
138446643|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138446644|NCT01845272|Amlodipine|amlodipine|mesh-list
138446645|NCT01845272|Candesartan|candesartan|mesh-list
138446646|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
138446647|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138446648|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138446649|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138446650|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446651|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138446652|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446653|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
138446654|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138446655|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138446657|NCT01845298|Rifamycins|rifamycins|mesh-list
138446658|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138446659|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
138446660|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138446661|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446662|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
138446663|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138446664|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446665|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446666|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138446667|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138446668|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138446669|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138446670|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138446671|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138446672|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
138446674|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138446676|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138446677|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446678|NCT01845428|Pravastatin|pravastatin|mesh-list
138446679|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138446680|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138446681|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
138446682|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446683|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138446684|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138446685|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446686|NCT01845493|Sulforaphane|sulforaphane|mesh-list
138446687|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138446688|NCT01845493|Protective Agents|protective agents|mesh-ancestor
138446689|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446690|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446691|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138446692|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
138446693|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
138446694|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138446695|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446696|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
138446697|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446698|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138446700|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138446701|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
138446702|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446703|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
138446704|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138446705|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
138446706|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138446707|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
138446708|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446709|NCT01845610|Manganese|manganese|mesh-list
138446710|NCT01845610|Trace Elements|trace elements|mesh-ancestor
138446711|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
138416338|NCT01664676|Incretins|incretins|mesh-ancestor
138446712|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446713|NCT01845675|Temozolomide|temozolomide|mesh-list
138446714|NCT01845675|Dacarbazine|dacarbazine|mesh-list
138446715|NCT01845675|Endostatins|endostatins|mesh-list
138446716|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138446717|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
138446718|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446719|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446720|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138446721|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138446722|NCT01845675|Growth Substances|growth substances|mesh-ancestor
138446723|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446724|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
138446725|NCT01845701|Artesunate|artesunate|mesh-list
138446726|NCT01845701|Lumefantrine|lumefantrine|mesh-list
138446727|NCT01845701|Artemether|artemether|mesh-list
138446728|NCT01845701|Piperaquine|piperaquine|mesh-list
138446729|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138446730|NCT01845701|Amodiaquine|amodiaquine|mesh-list
138446731|NCT01845701|Artenimol|artenimol|mesh-list
138446732|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
138446733|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138446734|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138446735|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446736|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446737|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
138446738|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
138446739|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138446741|NCT01845727|Amphotericin B|amphotericin b|mesh-list
138446742|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138446743|NCT01845727|Amebicides|amebicides|mesh-ancestor
138446745|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138446746|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446747|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138446748|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
138446749|NCT01845844|Ranibizumab|ranibizumab|mesh-list
138446750|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138446751|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138446752|NCT01845844|Growth Substances|growth substances|mesh-ancestor
138446753|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446754|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
138446755|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446756|NCT01846026|Vitamin D|vitamin d|mesh-list
138446757|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
138446758|NCT01846026|Vitamins|vitamins|mesh-ancestor
138446759|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
138446760|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446761|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138446762|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138446763|NCT01846117|Vitamin D|vitamin d|mesh-list
138446764|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
138446765|NCT01846117|Vitamins|vitamins|mesh-ancestor
138446766|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
138446767|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446768|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138446769|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
138446770|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138446771|NCT01846117|Estrogens|estrogens|mesh-ancestor
138446772|NCT01846117|Hormones|hormones|mesh-ancestor
138446773|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138446774|NCT01846143|Poly ICLC|poly iclc|mesh-list
138446775|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
138446776|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446777|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
138446778|NCT01846273|Ranibizumab|ranibizumab|mesh-list
138446779|NCT01846273|Verteporfin|verteporfin|mesh-list
138416417|NCT01665222|Morphine|morphine|mesh-list
138446780|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138446781|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138446782|NCT01846273|Growth Substances|growth substances|mesh-ancestor
138446783|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446784|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
138446785|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446786|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138446787|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
138446789|NCT01846325|Vitamins|vitamins|mesh-ancestor
138446790|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
138446791|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446792|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
138446793|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446794|NCT01846325|Protective Agents|protective agents|mesh-ancestor
138446795|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
138446796|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138446797|NCT01846364|Protective Agents|protective agents|mesh-ancestor
138446798|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446799|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446800|NCT01846559|Clopidogrel|clopidogrel|mesh-list
138446801|NCT01846559|Ticagrelor|ticagrelor|mesh-list
138446802|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138446803|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138446804|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138446805|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138446806|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
138446807|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446808|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446809|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446810|NCT01846650|Capecitabine|capecitabine|mesh-list
138446811|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138446812|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
138446813|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446814|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446815|NCT01846806|Rifaximin|rifaximin|mesh-list
138446816|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138446817|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446818|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138446819|NCT01846832|Interferons|interferons|mesh-list
138446820|NCT01846832|Ribavirin|ribavirin|mesh-list
138446821|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
138446822|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
138446823|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138446824|NCT01846832|Simeprevir|simeprevir|mesh-list
138446825|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138192621|NCT01926236|Vitamins|vitamins|mesh-ancestor
138446827|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446828|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
138446829|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446830|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
138446831|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446832|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
138446833|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446834|NCT01846962|Fluticasone|fluticasone|mesh-list
138446835|NCT01846962|Budesonide|budesonide|mesh-list
138446836|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138446837|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138446838|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
138446839|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446840|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446841|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138446842|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
138446843|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
138446844|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138446845|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
138446846|NCT01846962|Hormones|hormones|mesh-ancestor
138446847|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138446848|NCT01846975|Abatacept|abatacept|mesh-list
138446849|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138446850|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446851|NCT01846975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138446852|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446853|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138446854|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
138446855|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446856|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138446857|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138446858|NCT01847144|Gliclazide|gliclazide|mesh-list
138446859|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138446860|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138446861|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446862|NCT01847144|Incretins|incretins|mesh-ancestor
138446863|NCT01847144|Hormones|hormones|mesh-ancestor
138446864|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138446865|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
138446866|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446867|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446868|NCT01847157|Anesthetics|anesthetics|mesh-list
138446869|NCT01847157|Prilocaine|prilocaine|mesh-list
138446870|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138446871|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446872|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
138446873|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
138446874|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446875|NCT01847235|Temozolomide|temozolomide|mesh-list
138446876|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138446877|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
138446878|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446879|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446881|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
138446882|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
138446883|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138446884|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446885|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
138446886|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446887|NCT01847404|Pantoprazole|pantoprazole|mesh-list
138446888|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446889|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446890|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138446891|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138446892|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138446893|NCT01847417|Pantoprazole|pantoprazole|mesh-list
138446894|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138446895|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138446896|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138446897|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446898|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446899|NCT01847456|Insulin|insulin|mesh-list
138446900|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138446901|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138446902|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446903|NCT01847495|Irinotecan|irinotecan|mesh-list
138446904|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138446905|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138446906|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446907|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446908|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446909|NCT01847521|Quercetin|quercetin|mesh-list
138446910|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
138446911|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446912|NCT01847521|Protective Agents|protective agents|mesh-ancestor
138446913|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446914|NCT01847599|Capecitabine|capecitabine|mesh-list
138446915|NCT01847599|Lapatinib|lapatinib|mesh-list
138446916|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138446917|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
138405867|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
138446918|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138393673|NCT01516567|Rituximab|rituximab|mesh-list
138446919|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446920|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138446921|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446922|NCT01847612|Methylene Blue|methylene blue|mesh-list
138446923|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446924|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446925|NCT01847664|Rifamycins|rifamycins|mesh-list
138446926|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
138446927|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138446928|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138192719|NCT03011905|Etoricoxib|etoricoxib|mesh-list
138446929|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138446930|NCT01847677|Paclitaxel|paclitaxel|mesh-list
138446931|NCT01847677|Bevacizumab|bevacizumab|mesh-list
138446932|NCT01847677|Carboplatin|carboplatin|mesh-list
138446933|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138446934|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138446935|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
138446936|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
138446937|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
138446938|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446939|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138446940|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138446941|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138446942|NCT01847677|Growth Substances|growth substances|mesh-ancestor
138446943|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446944|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
138446945|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
138446946|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138446947|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
138446948|NCT01847768|Dimercaprol|dimercaprol|mesh-list
138446949|NCT01847768|Chelating Agents|chelating agents|mesh-ancestor
138446951|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446952|NCT01847768|Miotics|miotics|mesh-ancestor
138446953|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
138446954|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446955|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446956|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138393720|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
138446957|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
138446958|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
138446959|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
138446960|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138446961|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
138446962|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446963|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138446964|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
138446965|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446966|NCT01847872|Vaccines|vaccines|mesh-list
138446967|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
138446968|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446969|NCT01847976|Doxycycline|doxycycline|mesh-list
138446970|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138446971|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138446972|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
138446973|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138446974|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138446975|NCT01848106|Bivalirudin|bivalirudin|mesh-list
138446976|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
138446977|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138446978|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
138446979|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138446980|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446981|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
138446982|NCT01848119|Gabapentin|gabapentin|mesh-list
138446983|NCT01848119|Analgesics|analgesics|mesh-ancestor
138446984|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
138446985|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446986|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138446987|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
138416594|NCT01666223|Cathartics|cathartics|mesh-ancestor
138446988|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138446989|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138446990|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138446991|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138188487|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138446992|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138446994|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138446995|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138446996|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
138446997|NCT01848132|Prednisone|prednisone|mesh-list
138446998|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
138446999|NCT01848132|Rituximab|rituximab|mesh-list
138447000|NCT01848132|Doxorubicin|doxorubicin|mesh-list
138447001|NCT01848132|Vincristine|vincristine|mesh-list
138447002|NCT01848132|Bortezomib|bortezomib|mesh-list
138447003|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138447004|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
138447005|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447006|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138447007|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138447008|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
138447009|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447010|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447011|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138447012|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138447013|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138447014|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138447015|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138447016|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447017|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138447018|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
138447019|NCT01848132|Hormones|hormones|mesh-ancestor
138447020|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138447022|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138447023|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
138447024|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
138447025|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
138447026|NCT01848197|Paclitaxel|paclitaxel|mesh-list
138447027|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138447028|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447029|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
138447030|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
138447031|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
138447032|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447033|NCT01848236|Vitamin D|vitamin d|mesh-list
138447034|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
138447035|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
138447036|NCT01848236|Vitamins|vitamins|mesh-list
138447037|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
138447038|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447039|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138447040|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138447041|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
138447042|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
138447043|NCT01848301|Acetylcholine|acetylcholine|mesh-list
138447044|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
138447045|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138447046|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
138447047|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447048|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447049|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447050|NCT01848340|Cabotegravir|cabotegravir|mesh-list
138192907|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
138447051|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138447052|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138447053|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447054|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447055|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138447056|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138447057|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
138447058|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447059|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138447060|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447061|NCT01848613|Vinorelbine|vinorelbine|mesh-list
138447062|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138447063|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447064|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
138447065|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
138447066|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
138406018|NCT01592019|Diclofenac|diclofenac|mesh-list
138447067|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447069|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138447070|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447071|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138447072|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138447073|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447074|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447075|NCT01848665|Indomethacin|indomethacin|mesh-list
138447076|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138447077|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138447078|NCT01848665|Analgesics|analgesics|mesh-ancestor
138447080|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447081|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138192966|NCT01928498|Paclitaxel|paclitaxel|mesh-list
138447082|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138447083|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138447084|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
138447085|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
138447086|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138447087|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138447088|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447089|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447090|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
138447091|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
138447092|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447093|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
138447094|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447095|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447096|NCT01848743|Tenofovir|tenofovir|mesh-list
138447097|NCT01848743|Lamivudine|lamivudine|mesh-list
138447098|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
138447099|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447100|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138447101|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138447102|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447103|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447104|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138447105|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138447106|NCT01848769|Beclomethasone|beclomethasone|mesh-list
138447107|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
138447108|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138447109|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
138447110|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447111|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447112|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138447113|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
138447114|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138393938|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
138447115|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138447116|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138447117|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
138416699|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
138447118|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447119|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138192988|NCT04558502|Antacids|antacids|mesh-ancestor
138447120|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138447121|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
138447122|NCT01848769|Hormones|hormones|mesh-ancestor
138447123|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138447124|NCT01848808|Wobenzym|wobenzym|mesh-list
138447125|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138447126|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
138447127|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447128|NCT01848873|Amlodipine|amlodipine|mesh-list
138447129|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138447130|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138447131|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138447132|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447133|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138447134|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447135|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
138447136|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
138447137|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447138|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
138447139|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447140|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447141|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138447142|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
138447143|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138447144|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
138447145|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447146|NCT01849016|Expectorants|expectorants|mesh-ancestor
138447147|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
138447148|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138447149|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
138447150|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447151|NCT01849016|Protective Agents|protective agents|mesh-ancestor
138193018|NCT04759742|Ropivacaine|ropivacaine|mesh-list
138447152|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447153|NCT01849016|Antidotes|antidotes|mesh-ancestor
138447154|NCT01849042|Donepezil|donepezil|mesh-list
138447155|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138447156|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447157|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447158|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
138447159|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447160|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447161|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
138447162|NCT01849094|Milrinone|milrinone|mesh-list
138447163|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138447164|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138447165|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
138447166|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138447167|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138447168|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447169|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447170|NCT01849094|Protective Agents|protective agents|mesh-ancestor
138447171|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447172|NCT01849211|Rocuronium|rocuronium|mesh-list
138447173|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138447174|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138447175|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138447176|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447177|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447178|NCT01849406|Budesonide|budesonide|mesh-list
138447179|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138447180|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138447181|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
138447182|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447183|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447184|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138447185|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
138447186|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
138447187|NCT01849406|Hormones|hormones|mesh-ancestor
138447188|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138447189|NCT01849640|Piperaquine|piperaquine|mesh-list
138447190|NCT01849640|Primaquine|primaquine|mesh-list
138447191|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
138447192|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138447193|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138447194|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447195|NCT01849666|Vemurafenib|vemurafenib|mesh-list
138447196|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
138447197|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447198|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138447199|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447200|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447201|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
138447202|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
138447203|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138447204|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138447205|NCT01849835|Menthol|menthol|mesh-list
138447206|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
138447207|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
138447208|NCT01849861|Methimazole|methimazole|mesh-list
138447209|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
138447210|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
138447211|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138447212|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447213|NCT01849926|Amdinocillin|amdinocillin|mesh-list
138447214|NCT01849926|Ibuprofen|ibuprofen|mesh-list
138447215|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138447217|NCT01849926|Analgesics|analgesics|mesh-ancestor
138447218|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
138447219|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447220|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447221|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138394065|NCT01518465|Dexamethasone|dexamethasone|mesh-list
138447222|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138447223|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138447224|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447225|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447226|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138447227|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447228|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138447229|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
138447230|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
138447231|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447232|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
138447233|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138447234|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138447235|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447236|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138447237|NCT01850017|Analgesics|analgesics|mesh-ancestor
138447238|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
138447239|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447240|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138447241|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138447242|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138447243|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
138447244|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447245|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447246|NCT01850095|Azelaic acid|azelaic acid|mesh-list
138447247|NCT01850095|Estradiol|estradiol|mesh-list
138447248|NCT01850095|Estrogens|estrogens|mesh-ancestor
138447249|NCT01850095|Hormones|hormones|mesh-ancestor
138447250|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138447251|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447252|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447253|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
138447254|NCT01850121|Infliximab|infliximab|mesh-list
138447255|NCT01850121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138447256|NCT01850121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138447257|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
138447258|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138447259|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138447260|NCT01850147|Sunitinib|sunitinib|mesh-list
138447261|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447262|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138447263|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138447264|NCT01850147|Growth Substances|growth substances|mesh-ancestor
138447265|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447266|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
138447267|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138447268|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447269|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447270|NCT01850160|Valsartan|valsartan|mesh-list
138447271|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
138193141|NCT00955253|Guanfacine|guanfacine|mesh-list
138447272|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
138447273|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
138447274|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138447275|NCT01850160|Diuretics|diuretics|mesh-list
138394209|NCT01519154|Ketamine|ketamine|mesh-list
138447276|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
138447277|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138447278|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447279|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
138447280|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447281|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138447282|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138447283|NCT01850251|Vitamin D|vitamin d|mesh-list
138447284|NCT01850251|Vitamins|vitamins|mesh-ancestor
138447285|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
138447286|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447287|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138447288|NCT01850277|Amiodarone|amiodarone|mesh-list
138406239|NCT01593280|Morphine|morphine|mesh-list
138447289|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447290|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138447291|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
138447292|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138447293|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138447294|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138447295|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138447296|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138394260|NCT01519401|Estradiol|estradiol|mesh-list
138447297|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447298|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138447299|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138447300|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138447301|NCT01850511|Phenylephrine|phenylephrine|mesh-list
138193170|NCT01017653|Irinotecan|irinotecan|mesh-list
138447302|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
138447303|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138447304|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138447305|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
138447306|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447307|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447308|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447309|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
138447310|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
138447311|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447312|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
138447313|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138447314|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
138447315|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138447317|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138447318|NCT01850511|Protective Agents|protective agents|mesh-ancestor
138447320|NCT01850628|Trastuzumab|trastuzumab|mesh-list
138447321|NCT01850628|Pertuzumab|pertuzumab|mesh-list
138447322|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138447323|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447324|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
138447325|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
138447326|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
138447327|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447328|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138447329|NCT01850680|Folic Acid|folic acid|mesh-list
138447330|NCT01850680|Methotrexate|methotrexate|mesh-list
138447331|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138447332|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
138199860|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447333|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138199861|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
138199862|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138199863|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
138199865|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138447334|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447335|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138447336|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
138447337|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447338|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447339|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
138447340|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138193207|NCT00971633|Ondansetron|ondansetron|mesh-list
138447341|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138447342|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138447344|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138447345|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138447347|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
138447348|NCT01850680|Vitamins|vitamins|mesh-ancestor
138447349|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
138447350|NCT01850940|Tolvaptan|tolvaptan|mesh-list
138416894|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138447351|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138447352|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447353|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
138447354|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447355|NCT01850953|Varenicline|varenicline|mesh-list
138447356|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138447357|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138447358|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
138447359|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447360|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447361|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447362|NCT01850979|Tacrolimus|tacrolimus|mesh-list
138447363|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138447364|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
138447365|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447366|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138447367|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447368|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447370|NCT01851005|Remifentanil|remifentanil|mesh-list
138447371|NCT01851005|Anesthetics|anesthetics|mesh-list
138447372|NCT01851005|Propofol|propofol|mesh-list
138447373|NCT01851005|Sevoflurane|sevoflurane|mesh-list
138447374|NCT01851005|Rocuronium|rocuronium|mesh-list
138447375|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138193242|NCT00972335|Growth Substances|growth substances|mesh-ancestor
138447376|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447377|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138447378|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138447379|NCT01851005|Analgesics|analgesics|mesh-ancestor
138447380|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
138447381|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447382|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138447383|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138447384|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138447385|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
138447386|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447387|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447388|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138447389|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
138447390|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138447391|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138447392|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138447393|NCT01851005|Narcotics|narcotics|mesh-ancestor
138447394|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138447395|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138447396|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138447397|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
138447398|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138447399|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
138447400|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447401|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447402|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447403|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
138394457|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138447404|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138447405|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447406|NCT01851200|Immunotoxins|immunotoxins|mesh-ancestor
138447407|NCT01851200|Immunoconjugates|immunoconjugates|mesh-ancestor
138447408|NCT01851200|Immunologic Factors|immunologic factors|mesh-ancestor
138447409|NCT01851200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447411|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138447412|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447413|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447414|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447415|NCT01851278|Triamcinolone|triamcinolone|mesh-list
138447416|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138447417|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138447418|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138447419|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138447420|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
138447421|NCT01851278|Hormones|hormones|mesh-ancestor
138447422|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138447423|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447424|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138447425|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
138447426|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447427|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447428|NCT01851408|Sirolimus|sirolimus|mesh-list
138447429|NCT01851408|Sorafenib|sorafenib|mesh-list
138447430|NCT01851408|Temsirolimus|temsirolimus|mesh-list
138447431|NCT01851408|MTOR Inhibitors|mtor inhibitors|mesh-list
138447432|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447434|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447435|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447436|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138447437|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
138447438|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138193326|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
138447439|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138447440|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447441|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138447442|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
138447443|NCT01851473|Quinine|quinine|mesh-list
138447444|NCT01851473|Acetazolamide|acetazolamide|mesh-list
138447445|NCT01851473|Cocaine|cocaine|mesh-list
138447446|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
138447447|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138447448|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447449|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447450|NCT01851473|Diuretics|diuretics|mesh-ancestor
138447451|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
138447452|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447453|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
138447454|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
138447455|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138447456|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
138394681|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
138447457|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447458|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138447459|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138447460|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138447461|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138447462|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
138447463|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447464|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
138447465|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138447466|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138447467|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447468|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138447469|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138447470|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138447471|NCT01851473|Analgesics|analgesics|mesh-ancestor
138447472|NCT01851486|Clonidine|clonidine|mesh-list
138447473|NCT01851486|Naloxone|naloxone|mesh-list
138447474|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138447475|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138348548|NCT02540226|Coagulants|coagulants|mesh-ancestor
138447476|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
138348549|NCT02541864|Amoxicillin|amoxicillin|mesh-list
138447477|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447478|NCT01851486|Analgesics|analgesics|mesh-ancestor
138447479|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138447480|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
138447481|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
138447482|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138447483|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138447484|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138447485|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
138447486|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447487|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447488|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138447489|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138447490|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447491|NCT01851551|Rituximab|rituximab|mesh-list
138447492|NCT01851551|Vincristine|vincristine|mesh-list
138447493|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138447494|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447495|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
138447496|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447497|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138447498|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138447499|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
138447500|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
138447501|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
138447502|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447503|NCT01851681|Amoxicillin|amoxicillin|mesh-list
138447504|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138447505|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447506|NCT01851733|Doxorubicin|doxorubicin|mesh-list
138447507|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138447508|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138394801|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
138193418|NCT03828032|Mannitol|mannitol|mesh-list
138447509|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138447510|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138447511|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447512|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447513|NCT01851759|Cinepazide|cinepazide|mesh-list
138447514|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
138447515|NCT01851824|Vemurafenib|vemurafenib|mesh-list
138447516|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
138447517|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447518|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138447519|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447520|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447521|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
138447522|NCT01851850|Opicapone|opicapone|mesh-list
138447523|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138447524|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447525|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447526|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138447527|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138447528|NCT01851941|Leucovorin|leucovorin|mesh-list
138447529|NCT01851941|Folic Acid|folic acid|mesh-list
138447530|NCT01851941|Fluorouracil|fluorouracil|mesh-list
138447531|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
138447532|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
138447533|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
138447534|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447535|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138447536|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447537|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138447538|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
138447539|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447540|NCT01851941|Antidotes|antidotes|mesh-ancestor
138193453|NCT04129112|Propofol|propofol|mesh-list
138447541|NCT01851941|Protective Agents|protective agents|mesh-ancestor
138447542|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
138447544|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
138447545|NCT01851941|Hematinics|hematinics|mesh-ancestor
138447546|NCT01851954|Clarithromycin|clarithromycin|mesh-list
138447547|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138447548|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447549|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138447550|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447551|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447552|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138447553|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138447554|NCT01851980|Furosemide|furosemide|mesh-list
138447555|NCT01851980|Diuretics|diuretics|mesh-ancestor
138447556|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
138447557|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447558|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138447559|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138447560|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447561|NCT01851993|Ondansetron|ondansetron|mesh-list
138447562|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
138447563|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
138447564|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447565|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447566|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138447567|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
138447568|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
138447569|NCT01851993|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138447570|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138447572|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447573|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447574|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
138447575|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138394886|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138447576|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138447577|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447578|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
138447579|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
138447581|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
138447582|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447583|NCT01852318|Fexofenadine|fexofenadine|mesh-list
138447584|NCT01852318|Pregabalin|pregabalin|mesh-list
138447585|NCT01852318|Analgesics|analgesics|mesh-ancestor
138447586|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
138447587|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447588|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447589|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
138447590|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138447591|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138447592|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447593|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138447594|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138447595|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138447596|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138447597|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138447598|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138447599|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138447600|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138447601|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
138193545|NCT01022567|Ertapenem|ertapenem|mesh-list
138447602|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
138447603|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447605|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138447606|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447607|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138447608|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138447609|NCT01852409|Growth Substances|growth substances|mesh-ancestor
138447610|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447611|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
138447612|NCT01852461|Poractant alfa|poractant alfa|mesh-list
138447614|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138447615|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
138447616|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
138447617|NCT01852539|Propofol|propofol|mesh-list
138447618|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138447619|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138447620|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447621|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138447622|NCT01852539|Analgesics|analgesics|mesh-ancestor
138447623|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
138447624|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447625|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138447626|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138447627|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138447628|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
138447629|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447630|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447631|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138447632|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
138447633|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
138447634|NCT01852565|Diltiazem|diltiazem|mesh-list
138447635|NCT01852565|Darapladib|darapladib|mesh-list
138447636|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138447637|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138447638|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138447639|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447640|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138447641|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447642|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
138447643|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138447644|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447645|NCT01852604|Interferons|interferons|mesh-list
138447646|NCT01852604|Ritonavir|ritonavir|mesh-list
138447647|NCT01852604|Ribavirin|ribavirin|mesh-list
138447648|NCT01852604|Simeprevir|simeprevir|mesh-list
138447649|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447650|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
138447651|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447652|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138447653|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138447654|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
138447655|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447656|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447657|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138447658|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138447659|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138447660|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138447661|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
138447662|NCT01852630|Imipenem|imipenem|mesh-list
138447663|NCT01852630|Cefepime|cefepime|mesh-list
138447664|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138447666|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
138447667|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
138447668|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138447669|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138447670|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447671|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138447672|NCT01852903|Vitamins|vitamins|mesh-list
138447673|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
138447674|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
138447675|NCT01852903|Calcium|calcium|mesh-list
138447676|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
138447677|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447678|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138447679|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
138447680|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447681|NCT01852903|Protective Agents|protective agents|mesh-ancestor
138447682|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
138447683|NCT01852994|Testosterone|testosterone|mesh-list
138447684|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
138447685|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
138447686|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138447688|NCT01852994|Hormones|hormones|mesh-ancestor
138447689|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138447690|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447691|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138447692|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447693|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
138447694|NCT01853111|Aldesleukin|aldesleukin|mesh-list
138447695|NCT01853111|Interleukin-2|interleukin-2|mesh-list
138447696|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447697|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138447698|NCT01853111|Analgesics|analgesics|mesh-ancestor
138447699|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
138447700|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447701|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447702|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138447703|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138447704|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
138447705|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447706|NCT01853306|Veliparib|veliparib|mesh-list
138447707|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138447708|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447709|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447710|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447711|NCT01853423|Sirolimus|sirolimus|mesh-list
138447712|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138447713|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447714|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138447715|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447716|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
138447717|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138447718|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
138447719|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447720|NCT01853449|Fentanyl|fentanyl|mesh-list
138447721|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138447722|NCT01853449|Narcotics|narcotics|mesh-ancestor
138447723|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138447724|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447726|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
138447727|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447728|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138447729|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138447730|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
138447731|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
138447732|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
138447733|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
138447734|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138447735|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138447736|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447737|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447738|NCT01853540|Urological Agents|urological agents|mesh-ancestor
138447739|NCT01853566|Hormones|hormones|mesh-list
138406689|NCT01595789|Hormones|hormones|mesh-ancestor
138447740|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138447741|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447743|NCT01853709|Cathartics|cathartics|mesh-ancestor
138447744|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138447745|NCT01853709|Laxatives|laxatives|mesh-ancestor
138447746|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
138447748|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138447749|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
138447750|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447751|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447752|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138447753|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
138447754|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138447755|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138447756|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138447757|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
138447758|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447759|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447760|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
138447761|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138447762|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
138447763|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138447764|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
138447765|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447766|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447767|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
138447768|NCT01853813|Bevacizumab|bevacizumab|mesh-list
138447769|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138447770|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447771|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138447772|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138447773|NCT01853813|Growth Substances|growth substances|mesh-ancestor
138447774|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447775|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
138447776|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
138447777|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
138447778|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447779|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447780|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447781|NCT01853956|Alprazolam|alprazolam|mesh-list
138447782|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138447783|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138447784|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447785|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138447786|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138447787|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138447788|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
138447789|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
138447790|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447791|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447792|NCT01854021|Anesthetics|anesthetics|mesh-list
138447793|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138417222|NCT01672359|Choline|choline|mesh-list
138447795|NCT01854073|Scopolamine|scopolamine|mesh-list
138447796|NCT01854073|Bromides|bromides|mesh-list
138447797|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138447798|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
138193729|NCT01222585|Metronidazole|metronidazole|mesh-list
138447799|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138447800|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
138447801|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
138447802|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447803|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447804|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138447805|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
138447806|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138447807|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
138447808|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447809|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447810|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138447811|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
138447812|NCT01854086|Diphosphonates|diphosphonates|mesh-list
138447813|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138406774|NCT01596075|Cannabidiol|cannabidiol|mesh-list
138447814|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447816|NCT01854203|Gemcitabine|gemcitabine|mesh-list
138447817|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447818|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138447819|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
138447820|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447821|NCT01854216|Rotigotine|rotigotine|mesh-list
138447822|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
138447823|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
138447824|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395369|NCT06051370|Anesthetics|anesthetics|mesh-ancestor
138447825|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447826|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447827|NCT01854411|Analgesics|analgesics|mesh-list
138447828|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
138447829|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447830|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447831|NCT01854424|Dimercaprol|dimercaprol|mesh-list
138447832|NCT01854424|Chelating Agents|chelating agents|mesh-ancestor
138447833|NCT01854424|Sequestering Agents|sequestering agents|mesh-ancestor
138447834|NCT01854424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447835|NCT01854463|Vitamin D|vitamin d|mesh-list
138447836|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
138447837|NCT01854463|Vitamins|vitamins|mesh-ancestor
138447838|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
138447839|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447840|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138447841|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138447842|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
138447843|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138447844|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138447845|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447846|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
138447847|NCT01854476|Coagulants|coagulants|mesh-ancestor
138447848|NCT01854489|Rifampin|rifampin|mesh-list
138447849|NCT01854489|Buprenorphine|buprenorphine|mesh-list
138447850|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138447851|NCT01854489|Narcotics|narcotics|mesh-ancestor
138447852|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138447853|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447854|NCT01854489|Analgesics|analgesics|mesh-ancestor
138447855|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
138447856|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447857|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138447858|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138447859|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
138447860|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138395442|NCT05973786|Analgesics|analgesics|mesh-ancestor
138447861|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138447862|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
138447863|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138447864|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447865|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447866|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138447867|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138447868|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138447869|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138447870|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138447871|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138447872|NCT01854502|Fluorides|fluorides|mesh-list
138447873|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
138447874|NCT01854502|Protective Agents|protective agents|mesh-ancestor
138447875|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447876|NCT01854515|Dexamethasone|dexamethasone|mesh-list
138447877|NCT01854515|Budesonide|budesonide|mesh-list
138447878|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
138447879|NCT01854515|BB 1101|bb 1101|mesh-list
138447880|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138447881|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
138447882|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
138447883|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447884|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447885|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138447886|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
138447887|NCT01854515|Hormones|hormones|mesh-ancestor
138395532|NCT05603702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138447888|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138447889|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138447890|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447891|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138447892|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138447893|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
138447894|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
138447895|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447896|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447898|NCT01854606|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138447899|NCT01854606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138447900|NCT01854606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447901|NCT01854606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447902|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138199900|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138447903|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
138447904|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447905|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447906|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
138447907|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138447908|NCT01854723|Insulin|insulin|mesh-list
138447909|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138447910|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
138447911|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
138447912|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
138447913|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
138447914|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138447915|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447917|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138447918|NCT01854762|Ritonavir|ritonavir|mesh-list
138447919|NCT01854762|Lopinavir|lopinavir|mesh-list
138447920|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
138447921|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138447922|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138447923|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
138447924|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447925|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447926|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138447927|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138447928|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
138447929|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138395591|NCT05368090|Adrenergic Agents|adrenergic agents|mesh-ancestor
138447930|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138447931|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138447932|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138447933|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138447934|NCT01854970|Esomeprazole|esomeprazole|mesh-list
138447935|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138447936|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138447937|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138447938|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447939|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447940|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
138447942|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
138447943|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
138447944|NCT01855009|Calcium|calcium|mesh-list
138447945|NCT01855009|Vitamins|vitamins|mesh-ancestor
138447946|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
138447947|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447948|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138447949|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138447950|NCT01855009|Antacids|antacids|mesh-ancestor
138447951|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447952|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138447953|NCT01855061|Midazolam|midazolam|mesh-list
138447954|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138447955|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138447956|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138447957|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447958|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138447959|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138395685|NCT05249309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138395686|NCT05249309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395687|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138395688|NCT05176964|Capecitabine|capecitabine|mesh-list
138395689|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
138395690|NCT05176964|Tislelizumab|tislelizumab|mesh-list
138395691|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138395692|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
138395693|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138395694|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138395695|NCT05176964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138395696|NCT05095571|Niacinamide|niacinamide|mesh-list
138199905|NCT00437216|Clobetasol|clobetasol|mesh-list
138395698|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
138395699|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
138395700|NCT05095571|Vitamins|vitamins|mesh-ancestor
138395701|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
138395702|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138447960|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138447961|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138447962|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
138447963|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
138447964|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
138447965|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
138447966|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138247762|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138447967|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447968|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
138447969|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138447970|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
138447971|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138447972|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
138447973|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447974|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447975|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
138447976|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
138447977|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138447978|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
138447979|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138447980|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
138447981|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138447982|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447983|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
138447985|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
138447986|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
138447987|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138447988|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395745|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138395746|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395747|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
138395748|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138395749|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138395750|NCT04888858|Narcotics|narcotics|mesh-ancestor
138395751|NCT04888858|Analgesics|analgesics|mesh-ancestor
138395752|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138395753|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138395754|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
138447989|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138447990|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138447991|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
138447992|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138447993|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138447994|NCT01855256|Urological Agents|urological agents|mesh-ancestor
138447996|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
138447998|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
138447999|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448000|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138448001|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138448002|NCT01855334|Spironolactone|spironolactone|mesh-list
138448003|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138448004|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
138448005|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138448006|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448007|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138448008|NCT01855334|Diuretics|diuretics|mesh-ancestor
138448009|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
138448010|NCT01855386|Liver Extracts|liver extracts|mesh-list
138448011|NCT01855386|Hematinics|hematinics|mesh-ancestor
138448012|NCT01855490|Exenatide|exenatide|mesh-list
138448013|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138448014|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448015|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138448016|NCT01855490|Incretins|incretins|mesh-ancestor
138448017|NCT01855490|Hormones|hormones|mesh-ancestor
138448018|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138448019|NCT01855516|Heparin|heparin|mesh-list
138448020|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
138448021|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138448022|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138448023|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448025|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
138448026|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
138448027|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448028|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448029|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
138448030|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448031|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
138448032|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138395986|NCT04038619|Loperamide|loperamide|mesh-list
138448033|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138448034|NCT01855555|Propofol|propofol|mesh-list
138448035|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138448036|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448037|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448038|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138448039|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
138448040|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
138448041|NCT01855568|Methotrexate|methotrexate|mesh-list
138448042|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138448043|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
138448044|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138448045|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448046|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138448048|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448049|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138396067|NCT03723187|Heparin|heparin|mesh-list
138448050|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
138448051|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448052|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138448053|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138448054|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
138448055|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138448056|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138448058|NCT01855581|Propofol|propofol|mesh-list
138448059|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138448060|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448061|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448062|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138448063|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
138448064|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
138448065|NCT01855581|Analgesics|analgesics|mesh-ancestor
138448066|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
138396106|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138417438|NCT05596968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138396107|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138396109|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138396110|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138396111|NCT03186638|Analgesics|analgesics|mesh-ancestor
138396112|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
138396113|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448067|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448068|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138448069|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138448070|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138448071|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448072|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448073|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
138448074|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
138448075|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138448076|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448077|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448078|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
138448079|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138448080|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448081|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448082|NCT01855711|Alosetron|alosetron|mesh-list
138448083|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138448084|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138448085|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
138448086|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448087|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448088|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396171|NCT02846623|Venetoclax|venetoclax|mesh-list
138448090|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138448091|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
138448092|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448093|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448094|NCT01855737|Warfarin|warfarin|mesh-list
138448095|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
138448096|NCT01855763|Insulin|insulin|mesh-list
138448097|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138448098|NCT01855763|Metformin|metformin|mesh-list
138417474|NCT05596552|Fentanyl|fentanyl|mesh-list
138448099|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138448100|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448101|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138448103|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448104|NCT01855971|Protective Agents|protective agents|mesh-ancestor
138448105|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448106|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138448107|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138448108|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448109|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138448110|NCT01855984|Tocotrienols|tocotrienols|mesh-list
138448111|NCT01855984|Vitamin E|vitamin e|mesh-list
138448112|NCT01855984|Tocopherols|tocopherols|mesh-list
138448114|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
138448115|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448116|NCT01855984|Protective Agents|protective agents|mesh-ancestor
138448117|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448118|NCT01855984|Vitamins|vitamins|mesh-ancestor
138448119|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
138448120|NCT01856062|Dexamethasone|dexamethasone|mesh-list
138448121|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138448122|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
138448123|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
138448124|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448125|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448126|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138448128|NCT01856062|Hormones|hormones|mesh-ancestor
138448129|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138448130|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138448131|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448132|NCT01856101|Dactolisib|dactolisib|mesh-list
138448133|NCT01856101|MTOR Inhibitors|mtor inhibitors|mesh-list
138448134|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448135|NCT01856101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138448136|NCT01856101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448137|NCT01856101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448138|NCT01856101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138448139|NCT01856101|Immunologic Factors|immunologic factors|mesh-ancestor
138448140|NCT01856101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448141|NCT01856127|Sertraline|sertraline|mesh-list
138448142|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
138448143|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
138448144|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138448145|NCT01856127|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138448146|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138448147|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138448148|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448149|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448150|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
138448151|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448152|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138199922|NCT00002524|Prednisolone|prednisolone|mesh-list
138199923|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
138448153|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138448154|NCT01856166|Sufentanil|sufentanil|mesh-list
138448155|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
138448156|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138448157|NCT01856166|Narcotics|narcotics|mesh-ancestor
138448158|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448159|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448160|NCT01856166|Analgesics|analgesics|mesh-ancestor
138448161|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
138448162|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448164|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138448165|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
138448166|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
138448167|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
138448168|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
138448169|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138448171|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
138448172|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138448173|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
138448174|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448175|NCT01856348|Vitamin D|vitamin d|mesh-list
138448176|NCT01856348|Vitamins|vitamins|mesh-ancestor
138448177|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
138448178|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448179|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138448180|NCT01856374|Sirolimus|sirolimus|mesh-list
138448181|NCT01856374|Everolimus|everolimus|mesh-list
138448183|NCT01856374|Pravastatin|pravastatin|mesh-list
138448184|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138448185|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138448186|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
138417539|NCT05596071|Sensory System Agents|sensory system agents|mesh-ancestor
138448187|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448188|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138448189|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138448190|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448191|NCT01856374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138448192|NCT01856374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138448193|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138448194|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
138448195|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448196|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448197|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138448198|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138448199|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138448200|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
138448201|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
138448202|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
138194145|NCT04273100|Lenvatinib|lenvatinib|mesh-list
138448203|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448204|NCT01856517|Clonidine|clonidine|mesh-list
138448205|NCT01856517|Analgesics|analgesics|mesh-ancestor
138448206|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
138448207|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448208|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448209|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138448210|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
138448211|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
138448212|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138448213|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138448214|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138448215|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
138448216|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448217|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448218|NCT01856556|Glycine|glycine|mesh-list
138448219|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
138448220|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138417576|NCT05557253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448221|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448222|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448223|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138448225|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138448226|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
138448227|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448228|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448229|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138448230|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
138448231|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
138448232|NCT01856621|Hormones|hormones|mesh-ancestor
138448233|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138448234|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
138448235|NCT01856621|Antidotes|antidotes|mesh-ancestor
138448236|NCT01856621|Protective Agents|protective agents|mesh-ancestor
138448237|NCT01856738|Rivastigmine|rivastigmine|mesh-list
138448238|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138448239|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247777|NCT03556761|Furosemide|furosemide|mesh-list
138448240|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448241|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
138448242|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448243|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448244|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138448245|NCT01856738|Protective Agents|protective agents|mesh-ancestor
138448246|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
138448247|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138448248|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
138448249|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448250|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138448251|NCT01856946|Vitamin D|vitamin d|mesh-list
138448252|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
138448253|NCT01856946|Vitamins|vitamins|mesh-ancestor
138448254|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
138448255|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448256|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138448257|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138448258|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
138448259|NCT01856959|Albuterol|albuterol|mesh-list
138448260|NCT01856959|Analgesics|analgesics|mesh-ancestor
138448261|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
138448262|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448263|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448265|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448266|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138448267|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
138448268|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138448269|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138448270|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448271|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138448273|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138448274|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138448275|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
138448276|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138448277|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
138448278|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138448279|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138448280|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138448281|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
138448282|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448283|NCT01856985|Misoprostol|misoprostol|mesh-list
138448284|NCT01856985|Mifepristone|mifepristone|mesh-list
138448285|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138448286|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
138448287|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138448288|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448289|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138448290|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138448291|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
138448292|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138448293|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138448294|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138448295|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138448296|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
138448297|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138448298|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138448299|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
138448300|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138448301|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
138448302|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138448303|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138448304|NCT01856998|Propofol|propofol|mesh-list
138448305|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138448306|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448307|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448308|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138448309|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
138448310|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
138448311|NCT01857011|Iron|iron|mesh-list
138448312|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138448313|NCT01857011|Teferrol|teferrol|mesh-list
138448314|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
138448315|NCT01857011|Trace Elements|trace elements|mesh-ancestor
138448316|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
138448317|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448318|NCT01857011|Hematinics|hematinics|mesh-ancestor
138448319|NCT01857024|Sevelamer|sevelamer|mesh-list
138448320|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
138448321|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
138448322|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448323|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
138448324|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138448325|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448326|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448327|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138448329|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
138448330|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138396893|NCT01527669|Lovastatin|lovastatin|mesh-list
138448331|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138448332|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138448333|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138448334|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
138448335|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448336|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448337|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
138448339|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
138448340|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
138448341|NCT01857154|Calcium|calcium|mesh-list
138448343|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
138448344|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448345|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138448346|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138448348|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448349|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138448351|NCT01857193|Exemestane|exemestane|mesh-list
138448352|NCT01857193|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138448353|NCT01857193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138448354|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448355|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448356|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138448357|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
138448358|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448359|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448360|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138448361|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138448362|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138448363|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
138448364|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138448365|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
138448366|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138448367|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138448368|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138448369|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
138448370|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138448371|NCT01857349|Ethanol|ethanol|mesh-list
138448372|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
138448373|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138448374|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138448375|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138448376|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448377|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448378|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
138448379|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
138448380|NCT01857375|Insulin|insulin|mesh-list
138448381|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138448382|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448383|NCT01857453|Etoposide|etoposide|mesh-list
138448384|NCT01857453|Carboplatin|carboplatin|mesh-list
138448385|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138448386|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448387|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138448388|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138448389|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448390|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448391|NCT01857479|Amphotericin B|amphotericin b|mesh-list
138417711|NCT04624854|Aspirin|aspirin|mesh-list
138448392|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138448393|NCT01857479|Budesonide|budesonide|mesh-list
138448394|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138448395|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138448396|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
138448397|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138397148|NCT01529164|Leucovorin|leucovorin|mesh-list
138448398|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448399|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138448400|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
138448401|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
138448402|NCT01857479|Hormones|hormones|mesh-ancestor
138448403|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138448404|NCT01857479|Amebicides|amebicides|mesh-ancestor
138448405|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138448406|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138448407|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138448408|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138448409|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
138448410|NCT01857544|Aflibercept|aflibercept|mesh-list
138448411|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138448412|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138448413|NCT01857544|Growth Substances|growth substances|mesh-ancestor
138448414|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448415|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
138448416|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448418|NCT01857596|Bupropion|bupropion|mesh-list
138448419|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138407377|NCT01598649|Caseins|caseins|mesh-list
138448420|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
138448421|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138448422|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138448423|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138448424|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138448425|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448426|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
138448427|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448428|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448429|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138448430|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138448431|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448432|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138448433|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138448434|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448435|NCT01857596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138448436|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
138448437|NCT01857609|Metformin|metformin|mesh-list
138448438|NCT01857609|Rabeprazole|rabeprazole|mesh-list
138448439|NCT01857609|Pantoprazole|pantoprazole|mesh-list
138448440|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138448441|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448442|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138448443|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138448444|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138448445|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448446|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448447|NCT01857726|Doxorubicin|doxorubicin|mesh-list
138448448|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448449|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138448450|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138448451|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138448452|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448453|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448454|NCT01857752|Temozolomide|temozolomide|mesh-list
138247788|NCT03559179|Analgesics|analgesics|mesh-ancestor
138448455|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138448456|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
138448457|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448458|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448459|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138448460|NCT01857804|Amoxicillin|amoxicillin|mesh-list
138448461|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
138448462|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138448463|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138448464|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138448465|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
138448466|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
138448468|NCT01857817|Propranolol|propranolol|mesh-list
138448469|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138448470|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138448471|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
138448472|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448473|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448474|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448475|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138448476|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138448478|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138448479|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138448480|NCT01857817|Analgesics|analgesics|mesh-ancestor
138448481|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
138448482|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448483|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138448484|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138448485|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138448486|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138194584|NCT01451918|Resveratrol|resveratrol|mesh-list
138448487|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448489|NCT01857843|Simvastatin|simvastatin|mesh-list
138448490|NCT01857843|Ezetimibe|ezetimibe|mesh-list
138448491|NCT01857843|Pravastatin|pravastatin|mesh-list
138448492|NCT01857843|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138397554|NCT01530984|Ipilimumab|ipilimumab|mesh-list
138448493|NCT01857843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138448494|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448495|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448496|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138448497|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
138448498|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448499|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448500|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138448501|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138448502|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
138448503|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138448504|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138448505|NCT01857856|Eplerenone|eplerenone|mesh-list
138448506|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138448507|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
138448508|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138448509|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448510|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138448511|NCT01857856|Diuretics|diuretics|mesh-ancestor
138397696|NCT01531764|Afatinib|afatinib|mesh-list
138448512|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
138448513|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138448514|NCT01857895|Exenatide|exenatide|mesh-list
138448515|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138448516|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448517|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138448518|NCT01857895|Incretins|incretins|mesh-ancestor
138448519|NCT01857895|Hormones|hormones|mesh-ancestor
138448520|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138448521|NCT01857921|Trimetazidine|trimetazidine|mesh-list
138448522|NCT01857921|Atorvastatin|atorvastatin|mesh-list
138448523|NCT01857921|Pravastatin|pravastatin|mesh-list
138448524|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138448525|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138448526|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
138448527|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448528|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138448529|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138448530|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448531|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
138448532|NCT01857999|Losartan|losartan|mesh-list
138448533|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138397756|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
138448534|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138448535|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138448536|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138448537|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448540|NCT01858025|Mitomycin|mitomycin|mesh-list
138448541|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
138448542|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448543|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138448544|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448545|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138448546|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
138448547|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448548|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138448549|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
138448550|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138448551|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448552|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
138448553|NCT01858051|Vitamin D|vitamin d|mesh-list
138448554|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138448555|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448556|NCT01858051|Vitamins|vitamins|mesh-ancestor
138448557|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
138448558|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138448559|NCT01858077|Everolimus|everolimus|mesh-list
138397945|NCT01533324|Leucovorin|leucovorin|mesh-list
138448560|NCT01858077|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138448561|NCT01858077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138448562|NCT01858077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448563|NCT01858077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448564|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138448565|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
138448566|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448567|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448568|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
138407529|NCT05689983|Budesonide|budesonide|mesh-list
138448570|NCT01858090|Diclofenac|diclofenac|mesh-list
138448571|NCT01858090|Atropine|atropine|mesh-list
138448572|NCT01858090|Ephedrine|ephedrine|mesh-list
138448573|NCT01858090|Fentanyl|fentanyl|mesh-list
138448574|NCT01858090|Sufentanil|sufentanil|mesh-list
138448575|NCT01858090|Meperidine|meperidine|mesh-list
138448577|NCT01858090|Propofol|propofol|mesh-list
138448578|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
138398013|NCT01533662|Phenylephrine|phenylephrine|mesh-list
138448579|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138448580|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448581|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448582|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138448583|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
138448584|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
138448585|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138448586|NCT01858090|Narcotics|narcotics|mesh-ancestor
138448587|NCT01858090|Analgesics|analgesics|mesh-ancestor
138448588|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
138448589|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448590|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138448591|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138448592|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138448593|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138448594|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138448595|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138448596|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448597|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448598|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138448599|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138448600|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
138448601|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138448602|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
138448603|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
138448604|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
138448605|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138448606|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138448607|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
138448608|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448609|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138448610|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
138448611|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
138448612|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138448613|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138448614|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
138448615|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
138448616|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138448617|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
138448618|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
138194893|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138448619|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138398102|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
138448620|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138448621|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
138448622|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138448623|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
138448624|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138448625|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
138448626|NCT01858155|Melatonin|melatonin|mesh-list
138448627|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
138448628|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448629|NCT01858155|Protective Agents|protective agents|mesh-ancestor
138448630|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448631|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448632|NCT01858168|Irinotecan|irinotecan|mesh-list
138448633|NCT01858168|Temozolomide|temozolomide|mesh-list
138448634|NCT01858168|Olaparib|olaparib|mesh-list
138194958|NCT01890902|Ketoprofen|ketoprofen|mesh-list
138448635|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138448636|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138448637|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448638|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448639|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448640|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138448641|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
138448642|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138398236|NCT01535079|Ibuprofen|ibuprofen|mesh-list
138448643|NCT01858207|Doxorubicin|doxorubicin|mesh-list
138448644|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138448645|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448646|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138448647|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138448648|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448649|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448651|NCT01858311|Vitamin E|vitamin e|mesh-list
138448652|NCT01858311|Tocopherols|tocopherols|mesh-list
138448653|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
138448654|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448655|NCT01858311|Protective Agents|protective agents|mesh-ancestor
138398289|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448656|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448657|NCT01858311|Vitamins|vitamins|mesh-ancestor
138448658|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
138448659|NCT01858402|Acetaminophen|acetaminophen|mesh-list
138448660|NCT01858402|Dipyrone|dipyrone|mesh-list
138448661|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138448662|NCT01858402|Analgesics|analgesics|mesh-ancestor
138448663|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
138448664|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247804|NCT03368235|Hormones|hormones|mesh-ancestor
138448665|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448666|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
138448667|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138448668|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138448669|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138448670|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
138448671|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448672|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138448673|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448674|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448675|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
138448676|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138448677|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448678|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138448679|NCT01858571|Thalidomide|thalidomide|mesh-list
138448680|NCT01858571|Celecoxib|celecoxib|mesh-list
138448681|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
138448682|NCT01858571|Etoposide|etoposide|mesh-list
138195061|NCT01891526|Tretinoin|tretinoin|mesh-list
138448683|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138448684|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
138448685|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448686|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138448687|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138448688|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
138448689|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448690|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448691|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138448692|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138448693|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138448694|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138448695|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448696|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138448697|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138448698|NCT01858571|Analgesics|analgesics|mesh-ancestor
138448699|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
138448700|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448701|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138448702|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138448703|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138448704|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
138448705|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138448706|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138448707|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138448708|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138448709|NCT01858571|Growth Substances|growth substances|mesh-ancestor
138448710|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
138417996|NCT02549677|Docetaxel|docetaxel|mesh-list
138448712|NCT01858610|Irbesartan|irbesartan|mesh-list
138448713|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138448714|NCT01858610|Diuretics|diuretics|mesh-ancestor
138448715|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
138448716|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448717|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138448718|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138448719|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138407681|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138199959|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
138199960|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138448720|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138448721|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138448722|NCT01858623|Losartan|losartan|mesh-list
138448723|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138448724|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138448725|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138448726|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138448727|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138448728|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448730|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
138448731|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448732|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138448733|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138448734|NCT01858649|Bevacizumab|bevacizumab|mesh-list
138448735|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
138448736|NCT01858649|Irinotecan|irinotecan|mesh-list
138448737|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138448738|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448739|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138448740|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138448741|NCT01858649|Growth Substances|growth substances|mesh-ancestor
138448742|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448743|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
138448744|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138448745|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138448746|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448747|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448748|NCT01858662|Leucovorin|leucovorin|mesh-list
138448749|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
138448750|NCT01858662|Irinotecan|irinotecan|mesh-list
138448751|NCT01858662|Cetuximab|cetuximab|mesh-list
138448752|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448753|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138418024|NCT02257970|Analgesics|analgesics|mesh-ancestor
138448754|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138448755|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448756|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448757|NCT01858662|Antidotes|antidotes|mesh-ancestor
138448758|NCT01858662|Protective Agents|protective agents|mesh-ancestor
138448759|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448760|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
138448761|NCT01858662|Vitamins|vitamins|mesh-ancestor
138448762|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
138448763|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138448764|NCT01858792|Belimumab|belimumab|mesh-list
138448765|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138448766|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
138448767|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448768|NCT01858831|Atovaquone|atovaquone|mesh-list
138448769|NCT01858831|Proguanil|proguanil|mesh-list
138448770|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
138448771|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138448772|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
138448773|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138448774|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138448775|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448776|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448777|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
138448778|NCT01858870|Lacosamide|lacosamide|mesh-list
138448779|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
138448780|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138448781|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138448782|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138448783|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448784|NCT01858909|Melatonin|melatonin|mesh-list
138448785|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
138448786|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448787|NCT01858909|Protective Agents|protective agents|mesh-ancestor
138448788|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448789|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448790|NCT01858961|Interferons|interferons|mesh-list
138448791|NCT01858961|Ribavirin|ribavirin|mesh-list
138448792|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138407761|NCT04530747|Metformin|metformin|mesh-list
138448793|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
138448794|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138448795|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
138247814|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138448796|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448798|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
138448799|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138448800|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448801|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138418058|NCT05838001|Hormones|hormones|mesh-ancestor
138448802|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138448803|NCT01859234|Growth Substances|growth substances|mesh-ancestor
138448804|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448805|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
138195377|NCT02556918|Insulin|insulin|mesh-list
138448806|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138448807|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448808|NCT01859377|Ibuprofen|ibuprofen|mesh-list
138448809|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138448810|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138448811|NCT01859377|Analgesics|analgesics|mesh-ancestor
138448812|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
138448813|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448814|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448815|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138448816|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138448817|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138448818|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448819|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448820|NCT01859455|Atorvastatin|atorvastatin|mesh-list
138448821|NCT01859455|Simvastatin|simvastatin|mesh-list
138448822|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138448823|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138448824|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
138448825|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448826|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138448827|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138448828|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448829|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
138448830|NCT01859468|Calcium|calcium|mesh-list
138195505|NCT05507398|Antimetabolites|antimetabolites|mesh-ancestor
138448831|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138398941|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
138448832|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448833|NCT01859468|Antacids|antacids|mesh-ancestor
138448834|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448835|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138448836|NCT01859481|Eletriptan|eletriptan|mesh-list
138448837|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138448838|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
138448839|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448840|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448841|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448842|NCT01859585|Ketorolac|ketorolac|mesh-list
138448843|NCT01859585|Parecoxib|parecoxib|mesh-list
138448844|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138448845|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138448846|NCT01859585|Analgesics|analgesics|mesh-ancestor
138418087|NCT05836545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138448848|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448849|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448850|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138448851|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138448852|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138448853|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448854|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448855|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138448856|NCT01859624|Albuterol|albuterol|mesh-list
138448857|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138448858|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
138199969|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
138448859|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448860|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448861|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138448862|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
138448863|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
138448864|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138448865|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138448866|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138448867|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138448868|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
138448869|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448870|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448871|NCT01859728|Cisplatin|cisplatin|mesh-list
138448872|NCT01859728|Gemcitabine|gemcitabine|mesh-list
138448873|NCT01859728|Irinotecan|irinotecan|mesh-list
138448874|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448875|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138448876|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
138448877|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448878|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138448879|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138448880|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448881|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
138448882|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138448883|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138448884|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
138448885|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448888|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
138448889|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
138448890|NCT01860066|Fluticasone|fluticasone|mesh-list
138448891|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138448892|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138448893|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138448894|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138448895|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
138448896|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448897|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448898|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138448899|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
138448900|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
138448901|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138448902|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138448903|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138448904|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138448905|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
138448906|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138195734|NCT00996502|Prednisone|prednisone|mesh-list
138448907|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448908|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
138448909|NCT01860066|Hormones|hormones|mesh-ancestor
138448910|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138448911|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
138448912|NCT01860105|Clopidogrel|clopidogrel|mesh-list
138448913|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138448914|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138448915|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138448916|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138448917|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
138448918|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448919|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448920|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448921|NCT01860144|Bevacizumab|bevacizumab|mesh-list
138448922|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138448923|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448924|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138448925|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138448926|NCT01860144|Growth Substances|growth substances|mesh-ancestor
138448927|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448928|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
138448929|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
138448930|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138448931|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448932|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138448933|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
138448934|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138448935|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138448936|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138195841|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448937|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448938|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138448939|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138448940|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138407952|NCT05702190|Opium|opium|mesh-list
138448941|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448942|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138448943|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138448944|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448945|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
138448946|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448947|NCT01860235|Anesthetics|anesthetics|mesh-list
138448948|NCT01860235|Benzocaine|benzocaine|mesh-list
138448949|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
138448950|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448951|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448952|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
138448953|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448954|NCT01860300|Amoxicillin|amoxicillin|mesh-list
138448955|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
138448956|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
138453604|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138448957|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138448958|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138448959|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138448960|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138448961|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418189|NCT05727579|Ertugliflozin|ertugliflozin|mesh-list
138448962|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448964|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
138448965|NCT01860391|Protective Agents|protective agents|mesh-ancestor
138448966|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448967|NCT01860417|Mepivacaine|mepivacaine|mesh-list
138448968|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
138448969|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
138448970|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138448971|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448972|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
138448973|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138448974|NCT01860469|Vancomycin|vancomycin|mesh-list
138448975|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138448976|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138448977|NCT01860482|Rabeprazole|rabeprazole|mesh-list
138448978|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138448979|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138448980|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138448981|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138196035|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138448982|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448983|NCT01860508|Carboplatin|carboplatin|mesh-list
138448984|NCT01860508|Pemetrexed|pemetrexed|mesh-list
138448985|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138448986|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453605|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448987|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448988|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138448989|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138448990|NCT01860625|Donepezil|donepezil|mesh-list
138448991|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138448992|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138448993|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138448994|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
138448995|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138448996|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138448997|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
138448998|NCT01860638|Bevacizumab|bevacizumab|mesh-list
138448999|NCT01860638|Temozolomide|temozolomide|mesh-list
138449000|NCT01860638|Lomustine|lomustine|mesh-list
138449001|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138449002|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449003|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138449005|NCT01860638|Growth Substances|growth substances|mesh-ancestor
138449006|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449007|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
138449008|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138449009|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
138449010|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449011|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
138449012|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138449013|NCT01860690|Methotrexate|methotrexate|mesh-list
138449014|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138449015|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
138449016|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138449017|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449018|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138449020|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449021|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449022|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
138449023|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449024|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138449025|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138449026|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
138449027|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138449028|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138449029|NCT01860716|Melatonin|melatonin|mesh-list
138449030|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
138449031|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449032|NCT01860716|Protective Agents|protective agents|mesh-ancestor
138449033|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138196104|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
138449034|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449035|NCT01860729|Anacetrapib|anacetrapib|mesh-list
138449036|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138449037|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138449038|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
138449039|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449040|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138449041|NCT01860742|Interferons|interferons|mesh-list
138449042|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
138449043|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
138449044|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138449045|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449046|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
138449047|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449048|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
138449049|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449050|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138449051|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449052|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138449053|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138449054|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138449055|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449056|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449057|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138449058|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138449059|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138449060|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
138449061|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138196125|NCT00731770|Xhance|xhance|mesh-list
138449062|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449063|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138449064|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138449065|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
138449067|NCT01860833|Celecoxib|celecoxib|mesh-list
138449068|NCT01860833|Diclofenac|diclofenac|mesh-list
138449069|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138449070|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138449071|NCT01860833|Analgesics|analgesics|mesh-ancestor
138449072|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
138449073|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449074|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449075|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138449076|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138449077|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138449078|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449079|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449080|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138449081|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
138449082|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449083|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449085|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
138449086|NCT01861015|Epinephrine|epinephrine|mesh-list
138449087|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138449088|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138408053|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
138449089|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
138449090|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449091|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449092|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449093|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138449094|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138449095|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
138449096|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449098|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
138449099|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
138449100|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
138449101|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138449102|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
138449103|NCT01861015|Coagulants|coagulants|mesh-ancestor
138449104|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138449105|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
138449106|NCT01861041|Bupivacaine|bupivacaine|mesh-list
138449107|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
138449108|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
138449109|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449110|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449111|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
138449112|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449113|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
138449114|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138449115|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
138449116|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138449117|NCT01861223|Afatinib|afatinib|mesh-list
138449118|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
138449119|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449120|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138449121|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449122|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449123|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138449124|NCT01861340|Dexamethasone|dexamethasone|mesh-list
138449125|NCT01861340|Lenalidomide|lenalidomide|mesh-list
138449126|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138449127|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
138449128|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
138449129|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449130|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449131|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138449132|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
138449133|NCT01861340|Hormones|hormones|mesh-ancestor
138449134|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138449135|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138449136|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449137|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
138418306|NCT05108259|Adalimumab|adalimumab|mesh-list
138449138|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138449139|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138449140|NCT01861340|Growth Substances|growth substances|mesh-ancestor
138449141|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
138449143|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138449144|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
138449145|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449146|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449147|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
138449148|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
138449149|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138449150|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
138449151|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449152|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138449153|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138449154|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
138449155|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449156|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449157|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138449158|NCT01861626|Isotretinoin|isotretinoin|mesh-list
138449159|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
138449160|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
138449161|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
138449162|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449163|NCT01861951|Doxorubicin|doxorubicin|mesh-list
138449164|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138449165|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449166|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138449167|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138449168|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449169|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449170|NCT01861990|Valproic Acid|valproic acid|mesh-list
138449171|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
138196454|NCT00000778|Vitamins|vitamins|mesh-ancestor
138449172|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418340|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449173|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449174|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
138449175|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449176|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449177|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
138449178|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138449179|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449180|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138449181|NCT01862003|Leucovorin|leucovorin|mesh-list
138449182|NCT01862003|Folic Acid|folic acid|mesh-list
138449183|NCT01862003|Fluorouracil|fluorouracil|mesh-list
138449184|NCT01862003|Irinotecan|irinotecan|mesh-list
138449185|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
138449186|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
138449187|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449188|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138449189|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449190|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138449191|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
138449192|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449193|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138449194|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138449195|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449196|NCT01862003|Antidotes|antidotes|mesh-ancestor
138196512|NCT02389946|Sirolimus|sirolimus|mesh-list
138449197|NCT01862003|Protective Agents|protective agents|mesh-ancestor
138449198|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
138449199|NCT01862003|Vitamins|vitamins|mesh-ancestor
138449200|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
138449201|NCT01862003|Hematinics|hematinics|mesh-ancestor
138449202|NCT01862081|Paclitaxel|paclitaxel|mesh-list
138449203|NCT01862081|Docetaxel|docetaxel|mesh-list
138399990|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138449204|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138449205|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449206|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
138449207|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
138449208|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
138449209|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449211|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418381|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
138449212|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138449213|NCT01862120|Analgesics|analgesics|mesh-ancestor
138449214|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
138449215|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449216|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449217|NCT01862263|Vildagliptin|vildagliptin|mesh-list
138449218|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138449219|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449220|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138449221|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
138449222|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449223|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449224|NCT01862302|Haloperidol|haloperidol|mesh-list
138449225|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
138449226|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
138449227|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
138400050|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
138449228|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449229|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449230|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138196559|NCT01892384|BI 409306|bi 409306|mesh-list
138449232|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138449233|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449234|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138449235|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138449236|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
138449237|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449238|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449239|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138449240|NCT01862354|Anesthetics|anesthetics|mesh-list
138449241|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188488|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449242|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449243|NCT01862497|Carvedilol|carvedilol|mesh-list
138449244|NCT01862497|Prazosin|prazosin|mesh-list
138449245|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138449246|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138449247|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
138449248|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449249|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449250|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449251|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138449252|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
138449253|NCT01862497|Protective Agents|protective agents|mesh-ancestor
138449254|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138449255|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138449256|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138449257|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
138449258|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138449259|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138449261|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
138449262|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
138449263|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
138449264|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449265|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449266|NCT01862835|Anastrozole|anastrozole|mesh-list
138449267|NCT01862835|Testosterone|testosterone|mesh-list
138449268|NCT01862835|Estrogens|estrogens|mesh-list
138449270|NCT01862835|Hormones|hormones|mesh-ancestor
138449271|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138449272|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449273|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138449274|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449275|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138449276|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138449277|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138199991|NCT00002536|Vincristine|vincristine|mesh-list
138449278|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449279|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138449280|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
138449281|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
138449282|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138449283|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449284|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138449285|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138449286|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449287|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449288|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449290|NCT01862926|Rituximab|rituximab|mesh-list
138449291|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138449292|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
138449293|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449294|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138449295|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138449296|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
138449297|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449298|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449299|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138449300|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138449302|NCT01862978|Nadroparin|nadroparin|mesh-list
138449303|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
138449304|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138449305|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138449306|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449307|NCT01863004|Bortezomib|bortezomib|mesh-list
138449308|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449309|NCT01863069|Interferons|interferons|mesh-list
138449310|NCT01863069|Interferon-beta|interferon-beta|mesh-list
138449311|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
138449312|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449313|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
138449314|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449315|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
138449316|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449317|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138449318|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138449319|NCT01863147|Acarbose|acarbose|mesh-list
138449320|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138449321|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449322|NCT01863147|Incretins|incretins|mesh-ancestor
138449323|NCT01863147|Hormones|hormones|mesh-ancestor
138400323|NCT01547416|Fentanyl|fentanyl|mesh-list
138449324|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138449325|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138449326|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
138449327|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449328|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449329|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138449330|NCT01863173|Metoprolol|metoprolol|mesh-list
138449331|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138449332|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138449333|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
138449334|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
138449335|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449336|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418485|NCT02638519|Xenon|xenon|mesh-list
138449337|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138449338|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138449339|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138449340|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
138449341|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449342|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449343|NCT01863199|Ranibizumab|ranibizumab|mesh-list
138449344|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138449345|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138449346|NCT01863199|Growth Substances|growth substances|mesh-ancestor
138449347|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449348|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
138449349|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449351|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138449352|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138449353|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138449354|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
138449355|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449356|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138449357|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138449358|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449359|NCT01863238|Ivacaftor|ivacaftor|mesh-list
138449360|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138449361|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138197079|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449362|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449363|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138449364|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138449365|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138449366|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138449367|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449368|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
138449369|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449370|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449371|NCT01863277|Melatonin|melatonin|mesh-list
138449372|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
138197146|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449373|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449374|NCT01863277|Protective Agents|protective agents|mesh-ancestor
138449375|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449376|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449378|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138449379|NCT01863355|Narcotics|narcotics|mesh-ancestor
138449380|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449381|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449382|NCT01863355|Analgesics|analgesics|mesh-ancestor
138449383|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
138449384|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449385|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138449386|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138449387|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
138449388|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
138449389|NCT01863407|Metronidazole|metronidazole|mesh-list
138188489|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138449390|NCT01863407|Dexamethasone|dexamethasone|mesh-list
138449391|NCT01863407|Allantoin|allantoin|mesh-list
138449392|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138449393|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
138449394|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
138449395|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449396|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449397|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138449398|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
138449399|NCT01863407|Hormones|hormones|mesh-ancestor
138449400|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138449401|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138449402|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449403|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449404|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138449405|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138449406|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138449407|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
138449408|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138449409|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138449410|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449411|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138449412|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138197327|NCT04331470|Amebicides|amebicides|mesh-ancestor
138449413|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138449414|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449415|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
138449416|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449417|NCT01863485|Vorolanib|vorolanib|mesh-list
138449418|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138449419|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449420|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199995|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
138449421|NCT01863511|Tolvaptan|tolvaptan|mesh-list
138449422|NCT01863511|Diuretics|diuretics|mesh-list
138449423|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
138449424|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
138449425|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449426|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138449427|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138197397|NCT00000286|Nefazodone|nefazodone|mesh-list
138449428|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138449429|NCT01863589|Adefovir|adefovir|mesh-list
138449430|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
138449431|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449432|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138197456|NCT00000298|Naloxone|naloxone|mesh-list
138449433|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138449434|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449435|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449437|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
138449438|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138449439|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138449440|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449441|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138449442|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449443|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138449444|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138449445|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449446|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138449447|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138449448|NCT01863615|Isotretinoin|isotretinoin|mesh-list
138449449|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
138449450|NCT01863641|Calcitriol|calcitriol|mesh-list
138449451|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138449452|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138400728|NCT01549847|Piracetam|piracetam|mesh-list
138449453|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138449454|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138197594|NCT00001108|Didanosine|didanosine|mesh-list
138449455|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449456|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138449457|NCT01863641|Vitamins|vitamins|mesh-ancestor
138449458|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
138449459|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138449460|NCT01863654|Montelukast|montelukast|mesh-list
138408432|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138449461|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138449462|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
138449463|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138449464|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
138449465|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138449466|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138197714|NCT01149733|Tamsulosin|tamsulosin|mesh-list
138449467|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138449468|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138449469|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449470|NCT01863706|Misoprostol|misoprostol|mesh-list
138449471|NCT01863706|Oxytocin|oxytocin|mesh-list
138449472|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
138449473|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138449474|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449475|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138449476|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
138449477|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138449478|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138449480|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138449481|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449482|NCT01863810|Pregabalin|pregabalin|mesh-list
138449483|NCT01863810|Analgesics|analgesics|mesh-ancestor
138449484|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
138449485|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449486|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449487|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
138449488|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138449489|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138449490|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449491|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138449492|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138449493|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138449494|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449495|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138449496|NCT01863823|Amoxicillin|amoxicillin|mesh-list
138449497|NCT01863823|Tetracycline|tetracycline|mesh-list
138449498|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138449499|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449500|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138449501|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449502|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449503|NCT01863888|Teriflunomide|teriflunomide|mesh-list
138449504|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
138449505|NCT01863888|Charcoal|charcoal|mesh-list
138449506|NCT01863888|Antidotes|antidotes|mesh-ancestor
138449507|NCT01863888|Protective Agents|protective agents|mesh-ancestor
138449508|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449509|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138449510|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138449511|NCT01863888|Analgesics|analgesics|mesh-ancestor
138449512|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
138449513|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449514|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138449515|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138449516|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138449517|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
138449518|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138449519|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138449520|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
138449521|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449522|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138449523|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138449524|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138449525|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138449526|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
138449527|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138198021|NCT01231399|Vitamins|vitamins|mesh-ancestor
138449528|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138449529|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138449530|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449532|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
138449533|NCT01864057|Vitamins|vitamins|mesh-ancestor
138449534|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
138449535|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449536|NCT01864070|Everolimus|everolimus|mesh-list
138198101|NCT00002074|Amebicides|amebicides|mesh-ancestor
138449537|NCT01864070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138449538|NCT01864070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138449539|NCT01864070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449540|NCT01864070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449541|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138449542|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
138449543|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449544|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449547|NCT01864083|Protective Agents|protective agents|mesh-ancestor
138449548|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138198145|NCT00000496|Aspirin|aspirin|mesh-list
138449550|NCT01864161|Trace Elements|trace elements|mesh-ancestor
138449551|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
138449552|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449554|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138449555|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449556|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449557|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138449558|NCT01864187|Analgesics|analgesics|mesh-ancestor
138449559|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
138200002|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138449560|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449561|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138449562|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138449563|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138449564|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
138449565|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449566|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449567|NCT01864213|Tetracaine|tetracaine|mesh-list
138449568|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
138449570|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449571|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449572|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
138449573|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449574|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
138449575|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
138449576|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
138449577|NCT01864265|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138449578|NCT01864265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138449579|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138449580|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
138449581|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449582|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138449583|NCT01864551|Lamotrigine|lamotrigine|mesh-list
138449584|NCT01864551|Olanzapine|olanzapine|mesh-list
138449585|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
138449586|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
138449587|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449588|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449589|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138449590|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138449591|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138449592|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449593|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138449594|NCT01864551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138449595|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138449596|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138449597|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449598|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449599|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
138449600|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
138449601|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138449602|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138449603|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138449605|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
138449606|NCT01864616|Vitamins|vitamins|mesh-ancestor
138449607|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
138449608|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449609|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138449610|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138449611|NCT01864655|Saracatinib|saracatinib|mesh-list
138449612|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449613|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449614|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449615|NCT01864681|Metformin|metformin|mesh-list
138449616|NCT01864681|Gefitinib|gefitinib|mesh-list
138449617|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138449618|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449619|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449620|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138449621|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449622|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449623|NCT01864798|Denosumab|denosumab|mesh-list
138449624|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138449625|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449626|NCT01864824|Vitamins|vitamins|mesh-list
138449627|NCT01864824|Folic Acid|folic acid|mesh-list
138449628|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
138449629|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
138449630|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
138449631|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
138449632|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449633|NCT01864824|Hematinics|hematinics|mesh-ancestor
138449634|NCT01864863|Bosentan|bosentan|mesh-list
138449635|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138449636|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138449637|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449638|NCT01864915|Prucalopride|prucalopride|mesh-list
138449639|NCT01864915|Laxatives|laxatives|mesh-ancestor
138449640|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138449641|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138449642|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138449643|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
138449644|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449645|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449646|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449648|NCT01865175|Trace Elements|trace elements|mesh-ancestor
138449649|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
138401291|NCT01554397|Cisplatin|cisplatin|mesh-list
138449650|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449651|NCT01865188|Amlodipine|amlodipine|mesh-list
138449652|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138449653|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138449654|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138449655|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138449656|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449657|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138449658|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449659|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
138449660|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138449661|NCT01865201|Mannitol|mannitol|mesh-list
138449662|NCT01865201|Edaravone|edaravone|mesh-list
138449663|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138449664|NCT01865201|Diuretics|diuretics|mesh-ancestor
138449665|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
138449666|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449667|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138449668|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
138449669|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449670|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138449671|NCT01865201|Protective Agents|protective agents|mesh-ancestor
138449672|NCT01865279|Insulin|insulin|mesh-list
138449673|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138449674|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
138449675|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
138449676|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
138449677|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
138449678|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138449679|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449680|NCT01865292|Insulin|insulin|mesh-list
138449681|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138449682|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
138449683|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138449685|NCT01865305|Insulin|insulin|mesh-list
138449686|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138449687|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
138449688|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
138449689|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138449690|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
138418871|NCT06223074|Glucocorticoids|glucocorticoids|mesh-ancestor
138449691|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138449692|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
138449693|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138449694|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449695|NCT01865318|Insulin|insulin|mesh-list
138449696|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138449697|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449698|NCT01865331|Insulin|insulin|mesh-list
138449699|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138449700|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
138449701|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
138449702|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138449703|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449704|NCT01865500|Prednisolone|prednisolone|mesh-list
138449705|NCT01865500|Budesonide|budesonide|mesh-list
138449706|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138449707|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
138449708|NCT01865500|Hormones|hormones|mesh-ancestor
138401371|NCT01554930|Diuretics|diuretics|mesh-ancestor
138449709|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138449710|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449711|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138449712|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449713|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
138449714|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449715|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138449716|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138449717|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
138449718|NCT01865630|Etanercept|etanercept|mesh-list
138449719|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138449720|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138449721|NCT01865630|Analgesics|analgesics|mesh-ancestor
138449722|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
138449723|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449724|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449725|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138449726|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138449727|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138449728|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138449729|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
138449730|NCT01865669|Oxytocin|oxytocin|mesh-list
138449731|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
138449732|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138449733|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449735|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138449736|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
138449737|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449738|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449739|NCT01865760|Octreotide|octreotide|mesh-list
138449740|NCT01865760|Somatostatin|somatostatin|mesh-list
138449741|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138449742|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138449743|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449744|NCT01865760|Hormones|hormones|mesh-ancestor
138449745|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138449746|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449747|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
138449748|NCT01865916|Bisacodyl|bisacodyl|mesh-list
138449749|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
138449750|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449751|NCT01865916|Protective Agents|protective agents|mesh-ancestor
138449752|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449754|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
138449755|NCT01865916|Cathartics|cathartics|mesh-ancestor
138449756|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138449757|NCT01865916|Laxatives|laxatives|mesh-ancestor
138449758|NCT01865968|Vaccines|vaccines|mesh-list
138449759|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
138449760|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449761|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138449762|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
138449763|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138408725|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
138449764|NCT01866059|Methamphetamine|methamphetamine|mesh-list
138449766|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138449767|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449768|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138449769|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
138449770|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
138449771|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449772|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
138449773|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449774|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449775|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
138449776|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138449777|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138200014|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
138449778|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138418938|NCT06221683|Sensory System Agents|sensory system agents|mesh-ancestor
138449779|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138449780|NCT01866241|Misoprostol|misoprostol|mesh-list
138449781|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138449782|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
138449783|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138449784|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449785|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138449786|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138449787|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
138449789|NCT01866254|Hydromorphone|hydromorphone|mesh-list
138449790|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138449791|NCT01866254|Narcotics|narcotics|mesh-ancestor
138449792|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449793|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449794|NCT01866254|Analgesics|analgesics|mesh-ancestor
138449795|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
138449796|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449797|NCT01866267|Maraviroc|maraviroc|mesh-list
138449798|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138198637|NCT00000670|Zidovudine|zidovudine|mesh-list
138449799|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138401593|NCT05847660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449800|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449801|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138449802|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138449803|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
138449804|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449805|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138449806|NCT01866397|Cidofovir|cidofovir|mesh-list
138449807|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
138449808|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449809|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449810|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449811|NCT01866488|Misoprostol|misoprostol|mesh-list
138449812|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138449813|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
138449814|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138198682|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
138449815|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449816|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138449817|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138449819|NCT01866514|Lidocaine|lidocaine|mesh-list
138449820|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
138449821|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
138247883|NCT01803074|Emtricitabine|emtricitabine|mesh-list
138449822|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449823|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449824|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
138449825|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449826|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138449827|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138449828|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138449829|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138449830|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449831|NCT01866553|Interferons|interferons|mesh-list
138449832|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
138449833|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
138449834|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138449835|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449836|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
138449837|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449838|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
138449839|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449841|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138449842|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138449843|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449844|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449845|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138449846|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138200017|NCT01204255|Haloperidol|haloperidol|mesh-list
138200018|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
138449847|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138449848|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138449849|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
138449850|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
138449851|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
138449852|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
138449853|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449854|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449855|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
138449856|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138449857|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
138449858|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449859|NCT01866644|Expectorants|expectorants|mesh-ancestor
138449860|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
138449861|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138449862|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
138449863|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449864|NCT01866644|Protective Agents|protective agents|mesh-ancestor
138449865|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449866|NCT01866644|Antidotes|antidotes|mesh-ancestor
138449867|NCT01867138|Vancomycin|vancomycin|mesh-list
138449868|NCT01867138|Cefazolin|cefazolin|mesh-list
138449869|NCT01867138|Amikacin|amikacin|mesh-list
138449870|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138449871|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449872|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138449873|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138449874|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138449875|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138449876|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449877|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449878|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449879|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138449880|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
138449881|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138449882|NCT01867268|Acetazolamide|acetazolamide|mesh-list
138449883|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
138449884|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138449885|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449886|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449887|NCT01867268|Diuretics|diuretics|mesh-ancestor
138449888|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
138449889|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449890|NCT01867281|Aspirin|aspirin|mesh-list
138449891|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138449892|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138449893|NCT01867281|Analgesics|analgesics|mesh-ancestor
138449894|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
138449895|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138449896|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449897|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138449898|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138449899|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138449900|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138449901|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449902|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138449903|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138449904|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449905|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
138449906|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138449907|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138449908|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
138449909|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449910|NCT01867463|Antacids|antacids|mesh-ancestor
138401835|NCT05839236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138449911|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449912|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138449913|NCT01867502|Metformin|metformin|mesh-list
138449914|NCT01867502|Vildagliptin|vildagliptin|mesh-list
138200019|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138449915|NCT01867502|Glyburide|glyburide|mesh-list
138449916|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138449917|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449918|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138449919|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
138449920|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449921|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449922|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
138449923|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138449924|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449926|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138449927|NCT01867645|Antibodies|antibodies|mesh-list
138449928|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
138449930|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
138449931|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449932|NCT01867697|Leucovorin|leucovorin|mesh-list
138449933|NCT01867697|Folic Acid|folic acid|mesh-list
138449934|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
138449935|NCT01867697|Irinotecan|irinotecan|mesh-list
138449936|NCT01867697|Cetuximab|cetuximab|mesh-list
138449937|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
138449938|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
138449939|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449940|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449941|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138449942|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138449943|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449944|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449945|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138449946|NCT01867697|Antidotes|antidotes|mesh-ancestor
138449947|NCT01867697|Protective Agents|protective agents|mesh-ancestor
138449948|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
138449949|NCT01867697|Vitamins|vitamins|mesh-ancestor
138449950|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
138449951|NCT01867697|Hematinics|hematinics|mesh-ancestor
138449952|NCT01867697|Antacids|antacids|mesh-ancestor
138449953|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138449954|NCT01867775|Mirtazapine|mirtazapine|mesh-list
138449955|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
138449956|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138449957|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138419104|NCT06118905|Zoledronic Acid|zoledronic acid|mesh-list
138449958|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
138449959|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
138449960|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138449961|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449962|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449963|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138198841|NCT00002182|Megestrol|megestrol|mesh-list
138449964|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138247892|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
138449965|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138449966|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138449967|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138449968|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138449969|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
138449970|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138449971|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138449972|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
138449973|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138449974|NCT01867866|Trifluridine|trifluridine|mesh-list
138449975|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
138449976|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449977|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
138449978|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138449979|NCT01867892|Leucovorin|leucovorin|mesh-list
138449980|NCT01867892|Gemcitabine|gemcitabine|mesh-list
138449981|NCT01867892|Fluorouracil|fluorouracil|mesh-list
138449982|NCT01867892|Irinotecan|irinotecan|mesh-list
138449983|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
138449984|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138449985|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
138449986|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138449987|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138449988|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138449989|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
138449990|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138449991|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138408951|NCT01611909|Terpin|terpin|mesh-list
138449992|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138449993|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138449994|NCT01867892|Antidotes|antidotes|mesh-ancestor
138449995|NCT01867892|Protective Agents|protective agents|mesh-ancestor
138449996|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
138449997|NCT01867892|Vitamins|vitamins|mesh-ancestor
138449998|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
138449999|NCT01868048|Nabiximols|nabiximols|mesh-list
138450000|NCT01868048|Analgesics|analgesics|mesh-ancestor
138450001|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
138450002|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450003|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450004|NCT01868113|Fluticasone|fluticasone|mesh-list
138450005|NCT01868113|Xhance|xhance|mesh-list
138450006|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138450007|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138450008|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
138450009|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450010|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450011|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138450012|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
138450013|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
138450014|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138450015|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138450016|NCT01868126|Latanoprost|latanoprost|mesh-list
138450017|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138450018|NCT01868191|Thiamine|thiamine|mesh-list
138450019|NCT01868191|Benphothiamine|benphothiamine|mesh-list
138450020|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138450021|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
138450022|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450023|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
138450024|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
138450025|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450026|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
138450027|NCT01868191|Vitamins|vitamins|mesh-ancestor
138450028|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
138450029|NCT01868360|Aflibercept|aflibercept|mesh-list
138450030|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138450031|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138450032|NCT01868360|Growth Substances|growth substances|mesh-ancestor
138450033|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450034|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
138450035|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450036|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
138450037|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138450038|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
138450039|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450040|NCT01868529|Insulin|insulin|mesh-list
138450041|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138450042|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
138450043|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138450044|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450045|NCT01868555|Insulin|insulin|mesh-list
138450046|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138450047|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
138450048|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
138198925|NCT00002194|Clarithromycin|clarithromycin|mesh-list
138450049|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138450050|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138450051|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450052|NCT01868568|Insulin|insulin|mesh-list
138450053|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138450054|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
138450055|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
138450056|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138450057|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
138450058|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
138450059|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138450060|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450061|NCT01868581|Insulin|insulin|mesh-list
138450062|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138450063|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
138450064|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
138450065|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138450066|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450067|NCT01868750|Calcitriol|calcitriol|mesh-list
138450068|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138450069|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450070|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138450071|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138450072|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450073|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138450075|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
138450076|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138450077|NCT01868802|Ketamine|ketamine|mesh-list
138450078|NCT01868802|Analgesics|analgesics|mesh-ancestor
138402218|NCT04239040|Nivolumab|nivolumab|mesh-list
138450079|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
138450080|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450081|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450082|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138450083|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138450084|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
138450085|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
138450086|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450087|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138450088|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138450089|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450090|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450091|NCT01868906|Temozolomide|temozolomide|mesh-list
138450092|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138450093|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
138450094|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450095|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450097|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
138450098|NCT01868945|Calcifediol|calcifediol|mesh-list
138450099|NCT01868945|Vitamins|vitamins|mesh-ancestor
138450100|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
138450101|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450102|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138450103|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138450104|NCT01868984|Paclitaxel|paclitaxel|mesh-list
138450105|NCT01868984|Heparin|heparin|mesh-list
138450106|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138450107|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450108|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
138450109|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
138450110|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
138450111|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450112|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
138450113|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138450114|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138450115|NCT01869010|Tenofovir|tenofovir|mesh-list
138450116|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
138450117|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450118|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138450119|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138450120|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450121|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450122|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138450123|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138450124|NCT01869023|Gemcitabine|gemcitabine|mesh-list
138450125|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450126|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138450127|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
138450128|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450129|NCT01869036|Morphine|morphine|mesh-list
138450130|NCT01869036|Anesthetics|anesthetics|mesh-list
138450131|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450132|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450133|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138450134|NCT01869036|Narcotics|narcotics|mesh-ancestor
138450135|NCT01869036|Analgesics|analgesics|mesh-ancestor
138450136|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
138450137|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450138|NCT01869205|Ivermectin|ivermectin|mesh-list
138450139|NCT01869205|Abamectin|abamectin|mesh-list
138450140|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138409098|NCT01612871|Exemestane|exemestane|mesh-list
138450141|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450142|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
138450143|NCT01869257|Triclosan|triclosan|mesh-list
138450144|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138450145|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450146|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138450147|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138450148|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
138450149|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450150|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138450151|NCT01869309|Ticagrelor|ticagrelor|mesh-list
138450152|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138450153|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138450154|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138450155|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138450156|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138450157|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
138450158|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450159|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450160|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453606|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450161|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
138450162|NCT01869491|Antacids|antacids|mesh-ancestor
138450163|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450164|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138450165|NCT01869556|Oxytocin|oxytocin|mesh-list
138450166|NCT01869556|Carboprost|carboprost|mesh-list
138450167|NCT01869556|Carboprost tromethamine|carboprost tromethamine|mesh-list
138450168|NCT01869556|Ergonovine|ergonovine|mesh-list
138450169|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
138450170|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138450171|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450172|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138199081|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
138450173|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
138450175|NCT01869569|Analgesics|analgesics|mesh-ancestor
138450176|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
138450177|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450178|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450179|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
138450180|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138199136|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
138450181|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138450182|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138199215|NCT03009877|Fentanyl|fentanyl|mesh-list
138450183|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138450184|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138450185|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138450186|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450187|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138450189|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138450190|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450191|NCT01869673|Anesthetics|anesthetics|mesh-list
138450192|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450193|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450194|NCT01869751|Prucalopride|prucalopride|mesh-list
138450195|NCT01869751|Laxatives|laxatives|mesh-ancestor
138450196|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138450197|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138450198|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138450199|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
138450200|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450201|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450202|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450203|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
138450204|NCT01869803|Calicheamicins|calicheamicins|mesh-list
138450205|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138450206|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450207|NCT01869803|Immunotoxins|immunotoxins|mesh-ancestor
138450208|NCT01869803|Immunoconjugates|immunoconjugates|mesh-ancestor
138450209|NCT01869803|Immunologic Factors|immunologic factors|mesh-ancestor
138199410|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
138450210|NCT01869803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450211|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138450212|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
138450213|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138450214|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138450215|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450216|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138450217|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138450219|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450220|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450221|NCT01869907|Minocycline|minocycline|mesh-list
138450222|NCT01869907|Amitriptyline|amitriptyline|mesh-list
138450223|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138450224|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450225|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138450226|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
138450227|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138450228|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138450229|NCT01869907|Analgesics|analgesics|mesh-ancestor
138450230|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
138450231|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450232|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450233|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138450234|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138450235|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138450236|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450237|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
138450238|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450239|NCT01869946|Ropivacaine|ropivacaine|mesh-list
138450240|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
138450241|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
138450242|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450243|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450244|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
138450245|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450246|NCT01870011|Anesthetics|anesthetics|mesh-list
138450247|NCT01870011|Propofol|propofol|mesh-list
138450248|NCT01870011|Desflurane|desflurane|mesh-list
138199744|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450249|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450250|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450251|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138450252|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138450253|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
138450254|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138450255|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
138450257|NCT01870024|Clonazepam|clonazepam|mesh-list
138450258|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
138450259|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
138450260|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
138450261|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450262|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450263|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138450264|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138450265|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450267|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138450268|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138450269|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
138450270|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
138450271|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450272|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450273|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138450274|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138450275|NCT01870050|Dapsone|dapsone|mesh-list
138450276|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450277|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
138450278|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138450279|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138450280|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138450281|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450282|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450283|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
138450284|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138450285|NCT01870115|Vitamin D|vitamin d|mesh-list
138450286|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
138450287|NCT01870115|Melatonin|melatonin|mesh-list
138450288|NCT01870115|Vitamins|vitamins|mesh-ancestor
138450289|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
138450290|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450291|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138450292|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450293|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138450294|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
138450295|NCT01870115|Protective Agents|protective agents|mesh-ancestor
138450296|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450297|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
138450298|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
138450299|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
138450300|NCT01870128|Methotrexate|methotrexate|mesh-list
138450301|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138450302|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
138450303|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138450304|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450305|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138450307|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450308|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450309|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
138450310|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450311|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138450312|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138450314|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200226|NCT01804790|Capecitabine|capecitabine|mesh-list
138450315|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138450316|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138450317|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
138450318|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
138450319|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450320|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138450321|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
138450322|NCT01870128|Hormones|hormones|mesh-ancestor
138247910|NCT01822886|Romidepsin|romidepsin|mesh-list
138450323|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138450324|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138450325|NCT01870128|Protective Agents|protective agents|mesh-ancestor
138450326|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
138450327|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138450328|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138450329|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450330|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138450331|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138450332|NCT01870128|Analgesics|analgesics|mesh-ancestor
138450333|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
138403360|NCT05570669|Simethicone|simethicone|mesh-list
138450334|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138450335|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138450336|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450337|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138450338|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450339|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450341|NCT01870219|Anesthetics|anesthetics|mesh-list
138450342|NCT01870219|Sevoflurane|sevoflurane|mesh-list
138450343|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
138450344|NCT01870219|Analgesics|analgesics|mesh-ancestor
138450345|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
138450346|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450347|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450348|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138450349|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
138200037|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
138450350|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450351|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138450352|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138450354|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450355|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138450356|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138450357|NCT01870284|Adalimumab|adalimumab|mesh-list
138450358|NCT01870284|Ixekizumab|ixekizumab|mesh-list
138450359|NCT01870284|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138450360|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138450361|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138450362|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
138450363|NCT01870427|Aflibercept|aflibercept|mesh-list
138450364|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138450365|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138450366|NCT01870427|Growth Substances|growth substances|mesh-ancestor
138450367|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450368|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
138450369|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450371|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138450372|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138450373|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
138450374|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450375|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450376|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450377|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138450378|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
138450379|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
138450380|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450381|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138450382|NCT01870440|Dexamethasone|dexamethasone|mesh-list
138450383|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
138450384|NCT01870440|BB 1101|bb 1101|mesh-list
138450385|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138450386|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
138450387|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
138450388|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450389|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450390|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138450391|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
138450392|NCT01870440|Hormones|hormones|mesh-ancestor
138450393|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138450394|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138450395|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450396|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
138450397|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450398|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450399|NCT01870466|Cilostazol|cilostazol|mesh-list
138450400|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138450401|NCT01870466|Simvastatin|simvastatin|mesh-list
138450402|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138450403|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138450404|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
138450405|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450406|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138453607|NCT01886209|Prednisone|prednisone|mesh-list
138403585|NCT03893435|Valsartan|valsartan|mesh-list
138450407|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138200815|NCT00002704|Antidotes|antidotes|mesh-ancestor
138450408|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450409|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138450411|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450412|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450413|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138450414|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
138450415|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138450416|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138450417|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138450418|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
138450419|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138450420|NCT01870466|Protective Agents|protective agents|mesh-ancestor
138450421|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138450422|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138450423|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138450424|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138450425|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138450426|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450427|NCT01870635|Ondansetron|ondansetron|mesh-list
138450428|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
138450429|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
138450430|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450431|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450432|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138450433|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
138450434|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
138450435|NCT01870635|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138403695|NCT02713373|Antibodies|antibodies|mesh-list
138450436|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138450437|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
138450438|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138419806|NCT05662306|Aripiprazole|aripiprazole|mesh-list
138450439|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450440|NCT01870648|Ondansetron|ondansetron|mesh-list
138450441|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
138450442|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
138450443|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450444|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450445|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138450446|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
138450447|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
138450448|NCT01870648|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138450449|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138450450|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
138450451|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450452|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450453|NCT01870674|Prucalopride|prucalopride|mesh-list
138450455|NCT01870674|Laxatives|laxatives|mesh-ancestor
138450456|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138450457|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138450458|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138450459|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
138450460|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450461|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450462|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450463|NCT01870804|Atorvastatin|atorvastatin|mesh-list
138450464|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138450465|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138450466|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138450467|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
138450468|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450469|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138450470|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138450471|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450472|NCT01870895|Ramosetron|ramosetron|mesh-list
138450473|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
138450474|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
138450475|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450476|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450477|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138450478|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138450479|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
138450480|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450481|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450482|NCT01870908|Tacrolimus|tacrolimus|mesh-list
138450483|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200043|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138450484|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
138200044|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
138450485|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450486|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138450487|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450488|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450490|NCT01870986|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138450491|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138450492|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138450493|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
138450494|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138450495|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450496|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450497|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138450498|NCT01871129|Analgesics|analgesics|mesh-ancestor
138450499|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
138450500|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450501|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138450502|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138450503|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138450504|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
138450505|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450506|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450507|NCT01871363|Capecitabine|capecitabine|mesh-list
138201252|NCT04755062|Micronutrients|micronutrients|mesh-list
138450508|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450509|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138450510|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
138450511|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450512|NCT01871376|Aflibercept|aflibercept|mesh-list
138450513|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138450514|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138450515|NCT01871376|Growth Substances|growth substances|mesh-ancestor
138450516|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450517|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
138450518|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450519|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
138450520|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138450521|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450522|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450523|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138450524|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138450525|NCT01871454|Protective Agents|protective agents|mesh-ancestor
138201384|NCT04302454|Leuprolide|leuprolide|mesh-list
138450526|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450527|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
138450528|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138450529|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
138450530|NCT01871467|Sargramostim|sargramostim|mesh-list
138450531|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
138450532|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450534|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450535|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138450536|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247914|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450537|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450538|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
138450539|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138450540|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450541|NCT01871649|Golimumab|golimumab|mesh-list
138450542|NCT01871649|Methotrexate|methotrexate|mesh-list
138201463|NCT04896658|Hormones|hormones|mesh-ancestor
138450543|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138450544|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
138450545|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138450546|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450547|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138450548|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
138404039|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
138450549|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450550|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450551|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
138450552|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450553|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138450554|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138450555|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
138450556|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138450557|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138450558|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138450559|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138450561|NCT01871662|Ribavirin|ribavirin|mesh-list
138450562|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
138450564|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138450565|NCT01871662|Silybin|silybin|mesh-list
138450566|NCT01871662|Silymarin|silymarin|mesh-list
138450567|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450568|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
138450569|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201633|NCT01158703|Analgesics|analgesics|mesh-ancestor
138450570|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
138419911|NCT05630872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138450571|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450572|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
138450573|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450574|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
138450575|NCT01871662|Protective Agents|protective agents|mesh-ancestor
138453608|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
138450576|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138450577|NCT01871675|Rituximab|rituximab|mesh-list
138450578|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138450579|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138450580|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450581|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
138450582|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450583|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138450584|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138450585|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
138450586|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450587|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
138450588|NCT01871701|Dexetimide|dexetimide|mesh-list
138450589|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138450590|NCT01871701|Citalopram|citalopram|mesh-list
138450591|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138450592|NCT01871701|Escitalopram|escitalopram|mesh-list
138450593|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138450594|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450595|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138450597|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450598|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450599|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450600|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138450602|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138450603|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450604|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138450605|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138450606|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138450607|NCT01871701|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138450608|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138450609|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138450611|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
138450612|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138450613|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138450614|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
138450615|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
138450616|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450618|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138450619|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
138450620|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138450621|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
138450622|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138450623|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138450624|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138404267|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
138450625|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450627|NCT01871740|Enalapril|enalapril|mesh-list
138450628|NCT01871740|Enalaprilat|enalaprilat|mesh-list
138450629|NCT01871740|Maleic acid|maleic acid|mesh-list
138450630|NCT01871740|Hematinics|hematinics|mesh-ancestor
138450631|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
138450632|NCT01871740|Vitamins|vitamins|mesh-ancestor
138450633|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
138450634|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450635|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450636|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450637|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138450638|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
138450639|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138450640|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
138450641|NCT01871792|Pitavastatin|pitavastatin|mesh-list
138450642|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138450643|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138450644|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138450645|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
138202014|NCT04348370|Vaccines|vaccines|mesh-list
138450646|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450647|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450648|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138450649|NCT01871844|Octreotide|octreotide|mesh-list
138450650|NCT01871844|Somatostatin|somatostatin|mesh-list
138450651|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138450652|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138450654|NCT01871844|Hormones|hormones|mesh-ancestor
138450655|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138450656|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450657|NCT01871857|Epinephrine|epinephrine|mesh-list
138450658|NCT01871857|Racepinephrine|racepinephrine|mesh-list
138450659|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
138450660|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138450661|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138450662|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
138450663|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450664|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450665|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450666|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138450667|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138450668|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
138450669|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450670|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138450671|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
138450672|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
138450673|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
138450674|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138450675|NCT01871922|Atropine|atropine|mesh-list
138450676|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138450677|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138450678|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138450679|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
138450680|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450681|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450682|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138450683|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
138450684|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
138450685|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
138420104|NCT05466279|Midazolam|midazolam|mesh-list
138450686|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138404491|NCT01572857|Antibodies|antibodies|mesh-list
138450687|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138450688|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
138450689|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450690|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450692|NCT01871935|Remifentanil|remifentanil|mesh-list
138450693|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138450694|NCT01871935|Narcotics|narcotics|mesh-ancestor
138450695|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450696|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450697|NCT01871935|Analgesics|analgesics|mesh-ancestor
138450698|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
138450699|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450700|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138450701|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138450702|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
138450703|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
138450704|NCT01871961|Methotrexate|methotrexate|mesh-list
138450705|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138450706|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
138450707|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138450708|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450709|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138450710|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
138450711|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450712|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450713|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
138450714|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450715|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138450716|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138450717|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
138450718|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138450719|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138450720|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138450721|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
138450722|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138450723|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138450724|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138450725|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450726|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450727|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138450728|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
138450729|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138450730|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138450731|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138450732|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450733|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450735|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138450736|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
138450737|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138450738|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450739|NCT01872026|ASP7991|asp7991|mesh-list
138450740|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
138450741|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
138450742|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138450743|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450745|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138450746|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138450747|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138450748|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450749|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138450750|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450751|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
138450752|NCT01871311|Cetuximab|cetuximab|mesh-list
138450753|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138450754|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450755|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
138450756|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
138450757|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
138450758|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450760|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450761|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
138450762|NCT01872351|Vitamins|vitamins|mesh-ancestor
138450763|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
138450764|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
138450765|NCT01872403|Paclitaxel|paclitaxel|mesh-list
138450766|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138450767|NCT01872403|Carboplatin|carboplatin|mesh-list
138450768|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138450769|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450770|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202577|NCT00003130|Paclitaxel|paclitaxel|mesh-list
138450771|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
138450772|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
138450773|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450774|NCT01872416|Doxorubicin|doxorubicin|mesh-list
138450775|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138450776|NCT01872416|Ifosfamide|ifosfamide|mesh-list
138450777|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138450778|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450779|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138450780|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138450781|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450782|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450783|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138450784|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
138450785|NCT01872442|Interferons|interferons|mesh-list
138450786|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
138450787|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
138450788|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138450789|NCT01872442|Dasatinib|dasatinib|mesh-list
138450790|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450791|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
138450792|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450793|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
138450794|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450795|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138450796|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450797|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450798|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
138450799|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
138450800|NCT01872494|Pentazocine|pentazocine|mesh-list
138450801|NCT01872494|Palonosetron|palonosetron|mesh-list
138450802|NCT01872494|Ropivacaine|ropivacaine|mesh-list
138450803|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
138450804|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
138450805|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450806|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450807|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
138450808|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450809|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
138450810|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
138450811|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138404816|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450812|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138450814|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
138450815|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138450816|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450817|NCT01872494|Analgesics|analgesics|mesh-ancestor
138450818|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138409767|NCT01616732|Hormones|hormones|mesh-ancestor
138450819|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138450820|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138450821|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138450822|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138450823|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450824|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138450825|NCT01872494|Narcotics|narcotics|mesh-ancestor
138450826|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138450827|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138450828|NCT01872546|Adalimumab|adalimumab|mesh-list
138450829|NCT01872546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138450830|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138450831|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138450833|NCT01872702|Primaquine|primaquine|mesh-list
138450835|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
138450836|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138450837|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138450838|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450839|NCT01872728|Anesthetics|anesthetics|mesh-list
138450840|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450841|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450842|NCT01872754|Remifentanil|remifentanil|mesh-list
138450843|NCT01872754|Propofol|propofol|mesh-list
138450844|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138450845|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450846|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450847|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138450848|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
138450849|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
138200066|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138450850|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138450851|NCT01872754|Narcotics|narcotics|mesh-ancestor
138202939|NCT00003634|Oregovomab|oregovomab|mesh-list
138450852|NCT01872754|Analgesics|analgesics|mesh-ancestor
138450853|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
138450854|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450855|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
138450856|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138404924|NCT01576770|Lidocaine|lidocaine|mesh-list
138450857|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450858|NCT01872832|Verinurad|verinurad|mesh-list
138450859|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
138450860|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138450861|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138450862|NCT01872845|Pravastatin|pravastatin|mesh-list
138450863|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138450864|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138450865|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
138450866|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450867|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138453609|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138450868|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138450869|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450871|NCT01872858|Cilostazol|cilostazol|mesh-list
138203071|NCT04773236|Lidocaine|lidocaine|mesh-list
138450872|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138450873|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138450874|NCT01872858|Analgesics|analgesics|mesh-ancestor
138450875|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
138450876|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450877|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450878|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138450879|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138450880|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138450881|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138203125|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138450882|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450883|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138450884|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138450885|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450886|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
138450887|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138450888|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
138203222|NCT00002866|Docetaxel|docetaxel|mesh-list
138450889|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138450890|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
138409849|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
138450891|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
138450892|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138450893|NCT01872858|Protective Agents|protective agents|mesh-ancestor
138450894|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138450895|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138450896|NCT01872871|Acetaminophen|acetaminophen|mesh-list
138450897|NCT01872871|Anesthetics|anesthetics|mesh-list
138450898|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
138450899|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450900|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450901|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138450902|NCT01872871|Analgesics|analgesics|mesh-ancestor
138450903|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
138450904|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450905|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
138450906|NCT01872884|Remifentanil|remifentanil|mesh-list
138450907|NCT01872884|Sevoflurane|sevoflurane|mesh-list
138450908|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138450909|NCT01872884|Narcotics|narcotics|mesh-ancestor
138450910|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138450911|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450912|NCT01872884|Analgesics|analgesics|mesh-ancestor
138450913|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
138450914|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200068|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
138450915|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138450916|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138450917|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
138450918|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
138450919|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
138450920|NCT01872897|Antacids|antacids|mesh-ancestor
138450921|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450922|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138450923|NCT01872923|Bleomycin|bleomycin|mesh-list
138450924|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138450925|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450926|NCT01872936|Ribavirin|ribavirin|mesh-list
138450927|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
138450928|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450929|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
138450930|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450931|NCT01872962|Cisplatin|cisplatin|mesh-list
138450932|NCT01872962|Gemcitabine|gemcitabine|mesh-list
138450933|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450934|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138450936|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450938|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
138450939|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450940|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138450941|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138450942|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450943|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450945|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138450946|NCT01873001|Pioglitazone|pioglitazone|mesh-list
138450947|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
138450948|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138450949|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450950|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450951|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138450952|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450953|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450954|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
138450955|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138450956|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138450957|NCT01873027|Sirolimus|sirolimus|mesh-list
138450958|NCT01873027|Umirolimus|umirolimus|mesh-list
138450959|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138450960|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138450961|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
138450962|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138450963|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138450964|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450965|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138450966|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138450967|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
138450968|NCT01873079|Esomeprazole|esomeprazole|mesh-list
138450969|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138450971|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138450972|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138450973|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450975|NCT05855629|Adapalene|adapalene|mesh-list
138450976|NCT05855629|Benzoyl Peroxide|benzoyl peroxide|mesh-list
138450977|NCT05855629|Dermatologic Agents|dermatologic agents|mesh-ancestor
138450978|NCT05855629|Vitamin B Complex|vitamin b complex|mesh-ancestor
138450979|NCT05855629|Vitamins|vitamins|mesh-ancestor
138405396|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
138450980|NCT05855629|Micronutrients|micronutrients|mesh-ancestor
138450981|NCT05855629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420370|NCT05282277|Estrogens|estrogens|mesh-ancestor
138450982|NCT05855629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138450983|NCT05855629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138450984|NCT05855629|Analgesics|analgesics|mesh-ancestor
138450985|NCT05855629|Sensory System Agents|sensory system agents|mesh-ancestor
138450986|NCT05855629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138450987|NCT05855629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138450988|NCT05855629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138450989|NCT05855616|Chlorhexidine|chlorhexidine|mesh-list
138450990|NCT05855616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138450991|NCT05855616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138450992|NCT05855616|Disinfectants|disinfectants|mesh-ancestor
138450993|NCT05855590|Tranexamic Acid|tranexamic acid|mesh-list
138450994|NCT05855590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138450995|NCT05855590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138450996|NCT05855590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138450997|NCT05855590|Hemostatics|hemostatics|mesh-ancestor
138450998|NCT05855590|Coagulants|coagulants|mesh-ancestor
138450999|NCT05855486|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138451000|NCT05855486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138451001|NCT05855187|Modafinil|modafinil|mesh-list
138451002|NCT05855187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138451003|NCT05855187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451004|NCT05855187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138451005|NCT05855187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138451006|NCT05855187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138451007|NCT05855187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451008|NCT05855070|Verapamil|verapamil|mesh-list
138451009|NCT05855070|Hyaluronic Acid|hyaluronic acid|mesh-list
138451010|NCT05855070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138451011|NCT05855070|Immunologic Factors|immunologic factors|mesh-ancestor
138451012|NCT05855070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451013|NCT05855070|Viscosupplements|viscosupplements|mesh-ancestor
138451014|NCT05855070|Protective Agents|protective agents|mesh-ancestor
138451015|NCT05855070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138451016|NCT05855070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138451017|NCT05855070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138451018|NCT05855070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451019|NCT05855070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138451020|NCT05855070|Vasodilator Agents|vasodilator agents|mesh-ancestor
138451021|NCT05855018|Atropine|atropine|mesh-list
138451022|NCT05855018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138451023|NCT05855018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138451024|NCT05855018|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138451025|NCT05855018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138451026|NCT05855018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138451027|NCT05855018|Autonomic Agents|autonomic agents|mesh-ancestor
138451028|NCT05855018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138451029|NCT05855018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451030|NCT05855018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138451031|NCT05855018|Respiratory System Agents|respiratory system agents|mesh-ancestor
138451032|NCT05855018|Mydriatics|mydriatics|mesh-ancestor
138451033|NCT05855018|Parasympatholytics|parasympatholytics|mesh-ancestor
138451034|NCT05855018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138451035|NCT05855018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138451036|NCT05855018|Cholinergic Agents|cholinergic agents|mesh-ancestor
138451037|NCT05855018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451038|NCT05855018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451040|NCT05854849|Apatinib|apatinib|mesh-list
138451041|NCT05854849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451042|NCT05854849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138451043|NCT05854849|Antimetabolites|antimetabolites|mesh-ancestor
138451044|NCT05854849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451045|NCT05854849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138451046|NCT05854849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451048|NCT05854537|Bupivacaine|bupivacaine|mesh-list
138451049|NCT05854537|Anesthetics, Local|anesthetics, local|mesh-ancestor
138451050|NCT05854537|Anesthetics|anesthetics|mesh-ancestor
138451051|NCT05854537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138451052|NCT05854537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451053|NCT05854537|Sensory System Agents|sensory system agents|mesh-ancestor
138451054|NCT05854537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138203837|NCT00004036|Amifostine|amifostine|mesh-list
138451055|NCT05854537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138451056|NCT05854537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138451057|NCT05854537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138451058|NCT05854537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138451059|NCT05854537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451060|NCT05854511|Sofosbuvir|sofosbuvir|mesh-list
138451061|NCT05854511|Antiviral Agents|antiviral agents|mesh-ancestor
138451062|NCT05854511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451063|NCT05854342|Calcium|calcium|mesh-list
138451064|NCT05854342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138451065|NCT05854342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451066|NCT05854225|Thiotepa|thiotepa|mesh-list
138451067|NCT05854225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138451068|NCT05854225|Alkylating Agents|alkylating agents|mesh-ancestor
138451069|NCT05854225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451070|NCT05854225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451071|NCT05854225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138451072|NCT05854225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138451073|NCT05854225|Immunologic Factors|immunologic factors|mesh-ancestor
138451074|NCT05854225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451076|NCT05854082|Anesthetics, Local|anesthetics, local|mesh-ancestor
138451078|NCT05854082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138451079|NCT05854082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451080|NCT05854082|Sensory System Agents|sensory system agents|mesh-ancestor
138203969|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138451081|NCT05854082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138451082|NCT05854082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138451083|NCT05854082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138451084|NCT05854082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138451085|NCT05854082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138451086|NCT05854082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451087|NCT05853965|Venetoclax|venetoclax|mesh-list
138451088|NCT05853965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451089|NCT05853718|Tenofovir|tenofovir|mesh-list
138451090|NCT05853718|Antiviral Agents|antiviral agents|mesh-ancestor
138451091|NCT05853718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451092|NCT05853718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138451093|NCT05853718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138451094|NCT05853718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451095|NCT05853718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451096|NCT05853718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138451097|NCT05853718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138451098|NCT05853627|Propranolol|propranolol|mesh-list
138451099|NCT05853627|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138451100|NCT05853627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138451101|NCT05853627|Adrenergic Agents|adrenergic agents|mesh-ancestor
138451102|NCT05853627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451103|NCT05853627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451104|NCT05853627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451105|NCT05853627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138451106|NCT05853627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138451107|NCT05853627|Vasodilator Agents|vasodilator agents|mesh-ancestor
138451108|NCT05852730|Promethazine|promethazine|mesh-list
138451109|NCT05852730|Diphenhydramine|diphenhydramine|mesh-list
138451110|NCT05852730|Meclizine|meclizine|mesh-list
138451111|NCT05852730|Scopolamine|scopolamine|mesh-list
138451112|NCT05852730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138451113|NCT05852730|Antiemetics|antiemetics|mesh-ancestor
138451114|NCT05852730|Autonomic Agents|autonomic agents|mesh-ancestor
138451115|NCT05852730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138451116|NCT05852730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451117|NCT05852730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138451118|NCT05852730|Mydriatics|mydriatics|mesh-ancestor
138451119|NCT05852730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138451120|NCT05852730|Cholinergic Agents|cholinergic agents|mesh-ancestor
138451121|NCT05852730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451122|NCT05852730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451123|NCT05852730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138451124|NCT05852730|Antipruritics|antipruritics|mesh-ancestor
138451125|NCT05852730|Dermatologic Agents|dermatologic agents|mesh-ancestor
138451126|NCT05852730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138451127|NCT05852730|Histamine Antagonists|histamine antagonists|mesh-ancestor
138451128|NCT05852730|Histamine Agents|histamine agents|mesh-ancestor
138451129|NCT05852730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138451130|NCT05852730|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138451131|NCT05852730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138451132|NCT05852730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138451133|NCT05852730|Anesthetics, Local|anesthetics, local|mesh-ancestor
138451135|NCT05852730|Sensory System Agents|sensory system agents|mesh-ancestor
138451136|NCT05845489|Anticoagulants|anticoagulants|mesh-list
138451137|NCT05845489|Clopidogrel|clopidogrel|mesh-list
138451138|NCT05845489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138451139|NCT05845489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138348550|NCT02541864|Metronidazole|metronidazole|mesh-list
138348551|NCT02541864|Clarithromycin|clarithromycin|mesh-list
138348560|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138348562|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451140|NCT05845489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138451141|NCT05845489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138451142|NCT05845489|Purinergic Agents|purinergic agents|mesh-ancestor
138451143|NCT05845489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451144|NCT05845489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451145|NCT05845489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451146|NCT05826873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138451147|NCT05826873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451148|NCT05815602|Mebeverine|mebeverine|mesh-list
138451149|NCT05815602|Ebastine|ebastine|mesh-list
138451150|NCT05815602|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138451151|NCT05815602|Histamine Antagonists|histamine antagonists|mesh-ancestor
138451152|NCT05815602|Histamine Agents|histamine agents|mesh-ancestor
138451153|NCT05815602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451154|NCT05815602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451155|NCT05815602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451156|NCT05815602|Anticonvulsants|anticonvulsants|mesh-ancestor
138451157|NCT05815602|Parasympatholytics|parasympatholytics|mesh-ancestor
138451158|NCT05815602|Autonomic Agents|autonomic agents|mesh-ancestor
138451159|NCT05815602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138451160|NCT05755737|Ondansetron|ondansetron|mesh-list
138451161|NCT05755737|Antiemetics|antiemetics|mesh-ancestor
138451162|NCT05755737|Autonomic Agents|autonomic agents|mesh-ancestor
138451163|NCT05755737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138451164|NCT05755737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451165|NCT05755737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138451166|NCT05755737|Antipruritics|antipruritics|mesh-ancestor
138451167|NCT05755737|Dermatologic Agents|dermatologic agents|mesh-ancestor
138451168|NCT05755737|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138451170|NCT05755737|Serotonin Agents|serotonin agents|mesh-ancestor
138451171|NCT05755737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138204470|NCT05775874|Tislelizumab|tislelizumab|mesh-list
138451172|NCT05755737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451174|NCT05736952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138451175|NCT05736952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138451176|NCT05736952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451177|NCT05736952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451178|NCT05736952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451180|NCT05732506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138451181|NCT05732506|Antithrombins|antithrombins|mesh-ancestor
138451182|NCT05732506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138451183|NCT05732506|Protease Inhibitors|protease inhibitors|mesh-ancestor
138451184|NCT05732506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451185|NCT05732506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451186|NCT05732506|Anticoagulants|anticoagulants|mesh-ancestor
138451187|NCT05674656|Dolutegravir|dolutegravir|mesh-list
138451188|NCT05674656|Rilpivirine|rilpivirine|mesh-list
138204594|NCT05463341|Fentanyl|fentanyl|mesh-list
138451189|NCT05674656|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
138451190|NCT05674656|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138451191|NCT05674656|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138451192|NCT05674656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451193|NCT05674656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451194|NCT05674656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138410196|NCT01619137|Povidone|povidone|mesh-list
138451195|NCT05674656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138451196|NCT05674656|Antiviral Agents|antiviral agents|mesh-ancestor
138451197|NCT05674656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451198|NCT05674656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138451199|NCT05674656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138451201|NCT05651633|Anesthetics, Local|anesthetics, local|mesh-ancestor
138451202|NCT05651633|Anesthetics|anesthetics|mesh-ancestor
138451203|NCT05651633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138451204|NCT05651633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451205|NCT05651633|Sensory System Agents|sensory system agents|mesh-ancestor
138451206|NCT05651633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138420551|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
138451207|NCT05651633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138451208|NCT05651633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138405917|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
138451209|NCT05651633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138451210|NCT05651633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138200077|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
138451211|NCT05651633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451212|NCT05648448|Oseltamivir|oseltamivir|mesh-list
138451213|NCT05648448|Favipiravir|favipiravir|mesh-list
138451214|NCT05648448|Zanamivir|zanamivir|mesh-list
138451215|NCT05648448|Molnupiravir|molnupiravir|mesh-list
138451216|NCT05648448|Baloxavir|baloxavir|mesh-list
138451217|NCT05648448|Peramivir|peramivir|mesh-list
138451218|NCT05648448|Laninamivir|laninamivir|mesh-list
138451219|NCT05648448|Antiviral Agents|antiviral agents|mesh-ancestor
138451220|NCT05648448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451221|NCT05648448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451222|NCT05648448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451223|NCT05641064|Dexmedetomidine|dexmedetomidine|mesh-list
138451224|NCT05641064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138451225|NCT05641064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138451226|NCT05641064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451227|NCT05641064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138451228|NCT05641064|Analgesics|analgesics|mesh-ancestor
138406049|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451229|NCT05641064|Sensory System Agents|sensory system agents|mesh-ancestor
138451230|NCT05641064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138451231|NCT05641064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138451232|NCT05641064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138451233|NCT05641064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138451234|NCT05641064|Adrenergic Agents|adrenergic agents|mesh-ancestor
138451235|NCT05641064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451236|NCT05641064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451237|NCT05634967|Ofatumumab|ofatumumab|mesh-list
138451238|NCT05634967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451239|NCT05563558|Carboplatin|carboplatin|mesh-list
138451240|NCT05563558|Pembrolizumab|pembrolizumab|mesh-list
138451241|NCT05563558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451242|NCT05563558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138204835|NCT03377491|Paclitaxel|paclitaxel|mesh-list
138451243|NCT05563558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138451244|NCT05563558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451245|NCT05545735|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138451246|NCT05545735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451247|NCT05531994|Montelukast|montelukast|mesh-list
138451248|NCT05531994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138451249|NCT05531994|Respiratory System Agents|respiratory system agents|mesh-ancestor
138451250|NCT05531994|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138451251|NCT05531994|Hormone Antagonists|hormone antagonists|mesh-ancestor
138451252|NCT05531994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138451253|NCT05531994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451254|NCT05531994|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138451255|NCT05531994|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138451256|NCT05531994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451257|NCT05528718|Midazolam|midazolam|mesh-list
138451258|NCT05528718|Nitrous Oxide|nitrous oxide|mesh-list
138451259|NCT05528718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138451260|NCT05528718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138451261|NCT05528718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138451262|NCT05528718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451263|NCT05528718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138451264|NCT05528718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138451265|NCT05528718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138451266|NCT05528718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138451267|NCT05528718|Anesthetics, General|anesthetics, general|mesh-ancestor
138451268|NCT05528718|Anesthetics|anesthetics|mesh-ancestor
138451269|NCT05528718|GABA Modulators|gaba modulators|mesh-ancestor
138451271|NCT05528718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451272|NCT05528718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451273|NCT05528718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138451274|NCT05528718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138451275|NCT05528718|Analgesics|analgesics|mesh-ancestor
138451276|NCT05528718|Sensory System Agents|sensory system agents|mesh-ancestor
138451277|NCT05528718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138451278|NCT05528198|Montelukast|montelukast|mesh-list
138451279|NCT05528198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138451280|NCT05528198|Respiratory System Agents|respiratory system agents|mesh-ancestor
138451281|NCT05528198|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138451282|NCT05528198|Hormone Antagonists|hormone antagonists|mesh-ancestor
138215214|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451283|NCT05528198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138451284|NCT05528198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205121|NCT00109395|Midazolam|midazolam|mesh-list
138451286|NCT05528198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138451287|NCT05528198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451288|NCT05458375|Estradiol|estradiol|mesh-list
138451289|NCT05458375|Estrogens|estrogens|mesh-ancestor
138451290|NCT05458375|Hormones|hormones|mesh-ancestor
138451291|NCT05458375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138451292|NCT05458375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451293|NCT05420584|Tislelizumab|tislelizumab|mesh-list
138420627|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
138451294|NCT05420584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138451295|NCT05420584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451296|NCT05416580|Metformin|metformin|mesh-list
138451297|NCT05416580|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138451298|NCT05416580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138451299|NCT05416580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451300|NCT05416580|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138451301|NCT05416580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138451302|NCT05385406|Acetic Acid|acetic acid|mesh-list
138451303|NCT05385406|Retinol acetate|retinol acetate|mesh-list
138451304|NCT05385406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138451305|NCT05385406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451306|NCT05385406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138451307|NCT05385406|Immunologic Factors|immunologic factors|mesh-ancestor
138451308|NCT05385406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451309|NCT05385406|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138451310|NCT05385406|Protective Agents|protective agents|mesh-ancestor
138451311|NCT05385406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451313|NCT05357547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138451314|NCT05357547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138451315|NCT05357547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138451316|NCT05357547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451317|NCT05357547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138451318|NCT05357547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138451319|NCT05357547|Serotonin Agents|serotonin agents|mesh-ancestor
138451320|NCT05357547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451321|NCT05357547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451322|NCT05344833|Lenalidomide|lenalidomide|mesh-list
138451323|NCT05344833|Immunologic Factors|immunologic factors|mesh-ancestor
138451324|NCT05344833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451325|NCT05344833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138451326|NCT05344833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138451327|NCT05344833|Growth Substances|growth substances|mesh-ancestor
138451328|NCT05344833|Growth Inhibitors|growth inhibitors|mesh-ancestor
138451329|NCT05344833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451330|NCT05323838|Complement System Proteins|complement system proteins|mesh-list
138451331|NCT05323838|Immunologic Factors|immunologic factors|mesh-ancestor
138451332|NCT05323838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451334|NCT05302999|Analgesics|analgesics|mesh-ancestor
138451335|NCT05302999|Sensory System Agents|sensory system agents|mesh-ancestor
138451336|NCT05302999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138451337|NCT05302999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451338|NCT05302999|Anticonvulsants|anticonvulsants|mesh-ancestor
138451339|NCT05302999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138451340|NCT05302999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138451342|NCT05302999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138451343|NCT05302999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138451344|NCT05302999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138451345|NCT05302999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138205329|NCT01217515|Diltiazem|diltiazem|mesh-list
138451346|NCT05302999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451347|NCT05302999|Antimanic Agents|antimanic agents|mesh-ancestor
138451349|NCT05265806|Oxytocics|oxytocics|mesh-ancestor
138451350|NCT05265806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138451351|NCT05265806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451352|NCT05242419|Huperzine A|huperzine a|mesh-list
138451353|NCT05242419|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138451354|NCT05242419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451355|NCT05242419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451356|NCT05242419|Cholinergic Agents|cholinergic agents|mesh-ancestor
138451357|NCT05242419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451358|NCT05242419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451359|NCT05242419|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138451360|NCT05242419|Protective Agents|protective agents|mesh-ancestor
138451361|NCT05232227|Primaquine|primaquine|mesh-list
138205405|NCT00005032|Oblimersen|oblimersen|mesh-list
138451362|NCT05232227|Antimalarials|antimalarials|mesh-ancestor
138451363|NCT05232227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138451364|NCT05232227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138451365|NCT05232227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451367|NCT05225363|Fludarabine|fludarabine|mesh-list
138451368|NCT05225363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138451369|NCT05225363|Immunologic Factors|immunologic factors|mesh-ancestor
138451370|NCT05225363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451371|NCT05225363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138451372|NCT05225363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138451373|NCT05225363|Alkylating Agents|alkylating agents|mesh-ancestor
138451374|NCT05225363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451375|NCT05225363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451376|NCT05225363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138451378|NCT05221229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138451379|NCT05221229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451380|NCT05221229|Incretins|incretins|mesh-ancestor
138451381|NCT05221229|Hormones|hormones|mesh-ancestor
138451382|NCT05221229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138451383|NCT05184842|Decitabine|decitabine|mesh-list
138451384|NCT05184842|Venetoclax|venetoclax|mesh-list
138451385|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138451386|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
138451387|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451388|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451389|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451390|NCT05135650|Sotrovimab|sotrovimab|mesh-list
138451391|NCT05135650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138451392|NCT05135650|Antibodies|antibodies|mesh-list
138451393|NCT05135650|Immunoglobulins|immunoglobulins|mesh-list
138451394|NCT05135650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138451395|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
138451396|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451397|NCT05135650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451398|NCT05135650|Antiviral Agents|antiviral agents|mesh-ancestor
138451399|NCT05135650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451400|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
138451401|NCT05073822|Tacrolimus|tacrolimus|mesh-list
138451402|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138451403|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
138451404|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451405|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138451406|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451407|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451408|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138451409|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205525|NCT00004246|Fludarabine|fludarabine|mesh-list
138451410|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138247940|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451411|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
138451412|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138451413|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451415|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
138451416|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138451417|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138451418|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138451419|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138451420|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451421|NCT05047952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138406539|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138451422|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138451423|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138451424|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451425|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451427|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138451428|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138451429|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138200079|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138451430|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138451431|NCT05001828|Azacitidine|azacitidine|mesh-list
138451432|NCT05001828|Venetoclax|venetoclax|mesh-list
138451433|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138451434|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
138451435|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451436|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451437|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451438|NCT04965454|Choline|choline|mesh-list
138451439|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
138451440|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138451441|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
138451442|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451443|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138451444|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138451445|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
138451446|NCT04933552|Siponimod|siponimod|mesh-list
138451447|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138451448|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451449|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138451450|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
138451451|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451452|NCT04917484|Octreotide|octreotide|mesh-list
138451453|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
138451454|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138451455|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138451456|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138205807|NCT00030992|Promethazine|promethazine|mesh-list
138451457|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138451458|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451459|NCT04916613|Androgens|androgens|mesh-list
138451460|NCT04916613|Hormones|hormones|mesh-ancestor
138451461|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138451462|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451463|NCT04893525|Buprenorphine|buprenorphine|mesh-list
138451464|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
138451465|NCT04893525|Naloxone|naloxone|mesh-list
138451466|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138451467|NCT04893525|Narcotics|narcotics|mesh-ancestor
138406648|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138451468|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138451469|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451471|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
138451472|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138451473|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138451474|NCT04865848|Anesthetics|anesthetics|mesh-list
138205869|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
138451475|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138451476|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451478|NCT04859322|Somatostatin|somatostatin|mesh-list
138451479|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451480|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138451481|NCT04859322|Hormones|hormones|mesh-ancestor
138451482|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138451483|NCT04839666|Propofol|propofol|mesh-list
138451484|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138451485|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138451486|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138205926|NCT02197273|Bupivacaine|bupivacaine|mesh-list
138451488|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
138451489|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
138451490|NCT04804007|Etoposide|etoposide|mesh-list
138451491|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138410437|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138451492|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451493|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138451494|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138451495|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451496|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451497|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138451498|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
138451499|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451500|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138451501|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138451502|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420804|NCT04648358|Hormones|hormones|mesh-ancestor
138451503|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451504|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138451505|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138451506|NCT04757584|Propranolol|propranolol|mesh-list
138451507|NCT04757584|Metoprolol|metoprolol|mesh-list
138451508|NCT04757584|Atenolol|atenolol|mesh-list
138451509|NCT04757584|Sotalol|sotalol|mesh-list
138451510|NCT04757584|Nadolol|nadolol|mesh-list
138451511|NCT04757584|Acebutolol|acebutolol|mesh-list
138451512|NCT04757584|Carvedilol|carvedilol|mesh-list
138451513|NCT04757584|Nebivolol|nebivolol|mesh-list
138451514|NCT04757584|Bisoprolol|bisoprolol|mesh-list
138451515|NCT04757584|Labetalol|labetalol|mesh-list
138451516|NCT04757584|Pindolol|pindolol|mesh-list
138451517|NCT04757584|Betaxolol|betaxolol|mesh-list
138451518|NCT04757584|Penbutolol|penbutolol|mesh-list
138451519|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138451520|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138451521|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
138451522|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451523|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451524|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451525|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138451526|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138451527|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
138451528|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
138451529|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
138451530|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138206118|NCT00005800|Doxorubicin|doxorubicin|mesh-list
138451531|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138451533|NCT04757584|Protective Agents|protective agents|mesh-ancestor
138451534|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138451535|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138406868|NCT01596517|Ribavirin|ribavirin|mesh-list
138451536|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138451537|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138451538|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138451539|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138451540|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138451541|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138451542|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
138451543|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138451544|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
138451545|NCT04756791|Anesthetics|anesthetics|mesh-list
138451546|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138451547|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451548|NCT04752475|Furosemide|furosemide|mesh-list
138451549|NCT04752475|Diuretics|diuretics|mesh-ancestor
138451550|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
138451551|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451552|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138451553|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138206159|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138451554|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138406931|NCT01596673|Hydrocodone|hydrocodone|mesh-list
138451556|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138451557|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
138451558|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451559|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138451560|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451561|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451562|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
138451563|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138451564|NCT04717362|Testosterone|testosterone|mesh-list
138451565|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
138451566|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
138451567|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138451568|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451569|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
138451570|NCT04717362|Hormones|hormones|mesh-ancestor
138200083|NCT01156597|Pioglitazone|pioglitazone|mesh-list
138406986|NCT01596803|Tocopherols|tocopherols|mesh-list
138451571|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138451572|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451574|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
138451575|NCT04700826|Apixaban|apixaban|mesh-list
138451576|NCT04700826|Edoxaban|edoxaban|mesh-list
138451577|NCT04700826|Dabigatran|dabigatran|mesh-list
138451578|NCT04700826|Anticoagulants|anticoagulants|mesh-list
138451579|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138451581|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138451582|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
138451583|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407073|NCT01597206|Cobalt|cobalt|mesh-list
138451584|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451585|NCT04549207|Denosumab|denosumab|mesh-list
138451586|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
138451587|NCT04549207|Pamidronate|pamidronate|mesh-list
138451588|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138451589|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451590|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
138451591|NCT04319328|Cefazolin|cefazolin|mesh-list
138451592|NCT04319328|Ceftazidime|ceftazidime|mesh-list
138451593|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138451594|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451595|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138451596|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138451597|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451598|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451599|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451600|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138451601|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138451603|NCT04255160|Estrogens|estrogens|mesh-ancestor
138451604|NCT04255160|Hormones|hormones|mesh-ancestor
138451605|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138451606|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451607|NCT04092387|Nicotine|nicotine|mesh-list
138451608|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138451609|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
138451610|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138451611|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451612|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138451613|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138451614|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
138451615|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451616|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451617|NCT04062656|Leucovorin|leucovorin|mesh-list
138451618|NCT04062656|Folic Acid|folic acid|mesh-list
138451619|NCT04062656|Docetaxel|docetaxel|mesh-list
138451620|NCT04062656|Fluorouracil|fluorouracil|mesh-list
138451621|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
138451623|NCT04062656|Relatlimab|relatlimab|mesh-list
138451624|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451625|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
138451626|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
138451627|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
138451628|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451629|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
138451630|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138451631|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138451632|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
138451633|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451634|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138451635|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138451636|NCT04062656|Antidotes|antidotes|mesh-ancestor
138451637|NCT04062656|Protective Agents|protective agents|mesh-ancestor
138451638|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
138451639|NCT04062656|Vitamins|vitamins|mesh-ancestor
138410600|NCT01621620|Yohimbine|yohimbine|mesh-list
138451640|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
138451641|NCT04062656|Hematinics|hematinics|mesh-ancestor
138451642|NCT04041050|Celecoxib|celecoxib|mesh-list
138451643|NCT04041050|Navitoclax|navitoclax|mesh-list
138451644|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138451645|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138451646|NCT04041050|Analgesics|analgesics|mesh-ancestor
138451647|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
138451648|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138348726|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138451649|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451650|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138451651|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138451652|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138451653|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138451654|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407358|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
138451655|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451657|NCT04018313|Omalizumab|omalizumab|mesh-list
138451658|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138451659|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138451660|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138451661|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
138407433|NCT01599078|Paclitaxel|paclitaxel|mesh-list
138451662|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
138451663|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451664|NCT03976518|Atezolizumab|atezolizumab|mesh-list
138451665|NCT03976518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138451666|NCT03976518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451667|NCT03976518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138451668|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451669|NCT03973203|Niacin|niacin|mesh-list
138451670|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
138451671|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138451672|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
138451673|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451674|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138451675|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
138451676|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
138451677|NCT03973203|Vitamins|vitamins|mesh-ancestor
138451678|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
138451679|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451680|NCT03916926|Fluorides|fluorides|mesh-list
138451681|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
138407492|NCT05691088|Antipyretics|antipyretics|mesh-ancestor
138451683|NCT03916926|Protective Agents|protective agents|mesh-ancestor
138451684|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451685|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
138451686|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138451687|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451688|NCT03899857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138451689|NCT03899857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451690|NCT03871491|Azithromycin|azithromycin|mesh-list
138451691|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138451692|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451693|NCT03840967|Niraparib|niraparib|mesh-list
138451694|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138451695|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451696|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451697|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451698|NCT03839914|Vancomycin|vancomycin|mesh-list
138451699|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138451700|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451701|NCT03838263|Cisplatin|cisplatin|mesh-list
138451702|NCT03838263|Nivolumab|nivolumab|mesh-list
138451703|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451704|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138451705|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138451706|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451707|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
138407550|NCT05689957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138451708|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138451709|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451710|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138451711|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451712|NCT03713645|Tacrolimus|tacrolimus|mesh-list
138451713|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138451714|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
138420996|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138451715|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451716|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138451717|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200086|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
138451718|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451719|NCT03705507|Dexamethasone|dexamethasone|mesh-list
138451720|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138410660|NCT01621893|Calcium|calcium|mesh-list
138451721|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
138451722|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
138451723|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138451724|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451725|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138451726|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
138451727|NCT03705507|Hormones|hormones|mesh-ancestor
138451728|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138451729|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138451730|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451731|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
138407663|NCT05188820|Cortisone|cortisone|mesh-list
138451732|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138451733|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451734|NCT03663504|Metronidazole|metronidazole|mesh-list
138451735|NCT03663504|Neomycin|neomycin|mesh-list
138451736|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451737|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138451738|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138451739|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138451740|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138407729|NCT04689945|Morphine|morphine|mesh-list
138451741|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451742|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451743|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
138451744|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138451745|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138451746|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138451747|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138451748|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451749|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
138451750|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451751|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451752|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138451753|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138451754|NCT03582488|Corticosterone|corticosterone|mesh-list
138451755|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138451756|NCT03553810|Valsartan|valsartan|mesh-list
138451757|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
138451758|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138451759|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138451760|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138451761|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451762|NCT03404596|Nicotine|nicotine|mesh-list
138451763|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138451764|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
138451765|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138207189|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
138451766|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451767|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138451768|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138451769|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
138451770|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451771|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451772|NCT03340220|Itraconazole|itraconazole|mesh-list
138451773|NCT03340220|Antifungal Agents|antifungal agents|mesh-ancestor
138451774|NCT03340220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451775|NCT03340220|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138451776|NCT03340220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138451777|NCT03340220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451778|NCT03340220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451779|NCT03340220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138451780|NCT03340220|Hormone Antagonists|hormone antagonists|mesh-ancestor
138451781|NCT03340220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138451782|NCT03340220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451783|NCT03340220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138451784|NCT03317158|Gemcitabine|gemcitabine|mesh-list
138451785|NCT03317158|Docetaxel|docetaxel|mesh-list
138451786|NCT03317158|Durvalumab|durvalumab|mesh-list
138451787|NCT03317158|Tremelimumab|tremelimumab|mesh-list
138451788|NCT03317158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138451789|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
138451790|NCT03317158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138451791|NCT03317158|Antimetabolites|antimetabolites|mesh-ancestor
138451792|NCT03317158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451793|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451795|NCT03317158|Antimitotic Agents|antimitotic agents|mesh-ancestor
138451796|NCT03317158|Mitosis Modulators|mitosis modulators|mesh-ancestor
138451797|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138451798|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
138451799|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451800|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138451801|NCT03147859|Vedolizumab|vedolizumab|mesh-list
138451802|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138451803|NCT03131219|Ravulizumab|ravulizumab|mesh-list
138451804|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138451806|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
138451807|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451808|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138451809|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138451810|NCT02713945|Simvastatin|simvastatin|mesh-list
138451811|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138451812|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138451813|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
138451814|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451815|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138451816|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138451817|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451819|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138451820|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
138451821|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451822|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451823|NCT02664935|Docetaxel|docetaxel|mesh-list
138451824|NCT02664935|Durvalumab|durvalumab|mesh-list
138451825|NCT02664935|Palbociclib|palbociclib|mesh-list
138451826|NCT02664935|Osimertinib|osimertinib|mesh-list
138451827|NCT02664935|Crizotinib|crizotinib|mesh-list
138451828|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451830|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
138451831|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
138451832|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451833|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138451834|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138451835|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138247962|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
138451836|NCT02586207|Cisplatin|cisplatin|mesh-list
138451837|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
138451838|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451839|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138451840|NCT02586207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138451841|NCT02586207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451842|NCT02573324|Temozolomide|temozolomide|mesh-list
138451843|NCT02573324|ABT-414|abt-414|mesh-list
138451844|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138451845|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
138451846|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451847|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451848|NCT02573324|Immunoconjugates|immunoconjugates|mesh-ancestor
138451850|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451851|NCT02553642|Nivolumab|nivolumab|mesh-list
138451852|NCT02553642|Ipilimumab|ipilimumab|mesh-list
138451853|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138451854|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451855|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138451856|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138408184|NCT03106454|Estradiol|estradiol|mesh-list
138451857|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138451858|NCT02523092|Hormones|hormones|mesh-ancestor
138451859|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138451860|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451861|NCT02450773|Furosemide|furosemide|mesh-list
138451862|NCT02450773|Diuretics|diuretics|mesh-ancestor
138451863|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
138451864|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451865|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138451866|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138410807|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
138451867|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451868|NCT02445248|Tisagenlecleucel|tisagenlecleucel|mesh-list
138451869|NCT02445248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138451870|NCT02445248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451871|NCT02412566|SMOFlipid|smoflipid|mesh-list
138451872|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138451873|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138451874|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138451875|NCT02397226|Anesthetics|anesthetics|mesh-list
138451876|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138451877|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451878|NCT02296684|Cisplatin|cisplatin|mesh-list
138451879|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
138451880|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451881|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138451882|NCT02296684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138451883|NCT02296684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451885|NCT01939275|Trastuzumab|trastuzumab|mesh-list
138451886|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138451887|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451888|NCT01939275|Trace Elements|trace elements|mesh-ancestor
138451889|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
138451890|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451892|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138451893|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138451894|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138451895|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
138451896|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451898|NCT01342367|Finasteride|finasteride|mesh-list
138451899|NCT01342367|Dutasteride|dutasteride|mesh-list
138451900|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
138451901|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
138451902|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138207732|NCT03009409|Ketamine|ketamine|mesh-list
138451903|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451904|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451905|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138451906|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138451907|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451908|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451909|NCT01342367|Urological Agents|urological agents|mesh-ancestor
138451910|NCT01185171|Gefitinib|gefitinib|mesh-list
138451911|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451912|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138451913|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451914|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451915|NCT00896493|Cyclosporine|cyclosporine|mesh-list
138451916|NCT00896493|Cyclosporins|cyclosporins|mesh-list
138451918|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451919|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451920|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138451921|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
138451922|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451923|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
138451924|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451925|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
138451926|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138451927|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138451928|NCT00790010|Bevacizumab|bevacizumab|mesh-list
138451929|NCT00790010|Ipilimumab|ipilimumab|mesh-list
138207932|NCT00183794|Gemcitabine|gemcitabine|mesh-list
138451930|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138451931|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451932|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138451933|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138451934|NCT00790010|Growth Substances|growth substances|mesh-ancestor
138451935|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451936|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
138451937|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138451938|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451939|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
138451941|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138451942|NCT00003042|Tamoxifen|tamoxifen|mesh-list
138451943|NCT00003042|Paclitaxel|paclitaxel|mesh-list
138451944|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
138451945|NCT00003042|Doxorubicin|doxorubicin|mesh-list
138451946|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138451947|NCT00003042|Melphalan|melphalan|mesh-list
138451948|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138451949|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451950|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
138451951|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
138451952|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
138451953|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451954|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138451955|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
138451956|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451957|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138421214|NCT03662100|Analgesics|analgesics|mesh-ancestor
138451958|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138451959|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
138451961|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138451962|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138451963|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138451964|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138451965|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138451966|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
138451967|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138451968|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138451969|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138451970|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138451971|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138451972|NCT01873144|Epinephrine|epinephrine|mesh-list
138451973|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138451974|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138451975|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138451976|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
138451977|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138451978|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138451979|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138247970|NCT02328404|Vitamin D|vitamin d|mesh-list
138451980|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138451981|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138451983|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138451984|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138451985|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
138451986|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
138451987|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
138451988|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138451989|NCT01873157|Bortezomib|bortezomib|mesh-list
138451990|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138451991|NCT01873222|Sirolimus|sirolimus|mesh-list
138451992|NCT01873222|Umirolimus|umirolimus|mesh-list
138451993|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138451994|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138408513|NCT01599819|BAX 855|bax 855|mesh-list
138451995|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
138451996|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138451997|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138451998|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138451999|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138452000|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138208242|NCT00277394|Heparin|heparin|mesh-list
138452001|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
138452003|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
138452004|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
138452005|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452006|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452007|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
138200096|NCT05749900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452008|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452010|NCT01873339|Darapladib|darapladib|mesh-list
138452011|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138452012|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138452013|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452014|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452015|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138421232|NCT03616587|Everolimus|everolimus|mesh-list
138452016|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138452017|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138452018|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138452019|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
138452020|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
138452022|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
138452023|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138452024|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452025|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138452026|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452027|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138452028|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
138452029|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138452030|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
138452031|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138452032|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452033|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138452034|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138200098|NCT05749900|Antimetabolites|antimetabolites|mesh-ancestor
138200099|NCT05749900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452035|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452036|NCT01873430|Melatonin|melatonin|mesh-list
138452037|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
138208494|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452038|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452039|NCT01873430|Protective Agents|protective agents|mesh-ancestor
138452040|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452041|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452044|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138452045|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452046|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
138452047|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452048|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452049|NCT01873443|Hematinics|hematinics|mesh-ancestor
138200100|NCT05749900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138200101|NCT05749900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138200111|NCT05749666|Prednisolone|prednisolone|mesh-list
138200112|NCT05749666|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138200113|NCT05749666|Methylprednisolone|methylprednisolone|mesh-list
138200114|NCT05749666|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138200115|NCT05749666|Prednisolone acetate|prednisolone acetate|mesh-list
138452050|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
138452051|NCT01873443|Vitamins|vitamins|mesh-ancestor
138452052|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
138452053|NCT01873573|Triamcinolone|triamcinolone|mesh-list
138452054|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138452055|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
138452056|NCT01873573|Hormones|hormones|mesh-ancestor
138452057|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138452058|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452059|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
138452060|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452061|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452062|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138452063|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138452064|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452065|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452066|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452067|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138452068|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138452069|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
138452070|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
138452071|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138452072|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138452073|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452076|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
138452077|NCT01873807|Etoposide|etoposide|mesh-list
138452078|NCT01873807|Idarubicin|idarubicin|mesh-list
138452079|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138452080|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
138452081|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452082|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452083|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138452084|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
138452085|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452086|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452087|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138452088|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138452089|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138452090|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138452091|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452092|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138452093|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
138452094|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
138452095|NCT01873820|Calcium|calcium|mesh-list
138408818|NCT01610934|Liraglutide|liraglutide|mesh-list
138452096|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138452097|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452098|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
138452099|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452100|NCT01873820|Protective Agents|protective agents|mesh-ancestor
138452101|NCT01873820|Vitamins|vitamins|mesh-ancestor
138452102|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
138452103|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
138452104|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
138452105|NCT01874002|Sirolimus|sirolimus|mesh-list
138452106|NCT01874002|Temsirolimus|temsirolimus|mesh-list
138452107|NCT01874002|MTOR Inhibitors|mtor inhibitors|mesh-list
138452108|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452109|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452110|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138452111|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452112|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
138452113|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138452114|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
138452115|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452116|NCT01874002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138452117|NCT01874002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452118|NCT01874002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452119|NCT01874028|Trientine|trientine|mesh-list
138452120|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
138452121|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
138452122|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452123|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
138452124|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200116|NCT05749666|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138452125|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
138452126|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
138452127|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
138452128|NCT01874080|Metformin|metformin|mesh-list
138452129|NCT01874080|Saxagliptin|saxagliptin|mesh-list
138452130|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138452131|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452132|NCT01874080|Incretins|incretins|mesh-ancestor
138452133|NCT01874080|Hormones|hormones|mesh-ancestor
138452134|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138452135|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138452136|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
138452137|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452138|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452139|NCT01874171|Cetuximab|cetuximab|mesh-list
138452140|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452141|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138452142|NCT01874236|Bupivacaine|bupivacaine|mesh-list
138452143|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
138452144|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
138452145|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452146|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452147|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
138452148|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452149|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
138452150|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452151|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452152|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138452153|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138452154|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209122|NCT01453075|Valacyclovir|valacyclovir|mesh-list
138452155|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452156|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452157|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
138452159|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
138452160|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452161|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
138452162|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452163|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452164|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138452165|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138452166|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452167|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452168|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452169|NCT01874574|Triamcinolone|triamcinolone|mesh-list
138452170|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138452171|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138452172|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138452173|NCT01874574|Hylan|hylan|mesh-list
138452174|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138408942|NCT01611727|Cisplatin|cisplatin|mesh-list
138452175|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
138452176|NCT01874574|Hormones|hormones|mesh-ancestor
138452177|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138452178|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452179|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138452180|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
138452181|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138209313|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138452182|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452183|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
138452184|NCT01874574|Protective Agents|protective agents|mesh-ancestor
138452185|NCT01874639|Hemostatics|hemostatics|mesh-list
138452186|NCT01874639|Coagulants|coagulants|mesh-ancestor
138452187|NCT01874678|Cisplatin|cisplatin|mesh-list
138452188|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452189|NCT01874717|Midazolam|midazolam|mesh-list
138452190|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138452191|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138452192|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138209394|NCT04346030|Lidocaine|lidocaine|mesh-list
138452193|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452194|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138452195|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138452196|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138452197|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138452198|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
138452199|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
138452200|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
138452201|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
138452202|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138452203|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452204|NCT01874730|Anesthetics|anesthetics|mesh-list
138452205|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452206|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452207|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138452208|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138452209|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138452210|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
138452211|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452212|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138209511|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138452213|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138452214|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452216|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
138452217|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452218|NCT01874847|Protective Agents|protective agents|mesh-ancestor
138452219|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452220|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452221|NCT01874964|Methadone|methadone|mesh-list
138452222|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138452223|NCT01874964|Narcotics|narcotics|mesh-ancestor
138452224|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452225|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452226|NCT01874964|Analgesics|analgesics|mesh-ancestor
138452227|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
138452228|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452229|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
138452230|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
138452231|NCT01875107|Insulin|insulin|mesh-list
138452232|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138452233|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452234|NCT01875172|Bupropion|bupropion|mesh-list
138452235|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138452236|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
138452237|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138452238|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138209638|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
138452239|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138452240|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138452241|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452242|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
138452243|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138452244|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452245|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138452246|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138452248|NCT01875185|Aspirin|aspirin|mesh-list
138209699|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138452249|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138452250|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138452251|NCT01875185|Analgesics|analgesics|mesh-ancestor
138452252|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
138452253|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138247984|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138452254|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452255|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138452256|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452257|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138452258|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138452259|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452260|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138200120|NCT05749666|Glucocorticoids|glucocorticoids|mesh-ancestor
138348810|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
138452261|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138452262|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452264|NCT01875224|Abatacept|abatacept|mesh-list
138452265|NCT01875224|Tacrolimus|tacrolimus|mesh-list
138452266|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138452267|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
138452268|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409222|NCT01613534|Sucralfate|sucralfate|mesh-list
138452269|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138452270|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452271|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452272|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138452273|NCT01875224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138452274|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452275|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452277|NCT01875263|Cloxacillin|cloxacillin|mesh-list
138452278|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138452279|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452280|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452281|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138452282|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138452283|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452284|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452285|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452286|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138452287|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138452288|NCT01875653|Molgramostim|molgramostim|mesh-list
138452289|NCT01875653|Sargramostim|sargramostim|mesh-list
138452290|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
138409279|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138452291|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452292|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452293|NCT01875666|Trastuzumab|trastuzumab|mesh-list
138452294|NCT01875666|Pertuzumab|pertuzumab|mesh-list
138452295|NCT01875666|Lapatinib|lapatinib|mesh-list
138452296|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138452297|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452298|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138452299|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452300|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452301|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
138452302|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452303|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138452304|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452305|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452306|NCT01875757|Vitamin D|vitamin d|mesh-list
138452307|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
138452308|NCT01875757|Vitamins|vitamins|mesh-ancestor
138452309|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
138452310|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452311|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138421457|NCT03295240|Rituximab|rituximab|mesh-list
138452312|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138452313|NCT01875822|Curcumin|curcumin|mesh-list
138452314|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138452315|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138452316|NCT01875822|Analgesics|analgesics|mesh-ancestor
138452317|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
138452318|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452319|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452320|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138452321|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452322|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452323|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452324|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452325|NCT01875926|Gontivimab|gontivimab|mesh-list
138452326|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
138452327|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452328|NCT01875939|Levonadifloxacin|levonadifloxacin|mesh-list
138452329|NCT01875939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138452330|NCT01875939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452331|NCT01875939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200126|NCT05749666|Antiemetics|antiemetics|mesh-ancestor
138452332|NCT01875939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452333|NCT01875939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452334|NCT01875952|Isoniazid|isoniazid|mesh-list
138452335|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
138452336|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138247987|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452337|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452338|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138452339|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138452340|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
138452341|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452342|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138452343|NCT01876004|Methotrexate|methotrexate|mesh-list
138452344|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138452345|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
138452346|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138452347|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452348|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138452349|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
138452350|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452351|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452352|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
138452353|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452354|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138452355|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138452356|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
138452357|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452358|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138452360|NCT01876108|Azithromycin|azithromycin|mesh-list
138452361|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138452362|NCT01876108|Omeprazole|omeprazole|mesh-list
138452363|NCT01876108|Bismuth|bismuth|mesh-list
138452364|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452365|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452366|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138452367|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138452368|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138452369|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452370|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452371|NCT01876108|Antacids|antacids|mesh-ancestor
138452372|NCT01876121|Celecoxib|celecoxib|mesh-list
138452373|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138452374|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138452375|NCT01876121|Analgesics|analgesics|mesh-ancestor
138452376|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
138452377|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452378|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452379|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138452380|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452381|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138452382|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138452383|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452384|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452385|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
138452386|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138452387|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138452388|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
138452389|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138452390|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452391|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452392|NCT01876186|Urological Agents|urological agents|mesh-ancestor
138411345|NCT01627158|Budesonide|budesonide|mesh-list
138452394|NCT01876290|Ondansetron|ondansetron|mesh-list
138452395|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138452396|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
138452397|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
138452398|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452399|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452400|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138452401|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
138452402|NCT01876290|Hormones|hormones|mesh-ancestor
138452403|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138452404|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138452405|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452406|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
138452407|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
138452408|NCT01876290|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138452409|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138452410|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
138452411|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138452412|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452413|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
138452414|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452415|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138210144|NCT02528214|Prednisone|prednisone|mesh-list
138452416|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138452417|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138452418|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452419|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452420|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452422|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138452423|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138452424|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138452425|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
138421551|NCT02997228|Leucovorin|leucovorin|mesh-list
138452426|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138452427|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452428|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452429|NCT01876433|Urological Agents|urological agents|mesh-ancestor
138452430|NCT01876550|Mupirocin|mupirocin|mesh-list
138452431|NCT01876550|Calcium|calcium|mesh-list
138210195|NCT05902221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452432|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138452433|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452434|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452435|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452436|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138452437|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452438|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452440|NCT01876563|Vitamins|vitamins|mesh-ancestor
138452441|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
138452442|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452443|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138452444|NCT01876615|Diclofenac|diclofenac|mesh-list
138452445|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138452446|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138452447|NCT01876615|Analgesics|analgesics|mesh-ancestor
138210259|NCT05901571|Serotonin Agents|serotonin agents|mesh-ancestor
138452448|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
138452449|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452450|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452451|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138452452|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452453|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138452454|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452455|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452456|NCT01876641|Decitabine|decitabine|mesh-list
138452457|NCT01876641|Vemurafenib|vemurafenib|mesh-list
138452458|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138452459|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
138452460|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452461|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452462|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409641|NCT01615978|Liraglutide|liraglutide|mesh-list
138452463|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138452465|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138452466|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138452467|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138452468|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138200133|NCT05749666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138452469|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138452470|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
138452471|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138452472|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452473|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452474|NCT01876849|Exenatide|exenatide|mesh-list
138452475|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138452476|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452477|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138452478|NCT01876849|Incretins|incretins|mesh-ancestor
138452479|NCT01876849|Hormones|hormones|mesh-ancestor
138452480|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138452481|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138452482|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
138452483|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452484|NCT01876966|Ritonavir|ritonavir|mesh-list
138452485|NCT01876966|Darunavir|darunavir|mesh-list
138452486|NCT01876966|Lumefantrine|lumefantrine|mesh-list
138452487|NCT01876966|Artemether|artemether|mesh-list
138452488|NCT01876966|Etravirine|etravirine|mesh-list
138452489|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138452490|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138452491|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138452492|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
138452493|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452494|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452495|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138452496|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138452497|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
138452498|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452499|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138210344|NCT05897151|Anesthetics|anesthetics|mesh-list
138452500|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138452501|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
138452502|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138452503|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138452504|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138452505|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138452507|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138452508|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138452509|NCT01877122|Analgesics|analgesics|mesh-ancestor
138452510|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
138452511|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452512|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452513|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138452514|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452515|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138452516|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452517|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452519|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138452520|NCT01877226|Narcotics|narcotics|mesh-ancestor
138452521|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138200136|NCT05449535|Omalizumab|omalizumab|mesh-list
138200137|NCT05449535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138200138|NCT05449535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138200139|NCT05449535|Respiratory System Agents|respiratory system agents|mesh-ancestor
138452522|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452523|NCT01877226|Analgesics|analgesics|mesh-ancestor
138452524|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
138452525|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452526|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138452527|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138409724|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
138452528|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138200140|NCT05749276|Daratumumab|daratumumab|mesh-list
138200141|NCT05749276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200142|NCT05749042|Cisplatin|cisplatin|mesh-list
138452529|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452530|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
138452531|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138452532|NCT01877356|Anesthetics|anesthetics|mesh-list
138452533|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452534|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452535|NCT01877512|Hormones|hormones|mesh-list
138452536|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138452537|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452539|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
138411487|NCT01627639|Acetazolamide|acetazolamide|mesh-list
138452540|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
138452541|NCT01877577|Vitamins|vitamins|mesh-list
138452542|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
138452543|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452544|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138452545|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138452546|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
138452547|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
138421673|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452548|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452549|NCT01877590|Protective Agents|protective agents|mesh-ancestor
138452550|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452551|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
138452552|NCT01877590|Vitamins|vitamins|mesh-ancestor
138452553|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
138452554|NCT01877746|Prednisone|prednisone|mesh-list
138452555|NCT01877746|Azathioprine|azathioprine|mesh-list
138452556|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138452557|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
138452558|NCT01877746|Hormones|hormones|mesh-ancestor
138452559|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138452560|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452561|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138409770|NCT01616784|Insulin|insulin|mesh-list
138452562|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452563|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
138452564|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452565|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138452566|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138452567|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
138452568|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452569|NCT01877811|Agerafenib|agerafenib|mesh-list
138452570|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138452571|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452572|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452573|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
138452574|NCT01877889|Canagliflozin|canagliflozin|mesh-list
138210644|NCT04772209|Heparin|heparin|mesh-list
138452575|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138452576|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452577|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138452578|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452579|NCT01877954|Fluticasone|fluticasone|mesh-list
138452581|NCT01877954|Beclomethasone|beclomethasone|mesh-list
138452582|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138452583|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138452584|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
138452585|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452586|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452588|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
138452589|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
138452590|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138452591|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
138452592|NCT01877954|Hormones|hormones|mesh-ancestor
138452593|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138452594|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138452595|NCT01878136|Plasminogen|plasminogen|mesh-list
138452596|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138452597|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138452598|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452599|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
138452600|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138452601|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
138452602|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452603|NCT01878201|Valsartan|valsartan|mesh-list
138452604|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138452605|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138210710|NCT04668144|Cangrelor|cangrelor|mesh-list
138452606|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138452607|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452608|NCT01878227|Fenofibrate|fenofibrate|mesh-list
138452609|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138452610|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
138452611|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452612|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138452613|NCT01878318|Methotrexate|methotrexate|mesh-list
138452614|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138452616|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138452617|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452618|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138452619|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
138452620|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452621|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452622|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
138452623|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452624|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138452625|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138452626|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
138452627|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452628|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138452629|NCT01878357|Piperaquine|piperaquine|mesh-list
138452630|NCT01878357|Primaquine|primaquine|mesh-list
138452631|NCT01878357|Artenimol|artenimol|mesh-list
138452632|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
138452633|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138452634|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138452635|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452636|NCT01878422|Leucovorin|leucovorin|mesh-list
138452637|NCT01878422|Bevacizumab|bevacizumab|mesh-list
138452638|NCT01878422|Cetuximab|cetuximab|mesh-list
138452639|NCT01878422|Fluorouracil|fluorouracil|mesh-list
138452640|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
138452641|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138452642|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452643|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138452644|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138452645|NCT01878422|Growth Substances|growth substances|mesh-ancestor
138452646|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452647|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
138452649|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452650|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138452651|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138452652|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
138452653|NCT01878422|Antidotes|antidotes|mesh-ancestor
138452654|NCT01878422|Protective Agents|protective agents|mesh-ancestor
138452655|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
138452656|NCT01878422|Vitamins|vitamins|mesh-ancestor
138452657|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
138452658|NCT01878513|Risperidone|risperidone|mesh-list
138452659|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138200145|NCT02940509|Ketamine|ketamine|mesh-list
138200146|NCT02940509|Analgesics|analgesics|mesh-ancestor
138452660|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
138452661|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138452662|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200147|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
138452663|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200148|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452664|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138452665|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138452666|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452667|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138452668|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138452670|NCT01878539|Anticoagulants|anticoagulants|mesh-list
138452671|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
138452672|NCT01878578|Phenytoin|phenytoin|mesh-list
138452673|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
138452674|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138452675|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138452676|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138452677|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452678|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138452679|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138452680|NCT01878643|Vancomycin|vancomycin|mesh-list
138452681|NCT01878643|Gentamicins|gentamicins|mesh-list
138452682|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452683|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452684|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138452685|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452686|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452687|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
138452688|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138411634|NCT01628770|Hematinics|hematinics|mesh-ancestor
138452689|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
138452690|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452691|NCT01878695|Expectorants|expectorants|mesh-ancestor
138452692|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
138248000|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
138452693|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138452695|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452696|NCT01878695|Protective Agents|protective agents|mesh-ancestor
138452697|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452698|NCT01878695|Antidotes|antidotes|mesh-ancestor
138452699|NCT01878708|Dexamethasone|dexamethasone|mesh-list
138452700|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
138452702|NCT01878708|Pegaspargase|pegaspargase|mesh-list
138452703|NCT01878708|BB 1101|bb 1101|mesh-list
138452704|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138452705|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
138452706|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
138452707|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452708|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452709|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138452711|NCT01878708|Hormones|hormones|mesh-ancestor
138452712|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138452713|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138452714|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452715|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
138452716|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452717|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452719|NCT01878734|Trace Elements|trace elements|mesh-list
138452720|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452721|NCT01878864|Lidocaine|lidocaine|mesh-list
138452722|NCT01878864|Bupivacaine|bupivacaine|mesh-list
138211040|NCT01866930|Antimetabolites|antimetabolites|mesh-ancestor
138452723|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
138452724|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
138452725|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452726|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452727|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
138452728|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452729|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138452730|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138452731|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138452732|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138452733|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452734|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
138452735|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
138452736|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452737|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138452738|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138452739|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
138452740|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138200154|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452741|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452742|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138452743|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
138452744|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452745|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452746|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138452747|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138452748|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452749|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452750|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452753|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452754|NCT01879202|Methylphenidate|methylphenidate|mesh-list
138452755|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138452756|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452757|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138452758|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138452759|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138452760|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452761|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
138452762|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138452763|NCT01879293|Metformin|metformin|mesh-list
138452765|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452766|NCT01879358|Sirolimus|sirolimus|mesh-list
138452767|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452769|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138452770|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452771|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
138452772|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138452773|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
138452774|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452775|NCT01879423|Lamotrigine|lamotrigine|mesh-list
138452776|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
138452777|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138452778|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138452779|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452780|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138452781|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452783|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138452784|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452785|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138452786|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138452787|NCT01879488|Edetic Acid|edetic acid|mesh-list
138452788|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
138452789|NCT01879488|Antidotes|antidotes|mesh-ancestor
138452790|NCT01879488|Protective Agents|protective agents|mesh-ancestor
138452791|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452792|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
138452793|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
138452794|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452795|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138452796|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
138452797|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138452798|NCT01879514|Prednisone|prednisone|mesh-list
138452799|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138452800|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
138452801|NCT01879514|Hormones|hormones|mesh-ancestor
138452802|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138452803|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211264|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
138452804|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138452805|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452806|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138452807|NCT01879527|Amiloride|amiloride|mesh-list
138452808|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
138452809|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138452810|NCT01879527|Diuretics|diuretics|mesh-ancestor
138452811|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
138452812|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452813|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138452814|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138452815|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452816|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138452817|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138452818|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138452819|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138452820|NCT01879605|Bisacodyl|bisacodyl|mesh-list
138452821|NCT01879605|Sorbitol|sorbitol|mesh-list
138452822|NCT01879605|Cathartics|cathartics|mesh-ancestor
138452823|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138452824|NCT01879605|Laxatives|laxatives|mesh-ancestor
138452825|NCT01879748|Rasagiline|rasagiline|mesh-list
138452826|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138452827|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453610|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138452828|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452829|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138452830|NCT01879748|Protective Agents|protective agents|mesh-ancestor
138452831|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452832|NCT01879917|Liraglutide|liraglutide|mesh-list
138452833|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138452834|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452835|NCT01879917|Incretins|incretins|mesh-ancestor
138452836|NCT01879917|Hormones|hormones|mesh-ancestor
138452837|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138452838|NCT01879930|Doxycycline|doxycycline|mesh-list
138452839|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452840|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452841|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
138452842|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138452843|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138452845|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138452846|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452847|NCT01880125|Acetaminophen|acetaminophen|mesh-list
138452848|NCT01880125|Tramadol|tramadol|mesh-list
138452849|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138452850|NCT01880125|Analgesics|analgesics|mesh-ancestor
138452851|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
138452852|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452853|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452854|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
138452855|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138452856|NCT01880125|Narcotics|narcotics|mesh-ancestor
138452857|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452858|NCT01880138|Anesthetics|anesthetics|mesh-list
138452859|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452860|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452861|NCT01880216|Enoxaparin|enoxaparin|mesh-list
138452862|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
138452863|NCT01880216|Bemiparin|bemiparin|mesh-list
138452864|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
138452865|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138452866|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138452867|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452868|NCT01880307|Prednisolone|prednisolone|mesh-list
138452870|NCT01880307|Azathioprine|azathioprine|mesh-list
138452871|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138452872|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
138452873|NCT01880307|Hormones|hormones|mesh-ancestor
138200158|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200160|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
138452874|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138452875|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452876|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138452877|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452878|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138452879|NCT01880307|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138452880|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
138452881|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452882|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
138452883|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452884|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138452885|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138452886|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
138452887|NCT01880346|Vitamin D|vitamin d|mesh-list
138452888|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
138452889|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
138452890|NCT01880346|Vitamins|vitamins|mesh-list
138452891|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
138452892|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452893|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138452894|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138452895|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
138452896|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
138452897|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452898|NCT01880372|Protective Agents|protective agents|mesh-ancestor
138452899|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452901|NCT01880372|Vitamins|vitamins|mesh-ancestor
138452902|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
138452903|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
138452904|NCT01880385|Bevacizumab|bevacizumab|mesh-list
138452906|NCT01880385|Fluorouracil|fluorouracil|mesh-list
138452907|NCT01880385|Trastuzumab|trastuzumab|mesh-list
138452908|NCT01880385|Epirubicin|epirubicin|mesh-list
138452910|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
138452911|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138211387|NCT01657266|Nepafenac|nepafenac|mesh-list
138452912|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138452913|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138452914|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
138452915|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452916|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452917|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138452918|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138452919|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138452920|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138452921|NCT01880385|Growth Substances|growth substances|mesh-ancestor
138452922|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
138452923|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
138452924|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
138452925|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
138452927|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138452928|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138452929|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138452930|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138452931|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452932|NCT01880463|Vitamin D|vitamin d|mesh-list
138452933|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
138452934|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
138452935|NCT01880463|Vitamins|vitamins|mesh-list
138452936|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
138452937|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452938|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138452939|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138452940|NCT01880619|Tamsulosin|tamsulosin|mesh-list
138452941|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
138452942|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138452943|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138452944|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138452945|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
138452946|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138452947|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452948|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452949|NCT01880619|Urological Agents|urological agents|mesh-ancestor
138452950|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138452951|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138452952|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
138452953|NCT01880658|Capecitabine|capecitabine|mesh-list
138452954|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138452955|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
138452956|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200170|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138348811|NCT02056236|Propofol|propofol|mesh-list
138452957|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452958|NCT01880749|Everolimus|everolimus|mesh-list
138452959|NCT01880749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138452960|NCT01880749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138452961|NCT01880749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452962|NCT01880749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452963|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138452964|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
138453611|NCT01886209|Prednisolone|prednisolone|mesh-list
138452965|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452966|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138452967|NCT01880775|Bupivacaine|bupivacaine|mesh-list
138452968|NCT01880775|Prilocaine|prilocaine|mesh-list
138452969|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
138452970|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
138452971|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452972|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452973|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
138452974|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452975|NCT01879241|Rasagiline|rasagiline|mesh-list
138452976|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
138452977|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138452978|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138452979|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138452980|NCT01879241|Protective Agents|protective agents|mesh-ancestor
138452981|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452982|NCT01880931|Remifentanil|remifentanil|mesh-list
138452983|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138452984|NCT01880931|Narcotics|narcotics|mesh-ancestor
138452985|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138452986|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452987|NCT01880931|Analgesics|analgesics|mesh-ancestor
138452988|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
138248013|NCT01831934|Vaccines|vaccines|mesh-list
138452989|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138452990|NCT01881074|Listerine|listerine|mesh-list
138452991|NCT01881074|Triclosan|triclosan|mesh-list
138452992|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
138411938|NCT01630915|Clopidogrel|clopidogrel|mesh-list
138452993|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
138452995|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138452996|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138452997|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138452998|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
138452999|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138453000|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
138453001|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453002|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138453004|NCT01881100|Fluorides|fluorides|mesh-list
138453005|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
138453006|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
138453007|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
138453008|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
138453009|NCT01881100|Protective Agents|protective agents|mesh-ancestor
138453010|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453011|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138453012|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453014|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
138453015|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453016|NCT01881347|Protective Agents|protective agents|mesh-ancestor
138453017|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453018|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453019|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138453020|NCT01881464|Adalimumab|adalimumab|mesh-list
138453021|NCT01881464|Infliximab|infliximab|mesh-list
138453022|NCT01881464|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138453023|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138453024|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453025|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
138453026|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138453027|NCT01881503|HBOC 201|hboc 201|mesh-list
138453028|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
138453029|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
138348812|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138453030|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138453031|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138453032|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453034|NCT01881568|Coagulants|coagulants|mesh-ancestor
138453035|NCT01881919|Quercetin|quercetin|mesh-list
138453036|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
138453037|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453038|NCT01881919|Protective Agents|protective agents|mesh-ancestor
138453039|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453040|NCT01881971|Calcium|calcium|mesh-list
138453041|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138453042|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453043|NCT01881997|Fentanyl|fentanyl|mesh-list
138453044|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138453045|NCT01881997|Narcotics|narcotics|mesh-ancestor
138453046|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453047|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453048|NCT01881997|Analgesics|analgesics|mesh-ancestor
138453049|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
138453050|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453051|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138453052|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138453053|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
138453054|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
138453055|NCT01882010|Sargramostim|sargramostim|mesh-list
138453056|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
138453057|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453058|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138453059|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
138453060|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
138453061|NCT01882127|Dexamethasone|dexamethasone|mesh-list
138453063|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138453064|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
138453065|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
138453066|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453067|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453068|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138453069|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
138453070|NCT01882127|Hormones|hormones|mesh-ancestor
138453071|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138453072|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138453073|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453074|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
138453075|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
138453076|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
138453077|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
138453078|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
138453079|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
138453080|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138453081|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453082|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138453083|NCT01882179|Diuretics|diuretics|mesh-ancestor
138453084|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
138453086|NCT01882296|Pantoprazole|pantoprazole|mesh-list
138453087|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138453088|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138453089|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138453090|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453091|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453093|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138453094|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
138453095|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453096|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138453097|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453098|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453099|NCT01882361|Naltrexone|naltrexone|mesh-list
138453100|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138453101|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138453102|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453103|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
138453104|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453105|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138453106|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138453107|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
138453108|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
138453109|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138453110|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
138453111|NCT01882400|Alendronate|alendronate|mesh-list
138453112|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
138453113|NCT01882400|Diphosphonates|diphosphonates|mesh-list
138453114|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138453115|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453116|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138453117|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138453118|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453119|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138453120|NCT01882530|Acetaminophen|acetaminophen|mesh-list
138453121|NCT01882530|Ketoprofen|ketoprofen|mesh-list
138453122|NCT01882530|Morphine|morphine|mesh-list
138453123|NCT01882530|Nefopam|nefopam|mesh-list
138453124|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138453125|NCT01882530|Narcotics|narcotics|mesh-ancestor
138453126|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453127|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453128|NCT01882530|Analgesics|analgesics|mesh-ancestor
138453129|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
138453130|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453131|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138453132|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
138453133|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138453134|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138453135|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453136|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138453137|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453138|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453140|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138453141|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138453142|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138453143|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138453144|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138412080|NCT01631513|Narcotics|narcotics|mesh-ancestor
138453145|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
138453146|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453147|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453148|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138453149|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453150|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138453151|NCT01883011|Piracetam|piracetam|mesh-list
138453152|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138453153|NCT01883011|Protective Agents|protective agents|mesh-ancestor
138453154|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453155|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
138453156|NCT01883102|Capsaicin|capsaicin|mesh-list
138453157|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
138453158|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
138212333|NCT00537290|Rituximab|rituximab|mesh-list
138248023|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
138248039|NCT00377091|PENTA|penta|mesh-list
138453159|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
138453160|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453161|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453162|NCT01883167|Febuxostat|febuxostat|mesh-list
138453163|NCT01883167|Verinurad|verinurad|mesh-list
138453164|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
138453165|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453166|NCT01883193|Micronutrients|micronutrients|mesh-list
138453167|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453168|NCT01883232|Lidocaine|lidocaine|mesh-list
138453169|NCT01883232|Epinephrine|epinephrine|mesh-list
138453170|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
138453171|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
138453172|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453173|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453174|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
138453175|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453176|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138453177|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138453178|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138453179|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138453180|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453181|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138453182|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138453183|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
138453184|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453185|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138453186|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138453187|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
138453188|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138453189|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
138453190|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
138453191|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
138453192|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138453193|NCT01883323|Aldesleukin|aldesleukin|mesh-list
138453194|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
138453195|NCT01883323|Fludarabine|fludarabine|mesh-list
138453196|NCT01883323|Interleukin-2|interleukin-2|mesh-list
138453197|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138248135|NCT01841606|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138453198|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
138453199|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453200|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453201|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138453202|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
138453203|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453204|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453205|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138453206|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138453207|NCT01883323|Analgesics|analgesics|mesh-ancestor
138453208|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
138453209|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453210|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138248195|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138453211|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138453213|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453214|NCT01883518|Vaccines|vaccines|mesh-list
138453215|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
138453216|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453217|NCT01883531|Mannitol|mannitol|mesh-list
138453218|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138453219|NCT01883531|Diuretics|diuretics|mesh-ancestor
138453220|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
138453221|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453222|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
138453223|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138453224|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453225|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
138453227|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138453228|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138212632|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
138453229|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138453230|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138453231|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
138453232|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453233|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453234|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453235|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
138453236|NCT01883882|Narcotics|narcotics|mesh-ancestor
138453237|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453238|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453239|NCT01883882|Analgesics|analgesics|mesh-ancestor
138453240|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
138453241|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453242|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
138453243|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138453244|NCT01883921|Antibodies|antibodies|mesh-list
138453245|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
138453246|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453247|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
138453248|NCT01884116|Capsaicin|capsaicin|mesh-list
138453249|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
138453250|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
138453251|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
138453252|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453253|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453254|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138453255|NCT01884116|Analgesics|analgesics|mesh-ancestor
138453256|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138248302|NCT02265224|Antidotes|antidotes|mesh-ancestor
138453257|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453258|NCT01884168|Immunomodulating Agents|immunomodulating agents|mesh-list
138453259|NCT01884168|Immunologic Factors|immunologic factors|mesh-ancestor
138453260|NCT01884168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453262|NCT01884272|Indomethacin|indomethacin|mesh-list
138212829|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
138453264|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138453265|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138453266|NCT01884272|Analgesics|analgesics|mesh-ancestor
138453267|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
138453268|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453269|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453270|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138453271|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453272|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
138453273|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138453274|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453275|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453276|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
138453277|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138453278|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
138453279|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
138453280|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453281|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138453282|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453283|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453285|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138453286|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453287|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138453289|NCT01884298|Remifentanil|remifentanil|mesh-list
138453290|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
138453291|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
138453292|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138453293|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453294|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
138453295|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453296|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138453297|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138453298|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138453299|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138213017|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
138453300|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453301|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138200177|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138453303|NCT01884298|Analgesics|analgesics|mesh-ancestor
138453304|NCT01884402|Ribavirin|ribavirin|mesh-list
138453305|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138453306|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
138453307|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200178|NCT04094207|Protective Agents|protective agents|mesh-ancestor
138200179|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200180|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
138200181|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138200182|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
138453308|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
138453309|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453310|NCT01884415|Vaccines|vaccines|mesh-list
138453311|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
138453312|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453314|NCT01884428|Gemcitabine|gemcitabine|mesh-list
138453315|NCT01884428|Vinorelbine|vinorelbine|mesh-list
138453316|NCT01884428|Ifosfamide|ifosfamide|mesh-list
138453317|NCT01884428|Panobinostat|panobinostat|mesh-list
138453318|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138453319|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
138453320|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453321|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453322|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138453323|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
138453324|NCT01884428|Hormones|hormones|mesh-ancestor
138453325|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138453326|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453327|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138453328|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138453329|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
138453330|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
138453331|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
138453332|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138453333|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
138453334|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138453335|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453336|NCT01884441|Gemcitabine|gemcitabine|mesh-list
138453337|NCT01884441|Vinorelbine|vinorelbine|mesh-list
138453338|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138248451|NCT02332824|Candesartan|candesartan|mesh-list
138453339|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138453340|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
138453341|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453342|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453343|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138453344|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
138453345|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
138453346|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
138453347|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138453348|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
138453350|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138453351|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453352|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138453353|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138213410|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453354|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453357|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138453358|NCT01884506|Trace Elements|trace elements|mesh-ancestor
138453359|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
138453360|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453361|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
138248499|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
138453612|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
138453362|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453363|NCT01884506|Protective Agents|protective agents|mesh-ancestor
138453364|NCT01884506|Vitamins|vitamins|mesh-ancestor
138453365|NCT01884558|Metformin|metformin|mesh-list
138453366|NCT01884558|Isavuconazole|isavuconazole|mesh-list
138453367|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138453368|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453369|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
138453370|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453372|NCT01884623|Cetuximab|cetuximab|mesh-list
138412304|NCT01633762|Gentamicins|gentamicins|mesh-list
138453373|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138453374|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
138453375|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138453376|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453377|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138453378|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
138453379|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453380|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453381|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
138213481|NCT01395043|Epinephrine|epinephrine|mesh-list
138453382|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453383|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138453384|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138453385|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
138453386|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453387|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138453388|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138453389|NCT01884636|Isavuconazole|isavuconazole|mesh-list
138453390|NCT01884636|Methotrexate|methotrexate|mesh-list
138453391|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138453392|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
138411376|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453393|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138453394|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453395|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138453396|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
138453397|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453398|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453399|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
138453400|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453401|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138453402|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138453403|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
138453404|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453405|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138453406|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
138453407|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453409|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138453410|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138453411|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
138453412|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
138453413|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138411509|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138453414|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453415|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138453416|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138453417|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138453419|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138213640|NCT02209519|Metronidazole|metronidazole|mesh-list
138453420|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453422|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138453423|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138453424|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
138453425|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
138453426|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453427|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453428|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138453429|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138453430|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138453431|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
138453432|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138411580|NCT01628445|Liraglutide|liraglutide|mesh-list
138453433|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453435|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138453436|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138453437|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
138453438|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
138453439|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453440|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453441|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138453442|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138453443|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138200194|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138200195|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200196|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138200197|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138200198|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138248651|NCT04066647|Hormones|hormones|mesh-ancestor
138412382|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
138453445|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453446|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453447|NCT01884935|Natalizumab|natalizumab|mesh-list
138453448|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
138453449|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453450|NCT01885013|Metformin|metformin|mesh-list
138453451|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
138453452|NCT01885013|Doxorubicin|doxorubicin|mesh-list
138453453|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138453454|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
138453455|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453456|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453457|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138453458|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
138453459|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453460|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453461|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138248690|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
138453462|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138453463|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138453464|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138453465|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138453466|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214035|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
138453469|NCT01885091|Growth Substances|growth substances|mesh-ancestor
138453470|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453471|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
138453472|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138453473|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
138453474|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453475|NCT01885338|Expectorants|expectorants|mesh-ancestor
138453476|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
138453477|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138453478|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
138453479|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453480|NCT01885338|Protective Agents|protective agents|mesh-ancestor
138248745|NCT03881163|Antidotes|antidotes|mesh-ancestor
138453482|NCT01885338|Antidotes|antidotes|mesh-ancestor
138453483|NCT01885364|Remifentanil|remifentanil|mesh-list
138453484|NCT01885364|Propofol|propofol|mesh-list
138453485|NCT01885364|Esmolol|esmolol|mesh-list
138453486|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138453487|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138411690|NCT01629225|Candesartan|candesartan|mesh-list
138453488|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453489|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138453490|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
138453492|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138453493|NCT01885364|Narcotics|narcotics|mesh-ancestor
138453494|NCT01885364|Analgesics|analgesics|mesh-ancestor
138453495|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
138453496|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453497|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138453498|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138453499|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138453500|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
138453501|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453502|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453503|NCT01885481|Dexamethasone|dexamethasone|mesh-list
138453504|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
138453505|NCT01885481|Betamethasone|betamethasone|mesh-list
138453506|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
138453507|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138453508|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
138214104|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
138453509|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138453510|NCT01885481|BB 1101|bb 1101|mesh-list
138453511|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138453512|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
138248800|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
138453514|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453515|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453516|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138453517|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
138453518|NCT01885481|Hormones|hormones|mesh-ancestor
138453519|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138412527|NCT01634932|Iron|iron|mesh-list
138453520|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138453521|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138453522|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
138453523|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453524|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453525|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138453526|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
138453528|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138453529|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
138214139|NCT01522963|Nicotine|nicotine|mesh-list
138453530|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138453531|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
138453532|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453533|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453534|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
138453535|NCT01885598|Apixaban|apixaban|mesh-list
138411782|NCT01629680|Moxaverine|moxaverine|mesh-list
138453536|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138453537|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
138453538|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138453539|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
138453540|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453541|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453542|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
138453543|NCT01885715|Neostigmine|neostigmine|mesh-list
138453544|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138453545|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453546|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453548|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453549|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453550|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138453551|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
138214256|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138453552|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138453553|NCT01885988|Nebivolol|nebivolol|mesh-list
138453555|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
138453556|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138453557|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138453558|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138453559|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
138453560|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138453561|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138453562|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138453563|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
138453564|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138453565|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
138453567|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138453568|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138453569|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
138453570|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
138453571|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
138453572|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
138453573|NCT01886014|Oxytocin|oxytocin|mesh-list
138453574|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
138411892|NCT01630564|Analgesics|analgesics|mesh-ancestor
138638007|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638008|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638009|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
138638010|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138638011|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138200201|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138200202|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138200204|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638012|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
138638013|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200205|NCT05232461|Ciprofloxacin|ciprofloxacin|mesh-list
138638014|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
138638015|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138638016|NCT00287352|Analgesics|analgesics|mesh-ancestor
138638017|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
138638018|NCT04823962|Molgramostim|molgramostim|mesh-list
138638019|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638020|NCT00252668|Etanercept|etanercept|mesh-list
138638022|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138638023|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
138638024|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138638025|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638026|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138638027|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
138638028|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638029|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138412019|NCT01631383|Analgesics|analgesics|mesh-ancestor
138638030|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
138638031|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138214386|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138638033|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138638034|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
138638035|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138638036|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138638037|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138638038|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138638039|NCT00252668|Analgesics|analgesics|mesh-ancestor
138638040|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
138638041|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638042|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138638043|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138638044|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
138638045|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
138638046|NCT02271997|Trace Elements|trace elements|mesh-ancestor
138638047|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
138638048|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638050|NCT00287391|Rabeprazole|rabeprazole|mesh-list
138638051|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138638052|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138638053|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138638055|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638056|NCT00252707|Docetaxel|docetaxel|mesh-list
138638057|NCT00252707|Gefitinib|gefitinib|mesh-list
138638058|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638059|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
138638060|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
138638062|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638063|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138638064|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638065|NCT01680406|Chloroquine|chloroquine|mesh-list
138638066|NCT01680406|Lumefantrine|lumefantrine|mesh-list
138638068|NCT01680406|Primaquine|primaquine|mesh-list
138638069|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138638070|NCT01680406|Amebicides|amebicides|mesh-ancestor
138638071|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138638072|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138638073|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138638074|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
138638075|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138638076|NCT00287430|Hormones|hormones|mesh-list
138638077|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138638078|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638079|NCT01680679|Vaccines|vaccines|mesh-list
138638080|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
138638081|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638082|NCT01680718|Vasopressins|vasopressins|mesh-list
138638083|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
138638084|NCT01680718|Oxytocin|oxytocin|mesh-list
138638085|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
138638086|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138638087|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138214551|NCT01579513|Hormones|hormones|mesh-ancestor
138638089|NCT01680718|Coagulants|coagulants|mesh-ancestor
138638090|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138638091|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138249043|NCT03997851|Analgesics|analgesics|mesh-ancestor
138638092|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
138638093|NCT01680796|Dexamethasone|dexamethasone|mesh-list
138638094|NCT01680796|Bortezomib|bortezomib|mesh-list
138638095|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138638097|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
138638098|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638099|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638100|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138638101|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
138638103|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138638104|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138638105|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638107|NCT00252785|Theophylline|theophylline|mesh-list
138638108|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
138638109|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138638110|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138638111|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
138638112|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638113|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638114|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138638115|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
138638116|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
138638117|NCT00252785|Hormones|hormones|mesh-ancestor
138638118|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138638119|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138638120|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138249080|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138638121|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138638122|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
138638123|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638124|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638125|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138638126|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638127|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
138638128|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138638129|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138638130|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
138638132|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138638133|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638134|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
138638135|NCT01680952|Sirolimus|sirolimus|mesh-list
138638136|NCT01680952|Tacrolimus|tacrolimus|mesh-list
138638137|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138638138|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
138638139|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638140|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138638141|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138412418|NCT01634412|Amitriptyline|amitriptyline|mesh-list
138638142|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638143|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138638144|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638145|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138638146|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
138638147|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138638148|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138638149|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
138638151|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
138638152|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138638153|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138638154|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
138200213|NCT05232461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200214|NCT05232461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138214703|NCT00605384|Tenofovir|tenofovir|mesh-list
138249128|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138200215|NCT05232461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138200216|NCT05232461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138638155|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638156|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638157|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138638158|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
138638159|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
138638160|NCT00252824|Hormones|hormones|mesh-ancestor
138214761|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
138638161|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138638162|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138638163|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138638164|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138638165|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
138638166|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638167|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638169|NCT00281190|Chelating Agents|chelating agents|mesh-ancestor
138638170|NCT00281190|Sequestering Agents|sequestering agents|mesh-ancestor
138638171|NCT00281190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638172|NCT00252863|Fluticasone|fluticasone|mesh-list
138638173|NCT00252863|Xhance|xhance|mesh-list
138638174|NCT00252863|Budesonide|budesonide|mesh-list
138638175|NCT00252863|Theophylline|theophylline|mesh-list
138638176|NCT00252863|Albuterol|albuterol|mesh-list
138638177|NCT00252863|Terbutaline|terbutaline|mesh-list
138638178|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
138412547|NCT01635114|Resveratrol|resveratrol|mesh-list
138638179|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138638180|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138638181|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138638182|NCT00252863|Montelukast|montelukast|mesh-list
138638183|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138638184|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138638185|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
138638186|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138412596|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138638187|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638188|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138214883|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
138638189|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
138638190|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
138638191|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138638192|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
138638194|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138638195|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138638196|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138638198|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
138638199|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638200|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638201|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
138638202|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138638203|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138638204|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
138638205|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138638206|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138638207|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138249206|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
138638208|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638209|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
138638210|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138638211|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138200222|NCT05232461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138638212|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
138200223|NCT05232461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200224|NCT05232461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138638213|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
138638214|NCT01681537|Cytarabine|cytarabine|mesh-list
138638215|NCT01681537|Etoposide|etoposide|mesh-list
138638216|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
138638217|NCT01681537|Lenalidomide|lenalidomide|mesh-list
138638218|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138638219|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638220|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138412742|NCT01636245|Vaccines|vaccines|mesh-list
138638221|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138638222|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638223|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638224|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138638225|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
138638226|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
138638227|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138638228|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138638229|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
138314870|NCT01712178|Adalimumab|adalimumab|mesh-list
138638231|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138638232|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138638233|NCT01681537|Growth Substances|growth substances|mesh-ancestor
138638234|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
138638235|NCT01681537|Analgesics|analgesics|mesh-ancestor
138638236|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
138638237|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638238|NCT01681693|Metformin|metformin|mesh-list
138638239|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138638240|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638242|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138638243|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
138638244|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
138638245|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138638246|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638247|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
138638248|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638249|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138638250|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138638251|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138638252|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138638253|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638254|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138215117|NCT00619970|Rifaximin|rifaximin|mesh-list
138638255|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138638256|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138638257|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
138638258|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638259|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249358|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
138638261|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138638262|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
138638264|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138638265|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
138638266|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138215179|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
138638267|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638268|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138638269|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138638271|NCT00281307|Tocopherols|tocopherols|mesh-list
138638272|NCT00281307|Vitamin E|vitamin e|mesh-list
138638273|NCT00281307|Tocotrienols|tocotrienols|mesh-list
138638274|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
138638275|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
138638276|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638277|NCT00281307|Protective Agents|protective agents|mesh-ancestor
138200230|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200231|NCT01313702|Atenolol|atenolol|mesh-list
138200232|NCT01313702|Lisinopril|lisinopril|mesh-list
138638278|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638279|NCT00281307|Vitamins|vitamins|mesh-ancestor
138638280|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
138638281|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
138249359|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249360|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249361|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138249362|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138249363|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
138249365|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138200241|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138200242|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
138200243|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138200244|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138200245|NCT01313702|Protective Agents|protective agents|mesh-ancestor
138200246|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200247|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138200249|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
138200250|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200251|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138249370|NCT05289050|Ketamine|ketamine|mesh-list
138638282|NCT01682746|Trioxsalen|trioxsalen|mesh-list
138638283|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638284|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
138638285|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138638287|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138638288|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138638289|NCT01682902|Insulin|insulin|mesh-list
138638290|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138638291|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
138638292|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
138638293|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138638294|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138412958|NCT01637194|Everolimus|everolimus|mesh-list
138638295|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638296|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138638298|NCT01683175|Vinorelbine|vinorelbine|mesh-list
138638299|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638300|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138249402|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138249403|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
138200252|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138200253|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138200254|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
138249404|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138249405|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138249406|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138249407|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638302|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638304|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
138638305|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
138638306|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
138638307|NCT01683253|Dopamine|dopamine|mesh-list
138638308|NCT01683253|Levodopa|levodopa|mesh-list
138638309|NCT01683253|Carbidopa|carbidopa|mesh-list
138638310|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
138638311|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138215291|NCT00653276|Cyclosporine|cyclosporine|mesh-list
138638313|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
138638314|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638315|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638316|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638317|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138638318|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638319|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138638320|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
138638321|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
138638322|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638323|NCT01683253|Protective Agents|protective agents|mesh-ancestor
138638324|NCT01683292|Apomorphine|apomorphine|mesh-list
138638325|NCT01683292|Emetics|emetics|mesh-ancestor
138638326|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638327|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
138638328|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638329|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138638330|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
138638331|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
138638332|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249456|NCT01280643|Antibodies|antibodies|mesh-list
138638333|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638335|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138413071|NCT01637558|Lopinavir|lopinavir|mesh-list
138638336|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138638337|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138638338|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
138638339|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
138638340|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638341|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638342|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638344|NCT01683682|Vinorelbine|vinorelbine|mesh-list
138638345|NCT01683682|Nintedanib|nintedanib|mesh-list
138638346|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638347|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138638348|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
138638349|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
138638350|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
138638351|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638352|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138638353|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638354|NCT00287742|Risperidone|risperidone|mesh-list
138638355|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138638356|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
138249498|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138638357|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249499|NCT02298192|Liraglutide|liraglutide|mesh-list
138249500|NCT02298192|Xultophy|xultophy|mesh-list
138638358|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638359|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638361|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138638362|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138638363|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138638364|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138638365|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
138638366|NCT04527562|Colchicine|colchicine|mesh-list
138638367|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
138638368|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138638369|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
138638370|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
138638371|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
138215388|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638372|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638373|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638374|NCT01684072|Vaccines|vaccines|mesh-list
138638375|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
138638376|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638379|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138638380|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638381|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
138638382|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
138638383|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
138315018|NCT01568034|Carbidopa|carbidopa|mesh-list
138638384|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638385|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138638386|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638387|NCT00253136|Risperidone|risperidone|mesh-list
138638388|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138638389|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
138638390|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638391|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638392|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638393|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138638394|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138638395|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138638396|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138638397|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138638398|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
138638399|NCT01684306|Modafinil|modafinil|mesh-list
138638400|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138638401|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638402|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138638403|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138638404|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138638405|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638406|NCT00287781|Lidocaine|lidocaine|mesh-list
138638407|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
138638408|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
138638409|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138638410|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638411|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
138638412|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638413|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138638414|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138638415|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138638416|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138638417|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638418|NCT00416871|Interferons|interferons|mesh-list
138638419|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
138638420|NCT00416871|Aldesleukin|aldesleukin|mesh-list
138638421|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638422|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
138638423|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138638424|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
138638425|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638427|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138638428|NCT01684657|Asenapine|asenapine|mesh-list
138638429|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138638430|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138638431|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138638432|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638433|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138638434|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
138638435|NCT00416910|Fludarabine|fludarabine|mesh-list
138638436|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
138638437|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138638438|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
138638439|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638440|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138638441|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138638442|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
138638443|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638444|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638445|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138638447|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
138638448|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138249706|NCT02379585|Paclitaxel|paclitaxel|mesh-list
138249707|NCT02379585|Docetaxel|docetaxel|mesh-list
138638449|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138638450|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138638451|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638452|NCT01684774|Bupivacaine|bupivacaine|mesh-list
138638453|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
138638454|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
138638455|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138638456|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638457|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
138638458|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638459|NCT02279992|Carboplatin|carboplatin|mesh-list
138638461|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638462|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
138638463|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138638464|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138638465|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638466|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638467|NCT02279992|Urological Agents|urological agents|mesh-ancestor
138638468|NCT00253175|Topiramate|topiramate|mesh-list
138638469|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
138638470|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138638471|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638472|NCT00287820|Olanzapine|olanzapine|mesh-list
138638473|NCT00287820|Risperidone|risperidone|mesh-list
138638474|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138638475|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
138638476|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638477|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638478|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638479|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138638480|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138638481|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138638482|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138638483|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138638484|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
138638485|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
138638486|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
138249755|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638487|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638488|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138249756|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138638489|NCT00287820|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138638490|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138638491|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138638494|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638495|NCT00253214|Galantamine|galantamine|mesh-list
138638496|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138638497|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638498|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638499|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
138638500|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638501|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638502|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138638503|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
138249789|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249790|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
138249791|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138249792|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138249794|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138249798|NCT02318901|Cetuximab|cetuximab|mesh-list
138638504|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638505|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
138638507|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138638508|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138638509|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638510|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638511|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638512|NCT01684969|Haloperidol|haloperidol|mesh-list
138638513|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
138638514|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
138638515|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
138638516|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638517|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638518|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138249843|NCT00965055|Ezetimibe|ezetimibe|mesh-list
138249844|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138249845|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138249846|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
138249847|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138249848|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138249849|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138249850|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249851|NCT02266797|Dexamethasone|dexamethasone|mesh-list
138638519|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138638520|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138638521|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138638522|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138638523|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138638524|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
138638525|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638526|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638527|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138638528|NCT01685125|Prednisone|prednisone|mesh-list
138638529|NCT01685125|Dasatinib|dasatinib|mesh-list
138638530|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
138638531|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138638532|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
138638533|NCT01685125|Hormones|hormones|mesh-ancestor
138638534|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138638535|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638536|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138638537|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638538|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138638539|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638540|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638541|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138638542|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
138638543|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138638545|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638546|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138638547|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138413539|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
138638548|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638549|NCT01685281|Metadoxine|metadoxine|mesh-list
138638550|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138638551|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138638552|NCT00417066|Ganirelix|ganirelix|mesh-list
138638553|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
138638554|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138638555|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
138638556|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138638557|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638558|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138638559|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138638560|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638562|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138638563|NCT01685398|Timolol|timolol|mesh-list
138638564|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138638565|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138638566|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638567|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138638568|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138638569|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
138638570|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138200284|NCT05732272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638571|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638572|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138638573|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138638574|NCT01685515|Decitabine|decitabine|mesh-list
138638575|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
138638576|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138638578|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638579|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638580|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638581|NCT00281502|Rifaximin|rifaximin|mesh-list
138638582|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138638583|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138638584|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138638585|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
138250006|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638586|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
138638587|NCT00253487|Temozolomide|temozolomide|mesh-list
138638588|NCT00253487|Busulfan|busulfan|mesh-list
138638590|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138638591|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
138638592|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638593|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638594|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138638595|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
138638596|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638597|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138638598|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638599|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
138638600|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138638601|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638602|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138638603|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
138638604|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138638605|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138638606|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638608|NCT04527211|Ivermectin|ivermectin|mesh-list
138638610|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138638611|NCT00253526|Bevacizumab|bevacizumab|mesh-list
138638612|NCT00253526|Gemcitabine|gemcitabine|mesh-list
138638613|NCT00253526|Antibodies|antibodies|mesh-list
138638614|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
138638615|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138638616|NCT00253526|Mitogens|mitogens|mesh-list
138638617|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138638618|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638619|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138638620|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138638621|NCT00253526|Growth Substances|growth substances|mesh-ancestor
138638622|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638623|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
138638624|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
138638625|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138638626|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
138638627|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638628|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
138638629|NCT01686217|Niacinamide|niacinamide|mesh-list
138638630|NCT01686217|Peficitinib|peficitinib|mesh-list
138638631|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638632|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638633|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138638634|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
138638635|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200286|NCT05513872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138200287|NCT05513872|Autonomic Agents|autonomic agents|mesh-ancestor
138638637|NCT01686217|Vitamins|vitamins|mesh-ancestor
138638638|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
138638639|NCT00253565|Capecitabine|capecitabine|mesh-list
138638640|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
138638641|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138638642|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
138638643|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638644|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638645|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138638646|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638647|NCT01686529|Bevacizumab|bevacizumab|mesh-list
138638648|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138638649|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638650|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138638651|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138638652|NCT01686529|Growth Substances|growth substances|mesh-ancestor
138638653|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638654|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
138638655|NCT01686607|Itraconazole|itraconazole|mesh-list
138638656|NCT01686607|Fluconazole|fluconazole|mesh-list
138638657|NCT01686607|Voriconazole|voriconazole|mesh-list
138638658|NCT01686607|Amphotericin B|amphotericin b|mesh-list
138638659|NCT01686607|Caspofungin|caspofungin|mesh-list
138638661|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
138638662|NCT01686607|Clotrimazole|clotrimazole|mesh-list
138638663|NCT01686607|Miconazole|miconazole|mesh-list
138638664|NCT01686607|Anidulafungin|anidulafungin|mesh-list
138638665|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138638666|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138638667|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138638668|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638669|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638670|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138638671|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
138638672|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138250149|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
138250164|NCT01784991|Morphine|morphine|mesh-list
138638673|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638674|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138638675|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138638676|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138638677|NCT01686607|Amebicides|amebicides|mesh-ancestor
138638678|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138638679|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138638680|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138638681|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138638682|NCT01686802|Ibuprofen|ibuprofen|mesh-list
138638683|NCT01686802|Morphine|morphine|mesh-list
138638684|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138638685|NCT01686802|Narcotics|narcotics|mesh-ancestor
138638686|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138638687|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638688|NCT01686802|Analgesics|analgesics|mesh-ancestor
138638689|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
138638690|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638691|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138638692|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138200296|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
138638693|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138638694|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138638695|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138638696|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638697|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638699|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138638701|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638702|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638703|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138638704|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138638705|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
138638706|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638707|NCT00281892|Vidarabine|vidarabine|mesh-list
138638708|NCT00281892|Fludarabine|fludarabine|mesh-list
138638709|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
138413771|NCT01650090|Cisplatin|cisplatin|mesh-list
138638710|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638711|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138638712|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
138638713|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638714|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138638715|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
138638716|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638717|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
138638718|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138638720|NCT02274571|Hormones|hormones|mesh-ancestor
138638721|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138638722|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638723|NCT00253799|Hylan|hylan|mesh-list
138638724|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
138638725|NCT00253799|Protective Agents|protective agents|mesh-ancestor
138250189|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250197|NCT01691079|Bromides|bromides|mesh-list
138638727|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
138638728|NCT00281931|Rituximab|rituximab|mesh-list
138638729|NCT00281931|Fludarabine|fludarabine|mesh-list
138638730|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
138638731|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138638732|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
138638733|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638734|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138638735|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138638736|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
138638737|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638738|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638739|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138638741|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138638742|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
138638743|NCT01687348|Lidocaine|lidocaine|mesh-list
138638744|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
138638745|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
138638746|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138200319|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
138638747|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638748|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
138200321|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138638749|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138413936|NCT01651130|Carbetocin|carbetocin|mesh-list
138638750|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138638751|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138638752|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138638753|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138638754|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638755|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138638756|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138638757|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138638758|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138638759|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138638760|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
138638761|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638762|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638763|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638765|NCT01687582|Exenatide|exenatide|mesh-list
138638766|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138638767|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638768|NCT01687582|Incretins|incretins|mesh-ancestor
138638770|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138638771|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138638773|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138638774|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
138453575|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138638775|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138638776|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638777|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138638778|NCT01687699|Diuretics|diuretics|mesh-ancestor
138638779|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
138638780|NCT00287937|Paclitaxel|paclitaxel|mesh-list
138638781|NCT00287937|Carboplatin|carboplatin|mesh-list
138638782|NCT00287937|Vorinostat|vorinostat|mesh-list
138638783|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138638784|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638785|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
138638786|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
138638787|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
138638788|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638789|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138638790|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638792|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
138638793|NCT01687894|Propofol|propofol|mesh-list
138638794|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
138638795|NCT01687894|Anesthetics|anesthetics|mesh-list
138638796|NCT01687894|Sevoflurane|sevoflurane|mesh-list
138638797|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
138638798|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138638799|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138638800|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638801|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138638802|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138638803|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
138638804|NCT01687894|Coagulants|coagulants|mesh-ancestor
138638805|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138638806|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138250242|NCT00357383|Azithromycin|azithromycin|mesh-list
138638807|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
138638808|NCT00287976|Irinotecan|irinotecan|mesh-list
138638809|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138638810|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138638811|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638812|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638813|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638814|NCT01688089|Levodopa|levodopa|mesh-list
138638815|NCT01688089|Carbidopa|carbidopa|mesh-list
138638816|NCT01688089|Entacapone|entacapone|mesh-list
138638817|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138638818|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138638819|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
138638820|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638821|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638822|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638823|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138638824|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200341|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200342|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138200343|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
138200344|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
138200345|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
138200346|NCT02087306|Brincidofovir|brincidofovir|mesh-list
138200347|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
138200348|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138638825|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138638826|NCT01688206|Atezolizumab|atezolizumab|mesh-list
138638827|NCT01688206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138638828|NCT01688206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638829|NCT01688206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138638830|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638831|NCT00288171|Allopurinol|allopurinol|mesh-list
138638832|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
138638833|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638834|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638835|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
138638836|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138638837|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138638838|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
138638839|NCT00288171|Protective Agents|protective agents|mesh-ancestor
138638840|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200349|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
138200350|NCT00002554|Busulfan|busulfan|mesh-list
138200351|NCT00002554|Methotrexate|methotrexate|mesh-list
138200352|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200353|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
138200370|NCT00002560|Antibodies|antibodies|mesh-list
138638841|NCT00253955|Levofloxacin|levofloxacin|mesh-list
138638842|NCT00253955|Tazobactam|tazobactam|mesh-list
138638843|NCT00253955|Piperacillin|piperacillin|mesh-list
138638844|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138638845|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138638847|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138638848|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138638849|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138638850|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638851|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138250280|NCT05550519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138250281|NCT01203371|Naftopidil|naftopidil|mesh-list
138250282|NCT01203371|Tamsulosin|tamsulosin|mesh-list
138638852|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638853|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138638854|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138638855|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138638856|NCT00288249|Sagopilone|sagopilone|mesh-list
138638857|NCT00288249|Epothilones|epothilones|mesh-list
138638858|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638859|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
138638860|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
138638861|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
138638862|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638863|NCT00254033|Methylphenidate|methylphenidate|mesh-list
138638864|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
138638865|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138638866|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638867|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138638868|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138638869|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138638870|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638871|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
138638872|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638873|NCT01600573|Topotecan|topotecan|mesh-list
138638874|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138638875|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138638876|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138216145|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
138638877|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638878|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638879|NCT01600612|Oxytocin|oxytocin|mesh-list
138638880|NCT01600612|Carbetocin|carbetocin|mesh-list
138638881|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
138638882|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138638883|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638884|NCT01600768|Lactams|lactams|mesh-list
138638885|NCT01600768|beta-Lactams|beta-lactams|mesh-list
138638886|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138638887|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138638888|NCT00414947|Vildagliptin|vildagliptin|mesh-list
138638889|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138638890|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638891|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138638892|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
138638893|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638894|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638897|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638898|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
138638899|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
138638900|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
138638901|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638902|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638903|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138638904|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
138638905|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638906|NCT00415064|Dexamethasone|dexamethasone|mesh-list
138638907|NCT00415064|Lenalidomide|lenalidomide|mesh-list
138200387|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414221|NCT01652378|Lidocaine|lidocaine|mesh-list
138638908|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138638910|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
138638911|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138638912|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638913|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138638914|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
138638915|NCT00415064|Hormones|hormones|mesh-ancestor
138638916|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138638917|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138638918|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138250349|NCT05722301|Hormones|hormones|mesh-ancestor
138638919|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
138638920|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138638921|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138638922|NCT00415064|Growth Substances|growth substances|mesh-ancestor
138638923|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
138638925|NCT00415103|Palonosetron|palonosetron|mesh-list
138638926|NCT00415103|Granisetron|granisetron|mesh-list
138638927|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
138638928|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
138638930|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638931|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138638932|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138638933|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638934|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638935|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138638936|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138638937|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
138638939|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
138638940|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138638941|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138638942|NCT00417729|Acarbose|acarbose|mesh-list
138638943|NCT00417729|Glyburide|glyburide|mesh-list
138638944|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138638945|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138414334|NCT01652781|Azacitidine|azacitidine|mesh-list
138638946|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638947|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138638948|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638950|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138638951|NCT00254189|Estradiol|estradiol|mesh-list
138638952|NCT00254189|Estrogens|estrogens|mesh-ancestor
138638953|NCT00254189|Hormones|hormones|mesh-ancestor
138216585|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138638954|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138638955|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138638956|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138638957|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
138638958|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138638959|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138638960|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138638961|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138638962|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138638963|NCT01600807|Gemcitabine|gemcitabine|mesh-list
138638964|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138638965|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138638966|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
138638967|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638968|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638969|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138638970|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638971|NCT00288483|Policosanol|policosanol|mesh-list
138638972|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138638973|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138638974|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
138638975|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638976|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138216715|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
138638977|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138638978|NCT01600963|Bedaquiline|bedaquiline|mesh-list
138200393|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
138638979|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
138638980|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
138638981|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138638982|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138638983|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138638985|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138638986|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
138638987|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138638988|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138638989|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638990|NCT01601002|Mirtazapine|mirtazapine|mesh-list
138638991|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
138638992|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138638993|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138638994|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
138638995|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
138638996|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138638997|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138638998|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639000|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138639001|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639002|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138639003|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138639004|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138639005|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
138639006|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138639007|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138639008|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
138639009|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138250418|NCT05258565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138639011|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138639012|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138639013|NCT00288561|Growth Substances|growth substances|mesh-ancestor
138639014|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639015|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
138639016|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639018|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
138639019|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138639020|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138639021|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639022|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138639023|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639024|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138639025|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138639026|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639027|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138639028|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138639029|NCT01607125|Vortioxetine|vortioxetine|mesh-list
138639030|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
138639031|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138639032|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138639033|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138639034|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138200397|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
138200398|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200399|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138200400|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138200401|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
138200402|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138639035|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639036|NCT01607125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138639037|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138639038|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138639039|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639040|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639041|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
138639042|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138639043|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138414592|NCT01654497|HU 211|hu 211|mesh-list
138639045|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138639046|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138639047|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
138639048|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138639049|NCT00254345|Protective Agents|protective agents|mesh-ancestor
138639050|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639051|NCT00254618|Mesalamine|mesalamine|mesh-list
138217231|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
138639052|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138639053|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138639054|NCT00254618|Analgesics|analgesics|mesh-ancestor
138639055|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
138639056|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138250453|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
138639057|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639059|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138639060|NCT00288717|Telmisartan|telmisartan|mesh-list
138639062|NCT00288717|Candesartan cilexetil|candesartan cilexetil|mesh-list
138639063|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138639064|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138639065|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138639066|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639068|NCT01601314|Analgesics|analgesics|mesh-ancestor
138639069|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
138639070|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639071|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639072|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
138639073|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639074|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138639075|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
138639076|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138639077|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138639078|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639079|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138639080|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
138639081|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138639082|NCT00254657|Levetiracetam|levetiracetam|mesh-list
138639083|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
138639084|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
138639086|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639087|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138639088|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138639089|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639090|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639091|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138639092|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
138639093|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138639094|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639095|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138639096|NCT00254735|Clomipramine|clomipramine|mesh-list
138639097|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
138639098|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138639099|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138639100|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138639101|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138217441|NCT01275638|Hormones|hormones|mesh-ancestor
138639102|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639103|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138639104|NCT00254735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138250476|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200413|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639105|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138639106|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138639107|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639108|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639110|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
138639111|NCT00288873|Vitamin D|vitamin d|mesh-list
138639112|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
138639113|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138414648|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639114|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639116|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
138639117|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138639118|NCT01608139|Curcumin|curcumin|mesh-list
138639119|NCT01608139|Sorafenib|sorafenib|mesh-list
138639120|NCT01608139|Vorinostat|vorinostat|mesh-list
138639121|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639122|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138639123|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639124|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639125|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138639126|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138639127|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138639128|NCT01608139|Analgesics|analgesics|mesh-ancestor
138639129|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
138639130|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639131|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639132|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138639133|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138639135|NCT01607671|Maleic acid|maleic acid|mesh-list
138639136|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639137|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639138|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138639139|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138639140|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
138639141|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639142|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639143|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138639144|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138639145|NCT00288951|Travoprost|travoprost|mesh-list
138639146|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138639147|NCT00254774|Valproic Acid|valproic acid|mesh-list
138639148|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138639149|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
138639150|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138639151|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138639152|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138250505|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639153|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639154|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639155|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
138639156|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639157|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639158|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
138639159|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639160|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
138639161|NCT01608334|Fentanyl|fentanyl|mesh-list
138639162|NCT01608334|Sufentanil|sufentanil|mesh-list
138639163|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138639164|NCT01608334|Narcotics|narcotics|mesh-ancestor
138639165|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639166|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639167|NCT01608334|Analgesics|analgesics|mesh-ancestor
138639168|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
138639169|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639170|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138639171|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138639172|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
138639173|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
138639175|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
138639176|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
138639177|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639178|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639179|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
138639180|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639181|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138639182|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138639183|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138639184|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138639185|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639186|NCT01608412|Everolimus|everolimus|mesh-list
138639187|NCT01608412|Tacrolimus|tacrolimus|mesh-list
138639188|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138639189|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
138639190|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639191|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138639193|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639194|NCT01608412|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138639195|NCT01608412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138639196|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639197|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138639198|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
138250531|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138639199|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138639200|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138639201|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138639202|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639203|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639204|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
138315838|NCT01514370|Curcumin|curcumin|mesh-list
138639205|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639206|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138639207|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639208|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138639209|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639210|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639212|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138639213|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
138639214|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639215|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639216|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218043|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
138639217|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138639218|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138414953|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
138639219|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639220|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138639221|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138639222|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
138639223|NCT02273440|Theophylline|theophylline|mesh-list
138639224|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138639225|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
138639226|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639227|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639228|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138639229|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
138639230|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138639231|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639232|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639233|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
138639234|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138639235|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138639236|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
138639237|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639238|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
138639239|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138639240|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138639241|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138639242|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
138639243|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138250560|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639244|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639245|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138218259|NCT00794144|Analgesics|analgesics|mesh-ancestor
138639248|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
138639249|NCT01588756|Goralatide|goralatide|mesh-list
138639250|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
138639251|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639252|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138639253|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639254|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
138639255|NCT01588756|Growth Substances|growth substances|mesh-ancestor
138639256|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639257|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138639258|NCT01588756|Protective Agents|protective agents|mesh-ancestor
138639261|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639262|NCT04719104|Protective Agents|protective agents|mesh-ancestor
138415067|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138639263|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639265|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
138639266|NCT01588795|Diuretics|diuretics|mesh-list
138639267|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138639268|NCT01588795|Vitamins|vitamins|mesh-ancestor
138639269|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
138218442|NCT03802214|Vedolizumab|vedolizumab|mesh-list
138639270|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639271|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138639272|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138639273|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
138639274|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639276|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138639277|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639278|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
138639279|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639281|NCT00255242|Simvastatin|simvastatin|mesh-list
138250588|NCT05719961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138250590|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
138639282|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138639283|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138639284|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
138639285|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639286|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138639287|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138639288|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639289|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
138639290|NCT00270114|Hematinics|hematinics|mesh-ancestor
138639291|NCT00107380|Prednisone|prednisone|mesh-list
138639292|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
138639293|NCT00107380|Rituximab|rituximab|mesh-list
138639294|NCT00107380|Doxorubicin|doxorubicin|mesh-list
138639295|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138639296|NCT00107380|Vincristine|vincristine|mesh-list
138639297|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
138639298|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138639299|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
138639300|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639301|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138639302|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138639303|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
138639304|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639305|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639306|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138639307|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138639308|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138639309|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138200420|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200421|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
138200422|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639310|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138639311|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200423|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138200424|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200425|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
138639312|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138639313|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
138639314|NCT00107380|Hormones|hormones|mesh-ancestor
138639315|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138639316|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138218643|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639317|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138639319|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
138639320|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
138639321|NCT00270153|Enalapril|enalapril|mesh-list
138639322|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138250628|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138639324|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639325|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138218694|NCT00776594|Hormones|hormones|mesh-ancestor
138639326|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138639327|NCT04054531|Paclitaxel|paclitaxel|mesh-list
138639328|NCT04054531|Carboplatin|carboplatin|mesh-list
138639329|NCT04054531|Pemetrexed|pemetrexed|mesh-list
138639330|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138639331|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639332|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
138639333|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
138639334|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
138639335|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639336|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639337|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138639338|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138639339|NCT00289263|Paclitaxel|paclitaxel|mesh-list
138639340|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138639341|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639342|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
138639343|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
138639344|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
138639345|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639346|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138639347|NCT00255437|Hematinics|hematinics|mesh-ancestor
138639348|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138639349|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138639350|NCT00255476|Gefitinib|gefitinib|mesh-list
138639351|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639352|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138639353|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639354|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639357|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138639358|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138639359|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639360|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138639361|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
138639362|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138250660|NCT05663801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639363|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138200426|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200427|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138200428|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
138200430|NCT00002578|Antidotes|antidotes|mesh-ancestor
138639364|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138415410|NCT01658215|Nicotine|nicotine|mesh-list
138639365|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639366|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639367|NCT00289419|Ketorolac|ketorolac|mesh-list
138639368|NCT00289419|Epinephrine|epinephrine|mesh-list
138639369|NCT00289419|Racepinephrine|racepinephrine|mesh-list
138639370|NCT00289419|Morphine|morphine|mesh-list
138639371|NCT00289419|Ropivacaine|ropivacaine|mesh-list
138639372|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
138639373|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138639374|NCT00289419|Narcotics|narcotics|mesh-ancestor
138639375|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639376|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639377|NCT00289419|Analgesics|analgesics|mesh-ancestor
138639378|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
138639379|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639380|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
138218942|NCT06212973|Azelastine|azelastine|mesh-list
138639382|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138639383|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138639384|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138639385|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138639386|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138639387|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639388|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138219004|NCT06212661|Erenumab|erenumab|mesh-list
138639389|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138639390|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138639392|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639393|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138639394|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138639395|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
138250698|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639398|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
138639399|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
138639400|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138639401|NCT00255554|Escitalopram|escitalopram|mesh-list
138639402|NCT00255554|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138639403|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138639404|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138639405|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639406|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639407|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
138639408|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639409|NCT00270348|Ciclesonide|ciclesonide|mesh-list
138639410|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
138639411|NCT00270348|Hormones|hormones|mesh-ancestor
138219124|NCT06200194|Mydriatics|mydriatics|mesh-ancestor
138639412|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138639413|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639414|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138639415|NCT00255593|Rituximab|rituximab|mesh-list
138639416|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138639417|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639418|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
138639419|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639420|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138639421|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138639422|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
138639423|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639424|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
138639425|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
138639426|NCT00255710|Fludarabine|fludarabine|mesh-list
138639428|NCT00255710|Tacrolimus|tacrolimus|mesh-list
138316060|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138639429|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138415513|NCT01659047|Idelalisib|idelalisib|mesh-list
138639430|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
138639431|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639432|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138639433|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138639434|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
138200448|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138639435|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639436|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639437|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138639438|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138639439|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
138639440|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138639441|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639442|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138250738|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639443|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138639445|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138639446|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138415549|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
138639448|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138639449|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
138639450|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639451|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639452|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138639453|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
138639454|NCT00255749|Hematinics|hematinics|mesh-ancestor
138639455|NCT04482361|Antibodies|antibodies|mesh-list
138639456|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
138639457|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639459|NCT00270543|Fluorouracil|fluorouracil|mesh-list
138639460|NCT00270543|Docetaxel|docetaxel|mesh-list
138639461|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
138639462|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639463|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138639464|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639465|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138639466|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
138639467|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639469|NCT00270543|Protective Agents|protective agents|mesh-ancestor
138639470|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
138639471|NCT00270543|Vitamins|vitamins|mesh-ancestor
138639472|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
138639473|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
138639474|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
138639475|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
138639477|NCT02960919|Gentamicins|gentamicins|mesh-list
138639478|NCT02960919|Penicillins|penicillins|mesh-list
138639479|NCT02960919|Ampicillin|ampicillin|mesh-list
138639480|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138639481|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138639482|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138639483|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639484|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639486|NCT00270582|Docetaxel|docetaxel|mesh-list
138639487|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639488|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138639489|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
138639490|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639491|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
138639492|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
138639493|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
138639495|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
138639496|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138639497|NCT01600456|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138639498|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138639499|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138200451|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200452|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138200453|NCT00199082|Cytarabine|cytarabine|mesh-list
138639500|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200454|NCT00199082|Dexamethasone|dexamethasone|mesh-list
138200455|NCT00199082|Prednisolone|prednisolone|mesh-list
138200456|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
138200457|NCT00199082|Ifosfamide|ifosfamide|mesh-list
138639501|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639502|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
138316141|NCT06175403|Niacin|niacin|mesh-list
138639503|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639504|NCT00289809|Ifosfamide|ifosfamide|mesh-list
138639505|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138639506|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
138639507|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639508|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639510|NCT00256100|Fondaparinux|fondaparinux|mesh-list
138639511|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138639512|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
138639513|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138639514|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
138639515|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639516|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639517|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
138639518|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138639519|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138639520|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138639521|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138639522|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
138639523|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639524|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
138639525|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639526|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
138250796|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138639528|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639529|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138639531|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
138639532|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639533|NCT01609387|Protective Agents|protective agents|mesh-ancestor
138639534|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639535|NCT01609387|Vitamins|vitamins|mesh-ancestor
138639536|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
138639537|NCT00256178|Simvastatin|simvastatin|mesh-list
138639538|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138639539|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138639540|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
138639541|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639542|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138639543|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138639544|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639545|NCT02488408|Cytarabine|cytarabine|mesh-list
138639546|NCT02488408|Decitabine|decitabine|mesh-list
138639547|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138639548|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
138639549|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639550|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639551|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
138639552|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138220541|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639554|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
138639555|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639556|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639558|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
138639559|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
138639560|NCT00270777|Epinephrine|epinephrine|mesh-list
138639561|NCT00270777|Racepinephrine|racepinephrine|mesh-list
138639562|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
138639563|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138220602|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
138639564|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138200461|NCT00199082|Doxorubicin|doxorubicin|mesh-list
138200462|NCT00199082|Vindesine|vindesine|mesh-list
138639565|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138639566|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
138200463|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200464|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
138639567|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138415674|NCT01659788|Ubiquinone|ubiquinone|mesh-list
138250855|NCT02294604|Povidone|povidone|mesh-list
138639568|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639570|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138639571|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138639572|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
138639573|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639574|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138639575|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
138639576|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
138639577|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
138639578|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138639579|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
138639580|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
138639581|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138639582|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
138639583|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
138639584|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138639585|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138639586|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138639587|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639588|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
138639589|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
138639590|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
138639591|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
138639592|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138639593|NCT00256256|Glucagon|glucagon|mesh-list
138639594|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138639595|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138639596|NCT00256256|Hormones|hormones|mesh-ancestor
138639597|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138639598|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138250868|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138639599|NCT00256256|Incretins|incretins|mesh-ancestor
138639600|NCT00256334|Resveratrol|resveratrol|mesh-list
138250870|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639602|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639603|NCT00256334|Protective Agents|protective agents|mesh-ancestor
138220886|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
138639604|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639605|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639606|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138639607|NCT01609855|Scopolamine|scopolamine|mesh-list
138639608|NCT01609855|Bromides|bromides|mesh-list
138639609|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138639610|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
138639611|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138639612|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
138639613|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
138220965|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639614|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639615|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639616|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138639617|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
138639618|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138639619|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
138639620|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639621|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639622|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138639623|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
138639624|NCT00270816|Interferons|interferons|mesh-list
138639625|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639626|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
138639627|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138639628|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
138639629|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639630|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138639631|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
138639632|NCT01609816|Dasatinib|dasatinib|mesh-list
138639633|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639634|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138639635|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639636|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138221089|NCT01853748|Paclitaxel|paclitaxel|mesh-list
138639637|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
138639638|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138639639|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639640|NCT00290082|Midazolam|midazolam|mesh-list
138639641|NCT00290082|Loxapine|loxapine|mesh-list
138639642|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138639643|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138639644|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639645|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639646|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138639647|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138639648|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138639649|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138639650|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
138639651|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
138639652|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
138639653|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
138639654|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639655|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639656|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138639657|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138639658|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
138639659|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
138639660|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138639661|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639662|NCT02270437|Epinephrine|epinephrine|mesh-list
138639663|NCT02270437|Racepinephrine|racepinephrine|mesh-list
138639664|NCT02270437|Fentanyl|fentanyl|mesh-list
138639665|NCT02270437|Ropivacaine|ropivacaine|mesh-list
138639666|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
138639667|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
138639668|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
138639669|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639670|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639671|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
138639672|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639673|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138639674|NCT02270437|Narcotics|narcotics|mesh-ancestor
138639675|NCT02270437|Analgesics|analgesics|mesh-ancestor
138639676|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138639677|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138639678|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
138639679|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138639680|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138639681|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
138639682|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639683|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639684|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138639685|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138639686|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
138639687|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138639688|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
138639689|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
138639690|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
138639691|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138639692|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
138639693|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
138639694|NCT02270749|Vitamins|vitamins|mesh-ancestor
138639695|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
138639696|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639697|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
138639698|NCT02270749|Hematinics|hematinics|mesh-ancestor
138639699|NCT02270788|Leucovorin|leucovorin|mesh-list
138639700|NCT02270788|Cytarabine|cytarabine|mesh-list
138639701|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
138639702|NCT02270788|Methotrexate|methotrexate|mesh-list
138639703|NCT02270788|Sorafenib|sorafenib|mesh-list
138639704|NCT02270788|Crenolanib|crenolanib|mesh-list
138639705|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138639706|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
138639707|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138639708|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639709|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200470|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200471|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138200472|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200473|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
138639711|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639712|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639713|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
138639714|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639715|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138639716|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138639717|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
138639718|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138639719|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138639720|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
138639721|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138639722|NCT02270788|Antidotes|antidotes|mesh-ancestor
138639723|NCT02270788|Protective Agents|protective agents|mesh-ancestor
138639724|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
138639725|NCT02270788|Vitamins|vitamins|mesh-ancestor
138639726|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
138639727|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138639728|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138639729|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
138639730|NCT02270827|Aminophylline|aminophylline|mesh-list
138639731|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138639732|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138250981|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138316356|NCT06131905|Propofol|propofol|mesh-list
138639733|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
138639734|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639735|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639736|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138639737|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
138639738|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138639739|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138639740|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639741|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639742|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138639743|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138639744|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
138639745|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639746|NCT02270827|Protective Agents|protective agents|mesh-ancestor
138639748|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
138639749|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
138639750|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639751|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639752|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138639753|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138639754|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138639755|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639756|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138639757|NCT00290121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138639758|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138639759|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138639760|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251006|NCT05575505|Protective Agents|protective agents|mesh-ancestor
138200474|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
138639761|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639762|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
138200475|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639763|NCT04709744|Vitamin D|vitamin d|mesh-list
138639764|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
138639765|NCT04709744|Cholecalciferol|cholecalciferol|mesh-list
138639766|NCT04709744|Vitamins|vitamins|mesh-list
138639767|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
138639768|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639769|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138639770|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138639771|NCT02271295|Enoxaparin|enoxaparin|mesh-list
138639772|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
138639773|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138639774|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138639775|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639776|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138639777|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138639778|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138639779|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138639780|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639781|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639782|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639783|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
138639784|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138639785|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138639786|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
138639787|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639788|NCT02271646|Bupivacaine|bupivacaine|mesh-list
138639789|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
138639790|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
138639791|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639792|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639793|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
138639794|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639795|NCT02271802|Butyric Acid|butyric acid|mesh-list
138415965|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
138639796|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
138639798|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639799|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639800|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639801|NCT02271958|Mifepristone|mifepristone|mesh-list
138639802|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138639803|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
138251057|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138639804|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138639805|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639806|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138639807|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138639808|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138639809|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
138639810|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138639811|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138639812|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
138639813|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138639814|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
138639815|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138639816|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138639818|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138639819|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138639820|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138639821|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138639822|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138639823|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138221664|NCT02193815|Calcitriol|calcitriol|mesh-list
138639824|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639825|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639826|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138639827|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138639828|NCT00257075|Risperidone|risperidone|mesh-list
138639829|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138200493|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138639830|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
138639831|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639832|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639833|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639834|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138639835|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138639836|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639837|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138639838|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138639839|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
138639841|NCT02272270|Temozolomide|temozolomide|mesh-list
138639842|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138639843|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
138639844|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639845|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639846|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138639847|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138639848|NCT02272387|Vitamin D|vitamin d|mesh-list
138251088|NCT00001677|Methotrexate|methotrexate|mesh-list
138639849|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
138639850|NCT02272387|Vitamins|vitamins|mesh-ancestor
138639851|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
138639852|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639853|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138639854|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138639855|NCT00257114|Bortezomib|bortezomib|mesh-list
138639856|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639857|NCT00271206|Progesterone|progesterone|mesh-list
138639858|NCT00271206|Progestins|progestins|mesh-ancestor
138639859|NCT00271206|Hormones|hormones|mesh-ancestor
138639860|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138639861|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639862|NCT02272582|Heparin|heparin|mesh-list
138639863|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
138639864|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138639865|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138639866|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639867|NCT02272660|Parecoxib|parecoxib|mesh-list
138639868|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138639869|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138639870|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639871|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639872|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138639873|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138639874|NCT02272660|Analgesics|analgesics|mesh-ancestor
138639875|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
138639876|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639877|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138221794|NCT04311710|Nivolumab|nivolumab|mesh-list
138639878|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138639879|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138639880|NCT02272699|Paclitaxel|paclitaxel|mesh-list
138639881|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
138639882|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138639883|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639884|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
138639885|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
138639886|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
138639887|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200496|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
138200497|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138200498|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138639888|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138639889|NCT02272738|Paclitaxel|paclitaxel|mesh-list
138251118|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138251119|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251120|NCT00000273|Fentanyl|fentanyl|mesh-list
138251121|NCT00000273|Morphine|morphine|mesh-list
138251122|NCT00000273|Oxycodone|oxycodone|mesh-list
138639891|NCT02272738|Gemcitabine|gemcitabine|mesh-list
138416249|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
138639892|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138639893|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639894|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
138639895|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
138639896|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
138639897|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639898|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138639899|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
138639900|NCT00271245|Selenium|selenium|mesh-list
138639901|NCT00271245|Selenic Acid|selenic acid|mesh-list
138639902|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
138639903|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639904|NCT00271245|Protective Agents|protective agents|mesh-ancestor
138639905|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639906|NCT00271245|Trace Elements|trace elements|mesh-ancestor
138639907|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
138639908|NCT02272855|Ipilimumab|ipilimumab|mesh-list
138639909|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138639910|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639911|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138639912|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639913|NCT00257270|Gabapentin|gabapentin|mesh-list
138639914|NCT00257270|Analgesics|analgesics|mesh-ancestor
138639915|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
138221884|NCT00815360|Hormones|hormones|mesh-ancestor
138639916|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639917|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639919|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138639920|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138639921|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138639922|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138639923|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138639924|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138639925|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138639926|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639927|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
138639928|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
138639929|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138639930|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639931|NCT00257348|Docetaxel|docetaxel|mesh-list
138639932|NCT00257348|Capecitabine|capecitabine|mesh-list
138639933|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639934|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
138221997|NCT02203565|Eusol|eusol|mesh-list
138200506|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639935|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
138200507|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138639937|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639938|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138200508|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138639940|NCT02273128|Calcitonin|calcitonin|mesh-list
138639941|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138639942|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639943|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138639944|NCT00257387|Cyclosporine|cyclosporine|mesh-list
138639945|NCT00257387|Cyclosporins|cyclosporins|mesh-list
138639946|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639947|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639948|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138639949|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
138639950|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639951|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
138639953|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
138639954|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138639955|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138639957|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138639958|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138316584|NCT05660213|Growth Substances|growth substances|mesh-ancestor
138639959|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639960|NCT01601509|Tramazoline|tramazoline|mesh-list
138639961|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
138639962|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
138639963|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138639964|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639966|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138639967|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
138639968|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639969|NCT00416325|Protective Agents|protective agents|mesh-ancestor
138639970|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639971|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138639972|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138639973|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138639974|NCT00257465|Vaccines|vaccines|mesh-list
138251179|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138639976|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138639979|NCT01601899|Efavirenz|efavirenz|mesh-list
138639980|NCT01601899|Stavudine|stavudine|mesh-list
138639982|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138639983|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138639984|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138639985|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138639986|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639987|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138639988|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138639989|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138639990|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138639991|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138639992|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138639993|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138639994|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138639995|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
138639996|NCT01601938|Selenium|selenium|mesh-list
138639997|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
138639998|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138639999|NCT01601938|Protective Agents|protective agents|mesh-ancestor
138640000|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640001|NCT01601938|Trace Elements|trace elements|mesh-ancestor
138640002|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
138200526|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138200527|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138200528|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138640003|NCT01602055|Azithromycin|azithromycin|mesh-list
138200529|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138640004|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138200530|NCT00002620|Cobalt|cobalt|mesh-list
138640005|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640006|NCT01602250|Ropivacaine|ropivacaine|mesh-list
138200531|NCT00002620|Carmustine|carmustine|mesh-list
138640007|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
138640008|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138640009|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
138640011|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138640012|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640013|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
138640014|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640015|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138640016|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138640017|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138640018|NCT00257582|Cetirizine|cetirizine|mesh-list
138640019|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138640020|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138640021|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138640022|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
138640023|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
138640024|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640025|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640026|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640027|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138640028|NCT01602289|Gefitinib|gefitinib|mesh-list
138640029|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640030|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138640031|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640032|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640033|NCT00257621|Ritonavir|ritonavir|mesh-list
138316656|NCT05546853|Leucovorin|leucovorin|mesh-list
138640034|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138640035|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138640037|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138251252|NCT00000303|Baclofen|baclofen|mesh-list
138640038|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640039|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138640040|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138640041|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
138640042|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640043|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138640044|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138640046|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138640047|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640048|NCT00290628|Cyclosporine|cyclosporine|mesh-list
138640049|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
138640050|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
138640051|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
138640053|NCT00290628|Busulfan|busulfan|mesh-list
138640054|NCT00290628|Cyclosporins|cyclosporins|mesh-list
138640055|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138640056|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138640057|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
138640058|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640059|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138640060|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138640061|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
138640062|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640063|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640064|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138251304|NCT00000885|Abacavir|abacavir|mesh-list
138640065|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640066|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
138640067|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138200533|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138200534|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
138640068|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
138200536|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640069|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138640070|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138640071|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138640072|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
138640073|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138640074|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640076|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
138640077|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640078|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138640079|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
138640080|NCT00290628|Hormones|hormones|mesh-ancestor
138640081|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640082|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138640083|NCT00290628|Protective Agents|protective agents|mesh-ancestor
138640084|NCT01602523|Budesonide|budesonide|mesh-list
138640085|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
138640086|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640087|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138640088|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
138640089|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640090|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251355|NCT00001863|Leflunomide|leflunomide|mesh-list
138251356|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640091|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138640092|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
138640095|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640096|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138640097|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138640098|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138640099|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
138640100|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640101|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640103|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640104|NCT01602640|Midazolam|midazolam|mesh-list
138640105|NCT01602640|Fentanyl|fentanyl|mesh-list
138640106|NCT01602640|Morphine|morphine|mesh-list
138640107|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138640108|NCT01602640|Narcotics|narcotics|mesh-ancestor
138416770|NCT01667445|Narcotics|narcotics|mesh-ancestor
138640109|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138640110|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640111|NCT01602640|Analgesics|analgesics|mesh-ancestor
138640112|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
138640113|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640114|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138640115|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138640116|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138640117|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138640118|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138640119|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138640120|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
138640121|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
138640122|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
138640123|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
138640124|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640125|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640127|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
138640128|NCT00290667|Rituximab|rituximab|mesh-list
138200545|NCT00002638|Sargramostim|sargramostim|mesh-list
138200546|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138200547|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
138200548|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200549|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138200550|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138251399|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138251400|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
138200551|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
138640129|NCT00290667|Doxorubicin|doxorubicin|mesh-list
138640130|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138640131|NCT00290667|Vincristine|vincristine|mesh-list
138640132|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138640133|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
138640134|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640135|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138640136|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138640137|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
138640138|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640139|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640140|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138640141|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138640142|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138640143|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138640144|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138640145|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640146|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640147|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
138640148|NCT00290667|Hormones|hormones|mesh-ancestor
138222995|NCT03855332|Cilostazol|cilostazol|mesh-list
138640149|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640150|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138640151|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138640152|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
138251438|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138251439|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138251440|NCT00001893|Analgesics|analgesics|mesh-ancestor
138251441|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
138251442|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138251443|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251444|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138251445|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138251446|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138251447|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138251448|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
138640153|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
138640154|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
138640156|NCT01602757|Tetracaine|tetracaine|mesh-list
138640157|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
138640158|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
138640159|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138640160|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640161|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
138640162|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640163|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138640164|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138640165|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138640166|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138640167|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640168|NCT02961101|Decitabine|decitabine|mesh-list
138640169|NCT02961101|Antibodies|antibodies|mesh-list
138640170|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
138640171|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640172|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138640173|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
138640174|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200554|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138200555|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138200556|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138640175|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640176|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640177|NCT01602913|Paroxetine|paroxetine|mesh-list
138640178|NCT01602913|Pravastatin|pravastatin|mesh-list
138640179|NCT01602913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138640180|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138640181|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138640182|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640183|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640184|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
138640185|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640186|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138251479|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138640187|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
138416986|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
138640189|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138640190|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138640191|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640192|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138640193|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138640194|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
138251519|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138640195|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138640196|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138640197|NCT00257699|Metronidazole|metronidazole|mesh-list
138640198|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
138640199|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640200|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138640201|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138640202|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138640203|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138640204|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138640205|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640206|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640207|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640208|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138640209|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138640211|NCT01603030|Prednisolone|prednisolone|mesh-list
138640212|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138640213|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
138640214|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138640215|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
138640216|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138640217|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138640218|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
138640219|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640220|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
138640221|NCT01603030|Hormones|hormones|mesh-ancestor
138640222|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640223|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640224|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138640225|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640226|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
138640227|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
138640228|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640229|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138640230|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138640231|NCT01603030|Protective Agents|protective agents|mesh-ancestor
138640232|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138640233|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640234|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138640235|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138640236|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640237|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640238|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138640239|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
138640240|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138223292|NCT05674565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138640241|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138640242|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138640243|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138640245|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138640246|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640247|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138640248|NCT00290823|Albendazole|albendazole|mesh-list
138640249|NCT00290823|Dexamethasone|dexamethasone|mesh-list
138640250|NCT00290823|Omeprazole|omeprazole|mesh-list
138640251|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640252|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
138640253|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
138640254|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640255|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640256|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138640257|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
138316887|NCT04756401|Hormones|hormones|mesh-ancestor
138640258|NCT00290823|Hormones|hormones|mesh-ancestor
138640259|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640260|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138640262|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138640263|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138640264|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640265|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640266|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
138640267|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138640268|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640269|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
138640270|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138640271|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138640272|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
138640273|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
138640274|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
138640275|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138640276|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
138640277|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138640278|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138640279|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138417148|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138640280|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138640281|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640283|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138640284|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
138640285|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
138640286|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
138640287|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138223633|NCT03356483|Niacin|niacin|mesh-list
138640288|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640289|NCT00257816|Topotecan|topotecan|mesh-list
138640290|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640291|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138640292|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138640293|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640294|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640295|NCT00271323|Docetaxel|docetaxel|mesh-list
138640296|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640297|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
138640298|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
138640299|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
138251587|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138251600|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138640300|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640302|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138640303|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138640304|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138640305|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138640306|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
138640307|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640308|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200569|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
138200570|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640309|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640311|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
138640312|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138640313|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138640314|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640315|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138640316|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640317|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138640319|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138640320|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138640321|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138640322|NCT01603498|Dexamethasone|dexamethasone|mesh-list
138640323|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
138640324|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138223810|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
138640325|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138640326|NCT01603498|Prednisolone|prednisolone|mesh-list
138640327|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
138640328|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138640329|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
138640330|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640331|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
138640332|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
138640333|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640334|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640335|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138640336|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
138640337|NCT01603498|Hormones|hormones|mesh-ancestor
138251631|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138640338|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640339|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138640340|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640341|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138640342|NCT01603498|Protective Agents|protective agents|mesh-ancestor
138640344|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
138640345|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
138640346|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640347|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
138640348|NCT01603654|Protective Agents|protective agents|mesh-ancestor
138640349|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640350|NCT01603654|Vitamins|vitamins|mesh-ancestor
138640351|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
138640352|NCT01603654|Cathartics|cathartics|mesh-ancestor
138640353|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138640354|NCT00257972|Aripiprazole|aripiprazole|mesh-list
138640356|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138640357|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138640359|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138640360|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640361|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
138640362|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
138640363|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640364|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640365|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138640366|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138640367|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
138640368|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138200577|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
138200580|NCT00002656|NSC 366140|nsc 366140|mesh-list
138640369|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138640370|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138640371|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138640372|NCT01603693|Calcium|calcium|mesh-list
138640373|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138640374|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138251680|NCT00001095|Lamivudine|lamivudine|mesh-list
138640375|NCT00258050|Lapatinib|lapatinib|mesh-list
138640376|NCT00258050|Midazolam|midazolam|mesh-list
138640377|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138640378|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138640379|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138640380|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640381|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138640382|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138640383|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138640384|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138640385|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
138640386|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
138640387|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
138640389|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640390|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640391|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640392|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138640393|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640394|NCT00271401|Heparin|heparin|mesh-list
138640395|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
138640396|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138640397|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138640398|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640399|NCT00258089|Levofloxacin|levofloxacin|mesh-list
138640400|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138640401|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640402|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138640403|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138640404|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138640405|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640406|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640407|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640408|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138640409|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138640411|NCT00290901|Tramadol|tramadol|mesh-list
138640412|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138640413|NCT00290901|Narcotics|narcotics|mesh-ancestor
138640414|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138640415|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640416|NCT00290901|Analgesics|analgesics|mesh-ancestor
138640417|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
138640418|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640419|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138640420|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138640421|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640422|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138640423|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138640424|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138640425|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640426|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640428|NCT00258245|Vitamins|vitamins|mesh-list
138640429|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
138640430|NCT00258245|Thalidomide|thalidomide|mesh-list
138640431|NCT00258245|Dexamethasone|dexamethasone|mesh-list
138640432|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
138640433|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
138640435|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
138251758|NCT00002019|Amphotericin B|amphotericin b|mesh-list
138200597|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640436|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138640437|NCT00258245|BB 1101|bb 1101|mesh-list
138640438|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
138640439|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640440|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640441|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
138640442|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
138640443|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640444|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138640445|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
138640446|NCT00258245|Hormones|hormones|mesh-ancestor
138640447|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640448|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138640450|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
138640451|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640452|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138224215|NCT01531439|Naloxone|naloxone|mesh-list
138640453|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138640454|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138640455|NCT00258245|Analgesics|analgesics|mesh-ancestor
138640456|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
138640457|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138640458|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138640459|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138640460|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138640461|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138640462|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
138640463|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
138640464|NCT00258245|Protective Agents|protective agents|mesh-ancestor
138640465|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138640466|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
138640467|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
138224271|NCT01832558|Eplerenone|eplerenone|mesh-list
138640468|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138640469|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138251798|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640470|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138640471|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138640472|NCT00258245|Growth Substances|growth substances|mesh-ancestor
138640473|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
138640475|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138640476|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640477|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
138640478|NCT01604629|Adalimumab|adalimumab|mesh-list
138640479|NCT01604629|Infliximab|infliximab|mesh-list
138640480|NCT01604629|Golimumab|golimumab|mesh-list
138640481|NCT01604629|Etanercept|etanercept|mesh-list
138640482|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138640483|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138640484|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640485|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138640486|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
138640487|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138640488|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138640489|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138640490|NCT01604629|Analgesics|analgesics|mesh-ancestor
138640491|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
138640492|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640493|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640494|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138640495|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
138640496|NCT00258284|Docetaxel|docetaxel|mesh-list
138640497|NCT00258284|Capecitabine|capecitabine|mesh-list
138640498|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640499|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
138640500|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
138640501|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
138640502|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640503|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138640505|NCT00290940|Metformin|metformin|mesh-list
138640506|NCT00290940|Pioglitazone|pioglitazone|mesh-list
138640507|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138640508|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640509|NCT00258323|Fluorouracil|fluorouracil|mesh-list
138640510|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640511|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
138640512|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640513|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138640514|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138640515|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
138640516|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640517|NCT01604863|Paclitaxel|paclitaxel|mesh-list
138640518|NCT01604863|Etoposide|etoposide|mesh-list
138640519|NCT01604863|Docetaxel|docetaxel|mesh-list
138640520|NCT01604863|Carboplatin|carboplatin|mesh-list
138640521|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138640522|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640524|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
138640525|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
138640526|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640527|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138640528|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138640529|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138224477|NCT01451411|Conivaptan|conivaptan|mesh-list
138640530|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
138640531|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138640532|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640533|NCT00258479|Modafinil|modafinil|mesh-list
138640534|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138640535|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640536|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138640537|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138640538|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138640539|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640540|NCT00271518|Hormones|hormones|mesh-list
138640541|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640542|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640543|NCT01340014|Timolol|timolol|mesh-list
138640544|NCT01340014|Dorzolamide|dorzolamide|mesh-list
138640545|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138640547|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138640548|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138640549|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138640550|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
138640551|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640552|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200628|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138200630|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640553|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200631|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200632|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138200633|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138640554|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138640555|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138640556|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138640557|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640558|NCT00258557|Darunavir|darunavir|mesh-list
138640559|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138640560|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138640561|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
138640562|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640563|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640564|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138640565|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138251935|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
138251936|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138640566|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
138224636|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640567|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640568|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138640569|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
138640570|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640571|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
138640572|NCT00271635|Vitamins|vitamins|mesh-ancestor
138640573|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
138640574|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640575|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
138640576|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640577|NCT00271635|Protective Agents|protective agents|mesh-ancestor
138640578|NCT00258596|Sirolimus|sirolimus|mesh-list
138640579|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138640580|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640581|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138640582|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640583|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
138640584|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138640585|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
138640586|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640587|NCT01339273|Anesthetics|anesthetics|mesh-list
138640588|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
138640589|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138640590|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640591|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
138640592|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640593|NCT04709315|Choline|choline|mesh-list
138640595|NCT04709315|Succinylcholine|succinylcholine|mesh-list
138640596|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138640597|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138640598|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138640599|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640600|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640601|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
138640602|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138640603|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
138640604|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640605|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138640606|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138640608|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138640610|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640611|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138200637|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138640612|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200638|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138640613|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640614|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
138640615|NCT00271713|Vitamin D|vitamin d|mesh-list
138640616|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
138640617|NCT00271713|Cholecalciferol|cholecalciferol|mesh-list
138640618|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
138640619|NCT00271713|Vitamins|vitamins|mesh-list
138640621|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
138640622|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640623|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138640624|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138640625|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
138640626|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
138640627|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138640628|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138640629|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640630|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640631|NCT01334554|Urological Agents|urological agents|mesh-ancestor
138640633|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
138640634|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
138640635|NCT01332799|Allopurinol|allopurinol|mesh-list
138317265|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
138640636|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
138640637|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640638|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640639|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
138640640|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138640641|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138640642|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
138640643|NCT01332799|Protective Agents|protective agents|mesh-ancestor
138640644|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640645|NCT00258791|Ibuprofen|ibuprofen|mesh-list
138640646|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138640647|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138640648|NCT00258791|Analgesics|analgesics|mesh-ancestor
138640649|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
138640650|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640651|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640652|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640653|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138640654|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138640655|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252010|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
138417959|NCT02931890|Paclitaxel|paclitaxel|mesh-list
138640656|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640658|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
138252024|NCT00002103|Leucovorin|leucovorin|mesh-list
138640659|NCT00291369|Interleukin-2|interleukin-2|mesh-list
138640660|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138640663|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
138640664|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640665|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
138640666|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138224977|NCT00910208|Analgesics|analgesics|mesh-ancestor
138640667|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138640668|NCT00291369|Analgesics|analgesics|mesh-ancestor
138640669|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
138640670|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640671|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138640672|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138640673|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138640674|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
138640675|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138640676|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138640677|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138200650|NCT00002692|Fluorouracil|fluorouracil|mesh-list
138640678|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138200651|NCT00002692|Calcium|calcium|mesh-list
138200652|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
138640679|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138640680|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
138640681|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138640682|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
138640683|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640684|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640686|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
138640687|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138640688|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
138640689|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640690|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640691|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138640692|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
138640694|NCT00291408|Protective Agents|protective agents|mesh-ancestor
138640695|NCT00271791|Prednisone|prednisone|mesh-list
138640696|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640697|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
138640698|NCT00271791|Hormones|hormones|mesh-ancestor
138640699|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640700|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640701|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138640702|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640703|NCT01332331|Ambrisentan|ambrisentan|mesh-list
138640704|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138640705|NCT00259064|Gefitinib|gefitinib|mesh-list
138640706|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640707|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138640708|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640709|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640710|NCT01332292|Fluticasone|fluticasone|mesh-list
138418142|NCT05797558|Eplerenone|eplerenone|mesh-list
138640712|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640713|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138640714|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
138640715|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640716|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640717|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138640718|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
138640719|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
138640720|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138640721|NCT00259142|Chloroquine|chloroquine|mesh-list
138640722|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
138640723|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
138640724|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138640725|NCT00259142|Amebicides|amebicides|mesh-ancestor
138640726|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138640727|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138640728|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640729|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
138640730|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138640731|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138640732|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640733|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640734|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138640735|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
138640736|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138640737|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138640738|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138640739|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138225220|NCT01574807|Lidocaine|lidocaine|mesh-list
138640740|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
138640741|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
138640742|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
138640743|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138640744|NCT00259181|Protective Agents|protective agents|mesh-ancestor
138640745|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200660|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
138640746|NCT00291720|Spironolactone|spironolactone|mesh-list
138640747|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138640748|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
138640749|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640750|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640751|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138640753|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
138640754|NCT00259220|Erythromycin|erythromycin|mesh-list
138640755|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
138640756|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138640757|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
138640758|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138640759|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640760|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138640761|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138640762|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640763|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640764|NCT00291759|Tamoxifen|tamoxifen|mesh-list
138640765|NCT00291759|Anastrozole|anastrozole|mesh-list
138640766|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138640767|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
138252111|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138252113|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
138640768|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640769|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640770|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138640772|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138640773|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138640774|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138640775|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138418377|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
138640776|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138640777|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640778|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640779|NCT00272025|Escitalopram|escitalopram|mesh-list
138640780|NCT00272025|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138640781|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138640782|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138225321|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640783|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640784|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640785|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
138640786|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640787|NCT04709081|Itraconazole|itraconazole|mesh-list
138640788|NCT04709081|Digoxin|digoxin|mesh-list
138640789|NCT04709081|Midazolam|midazolam|mesh-list
138640790|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138640791|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138418430|NCT03875755|Inositol|inositol|mesh-list
138640792|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138640793|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640795|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138640796|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138640797|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138640798|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
138640799|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
138640800|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
138640801|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
138640802|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138252161|NCT00002127|Thalidomide|thalidomide|mesh-list
138640810|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
138640811|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640812|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138200669|NCT05293210|Autonomic Agents|autonomic agents|mesh-ancestor
138200670|NCT05293210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640813|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138640814|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138640815|NCT04709081|Protective Agents|protective agents|mesh-ancestor
138640817|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138640818|NCT00272064|Metformin|metformin|mesh-list
138640819|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
138640820|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
138640821|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138418545|NCT01681446|Interferons|interferons|mesh-list
138418546|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
138418547|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418548|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
138418549|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640822|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640823|NCT00259376|Dronedarone|dronedarone|mesh-list
138640824|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138640825|NCT01332019|Interferons|interferons|mesh-list
138640826|NCT01332019|Interferon-beta|interferon-beta|mesh-list
138640827|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
138640828|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640829|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
138640830|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640831|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
138640832|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640833|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138640834|NCT00415376|Levetiracetam|levetiracetam|mesh-list
138640835|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
138252208|NCT00001629|Giapreza|giapreza|mesh-list
138418614|NCT06225271|Micronutrients|micronutrients|mesh-ancestor
138418623|NCT06225232|Psilocybin|psilocybin|mesh-list
138640837|NCT00291915|Adalimumab|adalimumab|mesh-list
138640838|NCT00291915|Methotrexate|methotrexate|mesh-list
138640839|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138640840|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
138640841|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138640842|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640843|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138418666|NCT06224894|Autonomic Agents|autonomic agents|mesh-ancestor
138418667|NCT06224894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418668|NCT06224894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418669|NCT06224894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138418670|NCT06224881|Ascorbic Acid|ascorbic acid|mesh-list
138418671|NCT06224881|Antioxidants|antioxidants|mesh-ancestor
138418672|NCT06224881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418673|NCT06224881|Protective Agents|protective agents|mesh-ancestor
138418674|NCT06224881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138418675|NCT06224881|Vitamins|vitamins|mesh-ancestor
138418676|NCT06224881|Micronutrients|micronutrients|mesh-ancestor
138418680|NCT06224842|Azacitidine|azacitidine|mesh-list
138418716|NCT06224569|Caffeine|caffeine|mesh-list
138640845|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640846|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640847|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
138640848|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640849|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138640850|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138640851|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
138200677|NCT05293210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640852|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138418733|NCT06224348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418734|NCT06224348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200678|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
138200679|NCT01895348|Remifentanil|remifentanil|mesh-list
138200680|NCT01895348|Propofol|propofol|mesh-list
138200681|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138200682|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138418735|NCT06224309|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138418736|NCT06224309|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138418737|NCT06224309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640853|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138640854|NCT00291915|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138640855|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640857|NCT00259766|Terbutaline|terbutaline|mesh-list
138640858|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
138640859|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640860|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138640861|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
138640862|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640863|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640864|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138640865|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
138640866|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
138640867|NCT00259766|Hormones|hormones|mesh-ancestor
138640868|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138640869|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138640870|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138640871|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138640872|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
138418799|NCT06223698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138418800|NCT06223698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138418801|NCT06223698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418802|NCT06223698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138418803|NCT06223698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138640874|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640875|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
138640876|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
138640877|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138640878|NCT00292071|Caspofungin|caspofungin|mesh-list
138640879|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
138640880|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640881|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640882|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640883|NCT00292110|Methadone|methadone|mesh-list
138640884|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138640885|NCT00292110|Narcotics|narcotics|mesh-ancestor
138640886|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138640887|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640888|NCT00292110|Analgesics|analgesics|mesh-ancestor
138640889|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
138640890|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640891|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
138640892|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
138640893|NCT00259805|Rituximab|rituximab|mesh-list
138640894|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138640895|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640896|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
138640897|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640898|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138640899|NCT00259883|Paroxetine|paroxetine|mesh-list
138640900|NCT00259883|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138640901|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138640902|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138640903|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200690|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138200691|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
138200695|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
138640904|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640905|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
138640906|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640907|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138418984|NCT06207734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138418985|NCT06207734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138418987|NCT06199232|Cetuximab|cetuximab|mesh-list
138640908|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
138640910|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138640911|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138640912|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138252305|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
138640913|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
138640914|NCT04718376|Analgesics|analgesics|mesh-ancestor
138640915|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
138640916|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640917|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640918|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419065|NCT06144944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138419066|NCT06144944|Cyclophosphamide|cyclophosphamide|mesh-list
138419067|NCT06144944|Doxorubicin|doxorubicin|mesh-list
138419068|NCT06144944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138419070|NCT06144944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138419071|NCT06144944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419072|NCT06144944|Tubulin Modulators|tubulin modulators|mesh-ancestor
138419073|NCT06144944|Antimitotic Agents|antimitotic agents|mesh-ancestor
138419074|NCT06144944|Mitosis Modulators|mitosis modulators|mesh-ancestor
138419075|NCT06144944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419076|NCT06144944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138419077|NCT06144944|Immunologic Factors|immunologic factors|mesh-ancestor
138419078|NCT06144944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419079|NCT06144944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138419080|NCT06144944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138419081|NCT06144944|Alkylating Agents|alkylating agents|mesh-ancestor
138640919|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138640920|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138640921|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640922|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640923|NCT00272415|Temozolomide|temozolomide|mesh-list
138640924|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138640925|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
138640926|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640927|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640929|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138640930|NCT00272454|Aspirin|aspirin|mesh-list
138640931|NCT00272454|Cilostazol|cilostazol|mesh-list
138419111|NCT06111781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138419112|NCT06111781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419143|NCT06101394|Cetuximab|cetuximab|mesh-list
138419144|NCT06101394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419145|NCT06101394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419146|NCT06094296|Paclitaxel|paclitaxel|mesh-list
138252345|NCT02293902|Folic Acid|folic acid|mesh-list
138419147|NCT06094296|Carboplatin|carboplatin|mesh-list
138419148|NCT06094296|Nivolumab|nivolumab|mesh-list
138419149|NCT06094296|Pemetrexed|pemetrexed|mesh-list
138419150|NCT06094296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138419151|NCT06094296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419152|NCT06094296|Tubulin Modulators|tubulin modulators|mesh-ancestor
138419153|NCT06094296|Antimitotic Agents|antimitotic agents|mesh-ancestor
138225574|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
138419154|NCT06094296|Mitosis Modulators|mitosis modulators|mesh-ancestor
138419155|NCT06094296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200705|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419156|NCT06094296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419157|NCT06094296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138419158|NCT06094296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419159|NCT06094296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138419160|NCT06094296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138419164|NCT06084338|Testosterone|testosterone|mesh-list
138419165|NCT06084338|Androgens|androgens|mesh-ancestor
138419166|NCT06084338|Hormones|hormones|mesh-ancestor
138419167|NCT06084338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138419168|NCT06084338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419169|NCT06071767|Vesatolimod|vesatolimod|mesh-list
138419170|NCT06071767|Antiviral Agents|antiviral agents|mesh-ancestor
138419171|NCT06071767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640932|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138640933|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138317562|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640935|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
138640936|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138640937|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640938|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138640939|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138252375|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138640940|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138640941|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138640942|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640943|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138419178|NCT06058377|Cyclophosphamide|cyclophosphamide|mesh-list
138419179|NCT06058377|Doxorubicin|doxorubicin|mesh-list
138419180|NCT06058377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138419181|NCT06058377|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138419182|NCT06058377|Durvalumab|durvalumab|mesh-list
138419183|NCT06058377|Daunorubicin|daunorubicin|mesh-list
138419184|NCT06058377|Immunoglobulins|immunoglobulins|mesh-list
138419185|NCT06058377|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138419186|NCT06058377|Immunoglobulin G|immunoglobulin g|mesh-list
138640945|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138640946|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
138640947|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138640948|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
138640949|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138640950|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
138640951|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
138640952|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138640953|NCT00272454|Protective Agents|protective agents|mesh-ancestor
138419269|NCT06027840|Varenicline|varenicline|mesh-list
138419270|NCT06027840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138419271|NCT06027840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138419272|NCT06027840|Cholinergic Agents|cholinergic agents|mesh-ancestor
138419273|NCT06027840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138419274|NCT06027840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419275|NCT06027840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419276|NCT06023641|Dactinomycin|dactinomycin|mesh-list
138419277|NCT06023641|Cyclophosphamide|cyclophosphamide|mesh-list
138419278|NCT06023641|Temozolomide|temozolomide|mesh-list
138419280|NCT06023641|Vincristine|vincristine|mesh-list
138419281|NCT06023641|Vinorelbine|vinorelbine|mesh-list
138225675|NCT01045694|Hormones|hormones|mesh-ancestor
138419282|NCT06023641|Lenograstim|lenograstim|mesh-list
138419283|NCT06023641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138419284|NCT06023641|Immunologic Factors|immunologic factors|mesh-ancestor
138419285|NCT06023641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419286|NCT06023641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138419287|NCT06023641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138419288|NCT06023641|Alkylating Agents|alkylating agents|mesh-ancestor
138419289|NCT06023641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419290|NCT06023641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419291|NCT06023641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138419292|NCT06023641|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138419293|NCT06023641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138419295|NCT06023641|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138419296|NCT06023641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138419297|NCT06023641|Tubulin Modulators|tubulin modulators|mesh-ancestor
138419298|NCT06023641|Antimitotic Agents|antimitotic agents|mesh-ancestor
138419299|NCT06023641|Mitosis Modulators|mitosis modulators|mesh-ancestor
138640954|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138640955|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138640956|NCT00272493|Vaccines|vaccines|mesh-list
138640957|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
138640958|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640959|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
138640960|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138640961|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
138640962|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640963|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640964|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
138640965|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640967|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
138640968|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640972|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138640973|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138640974|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138640976|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138640977|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138640978|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138419387|NCT05991401|Rifampin|rifampin|mesh-list
138640979|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640980|NCT00272610|Vitamin A|vitamin a|mesh-list
138640981|NCT00272610|Vitamins|vitamins|mesh-ancestor
138640982|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
138640983|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640984|NCT00260351|Vaccines|vaccines|mesh-list
138640985|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
138640986|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640987|NCT00272688|Levodopa|levodopa|mesh-list
138640988|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138419429|NCT05972720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419430|NCT05972720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419431|NCT05972720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138419445|NCT05952804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138419446|NCT05952804|Immunoglobulins|immunoglobulins|mesh-list
138419447|NCT05952804|Antibodies|antibodies|mesh-list
138419448|NCT05952804|gamma-Globulins|gamma-globulins|mesh-list
138419449|NCT05952804|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138419450|NCT05952804|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138419451|NCT05952804|Immunologic Factors|immunologic factors|mesh-ancestor
138419452|NCT05952804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419453|NCT05947851|Rituximab|rituximab|mesh-list
138419454|NCT05947851|Venetoclax|venetoclax|mesh-list
138419455|NCT05947851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419456|NCT05947851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419457|NCT05947851|Immunologic Factors|immunologic factors|mesh-ancestor
138419458|NCT05947851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419459|NCT05947851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138419460|NCT05944016|Dapagliflozin|dapagliflozin|mesh-list
138640989|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138640990|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
138640991|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138640992|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138640993|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138640994|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
138640995|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138640996|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138640997|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
138640998|NCT00260390|Hormones|hormones|mesh-ancestor
138640999|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138641000|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641001|NCT00260624|Escitalopram|escitalopram|mesh-list
138200724|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
138200726|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138419496|NCT05899127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138419497|NCT05899127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138419499|NCT05899127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138419500|NCT05899127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419501|NCT05899127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138419502|NCT05899127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138419503|NCT05899127|Anesthetics, General|anesthetics, general|mesh-ancestor
138419504|NCT05899127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138419505|NCT05899127|Narcotics|narcotics|mesh-ancestor
138419506|NCT05899127|Analgesics|analgesics|mesh-ancestor
138419507|NCT05899127|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138419508|NCT05899127|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138419509|NCT05899127|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138419510|NCT05899127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138419523|NCT05896566|Anastrozole|anastrozole|mesh-list
138419524|NCT05896566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138225852|NCT03005171|Lidocaine|lidocaine|mesh-list
138419525|NCT05896566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138419527|NCT05896566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138419528|NCT05896566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138419529|NCT05896566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419552|NCT05878184|Fludarabine|fludarabine|mesh-list
138641002|NCT00260624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138641003|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138641004|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641005|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138252605|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641006|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641007|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
138641008|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419556|NCT05878184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138419557|NCT05878184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138419558|NCT05878184|Alkylating Agents|alkylating agents|mesh-ancestor
138419559|NCT05878184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419560|NCT05878184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419561|NCT05878184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138419562|NCT05870800|Leucovorin|leucovorin|mesh-list
138419563|NCT05870800|Capecitabine|capecitabine|mesh-list
138419564|NCT05870800|Fluorouracil|fluorouracil|mesh-list
138419565|NCT05870800|Oxaliplatin|oxaliplatin|mesh-list
138419566|NCT05870800|Atezolizumab|atezolizumab|mesh-list
138419567|NCT05870800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138419568|NCT05870800|Antimetabolites|antimetabolites|mesh-ancestor
138419569|NCT05870800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419570|NCT05870800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419571|NCT05870800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138419572|NCT05870800|Immunologic Factors|immunologic factors|mesh-ancestor
138419573|NCT05870800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419574|NCT05870800|Antidotes|antidotes|mesh-ancestor
138419575|NCT05870800|Protective Agents|protective agents|mesh-ancestor
138419576|NCT05870800|Vitamin B Complex|vitamin b complex|mesh-ancestor
138419577|NCT05870800|Vitamins|vitamins|mesh-ancestor
138419578|NCT05870800|Micronutrients|micronutrients|mesh-ancestor
138419579|NCT05870800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138641009|NCT00292695|Ifosfamide|ifosfamide|mesh-list
138225961|NCT03400592|Irinotecan|irinotecan|mesh-list
138641010|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200730|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138317636|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
138252665|NCT00002451|Lamivudine|lamivudine|mesh-list
138641011|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138641012|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
138641013|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641015|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138641016|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138641017|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138641018|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641019|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138641020|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
138641021|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
138419634|NCT05781152|Adalimumab|adalimumab|mesh-list
138419635|NCT05781152|Infliximab|infliximab|mesh-list
138419636|NCT05781152|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138419637|NCT05781152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138419638|NCT05781152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138419639|NCT05781152|Dermatologic Agents|dermatologic agents|mesh-ancestor
138419640|NCT05781152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138419650|NCT05753956|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
138419651|NCT05753956|Hallucinogens|hallucinogens|mesh-ancestor
138419652|NCT05753956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419653|NCT05753956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138419654|NCT05753956|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138419655|NCT05753956|Serotonin Agents|serotonin agents|mesh-ancestor
138419656|NCT05753956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138419657|NCT05753956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419658|NCT05753956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138419659|NCT05746559|Ravulizumab|ravulizumab|mesh-list
138419660|NCT05746559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138419661|NCT05746559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138419662|NCT05746559|Immunologic Factors|immunologic factors|mesh-ancestor
138419663|NCT05746559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419664|NCT05745480|Analgesics, Opioid|analgesics, opioid|mesh-list
138419665|NCT05745480|Narcotics|narcotics|mesh-ancestor
138419666|NCT05745480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138252700|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138419667|NCT05745480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419669|NCT05745480|Sensory System Agents|sensory system agents|mesh-ancestor
138419670|NCT05745480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138419671|NCT05732961|Luspatercept|luspatercept|mesh-list
138419672|NCT05732961|Hematinics|hematinics|mesh-ancestor
138641022|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641023|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641024|NCT00260702|Omalizumab|omalizumab|mesh-list
138641025|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138641026|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138641027|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
138641028|NCT00260819|Bosentan|bosentan|mesh-list
138641029|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138641030|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138641031|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419688|NCT05706870|Clobetasol|clobetasol|mesh-list
138419689|NCT05706870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138419690|NCT05706870|Glucocorticoids|glucocorticoids|mesh-ancestor
138419691|NCT05706870|Hormones|hormones|mesh-ancestor
138419692|NCT05706870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138419693|NCT05706870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138419694|NCT05704933|Nivolumab|nivolumab|mesh-list
138419695|NCT05704933|Ipilimumab|ipilimumab|mesh-list
138419696|NCT05704933|Relatlimab|relatlimab|mesh-list
138419697|NCT05704933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419708|NCT05694364|Cyclophosphamide|cyclophosphamide|mesh-list
138641032|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
138641033|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
138641034|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138200749|NCT01113476|Growth Substances|growth substances|mesh-ancestor
138200750|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200751|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
138200752|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138641035|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641036|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138641037|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138641038|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
138641039|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641040|NCT00292890|Insulin|insulin|mesh-list
138641041|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138641042|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641043|NCT00292929|Artesunate|artesunate|mesh-list
138641044|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
138641045|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138641046|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138641047|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641048|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641049|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
138641050|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
138226046|NCT04526951|Analgesics|analgesics|mesh-ancestor
138641051|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138641052|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
138641053|NCT00424853|Cisplatin|cisplatin|mesh-list
138641054|NCT00424853|Gemcitabine|gemcitabine|mesh-list
138641055|NCT00424853|Docetaxel|docetaxel|mesh-list
138641056|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641057|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138641058|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
138641059|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641060|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
138641061|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
138641062|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
138641063|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
138641064|NCT00298506|Tacrolimus|tacrolimus|mesh-list
138641065|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138641066|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
138641067|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641068|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138641069|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641070|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641071|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138641072|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641073|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138641074|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
138641075|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138641076|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641077|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138641078|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138641079|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138641080|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641081|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641082|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641083|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641084|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
138641085|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138641086|NCT00424931|Modafinil|modafinil|mesh-list
138641087|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138641088|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641089|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138641090|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138641091|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138641092|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641093|NCT00298545|Calcitriol|calcitriol|mesh-list
138641094|NCT00298545|Calcium|calcium|mesh-list
138641095|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138641096|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641097|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138641098|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641099|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641100|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138641101|NCT00298545|Vitamins|vitamins|mesh-ancestor
138641102|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
138641103|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138641105|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
138641106|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641107|NCT00424970|Acetazolamide|acetazolamide|mesh-list
138641108|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
138641109|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138419837|NCT05655689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138419838|NCT05655689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138419839|NCT05655689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138226240|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
138419840|NCT05655689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138419841|NCT05655689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138419842|NCT05655689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138419843|NCT05655689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138419844|NCT05655689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138419845|NCT05655689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419846|NCT05655689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252816|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
138252817|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
138419848|NCT05655689|Antifungal Agents|antifungal agents|mesh-ancestor
138419849|NCT05655689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138419850|NCT05655689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138641110|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641111|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641112|NCT00424970|Diuretics|diuretics|mesh-ancestor
138641113|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
138641114|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641116|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138641117|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138641118|NCT01331005|Analgesics|analgesics|mesh-ancestor
138641119|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
138641120|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641121|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641122|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138641123|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138641124|NCT01330459|Acetaminophen|acetaminophen|mesh-list
138641125|NCT01330459|Ibuprofen|ibuprofen|mesh-list
138641126|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138641127|NCT01330459|Lidocaine|lidocaine|mesh-list
138641128|NCT01330459|Hydrocodone|hydrocodone|mesh-list
138641129|NCT01330459|Lorazepam|lorazepam|mesh-list
138641130|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
138641131|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
138641132|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138641133|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641134|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
138641135|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641136|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138419898|NCT05633667|Immunologic Factors|immunologic factors|mesh-ancestor
138641137|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138200770|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
138641138|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138200777|NCT00002704|Etoposide|etoposide|mesh-list
138641139|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641140|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641141|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138641142|NCT01330459|Analgesics|analgesics|mesh-ancestor
138374425|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138641144|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138641145|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138641146|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138641147|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138641148|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641149|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138641150|NCT01330459|Narcotics|narcotics|mesh-ancestor
138641151|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
138641152|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
138641153|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
138641154|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
138641155|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
138641156|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138641157|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138641158|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138641159|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138641160|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138641161|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
138641162|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
138641163|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641164|NCT00293085|Docetaxel|docetaxel|mesh-list
138641165|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641166|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
138641167|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
138641168|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
138641169|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641170|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
138419942|NCT05614739|Pembrolizumab|pembrolizumab|mesh-list
138419943|NCT05614739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138419944|NCT05614739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138419945|NCT05614739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138419946|NCT05614739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641171|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138641172|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138641173|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
138641174|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641175|NCT00298662|Interferons|interferons|mesh-list
138641176|NCT00298662|Interferon-beta|interferon-beta|mesh-list
138641177|NCT00298662|Tacrolimus|tacrolimus|mesh-list
138641178|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
138641179|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641180|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
138641181|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641182|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138641183|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
138641184|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641185|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138641186|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420011|NCT05539053|Acetylcysteine|acetylcysteine|mesh-list
138420012|NCT05539053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138420013|NCT05539053|Antiviral Agents|antiviral agents|mesh-ancestor
138420014|NCT05539053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420015|NCT05539053|Expectorants|expectorants|mesh-ancestor
138420016|NCT05539053|Respiratory System Agents|respiratory system agents|mesh-ancestor
138420017|NCT05539053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138420018|NCT05539053|Antioxidants|antioxidants|mesh-ancestor
138420019|NCT05539053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200787|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138420020|NCT05539053|Protective Agents|protective agents|mesh-ancestor
138420021|NCT05539053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420022|NCT05539053|Antidotes|antidotes|mesh-ancestor
138200788|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
138420023|NCT05536804|Tirzepatide|tirzepatide|mesh-list
138420024|NCT05536804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138420025|NCT05536804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420026|NCT05536804|Incretins|incretins|mesh-ancestor
138420027|NCT05536804|Hormones|hormones|mesh-ancestor
138420028|NCT05536804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138420029|NCT05536011|Sodium Oxybate|sodium oxybate|mesh-list
138420030|NCT05536011|Methylphenidate|methylphenidate|mesh-list
138420031|NCT05536011|Modafinil|modafinil|mesh-list
138420032|NCT05536011|Amphetamine|amphetamine|mesh-list
138420033|NCT05536011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138420034|NCT05536011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420035|NCT05536011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138420036|NCT05536011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138420037|NCT05536011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138420039|NCT05536011|Dopamine Agents|dopamine agents|mesh-ancestor
138641187|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138374493|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138641189|NCT01330381|Prucalopride|prucalopride|mesh-list
138641190|NCT01330381|Laxatives|laxatives|mesh-ancestor
138641191|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138641192|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138641193|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138641194|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
138641195|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641196|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641197|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641198|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
138641199|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641200|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
138641201|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641202|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138420043|NCT05536011|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138420044|NCT05536011|Sympathomimetics|sympathomimetics|mesh-ancestor
138420045|NCT05536011|Autonomic Agents|autonomic agents|mesh-ancestor
138420046|NCT05536011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138420047|NCT05536011|Adrenergic Agents|adrenergic agents|mesh-ancestor
138420048|NCT05536011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138420052|NCT05536011|Anesthetics|anesthetics|mesh-ancestor
138641203|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641204|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641205|NCT01330108|Ambrisentan|ambrisentan|mesh-list
138641206|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138641207|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
138641208|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138641209|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138641210|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138641211|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641212|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641213|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
138641214|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641215|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641216|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138641217|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641218|NCT00261170|Bupropion|bupropion|mesh-list
138641219|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138641220|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
138641221|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138641222|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138641223|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138641224|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641225|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641226|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
138641227|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641228|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420163|NCT05428826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138420164|NCT05428826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420165|NCT05428826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138420166|NCT05428826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420167|NCT05421741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138420168|NCT05421741|Vancomycin|vancomycin|mesh-list
138420169|NCT05421741|Gentamicins|gentamicins|mesh-list
138420170|NCT05421741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138420171|NCT05421741|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138420172|NCT05421741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420173|NCT05421741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420174|NCT05414474|Ascorbic Acid|ascorbic acid|mesh-list
138641229|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138641230|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138641231|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641232|NCT00261287|Ciclesonide|ciclesonide|mesh-list
138641233|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
138641234|NCT00261287|Hormones|hormones|mesh-ancestor
138641235|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138641236|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641237|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138641238|NCT00261326|Simvastatin|simvastatin|mesh-list
138641239|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138641240|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138641241|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
138641242|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641243|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138641244|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138641245|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641247|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
138641248|NCT00293163|Protective Agents|protective agents|mesh-ancestor
138641249|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641251|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138641252|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641253|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138641254|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641255|NCT00293280|Lomustine|lomustine|mesh-list
138641256|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138641257|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
138641258|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641259|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641260|NCT00298779|Bortezomib|bortezomib|mesh-list
138641261|NCT00298779|Omeprazole|omeprazole|mesh-list
138641262|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641263|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138641264|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138641265|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138641266|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420232|NCT05363111|Daratumumab|daratumumab|mesh-list
138641267|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641268|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138641269|NCT00261482|Norelgestromin|norelgestromin|mesh-list
138641270|NCT00261482|Estradiol|estradiol|mesh-list
138641271|NCT00261482|Estrogens|estrogens|mesh-ancestor
138641272|NCT00261482|Hormones|hormones|mesh-ancestor
138641273|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138641274|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374608|NCT01428492|Hormones|hormones|mesh-ancestor
138641275|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138641276|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
138641277|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138641278|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138641279|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138641280|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138641281|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
138641282|NCT00261521|Hematinics|hematinics|mesh-ancestor
138641283|NCT00298857|Valproic Acid|valproic acid|mesh-list
138641284|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
138641285|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641286|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641287|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
138200796|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138200797|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
138641288|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641289|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641290|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
138641291|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138226864|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
138641292|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138641293|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138641294|NCT00261560|Acetaminophen|acetaminophen|mesh-list
138641295|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138641296|NCT00261560|Analgesics|analgesics|mesh-ancestor
138226900|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
138641297|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
138641298|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641299|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641300|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
138641302|NCT00261599|Fospropofol|fospropofol|mesh-list
138420328|NCT05284552|Tinzaparin|tinzaparin|mesh-list
138641303|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138374656|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138641304|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138641305|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138641306|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641307|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138641308|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138641309|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138641310|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138641311|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
138641312|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
138641313|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
138641314|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
138641315|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641316|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641317|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
138641318|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641319|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641320|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641321|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138641322|NCT00293358|Carboplatin|carboplatin|mesh-list
138641323|NCT00293358|Etoposide|etoposide|mesh-list
138641324|NCT00293358|Ifosfamide|ifosfamide|mesh-list
138641325|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
138641326|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641327|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138641328|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138420440|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420441|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420442|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420443|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
138420444|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
138420445|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641329|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138641330|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138374698|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138641331|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200805|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
138200806|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
138200813|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
138641332|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138641333|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
138641334|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
138641335|NCT00261677|Hematinics|hematinics|mesh-ancestor
138641336|NCT00298974|Acetaminophen|acetaminophen|mesh-list
138641337|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138641338|NCT00298974|Hydrocodone|hydrocodone|mesh-list
138641339|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138420505|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
138420506|NCT04995003|Nivolumab|nivolumab|mesh-list
138420507|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138420508|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420509|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420510|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420511|NCT04982445|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
138641342|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641343|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641344|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
138641345|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138641346|NCT00298974|Narcotics|narcotics|mesh-ancestor
138641347|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138641348|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
138641349|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
138641350|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138641351|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138641352|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138641353|NCT00293436|Celecoxib|celecoxib|mesh-list
138420569|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
138420570|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420571|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420572|NCT04897022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420573|NCT04897022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420574|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
138420575|NCT04895761|Letrozole|letrozole|mesh-list
138420576|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138420577|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
138420578|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138227198|NCT02449902|Estradiol|estradiol|mesh-list
138374742|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
138641354|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138641355|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641356|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138641357|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641358|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641359|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138641360|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138641362|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
138641363|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641364|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641365|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138641366|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138641367|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138641368|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138641369|NCT00261872|Methylphenidate|methylphenidate|mesh-list
138641370|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138641371|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641372|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138641373|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138641374|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641375|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641376|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
138200837|NCT00002716|Hormones|hormones|mesh-ancestor
138227333|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
138641377|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641378|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
138641380|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138641382|NCT00293475|Methotrexate|methotrexate|mesh-list
138641383|NCT00293475|Mannitol|mannitol|mesh-list
138641384|NCT00293475|Antibodies|antibodies|mesh-list
138641385|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
138318016|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641386|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138641387|NCT00293475|Antidotes|antidotes|mesh-list
138641388|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
138641389|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641390|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641391|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138641392|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138641393|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
138641394|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138641395|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138420753|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
138641397|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641398|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
138641399|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641400|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138641401|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138641402|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138641403|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138641404|NCT00293475|Diuretics|diuretics|mesh-ancestor
138641405|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
138641406|NCT00293475|Protective Agents|protective agents|mesh-ancestor
138641407|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
138641408|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
138641409|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138641410|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641411|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
138641412|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
138641413|NCT00261911|Sibutramine|sibutramine|mesh-list
138641414|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
138641415|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138641416|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
138641417|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138641419|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138641420|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
138641421|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138641422|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
138641423|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138374826|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138641425|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200841|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138200842|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
138641426|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
138641428|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138641429|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641430|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138641431|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641433|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
138641434|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641435|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138641436|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138641437|NCT00299013|Protective Agents|protective agents|mesh-ancestor
138641438|NCT00293514|Thrombin|thrombin|mesh-list
138641439|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
138227641|NCT01623323|Xhance|xhance|mesh-list
138641440|NCT00293514|Coagulants|coagulants|mesh-ancestor
138641441|NCT00299091|Efavirenz|efavirenz|mesh-list
138641442|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138641443|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138420944|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138420945|NCT04390763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138420965|NCT04339062|Sirolimus|sirolimus|mesh-list
138420966|NCT04339062|Prednisone|prednisone|mesh-list
138420967|NCT04339062|Everolimus|everolimus|mesh-list
138420968|NCT04339062|Cemiplimab|cemiplimab|mesh-list
138420969|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138420970|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
138420971|NCT04339062|Hormones|hormones|mesh-ancestor
138420972|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138374859|NCT01429935|Ibuprofen|ibuprofen|mesh-list
138420973|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420974|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138420975|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138420976|NCT04339062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138420977|NCT04339062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138420978|NCT04339062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138420979|NCT04339062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138420980|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138420981|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
138641444|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641445|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641447|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641448|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138641449|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138641450|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138641451|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138641452|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138641453|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138641454|NCT00299208|Azithromycin|azithromycin|mesh-list
138641455|NCT00299208|Artesunate|artesunate|mesh-list
138641456|NCT00299208|Quinine|quinine|mesh-list
138641457|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138641458|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641459|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
138641460|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138641461|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138641462|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641463|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
138641464|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
138641465|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138641466|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
138641467|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138641479|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
138641480|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641481|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138374905|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138641482|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138641483|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
138641484|NCT00293592|Hormones|hormones|mesh-ancestor
138421052|NCT04145115|Nivolumab|nivolumab|mesh-list
138421053|NCT04145115|Ipilimumab|ipilimumab|mesh-list
138421054|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138421055|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421056|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138227954|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138641485|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138641486|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138641487|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641489|NCT00293631|Lornoxicam|lornoxicam|mesh-list
138641490|NCT00293631|Piroxicam|piroxicam|mesh-list
138641491|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138641492|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138641493|NCT00293631|Analgesics|analgesics|mesh-ancestor
138641494|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
138228001|NCT01011218|Modafinil|modafinil|mesh-list
138641495|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641496|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641497|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138641498|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138641499|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138641500|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421106|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138421107|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
138421108|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421110|NCT03919071|Dabrafenib|dabrafenib|mesh-list
138421111|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138421112|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421113|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138421114|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138421115|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421116|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138421117|NCT03919071|Protective Agents|protective agents|mesh-ancestor
138421118|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421119|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138421120|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
138421121|NCT03871257|Carboplatin|carboplatin|mesh-list
138421122|NCT03871257|Vincristine|vincristine|mesh-list
138641501|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641502|NCT00262262|Levetiracetam|levetiracetam|mesh-list
138641503|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
138641504|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
138374944|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641505|NCT00293670|Goserelin|goserelin|mesh-list
138641506|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138641507|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641508|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
138641509|NCT00262379|Hematinics|hematinics|mesh-ancestor
138641510|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
138641511|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
138641512|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
138228136|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
138641513|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138641514|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138641515|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641516|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138641517|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641518|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641519|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138641520|NCT00262418|Ivermectin|ivermectin|mesh-list
138641521|NCT00262418|Permethrin|permethrin|mesh-list
138641522|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138641523|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641524|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641525|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641526|NCT00299286|Lapatinib|lapatinib|mesh-list
138641527|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641528|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138641529|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641530|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641531|NCT00293787|Timolol|timolol|mesh-list
138641532|NCT00293787|Travoprost|travoprost|mesh-list
138641533|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138641534|NCT00293787|Latanoprost|latanoprost|mesh-list
138641535|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138200865|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641536|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641537|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138641538|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138641539|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
138374974|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641540|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641541|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641542|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138641543|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138641544|NCT00299364|Tibolone|tibolone|mesh-list
138641545|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
138641546|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
138641547|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138641548|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641549|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138641550|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138641551|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641552|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138641553|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
138641554|NCT00299364|Hormones|hormones|mesh-ancestor
138641555|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138641556|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
138641557|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641558|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138641559|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
138641560|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641561|NCT00262769|Cisplatin|cisplatin|mesh-list
138641562|NCT00262769|Gemcitabine|gemcitabine|mesh-list
138641563|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641564|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138641565|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
138228293|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138641566|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641568|NCT00299520|Iclaprim|iclaprim|mesh-list
138641569|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138641570|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641571|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138641572|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641573|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641574|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138641575|NCT00261755|Analgesics|analgesics|mesh-list
138641576|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
138641577|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641578|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641579|NCT00262808|Leucovorin|leucovorin|mesh-list
138641580|NCT00262808|Fluorouracil|fluorouracil|mesh-list
138641581|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
138641582|NCT00262808|Calcium|calcium|mesh-list
138641583|NCT00262808|Sargramostim|sargramostim|mesh-list
138641584|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
138641585|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138641586|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641587|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
138641588|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641589|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138641590|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641591|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138641592|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
138641593|NCT00262808|Antidotes|antidotes|mesh-ancestor
138641594|NCT00262808|Protective Agents|protective agents|mesh-ancestor
138641595|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
138641596|NCT00262808|Vitamins|vitamins|mesh-ancestor
138641597|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
138200877|NCT00002734|Topotecan|topotecan|mesh-list
138641598|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
138641599|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
138641600|NCT00262886|Fludarabine|fludarabine|mesh-list
138641601|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
138641602|NCT00262886|Tacrolimus|tacrolimus|mesh-list
138641603|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138228424|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
138375062|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641604|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138641605|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
138641606|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641607|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138641608|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138641609|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
138641610|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641611|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641612|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138641613|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138641614|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
138641615|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138421374|NCT03511118|Diuretics|diuretics|mesh-ancestor
138641616|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641617|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138641618|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138641619|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
138641620|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138641621|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641622|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138641624|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138641625|NCT00263003|Diuretics|diuretics|mesh-ancestor
138641626|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
138641627|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641628|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138421438|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138421439|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138421440|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138421441|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421442|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138375103|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138641629|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641630|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641631|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138641632|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138641633|NCT00299559|Camphor|camphor|mesh-list
138641634|NCT00299559|Menthol|menthol|mesh-list
138641635|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
138641636|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
138641637|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138641638|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641639|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138641640|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641641|NCT00263198|Letrozole|letrozole|mesh-list
138641642|NCT00263198|Vatalanib|vatalanib|mesh-list
138641643|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641644|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138421504|NCT03120780|Fentanyl|fentanyl|mesh-list
138641645|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138641646|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641647|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641648|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138641649|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
138641650|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138641651|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641652|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138641653|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138200893|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138641654|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138641655|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
138641656|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228597|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641658|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641659|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138641661|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138641662|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375145|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
138375146|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138641663|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641665|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641666|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641667|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138641668|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
138641669|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641670|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
138641671|NCT00263276|Metformin|metformin|mesh-list
138641672|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
138641673|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138641674|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641675|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138641676|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641677|NCT00299754|Misoprostol|misoprostol|mesh-list
138641678|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138641679|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
138641680|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138641681|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138228714|NCT01004354|Vitamin D|vitamin d|mesh-list
138641682|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138641683|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138641684|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
138641685|NCT00263315|Amphotericin B|amphotericin b|mesh-list
138641686|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138641687|NCT00263315|Amebicides|amebicides|mesh-ancestor
138641688|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138641689|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138641690|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641691|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138641692|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
138641693|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
138641694|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641695|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138641696|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641697|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641699|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641700|NCT00263393|Atenolol|atenolol|mesh-list
138641701|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138641702|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138641703|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138375183|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138641704|NCT00263393|Diuretics|diuretics|mesh-ancestor
138641705|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
138641706|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641707|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138641708|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641709|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641710|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138641711|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
138641712|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
138641713|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138228814|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641714|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138641715|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138641716|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138641717|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
138641718|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641719|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
138641720|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641721|NCT00299871|Lixisenatide|lixisenatide|mesh-list
138641722|NCT00299871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138641723|NCT00299871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641724|NCT00299910|Montelukast|montelukast|mesh-list
138641725|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138641726|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
138641727|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138641728|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
138641729|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138641730|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641731|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138641732|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138641733|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641734|NCT00263627|Immunomodulating Agents|immunomodulating agents|mesh-list
138641735|NCT00263627|Immunologic Factors|immunologic factors|mesh-ancestor
138641736|NCT00263627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641738|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
138641739|NCT00425594|Cathartics|cathartics|mesh-ancestor
138641740|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138641741|NCT00425594|Laxatives|laxatives|mesh-ancestor
138641742|NCT00294255|Risperidone|risperidone|mesh-list
138641743|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138641744|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
138641745|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641746|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641747|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641748|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138641749|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138641750|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138641751|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138641752|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138641753|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
138641754|NCT00263705|Capecitabine|capecitabine|mesh-list
138641755|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138641756|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
138641757|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641758|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641759|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138641760|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138641761|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
138641762|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641763|NCT00263744|Antacids|antacids|mesh-ancestor
138229136|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641764|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641765|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138641766|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138421700|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138421701|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641767|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
138641768|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641769|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138641770|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641771|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138641772|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641773|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641774|NCT00300222|Capsaicin|capsaicin|mesh-list
138641775|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
138641776|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
138641777|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
138641778|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641779|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641780|NCT00263978|Defibrotide|defibrotide|mesh-list
138641781|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138641782|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138641783|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641784|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138641786|NCT00264134|Docetaxel|docetaxel|mesh-list
138641787|NCT00264134|Irinotecan|irinotecan|mesh-list
138641788|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641789|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
138641790|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
138641791|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
138641792|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641793|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138641794|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138641796|NCT00300339|Clopidogrel|clopidogrel|mesh-list
138641797|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138641798|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138641799|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138641800|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138641801|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
138421757|NCT02088060|Cannabidiol|cannabidiol|mesh-list
138421758|NCT02088060|Olanzapine|olanzapine|mesh-list
138421759|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
138421760|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
138421761|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138421762|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138421763|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138421764|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138421765|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138421766|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138421767|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138421768|NCT02088060|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138421769|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138421770|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138421771|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138421772|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138421773|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
138421774|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
138421775|NCT02078427|BAX 855|bax 855|mesh-list
138641802|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641803|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641804|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641805|NCT00264173|Valproic Acid|valproic acid|mesh-list
138641806|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
138641807|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641808|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641809|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
138641810|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641811|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641812|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
138641813|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138641814|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138641815|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138641816|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138641817|NCT00264212|Irbesartan|irbesartan|mesh-list
138641818|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138641819|NCT00264212|Diuretics|diuretics|mesh-ancestor
138641820|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
138641821|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641822|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138641823|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641824|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641825|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138641826|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138641827|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138641828|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138641829|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138641830|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138348900|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
138641831|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641832|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641833|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641834|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
138641835|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138641836|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
138641837|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138641838|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641840|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
138641841|NCT00294567|Calcium|calcium|mesh-list
138641842|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138641843|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641844|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138229412|NCT01113398|Bevacizumab|bevacizumab|mesh-list
138641845|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641846|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641847|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
138641848|NCT00294606|Phenylephrine|phenylephrine|mesh-list
138641849|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
138641850|NCT00294606|Norepinephrine|norepinephrine|mesh-list
138641851|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138641852|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
138641853|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
138641854|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641855|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641856|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
138641857|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138641858|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
138641859|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
138641860|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138641861|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138641862|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138641863|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
138641864|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641865|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641866|NCT00294606|Protective Agents|protective agents|mesh-ancestor
138641867|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
138641868|NCT04708964|Analgesics|analgesics|mesh-ancestor
138229538|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
138641869|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
138641870|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641871|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641872|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138641873|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138641874|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138641875|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138641876|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138641877|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641878|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641879|NCT00264368|Ganciclovir|ganciclovir|mesh-list
138641880|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
138641881|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
138641882|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138641883|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138641884|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641885|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641886|NCT00264407|Hormones|hormones|mesh-list
138200925|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
138200926|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
138200927|NCT00002740|Protective Agents|protective agents|mesh-ancestor
138641887|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138641888|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641889|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
138641890|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138641891|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138641892|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641893|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641894|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
138641895|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375345|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
138641900|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641901|NCT00264485|Fentanyl|fentanyl|mesh-list
138641902|NCT00264485|Morphine|morphine|mesh-list
138641903|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138641904|NCT00264485|Narcotics|narcotics|mesh-ancestor
138641905|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138641906|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641907|NCT00264485|Analgesics|analgesics|mesh-ancestor
138641908|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
138641909|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641910|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138641911|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138641912|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
138318537|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138641914|NCT00294918|Hormones|hormones|mesh-list
138641915|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138641916|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641918|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
138641919|NCT00264680|Valproic Acid|valproic acid|mesh-list
138641920|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138641921|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138641922|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641923|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138641924|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641925|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138641926|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138641927|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138641928|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138641929|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138641930|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641932|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641933|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
138641934|NCT00300729|Celecoxib|celecoxib|mesh-list
138641935|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138641936|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138641937|NCT00300729|Analgesics|analgesics|mesh-ancestor
138641938|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
138641939|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641940|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641941|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138229835|NCT02481219|Metoclopramide|metoclopramide|mesh-list
138641943|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138200941|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
138200942|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641944|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138641945|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641946|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641947|NCT00264719|Metoclopramide|metoclopramide|mesh-list
138641948|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
138641949|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
138641950|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138641951|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641952|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138641953|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138641955|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
138641956|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641957|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641959|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138641960|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641961|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
138641962|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641963|NCT00264953|Prednisone|prednisone|mesh-list
138641964|NCT00264953|Etoposide|etoposide|mesh-list
138641965|NCT00264953|Vincristine|vincristine|mesh-list
138641966|NCT00264953|Doxorubicin|doxorubicin|mesh-list
138641967|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138641968|NCT00264953|Bleomycin|bleomycin|mesh-list
138641969|NCT00264953|Vinblastine|vinblastine|mesh-list
138641970|NCT00264953|Procarbazine|procarbazine|mesh-list
138641971|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138641972|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
138641973|NCT00264953|Hormones|hormones|mesh-ancestor
138641974|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138641975|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138229998|NCT02384850|Leucovorin|leucovorin|mesh-list
138641976|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138641977|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138641978|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138641979|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138641981|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138641982|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641983|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
138641984|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
138641985|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
138641986|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138641987|NCT00300846|Aripiprazole|aripiprazole|mesh-list
138641988|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
138641989|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138641990|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138641991|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138641992|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138641993|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138641994|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
138641995|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
138641996|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138641997|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138641999|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138642000|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
138642001|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138642002|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138200961|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200962|NCT01050647|Castor Oil|castor oil|mesh-list
138200963|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
138200964|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
138200965|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138200966|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
138200967|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138200968|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642003|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138642004|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138642005|NCT00294996|Doxorubicin|doxorubicin|mesh-list
138642006|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138642007|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642008|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138642009|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138642010|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642011|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642013|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
138642015|NCT00265031|Vincristine|vincristine|mesh-list
138642016|NCT00265031|Doxorubicin|doxorubicin|mesh-list
138642017|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138642018|NCT00265031|Bleomycin|bleomycin|mesh-list
138642019|NCT00265031|Procarbazine|procarbazine|mesh-list
138642020|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138642021|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
138642022|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642023|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138642024|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138642025|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
138642026|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642027|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642028|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138642029|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138642030|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
138642031|NCT00265031|Hormones|hormones|mesh-ancestor
138642032|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138642033|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138642034|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138375424|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138375425|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138642036|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138642037|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642038|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
138642039|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
138642040|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
138642041|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138642042|NCT00300924|Acetaminophen|acetaminophen|mesh-list
138642043|NCT00300924|Rizatriptan|rizatriptan|mesh-list
138642044|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138642045|NCT00300924|Analgesics|analgesics|mesh-ancestor
138642046|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
138642047|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642048|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642049|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
138642050|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138642051|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
138642052|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642053|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642055|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642056|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138642057|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642058|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642059|NCT00295035|Celecoxib|celecoxib|mesh-list
138642060|NCT00295035|Curcumin|curcumin|mesh-list
138642061|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138642062|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138642063|NCT00295035|Analgesics|analgesics|mesh-ancestor
138642064|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
138642065|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138200971|NCT01050647|Cathartics|cathartics|mesh-ancestor
138200973|NCT00002764|Doxorubicin|doxorubicin|mesh-list
138642066|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642067|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138642068|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138642069|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138642070|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138642071|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642072|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138200984|NCT05167175|Prednisone|prednisone|mesh-list
138200985|NCT05167175|Olaparib|olaparib|mesh-list
138200986|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
138200987|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138200988|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
138200989|NCT05167175|Hormones|hormones|mesh-ancestor
138200990|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138200991|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138200992|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138200993|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138200994|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138642073|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642074|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138642075|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138642076|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138642077|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138642078|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642079|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
138642080|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642081|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642082|NCT00418275|Plasminogen|plasminogen|mesh-list
138642083|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138642084|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138642085|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375469|NCT01434147|Bevacizumab|bevacizumab|mesh-list
138642087|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138642088|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138642090|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
138642091|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642092|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642093|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138642094|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138642095|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138642096|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642097|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642098|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
138642099|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138642100|NCT00265460|Lobeline|lobeline|mesh-list
138642101|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138642102|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
138642103|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642104|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642105|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138642106|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138642107|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
138642108|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642109|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230190|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
138642110|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
138642111|NCT00301002|Alefacept|alefacept|mesh-list
138642112|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
138642113|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
138642114|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642115|NCT00265694|Carboplatin|carboplatin|mesh-list
138642116|NCT00265694|Gemcitabine|gemcitabine|mesh-list
138642117|NCT00265694|Vinorelbine|vinorelbine|mesh-list
138642118|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642119|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138642120|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
138642121|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642122|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138642123|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
138642124|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
138375483|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138642125|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
138642127|NCT00265733|Capecitabine|capecitabine|mesh-list
138642128|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138642129|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138642130|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642131|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
138642132|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
138642133|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
138642134|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138230244|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
138642135|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138642137|NCT00265772|Prednisolone|prednisolone|mesh-list
138642138|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138642139|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
138642140|NCT00265772|Hormones|hormones|mesh-ancestor
138642141|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138642142|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642143|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138642144|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642145|NCT00265811|Cetuximab|cetuximab|mesh-list
138642146|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138642147|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642149|NCT00295308|Analgesics|analgesics|mesh-ancestor
138642150|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
138642151|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642152|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642153|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138642154|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
138642155|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
138642156|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138642157|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138642158|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138642159|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
138642160|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642161|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642162|NCT00265928|Rituximab|rituximab|mesh-list
138642163|NCT00265928|Bortezomib|bortezomib|mesh-list
138642164|NCT00265928|Antibodies|antibodies|mesh-list
138642165|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
138642166|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138642167|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138642168|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
138642169|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642170|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138642171|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642172|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138230417|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
138642173|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642175|NCT00295347|Spironolactone|spironolactone|mesh-list
138642176|NCT00295347|Escitalopram|escitalopram|mesh-list
138642177|NCT00295347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138642178|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138642179|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138642180|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642182|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
138230560|NCT04423029|Nivolumab|nivolumab|mesh-list
138642183|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642184|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138642185|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
138642186|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138642187|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138642189|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
138642190|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138642191|NCT00265967|Irbesartan|irbesartan|mesh-list
138230616|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
138642192|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138642193|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138642194|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138642195|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642197|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138642198|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138642199|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642200|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
138642201|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138642202|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642203|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138642204|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138642205|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138642206|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642207|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
138642208|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642210|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
138642211|NCT00295425|Cyclosporins|cyclosporins|mesh-list
138642212|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642213|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642214|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138642215|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
138642216|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642217|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
138642218|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138642219|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
138642220|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138642221|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138642222|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138642223|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642224|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138375545|NCT01434303|Trastuzumab|trastuzumab|mesh-list
138642225|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
138642226|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138642227|NCT00266123|Sirolimus|sirolimus|mesh-list
138642228|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138642229|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138642230|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138230880|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
138642231|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642232|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
138642233|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138642234|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
138642235|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642237|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138642238|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138642239|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642241|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138642242|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
138642243|NCT00295464|Hormones|hormones|mesh-ancestor
138642244|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138642245|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642247|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
138642248|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138642249|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138642250|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642251|NCT00301392|Pitavastatin|pitavastatin|mesh-list
138642252|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138231060|NCT05857891|Epoetin Alfa|epoetin alfa|mesh-list
138642254|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138642255|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
138642256|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642257|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642258|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138642259|NCT00415844|Levodopa|levodopa|mesh-list
138642260|NCT00415844|Carbidopa|carbidopa|mesh-list
138642261|NCT00415844|Entacapone|entacapone|mesh-list
138642262|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138642263|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138231129|NCT05655273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375574|NCT01434849|Timolol|timolol|mesh-list
138642264|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138642266|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642267|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642268|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642269|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138642270|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642271|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138642272|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138642273|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
138642274|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
138642275|NCT00415883|Valsartan|valsartan|mesh-list
138642276|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138642277|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138642278|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138642279|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642280|NCT00295542|Atenolol|atenolol|mesh-list
138642282|NCT00295542|Telmisartan|telmisartan|mesh-list
138642283|NCT00295542|Carvedilol|carvedilol|mesh-list
138318919|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
138642284|NCT00295542|Olmesartan|olmesartan|mesh-list
138642285|NCT00295542|Enalapril|enalapril|mesh-list
138642286|NCT00295542|Lisinopril|lisinopril|mesh-list
138642287|NCT00295542|Nebivolol|nebivolol|mesh-list
138642288|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
138642289|NCT00295542|Doxazosin|doxazosin|mesh-list
138642290|NCT00295542|Indapamide|indapamide|mesh-list
138642291|NCT00295542|Quinapril|quinapril|mesh-list
138642292|NCT00295542|Torsemide|torsemide|mesh-list
138642293|NCT00295542|Spirapril|spirapril|mesh-list
138642294|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138642295|NCT00295542|Diuretics|diuretics|mesh-list
138642296|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138231252|NCT05232123|Cannabidiol|cannabidiol|mesh-list
138642297|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138642298|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642299|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138642300|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
138642301|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642302|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642303|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
138642304|NCT00295542|Protective Agents|protective agents|mesh-ancestor
138642305|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138642306|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138642307|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138642309|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138642310|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138642311|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138642312|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
138231377|NCT04250051|Ivosidenib|ivosidenib|mesh-list
138642313|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642314|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
138375612|NCT01434914|Octenidine|octenidine|mesh-list
138642316|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138642318|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
138642319|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642320|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138642321|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138642322|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138642324|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138642325|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138642326|NCT00266318|Interferons|interferons|mesh-list
138642327|NCT00266318|Ribavirin|ribavirin|mesh-list
138642328|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
138642329|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642330|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
138642331|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138642332|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
138642333|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642334|NCT00266357|Gaboxadol|gaboxadol|mesh-list
138642335|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642336|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642337|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642338|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642339|NCT00266357|Analgesics|analgesics|mesh-ancestor
138642340|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
138642341|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
138642342|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
138642343|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
138642344|NCT00301509|Ribavirin|ribavirin|mesh-list
138642345|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
138642346|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138231512|NCT03435458|Misoprostol|misoprostol|mesh-list
138642347|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
138642348|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138642349|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
138642350|NCT00295698|Filaricides|filaricides|mesh-ancestor
138642351|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
138642352|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
138642353|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138642354|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138375628|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138642355|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138642356|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642357|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642358|NCT00266552|Risperidone|risperidone|mesh-list
138318991|NCT03599778|Apatinib|apatinib|mesh-list
138642359|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138642360|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
138642361|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642362|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642363|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642364|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138642365|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138642366|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138642367|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138642368|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138642370|NCT00301587|Folic Acid|folic acid|mesh-list
138642371|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
138642372|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138642373|NCT00301587|Norgestimate|norgestimate|mesh-list
138642374|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138642375|NCT00301587|Estradiol|estradiol|mesh-list
138642376|NCT00301587|Estrogens|estrogens|mesh-ancestor
138642377|NCT00301587|Hormones|hormones|mesh-ancestor
138642378|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138642379|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642380|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138642381|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
138642382|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138642383|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138642384|NCT00301587|Hematinics|hematinics|mesh-ancestor
138642385|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
138642386|NCT00301587|Vitamins|vitamins|mesh-ancestor
138642387|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
138642388|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138642389|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138642390|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138642391|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138642392|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138642393|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138642394|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138642395|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642396|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642397|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375664|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642400|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
138231691|NCT01665677|Calcium|calcium|mesh-list
138642401|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138642402|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642403|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
138642404|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138642405|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138642406|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138642407|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138642408|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642410|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642411|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642412|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138642413|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642415|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
138642416|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138642417|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138642418|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642419|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138642420|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642421|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138642422|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138642423|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138231805|NCT05159193|Docetaxel|docetaxel|mesh-list
138642424|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138642425|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138642426|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
138642427|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
138642428|NCT00266747|Amibegron|amibegron|mesh-list
138642429|NCT00266747|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
138642430|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138201051|NCT00002788|Dexamethasone|dexamethasone|mesh-list
138642431|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138642432|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
138201052|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
138642433|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642434|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642435|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642436|NCT00266747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138642438|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138642439|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138642440|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138231871|NCT00364143|Irinotecan|irinotecan|mesh-list
138642441|NCT00266786|Analgesics|analgesics|mesh-ancestor
138642442|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
138642443|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642444|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642445|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138375695|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642447|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138642448|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642449|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642450|NCT00295815|Lomustine|lomustine|mesh-list
138642451|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138642452|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
138642453|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642454|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642455|NCT00295971|Fludarabine|fludarabine|mesh-list
138642456|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
138642457|NCT00295971|Thiotepa|thiotepa|mesh-list
138642458|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138642459|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642460|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138642462|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642463|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138642464|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
138642465|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642466|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138642467|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
138642468|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138642469|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
138642470|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138642471|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138642472|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642473|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642474|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138642475|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138642476|NCT00267176|Analgesics|analgesics|mesh-ancestor
138642477|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
138642478|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642479|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642480|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138642481|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138642482|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
138642483|NCT00296010|Doxorubicin|doxorubicin|mesh-list
138642484|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138642485|NCT00296010|Methotrexate|methotrexate|mesh-list
138642486|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138642488|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642489|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138642490|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138642491|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
138375718|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375731|NCT01435707|Hormones|hormones|mesh-ancestor
138642492|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642494|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138642495|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138642496|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138642497|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138642498|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642499|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138642500|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
138642501|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138642502|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138642503|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
138642504|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
138642505|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138642506|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138642507|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
138642508|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138642509|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138642510|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642511|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642512|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138642513|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138642514|NCT00267215|Analgesics|analgesics|mesh-ancestor
138642515|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
138642516|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642517|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642518|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138642519|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138642520|NCT00296049|Vancomycin|vancomycin|mesh-list
138642521|NCT00296049|Daptomycin|daptomycin|mesh-list
138642522|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138642523|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138642524|NCT00267254|Atorvastatin|atorvastatin|mesh-list
138642525|NCT00267254|Simvastatin|simvastatin|mesh-list
138642526|NCT00267254|Torcetrapib|torcetrapib|mesh-list
138642527|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138642528|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138642529|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
138642530|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642531|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138642532|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138642533|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642534|NCT00301782|Carboplatin|carboplatin|mesh-list
138642535|NCT00301782|Etoposide|etoposide|mesh-list
138642536|NCT00301782|Vincristine|vincristine|mesh-list
138642537|NCT00301782|Bleomycin|bleomycin|mesh-list
138642539|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138375745|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138375748|NCT01435915|Ropinirole|ropinirole|mesh-list
138642540|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138642541|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138642543|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642544|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642545|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
138642546|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
138642547|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
138642548|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138642550|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138642551|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642552|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138642553|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138642554|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138642555|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642557|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138642558|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138642559|NCT04718649|Analgesics|analgesics|mesh-ancestor
138642560|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
138642561|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642562|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642563|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138642564|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138642565|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138642566|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138642567|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642568|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642569|NCT00301860|Cyclosporine|cyclosporine|mesh-list
138201059|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
138201060|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201061|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201064|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
138642570|NCT00301860|Methotrexate|methotrexate|mesh-list
138642571|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
138642572|NCT00301860|Fludarabine|fludarabine|mesh-list
138642573|NCT00301860|Melphalan|melphalan|mesh-list
138642574|NCT00301860|Cyclosporins|cyclosporins|mesh-list
138642575|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
138642576|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138642577|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
138642578|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138642579|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642580|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138642581|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
138642582|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642583|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642584|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
138642585|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642586|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138642587|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138642588|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
138642589|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138642590|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138642591|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
138375785|NCT01435980|Exenatide|exenatide|mesh-list
138642593|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138642594|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138642595|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
138642596|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138642599|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138642600|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642602|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138642603|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138642604|NCT00296127|Analgesics|analgesics|mesh-ancestor
138642605|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
138642606|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642607|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642608|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138642609|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138642610|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138642611|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138642612|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642613|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642614|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
138642615|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138642616|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
138642617|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642618|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138642619|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138642620|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
138642621|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642622|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642623|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138642625|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
138642626|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642627|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
138642628|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642629|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138642630|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642631|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642633|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138642634|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
138642635|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642636|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138642638|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642641|NCT00415922|Entacapone|entacapone|mesh-list
138642642|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138642643|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138642644|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138642645|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
138642646|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642647|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642648|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642649|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138642650|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642651|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138642653|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
138642654|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
138642656|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138642657|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642658|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
138642659|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
138642660|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
138642661|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642663|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138642664|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138642665|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138642666|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642667|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138642668|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138642669|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138642670|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138642671|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
138642672|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
138642673|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
138642674|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
138642675|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642676|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642677|NCT00296478|Progesterone|progesterone|mesh-list
138642678|NCT00296478|Progestins|progestins|mesh-ancestor
138642680|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138642681|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642682|NCT00268151|Capecitabine|capecitabine|mesh-list
138642683|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
138642684|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138642685|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
138642686|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642687|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642688|NCT00418080|Bicalutamide|bicalutamide|mesh-list
138642689|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
138642690|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
138642691|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138642693|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642694|NCT00268229|Cytarabine|cytarabine|mesh-list
138642695|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
138642696|NCT00268229|Daunorubicin|daunorubicin|mesh-list
138642697|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138642698|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
138642699|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642700|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642701|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
138642702|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138642703|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138642704|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
138642705|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642706|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138642707|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642708|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138642709|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138642710|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138642711|NCT00302289|Caffeine|caffeine|mesh-list
138642712|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138642713|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642714|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138642715|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642716|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642717|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138642718|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138201070|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138642719|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
138642720|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642721|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138642722|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138642723|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
138642724|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642725|NCT00296634|Antacids|antacids|mesh-ancestor
138642726|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138375856|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138642728|NCT00268619|Ramipril|ramipril|mesh-list
138232642|NCT02615535|Alprostadil|alprostadil|mesh-list
138642729|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138642730|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
138642731|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642732|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642733|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138642735|NCT00296712|Citalopram|citalopram|mesh-list
138642736|NCT00296712|Bupropion|bupropion|mesh-list
138642737|NCT00296712|Escitalopram|escitalopram|mesh-list
138642738|NCT00296712|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138642739|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138642740|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138642741|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642742|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642743|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
138232691|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
138642744|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642745|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138642746|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138642747|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
138642749|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642750|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138642751|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138642752|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
138232749|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
138642753|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138642754|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
138642755|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138642756|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138642757|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
138642758|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138642759|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138642760|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642761|NCT00268697|Ezetimibe|ezetimibe|mesh-list
138642762|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138642763|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138642764|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
138642765|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642766|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138642767|NCT00296751|Fentanyl|fentanyl|mesh-list
138642768|NCT00296751|Meperidine|meperidine|mesh-list
138642769|NCT00296751|Bupivacaine|bupivacaine|mesh-list
138642770|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
138642771|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
138642772|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138642773|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642774|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
138642775|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642776|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138642777|NCT00296751|Narcotics|narcotics|mesh-ancestor
138642778|NCT00296751|Analgesics|analgesics|mesh-ancestor
138642779|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138642780|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138642781|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
138642782|NCT00302367|Methylphenidate|methylphenidate|mesh-list
138642783|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138375896|NCT01437007|TKM-080301|tkm-080301|mesh-list
138642784|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642785|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138642786|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138642787|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138642788|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642789|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
138642790|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642792|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138642793|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138232874|NCT05730621|Aspirin|aspirin|mesh-list
138642794|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138642795|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642797|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
138642798|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
138642799|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642800|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642801|NCT00302406|Methylphenidate|methylphenidate|mesh-list
138642802|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138642803|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642804|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138642805|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138642806|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138642807|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642808|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
138642809|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642810|NCT00268814|Methadone|methadone|mesh-list
138642811|NCT00268814|Heroin|heroin|mesh-list
138642812|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138642813|NCT00268814|Narcotics|narcotics|mesh-ancestor
138642814|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138642815|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642816|NCT00268814|Analgesics|analgesics|mesh-ancestor
138642817|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
138642818|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642819|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
138642820|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
138642821|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
138232984|NCT01349972|Analgesics|analgesics|mesh-ancestor
138642822|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138642823|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642825|NCT00296868|Vitamins|vitamins|mesh-ancestor
138642826|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
138642827|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642828|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
138642829|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642830|NCT00296868|Protective Agents|protective agents|mesh-ancestor
138642831|NCT00268970|Paclitaxel|paclitaxel|mesh-list
138642833|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138642834|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642835|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
138642836|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
138642837|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
138642838|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642839|NCT00296946|Bromides|bromides|mesh-list
138642840|NCT00296946|Ipratropium|ipratropium|mesh-list
138642841|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
138642842|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138642843|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
138642844|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642845|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642846|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138642847|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
138642848|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138642849|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
138642850|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642851|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642852|NCT00269048|Darapladib|darapladib|mesh-list
138642853|NCT00269048|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138642854|NCT00269048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642855|NCT00269048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642856|NCT00302523|Tacrolimus|tacrolimus|mesh-list
138642857|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138201077|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
138642858|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
138201078|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138642859|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642860|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138642861|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642862|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642863|NCT02960412|Furosemide|furosemide|mesh-list
138642864|NCT02960412|Diuretics|diuretics|mesh-ancestor
138642865|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
138642866|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642867|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138642868|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138642869|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642870|NCT00269126|Fluticasone|fluticasone|mesh-list
138642871|NCT00269126|Xhance|xhance|mesh-list
138642872|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138642873|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138375934|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
138642875|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138642876|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
138642877|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642878|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642879|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138642880|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
138642881|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
138642882|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138642883|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138642884|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138642885|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138642886|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
138642887|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138642888|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642889|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
138642891|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138642892|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
138642893|NCT00269204|Niacin|niacin|mesh-list
138642894|NCT00269204|Niacinamide|niacinamide|mesh-list
138642896|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138642897|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
138642898|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642899|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138642900|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
138642901|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
138642902|NCT00269204|Vitamins|vitamins|mesh-ancestor
138642903|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
138642906|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
138642907|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138642908|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
138642909|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642910|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642911|NCT00269243|Quinapril|quinapril|mesh-list
138642912|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138642913|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
138642914|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138642915|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642916|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138642917|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138201084|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
138201085|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
138201086|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201087|NCT04783792|Protective Agents|protective agents|mesh-ancestor
138642918|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138642919|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642920|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138642921|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
138642922|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375964|NCT01437371|Protective Agents|protective agents|mesh-ancestor
138642924|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
138642926|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138642927|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642928|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138642929|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138642930|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
138642931|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138642932|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138642933|NCT00418353|Dexamethasone|dexamethasone|mesh-list
138642934|NCT00418353|Betamethasone|betamethasone|mesh-list
138642935|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
138642936|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138642937|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
138642938|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
138642939|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138642940|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138642941|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
138642942|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
138642943|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138642944|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642945|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138642946|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
138642947|NCT00418353|Hormones|hormones|mesh-ancestor
138642948|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138642949|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138233766|NCT02631057|Warfarin|warfarin|mesh-list
138642950|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642951|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138642952|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
138642953|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138642954|NCT00418392|Minocycline|minocycline|mesh-list
138642955|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138233812|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138642956|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138642957|NCT00269555|Genistein|genistein|mesh-list
138642958|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138642959|NCT00269555|Protective Agents|protective agents|mesh-ancestor
138642960|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642961|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642962|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138642963|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138375993|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642964|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642965|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
138642966|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138642967|NCT00269555|Estrogens|estrogens|mesh-ancestor
138642968|NCT00269555|Hormones|hormones|mesh-ancestor
138642969|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138642971|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138642972|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138642973|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138642974|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138642975|NCT00418431|Growth Substances|growth substances|mesh-ancestor
138642976|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642977|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
138642978|NCT00269594|Lamotrigine|lamotrigine|mesh-list
138642979|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
138642980|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138642981|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138642982|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138642983|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138642984|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642985|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138642986|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138642987|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138642988|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138642989|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138642990|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138642991|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138642992|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138642993|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
138642994|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138642995|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
138642996|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138642997|NCT00302835|Analgesics|analgesics|mesh-list
138642998|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
138642999|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643000|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643001|NCT00269750|Oxybutynin|oxybutynin|mesh-list
138643002|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
138643003|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
138643004|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643005|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643006|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138643007|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138643008|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
138643009|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376025|NCT01437748|Bromides|bromides|mesh-list
138643010|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643011|NCT00269750|Urological Agents|urological agents|mesh-ancestor
138643012|NCT00269789|Methylphenidate|methylphenidate|mesh-list
138643013|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138643014|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643015|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138643016|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138643017|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138643018|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643019|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
138643020|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643021|NCT00302913|Clopidogrel|clopidogrel|mesh-list
138643022|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138643023|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138643024|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138643025|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138643026|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
138643027|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138233975|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
138643028|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643029|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643031|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138643032|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
138643033|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138643034|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643036|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
138643037|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
138643038|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643040|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138643041|NCT00269867|Antibodies|antibodies|mesh-list
138643042|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
138201101|NCT04330300|Verapamil|verapamil|mesh-list
138201102|NCT04330300|Felodipine|felodipine|mesh-list
138201103|NCT04330300|Amlodipine|amlodipine|mesh-list
138201104|NCT04330300|Valsartan|valsartan|mesh-list
138201105|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138201106|NCT04330300|Telmisartan|telmisartan|mesh-list
138201107|NCT04330300|Candesartan|candesartan|mesh-list
138201108|NCT04330300|Ramipril|ramipril|mesh-list
138643043|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138643044|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
138376054|NCT01437826|Antioxidants|antioxidants|mesh-list
138643045|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643046|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643047|NCT00269867|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138643048|NCT00269867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138643049|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
138643050|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138643051|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138643052|NCT00269906|Abciximab|abciximab|mesh-list
138643054|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138643055|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
138643056|NCT00269945|Hematinics|hematinics|mesh-ancestor
138643057|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
138643058|NCT00269984|Hematinics|hematinics|mesh-ancestor
138643059|NCT00297336|Topiramate|topiramate|mesh-list
138643060|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
138643061|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138643062|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643063|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
138643064|NCT00270023|Hematinics|hematinics|mesh-ancestor
138643065|NCT00297375|Acetaminophen|acetaminophen|mesh-list
138643067|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138643068|NCT00297375|Analgesics|analgesics|mesh-ancestor
138643069|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
138643070|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643071|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643072|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
138643073|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138643074|NCT00297375|Narcotics|narcotics|mesh-ancestor
138643075|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138643076|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
138643077|NCT00270062|Hematinics|hematinics|mesh-ancestor
138643078|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
138643079|NCT00270101|Hematinics|hematinics|mesh-ancestor
138643080|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
138643081|NCT00270140|Hematinics|hematinics|mesh-ancestor
138643082|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
138643083|NCT00270179|Hematinics|hematinics|mesh-ancestor
138643084|NCT00297570|Interferons|interferons|mesh-list
138643085|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
138643086|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643087|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
138643088|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138643089|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138643090|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643091|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376094|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643092|NCT00270335|Propofol|propofol|mesh-list
138643093|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138643094|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138376095|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138643096|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138643097|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
138643098|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
138319744|NCT04140318|Paclitaxel|paclitaxel|mesh-list
138643099|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138643100|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
138643101|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643102|NCT00270491|Paclitaxel|paclitaxel|mesh-list
138643103|NCT00270491|Capecitabine|capecitabine|mesh-list
138643104|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138643105|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201116|NCT04330300|Captopril|captopril|mesh-list
138201117|NCT04330300|Benazepril|benazepril|mesh-list
138201118|NCT04330300|Indapamide|indapamide|mesh-list
138234337|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
138643106|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
138643107|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
138643108|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
138643109|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643110|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138201119|NCT04330300|Nicardipine|nicardipine|mesh-list
138643112|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
138643113|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
138643114|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138643115|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
138643116|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138643117|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138643118|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138643119|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138643120|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643121|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643122|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138643124|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138643125|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
138643126|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643127|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138643128|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643129|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643131|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643132|NCT00297804|Paclitaxel|paclitaxel|mesh-list
138643133|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138643134|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643135|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
138643136|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
138643137|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
138643138|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643140|NCT00270647|Vitamin E|vitamin e|mesh-list
138643142|NCT00270647|Carotenoids|carotenoids|mesh-list
138643143|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
138643144|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643145|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
138643146|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643147|NCT00270647|Protective Agents|protective agents|mesh-ancestor
138643148|NCT00270647|Provitamins|provitamins|mesh-ancestor
138643149|NCT00297960|Olanzapine|olanzapine|mesh-list
138643150|NCT00297960|Ziprasidone|ziprasidone|mesh-list
138643151|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
138643152|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
138643153|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643154|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643155|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138643156|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138643157|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138643158|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138643159|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138643160|NCT00297960|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138643161|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138234660|NCT01387178|Bromides|bromides|mesh-list
138643162|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138643163|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643164|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643165|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
138643166|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138643167|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138643168|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
138643169|NCT00270881|Cytarabine|cytarabine|mesh-list
138643170|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
138643171|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138643172|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
138643173|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643174|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138643175|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138643176|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
138643177|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643178|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643179|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138643180|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138643183|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138643185|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138643186|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643187|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643188|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
138643189|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643190|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376153|NCT05418088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138376154|NCT05418088|Immunologic Factors|immunologic factors|mesh-ancestor
138643191|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138643192|NCT00418548|Etanercept|etanercept|mesh-list
138643193|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138643194|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138643196|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
138643197|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643198|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643199|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138643200|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138643201|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138643202|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138643203|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
138643204|NCT00418587|Vitamin D|vitamin d|mesh-list
138643205|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
138234915|NCT01414010|Amoxicillin|amoxicillin|mesh-list
138643206|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
138643207|NCT00418587|Vitamins|vitamins|mesh-list
138643208|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
138643209|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643210|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138643211|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138643212|NCT00416273|Bortezomib|bortezomib|mesh-list
138643213|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643214|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
138643215|NCT00306462|Nifedipine|nifedipine|mesh-list
138643216|NCT00306462|Analgesics|analgesics|mesh-ancestor
138643217|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
138643218|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643219|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643220|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
138643221|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138643222|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138643223|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
138643224|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138643225|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138643226|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643227|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138643228|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
138643229|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138643230|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
138643231|NCT00416390|Lycopene|lycopene|mesh-list
138643232|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138643233|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
138643234|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376177|NCT05371275|Palbociclib|palbociclib|mesh-list
138643235|NCT00416390|Protective Agents|protective agents|mesh-ancestor
138643236|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643237|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138643238|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138643240|NCT00416429|Interferons|interferons|mesh-list
138643241|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
138643242|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
138643243|NCT00416429|Aldesleukin|aldesleukin|mesh-list
138643244|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138643245|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
138643246|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643247|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
138643248|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138643249|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
138643250|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643251|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138643252|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138643253|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138643254|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138643255|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138643256|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
138643257|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138643258|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138643259|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138643260|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138643261|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138643262|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138643263|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
138643264|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138643265|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138643266|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138643267|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138643268|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643269|NCT00271271|Gemcitabine|gemcitabine|mesh-list
138643271|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
138643272|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138643273|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
138643274|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643275|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643276|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138643277|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
138235306|NCT04457219|Hemostatics|hemostatics|mesh-list
138643278|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
138643279|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
138643280|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
138643281|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643282|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
138376205|NCT05164159|Propofol|propofol|mesh-list
138643285|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643287|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138643288|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138643290|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643291|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643292|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138643293|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
138643294|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
138643295|NCT00271349|Hormones|hormones|mesh-ancestor
138643296|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138643297|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
138643298|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138643299|NCT00306696|Spironolactone|spironolactone|mesh-list
138643301|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138643302|NCT00306696|Diuretics|diuretics|mesh-ancestor
138235439|NCT01421186|Hormones|hormones|mesh-ancestor
138643304|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643305|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138643306|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138643307|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643308|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138643309|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
138643310|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138643311|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138643312|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138643313|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138643314|NCT00271427|Selenium|selenium|mesh-list
138643315|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
138453576|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643316|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643317|NCT00271427|Protective Agents|protective agents|mesh-ancestor
138643318|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138376234|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138643319|NCT00271427|Trace Elements|trace elements|mesh-ancestor
138643320|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
138643321|NCT00271466|Fentanyl|fentanyl|mesh-list
138643322|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138643323|NCT00271466|Narcotics|narcotics|mesh-ancestor
138643324|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138643325|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643326|NCT00271466|Analgesics|analgesics|mesh-ancestor
138643327|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
138201126|NCT04330300|Nitrendipine|nitrendipine|mesh-list
138201127|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
138643328|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643329|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138643330|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138643331|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
138643332|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
138643333|NCT00306735|Palonosetron|palonosetron|mesh-list
138643334|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
138643335|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
138643336|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643337|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643338|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138643339|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138643340|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138643341|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
138643342|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643343|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643344|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
138643345|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138643346|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
138643347|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138643348|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643349|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138643350|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138643351|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138643352|NCT00306774|Vitamin D|vitamin d|mesh-list
138643353|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
138643354|NCT00306774|Vitamins|vitamins|mesh-ancestor
138643355|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
138643356|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643357|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138643358|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138643359|NCT00306813|Lenalidomide|lenalidomide|mesh-list
138643360|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
138643361|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643362|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138643363|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138643364|NCT00306813|Growth Substances|growth substances|mesh-ancestor
138643365|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
138453577|NCT01886053|Ertapenem|ertapenem|mesh-list
138643366|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643367|NCT00271973|Oxycodone|oxycodone|mesh-list
138235669|NCT01427504|Etravirine|etravirine|mesh-list
138643368|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138643369|NCT00271973|Narcotics|narcotics|mesh-ancestor
138643370|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138643371|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643372|NCT00271973|Analgesics|analgesics|mesh-ancestor
138643373|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
138643374|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643375|NCT00306969|Bexarotene|bexarotene|mesh-list
138643376|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643377|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
138643378|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138643379|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643380|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138201136|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138201137|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138201138|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643381|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
138643382|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201139|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
138201141|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138643383|NCT00272051|Xaliproden|xaliproden|mesh-list
138643384|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138643385|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138643386|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
138643387|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643388|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643389|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643390|NCT00307203|Bupropion|bupropion|mesh-list
138643391|NCT00307203|Nicotine|nicotine|mesh-list
138643392|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138643393|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
138643394|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643395|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643396|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138643397|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138643398|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
138643399|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138235798|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643400|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376307|NCT04375202|Colchicine|colchicine|mesh-list
138643401|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138643402|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
138643403|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138643404|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138643405|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138643406|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138643407|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
138643408|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138643409|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138643410|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643411|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
138643412|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138643413|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643414|NCT00272207|Nabilone|nabilone|mesh-list
138643415|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
138643416|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
138643417|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643418|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643419|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138643420|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138643421|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138643422|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138643423|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138643424|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
138643425|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
138643426|NCT00307515|Coagulants|coagulants|mesh-ancestor
138643427|NCT00272285|Granisetron|granisetron|mesh-list
138643428|NCT00272285|Ramosetron|ramosetron|mesh-list
138643429|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
138643430|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
138643431|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138235919|NCT02425098|Vaccines|vaccines|mesh-list
138643432|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643433|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138643434|NCT00272285|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138643435|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138643436|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
138643437|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643438|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643439|NCT00272324|Aspirin|aspirin|mesh-list
138376339|NCT04322552|Protective Agents|protective agents|mesh-ancestor
138376341|NCT04234061|Tisagenlecleucel|tisagenlecleucel|mesh-list
138643441|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138643442|NCT00272324|Analgesics|analgesics|mesh-ancestor
138643443|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
138643444|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643445|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643446|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138643447|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138643448|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138643449|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138643450|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643451|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138643452|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138643455|NCT00307593|Infliximab|infliximab|mesh-list
138643456|NCT00307593|Rituximab|rituximab|mesh-list
138643457|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138643458|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138236036|NCT05447949|Anesthetics|anesthetics|mesh-ancestor
138643459|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
138643460|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643461|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138643462|NCT00307593|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138643463|NCT00307593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138643464|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
138643465|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138643468|NCT00307632|Estrogens|estrogens|mesh-ancestor
138643469|NCT00307632|Hormones|hormones|mesh-ancestor
138643470|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138643471|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643472|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138643473|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
138643474|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138201150|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
138201151|NCT04352855|Tazobactam|tazobactam|mesh-list
138201152|NCT04352855|Ceftolozane|ceftolozane|mesh-list
138201153|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
138201154|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138201155|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138643475|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138643476|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138643477|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138643478|NCT00272480|Lamivudine|lamivudine|mesh-list
138643479|NCT00272480|Zidovudine|zidovudine|mesh-list
138643480|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138376373|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138376375|NCT03558724|Bevacizumab|bevacizumab|mesh-list
138643482|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643483|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643484|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
138643485|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138643486|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138643487|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138643488|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
138643489|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
138643490|NCT00307671|Prednisone|prednisone|mesh-list
138643492|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138643493|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138643494|NCT00307671|Prednisolone|prednisolone|mesh-list
138643495|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
138643496|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
138643497|NCT00307671|Methotrexate|methotrexate|mesh-list
138643498|NCT00307671|Azathioprine|azathioprine|mesh-list
138643499|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138643500|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
138643502|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
138643503|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643504|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138643505|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138643506|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
138643507|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643508|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643509|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138643510|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138643511|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
138643513|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138643514|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138643515|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138643516|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
138643517|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138643518|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138643519|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
138643520|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
138643521|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376412|NCT03227731|Tenofovir|tenofovir|mesh-list
138643523|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138643524|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138643525|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138643526|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
138643527|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138643528|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138643529|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
138643530|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
138643531|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643532|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138643533|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138643534|NCT00307671|Protective Agents|protective agents|mesh-ancestor
138643535|NCT00272558|Carboplatin|carboplatin|mesh-list
138643536|NCT00272558|Vinorelbine|vinorelbine|mesh-list
138643537|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643538|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138643539|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
138643540|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
138643541|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
138643542|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643543|NCT00272597|Risperidone|risperidone|mesh-list
138643544|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138643545|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
138643546|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643547|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643548|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643549|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138643550|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138643551|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138643552|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138643553|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138643555|NCT00272636|Amiodarone|amiodarone|mesh-list
138643556|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138643557|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
138643558|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138643559|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138643560|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643562|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138453578|NCT01886053|beta-Lactams|beta-lactams|mesh-list
138643563|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138643564|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643565|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138643566|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138643567|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138376445|NCT02986334|Analgesics|analgesics|mesh-ancestor
138376446|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
138643570|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
138643571|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
138643572|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
138643573|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643574|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
138643575|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138643576|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138643577|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138643578|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
138643579|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
138643580|NCT00307827|Visilizumab|visilizumab|mesh-list
138643581|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
138643582|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643583|NCT00272753|Budesonide|budesonide|mesh-list
138643584|NCT00272753|Albuterol|albuterol|mesh-list
138643585|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
138643586|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138643587|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138643588|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
138643589|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643590|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643591|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138643592|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
138643594|NCT00272753|Hormones|hormones|mesh-ancestor
138643595|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138643596|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138643597|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138643598|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138643599|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
138643600|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643601|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643602|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
138643603|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138643604|NCT00272831|Cilostazol|cilostazol|mesh-list
138643605|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138643606|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
138643607|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643608|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643609|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138643610|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
138643612|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138201195|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
138201196|NCT01662050|Cytarabine|cytarabine|mesh-list
138201197|NCT01662050|Rituximab|rituximab|mesh-list
138201198|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138201199|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138201200|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201201|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
138201202|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643613|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643614|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138643615|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
138236765|NCT05451381|Anesthetics|anesthetics|mesh-ancestor
138643616|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138643617|NCT00272831|Protective Agents|protective agents|mesh-ancestor
138643618|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138643619|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138643620|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643621|NCT00416468|Valsartan|valsartan|mesh-list
138643622|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138643623|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138643624|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138643625|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643626|NCT00307944|Pantoprazole|pantoprazole|mesh-list
138643627|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138643628|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138643629|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138643630|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643631|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643632|NCT00416507|Gemcitabine|gemcitabine|mesh-list
138643633|NCT00416507|Fluorouracil|fluorouracil|mesh-list
138643634|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643635|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138643636|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
138643637|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643638|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138643640|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643641|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
138643642|NCT00282126|Diuretics|diuretics|mesh-ancestor
138643643|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
138643644|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643645|NCT00282126|Expectorants|expectorants|mesh-ancestor
138643646|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
138643647|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
138643648|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643649|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643650|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643651|NCT00272909|Piclozotan|piclozotan|mesh-list
138643652|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138643653|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138643654|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
138643655|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643656|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643657|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643658|NCT00282165|Naratriptan|naratriptan|mesh-list
138643659|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138643660|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138201203|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138201204|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138643661|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138643662|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
138643663|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138236944|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
138643664|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643665|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643666|NCT00272948|Defibrotide|defibrotide|mesh-list
138643667|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138643668|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138237003|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
138643669|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643670|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138643671|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138643673|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
138643675|NCT00273026|Xhance|xhance|mesh-list
138643676|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138643677|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138643678|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138643679|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
138643680|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643681|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643682|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138643683|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
138643684|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
138643685|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138643686|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138643687|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138643688|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138643689|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
138643690|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643691|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643692|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138643693|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643694|NCT00282360|Trimetazidine|trimetazidine|mesh-list
138643695|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
138643696|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
138643697|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138643699|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643700|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643701|NCT00418704|Docetaxel|docetaxel|mesh-list
138643702|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138643703|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643704|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
138643705|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
138643706|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
138643707|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643708|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138643709|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643711|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
138643712|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643714|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138643715|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138643716|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138643717|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138453579|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138643718|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643719|NCT00273299|Diuretics|diuretics|mesh-ancestor
138643720|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
138643721|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643722|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138643723|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138201228|NCT01620788|Indapamide|indapamide|mesh-list
138201229|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138201230|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138643725|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138643726|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138643727|NCT00418782|Analgesics|analgesics|mesh-ancestor
138643728|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
138237390|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643729|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643730|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643731|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138643732|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138643733|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
138643734|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138643735|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643736|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643737|NCT00273338|Calcitriol|calcitriol|mesh-list
138643738|NCT00273338|Docetaxel|docetaxel|mesh-list
138643739|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643740|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
138643741|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
138643742|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
138643743|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643744|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138643745|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643746|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138643747|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138643748|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138643749|NCT00273338|Vitamins|vitamins|mesh-ancestor
138643750|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
138376618|NCT01438567|Naloxone|naloxone|mesh-list
138376619|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138643751|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138643752|NCT00273377|Dexamethasone|dexamethasone|mesh-list
138237526|NCT06194734|Antimetabolites|antimetabolites|mesh-ancestor
138643753|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138643754|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
138643755|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
138643756|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643757|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643758|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138643759|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
138643760|NCT00273377|Hormones|hormones|mesh-ancestor
138643761|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138643762|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138643763|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643764|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
138643765|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
138643766|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138643767|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138643768|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643769|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643770|NCT00273416|Urological Agents|urological agents|mesh-ancestor
138643771|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138643772|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
138643773|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138643774|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138643775|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138643776|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138643777|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643778|NCT00273455|Timolol|timolol|mesh-list
138643779|NCT00273455|Bimatoprost|bimatoprost|mesh-list
138643780|NCT00273455|Dorzolamide|dorzolamide|mesh-list
138237590|NCT06191640|Ivacaftor|ivacaftor|mesh-list
138643781|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643782|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643783|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138643784|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138643785|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
138643786|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643787|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643788|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138643789|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138643790|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138643791|NCT00273533|Ramipril|ramipril|mesh-list
138643792|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138643793|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
138643794|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138376661|NCT01438736|Progestins|progestins|mesh-ancestor
138643796|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138643797|NCT00273611|Vitamin D|vitamin d|mesh-list
138643798|NCT00273611|Vitamins|vitamins|mesh-ancestor
138643799|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
138643800|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138237703|NCT06190483|Anesthetics|anesthetics|mesh-ancestor
138643801|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138643802|NCT00273689|Albuterol|albuterol|mesh-list
138643803|NCT00273689|Montelukast|montelukast|mesh-list
138643804|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138643805|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
138643806|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138643807|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
138643808|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138643809|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643810|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138643811|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138643812|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643813|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138643814|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
138643815|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643816|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
138643817|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138643818|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138643819|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138643820|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138643821|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
138643822|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643823|NCT00308334|Domperidone|domperidone|mesh-list
138643824|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
138643825|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
138643826|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643827|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643828|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138643829|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138643830|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
138643831|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643832|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643833|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
138643834|NCT00273767|Hematinics|hematinics|mesh-ancestor
138376690|NCT01438866|Protective Agents|protective agents|mesh-ancestor
138643835|NCT00314379|Vitamin E|vitamin e|mesh-list
138376694|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
138643836|NCT00314379|Vitamins|vitamins|mesh-ancestor
138643837|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
138643838|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643839|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
138643840|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643841|NCT00314379|Protective Agents|protective agents|mesh-ancestor
138643842|NCT00273884|Cytarabine|cytarabine|mesh-list
138201237|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138201238|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138201240|NCT03014843|Naloxone|naloxone|mesh-list
138643843|NCT00273884|Amonafide|amonafide|mesh-list
138201241|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
138201242|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
138201243|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138201244|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201245|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
138201247|NCT05081375|Enoxaparin|enoxaparin|mesh-list
138643844|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138643846|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643847|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643848|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
138643849|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138643850|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138643851|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
138643852|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643853|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643854|NCT00308373|Metformin|metformin|mesh-list
138643855|NCT00308373|Pioglitazone|pioglitazone|mesh-list
138643856|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
138643857|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138643858|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643860|NCT00273962|Ipratropium|ipratropium|mesh-list
138643861|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138643863|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643864|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643865|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138643866|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
138643867|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
138643868|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138643869|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138643870|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138643871|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138643872|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
138643873|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643874|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643875|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138643876|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
138643877|NCT00274001|Nevirapine|nevirapine|mesh-list
138643878|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138643879|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138643880|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643881|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643882|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
138643883|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138643884|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138643885|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138643886|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138643887|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138643888|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
138643889|NCT00274040|Ipratropium|ipratropium|mesh-list
138643890|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138643891|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
138643892|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643893|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643894|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138643895|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
138643896|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
138643897|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138643898|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
138643899|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643900|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643901|NCT00314457|Bupivacaine|bupivacaine|mesh-list
138643902|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
138643903|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
138643904|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138643905|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643906|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
138643907|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643908|NCT00308451|Chromium|chromium|mesh-list
138643909|NCT00308451|Biotin|biotin|mesh-list
138643910|NCT00308451|Picolinic acid|picolinic acid|mesh-list
138643911|NCT00308451|Trace Elements|trace elements|mesh-ancestor
138643912|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
138643913|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643914|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
138643915|NCT00308451|Vitamins|vitamins|mesh-ancestor
138643916|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138643917|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
138643918|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
138643921|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138643922|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
138643923|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138643924|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643925|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138643926|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
138643927|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
138643928|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138643929|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
138643930|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138643931|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643932|NCT00274118|Telmisartan|telmisartan|mesh-list
138643933|NCT00274118|Enalapril|enalapril|mesh-list
138643934|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138238256|NCT06026852|Tazobactam|tazobactam|mesh-list
138643935|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138643936|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138643937|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643938|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138643939|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
138643940|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643941|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138643942|NCT00308490|Hematinics|hematinics|mesh-ancestor
138643943|NCT00416585|Isotretinoin|isotretinoin|mesh-list
138643944|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
138643945|NCT00308529|Bevacizumab|bevacizumab|mesh-list
138643946|NCT00308529|Carboplatin|carboplatin|mesh-list
138643947|NCT00308529|Irinotecan|irinotecan|mesh-list
138643948|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138643949|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643950|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138643951|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138643952|NCT00308529|Growth Substances|growth substances|mesh-ancestor
138643953|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643954|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
138643955|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138643956|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138643957|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643958|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138376792|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138643960|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
138643961|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138643962|NCT00274235|Mefloquine|mefloquine|mesh-list
138643963|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
138643964|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138643965|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138643966|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138643967|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138643968|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138643969|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643970|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138643972|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138643973|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
138643974|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
138643975|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138643976|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643977|NCT00308607|Interferons|interferons|mesh-list
138643978|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
138643979|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
138643980|NCT00308607|Bevacizumab|bevacizumab|mesh-list
138643981|NCT00308607|Dacarbazine|dacarbazine|mesh-list
138643982|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138643983|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138643984|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138643985|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138643986|NCT00308607|Growth Substances|growth substances|mesh-ancestor
138643987|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138643988|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
138643989|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
138643990|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138643991|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
138643992|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138643993|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
138643994|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138643995|NCT00314613|Risperidone|risperidone|mesh-list
138643996|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
138643997|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138643998|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
138643999|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644000|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644001|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644002|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138376833|NCT01440127|Metformin|metformin|mesh-list
138644003|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138644004|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138644005|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138644007|NCT00274352|Adalimumab|adalimumab|mesh-list
138320641|NCT00004092|Thiotepa|thiotepa|mesh-list
138644009|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138644010|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138644012|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138644013|NCT00314652|Narcotics|narcotics|mesh-ancestor
138644014|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138644015|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644016|NCT00314652|Analgesics|analgesics|mesh-ancestor
138644017|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
138644018|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644019|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138644020|NCT00274391|Amiloride|amiloride|mesh-list
138644021|NCT00274391|Diuretics|diuretics|mesh-ancestor
138644022|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
138644023|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644024|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
138644025|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138644026|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138644027|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644028|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
138644029|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138644031|NCT00274430|Tadalafil|tadalafil|mesh-list
138644032|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138644033|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
138644034|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
138644035|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644036|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644037|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138644039|NCT00274430|Hormones|hormones|mesh-ancestor
138644040|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138644041|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138644042|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644043|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
138644044|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138644045|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138644046|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644047|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644048|NCT00274430|Urological Agents|urological agents|mesh-ancestor
138644049|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
138644050|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138644051|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
138644052|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644053|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644054|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138644055|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
138644056|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
138644057|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138644058|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
138644059|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644060|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644061|NCT00308763|Bupropion|bupropion|mesh-list
138644062|NCT00308763|Nicotine|nicotine|mesh-list
138644063|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138644064|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
138644065|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644066|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644067|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138644068|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138644069|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
138644070|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644071|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644072|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138644073|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
138644074|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138644075|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138644076|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138644077|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138644078|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
138376898|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
138644080|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138644081|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644082|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
138644083|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138644085|NCT00274820|Thalidomide|thalidomide|mesh-list
138644086|NCT00274820|Dexamethasone|dexamethasone|mesh-list
138644087|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
138644088|NCT00274820|Vitamins|vitamins|mesh-ancestor
138644089|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
138644090|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644091|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138644093|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
138644094|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644095|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138644096|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
138644097|NCT00274820|Hormones|hormones|mesh-ancestor
138644098|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138644099|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138644100|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644101|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
138644102|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644103|NCT00274820|Protective Agents|protective agents|mesh-ancestor
138644104|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138644105|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
138644106|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
138644107|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138644108|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644109|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138644110|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138644111|NCT00274820|Growth Substances|growth substances|mesh-ancestor
138644112|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
138644113|NCT00308841|Lidocaine|lidocaine|mesh-list
138644114|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
138644115|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
138644116|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138201251|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201253|NCT04755062|Trace Elements|trace elements|mesh-list
138644117|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644118|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
138644119|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644120|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138644121|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138644122|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138644123|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138644124|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644125|NCT00274859|Gemcitabine|gemcitabine|mesh-list
138644126|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
138644127|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138644128|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
138644129|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238746|NCT05699473|Vitamin B Complex|vitamin b complex|mesh-ancestor
138376928|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644133|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644135|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
138644136|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
138644137|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644138|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138644139|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138644140|NCT00274898|Analgesics|analgesics|mesh-ancestor
138644141|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
138644142|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644143|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644144|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138644145|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138644146|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138644147|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138644148|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644149|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
138644150|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138644151|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138644152|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138320796|NCT06125483|Immunologic Factors|immunologic factors|mesh-ancestor
138644153|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
138644155|NCT00277199|Abatacept|abatacept|mesh-list
138644156|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138644157|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138238993|NCT05583474|Sympatholytics|sympatholytics|mesh-ancestor
138644158|NCT00277199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138644160|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138644161|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
138644162|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644163|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138644164|NCT00277472|Valsartan|valsartan|mesh-list
138644165|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138644166|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138376958|NCT01440933|Analgesics|analgesics|mesh-ancestor
138644168|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138644169|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644170|NCT00277472|Diuretics|diuretics|mesh-ancestor
138644171|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
138644172|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644173|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138644174|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138644175|NCT00277511|Levofloxacin|levofloxacin|mesh-list
138644176|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138644177|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644178|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138644179|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138644180|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138644182|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644183|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644184|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138644185|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138644186|NCT00315003|Azithromycin|azithromycin|mesh-list
138644187|NCT00315003|Telithromycin|telithromycin|mesh-list
138644188|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138644189|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644191|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138644192|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
138644193|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644194|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644195|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644196|NCT00277589|Iodine|iodine|mesh-list
138644197|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138644198|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644199|NCT00277589|Trace Elements|trace elements|mesh-ancestor
138644200|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
138644201|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644202|NCT00315042|Penicillins|penicillins|mesh-list
138644203|NCT00315042|Telithromycin|telithromycin|mesh-list
138644204|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138644205|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644206|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138644207|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
138644208|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138644210|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138644212|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644213|NCT00315081|Bromocriptine|bromocriptine|mesh-list
138644214|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138644215|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138644216|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
138644217|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138644218|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644219|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
138644220|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
138644221|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644222|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644223|NCT00277706|Vitamin D|vitamin d|mesh-list
138644226|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
138644227|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644228|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138644229|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138644230|NCT00277862|Ribavirin|ribavirin|mesh-list
138644231|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
138644232|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
138644233|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138644234|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138644235|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
138644236|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644237|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
138644238|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644239|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
138644240|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644241|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644242|NCT00278018|Immunomodulating Agents|immunomodulating agents|mesh-list
138644243|NCT00278018|Immunologic Factors|immunologic factors|mesh-ancestor
138644244|NCT00278018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644245|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
138644246|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138644247|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644248|NCT00315276|Modafinil|modafinil|mesh-list
138644249|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138644250|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644251|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138644252|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138644253|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138644254|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644255|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
138644256|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138644257|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644258|NCT00278174|Interferons|interferons|mesh-list
138644259|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
138644260|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
138644261|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644262|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
138644263|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644265|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644266|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
138644267|NCT00278213|Fludarabine|fludarabine|mesh-list
138644268|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
138644269|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
138644270|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
138644271|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138644272|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
138644273|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644274|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138644275|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138644276|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
138644277|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644278|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644279|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138644280|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138644281|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
138644282|NCT00278213|Analgesics|analgesics|mesh-ancestor
138644283|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
138644284|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644285|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138644287|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644288|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138644289|NCT00278252|Etoposide|etoposide|mesh-list
138644290|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138644291|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644292|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138644293|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138644294|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138239543|NCT05100017|Oxybutynin|oxybutynin|mesh-list
138644295|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644296|NCT00315432|Interferons|interferons|mesh-list
138644297|NCT00315432|Ribavirin|ribavirin|mesh-list
138644298|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644299|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
138644300|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644301|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
138644302|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644303|NCT00278330|Vorinostat|vorinostat|mesh-list
138644305|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644306|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138644307|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644308|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644309|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
138644310|NCT00278330|Growth Substances|growth substances|mesh-ancestor
138644311|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644312|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138377044|NCT01441388|Bevacizumab|bevacizumab|mesh-list
138644313|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138644314|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138644315|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138644316|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
138644317|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644318|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138644319|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138644320|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644322|NCT00278369|Interleukin-2|interleukin-2|mesh-list
138644323|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
138644324|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644325|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138644326|NCT00278369|Analgesics|analgesics|mesh-ancestor
138644327|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
138201272|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201273|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
138644328|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644329|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644330|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138644331|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138644332|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
138239673|NCT04963296|Hormones|hormones|mesh-ancestor
138644333|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644335|NCT00315549|Telithromycin|telithromycin|mesh-list
138644336|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138644337|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644338|NCT00278408|Prednisone|prednisone|mesh-list
138644339|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
138644340|NCT00278408|Rituximab|rituximab|mesh-list
138644341|NCT00278408|Doxorubicin|doxorubicin|mesh-list
138644342|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138644343|NCT00278408|Vincristine|vincristine|mesh-list
138644344|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138644345|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
138644346|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644347|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138644348|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138644349|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
138644350|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644351|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644352|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138644353|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138644354|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138644355|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138644356|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138644357|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644358|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138644359|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
138377063|NCT01441505|Midazolam|midazolam|mesh-list
138644360|NCT00278408|Hormones|hormones|mesh-ancestor
138644361|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138644362|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138377064|NCT01441505|Ketamine|ketamine|mesh-list
138644363|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138644365|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
138644366|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
138644367|NCT00315666|Memantine|memantine|mesh-list
138644368|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138644369|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138644370|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
138644371|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644372|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644373|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644374|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138644375|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138644376|NCT00315744|Fluticasone|fluticasone|mesh-list
138644377|NCT00315744|Xhance|xhance|mesh-list
138644378|NCT00315744|Albuterol|albuterol|mesh-list
138321033|NCT06123715|Vitamins|vitamins|mesh-ancestor
138644379|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138644380|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138644381|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138644382|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
138644383|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644384|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644385|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138201280|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644386|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
138644387|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
138201281|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201282|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138201283|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138201284|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
138644388|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138644389|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138644390|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138239893|NCT04653246|Hormones|hormones|mesh-ancestor
138644391|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138644392|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
138644393|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644394|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644395|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
138644396|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138644398|NCT00309543|Fluorouracil|fluorouracil|mesh-list
138644399|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
138644400|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644401|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138644402|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644403|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138644404|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
138644405|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644406|NCT00309543|Antidotes|antidotes|mesh-ancestor
138644407|NCT00309543|Protective Agents|protective agents|mesh-ancestor
138644408|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
138644409|NCT00309543|Vitamins|vitamins|mesh-ancestor
138644410|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
138644414|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644415|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644416|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138644417|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138644418|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138644419|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138644420|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
138644421|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138644423|NCT00315900|Valproic Acid|valproic acid|mesh-list
138644424|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138644425|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
138644426|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138644427|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138644428|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138644429|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138644430|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644431|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
138644432|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644433|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644434|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
138644435|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644436|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
138644437|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
138644438|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
138644439|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644440|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138644441|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138644442|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
138644443|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138644444|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138644445|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138644446|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138644447|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644448|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138644449|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138644450|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
138644451|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644452|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644453|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138644454|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138644455|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
138644456|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
138644457|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
138644458|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138644459|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138644460|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644461|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644462|NCT00309816|Urological Agents|urological agents|mesh-ancestor
138644464|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
138644466|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
138644467|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644468|NCT00316095|Telmisartan|telmisartan|mesh-list
138644469|NCT00316095|Simvastatin|simvastatin|mesh-list
138644470|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138644471|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138644472|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
138644473|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644474|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138644475|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138644476|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644477|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138644478|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138644479|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138644480|NCT00279344|Fentanyl|fentanyl|mesh-list
138644481|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138644482|NCT00279344|Narcotics|narcotics|mesh-ancestor
138644483|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138644484|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138240364|NCT04094298|FX006|fx006|mesh-list
138644486|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
138644487|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644488|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138644489|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138644490|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
138644491|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
138644492|NCT00418860|Aspirin|aspirin|mesh-list
138644493|NCT00418860|Clopidogrel|clopidogrel|mesh-list
138240404|NCT04045431|Hylan|hylan|mesh-list
138644494|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138644495|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138644496|NCT00418860|Analgesics|analgesics|mesh-ancestor
138644497|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
138644498|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644499|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644500|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138644501|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138644502|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138644503|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138644504|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644505|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138644506|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138644507|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644508|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
138644509|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138377138|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
138644511|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138240471|NCT03944772|Etoposide|etoposide|mesh-list
138644512|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
138644513|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644514|NCT00316212|INS 50589|ins 50589|mesh-list
138644515|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138644516|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138644517|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
138644518|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644519|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644520|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644521|NCT00309855|Anastrozole|anastrozole|mesh-list
138644522|NCT00309855|Testosterone|testosterone|mesh-list
138644523|NCT00309855|Dutasteride|dutasteride|mesh-list
138644524|NCT00309855|Androgens|androgens|mesh-ancestor
138644525|NCT00309855|Hormones|hormones|mesh-ancestor
138644526|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138644527|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644528|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138644529|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644530|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138644531|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138644532|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644533|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644534|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
138644535|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138644536|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138644537|NCT00279383|Thrombin|thrombin|mesh-list
138644538|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
138644539|NCT00279383|Coagulants|coagulants|mesh-ancestor
138644540|NCT00279422|Visilizumab|visilizumab|mesh-list
138644541|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
138644542|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644543|NCT00309894|Ketoconazole|ketoconazole|mesh-list
138644544|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
138644545|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
138644546|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
138644547|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
138644548|NCT00309894|Sargramostim|sargramostim|mesh-list
138644549|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138644550|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
138644551|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644552|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
138644553|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138240653|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644554|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138644555|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138644557|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644558|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138644559|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
138644560|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138644562|NCT00279461|Vitamin D|vitamin d|mesh-list
138644563|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
138644564|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
138644565|NCT00279461|Vitamins|vitamins|mesh-list
138644566|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
138644567|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644568|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138453580|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644569|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138644570|NCT00316329|Artesunate|artesunate|mesh-list
138644571|NCT00316329|Amodiaquine|amodiaquine|mesh-list
138644572|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
138644573|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138644574|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138644575|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644576|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644577|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
138644578|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
138644579|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138644580|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
138644582|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
138644583|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
138644584|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138240758|NCT03492177|Selexipag|selexipag|mesh-list
138644585|NCT00279539|Growth Substances|growth substances|mesh-ancestor
138644586|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644588|NCT00279578|Factor VIII|factor viii|mesh-list
138644589|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138644590|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138644591|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644593|NCT00279578|Coagulants|coagulants|mesh-ancestor
138644595|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
138644596|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
138644597|NCT00310011|Paclitaxel|paclitaxel|mesh-list
138644598|NCT00310011|Gemcitabine|gemcitabine|mesh-list
138644599|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138644600|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644601|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
138644602|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
138321247|NCT05895266|Midazolam|midazolam|mesh-list
138644603|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
138644604|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644605|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138201291|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
138644606|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
138644608|NCT00316407|Carboplatin|carboplatin|mesh-list
138644609|NCT00316407|Lapatinib|lapatinib|mesh-list
138377194|NCT01442428|Naproxen|naproxen|mesh-list
138644610|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138644611|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644612|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
138644613|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
138644615|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644616|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138644617|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644619|NCT00310089|Docetaxel|docetaxel|mesh-list
138644620|NCT00310089|Doxorubicin|doxorubicin|mesh-list
138644621|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138644622|NCT00310089|Cediranib|cediranib|mesh-list
138644623|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138644624|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
138644625|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138241023|NCT03055221|Treprostinil|treprostinil|mesh-list
138644626|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138644627|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138644628|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
138644629|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644630|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644631|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138644632|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
138644633|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
138644634|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
138644635|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138644636|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138644637|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138644638|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644639|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138644640|NCT00279734|Abatacept|abatacept|mesh-list
138644641|NCT00279734|Vaccines|vaccines|mesh-list
138644642|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
138644643|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644644|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138644645|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644646|NCT00279734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138644647|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644648|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138644649|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138644651|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
138644652|NCT00310128|Rituximab|rituximab|mesh-list
138644653|NCT00310128|Etoposide|etoposide|mesh-list
138644654|NCT00310128|Antibodies|antibodies|mesh-list
138644655|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
138644656|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138644657|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
138644658|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644660|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644661|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138644662|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138644663|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138644664|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138644665|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644666|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644667|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138644668|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
138201292|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644669|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
138201293|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201295|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
138201296|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138644670|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201297|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138644671|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138644672|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138644673|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
138241291|NCT02094794|Etoposide|etoposide|mesh-list
138644674|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
138644675|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644676|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138644677|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
138644678|NCT00310128|Hormones|hormones|mesh-ancestor
138644679|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138644680|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138644681|NCT00310128|Protective Agents|protective agents|mesh-ancestor
138644682|NCT00316563|Dronabinol|dronabinol|mesh-list
138644683|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
138644684|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644685|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138644686|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138644687|NCT00316563|Analgesics|analgesics|mesh-ancestor
138644688|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
138644689|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644690|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138644691|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138644692|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644693|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644695|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138644696|NCT00416819|Leucovorin|leucovorin|mesh-list
138644697|NCT00416819|Cytarabine|cytarabine|mesh-list
138644698|NCT00416819|Rituximab|rituximab|mesh-list
138644699|NCT00416819|Methotrexate|methotrexate|mesh-list
138644700|NCT00416819|Etoposide|etoposide|mesh-list
138644701|NCT00416819|Temozolomide|temozolomide|mesh-list
138644702|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
138644703|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
138644704|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138644705|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644706|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
138644707|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644708|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138644709|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138644710|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
138644711|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138644712|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138644713|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
138644714|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644715|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
138644716|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644717|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138644718|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138644719|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138241545|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
138644720|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138644721|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138644722|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138644723|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
138644724|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644725|NCT00416819|Antidotes|antidotes|mesh-ancestor
138644726|NCT00416819|Protective Agents|protective agents|mesh-ancestor
138644727|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
138644729|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
138644730|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138644731|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
138644732|NCT00310206|Vaccines|vaccines|mesh-list
138201301|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138201302|NCT00866840|Protective Agents|protective agents|mesh-ancestor
138644733|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
138644734|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644735|NCT00280007|Bevacizumab|bevacizumab|mesh-list
138644736|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138644737|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644738|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138453581|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
138644739|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138644740|NCT00280007|Growth Substances|growth substances|mesh-ancestor
138644741|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644742|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
138644743|NCT00316680|Vaccines|vaccines|mesh-list
138644744|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
138377274|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138644745|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644746|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
138644747|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
138644748|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138644749|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644750|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
138644751|NCT00310323|Caffeine|caffeine|mesh-list
138644752|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138644753|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644754|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138644755|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138321387|NCT05391828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644756|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644757|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138644758|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138644759|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
138644760|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644761|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
138644762|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
138644763|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138644764|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138644766|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138644767|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644768|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138644769|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644770|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138644771|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
138644772|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
138644773|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644774|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644775|NCT00316758|Metformin|metformin|mesh-list
138644776|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138241736|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
138644777|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644778|NCT00280358|Fluticasone|fluticasone|mesh-list
138644780|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
138644781|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138644782|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138644783|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
138644784|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644785|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644786|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138644787|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
138377309|NCT01442909|Docetaxel|docetaxel|mesh-list
138644788|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
138644789|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138644790|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138644791|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138644792|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138644793|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
138644794|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644795|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138241780|NCT01576874|Oxytocin|oxytocin|mesh-list
138644797|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644798|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138644799|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138644800|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644801|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644802|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
138644803|NCT00280436|Casopitant|casopitant|mesh-list
138644804|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
138644805|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
138241835|NCT01578278|Fluticasone|fluticasone|mesh-list
138644806|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644807|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644808|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138644809|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138644810|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644811|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644812|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
138644813|NCT00280514|Cefpirome|cefpirome|mesh-list
138644814|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138644815|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644816|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138644817|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138644818|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644819|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644820|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644821|NCT00280553|Bupivacaine|bupivacaine|mesh-list
138644822|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
138644823|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
138644824|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138644825|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644826|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
138644827|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644828|NCT00316875|Doxorubicin|doxorubicin|mesh-list
138644829|NCT00316875|Lapatinib|lapatinib|mesh-list
138377348|NCT01442974|Paclitaxel|paclitaxel|mesh-list
138644830|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138644831|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138321469|NCT05171179|Lidocaine|lidocaine|mesh-list
138644832|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138644833|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138644835|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644836|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138644837|NCT00316953|Dasatinib|dasatinib|mesh-list
138644838|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644839|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138644840|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644841|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644842|NCT00419172|Rifampin|rifampin|mesh-list
138644843|NCT00419172|Deferasirox|deferasirox|mesh-list
138644844|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138644845|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
138644846|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138644847|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644848|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
138644849|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138644850|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644851|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644853|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138644854|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138644855|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138644856|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138644857|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138644858|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138644859|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
138644860|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
138644861|NCT00280787|Paclitaxel|paclitaxel|mesh-list
138644862|NCT00280787|Carboplatin|carboplatin|mesh-list
138644863|NCT00280787|Irinotecan|irinotecan|mesh-list
138644864|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138644865|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644866|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
138644867|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
138644868|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
138644869|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138242210|NCT02914119|Rocuronium|rocuronium|mesh-list
138644870|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138644871|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138644872|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644873|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
138644874|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
138644875|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138644876|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138644877|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138644878|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138377374|NCT01443065|Fluorouracil|fluorouracil|mesh-list
138377375|NCT01443065|Rilotumumab|rilotumumab|mesh-list
138377376|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
138644879|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377405|NCT01443117|Vaccines|vaccines|mesh-list
138644880|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644881|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644882|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138644883|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
138644884|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138644885|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644886|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138644887|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138644888|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138644890|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138644891|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644893|NCT00317031|Acamprosate|acamprosate|mesh-list
138644894|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138644895|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138242321|NCT00551291|Hormones|hormones|mesh-ancestor
138644896|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644897|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
138644898|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644899|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
138644900|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138644901|NCT00317070|Protective Agents|protective agents|mesh-ancestor
138644902|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644903|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138644904|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
138321540|NCT04827966|Listerine|listerine|mesh-list
138644905|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644906|NCT00281255|Allopurinol|allopurinol|mesh-list
138644908|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
138644909|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644910|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644911|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
138644912|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138644913|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138644914|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
138644915|NCT00281255|Protective Agents|protective agents|mesh-ancestor
138644916|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644917|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138644918|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
138644919|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
138644920|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644921|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138644923|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138644924|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
138644925|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644927|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
138644928|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644929|NCT00310908|Tramadol|tramadol|mesh-list
138644930|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138644931|NCT00310908|Narcotics|narcotics|mesh-ancestor
138644932|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138644933|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644934|NCT00310908|Analgesics|analgesics|mesh-ancestor
138644935|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
138644936|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644937|NCT00281489|Anesthetics|anesthetics|mesh-list
138644938|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138644939|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644940|NCT00317343|Anticoagulants|anticoagulants|mesh-list
138644941|NCT00317343|Bivalirudin|bivalirudin|mesh-list
138644942|NCT00317343|Thrombin|thrombin|mesh-list
138644943|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
138644944|NCT00317343|Coagulants|coagulants|mesh-ancestor
138644945|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
138644946|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138644947|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
138644948|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644949|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644950|NCT00416858|Fluorouracil|fluorouracil|mesh-list
138644951|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138644952|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
138644953|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644954|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138644955|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138644956|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
138644957|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644959|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138644960|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
138644961|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
138644962|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138644963|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644964|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138644965|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
138644966|NCT00416897|Hormones|hormones|mesh-ancestor
138377431|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138644967|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138644968|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138644969|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242637|NCT02920749|Propofol|propofol|mesh-list
138644971|NCT00417014|Vinblastine|vinblastine|mesh-list
138644972|NCT00417014|Procarbazine|procarbazine|mesh-list
138644973|NCT00417014|Chlorambucil|chlorambucil|mesh-list
138644974|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138644975|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
138644976|NCT00417014|Hormones|hormones|mesh-ancestor
138644977|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138321629|NCT04579523|Antibodies|antibodies|mesh-list
138644978|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138644979|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138644980|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138242686|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138644981|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138644982|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
138644983|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
138644984|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
138644985|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644986|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138644987|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
138644988|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
138644989|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138644990|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
138644991|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138644992|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138644993|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138644994|NCT00317421|Urological Agents|urological agents|mesh-ancestor
138644997|NCT00417053|Busulfan|busulfan|mesh-list
138644998|NCT00417053|Carboplatin|carboplatin|mesh-list
138645000|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138201314|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201315|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201318|NCT01058993|Plerixafor|plerixafor|mesh-list
138645001|NCT00417053|Etoposide|etoposide|mesh-list
138645002|NCT00417053|Vincristine|vincristine|mesh-list
138645003|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
138645004|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138645005|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
138645006|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645007|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138645008|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138645009|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
138645010|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645011|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645012|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138645013|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138377463|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138645015|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138645016|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645017|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138645018|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
138645019|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
138645020|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
138645021|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
138645022|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138645023|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
138645024|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645025|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645026|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138645027|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
138645028|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
138645029|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138645030|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
138645031|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645032|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645033|NCT00317499|Etanercept|etanercept|mesh-list
138645034|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138645035|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138645036|NCT00317499|Analgesics|analgesics|mesh-ancestor
138645037|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
138645038|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645039|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645040|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138645041|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138645042|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138645044|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
138645045|NCT00281606|Ritonavir|ritonavir|mesh-list
138645046|NCT00281606|Lopinavir|lopinavir|mesh-list
138645047|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138645048|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138645049|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
138645050|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645051|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645052|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138645053|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138645054|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
138645055|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645056|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138645057|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138645058|NCT00317538|Infliximab|infliximab|mesh-list
138201323|NCT04652518|Pirfenidone|pirfenidone|mesh-list
138645059|NCT00317538|Etanercept|etanercept|mesh-list
138645060|NCT00317538|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138645061|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138645062|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
138645063|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138645064|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138377493|NCT01443624|Hematinics|hematinics|mesh-ancestor
138645066|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138645067|NCT00317538|Analgesics|analgesics|mesh-ancestor
138645068|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
138645069|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645070|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645071|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138645072|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
138645073|NCT00281645|Analgesics|analgesics|mesh-list
138645074|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
138645075|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645076|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645077|NCT00317577|Timolol|timolol|mesh-list
138645078|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
138645079|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138645080|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138645081|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
138645082|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645083|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645084|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645085|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138645086|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138645087|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138645088|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138645089|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138645090|NCT00317655|Ibuprofen|ibuprofen|mesh-list
138645091|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138645092|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138645093|NCT00317655|Analgesics|analgesics|mesh-ancestor
138645094|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
138243240|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
138645096|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645097|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138645098|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138645099|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138645100|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645101|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645102|NCT00281996|Gemcitabine|gemcitabine|mesh-list
138645103|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
138645104|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138645105|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
138645106|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645107|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645108|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138645109|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201338|NCT04650490|Immunomodulating Agents|immunomodulating agents|mesh-list
138201339|NCT04650490|Immunologic Factors|immunologic factors|mesh-ancestor
138201340|NCT04650490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201342|NCT03014687|Cefdinir|cefdinir|mesh-list
138645110|NCT00311259|Melatonin|melatonin|mesh-list
138201343|NCT03014687|Cephalosporins|cephalosporins|mesh-list
138201344|NCT03014687|Trimethoprim|trimethoprim|mesh-list
138201345|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
138201346|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201347|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138201348|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
138201349|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138645111|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
138645112|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645113|NCT00311259|Protective Agents|protective agents|mesh-ancestor
138645114|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645115|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138645116|NCT00317733|Ketoprofen|ketoprofen|mesh-list
138645117|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138645118|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138645119|NCT00317733|Analgesics|analgesics|mesh-ancestor
138645121|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645122|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645123|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138645124|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138645125|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138645126|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645127|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645128|NCT00311337|Bortezomib|bortezomib|mesh-list
138321761|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
138645129|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645132|NCT00317811|Melphalan|melphalan|mesh-list
138645133|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645134|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138645135|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
138645136|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645137|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138243500|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138645138|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138645139|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
138645140|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645141|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
138645142|NCT00317811|Protective Agents|protective agents|mesh-ancestor
138645143|NCT00317811|Vitamins|vitamins|mesh-ancestor
138645144|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
138645145|NCT00282386|Rofecoxib|rofecoxib|mesh-list
138645146|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645147|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645148|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645149|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138645150|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138645151|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645152|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138645153|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138645154|NCT00282386|Analgesics|analgesics|mesh-ancestor
138645155|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
138645156|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138645157|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138645158|NCT00317850|Gabapentin|gabapentin|mesh-list
138645159|NCT00317850|Analgesics|analgesics|mesh-ancestor
138645160|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
138645161|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645162|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645163|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
138645164|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138645165|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138645166|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138645167|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138645168|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138645169|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138645170|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645171|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645172|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
138645173|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
138645174|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138645175|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138645176|NCT00282503|Prednisolone|prednisolone|mesh-list
138645177|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
138645178|NCT00282503|Methoxsalen|methoxsalen|mesh-list
138645179|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138645180|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
138645181|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138645182|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
138645183|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
138645184|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645185|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645186|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138645187|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
138645188|NCT00282503|Hormones|hormones|mesh-ancestor
138243681|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
138645189|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138645190|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138645191|NCT00282503|Protective Agents|protective agents|mesh-ancestor
138645192|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138645193|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645194|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138645195|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
138645196|NCT00317928|Metformin|metformin|mesh-list
138645197|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138645198|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645199|NCT00282698|Insulin|insulin|mesh-list
138645200|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138645201|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138321834|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
138645203|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138645204|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138645205|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
138645206|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645207|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138645208|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138645209|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645211|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138645213|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138645214|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645215|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645216|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138645217|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138645218|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138645219|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
138645220|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645221|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645222|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645223|NCT00282932|Urological Agents|urological agents|mesh-ancestor
138645224|NCT00318162|Naltrexone|naltrexone|mesh-list
138645225|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138645226|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138645227|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645228|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
138645229|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645230|NCT00283088|Plasminogen|plasminogen|mesh-list
138645231|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138645233|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138645234|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645235|NCT00318201|Erythromycin|erythromycin|mesh-list
138645236|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
138645237|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138645238|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
138645239|NCT00318201|Diltiazem|diltiazem|mesh-list
138645240|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138645241|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138645242|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138645243|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645244|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138645245|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645246|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
138645247|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138645248|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645249|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138201355|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138201356|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138645250|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138645251|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645252|NCT00311688|Interleukin-2|interleukin-2|mesh-list
138645253|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645254|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138645256|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
138645257|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645258|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645259|NCT00283478|Gemcitabine|gemcitabine|mesh-list
138645260|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138377597|NCT01444547|Paclitaxel|paclitaxel|mesh-list
138645262|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645264|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138645265|NCT00318318|Estrogens|estrogens|mesh-ancestor
138645266|NCT00318318|Hormones|hormones|mesh-ancestor
138645267|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138645268|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645269|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
138645270|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138243908|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
138645271|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138645272|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645273|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138645274|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
138645275|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
138645276|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138321917|NCT03710343|Metformin|metformin|mesh-list
138645277|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138645278|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645279|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645280|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645281|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138645283|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138645284|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138645285|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645286|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645287|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645288|NCT00283634|Bortezomib|bortezomib|mesh-list
138645289|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138645290|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645291|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138645292|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645293|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645294|NCT00318513|Bevacizumab|bevacizumab|mesh-list
138645295|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138645296|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645297|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138645298|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138645299|NCT00318513|Growth Substances|growth substances|mesh-ancestor
138645300|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645301|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
138645302|NCT00318552|Meropenem|meropenem|mesh-list
138645304|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645305|NCT00283751|Insulin|insulin|mesh-list
138645306|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138645307|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
138645308|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
138645309|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138645310|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645311|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
138645312|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138645313|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645315|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138645316|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138645317|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138201363|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201364|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
138645318|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645319|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138645320|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
138645321|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
138645322|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645323|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645324|NCT00318669|Paroxetine|paroxetine|mesh-list
138645325|NCT00318669|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138645326|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138645327|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138645328|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645329|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645330|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
138244206|NCT01637090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138645331|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645332|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138645333|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
138645334|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138645335|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138645336|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138645337|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645338|NCT00283829|Docetaxel|docetaxel|mesh-list
138244284|NCT01602068|Hormones|hormones|mesh-ancestor
138645339|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645340|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
138645341|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
138645342|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
138645343|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645344|NCT00311961|Prednisolone|prednisolone|mesh-list
138645345|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138645346|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
138645349|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138645350|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
138645351|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138645353|NCT00311961|Hormones|hormones|mesh-ancestor
138645354|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138645355|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645356|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138645357|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645360|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645362|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138645363|NCT00311961|Protective Agents|protective agents|mesh-ancestor
138645364|NCT00283946|Zolpidem|zolpidem|mesh-list
138645365|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138645366|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138645367|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138645368|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645369|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138645370|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
138645371|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
138645373|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645374|NCT00312000|Capecitabine|capecitabine|mesh-list
138645375|NCT00312000|Irinotecan|irinotecan|mesh-list
138645376|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138645377|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
138645378|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645379|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645380|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138645381|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138645382|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645383|NCT00283985|Dexamethasone|dexamethasone|mesh-list
138645384|NCT00283985|Methotrexate|methotrexate|mesh-list
138645385|NCT00283985|Asparaginase|asparaginase|mesh-list
138645386|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138645387|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
138645388|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
138645389|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645390|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645391|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138645394|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138645395|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138645396|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138349142|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
138349143|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138645397|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138645398|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
138645399|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138377676|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
138377677|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138377678|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645400|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138645401|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
138645402|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645404|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645405|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138645406|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138645407|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
138645408|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138645409|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138645410|NCT00419250|Lenalidomide|lenalidomide|mesh-list
138645411|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
138645412|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645413|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138645414|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138645415|NCT00419250|Growth Substances|growth substances|mesh-ancestor
138645416|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
138645417|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645418|NCT00284024|Domperidone|domperidone|mesh-list
138645419|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
138645420|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
138645421|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645422|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645423|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138645424|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138645425|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
138645426|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645427|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645428|NCT00284258|Irinotecan|irinotecan|mesh-list
138645429|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138645430|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138645431|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645432|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645433|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645434|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
138645435|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
138645436|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138645437|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645438|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
138645439|NCT00284336|Doxorubicin|doxorubicin|mesh-list
138645440|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138645441|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138645442|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
138377699|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645444|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138645445|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138645446|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
138645447|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645448|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645449|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138645450|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138645451|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138645452|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138645453|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645454|NCT00312156|Insulin|insulin|mesh-list
138645455|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138645456|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
138645457|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
138645458|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
138645459|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
138645460|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
138645461|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138645462|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645464|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138645465|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
138645466|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
138645467|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138645468|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645469|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138645470|NCT00318825|Analgesics|analgesics|mesh-ancestor
138645471|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
138645472|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645473|NCT00284531|Daclizumab|daclizumab|mesh-list
138244827|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
138645475|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
138645476|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645477|NCT00312273|Aminophylline|aminophylline|mesh-list
138645478|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138645479|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
138645480|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645481|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645482|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138645483|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
138645484|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138645485|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138645486|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645487|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645488|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138645489|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138645490|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
138645491|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645492|NCT00312273|Protective Agents|protective agents|mesh-ancestor
138645493|NCT00312312|Immunomodulating Agents|immunomodulating agents|mesh-list
138645494|NCT00312312|Immunologic Factors|immunologic factors|mesh-ancestor
138645495|NCT00312312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645496|NCT00284687|Artesunate|artesunate|mesh-list
138645497|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
138645498|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138645499|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138645500|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645501|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645502|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
138645503|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
138645504|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138645505|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
138645506|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
138645507|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138645508|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138645509|NCT00284765|Analgesics|analgesics|mesh-ancestor
138645510|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
138645511|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645512|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645513|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138645514|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138645515|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
138645516|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138645517|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645518|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138645519|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
138645520|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138645521|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645522|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645523|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645524|NCT00319059|Annexin A5|annexin a5|mesh-list
138645525|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645526|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645528|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
138645529|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
138645530|NCT00312546|Valproic Acid|valproic acid|mesh-list
138645531|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
138645532|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645533|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645534|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
138645535|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645536|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645537|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
138645538|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138244946|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
138645539|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138645540|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138645541|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138645542|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138645544|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138645546|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645547|NCT00425009|Metformin|metformin|mesh-list
138645548|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138349268|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
138645549|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645550|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
138645551|NCT04718402|Analgesics|analgesics|mesh-ancestor
138645552|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
138645553|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645554|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645555|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645556|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138645557|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138645558|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645559|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645560|NCT00319215|Zopiclone|zopiclone|mesh-list
138645561|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138645562|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138645563|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645564|NCT00285155|Bupropion|bupropion|mesh-list
138645565|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138645566|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
138645567|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138645568|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138645569|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138645570|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138645571|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645572|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
138645573|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645574|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645575|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138645576|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138645577|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645579|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138645580|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645581|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
138645582|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645583|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
138645584|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138645585|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645586|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138645587|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
138645588|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138645589|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645590|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645591|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645592|NCT00285389|Dexamethasone|dexamethasone|mesh-list
138645593|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
138645594|NCT00285389|Melphalan|melphalan|mesh-list
138645595|NCT00285389|Chlorambucil|chlorambucil|mesh-list
138645596|NCT00285389|Rituximab|rituximab|mesh-list
138377783|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138645597|NCT00285389|Vincristine|vincristine|mesh-list
138645599|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138645600|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
138645601|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645602|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138645603|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138645605|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645606|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645607|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138645608|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138645610|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
138645611|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645612|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138645613|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
138645614|NCT00285389|Hormones|hormones|mesh-ancestor
138645615|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138645616|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138645617|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138645618|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138645619|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
138645620|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
138645621|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
138645622|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138645623|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138645624|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138645625|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645626|NCT00285428|Veltuzumab|veltuzumab|mesh-list
138645627|NCT00285428|Antibodies|antibodies|mesh-list
138645628|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
138645629|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645630|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645631|NCT00312819|Disulfiram|disulfiram|mesh-list
138645632|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138645633|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
138645634|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645635|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645636|NCT00319488|Budesonide|budesonide|mesh-list
138645637|NCT00319488|Albuterol|albuterol|mesh-list
138645638|NCT00319488|Montelukast|montelukast|mesh-list
138645639|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
138645640|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138645641|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138645642|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
138645643|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645644|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645645|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138645646|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
138645647|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
138645648|NCT00319488|Hormones|hormones|mesh-ancestor
138453582|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138645649|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138645651|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138645652|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138645653|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645655|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138645656|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138645657|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138645658|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138645659|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
138645660|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645662|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
138645663|NCT00285623|Coagulants|coagulants|mesh-ancestor
138645664|NCT00285662|Artesunate|artesunate|mesh-list
138645665|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
138645666|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
138645667|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138645668|NCT00285662|Amodiaquine|amodiaquine|mesh-list
138645669|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
138645670|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138645671|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138645672|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645673|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645674|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
138645675|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
138645676|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138645677|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
138645678|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138645679|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645680|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645681|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138645682|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138645683|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
138645684|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138645685|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138645686|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138645687|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138645689|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138645690|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645691|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138645692|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138245221|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
138645693|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138645694|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138645695|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645697|NCT00319566|Hormones|hormones|mesh-ancestor
138645698|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138645699|NCT00319605|Levetiracetam|levetiracetam|mesh-list
138645701|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
138645702|NCT00313053|Vincristine|vincristine|mesh-list
138645703|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138645704|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645705|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
138645706|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
138645707|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
138645708|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645709|NCT00285896|Glucagon|glucagon|mesh-list
138645710|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138645711|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138645712|NCT00285896|Hormones|hormones|mesh-ancestor
138645713|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138645714|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645715|NCT00285896|Incretins|incretins|mesh-ancestor
138645716|NCT00319683|Eniluracil|eniluracil|mesh-list
138645717|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645718|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645719|NCT00286052|Naloxone|naloxone|mesh-list
138645720|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138645721|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645722|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
138645723|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645724|NCT00319761|Calcitriol|calcitriol|mesh-list
138645725|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138645726|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645727|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138645728|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138645729|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645730|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138645731|NCT00319761|Vitamins|vitamins|mesh-ancestor
138645732|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
138645733|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138645734|NCT00286130|Leucovorin|leucovorin|mesh-list
138645735|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
138645736|NCT00286130|Irinotecan|irinotecan|mesh-list
138645737|NCT00286130|Cetuximab|cetuximab|mesh-list
138645738|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645739|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138645740|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138645741|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645742|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645743|NCT00286130|Antidotes|antidotes|mesh-ancestor
138645744|NCT00286130|Protective Agents|protective agents|mesh-ancestor
138645745|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645746|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
138645748|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
138645749|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138645750|NCT00286208|Misoprostol|misoprostol|mesh-list
138645751|NCT00286208|Mifepristone|mifepristone|mesh-list
138645752|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138645753|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
138645754|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138645755|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645756|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138645757|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138645758|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
138645759|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138645760|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138645761|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138645762|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138645763|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
138645764|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138645765|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138645766|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
138645767|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138645768|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
138645769|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138645770|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138645772|NCT00319800|Gefitinib|gefitinib|mesh-list
138645773|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138645774|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138645775|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645776|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645777|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645778|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138645779|NCT00313131|Metronidazole|metronidazole|mesh-list
138645780|NCT00313131|Fluconazole|fluconazole|mesh-list
138645781|NCT00313131|Clotrimazole|clotrimazole|mesh-list
138645782|NCT00313131|Miconazole|miconazole|mesh-list
138645783|NCT00313131|Tinidazole|tinidazole|mesh-list
138645784|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645785|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138645786|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138645787|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138645788|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
138645789|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138645790|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138645791|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138377873|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
138377877|NCT01446120|Insulin|insulin|mesh-list
138645792|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645794|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
138645795|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138645796|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645797|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138245424|NCT04121403|Rituximab|rituximab|mesh-list
138645798|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138645799|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138645800|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138322437|NCT03524820|Cetuximab|cetuximab|mesh-list
138645801|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
138645802|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138645803|NCT00319878|Cyclosporine|cyclosporine|mesh-list
138645804|NCT00319878|Sirolimus|sirolimus|mesh-list
138645805|NCT00319878|Cyclosporins|cyclosporins|mesh-list
138645806|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645807|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645808|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138645809|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
138645810|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645811|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
138645812|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645813|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
138645814|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138645815|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138645816|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138645817|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138645818|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645819|NCT00286364|Androgens|androgens|mesh-list
138645820|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138645821|NCT00286364|Hormones|hormones|mesh-ancestor
138645822|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138645823|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645824|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138645825|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645826|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645827|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138645828|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
138645829|NCT00319917|Tacrolimus|tacrolimus|mesh-list
138645830|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138645831|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
138645832|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645833|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138645834|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645835|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645836|NCT00286403|Fenoldopam|fenoldopam|mesh-list
138645837|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645838|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138645839|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
138645840|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
138645841|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
138645842|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138245515|NCT01769027|Azithromycin|azithromycin|mesh-list
138645843|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645844|NCT00313287|Clevudine|clevudine|mesh-list
138645845|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
138645846|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645847|NCT00286481|Simvastatin|simvastatin|mesh-list
138645848|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138645849|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138645850|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
138645851|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645852|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138645853|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138645854|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645855|NCT00320034|Albuterol|albuterol|mesh-list
138645856|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138645857|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
138645858|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645859|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645860|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138645861|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
138645862|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
138645863|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138645864|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138645865|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138645866|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138645867|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
138645868|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645869|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645870|NCT00320073|Pemetrexed|pemetrexed|mesh-list
138645871|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138245569|NCT03296163|Paclitaxel|paclitaxel|mesh-list
138645872|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645873|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645874|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645875|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138645876|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138645877|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138645878|NCT00286871|Tacrolimus|tacrolimus|mesh-list
138645879|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138645880|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
138645881|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645882|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138645883|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645884|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645886|NCT00417326|Glycine|glycine|mesh-list
138645887|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138645888|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
138645889|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645890|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645891|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
138645892|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645893|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645895|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
138645896|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138645897|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138245603|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
138645899|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138645900|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138645901|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138645902|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138645903|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645904|NCT00417404|Vitamins|vitamins|mesh-list
138645905|NCT00417404|Vitamin A|vitamin a|mesh-list
138645906|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
138645907|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
138645908|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645909|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
138645910|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645912|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138645913|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645914|NCT00417443|Clonidine|clonidine|mesh-list
138645915|NCT00417443|Analgesics|analgesics|mesh-ancestor
138645916|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
138645917|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138645918|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645919|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138645921|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
138645922|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138645923|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138645924|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138645925|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
138645926|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138645927|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138377961|NCT01446484|Everolimus|everolimus|mesh-list
138645928|NCT00313482|Prednisone|prednisone|mesh-list
138645929|NCT00313482|Docetaxel|docetaxel|mesh-list
138645930|NCT00313482|Sargramostim|sargramostim|mesh-list
138645931|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645932|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
138645933|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
138645934|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
138645935|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645936|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138645937|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
138645938|NCT00313482|Hormones|hormones|mesh-ancestor
138645939|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138645940|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645941|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138645942|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
138645943|NCT00286988|Topiramate|topiramate|mesh-list
138645944|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
138645945|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138645946|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645947|NCT00320307|Abacavir|abacavir|mesh-list
138645948|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138645949|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138645950|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645951|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645952|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
138645953|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138645954|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138645955|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138645956|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
138645957|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645958|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138645959|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138645960|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138645961|NCT02960906|Nivolumab|nivolumab|mesh-list
138645962|NCT02960906|Ipilimumab|ipilimumab|mesh-list
138645963|NCT02960906|Sunitinib|sunitinib|mesh-list
138645964|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138645965|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645966|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138645967|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645968|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138645969|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138645970|NCT02960906|Growth Substances|growth substances|mesh-ancestor
138645971|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645972|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
138377996|NCT01446523|Lactulose|lactulose|mesh-list
138645973|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138645974|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138645975|NCT00287066|Insulin|insulin|mesh-list
138645976|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138645977|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138645978|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645979|NCT00313521|Thiotepa|thiotepa|mesh-list
138645980|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138645981|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
138645982|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138645983|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645984|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138645985|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138645986|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
138645987|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138245890|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
138645988|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
138645989|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138645990|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138645992|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138645993|NCT00313599|Lapatinib|lapatinib|mesh-list
138645994|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138645995|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645996|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
138645997|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
138645998|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
138215215|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138215216|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138645999|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646000|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138646001|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646002|NCT00287300|Azithromycin|azithromycin|mesh-list
138646003|NCT00287300|Artesunate|artesunate|mesh-list
138646004|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
138646005|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
138646006|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138646007|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138646008|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646009|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
138646010|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138646011|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138646012|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646013|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
138646014|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
138646016|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
138646017|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138646018|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646019|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646020|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138646021|NCT00287378|Omalizumab|omalizumab|mesh-list
138646022|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138646023|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138646024|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
138646025|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138646026|NCT00320580|Norelgestromin|norelgestromin|mesh-list
138322665|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646027|NCT00320580|Estradiol|estradiol|mesh-list
138646028|NCT00320580|Estrogens|estrogens|mesh-ancestor
138646029|NCT00320580|Hormones|hormones|mesh-ancestor
138646030|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138646031|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646032|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138646033|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
138646034|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138646035|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138646036|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138646037|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138646038|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
138646039|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138646040|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138646041|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646042|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
138646043|NCT00320619|Coagulants|coagulants|mesh-ancestor
138646044|NCT00287456|Insulin|insulin|mesh-list
138646045|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138646046|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138646047|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646048|NCT00313833|Buprenorphine|buprenorphine|mesh-list
138378077|NCT01447212|Heroin|heroin|mesh-list
138646050|NCT00313833|Narcotics|narcotics|mesh-ancestor
138646051|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646052|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646054|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
138646055|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646056|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138646057|NCT00287495|Sorafenib|sorafenib|mesh-list
138646058|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246104|NCT01710332|Aflibercept|aflibercept|mesh-list
138646060|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646061|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646062|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138646063|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138646064|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
138646065|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646066|NCT00320658|Antacids|antacids|mesh-ancestor
138646067|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646068|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138646069|NCT00287534|Tamoxifen|tamoxifen|mesh-list
138646070|NCT00287534|Anastrozole|anastrozole|mesh-list
138646071|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138646072|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
138646073|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138646074|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646075|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138646076|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646077|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138646078|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138646079|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138646080|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138646081|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138646082|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646083|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646084|NCT00320697|Bupropion|bupropion|mesh-list
138646085|NCT00320697|Nicotine|nicotine|mesh-list
138646086|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138646087|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
138646088|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646089|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646090|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138646091|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138646092|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
138646093|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646094|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646095|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138646097|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138646098|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138378105|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138378106|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
138378107|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646100|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138646101|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
138646102|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138646103|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138646104|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646106|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138646107|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138646108|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646110|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646111|NCT00320736|Galantamine|galantamine|mesh-list
138646112|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138646113|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646114|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646115|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
138646116|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646117|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646118|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138646119|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
138646120|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646121|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
138646122|NCT00287768|Docetaxel|docetaxel|mesh-list
138646123|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646124|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
138646125|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
138646126|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
138646127|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646128|NCT00320775|Aflibercept|aflibercept|mesh-list
138646129|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138646130|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138646131|NCT00320775|Growth Substances|growth substances|mesh-ancestor
138646132|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646133|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
138646134|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646136|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138646137|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138646138|NCT00320814|Growth Substances|growth substances|mesh-ancestor
138646139|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646140|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
138646141|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646142|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
138646143|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646145|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138246476|NCT01747850|Analgesics|analgesics|mesh-ancestor
138646146|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646147|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
138646148|NCT00322413|Hematinics|hematinics|mesh-ancestor
138646150|NCT00320853|Vitamins|vitamins|mesh-ancestor
138646151|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
138215217|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
138215218|NCT01799954|Vaccines|vaccines|mesh-list
138215219|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
138646152|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646153|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138646154|NCT00287885|Docetaxel|docetaxel|mesh-list
138646155|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646156|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
138246528|NCT02355821|Moxonidine|moxonidine|mesh-list
138646157|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
138646158|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
138646159|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646160|NCT00287924|Methotrexate|methotrexate|mesh-list
138646161|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138646162|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
138646163|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138646164|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646165|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138646166|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
138646167|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646168|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646169|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
138646170|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646171|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138646172|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138646173|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
138322813|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
138646174|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138646175|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138646177|NCT00287963|Vinorelbine|vinorelbine|mesh-list
138646178|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138646179|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138646180|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646181|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646182|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646183|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138646184|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
138378155|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138646185|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
138646186|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
138646188|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138646189|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138646190|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138646191|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138646192|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
138646193|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646194|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646195|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138646196|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
138646197|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
138646198|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
138646199|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138646200|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138646201|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
138646202|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646203|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646204|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138646205|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
138646206|NCT00288002|Docetaxel|docetaxel|mesh-list
138646207|NCT00288002|Capecitabine|capecitabine|mesh-list
138646208|NCT00288002|Trastuzumab|trastuzumab|mesh-list
138646209|NCT00288002|Epirubicin|epirubicin|mesh-list
138646210|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138646211|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
138646212|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646213|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138201371|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138646214|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138646215|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
138646216|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646217|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138246861|NCT04769258|Vaccines|vaccines|mesh-list
138646218|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138646219|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
138646220|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
138646221|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
138646222|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138646223|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
138646224|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138646225|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138646226|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138378187|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
138646227|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138646229|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
138646230|NCT00322569|Paclitaxel|paclitaxel|mesh-list
138646231|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138646232|NCT00322569|Tacrolimus|tacrolimus|mesh-list
138646233|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138646234|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646235|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
138646236|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
138646237|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
138646238|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646239|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138646240|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138646241|NCT00322569|Analgesics|analgesics|mesh-ancestor
138646242|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
138646243|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646244|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646245|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138646246|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138646247|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
138646248|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138646249|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
138646250|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138646251|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646252|NCT00288041|Paclitaxel|paclitaxel|mesh-list
138646253|NCT00288041|Carboplatin|carboplatin|mesh-list
138646254|NCT00288041|Bortezomib|bortezomib|mesh-list
138646255|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138646256|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646257|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
138646258|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
138646259|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
138646260|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646261|NCT00320970|Candesartan|candesartan|mesh-list
138646262|NCT00320970|Candesartan cilexetil|candesartan cilexetil|mesh-list
138646263|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138646264|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138646265|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138646266|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646267|NCT00288158|Allopurinol|allopurinol|mesh-list
138646268|NCT00288158|Probenecid|probenecid|mesh-list
138646269|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
138646270|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646271|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646272|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
138646273|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138646274|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138646275|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
138646277|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646278|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
138646279|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138646280|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138646281|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646282|NCT00288197|Voriconazole|voriconazole|mesh-list
138646283|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
138646284|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646285|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138646286|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138646287|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646288|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646289|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138646290|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
138453583|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646291|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138646292|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646293|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138646294|NCT00288236|Rimonabant|rimonabant|mesh-list
138646295|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138646296|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
138646297|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138646298|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646299|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646300|NCT00288236|Hormones|hormones|mesh-ancestor
138646301|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138646302|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646303|NCT00321126|Zinc|zinc|mesh-list
138646304|NCT00321126|Trace Elements|trace elements|mesh-ancestor
138646305|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
138646306|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646307|NCT00288353|Aripiprazole|aripiprazole|mesh-list
138646308|NCT00288353|Ziprasidone|ziprasidone|mesh-list
138646309|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
138646310|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138646311|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138646312|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138646313|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646314|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646315|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
138646316|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
138646317|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646318|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646319|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138646320|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138646321|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
138646322|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138378247|NCT01448317|Protease Inhibitors|protease inhibitors|mesh-ancestor
138646323|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138646324|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138646325|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138646327|NCT00288431|Doxorubicin|doxorubicin|mesh-list
138646328|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138646329|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646330|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138646331|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138646332|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138453584|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646333|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646334|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138646335|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646336|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
138646337|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138646338|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
138646339|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646340|NCT00321165|Taurolidine|taurolidine|mesh-list
138646341|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646342|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138646343|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646344|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
138646345|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
138646346|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138646347|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138646348|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646349|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646350|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138646351|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138646352|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
138646353|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
138646354|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646355|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247240|NCT02261948|Simendan|simendan|mesh-list
138704041|NCT06205407|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138704042|NCT06205407|Hormone Antagonists|hormone antagonists|mesh-ancestor
138704043|NCT06205407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138704044|NCT06205407|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138704046|NCT06199466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138704047|NCT06199466|Gemcitabine|gemcitabine|mesh-list
138704048|NCT06199466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138704049|NCT06199466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704050|NCT06199466|Tubulin Modulators|tubulin modulators|mesh-ancestor
138704051|NCT06199466|Antimitotic Agents|antimitotic agents|mesh-ancestor
138704052|NCT06199466|Mitosis Modulators|mitosis modulators|mesh-ancestor
138704053|NCT06199466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704054|NCT06199466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138704055|NCT06199466|Antimetabolites|antimetabolites|mesh-ancestor
138704056|NCT06199297|Bevacizumab|bevacizumab|mesh-list
138704057|NCT06199297|Atezolizumab|atezolizumab|mesh-list
138704058|NCT06199297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138378274|NCT01448395|Avibactam|avibactam|mesh-list
138704061|NCT06199297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138704062|NCT06199297|Growth Substances|growth substances|mesh-ancestor
138704063|NCT06199297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704064|NCT06199297|Growth Inhibitors|growth inhibitors|mesh-ancestor
138704065|NCT06199297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138704066|NCT06199297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704067|NCT06190093|Bevacizumab|bevacizumab|mesh-list
138704068|NCT06190093|Ranibizumab|ranibizumab|mesh-list
138704069|NCT06190093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138704070|NCT06190093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704071|NCT06190093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138247282|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
138704072|NCT06190093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138704074|NCT06190093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138704075|NCT06190093|Growth Inhibitors|growth inhibitors|mesh-ancestor
138704076|NCT06180356|Niraparib|niraparib|mesh-list
138704077|NCT06180356|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138704078|NCT06180356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138704079|NCT06180356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138704080|NCT06180356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138704081|NCT06177912|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138704082|NCT06177912|Immunologic Factors|immunologic factors|mesh-ancestor
138704083|NCT06177912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646356|NCT00322920|Topotecan|topotecan|mesh-list
138247333|NCT01877642|Lorazepam|lorazepam|mesh-list
138646358|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138646359|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138646360|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646361|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646362|NCT00321009|Enoxaparin|enoxaparin|mesh-list
138646363|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
138646364|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138646365|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138646366|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646367|NCT00417677|Sirolimus|sirolimus|mesh-list
138646368|NCT00417677|Sunitinib|sunitinib|mesh-list
138646370|NCT00417677|MTOR Inhibitors|mtor inhibitors|mesh-list
138646371|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646372|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138646373|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138646374|NCT00417677|Growth Substances|growth substances|mesh-ancestor
138646375|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646376|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
138646377|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138646378|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646379|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646380|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138646381|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
138646382|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138646383|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646384|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138646385|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
138646386|NCT00417716|Bevacizumab|bevacizumab|mesh-list
138646387|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138646388|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646389|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138646390|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138646391|NCT00417716|Growth Substances|growth substances|mesh-ancestor
138646392|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646393|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
138646395|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
138646396|NCT00288470|Protective Agents|protective agents|mesh-ancestor
138646397|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646398|NCT00321360|Propofol|propofol|mesh-list
138646399|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138646400|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646401|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646402|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138646403|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
138646405|NCT00288548|Metoprolol|metoprolol|mesh-list
138646406|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138646407|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138646408|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
138646409|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
138646410|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646411|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646412|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138646413|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138646414|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138646416|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646417|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646419|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
138646420|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
138646421|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646422|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646423|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138378323|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
138646424|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
138646425|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646426|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646427|NCT00321516|Aripiprazole|aripiprazole|mesh-list
138646428|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
138646429|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138323113|NCT03308916|Liver Extracts|liver extracts|mesh-list
138646430|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138646431|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138646432|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646433|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646434|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
138646435|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
138646436|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646437|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646438|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138646439|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138646440|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
138646441|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138646442|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138646443|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138646444|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138646445|NCT06140277|Chitosan|chitosan|mesh-list
138646446|NCT06140277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138646447|NCT06140277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138646448|NCT06140277|Antimetabolites|antimetabolites|mesh-ancestor
138646449|NCT06140277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646450|NCT06140277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138646451|NCT06140277|Chelating Agents|chelating agents|mesh-ancestor
138646452|NCT06140277|Sequestering Agents|sequestering agents|mesh-ancestor
138646453|NCT06140277|Hemostatics|hemostatics|mesh-ancestor
138646454|NCT06140277|Coagulants|coagulants|mesh-ancestor
138646455|NCT06140251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138646456|NCT06140251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646457|NCT06140251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138646458|NCT06140251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646460|NCT06140238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138646461|NCT06140238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138646462|NCT06140238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646463|NCT06140238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646464|NCT06140238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138646465|NCT06140238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138646466|NCT06140238|Analgesics|analgesics|mesh-ancestor
138646467|NCT06140238|Sensory System Agents|sensory system agents|mesh-ancestor
138646468|NCT06140238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646469|NCT06140238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646470|NCT06140238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138646471|NCT06140238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138646474|NCT06140095|Atorvastatin|atorvastatin|mesh-list
138646476|NCT06140095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138646477|NCT06140095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138646478|NCT06140095|Antimetabolites|antimetabolites|mesh-ancestor
138646479|NCT06140095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138247824|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
138646481|NCT06140095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138646482|NCT06140095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646483|NCT06140095|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138646484|NCT06140095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138646485|NCT06140095|Protease Inhibitors|protease inhibitors|mesh-ancestor
138646486|NCT06139952|Acetylcysteine|acetylcysteine|mesh-list
138646487|NCT06139952|Atorvastatin|atorvastatin|mesh-list
138646488|NCT06139952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138247880|NCT01803074|Ritonavir|ritonavir|mesh-list
138646489|NCT06139952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138646490|NCT06139952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138646491|NCT06139952|Antimetabolites|antimetabolites|mesh-ancestor
138646492|NCT06139952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646493|NCT06139952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138646494|NCT06139952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138646495|NCT06139952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646496|NCT06139952|Antiviral Agents|antiviral agents|mesh-ancestor
138646497|NCT06139952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646498|NCT06139952|Expectorants|expectorants|mesh-ancestor
138646499|NCT06139952|Respiratory System Agents|respiratory system agents|mesh-ancestor
138646500|NCT06139952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138646501|NCT06139952|Antioxidants|antioxidants|mesh-ancestor
138646502|NCT06139952|Protective Agents|protective agents|mesh-ancestor
138646503|NCT06139952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646504|NCT06139952|Antidotes|antidotes|mesh-ancestor
138646505|NCT06139926|Dexmedetomidine|dexmedetomidine|mesh-list
138646506|NCT06139926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138646507|NCT06139926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646508|NCT06139926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646509|NCT06139926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138646510|NCT06139926|Analgesics|analgesics|mesh-ancestor
138646511|NCT06139926|Sensory System Agents|sensory system agents|mesh-ancestor
138646512|NCT06139926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646514|NCT06139926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138646515|NCT06139926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138646516|NCT06139926|Adrenergic Agents|adrenergic agents|mesh-ancestor
138646517|NCT06139926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646518|NCT06139926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646519|NCT06139666|Bupivacaine|bupivacaine|mesh-list
138201382|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
138646520|NCT06139666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138201383|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646521|NCT06139666|Anesthetics, Local|anesthetics, local|mesh-ancestor
138646522|NCT06139666|Anesthetics|anesthetics|mesh-ancestor
138201385|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138201386|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
138201387|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138201388|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646523|NCT06139666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646524|NCT06139666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646525|NCT06139666|Sensory System Agents|sensory system agents|mesh-ancestor
138646526|NCT06139666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646528|NCT06139419|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138378383|NCT01449045|Artemether|artemether|mesh-list
138646529|NCT06139419|Cisplatin|cisplatin|mesh-list
138646530|NCT06139419|Tislelizumab|tislelizumab|mesh-list
138646531|NCT06139419|Thymalfasin|thymalfasin|mesh-list
138646532|NCT06139419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138378385|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
138646533|NCT06139419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646534|NCT06139419|Tubulin Modulators|tubulin modulators|mesh-ancestor
138646535|NCT06139419|Antimitotic Agents|antimitotic agents|mesh-ancestor
138646536|NCT06139419|Mitosis Modulators|mitosis modulators|mesh-ancestor
138646537|NCT06139419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646538|NCT06139419|Immunologic Factors|immunologic factors|mesh-ancestor
138646539|NCT06139419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646540|NCT06139419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138646541|NCT06139419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138646543|NCT06139393|Gout Suppressants|gout suppressants|mesh-ancestor
138646544|NCT06139393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138646545|NCT06139211|Leucovorin|leucovorin|mesh-list
138646546|NCT06139211|Paclitaxel|paclitaxel|mesh-list
138646547|NCT06139211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138646548|NCT06139211|Bevacizumab|bevacizumab|mesh-list
138646549|NCT06139211|Gemcitabine|gemcitabine|mesh-list
138646550|NCT06139211|Capecitabine|capecitabine|mesh-list
138646551|NCT06139211|Fluorouracil|fluorouracil|mesh-list
138646552|NCT06139211|Oxaliplatin|oxaliplatin|mesh-list
138646553|NCT06139211|Irinotecan|irinotecan|mesh-list
138248054|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
138646554|NCT06139211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138646555|NCT06139211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646556|NCT06139211|Tubulin Modulators|tubulin modulators|mesh-ancestor
138646557|NCT06139211|Antimitotic Agents|antimitotic agents|mesh-ancestor
138646558|NCT06139211|Mitosis Modulators|mitosis modulators|mesh-ancestor
138646559|NCT06139211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646560|NCT06139211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138646561|NCT06139211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138646562|NCT06139211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138646563|NCT06139211|Growth Substances|growth substances|mesh-ancestor
138646564|NCT06139211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646565|NCT06139211|Growth Inhibitors|growth inhibitors|mesh-ancestor
138646566|NCT06139211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138646567|NCT06139211|Antimetabolites|antimetabolites|mesh-ancestor
138646568|NCT06139211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138646569|NCT06139211|Immunologic Factors|immunologic factors|mesh-ancestor
138646570|NCT06139211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138646571|NCT06139211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138646572|NCT06139211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646573|NCT06139211|Antidotes|antidotes|mesh-ancestor
138646574|NCT06139211|Protective Agents|protective agents|mesh-ancestor
138646575|NCT06139211|Vitamin B Complex|vitamin b complex|mesh-ancestor
138646576|NCT06139211|Vitamins|vitamins|mesh-ancestor
138646578|NCT06138834|Cilostazol|cilostazol|mesh-list
138646579|NCT06138834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138646580|NCT06138834|Autonomic Agents|autonomic agents|mesh-ancestor
138646581|NCT06138834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646582|NCT06138834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646583|NCT06138834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138646584|NCT06138834|Respiratory System Agents|respiratory system agents|mesh-ancestor
138646585|NCT06138834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138646586|NCT06138834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138646587|NCT06138834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646588|NCT06138834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138646590|NCT06138834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138646591|NCT06138834|Protective Agents|protective agents|mesh-ancestor
138646592|NCT06138834|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138646593|NCT06138834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138646594|NCT06138834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646595|NCT06138769|Lenvatinib|lenvatinib|mesh-list
138646596|NCT06138769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646597|NCT06138769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138646598|NCT06138769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646599|NCT06138769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646600|NCT06138587|Aldesleukin|aldesleukin|mesh-list
138646601|NCT06138587|Interleukin-2|interleukin-2|mesh-list
138646602|NCT06138587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646603|NCT06138587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138646604|NCT06138587|Analgesics|analgesics|mesh-ancestor
138646605|NCT06138587|Sensory System Agents|sensory system agents|mesh-ancestor
138646606|NCT06138587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646607|NCT06138587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646608|NCT06138587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138646609|NCT06138587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138646610|NCT06138587|Antiviral Agents|antiviral agents|mesh-ancestor
138646611|NCT06138587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646612|NCT06138574|Dexmedetomidine|dexmedetomidine|mesh-list
138646613|NCT06138574|Remifentanil|remifentanil|mesh-list
138646614|NCT06138574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138646615|NCT06138574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646616|NCT06138574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646617|NCT06138574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138646618|NCT06138574|Analgesics|analgesics|mesh-ancestor
138646619|NCT06138574|Sensory System Agents|sensory system agents|mesh-ancestor
138646620|NCT06138574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646621|NCT06138574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138646622|NCT06138574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138646623|NCT06138574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138646624|NCT06138574|Adrenergic Agents|adrenergic agents|mesh-ancestor
138646625|NCT06138574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646626|NCT06138574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646627|NCT06138574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138646628|NCT06138574|Narcotics|narcotics|mesh-ancestor
138646629|NCT06138535|Salicylic Acid|salicylic acid|mesh-list
138646630|NCT06138535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646631|NCT06138535|Antifungal Agents|antifungal agents|mesh-ancestor
138646632|NCT06138535|Keratolytic Agents|keratolytic agents|mesh-ancestor
138646633|NCT06138535|Dermatologic Agents|dermatologic agents|mesh-ancestor
138646635|NCT06138509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138646636|NCT06138509|Serotonin Agents|serotonin agents|mesh-ancestor
138646637|NCT06138509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646638|NCT06138509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646639|NCT06138509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646641|NCT06138496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646642|NCT06138496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138646643|NCT06138496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646644|NCT06138496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646645|NCT06138340|Dexmedetomidine|dexmedetomidine|mesh-list
138646646|NCT06138340|Propofol|propofol|mesh-list
138646647|NCT06138340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138646648|NCT06138340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646649|NCT06138340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646650|NCT06138340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138646651|NCT06138340|Analgesics|analgesics|mesh-ancestor
138646652|NCT06138340|Sensory System Agents|sensory system agents|mesh-ancestor
138646653|NCT06138340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138248686|NCT02353572|Dexamethasone|dexamethasone|mesh-list
138646654|NCT06138340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138646655|NCT06138340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138646656|NCT06138340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138646657|NCT06138340|Adrenergic Agents|adrenergic agents|mesh-ancestor
138646658|NCT06138340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646659|NCT06138340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646660|NCT06138340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138646661|NCT06138340|Anesthetics, General|anesthetics, general|mesh-ancestor
138646662|NCT06138340|Anesthetics|anesthetics|mesh-ancestor
138646663|NCT06138249|Vitamin D|vitamin d|mesh-list
138646664|NCT06138249|Vitamins|vitamins|mesh-ancestor
138646665|NCT06138249|Micronutrients|micronutrients|mesh-ancestor
138646666|NCT06138249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646667|NCT06138249|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138646668|NCT06137690|Antifungal Agents|antifungal agents|mesh-list
138646669|NCT06137690|Clotrimazole|clotrimazole|mesh-list
138646670|NCT06137690|Miconazole|miconazole|mesh-list
138646671|NCT06137690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646672|NCT06137690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138646673|NCT06137690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138646674|NCT06137690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138646675|NCT06137690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349349|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
138646676|NCT06137690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646677|NCT06137690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138646678|NCT06137690|Hormone Antagonists|hormone antagonists|mesh-ancestor
138646679|NCT06137690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138646680|NCT06137690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646681|NCT06137690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138646682|NCT06137690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138646683|NCT06136754|Fluorides|fluorides|mesh-list
138646686|NCT06136754|Protective Agents|protective agents|mesh-ancestor
138646687|NCT06136754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646688|NCT06135831|Calcium, Dietary|calcium, dietary|mesh-list
138646689|NCT06135831|Vitamin D|vitamin d|mesh-list
138646690|NCT06135831|Diphosphonates|diphosphonates|mesh-list
138646691|NCT06135831|Vitamins|vitamins|mesh-list
138646692|NCT06135831|Calcium|calcium|mesh-list
138646693|NCT06135831|Micronutrients|micronutrients|mesh-ancestor
138646694|NCT06135831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646695|NCT06135831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138646696|NCT06135831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138646697|NCT06133062|Bevacizumab|bevacizumab|mesh-list
138646698|NCT06133062|Atezolizumab|atezolizumab|mesh-list
138646699|NCT06133062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138646700|NCT06133062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646701|NCT06133062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138646702|NCT06133062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138646703|NCT06133062|Growth Substances|growth substances|mesh-ancestor
138646704|NCT06133062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646705|NCT06133062|Growth Inhibitors|growth inhibitors|mesh-ancestor
138646706|NCT06133062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138646707|NCT06133062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646708|NCT06130423|Nicotine|nicotine|mesh-list
138646709|NCT06130423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138646710|NCT06130423|Autonomic Agents|autonomic agents|mesh-ancestor
138646711|NCT06130423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646712|NCT06130423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646713|NCT06130423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138646714|NCT06130423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138646715|NCT06130423|Cholinergic Agents|cholinergic agents|mesh-ancestor
138646716|NCT06130423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646717|NCT06130423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646718|NCT06129916|Buprenorphine|buprenorphine|mesh-list
138646719|NCT06129916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138646720|NCT06129916|Narcotics|narcotics|mesh-ancestor
138646721|NCT06129916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646722|NCT06129916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646723|NCT06129916|Analgesics|analgesics|mesh-ancestor
138646724|NCT06129916|Sensory System Agents|sensory system agents|mesh-ancestor
138646725|NCT06129916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646726|NCT06129916|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138378477|NCT01449448|Triamcinolone|triamcinolone|mesh-list
138646727|NCT06103617|Penicillamine|penicillamine|mesh-list
138646729|NCT06103617|Protective Agents|protective agents|mesh-ancestor
138646730|NCT06103617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646731|NCT06103617|Chelating Agents|chelating agents|mesh-ancestor
138646732|NCT06103617|Sequestering Agents|sequestering agents|mesh-ancestor
138704084|NCT06170788|Pembrolizumab|pembrolizumab|mesh-list
138646733|NCT06103617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646734|NCT06103617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138646736|NCT06096025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646737|NCT06083480|Acetylcysteine|acetylcysteine|mesh-list
138646738|NCT06083480|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138646739|NCT06083480|Glycine|glycine|mesh-list
138646740|NCT06083480|Antiviral Agents|antiviral agents|mesh-ancestor
138646741|NCT06083480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646742|NCT06083480|Expectorants|expectorants|mesh-ancestor
138646743|NCT06083480|Respiratory System Agents|respiratory system agents|mesh-ancestor
138201397|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201398|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646744|NCT06083480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138646745|NCT06083480|Antioxidants|antioxidants|mesh-ancestor
138646746|NCT06083480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646747|NCT06083480|Protective Agents|protective agents|mesh-ancestor
138646748|NCT06083480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646749|NCT06083480|Antidotes|antidotes|mesh-ancestor
138646750|NCT06083480|Glycine Agents|glycine agents|mesh-ancestor
138646751|NCT06083480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646752|NCT06060626|Fentanyl|fentanyl|mesh-list
138646753|NCT06060626|Propofol|propofol|mesh-list
138646754|NCT06060626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138646755|NCT06060626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646756|NCT06060626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646757|NCT06060626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138646758|NCT06060626|Anesthetics, General|anesthetics, general|mesh-ancestor
138646759|NCT06060626|Anesthetics|anesthetics|mesh-ancestor
138646760|NCT06060626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138646761|NCT06060626|Narcotics|narcotics|mesh-ancestor
138646762|NCT06060626|Analgesics|analgesics|mesh-ancestor
138249112|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
138646763|NCT06060626|Sensory System Agents|sensory system agents|mesh-ancestor
138646764|NCT06060626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646765|NCT06060626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138646766|NCT06059014|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
138646767|NCT06059014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646768|NCT06053853|Antitoxins|antitoxins|mesh-list
138646769|NCT06053853|Diphtheria Antitoxin|diphtheria antitoxin|mesh-list
138646770|NCT06053853|Immunologic Factors|immunologic factors|mesh-ancestor
138646771|NCT06053853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646772|NCT06020144|Tofacitinib|tofacitinib|mesh-list
138646773|NCT06020144|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138646774|NCT06020144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138646775|NCT06020144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138249168|NCT00378417|Vaccines|vaccines|mesh-list
138646776|NCT06020144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646778|NCT06002490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138646779|NCT06002490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138646780|NCT06002490|Analgesics|analgesics|mesh-ancestor
138646781|NCT06002490|Sensory System Agents|sensory system agents|mesh-ancestor
138646782|NCT06002490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646783|NCT06002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249228|NCT02749227|Hormones|hormones|mesh-ancestor
138646784|NCT06002490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138378508|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
138646785|NCT06002490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138646786|NCT06002490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138646787|NCT06002490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138646788|NCT06002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378510|NCT01449578|Protective Agents|protective agents|mesh-ancestor
138646789|NCT06002490|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138646790|NCT06002490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138646791|NCT06002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646793|NCT05969795|Progesterone|progesterone|mesh-list
138646794|NCT05969795|Progestins|progestins|mesh-ancestor
138646796|NCT05969795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138646797|NCT05969795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646798|NCT05961189|Azithromycin|azithromycin|mesh-list
138646799|NCT05961189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138646800|NCT05961189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201404|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138646801|NCT05957081|Pembrolizumab|pembrolizumab|mesh-list
138201407|NCT01059929|Midazolam|midazolam|mesh-list
138646802|NCT05957081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138646803|NCT05957081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646804|NCT05957081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138646805|NCT05957081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646807|NCT05931302|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138646808|NCT05931302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646809|NCT05921760|Nivolumab|nivolumab|mesh-list
138646810|NCT05921760|Ipilimumab|ipilimumab|mesh-list
138646811|NCT05921760|Ivosidenib|ivosidenib|mesh-list
138646812|NCT05921760|Glycine|glycine|mesh-list
138646813|NCT05921760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138646814|NCT05921760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646815|NCT05921760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138646816|NCT05921760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646817|NCT05921760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646818|NCT05921760|Glycine Agents|glycine agents|mesh-ancestor
138646819|NCT05921760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646820|NCT05921760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646821|NCT05918055|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
138646822|NCT05918055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138646823|NCT05918055|Antimetabolites|antimetabolites|mesh-ancestor
138646824|NCT05918055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646825|NCT05918055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646826|NCT05907057|Azacitidine|azacitidine|mesh-list
138646827|NCT05907057|Ivosidenib|ivosidenib|mesh-list
138646828|NCT05907057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138646829|NCT05907057|Antimetabolites|antimetabolites|mesh-ancestor
138646830|NCT05907057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646831|NCT05907057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646832|NCT05907057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646833|NCT05886712|Naloxone|naloxone|mesh-list
138646834|NCT05886712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138646835|NCT05886712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646836|NCT05886712|Sensory System Agents|sensory system agents|mesh-ancestor
138646837|NCT05886712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646838|NCT05884866|Dapagliflozin|dapagliflozin|mesh-list
138646839|NCT05884866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138646840|NCT05884866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646841|NCT05884866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138646842|NCT05884866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646843|NCT05875441|Moxidectin|moxidectin|mesh-list
138646844|NCT05875441|Anthelmintics|anthelmintics|mesh-ancestor
138378520|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138378521|NCT01449617|Analgesics|analgesics|mesh-ancestor
138646846|NCT05875441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646847|NCT05875441|Antinematodal Agents|antinematodal agents|mesh-ancestor
138646848|NCT05863312|Temazepam|temazepam|mesh-list
138646849|NCT05863312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138646850|NCT05863312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646851|NCT05863312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646852|NCT05863312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138646853|NCT05863312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138646854|NCT05863312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138646855|NCT05863312|GABA Modulators|gaba modulators|mesh-ancestor
138646856|NCT05863312|GABA Agents|gaba agents|mesh-ancestor
138646857|NCT05863312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646858|NCT05863312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646859|NCT05848375|Levobupivacaine|levobupivacaine|mesh-list
138646860|NCT05848375|Ropivacaine|ropivacaine|mesh-list
138646861|NCT05848375|Anesthetics, Local|anesthetics, local|mesh-ancestor
138646862|NCT05848375|Anesthetics|anesthetics|mesh-ancestor
138646863|NCT05848375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646864|NCT05848375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646865|NCT05848375|Sensory System Agents|sensory system agents|mesh-ancestor
138646866|NCT05848375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646867|NCT05834036|Amoxicillin|amoxicillin|mesh-list
138646868|NCT05834036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138646869|NCT05834036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646870|NCT05826912|Minocycline|minocycline|mesh-list
138646871|NCT05826912|Candesartan|candesartan|mesh-list
138646872|NCT05826912|Candesartan cilexetil|candesartan cilexetil|mesh-list
138646873|NCT05826912|Atorvastatin|atorvastatin|mesh-list
138646874|NCT05826912|Calcium|calcium|mesh-list
138646875|NCT05826912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138646876|NCT05826912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646877|NCT05826912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138646878|NCT05826912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138646879|NCT05826912|Antimetabolites|antimetabolites|mesh-ancestor
138646880|NCT05826912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646881|NCT05826912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138646882|NCT05826912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138646883|NCT05826912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646884|NCT05826912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138646885|NCT05826912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646886|NCT05826912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138646887|NCT05826912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138646888|NCT05826912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138646890|NCT05799144|Vaccines|vaccines|mesh-list
138646891|NCT05799144|Immunologic Factors|immunologic factors|mesh-ancestor
138646892|NCT05799144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646893|NCT05799144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138646894|NCT05799144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646895|NCT05799144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138646896|NCT05799144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646897|NCT05792774|Bupivacaine|bupivacaine|mesh-list
138646898|NCT05792774|Anesthetics, Local|anesthetics, local|mesh-ancestor
138646899|NCT05792774|Anesthetics|anesthetics|mesh-ancestor
138646900|NCT05792774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138646901|NCT05792774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646902|NCT05792774|Sensory System Agents|sensory system agents|mesh-ancestor
138646903|NCT05792774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138646904|NCT05781542|MEDI9197|medi9197|mesh-list
138646905|NCT05781542|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138646906|NCT05781542|Immunologic Factors|immunologic factors|mesh-ancestor
138646907|NCT05781542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646908|NCT05781217|Goserelin|goserelin|mesh-list
138646911|NCT05781217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138646912|NCT05781217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646913|NCT05781217|Luteolytic Agents|luteolytic agents|mesh-ancestor
138646914|NCT05781217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138646915|NCT05781217|Contraceptive Agents|contraceptive agents|mesh-ancestor
138646916|NCT05781217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138646917|NCT05781217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646918|NCT05781217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138646919|NCT05781217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138646920|NCT05781217|Fertility Agents|fertility agents|mesh-ancestor
138646921|NCT05775471|Pembrolizumab|pembrolizumab|mesh-list
138249640|NCT02429583|Vaccines|vaccines|mesh-list
138646922|NCT05775471|Immunoconjugates|immunoconjugates|mesh-list
138646923|NCT05775471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138646924|NCT05775471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646925|NCT05775471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138646926|NCT05775471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646927|NCT05775471|Immunologic Factors|immunologic factors|mesh-ancestor
138646928|NCT05775471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646929|NCT05767736|Dimethyl Fumarate|dimethyl fumarate|mesh-list
138646930|NCT05767736|Dermatologic Agents|dermatologic agents|mesh-ancestor
138646931|NCT05767736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138646932|NCT05767736|Immunologic Factors|immunologic factors|mesh-ancestor
138646933|NCT05767736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646934|NCT05766345|BCG Vaccine|bcg vaccine|mesh-list
138646935|NCT05766345|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138646936|NCT05766345|Immunologic Factors|immunologic factors|mesh-ancestor
138646937|NCT05766345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646938|NCT05763121|Pramipexole|pramipexole|mesh-list
138646939|NCT05763121|Antioxidants|antioxidants|mesh-ancestor
138646940|NCT05763121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646941|NCT05763121|Protective Agents|protective agents|mesh-ancestor
138646942|NCT05763121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646943|NCT05763121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138646944|NCT05763121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138646945|NCT05763121|Dopamine Agonists|dopamine agonists|mesh-ancestor
138646946|NCT05763121|Dopamine Agents|dopamine agents|mesh-ancestor
138646947|NCT05763121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646948|NCT05745467|Povidone-Iodine|povidone-iodine|mesh-list
138646950|NCT05745467|Plasma Substitutes|plasma substitutes|mesh-ancestor
138646951|NCT05745467|Blood Substitutes|blood substitutes|mesh-ancestor
138646952|NCT05745467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138646953|NCT05745467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646955|NCT05718843|Nootropic Agents|nootropic agents|mesh-ancestor
138646956|NCT05712707|Lofexidine|lofexidine|mesh-list
138323640|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646957|NCT05712707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138646958|NCT05712707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138646959|NCT05712707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646960|NCT05712707|Sensory System Agents|sensory system agents|mesh-ancestor
138646961|NCT05712707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138378551|NCT01449825|Sunitinib|sunitinib|mesh-list
138646962|NCT05712707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138646963|NCT05712707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138646965|NCT05712707|Adrenergic Agents|adrenergic agents|mesh-ancestor
138646966|NCT05712707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646967|NCT05712707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646968|NCT05692154|Fexofenadine|fexofenadine|mesh-list
138646969|NCT05692154|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138646970|NCT05692154|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138646971|NCT05692154|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138646972|NCT05692154|Histamine Antagonists|histamine antagonists|mesh-ancestor
138646973|NCT05692154|Histamine Agents|histamine agents|mesh-ancestor
138646974|NCT05692154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138646975|NCT05692154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646976|NCT05692154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646978|NCT05649956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138646979|NCT05649956|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138646980|NCT05649956|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138646981|NCT05649956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138646982|NCT05649956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138646983|NCT05649956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138646984|NCT05649956|Hormone Antagonists|hormone antagonists|mesh-ancestor
138646985|NCT05649956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138646986|NCT05649956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646988|NCT05645900|Immunologic Factors|immunologic factors|mesh-ancestor
138646989|NCT05645900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138646990|NCT05638217|Listerine|listerine|mesh-list
138646991|NCT05638217|Fluorides|fluorides|mesh-list
138646992|NCT05638217|Sodium Fluoride|sodium fluoride|mesh-list
138646993|NCT05638217|Fluorides, Topical|fluorides, topical|mesh-list
138646994|NCT05638217|Cariostatic Agents|cariostatic agents|mesh-ancestor
138646995|NCT05638217|Protective Agents|protective agents|mesh-ancestor
138646996|NCT05638217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138249924|NCT01908842|Analgesics|analgesics|mesh-ancestor
138646997|NCT05638217|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138646998|NCT05638217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138646999|NCT05597098|Cantharidin|cantharidin|mesh-list
138647000|NCT05597098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647001|NCT05597098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647002|NCT05585151|Evolocumab|evolocumab|mesh-list
138647003|NCT05585151|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138647004|NCT05585151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138647005|NCT05585151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138647006|NCT05585151|Antimetabolites|antimetabolites|mesh-ancestor
138201431|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
138201432|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
138201433|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138201434|NCT01059929|Narcotics|narcotics|mesh-ancestor
138201435|NCT04162522|Escitalopram|escitalopram|mesh-list
138647007|NCT05585151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647008|NCT05585151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138647010|NCT05585151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647011|NCT05585151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138647012|NCT05585125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138647013|NCT05585125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138647014|NCT05585125|Adrenergic Agents|adrenergic agents|mesh-ancestor
138647015|NCT05585125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647016|NCT05585125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647017|NCT05585125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201436|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
138647019|NCT05541497|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138201437|NCT04162522|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138201438|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138201439|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138201440|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201442|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
138201443|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647020|NCT05541497|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138647021|NCT05541497|Cholinergic Agents|cholinergic agents|mesh-ancestor
138647022|NCT05541497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647023|NCT05541497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647024|NCT05541497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647025|NCT05536219|Antibodies|antibodies|mesh-list
138647026|NCT05536219|Immunologic Factors|immunologic factors|mesh-ancestor
138647027|NCT05536219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647028|NCT05440708|Bevacizumab|bevacizumab|mesh-list
138647029|NCT05440708|Pembrolizumab|pembrolizumab|mesh-list
138647030|NCT05440708|Atezolizumab|atezolizumab|mesh-list
138647031|NCT05440708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647032|NCT05440708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647033|NCT05440708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138647034|NCT05440708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138647035|NCT05440708|Growth Substances|growth substances|mesh-ancestor
138647036|NCT05440708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647037|NCT05440708|Growth Inhibitors|growth inhibitors|mesh-ancestor
138647038|NCT05440708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647039|NCT05440708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647041|NCT05435547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138647043|NCT05435547|Autonomic Agents|autonomic agents|mesh-ancestor
138647044|NCT05435547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138647045|NCT05435547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647046|NCT05435547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138647047|NCT05435547|Glucocorticoids|glucocorticoids|mesh-ancestor
138647048|NCT05435547|Hormones|hormones|mesh-ancestor
138647049|NCT05435547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138647050|NCT05435547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138647051|NCT05435547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647052|NCT05343572|Plerixafor|plerixafor|mesh-list
138647053|NCT05343572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138647054|NCT05343572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138647055|NCT05343572|Antiviral Agents|antiviral agents|mesh-ancestor
138647056|NCT05343572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138647057|NCT05313620|Adalimumab|adalimumab|mesh-list
138647058|NCT05313620|Infliximab|infliximab|mesh-list
138647059|NCT05313620|Golimumab|golimumab|mesh-list
138647060|NCT05313620|Tofacitinib|tofacitinib|mesh-list
138647061|NCT05313620|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138647062|NCT05313620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138647063|NCT05313620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138647064|NCT05313620|Dermatologic Agents|dermatologic agents|mesh-ancestor
138647065|NCT05313620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138647066|NCT05313620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138647067|NCT05313620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138647069|NCT05313620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647070|NCT05313620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138647071|NCT05313620|Immunologic Factors|immunologic factors|mesh-ancestor
138647072|NCT05313620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647073|NCT05293288|Anesthetics|anesthetics|mesh-list
138647074|NCT05293288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138647075|NCT05293288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647076|NCT05285917|Hydroxyurea|hydroxyurea|mesh-list
138647077|NCT05285917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201494|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138647078|NCT05285917|Antisickling Agents|antisickling agents|mesh-ancestor
138647079|NCT05285917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647080|NCT05285917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647081|NCT05285917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138647082|NCT05278975|Thiostrepton|thiostrepton|mesh-list
138647083|NCT05278975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138647084|NCT05278975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138647085|NCT05278494|Dextromethorphan|dextromethorphan|mesh-list
138647086|NCT05278494|Antitussive Agents|antitussive agents|mesh-ancestor
138250430|NCT05715437|Analgesics|analgesics|mesh-ancestor
138647087|NCT05278494|Respiratory System Agents|respiratory system agents|mesh-ancestor
138647088|NCT05278494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138647089|NCT05278494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138647090|NCT05278494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647091|NCT05278494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647092|NCT05278494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647093|NCT05252585|Everolimus|everolimus|mesh-list
138647094|NCT05252585|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138647095|NCT05252585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138647096|NCT05252585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647097|NCT05252585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647098|NCT05252585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138647099|NCT05252585|Immunologic Factors|immunologic factors|mesh-ancestor
138647100|NCT05252585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647101|NCT05252585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647102|NCT05222529|Glycopyrrolate|glycopyrrolate|mesh-list
138647103|NCT05222529|Bromides|bromides|mesh-list
138647104|NCT05222529|Anticonvulsants|anticonvulsants|mesh-ancestor
138647105|NCT05222529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138647106|NCT05222529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138647107|NCT05222529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138647108|NCT05222529|Cholinergic Agents|cholinergic agents|mesh-ancestor
138647109|NCT05222529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647110|NCT05222529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647111|NCT05222529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647112|NCT05203172|Cetuximab|cetuximab|mesh-list
138647113|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647114|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647115|NCT05194397|Niacinamide|niacinamide|mesh-list
138647116|NCT05194397|Niacin|niacin|mesh-list
138647117|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
138647118|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
138647119|NCT05194397|Vitamins|vitamins|mesh-ancestor
138647120|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
138647121|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647122|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138647123|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
138647124|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647125|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138647126|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
138201515|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201516|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201517|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138201518|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138201520|NCT04038970|Methotrexate|methotrexate|mesh-list
138647128|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647129|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647130|NCT05117242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647131|NCT05117242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647132|NCT05114096|Betamethasone|betamethasone|mesh-list
138647133|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
138647134|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138647135|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
138647136|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138647137|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138647138|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
138647139|NCT05114096|Hormones|hormones|mesh-ancestor
138647140|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138647141|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647142|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138647143|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
138647144|NCT05109728|Temozolomide|temozolomide|mesh-list
138647145|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138647159|NCT05000294|Atezolizumab|atezolizumab|mesh-list
138647160|NCT05000294|Tivozanib|tivozanib|mesh-list
138647161|NCT05000294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647162|NCT05000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647163|NCT05000294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647164|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647165|NCT05000294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138647166|NCT05000294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647167|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
138647169|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
138647170|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
138250875|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138647171|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138647172|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138647174|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
138250948|NCT03360903|Caffeine|caffeine|mesh-list
138647187|NCT04937153|Pembrolizumab|pembrolizumab|mesh-list
138647188|NCT04937153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647189|NCT04937153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647190|NCT04937153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138251076|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138647191|NCT04937153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647192|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
138647195|NCT04889664|Analgesics|analgesics|mesh-ancestor
138647196|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
138647197|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138647198|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647199|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138647200|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138647201|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
138647202|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
138647203|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138647204|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138647205|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138647206|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647207|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647208|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
138647210|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138647211|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647212|NCT04827992|Analgesics|analgesics|mesh-ancestor
138647213|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
138647214|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138647215|NCT04740671|Ranibizumab|ranibizumab|mesh-list
138647216|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138647217|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138647218|NCT04740671|Growth Substances|growth substances|mesh-ancestor
138647219|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647220|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
138647221|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647222|NCT04734262|Paclitaxel|paclitaxel|mesh-list
138647223|NCT04734262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138647224|NCT04734262|Tislelizumab|tislelizumab|mesh-list
138647225|NCT04734262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138647226|NCT04734262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647227|NCT04734262|Tubulin Modulators|tubulin modulators|mesh-ancestor
138647228|NCT04734262|Antimitotic Agents|antimitotic agents|mesh-ancestor
138647229|NCT04734262|Mitosis Modulators|mitosis modulators|mesh-ancestor
138647230|NCT04734262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647231|NCT04734262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647232|NCT04704661|Trastuzumab|trastuzumab|mesh-list
138647233|NCT04704661|Camptothecin|camptothecin|mesh-list
138647234|NCT04704661|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
138647235|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
138647236|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647237|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647238|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
138647239|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647240|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138647241|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138647242|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138647243|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647244|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647246|NCT04684212|Rivaroxaban|rivaroxaban|mesh-list
138647247|NCT04684212|Dabigatran|dabigatran|mesh-list
138647248|NCT04684212|Edoxaban|edoxaban|mesh-list
138647249|NCT04684212|Apixaban|apixaban|mesh-list
138647250|NCT04684212|Betrixaban|betrixaban|mesh-list
138647251|NCT04684212|Anticoagulants|anticoagulants|mesh-ancestor
138647252|NCT04684212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138647253|NCT04684212|Antithrombins|antithrombins|mesh-ancestor
138647254|NCT04684212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138647255|NCT04684212|Protease Inhibitors|protease inhibitors|mesh-ancestor
138647256|NCT04684212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647257|NCT04684212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647258|NCT04679012|Prednisone|prednisone|mesh-list
138647260|NCT04679012|Rituximab|rituximab|mesh-list
138647261|NCT04679012|Doxorubicin|doxorubicin|mesh-list
138647262|NCT04679012|Etoposide|etoposide|mesh-list
138647263|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138647264|NCT04679012|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
138647265|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138647266|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
138647267|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647268|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138647269|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138647270|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
138647271|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647272|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647273|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138647274|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647275|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138647276|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138647277|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138647278|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647279|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138647280|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
138647281|NCT04679012|Hormones|hormones|mesh-ancestor
138647282|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138647283|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138647284|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138647285|NCT04679012|Immunoconjugates|immunoconjugates|mesh-ancestor
138647286|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
138251538|NCT00001017|Amebicides|amebicides|mesh-ancestor
138647287|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647288|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647289|NCT04633278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138201535|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138647290|NCT04633278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647291|NCT04612790|Benralizumab|benralizumab|mesh-list
138647292|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138647293|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
138647294|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
138647295|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647296|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647297|NCT04602377|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647298|NCT04602377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647299|NCT04579380|Trastuzumab|trastuzumab|mesh-list
138647300|NCT04579380|Fulvestrant|fulvestrant|mesh-list
138251582|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
138647302|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647303|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647304|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138647305|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138647306|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138647307|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
138453585|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138647308|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138647309|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647310|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138647312|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647313|NCT04572295|Fulvestrant|fulvestrant|mesh-list
138647314|NCT04572295|Exemestane|exemestane|mesh-list
138647315|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138647316|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647317|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138251716|NCT00002013|Zidovudine|zidovudine|mesh-list
138647319|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
138647320|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138647321|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647322|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138647323|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138647324|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647325|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138251800|NCT05270057|Prednisone|prednisone|mesh-list
138647328|NCT04569747|Pertuzumab|pertuzumab|mesh-list
138647329|NCT04569747|Letrozole|letrozole|mesh-list
138647330|NCT04569747|Anastrozole|anastrozole|mesh-list
138647331|NCT04569747|Leuprolide|leuprolide|mesh-list
138647332|NCT04569747|Exemestane|exemestane|mesh-list
138647333|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647334|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647335|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138647336|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138647337|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647338|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647339|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138647340|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
138647341|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138647342|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647343|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138201548|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138201549|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201550|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201551|NCT01246063|Dexamethasone|dexamethasone|mesh-list
138201561|NCT01246063|Hormones|hormones|mesh-ancestor
138647344|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138647345|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138647346|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138647347|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138647348|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
138647349|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138647350|NCT04568616|Letrozole|letrozole|mesh-list
138647351|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647352|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138647353|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138647354|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647355|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647356|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138647357|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
138647358|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138647359|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647360|NCT04544189|Fulvestrant|fulvestrant|mesh-list
138647361|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138647362|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647363|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138647364|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138647365|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
138647366|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138647367|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647368|NCT04543409|Benralizumab|benralizumab|mesh-list
138647369|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138647370|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
138647371|NCT04495088|Leucovorin|leucovorin|mesh-list
138647372|NCT04495088|Folic Acid|folic acid|mesh-list
138647373|NCT04495088|Capecitabine|capecitabine|mesh-list
138647374|NCT04495088|Fluorouracil|fluorouracil|mesh-list
138647375|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
138647376|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
138647377|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138647378|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
138647379|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647380|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647381|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138647382|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
138252033|NCT00002103|Vitamins|vitamins|mesh-ancestor
138647383|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647384|NCT04495088|Antidotes|antidotes|mesh-ancestor
138647385|NCT04495088|Protective Agents|protective agents|mesh-ancestor
138647386|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
138647387|NCT04495088|Vitamins|vitamins|mesh-ancestor
138647388|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
138647389|NCT04495088|Hematinics|hematinics|mesh-ancestor
138647390|NCT04421560|Rituximab|rituximab|mesh-list
138647391|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
138647392|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647393|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647394|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
138647395|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647396|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138647397|NCT04421560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647398|NCT04421560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138378849|NCT05961761|Vasodilator Agents|vasodilator agents|mesh-ancestor
138647401|NCT04405167|Ixazomib|ixazomib|mesh-list
138201565|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138201567|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138647402|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138647403|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
138201568|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201569|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201570|NCT03836014|Dexamethasone|dexamethasone|mesh-list
138201571|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
138647404|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
138647405|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138324085|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647406|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647407|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138647408|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
138647410|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138647411|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138647412|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647413|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
138647414|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647415|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647416|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
138647417|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138647418|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138647419|NCT04405167|Growth Substances|growth substances|mesh-ancestor
138647420|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
138647421|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138647422|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138647423|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138647424|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138647425|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
138647426|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138647427|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138647429|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138647430|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
138647431|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138647432|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647433|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138647434|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138647435|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
138647436|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647437|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647438|NCT04338763|Gemcitabine|gemcitabine|mesh-list
138647439|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138647440|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
138647441|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647442|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647443|NCT04268771|Rituximab|rituximab|mesh-list
138647444|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647445|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138252262|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138647446|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
138647447|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647448|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138647449|NCT04253145|Atezolizumab|atezolizumab|mesh-list
138647450|NCT04253145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647451|NCT04253145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647452|NCT04253145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647453|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647454|NCT04251741|Adalimumab|adalimumab|mesh-list
138647455|NCT04251741|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138647456|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138647458|NCT04239339|Escitalopram|escitalopram|mesh-list
138647459|NCT04239339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138647460|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138647461|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138647462|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647463|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647464|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
138647465|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647467|NCT04222920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138647468|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138647469|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138647471|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138647472|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
138647473|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647474|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138647475|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647476|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647477|NCT04194827|Adalimumab|adalimumab|mesh-list
138647478|NCT04194827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138647479|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138647480|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138647481|NCT04158258|Bevacizumab|bevacizumab|mesh-list
138647482|NCT04158258|Trastuzumab|trastuzumab|mesh-list
138647483|NCT04158258|Atezolizumab|atezolizumab|mesh-list
138647484|NCT04158258|Pertuzumab|pertuzumab|mesh-list
138647485|NCT04158258|Capecitabine|capecitabine|mesh-list
138453586|NCT01886079|Analgesics|analgesics|mesh-ancestor
138647486|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138647487|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647488|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138647489|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138647490|NCT04158258|Growth Substances|growth substances|mesh-ancestor
138647491|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647492|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
138647493|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138647494|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
138647495|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647496|NCT04158258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138647498|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138647499|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
138252518|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138647500|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138647501|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647502|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138647504|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
138647505|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647506|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647508|NCT04116541|Dabrafenib|dabrafenib|mesh-list
138647509|NCT04116541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138647510|NCT04116541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138647511|NCT04116541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138647512|NCT04116541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647513|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
138647514|NCT04085744|Lidocaine|lidocaine|mesh-list
138647515|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
138647516|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
138647517|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138647518|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138647519|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
138647520|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138647521|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138647522|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138647523|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138647524|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138647525|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647526|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138647527|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
138647528|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138647530|NCT04030143|Antidepressive Agents|antidepressive agents|mesh-ancestor
138647531|NCT04030143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138647532|NCT04030143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138647533|NCT04030143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138647534|NCT04030143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138647535|NCT04030143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138252630|NCT00002223|Ritonavir|ritonavir|mesh-list
138647536|NCT04030143|Dopamine Agonists|dopamine agonists|mesh-ancestor
138647537|NCT04030143|Dopamine Agents|dopamine agents|mesh-ancestor
138647538|NCT04030143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138647539|NCT04030143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138647540|NCT04030143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138647541|NCT04030143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138647542|NCT04030143|Serotonin Agents|serotonin agents|mesh-ancestor
138647543|NCT04030143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138647544|NCT04030143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138647545|NCT04030143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138647546|NCT04030143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138378928|NCT05928611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138647547|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
138647548|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138647549|NCT03973489|Methamphetamine|methamphetamine|mesh-list
138647550|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138647551|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138324237|NCT04550520|Hormones|hormones|mesh-ancestor
138185759|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185760|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138185761|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
138185762|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185763|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
138185764|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185765|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
138185766|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185767|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138185768|NCT01047293|Leucovorin|leucovorin|mesh-list
138185769|NCT01047293|Bevacizumab|bevacizumab|mesh-list
138185770|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
138185771|NCT01047293|Everolimus|everolimus|mesh-list
138185772|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138185773|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185774|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138374394|NCT01427270|Narcotics|narcotics|mesh-ancestor
138185775|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138185777|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185778|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
138185779|NCT01047293|Antidotes|antidotes|mesh-ancestor
138185780|NCT01047293|Protective Agents|protective agents|mesh-ancestor
138185781|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
138185782|NCT01047293|Vitamins|vitamins|mesh-ancestor
138185783|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
138185784|NCT01047293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138185785|NCT01047293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138185786|NCT01047293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185787|NCT01047293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185788|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138185789|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
138185790|NCT01045967|Lansoprazole|lansoprazole|mesh-list
138185791|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
138185792|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138185793|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138185794|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138185795|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185796|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185797|NCT02808052|Minocycline|minocycline|mesh-list
138185798|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138185799|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185800|NCT02924350|Fluorides|fluorides|mesh-list
138185801|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
138185802|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
138185803|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
138185804|NCT02924350|Protective Agents|protective agents|mesh-ancestor
138185805|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201583|NCT03836014|Hormones|hormones|mesh-ancestor
138201584|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185806|NCT00945139|Bevacizumab|bevacizumab|mesh-list
138185807|NCT00945139|Doxorubicin|doxorubicin|mesh-list
138201585|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138185808|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138185809|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185811|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138185812|NCT00945139|Growth Substances|growth substances|mesh-ancestor
138185813|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185814|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
138185815|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138185816|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138185817|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138185818|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185819|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185820|NCT02812342|Tofacitinib|tofacitinib|mesh-list
138185821|NCT02812342|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138185822|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138185823|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185824|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185825|NCT03871465|Triamcinolone|triamcinolone|mesh-list
138185826|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138185827|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138185828|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138185829|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138185830|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
138374643|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
138185832|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185833|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185834|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138185835|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
138185836|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185837|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185838|NCT00931489|Ranibizumab|ranibizumab|mesh-list
138185839|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138185840|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138185841|NCT00931489|Growth Substances|growth substances|mesh-ancestor
138185842|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185843|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
138185844|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185846|NCT04363255|Carboplatin|carboplatin|mesh-list
138185847|NCT04363255|Etoposide|etoposide|mesh-list
138185848|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
138185849|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185850|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138185851|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138185852|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138185853|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185854|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185855|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
138185856|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138185857|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138185858|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138185859|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138185860|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185861|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
138185862|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185863|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185864|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138185865|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185868|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185869|NCT03490825|Protective Agents|protective agents|mesh-ancestor
138185870|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185871|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138185872|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138201594|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
138201595|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
138201596|NCT01205503|Doxorubicin|doxorubicin|mesh-list
138185873|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185874|NCT03317899|Lenograstim|lenograstim|mesh-list
138185876|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
138185877|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185878|NCT04353505|Dexamethasone|dexamethasone|mesh-list
138185879|NCT04353505|Ketorolac|ketorolac|mesh-list
138185880|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138185881|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
138185882|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
138185883|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138185884|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185885|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138185886|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
138185887|NCT04353505|Hormones|hormones|mesh-ancestor
138185888|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185889|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138185890|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185891|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138185892|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138185893|NCT04353505|Analgesics|analgesics|mesh-ancestor
138185894|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
138185895|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185896|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138185897|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185898|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185899|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
138185900|NCT02929927|Eusol|eusol|mesh-list
138185901|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
138185902|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138379012|NCT05849753|Pancrelipase|pancrelipase|mesh-list
138379013|NCT05849753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138185903|NCT04362241|Prednisolone|prednisolone|mesh-list
138185904|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138185905|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
138185906|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138185907|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
138185908|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138185910|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138185911|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
138185912|NCT04362241|Hormones|hormones|mesh-ancestor
138185913|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138185914|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185915|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138185916|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185917|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
138185918|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
138185920|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138185921|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138185922|NCT04362241|Protective Agents|protective agents|mesh-ancestor
138185923|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
138185924|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
138185925|NCT01384513|Busulfan|busulfan|mesh-list
138185926|NCT01384513|Fludarabine|fludarabine|mesh-list
138185927|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
138185928|NCT01384513|Tacrolimus|tacrolimus|mesh-list
138185929|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138185930|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
138201603|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201604|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185931|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185932|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185933|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138201605|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138201606|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138201608|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138185934|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
138185935|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185936|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185937|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138185938|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138185939|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
138185940|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185941|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138185942|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185943|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138185944|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138185945|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
138185946|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138185948|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
138185949|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
138185950|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138185951|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185952|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
138185953|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138379045|NCT05801315|Glycine|glycine|mesh-list
138185954|NCT02933320|Rituximab|rituximab|mesh-list
138185955|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138185956|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138185957|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
138185958|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185959|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138185960|NCT05563675|Cholinergic Agents|cholinergic agents|mesh-list
138185961|NCT05563675|Muscarinic Antagonists|muscarinic antagonists|mesh-list
138185962|NCT05563675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138185963|NCT05563675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185964|NCT05563675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185965|NCT05563675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138185967|NCT05555251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138185969|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
138185970|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
138185971|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
138185972|NCT03035305|Amodiaquine|amodiaquine|mesh-list
138185973|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
138185974|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138185975|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138185976|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185977|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138185978|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138185979|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185980|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138185981|NCT03034759|Insulin|insulin|mesh-list
138185982|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138185983|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138185985|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138185986|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
138185987|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138185988|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138375017|NCT01431404|Etanercept|etanercept|mesh-list
138185989|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
138185990|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138185991|NCT04361461|Azithromycin|azithromycin|mesh-list
138185992|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
138185993|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138185994|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138185995|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
138185996|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138185997|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138375069|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
138185999|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201617|NCT03187834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138201618|NCT03187834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138201619|NCT01206595|Bupivacaine|bupivacaine|mesh-list
138201620|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
138186000|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138186002|NCT03002506|Ceftolozane|ceftolozane|mesh-list
138186003|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
138186004|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138186005|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186006|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138186007|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186008|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186009|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138186010|NCT02822950|Ceftazidime|ceftazidime|mesh-list
138186011|NCT02822950|Avibactam|avibactam|mesh-list
138186012|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
138186013|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138186014|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186015|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138186016|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186017|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186018|NCT02935738|Prednisolone|prednisolone|mesh-list
138186019|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138186020|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
138186021|NCT02935738|Hormones|hormones|mesh-ancestor
138186022|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138186023|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138375140|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
138186024|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138186025|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186026|NCT00939991|Bevacizumab|bevacizumab|mesh-list
138186027|NCT00939991|Temozolomide|temozolomide|mesh-list
138186028|NCT00939991|Vorinostat|vorinostat|mesh-list
138186029|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138186030|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186031|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138186032|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138186033|NCT00939991|Growth Substances|growth substances|mesh-ancestor
138186034|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186035|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
138186036|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138186037|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
138186038|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186039|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138186040|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186041|NCT04361305|Tadalafil|tadalafil|mesh-list
138186042|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
138186043|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138186044|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138186045|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186046|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186047|NCT04361305|Urological Agents|urological agents|mesh-ancestor
138186049|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
138186050|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
138186051|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
138186052|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186053|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186055|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138186056|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
138186057|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
138186058|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186059|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186060|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
138186061|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186062|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138186063|NCT00947167|Pertuzumab|pertuzumab|mesh-list
138186064|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201625|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186065|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138186066|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186067|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186068|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138186069|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
138186070|NCT04360759|Chloroquine|chloroquine|mesh-list
138186071|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
138186072|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138186073|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138186074|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186075|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186076|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186077|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138186078|NCT04360759|Amebicides|amebicides|mesh-ancestor
138186079|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138186080|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138186081|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138201635|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138201636|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201637|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138201638|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138201639|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138201640|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138201641|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186082|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
138186083|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186084|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186085|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138186086|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138186087|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
138186089|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
138186090|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138186091|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138186092|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138186093|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138186094|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186095|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
138186096|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186097|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186098|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138186099|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186100|NCT03033121|Hormones|hormones|mesh-list
138186101|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138186102|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186104|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138186105|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
138186106|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
138186107|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186108|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186109|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138186110|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
138186111|NCT03033199|Hormones|hormones|mesh-ancestor
138186112|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138186113|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138186114|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186115|NCT00940927|Albuterol|albuterol|mesh-list
138186116|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138186117|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
138186118|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186119|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186120|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138186121|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
138186122|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
138186123|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138186124|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138186125|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138186126|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138379156|NCT05603104|Dopamine Agents|dopamine agents|mesh-ancestor
138186127|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
138186128|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186129|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186130|NCT00934375|Donepezil|donepezil|mesh-list
138186131|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138186132|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186133|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186134|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
138186135|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186136|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186137|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
138186138|NCT03002974|Triamcinolone|triamcinolone|mesh-list
138186139|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138186140|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138186141|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138186142|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138186143|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138186144|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
138186145|NCT03002974|Hormones|hormones|mesh-ancestor
138186146|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138186147|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186148|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138186149|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
138186150|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186151|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186153|NCT02245477|Mitogens|mitogens|mesh-list
138186154|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
138186155|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
138186156|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186157|NCT02245477|Growth Substances|growth substances|mesh-ancestor
138186158|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186160|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
138186161|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
138186162|NCT02825212|Ledipasvir|ledipasvir|mesh-list
138186163|NCT02825212|Velpatasvir|velpatasvir|mesh-list
138186164|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
138186165|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186166|NCT00373672|Modafinil|modafinil|mesh-list
138186167|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138186168|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186169|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138186170|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138186171|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138186172|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186174|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138186175|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138186176|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186177|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
138186178|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186179|NCT04359511|Prednisone|prednisone|mesh-list
138186180|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
138186181|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138186182|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
138186183|NCT04359511|Hormones|hormones|mesh-ancestor
138186184|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138186185|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186186|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138186187|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186188|NCT03032419|Vaccines|vaccines|mesh-list
138186189|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
138186190|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186191|NCT00373906|Bortezomib|bortezomib|mesh-list
138186192|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186193|NCT00955513|Diclofenac|diclofenac|mesh-list
138186194|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138375789|NCT01435980|Incretins|incretins|mesh-ancestor
138186195|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138186196|NCT00955513|Analgesics|analgesics|mesh-ancestor
138186197|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
138186198|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186199|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186200|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138186201|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138186202|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138186203|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186204|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186205|NCT00935311|Acetaminophen|acetaminophen|mesh-list
138186206|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138186207|NCT00935311|Hydrocodone|hydrocodone|mesh-list
138186208|NCT00935311|Oxycodone|oxycodone|mesh-list
138186209|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138186210|NCT00935311|Analgesics|analgesics|mesh-ancestor
138186211|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
138186212|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138375835|NCT01436513|Estrogens|estrogens|mesh-ancestor
138186215|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138186216|NCT00935311|Narcotics|narcotics|mesh-ancestor
138186217|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186218|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
138186219|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
138186220|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138379216|NCT05498233|Antiemetics|antiemetics|mesh-ancestor
138186221|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138186222|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138186223|NCT02946034|Ribavirin|ribavirin|mesh-list
138186224|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
138186225|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186226|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
138186227|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186228|NCT00955747|Tagatose|tagatose|mesh-list
138186229|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138186230|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
138186231|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
138186232|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186233|NCT02946892|Carvedilol|carvedilol|mesh-list
138186234|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138186235|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138186236|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
138186237|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186238|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186239|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186240|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138186241|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
138186242|NCT02946892|Protective Agents|protective agents|mesh-ancestor
138186243|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138186244|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138186245|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138186246|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
138186247|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138186248|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138186249|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
138186250|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
138186251|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138186252|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138186253|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186254|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186255|NCT03402191|Urological Agents|urological agents|mesh-ancestor
138186256|NCT03402113|Midazolam|midazolam|mesh-list
138186257|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
138186258|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138186259|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186260|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186261|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138186262|NCT03402113|Analgesics|analgesics|mesh-ancestor
138186263|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
138186264|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186265|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138186266|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138186267|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138186268|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
138186269|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186270|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186271|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138186272|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138186273|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138186274|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138186275|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138186276|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
138186277|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
138186278|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
138186279|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
138186280|NCT03031405|Oxytocin|oxytocin|mesh-list
138186281|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
138186282|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138186283|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186284|NCT03031249|Cytarabine|cytarabine|mesh-list
138186286|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
138186287|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138186288|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
138186289|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201686|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
138186290|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186291|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
138201687|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201693|NCT00002896|Cobalt|cobalt|mesh-list
138186292|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186293|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138186294|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
138186295|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186296|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
138186297|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
138186298|NCT02980315|Immunomodulating Agents|immunomodulating agents|mesh-list
138186299|NCT02980315|Immunologic Factors|immunologic factors|mesh-ancestor
138186300|NCT02980315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186302|NCT01042535|Vaccines|vaccines|mesh-list
138186303|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
138186304|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186305|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138186306|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
138186307|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138186308|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138186309|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
138186310|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138186311|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138186312|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
138186313|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186314|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
138186315|NCT03031327|Protective Agents|protective agents|mesh-ancestor
138186317|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138186318|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186319|NCT04358965|Misoprostol|misoprostol|mesh-list
138186320|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
138186321|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138186322|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138186323|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186324|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
138186325|NCT04358965|Coagulants|coagulants|mesh-ancestor
138186326|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138186327|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
138186328|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138186329|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186330|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138186331|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138186332|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
138186334|NCT01041287|Nebivolol|nebivolol|mesh-list
138186335|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138186336|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138186337|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
138186338|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
138186339|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186340|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186341|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138186342|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138186343|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138186344|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
138186345|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186346|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186347|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
138186348|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138186349|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138186350|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138186351|NCT03016741|Prednisone|prednisone|mesh-list
138186352|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
138186353|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138186354|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
138186355|NCT03016741|Hormones|hormones|mesh-ancestor
138186356|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138201697|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138201698|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186357|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201699|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
138201700|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186358|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138186359|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138379305|NCT05264168|Rivaroxaban|rivaroxaban|mesh-list
138186360|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138186361|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186362|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186363|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
138186364|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138186367|NCT01042925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138186368|NCT01042925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186369|NCT01042925|Tubulin Modulators|tubulin modulators|mesh-ancestor
138186370|NCT01042925|Antimitotic Agents|antimitotic agents|mesh-ancestor
138186371|NCT01042925|Mitosis Modulators|mitosis modulators|mesh-ancestor
138186372|NCT01042925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186373|NCT01042925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138186374|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
138186375|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
138186376|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
138186377|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186378|NCT03400709|Expectorants|expectorants|mesh-ancestor
138186379|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
138186380|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138186381|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
138186382|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186383|NCT03400709|Protective Agents|protective agents|mesh-ancestor
138186384|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186386|NCT02049957|Fulvestrant|fulvestrant|mesh-list
138186387|NCT02049957|Exemestane|exemestane|mesh-list
138186388|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138186389|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186390|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138186391|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138186392|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
138186393|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138186394|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186395|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138186396|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138186397|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138379337|NCT05179512|Fluticasone|fluticasone|mesh-list
138186398|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186399|NCT03030937|Irinotecan|irinotecan|mesh-list
138186400|NCT03030937|Apatinib|apatinib|mesh-list
138186401|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138186402|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138186403|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186404|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186405|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186406|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138186407|NCT00950365|Pemetrexed|pemetrexed|mesh-list
138186408|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138186409|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186410|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186411|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186412|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138186413|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138186414|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138186415|NCT01908465|Ebastine|ebastine|mesh-list
138186416|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138186417|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
138186418|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
138186419|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201704|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
138201705|NCT00002896|Antidotes|antidotes|mesh-ancestor
138201706|NCT00002896|Protective Agents|protective agents|mesh-ancestor
138201707|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
138186420|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186421|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186422|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138186423|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
138186424|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186425|NCT02246023|Propofol|propofol|mesh-list
138186426|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138379371|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138186427|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186428|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186429|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138186430|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
138186432|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138186433|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186434|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138186435|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186436|NCT00357825|Reboxetine|reboxetine|mesh-list
138186437|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
138186438|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138186439|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138186440|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138186441|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138186442|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186443|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
138186444|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186445|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186446|NCT03400241|Bromides|bromides|mesh-list
138186447|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
138186448|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138186449|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
138186450|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186451|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186452|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138186453|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
138186454|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
138186455|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138186456|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
138186457|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186458|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186459|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
138186461|NCT05706987|Anesthetics, Local|anesthetics, local|mesh-ancestor
138186462|NCT05706987|Anesthetics|anesthetics|mesh-ancestor
138186463|NCT05706987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186464|NCT05706987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186465|NCT05706987|Sensory System Agents|sensory system agents|mesh-ancestor
138186466|NCT05706987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186467|NCT05706987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138186468|NCT05706987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138186469|NCT05706987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138186470|NCT05706987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138186471|NCT05706987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186472|NCT00729573|Tenofovir|tenofovir|mesh-list
138186473|NCT00729573|Emtricitabine|emtricitabine|mesh-list
138186474|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138186475|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
138186476|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186477|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138186478|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138186479|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186480|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186481|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138186482|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138186484|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138186485|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138186486|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186487|NCT02959359|Ribavirin|ribavirin|mesh-list
138186488|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
138186489|NCT02959359|Ledipasvir|ledipasvir|mesh-list
138186490|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
138186491|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186492|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
138186493|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186494|NCT02829034|Ranolazine|ranolazine|mesh-list
138186495|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138186496|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138186497|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186498|NCT00924209|Bevacizumab|bevacizumab|mesh-list
138186499|NCT00924209|Gemcitabine|gemcitabine|mesh-list
138186501|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138186502|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186503|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138186504|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138186505|NCT00924209|Growth Substances|growth substances|mesh-ancestor
138186506|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186507|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
138186508|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138379456|NCT05075980|Cisplatin|cisplatin|mesh-list
138186511|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138186512|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138186513|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138186514|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186515|NCT05719467|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138186516|NCT05719467|Parasympatholytics|parasympatholytics|mesh-ancestor
138186517|NCT05719467|Autonomic Agents|autonomic agents|mesh-ancestor
138186518|NCT05719467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186519|NCT05719467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186520|NCT05719467|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138186521|NCT05719467|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138186522|NCT05719467|Cholinergic Agents|cholinergic agents|mesh-ancestor
138186523|NCT05719467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186524|NCT05719467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186526|NCT03408119|Calcium|calcium|mesh-list
138186527|NCT03408119|Vitamins|vitamins|mesh-ancestor
138186528|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
138186529|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186530|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138186531|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138186532|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138186533|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
138186534|NCT04374929|Hormones|hormones|mesh-ancestor
138186535|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138186536|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186537|NCT05717361|Lidocaine|lidocaine|mesh-list
138186538|NCT05717361|Ketamine|ketamine|mesh-list
138186539|NCT05717361|Remifentanil|remifentanil|mesh-list
138376868|NCT01440439|Insulin|insulin|mesh-list
138186540|NCT05717361|Anesthetics, Local|anesthetics, local|mesh-ancestor
138186541|NCT05717361|Anesthetics|anesthetics|mesh-ancestor
138186542|NCT05717361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186543|NCT05717361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186544|NCT05717361|Sensory System Agents|sensory system agents|mesh-ancestor
138186545|NCT05717361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186546|NCT05717361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138186547|NCT05717361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138186549|NCT05717361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138186550|NCT05717361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186552|NCT05717361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138186553|NCT05717361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138186554|NCT05717361|Anesthetics, General|anesthetics, general|mesh-ancestor
138186555|NCT05717361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138186556|NCT05717361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138186557|NCT05717361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186558|NCT05717361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138186559|NCT05717361|Narcotics|narcotics|mesh-ancestor
138186560|NCT02951884|Bupivacaine|bupivacaine|mesh-list
138186561|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
138186562|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
138186563|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186564|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138349667|NCT05452434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138349668|NCT05452434|Adrenergic Agents|adrenergic agents|mesh-ancestor
138349669|NCT05452434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138349849|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186565|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
138186566|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186567|NCT05574387|Metformin|metformin|mesh-list
138186568|NCT05574387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138186569|NCT05574387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186570|NCT02978001|Glycerol|glycerol|mesh-list
138186571|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138186572|NCT02978001|Protective Agents|protective agents|mesh-ancestor
138186573|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186574|NCT02978313|Cetuximab|cetuximab|mesh-list
138186575|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138186576|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186578|NCT00014495|Bismuth|bismuth|mesh-list
138186579|NCT00014495|Antibodies|antibodies|mesh-list
138186580|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138186581|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
138186582|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186583|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138186584|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
138186585|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186586|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138377039|NCT01441297|Nintedanib|nintedanib|mesh-list
138186587|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
138186588|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186589|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138186590|NCT00014495|Antacids|antacids|mesh-ancestor
138186591|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138186592|NCT05566041|Carboplatin|carboplatin|mesh-list
138186593|NCT05566041|Etoposide|etoposide|mesh-list
138186594|NCT05566041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186595|NCT05566041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138186596|NCT05566041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138186597|NCT05566041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138186598|NCT05566041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186599|NCT05566041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186600|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
138186601|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138186602|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138186604|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
138186605|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138186606|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
138186607|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138186608|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
138186609|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
138186610|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186611|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186612|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138186613|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
138186615|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138186616|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138186617|NCT04374071|Protective Agents|protective agents|mesh-ancestor
138186618|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138186619|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186620|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
138186621|NCT00357981|Ortho Evra|ortho evra|mesh-list
138186622|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138186623|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186624|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138186625|NCT03030703|Inositol|inositol|mesh-list
138201715|NCT01249027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186626|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
138186627|NCT03030703|Vitamins|vitamins|mesh-ancestor
138186628|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
138201716|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138186629|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186630|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
138186631|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138186632|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
138186634|NCT03030469|Analgesics|analgesics|mesh-list
138186635|NCT03030469|Narcotics|narcotics|mesh-ancestor
138186636|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186637|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186638|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
138186639|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186640|NCT00952081|Clevidipine|clevidipine|mesh-list
138186641|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138186642|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138186643|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186644|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138186646|NCT05716347|Vaccines|vaccines|mesh-list
138186647|NCT05716347|Immunologic Factors|immunologic factors|mesh-ancestor
138186648|NCT05716347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186649|NCT02959840|Ondansetron|ondansetron|mesh-list
138186651|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
138186652|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
138186653|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186654|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186656|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
138186657|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
138186658|NCT02959840|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138186659|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138186660|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
138186661|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186662|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186663|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138186666|NCT04358341|Doxorubicin|doxorubicin|mesh-list
138186667|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138186668|NCT04358341|Fluorouracil|fluorouracil|mesh-list
138186670|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138186671|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186672|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138186673|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138186674|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186675|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186676|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
138186677|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138186678|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138186679|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
138186680|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186681|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138186682|NCT02978547|Metformin|metformin|mesh-list
138186683|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138377319|NCT01442935|Leucovorin|leucovorin|mesh-list
138186684|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186685|NCT02959996|Bupivacaine|bupivacaine|mesh-list
138186686|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
138186687|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
138379575|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
138186688|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186689|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186690|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
138186691|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186692|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
138186693|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138186694|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138201727|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138201728|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
138201730|NCT02992756|Mitogens|mitogens|mesh-list
138186695|NCT00929981|Prednisolone|prednisolone|mesh-list
138186696|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
138186697|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138186698|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
138186699|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138186700|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
138377382|NCT01443065|Vitamins|vitamins|mesh-ancestor
138186701|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
138186702|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186703|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186704|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138186705|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
138186706|NCT00929981|Hormones|hormones|mesh-ancestor
138186707|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138186708|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138186709|NCT00929981|Protective Agents|protective agents|mesh-ancestor
138186710|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138186711|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138186712|NCT00961441|Levetiracetam|levetiracetam|mesh-list
138186713|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
138186714|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
138186715|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
138186716|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
138379608|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138379610|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138186717|NCT02240459|Fesoterodine|fesoterodine|mesh-list
138186719|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138186720|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138186721|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
138186722|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186723|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186724|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186725|NCT02240459|Urological Agents|urological agents|mesh-ancestor
138186726|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
138186727|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
138186728|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186729|NCT02240537|Sargramostim|sargramostim|mesh-list
138186730|NCT02240537|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138186731|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
138186732|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186733|NCT02240537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138186734|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
138186735|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138186736|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186737|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138186738|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186741|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
138186742|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
138186743|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138186744|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138186745|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186746|NCT03038308|Ropinirole|ropinirole|mesh-list
138377486|NCT01443572|Desflurane|desflurane|mesh-list
138186749|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
138186750|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
138186751|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186752|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186753|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186754|NCT04358497|Ibuprofen|ibuprofen|mesh-list
138186755|NCT04358497|Polidocanol|polidocanol|mesh-list
138186756|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138186757|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138201741|NCT00002908|Vincristine|vincristine|mesh-list
138186758|NCT04358497|Analgesics|analgesics|mesh-ancestor
138201742|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
138201743|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138186759|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
138186760|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186761|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186762|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138186763|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138186764|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138186765|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186766|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186767|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138186769|NCT02851108|Primaquine|primaquine|mesh-list
138186770|NCT02851108|Phenothiazine|phenothiazine|mesh-list
138186771|NCT02851108|Methylene Blue|methylene blue|mesh-list
138186772|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
138186773|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138186774|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138186775|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186776|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186777|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186778|NCT00930293|Dexetimide|dexetimide|mesh-list
138186779|NCT00930293|Citalopram|citalopram|mesh-list
138186780|NCT00930293|Escitalopram|escitalopram|mesh-list
138186781|NCT00930293|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138186782|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138186783|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138186784|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186785|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186786|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
138186787|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186788|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138186789|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
138186790|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138186791|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138186792|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138186793|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
138186794|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
138186795|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186796|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138186797|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138186798|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
138186799|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138186800|NCT02855086|Cetuximab|cetuximab|mesh-list
138186801|NCT02855086|Antibodies|antibodies|mesh-list
138186802|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
138186803|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138379679|NCT06040489|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
138186804|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
138186805|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186808|NCT05368857|Dermatologic Agents|dermatologic agents|mesh-ancestor
138186809|NCT04347005|Allopurinol|allopurinol|mesh-list
138186810|NCT04347005|Febuxostat|febuxostat|mesh-list
138186811|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
138186812|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186813|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186814|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
138186815|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138186816|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138186817|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
138377649|NCT01444846|Ebselen|ebselen|mesh-list
138186819|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186820|NCT00358293|Tizanidine|tizanidine|mesh-list
138186821|NCT00358293|Analgesics|analgesics|mesh-ancestor
138186822|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
138186823|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186824|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186826|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138186828|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
138186830|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138186831|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138186832|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138186833|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
138186834|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186835|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186836|NCT02241083|Dopamine|dopamine|mesh-list
138186837|NCT02241083|Norepinephrine|norepinephrine|mesh-list
138186838|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138186839|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138186840|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
138186841|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186842|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186843|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186844|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
138186845|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
138186846|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186847|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138186848|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138186849|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
138186850|NCT02241083|Protective Agents|protective agents|mesh-ancestor
138186851|NCT04372589|Heparin|heparin|mesh-list
138186852|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
138186853|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138186854|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138186855|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186856|NCT04364399|Vaccines|vaccines|mesh-list
138186857|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
138186858|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186859|NCT02982551|Insulin|insulin|mesh-list
138186860|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138186861|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186862|NCT02965924|Phenylephrine|phenylephrine|mesh-list
138186863|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
138186864|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138186865|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
138186866|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
138186867|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186868|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186869|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
138186870|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138186872|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
138186873|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138186874|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138186875|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138186876|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
138186877|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186878|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186879|NCT02965924|Protective Agents|protective agents|mesh-ancestor
138186880|NCT04364321|Diazepam|diazepam|mesh-list
138186881|NCT04364321|Clonazepam|clonazepam|mesh-list
138186882|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138186883|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
138186885|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
138186886|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186887|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186888|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138186889|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138186890|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186891|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138186893|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138186894|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138186895|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138186896|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138186897|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
138186898|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
138186899|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
138186900|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
138186901|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186902|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186903|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
138186904|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138186905|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
138186906|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186907|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186908|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186910|NCT05528913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138186911|NCT05528913|Respiratory System Agents|respiratory system agents|mesh-ancestor
138186912|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138186913|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138186914|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
138186915|NCT04371965|Povidone|povidone|mesh-list
138186916|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
138186917|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
138186918|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138186919|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186920|NCT02959125|Micronutrients|micronutrients|mesh-list
138186921|NCT02959125|Trace Elements|trace elements|mesh-list
138186922|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186923|NCT02972554|Propranolol|propranolol|mesh-list
138186924|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138186925|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138186926|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
138186927|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186928|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186929|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186930|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138186931|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138186932|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
138186934|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138186935|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186936|NCT00359151|Celecoxib|celecoxib|mesh-list
138186937|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138186938|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138186939|NCT00359151|Analgesics|analgesics|mesh-ancestor
138186941|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186942|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186943|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138186944|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138186945|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138186946|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138186947|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186948|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186949|NCT02242097|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138186951|NCT02242097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138186952|NCT02242097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186953|NCT00374686|Valganciclovir|valganciclovir|mesh-list
138186954|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
138186955|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138186956|NCT04371575|Carbamazepine|carbamazepine|mesh-list
138186958|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
138186959|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
138186960|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138186961|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186962|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186963|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138186964|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138186965|NCT04371575|Analgesics|analgesics|mesh-ancestor
138186966|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
138186967|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186968|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138186969|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138186970|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186971|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138186972|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138186973|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138186974|NCT00359229|Zolpidem|zolpidem|mesh-list
138186975|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138186976|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138186977|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186978|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186979|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138186980|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
138186981|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
138186982|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138186983|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186984|NCT04371341|Bupivacaine|bupivacaine|mesh-list
138186985|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
138186986|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
138186987|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186988|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379807|NCT06039540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138186989|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
138186990|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138186991|NCT00374764|Risperidone|risperidone|mesh-list
138186992|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138186993|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
138186994|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138378292|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138186995|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138186996|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138186997|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138201750|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
138186998|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138186999|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187000|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138187001|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138187002|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
138187003|NCT04371185|Ustekinumab|ustekinumab|mesh-list
138187004|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
138187005|NCT01005355|Ramucirumab|ramucirumab|mesh-list
138187006|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187007|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
138187008|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
138187009|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138187010|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
138187011|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187012|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187013|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138187014|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
138187015|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
138187016|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138187017|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
138187018|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187019|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187020|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138187021|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138187022|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138187023|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
138187024|NCT05285943|Betamethasone|betamethasone|mesh-list
138187025|NCT05285943|Betamethasone Valerate|betamethasone valerate|mesh-list
138187026|NCT05285943|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138187027|NCT05285943|Betamethasone benzoate|betamethasone benzoate|mesh-list
138187028|NCT05285943|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138187029|NCT05285943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138187030|NCT05285943|Glucocorticoids|glucocorticoids|mesh-ancestor
138187031|NCT05285943|Hormones|hormones|mesh-ancestor
138187032|NCT05285943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138187033|NCT05285943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187034|NCT05285943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138187035|NCT05285943|Respiratory System Agents|respiratory system agents|mesh-ancestor
138187036|NCT03030001|Antibodies|antibodies|mesh-list
138187037|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
138187038|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187040|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138187041|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138187042|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138187043|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187044|NCT03030157|Pirarubicin|pirarubicin|mesh-list
138187045|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201751|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201752|NCT00002920|Tamoxifen|tamoxifen|mesh-list
138201753|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138201754|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
138201755|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138201756|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
138187046|NCT00359385|Alendronate|alendronate|mesh-list
138187047|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138187048|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187049|NCT03029455|Ivacaftor|ivacaftor|mesh-list
138187050|NCT03029455|VX-659|vx-659|mesh-list
138187051|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138187052|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138187053|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187055|NCT02245789|Propofol|propofol|mesh-list
138187056|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
138187057|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187058|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187059|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138187060|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138187061|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
138187062|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138187063|NCT02245789|Narcotics|narcotics|mesh-ancestor
138187064|NCT02245789|Analgesics|analgesics|mesh-ancestor
138187065|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
138187066|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187067|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
138187068|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
138187069|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138187070|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138187071|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138187072|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187073|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187074|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187075|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
138187076|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
138187078|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138379871|NCT06039137|Cetirizine|cetirizine|mesh-list
138187080|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187081|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187082|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187083|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138187084|NCT02242877|Telmisartan|telmisartan|mesh-list
138187085|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138187086|NCT02242877|Diuretics|diuretics|mesh-ancestor
138201764|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138187087|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
138201766|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138201767|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
138201768|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138201769|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138378465|NCT01449435|Miotics|miotics|mesh-ancestor
138187089|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138187090|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138187091|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187092|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138187093|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138187094|NCT01007071|Hormones|hormones|mesh-list
138378484|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187095|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138187096|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187098|NCT05475639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138187099|NCT05475639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138187100|NCT05475639|Analgesics|analgesics|mesh-ancestor
138187101|NCT05475639|Sensory System Agents|sensory system agents|mesh-ancestor
138187102|NCT05475639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187103|NCT05475639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187104|NCT05475639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138187105|NCT05475639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187106|NCT05475639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138187107|NCT05475639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187108|NCT05475639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187109|NCT02242955|Diazepam|diazepam|mesh-list
138187110|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138187111|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
138187112|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
138187113|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
138187114|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187115|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187116|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138378579|NCT01450163|Pregabalin|pregabalin|mesh-list
138187117|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138187118|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187119|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138187120|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138187121|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138187122|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138187123|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138187124|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138187125|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
138187126|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
138187127|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
138187128|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
138187129|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187130|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187131|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
138187132|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138187133|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187134|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138187135|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187136|NCT01008319|Citric Acid|citric acid|mesh-list
138187137|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
138187139|NCT01008319|Enclomiphene|enclomiphene|mesh-list
138187140|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
138187141|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
138187142|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
138187143|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
138187144|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
138187145|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187146|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138187147|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
138187148|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138187149|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187150|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138187152|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138187153|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138187154|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138187155|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
138187156|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138187157|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138187158|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138187159|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138187160|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187161|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187162|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187163|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
138187164|NCT00358683|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138187165|NCT00358683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138187166|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138187167|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
138187168|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187169|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187170|NCT00967369|Carboplatin|carboplatin|mesh-list
138187171|NCT00967369|Etoposide|etoposide|mesh-list
138187172|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
138187173|NCT00967369|Bortezomib|bortezomib|mesh-list
138187174|NCT00967369|Ifosfamide|ifosfamide|mesh-list
138187175|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
138187176|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
138187177|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187178|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138187179|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138187180|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138187181|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187182|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187183|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138187184|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
138187185|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
138187186|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
138187187|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
138187188|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
138187196|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138187197|NCT00968071|Decitabine|decitabine|mesh-list
138187198|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
138187199|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138187200|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
138201807|NCT01214083|Expectorants|expectorants|mesh-ancestor
138201808|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
138201809|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138201810|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
138201811|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201812|NCT01214083|Protective Agents|protective agents|mesh-ancestor
138187201|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187202|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187203|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187204|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138187205|NCT00968071|Immunotoxins|immunotoxins|mesh-ancestor
138187206|NCT00968071|Immunoconjugates|immunoconjugates|mesh-ancestor
138187207|NCT00968071|Immunologic Factors|immunologic factors|mesh-ancestor
138187208|NCT00968071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187209|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
138187210|NCT00971737|Trastuzumab|trastuzumab|mesh-list
138187211|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138187212|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
138187213|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187214|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138379960|NCT06010927|Analgesics|analgesics|mesh-ancestor
138187215|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138187216|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
138187217|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187218|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187219|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138187220|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138187222|NCT04368377|PENTA|penta|mesh-list
138187223|NCT04368377|Tirofiban|tirofiban|mesh-list
138187224|NCT04368377|Fondaparinux|fondaparinux|mesh-list
138187225|NCT04368377|Clopidogrel|clopidogrel|mesh-list
138187226|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138187227|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138187228|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138187229|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138187230|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
138187231|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187232|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187233|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187234|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138379043|NCT05814146|Dialysis Solutions|dialysis solutions|mesh-list
138187235|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138187236|NCT04368377|Analgesics|analgesics|mesh-ancestor
138187237|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
138187238|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187239|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138187240|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187241|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138187242|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138187243|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138187244|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187245|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
138187246|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138187247|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
138187248|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138187249|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
138187250|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
138187253|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
138187254|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
138187255|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138379151|NCT05603104|Serotonin Agents|serotonin agents|mesh-ancestor
138187262|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138187263|NCT05595993|Cilostazol|cilostazol|mesh-list
138187264|NCT05595993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138187265|NCT05595993|Autonomic Agents|autonomic agents|mesh-ancestor
138187266|NCT05595993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187267|NCT05595993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187268|NCT05595993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138187269|NCT05595993|Respiratory System Agents|respiratory system agents|mesh-ancestor
138380003|NCT05810649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187271|NCT05595993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138380004|NCT05810649|Viscosupplements|viscosupplements|mesh-ancestor
138187272|NCT05595993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187273|NCT05595993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138187275|NCT05595993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138187276|NCT05595993|Protective Agents|protective agents|mesh-ancestor
138187277|NCT05595993|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138187278|NCT05595993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138187279|NCT05595993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187280|NCT00972205|Paclitaxel|paclitaxel|mesh-list
138187281|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
138187282|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138187283|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187284|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
138187285|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
138187286|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
138187287|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187288|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138187289|NCT00928421|Polidocanol|polidocanol|mesh-list
138187290|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138187291|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138187292|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138187293|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138187294|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138187295|NCT00932321|Norethindrone|norethindrone|mesh-list
138187296|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
138187297|NCT00932321|Estradiol|estradiol|mesh-list
138187298|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138187299|NCT00932321|Estrogens|estrogens|mesh-ancestor
138187300|NCT00932321|Hormones|hormones|mesh-ancestor
138187301|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138187302|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187303|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138187304|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
138187305|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138187306|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138187307|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138187308|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138187309|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138187310|NCT01011829|Varenicline|varenicline|mesh-list
138187311|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138187312|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138187313|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
138187314|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187315|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187316|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187317|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138187318|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
138187319|NCT00932477|Glycerol|glycerol|mesh-list
138187320|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138187321|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138187322|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138187323|NCT00932477|Protective Agents|protective agents|mesh-ancestor
138187324|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187325|NCT00932477|Laxatives|laxatives|mesh-ancestor
138187326|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138187327|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
138187328|NCT00972439|Norinyl|norinyl|mesh-list
138187329|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
138187330|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138187331|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187332|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138187333|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
138187334|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138187335|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138187336|NCT00358371|Floxacillin|floxacillin|mesh-list
138187337|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138187338|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138187339|NCT02989714|Nivolumab|nivolumab|mesh-list
138187340|NCT02989714|Interleukin-2|interleukin-2|mesh-list
138187341|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138187342|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187343|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138187344|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187345|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138187346|NCT02989714|Analgesics|analgesics|mesh-ancestor
138187347|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
138187348|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187349|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187350|NCT05582499|Paclitaxel|paclitaxel|mesh-list
138187351|NCT05582499|Cyclophosphamide|cyclophosphamide|mesh-list
138187352|NCT05582499|Carboplatin|carboplatin|mesh-list
138187353|NCT05582499|Trastuzumab|trastuzumab|mesh-list
138187354|NCT05582499|Letrozole|letrozole|mesh-list
138187355|NCT05582499|Epirubicin|epirubicin|mesh-list
138187356|NCT05582499|Pertuzumab|pertuzumab|mesh-list
138187357|NCT05582499|Goserelin|goserelin|mesh-list
138187358|NCT05582499|Fluzoparib|fluzoparib|mesh-list
138187359|NCT05582499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138187360|NCT05582499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187361|NCT05582499|Tubulin Modulators|tubulin modulators|mesh-ancestor
138187362|NCT05582499|Antimitotic Agents|antimitotic agents|mesh-ancestor
138187363|NCT05582499|Mitosis Modulators|mitosis modulators|mesh-ancestor
138187364|NCT05582499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138379631|NCT04879420|Teriparatide|teriparatide|mesh-list
138187365|NCT05582499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138187366|NCT05582499|Immunologic Factors|immunologic factors|mesh-ancestor
138380058|NCT05548985|Sympathomimetics|sympathomimetics|mesh-ancestor
138380059|NCT05548985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138187367|NCT05582499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187368|NCT05582499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187369|NCT05582499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138187370|NCT05582499|Alkylating Agents|alkylating agents|mesh-ancestor
138187371|NCT05582499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138187372|NCT05582499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138187373|NCT05582499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138187374|NCT05582499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138187375|NCT05582499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187376|NCT05582499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138187377|NCT05582499|Hormone Antagonists|hormone antagonists|mesh-ancestor
138187378|NCT05582499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138187379|NCT05582499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138187380|NCT05582499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138187381|NCT05582499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138187382|NCT05582499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138187383|NCT05582499|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138187385|NCT02881996|Ketorolac|ketorolac|mesh-list
138187386|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138187387|NCT02881996|Analgesics|analgesics|mesh-ancestor
138187388|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
138187389|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187390|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187391|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
138187392|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138187393|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138187394|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187395|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138187396|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187397|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187399|NCT04367831|Calcium heparin|calcium heparin|mesh-list
138187400|NCT04367831|Enoxaparin|enoxaparin|mesh-list
138187401|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
138187402|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
138187403|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138187404|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138187405|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187407|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138187408|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138187409|NCT03051646|Analgesics|analgesics|mesh-ancestor
138187410|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
138187411|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187412|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187414|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187415|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138201846|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187416|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138187417|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380082|NCT05473741|Dopamine Agents|dopamine agents|mesh-ancestor
138187418|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138187419|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138187420|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187421|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
138187424|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
138187425|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138379949|NCT06037434|Protease Inhibitors|protease inhibitors|mesh-ancestor
138187426|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138187428|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138187429|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187430|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138187431|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187432|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
138187433|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
138187434|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138187435|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187437|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
138187438|NCT00359853|Norfloxacin|norfloxacin|mesh-list
138187439|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138187440|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138187441|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138187442|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138187443|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187444|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187445|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187446|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138187447|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138187448|NCT05168709|Vaccines|vaccines|mesh-list
138380069|NCT05473741|Risperidone|risperidone|mesh-list
138187449|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
138187450|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187451|NCT03111316|Dinoprostone|dinoprostone|mesh-list
138187452|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
138187453|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138187454|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187455|NCT03054844|Lidocaine|lidocaine|mesh-list
138187456|NCT03054844|Midazolam|midazolam|mesh-list
138187457|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
138187458|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
138380109|NCT05401214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138187460|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187461|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
138187462|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187463|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138187464|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138187465|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138187466|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138187467|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187468|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138187469|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138187471|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138187473|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138187474|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
138187475|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
138187476|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
138187477|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187478|NCT05405595|Pembrolizumab|pembrolizumab|mesh-list
138187479|NCT05405595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138187480|NCT05405595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187482|NCT05405595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187483|NCT00359697|Mannitol|mannitol|mesh-list
138187484|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138187485|NCT00359697|Diuretics|diuretics|mesh-ancestor
138187486|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
138187487|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187489|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138187490|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138187491|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
138187492|NCT05120505|Metformin|metformin|mesh-list
138380180|NCT05192889|Hormones|hormones|mesh-ancestor
138187493|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138187494|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187495|NCT02977533|Acyclovir|acyclovir|mesh-list
138187496|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
138187497|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138187498|NCT01012297|Bevacizumab|bevacizumab|mesh-list
138380248|NCT05113784|Meplazumab|meplazumab|mesh-list
138187499|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138187501|NCT01012297|Docetaxel|docetaxel|mesh-list
138187502|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
138187503|NCT01012297|Antibodies|antibodies|mesh-list
138187504|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
138187505|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138187506|NCT01012297|Lenograstim|lenograstim|mesh-list
138380142|NCT05223673|Trifluridine|trifluridine|mesh-list
138187508|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187509|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138187510|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138187511|NCT01012297|Growth Substances|growth substances|mesh-ancestor
138187512|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187513|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
138187515|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138187516|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
138187517|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187518|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
138187519|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
138187520|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
138187521|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138187523|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187524|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138187525|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138187526|NCT00923117|Growth Substances|growth substances|mesh-ancestor
138187527|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187528|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
138187529|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138187530|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187531|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187532|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
138187533|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138187534|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138187535|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
138187536|NCT02977611|Hematinics|hematinics|mesh-ancestor
138187537|NCT04360655|Antibodies|antibodies|mesh-list
138187538|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138187539|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
138187540|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187541|NCT00375232|Montelukast|montelukast|mesh-list
138187542|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138380378|NCT04421079|Resveratrol|resveratrol|mesh-list
138187543|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
138380172|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380175|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
138187546|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138187547|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187548|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138187549|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138187550|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187552|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138187553|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
138187554|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
138187555|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187556|NCT02244437|Acetaminophen|acetaminophen|mesh-list
138187557|NCT02244437|Ibuprofen|ibuprofen|mesh-list
138187558|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138187559|NCT02244437|Analgesics|analgesics|mesh-ancestor
138187560|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
138187561|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187562|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187563|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
138187564|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138187565|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138187566|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187567|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138187568|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187569|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187570|NCT03023527|Dexamethasone|dexamethasone|mesh-list
138187571|NCT03023527|Nivolumab|nivolumab|mesh-list
138187572|NCT03023527|Pomalidomide|pomalidomide|mesh-list
138187573|NCT03023527|Elotuzumab|elotuzumab|mesh-list
138187574|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138187575|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
138187576|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
138187577|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187578|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187579|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138187581|NCT03023527|Hormones|hormones|mesh-ancestor
138187582|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138187583|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138187584|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187585|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138187586|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138187587|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187588|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
138380549|NCT03404180|Propofol|propofol|mesh-list
138187589|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138187590|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138187591|NCT03023527|Growth Substances|growth substances|mesh-ancestor
138187592|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
138187593|NCT04878627|Cannabidiol|cannabidiol|mesh-list
138187594|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
138380211|NCT05168163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138187597|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187598|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187599|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138187601|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
138187602|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187603|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138187604|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138187605|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138187606|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
138187607|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187608|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187610|NCT04360031|Tacrolimus|tacrolimus|mesh-list
138187611|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138187612|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
138187613|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187614|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138187615|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187616|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187617|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138187618|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187619|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138187620|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
138187621|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138187622|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138187623|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
138187624|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
138187625|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
138187627|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187629|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138187630|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138187631|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187632|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138187633|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138187634|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
138187635|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187638|NCT03023059|Carbidopa|carbidopa|mesh-list
138187639|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
138187640|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138201859|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138201860|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138201861|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201862|NCT00383656|Hormones|hormones|mesh-list
138187641|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138187642|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
138187643|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187644|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187645|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187646|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138187647|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187648|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138187649|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
138187650|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
138187651|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
138187652|NCT02244827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138187653|NCT02244827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187654|NCT02244827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187655|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138187656|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138187657|NCT04359485|Glycolic acid|glycolic acid|mesh-list
138187658|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
138187659|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
138187661|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
138187662|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138187663|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187664|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187665|NCT02244281|Tamsulosin|tamsulosin|mesh-list
138187666|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138187667|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138187668|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138187669|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
138187670|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187671|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187672|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187673|NCT02244281|Urological Agents|urological agents|mesh-ancestor
138187674|NCT00361413|Alefacept|alefacept|mesh-list
138187675|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
138187676|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
138187677|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187678|NCT03062488|Acetaminophen|acetaminophen|mesh-list
138187679|NCT03062488|Fentanyl|fentanyl|mesh-list
138187680|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138187682|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187683|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187685|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
138187686|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187687|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138187688|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138187690|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
138187691|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138187692|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
138187693|NCT00936299|Bupropion|bupropion|mesh-list
138187694|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138187695|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
138187696|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138187697|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138381025|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
138187698|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138187699|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138187700|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187701|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
138187702|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201868|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187703|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201869|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201870|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187704|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138187705|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138187706|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187707|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138187708|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138381091|NCT04279054|Morphine|morphine|mesh-list
138187709|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187711|NCT03117634|Aflibercept|aflibercept|mesh-list
138187712|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138187713|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138187714|NCT03117634|Growth Substances|growth substances|mesh-ancestor
138187715|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187716|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
138187717|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187718|NCT00937235|Varenicline|varenicline|mesh-list
138187719|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138187720|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138187721|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
138187722|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187723|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187724|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187726|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
138187727|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138187728|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138187729|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187730|NCT05405608|Ondansetron|ondansetron|mesh-list
138187731|NCT05405608|Antiemetics|antiemetics|mesh-ancestor
138187732|NCT05405608|Autonomic Agents|autonomic agents|mesh-ancestor
138187733|NCT05405608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187734|NCT05405608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187735|NCT05405608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138187736|NCT05405608|Antipruritics|antipruritics|mesh-ancestor
138187737|NCT05405608|Dermatologic Agents|dermatologic agents|mesh-ancestor
138187738|NCT05405608|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138187739|NCT05405608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138187740|NCT05405608|Serotonin Agents|serotonin agents|mesh-ancestor
138187741|NCT05405608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138381210|NCT04019093|Ethanol|ethanol|mesh-list
138187742|NCT05405608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187743|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
138187744|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138187745|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138187746|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138187747|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138187748|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187749|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
138187750|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187751|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187752|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138187753|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187754|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
138187755|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138187756|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138187757|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187758|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
138187759|NCT00375466|Coagulants|coagulants|mesh-ancestor
138187761|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187762|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138187763|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138201879|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138201880|NCT00383812|Growth Substances|growth substances|mesh-ancestor
138201881|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201882|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
138201883|NCT02189629|Trifarotene|trifarotene|mesh-list
138201884|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
138201885|NCT00002926|Cytarabine|cytarabine|mesh-list
138187764|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187765|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
138187766|NCT04357535|Giapreza|giapreza|mesh-list
138187767|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
138187768|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
138187769|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138187770|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
138187771|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187772|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138187773|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138187775|NCT01015807|Clonidine|clonidine|mesh-list
138187776|NCT01015807|Bupivacaine|bupivacaine|mesh-list
138187777|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
138380322|NCT04595825|Antibodies|antibodies|mesh-list
138380323|NCT04595825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138187778|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
138187779|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187780|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187781|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
138187782|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187783|NCT01015807|Analgesics|analgesics|mesh-ancestor
138187784|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138187785|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
138187786|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
138187787|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138187788|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138187789|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138187790|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
138187791|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187792|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187794|NCT01575925|Dexamethasone|dexamethasone|mesh-list
138187795|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
138187796|NCT01575925|Pomalidomide|pomalidomide|mesh-list
138187798|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138187799|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
138187800|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
138187801|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187802|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187803|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138187804|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
138187805|NCT01575925|Hormones|hormones|mesh-ancestor
138187806|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138187807|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138187808|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187809|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
138187810|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187811|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187812|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
138187813|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138187814|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138187815|NCT01575925|Growth Substances|growth substances|mesh-ancestor
138187816|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
138187817|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138187818|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
138187819|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138187821|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
138380353|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
138380354|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187822|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138187823|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187824|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187825|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138187827|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
138187828|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187829|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138187830|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138187831|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138187832|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
138187833|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187834|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187836|NCT04359095|Emtricitabine|emtricitabine|mesh-list
138187837|NCT04359095|Colchicine|colchicine|mesh-list
138187838|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138187839|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
138187840|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138187841|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138187842|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138187843|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187844|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187845|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138187846|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138187847|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138187848|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138187849|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
138187850|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138187851|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138187852|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
138187853|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187854|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
138380383|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187855|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
138187856|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
138187857|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187858|NCT02163421|Vedolizumab|vedolizumab|mesh-list
138187859|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138187862|NCT02982395|Mitomycins|mitomycins|mesh-list
138187863|NCT02982395|Mitomycin|mitomycin|mesh-list
138187864|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187865|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
138187866|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
138187867|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
138187868|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381837|NCT00544115|Cyclosporine|cyclosporine|mesh-list
138187869|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138187870|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
138187871|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138187873|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138187874|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138187875|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138187876|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187877|NCT02982005|Brodalumab|brodalumab|mesh-list
138187878|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
138187879|NCT04736836|Rifaximin|rifaximin|mesh-list
138187880|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138187881|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138187882|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138187883|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138187884|NCT03126370|Emtricitabine|emtricitabine|mesh-list
138187885|NCT03126370|Tenofovir|tenofovir|mesh-list
138187886|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
138187887|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
138187888|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138187889|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138187890|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187891|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187892|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
138187893|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138187894|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138187896|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138187897|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
138381965|NCT01460030|Cinacalcet|cinacalcet|mesh-list
138187898|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138187899|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138187900|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138187901|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201888|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138201889|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201890|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138201891|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138187902|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
138187903|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187904|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187905|NCT00979615|Azelastine|azelastine|mesh-list
138187906|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
138187907|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138187908|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
138187909|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187910|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187911|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138187912|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
138187913|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138187914|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187915|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187916|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138187917|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138187918|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138187919|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
138462785|NCT05411757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187920|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
138187921|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187922|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138187923|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138380464|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187926|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138187927|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187928|NCT03126682|Bupropion|bupropion|mesh-list
138187929|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138187930|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
138187931|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138187932|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138187933|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138187934|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138382082|NCT01460836|Aztreonam|aztreonam|mesh-list
138187935|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187937|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138187938|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187939|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138187940|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138187941|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187942|NCT05236738|Atazanavir Sulfate|atazanavir sulfate|mesh-list
138187943|NCT05236738|Cobicistat|cobicistat|mesh-list
138187944|NCT05236738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138187945|NCT05236738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138187946|NCT05236738|Protease Inhibitors|protease inhibitors|mesh-ancestor
138187947|NCT05236738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187948|NCT05236738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187949|NCT05236738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138187950|NCT05236738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138187951|NCT05236738|Antiviral Agents|antiviral agents|mesh-ancestor
138187952|NCT05236738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138187953|NCT05236738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138187954|NCT05236738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138187955|NCT00980395|Rituximab|rituximab|mesh-list
138187956|NCT00980395|Bortezomib|bortezomib|mesh-list
138187957|NCT00980395|Cladribine|cladribine|mesh-list
138187958|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138187959|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187960|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
138187961|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187962|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138187963|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138187964|NCT02976597|Morphine|morphine|mesh-list
138187965|NCT02976597|Bupivacaine|bupivacaine|mesh-list
138187966|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
138187967|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
138380505|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187971|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138187972|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138187973|NCT02976597|Narcotics|narcotics|mesh-ancestor
138187974|NCT02976597|Analgesics|analgesics|mesh-ancestor
138187975|NCT03020329|Paclitaxel|paclitaxel|mesh-list
138187976|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138187977|NCT03020329|Cisplatin|cisplatin|mesh-list
138187978|NCT03020329|Fluorouracil|fluorouracil|mesh-list
138187979|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138187980|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138187981|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
138187982|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
138187983|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
138187984|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187985|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
138187986|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138187987|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138187988|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
138187989|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138187990|NCT00980785|Ramipril|ramipril|mesh-list
138187991|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138187992|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
138187993|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138187994|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138187995|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138382391|NCT01464099|Insulin|insulin|mesh-list
138188005|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188006|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138188008|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138188009|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188011|NCT05026905|Paclitaxel|paclitaxel|mesh-list
138188012|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138188013|NCT05026905|Gemcitabine|gemcitabine|mesh-list
138188014|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
138382466|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
138188015|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138188016|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188017|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
138188018|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
138188019|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
138188020|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188021|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138188023|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188025|NCT05026905|Protective Agents|protective agents|mesh-ancestor
138188026|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
138188028|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
138188029|NCT00982189|Lisinopril|lisinopril|mesh-list
138188030|NCT00982189|Pravastatin|pravastatin|mesh-list
138188031|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138188032|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138188033|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
138382584|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188034|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188035|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138188036|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138188037|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188038|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138188039|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
138188040|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138188041|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138188042|NCT00982189|Protective Agents|protective agents|mesh-ancestor
138188043|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188053|NCT03128008|Paclitaxel|paclitaxel|mesh-list
138188054|NCT03128008|Carboplatin|carboplatin|mesh-list
138188055|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138188056|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382658|NCT01467596|Lidocaine|lidocaine|mesh-list
138188057|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
138188058|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
138188059|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
138188060|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188061|NCT05017311|Escitalopram|escitalopram|mesh-list
138188062|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
138188063|NCT05017311|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138188064|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138188065|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138188066|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188067|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188070|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
138188072|NCT00360087|Bosentan|bosentan|mesh-list
138188073|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138188074|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
138188075|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188076|NCT00982423|Furosemide|furosemide|mesh-list
138188077|NCT00982423|Diuretics|diuretics|mesh-ancestor
138188078|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
138380564|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
138380566|NCT03390686|Paclitaxel|paclitaxel|mesh-list
138188080|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138188081|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138188082|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188084|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188085|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188086|NCT02981719|Gemcitabine|gemcitabine|mesh-list
138188088|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
138188089|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188090|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188092|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138188093|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188094|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188095|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
138188096|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188097|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188098|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
138188099|NCT04718961|Volixibat|volixibat|mesh-list
138188100|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138188101|NCT03130738|Miconazole|miconazole|mesh-list
138188102|NCT03130738|Clotrimazole|clotrimazole|mesh-list
138188103|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
138188104|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188105|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138188106|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138188107|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188108|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188109|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138188110|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
138188111|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138188112|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188113|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138188114|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138188115|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138188116|NCT00984139|Vaccines|vaccines|mesh-list
138188117|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
138188118|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188120|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
138188121|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
138188122|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188123|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138188124|NCT00985543|Ritonavir|ritonavir|mesh-list
138188125|NCT00985543|Lopinavir|lopinavir|mesh-list
138188126|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
138188127|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138188128|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
138188129|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188130|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380592|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138188131|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138188132|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138188133|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
138188134|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188135|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138188136|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138188138|NCT05394415|Carboplatin|carboplatin|mesh-list
138188139|NCT05394415|Tislelizumab|tislelizumab|mesh-list
138201900|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188140|NCT05394415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138188141|NCT05394415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188142|NCT05394415|Tubulin Modulators|tubulin modulators|mesh-ancestor
138188143|NCT05394415|Antimitotic Agents|antimitotic agents|mesh-ancestor
138188144|NCT05394415|Mitosis Modulators|mitosis modulators|mesh-ancestor
138383002|NCT06076837|Amebicides|amebicides|mesh-ancestor
138188145|NCT05394415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188146|NCT05394415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138188148|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
138188149|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188150|NCT00360945|Temozolomide|temozolomide|mesh-list
138188151|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188152|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138188153|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
138188154|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188155|NCT03019237|Omalizumab|omalizumab|mesh-list
138188156|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138188157|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138188158|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
138188160|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138188161|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138188162|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138188163|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138188164|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188165|NCT00986401|Metformin|metformin|mesh-list
138188166|NCT00986401|Trospium chloride|trospium chloride|mesh-list
138188167|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138188168|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188169|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
138188170|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
138188171|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188172|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138188173|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138188175|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188176|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188177|NCT00986401|Urological Agents|urological agents|mesh-ancestor
138188179|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
138188180|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138188181|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138188182|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188183|NCT00987415|Allopurinol|allopurinol|mesh-list
138188184|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
138188185|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188186|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188187|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
138383194|NCT06072248|Meropenem|meropenem|mesh-list
138188188|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138188189|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138188190|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
138188191|NCT00987415|Protective Agents|protective agents|mesh-ancestor
138188192|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188193|NCT04807504|Ropivacaine|ropivacaine|mesh-list
138188194|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
138188195|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
138188196|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188197|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188198|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
138188199|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188200|NCT04707118|Paclitaxel|paclitaxel|mesh-list
138188201|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138188202|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138188203|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188204|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
138188205|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
138188206|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
138201909|NCT02898610|Colchicine|colchicine|mesh-list
138188207|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188209|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
138188210|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138188211|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
138188212|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138188213|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138380647|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
138188214|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
138380648|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188215|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
138188216|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138188217|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138188218|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138188220|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
138188221|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
138188223|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
138188224|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
138188225|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138188226|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138188227|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138188228|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188229|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188230|NCT00375622|Tamoxifen|tamoxifen|mesh-list
138188231|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138188232|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
138188233|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138188234|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188235|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138188236|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188237|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138188238|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138188239|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138188240|NCT03087604|Lidocaine|lidocaine|mesh-list
138188241|NCT03087604|Epinephrine|epinephrine|mesh-list
138188242|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
138188243|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
138188244|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188245|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383441|NCT05788328|Dabigatran|dabigatran|mesh-list
138188246|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
138188247|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188248|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138188249|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138188250|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138188251|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138188252|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188253|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138188255|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
138188256|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188257|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138188258|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138188259|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
138188260|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138188261|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
138188262|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
138188263|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
138380678|NCT02807207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138188264|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138188265|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138188266|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
138188267|NCT00987727|Glycerol|glycerol|mesh-list
138188268|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138188269|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
138188270|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188271|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
138188272|NCT00987727|Protective Agents|protective agents|mesh-ancestor
138188273|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138188274|NCT00987727|Laxatives|laxatives|mesh-ancestor
138188275|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138188276|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138188277|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138188278|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138188279|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138188280|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188282|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138188283|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188284|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
138188285|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138188286|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
138188287|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138188288|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188289|NCT04913337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138188290|NCT04913337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188291|NCT05386459|Interferons|interferons|mesh-list
138462786|NCT05411757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138462787|NCT05411757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138462788|NCT05411757|Growth Substances|growth substances|mesh-ancestor
138462789|NCT05411757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462790|NCT05411757|Growth Inhibitors|growth inhibitors|mesh-ancestor
138462791|NCT05411757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138462792|NCT05411757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462793|NCT05411757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462794|NCT05411666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138462795|NCT05411276|Maleic acid|maleic acid|mesh-list
138462796|NCT05411276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462797|NCT05411276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462798|NCT05396781|Proflavine|proflavine|mesh-list
138462799|NCT05396781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138462800|NCT05396781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462801|NCT05303038|Bevacizumab|bevacizumab|mesh-list
138462802|NCT05303038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138462803|NCT05303038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462804|NCT05303038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138462805|NCT05303038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138462806|NCT05303038|Growth Substances|growth substances|mesh-ancestor
138462807|NCT05303038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462809|NCT05077800|Losartan|losartan|mesh-list
138462810|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138462811|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138462812|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138462813|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138462814|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462815|NCT05042674|Ergothioneine|ergothioneine|mesh-list
138462816|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
138462817|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462818|NCT05042674|Protective Agents|protective agents|mesh-ancestor
138462819|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462820|NCT04927585|Vaccines|vaccines|mesh-list
138462821|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
138462822|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462823|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
138462825|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462826|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462827|NCT04898478|Analgesics|analgesics|mesh-ancestor
138462828|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
138462829|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462830|NCT04725864|Progesterone|progesterone|mesh-list
138462831|NCT04725864|Progestins|progestins|mesh-ancestor
138462832|NCT04725864|Hormones|hormones|mesh-ancestor
138201921|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138201922|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138201923|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138201924|NCT00002932|Cisplatin|cisplatin|mesh-list
138201925|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201926|NCT01572662|Methotrexate|methotrexate|mesh-list
138201927|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
138201928|NCT01572662|Fludarabine|fludarabine|mesh-list
138201929|NCT01572662|Busulfan|busulfan|mesh-list
138462833|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138462834|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462835|NCT04721821|Tofacitinib|tofacitinib|mesh-list
138462836|NCT04721821|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
138462837|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138462838|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383870|NCT05104866|Gemcitabine|gemcitabine|mesh-list
138462839|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462840|NCT04655391|Decitabine|decitabine|mesh-list
138462841|NCT04655391|Venetoclax|venetoclax|mesh-list
138462842|NCT04655391|Ivosidenib|ivosidenib|mesh-list
138462843|NCT04655391|Maleic acid|maleic acid|mesh-list
138462844|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138462845|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
138462846|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462847|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462848|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380728|NCT02265770|Methotrexate|methotrexate|mesh-list
138462851|NCT04609098|Tafenoquine|tafenoquine|mesh-list
138462852|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
138462853|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138462854|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138462855|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462857|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
138462858|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138462859|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462860|NCT04605614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138462861|NCT04605614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462862|NCT04605614|Trace Elements|trace elements|mesh-ancestor
138462863|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
138462864|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462865|NCT04475016|Paclitaxel|paclitaxel|mesh-list
138462866|NCT04475016|Ifosfamide|ifosfamide|mesh-list
138462867|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138462868|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
138462869|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138462870|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462871|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
138384003|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
138462873|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
138462874|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462875|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138462876|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
138462877|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138462878|NCT04321551|Letrozole|letrozole|mesh-list
138462879|NCT04321551|Methyltestosterone|methyltestosterone|mesh-list
138462880|NCT04321551|Testosterone|testosterone|mesh-list
138462881|NCT04321551|Testosterone undecanoate|testosterone undecanoate|mesh-list
138462882|NCT04321551|Testosterone enanthate|testosterone enanthate|mesh-list
138462883|NCT04321551|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138462884|NCT04321551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462885|NCT04321551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138462886|NCT04321551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138462887|NCT04321551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462888|NCT04321551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462889|NCT04321551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138380762|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462891|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138462892|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462894|NCT04321551|Hormones|hormones|mesh-ancestor
138462895|NCT04321551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138201932|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
138462896|NCT04321551|Anabolic Agents|anabolic agents|mesh-ancestor
138462897|NCT04174781|Immunomodulating Agents|immunomodulating agents|mesh-list
138462898|NCT04174781|Immunologic Factors|immunologic factors|mesh-ancestor
138462899|NCT04174781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462900|NCT04074460|Propofol|propofol|mesh-list
138462901|NCT04074460|Sevoflurane|sevoflurane|mesh-list
138462902|NCT04074460|Desflurane|desflurane|mesh-list
138462903|NCT04074460|Isoflurane|isoflurane|mesh-list
138462904|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138462905|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462906|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462907|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138462908|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
138462909|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
138462910|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138462911|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138462912|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138462913|NCT03817125|Vancomycin|vancomycin|mesh-list
138462914|NCT03817125|Nivolumab|nivolumab|mesh-list
138462915|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138462916|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138462917|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138462918|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462919|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462921|NCT03703102|Dermatologic Agents|dermatologic agents|mesh-ancestor
138462922|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
138462923|NCT03581370|Cephalosporins|cephalosporins|mesh-list
138462924|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
138462925|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138462926|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462927|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138462928|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138462929|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138380798|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138380804|NCT01376505|Vaccines|vaccines|mesh-list
138462930|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462931|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138462932|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138462933|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
138462934|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462935|NCT03539055|Dabigatran|dabigatran|mesh-list
138462936|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
138188292|NCT05386459|Interferon-gamma|interferon-gamma|mesh-list
138462937|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138462938|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
138462939|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462940|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462941|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
138462942|NCT03485534|Tenofovir|tenofovir|mesh-list
138462943|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
138462944|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462945|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138462946|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138462947|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138462948|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462949|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138462950|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138201944|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138462951|NCT03395704|Hepcidins|hepcidins|mesh-list
138201951|NCT01258153|MEN 11420|men 11420|mesh-list
138462952|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138462953|NCT03246503|Bilirubin|bilirubin|mesh-list
138462954|NCT03246503|Antioxidants|antioxidants|mesh-ancestor
138462955|NCT03246503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462956|NCT03246503|Protective Agents|protective agents|mesh-ancestor
138462957|NCT03246503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462958|NCT03091881|Granisetron|granisetron|mesh-list
138462959|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
138201962|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462960|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
138201963|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138201964|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
138201965|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138201966|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138201967|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
138462961|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462962|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462963|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138462964|NCT03091881|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138462965|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138462966|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
138462967|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462968|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462969|NCT02864368|Temozolomide|temozolomide|mesh-list
138462970|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138462971|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
138462972|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462973|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138380832|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138380837|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
138462974|NCT02856698|Midazolam|midazolam|mesh-list
138462975|NCT02856698|Morphine|morphine|mesh-list
138462976|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138462977|NCT02856698|Narcotics|narcotics|mesh-ancestor
138462978|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138462979|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138462980|NCT02856698|Analgesics|analgesics|mesh-ancestor
138462981|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
138462982|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138462983|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138462984|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138462985|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138462986|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138462987|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138462988|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138462989|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
138462990|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
138462991|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
138462992|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
138462993|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138462994|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138462995|NCT02625610|Leucovorin|leucovorin|mesh-list
138462996|NCT02625610|Capecitabine|capecitabine|mesh-list
138462997|NCT02625610|Fluorouracil|fluorouracil|mesh-list
138462998|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
138462999|NCT02625610|Avelumab|avelumab|mesh-list
138463000|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
138380862|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138463001|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138463002|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
138463003|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384298|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
138380863|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138380864|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138463005|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138463006|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
138463007|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463009|NCT02625610|Protective Agents|protective agents|mesh-ancestor
138463010|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
138463012|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
138463013|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138463014|NCT02515591|Dimercaprol|dimercaprol|mesh-list
138463015|NCT02515591|Chelating Agents|chelating agents|mesh-ancestor
138463016|NCT02515591|Sequestering Agents|sequestering agents|mesh-ancestor
138463017|NCT02515591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463018|NCT02514447|Topotecan|topotecan|mesh-list
138202025|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202026|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
138463019|NCT02514447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138463020|NCT02514447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202031|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
138463021|NCT02514447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463022|NCT02514447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463023|NCT02514447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463024|NCT02257346|Lidocaine|lidocaine|mesh-list
138463025|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
138463026|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
138463027|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463028|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463029|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
138463030|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463031|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138463032|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138463033|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138463034|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138463035|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463036|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
138463037|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
138463038|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
138463039|NCT00712322|Darifenacin|darifenacin|mesh-list
138463040|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138463041|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138463042|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
138463043|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463044|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384364|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
138463045|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463046|NCT00712322|Urological Agents|urological agents|mesh-ancestor
138463047|NCT00323856|Factor VIII|factor viii|mesh-list
138463048|NCT00323856|Coagulants|coagulants|mesh-ancestor
138463049|NCT05415150|Fibrinolytic Agents|fibrinolytic agents|mesh-list
138463050|NCT05415150|Eptifibatide|eptifibatide|mesh-list
138380911|NCT04742777|Sirolimus|sirolimus|mesh-list
138463051|NCT05415150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138463052|NCT05415150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138463053|NCT05415150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463054|NCT05414942|Analgesics, Opioid|analgesics, opioid|mesh-list
138463055|NCT05414942|Narcotics|narcotics|mesh-ancestor
138463056|NCT05414942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463057|NCT05414942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463058|NCT05414942|Analgesics|analgesics|mesh-ancestor
138463059|NCT05414942|Sensory System Agents|sensory system agents|mesh-ancestor
138463060|NCT05414942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463061|NCT05414721|Anesthetics|anesthetics|mesh-list
138463063|NCT05414721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463064|NCT05414721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463065|NCT05414721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138463066|NCT05414721|Anesthetics, General|anesthetics, general|mesh-ancestor
138463067|NCT05414669|Allopurinol|allopurinol|mesh-list
138202036|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
138202037|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202038|NCT00002950|Topotecan|topotecan|mesh-list
138463068|NCT05414669|Antimetabolites|antimetabolites|mesh-ancestor
138463069|NCT05414669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463070|NCT05414669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463071|NCT05414669|Gout Suppressants|gout suppressants|mesh-ancestor
138463072|NCT05414669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138384422|NCT04093362|Gemcitabine|gemcitabine|mesh-list
138463073|NCT05414669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138463074|NCT05414669|Antioxidants|antioxidants|mesh-ancestor
138463075|NCT05414669|Protective Agents|protective agents|mesh-ancestor
138463076|NCT05414669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463077|NCT05414149|Ranibizumab|ranibizumab|mesh-list
138463078|NCT05414149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138463079|NCT05414149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138463080|NCT05414149|Growth Substances|growth substances|mesh-ancestor
138463081|NCT05414149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463082|NCT05414149|Growth Inhibitors|growth inhibitors|mesh-ancestor
138463083|NCT05414149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463084|NCT05413902|Acetaminophen|acetaminophen|mesh-list
138463085|NCT05413902|Methylprednisolone|methylprednisolone|mesh-list
138463086|NCT05413902|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138463087|NCT05413902|Lidocaine|lidocaine|mesh-list
138463088|NCT05413902|Epinephrine|epinephrine|mesh-list
138463089|NCT05413902|Morphine|morphine|mesh-list
138463091|NCT05413902|Gabapentin|gabapentin|mesh-list
138463092|NCT05413902|Orphenadrine|orphenadrine|mesh-list
138463093|NCT05413902|Bupivacaine|bupivacaine|mesh-list
138463094|NCT05413902|Anesthetics, Local|anesthetics, local|mesh-ancestor
138463095|NCT05413902|Anesthetics|anesthetics|mesh-ancestor
138463097|NCT05413902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463098|NCT05413902|Sensory System Agents|sensory system agents|mesh-ancestor
138463099|NCT05413902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463100|NCT05413902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138463101|NCT05413902|Analgesics|analgesics|mesh-ancestor
138463102|NCT05413902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138463103|NCT05413902|Antipyretics|antipyretics|mesh-ancestor
138463104|NCT05413902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463105|NCT05413902|Antiemetics|antiemetics|mesh-ancestor
138463106|NCT05413902|Autonomic Agents|autonomic agents|mesh-ancestor
138463107|NCT05413902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463108|NCT05413902|Glucocorticoids|glucocorticoids|mesh-ancestor
138463109|NCT05413902|Hormones|hormones|mesh-ancestor
138463110|NCT05413902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138463111|NCT05413902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138463112|NCT05413902|Protective Agents|protective agents|mesh-ancestor
138463113|NCT05413902|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138463114|NCT05413902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138463115|NCT05413902|Adrenergic Agents|adrenergic agents|mesh-ancestor
138463116|NCT05413902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463117|NCT05413902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463118|NCT05413902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138463119|NCT05413902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138463120|NCT05413902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138463121|NCT05413902|Respiratory System Agents|respiratory system agents|mesh-ancestor
138463122|NCT05413902|Mydriatics|mydriatics|mesh-ancestor
138463123|NCT05413902|Sympathomimetics|sympathomimetics|mesh-ancestor
138463124|NCT05413902|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138463125|NCT05413902|Anticonvulsants|anticonvulsants|mesh-ancestor
138463126|NCT05413902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138463127|NCT05413902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138463128|NCT05413902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138463129|NCT05413902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138463130|NCT05413902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138463131|NCT05413902|Antimanic Agents|antimanic agents|mesh-ancestor
138463132|NCT05413902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138463133|NCT05413902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138463134|NCT05413902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138463135|NCT05413902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138463136|NCT05413902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138463137|NCT05413902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138463138|NCT05413902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138463139|NCT05413902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463140|NCT05413902|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138380963|NCT04666740|Olaparib|olaparib|mesh-list
138463141|NCT05413902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138463142|NCT05413902|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138463143|NCT05413902|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138380964|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138463144|NCT05413902|Parasympatholytics|parasympatholytics|mesh-ancestor
138463145|NCT05413902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138463146|NCT05413902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138463147|NCT05413902|Cholinergic Agents|cholinergic agents|mesh-ancestor
138463148|NCT05413902|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
138463149|NCT05413902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138463150|NCT05413746|Antioxidants|antioxidants|mesh-list
138463151|NCT05413746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463152|NCT05413746|Protective Agents|protective agents|mesh-ancestor
138463153|NCT05413746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463155|NCT05409365|Immunoglobulins|immunoglobulins|mesh-list
138463156|NCT05409365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138463157|NCT05409365|Immunologic Factors|immunologic factors|mesh-ancestor
138463158|NCT05409365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463159|NCT05397587|Vaccines|vaccines|mesh-list
138463160|NCT05397587|Immunologic Factors|immunologic factors|mesh-ancestor
138463161|NCT05397587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463162|NCT05352178|Ascorbic Acid|ascorbic acid|mesh-list
138463163|NCT05352178|Methyltestosterone|methyltestosterone|mesh-list
138463164|NCT05352178|Androgens|androgens|mesh-list
138463165|NCT05352178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138463166|NCT05352178|Hormones|hormones|mesh-ancestor
138463167|NCT05352178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138463168|NCT05352178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463170|NCT05352178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463171|NCT05352178|Protective Agents|protective agents|mesh-ancestor
138463172|NCT05352178|Vitamins|vitamins|mesh-ancestor
138463173|NCT05352178|Micronutrients|micronutrients|mesh-ancestor
138463174|NCT05352178|Estrogens|estrogens|mesh-ancestor
138463175|NCT05352178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138463176|NCT05352178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463177|NCT05352178|Anabolic Agents|anabolic agents|mesh-ancestor
138463178|NCT05328141|Ascorbic Acid|ascorbic acid|mesh-list
138463179|NCT05328141|Antioxidants|antioxidants|mesh-ancestor
138463180|NCT05328141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463181|NCT05328141|Protective Agents|protective agents|mesh-ancestor
138463182|NCT05328141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463183|NCT05328141|Vitamins|vitamins|mesh-ancestor
138463184|NCT05328141|Micronutrients|micronutrients|mesh-ancestor
138463185|NCT05310916|Dapagliflozin|dapagliflozin|mesh-list
138463186|NCT05310916|Hypoglycemic Agents|hypoglycemic agents|mesh-list
138463187|NCT05310916|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138463188|NCT05310916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463189|NCT05310916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463190|NCT05233709|Fesoterodine|fesoterodine|mesh-list
138463191|NCT05233709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138463192|NCT05233709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138463193|NCT05233709|Cholinergic Agents|cholinergic agents|mesh-ancestor
138463194|NCT05233709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463195|NCT05233709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463196|NCT05233709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463197|NCT05233709|Urological Agents|urological agents|mesh-ancestor
138463198|NCT05173896|Tadalafil|tadalafil|mesh-list
138463199|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
138463200|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138463201|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138463202|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463203|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463204|NCT05173896|Urological Agents|urological agents|mesh-ancestor
138463205|NCT05111821|Deferiprone|deferiprone|mesh-list
138463206|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138463207|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
138463208|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
138463209|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463210|NCT05105282|Anesthetics|anesthetics|mesh-list
138463211|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
138463212|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463213|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463214|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
138463215|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463216|NCT05005455|Bevacizumab|bevacizumab|mesh-list
138463217|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138463218|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463219|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138463220|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138463221|NCT05005455|Growth Substances|growth substances|mesh-ancestor
138463222|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463223|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
138463225|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138381029|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
138463228|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138463229|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138463230|NCT04641234|Growth Substances|growth substances|mesh-ancestor
138463231|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463232|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
138463233|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463234|NCT04636034|Anesthetics|anesthetics|mesh-list
138463235|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
138463236|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463237|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463238|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
138463239|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463241|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
138463242|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463243|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463244|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138463245|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138463246|NCT04435795|Ciclesonide|ciclesonide|mesh-list
138463247|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
138463248|NCT04435795|Hormones|hormones|mesh-ancestor
138463249|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138463250|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463251|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138463252|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
138463253|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138463254|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463255|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138463256|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463257|NCT04222283|Emtricitabine|emtricitabine|mesh-list
138463258|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
138463259|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138463260|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138463261|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138463262|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463263|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463264|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138381060|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
138463268|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138463269|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
138463270|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138463271|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463272|NCT03962998|Lactulose|lactulose|mesh-list
138463273|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463274|NCT03859635|Bupivacaine|bupivacaine|mesh-list
138463275|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
138463276|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
138463277|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463278|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202061|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138463279|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
138463280|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463281|NCT03783013|Lycopene|lycopene|mesh-list
138463282|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463283|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
138463284|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463285|NCT03783013|Protective Agents|protective agents|mesh-ancestor
138463286|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463287|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138463288|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138463289|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463290|NCT03726229|Cholic Acids|cholic acids|mesh-list
138463291|NCT03726229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463292|NCT03712228|Antibodies|antibodies|mesh-list
138463293|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138463294|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
138463295|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463296|NCT03626922|Folic Acid|folic acid|mesh-list
138463297|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
138463298|NCT03626922|Dexamethasone|dexamethasone|mesh-list
138463299|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
138463300|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
138463301|NCT03626922|Pemetrexed|pemetrexed|mesh-list
138463302|NCT03626922|Vitamins|vitamins|mesh-ancestor
138463303|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
138463304|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463305|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463306|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
138463307|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
138463308|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463309|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138381093|NCT04279054|Narcotics|narcotics|mesh-ancestor
138463310|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
138463311|NCT03626922|Hormones|hormones|mesh-ancestor
138463312|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138463313|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138463314|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381095|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463315|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138463316|NCT03626922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138463317|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384871|NCT02681211|Promethazine|promethazine|mesh-list
138463318|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463319|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138381117|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138463320|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138463321|NCT03626922|Hematinics|hematinics|mesh-ancestor
138463322|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
138463324|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463325|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
138463326|NCT03600818|Hormones|hormones|mesh-ancestor
138463327|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138463328|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463329|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138463330|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463331|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
138463332|NCT03578276|Prednisolone|prednisolone|mesh-list
138202081|NCT04780412|Misoprostol|misoprostol|mesh-list
138202082|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138463334|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
138463335|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138202083|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
138202084|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138202085|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463336|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
138463337|NCT03578276|Bromfenac|bromfenac|mesh-list
138463338|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138463339|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
138463340|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463341|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
138463342|NCT03578276|Hormones|hormones|mesh-ancestor
138463343|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138463344|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463345|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138463346|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463347|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
138463348|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
138463349|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463350|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463351|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138463352|NCT03578276|Protective Agents|protective agents|mesh-ancestor
138463353|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138463354|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138463355|NCT03578276|Analgesics|analgesics|mesh-ancestor
138463356|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
138463357|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138463358|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138463359|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138463361|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138463362|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138463363|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138463365|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463367|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463368|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
138463369|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
138463370|NCT03174184|Amoxicillin|amoxicillin|mesh-list
138463371|NCT03174184|Rifampin|rifampin|mesh-list
138463372|NCT03174184|Meropenem|meropenem|mesh-list
138463373|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
138463374|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
138463375|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138463376|NCT03174184|Rifamycins|rifamycins|mesh-list
138463377|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138463378|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138463379|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138463380|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
138463381|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
138385035|NCT02248597|Fludarabine|fludarabine|mesh-list
138463382|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138463383|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463384|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463385|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138463386|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138202095|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202096|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202097|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138202098|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202099|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202100|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202101|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202102|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
138202104|NCT00754364|Gemcitabine|gemcitabine|mesh-list
138202105|NCT00754364|Pemetrexed|pemetrexed|mesh-list
138202106|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202107|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138463387|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138463388|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138463390|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138463391|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138463393|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138463394|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
138463395|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463396|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463397|NCT02959697|Lidocaine|lidocaine|mesh-list
138463398|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
138463399|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
138463400|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463401|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138381145|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463402|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
138463403|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463405|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138463406|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138463407|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138463408|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463409|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
138463410|NCT02900560|Azacitidine|azacitidine|mesh-list
138463412|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138463413|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463414|NCT02900560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138463415|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463416|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138463417|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
138463418|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463419|NCT02877550|Venetoclax|venetoclax|mesh-list
138463420|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
138463421|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463422|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138463423|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
138463424|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463425|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138463426|NCT02775812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138463427|NCT02775812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463428|NCT02679170|Crizotinib|crizotinib|mesh-list
138463429|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463430|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138463431|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463432|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463433|NCT02518009|Estrogens|estrogens|mesh-list
138463434|NCT02518009|Androgens|androgens|mesh-list
138463435|NCT02518009|Hormones|hormones|mesh-ancestor
138463436|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138463437|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463438|NCT02238496|Sirolimus|sirolimus|mesh-list
138463439|NCT02238496|Temsirolimus|temsirolimus|mesh-list
138463440|NCT02238496|MTOR Inhibitors|mtor inhibitors|mesh-list
138463441|NCT02238496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138463442|NCT02238496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463443|NCT02238496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463445|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
138463446|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463447|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463448|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138463449|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138463450|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138463451|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
138463453|NCT02034110|Dabrafenib|dabrafenib|mesh-list
138463454|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138381177|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463455|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138463456|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463457|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463459|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138463460|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463461|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463462|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463463|NCT01498458|Capecitabine|capecitabine|mesh-list
138463464|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138463465|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
138463466|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463467|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463468|NCT01427712|Pancrelipase|pancrelipase|mesh-list
138463469|NCT01427712|Pancreatin|pancreatin|mesh-list
138463470|NCT01427712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463471|NCT01369147|Clevidipine|clevidipine|mesh-list
138463472|NCT01369147|Propofol|propofol|mesh-list
138463473|NCT01369147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138463474|NCT01369147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138385221|NCT01035463|Cytarabine|cytarabine|mesh-list
138463475|NCT01369147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463476|NCT01369147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138463477|NCT01369147|Anesthetics, General|anesthetics, general|mesh-ancestor
138463478|NCT01369147|Anesthetics|anesthetics|mesh-ancestor
138463479|NCT01369147|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138463480|NCT01369147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138463481|NCT01369147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463482|NCT01369147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138463484|NCT01197066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138463485|NCT01197066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463486|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138463487|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
138463488|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463489|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138463490|NCT01945840|Hormones|hormones|mesh-list
138463491|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138463492|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463493|NCT01945879|Heparin|heparin|mesh-list
138463494|NCT01945879|Enoxaparin|enoxaparin|mesh-list
138463495|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
138463496|NCT01945879|Tinzaparin|tinzaparin|mesh-list
138463497|NCT01945879|Dalteparin|dalteparin|mesh-list
138463498|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
138463500|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138463501|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463502|NCT01945892|Dexamethasone|dexamethasone|mesh-list
138463503|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463504|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
138463505|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
138463506|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463507|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463508|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463509|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
138463510|NCT01945892|Hormones|hormones|mesh-ancestor
138463511|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138463512|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138463513|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463514|NCT01945957|Oxytocin|oxytocin|mesh-list
138463515|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
138463516|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138202109|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202110|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463517|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463518|NCT01945983|Norepinephrine|norepinephrine|mesh-list
138463519|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138463520|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138463521|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
138463522|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463523|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463524|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463525|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
138463526|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
138463527|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463528|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138463529|NCT01946009|Cidofovir|cidofovir|mesh-list
138463530|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
138463531|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138463532|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385369|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463533|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463535|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138463536|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138463537|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138463538|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138463539|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
138463540|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463541|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463542|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138188293|NCT05386459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463543|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
138463544|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463545|NCT01946256|Amoxicillin|amoxicillin|mesh-list
138463546|NCT01946256|Erythromycin|erythromycin|mesh-list
138381236|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138463547|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
138463548|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
138463549|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
138463550|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138463551|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138463552|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463553|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138463554|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463555|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463557|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138463558|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463559|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138463560|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
138463561|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
138463562|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463563|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463564|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463565|NCT01946386|Betamethasone|betamethasone|mesh-list
138463566|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
138463567|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138463568|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
138463569|NCT01946386|Clobetasol|clobetasol|mesh-list
138463570|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138463571|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463573|NCT01946386|Hormones|hormones|mesh-ancestor
138463574|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138463575|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463576|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138463577|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
138463578|NCT01946399|Dexamethasone|dexamethasone|mesh-list
138463579|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463580|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
138463581|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
138463582|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463583|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463584|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463585|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
138463586|NCT01946399|Hormones|hormones|mesh-ancestor
138463587|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138463588|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138463589|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463590|NCT01946555|Fentanyl|fentanyl|mesh-list
138463591|NCT01946555|Morphine|morphine|mesh-list
138463592|NCT01946555|Oxycodone|oxycodone|mesh-list
138463593|NCT01946555|Buprenorphine|buprenorphine|mesh-list
138463594|NCT01946555|Methadone|methadone|mesh-list
138463595|NCT01946555|Hydromorphone|hydromorphone|mesh-list
138463596|NCT01946555|Tapentadol|tapentadol|mesh-list
138463597|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138463599|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463600|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463601|NCT01946555|Analgesics|analgesics|mesh-ancestor
138463602|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
138463603|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463605|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138463607|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
138463608|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138463609|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
138463610|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
138463611|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138463613|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138463614|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463615|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
138463616|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463617|NCT01946568|Dalbavancin|dalbavancin|mesh-list
138463618|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138463619|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138463620|NCT01946594|Acetaminophen|acetaminophen|mesh-list
138463621|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138463622|NCT01946594|Analgesics|analgesics|mesh-ancestor
138463623|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
138463624|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463625|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463626|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
138463627|NCT01946607|Citalopram|citalopram|mesh-list
138463628|NCT01946607|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138463629|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138463630|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138463631|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463632|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463633|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
138463634|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463635|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138463636|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
138463637|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138463638|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
138463641|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463642|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463643|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138463644|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
138463645|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138463646|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138463647|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138463648|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
138463649|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138381280|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138463650|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463652|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138463653|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138463654|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463655|NCT01946971|Lansoprazole|lansoprazole|mesh-list
138463656|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
138463657|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138463658|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463659|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138463660|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463661|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463663|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
138463664|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138463665|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138463666|NCT01946984|Analgesics|analgesics|mesh-ancestor
138463667|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
138463668|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349832|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
138349833|NCT04095624|Narcotics|narcotics|mesh-ancestor
138349838|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138349840|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138463669|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463670|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463671|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138463672|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138463673|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385620|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
138463674|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463675|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138463676|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
138463677|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463678|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
138463679|NCT01947062|Cisplatin|cisplatin|mesh-list
138463680|NCT01947062|Etoposide|etoposide|mesh-list
138463681|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
138463682|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138463683|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
138463684|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463685|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138463686|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138463687|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
138463688|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463689|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463690|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138463691|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138463692|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138463693|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138463694|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463696|NCT01947114|Remifentanil|remifentanil|mesh-list
138381312|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463698|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138463699|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463700|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463701|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138463702|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
138463703|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
138463704|NCT01947114|Analgesics|analgesics|mesh-ancestor
138463705|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
138463706|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463707|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138463708|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138463709|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138463710|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463711|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463712|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138463713|NCT01947114|Narcotics|narcotics|mesh-ancestor
138463714|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
138463715|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138463716|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138463718|NCT01947205|Acetaminophen|acetaminophen|mesh-list
138463719|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
138463720|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138463721|NCT01947205|Analgesics|analgesics|mesh-ancestor
138463722|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
138463723|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463724|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463725|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
138463726|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138463727|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463728|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138463729|NCT01947309|Lenalidomide|lenalidomide|mesh-list
138463730|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
138463731|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463732|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138463733|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138463734|NCT01947309|Growth Substances|growth substances|mesh-ancestor
138463735|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
138463736|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463738|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
138381338|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
138463740|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
138463741|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138463742|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463743|NCT01947608|Ceritinib|ceritinib|mesh-list
138463744|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463745|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138463746|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463747|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463748|NCT01947660|Anesthetics|anesthetics|mesh-list
138463749|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463750|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463751|NCT01947699|Glyburide|glyburide|mesh-list
138463752|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138463753|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463754|NCT01947777|Rifampin|rifampin|mesh-list
138463755|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138463756|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
138463757|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138463758|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138463759|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
138463760|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138463761|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463762|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463763|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138463764|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138463765|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138463766|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138463767|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138463768|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138463770|NCT01947790|Pioglitazone|pioglitazone|mesh-list
138463771|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138463772|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463773|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
138463774|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138463775|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138463776|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463777|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463778|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138463779|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138463780|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138463782|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463783|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381373|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463785|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138463786|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
138463787|NCT01947920|Tramadol|tramadol|mesh-list
138463788|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138463789|NCT01947920|Narcotics|narcotics|mesh-ancestor
138463790|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463791|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463793|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
138463794|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463795|NCT01947933|Mirikizumab|mirikizumab|mesh-list
138463796|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138463797|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138463798|NCT01947933|Analgesics|analgesics|mesh-ancestor
138463799|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
138463800|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463801|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463802|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463803|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138463804|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138463805|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463806|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
138463807|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138463808|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
138202128|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202129|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202130|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202131|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
138202132|NCT00003418|Tamoxifen|tamoxifen|mesh-list
138202133|NCT00003418|Exemestane|exemestane|mesh-list
138463809|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138463810|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
138463811|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463812|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463813|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
138463814|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
138463815|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138463816|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
138463817|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138463818|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
138463819|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463820|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463821|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
138463822|NCT01947998|Warfarin|warfarin|mesh-list
138463823|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
138463824|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
138463825|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
138463826|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138463827|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
138463828|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138463829|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
138463830|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463831|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463832|NCT01948011|Racecadotril|racecadotril|mesh-list
138463834|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
138463835|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138463836|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
138463837|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381401|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138463838|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463840|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138463841|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138463842|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463843|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463844|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138463845|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
138463846|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138463847|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
138463848|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
138463849|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463850|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463851|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138463852|NCT01948115|Analgesics|analgesics|mesh-ancestor
138463853|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
138202135|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138463854|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463855|NCT01948128|Vitamin D|vitamin d|mesh-list
138202136|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
138202137|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138202138|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202139|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138202140|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202141|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138202142|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138202143|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138202144|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138202145|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138202146|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202147|NCT04777838|Amitriptyline|amitriptyline|mesh-list
138202148|NCT04777838|Citalopram|citalopram|mesh-list
138463856|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
138463857|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
138463858|NCT01948128|Vitamins|vitamins|mesh-list
138463859|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
138463860|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463861|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138463862|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138463863|NCT01948232|Perindopril|perindopril|mesh-list
138463864|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138463865|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
138463866|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463867|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463868|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138463869|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
138463870|NCT01948336|Ketamine|ketamine|mesh-list
138463871|NCT01948336|Propofol|propofol|mesh-list
138463872|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138463873|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463874|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463875|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138463876|NCT01948336|Analgesics|analgesics|mesh-ancestor
138463877|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
138463878|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463879|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138381424|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
138463881|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138463882|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
138463883|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463884|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463885|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138463886|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
138463887|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
138463888|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138463889|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138463890|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138463891|NCT01948362|Sulforaphane|sulforaphane|mesh-list
138463892|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138463893|NCT01948362|Protective Agents|protective agents|mesh-ancestor
138463894|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463895|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463896|NCT01948401|Prednisolone|prednisolone|mesh-list
138463897|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138463899|NCT01948401|Hormones|hormones|mesh-ancestor
138463900|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138463901|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463902|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138463903|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463904|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
138463905|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138463906|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
138463907|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463908|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
138463909|NCT01948583|Protective Agents|protective agents|mesh-ancestor
138463910|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
138386414|NCT01476592|Protective Agents|protective agents|mesh-ancestor
138463912|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138463913|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
138463914|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463915|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138463916|NCT01948765|Propofol|propofol|mesh-list
138463917|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138463918|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463919|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463920|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138463921|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
138463923|NCT01948804|Letrozole|letrozole|mesh-list
138381455|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381457|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463924|NCT01948804|Clomiphene|clomiphene|mesh-list
138463925|NCT01948804|Cetrorelix|cetrorelix|mesh-list
138463926|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
138463927|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463928|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138463929|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138463930|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138463931|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463932|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138463933|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
138463934|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138463935|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463936|NCT01948804|Hormones|hormones|mesh-ancestor
138463937|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138463938|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
138463939|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138463940|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138463941|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138463942|NCT01948817|Deferasirox|deferasirox|mesh-list
138463943|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138463944|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
138463945|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
138463946|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463947|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138463948|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138463949|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138463950|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138463951|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463952|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463953|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463954|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
138463955|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138463956|NCT01948921|Meperidine|meperidine|mesh-list
138463957|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138463958|NCT01948921|Narcotics|narcotics|mesh-ancestor
138463959|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138202149|NCT04777838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138202150|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138202151|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138202152|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202153|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138202154|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
138202155|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202156|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138202157|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
138202158|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138202159|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138202160|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138463960|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463961|NCT01948921|Analgesics|analgesics|mesh-ancestor
138463962|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
138463963|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138463964|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138463965|NCT01948960|Everolimus|everolimus|mesh-list
138463966|NCT01948960|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138463967|NCT01948960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138381484|NCT03170960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381485|NCT03170960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138381486|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463969|NCT01948960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463970|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138463971|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
138463972|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463973|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138463974|NCT01948999|Anesthetics|anesthetics|mesh-list
138463975|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463976|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463978|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138463979|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138463980|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138463981|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138463982|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138463983|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138463984|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
138463985|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
138463986|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138463987|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463988|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
138386571|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138463989|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138463990|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
138463991|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
138463992|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
138463993|NCT01949168|Ribavirin|ribavirin|mesh-list
138463994|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138463995|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
138463996|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138463997|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
138463998|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138463999|NCT01949233|Doxycycline|doxycycline|mesh-list
138464000|NCT01949233|Irbesartan|irbesartan|mesh-list
138464001|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138464002|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464003|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
138464004|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138464005|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138464006|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138464007|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138464008|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138464009|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464010|NCT01949363|Cefixime|cefixime|mesh-list
138464011|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138464012|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464013|NCT01949454|Fluorometholone|fluorometholone|mesh-list
138381510|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381512|NCT02874742|Dexamethasone|dexamethasone|mesh-list
138464014|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138464015|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
138464016|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138202175|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138202176|NCT00002998|Gemcitabine|gemcitabine|mesh-list
138202177|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202178|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138202179|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
138464017|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138464018|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
138464020|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138464021|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464022|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138464023|NCT01949519|Lycopene|lycopene|mesh-list
138464024|NCT01949519|Docetaxel|docetaxel|mesh-list
138464025|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464026|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
138464027|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
138464028|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
138464029|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464030|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138464031|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
138464032|NCT01949519|Protective Agents|protective agents|mesh-ancestor
138464033|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464034|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138464036|NCT01949571|Mirtazapine|mirtazapine|mesh-list
138464037|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
138464038|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138464039|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138464040|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
138464041|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
138464042|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464043|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464044|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464045|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138464046|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138464047|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138464048|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138464049|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138202180|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202181|NCT00003004|Paclitaxel|paclitaxel|mesh-list
138464050|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138464051|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
138464052|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138464053|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138464054|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
138464055|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138381537|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138464057|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
138464058|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464059|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
138464060|NCT01949766|Glycerol|glycerol|mesh-list
138464061|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
138464062|NCT01949766|Protective Agents|protective agents|mesh-ancestor
138464063|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464064|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464065|NCT01948245|Taurolidine|taurolidine|mesh-list
138464066|NCT01948245|Heparin|heparin|mesh-list
138464067|NCT01948245|Calcium heparin|calcium heparin|mesh-list
138464068|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
138464069|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464070|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138464071|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138464072|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464073|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138464074|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464075|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
138464076|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138464077|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
138464078|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464079|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
138464080|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464081|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464082|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138464083|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
138464084|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464085|NCT01949818|Prednisone|prednisone|mesh-list
138464086|NCT01949818|Prednisolone|prednisolone|mesh-list
138464087|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
138464088|NCT01949818|Doxorubicin|doxorubicin|mesh-list
138464089|NCT01949818|Vincristine|vincristine|mesh-list
138464090|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138464091|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
138464092|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464093|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138464094|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138464095|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
138464096|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464097|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464098|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138464099|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138381572|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
138386690|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138464100|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138464101|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138464102|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464103|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138464104|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
138464106|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138464107|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138464108|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138464109|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
138464110|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
138464111|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
138464112|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
138464113|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138464114|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
138464115|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464117|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138464118|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464119|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138464120|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464121|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464122|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138464123|NCT01949948|Tenecteplase|tenecteplase|mesh-list
138464124|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138464125|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138386724|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464126|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464127|NCT01950000|Fentanyl|fentanyl|mesh-list
138464128|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138464129|NCT01950000|Narcotics|narcotics|mesh-ancestor
138464130|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138464131|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464132|NCT01950000|Analgesics|analgesics|mesh-ancestor
138464133|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
138464134|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464135|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138464136|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138464137|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
138464138|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
138464139|NCT01950182|Tamoxifen|tamoxifen|mesh-list
138464140|NCT01950182|Gemcitabine|gemcitabine|mesh-list
138464141|NCT01950182|Capecitabine|capecitabine|mesh-list
138464142|NCT01950182|Trastuzumab|trastuzumab|mesh-list
138464143|NCT01950182|Vinorelbine|vinorelbine|mesh-list
138464144|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
138464145|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138464146|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
138464147|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464148|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464149|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138464150|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138381604|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464152|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
138464153|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
138464154|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138464155|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
138464156|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138464157|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464158|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138464159|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138464160|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138464161|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138464162|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138464163|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464164|NCT01950195|Ipilimumab|ipilimumab|mesh-list
138464165|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138464166|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464167|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138464168|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464169|NCT01950416|Clopidogrel|clopidogrel|mesh-list
138464170|NCT01950416|Ticagrelor|ticagrelor|mesh-list
138464171|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138464172|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138464173|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138464174|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138464175|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
138464176|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464177|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464178|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464179|NCT01950481|Ceritinib|ceritinib|mesh-list
138464180|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464181|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138464182|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464183|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464184|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
138464185|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138464186|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464187|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
138464188|NCT01950507|Fluconazole|fluconazole|mesh-list
138464189|NCT01950507|Voriconazole|voriconazole|mesh-list
138464190|NCT01950507|Micafungin|micafungin|mesh-list
138464191|NCT01950507|Budesonide|budesonide|mesh-list
138464192|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138464193|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138464194|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
138464195|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464196|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464197|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138464198|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
138464199|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
138464201|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138464202|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
138464203|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464204|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138464205|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138464206|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464207|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138386880|NCT01479088|Cinacalcet|cinacalcet|mesh-list
138464208|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138464209|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
138464210|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138464211|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138464212|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138464214|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
138464215|NCT01950546|Protective Agents|protective agents|mesh-ancestor
138464216|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464218|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464219|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
138464220|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464221|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464222|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138464223|NCT01950611|Bortezomib|bortezomib|mesh-list
138464224|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464225|NCT01950689|Nimorazole|nimorazole|mesh-list
138464226|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
138464227|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138464228|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138464229|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464230|NCT01950793|Triamcinolone|triamcinolone|mesh-list
138464231|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138464232|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138464233|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
138464234|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138464235|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138464236|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
138464237|NCT01950793|Hormones|hormones|mesh-ancestor
138464238|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138464239|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464240|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138464241|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
138464242|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464243|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464244|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138464246|NCT01950793|Protective Agents|protective agents|mesh-ancestor
138464248|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138464249|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138464250|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
138464251|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464252|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138464253|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
138464254|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464255|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
138464256|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138464257|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138464258|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464259|NCT01950923|Urological Agents|urological agents|mesh-ancestor
138464260|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138464261|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
138464262|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
138464263|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138464264|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138464265|NCT01951027|Lenograstim|lenograstim|mesh-list
138464266|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138202223|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
138464267|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
138464268|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464269|NCT01951053|Citalopram|citalopram|mesh-list
138464270|NCT01951053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138464271|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138464272|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138464273|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464274|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464275|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
138464276|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464277|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138464278|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
138464279|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138464280|NCT01951079|Digoxin|digoxin|mesh-list
138464281|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138464282|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138464283|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464284|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464285|NCT01951079|Protective Agents|protective agents|mesh-ancestor
138464286|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464287|NCT01951144|Lorazepam|lorazepam|mesh-list
138464288|NCT01951144|PF-06372865|pf-06372865|mesh-list
138464289|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
138464290|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
138464291|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
138464292|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464293|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464295|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138464296|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138464297|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138464298|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138464299|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138464300|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
138464301|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
138464302|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464303|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464304|NCT01951209|Rifaximin|rifaximin|mesh-list
138464305|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138464306|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464307|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138464308|NCT01951404|Allopurinol|allopurinol|mesh-list
138464309|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
138464310|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464311|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464312|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
138464313|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138464314|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138464316|NCT01951404|Protective Agents|protective agents|mesh-ancestor
138464317|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464318|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138464319|NCT01951430|Cephalosporins|cephalosporins|mesh-list
138464320|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
138464321|NCT01951430|Itraconazole|itraconazole|mesh-list
138464322|NCT01951430|Fluconazole|fluconazole|mesh-list
138387043|NCT01480141|Afatinib|afatinib|mesh-list
138464323|NCT01951430|Posaconazole|posaconazole|mesh-list
138464324|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
138464325|NCT01951430|Clotrimazole|clotrimazole|mesh-list
138464326|NCT01951430|Miconazole|miconazole|mesh-list
138464327|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464328|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138464329|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138464330|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464331|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464332|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138464333|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
138464334|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138464335|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464336|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138464337|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138464338|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138464339|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
138464340|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138464341|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138464342|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138464343|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138464344|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
138464345|NCT01951482|Bevacizumab|bevacizumab|mesh-list
138464346|NCT01951482|Cisplatin|cisplatin|mesh-list
138464347|NCT01951482|Pemetrexed|pemetrexed|mesh-list
138464348|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138464349|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464350|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138464351|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138464352|NCT01951482|Growth Substances|growth substances|mesh-ancestor
138464353|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464354|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
138464355|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464356|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464357|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138464358|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138464359|NCT01951508|Methylphenidate|methylphenidate|mesh-list
138464360|NCT01951508|Modafinil|modafinil|mesh-list
138464361|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138464362|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464363|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138188295|NCT05386459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464364|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138464365|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138464366|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464367|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
138464368|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464369|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138464370|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138464371|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138464372|NCT01951560|Valproic Acid|valproic acid|mesh-list
138381742|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138464374|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464375|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464376|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
138464377|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464378|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464379|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
138464380|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138464381|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138464382|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138464383|NCT01951599|Osimertinib|osimertinib|mesh-list
138464385|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138464386|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464387|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464388|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138464389|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
138464390|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464391|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138464392|NCT01951677|Antacids|antacids|mesh-ancestor
138464393|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464394|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138464396|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138464397|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138464398|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138464399|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
138464400|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464401|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464402|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138464403|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
138464404|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
138464405|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
138464406|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138349841|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
138464407|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138464408|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
138464409|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464410|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464411|NCT01951846|Nintedanib|nintedanib|mesh-list
138464412|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464413|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138464414|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464415|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464416|NCT01951872|Caffeine|caffeine|mesh-list
138464417|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138464418|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464419|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138464420|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464421|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464422|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138464423|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138464424|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
138464425|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464426|NCT01951898|Montelukast|montelukast|mesh-list
138464427|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138464428|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
138464429|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138464430|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
138464431|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138464432|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464433|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138464434|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138381777|NCT01267812|Bortezomib|bortezomib|mesh-list
138464435|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464437|NCT01951911|Analgesics|analgesics|mesh-ancestor
138464438|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
138464439|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464440|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464441|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138464442|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138464443|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
138464444|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
138464445|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138464446|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138464447|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138464448|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464449|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464450|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
138464451|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138464453|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
138464454|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
138464455|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464456|NCT01952314|Naftopidil|naftopidil|mesh-list
138464457|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138464458|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138464459|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
138464460|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464461|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464462|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464463|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138464464|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138464465|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138464466|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138464467|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138464468|NCT01952561|Dapivirine|dapivirine|mesh-list
138464469|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138464470|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138464471|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
138464473|NCT01952626|Ondansetron|ondansetron|mesh-list
138464474|NCT01952626|Palonosetron|palonosetron|mesh-list
138464475|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
138464476|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
138464477|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464478|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464479|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138464480|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
138381787|NCT01042379|Metformin|metformin|mesh-list
138464481|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
138464482|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138464483|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138464484|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
138464485|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464486|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464488|NCT01952652|Codeine|codeine|mesh-list
138464489|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138464490|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138464491|NCT01952652|Analgesics|analgesics|mesh-ancestor
138464492|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
138464493|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464494|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464495|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138464496|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138464497|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
138464498|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138464499|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464500|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464501|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138464502|NCT01952652|Narcotics|narcotics|mesh-ancestor
138464503|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138464504|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
138464505|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
138464506|NCT01952756|Cilostazol|cilostazol|mesh-list
138464507|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138464508|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
138464509|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464510|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464511|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138464512|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
138464513|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138464514|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138464515|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464516|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138464517|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
138464518|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138464519|NCT01952756|Protective Agents|protective agents|mesh-ancestor
138464520|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138464521|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138202244|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202246|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138202247|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138202248|NCT02432378|Analgesics|analgesics|mesh-ancestor
138202249|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
138202257|NCT00003466|Temozolomide|temozolomide|mesh-list
138464522|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464523|NCT01952769|Pidilizumab|pidilizumab|mesh-list
138464524|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138464525|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464527|NCT05876598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464528|NCT05876585|Ondansetron|ondansetron|mesh-list
138464529|NCT05876585|Metoclopramide|metoclopramide|mesh-list
138464530|NCT05876585|Antiemetics|antiemetics|mesh-ancestor
138464531|NCT05876585|Autonomic Agents|autonomic agents|mesh-ancestor
138464532|NCT05876585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464533|NCT05876585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464534|NCT05876585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138464535|NCT05876585|Antipruritics|antipruritics|mesh-ancestor
138464536|NCT05876585|Dermatologic Agents|dermatologic agents|mesh-ancestor
138464537|NCT05876585|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138464538|NCT05876585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138464539|NCT05876585|Serotonin Agents|serotonin agents|mesh-ancestor
138464540|NCT05876585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464541|NCT05876585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464542|NCT05876585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138464544|NCT05876585|Dopamine Agents|dopamine agents|mesh-ancestor
138464545|NCT05876481|Psilocybin|psilocybin|mesh-list
138464546|NCT05876481|Hallucinogens|hallucinogens|mesh-ancestor
138464547|NCT05876481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464548|NCT05876481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138464549|NCT05876195|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138464550|NCT05876195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
138464551|NCT05876195|Freund's Adjuvant|freund's adjuvant|mesh-list
138464552|NCT05876195|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
138464553|NCT05876195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138464554|NCT05876195|Immunologic Factors|immunologic factors|mesh-ancestor
138464555|NCT05876195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464556|NCT05876195|Antacids|antacids|mesh-ancestor
138464557|NCT05876195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464558|NCT05876195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138464559|NCT05876169|Salicylic Acid|salicylic acid|mesh-list
138464560|NCT05876169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464561|NCT05876169|Antifungal Agents|antifungal agents|mesh-ancestor
138464562|NCT05876169|Keratolytic Agents|keratolytic agents|mesh-ancestor
138464563|NCT05876169|Dermatologic Agents|dermatologic agents|mesh-ancestor
138464564|NCT05876039|Remifentanil|remifentanil|mesh-list
138464565|NCT05876039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138464566|NCT05876039|Narcotics|narcotics|mesh-ancestor
138464567|NCT05876039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138464568|NCT05876039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464569|NCT05876039|Analgesics|analgesics|mesh-ancestor
138464570|NCT05876039|Sensory System Agents|sensory system agents|mesh-ancestor
138387471|NCT01482897|Prednisolone|prednisolone|mesh-list
138464571|NCT05876039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464572|NCT05875714|Apremilast|apremilast|mesh-list
138464573|NCT05875714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138464574|NCT05875714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138464575|NCT05875714|Analgesics|analgesics|mesh-ancestor
138464576|NCT05875714|Sensory System Agents|sensory system agents|mesh-ancestor
138464577|NCT05875714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464578|NCT05875714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464579|NCT05875714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138381851|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464580|NCT05875714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138464581|NCT05875714|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
138464583|NCT05875714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464584|NCT05875714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464585|NCT05875675|Pioglitazone|pioglitazone|mesh-list
138464586|NCT05875675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138464587|NCT05875675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464588|NCT05875610|Gabapentin|gabapentin|mesh-list
138464589|NCT05875610|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138464590|NCT05875610|Analgesics|analgesics|mesh-ancestor
138464591|NCT05875610|Sensory System Agents|sensory system agents|mesh-ancestor
138464592|NCT05875610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464593|NCT05875610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464594|NCT05875610|Anticonvulsants|anticonvulsants|mesh-ancestor
138464595|NCT05875610|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138464596|NCT05875610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138464597|NCT05875610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138464599|NCT05875610|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138464600|NCT05875610|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138464601|NCT05875610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464602|NCT05875610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464603|NCT05875610|Antimanic Agents|antimanic agents|mesh-ancestor
138464604|NCT05875610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138464605|NCT05875610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138464606|NCT05875610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138464607|NCT05875610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138464608|NCT05875610|Antidepressive Agents|antidepressive agents|mesh-ancestor
138464609|NCT05875571|Ketorolac|ketorolac|mesh-list
138464610|NCT05875571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138464611|NCT05875571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138464612|NCT05875571|Analgesics|analgesics|mesh-ancestor
138464613|NCT05875571|Sensory System Agents|sensory system agents|mesh-ancestor
138464614|NCT05875571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464615|NCT05875571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464616|NCT05875571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138464617|NCT05875571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138464618|NCT05875571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138464619|NCT05875571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464620|NCT05875571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464621|NCT05875519|Nordefrin|nordefrin|mesh-list
138464622|NCT05875519|Mepivacaine|mepivacaine|mesh-list
138464623|NCT05875519|Anesthetics|anesthetics|mesh-ancestor
138464624|NCT05875519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138464625|NCT05875519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464626|NCT05875519|Anesthetics, Local|anesthetics, local|mesh-ancestor
138464627|NCT05875519|Sensory System Agents|sensory system agents|mesh-ancestor
138381869|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138464628|NCT05875519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464629|NCT05875519|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138464630|NCT05875428|Mitoxantrone|mitoxantrone|mesh-list
138464631|NCT05875428|Analgesics|analgesics|mesh-ancestor
138464632|NCT05875428|Sensory System Agents|sensory system agents|mesh-ancestor
138464633|NCT05875428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464634|NCT05875428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464635|NCT05875428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464636|NCT05875428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138464637|NCT05875428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138464638|NCT05875428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464639|NCT05875428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464640|NCT05875285|Methotrexate|methotrexate|mesh-list
138464641|NCT05875285|Coal Tar|coal tar|mesh-list
138464642|NCT05875285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138464643|NCT05875285|Abortifacient Agents|abortifacient agents|mesh-ancestor
138464644|NCT05875285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138464645|NCT05875285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464646|NCT05875285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138464647|NCT05875285|Antimetabolites|antimetabolites|mesh-ancestor
138464648|NCT05875285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464649|NCT05875285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464650|NCT05875285|Dermatologic Agents|dermatologic agents|mesh-ancestor
138464651|NCT05875285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464652|NCT05875285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138464653|NCT05875285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138464654|NCT05875285|Immunologic Factors|immunologic factors|mesh-ancestor
138464655|NCT05875285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202276|NCT00003022|Antibodies|antibodies|mesh-list
138464656|NCT05875285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138464657|NCT05875285|Keratolytic Agents|keratolytic agents|mesh-ancestor
138464658|NCT05874882|Chlorhexidine|chlorhexidine|mesh-list
138464659|NCT05874882|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138464660|NCT05874882|Resveratrol|resveratrol|mesh-list
138464661|NCT05874882|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138464663|NCT05874882|Disinfectants|disinfectants|mesh-ancestor
138464664|NCT05874882|Dermatologic Agents|dermatologic agents|mesh-ancestor
138464665|NCT05874882|Antioxidants|antioxidants|mesh-ancestor
138464666|NCT05874882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464667|NCT05874882|Protective Agents|protective agents|mesh-ancestor
138464668|NCT05874882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464669|NCT05874882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138381895|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
138464670|NCT05874882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138464671|NCT05874778|Prednisone|prednisone|mesh-list
138464672|NCT05874778|Cyclophosphamide|cyclophosphamide|mesh-list
138464673|NCT05874778|Vincristine|vincristine|mesh-list
138464674|NCT05874778|Rituximab|rituximab|mesh-list
138464675|NCT05874778|Doxorubicin|doxorubicin|mesh-list
138464676|NCT05874778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138464677|NCT05874778|Immunologic Factors|immunologic factors|mesh-ancestor
138464678|NCT05874778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464679|NCT05874778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138464680|NCT05874778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138464681|NCT05874778|Alkylating Agents|alkylating agents|mesh-ancestor
138464682|NCT05874778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464683|NCT05874778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464684|NCT05874778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138464685|NCT05874778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138464686|NCT05874778|Glucocorticoids|glucocorticoids|mesh-ancestor
138464687|NCT05874778|Hormones|hormones|mesh-ancestor
138464688|NCT05874778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138464690|NCT05874778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138464692|NCT05874778|Antimitotic Agents|antimitotic agents|mesh-ancestor
138464693|NCT05874778|Mitosis Modulators|mitosis modulators|mesh-ancestor
138464694|NCT05874778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138464695|NCT05874778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138464696|NCT05874778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138464697|NCT05874778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138464698|NCT05874778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464699|NCT05874700|Sivelestat|sivelestat|mesh-list
138464700|NCT05874700|Glycine|glycine|mesh-list
138464701|NCT05874700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138464702|NCT05874700|Protease Inhibitors|protease inhibitors|mesh-ancestor
138464703|NCT05874700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464704|NCT05874700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464705|NCT05874700|Glycine Agents|glycine agents|mesh-ancestor
138464706|NCT05874700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464707|NCT05874700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464708|NCT05874674|Nafamostat|nafamostat|mesh-list
138464709|NCT05874674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138464710|NCT05874674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138464711|NCT05874674|Analgesics|analgesics|mesh-ancestor
138464712|NCT05874674|Sensory System Agents|sensory system agents|mesh-ancestor
138464713|NCT05874674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464714|NCT05874674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464715|NCT05874674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138381928|NCT01457508|Antidotes|antidotes|mesh-ancestor
138464717|NCT05874674|Anticoagulants|anticoagulants|mesh-ancestor
138464718|NCT05874674|Protease Inhibitors|protease inhibitors|mesh-ancestor
138464719|NCT05874674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464720|NCT05874674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202280|NCT01258387|Mitogens|mitogens|mesh-list
138464721|NCT05874674|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138464722|NCT05874674|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138464723|NCT05874674|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138464724|NCT05874674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138464725|NCT05874674|Immunologic Factors|immunologic factors|mesh-ancestor
138464726|NCT05874583|Tranexamic Acid|tranexamic acid|mesh-list
138464727|NCT05874583|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138464728|NCT05874583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138464729|NCT05874583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464730|NCT05874583|Hemostatics|hemostatics|mesh-ancestor
138464731|NCT05874583|Coagulants|coagulants|mesh-ancestor
138464732|NCT05874518|Letrozole|letrozole|mesh-list
138464733|NCT05874518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464734|NCT05874518|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138464735|NCT05874518|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138464736|NCT05874518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138387903|NCT01485978|Ramipril|ramipril|mesh-list
138464737|NCT05874518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464739|NCT05874518|Hormone Antagonists|hormone antagonists|mesh-ancestor
138464740|NCT05874518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138464741|NCT05874518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464742|NCT05874505|Adalimumab|adalimumab|mesh-list
138464743|NCT05874505|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138464744|NCT05874505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138464745|NCT05874505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138464746|NCT05872412|Paclitaxel|paclitaxel|mesh-list
138464747|NCT05872412|Cyclophosphamide|cyclophosphamide|mesh-list
138464748|NCT05872412|Carboplatin|carboplatin|mesh-list
138464749|NCT05872412|Doxorubicin|doxorubicin|mesh-list
138464750|NCT05872412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138464751|NCT05872412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464752|NCT05872412|Tubulin Modulators|tubulin modulators|mesh-ancestor
138464753|NCT05872412|Antimitotic Agents|antimitotic agents|mesh-ancestor
138464754|NCT05872412|Mitosis Modulators|mitosis modulators|mesh-ancestor
138464755|NCT05872412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464756|NCT05872412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138464757|NCT05872412|Immunologic Factors|immunologic factors|mesh-ancestor
138464758|NCT05872412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464759|NCT05872412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138464760|NCT05872412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138464761|NCT05872412|Alkylating Agents|alkylating agents|mesh-ancestor
138381960|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138381961|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
138381962|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138464764|NCT05872412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138464765|NCT05872412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138464766|NCT05872412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464767|NCT05871476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138464768|NCT05871476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464769|NCT05823675|Methylprednisolone|methylprednisolone|mesh-list
138464770|NCT05823675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138464771|NCT05823675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138464772|NCT05823675|Prednisolone|prednisolone|mesh-list
138464773|NCT05823675|Prednisolone acetate|prednisolone acetate|mesh-list
138202291|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202292|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464774|NCT05823675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138464775|NCT05823675|Prednisolone phosphate|prednisolone phosphate|mesh-list
138464776|NCT05823675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138464777|NCT05823675|Antiemetics|antiemetics|mesh-ancestor
138464778|NCT05823675|Autonomic Agents|autonomic agents|mesh-ancestor
138464779|NCT05823675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464780|NCT05823675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387993|NCT01486511|Liver Extracts|liver extracts|mesh-list
138464781|NCT05823675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138464782|NCT05823675|Glucocorticoids|glucocorticoids|mesh-ancestor
138464783|NCT05823675|Hormones|hormones|mesh-ancestor
138464784|NCT05823675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138464785|NCT05823675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138464786|NCT05823675|Protective Agents|protective agents|mesh-ancestor
138464787|NCT05823675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138464788|NCT05823675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464789|NCT05874869|Piperaquine|piperaquine|mesh-list
138464790|NCT05874869|Artenimol|artenimol|mesh-list
138464791|NCT05874869|Antimalarials|antimalarials|mesh-ancestor
138464792|NCT05874869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138464793|NCT05874869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138464794|NCT05874869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464795|NCT05799820|Bevacizumab|bevacizumab|mesh-list
138464796|NCT05799820|Capecitabine|capecitabine|mesh-list
138464797|NCT05799820|Oxaliplatin|oxaliplatin|mesh-list
138464798|NCT05799820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138464799|NCT05799820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464800|NCT05799820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138464801|NCT05799820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138464802|NCT05799820|Growth Substances|growth substances|mesh-ancestor
138464803|NCT05799820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464804|NCT05799820|Growth Inhibitors|growth inhibitors|mesh-ancestor
138464805|NCT05799820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138464806|NCT05799820|Antimetabolites|antimetabolites|mesh-ancestor
138464807|NCT05799820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464809|NCT05790161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138464810|NCT05790161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464811|NCT05790161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138464812|NCT05790161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464813|NCT05790161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138381987|NCT01460212|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138464814|NCT05790161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138464815|NCT05790161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138464816|NCT05790161|Purinergic Agents|purinergic agents|mesh-ancestor
138464817|NCT05790161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464819|NCT05786040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138464820|NCT05786040|Antibodies|antibodies|mesh-list
138464821|NCT05786040|Immunoglobulins|immunoglobulins|mesh-list
138464822|NCT05786040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138464823|NCT05786040|Immunologic Factors|immunologic factors|mesh-ancestor
138464824|NCT05786040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464825|NCT05786040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464826|NCT05786040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138464827|NCT05671315|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138464828|NCT05671315|Antiviral Agents|antiviral agents|mesh-ancestor
138464829|NCT05671315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464830|NCT05641467|Methamphetamine|methamphetamine|mesh-list
138464831|NCT05641467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138464832|NCT05641467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464833|NCT05641467|Sympathomimetics|sympathomimetics|mesh-ancestor
138464834|NCT05641467|Autonomic Agents|autonomic agents|mesh-ancestor
138464835|NCT05641467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464836|NCT05641467|Dopamine Agents|dopamine agents|mesh-ancestor
138464837|NCT05641467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464838|NCT05641467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464839|NCT05641467|Adrenergic Agents|adrenergic agents|mesh-ancestor
138464840|NCT05641467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138464841|NCT05641467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138464842|NCT05641467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138464843|NCT05641467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138464844|NCT05574712|Leuprolide|leuprolide|mesh-list
138464845|NCT05574712|Abiraterone Acetate|abiraterone acetate|mesh-list
138464846|NCT05574712|Belzutifan|belzutifan|mesh-list
138464847|NCT05574712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138464848|NCT05574712|Fertility Agents|fertility agents|mesh-ancestor
138464849|NCT05574712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138464850|NCT05574712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464851|NCT05574712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138464852|NCT05574712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464853|NCT05574712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138464854|NCT05574712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464855|NCT05574712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464857|NCT05574712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138464858|NCT05574712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138464859|NCT05510063|Adalimumab|adalimumab|mesh-list
138464860|NCT05510063|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138464861|NCT05510063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138464862|NCT05510063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138464863|NCT05508815|Methotrexate|methotrexate|mesh-list
138464864|NCT05508815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138464865|NCT05508815|Abortifacient Agents|abortifacient agents|mesh-ancestor
138382006|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138464867|NCT05508815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464868|NCT05508815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138464869|NCT05508815|Antimetabolites|antimetabolites|mesh-ancestor
138464870|NCT05508815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464871|NCT05508815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464872|NCT05508815|Dermatologic Agents|dermatologic agents|mesh-ancestor
138464873|NCT05508815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464874|NCT05508815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138464875|NCT05508815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138464876|NCT05508815|Immunologic Factors|immunologic factors|mesh-ancestor
138464877|NCT05508815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138464878|NCT05508815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138464879|NCT05463861|Lemborexant|lemborexant|mesh-list
138464880|NCT05463861|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
138464881|NCT05463861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464882|NCT05463861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464883|NCT05463861|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138464884|NCT05463861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138202324|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202325|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138349847|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
138464885|NCT05463861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138464886|NCT05463861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464887|NCT05323708|Denosumab|denosumab|mesh-list
138464888|NCT05323708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138464889|NCT05323708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464890|NCT05285566|Lidocaine|lidocaine|mesh-list
138464891|NCT05285566|Bupivacaine|bupivacaine|mesh-list
138464892|NCT05285566|Anesthetics, Local|anesthetics, local|mesh-ancestor
138464893|NCT05285566|Anesthetics|anesthetics|mesh-ancestor
138464894|NCT05285566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138464895|NCT05285566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464896|NCT05285566|Sensory System Agents|sensory system agents|mesh-ancestor
138464897|NCT05285566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464898|NCT05285566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138464899|NCT05285566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138464900|NCT05285566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138464901|NCT05285566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138388326|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
138464902|NCT05285566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464903|NCT05129722|Empagliflozin|empagliflozin|mesh-list
138464904|NCT05129722|Eplerenone|eplerenone|mesh-list
138464905|NCT05129722|Bumetanide|bumetanide|mesh-list
138464906|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138464907|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464908|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138382033|NCT01460537|Gemcitabine|gemcitabine|mesh-list
138464909|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464910|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138464911|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
138464912|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138464913|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138464914|NCT05129722|Diuretics|diuretics|mesh-ancestor
138464915|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
138464916|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138464917|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138464918|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138464919|NCT05044962|Rilpivirine|rilpivirine|mesh-list
138464920|NCT05044962|Cabotegravir|cabotegravir|mesh-list
138464921|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138464922|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
138464923|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
138464924|NCT05044962|Etonogestrel|etonogestrel|mesh-list
138464925|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138464926|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
138464927|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138464928|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464929|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138464930|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138464931|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138464932|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138464933|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138464934|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138464935|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464936|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138464937|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138464938|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464939|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464940|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
138464941|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138464942|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138464943|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138464944|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138464945|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138464946|NCT05027919|Lofexidine|lofexidine|mesh-list
138464947|NCT05027919|Clonidine|clonidine|mesh-list
138464948|NCT05027919|Morphine|morphine|mesh-list
138464949|NCT05027919|Naloxone|naloxone|mesh-list
138464950|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138464951|NCT05027919|Narcotics|narcotics|mesh-ancestor
138464952|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138464953|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464954|NCT05027919|Analgesics|analgesics|mesh-ancestor
138464955|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
138464956|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464957|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138464959|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138464960|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138464961|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138464962|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
138464963|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464964|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464965|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
138464966|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
138464968|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138464969|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138388635|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138464970|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138464971|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
138464972|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464973|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464974|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464975|NCT04994431|Urological Agents|urological agents|mesh-ancestor
138464977|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138464978|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138464979|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
138464980|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138464981|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138464982|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138464983|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138464984|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138464985|NCT04912063|Azacitidine|azacitidine|mesh-list
138464986|NCT04912063|Venetoclax|venetoclax|mesh-list
138464987|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138464988|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
138464989|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388708|NCT01490268|Dsuvia|dsuvia|mesh-list
138464990|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464991|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138464993|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
138464994|NCT04853446|BB 1101|bb 1101|mesh-list
138464995|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138464996|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
138382089|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138464998|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138464999|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465000|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138465001|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
138465002|NCT04853446|Hormones|hormones|mesh-ancestor
138465003|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138465004|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138465005|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465006|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
138465007|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465008|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465009|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138465010|NCT04846231|Red yeast rice|red yeast rice|mesh-list
138465011|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138465012|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138202330|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138465013|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
138465014|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465015|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138465016|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138465017|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465018|NCT04705428|Fluorides|fluorides|mesh-list
138465019|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
138465020|NCT04705428|Protective Agents|protective agents|mesh-ancestor
138465021|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465022|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
138465023|NCT04664933|Protective Agents|protective agents|mesh-ancestor
138465024|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465025|NCT04660760|Trifluridine|trifluridine|mesh-list
138465027|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138465028|NCT04660760|Ramucirumab|ramucirumab|mesh-list
138465029|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138465030|NCT04660760|Antibodies|antibodies|mesh-list
138465031|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
138465033|NCT04660760|Lexatumumab|lexatumumab|mesh-list
138465034|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138465035|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465036|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
138465037|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
138465038|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
138465039|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465040|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
138465041|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465042|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
138465043|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
138465044|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138465045|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
138465046|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138382123|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
138465047|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138465048|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465051|NCT04507217|Carboplatin|carboplatin|mesh-list
138465052|NCT04507217|Pemetrexed|pemetrexed|mesh-list
138465053|NCT04507217|Tislelizumab|tislelizumab|mesh-list
138465054|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465055|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465056|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465057|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138465058|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138465059|NCT04507217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138465060|NCT04447846|Cannabidiol|cannabidiol|mesh-list
138465061|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
138465062|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138465063|NCT04405245|Latanoprost|latanoprost|mesh-list
138465064|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138465065|NCT04335968|Melatonin|melatonin|mesh-list
138465066|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
138465067|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465068|NCT04335968|Protective Agents|protective agents|mesh-ancestor
138465069|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465070|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138465071|NCT04262024|Cabergoline|cabergoline|mesh-list
138465072|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138465073|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138465074|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
138465075|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
138388933|NCT01491295|Tenofovir|tenofovir|mesh-list
138465076|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465077|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465078|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465080|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138465081|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
138465082|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138465083|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465084|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138465085|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
138465086|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465087|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465088|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
138465089|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465090|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138465091|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138465092|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
138465093|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138465094|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138465095|NCT04201964|Tenecteplase|tenecteplase|mesh-list
138465096|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138465097|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138465098|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465101|NCT04198805|Tocopherols|tocopherols|mesh-list
138382145|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382146|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465103|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
138465104|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
138465105|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465106|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
138465107|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465108|NCT04198805|Protective Agents|protective agents|mesh-ancestor
138465109|NCT04179890|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138465110|NCT04179890|Gefitinib|gefitinib|mesh-list
138465111|NCT04179890|Osimertinib|osimertinib|mesh-list
138465113|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465114|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138465115|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465116|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465117|NCT04084210|Nicotine|nicotine|mesh-list
138465118|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138465119|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
138465120|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465121|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465122|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138465123|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138465124|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
138465125|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465126|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465127|NCT04030026|Nalbuphine|nalbuphine|mesh-list
138465128|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138465129|NCT04030026|Narcotics|narcotics|mesh-ancestor
138465130|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138465131|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465132|NCT04030026|Analgesics|analgesics|mesh-ancestor
138465133|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
138465134|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465135|NCT03927274|Topotecan|topotecan|mesh-list
138465136|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138465137|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138465138|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465139|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465140|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202365|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138202366|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138202368|NCT04775732|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138202369|NCT04775732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138202370|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
138465141|NCT03923699|Anesthetics|anesthetics|mesh-list
138465142|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138465143|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465144|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
138465145|NCT03883880|Capsaicin|capsaicin|mesh-list
138465146|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
138465147|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
138465148|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
138465149|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465150|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465151|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
138465152|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465153|NCT03883880|Protective Agents|protective agents|mesh-ancestor
138465154|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138465155|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138465156|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465157|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138465158|NCT03801369|Durvalumab|durvalumab|mesh-list
138465159|NCT03801369|Olaparib|olaparib|mesh-list
138465160|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
138465161|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
138465162|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138465163|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
138382168|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
138465164|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138465165|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465166|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
138465167|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382184|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138465169|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465171|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
138465172|NCT03649659|Protective Agents|protective agents|mesh-ancestor
138465173|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465174|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
138465175|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
138465176|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465177|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465178|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465179|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
138465180|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
138465181|NCT03486106|Propofol|propofol|mesh-list
138389253|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
138465183|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138465184|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465185|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138465186|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
138465187|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
138465188|NCT03434275|Meloxicam|meloxicam|mesh-list
138465189|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138465190|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138465191|NCT03434275|Analgesics|analgesics|mesh-ancestor
138465192|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
138465193|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465194|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465195|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138465196|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138389310|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
138465197|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138465198|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138465199|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465200|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465201|NCT03354013|Calcium|calcium|mesh-list
138465202|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138465203|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465204|NCT03348423|Fentanyl|fentanyl|mesh-list
138465205|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138465206|NCT03348423|Narcotics|narcotics|mesh-ancestor
138465207|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138465208|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465209|NCT03348423|Analgesics|analgesics|mesh-ancestor
138465210|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
138465211|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465212|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138465213|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138465214|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
138465216|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
138465217|NCT03262142|Tazobactam|tazobactam|mesh-list
138465218|NCT03262142|Piperacillin|piperacillin|mesh-list
138465219|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
138465220|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138465221|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138465222|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138465223|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138465224|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465225|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465226|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138389427|NCT01494805|Ranibizumab|ranibizumab|mesh-list
138465227|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138465228|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138465229|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138465230|NCT03150810|Temozolomide|temozolomide|mesh-list
138465231|NCT03150810|Pamiparib|pamiparib|mesh-list
138465232|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138465233|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
138465234|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465235|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465236|NCT03150810|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138465237|NCT03150810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465238|NCT03117998|Volagidemab|volagidemab|mesh-list
138465239|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138465240|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465241|NCT03114865|Dexamethasone|dexamethasone|mesh-list
138465242|NCT03114865|Blinatumomab|blinatumomab|mesh-list
138465243|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
138465244|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138465246|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
138465247|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465248|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465249|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138465250|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
138465251|NCT03114865|Hormones|hormones|mesh-ancestor
138465252|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138465253|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138465254|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138188296|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
138465255|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
138465256|NCT02920008|Guadecitabine|guadecitabine|mesh-list
138465257|NCT02920008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465259|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138465260|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465261|NCT02766335|Docetaxel|docetaxel|mesh-list
138465263|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
138465264|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138465265|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
138382203|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138465266|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465267|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
138465268|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
138382204|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
138465269|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
138389614|NCT01495884|Lapatinib|lapatinib|mesh-list
138465270|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465271|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138465272|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
138465273|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465274|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
138465275|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138465276|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
138465277|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465278|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138202372|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202381|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
138465279|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465280|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
138389668|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
138465281|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138465283|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
138465284|NCT02739711|Protective Agents|protective agents|mesh-ancestor
138465285|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
138465286|NCT02607423|Cisplatin|cisplatin|mesh-list
138465287|NCT02607423|Gemcitabine|gemcitabine|mesh-list
138465288|NCT02607423|Docetaxel|docetaxel|mesh-list
138465289|NCT02607423|Pemetrexed|pemetrexed|mesh-list
138465290|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138465291|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465292|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138465294|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465295|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
138465296|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
138465297|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
138465298|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465299|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138465300|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138465301|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138465302|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
138465303|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138465304|NCT02577523|Levodopa|levodopa|mesh-list
138465305|NCT02577523|Carbidopa|carbidopa|mesh-list
138465306|NCT02577523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138465307|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138465308|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138465309|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
138465310|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465311|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465312|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465313|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
138465314|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465315|NCT02499328|Durvalumab|durvalumab|mesh-list
138465316|NCT02499328|Tremelimumab|tremelimumab|mesh-list
138465319|NCT02344810|Leucovorin|leucovorin|mesh-list
138465320|NCT02344810|Fluorouracil|fluorouracil|mesh-list
138465321|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
138465322|NCT02344810|Calcium|calcium|mesh-list
138465323|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
138465324|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138465325|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465326|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
138465327|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465328|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138465329|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465330|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138465331|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
138465332|NCT02344810|Antidotes|antidotes|mesh-ancestor
138465333|NCT02344810|Protective Agents|protective agents|mesh-ancestor
138465334|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
138465335|NCT02344810|Vitamins|vitamins|mesh-ancestor
138389858|NCT01497431|Selenium|selenium|mesh-list
138465337|NCT02333565|Everolimus|everolimus|mesh-list
138465338|NCT02333565|Octreotide|octreotide|mesh-list
138465339|NCT02333565|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138465340|NCT02333565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138465341|NCT02333565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465342|NCT02333565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465343|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138465344|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
138465345|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465346|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465347|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138202385|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138465348|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138465349|NCT02278185|Leuprolide|leuprolide|mesh-list
138465350|NCT02278185|Goserelin|goserelin|mesh-list
138465351|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138465352|NCT02278185|Tryptophan|tryptophan|mesh-list
138465353|NCT02278185|Androgens|androgens|mesh-list
138465354|NCT02278185|Hormones|hormones|mesh-ancestor
138465355|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138465356|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465357|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138382261|NCT01463163|Ticagrelor|ticagrelor|mesh-list
138465358|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
138465359|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138465360|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138465361|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465362|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
138465363|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138465364|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
138465365|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138465366|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138465367|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
138465368|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138465369|NCT02177695|Gemcitabine|gemcitabine|mesh-list
138465372|NCT02177695|Vinblastine|vinblastine|mesh-list
138465373|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465374|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138465375|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
138465376|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465377|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138465378|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138465379|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138465380|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465381|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138465382|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
138465383|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138465384|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465385|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
138465386|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138465387|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138465388|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
138465389|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138390084|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
138465390|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138465391|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138465392|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
138465393|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
138465394|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
138465395|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
138465397|NCT02106572|Mitomycin|mitomycin|mesh-list
138465398|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138465399|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382292|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
138465401|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465402|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138465403|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465404|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138390148|NCT01499121|Sunitinib|sunitinib|mesh-list
138465406|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
138465407|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138465408|NCT01840566|Cytarabine|cytarabine|mesh-list
138465409|NCT01840566|Etoposide|etoposide|mesh-list
138465410|NCT01840566|Melphalan|melphalan|mesh-list
138465411|NCT01840566|Carmustine|carmustine|mesh-list
138465412|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138465413|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465414|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138465415|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138465416|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465417|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465418|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138465419|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
138465420|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
138465421|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138465422|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138465423|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
138465424|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465425|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138465426|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
138465428|NCT01719237|Ropivacaine|ropivacaine|mesh-list
138465429|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
138465430|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
138465431|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
138465432|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138465433|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465434|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
138465435|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465436|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138465437|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138382326|NCT01463735|Vitamins|vitamins|mesh-ancestor
138465438|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138465439|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465440|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465441|NCT01004731|Carboplatin|carboplatin|mesh-list
138465443|NCT01004731|Cetuximab|cetuximab|mesh-list
138382327|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
138465445|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138465446|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
138465447|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465448|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138465449|NCT00771017|Leuprolide|leuprolide|mesh-list
138465450|NCT00771017|Goserelin|goserelin|mesh-list
138465451|NCT00771017|Bicalutamide|bicalutamide|mesh-list
138465452|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138465453|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
138465454|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138465455|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465456|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138465457|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465458|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
138465459|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
138465460|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138465461|NCT00499291|Paclitaxel|paclitaxel|mesh-list
138465462|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138465463|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138465464|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465465|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
138465466|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
138465467|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
138465468|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465469|NCT00318903|Docetaxel|docetaxel|mesh-list
138465470|NCT00318903|Irinotecan|irinotecan|mesh-list
138465471|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465472|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
138465473|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
138465474|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
138465475|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465476|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138465477|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138465478|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465480|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138465481|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465482|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
138465483|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465484|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138465485|NCT01952886|Ondansetron|ondansetron|mesh-list
138465486|NCT01952886|Granisetron|granisetron|mesh-list
138465487|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
138465488|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
138465489|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465490|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465491|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138465492|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
138465493|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
138465494|NCT01952886|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138465495|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138465496|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
138465497|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382358|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
138465498|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390511|NCT01501136|Hormones|hormones|mesh-ancestor
138465499|NCT01952951|Capecitabine|capecitabine|mesh-list
138465500|NCT01952951|Fluorouracil|fluorouracil|mesh-list
138465501|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
138465502|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138465503|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
138465504|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465505|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465506|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138465507|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
138465508|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465509|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
138465510|NCT01953107|Trace Elements|trace elements|mesh-ancestor
138465511|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
138465512|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465513|NCT01953172|Tocotrienols|tocotrienols|mesh-list
138465514|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
138465515|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
138390567|NCT01501370|Lenalidomide|lenalidomide|mesh-list
138465516|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465517|NCT01953172|Protective Agents|protective agents|mesh-ancestor
138465518|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465519|NCT01953172|Vitamins|vitamins|mesh-ancestor
138465520|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
138465521|NCT01953367|Tobramycin|tobramycin|mesh-list
138465522|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138465523|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138465524|NCT01953406|Fluorouracil|fluorouracil|mesh-list
138465525|NCT01953406|Mitomycins|mitomycins|mesh-list
138465526|NCT01953406|Mitomycin|mitomycin|mesh-list
138465527|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
138465528|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465529|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138465530|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465531|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138465532|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
138390627|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
138465533|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465534|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138465535|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
138465536|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138465537|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465538|NCT01953419|Pemetrexed|pemetrexed|mesh-list
138465539|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465540|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138382381|NCT01464060|Clarithromycin|clarithromycin|mesh-list
138465541|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465543|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138465544|NCT01953445|Paclitaxel|paclitaxel|mesh-list
138465546|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465547|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
138465548|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
138465549|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
138465550|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465551|NCT01953536|Folic Acid|folic acid|mesh-list
138465552|NCT01953536|Paclitaxel|paclitaxel|mesh-list
138465553|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138465554|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138465556|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
138465557|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
138465558|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
138465559|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465560|NCT01953536|Hematinics|hematinics|mesh-ancestor
138465561|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
138465562|NCT01953536|Vitamins|vitamins|mesh-ancestor
138465563|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
138465564|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465565|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
138465566|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138465567|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
138465568|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138465569|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465570|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138465571|NCT01953731|Rifampin|rifampin|mesh-list
138465572|NCT01953731|Palbociclib|palbociclib|mesh-list
138465573|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465574|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138465575|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465576|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465577|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138465578|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
138465579|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138465580|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138382415|NCT01464138|Clindamycin|clindamycin|mesh-list
138465581|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
138465582|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138465583|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138390806|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
138465584|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138465585|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138465586|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138465587|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138465588|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138465590|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
138465591|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
138465592|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138465593|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138465594|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138465595|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465596|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465597|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138465598|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
138465599|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138465600|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465601|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138465602|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138465603|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138465604|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138465606|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
138465607|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
138465608|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
138465609|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
138465610|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465611|NCT01953757|Hematinics|hematinics|mesh-ancestor
138465612|NCT01953770|Cytarabine|cytarabine|mesh-list
138465613|NCT01953770|Prednisone|prednisone|mesh-list
138465614|NCT01953770|Methotrexate|methotrexate|mesh-list
138465615|NCT01953770|Daunorubicin|daunorubicin|mesh-list
138465616|NCT01953770|Asparaginase|asparaginase|mesh-list
138465617|NCT01953770|Pegaspargase|pegaspargase|mesh-list
138465618|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138465619|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
138465620|NCT01953770|Hormones|hormones|mesh-ancestor
138382449|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
138465622|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465623|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138465624|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138391048|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138465625|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138465626|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
138465627|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138465628|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138202411|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202412|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202413|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465629|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
138465630|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465631|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
138465632|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465633|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138465634|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138465635|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
138465636|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138465637|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138465638|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
138465639|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138465640|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138465641|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138465642|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138465644|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138465645|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
138391110|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138465646|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138465647|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465648|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138465649|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
138465650|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138465651|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138465652|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138465653|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138465654|NCT01953835|Simvastatin|simvastatin|mesh-list
138465655|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138465656|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138465657|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
138465658|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465659|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138465660|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138465661|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465663|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
138382491|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138465665|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138465666|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138465667|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
138465668|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465669|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465670|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465671|NCT01953848|Urological Agents|urological agents|mesh-ancestor
138465672|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138465673|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138465674|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
138465675|NCT01953887|Tamsulosin|tamsulosin|mesh-list
138465676|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
138391223|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465677|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138465678|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138465679|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138465680|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
138465681|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465682|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465683|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465684|NCT01953887|Urological Agents|urological agents|mesh-ancestor
138465685|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138202416|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138202417|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138465686|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138465687|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
138465689|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465690|NCT01953978|Acetaminophen|acetaminophen|mesh-list
138465691|NCT01953978|Dexamethasone|dexamethasone|mesh-list
138465692|NCT01953978|Ibuprofen|ibuprofen|mesh-list
138465693|NCT01953978|Morphine|morphine|mesh-list
138465694|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138465695|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
138465696|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
138465697|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465698|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465699|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138465700|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
138465701|NCT01953978|Hormones|hormones|mesh-ancestor
138465702|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138465703|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138465704|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465705|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138465706|NCT01953978|Narcotics|narcotics|mesh-ancestor
138465707|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138465708|NCT01953978|Analgesics|analgesics|mesh-ancestor
138465709|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
138382542|NCT01467115|Docetaxel|docetaxel|mesh-list
138465710|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138465711|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138465712|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138465713|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138465714|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465715|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465716|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
138465717|NCT01954030|Bevacizumab|bevacizumab|mesh-list
138465718|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
138465719|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138465721|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138465722|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138465723|NCT01954030|Growth Substances|growth substances|mesh-ancestor
138465724|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465725|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
138465726|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138465727|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138465728|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465729|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138465731|NCT01954043|Dabrafenib|dabrafenib|mesh-list
138465732|NCT01954043|Rabeprazole|rabeprazole|mesh-list
138465733|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138465735|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138465736|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465737|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465738|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138465739|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
138465740|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138465741|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202430|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
138202431|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465742|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
138465743|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138465744|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138202432|NCT00384436|Escitalopram|escitalopram|mesh-list
138202433|NCT00384436|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138465745|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138465748|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138465749|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138465751|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138465752|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
138465753|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138465754|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
138465755|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465756|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
138465757|NCT01954108|Protective Agents|protective agents|mesh-ancestor
138465758|NCT01954186|Oxytocin|oxytocin|mesh-list
138465759|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
138465760|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138465761|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465762|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
138465763|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138465764|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
138465765|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138465766|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
138465767|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465768|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465769|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
138465770|NCT01954290|Mannitol|mannitol|mesh-list
138465771|NCT01954290|Conivaptan|conivaptan|mesh-list
138465772|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138465774|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
138465775|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465776|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138465777|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465778|NCT01954355|Paclitaxel|paclitaxel|mesh-list
138465779|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138465780|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465781|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
138465782|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
138465783|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
138465784|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465786|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138465787|NCT01954368|Narcotics|narcotics|mesh-ancestor
138465788|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138465789|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382587|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
138465791|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
138465792|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465793|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138465794|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138465795|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
138465796|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
138465797|NCT01954693|Everolimus|everolimus|mesh-list
138465798|NCT01954693|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138465799|NCT01954693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138465800|NCT01954693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465801|NCT01954693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465802|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138465803|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
138465804|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465805|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465806|NCT01954732|Metformin|metformin|mesh-list
138465807|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138465808|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465809|NCT01954784|Cyclosporine|cyclosporine|mesh-list
138465810|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
138465811|NCT01954784|Fludarabine|fludarabine|mesh-list
138465812|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
138465813|NCT01954784|Lenalidomide|lenalidomide|mesh-list
138465814|NCT01954784|Bortezomib|bortezomib|mesh-list
138465816|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465817|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138465818|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
138465819|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465820|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138465821|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
138465822|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465823|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465824|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
138465825|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138465826|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
138465827|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138465828|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138465829|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138465830|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138465831|NCT01954784|Growth Substances|growth substances|mesh-ancestor
138465832|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
138465833|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138465834|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138465835|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
138465836|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138382618|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138465837|NCT01954914|Plerixafor|plerixafor|mesh-list
138382619|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382621|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138465842|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
138465843|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
138465844|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465845|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
138465846|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465847|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465849|NCT01955070|Analgesics|analgesics|mesh-ancestor
138465850|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
138465851|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465852|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465853|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138465854|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138465855|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
138465856|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
138465857|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138465858|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138465859|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138465860|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465861|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465862|NCT01955135|Ketamine|ketamine|mesh-list
138465863|NCT01955135|Propofol|propofol|mesh-list
138465864|NCT01955135|Sevoflurane|sevoflurane|mesh-list
138465865|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138465866|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138465867|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465868|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138465869|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
138465870|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
138465871|NCT01955135|Analgesics|analgesics|mesh-ancestor
138465872|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
138465873|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465874|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138465876|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138465877|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465878|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465879|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138465880|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138465882|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138202459|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465883|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138465884|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465885|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
138382648|NCT01467531|Dolutegravir|dolutegravir|mesh-list
138465886|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465887|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465888|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
138465889|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138465890|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138465891|NCT01955187|Prednisolone|prednisolone|mesh-list
138465892|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
138465893|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
138465894|NCT01955187|Rituximab|rituximab|mesh-list
138465895|NCT01955187|Tacrolimus|tacrolimus|mesh-list
138465896|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138465897|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
138465898|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138465899|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
138465900|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465901|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138465902|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138465903|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
138465904|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465905|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465906|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138465907|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138465908|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138465909|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465911|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
138465912|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
138465913|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465914|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138465915|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
138465916|NCT01955187|Hormones|hormones|mesh-ancestor
138465918|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138465919|NCT01955187|Protective Agents|protective agents|mesh-ancestor
138465920|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138465921|NCT01955200|Cilostazol|cilostazol|mesh-list
138465922|NCT01955200|Clopidogrel|clopidogrel|mesh-list
138465923|NCT01955200|Ticagrelor|ticagrelor|mesh-list
138465924|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138465925|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138465926|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138465927|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138465928|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
138465929|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465930|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138382666|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138465931|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382671|NCT01467648|Doripenem|doripenem|mesh-list
138465932|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138465934|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465935|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138465936|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
138465937|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138465938|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138465939|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
138465940|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138465941|NCT01955200|Protective Agents|protective agents|mesh-ancestor
138465942|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138465943|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138465944|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465945|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
138392226|NCT01508611|Fluorides|fluorides|mesh-list
138465946|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138465947|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465948|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
138465949|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465951|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138465952|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138465953|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
138465954|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138465955|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138392294|NCT01508923|Hormones|hormones|mesh-ancestor
138465957|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
138465958|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
138465959|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465960|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465961|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465962|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138465964|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138465965|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138465966|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465967|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465968|NCT01955577|Vitamin D|vitamin d|mesh-list
138465969|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
138465970|NCT01955577|Vitamins|vitamins|mesh-ancestor
138465971|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
138392354|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138465972|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465973|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138382696|NCT01467986|Temozolomide|temozolomide|mesh-list
138382697|NCT01467986|Dasatinib|dasatinib|mesh-list
138382698|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138465974|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138465976|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138465977|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138465978|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138465979|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138465980|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
138465981|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465982|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465983|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465984|NCT01955655|Baclofen|baclofen|mesh-list
138465985|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138465986|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465987|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138465988|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138465989|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138465990|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
138465991|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
138465992|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138465993|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138465994|NCT01955694|Eplerenone|eplerenone|mesh-list
138465995|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138465996|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
138465997|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138392539|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138465998|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138465999|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138466000|NCT01955694|Diuretics|diuretics|mesh-ancestor
138466001|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
138466002|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138466004|NCT01955759|Bisoprolol|bisoprolol|mesh-list
138466005|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138382728|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138382729|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466006|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
138466007|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138466008|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138466009|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
138466010|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466011|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138466012|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138466013|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466014|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138466015|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
138466016|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466017|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466018|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138466019|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
138466020|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138466021|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138466022|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138466023|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138466024|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138466025|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138466026|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138466027|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138466028|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138466029|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
138466030|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
138466031|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466032|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138466034|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
138466035|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
138466036|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466037|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466038|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
138466039|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466040|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138466041|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138466042|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138466043|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138466044|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466045|NCT01955967|Lidocaine|lidocaine|mesh-list
138466046|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
138466047|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
138466048|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466049|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466050|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
138466051|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466052|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138466053|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138466054|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138466055|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138466056|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466058|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138466059|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138466060|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
138466061|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138466062|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138392791|NCT01511731|Famotidine|famotidine|mesh-list
138466063|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466064|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466065|NCT01956006|Protective Agents|protective agents|mesh-ancestor
138466066|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466068|NCT01956201|Fenofibrate|fenofibrate|mesh-list
138466069|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138466070|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138466071|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
138466072|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466073|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138466074|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138466075|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466077|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138466078|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466079|NCT01956474|Riboflavin|riboflavin|mesh-list
138466080|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
138466081|NCT01956474|Vitamins|vitamins|mesh-ancestor
138466082|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
138466083|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466084|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138466085|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
138466086|NCT01956487|Propafenone|propafenone|mesh-list
138466087|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138466088|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138466089|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138466090|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138392907|NCT01512147|Propofol|propofol|mesh-list
138466091|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466092|NCT01956591|Oxybutynin|oxybutynin|mesh-list
138466093|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
138466094|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
138466095|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466096|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138382792|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138466098|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138466099|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
138466100|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466101|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466102|NCT01956591|Urological Agents|urological agents|mesh-ancestor
138466103|NCT01956604|Clonidine|clonidine|mesh-list
138466104|NCT01956604|Analgesics|analgesics|mesh-ancestor
138466105|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
138466106|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466107|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466108|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138466109|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
138466110|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
138466111|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138466112|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138466113|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138466114|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
138466115|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466116|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466117|NCT01956695|Rituximab|rituximab|mesh-list
138466118|NCT01956695|Lenalidomide|lenalidomide|mesh-list
138466119|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138466120|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466121|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
138466122|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466123|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138466124|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138466125|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138466126|NCT01956695|Growth Substances|growth substances|mesh-ancestor
138466127|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
138466128|NCT01956734|Temozolomide|temozolomide|mesh-list
138202485|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466129|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138466130|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
138466131|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466132|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466133|NCT01956786|Amlodipine|amlodipine|mesh-list
138466134|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138466135|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138466136|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138202507|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138202508|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
138202509|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138202510|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138202511|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138202512|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202513|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202514|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
138202515|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202516|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
138202517|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
138202518|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
138466137|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466138|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138393076|NCT01513070|Analgesics|analgesics|mesh-ancestor
138466139|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466140|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
138466141|NCT01956864|Vitamin D|vitamin d|mesh-list
138466142|NCT01956864|Vitamins|vitamins|mesh-ancestor
138466143|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
138466144|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466145|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138466147|NCT01956929|Lactulose|lactulose|mesh-list
138466148|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138466149|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466150|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138466151|NCT01956955|Heparin|heparin|mesh-list
138466152|NCT01956955|Enoxaparin|enoxaparin|mesh-list
138466153|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138466154|NCT01956955|Calcium heparin|calcium heparin|mesh-list
138466155|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
138466157|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138466158|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466159|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
138466160|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
138466161|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138382822|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
138466164|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138466165|NCT01956981|Analgesics|analgesics|mesh-ancestor
138382831|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138466166|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
138466167|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466168|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138466169|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138466170|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138466171|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
138466172|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466173|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466175|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138466176|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
138466177|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138466178|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138466179|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138466180|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
138466181|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138466182|NCT01957007|Docetaxel|docetaxel|mesh-list
138393265|NCT01514175|Ibuprofen|ibuprofen|mesh-list
138466183|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466184|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
138466185|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
138466186|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
138466187|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466188|NCT01957046|Laxatives|laxatives|mesh-list
138466189|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138466190|NCT01957189|Tamsulosin|tamsulosin|mesh-list
138466191|NCT01957189|Dutasteride|dutasteride|mesh-list
138466193|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138466194|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138466195|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
138466196|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466197|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466198|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466199|NCT01957189|Urological Agents|urological agents|mesh-ancestor
138466200|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
138466201|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138466202|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466203|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
138466204|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138466205|NCT01957293|Albuterol|albuterol|mesh-list
138466207|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
138466208|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466209|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466210|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138382836|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138466211|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
138466212|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
138466213|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138466214|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138466215|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138466216|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138466217|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
138466218|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466219|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466220|NCT01957319|Vitamin E|vitamin e|mesh-list
138466221|NCT01957319|Silybin|silybin|mesh-list
138466222|NCT01957319|Vitamins|vitamins|mesh-ancestor
138466223|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
138466224|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466225|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
138466226|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466227|NCT01957319|Protective Agents|protective agents|mesh-ancestor
138466228|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138466229|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466230|NCT01957449|Propranolol|propranolol|mesh-list
138466231|NCT01957449|Metoprolol|metoprolol|mesh-list
138466232|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138466233|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138466234|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
138466235|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466236|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466237|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466238|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138466239|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138466240|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
138466241|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
138466242|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
138466243|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466244|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138466245|NCT01957540|Ticagrelor|ticagrelor|mesh-list
138466246|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138466247|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138466248|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138466249|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138466250|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138466251|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
138466252|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466253|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466254|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466255|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
138466256|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138466257|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138466258|NCT01957631|Prednisolone|prednisolone|mesh-list
138466259|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
138466261|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138466262|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
138466263|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
138202573|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138466265|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466266|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466267|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
138466268|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466269|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138466270|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
138466271|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
138466272|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138466273|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
138466274|NCT01957631|Hormones|hormones|mesh-ancestor
138466275|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138466276|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138466277|NCT01957631|Protective Agents|protective agents|mesh-ancestor
138466278|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138466279|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466280|NCT01957839|Cabergoline|cabergoline|mesh-list
138466281|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138466282|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138466283|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
138466284|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
138466285|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466286|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466287|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466289|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
138466290|NCT01957852|Coagulants|coagulants|mesh-ancestor
138466291|NCT01957943|SMOFlipid|smoflipid|mesh-list
138466292|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138466293|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138466294|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138466295|NCT01957995|Docetaxel|docetaxel|mesh-list
138466296|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466297|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
138466298|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
138466299|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
138466300|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466301|NCT01958138|Propofol|propofol|mesh-list
138466302|NCT01958138|Isoflurane|isoflurane|mesh-list
138466303|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138466304|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466305|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466306|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138466307|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
138466308|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
138466309|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138466310|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
138466311|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
138466312|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138466313|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138466314|NCT01958372|Etoposide|etoposide|mesh-list
138466315|NCT01958372|Pemetrexed|pemetrexed|mesh-list
138466316|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202591|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202592|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202593|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202594|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202600|NCT00059228|Estradiol|estradiol|mesh-list
138466317|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138466318|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138466319|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138466320|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466321|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466322|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138466323|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138466324|NCT01958580|Gemcitabine|gemcitabine|mesh-list
138466325|NCT01958580|Docetaxel|docetaxel|mesh-list
138382860|NCT01468740|Bleomycin|bleomycin|mesh-list
138382861|NCT01468740|Vinblastine|vinblastine|mesh-list
138466327|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
138466328|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466329|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466330|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
138466331|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
138466332|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
138466334|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
138466335|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138466336|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
138466337|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138466338|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466339|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138466340|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138466341|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138466342|NCT01958684|Trace Elements|trace elements|mesh-ancestor
138466343|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
138466344|NCT01958775|Glucagon|glucagon|mesh-list
138466345|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138466346|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138466347|NCT01958775|Hormones|hormones|mesh-ancestor
138466348|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138466349|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466350|NCT01958775|Incretins|incretins|mesh-ancestor
138466351|NCT01958814|Albuterol|albuterol|mesh-list
138466352|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138393695|NCT01516580|Cytarabine|cytarabine|mesh-list
138466353|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
138466354|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466355|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466356|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138466357|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
138466358|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
138466359|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138466360|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138466361|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138393762|NCT01516840|Heparin|heparin|mesh-list
138466363|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
138466364|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466365|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466366|NCT01958866|Acetaminophen|acetaminophen|mesh-list
138382892|NCT01469169|Iloprost|iloprost|mesh-list
138382894|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
138466368|NCT01958866|Analgesics|analgesics|mesh-ancestor
138466369|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
138466370|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466371|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466372|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
138202611|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138466373|NCT01958905|Lumefantrine|lumefantrine|mesh-list
138466374|NCT01958905|Artemether|artemether|mesh-list
138202612|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466375|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138466376|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
138466377|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138466378|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138466379|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138466380|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
138466381|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138466382|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
138393821|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
138393828|NCT01517321|Incretins|incretins|mesh-ancestor
138466384|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466385|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138466386|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
138466387|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138466388|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
138466389|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466390|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466391|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138466392|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
138466393|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
138466394|NCT01958944|Protective Agents|protective agents|mesh-ancestor
138466396|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138466397|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466398|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138466399|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138466400|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466401|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466403|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138466404|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138466405|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138466406|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138466407|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
138466408|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466409|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466410|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466411|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
138466412|NCT01959061|Raltitrexed|raltitrexed|mesh-list
138466413|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
138466414|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466415|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138466416|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
138466417|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466418|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138466419|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466420|NCT01959074|Aceclofenac|aceclofenac|mesh-list
138466422|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138466423|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138466424|NCT01959074|Analgesics|analgesics|mesh-ancestor
138466425|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
138466426|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138393937|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138466428|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138466429|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138466430|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138466431|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138466432|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
138466433|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466434|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466435|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138466436|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138466437|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138466438|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138466439|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138466440|NCT01959100|Azithromycin|azithromycin|mesh-list
138466441|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138466442|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138466443|NCT01959152|Imidacloprid|imidacloprid|mesh-list
138466444|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
138466445|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466446|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466447|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466448|NCT01959191|Aspirin|aspirin|mesh-list
138466449|NCT01959191|Clopidogrel|clopidogrel|mesh-list
138466450|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138466451|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138466452|NCT01959191|Analgesics|analgesics|mesh-ancestor
138466453|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
138466454|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466455|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466456|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138466457|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138466458|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138466459|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138466460|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466461|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138466462|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138466463|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466465|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138466466|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138466467|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138466468|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
138466469|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138382941|NCT06077539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138382951|NCT06077292|Dronabinol|dronabinol|mesh-list
138466471|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138466472|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466473|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138466475|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138466476|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138466477|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
138466478|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466479|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138466480|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138466482|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138466483|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
138466484|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466485|NCT01959438|Selenious Acid|selenious acid|mesh-list
138466486|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
138466487|NCT01959438|Trace Elements|trace elements|mesh-ancestor
138466488|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
138466489|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466490|NCT01959451|Clopidogrel|clopidogrel|mesh-list
138466491|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
138466492|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138466493|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138466494|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138466495|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138466496|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
138202624|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138466497|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466498|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466499|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466500|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
138466502|NCT01959477|Etoposide|etoposide|mesh-list
138466503|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
138466504|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138466505|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
138466506|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466507|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138466508|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138466509|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
138382970|NCT06077058|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138382971|NCT06077058|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138466510|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466511|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466512|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138466513|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138466514|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138466515|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138466517|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
138466518|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138466519|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
138466520|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466521|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466522|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138466523|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
138466524|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138466525|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
138466526|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466527|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466528|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
138466529|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
138466530|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
138466531|NCT01959828|Protective Agents|protective agents|mesh-ancestor
138466532|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
138466533|NCT01959854|Laxatives|laxatives|mesh-ancestor
138466534|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138466535|NCT01959971|Alirocumab|alirocumab|mesh-list
138466536|NCT01959971|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
138466537|NCT01959971|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138466538|NCT01959971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138466539|NCT01959971|Antimetabolites|antimetabolites|mesh-ancestor
138466540|NCT01959971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466541|NCT01959971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138466542|NCT01959971|Protease Inhibitors|protease inhibitors|mesh-ancestor
138466543|NCT01959971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466544|NCT01959971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138466545|NCT01960023|Cetuximab|cetuximab|mesh-list
138466546|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138466547|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466548|NCT01960049|Ropivacaine|ropivacaine|mesh-list
138466549|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
138466550|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
138466551|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466552|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466553|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
138466554|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466555|NCT01960153|Tadalafil|tadalafil|mesh-list
138466556|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
138466557|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138466558|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138466559|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202651|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138202652|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
138466560|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466561|NCT01960153|Urological Agents|urological agents|mesh-ancestor
138466562|NCT01960179|Lixisenatide|lixisenatide|mesh-list
138466563|NCT01960179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138466564|NCT01960179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466566|NCT01960205|Saxagliptin|saxagliptin|mesh-list
138466567|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138466568|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466569|NCT01960205|Incretins|incretins|mesh-ancestor
138466570|NCT01960205|Hormones|hormones|mesh-ancestor
138466571|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138466572|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138466573|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
138466574|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466575|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466576|NCT01960283|Methotrexate|methotrexate|mesh-list
138466577|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138466578|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
138466579|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138466580|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466581|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138466582|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
138466583|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466584|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466585|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
138466586|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466587|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138466588|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138466589|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
138466590|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138466591|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138466592|NCT01960426|Adalimumab|adalimumab|mesh-list
138466593|NCT01960426|Infliximab|infliximab|mesh-list
138466594|NCT01960426|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138466595|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138466596|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138466597|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
138466598|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138466599|NCT01960543|Fentanyl|fentanyl|mesh-list
138466600|NCT01960543|Bupivacaine|bupivacaine|mesh-list
138466601|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
138466602|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
138466604|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466605|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466606|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
138466607|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466608|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138466609|NCT01960543|Narcotics|narcotics|mesh-ancestor
138466610|NCT01960543|Analgesics|analgesics|mesh-ancestor
138466611|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138466612|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138466613|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
138466614|NCT01960569|Hirudins|hirudins|mesh-list
138466615|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
138466616|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138466617|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
138466618|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466619|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383039|NCT06076759|Morphine|morphine|mesh-list
138466621|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138466622|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138466624|NCT01960595|Bupivacaine|bupivacaine|mesh-list
138466625|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
138466626|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
138466627|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466628|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466629|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
138202661|NCT00067028|Clofarabine|clofarabine|mesh-list
138202662|NCT00067028|Idarubicin|idarubicin|mesh-list
138466630|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466631|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138466632|NCT01960595|Narcotics|narcotics|mesh-ancestor
138466633|NCT01960595|Analgesics|analgesics|mesh-ancestor
138466634|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138466635|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138466636|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
138466637|NCT01960647|Paclitaxel|paclitaxel|mesh-list
138466638|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138466639|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466640|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
138466641|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
138466642|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
138466643|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466644|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138466645|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138466646|NCT01960829|Everolimus|everolimus|mesh-list
138466647|NCT01960829|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138466648|NCT01960829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138466649|NCT01960829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466650|NCT01960829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466651|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138466652|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
138466653|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466654|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466655|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138466656|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
138466657|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138466658|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
138383046|NCT06076759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138383049|NCT06076759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138466662|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466663|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
138466664|NCT01961154|Hormones|hormones|mesh-ancestor
138466665|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138466666|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
138466667|NCT01961180|Escitalopram|escitalopram|mesh-list
138466668|NCT01961180|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138466669|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138466670|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138466671|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466672|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466674|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466675|NCT01961193|Silicon|silicon|mesh-list
138466676|NCT01961193|Trace Elements|trace elements|mesh-ancestor
138466677|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
138202670|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
138202671|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466678|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466679|NCT01961336|Testosterone|testosterone|mesh-list
138466680|NCT01961336|Androgens|androgens|mesh-ancestor
138466681|NCT01961336|Hormones|hormones|mesh-ancestor
138466682|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138394640|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466683|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466684|NCT01961388|Metformin|metformin|mesh-list
138466685|NCT01961388|Acarbose|acarbose|mesh-list
138466686|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138466687|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466688|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
138466689|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466690|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466691|NCT01961414|Aflibercept|aflibercept|mesh-list
138466692|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138466693|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138466694|NCT01961414|Growth Substances|growth substances|mesh-ancestor
138466695|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466696|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
138466697|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466699|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
138466700|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
138466701|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138466702|NCT01961453|Diuretics|diuretics|mesh-ancestor
138466703|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
138466704|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466705|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
138383081|NCT06074185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466707|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466708|NCT01961635|Cimetidine|cimetidine|mesh-list
138466709|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138394761|NCT01522846|Heparin|heparin|mesh-list
138466711|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138466712|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
138466713|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
138466714|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466715|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466716|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466717|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138466718|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138466720|NCT01961739|Lidocaine|lidocaine|mesh-list
138466721|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
138466722|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
138466723|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466725|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
138466726|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466727|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138466728|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138466729|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138202696|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202697|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138202698|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138202699|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138202700|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138202701|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
138202702|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138202703|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138202704|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466730|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138466731|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466732|NCT01961752|Triamcinolone|triamcinolone|mesh-list
138466733|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138466734|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138466735|NCT01961752|Bupivacaine|bupivacaine|mesh-list
138466736|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138466737|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
138466738|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
138466739|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466740|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466741|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
138466742|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466743|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138466744|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
138466745|NCT01961752|Hormones|hormones|mesh-ancestor
138466746|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138466747|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138466748|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
138466749|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466750|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466751|NCT01961830|Arbekacin|arbekacin|mesh-list
138466752|NCT01961830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138466753|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138466754|NCT01961843|Prednisone|prednisone|mesh-list
138466755|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
138394947|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
138466756|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138466757|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
138466758|NCT01961843|Hormones|hormones|mesh-ancestor
138466759|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138466760|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466761|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138466762|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466763|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138466764|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466765|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466766|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
138466767|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138466770|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138466771|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138466772|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138466773|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138466774|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
138466775|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466776|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466777|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466778|NCT01961947|Vaccines|vaccines|mesh-list
138466779|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
138466780|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466781|NCT01962116|Heparin|heparin|mesh-list
138466783|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
138466784|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466785|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138466786|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138466787|NCT01962181|Methylphenidate|methylphenidate|mesh-list
138466788|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138466789|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466790|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138466791|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138466792|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138202721|NCT00003598|Tretinoin|tretinoin|mesh-list
138466793|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466794|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
138466795|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466797|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138395044|NCT01524094|Fluorouracil|fluorouracil|mesh-list
138466798|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466799|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466800|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138466801|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
138466802|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
138466803|NCT01962363|Tocotrienols|tocotrienols|mesh-list
138466804|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
138466805|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
138466806|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466807|NCT01962363|Protective Agents|protective agents|mesh-ancestor
138466808|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466809|NCT01962363|Vitamins|vitamins|mesh-ancestor
138466810|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
138466811|NCT01962376|Bevacizumab|bevacizumab|mesh-list
138466812|NCT01962376|Capecitabine|capecitabine|mesh-list
138466813|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
138466814|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138466815|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466816|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138395157|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
138466817|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138466818|NCT01962376|Growth Substances|growth substances|mesh-ancestor
138466819|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383128|NCT06073015|Antidepressive Agents|antidepressive agents|mesh-ancestor
138466821|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138466822|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
138466823|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466824|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
138466825|NCT01962454|Testosterone|testosterone|mesh-list
138466826|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
138466827|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
138466828|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
138466829|NCT01962454|Androgens|androgens|mesh-ancestor
138466830|NCT01962454|Hormones|hormones|mesh-ancestor
138466831|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138466832|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466833|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138466834|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466835|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
138466836|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
138466837|NCT01962571|Hematinics|hematinics|mesh-ancestor
138466838|NCT01962831|Dinoprostone|dinoprostone|mesh-list
138466839|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
138466840|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138466841|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466842|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
138466843|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
138466844|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
138466845|NCT01963039|Protective Agents|protective agents|mesh-ancestor
138466846|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466847|NCT01963182|Irinotecan|irinotecan|mesh-list
138466848|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138466849|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138466850|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466851|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466852|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466853|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138466854|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138466855|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466856|NCT01963299|Clonidine|clonidine|mesh-list
138466857|NCT01963299|Ropivacaine|ropivacaine|mesh-list
138466858|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
138466859|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
138466860|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466861|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466862|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
138466863|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466864|NCT01963299|Analgesics|analgesics|mesh-ancestor
138466865|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138466866|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
138466867|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
138349848|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
138466868|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138466869|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138466870|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138395281|NCT06052111|Analgesics|analgesics|mesh-ancestor
138466872|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466873|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466874|NCT01963325|Paclitaxel|paclitaxel|mesh-list
138466875|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138466876|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138466877|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466878|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
138466879|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
138383145|NCT06072898|Hallucinogens|hallucinogens|mesh-ancestor
138466880|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
138383146|NCT06072898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138383147|NCT06072729|Magnesium Sulfate|magnesium sulfate|mesh-list
138466881|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466883|NCT01963390|Androgens|androgens|mesh-ancestor
138466884|NCT01963390|Hormones|hormones|mesh-ancestor
138466885|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138466886|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466887|NCT01963416|Micronutrients|micronutrients|mesh-list
138466888|NCT01963416|Trace Elements|trace elements|mesh-list
138466889|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466890|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138466892|NCT01963442|beta-Lactams|beta-lactams|mesh-list
138466893|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138466894|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138466895|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138466896|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466897|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466898|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
138466899|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466900|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466901|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138466902|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138466903|NCT01963546|Analgesics|analgesics|mesh-ancestor
138466904|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
138466905|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466906|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138466907|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138466908|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138466909|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
138466910|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466911|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466914|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138466915|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
138466916|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
138466917|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466918|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466919|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
138466920|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466921|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138466922|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138466924|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138466925|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466926|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138466927|NCT01963663|Metformin|metformin|mesh-list
138202723|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
138202724|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
138202725|NCT00003604|Aldesleukin|aldesleukin|mesh-list
138202726|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202727|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138202728|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138202729|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
138202730|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138466928|NCT01963663|Pioglitazone|pioglitazone|mesh-list
138466929|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138466930|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466931|NCT01963702|Capecitabine|capecitabine|mesh-list
138466932|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
138466933|NCT01963702|Docetaxel|docetaxel|mesh-list
138466934|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138466935|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
138466936|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466937|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138466938|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
138466939|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
138466940|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
138466942|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
138466943|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
138466944|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466945|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466946|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466947|NCT01963754|Epinephrine|epinephrine|mesh-list
138466948|NCT01963754|Racepinephrine|racepinephrine|mesh-list
138466949|NCT01963754|Anesthetics|anesthetics|mesh-list
138466950|NCT01963754|Carticaine|carticaine|mesh-list
138466951|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
138466952|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138466953|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466954|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138466955|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138466956|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
138466957|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466958|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466959|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138466960|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138466961|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
138466962|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138466963|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138466964|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
138466965|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
138466966|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
138466967|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138466968|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
138466969|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
138466971|NCT01963832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138466972|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138466973|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138383190|NCT06072352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138466974|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138466975|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138466976|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
138466977|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138395563|NCT05470400|Vaccines|vaccines|mesh-list
138466978|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138466979|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
138466980|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138466981|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138466982|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138466983|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138466985|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
138466986|NCT01963910|Diuretics|diuretics|mesh-ancestor
138466987|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
138466988|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466989|NCT01963962|Copper|copper|mesh-list
138466990|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
138466991|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138466992|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
138466993|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138466994|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138466995|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138466996|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138466997|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138466998|NCT01963962|Trace Elements|trace elements|mesh-ancestor
138466999|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
138467001|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
138467002|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
138467003|NCT01964001|Pyridoxal|pyridoxal|mesh-list
138467004|NCT01964001|Pyridoxine|pyridoxine|mesh-list
138467005|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
138467006|NCT01964001|Ubiquinone|ubiquinone|mesh-list
138467007|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
138467008|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467009|NCT01964027|Irinotecan|irinotecan|mesh-list
138467010|NCT01964027|Epirubicin|epirubicin|mesh-list
138467011|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138467012|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138467013|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467014|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138383217|NCT06071871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138383218|NCT06071871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383219|NCT06071871|Immunoconjugates|immunoconjugates|mesh-ancestor
138467015|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467016|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138467017|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138467018|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
138467019|NCT01964040|Bupivacaine|bupivacaine|mesh-list
138467020|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
138467021|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
138467022|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467023|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467024|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
138467025|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467026|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138467027|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138395645|NCT05296564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138467029|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138467030|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138467031|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138467032|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
138467033|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467034|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467035|NCT01964079|Losartan|losartan|mesh-list
138467036|NCT01964079|Amlodipine|amlodipine|mesh-list
138467037|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138467038|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138467039|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138467040|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467041|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138467042|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467043|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
138467044|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138467045|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138467046|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138467047|NCT01964157|Ceritinib|ceritinib|mesh-list
138467048|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467049|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138467050|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467051|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467052|NCT01964170|Goserelin|goserelin|mesh-list
138467053|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138467054|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467055|NCT01964183|Mirabegron|mirabegron|mesh-list
138467056|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
138467057|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
138467058|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138467060|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
138467061|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467062|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467063|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467064|NCT01964183|Urological Agents|urological agents|mesh-ancestor
138467065|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138467066|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138467067|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
138467068|NCT01964248|Lidocaine|lidocaine|mesh-list
138202731|NCT00002794|Carboplatin|carboplatin|mesh-list
138467069|NCT01964248|Prilocaine|prilocaine|mesh-list
138467070|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
138467071|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
138467072|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
138467073|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467074|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467075|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
138467076|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467077|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138467078|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138467079|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138467080|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138467081|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467082|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
138467083|NCT01964287|Leucovorin|leucovorin|mesh-list
138467084|NCT01964287|Paclitaxel|paclitaxel|mesh-list
138467085|NCT01964287|Gemcitabine|gemcitabine|mesh-list
138467087|NCT01964287|Irinotecan|irinotecan|mesh-list
138467088|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138467089|NCT01964287|Folfirinox|folfirinox|mesh-list
138467090|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138467091|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467092|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
138467093|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
138467094|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
138467095|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467096|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138467097|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
138467098|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138467099|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138467100|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467101|NCT01964287|Antidotes|antidotes|mesh-ancestor
138467102|NCT01964287|Protective Agents|protective agents|mesh-ancestor
138467103|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467104|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
138467105|NCT01964287|Vitamins|vitamins|mesh-ancestor
138467106|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
138467107|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
138467108|NCT01964365|Fenofibrate|fenofibrate|mesh-list
138467109|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138467110|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138467111|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
138383280|NCT06048588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138383282|NCT06048588|Antimetabolites|antimetabolites|mesh-ancestor
138467112|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467113|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138467114|NCT01964391|Paclitaxel|paclitaxel|mesh-list
138395849|NCT04562831|Niacin|niacin|mesh-list
138202732|NCT00002794|Vincristine|vincristine|mesh-list
138202733|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202734|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202735|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
138467117|NCT01964391|Carboplatin|carboplatin|mesh-list
138467118|NCT01964391|Doxorubicin|doxorubicin|mesh-list
138467119|NCT01964391|Trastuzumab|trastuzumab|mesh-list
138467120|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138467121|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467122|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
138467123|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
138467124|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
138467125|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188297|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138467126|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138467127|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
138467128|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467129|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138467130|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138467131|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
138467132|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138467133|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138467134|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138467135|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138467136|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467137|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138467138|NCT01964404|Dronabinol|dronabinol|mesh-list
138467139|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
138467140|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467141|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138467142|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138467143|NCT01964404|Analgesics|analgesics|mesh-ancestor
138467144|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
138467145|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467146|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
138467147|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
138467148|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467149|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467150|NCT01964404|Hormones|hormones|mesh-ancestor
138467151|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138467152|NCT01964534|Gemcitabine|gemcitabine|mesh-list
138467153|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138383302|NCT06020781|Analgesics|analgesics|mesh-ancestor
138383309|NCT06017583|Capecitabine|capecitabine|mesh-list
138467156|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467157|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467160|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
138467161|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467162|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467163|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467165|NCT01964586|Epinephrine|epinephrine|mesh-list
138467166|NCT01964586|Racepinephrine|racepinephrine|mesh-list
138467167|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
138467168|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
138467169|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
138467170|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
138467171|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467172|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467173|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
138467174|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467175|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138467176|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138467177|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138467178|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138467179|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467180|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138467181|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138467182|NCT01964586|Analgesics|analgesics|mesh-ancestor
138467183|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138467184|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138467185|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138467186|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
138467187|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467188|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138467189|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138467190|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
138467191|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138467192|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
138467193|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
138467194|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
138467195|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138467196|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
138467197|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467198|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138188298|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138467200|NCT01964781|Racepinephrine|racepinephrine|mesh-list
138467201|NCT01964781|Bupivacaine|bupivacaine|mesh-list
138467202|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
138467203|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
138467204|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
138467205|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
138467206|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467207|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467208|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
138467209|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467210|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138467211|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138467212|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467213|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
138467214|NCT01964781|Coagulants|coagulants|mesh-ancestor
138467215|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138467216|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138467217|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
138467218|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467219|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138467220|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138467222|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138467223|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
138467224|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
138467225|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
138467226|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138467228|NCT01964846|Resveratrol|resveratrol|mesh-list
138467229|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138467230|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138467231|NCT01964846|Analgesics|analgesics|mesh-ancestor
138467232|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
138467233|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467234|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467235|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138467236|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138467237|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467238|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467239|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467240|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
138467241|NCT01964846|Protective Agents|protective agents|mesh-ancestor
138467242|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138467243|NCT01964911|Ropivacaine|ropivacaine|mesh-list
138467244|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
138467245|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
138467246|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467247|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467248|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
138467249|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138202758|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
138202759|NCT00072566|Bevacizumab|bevacizumab|mesh-list
138383369|NCT05939674|Flumazenil|flumazenil|mesh-list
138467251|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138467252|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138467253|NCT01965041|Growth Substances|growth substances|mesh-ancestor
138467254|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467255|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
138467256|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467257|NCT01965080|Exemestane|exemestane|mesh-list
138467258|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467259|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138467260|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138467262|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467263|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138467264|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
138396086|NCT03565991|Avelumab|avelumab|mesh-list
138467265|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138467266|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467267|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138467268|NCT01965275|Gefitinib|gefitinib|mesh-list
138467269|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467270|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138467271|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467272|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467273|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
138467274|NCT01965301|Promethazine|promethazine|mesh-list
138467275|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138467276|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138467277|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467278|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467279|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
138467280|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
138467281|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
138467282|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467283|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
138467284|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
138467285|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138467286|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138467287|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
138467288|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
138467289|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138396191|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138467290|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467291|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138467292|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
138467293|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
138467294|NCT01965353|Dexamethasone|dexamethasone|mesh-list
138383395|NCT05875961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383396|NCT05860881|Sirolimus|sirolimus|mesh-list
138467296|NCT01965353|Bortezomib|bortezomib|mesh-list
138467297|NCT01965353|Panobinostat|panobinostat|mesh-list
138467298|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138467299|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
138467300|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
138467301|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467302|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467303|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138467304|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
138467305|NCT01965353|Hormones|hormones|mesh-ancestor
138467306|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138467307|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138467308|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467309|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
138467310|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138467311|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138467312|NCT01965353|Growth Substances|growth substances|mesh-ancestor
138467313|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
138202760|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138467314|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138467315|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467316|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467317|NCT01965522|Vitamin D|vitamin d|mesh-list
138467318|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
138467319|NCT01965522|Cholecalciferol|cholecalciferol|mesh-list
138467320|NCT01965522|Vitamins|vitamins|mesh-list
138467321|NCT01965522|Melatonin|melatonin|mesh-list
138467322|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
138467323|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467324|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138467325|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138467327|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467328|NCT01965522|Protective Agents|protective agents|mesh-ancestor
138467329|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467330|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
138467331|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138467332|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
138467333|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138467334|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467335|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138467336|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138467337|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138467339|NCT01965626|Dexamethasone|dexamethasone|mesh-list
138467340|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138467341|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
138467342|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
138467343|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467344|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383423|NCT05789303|Dexamethasone|dexamethasone|mesh-list
138467345|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138383424|NCT05789303|Pomalidomide|pomalidomide|mesh-list
138383432|NCT05789303|Hormones|hormones|mesh-ancestor
138467346|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
138467348|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138467349|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138467350|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467351|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
138467352|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138467353|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467354|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467355|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
138467356|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138467357|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138467358|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467359|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
138467360|NCT01965730|Coagulants|coagulants|mesh-ancestor
138467362|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138467363|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
138467364|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138467365|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138467366|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138467367|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138467368|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467369|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
138467370|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467371|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467372|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138467373|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138467374|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467375|NCT01965925|Modafinil|modafinil|mesh-list
138467376|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138467377|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467378|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
138467379|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138467380|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138467381|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467382|NCT01965977|Bortezomib|bortezomib|mesh-list
138467383|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467385|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138467386|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138467387|NCT01966133|Doxorubicin|doxorubicin|mesh-list
138467388|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138467390|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138467391|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467392|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138467393|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138467394|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138383448|NCT05788328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138383449|NCT05788328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467396|NCT01966172|Acetaminophen|acetaminophen|mesh-list
138467397|NCT01966172|Ibuprofen|ibuprofen|mesh-list
138467398|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138467399|NCT01966172|Morphine|morphine|mesh-list
138467400|NCT01966172|Gabapentin|gabapentin|mesh-list
138467401|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138467402|NCT01966172|Narcotics|narcotics|mesh-ancestor
138467403|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467404|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467405|NCT01966172|Analgesics|analgesics|mesh-ancestor
138467406|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
138467407|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467408|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138467409|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138467410|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138467411|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138467412|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467413|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467414|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
138467415|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
138467416|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138467417|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138467418|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138467419|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138467420|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138467421|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467422|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
138467423|NCT01966276|Methylphenidate|methylphenidate|mesh-list
138467424|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138467425|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467426|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138467427|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138467428|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138467429|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467430|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
138467431|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467432|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
138467433|NCT01966289|Guadecitabine|guadecitabine|mesh-list
138467434|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
138467435|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467436|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138467437|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138467438|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138467439|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
138467440|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467441|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383473|NCT05775159|Growth Inhibitors|growth inhibitors|mesh-ancestor
138467442|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138467443|NCT01966302|Beraprost|beraprost|mesh-list
138467444|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138467446|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138467447|NCT01966341|Laxatives|laxatives|mesh-list
138467448|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
138467449|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138467450|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138467451|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
138467452|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467453|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467454|NCT01966484|Succinylcholine|succinylcholine|mesh-list
138467455|NCT01966484|Mivacurium|mivacurium|mesh-list
138467456|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138467457|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138467458|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138467459|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467460|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467461|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138467462|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
138467463|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
138467465|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138467466|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138467467|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138467468|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
138467469|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138467470|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467471|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138467472|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138467473|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138467474|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138467475|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467476|NCT01966575|Hormones|hormones|mesh-ancestor
138467477|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138467478|NCT01966627|Liver Extracts|liver extracts|mesh-list
138467479|NCT01966627|Hematinics|hematinics|mesh-ancestor
138467480|NCT01966653|Fosfomycin|fosfomycin|mesh-list
138467481|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
138467482|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138467483|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138467484|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138467485|NCT01966692|Fluticasone|fluticasone|mesh-list
138467487|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138467488|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138467489|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
138467490|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467491|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467492|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138467493|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
138467494|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
138467495|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138467496|NCT01966783|Budesonide|budesonide|mesh-list
138467497|NCT01966783|Mesalamine|mesalamine|mesh-list
138467498|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138467499|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138467500|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
138467501|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467502|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138396735|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
138467503|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138467504|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
138467505|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
138467507|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138467508|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138467509|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138467510|NCT01966783|Analgesics|analgesics|mesh-ancestor
138467511|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
138467512|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138467513|NCT01966822|Ritonavir|ritonavir|mesh-list
138467514|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
138467515|NCT01966822|Dolutegravir|dolutegravir|mesh-list
138467516|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
138202782|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202783|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202784|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202785|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
138467517|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
138467518|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467519|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467520|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138467521|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138467522|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
138467523|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138467524|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138467525|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138467526|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138467527|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138467528|NCT01966913|Bevacizumab|bevacizumab|mesh-list
138467529|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138467530|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467531|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138467532|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138467533|NCT01966913|Growth Substances|growth substances|mesh-ancestor
138467534|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467535|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
138467536|NCT01967017|Lidocaine|lidocaine|mesh-list
138467537|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
138467538|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
138467539|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467540|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467541|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
138467542|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467543|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138467544|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138467545|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138383534|NCT05733364|Vitamins|vitamins|mesh-ancestor
138383535|NCT05733364|Micronutrients|micronutrients|mesh-ancestor
138467560|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467562|NCT01967199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138467563|NCT01967199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467564|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138383548|NCT05700045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467565|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
138467566|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467568|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138467569|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138467570|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467571|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467572|NCT01967264|Udenafil|udenafil|mesh-list
138467573|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138467574|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138467575|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467576|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467577|NCT01967368|Vaccines|vaccines|mesh-list
138467578|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
138467579|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467580|NCT01967381|Methamphetamine|methamphetamine|mesh-list
138467581|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138467582|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467583|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
138202788|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202789|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138202790|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138202791|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
138202792|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202793|NCT00384046|Testosterone|testosterone|mesh-list
138467584|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
138467585|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467586|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
138467587|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467588|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467589|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
138467590|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138467591|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138467592|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138467593|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138467594|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
138467595|NCT01967459|Vitamin D|vitamin d|mesh-list
138467596|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138467597|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467599|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
138467600|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138467601|NCT01967472|Artesunate|artesunate|mesh-list
138467602|NCT01967472|Lumefantrine|lumefantrine|mesh-list
138467603|NCT01967472|Artemether|artemether|mesh-list
138467604|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138467605|NCT01967472|Amodiaquine|amodiaquine|mesh-list
138467606|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
138467607|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138467608|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138467609|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138467610|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467611|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
138467612|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
138467614|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
138467616|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138467617|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
138467618|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
138467619|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
138467620|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138467621|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467622|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
138467623|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138467624|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467625|NCT01967524|Ropivacaine|ropivacaine|mesh-list
138467626|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138467627|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
138467628|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138467629|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
138467630|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
138467631|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467632|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467633|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
138467634|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467635|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138467636|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138467637|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467638|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
138467639|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467640|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138467641|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138467642|NCT01967758|Amoxicillin|amoxicillin|mesh-list
138397114|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138467643|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
138467644|NCT01967758|Trimethoprim|trimethoprim|mesh-list
138467645|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
138467646|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138467647|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138467648|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
138467649|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138467650|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138467651|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138467652|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467653|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467654|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138467655|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
138467656|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138467657|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138467658|NCT01967823|Aldesleukin|aldesleukin|mesh-list
138467659|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
138467660|NCT01967823|Fludarabine|fludarabine|mesh-list
138467661|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138467662|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
138467663|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467664|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138467665|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138467666|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
138467667|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467668|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467669|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138467670|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138467671|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138467672|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
138467673|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138467675|NCT01967875|Capecitabine|capecitabine|mesh-list
138467676|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467677|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
138467678|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
138383589|NCT05678257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138467679|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
138467680|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467681|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138467683|NCT01967927|Imidazole|imidazole|mesh-list
138467684|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467685|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467686|NCT01967979|Itraconazole|itraconazole|mesh-list
138467687|NCT01967979|Fluoxetine|fluoxetine|mesh-list
138467688|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
138467689|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138467690|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138467691|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138467692|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467693|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467694|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138467695|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
138467696|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138467697|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467698|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138467699|NCT01967979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138467700|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138467701|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138467702|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467704|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138467705|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
138467706|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138202810|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
138467707|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138467708|NCT01968005|Etodolac|etodolac|mesh-list
138467709|NCT01968005|Lidocaine|lidocaine|mesh-list
138467710|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
138467711|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
138467712|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467713|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467714|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
138467715|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467716|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138467717|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138467718|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138467719|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138383621|NCT05656248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138467720|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467721|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138467723|NCT01968005|Analgesics|analgesics|mesh-ancestor
138467724|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138467725|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138467726|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138467727|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138467728|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467729|NCT01968018|Acetaminophen|acetaminophen|mesh-list
138467730|NCT01968018|Tramadol|tramadol|mesh-list
138467731|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138467732|NCT01968018|Analgesics|analgesics|mesh-ancestor
138467733|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
138467734|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467735|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467736|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
138467737|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138467738|NCT01968018|Narcotics|narcotics|mesh-ancestor
138467739|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467740|NCT01968044|Linagliptin|linagliptin|mesh-list
138467741|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138467742|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467743|NCT01968044|Incretins|incretins|mesh-ancestor
138467745|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138467746|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138467747|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
138467748|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467749|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467750|NCT01968083|Vaccines|vaccines|mesh-list
138397361|NCT01530022|Lacosamide|lacosamide|mesh-list
138467752|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467753|NCT01968161|Asenapine|asenapine|mesh-list
138467754|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138467755|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138467756|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467757|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467758|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138467759|NCT01968239|Ranibizumab|ranibizumab|mesh-list
138467760|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138467761|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138467762|NCT01968239|Growth Substances|growth substances|mesh-ancestor
138467763|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467764|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
138467765|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467766|NCT01968395|Caspofungin|caspofungin|mesh-list
138467767|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
138467768|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138383664|NCT05605470|Vaccines|vaccines|mesh-list
138467769|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467770|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467771|NCT01968486|Ranibizumab|ranibizumab|mesh-list
138467772|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138467773|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138202822|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202824|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
138467774|NCT01968486|Growth Substances|growth substances|mesh-ancestor
138467775|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138397422|NCT01530308|Dopamine|dopamine|mesh-list
138467776|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
138467777|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467779|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138467780|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138467781|NCT01968564|Analgesics|analgesics|mesh-ancestor
138467782|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
138467783|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467784|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467785|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138467786|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138467787|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467788|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467789|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467790|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138467791|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138467792|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138467793|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
138467794|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467795|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138467796|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138467797|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467798|NCT01968616|Ranibizumab|ranibizumab|mesh-list
138467799|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138467800|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138467801|NCT01968616|Growth Substances|growth substances|mesh-ancestor
138467802|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467803|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
138467804|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467805|NCT01968655|Factor VIII|factor viii|mesh-list
138467806|NCT01968655|Coagulants|coagulants|mesh-ancestor
138467807|NCT01968759|Ramipril|ramipril|mesh-list
138467808|NCT01968759|Irbesartan|irbesartan|mesh-list
138467809|NCT01968759|Sevelamer|sevelamer|mesh-list
138383680|NCT05558124|Antimetabolites|antimetabolites|mesh-ancestor
138383683|NCT05558124|Antiviral Agents|antiviral agents|mesh-ancestor
138467810|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138467811|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
138467812|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467813|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467814|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138467815|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138467816|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138467817|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
138467818|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
138467819|NCT01968798|Aspirin|aspirin|mesh-list
138467820|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138467821|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138467822|NCT01968798|Analgesics|analgesics|mesh-ancestor
138467823|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
138467824|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467825|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467827|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138202829|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138202830|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138202831|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
138202832|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
138202833|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
138202835|NCT00002812|Cytarabine|cytarabine|mesh-list
138467828|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138467829|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138467830|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467831|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138467832|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138467833|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467834|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
138467835|NCT01968850|Vitamin D|vitamin d|mesh-list
138467836|NCT01968850|Alendronate|alendronate|mesh-list
138467837|NCT01968850|Vitamins|vitamins|mesh-ancestor
138467838|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
138467839|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467840|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138467842|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138467843|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467844|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
138467845|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
138467846|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
138467847|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467848|NCT01969006|Bupivacaine|bupivacaine|mesh-list
138467849|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
138467850|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
138397633|NCT01531361|Sorafenib|sorafenib|mesh-list
138467851|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138467852|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467853|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
138383714|NCT05487196|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138383723|NCT05471700|Venetoclax|venetoclax|mesh-list
138467854|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467856|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
138467857|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138467858|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138467859|NCT01969019|Prednisolone|prednisolone|mesh-list
138467860|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
138467861|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138467862|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
138467863|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138467864|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
138467865|NCT01969019|Hormones|hormones|mesh-ancestor
138467866|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138467867|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467868|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138467869|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467871|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
138467872|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467873|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138467874|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138467875|NCT01969019|Protective Agents|protective agents|mesh-ancestor
138467877|NCT01969032|Doxorubicin|doxorubicin|mesh-list
138467878|NCT01969032|Capecitabine|capecitabine|mesh-list
138467879|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
138467880|NCT01969032|Carboplatin|carboplatin|mesh-list
138467881|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138467882|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467883|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
138467884|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
138467885|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
138467886|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467887|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138467888|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138467889|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138467890|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467891|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138467892|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
138467893|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138467894|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
138467895|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467896|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138467897|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138467898|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
138467899|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138467900|NCT01969071|Simendan|simendan|mesh-list
138467901|NCT01969071|Dobutamine|dobutamine|mesh-list
138467902|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138467903|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
138467904|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138467905|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138467906|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467907|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467908|NCT01969071|Protective Agents|protective agents|mesh-ancestor
138383746|NCT05447286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138383747|NCT05447286|Analgesics|analgesics|mesh-ancestor
138467910|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
138467911|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
138467912|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467913|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138467914|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138467915|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138467916|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
138467917|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467918|NCT01969149|Insulin|insulin|mesh-list
138467919|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138467920|NCT01969149|Exenatide|exenatide|mesh-list
138467921|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
138467922|NCT01969149|Incretins|incretins|mesh-list
138467923|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138467924|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467925|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138467926|NCT01969149|Hormones|hormones|mesh-ancestor
138467927|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138467928|NCT01969318|Metformin|metformin|mesh-list
138467929|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138467930|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467931|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138397790|NCT01532544|Tinzaparin|tinzaparin|mesh-list
138467933|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467934|NCT01969357|Incretins|incretins|mesh-ancestor
138467936|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138467937|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138467938|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
138467939|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467940|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467942|NCT01969617|Nalmefene|nalmefene|mesh-list
138467943|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138467944|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467945|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
138467946|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467947|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
138467948|NCT01969656|Calcitriol|calcitriol|mesh-list
138467949|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138383767|NCT05431595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138383768|NCT05431595|Anticonvulsants|anticonvulsants|mesh-ancestor
138467950|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467952|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138383801|NCT05287100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138467953|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467954|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138467955|NCT01969656|Vitamins|vitamins|mesh-ancestor
138467956|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
138467957|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138467958|NCT01969669|Ketoconazole|ketoconazole|mesh-list
138467959|NCT01969669|Venetoclax|venetoclax|mesh-list
138467960|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467961|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
138467962|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138467963|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138467964|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138467965|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467966|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467967|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138467968|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
138467969|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138467970|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138467971|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138467972|NCT01969682|Rifampin|rifampin|mesh-list
138467973|NCT01969682|Venetoclax|venetoclax|mesh-list
138467974|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467975|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138467976|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
138467977|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138467978|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138467979|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
138397899|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467980|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138467981|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138467982|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467983|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138467984|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138467985|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138467986|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138467987|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138467988|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138467990|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138467991|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
138467992|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138467993|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138467994|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138467995|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138398022|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
138467996|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138467997|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
138467998|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138467999|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468000|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138468001|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468002|NCT01969877|Cetuximab|cetuximab|mesh-list
138468003|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468004|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138468005|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
138468006|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138468007|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138468008|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468009|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138468010|NCT01969903|Analgesics|analgesics|mesh-ancestor
138468011|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
138468012|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468013|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138468014|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138468015|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138468016|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
138468017|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138398086|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138468018|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468020|NCT01969942|Busulfan|busulfan|mesh-list
138468021|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138468022|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
138468023|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468024|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468025|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138468026|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138468027|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
138468028|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468029|NCT01969955|Paclitaxel|paclitaxel|mesh-list
138468030|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138398125|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138468031|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138383827|NCT05224141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138468032|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383828|NCT05224141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138383829|NCT05224141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468035|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
138468036|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468038|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138468039|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468040|NCT01970059|Metoprolol|metoprolol|mesh-list
138468041|NCT01970059|Carvedilol|carvedilol|mesh-list
138468042|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138468043|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138468044|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
138468045|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
138468046|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468047|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468048|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
138468049|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138468050|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138468051|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
138468052|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138468053|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468054|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
138468055|NCT01970059|Protective Agents|protective agents|mesh-ancestor
138398248|NCT01535092|Silybin|silybin|mesh-list
138468056|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138468057|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138468058|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138468059|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
138468060|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138468061|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138468063|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138468064|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138468065|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138468066|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468067|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138468068|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138468069|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138468070|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138468072|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
138468073|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
138468074|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
138468075|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138468076|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468077|NCT01970202|Enoxaparin|enoxaparin|mesh-list
138468078|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
138468079|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
138468080|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138468081|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138468082|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468083|NCT01970215|Atorvastatin|atorvastatin|mesh-list
138468084|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138468085|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138383857|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468086|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138468087|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
138468088|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468089|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138468090|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138468091|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468093|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
138468094|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138468095|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138202855|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138202857|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138202858|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138468096|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468097|NCT01970358|Poly ICLC|poly iclc|mesh-list
138468098|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
138468099|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
138468100|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468101|NCT01970449|Vaccines|vaccines|mesh-list
138468102|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
138468103|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398425|NCT01536158|Ibuprofen|ibuprofen|mesh-list
138468104|NCT01970553|Gemcitabine|gemcitabine|mesh-list
138468105|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138468106|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
138468107|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468108|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468110|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138468111|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468112|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
138468113|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
138468114|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
138468115|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468116|NCT01970748|Propranolol|propranolol|mesh-list
138468117|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138468118|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138468119|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
138468120|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138468121|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468122|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468123|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138468124|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138468125|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
138468127|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138468128|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468129|NCT01970904|Ribavirin|ribavirin|mesh-list
138468130|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138468131|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
138468132|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468133|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
138468134|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138468135|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138468136|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138468137|NCT01971034|Metformin|metformin|mesh-list
138468138|NCT01971034|Paclitaxel|paclitaxel|mesh-list
138468139|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138398611|NCT01537146|Ropivacaine|ropivacaine|mesh-list
138468140|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468141|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
138468142|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
138468143|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
138468144|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468145|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138468146|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468147|NCT01971047|Insulin|insulin|mesh-list
138468148|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
138468149|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138468150|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138468151|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468152|NCT01971190|Aflibercept|aflibercept|mesh-list
138468154|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138468155|NCT01971190|Growth Substances|growth substances|mesh-ancestor
138468156|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468157|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
138468158|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468159|NCT01971242|Exenatide|exenatide|mesh-list
138468160|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138202868|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138468161|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468162|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138468163|NCT01971242|Incretins|incretins|mesh-ancestor
138468164|NCT01971242|Hormones|hormones|mesh-ancestor
138468165|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138468166|NCT01971268|Cimetidine|cimetidine|mesh-list
138468167|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138468168|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138468169|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138202877|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138468170|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
138468171|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
138468172|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138202878|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138202879|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
138202880|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138202881|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138468173|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468174|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468175|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138468176|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138468177|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468178|NCT01971281|Paclitaxel|paclitaxel|mesh-list
138468179|NCT01971281|Gemcitabine|gemcitabine|mesh-list
138468180|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138468181|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138383910|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
138383911|NCT05081687|Irinotecan|irinotecan|mesh-list
138468183|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
138468184|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
138398780|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
138468185|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468186|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138468188|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
138468190|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
138468191|NCT01971411|Cholecalciferol|cholecalciferol|mesh-list
138468192|NCT01971411|Vitamins|vitamins|mesh-list
138468193|NCT01971411|Calcium|calcium|mesh-list
138468194|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
138468195|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468196|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138468197|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138468198|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
138468199|NCT01971424|Antacids|antacids|mesh-ancestor
138468200|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468201|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138468203|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138468204|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
138468205|NCT01971515|Tamoxifen|tamoxifen|mesh-list
138468206|NCT01971515|Trastuzumab|trastuzumab|mesh-list
138468207|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138468208|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468209|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138468210|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
138468211|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138468212|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138398905|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138468213|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138468214|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138468215|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138468216|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138468217|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138468218|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138468219|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138468220|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
138468221|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468222|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138468223|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138188299|NCT03018535|Prednisolone|prednisolone|mesh-list
138468224|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468226|NCT01971632|Naloxone|naloxone|mesh-list
138383934|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468229|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138468230|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468231|NCT01971632|Analgesics|analgesics|mesh-ancestor
138468232|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
138468233|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468234|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138468235|NCT01971658|Thalidomide|thalidomide|mesh-list
138468236|NCT01971658|Dexamethasone|dexamethasone|mesh-list
138468237|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
138468238|NCT01971658|Bortezomib|bortezomib|mesh-list
138468239|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138468240|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
138468241|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468242|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138468243|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138468244|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
138468245|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468246|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468247|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138468248|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138468250|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
138468251|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468252|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138468253|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
138468254|NCT01971658|Hormones|hormones|mesh-ancestor
138468255|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138468256|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138468257|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
138468258|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138468259|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138468260|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138468261|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138468262|NCT01971658|Growth Substances|growth substances|mesh-ancestor
138383963|NCT05062317|Irinotecan|irinotecan|mesh-list
138468263|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
138468264|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
138468265|NCT01971684|Sirolimus|sirolimus|mesh-list
138468266|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
138468267|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468268|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
138468269|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468270|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138468271|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138468272|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
138468273|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138468274|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138468275|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468276|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468277|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
138468278|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138468279|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
138468280|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138468281|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138468283|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
138468284|NCT01971801|Vitamins|vitamins|mesh-ancestor
138468285|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
138468286|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468287|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138468288|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138468290|NCT01971814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138468291|NCT01971814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138468292|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
138468293|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138468294|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138468295|NCT01971918|Antibodies|antibodies|mesh-list
138468296|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
138468297|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468298|NCT01972113|Vitamins|vitamins|mesh-list
138468299|NCT01972113|Vitamin K|vitamin k|mesh-list
138468300|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
138468301|NCT01972113|Menaquinone 7|menaquinone 7|mesh-list
138468302|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
138468303|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468304|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
138468305|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138468306|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138399272|NCT01540812|Prednisone|prednisone|mesh-list
138468307|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
138468308|NCT01972113|Coagulants|coagulants|mesh-ancestor
138468309|NCT01972230|Remifentanil|remifentanil|mesh-list
138468310|NCT01972230|Sevoflurane|sevoflurane|mesh-list
138468311|NCT01972230|Propofol|propofol|mesh-list
138202940|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138468312|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138468313|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138202941|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468314|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
138468315|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
138384000|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138468316|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138468317|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468318|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138468320|NCT01972230|Analgesics|analgesics|mesh-ancestor
138468321|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
138468322|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468323|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138468324|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138468326|NCT01972269|Fentanyl|fentanyl|mesh-list
138468327|NCT01972269|Bupivacaine|bupivacaine|mesh-list
138468328|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
138468329|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
138468330|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138468331|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468332|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
138468333|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468334|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138468335|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138468336|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138468337|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138468338|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468339|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138468340|NCT01972269|Narcotics|narcotics|mesh-ancestor
138468341|NCT01972269|Analgesics|analgesics|mesh-ancestor
138468342|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138468343|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138202950|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138202951|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468344|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
138468345|NCT01972373|Bevacizumab|bevacizumab|mesh-list
138468346|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138468347|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468348|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138468349|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138468350|NCT01972373|Growth Substances|growth substances|mesh-ancestor
138468351|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468352|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
138468353|NCT01972490|Bevacizumab|bevacizumab|mesh-list
138468354|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138468355|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468356|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138468357|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138468358|NCT01972490|Growth Substances|growth substances|mesh-ancestor
138468359|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468360|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
138468361|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
138468362|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468363|NCT01972620|Bupivacaine|bupivacaine|mesh-list
138468364|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
138468365|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
138468366|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138468367|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468368|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
138384024|NCT04962230|Ritonavir|ritonavir|mesh-list
138468369|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468371|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138468372|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138468373|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138468374|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468375|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138468376|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138468378|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138468379|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468380|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138468381|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
138468382|NCT01972763|Ranibizumab|ranibizumab|mesh-list
138468383|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138468384|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138468385|NCT01972763|Growth Substances|growth substances|mesh-ancestor
138468386|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468387|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
138468388|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468389|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
138468390|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
138468391|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
138468393|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138468394|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468395|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138468396|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468397|NCT01972906|Ibuprofen|ibuprofen|mesh-list
138468398|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138468399|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138468400|NCT01972906|Analgesics|analgesics|mesh-ancestor
138468401|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
138468402|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468403|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468404|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138468405|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138468406|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138468407|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384050|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
138468408|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468410|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138468411|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468413|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138468414|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468415|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468416|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138468417|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
138468418|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138468419|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468420|NCT01973010|Ibuprofen|ibuprofen|mesh-list
138468421|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138468422|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138468423|NCT01973010|Analgesics|analgesics|mesh-ancestor
138468424|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
138468425|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468426|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468427|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138468428|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138468429|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138468430|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468431|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468432|NCT01973101|Cisplatin|cisplatin|mesh-list
138468433|NCT01973101|Gemcitabine|gemcitabine|mesh-list
138468434|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468435|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138468436|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
138468437|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468438|NCT01973114|Latanoprost|latanoprost|mesh-list
138468439|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138468440|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138468441|NCT01973140|Tolvaptan|tolvaptan|mesh-list
138468442|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
138468443|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468445|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468446|NCT01973309|Paclitaxel|paclitaxel|mesh-list
138468447|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138468448|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468449|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
138468450|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
138399796|NCT01543945|BB 1101|bb 1101|mesh-list
138468452|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468453|NCT01973322|Vaccines|vaccines|mesh-list
138468454|NCT01973322|Complement Factor H|complement factor h|mesh-list
138468455|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
138468456|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468457|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
138468458|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138468459|NCT01973400|Tocotrienols|tocotrienols|mesh-list
138468460|NCT01973400|Vitamin E|vitamin e|mesh-list
138468461|NCT01973400|Tocopherols|tocopherols|mesh-list
138468462|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
138468463|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384086|NCT04933695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384087|NCT04926818|Ofatumumab|ofatumumab|mesh-list
138384090|NCT04926818|Siponimod|siponimod|mesh-list
138468465|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468466|NCT01973400|Vitamins|vitamins|mesh-ancestor
138468467|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
138468468|NCT01973504|Chrysarobin|chrysarobin|mesh-list
138468469|NCT01973504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138468470|NCT01973504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138468472|NCT01973504|Sensory System Agents|sensory system agents|mesh-ancestor
138468473|NCT01973504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138203005|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203006|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203007|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138468474|NCT01973504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468475|NCT01973504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138468476|NCT01973504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138468477|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138468478|NCT01973517|Hematinics|hematinics|mesh-ancestor
138468479|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138468480|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138468482|NCT01973660|Paclitaxel|paclitaxel|mesh-list
138468483|NCT01973660|Trastuzumab|trastuzumab|mesh-list
138468484|NCT01973660|Letrozole|letrozole|mesh-list
138468485|NCT01973660|Lapatinib|lapatinib|mesh-list
138468486|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138468487|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468488|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
138468489|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
138203013|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203014|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138203015|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138203016|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
138203022|NCT01260883|Ketorolac|ketorolac|mesh-list
138468490|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
138468491|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468492|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138468493|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138468494|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138468495|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468496|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138468497|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
138468498|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138468499|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468500|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138468501|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138468502|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138468503|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138468504|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138468506|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138468507|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138399962|NCT01544829|Theobromine|theobromine|mesh-list
138468508|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
138468509|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468510|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468511|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138468512|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
138468513|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
138468514|NCT01973751|Hormones|hormones|mesh-ancestor
138468515|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138468517|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138468518|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468519|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138384103|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138468520|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
138468521|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138468522|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468523|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138468524|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
138188300|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
138468525|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138468526|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
138468527|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138468529|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
138468531|NCT01973816|Estrogens|estrogens|mesh-ancestor
138468532|NCT01973816|Hormones|hormones|mesh-ancestor
138468533|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138468534|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468535|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138468536|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
138468537|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138468538|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138468539|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
138468540|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
138468541|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468542|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138468543|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
138468544|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138468545|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138468546|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
138468547|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138468548|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
138468549|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138468550|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468551|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138468552|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138468553|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468555|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
138203072|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
138468556|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468557|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
138468558|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138468559|NCT01973868|Cetuximab|cetuximab|mesh-list
138468560|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138468561|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468562|NCT01973920|Insulin|insulin|mesh-list
138468563|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138468564|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468565|NCT01973933|Metformin|metformin|mesh-list
138384125|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468566|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
138468567|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138468568|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468569|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
138468570|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138468571|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138468572|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138468573|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138468574|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468575|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468576|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
138468577|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138468578|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138468579|NCT01974024|Prednisolone|prednisolone|mesh-list
138468580|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
138468581|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138468582|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
138468583|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138468584|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
138468585|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
138468586|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468587|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468588|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138468589|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
138468590|NCT01974024|Hormones|hormones|mesh-ancestor
138468591|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138468592|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138468593|NCT01974024|Protective Agents|protective agents|mesh-ancestor
138468594|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138468595|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468596|NCT01974037|Capsaicin|capsaicin|mesh-list
138468597|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
138468598|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
138468599|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
138468600|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468601|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468604|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
138468605|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138384153|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138468606|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468607|NCT01974167|Vitamins|vitamins|mesh-ancestor
138468608|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
138468610|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468611|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138468612|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468613|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468615|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
138468616|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138468617|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138468618|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
138468619|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468620|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138468621|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138468622|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468623|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
138468624|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138468625|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138468626|NCT01974375|Fluconazole|fluconazole|mesh-list
138468628|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
138468629|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138468630|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
138468631|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138468632|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468633|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468634|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138468635|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
138468636|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138468637|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468638|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
138468639|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
138468641|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138468642|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138468643|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
138468644|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
138468645|NCT01974518|Rituximab|rituximab|mesh-list
138468646|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138468647|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
138468648|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468649|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138468650|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138468651|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
138468652|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468653|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468654|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138468655|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138468656|NCT01974622|Verteporfin|verteporfin|mesh-list
138468657|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
138468658|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
138468659|NCT01974648|Remifentanil|remifentanil|mesh-list
138468660|NCT01974648|Propofol|propofol|mesh-list
138468661|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138468662|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138468663|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468664|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138468665|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
138468666|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
138468667|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138468668|NCT01974648|Narcotics|narcotics|mesh-ancestor
138468669|NCT01974648|Analgesics|analgesics|mesh-ancestor
138468670|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
138468671|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468672|NCT01974843|Bupivacaine|bupivacaine|mesh-list
138468673|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
138468674|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
138468675|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
138384185|NCT04700046|Mexiletine|mexiletine|mesh-list
138468679|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468680|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138468681|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138468682|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138468683|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138468684|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468685|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138400682|NCT01549600|Cathartics|cathartics|mesh-ancestor
138468686|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468687|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
138468688|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138468689|NCT01975012|Rilpivirine|rilpivirine|mesh-list
138468690|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138203080|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138468691|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138468692|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468693|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468694|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
138468695|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138468696|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138468697|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138468698|NCT01975051|Miltefosine|miltefosine|mesh-list
138468699|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
138468700|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138468701|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468702|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138468703|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138468704|NCT01975129|Oxytocin|oxytocin|mesh-list
138468705|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
138468706|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138468707|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468708|NCT01975142|Trastuzumab|trastuzumab|mesh-list
138468709|NCT01975142|Maytansine|maytansine|mesh-list
138468710|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138468711|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138400821|NCT01550640|Remifentanil|remifentanil|mesh-list
138468712|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138468713|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
138468714|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
138468716|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468717|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138468718|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138468719|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138468720|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
138468721|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468722|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138468723|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138468724|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468725|NCT01975259|Glucagon|glucagon|mesh-list
138468726|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
138468727|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138468728|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138468729|NCT01975259|Hormones|hormones|mesh-ancestor
138468730|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138468731|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468732|NCT01975259|Incretins|incretins|mesh-ancestor
138468733|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
138468734|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
138468735|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138468736|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468737|NCT01975363|Curcumin|curcumin|mesh-list
138468738|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138401003|NCT01551719|Vancomycin|vancomycin|mesh-list
138468739|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138468740|NCT01975363|Analgesics|analgesics|mesh-ancestor
138468741|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
138468742|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468743|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468744|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138468745|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138468746|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468747|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468748|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468749|NCT01975441|Ivermectin|ivermectin|mesh-list
138468750|NCT01975441|Albendazole|albendazole|mesh-list
138468751|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
138468752|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138384236|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
138468754|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
138468755|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
138468756|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138401137|NCT01552850|Oxycodone|oxycodone|mesh-list
138468758|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
138468759|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
138468760|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
138468761|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468762|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468763|NCT01975441|Filaricides|filaricides|mesh-ancestor
138468764|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
138468765|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138468766|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468767|NCT01975454|Capecitabine|capecitabine|mesh-list
138468768|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
138468769|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138468771|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468772|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468773|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138468774|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138468775|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138468776|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138468777|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468778|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138468779|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468780|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
138468781|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138468782|NCT01975662|Vancomycin|vancomycin|mesh-list
138468783|NCT01975662|Daptomycin|daptomycin|mesh-list
138468784|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138468785|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138468786|NCT01975688|Nabiximols|nabiximols|mesh-list
138468787|NCT01975688|Analgesics|analgesics|mesh-ancestor
138468788|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
138468789|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468790|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468791|NCT01975714|Bimatoprost|bimatoprost|mesh-list
138468792|NCT01975714|Latanoprost|latanoprost|mesh-list
138468793|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138468794|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138468795|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138468796|NCT01975727|Dexamethasone|dexamethasone|mesh-list
138468797|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
138468798|NCT01975727|BB 1101|bb 1101|mesh-list
138468799|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138468800|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
138384259|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
138384260|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138468803|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468804|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138468806|NCT01975727|Hormones|hormones|mesh-ancestor
138468807|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138468808|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138468809|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468810|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
138468811|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468812|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468813|NCT01975753|Fentanyl|fentanyl|mesh-list
138468814|NCT01975753|Morphine|morphine|mesh-list
138468815|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138468816|NCT01975753|Narcotics|narcotics|mesh-ancestor
138468817|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138468818|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468819|NCT01975753|Analgesics|analgesics|mesh-ancestor
138468820|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
138401392|NCT01555099|Budesonide|budesonide|mesh-list
138203097|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203099|NCT00002836|Thiotepa|thiotepa|mesh-list
138468821|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468822|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138468823|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138468824|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
138468826|NCT01975779|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
138468827|NCT01975779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138468828|NCT01975779|Serotonin Agents|serotonin agents|mesh-ancestor
138468829|NCT01975779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138468830|NCT01975779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138401453|NCT01555658|Heparin|heparin|mesh-list
138468831|NCT01975779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468833|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138468834|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
138468835|NCT01975805|Povidone|povidone|mesh-list
138468836|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138468837|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138468838|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
138468839|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
138468840|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
138468841|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
138468842|NCT01975961|Telmisartan|telmisartan|mesh-list
138468843|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138468844|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138468845|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138468846|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
138468847|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468848|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138468849|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138468851|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138468852|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138468853|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138468855|NCT01976078|Esomeprazole|esomeprazole|mesh-list
138468856|NCT01976078|Ranitidine|ranitidine|mesh-list
138468857|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138468858|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138468859|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138468860|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138468861|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468862|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138384285|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468863|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138468870|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138468871|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468872|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138468873|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138203120|NCT00003664|Fluorouracil|fluorouracil|mesh-list
138468874|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138468875|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468876|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138468877|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
138468878|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
138468879|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
138468880|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468881|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138468882|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138468883|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468884|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468885|NCT01976195|Thalidomide|thalidomide|mesh-list
138468886|NCT01976195|Dexamethasone|dexamethasone|mesh-list
138468887|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138468888|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
138468889|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
138468890|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468891|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468892|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138468893|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
138468895|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138468896|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138468897|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468898|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138468899|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
138468900|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
138468901|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138468902|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138468903|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138468904|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138468905|NCT01976195|Growth Substances|growth substances|mesh-ancestor
138468906|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
138468907|NCT01976208|Omalizumab|omalizumab|mesh-list
138468908|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138468909|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138468910|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
138468911|NCT01976520|Vaccines|vaccines|mesh-list
138468912|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
138468913|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468914|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
138468915|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138468916|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138468917|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138468918|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138468919|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468920|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
138384296|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138384297|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468922|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468923|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138468924|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468925|NCT01976676|Folic Acid|folic acid|mesh-list
138468926|NCT01976676|Hematinics|hematinics|mesh-ancestor
138468927|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
138468928|NCT01976676|Vitamins|vitamins|mesh-ancestor
138468929|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
138468930|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468931|NCT01976780|Artesunate|artesunate|mesh-list
138468932|NCT01976780|Lumefantrine|lumefantrine|mesh-list
138468933|NCT01976780|Artemether|artemether|mesh-list
138468934|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138468935|NCT01976780|Mefloquine|mefloquine|mesh-list
138468936|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
138468937|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138468938|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138468939|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138468940|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468941|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
138468942|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
138468943|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138468944|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
138468945|NCT01976923|Bevacizumab|bevacizumab|mesh-list
138468946|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138468947|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138468948|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138468949|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138468950|NCT01976923|Growth Substances|growth substances|mesh-ancestor
138468951|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468952|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
138468953|NCT01976936|Lovastatin|lovastatin|mesh-list
138468954|NCT01976936|L 647318|l 647318|mesh-list
138468955|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
138468956|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138468957|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138468958|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
138468959|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468960|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138468961|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138468962|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468963|NCT01977118|Streptokinase|streptokinase|mesh-list
138468964|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138468965|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138468966|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468967|NCT01977209|Gossypol|gossypol|mesh-list
138468968|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138468969|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
138468970|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138468971|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468972|NCT01977300|Valproic Acid|valproic acid|mesh-list
138468973|NCT01977300|Olanzapine|olanzapine|mesh-list
138468974|NCT01977300|Risperidone|risperidone|mesh-list
138468975|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
138468976|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138468977|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
138468978|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138468979|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138468980|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138468981|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138468983|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138468984|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138468985|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138468986|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
138468987|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
138468988|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
138468989|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138468990|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138402106|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
138468991|NCT01977300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138468992|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138468993|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138468994|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
138468995|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138468996|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
138468997|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
138468998|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
138468999|NCT01977339|Bupivacaine|bupivacaine|mesh-list
138469000|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
138469001|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
138469002|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138402182|NCT04305444|Everolimus|everolimus|mesh-list
138469003|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469004|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
138469005|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469006|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138469007|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
138469008|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138469009|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138469010|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138469011|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469012|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469013|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469014|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138469015|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
138469016|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138469017|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138469018|NCT01977430|Furosemide|furosemide|mesh-list
138469019|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138469020|NCT01977430|Diuretics|diuretics|mesh-ancestor
138469021|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
138469022|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469023|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138469024|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138469025|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469026|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
138384325|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
138384333|NCT04364230|Poly ICLC|poly iclc|mesh-list
138469029|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138469030|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138469031|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469032|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469033|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138469034|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138469035|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
138469036|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
138469037|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469039|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138469040|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469041|NCT01978015|Timolol|timolol|mesh-list
138469042|NCT01978015|Bimatoprost|bimatoprost|mesh-list
138469043|NCT01978015|Travoprost|travoprost|mesh-list
138469044|NCT01978015|Dextrans|dextrans|mesh-list
138469045|NCT01978015|Latanoprost|latanoprost|mesh-list
138469046|NCT01978015|Maleic acid|maleic acid|mesh-list
138469047|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469048|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469049|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138469050|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138469051|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
138469052|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469053|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469054|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138469055|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138469056|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138469057|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138469058|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
138469059|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
138469060|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
138469061|NCT01978041|Fluorides|fluorides|mesh-list
138469062|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
138469063|NCT01978041|Protective Agents|protective agents|mesh-ancestor
138469064|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469065|NCT01978301|Triamcinolone|triamcinolone|mesh-list
138469066|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
138469067|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
138469068|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
138469069|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138469070|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
138469072|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469073|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469074|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138384361|NCT04314375|Budesonide|budesonide|mesh-list
138469075|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
138469076|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469077|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469079|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
138469080|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469082|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469083|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
138469084|NCT01978405|Vitamins|vitamins|mesh-ancestor
138469085|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
138469086|NCT01978418|Albuterol|albuterol|mesh-list
138469087|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138469088|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
138469089|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469090|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469091|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138469092|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
138469093|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
138469094|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138469095|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138469096|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138469097|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138469098|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
138469099|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469100|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469101|NCT01978457|Propranolol|propranolol|mesh-list
138469102|NCT01978457|Cocaine|cocaine|mesh-list
138469103|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138469104|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138469105|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
138384383|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138384384|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138384386|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
138469106|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469107|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469108|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469109|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138469110|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138469112|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
138469114|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469115|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
138469116|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469117|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138469118|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138469119|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138469120|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138469121|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
138469122|NCT01978483|Denosumab|denosumab|mesh-list
138469123|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138402722|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
138469124|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469126|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138469127|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
138469128|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469129|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469130|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469131|NCT01978665|Prednisone|prednisone|mesh-list
138469132|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138469133|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
138469134|NCT01978665|Hormones|hormones|mesh-ancestor
138384448|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138384449|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138384450|NCT04033029|Tazobactam|tazobactam|mesh-list
138469135|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469136|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469137|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138469138|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469140|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138469141|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138469142|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
138469143|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469144|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469145|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138469146|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
138469147|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
138469148|NCT01978678|Hormones|hormones|mesh-ancestor
138402903|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469149|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469150|NCT01978704|Insulin|insulin|mesh-list
138469151|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138469152|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138469153|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469154|NCT01978717|Anesthetics|anesthetics|mesh-list
138469155|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469156|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469157|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
138469158|NCT01978782|Citalopram|citalopram|mesh-list
138469159|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138469160|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138469161|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
138469162|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469163|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
138469164|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
138469165|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469166|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138402980|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
138469167|NCT01978782|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138469168|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138384492|NCT03844750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469169|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138384517|NCT03756896|Hormones|hormones|mesh-ancestor
138469171|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
138469172|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469173|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138469174|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
138469175|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138469176|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
138469177|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
138469179|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
138469180|NCT01978873|Hormones|hormones|mesh-ancestor
138469181|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469182|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469183|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
138469184|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469185|NCT01978873|Protective Agents|protective agents|mesh-ancestor
138469187|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
138469188|NCT01978873|Estrogens|estrogens|mesh-ancestor
138469189|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138469190|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469191|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
138469192|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138469193|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
138469194|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469195|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
138469196|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138469197|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
138469198|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138384529|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384530|NCT03737955|Immunotoxins|immunotoxins|mesh-ancestor
138384531|NCT03737955|Immunoconjugates|immunoconjugates|mesh-ancestor
138469199|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138469200|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138469201|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469202|NCT01979354|Morphine|morphine|mesh-list
138469203|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138469204|NCT01979354|Narcotics|narcotics|mesh-ancestor
138469205|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469206|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469207|NCT01979354|Analgesics|analgesics|mesh-ancestor
138469208|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
138469209|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469210|NCT01979406|Vaccines|vaccines|mesh-list
138469211|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
138469212|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469213|NCT01979510|Acetaminophen|acetaminophen|mesh-list
138469214|NCT01979510|Etoricoxib|etoricoxib|mesh-list
138469215|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138469216|NCT01979510|Analgesics|analgesics|mesh-ancestor
138469217|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
138469218|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469219|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469221|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138469222|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138469223|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138469224|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138469225|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138384578|NCT03567473|BB 1101|bb 1101|mesh-list
138403348|NCT01559974|Vitamin D|vitamin d|mesh-list
138469227|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469228|NCT01979653|Midazolam|midazolam|mesh-list
138469229|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
138469230|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138469231|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469232|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469234|NCT01979653|Analgesics|analgesics|mesh-ancestor
138469235|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
138469236|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469237|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138469238|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138469239|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138469240|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
138469241|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469242|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469243|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138469244|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138403482|NCT05391555|Remifentanil|remifentanil|mesh-list
138469245|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138469246|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138469247|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138469248|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
138469249|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
138469250|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
138469251|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
138469252|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
138469253|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138469254|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138469255|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469256|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469257|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138384624|NCT03500328|Natalizumab|natalizumab|mesh-list
138384626|NCT03500328|(T,G)-A-L|(t,g)-a-l|mesh-list
138469258|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
138469259|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138469261|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
138469262|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469263|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469264|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138469265|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138469266|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
138469267|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138469268|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138469269|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
138469271|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138469272|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138469273|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469274|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
138469275|NCT01980004|Diuretics|diuretics|mesh-ancestor
138469276|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
138469277|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469278|NCT01980004|Expectorants|expectorants|mesh-ancestor
138469279|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
138469280|NCT01980069|Neostigmine|neostigmine|mesh-list
138469281|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138469282|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469283|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469284|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
138469285|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469286|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469287|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
138469288|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
138469289|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469290|NCT01980082|Cefazolin|cefazolin|mesh-list
138469291|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138469292|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469293|NCT01980277|Paclitaxel|paclitaxel|mesh-list
138469294|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138469295|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469296|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
138469297|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
138469298|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
138469300|NCT01980303|Esketamine|esketamine|mesh-list
138469301|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
138469302|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138469303|NCT01980316|Heparin|heparin|mesh-list
138469304|NCT01980316|Calcium heparin|calcium heparin|mesh-list
138469305|NCT01980316|Argatroban|argatroban|mesh-list
138469306|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
138469307|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138469308|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138469309|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469310|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
138403854|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138469311|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138469312|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
138469313|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469314|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138469315|NCT01980329|Maraviroc|maraviroc|mesh-list
138469316|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
138469317|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
138403922|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469318|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469320|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138469321|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
138469322|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469323|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
138469324|NCT01980407|Leucovorin|leucovorin|mesh-list
138469325|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
138469326|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
138469327|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138384701|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138469329|NCT01980407|Protective Agents|protective agents|mesh-ancestor
138469330|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469331|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
138469332|NCT01980407|Vitamins|vitamins|mesh-ancestor
138469333|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
138469334|NCT01980472|Paclitaxel|paclitaxel|mesh-list
138469335|NCT01980472|Bevacizumab|bevacizumab|mesh-list
138469336|NCT01980472|Carboplatin|carboplatin|mesh-list
138469337|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138469338|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469339|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
138469340|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
138469341|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
138469342|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469343|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138469344|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138404123|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
138469345|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138469346|NCT01980472|Growth Substances|growth substances|mesh-ancestor
138469347|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469349|NCT01980498|Fentanyl|fentanyl|mesh-list
138469350|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138469351|NCT01980498|Narcotics|narcotics|mesh-ancestor
138469352|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469353|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469354|NCT01980498|Analgesics|analgesics|mesh-ancestor
138469355|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
138469356|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469357|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138469358|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138469359|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
138469360|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
138469361|NCT01980550|Nicotine|nicotine|mesh-list
138469362|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138469363|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
138469364|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469365|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469366|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138469367|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138469368|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
138469369|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469370|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469371|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
138469372|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138469373|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
138469375|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469376|NCT01980680|Estradiol|estradiol|mesh-list
138469377|NCT01980680|Progesterone|progesterone|mesh-list
138469378|NCT01980680|Estrogens|estrogens|mesh-ancestor
138469379|NCT01980680|Hormones|hormones|mesh-ancestor
138469380|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469381|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469382|NCT01980680|Progestins|progestins|mesh-ancestor
138469383|NCT01980745|Chloroquine|chloroquine|mesh-list
138469384|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138469385|NCT01980745|Amebicides|amebicides|mesh-ancestor
138469386|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138469387|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138469388|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469389|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
138469390|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138469391|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138384745|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138469392|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138469393|NCT01980745|Analgesics|analgesics|mesh-ancestor
138384746|NCT03096782|Lenograstim|lenograstim|mesh-list
138469395|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469396|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469397|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138469398|NCT01980745|Filaricides|filaricides|mesh-ancestor
138404323|NCT01572181|Busulfan|busulfan|mesh-list
138469400|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
138469401|NCT01980810|Paclitaxel|paclitaxel|mesh-list
138203209|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138469402|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138203210|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203211|NCT00384592|Esomeprazole|esomeprazole|mesh-list
138469403|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138469404|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469405|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
138469406|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
138469407|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
138469408|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469409|NCT01980849|Nadroparin|nadroparin|mesh-list
138469410|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
138469411|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138469412|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138469413|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469415|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
138469416|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469417|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469418|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469419|NCT01980979|Treprostinil|treprostinil|mesh-list
138469420|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138469421|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
138469422|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138469423|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469424|NCT01981278|Tapentadol|tapentadol|mesh-list
138469425|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138469426|NCT01981278|Narcotics|narcotics|mesh-ancestor
138469427|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469428|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469429|NCT01981278|Analgesics|analgesics|mesh-ancestor
138469430|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
138469431|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469432|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138469433|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138469434|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138469435|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469436|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
138469437|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469438|NCT01981291|Anesthetics|anesthetics|mesh-list
138469439|NCT01981291|Mepivacaine|mepivacaine|mesh-list
138469440|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
138469441|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469442|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138404497|NCT01572961|Analgesics|analgesics|mesh-ancestor
138469444|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469445|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
138469446|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138469447|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
138469448|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469449|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
138469450|NCT01981330|Protective Agents|protective agents|mesh-ancestor
138469451|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
138469452|NCT01981369|Propofol|propofol|mesh-list
138469453|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138469454|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469455|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469456|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138469457|NCT01981369|Analgesics|analgesics|mesh-ancestor
138469458|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
138469459|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469460|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138469461|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138469462|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138469463|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
138469464|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469465|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203223|NCT00002866|Epirubicin|epirubicin|mesh-list
138469466|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138469467|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
138469468|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
138469469|NCT01981447|Lacosamide|lacosamide|mesh-list
138469470|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
138384789|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
138384790|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
138469471|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138469472|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138469473|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138469474|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469475|NCT01981460|Methylene Blue|methylene blue|mesh-list
138469476|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469477|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469478|NCT01981499|Cetirizine|cetirizine|mesh-list
138469479|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138469480|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138469481|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138469482|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
138469484|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469485|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469486|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469487|NCT01981525|Metformin|metformin|mesh-list
138469488|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138469490|NCT01981707|Choline|choline|mesh-list
138469491|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
138469492|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138469493|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
138469494|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469495|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138469496|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138469497|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
138469498|NCT01981746|Ropivacaine|ropivacaine|mesh-list
138469499|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
138469500|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
138469501|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469502|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469503|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
138469504|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469505|NCT01981811|Aripiprazole|aripiprazole|mesh-list
138469506|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
138469507|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138469508|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138469509|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138469510|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469511|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469512|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
138469514|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469515|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469516|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138469519|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
138469520|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
138469521|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138469522|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138469524|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138469525|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
138469526|NCT01981889|Hormones|hormones|mesh-ancestor
138469527|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469528|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469529|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138469530|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469531|NCT01981941|Gabapentin|gabapentin|mesh-list
138469532|NCT01981941|Analgesics|analgesics|mesh-ancestor
138469533|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
138469534|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469535|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469536|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
138469537|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138469538|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138469539|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469540|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138469541|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138469542|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138469543|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469544|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138404905|NCT01576731|Tenofovir|tenofovir|mesh-list
138469545|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
138469547|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469548|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469549|NCT01982071|Micafungin|micafungin|mesh-list
138384872|NCT02681211|Ketorolac|ketorolac|mesh-list
138469551|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469552|NCT01982097|Sorafenib|sorafenib|mesh-list
138469553|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469554|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138469555|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469556|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469557|NCT01982201|Lesinurad|lesinurad|mesh-list
138469558|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
138469559|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138469560|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
138469561|NCT01982396|Lamivudine|lamivudine|mesh-list
138469562|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138469563|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138469564|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469565|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469566|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
138469567|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469568|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138469569|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138469570|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138469571|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138469572|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138469573|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
138469574|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469575|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138469576|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138469577|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469578|NCT01982578|Genistein|genistein|mesh-list
138469579|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
138469580|NCT01982578|Protective Agents|protective agents|mesh-ancestor
138384910|NCT02632708|Daunorubicin|daunorubicin|mesh-list
138384911|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
138469581|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469582|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469583|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138469584|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469585|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469586|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
138469587|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
138469588|NCT01982578|Estrogens|estrogens|mesh-ancestor
138469589|NCT01982578|Hormones|hormones|mesh-ancestor
138469590|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469591|NCT01982734|Curcumin|curcumin|mesh-list
138469592|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138469593|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138203236|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138203237|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
138469594|NCT01982734|Analgesics|analgesics|mesh-ancestor
138469595|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
138469596|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138203238|NCT00003232|Hormones|hormones|mesh-ancestor
138203243|NCT00003232|Analgesics|analgesics|mesh-ancestor
138469597|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469598|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138469599|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138469600|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469601|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469602|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469603|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138469604|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
138469605|NCT01982760|Coagulants|coagulants|mesh-ancestor
138469606|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138469607|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
138469608|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469609|NCT01982799|Acetaminophen|acetaminophen|mesh-list
138469610|NCT01982799|Ibuprofen|ibuprofen|mesh-list
138469611|NCT01982799|Naproxen|naproxen|mesh-list
138469612|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
138469613|NCT01982799|Hydrocodone|hydrocodone|mesh-list
138469614|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138469615|NCT01982799|Analgesics|analgesics|mesh-ancestor
138469616|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
138469617|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469618|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469619|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
138469620|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138384955|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469621|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138469622|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138469623|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138469624|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469625|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469627|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138469629|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469630|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
138469631|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
138469632|NCT01982864|Gentamicins|gentamicins|mesh-list
138469633|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138469634|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469635|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138469636|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469637|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469638|NCT01982929|Epinephrine|epinephrine|mesh-list
138469639|NCT01982929|Bupivacaine|bupivacaine|mesh-list
138469640|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
138469641|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
138469642|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469643|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469644|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
138469645|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469646|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138469647|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138469648|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
138469649|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469650|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469651|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138469652|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138469653|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
138384990|NCT02352948|Tremelimumab|tremelimumab|mesh-list
138469654|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138385005|NCT02315326|Rituximab|rituximab|mesh-list
138469656|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
138469657|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
138469658|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138469659|NCT01983124|Vemurafenib|vemurafenib|mesh-list
138469660|NCT01983124|Fotemustine|fotemustine|mesh-list
138469661|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203252|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469662|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138469663|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469664|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469665|NCT01983137|Oxycodone|oxycodone|mesh-list
138469666|NCT01983137|Naloxone|naloxone|mesh-list
138469667|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138469668|NCT01983137|Narcotics|narcotics|mesh-ancestor
138469669|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469670|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469672|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
138469673|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469674|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138469675|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138469676|NCT01983371|Hematinics|hematinics|mesh-ancestor
138469677|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138469678|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138469679|NCT01983384|Anesthetics|anesthetics|mesh-list
138469680|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469681|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469682|NCT01983449|Dexamethasone|dexamethasone|mesh-list
138469683|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
138469684|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
138469685|NCT01983449|BB 1101|bb 1101|mesh-list
138469686|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138469687|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
138385030|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469688|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
138469689|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469690|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469691|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138469692|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
138469694|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469695|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138469696|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469697|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
138469698|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469699|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469700|NCT01983475|Denosumab|denosumab|mesh-list
138469701|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138469702|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469703|NCT01983501|Tucatinib|tucatinib|mesh-list
138469704|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469705|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469706|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138469707|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469708|NCT01983514|Oxytocin|oxytocin|mesh-list
138469709|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
138469710|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138469711|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469712|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
138469713|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138469714|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138469715|NCT01983527|Prednisolone|prednisolone|mesh-list
138469716|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
138469717|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138469718|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
138469719|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138469720|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
138469721|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
138469722|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469723|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469724|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138469726|NCT01983527|Hormones|hormones|mesh-ancestor
138469727|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469728|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138469730|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138469731|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469732|NCT01983540|Vaccines|vaccines|mesh-list
138469733|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138469734|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
138469735|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469736|NCT01983657|Molgramostim|molgramostim|mesh-list
138469737|NCT01983657|Sargramostim|sargramostim|mesh-list
138469738|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
138469739|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469740|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469741|NCT01983722|Stiripentol|stiripentol|mesh-list
138469742|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
138385073|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469743|NCT01983735|Niacin|niacin|mesh-list
138469744|NCT01983735|Amlodipine|amlodipine|mesh-list
138469745|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138385075|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469746|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138469747|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138469748|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469749|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138469750|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469751|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
138469752|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138469753|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
138469754|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138469755|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
138469757|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
138469758|NCT01983761|Vidarabine|vidarabine|mesh-list
138469759|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
138469760|NCT01983761|Fludarabine|fludarabine|mesh-list
138469761|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
138469762|NCT01983761|Melphalan|melphalan|mesh-list
138469763|NCT01983761|Busulfan|busulfan|mesh-list
138469764|NCT01983761|Clofarabine|clofarabine|mesh-list
138469765|NCT01983761|Tacrolimus|tacrolimus|mesh-list
138469766|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469767|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
138405659|NCT01587378|Metformin|metformin|mesh-list
138469768|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469769|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138469770|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
138469771|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469772|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138469773|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
138469774|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469775|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138405722|NCT01589614|Erythromycin|erythromycin|mesh-list
138469776|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469777|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138469778|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138469779|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
138469780|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138469781|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138469782|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
138469783|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138469784|NCT01983800|Midazolam|midazolam|mesh-list
138469785|NCT01983800|Propofol|propofol|mesh-list
138469786|NCT01983800|Isoflurane|isoflurane|mesh-list
138469787|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138469788|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469789|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469790|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138469791|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
138469792|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
138469793|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138469794|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138469795|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138469796|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138188301|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
138469798|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
138469799|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469800|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469801|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138469802|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
138469803|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469804|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
138469805|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469806|NCT01983943|Protective Agents|protective agents|mesh-ancestor
138469807|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469808|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138469809|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
138469810|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
138469811|NCT01984008|Citric Acid|citric acid|mesh-list
138469812|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
138469813|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
138469815|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
138469816|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
138469817|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469818|NCT01984008|Cathartics|cathartics|mesh-ancestor
138469819|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138385133|NCT02096042|Immunologic Factors|immunologic factors|mesh-ancestor
138469822|NCT01984073|Niacinamide|niacinamide|mesh-list
138469823|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
138469824|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138469825|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
138469826|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469827|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138469828|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
138469829|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
138469830|NCT01984073|Vitamins|vitamins|mesh-ancestor
138469831|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
138405841|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
138469832|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469833|NCT01984086|Albuterol|albuterol|mesh-list
138469834|NCT01984086|Charcoal|charcoal|mesh-list
138469835|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138469836|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
138469837|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469838|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469839|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138469840|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
138469841|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
138469842|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138469843|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
138469844|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138469845|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138469846|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
138469847|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469848|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469849|NCT01984086|Antidotes|antidotes|mesh-ancestor
138469850|NCT01984086|Protective Agents|protective agents|mesh-ancestor
138469851|NCT01984099|Folic Acid|folic acid|mesh-list
138469853|NCT01984099|Methotrexate|methotrexate|mesh-list
138385169|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469854|NCT01984099|Vitamins|vitamins|mesh-ancestor
138469855|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
138469856|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469857|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138469858|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
138469859|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138469860|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138469861|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
138469862|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469863|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469864|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
138469865|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469866|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138469867|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138469868|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
138469869|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138469870|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138469871|NCT01984099|Hematinics|hematinics|mesh-ancestor
138469873|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138469874|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
138469875|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469876|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469877|NCT01984255|Ipilimumab|ipilimumab|mesh-list
138469878|NCT01984255|Bavituximab|bavituximab|mesh-list
138469879|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138469880|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385210|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
138469882|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469883|NCT01984372|Insulin|insulin|mesh-list
138469884|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138469885|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469886|NCT01984463|Fentanyl|fentanyl|mesh-list
138469887|NCT01984463|Morphine|morphine|mesh-list
138469888|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138469889|NCT01984463|Narcotics|narcotics|mesh-ancestor
138469890|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469891|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469892|NCT01984463|Analgesics|analgesics|mesh-ancestor
138469893|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
138469894|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469895|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138469896|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138469897|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
138469898|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
138469899|NCT01984567|Vitamin E|vitamin e|mesh-list
138469900|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
138469901|NCT01984567|Vitamins|vitamins|mesh-ancestor
138469902|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
138469903|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469904|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
138469905|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469906|NCT01984567|Protective Agents|protective agents|mesh-ancestor
138469907|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
138469908|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
138469909|NCT01984606|Empagliflozin|empagliflozin|mesh-list
138469910|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138469911|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469912|NCT01984606|Incretins|incretins|mesh-ancestor
138469913|NCT01984606|Hormones|hormones|mesh-ancestor
138469914|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138469915|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
138469916|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
138469917|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469918|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469919|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138469920|NCT01984749|Febuxostat|febuxostat|mesh-list
138469921|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
138469922|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138469923|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
138469924|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138469925|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469926|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138469927|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138469928|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469929|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469930|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469931|NCT01984931|Medazepam|medazepam|mesh-list
138469932|NCT01984931|Metoclopramide|metoclopramide|mesh-list
138469933|NCT01984931|Bromazepam|bromazepam|mesh-list
138469934|NCT01984931|Simethicone|simethicone|mesh-list
138469935|NCT01984931|Trimebutine|trimebutine|mesh-list
138469936|NCT01984931|Mosapride|mosapride|mesh-list
138469937|NCT01984931|Maleic acid|maleic acid|mesh-list
138469938|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138469939|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203289|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138203290|NCT00003688|Dactinomycin|dactinomycin|mesh-list
138469940|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
138469942|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138469943|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469944|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138469945|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138469946|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138469948|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138469949|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
138469950|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138469951|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
138469952|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
138469953|NCT01984931|Emollients|emollients|mesh-ancestor
138469954|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
138469955|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138469957|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138469958|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138469959|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
138469960|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
138469961|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
138469962|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138469963|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138469964|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138469965|NCT01985061|Busulfan|busulfan|mesh-list
138469966|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
138469967|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469968|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138469969|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
138469970|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138469971|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138469972|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138469973|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138469974|NCT01985087|Temozolomide|temozolomide|mesh-list
138469975|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138469976|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
138406500|NCT01594619|Naloxegol|naloxegol|mesh-list
138385293|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138469977|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469978|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138385294|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138469980|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
138469982|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138469983|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469984|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
138469985|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138469986|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
138469987|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138469988|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138469989|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
138469990|NCT01985256|Flucytosine|flucytosine|mesh-list
138469991|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
138469992|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138469993|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
138469994|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138469995|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
138469996|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138469997|NCT01985373|Antibodies|antibodies|mesh-list
138469998|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
138469999|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138470000|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
138470001|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470002|NCT01985451|Temozolomide|temozolomide|mesh-list
138470003|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138470004|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
138470005|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470006|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203304|NCT00003934|Tretinoin|tretinoin|mesh-list
138470007|NCT01985477|Dexamethasone|dexamethasone|mesh-list
138470008|NCT01985477|Lenalidomide|lenalidomide|mesh-list
138470009|NCT01985477|Tretinoin|tretinoin|mesh-list
138470011|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
138470012|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
138470013|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470014|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470015|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138470017|NCT01985477|Hormones|hormones|mesh-ancestor
138470018|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470019|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138470020|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470021|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
138470022|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138470023|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138470024|NCT01985477|Growth Substances|growth substances|mesh-ancestor
138470025|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
138470026|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
138470027|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
138470028|NCT01985594|Nifedipine|nifedipine|mesh-list
138470029|NCT01985594|Progesterone|progesterone|mesh-list
138470030|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138470031|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138470032|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470033|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138470034|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470035|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
138470037|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138470038|NCT01985594|Progestins|progestins|mesh-ancestor
138470040|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470041|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
138470042|NCT01985724|Docetaxel|docetaxel|mesh-list
138470043|NCT01985724|Epirubicin|epirubicin|mesh-list
138470045|NCT01985724|Lenograstim|lenograstim|mesh-list
138470046|NCT01985724|Mitogens|mitogens|mesh-list
138470047|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138470048|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
138470049|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470050|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138470051|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138470052|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
138470053|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470054|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470055|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138470056|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
138470057|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
138470059|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138470060|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138470061|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138470062|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470063|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
138470064|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138470065|NCT01985724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138470066|NCT01985750|Cycloserine|cycloserine|mesh-list
138470067|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138470068|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470069|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138470070|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
138470071|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138470072|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
138470073|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470074|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
138470075|NCT01985789|Promethazine|promethazine|mesh-list
138470076|NCT01985789|Cetirizine|cetirizine|mesh-list
138470077|NCT01985789|Desloratadine|desloratadine|mesh-list
138470078|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138470079|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138203313|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
138470080|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138470081|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470083|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
138470084|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
138470085|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470086|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
138470087|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
138470088|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138470089|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138470090|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
138470091|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
138470092|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470093|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470094|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
138470095|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
138470096|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
138470097|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
138470098|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138470099|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
138470100|NCT01985828|Androgens|androgens|mesh-list
138470101|NCT01985828|Hormones|hormones|mesh-ancestor
138470102|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470103|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470104|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
138470105|NCT01985841|Docetaxel|docetaxel|mesh-list
138188302|NCT03018535|Rituximab|rituximab|mesh-list
138470106|NCT01985841|Fluorouracil|fluorouracil|mesh-list
138470107|NCT01985841|Epirubicin|epirubicin|mesh-list
138470108|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138470110|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470111|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138470112|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138470113|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
138470114|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470115|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470116|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138470117|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
138470118|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
138470119|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
138470120|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
138470121|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138406975|NCT01596777|Analgesics|analgesics|mesh-ancestor
138470122|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138470123|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138470124|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138470125|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470127|NCT01985854|Desflurane|desflurane|mesh-list
138470128|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138470129|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138470130|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470131|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138470132|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
138470133|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
138470134|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138470135|NCT01985893|Trastuzumab|trastuzumab|mesh-list
138470136|NCT01985893|Lapatinib|lapatinib|mesh-list
138470137|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138470138|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470139|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138470140|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138407031|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
138470141|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203321|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470143|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138470144|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470145|NCT01986049|Bupivacaine|bupivacaine|mesh-list
138470146|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
138470147|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
138470148|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138470149|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470150|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
138470151|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470152|NCT01986088|Sumatriptan|sumatriptan|mesh-list
138470153|NCT01986088|Eletriptan|eletriptan|mesh-list
138470154|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138470155|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138470156|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138470157|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
138470158|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470159|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385394|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470160|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470161|NCT01986127|Adalimumab|adalimumab|mesh-list
138470162|NCT01986127|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138470163|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138470164|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138470165|NCT01986192|Warfarin|warfarin|mesh-list
138470166|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
138470167|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
138470168|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138470169|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
138470170|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138470171|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
138407090|NCT01597310|Pramipexole|pramipexole|mesh-list
138470172|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470173|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470174|NCT01986218|BMS-986115|bms-986115|mesh-list
138470175|NCT01986218|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
138407134|NCT01597531|Incretins|incretins|mesh-ancestor
138470177|NCT01986218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470178|NCT01986270|Sumatriptan|sumatriptan|mesh-list
138470179|NCT01986270|Eletriptan|eletriptan|mesh-list
138470180|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138470181|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
138470182|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138470183|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
138470184|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470185|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470186|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470188|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138470189|NCT01986283|Narcotics|narcotics|mesh-ancestor
138470190|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138470191|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470194|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470195|NCT01986309|Lidocaine|lidocaine|mesh-list
138470196|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
138470197|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
138470198|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138470199|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470200|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
138470201|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470202|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138470203|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138470204|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138470205|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138470206|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470207|NCT01986322|Vaccines|vaccines|mesh-list
138470208|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
138203332|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
138470209|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470210|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
138470211|NCT01986426|Ipilimumab|ipilimumab|mesh-list
138470212|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138470213|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470214|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138470215|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470216|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138470217|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
138470218|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138470219|NCT01986465|Prednisolone|prednisolone|mesh-list
138470220|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
138470221|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138470222|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
138203343|NCT00003250|Protective Agents|protective agents|mesh-ancestor
138470223|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138203344|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203345|NCT00003256|Alvocidib|alvocidib|mesh-list
138470224|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
138470225|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
138470226|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470227|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470228|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138470229|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
138470230|NCT01986465|Hormones|hormones|mesh-ancestor
138385473|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385478|NCT01469884|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138470232|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138470233|NCT01986465|Protective Agents|protective agents|mesh-ancestor
138470234|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138470235|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470237|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
138470238|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138470239|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
138470240|NCT01986582|Phenylephrine|phenylephrine|mesh-list
138470241|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
138470242|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138470243|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138470244|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
138470245|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470246|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470247|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470248|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
138470249|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
138470250|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470251|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
138470252|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138470253|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
138470254|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138470255|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
138470256|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
138470257|NCT01986582|Protective Agents|protective agents|mesh-ancestor
138470258|NCT01986608|Lacosamide|lacosamide|mesh-list
138470259|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
138470260|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138470261|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138470262|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138470263|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470264|NCT01986660|Ibuprofen|ibuprofen|mesh-list
138470265|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138470266|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138470267|NCT01986660|Analgesics|analgesics|mesh-ancestor
138470268|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
138470269|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470270|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470271|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138470272|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138470273|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138470274|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385504|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138470275|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470276|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
138470277|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
138470278|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138470279|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138470280|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470281|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470282|NCT01986673|Urological Agents|urological agents|mesh-ancestor
138470283|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138470284|NCT01986764|Estradiol|estradiol|mesh-list
138470285|NCT01986764|Estrogens|estrogens|mesh-list
138470286|NCT01986764|Hormones|hormones|mesh-ancestor
138203404|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
138203405|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203406|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470287|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470288|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470289|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138407635|NCT05344911|Anesthetics, General|anesthetics, general|mesh-ancestor
138470290|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138470291|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138470292|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138203411|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138203412|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138203413|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138470293|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470294|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
138470295|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470296|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
138470297|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138470298|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470299|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138470300|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138470301|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138470302|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470303|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
138470304|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470305|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
138470306|NCT01986894|Thalidomide|thalidomide|mesh-list
138470307|NCT01986894|Pomalidomide|pomalidomide|mesh-list
138385531|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138385532|NCT01470092|Tibolone|tibolone|mesh-list
138470309|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470310|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138470311|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138470312|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470313|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470314|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470315|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470316|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
138470317|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138470318|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138470319|NCT01986894|Growth Substances|growth substances|mesh-ancestor
138470320|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
138470321|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138470322|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
138470325|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138470326|NCT01986998|Prednisolone|prednisolone|mesh-list
138470327|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
138470328|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138470329|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
138470330|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138470332|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
138470333|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470334|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470335|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138470336|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
138470338|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470339|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138470340|NCT01986998|Protective Agents|protective agents|mesh-ancestor
138470341|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138470342|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470343|NCT01987076|Prednisone|prednisone|mesh-list
138470344|NCT01987076|Clobetasol|clobetasol|mesh-list
138470345|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138470346|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
138470347|NCT01987076|Hormones|hormones|mesh-ancestor
138385568|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138385569|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
138470348|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470349|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470350|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138470351|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470352|NCT01987128|Ropivacaine|ropivacaine|mesh-list
138470353|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
138470354|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
138470355|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138470357|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
138470358|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470359|NCT01987154|Caseins|caseins|mesh-list
138470360|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
138470361|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
138470362|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470363|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
138470364|NCT01987167|Hormones|hormones|mesh-ancestor
138470365|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470366|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470368|NCT01987297|Daunorubicin|daunorubicin|mesh-list
138470369|NCT01987297|Idarubicin|idarubicin|mesh-list
138470370|NCT01987297|Tretinoin|tretinoin|mesh-list
138470371|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
138470372|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138470373|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
138470374|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470375|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470376|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
138470377|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470378|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138470379|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
138470380|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470381|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138470382|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138470383|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138470384|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470385|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
138470386|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
138470387|NCT01987310|Atorvastatin|atorvastatin|mesh-list
138470388|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138470389|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138470390|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
138385601|NCT01470456|Rituximab|rituximab|mesh-list
138385602|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138470391|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470393|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138470394|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470395|NCT01987323|Latanoprost|latanoprost|mesh-list
138470396|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
138470397|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138470398|NCT01987375|Cetuximab|cetuximab|mesh-list
138470399|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138470400|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470401|NCT01987570|Allopurinol|allopurinol|mesh-list
138188303|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138470402|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
138470403|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470404|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470405|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
138470406|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138470407|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138470408|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
138470409|NCT01987570|Protective Agents|protective agents|mesh-ancestor
138470410|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470411|NCT01987739|Zolpidem|zolpidem|mesh-list
138470412|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
138470413|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138470414|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138470415|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470416|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
138470417|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
138470418|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
138470419|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470420|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470421|NCT01987804|Oxytocin|oxytocin|mesh-list
138470422|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
138470423|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138470424|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470425|NCT01988077|Ipilimumab|ipilimumab|mesh-list
138470426|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138470427|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470428|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138470429|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470430|NCT01988116|Calcitriol|calcitriol|mesh-list
138470431|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138470432|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470433|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
138470434|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138470435|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470436|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138470437|NCT01988116|Vitamins|vitamins|mesh-ancestor
138470438|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
138470439|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138470440|NCT01988298|Acetaminophen|acetaminophen|mesh-list
138470441|NCT01988298|Ibuprofen|ibuprofen|mesh-list
138470442|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138470443|NCT01988298|Analgesics|analgesics|mesh-ancestor
138470444|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
138470445|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470446|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470447|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
138470448|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138470449|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138385675|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138470450|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138470451|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138470452|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470453|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470455|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
138385725|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470456|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470457|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138470458|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
138470459|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138470460|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470461|NCT01988506|Interleukin-2|interleukin-2|mesh-list
138470462|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470463|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138470464|NCT01988506|Analgesics|analgesics|mesh-ancestor
138470465|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
138470466|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470467|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470468|NCT01988545|Exenatide|exenatide|mesh-list
138470469|NCT01988545|Glucagon|glucagon|mesh-list
138470470|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
138470471|NCT01988545|Incretins|incretins|mesh-ancestor
138470472|NCT01988545|Hormones|hormones|mesh-ancestor
138470473|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470474|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470475|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138470476|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138470477|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138470478|NCT01988610|Mifepristone|mifepristone|mesh-list
138470479|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
138470481|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138470482|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470483|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138470484|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138470485|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138470486|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
138470487|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
138385726|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
138470488|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
138470489|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
138470490|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470491|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
138385728|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
138470492|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138203489|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138470493|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
138470496|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138470497|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470498|NCT01988831|Propranolol|propranolol|mesh-list
138470499|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138470500|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138470501|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
138470502|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470503|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470504|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470505|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138470506|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138470507|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
138470509|NCT01988896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138470510|NCT01988896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470511|NCT01988896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138470512|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470513|NCT01988961|Golimumab|golimumab|mesh-list
138470514|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
138470515|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138470516|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138470517|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
138470518|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470519|NCT01989000|Gemcitabine|gemcitabine|mesh-list
138470520|NCT01989000|Imidazole|imidazole|mesh-list
138470521|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138470522|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
138470523|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470524|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470525|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470526|NCT01989052|Lomustine|lomustine|mesh-list
138470527|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
138470528|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138470529|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
138470530|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470531|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470532|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138470533|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138470534|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138470535|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470536|NCT01989078|Losartan|losartan|mesh-list
138470537|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138470538|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138470539|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138470540|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138470541|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470542|NCT01989091|Heparin|heparin|mesh-list
138470543|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
138470544|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138470545|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138470546|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470547|NCT01989312|Lidocaine|lidocaine|mesh-list
138470548|NCT01989312|Epinephrine|epinephrine|mesh-list
138470549|NCT01989312|Midazolam|midazolam|mesh-list
138470550|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
138470551|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
138470552|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
138385794|NCT01471886|Analgesics|analgesics|mesh-ancestor
138385795|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
138385804|NCT01471899|Ketorolac|ketorolac|mesh-list
138470554|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470555|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
138470556|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470557|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138203497|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470558|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138470559|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138470560|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138470561|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470562|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138470563|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138470564|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138470565|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138470566|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138470567|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138470568|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
138470569|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
138470570|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
138470571|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470572|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138470573|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138470574|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
138470575|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138470576|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138470577|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
138470578|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138470579|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
138385844|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
138385851|NCT01472029|Leucovorin|leucovorin|mesh-list
138470582|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138470583|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
138470584|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138470585|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138470586|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470587|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
138470588|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
138470590|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138470591|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
138470592|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470593|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470594|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138470595|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138470596|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
138470597|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470598|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470599|NCT01989559|Vaccines|vaccines|mesh-list
138470600|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
138470601|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470602|NCT01989611|Tenofovir|tenofovir|mesh-list
138470603|NCT01989611|Emtricitabine|emtricitabine|mesh-list
138470604|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
138470605|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470606|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138470607|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138470608|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470609|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470611|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138470612|NCT01989663|Tenofovir|tenofovir|mesh-list
138470613|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
138470614|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470615|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138470616|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138470617|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409038|NCT01612377|Prednisone|prednisone|mesh-list
138470618|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203506|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470619|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138470620|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138470621|NCT01989676|Paclitaxel|paclitaxel|mesh-list
138470622|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138470623|NCT01989676|Trastuzumab|trastuzumab|mesh-list
138385890|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
138470624|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138470625|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470627|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
138470628|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
138470629|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470630|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138470631|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
138470632|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138470633|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
138470634|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138470635|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
138470636|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138409092|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138470637|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470638|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
138470640|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470641|NCT01989897|Phenol|phenol|mesh-list
138470642|NCT01989897|Histamine|histamine|mesh-list
138470643|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
138470644|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
138470645|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470646|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470647|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138409170|NCT01613092|Vancomycin|vancomycin|mesh-list
138470648|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138470649|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470650|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
138470651|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
138470652|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138470653|NCT01989923|Nicotine|nicotine|mesh-list
138470654|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138470655|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
138470656|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470657|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470658|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138470659|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138470660|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
138470661|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470662|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470663|NCT01989936|Eletriptan|eletriptan|mesh-list
138470664|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138470665|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
138470666|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470667|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470670|NCT01990079|Nicotine|nicotine|mesh-list
138470671|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138470672|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
138470673|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470674|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470675|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138470676|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138470677|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
138470678|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470679|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470680|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138470681|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
138470682|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138470683|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
138470684|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138409408|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138470685|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138470687|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
138470688|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138470689|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470690|NCT01990118|Cyclosporine|cyclosporine|mesh-list
138470691|NCT01990118|Cyclosporins|cyclosporins|mesh-list
138470692|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470693|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470694|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138470695|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
138470696|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470697|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
138470698|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470699|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
138470700|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138470701|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138470703|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138470704|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138470705|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470706|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
138470707|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470708|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138470709|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138470710|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
138470711|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470712|NCT01990378|Rabeprazole|rabeprazole|mesh-list
138470713|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138470714|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138470715|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138470716|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138385956|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138385957|NCT01472978|Metronidazole|metronidazole|mesh-list
138470719|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138470720|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
138470721|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
138409595|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138470722|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138470723|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470724|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138470725|NCT01990404|Analgesics|analgesics|mesh-ancestor
138470726|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
138470727|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470728|NCT01990443|Reslizumab|reslizumab|mesh-list
138470729|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138470730|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
138470731|NCT01990586|Rabeprazole|rabeprazole|mesh-list
138470732|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138470733|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138470734|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138470735|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470736|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470737|NCT01990690|Antioxidants|antioxidants|mesh-list
138470738|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203536|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
138203537|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
138470739|NCT01990690|Protective Agents|protective agents|mesh-ancestor
138470740|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470741|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
138470742|NCT01990755|Olanzapine|olanzapine|mesh-list
138470743|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
138470744|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
138470745|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470746|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470747|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138470748|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138470749|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138470750|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138385978|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
138470751|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138385979|NCT01473147|Exenatide|exenatide|mesh-list
138385980|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138470752|NCT01990755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138470753|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138470754|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138470755|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470756|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470758|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
138470759|NCT01990781|Dexamethasone|dexamethasone|mesh-list
138470760|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
138470761|NCT01990781|Lidocaine|lidocaine|mesh-list
138470762|NCT01990781|BB 1101|bb 1101|mesh-list
138470763|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138470764|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
138470765|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
138470766|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470767|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470768|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138470769|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
138470770|NCT01990781|Hormones|hormones|mesh-ancestor
138470771|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470772|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138470773|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138386014|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470775|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470776|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470777|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
138470778|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
138470779|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138470780|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
138470781|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138470782|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138470783|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138470784|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138470786|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138470787|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470788|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138470789|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138470790|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470791|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470792|NCT01990872|Vitamin D|vitamin d|mesh-list
138470793|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
138470794|NCT01990872|Vitamins|vitamins|mesh-ancestor
138470795|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
138470796|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470797|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138470798|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138470799|NCT01990937|Midazolam|midazolam|mesh-list
138470800|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138470801|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138470802|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138470803|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203554|NCT00086138|Sertraline|sertraline|mesh-list
138203555|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
138470804|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138470805|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138470806|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138470807|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138470808|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
138470809|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
138470810|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
138470811|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
138386065|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138470812|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470813|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470814|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138470816|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
138470817|NCT01991054|Vitamins|vitamins|mesh-ancestor
138470818|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
138470819|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470820|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138470821|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138470823|NCT01991119|Propafenone|propafenone|mesh-list
138470824|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138470825|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138470826|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138470827|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138470828|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470829|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
138470830|NCT01991145|Hematinics|hematinics|mesh-ancestor
138470831|NCT01991158|Dexamethasone|dexamethasone|mesh-list
138470832|NCT01991158|Gemcitabine|gemcitabine|mesh-list
138470833|NCT01991158|Methotrexate|methotrexate|mesh-list
138470834|NCT01991158|Pegaspargase|pegaspargase|mesh-list
138470835|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138470836|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
138470837|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
138470838|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470839|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470840|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138470841|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
138470842|NCT01991158|Hormones|hormones|mesh-ancestor
138470843|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470844|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138470845|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470846|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138470847|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
138470848|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470849|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138470850|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
138470851|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138470852|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
138188304|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
138386102|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470854|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138470855|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138470856|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
138470857|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138470858|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138470860|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138470862|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138470863|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470865|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
138470866|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470867|NCT01991288|Epinephrine|epinephrine|mesh-list
138470868|NCT01991288|Racepinephrine|racepinephrine|mesh-list
138470869|NCT01991288|Bupivacaine|bupivacaine|mesh-list
138470870|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
138470871|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
138470872|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
138470873|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
138470874|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138470875|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470876|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
138386134|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386135|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138470877|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470878|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138470879|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138470880|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
138470881|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138470882|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470883|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138470884|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138470885|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
138470886|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138470887|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
138470888|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
138470889|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
138470890|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138470891|NCT01991327|Enclomiphene|enclomiphene|mesh-list
138470892|NCT01991327|Clomiphene|clomiphene|mesh-list
138470893|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
138470894|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138470895|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
138470896|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470897|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470898|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138470899|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
138470900|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138470901|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138470902|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138470903|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
138470904|NCT01991561|Vaccines|vaccines|mesh-list
138470905|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
138470906|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410317|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
138470907|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138470909|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470910|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138386183|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
138386184|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138470913|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138470914|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470915|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
138470916|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
138470917|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470918|NCT01991587|Vaccines|vaccines|mesh-list
138470919|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
138470920|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470921|NCT01991626|Iron|iron|mesh-list
138470922|NCT01991626|Trace Elements|trace elements|mesh-list
138470923|NCT01991626|Micronutrients|micronutrients|mesh-list
138470924|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470925|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
138470926|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470927|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138470928|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138470929|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470930|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470931|NCT01991834|Cefazolin|cefazolin|mesh-list
138470932|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138470933|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470934|NCT01991951|Warfarin|warfarin|mesh-list
138470935|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
138470936|NCT01992133|Vitamin D|vitamin d|mesh-list
138470937|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
138470938|NCT01992133|Vitamins|vitamins|mesh-ancestor
138470939|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
138470940|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138215220|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386224|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
138215221|NCT00623714|Fluticasone|fluticasone|mesh-list
138386225|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470941|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138470942|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138470943|NCT01992146|Naloxone|naloxone|mesh-list
138470944|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
138470945|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138410492|NCT01621165|Prazosin|prazosin|mesh-list
138470946|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
138470947|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138470948|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
138470949|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138470950|NCT01992198|Metronidazole|metronidazole|mesh-list
138470951|NCT01992198|Meropenem|meropenem|mesh-list
138470952|NCT01992198|Cefoperazone|cefoperazone|mesh-list
138470953|NCT01992198|Sulperazone|sulperazone|mesh-list
138470954|NCT01992198|Somatostatin|somatostatin|mesh-list
138470955|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138470956|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138470957|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
138470958|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
138470959|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138470960|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138470961|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138470962|NCT01992198|Hormones|hormones|mesh-ancestor
138470963|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138470964|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470965|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
138470966|NCT01992211|Metformin|metformin|mesh-list
138470967|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138470968|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138470969|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470970|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138470971|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138470972|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
138470973|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138470974|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138470975|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138470976|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138470977|NCT01992263|Vitamin D|vitamin d|mesh-list
138470978|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
138470979|NCT01992263|Cholecalciferol|cholecalciferol|mesh-list
138470980|NCT01992263|Vitamins|vitamins|mesh-list
138470981|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
138386267|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
138470982|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470983|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138470984|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138470986|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
138470987|NCT01992328|Antibodies|antibodies|mesh-list
138470988|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
138470989|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
138470990|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
138470991|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
138470992|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138470993|NCT01992341|Paclitaxel|paclitaxel|mesh-list
138470994|NCT01992341|Trebananib|trebananib|mesh-list
138470995|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138470996|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138470997|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
138470998|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
138470999|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
138471000|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203573|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
138471001|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138203574|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
138203575|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138203576|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471002|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138471003|NCT01992341|Growth Substances|growth substances|mesh-ancestor
138471004|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471005|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
138471006|NCT01992562|Ziconotide|ziconotide|mesh-list
138471007|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138471008|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138203583|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
138471009|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471010|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138203584|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
138203585|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
138471011|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471012|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138471013|NCT01992562|Protective Agents|protective agents|mesh-ancestor
138471014|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138471015|NCT01992562|Analgesics|analgesics|mesh-ancestor
138471016|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
138471017|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471018|NCT01992588|Insulin|insulin|mesh-list
138471019|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138471020|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
138471021|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
138471022|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138471023|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138471024|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471025|NCT01992601|Telmisartan|telmisartan|mesh-list
138471026|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
138471027|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138471028|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138471029|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
138471030|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471031|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138471032|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138471033|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471034|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138471035|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138471036|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138471037|NCT01992705|Fluorouracil|fluorouracil|mesh-list
138471038|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
138471039|NCT01992705|Irinotecan|irinotecan|mesh-list
138471040|NCT01992705|Folfirinox|folfirinox|mesh-list
138471041|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
138471042|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471043|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138471044|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471045|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138471046|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
138471047|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471048|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138386338|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
138471050|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471051|NCT01992796|Telmisartan|telmisartan|mesh-list
138471052|NCT01992796|Candesartan|candesartan|mesh-list
138471053|NCT01992796|Olmesartan|olmesartan|mesh-list
138471054|NCT01992796|Irbesartan|irbesartan|mesh-list
138471055|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138471056|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138471057|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138471058|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471059|NCT01992900|Piperaquine|piperaquine|mesh-list
138471061|NCT01992900|Artemisinins|artemisinins|mesh-list
138471062|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
138471063|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138471064|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138471065|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471066|NCT01993134|Cefazolin|cefazolin|mesh-list
138471067|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138471068|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471069|NCT01993173|Vaccines|vaccines|mesh-list
138471070|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
138471071|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471072|NCT01993212|Enclomiphene|enclomiphene|mesh-list
138471073|NCT01993212|Testosterone|testosterone|mesh-list
138471074|NCT01993212|Androgens|androgens|mesh-ancestor
138471075|NCT01993212|Hormones|hormones|mesh-ancestor
138471076|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138471077|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471078|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138471079|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
138471080|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138203646|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138471081|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
138471083|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138471084|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138471085|NCT01993225|Enclomiphene|enclomiphene|mesh-list
138471086|NCT01993225|Testosterone|testosterone|mesh-list
138471087|NCT01993225|Androgens|androgens|mesh-ancestor
138471088|NCT01993225|Hormones|hormones|mesh-ancestor
138471089|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138471090|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471091|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138471092|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
138411103|NCT01625026|Cathartics|cathartics|mesh-ancestor
138471093|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138471094|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
138471095|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138471096|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
138471097|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
138471098|NCT01993251|Melatonin|melatonin|mesh-list
138471099|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
138471100|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471101|NCT01993251|Protective Agents|protective agents|mesh-ancestor
138471102|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471103|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471104|NCT01993290|Ropivacaine|ropivacaine|mesh-list
138471105|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
138471106|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
138471107|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138411214|NCT01625936|Growth Substances|growth substances|mesh-ancestor
138471108|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471109|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
138471110|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471112|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138471113|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138471114|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138471115|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138411282|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
138471116|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471117|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138471118|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138471119|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138471120|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138471121|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
138471122|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
138471123|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
138471124|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
138471125|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471126|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471127|NCT01993472|Andrographolide|andrographolide|mesh-list
138471129|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138471130|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
138471131|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471132|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471133|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471134|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138471135|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138471136|NCT01993472|Analgesics|analgesics|mesh-ancestor
138471137|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
138471138|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471139|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471140|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138471141|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138471142|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138471143|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471144|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
138471145|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138471146|NCT01993537|Vitamin D|vitamin d|mesh-list
138203655|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471147|NCT01993537|Vitamins|vitamins|mesh-ancestor
138471148|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
138471149|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471150|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138471151|NCT01993589|Acetaminophen|acetaminophen|mesh-list
138471152|NCT01993589|Analgesics|analgesics|mesh-list
138471153|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138471155|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471156|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471157|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
138471158|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
138471160|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
138471161|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
138471162|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138471163|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471164|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471165|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
138471166|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471167|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471168|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471170|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471171|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386512|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138471172|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
138471173|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138471174|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471175|NCT01993979|Cisplatin|cisplatin|mesh-list
138471176|NCT01993979|Carboplatin|carboplatin|mesh-list
138471177|NCT01993979|Gemcitabine|gemcitabine|mesh-list
138471178|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471179|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138471180|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
138471181|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471182|NCT01994031|Paclitaxel|paclitaxel|mesh-list
138471183|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138471184|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138471185|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471186|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
138471187|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
138471188|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
138471189|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471190|NCT01994070|Procainamide|procainamide|mesh-list
138471191|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138471192|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138471193|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138471194|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138471195|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471196|NCT01994096|Caspofungin|caspofungin|mesh-list
138471197|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
138471198|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471199|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471200|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471201|NCT01994265|Warfarin|warfarin|mesh-list
138471202|NCT01994265|Dabigatran|dabigatran|mesh-list
138471203|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
138471204|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
138471205|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138471206|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
138471207|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471208|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471209|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
138471210|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
138471211|NCT01994330|Coagulants|coagulants|mesh-ancestor
138471212|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
138471213|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
138471214|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471215|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
138411710|NCT01629368|Analgesics|analgesics|mesh-ancestor
138471216|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138471217|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471218|NCT01994460|Linezolid|linezolid|mesh-list
138471219|NCT01994460|Ethambutol|ethambutol|mesh-list
138471220|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138471221|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471222|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138471223|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471224|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471225|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
138471226|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
138471227|NCT01994642|Dexamethasone|dexamethasone|mesh-list
138471228|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
138471229|NCT01994642|BB 1101|bb 1101|mesh-list
138471230|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471231|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
138471232|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
138471233|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471234|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471235|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138471236|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
138471237|NCT01994642|Hormones|hormones|mesh-ancestor
138471238|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138471239|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138471240|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471241|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
138471242|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471243|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471244|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138471245|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471246|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138471247|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138471248|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
138471249|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138471250|NCT01994668|Lorazepam|lorazepam|mesh-list
138471251|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
138471252|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
138471253|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
138471254|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471255|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471256|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138471257|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138471258|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471259|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138471260|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138471261|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138471262|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
138471263|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
138471264|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471265|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471266|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
138471267|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
138471268|NCT01994733|Calcium|calcium|mesh-list
138411953|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471269|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138471270|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471271|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138471273|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471274|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138471275|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
138471276|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138471277|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471278|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
138471279|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
138471280|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471281|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471282|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138471283|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
138471284|NCT01994759|Hormones|hormones|mesh-ancestor
138471285|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138386640|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386644|NCT01477931|Bupropion|bupropion|mesh-list
138471287|NCT01994759|Protective Agents|protective agents|mesh-ancestor
138471288|NCT01994941|Clopidogrel|clopidogrel|mesh-list
138471289|NCT01994941|Ticagrelor|ticagrelor|mesh-list
138471290|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138471291|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138471292|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138412083|NCT01631513|Analgesics|analgesics|mesh-ancestor
138471293|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138471294|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
138471295|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471296|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471297|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471298|NCT01994967|Bupivacaine|bupivacaine|mesh-list
138471299|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
138471302|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471303|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471304|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
138471305|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471306|NCT01995006|Dipyrone|dipyrone|mesh-list
138471308|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138471309|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138471310|NCT01995006|Analgesics|analgesics|mesh-ancestor
138471311|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
138471312|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471313|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471314|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471315|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138471316|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
138471317|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138471318|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471319|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471320|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
138471321|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
138471322|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138471323|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138471324|NCT01995019|Prednisolone|prednisolone|mesh-list
138471325|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
138471326|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138471327|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
138471328|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471329|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
138471330|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
138471331|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471332|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471333|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138471334|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
138471336|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138471337|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138471338|NCT01995019|Protective Agents|protective agents|mesh-ancestor
138471339|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138471340|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471341|NCT01995032|Metformin|metformin|mesh-list
138471342|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138471343|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471344|NCT01995058|Prednisone|prednisone|mesh-list
138471345|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
138471346|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138412272|NCT01633450|Zinc|zinc|mesh-list
138471347|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
138471348|NCT01995058|Hormones|hormones|mesh-ancestor
138471349|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138471350|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471351|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138471352|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471353|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138471355|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138203671|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138471356|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
138471357|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138471358|NCT01995084|Imidazole|imidazole|mesh-list
138386695|NCT01478165|Palonosetron|palonosetron|mesh-list
138471359|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138386696|NCT01478165|Anesthetics|anesthetics|mesh-list
138471360|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471361|NCT01995188|Bevacizumab|bevacizumab|mesh-list
138471362|NCT01995188|Carboplatin|carboplatin|mesh-list
138471363|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138471364|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471365|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138471366|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138471367|NCT01995188|Growth Substances|growth substances|mesh-ancestor
138471368|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471369|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
138471371|NCT01995214|Sevoflurane|sevoflurane|mesh-list
138471372|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138412430|NCT01634412|Analgesics|analgesics|mesh-ancestor
138471373|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471374|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471375|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138471376|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
138471377|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
138471378|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138471379|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138188305|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138471380|NCT01995292|Anesthetics|anesthetics|mesh-list
138471381|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
138471382|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471383|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471384|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
138471385|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471386|NCT01995331|Cyclosporine|cyclosporine|mesh-list
138471387|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
138471389|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138386746|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
138471390|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
138471391|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471392|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138471393|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138471394|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
138471395|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471396|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471397|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138471398|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471399|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
138412502|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
138471400|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471401|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
138471402|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138471403|NCT01995370|Aspirin|aspirin|mesh-list
138471404|NCT01995370|Cilostazol|cilostazol|mesh-list
138471405|NCT01995370|Clopidogrel|clopidogrel|mesh-list
138471407|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138471408|NCT01995370|Analgesics|analgesics|mesh-ancestor
138471409|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
138471410|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471411|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471412|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471413|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138471414|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138471415|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138471416|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471417|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138471418|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138471419|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138203682|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138203683|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138471420|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
138471421|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138471422|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138471424|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
138471425|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471426|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138471427|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
138386789|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
138471429|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
138471430|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
138471431|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138471432|NCT01995370|Protective Agents|protective agents|mesh-ancestor
138471433|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
138412698|NCT01636037|Levodopa|levodopa|mesh-list
138471434|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138471435|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138471436|NCT01995695|Vaccines|vaccines|mesh-list
138471437|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
138471438|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471439|NCT01995734|Pasireotide|pasireotide|mesh-list
138471440|NCT01995734|Hormones|hormones|mesh-ancestor
138471441|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138471442|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471443|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
138471444|NCT01995799|Hematinics|hematinics|mesh-ancestor
138471445|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
138471446|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138471447|NCT01995890|Nepafenac|nepafenac|mesh-list
138386830|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
138471448|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138471450|NCT01995890|Analgesics|analgesics|mesh-ancestor
138412831|NCT01636557|Coagulants|coagulants|mesh-ancestor
138471451|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
138471452|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471453|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471454|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471455|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138471456|NCT01996085|Amlodipine|amlodipine|mesh-list
138471457|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
138471458|NCT01996085|Telmisartan|telmisartan|mesh-list
138471459|NCT01996085|Lisinopril|lisinopril|mesh-list
138471460|NCT01996085|Nebivolol|nebivolol|mesh-list
138471461|NCT01996085|Indapamide|indapamide|mesh-list
138471462|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138471463|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138471464|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138471465|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471466|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138471467|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471468|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
138471469|NCT01996085|Diuretics|diuretics|mesh-ancestor
138471470|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
138471471|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
138412897|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
138471472|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
138471473|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
138386911|NCT01479283|Cefazolin|cefazolin|mesh-list
138471474|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
138471475|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
138471476|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471477|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138471478|NCT01996085|Protective Agents|protective agents|mesh-ancestor
138471479|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138471480|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
138471481|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138471482|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
138203694|NCT00003322|Paclitaxel|paclitaxel|mesh-list
138471483|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471485|NCT01996150|Eusol|eusol|mesh-list
138471486|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
138471487|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471488|NCT01996189|Insulin|insulin|mesh-list
138471489|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138471490|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471491|NCT01996306|Leucovorin|leucovorin|mesh-list
138471492|NCT01996306|Bevacizumab|bevacizumab|mesh-list
138471493|NCT01996306|Capecitabine|capecitabine|mesh-list
138471494|NCT01996306|Fluorouracil|fluorouracil|mesh-list
138471496|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138471497|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471498|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138471499|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138471500|NCT01996306|Growth Substances|growth substances|mesh-ancestor
138471501|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471502|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
138471503|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138471505|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471506|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138471507|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
138471508|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138471509|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138471510|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471511|NCT01996306|Antidotes|antidotes|mesh-ancestor
138471512|NCT01996306|Protective Agents|protective agents|mesh-ancestor
138471513|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
138471514|NCT01996306|Vitamins|vitamins|mesh-ancestor
138471515|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
138471516|NCT01996358|Rocuronium|rocuronium|mesh-list
138471517|NCT01996358|Succinylcholine|succinylcholine|mesh-list
138471518|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138413148|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
138471519|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138471520|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138471521|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471522|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471523|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
138471524|NCT01996384|Lidocaine|lidocaine|mesh-list
138471525|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
138471526|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
138471527|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471528|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138386933|NCT01479556|Pregabalin|pregabalin|mesh-list
138471529|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
138471530|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471531|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138471532|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138471533|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138471534|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138471535|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471538|NCT01996423|Vitamins|vitamins|mesh-ancestor
138471539|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
138471540|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471541|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138471542|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138471543|NCT01996462|Dexetimide|dexetimide|mesh-list
138471544|NCT01996462|Citalopram|citalopram|mesh-list
138471545|NCT01996462|Escitalopram|escitalopram|mesh-list
138471546|NCT01996462|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138471547|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138471548|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138471549|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471550|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471551|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
138471552|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471553|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138471554|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138215222|NCT00623714|Xhance|xhance|mesh-list
138471555|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
138471556|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
138471557|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471558|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138471559|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138471560|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
138471561|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138471562|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
138471563|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138471564|NCT01996475|Dexetimide|dexetimide|mesh-list
138471565|NCT01996475|Citalopram|citalopram|mesh-list
138471566|NCT01996475|Escitalopram|escitalopram|mesh-list
138413342|NCT01638767|NuvaRing|nuvaring|mesh-list
138471567|NCT01996475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138471568|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138203706|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471569|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138471570|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471571|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471572|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
138471573|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471574|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138471575|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138471576|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
138471577|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
138471578|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471579|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138471580|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138471581|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
138471582|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138471583|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
138471584|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138471585|NCT01996488|Olanzapine|olanzapine|mesh-list
138471586|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
138471587|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
138471588|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471589|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471590|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138471591|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138471592|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138471593|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138413443|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
138471594|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138471595|NCT01996488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138471596|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138471597|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138471598|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471599|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471602|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
138471603|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
138471604|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471605|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471606|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138471607|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138471608|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138471609|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471610|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138471611|NCT01996501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138471612|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138471613|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138471614|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471616|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
138471617|NCT01996579|Lactoferrin|lactoferrin|mesh-list
138471618|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471619|NCT01996618|Ranolazine|ranolazine|mesh-list
138413568|NCT01640743|Hormones|hormones|mesh-ancestor
138471620|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138471621|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138471622|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471623|NCT01996683|Deferiprone|deferiprone|mesh-list
138471624|NCT01996683|Deferoxamine|deferoxamine|mesh-list
138471625|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
138471626|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
138471627|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
138471628|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471629|NCT01996683|Siderophores|siderophores|mesh-ancestor
138413634|NCT01643434|Clonidine|clonidine|mesh-list
138471633|NCT01996735|Ticagrelor|ticagrelor|mesh-list
138471634|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138471635|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
138471636|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
138471637|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138471638|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
138471639|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471640|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471641|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471642|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
138471643|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138471644|NCT01996761|Protective Agents|protective agents|mesh-ancestor
138471645|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471646|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
138471647|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
138471648|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
138471649|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138471650|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471651|NCT01997099|Diazepam|diazepam|mesh-list
138203779|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
138471652|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138471653|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
138471654|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
138471655|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
138471656|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471657|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471658|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138471659|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138471660|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471661|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138471662|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138471663|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138471664|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138471665|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138471666|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138471667|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
138471668|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
138471669|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
138471670|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
138471671|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138413818|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471672|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471673|NCT01997112|Acetaminophen|acetaminophen|mesh-list
138471674|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138471675|NCT01997112|Analgesics|analgesics|mesh-ancestor
138471676|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
138471677|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471678|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471679|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
138413881|NCT01650649|Analgesics|analgesics|mesh-ancestor
138471680|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
138471681|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138471682|NCT01997164|Aflibercept|aflibercept|mesh-list
138471683|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138471684|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138471685|NCT01997164|Growth Substances|growth substances|mesh-ancestor
138471686|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471687|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
138471688|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471690|NCT01997203|Interferons|interferons|mesh-list
138471692|NCT01997203|Vitamins|vitamins|mesh-ancestor
138471693|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
138471694|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471695|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138471696|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471698|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471700|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471702|NCT01997255|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138471703|NCT01997255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138471704|NCT01997255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471705|NCT01997255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471706|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138471707|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
138471708|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138203839|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
138471709|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471710|NCT01997294|Atorvastatin|atorvastatin|mesh-list
138471711|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138471712|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138471713|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
138471714|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471715|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138471716|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138471717|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471718|NCT01997580|Escitalopram|escitalopram|mesh-list
138471719|NCT01997580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138471720|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138471721|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138387080|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471722|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471723|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471724|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
138471725|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471727|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
138471728|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
138471729|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471730|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471731|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
138471732|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471733|NCT01997632|Vaccines|vaccines|mesh-list
138471734|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
138471735|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471736|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
138471737|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138471738|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138471739|NCT01997658|Prednisolone|prednisolone|mesh-list
138471740|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
138471741|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138471742|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
138471743|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471744|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
138471745|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
138471746|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471747|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471748|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138471749|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
138387081|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138387090|NCT01480609|Ezogabine|ezogabine|mesh-list
138471751|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138471752|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138471753|NCT01997658|Protective Agents|protective agents|mesh-ancestor
138471754|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138471755|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471757|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
138471758|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471759|NCT01997762|Protective Agents|protective agents|mesh-ancestor
138471760|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471761|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471762|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138471764|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138471765|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471766|NCT01997788|Morphine|morphine|mesh-list
138471767|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138471768|NCT01997788|Narcotics|narcotics|mesh-ancestor
138471769|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471770|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471771|NCT01997788|Analgesics|analgesics|mesh-ancestor
138471772|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
138471773|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471774|NCT01997801|Ketamine|ketamine|mesh-list
138471775|NCT01997801|Analgesics|analgesics|mesh-ancestor
138471776|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
138203858|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
138203859|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
138471777|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471778|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471779|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138471780|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138471781|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
138471782|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
138471783|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471784|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138471785|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138471786|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138414296|NCT01652586|Analgesics|analgesics|mesh-ancestor
138387098|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138387100|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138471789|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
138471790|NCT01997814|Immunomodulating Agents|immunomodulating agents|mesh-list
138471791|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471792|NCT01997944|Interferons|interferons|mesh-list
138471793|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
138471794|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
138471795|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
138471796|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471797|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
138471798|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471799|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
138471800|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471801|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
138471802|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138471803|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138471804|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138414372|NCT01652924|Anesthetics|anesthetics|mesh-list
138471805|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
138471806|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471807|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471808|NCT01998061|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
138471809|NCT01998061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138471810|NCT01998061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471811|NCT01998061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471813|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138471814|NCT01998113|Metformin|metformin|mesh-list
138387135|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138471815|NCT01998113|Glyburide|glyburide|mesh-list
138471816|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138471817|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471818|NCT01998126|Nivolumab|nivolumab|mesh-list
138471819|NCT01998126|Ipilimumab|ipilimumab|mesh-list
138471820|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138471821|NCT01998126|Crizotinib|crizotinib|mesh-list
138471822|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138471823|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471824|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138471825|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471826|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138471827|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471828|NCT01998165|Remifentanil|remifentanil|mesh-list
138471829|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138471830|NCT01998165|Narcotics|narcotics|mesh-ancestor
138414443|NCT01653236|Ribavirin|ribavirin|mesh-list
138471831|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471832|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471833|NCT01998165|Analgesics|analgesics|mesh-ancestor
138387136|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138471834|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
138471835|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471836|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
138471837|NCT01998217|Remifentanil|remifentanil|mesh-list
138471838|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138471839|NCT01998217|Narcotics|narcotics|mesh-ancestor
138203871|NCT00096122|Cytarabine|cytarabine|mesh-list
138471840|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471841|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471842|NCT01998217|Analgesics|analgesics|mesh-ancestor
138471843|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
138471844|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471845|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138471846|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138471847|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471848|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138471849|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138471850|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471851|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471852|NCT01998295|Lumefantrine|lumefantrine|mesh-list
138471853|NCT01998295|Artemether|artemether|mesh-list
138414486|NCT01653470|Vitamins|vitamins|mesh-ancestor
138471854|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138471855|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
138471856|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138471857|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138471858|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471859|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
138471860|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138471861|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
138471862|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471863|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
138471864|NCT01998308|Protective Agents|protective agents|mesh-ancestor
138471865|NCT01998347|Paclitaxel|paclitaxel|mesh-list
138471866|NCT01998347|Fluorouracil|fluorouracil|mesh-list
138471867|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138471868|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471869|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
138471870|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
138471871|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
138471872|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471873|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
138471874|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138471875|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138471876|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
138471877|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471878|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
138471879|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138471880|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471881|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
138471882|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
138471883|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138471884|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
138471885|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138471887|NCT01998503|Bortezomib|bortezomib|mesh-list
138471888|NCT01998503|Melphalan|melphalan|mesh-list
138471889|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138471890|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
138471891|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
138471892|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471893|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471894|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138471895|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
138471896|NCT01998503|Hormones|hormones|mesh-ancestor
138471897|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138471898|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138471899|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138414594|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
138471901|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138471902|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
138471903|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471904|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138471905|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138471906|NCT01998685|Midazolam|midazolam|mesh-list
138471907|NCT01998685|Fentanyl|fentanyl|mesh-list
138471908|NCT01998685|Remifentanil|remifentanil|mesh-list
138471909|NCT01998685|Propofol|propofol|mesh-list
138471910|NCT01998685|Sevoflurane|sevoflurane|mesh-list
138471911|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138471912|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471913|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471914|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138471915|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
138471916|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
138471917|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138471918|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
138471919|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138387183|NCT01481194|Dexamethasone|dexamethasone|mesh-list
138471920|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138471921|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
138471923|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471924|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471925|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138471926|NCT01998685|Narcotics|narcotics|mesh-ancestor
138471927|NCT01998685|Analgesics|analgesics|mesh-ancestor
138471928|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
138471929|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471930|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138471931|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138471932|NCT01998698|Lidocaine|lidocaine|mesh-list
138471933|NCT01998698|Dipivefrin|dipivefrin|mesh-list
138471934|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
138471935|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138471936|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
138471937|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138471938|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471939|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138414748|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
138471940|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138471941|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
138471942|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
138471943|NCT01998698|Protective Agents|protective agents|mesh-ancestor
138471944|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
138471945|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
138471946|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138471947|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
138471948|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471949|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138471950|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138471951|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138471952|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138471953|NCT01998763|Vitamin D|vitamin d|mesh-list
138471954|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
138471955|NCT01998763|Vitamins|vitamins|mesh-ancestor
138471956|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
138471957|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471958|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138471959|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138471960|NCT01998776|Misoprostol|misoprostol|mesh-list
138414881|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138471961|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138471963|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138471964|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471965|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138471966|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138471967|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
138471968|NCT01998789|Everolimus|everolimus|mesh-list
138471969|NCT01998789|Tacrolimus|tacrolimus|mesh-list
138471970|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138471971|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
138471972|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471973|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138471974|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471975|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471976|NCT01998789|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
138471977|NCT01998789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138471978|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471979|NCT01999153|Ropivacaine|ropivacaine|mesh-list
138471980|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
138471981|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
138471982|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138188306|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
138471983|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471984|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
138471985|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138471986|NCT01999270|Bevacizumab|bevacizumab|mesh-list
138471987|NCT01999270|Irinotecan|irinotecan|mesh-list
138471988|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138414956|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
138471989|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138471990|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138471991|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138471992|NCT01999270|Growth Substances|growth substances|mesh-ancestor
138471993|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138471994|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
138471995|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138471996|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138471997|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138471998|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138471999|NCT01999309|Simvastatin|simvastatin|mesh-list
138472000|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138472001|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138472002|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
138472004|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138472005|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138472006|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472008|NCT01999413|Daunorubicin|daunorubicin|mesh-list
138472009|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138472010|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
138472011|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472012|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472013|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
138472014|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472015|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138472016|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
138472017|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472018|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138472019|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138472020|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138472021|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472022|NCT01999647|Ropivacaine|ropivacaine|mesh-list
138472023|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
138472024|NCT01999647|Anesthetics|anesthetics|mesh-list
138472025|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138472026|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472027|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
138472028|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472029|NCT01999673|Docetaxel|docetaxel|mesh-list
138472030|NCT01999673|Bavituximab|bavituximab|mesh-list
138472031|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138472032|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472033|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
138472034|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
138472035|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
138472036|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472038|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
138472039|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472040|NCT01999686|Metformin|metformin|mesh-list
138472041|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138415118|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138472042|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472043|NCT01999738|Folic Acid|folic acid|mesh-list
138472044|NCT01999738|Hematinics|hematinics|mesh-ancestor
138472045|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
138472046|NCT01999738|Vitamins|vitamins|mesh-ancestor
138472047|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
138472048|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472049|NCT01999829|Caffeine|caffeine|mesh-list
138472050|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472051|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138472052|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472053|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138472054|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472055|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138472056|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138472057|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
138472058|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472059|NCT01999842|Vaccines|vaccines|mesh-list
138472061|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472062|NCT01999907|Vitamin D|vitamin d|mesh-list
138472063|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
138472064|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
138472066|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
138472067|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472068|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138472069|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138472071|NCT01999933|Docetaxel|docetaxel|mesh-list
138472072|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472073|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
138472074|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
138472075|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
138472076|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472077|NCT02000102|Aflibercept|aflibercept|mesh-list
138472078|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138472079|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138472080|NCT02000102|Growth Substances|growth substances|mesh-ancestor
138472081|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472082|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
138472083|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472084|NCT02000193|Fulvestrant|fulvestrant|mesh-list
138387334|NCT01481844|Antacids|antacids|mesh-ancestor
138387338|NCT01481870|Sorafenib|sorafenib|mesh-list
138472087|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138472088|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138472089|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
138472090|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138472091|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472092|NCT02000206|Ketamine|ketamine|mesh-list
138472093|NCT02000206|Alfentanil|alfentanil|mesh-list
138472094|NCT02000206|Propofol|propofol|mesh-list
138472095|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138472096|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138472097|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472098|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138472099|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
138472100|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
138472101|NCT02000206|Analgesics|analgesics|mesh-ancestor
138472102|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
138472103|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472104|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138472105|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138472106|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138415204|NCT01657448|Methylene Blue|methylene blue|mesh-list
138472107|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138203904|NCT00003784|Vincristine|vincristine|mesh-list
138203905|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
138472108|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472109|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138472110|NCT02000206|Narcotics|narcotics|mesh-ancestor
138472111|NCT02000336|Prednisolone|prednisolone|mesh-list
138472112|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472113|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
138472114|NCT02000336|Hormones|hormones|mesh-ancestor
138472115|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138472116|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472117|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138472118|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472119|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
138472120|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138472121|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
138472122|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138387380|NCT01482156|Dactolisib|dactolisib|mesh-list
138472125|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138203914|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138203915|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138472126|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138472127|NCT02000388|Analgesics|analgesics|mesh-ancestor
138472128|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
138472129|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472130|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472131|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472132|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138472133|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138472134|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472135|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472137|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
138472138|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138472139|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138472140|NCT02000401|Analgesics|analgesics|mesh-ancestor
138472141|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
138472142|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472143|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472144|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472145|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138472146|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138472147|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472148|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472149|NCT02000414|Daptomycin|daptomycin|mesh-list
138472150|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138472151|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472152|NCT02000674|Rocuronium|rocuronium|mesh-list
138472153|NCT02000674|Succinylcholine|succinylcholine|mesh-list
138472154|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138472155|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138472156|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138472157|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472158|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415423|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
138472160|NCT02000700|Canagliflozin|canagliflozin|mesh-list
138472161|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138472162|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472163|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138472164|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472165|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
138472167|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138472168|NCT02000726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
138472169|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138472170|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138472171|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472172|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472173|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
138472174|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138415553|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138472175|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138472176|NCT02000765|Gepotidacin|gepotidacin|mesh-list
138472177|NCT02000765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138472178|NCT02000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472179|NCT02000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472180|NCT02000765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472181|NCT02000804|Darapladib|darapladib|mesh-list
138472182|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
138472183|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472184|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472185|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
138472186|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472187|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472188|NCT02000947|Durvalumab|durvalumab|mesh-list
138472189|NCT02000947|Tremelimumab|tremelimumab|mesh-list
138472190|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138472191|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138472192|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472193|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
138472194|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472195|NCT02001012|Chloroquine|chloroquine|mesh-list
138472196|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
138472197|NCT02001012|Lumefantrine|lumefantrine|mesh-list
138472198|NCT02001012|Artemether|artemether|mesh-list
138472199|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
138472200|NCT02001012|Amebicides|amebicides|mesh-ancestor
138472201|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138472202|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138472203|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472204|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
138472205|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138472206|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138472207|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138472208|NCT02001012|Analgesics|analgesics|mesh-ancestor
138472209|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
138472210|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472211|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472212|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472213|NCT02001012|Filaricides|filaricides|mesh-ancestor
138472214|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
138472215|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
138472216|NCT02001103|Memantine|memantine|mesh-list
138472217|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138472218|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138472219|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
138472220|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472221|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472222|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472223|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138472224|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138472225|NCT02001168|Docetaxel|docetaxel|mesh-list
138472226|NCT02001168|Pemetrexed|pemetrexed|mesh-list
138472227|NCT02001168|Cisplatin|cisplatin|mesh-list
138472228|NCT02001168|Endostatins|endostatins|mesh-list
138472229|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472230|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
138472231|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
138472232|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
138472233|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472234|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472235|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138472236|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138472237|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138472238|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138472239|NCT02001168|Growth Substances|growth substances|mesh-ancestor
138472240|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472241|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
138472242|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
138203972|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138203973|NCT00384826|Paclitaxel|paclitaxel|mesh-list
138203974|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138203975|NCT00384826|Carboplatin|carboplatin|mesh-list
138203977|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472243|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472244|NCT02001259|Lidocaine|lidocaine|mesh-list
138472245|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
138472246|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
138472247|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138415770|NCT01660373|Tirofiban|tirofiban|mesh-list
138472248|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472249|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
138472250|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472251|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138472252|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138387456|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
138472253|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138472254|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138472255|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472256|NCT02001272|Paclitaxel|paclitaxel|mesh-list
138472257|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138472258|NCT02001272|Carboplatin|carboplatin|mesh-list
138472259|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138472260|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472261|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
138472262|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
138472263|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
138472264|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472265|NCT02001285|Remifentanil|remifentanil|mesh-list
138472266|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138472267|NCT02001285|Narcotics|narcotics|mesh-ancestor
138472268|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138472269|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472270|NCT02001285|Analgesics|analgesics|mesh-ancestor
138472271|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
138472272|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472273|NCT02001298|Nitroprusside|nitroprusside|mesh-list
138472274|NCT02001298|Remifentanil|remifentanil|mesh-list
138472275|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138472276|NCT02001298|Narcotics|narcotics|mesh-ancestor
138472277|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138472278|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472279|NCT02001298|Analgesics|analgesics|mesh-ancestor
138472280|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
138472281|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472282|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138472283|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
138204000|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138204001|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204002|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138204003|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
138204004|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
138204006|NCT00004066|Gemcitabine|gemcitabine|mesh-list
138472284|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
138472285|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472286|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
138472287|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
138472288|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138472289|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472290|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
138472291|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
138472292|NCT02001363|Liraglutide|liraglutide|mesh-list
138472293|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138472294|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472295|NCT02001363|Incretins|incretins|mesh-ancestor
138472297|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138472298|NCT02001428|Piperaquine|piperaquine|mesh-list
138472299|NCT02001428|Artenimol|artenimol|mesh-list
138472300|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
138472301|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138472302|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138472303|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472304|NCT02001506|Docetaxel|docetaxel|mesh-list
138472305|NCT02001506|Epirubicin|epirubicin|mesh-list
138472306|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472307|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
138472308|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
138472309|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
138472310|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472311|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138472312|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138472313|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138472314|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472315|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
138387531|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472316|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472317|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138472318|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472319|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472321|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138204028|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204029|NCT00004834|Imipramine|imipramine|mesh-list
138204030|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
138204031|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
138204032|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138204033|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
138204044|NCT00004852|Lamivudine|lamivudine|mesh-list
138472322|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472323|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138472324|NCT02001584|Memantine|memantine|mesh-list
138472325|NCT02001584|Baclofen|baclofen|mesh-list
138416069|NCT01662193|Vitamin D|vitamin d|mesh-list
138472326|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
138472327|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
138472328|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
138472329|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472330|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472331|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472332|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138472333|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138472334|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138472335|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138472336|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416136|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
138472338|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
138472340|NCT02001740|Lidocaine|lidocaine|mesh-list
138472341|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
138472342|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
138472343|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138387631|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138472344|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472345|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
138472346|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472347|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138472348|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138472349|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138472350|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138472351|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472352|NCT02001857|Hemostatics|hemostatics|mesh-list
138472353|NCT02001857|Coagulants|coagulants|mesh-ancestor
138472354|NCT02001883|Policosanol|policosanol|mesh-list
138472355|NCT02001883|Atorvastatin|atorvastatin|mesh-list
138472357|NCT02001883|Red yeast rice|red yeast rice|mesh-list
138472358|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138472359|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138387645|NCT01484990|Levodopa|levodopa|mesh-list
138472360|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
138472361|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472362|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138472363|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138472364|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472365|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138472366|NCT02001896|Carboplatin|carboplatin|mesh-list
138472367|NCT02001896|Gemcitabine|gemcitabine|mesh-list
138472368|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138472369|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472370|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138472371|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
138472372|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472373|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138472374|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472375|NCT02001909|Neomycin|neomycin|mesh-list
138472376|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138472377|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472378|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
138416263|NCT01663961|Digoxin|digoxin|mesh-list
138472379|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472380|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472381|NCT02001935|Theophylline|theophylline|mesh-list
138472382|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138472383|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
138387684|NCT01485185|Gabapentin|gabapentin|mesh-list
138472384|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204059|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
138204060|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
138204062|NCT00004858|Genistein|genistein|mesh-list
138472385|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472386|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138472387|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
138472388|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138472389|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472390|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472391|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
138472392|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
138472393|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
138416333|NCT01664650|Hormones|hormones|mesh-ancestor
138472394|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
138472395|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472396|NCT02001948|Morphine|morphine|mesh-list
138472397|NCT02001948|Bupivacaine|bupivacaine|mesh-list
138472398|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
138472399|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
138472400|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138472401|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472402|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
138472403|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472404|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138472405|NCT02001948|Narcotics|narcotics|mesh-ancestor
138472406|NCT02001948|Analgesics|analgesics|mesh-ancestor
138472407|NCT02001974|Paclitaxel|paclitaxel|mesh-list
138472408|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138472409|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472410|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
138472411|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
138472412|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
138472413|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472414|NCT02002000|Vitamin D|vitamin d|mesh-list
138472415|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
138472416|NCT02002000|Vitamins|vitamins|mesh-ancestor
138472417|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
138472418|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138416371|NCT01664845|Ribavirin|ribavirin|mesh-list
138472419|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138472420|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138472421|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
138472422|NCT02002039|Hematinics|hematinics|mesh-ancestor
138472423|NCT02002065|Vaccines|vaccines|mesh-list
138472424|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
138472425|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472426|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138472427|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
138472428|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
138472430|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
138472431|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138472432|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
138472433|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472434|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
138204066|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204067|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472435|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
138472436|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138416422|NCT01665222|Analgesics|analgesics|mesh-ancestor
138472437|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472438|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138472440|NCT02002078|Hormones|hormones|mesh-ancestor
138472441|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138472442|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138472443|NCT02002078|Protective Agents|protective agents|mesh-ancestor
138472444|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138472445|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472446|NCT02002156|Vaccines|vaccines|mesh-list
138472447|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
138472448|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
138472449|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
138472450|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472451|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138472452|NCT02002195|Leucovorin|leucovorin|mesh-list
138472453|NCT02002195|Capecitabine|capecitabine|mesh-list
138472454|NCT02002195|Fluorouracil|fluorouracil|mesh-list
138472455|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
138472456|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138472457|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
138472458|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472459|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472460|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138387853|NCT01485744|Vitamins|vitamins|mesh-ancestor
138387889|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138472461|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
138472462|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472463|NCT02002195|Antidotes|antidotes|mesh-ancestor
138472464|NCT02002195|Protective Agents|protective agents|mesh-ancestor
138472465|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
138472466|NCT02002195|Vitamins|vitamins|mesh-ancestor
138472467|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
138472468|NCT02002247|Selenium|selenium|mesh-list
138472469|NCT02002247|Selenious Acid|selenious acid|mesh-list
138472470|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
138472471|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
138472472|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472473|NCT02002247|Protective Agents|protective agents|mesh-ancestor
138472474|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472475|NCT02002247|Trace Elements|trace elements|mesh-ancestor
138472476|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
138472477|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
138472478|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
138472479|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
138472480|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
138472481|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
138472482|NCT02002260|Estradiol|estradiol|mesh-list
138472483|NCT02002260|Estrogens|estrogens|mesh-ancestor
138472485|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138472486|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472487|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138472488|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138472489|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138472490|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
138472491|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
138472492|NCT02002286|Triptolide|triptolide|mesh-list
138472493|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
138472494|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472495|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
138472496|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
138472497|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138472498|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138472499|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
138472500|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138472501|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
138204087|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472502|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472503|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472504|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
138472505|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
138472506|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
138472507|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472508|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
138472509|NCT02002325|Plasminogen|plasminogen|mesh-list
138472510|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138472511|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138472512|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472513|NCT02002377|Aflibercept|aflibercept|mesh-list
138472514|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138472515|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138472516|NCT02002377|Growth Substances|growth substances|mesh-ancestor
138472517|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472518|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
138472519|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472520|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
138472521|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
138472522|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472523|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138472524|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
138472525|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472527|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138472528|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
138472529|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138472530|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472531|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
138472532|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
138204098|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
138204099|NCT02972866|Hormones|hormones|mesh-ancestor
138204102|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472533|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138472534|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472535|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
138472536|NCT02002598|Dexamethasone|dexamethasone|mesh-list
138472537|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
138472538|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138387984|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
138472540|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472542|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
138472543|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472544|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472545|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138472546|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
138472547|NCT02002598|Hormones|hormones|mesh-ancestor
138472548|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138472549|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138472550|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472551|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
138472552|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472553|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472554|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138472555|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
138472556|NCT02002611|Warfarin|warfarin|mesh-list
138472557|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
138472558|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
138472559|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
138388027|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
138388035|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
138472562|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
138472563|NCT02002663|Morphine|morphine|mesh-list
138472564|NCT02002663|Ropivacaine|ropivacaine|mesh-list
138472565|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
138472566|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
138472567|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138472568|NCT02002663|Narcotics|narcotics|mesh-ancestor
138472569|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138472570|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472571|NCT02002663|Analgesics|analgesics|mesh-ancestor
138472572|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
138472573|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472575|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
138472576|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472577|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
138472578|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
138472579|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138472580|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
138472581|NCT02002663|Hormones|hormones|mesh-ancestor
138472582|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138472583|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
138472584|NCT02002663|Protective Agents|protective agents|mesh-ancestor
138472585|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138472586|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472588|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472589|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138416725|NCT01666769|Micafungin|micafungin|mesh-list
138204140|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472591|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138204141|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472592|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472593|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138472594|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
138472595|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
138472596|NCT02002715|Hormones|hormones|mesh-ancestor
138472597|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138472598|NCT02002741|Acetaminophen|acetaminophen|mesh-list
138472599|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138472600|NCT02002741|Analgesics|analgesics|mesh-ancestor
138472601|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
138472602|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472603|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472604|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
138472605|NCT02002754|Bambuterol|bambuterol|mesh-list
138472606|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
138472607|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
138472608|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472609|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472610|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138472611|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
138472612|NCT02002806|Ethanol|ethanol|mesh-list
138472613|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138472614|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472615|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388132|NCT01487317|Protective Agents|protective agents|mesh-ancestor
138388133|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
138472616|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472618|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138472619|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
138472620|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472621|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472622|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138472623|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138472624|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
138472625|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472626|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472627|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
138472628|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138472629|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138472630|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472632|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472633|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472634|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
138472635|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138472636|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138472637|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138472638|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138472639|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472640|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
138472641|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472642|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472643|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138472644|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472645|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
138388178|NCT01487629|Growth Substances|growth substances|mesh-ancestor
138472646|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138472647|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138472648|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472649|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
138472650|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472651|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472652|NCT02001818|Interferons|interferons|mesh-list
138472653|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
138472655|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
138472656|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
138472657|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472658|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
138472659|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472660|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
138472661|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472662|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138472663|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472664|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472665|NCT02003313|Vaccines|vaccines|mesh-list
138417098|NCT01669447|Ranibizumab|ranibizumab|mesh-list
138472666|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
138388224|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138472667|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472669|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138472670|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472671|NCT02003495|Vaccines|vaccines|mesh-list
138472672|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
138472673|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472674|NCT02003664|Baclofen|baclofen|mesh-list
138472675|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
138472676|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472678|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472679|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
138472680|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
138472681|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
138472682|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472683|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472684|NCT02003677|Insulin|insulin|mesh-list
138472685|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
138472686|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
138472687|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
138472688|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
138472689|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138472690|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472692|NCT02003768|Desflurane|desflurane|mesh-list
138472693|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138472694|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138388277|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
138472695|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472696|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138472697|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
138472698|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
138472699|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138472701|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138472702|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
138472703|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
138472704|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138472705|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472706|NCT02004067|Cyclosporine|cyclosporine|mesh-list
138472707|NCT02004067|Castor Oil|castor oil|mesh-list
138472708|NCT02004067|Cyclosporins|cyclosporins|mesh-list
138472709|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472710|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472711|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138472712|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
138472713|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204169|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138472714|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
138204170|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204171|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
138472715|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472716|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
138472717|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138472718|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138472719|NCT02004067|Cathartics|cathartics|mesh-ancestor
138472721|NCT02004171|Nicotine|nicotine|mesh-list
138472722|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138472723|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
138472724|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472725|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472726|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138472727|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138472728|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
138472729|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472730|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472731|NCT02004184|Pemetrexed|pemetrexed|mesh-list
138472732|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472733|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472734|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472735|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138472736|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138472737|NCT02004197|Amoxicillin|amoxicillin|mesh-list
138472738|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
138472740|NCT02004197|Ranitidine|ranitidine|mesh-list
138472741|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
138417334|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138472742|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138388379|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388386|NCT01489059|Ipilimumab|ipilimumab|mesh-list
138472743|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138204184|NCT00004876|Thalidomide|thalidomide|mesh-list
138204198|NCT00003862|Paclitaxel|paclitaxel|mesh-list
138472744|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472745|NCT02004197|Antacids|antacids|mesh-ancestor
138472746|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138472747|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138472748|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
138472749|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
138472750|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
138472751|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472752|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472753|NCT02004301|Diclofenac|diclofenac|mesh-list
138472754|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138472755|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138472756|NCT02004301|Analgesics|analgesics|mesh-ancestor
138472757|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
138472758|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472759|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472760|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472761|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138472762|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138472763|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472764|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472766|NCT02004314|Amebicides|amebicides|mesh-ancestor
138472767|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138472768|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138472769|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472770|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
138472771|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138472772|NCT02004418|Choline|choline|mesh-list
138472773|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
138472774|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138472775|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
138472776|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472777|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138472778|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138472779|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
138472780|NCT02004509|Anticoagulants|anticoagulants|mesh-list
138472781|NCT02004574|Betamethasone|betamethasone|mesh-list
138472782|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
138472783|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
138472784|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
138472785|NCT02004574|Calcipotriene|calcipotriene|mesh-list
138472786|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
138472787|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472788|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
138472789|NCT02004574|Hormones|hormones|mesh-ancestor
138472790|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138472791|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472792|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
138472793|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
138472794|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
138472795|NCT02004652|Prucalopride|prucalopride|mesh-list
138472796|NCT02004652|Laxatives|laxatives|mesh-ancestor
138472797|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138472798|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
138472799|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
138472800|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
138472801|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138388489|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138472803|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472804|NCT02004769|Docetaxel|docetaxel|mesh-list
138472805|NCT02004769|Capecitabine|capecitabine|mesh-list
138472806|NCT02004769|Trastuzumab|trastuzumab|mesh-list
138472807|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472808|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
138388522|NCT01489644|Repaglinide|repaglinide|mesh-list
138472809|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
138472810|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
138472811|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472812|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138472813|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
138472814|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138472816|NCT02004860|Tacrolimus|tacrolimus|mesh-list
138472817|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138472818|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
138472819|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472820|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
138472821|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472822|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472823|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
138472824|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472825|NCT02004899|Fentanyl|fentanyl|mesh-list
138472826|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138472827|NCT02004899|Narcotics|narcotics|mesh-ancestor
138472828|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138472829|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472830|NCT02004899|Analgesics|analgesics|mesh-ancestor
138472831|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
138472832|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472833|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138388523|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138472834|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138472835|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
138472836|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
138472837|NCT02005068|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
138472838|NCT02005068|Cephalosporins|cephalosporins|mesh-list
138472839|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138472840|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472841|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
138472842|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
138472843|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
138472844|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138417623|NCT05405621|Exatecan|exatecan|mesh-list
138472845|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472846|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138472847|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472848|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138472849|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
138472850|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138472852|NCT02005120|Endostatins|endostatins|mesh-list
138472853|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138472855|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138472856|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138472857|NCT02005120|Growth Substances|growth substances|mesh-ancestor
138472858|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472859|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
138472861|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
138472862|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
138472863|NCT02005302|Vitamins|vitamins|mesh-list
138472864|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
138472865|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472866|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138472867|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138472868|NCT02005315|Paclitaxel|paclitaxel|mesh-list
138472869|NCT02005315|Gemcitabine|gemcitabine|mesh-list
138472870|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138472871|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472872|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
138472873|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
138472874|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
138472875|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472876|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138472877|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
138472878|NCT02005419|Metformin|metformin|mesh-list
138472879|NCT02005419|Gemcitabine|gemcitabine|mesh-list
138472880|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138472881|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
138204235|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138472882|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472883|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472884|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138472885|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472886|NCT02005523|RNS60|rns60|mesh-list
138472887|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138472888|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138472889|NCT02005523|Analgesics|analgesics|mesh-ancestor
138472890|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
138472891|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472892|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472893|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472894|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138472895|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138472896|NCT02005575|Dexamethasone|dexamethasone|mesh-list
138472898|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472899|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
138472900|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
138472901|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472902|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472903|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138472904|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
138472905|NCT02005575|Hormones|hormones|mesh-ancestor
138472906|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138472907|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138472908|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472909|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
138472910|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
138472911|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138472912|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
138472913|NCT02005588|Iron|iron|mesh-list
138472914|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
138472915|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
138472916|NCT02005588|Trace Elements|trace elements|mesh-ancestor
138472917|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
138472918|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472919|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
138472920|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
138472921|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472922|NCT02005653|Doxycycline|doxycycline|mesh-list
138472923|NCT02005653|Albendazole|albendazole|mesh-list
138472924|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
138472925|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138472926|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472928|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138472929|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138472930|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
138472931|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
138472932|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
138472933|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
138472934|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
138472935|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
138472936|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472937|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472938|NCT02005653|Filaricides|filaricides|mesh-ancestor
138472939|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
138472940|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
138472941|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138204252|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138204254|NCT00004102|Fluorouracil|fluorouracil|mesh-list
138472942|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
138472943|NCT02005718|Vitamin D|vitamin d|mesh-list
138472944|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138472945|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472946|NCT02005718|Vitamins|vitamins|mesh-ancestor
138472947|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
138472948|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138472949|NCT02005757|Mizoribine|mizoribine|mesh-list
138388697|NCT01490255|Amlodipine|amlodipine|mesh-list
138388698|NCT01490255|Ranolazine|ranolazine|mesh-list
138472950|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138472951|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138472953|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
138472954|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138472955|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472956|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138472957|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138472958|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138472959|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138472960|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138472961|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472962|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
138472963|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
138472964|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
138472965|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472966|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472967|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138472968|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
138472969|NCT02005770|Propofol|propofol|mesh-list
138472971|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138472972|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138472973|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472975|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
138472977|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138472978|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
138472979|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
138472980|NCT02005783|Docetaxel|docetaxel|mesh-list
138472981|NCT02005783|Epirubicin|epirubicin|mesh-list
138472982|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138472983|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
138472984|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138472985|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138472986|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138472987|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
138472988|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138472989|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138472990|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138472991|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
138417837|NCT03512964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138472992|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
138472993|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
138472994|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138472995|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138472996|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138472997|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138472998|NCT02005822|Valganciclovir|valganciclovir|mesh-list
138204268|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
138472999|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
138204271|NCT00003880|Paclitaxel|paclitaxel|mesh-list
138473000|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473001|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
138473002|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
138473003|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
138473004|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138388803|NCT01490762|Insulin|insulin|mesh-list
138473005|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473006|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
138473007|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138473008|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
138473009|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473010|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138473011|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473012|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473013|NCT02006173|Lidocaine|lidocaine|mesh-list
138473014|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
138473015|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
138473016|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473017|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138388845|NCT01491009|Remifentanil|remifentanil|mesh-list
138388846|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138473018|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
138473019|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473020|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138473021|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138473022|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138473023|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138473024|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473025|NCT02006225|Plerixafor|plerixafor|mesh-list
138473026|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138473027|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138473028|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
138473029|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473030|NCT02006277|Crizotinib|crizotinib|mesh-list
138473031|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
138473032|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473033|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138473034|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473035|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473036|NCT02006355|Ropivacaine|ropivacaine|mesh-list
138473037|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
138473038|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
138473039|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473040|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473041|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
138473042|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473043|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
138388907|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473045|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138473046|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
138473047|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473048|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473049|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
138473050|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473051|NCT05970900|Imatinib Mesylate|imatinib mesylate|mesh-list
138473052|NCT05970900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473053|NCT05970900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138473054|NCT05970900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473055|NCT05970900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473056|NCT05970822|Azacitidine|azacitidine|mesh-list
138204290|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138204291|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
138473057|NCT05970822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138473058|NCT05970822|Antimetabolites|antimetabolites|mesh-ancestor
138473059|NCT05970822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473060|NCT05970822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418014|NCT02450253|Tadalafil|tadalafil|mesh-list
138473061|NCT05970822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473062|NCT05970705|Trifluridine|trifluridine|mesh-list
138473063|NCT05970705|Antimetabolites|antimetabolites|mesh-ancestor
138473064|NCT05970705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473065|NCT05970705|Antiviral Agents|antiviral agents|mesh-ancestor
138473066|NCT05970705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473067|NCT05970679|Atorvastatin|atorvastatin|mesh-list
138473069|NCT05970679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
138473070|NCT05970679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138473071|NCT05970679|Antimetabolites|antimetabolites|mesh-ancestor
138473072|NCT05970679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473073|NCT05970679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138473074|NCT05970679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
138473075|NCT05970679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473077|NCT05970627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473078|NCT05970536|Acetic Acid|acetic acid|mesh-list
138418043|NCT05838105|Hormones|hormones|mesh-ancestor
138473079|NCT05970536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138473080|NCT05970536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473081|NCT05970302|Bevacizumab|bevacizumab|mesh-list
138473082|NCT05970302|Tislelizumab|tislelizumab|mesh-list
138473083|NCT05970302|Capecitabine|capecitabine|mesh-list
138473084|NCT05970302|Oxaliplatin|oxaliplatin|mesh-list
138473085|NCT05970302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138473086|NCT05970302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473087|NCT05970302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138473088|NCT05970302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138418105|NCT05835726|Daratumumab|daratumumab|mesh-list
138473089|NCT05970302|Growth Substances|growth substances|mesh-ancestor
138473090|NCT05970302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473091|NCT05970302|Growth Inhibitors|growth inhibitors|mesh-ancestor
138473092|NCT05970302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138473093|NCT05970302|Antimetabolites|antimetabolites|mesh-ancestor
138473094|NCT05970302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473095|NCT05970250|Vitamin D|vitamin d|mesh-list
138473096|NCT05970250|Calcium|calcium|mesh-list
138473097|NCT05970250|Vitamins|vitamins|mesh-ancestor
138473100|NCT05970250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138473101|NCT05970250|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
138473102|NCT05969990|Tryptophan|tryptophan|mesh-list
138473103|NCT05969990|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
138473104|NCT05969990|Antidepressive Agents|antidepressive agents|mesh-ancestor
138473105|NCT05969990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138473106|NCT05969899|Bevacizumab|bevacizumab|mesh-list
138473107|NCT05969899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138473108|NCT05969899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473109|NCT05969899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138473110|NCT05969899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138473111|NCT05969899|Growth Substances|growth substances|mesh-ancestor
138473112|NCT05969899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473113|NCT05969899|Growth Inhibitors|growth inhibitors|mesh-ancestor
138473114|NCT05969847|Capecitabine|capecitabine|mesh-list
138473116|NCT05969847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138473117|NCT05969847|Antimetabolites|antimetabolites|mesh-ancestor
138473118|NCT05969847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389063|NCT01492712|Propofol|propofol|mesh-list
138418177|NCT05772156|Methylergonovine|methylergonovine|mesh-list
138473120|NCT05969834|Triptorelin Pamoate|triptorelin pamoate|mesh-list
138473121|NCT05969834|Luteolytic Agents|luteolytic agents|mesh-ancestor
138473122|NCT05969834|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
138473123|NCT05969834|Contraceptive Agents|contraceptive agents|mesh-ancestor
138473124|NCT05969834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138473125|NCT05969834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473126|NCT05969834|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
138473127|NCT05969834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138473128|NCT05969834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473129|NCT05969743|Letermovir|letermovir|mesh-list
138473130|NCT05969743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
138473131|NCT05969743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473132|NCT05969743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473133|NCT05969743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473134|NCT05969743|Antiviral Agents|antiviral agents|mesh-ancestor
138473135|NCT05969743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473136|NCT05969561|Analgesics|analgesics|mesh-list
138473137|NCT05969561|Sensory System Agents|sensory system agents|mesh-ancestor
138473138|NCT05969561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473139|NCT05969561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473140|NCT05969522|Cyclophosphamide|cyclophosphamide|mesh-list
138473141|NCT05969522|Glucocorticoids|glucocorticoids|mesh-list
138473142|NCT05969522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138473143|NCT05969522|Immunologic Factors|immunologic factors|mesh-ancestor
138473144|NCT05969522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473145|NCT05969522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138473146|NCT05969522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138389103|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
138473148|NCT05969522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473149|NCT05969522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473150|NCT05969522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138473151|NCT05969522|Hormones|hormones|mesh-ancestor
138418210|NCT05597254|Vitamin B Complex|vitamin b complex|mesh-ancestor
138473152|NCT05969522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473154|NCT05969457|Anesthetics, Local|anesthetics, local|mesh-ancestor
138473155|NCT05969457|Anesthetics|anesthetics|mesh-ancestor
138473156|NCT05969457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473157|NCT05969457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473158|NCT05969457|Sensory System Agents|sensory system agents|mesh-ancestor
138473159|NCT05969457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473160|NCT05969392|Ethanol|ethanol|mesh-list
138473161|NCT05969392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138473162|NCT05969392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473163|NCT05969392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473164|NCT05969392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473165|NCT05969184|Trastuzumab|trastuzumab|mesh-list
138473166|NCT05969184|Pertuzumab|pertuzumab|mesh-list
138473167|NCT05969184|Letrozole|letrozole|mesh-list
138473168|NCT05969184|Exemestane|exemestane|mesh-list
138473169|NCT05969184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138473170|NCT05969184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138418255|NCT05312242|Folic Acid|folic acid|mesh-list
138473171|NCT05969184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
138473172|NCT05969184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
138473173|NCT05969184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473174|NCT05969184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473175|NCT05969184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138473176|NCT05969184|Hormone Antagonists|hormone antagonists|mesh-ancestor
138473177|NCT05969184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473178|NCT05969184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473179|NCT05969171|Gemcitabine|gemcitabine|mesh-list
138473180|NCT05969171|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
138473181|NCT05969171|Paclitaxel|paclitaxel|mesh-list
138473182|NCT05969171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138473183|NCT05969171|Antimetabolites|antimetabolites|mesh-ancestor
138473184|NCT05969171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473185|NCT05969171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473186|NCT05969171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138473187|NCT05969171|Tubulin Modulators|tubulin modulators|mesh-ancestor
138473188|NCT05969171|Antimitotic Agents|antimitotic agents|mesh-ancestor
138473189|NCT05969171|Mitosis Modulators|mitosis modulators|mesh-ancestor
138389143|NCT01493115|Insulin|insulin|mesh-list
138473191|NCT05969119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
138473192|NCT05969119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473193|NCT05969119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473194|NCT05969119|Cholinergic Agents|cholinergic agents|mesh-ancestor
138473195|NCT05969119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473196|NCT05969119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138204299|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138204300|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138204301|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138473198|NCT05968885|Solifenacin Succinate|solifenacin succinate|mesh-list
138473199|NCT05968885|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
138473200|NCT05968885|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
138473201|NCT05968885|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138473202|NCT05968885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473203|NCT05968885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473204|NCT05968885|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
138473205|NCT05968885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138473206|NCT05968885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473208|NCT05968885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473211|NCT05968885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138473212|NCT05968885|Adrenergic Agents|adrenergic agents|mesh-ancestor
138473213|NCT05968885|Urological Agents|urological agents|mesh-ancestor
138473214|NCT05968885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138473215|NCT05968885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138473216|NCT05968846|Iodine|iodine|mesh-list
138473217|NCT05968846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138473218|NCT05968846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473219|NCT05968846|Trace Elements|trace elements|mesh-ancestor
138473220|NCT05968846|Micronutrients|micronutrients|mesh-ancestor
138473221|NCT05968846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473222|NCT05968651|Oxytocin|oxytocin|mesh-list
138473223|NCT05968651|Oxytocics|oxytocics|mesh-ancestor
138473224|NCT05968651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138473225|NCT05968651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473226|NCT05968482|Diclofenac|diclofenac|mesh-list
138473227|NCT05968482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138204308|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138204309|NCT00004114|Cytarabine|cytarabine|mesh-list
138473228|NCT05968482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138473229|NCT05968482|Analgesics|analgesics|mesh-ancestor
138473230|NCT05968482|Sensory System Agents|sensory system agents|mesh-ancestor
138473231|NCT05968482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473232|NCT05968482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473233|NCT05968482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138473234|NCT05968482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138473235|NCT05968482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138473236|NCT05968482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473237|NCT05968482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473238|NCT05968001|Obinutuzumab|obinutuzumab|mesh-list
138473239|NCT05968001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138473240|NCT05968001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473241|NCT05967936|Bupivacaine|bupivacaine|mesh-list
138473242|NCT05967936|Anesthetics, Local|anesthetics, local|mesh-ancestor
138473243|NCT05967936|Anesthetics|anesthetics|mesh-ancestor
138473244|NCT05967936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473245|NCT05967936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473246|NCT05967936|Sensory System Agents|sensory system agents|mesh-ancestor
138473247|NCT05967936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473248|NCT05967884|Cemiplimab|cemiplimab|mesh-list
138473249|NCT05967884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138473250|NCT05967884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473252|NCT05967650|Immunologic Factors|immunologic factors|mesh-ancestor
138473253|NCT05967650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473254|NCT05967442|Magnesium Sulfate|magnesium sulfate|mesh-list
138473255|NCT05967442|Metoclopramide|metoclopramide|mesh-list
138473256|NCT05967442|Prochlorperazine|prochlorperazine|mesh-list
138473257|NCT05967442|Analgesics|analgesics|mesh-ancestor
138473258|NCT05967442|Sensory System Agents|sensory system agents|mesh-ancestor
138473259|NCT05967442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473260|NCT05967442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473261|NCT05967442|Anesthetics|anesthetics|mesh-ancestor
138473262|NCT05967442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473263|NCT05967442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138473264|NCT05967442|Anticonvulsants|anticonvulsants|mesh-ancestor
138473265|NCT05967442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138473266|NCT05967442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138473267|NCT05967442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473268|NCT05967442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138473269|NCT05967442|Tocolytic Agents|tocolytic agents|mesh-ancestor
138418470|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138473270|NCT05967442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138473271|NCT05967442|Antiemetics|antiemetics|mesh-ancestor
138473272|NCT05967442|Autonomic Agents|autonomic agents|mesh-ancestor
138473273|NCT05967442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138473274|NCT05967442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
138389284|NCT01494155|Capecitabine|capecitabine|mesh-list
138473275|NCT05967442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
138473276|NCT05967442|Dopamine Agents|dopamine agents|mesh-ancestor
138473277|NCT05967442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473278|NCT05967442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
138473279|NCT05967442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138473280|NCT05967442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138473281|NCT05967377|Leucovorin|leucovorin|mesh-list
138473282|NCT05967377|Sorafenib|sorafenib|mesh-list
138473283|NCT05967377|Fluorouracil|fluorouracil|mesh-list
138473284|NCT05967377|Methotrexate|methotrexate|mesh-list
138473285|NCT05967377|Carboplatin|carboplatin|mesh-list
138473286|NCT05967377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473287|NCT05967377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138473288|NCT05967377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473289|NCT05967377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473290|NCT05967377|Antidotes|antidotes|mesh-ancestor
138473291|NCT05967377|Protective Agents|protective agents|mesh-ancestor
138473292|NCT05967377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473293|NCT05967377|Vitamin B Complex|vitamin b complex|mesh-ancestor
138473294|NCT05967377|Vitamins|vitamins|mesh-ancestor
138204356|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
138473295|NCT05967377|Micronutrients|micronutrients|mesh-ancestor
138473296|NCT05967377|Antimetabolites|antimetabolites|mesh-ancestor
138473297|NCT05967377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138473298|NCT05967377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138473299|NCT05967377|Immunologic Factors|immunologic factors|mesh-ancestor
138473300|NCT05967377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
138473301|NCT05967377|Abortifacient Agents|abortifacient agents|mesh-ancestor
138473302|NCT05967377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138473303|NCT05967377|Dermatologic Agents|dermatologic agents|mesh-ancestor
138473304|NCT05967377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
138473305|NCT05967377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138473306|NCT05967377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138473307|NCT05967156|Empagliflozin|empagliflozin|mesh-list
138473308|NCT05967156|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138473309|NCT05967156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473310|NCT05967156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138473311|NCT05967156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473313|NCT05966818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
138473314|NCT05966818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138473315|NCT05966818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473316|NCT05966818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138473317|NCT05966818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473318|NCT05966818|Protease Inhibitors|protease inhibitors|mesh-ancestor
138473319|NCT05966818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473320|NCT05966792|Metformin|metformin|mesh-list
138473321|NCT05966792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
138473322|NCT05966792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138473323|NCT05966792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389365|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
138473325|NCT05965908|Metformin|metformin|mesh-list
138389414|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
138473326|NCT05965908|Liraglutide|liraglutide|mesh-list
138473327|NCT05965908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138473328|NCT05965908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473329|NCT05965908|Incretins|incretins|mesh-ancestor
138473330|NCT05965908|Hormones|hormones|mesh-ancestor
138473331|NCT05965908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473332|NCT05951387|Dexmedetomidine|dexmedetomidine|mesh-list
138473333|NCT05951387|Ketamine|ketamine|mesh-list
138473334|NCT05951387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138473335|NCT05951387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473336|NCT05951387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473337|NCT05951387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138473338|NCT05951387|Analgesics|analgesics|mesh-ancestor
138473339|NCT05951387|Sensory System Agents|sensory system agents|mesh-ancestor
138473340|NCT05951387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473341|NCT05951387|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138473342|NCT05951387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138473343|NCT05951387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138473344|NCT05951387|Adrenergic Agents|adrenergic agents|mesh-ancestor
138473345|NCT05951387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473346|NCT05951387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473347|NCT05951387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138473348|NCT05951387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138473349|NCT05951387|Anesthetics, General|anesthetics, general|mesh-ancestor
138473350|NCT05951387|Anesthetics|anesthetics|mesh-ancestor
138473351|NCT05951387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138473352|NCT05951387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138473353|NCT05940220|Acetazolamide|acetazolamide|mesh-list
138473354|NCT05940220|Anticonvulsants|anticonvulsants|mesh-ancestor
138473355|NCT05940220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
138473356|NCT05940220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473357|NCT05940220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473358|NCT05940220|Diuretics|diuretics|mesh-ancestor
138473359|NCT05940220|Natriuretic Agents|natriuretic agents|mesh-ancestor
138473360|NCT05940220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473362|NCT05935631|Hematinics|hematinics|mesh-ancestor
138473363|NCT05935631|Vitamin B Complex|vitamin b complex|mesh-ancestor
138473364|NCT05935631|Vitamins|vitamins|mesh-ancestor
138473365|NCT05935631|Micronutrients|micronutrients|mesh-ancestor
138473366|NCT05935631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473367|NCT05934214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138473368|NCT05934214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473369|NCT05934214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138473370|NCT05934214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473371|NCT05928858|Calcium|calcium|mesh-list
138473372|NCT05928858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138473373|NCT05928858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473374|NCT05923476|Lithium Carbonate|lithium carbonate|mesh-list
138389471|NCT01495117|Iodine|iodine|mesh-list
138473375|NCT05923476|Antidepressive Agents|antidepressive agents|mesh-ancestor
138473376|NCT05923476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
138473377|NCT05923476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473378|NCT05923476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473379|NCT05923476|Antimanic Agents|antimanic agents|mesh-ancestor
138473380|NCT05923476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
138473381|NCT05923476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473382|NCT05923476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473383|NCT05878639|Lactulose|lactulose|mesh-list
138473384|NCT05878639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138473385|NCT05876858|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
138473386|NCT05876858|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
138473387|NCT05876858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473388|NCT05871684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
138473389|NCT05871684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473390|NCT05871684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138473391|NCT05871684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473392|NCT05845138|Capecitabine|capecitabine|mesh-list
138473393|NCT05845138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138473394|NCT05845138|Antimetabolites|antimetabolites|mesh-ancestor
138473395|NCT05845138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473396|NCT05845138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473397|NCT05835258|Melatonin|melatonin|mesh-list
138473398|NCT05835258|Capsaicin|capsaicin|mesh-list
138473399|NCT05835258|Antioxidants|antioxidants|mesh-ancestor
138473400|NCT05835258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473401|NCT05835258|Protective Agents|protective agents|mesh-ancestor
138473402|NCT05835258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473403|NCT05835258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473404|NCT05835258|Antipruritics|antipruritics|mesh-ancestor
138418791|NCT06223711|Durvalumab|durvalumab|mesh-list
138473405|NCT05835258|Dermatologic Agents|dermatologic agents|mesh-ancestor
138473406|NCT05835258|Sensory System Agents|sensory system agents|mesh-ancestor
138473407|NCT05835258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473408|NCT05783544|Interferons|interferons|mesh-list
138473409|NCT05783544|Interferon-gamma|interferon-gamma|mesh-list
138473410|NCT05783544|Interleukin-4|interleukin-4|mesh-list
138188307|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473411|NCT05783544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473412|NCT05783544|Antiviral Agents|antiviral agents|mesh-ancestor
138473413|NCT05783544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473414|NCT05783544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
138473415|NCT05783544|Immunologic Factors|immunologic factors|mesh-ancestor
138473416|NCT05783544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473417|NCT05783544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138473419|NCT05760677|Pioglitazone|pioglitazone|mesh-list
138473420|NCT05760677|Orlistat|orlistat|mesh-list
138473421|NCT05760677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138389561|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
138473422|NCT05760677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138389562|NCT01495377|Narcotics|narcotics|mesh-ancestor
138204364|NCT00003892|ISIS 5132|isis 5132|mesh-list
138418819|NCT06223659|Anesthetics|anesthetics|mesh-list
138473423|NCT05760677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473424|NCT05760677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473425|NCT05760677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
138473426|NCT05760677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138473428|NCT05725031|Rocuronium|rocuronium|mesh-list
138473429|NCT05725031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138473430|NCT05725031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138473431|NCT05725031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138473432|NCT05725031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473433|NCT05725031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473434|NCT05725031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
138473435|NCT05725031|Sympathomimetics|sympathomimetics|mesh-ancestor
138473436|NCT05725031|Autonomic Agents|autonomic agents|mesh-ancestor
138473437|NCT05725031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
138473438|NCT05725031|Adrenergic Agents|adrenergic agents|mesh-ancestor
138473439|NCT05725031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473440|NCT05725031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473441|NCT05707754|Bupivacaine|bupivacaine|mesh-list
138473442|NCT05707754|Anesthetics, Local|anesthetics, local|mesh-ancestor
138473443|NCT05707754|Anesthetics|anesthetics|mesh-ancestor
138473444|NCT05707754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473445|NCT05707754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473446|NCT05707754|Sensory System Agents|sensory system agents|mesh-ancestor
138473447|NCT05707754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473449|NCT05699824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
138473450|NCT05699824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
138473451|NCT05699824|Adrenergic Agents|adrenergic agents|mesh-ancestor
138473452|NCT05699824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473453|NCT05699824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473454|NCT05699824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473455|NCT05699824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138473456|NCT05699824|Antioxidants|antioxidants|mesh-ancestor
138473457|NCT05699824|Protective Agents|protective agents|mesh-ancestor
138473458|NCT05699824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138473459|NCT05699824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138473460|NCT05699824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138473461|NCT05699824|Vasodilator Agents|vasodilator agents|mesh-ancestor
138473462|NCT05699824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
138473463|NCT05699824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
138473464|NCT05694637|Varenicline|varenicline|mesh-list
138473465|NCT05694637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138473466|NCT05694637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138473467|NCT05694637|Cholinergic Agents|cholinergic agents|mesh-ancestor
138473468|NCT05694637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473469|NCT05694637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473470|NCT05694637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473471|NCT05687253|Bromides|bromides|mesh-list
138473472|NCT05687253|Rocuronium|rocuronium|mesh-list
138473473|NCT05687253|Anticonvulsants|anticonvulsants|mesh-ancestor
138473474|NCT05687253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
138389657|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
138473475|NCT05687253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
138473476|NCT05687253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
138473477|NCT05687253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138418996|NCT06193889|Immunologic Factors|immunologic factors|mesh-ancestor
138473478|NCT05687253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473479|NCT05683821|Nicotine|nicotine|mesh-list
138473480|NCT05683821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138473481|NCT05683821|Autonomic Agents|autonomic agents|mesh-ancestor
138473482|NCT05683821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473483|NCT05683821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473484|NCT05683821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138473485|NCT05683821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138473486|NCT05683821|Cholinergic Agents|cholinergic agents|mesh-ancestor
138473487|NCT05683821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473488|NCT05683821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473489|NCT05680805|Metformin|metformin|mesh-list
138473490|NCT05680805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138419100|NCT06136559|Acalabrutinib|acalabrutinib|mesh-list
138473491|NCT05680805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473493|NCT05637970|Coagulants|coagulants|mesh-ancestor
138473494|NCT05561543|Peppermint oil|peppermint oil|mesh-list
138473495|NCT05561543|Antiemetics|antiemetics|mesh-ancestor
138473496|NCT05561543|Autonomic Agents|autonomic agents|mesh-ancestor
138473497|NCT05561543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473498|NCT05561543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473499|NCT05561543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138473500|NCT05561543|Parasympatholytics|parasympatholytics|mesh-ancestor
138473501|NCT05555823|Repaglinide|repaglinide|mesh-list
138473502|NCT05555823|Celecoxib|celecoxib|mesh-list
138473503|NCT05555823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
138473504|NCT05555823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138473505|NCT05555823|Analgesics|analgesics|mesh-ancestor
138473506|NCT05555823|Sensory System Agents|sensory system agents|mesh-ancestor
138473507|NCT05555823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473508|NCT05555823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473509|NCT05555823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138473510|NCT05555823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138473511|NCT05555823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
138473512|NCT05555823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
138473513|NCT05555823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473514|NCT05555823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389757|NCT01496742|Pemetrexed|pemetrexed|mesh-list
138473515|NCT05555823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138389759|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473518|NCT05539729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473519|NCT05501886|Fulvestrant|fulvestrant|mesh-list
138473520|NCT05501886|Palbociclib|palbociclib|mesh-list
138473521|NCT05501886|Gedatolisib|gedatolisib|mesh-list
138473522|NCT05501886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138473523|NCT05501886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473524|NCT05501886|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138473525|NCT05501886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138473526|NCT05501886|Hormone Antagonists|hormone antagonists|mesh-ancestor
138473527|NCT05501886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473528|NCT05501886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473529|NCT05501886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138473530|NCT05501886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473531|NCT05501886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473533|NCT05493371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138473534|NCT05493371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473535|NCT05493371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138473536|NCT05493371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473537|NCT05490680|Sildenafil Citrate|sildenafil citrate|mesh-list
138473538|NCT05490680|Vasodilator Agents|vasodilator agents|mesh-ancestor
138473539|NCT05490680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
138473540|NCT05490680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
138473541|NCT05490680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473542|NCT05490680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473543|NCT05490680|Urological Agents|urological agents|mesh-ancestor
138473544|NCT05488366|Pembrolizumab|pembrolizumab|mesh-list
138473545|NCT05488366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138473546|NCT05488366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473547|NCT05488366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138473548|NCT05488366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473549|NCT05474560|Allopurinol|allopurinol|mesh-list
138473550|NCT05474560|Febuxostat|febuxostat|mesh-list
138473551|NCT05474560|Antimetabolites|antimetabolites|mesh-ancestor
138473552|NCT05474560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138389864|NCT01497431|Trace Elements|trace elements|mesh-ancestor
138473553|NCT05474560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473554|NCT05474560|Gout Suppressants|gout suppressants|mesh-ancestor
138473555|NCT05474560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138473556|NCT05474560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
138473558|NCT05474560|Protective Agents|protective agents|mesh-ancestor
138473559|NCT05474560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473560|NCT05469893|Dexamethasone|dexamethasone|mesh-list
138473562|NCT05469893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138473563|NCT05469893|Antiemetics|antiemetics|mesh-ancestor
138473564|NCT05469893|Autonomic Agents|autonomic agents|mesh-ancestor
138473565|NCT05469893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473566|NCT05469893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473568|NCT05469893|Glucocorticoids|glucocorticoids|mesh-ancestor
138473569|NCT05469893|Hormones|hormones|mesh-ancestor
138473570|NCT05469893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473571|NCT05469893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138473572|NCT05469893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473573|NCT05469893|Immunologic Factors|immunologic factors|mesh-ancestor
138473574|NCT05469893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138473575|NCT05469893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138473576|NCT05469893|Growth Substances|growth substances|mesh-ancestor
138473577|NCT05469893|Growth Inhibitors|growth inhibitors|mesh-ancestor
138473578|NCT05468957|Hemostatics|hemostatics|mesh-list
138389923|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
138473580|NCT05444751|Anesthetics|anesthetics|mesh-list
138473581|NCT05444751|Anesthetics, General|anesthetics, general|mesh-list
138473582|NCT05444751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473583|NCT05444751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473584|NCT05422534|Ubiquinone|ubiquinone|mesh-list
138473585|NCT05422534|Micronutrients|micronutrients|mesh-ancestor
138473586|NCT05422534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473588|NCT05422066|Cyclophosphamide|cyclophosphamide|mesh-list
138473589|NCT05422066|Rituximab|rituximab|mesh-list
138473590|NCT05422066|Doxorubicin|doxorubicin|mesh-list
138473591|NCT05422066|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
138473592|NCT05422066|Vincristine|vincristine|mesh-list
138473593|NCT05422066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138473594|NCT05422066|Immunologic Factors|immunologic factors|mesh-ancestor
138473595|NCT05422066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473596|NCT05422066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138473597|NCT05422066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138473599|NCT05422066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473600|NCT05422066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473601|NCT05422066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138473602|NCT05422066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138473603|NCT05422066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
138473604|NCT05422066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138473605|NCT05422066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138473606|NCT05422066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473607|NCT05422066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138473608|NCT05422066|Glucocorticoids|glucocorticoids|mesh-ancestor
138473609|NCT05422066|Hormones|hormones|mesh-ancestor
138473610|NCT05422066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473611|NCT05422066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138473612|NCT05422066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138390036|NCT01498562|Gefitinib|gefitinib|mesh-list
138473613|NCT05422066|Tubulin Modulators|tubulin modulators|mesh-ancestor
138473614|NCT05422066|Antimitotic Agents|antimitotic agents|mesh-ancestor
138473615|NCT05422066|Mitosis Modulators|mitosis modulators|mesh-ancestor
138473616|NCT05419505|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
138473617|NCT05419505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138473618|NCT05419505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473620|NCT05419505|Coagulants|coagulants|mesh-ancestor
138473621|NCT05413343|Ceftazidime|ceftazidime|mesh-list
138473622|NCT05413343|Avibactam|avibactam|mesh-list
138473623|NCT05413343|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
138473625|NCT05413343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473626|NCT05413343|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
138473627|NCT05413343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473628|NCT05413343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473629|NCT05375929|Abrocitinib|abrocitinib|mesh-list
138473630|NCT05375929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138473631|NCT05375929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473632|NCT05375929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473633|NCT05319899|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
138204378|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138204379|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138473634|NCT05319899|Choline|choline|mesh-list
138473635|NCT05319899|Omeprazole|omeprazole|mesh-list
138473636|NCT05319899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
138204380|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
138204381|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
138473637|NCT05319899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138473638|NCT05319899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
138473639|NCT05319899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473640|NCT05319899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473641|NCT05319899|Lipotropic Agents|lipotropic agents|mesh-ancestor
138473642|NCT05319899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138473643|NCT05319899|Antimetabolites|antimetabolites|mesh-ancestor
138473644|NCT05319899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138473646|NCT05319899|Chelating Agents|chelating agents|mesh-ancestor
138473647|NCT05319899|Sequestering Agents|sequestering agents|mesh-ancestor
138473648|NCT05319899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
138473649|NCT05319899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
138473650|NCT05319899|Growth Substances|growth substances|mesh-ancestor
138473651|NCT05319899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473652|NCT05319899|Growth Inhibitors|growth inhibitors|mesh-ancestor
138473653|NCT05319899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473656|NCT05291364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138473657|NCT05291364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473658|NCT05291364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473659|NCT05291364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138473660|NCT05291364|Analgesics|analgesics|mesh-ancestor
138473661|NCT05291364|Sensory System Agents|sensory system agents|mesh-ancestor
138473662|NCT05291364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473663|NCT05291364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138473664|NCT05291364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138473665|NCT05291364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138473666|NCT05291364|Adrenergic Agents|adrenergic agents|mesh-ancestor
138473667|NCT05291364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473668|NCT05291364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473669|NCT05291364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
138473670|NCT05291364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473671|NCT05291221|Lidocaine|lidocaine|mesh-list
138473672|NCT05291221|Dexmedetomidine|dexmedetomidine|mesh-list
138473673|NCT05291221|Anesthetics, Local|anesthetics, local|mesh-ancestor
138473674|NCT05291221|Anesthetics|anesthetics|mesh-ancestor
138473675|NCT05291221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473676|NCT05291221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138420309|NCT05298423|Paclitaxel|paclitaxel|mesh-list
138473677|NCT05291221|Sensory System Agents|sensory system agents|mesh-ancestor
138473678|NCT05291221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473679|NCT05291221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
138473680|NCT05291221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
138473681|NCT05291221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
138473682|NCT05291221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138473683|NCT05291221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473685|NCT05291221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138473686|NCT05291221|Analgesics|analgesics|mesh-ancestor
138473687|NCT05291221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138473688|NCT05291221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138473689|NCT05291221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138473690|NCT05291221|Adrenergic Agents|adrenergic agents|mesh-ancestor
138473691|NCT05291221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138390255|NCT01499875|Penicillin V|penicillin v|mesh-list
138473693|NCT05280132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
138473698|NCT05274269|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
138473699|NCT05274269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138473700|NCT05274269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473702|NCT05268614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473703|NCT05266924|Hormones|hormones|mesh-list
138473704|NCT05266924|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
138473705|NCT05266924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473706|NCT05266924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473707|NCT05266196|Cyclophosphamide|cyclophosphamide|mesh-list
138473708|NCT05266196|Topotecan|topotecan|mesh-list
138204391|NCT05776940|BB 1101|bb 1101|mesh-list
138473709|NCT05266196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138473710|NCT05266196|Immunologic Factors|immunologic factors|mesh-ancestor
138473711|NCT05266196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473712|NCT05266196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138473713|NCT05266196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
138473714|NCT05266196|Alkylating Agents|alkylating agents|mesh-ancestor
138390317|NCT01500408|Interferon-beta|interferon-beta|mesh-list
138390318|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
138473715|NCT05266196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473716|NCT05266196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473717|NCT05266196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138473718|NCT05266196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
138473719|NCT05266196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
138473720|NCT05266196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473722|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
138473723|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473724|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138473725|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473726|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
138473727|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473728|NCT05190562|Astringents|astringents|mesh-ancestor
138473729|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
138473730|NCT05184101|Heparin|heparin|mesh-list
138473731|NCT05184101|Calcium heparin|calcium heparin|mesh-list
138473733|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
138473734|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
138473735|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473736|NCT05152472|Atezolizumab|atezolizumab|mesh-list
138473737|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
138473738|NCT05152472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
138473739|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473740|NCT05152472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
138473741|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473742|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
138473743|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473749|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
138473750|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
138473752|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
138473753|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
138473754|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473755|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473757|NCT05076942|Cisplatin|cisplatin|mesh-list
138473758|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473759|NCT05022147|Dopamine|dopamine|mesh-list
138473760|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
138473761|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138473762|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
138473763|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
138473764|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473765|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473766|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
138473767|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473768|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473769|NCT05022147|Protective Agents|protective agents|mesh-ancestor
138473770|NCT05010538|Sarecycline|sarecycline|mesh-list
138473771|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
138473772|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473773|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
138473774|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
138473775|NCT05005299|Fludarabine|fludarabine|mesh-list
138473776|NCT05005299|Venetoclax|venetoclax|mesh-list
138473777|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138473778|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
138473779|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473780|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
138390495|NCT01501136|Gemcitabine|gemcitabine|mesh-list
138390496|NCT01501136|Etoposide|etoposide|mesh-list
138204408|NCT05776407|Cyclophosphamide|cyclophosphamide|mesh-list
138473782|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
138473783|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473784|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473785|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
138473786|NCT04999449|Scopolamine|scopolamine|mesh-list
138473787|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
138473788|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
138473789|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
138473790|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
138473791|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473792|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473793|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
138473794|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
138473795|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
138473796|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
138473797|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473798|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473799|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
138473800|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
138473801|NCT04971187|Cisplatin|cisplatin|mesh-list
138473802|NCT04971187|Carboplatin|carboplatin|mesh-list
138473803|NCT04971187|Pemetrexed|pemetrexed|mesh-list
138473804|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473806|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473808|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138390548|NCT01501214|Atosiban|atosiban|mesh-list
138473810|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
138473811|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
138473812|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473813|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
138473814|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
138473815|NCT04929080|Antibodies|antibodies|mesh-list
138473816|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
138473817|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
138473818|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
138473819|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
138473820|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473821|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473823|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
138473824|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
138473825|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473826|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473827|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
138473828|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473829|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
138473830|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
138473831|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473832|NCT04914195|Leuprolide|leuprolide|mesh-list
138473833|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
138473834|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
138473835|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
138473836|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473837|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138390589|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
138473839|NCT04901299|Fulvestrant|fulvestrant|mesh-list
138473840|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
138421103|NCT03939637|Antibodies|antibodies|mesh-list
138473841|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473842|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
138473843|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
138473844|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
138473845|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473846|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473847|NCT04898075|Nicotine|nicotine|mesh-list
138473848|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
138473849|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
138473850|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473851|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473852|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
138473853|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
138473854|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
138473855|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473856|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473857|NCT04893655|Dobutamine|dobutamine|mesh-list
138473858|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
138473859|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
138473860|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
138473861|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473862|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473863|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
138473865|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138473866|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
138473867|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473868|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138390635|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
138473869|NCT04893655|Protective Agents|protective agents|mesh-ancestor
138473870|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
138473872|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473874|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
138473875|NCT04841343|Triamcinolone|triamcinolone|mesh-list
138473876|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
138473877|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
138473878|NCT04841343|Hormones|hormones|mesh-ancestor
138473879|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473880|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473881|NCT04840342|Amlodipine|amlodipine|mesh-list
138473882|NCT04840342|Eplerenone|eplerenone|mesh-list
138473883|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
138473884|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
138473885|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
138421249|NCT03593473|Oxytocin|oxytocin|mesh-list
138473886|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473887|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
138473888|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473889|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
138473890|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
138473891|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
138473892|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473893|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
138473894|NCT04840342|Diuretics|diuretics|mesh-ancestor
138473895|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
138473896|NCT04839627|Progesterone|progesterone|mesh-list
138473897|NCT04839627|Progestins|progestins|mesh-ancestor
138473898|NCT04839627|Hormones|hormones|mesh-ancestor
138473899|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
138473900|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473901|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
138473902|NCT04816162|Ketamine|ketamine|mesh-list
138473903|NCT04816162|Propofol|propofol|mesh-list
138473904|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
138473905|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
138473906|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
138473907|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
138473908|NCT04816162|Analgesics|analgesics|mesh-ancestor
138390676|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
138390677|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
138473909|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
138473910|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
138473911|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
138473912|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
138473913|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
138473914|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
138473915|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
138473916|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473917|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
138473918|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
138473920|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
138473921|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
138350228|NCT06083961|Protease Inhibitors|protease inhibitors|mesh-ancestor
138473922|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
138473923|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
138473924|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
138473925|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
138473926|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138473927|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473928|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138473929|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
138473930|NCT04792580|Lifitegrast|lifitegrast|mesh-list
138473931|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
138473932|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
138473933|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
138473934|NCT04742491|Emtricitabine|emtricitabine|mesh-list
138473935|NCT04742491|Tenofovir|tenofovir|mesh-list
138473936|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
138473937|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
138473938|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
138390707|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
138473939|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
138473940|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
138473941|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
138473942|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
138473943|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
138473944|NCT04741945|Metformin|metformin|mesh-list
138473945|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
138473946|NCT04741945|Physiological E